<SEC-DOCUMENT>0001736035-24-000006.txt : 20240228
<SEC-HEADER>0001736035-24-000006.hdr.sgml : 20240228
<ACCEPTANCE-DATETIME>20240228064655
ACCESSION NUMBER:		0001736035-24-000006
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		101
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240228
DATE AS OF CHANGE:		20240228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Blackstone Secured Lending Fund
		CENTRAL INDEX KEY:			0001736035
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	814-01299
		FILM NUMBER:		24690096

	BUSINESS ADDRESS:	
		STREET 1:		345 PARK AVENUE
		STREET 2:		31ST FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10154
		BUSINESS PHONE:		212-503-2100

	MAIL ADDRESS:	
		STREET 1:		345 PARK AVENUE
		STREET 2:		31ST FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10154

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Blackstone / GSO Secured Lending Fund
		DATE OF NAME CHANGE:	20180329
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>bxsl-20231231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:bxsl="http://www.bxsl.com/20231231" xmlns="http://www.w3.org/1999/xhtml" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bxsl-20231231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-32">0001736035</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-33">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-34">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-35">FALSE</ix:nonNumeric><ix:nonFraction unitRef="shares" contextRef="c-6" xsi:nil="true" name="us-gaap:CommonStockSharesAuthorized" id="f-265"></ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-5" xsi:nil="true" name="us-gaap:CommonStockSharesAuthorized" id="f-266"></ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bxsl-20231231.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-02-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">bxsl:DelayedDrawTermLoansAndRevolversMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AbilityToAchieveInvestmentObjectivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayHaveDifficultySourcingInvestmentOpportunitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheImpactOfFinancialReformLegislationOnUsIsUncertainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayExperienceFluctuationsInOurQuarterlyResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ForceMajeureEventsMayAdverselyAffectOurOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeGenerallyDoNotControlOurPortfolioCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAreSubjectToRisksRelatedToESGInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurPortfolioCompaniesMayBeHighlyLeveragedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayNotRealizeGainsFromOurEquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayEnterIntoSecuritiesLendingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayInvestThroughVariousJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayDefaultUnderOurCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:NoShareholderApprovalIsRequiredForCertainMergersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:InvestingInOurSharesInvolvesAHighDegreeOfRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheNAVOfOurSharesMayFluctuateSignificantlyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Corfin Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Corfin Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Frontgrade Technologies Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Linquest Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MAG DS Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Magneto Components BuyCo, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Maverick Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>TCFI AEVEX, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AerospaceAndDefenseSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AGI-CFI Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AGI-CFI Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ENV Bidco AB 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ENV Bidco AB 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Livingston International, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mode Purchaser, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mode Purchaser, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Redwood Services Group, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RoadOne Inc</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RWL Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC 4</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AirFreightLogisticsSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Fencing Supply Group Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jacuzzi Brands, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jacuzzi Brands, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>L&amp;S Mechanical Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Lindstrom, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Windows Acquisition Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:BuildingProductsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Formulations Parent Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bazaarvoice, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bazaarvoice, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CFS Brands, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>FusionSite Midco, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>FusionSite Midco, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Iris Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Java Buyer, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Java Buyer, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>JSS Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>JSS Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Knowledge Pro Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>KPSKY Acquisition, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>KPSKY Acquisition, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Onex Baltimore Buyer, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Onex Baltimore Buyer, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Veregy Consolidated, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:CommercialServicesSuppliesSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ASP Endeavor Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>COP Home Services TopCo IV, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ConstructionEngineeringSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ContainerAndPackagingSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BP Purchaser, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BradyIFS Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BradyIFS Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bution Holdco 2, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Dana Kepner Company, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Genuine Cable Group, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NDC Acquisition Corp. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NDC Acquisition Corp. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tailwind Colony Holding Corporation 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tailwind Colony Holding Corporation 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Unified Door &amp; Hardware Group, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DistributorsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BPPH2 Limited</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cambium Learning Group, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Endeavor Schools Holdings LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Endeavor Schools Holdings LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Go Car Wash Management Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Groundworks, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ConsumerSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Barbri Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>More Cowbell II, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>More Cowbell II, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SelectQuote, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:FinancialServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Acquisition, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Acquisition, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DiversifiedTelecommunicationServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Qualus Power Services Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Qualus Power Services Corp. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricUtilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Emergency Power Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Shoals Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricalEquipmentSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Albireo Energy, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Albireo Energy, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Albireo Energy, LLC 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CPI Intermediate Holdings Inc</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Phoenix 1 Buyer Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectronicEquipmentInstrumentsComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Abaco Energy Technologies, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ISQ Hawkeye Holdco, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tetra Technologies, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:EnergySectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Quality Distribution LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Quality Distribution LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:GroundTransportationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bamboo US BidCo LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bamboo US BidCo LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CPI Buyer, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GCX Corporation Buyer, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GCX Corporation Buyer, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareEquipmentSuppliesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>123Dentist, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ADCS Clinics Intermediate Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ADCS Clinics Intermediate Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerivet Partners Management, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerivet Partners Management, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CCBlue Bidco, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>DCA Investment Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>DCA Investment Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Epoch Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Kwol Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Navigator Acquiror, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Odyssey Holding Company, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Odyssey Holding Company, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>PPV Intermediate Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Smile Doctors, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Snoopy Bidco, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Stepping Stones Healthcare Services, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The GI Alliance Management, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>UMP Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>UMP Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Unified Physician Management, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>WHCG Purchaser III, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>WHCG Purchaser III, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Color Intermediate LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Edifecs, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Edifecs, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Healthcomp Holding Company, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Neptune Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NMC Crimson Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NMC Crimson Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Project Ruby Ultimate Parent Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RPBLS Midco, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RPBLS Midco, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Alera Group, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CFCo LLC (Benefytt Technologies, Inc.)</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Daylight Beta Parent LLC (Benefytt Technologies, Inc.)</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Foundation Risk Partners Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Galway Borrower, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC 5</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>PGIS Intermediate Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>PGIS Intermediate Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SG Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Shelf Bidco Ltd</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 4</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>World Insurance Associates, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:InsuranceSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Donuts, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AI Altius Bidco, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AI Altius Bidco, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Infostretch Corporation</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Inovalon Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing, S.A.R.L 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sek"><xbrli:measure>iso4217:SEK</xbrli:measure></xbrli:unit><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing, S.A.R.L 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing, S.A.R.L 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing, S.A.R.L 4</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="dkk"><xbrli:measure>iso4217:DKK</xbrli:measure></xbrli:unit><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing, S.A.R.L 5</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="nok"><xbrli:measure>iso4217:NOK</xbrli:measure></xbrli:unit><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Razor Holdco, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Red River Technology, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>S&amp;P Global Engineering Solutions</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc. 4</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ITServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MHE Intermediate Holdings 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MHE Intermediate Holdings 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Armada Parent, Inc. </us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trader Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Eagle Midstream Canada Finance, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>KKR Alberta Midstream Finance Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:OilGasConsumableFuelsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PaperForestProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Doc Generici (Diocle S.p.A.)</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Ergomed Plc</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PharmaceuticalsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ALKU, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Apex Companies, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CFGI Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Clearview Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Guidehouse, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>IG Investments Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Kaufman Hall &amp; Associates, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Legacy Intermediate, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Material Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Minotaur Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Pavion Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Petrus Buyer Inc</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sherlock Buyer Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Thevelia US, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Titan Investment Company, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trinity Partners Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>West Monroe Partners, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>West Monroe Partners, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ProfessionalServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Castle Management Borrower, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:RealEstateManagementDevelopmentSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Anaplan, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Beeline, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc.  3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bluefin Holding, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Brave Parent Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Circana Group, L.P. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Circana Group, L.P. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Circana Group, L.P.  2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Circana Group, L.P. 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Community Brands ParentCo, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Confine Visual Bidco</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Confine Visual Bidco </us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Connatix Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Coupa Software Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Crewline Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Denali Bidco Ltd 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Denali Bidco Ltd 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Diligent Corporation</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Discovery Education, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Discovery Education, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Episerver, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Experity, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GI Consilio Parent, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Gigamon Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GovernmentJobs.com, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC 4</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>LD Lower Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Lightbox Intermediate, LP</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Magnesium BorrowerCo, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Magnesium BorrowerCo, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Medallia, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Medallia, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monk Holding Co. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monk Holding Co. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NAVEX TopCo, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Nintex Topco Limited</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Oranje Holdco Inc</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Relativity ODA, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Spitfire Parent, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Spitfire Parent, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Stamps.com, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Triple Lift, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Triple Lift, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>WPEngine, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc </us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SoftwareSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CustomInk, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Lytx, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Porcelain Acquisition Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Capstone Logistics, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Frontline Road Safety, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Frontline Road Safety, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Helix TS, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Helix TS, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Italian Motorway Holdings S.&#224;.r.l</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Roadsafe Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Roadsafe Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Roadsafe Holdings, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Safety Borrower Holdings LP 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Safety Borrower Holdings LP 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>TRP Infrastructure Services, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TransportationInfrastructureSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-492"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd. 4</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Buyer, LLC 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Victory Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Inovalon Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Thevelia US, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc. 4</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-499"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Healthcomp Holding Company, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Micross Topco, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AGI Group Holdings LP - A2 Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mode Holdings, L.P. - Class A-2 Common Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AirFreightLogisticsSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GTCR Investors LP - A-1 Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Box Co-Invest Blocker, LLC - Class A Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Box Co-Invest Blocker, LLC - Class C Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>EIS Acquisition Holdings, LP - Class A Common Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DistributorsSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cambium Holdings, LLC - Senior Preferred Interests</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>THL Fund IX Investors (Plymouth II), LP</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class A Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class B Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class Additional A Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class Additional B Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DiversifiedTelecommunicationServicesSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GCX Corporation Group Holdings, L.P. - Class A-2 Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AVE Holdings I Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Holdings, LP - A-1 Common Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Holdings, LP - A-2 Common Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus Midco 2 S.&#192;. R.L - Additional Vehicle Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus Midco 2 S.&#192;. R.L - Vehicle Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Healthcomp Holding Company, LLC - Preferred Interest</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CFCo LLC (Benefytt Technologies, Inc.) - Class B Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Shelf Holdco Ltd Common Equity</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:InsuranceSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NC Ocala Co-Invest Beta, L.P. - LP Interest</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-532"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>OHCP V TC COI, LP. - LP Interest</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-533"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tricor Horizon, LP</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-534"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ProfessionalServicesSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-535"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Connatix Parent, LLC - Class L Common Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Descartes Holdings, Inc</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-537"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Expedition Holdco, LLC - Class A Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-538"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Expedition Holdco, LLC - Class B Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Lobos Parent, Inc. - Series A Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Holdings, Inc. - Series A Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-541"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mimecast Limited</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>TPG IX Newark CI, L.P. - LP Interests</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-543"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Zoro Common Equity</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Zoro Series A Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-545"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SoftwareSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-546"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CustomInk, LLC - Series A Preferred Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Frontline Road Safety Investments, LLC - Class A Common Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Ncp Helix Holdings, LLC. - Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TransportationInfrastructureSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-550"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD) </us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-552"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-553"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-554"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:InvestmentPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-555"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>State Street Institutional U.S. Government Money Market Fund</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-556"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Other Cash and Cash Equivalents</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-557"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-558"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:QualifyingAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-559"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:NonQualifyingAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-560"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>123Dentist, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-561"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-562"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-563"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ADCS Clinics Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-564"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AI Altius Bidco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Alera Group, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-566"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-567"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-568"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-569"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerivet Partners Management, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-570"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Anaplan, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-571"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Apex Companies, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-572"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Armada Parent, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-573"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Armada Parent, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-574"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-575"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bamboo US BidCo LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-576"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bamboo US BidCo LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-577"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bazaarvoice, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-578"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Beeline, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-579"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Beeline, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-580"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-581"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bluefin Holding, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-582"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BradyIFS Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-583"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BradyIFS Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-584"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Brave Parent Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-585"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Brave Parent Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-586"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-587"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-588"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-589"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cambium Learning Group, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-590"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Castle Management Borrower, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-591"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CFGI Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-592"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CFS Brands, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-593"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CFS Brands, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-594"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Circana Group, L.P., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-595"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Clearview Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-596"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Clearview Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-597"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Community Brands ParentCo, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-598"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Community Brands ParentCo, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-599"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Confine Visual Bidco, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-600"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Connatix Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>COP Home Services TopCo IV, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>COP Home Services TopCo IV, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Coupa Software Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Coupa Software Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-605"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CPI Buyer, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CPI Intermediate Holdings Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-607"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Crewline Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Denali Bidco Ltd, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Discovery Education, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Doc Generici (Diocle S.p.A.), Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Emergency Power Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Endeavor Schools Holdings LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ENV Bidco AB, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Episerver, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Ergomed Plc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Experity, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Fencing Supply Group Acquisition, LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-620"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Fencing Supply Group Acquisition, LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Formulations Parent Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Foundation Risk Partners Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Foundation Risk Partners Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-624"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Freya Bidco Limited, Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Freya Bidco Limited, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Freya Bidco Limited, Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Freya Bidco Limited, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Frontgrade Technologies Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Frontline Road Safety, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>FusionSite Midco, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-631"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>FusionSite Midco, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-632"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Galway Borrower, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-633"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GI Consilio Parent, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-634"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-635"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-636"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Gigamon Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-637"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GovernmentJobs.com, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-638"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-639"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Groundworks, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-640"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Groundworks, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-641"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-642"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-643"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-644"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-645"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Icefall Parent Inc, Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-646"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Icefall Parent Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-647"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>IG Investments Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-648"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Inova Pharmaceutical, Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-649"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Inova Pharmaceutical, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-650"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Inovalon Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-651"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-652"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-653"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Iris Buyer, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-654"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Iris Buyer, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-655"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ISQ Hawkeye Holdco, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-656"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ISQ Hawkeye Holdco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-657"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Java Buyer, Inc., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-658"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Java Buyer, Inc., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-659"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Knowledge Pro Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-660"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Knowledge Pro Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-661"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Kwol Acquisition, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-662"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Magnesium BorrowerCo, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-663"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Magneto Components BuyCo, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-664"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Magneto Components BuyCo, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-665"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-666"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-667"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Material Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-668"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mercury Bidco Globe Limited, Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-669"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mercury Bidco Globe Limited, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-670"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MHE Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-671"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monk Holding Co., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-672"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing, S.A.R.L, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-673"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>More Cowbell II, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-674"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>More Cowbell II, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-675"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MPG Parent Holdings LLC, Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-676"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MPG Parent Holdings LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-677"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MPG Parent Holdings LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-678"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Revolver 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-679"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Revolver 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-680"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-681"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Revolver 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-682"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Revolver 4</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-683"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NAVEX TopCo, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-684"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Navigator Acquiror, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-685"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NDC Acquisition Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-686"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Neptune Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-687"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NMC Crimson Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-688"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Onex Baltimore Buyer, Inc., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-689"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Onex Baltimore Buyer, Inc., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-690"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Oranje Holdco Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-691"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Pavion Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-692"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Pavion Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-693"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Petrus Buyer Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-694"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Petrus Buyer Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-695"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>PGIS Intermediate Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-696"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>PGIS Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-697"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Phoenix 1 Buyer Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-698"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>PPV Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-699"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>PPV Intermediate Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-700"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC, Revolver 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC, Revolver 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-703"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-704"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Pye-Barker Fire &amp; Safety LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Quality Distribution LLC, Revolver 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Quality Distribution LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-707"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Quality Distribution LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-708"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Quality Distribution LLC, Revolver 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Qualus Power Services Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-710"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-711"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-712"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Redwood Services Group, LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Redwood Services Group, LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Relativity ODA, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RoadOne Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-716"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RoadOne Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>S&amp;P Global Engineering Solutions, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-718"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Safety Borrower Holdings LP, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-722"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sherlock Buyer Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sherlock Buyer Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Smile Doctors, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Smile Doctors, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Snoopy Bidco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Stepping Stones Healthcare Services, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Stepping Stones Healthcare Services, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-732"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trader Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-733"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-734"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-735"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-736"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trinity Partners Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-737"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Triple Lift, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-738"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-739"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-740"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>UMP Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-741"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Unified Physician Management, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-742"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-743"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-744"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>West Monroe Partners, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-745"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>WHCG Purchaser III, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-746"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>World Insurance Associates, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-747"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>World Insurance Associates, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-748"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>WPEngine, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-749"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-750"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-751"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment One</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-752"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment Two</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-753"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment Three</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-754"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment Four</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-755"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment Five</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-756"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment Six</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-757"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment Seven</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-758"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">bxsl:BlackstoneDonegalHoldingsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-759"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">bxsl:BlackstoneDonegalHoldingsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-760"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">bxsl:BlackstoneDonegalHoldingsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-761"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-762"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-763"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-764"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Corfin Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-765"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Corfin Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-766"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Linquest Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-767"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MAG DS Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-768"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Maverick Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-769"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>TCFI AEVEX, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-770"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AerospaceAndDefenseSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-771"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AGI-CFI Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-772"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ENV Bidco AB 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-773"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ENV Bidco AB 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-774"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Livingston International, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-775"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mode Purchaser, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-776"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mode Purchaser, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-777"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Redwood Services Group, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-778"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RoadOne Inc</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-779"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RWL Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-780"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-781"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-782"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AirFreightLogisticsSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-783"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Fencing Supply Group Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-784"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jacuzzi Brands, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-785"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>L&amp;S Mechanical Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-786"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Lindstrom, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-787"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Windows Acquisition Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-788"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:BuildingProductsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-789"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bazaarvoice, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-790"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Java Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-791"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>JSS Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-792"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>JSS Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-793"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Knowledge Pro Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-794"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>KPSKY Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-795"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Onex Baltimore Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-796"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The Action Environmental Group, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-797"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The Action Environmental Group, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-798"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Veregy Consolidated, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-799"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:CommercialServicesSuppliesSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-800"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ASP Endeavor Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>COP Home Services TopCo IV, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ConstructionEngineeringSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-805"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ContainerAndPackagingSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BP Purchaser, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-807"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bution Holdco 2, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-808"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Dana Kepner Company, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Dana Kepner Company, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Genuine Cable Group, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-814"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NDC Acquisition Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tailwind Colony Holding Corporation</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Unified Door &amp; Hardware Group, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Unified Door &amp; Hardware Group, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Unified Door &amp; Hardware Group, LLC 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DistributorsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-820"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cambium Learning Group, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Dreambox Learning Holding LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Go Car Wash Management Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ConsumerSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Barbri Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-825"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SelectQuote, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-826"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:FinancialServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-827"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-828"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Qualus Power Services Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-829"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Emergency Power Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Relay Purchaser, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Shoals Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-832"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricalEquipmentSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-833"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Albireo Energy, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-834"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CPI Intermediate Holdings Inc</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-835"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectronicEquipmentInstrumentsComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-836"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Abaco Energy Technologies, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-837"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ISQ Hawkeye Holdco, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-838"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tetra Technologies, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-839"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:EnergySectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-840"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CPI Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-841"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GCX Corporation Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-842"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareEquipmentSuppliesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-843"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>123Dentist, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-844"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-845"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ADCS Clinics Intermediate Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-846"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerivet Partners Management, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-847"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-848"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CCBlue Bidco, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-849"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cross Country Healthcare, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-850"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>DCA Investment Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Epoch Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-852"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Healthcomp Holding Company, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-853"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Healthcomp Holding Company, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-854"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-855"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Navigator Acquiror, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-856"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Odyssey Holding Company, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-857"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>PPV Intermediate Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-858"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Smile Doctors, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-859"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Snoopy Bidco, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-860"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-861"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Stepping Stones Healthcare Services, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-862"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-863"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-864"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The GI Alliance Management, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-865"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Unified Physician Management, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-866"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>United Mutual Acquisition Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-867"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-868"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>WHCG Purchaser III, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-869"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-870"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-871"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-872"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Color Intermediate LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-873"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Edifecs, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-874"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Edifecs, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-875"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-876"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NMC Crimson Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-877"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Project Ruby Ultimate Parent Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-878"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RPBLS Midco, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-879"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-880"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Alera Group, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-881"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-882"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Benefytt Technologies, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-883"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Foundation Risk Partners Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-884"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Galway Borrower, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-885"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-886"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-887"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jones Deslauriers Insurance Management, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-888"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>PGIS Intermediate Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-889"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SG Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-890"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Shelf Bidco Ltd</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-891"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-892"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-893"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-894"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 4</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-895"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Westland Insurance Group LTD 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-896"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Westland Insurance Group LTD 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-897"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:InsuranceSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-898"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Donuts, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-899"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AI Altius Bidco, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-900"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AI Altius Bidco, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Infostretch Corporation</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Inovalon Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing S.&#224;.r.l 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-904"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing S.&#224;.r.l 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing S.&#224;.r.l 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-906"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing S.&#224;.r.l 4</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-907"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Razor Holdco, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Red River Technology, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-910"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ITServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-912"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MHE Intermediate Holdings 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-913"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MHE Intermediate Holdings 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Armada Parent, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-916"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trader Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Eagle Midstream Canada Finance, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>KKR Alberta Midstream Finance Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:OilGasConsumableFuelsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-920"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-921"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-922"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PaperForestProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Doc Generici (Diocle S.p.A.)</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ALKU, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ALKU, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BPPH2 Limited</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CFGI Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Clearview Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-931"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Guidehouse, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-932"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-933"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>IG Investments Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-934"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Kaufman Hall &amp; Associates, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-935"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Legacy Intermediate, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-936"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Material Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-937"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Minotaur Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-938"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Petrus Buyer Inc</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-939"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sherlock Buyer Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-940"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Thevelia US, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-941"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Titan Investment Company, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-942"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-943"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trinity Partners Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-944"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>West Monroe Partners, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-945"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ProfessionalServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-946"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-947"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-948"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:RealEstateManagementDevelopmentSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-949"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Gruden Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-950"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Anaplan, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-951"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AxiomSL Group, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-952"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-953"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Community Brands ParentCo, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-954"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Confine Visual Bidco</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-955"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Connatix Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-956"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Diligent Corporation</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-957"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Discovery Education, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-958"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Episerver, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-959"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Experity, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-960"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Gigamon Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-961"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GovernmentJobs.com, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-962"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-963"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>LD Lower Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-964"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Lightbox Intermediate, LP</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-965"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Magnesium BorrowerCo, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-966"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Magnesium BorrowerCo, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-967"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-968"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Medallia, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-969"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monk Holding Co.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-970"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-971"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Nintex Topco Limited</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-972"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Project Boost Purchaser, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-973"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-974"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Relativity ODA, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-975"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Spitfire Parent, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-976"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Spitfire Parent, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-977"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Spitfire Parent, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-978"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Stamps.com, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-979"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The NPD Group L.P. 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-980"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The NPD Group L.P. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-981"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Triple Lift, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-982"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-983"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SoftwareSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-984"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CustomInk, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-985"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Lytx, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-986"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Porcelain Acquisition Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-987"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The Cook &amp; Boardman Group, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-988"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TradingCompaniesDistributorsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-989"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Capstone Logistics, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-990"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Frontline Road Safety, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-991"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Helix TS, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-992"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Italian Motorway Holdings S.&#224;.r.l</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-993"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Roadsafe Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-994"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Safety Borrower Holdings LP</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-995"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-996"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>TRP Infrastructure Services, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-997"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TransportationInfrastructureSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-998"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-999"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>COP Home Services TopCo IV, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1000"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Buyer, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Victory Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1004"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Inovalon Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1005"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Thevelia US, LLC 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1006"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1007"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Micross Topco, Inc.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1009"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AGI Group Holdings LP - A2 Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1010"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mode Holdings, L.P. - Class A-2 Common Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1011"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AirFreightLogisticsSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1012"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Box Co-Invest Blocker, LLC</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1013"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>EIS Acquisition Holdings, LP - Class A Common Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1014"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DistributorsSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cambium Holdings, LLC - Senior Preferred Interests</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1016"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Deneb Ultimate Topco, LLC - Class A Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1017"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ConsumerSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1018"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class A Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1019"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class B Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class Additional A Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class Additional B Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DiversifiedTelecommunicationServicesSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GCX Corporation Group Holdings, L.P. - Class A-2 Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1024"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AVE Holdings I Corp.</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Holdings, LP - A-1 Common Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Holdings, LP - A-2 Common Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus Midco 2 S.&#192;. R.L - Additional Vehicle Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus Midco 2 S.&#192;. R.L - Vehicle Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Shelf Holdco Ltd Common Equity</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1032"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NC Ocala Co-Invest Beta, L.P. - LP Interest</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1033"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Guidehouse Holding Corp. - Preferred Equity</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1034"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>OHCP V TC COI, LP. - LP Interest</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1035"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Tricor Horizon, LP</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1036"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ProfessionalServicesSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1037"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Connatix Parent, LLC - Class L Common Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1038"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Expedition Holdco, LLC - Class A Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1039"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Expedition Holdco, LLC - Class B Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1040"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Lobos Parent, Inc. - Series A Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1041"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Holdings, Inc. - Series A Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1042"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mimecast Limited</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1043"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Zoro Common Equity</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1044"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Zoro Series A Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1045"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SoftwareSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1046"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CustomInk, LLC - Series A Preferred Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1047"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Frontline Road Safety Investments, LLC - Class A Common Units</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1048"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Ncp Helix Holdings, LLC. - Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1049"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TransportationInfrastructureSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1050"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1051"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD)</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1052"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1053"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:InvestmentPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1054"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Other Cash and Cash Equivalents</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1055"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1056"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:QualifyingAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1057"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:NonQualifyingAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1058"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>123Dentist, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1059"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1060"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1061"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ADCS Clinics Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1062"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ADCS Clinics Intermediate Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1063"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AI Altius Bidco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1064"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1065"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1066"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerivet Partners Management, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1067"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Amerivet Partners Management, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1068"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Anaplan, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1069"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Armada Parent, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1070"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Armada Parent, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1071"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1072"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AxiomSL Group, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1073"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>AxiomSL Group, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1074"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Bazaarvoice, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1075"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Benefytt Technologies, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1076"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1077"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1078"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1079"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Revolver 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1080"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Revolver 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1081"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1082"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cambium Learning Group, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1083"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1084"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1085"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CCBlue Bidco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1086"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CFGI Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1087"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CFGI Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1088"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Clearview Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1089"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Clearview Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1090"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Community Brands ParentCo, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1091"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Community Brands ParentCo, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1092"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Confine Visual Bidco, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1093"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Connatix Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1094"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Connatix Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1095"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>COP Home Services TopCo IV, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1096"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CPI Buyer, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1097"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CPI Buyer, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1098"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>CPI Intermediate Holdings Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1099"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>DCA Investment Holdings, LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>DCA Investment Holdings, LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Discovery Education, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Discovery Education, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Doc Generici (Diocle S.p.A.), Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Emergency Power Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ENV BIDCO AB, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Episerver, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Experity, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Foundation Risk Partners Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Galway Borrower, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Galway Borrower, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GCX Corporation Buyer, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The GI Alliance Management, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Gigamon Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Go Car Wash Management Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GovernmentJobs.com, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GovernmentJobs.com, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Gruden Acquisition, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Gruden Acquisition, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Healthcomp Holding Company, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Helix TS, LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Helix TS, LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>IG Investments Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Inovalon Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ISQ Hawkey Holdco, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>ISQ Hawkey Holdco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Java Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Buyer, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Knowledge Pro Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Knowledge Pro Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>KPSKY Acquisition, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>LD Lower Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Legacy Intermediate, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Legacy Intermediate, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Linquest Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Magnesium BorrowerCo, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Material Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Material Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MHE Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monk Holding Co., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing S.&#224;.r.l, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Revolver 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Revolver 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Navigator Acquiror, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NDC Acquisition Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>NMC Crimson Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Onex Baltimore Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Petrus Buyer Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Petrus Buyer Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>PGIS Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Acquisition, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Porcelain Acquisition Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>PPV Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>PPV Intermediate Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Project Boost Purchaser, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Project Boost Purchaser, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Qualus Power Services Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Red River Technology, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Redwood Services Group, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Relativity ODA, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Relay Purchaser, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RoadOne Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RoadOne Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Roadsafe Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RPBLS Midco, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>RWL Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Safety Borrower Holdings LP, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sherlock Buyer Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Sherlock Buyer Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Smile Doctors, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Snoopy Bidco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Spitfire Parent, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Stepping Stones Healthcare Services, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Stepping Stones Healthcare Services, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The NPD Group L.P., Revolver 1</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>The NPD Group L.P., Revolver 2</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trader Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Trinity Partners Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Triple Lift, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>TRP Infrastructure Services, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Unified Physician Management, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Unified Physician Management, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>United Mutual Acquisition Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>West Monroe Partners, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>West Monroe Partners, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Westland Insurance Group LTD, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>WHCG Purchaser III, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>WHCG Purchaser III, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment  One</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment Two</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment Three</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment Four</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment Five</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment Six</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:InvestmentIdentifierAxis.domain>Investment Seven</us-gaap:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">bxsl:BlackstoneDonegalHoldingsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">bxsl:BlackstoneDonegalHoldingsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-18</xbrli:startDate><xbrli:endDate>2021-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-06</xbrli:startDate><xbrli:endDate>2021-05-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-06</xbrli:startDate><xbrli:endDate>2020-05-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-02</xbrli:startDate><xbrli:endDate>2023-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverNotInPlaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-18</xbrli:startDate><xbrli:endDate>2021-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverInPlaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-28</xbrli:startDate><xbrli:endDate>2021-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-28</xbrli:startDate><xbrli:endDate>2021-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-29</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-18</xbrli:startDate><xbrli:endDate>2021-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverInPlaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-28</xbrli:startDate><xbrli:endDate>2021-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-28</xbrli:startDate><xbrli:endDate>2021-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:IncomeBasedIncentiveFeesScenarioAxis">bxsl:PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-28</xbrli:startDate><xbrli:endDate>2021-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverNotInPlaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bxsl:IncomeBasedIncentiveFeesScenarioAxis">bxsl:PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-28</xbrli:startDate><xbrli:endDate>2021-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverInPlaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bxsl:IncomeBasedIncentiveFeesScenarioAxis">bxsl:PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-28</xbrli:startDate><xbrli:endDate>2021-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:IncomeBasedIncentiveFeesScenarioAxis">bxsl:PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverNotInPlaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-28</xbrli:startDate><xbrli:endDate>2021-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverInPlaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bxsl:IncomeBasedIncentiveFeesScenarioAxis">bxsl:PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-28</xbrli:startDate><xbrli:endDate>2021-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverNotInPlaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-28</xbrli:startDate><xbrli:endDate>2021-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-29</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:AdministrationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:AdministrationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:AdministrationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:SubAdministrationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:ExpenseSupportAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-12</xbrli:startDate><xbrli:endDate>2018-12-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:ExpenseSupportAgreementExcessOperatingFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-12</xbrli:startDate><xbrli:endDate>2018-12-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:ExpenseSupportAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:ExpenseSupportAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AerospaceAndDefenseSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AerospaceAndDefenseSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AirFreightLogisticsSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AirFreightLogisticsSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:BuildingProductsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:BuildingProductsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ChemicalsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ChemicalsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:CommercialServicesSuppliesSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:CommercialServicesSuppliesSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ConstructionEngineeringSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ConstructionEngineeringSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ContainerAndPackagingSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ContainerAndPackagingSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DistributorsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DistributorsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ConsumerSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ConsumerSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:FinancialServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:FinancialServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DiversifiedTelecommunicationServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DiversifiedTelecommunicationServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricalEquipmentSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricalEquipmentSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectronicEquipmentInstrumentsAndComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectronicEquipmentInstrumentsAndComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricUtilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricUtilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:EnergySectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:EnergySectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:GroundTransportationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:GroundTransportationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareEquipmentSuppliesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareEquipmentSuppliesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:IndustrialConglomeratesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:IndustrialConglomeratesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:InsuranceSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:InsuranceSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:InternetAndDirectMarketingRetailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:InternetAndDirectMarketingRetailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ITServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ITServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MarineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MarineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MediaSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MediaSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:OilGasAndConsumableFuelsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:OilGasAndConsumableFuelsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PaperAndForestProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PaperAndForestProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PharmaceuticalsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PharmaceuticalsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ProfessionalServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ProfessionalServicesSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:RealEstateManagementDevelopmentSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:RealEstateManagementDevelopmentSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:RoadAndRailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:RoadAndRailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SoftwareSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SoftwareSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SpecialtyRetailMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SpecialtyRetailMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TechnologyHardwareStorageAndPeripheralsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TechnologyHardwareStorageAndPeripheralsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TradingCompaniesDistributorsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TradingCompaniesDistributorsSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TransportationInfrastructureSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TransportationInfrastructureSectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bxsl:BERMUDAAndCAYMANISLANDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bxsl:BERMUDAAndCAYMANISLANDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="loan"><xbrli:measure>bxsl:loan</xbrli:measure></xbrli:unit><xbrli:context id="c-1362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentsAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesVariableRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentsAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesVariableRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentsAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFixedRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentsAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFixedRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienRealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienRealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:UnsecuredDebtRealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:EquitySecuritiesRealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:InvestmentsRealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienUnrealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienUnrealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:UnsecuredDebtUnrealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:EquitySecuritiesUnrealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:InvestmentsUnrealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienRealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienRealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:EquitySecuritiesRealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:InvestmentsRealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienUnrealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienUnrealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:EquitySecuritiesUnrealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:InvestmentsUnrealizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationAssetRecoverabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationAssetRecoverabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputMarketMultipleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationAssetRecoverabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputMarketMultipleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationAssetRecoverabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputMarketMultipleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputPerformanceMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputPerformanceMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputPerformanceMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputQuotedPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputQuotedPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputQuotedPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputPerformanceMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputPerformanceMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputPerformanceMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1492"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1499"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityForeignCurrencyAdvancesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-16</xbrli:startDate><xbrli:endDate>2022-09-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityDollarAdvancesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-16</xbrli:startDate><xbrli:endDate>2022-09-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-16</xbrli:startDate><xbrli:endDate>2022-09-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-19</xbrli:startDate><xbrli:endDate>2022-05-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-19</xbrli:startDate><xbrli:endDate>2022-05-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-19</xbrli:startDate><xbrli:endDate>2022-05-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-19</xbrli:startDate><xbrli:endDate>2022-05-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-19</xbrli:startDate><xbrli:endDate>2022-05-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-19</xbrli:startDate><xbrli:endDate>2022-05-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-19</xbrli:startDate><xbrli:endDate>2022-05-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-19</xbrli:startDate><xbrli:endDate>2022-05-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-30</xbrli:startDate><xbrli:endDate>2023-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-30</xbrli:startDate><xbrli:endDate>2023-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-30</xbrli:startDate><xbrli:endDate>2023-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-30</xbrli:startDate><xbrli:endDate>2023-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-30</xbrli:startDate><xbrli:endDate>2023-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-30</xbrli:startDate><xbrli:endDate>2023-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-28</xbrli:startDate><xbrli:endDate>2022-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-28</xbrli:startDate><xbrli:endDate>2022-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-28</xbrli:startDate><xbrli:endDate>2022-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1532"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-28</xbrli:startDate><xbrli:endDate>2022-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1533"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1534"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-28</xbrli:startDate><xbrli:endDate>2022-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1535"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-28</xbrli:startDate><xbrli:endDate>2022-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1537"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-28</xbrli:startDate><xbrli:endDate>2022-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1538"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A3650NotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1541"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A3625NotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A3625NotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1543"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2750NotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2750NotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1545"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2125SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1546"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2850NotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1550"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A3625NotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2750NotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1552"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2125SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1553"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2850NotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1554"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1555"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1556"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1557"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1558"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A3650NotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1559"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A3625NotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1560"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2750NotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1561"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2125SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1562"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2850NotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1563"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">bxsl:DelayedDrawTermLoansAndRevolversMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1564"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-14</xbrli:startDate><xbrli:endDate>2023-08-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1566"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-18</xbrli:startDate><xbrli:endDate>2023-08-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="equity_distribution_agreement"><xbrli:measure>bxsl:equity_distribution_agreement</xbrli:measure></xbrli:unit><xbrli:context id="c-1567"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">bxsl:AtTheMarketOfferingOffering1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1568"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">bxsl:AtTheMarketOfferingOffering1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1569"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-28</xbrli:startDate><xbrli:endDate>2021-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1570"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1571"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-04</xbrli:startDate><xbrli:endDate>2021-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1572"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-08</xbrli:startDate><xbrli:endDate>2021-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1573"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-08</xbrli:startDate><xbrli:endDate>2021-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1574"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1575"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1576"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1577"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1578"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-27</xbrli:startDate><xbrli:endDate>2023-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1579"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-10</xbrli:startDate><xbrli:endDate>2023-05-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1580"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-20</xbrli:startDate><xbrli:endDate>2023-06-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1581"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-08</xbrli:startDate><xbrli:endDate>2023-11-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1582"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-18</xbrli:startDate><xbrli:endDate>2021-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1583"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-18</xbrli:startDate><xbrli:endDate>2021-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1584"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-23</xbrli:startDate><xbrli:endDate>2022-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1585"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-18</xbrli:startDate><xbrli:endDate>2021-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1586"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-02</xbrli:startDate><xbrli:endDate>2022-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1587"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-18</xbrli:startDate><xbrli:endDate>2021-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1588"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-30</xbrli:startDate><xbrli:endDate>2022-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1589"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends8Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-02</xbrli:startDate><xbrli:endDate>2022-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1590"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-24</xbrli:startDate><xbrli:endDate>2021-02-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1591"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-07</xbrli:startDate><xbrli:endDate>2021-06-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1592"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-07</xbrli:startDate><xbrli:endDate>2021-06-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1593"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-07</xbrli:startDate><xbrli:endDate>2021-09-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1594"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-07</xbrli:startDate><xbrli:endDate>2021-09-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1595"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-18</xbrli:startDate><xbrli:endDate>2021-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1596"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-31</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1597"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-27</xbrli:startDate><xbrli:endDate>2023-04-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1598"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-27</xbrli:startDate><xbrli:endDate>2023-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1599"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-26</xbrli:startDate><xbrli:endDate>2023-10-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1600"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-31</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-13</xbrli:startDate><xbrli:endDate>2022-05-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-12</xbrli:startDate><xbrli:endDate>2022-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-14</xbrli:startDate><xbrli:endDate>2022-11-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-29</xbrli:startDate><xbrli:endDate>2021-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1605"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-14</xbrli:startDate><xbrli:endDate>2021-05-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-13</xbrli:startDate><xbrli:endDate>2021-08-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1607"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-12</xbrli:startDate><xbrli:endDate>2021-11-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b18PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b18PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1620"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1624"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1631"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1632"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1633"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1634"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1635"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1636"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:TransferRestrictionsAxis">bxsl:InitialPublicOfferingShareholderTransferRestrictionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1637"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:TransferRestrictionsAxis">bxsl:InitialPublicOfferingShareholderTransferRestrictionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1638"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:TransferRestrictionsAxis">bxsl:InitialPublicOfferingShareholderTransferRestrictionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1639"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bxsl:TransferRestrictionsAxis">bxsl:InitialPublicOfferingShareholderTransferRestrictionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1640"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1641"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1642"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1643"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:DividendsOrdinaryIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1644"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:DividendsCapitalGainsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1645"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:DividendsOrdinaryIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1646"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:DividendsCapitalGainsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1647"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1648"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1649"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1650"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1651"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1652"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1653"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:SubscriptionFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1654"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:SubscriptionFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1655"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:SubscriptionFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1656"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:SubscriptionFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1657"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:SubscriptionFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1658"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:SubscriptionFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1659"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1660"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1661"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1662"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1663"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1664"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1665"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1666"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1667"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1668"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1669"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1670"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1671"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1672"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1673"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1674"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1675"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1676"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1677"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1678"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1679"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1680"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1681"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1682"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1683"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1684"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1685"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1686"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1687"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1688"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1689"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1690"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1691"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1692"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1693"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1694"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1695"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1696"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1697"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1698"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1699"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1700"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1703"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1704"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1707"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1708"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1710"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1711"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1712"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736035</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-28</xbrli:startDate><xbrli:endDate>2024-02-28</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1890" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1890" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1890" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1890" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1890" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3612" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3612" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3612" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3612" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3619" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3619" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3619" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3619" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1859" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1859" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1859" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1859" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1859" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1859" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1859" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1858" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1858" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1858" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1858" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1858" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1858" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1857" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1857" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1857" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1857" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1857" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1856" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1856" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1856" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1856" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1856" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1869" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1869" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1869" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1868" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1868" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1868" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1865" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1865" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1865" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1865" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1865" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1864" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1864" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1864" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1864" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1863" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1863" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1863" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1863" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1863" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1862" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1862" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1862" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1862" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1862" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1860" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1860" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1860" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1860" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1860" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1879" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1879" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1879" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1879" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1879" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1879" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1878" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1878" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1878" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1878" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1878" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1877" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1877" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1877" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1877" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1877" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1877" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1877" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1875" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1875" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1875" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1874" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1874" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1874" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1872" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1872" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1872" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1870" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1870" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1870" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1870" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1887" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1887" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1887" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1886" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1886" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1886" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1885" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1885" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1885" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1885" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1884" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1884" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1884" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1883" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1883" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1883" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1883" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1883" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1882" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1882" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1882" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1882" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1880" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1880" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1880" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1880" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1880" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3684" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3684" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3684" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3684" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3687" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3687" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3687" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3687" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1017" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1017" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1017" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1016" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1016" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1016" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1015" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1015" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1015" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1015" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1014" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1014" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1014" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1013" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1013" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1013" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1013" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1013" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1012" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1012" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1012" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1012" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1011" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1011" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1010" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1010" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1029" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1029" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1029" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1028" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1028" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1028" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1028" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1027" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1027" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1027" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1026" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1026" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1026" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1026" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1026" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1023" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1023" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1023" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1022" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1022" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1022" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1020" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1020" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1020" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1038" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1038" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1036" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1036" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1034" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1034" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1034" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3690" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3690" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3690" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3690" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3690" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3693" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3693" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3693" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3693" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3693" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3698" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3698" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3698" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3698" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3698" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3698" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3698" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3699" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3699" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3699" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3699" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3699" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1045" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1045" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1044" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1044" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1042" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1042" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1040" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1040" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1040" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1008" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1008" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4130" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4130" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4130" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4130" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4132" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4132" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4137" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4137" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4137" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4137" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4138" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4138" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4138" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4138" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4138" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1096" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1096" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1096" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1095" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1095" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1095" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1093" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1093" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1093" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-783" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-783" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-783" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-786" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-786" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-786" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-787" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-787" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-787" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-787" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-785" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-785" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-785" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4147" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4147" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-756" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-756" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-750" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-750" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-750" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1054" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1054" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1053" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1053" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-753" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-753" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1051" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1051" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-751" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-751" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-751" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-752" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-752" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-752" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-752" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-744" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-744" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-744" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-744" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-744" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-745" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-745" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-745" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-745" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-749" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-749" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-749" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-743" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-743" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-743" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-743" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-743" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2393" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2393" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2393" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2393" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-741" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-741" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-741" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-741" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-741" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1081" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1081" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1081" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-777" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-777" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-777" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-778" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-778" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-778" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-778" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-771" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-771" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-771" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-772" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-772" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-772" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-772" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-770" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-770" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-770" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-770" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-770" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-775" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-775" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-775" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-775" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-773" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-773" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-773" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-768" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-768" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-768" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-769" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-769" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-769" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-769" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-766" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-766" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-766" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-766" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1090" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1090" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1090" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1089" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1089" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1089" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1088" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1088" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1088" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1088" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1087" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1087" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1087" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1086" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1086" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1086" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1086" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1086" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1085" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1085" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1085" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1085" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1084" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1084" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1084" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-762" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-762" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-762" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-762" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1083" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1083" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1083" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-714" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-714" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-714" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-717" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-717" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-717" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1939" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1939" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1939" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1939" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1938" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1938" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1938" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1936" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1936" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1936" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1936" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1934" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1934" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1934" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1934" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1948" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1948" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1942" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1942" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1942" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1942" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1942" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1941" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1941" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1941" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1940" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1940" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1940" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-736" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-736" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-739" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-739" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-739" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-739" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-739" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-739" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1957" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1957" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1957" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1957" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1957" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1956" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1956" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1956" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1956" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1955" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1955" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1955" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1955" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1954" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1954" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1954" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1954" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1954" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1953" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1953" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1953" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1953" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1951" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1951" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1951" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1951" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1951" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-730" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-730" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-730" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-730" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-730" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-724" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-724" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-724" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-724" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-728" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-728" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-728" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-729" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-729" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-729" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-726" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-726" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-726" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-727" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-727" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-727" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-727" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1969" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1969" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1966" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1966" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1966" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1966" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1966" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1965" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1965" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1965" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1965" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1964" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1964" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1964" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1964" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1964" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1964" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1963" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1963" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1963" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1963" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1963" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1962" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1962" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1962" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1962" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1961" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1961" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1961" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1961" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1960" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1960" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1960" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1960" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1960" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-720" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-720" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-720" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-720" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1909" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1909" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1909" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1909" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1909" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1908" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1908" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1908" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1908" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1906" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1906" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1906" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1906" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1906" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1905" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1905" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1905" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1905" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1903" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1903" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1903" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1903" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1903" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1902" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1902" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1902" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1902" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1900" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1900" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1900" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1900" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1900" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1918" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1918" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1918" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1918" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1918" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1917" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1917" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1917" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1917" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1915" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1915" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1915" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1915" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1915" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1914" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1914" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1914" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1914" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1912" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1912" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1912" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1912" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1912" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1911" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1911" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1911" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1911" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1929" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1929" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1929" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1929" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1926" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1926" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1926" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1926" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1921" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1921" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1921" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1921" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1921" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1920" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1920" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1920" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1920" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3720" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3720" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3720" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3724" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3724" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3724" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3724" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3726" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3726" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3726" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3727" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3727" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3727" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3727" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3728" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3728" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3728" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3728" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3728" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3728" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3729" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3729" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3729" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3729" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3714" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3714" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3714" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3717" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3717" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3717" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3741" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3741" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3743" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3743" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3744" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3744" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3745" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3745" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3745" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3745" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3749" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3749" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3749" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3749" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3730" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3730" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3730" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3730" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3730" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3736" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3736" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3736" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3736" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3736" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3737" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3737" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3737" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3737" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3738" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3738" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3738" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3738" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3739" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3739" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1989" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1989" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1989" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1989" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1987" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1987" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1987" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1987" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1984" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1984" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1984" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1984" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1984" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1983" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1983" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1983" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1983" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1983" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1982" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1982" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1982" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1982" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1982" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1981" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1981" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1981" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1981" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1981" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1981" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1999" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1999" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1999" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1999" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1999" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1999" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1999" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1998" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1998" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1998" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1998" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1998" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1998" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1997" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1997" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1997" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1997" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1996" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1996" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1996" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1996" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1995" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1995" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1995" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1995" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1995" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1994" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1994" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1994" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1994" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1993" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1993" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1993" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1993" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1993" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1993" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1991" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1991" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1991" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1991" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1991" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1990" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1990" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1990" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1990" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1138" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1138" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1138" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1137" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1137" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1137" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1133" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1133" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1133" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1133" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2460" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2460" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2460" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2484" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2484" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2499" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2499" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3762" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3762" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3762" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3762" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3766" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3766" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3766" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3766" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3769" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3769" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3769" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3769" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-590" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-590" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3750" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3750" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3750" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3750" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3751" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3751" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3756" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3756" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3756" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3756" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2439" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2439" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2439" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2439" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2436" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2436" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2435" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2435" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2435" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-587" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-587" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-587" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-587" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3783" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3783" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3783" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3783" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3783" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3785" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3785" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3785" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3785" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3785" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3786" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3786" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3786" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3786" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3786" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3786" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3786" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3787" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3787" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3787" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3787" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3787" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-12" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-12" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-12" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-12" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-12" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2444" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2444" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2444" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-12" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3770" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3770" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3770" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3770" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3770" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3771" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3771" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3771" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3771" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3772" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3772" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3772" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3772" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3773" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3773" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3773" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3773" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3775" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3775" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3775" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3775" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3777" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3777" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3777" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3777" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3778" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3778" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3778" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3778" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4240" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4240" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4240" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-690" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-690" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-690" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-690" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-695" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-695" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-695" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-695" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-693" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-693" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-693" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-693" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-696" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-696" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-696" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-696" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4264" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4264" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-684" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-684" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-684" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-684" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-684" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-687" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-687" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-687" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-687" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-619" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-619" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-619" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-619" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3841" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3841" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3841" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3841" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3841" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3842" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3842" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3842" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3842" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3842" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3842" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3843" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3843" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3843" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3843" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3843" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3844" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3844" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3844" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3844" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3844" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3831" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3831" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3831" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3831" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3831" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3835" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3835" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3835" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3835" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3835" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3837" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3837" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3837" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3837" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3837" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3838" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3838" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3838" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3838" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3838" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3839" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3839" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3839" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3839" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3839" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3860" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3860" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3860" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3862" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3862" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3862" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3863" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3863" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3863" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3863" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3864" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3864" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3864" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3865" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3865" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3865" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3868" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3868" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3868" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3868" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3868" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3869" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3869" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3869" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3869" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3869" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3869" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3856" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3856" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3856" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3856" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3856" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3856" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3857" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3857" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2535" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2535" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3800" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3800" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3800" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3800" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3800" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3800" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3801" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3801" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3801" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3801" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3801" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3802" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3802" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3802" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3802" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3802" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3809" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3809" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3809" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3820" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3820" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3820" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3811" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3811" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3811" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3813" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3813" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3813" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3814" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3814" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3814" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3815" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3815" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3815" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3817" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3817" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3817" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3819" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3819" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3819" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1264" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1264" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1264" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4306" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4306" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4306" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4306" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3880" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3880" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3880" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3882" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3882" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3882" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3883" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3883" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3883" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3884" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3884" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3884" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3884" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3885" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3885" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3885" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3885" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3885" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3885" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3887" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3887" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3887" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3887" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3870" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3870" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3870" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3870" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3870" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3872" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3872" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3872" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3872" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3874" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3874" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3874" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3874" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3875" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3875" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3875" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3875" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3875" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3877" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3877" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3877" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3877" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3878" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3878" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3878" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3879" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3879" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3879" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3879" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3879" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3890" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3890" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3890" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3890" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1240" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1240" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1240" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4393" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4393" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4393" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-999" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-999" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-999" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-997" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-997" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-997" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-997" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-998" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-998" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-998" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-998" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-998" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-991" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-991" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-991" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-990" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-990" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-990" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-995" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-995" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-996" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-996" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-993" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-993" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-994" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-994" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-994" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-989" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-989" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-989" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-987" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-987" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-987" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-981" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-981" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-984" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-984" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-982" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-982" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-982" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-983" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-983" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-955" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-955" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-955" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-956" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-956" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-953" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-953" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-953" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-953" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-954" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-954" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-957" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-957" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-951" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-951" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-950" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-950" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-942" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-942" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-942" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-948" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-948" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-949" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-949" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-949" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-940" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-940" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-940" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-940" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-941" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-941" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-941" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-941" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-941" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3900" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3900" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3900" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3900" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3900" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3902" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3902" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3902" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3902" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3903" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3903" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3903" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3903" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3905" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3905" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3905" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3905" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3906" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3906" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3906" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3906" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3906" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3908" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3908" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3908" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3908" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3909" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3909" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3909" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3909" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-970" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-970" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-970" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-970" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-970" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-971" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-971" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-971" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-971" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-969" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-969" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-969" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-969" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-962" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-962" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-963" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-963" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-960" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-960" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-961" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-961" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-961" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-911" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-911" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-911" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-911" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-912" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-912" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-915" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-915" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-914" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-914" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-917" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-917" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-917" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-917" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-917" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-918" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-918" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-918" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-900" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-900" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-901" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-904" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-905" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-905" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-905" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-905" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-902" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-902" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-903" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-903" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-908" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-908" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-909" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-909" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-906" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-906" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-907" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-934" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-934" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-934" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-938" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-938" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-936" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-936" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-939" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-939" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-920" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-920" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-920" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-921" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-921" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-921" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-926" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-926" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-926" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-926" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-929" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-929" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-929" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-929" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-929" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3960" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3960" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3960" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3960" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3961" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3961" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3961" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3961" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3961" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3962" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3962" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3962" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3962" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3963" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3963" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3963" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3963" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3964" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3964" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3964" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3964" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3964" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3965" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3965" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3965" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3965" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3965" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3965" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3965" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3966" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3966" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3966" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3966" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3966" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3967" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3968" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3969" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3969" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3969" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3969" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3969" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3950" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3950" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3950" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3950" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3950" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3950" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3951" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3951" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3951" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3951" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3952" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3953" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3953" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3953" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3953" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3954" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3954" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3954" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3954" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3955" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3955" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1306" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1306" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1306" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1306" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3958" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3959" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3980" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3981" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3981" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3981" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3981" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3982" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3982" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3985" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3986" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3987" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3987" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3987" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3987" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3988" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3989" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3989" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3989" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3989" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3970" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3970" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3970" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3970" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3971" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3971" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3971" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3971" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3971" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3971" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3972" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3973" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3974" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3975" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3976" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3977" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3978" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3979" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3920" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3920" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3920" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3921" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3921" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3921" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3921" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3923" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3924" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3925" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3926" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3926" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3926" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3926" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3927" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3928" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3910" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3911" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3911" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3911" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3911" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3912" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3912" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3912" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3912" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3912" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3913" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3914" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3914" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3914" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3914" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3915" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3915" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3915" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3916" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3917" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3917" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3917" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3918" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3918" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3918" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3918" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3919" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3940" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3940" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3943" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3944" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3945" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3946" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3947" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3948" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3948" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3948" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3948" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3948" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3949" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3949" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3949" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3949" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3930" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3931" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3932" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3933" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3934" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3934" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3934" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3934" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3934" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3935" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3936" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3936" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3936" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3936" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3936" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3937" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3938" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3938" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3938" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3938" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3938" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3939" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3939" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3939" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3939" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3939" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2611" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2611" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4435" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4435" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4438" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4438" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4423" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4423" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4423" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4423" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-14" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-14" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-14" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1333" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1332" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3990" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3990" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3990" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3990" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3991" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3991" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3991" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3992" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3993" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3993" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3993" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3994" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3994" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3994" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3994" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3995" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3995" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3995" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3996" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3996" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3996" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3997" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3997" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4492" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4492" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4493" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4493" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4493" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4496" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4496" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4497" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4497" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4497" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4498" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4498" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4499" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4499" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4481" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4481" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4481" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4481" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4482" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4482" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4482" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4482" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4483" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4483" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4483" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4483" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4484" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4484" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4484" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4484" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4485" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4485" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4485" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4485" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4486" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4486" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4486" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4486" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4487" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4487" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4487" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4487" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-876" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-870" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-870" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-871" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-874" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-874" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-874" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-874" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-875" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-875" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-875" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-872" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-872" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-872" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-872" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-872" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-873" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-867" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-868" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-868" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-868" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-865" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-865" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-865" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-869" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-869" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4444" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4444" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4444" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4444" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-860" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-860" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-860" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-860" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-863" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-863" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-864" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-864" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-861" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-862" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-862" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-862" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-898" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-899" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4476" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4476" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4476" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4476" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3147" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3147" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3147" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3147" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4478" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4478" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4478" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4478" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-892" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-893" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-890" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-890" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-890" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-891" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-896" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-897" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-894" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-895" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-889" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-887" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-887" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-887" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-887" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-887" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3130" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3130" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3130" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-888" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3132" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3132" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3132" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3133" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3133" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3133" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3133" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4466" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4466" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4466" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-881" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-882" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-882" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-880" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-880" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-880" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-885" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-885" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-886" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-886" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-886" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-886" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-883" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-883" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-883" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-884" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-884" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-835" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-835" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-838" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-838" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-831" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-831" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-831" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-820" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-820" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-820" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-854" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-855" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-859" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-859" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-859" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-852" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-853" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-850" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-851" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-844" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-844" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-844" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-844" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-813" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-813" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-813" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-811" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-811" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-811" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-811" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-817" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-817" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-817" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-814" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-814" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-814" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-814" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-815" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-815" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-815" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-819" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-819" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-801" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-801" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-802" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-802" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-802" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-800" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-800" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-800" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-800" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-809" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-809" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-809" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1423" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1423" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1423" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1439" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1439" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1439" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1439" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1438" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1438" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1438" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1438" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1438" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1438" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1437" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1437" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1437" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1437" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1437" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1436" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1436" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1436" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1436" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1435" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1435" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1435" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1435" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1444" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1444" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1444" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1444" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1444" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4532" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4532" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4533" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4533" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4534" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4534" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4535" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4535" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4535" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1499" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1499" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1499" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1499" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1499" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1498" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1498" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1498" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1498" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1498" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1497" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1497" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1497" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1497" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1497" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1497" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1496" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1496" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1496" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1496" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1496" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1493" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1493" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1493" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1493" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1492" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1492" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1492" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1492" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1491" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1491" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1491" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1491" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1491" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1490" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1490" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1490" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1490" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4520" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4520" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4520" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4521" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4521" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4525" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4525" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4526" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4526" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4552" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4552" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4553" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4553" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4558" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4558" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4558" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4559" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4559" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4540" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4540" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4541" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4541" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4544" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4544" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1469" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1469" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1469" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1466" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1466" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1466" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1466" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1460" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1460" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1460" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4510" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4510" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4511" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4511" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4512" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4512" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4512" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4514" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4514" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1478" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1478" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1478" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1478" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1476" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1476" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1476" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1476" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1476" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4500" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4500" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4502" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4502" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4504" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4504" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4508" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4508" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4508" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4509" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4509" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1489" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1489" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1489" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1489" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1489" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1489" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1485" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1485" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1484" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1484" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1484" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1484" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1483" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1483" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1483" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1483" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1482" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1482" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1482" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1482" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1482" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1481" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1481" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1481" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1481" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-28" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-28" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-28" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-28" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-28" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-28" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-28" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-28" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-28" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-28" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-28" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-28" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3264" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3264" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3264" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4590" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4590" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1535" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1535" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1535" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1535" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1535" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1534" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1534" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1534" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1534" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1534" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1533" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1533" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1533" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1533" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1533" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1533" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1532" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1532" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1532" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1532" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1532" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1548" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1548" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1548" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1548" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1548" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1548" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1547" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1547" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1547" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1547" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1544" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1544" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1544" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1544" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1541" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1541" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1541" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1541" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1541" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1540" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1540" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1540" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1540" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1540" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1559" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1559" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1559" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1559" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1558" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1558" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1558" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1558" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1553" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1553" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1553" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1553" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1553" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1552" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1552" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1552" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1552" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1552" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1509" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1509" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1509" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1509" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1508" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1508" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1508" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1506" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1506" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1506" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1506" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1505" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1505" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-15" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1505" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1505" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1505" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1504" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1504" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1504" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1504" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-15" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1504" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-15" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1502" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1502" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1502" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1502" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-15" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1502" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-15" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1500" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1500" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1500" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1500" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1500" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-15" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1500" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1518" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1518" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1518" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1518" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1518" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1518" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1517" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1517" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1517" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1517" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1516" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1516" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1516" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1516" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1514" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1514" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1514" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1514" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1512" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1512" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1512" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1512" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1512" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1511" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1511" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1511" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1510" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1510" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1510" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1529" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1529" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1529" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1529" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1528" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1528" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1528" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1528" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1526" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1526" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1526" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1526" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1525" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1525" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1525" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1525" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1525" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1525" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1521" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1521" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1521" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1521" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1521" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1521" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1520" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1520" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1520" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1520" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1520" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3320" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3321" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3322" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3323" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3325" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3326" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3327" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3328" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3329" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3310" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3311" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3312" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3313" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3314" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3315" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3316" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3317" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3319" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3340" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3341" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3343" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3344" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3345" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3346" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3347" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3348" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3349" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2008" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2008" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2008" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2008" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2008" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2008" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2008" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2005" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2005" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2005" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2005" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2005" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2005" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2005" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2004" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2004" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2004" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2004" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2004" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2003" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2003" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2003" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2003" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2003" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3330" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3331" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3334" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3335" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3336" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3337" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3338" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3339" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2017" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2017" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2017" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2017" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2014" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2014" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2012" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2012" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2012" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2011" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2011" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2010" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2010" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2010" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2010" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2010" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2010" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4611" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4611" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4612" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4612" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4612" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4619" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4619" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1587" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1587" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1587" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1587" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1587" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3300" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3301" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3302" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3303" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3304" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3305" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3306" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3306" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3306" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3306" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3307" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3308" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-25" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3309" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1590" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1590" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1590" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1590" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1590" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2063" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2063" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2063" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2063" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2063" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2062" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2062" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2062" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2062" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2062" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2062" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2062" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3392" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2081" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2081" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2081" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3393" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3393" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3393" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3393" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3394" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3395" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3396" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3398" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2078" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2078" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2078" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2078" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2078" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2077" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2077" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2077" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2077" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2077" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2076" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2076" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2076" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2076" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2076" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2076" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2093" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2093" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2093" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2093" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2090" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2090" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2090" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2089" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2089" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2089" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2088" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2088" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2088" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2088" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2087" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2087" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2087" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2086" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2086" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2086" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2086" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2086" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2085" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2085" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2085" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2085" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2084" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2084" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2084" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2083" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2083" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2083" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2096" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2096" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2096" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2096" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2095" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2095" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2095" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2095" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3360" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3362" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3363" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3364" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3365" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3366" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3367" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3368" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3369" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2029" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2029" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2029" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2028" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2028" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2028" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2027" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2027" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2027" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2027" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2026" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2026" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2026" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2023" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2023" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2023" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2023" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2022" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2022" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2022" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2020" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2020" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2020" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2020" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3350" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3351" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3352" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3354" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3355" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3356" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3357" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3358" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3359" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2038" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2038" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2038" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2038" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2038" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2036" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2036" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2036" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2036" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2036" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2036" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2034" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2034" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2034" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2034" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2033" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2033" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2033" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2033" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2033" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2032" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2032" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2032" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2032" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3381" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3382" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3383" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3384" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3385" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3386" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3387" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3388" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3389" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2048" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2048" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2048" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2048" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2048" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2047" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2047" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2047" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2047" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2047" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2046" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2046" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2046" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2046" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2046" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2046" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2045" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2045" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2045" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2045" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2045" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2044" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2044" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2044" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2044" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2044" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2044" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2044" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2042" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2042" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2042" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2042" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2042" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2042" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2040" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2040" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2040" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2040" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2040" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3390" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3370" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3371" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3372" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3374" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3375" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3376" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3377" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3378" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3379" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2054" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2054" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2054" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2054" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2054" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2053" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2053" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2053" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2053" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2053" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2051" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2051" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2051" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2051" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2051" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3380" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1609" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1608" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1607" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1606" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1605" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1604" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1603" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1602" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1601" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1659" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1658" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1657" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1656" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1655" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1654" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1653" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1652" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1651" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1650" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1669" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1668" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1667" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1666" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1665" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1664" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1663" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1662" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1661" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1660" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1679" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1678" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1677" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1676" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1675" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1674" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1673" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1672" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1670" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1689" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1688" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1687" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1687" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1687" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1686" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1685" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1684" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1684" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1684" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1683" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1682" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1681" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1680" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1618" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1617" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1616" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1615" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1614" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1613" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1612" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1612" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1612" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1612" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1612" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1611" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1611" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1611" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1611" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1611" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1629" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1628" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1627" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1626" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1625" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1624" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1623" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1622" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1638" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1637" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1636" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1635" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1634" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1633" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1632" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1631" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1630" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1649" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1648" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1647" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1646" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1645" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1644" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1643" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1642" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1641" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1640" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3440" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3441" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3442" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3443" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3445" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3446" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3447" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3448" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3449" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2109" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2108" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2107" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2106" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2105" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2104" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2103" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2101" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2100" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3430" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3431" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3432" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3433" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3434" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3435" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3435" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3436" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3436" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3436" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3437" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3437" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3437" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3437" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3437" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3438" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3438" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3438" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3439" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3439" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3439" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3439" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2119" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2118" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2117" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2116" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2115" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2114" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2113" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2112" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2111" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2110" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3460" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3460" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3460" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3460" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3461" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3462" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3463" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3464" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3465" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3466" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3466" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3466" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3466" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3466" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3467" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3468" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3469" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3469" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3469" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3469" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3469" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2129" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2127" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2126" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2125" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2124" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2123" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2122" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2121" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2120" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3451" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3452" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3453" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3454" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3455" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3456" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3457" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3458" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3459" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2139" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2138" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2138" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2138" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2137" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2137" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2137" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2136" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2135" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2134" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2133" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2133" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2133" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2133" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2132" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2132" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2132" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2130" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2130" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2130" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2130" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3400" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3401" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3402" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3403" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3404" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3405" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3406" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3407" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3408" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3409" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1699" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1699" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1699" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1699" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1699" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1698" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1698" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1698" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1698" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1698" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1697" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1696" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1696" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1696" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1696" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1696" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1695" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1695" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1695" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1695" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1695" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1695" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1695" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1694" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1693" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1693" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1693" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1692" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1691" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1690" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1690" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1690" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3421" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3422" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3423" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3423" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3423" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3423" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3424" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3425" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3426" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3427" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3428" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3429" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3410" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3411" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3412" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3413" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3414" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3415" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3416" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3417" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3418" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3419" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2192" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2191" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2189" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2188" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2187" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2186" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2185" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2184" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2183" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2182" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2199" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2198" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2197" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2196" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2195" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2194" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2193" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-568" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3480" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3481" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3481" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3481" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3482" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3482" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3482" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3483" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3483" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3484" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3484" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3485" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3485" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3485" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3485" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3486" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3486" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3486" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3486" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3486" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3486" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3487" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3487" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3487" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3487" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3488" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3489" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3489" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3489" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3489" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2149" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2148" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2147" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2147" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2147" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2147" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2146" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2145" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2144" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2143" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2142" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2141" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2140" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3490" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3490" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3490" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3490" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3470" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3471" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3472" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3473" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3474" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3475" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3476" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3476" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3476" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3477" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3478" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3478" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3478" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2159" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2158" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2157" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2156" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2155" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2154" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2153" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2152" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2151" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2150" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2170" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2168" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2167" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2166" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2165" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2164" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2163" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2162" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2161" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2181" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3491" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3491" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3491" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3491" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2180" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3492" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3492" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3492" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3492" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3492" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3492" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3493" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3493" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3493" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3493" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3494" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3495" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3496" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3496" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3496" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3496" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2179" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2178" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2177" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2175" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2174" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2173" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2172" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2171" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1709" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1708" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1707" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1706" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1705" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1704" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1703" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1702" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1700" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1719" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1718" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1717" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1717" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1717" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1717" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1716" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1715" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1714" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1714" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1714" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1714" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1714" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1713" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1712" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1711" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1710" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1728" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1728" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1727" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1727" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1727" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1727" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1726" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1726" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1726" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1726" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1725" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1724" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1724" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1724" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1724" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1723" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1721" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1720" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1720" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1720" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1720" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1779" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1778" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1778" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1778" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1777" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1777" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1777" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1775" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1775" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1775" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1774" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1773" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1773" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1773" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1773" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1770" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1770" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1789" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1788" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1785" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1785" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1784" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1783" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1783" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1783" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1783" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1782" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1781" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1780" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3500" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-29" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3500" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3500" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-29" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3501" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3502" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3502" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-29" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3502" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-29" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3503" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3504" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3504" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3504" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-29" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3505" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3505" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3505" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-29" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3506" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3506" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3506" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3506" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3507" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3508" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3508" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3508" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3508" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1799" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3509" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3509" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3509" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3509" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3509" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1798" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1797" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1796" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1795" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1794" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1793" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1792" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1791" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1790" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-8" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1739" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1739" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1739" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1739" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1738" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1738" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1738" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1738" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1738" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1738" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1737" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1737" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1737" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1737" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1737" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1736" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1736" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1736" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1736" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1736" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1735" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1734" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1733" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1732" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1731" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1749" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1749" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1749" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1749" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1749" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1748" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1747" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1746" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1743" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1743" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1742" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1741" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1741" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1741" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1741" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1740" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1759" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1758" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1757" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1756" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1756" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1756" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1756" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1756" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1756" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1755" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1754" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1753" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1753" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1753" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1753" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1753" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1753" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1753" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1753" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1752" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1752" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1752" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1752" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1752" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1752" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1752" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1751" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1751" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1751" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1751" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1750" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1750" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1750" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1750" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1769" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1769" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1769" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1769" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1768" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1768" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1768" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1768" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1767" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1766" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1766" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1766" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1766" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1765" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1764" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1763" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1762" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1762" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1762" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1762" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1761" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1760" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3560" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3561" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="8"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3562" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3563" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3564" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3565" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3566" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3567" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3569" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2229" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2228" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2227" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2226" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2225" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2224" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2223" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2222" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2221" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2220" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3550" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3551" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3552" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3552" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3552" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3552" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3553" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3553" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3553" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3553" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3554" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3555" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3557" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3558" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3558" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3558" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3558" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3558" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3559" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3559" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3559" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3559" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3559" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2239" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2238" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2237" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2236" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2235" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2234" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2233" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2232" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-6" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2231" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3580" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3581" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3582" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3583" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3584" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3585" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3586" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3587" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3587" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3587" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3588" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3589" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2249" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2248" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2247" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2246" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2244" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2243" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2241" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2240" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2240" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2240" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2240" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2240" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2240" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3570" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3571" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3572" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3573" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3574" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3575" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3576" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3577" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3578" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3579" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2259" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2258" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2257" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2256" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2255" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2254" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2253" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2252" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2251" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2250" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3520" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3520" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3521" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3521" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3521" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3521" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3522" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3523" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3524" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3525" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3525" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3525" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3525" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3526" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3526" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3526" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3526" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3528" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3528" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3528" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3528" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3528" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3528" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3528" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3529" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3529" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3529" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3529" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3529" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3510" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3510" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3510" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3510" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3511" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3511" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3511" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3511" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3512" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3512" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3512" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3512" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3513" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3514" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3514" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3514" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3514" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3515" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3516" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3516" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3516" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3516" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3517" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3517" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3517" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3517" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3518" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3518" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3518" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3519" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3540" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3540" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3540" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3540" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3540" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3541" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3541" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3541" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3541" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3541" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3542" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3543" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3544" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3544" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3544" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3544" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3544" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3545" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3546" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3547" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3547" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3547" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3547" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3547" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3548" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3548" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3548" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3548" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3549" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2209" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2208" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2207" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2206" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2205" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2204" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2203" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2202" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2201" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2200" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3530" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3531" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3532" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3532" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3532" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3532" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3532" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3533" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3533" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3533" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3534" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3534" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3535" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3535" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3536" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3537" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3539" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2219" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2218" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2217" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2216" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2215" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2214" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2213" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2212" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2211" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-16" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2210" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4010" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4010" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4010" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4011" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4011" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4011" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4012" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4012" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4012" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4013" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4013" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4013" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4013" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4013" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4014" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4014" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4014" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4015" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4015" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4015" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4015" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4016" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4016" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4016" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4017" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4017" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4017" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4018" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4019" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4000" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4001" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4002" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4003" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4003" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4003" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4003" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4003" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4003" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4004" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4004" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4004" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4004" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4004" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4005" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4005" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4005" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4005" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4005" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4006" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4007" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4008" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4008" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4008" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4009" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4030" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4031" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4032" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4032" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4032" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4032" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4032" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4033" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4033" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4033" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4033" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4033" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4033" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4034" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4034" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4034" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4034" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4034" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4035" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4036" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4036" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4036" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4036" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4037" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4038" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4038" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4038" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4038" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4039" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4040" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4040" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4040" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4040" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4020" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4020" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4020" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4020" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4020" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4021" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4022" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4022" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4022" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4022" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4022" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4023" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-22" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4023" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4023" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4023" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4023" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4024" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4025" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4026" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4026" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4026" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4026" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4027" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4027" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4027" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4027" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4027" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4028" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4028" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4028" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4028" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4029" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4029" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4029" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4029" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2269" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2268" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2267" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2266" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2265" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2264" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2264" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2264" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2264" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2263" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2262" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2261" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2260" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2280" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3590" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3590" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3590" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3591" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3592" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3593" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3594" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3595" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3596" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3597" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3598" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3599" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2279" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2278" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2277" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2276" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2275" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2274" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2273" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2272" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2271" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2270" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2291" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2290" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2289" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2288" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2287" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2286" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2285" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2284" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2283" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2281" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2299" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2298" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2297" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2296" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2295" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2294" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2293" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2292" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4096" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4096" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4096" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4096" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4097" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4098" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4099" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1819" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1819" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1819" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1819" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1818" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1817" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1817" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1817" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1817" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1816" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1815" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1815" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1815" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1815" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1815" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1814" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1814" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1814" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1814" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1814" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1813" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1813" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1813" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1813" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1813" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1812" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1811" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1811" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1811" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1811" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1811" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1810" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4085" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4085" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4085" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4085" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4086" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4086" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4087" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4087" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4087" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4088" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4088" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4089" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4089" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1829" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1828" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1826" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1825" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1824" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1823" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1822" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1821" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1820" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1820" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1820" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1820" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4090" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4090" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4090" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4090" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4091" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4092" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4093" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4093" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4093" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4093" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4093" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4094" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4095" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4095" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4095" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4095" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1839" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1839" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1839" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1839" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1838" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1838" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1838" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1838" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1837" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1837" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1837" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1837" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1836" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1835" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1835" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1835" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1835" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1834" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1833" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1832" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1831" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1831" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1831" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1831" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1830" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1849" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1848" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1847" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1846" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1845" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1844" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1844" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1844" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1843" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1843" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1843" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1843" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1842" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1842" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1842" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1841" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1841" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1841" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1841" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1841" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4052" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4053" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4053" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4053" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4053" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4054" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4054" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4054" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4054" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4054" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4055" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4056" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4057" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4058" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4059" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4060" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4061" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4062" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4062" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4062" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4062" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4062" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4041" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4042" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4042" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4042" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4043" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4044" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4044" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4044" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4045" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4045" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4045" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4045" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4046" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4046" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4046" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4047" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-27" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4047" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4047" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4048" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4048" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4048" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4048" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4049" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4050" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4051" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4051" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4051" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4051" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4051" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4074" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4075" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4076" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4076" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4076" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4076" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4076" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4077" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4077" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4077" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4077" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4077" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4078" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4078" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4078" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4078" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4078" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4079" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4080" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4081" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4081" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4081" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4081" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4081" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4081" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4082" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4083" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4083" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4083" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4083" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4083" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4084" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-24" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4084" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4063" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4063" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4063" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4063" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4063" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4063" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4064" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4065" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4066" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4067" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4068" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4069" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1809" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1809" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1809" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1809" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1809" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-7" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1809" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1808" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1807" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1806" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1805" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-13" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1804" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1803" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-10" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1800" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1800" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4070" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4071" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4072" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-26" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-18" order="7"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-23" order="5"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-30" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-21" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-4073" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-20" order="6"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-839 f-837 f-840" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-11" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3695 f-3696 f-4133 f-4134 f-4148 f-4149 f-3752 f-3753 f-3858 f-3859 f-4385 f-4386 f-4358 f-4359 f-3956 f-3957 f-3983 f-3984 f-3941 f-3942 f-4436 f-4437 f-4439 f-3998 f-3999 f-4489 f-4490 f-4491 f-4459 f-4440 f-4460 f-4461 f-3137 f-3138 f-3206 f-3207 f-4528 f-4529 f-4547 f-4548 f-4516 f-4517 f-4505 f-4506 f-3240 f-4577 f-4578 f-4566 f-4567 f-3239 f-4653 f-4654 f-4656 f-4657 f-4659 f-4671 f-4672 f-4674 f-4675 f-4677 f-4678 f-4660 f-4662 f-3332 f-4663 f-3333 f-4665 f-4666 f-4668 f-4669 f-4601 f-4602 f-4638 f-4639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-17" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2306 f-2305 f-1949 f-737 f-738 f-1950 f-2419 f-2417 f-2416 f-1971 f-1970 f-2469 f-2468 f-2466 f-2465 f-2478 f-2477 f-2476 f-2423 f-2422 f-2420 f-2438 f-2437 f-698 f-699 f-1180 f-1179 f-612 f-611 f-1394 f-1393 f-1487 f-1486 f-2016 f-2015 f-2013 f-1619 f-1620 f-1729 f-1772 f-1771 f-1787 f-1786 f-1730 f-1745 f-1744 f-1802 f-1801" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-3497" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-19" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-1031 f-1046 f-1003 f-1061 f-1076 f-1130 f-1145 f-2491 f-1109 f-2510 f-2538 f-2584 f-2599 f-2557 f-2573 f-964 f-2644 f-2659 f-2668 f-2662 f-2677 f-2674 f-2671 f-2689 f-2686 f-2683 f-2680 f-877 f-856 f-841" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-2479 f-2489 f-2487 f-2486 f-2485 f-2483 f-2482 f-2481 f-2498 f-2497 f-2496 f-2494 f-2490 f-2509 f-2508 f-2506 f-2505 f-2504 f-2502 f-2501 f-2500 f-2518 f-2517 f-2516 f-2514 f-2529 f-2528 f-2526 f-2525 f-2524 f-2522 f-2521 f-2520 f-2537 f-2536 f-2534 f-2533 f-2532 f-2530 f-2589 f-2587 f-2594 f-2593 f-2591 f-2590 f-2549 f-2548 f-2547 f-2545 f-2544 f-2543 f-2541 f-2556 f-2555 f-2553 f-2552 f-2551 f-2569 f-2563 f-2562 f-2560 f-2579 f-2578 f-2576 f-2572 f-2571 f-2629 f-2627 f-2626 f-2625 f-2623 f-2622 f-2621 f-2638 f-2637 f-2635 f-2630 f-2649 f-2647 f-2643 f-2642 f-2640 f-2658 f-2657 f-2655 f-2654 f-2653 f-2651 f-2650 f-2609 f-2608 f-2606 f-2605 f-2604 f-2602 f-2619 f-2617 f-2616 f-2614 f-2613 f-2612 f-2610" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i33edc808e7824948b94b269ed713a939_1"></div><div style="min-height:7.2pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.773%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:700;line-height:120%">_______________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:700;line-height:120%">_______________________________________________________________________</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.773%"><tr><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-4"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-3">December 31</ix:nonNumeric>, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.773%"><tr><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">814-01299</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:700;line-height:120%">_______________________________________________________________________</span></div><div style="text-align:center"><img src="bxsl-20231231_g1.jpg" alt="Picture1.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:240px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:23pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">Blackstone Secured Lending Fund</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of Registrant as specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:700;line-height:120%">_______________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.642%"><tr><td style="width:1.0%"/><td style="width:46.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">82-7020632</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">345 Park Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-11">31st Floor</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-12">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-13">New York</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-14">10154</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-15">(212)</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-16">503-2100</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:700;line-height:120%">_______________________________________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.018%"><tr><td style="width:1.0%"/><td style="width:32.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.082%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.082%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Shares of Beneficial Interest, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">BXSL</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-20">Yes</ix:nonNumeric>&#160; &#9746; &#160;&#160;No&#160; &#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the Registrant is not required to file reports pursuant to Section&#160;13 or Section 15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160; &#9744; &#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-21">No</ix:nonNumeric>&#160; &#9746;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-22">Yes</ix:nonNumeric>&#160; &#9746; &#160;&#160;No&#160; &#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant has submitted electronically&#160;every Interactive Data File required to be submitted&#160;pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the Registrant was required to submit&#160;such files).<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-23">Yes</ix:nonNumeric>&#160; &#9746; No&#160; &#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act:</span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.642%"><tr><td style="width:1.0%"/><td style="width:20.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.507%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.741%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-24">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-25">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-26">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160; <ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-27">&#9746;</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  <ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-28">&#9744;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).  &#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is a shell company (as defined in Rule&#160;12b-2 of the Act).&#160;&#160;&#160;YES&#160; &#9744; &#160;&#160;NO&#160; <ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-29">&#9746;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June 30, 2023, the aggregate market value of the common shares of beneficial interest (&#8220;Common Shares&#8221;) held by non-affiliates of the Registrant was $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-6" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="6" id="f-30">4,432</ix:nonFraction> million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of shares of Registrant&#8217;s common shares of beneficial interest (&#8220;Common Shares&#8221;), $0.001 par value per share, outstanding as of February&#160;20, 2024 was <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-31">191,600,986</ix:nonFraction>.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.773%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:7.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_7"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.942%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_13">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_16">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_19">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_19">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_19">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_46">Item&#160;1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_46">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_46">112</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_46">Item&#160;1</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_46">C</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_46">.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_3185">Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_3185">113</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_49">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_49">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_49">114</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_52">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_52">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_52">114</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_55">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_55">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_55">114</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_58">PART&#160;II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_61">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_61">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_61">115</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_70">Item&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_70">(Reserved)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_70">117</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_73">Item&#160;7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_73">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_73">118</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_109">Item&#160;7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_109">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_109">130</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_112">Item&#160;8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_112">Consolidated Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_112">132</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_193">Item&#160;9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_193">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_193">211</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_196">Item&#160;9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_196">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_196">211</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_202">Item&#160;9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_202">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_202">212</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_205">Item&#160;9C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_205">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_202">212</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_208">PART&#160;III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_211">Item&#160;10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_211">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_211">213</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_214">Item&#160;11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_214">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_214">220</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_217">Item&#160;12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_217">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_217">220</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_220">Item&#160;13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_220">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_220">222</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_223">Item&#160;14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_223">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_223">223</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_226">PART&#160;IV</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_229">Item&#160;15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_229">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_229">226</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_232">Item&#160;16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_232">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_232">231</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_235">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_235">232</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_10"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about Blackstone Secured Lending Fund (together, with its consolidated subsidiaries, the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Company,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;we,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;us,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;our&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), our current and prospective portfolio investments, our industry, our beliefs and opinions, and our assumptions. Words such as &#8220;anticipates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;continue,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;targets,&#8221; &#8220;projects,&#8221; &#8220;outlook,&#8221; &#8220;potential,&#8221; &#8220;predicts&#8221; and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our future operating results;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our business prospects and the prospects of the companies in which we may invest;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the investments that we expect to make;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to raise sufficient capital and buy back shares to execute our investment strategy;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">general economic, logistical and political trends and other external factors, including inflation and recent supply chain disruptions and their impacts on our portfolio companies and on the industries in which we invest;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our portfolio companies to achieve their objectives;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our current and expected financing arrangements and investments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the general interest rate environment;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the adequacy of our cash resources, financing sources and working capital;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and amount of cash flows, distributions and dividends, if any, from our portfolio companies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our contractual arrangements and relationships with third parties;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual and potential conflicts of interest with Blackstone Credit BDC Advisors LLC (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Adviser&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or any of its affiliates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the dependence of our future success on the general economy and its effect on the industries in which we may invest;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our use of financial leverage including the use of borrowed money to finance a portion of our investments and the availability of equity and debt capital on favorable terms or at all;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our business prospects and the prospects of our portfolio companies, including our and their ability to effectively respond to the macroeconomic effects from adverse public health developments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the Adviser to source suitable investments for us and to monitor and administer our investments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of future acquisitions and divestitures;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the Adviser or its affiliates to attract and retain highly talented professionals;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general price and volume fluctuations in the stock market;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain our qualification as a regulated investment company and as a business development company (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BDC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">);</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact on our business of U.S. and international financial reform legislation, rules and regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of changes to tax legislation and our tax position; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the tax status of the enterprises in which we may invest.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of any projection or forward-looking statement in this report should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described or identified in the section entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1A. Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and elsewhere in this report. These forward-looking statements apply only as of the date of this report. Moreover, we assume no duty and do not undertake to update the forward-looking statements, except as required by applicable law. You are advised to consult any additional disclosures that we make directly to you or through reports that we have filed or in the future file with the Securities and Exchange Commission (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;SEC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) including annual reports on Form 10-K, registration statements on Form N-2, quarterly reports on Form 10-Q and current reports on Form 8-K. This annual report on Form 10-K contains statistics and other data that have been obtained from or compiled from information made available by third-party service providers. We have not independently verified such statistics or data.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we are an investment company, the forward-looking statements and projections contained in this report are excluded from the safe harbor protection provided by Section 21E of the U.S. Securities Exchange Act of 1934, as amended (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Exchange Act&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factor Summary</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following is only a summary of the principal risks that may materially adversely affect our business, financial condition, results of operations and cash flows. The following should be read in conjunction with the more complete discussion of the risk factors we face, which are set forth in the section entitled &#8220;Item 1A. Risk Factors&#8221; in this report.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Structure</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Price declines in the medium- and large-sized U.S. corporate debt market may adversely affect the fair value of our portfolio and our market price.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to achieve our investment objectives depends on the ability of the Adviser to manage and support our investment process largely through relationships with private equity sponsors, investment banks and commercial banks.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our Board of Trustees (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Board&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) may change our operating policies and strategies or amend our Declaration of Trust without prior notice or shareholder approval, the effects of which may be adverse to our results of operations and financial condition.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may face increasing competition for investment opportunities, have difficulty sourcing investment opportunities and experience fluctuations in our quarterly results.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As required by the 1940 Act (as defined below), a significant portion of our investment portfolio is and will be recorded at fair value as determined in good faith by our Board and, as a result, there is and will be uncertainty as to the value of our portfolio investments.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">There is a risk that investors in our shares may not receive distributions or that our distributions may decrease over time.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in laws or regulations governing our operations and the possibility of increased regulatory focus on areas related to our business could result in additional burdens on our business.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General economic conditions could adversely affect the performance of our investments and our market price, including recessionary fears, geopolitical events and inflation.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and our portfolio companies and service providers may be subject to cybersecurity risks and our business could be adversely affected by changes to data protection laws and regulations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Investments</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We generally will not control our portfolio companies and our investments in prospective portfolio companies may be risky.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Economic recessions or downturns or restrictions on trade could impair our portfolio companies and adversely affect our operating results.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies and breach covenants or defaults on such debt.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are exposed to risks associated with changes in interest rates.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Second priority liens on collateral securing debt investments that we make to our portfolio companies may be subject to control by senior creditors with first priority liens.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our portfolio may be concentrated in a limited number of industries, which may subject us to specific risks.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Adviser and Its Affiliates</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Adviser and its affiliates, including our officers and some of our trustees, face conflicts of interest caused by compensation arrangements with us and our affiliates, which could result in actions that are not in the best interests of our shareholders.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be obligated to pay the Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio and the compensation paid to the Adviser is determined without independent assessment.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Adviser relies on key personnel, the loss of any of whom could impair its ability to successfully manage us.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Business Development Companies</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The requirement that we invest a sufficient portion of our assets in assets of the type listed in Section 55(a) of the 1940 Act (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Qualifying Assets&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) could preclude us from investing in accordance with our current business strategy; conversely, the failure to invest a sufficient portion of our assets in Qualifying Assets could result in our failure to maintain our status as a BDC.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulations governing our operation as a BDC and regulated investment company (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;RIC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) will affect our ability to raise, and the way in which we raise, additional capital or borrow for investment purposes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Debt Financing</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We borrow money, which magnifies the potential for loss on amounts invested in us and may increase the risk of investing in us. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provisions in a credit facility may limit our investment discretion.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to risks associated with the unsecured notes and debt securitizations that we have issued and our credit facilities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Income Tax Risks</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will be subject to corporate-level income tax if we are unable to maintain RIC tax treatment under Subchapter M of Internal Revenue Code of 1986, as amended (together with the rules and regulations promulgated thereunder, the &#8220;Code&#8221;) or satisfy RIC distribution requirements.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our portfolio investments may present special tax issues.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Legislative or regulatory tax changes could adversely affect investors.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to an Investment in the Common Shares</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Shares of closed-end management investment companies, including BDCs, often trade at a discount to their net asset value.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An investment in our shares involves a high degree of risk and the market price of our securities could fluctuate significantly.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">There is a risk that investors in our equity securities will not receive distributions or that our distributions do not grow over time and a portion of our distributions could be a return of capital.</span></div><div style="margin-top:9pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Website Disclosure</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use our website (www.bxsl.com) as a channel of distribution of company information. The information we post through this channel may be deemed material. Accordingly, investors should monitor this channel, in addition to following our press releases, SEC filings and public conference calls, and webcasts. In addition, you may automatically receive email alerts and other information about the Company when you enroll your email address by visiting the &#8220;Contact Us&#8221; section of our website at http://ir.bxsl.com. The contents of our website and any alerts are not, however, a part of this report.</span></div><div style="margin-top:9pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Disclosure</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent required by laws implementing the European Union Directive on Alternative Investment Fund Managers (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directive&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in any relevant European Economic Area member state, the information in respect of the Company required to be disclosed pursuant to Article 23(4) and (5) of the Directive will be made available to each applicable shareholder. In respect of the period ended December&#160;31, 2023, there have been no material changes to the information listed in Article 23 of the Directive.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_13"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i33edc808e7824948b94b269ed713a939_16"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Secured Lending Fund (together with its consolidated subsidiaries, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Company&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;we&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;us,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;our&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), is a Delaware statutory trust formed on March 26, 2018, and structured as an externally managed, non-diversified, closed-end management investment company. On October 26, 2018, the Company elected to be regulated as a business development company (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BDC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) under the&#160;Investment Company Act of 1940, as amended (together with the&#160;rules and regulations promulgated thereunder, the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;1940 Act&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). In addition, the Company has elected to be treated for U.S. federal income tax purposes, and intends to qualify annually, as a regulated investment company (a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;RIC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) under the Subchapter M of the Internal Revenue Code of&#160;1986, as amended (together with the rules and regulations promulgated thereunder, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Code&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are externally managed by Blackstone Credit BDC Advisors LLC (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Adviser&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), an affiliate of Blackstone Alternative Credit Advisors LP (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Administrator&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and, collectively with its affiliates in the credit, asset based finance and insurance asset management business unit of Blackstone Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Blackstone&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Blackstone Credit &amp; Insurance,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BXCI,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Administration Agreement&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).&#160;References herein to information about Blackstone Credit &amp; Insurance from December 31, 2023 or prior refers solely to the Adviser and Blackstone Alternative Credit Advisors LP, collectively with their credit-focused affiliates within Blackstone Credit &amp; Insurance.</span></div><ix:nonNumeric contextRef="c-1" name="cef:InvestmentObjectivesAndPracticesTextBlock" id="f-36" continuedAt="f-36-1" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. We believe that Blackstone&#8217;s investment platform provides us with a competitive advantage in selecting investments, and to achieve our investment objectives, we will leverage the Adviser&#8217;s investment team&#8217;s and Blackstone&#8217;s extensive network of relationships with other sophisticated institutions to source, evaluate and, as appropriate, partner with on transactions. There are no assurances that we will achieve our investment objectives.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under normal market conditions, we generally invest at least 80% of our total assets (net assets plus borrowings for investment purposes) in secured debt investments. Our portfolio is composed primarily of first lien senior secured and unitranche loans. To a lesser extent, we have and may continue to also invest in second lien, third lien, unsecured or subordinated loans and other debt and equity securities. In limited instances we may retain the &#8220;last out&#8221; portion of a first-lien loan. In such cases, the &#8220;first out&#8221; portion of the first lien loan would receive priority with respect to payment over our &#8220;last out&#8221; position. In exchange for the higher risk of loss associated with such &#8220;last out&#8221; portion, we would earn a higher rate of interest than the &#8220;first out&#8221; position. We do not currently expect to focus on investments in issuers that are distressed or in need of rescue financing. Subject to the limitations of the 1940 Act, we may invest in loans or other securities, the proceeds of which may refinance or otherwise repay debt or securities of companies whose debt is owned by other Blackstone Credit &amp; Insurance funds.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a BDC, at least 70% of our assets must be the type of &#8220;qualifying&#8221; assets listed in Section 55(a) of the 1940 Act, as described herein, which are generally privately-offered securities issued by U.S. private or thinly-traded companies. We may also invest up to 30% of our portfolio opportunistically in &#8220;non-qualifying&#8221; portfolio investments, such as investments in non-U.S. companies. We generally intend to distribute substantially all of our available earnings annually by making quarterly cash distributions. We use leverage and intend to continue to use leverage for our investment activities. We use and intend to continue to use leverage, which is permitted up to the maximum amount allowed by the 1940 Act (currently limited to a debt-to-equity ratio of 2:1), to enhance potential returns. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Financial Condition, Liquidity and Capital Resources&#8212;Borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the Company priced its initial public offering (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;IPO&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), and the Company's common shares of beneficial interest (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Common Shares&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) began trading on the New York Stock Exchange (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;NYSE&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Consolidated Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 8. Net Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Investment Adviser</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment activities are managed by our Adviser, a subsidiary of Blackstone Alternative Credit Advisors LP. The principal executive offices of our Adviser are located at 345 Park Avenue, 31st Floor New York, NY, 10154. Our Adviser is responsible for originating prospective investments, conducting research and due diligence investigations on potential investments, analyzing investment opportunities, negotiating and structuring our investments and monitoring our investments and portfolio companies on an ongoing basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conducting our investment activities, we believe that we benefit from the significant scale and resources of Blackstone Credit &amp; Insurance, including our Adviser and its affiliates, subject to the policies and procedures of Blackstone regarding the management of conflicts of interest. In order to source transactions, the Adviser utilizes its significant access to transaction flow, along with its trading platform. The Adviser seeks to generate investment opportunities through direct origination channels as well as through syndicate and club deals. With respect to Blackstone Credit &amp; Insurance&#8217;s origination channel, the global presence of Blackstone Credit &amp; Insurance generates access to a substantial amount of directly originated transactions with what we believe to be attractive investment characteristics. With respect to syndicate and club deals (i.e., where a limited number of investors participate in a loan transaction), Blackstone Credit &amp; Insurance has built a network of relationships with commercial and investment banks, finance companies and other investment funds as a result of the long track record of its investment professionals in the leveraged finance marketplace. Blackstone Credit &amp; Insurance also has a significant trading platform, which, we believe, allows us access to the secondary market for investment opportunities. Blackstone Credit &amp; Insurance employs a rigorous investment process and defensive investment approach to evaluate all potential opportunities with a focus on long-term credit performance and principal protection. The investment professionals employed by Blackstone Credit &amp; Insurance have spent their careers developing the resources necessary to invest in private companies. Before undertaking an investment, the Adviser&#8217;s transaction team conducts a thorough and rigorous due diligence review of the opportunity to ensure the portfolio company fits our investment strategy.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Adviser&#8217;s investment committee (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Investment Committee&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is responsible for reviewing and approving our investment opportunities. The Adviser&#8217;s Investment Committee review process is consensus-driven, multi-step and iterative, and occurs in parallel with the diligence and structuring of investments. Others who participate in the Investment Committee process include the team responsible for conducting due diligence, others on the investing team and other senior members of Blackstone and Blackstone Credit &amp; Insurance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreed to pay our Adviser a management fee at an annual rate of 1.0% of the average value of our gross assets at the end of the two most recently completed calendar quarters. We also pay the Adviser an income based incentive fee based on our aggregate pre-incentive fee net investment income from the calendar quarter then ending and the eleven preceding calendar quarters. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Advisory Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The members of the senior management and Investment Team of the Adviser serve or may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do, or of investment funds managed by the same personnel. As a result, the Adviser, its officers and employees and certain of its affiliates will have conflicts of interest in allocating their time between us and other activities in which they are or may become involved, including the management of its affiliated equipment funds. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 1A. Risk Factors&#8212;Risks Related to the Adviser and Its Affiliates and &#8211;Allocation of Investment Opportunities and Potential Conflicts of Interests and &#8211;Allocation of Investment Opportunities and Potential Conflicts of Interests&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Administrator</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Alternative Credit Advisors LP, a Delaware limited partnership, serves as our Administrator. The principal executive offices of our Administrator are located at 345 Park Avenue, New York, New York 10154. We reimburse the Administrator for its costs, expenses and allocable overhead (including rent, office equipment and utilities) in connection with administrative services performed for us. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Administration Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for more information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Credit &amp; Insurance</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance is the credit, asset based finance and insurance asset management business unit of Blackstone, which is the largest alternative asset manager in the world with leading investment businesses across asset classes. Blackstone&#8217;s platform provides significant competitive advantages including scale, expertise across industries and capital structures, and deep relationships with companies and financial sponsors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone&#8217;s four business segments are real estate, private equity, credit and insurance, and hedge fund solutions. Through its different investment businesses, as of December&#160;31, 2023, Blackstone had total assets under management (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;AUM&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of more than $1&#160;trillion. As of December&#160;31, 2023, Blackstone Credit &amp; Insurance&#8217;s asset management operation had aggregate AUM of $318.9&#160;billion across private corporate credit, liquid corporate credit, and infrastructure and asset based credit. Blackstone Credit &amp; Insurance&#8217;s total AUM includes AUM of a platform managed by Harvest Fund Advisors LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Harvest&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which primarily invests in publicly traded energy infrastructure, renewables and master limited partnerships holding midstream energy assets in North America. Effective the second quarter of 2024, Harvest will be included in Blackstone Alternative Asset Management, which will be renamed Blackstone Multi-Asset Investing effective the first quarter of 2024. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance, through its affiliates, employed 626 people headquartered in New York and in offices globally as of January 1, 2024. Blackstone Credit &amp; Insurance&#8217;s 360-person private credit investment team also includes an 84-person Chief Investment Office team, which consists of individuals focused on Underwriting &amp; Execution, Capital Formation, Asset Allocation, Structuring, Asset Management, Portfolio Insights, and Portfolio Analytics. Blackstone Credit &amp; Insurance&#8217;s Senior Managing Directors have on average 24 years of industry experience. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Opportunity</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that there are and will continue to be significant investment opportunities in the targeted asset classes discussed below.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attractive Opportunities in Floating Rate, Senior Secured Loans</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that opportunities in senior secured loans are significant because of the strong defensive characteristics of this asset class. While there is inherent risk in investing in any securities, senior secured debt is on the top of the capital structure and thus has priority in payment among an issuer&#8217;s security holders (i.e., senior secured debt holders are due to receive payment before junior creditors and equity holders). Further, these investments are secured by the issuer&#8217;s assets, which may be collateralized in the event of a default, if necessary. Senior secured debt often has restrictive covenants for the purpose of additional principal protection and ensuring repayment before junior creditors (i.e., most types of unsecured bondholders, and other security holders) and preserving collateral to protect against credit deterioration. The senior secured loans we invest in will generally pay floating interest rates based on a variable base rate, such as the Secured Overnight Financing Rate (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;SOFR&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). We expect that our loans will generally pay floating interest rates and are likely to benefit from a rising rate environment. With base rates (3 month SOFR) at approximately 5.33% as of December 29, 2023, we believe the market provides an attractive opportunity to generate strong all-in yields and risk-adjusted returns for investors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opportunity in U.S. Private Companies</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to investing in senior secured loans generally, we believe that the market for lending to private companies, which includes larger and middle market private companies within the United States, is underserved and presents a compelling investment opportunity. We believe that the following characteristics support our belief:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Secular Tailwinds in the Private Market, Including Private Credit.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> One of the important drivers of growth in the strategy is the increasing secular tailwinds in the private markets (i.e., social or economic trends positively impacting private markets), including growing demand for private credit, which has created attractive opportunities for private capital providers like&#160;Blackstone Credit &amp; Insurance. Private equity funds with strategies focused on North America had approximately $1.5&#160;trillion of &#8220;dry powder&#8221; (i.e., uncalled capital commitments) (as of December&#160;31, 2023, as published by Preqin as of February 22, 2024), which should similarly drive demand for private capital providers like&#160;Blackstone Credit &amp; Insurance. This shift is partially due to traditional banks continuing to face regulatory limitations and retreating from the space, creating additional opportunities for private credit to take advantage of. Further, financial sponsors and companies are becoming increasingly interested in working directly with private lenders as they are seeing the tremendous benefits versus accessing the public credit markets. The Company believes some of these benefits include faster execution and greater certainty, ability to partner with sophisticated lenders, a more efficient process, and in some instances fewer regulatory requirements. As a result,&#160;Blackstone Credit &amp; Insurance benefits from increasing flow of larger scale deals that have become increasingly available to the direct lending universe over traditional banks and other financing institutions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Attractive Market Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe that the underserved nature of such a large segment of the market can at times create a significant opportunity for investment. In many environments, we believe that private companies are more likely to offer attractive economics in terms of transaction pricing, up-front and ongoing fees, prepayment penalties and security features in the form of stricter covenants and quality collateral than loans to public companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limited Investment Competition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Despite the size of the market, we believe that regulatory changes and other factors have diminished the role of traditional financial institutions and certain other capital providers in providing financing to companies. As tracked by Leverage Commentary &amp; Data (LCD), private credit markets financed 177 leveraged buyouts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LBO&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) (86% of total LBOs in 2023) compared to the publicly syndicated markets, which financed only 28 (14% of total LBOs in 2023). In addition, due to bank consolidation, the number of banks has also declined during the past several decades, furthering the lack of supply in financing to private companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also believe that lending and originating new loans to private companies generally requires a greater dedication of the lender&#8217;s time and resources compared to lending to public companies, due in part to the size of each investment and the often fragmented nature of information available from these companies. Further, we believe that many investment firms lack the breadth and scale necessary to identify investment opportunities, particularly in regards to directly originated investments in private companies, and thus attractive investment opportunities are often overlooked. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Credit &amp; Insurance Strengths</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance is one of the largest private credit investment platforms globally and a key player in the direct lending space. Blackstone Credit &amp; Insurance has experience scaling funds across its platform that invest in all parts of the capital structure. Blackstone Credit &amp; Insurance focuses on transactions where it can differentiate itself from other providers of capital, targeting large transactions and those where Blackstone Credit &amp; Insurance can bring its expertise and experience in negotiating and structuring. We believe that Blackstone Credit &amp; Insurance has the scale and platform to effectively manage a North American private credit investment strategy, offering investors the following potential strengths:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ability to Provide Scale, Differentiated Capital Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe that the breadth and scale of Blackstone Credit &amp; Insurance&#8217;s platform, with $318.9&#160;billion AUM as of December&#160;31, 2023, and affiliation with Blackstone provide a distinct advantage in sourcing and deploying capital toward proprietary investment opportunities including those that are large and complex. Blackstone Credit &amp; Insurance is invested in over 4,500 corporate issuers across portfolios globally</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and offers its clients and borrowers a comprehensive solution across corporate and asset-based, as well as investment grade and non-investment grade credit. Blackstone Credit &amp; Insurance expects that in the current environment, where committed capital from banks remains scarce, that the ability to provide flexible, well-structured capital commitments in appropriate sizes will enable Blackstone Credit &amp; Insurance to command more favorable terms for its investments. Blackstone Credit &amp; Insurance seeks to generate investment opportunities through its direct origination channels and through syndicate and club deals (generally, investments made by a small group of investment firms). With respect to Blackstone Credit &amp; Insurance&#8217;s origination channel, we seek to leverage the global presence of Blackstone Credit &amp; Insurance to generate access to a substantial amount of directly originated transactions with attractive investment characteristics. We believe that the broad network of Blackstone Credit &amp; Insurance provides a significant pipeline of investment opportunities for us. With respect to syndicate and club deals, Blackstone Credit &amp; Insurance has built a network of relationships with commercial and investment banks, finance companies and other investment funds. Blackstone Credit &amp; Insurance also has a significant trading platform, which, we believe, allows us access to the secondary market for investment opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Established Origination Platform with Strong Credit Expertise. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global presence of Blackstone Credit &amp; Insurance generates access to a substantial amount of directly originated transactions with what Blackstone Credit &amp; Insurance believes to be attractive investment characteristics. Over the last several years, Blackstone Credit &amp; Insurance has expanded its origination and sponsor coverage footprint with regional offices in select markets. We anticipate capitalizing on Blackstone Credit &amp; Insurance&#8217;s global footprint and broad and diverse origination platform to provide, primarily, senior secured financings.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> As of December&#160;31, 2023. Reflects unique corporate issuers across funds and accounts managed by Liquid Credit Strategies, Private Credit Strategies, Infrastructure &amp; Asset Based Credit.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Blackstone Credit &amp; Insurance&#8217;s strong reputation and longstanding relationships with corporate boards, management teams, leveraged buyout sponsors, financial advisors, and intermediaries position Blackstone Credit &amp; Insurance as a partner and counterparty of choice and provides us with attractive sourcing capabilities. In Blackstone Credit &amp; Insurance&#8217;s experience, these relationships help drive substantial proprietary deal flow and insight into investment opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance believes that having one team responsible for private origination allows us to leverage the strengths and experiences of investment professionals to deliver the leading financing solutions to our companies. The team has operated through multiple industry cycles, with deep credit expertise, providing them valuable experience and a long-term view of the market. The team is also focused on making investments in what are characterized as &#8220;good neighborhoods,&#8221; which are industries experiencing favorable tailwinds, such as life sciences, software &amp; technology, and renewable energy. In addition, the team is able to leverage the expertise of other parts of Blackstone&#8217;s business that specialize in these fields.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, over the last several years, Blackstone Credit &amp; Insurance has expanded its North American origination and sponsor coverage footprint by opening regional offices in select markets. Blackstone Credit &amp; Insurance has investment professionals across North America, Europe, Asia and Australia, and has developed a reputation for being a valued partner with the ability to provide speed, creativity, and assurance of transaction execution. We believe Blackstone Credit &amp; Insurance&#8217;s global presence may help Blackstone Credit &amp; Insurance to more effectively source investment opportunities from mid-sized leveraged buyout sponsors, thereby potentially strengthening the Blackstone Credit &amp; Insurance brand.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value-Added Capital Provider and Partner Leveraging the Blackstone Credit &amp; Insurance Value Creation Program. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance has established a reputation for providing creative, value-added solutions to address a company&#8217;s financing requirements and we believe our ability to solve a need for a company can lead to attractive investment opportunities. In addition, Blackstone Credit &amp; Insurance has access to the significant resources of the Blackstone platform, including the Blackstone Credit &amp; Insurance Value Creation Program (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Value Creation Program&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which is a global platform that intends to help Blackstone Credit &amp; Insurance investments create meaningful value by leveraging the scale, network, and expertise within the Blackstone platform. Specifically, the Value Creation Program focuses on three areas of improvement (i) reducing costs by leveraging the scale and purchasing power of Blackstone through our Group Purchasing Organization, preferred partnerships, and the Blackstone Sourcing Center, (ii) identifying cross-sell opportunities across Blackstone&#8217;s portfolio for potential introductions to other Blackstone portfolio companies, which includes a network of over 350 Blackstone portfolio companies as of December&#160;31, 2023 and (iii) providing valuable access to industry and functional experts both within the Blackstone organization (including the Blackstone Portfolio Operations team which consists of over 100 internal resources as of December&#160;31, 2023) who are focused on areas such as cybersecurity, ESG, data science, healthcare, human resources, information technology, among others, and the network among portfolio companies. Through the Value Creation Program, which BXSL portfolio companies can fully access, Blackstone has generated meaningful revenue for Blackstone portfolio companies through cross-sell introductions across Blackstone and created over $3.5&#160;billion of implied enterprise value across Blackstone Credit &amp; Insurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Flexible Investment Approach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance believes that the ability to invest opportunistically throughout a capital structure is a meaningful strength when sourcing transactions and enables the Company to seek investments that provide the best risk/return proposition in any given transaction. Blackstone Credit &amp; Insurance&#8217;s creativity and flexibility with regard to deal-structuring distinguishes it from other financing sources, including traditional mezzanine providers, whose investment mandates are typically more restrictive. Over time, Blackstone Credit &amp; Insurance has demonstrated the ability to negotiate favorable terms for its investments by providing creative structures that add value for an issuer. Blackstone Credit &amp; Insurance will continue to seek to use this flexible investment approach to focus on principal preservation, while generating attractive returns throughout different economic and market cycles.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Amounts presented are since inception of the Value Creation Program in 2016, and data presented is based on internal Blackstone data recorded and not from financial statements of portfolio companies. Represents (a) identified total cost reduction at the time cost is benchmarked with portfolio companies, multiplied by (b) enterprise value multiple at the time of Blackstone Credit &amp; Insurance&#8217;s initial investment. The number is presented for illustrative purposes and does not reflect actual realized proceeds to Blackstone Credit &amp; Insurance or to the equity sponsor or the company, and there can be no assurance that realized proceeds received by Blackstone or any investor in a Blackstone fund, including us, will be increased as a result.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Investment Horizon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term investment horizon gives us great flexibility, which we believe allows us to maximize returns on our investments. Unlike most private equity and venture capital funds, as well as many private debt funds, we will not be required to return capital to our shareholders once we exit a portfolio investment. We believe that freedom from such capital return requirements, which allows us to invest using a long-term focus, provides us with an attractive opportunity to increase total returns on invested capital.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disciplined Investment Process and Income-Oriented Investment Philosophy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance employs a rigorous investment process and defensive investment approach to evaluate all potential opportunities with a focus on long-term credit performance and principal protection. We believe Blackstone Credit &amp; Insurance has generated attractive risk-adjusted returns in its investing activities throughout many economic and credit cycles by (i) maintaining its investment discipline; (ii) performing intensive credit work; (iii) carefully structuring transactions; and (iv) actively managing its portfolios. Blackstone Credit &amp; Insurance&#8217;s investment approach involves a multi-stage selection process for each investment opportunity, as well as ongoing monitoring of each investment made, with particular emphasis on early detection of deteriorating credit conditions at portfolio companies, which would result in adverse portfolio developments. This strategy is designed to maximize current income and minimize the risk of capital loss while maintaining the potential for long-term capital appreciation. Additionally, Blackstone Credit &amp; Insurance&#8217;s senior investment professionals have dedicated their careers to the leveraged finance and private equity sectors, and we believe that their experience in due diligence, credit analysis and ongoing management of investments is invaluable to the success of the North America direct lending investment strategy. Blackstone Credit &amp; Insurance generally targets businesses with leading market share positions, sustainable barriers to entry, high free cash flow generation, strong asset values, liquidity to withstand market cycles, favorable underlying industry trends, strong internal controls and high-quality management teams.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strong Investment Track Record.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blackstone Credit &amp; Insurance&#8217;s track record in private debt lending and investing in below investment grade credit dates back to the inception of Blackstone Credit &amp; Insurance. Since 2005 through December&#160;31, 2023, Blackstone Credit &amp; Insurance has provided approximately $164 billion in capital in privately-originated transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone Credit &amp; Insurance believes that the depth and breadth of its team provides it with a significant competitive advantage in sourcing product on a global basis, structuring transactions and actively managing investments in the portfolio.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Efficient Cost Structure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe that we have an efficient cost structure, as compared to other publicly traded BDCs, with low management fees, expenses, and financing costs. We believe our operating efficiency and senior investment strategy enable us to generate greater risk-adjusted investment returns for our investors relative to other publicly traded BDCs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Scale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Scale allows for more resources to source, diligence and monitor investments, and enables us to move up market where there is often less competition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investment Strategy</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. We seek to meet our investment objectives by:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">utilizing the experience and expertise of the management team of the Adviser, along with the broader resources of Blackstone Credit &amp; Insurance, which include its access to the relationships and human capital of Blackstone Credit &amp; Insurance&#8217;s parent, Blackstone, in sourcing, evaluating and structuring transactions, subject to Blackstone&#8217;s policies and procedures regarding the management of conflicts of interest;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employing a defensive investment approach focused on long-term credit performance and principal protection, generally lending on what the Adviser believes are (i) protective multiples of the borrower&#8217;s earnings before interest, taxes, depreciation and amortization (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;EBITDA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) to its interest coverage obligations, (ii) conservative loan-to-value ratios and (iii) favorable financial covenant protections;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">focusing primarily on loans and securities of private U.S. companies, including syndicated loans, specifically larger and middle market companies. In many market environments, we believe such a focus offers an opportunity for superior risk-adjusted returns;</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Includes invested and committed capital for privately originated and anchor investments across private credit strategies and vehicles since 2005, including Direct Lending, Sustainable Resources, Mezzanine, and Opportunistic. Excludes liquid credit strategy investments.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintaining rigorous portfolio monitoring in an attempt to anticipate and pre-empt negative credit events within our portfolio; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">utilizing the power and scale of Blackstone and the Blackstone Credit &amp; Insurance platform to offer operational expertise to portfolio companies through the Blackstone Credit &amp; Insurance Value Creation Program.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under normal market conditions, we generally invest at least 80% of our total assets (net assets plus borrowings for investment purposes) in secured debt investments and our portfolio is composed primarily of first lien senior secured and unitranche loans. To a lesser extent, we have and may continue to also invest in second lien, third lien, unsecured or subordinated loans and other debt and equity securities. In limited instances we may retain the &#8220;last out&#8221; portion of a first-lien loan. In such cases, the &#8220;first out&#8221; portion of the first lien loan would receive priority with respect to payment over our &#8220;last out&#8221; position. In exchange for the higher risk of loss associated with such &#8220;last out&#8221; portion, we would earn a higher rate of interest than the &#8220;first out&#8221; position. We do not currently focus on investments in issuers that are distressed or in need of rescue financing. Subject to the limitations of the 1940 Act, we may invest in loans or other securities the proceeds of which may refinance or otherwise repay debt or securities of companies whose debt is owned by other Blackstone Credit &amp; Insurance funds.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we do not expect a significant portion of our portfolio to be composed of second lien, third lien, unsecured or subordinated loans, there is no limit on the amount of such loans in which we may invest, subject to compliance with our 80% policy. We may purchase interests in loans or make other debt investments, including investments in senior secured bonds, through secondary market transactions in the &#8220;over-the-counter&#8221; market or directly from our target companies as primary market, directly originated or syndicated investments. In connection with our debt investments, we may on occasion receive equity interests such as warrants or options as additional consideration. We have and may continue to also purchase or otherwise acquire minority interests in the form of common or preferred equity or equity-related securities, such as rights and warrants that may be converted into or exchanged for our common shares or other equity or the cash value of shares or other equity, in our target companies, generally in conjunction with one of our debt investments or through a co-investment with a financial sponsor, such as an institutional investor or private equity firm, or a finance company transaction (such as a joint venture). In addition, a portion of our portfolio may be composed of unsecured bonds, CLOs, other debt securities and derivatives, including total return swaps and credit default swaps. Depending on market conditions, we may increase or decrease our exposure to less senior portions of the capital structure or otherwise make opportunistic investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investment Selection</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When identifying prospective investment opportunities, the Adviser currently intends to rely on fundamental credit analysis in order to minimize the loss of the Company&#8217;s capital. The Adviser expects to invest in companies possessing the following attributes, which it believes will help achieve our investment objectives:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leading, Defensible Market Positions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Adviser intends to invest in companies that it believes have developed strong positions within their respective markets and exhibit the potential to maintain sufficient cash flows and profitability to service their obligations in a range of economic environments. The Adviser will seek companies that it believes possess advantages in scale, scope, customer loyalty, product pricing, or product quality versus their competitors, thereby minimizing business risk and protecting profitability.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proven Management Teams.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Adviser focuses on investments in which the target company has an experienced and high-quality management team with an established track record of success. The Adviser typically requires companies to have in place proper incentives to align management&#8217;s goals with the Company&#8217;s goals.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Equity Sponsorship.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Often the Adviser seeks to participate in transactions sponsored by what it believes to be high-quality private equity firms. The Adviser believes that a private equity sponsor&#8217;s willingness to invest significant sums of equity capital into a company is an implicit endorsement of the quality of the investment. Further, private equity sponsors of companies with significant investments at risk generally have the ability and a strong incentive to contribute additional capital in difficult economic times should operational issues arise, which could provide additional protections for our investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Broad Exposure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Adviser seeks to invest broadly among industries and issuers, thereby potentially reducing the risk of a downturn in any one company or industry having a disproportionate impact on the value of the Company&#8217;s portfolio.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Viable Exit Strategy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to payments of principal and interest, we expect the primary methods for the strategy to realize returns on our investments include refinancings, sales of portfolio companies, and in some cases initial public offerings and secondary offerings. While many debt instruments in which we will invest have stated maturities of five to eight years, we expect the majority to be redeemed or sold prior to maturity. These instruments often have call protection that requires an issuer to pay a premium if it redeems in the early years of an investment. The Investment Team regularly reviews investments and related market conditions in order to determine if an opportunity exists to realize returns on a particular investment. We believe the ability to utilize the entire resources of Blackstone Credit &amp; Insurance, including the public market traders and research analysts, allows the Adviser to gain access to current market information where the opportunity may exist to sell positions into the market at attractive prices.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investment Process Overview</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment activities are managed by our Adviser. The Adviser is responsible for originating prospective investments, conducting research and due diligence investigations on potential investments, analyzing investment opportunities, negotiating and structuring our investments and monitoring our investments and portfolio companies on an ongoing basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The investment professionals employed by Blackstone Credit &amp; Insurance have spent their careers developing the resources necessary to invest in private companies. Our transaction process is highlighted below.</span></div><div style="margin-top:12pt;text-align:center"><img src="bxsl-20231231_g2.jpg" alt="bgxa01.jpg" style="height:40px;margin-bottom:5pt;vertical-align:text-bottom;width:521px"/></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sourcing and Origination</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The private credit investment team, comprised of 97 dedicated investment professionals as of January 1, 2024, is responsible for establishing regular dialogue with, and coverage of, the financial advisory, corporate issuer, financial sponsor, legal and restructuring communities. The team also has regular contact with Wall Street firms, business brokers, industry executives and others who help identify direct origination investment opportunities. Blackstone Credit &amp; Insurance seeks to be a value-added partner to its counterparties in connection with their capital needs, and believes that these relationships have driven, and will continue to drive, substantial proprietary deal flow and insight into investment opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BXSL will seek to generate investment opportunities primarily through direct origination channels. The global presence of Blackstone Credit &amp; Insurance generates access to a substantial amount of directly originated transactions with what it believes to be attractive investment characteristics. Blackstone Credit &amp; Insurance&#8217;s team covers over 200 sponsors with a primary focus on what it believes are the largest, highest quality, and most-well capitalized sponsors, leading to substantial repeat counterparties and making Blackstone Credit &amp; Insurance a partner of choice to these sponsors. In addition to the depth and breadth of Blackstone Credit &amp; Insurance&#8217;s relationships, sponsor and advisor partners also seek to transact with 'Blackstone Credit &amp; Insurance due to its value-add through the Value Creation Program by not only helping companies with operational support, but also enhancing revenue generation and cost savings opportunities for Blackstone Credit &amp; Insurance&#8217;s portfolio companies, all of which further contribute to its origination efforts. With respect to syndicate and club deals, Blackstone Credit &amp; Insurance has built a network of relationships with commercial and investment banks, finance companies and other investment funds as a result of the long track record of its investment professionals in the leveraged finance marketplace. Blackstone Credit &amp; Insurance also has a $109 billion Liquid Credit platform, which, we believe, allows us access to the secondary market for investment opportunities. Blackstone Credit &amp; Insurance covers over 4,500 issuers across its $318.9&#160;billion platform which we believe offers us deep insight across all sectors and industries in our market.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance aims to leverage the broader Blackstone network to generate additional deal flow. Blackstone&#8217;s Private Equity platform has been built over the past 35 years and invests globally across industries in both established and growth-oriented structures. Blackstone&#8217;s Real Estate group is among the largest owners of commercial real estate in the world. Blackstone&#8217;s General Partnership Stakes group,&#160;seeks to serve as a strategic partner to talented managers at all stages of their life cycles and help them build enduring franchises. Through such other business units of Blackstone, Blackstone Credit &amp;&#160;Insurance aims to increase its connectivity and deepen sponsor relationships.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that B</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lackstone</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&amp;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance&#8217;s</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">strong reputation</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">longstanding</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relationships</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">broad</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">network</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">help</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">drive</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">substantial</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proprietary</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deal</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">flow and</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">significant</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pipeline</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opportunities</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">us.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation and Due Diligence</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The hallmark of Blackstone Credit &amp; Insurance&#8217;s approach to investing will continue to be defined by a rigorous due diligence process focused on downside protection and capital preservation. This process includes a thorough business review of the industry, competitive landscape, products, customers, returns on capital, strength of management team and consultation with outside advisors and industry experts, and benefits from Blackstone&#8217;s global platform, offering broad access and insight. When a new investment opportunity is sourced, the Blackstone Credit &amp; Insurance team spends time with management, analyzing the company&#8217;s assets and its financial position. This initial assessment is then followed by extensive credit analysis, including asset valuation work; financial modeling and scenario analysis; cash flow and liquidity analyses; and legal, tax and accounting review. Blackstone Credit &amp; Insurance&#8217;s diligence process will also include a detailed review of key qualitative factors, including the strength of management, quality / strategic value of the company&#8217;s assets, and potential operational risks. Further detail on this process is outlined below.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Review.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The investment team examines information furnished by the target company and external sources, including financial sponsors, banks, advisors and rating agencies, if applicable, to determine whether the investment meets our basic investment criteria within the context of proper allocation of our portfolio among various issuers and industries, and offers an acceptable probability of attractive returns with identifiable downside risk. Blackstone Credit &amp; Insurance conducts detailed due diligence investigations. Given its incumbent positions, for the majority of securities available on the secondary market, a comprehensive analysis is conducted and continuously maintained by a dedicated Blackstone Credit &amp; Insurance research analyst, the results of which are available for the transaction team to review.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Analysis/Due Diligence.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Before undertaking an investment, the investment team conducts a thorough and rigorous due diligence review of the opportunity to ensure the company fits our investment strategy for originated investments, which may include:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a full operational analysis to identify the key risks and opportunities of the target&#8217;s business, including a detailed review of historical and estimated financial results;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a detailed analysis of industry and customer dynamics, competitive position, regulatory, tax, legal, environmental, social and governance matters;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a detailed financial modeling and scenario analysis;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reference calls within the Blackstone network on the company and relevant industry outlook;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on-site visits and customer and supplier reference calls, if deemed necessary;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">background checks to further evaluate management and other key personnel;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a review by legal and accounting professionals, environmental or other industry consultants, if necessary;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a review of financial sponsor due diligence, including portfolio company and lender reference checks, if necessary; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a review of management&#8217;s experience and track record.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties are often involved in the Adviser&#8217;s due diligence process, whether they are hired by the Adviser or by the lead sponsor in a transaction. Utilizing consultants to help evaluate a business and test an investment thesis is typically very beneficial. When possible, the Adviser seeks to structure transactions in such a way that our target companies are required to bear the costs of due diligence, including those costs related to any outside consulting work we may require.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing initial assessment is then followed by extensive credit analysis, including asset valuation, financial analysis, cash flow analysis and scenario analysis, legal and accounting review, and comparable credit and equity analyses. A thorough assessment of structure and leverage of a transaction and how the particular investment fits into the overall investment strategy of the portfolio is conducted. Blackstone Credit &amp; Insurance&#8217;s typical investment process (including diligence) for an originated investment opportunity typically spans two to six months, from the initial screen through final approval and funding. Depending on the deal, each investment team typically consists of four to five investment professionals, consisting of a senior managing director, managing director, principal or vice president and associate and/or analyst.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investment Committee utilizes a consensus-driven approach and includes long-tenured professionals that have been with Blackstone Credit &amp; Insurance on average of over 15 years and have over 22 years of industry experience: Brad Marshall, Michael Zawadzki, Michael Carruthers, Brad Colman, Robert Horn, Valerie Kritsberg, Daniel Oneglia, Viral Patel, Robert Petrini and Louis Salvatore. For transactions above certain size parameters, others who participate in the Investment Committee process include members of Blackstone senior leadership, Jon Gray, Michael Chae, Vik Sawhney, and Ken Caplan, as well as others on the investment team responsible for conducting due diligence, and other senior members of Blackstone Credit &amp; Insurance and broader Blackstone. For certain investments, generally smaller investments where the Company is participating alongside other lenders in a &#8220;club&#8221; deal, providing an anchor order or purchasing broadly syndicated loans, the Investment Committee has delegated the authority to make an investment decision to the CIO or Portfolio Manager of a strategy or fund.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investment Committee review process is multi-step and iterative and occurs in parallel with the diligence and structuring of investments. The initial investment screening process involves an Investment Committee &#8220;Heads-Up&#8221; review presentation by the senior managing director leading a given transaction and members of the investment team. The Heads-Up review involves the production of a short memorandum with a focus on the following diligence items: an early diligence review of the underlying business fundamentals; expected return potential; expected investment size; assessment of key risks; and an appropriate initial diligence plan. At this point in the decision-making process, the Investment Committee will decide whether or not the investment team should proceed with deeper diligence on the investment opportunity.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once in-depth diligence has commenced, the investment team compiles its findings, credit risks and mitigants, and preliminary transaction recommendation into a memorandum that is presented to a select group of senior managing directors in a weekly forum referred to as &#8220;Office Hours.&#8221; Office Hours provides a subset of the Investment Committee the opportunity to review the investment team&#8217;s detailed diligence findings in advance of presenting to the full Investment Committee, and to pose questions and recommendations to the investment team regarding its credit evaluation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate results and findings of the investment analysis, including any follow up diligence items identified at Office Hours, are compiled in comprehensive investment memoranda that are used as the basis to support the investment thesis and are utilized by the Investment Committee (or delegate, if applicable) for final investment review and approval. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each investment requires the consent of the Investment Committee (or delegate, if applicable), which may emphasize the following key criteria (among others) in making a decision:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Company Analysis:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Does the company meet the below key investment criteria? </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">Leading market share position </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">Consistent revenue growth</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">Sustainable barriers to entry that drive pricing power</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">High quality management team</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">Stable financials: strong free cash flow generation, high earnings before interest and tax margins</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">Conservative capital structure with significant underlying equity value</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">Liquidity to withstand market cycles</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Industry Analysis:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Is there a favorable industry structure with respect to customers, suppliers and regulation?</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Due Diligence:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Have we fully diligenced each of the investment criteria? Have we completely vetted each of the risk factors identified throughout the diligence and Investment Committee process? </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Risk of Principal Loss &amp; Risk/Reward:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> What is the expected risk of default on the investment? What is the expected recovery in a severe downside case?</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Valuation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> What is the intrinsic value of the business? How has the business historically generated returns on capital? Will these returns continue in the future? What growth opportunities does the business have, if any? Is there substantial equity value to support the capital structure?</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Sponsor and Management:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Is the sponsor and management someone we want to partner with? Are their incentives aligned with ours?</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Documentation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Do the key terms of the transaction documentation protect us sufficiently?</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Portfolio Construction: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Does the investment fit the broader portfolio? Are we too concentrated with a particular sponsor or industry? </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Return Hurdles:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Is the investment expected to generate a rate of return that meets the Company&#8217;s objectives?</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Exit Plan:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Do we expect refinancings, a sale of the company, or other exit opportunities?</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Portfolio Monitoring</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Active management of our investments is performed by the team responsible for making the initial investment as well as by members of the Office of the CIO. Blackstone Credit &amp; Insurance believes that actively managing an investment allows it to identify problems early and work with companies to develop constructive solutions when necessary. Blackstone Credit &amp; Insurance will monitor our portfolio with a focus toward anticipating negative credit events. In seeking to maintain portfolio company performance and help to ensure a successful exit, Blackstone Credit &amp; Insurance will work closely with, as applicable, the lead equity sponsor, loan syndicator, portfolio company management, consultants, advisers and other security holders to discuss financial position, compliance with covenants, financial requirements and execution of the company&#8217;s business plan. In addition, depending on the size, nature and performance of the transaction, we may occupy a seat or serve as an observer on a portfolio company&#8217;s board of directors or similar governing body.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Typically, Blackstone Credit &amp; Insurance will receive financial reports detailing operating performance, sales volumes, margins, cash flows, financial position and other key operating metrics on a monthly or quarterly basis from portfolio companies. Blackstone Credit &amp; Insurance will use this data, combined with due diligence gained through contact with the company&#8217;s customers, suppliers, competitors, market research and other methods, to conduct an ongoing rigorous assessment of the company&#8217;s operating performance and prospects.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the initial investment team remains primarily responsible for the collection, analysis, and dissemination of financial information received from portfolio companies, portfolio managers and members of the Office of the CIO, consisting of 84 professionals as of January 1, 2024, also review portfolio reporting on a daily, weekly, and monthly basis to identify early signs of outperformance or underperformance. Blackstone Credit &amp; Insurance maintains several formal forums to review and monitor the portfolio. Quarterly portfolio reviews are conducted to identify broad trends across the portfolio and assess recent performance. Blackstone Credit &amp; Insurance conducts industry-specific reviews across both our private and liquids businesses to provide in-depth insights into particular sectors, bringing together comprehensive insights across our platform. In addition, weekly portfolio review committees and monthly Watch List Committee meetings are used for in-depth reviews of credits, as further described below.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In instances of weaker than expected performance, members of the Office of the CIO, including 24 professionals dedicated to portfolio and asset management, may work closely with deal teams to review and diligence the source of underperformance, re-underwrite the business, and develop a comprehensive strategy for go-forward management of the position. Blackstone Credit &amp; Insurance&#8217;s Asset Management Group, housed within the Office of the CIO, comprises a team of functionally-oriented professionals focused on three verticals: Financial Solutions, Operational Asset Management, and Legal / Restructuring. Financial Solutions provides detailed financial analysis, re-underwriting capabilities, and support for portfolio companies such as cash flow estimates or other financial management tools, as needed. Operational Asset Management assesses portfolio company processes, management, and operational capabilities to support and drive operational improvements. Operational Asset Management also is responsible for our Blackstone Credit &amp; Insurance Value Creation Program, which leverages the scale of the broader Blackstone platform in order to improve operations and profitability at Blackstone Credit &amp; Insurance portfolio companies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial reporting for portfolio companies is reviewed on a daily, weekly and monthly basis by deal teams and members of the Office of the CIO, including the Asset Management Group. Blackstone Credit &amp; Insurance utilizes a series of proprietary portfolio dashboards and automated reports to ensure responsible parties receive detailed information on a timely basis. Each week, all financial reporting results across the portfolio are aggregated and distributed to the portfolio management team for review. Portfolio company performance updates, including recent developments and go-forward action plans for underperforming assets, are reviewed at portfolio review committee and Watch List Committee meetings. Individual credits are discussed in depth at weekly portfolio review committee meetings, which include members of the Investment Committee. Our formal watch list, which is managed by the Office of the CIO, is reviewed at monthly Watch List Committee meetings, with interim updates as needed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Watch List Committee is comprised of members of the Investment Committee and includes investment professionals from both our Liquid Credit and Private Credit businesses. On a quarterly basis, the watch list is also reviewed in depth with Blackstone senior management including President and COO Jonathan Gray, CFO Michael Chae, and Global Co-CIO Ken Caplan.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation Process</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each quarter, we will value investments in our portfolio, and such values will be disclosed each quarter in reports filed with the SEC. With respect to investments for which market quotations are not readily available, the Board of Trustees reviews the valuation recommendations of the Audit Committee and determines the fair value of each investment in the portfolio in good faith, based on the input of the Audit Committee, the Adviser&#8217;s valuation committee and where applicable, the independent valuation firms and other external service providers, based on procedures adopted by, and subject to the supervision of, the Board of Trustees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managerial Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a BDC, we must offer, and provide upon request, significant managerial assistance to certain of our portfolio companies except where the Company purchases securities of an issuer in conjunction with one or more other persons acting together, one of the other persons in the group makes available such managerial assistance. This assistance could involve, among other things, monitoring the operations of our portfolio companies, participating in board and management meetings, consulting with and advising officers of portfolio companies and providing other organizational and financial guidance, including through the Blackstone Credit &amp; Insurance Value Creation Program. The Adviser and the Administrator will provide such managerial assistance on our behalf to portfolio companies that request this assistance. To the extent fees are paid for these services, we, rather than the Adviser, will retain any fees paid for such assistance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to payments of principal and interest, we expect the primary methods for the strategy to realize returns on its investments to include refinancings, sales of portfolio companies, and in some cases initial public offerings and secondary offerings. While many debt securities in which we will invest have stated maturities of five to seven years, based on Blackstone Credit &amp; Insurance&#8217;s past experience, we believe most of these securities will be redeemed or sold prior to maturity. These securities often have call protection that requires an issuer to pay a premium if it redeems in the early years of an investment. However, there is no assurance that our investments will achieve realization events as a result of refinancings, sales of portfolio companies or public offerings and these realization events will become more unlikely when conditions in the credit and capital markets have deteriorated.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The investment team regularly reviews investments and related market conditions in order to determine if an opportunity exists to realize returns on a particular investment. We believe the Adviser&#8217;s ability to utilize the entire resources of Blackstone Credit &amp; Insurance, including the public market traders, research analysts and capital markets functions, allows the Adviser to gain access to current market information where the opportunity may exist to sell positions into the market at attractive prices.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allocation of Investment Opportunities and Potential Conflicts of Interest</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance, including the Adviser, provides investment management services to other registered investment companies, investment funds, client accounts and proprietary accounts that Blackstone Credit &amp; Insurance may establish (other than the Company) (collectively the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Other Blackstone Credit &amp; Insurance Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). In addition, Blackstone provides investment management services to other registered investment companies, investment funds, client accounts and proprietary accounts that Blackstone may establish (together with the Other Blackstone Credit &amp; Insurance Clients, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Other Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).&#160;See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Item 1A. Risk Factors&#8212;Risks Related to the Adviser and Its Affiliates&#8212;There may be conflicts of interest related to obligations that the Adviser&#8217;s senior management and Investment Team have to other clients.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance will share any investment and sale opportunities with its other clients and the Company in accordance with the Investment Advisers Act of 1940, as amended (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Advisers Act&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and firm-wide allocation policies, which generally provide for sharing pro rata based on targeted acquisition size or targeted sale size. Subject to the Advisers Act and as further set forth in this annual report, certain other clients may receive certain priority or other allocation rights with respect to certain investments, subject to various conditions set forth in such other clients&#8217; respective governing agreements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a BDC regulated under the 1940 Act, the Company is subject to certain limitations relating to co-investments and joint transactions with affiliates, which likely in certain circumstances limit the Company&#8217;s ability to make investments or enter into other transactions alongside other clients.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Co-Investment Relief</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in the past co-invested, and in the future may co-invest, with certain affiliates of the Adviser. We have received an exemptive order from the SEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions which could limit our ability to participate in co-investment transactions. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 13. Certain Relationships and Related Transactions, and Director Independence&#8212;Transactions with Related Persons&#8212;Co-Investment Relief.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 the fair value of our investments was $9,868.4 million in 196 portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 the Company had unfunded delayed draw terms loans and revolvers in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="6" id="f-37">985.9</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the Consolidated Schedule of Investments as of&#160;December&#160;31, 2023 in our consolidated financial statements in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Consolidated Financial Statements and Supplementary Data&#8212;Consolidated Schedule of Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for more information on these investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Resources and Borrowings</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a RIC, we intend to distribute substantially all of our investment company taxable income (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ICTI&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) (as that term is defined in the Code, determined without regard to the deduction for dividends paid) to our shareholders. We anticipate generating cash in the future from the issuance of shares and cash flows from operations, including interest received on our debt investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we are permitted, under specified conditions, to issue multiple classes of indebtedness and one class of shares senior to our shares if our asset coverage, as defined in the 1940 Act, is at least equal to 150% immediately after each such issuance. As of December&#160;31, 2023 and December&#160;31, 2022, the Company&#8217;s asset coverage was <ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" scale="-2" id="f-38">200.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" scale="-2" id="f-39">174.8</ix:nonFraction>%, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, while any indebtedness and senior securities remain outstanding, we must take provisions to prohibit any distribution to our shareholders (which may cause us to fail to distribute amounts necessary to avoid entity-level taxation under the Code), or the repurchase of such securities or shares unless we meet the applicable asset coverage ratios at the time of the distribution or repurchase. In addition, we must also comply with positive and negative covenants customary for these types of facilities. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Financial Condition, Liquidity and Capital Resources.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investment Advisory Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser provides management services to us pursuant to the Investment Advisory Agreement. The Investment Advisory Agreement has been approved by the Board.&#160;Under the terms of the Investment Advisory Agreement, the Adviser is responsible for the following:</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">determining the composition of our portfolio, the nature and timing of the changes to our portfolio and the manner of implementing such changes in accordance with our investment objectives, policies and restrictions;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">identifying investment opportunities and making investment decisions for us, including negotiating the terms of investments in, and dispositions of, portfolio securities and other instruments on our behalf;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">monitoring our investments;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">performing due diligence on prospective portfolio companies;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">exercising voting rights in respect of portfolio securities and other investments for us;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">serving on, and exercising observer rights for, boards of directors and similar committees of our portfolio companies;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">negotiating, obtaining and managing financing facilities and other forms of leverage; and</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">providing us with such other investment advisory and related services as we may, from time to time, reasonably require for the investment of capital.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser&#8217;s services under the Investment Advisory Agreement are not exclusive, and it is free to furnish similar services to other entities, and it intends to do so, so long as its services to us are not impaired.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Investment Advisory Agreement, we pay our Adviser a fee for investment advisory and management services consisting of two components: a management fee and an incentive fee. The cost of both the management fee and the incentive fee will ultimately be borne by the shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The management fee is payable quarterly in arrears at an annual rate 1.0% (which rate was 0.75% prior to the IPO) of the average value of our gross assets at the end of the two most recently completed calendar quarters. For purposes of the Investment Advisory Agreement, &#8220;gross assets&#8221; means our total assets determined on a consolidated basis in accordance with accounting principles generally accepted in the United States (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;GAAP&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), excluding undrawn commitments but including assets purchased with borrowed amounts. For the quarter in which the IPO occurred, the management fee was calculated at a weighted rate calculated based on the fee rates applicable before and after the IPO based on the number of days in such calendar quarter before and after the IPO.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to maintain the same management fee arrangement that the Company had in place prior to the IPO for a period of time following the IPO, the Adviser voluntarily waived its right to receive the base management fee in excess of 0.75% of the average value of the Company&#8217;s gross assets at the end of the two most recently completed calendar quarters from the date of consummation of the IPO through the two year anniversary of the consummation of the IPO (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Waiver Period&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The Waiver Period ended on October 28, 2023. As a result of the fee waiver, the pre-listing management fee and incentive fee rates paid by the Company to the Adviser did not increase during the Waiver Period. Amounts waived by the Adviser are not subject to recoupment by the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The incentive fees consist of two components that are determined independently of each other, with the result that one component may be payable even if the other is not. One component of the incentive fee is based on our income and the other component is based on of our capital gains, each as described below.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(i) Income based incentive fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first part of the incentive fees is based on Pre-Incentive Fee Net Investment Income Returns. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Pre-Incentive Fee Net Investment Income Returns&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means, as the context requires, either the dollar value of, or percentage rate of return on the value of our net assets at the end of the immediately preceding quarter from, interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus our operating expenses accrued for the quarter (including the management fee, expenses payable under the Administration Agreement, and any interest expense or fees on any credit facilities or outstanding debt and dividends paid on any issued and outstanding preferred shares, but excluding the incentive fee).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-Incentive Fee Net Investment Income Returns include, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with payment-in-kind (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;PIK&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) interest and zero coupon securities), accrued income that we have not yet received in cash. Pre-Incentive Fee Net Investment Income Returns do not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The Company excludes the impact of expense support payments and recoupments from pre-incentive fee net investment income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-Incentive Fee Net Investment Income Returns, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, is compared to a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;hurdle rate&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of return of 1.5% per quarter (6.0% annualized).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Investment Advisory Agreement, the Company is required to pay an income based incentive fee of 17.5% (15% prior to the consummation of the IPO), with a 1.5% hurdle and 100% catch-up. The Adviser implemented a voluntary waiver with respect to the income based incentive fee and thereby voluntarily waived its right to receive an income based incentive fee above 15% during the Waiver Period only.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company pays its Adviser an income based incentive fee based on its aggregate pre-incentive fee net investment income, as adjusted as described above, from the calendar quarter then ending and the eleven preceding calendar quarters (such period, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Trailing Twelve Quarters&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The hurdle amount for the income based incentive fee will be determined on a quarterly basis and is equal to 1.5% multiplied by the Company&#8217;s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters. The hurdle amount is calculated after making appropriate adjustments for issuances by the Company of common shares, including issuances pursuant to its dividend reinvestment plan and distributions that occurred during the relevant Trailing Twelve Quarters. The income based incentive fee for any partial period will be appropriately prorated.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the income based incentive fee, the Company will pay the Adviser a quarterly incentive fee based on the amount by which (A) aggregate pre-incentive fee net investment income in respect of the relevant Trailing Twelve Quarters exceeds (B) the hurdle amount for such Trailing Twelve Quarters. The amount of the excess of (A) over (B) described in this paragraph for such Trailing Twelve Quarters is referred to as the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Excess Income Amount.&#8221;</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income based incentive fee for each quarter will be determined as follows:</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">No income based incentive fee is payable to the Adviser for any calendar quarter for which there is no Excess Income Amount;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The Adviser will be paid 100% of the pre-incentive fee net investment income in respect of the Trailing Twelve Quarters, if any, that exceeds the hurdle amount for such Trailing Twelve Quarters, but is less than or equal to an amount, which we refer to as the &#8220;Catch-up Amount,&#8221; determined as the sum of 1.82% (7.27% annualized) (1.76% (7.06% annualized) prior to the end of the Waiver Period), multiplied by the Company&#8217;s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters that is included in the calculation of the Incentive Fee based on income.</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The Adviser will be paid 17.5% (15% prior to the end of the Waiver Period), of the pre-incentive fee net investment income in respect of the Trailing Twelve Quarters that exceeds the Catch-up Amount.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the income based incentive fee that will be paid to the Adviser for a particular quarter will equal the excess of (a) the income based incentive fee so calculated over (b) the aggregate income based incentive fee that was paid in respect of the first eleven calendar quarters included in the relevant Trailing Twelve Quarters subject to the Incentive Fee Cap as described below.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income based incentive fee that will be paid to the Adviser for a particular quarter is subject to a cap (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Incentive Fee Cap&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The Incentive Fee Cap for any quarter is an amount equal to (a) 17.5% (15% prior to the end of the Waiver Period), of the Cumulative Net Return (as defined below) during the relevant Trailing Twelve Quarters minus (b) the aggregate income based incentive fee that was paid in respect of the first eleven calendar quarters (or the portion thereof) included in the relevant Trailing Twelve Quarters.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Cumulative Net Return&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means (x) the pre-incentive fee net investment income in respect of the relevant Trailing Twelve Quarters minus (y) any Net Capital Loss (as defined below), if any, in respect of the relevant Trailing Twelve Quarters. If, in any quarter, the Incentive Fee Cap is zero or a negative value, the Company will pay no income based incentive fee to the Adviser for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is a positive value but is less than the income based incentive fee that is payable to the Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company will pay an income based incentive fee to the Adviser equal to the Incentive Fee Cap for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is equal to or greater than the income based incentive fee that is payable to the Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company will pay an income based incentive fee to the Adviser equal to the incentive fee calculated as described above for such quarter without regard to the Incentive Fee Cap.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Net Capital Loss&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in respect of a particular period means the difference, if positive, between (i) aggregate capital losses, whether realized or unrealized, in such period and (ii) aggregate capital gains, whether realized or unrealized, in such period.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These calculations are prorated for any period of less than three months and adjusted for any share issuances or repurchases during the relevant quarter. A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, an increase in interest rates would make it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase of the amount of incentive fees payable to the Adviser with respect to Pre-Incentive Fee Net Investment Income Returns. Because of the structure of the incentive fee, it is possible that we may pay an incentive fee in a calendar quarter in which we incur an overall loss taking into account capital account losses. For example, if we receive Pre-Incentive Fee Net Investment Income Returns in excess of the quarterly hurdle rate, we will pay the applicable incentive fee even if we have incurred a loss in that calendar quarter due to realized and unrealized capital losses. Because the Waiver Period ended on a date other than the first day of a calendar quarter (the Waiver Period ended on October 28, 2023), the applicable Incentive Fee was calculated for such calendar quarter at a weighted rate calculated based on the fee rates applicable during and after the Waiver Period based on the number of days in such calendar quarter during and after the Waiver Period. In no event will the amendments to the income based incentive fee to include the three year income and total return lookback features allow the Adviser to receive greater cumulative income based incentive fees under the Investment Advisory Agreement than it would have under the prior investment advisory agreement. Amounts waived by the Adviser are not subject to recoupment by the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a graphical representation of the calculation of the Incentive Fee based on income:</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Incentive Fee Based on Income Prior to the end of the Waiver Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Percentage of pre-incentive fee net income comprising the Incentive Fee based on Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(expressed as an annualized rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">of return on the value of net assets as of the beginning of each of the quarters included in the Trailing Twelve Quarters)</span></div><div style="margin-top:12pt;text-align:center"><img src="bxsl-20231231_g3.jpg" alt="Capture (002).jpg" style="height:133px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Following the end of the Waiver Period, the Catch-up Amount increased to 7.27% annualized and the income based incentive fee increased to 17.5%.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">The income based incentive fee is determined on a quarterly basis but has been annualized for purposes of the above diagram. The diagram also does not reflect the Incentive Fee Cap.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(ii) Capital Gains based incentive fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the consummation of the IPO, the second part of the incentive fee, a capital gains incentive fee, has been determined and payable in arrears as of the end of each calendar year in an amount equal to 17.5% of realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees as calculated in accordance with GAAP.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, the second part of the incentive fee, a capital gains incentive fee, was determined and payable in arrears as of the end of each calendar year in an amount equal to 15.0% of realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees as calculated in accordance with GAAP.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, similar to the voluntary waivers referenced above, the Adviser voluntarily waived its right to receive a capital gains based incentive fee above 15% from the date of consummation of the IPO through the Waiver Period, which ended on October 28, 2023. The Company will accrue, but will not pay, a capital gains incentive fee with respect to unrealized appreciation because a capital gains incentive fee would be owed to the Adviser if the Company were to sell the relevant investment and realize a capital gain. Amounts waived by the Adviser are not subject to recoupment by the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fees that are payable under the Investment Advisory Agreement for any partial period are appropriately prorated.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Administration Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Administration Agreement, the Administrator provides, or oversees the performance of, administrative and compliance services, including, but not limited to, maintaining financial records, overseeing the calculation of NAV, compliance monitoring (including diligence and oversight of our other service providers),&#160;preparing reports to shareholders and reports filed with the SEC, preparing materials and coordinating meetings of our Board, managing the payment of expenses and the performance of administrative and professional services rendered by others and providing office space, equipment and office services. We will reimburse the Administrator for its costs, expenses and allocable portion of overhead (including rent, office equipment and utilities) in connection with the services performed for us pursuant to the terms of the Administration Agreement. In addition, pursuant to the terms of the Administration Agreement, the Administrator may delegate its obligations under the Administration Agreement to an affiliate or to a third party and we will reimburse the Administrator for any services performed for us by such affiliate or third party. The Administrator has hired a sub-administrator to assist in the provision of administrative services. The sub-administrator receives compensation for its provision of sub-administrative services under a sub-administration agreement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Terms of the Investment Advisory Agreement and Administration Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Investment Advisory Agreement and the Administration Agreement has been approved by the Board.&#160;Unless earlier terminated as described below, each of the Investment Advisory Agreement and the Administration Agreement will remain in effect for a period of two years from the date it first became effective and will remain in effect from year-to-year thereafter if approved annually by a majority of the Board or by the holders of a majority of our outstanding voting securities and, in each case, a majority of the independent trustees. We may terminate the Investment Advisory Agreement or the Administration Agreement, without payment of any penalty, upon 60 days&#8217; written notice.&#160;The decision to terminate either agreement may be made by a majority of the Board or the shareholders holding a majority outstanding voting securities, which means the lesser of (1) 67% or more of such company&#8217;s voting securities present at a meeting if more than 50% of the outstanding voting securities of such company are present or represented by proxy, or (b) more than 50% of the outstanding voting securities of such company.&#160;In addition, the Adviser may terminate the Investment Advisory Agreement or the Administrator may terminate the Administration Agreement, without payment of any penalty, upon 60 days&#8217; written notice.&#160;The Investment Advisory Agreement will automatically terminate within the meaning of the 1940 Act and related SEC guidance and interpretations in the event of its assignment.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser and the Administrator shall not be liable for any error of judgment or mistake of law or for any act or omission or any loss suffered by the Company in connection with the matters to which the Investment Advisory Agreement&#160;and Administration Agreement, respectively, relate, provided that the Adviser and Administrator shall not be protected against any liability to the Company or its shareholders to which the Adviser or Administrator would otherwise be subject by reason of willful misfeasance, bad faith or gross negligence on its part in the performance of its duties or by reason of the reckless disregard of its duties and obligations (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;disabling conduct&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Each of the Investment Advisory Agreement and the Administration Agreement provides that, absent disabling conduct, each of our Adviser and our Administrator, as applicable, and its officers, managers, partners, agents, employees, controlling persons, members and any other person or entity affiliated with it are entitled to indemnification from us for any damages, liabilities, costs and expenses (including reasonable attorneys&#8217; fees and amounts reasonably paid in settlement) arising from the rendering of our Adviser&#8217;s services under the Investment Advisory Agreement and our Administrator&#8217;s services under the Administration Agreement or otherwise as adviser or administrator for us. The Adviser and the Administrator shall not be liable under their respective agreements with us or otherwise for any loss due to the mistake, action, inaction, negligence, dishonesty, fraud or bad faith of any broker or other agent; provided, that such broker or other agent shall have been selected, engaged or retained and monitored by the Adviser or the Administrator in good faith, unless such action or inaction was made by reason of disabling conduct, or in the case of a criminal action or proceeding, where the Adviser or Administrator had reasonable cause to believe its conduct was unlawful.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally intend to distribute substantially all of our available earnings annually by paying distributions on a quarterly basis, as determined by the Board in its discretion. We cannot assure investors that we will achieve investment results that will allow us to make a specified level of cash distributions or year-to-year increases in cash distributions. Our distributions will generally be paid from current and/or accumulated tax earnings and profits, which includes interest income and capital gains generated by our investment portfolio, and any other income, including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees, that we receive from portfolio companies, if any. However, if we do not have sufficient current and/or accumulated tax earnings and profits to support our distributions, all or a part of such a distribution may be characterized as a return of capital for U.S. tax purposes. The specific tax characteristics of our dividends and other distributions are reported to shareholders after the end of each calendar year. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities &#8211; Distributions and Dividend Reinvestment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Plan</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Board authorized a share repurchase plan, under which we may repurchase up to $250&#160;million in the aggregate of our outstanding common shares in the open market at prices below our NAV per share for a one-year term, in accordance with the guidelines specified in Rule 10b-18 of the Exchange Act (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Company 10b-18 Plan&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing, manner, price and amount of any share repurchases will be determined by us, in our sole discretion, based upon the evaluation of economic and market conditions, stock price, applicable legal and regulatory requirements and other factors. The Company 10b-18 Plan does not require us to repurchase any specific number of shares of common shares or any shares of common shares at all. Consequently, we cannot assure shareholders that any specific number of shares of common shares, if any, will be repurchased under the Company 10b-18 Plan. The Company 10b-18 Plan may be suspended, extended, modified or discontinued at any time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on our distributions and dividend reinvestment plan, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 8. Consolidated Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 8. Net Assets.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete for investments with other BDCs and investment funds (including private equity funds, mezzanine funds, performing and other credit funds, and funds that invest in CLOs, structured notes, derivatives and other types of collateralized securities and structured products), as well as traditional financial services companies such as commercial banks and other sources of funding. These other BDCs and investment funds might be reasonable investment alternatives to us and may be less costly or complex with fewer and/or different risks than we have. Moreover, alternative investment vehicles, such as hedge funds, have begun to invest in areas in which they have not traditionally invested, including making investments in middle market private U.S. companies. As a result of these new entrants, competition for investment opportunities in middle market private U.S. companies may intensify. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of capital and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have. These characteristics could allow our competitors to consider a wider variety of investments, establish more relationships and offer better pricing and more flexible structuring than we are able to do. We may lose investment opportunities if we do not match our competitors&#8217; pricing, terms or structure. If we are forced to match our competitors&#8217; pricing, terms or structure, we may not be able to achieve acceptable returns on our investments or may bear substantial risk of capital loss. A significant part of our competitive advantage stems from the fact that the market for investments in middle market private U.S. companies is underserved by traditional commercial banks and other financial sources. A significant increase in the number and/or the size of our competitors in this target market could force us to accept less attractive investment terms. Furthermore, many of our competitors have greater experience operating under, or are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information concerning the competitive risks we face, see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Item 1A.&#8212;Risk Factors&#8212;Risks Related To Our Business And Structure.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Resource Capital</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently have any employees and do not expect to have any employees. Services necessary for our business are provided by individuals who are employees of the Adviser or its affiliates pursuant to the terms of the Investment Advisory Agreement and the Administrator or its affiliates pursuant to the Administration Agreement. Each of our executive officers described herein is employed by the Adviser or its affiliates. Our day-to-day investment operations are managed by the Adviser. The services necessary for the sourcing and administration of our investment portfolio will be provided by investment professionals employed by the Adviser or its affiliates. The Investment Team will focus on origination, non-originated investments and transaction development and the ongoing monitoring of our investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation as a Business Development Company</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion is a general summary of the material prohibitions and descriptions governing BDCs generally. It does not purport to be a complete description of all of the laws and regulations affecting BDCs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Qualifying Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, a BDC may</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acquire any asset other than assets of the type listed in Section&#160;55(a) of the 1940 Act, which are referred to as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Qualifying Assets&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> unless, at the time the acquisition is made, Qualifying Assets represent at least 70% of the company&#8217;s total assets. The principal categories of Qualifying Assets relevant to our business are any of the following:</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Securities purchased in transactions not involving any public offering from the issuer of such securities, which issuer (subject to certain limited exceptions) is an Eligible Portfolio Company (as defined below), or from any person who is, or has been during the preceding 13 months, an affiliated person of an Eligible Portfolio Company, or from any other person, subject to such rules as may be prescribed by the SEC. An </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Eligible Portfolio Company&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is defined in the 1940 Act as any issuer which:</span></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">is organized under the laws of, and has its principal place of business in, the United States;</span></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">is not an investment company (other than a small business investment company wholly-owned by the BDC) or a company that would be an investment company but for certain exclusions under the 1940 Act; and</span></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">satisfies any of the following:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;padding-left:144pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">does not have any class of securities that is traded on a national securities exchange;</span></div><div style="margin-top:9pt;padding-left:144pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">has a class of securities listed on a national securities exchange, but has an aggregate market value of outstanding voting and non-voting common equity of less than $250 million;</span></div><div style="margin-top:9pt;padding-left:144pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">is controlled by a BDC or a group of companies including a BDC and the BDC has an affiliated person who is a director of the Eligible Portfolio Company; or</span></div><div style="margin-top:9pt;padding-left:144pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">is a small and solvent company having total assets of not more than $4 million and capital and surplus of not less than $2 million.</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Securities of any Eligible Portfolio Company controlled by the BDC.</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Securities purchased in a private transaction from a U.S. issuer that is not an investment company or from an affiliated person of the issuer, or in transactions incident thereto, if the issuer is in bankruptcy and subject to reorganization or if the issuer, immediately prior to the purchase of its securities was unable to meet its obligations as they came due without material assistance other than conventional lending or financing arrangements.</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Securities of an Eligible Portfolio Company purchased from any person in a private transaction if there is no ready market for such securities and the BDC already owns 60% of the outstanding equity of the Eligible Portfolio Company.</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Securities received in exchange for or distributed on or with respect to securities described in (1)&#160;through (4)&#160;above, or pursuant to the exercise of warrants or rights relating to such securities.</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Cash, cash equivalents, U.S. government securities or high-quality debt securities maturing in one year or less from the time of investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a BDC must be operated for the purpose of making investments in the types of securities described in (1), (2)&#160;or (3)&#160;above.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Managerial Assistance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;A BDC must have been organized and have its principal place of business in the United States and must be operated for the purpose of making investments in the types of securities described above. However, in order to count portfolio securities as Qualifying Assets for the purpose of the 70% test, the BDC must either control the issuer of the securities or must offer to make available to the issuer of the securities (other than small and solvent companies described above) significant managerial assistance; except that, where the BDC purchases such securities in conjunction with one or more other persons acting together, one of the other persons in the group may make available such managerial assistance. Making available significant managerial assistance means, among other things, any arrangement whereby the BDC, through its trustees, officers or employees, offers to provide and, if accepted, does so provide, significant guidance and counsel concerning the management, operations or business objectives and policies of a portfolio company through monitoring of portfolio company operations, selective participation in board and management meetings, consulting with and advising a portfolio company&#8217;s officers or other organizational or financial guidance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Temporary Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Pending investment in other types of Qualifying Assets, as described above, our investments can consist of cash, cash equivalents, U.S. government securities or high-quality debt securities maturing in one year or less from the time of investment, which are referred to herein, collectively, as temporary investments, so that 70% of our assets would be Qualifying Assets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Under the 1940 Act, a BDC is subject to restrictions on the issuance, terms and amount of warrants, options or rights to purchase shares that it may have outstanding at any time. In particular, the amount of shares that would result from the conversion or exercise of all outstanding warrants, options or rights to purchase shares cannot exceed 25% of the BDC&#8217;s total outstanding shares.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leverage and Senior Securities; Coverage Ratio.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We are permitted, under specified conditions, to issue multiple classes of indebtedness and one class of stock senior to our shares if our asset coverage, as defined in the 1940 Act, is at or above 150% immediately after each such issuance. On September&#160;25, 2018, our sole shareholder approved the adoption of this 150% threshold pursuant to Section&#160;61(a)(2) of the 1940 Act and such election became effective the following day. In addition, while any senior securities remain outstanding, we are required to make provisions to prohibit any dividend distribution to our shareholders or the repurchase of such securities or shares unless we meet the applicable asset coverage ratios at the time of the dividend distribution or repurchase. We are also permitted to borrow amounts up to 5% of the value of our total assets for temporary or emergency purposes, which borrowings would not be considered senior securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established asset based credit facilities and may establish future facilities or enter into other financing arrangements to facilitate investments and the timely payment of our expenses. Our existing financing facilities bear, and it is anticipated that any future credit facilities will bear interest at floating rates at to be determined spreads over LIBOR. Shareholders indirectly bear the costs associated with any borrowings under a credit facility or otherwise, including increased management fees payable to the Adviser as a result of such borrowings. Our current credit facilities require us, and future lenders may require us to pledge assets, commitments and/or drawdowns (and the ability to enforce the payment thereof) and to comply with positive or negative covenants that could have an effect on our operations. In addition, from time to time, our losses on leveraged investments may result in the liquidation of other investments held by us and may result in additional drawdowns to repay such amounts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also issued unsecured bonds and may have additional bond offerings in the future. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may enter into a total return swap (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;TRS&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) agreement. A TRS is a contract in which one party agrees to make periodic payments to another party based on the change in the market value of the assets underlying the TRS, which may include a specified security, basket of securities or securities indices during a specified period, in return for periodic payments based on a fixed or variable interest rate. A TRS effectively adds leverage to a portfolio by providing investment exposure to a security or market without owning or taking physical custody of such security or investing directly in such market. Because of the unique structure of a TRS, a TRS often offers lower financing costs than are offered through more traditional borrowing arrangements. The Company would typically have to post collateral to cover this potential obligation.&#160;To the extent the Company complies with the applicable requirements of Rule 18f-4, the leverage incurred through TRS will not be considered a borrowing for purposes of the Company&#8217;s overall leverage limitation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also created leverage by securitizing our assets (including in CLOs) and retaining the equity portion of the securitized vehicle and may enter into other debt securitizations in the future. Debt securitizations (including in CLOs) are a form of secured financing, which would generally be consolidated on our financial statements and subject to our overall asset coverage requirement. There can be no assurance that we will be able to obtain a CLO debt securitization on favorable terms or at all or that any such financing will benefit our investment performance. We may also from time to time make secured loans of our marginable securities to brokers, dealers and other financial institutions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Code of Ethics.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We and the Adviser have adopted a code of ethics pursuant to Rule 17j-1 under the 1940 Act and Rule 204A-1 under the Advisers Act, respectively, that establishes procedures for personal investments and restricts certain personal securities transactions. Personnel subject to the code are permitted to invest in securities for their personal investment accounts, including securities that may be purchased or held by us, so long as such investments are made in accordance with the code&#8217;s requirements. You may obtain copies of the codes of ethics, after paying a duplicating fee, by electronic request at the following email address: publicinfo@sec.gov.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Affiliated Transactions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We may be prohibited under the 1940 Act from conducting certain transactions with our affiliates without the prior approval of our trustees who are not interested persons and, in some</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cases, the prior approval of the SEC. We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We will be periodically examined by the SEC for compliance with the 1940 Act, and be subject to the periodic reporting and related requirements of the 1934 Act.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also required to provide and maintain a bond issued by a reputable fidelity insurance company to protect against larceny and embezzlement. Furthermore, as a BDC, we are prohibited from protecting any trustee or officer against any liability to our shareholders arising from willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such person&#8217;s office.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also required to designate a chief compliance officer and to adopt and implement written policies and procedures reasonably designed to prevent violation of the federal securities laws and to review these policies and procedures annually for their adequacy and the effectiveness of their implementation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not permitted to change the nature of our business so as to cease to be, or to withdraw our election as, a BDC unless approved by a majority of our outstanding voting securities. A majority of the outstanding voting securities of a company is defined under the 1940 Act as the lesser of: (i)&#160;67% or more of such company&#8217;s shares present at a meeting if more than 50% of the outstanding shares of such company are present or represented by proxy, or (ii)&#160;more than 50% of the outstanding shares of such company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proxy Voting Policies and Procedures</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have delegated our proxy voting responsibility to the Adviser. The Proxy Voting Policies and Procedures of the Adviser are set forth below. The guidelines are reviewed periodically by the Adviser, and, accordingly, are subject to change.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an investment adviser registered under the Advisers Act, the Adviser has a duty to monitor corporate events and to vote proxies, as well as a duty to cast votes in the best interest of clients and not subrogate client interests to its own interests. Rule 206(4)-6 under the Advisers Act places specific requirements on registered investment advisers with proxy voting authority.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proxy Policies</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser&#8217;s policies and procedures are reasonably designed to ensure that the Adviser votes proxies in the best interest of the Company and addresses how it will resolve any conflict of interest that may arise when voting proxies and, in so doing, to maximize the value of the investments made by the Company, taking into consideration the Company&#8217;s investment horizons and other relevant factors. It will review on a case-by-case basis each proposal submitted for a shareholder vote to determine its impact on the portfolio securities held by its clients. Although the Adviser will generally vote against proposals that may have a negative impact on its clients&#8217; portfolio securities, it may vote for such a proposal if there exists compelling long-term reasons to do so.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Decisions on how to vote a proxy generally are made by the Adviser. The Investment Committee and the members of the Investment Team covering the applicable security often have the most intimate knowledge of both a company&#8217;s operations and the potential impact of a proxy vote&#8217;s outcome. Decisions are based on a number of factors which may vary depending on a proxy&#8217;s subject matter, but are guided by the general policies described in the proxy policy. In addition, the Adviser may determine not to vote a proxy after consideration of the vote&#8217;s expected benefit to clients and the cost of voting the proxy. To ensure that its vote is not the product of a conflict of interest, the Adviser will require the members of the Investment Committee to disclose any personal conflicts of interest they may have with respect to overseeing a Company&#8217;s investment in a particular company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proxy Voting Records</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may obtain information, without charge, regarding how we voted proxies with respect to our portfolio securities by making a written request for proxy voting information to: Chief Compliance Officer, Blackstone Credit BDC Advisors LLC, 345 Park Avenue, 31st Floor, New York, NY 10154.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material U.S. Federal Income Tax Considerations</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion is a general summary of certain U.S. federal income tax considerations applicable to the Company. This discussion does not purport to be complete or to deal with all aspects of U.S. federal income taxation that may be relevant to the Company. This discussion is based upon present provisions of the Code, the regulations promulgated thereunder, and judicial and administrative ruling authorities, all of which are subject to change, or differing interpretations (possibly with retroactive effect). Prospective investors should consult their tax advisors with regard to the U.S. federal tax consequences of the purchase, ownership, or disposition of our shares, as well as the tax consequences arising under the laws of any state, foreign country or other taxing jurisdiction.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to be treated, and intends to qualify each taxable year, as a RIC under Subchapter M of the Code.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To qualify for the favorable tax treatment accorded to RICs under Subchapter M of the Code, the Company must, among other things: (1) have an election in effect to be treated as a BDC under the 1940 Act at all times during each taxable year; (2) have filed with its return for the taxable year an election to be a RIC or have made such election for a previous taxable year; (3) derive in each taxable year at least 90% of its gross income from (a) dividends, interest, payments with respect to certain securities loans, and gains from the sale or other disposition of stock or securities or foreign currencies, or other income (including but not limited to gains from options, futures or forward contracts) derived with respect to its business of investing in such stock, securities, or currencies; and (b) net income derived from an interest in certain publicly traded partnerships that are treated as partnerships for U.S. federal income tax purposes and that derive less than 90% of their gross income from the items described in (a) above (each, a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Qualified Publicly Traded Partnership&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">); and (4) diversify its holdings so that, at the end of each quarter of each taxable year of the Company (a) at least 50% of the value of the Company&#8217;s total assets is represented by cash and cash items (including receivables), U.S. government securities and securities of other RICs, and other securities for purposes of this calculation limited, in respect of any one issuer to an amount not greater in value than 5% of the value of the Company&#8217;s total assets and to not more than 10% of the outstanding voting securities of such issuer, and (b) not more than 25% of the value of the Company&#8217;s total assets is invested in the securities (other than U.S. government securities or securities of other RICs) of (I) any one issuer, (II) any two or more issuers which the Company controls and which are determined to be engaged in the same or similar trades or businesses or related trades or businesses or (III) any one or more Qualified Publicly Traded Partnerships (described in 3b above).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a RIC, the Company generally will not be subject to U.S. federal income tax on its investment company taxable income (as that term is defined in the Code, determined without regard to the deduction for dividends paid) and net capital gain (the excess of net long-term capital gain over net short-term capital loss), if any, that it distributes in each taxable year to its shareholders, provided that it distributes at least 90% of the sum of its investment company taxable income and its net tax-exempt income for such taxable year. The Company intends to distribute to its shareholders, at least annually, substantially all of its investment company taxable income and net capital gain.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts not distributed on a timely basis in accordance with a calendar year distribution requirement are subject to a nondeductible 4% U.S. federal excise tax. To prevent imposition of the excise tax, the Company must distribute during each calendar year an amount at least equal to the sum of (i) 98% of its ordinary income (not taking into account any capital gains or losses) for the calendar year, (ii) 98.2% of its capital gains in excess of its capital losses (adjusted for certain ordinary losses) for the one-year period ending October 31 of the calendar year, and (iii) any ordinary income and capital gains for previous years that were not distributed during those years. For these purposes, the Company will be deemed to have distributed any income or gains on which it paid U.S. federal income tax.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A distribution will be treated as paid on December 31 of any calendar year if it is declared by the Company in October, November or December with a record date in such a month and paid by the Company during January of the following calendar year. Such distributions will be taxable to shareholders in the calendar year in which the distributions are declared, rather than the calendar year in which the distributions are received.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company fails to qualify as a RIC or fails to satisfy the 90% distribution requirement in any taxable year, the Company would be subject to U.S. federal income tax at regular corporate rates on its taxable income (including distributions of net capital gain), even if such income were distributed to its shareholders, and all distributions out of earnings and profits would be taxed to shareholders as ordinary dividend income. Such distributions generally would be eligible (i) to be treated as &#8220;qualified dividend income&#8221; in the case of individual and other non-corporate shareholders and (ii) for the dividends received deduction in the case of corporate shareholders. In addition, the Company could be required to recognize unrealized gains, pay taxes and make distributions (which could be subject to interest charges) before requalifying for taxation as a RIC.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reporting Obligations and Available Information</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We furnish our shareholders with annual reports containing audited financial statements, quarterly reports, and such other periodic reports as we determine to be appropriate or as may be required by law. We are required to comply with all periodic reporting, proxy solicitation and other applicable requirements under the 1934 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, Definitive Proxy Statement on Schedule 14A, and our trustees, officers and 10% beneficial owners file reports on Forms 3, 4 and 5 pursuant to section 13(a), 15(d) or 16(a) of the 1934 Act. The SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information. We have made available free of charge on our website (www.bxsl.com) our annual reports on Form 10-K, quarterly reports on Form 10-Q, our current reports on Form 8-K and our governing documents.</span></div><div id="i33edc808e7824948b94b269ed713a939_19"></div><ix:nonNumeric contextRef="c-1" name="cef:RiskFactorsTableTextBlock" id="f-40" continuedAt="f-40-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in our shares involves a number of significant risks. In addition to the other information contained in this annual report, shareholders should consider carefully the following information before making an investment in our Common Shares. The risks set forth below are not the only risks we face. Such additional risks and uncertainties not presently known to us or not presently deemed material by us may also impair our operations and performance. If any of the following events occur, our business, financial condition and results of operations could be materially and adversely affected. In such cases, the NAV of our Common Shares could decline, and shareholders may lose all or part of their investment.</span></div></ix:nonNumeric><div id="i33edc808e7824948b94b269ed713a939_22"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.</span><ix:continuation id="f-40-1" continuedAt="f-40-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">Risks Related to Our Business and Structure</span></ix:continuation></div><ix:continuation id="f-40-2" continuedAt="f-40-3"><ix:nonNumeric contextRef="c-7" name="cef:RiskTextBlock" id="f-41" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Price declines in the medium- and large-sized U.S. corporate debt market may adversely affect the fair value of our portfolio, reducing our NAV through increased net unrealized depreciation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conditions in the medium- and large-sized U.S. corporate debt market may deteriorate, as seen during the recent financial crisis, which may cause pricing levels to similarly decline or be volatile. During the 2008-2009 financial crisis, many institutions were forced to raise cash by selling their interests in performing assets in order to satisfy margin requirements or the equivalent of margin requirements imposed by their lenders and/or, in the case of hedge funds and other investment vehicles, to satisfy widespread redemption requests. This resulted in a forced deleveraging cycle of price declines, compulsory sales, and further price declines, with falling underlying credit values, and other constraints resulting from the credit crisis generating further selling pressure. If similar events occurred in the medium- and large-sized U.S. corporate debt market, our NAV could decline through an increase in unrealized depreciation and incurrence of realized losses in connection with the sale of our investments, which could have a material adverse impact on our business, financial condition and results of operations and the market price of our shares.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-8" name="cef:RiskTextBlock" id="f-42" continuedAt="f-42-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to achieve our investment objectives depends on the ability of the Adviser to manage and support our investment process. If the Adviser or Blackstone Credit &amp; Insurance were to lose any members of their respective senior management teams, our ability to achieve our investment objectives could be significantly harmed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we have no employees, we depend on the investment expertise, skill and network of business contacts of the broader networks of the Adviser and its affiliates. The Adviser evaluates, negotiates, structures, executes, monitors and services our investments. Our future success depends to a significant extent on the continued service and coordination of Blackstone Credit &amp; Insurance and its senior management team. The departure of any members of Blackstone Credit &amp; Insurance&#8217;s senior management team could have a material adverse effect on our ability to achieve our investment objectives.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-3" continuedAt="f-40-4"><ix:continuation id="f-42-1" continuedAt="f-42-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to achieve our investment objectives depends on the Adviser&#8217;s ability to identify and analyze, and to invest in, finance and monitor companies that meet our investment criteria. The Adviser&#8217;s capabilities in structuring the investment process, providing competent, attentive and efficient services to us, and facilitating access to financing on acceptable terms depend on the employment of investment professionals in an adequate number and of adequate sophistication to match the corresponding flow of transactions. To achieve our investment objectives, the Adviser may need to hire, train, supervise and manage new investment professionals to participate in our investment selection and monitoring process. The Adviser may not be able to find investment professionals in a timely manner or at all. Failure to support our investment process could have a material adverse effect on our business, financial condition and results of operations.</span></div></ix:continuation><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-42-2">The Investment Advisory Agreement has been approved pursuant to Section 15 of the 1940 Act. In addition, the Investment Advisory Agreement has termination provisions that allow the parties to terminate the agreement. The Investment Advisory Agreement may be terminated at any time, without penalty, by us or by the Adviser, upon 60 days&#8217; written notice. If the Investment Advisory Agreement is terminated, it may adversely affect the quality of our investment opportunities. In addition, in the event the Investment Advisory Agreement is terminated, it may be difficult for us to replace the Adviser.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-9" name="cef:RiskTextBlock" id="f-43" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because our business model depends to a significant extent upon relationships with private equity sponsors, investment banks and commercial banks, the inability of the Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser depends on its broader organization&#8217;s relationships with private equity sponsors, investment banks and commercial banks, and we rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the Adviser or its broader organization fail to maintain their existing relationships or develop new relationships with other sponsors or sources of investment opportunities, we may not be able to grow our investment portfolio. In addition, individuals with whom the Adviser or its broader organizations have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-10" name="cef:RiskTextBlock" id="f-44" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face increasing competition for investment opportunities, which could delay deployment of our capital, reduce returns and result in losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete for investments with other BDCs and investment funds (including private equity funds, mezzanine funds, performing and other credit funds, and funds that invest in CLOs, structured notes, derivatives and other types of collateralized securities and structured products), as well as traditional financial services companies such as commercial banks and other sources of funding. These other BDCs and investment funds might be reasonable investment alternatives to us and may be less costly or complex with fewer and/or different risks than we have. Moreover, alternative investment vehicles, such as hedge funds, have begun to invest in areas in which they have not traditionally invested, including making investments in U.S. private companies. As a result of these new competitors entering the financing markets in which we operate, competition for investment opportunities in U.S. private companies may intensify. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of capital and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have. These characteristics could allow our competitors to consider a wider variety of investments, establish more relationships and offer better pricing and more flexible structuring than we are able to do. We may lose investment opportunities if we do not match our competitors&#8217; pricing, terms or structure. If we are forced to match our competitors&#8217; pricing, terms or structure, we may not be able to achieve acceptable returns on our investments or may bear substantial risk of capital loss. A significant part of our competitive advantage stems from the fact that the market for investments in U.S. private companies is underserved by traditional commercial banks and other financial sources. A significant increase in the number and/or the size of our competitors in this target market could force us to accept less attractive investment terms. Furthermore, many of our competitors have greater experience operating under, or are not subject to, the regulatory restrictions that the 1940 Act imposes on us as a BDC.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-4" continuedAt="f-40-5"><ix:nonNumeric contextRef="c-11" name="cef:RiskTextBlock" id="f-45" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulty sourcing investment opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure investors that we will be able to locate a sufficient number of suitable investment opportunities to allow us to deploy all available capital successfully. In addition, privately-negotiated investments in loans and illiquid securities of private middle market companies require substantial due diligence and structuring, and we cannot assure investors that we will achieve our anticipated investment pace. As a result, investors will be unable to evaluate any future portfolio company investments prior to purchasing our shares. Our shareholders will have no input with respect to investment decisions. These factors increase the uncertainty, and thus the risk, of investing in our shares. To the extent we are unable to deploy all available capital, our investment income and, in turn, our results of operations, will likely be materially adversely affected.&#160;There is no assurance that we will be able to consummate investment transactions or that such transactions will be successful.&#160;Blackstone Credit &amp; Insurance, the Company and their affiliates may also face certain conflicts of interests in connection with any transaction, including any warehousing transaction, involving an affiliate.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-12" name="cef:RiskTextBlock" id="f-46" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks associated with the deployment of our capital.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the nature of our periodic public offerings in relation to our investment strategy and the need to be able to deploy potentially large amounts of capital quickly to capitalize on potential investment opportunities, if we have difficulty identifying suitable investments on attractive terms, there could be a delay between the time we receive net proceeds from the sale of shares of our Common Shares in any periodic public offering and the time we invest the net proceeds. Our proportion of privately-negotiated investments may be lower than expected. We may also from time to time hold cash pending deployment into investments or have less than our targeted leverage, which cash or shortfall in target leverage may at times be significant, particularly at times when we are receiving high amounts of offering proceeds and/or times when there are few attractive investment opportunities. Such cash may be held in an account for the benefit of our shareholders that may be invested in money market accounts or other similar temporary investments, each of which is subject to management fees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event we are unable to find suitable investments such cash may be maintained for longer periods which would be dilutive to overall investment returns. This could cause a substantial delay in the time it takes for your investment to realize its full potential return and could adversely affect our ability to pay regular distributions of cash flow from operations to you. It is not anticipated that the temporary investment of such cash into money market accounts or other similar temporary investments pending deployment into investments will generate significant interest, and investors should understand that such low interest payments on the temporarily invested cash may adversely affect overall returns. In the event we fail to timely invest the net proceeds of sales of our Common Shares or do not deploy sufficient capital to meet our targeted leverage, our results of operations and financial condition may be adversely affected.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-13" name="cef:RiskTextBlock" id="f-47" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As required by the 1940 Act, a significant portion of our investment portfolio is and will be recorded at fair value as determined in good faith and, as a result, there is and will be uncertainty as to the value of our portfolio investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, we are required to carry our portfolio investments at market value or, if there is no readily available market value, at fair value as determined pursuant to policies adopted by, and subject to the oversight of, our Board. There is not a public market for the securities of the privately-held companies in which we invest. Many of our investments are not publicly-traded or actively traded on a secondary market. As a result, we value these securities quarterly at fair value as determined in good faith as required by the 1940 Act. In connection with striking a NAV as of a date other than quarter end for share issuances and repurchases, the Company will consider whether there has been a material change to such investments as to affect their fair value, but such analysis will be more limited than the quarter end process.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our valuation process, we will take into account relevant factors in determining the fair value of the Company&#8217;s investments, without market quotations, many of which are loans, including and in combination, as relevant: (i) the estimated enterprise value of a portfolio company, (ii) the nature and realizable value of any collateral, (iii) the portfolio company&#8217;s ability to make payments based on its earnings and cash flow, (iv) the markets in which the portfolio company does business, (v) a comparison of the portfolio company&#8217;s securities to any similar publicly traded securities, and (vi) overall changes in the interest rate environment and the credit markets that may affect the price at which similar investments may be made in the future. Our determinations of fair value may differ materially from the values that would have been used if a ready market for these non-traded securities existed. Due to this uncertainty, our fair value determinations may cause our NAV on a given date to materially differ from the value that we may ultimately realize upon the sale of one or more of our investments.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-5" continuedAt="f-40-6"><ix:nonNumeric contextRef="c-14" name="cef:RiskTextBlock" id="f-48" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There is a risk that investors in our shares may not receive distributions or that our distributions may decrease over time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not achieve investment results that will allow us to make a specified or stable level of cash distributions and our distributions may decrease over time. In addition, due to the asset coverage test applicable to us as a BDC, we may be limited in our ability to make distributions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-15" name="cef:RiskTextBlock" id="f-49" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The amount of any distributions we may make is uncertain. Our distributions may exceed our earnings, particularly during the period before we have substantially invested the net proceeds from any securities offering. Therefore, portions of the distributions that we make may represent a return of capital to a shareholder that will lower such shareholder&#8217;s tax basis in its shares and reduce the amount of funds we have for investment in targeted assets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may fund our cash distributions to shareholders from any sources of funds available to us, including offering proceeds, borrowings, net investment income from operations, capital gains proceeds from the sale of assets, non-capital gains proceeds from the sale of assets, dividends or other distributions paid to us on account of preferred and common equity investments in portfolio companies and fee and expense reimbursement waivers from the Adviser or the Administrator, if any. Our ability to pay distributions, if any, might be adversely affected by, among other things, the impact of one or more of the risk factors described in this annual report. In addition, the inability to satisfy the asset coverage test applicable to us as a BDC may limit our ability to pay distributions. All distributions are and will be paid at the discretion of our Board and will depend on our earnings, our financial condition, maintenance of our RIC status, compliance with applicable BDC regulations and such other factors as our Board may deem relevant from time to time. We cannot assure shareholders that we will continue to pay distributions to our shareholders in the future. In the event that we encounter delays in locating suitable investment opportunities, we may pay all or a substantial portion of our distributions from the proceeds of our prior offerings or from borrowings or sources other than cash flow from operations in anticipation of future cash flow, which may constitute a return of shareholders&#8217; capital. A return of capital is a return of a shareholder&#8217;s investment, rather than a return of earnings or gains derived from our investment activities. A shareholder will not be subject to immediate taxation on the amount of any distribution treated as a return of capital to the extent of the shareholder&#8217;s basis in its shares; however, the shareholder&#8217;s basis in its shares will be reduced (but not below zero) by the amount of the return of capital, which will result in the shareholder recognizing additional gain (or a lower loss) when the shares are sold. To the extent that the amount of the return of capital exceeds the shareholder&#8217;s basis in its shares, such excess amount will be treated as gain from the sale of the shareholder&#8217;s shares. Distributions from the proceeds of our prior offerings or from borrowings also could reduce the amount of capital we ultimately invest in our portfolio companies.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-16" name="cef:RiskTextBlock" id="f-50" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have not established any limit on the amount of funds we may use from available sources, such as borrowings, if any, or proceeds from securities offerings, to fund distributions (which may reduce the amount of capital we ultimately invest in assets).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any distributions made from sources other than cash flow from operations or relying on fee or expense reimbursement waivers, if any, from the Adviser or the Administrator are not based on our investment performance, and can only be sustained if we achieve positive investment performance in future periods and/or the Adviser or the Administrator continues to make such expense reimbursements, if any. The extent to which we pay distributions from sources other than cash flow from operations will depend on various factors, including the level of participation in our dividend reinvestment plan, how quickly we invest the proceeds from this and any future offering and the performance of our investments. Shareholders should also understand that our future repayments to the Adviser will reduce the distributions that they would otherwise receive. There can be no assurance that we will achieve such performance in order to sustain these distributions, or be able to pay distributions at all. The Adviser and the Administrator have no obligation to waive fees or receipt of expense reimbursements, if any.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-6" continuedAt="f-40-7"><ix:nonNumeric contextRef="c-17" name="cef:RiskTextBlock" id="f-51" continuedAt="f-51-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a public reporting company, we are subject to regulations not applicable to private companies, such as provisions of the Sarbanes-Oxley Act. Efforts to comply with such regulations will involve significant expenditures, and non-compliance with such regulations may adversely affect us.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-51-1">As a public reporting company, we are subject to the Sarbanes-Oxley Act, and the related rules and regulations promulgated by the SEC. Our management is required to report on our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. We are required to review on an annual basis our internal control over financial reporting, and on a quarterly and annual basis to evaluate and disclose changes in our internal control over financial reporting. Developing and maintaining an effective system of internal controls may require significant expenditures, which may negatively impact our financial performance and our ability to make distributions. This process also will result in a diversion of our management&#8217;s time and attention. We cannot be certain of when our evaluation, testing and remediation actions will be completed or the impact of the same on our operations. In addition, we may be unable to ensure that the process is effective or that our internal controls over financial reporting are or will be effective in a timely manner. In the event that we are unable to develop or maintain an effective system of internal controls and maintain or achieve compliance with the Sarbanes-Oxley Act and related rules, we may be adversely affected.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-18" name="cef:RiskTextBlock" id="f-52" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in laws or regulations governing our operations may adversely affect our business or cause us to alter our business strategy. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, our portfolio companies and other counterparties are subject to regulation at the local, state and federal level. New legislation may be enacted or new interpretations, rulings or regulations could be adopted, including those governing the types of investments we are permitted to make, any of which could harm us and our shareholders, potentially with retroactive effect.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President Biden may support an enhanced regulatory agenda that imposes greater costs on all sectors and on financial services companies in particular. In addition, uncertainty regarding legislation and regulations affecting the financial services industry or taxation could also adversely impact our business or the business of our portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, any changes to or repeal of the laws and regulations governing our operations relating to permitted investments may cause us to alter our investment strategy to avail ourselves of new or different opportunities. Such changes could result in material differences to our strategies and plans as set forth in this annual report and may result in our investment focus shifting from the areas of expertise of the Adviser to other types of investments in which the Adviser may have less expertise or little or no experience. Thus, any such changes, if they occur, could have a material adverse effect on our financial condition and results of operations and the value of a shareholder&#8217;s investment.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-19" name="cef:RiskTextBlock" id="f-53" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial regulatory changes in the United States could adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial services industry continues to be the subject of heightened regulatory scrutiny in the United States. There has been active debate over the appropriate extent of regulation and oversight of investment funds and their managers. We may be adversely affected as a result of new or revised regulations imposed by the SEC or other U.S. governmental regulatory authorities or self-regulatory organizations that supervise the financial markets. We also may be adversely affected by changes in the interpretation or enforcement of existing laws and regulations by these governmental authorities and self-regulatory organizations. Further, new regulations or interpretations of existing laws may result in enhanced disclosure obligations, including with respect to climate change or environmental, social and governance factors, which could negatively affect us and materially increase our regulatory burden. Increased regulations generally increase our costs, and we could continue to experience higher costs if new laws require us to spend more time or buy new technology to comply effectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any changes in the regulatory framework applicable to our business, including the changes described above, may impose additional compliance and other costs, increase regulatory investigations of the investment activities of our funds, require the attention of our senior management, affect the manner in which we conduct our business and adversely affect our profitability. The full extent of the impact on us of any new laws, regulations or initiatives that may be proposed is impossible to determine.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-7" continuedAt="f-40-8"><ix:nonNumeric contextRef="c-20" name="cef:RiskTextBlock" id="f-54" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We, the Adviser and its affiliates are subject to regulatory oversight, which could negatively impact our operations, cash flow or financial condition, impose additional costs on us or otherwise adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and the businesses of the Adviser and its affiliates are subject to&#160;extensive regulation, including periodic examinations, inquiries and investigations which may result in enforcement and other proceedings, by governmental agencies&#160;and self-regulatory organizations in the jurisdictions in which we and they operate around the world, including the SEC and various other U.S. federal, state&#160;and local agencies. These&#160;authorities have regulatory powers dealing with many aspects of financial services, including the authority to&#160;grant, and in specific circumstances to cancel, permissions to carry on particular activities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the Adviser and its respective affiliates have received, and may in the future receive, requests for information, inquiries and informal or formal investigations or subpoenas from such regulators from time to time in connection with such inquiries and proceedings and otherwise in the ordinary course of business. These requests could relate to a broad range of matters, including specific practices of our business, the Adviser, our investments or other investments the Adviser or its affiliates make on behalf of their clients, potential conflicts of interest between us and the Adviser or its affiliates, or industry wide practices. SEC actions and initiatives can have an adverse effect on our financial results,&#160;including as a result of the imposition of a sanction, a limitation on our, Blackstone&#8217;s or our personnel&#8217;s&#160;activities, or changing our historic practices. Any adverse publicity relating to an investigation, proceeding or imposition of these sanctions could&#160;harm our or Blackstone&#8217;s reputation and have an&#160;adverse effect on our future fundraising or operations. The costs of responding to legal or regulatory&#160;information requests, any increased reporting, registration and compliance requirements will be borne by us&#160;in the form of legal or other expenses, litigation, regulatory proceedings or penalties, may divert the attention of our management, may cause negative publicity that adversely affects investor sentiment, and may place us at a competitive disadvantage, including to the extent that we, the Adviser or any of its affiliates are required to disclose sensitive business information or alter business practices.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, efforts by the current administration or future administrations could have further impacts on our industry if previously enacted laws are amended or if new legislative or regulatory reforms are adopted. In addition, a future change in administration may lead to leadership changes at a number of U.S. federal regulatory agencies with oversight over the U.S. financial services industry. Such changes would pose uncertainty with respect to such agencies&#8217; ongoing policy priorities and could lead to increased regulatory enforcement activity in the financial services industry. Any changes or reforms may impose additional costs on our current or future investments, require the attention of senior management or result in other limitations on our business or investments. We are unable to predict at this time the likelihood or effect of any such changes or reforms.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-21" name="cef:RiskTextBlock" id="f-55" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The impact of financial reform legislation on us is uncertain.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of past market conditions in the U.S. and global financial markets, the U.S. and global economy, legislators, the presidential administration and regulators have increased their focus on the regulation of the financial services industry, including the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Dodd-Frank Act,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which instituted a wide range of reforms that have impacted all financial institutions to varying degrees. Because these requirements are relatively new and evolving, the full impact such requirements will have on our business, results of operations or financial condition is unclear. While we cannot predict what effect any changes in the laws or regulations or their interpretations would have on us, these changes could be materially adverse to us and our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any changes in the regulatory framework applicable to our business, including the changes described above, may impose additional compliance and other costs, increase regulatory investigations of the investment activities of our funds, require the attention of our senior management, affect the manner in which we conduct our business and adversely affect our profitability. The full extent of the impact on us of any new laws, regulations or initiatives that may be proposed is impossible to determine.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-22" name="cef:RiskTextBlock" id="f-56" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience fluctuations in our quarterly results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could experience fluctuations in our quarterly operating results due to a number of factors, including our ability or inability to make investments in companies that meet our investment criteria, the interest rate payable on the loans or other debt securities we originate or acquire, the level of our expenses (including our borrowing costs), variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our markets and general economic conditions. As a result of these factors, results for any previous period should not be relied upon as being indicative of performance in future periods.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-8" continuedAt="f-40-9"><ix:nonNumeric contextRef="c-23" name="cef:RiskTextBlock" id="f-57" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transactions denominated in foreign currencies subject us to foreign currency risks.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold assets and have made borrowings denominated in foreign currencies and may acquire assets or make borrowings denominated in other foreign currencies, which exposes us to foreign currency risk. As a result, a change in foreign currency exchange rates may have an adverse impact on the valuation of our assets or liabilities, as well as our income and cash flows. As a result of foreign currency fluctuations, the value of our liabilities and expenses may increase or the value of our assets and income may decrease due to factors outside of our control, which can have a negative effect on our NAV and cash available for distribution. Any such changes in foreign currency exchange rates may impact the measurement of such assets or liabilities for purposes of maintaining RIC tax treatment or the requirements under the 1940 Act. We may seek to hedge against currency exchange rate fluctuations by using financial instruments such as futures, options, swaps and forward contracts, subject to the requirements of the 1940 Act, but there is no guarantee such efforts will be successful and such hedging strategies create additional costs. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;We may acquire various financial instruments for purposes of &#8220;hedging&#8221; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders.&#8221;</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-24" name="cef:RiskTextBlock" id="f-58" continuedAt="f-58-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General economic conditions could adversely affect the performance of our investments and operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our portfolio companies are susceptible to the effects of economic slowdowns or recessions. The global growth cycle is in a mature phase and signs of slowdown are evident in certain regions around the world, although most economists continue to expect moderate economic growth in the near term, with limited signals of an imminent recession in the U.S. as consumer and government spending remain healthy. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of non&#8209;performing loans on the balance sheets of European banks, the effect of the United Kingdom (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;U.K.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) leaving the European Union (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;E.U.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), instability in the Chinese capital markets and the COVID-19 pandemic. Although the broader outlook remains constructive, geopolitical instability continues to pose risk. In particular, the current U.S. political environment and the resulting uncertainties regarding actual and potential shifts in U.S. foreign investment, trade, taxation, economic, environmental and other policies under the current Administration, as well as the impact of geopolitical tension, such as a deterioration in the bilateral relationship between the U.S. and China or the current ongoing conflict between Russia and Ukraine and the escalating conflict in the Middle East, and the rapidly evolving measures in response, could lead to disruption, instability and volatility in the global markets. Certain of our portfolio companies may operate in, or have dealings with, countries subject to sanctions or embargoes imposed by the U.S. government, foreign governments, or the United Nations or other international organizations. U.S. debt ceiling and budget deficit concerns have increased the possibility of additional credit-rating downgrades and economic slowdowns or a recession in the United States. A decreased U.S. government credit rating, any default by the U.S. government on its obligations, or any prolonged U.S. government shutdown, could create broader financial turmoil and uncertainty, which may weigh heavily on our financial performance and the value of our common shares. Unfavorable economic conditions would be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events may limit our investment originations, and limit our ability to grow and could have a material negative impact on our operating results, financial condition, results of operations and cash flows and the fair values of our debt and equity investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any deterioration of general economic conditions may lead to significant declines in corporate earnings or loan performance, and the ability of corporate borrowers to service their debt, any of which could trigger a period of global economic slowdown, and have an adverse impact on the performance and financial results of the Company, and the value and the liquidity of the shares. In an economic downturn, we may have non-performing assets or non-performing assets may increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions&#160;impacted&#160;the value of any collateral securing our senior secured debt in 2023 and may continue to impact such collateral in 2024. A severe recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income, assets and net worth. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on favorable terms or at all. These events could prevent us from increasing investments and harm our operating results.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-9" continuedAt="f-40-10"><ix:continuation id="f-58-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the failure of certain financial institutions, namely banks, may increase the possibility of a sustained deterioration of financial market liquidity, or illiquidity at clearing, cash management and/or custodial financial institutions. The failure of a bank (or banks) with which we and/or our portfolio companies have a commercial relationship could adversely affect, among other things, our and/or our portfolio companies&#8217; ability to pursue key strategic initiatives, including by affecting our or our portfolio company&#8217;s ability to access deposits or borrow from financial institutions on favorable terms. Additionally, if a portfolio company or its sponsor has a commercial relationship with a bank that has failed or is otherwise distressed, the portfolio company may experience issues receiving financial support from a sponsor to support its operations or consummate transactions, to the detriment of their business, financial condition and/or results of operations. In addition, such bank failure(s) could affect, in certain circumstances, the ability of both affiliated and unaffiliated co-lenders, including syndicate banks or other fund vehicles, to undertake and/or execute co-investment transactions with the Company, which in turn may result in fewer co-investment opportunities being made available to the Company or impact the Company&#8217;s ability to provide additional follow-on support to portfolio companies. The ability of the Company, its subsidiaries and portfolio companies to spread banking relationships among multiple institutions may be limited by certain contractual arrangements, including liens placed on their respective assets as a result of a bank agreeing to provide financing.</span></div></ix:continuation><ix:nonNumeric contextRef="c-25" name="cef:RiskTextBlock" id="f-59" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inflation and supply chain risks have had and may continue to have an adverse impact on our financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflation in the United States remained elevated throughout 2022 and 2023 and may continue to remain high in the future. While inflation has shown signs of moderating, it remains uncertain whether substantial inflation in the United States will be sustained over an extended period of time or have a significant effect on the United States or other economies. Elevated inflation could have an adverse impact on our operating costs, credit facilities, and general and administrative expenses, as these costs could increase at a rate higher than our revenue. Certain of our portfolio companies are in industries that have been impacted by inflation and global supply chain issues. Recent inflationary pressures have increased the costs of labor, energy and raw materials and have adversely affected consumer spending, economic growth and our portfolio companies&#8217; operations and such pressures and related volatility may continue during 2024. If such portfolio companies are unable to pass any increases in their costs of operations along to their customers, it could adversely affect their operating results and impact their ability to pay interest and principal on our loans, particularly if interest rates rise in response to inflation. In addition, any projected future decreases in our portfolio companies&#8217; operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of our investments could result in future realized or unrealized losses and therefore reduce our net assets resulting from operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-26" name="cef:RiskTextBlock" id="f-60" continuedAt="f-60-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be impacted by general European economic conditions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our investment activities could be affected by general economic and market conditions in Europe and in the rest of the world, as well as by changes in applicable laws and regulations (including laws relating to taxation of our investments), trade barriers, currency exchange controls, rate of inflation, currency depreciation, asset re-investment, resource self-sufficiency and national and international political and socioeconomic circumstances in respect of the European and other non-U.S. countries in which we may invest. These factors will affect the level and volatility of securities prices and the liquidity of the Company&#8217;s investments, which could impair our profitability or result in losses. General fluctuations in the market prices of securities and interest rates may affect our investment opportunities and the value of our investments. We may maintain substantial trading positions that can be adversely affected by the level of volatility in the financial markets; the larger the positions, the greater the potential for loss. Declines in the performance of national economies or the credit markets in certain jurisdictions have had a negative impact on general economic and market conditions globally, and as a result, could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser&#8217;s financial condition may be adversely affected by a significant general economic downturn and it may be subject to legal, regulatory, reputational and other unforeseen risks that could have a material adverse effect on the Adviser&#8217;s businesses and operations (including those of the Company). A recession, slowdown and/or sustained downturn in the global economy (or any particular segment thereof) could have a pronounced impact on the Company and could adversely affect the Company&#8217;s profitability, impede the ability of the Company&#8217;s portfolio companies to perform under or refinance their existing obligations and impair the Company&#8217;s ability to effectively deploy its capital or realize its investments on favorable terms.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-10" continuedAt="f-40-11"><ix:continuation id="f-60-1" continuedAt="f-60-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, economic problems in a single country are increasingly affecting other markets and economies. A continuation of this trend could result in problems in one country adversely affecting regional and even global economic conditions and markets. For example, concerns about the fiscal stability and growth prospects of certain European countries in the last economic downturn had a negative impact on most economies of the Eurozone and global markets and the current ongoing conflict between Russia and Ukraine could have a negative impact on those countries and others in the region. The occurrence of similar crises in the future could cause increased volatility in the economies and financial markets of countries throughout a region, or even globally.</span></div></ix:continuation><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-60-2">Any of the foregoing events could result in substantial or total losses to the Company in respect of certain investments, which losses will likely be exacerbated by the presence of leverage in a portfolio company&#8217;s capital structure.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-27" name="cef:RiskTextBlock" id="f-61" continuedAt="f-61-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">It may be difficult to bring suit or foreclosure in non-U.S. countries.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-61-1">Because the effectiveness of the judicial systems in the countries in which the Company may invest varies, the Company (or any portfolio company) may have difficulty in foreclosing or successfully pursuing claims in the courts of such countries, as compared to the United States or other countries. Further, to the extent the Company or a portfolio company may obtain a judgment but is required to seek its enforcement in the courts of one of these countries in which the Company invests, there can be no assurance that such courts will enforce such judgment. The laws of other countries often lack the sophistication and consistency found in the United States with respect to foreclosure, bankruptcy, corporate reorganization or creditors&#8217; rights.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-28" name="cef:RiskTextBlock" id="f-62" continuedAt="f-62-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MiFID II obligations could have an adverse effect on the ability of Blackstone Credit &amp; Insurance and its MiFID-authorized EEA affiliates to obtain and research in connection with the provision of an investment service.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Recast European Union Directive on Markets in Financial Instruments (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;MiFID II&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) came into effect on January 3, 2018, and imposes regulatory obligations in respect of providing financial services in the European Economic Area (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;EEA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by EEA banks and EEA investment firms providing regulated services (each an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Investment Firm&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The Adviser is a non-EEA investment company and is, therefore, not subject to MiFID II but can be indirectly affected. The regulatory obligations imposed by MiFID II may impact, and constrain the implementation of, the investment strategy of the Company. MiFID II restricts Investment Firms&#8217; ability to obtain research in connection with the provision of an investment service. For example, Investment Firms providing portfolio management or independent investment advice may purchase investment research only at their own expense or out of specifically dedicated research payment accounts agreed upon with their clients. Research will also have to be unbundled and paid separately from the trading commission. EEA broker-dealers will unbundle research costs and invoice them to Investment Firms separated from dealing commissions. </span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-62-1">Therefore, in light of the above, MiFID II could have an adverse effect on the ability of Blackstone Credit &amp; Insurance and its MiFID-authorized EEA affiliates to obtain and to provide research. The new requirements regarding the unbundling of research costs under MiFID II are not consistent with market practice in the United States and the regulatory framework concerning the use of commissions to acquire research developed by the SEC, although the SEC has issued temporary no-action letters to facilitate compliance by firms with the research requirements under MiFID II in a manner that is consistent with the U.S. federal securities laws. Blackstone Credit &amp; Insurance&#8217;s access to third-party research may nonetheless be significantly limited. Some EEA jurisdictions extend certain MiFID II obligations also to other market participants (e.g., Alternative Investment Fund Managers) under national law. There is very little guidance, and limited market practice, that has developed in preparation for MiFID II. As such, the precise impact of MiFID II on Blackstone Credit &amp; Insurance and the Company cannot be fully predicted at this stage.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-29" name="cef:RiskTextBlock" id="f-63" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available for distribution.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at the fair value as determined in good faith pursuant to procedures adopted by, and under oversight of, our Board. Decreases in the market value or fair value of our investments relative to amortized cost will be recorded as unrealized depreciation. Any unrealized losses in our portfolio could be an indication of a portfolio company&#8217;s inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods. In addition, decreases in the market value or fair value of our investments will reduce our NAV.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-11" continuedAt="f-40-12"><ix:nonNumeric contextRef="c-30" name="cef:RiskTextBlock" id="f-64" continuedAt="f-64-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terrorist attacks, acts of war or natural disasters may adversely affect our operations.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-64-1">Terrorist acts, acts of war or natural disasters may disrupt our operations, as well as the operations of the businesses in which we invest. Such acts, including the current ongoing conflict between Russia and Ukraine and the escalating conflict in the Middle East, have created, and continue to create, economic and political uncertainties and have contributed to recent global economic instability. Future terrorist activities, military or security operations, or natural disasters could further weaken the domestic/global economies and create additional uncertainties, which may negatively impact the businesses in which we invest directly or indirectly and, in turn, could have a material adverse impact on our business, operating results and financial condition. Losses from terrorist attacks and natural disasters are generally uninsurable.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-31" name="cef:RiskTextBlock" id="f-65" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Force Majeure events may adversely affect our operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be affected by force majeure events (e.g., acts of God, fire, flood, earthquakes, outbreaks of an infectious disease, pandemic or any other serious public health concern, war, terrorism, nationalization of industry and labor strikes). Force Majeure events could adversely affect the ability of the Company or a counterparty to perform its obligations. The liability and cost arising out of a failure to perform obligations as a result of a force majeure event could be considerable and could be borne by the Company. Certain Force Majeure events, such as war or an outbreak of an infectious disease, could have a broader negative impact on the global or local economy, thereby affecting us. Additionally, a major governmental intervention into industry, including the nationalization of an industry or the assertion of control, could result in a loss to the Company if an investment is affected, and any compensation provided by the relevant government may not be adequate.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-32" name="cef:RiskTextBlock" id="f-66" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Another pandemic or global health crisis like the COVID-19 pandemic may adversely impact our performance and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From 2020 to 2022, in response to the COVID-19 pandemic, many countries instituted quarantine restrictions and took other measures to limit the spread of the virus. This resulted in labor shortages and disruption of supply chains and contributed to prolonged disruption of the global economy. A widespread reoccurrence of another pandemic or global health crisis could increase the possibility of periods of increased restrictions on business operations, which may adversely impact our business, financial condition, results of operations, liquidity and prospects materially and exacerbate many of the other risks discussed in this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Risk Factors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of another pandemic or global health crisis like the COVID-19 pandemic, our portfolio companies may experience decreased revenues and earnings, which may adversely impact our ability to realize value from such investments and in turn reduce our performance revenues. Investments in certain sectors, including hospitality, location-based entertainment, retail, travel, leisure and events, and in certain geographies, office and residential, could be particularly negatively impacted, as was the case during the COVID-19 pandemic. Our portfolio companies may also face increased credit and liquidity risk due to volatility in financial markets, reduced revenue streams and limited access or higher cost of financing, which may result in potential impairment of our investments. In addition, borrowers of loans, notes and other credit instruments may be unable to meet their principal or interest payment obligations or satisfy financial covenants, resulting in a decrease in value of our investments. In the event of significant credit market contraction as a result of a pandemic or similar global health crisis, we may be limited in our ability to sell assets at attractive prices or in a timely manner in order to avoid losses and margin calls from credit providers. Shareholders may also be negatively impacted if we experience a decline in the pace of capital deployment or fundraising.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a pandemic or global health crisis may pose enhanced operational risks. For example, the employees of our Adviser and/or its affiliates may become sick or otherwise unable to perform their duties for an extended period, and extended public health restrictions and remote working arrangements may affect our Adviser and/or its affiliates by impacting employee morale, integration of new employees and preservation of their culture. Remote working environments may also be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts. Moreover, our third-party service providers could be impacted by an inability to perform due to pandemic-related restrictions or by failures of, or attacks on, their technology platforms.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-33" name="cef:RiskTextBlock" id="f-67" continuedAt="f-67-1" escape="true"><ix:continuation id="f-40-12" continuedAt="f-40-13"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity and data protection risks could result in the loss of data, interruptions in our business, and damage to our reputation, and subject us to regulatory actions&#160;, increased costs and financial losses, each of which could have a material adverse effect on our business and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are highly dependent on technology platforms and we rely heavily on Blackstone&#8217;s and its affiliates&#8217; analytical, financial, accounting, communications and other data processing systems. Blackstone&#8217;s and its affiliates&#8217; systems face ongoing cybersecurity threats and attacks, which could result in the loss of confidentiality, integrity or availability of such systems and the data held by such systems. Attacks on Blackstone&#8217;s and/or its affiliates&#8217; systems could involve, and in some instances have in the past involved, attempts intended to obtain unauthorized access to our proprietary information, destroy data or disable, degrade or sabotage our systems, or divert or otherwise steal funds, including through the introduction of computer viruses, &#8220;phishing&#8221; attempts and other forms of social engineering. Attacks on Blackstone&#8217;s and/or its affiliates&#8217; systems could also involve ransomware or other forms of cyber extortion. Cyberattacks and other data security threats could originate from a wide variety of external sources, including cyber criminals, nation state hackers, hacktivists and other outside parties. Cyberattacks and other security threats could also originate from the malicious or accidental acts of insiders, such as employees, consultants, independent contractors or other service providers.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been an increase in the frequency and sophistication of the cyber and data security threats, with attacks ranging from those common to businesses generally to those that are more advanced and persistent, which may target Blackstone and/or its affiliates because they hold a significant amount of confidential and sensitive information about investors, portfolio companies and potential investments. As a result, Blackstone&#8217;s and its affiliates&#8217; may face a heightened risk of a security breach or disruption with respect to this information. Measures taken by Blackstone&#8217;s and/or its affiliates&#8217; to ensure the integrity of their systems may not provide adequate protection, especially because cyberattack techniques are continually evolving, may persist undetected over extended periods of time, and may not be mitigated in a timely manner to prevent or minimize the impact of an attack on Blackstone and/or its affiliates&#8217;, our investors, our portfolio companies or potential investments. If Blackstone&#8217;s and/or its affiliates&#8217; systems or those of third party service providers are compromised either as a result of malicious activity or through inadvertent transmittal or other loss of data, do not operate properly or are disabled, or we fail to provide the appropriate regulatory or other notifications in a timely manner, we could suffer financial loss, increased costs, a disruption of our businesses, liability to our counterparties, portfolio companies or fund investors, regulatory intervention or reputational damage. The costs related to cyber or other data security threats or disruptions may not be fully insured or indemnified by other means.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we could also suffer losses in connection with updates to, or the failure to timely update, the technology platforms on which we rely. We are reliant on third party service providers for certain aspects of our business, including for our administration, as well as for certain technology platforms, including cloud-based services. These third-party service providers could also face ongoing cybersecurity threats and compromises of their systems and as a result, unauthorized individuals could gain, and in some past instances have gained, access to certain confidential data.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybersecurity and data protection have become top priorities for regulators around the world. Many jurisdictions in which we, Blackstone and/or its affiliates operate have laws and regulations relating to privacy, data protection and cybersecurity, including, as examples, the General Data Protection Regulation (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;GDPR&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in the European Union, the U.K. Data Protection Act, and the California Privacy Rights Act (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;CPRA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). For example, in February 2022, the SEC proposed rules regarding registered investment advisers' and funds' cybersecurity risk management requiring the adoption and implementation of cybersecurity policies and procedures, enhanced disclosure in regulatory filings and prompt reporting of incidents to the SEC, which, if adopted, could increase our compliance costs and potential regulatory liability related to cybersecurity. Some jurisdictions have also enacted or proposed laws requiring companies to notify individuals and government agencies of data security breaches involving certain types of personal data.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-13" continuedAt="f-40-14"><ix:continuation id="f-67-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breaches in our, Blackstone&#8217;s and/or its affiliates&#8217; security or in the security of third party service providers, whether malicious in nature or through inadvertent transmittal or other loss of data, could potentially jeopardize our, Blackstone&#8217;s and/or its affiliates&#8217;, including the Adviser&#8217;s, employees or our shareholders' or counterparties' confidential, proprietary and other information processed and stored in, and transmitted through, computer systems and networks, or otherwise cause interruptions or malfunctions in our, Blackstone&#8217;s and/or its affiliates&#8217;, including the Adviser&#8217;s, employees', our shareholders', our counterparties' or third parties' business and operations, which could result in significant financial losses, increased costs, liability to our shareholders and other counterparties, regulatory intervention and reputational damage. Furthermore, if we, Blackstone and/or its affiliates fail to comply with the relevant laws and regulations or fail to provide the appropriate regulatory or other notifications of breach in a timely matter, it could result in regulatory investigations and penalties, which could lead to negative publicity and reputational harm and may cause our shareholders to lose confidence in the effectiveness of our security measures and Blackstone more generally.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio companies also rely on data processing systems and the secure processing, storage and transmission of information, including payment and health information, which in some instances are provided by third parties. A disruption or compromise of these systems could have a material adverse effect on the value of these businesses. We may invest in strategic assets having a national or regional profile or in infrastructure, the nature of which could expose them to a greater risk of being subject to a terrorist attack or a security breach than other assets or businesses. Such an event may have material adverse consequences on our investment or assets of the same type or may require portfolio companies to increase preventative security measures or expand insurance coverage.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, Blackstone&#8217;s and/or its affiliates&#8217; and our portfolio companies' technology platforms, data and intellectual property are also subject to a heightened risk of theft or compromise to the extent they engage in operations outside the United States, in particular in those jurisdictions that do not have comparable levels of protection of proprietary information and assets such as intellectual property, trademarks, trade secrets, know-how and customer information and records. In addition, they may be required to compromise protections or forego rights to technology, data and intellectual property in order to operate in or access markets in a foreign jurisdiction. Any such direct or indirect compromise of these assets could have a material adverse impact on us and our portfolio companies.</span></div></ix:continuation><ix:nonNumeric contextRef="c-34" name="cef:RiskTextBlock" id="f-68" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to obtain and maintain all required state licenses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to obtain various state licenses in order to, among other things, originate commercial loans. Applying for, obtaining and maintaining required licenses can be costly and take several months. There is no assurance that we will obtain, and maintain, all of the licenses that we need on a timely basis. Furthermore, we will be subject to various information and other requirements in order to obtain and maintain these licenses, and there is no assurance that we will satisfy those requirements. Our failure to obtain or maintain licenses might restrict investment options and have other adverse consequences.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-35" name="cef:RiskTextBlock" id="f-69" escape="true"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with the SEC&#8217;s Regulation Best Interest by participating broker-dealers may negatively impact our ability to raise capital in a public offering, which could harm our ability to achieve our investment objectives.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Broker-dealers are required to comply with Regulation Best Interest, which, among other requirements, establishes a new standard of conduct for broker-dealers and their associated persons when making a recommendation of any securities transaction or investment strategy involving securities to a retail customer. The full impact of Regulation Best Interest on participating broker-dealers cannot be determined at this time, and it may negatively impact whether participating broker-dealers and their associated persons recommend the offering to certain retail customers. In particular, under SEC guidance concerning Regulation Best Interest, a broker-dealer recommending an investment in our shares should consider a number of factors, under the care obligation of Regulation Best Interest, including but not limited to cost and complexity of the investment and reasonably available alternatives in determining whether there is a reasonable basis for the recommendation. As a result, high cost, high risk and complex products may be subject to greater scrutiny by broker-dealers. Broker-dealers may recommend a more costly or complex product as long as they have a reasonable basis to believe is in the best interest of a particular retail customer. However, if broker-dealers choose alternatives to our shares, many of which likely exist, such as an investment in listed entities, which may be a reasonable alternative to an investment in us as such investments may feature characteristics like lower cost, nominal commissions at the time of initial purchase, less complexity and lesser or different risks, our ability to raise capital will be adversely affected. If compliance by broker-dealers with Regulation Best Interest negatively impacts our ability to raise capital in a public offering, it may harm our ability to create a diversified portfolio of investments and achieve our investment objectives.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-36" name="cef:RiskTextBlock" id="f-70" continuedAt="f-70-1" escape="true"><ix:continuation id="f-40-14" continuedAt="f-40-15"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a Delaware statutory trust, we are subject to the control share acquisition statute contained in the Delaware Statutory Trust Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is organized as a Delaware statutory trust and thus is subject to the control share acquisition statute contained in Subchapter III of the Delaware Statutory Trust Act (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;DSTA Control Share Statute&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The DSTA Control Share Statute applies to any closed-end management investment company that has elected to be regulated as a business development company under the 1940 Act organized as a Delaware statutory trust and listed on a national securities exchange, such as the Company. The DSTA Control Share Statute became automatically applicable to the Company on August 1, 2022.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSTA Control Share Statute defines &#8220;control beneficial interests&#8221; (referred to as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;control shares&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein) by reference to a series of voting power thresholds and provides that a holder of control shares acquired in a control share acquisition has no voting rights under the Delaware Statutory Trust Act (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;DSTA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or the Company&#8217;s governing documents with respect to the control shares acquired in the control share acquisition, except to the extent approved by the Company&#8217;s shareholders by the affirmative vote of two&#8211;thirds of all the votes entitled to be cast on the matter, excluding all interested shares (generally, shares held by the acquiring person and their associates and shares held by Company insiders).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSTA Control Share Statute provides for a series of voting power thresholds above which shares are considered control shares. Whether one of these thresholds of voting power is met is determined by aggregating the holdings of the acquiring person as well as those of his, her or its &#8220;associates.&#8221; These thresholds are:</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) 10% or more, but less than 15% of all voting power;</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) 15% or more, but less than 20% of all voting power;</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) 20% or more, but less than 25% of all voting power;</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) 25% or more, but less than 30% of all voting power;</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5) 30% or more, but less than a majority of all voting power; or</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6) a majority or more of all voting power.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the DSTA Control Share Statute, once a threshold is reached, an acquirer has no voting rights with respect to shares in excess of that threshold (i.e., the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;control shares&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) until approved by a vote of shareholders, as described above, or otherwise exempted by the Board of Trustees. The DSTA Control Share Statute contains a statutory process for an acquiring person to request a shareholder meeting for the purpose of considering the voting rights to be accorded control shares. An acquiring person must repeat this process at each threshold level.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the DSTA Control Share Statute, an acquiring person&#8217;s &#8220;associates&#8221; are broadly defined to include, among others, relatives of the acquiring person, anyone in a control relationship with the acquiring person, any investment fund or other collective investment vehicle that has the same investment adviser as the acquiring person, any investment adviser of an acquiring person that is an investment fund or other collective investment vehicle and any other person acting or intending to act jointly or in concert with the acquiring person.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Voting power under the DSTA Control Share Statute is the power (whether such power is direct or indirect or through any contract, arrangement, understanding, relationship or otherwise) to directly or indirectly exercise or direct the exercise of the voting power of shares of the Company in the election of the Trustees (either generally or with respect to any subset, series or class of trustees, including any Trustees elected solely by a particular series or class of shares, such as the preferred shares).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any control shares of the Company acquired before August 1, 2022 are not subject to the DSTA Control Share Statute; however, any further acquisitions on or after August 1, 2022 are considered control shares subject to the DSTA Control Share Statute.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-15" continuedAt="f-40-16"><ix:continuation id="f-70-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSTA Control Share Statute requires shareholders to disclose to the Company any control share acquisition within 10 days of such acquisition, and also permits the Company to require a shareholder or an associate of such person to disclose the number of shares owned or with respect to which such person or an associate thereof can directly or indirectly exercise voting power. Further, the DSTA Control Share Statute requires a shareholder or an associate of such person to provide to the Company within 10 days of receiving a request therefor from the Company any information that the Trustees reasonably believe is necessary or desirable to determine whether a control share acquisition has occurred.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSTA Control Share Statute permits the Board, through a provision in the Company&#8217;s governing documents or by Board action alone, to eliminate the application of the DSTA Control Share Statute to the acquisition of control shares in the Company specifically, generally, or generally by types, as to specifically identified or unidentified existing or future beneficial owners or their affiliates or associates or as to any series or classes of shares. The DSTA Control Share Statute does not provide that the Company can generally &#8220;opt out&#8221; of the application of the DSTA Control Share Statute; rather, specific acquisitions or classes of acquisitions may be exempted by the Board, either in advance or retroactively, but other aspects of the DSTA Control Share Statute, which are summarized above, would continue to apply. The DSTA Control Share Statute further provides that the Board of Trustees is under no obligation to grant any such exemptions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing is only a summary of the material terms of the DSTA Control Share Statute. Shareholders should consult their own counsel with respect to the application of the DSTA Control Share Statute to any particular circumstance.</span></div></ix:continuation><ix:nonNumeric contextRef="c-37" name="cef:RiskTextBlock" id="f-71" escape="true"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Declaration of Trust includes exclusive forum and jury trial waiver provisions that could limit a shareholder&#8217;s ability to bring a claim or, if such provisions are deemed inapplicable or unenforceable by a court, may cause the Company to incur additional costs associated with such action.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Declaration of Trust provides that, to the fullest extent permitted by law, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of a duty owed by any trustee, officer or other agent of the Company to the Company or our shareholders, (iii) any action asserting a claim arising pursuant to any provision of Title 12 of the Delaware Code, Delaware statutory or common law, our Declaration of Trust, or (iv) any action asserting a claim governed by the internal affairs doctrine (for the avoidance of doubt, including any claims brought to interpret, apply or enforce the federal securities laws of the United States, including, without limitation, the 1940 Act or the securities or anti-fraud laws of any international, national, state, provincial, territorial, local or other governmental or regulatory authority, including, in each case, the applicable rules and regulations promulgated thereunder) shall be the Court of Chancery of the State of Delaware or, if such court does not have subject matter jurisdiction thereof, any other court in the State of Delaware with subject matter jurisdiction. In addition, our Declaration of Trust provides that no shareholder may maintain a derivative action on behalf of the Company unless holders of at least ten percent (10%) of the outstanding shares join in the bringing of such action. These provisions of our Declaration of Trust may make it more difficult for shareholders to bring a derivative action than a company without such provisions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Declaration of Trust also includes an irrevocable waiver of the right to trial by jury in all such claims, suits, actions and proceedings. Any person purchasing or otherwise acquiring any of our Common Shares shall be deemed to have notice of and to have consented to these provisions of our Declaration of Trust. These provisions may limit a shareholder&#8217;s ability to bring a claim in a judicial forum or in a manner that it finds favorable for disputes with the Company or the Company&#8217;s trustees or officers, which may discourage such lawsuits. Alternatively, if a court were to find the exclusive forum provision or the jury trial waiver provision to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions or in other manners, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any of the foregoing, neither we nor any of our investors are permitted to waive compliance with any provision of the U.S. federal securities laws and the rules and regulations promulgated thereunder.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-16" continuedAt="f-40-17"><ix:nonNumeric contextRef="c-38" name="cef:RiskTextBlock" id="f-72" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Board may change our operating policies and strategies without prior notice or shareholder approval, the effects of which may be adverse to our results of operations and financial condition.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board has the authority to modify or waive our current operating policies, investment criteria and strategies without prior notice and without shareholder approval, unless required by the 1940 Act or applicable law. We cannot predict the effect any changes to our current operating policies, investment criteria and strategies would have on our business, NAV, operating results and value of our shares. However, the effects might be adverse, which could negatively impact our ability to pay shareholders distributions and cause shareholders to lose all or part of their investment. Moreover, we have significant flexibility in investing the net proceeds from our continuous offering and may use the net proceeds from our continuous offering in ways with which investors may not agree or for purposes other than those contemplated in this annual report.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-39" name="cef:RiskTextBlock" id="f-73" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Board may amend our Declaration of Trust without prior shareholder approval.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board may, without shareholder vote, subject to certain exceptions, amend or otherwise supplement the Declaration of Trust by making an amendment, a Declaration of Trust supplemental thereto or an amended and restated Declaration of Trust, including without limitation to classify the Board, to impose advance notice bylaw provisions for Trustee nominations or for shareholder proposals, to require super-majority approval of transactions with significant shareholders or other provisions that may be characterized as anti-takeover in nature.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-40" name="cef:RiskTextBlock" id="f-74" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain provisions of our Declaration of Trust could deter takeover attempts and have an adverse impact on the value of our common shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Declaration of Trust contains anti-takeover provisions that could have the effect of limiting the ability of other entities or persons to acquire control of the Company or to change the composition of our Board of Trustees. Our Board of Trustees is divided into three classes of trustees serving staggered three-year terms. This provision could delay for up to two years the replacement of a majority of our Board of Trustees. These provisions could have the effect of depriving shareholders of an opportunity to sell their common shares at a premium over prevailing market prices by discouraging a third party from seeking to obtain control over the Company.</span></div></ix:nonNumeric></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_25"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.</span><ix:continuation id="f-40-17" continuedAt="f-40-18"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt">Risks Related to Our Investments</span></ix:continuation></div><ix:nonNumeric contextRef="c-41" name="cef:RiskTextBlock" id="f-75" continuedAt="f-75-1" escape="true"><ix:continuation id="f-40-18" continuedAt="f-40-19"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in prospective portfolio companies may be risky, and we could lose all or part of our investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in senior secured loans, senior secured bonds, subordinated debt and equity of private U.S. companies, including middle market companies, may be risky and, subject to compliance with our 80% policy, there is no limit on the amount of any such investments in which we may invest.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Loans and Senior Secured Bonds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a risk that any collateral pledged by portfolio companies in which we have taken a security interest may decrease in value over time or lose its entire value, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. Such risks have become more pronounced due to rising interest rates and market volatility.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent our debt investment is collateralized by the securities of a portfolio company&#8217;s subsidiaries, such securities may lose some or all of their value in the event of the bankruptcy or insolvency of the portfolio company. Also, in some circumstances, our security interest may be contractually or structurally subordinated to claims of other creditors. In addition, deterioration in a portfolio company&#8217;s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the debt. Secured debt that is under-collateralized involves a greater risk of loss. In addition, second lien debt is granted a second priority security interest in collateral, which means that any realization of collateral will generally be applied to pay senior secured debt in full before second lien debt is paid. Similarly, investments in &#8220;last out&#8221; pieces of unitranche loans will be similar to second lien loans in that such investments will be junior in priority to the &#8220;first out&#8221; piece of the same unitranche loan with respect to payment of principal, interest and other amounts. Consequently, the fact that debt is secured does not guarantee that we will receive principal and interest payments according to the debt&#8217;s terms, or at all, or that we will be able to collect on the debt should we be forced to enforce our remedies.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-75-1" continuedAt="f-75-2"><ix:continuation id="f-40-19" continuedAt="f-40-20"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subordinated Debt. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our subordinated debt investments will generally rank junior in priority of payment to senior debt and will generally be unsecured. This may result in a heightened level of risk and volatility or a loss of principal, which could lead to the loss of the entire investment. These investments may involve additional risks that could adversely affect our investment returns. To the extent interest payments associated with such debt are deferred, such debt may be subject to greater fluctuations in valuations, and such debt could subject us and our shareholders to non-cash income. Because we will not receive any principal repayments prior to the maturity of some of our subordinated debt investments, such investments will be of greater risk than amortizing loans.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may make select equity investments. In addition, in connection with our debt investments, we on occasion may receive equity interests such as warrants or options as additional consideration. The equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in preferred securities involve certain risks. Certain preferred securities contain provisions that allow an issuer under certain conditions to skip or defer distributions. If the Company owns a preferred security that is deferring its distribution, the Company may be required to include the amount of the deferred distribution in its taxable income for tax purposes although it does not currently receive such amount in cash. In order to receive the special treatment accorded to RICs and their shareholders under the Code and to avoid U.S. federal income and/or excise taxes at the Company level, the Company may be required to distribute this income to shareholders in the tax year in which the income is recognized (without a corresponding receipt of cash). Therefore, the Company may be required to pay out as an income distribution in any such tax year an amount greater than the total amount of cash income the Company actually received, and to sell portfolio securities, including at potentially disadvantageous times or prices, to obtain cash needed for these income distributions. Preferred securities often are subject to legal provisions that allow for redemption in the event of certain tax or legal changes or at the issuer&#8217;s call. In the event of redemption, the Company may not be able to reinvest the proceeds at comparable rates of return. Preferred securities are subordinated to bonds and other debt securities in an issuer&#8217;s capital structure in terms of priority for corporate income and liquidation payments, and therefore will be subject to greater credit risk than those debt securities. Preferred securities may trade less frequently and in a more limited volume and may be subject to more abrupt or erratic price movements than many other securities, such as common stocks, corporate debt securities and U.S. government securities. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-U.S. Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may invest in non-U.S. securities, which may include securities denominated in U.S. dollars or in non-U.S. currencies, to the extent permitted by the 1940 Act. Because evidence of ownership of such securities usually is held outside the United States, we would be subject to additional risks if we invested in non-U.S. securities, which include possible adverse political and economic developments, seizure or nationalization of foreign deposits and adoption of governmental restrictions, which might adversely affect or restrict the payment of principal and interest on the non-U.S. securities to shareholders located outside the country of the issuer, whether from currency blockage or otherwise. Because non-U.S. securities may be purchased with and payable in foreign currencies, the value of these assets as measured in U.S. dollars may be affected unfavorably by changes in currency rates and exchange control regulations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loans Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The loans that the Company may invest in include loans that are first lien, second lien, third lien or that are unsecured. In addition, the loans the Company will invest in will usually be rated below investment grade or may also be unrated. Loans are subject to a number of risks described elsewhere in the prospectus, including credit risk, liquidity risk, below investment grade instruments risk and management risk. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although certain loans in which the Company may invest will be secured by collateral, there can be no assurance that such collateral could be readily liquidated or that the liquidation of such collateral would satisfy the borrower&#8217;s obligation in the event of non-payment of scheduled interest or principal. In the event of the bankruptcy or insolvency of a borrower, the Company could experience delays or limitations with respect to its ability to realize the benefits of the collateral securing a loan. In the event of a decline in the value of the already pledged collateral, if the terms of a loan do not require the borrower to pledge additional collateral, the Company will be exposed to the risk that the value of the collateral will not at all times equal or exceed the amount of the borrower&#8217;s obligations under the loans. To the extent that a loan is collateralized by stock in the borrower or its subsidiaries, such stock may lose some or all of its value in the event of the bankruptcy or insolvency of the borrower. Those loans that are under-collateralized involve a greater risk of loss. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-75-2" continuedAt="f-75-3"><ix:continuation id="f-40-20" continuedAt="f-40-21"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, there is a risk that any collateral pledged by portfolio companies in which the Company has taken a security interest may decrease in value over time or lose its entire value, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. To the extent the Company&#8217;s debt investment is collateralized by the securities of a portfolio company&#8217;s subsidiaries, such securities may lose some or all of their value in the event of the bankruptcy or insolvency of the portfolio company. Also, in some circumstances, the Company&#8217;s security interest may be contractually or structurally subordinated to claims of other creditors. In addition, deterioration in a portfolio company&#8217;s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the debt. Secured debt that is under-collateralized involves a greater risk of loss. In addition, second lien debt is granted a second priority security interest in collateral, which means that any realization of collateral will generally be applied to pay senior secured debt in full before second lien debt is paid. Consequently, the fact that debt is secured does not guarantee that the Company will receive principal and interest payments according to the debt&#8217;s terms, or at all, or that the Company will be able to collect on the debt should it be forced to enforce remedies. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans are not registered with the SEC, or any state securities commission, and are not listed on any national securities exchange. There is less readily available or reliable information about most loans than is the case for many other types of securities, including securities issued in transactions registered under the Securities Act or registered under the Exchange Act. No active trading market may exist for some loans, and some loans may be subject to restrictions on resale. A secondary market may be subject to irregular trading activity, wide bid/ask spreads and extended trade settlement periods, which may impair the ability to realize full value and thus cause a material decline in the Company&#8217;s NAV. In addition, the Company may not be able to readily dispose of its loans at prices that approximate those at which the Company could sell such loans if they were more widely-traded and, as a result of such illiquidity, the Company may have to sell other investments or engage in borrowing transactions if necessary to raise cash to meet its obligations. During periods of limited supply and liquidity of loans, the Company&#8217;s yield may be lower. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some loans are subject to the risk that a court, pursuant to fraudulent conveyance or other similar laws, could subordinate the loans to presently existing or future indebtedness of the borrower or take other action detrimental to lenders, including the Company. Such court action could under certain circumstances include invalidation of loans. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If legislation of state or federal regulations impose additional requirements or restrictions on the ability of financial institutions to make loans, the availability of loans for investment by the Company may be adversely affected. In addition, such requirements or restrictions could reduce or eliminate sources of financing for certain borrowers. This would increase the risk of default. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If legislation or federal or state regulations require financial institutions to increase their capital requirements this may cause financial institutions to dispose of loans that are considered highly levered transactions. Such sales could result in prices that, in the opinion of the Adviser, do not represent fair value. If the Company attempts to sell a loan at a time when a financial institution is engaging in such a sale, the price the Company could get for the loan may be adversely affected. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may acquire loans through assignments or participations. The Company will typically acquire loans through assignment. The purchaser of an assignment typically succeeds to all the rights and obligations of the assigning institution and becomes a lender under the credit agreement with respect to the debt obligation; however, the purchaser&#8217;s rights can be more restricted than those of the assigning institution, and the Company may not be able to unilaterally enforce all rights and remedies under the loan and with regard to any associated collateral. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A participation typically results in a contractual relationship only with the institution selling the participation interest, not with the borrower. Sellers of participations typically include banks, broker-dealers, other financial institutions and lending institutions. Certain participation agreements also include the option to convert the participation to a full assignment under agreed upon circumstances. The Adviser has adopted best execution procedures and guidelines to mitigate credit and counterparty risk in the atypical situation when the Company must acquire a loan through a participation. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-75-3" continuedAt="f-75-4"><ix:continuation id="f-40-21" continuedAt="f-40-22"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In purchasing participations, the Company generally will have no right to enforce compliance by the borrower with the terms of the loan agreement against the borrower, and the Company may not directly benefit from the collateral supporting the debt obligation in which it has purchased the participation. As a result, the Company will be exposed to the credit risk of both the borrower and the institution selling the participation. Further, in purchasing participations in lending syndicates, the Company will not be able to conduct the due diligence on the borrower or the quality of the loan with respect to which it is buying a participation that the Company would otherwise conduct if it were investing directly in the loan, which may result in the Company being exposed to greater credit or fraud risk with respect to the borrower or the loan than the Company expected when initially purchasing the participation. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also may originate loans or acquire loans by participating in the initial issuance of the loan as part of a syndicate of banks and financial institutions, or receive its interest in a loan directly from the borrower. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser has established a counterparty and liquidity sub-committee that regularly reviews each broker-dealer counterparty for, among other things, its quality and the quality of its execution. The established procedures and guidelines require trades to be placed for execution only with broker counterparties approved by the counterparty and liquidity sub-committee of the Adviser. The factors considered by the sub-committee when selecting and approving brokers and dealers include, but are not limited to: (i) quality, accuracy, and timeliness of execution, (ii) review of the reputation, financial strength and stability of the financial institution, (iii) willingness and ability of the counterparty to commit capital, (iv) ongoing reliability and (v) access to underwritten offerings and secondary markets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Junior, Unsecured Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our strategy may entail acquiring securities that are junior or unsecured instruments. While this approach can facilitate obtaining control and then adding value through active management, it also means that certain of the Company&#8217;s investments may be unsecured. If a portfolio company becomes financially distressed or insolvent and does not successfully reorganize, we will have no assurance (compared to those distressed securities investors that acquire only fully collateralized positions) that we will recover any of the principal that we have invested. Similarly, investments in &#8220;last out&#8221; pieces of unitranche loans will be similar to second lien loans in that such investments will be junior in priority to the &#8220;first out&#8221; piece of the same unitranche loan with respect to payment of principal, interest and other amounts. Consequently, the fact that debt is secured does not guarantee that we will receive principal and interest payments according to the debt&#8217;s terms, or at all, or that we will be able to collect on the debt should it be forced to enforce its remedies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While such junior or unsecured investments may benefit from the same or similar financial and other covenants as those enjoyed by the indebtedness ranking more senior to such investments and may benefit from cross-default provisions and security over the issuer&#8217;s assets, some or all of such terms may not be part of particular Investments. Moreover, our ability to influence an issuer&#8217;s affairs, especially during periods of financial distress or following insolvency, is likely to be substantially less than that of senior creditors. For example, under typical subordination terms, senior creditors are able to block the acceleration of the junior debt or the exercise by junior debt holders of other rights they may have as creditors. Accordingly, we may not be able to take steps to protect investments in a timely manner or at all, and there can be no assurance that our rate of return objectives or any particular investment will be achieved. In addition, the debt securities in which we will invest may not be protected by financial covenants or limitations upon additional indebtedness, may have limited liquidity and are not expected to be rated by a credit rating agency.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early repayments of our investments may have a material adverse effect on our investment objectives. In addition, depending on fluctuations of the equity markets and other factors, warrants and other equity investments may become worthless.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that attempts to provide downside protection through contractual or structural terms with respect to our investments will achieve their desired effect and potential investors should regard an investment in us as being speculative and having a high degree of risk. Furthermore, we have limited flexibility to negotiate terms when purchasing newly issued investments in connection with a syndication of mezzanine or certain other junior or subordinated investments or in the secondary market.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-75-4" continuedAt="f-75-5"><ix:continuation id="f-40-22" continuedAt="f-40-23"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Below Investment Grade Risk. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as &#8220;junk,&#8221; have predominantly speculative characteristics with respect to the issuer&#8217;s capacity to pay interest and repay principal. They may also be difficult to value and illiquid. The major risks of below investment grade securities include:</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Below investment grade securities may be issued by less creditworthy issuers. Issuers of below investment grade securities may have a larger amount of outstanding debt relative to their assets than issuers of investment grade securities. In the event of an issuer&#8217;s bankruptcy, claims of other creditors may have priority over the claims of holders of below investment grade securities, leaving few or no assets available to repay holders of below investment grade securities.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Prices of below investment grade securities are subject to extreme price fluctuations. Adverse changes in an issuer&#8217;s industry and general economic conditions may have a greater impact on the prices of below investment grade securities than on other higher-rated fixed-income securities.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Issuers of below investment grade securities may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments, or the unavailability of additional financing.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Below investment grade securities frequently have redemption features that permit an issuer to repurchase the security from us before it matures. If the issuer redeems below investment grade securities, we may have to invest the proceeds in securities with lower yields and may lose income.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Below investment grade securities may be less liquid than higher-rated fixed-income securities, even under normal economic conditions. There are fewer dealers in the below investment grade securities market, and there may be significant differences in the prices quoted by the dealers. Judgment may play a greater role in valuing these securities and we may be unable to sell these securities at an advantageous time or price.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit rating of a high-yield security does not necessarily address its market value risk. Ratings and market value may change from time to time, positively or negatively, to reflect new developments regarding the issuer.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mezzanine Loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Our mezzanine loans generally will be subordinated to senior secured loans on a payment basis, are typically unsecured and rank</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pari passu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with other unsecured creditors.&#160;As such, other creditors may rank senior to us in the event of insolvency.&#160;This may result in an above average amount of risk and loss of principal. Our mezzanine debt securities generally will have ratings or implied or imputed ratings below investment grade. They will be obligations of corporations, partnerships or other entities that are generally unsecured, typically are subordinated to other obligations of the obligor and generally have greater credit and liquidity risk than is typically associated with investment grade corporate obligations. Accordingly, the risks associated with mezzanine debt securities include a greater possibility that adverse changes in the financial condition of the obligor or in general economic conditions (including a sustained period of rising interest rates or an economic downturn) may adversely affect the obligor&#8217;s ability to pay principal and interest on its debt. Many obligors on mezzanine debt securities are highly leveraged, and specific developments affecting such obligors, including reduced cash flow from operations or the inability to refinance debt at maturity, may also adversely affect such obligors&#8217; ability to meet debt service obligations. Mezzanine debt securities are often issued in connection with leveraged acquisitions or recapitalizations, in which the issuers incur a substantially higher amount of indebtedness than the level at which they had previously operated. Default rates for mezzanine debt securities have historically been higher than has been the case for investment grade securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Retention Vehicles</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We may invest in CLO debt and equity tranches and warehouse investments directly or indirectly through an investment in U.S. and/or European vehicles (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Retention Vehicles</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) established for the purpose of satisfying U.S. and/or E.U. regulations that require eligible risk retainers to purchase and retain specified amounts of the credit risk associated with certain CLOs, which vehicles themselves are invested in CLO securities, warehouse investments and/or senior secured obligations. Risk Retention Vehicles will be structured to satisfy the retention requirements by purchasing and retaining the percentage of CLO notes prescribed under the applicable retention requirements (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retention Notes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and will not include Risk Retention Vehicles that are deemed to be controlled by the Adviser or its affiliates (other than Risk Retention Vehicles we control).</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-23" continuedAt="f-40-24"><ix:continuation id="f-75-5"><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indirect investments in CLO equity securities (and in some instances more senior CLO securities) and warehouse investments through entities that have been established to satisfy the U.S. retention requirements and/or the European retention requirements may allow for better economics for us (including through fee rebate arrangements) by creating stronger negotiating positions with CLO managers and underwriting banks who are incentivized to issue CLOs and who require the participation of a Risk Retention Vehicle to enable the CLO securities to be issued. However, Retention Notes differ from other securities of the same ranking since the retention requirements prescribe that such Retention Notes must be held by the relevant risk retainer for a specified period. In the case of European Risk Retention Vehicles, the prescribed holding period is the lifetime of the CLO, and in the case of U.S. Risk Retention Vehicles it is the longer of (x) the period until the CLO has paid down its securities to 33% of their original principal amount, (y) the period until the CLO has sold down its assets to 33% of their original principal amount and (z) two years after the closing of the CLO. In addition, Retention Notes are subject to other restrictions not imposed on other securities of the same ranking; for example, Retention Notes may not be subject to credit risk mitigation, and breach of the retention requirements may result in the imposition of regulatory sanctions or, in the case of the European retention requirements, in claims being brought against the retaining party.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Covenant-lite&#8221; Obligations.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We may invest in, or obtain exposure to, obligations that may be &#8220;covenant-lite,&#8221; which means such obligations lack certain financial maintenance covenants. While these loans may still contain other collateral protections, a covenant-lite loan may carry more risk than a covenant-heavy loan made by the same borrower, as it does not require the borrower to provide affirmation that certain specific financial tests have been satisfied on a routine basis as is required under a covenant-heavy loan agreement. Should a loan we hold begin to deteriorate in quality, our ability to negotiate with the borrower may be delayed under a covenant-lite loan compared to a loan with full maintenance covenants. This may in turn delay our ability to seek to recover its investment.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consumer Loans.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We may invest in, or obtain exposure to, consumer lending, which involves risk elements in addition to normal credit risk. Consumer loan terms vary according to the type and value of collateral and creditworthiness of the borrower. In underwriting consumer loans, a thorough analysis of the borrower&#8217;s financial ability to repay the loan as agreed is typically performed. The ability to repay shall be determined by, among others, the borrower&#8217;s employment history, current financial conditions, and credit background. While these loans typically have higher yields than many other loans, such loans involve risk elements in addition to normal credit risk. Consumer loans may entail greater credit risk than other loans particularly in the case of unsecured consumer loans or consumer loans secured by rapidly depreciable assets, such as automobiles. In such cases, any repossessed collateral for a defaulted consumer loan may not provide an adequate source of repayment of the outstanding loan balance as a result of the greater likelihood of damage, loss or depreciation. In addition, consumer loan collections are dependent on the borrower&#8217;s continuing financial stability, and thus are more likely to be affected by adverse personal circumstances. During periods of deteriorating economic conditions, such as recessions or periods of rising unemployment, delinquencies and losses generally increase, sometimes dramatically, with respect to consumer loans. Furthermore, the application of various federal and state laws, including bankruptcy and insolvency laws, and/or state consumer protection laws may limit the amount which can be recovered on such loans.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bridge Financings.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> From time to time, we may lend to portfolio companies on a short-term, unsecured basis or otherwise invest on an interim basis in portfolio companies in anticipation of a future issuance of equity or long-term debt securities or other refinancing or syndication. Such bridge loans would typically be convertible into a more permanent, long-term security; however, for reasons not always in the Company&#8217;s control, such long-term securities issuance or other refinancing or syndication may not occur and such bridge loans and interim investments may remain outstanding. In such event, the interest rate on such loans or the terms of such interim investments may not adequately reflect the risk associated with the position taken by the Company.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructurings.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in companies operating in workout or bankruptcy modes present additional legal risks, including fraudulent conveyance, voidable preference and equitable subordination risks. The level of analytical sophistication, both financial and legal, necessary for successful investment in companies experiencing significant business and financial difficulties is unusually high. There is no assurance that we will correctly evaluate the value of the assets collateralizing our loans or the prospects for a successful reorganization or similar action.</span></div></ix:continuation><ix:nonNumeric contextRef="c-42" name="cef:RiskTextBlock" id="f-76" continuedAt="f-76-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to risks associated with changes in interest rates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to financial market risks, including changes in interest rates. General interest rate fluctuations may have a substantial negative impact on our investments and investment opportunities and, accordingly, have a material adverse effect on our investment objectives and our rate of return on invested capital. In addition, an increase in interest rates would make it more expensive to use debt for our financing needs.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-24" continuedAt="f-40-25"><ix:continuation id="f-76-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During periods of falling interest rates, payments under the floating rate debt instruments that we hold would generally decrease, resulting in less revenue to us. In the event of a sharply rising interest rate environment, such as during 2022 and 2023, payments under floating rate debt instruments generally would rise and there may be a significant number of issuers of such floating rate debt instruments that would be unable or unwilling to pay such increased interest costs and may otherwise be unable to repay their loans. Investments in floating rate debt instruments may also decline in value in response to rising interest rates if the interest rates of such investments do not rise as much, or as quickly, as market interest rates in general. Similarly, during periods of rising interest rates, fixed-rate debt instruments may decline in value because the fixed rates of interest paid thereunder may be below market interest rates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, an increase in interest rates would make it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase in the amount of incentive fees payable to the Adviser with respect to pre-incentive fee net investment income.</span></div></ix:continuation><ix:nonNumeric contextRef="c-43" name="cef:RiskTextBlock" id="f-77" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio companies may have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt in which we invest. By their terms, such debt instruments may entitle the holders to receive payment of interest or principal on or before the dates on which we are entitled to receive payments with respect to the debt instruments in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any proceeds. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt instruments in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-44" name="cef:RiskTextBlock" id="f-78" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If one of our portfolio companies were to file for bankruptcy, depending on the facts and circumstances, including the extent to which we actually provided managerial assistance to that portfolio company, a bankruptcy court might re-characterize our debt investment and subordinate all or a portion of our claim to that of other creditors. We may also be subject to lender liability claims for actions taken by us with respect to a borrower&#8217;s business or instances where we exercise control over the borrower.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-45" name="cef:RiskTextBlock" id="f-79" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We generally do not control our portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not expect to control most of our portfolio companies, even though we may have board representation or board observation rights, and our debt agreements with such portfolio companies may contain certain restrictive covenants. As a result, we are subject to the risk that a portfolio company in which we invest may make business decisions with which we disagree and the management of such company, as representatives of the holders of the company&#8217;s common equity, may take risks or otherwise act in ways that do not serve our interests as debt investors. Due to the lack of liquidity for our investments in non-traded companies, we may not be able to dispose of our interests in our portfolio companies as readily as we would like or at an appropriate valuation. As a result, a portfolio company may make decisions that could decrease the value of our portfolio holdings.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-46" name="cef:RiskTextBlock" id="f-80" continuedAt="f-80-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks related to ESG matters.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Adviser&#8217;s consideration of ESG factors is intended to aid the Adviser in evaluating the return and risk profile of a given investment and is not expected to by itself determine an investment decision for us, the Adviser&#8217;s consideration of ESG factors could, to the extent material economic risks associated with an investment are identified, cause the Adviser to consider taking action with respect to a company differently than may have been taken in the absence of such consideration, which could cause us to perform differently compared to funds that do not have such considerations. Further, although the Adviser views application of its ESG framework to be an opportunity to potentially enhance or protect the performance of investments over the long-term, the Adviser cannot guarantee that any consideration of ESG factors or engagement with portfolio companies on ESG, which depends in part on skill and qualitative judgments, will positively impact the performance of any individual portfolio company or us.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-25" continuedAt="f-40-26"><ix:continuation id="f-80-1" continuedAt="f-80-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors and other stakeholders have become more focused on understanding how companies address a variety of ESG factors. As they evaluate investment decisions, many investors look not only at company disclosures but also to ESG rating systems that have been developed by third parties to allow ESG comparisons among companies. The criteria used in these ratings systems may conflict and change frequently, and we cannot predict how these third parties will score us, nor can we have any assurance that they score us accurately or other companies accurately or that other companies have provided them with accurate data. If our ESG ratings, disclosures or practices do not meet the standards set by such investors or our shareholders, they may choose not to invest in our shares. Relatedly, we risk damage to our reputation, if we do not, or are perceived to not, act responsibly in a number of areas, such as greenhouse gas emissions, energy management, human rights, community relations, workforce health and safety, and business ethics and transparency. Adverse incidents with respect to ESG matters or negative ESG ratings or assessments by third-party ESG raters could impact the value of our brand, or the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations.</span></div></ix:continuation><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-80-2">There is a growing regulatory interest across jurisdictions in improving transparency regarding the definition, measurement and disclosure of ESG factors in order to allow investors to validate and better understand sustainability claims. New regulatory initiatives related to ESG that are applicable to us could adversely affect our business. For example, the SEC has proposed rules that would require additional disclosures about ESG investment practices by investment advisers and certain funds, including BDCs. These changing rules, regulations and stakeholder expectations have resulted in, and are likely to continue to result in, increased general and administrative expenses and increased management time and attention spent complying with or meeting such regulations and expectations. If we fail or are perceived to fail to comply with applicable rules, regulations and stakeholder expectations, it could negatively impact our reputation and our business results.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-47" name="cef:RiskTextBlock" id="f-81" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our investment adviser could be the target of litigation or regulatory investigations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We as well as our investment adviser and its affiliates participate in a highly regulated industry and are each subject to regulatory examinations in the ordinary course of business. There can be no assurance that we and our investment adviser and/or any of its affiliates will avoid regulatory investigation and possible enforcement actions stemming therefrom. Our investment adviser is a registered investment adviser and, as such, is subject to the provisions of the Advisers Act. We and our investment adviser are each, from time to time, subject to formal and informal examinations, investigations, inquiries, audits and reviews from numerous regulatory authorities both in response to issues and questions raised in such examinations or investigations and in connection with the changing priorities of the applicable regulatory authorities across the market in general.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment adviser, its affiliates and/or any of their respective principals and employees could also be named as defendants in, or otherwise become involved in, litigation. Litigation and regulatory actions can be time-consuming and expensive and can lead to unexpected losses, which expenses and losses are often subject to indemnification by us. Legal proceedings could continue without resolution for long periods of time and their outcomes, which could materially and adversely affect the value of us or the ability of our investment adviser to manage us, are often impossible to anticipate. Our investment adviser would likely be required to expend significant resources responding to any litigation or regulatory action related to it, and these actions could be a distraction to the activities of our investment adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment activities are subject to the normal risks of becoming involved in litigation by third parties. This risk would be somewhat greater if we were to exercise control or significant influence over a portfolio company&#8217;s direction. The expense of defending against claims by third parties and paying any amounts pursuant to settlements or judgments would, absent willful misfeasance, bad faith, gross negligence, or reckless disregard of the duties involved by our investment adviser, our administrator, or any of our officers, be borne by us and would reduce our net assets. Our investment adviser and others are indemnified by us in connection with such litigation, subject to certain conditions.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-26" continuedAt="f-40-27"><ix:nonNumeric contextRef="c-48" name="cef:RiskTextBlock" id="f-82" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Second priority liens on collateral securing debt investments that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. If there is a default, the value of the collateral may not be sufficient to repay in full both the first priority creditors and us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain debt investments that we make to portfolio companies may be secured on a second priority basis by the same collateral securing first priority debt of such companies. The first priority liens on the collateral will secure the portfolio company&#8217;s obligations under any outstanding senior debt and may secure certain other future debt that may be permitted to be incurred by the company under the agreements governing the loans. The holders of obligations secured by the first priority liens on the collateral will generally control the liquidation of and be entitled to receive proceeds from any realization of the collateral to repay their obligations in full before us. In addition, the value of the collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from the sale or sales of all of the collateral would be sufficient to satisfy the debt obligations secured by the second priority liens after payment in full of all obligations secured by the first priority liens on the collateral. If such proceeds are not sufficient to repay amounts outstanding under the debt obligations secured by the second priority liens, then we, to the extent not repaid from the proceeds of the sale of the collateral, will only have an unsecured claim against the company&#8217;s remaining assets, if any.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also make unsecured debt investments in portfolio companies, meaning that such investments will not benefit from any interest in collateral of such companies. Liens on such portfolio companies&#8217; collateral, if any, will secure the portfolio company&#8217;s obligations under its outstanding secured debt and may secure certain future debt that is permitted to be incurred by the portfolio company under its secured debt agreements. The holders of obligations secured by such liens will generally control the liquidation of, and be entitled to receive proceeds from, any realization of such collateral to repay their obligations in full before we are so entitled. In addition, the value of such collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from sales of such collateral would be sufficient to satisfy its unsecured debt obligations after payment in full of all secured debt obligations. If such proceeds were not sufficient to repay the outstanding secured debt obligations, then its unsecured claims would rank equally with the unpaid portion of such secured creditors&#8217; claims against the portfolio company&#8217;s remaining assets, if any.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights we may have with respect to the collateral securing the debt investments we make to our portfolio companies with senior debt outstanding may also be limited pursuant to the terms of one or more intercreditor agreements that we enter into with the holders of senior debt. Under such an intercreditor agreement, at any time that obligations that have the benefit of the first priority liens are outstanding, any of the following actions that may be taken in respect of the collateral will be at the direction of the holders of the obligations secured by the first priority liens: the ability to cause the commencement of enforcement proceedings against the collateral; the ability to control the conduct of such proceedings; the approval of amendments to collateral documents; releases of liens on the collateral; and waivers of past defaults under collateral documents. We may not have the ability to control or direct such actions, even if our rights are adversely affected.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-49" name="cef:RiskTextBlock" id="f-83" continuedAt="f-83-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic recessions or downturns or restrictions on trade could impair our portfolio companies and adversely affect our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks associated with our and our portfolio companies&#8217; businesses are more severe during periods of economic slowdown or recession. In recent years, we have experienced periods of economic slowdown and in some instances, contraction, as countries and industries around the globe grappled with the short- and long-term economic impacts of the COVID-19 pandemic, elevated inflation, supply chain challenges, labor shortages, high interest rates, foreign currency exchange volatility and volatility in global capital markets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our portfolio companies may be susceptible to economic recessions or downturns and may be unable to repay our debt investments during these periods. Therefore, our non-performing assets are likely to increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions may also decrease the value of any collateral securing our senior secured debt. A prolonged recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income and NAV. Certain of our portfolio companies may also be impacted by tariffs or other matters affecting international trade. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on terms we deem acceptable. These events could prevent us from increasing investments and adversely affect our operating results.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-27" continuedAt="f-40-28"><ix:continuation id="f-83-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portfolio company&#8217;s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, acceleration of the time when the loans are due and foreclosure on its assets representing collateral for its obligations, which could trigger cross defaults under other agreements and jeopardize our portfolio company&#8217;s ability to meet its obligations under the debt investments that we hold and the value of any equity securities we own. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting portfolio company.</span></div></ix:continuation><ix:nonNumeric contextRef="c-50" name="cef:RiskTextBlock" id="f-84" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in CLOs may be riskier than a direct investment in the debt or other securities of the underlying companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When investing in CLOs, we may invest in any level of a CLO&#8217;s subordination chain, including subordinated (lower-rated) tranches and residual interests (the lowest tranche). CLOs are typically highly levered and therefore, the junior debt and equity tranches that we may invest in are subject to a higher risk of total loss and deferral or nonpayment of interest than the more senior tranches to which they are subordinated. In addition, we will generally have the right to receive payments only from the CLOs, and will generally not have direct rights against the underlying borrowers or entities that sponsored the CLOs. Furthermore, the investments we make in CLOs are at times thinly traded or have only a limited trading market. As a result, investments in such CLOs may be characterized as illiquid securities.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-51" name="cef:RiskTextBlock" id="f-85" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A covenant breach or other default by our portfolio companies may adversely affect our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portfolio company&#8217;s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, termination of its loans and foreclosure on its secured assets, which could trigger cross-defaults under other agreements and jeopardize a portfolio company&#8217;s ability to meet its obligations under the debt or equity securities that we hold. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms, which may include the waiver of certain financial covenants, with a defaulting portfolio company. In addition, lenders in certain cases can be subject to lender liability claims for actions taken by them when they become too involved in the borrower&#8217;s business or exercise control over a borrower. It is possible that we could become subject to a lender&#8217;s liability claim, including as a result of actions taken if we render significant managerial assistance to the borrower. Furthermore, if one of our portfolio companies were to file for bankruptcy protection, a bankruptcy court might re-characterize our debt holding and subordinate all or a portion of our claim to claims of other creditors, even though we may have structured our investment as senior secured debt. The likelihood of such a re-characterization would depend on the facts and circumstances, including the extent to which we provided managerial assistance to that portfolio company.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-52" name="cef:RiskTextBlock" id="f-86" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our portfolio companies may be highly leveraged.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our portfolio companies may be highly leveraged, which may have adverse consequences to these companies and to us as an investor. These companies may be subject to restrictive financial and operating covenants and the leverage may impair these companies&#8217; ability to finance their future operations and capital needs. As a result, these companies&#8217; flexibility to respond to changing business and economic conditions and to take advantage of business opportunities may be limited. Further, a leveraged company&#8217;s income and net assets will tend to increase or decrease at a greater rate than if borrowed money were not used.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-53" name="cef:RiskTextBlock" id="f-87" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our portfolio may be concentrated in a limited number of industries, which may subject us to a risk of significant loss if there is a downturn in a particular industry in which a number of our investments are concentrated.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio may be concentrated in a limited number of industries. Our portfolio will be considered to be concentrated in a particular industry when 25% or greater of its total assets are invested in issuers that are a part of that industry. A downturn in any industry in which we are invested could significantly impact the aggregate returns we realize. We anticipate that we may concentrate our investments in issuers that are part of the software industry, which currently represent close to 25% of our total assets, as a result of additional investments in the software industry and/or fluctuations in the fair value of our investments in the software industry and other industries.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an industry in which we have significant investments suffers from adverse business or economic conditions, as individual industries have historically experienced to varying degrees, a material portion of our investment portfolio could be affected adversely, which, in turn, could adversely affect our financial position and results of operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-28" continuedAt="f-40-29"><ix:nonNumeric contextRef="c-54" name="cef:RiskTextBlock" id="f-88" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to risks associated with our investments in the software industry.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue, income (or losses) and valuations of software and other technology-related companies can and often do fluctuate suddenly and dramatically. In addition, because of rapid technological change, the average selling prices of software products have historically decreased over their productive lives. As a result, the average selling prices of software offered by our portfolio companies may decrease over time, which could adversely affect their operating results and, correspondingly, the value of any securities that we may hold. Additionally, companies operating in the software industry are subject to vigorous competition, changing technology, changing client and end-consumer needs, evolving industry standards and frequent introductions of new products and services. Our portfolio companies in the software industry could compete with companies that are larger and could be engaged in a greater range of businesses or have greater financial, technical, sales or other resources than our portfolio companies do. Our portfolio companies could lose market share if their competitors introduce or acquire new products that compete with their software and related services or add new features to existing products. Any deterioration in the results of our portfolio companies due to competition or otherwise could, in turn, materially adversely affect our business, financial condition and results of operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-55" name="cef:RiskTextBlock" id="f-89" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in the healthcare providers and services industry face considerable uncertainties.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and rules governing the business of healthcare companies and interpretations of those laws and rules are subject to frequent change. Broad latitude is given to the agencies administering those regulations. Existing or future laws and rules could force our portfolio companies engaged in healthcare to change how they do business, restrict revenue, increase costs, change reserve levels and change business practices.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare companies often must obtain and maintain regulatory approvals to market many of their products, change prices for certain regulated products and consummate some of their acquisitions and divestitures. Delays in obtaining or failing to obtain or maintain these approvals could reduce revenue or increase costs. Policy changes on the local, state and federal level, such as the expansion of the government&#8217;s role in the healthcare arena and alternative assessments and tax increases specific to the healthcare industry or healthcare products as part of federal health care reform initiatives, could fundamentally change the dynamics of the healthcare industry.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-56" name="cef:RiskTextBlock" id="f-90" continuedAt="f-90-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing in large private U.S. borrowers may limit the Company&#8217;s ability to achieve high growth rates during times of economic expansion. </span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-90-1">Investing in originated assets made to large private U.S. borrowers may result in us underperforming in other segments of the market, particularly during times of economic expansion, because large private U.S. borrowers may be less responsive to competitive challenges and opportunities in the financial markets. As a result, our value may not rise at the same rate, if at all, as other funds that invest in smaller market capitalization companies that are more capable of responding to economic and industrial changes.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-57" name="cef:RiskTextBlock" id="f-91" continuedAt="f-91-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing in private companies involves a number of significant risks, any one of which could have a material adverse effect on our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks include that:</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing on any guarantees we may have obtained in connection with our investment; </span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies frequently have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tends to render them more vulnerable to competitors&#8217; actions and changing market conditions, as well as general economic downturns; </span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us; </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-29" continuedAt="f-40-30"><ix:continuation id="f-91-1" continuedAt="f-91-2"><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, Trustees and members of the Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and </span></div></ix:continuation><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><ix:continuation id="f-91-2" continuedAt="f-91-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"><ix:continuation id="f-91-3">these companies may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-58" name="cef:RiskTextBlock" id="f-92" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not realize gains from our equity investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain investments that we may make could include warrants or other equity securities. In addition, we may make direct equity investments in portfolio companies. Our goal is ultimately to realize gains upon our disposition of such equity interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. We also may be unable to realize any value if a portfolio company does not have a liquidity event, such as a sale of the business, recapitalization or public offering, which would allow us to sell the underlying equity interests. We intend to seek puts or similar rights to give us the right to sell our equity securities back to the portfolio company issuer. We may be unable to exercise these put rights for the consideration provided in our investment documents if the issuer is in financial distress.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-59" name="cef:RiskTextBlock" id="f-93" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An investment strategy focused primarily on privately-held companies presents certain challenges, including, but not limited to, the lack of available information about these companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest primarily in privately-held companies. Investments in private companies pose significantly greater risks than investments in public companies. First, private companies have reduced access to the capital markets, resulting in diminished capital resources and the ability to withstand financial distress. Second, the depth and breadth of experience of management in private companies tends to be less than that at public companies, which makes such companies more likely to depend on the management talents and efforts of a smaller group of persons and/or persons. Therefore, the decisions made by such management teams and/or the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our investments and, in turn, on us. Third, the investments themselves tend to be less liquid. As such, we may have difficulty exiting an investment promptly or at a desired price prior to maturity or outside of a normal amortization schedule. As a result, the relative lack of liquidity and the potential diminished capital resources of our target portfolio companies may affect our investment returns. Fourth, limited public information generally exists about private companies. Fifth, these companies may not have third-party debt ratings or audited financial statements. We must therefore rely on the ability of the Adviser to obtain adequate information through due diligence to evaluate the creditworthiness and potential returns from investing in these companies. The Adviser typically assesses an investment in a portfolio company based on the Adviser&#8217;s estimate of the portfolio company&#8217;s earnings and enterprise value, among other things, and these estimates may be based on limited information and may otherwise be inaccurate, causing the Adviser to make different investment decisions than it may have made with more complete information. These private companies and their financial information are not subject to the Sarbanes-Oxley Act and other rules that govern public companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-30" continuedAt="f-40-31"><ix:nonNumeric contextRef="c-60" name="cef:RiskTextBlock" id="f-94" continuedAt="f-94-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in securities or assets of publicly-traded companies are subject to the risks inherent in investing in public securities.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-94-1">We may invest a portion of our portfolio in publicly-traded assets. For example, it is not expected that we will be able to negotiate additional financial covenants or other contractual rights, which we might otherwise be able to obtain in making privately negotiated investments. In addition, by investing in publicly-traded securities or assets, we will be subject to U.S. federal and state securities laws, as well as non-U.S. securities laws, that may, among other things, restrict or prohibit our ability to make or sell an investment. Moreover, we may not have the same access to information in connection with investments in public securities, either when investigating a potential investment or after making an investment, as compared to privately negotiated investments. Furthermore, we may be limited in our ability to make investments and to sell existing investments in public securities because the Firm may be deemed to have material, non-public information regarding the issuers of those securities or as a result of other internal policies. The inability to sell public securities in these circumstances could materially adversely affect our investment results. In addition, an investment may be sold by us to a public company where the consideration received is a combination of cash and stock of the public company, which may, depending on the securities laws of the relevant jurisdiction, be subject to lock-up periods.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-61" name="cef:RiskTextBlock" id="f-95" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A lack of liquidity in certain of our investments may adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally invest in companies whose securities are not publicly-traded or actively traded on the secondary market, and whose securities are subject to legal and other restrictions on resale or will otherwise be less liquid than publicly-traded securities. The illiquidity of certain of our investments may make it difficult for us to sell these investments when desired. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we had previously recorded these investments. The reduced liquidity of our investments may make it difficult for us to dispose of them at a favorable price, and, as a result, we may suffer losses.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-62" name="cef:RiskTextBlock" id="f-96" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments. After our initial investment in a portfolio company, we may be called upon from time to time to provide additional funds to such company or have the opportunity to increase our investment through the exercise of a warrant to purchase shares. There is no assurance that we will make, or will have sufficient funds to make, follow-on investments. Any decisions not to make a follow-on investment or any inability on our part to make such an investment may have a negative impact on a portfolio company in need of such an investment, may result in a missed opportunity for us to increase our participation in a successful operation or may reduce the expected return on the investment.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-63" name="cef:RiskTextBlock" id="f-97" continuedAt="f-97-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments may include original issue discount and payment-in-kind instruments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we invest in original issue discount or payment-in-kind (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;PIK&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) instruments and the accretion of original issue discount or PIK interest income constitutes a portion of our income, we will be exposed to risks associated with the requirement to include such non-cash income in taxable and accounting income prior to receipt of cash, including the following:&#160;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the higher interest rates on PIK instruments reflect the payment deferral and increased credit risk associated with these instruments, and PIK instruments generally represent a significantly higher credit risk than coupon loans;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">original issue discount and PIK instruments may have unreliable valuations because the accruals require judgments about collectability of the deferred payments and the value of any associated collateral;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">an election to defer PIK interest payments by adding them to the principal on such instruments increases our future investment income which increases our gross assets and, as such, increases the Adviser&#8217;s future base management fees which, thus, increases the Adviser&#8217;s future income incentive fees at a compounding rate;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">market prices of PIK instruments and other zero-coupon instruments are affected to a greater extent by interest rate changes, and may be more volatile than instruments that pay interest periodically in cash. While PIK instruments are usually less volatile than zero-coupon debt instruments, PIK instruments are generally more volatile than cash pay securities;</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-31" continuedAt="f-40-32"><ix:continuation id="f-97-1"><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the deferral of PIK interest on an instrument increases the loan-to-value ratio, which is a measure of the riskiness of a loan, with respect to such instrument;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">even if the conditions for income accrual under GAAP are satisfied, a borrower could still default when actual payment is due upon the maturity of such loan;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">for accounting purposes, cash distributions to investors representing original issue discount income do not come from paid-in capital, although they may be paid from the offering proceeds. Thus, although a distribution of original issue discount income may come from the cash invested by investors, the 1940 Act does not require that investors be given notice of this fact;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the required recognition of original issue discount or PIK interest for U.S. federal income tax purposes may have a negative impact on liquidity, as it represents a non-cash component of our investment company taxable income that may require cash distributions to shareholders in order to maintain our ability to be subject to tax as a RIC; and</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">original issue discount may create a risk of non-refundable cash payments to the Adviser based on non-cash accruals that may never be realized.</span></div></ix:continuation><ix:nonNumeric contextRef="c-64" name="cef:RiskTextBlock" id="f-98" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may enter into a TRS agreement that exposes us to certain risks, including market risk, liquidity risk and other risks similar to those associated with the use of leverage.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total return swap (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;TRS&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is a contract in which one party agrees to make periodic payments to another party based on the change in the market value of the assets underlying the TRS, which may include a specified security, basket of securities or securities indices during a specified period, in return for periodic payments based on a fixed or variable interest rate. A TRS effectively adds leverage to a portfolio by providing investment exposure to a security or market without owning or taking physical custody of such security or investing directly in such market. Because of the unique structure of a TRS, a TRS often offers lower financing costs than are offered through more traditional borrowing arrangements. The Company would typically have to post collateral to cover this potential obligation. To the extent the Company complied with the applicable requirements of Rule 18f-4, the leverage incurred through TRS will not be considered a borrowing for purposes of the Company&#8217;s overall leverage limitation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A TRS is subject to market risk, liquidity risk and risk of imperfect correlation between the value of the TRS and the loans underlying the TRS. In addition, we may incur certain costs in connection with the TRS that could in the aggregate be significant. A TRS is also subject to the risk that a counterparty will default on its payment obligations thereunder or that we will not be able to meet our obligations to the counterparty.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-65" name="cef:RiskTextBlock" id="f-99" continuedAt="f-99-1" escape="true"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may enter into repurchase agreements or reverse repurchase agreements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to our investment objectives and policies, we may invest in repurchase agreements as a buyer for investment purposes. Repurchase agreements typically involve the acquisition by us of debt securities from a selling financial institution such as a bank, savings and loan association or broker-dealer. The agreement provides that we will sell the securities back to the institution at a fixed time in the future for the purchase price plus premium (which often reflects the interests). We do not bear the risk of a decline in the value of the underlying security unless the seller defaults under its repurchase obligation. In the event of the bankruptcy or other default of a seller of a repurchase agreement, we could experience both delays in liquidating the underlying securities and losses, including (1) possible decline in the value of the underlying security during the period in which we seek to enforce its rights thereto; (2) possible lack of access to income on the underlying security during this period; and (3) expenses of enforcing its rights. In addition, as described above, the value of the collateral underlying the repurchase agreement will be at least equal to the repurchase price, including any accrued interest earned on the repurchase agreement. In the event of a default or bankruptcy by a selling financial institution, we generally will seek to liquidate such collateral. However, the exercise of our right to liquidate such collateral could involve certain costs or delays and, to the extent that proceeds from any sale upon a default of the obligation to repurchase were less than the repurchase price, we could suffer a loss.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-32" continuedAt="f-40-33"><ix:continuation id="f-99-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to our investment objectives and policies, we invest in repurchase agreements as a seller, also known as a &#8220;reverse repurchase agreement.&#8221; Our use of reverse repurchase agreements involves many of the same risks involved in our use of leverage, as the proceeds from reverse repurchase agreements are generally invested in additional portfolio investments. There is a risk that the market value of the securities acquired from the proceeds received in connection with a reverse repurchase agreement may decline below the price of the securities underlying the reverse repurchase agreement that we have sold but remain obligated to repurchase. Reverse repurchase agreements also involve the risk that the counterparty liquidates the securities we delivered to it under the reverse repurchase agreements following the occurrence of an event of default under the applicable repurchase agreement by us. In addition, there is a risk that the market value of the securities we retain may decline. If the buyer of securities under a reverse repurchase agreement were to file for bankruptcy or experiences insolvency, we may be adversely affected. Furthermore, our counterparty may require us to provide additional margin in the form of cash, securities or other forms of collateral under the terms of the derivative contract. Also, in entering into reverse repurchase agreements, we bear the risk of loss to the extent that the proceeds of the reverse repurchase agreement are less than the value of the underlying securities. In addition, the interest costs associated with reverse repurchase agreements transactions, may adversely affect our results of operations and financial condition, and, in some cases, we may be worse off than if we had not used such instruments.</span></div></ix:continuation><ix:nonNumeric contextRef="c-66" name="cef:RiskTextBlock" id="f-100" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may enter into securities lending agreements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may from time to time make secured loans of our marginable securities to brokers, dealers and other financial institutions if our asset coverage, as defined in the 1940 Act, is at or above 150% immediately after each such loan. The risks in lending portfolio securities, as with other extensions of credit, consist of possible delay in recovery of the securities or possible loss of rights in the collateral should the borrower fail financially. However, such loans will be made only to brokers and other financial institutions that are believed by the Adviser to be of high credit standing. Securities loans are made to broker-dealers pursuant to agreements requiring that loans be continuously secured by collateral consisting of U.S. government securities, cash or cash equivalents (e.g., negotiable certificates of deposit, bankers&#8217; acceptances or letters of credit) maintained on a daily mark-to-market basis in an amount at least equal at all times to the market value of the securities lent. If the Company enters into a securities lending arrangement, the Adviser, as part of its responsibilities under the Investment Advisory Agreement, will invest the Company&#8217;s cash collateral in accordance with the Company&#8217;s investment objectives and strategies. The Company will pay the borrower of the securities a fee based on the amount of the cash collateral posted in connection with the securities lending program. The borrower will pay to the Company, as the lender, an amount equal to any dividends or interest received on the securities lent.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may invest the cash collateral received only in accordance with its investment objectives, subject to the Company&#8217;s agreement with the borrower of the securities. In the case of cash collateral, the Company expects to pay a rebate to the borrower. The reinvestment of cash collateral will result in a form of effective leverage for the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although voting rights or rights to consent with respect to the loaned securities pass to the borrower, the Company, as the lender, will retain the right to call the loans and obtain the return of the securities loaned at any time on reasonable notice, and it will do so in order that the securities may be voted by the Company if the holders of such securities are asked to vote upon or consent to matters materially affecting the investment. The Company may also call such loans in order to sell the securities involved. When engaged in securities lending, the Company&#8217;s performance will continue to reflect changes in the value of the securities loaned and will also reflect the receipt of interest through investment of cash collateral by the Company in permissible investments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-67" name="cef:RiskTextBlock" id="f-101" continuedAt="f-101-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may from time to time enter into credit default swaps or other derivative transactions which expose us to certain risks, including credit risk, market risk, liquidity risk and other risks similar to those associated with the use of leverage.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may from time to time enter into credit default swaps or other derivative transactions that seek to modify or replace the investment performance of a particular reference security or other asset. These transactions are typically individually negotiated, non-standardized agreements between two parties to exchange payments, with payments generally calculated by reference to a notional amount or quantity. Swap contracts and similar derivative contracts are not traded on exchanges; rather, banks and dealers act as principals in these markets. These investments may present risks in excess of those resulting from the referenced security or other asset. Because these transactions are not an acquisition of the referenced security or other asset itself, the investor has no right directly to enforce compliance with the terms of the referenced security or other asset and has no voting or other consensual rights of ownership with respect to the referenced security or other asset. In the event of insolvency of a counterparty, we will be treated as a general creditor of the counterparty and will have no claim of title with respect to the referenced security or other asset.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-33" continuedAt="f-40-34"><ix:continuation id="f-101-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A credit default swap is a contract in which one party buys or sells protection against a credit event with respect to an issuer, such as an issuer&#8217;s failure to make timely payments of interest or principal on its debt obligations, bankruptcy or restructuring during a specified period. Generally, if we sell credit protection using a credit default swap, we will receive fixed payments from the swap counterparty and if a credit event occurs with respect to the applicable issuer, we will pay the swap counterparty par for the issuer&#8217;s defaulted debt securities and the swap counterparty will deliver the defaulted debt securities to us. Generally, if we buy credit protection using a credit default swap, we will make fixed payments to the counterparty and if a credit event occurs with respect to the applicable issuer, we will deliver the issuer&#8217;s defaulted securities underlying the swap to the swap counterparty and the counterparty will pay us par for the defaulted securities. Alternatively, a credit default swap may be cash settled and the buyer of protection would receive the difference between the par value and the market value of the issuer&#8217;s defaulted debt securities from the seller of protection.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit default swaps are subject to the credit risk of the underlying issuer. If we are selling credit protection, there is a risk that we will not properly assess the risk of the underlying issuer, a credit event will occur and we will have to pay the counterparty. If we are buying credit protection, there is a risk that we will not properly assess the risk of the underlying issuer, no credit event will occur and we will receive no benefit for the premium paid.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A derivative transaction is also subject to the risk that a counterparty will default on its payment obligations thereunder or that we will not be able to meet our obligations to the counterparty. In some cases, we may post collateral to secure our obligations to the counterparty, and we may be required to post additional collateral upon the occurrence of certain events such as a decrease in the value of the reference security or other asset. In some cases, the counterparty may not collateralize any of its obligations to us. Derivative investments effectively add leverage to a portfolio by providing investment exposure to a security or market without owning or taking physical custody of such security or investing directly in such market. In addition to the risks described above, such arrangements are subject to risks similar to those associated with the use of leverage. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain categories of credit default swaps are subject to mandatory clearing, and more categories may be subject to mandatory clearing in the future. The counterparty risk for cleared derivatives is generally lower than for uncleared over-the-counter derivative transactions because generally a clearing organization becomes substituted for each counterparty to a cleared derivative contract and, in effect, guarantees the parties&#8217; performance under the contract as each party to a trade looks only to the clearing house for performance of financial obligations. However, there can be no assurance that a clearing house, or its members, will satisfy the clearing house&#8217;s obligations (including, but not limited to, financial obligations and legal obligations to segregate margins collected by the clearing house) to the Company. Counterparty risk with respect to certain exchange-traded and over-the-counter derivatives are considered as part of the value at risk provisions of Rule 18f-4. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Risk Factors&#8212;Risks Related to Debt Financing.&#8221;</span></div></ix:continuation><ix:nonNumeric contextRef="c-68" name="cef:RiskTextBlock" id="f-102" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may acquire various financial instruments for purposes of &#8220;hedging&#8221; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek to hedge against interest rate and currency exchange rate fluctuations and credit risk by using financial instruments such as futures, options, swaps and forward contracts, subject to the requirements of the 1940 Act. These financial instruments may be purchased on exchanges or may be individually negotiated and traded in over-the-counter markets. Use of such financial instruments for hedging purposes may present significant risks, including the risk of loss of the amounts invested. Defaults by the other party to a hedging transaction can result in losses in the hedging transaction. Hedging activities also involve the risk of an imperfect correlation between the hedging instrument and the asset being hedged, which could result in losses both on the hedging transaction and on the instrument being hedged. Use of hedging activities may not prevent significant losses and could increase our losses. Further, hedging transactions may reduce cash available to pay distributions to our shareholders.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-69" name="cef:RiskTextBlock" id="f-103" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the risk that the investments we make in our portfolio companies may be repaid prior to maturity. When this occurs, we will generally reinvest these proceeds in temporary investments, pending their future investment in new portfolio companies. These temporary investments will typically have substantially lower yields than the debt being prepaid and we could experience significant delays in reinvesting these amounts. Any future investment in a new portfolio company may also be at lower yields than the debt that was repaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Additionally, prepayments, net of prepayment fees, could negatively impact our return on equity.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-34" continuedAt="f-40-35"><ix:nonNumeric contextRef="c-70" name="cef:RiskTextBlock" id="f-104" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technological or other innovations and industry disruptions may negatively impact us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent trends in the market generally have been toward disrupting the industry with technological or other innovations, and multiple young companies have been successful in capitalizing on this trend toward disruption. In this period of rapid technological and commercial innovation, new businesses and approaches may be created that could affect the Company and/or its portfolio companies or alter the market practices that help frame its strategy. Any of these new approaches could damage the Company&#8217;s investments, significantly disrupt the market in which it operates and subject it to increased competition, which could materially and adversely affect its business, financial condition and results of investments. Moreover, given the pace of innovation in recent years, the impact on a particular investment may not have been foreseeable at the time we made the investment. Furthermore, we could base investment decisions on views about the direction or degree of innovation that prove inaccurate and lead to losses.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-71" name="cef:RiskTextBlock" id="f-105" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may invest through various joint ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may hold a portion of its investments through partnerships, joint ventures, securitization vehicles or other entities with third-party investors (collectively, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">joint ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Joint venture investments involve various risks, including the risk that we will not be able to implement investment decisions or exit strategies because of limitations on our control under applicable agreements with joint venture partners, the risk that a joint venture partner may become bankrupt or may at any time have economic or business interests or goals that are inconsistent with those of the Company, the risk that a joint venture partner may be in a position to take action contrary to the Company&#8217;s objectives, the risk of liability based upon the actions of a joint venture partner and the risk of disputes or litigation with such partner and the inability to enforce fully all rights (or the incurrence of additional risk in connection with enforcement of rights) one partner may have against the other, including in connection with foreclosure on partner loans, because of risks arising under state law. In addition, we may, in certain cases, be liable for actions of our joint venture partners. The joint ventures in which we participate may sometimes be allocated investment opportunities that might have otherwise gone entirely to the Company, which may reduce our return on equity. Additionally, our joint venture investments may be held on an unconsolidated basis and at times may be highly leveraged. Such leverage would not count toward the investment limits imposed on us by the 1940 Act.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-72" name="cef:RiskTextBlock" id="f-106" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks associated with investing alongside other third parties.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We may invest in joint ventures alongside third parties through joint ventures, partnerships or other entities in the future. Such investments may involve risks not present in investments where a third party is not involved, including the possibility that such third party may at any time have economic or business interests or goals which are inconsistent with ours, or may be in a position to take action contrary to our investment objectives. In addition, we may in certain circumstances be liable for actions of such third party.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More specifically, joint ventures involve a third party that has approval rights over activity of the joint venture. The third party may take actions that are inconsistent with our interests. For example, the third party may decline to approve an investment for the joint venture that we otherwise want the joint venture to make. A joint venture may also use investment leverage which magnifies the potential for gain or loss on amounts invested. Generally, the amount of borrowing by the joint venture is not included when calculating our total borrowing and related leverage ratios and is not subject to asset coverage requirements imposed by the 1940 Act. If the activities of the joint venture were required to be consolidated with our activities because of a change in GAAP rules or SEC staff interpretations, it is likely that we would have to reorganize any such joint venture.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-73" name="cef:RiskTextBlock" id="f-107" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may syndicate co-investment opportunities, which may be costly.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may make an investment with the expectation of offering a portion of its interests therein as a co-investment opportunity to third-party investors. There can be no assurance that we will be successful in syndicating any such co-investment, in whole or in part, that the closing of such co-investment will be consummated in a timely manner, that any syndication will take place on terms and conditions that will be preferable for the Company or that expenses incurred by us with respect to any such syndication will not be substantial. In the event that we are not successful in syndicating any such co-investment, in whole or in part, we may consequently hold a greater concentration and have more exposure in the related investment than initially was intended, which could make the Company more susceptible to fluctuations in value resulting from adverse economic and/or business conditions with respect thereto. Moreover, an investment by the Company that is not syndicated to co-investors as originally anticipated could significantly reduce our overall investment returns.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-74" name="cef:RiskTextBlock" id="f-108" escape="true"><ix:continuation id="f-40-35" continuedAt="f-40-36"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may use a wide range of investment techniques that could expose us to a diverse range of risks.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser may employ investment techniques or invest in instruments that it believes will help achieve our investment objectives, whether or not such investment techniques or instruments are specifically defined herein, so long as such investments are consistent with our investment strategies and objectives and subject to applicable law. Such investment techniques or instruments may not be thoroughly tested in the market before being employed and may have operational or theoretical shortcomings which could result in unsuccessful investments and, ultimately, losses to us. In addition, any such investment technique or instrument may be more speculative than other investment techniques or instruments specifically described herein and may involve material and unanticipated risks. There can be no assurance that the Adviser will be successful in implementing any such investment technique. Furthermore, the diversification and type of investments may differ substantially from our prior investments.</span></div></ix:continuation></ix:nonNumeric><div id="i33edc808e7824948b94b269ed713a939_28"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C.</span><ix:continuation id="f-40-36" continuedAt="f-40-37"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">Risks Related to the Adviser and Its Affiliates</span></ix:continuation></div><ix:continuation id="f-40-37" continuedAt="f-40-38"><ix:nonNumeric contextRef="c-75" name="cef:RiskTextBlock" id="f-109" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Adviser and its affiliates, including our officers and some of our trustees, face conflicts of interest caused by compensation arrangements with us and our affiliates, which could result in actions that are not in the best interests of our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser and its affiliates receive substantial fees from us in return for their services, and these fees could influence the advice provided to us. We pay to the Adviser an incentive fee that is based on the performance of our portfolio and an annual base management fee that is based on the average value of our gross assets at the end of the two most recently completed calendar quarters. Because the incentive fee is based on the performance of our portfolio, the Adviser may be incentivized to make investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The way in which the incentive fee is determined may also encourage the Adviser to use leverage to increase the return on our investments. In addition, because the base management fee is based on the average value of our gross assets at the end of the two most recently completed calendar quarters, which includes any borrowings for investment purposes, the Adviser may be incentivized to recommend the use of leverage or the issuance of additional equity to make additional investments and increase the average value of our gross assets at the end of the two most recently completed calendar quarters. Under certain circumstances, the use of leverage may increase the likelihood of default, which could disfavor our shareholders. Our compensation arrangements could therefore result in our making riskier or more speculative investments, or relying more on leverage to make investments, than would otherwise be the case. This could result in higher investment losses, particularly during cyclical economic downturns. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.&#8221;</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-76" name="cef:RiskTextBlock" id="f-110" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be obligated to pay the Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Investment Advisory Agreement entitles the Adviser to receive Pre-Incentive Fee Net Investment Income Returns regardless of any capital losses. In such case, we may be required to pay the Adviser incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or if we incur a net loss for that quarter.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any Pre-Incentive Fee Net Investment Income Returns may be computed and paid on income that may include interest that has been accrued but not yet received. If a portfolio company defaults on a loan that is structured to provide accrued interest, it is possible that accrued interest previously included in the calculation of the incentive fee will become uncollectible. The Adviser is not under any obligation to reimburse us for any part of the incentive fee it received that was based on accrued income that we never received as a result of a default by an entity on the obligation that resulted in the accrual of such income, and such circumstances would result in our paying an incentive fee on income we never received.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-38" continuedAt="f-40-39"><ix:nonNumeric contextRef="c-77" name="cef:RiskTextBlock" id="f-111" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The incentive fee based on income takes into account our past performance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Incentive Fee based on income is determined and paid quarterly in arrears at the end of each calendar quarter by reference to our aggregate net investment income, as adjusted, from the calendar quarter then ending and the Trailing Twelve Quarters. The effect of calculating the incentive fee using reference to the Trailing Twelve Quarters is that, in certain circumstances, an incentive fee based on income is payable to the Adviser although our net income for such quarter did not exceed the hurdle rate or the incentive fee will be higher than it would have been if calculated based on our performance for the applicable quarter without taking into account the Trailing Twelve Quarters. For example, if we experience a net loss for any particular quarter, an incentive fee may still be paid to the Adviser if such net loss is less than the net loss for the most recent quarter that preceded the Trailing Twelve Quarters. In such circumstances, the Adviser would be entitled to an incentive fee whereas it would not have been entitled to an incentive fee if calculated solely on the basis of our performance for the applicable quarter.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-78" name="cef:RiskTextBlock" id="f-112" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There may be conflicts of interest related to obligations that the Adviser&#8217;s senior management and Investment Team have to Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The members of the senior management and Investment Team of the Adviser serve or may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do, or of investment funds managed by the same personnel. In serving in these multiple capacities, they may have obligations to Other Clients or investors in those entities, the fulfillment of which may not be in our best interests or in the best interest of our shareholders. Our investment objectives may overlap with the investment objectives of such investment funds, accounts or other investment vehicles. In particular, we will rely on the Adviser to manage our day-to-day activities and to implement our investment strategy. The Adviser and certain of its affiliates are presently, and plan in the future to continue to be, involved with activities that are unrelated to us. As a result of these activities, the Adviser, its officers and employees and certain of its affiliates will have conflicts of interest in allocating their time between us and other activities in which they are or may become involved, including the management of its affiliated equipment funds. The Adviser and its officers and employees will devote only as much of its or their time to our business as the Adviser and its officers and employees, in their judgment, determine is reasonably required, which may be substantially less than their full time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely, in part, on the Adviser to assist with identifying investment opportunities and making investment recommendations to the Adviser. The Adviser and its affiliates are not restricted from forming additional investment funds, entering into other investment advisory relationships or engaging in other business activities. These activities could be viewed as creating a conflict of interest in that the time and effort of the members of the Adviser, its affiliates and their officers and employees will not be devoted exclusively to our business, but will be allocated between us and such other business activities of the Adviser and its affiliates in a manner that the Adviser deems necessary and appropriate consistent with its fiduciary duties and the 1940 Act. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.&#8221;</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-79" name="cef:RiskTextBlock" id="f-113" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The time and resources that individuals employed by the Adviser devote to us may be diverted and we may face additional competition due to the fact that individuals employed by the Adviser are not prohibited from raising money for or managing other entities that make the same types of investments that we target.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser and individuals employed by the Adviser are generally not prohibited from raising capital for and managing other investment entities that make the same types of investments as those we target. As a result, the time and resources that these individuals may devote to us may be diverted. In addition, we may compete with any such investment entity for the same investors and investment opportunities. We may participate in certain transactions originated by the Adviser or its affiliates under our exemptive relief from the SEC that allows us to engage in co-investment transactions with the Adviser and its affiliates, subject to certain terms and conditions. However, while the terms of the exemptive relief require that the Adviser will be given the opportunity to cause us to participate in certain transactions originated by affiliates of the Adviser, the Adviser may determine that we not participate in those transactions and for certain other transactions (as set forth in guidelines approved by the Board) the Adviser may not have the opportunity to cause us to participate. Affiliates of the Adviser, whose primary business includes the origination of investments or investing in non-originated assets, engage in investment advisory business with accounts that compete with us. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us."</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-39" continuedAt="f-40-40"><ix:nonNumeric contextRef="c-80" name="cef:RiskTextBlock" id="f-114" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our shares may be purchased by the Adviser or its affiliates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Affiliates of the Adviser have purchased and in the future expect to purchase our shares. The Adviser and its affiliates will not acquire any shares with the intention to resell or re-distribute such shares. The purchase of shares by the Adviser and its affiliates could create certain risks, including, but not limited to, the following:</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Adviser and its affiliates may have an interest in disposing of our assets at an earlier date so as to recover their investment in our shares; and</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">substantial purchases of shares by the Adviser and its affiliates may limit the Adviser&#8217;s ability to fulfill any financial obligations that it may have to us or incurred on our behalf.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-81" name="cef:RiskTextBlock" id="f-115" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Adviser relies on key personnel, the loss of any of whom could impair its ability to successfully manage us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends, to a significant extent, on the continued services of the officers and employees of the Adviser or its affiliates. The loss of services of one or more members of the Adviser&#8217;s management team, including members of the Investment Committee, could adversely affect our financial condition, business and results of operations. The Adviser does not have an employment agreement with any of these key personnel and we cannot guarantee that all, or any particular one, will remain affiliated with us and/or the Adviser. Further, we do not intend to separately maintain key person life insurance on any of these individuals.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-82" name="cef:RiskTextBlock" id="f-116" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on the Adviser to select our investments and otherwise conduct our business, and any material adverse change in its financial condition or our relationship with the Adviser could have a material adverse effect on our business and ability to achieve our investment objectives.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success is dependent upon our relationship with, and the performance of, the Adviser in the acquisition and management of our portfolio investments, and our corporate operations, as well as the persons and firms the Adviser retains to provide services on our behalf. The Adviser may suffer or become distracted by adverse financial or operational problems in connection with Blackstone&#8217;s business and activities unrelated to us and over which we have no control. Should the Adviser fail to allocate sufficient resources to perform its responsibilities to us for any reason, we may be unable to achieve our investment objectives or to pay distributions to our shareholders.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-83" name="cef:RiskTextBlock" id="f-117" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The compensation we pay to the Adviser will be determined without independent assessment on our behalf, and these terms may be less advantageous to us than if such terms had been the subject of arm&#8217;s-length negotiations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investment Advisory Agreement will not be entered into on an arm&#8217;s-length basis with an unaffiliated third party. As a result, the form and amount of compensation we pay the Adviser may be less favorable to us than they might have been had an investment advisory agreement been entered into through arm&#8217;s-length transactions with an unaffiliated third party.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-84" name="cef:RiskTextBlock" id="f-118" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Adviser&#8217;s influence on conducting our operations gives it the ability to increase its fees, which may reduce the amount of cash flow available for distribution to our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser is paid a base management fee calculated as a percentage of our gross assets and unrelated to net income or any other performance base or measure. The Adviser may advise us to consummate transactions or conduct our operations in a manner that, in the Adviser&#8217;s reasonable discretion, is in the best interests of our shareholders. These transactions, however, may increase the amount of fees paid to the Adviser. The Adviser&#8217;s ability to influence the base management fee paid to it by us could reduce the amount of cash flow available for distribution to our shareholders.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-85" name="cef:RiskTextBlock" id="f-119" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There may be trademark risk, as we do not own the Blackstone name.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not own the Blackstone name, but we are permitted to use it as part of our corporate name pursuant to the Investment Advisory Agreement. Use of the name by other parties or the termination of the Investment Advisory Agreement may harm our business.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-40" continuedAt="f-40-41"><ix:nonNumeric contextRef="c-86" name="cef:RiskTextBlock" id="f-120" continuedAt="f-120-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to additional potential conflicts of interests as a consequence of Blackstone&#8217;s status as a public company.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-120-1">As a consequence of Blackstone&#8217;s status as a public company, our officers and trustees, and the employees&#160;of the Adviser may take into account certain considerations and other factors in connection with the management of the business and affairs of us and our affiliates that would not necessarily be taken into account if Blackstone were not a public company.</ix:continuation> </span></div></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_31"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.</span><ix:continuation id="f-40-41" continuedAt="f-40-42"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">Risks Related to Business Development Companies</span></ix:continuation></div><ix:continuation id="f-40-42" continuedAt="f-40-43"><ix:nonNumeric contextRef="c-87" name="cef:RiskTextBlock" id="f-121" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The requirement that we invest a sufficient portion of our assets in Qualifying Assets could preclude us from investing in accordance with our current business strategy; conversely, the failure to invest a sufficient portion of our assets in Qualifying Assets could result in our failure to maintain our status as a BDC.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, a BDC may not acquire any asset other than assets of the type listed in section 55(a) of the 1940 Act described as &#8220;qualifying&#8221; assets (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Qualifying Assets&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), unless, at the time of and after giving effect to such acquisition, at least 70% of our total assets are Qualifying Assets. Therefore, we may be precluded from investing in what we believe are attractive investments if such investments are not Qualifying Assets. Conversely, if we fail to invest a sufficient portion of our assets in Qualifying Assets, we could lose our status as a BDC, which would have a material adverse effect on our business, financial condition and results of operations. Similarly, these rules could prevent us from making additional investments in existing portfolio companies, which could result in the dilution of our position, or could require us to dispose of investments at an inopportune time to comply with the 1940 Act. If we were forced to sell non-qualifying investments in the portfolio for compliance purposes, the proceeds from such sale could be significantly less than the current value of such investments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-88" name="cef:RiskTextBlock" id="f-122" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to maintain our status as a BDC would reduce our operating flexibility.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not remain a BDC, we might be regulated as a registered closed-end management investment company under the 1940 Act, which would subject us to substantially more regulatory restrictions under the 1940 Act and correspondingly decrease our operating flexibility.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-89" name="cef:RiskTextBlock" id="f-123" continuedAt="f-123-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulations governing our operation as a BDC and RIC will affect our ability to raise, and the way in which we raise, additional capital or borrow for investment purposes, which may have a negative effect on our growth.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of meeting the annual distribution requirement to avoid paying U.S. federal corporate income tax, as a RIC, we may need to periodically access the capital markets to raise cash in order to fund new investments. We may issue &#8220;senior securities,&#8221; as defined under the 1940 Act, including borrowing money from banks or other financial institutions only in amounts such that our asset coverage meets the threshold set forth in the 1940 Act immediately after each such issuance. The 1940 Act currently requires an asset coverage of at least 150% (i.e., the amount of debt may not exceed two-thirds of the value of our assets). Our ability to issue different types of securities is also limited. Compliance with these requirements may unfavorably limit our investment opportunities and reduce our ability in comparison to other companies to profit from favorable spreads between the rates at which we can borrow and the rates at which we can lend. As a BDC, therefore, we intend to continuously issue equity at a rate more frequent than our privately-owned competitors, which may lead to greater shareholder dilution. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. federal income tax purposes, we are required to recognize taxable income (which may include deferred interest that is accrued as original issue discount) in some circumstances in which we do not receive a corresponding payment in cash and to make distributions with respect to such income in order to avoid corporate income tax as a RIC. Under such circumstances, we may have difficulty meeting the annual distribution requirement necessary to eliminate any corporate income tax as a RIC under the Code. This difficulty in making the required distribution may be amplified to the extent that we are required to pay an incentive fee with respect to such accrued income. As a result, we may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital, or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may not meet the distribution requirements prescribed by the Code for a RIC and as such may become subject to corporate income tax.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We borrow for investment purposes. If the value of our assets declines, we may be unable to satisfy the asset coverage test, which would prohibit us from paying distributions and could result in a corporate income tax to the Company. If we cannot satisfy the asset coverage test, we may be required to sell a portion of our investments and, depending on the nature of our debt financing, repay a portion of our indebtedness at a time when such sales may be disadvantageous.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-43" continuedAt="f-40-44"><ix:continuation id="f-123-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, we generally are prohibited from issuing or selling our shares at a price per share, after deducting selling commissions and dealer manager fees, that is below our NAV per share, which may be a disadvantage as compared with other public companies. We may, however, sell our shares, or warrants, options or rights to acquire our shares, at a price below the current NAV of our shares if our Board, including our independent trustees, determine that such sale is in our best interests and the best interests of our shareholders, and our shareholders, as well as those shareholders that are not affiliated with us, approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board, closely approximates the fair value of such securities.</span></div></ix:continuation><ix:nonNumeric contextRef="c-90" name="cef:RiskTextBlock" id="f-124" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to enter into transactions with our affiliates is restricted.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are prohibited under the 1940 Act from participating in certain transactions with certain of our affiliates (including portfolio companies of Other Clients) without the prior approval of a majority of the independent members of our Board and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of our outstanding voting securities will be our affiliate for purposes of the 1940 Act and generally we will be prohibited from buying or selling any securities from or to such affiliate, absent the prior approval of our Board. However, we may under certain circumstances purchase any such affiliate's loans or securities in the secondary market, which could create a conflict for the Adviser between our interests and the interests of such affiliate, in that the ability of the Adviser to recommend actions in our best interest may be limited. The 1940 Act also prohibits certain &#8220;joint&#8221; transactions with certain of our affiliates, which could include investments in the same portfolio company (whether at the same or closely related times), without prior approval of our Board and, in some cases, the SEC. If a person acquires more than 25% of our voting securities, we will be prohibited from buying or selling any security from or to such person or certain of that person&#8217;s affiliates, or entering into prohibited joint transactions (including certain co-investments) with such persons, absent the prior approval of the SEC. Similar restrictions limit our ability to transact business with our officers, trustees, investment advisers, sub-advisers or their affiliates. As a result of these restrictions, we may be prohibited from buying or selling any security from or to any fund or any portfolio company of a fund managed by the Adviser, or entering into joint arrangements such as certain co-investments with these companies or funds without the prior approval of the SEC, which may limit the scope of investment opportunities that would otherwise be available to us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have obtained exemptive relief from the SEC that allows us to engage in co-investment transactions with the Adviser and its affiliates, subject to certain terms and conditions. However, while the terms of the exemptive relief require that the Adviser will be given the opportunity to cause us to participate in certain transactions originated by affiliates of the Adviser, the Adviser may determine that we not participate in those transactions and for certain other transactions (as set forth in guidelines approved by the Board) the Adviser may not have the opportunity to cause us to participate.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-91" name="cef:RiskTextBlock" id="f-125" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are uncertain of our sources for funding our future capital needs; if we cannot obtain debt or equity financing on acceptable terms, our ability to acquire investments and to expand our operations will be adversely affected.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the sale of shares will be used for our investment opportunities, operating expenses and for payment of various fees and expenses such as base management fees, incentive fees and other expenses. Any working capital reserves we maintain may not be sufficient for investment purposes, and we may require debt or equity financing to operate. Accordingly, in the event that we develop a need for additional capital in the future for investments or for any other reason, these sources of funding may not be available to us. Consequently, if we cannot obtain debt or equity financing on acceptable terms, our ability to acquire investments and to expand our operations will be adversely affected. As a result, we would be less able to create and maintain a broad portfolio of investments and achieve our investment objectives, which may negatively impact our results of operations and reduce our ability to make distributions to our shareholders.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-92" name="cef:RiskTextBlock" id="f-126" escape="true"><ix:continuation id="f-40-44" continuedAt="f-40-45"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a non-diversified investment company within the meaning of the 1940 Act, and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are classified as a non-diversified investment company within the meaning of the 1940 Act, which means that we are not limited by the 1940 Act with respect to the proportion of our assets that we may invest in securities of a single issuer. Under the 1940 Act, a &#8220;diversified&#8221; investment company is required to invest at least 75% of the value of its total assets in cash and cash items, government securities, securities of other investment companies and other securities limited in respect of any one issuer to an amount not greater than 5% of the value of the total assets of such company and no more than 10% of the outstanding voting securities of such issuer. As a non-diversified investment company, we are not subject to this requirement. To the extent that we assume large positions in the securities of a small number of issuers, or within a particular industry, our NAV may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market&#8217;s assessment of the issuer. We may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company or to a general downturn in the economy. However, we will be subject to the diversification requirements applicable to RICs under Subchapter M of the Code.</span></div></ix:continuation></ix:nonNumeric><div id="i33edc808e7824948b94b269ed713a939_34"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E.</span><ix:continuation id="f-40-45" continuedAt="f-40-46"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt">Risks Related to Debt Financing</span></ix:continuation></div><ix:nonNumeric contextRef="c-93" name="cef:RiskTextBlock" id="f-127" continuedAt="f-127-1" escape="true"><ix:continuation id="f-40-46" continuedAt="f-40-47"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">When we use leverage, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us. Leverage may also adversely affect the return on our assets, reduce cash available for distribution to our shareholders, and result in losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of borrowings, also known as leverage, increases the volatility of investments by magnifying the potential for loss on invested equity capital. When we use leverage to partially finance our investments, through borrowing from banks and other lenders, shareholders will experience increased risks of investing in our shares. If the value of our assets decreases, leveraging would cause NAV to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Such a decline could negatively affect our ability to make distributions to our shareholders. In addition, our shareholders will bear the burden of any increase in our expenses as a result of our use of leverage, including interest expenses and any increase in the management or incentive fees payable to the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use and intend to continue to use leverage to finance our investments. The amount of leverage that we employ will depend on the Adviser&#8217;s and our Board&#8217;s assessment of market and other factors at the time of any proposed borrowing. There can be no assurance that leveraged financing will be available to us on favorable terms or at all. However, to the extent that we use leverage to finance our assets, our financing costs will reduce cash available for distributions to shareholders. Moreover, we may not be able to meet our financing obligations and, to the extent that we cannot, we risk the loss of some or all of our assets to liquidation or sale to satisfy the obligations. In such an event, we may be forced to sell assets at significantly depressed prices due to market conditions or otherwise, which may result in losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a BDC, we generally are required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred shares that we may issue in the future, of at least 150%. If this ratio were to fall below 150%, we could not incur additional debt and could be required to sell a portion of our investments to repay some debt when it is disadvantageous to do so. This could have a material adverse effect on our operations and investment activities. Moreover, our ability to make distributions to shareholders may be significantly restricted or we may not be able to make any such distributions whatsoever. The amount of leverage that we will employ will be subject to oversight by our Board of Trustees, a majority of whom are independent Trustees with no material interests in such transactions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into reverse repurchase agreements. Transactions under such agreements constitute leverage. When the Company enters into a reverse repurchase agreement, any fluctuations in the market value of either the securities transferred to another party or the securities in which the proceeds may be invested would affect the market value of the Company&#8217;s assets. As a result, the use of such leverage transactions may increase fluctuations in the market value of the Company&#8217;s assets compared to what would occur without the use of such transactions. Because reverse repurchase agreements may be considered to be the practical equivalent of borrowing funds, they constitute a form of leverage. If the Company reinvests the proceeds of a reverse repurchase agreement at a rate lower than the cost of the agreement, transacting under such agreement will lower the Company&#8217;s yield. </span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-47" continuedAt="f-40-48"><ix:continuation id="f-127-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although leverage has the potential to enhance overall returns that exceed the Company&#8217;s cost of funds, they will further diminish returns (or increase losses on capital) to the extent overall returns are less than the Company&#8217;s cost of funds. In addition, borrowings and reverse repurchase agreements or similar arrangements in which the Company may engage may be secured by the shareholders&#8217; investments as well as by the Company&#8217;s assets and the documentation relating to such transactions may provide that during the continuance of a default under such arrangement, the interests of the holders of Common Shares may be subordinated to the interests of the Company&#8217;s lenders or debt-holders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit facilities and unsecured notes impose financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a regulated investment company under the 1940 Act. A failure to renew our facilities or to add new or replacement debt facilities or issue additional debt securities or other evidences of indebtedness could have a material adverse effect on our business, financial condition, results of operations and/or liquidity.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8212; Financial Condition, Liquidity and Capital Resources&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information regarding our borrowings.</span></div></ix:continuation><ix:nonNumeric contextRef="c-94" name="cef:RiskTextBlock" id="f-128" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may default under our credit facilities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event we default under our credit facilities or other borrowings, our business could be adversely affected as we may be forced to sell a portion of our investments quickly and prematurely at what may be disadvantageous prices to us in order to meet our outstanding payment obligations and/or support working capital requirements under such borrowing facility, any of which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, following any such default, the agent for the lenders under such borrowing facility could assume control of the disposition of any or all of our assets, including the selection of such assets to be disposed and the timing of such disposition, which would have a material adverse effect on our business, financial condition, results of operations and cash flows.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-95" name="cef:RiskTextBlock" id="f-129" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our current or future credit ratings may not reflect all risks of an investment in our debt securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any current or future credit ratings of us are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our current or future credit ratings will generally affect the market value of our debt securities. Our current or future credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of or trading market for the publicly issued debt securities.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-96" name="cef:RiskTextBlock" id="f-130" continuedAt="f-130-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The trading market or market value of our issued debt securities may fluctuate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our issued debt securities may or may not have an established trading market. We cannot assure our noteholders that a trading market for our issued debt securities will ever develop or be maintained if developed. In addition to our creditworthiness, many factors may materially adversely affect the trading market for, and market value of, our issued debt securities. These factors include, but are not limited to, the following:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the time remaining to the maturity of these debt securities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outstanding principal amount of debt securities with terms identical to these debt securities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ratings assigned by national statistical ratings agencies;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the general economic environment;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the supply of debt securities trading in the secondary market, if any;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the redemption or repayment features, if any, of these debt securities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level, direction and volatility of market interest rates generally; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market rates of interest higher or lower than rates borne by the debt securities.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-48" continuedAt="f-40-49"><ix:continuation id="f-130-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our noteholders should also be aware that there may be a limited number of buyers when they decide to sell their debt securities. This too may materially adversely affect the market value of the debt securities or the trading market for the debt securities.</span></div></ix:continuation><ix:nonNumeric contextRef="c-97" name="cef:RiskTextBlock" id="f-131" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms relating to redemption may materially adversely affect our noteholders return on any debt securities that we may issue.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our noteholders&#8217; debt securities are redeemable at our option, we may choose to redeem their debt securities at times when prevailing interest rates are lower than the interest rate paid on their debt securities. In addition, if our noteholders&#8217; debt securities are subject to mandatory redemption, we may be required to redeem their debt securities also at times when prevailing interest rates are lower than the interest rate paid on their debt securities. In this circumstance, our noteholders may not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as their debt securities being redeemed.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-98" name="cef:RiskTextBlock" id="f-132" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we issue preferred shares or convertible debt securities, the net asset value of our common shares may become more volatile.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that the issuance of preferred shares and/or convertible debt securities would result in a higher yield or return to the holders of our common shares. The issuance of preferred shares or convertible debt would likely cause the NAV of our common shares to become more volatile. If the dividend rate on the preferred shares, or the interest rate on the convertible debt securities, were to approach the net rate of return on our investment portfolio, the benefit of such leverage to the holders of our common shares would be reduced. If the dividend rate on the preferred shares, or the interest rate on the convertible debt securities, were to exceed the net rate of return on our portfolio, the use of leverage would result in a lower rate of return to the holders of common shares than if we had not issued the preferred shares or convertible debt securities. Any decline in the NAV of our investment would be borne entirely by the holders of our common shares. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in NAV to the holders of our common shares than if we were not leveraged through the issuance of preferred shares or debt securities. This decline in NAV would also tend to cause a greater decline in the market price, if any, for our common shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also a risk that, in the event of a sharp decline in the value of our net assets, we would be in danger of failing to maintain required asset coverage ratios, which may be required by the preferred shares or convertible debt, or our current investment income might not be sufficient to meet the dividend requirements on the preferred shares or the interest payments on the debt securities. In order to counteract such an event, we might need to liquidate investments in order to fund the redemption of some or all of the preferred shares or convertible debt. In addition, we would pay (and the holders of our common shares would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred shares, debt securities, convertible debt, or any combination of these securities. Holders of preferred shares or convertible debt may have different interests than holders of common shares and may at times have disproportionate influence over our affairs.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-99" name="cef:RiskTextBlock" id="f-133" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders of any preferred shares that we may issue will have the right to elect certain members of our Board and have class voting rights on certain matters.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 1940 Act requires that holders of preferred shares must be entitled as a class to elect two trustees at all times and to elect a majority of the trustees if dividends on such preferred shares are in arrears by two years or more, until such arrearage is eliminated. In addition, certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred shares, including changes in fundamental investment restrictions and conversion to open-end status and, accordingly, preferred shareholders could veto any such changes. Restrictions imposed on the declarations and payment of dividends or other distributions to the holders of our common shares and preferred shares, both by the 1940 Act and by requirements imposed by rating agencies, might impair our ability to maintain our tax treatment as a RIC for U.S. federal income tax purposes.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-100" name="cef:RiskTextBlock" id="f-134" escape="true"><ix:continuation id="f-40-49" continuedAt="f-40-50"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in a credit facility may limit our investment discretion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A credit facility may be backed by all or a portion of our loans and securities on which the lenders will have a security interest. We may pledge up to 100% of our assets and may grant a security interest in all of our assets under the terms of any debt instrument we enter into with lenders. We expect that any security interests we grant will be set forth in a pledge and security agreement and evidenced by the filing of financing statements by the agent for the lenders. In addition, we expect that the custodian for our securities serving as collateral for such loan would include in its electronic systems notices indicating the existence of such security interests and, following notice of occurrence of an event of default, if any, and during its continuance, will only accept transfer instructions with respect to any such securities from the lender or its designee. If we were to default under the terms of any debt instrument, the agent for the applicable lenders would be able to assume control of the timing of disposition of any or all of our assets securing such debt, which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In connection with one or more credit facilities entered into by the Company, distributions to shareholders may be subordinated to payments required in connection with any indebtedness contemplated thereby.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any security interests and/or negative covenants required by a credit facility may limit our ability to create liens on assets to secure additional debt and may make it difficult for us to restructure or refinance indebtedness at or prior to maturity or obtain additional debt or equity financing. In addition, if our borrowing base under a credit facility were to decrease, we may be required to secure additional assets in an amount sufficient to cure any borrowing base deficiency. In the event that all of our assets are secured at the time of such a borrowing base deficiency, we could be required to repay advances under a credit facility or make deposits to a collection account, either of which could have a material adverse impact on our ability to fund future investments and to make distributions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may be subject to limitations as to how borrowed funds may be used, which may include restrictions on geographic and industry concentrations, loan size, payment frequency and status, average life, collateral interests and investment ratings, as well as regulatory restrictions on leverage which may affect the amount of funding that may be obtained. There may also be certain requirements relating to portfolio performance, including required minimum portfolio yield and limitations on delinquencies and charge-offs, a violation of which could limit further advances and, in some cases, result in an event of default. An event of default under a credit facility could result in an accelerated maturity date for all amounts outstanding thereunder, which could have a material adverse effect on our business and financial condition. This could reduce our liquidity and cash flow and impair our ability to grow our business.</span></div><ix:nonNumeric contextRef="c-1" name="cef:EffectsOfLeverageTableTextBlock" id="f-135" escape="true"><div style="margin-top:12pt;text-indent:36pt"><ix:nonNumeric contextRef="c-1" name="cef:EffectsOfLeveragePurposeTextBlock" id="f-136" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the effect of leverage on returns from an investment in our shares assuming various annual returns on our portfolio, net of expenses. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below.</span></ix:nonNumeric><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.626%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assumed Return on Our Portfolio (Net of Expenses)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corresponding return to common stockholder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#160;(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-<ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" sign="-" name="cef:ReturnAtMinusTenPercent" scale="-2" id="f-137">25.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-<ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" sign="-" name="cef:ReturnAtMinusFivePercent" scale="-2" id="f-138">15.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-<ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" sign="-" name="cef:ReturnAtZeroPercent" scale="-2" id="f-139">5.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="cef:ReturnAtPlusFivePercent" scale="-2" id="f-140">5.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="cef:ReturnAtPlusTenPercent" scale="-2" id="f-141">15.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Based on (i) $10.1 billion in total assets as of December&#160;31, 2023, (ii) $4.9 billion in outstanding indebtedness, at par, as of December&#160;31, 2023, (iii) $5.0 billion in net assets as of December&#160;31, 2023 and (iv)&#160;an annualized average interest rate, including fees (such as fees on undrawn amounts and amortization of financing costs), on our indebtedness, as of December&#160;31, 2023, of 5.05%.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on an outstanding indebtedness, at par, of&#160;$4.9 billion&#160;as of&#160;December&#160;31, 2023 and the weighted average effective annual interest rate, including fees (such as fees on undrawn amounts and amortization of financing costs), of 5.05% as of that date, our investment portfolio at fair value would have had to produce an annual return of approximately 2.46% to cover annual interest payments on the outstanding debt. For more information on our indebtedness, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Financial Condition, Liquidity and Capital Resources.&#8221;</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-50" continuedAt="f-40-51"><ix:nonNumeric contextRef="c-101" name="cef:RiskTextBlock" id="f-142" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in interest rates may affect our cost of capital and net investment income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we use debt to finance a portion of our investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In periods of rising interest rates when we have debt outstanding, our cost of funds will increase, which could reduce our net investment income. We expect that our long-term fixed-rate investments will be financed primarily with equity and long-term debt. We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. These techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. These activities may limit our ability to participate in the benefits of lower interest rates with respect to the hedged portfolio. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations. Also, we have limited experience in entering into hedging transactions, and we will initially have to purchase or develop such expertise.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-102" name="cef:RiskTextBlock" id="f-143" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with SEC Rule 18f-4 governing derivatives and use of leverage may limit our investment discretion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, Rule 18f-4 under the 1940 Act, eliminates the asset segregation framework arising from prior SEC guidance for covering positions in derivatives and certain financial instruments. Rule 18f-4 also limits a fund&#8217;s derivatives exposure through a value-at-risk test and requires the adoption and implementation of a derivatives risk management program for certain derivatives users. Subject to certain conditions, limited derivatives users (as defined in Rule 18f-4), such as the Company, however, would not be subject to the full requirements of Rule 18f-4. Under Rule 18f-4, a fund may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the fund has, among other things, a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. The Company has adopted policies and procedures to comply with the requirements of the rule. Compliance with Rule 18f-4 may limit our ability to use derivatives and/or enter into certain other financial contracts.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-103" name="cef:RiskTextBlock" id="f-144" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may form CLOs in the future, which may subject us to certain structured financing risks.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To finance investments, we may securitize certain of our secured loans or other investments, including through the formation of one or more CLOs, while retaining all or most of the exposure to the performance of these investments. This would involve contributing a pool of assets to a special purpose entity, and selling debt interests in such entity on a non-recourse or limited-recourse basis to purchasers. Depending on how these CLOs are structured, an interest in any such CLO held by us may be considered a &#8220;non-qualifying&#8221; portfolio investment for purposes of the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the CLOs we may in the future create we will depend in part on distributions from the CLO&#8217;s assets out of its earnings and cash flows to enable us to make distributions to shareholders. The ability of a CLO to make distributions will be subject to various limitations, including the terms and covenants of the debt it issues. Also, a CLO may take actions that delay distributions in order to preserve ratings and to keep the cost of present and future financings lower or the CLO may be obligated to retain cash or other assets to satisfy over-collateralization requirements commonly provided for holders of the CLO&#8217;s debt, which could impact our ability to receive distributions from the CLO. If we do not receive cash flow from any such CLO that is necessary to satisfy the annual distribution requirement for maintaining RIC status, and we are unable to obtain cash from other sources necessary to satisfy this requirement, we may not maintain our qualification as a RIC, which would have a material adverse effect on an investment in the shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a decline in the credit quality of loans in a CLO due to poor operating results of the relevant borrowers, declines in the value of loan collateral or increases in defaults, among other things, may force a CLO to sell certain assets at a loss, reducing their earnings and, in turn, cash potentially available for distribution to us for distribution to shareholders. To the extent that any losses are incurred by the CLO in respect of any collateral, such losses will be borne first by us as owner of equity interests in the CLO.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manager for a CLO that we create may be the Company, the Adviser or an affiliate, and such manager may be entitled to receive compensation for structuring and/or management services. To the extent the Adviser or an affiliate other than the Company serves as manager and the Company is obligated to compensate the Adviser or the affiliate for such services, we, the Adviser or the affiliate will implement offsetting arrangements to assure that we, and indirectly, our shareholders, pay no additional management fees to the Adviser or the affiliate in connection therewith. To the extent we serve as manager, we will waive any right to receive fees for such services from the Company (and indirectly its shareholders) or any affiliate.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_37"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F.</span><ix:continuation id="f-40-51" continuedAt="f-40-52"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.4pt">Federal Income Tax Risks</span></ix:continuation></div><ix:continuation id="f-40-52" continuedAt="f-40-53"><ix:nonNumeric contextRef="c-104" name="cef:RiskTextBlock" id="f-145" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will be subject to corporate-level income tax if we are unable to maintain RIC tax treatment under Subchapter M of the Code or satisfy RIC distribution requirements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain and maintain RIC tax treatment under Subchapter M of the Code, we must, among other things, meet annual distribution, income source and quarterly asset diversification requirements. If we do not qualify for or maintain RIC tax treatment for any reason and are subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-105" name="cef:RiskTextBlock" id="f-146" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For federal income tax purposes, we may be required to recognize taxable income in circumstances in which we do not receive a corresponding payment in cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount (such as zero-coupon securities, debt instruments with PIK interest or, in certain cases, increasing interest rates or debt instruments that were issued with warrants), we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. We may also have to include in income other amounts that we have not yet received in cash, such as deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. We anticipate that a portion of our income may constitute original issue discount or other income required to be included in taxable income prior to receipt of cash. Furthermore, we have elected to amortize market discount and include such amounts in our taxable income on a current basis, instead of upon disposition of the applicable debt obligation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because any original issue discount, market discount or other amounts accrued will be included in our investment company taxable income for the year of the accrual, we may be required to make a distribution to our shareholders in order to satisfy the annual distribution requirement, even though we will not have received any corresponding cash amount. As a result, we may have difficulty meeting the annual distribution requirement necessary to eliminate any corporate income tax as a RIC under Subchapter M of the Code. We may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may not qualify for or maintain RIC tax treatment and thus we may become subject to corporate-level income tax.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-106" name="cef:RiskTextBlock" id="f-147" continuedAt="f-147-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our investments may be subject to corporate-level income tax.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><ix:continuation id="f-147-1"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may invest in certain debt and equity investments through taxable subsidiaries and the taxable income of these taxable subsidiaries will be subject to federal and state corporate income taxes. We may invest in certain foreign debt and equity investments which could be subject to foreign taxes (such as income tax, withholding and value added taxes).</span></ix:continuation><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="c-107" name="cef:RiskTextBlock" id="f-148" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our portfolio investments may present special tax issues.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to invest in debt securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Investments in these types of instruments may present special tax issues for the Company. U.S. federal income tax rules are not entirely clear about issues such as when the Company may cease to accrue interest, original issue discount or market discount, when and to what extent deductions may be taken for bad debts or worthless instruments, how payments received on obligations in default should be allocated between principal and income and whether exchanges of debt obligations in a bankruptcy or workout context are taxable. These and other issues will be addressed by the Company, to the extent necessary, to preserve its status as a RIC and to distribute sufficient income to not become subject to U.S. federal income tax.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-108" name="cef:RiskTextBlock" id="f-149" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legislative or regulatory tax changes could adversely affect investors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any time, the federal income tax laws governing RICs or the administrative interpretations of those laws or regulations may be amended. Any of those new laws, regulations or interpretations may take effect retroactively and could adversely affect the taxation of us or our shareholders. Therefore, changes in tax laws, regulations or administrative interpretations or any amendments thereto could diminish the value of an investment in our shares or the value or the resale potential of our investments.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_40"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">G.</span><ix:continuation id="f-40-53" continuedAt="f-40-54"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.73pt">Risks Related to an Investment in the Common Shares</span></ix:continuation></div><ix:continuation id="f-40-54" continuedAt="f-40-55"><ix:nonNumeric contextRef="c-109" name="cef:RiskTextBlock" id="f-150" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot assure you that the market price of common shares will not decline below the IPO price or below our NAV. The market price of common shares may be volatile and may fluctuate substantially.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently list our common shares on the NYSE under the symbol &#8220;BXSL.&#8221; We cannot assure you that the trading market can be sustained. In addition, we cannot predict the prices at which our common shares will trade. Shares of closed-end management investment companies, including BDCs, frequently trade at a discount from their NAV and our shares may also be discounted in the market. This characteristic of closed-end management investment companies is separate and distinct from the risk that our NAV per share may decline. We cannot predict whether our common shares will trade at, above or below NAV. The risk of loss associated with this characteristic of closed-end management investment companies may be greater for investors expecting to sell common shares purchased in the offering soon after the offering. In addition, if our common shares trades below its NAV, we will generally not be able to sell additional common shares to the public at its market price without first obtaining the approval of a majority of our shareholders (including a majority of our unaffiliated shareholders) and our independent directors for such issuance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price and liquidity of the market for our common shares may be si</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gnificantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant volatility in the market price and trading volume of securities of BDCs or other companies in the sector in which we operate, which are not necessarily related to the operating performance of these companies;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of RIC or BDC status;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in earnings or variations in operating results;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the value of our portfolio of investments;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting guidelines governing valuation of our investments;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any shortfall in revenue or net income or any increase in losses from levels expected by shareholders or securities analysts;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">departure of either of the Adviser or certain of its respective key personnel;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating performance of companies comparable to us;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic trends and other external factors; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of a major funding source.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-110" name="cef:RiskTextBlock" id="f-151" continuedAt="f-151-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A shareholder&#8217;s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our shareholders do not have preemptive rights to purchase any shares we issue in the future. Our charter authorizes us to issue an unlimited number of shares. Our Board may elect to sell additional shares in the future or issue equity interests in private offerings. To the extent we issue additional equity interests at or below NAV, your percentage ownership interest in us may be diluted. In addition, depending upon the terms and pricing of any additional offerings and the value of our investments, you may also experience dilution in the book value and fair value of your shares.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-55" continuedAt="f-40-56"><ix:continuation id="f-151-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, we generally are prohibited from issuing or selling our common shares at a price below NAV per share, which may be a disadvantage as compared with certain public companies. We may, however, sell our common shares, or warrants, options, or rights to acquire our common shares, at a price below the current NAV of our common shares if our Board and independent directors determine that such sale is in our best interests and the best interests of our shareholders, and our shareholders, including a majority of those shareholders that are not affiliated with us, approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board, closely approximates the fair value of such securities (less any distributing commission or discount). If we raise additional funds by issuing common shares or senior securities convertible into, or exchangeable for, our common shares, then the percentage ownership of our shareholders at that time will decrease and you will experience dilution.</span></div></ix:continuation><ix:nonNumeric contextRef="c-111" name="cef:RiskTextBlock" id="f-152" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulty paying distributions and the tax character of any distributions is uncertain.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally intend to distribute substantially all of our available earnings annually by paying distributions on a quarterly basis, as determined by the Board in its discretion. We cannot assure shareholders that we will achieve investment results that will allow us to make a specified level of cash distributions (particularly during the early stages of our operations) or year-to-year increases in cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this annual report. Due to the asset coverage test applicable to us under the 1940 Act as a BDC, we may be limited in our ability to make distributions. In addition, if we enter into a credit facility or any other borrowing facility, for so long as such facility is outstanding, we anticipate that we may be required by its terms to use all payments of interest and principal that we receive from our current investments as well as any proceeds received from the sale of our current investments to repay amounts outstanding thereunder, which could adversely affect our ability to make distributions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the tax treatment and characterization of our distributions may vary significantly from time to time due to the nature of our investments. The ultimate tax characterization of our distributions made during a taxable year may not finally be determined until after the end of that taxable year. We may make distributions during a taxable year that exceed our investment company taxable income and net capital gains for that taxable year. In such a situation, the amount by which our total distributions exceed investment company taxable income and net capital gains generally would be treated as a return of capital up to the amount of a shareholder&#8217;s tax basis in the shares, with any amounts exceeding such tax basis treated as a gain from the sale or exchange of such shares. A return of capital generally is a return of a shareholder&#8217;s investment rather than a return of earnings or gains derived from our investment activities. Moreover, we may pay all or a substantial portion of our distributions from the proceeds of the sale of our shares or from borrowings or sources other than cash flow from operations in anticipation of future cash flow, which could constitute a return of shareholders&#8217; capital and will lower such shareholders&#8217; tax basis in our shares, which may result in increased tax liability to shareholders when they sell such shares.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-112" name="cef:RiskTextBlock" id="f-153" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributions on our common shares may exceed our taxable earnings and profits. Therefore, portions of the distributions that we pay may represent a return of capital to you. A return of capital is a return of a portion of your original investment in common shares. As a result, a return of capital will (i) lower your tax basis in your shares and thereby increase the amount of capital gain (or decrease the amount of capital loss) realized upon a subsequent sale or redemption of such shares, and (ii) reduce the amount of funds we have for investment in portfolio companies. We have not established any limit on the extent to which we may use offering proceeds to fund distributions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may pay our distributions from offering proceeds in anticipation of future cash flow, which may constitute a return of your capital and will lower your tax basis in your shares, thereby increasing the amount of capital gain (or decreasing the amount of capital loss) realized upon a subsequent sale or redemption of such shares, even if such shares have not increased in value or have, in fact, lost value.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-113" name="cef:RiskTextBlock" id="f-154" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders will experience dilution in their ownership percentage if they do not participate in our dividend reinvestment plan.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All distributions declared in cash payable to shareholders that are participants in our dividend reinvestment plan will generally be automatically reinvested in common shares if the investor opts in to the plan. As a result, shareholders that do not elect to participate in our dividend reinvestment plan may experience dilution over time.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-40-56" continuedAt="f-40-57"><ix:nonNumeric contextRef="c-114" name="cef:RiskTextBlock" id="f-155" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders may experience dilution in the net asset value of their shares if they do not participate in our dividend reinvestment plan and if our shares are trading at a discount to net asset value.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All distributions declared in cash payable to shareholders that are participants in our dividend reinvestment plan will generally be automatically reinvested in common shares if the investor opts in to the plan. As a result, shareholders that do not elect to participate in our dividend reinvestment plan may experience accretion to the NAV of their shares if our shares are trading at a premium to NAV and dilution if our shares are trading at a discount to NAV. The level of accretion or discount would depend on various factors, including the proportion of our shareholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to shareholders.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-115" name="cef:RiskTextBlock" id="f-156" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">No shareholder approval is required for certain mergers.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board may undertake to approve mergers between us and certain other funds or vehicles.&#160;Subject to the requirements of the 1940 Act and NYSE rules, such mergers will not require shareholder approval so shareholders will not be given an opportunity to vote on these matters unless such mergers are reasonably anticipated to result in a material dilution of the NAV per share of the Company.&#160;These mergers may involve funds managed by affiliates of Blackstone Credit &amp; Insurance.&#160;The Board may also convert the form and/or jurisdiction of organization, including to take advantage of laws that are more favorable to maintaining board control in the face of dissident shareholders.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-116" name="cef:RiskTextBlock" id="f-157" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing in our shares involves a high degree of risk.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The investments we make in accordance with our investment objectives may result in a higher amount of risk than alternative investment options and volatility or loss of principal. Our investments in portfolio companies may be highly speculative and aggressive and, therefore, an investment in our shares may not be suitable for someone with lower risk tolerance.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-117" name="cef:RiskTextBlock" id="f-158" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The NAV of our shares may fluctuate significantly.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NAV and liquidity, if any, of the market for our shares may be significantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant volatility in the market price and trading volume of securities of BDCs or other companies in the sector in which we operate, which are not necessarily related to the operating performance of these companies;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of RIC or BDC status;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in earnings or variations in operating results;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the value of our portfolio of investments;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting guidelines governing valuation of our investments;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any shortfall in revenue or net income or any increase in losses from levels expected by shareholders or securities analysts;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">departure of either of the Adviser or certain of its respective key personnel;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating performance of companies comparable to us;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic trends and other external factors; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of a major funding source.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-118" name="cef:RiskTextBlock" id="f-159" escape="true"><ix:continuation id="f-40-57" continuedAt="f-40-58"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of substantial amounts of our common shares in the public market may have an adverse effect on the market price of our common shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of substantial amounts of our common shares, or the availability of such common shares for sale, could adversely affect the prevailing market prices for our common shares. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so.</span></div></ix:continuation></ix:nonNumeric><div id="i33edc808e7824948b94b269ed713a939_43"></div><ix:nonNumeric contextRef="c-119" name="cef:RiskTextBlock" id="f-160" continuedAt="f-160-1" escape="true"><ix:continuation id="f-40-58" continuedAt="f-40-59"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser, Blackstone Credit &amp; Insurance, Blackstone and their respective affiliates will be subject to certain conflicts of interest with respect to the services the Adviser and the Administrator provide to us. These conflicts will arise primarily from the involvement of Blackstone Credit &amp; Insurance, Blackstone and their respective affiliates (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Firm&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), in other activities that may conflict with our activities. You should be aware that individual conflicts will not necessarily be resolved in favor of your interest. The foregoing list of conflicts does not purport to be a complete enumeration or explanation of the actual and potential conflicts involved in an investment in the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this discussion and ease of reference, the following terms shall have the meanings as set forth below:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Blackstone Credit &amp; Insurance Clients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means, collectively, the investment funds, client accounts (including managed accounts) and proprietary accounts and/or other similar arrangements (including such arrangements in which the Company or one or more Other Blackstone Credit &amp; Insurance Clients own interests) that Blackstone Credit &amp; Insurance may establish, advise or sub-advise from time to time and to which Blackstone Credit &amp; Insurance provides investment management or sub-advisory services (other than the Company and any such funds and accounts in which the Company has an interest), in each case including any alternative investment vehicles and additional capital vehicles relating thereto and any vehicles established by Blackstone Credit &amp; Insurance to exercise its side-by-side or other general partner investment rights as set forth in their respective governing documents; provided, that for the avoidance of doubt, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Other Blackstone Credit &amp; Insurance Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not include Blackstone Credit &amp; Insurance in its role as principal of any account, including any such accounts for which Blackstone Credit &amp; Insurance or an affiliate thereof acts as an advisor.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blackstone Clients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means, collectively, the investment funds, client accounts (including managed accounts) and proprietary accounts and/or other similar arrangements (including such arrangements in which the Company or one or more Blackstone Clients own interests) that Blackstone may establish, advise or sub-advise from time to time and to which Blackstone provides investment management or sub-advisory services (other than the Company, any such funds and accounts in which the Company has an interest and Other Blackstone Credit &amp; Insurance Clients), in each case including any alternative investment vehicles and additional capital vehicles relating thereto and any vehicles established by Blackstone to exercise its side-by-side or other general partner investment rights as set forth in their respective governing documents; provided that, for the avoidance of doubt, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Blackstone Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not include Blackstone in its role as principal of any account, including any accounts for which Blackstone or an affiliate thereof acts as an advisor.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Clients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means, collectively, Other Blackstone Credit &amp; Insurance Clients and Blackstone Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Based Compensation and Management Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The existence of the incentive fees payable to Blackstone Credit &amp; Insurance may create a greater incentive for Blackstone Credit &amp; Insurance to make more speculative investments on behalf of the Company, or to time the purchase or sale of investments in a manner motivated by the personal interests of Blackstone Credit &amp; Insurance and/or Blackstone personnel. However, the fact that the hurdle rate for the incentive fee based on income is calculated on an aggregate basis each quarter and that realized and unrealized losses are netted against realized gains for the incentive fee based on capital gains should reduce the incentives for the Adviser to make more speculative investments or otherwise time the purchase or sale of investments. Our Board of Trustees will seek to monitor these conflicts but there can be no assurances that such monitoring will fully mitigate any such conflicts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the manner in which the Adviser&#8217;s entitlement to incentive fees is determined may result in a conflict between its interests and the interests of shareholders with respect to the sequence and timing of disposals of investments, as the Adviser may want to dispose of lower yielding investments in favor of higher yielding ones. With respect to the Adviser&#8217;s entitlement to incentive fees on capital gains, the Adviser may be incentivized to realize capital gains prior to a year end if such gains, net of realized and unrealized losses, would result in an incentive fee on capital gains.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-1" continuedAt="f-160-2"><ix:continuation id="f-40-59" continuedAt="f-40-60"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Firm&#8217;s Policies and Procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm has implemented policies and procedures to address conflicts that arise as a result of its various activities, as well as regulatory and other legal considerations. Specified policies and procedures implemented by the Firm to mitigate potential conflicts of interest and address certain regulatory requirements and contractual restrictions are expected to reduce the synergies across the Firm&#8217;s various businesses that the Company expects to draw on for purposes of pursuing attractive investment opportunities. Because the Firm has many different asset management and advisory businesses, including private equity, a credit business, a hedge fund business, a capital markets group, a life sciences business and a real estate advisory business, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would otherwise be subject if it had just one line of business. In addressing these conflicts and regulatory, legal and contractual requirements across its various businesses and to protect against the inappropriate sharing and/or use of information between the Company and the other business units at the Firm, the Firm has implemented certain policies and procedures (e.g., information wall policy) regarding the sharing of information that could reduce the positive synergies that the Company expects to utilize for purposes of identifying and managing attractive investments. For example, the Firm will from time to time come into possession of material non-public information with respect to companies, including companies in which the Company has investments or might be considering making an investment or companies that are clients of the Firm. As a consequence, that information, which could be of benefit to the Company, might become restricted to those other respective businesses and otherwise be unavailable to the Company. It is also possible that the Company could be restricted from trading despite the fact that the Company did not receive such information. There can be no assurance, however, that any such policies and/or procedures will be effective in accomplishing their stated purpose and/or that they will not otherwise adversely affect the ability of the Company to effectively achieve its investment objective by unduly limiting the investment flexibility of the Company and/or the flow of otherwise appropriate information between Blackstone Credit &amp; Insurance and other business units at the Firm. Personnel of the Firm could be unable, for example, to assist with the activities of the Company as a result of these walls. There can be no assurance that additional restrictions will not be imposed that would further limit the ability of the Firm to share information internally.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to the extent that the Firm is in possession of material non-public information or is otherwise restricted from trading in certain securities, the Company and the Adviser could also be deemed to be in possession of such information or otherwise restricted. Additionally, the terms of confidentiality or other agreements with or related to companies in which any Other Client has or has considered making an investment or which is otherwise a client of the Firm will from time to time restrict or otherwise limit the ability of the Company and/or its portfolio companies and their affiliates to make investments in or otherwise engage in businesses or activities competitive with such companies. The Firm could enter into one or more strategic relationships in certain regions or with respect to certain types of investments that, although intended to provide greater opportunities for the Company, could require the Company to share such opportunities or otherwise limit the amount of an opportunity the Company can otherwise take.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allocation of Personnel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser and its members, officers and employees will devote as much of their time to the activities of the Company as they deem necessary to conduct its business affairs in an appropriate manner. By the terms of the Investment Advisory Agreement, the Firm is not restricted from forming additional investment funds, from entering into other investment advisory relationships or from engaging in other business activities, even though such activities have the potential to be in competition with the Company and/or to involve substantial time and resources of the Adviser. Firm personnel, including members of the investment committee, will work on other projects, serve on other committees (including boards of directors) and source potential investments for and otherwise assist the investment programs of Other Clients and their portfolio companies, including other investment programs to be developed in the future. Certain members of Blackstone Credit &amp; Insurance&#8217;s investment team are also members of Other Clients&#8217; investment teams and will continue to serve in those roles (which could be their primary responsibility) and as a result, not all of their business time will be devoted to Blackstone or the Company. Certain non-investment professionals are not dedicated solely to the Company and are permitted to perform work for Other Clients which is expected to detract from the time such persons devote to the Company. These activities could be viewed as creating a conflict of interest in that the time and effort of the members of the Adviser and its officers and employees will not be devoted exclusively to the business of the Company, but will be allocated between the business of the Company and the management of the monies of such other advisees of the Adviser. Time spent on these other initiatives diverts attention from the activities of the Company, which could negatively impact the Company and shareholders. Furthermore, Blackstone Credit &amp; Insurance and Blackstone Credit &amp; Insurance personnel derive financial benefit from these other activities, including fees and performance-based compensation. Firm personnel outside of Blackstone Credit &amp; Insurance can share in the fees and performance-based compensation from the Company; similarly, Blackstone Credit &amp; Insurance personnel can share in the fees and performance-based compensation generated by Other Clients. These and other factors create conflicts of interest in the allocation of time by Firm personnel. Blackstone Credit &amp; Insurance&#8217;s determination of the amount of time necessary to conduct the Company&#8217;s activities will be conclusive, and shareholders rely on Blackstone Credit &amp; Insurance&#8217;s judgment in this regard.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-2" continuedAt="f-160-3"><ix:continuation id="f-40-60" continuedAt="f-40-61"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Outside Activities of Principals and Other Personnel and their Related Parties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain of the principals and employees of the Adviser will, in certain circumstances, be subject to a variety of conflicts of interest relating to their responsibilities to the Company, Other Clients and their respective portfolio companies, and their outside personal or business activities, including as members of investment or advisory committees or boards of directors of or advisors to investment funds, corporations, foundations or other organizations. Such positions create a conflict if such other entities have interests that are adverse to those of the Company, including if such other entities compete with the Company for investment opportunities or other resources. The other managed accounts and/or investment funds in which such individuals may become involved may have investment objectives that overlap with the Company. Furthermore, certain principals and employees of the Adviser are likely to have a greater financial interest in the performance of such other funds or accounts than the performance of the Company. Such involvement is expected to create conflicts of interest in making investments on behalf of the Company and such other funds and accounts. Although such principals and employees will seek to limit any such conflicts in a manner that is in accordance with their fiduciary duties to the Company, there can be no assurance they will be resolved favorably for the Company. Also, Blackstone personnel, Firm employees, including employees of the Adviser, are generally permitted to invest in alternative investment funds, private equity funds, credit funds, real estate funds, hedge funds and other investment vehicles, as well as engage in other personal trading activities relating to companies, assets, securities or instruments (subject to the Firm&#8217;s Code of Ethics requirements), some of which will involve conflicts of interests. Such personal securities transactions will, in certain circumstances, relate to securities or instruments which can be expected to also be held or acquired by Other Clients, the Company, or otherwise relate to portfolio companies in which the Company has or acquires a different principal investment (including, for example, with respect to seniority), which is expected to give rise to conflicts of interest related to misaligned interests between the Company and such persons. There could be situations in which such alternative investment funds invest in the same portfolio companies as the Company and there could be situations in which such alternative investment funds purchase securities from, or sell securities to, the Company if permitted under the 1940 Act and other applicable law. There can be no assurance that conflicts of interest arising out of such activities will be resolved in favor of the Company. Shareholders will not receive any benefit from any such investments, and the financial incentives of Firm personnel in such other investments could be greater than their financial incentives in relation to the Company and are not expected to receive notice should the Company make investments in which such persons hold direct or indirect interests.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain employees and other professionals of the Firm have family members or relatives employed by such advisers and service providers (or their affiliates) or otherwise actively involved in industries and sectors in which the Company invests, and/or have business, financial, personal or other relationships with companies in such industries and sectors (including the advisors and service providers described above) or other industries, which gives rise to potential or actual conflicts of interest. For example, such family members or relatives might be employees, officers, directors, personnel or owners of companies or assets that are actual or potential investments of the Company or other counterparties of the Company and its portfolio companies and/or assets. Moreover, in certain instances, the Company or its portfolio companies can be expected to issue loans to or acquire securities from, or otherwise transact with, companies that are owned by such family members or relatives or in respect of which such family members or relatives have other involvement. These relationships have the potential to influence Blackstone, the Adviser and/or Blackstone Credit &amp; Insurance in deciding whether to select, recommend or create such service providers to perform services for the Company or portfolio companies (the cost of which will generally be borne directly or indirectly by the Company or such portfolio companies, as applicable). Notwithstanding the foregoing, investment transactions relating to the Company that require the use of a service provider will generally be allocated to service providers on the basis of best execution, the evaluation of which includes, among other considerations, such service provider&#8217;s provision of certain investment-related services and research that the Adviser believes to be of benefit to the Company. To the extent that the Firm determines appropriate, conflict mitigation strategies can be expected to be put in place with respect to a particular circumstance, such as internal information barriers or recusal, disclosure or other steps determined appropriate by the Firm. The shareholders rely on the Firm to manage these conflicts in its sole discretion.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-3" continuedAt="f-160-4"><ix:continuation id="f-40-61" continuedAt="f-40-62"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Secondments and Internships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain personnel of Blackstone and its affiliates, including consultants, will, in certain circumstances, be seconded to one or more portfolio companies, vendors and service providers and vendors or shareholders or other investors of the Company and Other Clients to provide finance, accounting, operational support, data management and other similar services, including the sourcing of investments for the Company or other parties. The salaries, benefits, overhead and other similar expenses for such personnel during the secondment could be borne by Blackstone and its affiliates or the organization for which the personnel are working or both. In addition, personnel of portfolio companies, vendors, service providers (including law firms and accounting firms) and shareholders or other investors of the Company and Other Clients will, in certain circumstances, be seconded to, serve internships at or otherwise provide consulting services to, Blackstone, the Company, Other Clients and portfolio companies of the Company and Other Clients. While often the Company, Other Clients and their respective portfolio companies are the beneficiaries of these types of arrangements, Blackstone is from time to time a beneficiary of these arrangements as well, including in circumstances where the vendor, personnel or service provider or otherwise also provides services to the Company, Other Clients, their respective portfolio companies or Blackstone in the ordinary course. Blackstone, the Company, Other Clients or their portfolio companies could receive benefits from these arrangements at no cost, or alternatively could pay all or a portion of the fees, compensation or other expenses in respect of these arrangements. If a portfolio company pays the cost it will be borne directly or indirectly by the Company. To the extent such fees, compensation or other expenses are borne by the Company, including indirectly through its portfolio companies or reimbursement of Blackstone for such costs, the management fee will not be reduced as a result of these arrangements or any fees, expense reimbursements or other costs related thereto. The personnel described above may provide services in respect of multiple matters, including in respect of matters related to Blackstone, the Company, Other Clients, portfolio companies, each of their respective affiliates and related parties, and any costs of such personnel may be allocated accordingly, Blackstone will endeavor in good faith to allocate the costs of these arrangements, if any, to Blackstone, the Company, Other Clients, portfolio companies and other parties based on time spent by the personnel or another methodology Blackstone deems appropriate in a particular circumstance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone Credit &amp; Insurance and its personnel and related parties will receive intangible and other benefits, discounts and perquisites arising or resulting from their activities on behalf of the Company, the value of which will not reduce the management fees or incentive fees or otherwise be shared with the Company or its portfolio companies. For example, airline travel or hotel stays incurred as Fund expenses, as set forth in the Investment Advisory Agreement and Administration Agreement (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Fund Expenses&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), often result in &#8220;miles&#8221; or &#8220;points&#8221; or credit in loyalty or status programs, and certain purchases made by credit card will result in &#8220;credit card points, &#8220;cash back&#8221; or rebates in addition to such loyalty or status program miles or points. Such benefits and/or amounts will, whether or not de minimis or difficult to value, inure exclusively to the benefit of Blackstone Credit &amp; Insurance, its affiliates or their personnel (and not the Company and/or portfolio companies) even though the cost of the underlying service is borne by the Company and/or portfolio companies. (See also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Service Providers, Vendors and Other Counterparties Generally&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Portfolio Company Relationships Generally&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein.) Similarly, Blackstone Credit &amp; Insurance, its affiliates and their personnel and related parties, and third parties designated by the foregoing, also receive discounts on products and services provided by portfolio companies and customers or suppliers of such portfolio companies. Such other benefits or fees have the potential to give rise to conflicts of interest in connection with the Company&#8217;s investment activities, and while the Adviser and Blackstone Credit &amp; Insurance will seek to resolve any such conflicts in a fair and equitable manner, there is no assurance that any such conflicts will be resolved in favor of the Company. See also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Service Providers, Vendors and Other Counterparties Generally&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Portfolio Company Relationships Generally&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Advisors, Industry Experts and Operating Partners</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blackstone Credit &amp; Insurance is expected to engage and retain strategic advisors, consultants, senior advisors, executive advisors, industry experts, operating partners, deal sourcers, consultants and other similar professionals (which is expected to include current and former executives or other personnel of Blackstone and/or Blackstone Credit &amp; Insurance, as well as current and former executives or other personnel of Blackstone&#8217;s and/or Blackstone Credit &amp; Insurance&#8217;s portfolio companies) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Senior and Other Advisors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) who are not employees or affiliates of Blackstone Credit &amp; Insurance and who will, from time to time, receive payments from, or allocations of a profits interest with respect to, portfolio companies (as well as from Blackstone Credit &amp; Insurance or the Company). In particular, in some cases, consultants, including those with a &#8220;Senior Advisor&#8221; title, have been and will be engaged with the responsibility to source, diligence and recommend transactions to Blackstone Credit &amp; Insurance or to undertake a build-up strategy to originate, acquire and develop assets and businesses in a particular sector or involving a particular strategy, potentially on a full-time and/or exclusive basis and notwithstanding any overlap with the responsibilities of Blackstone Credit &amp; Insurance under the Investment Advisory Agreement, the compensation to such consultants is expected to be borne fully by the Company and/or portfolio companies (with no reduction or offset to management fee payable by the Company) and not Blackstone Credit &amp; Insurance. Similarly, the Company, Other Clients and their portfolio companies are expected to retain and pay compensation to Senior and Other Advisors to provide services.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-4" continuedAt="f-160-5"><ix:continuation id="f-40-62" continuedAt="f-40-63"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any amounts paid by the Company or a portfolio company to Senior and Other Advisors in connection with the above services, including cash fees, profits, or equity interests in a portfolio company, discretionary bonus awards, performance-based compensation (e.g., promote), sourcing fees, retainers and expense reimbursements, will be treated as Company Expenses or expenses of the portfolio company, as the case may be, and will not, even if they have the effect of reducing any retainers or minimum amounts otherwise payable by Blackstone Credit &amp; Insurance, be chargeable to Blackstone Credit &amp; Insurance or be deemed paid to or received by Blackstone Credit &amp; Insurance, and such amounts will not reduce the management fees or incentive fees payable. Amounts charged by Senior and Other Advisors will not necessarily be confirmed as being comparable to market rates for such services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent permitted by applicable law and/or any applicable SEC granted exemptive or no action relief, these Senior and Other Advisors often have the right or could be offered the ability to (i) co-invest alongside the Company, including in the specific investments in which they are involved (and for which they can be entitled to receive performance-related incentive fees, which will reduce the Company&#8217;s returns), (ii) otherwise participate in equity plans for management of any such portfolio company, or (iii) invest directly in the Company or in a vehicle controlled by the Company subject to reduced or waived advisory fees and/or incentive fees, including after the termination of their engagement by or other status with the Firm. Such co-investment and/or participation (which generally will result in the Company being allocated a smaller share of the applicable investment) will not be considered as part of the Firm&#8217;s side-by-side co-investment rights. Such co-investment and/or participation could vary by transaction (and such participation can, depending on its structure, reduce the Company&#8217;s returns. Additionally, and notwithstanding the foregoing, these Senior and Other Advisors, as well as other Blackstone Clients could be (or could have the preferred right to be) investors in Blackstone Credit &amp; Insurance&#8217;s portfolio companies (which, in some cases, can involve agreements to pay performance fees, or allocate profits interests, to such persons in connection with the Company&#8217;s investment therein, which will reduce the Company&#8217;s returns) and/or Other Clients. Such Senior and Other Advisors, as well as other Blackstone Clients, could also, subject to applicable law, have rights to co-invest with the Company on a side-by-side basis, which rights are generally offered on a no-fee/no-carried interest basis and generally result in the Company being allocated a smaller share of an investment than would otherwise be the case in the absence of such side-by-side participation. Senior and Other Advisors&#8217; benefits described in this paragraph will, in certain circumstances, continue after termination of status as a Senior and Other Advisors.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The time, dedication and scope of work of, and the nature of the relationship with, each of the Senior and Other Advisors vary considerably. In certain cases, they could advise the Adviser and/or Blackstone Credit &amp; Insurance on transactions, provide the Adviser and/or Blackstone with industry-specific insights and feedback on investment themes, assist in transaction due diligence, or make introductions to and provide reference checks on management teams. In other cases, they take on more extensive roles (and could be exclusive service providers to Blackstone Credit &amp; Insurance) and serve as executives or directors on the boards of portfolio companies or contribute to the identification and origination of new investment opportunities. The Company expects to rely on these Senior and Other Advisors to recommend Blackstone as a preferred investment partner, identify investments, source opportunities, and otherwise carry out its investment program, but there is no assurance that these advisers will continue to be involved with the Company for any length of time. In certain instances, Blackstone Credit &amp; Insurance can be expected to have formal or informal arrangements with these Senior and Other Advisors (which may or may not be terminable upon notice by any party), and in other cases the relationships are more informal. They are either compensated (including pursuant to retainers and expense reimbursement, and, in any event, pursuant to negotiated arrangements that will not be confirmed as being comparable to the market rates for such services) by Blackstone, the Company, and/or portfolio companies or otherwise uncompensated or entitled to deferred compensation until occurrence of a future event, such as commencement of a formal engagement. In certain cases, they have certain attributes of Blackstone Credit &amp; Insurance &#8220;employees&#8221; (e.g., they can be expected to have dedicated offices at Blackstone Credit &amp; Insurance, receive administrative support from Blackstone Credit &amp; Insurance personnel, participate in general meetings and events for Blackstone Credit &amp; Insurance personnel, work on Blackstone Credit &amp; Insurance matters as their primary or sole business activity, service Blackstone exclusively, have Blackstone-related e-mail addresses and/or business cards and participate in certain benefit arrangements typically reserved for Blackstone employees, etc.) even though they are not considered Blackstone Credit &amp; Insurance employees, affiliates or personnel for purposes of the Investment Advisory Agreement between the Company and Blackstone Credit &amp; Insurance. Under many of these arrangements, there can be no assurance that the amount of compensation paid in a particular period of time will be proportional to the amount of hours worked or the amount or tangible work product generated by the Senior and Other Advisors during such time. Some Senior and Other Advisors work only for the Company and its portfolio companies, while others may have other clients. In particular, in some cases, Senior and Other Advisors, including those with a &#8220;Senior Advisor&#8221; or &#8220;Operating Advisor&#8221; title, have been and will be engaged with the responsibility to source and recommend transactions to the Adviser potentially on a full-time and/or exclusive basis and, notwithstanding any overlap with the responsibilities of the Adviser under the Investment Advisory Agreement, the compensation to such Senior and Other Advisors will be borne fully portfolio companies (with no reduction to management fees) and not the Adviser. Senior and Other </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-5" continuedAt="f-160-6"><ix:continuation id="f-40-63" continuedAt="f-40-64"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advisors could have conflicts of interest between their work for the Company and its portfolio companies, on the one hand, and themselves or other clients, on the other hand, and Blackstone Credit &amp; Insurance is limited in its ability to monitor and mitigate these conflicts. Blackstone Credit &amp; Insurance expects, where applicable, to allocate the costs of such Senior and Other Advisors to the Company and/or applicable portfolio companies, and to the extent any such costs are allocated to the Company, they would be treated as Company Expenses. Payments or allocations to Senior and Other Advisors will not be reduced by the management fee, and can be expected to increase the overall costs and expenses borne indirectly by investors in the Company. There can be no assurance that any of the Senior and Other Advisors, to the extent engaged, will continue to serve in such roles and/or continue their arrangements with Blackstone Credit &amp; Insurance, the Company and/or any portfolio companies for the duration of the relevant investments or throughout the term of the Company. Additionally, from time to time, Senior and Other Advisors provide services on behalf of both the Company and Other Clients, and any work performed by Senior and Other Advisors retained on behalf of the Company could benefit the Other Clients (and alternatively, work performed by Senior and Other Advisors on behalf of Other Clients could benefit the Company), and Blackstone Credit &amp; Insurance shall have no obligation to allocate any portion of the costs to be borne by the Company in respect of such Senior and Other Advisors to the Other Clients, except as described below.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of the foregoing, in certain investments including involving a &#8220;platform company,&#8221; the Company will, in certain circumstances, enter into an arrangement with one or more individuals (who could be former personnel of the Firm or current or former personnel of portfolio companies of the Company or Other Clients, generally will have experience or capability in sourcing or managing investments, and could form a management team) to undertake a new business line or a build-up strategy to acquire and develop assets and businesses in a particular sector or involving a particular strategy. The services provided by such individuals or relevant portfolio company, as the case may be, could include the following with respect to investments: origination or sourcing, due diligence, evaluation, negotiation, servicing, development, management (including turnaround) and disposition. The individuals or relevant portfolio company could be compensated with a salary and equity incentive plan, including a portion of profits derived from the Company or a portfolio company or asset of the Company (which, to the extent permitted by applicable law and/or any applicable SEC granted exemptive or no action relief, can take the form of a management fee and/or profits allocation (whether paid directly to such individuals or to an affiliate entity controlled by such individuals), or other long-term incentive plans. Compensation could also be based on assets under management, a waterfall similar to a carried interest, respectively, or another similar metric. The Company could initially bear the cost of overhead (including rent, utilities, benefits, salary or retainers for the individuals or their affiliates entities) and the sourcing, diligence and analysis of investments, as well as the compensation for the individuals and entity undertaking the build-up strategy. Such expenses could be borne directly by the Company as Company Expenses (or broken deal expenses, if applicable) or indirectly through expenditures by a portfolio company. None the fees, costs or expenses described above will reduce the management fee.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Adviser will, in certain circumstances, engage third parties as Senior and Other Advisors (or in another similar capacity) in order to advise it with respect to existing investments, specific investment opportunities, and economic and industry trends. Such Senior and Other Advisors can receive reimbursement of reasonable related expenses by portfolio companies or the Company and could have the opportunity to invest in a portion of the equity and/or debt available to the Company for investment that would otherwise be taken by the Adviser and its affiliates. If such Senior and Other Advisors generate investment opportunities on the Company&#8217;s behalf, such Senior and Other Advisors are permitted to receive special additional fees or allocations which have the potential to not be comparable to those received by a third party in an arm&#8217;s length transaction and such additional fees or allocations would be borne fully by the Company and/or portfolio companies (with no reduction or offset to management fees) and not Blackstone Credit &amp; Insurance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Minority Investments in Asset Management Firms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone and Other Clients, including Blackstone Strategic Capital Holdings (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BSCH&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and its related parties, regularly make minority investments in alternative asset management firms that are not affiliated with Blackstone, the Company, Other Clients and their respective portfolio companies, and which from time to time engage in similar investment transactions, including with respect to purchase and sale of investments, with these asset management firms and their advised funds and portfolio companies. Typically, the Blackstone related party with an interest in the asset management firm would be entitled to receive a share of carried interest/performance based incentive compensation and net fee income or revenue share generated by the various products, vehicles, funds and accounts managed by that third party asset management firm that are included in the transaction or activities of the third party asset management firm, or a subset of such activities such as transactions with a Blackstone related party. In addition, while such minority investments are generally structured so that Blackstone does not &#8220;control&#8221; such third party asset management firms, Blackstone could nonetheless be afforded certain governance rights in relation to such investments (typically in the nature of &#8220;protective&#8221; rights, negative control rights or anti-dilution arrangements, as well as certain reporting and consultation rights) that afford Blackstone the ability to influence the firm. Although Blackstone and Other Clients, including BSCH, do not intend to control such third </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-6" continuedAt="f-160-7"><ix:continuation id="f-40-64" continuedAt="f-40-65"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">party asset management firms, there can be no assurance that all third parties will similarly conclude that such investments are non-control investments or that, due to the provisions of the governing documents of such third party asset management firms or the interpretation of applicable law or regulations, investments by Blackstone and Other Clients, including BSCH, will not be deemed to have control elements for certain contractual, regulatory or other purposes. While such third party asset managers will not be deemed affiliated with the Company within the meaning of the 1940 Act, Blackstone expects to, under certain circumstances, be in a position to influence the management and operations of such asset managers and the existence of its economic/revenue sharing interest therein can give rise to conflicts of interest. Participation rights in a third party asset management firm (or other similar business), negotiated governance arrangements and/or the interpretation of applicable law or regulations could expose the investments of the Company to claims by third parties in connection with such investments (as indirect owners of such asset management firms or similar businesses) that would have an adverse financial or reputational impact on the performance of the Company. The Company, its affiliates and their respective portfolio companies are expected to, from time to time engage in transactions with, and buy and sell investments from, any such third party asset managers and their sponsored funds and transactions and other commercial arrangements between such third party asset managers and the Company and its portfolio companies are not subject to approval by the Board of Trustees. There can be no assurance that the terms of these transactions between parties related to Blackstone, on the one hand, and the Company and its portfolio companies, on the other hand, will be at arm&#8217;s length or that Blackstone will not receive a benefit from such transactions, which can be expected to incentivize Blackstone to cause these transactions to occur. Such conflicts related to investments in and arrangements with other asset management firms will not necessarily be resolved in favor of the Company. Shareholders will not be entitled to receive notice or disclosure of the terms or occurrence of either the investments in alternative asset management firms or transactions therewith and will not receive any benefit from such transactions. By executing a subscription agreement with respect to the Company, each shareholder acknowledges these conflicts related to investments in and arrangements with other asset management firms, acknowledges that these conflicts will not necessarily be resolved in favor of the Company, agrees that shareholders will not be entitled to receive notice or disclosure of the terms or occurrence of either the investments in alternative asset management firms or transactions therewith, otherwise understands that shareholders will not receive any benefit from such transactions, consents to all such transactions and arrangements to the fullest extent permitted by law, and waives any claim against Blackstone and releases Blackstone from any liability arising from the existence of any such conflict of interest.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, certain advisors and service providers (including law firms) temporarily provide their personnel to Blackstone, Other Clients or their portfolio companies pursuant to various arrangements including at cost or at no cost. (See also &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Secondments and Internships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; herein.) While often the Company, Other Clients and their portfolio companies are the beneficiaries of these types of arrangements, Blackstone is from time to time a beneficiary of these arrangements as well, including in circumstances where the advisor or service provider also provides services to the Company, Other Clients or Blackstone in the ordinary course. Blackstone, the Company, Other Clients or their portfolio companies could receive benefits from these arrangements at no cost, or alternatively could pay all or a portion of the fees, compensation or other expenses in respect of these arrangements. The management fee will not be offset or reduced as a result of these arrangements or any fees, expense reimbursements or other costs related thereto. The personnel described above could provide services in respect of multiple matters, including in respect of matters related to Blackstone, the Company, Other Clients, portfolio companies, each of their respective affiliates and related parties, and Blackstone will endeavor in good faith to allocate the costs of these arrangements, if any, to Blackstone, the Company, Other Clients, portfolio companies and other parties based on time spent by the personnel or another methodology the Firm deems appropriate in a particular circumstance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Multiple Blackstone Business Lines. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone has multiple business lines, including the Blackstone Capital Markets Group, which Blackstone Credit &amp; Insurance, the Company, Other Clients, portfolio companies of the Company and Other Clients and third parties will, in certain circumstances, engage for debt and equity financings and to provide other investment banking, brokerage, investment advisory or other services. As a result of these activities, Blackstone is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than if it had one line of business. For example, from time to time, Blackstone could come into possession of information that limits the Company&#8217;s ability to engage in potential transactions. Similarly, other Blackstone businesses and their personnel could be prohibited by law or contract from sharing information with Blackstone that would be relevant to monitoring the investments and other activities. These types of restrictions from time to time will negatively impact the ability of the Company to implement its investment program. Finally, Blackstone personnel who are members of the investment team or investment committee could be excluded from participating in certain investment decisions due to conflicts involving other Blackstone businesses or for other reasons, including other business activities, in which case the Company will not benefit from their experience. The shareholders will not receive a benefit from any fees earned by Blackstone or its personnel from these other businesses.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-7" continuedAt="f-160-8"><ix:continuation id="f-40-65" continuedAt="f-40-66"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone is under no obligation to decline any engagements or investments in order to make an investment opportunity available to the Company. Blackstone has long-term relationships with a significant number of corporations and their senior management. Blackstone will consider those relationships when evaluating an investment opportunity, which has the potential to result in Blackstone choosing not to make such an investment due to such relationships (e.g., investments in a competitor of a client or other person with whom Blackstone has a relationship). The Company could be required to sell or hold existing investments as a result of investment banking relationships or other relationships that Blackstone has or will have or transactions or investments that Blackstone makes or has made. (See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Allocation of Investment Opportunities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Portfolio Company Relationships&#8221;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Therefore, there can be no assurance that all potentially suitable investment opportunities that come to the attention of Blackstone will be made available to the Company. The Company is also permitted to co-invest with Other Clients or other persons with whom Blackstone has a relationship in particular investment opportunities, and other aspects of these Blackstone relationships could influence the decisions made by Blackstone with respect to the investments and otherwise result in a conflict (see also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Other Clients; Allocation of Investment Opportunities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein). Company would otherwise have to buy or sell certain assets, and may require that the Company dispose of an investment at an inopportune time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blackstone Policies and Procedures; Information Walls.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blackstone has implemented policies and procedures to address conflicts that arise as a result of its various activities, as well as regulatory and other legal considerations. Some of these policies and procedures, such as Blackstone&#8217;s information wall policy, are implemented by Blackstone to mitigate potential conflicts of interest and address certain regulatory requirements and contractual restrictions will reduce the synergies and collaboration across Blackstone&#8217;s various businesses that the Company expects to draw on for purposes of identifying, pursuing and managing attractive investment opportunities. Because Blackstone has many different asset management and advisory businesses, including private equity, growth equity, a credit business, a hedge fund business, a capital markets group, a life sciences business and a real estate advisory business, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would otherwise be subject if it had just one line of business. In addressing these conflicts and regulatory, legal and contractual requirements across its various businesses and to protect against the inappropriate sharing and/or use of information between the Company and the other business units at Blackstone, Blackstone has implemented certain policies and procedures (e.g., Blackstone&#8217;s information wall policy) regarding the sharing of information that have the potential to reduce the positive synergies and collaborations that the Company could otherwise expect to utilize for purposes of identifying and managing attractive investments. For example, Blackstone will from time to time come into possession of material non-public information with respect to companies in which Other Clients have investments or might be considering making an investment or companies that are clients of Blackstone. As a consequence, that information, which could be of benefit to the Company, might become restricted to those other respective businesses and otherwise be unavailable to the Company. It is also possible that the Company could be restricted from trading despite the fact that the Company did not receive such information. There can be no assurance, however, that any such policies and/or procedures will be effective in accomplishing their stated purpose and/or that they will not otherwise adversely affect the ability of the Company to effectively achieve its investment objective by unduly limiting the investment flexibility of the Company and/or the flow of otherwise appropriate information between Blackstone Credit &amp; Insurance and other business units at Blackstone. For example, in some instances, personnel of Blackstone would be unable to assist with the activities of the Company as a result of these walls. There can be no assurance that additional restrictions will not be imposed that would further limit the ability of Blackstone to share information internally. In addition, due to these restrictions, it is possible that the Company will not be able to initiate a transaction that it otherwise might have initiated and will not be able to purchase or sell an investment that it otherwise might have purchased or sold, which could negatively affect its operations or performance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to the extent that Blackstone is in possession of material non-public information or is otherwise restricted from making certain investments, the Company and the Adviser would also be deemed to be in possession of such information or otherwise restricted. Additionally, the terms of confidentiality or other agreements with or related to companies in which any Blackstone fund has or has considered making an investment or which is otherwise a client of Blackstone will from time to time restrict or otherwise limit the ability of the Company and/or its portfolio companies and their affiliates to make investments in or otherwise engage in businesses or activities competitive with such companies. Blackstone has in the past entered into, and reserves the right to enter into in the future, one or more strategic relationships in certain regions or with respect to certain types of investments that, although intended to provide greater opportunities for the Company, require the Company to share such opportunities or otherwise limit the amount of an opportunity the Company can otherwise take. (See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Allocation of Investment Opportunities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-8" continuedAt="f-160-9"><ix:continuation id="f-40-66" continuedAt="f-40-67"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm receives, generates and/or obtains various kinds of data and information from the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and limited partners in Other Clients and service providers, including but not limited to data and information relating to or created in connection with business operations, financial information results, trends, budgets, energy usage, plans, ESG, carbon emissions and related metrics, customer and user data, employee and contractor data, supplier and cost data, and other related data and information, some of which is sometimes referred to as &#8220;alternative data&#8221; or &#8220;big data&#8221;. The Firm can be expected to be better able to anticipate macroeconomic and other trends, and otherwise develop investment themes or identify specific investment, trading or business opportunities, as a result of its access to (and rights regarding, including use, ownership, distribution and derived works rights over) this data and information from the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and limited partners in Other Clients, related parties and service providers. The Firm has entered and will continue to enter into information sharing and use, measurement and other arrangements, which will give the Firm access to (and rights regarding, including ownership, use, distribution and derived works rights over) data that it would not otherwise obtain in the ordinary course, with the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and in Other Clients, as well as with related parties and service providers. Further, this alternative data is expected to be aggregated across the Company, Other Clients and their respective portfolio companies. Although the Firm believes that these activities improve the Firm&#8217;s investment management activities on behalf of the Company and Other Clients, information obtained from the Company and its portfolio companies, and investors in the Company and in Other Clients also provides material benefits to Blackstone or Other Clients without compensation or other benefit accruing to the Company or its shareholders. For example, information from a portfolio company in which the Company holds an interest can be expected to enable the Firm to better understand a particular industry, enhance the Firm&#8217;s ability to provide advice or direction to a portfolio company&#8217;s management team on strategy or operations and enable the Firm to execute trading and investment strategies in reliance on that understanding for Blackstone and Other Clients that do not own an interest in the portfolio company, typically without compensation or benefit to the Company or its portfolio companies. Blackstone would serve as the repository for data described in this paragraph, including with ownership and use rights therein. The Firm is also permitted to share data from a portfolio company (on an anonymized basis) with a portfolio company of an Other Client, which has the potential to increase a competitive disadvantage for, and indirectly harm, such portfolio company (although the opposite may be true as well, in which case a portfolio company of the Company may receive data from a portfolio company of an Other Client). In addition, the Firm could have an incentive to pursue an investment in a particular company based on the data and information expected to be received or generated in connection with such investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, except for contractual obligations to third parties to maintain confidentiality of certain information or otherwise limit the scope and purpose of its use or distribution, and regulatory limitations on the use of material nonpublic information, the Firm is generally free to use and distribute data and information from the Company&#8217;s activities to assist in the pursuit of the Firm&#8217;s various other activities, including but not limited to trading activities or use for the benefit of the Firm and/or an Other Client. Any confidentiality obligations in the operative documents do not limit the Firm&#8217;s ability to do so. For example, the Firm&#8217;s ability to trade in securities of an issuer relating to a specific industry can, subject to applicable law, be enhanced by information of a portfolio company in the same or related industry. Such trading or other business activities is expected to provide a material benefit to the Firm without compensation or other benefit to the Company or shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sharing and use of &#8220;big data&#8221; and other information presents potential conflicts of interest and the shareholders acknowledge and agree that any benefits received by the Firm or its personnel (including fees (in cash or in kind), costs and expenses) will not reduce the management fees or incentive fees payable to the Adviser or otherwise shared with the Company or its shareholders. As a result, the Adviser has an incentive to pursue investments that have data and information that can be utilized in a manner that benefits the Firm or Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data Management Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone or an affiliate of Blackstone formed in the future may provide data management services to portfolio companies and investors in the Company and in Other Clients and will provide such services directly to the Company and Other Clients (collectively,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Data Holders&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Such services are expected to include assistance with obtaining, analyzing, curating, processing, packaging, organizing, mapping, holding, transforming, enhancing, marketing and selling such data (among other related data management and consulting services) for monetization through licensing or sale arrangements with third parties and, subject to applicable law and the limitations in the Investment Advisory Agreement and any other applicable contractual limitations, with the Company, Other Clients, portfolio companies, investors in the Company and in Other Clients, and other Blackstone affiliates and associated entities (including funds in which Blackstone and Other Clients make investments, and portfolio companies thereof). If Blackstone enters into data services arrangements with portfolio companies and receives compensation from such portfolio companies for such data services, the Company will indirectly bear its share of such compensation based on its pro rata ownership of such portfolio companies. Where Blackstone believes appropriate, data from one Data Holder will be aggregated or pooled with data from other Data Holders. Any revenues arising </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-9" continuedAt="f-160-10"><ix:continuation id="f-40-67" continuedAt="f-40-68"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from such aggregated or pooled data sets would be allocated between applicable Data Holders on a fair and reasonable basis as determined by Blackstone Credit &amp; Insurance in its sole discretion, with Blackstone Credit &amp; Insurance able to make corrective allocations should it determine subsequently that such corrections were necessary or advisable. Blackstone is expected to receive compensation for such data management services, which is expected to include a percentage of the revenues generated through any licensing or sale arrangements with respect to the relevant data, and which compensation is also expected to include fees, royalties and cost and expense reimbursement (including start-up costs and allocable overhead associated with personnel working on relevant matters (including salaries, benefits and other similar expenses)). Additionally, Blackstone is expected to share and distribute the products from such data management services within Blackstone or its affiliates (including Other Clients or their portfolio companies) at no charge and, in such cases, the Data Holders will not receive any financial or other benefit from having provided such data to Blackstone. The potential receipt of such compensation by Blackstone creates incentives for Blackstone to cause the Company to invest in portfolio companies with a significant amount of data that it might not otherwise have invested in or on terms less favorable than it otherwise would have sought to obtain.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blackstone and Blackstone Credit &amp; Insurance Strategic Relationships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone and Blackstone Credit &amp; Insurance have entered, and it can be expected that Blackstone and Blackstone Credit &amp; Insurance in the future will enter, into both (i) strategic relationships with investors (and/or one or more of their affiliates) that involve an overall relationship with Blackstone or Blackstone Credit &amp; Insurance (which will afford such investor special rights and benefits) that could (but is not required to) incorporate one or more strategies (including, but not limited to, a different sector and/or geographical focus within the same or a different Blackstone business unit) in addition to the Company&#8217;s strategy and (ii) arrangements that involve an agreement or understanding to make an investment in or a capital commitment to (as applicable) the Company and one or more Other Clients, as applicable (which can include a subscription or capital commitment, as applicable, already made recently to another Other Client) (any such overall relationship and/or multi-fund arrangement in the foregoing (i) and (ii), (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Strategic Relationships&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), with terms and conditions applicable solely to such investor and its investment in multiple Blackstone or Blackstone Credit &amp; Insurance strategies that would not apply to any other investor&#8217;s investment in the Company. A Strategic Relationship often involves (but is not required to involve) an investor agreeing to make a capital commitment to or investment in (as applicable) multiple Blackstone or Blackstone Credit &amp; Insurance Clients, one of which could include the Company. Shareholders will not receive a copy of any agreement memorializing such a Strategic Relationship program (even if in the form of a side letter) or receive any other disclosure or reporting of the terms of or existence of any Strategic Relationship and will be unable to elect in the &#8220;most-favored-nations&#8221; election process (if any) any rights or benefits afforded through a Strategic Relationship (for the avoidance of doubt, no further disclosure or reporting information will be shared with the shareholders about any Strategic Relationship). Specific examples of such additional rights and benefits have included and can be expected to include, among others, specialized reporting, discounts or reductions on and/or reimbursements or rebates of management fees or carried interest (as applicable), secondment of personnel from the investor to Blackstone or Blackstone Credit &amp; Insurance (or vice versa), rights to participate in the investment review and evaluation process, as well as priority rights or targeted amounts for co-investments alongside Blackstone Credit &amp; Insurance or Blackstone funds (including, without limitation, preferential or favorable allocation of co-investment and preferential terms and conditions related to co-investment or other participation in Blackstone or Blackstone Credit &amp; Insurance Clients (including in respect of any carried interest (as applicable) and/or management fees to be charged with respect thereto, as well as any additional discounts, reductions, reimbursements or rebates with respect thereto or other penalties that may result if certain target co-investment allocations or other conditions under such arrangements are not achieved)). Any co-investment that is part of a Strategic Relationship could include co-investment in investments made by the Company. Blackstone, including its personnel (including Blackstone Credit &amp; Insurance personnel), reserves the right to receive compensation from Strategic Relationships and could be incentivized to allocate investment opportunities away from the Company to or source investment opportunities for Strategic Relationships. Strategic Relationships will in certain circumstances, result in fewer co-investment opportunities (or reduced or no allocations) being made available to shareholders, subject to the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blackstone Credit &amp; Insurance Value Creation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone Credit &amp; Insurance Value Creation is a global platform that is part of Blackstone&#8217;s Portfolio Operations Group (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Portfolio Operations Group&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and seeks to provide access to a range of cost-saving, revenue-generating and best-practice sharing opportunities for Blackstone Credit &amp; Insurance portfolio companies. The Portfolio Operations Group is organized into seven functional areas, across geographic regions and industry verticals:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Procurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Blackstone&#8217;s group purchasing program harnesses spending from portfolio companies across more than 75 categories, including IT hardware and software, office supplies, shipping, energy and telecommunications.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-10" continuedAt="f-160-11"><ix:continuation id="f-40-68" continuedAt="f-40-69"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Cost Containment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Blackstone&#8217;s Equity Healthcare team partners with portfolio companies to optimize the strategy and value of healthcare spending by reducing cost and improving the quality of healthcare services received by employees and their dependents. Equity Healthcare is one of the largest private sector purchasers of healthcare services in the United States and has helped drive cumulative healthcare cost savings to portfolio companies and strengthened portfolio companies&#8217; ability to attract and retain talent.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lean Process</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The lean process team seeks to drive transformational improvements focused on material and information flows by reducing waste and non-value add activities across manufacturing functions. It develops prescriptive solutions for portfolio companies and aligns with senior leadership to support tailored strategies and guide management teams in executing and sustaining improved workflow processes.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leadership and Talent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Portfolio Operations Group employs the following strategies to optimize leadership and organizational performance: (i) delivering fit-for-purpose resources to portfolio companies, which include non-executive chairpersons, board members, advisors, and operating specialists, (ii) strengthening company teams and organizational practices through assisting with restructuring, integrations and growth actions, and (iii) convening conferences for portfolio company executives to share best practices and improve alignment to the Firm.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sustainability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: By improving the operation and maintenance of mechanical systems, the Portfolio Operations Group seeks to reduce energy spend while improving productivity, safety, and environmental performance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Technology / BPO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Blackstone&#8217;s Technology / BPO team helps the portfolio management teams recruit/upgrade their information technology leadership teams; import contemporary operating systems and application software to address their respective business priorities; leverage portfolio investments in technology companies to promote and serve the overall portfolio interests; and evaluate and negotiate preferred partnerships with digital/technology suppliers, advisors, and consultants from around the world.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Science</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Firm has invested in a team of data scientists and engineers to help the portfolio companies realize operational efficiencies and drive new revenue through data and analytics. This team focuses on (i) building predictive models to enhance decision making; (ii) leveraging big data within operations; (iii) data visualization to democratize access to information; and (iv) data monetization.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of Blackstone&#8217;s Portfolio Operations Group (including Blackstone Credit &amp; Insurance Value Creation), who are Blackstone employees, are permitted to provide services to the Company&#8217;s portfolio companies, including without limitation those related to the functional areas described above and other similar management consulting, operational and financial matters and are permitted to participate in the Firm co-investment rights. Any payments made or fees paid (which fees or payments will also in certain instances be structured as a reimbursement of internal compensation costs for time spent) by such portfolio companies to Blackstone for services rendered to such portfolio companies will generally be no greater than what would be paid in an arm&#8217;s-length transaction for similar overalls services, and such payments or fees received will not reduce the management fee payable by the Company. As a result, Blackstone is likely to be incentivized to cause members of the Portfolio Operations Group to spend more time on the Company&#8217;s portfolio companies as compared to portfolio companies of Other Clients that do reduce the management fee. On the other hand, there can be no assurance that members of the Portfolio Operations Group will be able to provide their services to portfolio companies and/or that any individuals within the Portfolio Operations Group will remain employed by Blackstone through the life of the Company. The level of involvement and role of Blackstone&#8217;s Portfolio Operations Group within each part of Blackstone with respect to any of the Company&#8217;s portfolio companies are expected to vary, including having no involvement or role at all. In addition, the Portfolio Operations Group will provide services to the Company&#8217;s portfolio companies as described in more detail in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Firm Affiliated Service Providers&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including facilitation of arrangements for Portfolio Companies relating to group procurement (such as the group purchasing organization) and other operational, administrative or management related matters from third parties or Firm affiliates, and other similar operational initiatives. These services can result in commissions or similar payments, including related to a portion of the savings achieved by the portfolio companies. See also </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Other Fees&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Group Procurement; Discounts&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Firm Affiliated Service Providers&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information regarding such programs.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-11" continuedAt="f-160-12"><ix:continuation id="f-40-69" continuedAt="f-40-70"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Buying and Selling Investments or Assets from Certain Related Parties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company and its portfolio companies may purchase investments or assets from or sell investments or assets to shareholders, other portfolio companies of the Company, portfolio companies of Other Clients or their respective related parties. Purchases and sales of investments or assets between the Company or its portfolio companies, on the one hand, and shareholders, other portfolio companies of the Company, portfolio companies of Other Clients or their respective related parties, on the other hand, are not, unless required by applicable law, subject to the approval of the Board of Trustees or any shareholder. These transactions involve conflicts of interest, as the Firm may receive fees and other benefits, directly or indirectly, from or otherwise have interests in both parties to the transaction, including different financial incentives Blackstone could have with respect to the parties to the transaction. For example, there can be no assurance that any investment or asset sold by the Company to a shareholder, other portfolio companies of the Company, portfolio company of Other Clients or any of their respective related parties will not be valued or allocated a sale price that is lower than might otherwise have been the case if such asset were sold to a third party rather than to a shareholder, portfolio company of Other Clients or any of their respective related parties. The Firm will not be required to solicit third party bids or obtain a third party valuation prior to causing the Company or any of its portfolio companies to purchase or sell any asset or investment from or to a shareholder, other portfolio companies of the Company, portfolio company of Other Clients or any of their respective related parties as provided above.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Firm Businesses, Activities and Relationships. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its regular business, Blackstone provides a broad range of investment banking, advisory and other services. In addition, from time to time, the Firm will provide services in the future beyond those currently provided. Shareholders will not receive any benefit from any fees relating to such services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the regular course of its capital markets, investment banking, real estate advisory and other businesses, Blackstone represents potential purchasers, sellers and other involved parties, including corporations, financial buyers, management, shareholders and institutions, with respect to transactions that could give rise to other transactions that are suitable for the Company. In such a case, a Blackstone advisory client would typically require Blackstone to act exclusively on its behalf. Such advisory client requests have the potential to preclude all Blackstone-affiliated clients, including the Company, from participating in related transactions that would otherwise be suitable. Blackstone will be under no obligation to decline any such engagements in order to make an investment opportunity available to the Company. In connection with its capital markets, investment banking, advisory, real estate and other businesses, Blackstone comes into possession of information that limits its ability to engage in potential transactions. The Company&#8217;s activities are expected to be constrained as a result of the inability of Blackstone personnel to use such information. For example, employees of Blackstone from time to time are prohibited by law or contract from sharing information with members of the Company&#8217;s investment team. Additionally, there are expected to be circumstances in which one or more individuals associated with Blackstone affiliates (including clients) will be precluded from providing services related to the Company&#8217;s activities because of certain confidential information available to those individuals or to other parts of Blackstone (e.g., trading can be restricted). Where Blackstone affiliates are engaged to find buyers or financing sources for potential sellers of assets, the seller can permit the Company to act as a participant in such transactions (as a buyer or financing partner), which would raise certain conflicts of interest inherent in such a situation (including as to the negotiation of the purchase price).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may invest in securities of the same issuers as Other Clients, other investment vehicles, accounts and clients of the Firm and the Adviser. To the extent that the Company holds interests that are different (or more senior or junior) than those held by such Other Clients, Blackstone Credit &amp; Insurance may be presented with decisions involving circumstances where the interests of such Other Clients are in conflict with those of the Company. Furthermore, it is possible the Company&#8217;s interest could be subordinated or otherwise adversely affected by virtue of such Other Clients&#8217; involvement and actions relating to its investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the 1940 Act limits the Company&#8217;s ability to undertake certain transactions with its affiliates that are registered under the 1940 Act or regulated as BDCs under the 1940 Act. As a result of these restrictions, the Company could be prohibited from executing &#8220;joint&#8221; transactions with such affiliates, which could include investments in the same portfolio company (whether at the same or different times). These limitations have the potential to limit the scope of investment opportunities that would otherwise be available to the Company.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-12" continuedAt="f-160-13"><ix:continuation id="f-40-70" continuedAt="f-40-71"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance has received an exemptive order that permits certain funds, among other things, to co-invest with certain other persons, including certain affiliates of Blackstone Credit &amp; Insurance, and certain funds managed and controlled by Blackstone Credit &amp; Insurance and its affiliates subject to certain terms and conditions. In addition, other present and future activities of the Firm and its affiliates (including Blackstone Credit &amp; Insurance and the Adviser) will from time to time give rise to additional conflicts of interest relating to the Firm and its investment activities. In the event that any such conflict of interest arises, the Adviser will attempt to resolve such conflicts in a fair and equitable manner. Investors should be aware that, subject to applicable law, conflicts will not necessarily be resolved in favor of the Company&#8217;s interests.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transactions with Clients of Blackstone Insurance Solutions and Asset Based Finance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone Insurance Solutions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BIS&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is the business segment of Blackstone Credit &amp; Insurance that provides investment advisory services to insurers, including among others, (i) Fidelity Life Insurance Company and certain of its affiliates (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;FGL&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), (ii) Everlake Life Insurance Company and certain of its affiliates (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Everlake&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), (iii) certain subsidiaries of Corebridge Financial, Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Corebridge&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and (iv) certain subsidiaries of Resolution Life Group Holdings Ltd. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Resolution Life&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Certain of the insurers for which BIS provides services are, or may be in the future, owned, directly or indirectly, by Blackstone, the Company, or Other Clients, in whole or in part. Actual or potential conflicts of interest will likely arise in relation to the funds, vehicles or accounts BIS advises or sub-advises, including accounts where an insurer (including, without limitation, each of FGL, Everlake, Corebridge and Resolution Life) participates in investments directly and there is no separate vehicle controlled by Blackstone (for the purposes of this paragraph only, collectively, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BIS Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Blackstone Credit &amp; Insurance also advises funds and accounts focused on asset-based finance, including insurers and other types of investors (for the purposes of this paragraph only, collectively, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ABF Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and each BIS Client and ABF Client is an Other Client for&#160;purposes other than this paragraph). BIS Clients have invested and are expected to continue investing in Other Clients and/or the Company. For greater clarity, any references herein to Blackstone Credit &amp; Insurance or Other Blackstone Credit &amp; Insurance Clients do not include BIS, BIS Clients or ABF Clients. Certain BIS Clients and certain ABF Clients have investment objectives that overlap with those of the Company (and Blackstone Credit &amp; Insurance, or a business segment thereof, has entered into sub-management agreements with BIS to manage (for a fee, which such fees may be shared with BIS) the assets of certain such BIS Clients with respect to investments that overlap in part with the Company&#8217;s investment directive) or its portfolio companies and such BIS Clients and ABF Clients may invest, as permitted by applicable law and the Company&#8217;s co-investment exemptive relief, alongside (or in lieu of) the Company or such portfolio companies in certain investments, which will reduce the investment opportunities otherwise available to the Company or such portfolio companies. BIS Clients and ABF Clients will also engage in a variety of activities, including participating in transactions related to the Company and/or its portfolio companies (e.g., as originators, co-originators, counterparties or otherwise). Other transactions in which BIS Clients or ABF Clients will participate include, without limitation, investments in debt or other securities issued by portfolio companies or other forms of financing to portfolio companies (including special purpose vehicles established by the Company or such portfolio companies). When investing alongside the Company or its portfolio companies or in other transactions related to the Company or its portfolio companies, BIS Clients or ABF Clients may not invest or divest at the same time or on the same terms as the Company or the applicable portfolio companies or at a different time or on different terms. BIS Clients and ABF Clients will also from time to time acquire investments and portfolio companies directly or indirectly from the Company, as permitted by applicable law and the Company&#8217;s co-investment exemptive relief. In circumstances where Blackstone Credit &amp; Insurance determines in good faith that the conflict of interest is mitigated in whole or in part through various measures that Blackstone, Blackstone Credit &amp; Insurance or the Adviser implements, the Adviser may determine to proceed with the applicable transaction (subject to oversight by the Board of Trustees and the applicable law to which the Company is subject). In order to seek to mitigate any potential conflicts of interest with respect to such transactions (or other transactions involving BIS Clients or ABF Clients), Blackstone reserves the right, in its sole discretion, to involve independent members of the board of a portfolio company or a third party stakeholder in the transaction to negotiate price and terms on behalf of the BIS Clients or ABF Clients or otherwise cause the BIS Clients or ABF Clients to &#8220;follow the vote&#8221; thereof, and/or cause an independent client representative or other third party to approve the investment or otherwise represent the interests of one or more of the parties to the transaction. In addition, Blackstone or the Adviser may limit the percentage interest of the BIS Clients or ABF Clients participating in such transaction, or obtain appropriate price quotes or other benchmarks, or, alternatively, a third-party price opinion or other document to support the reasonableness of the price and terms of the transaction. From time to time, the applicable BIS Clients or ABF Clients participating in a transaction will be required to consent thereto (including in circumstances where the Adviser does not seek the consent of the Board of Trustees). There can be no assurance that any such measures or other measures that may be implemented by Blackstone will be effective at mitigating any actual or potential conflicts of interest. Moreover, under certain circumstances (e.g., where a BIS Client or ABF Client participates in a transaction directly (and not through a vehicle controlled by Blackstone) and independently consents to participating in a transaction), a BIS Client or ABF Client (or any other Blackstone Client participating via a similar arrangement) will not be an &#8220;Affiliate&#8221; as defined under the 1940 Act. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-13" continuedAt="f-160-14"><ix:continuation id="f-40-71" continuedAt="f-40-72"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allocation of Portfolios</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm will, in certain circumstances, have an opportunity to acquire a portfolio or pool of assets, securities and instruments that it determines should be divided and allocated among the Company and Other Clients. Such allocations generally would be based on the Firm&#8217;s assessment of the expected returns and risk profile of each of the assets. For example, some of the assets in a pool will have an opportunistic return profile, while others will have a return profile not appropriate for the Company. Also, a pool can contain both debt and equity instruments that the Firm determines should be allocated to different funds. In all of these situations, the combined purchase price paid to a seller would be allocated among the multiple assets, securities and instruments in the pool and therefore among the Company and Other Clients acquiring any of the assets, securities and instruments, although the Firm could, in certain circumstances, allocate value to the Company and such Other Clients on a different basis than the contractual purchase price. Similarly, there will likely be circumstances in which the Company and Other Clients will sell assets in a single or related transactions to a buyer. In some cases, a counterparty will require an allocation of value in the purchase or sale contract, though the Firm could determine such allocation of value is not accurate and should not be relied upon. The Firm will generally rely upon internal analysis to determine the ultimate allocation of value, though it could also obtain third party valuation reports. Regardless of the methodology for allocating value, the Firm will have conflicting duties to the Company and Other Clients when they buy or sell assets together in a portfolio, including as a result of different financial incentives the Firm has with respect to different vehicles, most clearly when the fees and compensation, including performance-based compensation, earned from the different vehicles differ. There can be no assurance that an investment of the Company will not be valued or allocated a purchase price that is higher or lower than it might otherwise have been allocated if such investment were acquired or sold independently rather than as a component of a portfolio shared with Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holding Entities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Firm may determine that for legal, tax, regulatory, accounting, administrative or other reasons the Company should hold a particular investment (or a portion of an investment or pool of assets) through a single holding entity through which the Company and one or more Other Clients hold different investments (or a different portion of such investment or pool of assets), including where such investment or pool has been divided and allocated among the Company and such Other Clients. Over time, it is possible that the Company and/or Other Clients may make different decisions with respect to the investments held through such holding entities and therefore may have differing economic rights, obligations or liabilities with respect to a holding entity. In such circumstances, the economic rights, liabilities and obligations in respect of the investment (or portion of an investment or pool of assets) that is indirectly held by the Company would be specifically attributed to the Company, and the Company would be deemed to hold its investment (or portion of an investment or pool of assets) separately from, and not jointly with, such Other Clients (and vice versa in respect of the investments (or portion of an investment or pool of assets) held indirectly through such holding entity by such Other Clients).&#160;Furthermore, certain holding structures may require a newly-established manager, advisor, service provider or other entity intended to address certain legal, tax, regulatory, accounting, administrative or other considerations applicable to the Company and/or Other Clients. It is possible that the Company or an affiliate will be initially responsible for the costs and expenses of establishing such holding structure (including any such newly-established entities) prior to, and/or, in anticipation of, Other Clients participating through such structure for their investments and it is expected that such Other Clients reimburse the Company or the Company would reimburse such affiliate for any such costs and expenses on a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> basis. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Affiliate Transactions and Investments in Different Levels of Capital Structure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company and the Other Clients may make investments at different levels of an issuer&#8217;s capital structure or otherwise in different classes of an issuer&#8217;s securities or loans, subject to the limitations of the 1940 Act. While less common, subject to applicable law, from time to time the Company could hold an investment in a different layer of the capital structure than an investor or another party with which Blackstone has a material relationship, in which case Blackstone could have an incentive to cause the Company or the portfolio company to offer more favorable terms to such parties (including, for instance, financing arrangements). Certain such investments inherently give rise to conflicts of interest or perceived conflicts of interest between or among the various classes of securities or loans that are expected to be held by such entities. To the extent the Company holds securities or loans that are different (including with respect to their relative seniority) than those held by an Other Client, the Adviser and its affiliates will be presented with decisions when the interests of the funds are in conflict. For example, conflicts could arise where the Company lends funds to a portfolio company while an Other Client invests in equity securities of such portfolio company. In this circumstance, for example, if such portfolio company were to go into bankruptcy, become insolvent or otherwise be unable to meet its payment obligations or comply with its debt covenants, conflicts of interest could arise between the holders of different types of securities or loans as to what actions the portfolio company should take. In addition, purchases or sales of securities or loans for the account of the Company (particularly marketable securities) will be bunched or aggregated with orders for Other Clients, including other funds. It is frequently not possible to receive the same price or execution on the entire volume of securities sold, and the various prices could be averaged, which has the potential to be disadvantageous to the Company. Further conflicts could arise after the Company and Other Clients have made their respective initial investments. For example, if additional financing is necessary as a result of financial or other difficulties, it is not always </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-14" continuedAt="f-160-15"><ix:continuation id="f-40-72" continuedAt="f-40-73"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the best interests of the Company to provide such additional financing. If the Other Clients were to lose their respective investments as a result of such difficulties, the ability of the Adviser to recommend actions in the best interests of the Company might be impaired. Any applicable co-investment exemptive order issued by the SEC may restrict the Company&#8217;s ability to participate in follow-on financings. Blackstone Credit &amp; Insurance may in its sole discretion take steps to reduce the potential for adversity between the Company and the Other Clients, including causing the Company and/or such Other Clients to take certain actions that, in the absence of such conflict, it would not take. Such conflicts will be more difficult if the Company and Other Clients hold significant or controlling interests in competing or different tranches of a portfolio company&#8217;s capital structure. Equity holders and debt holders have different (and often competing) motives, incentives, liquidity goals and other interests with respect to a portfolio company. In addition, there could be circumstances where Blackstone Credit &amp; Insurance agrees to implement certain procedures to ameliorate conflicts of interest that involve a forbearance of rights relating to the Company or Other Clients, such as where Blackstone Credit &amp; Insurance is expected to cause the Company or Other Clients to decline to exercise certain control-and/or foreclosure-related rights with respect to a portfolio company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the Company is prohibited under the 1940 Act from participating in certain transactions with certain of affiliates (including portfolio companies of Other Clients) without the prior approval of a majority of the independent members of the Board of Trustees and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of the outstanding voting securities may be an affiliate of the Company for purposes of the 1940 Act and generally the Company will be prohibited from buying or selling any securities from or to such affiliate, absent the prior approval of the Board of Trustees. However, the Company may under certain circumstances purchase any such affiliate&#8217;s loans or securities in the secondary market, which could create a conflict for the Adviser between the Company&#8217;s interests and the interests of such affiliate, in that the ability of the Adviser to recommend actions in the Company&#8217;s best interest may be limited. The 1940 Act also prohibits certain &#8220;joint&#8221; transactions with certain affiliates, which could include investments in the same portfolio company (whether at the same or closely related times), without prior approval of the Board of Trustees and, in some cases, the SEC.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, conflicts may arise in determining the amount of an investment, if any, to be allocated among potential investors and the respective terms thereof. There can be no assurance that any conflict will be resolved in favor of the Company, and each shareholder acknowledges and agrees that in some cases, subject to applicable law, a decision by Blackstone Credit &amp; Insurance to take any particular action could have the effect of benefiting an Other Client and therefore may not have been in the best interests of, and may be adverse to, the Company. There can be no assurance that the return on the Company&#8217;s investment will be equivalent to or better than the returns obtained by the Other Clients participating in the same or similar transactions. The shareholders will not receive any benefit from fees paid to any affiliate of the Adviser in respect of any Other Client&#8217;s investment in a portfolio company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Financing Counterparties. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may invest in companies or other entities in which Other Clients make an investment in a different part of the capital structure (and vice versa) subject to the requirements of the 1940 Act and the Company&#8217;s co-investment exemptive order. The Adviser requests in the ordinary course proposals from lenders and other sources to provide financing to the Company and its portfolio companies. Blackstone Credit &amp; Insurance takes into account various facts and circumstances it deems relevant in selecting financing sources, including whether a potential lender has expressed an interest in evaluating debt financing opportunities, whether a potential lender has a history of participating in debt financing opportunities generally and with the Firm in particular, the size of the potential lender&#8217;s loan amount, the timing of the relevant cash requirement, the availability of other sources of financing, the creditworthiness of the lender, whether the potential lender has demonstrated a long-term or continuing commitment to the success of Blackstone, Blackstone Credit &amp; Insurance and their funds, and such other factors that Blackstone and Blackstone Credit &amp; Insurance deem relevant under the circumstances. The cost of debt alone is not determinative.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that shareholders, Other Clients, their portfolio companies, co-investors and other parties with material relationships with the Firm, such as shareholders of and lenders to the Firm and lenders to Other Clients and their portfolio companies (as well as Blackstone itself), could provide additional financing to portfolio companies of the Company, subject to the requirements of the 1940 Act. The Firm could have incentives to cause the Company and its portfolio companies to accept less favorable financing terms from a shareholder, Other Clients, their portfolio companies, Blackstone, and other parties with material relationships with the Firm than it would from a third party. If the Company occupies a different, and in particular, a more senior, position in the capital structure than a shareholder, Other Client, their portfolio companies and other parties with material relationships with Blackstone, Blackstone could have an incentive to cause the Company or portfolio company to offer financing terms that are more favorable to such parties. In the case of a related party financing between the Company or its portfolio companies, on the one hand, and Blackstone or Other Clients&#8217; portfolio companies, on the other hand, to the extent permitted by the 1940 Act, the Adviser could, but is not obligated to, rely on a third party agent to confirm the terms offered by the counterparty are consistent with market terms, or the Adviser could instead rely on its own internal analysis, which the </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-15" continuedAt="f-160-16"><ix:continuation id="f-40-73" continuedAt="f-40-74"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adviser believes is often superior to third party analysis given the Firm&#8217;s scale in the market. If however any of the Firm, the Company, an Other Client or any of their portfolio companies delegates to a third party, such as another member of a financing syndicate or a joint venture partner, the negotiation of the terms of the financing, the transaction will be assumed to be conducted on an arms-length basis, even though the participation of the Firm related vehicle impacts the market terms. For example, in the case of a loan extended to the Company or a portfolio company by a financing syndicate in which an Other Client has agreed to participate on terms negotiated by a third party participant in the syndicate, it might have been necessary to offer better terms to the financing provider to fully subscribe the syndicate if the Other Client had not participated. It is also possible that the frequent participation of Other Clients in such syndicates could dampen interest among other potential financing providers, thereby lowering demand to participate in the syndicate and increasing the financing costs to the Company. The Adviser does not believe either of these effects is significant, but no assurance can be given to shareholders that these effects will not be significant in any circumstance. Unless required by applicable law, the Adviser will not seek any consent or approvals from shareholders or the Board of Trustees in the case of any of these conflicts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm could cause actions adverse to the Company to be taken for the benefit of Other Clients that have made an investment more senior in the capital structure of a portfolio company than the Company (e.g., provide financing to a portfolio company, the equity of which is owned by the Company) and, vice versa, actions may be taken for the benefit of the Company and its portfolio companies that are adverse to Other Clients. The Firm could seek to implement procedures to mitigate conflicts of interest in these situations such as (i) a forbearance of rights, including some or all non-economic rights, by the Company or relevant Other Client (or their respective portfolio companies, as the case may be) by, for example, agreeing to follow the vote of a third party in the same tranche of the capital structure, or otherwise deciding to recuse itself with respect to both normal course ongoing matters (such as consent rights with respect to loan modifications in intercreditor agreements) and also decisions on defaults, foreclosures, workouts, restructurings and other similar matters, (ii) causing the Company or relevant Other Client (or their respective portfolio companies, as the case may be) to hold only a non-controlling interest in any such portfolio company, (iii) retaining a third party loan servicer, administrative agent or other agent to make decisions on behalf of the Company or relevant Other Client (or their respective portfolio companies, as the case may be), or (iv) create groups of personnel within the Firm separated by information barriers (which may be temporary and limited purpose in nature), each of which would advise one of the clients that has a conflicting position with other clients. As an example, to the extent an Other Client holds an interest in a loan or security that is different (including with respect to relative seniority) than those held by the Company or its portfolio companies, the Firm can decline to exercise, or delegate to a third party, certain control, foreclosure and other similar governance rights of the Other Client. In these cases, the Firm would generally act on behalf of one of its clients, though the other client would generally retain certain control rights, such as the right to consent to certain actions taken by the trustee or administrative or other agent of the investment, including a release, waiver, forgiveness or reduction of any claim for principal or interest; extension of maturity date or due date of any payment of any principal or interest; release or substitution of any material collateral; release, waiver, termination or modification of any material provision of any guaranty or indemnity; subordination of any lien; and release, waiver or permission with respect to any covenants. The efficacy of following the vote of third-party creditors will be limited in circumstances where the Company or Other Client acquires all or substantially all of a relevant instrument, tranche or class of securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with negotiating loans and bank financings in respect of Blackstone Credit &amp; Insurance-sponsored transactions, Blackstone Credit &amp; Insurance will generally obtain the right to participate (for its own account or an Other Client) in a portion of the financings with respect to such Blackstone Credit &amp; Insurance-sponsored transactions on the same terms negotiated by third parties with the Firm or other terms the Adviser determines to be consistent with the market. Although the Firm could rely on third parties to verify market terms, the Firm may nonetheless have influence on such third parties. No assurance can be given that negotiating with a third party, or verification of market terms by a third party, will ensure that the Company and its portfolio companies receive market terms.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, it is anticipated that in a bankruptcy proceeding the Company&#8217;s interests will likely be subordinated or otherwise adverse to the interests of Other Clients with ownership positions that are more senior to those of the Company. For example, an Other Client that has provided debt financing to an investment of the Company will be permitted to take actions for its benefit, particularly if the Company&#8217;s investment is in financial distress, which adversely impact the value of the Company&#8217;s subordinated interests.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Other Clients can be expected to provide financing to the Company and its portfolio companies subject to the requirements of the 1940 Act, there can be no assurance that any Other Client will indeed provide any such financing with respect to any particular investment. Participation by Other Clients in some but not all financings of the Company and its portfolio companies has the potential to adversely impact the ability of the Company and its portfolio companies to obtain financing from third parties when Other Clients do not participate, as it could serve as a negative signal to market participants.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-16" continuedAt="f-160-17"><ix:continuation id="f-40-74" continuedAt="f-40-75"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any financing provided by a shareholder or an affiliate to the Company or a portfolio company is not an investment in the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The respective investment programs of the Company and the Other Clients may or may not be substantially similar. Blackstone Credit &amp; Insurance and/or Blackstone may give advice to, and recommend securities for, Other Clients that may differ from advice given to, or securities recommended or bought for, the Company, even though their investment objectives may be the same as or similar to those of the Company. While Blackstone Credit &amp; Insurance will seek to manage potential conflicts of interest in a fair and equitable manner, the portfolio strategies employed by Blackstone Credit &amp; Insurance and Blackstone in managing their respective Other Clients are likely to conflict from time to time with the transactions and strategies employed by the Adviser in managing the Company and may affect the prices and availability of the securities and instruments in which the Company invests. Participation in specific investment opportunities may be appropriate, at times, for both the Company and Other Clients. In any event, it is the policy of Blackstone Credit &amp; Insurance to allocate investment opportunities and sale opportunities on a basis deemed by Blackstone Credit &amp; Insurance, in its sole discretion, to be fair and equitable over time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conflicting Fiduciary Duties to Debt Funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Other Clients include funds and accounts that make investments in senior secured loans, distressed debt, subordinated debt, high-yield securities, commercial mortgage-backed securities and other debt instruments. As discussed above, it is expected that these Other Clients or investors therein will be offered the opportunity, subject to applicable law, to provide financing with respect to investments made by the Company and its portfolio companies. The Firm owes a fiduciary duty and/or other obligations to these Other Clients as well as to the Company and will encounter conflicts in the exercise of these duties and/or obligations. For example, if an Other Client purchases high-yield securities or other debt instruments of a portfolio company of the Company, or otherwise occupies a senior (or other different) position in the capital structure of an investment relative to the Company, the Firm will encounter conflicts in providing advice to the Company and to these Other Clients with regard to appropriate terms of such high-yield securities or other instruments, the enforcement of covenants, the terms of recapitalizations and the resolution of workouts or bankruptcies, among other matters. For example, in a bankruptcy proceeding, in circumstances where the Company holds an equity investment in a portfolio company, the holders of such portfolio company&#8217;s debt instruments (which can include one or more Other Clients) could take actions for their benefit (particularly in circumstances where such portfolio company faces financial difficulties or distress) that subordinate or adversely impact the value of the Company&#8217;s investment in such portfolio company. More commonly, the Company could hold an investment that is senior in the capital structure, such as a debt instrument, to an Other Client. Although measures described in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Financing Counterparties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; above can mitigate these conflicts, they cannot completely eliminate them. These conflicts related to fiduciary duties to such Other Clients will not necessarily be resolved in favor of the Company, and investors will not always be entitled to receive notice or disclosure of the occurrence of these conflicts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, certain Other Clients can be expected to invest in securities of publicly traded companies that are actual or potential investments of the Company or its portfolio companies. The trading activities of those vehicles can differ from or be inconsistent with activities that are undertaken for the account of the Company or its portfolio companies in any such securities or related securities. In addition, the Company could not pursue an investment in a portfolio company otherwise within the investment mandate of the Company as a result of such trading activities by Other Clients. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Blackstone and Blackstone Credit &amp; Insurance Clients; Allocation of Investment Opportunities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain inherent conflicts of interest arise from the fact that the Adviser, Blackstone Credit &amp; Insurance and Blackstone provide investment management, advisory and sub-advisory services to the Company and Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance and/or Blackstone may give advice to, and recommend securities for, Other Clients that may differ from advice given to, or securities recommended or bought for, the Company, even though their investment objectives may be the same as or similar to those of the Company. Blackstone Credit &amp; Insurance has adopted guidelines and policies, which can be expected to be updated from time to time, regarding allocation of investment opportunities. While Blackstone Credit &amp; Insurance will seek to manage potential conflicts of interest in a fair and equitable manner, the portfolio strategies employed by Blackstone Credit &amp; Insurance and Blackstone in managing their respective Other Clients are likely to conflict from time to time with the transactions and strategies employed by the Adviser in managing the Company and may affect the prices and availability of the securities and instruments in which the Company invests. Participation in specific investment opportunities may be appropriate, at times, for both the Company and Other Clients.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-17" continuedAt="f-160-18"><ix:continuation id="f-40-75" continuedAt="f-40-76"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance provides investment management services to Other Blackstone Credit &amp; Insurance Clients. In addition, Blackstone provides investment management services to Blackstone Clients. Blackstone Credit &amp; Insurance will share appropriate investment opportunities (and sale opportunities) (including, without limitation, secondary market transactions and certain syndicated primary issuance transactions (which generally will not be originated investments)) with Other Clients and the Company in accordance with Firm-wide allocation policies, which generally provide for sharing pro rata based on targeted acquisition size (generally based on available capacity) or targeted sale size (or, in some sales cases, the aggregate positions held by the Company and the applicable Other Clients), taking into account actual and anticipated investments and capital commitments (as appropriate), available cash, asset-based leverage and relative capital of the Company and the applicable Other Clients and such other factors as Blackstone Credit &amp; Insurance determines in good faith to be appropriate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent an opportunity is shared with one or more Other Clients, Blackstone Credit &amp; Insurance expects that such Other Clients generally will invest on substantially the same economic terms available to the Company (including sharing of transaction fees and expenses) and generally will exit investments at the same time and on substantially the same economic terms as the Company, and on a pro rata basis with the Company subject to legal, tax, regulatory, accounting or applicable considerations (including the terms of the governing agreements of, or portfolio management considerations applicable to, the Company or such Other Clients); provided that the Company may syndicate a portion of an investment where Other Clients do not also syndicate a portion of the investment. (See also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Transactions with Clients of Blackstone Insurance Solutions and Asset Based Finance.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allocation Methodology Considerations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, Blackstone Credit &amp; Insurance may also consider the following factors in making any allocation determinations, and such factors may result in a different allocation of investment and/or sale opportunities: (i)&#160;the risk-return and target return profile of the proposed investment relative to the Company&#8217;s and the Other Clients&#8217; current risk profiles; (ii)&#160;the Company&#8217;s and/or the Other Clients&#8217; investment strategies, mandates, guidelines, limitations, restrictions, terms and objectives (including whether such objectives are considered solely in light of the specific investment under consideration or in the context of the respective portfolios&#8217; overall holdings), other contractual provisions (including Other Clients with minimum allocation provisions), focus (including investment focus on a classification attributable to an investment, such as maturity), parameters and investor preferences of the Company and the Other Clients (including, without limitation, with respect to Other Clients that expect to invest in or alongside other funds or across asset classes based on expected return (such as certain managed accounts or other investment vehicles (whether now in existence or which may be established in the future)) with similar investment strategies and objectives); (iii) diversification and concentration considerations in the Company&#8217;s or the Other Clients&#8217; portfolios (including the potential for the proposed investment to create an industry, sector, geography, region, location, market or issuer imbalance in the Company&#8217;s and Other Clients&#8217; portfolios, as applicable) and taking into account any existing non-pro rata investment positions in the portfolio of the Company and Other Clients; (iv)&#160;liquidity considerations of the Company and the relevant Other Clients (including warehouse vehicles or arrangements (such as CLO warehouses and Blackstone-controlled or third party warehouse arrangements) established for the benefit of current Other Clients or potential future Other Clients), including during a ramp-up (which includes the period prior to or after the initial closing of an Other Client during which its manager is deploying funds already invested or committed (or that its manager anticipates will be invested or committed) and can continue for a period during an Other Client&#8217;s fundraising and/or acceptance of future subscriptions as deemed appropriate by the Firm, including to protect against zero or de minimis allocations or in anticipation of future subscriptions) or wind-down of one or more of the Company or such Other Clients, proximity to the end of the Company&#8217;s or Other Clients&#8217; specified term or investment period, any redemption/withdrawal requests, anticipated future contributions and available cash; (v)&#160;legal, tax, accounting and other considerations or consequences; (vi)&#160;regulatory or contractual provisions, obligations, terms, limitations, restrictions or consequences relating to the Company or Other Clients (including, without limitation, requirements under the 1940 Act and any related rules, orders, guidance or other authority applicable to the Company or Other Clients); (vii) avoiding a de minimis or odd lot allocation; (viii)&#160;availability and degree of leverage and any requirements or other terms of the investment, or of any existing leverage facilities; (ix)&#160;the Company&#8217;s or Other Clients&#8217; investment focus on a classification attributable to an investment or issuer of an investment, including, without limitation, investment strategy, geography, location, industry or business sector; (x)&#160;the nature and extent of involvement in the transaction on the part of the respective teams of investment professionals dedicated to the Company or such Other Clients; (xi)&#160;the management of any actual or potential conflict of interest; (xii)&#160;with respect to investments that are made available to Blackstone Credit &amp; Insurance by counterparties pursuant to negotiated trading platforms (e.g., ISDA contracts), the absence of such relationships which may not be available for the Company and all Other Clients; (xiii)&#160;co-investment arrangements, (xiv)&#160;available capital of the Company and such Other Clients, (xv) sourcing of the investment, (xvi)&#160;the specific nature (including size, type, amount, liquidity, holding period, anticipated maturity and minimum investment criteria) of the investment, (xvii)&#160;expected investment return, (xviii)&#160;expected cash characteristics (such as cash-on-cash yield, distribution rates or volatility of cash flows), (xix) capital expenditure required </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-18" continuedAt="f-160-19"><ix:continuation id="f-40-76" continuedAt="f-40-77"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as part of the investment, (xx)&#160;portfolio diversification and concentration concerns (including, but not limited to, whether a particular fund already has its desired exposure to the investment, sector, industry, geographic region or markets in question), (xxi) relation to existing investments in a fund, if applicable (e.g., &#8220;follow on&#8221; to existing investment, joint venture or other partner to existing investment, or same security as existing investment), (xxii) timing expected to be necessary to execute an investment, (xxiii) whether Blackstone Credit &amp; Insurance believes that allocating investment opportunities to an investor will help establish, recognize, strengthen and/or cultivate relationships that may provide indirectly longer-term benefits (including strategic, sourcing or similar benefits) to the Company, Other Clients and/or Blackstone and (xxiv) any other considerations deemed relevant by Blackstone Credit &amp; Insurance in good faith.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the requirements of the 1940 Act and the Company&#8217;s co-investment exemptive order, Blackstone Credit &amp; Insurance shall not have any obligation to present any investment opportunity (or portion of any investment opportunity) to the Company if Blackstone Credit &amp; Insurance determines in good faith that such opportunity (or portion thereof) should not be presented to the Company, including for any one or a combination of the reasons described above, or if Blackstone Credit &amp; Insurance is otherwise restricted from presenting such investment opportunity to the Company. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Alongside Regulated Funds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition,&#160;Blackstone Credit &amp; Insurance has received an exemptive order from the SEC that permits certain existing and future Other Blackstone Credit &amp; Insurance Clients that are closed-end management investment companies that have elected to be regulated as a BDC or are registered under the 1940 Act and who intend to rely on the exemptive order (each a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Regulated Fund&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and collectively, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Regulated Funds&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), including the Company, among other things, to co-invest with certain other persons, including certain affiliates of Blackstone Credit &amp; Insurance, and certain funds managed and controlled by Blackstone Credit &amp; Insurance and its affiliates, including the Company and Other Blackstone Credit &amp; Insurance Clients, subject to certain terms and conditions. For so long as any privately negotiated investment opportunity falls within certain established investment criteria of one or more Regulated Funds, such investment opportunity shall also be offered to such Regulated Fund(s). In the event that the aggregate targeted investment sizes of the Company, such Other Blackstone Credit &amp; Insurance Clients and such Regulated Fund(s) that are allocated an investment opportunity exceed the amount of such investment opportunity, allocation of such investment opportunity to each of the Company, such Other Blackstone Credit &amp; Insurance Clients and Regulated Fund(s) will be reduced proportionately based on their respective &#8220;available capital&#8221; as defined in the co-investment exemptive order, which may result in allocation to the Company in an amount less than what it would otherwise have been if such Other Blackstone Credit &amp; Insurance Client(s) and Regulated Fund(s) did not participate in such investment opportunity. The co-investment exemptive order also restricts the ability of the Company (or any such Other Blackstone Credit &amp; Insurance Client) from investing in any privately negotiated investment opportunity alongside a Regulated Fund except at the same time and on same terms, as described in the exemptive order. As a result, the Company risks being unable to make investments in different parts of the capital structure of the same issuer in which a Regulated Fund has invested or seeks to invest, and Regulated Funds risk being unable to make investments in different parts of the capital structure of the same issuer in which the Company has invested or seeks to invest. The Company may be unable to participate in or effect certain transactions, or take certain actions in respect of certain investments, on account of applicable restrictions under the 1940 Act, related guidance from the SEC and/or the Company&#8217;s exemptive order.&#160;For example, the Company may be restricted from participating in certain transactions or taking certain actions in respect of portfolio companies in which certain funds managed and controlled by Blackstone Credit &amp; Insurance and its affiliates and/or a Regulated Fund has also invested, which may include, but is not limited to declining to vote, participating in a potential co-investment opportunity (as such participation may not comply with the conditions of the co-investment exemptive order), exercising rights with respect to any such investment, and/or declining to participate in follow-on investments. The Company may also be required to sell an investment to avoid potential violations of the 1940 Act and/or related rules thereunder or for other reasons. In such cases, the Company&#8217;s interests in an investment may be adversely affected, including by resulting in the dilution of or decrease in the value of the Company&#8217;s investment, or otherwise by resulting in the Company being put in a disadvantageous position with respect to the investment as compared to Other Blackstone Credit &amp; Insurance Clients, including other Regulated Funds. Whether the Company participates or declines to participate in any such action or transaction will be made by the Adviser in its sole discretion and will take into account the Adviser&#8217;s fiduciary duties and applicable law, including the 1940 Act, the rules thereunder and/or the exemptive order. There is no assurance that any such determination will be resolved in favor of the Company&#8217;s interests. The rules promulgated by the SEC under the 1940 Act, as well as any related guidance from the SEC and/or the terms of the exemptive order itself, are subject to change, and Blackstone Credit &amp; Insurance could undertake to amend the exemptive order (subject to SEC approval), obtain additional exemptive relief, or otherwise be subject to other requirements in respect of co-investments involving the Company, any Other Blackstone Credit &amp; Insurance Client and any Regulated Funds, any of which could impact the amount of any allocation made available to Regulated Funds and thereby affect (and potentially decrease) the allocation made to the Company.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-19" continuedAt="f-160-20"><ix:continuation id="f-40-77" continuedAt="f-40-78"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, with respect to Blackstone Credit &amp; Insurance&#8217;s ability to allocate investment opportunities, including where such opportunities are within the common objectives and guidelines of the Company and one or more Other Clients (which allocations are to be made on a basis that Blackstone Credit &amp; Insurance believes in good faith to be fair and reasonable), Blackstone Credit &amp; Insurance and Blackstone have established general guidelines and policies, which it can be expected to update from time to time, for determining how such allocations are to be made, which, among other things, set forth principles regarding what constitutes &#8220;debt&#8221; or &#8220;debt-like&#8221; investments, criteria for defining &#8220;control-oriented equity&#8221; or &#8220;infrastructure&#8221; investments, guidance regarding allocation for certain types of investments (e.g., distressed assets) and other matters. In addition, certain Other Clients can receive certain priority or other allocation rights with respect to certain investments, subject to various conditions set forth in such Other Clients&#8217; respective governing agreements. The application of those guidelines and conditions could result in the Company or Other Clients not participating (and/or not participating to the same extent) in certain investment opportunities in which they would have otherwise participated had the related allocations been determined without regard to such guidelines and conditions and based only on the circumstances of those particular investments. Additionally, investment opportunities sourced by Blackstone Credit &amp; Insurance will be allocated in accordance with Blackstone&#8217;s and Blackstone Credit &amp; Insurance&#8217;s allocation policies, which provide that investment opportunities will be allocated in whole or in part to other business units of the Firm on a basis that Blackstone and Blackstone Credit &amp; Insurance believe in good faith to be fair and reasonable, based on various factors, including the involvement of the respective teams from Blackstone Credit &amp; Insurance and such other business units. It should also be noted that investment opportunities sourced by business units of the Firm other than Blackstone Credit &amp; Insurance will be allocated in accordance with such business units&#8217; allocation policies, which will result in such investment opportunities being allocated, in whole or in part, away from Blackstone Credit &amp; Insurance, the Company and Other Blackstone Credit &amp; Insurance Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Blackstone Credit &amp; Insurance determines not to pursue some or all of an investment opportunity for the Company that would otherwise be within the Company&#8217;s objectives and strategies, and Blackstone or Blackstone Credit &amp; Insurance provides the opportunity or offers the opportunity to Other Clients (or other parties, including portfolio companies), Blackstone or Blackstone Credit &amp; Insurance, including their personnel (including Blackstone Credit &amp; Insurance personnel), will, in certain circumstances, receive compensation from the Other Clients and/or other parties, whether or not in respect of a particular investment, including an allocation of carried interest or referral fees, and any such compensation could be greater than amounts paid by the Company to Blackstone Credit &amp; Insurance. As a result, Blackstone Credit &amp; Insurance (including Blackstone Credit &amp; Insurance personnel who receive such compensation) could be incentivized to allocate investment opportunities away from the Company to or source investment opportunities for Other Clients and/or other parties. In addition, in some cases Blackstone or Blackstone Credit &amp; Insurance can be expected to earn greater fees when Other Clients participate alongside or instead of the Company in an investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance makes good faith determinations for allocation decisions based on expectations that will, in certain circumstances, prove inaccurate. Information unavailable to Blackstone Credit &amp; Insurance, or circumstances not foreseen by Blackstone Credit &amp; Insurance at the time of allocation, can cause an investment opportunity to yield a different return than expected. Conversely, an investment that Blackstone Credit &amp; Insurance expects to be consistent with the Company&#8217;s return objectives will, in certain circumstances, fail to achieve them.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser is permitted, but will be under no obligation to, provide co-investment opportunities relating to investments made by the Company to Fund shareholders, Other Clients, investors in such Other Clients, subject to the Company&#8217;s exemptive relief and the 1940 Act. Such co-investment opportunities may be offered to such parties in the Adviser&#8217;s discretion subject to the Company&#8217;s exemptive relief. From time to time, Blackstone Credit &amp; Insurance may form one or more funds or accounts to co-invest in transactions with the Company (or transactions alongside any of the Company and one or more Other Clients). Furthermore, for the avoidance of doubt, to the extent that the Company has received its target amount in respect of an investment opportunity, any remaining portion of such investment opportunity initially allocated to the Company may be allocated to Other Clients or to co-investors in Blackstone Credit &amp; Insurance&#8217;s discretion pursuant to the Company&#8217;s exemptive relief.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Orders may be combined for the Company and other participating Other Clients, and if any order is not filled at the same price, they may be allocated on an average price basis. Similarly, if an order on behalf of more than one account cannot be fully executed under prevailing market conditions, securities may be allocated among the different accounts on a basis that Blackstone Credit &amp; Insurance or its affiliates consider equitable.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-20" continuedAt="f-160-21"><ix:continuation id="f-40-78" continuedAt="f-40-79"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, it can be expected that the Firm will, from time to time, enter into arrangements or strategic relationships with third parties, including other asset managers, financial firms or other businesses or companies, that, among other things, provide for referral, sourcing or sharing of investment opportunities. Blackstone or Blackstone Credit &amp; Insurance may pay management fees and performance-based compensation in connection with such arrangements. Blackstone or Blackstone Credit &amp; Insurance may also provide for or receive reimbursement of certain expenses incurred or received in connection with these arrangements, including diligence expenses and general overhead, administrative, deal sourcing and related corporate expenses. The amount of these rebates may relate to allocations of co-investment opportunities and increase if certain co-investment allocations are not made. While it is possible that the Company will, along with the Firm itself, benefit from the existence of those arrangements and/or relationships, it is also possible that investment opportunities that would otherwise be presented to or made by the Company would instead be referred (in whole or in part) to such third party, or, as indicated above, to other third parties, either as a contractual obligation or otherwise, resulting in fewer opportunities (or reduced allocations) being made available to the Company and/or shareholders. This means that co-investment opportunities that are sourced by the Company may be allocated to investors that are not shareholders. For example, a firm with which the Firm has entered into a strategic relationship may be afforded with &#8220;first-call&#8221; rights on a particular category of investment opportunities, although there is not expected to be substantial overlap in the investment strategies and/or objectives between the Company and any such firm. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Investments Inside the Company&#8217;s Mandate that are not Pursued by the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under certain circumstances, Blackstone or Blackstone Credit &amp; Insurance can be expected to determine not to pursue some or all of an investment opportunity within the Company&#8217;s mandate, including without limitation, as a result of business, reputational or other reasons applicable to the Company, Other Clients, their respective portfolio companies or Blackstone. In addition, Blackstone Credit &amp; Insurance will, in certain circumstances, determine that the Company should not pursue some or all of an investment opportunity, including, by way of example and without limitation, because the Company has already invested sufficient capital in the investment, sector, industry, geographic region or markets in question, as determined by Blackstone Credit &amp; Insurance in its good faith discretion, or the investment is not appropriate for the Company for other reasons as determined by Blackstone Credit &amp; Insurance in its good faith reasonable sole discretion. In any such case Blackstone or Blackstone Credit &amp; Insurance could, thereafter, offer such opportunity to other parties, including Other Clients or portfolio companies or limited partners or shareholders of the Company or Other Clients, joint venture partners, related parties or third parties. Any such Other Clients could be advised by a different Blackstone or Blackstone Credit &amp; Insurance business group with a different investment committee, which could determine an investment opportunity to be more attractive than Blackstone Credit &amp; Insurance believes to be the case. In any event, there can be no assurance that Blackstone Credit &amp; Insurance&#8217;s assessment will prove correct or that the performance of any investments actually pursued by the Company will be comparable to any investment opportunities that are not pursued by the Company. Blackstone and Blackstone Credit &amp; Insurance, including their personnel, are permitted to receive compensation from any such party that makes the investment, including an allocation of carried interest or referral fees, and any such compensation could be greater than amounts paid by the Company to Blackstone Credit &amp; Insurance. In some cases, Blackstone or Blackstone Credit &amp; Insurance earns greater fees when Other Clients participate alongside or instead of the Company in an investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Situations can arise where certain assets held by the Company are transferred to Other Clients and vice versa. Such transactions will be conducted in accordance with, and subject to, the Adviser&#8217;s contractual obligations to the Company and applicable law, including the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Co-Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will co-invest with its shareholders, limited partners and/or shareholders of the Other Clients, the Firm&#8217;s affiliates and other parties with whom Blackstone Credit &amp; Insurance has a material relationship. The allocation of co-investment opportunities is entirely and solely in the discretion of Blackstone Credit &amp; Insurance, subject to applicable law. In addition to participation by Consultants in specific transactions or investment opportunities, Consultants and/or other Firm employees may be permitted to participate in the Firm&#8217;s side-by-side co-investment rights. Such rights generally do not provide for an advisory fee or carried interest payable by participants therein and generally result in the Company being allocated a smaller share of an investment than would otherwise be the case in the absence of such side-by-side. Furthermore, Other Clients will be permitted (or have a preferred right) to participate in the Firm&#8217;s side-by-side co-investment rights.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-21" continuedAt="f-160-22"><ix:continuation id="f-40-79" continuedAt="f-40-80"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain circumstances, Blackstone Credit &amp; Insurance will determine that a co-investment opportunity should be offered to one or more third parties (such investors, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Co-Investors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and will maintain sole discretion with respect to which Co-Investors are offered any such opportunity. It is expected that many investors who will, in certain circumstances, have expressed an interest in co-investment opportunities will not be allocated any co-investment opportunities or will, in certain circumstances, receive a smaller amount of co-investment opportunities than the amount requested. Any co-investments offered by Blackstone Credit &amp; Insurance will be on such terms and conditions (including with respect to advisory fees, performance-based compensation and related arrangements and/or other fees applicable to co-investors) as Blackstone Credit &amp; Insurance determines to be appropriate in its sole discretion on a case-by-case basis, which may differ amongst co-investors with respect to the same co-investment. In addition, the performance of Other Clients co-investing with the Company is not considered for purposes of calculating the incentive fee payable by the Company to the Adviser. Furthermore, the Company and co-investors will often have different investment objectives and limitations, such as return objectives and maximum hold period. Blackstone Credit &amp; Insurance, as a result, will have conflicting incentives in making decisions with respect to such opportunities. Even if the Company and any such parties invest in the same securities on similar terms, conflicts of interest will still arise as a result of differing investment profiles of the investors, among other items.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">General Co-Investment Considerations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There are expected to be circumstances where an amount that would otherwise have been invested by the Company is instead allocated to co-investors (who could be shareholders of the Company or limited partners of Other Clients) or supplemental capital vehicles, and there is no guarantee that any shareholders will be offered any particular co-investment opportunity. Each co-investment opportunity (should any exist) is likely to be different, and allocation of each such opportunity will depend on the facts and circumstances specific to that unique situation (e.g., timing, industry, size, geography, asset class, projected holding period, exit strategy and counterparty). Different situations will require that the various facts and circumstances of each opportunity be weighted differently, as Blackstone Credit &amp; Insurance deems relevant to such opportunity. Such factors are likely to include, among others, whether a co-investor adds strategic value, industry expertise or other similar synergies; whether a potential co-investor has expressed an interest in evaluating co-investment opportunities; whether a potential co-investor has an overall strategic relationship with the Firm; whether a potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of Blackstone, Blackstone Credit &amp; Insurance, the Company, Other Clients or other co-investments (including whether a potential co-investor will help establish, recognize, strengthen and/or cultivate relationships that can provide indirectly longer-term benefits to the Company or Other Clients and their respective underlying portfolio companies, or whether the potential co-investor has significant capital under management by the Firm or intends to increase such amount); the ability of a potential co-investor to commit to a co-investment opportunity within the required timeframe of the particular transaction; Blackstone Credit &amp; Insurance&#8217;s assessment of a potential co-investor&#8217;s ability to invest an amount of capital that fits the needs of the investment (taking into account the amount of capital needed as well as the maximum number of investors that can realistically participate in the transaction); whether the co-investor is considered &#8220;strategic&#8221; to the investment because it is able to offer the Company certain benefits, including but not limited to, the ability to help consummate the investment, the ability to aid in operating or monitoring the portfolio company or the possession of certain expertise; the transparency, speed and predictability of the potential co-investor&#8217;s investment process; whether the Firm has previously expressed a general intention to seek to offer co-investment opportunities to such potential co-investor; whether a potential co-investor has the financial and operational resources and other relevant wherewithal to evaluate and participate in a co-investment opportunity; the familiarity the Firm has with the personnel and professionals of the investor in working together in investment contexts (which may include such potential co-investor&#8217;s history of investment in other Firm co-investment opportunities); the extent to which a potential co-investor has committed to an Other Client; the size of such potential co-investor&#8217;s interest to be held in the underlying portfolio company as a result of the Company&#8217;s investment (which is likely to be based on the size of the potential co-investor&#8217;s capital commitment or investment in the Company); the extent to which a potential co-investor has been provided a greater amount of co-investment opportunities relative to others; the ability of a potential co-investor to invest in potential add-on acquisitions for the portfolio company or participate in defensive investments; the likelihood that the potential co-investor would require governance rights that would complicate or jeopardize the transaction (or, alternatively, whether the investor would be willing to defer to the Firm and assume a more passive role in governing the portfolio company); any interests a potential co-investor might have in any competitors of the underlying portfolio company; the tax profile of the potential co-investor and the tax characteristics of the investment (including whether the potential co-investor would require particular structuring implementation or covenants that would not otherwise be required but for its participation or whether such co-investor&#8217;s participation is beneficial to the overall structuring of the investment); whether a potential co-investor&#8217;s participation in the transaction would subject the Company and/or the portfolio company to additional regulatory requirements, review and/or scrutiny, including any necessary governmental approvals required to consummate the investment; the potential co-investor&#8217;s interaction with the potential management team of the </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-22" continuedAt="f-160-23"><ix:continuation id="f-40-80" continuedAt="f-40-81"><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">portfolio company; whether the potential co-investor has any existing positions in the portfolio company (whether in the same security in which the Company is investing or otherwise); whether there is any evidence to suggest that there is a heightened risk with respect to the potential co-investor maintaining confidentiality; whether the potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of the Company, other affiliated funds and/or other co-investments, including the size of such commitment; whether the potential co-investor has any known investment policies and restrictions, guideline limitations or investment objectives that are relevant to the transaction, including the need for distributions; whether the expected holding period and risk-return profile of the investment is consistent with the stated goals of the investor; and such other factors as the Adviser deems relevant and believes to be appropriate under the circumstances. Furthermore, in connection with any such co-investment by third-party co-investors, the Adviser can establish one or more investment vehicles managed or advised by the Firm to facilitate such co-investors&#8217; investment alongside the Company. The factors listed in the foregoing sentence are neither presented in order of importance nor weighted, except that Blackstone Credit &amp; Insurance has historically primarily relied upon the following two factors in making the determination to offer co-investment opportunities to co-investors: (i) whether the potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of the Company (including whether a potential co-investor will help establish, recognize, strengthen and/or cultivate relationships that can provide indirectly longer-term benefits to the Company or Other Clients and their respective underlying portfolio companies), other affiliated funds, and/or other co-investments, including the size of any such commitment and fee revenue or profits generated for the benefit of Blackstone Credit &amp; Insurance or Blackstone as a result thereof and (ii) the ability of a potential co-investor to process a co-investment decision within the required timeline of the particular transaction. Except as otherwise described herein, co-investors generally will not share Broken Deal Expenses with the Company and Other Clients, with the result that the Company and such Other Clients will bear all such Broken Deal Expenses, and such expenses can be significant. However, the Adviser does not intend to offer any such co-investment opportunities to shareholders in their capacity as shareholders. Blackstone Credit &amp; Insurance may (but is not required to) establish co-investment vehicles (including dedicated or &#8220;standing&#8221; co-investment vehicles) for one or more investors (including third party investors and investors in the Company) in order to co-invest alongside the Company in one or more future investments. The existence of these vehicles could reduce the opportunity for other shareholders to receive allocations of co-investment. In addition, the allocation of investments to Other Clients, including as described under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Other Blackstone and Blackstone Credit &amp; Insurance Clients; Allocation of Investment Opportunities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein, may result in fewer co-investment opportunities (or reduced allocations) being made available to shareholders.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Additional Potential Conflicts of Interest with respect to Co-Investment; Strategic Relationships Involving Co-Investment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition, the Adviser and/or its affiliates will in certain circumstances be incentivized to offer certain potential co-investors (including, by way of example, as a part of an overall strategic relationship with the Firm) opportunities to co-invest because the extent to which any such co-investor participates in (or is offered) co-investment opportunities can impact the amount of performance-based compensation and/or management fees or other fees paid by the co-investor. The amount of carried interest or expenses charged and/or management fees paid by the Company may be less than or exceed such amounts charged or paid by co-investment vehicles pursuant to the terms of such vehicles&#8217; partnership agreements and/or other agreements with co-investors, and such variation in the amount of fees and expenses may create an economic incentive for Blackstone Credit &amp; Insurance to allocate a greater or lesser percentage of an investment opportunity to the Company or such co-investment vehicles or co-investors, as the case may be. In addition, other terms of existing and future co-investment vehicles may differ materially, and in some instances may be more favorable to Blackstone Credit &amp; Insurance, than the terms of the Company, and such different terms may create an incentive for Blackstone Credit &amp; Insurance to manage such vehicles, which could result in the Company receiving a lesser percentage of an investment opportunity than if such co-investment vehicles did not exist. Such relationships will from time to time give rise to conflicts of interest, and there can be no assurance that such conflicts of interest will be resolved in favor of the Company. Accordingly, any investment opportunities that would have otherwise been offered or allocated, in whole or in part, to the Company can be reduced and made available to co-investment vehicles. Co-investments may be offered by the Adviser on such terms and conditions as the Adviser determines in its discretion on a case-by-case basis.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-23" continuedAt="f-160-24"><ix:continuation id="f-40-81" continuedAt="f-40-82"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fund Co-Investment Opportunities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a BDC regulated under the 1940 Act, the Company is subject to certain limitations relating to co-investments and joint transactions with affiliates, which likely will in certain circumstances limit the Company&#8217;s ability to make investments or enter into other transactions alongside the Other Clients. There can be no assurance that such regulatory restrictions will not adversely affect the Company&#8217;s ability to capitalize on attractive investment opportunities. However, subject to the 1940 Act and any applicable co-investment exemptive order issued by the SEC, the Company may co-invest with Other Clients (including co-investment or other vehicles in which the Firm or its personnel invest and that co-invest with such Other Clients) in investments that are suitable for the Company and one or more of such Other Clients. Even if the Company and any such Other Clients and/or co-investment or other vehicles invest in the same securities, conflicts of interest may still arise.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions. Such order may restrict our ability to enter into follow-on investments or other transactions. Pursuant to such order, we may co-invest in a negotiated deal with certain affiliates of the Adviser or certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions. We may also receive an allocation in such a deal alongside affiliates pursuant to other mechanisms to the extent permitted by the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Portfolio Companies Alongside Other Clients. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company will co-invest with Other Clients (including co-investment or other vehicles in which the Firm or its personnel invest and that co-invest with such Other Clients) in investments that are suitable for both the Company and such Other Clients, as permitted by applicable law and/or any applicable SEC-granted order. Even if the Company and any such Other Clients invest in the same securities or loans, conflicts of interest are still expected to arise. For example, it is possible that as a result of legal, tax, regulatory, accounting, political, national security or other considerations, the terms of such investment (and divestment thereof) (including with respect to price and timing) for the Company and such other funds and vehicles are not the same. Additionally, the Company and such Other Clients and/or vehicles will generally have different investment periods and/or investment objectives (including return profiles) and Blackstone Credit &amp; Insurance, as a result, could have conflicting goals with respect to the amount, price and timing of disposition opportunities. As such, subject to applicable law and any applicable order issued by the SEC, the Company and/or such Other Clients may dispose of any such shared investment at different times and on different terms.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Firm Involvement in Financing of Third Party Dispositions by the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company is permitted from time to time dispose of all or a portion of an investment by way of accepting a third-party purchaser&#8217;s bid where the Firm or one or more Other Clients is providing financing as part of such bid or acquisition of the investment or underlying assets thereof. This generally would include the circumstance where the Firm or one or more Other Clients is making commitments to provide financing at or prior to the time such third-party purchaser commits to purchase such investments or assets from the Company. Such involvement of the Firm or one or more Other Clients as such a provider of debt financing in connection with the potential acquisition of portfolio investments by third parties from the Company may give rise to potential or actual conflicts of interest.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Self-Administration of the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance expects to provide certain fund administration services to the Company rather than engage or rely on a third party administrator to perform such services. The costs for providing these services are not included in the management fee under the Investment Advisory Agreement and will be paid separately by the Company. Blackstone Credit &amp; Insurance also reserves the right to charge the Company a reduced rate for these services, or to reduce or waive such charges entirely, subject to the 1940 Act. Blackstone Credit &amp; Insurance&#8217;s ability to determine the reimbursement obligation from the Company creates a conflict of interest. Blackstone Credit &amp; Insurance addresses this conflict by reviewing its fund administration costs to ensure that it is comparable and fair with regard to equivalent services performed by a non-affiliated third party at a rate negotiated on an arm&#8217;s length basis. The Board of Trustees periodically reviews the reimbursement obligation.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-24" continuedAt="f-160-25"><ix:continuation id="f-40-82" continuedAt="f-40-83"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Outsourcing. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the oversight and, in certain circumstances, approval by the Board of Trustees of the Company, Blackstone may outsource to third parties several of the services performed for the Company and/or its portfolio entities, including services (such as administrative, legal, accounting, tax, diligence, modeling, ongoing monitoring, preparation of internal templates and/or memos or other related services) that may be or historically have been performed in-house by Blackstone and its personnel. For certain third-party service providers, the fees, costs and expenses of such service providers will be borne by the Company, and in other circumstances, the fees, costs and expenses of such service providers will be borne by Blackstone. Certain third-party service providers and/or their employees will dedicate substantially all of their business time to the Company, Other Clients and/or their respective portfolio entities, while others will have other clients. In certain cases, third-party service providers and/or their employees may spend a significant amount of time at Blackstone offices, have dedicated office space at Blackstone, receive administrative support from Blackstone personnel or participate in meetings and events for Blackstone personnel, even though they are not Blackstone employees or affiliates. This creates a conflict of interest because Blackstone will have an incentive to outsource services to third parties due to a number of factors, including because retaining third parties will reduce Blackstone&#8217;s internal overhead and compensation costs for employees who would otherwise perform such services in-house.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The involvement of third-party service providers may present a number of risks due to Blackstone&#8217;s reduced control over the functions that are outsourced. There can be no assurances that Blackstone will be able to identify, prevent or mitigate the risks of engaging third-party service providers. The Company may suffer adverse consequences from actions, errors or failures to act by such third parties, and will have obligations, including indemnity obligations, and limited recourse against them. Outsourcing may not occur uniformly for all Blackstone managed vehicles and accounts and, accordingly, certain costs may be incurred by (or allocated to) the Company through the use of third-party service providers that are not incurred by (or allocated to) Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material, Non-Public Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance will come into possession of confidential information with respect to an issuer and other actual or prospective portfolio companies. Blackstone Credit &amp; Insurance can be restricted from buying, originating or selling securities, loans, or derivatives on behalf of the Company until such time as the information becomes public or is no longer deemed material such that it would preclude the Company from participating in an investment. Disclosure of such information to the Adviser&#8217;s personnel responsible for the affairs of the Company will be on a need-to-know basis only, and the Company might not be free to act upon any such information. Therefore, the Company will not always have access to confidential information in the possession of Blackstone Credit &amp; Insurance that might be relevant to an investment decision to be made for the Company. In addition, Blackstone Credit &amp; Insurance, in an effort to avoid buying or selling restrictions on behalf of the Company or Other Clients, can choose to forego an opportunity to receive (or elect not to receive) information that other market participants or counterparties, including those with the same positions in the issuer as the Company, are eligible to receive or have received, even if possession of such information would otherwise be advantageous to the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Break-up and other Similar Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Break-up or topping fees with respect to the Company&#8217;s investments can be paid to Blackstone Credit &amp; Insurance. Alternatively, the Company could receive the break-up or topping fees directly. Break-up or topping fees paid to Blackstone Credit &amp; Insurance or the Company in connection with a transaction could be allocated, or not, to Other Clients or co-investment vehicles that invest (or are expected to invest) alongside the Company, as determined by Blackstone Credit &amp; Insurance to be appropriate in the circumstances. Generally, Blackstone Credit &amp; Insurance would not allocate break-up or topping fees with respect to a potential investment to the Company, an Other Client or co-investment vehicle unless such person would also share in Broken Deal Expenses related to the potential investment. With respect to fees received by Blackstone Credit &amp; Insurance relating to the Company&#8217;s investments or from unconsummated transactions, shareholders will not receive the benefit of any fees relating to the Company&#8217;s investments (including, without limitation, as described above). In the case of fees for services as a director of a portfolio company, the management fee will not be reduced to the extent any Firm personnel continues to serve as a director after the Company has exited (or is in the process of exiting) the applicable portfolio company and/or following the termination of such employee&#8217;s employment with the Firm. For the avoidance of doubt, although the financial advisory and restructuring business of Blackstone has been spun out, to the extent any investment banking fees, consulting (including management consulting) fees, syndication fees, capital markets syndication and advisory fees (including underwriting fees), origination fees, servicing fees, healthcare consulting / brokerage fees, fees relating to group purchasing, financial advisory fees and similar fees for arranging acquisitions and other major financial restructurings, loan servicing and/or other types of insurance fees, operations fees, financing fees, fees for asset services, title insurance fees, and other similar fees and annual retainers (whether in cash or in kind) are received by Blackstone, such fees will not be required to be shared with the Company or the shareholders and will not reduce the management fee payable by the Company.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-25" continuedAt="f-160-26"><ix:continuation id="f-40-83" continuedAt="f-40-84"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Broken Deal Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any expenses that may be incurred by the Company for actual investments as described herein may also be incurred by the Company with respect to broken deals (i.e., investments that are not consummated) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Broken Deal Expenses&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Unless required by law or regulation, Blackstone Credit &amp; Insurance is not required to and, in most circumstances, will not seek reimbursement of Broken Deal Expenses (i.e., expenses incurred in pursuit of an investment that is not consummated) from third parties, including counterparties to the potential transaction or potential co-investors. Examples of such Broken Deal Expenses include, but are not limited to, reverse termination fees, extraordinary expenses such as litigation costs and judgments, meal, travel and entertainment expenses incurred, deposits or down payments which are forfeited in connection with unconsummated transactions, costs from onboarding (i.e., KYC) investment entities with a financial institution, commitment fees that become payable in connection with a proposed investment, consulting fees and expenses (including all expenses incurred in connection with any tax audit or investigation settlement), printing and publishing expenses, costs of negotiating co-investment documentation (including non-disclosure agreements with counterparties), and legal, accounting, tax and other due diligence and pursuit costs and expenses and broken deal expenses associated with services provided by portfolio companies, which may include expenses incurred prior to the commencement of the Company&#8217;s investment activities. Any such Broken Deal Expenses could, in the sole discretion of Blackstone Credit &amp; Insurance, be allocated solely to the Company and not to Other Clients or co-investment vehicles that could have made the investment, even when the Other Client or co-investment vehicle commonly invests alongside the Company in its investments or the Firm or Other Clients in their investments. In such cases, the Company&#8217;s shares of expenses would increase. The Adviser expects that until a potential investment of the Company is formally allocated to an Other Client (it being understood that final allocation decisions are typically made shortly prior to closing an investment), the Company is expected to bear the broken deal expenses for such investment, which may result in substantial amounts of broken deal expenses. In the event Broken Deal Expenses are allocated to an Other Client or a co-investment vehicle, Blackstone Credit &amp; Insurance or the Company will, in certain circumstances, advance such fees and expenses without charging interest until paid by the Other Client or co-investment vehicle, as applicable. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Firm Business Activities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm, Other Clients, their portfolio companies, and personnel and related parties of the foregoing will receive fees and compensation, including performance-based and other incentive fees, for products and services provided to the Company and its portfolio companies, such as fees for asset management (including, without limitation, management fees and carried interest/incentive arrangements), development and property management; portfolio operations support (such as those provided by Blackstone&#8217;s Portfolio Operations Group); arranging, underwriting (including without limitation, evaluation regarding value creation opportunities and ESG risk mitigation); syndication or refinancing of a loan or investment (or other additional fees, including acquisition fees, loan modification or restructuring fees); servicing; loan servicing; special servicing; administrative services; advisory services on purchase or sale of an asset or company; investment banking and capital markets services; placement agent services; fund administration; internal legal and tax planning services; information technology products and services; insurance procurement; brokerage; solutions and risk management services; data extraction and management products and services; fees for monitoring and oversight of loans or title insurance provided to portfolio companies or third parties; and other products and services. For example, the Firm or Other Clients may, directly or indirectly through a portfolio entity, from time to time acquire loans or other assets for the purpose of syndicating some or all the assets to the Company and/or Other Clients, and may receive syndication or other fees in connection therewith. Such parties will also provide products and services for fees to the Firm, Other Clients and their portfolio companies, and their personnel and related parties, as well as third parties. Through its innovations group, Blackstone incubates (or otherwise invests in) businesses that are expected to provide goods and services to the Company (subject to the requirements of the 1940 Act and applicable guidance) and Other Clients and their portfolio companies, as well as other Firm-related parties and third parties. By contracting for a product or service from a business related to the Firm, the Company and its portfolio companies would provide not only current income to the business and its stakeholders, but could also create significant enterprise value in them, which would not be shared with the Company or shareholders and could benefit the Firm directly and indirectly. Also, the Firm, Other Clients and their portfolio companies, and their personnel and related parties may receive compensation or other benefits, such as through additional ownership interests or otherwise, directly related to the consumption of products and services by the Company and its portfolio companies. The Company and its portfolio companies will incur expenses in negotiating for any such fees and services, which will be treated as Fund Expenses. In addition, the Firm may receive fees associated with capital invested by co-investors relating to investments in which the Company participates or otherwise, in connection with a joint venture in which the Company participates (subject to the 1940 Act) or otherwise with respect to assets or other interests retained by a seller or other commercial counterparty with respect to which the Firm performs services. Finally, the Firm and its personnel and related parties will, in certain circumstances, also receive compensation in connection with origination activities, referrals and other related activities of such business, and unconsummated transactions.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-26" continuedAt="f-160-27"><ix:continuation id="f-40-84" continuedAt="f-40-85"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will, as determined by Blackstone Credit &amp; Insurance and as permitted by the governing fund documents, bear the cost of fund administration, compliance and accounting (including, without limitation, maintaining financial records, filing of the Company&#8217;s tax returns, overseeing the calculation of the Company&#8217;s net asset value, compliance monitoring (including diligence and oversight of the Company&#8217;s other service providers), preparing reports to the Company&#8217;s shareholders and reports filed with the SEC and other regulators, preparing materials and coordinating meetings of the Board, managing the payment of expenses, the payment and receipt of funds for investments and the performance of administrative and professional services rendered by others, providing office space, equipment and office services), in house legal, tax planning and other related services provided by Firm personnel and related parties to the Company and its portfolio companies, including the allocation of their compensation and related overhead otherwise payable by the Firm, or pay for their services at market rates, as discussed above in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Self-Administration of the Company.&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such allocations or charges can be based on any of the following methodologies: (i) requiring personnel to periodically record or allocate their historical time spent with respect to the Company or the Firm approximating the proportion of certain personnel&#8217;s time spent with respect to the Company, and in each case allocating their compensation (including, without limitation, salary, bonus and benefits) and allocable overhead based on time spent, or charging their time spent at market rates, (ii) the assessment of an overall dollar amount (based on a fixed fee or percentage of assets under management) that the Firm believes represents a fair recoupment of expenses and a market rate for such services or (iii) any other similar methodology determined by the Firm to be appropriate under the circumstances. Certain Firm personnel will provide services to few, or only one, of the Company and Other Clients, in which case the Firm could rely upon rough approximations of time spent by the employee for purposes of allocating the salary and overhead of the person if the market rate for services is clearly higher than allocable salary and overhead. However, any methodology (including the choice thereof) involves inherent conflicts and may result in incurrence of greater expenses by the Company and its portfolio companies than would be the case if such services were provided by third parties.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance, Other Clients and their portfolio companies, and their affiliates, personnel and related parties could continue to receive fees, including performance-based or incentive fees, for the services described in the preceding paragraphs with respect to investments sold by the Company or a portfolio company to a third party buyer after the sale is consummated. Such post-disposition involvement will give rise to potential or actual conflicts of interest, particularly in the sale process. Moreover, Blackstone Credit &amp; Insurance, Other Clients and their portfolio companies, and their affiliates, personnel and related parties could acquire a stake in the relevant asset as part of the overall service relationship, at the time of the sale or thereafter.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance does not have any obligation to ensure that fees for products and services contracted by the Company or its portfolio companies are at market rates unless the counterparty is considered an affiliate of the Firm and given the breadth of the Firm&#8217;s investments and activities Blackstone Credit &amp; Insurance may not be aware of every commercial arrangement between the Company and its portfolio companies, on the one hand, and the Firm, Other Clients and their portfolio companies, and personnel and related parties of the foregoing, on the other hand.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as set forth above, the Company and shareholders will not receive the benefit (e.g., through a reduction to the management fee or otherwise) of any fees or other compensation or benefit received by Blackstone Credit &amp; Insurance, its affiliates or their personnel and related parties. (See also </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Service Providers, Vendors and Other Counterparties Generally&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Other Firm Business Activities.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities and Lending Activities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone, its affiliates and their related parties and personnel will from time to time participate in underwriting or lending syndicates with respect to current or potential portfolio companies, or will otherwise act as arrangers of financing, including with respect to the public offering and/or private placement of debt or equity securities issued by, or loan proceeds borrowed by the Company and its portfolio companies, or otherwise in arranging financing (including loans) for such portfolio companies or advise on such transactions. Such underwritings or engagements can be on a firm commitment basis or can be on an uncommitted &#8220;best efforts&#8221; basis, and the underwriting or financing parties are under no duty to provide any commitment unless specifically set forth in the relevant contract. Blackstone may also provide placement or other similar services to purchasers or sellers of securities, including loans or instruments issued by portfolio companies. There could also be circumstances in which the Company commits to purchase any portion of such issuance from the portfolio company that a Blackstone broker-dealer intends to syndicate to third parties. As a result thereof, subject to the limitations of the 1940 Act, Blackstone may be permitted to receive commissions or other compensation, thereby creating a potential conflict of interest. This could include, by way of example, fees and/ or commissions for equity syndications to co-investment vehicles. In certain cases, subject to the limitations of the 1940 Act, a Blackstone broker-dealer will, from time to time, act as the managing underwriter, or a member of the underwriting syndicate or broker for the Company or its portfolio companies, or as dealer, broker or advisor to a counterparty to the Company or a portfolio company, and purchase securities from or sell securities to the Company, Other Clients or portfolio companies of the Company or Other Clients or advise on such </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-27" continuedAt="f-160-28"><ix:continuation id="f-40-85" continuedAt="f-40-86"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transactions. Blackstone will also from time to time, on behalf of the Company or other parties to a transaction involving the Company or its portfolio companies, effect transactions, including transactions in the secondary markets that result in commissions or other compensation paid to Blackstone by the Company or its portfolio companies or the counterparty to the transaction, thereby creating a potential conflict of interest. This could include, by way of example, fees and/or commissions for equity syndications to co-investment vehicles. Subject to applicable law, Blackstone will from time to time receive underwriting fees, discounts, placement commissions, loan modification or restructuring fees, servicing fees, capital markets advisory fees, lending arrangement fees, asset/property management fees, insurance (including title insurance) incentive fees and consulting fees, monitoring fees, commitment fees, syndication fees, origination fees, organizational fees, operational fees, loan servicing fees, and financing and divestment fees (or, in each case, rebates in lieu of any such fees, whether in the form of purchase price discounts or otherwise, even in cases where Blackstone, an Other Client or its portfolio companies are purchasing debt) or other compensation with respect to the foregoing activities, which are not required to be shared with the Company. In addition, the management fee with respect to a shareholder generally will not be reduced by such amounts. Therefore, Blackstone will from time to time have a potential conflict of interest regarding the Company and the other parties to those transactions to the extent it receives commissions, discounts or other compensation from such other parties. The Board of Trustees, in its sole discretion, will approve any transactions, subject to the limitations of the 1940 Act, in which a Blackstone broker-dealer acts as an underwriter, as broker for the Company, or as dealer, broker or advisor, on the other side of a transaction with the Company only where the Board of Trustees believes in good faith that such transactions are appropriate for the Company and, by executing a subscription agreement for shares in the Company, a shareholder consents to all such transactions, along with the other transactions involving conflicts of interest described herein, to the fullest extent permitted by law.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Blackstone serves as underwriter with respect to securities of the Company or its portfolio companies, the Company and such portfolio companies could from time to time be subject to a &#8220;lock-up&#8221; period following the offering under applicable regulations during which time the Company or portfolio company would be unable to sell any securities subject to the &#8220;lock-up.&#8221; This could prejudice the ability of the Company and its portfolio companies to dispose of such securities at an opportune time. In addition, Blackstone Capital Markets can serve as underwriter in connection with the sale of securities by the Company or its portfolio companies. Conflicts would be expected to arise because such engagement would result in Blackstone Capital Markets receiving selling commissions or other compensation in connection with such sale. (See also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Portfolio Company Relationships Generally&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone and Blackstone Credit &amp; Insurance employees are generally permitted to invest in alternative investment funds, real estate funds, hedge funds or other investment vehicles, including potential competitors of the Company. The Company will not receive any benefit from any such investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PJT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On October 1, 2015, Blackstone spun off its financial and strategic advisory services, restructuring and reorganization advisory services, and its Park Hill fund placement businesses and combined these businesses with PJT Partners Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;PJT&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), an independent financial advisory firm founded by Paul J. Taubman. While PJT operates independently from Blackstone and is not an affiliate thereof, it is expected that there will be substantial overlapping ownership between Blackstone and PJT for a considerable period of time going forward. Therefore, conflicts of interest will arise in connection with transactions between or involving the Company and its portfolio companies, on the one hand, and PJT, on the other. The pre-existing relationship between Blackstone and its former personnel, the overlapping ownership and co-investment and other continuing arrangements between PJT and Blackstone can be expected to influence Blackstone Credit &amp; Insurance to select or recommend PJT to perform services for the Company or its portfolio companies, the cost of which will generally be borne directly or indirectly by the Company. Given that PJT is no longer an affiliate of Blackstone, Blackstone and its affiliates will be free to cause the Company and portfolio companies to transact with PJT generally without restriction under the applicable governing documents, notwithstanding the relationship between Blackstone and PJT. In addition, one or more investment vehicles controlled by Blackstone may be established to facilitate participation in Blackstone&#8217;s side-by-side investment program by employees and/or partners of PJT. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Portfolio Company Relationships Generally</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company&#8217;s portfolio companies, including special purpose vehicles that might be formed in connection with investments, are expected to be counterparties to or participants in agreements, transactions or other arrangements with the Company, Other Clients, and/or portfolio companies of the Company and Other Clients or other Blackstone affiliates and/or any portfolio companies of the foregoing for the provision of goods and services, purchase and sale of assets and other matters (including information-sharing and/or consulting). For example, from time to time, certain portfolio companies of the Company or Other Clients will provide or recommend goods or services to Blackstone, the Company, Other Clients, or other portfolio companies of the Company or Other Clients (including &#8220;platform&#8221; investments of the Company and Other Clients). As another example, it can also be expected that the management of one or more portfolio </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-28" continuedAt="f-160-29"><ix:continuation id="f-40-86" continuedAt="f-40-87"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies may consult with one another (or with one or more portfolio companies of an Other Client) in respect of seeking its expertise, industry view, or otherwise on a particular topic including but not limited to an asset and/or the purchase and /or sale thereof. Moreover, the Company and/or an Other Client can consult with a portfolio company or a portfolio company of an Other Client as part of the investment diligence for a potential investment by the Company or such Other Client. As a result of, or as part of such interactions or otherwise, personnel (including one or more members of the management team) at one portfolio company may also transfer to or become employed by another portfolio company (or a portfolio company of an Other Client), the Company, Blackstone or their respective affiliates (or vice versa). Any such transfer may result in payments by the entity that such personnel is going to, to the entity such personnel is departing from. Although the Firm might determine that such agreements, transactions or other arrangements are consistent with the requirements of such Other Clients&#8217; offering and/or governing agreements, such agreements, transactions or other arrangements might not have otherwise been entered into but for the affiliation with Blackstone Credit &amp; Insurance and/or Blackstone. These agreements, transactions or other agreements involve fees, commissions, servicing payments and/or discounts to Blackstone Credit &amp; Insurance, any Blackstone affiliate (including personnel) or a portfolio company, none of which reduce the management fee payable by the Company. This may give rise to actual or potential conflicts of interest for the Adviser, the Company and/or their respective affiliates, as such agreements, transactions and arrangements may be more favorable for one portfolio company than another, thus benefiting the Company or Other Clients at the expense of the other. For example, the Firm reserves the right to cause, or offer the opportunity to, portfolio companies to enter into agreements regarding group procurement (such as the group purchasing organization), benefits management, purchase of title and/or other insurance policies (which could be pooled across portfolio companies and discounted due to scale) and other operational, administrative or management related matters from a third party or a Firm affiliate, and other similar operational initiatives that can result in commissions or similar payments, including related to a portion of the savings achieved by the portfolio company. Such agreements, transactions or other arrangements will generally be entered into without the consent or direct involvement of the Company and/or such Other Client or the consent of the Board of Trustees and/or the shareholders of the Company or such Other Client (including, without limitation, in the case of minority and/or non-controlling investments by the Company in such portfolio companies or the sale of assets from one portfolio company to another) and/or such Other Client. In any such case, the Company might not be involved in the negotiation process, and there can be no assurance that the terms of any such agreement, transaction or other arrangement will be as favorable to the Company as otherwise would be the case if the counterparty were not related to the Firm.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, it is possible that certain portfolio companies of Other Clients or companies in which Other Clients have an interest will compete with the Company for one or more investment opportunities. It is also possible that certain portfolio companies of Other Clients will engage in activities that will have adverse consequences on the Company and/or its portfolio companies. As an example of the latter, the laws and regulations of certain jurisdictions (e.g., bankruptcy, environmental, consumer protection and/or labor laws) would not recognize the segregation of assets and liabilities as between separate entities and could permit recourse against the assets of not just the entity that has incurred the liabilities, but also the other entities that are under common control with, or part of the same economic group as, such entity. In such circumstances, the assets of the Company and/or its portfolio companies potentially will be used to satisfy the obligations or liabilities of one or more Other Clients, their portfolio companies and/or affiliates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, Blackstone and affiliates of Blackstone and Blackstone portfolio companies could also establish other investment products, vehicles and platforms focusing on specific asset classes or industry sectors that fall within the Company&#8217;s investment strategy, which would possibly compete with the Company for investment opportunities (it being understood that such arrangements would give rise to conflicts of interest that would not necessarily be resolved in favor of the Company).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain portfolio companies have established or invested in, or can be expected to in the future establish or invest in, vehicles that are managed exclusively by the portfolio company (and not the Company or the Firm or any of its affiliates) and that invest in asset classes or industry sectors (such as cyber security) that fall within the Company&#8217;s investment strategy. Such vehicles, which would not be considered affiliates of the Firm and would not be subject to the Firm&#8217;s policies and procedures, have the potential to compete with the Company for investment opportunities. Portfolio companies and affiliates of the Firm will also establish other investment products, vehicles and platforms focusing on specific asset classes or industry sectors (such as reinsurance) that can be expected to compete with the Company for investment opportunities (it being understood that such arrangements can give rise to conflicts of interest that would not necessarily be resolved in favor of the Company). In addition, the Company reserves the right to hold non-controlling interests in certain portfolio companies and, as a result, such portfolio companies could engage in activities outside of the Company&#8217;s control that would have adverse consequences on the Company and/or its other portfolio companies.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-29" continuedAt="f-160-30"><ix:continuation id="f-40-87" continuedAt="f-40-88"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone has also entered into certain investment management arrangements whereby it provides investment management services for compensation to insurance companies including (i) FGL and certain of its affiliates, (ii) Everlake and certain of its affiliates and (iii) certain subsidiaries of Corebridge and (iv) certain subsidiaries of Resolution Life. As of the date of the date hereof, Blackstone owns a 9.9% equity interest in the parent company of Everlake and Blackstone Clients own the remaining equity interests in the parent company of Everlake, and Blackstone owns a 9.9% equity interest in Corebridge. The foregoing insurance company investment management arrangements will involve investments by such insurance company clients across a variety of asset classes (including investments that would otherwise be appropriate for the Company). As a result, in addition to the compensation Blackstone receives for providing investment management services to insurance companies in which Blackstone or an Other Client owns an interest, in certain instances Blackstone receives additional compensation in its capacity as an indirect owner of such insurance companies and/or Other Clients. In the future Blackstone will likely enter into similar arrangements with other portfolio companies of the Company, Other Clients or other insurance companies. Such arrangements have the potential to reduce the allocations of investments to the Company, and Blackstone could be incentivized to allocate investments away from the Company to such insurance company client under such investment management arrangements or other vehicles/accounts to the extent the economic arrangements related thereto are more favorable to Blackstone relative to the terms of the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, portfolio companies with respect to which the Firm can elect members of the board of directors or a managing member could, as a result, subject the Company and/or such directors or managing member to fiduciary obligations to make decisions that they believe to be in the best interests of any such portfolio company. Although in most cases the interests of the Company and any such portfolio company will be aligned, this will not always be the case. This has the potential to create conflicts of interest between the relevant director&#8217;s or managing member&#8217;s obligations to any such portfolio company and its stakeholders, on the one hand, and the interests of the Company, on the other hand. Although Blackstone Credit &amp; Insurance will generally seek to minimize the impact of any such conflicts, there can be no assurance they will be resolved favorably for the Company. For instance, such positions could impair the ability of the Company to sell the securities of an issuer in the event a director receives material non- public information by virtue of their role, which would have an adverse effect on the Company. Furthermore, an employee of Blackstone serving as a director to a portfolio company owes a fiduciary duty and/or other obligations to the portfolio company, on the one hand, and the Company, on the other hand, and such employee could be in a position where they must make a decision that is either not in the best interest of the Company, or is not in the best interest of the portfolio company. Blackstone personnel serving as directors can make decisions for a portfolio company that negatively impact returns received by the Company as an investor in the portfolio company. In addition, to the extent an employee serves as a director on the board of more than one portfolio company, such employees&#8217; fiduciaries duties among the two portfolio companies can be expected to create a conflict of interest. In general, the Adviser and Blackstone personnel will be entitled to indemnification from the Company. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Portfolio Company Service Providers and Vendors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to applicable law, the Company, Other Clients, portfolio companies of each of the foregoing and Blackstone Credit &amp; Insurance can be expected to engage portfolio companies of the Company and Other Clients to provide some or all of the following services: (a)&#160;corporate support services (including, without limitation, accounts payable, accounts receivable, accounting/audit (e.g., valuation support services), account management (e.g., treasury, customer due diligence), insurance, procurement, placement, brokerage and consulting services, cash management, accounts receivable financing, corporate secretarial and executive assistant services, domiciliation, data management, directorship services, finance/budget, human resources (e.g., the onboarding and ongoing development of personnel), communication, public relations and publicity, information technology and software systems support, corporate governance and entity management (e.g., liquidation, dissolution and/or otherwise end of term services), risk management and compliance, internal compliance, know-your-client reviews and refreshes, judicial processes, legal, environmental due diligence support(e.g., review of property condition reports, energy consumption), climate accounting services, ESG program management services, engineering services, services related to the sourcing, development and implementation of renewable energy, ESG data collection and reporting services, capital planning services, operational coordination (i.e., coordination with joint venture partners, property managers), risk management, reporting (such as tax reporting, debt reporting or other reporting), tax and treasury, tax analysis and compliance (e.g., CIT and VAT compliance), transfer pricing and internal risk control, treasury and valuation services) and other services; (b) loan services (including, without limitation, monitoring, restructuring and work-out of performing, sub-performing and nonperforming loans, administrative services, and cash management); (c) management services (i.e., management by a portfolio company, Blackstone affiliate or third party (e.g., a third-party manager or operating partner) of operational services); (d) operational services (i.e., general management of day to day operations), including, without limitation, personnel, construction management (such as management of general contractors on capital projects), leasing services (such as leasing strategy, management of third party brokers, negotiation of major leases and negotiation of leases), project management (such as management of development projects, project design and execution, vendor management, and turnkey services); (e) risk management (tax and treasury); (f) transaction support services (including, without </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-30" continuedAt="f-160-31"><ix:continuation id="f-40-88" continuedAt="f-40-89"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">limitation, acquisition support; customer due diligence and related onboarding; liquidation; reporting; managing relationships with brokers, banks and other potential sources of investments, identifying potential investments, coordinating with investors, assembling relevant information, conducting financial and market analyses and modelling, coordinating closing/post-closing procedures for acquisitions, dispositions and other transactions, coordinating design and development works (such as recommending and implementing design decisions); and providing diligence and negotiation support to acquire the same; marketing and distribution, overseeing brokers, lawyers, accountants and other advisors, working with consultants and third parties to pursue entitlements; providing in-house legal, ESG and accounting services, assisting with due diligence, preparation of project feasibilities, site visits, transaction consulting and specification of technical analysis and review of (i) design and structural work, (ii) certifications, (iii) operations and maintenance manuals and (iv) statutory documents); (g) insurance procurement, placement, brokerage and consulting services; and (h)&#160;other services. Similarly, Blackstone Credit &amp; Insurance, Other Clients and their portfolio companies can be expected to engage portfolio companies of the Company to provide some or all of these services. Some of the services performed by portfolio company service providers could also be performed by Blackstone Credit &amp; Insurance from time to time and vice versa. Fees paid by the Company or its portfolio companies to or value created by other portfolio company service providers do not reduce the management fee payable by the Company and are not otherwise shared with the Company. In certain circumstances, Blackstone can be expected to play a substantial role in overseeing the personnel of portfolio company service providers that provide services to the Company, Other Clients and/or their portfolio companies on an ongoing basis, including with respect to the selection, hiring, retention and compensation of such personnel. For example, Blackstone expects that certain portfolio company service providers, as described below, with Blackstone&#8217;s oversight, will establish a team of personnel to provide support services exclusively to the Company and its portfolio companies (and/or other investment funds or accounts managed or controlled by Blackstone). Further, Blackstone has multiple business lines, which may result in competition with a portfolio company for high performing executive talent and presents actual and potential conflicts of interest. For example, Blackstone may &#8220;poach&#8221; a portfolio company executive, or such executive may interview with Blackstone during the applicable contractual period with respect to such person&#8217;s existing position and later be hired by Blackstone after such period. A portfolio company may want to retain such executives or other employees, and regardless, Blackstone is under no obligation to avoid interviewing or hiring such employees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portfolio companies of the Company and Other Clients some of which can be expected to provide services to the Company and its portfolio companies include, without limitation, the following, and could include additional portfolio companies that might be formed or acquired in the future: </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BTIG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. BTIG, LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BTIG&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is a global financial services firm in which certain Blackstone entities own a strategic minority investment. BTIG provides institutional trading, investment banking, research and related brokerage services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CoreTrust</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On September 30, 2022, certain Blackstone private equity funds and related entities closed the previously announced acquisition of a majority interest in CoreTrust (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;CoreTrust Acquisition&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), a group purchasing organization that provides purchasing services to member companies, which includes portfolio companies owned, in whole or in part, by certain Blackstone-managed funds. CoreTrust is expected to provide group purchasing services to the Company, portfolio companies, Other Clients and Blackstone. Generally, CoreTrust generates revenue from vendors based on a percentage of the amount of products or services purchased by its member companies and benefit plans maintained by its member companies. CoreTrust has historically shared a portion of the revenue generated through purchases made by Blackstone portfolio companies and paid Blackstone a consulting fee. Blackstone stopped accepting such revenue sharing arrangements and consulting fee upon the closing of the CoreTrust Acquisition. However, Blackstone may in its sole discretion reinstitute such or similar revenue sharing arrangements with CoreTrust in the future. In addition, prior to the CoreTrust Acquisition, CoreTrust generated revenue in respect of certain portfolio companies (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Applicable Portfolio Companies&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) from certain health and welfare benefit plan-related vendors (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Applicable Vendors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). For legal and regulatory reasons</span><span style="background-color:#dddddd;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">following the CoreTrust Acquisition, CoreTrust is limited in its ability to generate revenue from the Applicable Vendors in respect of portfolio companies&#8217; health benefit plans based on a percentage of the amount of products or services purchased by such plans. As a result, for Applicable Portfolio Companies and other portfolio companies that become CoreTrust members, CoreTrust intends to rebate all revenue received from Applicable Vendors to each such Portfolio Company&#8217;s applicable benefit plan. CoreTrust also intends to enter into with each Applicable Portfolio Company (and with other portfolio companies that become CoreTrust members) a separate agreement that will include the payment of an access fee in return for allowing such portfolio companies to use the goods and services provided by the Applicable Vendors through CoreTrust. The amount of the access fee will generally be determined either as a percentage of total company revenues or as a fixed fee (in each case subject to periodic review by CoreTrust and the Applicable Portfolio Company) and might not be subject to benchmarking, and the access fee could be greater or less than the amount of the revenue that CoreTrust previously generated from Applicable Vendors.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-31" continuedAt="f-160-32"><ix:continuation id="f-40-89" continuedAt="f-40-90"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Optiv</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Optiv Security, Inc. is a portfolio company held by certain Blackstone private equity funds that provides a full slate of information security services and solutions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PSAV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. PSAV, Inc. is a portfolio company held by certain Blackstone private equity funds that provides outsourced audiovisual services and event production.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refinitiv</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On October 1, 2018, a consortium led by Blackstone announced that private equity funds managed by Blackstone had completed an acquisition of Thomson Reuters&#8217; Financial &amp; Risk business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Refinitiv&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). On January 29, 2021, Refinitiv was sold to London Stock Exchange Group (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LSEG&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), with Blackstone private equity funds receiving a minority stake in LSEG. Refinitiv operates a pricing service that provides valuation services and may provide goods and services for the Company and its portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Kryalos. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone through one or more of its funds has made a minority investment in Kryalos, an operating partner in certain real estate investments made by Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Peridot Financial Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Peridot&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> and Global Supply Chain Finance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;GSCF&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone through one or more of its funds has made majority investments into Peridot and GSCF, which provide supply chain financing and accounts receivable services globally.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RE Tech Advisors </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;RE Tech&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Blackstone through one or more of its funds has made a majority investment in RE Tech, an energy audit/consulting firm that identifies and implements energy efficiency programs, calculates return on investment and tracks performance post-completion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legence (f.k.a Therma Holdings) (&#8220;Legence&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Legence is a portfolio company held by certain Blackstone private equity funds that provides carbon reduction and energy management services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revantage.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revantage is a portfolio entity of certain Blackstone Clients that provides corporate support services, including, without limitation, accounting, legal, tax, treasury, information technology and human resources and operational services and management services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There may be instances where current and former employees of Other Clients&#8217; portfolio companies are seconded to or temporarily hired by the Company&#8217;s portfolio companies or, at times, the Company&#8217;s investments directly. Such secondments or temporary hiring of current and former employees of Other Clients&#8217; portfolio companies by the Company&#8217;s portfolio companies (or its investments) may result in a potential conflict of interest between the Company&#8217;s portfolio companies and those of such Other Clients. The costs of such employees are expected to be borne by the Company or its relevant portfolio companies, as applicable, and the fees paid by the Company or such portfolio companies to, other portfolio company service providers or vendors do not offset or reduce the management fee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its portfolio companies will compensate one or more of these service providers and vendors owned by the Company or Other Clients, including through incentive based compensation payable to their management teams and other related parties. The incentive based compensation paid with respect to a portfolio company or asset of the Company or Other Clients will vary from the incentive based compensation paid with respect to other portfolio companies and assets of the Company and Other Clients; as a result the management team or other related parties can be expected to have greater incentives with respect to certain assets and portfolio companies relative to others, and the performance of certain assets and portfolio companies can be expected to provide incentives to retain management that also service other assets and portfolio companies. Some of these service providers and vendors owned or controlled by the Company or Other Clients may charge the Company and its portfolio companies for goods and services at rates generally consistent with those available in the market for similar goods and services. The discussion regarding the determination of market rates under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Firm Affiliated Service Providers&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein applies equally in respect of the fees and expenses of the portfolio company service providers, if charged at rates generally consistent with those available in the market. Other service providers and vendors owned and/or controlled by the Company or Other Clients pass through expenses on a cost reimbursement, no-profit or break-even basis, in which case the service provider allocates costs and expenses directly associated with work performed for the benefit of the Company and its portfolio companies to them, along with any related tax costs and an allocation of the service provider&#8217;s overhead, including any of the following: salaries, wages, benefits and travel expenses; marketing and advertising fees and expenses; legal, accounting and other professional fees and disbursements; office space and equipment; insurance premiums; technology expenditures, including hardware and software costs; costs to engage recruitment firms to hire employees; diligence expenses; one-time costs, including costs related to building-out and winding-down a portfolio company; costs that are of a limited </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-32" continuedAt="f-160-33"><ix:continuation id="f-40-90" continuedAt="f-40-91"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">duration or non-recurring (such as start-up or technology build-up costs, one-time technology and systems implementation costs, employee on-boarding and severance payments, and readiness of initial public offerings and other infrastructure costs); taxes; and other operating and capital expenditures. Any of the foregoing costs (including in prior periods, such as where any such costs are amortized over an extended period), although allocated in a particular period, will, in certain circumstances, relate to activities occurring outside the period, and further will, in certain circumstances, be of a general and administrative nature that is not specifically related to particular services, and therefore the Company could pay more than its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> portion of fees for services. In addition, in certain circumstances, Blackstone also relies on the management team of a portfolio company with respect to the determination of costs and expenses and allocation thereof and does not oversee or participate in such determinations or allocations. Moreover, to the extent a portfolio company uses an allocated cost model with respect to fees, costs and expenses, such fees, costs and expenses are typically estimated and/or accrued quarterly (or on another regular periodic basis) but not finalized until year-end and as a result, such year-end true-up is subject to fluctuation and increases such that for a given year, the year-end cumulative amount with respect to fees, costs and expenses may be greater than the sum of the quarterly estimates (or other periodic estimates where applicable) and/or accruals and therefore the Company could bear more fees, costs and expenses at year-end than had been anticipated throughout the year. The allocation of overhead among the entities and assets to which services are provided can be expected to be based on any of a number of different methodologies, including, without limitation, &#8220;cost&#8221; basis as described above, &#8220;time-allocation&#8221; basis, &#8220;per unit&#8221; basis, &#8220;per square footage&#8221; basis or &#8220;fixed percentage&#8221; basis, and the particular methodology used to allocate such overhead among the entities and assets to which services are provided are expected to vary depending on the types of services provided and the applicable asset class involved, and could, in certain circumstances, change from one period to another. There can be no assurance that a different manner of allocation would result in the Company and its portfolio companies bearing less or more costs and expenses. In addition, a portfolio company that uses a &#8220;cost&#8221; basis methodology may, in certain circumstances, change its allocation methodology, for example, to charging a flat fee for a particular service or instance (or vice versa) or to another methodology described herein or otherwise, and such changes may increase or reduce the amounts received by such portfolio companies for the same services, and shareholders will not necessarily be entitled to receive notice or disclosure of such changes in allocation methodology. In certain instances, particularly where such service providers and vendors are located in Europe or Asia, such service providers and vendors will charge the Company and its portfolio companies for goods and services at cost plus a percentage of cost for transfer pricing or other tax, legal, regulatory, accounting or other reasons or even decide to amortize any costs or expenses to address accounting or operational considerations. Further, the Company and its portfolio companies may compensate one or more of these service providers and vendors owned by the Company or Other Clients through incentive-based compensation payable to their management teams and other related parties. The incentive-based compensation paid with respect to a portfolio company or asset of the Company or Other Clients will vary from the incentive based compensation paid with respect to other portfolio companies and assets of the Company and Other Clients; as a result the management team or other related parties can be expected to have greater incentives with respect to certain assets and portfolio companies relative to others, and the performance of certain assets and portfolio companies could provide incentives to retain management that also service other assets and portfolio companies. Blackstone Credit &amp; Insurance will not always perform or obtain benchmarking analysis or third-party verification of expenses with respect to services provided on a cost reimbursement, no profit or break even basis, or in respect of incentive-based compensation. There can be no assurances that amounts charged by portfolio company service providers that are not controlled by the Company or Other Clients will be consistent with market rates or that any benchmarking, verification or other analysis will be performed with respect to such charges. If benchmarking is performed, the related expenses will be borne by the Company, Other Clients and their respective portfolio companies and will not reduce the management fee. A portfolio company service provider will, in certain circumstances, subcontract certain of its responsibilities to other portfolio companies. In such circumstances, the relevant subcontractor could invoice the portfolio company for fees (or in the case of a cost reimbursement arrangement, for allocable costs and expenses) in respect of the services provided by the subcontractor. The portfolio company, if charging on a cost reimbursement, no-profit or break-even basis, would in turn allocate those costs and expenses as it allocates other fees and expenses as described above. Similarly, Other Clients, their portfolio companies and Blackstone Credit &amp; Insurance can be expected to engage portfolio companies of the Company to provide services, and these portfolio companies will generally charge for services in the same manner described above, but the Company and its portfolio companies generally will not be reimbursed for any costs (such as start-up costs or technology build-up costs) relating to such portfolio companies incurred prior to such engagement. Some of the services performed by these service providers could also be performed by Blackstone Credit &amp; Insurance from time to time and vice versa. Fees paid by the Company or its portfolio companies to these service providers do not the management fee payable to the Adviser.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-33" continuedAt="f-160-34"><ix:continuation id="f-40-91" continuedAt="f-40-92"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where compensation paid to an affiliated service provider from the Company or its portfolio company is based on market rates, such compensation will not be based on the cost incurred by the applicable service provider and therefore will likely result in a profit to such service provider. In the event the service provider is an affiliate of Blackstone Credit &amp; Insurance, Blackstone Credit &amp; Insurance experiences a conflict of interest in determining the terms of any such engagement. There can be no assurance that an unaffiliated third party would not charge a lesser rate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Providers, Vendors and Other Counterparties Generally</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain third party advisors and other service providers and vendors or their affiliates to the Company and its portfolio companies (including accountants, administrators, paying agents, depositories, lenders, bankers, brokers, attorneys, consultants, title agents and investment or commercial banking firms) are owned by the Firm, the Company or Other Clients or provide goods or services to, or have other business, personal, financial or other relationships with, the Firm, the Other Clients and their respective portfolio companies and affiliates and personnel. Such advisors and service providers referred to above could be investors in the Company, affiliates of the Adviser, sources of financing and investment opportunities or co-investors or commercial counterparties or entities in which the Firm and/or Other Clients have an investment, and payments by the Company and/or such entities can be expected to indirectly benefit the Firm, the Other Clients and their respective portfolio companies or any affiliates or personnel. Also, advisors, lenders, investors, commercial counterparties, vendors and service providers (including any of their affiliates or personnel) to the Company and its portfolio companies could have other commercial or personal relationships with the Firm, Other Clients and their respective portfolio companies, or any affiliates, personnel or family members of personnel of the foregoing. Although the Firm selects service providers and vendors it believes are most appropriate in the circumstances based on its knowledge of such service providers and vendors (which knowledge is generally greater in the case of service providers and vendors that have other relationships to the Firm), the relationship of service providers and vendors to the Firm as described above will influence the Firm in deciding whether to select, recommend or form such an advisor or service provider to perform services for the Company, subject to applicable law, or a portfolio company, the cost of which will generally be borne directly or indirectly by the Company and can be expected to incentivize the Firm to engage such service provider over a third party, utilize the services of such service providers and vendors more frequently than would be the case absent the conflict, or to pay such service providers and vendors higher fees or commissions, resulting in higher fees and expenses being borne by the Company, than would be the case absent the conflict. The incentive could be created by current income and/or the generation of enterprise value in a service provider or vendor; the Firm can be expected to also have an incentive to invest in or create service providers and vendors to realize on these opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm has a practice of not entering into any arrangements with advisors, vendors or service providers that provide lower rates or discounts to the Firm itself compared to those it enters into on behalf of the Company and its portfolio companies for the same services. However, legal fees for unconsummated transactions are often charged at a discounted rate, such that if the Company and its portfolio companies consummate a higher percentage of transactions with a particular law firm than the Firm, the Company, Other Clients and their portfolio companies, the shareholders could indirectly pay a higher net effective rate for the services of that law firm than the Firm, the Company or Other Clients or their portfolio companies. Also, advisors, vendors and service providers often charge different rates or have different arrangements for different types of services. For example, advisors, vendors and service providers often charge fees based on the complexity of the matter as well as the expertise and time required to handle it. Therefore, to the extent the types of services used by the Company and its portfolio companies are different from those used by the Firm, Other Clients and their portfolio companies, and their affiliates and personnel, the Company and its portfolio companies can be expected to pay different amounts or rates than those paid by such other persons. Similarly, the Firm, the Company, the Other Clients and their portfolio companies and affiliates can be expected to enter into agreements or other arrangements with vendors and other similar counterparties (whether such counterparties are affiliated or unaffiliated with the Firm) from time to time whereby such counterparty will, in certain circumstances, charge lower rates (or no fee) or provide discounts or rebates for such counterparty&#8217;s products or services depending on certain factors, including without limitation the volume of transactions entered into with such counterparty by the Firm, the Company and its investment and/or portfolio companies in the aggregate or other factors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to applicable law, the Company, Other Clients and their portfolio companies are expected to enter into joint ventures with third parties to which the service providers and vendors described above will, in certain circumstances, provide services. In some of these cases, the third party joint venture partner may be permitted to negotiate to not pay its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> share of fees, costs and expenses to be allocated as described above, in which case the Company, Other Clients and their portfolio companies that also use the services of the portfolio company service provider will, directly or indirectly, pay the difference, or the portfolio company service provider will bear a loss equal to the difference.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-34" continuedAt="f-160-35"><ix:continuation id="f-40-92" continuedAt="f-40-93"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm might, from time to time, encourage service providers to funds and investments to use, generally at market rates and/or on arm&#8217;s length terms (and/or on the basis of best execution, if applicable), the Firm-affiliated service providers in connection with the business of the Company, portfolio companies, and unaffiliated entities. This practice creates a conflict of interest because it provides an indirect benefit to the Firm in the form of added business for the Firm-affiliated service providers without any reduction to the Company&#8217;s management fee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain portfolio companies that provide services to the Company, Other Clients and/or portfolio companies or assets of the Company and/or Other Clients could be transferred between and among the Company and/or Other Clients (where the Company may be a seller or a buyer in any such transfer) for minimal or no consideration (based on a third-party valuation confirming the same). Such transfers may give rise to actual or potential conflicts of interest for Blackstone Credit &amp; Insurance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Firm Affiliated Service Providers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s, the Firm&#8217;s and/or portfolio companies&#8217; advisers and other service providers, or their affiliates (including accountants, administrators, lenders, bankers, brokers, attorneys, consultants, and investment or commercial banking firms) also provide goods or services to, or have business, personal, financial or other relationships with, the Firm, its affiliates and portfolio companies. Such advisers and service providers (or their affiliates) may be investors in the Company, affiliates of the Firm, sources of investment opportunities, co-investors, commercial counterparties and/or portfolio companies in which the Firm and/or the Company has an investment. Accordingly, payments by the Company and/or such entities may indirectly benefit the Company and/or its affiliates, including the Firm and Other Clients. No fees charged by these service providers and vendors will reduce the management fees payable to the Adviser. Furthermore, the Firm, the Other Clients and their portfolio companies and their affiliates and related parties will use the services of these Firm affiliates, including at different rates. Although the Firm believes the services provided by its affiliates are equal or better than those of third parties, the Firm directly benefits from the engagement of these affiliates, and there is therefore an inherent conflict of interest such as those described above.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Firm has many different businesses, including the Blackstone Capital Markets Group, which Blackstone investment teams and portfolio companies can engage to provide underwriting and capital market advisory services, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would be subject if it had just one line of business. To the extent Blackstone determines appropriate, conflict mitigation strategies would be put in place with respect to a particular circumstance, such as internal information barriers or recusal, disclosure or other steps determined appropriate by the Adviser. Service providers affiliated with the Firm, which are generally expected to receive competitive market rate fees (as determined by the Adviser or its affiliates) with respect to certain investments, include:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.07pt">Aquicore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Aquicore is a cloud-based platform that tracks, analyzes and predicts key metrics in real estate, focused on the reduction of energy consumption. Blackstone holds a minority investment in Aquicore.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Equity Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Equity Healthcare LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Equity Healthcare&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is a Blackstone affiliate that negotiates with providers of standard administrative services and insurance carriers for health benefit plans and other related services for cost discounts, quality of service monitoring, data services and clinical consulting. Because of the combined purchasing power of its client participants, which include unaffiliated third parties, Equity Healthcare is able to negotiate pricing terms that are believed to be more favorable than those that the portfolio companies could obtain for themselves on an individual basis. The fees received by Equity Healthcare in connection with services provided to investments will not reduce the management fee payable by the Company.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.07pt">LNLS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lexington National Land Services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LNLS&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is a Blackstone affiliate that (i) acts as a title agent in facilitating and issuing title insurance, (ii) provides title support services for title insurance underwriters and (iii) acts as escrow agent in connection with investments by the Company, Other Clients and their portfolio companies, affiliates and related parties, and third parties. In exchange for such services LNLS earns fees which would have otherwise been paid to third parties. If LNLS is involved in a transaction in which the Company participates, Blackstone will benchmark the relevant costs to the extent market data is available except when LNLS is providing such services in a state where the insurance premium or escrow fee, as applicable, is regulated by the state or when LNLS is part of a syndicate of title insurance companies where the insurance premium is negotiated by other title insurance underwriters or their agents.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Refinitiv</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Portfolio Company Service Providers and Vendors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; above.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-35" continuedAt="f-160-36"><ix:continuation id="f-40-93" continuedAt="f-40-94"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Blackstone acquired a 9.9% interest in Corebridge, and in connection therewith has entered into a long-term asset management partnership with certain subsidiaries and/or affiliates of Corebridge to serve as the exclusive external manager with respect to certain asset classes within their investment portfolio, for compensation. While Blackstone will not control Corebridge, the aforementioned investment in Corebridge and asset management arrangements could incentivize Blackstone to cause (and Blackstone will benefit indirectly from causing) the Company and/or its portfolio companies to engage Corebridge or its affiliates (including Corebridge Financial, Inc. and its other affiliates and subsidiaries) to provide various services and engage in other transactions and otherwise present conflicts of interests as a result of Blackstone&#8217;s interest and relationship therewith.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain Blackstone-affiliated service providers and their respective personnel will receive a management promote, an incentive fee and other performance-based compensation in respect of investments, sales or other transaction volume. Furthermore, Blackstone-affiliated service providers can be expected to charge costs and expenses based on allocable overhead associated with personnel working on relevant matters (including salaries, benefits and other similar expenses).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with such relationships, Blackstone Credit &amp; Insurance and, if required by applicable law, the Board of Trustees, will make determinations of competitive market rates based on its consideration of a number of factors, which are generally expected to include Blackstone Credit &amp; Insurance&#8217;s experience with non-affiliated service providers, benchmarking data and other methodologies determined by Blackstone Credit &amp; Insurance to be appropriate under the circumstances (i.e., rates that fall within a range that Blackstone Credit &amp; Insurance has determined is reflective of rates in the applicable market and certain similar markets, though not necessarily equal to or lower than the median rate of comparable firms and in certain circumstances, is expected to be in the top of the range). In respect of benchmarking, while Blackstone Credit &amp; Insurance often obtains benchmarking data regarding the rates charged or quoted by third parties for services similar to those provided by Blackstone Credit &amp; Insurance affiliates in the applicable market or certain similar markets, relevant comparisons would not be available for a number of reasons, including, without limitation, as a result of a lack of a substantial market of providers or users of such services or the confidential or bespoke nature of such services (e.g., different assets could receive different services). In addition, benchmarking data is based on general market and broad industry overviews, rather than determined on an asset by asset basis. As a result, benchmarking data does not take into account specific characteristics of individual assets then invested in by the Company (such as location or size), or the particular characteristics of services provided. Further, it could be difficult to identify comparable third-party service providers that provide services of a similar scope and scale as the Firm-affiliated service providers that are the subject of the benchmarking analysis or to obtain detailed information about pricing of a service comparable to that being provided to the Company from third-party service providers if such service providers anticipate that Blackstone will not in fact engage their services. For these reasons, such market comparisons would not necessarily result in precise market terms for comparable services. Expenses to obtain benchmarking data will be borne by the Company, Other Clients and their respective portfolio companies and will not reduce the management fee. Finally, in certain circumstances Blackstone Credit &amp; Insurance may determine that third party benchmarking is unnecessary, including in circumstances where the price for a particular good or service is mandated by law (e.g., title insurance in rate regulated states) or because in Blackstone Credit &amp; Insurance&#8217;s view no comparable service provider offering such good or service (or an insufficient number of comparable service providers for a reasonable comparison) exists or because Blackstone Credit &amp; Insurance has access to adequate market data (including from third party clients of the Firm-affiliated service provider that is the subject of the benchmarking analysis) to make the determination without reference to third party benchmarking. For example, in certain circumstances a Firm-affiliated service provider or a portfolio company service provider could provide services to third parties, in which case if the rates charged to such third parties are consistent with the rates charged to the Company, Other Clients and their respective portfolio companies, then a separate benchmarking analysis of such rates is not expected to be prepared. Some of the services performed by Firm-affiliated service providers could also be performed by the Firm from time to time and vice versa. Fees paid by the Company or its portfolio companies to or value created in Firm affiliated service providers or vendors do not reduce the management fee. These conflicts related to Firm-affiliated service providers will not necessarily be resolved in favor of the Company, and shareholders might not be entitled to receive notice or disclosure of the occurrence of these conflicts.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-36" continuedAt="f-160-37"><ix:continuation id="f-40-94" continuedAt="f-40-95"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advisers and service providers, or their affiliates, often charge different rates, including below-market or no fee, or have different arrangements for different types of services. With respect to service providers, for example, the fee for a given type of work could vary depending on the complexity of the matter as well as the expertise required and demands placed on the service provider. Therefore, to the extent the types of services used by the Company and/or portfolio companies differ from those used by the Firm and its affiliates (including personnel), Blackstone Credit &amp; Insurance and/or Blackstone or their respective affiliates (including personnel) potentially will pay different amounts or rates than those paid by the Company and/or portfolio companies. However, Blackstone Credit &amp; Insurance and its affiliates have a longstanding practice of not entering into any arrangements with advisers or service providers that could provide for lower rates or discounts than those available to the Company, Other Clients and/or portfolio companies for the same services. Furthermore, it is possible that certain advisers and service providers will provide services exclusively to the Firm and its affiliates, including the Company, Other Clients and their portfolio companies, although such advisers and service providers would not be considered employees of Blackstone or Blackstone Credit &amp; Insurance. Similarly, Blackstone, Blackstone Credit &amp; Insurance, each of their respective affiliates, the Company, the Other Clients and/or their portfolio companies, can enter into agreements or other arrangements with vendors and other similar counterparties (whether such counterparties are affiliated or unaffiliated with the Firm) from time to time whereby such counterparty would charge lower rates (or no fee) and/or provide discounts or rebates for such counterparty&#8217;s products and/or services depending on certain factors, including volume of transactions entered into with such counterparty by the Firm, its affiliates, the Company, the Other Clients and their portfolio companies in the aggregate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, investment banks or other financial institutions, as well as certain Blackstone employees, are expected to also be investors in the Company. These institutions and employees are a potential source of information and ideas that could benefit the Company. Blackstone has procedures in place reasonably designed to prevent the inappropriate use of such information by the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transactions with Portfolio Companies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm and portfolio companies of the Company and Other Clients operate in multiple industries and provide products and services to or otherwise contract with the Company and its portfolio companies, among others. In the alternative, the Firm could form a joint venture with such a company to implement such referral arrangement. For example, such arrangements could include the establishment of a joint venture or other business arrangement between the Firm, on the one hand, and a portfolio company of the Company, portfolio company of an Other Client or third party, on the other hand, pursuant to which the joint venture or business provides services (including, without limitation, corporate support services, loan management services, management services, operational services, ongoing account services (e.g., interacting and coordinating with banks generally and with regard to their know your client requirements), risk management services, data management services, consulting services, brokerage services, sustainability and clean energy consulting services, insurance procurement, placement, brokerage and consulting services, and other services) to portfolio companies of the Company (and portfolio companies of Other Clients) that are referred to the joint venture or business by the Firm. The Firm, the Company and Other Clients and their respective portfolio companies and personnel and related parties of the foregoing can be expected to make referrals or introductions to the Company or portfolio companies of the Company or Other Clients in an effort, in part, to increase the customer base of such companies or businesses (and therefore the value of the investment held by the Company or Other Client, which would also benefit the Firm financially through its participation in such joint venture or business) or because such referrals or introductions will, in certain circumstances, result in financial benefits, such as cash payments, additional equity ownership, participation in revenue share and/or milestones benefiting the referring or introducing party that are tied or related to participation by the portfolio companies of the Company and/or of Other Clients, accruing to the party making the introduction. Such joint venture or business could use data obtained from such portfolio companies (see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Data&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">elsewhere herein). Furthermore, such introductions or referrals could involve the transfer of certain personnel or employees among Blackstone and the Company&#8217;s portfolio companies and Other Clients which might result in a termination fee or similar payments being due and payable from one such entity to another. The Company and the shareholders typically will not share in any fees, economics, equity or other benefits accruing to the Firm, Other Clients and their portfolio companies as a result of the introduction of the Company and its portfolio companies. Moreover, payments made to the Firm in connection with such arrangements will not reduce the management fee payable to the Adviser. There could, however, be instances in which the applicable arrangements provide that the Company or its portfolio companies share in some or all of any resulting financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) based on structures and allocation methodologies determined in the sole discretion of the Firm. Conversely, where the Company or one of its portfolio companies is the referring or introducing party, rather than receiving all of the financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) for similar types of referrals and/or introductions, such financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) could be similarly shared with the participating Other Clients or their respective portfolio companies.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-37" continuedAt="f-160-38"><ix:continuation id="f-40-95" continuedAt="f-40-96"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm is also permitted to enter into commercial relationships with third party companies, including those in which the Company considered making an investment (but ultimately chose not to pursue). For example, the Firm could enter into an introducer engagement with such company, pursuant to which the Firm introduces the company to unaffiliated third parties (which can include current and former portfolio companies and portfolio companies of Other Clients and/or their respective employees) in exchange for a fee from, or equity interest in, such company. Even though the Firm could benefit financially from this commercial relationship, the Firm will be under no obligation to reimburse the Company for Broken Deal Expenses incurred in connection with its consideration of the prospective investment and such arrangements will not be subject to the management fee payable to the Adviser and otherwise described herein.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Firm or an affiliate thereof will from time to time hold equity or other investments in companies or businesses (even if they are not &#8220;affiliates&#8221; of the Firm) that provide services to or otherwise contract with portfolio companies. Blackstone and Blackstone Credit &amp; Insurance have in the past entered (and can be expected in the future to enter) into relationships with companies in the information technology, corporate services and related industries whereby Blackstone acquires an equity or similar interest in such company. In connection with such relationships, Blackstone and/or Blackstone Credit &amp; Insurance reserves the right to also make referrals and/or introductions to portfolio companies (which could result in financial incentives (including additional equity ownership) and/or milestones benefitting Blackstone and/or Blackstone Credit &amp; Insurance that are tied or related to participation by portfolio companies). Such joint venture or business could use data obtained from portfolio companies of the Company and/or portfolio companies of Other Clients. These arrangements are expected to be entered into without the consent or direct involvement of the Company. The Company and the shareholders will not share in any fees or economics accruing to Blackstone and/or Blackstone Credit &amp; Insurance as a result of these relationships and/or participation by portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to transactions or agreements with portfolio companies (including, for the avoidance of doubt, long-term incentive plans), at times if officers unrelated to the Firm have not yet been appointed to represent a portfolio company, the Firm is permitted to negotiate and execute agreements between the Firm and/or the Company on the one hand, and the portfolio company or its affiliates, on the other hand, without arm&#8217;s length representation of the portfolio company, which could entail a conflict of interest in relation to efforts to enter into terms that are arm&#8217;s length. Among the measures the Firm can be expected to use to mitigate such conflicts are to involve outside counsel to review and advise on such agreements and provide insights into commercially reasonable terms, or establish separate groups with information barriers within the Firm to advise on each side of the negotiation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Leasing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to applicable law, the Company and its portfolio companies may lease property to or from Blackstone, Other Clients and their portfolio companies and affiliates and other related parties. The leases are generally expected to, but might not always, be at market rates. Blackstone can be expected to confirm market rates by reference to other leases it is aware of in the market, which Blackstone expects to be generally indicative of the market given the scale of Blackstone&#8217;s real estate business. Blackstone can be expected to, but might not always, nonetheless have conflicts of interest in making these determinations, and with regard to other decisions related to such assets and investments. There can be no assurance that the Company and its portfolio companies will lease to or from any such related parties on terms as favorable to the Company and its portfolio companies as would apply if the counterparties were unrelated.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-Guarantees and Cross-Collateralization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. While Blackstone Credit &amp; Insurance generally seeks to use reasonable efforts to avoid cross-guarantees and other similar arrangements, a counterparty, lender or other participant in any transaction to be pursued by the Company other than alternative investment vehicles and/or the Other Clients could require or prefer facing only one fund entity or group of entities, which can result in any of the Company, such Other Clients, the portfolio companies, such Other Clients&#8217; portfolio companies and/or other vehicles being jointly and severally liable for such applicable obligation (subject to any limitations set forth in the applicable governing documents thereof), which in each case could result in the Company, such Other Clients, such portfolio companies and portfolio companies, and/or vehicles entering into a back-to-back or other similar reimbursement agreement, subject to applicable law. In such situation, better financing terms could be available through a cross-collateralized arrangement, but it is not expected that any of the Company or such Other Clients or vehicles would be compensated (or provide compensation to the other) for being primarily liable vis-&#224;-vis such third party counterparty. Also, it is expected that cross-collateralization will generally occur at portfolio companies rather than the Company for obligations that are not recourse to the Company except in limited circumstances such as &#8220;bad boy&#8221; events. Any cross-collateralization arrangements with Other Clients could result in the Company losing its interests in otherwise performing investments due to poorly performing or non-performing investments of Other Clients in the collateral pool.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-38" continuedAt="f-160-39"><ix:continuation id="f-40-96" continuedAt="f-40-97"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, a lender could require that it face only one portfolio company of the Company and Other Clients, even though multiple portfolio companies of the Company and Other Clients benefit from the lending, which will typically result in (i) the portfolio company facing the lender being solely liable with respect to the entire obligation, and therefore being required to contribute amounts in respect of the shortfall attributable to other portfolio companies, and (ii) portfolio companies of the Company and Other Clients being jointly and severally liable for the full amount of the obligation, liable on a cross-collateralized basis or liable for an equity cushion (which cushion amount can vary depending upon the type of financing or refinancing (e.g., cushions for refinancings could be smaller)). The portfolio companies of the Company and Other Clients benefiting from a financing may enter into a back-to-back or other similar reimbursement agreements whereby each agrees that no portfolio company bears more than its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> portion of the debt and related obligations. It is not expected that the portfolio companies would be compensated (or provide compensation to other portfolio companies) for being primarily liable, or jointly liable, for other portfolio companies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> share of any financing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint Venture Partners</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company will from time to time enter into one or more joint venture arrangements with third party joint venture partners. Investments made with joint venture partners will often involve performance-based compensation and other fees payable to such joint venture partners, as determined by the Adviser in its sole discretion. The joint venture partners could provide services similar to those provided by the Adviser to the Company. Yet, no compensation or fees paid to the joint venture partners would reduce the management fees payable by the Company. Additional conflicts would arise if a joint venture partner is related to the Firm in any way, such as a limited partner investor in, lender to, a shareholder of, or a service provider to the Firm, the Company, Other Clients, or their respective portfolio companies, or any affiliate, personnel, officer or agent of any of the foregoing.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Group Procurement; Discounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company, subject to applicable law, and certain portfolio companies will enter into agreements regarding group procurement (including, but not limited to, CoreTrust, an independent group purchasing organization), benefits management, purchase of title and/or other insurance policies (which can be expected to include brokerage and/or placement thereof, and will from time to time be pooled across portfolio companies and discounted due to scale, including through sharing of deductibles and other forms of shared risk retention) from a third party or an affiliate of Blackstone Credit &amp; Insurance and/or Blackstone, and other operational, administrative or management related initiatives. The Firm will allocate the cost of these various services and products purchased on a group basis among the Company, Other Clients and their portfolio companies. Some of these arrangements result in commissions, discounts, rebates or similar payments to Blackstone Credit &amp; Insurance and/or Blackstone or their affiliates (including personnel), or Other Clients and their portfolio companies, including as a result of transactions entered into by the Company and its portfolio companies and/or related to a portion of the savings achieved by the portfolio companies. Such commissions or payment will not reduce the management fee. The Firm can be expected to also receive consulting, usage or other fees from the parties to these group procurement arrangements. To the extent that a portfolio company of an Other Client is providing such a service, such portfolio company and such Other Client will benefit. Further, the benefits received by a particular portfolio company providing the service could be greater than those received by the Company and its portfolio companies receiving the service. Conflicts exist in the allocation of the costs and benefits of these arrangements, and shareholders rely on the Adviser to handle them in its sole discretion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diverse Shareholder Group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s shareholders are expected to be based in a wide variety of jurisdictions and take a wide variety of forms. The shareholders may have conflicting investment, tax and other interests with respect to their investments in the Company and with respect to the interests of investors in other investment vehicles managed or advised by the Adviser and Blackstone Credit &amp; Insurance that may participate in the same investments as the Company. The conflicting interests of individual shareholders with respect to other shareholders and relative to investors in other investment vehicles would generally relate to or arise from, among other things, the nature of investments made by the Company and such other partnerships, the structuring or the acquisition of investments and the timing of disposition of investments. As a consequence, conflicts of interest may arise in connection with the decisions made by the Adviser or Blackstone Credit &amp; Insurance, including with respect to the nature or structuring of investments that may be more beneficial for one investor than for another investor, especially with respect to investors&#8217; individual tax situations. In addition, the Company may make investments that may have a negative impact on related investments made by the shareholders in separate transactions, such as credit investments that, by consequence of the exercise of remedies related to such investments, adversely impact equity-like investments in respect of those same issuers. In selecting and structuring investments appropriate for the Company, the Adviser or Blackstone Credit &amp; Insurance will consider the investment and tax objectives of the Company and the shareholders (and those of investors in other investment vehicles managed or advised by the Adviser or Blackstone Credit &amp; Insurance) as a whole, not the investment, tax or other objectives of any shareholder individually.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-39" continuedAt="f-160-40"><ix:continuation id="f-40-97" continuedAt="f-40-98"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain shareholders also may be investors in Other Clients, including supplemental capital vehicles and co-investment vehicles that invest alongside the Company in one or more investments, consistent with applicable law and/or any applicable SEC-granted order. Shareholders also might include affiliates of the Firm, such as Other Clients, affiliates of portfolio companies of the Company or Other Clients, charities, foundations or other entities or programs associated with Firm personnel and/or current or former Firm employees, the Firm&#8217;s senior advisors and/or operating partners and any affiliates, funds or persons may also invest in the Company through the vehicles established in connection with the Firm&#8217;s side-by-side co-investment rights, subject to applicable law, in each case, without being subject to management fees, and shareholders will not be afforded the benefits of such arrangements. Some of the foregoing Firm related parties are sponsors of feeder vehicles that could invest in the Company as shareholders. The Firm related sponsors of feeder vehicles generally charge their investors additional fees, including performance based fees, which could provide the Firm current income and increase the value of its ownership position in them. The Firm will therefore have incentives to refer potential investors to these feeder vehicles. All of these Firm related shareholders will have equivalent rights to vote and withhold consents as nonrelated shareholders. Nonetheless, the Firm could have the ability to influence, directly or indirectly, these Firm related shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is also possible that the Company or its portfolio companies will be a counterparty (such counterparties dealt with on an arm&#8217;s-length basis) or participant in agreements, transactions or other arrangements with a shareholder or an affiliate of a shareholder. Such transactions may include agreements to pay performance fees to operating partners, a management team and other related persons in connection with the Company&#8217;s investment therein, which will reduce the Company&#8217;s returns. Such shareholders described in the previous sentences may therefore have different information about the Firm and the Company than shareholders not similarly positioned. In addition, conflicts of interest may arise in dealing with any such shareholders, and the Adviser and its affiliates may not be motivated to act solely in accordance with its interests relating to the Company. Similar information disparity may occur as a result of shareholders monitoring their investments in vehicles such as the Company differently. For example, certain shareholders may periodically request from the Adviser information regarding the Company, its investments and/or portfolio companies that is not otherwise set forth in (or has yet to be set forth) in the reporting and other information required to be delivered to all shareholders. In such circumstances, the Adviser may provide such information to such shareholders, subject to applicable law and regulations. Unless required by applicable law, the Adviser will not be obligated to affirmatively provide such information to all shareholders (although the Adviser will generally provide the same information upon request and treat shareholders equally in that regard). As a result, certain shareholders may have more information about the Company than other shareholders, and, unless required by applicable law, the Adviser will have no duty to ensure all shareholders seek, obtain or process the same information regarding the Company, its investments and/or portfolio companies. Therefore, certain shareholders may be able to take actions on the basis of such information which, in the absence of such information, other shareholders do not take. Furthermore, at certain times the Firm may be restricted from disclosing to the shareholders material non-public information regarding any assets in which the Company invests, particularly those investments in which an Other Client or portfolio company that is publicly registered co-invests with the Company. In addition, investment banks or other financial institutions, as well as Firm personnel, may also be shareholders. These institutions and personnel are a potential source of information and ideas that could benefit the Company, and may receive information about the Company and its portfolio companies in their capacity as a service provider or vendor to the Company and its portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Possible Future Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm and its affiliates are expected to expand the range of services that it provides over time. Except as provided herein, the Firm and its affiliates will not be restricted in the scope of its business or in the performance of any such services (whether now offered or undertaken in the future) even if such activities could give rise to conflicts of interest, and whether or not such conflicts are described herein. The Firm and its affiliates have, and will continue to develop, relationships with a significant number of companies, financial sponsors and their senior managers, including relationships with clients who might hold or might have held investments similar to those intended to be made by the Company. These clients could themselves represent appropriate investment opportunities for the Company or could compete with the Company for investment opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restrictions Arising under the Securities Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm&#8217;s activities and the activities of Other Clients (including the holding of securities positions or having one of its employees on the board of directors of a portfolio company) could result in securities law restrictions on transactions in securities held by the Company, affect the prices of such securities or the ability of such entities to purchase, retain or dispose of such investments, or otherwise create conflicts of interest, any of which could have an adverse impact on the performance of the Company and thus the return to the shareholders.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-160-40"><ix:continuation id="f-40-98" continuedAt="f-40-99"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 1940 Act may limit the Company&#8217;s ability to undertake certain transactions with or alongside its affiliates that are registered under the 1940 Act. As a result of these restrictions, the Company may be prohibited from executing &#8220;joint&#8221; transactions with the Company&#8217;s 1940 Act registered affiliates, which could include investments in the same portfolio company (whether at the same or different times) or buying investments from, or selling them to, Other Clients. These limitations have the potential to limit the scope of investment opportunities that would otherwise be available to the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders&#8217; Outside Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A shareholder shall be entitled to and can be expected to have business interests and engage in activities in addition to those relating to the Company, including business interests and activities in direct competition with the Company and its portfolio companies, and can engage in transactions with, and provide services to, the Company or its portfolio companies (which will, in certain circumstances, include providing leverage or other financing to the Company or its portfolio companies as determined by the Adviser in its sole discretion). None of the Company, any shareholder or any other person shall have any rights by virtue of the Company&#8217;s operative documents or any related agreements in any business ventures of any shareholder. The shareholder, and in certain cases the Adviser, will have conflicting loyalties in these situations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser will cause the Company to purchase, and/or bear premiums, fees, costs and expenses (including any expenses or fees of insurance brokers) for insurance to insure the Company and the Board of Trustees against liability in connection with the activities of the Company. This includes a portion of any premiums, fees, costs and expenses for one or more &#8220;umbrella,&#8221; group or other insurance policies maintained by the Firm that cover the Company and one or more of the Other Clients, the Adviser, Blackstone Credit &amp; Insurance and/or Blackstone (including their respective directors, officers, employees, agents, representatives, independent client representative (if any) and other indemnified parties). The Adviser will make judgments about the allocation of premiums, fees, costs and expenses for such &#8220;umbrella,&#8221; group or other insurance policies among the Company, one or more Other Clients, the Adviser, Blackstone Credit &amp; Insurance and/or Blackstone on a fair and reasonable basis, subject to approval by the Board of Trustees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technological and Scientific Innovations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recent technological and scientific innovations have disrupted numerous established industries and those with incumbent power in them.&#160;As technological and scientific innovation continues to advance rapidly, it could impact one or more of the Company&#8217;s strategies.&#160;Moreover, given the pace of innovation in recent years, the impact on a particular portfolio company might not have been foreseeable at the time the Company made such investment and could adversely impact the Company and/or its portfolio companies. Furthermore, Blackstone Credit &amp; Insurance could base investment decisions on views about the direction or degree of innovation that prove inaccurate and lead to losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Potential Conflicts of Interest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The officers, directors, members, managers, employees and personnel of the Adviser may trade in securities for their own accounts, subject to restrictions and reporting requirements as may be required by law or the Firm&#8217;s policies, or otherwise determined from time to time by the Adviser. In addition, certain Other Clients may be subject to the 1940 Act or other regulations that, due to the role of the Firm, could restrict the ability of the Company to buy investments from, to sell investments to or to invest in the same securities as, such Other Clients. Such regulations may have the effect of limiting the investment opportunities available to the Company. In addition, as a consequence of Blackstone&#8217;s status as a public company, the officers, directors, members, managers and personnel of the Adviser may take into account certain considerations and other factors in connection with the management of the business and affairs of the Company and its affiliates that would not necessarily be taken into account if Blackstone were not a public company. The directors of Blackstone have fiduciary duties to shareholders of the public company that may conflict with their duties to the Company. Finally, although the Firm believes its positive reputation in the marketplace provides benefit to the Company and Other Clients, the Adviser could decline to undertake investment activity or transact with a counterparty on behalf of the Company for reputational reasons, and this decision could result in the Company foregoing a profit or suffering a loss.</span></div></ix:continuation></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_46"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. Unresolved Staff Comments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_3185"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1C. Cybersecurity</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Cybersecurity Risk Management and Strategy</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an externally managed closed-end management investment company that has elected to be treated as a BDC under the 1940 Act, our day-to-day operations are managed by the Adviser, Administrator and our executive officers under the oversight of our Board of Trustees. Our executive officers are senior Blackstone Credit &amp; Insurance professionals and each of the Adviser and Administrator is a subsidiary of Blackstone. As such, we are reliant on Blackstone for assessing, identifying and managing material risks to our business from cybersecurity threats. Below are details Blackstone has provided to us regarding its cybersecurity program that are relevant to us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone maintains a comprehensive cybersecurity program, including policies and procedures designed to protect its systems, operations, and the data entrusted to it, including by us and the Adviser, from anticipated threats or hazards. Blackstone utilizes a variety of protective measures as a part of its cybersecurity program. These measures include, where appropriate, physical and digital access controls, patch management, identity verification and mobile device management software, annual employee cybersecurity awareness and best practices training programs, security baselines and tools to report anomalous activity, and monitoring of data usage, hardware and software.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone tests its cybersecurity defenses regularly through automated and manual vulnerability scanning, to identify and remediate critical vulnerabilities. In addition, it conducts annual &#8220;white hat&#8221; penetration tests to validate its security posture. Blackstone examines its cybersecurity program every two to three years with third parties, evaluating its effectiveness in part by considering industry standards and established frameworks, such as the National Institute of Standards and Technology and Center for Internet Security, as guidelines. Further, Blackstone engages in cyber incident tabletop exercises and scenario planning exercises involving hypothetical cybersecurity incidents to test its cyber incident response processes. Blackstone&#8217;s Chief Security Officer (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;CSO&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and members of Blackstone&#8217;s senior management, Legal and Compliance, Technology and Innovations (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BXTI&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), and Global Corporate Affairs participate in these exercises. Learnings from these tabletop exercises and any events Blackstone experiences are reviewed, discussed, and incorporated into its cybersecurity framework as appropriate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Blackstone&#8217;s internal exercises to test aspects of its cybersecurity program, Blackstone periodically engages independent third parties to analyze data on the interactions of users of Blackstone information technology resources, including Blackstone employees, and conduct penetration tests and scanning exercises to assess the performance of Blackstone&#8217;s cybersecurity systems and processes.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone has a comprehensive Security Incident Response Plan (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;IRP&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) designed to inform the proper escalation (including, as appropriate, to our senior management) of non-routine suspected or confirmed information security or cybersecurity events based on the expected risk an event presents. As appropriate, a Security Incident Response Team composed of individuals from several internal technical and managerial functions may be formed to investigate and remediate the event and determine the extent of external advisor support required, including from external counsel, forensic investigators, and/or law enforcement. The IRP sets out ongoing monitoring or remediating actions to be taken after resolution of an incident. The IRP is reviewed at least annually by Blackstone&#8217;s CSO and members of BXTI and Blackstone&#8217;s Legal and Compliance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone maintains a formal cybersecurity risk management process and cybersecurity risk register, designed to track cybersecurity risks at the firm, and integrates these processes into the firm&#8217;s overall risk management practices described above. Blackstone&#8217;s CSO periodically discusses and reviews cybersecurity risks and related mitigants with its enterprise risk committee and incorporates relevant cybersecurity risk updates and metrics in the semi-annual enterprise-wide risk management report.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone has a process designed to assess, the cybersecurity risks associated with the engagement of third-party vendors, including those of companies externally managed by Blackstone such as us. This assessment is conducted on the basis of, among other factors, the types of services provided, and the extent and type of Blackstone data accessed or processed by a third-party vendor. On the basis of its preliminary risk assessment of a third-party vendor, Blackstone may conduct further cybersecurity reviews or request remediation of, or contractual protections related to, any actual or potential identified cybersecurity risks. In addition, where appropriate, Blackstone seeks to include in its contractual arrangements with certain of its third-party vendors provisions addressing best practices with respect to data and cybersecurity, as well as the right to assess, monitor, audit and test such vendors&#8217; cybersecurity programs and practices. Blackstone also utilizes a number of digital controls, which are reviewed at least annually, to monitor and manage third-party access to its internal systems and data.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of how risks from cybersecurity threats affect our business, and our reliance on Blackstone in managing these risks, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 1A. Risk Factors &#8211; Risk Related to our Business &#8211; Cybersecurity and data protection risks could result in the loss of data, interruptions in our business, and damage to our reputation, and subject us to regulatory actions&#160;, increased costs and financial losses, each of which could have a material adverse effect on our business and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Cybersecurity Governance</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone has a dedicated cybersecurity team, led by Blackstone&#8217;s CSO, who works closely with Blackstone senior management, including Blackstone&#8217;s Chief Technology Officer (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;CTO&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), to develop and advance the firm&#8217;s cybersecurity strategy, which applies to us and the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone&#8217;s CSO and CTO have extensive experience in cybersecurity and technology, respectively. Blackstone&#8217;s CSO, Adam Fletcher, is a Senior Managing Director in BXTI and is responsible for all aspects of cyber and physical security across Blackstone. Prior to his appointment as CSO in 2017, Mr. Fletcher was Blackstone&#8217;s Deputy CSO. Before joining Blackstone in 2014, Mr. Fletcher led the International Security organization for Equifax from 2012 to 2014. Mr. Fletcher received a BS in Operations Research and Industrial Engineering from Cornell University.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone&#8217;s CTO, John Stecher is a Senior Managing Director and head of BXTI. Mr. Stecher is responsible for all aspects of technology across Blackstone. Mr. Stecher also advises Blackstone&#8217;s investment teams and acts as a resource to Blackstone portfolio companies, and companies externally managed by Blackstone such as us, on technology-related matters. Before joining Blackstone in 2020, Mr. Stecher was a Managing Director and the Chief Technology Officer and Chief Innovation Officer at Barclays. He was also a member of the Barclays Technology Management Committee. Prior to joining Barclays in 2017, Mr. Stecher held a variety of senior management and engineering roles across Goldman Sachs&#8217; capital markets and technology divisions. Mr. Stecher received a BS in Computer Science from the University of Wisconsin &#8211; Madison and a MS in Computer Science from the University of Minnesota.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BXTI conducts periodic cybersecurity risk assessments, including assessments or audits of third-party vendors, and assists with the management and mitigation of identified cybersecurity risks. The CSO and CTO review Blackstone&#8217;s cybersecurity framework annually as well as on an event-driven basis as necessary. The CSO and CTO also review the scope of Blackstone&#8217;s cybersecurity measures periodically, including in the event of a change in business practices that may implicate the security or integrity of Blackstone&#8217;s information and systems.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Trustees is responsible for understanding the primary risks to our business. The Board of Trustees is responsible for reviewing periodically our and the Adviser&#8217;s information technology security controls and related compliance matters, with management. Blackstone&#8217;s CSO, or designee, reports to the Board of Trustees, or a committee thereof, at least annually on cybersecurity matters, including risks facing us and the Adviser and, as applicable, certain incidents. In addition to such periodic reports, the Board of Trustees or a committee thereof may receive updates from management as to our and the Adviser&#8217;s cybersecurity risks and Blackstone cybersecurity program developments.</span></div><div id="i33edc808e7824948b94b269ed713a939_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Properties.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not own any real estate or other physical properties materially important to our operation. Our corporate headquarters are located at 345 Park Avenue, 31st floor, New York, New York 10154 and are provided by the Administrator in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accordance</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with the terms of our Administration Agreement. We believe that our office facilities are suitable and adequate for our business as it is contemplated to be conducted.</span></div><div id="i33edc808e7824948b94b269ed713a939_52"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Legal Proceedings.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently subject to any material legal proceedings. From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Our business is also subject to extensive regulation, which may result in regulatory proceedings against us.</span></div><div id="i33edc808e7824948b94b269ed713a939_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_58"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i33edc808e7824948b94b269ed713a939_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the NYSE under the symbol &#8220;BXSL.&#8221; Our common stock has historically traded at prices above or below our NAV per share since our common stock began trading on the NYSE on October 28, 2021. It is not possible to predict whether our common stock will trade at a price per share at, above or below NAV per share. On February 27, 2024, the last reported closing sales price of our common stock on the NYSE was $29.94 per share, which represented a premium of 12.3% to NAV per share reported by us as of December&#160;31, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;20, 2024, there were 71 holders of record of our shares. This number does not include shareholders for whom shares are held in &#8220;nominee&#8221; or &#8220;street name.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions and Dividend Reinvestment</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally intend to distribute, out of assets legally available for distribution, substantially all of our available earnings, on a quarterly basis, as determined by the Board in its discretion. We can offer no assurance that we will achieve results that will permit the payment of any cash distributions and, if we issue senior securities, we will be prohibited from making distributions if doing so causes us to fail to maintain the asset coverage ratios stipulated by the 1940 Act or if distributions are limited by the terms of any of our borrowings.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our distributions declared and payable for the year ended December&#160;31, 2023 (dollars in thousands except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date Declared</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 20, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 26, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our dividend reinvestment plan, the following table summarizes the amounts received and shares issued to shareholders who have not opted out of our dividend reinvestment plan during the year ended December&#160;31, 2023 (dollars in thousands except share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Issued</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Plan</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, our Board authorized a share repurchase plan, under which we may repurchase up to $250 million in the aggregate of our outstanding common shares in the open market at prices below our NAV per share for a one-year term, in accordance with the guidelines specified in Rule 10b-18 of the Exchange Act (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Company 10b-18 Plan&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not repurchase any of its shares during the year ended December&#160;31, 2023.</span></div><div id="i33edc808e7824948b94b269ed713a939_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Price Range of Common Stock</span></div><ix:nonNumeric contextRef="c-1" name="cef:SharePriceTableTextBlock" id="f-161" continuedAt="f-161-1" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the net asset value per share of our common stock, the range of high and low closing sales prices of our common stock reported on the NYSE, the closing sales price as a premium (discount) to net asset value and the dividends declared by us in each fiscal quarter since we began trading on the NYSE.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.998%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price Range</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Asset Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High Sales Price Premium (Discount) to Net Asset Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low Sales Price Premium (Discount) to Net Asset Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Dividend Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-120" decimals="INF" name="cef:HighestPriceOrBid" scale="0" id="f-162">26.25</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-120" decimals="INF" name="cef:LowestPriceOrBid" scale="0" id="f-163">22.26</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-120" decimals="3" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-164">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-120" decimals="3" sign="-" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-165">14.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Quarter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-121" decimals="INF" name="cef:HighestPriceOrBid" scale="0" id="f-166">27.51</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-121" decimals="INF" name="cef:LowestPriceOrBid" scale="0" id="f-167">23.95</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-121" decimals="3" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-168">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-121" decimals="3" sign="-" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-169">8.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-122" decimals="INF" name="cef:HighestPriceOrBid" scale="0" id="f-170">28.77</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-122" decimals="INF" name="cef:LowestPriceOrBid" scale="0" id="f-171">26.67</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-122" decimals="3" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-172">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-122" decimals="3" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-173">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth Quarter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-123" decimals="INF" name="cef:HighestPriceOrBid" scale="0" id="f-174">28.63</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-123" decimals="INF" name="cef:LowestPriceOrBid" scale="0" id="f-175">26.06</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-123" decimals="3" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-176">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-123" decimals="3" sign="-" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-177">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Quarter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-124" decimals="INF" name="cef:HighestPriceOrBid" scale="0" id="f-178">31.75</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-124" decimals="INF" name="cef:LowestPriceOrBid" scale="0" id="f-179">27.88</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-124" decimals="3" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-180">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-124" decimals="3" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-181">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-125" decimals="INF" name="cef:HighestPriceOrBid" scale="0" id="f-182">28.99</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-125" decimals="INF" name="cef:LowestPriceOrBid" scale="0" id="f-183">23.30</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-125" decimals="3" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-184">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-125" decimals="3" sign="-" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-185">10.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Quarter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="INF" name="cef:HighestPriceOrBid" scale="0" id="f-186">25.24</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="INF" name="cef:LowestPriceOrBid" scale="0" id="f-187">22.11</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-126" decimals="3" sign="-" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-188">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-126" decimals="3" sign="-" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-189">14.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth Quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-127" decimals="INF" name="cef:HighestPriceOrBid" scale="0" id="f-190">24.68</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-127" decimals="INF" name="cef:LowestPriceOrBid" scale="0" id="f-191">22.35</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-127" decimals="3" sign="-" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-192">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-127" decimals="3" sign="-" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-193">13.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth Quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-128" decimals="INF" name="cef:HighestPriceOrBid" scale="0" id="f-194">37.64</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-128" decimals="INF" name="cef:LowestPriceOrBid" scale="0" id="f-195">27.63</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-128" decimals="3" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" scale="-2" id="f-196">43.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low closing sales prices. The NAV shown are based on outstanding shares at the end of the relevant quarter.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Calculated as the respective high or low closing sales price less NAV, divided by NAV (in each case, as of the applicable quarter). </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents the dividend or distribution declared and payable in the relevant quarter.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_67"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This graph compares the stockholder return on our common stock from October 28, 2021 (the date our common stock commenced trading on the NYSE) to December&#160;31, 2023, with that of the Standard &amp; Poor&#8217;s 500 Stock Index, Standard &amp; Poor&#8217;s 500 Financials Index, Standard &amp; Poor&#8217;s BDC Index and Morningstar LSTA Leveraged Loan Index. This graph assumes that on October 28, 2021, $100 was invested in our common stock, the Standard &amp; Poor&#8217;s 500 Stock Index, the Standard &amp; Poor&#8217;s 500 Financials Index, the Standard &amp; Poor&#8217;s BDC Index, and the Morningstar LSTA Leveraged Loan Index. The graph also assumes the reinvestment of all cash dividends prior to any tax effect. The graph and other information furnished under this Part II Item 5 of this Annual Report on Form 10-K shall not be deemed to be &#8220;soliciting material&#8221; or to be &#8220;filed&#8221; with the SEC or subject to Regulation 14A or 14C under, or to the liabilities of Section 18 of, the Exchange Act. The stock price performance included in the below graph is not necessarily indicative of future stock performance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPARISON OF CUMULATIVE TOTAL RETURN AMONG BLACKSTONE SECURED LENDING FUND, STANDARD &amp; POOR&#8217;S 500 INDEX, STANDARD &amp; POOR&#8217;S 500 FINANCIALS INDEX, STANDARD &amp; POOR&#8217;S BDC INDEX AND MORNINGSTAR&#8217;S LSTA LEVERAGED LOAN INDEX</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><img src="bxsl-20231231_g4.jpg" alt="Loan Index Chart Q4'23 v2.jpg" style="height:379px;margin-bottom:5pt;vertical-align:text-bottom;width:636px"/></div><div id="i33edc808e7824948b94b269ed713a939_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. (Reserved).</span></div><div><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_73"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This section of this Form 10-K generally discusses 2023 and 2022 items and year to year comparisons between 2023 and 2022. For the discussion of 2022 compared to 2021 see &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_73">Part II. Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_73">&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> of our Annual Report on Form 10-K for the year ended December 31, 2022, which specific discussion is incorporated herein by reference. The information contained in this section should be read in conjunction with the consolidated financial statements and notes thereto in Part II, Item 8 of this Form 10-K &#8220;Consolidated Financial Statements and Supplementary Data.&#8221; This discussion contains forward-looking statements and involves numerous risks and uncertainties, including, but not limited to those described in Part I, Item 1A of this Form 10-K &#8220;Risk Factors.&#8221;&#160;Our actual results could differ materially from those anticipated by such forward-looking information due to factors discussed under &#8220;Risk Factors&#8221; and &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; appearing elsewhere in this Form 10-K. </span></div><div id="i33edc808e7824948b94b269ed713a939_76"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview and Investment Framework</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a Delaware statutory trust structured as a non-diversified, closed-end management investment company that has elected to be regulated as a BDC under the 1940 Act. In addition, for U.S. federal income tax purposes, we elected to be treated as a RIC under the Code. We are managed by our Adviser. The Administrator will provide the administrative services necessary for us to operate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under normal market conditions, we generally invest at least 80% of our total assets (net assets plus borrowings for investment purposes) in secured debt investments and our portfolio is composed primarily of first lien senior secured and unitranche loans. To a lesser extent, we have and may continue to also invest in second lien, third lien, unsecured or subordinated loans and other debt and equity securities. In limited instances we may retain the &#8220;last out&#8221; portion of a first-lien loan. In such cases, the &#8220;first out&#8221; portion of the first lien loan would receive priority with respect to payment over our &#8220;last out&#8221; position. In exchange for the higher risk of loss associated with such &#8220;last out&#8221; portion, we would earn a higher rate of interest than the &#8220;first out&#8221; position. We do not currently focus on investments in issuers that are distressed or in need of rescue financing.</span></div><div id="i33edc808e7824948b94b269ed713a939_79"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Components of Our Results of Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We focus primarily on loans and securities, including syndicated loans, of private U.S. companies, which includes larger and middle market companies. In many market environments, we believe such a focus offers an opportunity for superior risk-adjusted returns.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our level of investment activity (both the number of investments and the size of each investment) can and will vary substantially from period to period depending on many factors, including the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity for such companies, the general economic environment, trading prices of loans and other securities and the competitive environment for the types of investments we make.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenues in the form of interest income from the debt securities we hold and dividends. Our debt investments typically have a term of five to eight years and bear interest at floating rates on the basis of a benchmark such as SOFR, SONIA, etc. In some instances, we receive payments on our debt investments based on scheduled amortization of the outstanding balances. In addition, we may receive repayments of some of our debt investments prior to their scheduled maturity date. The frequency or volume of these repayments fluctuates significantly from period to period. Our portfolio activity also reflects the proceeds of sales of securities. In some cases, our investments may provide for deferred interest payments or PIK interest. The principal amount of loans and any accrued but unpaid interest generally become due at the maturity date.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we generate revenue from various fees in the ordinary course of business such as in the form of commitment, loan origination, structuring, consent, waiver, amendment, syndication and other miscellaneous fees as well as fees for providing managerial assistance to our portfolio companies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expenses</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as specifically provided below, all investment professionals and staff of the Adviser, when and to the extent engaged in providing investment advisory services to us, and the base compensation, bonus and benefits, and the routine overhead expenses, of such personnel allocable to such services, will be provided and paid for by the Adviser. We bear all other costs and expenses of our operations, administration and transactions, including, but not limited to (a) investment advisory fees, including management fees and incentive fees, to the Adviser, pursuant to the Investment Advisory Agreement; (b) our allocable portion of compensation, overhead (including rent, office equipment and utilities) and other expenses incurred by the Administrator in performing its administrative obligations under the Administration Agreement, including but not limited to: (i) our chief compliance officer, chief financial officer and their respective staffs; (ii) investor relations, legal, operations and other non-investment professionals (including information technology professionals) at the Administrator that perform duties for us; and (iii) any internal audit group personnel of Blackstone or any of its affiliates; and (c) all other expenses of our operations, administrations and transactions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Adviser, the Administrator or their affiliates may pay third-party providers of goods or services on our behalf. We will reimburse the Adviser, Administrator or such affiliates thereof for any such amounts. From time to time, the Adviser or the Administrator may defer or waive fees and/or rights to be reimbursed for expenses. The Administrator has elected to forgo any reimbursement for rent and other occupancy costs for the years ended December&#160;31, 2023, 2022 and 2021. However, the Administrator may seek reimbursement for such costs in future periods. All of the foregoing expenses will ultimately be borne by our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs and expenses of the Administrator and the Adviser that are eligible for reimbursement by us will be reasonably allocated on the basis of time spent, assets under management, usage rates, proportionate holdings, a combination thereof or other reasonable methods determined by the Administrator in accordance with policies adopted by the Board.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_82"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Portfolio and Investment Activity</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2023, we made $1,945.9&#160;million aggregate principal amount of new investment commitments (including $662.9&#160;million of which remained unfunded as of December&#160;31, 2023), $1,931.4&#160;million of which was first lien debt, $10.2&#160;million of which was unsecured debt and $4.3&#160;million of which was equity.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment activity is presented below (information presented herein is at amortized cost unless otherwise indicated) (dollar amounts in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of and for the year ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments, beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,657,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,745,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,575,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New investments purchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,824,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment-in-kind interest capitalized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accretion of discount on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss) on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments sold or repaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,305,234)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,174,176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,734,419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,934,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,657,872&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,745,126&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of investments funded at principal:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First lien debt investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,672,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second lien debt investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,436&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019,263&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,884,436&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Proceeds from investments sold or repaid:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First lien debt investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,231,702)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,077,767)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,632,926)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second lien debt investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,351)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,024)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,535)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,453)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(932)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,305,234)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,174,176)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,734,419)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of new investments in new portfolio companies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average new investment commitment amount</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield of new investments </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield on investments fully sold or paid down</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of portfolio companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield on debt and income producing investments, at amortized cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield on debt and income producing investments, at fair value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average loan to value (LTV) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of debt investments bearing a floating rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of debt investments bearing a fixed rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of assets on non-accrual, at amortized cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Computed as (a) the annual stated interest rate or yield plus the annual accretion of discounts or less the annual amortization of premiums, as applicable, on accruing debt included in such securities, divided by (b) total debt investments (at fair value or cost, as applicable) included in such securities. Actual yields earned over the life of each investment could differ materially from the yields presented above.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">As of December&#160;31, 2023, 2022 and 2021, the weighted average total portfolio yield at cost was 11.8%, 10.5% and 7.2%, respectively. The weighted average total portfolio yield at fair value was 11.8%, 10.6% and 7.1%, respectively.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Includes all private debt investments for which fair value is determined by our Board in conjunction with a third-party valuation firm and excludes quoted assets. Average loan-to-value represents the net ratio of loan-to-value for each portfolio company, weighted based on the fair value of total applicable private debt investments. Loan-to-value is calculated as the current total net debt through each respective loan tranche divided by the estimated enterprise value of the portfolio company as of the most recent quarter end.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Amount rounds to less than 0.1% for December&#160;31, 2023.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">As a percentage of total amortized cost of Investments. Assets on non-accrual represented less than 0.1%, 0.0% and 0.0% of total fair value of Investments as of December&#160;31, 2023, 2022 and 2021, respectively. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">As a percentage of total fair value of debt investments. As of December&#160;31, 2023, 2022 and 2021, debt investments bearing a floating rate represented 98.9%, 98.3% and 98.2%, respectively, of total Investment at fair value.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, our portfolio companies had a weighted average annual revenue of $773.9&#160;million and weighted average annual EBITDA of $191.9&#160;million. These calculations include all private debt investments for which fair value is determined by the Board of Trustees in conjunction with a third-party valuation firm and excludes quoted assets. Amounts are weighted based on fair market value of each respective investment. Amounts were derived from the most recently available portfolio company financial statements, have not been independently verified by us, and may reflect a normalized or adjusted amount. Accordingly, we make no representation or warranty in respect of this information.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on our investments, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Consolidated Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 4. Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div id="i33edc808e7824948b94b269ed713a939_85"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the operating results (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.352%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.352%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143,517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net expenses before excise tax</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income before excise tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income after excise tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,676&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,929&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net increase (decrease) in net assets resulting from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,951&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404,556&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,422&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net increase (decrease) in net assets resulting from operations can vary from period to period as a result of various factors, including acquisitions, the level of new investment commitments, the recognition of realized gains and losses and changes in unrealized appreciation and depreciation on the investment portfolio. As a result, comparisons may not be meaningful.</span></div><div id="i33edc808e7824948b94b269ed713a939_2385"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment income was as follows (dollar amounts in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment-in-kind interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investment income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143,517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investment income increased to $1,143.5&#160;million for the year ended December&#160;31, 2023, an increase of $293.2 million, or 34%, compared to the year ended December&#160;31, 2022, primarily attributable to increased reference interest rates driving increased interest income from our investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, for the year ended December&#160;31, 2023, we recorded $19.3 million of non-recurring interest income (e.g., prepayment premiums, accelerated accretion of upfront loan origination fees and unamortized discounts, etc.) as compared to $4.9 million in the prior year primarily a result of increased prepayments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the years ended December&#160;31, 2023, and 2022, Payment-in-kind interest income represented 4.1% and 4.7% of investment income, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that investment income will vary based on a variety of factors including the pace of our originations, repayments and changes in interest rates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While rising interest rates have favorably impacted our investment income during the year ended December&#160;31, 2023, further interest rate increases, and the resulting higher cost of capital have the potential to negatively impact the free cash flow and credit quality of certain borrowers which could impact their ability to make principal and interest payments. If such interest rate increases occur concurrently with a period of economic weakness or a slowdown in growth, our borrowers&#8217; and/or our portfolio performance may be negatively impacted. Further, significant market dislocation as a result of changing economic conditions could limit the liquidity of certain assets traded in the credit markets, and this could impact our ability to sell such assets at attractive prices or in a timely manner.</span></div><div id="i33edc808e7824948b94b269ed713a939_2414"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expenses</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses were as follows (dollar amounts in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income based incentive fees </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital gains incentive fees</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board of Trustees' fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative service expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total expenses before excise tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees waived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,427)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive fees waived </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,604)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,879)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,333)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net expenses before excise tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472,817&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365,130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment income before excise tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment income after excise tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653,905&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,776&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,676&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total interest expense (including unused fees and other debt financing expenses), increased to $266.4 million for the year ended December&#160;31, 2023, an increase of $62.8 million or 31%, compared to the same period in the prior year, primarily driven by an increase in our weighted average interest rate on our borrowings relative to the prior year partially offset by a decrease in our average principal of debt outstanding. Our weighted average interest rate increased to 4.93% for the year ended December&#160;31, 2023, from 3.46% in the prior year. The average principal of debt outstanding decreased to $5,275.4 million for the year ended December&#160;31, 2023, from $5,732.6 million in the prior year.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management fees decreased to $98.1 million for the year ended December&#160;31, 2023, a decrease of $3.6 million, or 4%, compared to the year ended December&#160;31, 2022, primarily due to a decrease in average quarter end gross assets during 2023 compared to the prior year. Our average quarter end gross assets decreased to $9,839.3 million for the year ended December&#160;31, 2023, from $10,137.1 million at December&#160;31, 2022.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser voluntarily waived management fees following the IPO such that the management fee remained at 0.75% for a period of two years following the IPO (versus the contractual rate of 1.00%), which resulted in waivers of $20.2 million and $25.4 million for the years ended December&#160;31, 2023, and 2022, respectively. The Waiver Period ended on October 28, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Based Incentive Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income based incentive fees increased to $134.2 million for the year ended December&#160;31, 2023 from $97.2 million for the year ended December&#160;31, 2022, primarily due to an increase in pre-incentive fee net investment income. Pre-incentive fee net investment income increased to $767.0 million for the year ended December&#160;31, 2023, compared to $555.2 million for the same period in the prior year.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser voluntarily waived incentive fees following the IPO such that the fee remained at 15.0% for a period of two years following the IPO (versus the contractual rate of 17.5%), which resulted in waivers of $15.6 million and $13.9 million for the years ended December&#160;31, 2023, and 2022, respectively. The Waiver Period ended on October 28, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Gains Incentive Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reversed previously accrued capital gains incentive fees of $(5.5) million for the year ended December&#160;31, 2023, compared to a reversal of previously accrued capital gains incentive fees of $(11.9) million during the same period in the prior year. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reversal of previously accrued incentive fees was attributable to net realized and unrealized losses in the current year. The accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reduction of previously recorded expense if such cumulative amount is less in the prior period. If such cumulative amount is negative, then there is no accrual. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Expenses</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Professional fees include legal, rating agencies, audit, tax, valuation, technology and other professional fees incurred related to the management of us. Administrative service fees represent fees paid to the Administrator for our allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the administration agreement, including our allocable portion of the cost of certain of our executive officers, their respective staff and other non-investment professionals that perform duties for us. Other general and administrative expenses include insurance, filing, research, our sub-administrator, subscriptions and other costs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expenses increased to $15.3&#160;million for the year ended December&#160;31, 2023, from $13.9&#160;million for the same period in the prior year, primarily driven by an increase in Professional fees driven, in part, by inflationary pressure and increased market transactions driving increased costs.</span></div><div id="i33edc808e7824948b94b269ed713a939_2442"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes, Including Excise Taxes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected to be treated as a RIC under Subchapter M of the Code, and we intend to operate in a manner so as to continue to qualify for the tax treatment applicable to RICs. To qualify for tax treatment as a RIC, we must, among other things, distribute to our shareholders in each taxable year generally at least 90% of the sum of our investment company taxable income, as defined by the Code (without regard to the deduction for dividends paid), and net tax-exempt income for that taxable year. To maintain our tax treatment as a RIC, we, among other things, intend to make the requisite distributions to our shareholders, which generally relieve us from corporate-level U.S. federal income taxes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the level of taxable income earned in a tax year, we may carry forward taxable income (including net capital gains, if any) in excess of current year dividend distributions from the current tax year into the next tax year and pay a nondeductible 4% U.S. federal excise tax on such taxable income, as required. To the extent that we determine that our estimated current year annual taxable income will be in excess of estimated current year dividend distributions from such income, we will accrue excise tax on estimated excess taxable income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, we incurred $16.8 million, $1.4 million and $2.4 million, respectively, of U.S. federal excise tax.</span></div><div id="i33edc808e7824948b94b269ed713a939_2470"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Unrealized Gain (Loss)</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net change in unrealized gain (loss) was comprised of the following (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized gain (loss) on investments</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,841)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126,493)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized gain (loss) on translation of assets and liabilities in foreign currencies</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,732)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in unrealized gain (loss) on investments</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,573)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,149)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2023, the net change in unrealized loss of $54.6&#160;million was primarily driven by the decrease in the fair value of our debt investments. The fair value of our debt investments as a percentage of principal decreased by 0.2%, driven, in part, by changes in the economic outlook as well as portfolio company fundamentals.</span></div><div id="i33edc808e7824948b94b269ed713a939_2498"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Realized Gain (Loss)</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The realized gains and losses on fully exited and partially exited investments comprised of the following (dollar amounts in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss) on investments</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,205)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss) on foreign currency transactions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net realized gain (loss) on investments</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,619&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,929&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,568&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2023, we generated realized losses on investments of $23.9 million partially offset by realized gains on investments of $17.7 million, primarily from full or partial sales or restructures of our debt investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net realized loss on investments were offset by the net realized gain on foreign currency transactions of $18.8 million during the year ended December&#160;31, 2023, primarily a result of fluctuations in the CAD and GBP exchange rates vs. USD.</span></div><div id="i33edc808e7824948b94b269ed713a939_88"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Condition, Liquidity and Capital Resources</span></div><ix:nonNumeric contextRef="c-1" name="cef:EffectsOfLeverageTextBlock" id="f-197" continuedAt="f-197-1" escape="true"><ix:continuation id="f-161-1" continuedAt="f-161-2"><ix:continuation id="f-40-99" continuedAt="f-40-100"><ix:continuation id="f-36-1" continuedAt="f-36-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity and capital resources are generated primarily from cash flows from interest, dividends and fees earned from our investments and principal repayments, our credit facilities, debt securitization transactions, and other secured and unsecured debt. We may also generate cash flow from operations, future borrowings and future offerings of securities including public and/or private issuances of debt and/or equity securities through both registered offerings and private offerings. The primary uses of our cash and cash equivalents are for (i) originating loans and purchasing senior secured debt investments, (ii) funding the costs of our operations (including fees paid to our Adviser and expense reimbursements paid to our Administrator), (iii) debt service, repayment and other financing costs of our borrowings and (iv) cash distributions to the holders of our shares.</span></div></ix:continuation></ix:continuation></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><ix:continuation id="f-197-1"><ix:continuation id="f-161-2"><ix:continuation id="f-40-100"><ix:continuation id="f-36-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To&#160;facilitate public issuances of debt and/or equity securities, in July 2022, we filed a shelf registration statement with the SEC that is effective for a term of three years and expires in July 2025. The amount of securities to be issued pursuant to the shelf registration statement filed in July 2022 was not specified when it was filed and there is no specific dollar limit on the amount of securities we may issue. The securities covered by the registration statement filed in July 2022 include: (i) common shares; (ii) preferred shares; (iii) debt securities; (iv) subscription rights; and (v) warrants. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of any offering.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, our debt consisted of asset based leverage facilities, a revolving credit facility, and unsecured note issuances. We may from time to time enter into additional credit facilities, increase the size of our existing credit facilities or issue further debt securities. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors. In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. As of December&#160;31, 2023 and December&#160;31, 2022, we had an aggregate amount of $4,937.9 million and $5,563.0 million of senior securities outstanding, respectively, and our asset coverage ratio was 200.3% and 174.8%, respectively. We seek to carefully consider our unfunded commitments for the purpose of planning our ongoing financial leverage. Further, we maintain sufficient borrowing capacity within the 150% asset coverage limitation to cover any outstanding unfunded commitments we are required to fund. From time to time we may also repurchase our outstanding debt. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, and other factors. The amounts involved in any such purchase transactions, individually or in the aggregate, may be material.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents as of December&#160;31, 2023, taken together with our $1,662.1 million of unused capacity under our credit facilities (subject to borrowing base availability, $1,662.0 million is available to borrow) is expected to be sufficient for our investing activities and to conduct our operations in the near term. Additionally, we held $157.9 million of Level 2 debt investments as of December&#160;31, 2023, which could provide additional liquidity if necessary.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have historically been able to obtain sufficient borrowing capacity, a deterioration in economic conditions or any other negative economic developments could restrict our access to financing in the future. We may not be able to find new financing for future investments or liquidity needs and, even if we are able to obtain such financing, such financing may not be on as favorable terms as we have previously obtained. These factors may limit our ability to make new investments and adversely impact our results of operations. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we had </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$154.9 million in cash and cash equivalents. During the year ended December&#160;31, 2023, cash provided by operating activities was $458.8 million, primarily from receipt of interest payments from our investments, partially offset by purchases of investments, net of sales of investments and principal repayments, of $178.1 million.&#160;Cash used in financing activities was $432.2 million during the year, which was primarily as a result of net repayments on our credit facilities and Unsecured Notes of $650.9 million and dividends paid in cash of $438.0 million partially offset by $665.3 million of proceeds from the issuance of our common shares.</span></div></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_91"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2023, we completed a follow-on offering under our shelf registration statement, issuing 6,500,000 of our common shares of beneficial interest at a price to the underwriters of $26.78 per share. Net of underwriting fees, we received cash proceeds, before offering expenses, of $174.1 million. On August 18, 2023, the underwriters exercised, in full, their option to purchase an additional 975,000 shares of common shares, which resulted in cash proceeds, before offering expenses, of $26.1 million. We incurred offering expenses of $0.4 million in connection with the follow-on offering.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also access liquidity through our &#8220;at-the-market&#8221; offering program, pursuant to which we may sell, from time to time, up to $400.0 million of additional common shares of&#160;beneficial interest (which amount may be increased). During the year ended December&#160;31, 2023, we sold common shares for net proceeds of $465.5 million through our &#8220;at-the-market&#8221; offering program. As of December&#160;31, 2023, $328.9 million of common shares were available for issuance under our &#8220;at-the-market&#8221; offering program.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on our &#8220;at-the-market&#8221; offering program, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Consolidated Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 8. Net Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_2526"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributions</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our distributions declared and payable for the year ended December&#160;31, 2023 (dollar amounts in thousands except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date Declared</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 20, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 26, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;text-indent:18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the years ended December&#160;31, 2023, 2022, and 2021, interest-related dividends represented 87.6%, 86.4% and 85.2%, of total dividends paid by the Company, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the years ended December&#160;31, 2023, 2022 and 2021, short-term capital gain dividends represented 0.0%, 1.8% and 11.0%, of total dividends paid by the Company, respectively. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the years ended December&#160;31, 2023, 2022, and 2021, capital gain dividends represented 9.3%, 2.6%, and 0.0%, of total dividends paid by the Company, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to distributions, we have adopted an &#8220;opt out&#8221; dividend reinvestment plan for shareholders. As a result, in the event of a declared cash distribution or other distribution, each shareholder that has not &#8220;opted out&#8221; of the dividend reinvestment plan will have their dividends or distributions automatically reinvested in additional shares rather than receiving cash distributions. Shareholders who receive distributions in the form of shares will be subject to the same U.S. federal, state and local tax consequences as if they received cash distributions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on our distributions and dividend reinvestment plan, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Consolidated Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 8. Net Assets.&#8221;</span></div><div id="i33edc808e7824948b94b269ed713a939_94"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plan</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, our Board authorized a share repurchase plan, under which we may repurchase up to $250 million in the aggregate of our outstanding common shares in the open market at prices below our NAV per share for a one-year term, in accordance with the guidelines specified in Rule 10b-18 of the Exchange Act (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Company 10b-18 Plan&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The timing, manner, price and amount of any share repurchases will be determined by us, in our sole discretion, based upon the evaluation of economic and market conditions, stock price, applicable legal and regulatory requirements and other factors. During periods when we are able to issue shares under our &#8220;at-the-market&#8221; program, we will not repurchase shares under the 10b-18 share repurchase plan.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any of our shares during the year ended December&#160;31, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For additional information on our share repurchases see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Item 8. Consolidated Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 8. Net Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;</span></div><div id="i33edc808e7824948b94b269ed713a939_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Borrowings</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of December&#160;31, 2023 and December&#160;31, 2022, we had an aggregate principal amount of $4,937.9 million and $5,563.0 million, respectively, of debt outstanding.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For additional information on our debt obligations see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Item 8. Consolidated Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 6. Borrowings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_100"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Portfolio Company Commitments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment portfolio contains and is expected to continue to contain debt investments which are in the form of lines of credit or delayed draw commitments, which require us to provide funding when requested by portfolio companies in accordance with underlying loan agreements.&#160;As of December&#160;31, 2023, and December&#160;31, 2022, we had unfunded commitments, including delayed draw term loans and revolvers, with an aggregate principal amount of $985.9 million and $690.3 million, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, from time to time, the Adviser and its affiliates may commit to an investment on behalf of the investment vehicles it manages, including the Company. Certain terms of these investments are not finalized at the time of the commitment and each respective investment vehicle's allocation may change prior to the date of funding. In this regard, as of December&#160;31, 2023, and December&#160;31, 2022, we estimate that $221.3 million and $16.5 million, respectively, of investments were committed but not yet funded.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments and Contingencies</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become a party to certain legal proceedings incidental to the normal course of its business. As of December&#160;31, 2023, management is not aware of any material pending legal proceedings.</span></div><div style="margin-top:12pt;text-indent:36pt"><span><br/></span></div><div id="i33edc808e7824948b94b269ed713a939_2994"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Related-Party Transactions</span></div><div style="margin-top:12pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into a number of business relationships with affiliated or related parties, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Investment Advisory Agreement; and</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Administration Agreement;</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the aforementioned agreements, we, our Adviser and certain of our Adviser&#8217;s affiliates have been granted exemptive relief by the SEC to co-invest with other funds managed by our Adviser or its affiliates in a manner consistent with our investment objectives, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Consolidated Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 3. Agreements and Related Party Transactions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_103"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Macroeconomic Environment</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year ended December&#160;31, 2023 has been characterized by continued volatility in global markets, driven by investor concerns over inflation, rising interest rates, slowing economic growth, political and regulatory uncertainty and geopolitical conditions, including the war in Ukraine and Russia and the escalated conflict in the Middle East. Events affecting financial institutions during the year also contributed to volatility in global markets and diminished liquidity and credit availability.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, inflation began to moderate as a result of the monetary policy tightening actions taken by central banks, including raising interest rates. These higher interest rates have created further uncertainty for the economy and for our borrowers. Although our business model is such that rising interest rates will, all else being equal, correlate to increases in our net income, increases in interest rates may adversely affect our existing borrowers and lead to nonperformance, as higher costs </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may dampen consumer spending and slow corporate profit growth, which may negatively impact</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> our portfolio companies as they may be susceptible to economic downturns or recessions and may be unable to repay our loans during these periods. Therefore, during these periods our non-performing assets may increase and the value of our portfolio may decrease if we are required to write down the values of our investments. Adverse economic conditions may also decrease the value of collateral securing some of our loans and the value of our equity investments. It remains difficult to predict the full impact of recent changes and any future changes in interest rates or inflation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Banking Sector Conditions</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bank closures in the United States over the course of 2023 have caused uncertainty for financial services companies and fear of instability in the global financial system generally. In addition, certain financial institutions&#8212;in particular smaller and/or regional banks&#8212;have experienced volatile stock prices and significant losses in their equity value, and there is concern that depositors at these institutions have withdrawn, or may withdraw in the future, significant sums from their accounts at these institutions. Notwithstanding intervention by U.S. governmental agencies to protect the uninsured depositors of banks that have recently closed, there is no guarantee that the uninsured depositors of a financial institution that closes (which depositors could include the Company and/or its portfolio companies) will be made whole or, even if made whole, that such deposits will become available for withdrawal in short order. There is a risk that other banks, or other financial institutions, may be similarly impacted, and it is uncertain what steps (if any) regulators may take in such circumstances or what other economic or other impacts there may be. In addition, uncertainty caused by recent bank failures&#8212;and general concern regarding the financial health and outlook for other financial institutions&#8212;could have an overall negative effect on banking systems and financial markets generally. These recent developments may also have other implications for broader economic and monetary policy, including interest rate policy. For the foregoing reasons, there can be no assurances that conditions in the banking sector and in global financial markets will not worsen and/or adversely affect the Company, its portfolio companies or their respective financial performance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIBOR and certain other floating rate benchmark indices have been the subject of recent national, international and regulatory guidance and proposals for reform or replacement. The publication of USD LIBOR continued until June 30, 2023, and market participants have generally transitioned to SOFR thereafter. Additionally, market participants have transitioned from GBP LIBOR to the Sterling Overnight Index Average, or SONIA, in line with guidance from the U.K. regulators.</span></div><div id="i33edc808e7824948b94b269ed713a939_106"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets, and any other parameters used in determining such estimates could cause actual results to differ. Our critical accounting policies and estimates should be read in connection with our risk factors described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 1A. Risk Factors.&#8221;</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to report its investments, including those for which current market values are not readily available, at fair value in accordance with ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ASC 820&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the applicable measurement date, and&#160;Rule 2a-5 under the 1940 Act.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on observable market prices or parameters or derived from such prices or parameters when such quotations are readily available.&#160;In accordance with&#160;Rule 2a-5 under the 1940 Act, a market quotation is &#8220;readily available&#8221; only when it is a quoted price (unadjusted) in active markets for identical instruments that a fund can access at the measurement date, provided that such a quotation is not considered to be readily available if it is not reliable. The Company utilizes mid-market pricing (i.e., mid-point of average bid and ask prices) to value these investments. These market quotations are obtained from independent pricing services, if available; otherwise generally from at least two principal market makers or primary market dealers.&#160;To assess the continuing appropriateness of pricing sources and methodologies, the Adviser regularly performs price verification procedures and issues challenges, as necessary, to independent pricing services or brokers, and any differences are reviewed in accordance with the valuation procedures. The Adviser does not adjust the prices unless it has a reason to believe market quotations are not reflective of the fair value of an investment.&#160;Examples of events that would cause market quotations to not reflect fair value could include cases when a security trades infrequently or not at all, causing a quoted purchase or sale price to become stale, or in the event of a &#8220;fire sale&#8221; by a distressed seller.&#160;All price overrides require approval from the Board.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where prices or inputs are not available or, in the judgment of the Board are not reliable, valuation techniques based on the facts and circumstances of the particular investment will be utilized.&#160;Securities that are not publicly traded or for which market prices are not readily available are valued at fair value as determined in good faith by the Board, based on, among other things, the input of the Adviser, the Audit Committee of the Board (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Audit Committee&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and independent valuation firms engaged on the recommendation of the Adviser and at the direction of the Board.&#160;These valuation approaches involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments&#8217; complexity.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Board undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company&#8217;s investments for which reliable market quotations are not readily available, or are available but deemed not reflective of the fair value of an investment, which includes, among other procedures, the following:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The valuation process begins with each investment being preliminarily valued by the Adviser&#8217;s valuation team in conjunction with the Adviser&#8217;s investment professionals responsible for each portfolio investment;</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">In addition, independent valuation firms engaged by the Board prepare quarter-end valuations of such investments except de minimis investments, as determined by the Adviser. The independent valuation firms provide a final range of values on such investments to the Board and the Adviser. The independent valuation firms also provide analyses to support their valuation methodology and calculations;</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The Adviser&#8217;s Valuation Committee reviews each valuation recommendation to confirm they have been calculated in accordance with the valuation policy and compares such valuations to the independent valuation firms&#8217; valuation ranges to ensure the Adviser&#8217;s valuations are reasonable;</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The Adviser&#8217;s Valuation Committee makes valuation recommendations to the Audit Committee;</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The Audit Committee reviews the valuation recommendations made by the Adviser's Valuation Committee, including the independent valuation firms' quarterly valuations, and once approved, recommends them for approval by the Board; and</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The Board reviews the valuation recommendations of the Audit Committee and determines the fair value of each investment in the portfolio in good faith based on the input of the Audit Committee, the Adviser's Valuation Committee and, where applicable, the independent valuation firms and other external service providers.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation of each of our investments will generally be made, as described above, as of the end of each fiscal quarter. In cases where the Company determines its net asset value (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NAV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) at times other than a quarter end, the Company updates the value of securities with market quotations to the most recent market quotation. For securities without market quotations, non-quarterly valuations will generally be the most recent quarterly valuation unless the Adviser determines that a significant observable change has occurred since the most recent quarter end with respect to the investment (which determination may be as a result of a material event at a portfolio company, material change in market spreads, secondary market transaction in the securities of an investment or otherwise). If the Adviser determines such a change has occurred with respect to one or more investments, the Adviser will determine whether to update the value for each relevant investment using a range of values from an independent valuation firm, where applicable, in accordance with the Company's valuation policy, pursuant to authority delegated by the Board.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the valuation process, the Board takes into account relevant factors in determining the fair value of the Company's investments for which reliable market quotations are not readily available, many of which are loans, including and in combination, as relevant, of: (i) the estimated enterprise value of a portfolio company, (ii) the nature and realizable value of any collateral, (iii) the portfolio company&#8217;s ability to make payments based on its earnings and cash flow, (iv) the markets in which the portfolio company does business, (v) a comparison of the portfolio company&#8217;s securities to any similar publicly traded securities, and (vi) overall changes in the interest rate environment and the credit markets that may affect the price at which similar investments may be made in the future. When an external event such as a purchase transaction, public offering or subsequent equity or debt sale occurs, the Board with the assistance of the Adviser, the Audit Committee and Independent valuation firms, considers whether the pricing indicated by the external event corroborates its valuation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of the Company&#8217;s portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter, and the Board may reasonably rely on that assistance. However, the Board is responsible for the ultimate valuation of the portfolio investments at fair value as determined in good faith pursuant to the Company&#8217;s valuation policy and a consistently applied valuation process.</span></div><div id="i33edc808e7824948b94b269ed713a939_109"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertainty with respect to the economic conditions has introduced significant volatility in the financial markets, and the effect of the volatility could materially impact our market risks, including those listed below. We are subject to financial market risks, including valuation risk and interest rate risk.</span></div><div id="i33edc808e7824948b94b269ed713a939_2554"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation Risk</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have invested, and plan to continue to invest, primarily in illiquid debt and equity securities of private companies. Most of our investments will not have a readily available market price, and we value these investments at fair value as determined in good faith by our Board, based on, among other things, the input of the Adviser, our Audit Committee and independent third-party valuation firms engaged at the direction of the Board, and in accordance with our valuation policy. There is no single standard for determining fair value. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. If we were required to liquidate a portfolio investment in a forced or liquidation sale, we may realize amounts that are different from the amounts presented and such differences could be material.</span></div><div id="i33edc808e7824948b94b269ed713a939_2583"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate sensitivity refers to the change in earnings that may result from changes in the level of interest rates. We intend to fund portions of our investments with borrowings, and at such time, our net investment income will be affected by the difference between the rate at which we invest and the rate at which we borrow. Accordingly, we cannot assure shareholders that a significant change in market interest rates will not have a material adverse effect on our net investment income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a prolonged low interest rate environment, the difference between the total interest income earned on interest earning assets and the total interest expense incurred on interest bearing liabilities may be compressed, reducing our net income and potentially adversely affecting our operating results. Conversely, in a rising interest rate environment, such difference could potentially increase thereby increasing our net income as indicated per the table below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, 99.9% of our debt investments based on fair value in our portfolio were at floating rates. Based on our consolidated balance sheet as of December&#160;31, 2023, the following table shows the annualized impact on net income of hypothetical base rate changes in interest rates (considering interest rate floors and ceilings for floating rate instruments assuming no changes in our investment and borrowing structure) (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest<br/>Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest<br/>Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up 300 basis points</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,769&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up 200 basis points</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,783)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up 100 basis points</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,391)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Down 100 basis points</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,648)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Down 200 basis points</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199,296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156,513)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Excludes the impact of incentive fees. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Consolidated Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 3. Agreements and Related Party Transactions&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for further information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_112"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8. Consolidated Financial Statements and Supplementary Data. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:92.301%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_115">Report of Independent Registered Public Accounting Firm </a>(PCAOB ID No. <ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-198">34</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_115">133</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_118">Consolidated Statements of Assets and Liabilities as of </a>December&#160;31, 2023<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_118"> and </a>December&#160;31, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_118">136</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_121">Consolidated Statements of Operations for the years ended </a>December&#160;31, 2023<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_121">, </a>2022<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_121"> and </a>2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_121">137</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_124">Consolidated Statements of Changes in Net Assets for the years ended </a>December&#160;31, 2023<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_124">, </a>2022<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_124"> and </a>2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_124">138</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_127">Consolidated Statements of Cash Flows for the years ended</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_127"> </a>December&#160;31, 2023<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_127">, </a>2022<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_127"> and </a>2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_127">139</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_2639">Consolidated Schedules of Investments as of </a>December&#160;31, 2023<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_130"> and </a>December&#160;31, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_130">161</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_154">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i33edc808e7824948b94b269ed713a939_154">178</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_115"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Trustees of Blackstone Secured Lending Fund</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Opinion on the Financial Statements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We have audited the accompanying consolidated statements of assets and liabilities of Blackstone Secured Lending Fund and subsidiaries (the &#8220;Company&#8221;), including the consolidated schedules of investments, as of December 31, 2023 and 2022, the related consolidated statements of operations, changes in net assets, and cash flows for each of the three years in the period ended December 31, 2023, and the related notes (referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations, changes in net assets, and cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 28, 2024, expressed an unqualified opinion on the Company's internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of investments owned as of December 31, 2023 and 2022, by correspondence with the custodian, loan agents, and borrowers; when replies were not received, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Investments - Level 3 Fair Value Measurements &#8212; Refer to Footnote 2 and 5 in the financial statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As described in Note 5 to the financial statements, the Company held $9,710,582 thousand of investments classified as level 3 fair value measurements as of December 31, 2023. These investments include illiquid secured debt and unlisted equity securities. The valuation approaches used are based on the facts and circumstances of the underlying investments and involve estimates relating to unobservable valuation inputs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We identified the valuation of level 3 investments as a critical audit matter given the judgments involved in estimating fair value, including the selection of valuation approaches and development of unobservable inputs. This required a high degree of auditor judgment and extensive audit effort, including the need to involve fair value specialists. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our audit procedures related to the valuation of level 3 investments included the following, among others:</span><span style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:107%"> </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%;padding-left:14.5pt">We tested the design, implementation, and operating effectiveness of controls over the valuation of level 3 investments, including those over the selection of valuation methodologies and development of unobservable inputs.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">We evaluated the appropriateness of the valuation approaches used for level 3 investments.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">For certain investments, we tested management&#8217;s process for estimating fair value, including evaluating the unobservable valuation inputs by comparison to external sources. For select investments, we used the assistance of our fair value specialists. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">For certain investments, we developed our own independent estimate of the fair value and compared our estimate to management&#8217;s estimate. For select investments, we used the assistance of our fair value specialists.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">We evaluated the impact of current market events and conditions on the valuation methodologies and unobservable inputs.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-199">DELOITTE &amp; TOUCHE LLP</ix:nonNumeric></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-200">New York, New York</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 28, 2024</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2018. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i33edc808e7824948b94b269ed713a939_199"></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Trustees of Blackstone Secured Lending Fund</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the internal control over financial reporting of Blackstone Secured Lending Fund and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by COSO.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2023, of the Company and our report dated February 28, 2024, expressed an unqualified opinion on those consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:111%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ DELOITTE &amp; TOUCHE LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, New York</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 28, 2024</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_118"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Assets and Liabilities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:68.825%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlled/non-affiliated investments (cost of $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-201">9,934,158</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-202">9,621,233</ix:nonFraction> at December&#160;31, 2023 and December&#160;31, 2022, respectively)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-203">9,862,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-204">9,560,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlled/affiliated investments (cost of $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-205">1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-206">36,639</ix:nonFraction> at December&#160;31, 2023 and December&#160;31, 2022, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-207">5,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-208">56,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments at fair value (cost of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-209">9,934,159</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-210">9,657,872</ix:nonFraction> at December&#160;31, 2023 and December&#160;31, 2022, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-211">9,868,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-212">9,617,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-213">154,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-214">131,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable from non-controlled/non-affiliated investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:DividendAndInterestReceivable" format="ixt:num-dot-decimal" scale="3" id="f-215">93,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:DividendAndInterestReceivable" format="ixt:num-dot-decimal" scale="3" id="f-216">97,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet" format="ixt:num-dot-decimal" scale="3" id="f-217">16,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet" format="ixt:num-dot-decimal" scale="3" id="f-218">13,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable for investments sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ReceivableInvestmentSale" format="ixt:num-dot-decimal" scale="3" id="f-219">1,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ReceivableInvestmentSale" format="ixt:num-dot-decimal" scale="3" id="f-220">49,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-221">10,134,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-222">9,908,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt (net of unamortized debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-223">25,953</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-224">35,289</ix:nonFraction> at December&#160;31, 2023 and December&#160;31, 2022, respectively)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-225">4,911,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-226">5,527,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payable for investments purchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PayableInvestmentPurchase" format="ixt:num-dot-decimal" scale="3" id="f-227">8,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PayableInvestmentPurchase" format="ixt:num-dot-decimal" scale="3" id="f-228">20,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-229">8,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-230">10,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees payable (Note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ManagementFeePayable" format="ixt:num-dot-decimal" scale="3" id="f-231">23,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ManagementFeePayable" format="ixt:num-dot-decimal" scale="3" id="f-232">18,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income based incentive fees payable (Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="bxsl:IncentiveFeePayableIncome" format="ixt:num-dot-decimal" scale="3" id="f-233">34,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="bxsl:IncentiveFeePayableIncome" format="ixt:num-dot-decimal" scale="3" id="f-234">24,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital gains incentive fees payable (Note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="bxsl:IncentiveFeePayableCapitalGains" format="ixt:fixed-zero" scale="3" id="f-235">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="bxsl:IncentiveFeePayableCapitalGains" format="ixt:num-dot-decimal" scale="3" id="f-236">5,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-237">39,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-238">45,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution payable (Note 8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DistributionPayable" format="ixt:num-dot-decimal" scale="3" id="f-239">143,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DistributionPayable" format="ixt:num-dot-decimal" scale="3" id="f-240">96,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-241">12,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" scale="3" id="f-242">851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-243">5,182,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-244">5,750,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 7)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-245"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-6" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-246"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-247"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-248">0.001</ix:nonFraction></ix:nonFraction> par value (unlimited shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-249"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-250">185,782,408</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-251"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-252">160,362,861</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2023 and December&#160;31, 2022, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-253">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-254">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-255">4,701,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-256">4,033,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributable earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-257">250,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-258">125,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-259">4,952,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-260">4,158,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and net assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-261">10,134,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-262">9,908,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET ASSET VALUE PER SHARE</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-263">26.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-264">25.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_121"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">From non-controlled/non-affiliated investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeOperatingPaidInCash" format="ixt:num-dot-decimal" scale="3" id="f-267">1,089,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InterestIncomeOperatingPaidInCash" format="ixt:num-dot-decimal" scale="3" id="f-268">796,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InterestIncomeOperatingPaidInCash" format="ixt:num-dot-decimal" scale="3" id="f-269">610,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment-in-kind interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:InterestIncomeOperatingPaidInKind" format="ixt:num-dot-decimal" scale="3" id="f-270">47,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:InterestIncomeOperatingPaidInKind" format="ixt:num-dot-decimal" scale="3" id="f-271">40,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:InterestIncomeOperatingPaidInKind" format="ixt:num-dot-decimal" scale="3" id="f-272">8,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DividendIncomeOperating" scale="3" id="f-273">387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:DividendIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="f-274">9,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:DividendIncomeOperating" scale="3" id="f-275">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FeeIncome" format="ixt:num-dot-decimal" scale="3" id="f-276">7,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:FeeIncome" format="ixt:num-dot-decimal" scale="3" id="f-277">4,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:FeeIncome" format="ixt:num-dot-decimal" scale="3" id="f-278">5,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investment income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GrossInvestmentIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="f-279">1,143,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:GrossInvestmentIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="f-280">850,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:GrossInvestmentIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="f-281">624,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-282">266,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-283">203,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-284">120,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees (Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ManagementFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-285">98,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ManagementFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-286">101,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:ManagementFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-287">62,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income based incentive fees (Note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:IncomeBasedIncentiveFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-288">134,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:IncomeBasedIncentiveFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-289">97,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:IncomeBasedIncentiveFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-290">67,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital gains incentive fees (Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="bxsl:CapitalGainsIncentiveFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-291">5,506</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="bxsl:CapitalGainsIncentiveFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-292">11,883</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:CapitalGainsIncentiveFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-293">16,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-294">6,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-295">4,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-296">2,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board of Trustees' fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TrusteeFees" scale="3" id="f-297">907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:TrusteeFees" scale="3" id="f-298">853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:TrusteeFees" scale="3" id="f-299">571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative service expenses (Note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdministrativeFeesExpense" format="ixt:num-dot-decimal" scale="3" id="f-300">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:AdministrativeFeesExpense" format="ixt:num-dot-decimal" scale="3" id="f-301">2,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:AdministrativeFeesExpense" format="ixt:num-dot-decimal" scale="3" id="f-302">2,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-303">6,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-304">6,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-305">4,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total expenses before excise tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeInvestmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-306">508,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InvestmentIncomeInvestmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-307">404,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InvestmentIncomeInvestmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-308">277,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees waived (Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentCompanyContractualFeeWaived" format="ixt:num-dot-decimal" scale="3" id="f-309">20,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InvestmentCompanyContractualFeeWaived" format="ixt:num-dot-decimal" scale="3" id="f-310">25,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InvestmentCompanyContractualFeeWaived" format="ixt:num-dot-decimal" scale="3" id="f-311">4,195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive fees waived (Note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentCompanyVoluntaryFeeWaived" format="ixt:num-dot-decimal" scale="3" id="f-312">15,604</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InvestmentCompanyVoluntaryFeeWaived" format="ixt:num-dot-decimal" scale="3" id="f-313">13,879</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InvestmentCompanyVoluntaryFeeWaived" format="ixt:num-dot-decimal" scale="3" id="f-314">2,333</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net expenses before excise tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement" format="ixt:num-dot-decimal" scale="3" id="f-315">472,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement" format="ixt:num-dot-decimal" scale="3" id="f-316">365,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement" format="ixt:num-dot-decimal" scale="3" id="f-317">270,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment income before excise tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="3" id="f-318">670,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="3" id="f-319">485,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="3" id="f-320">354,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-321">16,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-322">1,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-323">2,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment income after excise tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax" format="ixt:num-dot-decimal" scale="3" id="f-324">653,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax" format="ixt:num-dot-decimal" scale="3" id="f-325">483,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax" format="ixt:num-dot-decimal" scale="3" id="f-326">351,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Realized and unrealized gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlled/non-affiliated investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" sign="-" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-327">36,685</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" sign="-" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-328">143,515</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-329">101,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlled/affiliated investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" sign="-" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-330">14,156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-331">17,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-332">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation of assets and liabilities in foreign currencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-333">3,732</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-334">4,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax" scale="3" id="f-335">549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in unrealized appreciation (depreciation)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-336">54,573</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-337">122,149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-338">104,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlled/non-affiliated investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" sign="-" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-339">14,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-340">37,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-341">7,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlled/affiliated investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-342">8,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-343">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-345">18,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-346">5,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-347">3,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net realized gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-348">12,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-349">42,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-350">4,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net realized and change in unrealized gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-351">41,954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-352">79,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-353">108,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net increase (decrease) in net assets resulting from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-354">611,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-355">404,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-356">460,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income per share (basic and diluted)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare" scale="0" id="f-357">3.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare" scale="0" id="f-358">2.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare" scale="0" id="f-359">2.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share (basic and diluted)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-360"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-361">3.65</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-362"><ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-363">2.44</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-364"><ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-365">3.19</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding (basic and diluted)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-366"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-367">167,615,433</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-135" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-368"><ix:nonFraction unitRef="shares" contextRef="c-135" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-369">166,072,919</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-136" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-370"><ix:nonFraction unitRef="shares" contextRef="c-136" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-371">144,510,122</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_124"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Changes in Net Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:52.497%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.913%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.913%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.913%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.916%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid in Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Distributable Earnings (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-372">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-373">3,232,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-374">35,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-375">3,267,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common shares, net of offering and underwriting costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-376">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-377">976,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-378">976,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinvestment of dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" scale="3" id="f-379">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-380">38,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-381">38,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax" format="ixt:num-dot-decimal" scale="3" id="f-382">351,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax" format="ixt:num-dot-decimal" scale="3" id="f-383">351,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss) on investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-384">4,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-385">4,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-386">104,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-387">104,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared from net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:InvestmentCompanyDividendDistribution" format="ixt:num-dot-decimal" scale="3" id="f-388">295,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InvestmentCompanyDividendDistribution" format="ixt:num-dot-decimal" scale="3" id="f-389">295,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax reclassification of shareholders' equity in accordance with GAAP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-390">2,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-391">2,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-392">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-393">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-394">4,245,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-395">202,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-396">4,447,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinvestment of dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" scale="3" id="f-397">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-398">52,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-399">52,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="f-400">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-401">263,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-402">263,017</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax" format="ixt:num-dot-decimal" scale="3" id="f-403">483,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax" format="ixt:num-dot-decimal" scale="3" id="f-404">483,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss) on investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-405">42,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-406">42,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-407">122,149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-408">122,149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared from net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:InvestmentCompanyDividendDistribution" format="ixt:num-dot-decimal" scale="3" id="f-409">482,434</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InvestmentCompanyDividendDistribution" format="ixt:num-dot-decimal" scale="3" id="f-410">482,434</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax reclassification of shareholders' equity in accordance with GAAP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-411">1,386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-412">1,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-414">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-415">4,033,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-416">125,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-417">4,158,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common shares, net of offering and underwriting costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-418">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-419">665,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-420">665,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinvestment of dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" scale="3" id="f-421">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-422">20,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-423">20,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax" format="ixt:num-dot-decimal" scale="3" id="f-424">653,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax" format="ixt:num-dot-decimal" scale="3" id="f-425">653,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss) on investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-426">12,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-427">12,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-428">54,573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-429">54,573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared from net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:InvestmentCompanyDividendDistribution" format="ixt:num-dot-decimal" scale="3" id="f-430">504,787</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentCompanyDividendDistribution" format="ixt:num-dot-decimal" scale="3" id="f-431">504,787</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax reclassification of shareholders' equity in accordance with GAAP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-432">17,171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-433">17,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-435">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-436">4,701,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-437">250,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-438">4,952,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_127"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="18" style="padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in net assets resulting from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-439">611,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-440">404,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-441">460,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized (appreciation) depreciation on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-442">50,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-443">126,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-444">104,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="f-445">3,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="f-446">4,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="f-447">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized (gain) loss on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-448">6,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-449">37,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-450">7,785</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accretion of discount and amortization of premium</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-451">52,865</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-452">47,429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-453">62,799</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment-in-kind interest capitalized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:PaidInKindInterestNoncash" format="ixt:num-dot-decimal" scale="3" id="f-454">51,558</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:PaidInKindInterestNoncash" format="ixt:num-dot-decimal" scale="3" id="f-455">40,324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:PaidInKindInterestNoncash" format="ixt:num-dot-decimal" scale="3" id="f-456">9,152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" format="ixt:num-dot-decimal" scale="3" id="f-457">5,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" format="ixt:num-dot-decimal" scale="3" id="f-458">4,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" format="ixt:num-dot-decimal" scale="3" id="f-459">2,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of original issue discount and debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-460">9,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-461">10,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-462">7,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity" format="ixt:num-dot-decimal" scale="3" id="f-463">1,483,303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity" format="ixt:num-dot-decimal" scale="3" id="f-464">961,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity" format="ixt:num-dot-decimal" scale="3" id="f-465">6,824,327</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of investments and principal repayments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromDispositionOfInvestmentOperatingActivity" format="ixt:num-dot-decimal" scale="3" id="f-466">1,305,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ProceedsFromDispositionOfInvestmentOperatingActivity" format="ixt:num-dot-decimal" scale="3" id="f-467">1,174,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:ProceedsFromDispositionOfInvestmentOperatingActivity" format="ixt:num-dot-decimal" scale="3" id="f-468">2,734,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-469">4,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-470">35,215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-471">41,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable for investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInReceivableForInvestmentSold" format="ixt:num-dot-decimal" scale="3" id="f-472">47,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInReceivableForInvestmentSold" format="ixt:num-dot-decimal" scale="3" id="f-473">93,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:IncreaseDecreaseInReceivableForInvestmentSold" format="ixt:num-dot-decimal" scale="3" id="f-474">28,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:fixed-zero" scale="3" id="f-475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="f-476">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="f-477">384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payable for investments purchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPayableForInvestmentPurchased" format="ixt:num-dot-decimal" scale="3" id="f-478">11,707</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPayableForInvestmentPurchased" format="ixt:num-dot-decimal" scale="3" id="f-479">15,944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPayableForInvestmentPurchased" format="ixt:num-dot-decimal" scale="3" id="f-480">12,365</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDueToAffiliates" format="ixt:num-dot-decimal" scale="3" id="f-481">1,884</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:IncreaseDecreaseInDueToAffiliates" format="ixt:num-dot-decimal" scale="3" id="f-482">4,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:IncreaseDecreaseInDueToAffiliates" format="ixt:num-dot-decimal" scale="3" id="f-483">1,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInManagementFeePayable" format="ixt:num-dot-decimal" scale="3" id="f-484">4,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:IncreaseDecreaseInManagementFeePayable" scale="3" id="f-485">783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:IncreaseDecreaseInManagementFeePayable" format="ixt:num-dot-decimal" scale="3" id="f-486">7,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income based incentive fee payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:IncreaseDecreaseInIncomeBasedIncentiveFeePayable" format="ixt:num-dot-decimal" scale="3" id="f-487">9,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:IncreaseDecreaseInIncomeBasedIncentiveFeePayable" format="ixt:num-dot-decimal" scale="3" id="f-488">4,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:IncreaseDecreaseInIncomeBasedIncentiveFeePayable" format="ixt:num-dot-decimal" scale="3" id="f-489">4,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital gains incentive fee payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="bxsl:IncreaseDecreaseInCapitalGainsIncentiveFeePayable" format="ixt:num-dot-decimal" scale="3" id="f-490">5,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="bxsl:IncreaseDecreaseInCapitalGainsIncentiveFeePayable" format="ixt:num-dot-decimal" scale="3" id="f-491">11,883</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:IncreaseDecreaseInCapitalGainsIncentiveFeePayable" format="ixt:num-dot-decimal" scale="3" id="f-492">16,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInterestPayableNet" format="ixt:num-dot-decimal" scale="3" id="f-493">5,409</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:IncreaseDecreaseInInterestPayableNet" format="ixt:num-dot-decimal" scale="3" id="f-494">6,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:IncreaseDecreaseInInterestPayableNet" format="ixt:num-dot-decimal" scale="3" id="f-495">24,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-496">11,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-497">2,244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-498">2,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-499">458,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-500">672,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-501">3,828,514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings on debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-502">1,440,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-503">920,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-504">5,778,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-505">2,091,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-506">877,152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-507">2,780,121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:PaymentsOfDebtIssuanceCostsLineOfCreditArrangements" format="ixt:num-dot-decimal" scale="3" id="f-508">8,589</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:PaymentsOfDebtIssuanceCostsLineOfCreditArrangements" format="ixt:num-dot-decimal" scale="3" id="f-509">3,789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:PaymentsOfDebtIssuanceCostsLineOfCreditArrangements" format="ixt:num-dot-decimal" scale="3" id="f-510">9,359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-511">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-512">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-513">3,398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred offering costs paid on issuance of common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-515">1,607</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-516">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid in cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-517">437,966</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-518">423,441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-519">253,776</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common shares, net of offering and underwriting costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-520">665,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-521">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-522">981,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions paid in cash </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-523">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-524">263,017</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-526">432,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-527">648,179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-528">3,713,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-529">26,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-530">24,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-531">115,114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign exchange rate changes on cash and cash equivalents </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-532">3,069</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-533">3,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-534">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-535">131,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-536">102,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-537">217,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-538">154,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-539">131,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-540">102,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="18" style="padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental information and non-cash activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid during the period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-541">256,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-542">182,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-543">94,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:DistributionCostsIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-544">143,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:DistributionCostsIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-545">96,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:DistributionCostsIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-546">89,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinvestment of distributions during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-547">20,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-548">52,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-549">38,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash deferred financing costs activity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction" format="ixt:fixed-zero" scale="3" id="f-550">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction" format="ixt:fixed-zero" scale="3" id="f-551">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction" scale="3" id="f-552">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash debt issuance costs activity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" format="ixt:fixed-zero" scale="3" id="f-553">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" format="ixt:fixed-zero" scale="3" id="f-554">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" scale="3" id="f-555">92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued but unpaid debt issuing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:DebtIssuanceCostsIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="f-556">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:DebtIssuanceCostsIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="f-557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:DebtIssuanceCostsIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-558">1,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:ExciseTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="f-559">5,245</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:ExciseTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="f-560">4,106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:ExciseTaxesPaid" scale="3" id="f-561">131</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_2639"></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i33edc808e7824948b94b269ed713a939_2642"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"/><td style="width:22.213%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.644%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.215%"/><td style="width:0.1%"/></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt - non-controlled/non-affiliated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aerospace &amp; Defense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corfin Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-166" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-562">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-166" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-563">11.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/27/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-564">198,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-565">196,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-566">192,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-166" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-567">3.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corfin Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-167" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-568">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-167" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-569">11.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/5/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-570">68,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-571">67,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-572">66,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-167" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-573">1.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Frontgrade Technologies Holdings, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-168" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-574">6.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-168" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-575">12.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/9/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-576">2,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-577">2,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-578">2,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-168" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-579">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Linquest Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-169" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-580">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-169" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-581">11.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/28/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-582">9,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-583">9,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-584">9,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-169" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-585">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MAG DS Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-170" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-586">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-170" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-587">10.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-588">80,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-589">76,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-590">77,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-170" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-591">1.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Magneto Components BuyCo, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-171" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-592">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-171" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-593">11.36</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/5/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-594">33,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-595">32,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-596">32,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-171" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-597">0.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maverick Acquisition, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-172" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-598">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-172" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-599">11.60</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-600">18,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-601">18,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-602">13,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-172" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-603">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TCFI AEVEX, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-173" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-604">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-173" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-605">11.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/18/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-606">110,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-607">109,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-608">110,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-173" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-609">2.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-610">512,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-611">504,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-174" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-612">10.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Air Freight &amp; Logistics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AGI-CFI Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-175" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-613">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-175" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-614">11.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/11/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-615">76,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-616">76,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-617">74,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-175" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-618">1.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AGI-CFI Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-176" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-619">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-176" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-620">11.18</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/11/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-621">18,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-622">18,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-623">17,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-176" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-624">0.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ENV Bidco AB</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-625">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-626">11.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-627">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-628">986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-629">1,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-630">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ENV Bidco AB</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-178" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-631">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-178" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-632">9.68</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-178" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-633">1,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-634">948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-635">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-178" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-636">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Livingston International, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-179" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-637">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-179" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-638">10.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/30/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-639">127,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-640">125,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-641">120,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-179" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-642">2.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mode Purchaser, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-180" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-643">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-180" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-644">11.77</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/9/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-645">143,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-646">141,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-647">143,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-180" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-648">2.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mode Purchaser, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-181" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-649">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-181" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-650">11.77</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/5/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-651">4,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-652">4,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-653">4,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-181" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-654">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redwood Services Group, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-182" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-655">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-182" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-656">11.70</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/15/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-657">4,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-658">4,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-659">4,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-182" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-660">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RoadOne Inc </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-183" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-661">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-183" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-662">11.72</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-663">1,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-664">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-665">1,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-183" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-666">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RWL Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-184" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-667">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-184" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-668">11.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-669">30,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-670">29,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-671">28,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-184" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-672">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEKO Global Logistics Network, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-185" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-673">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-185" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-674">10.72</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-675">5,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-676">5,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-677">5,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-185" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-678">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEKO Global Logistics Network, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">P +</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-186" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-679">4.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-186" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-680">12.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-681">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-682">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-683">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-186" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-684">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEKO Global Logistics Network, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-187" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-685">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-187" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-686">10.66</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-687">791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-688">785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-689">775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-187" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-690">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEKO Global Logistics Network, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-188" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-691">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-188" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-692">8.89</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-188" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-693">1,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-694">2,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-695">1,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-188" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-696">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-697">411,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-698">404,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-189" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-699">8.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Building Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fencing Supply Group Acquisition, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-190" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-700">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-190" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-701">11.64</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/26/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-702">53,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-703">53,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-704">52,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-190" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-705">1.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jacuzzi Brands, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-191" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-706">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-191" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-707">11.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-708">11,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-709">11,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-710">10,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-191" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-711">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jacuzzi Brands, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-192" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-712">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-192" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-713">11.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-714">77,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-715">77,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-716">70,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-192" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-717">1.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L&amp;S Mechanical Acquisition, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-193" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-718">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-193" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-719">11.70</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/1/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-720">12,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-721">12,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-722">12,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-193" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-723">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lindstrom, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-194" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-724">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-194" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-725">11.69</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/7/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-726">121,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-727">120,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-728">119,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-194" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-729">2.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Windows Acquisition Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-195" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-730">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-195" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-731">12.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/29/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-732">49,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-733">49,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-734">49,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-195" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-735">1.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-736">324,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-737">314,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-196" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-738">6.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Chemicals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Formulations Parent Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-197" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-739">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-197" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-740">11.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/15/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-741">8,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-742">8,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-743">8,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-197" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-744">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"/><td style="width:22.213%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.644%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.215%"/><td style="width:0.1%"/></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt - non-controlled/non-affiliated (continued)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial Services &amp; Supplies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bazaarvoice, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-198" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-745">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-198" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-746">11.18</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/7/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-747">226,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-748">226,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-749">226,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-198" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-750">4.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bazaarvoice, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-199" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-751">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-199" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-752">11.15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/7/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-753">15,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-754">15,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-755">15,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-199" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-756">0.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CFS Brands, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-200" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-757">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-200" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-758">11.34</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/2/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-759">118,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-760">115,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-761">115,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-200" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-762">2.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FusionSite Midco, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-201" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-763">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-201" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-764">11.36</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/17/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-765">25,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-766">25,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-767">25,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-201" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-768">0.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FusionSite Midco, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-202" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-769">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-202" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-770">11.39</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/17/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-771">2,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-772">2,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-773">2,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-202" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-774">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Iris Buyer, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-203" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-775">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-203" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-776">11.60</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/2/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-777">26,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-778">25,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-779">25,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-203" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-780">0.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Java Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-204" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-781">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-204" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-782">11.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/15/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-783">5,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-784">5,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-785">5,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-204" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-786">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Java Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-205" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-787">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-205" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-788">11.12</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/9/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-789">366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-790">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-791">353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-205" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-792">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">JSS Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-206" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-793">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-206" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-794">11.47</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/18/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-795">283,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-796">280,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-797">283,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-206" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-798">5.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">JSS Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-207" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-799">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-207" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-800">11.47</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/17/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-801">4,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-802">4,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-803">4,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-207" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-804">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Knowledge Pro Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-208" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-805">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-208" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-806">11.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/10/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-807">6,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-808">5,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-809">6,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-208" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-810">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">KPSKY Acquisition, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)(18)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-209" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-811">5.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-209" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-812">10.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/19/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-813">20,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-814">19,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-815">20,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-209" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-816">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">KPSKY Acquisition, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-210" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-817">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-210" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-818">10.76</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/19/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-819">2,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-820">2,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-821">2,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-210" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-822">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Onex Baltimore Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)(18)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-211" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-823">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-211" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-824">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-825">10,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-826">10,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-827">10,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-211" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-828">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Onex Baltimore Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-212" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-829">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-212" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-830">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-831">9,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-832">8,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-833">9,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-212" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-834">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Veregy Consolidated, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-213" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-835">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-213" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-836">11.64</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/2/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-837">20,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-838">20,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-839">18,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-213" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-840">0.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-841">770,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-842">771,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-214" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-843">15.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Construction &amp; Engineering</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASP Endeavor Acquisition, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-215" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-844">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-215" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-845">12.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/3/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-846">13,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-847">13,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-848">12,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-215" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-849">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COP Home Services TopCo IV, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-216" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-850">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-216" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-851">11.48</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-852">37,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-853">36,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-854">37,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-216" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-855">0.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-856">50,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-857">50,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-217" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-858">1.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Containers &amp; Packaging</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ascend Buyer, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-218" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-859">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-218" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-860">11.90</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/2/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-861">18,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-862">18,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-863">18,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-218" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-864">0.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ascend Buyer, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR +</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-219" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-865">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-219" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-866">11.90</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/30/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-867">1,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-868">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-869">1,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-219" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-870">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ascend Buyer, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-220" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-871">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-220" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-872">11.71</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/2/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-873">647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-874">622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-875">624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-220" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-876">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-877">20,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-878">20,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-221" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-879">0.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Distributors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BP Purchaser, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-222" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-880">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-222" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-881">11.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/10/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-882">7,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-883">7,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-884">6,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-222" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-885">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BradyIFS Holdings, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-223" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-886">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-223" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-887">11.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-888">91,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-889">89,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-890">89,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-223" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-891">1.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BradyIFS Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-224" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-892">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-224" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-893">11.37</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-894">2,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-895">2,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-896">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-224" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-897">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bution Holdco 2, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-225" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-898">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-225" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-899">11.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/17/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-900">70,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-901">69,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-902">70,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-225" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-903">1.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dana Kepner Company, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-226" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-904">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-226" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-905">11.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/29/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-906">49,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-907">49,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-908">49,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-226" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-909">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Genuine Cable Group, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-227" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-910">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-227" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-911">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/2/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-912">168,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-913">166,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-914">164,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-227" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-915">3.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marcone Yellowstone Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-228" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-916">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-228" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-917">11.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/23/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-918">4,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-919">4,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-920">4,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-228" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-921">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marcone Yellowstone Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-229" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-922">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-229" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-923">12.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/23/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-924">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-925">1,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-926">1,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-229" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-927">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marcone Yellowstone Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-230" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-928">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-230" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-929">11.77</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/23/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-930">1,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-931">1,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-932">1,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-230" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-933">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDC Acquisition Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-231" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-934">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-231" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-935">10.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/9/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-936">13,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-937">13,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-938">13,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-231" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-939">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDC Acquisition Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-232" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-940">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-232" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-941">10.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/9/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-942">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-943">464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-944">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-232" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-945">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tailwind Colony Holding Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-233" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-946">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-233" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-947">11.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/13/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-948">5,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-949">5,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-950">5,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-233" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-951">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tailwind Colony Holding Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-234" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-952">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-234" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-953">11.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/13/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-954">42,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-955">42,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-956">41,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-234" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-957">0.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unified Door &amp; Hardware Group, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-235" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-958">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-235" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-959">11.20</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/30/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-960">94,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-961">93,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-962">92,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-235" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-963">1.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-964">547,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-965">543,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-236" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-966">10.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"/><td style="width:22.213%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.644%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.215%"/><td style="width:0.1%"/></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt - non-controlled/non-affiliated (continued)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diversified Consumer Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BPPH2 Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-237" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-967">6.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-237" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-968">11.56</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GBP</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="c-237" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-969">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-970">35,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-971">33,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-237" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-972">0.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cambium Learning Group, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-238" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-973">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-238" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-974">11.02</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/20/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-975">289,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-976">287,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-977">289,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-238" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-978">5.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Endeavor Schools Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-239" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-979">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-239" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-980">11.65</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/18/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-981">22,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-982">21,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-983">21,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-239" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-984">0.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Endeavor Schools Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-240" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-985">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-240" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-986">11.64</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/18/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-987">4,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-988">3,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-989">3,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-240" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-990">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Go Car Wash Management Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-241" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-991">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-241" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-992">11.71</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-993">22,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-994">22,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-995">21,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-241" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-996">0.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Groundworks, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-242" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-997">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-242" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-998">11.90</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/14/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-999">804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1000">784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1001">802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-242" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1002">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1003">371,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1004">370,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-243" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1005">7.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diversified Financial Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Barbri Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-244" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1006">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-244" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1007">11.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/28/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1008">58,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1009">58,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1010">58,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-244" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1011">1.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">More Cowbell II, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-245" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1012">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-245" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1013">11.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/1/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1014">7,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1015">7,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1016">7,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-245" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1017">0.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">More Cowbell II, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-246" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1018">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-246" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1019">11.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/1/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1020">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1021">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1022">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-246" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1023">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SelectQuote, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-247" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1024">9.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-247" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1025">14.96</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-247" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1026">3.00</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/5/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1027">73,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1028">73,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1029">66,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-247" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1030">1.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1031">139,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1032">132,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-248" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1033">2.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diversified Telecommunication Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Point Broadband Acquisition, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-249" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1034">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-249" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1035">11.51</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/1/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1036">85,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1037">84,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1038">85,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-249" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1039">1.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Point Broadband Acquisition, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-250" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1040">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-250" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1041">11.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1042">38,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1043">38,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1044">38,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-250" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1045">0.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1046">122,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1047">124,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-251" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1048">2.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Electric Utilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Qualus Power Services Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-252" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1049">4.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-252" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1050">10.24</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/26/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1051">33,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1052">32,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1053">31,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-252" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1054">0.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Qualus Power Services Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-253" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1055">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-253" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1056">11.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/26/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1057">32,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1058">31,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1059">31,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-253" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1060">0.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1061">64,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1062">63,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-254" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1063">1.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Electrical Equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emergency Power Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-255" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1064">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-255" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1065">10.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1066">46,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1067">45,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1068">46,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-255" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1069">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shoals Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-256" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1070">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-256" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1071">11.28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/25/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1072">61,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1073">60,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1074">61,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-256" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1075">1.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1076">106,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1077">107,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-257" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1078">2.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Electronic Equipment, Instruments &amp; Components</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Albireo Energy, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-258" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1079">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-258" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1080">11.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/23/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1081">78,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1082">77,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1083">70,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-258" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1084">1.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Albireo Energy, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-259" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1085">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-259" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1086">11.49</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/23/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1087">6,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1088">6,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1089">5,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-259" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1090">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Albireo Energy, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-260" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1091">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-260" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1092">11.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/23/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1093">23,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1094">23,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1095">21,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-260" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1096">0.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CPI Intermediate Holdings Inc </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-261" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1097">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-261" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1098">10.87</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/8/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1099">4,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1100">3,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1101">3,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-261" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1102">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Phoenix 1 Buyer Corp.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-262" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1103">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-262" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1104">10.87</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/20/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1105">25,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1106">25,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1107">25,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-262" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1108">0.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1109">136,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1110">127,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-263" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1111">2.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Energy Equipment &amp; Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Abaco Energy Technologies, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(13)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-264" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1112">7.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-264" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1113">12.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/4/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1114">17,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1115">17,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1116">17,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-264" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1117">0.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ISQ Hawkeye Holdco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-265" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1118">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-265" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1119">11.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1120">938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1121">917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1122">934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-265" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1123">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tetra Technologies, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-266" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1124">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-266" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1125">11.71</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/10/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1126">17,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1127">17,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1128">17,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-266" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1129">0.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1130">36,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1131">36,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-267" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1132">0.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ground Transportation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quality Distribution LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-268" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1133">6.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-268" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1134">12.11</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/30/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1135">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1136">653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1137">681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-268" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1138">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quality Distribution LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-269" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1139">6.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-269" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1140">11.83</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1141">18,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1142">18,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1143">18,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-269" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1144">0.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1145">18,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1146">18,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-270" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1147">0.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"/><td style="width:22.213%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.644%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.215%"/><td style="width:0.1%"/></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt - non-controlled/non-affiliated (continued)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Equipment &amp; Supplies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bamboo US BidCo LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-271" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1148">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-271" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1149">11.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/30/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1150">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1151">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1152">667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-271" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1153">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bamboo US BidCo LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-272" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1154">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-272" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1155">9.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/30/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-272" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1156">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1157">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1158">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-272" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1159">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CPI Buyer, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-273" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1160">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-273" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1161">11.15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1162">31,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1163">30,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1164">30,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-273" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1165">0.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GCX Corporation Buyer, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-274" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1166">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-274" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1167">11.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/13/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1168">21,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1169">21,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1170">21,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-274" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1171">0.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GCX Corporation Buyer, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-275" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1172">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-275" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1173">11.02</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/13/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1174">5,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1175">5,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1176">5,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-275" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1177">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1178">58,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1179">57,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-276" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1180">1.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Providers &amp; Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123Dentist, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-277" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1181">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-277" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1182">10.94</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/10/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-277" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1183">1,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1184">1,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1185">1,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-277" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1186">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACI Group Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-278" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1187">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-278" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1188">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/2/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1189">115,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1190">113,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1191">114,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-278" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1192">2.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACI Group Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-279" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1193">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-279" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1194">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/2/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1195">1,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1196">1,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1197">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-279" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1198">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ADCS Clinics Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-280" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1199">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-280" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1200">11.79</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/7/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1201">6,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1202">6,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1203">6,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-280" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1204">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ADCS Clinics Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-281" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1205">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-281" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1206">11.53</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/7/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1207">1,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1208">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1209">1,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-281" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1210">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerivet Partners Management, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-282" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1211">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-282" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1212">11.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1213">1,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1214">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1215">1,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-282" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1216">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerivet Partners Management, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-283" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1217">5.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-283" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1218">11.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1219">4,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1220">4,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1221">4,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-283" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1222">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canadian Hospital Specialties Ltd. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-284" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1223">4.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-284" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1224">9.93</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/14/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-284" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1225">29,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1226">23,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1227">25,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-284" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1228">0.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canadian Hospital Specialties Ltd. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-285" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1229">4.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-285" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1230">9.93</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/15/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-285" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1231">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1232">2,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1233">2,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-285" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1234">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CCBlue Bidco, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-286" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1235">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-286" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1236">11.70</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-286" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1237">2.75</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/21/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1238">10,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1239">10,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1240">9,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-286" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1241">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DCA Investment Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-287" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1242">6.41</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-287" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1243">11.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/3/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1244">32,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1245">32,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1246">32,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-287" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1247">0.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DCA Investment Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-288" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1248">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-288" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1249">11.85</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/3/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1250">995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1251">983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1252">990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-288" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1253">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Epoch Acquisition, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-289" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1254">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-289" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1255">11.55</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/4/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1256">24,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1257">23,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1258">23,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-289" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1259">0.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jayhawk Buyer, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-290" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1260">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-290" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1261">10.45</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/15/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1262">153,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1263">151,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1264">146,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-290" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1265">2.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kwol Acquisition, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-291" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1266">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-291" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1267">11.43</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/6/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1268">6,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1269">6,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1270">6,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-291" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1271">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Navigator Acquiror, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-292" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1272">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-292" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1273">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/16/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1274">235,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1275">234,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1276">218,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-292" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1277">4.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Odyssey Holding Company, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-293" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1278">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-293" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1279">11.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/16/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1280">17,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1281">16,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1282">17,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-293" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1283">0.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Odyssey Holding Company, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-294" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1284">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-294" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1285">11.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/16/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1286">1,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1287">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1288">1,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-294" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1289">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PPV Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-295" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1290">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-295" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1291">11.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1292">1,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1293">1,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1294">1,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-295" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1295">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smile Doctors, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-296" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1296">5.90</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-296" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1297">11.30</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/23/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1298">10,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1299">10,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1300">10,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-296" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1301">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Snoopy Bidco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-297" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1302">6.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-297" decimals="4" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1303">12.65</ix:nonFraction>% PIK</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/1/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1304">313,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1305">309,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1306">302,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-297" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1307">6.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SpecialtyCare, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-298" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1308">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-298" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1309">11.41</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1310">12,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1311">11,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1312">11,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-298" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1313">0.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SpecialtyCare, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-299" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1314">4.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-299" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1315">9.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1316">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1317">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1318">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-299" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1319">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stepping Stones Healthcare Services, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-300" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1320">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-300" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1321">11.20</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/2/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1322">2,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1323">2,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1324">2,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-300" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1325">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Fertility Partners, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-301" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1326">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-301" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1327">11.36</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/16/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1328">5,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1329">5,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1330">4,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-301" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1331">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Fertility Partners, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-302" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1332">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-302" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1333">11.24</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/16/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-302" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1334">4,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1335">3,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1336">3,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-302" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1337">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Fertility Partners, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-303" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1338">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-303" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1339">11.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/16/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-303" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1340">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1341">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1342">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-303" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1343">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The GI Alliance Management, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-304" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1344">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-304" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1345">11.78</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/15/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1346">4,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1347">4,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1348">4,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-304" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1349">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UMP Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-305" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1350">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-305" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1351">11.15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/15/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1352">1,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1353">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1354">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-305" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1355">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UMP Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-306" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1356">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-306" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1357">11.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/15/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1358">1,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1359">1,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1360">1,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-306" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1361">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unified Physician Management, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-307" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1362">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-307" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1363">10.61</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1364">2,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1365">2,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1366">2,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-307" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1367">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"/><td style="width:22.213%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.644%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.215%"/><td style="width:0.1%"/></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt - non-controlled/non-affiliated (continued)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Providers &amp; Services (continued)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Oral Surgery Management Holdco, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-308" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1368">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-308" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1369">11.47</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/18/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1370">31,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1371">31,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1372">31,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-308" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1373">0.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Oral Surgery Management Holdco, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-309" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1374">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-309" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1375">11.45</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/18/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1376">16,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1377">15,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1378">15,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-309" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1379">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">WHCG Purchaser III, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-310" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1380">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-310" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1381">11.36</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/22/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1382">43,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1383">42,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1384">26,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-310" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1385">0.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">WHCG Purchaser III, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-311" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1386">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-311" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1387">11.36</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/22/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1388">6,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1389">6,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1390">4,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-311" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1391">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1392">1,088,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1393">1,042,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-312" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1394">21.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus US 1, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-313" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1395">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-313" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1396">10.85</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/25/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1397">9,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1398">9,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1399">9,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-313" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1400">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus US 1, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-314" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1401">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-314" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1402">11.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/25/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1403">3,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1404">3,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1405">3,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-314" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1406">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus US 1, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-315" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1407">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-315" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1408">11.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/25/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1409">809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1410">789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1411">791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-315" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1412">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Color Intermediate LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-316" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1413">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-316" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1414">10.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/4/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1415">20,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1416">19,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1417">20,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-316" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1418">0.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Edifecs, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-317" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1419">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-317" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1420">11.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/21/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1421">13,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1422">13,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1423">13,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-317" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1424">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Edifecs, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-318" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1425">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-318" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1426">11.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/21/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1427">216,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1428">214,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1429">216,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-318" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1430">4.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GI Ranger Intermediate, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-319" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1431">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-319" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1432">11.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1433">15,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1434">15,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1435">15,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-319" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1436">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GI Ranger Intermediate, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-320" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1437">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-320" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1438">11.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1439">720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1440">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1441">720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-320" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1442">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Healthcomp Holding Company, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-321" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1443">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-321" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1444">11.12</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/8/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1445">98,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1446">97,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1447">97,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-321" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1448">1.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Neptune Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-322" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1449">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-322" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1450">11.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1451">7,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1452">6,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1453">6,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-322" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1454">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NMC Crimson Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-323" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1455">6.09</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-323" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1456">11.64</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1457">71,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1458">69,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1459">71,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-323" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1460">1.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NMC Crimson Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-324" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1461">6.09</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-324" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1462">11.63</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/1/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1463">14,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1464">14,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1465">14,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-324" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1466">0.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Project Ruby Ultimate Parent Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-325" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1467">3.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-325" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1468">8.72</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/10/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1469">8,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1470">8,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1471">8,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-325" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1472">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RPBLS Midco, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-326" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1473">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-326" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1474">11.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/1/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1475">7,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1476">7,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1477">7,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-326" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1478">0.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RPBLS Midco, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-327" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1479">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-327" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1480">11.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1481">1,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1482">1,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1483">1,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-327" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1484">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1485">483,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1486">488,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-328" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1487">9.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alera Group, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-329" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1488">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-329" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1489">11.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/2/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1490">3,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1491">3,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1492">3,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-329" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1493">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerilife Holdings LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-330" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1494">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-330" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1495">11.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1496">2,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1497">2,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1498">2,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-330" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1499">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CFCo LLC (Benefytt Technologies, Inc.)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(8)(17)(18)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-331" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1500">0.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-331" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1501">0.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/13/2038</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1502">9,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1503">1,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1504">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-331" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1505">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Daylight Beta Parent LLC (Benefytt Technologies, Inc.)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-332" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1506">10.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-332" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1507">10.00</ix:nonFraction>% PIK</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/12/2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1508">5,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1509">5,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1510">5,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-332" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1511">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foundation Risk Partners Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-333" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1512">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-333" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1513">11.45</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1514">15,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1515">15,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1516">15,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-333" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1517">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Galway Borrower, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-334" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1518">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-334" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1519">10.70</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/29/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1520">12,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1521">12,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1522">12,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-334" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1523">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">High Street Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-335" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1524">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-335" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1525">11.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/14/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1526">52,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1527">51,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1528">52,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-335" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1529">1.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">High Street Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-336" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1530">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-336" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1531">11.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/16/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1532">11,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1533">11,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1534">11,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-336" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1535">0.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integrity Marketing Acquisition, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-337" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1536">6.05</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-337" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1537">11.54</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/27/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1538">139,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1539">138,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1540">138,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-337" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1541">2.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integrity Marketing Acquisition, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-338" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1542">6.02</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-338" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1543">11.41</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/27/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1544">1,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1545">1,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1546">1,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-338" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1547">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"/><td style="width:22.213%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.644%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.215%"/><td style="width:0.1%"/></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt - non-controlled/non-affiliated (continued)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance (continued)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integrity Marketing Acquisition, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-339" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1548">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-339" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1549">11.39</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/27/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1550">1,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1551">1,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1552">1,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-339" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1553">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integrity Marketing Acquisition, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-340" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1554">6.03</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-340" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1555">11.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/27/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1556">4,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1557">4,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1558">3,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-340" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1559">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PGIS Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-341" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1560">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-341" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1561">10.93</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/16/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-341" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1562">4,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-341" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1563">4,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-341" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1564">4,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-341" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1565">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PGIS Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-342" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1566">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-342" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1567">11.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/16/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1568">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1569">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1570">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-342" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1571">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG Acquisition, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-343" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1572">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-343" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1573">10.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/27/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1574">104,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1575">104,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1576">103,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-343" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1577">2.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shelf Bidco Ltd </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(10)(18)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-344" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1578">6.34</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-344" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1579">11.72</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/3/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1580">5,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1581">4,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1582">5,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-344" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1583">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee Bidco Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-345" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1584">7.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-345" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1585">10.97</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-345" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1586">2.50</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/3/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-345" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1587">1,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1588">1,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1589">2,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-345" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1590">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee Bidco Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-346" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1591">7.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-346" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1592">12.53</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-346" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1593">2.50</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/9/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1594">54,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1595">53,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1596">54,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-346" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1597">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee Bidco Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-347" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1598">7.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-347" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1599">12.43</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-347" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1600">2.50</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/3/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1601">16,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1602">16,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1603">16,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-347" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1604">0.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee Bidco Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-348" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1605">7.28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-348" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1606">12.21</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-348" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1607">2.50</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/9/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GBP</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="c-348" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1608">43,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1609">59,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1610">55,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-348" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1611">1.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">World Insurance Associates, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-349" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1612">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-349" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1613">11.42</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/3/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1614">38,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1615">36,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1616">36,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-349" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1617">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1618">530,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1619">525,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-350" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1620">10.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Internet &amp; Direct Marketing Retail</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Donuts, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-351" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1621">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-351" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1622">11.59</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/29/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1623">319,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1624">315,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1625">319,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-351" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1626">6.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IT Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AI Altius Bidco, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-352" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1627">9.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-352" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1628">9.75</ix:nonFraction>% PIK</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/21/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1629">965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1630">948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1631">960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-352" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1632">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AI Altius Bidco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-353" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1633">5.18</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-353" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1634">10.43</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/21/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1635">6,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1636">6,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1637">6,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-353" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1638">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Infostretch Corporation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-354" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1639">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-354" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1640">11.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1641">4,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1642">4,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1643">4,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-354" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1644">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inovalon Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-355" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1645">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-355" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1646">11.72</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-355" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1647">2.75</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/24/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1648">109,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1649">107,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1650">109,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-355" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1651">2.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monterey Financing, S.A.R.L </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ST +</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-356" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1652">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-356" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1653">10.04</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/28/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEK</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sek" contextRef="c-356" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1654">2,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1655">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1656">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-356" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1657">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monterey Financing, S.A.R.L </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-357" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1658">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-357" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1659">9.93</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/28/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-357" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1660">658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1661">625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1662">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-357" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1663">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monterey Financing, S.A.R.L </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-358" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1664">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-358" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1665">9.97</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/28/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-358" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1666">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-358" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1667">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-358" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1668">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-358" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1669">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monterey Financing, S.A.R.L </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CI +</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-359" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1670">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-359" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1671">9.89</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/28/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DKK</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="dkk" contextRef="c-359" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1672">4,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1673">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1674">708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-359" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1675">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monterey Financing, S.A.R.L </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N +</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-360" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1676">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-360" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1677">10.71</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/28/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NOK</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="nok" contextRef="c-360" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1678">5,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-360" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1679">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-360" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1680">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-360" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1681">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Razor Holdco, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-361" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1682">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-361" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1683">11.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/25/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-361" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1684">36,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-361" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1685">36,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-361" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1686">36,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-361" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1687">0.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"/><td style="width:22.213%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.644%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.215%"/><td style="width:0.1%"/></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt - non-controlled/non-affiliated (continued)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IT Services (continued)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Red River Technology, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-362" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1688">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-362" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1689">11.54</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/26/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1690">79,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1691">79,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1692">79,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-362" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1693">1.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S&amp;P Global Engineering Solutions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-363" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1694">7.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-363" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1695">12.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/2/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1696">1,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1697">1,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1698">1,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-363" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1699">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turing Holdco, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-364" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1700">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-364" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1701">11.40</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-364" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1702">2.50</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/28/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1703">8,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1704">8,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1705">8,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-364" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1706">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turing Holdco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-365" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1707">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-365" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1708">11.40</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-365" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1709">2.50</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/16/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1710">4,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1711">4,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1712">3,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-365" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1713">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turing Holdco, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-366" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1714">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-366" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1715">10.12</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-366" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1716">2.50</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/28/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-366" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1717">11,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1718">12,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1719">12,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-366" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1720">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turing Holdco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-367" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1721">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-367" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1722">9.97</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-367" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1723">2.50</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/3/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-367" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1724">4,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1725">4,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1726">4,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-367" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1727">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1728">269,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1729">271,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-368" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1730">5.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MHE Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-369" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1731">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-369" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1732">11.53</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/21/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1733">2,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1734">2,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1735">2,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-369" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1736">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MHE Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-370" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1737">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-370" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1738">11.78</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/21/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1739">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1740">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1741">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-370" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1742">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1743">2,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1744">2,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-371" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1745">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Armada Parent, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-372" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1746">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-372" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1747">11.24</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1748">25,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1749">25,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1750">25,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-372" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1751">0.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Media</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trader Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-373" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1752">6.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-373" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1753">12.19</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/22/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-373" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1754">9,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-373" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1755">6,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-373" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1756">7,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-373" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1757">0.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">snip</span></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">147</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_2645"></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.131%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.143%"/><td style="width:0.1%"/></tr><tr style="height:44pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt - non-controlled/non-affiliated (continued)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oil, Gas &amp; Consumable Fuels</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Eagle Midstream Canada Finance, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-374" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1758">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-374" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1759">11.63</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/15/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1760">65,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1761">64,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1762">65,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-374" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1763">1.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">KKR Alberta Midsteam Finance Inc </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-375" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1764">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-375" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1765">11.63</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/15/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1766">35,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1767">35,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1768">35,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-375" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1769">0.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1770">99,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1771">100,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-376" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1772">2.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paper &amp; Forest Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Profile Products, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-377" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1773">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-377" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1774">10.99</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/12/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-377" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1775">1,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-377" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1776">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-377" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1777">1,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-377" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1778">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Profile Products, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-378" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1779">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-378" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1780">10.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/12/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1781">6,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1782">6,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1783">5,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-378" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1784">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1785">7,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1786">7,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-379" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1787">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Doc Generici (Diocle S.p.A.) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-380" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1788">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-380" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1789">10.42</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/27/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-380" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1790">1,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1791">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1792">1,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-380" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1793">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ergomed Plc</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-381" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1794">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-381" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1795">11.60</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/18/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1796">20,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1797">20,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1798">21,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-381" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1799">0.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1800">21,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1801">22,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-382" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1802">0.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Professional Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ALKU, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-383" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1803">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-383" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1804">11.61</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/23/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1805">798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1806">780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1807">796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-383" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1808">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Apex Companies, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-384" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1809">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-384" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1810">11.63</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/31/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1811">1,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1812">1,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1813">1,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-384" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1814">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CFGI Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-385" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1815">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-385" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1816">10.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/2/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1817">6,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1818">6,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1819">6,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-385" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1820">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Clearview Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-386" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1821">5.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-386" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1822">10.70</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/26/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-386" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1823">9,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-386" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1824">9,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-386" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1825">8,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-386" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1826">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumming Group, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-387" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1827">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-387" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1828">11.11</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/26/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-387" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1829">80,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-387" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1830">79,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-387" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1831">78,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-387" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1832">1.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumming Group, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-388" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1833">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-388" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1834">11.11</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/16/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1835">9,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1836">9,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1837">9,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-388" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1838">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Guidehouse, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-389" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1839">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-389" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1840">11.11</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-389" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1841">2.00</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/16/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1842">307,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1843">304,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1844">303,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-389" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1845">6.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HIG Orca Acquisition Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-390" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1846">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-390" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1847">11.54</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1848">19,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1849">18,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1850">19,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-390" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1851">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HIG Orca Acquisition Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-391" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1852">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-391" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1853">11.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1854">2,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1855">2,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1856">2,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-391" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1857">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IG Investments Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-392" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1858">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-392" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1859">11.48</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/22/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1860">46,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1861">45,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1862">46,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-392" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1863">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kaufman Hall &amp; Associates, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-393" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1864">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-393" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1865">10.71</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/14/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1866">24,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1867">23,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1868">24,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-393" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1869">0.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legacy Intermediate, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-394" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1870">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-394" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1871">11.29</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1872">6,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1873">6,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1874">6,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-394" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1875">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Material Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-395" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1876">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-395" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1877">11.45</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/19/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1878">24,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1879">24,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1880">22,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-395" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1881">0.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Minotaur Acquisition, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-396" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1882">4.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-396" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1883">10.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/27/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1884">1,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1885">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1886">1,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-396" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1887">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pavion Corp.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-397" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1888">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-397" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1889">11.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/30/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1890">82,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1891">80,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1892">80,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-397" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1893">1.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Petrus Buyer Inc </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-398" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1894">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-398" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1895">11.99</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/17/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1896">1,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1897">1,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1898">1,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-398" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1899">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sherlock Buyer Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-399" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1900">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-399" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1901">11.20</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/8/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1902">8,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1903">8,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1904">8,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-399" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1905">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thevelia US, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)(6)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-400" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1906">4.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-400" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1907">9.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-400" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1908">1,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-400" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1909">1,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-400" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1910">1,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-400" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1911">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Titan Investment Company, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-401" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1912">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-401" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1913">11.28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/20/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1914">41,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1915">40,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1916">39,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-401" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1917">0.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Air Consultants Holdings Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-402" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1918">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-402" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1919">11.29</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/29/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1920">55,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1921">55,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1922">55,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-402" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1923">1.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Air Consultants Holdings Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-403" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1924">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-403" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1925">11.03</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/29/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1926">22,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1927">22,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1928">22,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-403" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1929">0.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Partners Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-404" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1930">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-404" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1931">11.03</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/21/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1932">4,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1933">4,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1934">4,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-404" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1935">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">West Monroe Partners, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-405" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1936">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-405" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1937">10.72</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/8/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1938">14,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1939">14,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1940">14,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-405" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1941">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">West Monroe Partners, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-406" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1942">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-406" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1943">10.72</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/8/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1944">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1945">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1946">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-406" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1947">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1948">764,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1949">761,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-407" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1950">15.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">148</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.131%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.143%"/><td style="width:0.1%"/></tr><tr style="height:44pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt - non-controlled/non-affiliated (continued)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Real Estate Management &amp; Development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Castle Management Borrower, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-408" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1951">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-408" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1952">10.84</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/3/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1953">23,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1954">22,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1955">22,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-408" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1956">0.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Progress Residential PM Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-409" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1957">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-409" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1958">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1959">67,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1960">67,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1961">67,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-409" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1962">1.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Progress Residential PM Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-410" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1963">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-410" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1964">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/25/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1965">833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1966">818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1967">833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-410" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1968">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.02pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 1.02pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-411" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1969">90,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-411" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1970">91,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-411" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1971">1.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Anaplan, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-412" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1972">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-412" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1973">11.85</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/21/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-412" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1974">1,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-412" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1975">1,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-412" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1976">1,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-412" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1977">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beeline, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-413" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1978">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-413" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1979">10.64</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/2/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1980">4,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1981">4,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1982">4,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-413" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1983">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BlueCat Networks USA, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-414" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1984">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-414" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1985">11.38</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-414" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1986">2.00</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/8/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-414" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1987">1,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-414" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-1988">1,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-414" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1989">1,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-414" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1990">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BlueCat Networks USA, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-415" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1991">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-415" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1992">11.42</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-415" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-1993">2.00</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/8/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-1994">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-1995">338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-1996">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-415" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-1997">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BlueCat Networks USA, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-416" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-1998">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-417" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-1999">11.35</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-417" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-2000">2.00</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/8/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-416" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-2001">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-416" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2002">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-416" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2003">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-416" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2004">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bluefin Holding, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-418" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2005">7.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-418" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2006">12.72</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/12/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2007">22,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2008">22,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2009">22,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-418" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2010">0.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brave Parent Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-419" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2011">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-419" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2012">10.36</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/28/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2013">64,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2014">63,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2015">63,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-419" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2016">1.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Circana Group, L.P. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-420" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2017">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-420" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2018">11.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2019">120,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2020">118,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2021">120,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-420" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2022">2.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Circana Group, L.P. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-421" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2023">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-422" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2024">11.61</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-422" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-2025">2.75</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-421" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2026">77,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-421" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2027">76,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-421" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2028">77,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-421" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2029">1.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Circana Group, L.P. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-423" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2030">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-423" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2031">11.11</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2032">2,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2033">2,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2034">2,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-423" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2035">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Community Brands ParentCo, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-424" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2036">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-424" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2037">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/24/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2038">4,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2039">4,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2040">4,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-424" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2041">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Confine Visual Bidco </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-425" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2042">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-426" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2043">11.81</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-426" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-2044">3.00</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2045">16,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2046">15,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2047">13,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-425" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2048">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Connatix Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-427" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2049">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-427" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2050">11.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/14/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2051">21,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2052">21,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2053">19,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-427" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2054">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Coupa Software Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-428" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2055">7.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-428" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2056">12.86</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/27/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2057">1,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2058">1,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2059">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-428" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2060">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crewline Buyer, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-429" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2061">6.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-429" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2062">12.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/8/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2063">59,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2064">58,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2065">58,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-429" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2066">1.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denali Bidco Ltd</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-430" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2067">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-430" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2068">11.19</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/29/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GBP</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="c-430" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2069">4,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2070">4,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2071">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-430" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2072">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denali Bidco Ltd</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-431" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2073">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-431" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2074">9.84</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/29/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-431" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2075">1,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-431" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2076">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-431" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2077">1,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-431" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2078">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diligent Corporation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-432" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2079">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-432" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2080">11.28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/4/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2081">58,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2082">58,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2083">58,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-432" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2084">1.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discovery Education, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-433" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2085">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-433" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2086">11.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/3/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2087">3,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2088">3,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2089">3,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-433" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2090">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discovery Education, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-434" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2091">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-434" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2092">11.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/9/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2093">33,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2094">32,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2095">31,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-434" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2096">0.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Episerver, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-435" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2097">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-435" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2098">10.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/9/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2099">9,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2100">9,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2101">9,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-435" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2102">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Experity, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-436" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2103">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-436" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2104">11.20</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/24/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2105">14,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2106">14,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2107">14,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-436" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2108">0.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GI Consilio Parent, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-437" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2109">3.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-437" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2110">8.94</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/14/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GBP</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="c-437" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-2111">442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2112">564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2113">554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-437" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2114">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">149</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.131%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.143%"/><td style="width:0.1%"/></tr><tr style="height:44pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt - non-controlled/non-affiliated (continued)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Software (continued)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gigamon Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-438" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2115">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-438" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2116">11.30</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/9/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2117">7,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2118">7,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2119">7,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-438" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2120">0.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GovernmentJobs.com, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-439" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2121">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-439" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2122">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2123">5,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2124">5,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2125">5,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-439" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2126">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GraphPAD Software, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-440" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2127">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-440" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2128">11.22</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/27/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2129">13,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2130">13,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2131">13,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-440" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2132">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GraphPAD Software, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-441" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2133">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-441" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2134">11.19</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/27/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2135">12,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2136">12,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2137">12,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-441" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2138">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GraphPAD Software, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-442" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2139">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-442" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2140">11.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/27/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2141">6,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2142">6,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2143">6,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-442" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2144">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GraphPAD Software, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">P +</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-443" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2145">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-443" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2146">13.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/27/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2147">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2148">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2149">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-443" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2150">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LD Lower Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-444" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2151">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-444" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2152">11.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/8/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2153">91,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2154">90,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2155">90,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-444" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2156">1.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lightbox Intermediate, LP </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-445" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2157">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-445" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2158">10.61</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/9/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2159">1,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2160">1,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2161">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-445" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2162">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Magnesium BorrowerCo, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-446" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2163">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-446" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2164">11.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/18/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2165">5,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2166">5,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2167">5,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-446" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2168">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Magnesium BorrowerCo, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-447" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2169">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-447" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2170">10.94</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/18/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GBP</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="c-447" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2171">3,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2172">4,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2173">4,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-447" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2174">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mandolin Technology Intermediate Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-448" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2175">3.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-448" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2176">9.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/31/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2177">8,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2178">8,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2179">7,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-448" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2180">0.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mandolin Technology Intermediate Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-449" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2181">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-449" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2182">11.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/9/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-449" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2183">6,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-449" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2184">6,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-449" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2185">6,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-449" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2186">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mandolin Technology Intermediate Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-450" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2187">3.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-450" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2188">9.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/31/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-450" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-2189">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-450" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2190">277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-450" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2191">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-450" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2192">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medallia, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-451" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2193">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-451" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2194">11.45</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-451" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-2195">4.00</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-451" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2196">364,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-451" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2197">359,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-451" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2198">356,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-451" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2199">7.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medallia, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-452" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2200">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-452" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2201">11.95</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-452" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-2202">4.00</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2203">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2204">2,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2205">2,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-452" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2206">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monk Holding Co. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)(18)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-453" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2207">5.70</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-453" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2208">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2209">4,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2210">4,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2211">4,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-453" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2212">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monk Holding Co. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-454" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2213">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-454" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2214">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-2215">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2216">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2217">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-454" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2218">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MRI Software, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-455" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2219">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-455" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2220">10.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/10/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2221">51,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2222">51,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2223">50,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-455" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2224">1.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NAVEX TopCo, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-456" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2225">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-456" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2226">11.11</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/9/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-456" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2227">61,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-456" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2228">59,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-456" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2229">59,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-456" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2230">1.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nintex Topco Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-457" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2231">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-457" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2232">11.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/13/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2233">33,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2234">33,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2235">32,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-457" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2236">0.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Oranje Holdco Inc</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-458" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2237">7.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-458" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2238">13.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2239">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2240">1,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2241">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-458" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2242">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rally Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-459" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2243">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-459" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2244">11.12</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-2245">840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2246">827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2247">824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-459" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2248">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rally Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-460" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2249">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-460" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2250">11.11</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-2251">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2252">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2253">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-460" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2254">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Relativity ODA, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-461" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2255">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-461" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2256">11.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/12/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2257">21,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2258">21,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2259">21,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-461" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2260">0.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spitfire Parent, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-462" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2261">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-462" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2262">10.96</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/11/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2263">78,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2264">77,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2265">78,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-462" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2266">1.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spitfire Parent, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-463" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2267">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-463" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2268">9.34</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/11/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-463" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2269">10,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2270">12,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2271">12,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-463" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2272">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stamps.com, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-464" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2273">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-464" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2274">11.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/5/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2275">285,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2276">281,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2277">278,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-464" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2278">5.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Triple Lift, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-465" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2279">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-465" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2280">11.27</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/5/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2281">61,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2282">60,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2283">59,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-465" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2284">1.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Triple Lift, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-466" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2285">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-466" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2286">11.31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/5/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2287">2,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2288">2,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2289">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-466" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2290">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">WPEngine, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-467" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2291">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-467" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2292">11.87</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/14/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2293">66,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2294">64,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2295">65,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-467" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2296">1.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Zendesk Inc </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-468" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2297">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-469" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2298">11.61</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-5" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-2299">3.25</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/30/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2300">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2301">1,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2302">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-468" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2303">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-470" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2304">1,718,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-470" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2305">1,706,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-470" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2306">34.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Retail</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CustomInk, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)(18)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-471" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2307">6.18</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-471" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2308">11.49</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/3/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2309">163,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2310">162,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2311">163,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-471" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2312">3.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology Hardware, Storage &amp; Peripherals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lytx, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-472" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2313">6.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-472" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2314">12.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/28/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2315">84,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2316">83,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2317">84,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-472" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2318">1.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">150</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.131%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.143%"/><td style="width:0.1%"/></tr><tr style="height:44pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt - non-controlled/non-affiliated (continued)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Companies &amp; Distributors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Porcelain Acquisition Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-473" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2319">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-473" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2320">11.49</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2321">54,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2322">53,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2323">52,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-473" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2324">1.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transportation Infrastructure</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capstone Logistics, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-474" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2325">4.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-474" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2326">10.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/12/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-474" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2327">5,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-474" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2328">5,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-474" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2329">5,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-474" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2330">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Frontline Road Safety, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-475" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2331">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-475" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2332">11.55</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/3/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-475" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2333">89,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-475" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2334">88,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-475" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2335">87,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-475" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2336">1.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Frontline Road Safety, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-476" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2337">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-476" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2338">11.39</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/3/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-476" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2339">10,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-476" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2340">10,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-476" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2341">10,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-476" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2342">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Helix TS, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-477" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2343">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-477" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2344">11.78</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/4/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-477" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2345">45,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-477" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2346">44,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-477" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2347">44,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-477" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2348">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Helix TS, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-478" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2349">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-478" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2350">11.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/4/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-2351">993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2352">979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2353">973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-478" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2354">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Italian Motorway Holdings S.&#224;.r.l </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-479" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2355">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-479" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2356">9.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/28/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-479" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2357">78,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-479" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2358">81,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-479" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2359">86,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-479" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2360">1.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Roadsafe Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-480" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2361">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-480" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2362">11.22</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/19/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-480" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2363">29,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-480" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2364">29,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-480" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2365">28,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-480" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2366">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Roadsafe Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-481" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2367">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-481" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2368">11.26</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/19/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-481" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2369">20,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-481" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2370">20,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-481" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2371">19,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-481" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2372">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Roadsafe Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-482" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2373">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-482" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2374">11.29</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/31/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-482" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2375">4,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-482" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2376">4,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-482" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2377">4,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-482" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2378">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Safety Borrower Holdings LP </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-483" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2379">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-483" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2380">10.90</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/1/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2381">5,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2382">5,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2383">5,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-483" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2384">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Safety Borrower Holdings LP </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">P +</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-484" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2385">4.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-484" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2386">12.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-2387">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2388">277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2389">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-484" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2390">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sam Holding Co, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-485" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2391">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-485" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2392">11.49</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/24/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2393">37,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2394">37,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2395">37,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-485" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2396">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sam Holding Co, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-486" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2397">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-486" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2398">11.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/24/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2399">11,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2400">11,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2401">11,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-486" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2402">0.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sam Holding Co, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-487" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2403">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-487" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2404">11.57</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/24/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-487" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2405">15,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-487" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2406">15,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-487" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2407">15,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-487" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2408">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRP Infrastructure Services, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-488" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2409">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-488" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2410">11.03</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/9/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2411">38,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2412">38,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2413">34,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-488" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2414">0.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2415">393,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2416">392,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-489" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2417">7.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total First Lien Debt - non-controlled/non-affiliated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-490" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2418">9,817,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-490" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2419">9,722,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-490" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2420">196.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total First Lien Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2421">9,817,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2422">9,722,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-491" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2423">196.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">151</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_2648"></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.593%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.113%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.269%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.992%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.570%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.992%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.992%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.120%"/><td style="width:0.1%"/></tr><tr style="height:44pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second Lien Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second Lien Debt - non-controlled/non-affiliated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Providers &amp; Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canadian Hospital Specialties Ltd. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-492" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2424">8.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-492" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2425">8.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/15/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-492" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2426">10,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-492" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2427">8,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-492" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2428">7,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-492" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2429">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jayhawk Buyer, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-493" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2430">8.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-493" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2431">14.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/15/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-493" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2432">5,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-493" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2433">5,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-493" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2434">4,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-493" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2435">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.02pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-494" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2436">13,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-494" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2437">12,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-494" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2438">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Industrial Conglomerates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Victory Buyer, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-495" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2439">7.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-495" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2440">12.64</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/1/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-495" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2441">9,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-495" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2442">9,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-495" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2443">8,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-495" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2444">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IT Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inovalon Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-496" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2445">10.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-496" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2446">15.97</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-496" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-2447">15.97</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/24/2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-496" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2448">12,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-496" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2449">12,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-496" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2450">12,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-496" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2451">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Professional Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thevelia US, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-497" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2452">6.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-497" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2453">12.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/17/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-497" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2454">4,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-497" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2455">4,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-497" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2456">4,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-497" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2457">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mandolin Technology Intermediate Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-498" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2458">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-498" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2459">12.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/30/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-498" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2460">3,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-498" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2461">3,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-498" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2462">3,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-498" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2463">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Second Lien Debt - non-controlled/non-affiliated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-499" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2464">43,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-499" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2465">41,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-499" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2466">0.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Second Lien Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2467">43,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2468">41,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-500" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2469">0.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">152</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_2651"></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.366%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.982%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.386%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.992%"/><td style="width:0.1%"/></tr><tr style="height:44pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unsecured Debt- non-controlled/non-affiliated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Healthcomp Holding Company, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-501" decimals="4" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-2470">13.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;<ix:nonFraction unitRef="number" contextRef="c-501" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-2471">13.75</ix:nonFraction>% PIK</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/8/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-501" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-2472">10,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-501" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2473">9,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-501" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2474">9,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-501" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2475">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Unsecured Debt - non-controlled/non-affiliated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-502" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2476">9,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-502" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2477">9,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-502" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2478">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity - non-controlled/non-affiliated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aerospace &amp; Defense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Micross Topco, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-503" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2479">4,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-503" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2480">4,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-503" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2481">4,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-503" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2482">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Air Freight &amp; Logistics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AGI Group Holdings LP - A2 Units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-504" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-2483">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-504" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2484">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-504" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2485">507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-504" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2486">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mode Holdings, L.P. - Class A-2 Common Units </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-505" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2487">5,486,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-505" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2488">5,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-505" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2489">9,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-505" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2490">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-506" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2491">6,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-506" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2492">10,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-506" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2493">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial Services &amp; Supplies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GTCR Investors LP - A-1 Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-507" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2494">417,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-507" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2495">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-507" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2496">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-507" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2497">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Distributors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Box Co-Invest Blocker, LLC - Class A Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-508" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2498">702,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-508" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2499">702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-508" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2500">358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-508" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2501">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Box Co-Invest Blocker, LLC - Class C Units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-509" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2502">85,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-509" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2503">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-509" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2504">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-509" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2505">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EIS Acquisition Holdings, LP - Class A Common Units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-510" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2506">6,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-510" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2507">3,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-510" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2508">13,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-510" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2509">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-511" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2510">4,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-511" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2511">13,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-511" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2512">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diversified Consumer Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cambium Holdings, LLC - Senior Preferred Interests </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-512" decimals="INF" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2513">11.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-512" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2514">12,511,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-512" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2515">12,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-512" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2516">15,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-512" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2517">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diversified Financial Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">THL Fund IX Investors (Plymouth II), LP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-513" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2518">248,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-513" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2519">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-513" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2520">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-513" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2521">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diversified Telecommunication Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Point Broadband Holdings, LLC - Class A Units </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-514" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2522">6,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-514" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2523">5,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-514" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2524">7,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-514" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2525">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Point Broadband Holdings, LLC - Class B Units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-515" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2526">369,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-515" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2527">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-515" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2528">2,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-515" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2529">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Point Broadband Holdings, LLC - Class Additional A Units </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-516" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2530">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-516" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2531">1,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-516" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2532">1,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-516" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2533">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Point Broadband Holdings, LLC - Class Additional B Units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-517" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2534">79,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-517" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2535">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-517" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2536">536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-517" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2537">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-518" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2538">8,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-518" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2539">11,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-518" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2540">0.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Equipment &amp; Supplies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GCX Corporation Group Holdings, L.P. - Class A-2 Units </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-519" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-2541">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-519" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2542">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-519" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2543">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-519" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2544">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Providers &amp; Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVE Holdings I Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-520" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2545">625,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-520" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2546">607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-520" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2547">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-520" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2548">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jayhawk Holdings, LP - A-1 Common Units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-521" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2549">2,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-521" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2550">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-521" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2551">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-521" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2552">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jayhawk Holdings, LP - A-2 Common Units </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-522" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2553">1,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-522" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2554">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-522" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2555">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-522" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2556">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-523" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2557">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-523" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2558">861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-523" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2559">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">153</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.366%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.982%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.386%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.992%"/><td style="width:0.1%"/></tr><tr style="height:44pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity - non-controlled/non-affiliated (continued)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus Midco 2 S.&#192;. R.L - Additional Vehicle Units </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-524" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2560">11,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-524" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2561">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-524" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2562">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-524" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2563">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus Midco 2 S.&#192;. R.L - Vehicle Units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-525" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2564">58,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-525" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2565">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-525" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2566">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-525" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2567">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Healthcomp Holding Company, LLC - Preferred Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-526" decimals="INF" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2568">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-526" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2569">9,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-526" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2570">985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-526" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2571">985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-526" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2572">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-527" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2573">1,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-527" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2574">1,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-527" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2575">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CFCo LLC (Benefytt Technologies, Inc.) - Class B Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-528" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2576">14,907,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-528" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:fixed-zero" scale="3" id="f-2577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-528" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:fixed-zero" scale="3" id="f-2578">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-528" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2579">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shelf Holdco Ltd Common Equity </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-529" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2580">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-529" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2581">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-529" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2582">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-529" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2583">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-530" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2584">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-530" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2585">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-530" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2586">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IT Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NC Ocala Co-Invest Beta, L.P. - LP Interest </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-531" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2587">2,854,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-531" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2588">2,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-531" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2589">3,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-531" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2590">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Professional Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHCP V TC COI, LP. - LP Interest </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-532" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2591">3,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2592">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2593">6,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-532" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2594">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tricor Horizon, LP </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-533" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2595">385,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-533" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2596">386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-533" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2597">386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-533" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2598">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-534" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2599">3,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-534" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2600">6,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-534" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2601">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Connatix Parent, LLC - Class L Common Units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-535" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2602">42,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-535" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2603">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-535" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2604">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-535" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2605">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Descartes Holdings, Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-536" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2606">49,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-536" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2607">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-536" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2608">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-536" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2609">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expedition Holdco, LLC - Class A Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-537" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-2610">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-537" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2611">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-537" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2612">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-537" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2613">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expedition Holdco, LLC - Class B Units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-538" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2614">90,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-538" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2615">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-538" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2616">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-538" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2617">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lobos Parent, Inc. - Series A Preferred Shares </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-539" decimals="INF" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2618">10.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-539" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2619">1,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-539" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2620">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-539" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2621">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-539" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2622">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mandolin Technology Holdings, Inc. - Series A Preferred Shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-540" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2623">3,550,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-540" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2624">3,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-540" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2625">3,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-540" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2626">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mimecast Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-541" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2627">651,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-541" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2628">651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-541" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2629">674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-541" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2630">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TPG IX Newark CI, L.P. - LP Interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-542" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2631">1,965,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-542" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2632">1,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-542" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2633">1,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-542" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2634">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Zoro Common Equity </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-543" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2635">2,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-543" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2636">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-543" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2637">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-543" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2638">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Zoro Series A Preferred Shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-544" decimals="INF" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-2639">12.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-544" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-2640">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-544" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2641">361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-544" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2642">418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-544" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2643">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-545" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2644">8,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-545" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2645">8,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-545" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2646">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Retail</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CustomInk, LLC - Series A Preferred Units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-546" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2647">384,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-546" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2648">5,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-546" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2649">7,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-546" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2650">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">154</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.366%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.982%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.386%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.992%"/><td style="width:0.1%"/></tr><tr style="height:44pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transportation Infrastructure</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Frontline Road Safety Investments, LLC - Class A Common Units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-547" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-2651">27,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-547" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2652">2,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-547" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2653">3,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-547" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2654">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ncp Helix Holdings, LLC. - Preferred Shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-548" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-2655">369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-548" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2656">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-548" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-2657">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-548" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2658">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-549" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2659">3,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-549" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2660">4,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-549" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2661">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Equity - non-controlled/non-affiliated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-550" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2662">63,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-550" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2663">89,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-550" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2664">1.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity - non-controlled/affiliated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(16)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-551" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2665">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-551" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2666">5,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-551" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2667">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Equity - non-controlled/affiliated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2668">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2669">5,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-552" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2670">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-553" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2671">63,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-553" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2672">94,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-553" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2673">1.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Investments - non-controlled/non-affiliated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2674">9,934,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2675">9,862,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-129" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2676">199.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Investments - non-controlled/affiliated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-2677">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2678">5,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-131" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2679">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Investment Portfolio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-554" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2680">9,934,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-554" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2681">9,868,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-554" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2682">199.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State Street Institutional U.S. Government Money Market Fund</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2683">19,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2684">19,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-555" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2685">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-556" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2686">134,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-556" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2687">134,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-556" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2688">2.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Portfolio Investments, Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-557" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-2689">10,089,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-557" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-2690">10,023,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-557" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2691">202.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:2pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:2pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">(1)</span><ix:footnote id="fn-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">Unless otherwise indicated, all debt and equity investments held by the Company (which such term &#8220;Company&#8221; shall include the Company&#8217;s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December&#160;31, 2023, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company&#8217;s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt"><ix:footnote id="fn-2" footnoteRole="http://www.xbrl.org/2003/role/footnote">Variable rate loans to the portfolio companies bear interest at a rate that is determined by reference to either Canadian Dollar Offered Rate (&#8220;CDOR&#8221; or &#8220;C&#8221;), Sterling Overnight Interbank Average Rate (&#8220;SONIA&#8221; or &#8220;S&#8221;), Euro Interbank Offer Rate (&#8220;Euribor&#8221; or &#8220;E&#8221;), Secured Overnight Financing Rate (&#8220;SOFR&#8221;), Stockholm Interbank Offered Rate (&#8220;STIBOR&#8221; or &#8220;ST&#8221;), Copenhagen Interbank Offered Rate (&#8220;CIBOR&#8221; or &#8220;CI&#8221;), Norwegian Interbank Offered Rate (&#8220;NIBOR&#8221; or &#8220;N&#8221;), or an alternate base rate (commonly based on the Federal Funds Rate (&#8220;F&#8221;) or the U.S. Prime Rate (&#8220;P&#8221;)), which generally resets periodically. For each loan, the Company has indicated the reference rate used and provided the spread and the interest rate in effect as of December&#160;31, 2023. Variable rate loans typically include an interest reference rate floor feature. As of December&#160;31, 2023, <ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="bxsl:InvestmentPercentageOfPortfolioAboveFloorRate" scale="-2" id="f-2692">93.7</ix:nonFraction>% of the debt portfolio at fair value had an interest rate floor above zero. Rates on equity instruments represents contractual dividend rates on certain preferred equity positions.</ix:footnote> </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">(3)</span><ix:footnote id="fn-3" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">(4)</span><ix:footnote id="fn-4" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">These investments were valued using unobservable inputs and are considered Level 3 investments. Fair value was determined in good faith by or under the direction of the Board of Trustees (see Note 2), pursuant to the Company&#8217;s valuation policy.</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:130%">(5)</span><ix:footnote id="fn-5" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:26.68pt">These investments are not pledged as collateral under any of the Company's credit facilities. For other debt investments that are pledged to the Company's credit facilities, a single investment may be divided into parts that are individually pledged as collateral to separate credit facilities. Any other debt investments listed above are pledged to financing facilities and are not available to satisfy the creditors of the Company.</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">(6)</span><ix:footnote id="fn-6" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">The investment is not a qualifying asset under Section 55(a) of the Investment Company Act of 1940, as amended (together with the rules and regulations promulgated thereunder, the &#8220;1940 Act&#8221;). The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least <ix:nonFraction unitRef="number" contextRef="c-558" decimals="INF" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2693">70</ix:nonFraction>% of the Company&#8217;s total assets. As of December&#160;31, 2023, non-qualifying assets represented <ix:nonFraction unitRef="number" contextRef="c-559" decimals="3" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-2694">11.0</ix:nonFraction>% of total assets as calculated in accordance with regulatory requirements.<br/><br/></span></ix:footnote></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">155</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%"><br/><br/><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><ix:footnote id="fn-7" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Position or portion thereof is an unfunded commitment, and no interest is being earned on the unfunded portion, although the investment may be subject to unused commitment fees. Negative cost and fair value results from unamortized fees, which are capitalized to the investment cost. The unfunded commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. See below for more information on the Company&#8217;s unfunded commitments:</span></ix:footnote></div><div id="i33edc808e7824948b94b269ed713a939_2871"></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"/><td style="width:33.750%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.342%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.367%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments&#8212;non-controlled/non-affiliated</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Type</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Expiration Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unfunded Commitment</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123Dentist, Inc. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/10/2029</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-560" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2695">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-560" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2696">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACI Group Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/2/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-561" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2697">9,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-561" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2698">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACI Group Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/2/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-562" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2699">14,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-562" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2700">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ADCS Clinics Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/7/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-563" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2701">1,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-563" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2702">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AI Altius Bidco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/20/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-564" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2703">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-564" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2704">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alera Group, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/17/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-565" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2705">1,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-565" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2706">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerilife Holdings LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-566" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2707">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-566" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2708">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerilife Holdings LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-567" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2709">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-567" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerilife Holdings LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/20/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-568" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2711">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-568" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2712">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerivet Partners Management, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-569" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2713">589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-569" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2714">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Anaplan, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/21/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-570" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2715">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-570" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2716">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Apex Companies, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/31/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-571" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2717">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-571" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2718">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Armada Parent, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/15/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-572" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2719">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-572" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2720">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Armada Parent, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-573" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2721">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-573" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2722">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ascend Buyer, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/30/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-574" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2723">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-574" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2724">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bamboo US BidCo LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/30/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-575" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2725">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-575" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2726">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bamboo US BidCo LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/28/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-576" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2727">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-576" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2728">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bazaarvoice, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/7/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-577" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2729">28,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-577" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2730">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beeline, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/2/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-578" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2731">591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-578" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2732">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beeline, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/2/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-579" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2733">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-579" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2734">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BlueCat Networks USA, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/8/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-580" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2735">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-580" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2736">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bluefin Holding, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/12/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2737">2,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2738">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BradyIFS Holdings, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-582" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2739">7,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-582" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2740">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BradyIFS Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-583" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2741">7,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-583" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2742">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brave Parent Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/28/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2743">7,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2744">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brave Parent Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/28/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-585" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2745">3,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-585" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2746">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus US 1, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/25/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-586" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2747">836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-586" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus US 1, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/25/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-587" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2749">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-587" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2750">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus US 1, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/25/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-588" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2751">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-588" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2752">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cambium Learning Group, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/20/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-589" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2753">43,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-589" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2754">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Castle Management Borrower, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/3/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-590" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2755">2,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-590" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2756">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CFGI Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/2/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-591" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2757">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-591" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2758">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CFS Brands, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/2/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-592" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2759">18,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-592" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2760">364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CFS Brands, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/2/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-593" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2761">12,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-593" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2762">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Circana Group, L.P. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-594" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2763">11,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-594" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2764">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Clearview Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/26/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-595" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2765">898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-595" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2766">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Clearview Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/26/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-596" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2767">3,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-596" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2768">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Community Brands ParentCo, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/24/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-597" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2769">588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-597" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2770">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Community Brands ParentCo, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/24/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-598" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2771">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-598" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2772">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Confine Visual Bidco </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/11/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-599" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2773">3,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-599" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2774">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Connatix Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/14/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-600" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2775">5,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-600" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2776">448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COP Home Services TopCo IV, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-601" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2777">3,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-601" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2778">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COP Home Services TopCo IV, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-602" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2779">8,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-602" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2780">131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Coupa Software Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/27/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-603" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2781">164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-603" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2782">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Coupa Software Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/27/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-604" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2783">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-604" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2784">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">156</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"/><td style="width:33.750%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.342%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.367%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments&#8212;non-controlled/non-affiliated</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Type</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Expiration Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unfunded Commitment</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CPI Buyer, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/1/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-605" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2785">3,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-605" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2786">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CPI Intermediate Holdings Inc </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/8/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-606" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2787">966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-606" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2788">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crewline Buyer, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/8/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-607" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2789">6,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-607" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2790">156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumming Group, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/16/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-608" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2791">12,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-608" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2792">190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumming Group, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/21/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-609" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2793">8,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-609" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2794">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denali Bidco Ltd</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/29/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-610" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2795">1,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-610" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2796">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discovery Education, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/9/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-611" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2797">2,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-611" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2798">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Doc Generici (Diocle S.p.A.) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/26/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-612" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2799">1,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-612" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2800">591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emergency Power Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-613" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2801">16,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-613" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2802">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Endeavor Schools Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/18/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-614" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2803">5,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-614" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2804">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ENV Bidco AB</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-615" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2805">433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-615" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2806">153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Episerver, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/9/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-616" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2807">2,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-616" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2808">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ergomed Plc</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/17/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-617" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2809">46,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-617" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2810">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Experity, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/24/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-618" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2811">1,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-618" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2812">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fencing Supply Group Acquisition, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/29/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-619" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2813">1,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-619" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2814">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fencing Supply Group Acquisition, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/26/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-620" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2815">1,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-620" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2816">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Formulations Parent Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/15/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-621" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2817">1,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-621" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2818">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foundation Risk Partners Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-622" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2819">2,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-622" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2820">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foundation Risk Partners Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-623" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2821">6,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-623" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2822">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Freya Bidco Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-624" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2823">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-624" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2824">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Freya Bidco Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-625" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2825">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-625" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2826">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Freya Bidco Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-626" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2827">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-626" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2828">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Freya Bidco Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-627" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2829">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-627" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Frontgrade Technologies Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/9/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-628" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2831">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-628" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2832">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Frontline Road Safety, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/15/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-629" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2833">10,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-629" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2834">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FusionSite Midco, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/17/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-630" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2835">8,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-630" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FusionSite Midco, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/17/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-631" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2837">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-631" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2838">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Galway Borrower, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/30/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-632" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2839">2,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-632" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2840">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GI Consilio Parent, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/14/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-633" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2841">561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-633" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GI Ranger Intermediate, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-634" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2843">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-634" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2844">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GI Ranger Intermediate, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/30/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-635" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2845">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-635" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gigamon Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/11/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-636" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2847">437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-636" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2848">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GovernmentJobs.com, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/30/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-637" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2849">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-637" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2850">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GraphPAD Software, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/27/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-638" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2851">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-638" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2852">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Groundworks, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/13/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-639" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2853">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-639" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2854">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Groundworks, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/14/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-640" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2855">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-640" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2856">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HIG Orca Acquisition Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-641" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2857">2,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-641" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2858">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HIG Orca Acquisition Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-642" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2859">3,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-642" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2860">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">High Street Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/16/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-643" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2861">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-643" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2862">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">High Street Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/16/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-644" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2863">9,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-644" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2864">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icefall Parent Inc</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/25/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-645" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2865">31,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-645" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2866">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icefall Parent Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/25/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-646" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2867">3,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-646" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2868">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IG Investments Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/22/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-647" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2869">3,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-647" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2870">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inova Pharmaceutical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/30/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-648" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2871">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-648" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2872">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inova Pharmaceutical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/30/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-649" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2873">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-649" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2874">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inovalon Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/24/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-650" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2875">11,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-650" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2876">138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integrity Marketing Acquisition, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/27/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-651" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2877">1,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-651" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2878">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integrity Marketing Acquisition, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/27/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-652" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2879">17,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-652" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2880">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Iris Buyer, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/2/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-653" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2881">3,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-653" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2882">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Iris Buyer, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/2/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-654" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2883">3,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-654" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2884">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ISQ Hawkeye Holdco, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-655" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2885">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-655" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">157</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"/><td style="width:33.750%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.342%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.367%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments&#8212;non-controlled/non-affiliated</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Type</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Expiration Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unfunded Commitment</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ISQ Hawkeye Holdco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-656" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2887">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-656" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2888">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Java Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/1/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-657" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2889">930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-657" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2890">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Java Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/9/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-658" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2891">1,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-658" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2892">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Knowledge Pro Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/10/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-659" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2893">784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-659" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2894">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Knowledge Pro Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/8/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-660" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2895">2,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-660" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2896">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kwol Acquisition, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/6/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-661" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2897">628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-661" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2898">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Magnesium BorrowerCo, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/18/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-662" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2899">485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-662" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2900">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Magneto Components BuyCo, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/5/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-663" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2901">5,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-663" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2902">138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Magneto Components BuyCo, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/5/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-664" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2903">6,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-664" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2904">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mandolin Technology Intermediate Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/30/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-665" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2905">916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-665" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2906">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marcone Yellowstone Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/23/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-666" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2907">342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-666" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2908">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Material Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-667" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2909">848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-667" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2910">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mercury Bidco Globe Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/31/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-668" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2911">59,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-668" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2912">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mercury Bidco Globe Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/31/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-669" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2913">14,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-669" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2914">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MHE Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/21/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-670" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2915">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-670" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2916">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monk Holding Co. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-671" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2917">830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-671" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2918">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monterey Financing, S.A.R.L </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/19/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-672" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2919">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-672" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2920">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">More Cowbell II, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/1/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-673" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2921">871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-673" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2922">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">More Cowbell II, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/1/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-674" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2923">968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-674" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2924">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MPG Parent Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/8/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-675" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2925">10,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-675" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2926">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MPG Parent Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/8/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-676" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2927">1,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-676" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2928">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MPG Parent Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/8/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-677" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2929">2,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-677" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2930">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MRI Software, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/10/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-678" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2931">1,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-678" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2932">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MRI Software, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/10/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-679" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2933">1,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-679" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2934">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MRI Software, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/10/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-680" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2935">40,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-680" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2936">201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MRI Software, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/10/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-681" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2937">4,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-681" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2938">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MRI Software, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/10/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-682" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2939">3,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-682" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2940">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NAVEX TopCo, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/9/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-683" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2941">5,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-683" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2942">108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Navigator Acquiror, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/16/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-684" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2943">24,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-684" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDC Acquisition Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/9/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-685" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2945">2,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-685" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Neptune Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/14/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-686" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2947">933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-686" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2948">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NMC Crimson Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/1/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-687" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2949">2,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-687" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2950">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Onex Baltimore Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/27/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-688" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2951">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-688" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2952">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Onex Baltimore Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/21/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-689" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2953">4,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-689" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Oranje Holdco Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-690" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2955">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-690" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2956">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pavion Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/30/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-691" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2957">9,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-691" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2958">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pavion Corp.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/30/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-692" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2959">18,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-692" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2960">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Petrus Buyer Inc </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/17/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-693" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2961">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-693" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2962">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Petrus Buyer Inc </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/17/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-694" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2963">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-694" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2964">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PGIS Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/16/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-695" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2965">4,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-695" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2966">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PGIS Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/16/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-696" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2967">469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-696" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2968">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Phoenix 1 Buyer Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/20/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-697" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2969">5,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-697" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2970">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PPV Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-698" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2971">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-698" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2972">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PPV Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-699" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2973">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-699" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2974">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Profile Products, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/12/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-700" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2975">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-700" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2976">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Profile Products, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/12/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-701" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2977">353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-701" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2978">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Progress Residential PM Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/26/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-702" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2979">16,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-702" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2980">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Progress Residential PM Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/25/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-703" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2981">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-703" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2982">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pye-Barker Fire &amp; Safety LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/26/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-704" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2983">18,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-704" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2984">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quality Distribution LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/3/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-705" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2985">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-705" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2986">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">158</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"/><td style="width:33.750%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.342%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.367%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments&#8212;non-controlled/non-affiliated</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Type</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Expiration Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unfunded Commitment</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quality Distribution LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/3/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-706" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2987">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-706" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2988">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quality Distribution LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/24/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-707" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2989">1,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-707" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2990">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quality Distribution LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/1/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-708" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2991">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-708" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-2992">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Qualus Power Services Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/26/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-709" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-2993">3,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-709" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2994">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rally Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-710" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2995">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-710" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2996">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rally Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-711" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2997">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-711" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-2998">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redwood Services Group, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/15/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-712" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-2999">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-712" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3000">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redwood Services Group, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/15/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-713" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3001">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-713" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3002">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Relativity ODA, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/12/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-714" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3003">3,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-714" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3004">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RoadOne Inc </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-715" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3005">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-715" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3006">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RoadOne Inc </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-716" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3007">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-716" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3008">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S&amp;P Global Engineering Solutions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/2/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-717" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3009">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-717" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3010">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Safety Borrower Holdings LP </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/1/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-718" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3011">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-718" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3012">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sam Holding Co, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/24/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-719" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3013">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-719" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3014">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sam Holding Co, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/24/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-720" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3015">9,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-720" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3016">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEKO Global Logistics Network, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-721" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3017">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-721" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3018">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sherlock Buyer Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/8/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-722" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3019">2,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-722" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3020">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sherlock Buyer Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/8/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-723" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3021">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-723" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3022">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smile Doctors, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/23/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-724" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3023">2,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-724" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3024">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smile Doctors, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/23/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-725" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3025">1,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-725" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3026">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Snoopy Bidco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/6/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-726" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3027">15,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-726" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3028">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SpecialtyCare, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-727" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3029">865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-727" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3030">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SpecialtyCare, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/19/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-728" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3031">1,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-728" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3032">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stepping Stones Healthcare Services, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/2/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-729" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3033">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-729" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3034">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stepping Stones Healthcare Services, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-730" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3035">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-730" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3036">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Fertility Partners, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/16/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-731" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3037">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-731" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3038">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trader Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/22/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-732" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3039">830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-732" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3040">190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Air Consultants Holdings Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/29/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-733" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3041">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-733" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3042">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Air Consultants Holdings Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/29/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-734" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3043">6,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-734" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3044">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Air Consultants Holdings Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/30/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-735" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3045">11,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-735" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3046">113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Partners Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/20/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-736" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3047">1,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-736" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3048">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Triple Lift, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/6/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-737" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3049">4,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-737" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3050">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turing Holdco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/3/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-738" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3051">31,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-738" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3052">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turing Holdco, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/3/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-739" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3053">20,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-739" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3054">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UMP Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/15/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-740" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3055">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-740" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3056">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unified Physician Management, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-741" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3057">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-741" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3058">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Oral Surgery Management Holdco, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/16/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-742" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3059">46,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-742" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3060">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Oral Surgery Management Holdco, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/18/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-743" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3061">3,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-743" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3062">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">West Monroe Partners, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/9/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-744" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3063">1,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-744" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3064">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">WHCG Purchaser III, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/22/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-745" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3065">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-745" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-3066">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">World Insurance Associates, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/3/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-746" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3067">47,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-746" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3068">470</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">World Insurance Associates, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/3/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-747" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3069">2,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-747" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3070">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">WPEngine, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/14/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-748" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3071">6,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-748" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3072">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Zendesk Inc </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/3/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-749" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3073">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-749" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3074">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Zendesk Inc </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/22/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-750" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-3075">361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-750" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-3076">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total unfunded commitments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-3077">985,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3078">6,660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">159</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.48pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments<br/>December&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)&#160;&#160;&#160;&#160;<ix:footnote id="fn-8" footnoteRole="http://www.xbrl.org/2003/role/footnote">There are <ix:nonFraction unitRef="number" contextRef="c-751" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" format="ixt:fixed-zero" scale="0" id="f-3079">no</ix:nonFraction> interest rate floors on these investments.</ix:footnote></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)&#160;&#160;&#160;&#160;<ix:footnote id="fn-9" footnoteRole="http://www.xbrl.org/2003/role/footnote">The interest rate floor on these investments as of December&#160;31, 2023 was <ix:nonFraction unitRef="number" contextRef="c-752" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" scale="-2" id="f-3080">0.50</ix:nonFraction>%.</ix:footnote></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)&#160;&#160;&#160;&#160;<ix:footnote id="fn-10" footnoteRole="http://www.xbrl.org/2003/role/footnote">The interest rate floor on these investments as of December&#160;31, 2023 was <ix:nonFraction unitRef="number" contextRef="c-753" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" scale="-2" id="f-3081">0.75</ix:nonFraction>%.</ix:footnote></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11)&#160;&#160;&#160;&#160;<ix:footnote id="fn-11" footnoteRole="http://www.xbrl.org/2003/role/footnote">The interest rate floor on these investments as of December&#160;31, 2023 was <ix:nonFraction unitRef="number" contextRef="c-754" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" scale="-2" id="f-3082">1.00</ix:nonFraction>%</ix:footnote>.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(12)&#160;&#160;&#160;&#160;The interest rate floor on these investments as of December&#160;31, 2023 was <ix:nonFraction unitRef="number" contextRef="c-755" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" scale="-2" id="f-3083">1.25</ix:nonFraction>%.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(13)&#160;&#160;&#160;&#160;<ix:footnote id="fn-12" footnoteRole="http://www.xbrl.org/2003/role/footnote">The interest rate floor on these investments as of December&#160;31, 2023 was <ix:nonFraction unitRef="number" contextRef="c-756" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" scale="-2" id="f-3084">1.50</ix:nonFraction>%.</ix:footnote></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14)&#160;&#160;&#160;&#160;The interest rate floor on these investments as of December&#160;31, 2023 was <ix:nonFraction unitRef="number" contextRef="c-757" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" scale="-2" id="f-3085">2.00</ix:nonFraction>%.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(15)&#160;&#160;&#160;&#160;<ix:footnote id="fn-13" footnoteRole="http://www.xbrl.org/2003/role/footnote">For unsettled positions the interest rate does not include the base rate.</ix:footnote></span></div><div id="i33edc808e7824948b94b269ed713a939_2657"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(16)</span><ix:footnote id="fn-14" continuedAt="fn-14-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">Under the 1940 Act, the Company would be deemed to &#8220;control&#8221; a portfolio company if the Company owned more than 25% of its outstanding voting securities and/or held the power to exercise control over the management or policies of the portfolio company. As of December&#160;31, 2023, the Company does not &#8220;control&#8221; any of these portfolio companies. Under the 1940 Act, the Company would be deemed an &#8220;affiliated person&#8221; of a portfolio company if the Company owns 5% or more of the portfolio company&#8217;s outstanding voting securities. As of December&#160;31, 2023, the Company&#8217;s non-controlled/affiliated investments were as follows:</span></ix:footnote></div><ix:continuation id="fn-14-1"><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.901%"><tr><td style="width:1.0%"/><td style="width:28.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.429%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.429%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.429%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.429%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.136%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.429%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.429%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.988%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value as of December&#160;31, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Reductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net change in Unrealized Gains (Losses)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Realized Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value as of December&#160;31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend and Interest Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlled/Affiliated Investments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Blackstone Donegal Holdings LP</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-758" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3086">56,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-759" decimals="-3" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" format="ixt:fixed-zero" scale="3" id="f-3087">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-759" decimals="-3" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions" format="ixt:num-dot-decimal" scale="3" id="f-3088">44,921</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-759" decimals="-3" sign="-" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-3089">14,156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-759" decimals="-3" name="us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-3090">8,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-760" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3091">5,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-759" decimals="-3" name="us-gaap:InterestAndDividendIncomeSecurities" format="ixt:fixed-zero" scale="3" id="f-3092">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-761" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3093">56,584</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-762" decimals="-3" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" format="ixt:fixed-zero" scale="3" id="f-3094">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-762" decimals="-3" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions" format="ixt:num-dot-decimal" scale="3" id="f-3095">44,921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-762" decimals="-3" sign="-" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-3096">14,156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-762" decimals="-3" name="us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-3097">8,283</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-763" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3098">5,790</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-762" decimals="-3" name="us-gaap:InterestAndDividendIncomeSecurities" format="ixt:fixed-zero" scale="3" id="f-3099">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:continuation><div style="text-align:center;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(17)</span><ix:footnote id="fn-15" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">Loan was on non-accrual status as of December&#160;31, 2023.</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(18)</span><ix:footnote id="fn-16" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">These loans are &#8220;last-out&#8221; portions of loans. The &#8220;last-out&#8221; portion of the Company's loan investment generally earns a higher interest rate than the &#8220;first-out&#8221; portion, and in exchange the &#8220;first-out&#8221; portion would generally receive priority with respect to payment principal, interest and any other amounts due thereunder over the &#8220;last-out&#8221; portion.</span></ix:footnote></div><div style="margin-top:12pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">160</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_130"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i33edc808e7824948b94b269ed713a939_133"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:23.048%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.833%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="54" style="padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments&#8212;non-controlled/non-affiliated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aerospace &amp; Defense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corfin Holdings, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-764" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3100">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-764" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3101">10.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/5/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-764" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3102">199,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-764" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3103">197,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-764" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3104">195,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-764" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3105">4.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corfin Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-765" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3106">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-765" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3107">10.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/5/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-765" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3108">69,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-765" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3109">68,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-765" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3110">67,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-765" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3111">1.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Linquest Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-766" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3112">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-766" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3113">9.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/28/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-766" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3114">9,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-766" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3115">9,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-766" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3116">9,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-766" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3117">0.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MAG DS Corp.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-767" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3118">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-767" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3119">10.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/1/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-767" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3120">81,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-767" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3121">76,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-767" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3122">74,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-767" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3123">1.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maverick Acquisition, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-768" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3124">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-768" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3125">10.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-768" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3126">18,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-768" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3127">18,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-768" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3128">17,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-768" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3129">0.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TCFI AEVEX, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-769" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3130">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-769" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3131">10.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/18/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-769" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3132">111,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-769" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3133">110,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-769" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3134">101,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-769" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3135">2.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-770" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3136">480,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-770" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3137">465,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-770" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3138">11.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Air Freight &amp; Logistics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AGI-CFI Holdings, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-771" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3139">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-771" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3140">9.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/11/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-771" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3141">96,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-771" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3142">94,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-771" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3143">95,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-771" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3144">2.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ENV Bidco AB</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-772" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3145">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-772" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3146">10.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-772" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3147">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-772" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-3148">983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-772" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-3149">981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-772" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3150">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ENV Bidco AB</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-773" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3151">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-773" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3152">8.20</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-773" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3153">1,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-773" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3154">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-773" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3155">1,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-773" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3156">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Livingston International, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-774" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3157">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-774" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3158">10.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/30/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-774" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3159">128,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-774" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3160">126,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-774" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3161">127,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-774" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3162">3.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mode Purchaser, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-775" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3163">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-775" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3164">10.57</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/9/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-775" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3165">173,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-775" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3166">171,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-775" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3167">173,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-775" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3168">4.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mode Purchaser, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-776" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3169">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-776" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3170">10.57</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/5/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-776" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3171">4,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-776" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3172">4,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-776" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3173">4,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-776" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3174">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redwood Services Group, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-777" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3175">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-777" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3176">10.69</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/15/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-777" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3177">2,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-777" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3178">2,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-777" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3179">2,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-777" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3180">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RoadOne Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-778" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3181">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-778" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3182">10.81</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-778" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3183">1,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-778" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3184">1,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-778" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3185">1,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-778" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3186">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RWL Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-779" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3187">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-779" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3188">10.48</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-779" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3189">24,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-779" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3190">23,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-779" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3191">23,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-779" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3192">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEKO Global Logistics Network, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-780" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3193">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-780" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3194">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-780" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3195">1,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-780" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3196">2,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-780" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3197">1,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-780" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3198">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEKO Global Logistics Network, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-781" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3199">4.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-781" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3200">9.48</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-781" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3201">6,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-781" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3202">6,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-781" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3203">6,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-781" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3204">0.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-782" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3205">435,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-782" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3206">438,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-782" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3207">10.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Building Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fencing Supply Group Acquisition, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-783" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3208">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-783" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3209">11.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/26/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-783" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3210">52,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-783" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3211">51,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-783" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3212">52,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-783" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3213">1.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jacuzzi Brands, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-784" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3214">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-784" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3215">10.32</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-784" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3216">94,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-784" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3217">94,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-784" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3218">94,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-784" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3219">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L&amp;S Mechanical Acquisition, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-785" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3220">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-785" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3221">10.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/1/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-785" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3222">12,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-785" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3223">12,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-785" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3224">11,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-785" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3225">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lindstrom, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-786" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3226">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-786" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3227">10.47</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/7/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-786" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3228">121,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-786" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3229">121,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-786" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3230">120,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-786" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3231">2.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Windows Acquisition Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-787" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3232">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-787" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3233">11.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/29/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-787" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3234">53,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-787" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3235">53,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-787" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3236">53,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-787" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3237">1.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-788" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3238">332,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-788" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3239">333,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-788" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3240">8.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial Services &amp; Supplies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bazaarvoice, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-789" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3241">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-789" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3242">10.28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/7/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-789" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3243">228,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-789" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3244">228,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-789" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3245">228,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-789" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3246">5.49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Java Buyer, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-790" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3247">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-790" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3248">10.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/15/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-790" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3249">5,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-790" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3250">4,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-790" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3251">4,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-790" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3252">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">JSS Holdings, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-791" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3253">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-791" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3254">10.34</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/27/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-791" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3255">285,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-791" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3256">282,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-791" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3257">285,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-791" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3258">6.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">JSS Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-792" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3259">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-792" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3260">10.34</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/27/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-792" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3261">4,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-792" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3262">4,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-792" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3263">4,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-792" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3264">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Knowledge Pro Buyer, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-793" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3265">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-793" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3266">10.04</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/10/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-793" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3267">5,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-793" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3268">5,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-793" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3269">5,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-793" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3270">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">KPSKY Acquisition, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-794" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3271">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-794" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3272">9.89</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/19/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-794" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3273">22,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-794" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3274">22,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-794" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3275">21,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-794" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3276">0.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Onex Baltimore Buyer, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-795" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3277">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-795" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3278">10.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-795" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3279">28,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-795" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3280">27,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-795" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3281">27,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-795" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3282">0.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Action Environmental Group, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(12)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-796" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3283">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-796" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3284">10.66</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/16/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-796" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3285">133,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-796" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3286">132,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-796" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3287">132,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-796" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3288">3.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">161</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:23.048%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.833%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="54" style="padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt (continued)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Action Environmental Group, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(12)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-797" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3289">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-797" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3290">7.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/16/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-797" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3291">11,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-797" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3292">11,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-797" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3293">10,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-797" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3294">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Veregy Consolidated, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-798" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3295">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-798" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3296">10.41</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/2/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-798" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3297">20,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-798" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3298">20,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-798" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3299">17,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-798" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3300">0.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-799" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3301">740,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-799" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3302">739,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-799" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3303">17.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Construction &amp; Engineering</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASP Endeavor Acquisition, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-800" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3304">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-800" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3305">11.06</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/3/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-800" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3306">13,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-800" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3307">13,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-800" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3308">13,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-800" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3309">0.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COP Home Services TopCo IV, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-801" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3310">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-801" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3311">9.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-801" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3312">22,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-801" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3313">21,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-801" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3314">21,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-801" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3315">0.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-802" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3316">35,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-802" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3317">34,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-802" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3318">0.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Containers &amp; Packaging</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ascend Buyer, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-803" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3319">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-803" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3320">10.67</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/2/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-803" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3321">18,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-803" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3322">18,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-803" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3323">18,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-803" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3324">0.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ascend Buyer, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-804" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3325">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-804" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3326">10.67</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/30/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-804" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3327">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-804" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3328">1,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-804" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3329">1,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-804" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3330">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-805" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3331">20,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-805" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3332">20,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-805" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3333">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Distributors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BP Purchaser, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-806" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3334">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-806" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3335">10.24</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/10/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-806" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3336">7,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-806" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3337">7,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-806" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3338">7,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-806" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3339">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bution Holdco 2, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-807" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3340">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-807" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3341">10.63</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/17/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-807" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3342">72,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-807" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3343">72,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-807" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3344">72,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-807" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3345">1.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dana Kepner Company, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-808" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3346">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-808" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3347">10.66</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/29/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-808" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3348">63,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-808" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3349">62,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-808" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3350">62,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-808" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3351">1.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dana Kepner Company, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-809" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3352">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-809" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3353">10.66</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/29/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-809" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3354">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-809" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3355">1,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-809" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3356">1,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-809" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3357">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Genuine Cable Group, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-810" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3358">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-810" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3359">10.17</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/2/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-810" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3360">179,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-810" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3361">177,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-810" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3362">176,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-810" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3363">4.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marcone Yellowstone Buyer, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-811" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3364">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-811" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3365">7.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/23/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-811" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3366">1,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-811" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3367">1,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-811" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3368">1,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-811" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3369">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marcone Yellowstone Buyer, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-812" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3370">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-812" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3371">10.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/23/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-812" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3372">4,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-812" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3373">4,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-812" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3374">4,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-812" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3375">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marcone Yellowstone Buyer, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-813" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3376">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-813" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3377">10.62</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/23/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-813" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3378">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-813" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3379">1,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-813" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3380">1,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-813" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3381">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDC Acquisition Corp.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-814" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3382">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-814" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3383">10.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/9/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-814" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3384">14,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-814" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3385">13,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-814" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3386">13,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-814" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3387">0.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tailwind Colony Holding Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-815" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3388">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-815" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3389">10.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/13/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-815" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3390">42,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-815" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3391">42,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-815" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3392">42,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-815" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3393">1.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unified Door &amp; Hardware Group, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-816" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3394">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-816" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3395">10.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/30/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-816" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-3396">998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-816" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-3397">955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-816" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-3398">953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-816" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3399">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unified Door &amp; Hardware Group, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-817" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3400">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-817" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3401">10.41</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/18/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-817" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3402">51,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-817" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3403">51,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-817" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3404">51,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-817" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3405">1.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unified Door &amp; Hardware Group, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-818" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3406">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-818" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3407">10.41</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/30/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-818" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3408">42,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-818" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3409">42,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-818" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3410">41,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-818" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3411">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-819" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3412">479,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-819" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3413">478,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-819" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3414">11.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diversified Consumer Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cambium Learning Group, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-820" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3415">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-820" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3416">9.74</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/20/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-820" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3417">292,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-820" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3418">289,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-820" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3419">292,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-820" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3420">7.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dreambox Learning Holding LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-821" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3421">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-821" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3422">9.44</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-821" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3423">7,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-821" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3424">6,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-821" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3425">6,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-821" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3426">0.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Go Car Wash Management Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(14)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-822" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3427">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-822" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3428">10.67</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-822" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3429">22,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-822" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3430">22,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-822" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3431">21,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-822" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3432">0.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-823" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3433">318,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-823" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3434">320,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-823" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3435">7.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diversified Financial Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Barbri Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-824" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3436">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-824" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3437">10.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/30/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-824" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3438">64,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-824" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3439">63,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-824" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3440">63,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-824" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3441">1.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SelectQuote, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-825" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3442">8.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-825" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3443">12.42</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-825" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-3444">2.00</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/5/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-825" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3445">74,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-825" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3446">73,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-825" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3447">67,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-825" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3448">1.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-826" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3449">137,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-826" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3450">131,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-826" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3451">3.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diversified Telecommunication Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Point Broadband Acquisition, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-827" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3452">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-827" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3453">10.56</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/1/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-827" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3454">104,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-827" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3455">102,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-827" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3456">101,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-827" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3457">2.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">162</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:23.048%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.833%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="54" style="padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt (continued)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Electric Utilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Qualus Power Services Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-828" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3458">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-828" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3459">10.01</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/26/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-828" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3460">33,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-828" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3461">32,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-828" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3462">33,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-828" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3463">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Electrical Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emergency Power Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-829" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3464">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-829" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3465">10.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-829" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3466">44,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-829" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3467">43,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-829" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3468">43,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-829" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3469">1.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Relay Purchaser, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-830" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3470">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-830" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3471">10.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/30/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-830" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3472">36,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-830" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3473">35,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-830" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3474">36,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-830" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3475">0.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shoals Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-831" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3476">3.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-831" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3477">7.51</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/25/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-831" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3478">83,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-831" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3479">82,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-831" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3480">83,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-831" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3481">2.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-832" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3482">161,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-832" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3483">163,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-832" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3484">3.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Electronic Equipment, Instruments &amp; Components</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Albireo Energy, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-833" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3485">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-833" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3486">10.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/23/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-833" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3487">109,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-833" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3488">107,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-833" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3489">101,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-833" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3490">2.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CPI Intermediate Holdings Inc</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-834" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3491">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-834" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3492">9.68</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/8/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-834" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3493">4,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-834" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3494">3,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-834" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3495">3,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-834" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3496">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-835" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3497">111,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-835" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3498">105,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-835" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3499">2.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Energy Equipment &amp; Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Abaco Energy Technologies, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(13)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-836" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3500">7.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-836" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3501">11.29</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/4/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-836" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3502">36,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-836" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3503">36,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-836" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3504">36,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-836" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3505">0.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ISQ Hawkeye Holdco, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-837" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3506">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-837" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3507">10.63</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-837" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-3508">908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-837" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-3509">884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-837" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-3510">893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-837" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3511">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tetra Technologies, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-838" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3512">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-838" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3513">10.63</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/10/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-838" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3514">17,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-838" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3515">17,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-838" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3516">17,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-838" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3517">0.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-839" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3518">54,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-839" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3519">55,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-839" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3520">1.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Equipment &amp; Supplies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CPI Buyer, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-840" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3521">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-840" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3522">10.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-840" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3523">30,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-840" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3524">29,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-840" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3525">29,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-840" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3526">0.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GCX Corporation Buyer, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-841" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3527">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-841" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3528">9.84</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/13/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-841" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3529">27,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-841" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3530">26,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-841" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3531">26,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-841" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3532">0.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-842" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3533">56,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-842" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3534">55,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-842" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3535">1.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Providers &amp; Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123Dentist, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-843" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3536">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-843" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3537">10.36</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/10/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-843" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3538">1,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-843" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3539">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-843" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3540">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-843" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3541">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACI Group Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-844" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3542">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-844" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3543">10.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/2/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-844" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3544">105,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-844" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3545">103,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-844" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3546">103,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-844" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3547">2.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ADCS Clinics Intermediate Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-845" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3548">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-845" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3549">11.66</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/7/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-845" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3550">8,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-845" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3551">8,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-845" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3552">8,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-845" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3553">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerivet Partners Management, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-846" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3554">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-846" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3555">10.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-846" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3556">5,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-846" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3557">5,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-846" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3558">5,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-846" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3559">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canadian Hospital Specialties Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-847" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3560">4.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-847" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3561">9.36</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/14/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-847" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3562">30,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-847" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3563">22,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-847" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3564">22,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-847" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3565">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CCBlue Bidco, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-848" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3566">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-848" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3567">9.92</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-848" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-3568">2.75</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/21/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-848" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3569">10,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-848" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3570">10,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-848" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3571">9,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-848" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3572">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross Country Healthcare, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-849" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3573">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-849" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3574">10.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/8/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-849" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3575">6,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-849" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3576">6,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-849" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3577">6,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-849" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3578">0.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DCA Investment Holdings, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-850" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3579">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-850" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3580">9.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/3/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-850" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3581">33,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-850" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3582">32,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-850" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3583">32,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-850" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3584">0.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Epoch Acquisition, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-851" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3585">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-851" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3586">10.19</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/4/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-851" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3587">24,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-851" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3588">24,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-851" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3589">24,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-851" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3590">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Healthcomp Holding Company, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-852" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3591">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-852" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3592">10.42</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/27/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-852" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3593">76,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-852" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3594">75,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-852" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3595">76,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-852" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3596">1.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Healthcomp Holding Company, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-853" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3597">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-853" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3598">10.42</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/27/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-853" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3599">32,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-853" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3600">31,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-853" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3601">32,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-853" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3602">0.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jayhawk Buyer, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-854" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3603">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-854" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3604">9.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/15/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-854" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3605">155,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-854" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3606">152,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-854" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3607">153,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-854" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3608">3.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Navigator Acquiror, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-855" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3609">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-855" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3610">9.98</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-855" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-3611">5.11</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/16/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-855" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3612">200,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-855" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3613">199,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-855" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3614">198,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-855" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3615">4.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Odyssey Holding Company, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-856" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3616">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-856" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3617">10.45</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/16/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-856" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3618">18,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-856" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3619">18,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-856" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3620">18,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-856" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3621">0.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PPV Intermediate Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-857" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3622">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-857" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3623">10.07</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-857" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3624">1,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-857" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3625">1,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-857" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3626">1,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-857" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3627">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">163</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:23.048%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.833%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="54" style="padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt (continued)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Providers &amp; Services (continued)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smile Doctors, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-858" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3628">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-858" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3629">11.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/21/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-858" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3630">11,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-858" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3631">11,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-858" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3632">11,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-858" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3633">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Snoopy Bidco, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-859" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3634">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-859" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3635">10.76</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-859" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3636">304,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-859" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3637">298,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-859" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3638">293,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-859" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3639">7.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SpecialtyCare, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-860" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3640">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-860" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3641">9.76</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-860" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3642">12,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-860" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3643">12,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-860" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3644">12,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-860" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3645">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stepping Stones Healthcare Services, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-861" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3646">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-861" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3647">10.51</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/2/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-861" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3648">2,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-861" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3649">2,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-861" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3650">2,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-861" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3651">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Fertility Partners, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-862" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3652">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-862" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3653">10.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/16/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-862" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3654">4,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-862" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3655">4,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-862" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3656">4,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-862" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3657">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Fertility Partners, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-863" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3658">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-863" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3659">10.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/16/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-863" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3660">5,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-863" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3661">4,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-863" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3662">4,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-863" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3663">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The GI Alliance Management, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-864" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3664">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-864" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3665">10.49</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/15/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-864" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3666">4,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-864" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3667">3,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-864" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3668">3,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-864" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3669">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unified Physician Management, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-865" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3670">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-865" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3671">10.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-865" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3672">2,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-865" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3673">2,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-865" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3674">2,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-865" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3675">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Mutual Acquisition Holdings, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-866" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3676">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-866" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3677">10.09</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/15/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-866" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3678">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-866" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3679">1,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-866" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3680">1,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-866" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3681">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Oral Surgery Management Holdco, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-867" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3682">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-867" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3683">10.18</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/18/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-867" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3684">41,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-867" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3685">40,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-867" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3686">41,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-867" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3687">0.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">WHCG Purchaser III, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-868" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3688">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-868" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3689">10.48</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/22/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-868" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3690">44,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-868" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3691">43,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-868" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3692">34,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-868" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3693">0.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-869" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3694">1,121,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-869" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3695">1,107,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-869" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3696">26.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus US 1, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-870" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3697">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-870" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3698">10.08</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/25/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3699">10,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3700">10,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3701">10,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-870" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3702">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus US 1, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-871" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3703">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-871" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3704">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/25/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3705">2,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3706">2,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3707">2,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-871" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3708">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Color Intermediate LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-872" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3709">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-872" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3710">10.18</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/4/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-872" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3711">20,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-872" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3712">19,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-872" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3713">19,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-872" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3714">0.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Edifecs, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-873" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3715">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-873" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3716">10.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/21/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-873" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3717">13,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-873" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3718">13,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-873" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3719">13,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-873" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3720">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Edifecs, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-874" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3721">7.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-874" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3722">12.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/21/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-874" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3723">219,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-874" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3724">215,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-874" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3725">223,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-874" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3726">5.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GI Ranger Intermediate, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-875" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3727">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-875" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3728">10.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-875" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3729">16,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-875" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3730">15,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-875" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3731">15,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-875" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3732">0.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NMC Crimson Holdings, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-876" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3733">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-876" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3734">9.74</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-876" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3735">75,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-876" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3736">74,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-876" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3737">74,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-876" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3738">1.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Project Ruby Ultimate Parent Corp.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-877" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3739">3.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-877" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3740">7.63</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/10/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-877" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3741">8,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-877" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3742">8,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-877" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3743">8,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-877" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3744">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RPBLS Midco, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-878" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3745">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-878" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3746">9.41</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-878" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3747">9,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-878" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3748">9,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-878" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3749">9,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-878" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3750">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-879" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3751">368,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-879" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3752">377,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-879" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3753">9.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alera Group, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-880" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3754">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-880" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3755">10.42</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/2/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-880" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3756">3,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-880" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3757">3,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-880" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3758">3,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-880" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3759">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerilife Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-881" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3760">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-881" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3761">9.01</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-881" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3762">2,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-881" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3763">2,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-881" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3764">2,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-881" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3765">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefytt Technologies, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-882" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3766">8.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-882" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3767">12.09</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-882" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-3768">7.75</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/12/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-882" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3769">13,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-882" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3770">13,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-882" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3771">10,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-882" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3772">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foundation Risk Partners Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-883" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3773">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-883" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3774">10.68</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-883" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3775">27,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-883" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3776">26,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-883" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3777">26,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-883" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3778">0.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Galway Borrower, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-884" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3779">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-884" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3780">8.99</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/30/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-884" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3781">22,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-884" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3782">21,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-884" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3783">21,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-884" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3784">0.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">High Street Buyer, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-885" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3785">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-885" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3786">10.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/14/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-885" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3787">61,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-885" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3788">60,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-885" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3789">61,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-885" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3790">1.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integrity Marketing Acquisition, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-886" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3791">6.05</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-886" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3792">11.28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/27/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-886" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3793">146,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-886" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3794">145,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-886" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3795">141,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-886" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3796">3.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jones Deslauriers Insurance Management, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)(6)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-887" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3797">4.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-887" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3798">8.81</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/27/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-887" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3799">86,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-887" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3800">68,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-887" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3801">59,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-887" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3802">1.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PGIS Intermediate Holdings, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-888" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3803">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-888" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3804">10.63</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/16/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-888" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3805">4,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-888" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3806">4,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-888" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3807">4,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-888" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3808">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG Acquisition, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-889" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3809">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-889" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3810">9.17</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/27/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-889" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3811">104,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-889" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3812">103,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-889" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3813">104,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-889" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3814">2.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shelf Bidco Ltd</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-890" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3815">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-890" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3816">6.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/3/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GBP</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="c-890" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3817">5,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-890" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3818">4,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-890" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3819">4,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-890" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3820">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">164</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:23.048%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.833%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="54" style="padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt (continued)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance (continued)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee Bidco Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-891" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3821">7.28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-891" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3822">8.47</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/9/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GBP</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="c-891" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3823">16,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-891" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3824">21,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-891" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3825">19,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-891" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3826">0.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee Bidco Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-892" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3827">7.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-892" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3828">7.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/9/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GBP</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="c-892" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3829">28,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-892" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3830">38,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-892" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3831">33,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-892" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3832">0.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee Bidco Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-893" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3833">7.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-893" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3834">10.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/9/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-893" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3835">54,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-893" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3836">52,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-893" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3837">53,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-893" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3838">1.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee Bidco Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-894" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3839">7.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-894" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3840">12.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/3/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-894" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3841">15,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-894" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3842">15,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-894" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3843">15,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-894" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3844">0.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Westland Insurance Group LTD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-895" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3845">7.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-895" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3846">11.39</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/5/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-895" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3847">42,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-895" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3848">39,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-895" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3849">41,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-895" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3850">0.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Westland Insurance Group LTD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-896" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3851">7.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-896" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3852">11.86</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/5/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-896" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3853">165,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-896" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3854">119,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-896" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3855">118,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-896" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3856">2.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-897" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3857">743,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-897" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3858">722,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-897" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3859">17.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Internet &amp; Direct Marketing Retail</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Donuts, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-898" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3860">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-898" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3861">10.43</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/29/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-898" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3862">322,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-898" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3863">318,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-898" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3864">319,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-898" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3865">7.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IT Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AI Altius Bidco, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-899" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3866">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-899" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3867">10.65</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/21/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-899" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3868">5,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-899" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3869">5,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-899" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3870">5,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-899" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3871">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AI Altius Bidco, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-900" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3872">9.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-900" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-3873">9.75</ix:nonFraction>% PIK</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/29/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-900" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-3874">835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-900" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-3875">814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-900" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-3876">808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-900" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3877">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Infostretch Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-901" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3878">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-901" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3879">10.48</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-901" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3880">4,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-901" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3881">4,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-901" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3882">4,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-901" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3883">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inovalon Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-902" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3884">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-902" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3885">10.95</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-902" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-3886">2.75</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/24/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-902" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3887">106,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-902" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3888">103,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-902" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3889">104,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-902" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3890">2.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monterey Financing S.&#224;.r.l</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-903" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3891">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-903" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3892">8.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/28/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-903" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-3893">658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-903" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-3894">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-903" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-3895">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-903" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3896">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monterey Financing S.&#224;.r.l</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CI +</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-904" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3897">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-904" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3898">8.42</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/28/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DKK</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="dkk" contextRef="c-904" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3899">4,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-904" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-3900">618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-904" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-3901">674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-904" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3902">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monterey Financing S.&#224;.r.l</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N +</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-905" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3903">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-905" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3904">9.26</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/28/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NOK</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="nok" contextRef="c-905" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3905">5,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-905" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-3906">461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-905" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-3907">510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-905" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3908">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monterey Financing S.&#224;.r.l</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ST +</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-906" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3909">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-906" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3910">8.65</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/28/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEK</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sek" contextRef="c-906" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3911">2,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-906" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-3912">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-906" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-3913">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-906" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3914">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Razor Holdco, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-907" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3915">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-907" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3916">9.42</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/25/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-907" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3917">37,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-907" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3918">36,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-907" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3919">36,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-907" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3920">0.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Red River Technology, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-908" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3921">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-908" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3922">10.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/26/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-908" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3923">80,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-908" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3924">79,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-908" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3925">80,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-908" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3926">1.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turing Holdco, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(7)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-909" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3927">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-909" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3928">8.00</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-909" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-3929">2.50</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/3/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-909" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3930">16,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-909" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3931">18,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-909" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3932">17,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-909" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3933">0.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turing Holdco, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-910" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3934">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-910" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3935">10.01</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/3/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-910" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3936">8,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-910" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3937">8,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-910" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3938">8,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-910" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3939">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-911" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3940">259,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-911" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3941">260,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-911" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3942">6.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MHE Intermediate Holdings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-912" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3943">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-912" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3944">9.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/21/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-912" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3945">4,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-912" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3946">4,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-912" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3947">4,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-912" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3948">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MHE Intermediate Holdings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-913" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3949">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-913" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3950">9.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/9/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-913" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-3951">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-913" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-3952">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-913" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-3953">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-913" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3954">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-914" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3955">4,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-914" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3956">4,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-914" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3957">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Armada Parent, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-915" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3958">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-915" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3959">10.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-915" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3960">25,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-915" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3961">25,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-915" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3962">25,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-915" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3963">0.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Media</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trader Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-916" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3964">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-916" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3965">10.40</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/22/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-916" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3966">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-916" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3967">7,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-916" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3968">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-916" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3969">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">165</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_136"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.232%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.411%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.239%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt (continued)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oil, Gas &amp; Consumable Fuels</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Eagle Midstream Canada Finance, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-917" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3970">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-917" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3971">10.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/15/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-917" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3972">74,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-917" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3973">73,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-917" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3974">73,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-917" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3975">1.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">KKR Alberta Midstream Finance Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-918" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3976">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-918" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3977">10.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/15/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-918" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3978">40,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-918" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3979">40,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-918" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3980">40,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-918" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3981">0.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-919" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3982">113,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-919" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3983">113,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-919" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3984">2.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paper &amp; Forest Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Profile Products, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-920" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3985">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-920" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3986">9.36</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/12/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-920" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3987">6,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-920" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3988">6,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-920" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3989">6,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-920" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3990">0.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Profile Products, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-921" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-3991">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-921" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-3992">10.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/12/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-921" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-3993">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-921" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3994">1,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-921" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3995">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-921" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3996">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-922" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-3997">7,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-922" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-3998">7,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-922" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-3999">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Doc Generici (Diocle S.p.A.)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-923" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4000">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-923" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4001">8.56</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/27/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-923" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4002">1,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-923" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4003">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-923" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4004">1,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-923" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4005">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Professional Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ALKU, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-924" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4006">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-924" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4007">9.67</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/1/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-924" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4008">74,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-924" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4009">74,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-924" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4010">74,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-924" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4011">1.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ALKU, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-925" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4012">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-925" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4013">9.42</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-925" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4014">38,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-925" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4015">37,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-925" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4016">38,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-925" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4017">0.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BPPH2 Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-926" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4018">6.87</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-926" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4019">10.30</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GBP</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="c-926" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4020">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-926" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4021">35,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-926" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4022">31,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-926" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4023">0.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CFGI Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-927" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4024">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-927" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4025">9.39</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/2/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-927" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4026">7,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-927" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4027">7,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-927" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4028">7,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-927" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4029">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Clearview Buyer, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-928" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4030">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-928" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4031">9.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/26/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-928" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4032">9,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-928" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4033">9,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-928" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4034">9,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-928" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4035">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumming Group, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-929" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4036">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-929" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4037">8.92</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/26/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-929" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4038">73,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-929" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4039">72,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-929" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4040">71,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-929" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4041">1.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumming Group, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-930" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4042">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-930" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4043">8.92</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/16/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-930" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4044">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-930" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4045">970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-930" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4046">970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-930" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4047">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Guidehouse, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-931" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4048">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-931" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4049">10.63</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/16/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-931" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4050">325,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-931" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4051">322,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-931" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4052">319,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-931" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4053">7.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HIG Orca Acquisition Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-932" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4054">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-932" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4055">9.78</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-932" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4056">23,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-932" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4057">23,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-932" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4058">23,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-932" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4059">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IG Investments Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-933" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4060">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-933" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4061">10.39</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/22/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-933" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4062">48,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-933" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4063">47,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-933" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4064">47,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-933" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4065">1.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kaufman Hall &amp; Associates, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-934" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4066">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-934" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4067">9.63</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/14/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-934" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4068">24,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-934" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4069">23,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-934" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4070">24,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-934" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4071">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legacy Intermediate, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-935" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4072">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-935" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4073">10.26</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-935" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4074">5,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-935" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4075">5,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-935" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4076">5,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-935" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4077">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Material Holdings, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-936" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4078">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-936" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4079">10.68</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/19/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-936" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4080">24,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-936" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4081">24,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-936" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4082">23,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-936" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4083">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Minotaur Acquisition, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-937" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4084">4.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-937" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4085">9.17</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/27/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-937" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4086">1,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-937" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4087">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-937" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4088">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-937" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4089">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Petrus Buyer Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-938" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4090">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-938" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4091">10.70</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/17/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-938" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4092">1,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-938" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4093">1,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-938" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4094">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-938" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4095">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sherlock Buyer Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-939" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4096">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-939" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4097">10.48</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/8/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-939" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4098">8,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-939" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4099">8,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-939" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4100">8,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-939" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4101">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thevelia US, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)(6)(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-940" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4102">4.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-940" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4103">8.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-940" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4104">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-940" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4105">1,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-940" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4106">1,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-940" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4107">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Titan Investment Company, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-941" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4108">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-941" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4109">10.07</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/20/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-941" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4110">42,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-941" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4111">40,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-941" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4112">40,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-941" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4113">0.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Air Consultants Holdings Corp.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-942" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4114">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-942" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4115">10.18</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/29/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-942" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4116">67,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-942" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4117">66,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-942" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4118">67,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-942" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4119">1.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Partners Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-943" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4120">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-943" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4121">9.99</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/21/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-943" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4122">4,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-943" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4123">4,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-943" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4124">4,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-943" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4125">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">West Monroe Partners, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-944" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4126">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-944" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4127">9.84</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/8/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-944" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4128">14,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-944" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4129">14,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-944" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4130">14,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-944" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4131">0.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-945" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4132">824,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-945" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4133">816,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-945" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4134">19.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Real Estate Management &amp; Development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Progress Residential PM Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-946" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4135">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-946" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4136">10.67</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-946" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4137">70,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-946" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4138">69,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-946" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4139">70,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-946" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4140">1.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Progress Residential PM Holdings, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-947" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4141">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-947" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4142">10.67</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/25/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-947" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-4143">833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-947" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4144">814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-947" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4145">833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-947" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4146">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-948" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4147">69,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-948" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4148">71,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-948" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4149">1.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">166</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.232%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.411%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.239%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt (continued)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Road &amp; Rail</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gruden Acquisition, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-949" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4150">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-949" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4151">7.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/1/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-949" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4152">16,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-949" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4153">16,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-949" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4154">16,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-949" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4155">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Anaplan, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-950" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4156">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-950" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4157">10.82</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/21/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-950" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4158">1,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-950" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4159">1,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-950" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4160">1,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-950" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4161">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AxiomSL Group, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-951" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4162">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-951" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4163">10.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/3/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-951" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4164">42,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-951" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4165">41,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-951" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4166">41,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-951" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4167">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BlueCat Networks USA, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-952" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4168">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-952" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4169">10.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/8/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-952" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4170">1,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-952" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4171">1,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-952" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4172">1,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-952" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4173">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Community Brands ParentCo, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-953" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4174">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-953" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4175">10.17</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/24/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-953" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4176">4,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-953" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4177">4,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-953" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4178">4,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-953" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4179">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Confine Visual Bidco</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-954" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4180">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-954" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4181">10.05</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-954" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4182">15,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-954" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4183">15,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-954" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4184">15,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-954" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4185">0.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Connatix Buyer, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-955" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4186">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-955" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4187">10.14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/14/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-955" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4188">21,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-955" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4189">21,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-955" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4190">21,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-955" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4191">0.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diligent Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-956" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4192">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-956" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4193">10.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/4/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-956" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4194">58,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-956" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4195">58,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-956" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4196">57,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-956" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4197">1.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discovery Education, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-957" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4198">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-957" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4199">9.83</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/9/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-957" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4200">26,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-957" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4201">26,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-957" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4202">25,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-957" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4203">0.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Episerver, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-958" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4204">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-958" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4205">9.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/9/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-958" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4206">9,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-958" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4207">9,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-958" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4208">9,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-958" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4209">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Experity, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-959" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4210">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-959" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4211">10.48</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/24/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-959" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4212">15,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-959" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4213">14,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-959" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4214">14,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-959" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4215">0.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gigamon Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-960" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4216">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-960" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4217">9.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/9/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-960" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4218">7,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-960" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4219">7,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-960" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4220">7,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-960" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4221">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GovernmentJobs.com, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-961" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4222">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-961" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4223">9.88</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-961" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4224">4,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-961" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4225">4,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-961" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4226">4,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-961" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4227">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GraphPAD Software, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-962" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4228">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-962" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4229">10.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/27/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-962" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4230">26,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-962" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4231">26,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-962" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4232">26,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-962" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4233">0.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LD Lower Holdings, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-963" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4234">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-963" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4235">11.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/8/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-963" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4236">92,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-963" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4237">91,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-963" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4238">91,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-963" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4239">2.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lightbox Intermediate, LP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-964" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4240">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-964" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4241">9.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/9/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-964" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4242">1,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-964" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4243">1,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-964" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4244">1,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-964" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4245">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Magnesium BorrowerCo, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-965" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4246">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-965" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4247">9.18</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/18/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GBP</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="c-965" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4248">3,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-965" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4249">4,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-965" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4250">4,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-965" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4251">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Magnesium BorrowerCo, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-966" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4252">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-966" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4253">10.17</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/18/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-966" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4254">5,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-966" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4255">5,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-966" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4256">5,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-966" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4257">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mandolin Technology Intermediate Holdings, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-967" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4258">3.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-967" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4259">8.16</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/31/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-967" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4260">9,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-967" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4261">9,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-967" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4262">9,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-967" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4263">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medallia, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-968" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4264">6.50</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-968" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4265">10.88</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-968" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-4266">5.44</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-968" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4267">350,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-968" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4268">345,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-968" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4269">343,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-968" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4270">8.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monk Holding Co.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-969" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4271">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-969" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4272">9.67</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-969" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4273">5,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-969" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4274">4,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-969" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4275">4,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-969" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4276">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MRI Software, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-970" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4277">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-970" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4278">10.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/10/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-970" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4279">27,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-970" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4280">27,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-970" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4281">26,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-970" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4282">0.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nintex Topco Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-971" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4283">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-971" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4284">10.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/13/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-971" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4285">34,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-971" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4286">33,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-971" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4287">31,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-971" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4288">0.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Project Boost Purchaser, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-972" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4289">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-972" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4290">9.65</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/2/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-972" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4291">4,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-972" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4292">4,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-972" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4293">4,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-972" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4294">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rally Buyer, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-973" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4295">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-973" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4296">8.78</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-973" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" scale="3" id="f-4297">718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-973" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4298">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-973" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4299">699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-973" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4300">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Relativity ODA, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-974" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4301">10.55</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-974" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4302">11.89</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-974" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-4303">11.55</ix:nonFraction>%)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/12/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-974" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4304">20,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-974" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4305">20,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-974" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4306">20,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-974" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4307">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spitfire Parent, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-975" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4308">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-975" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4309">9.28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/11/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-975" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4310">55,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-975" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4311">54,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-975" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4312">53,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-975" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4313">1.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spitfire Parent, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-976" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4314">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-976" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4315">7.86</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/11/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-976" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4316">10,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-976" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4317">12,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-976" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4318">10,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-976" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4319">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spitfire Parent, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-977" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4320">6.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-977" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4321">10.23</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/11/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-977" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4322">20,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-977" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4323">20,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-977" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4324">20,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-977" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4325">0.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stamps.com, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-978" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4326">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-978" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4327">10.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/5/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-978" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4328">288,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-978" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4329">283,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-978" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4330">280,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-978" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4331">6.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The NPD Group L.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-979" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4332">6.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-979" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4333">10.43</ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-979" decimals="INF" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-4334">2.75</ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-979" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4335">75,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-979" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4336">74,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-979" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4337">74,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-979" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4338">1.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The NPD Group L.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-980" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4339">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-980" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4340">10.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-980" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4341">123,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-980" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4342">120,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-980" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4343">121,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-980" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4344">2.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">167</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.232%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.411%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.239%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt (continued)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Software (continued)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Triple Lift, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-981" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4345">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-981" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4346">9.61</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/5/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-981" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4347">65,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-981" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4348">64,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-981" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4349">63,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-981" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4350">1.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Zendesk Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-982" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4351">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-982" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4352">11.04</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/22/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-982" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4353">1,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-982" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4354">1,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-982" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4355">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-982" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4356">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-983" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4357">1,414,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-983" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4358">1,403,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-983" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4359">33.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Retail</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CustomInk, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-984" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4360">6.18</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-984" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4361">7.18</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/3/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-984" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4362">163,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-984" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4363">162,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-984" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4364">163,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-984" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4365">3.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology Hardware, Storage &amp; Peripherals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lytx, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-985" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4366">6.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-985" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4367">11.17</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/28/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-985" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4368">84,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-985" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4369">83,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-985" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4370">81,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-985" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4371">1.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Companies &amp; Distributors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Porcelain Acquisition Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-986" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4372">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-986" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4373">10.48</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-986" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4374">55,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-986" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4375">53,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-986" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4376">54,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-986" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4377">1.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Cook &amp; Boardman Group, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-987" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4378">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-987" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4379">9.99</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/17/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-987" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4380">49,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-987" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4381">48,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-987" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4382">41,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-987" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4383">1.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-988" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4384">102,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-988" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4385">96,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-988" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4386">2.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transportation Infrastructure</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capstone Logistics, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-989" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4387">4.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-989" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4388">9.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/12/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-989" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4389">5,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-989" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4390">5,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-989" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4391">5,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-989" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4392">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Frontline Road Safety, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-990" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4393">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-990" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4394">6.68</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/3/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-990" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4395">90,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-990" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4396">88,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-990" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4397">84,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-990" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4398">2.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Helix TS, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-991" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4399">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-991" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4400">10.16</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/4/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-991" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4401">42,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-991" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4402">41,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-991" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4403">42,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-991" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4404">1.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Italian Motorway Holdings S.&#224;.r.l</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-992" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4405">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-992" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4406">7.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/28/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EUR</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-992" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4407">78,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-992" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4408">81,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-992" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4409">81,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-992" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4410">1.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Roadsafe Holdings, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-993" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4411">5.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-993" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4412">10.87</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/19/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-993" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4413">51,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-993" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4414">51,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-993" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4415">51,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-993" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4416">1.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Safety Borrower Holdings LP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-994" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4417">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-994" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4418">10.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/1/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-994" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4419">5,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-994" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4420">5,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-994" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4421">5,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-994" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4422">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sam Holding Co, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-995" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4423">5.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-995" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4424">9.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/24/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-995" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4425">42,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-995" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4426">41,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-995" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4427">41,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-995" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4428">0.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRP Infrastructure Services, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(7)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-996" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4429">5.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-996" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4430">10.08</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/9/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-996" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4431">39,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-996" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4432">38,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-996" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4433">36,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-996" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4434">0.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-997" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4435">353,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-997" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4436">347,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-997" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4437">8.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total First Lien Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-998" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4438">9,497,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-998" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4439">9,419,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-998" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4440">226.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">168</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_139"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.232%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.411%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.239%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(15)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second Lien Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Construction &amp; Engineering</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COP Home Services TopCo IV, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-999" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4441">8.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-999" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4442">13.13</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/29/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-999" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4443">7,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-999" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4444">7,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-999" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4445">7,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-999" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4446">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Providers &amp; Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canadian Hospital Specialties Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1000" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4447">8.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1000" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4448">8.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/15/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CAD</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="c-1000" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4449">10,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1000" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4450">8,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1000" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4451">7,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1000" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4452">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jayhawk Buyer, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1001" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4453">8.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1001" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4454">13.17</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/15/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1001" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4455">5,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1001" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4456">5,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1001" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4457">5,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1001" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4458">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1002" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4459">13,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1002" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4460">12,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1002" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4461">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Industrial Conglomerates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Victory Buyer, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1003" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4462">7.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1003" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4463">11.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/1/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1003" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4464">9,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1003" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4465">9,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1003" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4466">8,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1003" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4467">0.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IT Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inovalon Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1004" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4468">10.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1004" decimals="4" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-4469"><ix:nonFraction unitRef="number" contextRef="c-1004" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4470">15.20</ix:nonFraction></ix:nonFraction>% (incl. <ix:nonFraction unitRef="number" contextRef="c-1004" decimals="4" name="us-gaap:InvestmentInterestRatePaidInKind" scale="-2" id="f-4471"><ix:nonFraction unitRef="number" contextRef="c-1004" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4472">15.20</ix:nonFraction></ix:nonFraction>% PIK)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/24/2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1004" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4473">10,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1004" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4474">10,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1004" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4475">10,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1004" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4476">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Professional Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thevelia US, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SOFR + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1005" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4477">6.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1005" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4478">11.48</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/17/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1005" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4479">4,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1005" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4480">4,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1005" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4481">4,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1005" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4482">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mandolin Technology Intermediate Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">L + </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1006" decimals="INF" name="us-gaap:InvestmentBasisSpreadVariableRate" scale="-2" id="f-4483">6.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1006" decimals="4" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4484">10.91</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/30/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1006" decimals="-3" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="3" id="f-4485">3,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1006" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4486">3,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1006" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4487">3,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1006" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4488">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Second Lien Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1007" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4489">48,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1007" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4490">46,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1007" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4491">1.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">169</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_142"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.232%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.411%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.239%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aerospace &amp; Defense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Micross Topco, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1008" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4492">4,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1008" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4493">4,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1008" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4494">4,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1008" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4495">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Air Freight &amp; Logistics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AGI Group Holdings LP - A2 Units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1009" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-4496">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1009" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4497">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1009" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4498">724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1009" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4499">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mode Holdings, L.P. - Class A-2 Common Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1010" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4500">5,486,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1010" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4501">5,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1010" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4502">10,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1010" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4503">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1011" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4504">6,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1011" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4505">11,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1011" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4506">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Distributors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Box Co-Invest Blocker, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1012" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4507">702,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1012" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4508">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1012" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4509">625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1012" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4510">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EIS Acquisition Holdings, LP - Class A Common Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1013" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4511">6,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1013" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4512">3,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1013" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4513">13,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1013" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4514">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1014" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4515">4,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1014" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4516">13,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1014" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4517">0.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diversified Consumer Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cambium Holdings, LLC - Senior Preferred Interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1015" decimals="INF" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4518">11.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1015" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4519">12,511,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1015" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4520">12,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1015" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4521">15,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1015" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4522">0.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deneb Ultimate Topco, LLC - Class A Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1016" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-4523">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1016" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4524">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1016" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4525">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1016" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4526">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1017" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4527">12,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1017" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4528">15,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1017" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4529">0.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diversified Telecommunication Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Point Broadband Holdings, LLC - Class A Units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1018" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4530">6,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1018" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4531">5,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1018" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4532">5,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1018" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4533">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Point Broadband Holdings, LLC - Class B Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1019" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4534">369,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1019" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4535">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1019" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4536">762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1019" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4537">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Point Broadband Holdings, LLC - Class Additional A Units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1020" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4538">79,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1020" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4539">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1020" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4540">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1020" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4541">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Point Broadband Holdings, LLC - Class Additional B Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1021" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4542">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1021" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4543">1,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1021" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4544">1,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1021" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4545">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1022" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4546">8,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1022" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4547">7,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1022" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4548">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Equipment &amp; Supplies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GCX Corporation Group Holdings, L.P. - Class A-2 Units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1023" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-4549">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1023" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4550">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1023" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4551">324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1023" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4552">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Providers &amp; Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVE Holdings I Corp.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1024" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4553">625,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1024" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4554">607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1024" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4555">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1024" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4556">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jayhawk Holdings, LP - A-1 Common Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1025" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4557">2,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1025" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4558">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1025" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4559">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1025" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4560">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jayhawk Holdings, LP - A-2 Common Units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1026" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4561">1,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1026" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4562">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1026" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4563">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1026" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4564">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1027" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4565">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1027" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4566">1,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1027" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4567">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus Midco 2 S.&#192;. R.L - Additional Vehicle Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1028" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4568">11,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1028" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4569">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1028" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4570">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1028" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4571">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus Midco 2 S.&#192;. R.L - Vehicle Units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1029" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4572">58,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1029" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4573">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1029" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4574">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1029" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4575">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1030" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4576">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1030" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4577">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1030" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4578">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shelf Holdco Ltd Common Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1031" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4579">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1031" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4580">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1031" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4581">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1031" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4582">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IT Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NC Ocala Co-Invest Beta, L.P. - LP Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1032" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4583">2,854,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1032" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4584">2,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1032" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4585">2,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1032" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4586">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">170</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.232%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.411%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.239%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="54" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Footnotes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference Rate and Spread</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Amount/Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity (continued)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Professional Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Guidehouse Holding Corp. - Preferred Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1033" decimals="INF" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4587">11.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1033" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4588">15,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1033" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4589">15,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1033" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4590">16,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1033" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4591">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHCP V TC COI, LP. - LP Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1034" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4592">3,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1034" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4593">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1034" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4594">4,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1034" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4595">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tricor Horizon, LP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1035" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4596">382,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1035" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4597">382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1035" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4598">382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1035" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4599">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1036" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4600">19,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1036" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4601">21,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1036" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4602">0.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Connatix Parent, LLC - Class L Common Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1037" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4603">42,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1037" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4604">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1037" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4605">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1037" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4606">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expedition Holdco, LLC - Class A Units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1038" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-4607">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1038" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4608">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1038" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4609">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1038" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4610">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expedition Holdco, LLC - Class B Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1039" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4611">90,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1039" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4612">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1039" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4613">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1039" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4614">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lobos Parent, Inc. - Series A Preferred Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1040" decimals="INF" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4615">10.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1040" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4616">1,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1040" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4617">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1040" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4618">1,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1040" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4619">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mandolin Technology Holdings, Inc. - Series A Preferred Shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1041" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4620">3,550,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1041" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4621">3,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1041" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4622">3,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1041" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4623">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mimecast Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1042" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4624">651,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1042" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4625">651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1042" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4626">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1042" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4627">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Zoro Common Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1043" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4628">2,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1043" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4629">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1043" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4630">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1043" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4631">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Zoro Series A Preferred Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1044" decimals="INF" name="us-gaap:InvestmentInterestRate" scale="-2" id="f-4632">12.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1044" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-4633">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1044" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4634">362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1044" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4635">362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1044" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4636">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1045" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4637">6,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1045" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4638">6,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1045" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4639">0.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Retail</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CustomInk, LLC - Series A Preferred Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1046" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4640">384,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1046" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4641">5,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1046" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4642">6,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1046" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4643">0.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transportation Infrastructure</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Frontline Road Safety Investments, LLC - Class A Common Units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1047" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-4644">27,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1047" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4645">2,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1047" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4646">1,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1047" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4647">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ncp Helix Holdings, LLC. - Preferred Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1048" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-4648">369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1048" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-4649">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1048" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-4650">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1048" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4651">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1049" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4652">3,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1049" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4653">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1049" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4654">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Equity Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1050" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4655">74,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1050" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4656">94,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1050" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4657">2.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Investment - non-controlled/non-affiliated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4658">9,621,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4659">9,560,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-130" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4660">229.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments - non-controlled/affiliated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)(5)(6)(16)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1051" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4661">36,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1051" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4662">56,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1051" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4663">1.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1052" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4664">36,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1052" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4665">56,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1052" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4666">1.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Investments - non-controlled/affiliated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4667">36,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4668">56,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-132" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4669">1.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Investment Portfolio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1053" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4670">9,657,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1053" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4671">9,617,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1053" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4672">231.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1054" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4673">131,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1054" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4674">131,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1054" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4675">3.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Portfolio Investments, Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1055" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-4676">9,789,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1055" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-4677">9,748,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1055" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4678">234.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:2pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><ix:footnote id="fn-17" continuedAt="fn-17-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Unless otherwise indicated, all debt and equity investments held by the Company (which such term &#8220;Company&#8221; shall include the Company&#8217;s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December&#160;31, 2022, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in </span></ix:footnote></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">171</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><ix:continuation id="fn-17-1"><div style="margin-top:2pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><br/><br/><br/><br/><br/>thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company&#8217;s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.</span></div></ix:continuation><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt"><ix:footnote id="fn-18" footnoteRole="http://www.xbrl.org/2003/role/footnote">Variable rate loans to the portfolio companies bear interest at a rate that is determined by reference to either LIBOR (&#8220;L&#8221;), Canadian Dollar Offered Rate (&#8220;CDOR&#8221; or &#8220;C&#8221;), Sterling Overnight Interbank Average Rate (&#8220;SONIA&#8221; or &#8220;S&#8221;), Euro Interbank Offer Rate (&#8220;Euribor&#8221; or &#8220;E&#8221;), Secured Overnight Financing Rate (&#8220;SOFR&#8221;), Stockholm Interbank Offered Rate (&#8220;STIBOR&#8221; or &#8220;T&#8221;), Copenhagen Interbank Offered Rate (&#8220;CIBOR&#8221; or &#8220;CI&#8221;, Norwegian Interbank Offered Rate (&#8220;NIBOR&#8221; or &#8220;N&#8221;), or an alternate base rate (commonly based on the Federal Funds Rate (&#8220;F&#8221;) or the U.S. Prime Rate (&#8220;P&#8221;)), which generally resets periodically. For each loan, the Company has indicated the reference rate used and provided the spread and the interest rate in effect as of December&#160;31, 2022. Variable rate loans typically include an interest reference rate floor feature. As of December&#160;31, 2022, <ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="bxsl:InvestmentPercentageOfPortfolioAboveFloorRate" scale="-2" id="f-4679">93.1</ix:nonFraction>% of the debt portfolio at fair value had an interest rate floor above zero. Rates on equity instruments represents contractual dividend rates on certain preferred equity positions.</ix:footnote> </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><ix:footnote id="fn-19" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><ix:footnote id="fn-20" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">These investments were valued using unobservable inputs and are considered Level 3 investments. Fair value was determined in good faith by or under the direction of the Board of Trustees (see Note 2 and Note 5), pursuant to the Company&#8217;s valuation policy.</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(5)</span><ix:footnote id="fn-21" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:26.68pt">These debt investments are not pledged as collateral under any of the Company's credit facilities. For other debt investments that are pledged to the Company's credit facilities, a single investment may be divided into parts that are individually pledged as collateral to separate credit facilities. Any other debt investments listed above are pledged to financing facilities and are not available to satisfy the creditors of the Company.</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><ix:footnote id="fn-22" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">The investment is not a qualifying asset under Section 55(a) of the 1940 Act. The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least <ix:nonFraction unitRef="number" contextRef="c-1056" decimals="INF" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4680">70</ix:nonFraction>% of the Company&#8217;s total assets. As of December&#160;31, 2022, non-qualifying assets represented <ix:nonFraction unitRef="number" contextRef="c-1057" decimals="INF" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-4681">11.0</ix:nonFraction>% of total assets as calculated in accordance with regulatory requirements.</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><ix:footnote id="fn-23" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion, although the investment may be subject to unused commitment fees. Negative cost and fair value results from unamortized fees, which are capitalized to the investment cost. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. See below for more information on the Company&#8217;s unfunded commitments:</span></ix:footnote></div><div><span><br/></span></div><div id="i33edc808e7824948b94b269ed713a939_145"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments&#8212;non-controlled/non-affiliated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment<br/>Expiration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unfunded<br/>Commitment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123Dentist, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/10/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1058" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4682">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1058" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4683">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACI Group Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/2/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1059" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4684">26,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1059" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4685">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACI Group Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/2/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1060" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4686">10,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1060" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4687">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ADCS Clinics Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/7/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1061" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4688">1,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1061" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4689">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ADCS Clinics Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/7/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1062" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4690">468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1062" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4691">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AI Altius Bidco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/21/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1063" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4692">1,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1063" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4693">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerilife Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1064" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4694">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1064" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4695">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerilife Holdings, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1065" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4696">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1065" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4697">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerivet Partners Management, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1066" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4698">589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1066" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4699">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amerivet Partners Management, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1067" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4700">2,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1067" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4701">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Anaplan, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/21/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1068" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4702">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1068" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4703">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Armada Parent, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1069" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4704">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1069" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4705">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Armada Parent, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1070" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4706">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1070" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4707">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ascend Buyer, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/30/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1071" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4708">1,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1071" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4709">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AxiomSL Group, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/3/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1072" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4710">2,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1072" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4711">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AxiomSL Group, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/3/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1073" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4712">3,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1073" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4713">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bazaarvoice, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/7/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1074" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4714">28,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1074" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefytt Technologies, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/12/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1075" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4716">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1075" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4717">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BlueCat Networks USA, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/8/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1076" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4718">309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1076" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4719">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BlueCat Networks USA, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/8/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1077" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4720">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1077" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4721">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus US 1, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/25/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1078" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4722">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1078" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4723">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">172</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments&#8212;non-controlled/non-affiliated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment<br/>Expiration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unfunded<br/>Commitment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus US 1, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/25/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1079" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4724">732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1079" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4725">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus US 1, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/25/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1080" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4726">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1080" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4727">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Caerus US 1, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/25/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1081" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4728">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1081" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4729">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cambium Learning Group, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/20/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1082" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4730">43,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1082" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4731">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canadian Hospital Specialties Ltd. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/14/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1083" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4732">5,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1083" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canadian Hospital Specialties Ltd. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/14/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1084" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4734">1,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1084" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CCBlue Bidco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/21/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1085" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4736">1,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1085" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4737">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CFGI Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/2/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1086" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4738">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1086" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4739">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CFGI Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/2/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1087" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4740">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1087" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4741">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Clearview Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/26/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1088" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4742">898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1088" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4743">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Clearview Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/26/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1089" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4744">3,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1089" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4745">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Community Brands ParentCo, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/24/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1090" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4746">588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1090" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4747">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Community Brands ParentCo, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/24/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1091" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4748">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1091" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4749">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Confine Visual Bidco </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/11/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1092" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4750">3,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1092" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4751">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Connatix Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/14/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1093" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4752">5,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1093" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4753">109</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Connatix Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/14/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1094" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4754">10,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1094" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4755">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COP Home Services TopCo IV, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/31/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1095" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4756">1,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1095" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4757">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CPI Buyer, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/1/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1096" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4758">7,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1096" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4759">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CPI Buyer, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/1/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1097" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4760">3,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1097" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4761">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CPI Intermediate Holdings Inc</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/8/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1098" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4762">966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1098" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4763">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumming Group, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/26/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1099" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4764">7,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1099" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4765">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumming Group, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/26/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1100" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4766">11,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1100" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4767">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DCA Investment Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/12/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1101" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4768">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1101" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4769">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DCA Investment Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/3/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1102" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4770">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1102" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4771">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discovery Education, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/9/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1103" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4772">2,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1103" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4773">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discovery Education, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/9/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1104" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4774">6,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1104" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4775">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Doc Generici (Diocle S.p.A.)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/26/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1105" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4776">1,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1105" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4777">141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emergency Power Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1106" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4778">18,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1106" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4779">187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ENV BIDCO AB</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1107" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4780">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1107" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4781">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Episerver, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/9/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1108" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4782">2,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1108" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4783">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Experity, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/24/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1109" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4784">1,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1109" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4785">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foundation Risk Partners Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1110" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4786">1,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1110" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Galway Borrower, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/30/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1111" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4788">2,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1111" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4789">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Galway Borrower, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/30/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1112" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4790">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1112" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GCX Corporation Buyer, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/13/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1113" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4792">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1113" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4793">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The GI Alliance Management, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/15/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1114" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4794">883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1114" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4795">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GI Ranger Intermediate, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/29/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1115" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4796">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1115" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4797">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GI Ranger Intermediate, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/30/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1116" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4798">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1116" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gigamon Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/11/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1117" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4800">437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1117" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4801">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">173</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments&#8212;non-controlled/non-affiliated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment<br/>Expiration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unfunded<br/>Commitment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Go Car Wash Management Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1118" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4802">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1118" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4803">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GovernmentJobs.com, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/30/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1119" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4804">677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1119" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4805">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GovernmentJobs.com, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/30/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1120" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4806">2,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1120" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4807">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GraphPAD Software, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/27/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1121" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4808">2,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1121" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4809">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GraphPAD Software, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/27/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1122" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4810">6,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1122" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4811">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gruden Acquisition, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1123" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4812">2,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1123" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4813">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gruden Acquisition, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/1/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1124" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4814">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1124" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4815">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Healthcomp Holding Company, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/29/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1125" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4816">23,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1125" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4817">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Helix TS, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/3/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1126" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4818">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1126" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4819">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Helix TS, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/14/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1127" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4820">767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1127" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4821">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HIG Orca Acquisition Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1128" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4822">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1128" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4823">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HIG Orca Acquisition Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1129" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4824">3,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1129" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4825">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">High Street Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/16/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1130" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4826">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1130" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4827">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">High Street Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/16/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1131" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4828">11,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1131" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IG Investments Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/22/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1132" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4830">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1132" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4831">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inovalon Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/24/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1133" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4832">11,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1133" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4833">138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integrity Marketing Acquisition, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/27/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1134" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4834">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1134" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4835">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ISQ Hawkey Holdco, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1135" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4836">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1135" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4837">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ISQ Hawkey Holdco, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1136" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4838">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1136" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4839">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Java Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/15/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1137" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4840">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1137" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4841">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jayhawk Buyer, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/15/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1138" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4842">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1138" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4843">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Knowledge Pro Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/10/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1139" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4844">1,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1139" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4845">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Knowledge Pro Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/10/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1140" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4846">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1140" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">KPSKY Acquisition, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/19/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1141" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4848">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1141" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4849">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LD Lower Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/8/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1142" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4850">15,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1142" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legacy Intermediate, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1143" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4852">958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1143" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4853">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legacy Intermediate, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/25/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1144" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4854">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1144" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4855">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Linquest Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/27/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1145" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4856">4,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1145" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4857">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Magnesium BorrowerCo, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/18/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1146" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4858">485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1146" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4859">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mandolin Technology Intermediate Holdings, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/23/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1147" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4860">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1147" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4861">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marcone Yellowstone Buyer, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/23/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1148" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4862">342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1148" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4863">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Material Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/17/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1149" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4864">918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1149" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4865">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Material Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/19/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1150" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4866">1,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1150" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4867">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MHE Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/21/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1151" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4868">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1151" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monk Holding Co. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/12/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1152" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4870">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1152" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4871">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Monterey Financing S.&#224;.r.l</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/19/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1153" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4872">467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1153" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4873">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MRI Software, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/10/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1154" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4874">1,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1154" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4875">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MRI Software, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/10/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1155" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4876">4,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1155" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4877">347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Navigator Acquiror, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/16/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1156" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4878">49,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1156" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4879">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">174</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments&#8212;non-controlled/non-affiliated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment<br/>Expiration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unfunded<br/>Commitment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDC Acquisition Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/9/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1157" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4880">2,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1157" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4881">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NMC Crimson Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/1/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1158" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4882">26,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1158" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4883">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Onex Baltimore Buyer, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1159" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4884">2,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1159" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Petrus Buyer Inc</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/17/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1160" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4886">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1160" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4887">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Petrus Buyer Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/17/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1161" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4888">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1161" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4889">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PGIS Intermediate Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/16/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1162" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4890">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1162" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4891">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Point Broadband Acquisition, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1163" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4892">20,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1163" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4893">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Porcelain Acquisition Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1164" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4894">14,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1164" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PPV Intermediate Holdings, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1165" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4896">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1165" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4897">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PPV Intermediate Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/31/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1166" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4898">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1166" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4899">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Profile Products, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/12/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1167" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4900">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1167" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4901">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Profile Products, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/12/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1168" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4902">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1168" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4903">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Progress Residential PM Holdings, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/17/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1169" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4904">16,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1169" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4905">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Progress Residential PM Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/25/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1170" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4906">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1170" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4907">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Project Boost Purchaser, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/2/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1171" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4908">591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1171" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4909">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Project Boost Purchaser, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/2/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1172" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4910">905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1172" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4911">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Qualus Power Services Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/26/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1173" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4912">4,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1173" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4913">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rally Buyer, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1174" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4914">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1174" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4915">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rally Buyer, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1175" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4916">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1175" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4917">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Red River Technology, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/26/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1176" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4918">25,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1176" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4919">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redwood Services Group, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/15/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1177" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4920">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1177" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4921">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Relativity ODA, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/12/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1178" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4922">3,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1178" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4923">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Relay Purchaser, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/30/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1179" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4924">7,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1179" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4925">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RoadOne Inc</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1180" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4926">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1180" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4927">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RoadOne Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1181" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4928">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1181" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4929">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Roadsafe Holdings, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/31/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1182" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4930">2,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1182" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4931">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RPBLS Midco, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/1/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1183" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4932">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1183" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4933">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RWL Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1184" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4934">6,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1184" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4935">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Safety Borrower Holdings LP </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/1/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1185" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4936">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1185" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4937">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sam Holding Co, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/24/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1186" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4938">29,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1186" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4939">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sam Holding Co, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/24/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1187" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4940">5,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1187" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4941">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEKO Global Logistics Network, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1188" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4942">294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1188" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4943">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEKO Global Logistics Network, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1189" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4944">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1189" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4945">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sherlock Buyer Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/8/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1190" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4946">2,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1190" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4947">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sherlock Buyer Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/8/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1191" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4948">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1191" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4949">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smile Doctors, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/23/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1192" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4950">710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1192" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4951">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Snoopy Bidco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1193" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4952">15,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1193" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4953">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SpecialtyCare, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1194" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4954">614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1194" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4955">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SpecialtyCare, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1195" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4956">1,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1195" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4957">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">175</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments&#8212;non-controlled/non-affiliated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitment<br/>Expiration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unfunded<br/>Commitment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spitfire Parent, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/11/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1196" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4958">3,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1196" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4959">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stepping Stones Healthcare Services, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1197" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4960">441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1197" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4961">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stepping Stones Healthcare Services, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/30/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1198" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4962">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1198" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4963">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Fertility Partners, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/16/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1199" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4964">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1199" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4965">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Fertility Partners, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/16/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1200" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4966">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1200" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4967">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The NPD Group L.P. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1201" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4968">7,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1201" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4969">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The NPD Group L.P. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1202" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4970">4,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1202" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4971">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trader Corp.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/22/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1203" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4972">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1203" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4973">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Air Consultants Holdings Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/29/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1204" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4974">10,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1204" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4975">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Air Consultants Holdings Corp. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/29/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1205" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4976">6,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1205" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4977">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trinity Partners Holdings, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/21/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1206" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4978">1,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1206" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4979">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Triple Lift, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/6/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1207" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4980">4,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1207" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4981">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRP Infrastructure Services, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/9/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1208" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4982">7,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1208" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4983">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turing Holdco, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/3/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1209" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4984">3,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1209" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unified Physician Management, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1210" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4986">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1210" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4987">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unified Physician Management, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/18/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1211" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-4988">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1211" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4989">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Mutual Acquisition Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/15/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1212" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4990">1,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1212" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4991">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Oral Surgery Management Holdco, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/18/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1213" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4992">3,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1213" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4993">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Oral Surgery Management Holdco, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/18/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1214" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4994">3,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1214" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-4995">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">West Monroe Partners, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/9/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1215" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4996">3,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1215" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4997">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">West Monroe Partners, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/9/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1216" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-4998">1,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1216" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-4999">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Westland Insurance Group LTD </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/31/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1217" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-5000">572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1217" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-5001">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">WHCG Purchaser III, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/22/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1218" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-5002">4,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1218" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-5003">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">WHCG Purchaser III, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/22/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1219" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-5004">10,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1219" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:fixed-zero" scale="3" id="f-5005">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Zendesk Inc</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delayed Draw Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/22/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1220" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-5006">361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1220" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-5007">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Zendesk Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/3/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1221" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" scale="3" id="f-5008">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1221" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" scale="3" id="f-5009">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total unfunded commitments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="3" id="f-5010">690,256</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5011">3,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><ix:footnote id="fn-24" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">There are <ix:nonFraction unitRef="number" contextRef="c-1222" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" format="ixt:fixed-zero" scale="0" id="f-5012">no</ix:nonFraction> interest rate floors on these investments.</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</span><ix:footnote id="fn-25" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was <ix:nonFraction unitRef="number" contextRef="c-1223" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" scale="-2" id="f-5013">0.50</ix:nonFraction>%</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)</span><ix:footnote id="fn-26" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was <ix:nonFraction unitRef="number" contextRef="c-1224" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" scale="-2" id="f-5014">0.75</ix:nonFraction>%</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11)</span><ix:footnote id="fn-27" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was <ix:nonFraction unitRef="number" contextRef="c-1225" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" scale="-2" id="f-5015">1.00</ix:nonFraction>%</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(12)</span><ix:footnote id="fn-28" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was <ix:nonFraction unitRef="number" contextRef="c-1226" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" scale="-2" id="f-5016">1.25</ix:nonFraction>%.</span></ix:footnote></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(13)</span><ix:footnote id="fn-29" continuedAt="fn-29-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was <ix:nonFraction unitRef="number" contextRef="c-1227" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" scale="-2" id="f-5017">1.50</ix:nonFraction>%</span></ix:footnote></div><ix:continuation id="fn-29-1"><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was <ix:nonFraction unitRef="number" contextRef="c-1228" decimals="INF" name="us-gaap:InvestmentInterestRateFloor" scale="-2" id="f-5018">2.00</ix:nonFraction>%</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(15)</span><ix:footnote id="fn-30" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">For unsettled positions the interest rate does not include the base rate.</span></ix:footnote></div></ix:continuation><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">Under the Investment Company Act of 1940, as amended (together with the rules and regulations promulgated thereunder, the &#8220;1940 Act&#8221;), the Company would be deemed to &#8220;control&#8221; a portfolio company if the Company owned more than 25% of its outstanding voting securities and/or held the power to exercise control over the management or policies of the portfolio company. As of December&#160;31, 2022, the Company does not &#8220;control&#8221; any of these portfolio companies. Under the 1940 Act, the Company would be deemed an &#8220;affiliated person&#8221; of a portfolio company if the Company owns 5% or more of the portfolio company&#8217;s outstanding voting securities. As of December&#160;31, 2022, the Company&#8217;s non-controlled/affiliated investments were as follows:<br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">176</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_148"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Schedule of Investments</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:25.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Reductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net change in Unrealized Gains (Losses)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value as of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend and Interest Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlled/Affiliated Investments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Blackstone Donegal Holdings LP</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1229" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5019">35,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1230" decimals="-3" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" format="ixt:num-dot-decimal" scale="3" id="f-5020">3,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1230" decimals="-3" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions" format="ixt:fixed-zero" scale="3" id="f-5021">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1230" decimals="-3" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-5022">17,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-758" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5023">56,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1230" decimals="-3" name="us-gaap:InterestAndDividendIncomeSecurities" format="ixt:fixed-zero" scale="3" id="f-5024">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1231" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5025">35,683</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1232" decimals="-3" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" format="ixt:num-dot-decimal" scale="3" id="f-5026">3,879</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1232" decimals="-3" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions" format="ixt:fixed-zero" scale="3" id="f-5027">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1232" decimals="-3" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-5028">17,022</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-761" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5029">56,584</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1232" decimals="-3" name="us-gaap:InterestAndDividendIncomeSecurities" format="ixt:fixed-zero" scale="3" id="f-5030">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">177</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_154"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7"> of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share per share amounts, percentages and as otherwise noted)</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1. <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-5031" continuedAt="f-5031-1" escape="true">Organization</ix:nonNumeric></span></div><div id="i33edc808e7824948b94b269ed713a939_157"></div><ix:continuation id="f-5031-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Secured Lending Fund (together with its consolidated subsidiaries, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Company&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), is a Delaware statutory trust formed on March 26, 2018, and structured as an externally managed, non-diversified closed-end management investment company.&#160;On October 26, 2018, the Company elected to be regulated as a business development company (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BDC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) under the Investment Company Act of 1940, as amended (together with the&#160;rules and regulations promulgated thereunder, the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;1940 Act&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). In addition, the Company has elected to be treated for U.S. federal income tax purposes, and intends to qualify annually, as a regulated investment company (a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;RIC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), under Subchapter M of the Internal Revenue Code of 1986, as amended (together with the&#160;rules and regulations promulgated thereunder, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Code&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is externally managed by Blackstone Credit BDC Advisors LLC (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Adviser&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) an affiliate of Blackstone Alternative Credit Advisors LP (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Administrator&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and, collectively with its affiliates in the credit, asset based finance, and insurance asset management business unit of Blackstone Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Blackstone&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Blackstone Credit &amp; Insurance,&#8221; or &#8220;BXCI&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Administration Agreement&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).&#160;References herein to information about Blackstone Credit &amp; Insurance from December 31, 2023 or prior refers solely to the Adviser and Blackstone Alternative Credit Advisors LP, collectively with their credit-focused affiliates within Blackstone Credit &amp; Insurance.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation.&#160;The Company seeks to achieve its investment objectives primarily through originated loans and other securities, including syndicated loans, of private U.S. companies, typically in the form of first lien senior secured and unitranche loans (including first out/last out loans), and to a lesser extent, second lien, third lien, unsecured and subordinated loans and other debt and equity securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company commenced its loan origination and investment activities on November 20, 2018.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 28, 2021, the Company priced its initial public offering (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;IPO&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">), and the Company's common shares of beneficial interest (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Common Shares&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) began trading on the New York Stock Exchange (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;NYSE&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">). See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 8&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for further details.</span></div></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_160"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-5032" continuedAt="f-5032-1" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-5032-1" continuedAt="f-5032-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-5033" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;GAAP&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and pursuant to the requirements for reporting on Form 10-K and Article 6 of Regulation S-X. As an investment company, the Company applies the accounting and reporting guidance in Accounting Standards Codification (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ASC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Topic 946, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Services &#8211; Investment Companies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ASC 946&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) issued by the Financial Accounting Standards Board (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;FASB&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, all adjustments considered necessary for the fair presentation of the consolidated financial statements for the periods presented have been included.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intercompany balances and transactions have been eliminated.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period information has been reclassified to conform to the current period presentation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-5034" continuedAt="f-5034-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-5034-1">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Such amounts could differ from those estimates and such differences could be material.&#160;Assumptions and estimates regarding the valuation of investments involve a higher degree of judgment and complexity and these assumptions and estimates may be significant to the consolidated financial statements. Actual results may ultimately differ from those estimates.</ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">178</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5032-2" continuedAt="f-5032-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-5035" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Consolidation</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As provided under ASC 946, the Company will not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidated the results of the Company&#8217;s wholly-owned subsidiaries which are considered to be investment companies.&#160;As of December&#160;31, 2023, the Company's consolidated subsidiaries were BGSL Jackson Hole Funding LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Jackson Hole Funding&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), BGSL Breckenridge Funding LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Breckenridge Funding&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), BGSL Big Sky Funding LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Big Sky Funding&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), BGSL Investments LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BGSL Investments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), BXSL Associates GP (Lux) S.&#224; r.l, BXSL Direct Lending (Lux) SCSp, BXSL C-1 LLC, and BXSL C-2 Funding LLC.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-5036" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of demand deposits and highly liquid investments, such as money market funds, with original maturities of three months or less. Cash and cash equivalents are carried at cost, which approximates fair value. The Company deposits its cash and cash equivalents with financial institutions and, at times, may exceed the Federal Deposit Insurance Corporation insured limit.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentPolicyTextBlock" id="f-5037" continuedAt="f-5037-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment transactions are recorded on a trade date basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gains or losses are measured by the difference between the net proceeds received (excluding prepayment fees, if any) and the amortized cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include investments charged off during the period, net of recoveries, and is recorded within Net realized gain (loss) on the Consolidated Statements of Operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in unrealized gains or losses primarily reflects the change in investment values, including the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period, and is recorded within Net change in unrealized appreciation (depreciation) on the Consolidated Statements of Operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of Investments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to report its investments, including those for which current market values are not readily available, at fair value.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company values its investments in accordance with ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ASC 820&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the applicable measurement date, and Rule 2a-5 under the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on observable market prices or parameters or derived from such prices or parameters when such quotations are readily available.&#160;In accordance with&#160;Rule 2a-5 under the 1940 Act, a market quotation is &#8220;readily available&#8221; only when it is a quoted price (unadjusted) in active markets for identical instruments that a fund can access at the measurement date, provided that such a quotation is not considered to be readily available if it is not reliable.&#160;The Company utilizes mid-market pricing (i.e., mid-point of average bid and ask prices) to value these investments.&#160;These market quotations are obtained from independent pricing services, if available; otherwise generally from at least two principal market makers or primary market dealers.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where prices or inputs are not available or, in the judgment of the Board, not reliable, valuation techniques based on the facts and circumstances of the particular investment will be utilized. These valuation approaches involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments&#8217; complexity. In the absence of observable, reliable market prices, the Company values its investments using various valuation methodologies applied on a consistent basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An enterprise value (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;EV&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) analysis is generally performed to determine the value of equity investments, control debt investments and non-control debt investments that are credit-impaired, and to determine if debt investments are credit impaired. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">179</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5037-1" continuedAt="f-5037-2"><ix:continuation id="f-5032-3" continuedAt="f-5032-4"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser will generally utilize approaches including the market approach, the income approach or both approaches, as appropriate, when calculating EV.&#160;The primary method for determining EV for non-control investments, and control investments without reliable projections, uses a multiple analysis whereby appropriate multiples are applied to the portfolio company&#8217;s earnings before interest, taxes, depreciation and amortization (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;EBITDA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or another key financial metric (e.g., such as revenues, cash flows or net income) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Performance Multiple&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).&#160;Performance Multiples are typically determined based upon a review of publicly traded comparable companies and market comparable transactions, if any.&#160;The second method for determining EV (and primary method for control investments with reliable projections) uses a discounted cash flow analysis whereby future expected cash flows and the anticipated terminal value of the portfolio company are discounted to determine a present value using estimated discount rates.&#160;The income approach is generally used when the Adviser has visibility into the long term projected cash flows of a portfolio company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If debt investments are credit-impaired, which occurs when there is insufficient coverage under the enterprise value analysis through the respective investment&#8217;s position in the capital structure, the Adviser generally uses the enterprise value &#8220;waterfall&#8221; approach or a recovery method (if a liquidation or restructuring is deemed likely) to determine fair value. For debt investments that are not determined to be credit-impaired, the Adviser generally uses a market interest rate yield analysis to determine fair value. To determine fair value using a yield analysis, the expected cash flows are projected based on the contractual terms of the debt security and discounted back to the measurement date based on a market yield.&#160;A market yield is determined based upon an assessment of current and expected market yields for similar investments and risk profiles.&#160;The Company considers the current contractual interest rate, the maturity and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the enterprise value of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, the Company depends on primary market data, including newly funded transactions, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable.&#160;The fair value of loans with call protection is generally capped at par plus applicable prepayment premium in effect at the measurement date.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820 prioritizes the use of observable market prices derived from such prices. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The levels used for classifying investments are not necessarily an indication of the risk associated with investing in these securities. The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 1:&#160;Inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date. The types of financial instruments included in Level 1 include unrestricted securities, including equities and derivatives, listed in active markets.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 2:&#160;Inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. The types of financial instruments in this category include less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities and certain over-the-counter derivatives where the fair value is based on observable inputs.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 3:&#160;Inputs to the valuation methodology are unobservable and significant to overall fair value measurement. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in this category include debt and equity investments in privately held entities, collateralized loan obligations (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;CLOs&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and certain over-the-counter derivatives where the fair value is based on unobservable inputs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment&#8217;s level within the fair value hierarchy is based on the lowest level of input that is significant to the overall fair value measurement. The Adviser&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.&#160;Transfers between levels, if any, are recognized at the beginning of the quarter in which the transfer occurs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the source of the inputs, including any markets in which its investments are trading (or any markets in which securities with similar attributes are trading), in determining fair value. When an investment is valued based on prices provided by reputable dealers or pricing services (that is, broker quotes), the Company subjects those prices to various criteria in making the determination as to whether a particular investment would qualify for treatment as a Level 2 or Level 3 investment.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">180</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5032-4" continuedAt="f-5032-5"><ix:continuation id="f-5037-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company&#8217;s investments may fluctuate from period to period, and these differences could be material. Additionally, the fair value of the Company&#8217;s investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that the Company may ultimately realize. Further, such investments are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If the Company was required to liquidate a portfolio investment in a forced or liquidation sale, it could realize significantly less than the value at which the Company has recorded it. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected in the valuations currently assigned.&#160;See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations&#8212;Critical Accounting Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables/Payables From Investments Sold/Purchased</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables/payables from investments sold/purchased consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-5038" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes all derivative instruments as assets or liabilities at fair value in its consolidated financial statements. Derivative contracts entered into by the Company are not designated in hedge accounting relationships and all changes in fair value are recognized through current period gains or losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company has commitments and risks resulting from its investment transactions, which may include those involving derivative instruments. Derivative instruments are measured in terms of the notional contract amount and derive their value based upon one or more underlying instruments. While the notional amount gives some indication of the Company&#8217;s derivative activity, it generally is not exchanged, but is only used as the basis on which interest and other payments are exchanged. Derivative instruments are subject to various risks similar to non-derivative instruments including market, credit, liquidity, and operational risks. The Company manages these risks on an aggregate basis as part of its risk management process.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Purchase Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward purchase agreements are recognized at fair value through current period gains or losses on the date on which the contract is entered into and are subsequently re-measured at fair value. All forward purchase agreements are carried as assets when fair value is positive and as liabilities when fair value is negative.&#160;A forward purchase agreement is derecognized when the obligation specified in the contract is discharged, canceled or expired.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-5039" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Transactions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts denominated in foreign currencies are translated into U.S. dollars on the following basis: (i)&#160;investments and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates effective on the last business day of the period; and (ii)&#160;purchases and sales of investments, borrowings and repayments of such borrowings, income, and expenses denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates prevailing on the transaction dates.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes net changes in fair values on investments held resulting from foreign exchange rate fluctuations in Translation of assets and liabilities in foreign currencies on the Consolidated Statements of Operations, if any. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign security and currency translations may involve certain considerations and risks not typically associated with investing in U.S. companies and U.S. government securities. These risks include, but are not limited to, currency fluctuations and revaluations and future adverse political, social and economic developments, which could cause investments in foreign markets to be less liquid and prices more volatile than those of comparable U.S. companies or U.S. government securities.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">181</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5032-5" continuedAt="f-5032-6"><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="f-5040" continuedAt="f-5040-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income is recorded on an accrual basis and includes the accretion of discounts and amortizations of premiums.&#160;Discounts from and premiums to par value on debt investments purchased are accreted/amortized into interest income over the life of the respective security using the effective interest method.&#160;The amortized cost of debt investments represents the original cost, including loan origination fees and upfront fees received that are deemed to be an adjustment to yield, adjusted for the accretion of discounts and amortization of premiums, if any.&#160;Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income in the current period. For the years ended December&#160;31, 2023, 2022 and 2021 the Company recorded $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="6" id="f-5041">19.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="6" id="f-5042">4.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="6" id="f-5043">60.9</ix:nonFraction> million, respectively, in non-recurring interest income (e.g., prepayment premiums, accelerated accretion of upfront loan origination fees and unamortized discounts). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PIK Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has loans in its portfolio that contain payment-in-kind (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;PIK&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) provisions.&#160;PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity.&#160;Such income is included in payment-in-kind interest income in the Consolidated Statements of Operations.&#160;If at any point the Company believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status.&#160;When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through payment-in-kind interest income.&#160;To satisfy the Company&#8217;s annual RIC distribution requirements, this non-cash source of income must be included in determining the amounts to be paid out to shareholders in the form of dividends, even though the Company has not yet collected cash.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend income on preferred equity securities is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fee Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may receive various fees in the ordinary course of business such as structuring, consent, waiver, amendment, syndication and other miscellaneous fees as well as fees for managerial assistance rendered by the Company to the portfolio companies.&#160;Such fees are recognized as income when earned or the services are rendered.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Accrual Income</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-5040-1">Loans are generally placed on non-accrual status when there is reasonable doubt whether principal or interest will be collected in full.&#160;Accrued interest is generally reversed when a loan is placed on non-accrual status. Additionally, any original issue discount and market discount are no longer accreted to interest income as of the date the loan is placed on non-accrual status.&#160;Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management&#8217;s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management&#8217;s judgment, are likely to remain current. Management may make exceptions to this treatment and&#160;determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityPolicyTextBlock" id="f-5044" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Organization Expenses and Offering Expenses</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records expenses related to public equity offerings as a reduction of capital upon completion of an offering of registered securities. The costs associated with any renewals of a shelf registration statement will be expensed as incurred. For the year ended December&#160;31, 2023, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-5045">0.4</ix:nonFraction> million of offering costs in connection with its follow-on offering which were charged as a reduction of paid-in-capital. For the year ended December&#160;31, 2022, the Company incurred <ix:nonFraction unitRef="usd" contextRef="c-135" decimals="INF" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:fixed-zero" scale="0" id="f-5046">no</ix:nonFraction> offering costs. For the year ended December&#160;31, 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-5047">1.6</ix:nonFraction> million of offering costs relating to its IPO which were charged as a reduction of paid-in-capital. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">182</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5032-6" continuedAt="f-5032-7"><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtPolicyTextBlock" id="f-5048" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Financing Costs and Debt Issuance Costs</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred financing and debt issuance costs represent fees and other direct incremental costs incurred in connection with the Company&#8217;s borrowings.&#160;These expenses are deferred and amortized into interest expense over the life of the related debt instrument. Deferred financing costs related to revolving credit facilities are presented separately as an asset on the Company&#8217;s Consolidated Statements of Assets and Liabilities.&#160;Debt issuance costs related to any issuance of installment debt or notes are presented net against the outstanding debt balance of the related security.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-5049" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to be treated as a BDC under the 1940 Act.&#160;The Company also has elected to be treated as a RIC under the Code.&#160;So long as the Company maintains its status as a RIC, it generally will not pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that it distributes at least annually to its shareholders as dividends. Rather, any tax liability related to income earned and distributed by the Company would represent obligations of the Company&#8217;s investors and would not be reflected in the consolidated financial statements of the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are &#8220;more-likely-than-not&#8221; to be sustained by the applicable tax authority. Tax positions not deemed to meet the &#8220;more-likely-than-not&#8221; threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To qualify for and maintain qualification as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to qualify for RIC tax treatment, the Company must distribute to its shareholders, for each taxable year, at least 90% of the sum of (i) its &#8220;investment company taxable income&#8221; for that year (without regard to the deduction for dividends paid), which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses and (ii) its net tax-exempt income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, based on the excise tax distribution requirements, the Company is subject to a 4% nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner in each taxable year an amount at least equal to the sum of (i) 98% of its ordinary income for the calendar year, (ii) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October&#160;31 in that calendar year and (iii)&#160;any income realized, but not distributed, in prior years. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to corporate income tax is considered to have been distributed.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-5050">16.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-5051">1.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-5052">2.4</ix:nonFraction> million, respectively, of U.S. federal excise tax.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentCompanyDistributionPolicyTextBlock" id="f-5053" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributions</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that the Company has taxable income available, the Company intends to make quarterly distributions to its shareholders.&#160;Distributions to shareholders are recorded on the record date.&#160;All distributions will be paid at the discretion of the Board and will depend on the Company&#8217;s earnings, financial condition, maintenance of the Company's tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">183</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-5054" continuedAt="f-5054-1" escape="true"><ix:continuation id="f-5032-7" continuedAt="f-5032-8"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div></ix:continuation></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><ix:continuation id="f-5054-1" continuedAt="f-5054-2"><ix:continuation id="f-5032-8" continuedAt="f-5032-9"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Reference Rate Reform (Topic 848)&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional expedients and exceptions for applying </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Interbank Offered Rate (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LIBOR&#8221;</span></ix:continuation></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-5054-2"><ix:continuation id="f-5032-9">) or another reference rate expected to be discontinued because of reference rate reform. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848), which expanded the scope of Topic 848 to include derivative instruments impacted by discounting transition. ASU 2020-04 and ASU 2021-01 are effective for all entities through December 31, 2022. The expedients and exceptions provided by the amendments do not apply to contract modifications and hedging relationships entered into or evaluated after December 31, 2022, except for hedging transactions as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which deferred the sunset day of this guidance to December 31, 2024. There has been no material impact of these standards on the Company&#8217;s financial position, results of operations or cash flows</ix:continuation></ix:continuation>.</span></div><div id="i33edc808e7824948b94b269ed713a939_163"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-5055" continuedAt="f-5055-1" escape="true">Agreements and Related Party Transactions</ix:nonNumeric></span></div><ix:continuation id="f-5055-1" continuedAt="f-5055-2"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Advisory Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, the Company entered into the original investment advisory agreement with the Adviser. The Adviser is responsible for originating prospective investments, conducting research and due diligence investigations on potential investments, analyzing investment opportunities, negotiating and structuring the Company&#8217;s investments and monitoring its investments and portfolio companies on an ongoing basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2021, the Company entered into an amended and restated investment advisory agreement (as amended and restated, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Investment Advisory Agreement&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), pursuant to which the Adviser manages the Company on a day-to-day basis. The Investment Advisory Agreement is substantially the same as the prior investment advisory agreement except, following the IPO, the incentive fee on income became subject to a twelve-quarter lookback quarterly hurdle rate of <ix:nonFraction unitRef="number" contextRef="c-1233" decimals="INF" name="bxsl:RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate" scale="-2" id="f-5056">1.50</ix:nonFraction>% as opposed to a single quarter measurement and became subject to an Incentive Fee Cap (as defined below) based on the Company&#8217;s Cumulative Net Return (as defined below). The amendment to the Investment Advisory Agreement does not result in higher fees (on a cumulative basis) payable to the Adviser than the fees that would have otherwise been payable to the Adviser under the original investment advisory agreement.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company pays the Adviser a fee for its services under the Investment Advisory Agreement consisting of two components: a management fee and an incentive fee. The cost of both the management fee and the incentive fee is borne by the shareholders. The initial term of the Investment Advisory Agreement was <ix:nonNumeric contextRef="c-1233" name="bxsl:RelatedPartyTransactionInitialTerm" format="ixt-sec:durwordsen" id="f-5057">two years</ix:nonNumeric> from October 1, 2018, and on May 6, 2020 and May 6, 2021, it was renewed and approved by the Board, including a majority of trustees who are not parties to the Investment Advisory Agreement or &#8220;interested persons&#8221; (as such term is defined in Section 2(a)(19) of the 1940 Act) (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Independent Trustees&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), for a <ix:nonNumeric contextRef="c-1234" name="bxsl:RelatedPartyTransactionRenewalTerm" format="ixt-sec:durwordsen" id="f-5058"><ix:nonNumeric contextRef="c-1235" name="bxsl:RelatedPartyTransactionRenewalTerm" format="ixt-sec:durwordsen" id="f-5059">one-year</ix:nonNumeric></ix:nonNumeric> period. On October 18, 2021, the Board approved the amended and restated Investment Advisory Agreement for an initial term ending May 31, 2022. Unless earlier terminated, the Investment Advisory Agreement will renew automatically for successive annual periods, provided that such continuance is specifically approved at least annually by the vote of the Board and by the vote of a majority of the Independent Trustees. The Investment Advisory Agreement was most recently renewed and approved by the Board, including majority of the Independent Trustees, on May 2, 2023 for a <ix:nonNumeric contextRef="c-1236" name="bxsl:RelatedPartyTransactionRenewalTerm" format="ixt-sec:durwordsen" id="f-5060">one-year</ix:nonNumeric> period ending on May 31, 2024.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser implemented a waiver effective from the consummation of the IPO to extend the Company&#8217;s pre-IPO fee structure for a period of <ix:nonNumeric contextRef="c-1233" name="bxsl:RelatedPartyTransactionVoluntaryWaiverPeriod" format="ixt-sec:durwordsen" id="f-5061">two years</ix:nonNumeric>. With the waiver in place, instead of having the base management fee and each incentive fee increase to <ix:nonFraction unitRef="number" contextRef="c-1237" decimals="INF" name="us-gaap:ManagementAndServiceFeesBaseRate" scale="-2" id="f-5062">1.00</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-1237" decimals="INF" name="us-gaap:ManagementAndServiceFeesIncentiveRate" scale="-2" id="f-5063">17.5</ix:nonFraction>%, respectively, following the IPO, each such fee remained at <ix:nonFraction unitRef="number" contextRef="c-1238" decimals="INF" name="us-gaap:ManagementAndServiceFeesBaseRate" scale="-2" id="f-5064">0.75</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-1238" decimals="INF" name="us-gaap:ManagementAndServiceFeesIncentiveRate" scale="-2" id="f-5065">15.0</ix:nonFraction>% for a period of <ix:nonNumeric contextRef="c-1239" name="bxsl:RelatedPartyTransactionVoluntaryWaiverPeriod" format="ixt-sec:durwordsen" id="f-5066">two years</ix:nonNumeric> following the IPO (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Waiver Period&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). As a result of the fee waiver, the pre-listing management fee and incentive fee rates paid by the Company to the Adviser did not increase during the Waiver Period. Amounts waived by the Adviser are not subject to recoupment by the Adviser. The Waiver Period ended on October 28, 2023.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">184</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5055-2" continuedAt="f-5055-3"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Base Management Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting from the consummation of the IPO, the management fee pursuant to the Investment Advisory Agreement is payable quarterly in arrears at an annual rate of <ix:nonFraction unitRef="number" contextRef="c-1240" decimals="INF" name="us-gaap:ManagementAndServiceFeesRate" scale="-2" id="f-5067">1.0</ix:nonFraction>% of the average value of the Company&#8217;s gross assets at the end of the two most recently completed calendar quarters. For purposes of the Investment Advisory Agreement, "gross assets" means the Company&#8217;s total assets determined on a consolidated basis in accordance with GAAP, excluding undrawn commitments but including assets purchased with borrowed amounts. The management fee was calculated for the quarter ended December 31, 2021, and the quarter ended December 31, 2023, at a weighted rate calculated based on the fee rates applicable before and after the consummation of the IPO and the expiration of the Waiver Period based on the number of days in the calendar quarter before and after the consummation of the IPO and the expiration of the Waiver Period.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the consummation of the IPO, the management fee was <ix:nonFraction unitRef="number" contextRef="c-1241" decimals="INF" name="us-gaap:ManagementAndServiceFeesRate" scale="-2" id="f-5068">0.75</ix:nonFraction>% of the average value of the Company&#8217;s gross assets at the end of the two most recently completed calendar quarters. In order to maintain the same management fee arrangement that the Company had in place prior to the IPO for a period of time following the consummation of the IPO, the Adviser voluntarily waived its right to receive the base management fee in excess of <ix:nonFraction unitRef="number" contextRef="c-1242" decimals="INF" name="us-gaap:ManagementAndServiceFeesBaseRate" scale="-2" id="f-5069">0.75</ix:nonFraction>% of the average value of the Company&#8217;s gross assets at the end of the two most recently completed calendar quarters during the Waiver Period. Amounts waived by the Adviser are not subject to recoupment by the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, base management fees were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ManagementFeeExpense" format="ixt:num-dot-decimal" scale="6" id="f-5070">98.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:ManagementFeeExpense" format="ixt:num-dot-decimal" scale="6" id="f-5071">101.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:ManagementFeeExpense" format="ixt:num-dot-decimal" scale="6" id="f-5072">62.4</ix:nonFraction> million, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InvestmentCompanyContractualFeeWaived" format="ixt:num-dot-decimal" scale="6" id="f-5073">20.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:InvestmentCompanyContractualFeeWaived" format="ixt:num-dot-decimal" scale="6" id="f-5074">25.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:InvestmentCompanyContractualFeeWaived" format="ixt:num-dot-decimal" scale="6" id="f-5075">4.2</ix:nonFraction> million, respectively, were waived. As of December&#160;31, 2023 and December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ManagementFeePayable" format="ixt:num-dot-decimal" scale="6" id="f-5076">23.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ManagementFeePayable" format="ixt:num-dot-decimal" scale="6" id="f-5077">18.6</ix:nonFraction> million, respectively, was payable to the Adviser relating to management fees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The incentive fees consist of two components that are determined independently of each other, with the result that one component may be payable even if the other is not. One component is based on income and the other component is based on capital gains, each as described below:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(i) Income based incentive fees:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first part of the incentive fee, an income based incentive fee, is calculated and payable quarterly in arrears based on the Company&#8217;s Pre-Incentive Fee Net Investment Income Returns as defined in the Investment Advisory Agreement.&#160;Pre-Incentive Fee Net Investment Income Returns means, as the context requires, either the dollar value of, or percentage rate of return on the value of the Company&#8217;s net assets at the end of the immediately preceding quarter from, interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies) accrued during the calendar quarter, minus the Company&#8217;s operating expenses accrued for the quarter (including the management fee, expenses payable under the Administration Agreement, and any interest expense or fees on any credit facilities or outstanding debt and dividends paid on any issued and outstanding preferred shares, but excluding the incentive fee.&#160;Pre-Incentive Fee Net Investment Income Returns includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with PIK interest and zero-coupon securities)), accrued income that the Company has not yet received in cash.&#160;Pre-incentive fee net investment income excludes any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The Company excludes the impact of expense support payments and recoupments from pre-incentive fee net investment income. Shareholders may be charged a fee on an income amount that is higher than the income they may ultimately receive.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-Incentive Fee Net Investment Income Returns, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, is compared to a &#8220;hurdle rate&#8221; of return of <ix:nonFraction unitRef="number" contextRef="c-1243" decimals="INF" name="us-gaap:ManagementAndServiceFeesIncentiveRate" scale="-2" id="f-5078">1.5</ix:nonFraction>% per quarter (<ix:nonFraction unitRef="number" contextRef="c-1244" decimals="INF" name="us-gaap:ManagementAndServiceFeesIncentiveRate" scale="-2" id="f-5079">6.0</ix:nonFraction>% annualized). </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Investment Advisory Agreement, the Company is required to pay an income based incentive fee of <ix:nonFraction unitRef="number" contextRef="c-1245" decimals="INF" name="bxsl:IncomeBasedIncentiveFeesRate" scale="-2" id="f-5080">17.5</ix:nonFraction>% (<ix:nonFraction unitRef="number" contextRef="c-1241" decimals="INF" name="bxsl:IncomeBasedIncentiveFeesRate" scale="-2" id="f-5081">15</ix:nonFraction>% prior to the consummation of the IPO), with a <ix:nonFraction unitRef="number" contextRef="c-1245" decimals="INF" name="bxsl:RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate" scale="-2" id="f-5082">1.5</ix:nonFraction>% hurdle and <ix:nonFraction unitRef="number" contextRef="c-1245" decimals="INF" name="bxsl:ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage" scale="-2" id="f-5083">100</ix:nonFraction>% catch-up. However, the Adviser has implemented a voluntary waiver with respect to the income based incentive fee during the Waiver Period. The Adviser has voluntarily waived its right to receive an income based incentive fee above <ix:nonFraction unitRef="number" contextRef="c-1245" decimals="INF" name="bxsl:IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold" scale="-2" id="f-5084">15</ix:nonFraction>% during the Waiver Period and amounts waived by the Adviser are not subject to recoupment by the Adviser.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">185</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5055-3" continuedAt="f-5055-4"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company pays the Adviser an income based incentive fee based on its aggregate pre-incentive fee net investment income, as adjusted as described above, from the calendar quarter then ending and the eleven preceding calendar quarters (such period, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Trailing Twelve Quarters&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The hurdle amount for the income based incentive fee is determined on a quarterly basis and is equal to <ix:nonFraction unitRef="number" contextRef="c-1245" decimals="INF" name="bxsl:RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate" scale="-2" id="f-5085">1.5</ix:nonFraction>% multiplied by the Company&#8217;s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters. The hurdle amount is calculated after making appropriate adjustments for issuances by the Company of common shares, including issuances pursuant to its dividend reinvestment plan and distributions that occurred during the relevant Trailing Twelve Quarters. The income based incentive fee for any partial period will be appropriately prorated.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the income based incentive fee, the Company will pay the Adviser a quarterly incentive fee based on the amount by which (A) aggregate pre-incentive fee net investment income in respect of the relevant Trailing Twelve Quarters exceeds (B) the hurdle amount for such Trailing Twelve Quarters. The amount of the excess of (A) over (B) described in this paragraph for such Trailing Twelve Quarters is referred to as the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Excess Income Amount&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The income based incentive fee for each quarter will be determined as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:32.5pt">No income based incentive fee is payable to the Adviser for any calendar quarter for which there is no Excess Income Amount.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:32.5pt">The Adviser will be paid <ix:nonFraction unitRef="number" contextRef="c-1246" decimals="INF" name="bxsl:IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome" scale="-2" id="f-5086">100</ix:nonFraction>% of the pre-incentive fee net investment income in respect of the Trailing Twelve Quarters, if any, that exceeds the hurdle amount for such Trailing Twelve Quarters, but is less than or equal to an amount, which we refer to as the &#8220;Catch-up Amount,&#8221; determined as the sum of <ix:nonFraction unitRef="number" contextRef="c-1247" decimals="4" name="bxsl:IncomeBasedIncentiveFeesCatchUpAmountPercentage" scale="-2" id="f-5087">1.82</ix:nonFraction>% (<ix:nonFraction unitRef="number" contextRef="c-1247" decimals="4" name="bxsl:IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage" scale="-2" id="f-5088">7.27</ix:nonFraction>% annualized) (<ix:nonFraction unitRef="number" contextRef="c-1248" decimals="4" name="bxsl:IncomeBasedIncentiveFeesCatchUpAmountPercentage" scale="-2" id="f-5089">1.76</ix:nonFraction>% (<ix:nonFraction unitRef="number" contextRef="c-1248" decimals="4" name="bxsl:IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage" scale="-2" id="f-5090">7.06</ix:nonFraction>% annualized) during the Waiver Period), multiplied by the Company&#8217;s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters that is included in the calculation of the incentive fee based on income.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt">The Adviser will be paid <ix:nonFraction unitRef="number" contextRef="c-1249" decimals="INF" name="bxsl:IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome" scale="-2" id="f-5091">17.5</ix:nonFraction>% (<ix:nonFraction unitRef="number" contextRef="c-1250" decimals="INF" name="bxsl:IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome" scale="-2" id="f-5092">15</ix:nonFraction>% during the Waiver Period), of the pre-incentive fee net investment income in respect of the Trailing Twelve Quarters that exceeds the Catch-up Amount.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amount of the income based incentive fee that will be paid to the Adviser for a particular quarter will equal the excess of (a) the income based incentive fee so calculated over (b) the aggregate income based incentive fee that was paid in respect of the first eleven calendar quarters included in the relevant Trailing Twelve Quarters subject to the Incentive Fee Cap as described below.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The income based incentive fee that will be paid to the Adviser for a particular quarter is subject to a cap (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Incentive Fee Cap&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">). The Incentive Fee Cap for any quarter is an amount equal to (a) <ix:nonFraction unitRef="number" contextRef="c-1251" decimals="INF" name="bxsl:IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn" scale="-2" id="f-5093">17.5</ix:nonFraction>% (<ix:nonFraction unitRef="number" contextRef="c-1242" decimals="INF" name="bxsl:IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn" scale="-2" id="f-5094">15</ix:nonFraction>% prior to the end of the Waiver Period) of the Cumulative Net Return (as defined below) during the relevant Trailing Twelve Quarters minus (b) the aggregate income based incentive fee that was paid in respect of the first eleven calendar quarters (or the portion thereof) included in the relevant Trailing Twelve Quarters.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Cumulative Net Return&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> means (x) the pre-incentive fee net investment income in respect of the relevant Trailing Twelve Quarters minus (y) any Net Capital Loss (as defined below), if any, in respect of the relevant Trailing Twelve Quarters. If, in any quarter, the Incentive Fee Cap is zero or a negative value, the Company will pay no income based incentive fee to the Adviser for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is a positive value but is less than the income based incentive fee that is payable to the Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company will pay an income based incentive fee to the Adviser equal to the Incentive Fee Cap for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is equal to or greater than the income based incentive fee that is payable to the Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company will pay an income based incentive fee to the Adviser equal to the incentive fee calculated as described above for such quarter without regard to the Incentive Fee Cap.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Net Capital Loss&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in respect of a particular period means the difference, if positive, between (i) aggregate capital losses, whether realized or unrealized, in such period and (ii) aggregate capital gains, whether realized or unrealized, in such period.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">186</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5055-4" continuedAt="f-5055-5"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These calculations are prorated for any period of less than three months and adjusted for any share issuances or repurchases during the relevant quarter. As the consummation of the IPO occurred on a date other than the first day of a calendar quarter, the income based incentive fee with respect to the Company&#8217;s pre-incentive fee net investment income was calculated for such calendar quarter at a weighted rate calculated based on the fee rates applicable before and after the consummation of the IPO based on the number of days in such calendar quarter before and after the consummation of the IPO. In no event will the amendments to the income based incentive fee include the incentive fee cap and allow the Adviser to receive greater cumulative income based incentive fees under the Investment Advisory Agreement than it would have under the prior investment advisory agreement. Amounts waived by the Adviser are not subject to recoupment by the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(ii) Capital gains based incentive fee:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting from the completion of the IPO, the second part of the incentive fee, a capital gains incentive fee, is determined and payable in arrears as of the end of each calendar year in an amount equal to <ix:nonFraction unitRef="number" contextRef="c-1252" decimals="INF" name="bxsl:CapitalGainsBasedIncentiveFeesRate" scale="-2" id="f-5095">17.5</ix:nonFraction>% of realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees as calculated in accordance with GAAP. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, the second part of the incentive fee, a capital gains incentive fee, was determined and payable in arrears as of the end of each calendar year in an amount equal to <ix:nonFraction unitRef="number" contextRef="c-1241" decimals="INF" name="bxsl:CapitalGainsBasedIncentiveFeesRate" scale="-2" id="f-5096">15.0</ix:nonFraction>% of realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees as calculated in accordance with GAAP. However, similar to the voluntary waivers referenced above, the Adviser voluntarily waived its right to receive a capital gains based incentive fee above <ix:nonFraction unitRef="number" contextRef="c-1242" decimals="INF" name="bxsl:CapitalGainsBasedIncentiveFeesRate" scale="-2" id="f-5097">15</ix:nonFraction>% from the date of consummation of the IPO through the Waiver Period. The Company will accrue, but will not pay, a capital gains incentive fee with respect to unrealized appreciation because a capital gains incentive fee would be owed to the Adviser if the Company were to sell the relevant investment and realize a capital gain. Amounts waived by the Adviser are not subject to recoupment by the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, the Company accrued income based incentive fees of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="bxsl:IncomeBasedIncentiveFeeExpense" format="ixt:num-dot-decimal" scale="6" id="f-5098">134.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="bxsl:IncomeBasedIncentiveFeeExpense" format="ixt:num-dot-decimal" scale="6" id="f-5099">97.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="bxsl:IncomeBasedIncentiveFeeExpense" format="ixt:num-dot-decimal" scale="6" id="f-5100">67.3</ix:nonFraction> million, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InvestmentCompanyVoluntaryFeeWaived" format="ixt:num-dot-decimal" scale="6" id="f-5101">15.6</ix:nonFraction> million $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:InvestmentCompanyVoluntaryFeeWaived" format="ixt:num-dot-decimal" scale="6" id="f-5102">13.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:InvestmentCompanyVoluntaryFeeWaived" format="ixt:num-dot-decimal" scale="6" id="f-5103">2.3</ix:nonFraction> million, respectively, were waived. As of December&#160;31, 2023 and December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="bxsl:IncentiveFeePayableIncome" format="ixt:num-dot-decimal" scale="6" id="f-5104">34.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="bxsl:IncentiveFeePayableIncome" format="ixt:num-dot-decimal" scale="6" id="f-5105">24.8</ix:nonFraction> million, respectively, was payable to the Adviser for income based incentive fees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023 and 2022, the Company reversed previously accrued capital gains incentive fees of $(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="bxsl:CapitalGainsIncentiveFeeExpense" scale="6" id="f-5106">5.5</ix:nonFraction>) million and $(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" sign="-" name="bxsl:CapitalGainsIncentiveFeeExpense" scale="6" id="f-5107">11.9</ix:nonFraction>) million, respectively. For the year ended December&#160;31, 2021, the Company accrued $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="bxsl:CapitalGainsIncentiveFeeExpense" format="ixt:num-dot-decimal" scale="6" id="f-5108">16.3</ix:nonFraction> million of capital gains incentive fees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administration Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, the Company entered into an Administration Agreement with the Administrator. Under the terms of the Administration Agreement, the Administrator provides, or oversees the performance of, administrative and compliance services, including, but not limited to, maintaining financial records, overseeing the calculation of NAV, compliance monitoring (including diligence and oversight of the Company&#8217;s other service providers), preparing reports to shareholders and reports filed with the United States Securities and Exchange Commission (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;SEC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), preparing materials and coordinating meetings of the Company&#8217;s Board, managing the payment of expenses and the performance of administrative and professional services rendered by others and providing office space, equipment and office services. The Administrator may also offer to provide, on the Company&#8217;s behalf, managerial assistance to the Company&#8217;s portfolio companies. The initial term of the agreement was <ix:nonNumeric contextRef="c-1253" name="bxsl:RelatedPartyTransactionInitialTerm" format="ixt-sec:durwordsen" id="f-5109">two years</ix:nonNumeric> from October 1, 2018. Unless earlier terminated, the Administration Agreement will renew automatically for successive annual periods, provided that such continuance is approved at least annually by (i) the vote of the Board or by a majority vote of the outstanding voting securities of the Company and (ii) the vote of a majority of the Independent Trustees. The Administration Agreement was most recently renewed and approved by the Board, including a majority of the Independent Trustees, on May 2, 2023, for a one-year period.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">187</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5055-5" continuedAt="f-5055-6"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For providing these services, the Company will reimburse the Administrator for its costs, expenses and allocable portion of overhead (including rent, office equipment and utilities) and other expenses incurred by the Administrator in performing its administrative obligations under the Administration Agreement, including but not limited to: (i) the Company&#8217;s chief compliance officer, chief financial officer and their respective staffs; (ii) investor relations, legal, operations and other non-investment professionals (including information technology professionals) at the Administrator that perform duties for the Company; and (iii) any internal audit group personnel of Blackstone or any of its affiliates. The Administrator has elected to forgo any reimbursement for rent and other occupancy costs for the years ended December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdministrativeFeesExpense" format="ixt:num-dot-decimal" scale="6" id="f-5110">2.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:AdministrativeFeesExpense" format="ixt:num-dot-decimal" scale="6" id="f-5111">2.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:AdministrativeFeesExpense" format="ixt:num-dot-decimal" scale="6" id="f-5112">2.4</ix:nonFraction> million, respectively, in expenses under the Administration Agreement, which were recorded in Administrative service expenses in the Company&#8217;s Consolidated Statements of Operations. As of December&#160;31, 2023 and December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-1254" decimals="-5" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5113">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1255" decimals="-5" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5114">1.2</ix:nonFraction> million, respectively, was unpaid and included in &#8220;Due to affiliates&#8221; in the Consolidated Statements of Assets and Liabilities.</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sub-Administration and Custody Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, the Administrator entered into a sub-administration agreement (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Sub-Administration Agreement&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) with State Street Bank and Trust Company (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Sub-Administrator&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) under which the Sub-Administrator provides various accounting and administrative services to the Company.&#160;The Sub-Administrator also serves as the Company&#8217;s custodian (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Custodian&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).&#160;The initial term of the Sub-Administration Agreement is <ix:nonNumeric contextRef="c-1256" name="bxsl:RelatedPartyTransactionInitialTerm" format="ixt-sec:durwordsen" id="f-5115">two years</ix:nonNumeric> from the effective date and after expiration of the initial term and the Sub-Administration Agreement shall automatically renew for successive <ix:nonNumeric contextRef="c-1256" name="bxsl:RelatedPartyTransactionRenewalTerm" format="ixt-sec:durwordsen" id="f-5116">one-year</ix:nonNumeric> periods, unless a written notice of non-renewal is delivered prior to <ix:nonNumeric contextRef="c-1256" name="bxsl:RelatedPartyTransactionTerminationNoticePeriod" format="ixt-sec:durday" id="f-5117">120</ix:nonNumeric> days prior to the expiration of the initial term or renewal term.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expense Support and Conditional Reimbursement Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2018, the Company entered into an Expense Support and Conditional Reimbursement Agreement (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Expense Support Agreement&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) with the Adviser pursuant to which the Adviser was able to elect to pay certain expenses of the Company on the Company&#8217;s behalf (each, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Expense Payment&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), provided that no portion of the payment was used to pay any interest of the Company. Any Expense Payment that the Adviser committed to pay was to be paid by the Adviser to the Company in any combination of cash or other immediately available funds no later than <ix:nonNumeric contextRef="c-1257" name="bxsl:RelatedPartyTransactionExpensePaymentPeriod" format="ixt-sec:durwordsen" id="f-5118">forty-five days</ix:nonNumeric> after such commitment was made in writing, and/or offset against amounts due from the Company to the Adviser or its affiliates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Expense Support Agreement, following any calendar quarter in which Available Operating Funds (as defined below) exceeded the cumulative distributions accrued to the Company&#8217;s shareholders based on distributions declared with respect to record dates occurring in such calendar quarter (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Excess Operating Funds&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), the Company was required to pay such Excess Operating Funds, or a portion thereof, to the Adviser until such time as all Expense Payments made by the Adviser to the Company within <ix:nonNumeric contextRef="c-1258" name="bxsl:RelatedPartyTransactionExpensePaymentPeriod" format="ixt-sec:durwordsen" id="f-5119">three years</ix:nonNumeric> prior to the last business day of such calendar quarter were reimbursed. Any payments required to be made by the Company to the Adviser are referred to herein as a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Reimbursement Payment&#8221;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Available Operating Funds means the sum of (i) the Company&#8217;s net investment company taxable income (including net short-term capital gains reduced by net long-term capital losses), (ii) the Company&#8217;s net capital gains (including the excess of net long-term capital gains over net short-term capital losses) and (iii) dividends and other distributions paid to the Company on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Expense Support Agreement terminated by its own terms on October 28, 2021. The Company&#8217;s obligation to make Reimbursement Payments survived the termination of the Expense Support Agreement and may be made for a period of up to <ix:nonNumeric contextRef="c-1258" name="bxsl:RelatedPartyTransactionExpensePaymentPeriod" format="ixt-sec:durwordsen" id="f-5120">three years</ix:nonNumeric>, in accordance with the terms of the Expense Support Agreement. The Company&#8217;s obligation to make a Reimbursement Payment becomes a liability of the Company on the last business day of the applicable calendar quarter. As of December&#160;31, 2023, there are no amounts subject to the Reimbursement Payment obligation.</span></div></ix:continuation><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-5055-6">As of December&#160;31, 2023 and December&#160;31, 2022, there was <ix:nonFraction unitRef="usd" contextRef="c-1259" decimals="INF" name="us-gaap:OtherLiabilities" format="ixt:fixed-zero" scale="6" id="f-5121"><ix:nonFraction unitRef="usd" contextRef="c-1260" decimals="INF" name="us-gaap:OtherLiabilities" format="ixt:fixed-zero" scale="6" id="f-5122">no</ix:nonFraction></ix:nonFraction> unreimbursed Expense Payments. For the years ended December&#160;31, 2023, 2022 and 2021, the Adviser made no Expense Payments. For the years ended December&#160;31, 2023, 2022 and 2021, the Company made <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="bxsl:ExpenseSupportReimbursementRelatedParty" format="ixt-sec:numwordsen" scale="0" id="f-5123"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="INF" name="bxsl:ExpenseSupportReimbursementRelatedParty" format="ixt-sec:numwordsen" scale="0" id="f-5124"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="INF" name="bxsl:ExpenseSupportReimbursementRelatedParty" format="ixt-sec:numwordsen" scale="0" id="f-5125">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> Reimbursement Payments related to Expense Payments by the Adviser.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">188</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_166"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock" id="f-5126" continuedAt="f-5126-1" escape="true">Investments</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" id="f-5127" continuedAt="f-5127-1" escape="true"><ix:continuation id="f-5126-1" continuedAt="f-5126-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of the Company&#8217;s investment portfolio at cost and fair value was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.729%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total Investments at Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total Investments at Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First lien debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5128">9,817,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5129">9,722,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1261" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5130">98.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-998" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5131">9,497,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-998" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5132">9,419,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1262" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5133">97.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second lien debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5134">43,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5135">41,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1263" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5136">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1007" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5137">48,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1007" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5138">46,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1264" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5139">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1265" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5140">9,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1265" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5141">9,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1266" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5142">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1267" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:fixed-zero" scale="3" id="f-5143">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1267" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:fixed-zero" scale="3" id="f-5144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1268" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:fixed-zero" scale="-2" id="f-5145">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-553" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5146">63,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-553" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5147">94,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1269" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5148">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1270" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5149">111,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1270" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5150">150,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1271" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5151">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5152">9,934,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5153">9,868,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1272" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5154">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5155">9,657,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5156">9,617,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1273" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5157">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">189</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_3218"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5127-1" continuedAt="f-5127-2"><ix:continuation id="f-5126-2" continuedAt="f-5126-3"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The industry composition of investments at fair value was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aerospace &amp; Defense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1274" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5158">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1275" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5159">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Air Freight &amp; Logistics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1276" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5160">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1277" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5161">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1278" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5162">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1279" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5163">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1280" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5164">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1281" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:fixed-zero" scale="-2" id="f-5165">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Services &amp; Supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1282" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5166">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1283" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5167">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction &amp; Engineering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1284" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5168">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1285" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5169">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Containers &amp; Packaging</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1286" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5170">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1287" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5171">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1288" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5172">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1289" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5173">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diversified Consumer Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1290" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5174">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1291" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5175">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diversified Financial Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1292" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5176">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1293" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5177">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diversified Telecommunication Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1294" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5178">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1295" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5179">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrical Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1296" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5180">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1297" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5181">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electronic Equipment, Instruments &amp; Components</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1298" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5182">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1299" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5183">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electric Utilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1300" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5184">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1301" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5185">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Energy Equipment &amp; Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1302" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5186">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1303" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5187">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ground Transportation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1304" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5188">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1305" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:fixed-zero" scale="-2" id="f-5189">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Equipment &amp; Supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1306" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5190">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1307" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5191">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Providers &amp; Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1308" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5192">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1309" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5193">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1310" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5194">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1311" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5195">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial Conglomerates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1312" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5196">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1313" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5197">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1314" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5198">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1315" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5199">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet &amp; Direct Marketing Retail</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1316" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5200">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1317" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5201">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1318" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5202">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1319" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5203">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1320" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5204">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1321" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5205">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1322" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5206">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1323" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5207">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Media</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1324" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5208">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1325" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5209">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oil, Gas &amp; Consumable Fuels</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1326" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5210">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1327" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5211">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paper &amp; Forest Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1328" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5212">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1329" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5213">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceuticals </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1330" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5214">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1331" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5215">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1332" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5216">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1333" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5217">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate Management &amp; Development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1334" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5218">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1335" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5219">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Road &amp; Rail</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1336" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:fixed-zero" scale="-2" id="f-5220">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1337" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5221">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1338" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5222">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1339" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5223">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Retail</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1340" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5224">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1341" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5225">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology Hardware, Storage &amp; Peripherals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1342" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5226">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1343" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5227">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Companies &amp; Distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1344" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5228">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1345" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5229">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transportation Infrastructure</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1346" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5230">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1347" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5231">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1272" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5232">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1273" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5233">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Amount rounds to less than 0.1% as of December&#160;31, 2022.</span></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Amount rounds to less than 0.1% as of December&#160;31, 2023.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">190</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_3245"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5126-3"><ix:continuation id="f-5127-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The geographic composition of investments at cost and fair value was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total Investments at Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as % of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1348" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5234">9,381,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1348" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5235">9,317,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1349" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5236">94.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1348" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-5237">188.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1350" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5238">275,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1350" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5239">278,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1351" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5240">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1350" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-5241">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda/Cayman Islands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1352" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" scale="3" id="f-5242">436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1352" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" id="f-5243">473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1353" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5244">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1352" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-5245">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1354" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5246">276,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1354" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5247">272,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1355" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5248">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1354" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-5249">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5250">9,934,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5251">9,868,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1272" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5252">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-5253">199.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total<br/>Investments at<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>as % of Net<br/>Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1356" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5254">8,934,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1356" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5255">8,893,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1357" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5256">92.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1356" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-5257">213.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1358" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5258">510,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1358" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5259">520,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1359" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5260">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1358" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-5261">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1360" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5262">212,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1360" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5263">203,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1361" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5264">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1360" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-5265">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentOwnedAtCost" format="ixt:num-dot-decimal" scale="3" id="f-5266">9,657,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5267">9,617,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1273" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5268">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="us-gaap:InvestmentOwnedPercentOfNetAssets" scale="-2" id="f-5269">231.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, one borrower (<ix:nonFraction unitRef="loan" contextRef="c-5" decimals="INF" name="bxsl:InvestmentOwnedNonaccrualNumberOfLoans" format="ixt-sec:numwordsen" scale="6" id="f-5270">one</ix:nonFraction> loan) and <ix:nonFraction unitRef="loan" contextRef="c-6" decimals="INF" name="bxsl:InvestmentOwnedNonaccrualNumberOfLoans" format="ixt-sec:numwordsen" scale="0" id="f-5271">no</ix:nonFraction> borrowers in the portfolio were on non-accrual status, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, on a fair value basis, <ix:nonFraction unitRef="number" contextRef="c-1362" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5272">99.9</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-1363" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5273">99.9</ix:nonFraction>%, respectively, of our performing debt investments bore interest at a floating rate and <ix:nonFraction unitRef="number" contextRef="c-1364" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5274">0.1</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-1365" decimals="4" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-5275">0.1</ix:nonFraction>%, respectively, of our performing debt investments bore interest at a fixed rate.</span></div></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_169"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-5276" continuedAt="f-5276-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-5277" continuedAt="f-5277-1" escape="true"><ix:continuation id="f-5276-1" continuedAt="f-5276-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of financial instruments:</span></div></ix:continuation></ix:nonNumeric><div id="i33edc808e7824948b94b269ed713a939_1933"></div><ix:continuation id="f-5277-1" continuedAt="f-5277-2"><ix:continuation id="f-5276-2" continuedAt="f-5276-3"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First lien debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1366" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5278">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1367" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5279">157,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1368" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5280">9,564,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1369" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5281">9,722,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second lien debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1370" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5282">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1371" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5283">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1372" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5284">41,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1373" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5285">41,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1374" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5286">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1375" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5287">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1376" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5288">9,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1377" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5289">9,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1378" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5290">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1379" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1380" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5292">94,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1381" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5293">94,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1382" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1383" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5295">157,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1384" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5296">9,710,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5297">9,868,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_1962"></div><ix:continuation id="f-5277-2"><ix:continuation id="f-5276-3" continuedAt="f-5276-4"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First lien debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1385" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1386" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5299">144,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1387" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5300">9,275,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1388" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5301">9,419,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second lien debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1389" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5302">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1390" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5303">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1391" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5304">46,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1392" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5305">46,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1393" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1394" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5307">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1395" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5308">150,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1396" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5309">150,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1397" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-5310">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1398" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5311">144,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1399" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5312">9,472,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-5313">9,617,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">191</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_3115"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><div style="margin-top:12pt"><span><br/></span></div><div id="i33edc808e7824948b94b269ed713a939_1990"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-5314" continuedAt="f-5314-1" escape="true"><ix:continuation id="f-5276-4" continuedAt="f-5276-5"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the fair value of financial instruments for which Level 3 inputs were used to determine the fair value:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.554%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second Lien Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unsecured Debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1400" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5315">9,275,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1401" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5316">46,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1402" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="3" id="f-5317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1403" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5318">150,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1404" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5319">9,472,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1405" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="f-5320">1,492,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1406" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="f-5321">1,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1407" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="f-5322">9,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1408" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="f-5323">3,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1409" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="f-5324">1,508,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from principal repayments and sales of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1405" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:num-dot-decimal" scale="3" id="f-5325">1,114,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1406" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:num-dot-decimal" scale="3" id="f-5326">7,351</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1407" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="3" id="f-5327">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1408" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:num-dot-decimal" scale="3" id="f-5328">65,465</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1409" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:num-dot-decimal" scale="3" id="f-5329">1,187,790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of discount/amortization of premium</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1405" decimals="-3" name="bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" format="ixt:num-dot-decimal" scale="3" id="f-5330">50,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1406" decimals="-3" name="bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" scale="3" id="f-5331">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1407" decimals="-3" name="bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" scale="3" id="f-5332">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1408" decimals="-3" name="bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" format="ixt:fixed-zero" scale="3" id="f-5333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1409" decimals="-3" name="bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" format="ixt:num-dot-decimal" scale="3" id="f-5334">50,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1410" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5335">15,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1411" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="3" id="f-5336">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1412" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="3" id="f-5337">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1413" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5338">13,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1414" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5339">1,662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1415" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5340">37,739</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1416" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="3" id="f-5341">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1417" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="3" id="f-5342">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1418" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5343">7,941</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1419" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5344">45,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1405" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:num-dot-decimal" scale="3" id="f-5345">4,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1406" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="3" id="f-5346">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1407" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="3" id="f-5347">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1408" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="3" id="f-5348">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1409" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:num-dot-decimal" scale="3" id="f-5349">4,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1405" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:num-dot-decimal" scale="3" id="f-5350">91,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1406" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="3" id="f-5351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1407" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="3" id="f-5352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1408" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="3" id="f-5353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1409" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:num-dot-decimal" scale="3" id="f-5354">91,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1420" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5355">9,564,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1421" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5356">41,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1422" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5357">9,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1423" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5358">94,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1424" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5359">9,710,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments still held as of December&#160;31, 2023 included in change in net unrealized appreciation (depreciation) on the Consolidated Statements of Operations</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1405" decimals="-3" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-5360">38,013</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1406" decimals="-3" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="3" id="f-5361">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1407" decimals="-3" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="3" id="f-5362">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1408" decimals="-3" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-5363">6,437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1409" decimals="-3" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-5364">44,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i33edc808e7824948b94b269ed713a939_2018"></div><ix:continuation id="f-5314-1"><ix:continuation id="f-5276-5" continuedAt="f-5276-6"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First&#160;Lien&#160;Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second Lien Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1425" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5365">9,288,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1426" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5366">42,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1427" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5367">170,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1428" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5368">9,501,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1429" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="f-5369">934,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1430" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="f-5370">5,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1431" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="f-5371">12,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1432" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="f-5372">952,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from principal repayments and sales of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1429" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:num-dot-decimal" scale="3" id="f-5373">980,395</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1430" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="3" id="f-5374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1431" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:num-dot-decimal" scale="3" id="f-5375">61,967</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1432" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:num-dot-decimal" scale="3" id="f-5376">1,042,362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of discount/amortization of premium</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1429" decimals="-3" name="bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" format="ixt:num-dot-decimal" scale="3" id="f-5377">45,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1430" decimals="-3" name="bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" scale="3" id="f-5378">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1431" decimals="-3" name="bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" format="ixt:fixed-zero" scale="3" id="f-5379">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1432" decimals="-3" name="bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" format="ixt:num-dot-decimal" scale="3" id="f-5380">45,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1433" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5381">2,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1434" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="3" id="f-5382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1435" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5383">41,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1436" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5384">39,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1437" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5385">118,465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1438" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5386">2,630</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1439" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5387">11,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1440" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="3" id="f-5388">132,330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1429" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:num-dot-decimal" scale="3" id="f-5389">108,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1430" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="3" id="f-5390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1431" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="3" id="f-5391">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1432" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:num-dot-decimal" scale="3" id="f-5392">108,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1429" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="3" id="f-5393">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1430" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="3" id="f-5394">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1431" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="3" id="f-5395">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1432" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="3" id="f-5396">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1400" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5397">9,275,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1401" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5398">46,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1403" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5399">150,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1404" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-5400">9,472,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments still held as of December&#160;31, 2022 included in net change in unrealized appreciation (depreciation) on the Consolidated Statements of Operations</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1429" decimals="-3" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-5401">119,180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1430" decimals="-3" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-5402">2,629</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1431" decimals="-3" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-5403">24,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1432" decimals="-3" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-5404">97,281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">For the years ended December&#160;31, 2023 and 2022, transfers into or out of Level 3 were primarily due to decreased or increased price transparency.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">192</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_2046"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="f-5405" continuedAt="f-5405-1" escape="true"><ix:continuation id="f-5276-6" continuedAt="f-5276-7"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents quantitative information about the significant unobservable inputs of the Company&#8217;s Level 3 financial instruments. The table is not intended to be all-inclusive but instead captures the significant unobservable inputs relevant to the Company&#8217;s determination of fair value.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.514%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Low</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">High</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in first lien debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1441" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5406">9,533,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield Analysis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1442" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5407">7.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1443" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5408">30.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1444" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5409">10.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1445" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5410">30,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Recoverability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market Multiple</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1446" decimals="2" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" format="ixt:num-dot-decimal" id="f-5411">10.50</ix:nonFraction>x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1447" decimals="2" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" format="ixt:num-dot-decimal" id="f-5412">10.50</ix:nonFraction>x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1448" decimals="2" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" format="ixt:num-dot-decimal" id="f-5413">10.50</ix:nonFraction>x</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1368" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5414">9,564,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in second lien debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1449" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5415">41,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield Analysis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1450" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5416">10.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1451" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5417">14.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1452" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5418">12.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in unsecured debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1453" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5419">9,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield Analysis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1454" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" format="ixt:num-dot-decimal" id="f-5420">14.90</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1455" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" format="ixt:num-dot-decimal" id="f-5421">14.90</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1456" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" format="ixt:num-dot-decimal" id="f-5422">14.90</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1457" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5423">60,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market Approach</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance Multiple</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1458" decimals="2" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" format="ixt:num-dot-decimal" id="f-5424">6.40</ix:nonFraction>x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1459" decimals="2" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" format="ixt:num-dot-decimal" id="f-5425">30.00</ix:nonFraction>x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1460" decimals="2" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" format="ixt:num-dot-decimal" id="f-5426">11.47</ix:nonFraction>x</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1461" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5427">28,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option Pricing Model </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1462" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5428">32.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1463" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5429">55.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1464" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5430">42.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1465" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5431">6,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield Analysis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1466" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5432">10.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1467" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5433">17.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1468" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5434">14.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1380" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5435">94,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1384" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5436">9,710,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i33edc808e7824948b94b269ed713a939_2074"></div><ix:continuation id="f-5276-7" continuedAt="f-5276-8"><ix:continuation id="f-5405-1"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.514%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Low</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">High</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in first lien debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1469" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5437">9,037,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield analysis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1470" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5438">6.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1471" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5439">19.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1472" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5440">10.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1473" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5441">238,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market quotations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker quoted price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1474" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="0" id="f-5442">82.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1475" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="0" id="f-5443">96.75</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1476" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="0" id="f-5444">94.19</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1387" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5445">9,275,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in second lien debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1477" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5446">46,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield analysis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1478" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5447">10.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1479" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5448">14.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1480" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5449">12.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1481" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5450">105,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance multiple</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1482" decimals="2" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" format="ixt:num-dot-decimal" id="f-5451">5.50</ix:nonFraction>x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1483" decimals="2" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" format="ixt:num-dot-decimal" id="f-5452">29.00</ix:nonFraction>x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1484" decimals="2" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" format="ixt:num-dot-decimal" id="f-5453">13.41</ix:nonFraction>x</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1485" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5454">22,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option pricing model</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1486" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5455">30.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1487" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5456">50.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1488" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5457">43.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1489" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5458">22,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield analysis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1490" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5459">11.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1491" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5460">13.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1492" decimals="4" name="us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" scale="-2" id="f-5461">12.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1395" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5462">150,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1399" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5463">9,472,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Weighted averages are calculated based on fair value of investments.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-5464" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant unobservable input used in the yield analysis is the discount rate based on comparable market yields. The significant unobservable input used for market quotations are broker quoted prices provided by independent pricing services. The significant unobservable input used under the market approach is the Performance Multiple. Significant increases in discount rates would result in a significantly lower fair value measurement. Significant decreases in quoted prices or Performance Multiples would result in a significantly lower fair value measurement.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">193</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_2102"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5276-8" continuedAt="f-5276-9"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments Not Carried at Fair Value</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s SPV Financing Facilities (as defined in Note 6) and Revolving Credit Facility (as defined in Note 6), as of December&#160;31, 2023 and December&#160;31, 2022, approximates their carrying value as the credit facilities have variable interest based on selected short term rates. These financial instruments would be categorized as Level 3 within the hierarchy.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="f-5465" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value measurements of the Company's Unsecured Notes (as defined in Note 6) had they been accounted for at fair value. These financial instruments would be categorized as Level 3 as of December&#160;31, 2023 and as Level 2 as of December&#160;31, 2022 within the hierarchy.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.229%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1493" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:fixed-zero" scale="3" id="f-5466">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1494" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5467">397,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1495" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5468">763,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1496" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5469">740,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New 2026 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1497" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5470">643,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1498" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5471">619,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1499" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5472">583,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1500" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5473">546,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1501" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5474">561,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1502" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5475">522,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1503" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5476">2,551,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1504" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-5477">2,825,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-5276-9">The carrying amounts of the Company&#8217;s other assets and liabilities approximate fair value. These financial instruments are categorized as Level 3 within the hierarchy.</ix:continuation> </span></div><div id="i33edc808e7824948b94b269ed713a939_172"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-5478" continuedAt="f-5478-1" escape="true">Borrowings</ix:nonNumeric></span></div><ix:continuation id="f-5478-1" continuedAt="f-5478-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the 1940 Act, with certain limitations, the Company is allowed to borrow amounts such that its asset coverage, as defined in the 1940 Act, is at least 150% after such borrowing. As of December&#160;31, 2023 and December&#160;31, 2022, the Company&#8217;s asset coverage was <ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" scale="-2" id="f-5479">200.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" scale="-2" id="f-5480">174.8</ix:nonFraction>%, respectively.</span></div></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_2130"></div><ix:continuation id="f-5478-2" continuedAt="f-5478-3"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SPV Financing Facilities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following wholly-owned subsidiaries of the Company have entered into secured financing facilities, as described below: Jackson Hole Funding, Breckenridge Funding and Big Sky Funding which are collectively referred to as the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;SPVs&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and such secured financing facilities described below are collectively referred to as the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;SPV Financing Facilities&#8221;.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of each SPV to the lenders under the applicable SPV Financing Facility are secured by a first priority security interest in all of the applicable SPV&#8217;s portfolio investments and cash. The obligations of each SPV under the applicable SPV Financing Facility are non-recourse to the Company, and the Company&#8217;s exposure to the credit facility is limited to the value of its investment in the applicable SPV.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the SPV Financing Facilities, the applicable SPV has made certain customary representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar facilities. Each SPV Financing Facility contains customary events of default for similar financing transactions, including if a change of control of the applicable SPV occurs. Upon the occurrence and during the continuation of an event of default, the lenders under the applicable SPV Financing Facility may declare the outstanding advances and all other obligations under the applicable SPV Financing Facility immediately due and payable. The occurrence of an event of default triggers a requirement that the applicable SPV obtain the consent of the lenders under the applicable SPV Financing Facility prior to entering into any sale or disposition with respect to portfolio investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, the Company was in compliance with all covenants and other requirements of each of the SPV Financing Facilities.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">194</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5478-3" continuedAt="f-5478-4"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jackson Hole Funding Facility</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 16, 2018, Jackson Hole Funding, the Company&#8217;s wholly-owned subsidiary that holds primarily originated loan investments, entered into a senior secured revolving credit facility (which was subsequently amended and restated on December 16, 2021, and amended effective as of September 16, 2022, November 15, 2023 and December 18, 2023, and as further amended from time to time, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#8220;Jackson Hole Funding Facility&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) with JPMorgan Chase Bank, National Association (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#8220;JPM&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">). JPM serves as administrative agent, Citibank, N.A., serves as collateral agent and securities intermediary, Virtus Group, LP serves as collateral administrator and the Company serves as portfolio manager under the Jackson Hole Funding Facility.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advances under the Jackson Hole Funding Facility bear interest at a per annum rate equal to the benchmark in effect for the currency of the applicable advances (which is the three-month Term SOFR for dollar advances), plus the applicable margin of <ix:nonFraction unitRef="number" contextRef="c-1505" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5481">2.375</ix:nonFraction>% per annum for certain foreign currency advances to <ix:nonFraction unitRef="number" contextRef="c-1506" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5482">2.525</ix:nonFraction>% per annum for dollar advances. Jackson Hole Funding pays a commitment fee of <ix:nonFraction unitRef="number" contextRef="c-1507" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-5483">0.48</ix:nonFraction>% per annum on the average daily unused amount of the financing commitments until November 28, 2025. Jackson Hole Funding also pays to JPM an administrative agency fee, in addition to certain other fees, each as agreed between Jackson Hole Funding and JPM.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum commitment amount of the Jackson Hole Funding Facility as of December&#160;31, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-1508" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-5484">500.0</ix:nonFraction> million. The Jackson Hole Funding Facility has an accordion feature, subject to the satisfaction of various conditions, which could bring total commitments under the Jackson Hole Funding Facility to up to $<ix:nonFraction unitRef="usd" contextRef="c-1508" decimals="INF" name="bxsl:LineOfCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="6" id="f-5485">900.0</ix:nonFraction> million. Proceeds from borrowings under the Jackson Hole Funding Facility may be used to fund portfolio investments by Jackson Hole Funding and to make advances under delayed draw term loans where Jackson Hole Funding is a lender. The period during which Jackson Hole Funding may make borrowings under the Jackson Hole Funding Facility expires on November 28, 2025 and the Jackson Hole Funding Facility is scheduled to mature on May 17, 2027.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breckenridge Funding Facility</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 21, 2018, Breckenridge Funding, the Company&#8217;s wholly-owned subsidiary that holds primarily syndicated loan investments, entered into a senior secured revolving credit facility (which was subsequently amended on June 11, 2019, August 2, 2019, September 27, 2019, April 13, 2020, October 5, 2021, February 28, 2022, May 19, 2022, November 1, 2023 and January 17, 2024, and as further amended from time to time, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Breckenridge Funding Facility&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) with BNP Paribas (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;BNP&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">). BNP serves as administrative agent, Wells Fargo Bank, National Association (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Wells Fargo&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) serves as collateral agent and the Company serves as servicer under the Breckenridge Funding Facility.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advances under the Breckenridge Funding Facility bear interest at a per annum rate equal to the three-month Term SOFR (or other base rate) in effect, plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="c-1509" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5486">1.70</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-1510" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5487">2.05</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="c-1511" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5488">2.30</ix:nonFraction>% per annum, as applicable, depending on the nature of the advances being requested under the facility. Breckenridge Funding pays a commitment fee of <ix:nonFraction unitRef="number" contextRef="c-1512" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-5489">0.70</ix:nonFraction>% per annum if the unused facility amount is greater than <ix:nonFraction unitRef="number" contextRef="c-1513" decimals="INF" name="bxsl:LineOfCreditFacilityUnusedCapacityPercentage" scale="-2" id="f-5490">50</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="c-1514" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-5491">0.35</ix:nonFraction>% per annum if the unused facility amount is less than or equal to <ix:nonFraction unitRef="number" contextRef="c-1515" decimals="INF" name="bxsl:LineOfCreditFacilityUnusedCapacityPercentage" scale="-2" id="f-5492">50</ix:nonFraction>% and greater than <ix:nonFraction unitRef="number" contextRef="c-1516" decimals="INF" name="bxsl:LineOfCreditFacilityUnusedCapacityPercentage" scale="-2" id="f-5493">25</ix:nonFraction>%, based on the average daily unused amount of the financing commitments until December 21, 2024, in addition to certain other fees as agreed between Breckenridge Funding and BNP.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from borrowings under the Breckenridge Funding Facility may be used to fund portfolio investments by Breckenridge Funding and to make advances under delayed draw and revolving loans where Breckenridge Funding is a lender. The period during which Breckenridge Funding may make borrowings under the Breckenridge Funding Facility for the remaining commitment amounts expires on December 21, 2024 and the Breckenridge Funding Facility is scheduled to mature on December 21, 2026.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Big Sky Funding Facility</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 10, 2019, Big Sky Funding, the Company&#8217;s wholly-owned subsidiary, entered into a senior secured revolving credit facility (which was subsequently amended on December 30, 2020 and September 30, 2021 and amended and restated on June 29, 2022, and amended on March 30, 2023 and as further amended from time to time, the (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Big Sky Funding Facility&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) with Bank of America, N.A. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Bank of America&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">). Bank of America serves as administrative agent, Wells Fargo serves as collateral administrator and the Company serves as manager under the Big Sky Funding Facility.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">195</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5478-4" continuedAt="f-5478-5"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advances under the Big Sky Funding Facility bear interest at a per annum rate equal to the one-month Term SOFR in effect, plus the applicable margin of (a) until September 25, 2024, <ix:nonFraction unitRef="number" contextRef="c-1517" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5494">1.80</ix:nonFraction>% per annum, and (b) from and after September 25, 2024, a range between <ix:nonFraction unitRef="number" contextRef="c-1518" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5495">2.10</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-1519" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5496">2.45</ix:nonFraction>% per annum depending on the nature of the collateral securing the advances. Big Sky Funding is required to utilize a minimum percentage of <ix:nonFraction unitRef="number" contextRef="c-1520" decimals="INF" name="bxsl:LineOfCreditFacilityMinimumCapacityUtilizationPercentage" scale="-2" id="f-5497">80</ix:nonFraction>% of the financing commitments. Unused amounts below such minimum utilization amount accrue a fee at a rate of <ix:nonFraction unitRef="number" contextRef="c-1521" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-5498">1.60</ix:nonFraction>% per annum. In addition, Big Sky Funding pays an unused fee of <ix:nonFraction unitRef="number" contextRef="c-1522" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-5499">0.45</ix:nonFraction>% per annum on the daily unused amount of the financing commitments in excess of the minimum utilization amount, commencing three months after the closing date of the Big Sky Funding Facility.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from borrowings under the Big Sky Funding Facility may be used to fund portfolio investments by Big Sky Funding and to make advances under revolving loans or delayed draw term loans where Big Sky Funding is a lender. The period during which Big Sky Funding may make borrowings under the Big Sky Funding Facility expires on March 30, 2026 and the Big Sky Funding Facility is scheduled to mature on September 30, 2026.</span></div></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_2159"></div><ix:continuation id="f-5478-5" continuedAt="f-5478-6"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Revolving Credit Facility</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 15, 2020, the Company entered into a senior secured revolving credit facility (which was most recently amended on June 9, 2023 and as further amended from time to time, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Revolving Credit Facility&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) with Citibank, N.A. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Citi&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) serving as administrative agent and collateral agent.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility provides for borrowings in U.S. dollars and certain agreed upon foreign currencies. Borrowings under the Revolving Credit Facility are subject to compliance with a borrowing base. A portion of the Revolving Credit Facility consists of funded term loans in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-1523" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-5500">385.0</ix:nonFraction> million and the Revolving Credit Facility provides for the issuance of letters of credit on behalf of the Company in an aggregate face amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="c-1524" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-5501">175.0</ix:nonFraction> million. Proceeds from the borrowings under the Revolving Credit Facility may be used for general corporate purposes of the Company and its subsidiaries in the ordinary course of business. Availability of the revolver under the Revolving Credit Facility will terminate on June 28, 2027 (other than with respect to the foreign currency commitments of certain lenders in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-1525" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-5502">200.0</ix:nonFraction> million, which expire on June 28, 2026) and all amounts outstanding under the Revolving Credit Facility must be repaid by June 28, 2028 (other than with respect to the foreign currency commitments of certain lenders in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-1526" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-5503">200.0</ix:nonFraction> million which mature on June 28, 2027) pursuant to an amortization schedule.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans under the Revolving Credit Facility bear interest at a per annum rate equal to, (x) for loans for which the Company elects the base rate option, the &#8220;alternate base rate&#8221; (which is the greatest of (a) the prime rate as publicly announced by Citi, (b) the sum of (i) the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System plus (ii) <ix:nonFraction unitRef="number" contextRef="c-1527" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5504">0.5</ix:nonFraction>% and (c) one month adjusted Term SOFR plus <ix:nonFraction unitRef="number" contextRef="c-1528" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5505">1</ix:nonFraction>% per annum) plus (A) if the gross borrowing base is equal to or greater than <ix:nonFraction unitRef="number" contextRef="c-1529" decimals="INF" name="bxsl:LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier" scale="0" id="f-5506">1.6</ix:nonFraction> times the combined revolving debt amount, <ix:nonFraction unitRef="number" contextRef="c-1530" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5507">0.75</ix:nonFraction>%, or (B) if the gross borrowing base is less than <ix:nonFraction unitRef="number" contextRef="c-1531" decimals="INF" name="bxsl:LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier" scale="0" id="f-5508">1.6</ix:nonFraction> times the combined revolving debt amount, <ix:nonFraction unitRef="number" contextRef="c-1532" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5509">0.875</ix:nonFraction>%, and (y) for all other loans, the applicable benchmark rate for the related interest period for such borrowing plus (A) if the gross borrowing base is equal to or greater than <ix:nonFraction unitRef="number" contextRef="c-1533" decimals="INF" name="bxsl:LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier" scale="0" id="f-5510">1.6</ix:nonFraction> times the combined revolving debt amount, <ix:nonFraction unitRef="number" contextRef="c-1534" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5511">1.75</ix:nonFraction>%, or (B) if the gross borrowing base is less than <ix:nonFraction unitRef="number" contextRef="c-1535" decimals="INF" name="bxsl:LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier" scale="0" id="f-5512">1.6</ix:nonFraction> times the combined revolving debt amount, <ix:nonFraction unitRef="number" contextRef="c-1536" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-5513">1.875</ix:nonFraction>%. The Company will pay an unused fee of <ix:nonFraction unitRef="number" contextRef="c-1537" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-5514">0.375</ix:nonFraction>% per annum on the daily unused amount of the revolver commitments. The Company will pay letter of credit participation fees and a fronting fee on the average daily amount of any lender&#8217;s exposure with respect to any letters of credit issued under the Revolving Credit Facility.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations to the lenders under the Revolving Credit Facility are secured by a first priority security interest in substantially all of the Company&#8217;s assets.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Revolving Credit Facility, the Company has made certain customary representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar facilities. In addition, the Company must comply with the following financial covenants: (a) the Company must maintain a minimum shareholders&#8217; equity, measured as of each fiscal quarter end; and (b) the Company must maintain at all times a <ix:nonFraction unitRef="number" contextRef="c-1538" decimals="INF" name="bxsl:DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio" scale="-2" id="f-5515">150</ix:nonFraction>% asset coverage ratio.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility contains customary events of default for similar financing transactions. Upon the occurrence and during the continuation of an event of default, Citi may terminate the commitments and declare the outstanding advances and all other obligations under the Revolving Credit Facility immediately due and payable.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, the Company was in compliance with all covenants and other requirements of the Revolving Credit Facility.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">196</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_2187"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5478-6" continuedAt="f-5478-7"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Unsecured Notes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued unsecured notes, as further described below: 2023 Notes, 2026 Notes, New 2026 Notes, 2027 Notes and 2028 Notes (each as defined below) which are collectively referred to herein as the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Unsecured Notes&#8221;.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Unsecured Notes contain certain covenants, including covenants requiring the Company to comply with the asset coverage requirements of Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the 1940 Act, whether or not it is subject to those requirements, and to provide financial information to the holders of the Unsecured Notes and the Trustee (as defined below) if the Company is no longer subject to the reporting requirements under the Exchange Act. These covenants are subject to important limitations and exceptions that are described in each respective indenture governing the Unsecured Notes (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Unsecured Notes Indentures&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on the occurrence of a &#8220;change of control repurchase event,&#8221; as defined in each respective Unsecured Notes Indenture, the Company will generally be required to make an offer to purchase the outstanding Unsecured Notes at a price equal to <ix:nonFraction unitRef="number" contextRef="c-1539" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-5516">100</ix:nonFraction>% of the principal amount of such Unsecured Notes plus accrued and unpaid interest to the repurchase date.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, the Company was in compliance with all covenants and other requirements of each of the Unsecured Notes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Notes</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="c-1540" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-5517">400.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="c-1540" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5518">3.650</ix:nonFraction>% notes due July 14, 2023 (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2023 Notes&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) pursuant to an indenture (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Base Indenture&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and a supplemental indenture, each dated as of July 15, 2020 (and together with the Base Indenture, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2023 Notes Indenture&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), between the Company and U.S. Bank National Association (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Trustee&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes bore interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-1540" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5519">3.650</ix:nonFraction>% per year payable semi-annually on January 14 and July 14 of each year, which commenced on January 14, 2021. The 2023 Notes were general unsecured obligations of the Company that ranked senior in right of payment to all of the Company&#8217;s existing and future indebtedness that was expressly subordinated in right of payment to the 2023 Notes, ranked pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, ranked effectively junior to any of the Company&#8217;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and ranked structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#8217;s subsidiaries, financing vehicles or similar facilities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes matured on July 14, 2023 and were paid off consistent with the terms of the 2023 Notes Indenture. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2026 Notes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 23, 2020 and December 1, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="c-1541" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-5520">500.0</ix:nonFraction> million aggregate principal amount and $<ix:nonFraction unitRef="usd" contextRef="c-1542" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-5521">300.0</ix:nonFraction> million aggregate principal amount, respectively, of <ix:nonFraction unitRef="number" contextRef="c-1542" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5522"><ix:nonFraction unitRef="number" contextRef="c-1541" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5523">3.625</ix:nonFraction></ix:nonFraction>% notes due 2026 (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2026 Notes&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) pursuant to a supplemental indenture, dated as of October 23, 2020 (and together with the Base Indenture, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2026 Notes Indenture&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), to the Base Indenture between the Company and the Trustee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2026 Notes will mature on January 15, 2026 and may be redeemed in whole or in part at the Company&#8217;s option at any time or from time to time at the redemption prices set forth in the 2026 Notes Indenture. The 2026 Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-1541" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5524"><ix:nonFraction unitRef="number" contextRef="c-1542" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5525">3.625</ix:nonFraction></ix:nonFraction>% per year payable semi-annually on January 15 and July 15 of each year, commencing on July 15, 2021. The 2026 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2026 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company&#8217;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">197</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5478-7" continuedAt="f-5478-8"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New 2026 Notes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 16, 2021 and April 27, 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="c-1543" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-5526">400.0</ix:nonFraction> million aggregate principal amount and $<ix:nonFraction unitRef="usd" contextRef="c-1544" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-5527">300.0</ix:nonFraction> million aggregate principal amount, respectively, of <ix:nonFraction unitRef="number" contextRef="c-1544" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5528"><ix:nonFraction unitRef="number" contextRef="c-1543" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5529">2.750</ix:nonFraction></ix:nonFraction>% notes due 2026 (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;New 2026 Notes&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) pursuant to a supplemental indenture, dated as of March 16, 2021 (and together with the Base Indenture, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;New 2026 Notes Indenture&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), to the Base Indenture between the Company and the Trustee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The New 2026 Notes will mature on September 16, 2026 and may be redeemed in whole or in part at the Company&#8217;s option at any time or from time to time at the redemption prices set forth in the New 2026 Notes Indenture. The New 2026 Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-1543" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5530"><ix:nonFraction unitRef="number" contextRef="c-1544" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5531">2.750</ix:nonFraction></ix:nonFraction>% per year payable semi-annually on March 16 and September 16 of each year, commencing on September 16, 2021. The New 2026 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company&#8217;s existing and future indebtedness that is expressly subordinated in right of payment to the New 2026 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company&#8217;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#8217;s subsidiaries, financing vehicles or similar facilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2027 Notes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="c-1545" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-5532">650.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="c-1545" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5533">2.125</ix:nonFraction>% notes due 2027 (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2027 Notes&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) pursuant to a supplemental indenture, dated as of July 23, 2021 (and together with the Base Indenture, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2027 Notes Indenture&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), to the Base Indenture between the Company and the Trustee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2027 Notes will mature on February 15, 2027 and may be redeemed in whole or in part at the Company&#8217;s option at any time or from time to time at the redemption prices set forth in the 2027 Notes Indenture. The 2027 Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-1545" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5534">2.125</ix:nonFraction>% per year payable semi-annually on February 15 and August 15 of each year, commencing on February 15, 2022. The 2027 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company&#8217;s existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company&#8217;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#8217;s subsidiaries, financing vehicles or similar facilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Notes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="c-1546" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-5535">650.0</ix:nonFraction> million in aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="c-1546" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5536">2.850</ix:nonFraction>% notes due 2028 (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2028 Notes&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) pursuant to a supplemental indenture, dated as of September 30, 2021 (and together with the Base Indenture, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2028 Notes Indenture&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), to the Base Indenture between the Company and the Trustee. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2028 Notes will mature on September 30, 2028 and may be redeemed in whole or in part at the Company&#8217;s option at any time or from time to time at the redemption prices set forth in the 2028 Notes Indenture. The 2028 Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-1546" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-5537">2.850</ix:nonFraction>% per year payable semi-annually on March 30 and September 30 of each year, commencing on March 30, 2022. The 2028 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company&#8217;s existing and future indebtedness that is expressly subordinated in right of payment to the 2028 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company&#8217;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#8217;s subsidiaries, financing vehicles or similar facilities.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">198</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_1905"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="f-5538" continuedAt="f-5538-1" escape="true"><ix:continuation id="f-5478-8" continuedAt="f-5478-9"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s outstanding debt obligations were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Principal<br/>Committed</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding<br/>Principal</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Debt Issuance Costs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unused</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jackson Hole Funding Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1508" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5539">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1508" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5540">233,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1508" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5541">233,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1508" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" format="ixt:num-dot-decimal" scale="3" id="f-5542">266,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1508" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5543">266,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breckenridge Funding Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1547" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5544">1,025,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1547" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5545">741,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1547" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5546">741,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1547" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" format="ixt:num-dot-decimal" scale="3" id="f-5547">283,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1547" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5548">283,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Big Sky Funding Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1548" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5549">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1548" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5550">480,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1548" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5551">480,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1548" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" format="ixt:num-dot-decimal" scale="3" id="f-5552">19,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1548" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5553">19,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1549" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5554">1,775,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1549" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5555">682,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1549" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5556">682,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1549" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" format="ixt:num-dot-decimal" scale="3" id="f-5557">1,092,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1549" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5558">1,092,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1550" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-5559">800,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1550" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5560">800,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1550" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5561">796,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1550" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="f-5562">3,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New 2026 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1551" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-5563">700,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1551" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5564">700,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1551" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5565">695,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1551" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="f-5566">4,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1552" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-5567">650,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1552" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5568">650,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1552" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5569">641,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1552" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="f-5570">8,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1553" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-5571">650,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1553" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5572">650,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1553" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5573">641,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1553" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="f-5574">8,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-5575">6,600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5576">4,937,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5577">4,911,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="f-5578">25,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" format="ixt:num-dot-decimal" scale="3" id="f-5579">1,662,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5580">1,662,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The unused portion is the amount upon which commitment fees, if any, are based.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The amount available reflects any limitations related to each respective credit facility&#8217;s borrowing base.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Under the Jackson Hole Funding Facility, the Company may borrow in U.S. dollars (USD) or certain other permitted currencies. As of December&#160;31, 2023, the Company had <ix:nonFraction unitRef="eur" contextRef="c-1508" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:fixed-zero" scale="6" id="f-5581">no</ix:nonFraction> borrowings denominated in currencies other than USD. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Under the Revolving Credit Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2023, the Company had non-USD borrowings denominated in the following currencies:</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">Canadian Dollars (CAD) <ix:nonFraction unitRef="cad" contextRef="c-1549" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-5582">1.0</ix:nonFraction> million</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">Euros (EUR) <ix:nonFraction unitRef="eur" contextRef="c-1549" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-5583">94.4</ix:nonFraction> million</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">British Pounds (GBP) <ix:nonFraction unitRef="gbp" contextRef="c-1549" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-5584">66.9</ix:nonFraction> million</span></div></ix:continuation></ix:nonNumeric><div id="i33edc808e7824948b94b269ed713a939_3083"></div><ix:continuation id="f-5538-1" continuedAt="f-5538-2"><ix:continuation id="f-5478-9" continuedAt="f-5478-10"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Principal Committed</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Principal</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Debt Issuance Costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unused</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jackson Hole Funding Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1554" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5585">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1554" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5586">360,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1554" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5587">360,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1554" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" format="ixt:num-dot-decimal" scale="3" id="f-5588">39,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1554" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5589">39,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breckenridge Funding Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1555" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5590">825,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1555" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5591">825,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1555" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5592">825,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1555" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" format="ixt:fixed-zero" scale="3" id="f-5593">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1555" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:fixed-zero" scale="3" id="f-5594">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Big Sky Funding Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1556" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5595">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1556" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5596">499,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1556" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5597">499,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1556" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" scale="3" id="f-5598">394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1556" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="3" id="f-5599">394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1557" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5600">1,625,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1557" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5601">678,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1557" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5602">678,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1557" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" format="ixt:num-dot-decimal" scale="3" id="f-5603">946,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1557" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5604">936,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1558" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-5605">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1558" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5606">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1558" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5607">398,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1558" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="f-5608">1,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1559" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-5609">800,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1559" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5610">800,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1559" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5611">794,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1559" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="f-5612">5,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New 2026 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1560" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-5613">700,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1560" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5614">700,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1560" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5615">693,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1560" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="f-5616">6,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1561" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-5617">650,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1561" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5618">650,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1561" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5619">638,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1561" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="f-5620">11,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1562" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-5621">650,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1562" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5622">650,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1562" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5623">639,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1562" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="f-5624">10,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-5625">6,550,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-5626">5,563,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-5627">5,527,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="f-5628">35,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" format="ixt:num-dot-decimal" scale="3" id="f-5629">986,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-5630">976,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The unused portion is the amount upon which commitment fees, if any, are based.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The amount available reflects any limitations related to each respective credit facility&#8217;s borrowing base.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Under the Jackson Hole Funding Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2022, the Company had <ix:nonFraction unitRef="eur" contextRef="c-1554" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt-sec:numwordsen" scale="6" id="f-5631">no</ix:nonFraction> borrowings denominated in currencies other than USD.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Under the Revolving Credit Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2022, the Company had borrowings denominated in the following currencies:</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">Canadian Dollars (CAD) <ix:nonFraction unitRef="cad" contextRef="c-1557" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-5632">355.9</ix:nonFraction> million</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">Euros (EUR) <ix:nonFraction unitRef="eur" contextRef="c-1557" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-5633">97.9</ix:nonFraction> million</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">British Pounds (GBP) <ix:nonFraction unitRef="gbp" contextRef="c-1557" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-5634">66.6</ix:nonFraction> million</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">199</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_2216"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5478-10"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of&#160;December&#160;31, 2023 and December&#160;31, 2022,&#160;$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="bxsl:InterestPayableInterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-5635">38.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="bxsl:InterestPayableInterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-5636">44.5</ix:nonFraction> million, respectively, of interest expense and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="bxsl:InterestPayableDebtInstrumentUnusedBorrowingCapacityFee" format="ixt:num-dot-decimal" scale="6" id="f-5637">1.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="bxsl:InterestPayableDebtInstrumentUnusedBorrowingCapacityFee" format="ixt:num-dot-decimal" scale="6" id="f-5638">0.8</ix:nonFraction> million, respectively, of unused commitment fees were included in interest payable. For the years ended December&#160;31, 2023, 2022 and 2021, the weighted average interest rate on all borrowings outstanding was <ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:LongTermDebtWeightedAverageInterestRateOverTime" scale="-2" id="f-5639">4.93</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-135" decimals="4" name="us-gaap:LongTermDebtWeightedAverageInterestRateOverTime" scale="-2" id="f-5640">3.46</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="c-136" decimals="4" name="us-gaap:LongTermDebtWeightedAverageInterestRateOverTime" scale="-2" id="f-5641">2.92</ix:nonFraction>% (including unused fees and accretion of net discounts on unsecured debt), respectively, and the average principal debt outstanding was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LongTermDebtAverageAmountOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-5642">5,275.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:LongTermDebtAverageAmountOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-5643">5,732.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:LongTermDebtAverageAmountOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-5644">4,000.8</ix:nonFraction> million, respectively. </span></div><ix:continuation id="f-5538-2"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of interest expense were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-5645">246,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InterestExpenseBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-5646">187,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InterestExpenseBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-5647">107,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility unused fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityFee" format="ixt:num-dot-decimal" scale="3" id="f-5648">4,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityFee" format="ixt:num-dot-decimal" scale="3" id="f-5649">2,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityFee" format="ixt:num-dot-decimal" scale="3" id="f-5650">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" format="ixt:num-dot-decimal" scale="3" id="f-5651">5,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" format="ixt:num-dot-decimal" scale="3" id="f-5652">4,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" format="ixt:num-dot-decimal" scale="3" id="f-5653">2,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of original issue discount and debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-5654">9,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-5655">10,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-5656">7,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Interest Expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-5657">266,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-5658">203,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-5659">120,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-5660">256,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-5661">182,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-5662">94,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:continuation></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_175"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-5663" continuedAt="f-5663-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-5663-1"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Portfolio Company Commitments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment portfolio may contain debt investments which are in the form of lines of credit or delayed draw commitments, which require us to provide funding when requested by portfolio companies in accordance with underlying loan agreements.&#160;As of December&#160;31, 2023 and December&#160;31, 2022 the Company had unfunded commitments, including delayed draw terms loans and revolvers, with an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="6" id="f-5664">985.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1563" decimals="-5" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="6" id="f-5665">690.3</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, from time to time, the Adviser and its affiliates may commit to an investment on behalf of the investment vehicles it manages, including the Company. Certain terms of these investments are not finalized at the time of the commitment and each respective investment vehicle's allocation may change prior to the date of funding. In this regard, as of December&#160;31, 2023 and December&#160;31, 2022, the Company estimates that $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount" format="ixt:num-dot-decimal" scale="6" id="f-5666">221.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="bxsl:InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount" format="ixt:num-dot-decimal" scale="6" id="f-5667">16.5</ix:nonFraction> million, respectively, of investments that were committed but not yet funded. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Commitments and Contingencies</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become a party to certain legal proceedings incidental to the normal course of its business. At December&#160;31, 2023 and December&#160;31, 2022, management is not aware of any material pending legal proceedings.</span></div></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_178"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-5668" continuedAt="f-5668-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8. Net Assets</span></div></ix:nonNumeric><div id="i33edc808e7824948b94b269ed713a939_2244"></div><ix:continuation id="f-5668-1" continuedAt="f-5668-2"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Issued</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the authority to issue an unlimited number of common shares of beneficial interest at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-5669">0.001</ix:nonFraction> per share par value.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2023, the Company completed a follow-on offering under its shelf registration statement, issuing <ix:nonFraction unitRef="shares" contextRef="c-1564" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-5670">6,500,000</ix:nonFraction> of its common shares of beneficial interest at a price to the underwriters of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1565" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-5671">26.78</ix:nonFraction> per share. Net of underwriting fees, the Company received cash proceeds, before offering expenses, of $<ix:nonFraction unitRef="usd" contextRef="c-1564" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-5672">174.1</ix:nonFraction> million. On August 18, 2023, the underwriters exercised, in full, their option to purchase an additional <ix:nonFraction unitRef="shares" contextRef="c-1566" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-5673">975,000</ix:nonFraction> shares of common shares, which resulted in cash proceeds, before offering expenses, of $<ix:nonFraction unitRef="usd" contextRef="c-1566" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-5674">26.1</ix:nonFraction> million. The Company incurred offering expenses of $<ix:nonFraction unitRef="usd" contextRef="c-1566" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-5675">0.4</ix:nonFraction> million in connection with the follow-on offering.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">200</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5668-2" continuedAt="f-5668-3"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, the Company is party to <ix:nonFraction unitRef="equity_distribution_agreement" contextRef="c-5" decimals="INF" name="bxsl:NumberOfEquityDistributionAgreements" format="ixt-sec:numwordsen" scale="0" id="f-5676">five</ix:nonFraction> separate equity distribution agreements&#160;with sales agents (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Distribution Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), pursuant to which the Company may sell, from time to time, up to an aggregate sales price of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="bxsl:SaleOfStockNumberOfSharesIssuedInTransactionValue" format="ixt:num-dot-decimal" scale="6" id="f-5677">400.0</ix:nonFraction>&#160;million of its common shares of beneficial interest. Sales of common shares made pursuant to the Equity Distribution Agreements may be made in negotiated transactions or transactions that are deemed to be &#8220;at-the-market&#8221; offerings as defined in Rule 415(a)(5) under the Securities Act of 1933, as amended. Actual sales depend on a variety of factors including market conditions, the trading price of the Company&#8217;s common shares, the Company&#8217;s capital needs, and the Company&#8217;s determination of the appropriate sources of funding to meet such needs. As of December&#160;31, 2023, common shares with an aggregate sales price of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="bxsl:SaleOfStockRemainingAuthorizedAmount" format="ixt:num-dot-decimal" scale="6" id="f-5678">328.9</ix:nonFraction> million remained available for issuance under the Equity Distribution Agreements.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" id="f-5679" escape="true"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total common shares issued and proceeds received, for the year ended December&#160;31, 2023, through the &#8220;at-the-market&#8221; offering program (dollars in thousands except per share amounts):</span></div><div style="margin-bottom:8pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuances of Common Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Proceeds</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Placement Fees/Offering Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Share Price </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;At-the-market&#8221; Offering</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1567" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-5680">17,144,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1567" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-5681">466,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1567" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-5682">1,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1567" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5683">465,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1568" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-5684">27.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Represents the net offering price per share after deducting placement fees and commissions and offering expenses.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No common shares were issued for the year ended December&#160;31, 2022, other than those issued through the Company's dividend reinvestment program.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the Company priced its IPO, issuing <ix:nonFraction unitRef="shares" contextRef="c-1569" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-5685">9,180,000</ix:nonFraction> of its common shares of beneficial interest at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1570" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-5686">26.15</ix:nonFraction> per share. Net of underwriting fees, the Company received cash proceeds, before offering expenses, of $<ix:nonFraction unitRef="usd" contextRef="c-1569" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-5687">230.6</ix:nonFraction> million. On November 4, 2021, the underwriters exercised their option to purchase an additional <ix:nonFraction unitRef="shares" contextRef="c-1571" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-5688">1,377,000</ix:nonFraction> shares of common shares, which resulted in cash proceeds, before offering expenses, of $<ix:nonFraction unitRef="usd" contextRef="c-1571" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-5689">33.8</ix:nonFraction> million. The Company&#8217;s common shares began trading on the NYSE under the symbol &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BXSL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; on October 28, 2021.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the listing of the Company&#8217;s common shares on the NYSE, the Board decided to eliminate any outstanding fractional common shares (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Fractional Shares&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), as permitted by Delaware law by rounding down the number of Fractional Shares held by each of our shareholders to the nearest whole share and paying each shareholder cash for such Fractional Shares.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to September 8, 2021, the Company entered into additional subscription agreements (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Subscription Agreements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) with investors providing for the private placement of the Company&#8217;s shares. Under the terms of the Subscription Agreements, investors are required to fund drawdowns to purchase the Company&#8217;s shares up to the amount of their respective Capital Commitment on an as-needed basis each time the Company delivers a drawdown notice to its investors. As of September 8, 2021, all Capital Commitments in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-1572" decimals="-5" name="us-gaap:InvestmentCompanyCommittedCapital" format="ixt:num-dot-decimal" scale="6" id="f-5690">3,926.3</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-1573" decimals="-5" name="us-gaap:InvestmentCompanyCommittedCapital" format="ixt:num-dot-decimal" scale="6" id="f-5691">80.0</ix:nonFraction> million from affiliates of the Adviser) had been drawn. As of December&#160;31, 2021, the Company had received Capital Commitments totaling $<ix:nonFraction unitRef="usd" contextRef="c-1572" decimals="-5" name="us-gaap:InvestmentCompanyCommittedCapital" format="ixt:num-dot-decimal" scale="6" id="f-5692">3,926.3</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="6" id="f-5693">713.3</ix:nonFraction> million remaining undrawn), of which $<ix:nonFraction unitRef="usd" contextRef="c-1574" decimals="-5" name="us-gaap:InvestmentCompanyCommittedCapital" format="ixt:num-dot-decimal" scale="6" id="f-5694">80.0</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-1575" decimals="-5" name="us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" format="ixt:num-dot-decimal" scale="6" id="f-5695">8.0</ix:nonFraction> million remaining undrawn) were from affiliates of the Adviser.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockByClassTextBlock" id="f-5696" escape="true"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total common shares issued and proceeds received related to the Company&#8217;s capital drawdowns and IPO for the year ended December&#160;31, 2021 (dollars in millions except share amounts):</span></div><div style="margin-bottom:8pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Share Issuance Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Proceeds</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 8, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1576" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-5697">13,869,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1576" decimals="-5" name="bxsl:StockIssuedDuringPeriodValueNewIssuesGross" scale="6" id="f-5698">357.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 8, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1572" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-5699">13,723,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1572" decimals="-5" name="bxsl:StockIssuedDuringPeriodValueNewIssuesGross" scale="6" id="f-5700">356.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1577" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-5701">10,557,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1577" decimals="-5" name="bxsl:StockIssuedDuringPeriodValueNewIssuesGross" scale="6" id="f-5702">264.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-136" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-5703">38,149,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="bxsl:StockIssuedDuringPeriodValueNewIssuesGross" scale="6" id="f-5704">977.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Includes proceeds (net of any underwriting fees) from our initial public offering and the underwriter's exercise of the over-allotment option.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">201</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_2273"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5668-3" continuedAt="f-5668-4"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distributions </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DividendsDeclaredTableTextBlock" id="f-5705" continuedAt="f-5705-1" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s distributions declared and payable for the year ended December&#160;31, 2023 (dollars in thousands except per share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:20.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.186%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date Declared</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1578" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5706">0.7000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1578" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5707">112,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1579" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5708">0.7000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1579" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5709">115,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 20, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1580" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5710">0.7700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1580" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5711">133,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 26, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1581" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5712">0.7700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1581" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5713">143,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5714">2.9400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5715">504,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_3025"></div><ix:continuation id="f-5705-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s distributions declared and payable for the year ended December&#160;31, 2022 (dollars in thousands except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date Declared</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 18, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 18, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1582" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5716">0.1000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1582" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5717">16,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 18, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1583" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5718">0.1500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1583" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5719">25,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1584" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5720">0.5300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1584" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5721">89,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 18, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 16, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1585" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5722">0.2000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1585" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5723">33,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1586" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5724">0.5300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1586" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5725">89,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 18, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 18, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 14, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1587" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5726">0.2000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1587" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5727">32,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 14, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1588" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5728">0.6000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1588" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5729">97,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1589" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5730">0.6000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1589" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5731">96,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5732">2.9100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5733">482,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="30" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:17.68pt">Represents a special distribution.</span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s distributions declared and payable for the year ended December&#160;31, 2021 (dollars in thousands except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:20.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.186%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date Declared</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 14, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1590" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5734">0.5000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1590" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5735">65,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 13, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1591" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5736">0.3736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1591" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5737">48,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 13, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1592" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5738">0.1264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1592" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5739">18,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 12, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1593" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5740">0.3750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1593" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5741">54,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 12, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1594" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5742">0.1250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1594" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5743">19,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 18, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1595" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5744">0.5300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1595" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5745">89,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-5746">2.0300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-5747">295,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-top:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">202</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_2301"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5668-4" continuedAt="f-5668-5"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Reinvestment</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted a dividend reinvestment plan (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;DRIP&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), pursuant to which it reinvests all cash dividends declared by the Board on behalf of its shareholders who do not elect to receive their dividends in cash. As a result, if the Board and the Company declares, a cash dividend or other distribution, then the Company&#8217;s shareholders who have not opted out of its dividend reinvestment plan will have their cash distributions automatically reinvested in additional shares as described below, rather than receiving the cash dividend or other distribution. Starting from the consummation of the IPO, the number of shares to be issued to a shareholder is determined by dividing the total dollar amount of the cash dividend or distribution payable to a shareholder by the market price per common share at the close of regular trading on the NYSE on the payment date of a distribution, or if no sale is reported for such day, the average of the reported bid and ask prices. However, if the market price per share on the payment date of a cash dividend or distribution exceeds the most recently computed NAV per share, the Company will issue shares at the greater of (i) the most recently computed NAV per share and (ii) <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="bxsl:DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare" scale="-2" id="f-5748">95</ix:nonFraction>% of the current market price per share (or such lesser discount to the current market price per share that still exceeded the most recently computed NAV per share). For example, if the most recently computed NAV per share is $25.00 and the market price on the payment date of a cash dividend is $24.00 per share, the Company will issue shares at $24.00 per share. If the most recently computed NAV per share is $25.00 and the market price on the payment date of a cash dividend is $27.00 per share, the Company will issue shares at $25.65 per share (95% of the current market price). If the most recently computed NAV per share is $25.00 and the market price on the payment date of a cash dividend is $26.00 per share, the Company will issue shares at $25.00 per share.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders who receive distributions in the form of shares will generally be subject to the same U.S. federal, state and local tax consequences as if they received cash distributions; however, since their cash distributions will be reinvested, those shareholders will not receive cash with which to pay any applicable taxes. The Company intends to use newly issued shares to implement the plan.</span></div><ix:nonNumeric contextRef="c-1" name="bxsl:ScheduleOfDividendReinvestmentPlanTableTextBlock" id="f-5749" continuedAt="f-5749-1" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our dividend reinvestment plan, the following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company&#8217;s DRIP during the year ended December&#160;31, 2023 (dollars in thousands except share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Issued</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1596" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5750">5,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1596" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5751">208,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1597" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5752">5,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1597" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5753">213,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1598" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5754">4,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1598" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5755">172,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1599" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5756">5,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1599" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5757">205,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5758">20,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5759">799,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:3pt;text-indent:-9pt"><span><br/></span></div><div id="i33edc808e7824948b94b269ed713a939_3054"></div><ix:continuation id="f-5749-1" continuedAt="f-5749-2"><ix:continuation id="f-5668-5" continuedAt="f-5668-6"><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company's DRIP during the year ended December&#160;31, 2022 (dollars in thousands except share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Issued</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1600" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5760">11,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1600" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5761">417,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1601" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5762">16,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1601" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5763">640,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1602" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5764">11,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1602" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5765">455,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 14, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1603" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5766">12,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1603" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5767">541,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5768">52,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-135" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5769">2,054,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:3pt;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">203</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5749-2"><ix:continuation id="f-5668-6" continuedAt="f-5668-7"><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company's DRIP during the year ended December&#160;31, 2021 (dollars in thousands except share amounts):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Issued</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 29, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1604" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5770">11,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1604" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5771">443,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 14, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1605" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5772">8,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1605" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5773">339,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 13, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1606" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5774">9,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1606" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5775">352,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 12, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1607" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5776">9,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1607" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5777">327,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="3" id="f-5778">38,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-136" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan" format="ixt:num-dot-decimal" scale="0" id="f-5779">1,462,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:3pt"><span><br/></span></div><div id="i33edc808e7824948b94b269ed713a939_2329"></div><ix:continuation id="f-5668-7" continuedAt="f-5668-8"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plan</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2021, the Board approved a share repurchase plan (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Company 10b5-1 Plan&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), to acquire up to approximately $<ix:nonFraction unitRef="usd" contextRef="c-1608" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-5780">262</ix:nonFraction> million (representing the net proceeds from the IPO) in the aggregate of our common shares at prices below our NAV per share over a specified period, in accordance with the guidelines specified in Rule 10b-18 and Rule 10b5-1 of the Exchange Act.&#160;The Company 10b5-1 Plan terminated by its own terms in November 2022. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Board authorized a share repurchase plan, under which we may repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-1609" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-5781">250</ix:nonFraction> million in the aggregate of our outstanding common shares in the open market at prices below our NAV per share for a <ix:nonNumeric contextRef="c-1610" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durwordsen" id="f-5782">one-year</ix:nonNumeric> term, in accordance with the guidelines specified in Rule 10b-18 of the Exchange Act (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Company 10b-18 Plan&#8221;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and together with the Company 10b5-1 Plan, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Share Repurchase Plans&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023 and December&#160;31, 2021, the Company did <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="f-5783"><ix:nonFraction unitRef="shares" contextRef="c-136" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="f-5784">not</ix:nonFraction></ix:nonFraction> repurchase any of its shares under the Share Repurchase Plans.</span></div><ix:nonNumeric contextRef="c-1" name="bxsl:ScheduleOfSharesRepurchasedTableTextBlock" id="f-5785" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the shares repurchased under the Company 10b5-1 Plan during the year ended December&#160;31, 2022 (dollars in thousands except share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total Number of Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1 - April 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1611" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="f-5786">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1611" decimals="2" name="bxsl:StockRepurchasedDuringPeriodAverageCostPerShare" format="ixt:fixed-zero" scale="0" id="f-5787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1612" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="f-5788">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1613" decimals="-3" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="3" id="f-5789">262,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1 - May 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1614" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5790">774,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1614" decimals="2" name="bxsl:StockRepurchasedDuringPeriodAverageCostPerShare" scale="0" id="f-5791">25.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1615" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5792">774,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1616" decimals="-3" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="3" id="f-5793">242,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1 - June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1617" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5794">1,313,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1617" decimals="2" name="bxsl:StockRepurchasedDuringPeriodAverageCostPerShare" scale="0" id="f-5795">24.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1618" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5796">1,313,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1619" decimals="-3" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="3" id="f-5797">210,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1 - July 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1620" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5798">2,394,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1620" decimals="2" name="bxsl:StockRepurchasedDuringPeriodAverageCostPerShare" scale="0" id="f-5799">23.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1621" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5800">2,394,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1622" decimals="-3" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="3" id="f-5801">154,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1 - August 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1623" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5802">2,223,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1623" decimals="2" name="bxsl:StockRepurchasedDuringPeriodAverageCostPerShare" scale="0" id="f-5803">24.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1624" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5804">2,223,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1625" decimals="-3" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="3" id="f-5805">100,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1 - September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1626" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5806">2,251,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1626" decimals="2" name="bxsl:StockRepurchasedDuringPeriodAverageCostPerShare" scale="0" id="f-5807">24.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1627" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5808">2,251,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1628" decimals="-3" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="3" id="f-5809">46,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1 - October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1629" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5810">2,002,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1629" decimals="2" name="bxsl:StockRepurchasedDuringPeriodAverageCostPerShare" scale="0" id="f-5811">23.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1630" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5812">2,002,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1631" decimals="-3" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:fixed-zero" scale="3" id="f-5813">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Repurchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-135" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5814">10,959,931</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1632" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-5815">10,959,931</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div id="i33edc808e7824948b94b269ed713a939_2357"></div><ix:continuation id="f-5668-8" continuedAt="f-5668-9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholder Transfer Restrictions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For shareholders who held common shares prior to the IPO, without the consent of the Adviser:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to January 3, 2022, a shareholder was not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber any common share held by such shareholder prior to the IPO (and any DRIP shares received with respect to such common shares);</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">204</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5668-9"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to March 1, 2022, a shareholder was not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber <ix:nonFraction unitRef="number" contextRef="c-1633" decimals="INF" name="bxsl:InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction" scale="-2" id="f-5816">90</ix:nonFraction>% of the common shares held by such shareholder prior to the IPO (and any DRIP shares received with respect to such common shares);</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to May 1, 2022, a shareholder was not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber <ix:nonFraction unitRef="number" contextRef="c-1634" decimals="INF" name="bxsl:InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction" scale="-2" id="f-5817">75</ix:nonFraction>% of the common shares held by such shareholder prior to the IPO (and any DRIP shares received with respect to such common shares); and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to July 1, 2022, a shareholder was not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber <ix:nonFraction unitRef="number" contextRef="c-1635" decimals="INF" name="bxsl:InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction" scale="-2" id="f-5818">50</ix:nonFraction>% of the common shares held by such shareholder prior to the date of the IPO (and any DRIP shares received with respect to such common shares).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This means that, as a result of these transfer restrictions, without the consent of the Adviser, a shareholder who owned <ix:nonFraction unitRef="shares" contextRef="c-1636" decimals="INF" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-5819">100</ix:nonFraction> common shares on the date of the IPO could not sell any of such shares until January 3, 2022; prior to March 1, 2022, such shareholder could only sell up to <ix:nonFraction unitRef="shares" contextRef="c-1637" decimals="INF" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-5820">10</ix:nonFraction> of such shares; prior to May 1, 2022, such shareholder could only sell up to <ix:nonFraction unitRef="shares" contextRef="c-1638" decimals="INF" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-5821">25</ix:nonFraction> of such shares; prior to July 1, 2022, such shareholder could only sell up to <ix:nonFraction unitRef="shares" contextRef="c-1639" decimals="INF" name="us-gaap:InvestmentOwnedBalanceShares" scale="0" id="f-5822">50</ix:nonFraction> of such shares; and after July 1, 2022, such shareholder could sell all of such shares. Consent by the Adviser to waive any of the foregoing transfer restrictions is subject to the consent of the representatives on behalf of the underwriters in the IPO. In addition, the Company&#8217;s trustees have agreed for a period of 180 days after the date of the IPO and the Company&#8217;s executive officers who are not trustees have agreed for a period of 180 days after the date of the IPO, not to transfer (whether by sale, gift, merger, by operation of law or otherwise) their common shares without the prior written consent of the representatives on behalf of the underwriters in the IPO, subject to certain exceptions.</span></div></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_181"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-5823" continuedAt="f-5823-1" escape="true">Earnings Per Share</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-5824" escape="true"><ix:continuation id="f-5823-1"><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.941%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in net assets resulting from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-5825">611,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-5826">404,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-5827">460,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding (basic and diluted)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-5828"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-5829">167,615,433</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-135" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-5830"><ix:nonFraction unitRef="shares" contextRef="c-135" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-5831">166,072,919</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-136" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-5832"><ix:nonFraction unitRef="shares" contextRef="c-136" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-5833">144,510,122</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share (basic and diluted)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-5834"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-5835">3.65</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-5836"><ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-5837">2.44</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-5838"><ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-5839">3.19</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div id="i33edc808e7824948b94b269ed713a939_184"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-5840" continuedAt="f-5840-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-5840-1" continuedAt="f-5840-2"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments, as gains and losses are generally not included in taxable income until they are realized; (2) income or loss recognition on exited investments; (3) non-deductible U.S federal excise taxes; and (4) other non-deductible expenses.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes certain adjustments to the classification of net assets as a result of permanent book-to-tax differences, which include differences in the book and tax basis of certain assets and liabilities, and non-deductible federal taxes or losses among other items. To the extent these differences are permanent, they are charged or credited to additional paid in capital, undistributed net investment income or undistributed net realized gains on investments, as appropriate. <ix:nonNumeric contextRef="c-1" name="bxsl:InvestmentCompanyChangeInNetAssetsTableTextBlock" id="f-5841" continuedAt="f-5841-1" escape="true">For the years ended December&#160;31, 2023, 2022 and 2021, permanent differences were as follows:</ix:nonNumeric></span><ix:continuation id="f-5841-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.941%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undistributed net investment income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1640" decimals="-3" name="us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-5842">32,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1641" decimals="-3" name="us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-5843">60,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1642" decimals="-3" sign="-" name="us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-5844">17,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated net realized gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" sign="-" name="us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-5845">15,911</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-5846">58,963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-5847">19,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid In Capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" sign="-" name="us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-5848">16,984</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-5849">1,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" sign="-" name="us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-5850">2,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">205</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5840-2" continuedAt="f-5840-3"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, permanent differences were principally related to $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-5851">16.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-5852">1.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-5853">2.4</ix:nonFraction> million, respectively, of U.S. federal excise taxes and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome" format="ixt:num-dot-decimal" scale="6" id="f-5854">0.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome" format="ixt:num-dot-decimal" scale="6" id="f-5855">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome" format="ixt:fixed-zero" scale="6" id="f-5856">0.0 million</ix:nonFraction>, respectively, of non-deductible offering costs.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For tax purposes, the Company may elect to defer any portion of a post-October capital loss or late-year ordinary loss to the first day of the following fiscal year. As of December&#160;31, 2023, 2022 and 2021, there were none. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FederalIncomeTaxNoteTextBlock" id="f-5857" continuedAt="f-5857-1" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following reconciles the increase in net assets resulting from operations to taxable income for the years ended December&#160;31, 2023, 2022 and 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.823%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net increase (decrease) in net assets resulting from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-5858">611,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-5859">404,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-5860">460,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized (appreciation) depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome" format="ixt:num-dot-decimal" scale="3" id="f-5861">54,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome" format="ixt:num-dot-decimal" scale="3" id="f-5862">122,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="bxsl:InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome" format="ixt:num-dot-decimal" scale="3" id="f-5863">104,178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Realized gains (losses) for tax not included in book income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="bxsl:InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome" scale="3" id="f-5864">917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="bxsl:InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome" scale="3" id="f-5865">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome" scale="3" id="f-5866">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible capital gains incentive fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome" format="ixt:num-dot-decimal" scale="3" id="f-5867">5,506</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome" format="ixt:num-dot-decimal" scale="3" id="f-5868">11,883</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome" format="ixt:num-dot-decimal" scale="3" id="f-5869">16,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-deductible expenses and excise taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome" format="ixt:num-dot-decimal" scale="3" id="f-5870">16,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome" format="ixt:num-dot-decimal" scale="3" id="f-5871">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome" format="ixt:num-dot-decimal" scale="3" id="f-5872">2,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net post-October capital loss deferral (reversal)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome" format="ixt:fixed-zero" scale="3" id="f-5873">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome" format="ixt:fixed-zero" scale="3" id="f-5874">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="bxsl:InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome" format="ixt:num-dot-decimal" scale="3" id="f-5875">4,293</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Taxable/distributable income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="bxsl:InvestmentCompanyDistributableEarningsLossBeforeDeductions" format="ixt:num-dot-decimal" scale="3" id="f-5876">677,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="bxsl:InvestmentCompanyDistributableEarningsLossBeforeDeductions" format="ixt:num-dot-decimal" scale="3" id="f-5877">516,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="bxsl:InvestmentCompanyDistributableEarningsLossBeforeDeductions" format="ixt:num-dot-decimal" scale="3" id="f-5878">370,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Tax information for the fiscal year ended December&#160;31, 2023 is estimated and is not considered final until the Company files its tax return.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="bxsl:InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock" id="f-5879" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated gains (losses) as calculated on a tax basis for the years ended December&#160;31, 2023, 2022 and 2021 were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributable ordinary income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-5880">281,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-5881">104,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-5882">104,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributable capital gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-5883">26,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-5884">37,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-5885">3,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other temporary book/tax differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="bxsl:InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences" format="ixt:fixed-zero" scale="3" id="f-5886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="bxsl:InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences" format="ixt:num-dot-decimal" scale="3" id="f-5887">5,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" sign="-" name="bxsl:InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences" format="ixt:num-dot-decimal" scale="3" id="f-5888">17,389</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation/(depreciation) on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation" format="ixt:num-dot-decimal" scale="3" id="f-5889">58,065</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation" format="ixt:num-dot-decimal" scale="3" id="f-5890">10,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation" format="ixt:num-dot-decimal" scale="3" id="f-5891">109,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total accumulated under-distributed (over-distributed) earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-5892">250,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="bxsl:RetainedEarningsAccumulatedDeficitAudited" format="ixt:num-dot-decimal" scale="3" id="f-5893">125,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-5894">199,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:continuation id="f-5857-1"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and unrealized gain (loss) of the Company&#8217;s investments, as calculated on a tax basis, at December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.940%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrealized appreciation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TaxBasisOfInvestmentsGrossUnrealizedAppreciation" format="ixt:num-dot-decimal" scale="3" id="f-5895">86,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:TaxBasisOfInvestmentsGrossUnrealizedAppreciation" format="ixt:num-dot-decimal" scale="3" id="f-5896">88,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:TaxBasisOfInvestmentsGrossUnrealizedAppreciation" format="ixt:num-dot-decimal" scale="3" id="f-5897">132,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrealized depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TaxBasisOfInvestmentsGrossUnrealizedDepreciation" format="ixt:num-dot-decimal" scale="3" id="f-5898">146,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:TaxBasisOfInvestmentsGrossUnrealizedDepreciation" format="ixt:num-dot-decimal" scale="3" id="f-5899">129,296</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:TaxBasisOfInvestmentsGrossUnrealizedDepreciation" format="ixt:num-dot-decimal" scale="3" id="f-5900">22,232</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in unrealized appreciation (depreciation)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet" format="ixt:num-dot-decimal" scale="3" id="f-5901">59,338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet" format="ixt:num-dot-decimal" scale="3" id="f-5902">40,943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet" format="ixt:num-dot-decimal" scale="3" id="f-5903">109,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax cost of investments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TaxBasisOfInvestmentsCostForIncomeTaxPurposes" format="ixt:num-dot-decimal" scale="3" id="f-5904">9,927,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:TaxBasisOfInvestmentsCostForIncomeTaxPurposes" format="ixt:num-dot-decimal" scale="3" id="f-5905">9,658,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:TaxBasisOfInvestmentsCostForIncomeTaxPurposes" format="ixt:num-dot-decimal" scale="3" id="f-5906">9,855,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-1643" decimals="-5" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-5907">456.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1644" decimals="-5" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-5908">47.9</ix:nonFraction> million of the dividends declared were derived from ordinary income and capital gains, respectively, as determined on a tax basis.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-1645" decimals="-5" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-5909">470.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1646" decimals="-5" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-5910">12.4</ix:nonFraction> million of the dividends declared were derived from ordinary income and capital gains, respectively, as determined on a tax basis.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the dividends declared during the year ended December&#160;31, 2021 were derived from ordinary income, as determined on a tax basis. </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">206</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-5840-3"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BGSL Investments, a wholly-owned subsidiary that was formed in 2019, is a Delaware LLC which has elected to be treated as a corporation for U.S. tax purposes. As such, BGSL Investments is subject to U.S. Federal, state and local taxes. For the Company's tax year ended December&#160;31, 2023, BGSL Investments activity did not result in a material provision for income taxes.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management has analyzed the Company&#8217;s tax positions taken, or to be taken, on federal income tax returns for all open tax years, and has concluded that no provision for income tax is required in the Company&#8217;s financial statements. The Company&#8217;s federal tax returns are subject to examination by the Internal Revenue Service for a period of three fiscal years after they are filed.</span></div></ix:continuation><div id="i33edc808e7824948b94b269ed713a939_187"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11. <ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentCompanyFinancialHighlightsTextBlock" id="f-5911" continuedAt="f-5911-1" escape="true">Financial Highlights and Senior Securities</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock" id="f-5912" escape="true"><ix:continuation id="f-5911-1" continuedAt="f-5911-2"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the financial highlights for the years ended December&#160;31, 2023, 2022, 2021, 2020, 2019 and for the period ended December 31, 2018:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per Share Data </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net asset value, beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-5913">25.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-153" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-5914">26.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-146" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-5915">25.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1647" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-5916">26.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1648" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-5917">24.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1649" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-5918">25.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare" scale="0" id="f-5919">3.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare" scale="0" id="f-5920">2.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare" scale="0" id="f-5921">2.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1650" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare" scale="0" id="f-5922">2.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1651" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare" scale="0" id="f-5923">2.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1652" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare" scale="0" id="f-5924">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized and realized gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" id="f-5925">0.24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" sign="-" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" id="f-5926">0.47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" id="f-5927">0.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1650" decimals="2" sign="-" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" id="f-5928">0.22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1651" decimals="2" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" id="f-5929">0.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1652" decimals="2" sign="-" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" id="f-5930">0.57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in net assets resulting from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare" scale="0" id="f-5931">3.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare" scale="0" id="f-5932">2.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare" scale="0" id="f-5933">3.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1650" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare" scale="0" id="f-5934">2.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1651" decimals="2" name="us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare" scale="0" id="f-5935">3.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1652" decimals="2" sign="-" name="us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare" scale="0" id="f-5936">0.40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions declared </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:InvestmentCompanyDistributionToShareholdersPerShare" scale="0" id="f-5937">2.94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" name="us-gaap:InvestmentCompanyDistributionToShareholdersPerShare" scale="0" id="f-5938">2.91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" name="us-gaap:InvestmentCompanyDistributionToShareholdersPerShare" scale="0" id="f-5939">2.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1650" decimals="2" name="us-gaap:InvestmentCompanyDistributionToShareholdersPerShare" scale="0" id="f-5940">2.30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1651" decimals="2" name="us-gaap:InvestmentCompanyDistributionToShareholdersPerShare" scale="0" id="f-5941">2.00</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1652" decimals="2" name="us-gaap:InvestmentCompanyDistributionToShareholdersPerShare" format="ixt:fixed-zero" scale="0" id="f-5942">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in net assets from capital share transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare" scale="0" id="f-5943">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" name="us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare" scale="0" id="f-5944">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" sign="-" name="us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare" scale="0" id="f-5945">0.09</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1650" decimals="2" sign="-" name="us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare" scale="0" id="f-5946">0.81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1651" decimals="2" name="us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare" scale="0" id="f-5947">0.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1652" decimals="2" sign="-" name="us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare" scale="0" id="f-5948">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total increase (decrease) in net assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" id="f-5949">0.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" sign="-" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" id="f-5950">0.34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" id="f-5951">1.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1650" decimals="2" sign="-" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" id="f-5952">0.82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1651" decimals="2" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" id="f-5953">1.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1652" decimals="2" sign="-" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" id="f-5954">0.43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net asset value, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-5955">26.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-5956">25.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-153" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-5957">26.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-146" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-5958">25.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1647" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-5959">26.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1648" decimals="2" name="us-gaap:NetAssetValuePerShare" scale="0" id="f-5960">24.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-5961">185,782,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-5962">160,362,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-153" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-5963">169,274,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-146" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-5964">129,661,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1647" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-5965">64,289,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1648" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-5966">9,621,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return based on NAV </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" id="f-5967">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-135" decimals="4" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" id="f-5968">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-136" decimals="4" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" id="f-5969">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1650" decimals="4" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" id="f-5970">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1651" decimals="4" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" id="f-5971">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1652" decimals="4" sign="-" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" id="f-5972">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return based on market value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:InvestmentCompanyTotalReturnMarketValue" scale="-2" id="f-5973">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-135" decimals="4" sign="-" name="us-gaap:InvestmentCompanyTotalReturnMarketValue" scale="-2" id="f-5974">26.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-136" decimals="4" name="us-gaap:InvestmentCompanyTotalReturnMarketValue" scale="-2" id="f-5975">32.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ratio of net expenses to average net assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" scale="-2" id="f-5976">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-135" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" scale="-2" id="f-5977">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-136" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" scale="-2" id="f-5978">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1650" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" scale="-2" id="f-5979">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1651" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" scale="-2" id="f-5980">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1652" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" scale="-2" id="f-5981">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ratio of net investment income to average net assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:InvestmentCompanyInvestmentIncomeLossRatio" scale="-2" id="f-5982">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-135" decimals="4" name="us-gaap:InvestmentCompanyInvestmentIncomeLossRatio" scale="-2" id="f-5983">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-136" decimals="4" name="us-gaap:InvestmentCompanyInvestmentIncomeLossRatio" scale="-2" id="f-5984">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1650" decimals="4" name="us-gaap:InvestmentCompanyInvestmentIncomeLossRatio" scale="-2" id="f-5985">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1651" decimals="4" name="us-gaap:InvestmentCompanyInvestmentIncomeLossRatio" scale="-2" id="f-5986">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1652" decimals="4" name="us-gaap:InvestmentCompanyInvestmentIncomeLossRatio" scale="-2" id="f-5987">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portfolio turnover rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:InvestmentCompanyPortfolioTurnover" scale="-2" id="f-5988">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-135" decimals="4" name="us-gaap:InvestmentCompanyPortfolioTurnover" scale="-2" id="f-5989">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-136" decimals="4" name="us-gaap:InvestmentCompanyPortfolioTurnover" scale="-2" id="f-5990">35.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1650" decimals="4" name="us-gaap:InvestmentCompanyPortfolioTurnover" scale="-2" id="f-5991">46.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1651" decimals="4" name="us-gaap:InvestmentCompanyPortfolioTurnover" scale="-2" id="f-5992">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1652" decimals="4" name="us-gaap:InvestmentCompanyPortfolioTurnover" format="ixt:fixed-zero" scale="-2" id="f-5993">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets, end of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-5994">4,952,041</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-5995">4,158,966</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-5996">4,447,479</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-5997">3,267,809</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1647" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-5998">1,673,117</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1648" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-5999">236,365</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset coverage ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" scale="-2" id="f-6000">200.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" scale="-2" id="f-6001">174.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-153" decimals="3" name="us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" scale="-2" id="f-6002">180.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-146" decimals="3" name="us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" scale="-2" id="f-6003">230.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1647" decimals="3" name="us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" scale="-2" id="f-6004">215.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1648" decimals="3" name="us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" scale="-2" id="f-6005">227.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The per share data was derived by using the weighted average shares outstanding during the period.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The per share data for distributions was derived by using the actual shares outstanding at the date of the relevant transactions (refer to Note 8).</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Total return is calculated as the change in NAV per share during the period, plus distributions per share (assuming dividends and distributions are reinvested in accordance with the Company's dividend reinvestment plan) divided by the beginning NAV per share. Total return does not include sales load.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Total return based on market value is calculated as the change in market value per share during the respective periods, taking into account distributions, if any, reinvested in accordance with the Company&#8217;s dividend reinvestment plan. The beginning market value per share is based on the initial public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1570" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-6006">26.15</ix:nonFraction> per share and not annualized.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Amounts are annualized except for expense support amounts relating to organizational costs and management fee and income based incentive fee waivers by the Adviser (refer to Note 3). For the years ended December&#160;31, 2023, 2022, 2021, 2020, 2019 and the period ended December 31, 2018, the ratio of total operating expenses to average net assets was <ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" scale="-2" id="f-6007">11.7</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-135" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" scale="-2" id="f-6008">9.3</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-136" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" scale="-2" id="f-6009">7.4</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-1650" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" scale="-2" id="f-6010">6.4</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-1651" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" scale="-2" id="f-6011">8.5</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="c-1652" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" scale="-2" id="f-6012">14.1</ix:nonFraction>% respectively, on an annualized basis, excluding the effect of expense support/(recoupment) and management fee and income based incentive fee waivers by the Adviser which represented (<ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" sign="-" name="bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" scale="-2" id="f-6013">0.8</ix:nonFraction>)%, (<ix:nonFraction unitRef="number" contextRef="c-135" decimals="4" sign="-" name="bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" scale="-2" id="f-6014">0.9</ix:nonFraction>)%, (<ix:nonFraction unitRef="number" contextRef="c-136" decimals="4" sign="-" name="bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" scale="-2" id="f-6015">0.2</ix:nonFraction>)%, (<ix:nonFraction unitRef="number" contextRef="c-1650" decimals="4" sign="-" name="bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" scale="-2" id="f-6016">0.1</ix:nonFraction>)%, (<ix:nonFraction unitRef="number" contextRef="c-1651" decimals="4" sign="-" name="bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" scale="-2" id="f-6017">0.0</ix:nonFraction>)% and <ix:nonFraction unitRef="number" contextRef="c-1652" decimals="4" name="bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" scale="-2" id="f-6018">5.2</ix:nonFraction>%, respectively, of average net assets.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The period ended December 31, 2018 represents the period from November 20, 2018 (commencement of operations) to December 31, 2018.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">207</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_2892"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:nonNumeric contextRef="c-1" name="cef:SeniorSecuritiesTableTextBlock" id="f-6019" continuedAt="f-6019-1" escape="true"><ix:continuation id="f-5911-2" continuedAt="f-5911-3"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is information about the Company&#8217;s senior securities as of the dates indicated in the below table:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:33.114%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.761%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class and Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount Outstanding Exclusive of Treasury Securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($ in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Coverage per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($ in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Involuntary Liquidating Preference per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Market Value per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subscription Facility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1653" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6020">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1653" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6021">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1654" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6022">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1654" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="3" id="f-6023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1655" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6024">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1655" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="3" id="f-6025">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1656" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6026">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1656" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="3" id="f-6027">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1657" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6028">119.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1657" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6029">2,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1658" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6030">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1658" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="0" id="f-6031">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jackson Hole Funding Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1659" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6032">233.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1659" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6033">2,003</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1660" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6034">360.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1660" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6035">1,748</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1661" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6036">361.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1661" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6037">1,802</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1662" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6038">362.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1662" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6039">2,300</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1663" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6040">514.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1663" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6041">2,151</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1664" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6042">120.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1664" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6043">2,278</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Breckenridge Funding Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1665" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6044">741.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1665" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6045">2,003</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1666" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6046">825.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1666" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6047">1,748</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1667" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6048">568.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1667" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6049">1,802</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1668" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6050">569.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1668" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6051">2,300</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1669" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6052">820.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1669" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6053">2,151</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1670" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6054">65.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1670" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6055">2,278</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Big Sky Funding facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1671" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6056">480.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1671" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6057">2,003</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1672" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6058">499.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1672" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6059">1,748</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1673" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6060">499.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1673" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6061">1,802</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1674" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6062">200.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1674" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6063">2,300</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1675" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6064">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1675" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6065">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1676" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6066">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1676" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6067">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1677" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6068">682.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1677" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6069">2,003</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1678" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6070">678.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1678" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6071">1,748</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1679" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6072">915.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1679" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6073">1,802</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1680" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6074">182.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1680" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6075">2,300</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1681" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6076">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1681" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6077">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1682" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6078">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1682" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6079">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1683" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6080">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1683" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6081">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1684" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6082">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1684" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6083">1,748</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1685" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6084">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1685" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6085">1,802</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1686" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6086">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1686" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6087">2,300</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">208</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><ix:continuation id="f-6019-1"><ix:continuation id="f-5911-3"><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:33.114%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.761%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class and Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount Outstanding Exclusive of Treasury Securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($ in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Coverage per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($ in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Involuntary Liquidating Preference per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Market Value per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1687" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6088">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1687" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6089">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1688" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6090">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1688" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6091">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1689" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6092">800.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1689" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6093">2,003</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1690" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6094">800.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1690" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6095">1,748</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1691" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6096">800.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1691" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6097">1,802</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1692" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6098">800.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1692" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6099">2,300</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1693" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6100">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1693" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6101">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1694" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6102">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1694" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6103">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">New 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1695" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6104">700.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1695" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6105">2,003</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1696" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6106">700.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1696" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6107">1,748</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1697" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6108">700.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1697" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6109">1,802</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1698" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6110">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1698" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1699" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1699" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1700" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6114">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1700" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="0" id="f-6115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1701" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6116">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1701" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6117">2,003</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1702" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6118">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1702" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6119">1,748</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1703" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6120">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1703" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6121">1,802</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1704" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6122">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1704" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6123">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1705" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6124">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1705" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6125">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1706" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1706" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6127">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1707" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6128">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1707" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6129">2,003</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1708" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6130">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1708" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6131">1,748</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1709" decimals="-5" name="cef:SeniorSecuritiesAmt" scale="6" id="f-6132">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1709" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:num-dot-decimal" scale="0" id="f-6133">1,802</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1710" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6134">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1710" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6135">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1711" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6136">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1711" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6137">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1712" decimals="-5" name="cef:SeniorSecuritiesAmt" format="ixt:fixed-zero" scale="6" id="f-6138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1712" decimals="1" name="cef:SeniorSecuritiesCvgPerUnit" format="ixt:fixed-zero" scale="6" id="f-6139">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Total amount of each class of senior securities outstanding at the end of the period presented.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Asset coverage per unit is the ratio of the carrying value of our total assets, less all liabilities excluding indebtedness represented by senior securities in this table, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The amount to which such class of senior security would be entitled upon our involuntary liquidation in preference to any security junior to it. The &#8220;-&#8221; in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Not applicable because the senior securities are not registered for public trading.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The Subscription Facility was terminated on November 3, 2020.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The 2023 Notes matured on July 14, 2023 and were paid off consistent with the terms of the 2023 Notes Indenture.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">209</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_190"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Blackstone Secured Lending Fund</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data, percentages and as otherwise noted)</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12. <ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-6140" continuedAt="f-6140-1" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="f-6140-1"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management evaluated subsequent events through the date of issuance of the consolidated financial statements.&#160;There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of December&#160;31, 2023, except as discussed below.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;28, 2024 the Board declared a distribution of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1713" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-6141">0.77</ix:nonFraction> per share, which is payable on April 26, 2024, to shareholders of record as of March 31, 2024.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">210</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_193"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are not and have not been any disagreements between the Company and its accountant on any matter of accounting principles, practices, or financial statement disclosure.</span></div><div id="i33edc808e7824948b94b269ed713a939_196"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A. Controls and Procedures.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a) Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), that are designed to ensure that information required to be disclosed in the company&#8217;s reports under the Exchange Act is recorded, processed, and summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to the Company&#8217;s management, including its Co-Chief Executive Officers and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. An evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Annual Report on Form 10-K was made under the supervision and with the participation of our management, including our Co-Chief Executive Officers and Chief Financial Officer. Based upon this evaluation, our Co-Chief Executive Officers and Chief Financial Officer have concluded that our disclosure controls and procedures are (a) effective to ensure that information required to be disclosed by us in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by SEC rules and forms and (b) include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b) Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act). Our internal control over financial reporting is a process designed under the supervision of our Co-Chief Executive Officers and Chief Financial Officer to provide reasonable assurance regarding the reliability of financial reporting and the preparation of its consolidated financial statements for external reporting purposes in accordance with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our internal control over financial reporting includes policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect transactions and dispositions of assets of the Company; provide reasonable assurances that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with authorizations of the Company&#8217;s management and directors; and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on its financial statements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management conducted an assessment of the effectiveness of our internal control over financial reporting as of December&#160;31, 2023, based on the framework established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control&#8212;Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this assessment, management has determined that our internal control over financial reporting as of December&#160;31, 2023 was effective.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(c) Attestation Report of the Registered Public Accounting Firm</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent registered public accounting firm, Deloitte &amp; Touche LLP, has issued an attestation report on the effectiveness of our internal control over financial reporting which is included herein. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">211</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(d) Changes in Internal Controls Over Financial Reporting</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="i33edc808e7824948b94b269ed713a939_202"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B. Other Information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 13(r) Disclosure</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012, which added Section 13(r) of the Exchange Act, we hereby incorporate by reference herein Exhibit 99.1 of this report, which includes disclosures regarding activities at Mundys S.p.A., formerly &#8220;Atlantia S.p.A.,&#8221; which may be, or may have been at the time considered to be, an affiliate of Blackstone and, therefore, our affiliate.</span></div><div id="i33edc808e7824948b94b269ed713a939_205"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">212</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_208"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i33edc808e7824948b94b269ed713a939_211"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10. Directors, Executive Officers and Corporate Governance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and affairs are managed under the direction of the Board.&#160;The responsibilities of the Board include, among other things, the oversight of our investment activities, the quarterly and non-quarterly valuation of our assets, oversight of our financing arrangements and corporate governance activities.&#160;Our Board consists of seven members, five of whom are not &#8220;interested persons&#8221; of the Company or of the Adviser as defined in Section 2(a)(19) of the 1940 Act and are &#8220;independent,&#8221; as determined by the Board.&#160;These individuals are referred to as independent trustees.&#160;Our Board elects the Company&#8217;s executive officers, who serve at the discretion of the Board.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 18, 2021, the Board was divided into three classes, with the members of each class serving staggered, three-year terms. The terms of our Class I trustees will expire at the 2025 annual meeting of shareholders;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the terms of our Class II trustees will expire at the 2026 annual meeting of shareholders; and the terms of our Class III trustees will expire at the 2024 annual meeting of shareholders. On September 15, 2023, the Company held its 2023 annual meeting of shareholders, at which, among other things, our Class II trustees were elected to the Board to serve as trustees until the later of the Company&#8217;s 2026 annual meeting of shareholders or until their successors have been duly elected and qualified.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trustees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the Board is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year of Birth</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trustee Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trustee Since</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interested Trustee:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brad Marshall</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1972</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee, Chairperson, and Co-Chief Executive Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class III</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vikrant Sawhney</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1970</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class I</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Independent Trustees:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert Bass</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1949</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class II</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tracy Collins</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1963</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class III</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vicki Fuller</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1957</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class I</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James F. Clark</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1961</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class I</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michelle Greene</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1969</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class II</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The address for each of our trustees is c/o Blackstone Credit BDC Advisors LLC, 345 Park Avenue, 31st Floor, New York, NY 10154.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Officers Who are Not Trustees</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.340%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year of Birth</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Officer Since</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan Bock</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1982</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carlos Whitaker</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1976</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teddy Desloge</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1988</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Katherine Rubenstein</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1978</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Alcide</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1987</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer and Treasurer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023 (CAO);</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 (Treasurer)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oran Ebel</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1979</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Legal Officer and Secretary</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William Renahan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1969</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Compliance Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stacy Wang</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1989</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Head of Stakeholder Relations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">213</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trustees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our trustees have been divided into two groups&#8212;interested trustees and independent trustees. An interested trustee is an &#8220;interested person&#8221; as defined in Section&#160;2(a)(19) of the 1940 Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interested Trustees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Brad Marshall (Portfolio Manager)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Trustee, Chairperson and Co-Chief Executive Officer of the Company, Global Head of Private Credit Strategies and Senior Managing Director of Blackstone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Marshall is Co-CEO of both BXSL and Blackstone Private Credit Fund (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BCRED&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Marshall also sits on the various investment committees of Blackstone Credit &amp; Insurance. Before joining Blackstone Credit &amp; Insurance in 2005, Mr. Marshall worked in various roles at RBC, including fixed income research and business development within RBC&#8217;s private equity funds effort. Prior to RBC, Mr. Marshall helped develop a private equity funds business for TAL Global, a Canadian asset management division of CIBC, and prior to that, he co-founded a microchip verification software company where he served as Chief Financial Officer. Mr. Marshall received an M.B.A. from McGill University in Montreal and a B.A. (Honors) in Economics from Queen&#8217;s University in Kingston, Canada. Mr. Marshall also serves on the board of trustees of BCRED.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vikrant Sawhney</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trustee of the Company and Senior Managing Director, Chief Administrative Officer of Blackstone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Sawhney currently serves as Chief Administrative Officer and Global Head of Institutional Client Solutions of Blackstone Inc., an affiliate of the Adviser. Since joining Blackstone in 2007, Mr. Sawhney started Blackstone Capital Markets and also served as the Chief Operating Officer of the Private Equity group. Before joining Blackstone, Mr. Sawhney worked as a Managing Director in the Financial Sponsors Group at Deutsche Bank, and prior to that was an Associate at the law firm Simpson Thacher &amp; Bartlett LLP. Mr. Sawhney represented Blackstone as a Rockefeller Fellow during 2010-2011, and currently sits on the board of the Blackstone Charitable Foundation. He is also the Board Chair of Dream, an east Harlem-based educational and social services organization. He graduated from Dartmouth College and received a J.D. from Harvard Law School. Mr. Sawhney also serves on the board of trustees of BCRED.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Trustees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Robert Bass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Mr. Bass has served on the board of Groupon, Inc. since June 2012. He served as a Vice Chairman of Deloitte &amp; Touche LLP from 2006 through June 2012, and was a Partner in Deloitte from 1982 through June 2012, where he specialized in e-commerce, mergers and acquisitions, SEC filings and related issues. At Deloitte, Mr. Bass was responsible for all services provided to Forstmann Little and its portfolio companies and was the advisory partner for Blackstone, DIRECTV, 24 Hour Fitness, McKesson, IMG and CSC. In addition, he has been an advisory partner for RR Donnelley, Automatic Data Processing, Community Health Systems, and Avis Budget. Mr. Bass has served on the board of directors of Sims Metal Management (ASX: SGM.AX) and as a member of the risk and audit committee from September 2013 to December 31, 2018, including as Chairman of the risk and audit committee from November 2014, the board of directors and as a member of the audit committee of Apex Tool Group, LLC since December 2014, including as Chairman of the audit committee since April 2015, the board of directors and as Chairman of the audit committee of New Page Corporation from January 2013 (emergence from chapter XI) to January 2015 (sale of the company), and the board of directors and as Chairman of the audit committee of Redfin Corporation (NASDAQ: RDFN) since October 2016. Mr. Bass served on the board of directors of Bowlero Corporation and as the Chairman of the audit committee starting in December 2021. Mr. Bass is a certified public accountant licensed in New York and Connecticut. He is a member of the American Institute of Certified Public Accountants and the Connecticut State Society of Certified Public Accountants. Mr. Bass also serves on the board of trustees of BCRED.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tracy Collins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Ms. Collins is an independent finance professional and most recently served as CEO to SmartFinance LLC (2013-2017), a Fintech startup purchased by MidFirst Bank in December of 2017. During her career in financial services, Ms. Collins worked as a Senior Managing Director (Partner) and Head of Asset-Backed Securities Research at Bear Stearns &amp; Co., Inc. for six years and prior to that as a Managing Director (Partner) and Head of Asset-Backed Securities and Structured Products at Credit Suisse (formerly known as Credit Suisse First Boston) for nine years. During her tenure as a structured product specialist, Ms. Collins was consistently recognized as a &#8220;First Team All American Research Analyst.&#8221; Ms. Collins served as an independent director for KKR Financial from August 2006 to May 2014. She graduated from the University of Texas at Austin in the Plan II Honors Program. Ms. Collins&#8217; spouse is the founder, managing partner and co-Chief Investment Officer of Good Hill Partners LP (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Good Hill&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Good Hill is a registered investment adviser that manages various types of collective investment vehicles and investment accounts. Affiliates of the Adviser (but not the Adviser) have invested on behalf of their clients in Good Hill-managed vehicles or accounts since 2010, and the amount of such investment is material to Good Hill. Ms. Collins also serves on the board of trustees of BCRED.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">214</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vicki Fuller,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Ms. Fuller is founder and CEO of VLF Development LLC, where she oversees the execution of complex institutional advisory assignments. She previously has served as a Director of The Williams Companies, Inc. from 2018 to 2021, which she joined after retirement from the New York State Common Retirement Fund (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;NYSCRF&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), where she served as Chief Investment Officer from 2012 to 2018. NYSCRF is the third largest public pension fund in the nation and holds and invests the assets of the New York State and Local Retirement System on behalf of more than one million state and local government employees and retirees and their beneficiaries. Prior to joining NYSCRF, Ms. Fuller spent 27 years in leadership positions at AllianceBernstein Holding L.P., a global investment manager with more than $500 billion in assets under management. Ms. Fuller joined the company in 1993 from the Equitable Capital Management Corporation, which was acquired by Alliance Capital Management LP (in 2000, the company became AllianceBernstein LP after the company acquired Sanford C. Bernstein). In 2021, Ms. Fuller was appointed to the board of directors of Gusto, a company that provides cloud-based payroll, benefits and human resource management software for businesses. In 2019, Ms. Fuller was appointed to the board of directors of Treliant, LLC, an international multi-industry consulting firm specializing in regulatory requirements. In 2018, Ms. Fuller was appointed to the board of trustees for Fidelity Equity and High Income Funds. Ms. Fuller, who was inducted into the National Association of Securities Professionals Wall Street Hall of Fame, was named to Chief Investment Officer Magazine&#8217;s &#8220;Power 100&#8221; and received the Urban Technology Center&#8217;s Corporate Leadership Award. She has also been named one of the most powerful African Americans on Wall Street by Black Enterprise. In 2023, Ms. Fuller was appointed to the board of trustees of the Robert Wood Johnson Foundation. She has also been named one of the most powerful African Americans on Wall Street by Black Enterprise. Ms. Fuller also serves on the board of trustees of BCRED.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">James F. Clark</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Mr. Clark has served as a Partner with Sound Shore Management, Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Sound Shore&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which he joined in 2004. At Sound Shore, Mr. Clark is a generalist on the investment team, responsible for the firm&#8217;s investments in energy, industrials, materials, and utilities. His tenure also includes heading Sound Shore&#8217;s Environmental, Social, and Governance (ESG) Committee and having served on its Investment Committee and operating committee. Previously, Mr. Clark worked at Credit Suisse First Boston (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;CSFB&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) from 1984 to 2004, most recently as a Managing Director from 1996 to 2004. At CSFB, Mr. Clark served as Head of US Equity Research, from 2000-2004, and as the firm&#8217;s International and Domestic Oil Analyst, from 1989-2000. Mr. Clark was selected to Institutional Investor magazine&#8217;s All America Research teams, 1993-1999. Mr. Clark was also named a Wall Street Journal All-Star Analyst, for both International and Domestic Oils from 1993-1999. Mr. Clark was also recognized by the Wall Street Journal as an All-Star Analyst from 1994 to 1999, and named to that newspaper&#8217;s All-Star Analyst Hall of Fame in 1998 and 1999. Mr. Clark has an M.B.A. from Harvard University and a B.A. from Williams College, cum laude and with highest honors. Mr. Clark also served as a winter adjunct faculty member at Williams College, 2020-2021. Mr. Clark brings a broad range of knowledge and experience with investing in and analyzing securities investments, and his experience managing investments is a significant resource for the Company. Mr. Clark also serves on the board of trustees of BCRED.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Michelle Greene</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Ms. Greene is President Emeritus and a board member and Advisor to the Long-Term Stock Exchange (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LTSE&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), a venture-backed, SEC-approved National Market System exchange with listing standards designed to support companies seeking to partner with long-term shareholders, engage a broad group of stakeholders and build their businesses over time. In this role, she provides guidance to executives on governance and policy issues, including related to ESG, the role of the board, long-term investor and stakeholder engagement and IPOs. She also is on the board of directors and a Fellow at the Aspen Institute Business &amp; Society Program, which works with executives, investors, and scholars to align business decisions and investments with the long-term health of society and the planet. Prior to LTSE, Ms. Greene was Senior Vice President and Head of Global Corporate Responsibility at the New York Stock Exchange (NYSE), where she launched and led its global ESG team, advised Fortune 500 companies on sustainability programs and served as Executive Director of the NYSE Foundation. Previously, she served at the U.S. Department of the Treasury under two administrations, working on financial markets policy, including government response to the 2008 financial crisis and policy development on financial inclusion. Ms. Greene was also a Consultant at McKinsey &amp; Company and led the Carr Center for Human Rights Policy at Harvard University, having begun her career as a corporate securities lawyer. Ms. Greene has been a member of recent Aspen Institute working groups on employee voice on corporate boards and executive compensation and previously served on World Economic Forum advisory boards on financial inclusion and gender parity. She was previously Executive Director of the President&#8217;s Advisory Council on Financial Literacy and Financial Inclusion, a member of the White House Council on Women and Girls and an adjunct professor at Columbia University&#8217;s School of International and Public Affairs. Ms. Greene graduated from Dartmouth College and received a J.D. from Harvard Law School. Ms. Greene also serves on the board of trustees of BCRED.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">215</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Officers Who Are Not Trustees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Jonathan Bock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Co-Chief Executive Officer of the Company and Global Head of Market Research of Blackstone Credit &amp; Insurance and Senior Managing Director of Blackstone.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prior to joining Blackstone, Mr. Bock was the Chief Executive Officer of Barings BDC. In addition to this role, he served as the Co-Chief Executive Officer and President of Barings Private Credit Corporation, and Chief Financial Officer of Barings Capital Investment Corporation, Barings Corporate Investors, and Barings Participation Investors. Prior to joining Barings in July 2018, Mr. Bock was a Managing Director and Senior Equity Analyst at Wells Fargo Securities specializing in BDCs. He was the chief author of a leading BDC quarterly research publication: the BDC Scorecard. He is also published in the Journal of Alternative Investments. Prior to Wells Fargo, Mr. Bock followed the BDC industry at Stifel Nicolaus &amp; Company and A.G. Edwards Inc. Prior to entering sell-side research in 2006, Mr. Bock was an equity portfolio manager/analyst at Busey Wealth Management in Champaign, Illinois. Mr. Bock holds a Bachelor of Science in finance from the University of Illinois College of Business and is a member of the CFA Institute. Mr. Bock also serves as the Co-Chief Executive Officer of BCRED.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Carlos Whitaker</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> President of the Company and Senior Managing Director of Blackstone. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before joining Blackstone Credit &amp; Insurance, Mr. Whitaker had a 21-year career at Credit Suisse where he was a Managing Director and senior executive in the Global markets division. Mr. Whitaker is a member of the McCombs School of Business Advisory Council at the University of Texas at Austin. Mr. Whitaker also sits on the boards of New York for McCombs and Rising Stars Capital Management, which is a nonprofit focused on improving diversity in the finance industry. Mr. Whitaker received a Bachelor of Arts from the Plan II Honors Program, a Bachelor of Business Administration in Accounting, and a Master of Professional Accounting from the University of Texas at Austin, where he graduated with honors. Mr. Whitaker also serves as the President of BCRED.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Teddy Desloge (Portfolio Manager)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chief Financial Officer of the Company and Managing Director of Blackstone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Desloge is involved with investment management for Blackstone Credit &amp; Insurance&#8217;s various direct lending vehicles. Since joining Blackstone Credit &amp; Insurance in 2015, Mr. Desloge has focused on origination, research, and execution of private and opportunistic credit investments across industries, and supporting Blackstone Credit &amp; Insurance&#8217;s Private Credit Strategies. Before joining Blackstone Credit &amp; Insurance in 2015, Mr. Desloge was an Associate at Gefinor Capital where he focused on origination, research and execution of private credit and equity investments. He started his career in the Leveraged Finance Group at Jefferies. Mr. Desloge graduated from Hobart &amp; William Smith Colleges with a B.A. and a major in Economics. Mr. Desloge also serves as the Chief Financial Officer of BCRED.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Katherine Rubenstein</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chief Operating Officer of the Company and Managing Director of Blackstone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Since joining Blackstone in 2015, Ms. Rubenstein created and led the GSO Advantage platform (now Blackstone Credit &amp; Insurance Value Creation), which brings Blackstone&#8217;s broad set of capabilities to drive operational efficiencies and growth for Blackstone Credit &amp; Insurance&#8217;s portfolio companies. She subsequently created and led the Blackstone Credit &amp; Insurance Value Creation Program, focusing on building networks and expanding access to resources for portfolio companies across Blackstone business units. Ms. Rubenstein is on the Blackstone Charitable Foundation Leadership Council and on the board of Let&#8217;s Get Ready, a non-profit organization that provides low-income and first generation to college students support to gain admission to and graduate from college. Before joining Blackstone, Ms. Rubenstein originated senior secured loans and equipment finance opportunities in the industrial, consumer, and retail sectors for GE Capital and prior to that worked in brand management at World Kitchen. Ms. Rubenstein received an M.B.A. from The Johnson Graduate School of Management at Cornell University, where she was a Roy H. Park Leadership Fellow, and an A.B. from Dartmouth College. Ms. Rubenstein also serves as the Chief Operating Officer of BCRED.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Matthew Alcide</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chief Accounting Officer and Treasurer of the Company and Senior Vice President of Blackstone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Alcide is a member of the Blackstone Credit &amp; Insurance BDC Finance Group where he oversees the accounting and financial reporting for Blackstone&#8217;s BDCs. Prior to joining Blackstone, Mr. Alcide was a Director in the New York and London offices of PricewaterhouseCoopers where he provided assurance and accounting services to companies and investment funds across the asset management, investment banking and broker-dealer industries with a focus on SEC registrants and other publicly traded entities. Mr. Alcide graduated magna cum laude from Providence College with a B.S. in Accounting. Mr. Alcide is a Certified Public Accountant licensed in the State of New York. Mr. Alcide also serves as the Chief Accounting Officer and Treasurer of BCRED.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">216</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Oran Ebel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chief Legal Officer and Secretary of the Company and Managing Director of Blackstone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Ebel is Deputy General Counsel of Blackstone Credit &amp; Insurance and a Managing Director in Blackstone&#8217;s Legal &amp; Compliance Group. Mr. Ebel oversees legal matters relating to Blackstone Credit &amp; Insurance&#8217;s BDCs, is responsible for legal matters relating to Blackstone Credit &amp; Insurance&#8217;s Private Credit investments and plays a key role overseeing other legal functions relating to Blackstone&#8217;s Credit business. Prior to joining Blackstone in 2013, Mr. Ebel was an associate in the Finance Group of Debevoise &amp; Plimpton LLP in New York. Mr. Ebel received an A.B., cum laude, from Princeton University and a J.D., cum laude, from New York University School of Law. Mr. Ebel also serves as the Chief Legal Officer and Secretary of BCRED.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">William Renahan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Chief Compliance Officer of the Company and Managing Director of Blackstone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to joining Blackstone in 2022, Mr. Renahan had been working in the Investment Management industry for over 25 years. He has previously been an associate in the New York office of Battle Fowler LLP (which subsequently &#8220;merged&#8221; into Paul Hastings LLP). He also served for approximately 13 years at Legg Mason and predecessor firms as a Managing Director and Senior Counsel. Mr. Renahan&#8217;s position immediately prior to joining Blackstone was Senior Managing Director and Chief Compliance Officer of Duff &amp; Phelps Investment Management and its affiliated funds. Mr. Renahan has been an active member of the Investment Company Institute and served as Chairman of the ICI&#8217;s Closed-end Fund Committee from 2014&#8212;2018. He holds a B.A. from Hobart College, a J.D., cum laude, from Albany Law School (where he was also an editor of the Albany Law Review), and a Master of Laws in Taxation from New York University School of Law. Mr. Renahan also serves as the Chief Compliance Officer of BCRED.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stacy Wang</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Head of Stakeholder Relations of the Company and Managing Director of Blackstone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to her current role, Ms. Wang focused on fundraising, product strategy, and client relationships across private and opportunistic credit products for institutional and retail investors in Blackstone Credit &amp; Insurance products. Prior to joining Blackstone Credit &amp; Insurance in 2015, Ms. Wang worked as an Investment Banking Associate at Natixis, where she focused on leveraged finance and M&amp;A transactions. Ms. Wang graduated from the Stern School of Business at New York University with a B.S. in Finance and Journalism. Ms. Wang also serves as the Head of Stakeholder Relations of BCRED.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership Structure</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and affairs are managed under the direction of our Board. Among other things, our Board sets broad policies for us and approves the appointment of our investment adviser, administrator and officers. The role of our Board, and of any individual Trustee, is one of oversight and not of management of our day-to-day affairs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our bylaws, our Board may designate one of our Trustees as chair to preside over meetings of our Board and meetings of shareholders, and to perform such other duties as may be assigned to him or her by our Board. The Board has appointed Brad Marshall to serve in the role of chairperson of the Board. The chairperson&#8217;s role is to preside at all meetings of the Board and to act as a liaison with the Adviser, counsel and other Trustees generally between meetings. The chairperson serves as a key point person for dealings between management and the Trustees. The chairperson also may perform such other functions as may be delegated by the Board from time to time. The Board reviews matters related to its leadership structure annually. The Board has determined that its leadership structure is appropriate because it allows the Board to exercise informed and independent judgment over the matters under its purview and it allocates areas of responsibility among committees of Trustees and the full board in a manner that enhances effective oversight.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board believes that its leadership structure is the optimal structure for us at this time. Our Board, which will review its leadership structure periodically as part of its annual self-assessment process, further believes that its structure is presently appropriate to enable it to exercise its oversight of us.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board&#8217;s Role in Risk Oversight</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board performs its risk oversight function primarily through (i) its standing committees, which report to the entire Board and are comprised solely of independent Trustees, and (ii) active monitoring of our chief compliance officer and our compliance policies and procedures. Oversight of other risks is delegated to the committees.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">217</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Oversight of our investment activities extends to oversight of the risk management processes employed by the Adviser as part of its day-to-day management of our investment activities. The Board anticipates reviewing risk management processes at both regular and special board meetings throughout the year, consulting with appropriate representatives of the Adviser as necessary and periodically requesting the production of risk management reports or presentations. The goal of the Board&#8217;s risk oversight function is to ensure that the risks associated with our investment activities are accurately identified, thoroughly investigated and responsibly addressed. Investors should note, however, that the Board&#8217; oversight function cannot eliminate all risks or ensure that particular events do not adversely affect the value of investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the role of our Board in risk oversight is effective and appropriate given the extensive regulation to which we are already subject as a BDC. As a BDC, we are required to comply with certain regulatory requirements that control the levels of risk in our business and operations. For example, we are limited in our ability to enter into transactions with our affiliates, including investing in any portfolio company in which one of our affiliates currently has an investment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Governance</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Committees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has an Audit Committee, a Nominating and Governance Committee and a Compensation Committee and may form additional committees in the future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit Committee</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee is composed of Robert Bass, Tracy Collins, Vicki Fuller, James F. Clark and Michelle Greene, each of whom is not considered an &#8220;interested person&#8221; of the Company as that term is defined in Section&#160;2(a)(19) of the 1940 Act.&#160;Robert Bass serves as Chair of the Audit Committee.&#160;Our Board determined that Robert Bass is an &#8220;audit committee financial expert&#8221; as that term is defined under Item&#160;407 of Regulation&#160;S-K, as promulgated under the 1934 Act.&#160;The Audit Committee members meet the current independence and experience requirements of Rule&#160;10A-3 of the 1934 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with its written charter adopted by the Board, the Audit Committee (a)&#160;assists the Board&#8217;s oversight of the integrity of our financial statements, the independent registered public accounting firm&#8217;s qualifications and independence, our compliance with legal and regulatory requirements and the performance of our independent registered public accounting firm; (b)&#160;prepares an Audit Committee report, if required by the SEC, to be included in our annual proxy statement, if any; (c)&#160;oversees the scope of the annual audit of our financial statements, the quality and objectivity of our financial statements, accounting and financial reporting policies and internal controls; (d)&#160;determines the selection, appointment, retention and termination of our independent registered public accounting firm, as well as approving the compensation thereof; (e)&#160;pre-approves all audit and non-audit services provided to us and certain other persons by such independent registered public accounting firm; and (f)&#160;acts as a liaison between our independent registered public accounting firm and the Board.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nominating and Governance Committee</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating Committee is composed of Robert Bass, Tracy Collins, Vicki Fuller, James F. Clark, and Michelle Greene, each of whom is not considered an &#8220;interested person&#8221; of the Company as that term is defined in Section&#160;2(a)(19) of the 1940 Act. Tracy Collins serves as Chair of the Nominating Committee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with its written charter adopted by the Board, the Nominating Committee recommends to the Board persons to be nominated by the Board for election at the Company&#8217;s meetings of our shareholders, special or annual, if any, or to fill any vacancy on the Board that may arise between shareholder meetings.&#160;The Nominating Committee also makes recommendations with regard to the tenure of the trustees and is responsible for overseeing an annual evaluation of the Board and its committee structure to determine whether the structure is operating effectively.&#160;The Nominating Committee will consider for nomination to the Board candidates submitted by our shareholders or from other sources it deems appropriate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Committee</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee is composed of Robert Bass, Tracy Collins, Vicki Fuller, James F. Clark, and Michelle Greene, each of whom is not considered an &#8220;interested person&#8221; of the Company as that term is defined in Section 2(a)(19) of the 1940 Act. Vicki Fuller serves as Chair of the Compensation Committee.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">218</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee is responsible for annually reviewing and recommending for approval to the Board the Investment Advisory Agreement and the Administration Agreement. The Compensation Committee is also responsible for reviewing and approving the compensation of the independent trustees. In addition, although we do not directly compensate our executive officers currently, to the extent that we do so in the future, the Compensation Committee would also be responsible for reviewing and evaluating their compensation and making recommendations to the Board regarding their compensation. Lastly, the Compensation Committee would produce a report on our executive compensation practices and policies for inclusion in our proxy statement if required by applicable proxy rules and regulations and, if applicable, make recommendations to the Board on our executive compensation practices and policies. The Compensation Committee has the authority to engage compensation consultants and to delegate their duties and responsibilities to a member or to a subcommittee of the Compensation Committee. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Communications to the Board of Trustees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The independent trustees serving on our Board intend to meet in executive sessions at the conclusion of or preceding each regularly scheduled meeting of the Board, and additionally as needed, without the presence of any directors or other persons who are part of our management.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders and other interested parties may contact any member (or all members) of the Board by mail. To communicate with the Board, any individual trustees or any group or committee of trustees, correspondence should be addressed to the Board or any such individual trustees or group or committee of trustees by either name or title. The address for each of our trustees is c/o Blackstone Credit BDC Advisors LLC, 345 Park Avenue, 31st Floor, New York, NY 10154. Any communication to report potential issues regarding accounting, internal controls and other auditing matters will be directed to the Audit Committee. Appropriate Company personnel will review and sort through communications before forwarding them to the addressee(s).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Ethics</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a code of ethics pursuant to Rule 17j-1 under the 1940 Act that establishes procedures for personal investments and restricts certain personal securities transactions. Personnel subject to each code can invest in securities for their personal investment accounts, including securities that can be purchased or held by us, so long as such investments are made in accordance with the code&#8217;s requirements. You can view the code of ethics on the SEC&#8217;s website at www.sec.gov.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollar Range of Equity Securities Beneficially Owned by Directors</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the dollar range of equity securities of the Company beneficially owned by each trustee as of February&#160;20, 2024:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollar Range of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in the Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollar Range of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in the Fund Complex </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interested Trustees</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brad Marshall</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">over $100,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">over $100,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vikrant Sawhney</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">over $100,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Independent Trustees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert Bass</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">over $100,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">over $100,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tracy Collins</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vicki Fuller</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James F. Clark</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">over $100,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michelle Greene</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Dollar ranges are as follows: none, $1 &#8211; $10,000, $10,001 &#8211; $50,000, $50,001 &#8211; $100,000, or over $100,000.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Dollar ranges were determined using the number of shares that are beneficially owned as of February&#160;20, 2024, multiplied by the Company&#8217;s net asset value per share as of December&#160;31, 2023.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The &#8220;Fund Complex&#8221; consists of the Company, Blackstone Private Credit Fund, the Blackstone Credit &amp; Insurance Closed-End Funds (Blackstone Senior Floating Rate Term Fund, Blackstone Long-Short Credit Income Fund, Blackstone Strategic Credit Fund and Blackstone Floating Rate Enhanced Income Fund) and Blackstone Alternative Multi-Strategy Fund.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">219</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_214"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11. Executive Compensation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Compensation </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of our executive officers will receive direct compensation from us.&#160;We will reimburse the Administrator the allocable portion of the compensation paid by the Administrator (or its affiliates) to our chief compliance officer and chief financial officer and their respective staffs as well as other administrative personnel (based on the percentage of time such individuals devote, on an estimated basis, to our business and affairs).&#160;The members of the Investment Committee, through their financial interests in the Adviser, are entitled to a portion of the profits earned by the Adviser, which includes any fees payable to the Adviser under the terms of the Investment Advisory Agreement, less expenses incurred by the Adviser in performing its services under the Investment Advisory Agreement.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, we are prohibited under the 1940 Act from issuing equity incentive compensation, including stock options, stock appreciation rights, restricted stock and stock, to our officers, directors and employees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trustee Compensation </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No compensation is paid to our trustees who are &#8220;interested persons,&#8221; as such term is defined in Section&#160;2(a)(19)&#160;of the 1940 Act.&#160;Effective February 23, 2022, we pay each independent trustee: (i) $150,000 per year (prorated for any partial year), (ii) $2,500 for each regular meeting of the Board attended, (iii) $1,000 for each committee meeting attended (in addition to regular meeting fees to the extent committees meet on regular meeting dates) and (iv) $10,000 per year for the Chairman of the Audit Committee. We are also authorized to pay the reasonable out-of-pocket expenses of each independent trustee incurred by such trustee in connection with the fulfillment of his or her duties as an independent trustee.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Compensation earned from the Company for Fiscal Year 2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Compensation earned from Fund Complex for Fiscal Year 2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interested Trustees</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brad Marshall </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vikrant Sawhney </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Independent Trustees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert Bass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tracy Collins</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vicki Fuller</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James F. Clark</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michelle Greene</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">These are interested trustees and, as such, do not receive compensation from the Company or the Fund Complex for their services as trustees.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Includes compensation as Chairman of the Audit Committee.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The Company does not have a profit-sharing plan, and trustees do not receive any pension or retirement benefits from the Company.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The Blackstone Credit &amp; Insurance Closed-End Funds and Blackstone Alternative Multi Strategy Fund do not pay compensation to the trustees of the Company. Blackstone Private Credit Fund does pay compensation to the Independent Trustees of the Company.</span></div><div id="i33edc808e7824948b94b269ed713a939_217"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, as</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of February&#160;20, 2024, the beneficial ownership of each current trustee, the Company&#8217;s executive officers, each person known to us to benefici</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ally own 5% or more of the outstanding shares, and the executive officers and trustees as a group. Percentage of beneficial ownership is based on 191,600,986 shares outstanding as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;20, 2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the shares. Ownership information for those persons who beneficially own 5% or more of our shares is based upon filings by such persons with the SEC and other information obtained from such persons, if available.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">220</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated, we believe that each beneficial owner set forth in the table has sole voting and investment power and has the same address as the Company. Our trustees are divided into two groups&#8212;interested and independent. Interested trustees are &#8220;interested persons&#8221; of the Company or the Adviser as defined in Section 2(a)(19) of the 1940 Act. Unless otherwise indicated, the address of all executive officers and trustees is 345 Park Avenue, 31st Floor, New York, New York 10154.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.529%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Type of Ownership</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares Owned</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interested Trustees</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brad Marshall</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Record/Beneficial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,284</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vikrant Sawhney</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Independent Trustees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert Bass</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Record/Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,640</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tracy Collins</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vicki Fuller</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James F. Clark</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michelle Greene</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Officers Who Are Not Directors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan Bock</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carlos Whitaker</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Record/Beneficial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,895</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teddy Desloge</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Katherine Rubenstein</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Record/Beneficial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,839</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Alcide</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oran Ebel</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William Renahan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stacy Wang</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Record/Beneficial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,708</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Trustees and Executive Officers as a Group (15 persons)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,366</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Five-Percent Shareholder</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greenwich Venture Capital LLC </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Record/Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,595,999</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">QIA FIG Glass Holding Limited </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Record/Beneficial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,723,035</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Amounts round to less than 1%</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:107%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:107%;padding-left:17.68pt">Beneficial ownership information is based on information contained in the Schedule 13G/A filed on February 14, 2024 jointly by Greenwich Venture Capital LLC (&#8220;Greenwich Venture&#8221;), Locust Street Associates GP, LLC (&#8220;Locust Street&#8221;) and Michael Karp. According to the schedule, 12,595,999 of our Common Shares are held directly by Greenwich Venture. Locust Street is the sole member of Greenwich Venture.&#160;Mr. Karp is the sole member of Locust Street. Locust Street and Mr. Karp may be deemed to beneficially own the Common Shares held directly by Greenwich Venture. Included in the Number of Shares Owned listed above as beneficially owned by Mr. Karp are 12,595,999 shares over which Mr. Karp has shared voting power, and 12,595,999 shares over which Mr. Karp has shared dispositive power. In addition to the shares of our Common Shares listed above, Mr. Karp directly holds 3,275,976 shares over which Mr. Karp has sole voting and dispositive power. The address of each of the above is 1062 Lancaster Avenue, Suite 30B, Bryn Mawr, PA 19010.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:107%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:107%;padding-left:17.68pt">The address for QIA FIG Glass Holding Limited is Ooredoo Tower (Building 14), Al Dafna Street (Street 801), Al Dafna (Zone 61), Doha, State of Qatar</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">221</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_220"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13. Certain Relationships and Related Transactions, and Director Independence.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transactions with Related Persons</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Advisory Agreement; Administration Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into the Investment Advisory Agreement with the Adviser pursuant to which we pay the Adviser a management fee at an annual rate of (i) prior to an Exchange Listing, 0.75%, and (ii) following an Exchange Listing, 1.0%, in each case of the average value of our gross assets at the end of the two most recently completed calendar quarters, and a two-part incentive fee based on (i) the amount by which our pre-incentive fee net investment income returns exceed a certain &#8220;hurdle rate&#8221; and (ii) our capital gains. In addition, pursuant to the Investment Advisory Agreement and the Administration Agreement, we will reimburse the Adviser and Administrator for certain expenses as they occur. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Business&#8212;Investment Advisory Agreement,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Business&#8212;Administration Agreement,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Business&#8212;Payment of Our Expenses under the Investment Advisory and Administration Agreements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; Each of the Investment Advisory Agreement and the Administration Agreement has been approved by the Board. Unless earlier terminated, each of the Investment Advisory Agreement and the Administration Agreement will remain in effect for a period of two years from the date it first became effective and will remain in effect from year-to-year thereafter if approved annually by a majority of the Board, including a majority of independent trustees, or by the holders of a majority of our outstanding voting securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the years ended December&#160;31, 2023, 2022 and 2021, base management fees were $98.1 million, $101.7 million and $62.4 million, respectively, of which $20.2 million, $25.4 million and $4.2 million, respectively, were waived. As of December&#160;31, 2023 and December&#160;31, 2022, $23.0 million and $18.6 million, respectively, was payable to the Adviser relating to management fees. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, the Company accrued income based incentive fees of $134.2&#160;million, $97.2&#160;million and $67.3&#160;million, respectively, of which $15.6 million, $13.9 million and $2.3 million, respectively, were waived. As of December&#160;31, 2023 and December&#160;31, 2022, $34.4&#160;million and $24.8&#160;million, respectively was payable to the Adviser for income based incentive fees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023 and 2022 the Company reversed previously accrued capital gains incentive fees of $(5.5)&#160;million, $(11.9)&#160;million, respectively as a result of changes in net realized and unrealized losses for these years. For the year ended December&#160;31, 2021, the Company accrued capital gains incentive fees of $16.3&#160;million. As of December&#160;31, 2023 and December&#160;31, 2022, no amount was payable to the Adviser for capital gains based incentive fees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, the Company incurred $2.2&#160;million, $2.7&#160;million and $2.4&#160;million, respectively, under the Administration Agreement, which were recorded in administrative service fees in the Company&#8217;s Consolidated Statements of Operations. As of December&#160;31, 2023 and December&#160;31, 2022, $1.1&#160;million and $1.2&#160;million, respectively, was unpaid and included in due to affiliate in the Consolidated Statements of Assets and Liabilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Co-Investment Relief</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in the past co-invested, and in the future may co-invest, with certain affiliates of the Adviser.&#160;We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions. Pursuant to such order, the Company's Board has established Board Criteria clearly defining co-investment opportunities in which the Company will have the opportunity to participate with one or more Blackstone Credit &amp; Insurance BDCs and other public or private Blackstone Credit &amp; Insurance funds that target similar assets. If an investment falls within the Board Criteria, Blackstone Credit &amp; Insurance must offer an opportunity for the Blackstone Credit &amp; Insurance BDCs to participate.&#160;The Blackstone Credit &amp; Insurance BDCs may determine to participate or not to participate, depending on whether Blackstone Credit &amp; Insurance determines that the investment is appropriate for the Blackstone Credit &amp; Insurance BDCs (e.g., based on investment strategy).&#160;The co-investment is generally allocated to us, any other Blackstone Credit &amp; Insurance BDCs and the other Blackstone Credit &amp; Insurance funds that target similar assets pro rata based on available capital in the applicable asset class.&#160;If the Adviser determines that such investment is not appropriate for us, the investment will not be allocated to us, but the Adviser will be required to report such investment and the rationale for its determination for us to not participate in the investment to the Board at the next quarterly board meeting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">222</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transactions with Promoters and Certain Control Persons</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser may be deemed a promoter of the Company. We have entered into the Investment Advisory Agreement with the Adviser and the Administration Agreement with the Administrator. The Adviser, for its services to us, are entitled to receive management fees and incentive fees in addition to the reimbursement of certain expenses. The Administrator, for its services to us, are entitled to receive reimbursement of certain expenses. In addition, under the Investment Advisory Agreement and Administration Agreement, to the extent permitted by applicable law and in the discretion of our Board, we have indemnified the Adviser and the Administrator and certain of their affiliates. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Statement of Policy Regarding Transactions with Related Persons</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board will conduct quarterly reviews of any potential related party transactions brought to its attention and, during these reviews, it will consider any conflicts of interest brought to its attention pursuant to the Company&#8217;s compliance policies and procedures. Each of the Company&#8217;s trustees and executive officers is subject to the Company&#8217;s Code of Ethics, which places restrictions on related party transactions, and is instructed and periodically reminded to inform the Company&#8217;s Chief Compliance Officer or her designee of any potential related party transactions. In addition, each such trustee and executive officer completes a questionnaire on an annual basis designed to elicit information about any potential related party transactions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trustee Independence</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding the independence of our trustees, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 10. Directors, Executive Officers and Corporate Governance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div id="i33edc808e7824948b94b269ed713a939_223"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14. Principal Accounting Fees and Services.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate audit fees billed by Deloitte &amp; Touche LLP for the years ended December&#160;31, 2023 and 2022 were $1.2&#160;million and $1.0&#160;million, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fees included in the audit fees category are those associated with the annual audit of the Company&#8217;s financial statements and services that are normally provided in connection with statutory and regulatory filings.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit-Related Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate audit-related fees billed by Deloitte &amp; Touche LLP for the years ended December&#160;31, 2023 and 2022 were $0.2&#160;million and $0.1&#160;million, respectively. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit-related fees are for any services rendered to the Company that are reasonably related to the performance of the audits or reviews of the Company&#8217;s consolidated financial statements (but not reported as audit fees above). These services include attestation services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No audit related fees were billed by Deloitte &amp; Touche LLP to the Adviser, or any entity controlling, controlled by, or under common control with, the Adviser, that provides ongoing services to the Company, for engagements directly related to the Company&#8217;s operations and financial reporting, for the years ended December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No tax fees were billed by Deloitte &amp; Touche LLP for services rendered to the Company for professional tax services for the years ended December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fees included in the tax fees category comprise all services performed by professional staff in the independent registered public accountant&#8217;s tax division except those services related to the audits. This category comprises fees for services provided in connection with the preparation and review of the Company&#8217;s tax returns.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">223</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No tax fees were billed by Deloitte &amp; Touche LLP to the Adviser, or any entity controlling, controlled by, or under common control with, the Adviser, that provides ongoing services to the Company, for engagements directly related to the Company&#8217;s operations and financial reporting, for the years ended December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">All Other Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No fees were billed by Deloitte &amp; Touche LLP for products and services provided to the Company, other than the services reported in &#8220;Audit Fees&#8221; and &#8220;Audit Related Fees&#8221; above, for the years ended December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No fees were billed by Deloitte &amp; Touche LLP to the Adviser, or any entity controlling, controlled by, or under common control with, the Adviser, that provides ongoing services to the Company, for engagements directly related to the Company&#8217;s operations and financial reporting, for the years ended December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate Non-Audit Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No non-audit fees were billed to the Adviser and service affiliates by Deloitte &amp; Touche LLP for non-audit services for the years ended December&#160;31, 2023, 2022 and 2021. This includes any non-audit services required to be pre-approved or non-audit services that did not require pre-approval since they did not directly relate to the Company&#8217;s operations or financial reporting.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pre-Approval of Audit and Non-Audit Services Provided to the Company</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of this responsibility, the Audit Committee is required to pre-approve all audit and non-audit services performed by our independent auditor in order to assure that the performance of these services does not impair the auditor&#8217;s independence from the Company. Accordingly, the Audit Committee has adopted a Pre-Approval of Independent Auditor Services Policy (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Policy&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which sets forth the conditions and procedures governing the pre-approval of services that the Independent Auditor proposes to provide. Our independent auditor has reviewed the Policy and has confirmed that the implementation of the Policy will not adversely affect its independence.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Policy describes the audit, audit-related, tax and other services for the Company that have the pre-approval of the Audit Committee. The term of any pre-approval is 12 months from the date of pre-approval or until the next annual Independent Auditor services engagement is pre-approved, whichever is later. The Audit Committee will periodically revise the list of pre-approved services based on subsequent determinations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual Approval</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an annual basis, at the time of the appointment of our independent auditor and such other times as determined by the Audit Committee, the Audit Committee will consider and approve the services (including audit, audit-related, tax and all other services) that the Independent Auditor may initiate. The term of any pre-approval is 12 months from the date of the pre-approval or until the next annual Independent Auditor services engagement is pre-approved, whichever is later, unless the Audit Committee specifically provides for a different period. Summary descriptions of the types of services the Audit Committee believes are appropriate for annual approval are provided under the Policy. In addition, in connection with the annual pre-approval of services, the Audit Committee will supplementally review and approve a detailed presentation that sets forth the types of audit, audit-related, tax and other services proposed to be provided by the Independent Auditor, which shall include estimates of the fees for such services (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Services Proposal&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The Audit Committee may periodically revise the list of pre-approved services based on subsequent determinations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Specific Pre-Approval</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specific pre-approval is required for the provision of certain audit services as described in the Policy. In addition, if a service proposed to be performed by the Independent Auditor does not fall within an existing pre-approval, either because it is a new type of service or because provision of the service would cause the Independent Auditor to exceed the maximum dollar amount approved for a particular type of service, the proposed service will require specific pre-approval by the Audit Committee.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">224</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">De Minimis Exception</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that the Independent Auditor is inadvertently engaged other than by the Audit Committee for a non-audit service, such engagement will not be a violation of the Policy if: (i) any and all such services do not aggregate to more than 5% of total revenues paid by the Company to the Independent Auditor in the fiscal year when services are provided; (ii) the services were not recognized as non-audit services at the time of the engagement; (iii) the services are promptly brought to the attention of the Committee and approved prior to the completion of the audit by the Committee or one or more designated representatives; and (iv) separate disclosure of the services retroactively approved under this exception is made in accordance with the proxy disclosure rules.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee has considered these fees and the nature of the services rendered, and has concluded that they are compatible with maintaining the independence of Deloitte &amp; Touche LLP. The Audit Committee did not approve any of the audit-related, tax, or other non-audit fees described above pursuant to the &#8220;de minimis exceptions&#8221; set forth in Rule 2-01(c)(7)(i)(C) and Rule 2-01(c)(7)(ii) of Regulation S-X. Deloitte &amp; Touche LLP did not provide any audit-related services, tax services or other non-audit services to the Adviser or any entity controlling, controlled by or under common control with the Adviser that provides ongoing services to the Company that the Audit Committee was required to approve pursuant to Rule 2-01(c)(7)(ii) of Regulation S-X. The Audit Committee considered whether any provision of non-audit services rendered to the Adviser and any entity controlling, controlled by, or under common control with the Adviser that provides ongoing services to the Company that were not pre-approved by the Audit Committee because the engagement did not relate directly to the operations and financial reporting of the Company is compatible with maintaining Deloitte &amp; Touche LLP&#8217;s independence.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">225</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_226"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i33edc808e7824948b94b269ed713a939_229"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15. Exhibits, Financial Statement Schedules.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as part of this annual report:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Financial Statements &#8211; Financial statements are included in Item 8. See the Index to the consolidated financial statements on page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_112">132</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this annual report on Form 10-K.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Financial Statement Schedules &#8211; None. We have omitted financial statement schedules because they are not required or are not applicable, or the required information is shown in the consolidated statements or notes to the consolidated financial statements.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Exhibits &#8211; The following is a list of all exhibits filed as a part of this annual report on Form 10-K, including those incorporated by reference</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that the agreements included as exhibits to this Form 10-K are included to provide information regarding their terms and are not intended to provide any other factual or disclosure information about us or the other parties to the agreements. The agreements contain representations and warranties by each of the parties to the applicable agreement that have been made solely for the benefit of the other parties to the applicable agreement and may not describe the actual state of affairs as of the date they were made or at any other time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.305%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibits</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521301178/d124735dex99a1.htm">Fourth Amended and Restated Declaration of Trust, dated as of October 18, 2021 (incorporated by reference to Exhibit (a)(1) to the Company&#8217;s Registration Statement on Form N-2 filed on October 18, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312520314881/d96415dex31.htm">Certificate of Amendment to Certificate of Trust, effective December 10, 2020 (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on December 10, 2020).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521301178/d124735dex99b.htm">Amended and Restated Bylaws, dated as of October 18, 2021 (incorporated by reference to Exhibit (b) to the Company&#8217;s Registration Statement on Form N-2 filed on October 18, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1736035/000119312518289712/d595178dex41.htm">Form of Subscription Agreement (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Registration Statement on Form 10 filed on October 1, 2018).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312520194677/d34207dex41.htm">Indenture, dated as of July 15, 2020, by and between the Company and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on July 17, 2020).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312520194677/d34207dex42.htm">First Supplemental Indenture, dated as of July 15, 2020, relating to the 3.650% Notes due 2023, by and between the Company and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on July 17, 2020).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312520278063/d178586dex42.htm">Second Supplemental Indenture, dated as of October 23, 2020, relating to the 3.625% Notes due 2026, by and between the Company and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on October 27, 2020).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521085601/d122118dex42.htm">Third Supplemental Indenture, dated as of March</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521085601/d122118dex42.htm"> </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521085601/d122118dex42.htm">16, 2021, relating to the 2.750% Notes due 2026, by and between the Fund and U.S.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521085601/d122118dex42.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521085601/d122118dex42.htm">Bank National Association, as trustee (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on March 18, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">226</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.305%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521225863/d86203dex42.htm">Fourth Supplemental Indenture, dated as of July</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521225863/d86203dex42.htm"> </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521225863/d86203dex42.htm">23, 2021, relating to the 2.125% Notes due 2027, by and between the Fund and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521225863/d86203dex42.htm"> </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521225863/d86203dex42.htm">8-K filed on July 27, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521289887/d236745dex42.htm">Fifth Supplemental Indenture, dated as of September 30, 2021, relating to the 2.850% Notes due 2028, by and between the Fund and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on October 1, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312520194677/d34207dex42.htm">Form of 3.650% Notes Due 2023 (included as part of Exhibit 4.2) (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on July 17, 2020).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312520278063/d178586dex42.htm">Form of 3.625% Notes due 2026 (included as part of Exhibit 4.2) (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on October 27, 2020).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521085601/d122118dex42.htm">Form of 2.750% Notes due 2026 (included as part of Exhibit 4.2) (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on March 18, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521225863/d86203dex42.htm">Form of 2.125% Notes due 2027 (included as part of Exhibit 4.2) (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on July 27, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521289887/d236745dex42.htm">Form of 2.850% Notes due 2028 (included as part of Exhibit 4.2) (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on October 1, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521139560/d156273dex44.htm">Registration Rights Agreement, dated as of April 27, 2021, by and among the Fund and Citigroup Global Markets Inc., Goldman Sachs &amp; Co. LLC and SMBC Nikko Securities America, Inc., as the representatives of the Initial Purchasers (incorporated by reference to Exhibit 4.4 to the Company&#8217;s Current Report on Form 8-K filed on April 29, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521225863/d86203dex44.htm">Registration Rights Agreement, dated as of July 23, 2021, by and among the Fund and Citigroup Global Markets Inc., Goldman Sachs &amp; Co. LLC and Wells Fargo Securities, LLC, as the representatives of the Initial Purchasers (incorporated by reference to Exhibit 4.4 to the Company&#8217;s Current Report on Form 8-K filed on July 27, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521289887/d236745dex44.htm">Registration Rights Agreement, dated as of September 30, 2021, by and among the Fund and Citigroup Global Markets Inc., J.P. Morgan Securities, LLC, RBC Capital Markets, LLC, SMBC Nikko Securities America, Inc., and Wells Fargo Securities, LLC, as the representatives of the Initial Purchasers (incorporated by reference to Exhibit 4.4 to the Company&#8217;s Current Report on Form 8-K filed on October 1, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603522000006/bxsl-20211231xex46.htm">Description of Common Shares of Beneficial Interest (incorporated by reference to Exhibit 4.6 to the Company&#8217;s Annual Report on Form 10-K filed on February 28, 2022).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521301178/d124735dex99g.htm">Amended and Restated Investment Advisory Agreement between the Company and the Adviser, dated as of October 18, 2021 (incorporated by reference to Exhibit (g) to the Company&#8217;s Registration Statement on Form N-2 filed on October 18, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312521301178/d124735dex99k23.htm">Waiver Letter Agreement between the Company and the Adviser, dated October 18, 2021 (incorporated by reference to Exhibit (k)(23) to the Company&#8217;s Registration Statement on Form N-2 filed on October 18, 2021).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312518289712/d595178dex102.htm">Administration Agreement between the Company and the Administrator, dated October 1, 2018 (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Registration Statement on Form 10 filed on October 1, 2018).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">227</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.305%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000156459019008333/ck001736035-ex103_88.htm">Custodian Agreement between the Company and State Street Bank and Trust Company, dated October 1, 2018 (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Annual Report on Form 10-K filed on March 18, 2019).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312518289712/d595178dex104.htm">Custody Agreement between the Adviser and UMB Bank, n.a., dated September 14, 2018 (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Registration Statement on Form 10 filed on October 1, 2018).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312518289712/d595178dex105.htm">Agency Agreement between the Company and DST Systems, Inc., dated September 10, 2018 (incorporated by reference to Exhibit 10.5 to the Company&#8217;s Registration Statement on Form 10 filed on October 1, 2018).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312518351989/d679633dex101.htm">Expense Support and Conditional Reimbursement Agreement, dated December 12, 2018 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 18, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312518351989/d679633dex102.htm">Amended and Restated Dividend Reinvestment Plan (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on December 18, 2018).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603522000006/bxsl-20201231xex109.htm">Amended and Restated Loan and Security Agreement among Jackson Hole Funding, the Company, the lenders party thereto, Citibank, N.A., Virtus Group, LP and JPMorgan Chase Bank, National Association, dated December 16, 2021 (incorporated by reference to Exhibit 10.5 to the Company&#8217;s Annual Report on Form 10-K filed on February 28, 2022).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312522249288/d374168dex101.htm">First Amendment to Amended and Restated Loan and Security Agreement among Jackson Hole Funding, the Company, the lenders party thereto, Citibank, N.A., Virtus Group, LP and JPMorgan Chase Bank, National Association, dated December 16, 2021 (incorporated by reference to Exhibit 10.01 to the Company&#8217;s Current Report on Form 8-K filed on September 22, 2022).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312523279276/d601109dex101.htm">Second Amendment to Amended and Restated Loan and Security Agreement among Jackson Hole Funding, the Company, the lenders party thereto, Citibank, N.A., Virtus Group, LP and JPMorgan Chase Bank, National Association, dated November 15, 2023 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed November 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312523279276/d601109dex101.htm">7</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312523279276/d601109dex101.htm">, 2023).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312523301232/d492484dex101.htm">Third Amendment to Amended and Restated Loan and Security Agreement among Jackson Hole Funding, the Company, the lenders party thereto, Citibank, N.A., Virtus Group, LP and JPMorgan Chase Bank, National Association, dated December 18, 2023 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed December 21, 2023).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1736035/000119312518360910/d654261dex101.htm">Revolving Credit Facility among Breckenridge Funding, the lenders party thereto, BNP Paribas, the Company and Wells Fargo Bank, National Association, dated December 21, 2018 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 28, 2018).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1736035/000173603519000010/ex-101xbreckenridgearca.htm">First Amendment to the Revolving Credit Agreement between Breckenridge Funding, the lenders party thereto, BNP Paribas, the Company and Wells Fargo Bank, National Association, dated June 11, 2019 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 13, 2019).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603520000003/ex10112.htm">Second Amendment to the Revolving Credit Agreement between Breckenridge Funding, the lenders party thereto, BNP Paribas, the Company and Wells Fargo Bank, National Association, dated August 2, 2019 (incorporated by reference to Exhibit 10.10.2 to the Company&#8217;s Quarterly Report on Form 10-K filed on February 28, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1736035/000173603519000014/bgsl-20190930xex101.htm">Third Amendment to the Revolving Credit Agreement between Breckenridge Funding, the lenders party thereto, BNP Paribas, the Company and Wells Fargo Bank, National Association, dated September 27, 2019 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 14, 2019).</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">228</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.305%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibits</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603520000007/bgsl-20200331xex101.htm">Fourth Amendment to the Revolving Credit Agreement between Breckenridge Funding, the lenders party thereto, BNP Paribas, the Company and Wells Fargo Bank, National Association, dated April 13, 2020 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on May 7, 2020).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603522000006/bxsl-20201231xex10105.htm">Fifth Amendment to the Revolving Credit Agreement among Breckenridge Funding, the lenders party thereto, BNP Paribas, the Company and Wells Fargo Bank, National Association, dated October 5, 2021 (incorporated by reference to Exhibit 10.10.5 to the Company&#8217;s Annual Report on Form 10-K filed on February 28, 2022).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex10106.htm">Sixth Amendment to the Revolving Credit Agreement among Breckenridge Funding, the lenders party thereto, BNP Paribas, the Company and Wells Fargo Bank, National Association, dated February 28, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex10106.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex10106.htm">(incorporated by reference to Exhibit 10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex10106.htm">0.6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex10106.htm"> to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2023).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex10107.htm">Seventh Amendment to the Revolving Credit Agreement among Breckenridge Funding, the lenders party thereto, BNP Paribas, the Company and Wells Fargo Bank, National Association, dated May 19, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex10107.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex10107.htm">(incorporated by reference to Exhibit 10.10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex10107.htm">7</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex10107.htm"> to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2023).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10.8</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312523270438/d551029dex101.htm">Eighth Amendment to the Revolving Credit Agreement among Breckenridge Funding, the lenders party thereto, BNP Paribas, the Company and Wells Fargo Bank, National Association, dated November 1, 2023 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed November 3, 2023).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10.9</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="bxsl-20231231xex10109.htm">Ninth</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="bxsl-20231231xex10109.htm"> Amendment to the Revolving Credit Agreement among Breckenridge Funding, the lenders party thereto, BNP Paribas, the Company and Wells Fargo Bank, National Association, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="bxsl-20231231xex10109.htm">January</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="bxsl-20231231xex10109.htm"> 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="bxsl-20231231xex10109.htm">7</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="bxsl-20231231xex10109.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="bxsl-20231231xex10109.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="bxsl-20231231xex10109.htm">.*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex1011.htm">Second Amended and Restated Credit Agreement among Big Sky Funding, the lender parties thereto, and Bank of America, N.A., dated June 29, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex1011.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex1011.htm">(incorporated by reference to Exhibit 10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex1011.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex1011.htm"> to the Company&#8217;s Annual Report on Form 10-K filed on February 2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex1011.htm">7</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex1011.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex1011.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex1011.htm">).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312523092205/d468200dex101.htm">First Amendment to the Second Amended and Restated Credit Agreement among Big Sky Funding, the lender parties thereto, and Bank of America, N.A., dated March 30, 2023 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed April 5, 2023).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312522185972/d373808dex101.htm">Amendment and Restated Agreement, dated as of June 28, 2022, to the Senior Secured Credit Agreement, dated as of June 15, 2020, by and among the Company, each of the lenders from time to time party thereto and Citibank, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed June 30, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312522185972/d373808dex102.htm">Second Amended and Restated Senior Secured Credit Agreement, dated as of June 28, 2022, by and among the Company, each of the lenders from time to time party thereto, and Citibank, N.A., as administrative agent (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed June 30, 2022).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12.2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312523165679/d587743dex101.htm">First Amendment, Extension Agreement and Incremental Assumption Agreement to the Second Amended and Restated Senior Secured Credit Agreement dated June 9, 2023, by and among the Company, each of the Lenders from time to time party thereto and Citibank, N.A., as administrative agent and collateral agent (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed June 13, 2023).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">229</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.305%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12.3</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312523165679/d587743dex102.htm">Second Amended and Restated Senior Secured Credit Agreement dated June 9, 2023, by and among the Company, each of the Lenders from time to time party thereto and Citibank, N.A., as administrative agent and collateral agent (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed June 13, 2023).</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312523060123/d477426dex101.htm">Form of Equity Distribution Agreement, dated as of March 3, 2023, by and among Blackstone Secured Lending Fund, Blackstone Credit BDC Advisors LLC, Blackstone Alternative Credit Advisors LP and the sales agent party thereto (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed March 3, 2023).**</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312523179238/d481603dex101.htm">Form of Equity Distribution Agreement, dated as of June 30, 2023, by and among Blackstone Secured Lending Fund, Blackstone Credit BDC Advisors LLC, Blackstone Alternative Credit Advisors LP and the sales agent party thereto (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed June 30, 2023).**</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000119312523286802/d20053dex101.htm">Form of Equity Distribution Agreement, dated as of December 1, 2023, by and among Blackstone Secured Lending Fund, Blackstone Credit BDC Advisors LLC, Blackstone Alternative Credit Advisors LP and the sales agent party thereto (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed December 1, 2023).** </a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex14.htm">Code of Ethics</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex14.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736035/000173603523000008/bxsl-20221231xex14.htm">(incorporated by reference to Exhibit 14 to the Company&#8217;s Annual Report on Form 10-K filed February 27, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="bxsl-20231231xex211.htm">Subsidiaries*</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex231.htm">C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex231.htm">onsent of Deloitte and Touche</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex231.htm"> LLP</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex231.htm">*</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex311.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex312.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex313.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex321.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (furnished herewith)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex322.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (furnished herewith)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex323.htm">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (furnished herewith)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex971.htm">Blackstone Secured Lending Fund Incentive Compensation Clawback Policy*</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex991.htm">Section 13(r) Disclosure</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bxsl-20231231xex991.htm">*</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document*</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">230</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.305%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document*</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document*</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document*</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document*</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document*</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Certain schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule to the SEC upon its request.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div id="i33edc808e7824948b94b269ed713a939_232"></div><div style="-sec-extract:summary;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16. Form 10-K Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">231</span></div></div></div><div id="i33edc808e7824948b94b269ed713a939_235"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i33edc808e7824948b94b269ed713a939_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:40.920%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:52.781%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Blackstone Secured Lending Fund</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 28, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brad Marshall</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brad Marshall</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer</span></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated on February&#160;28, 2024.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:44.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:52.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brad Marshall</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer (Principal Executive Officer) and Trustee</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brad Marshall</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jonathan Bock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer (Principal Executive Officer)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan Bock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Teddy Desloge</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer (Principal Financial Officer)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teddy Desloge</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Matthew Alcide</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer and Treasurer (Principal Accounting Officer)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Alcide</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Vikrant Sawhney</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vikrant Sawhney</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert Bass</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert Bass</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Tracy Collins</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tracy Collins</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Vicki Fuller</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vicki Fuller</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James F. Clark</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James F. Clark</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michelle Greene</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trustee</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michelle Greene</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">232</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.109
<SEQUENCE>2
<FILENAME>bxsl-20231231xex10109.htm
<DESCRIPTION>EX-10.109
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i4e63a67e7e2a40b9b24cd0fedb5e2a41_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.10.9 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;     EXECUTION VERSION</font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This NINTH AMENDMENT TO THE REVOLVING CREDIT AND SECURITY AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), dated as of January 17, 2024 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), is entered into by and among BGSL BRECKENRIDGE FUNDING LLC, a Delaware limited liability company, as the borrower (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the LENDERS party to the Revolving Credit Agreement, BNP PARIBAS, as the administrative agent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), BLACKSTONE SECURED LENDING FUND, a Delaware statutory trust, as the equityholder (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Equityholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), BLACKSTONE SECURED LENDING FUND, a Delaware statutory trust, as the servicer (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and WELLS FARGO BANK, NATIONAL ASSOCIATION, as collateral agent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Collateral Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Borrower, the lenders from time to time party thereto, the Administrative Agent, the Equityholder, the Servicer and the Collateral Agent are party to the Revolving Credit and Security Agreement, dated as of December 21, 2018 (as amended from time to time prior to the date hereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the parties hereto desire to amend the Revolving Credit Agreement, in accordance with Section 13.01(b) of the Revolving Credit Agreement subject to the terms and conditions set forth herein.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW THEREFORE, in consideration of the foregoing premises and the mutual agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows&#58;</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.7pt;text-decoration:underline"><br><br>Definitions</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Terms used but not defined herein have the respective meanings given to such terms in the Revolving Credit Agreement.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:5.04pt;text-decoration:underline"><br><br>Amendments to Revolving Credit Agreement</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt">As of January 17, 2024 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Revolving Credit Agreement is hereby amended reflect the following amendments&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Section 1.01 of the Revolving Credit Agreement shall be amended by amending and restating the definition of &#8220;Interest Accrual Period&#8221; as set forth below&#58; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Accrual Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to any Advance (a) with respect to the first Payment Date following the related Borrowing Date, the period from and including the Borrowing Date for such Advance to and including the last Business Day of the calendar month preceding the month in which such first Payment Date occurs and (b)&#160;with respect to any subsequent Payment Date, the period beginning on (and including) the day immediately following the last day of the prior Interest Accrual Period and ending on (but excluding) the last Business Day of the calendar month preceding&#160;the month in which the next Payment Date occurs.&#8221;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Section 1.01 of the Revolving Credit Agreement shall be amended by modifying the definition of &#8220;Term SOFR&#8221; as set forth below&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any calculation with respect to an Advance, the Term SOFR Reference Rate for a tenor comparable to the applicable Interest Accrual Period on the day (such day, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Periodic Term SOFR Determination Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) that is two (2) U.S. Government Securities Business Days prior to the first day of such Interest Accrual Period, as such rate is published by the Term SOFR Administrator&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if as of 5&#58;00 p.m. (New York City time) on any Periodic Term SOFR Determination Day the Term SOFR Reference Rate the applicable tenor has not been published by the Term SOFR Administrator and a Benchmark Replacement Date with respect to the Term SOFR Reference Rate has not occurred, then Term SOFR will be the Term SOFR Reference Rate for such tenor as published by the Term SOFR Administrator on the first preceding U.S. Government Securities Business Day for which such Term SOFR Reference Rate for such tenor was published by the Term SOFR Administrator so long as such first preceding U.S. Government Securities Business Day is not more than three (3)  U.S. Government Securities Business Days prior to such Periodic Term SOFR Determination Day&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, with respect to the first Interest Accrual Period with respect to any Advance, Term SOFR shall be, (x) if the related Interest Accrual Period is three months in duration, the Term SOFR Reference Rate (as of the Periodic Term SOFR Determination Date) having a tenor of three months, as such rate is published by the Term SOFR Administrator, (y) if the related Interest Accrual Period is more than one month but less than three months in duration, the rate (rounded to the same number of decimal places as the two relevant Term SOFR Reference Rates) which results from interpolating (1) the applicable Term SOFR Reference Rate (as of the Periodic Term SOFR Determination Date) for the longest period for which the Term SOFR Reference Rate is available which is less than the Interest Accrual Period with respect to such Advance and (2) the applicable Term SOFR Reference Rate (as of the Periodic Term SOFR Determination Date) for the shortest period for which the Term SOFR Reference Rate is available which exceeds the Interest Accrual Period with respect to such Advance, or (z) if the related Interest Accrual Period is one month or less in duration, the Term SOFR Reference Rate (as of the Periodic Term SOFR Determination Date) having a tenor of one month, as such rate is published by the Term SOFR Administrator&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, further,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if Term SOFR determined as provided above (including pursuant to the proviso above) shall ever be less than the Floor, then Term SOFR shall be deemed to be the Floor.&#8221;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The amendments above are also set forth on the pages attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to delete the stricken text (indicated textually in the same manner as the following example&#58; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">stricken text</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and to add the bold and double-underlined text (indicated textually in the same manner as the following example&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">bold and double-underlined text</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). The Revolving Credit Agreement as amended pursuant to this Amendment is attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE III</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Representations and Warranties</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt">The Borrower and the Equityholder hereby represent and warrant to the Administrative Agent and the Lender that, as of the Amendment Date and the Amendment Effective Date, (i) no Default, Event of Default, Potential Servicer Removal Event or Servicer Removal Event has occurred and is continuing and (ii) the representations and warranties of the Borrower, the Servicer and the Equityholder contained in Sections 4.01, 4.02 and 4.03 of the Revolving Credit Agreement are true and correct in all material respects on and as of the Amendment Date and the Amendment Effective Date (other than any representation and warranty that is made as of a specific date).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:1.04pt;text-decoration:underline"><br><br>Conditions Precedent</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt">This Amendment will be effective on the Amendment Effective Date upon the execution and delivery of this Amendment by the parties hereto.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:5.7pt;text-decoration:underline"><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt;text-decoration:underline">Severability Clause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In case any provision in this Amendment deemed to be invalid, illegal or unenforceable, the remaining provisions of this Amendment remain in full force and effect.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt;text-decoration:underline">Ratification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as expressly amended hereby, the Revolving Credit Agreement is in all respects ratified and confirmed and all the terms, conditions and provisions thereof will remain in full force and effect.  When effective, this Amendment will form a part of the Revolving Credit Agreement for all purposes.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The parties hereto may sign one or more copies of this Amendment in counterparts, all of which together constitute one and the same agreement.  Delivery of an executed signature page of this Amendment by facsimile or email transmission is effective as delivery of a manually executed counterpart hereof.  This Amendment shall be valid, binding and enforceable against a party when executed and delivered by an authorized individual on behalf of the party by means of (i) an original manual signature&#59; (ii) a faxed, scanned or photocopied manual signature&#59; or (iii) any other electronic signature permitted by the federal Electronic Signatures in Global and National Commerce Act, state enactments of the Uniform Electronic Transactions Act, and&#47;or any other relevant electronic signatures law, including any relevant provisions of the Uniform Commercial Code (collectively, &#8220;Signature Law&#8221;), in each case, to the extent applicable&#59; provided that no electronic signatures may be affixed through the use of a third-party service provider.  Each faxed, scanned, or photocopied manual signature, or other electronic signature, shall for all purposes have the same validity, legal effect, and admissibility in evidence as an original manual signature.  Each party hereto shall be entitled to conclusively rely upon, and shall have no liability with respect to, any faxed, scanned, or photocopied manual signature, or other electronic signature, of any other party and shall have no duty to investigate, confirm or otherwise verify the validity or authenticity thereof.  For the avoidance of doubt, original manual signatures shall be used for execution or indorsement of writings when required under the Uniform Commercial Code or other Signature Law due to the character or intended character of the writings.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The headings of the Articles and Sections in this Amendment are for convenience of reference only and are not deemed to alter or affect the meaning or interpretation of any provisions hereof.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt;text-decoration:underline">Direction to Execute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each of the Borrower and the Administrative Agent hereby (i) authorizes and directs the Collateral Agent to execute this Amendment, (ii) acknowledges and agrees that the Collateral Agent shall be fully protected in relying upon the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">foregoing authorization and direction and (iii) releases the Collateral Agent and its officers, directors, agents, employees and shareholders from any liability for complying with such direction.  Each of the parties hereto hereby agree that in executing and delivering this Amendment, the Collateral Agent shall be afforded the same rights, protections, immunities and indemnities afforded to it under the Agreement&#59; provided that such rights, protections, immunities and indemnities shall be in addition to, and not in limitation of, any rights, protections, immunities and indemnities contained herein.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Pages Follow&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4</font></div></div></div><div id="i4e63a67e7e2a40b9b24cd0fedb5e2a41_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the Amendment Date.</font></div><div style="margin-top:24pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BORROWER&#58;</font></div><div style="margin-top:24pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BGSL BRECKENRIDGE FUNDING LLC</font></div><div style="margin-top:24pt;padding-left:259.2pt;text-indent:-25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  Blackstone Secured Lending Fund, its sole member</font></div><div style="margin-top:36pt;padding-left:259.2pt;text-indent:-25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">   &#47;s&#47; Oran Ebel&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Name&#58;  Oran Ebel<br>Title&#58;  Chief Legal Officer and Secretary</font></div><div style="margin-top:36pt;padding-left:259.2pt;text-indent:-25.2pt"><font><br></font></div><div style="margin-top:24pt;padding-left:234pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to Ninth Amendment to Revolving Credit and Security Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:234pt"><font><br></font></div><div style="margin-top:24pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EQUITYHOLDER&#58;</font></div><div style="margin-top:24pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BLACKSTONE SECURED LENDING FUND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,<br>as Equityholder</font></div><div style="margin-top:24pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">   &#47;s&#47; Oran Ebel&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;<br>         Name&#58;  Oran Ebel<br>         Title&#58;  Chief Legal Officer and Secretary</font></div><div style="margin-top:24pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SERVICER&#58;</font></div><div style="margin-top:24pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BLACKSTONE SECURED LENDING FUND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,<br>as Servicer</font></div><div style="margin-top:24pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">   &#47;s&#47; Oran Ebel&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;<br>         Name&#58;  Oran Ebel<br>         Title&#58;  Chief Legal Officer and Secretary</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to Third Amendment to Credit Agreement&#93;</font></div></div></div><div id="i4e63a67e7e2a40b9b24cd0fedb5e2a41_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:24pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ADMINISTRATIVE AGENT&#58;</font></div><div style="margin-top:24pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BNP PARIBAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,<br>as Administrative Agent</font></div><div style="margin-top:36pt;padding-left:259.2pt;text-indent:-25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">   &#47;s&#47; Meredith Middleton&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Name&#58;  Meredith Middleton<br>Title&#58;  Managing Director</font></div><div style="margin-top:36pt;padding-left:259.2pt;text-indent:-25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">   &#47;s&#47; Sohaib Naim&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Name&#58;  Sohaib Naim<br>Title&#58;  Director</font></div><div style="margin-top:24pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">LENDERS&#58;</font></div><div style="margin-top:24pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BNP PARIBAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,<br>as Lender</font></div><div style="margin-top:36pt;padding-left:259.2pt;text-indent:-25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">   &#47;s&#47; Meredith Middleton&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Name&#58;  Meredith Middleton<br>Title&#58;  Managing Director</font></div><div style="margin-top:36pt;padding-left:259.2pt;text-indent:-25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">   &#47;s&#47; Sohaib Naim&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Name&#58;  Sohaib Naim<br>Title&#58;  Director</font></div><div style="margin-top:36pt;padding-left:234pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to Ninth Amendment to Revolving Credit and Security Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CANADIAN IMPERIAL BANK OF COMMERCE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,<br>as Lender<br></font></div><div style="margin-top:36pt;padding-left:259.2pt;text-indent:-25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">   &#47;s&#47; Kathryn Lagroix&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Name&#58;  Kathryn Lagroix<br>Title&#58;  Managing Director</font></div><div style="margin-top:36pt;padding-left:234pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to Ninth Amendment to Revolving Credit and Security Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COLLATERAL AGENT&#58;</font></div><div style="margin-top:36pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WELLS FARGO BANK, NATIONAL ASSOCIATION<br></font></div><div style="margin-top:36pt;padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY&#58; COMPUTERSHARE TRUST<br>COMPANY, N.A., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as attorney-in-fact</font></div><div style="margin-top:36pt;padding-left:259.2pt;text-indent:-25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">   &#47;s&#47; Thomas J. Gateau&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Name&#58;  Thomas J. Gateau<br>Title&#58;  Vice President</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to Ninth Amendment to Revolving Credit and Security Agreement&#93;</font></div></div></div><div id="i4e63a67e7e2a40b9b24cd0fedb5e2a41_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">APPENDIX A</font></div><div style="padding-left:234pt"><font><br></font></div><div id="i4e63a67e7e2a40b9b24cd0fedb5e2a41_13"></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">APPENDIX B </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>bxsl-20231231xex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ifd6923bcc9a1425c858d4313bdacfea9_40"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 21.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUBSIDIARIES OF BLACKSTONE &#47; GSO SECURED LENDING FUND</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;                  </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BGSL JACKSON HOLE FUNDING LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BGSL BRECKENRIDGE FUNDING LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BGSL BIG SKY FUNDING LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BGSL INVESTMENTS LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BXSL C-1 LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BXSL C-2 Funding LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BXSL Associates GP (Lux) S.&#224; r.l</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BXSL Direct Lending (Lux) SCSp</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr></table></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>bxsl-20231231xex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i8d43bb7536cb449c99d18fe5c86e194d_64"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 23.1</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18.75pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:228%">We consent to the incorporation by reference in the Registration Statement No. 333-266323 on Form N-2ASR of our reports dated February 28, 2024, relating to the consolidated financial statements of Blackstone Secured Lending Fund and subsidiaries (the &#8220;Company&#8221;) and the effectiveness of Company&#8217;s internal control over financial reporting, appearing in the Annual Report on Form 10-K of Blackstone Secured Lending Fund for the year ended December 31, 2023.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18.75pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18.75pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:228%">We also consent to the reference to us under the headings &#34;Financial Highlights&#8221;, &#8220;Senior Securities&#8221;, and &#8220;Experts&#8221; in such Registration Statement.</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">      </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">      &#47;s&#47; DELOITTE &#38; TOUCHE LLP</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18.75pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:228%">New York, New York </font></div><div style="margin-bottom:18pt;margin-top:6pt;padding-left:18.75pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:228%">February 28, 2024</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>bxsl-20231231xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ibe21dad3ac9e40108cfaa86b23f545c5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brad Marshall, Co-Chief Executive Officer of Blackstone Secured Lending Fund, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this annual report on Form 10-K of Blackstone Secured Lending Fund (the &#8220;registrant&#8221;)&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:28.88pt">The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Securities Exchange Act of 1934 Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of trustees (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2024</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.436%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brad Marshall</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brad Marshall</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>bxsl-20231231xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i7973e8a533e640c2bc96eb91a8bef61d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jonathan Bock, Co-Chief Executive Officer of Blackstone Secured Lending Fund, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this annual report on Form 10-K of Blackstone Secured Lending Fund (the &#8220;registrant&#8221;)&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.88pt">The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Securities Exchange Act of 1934 Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of trustees (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2024</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.436%"></td><td style="width:0.1%"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jonathan Bock</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan Bock</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>7
<FILENAME>bxsl-20231231xex313.htm
<DESCRIPTION>EX-31.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i8c35ff707e4e46378ee2f21d850ff99f_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 31.3</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Teddy Desloge, Chief Financial Officer of Blackstone Secured Lending Fund, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this annual report on Form 10-K of Blackstone Secured Lending Fund (the &#8220;registrant&#8221;)&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.88pt">The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Securities Exchange Act of 1934 Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of trustees (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2024</font></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.436%"></td><td style="width:0.1%"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Teddy Desloge</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teddy Desloge</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>bxsl-20231231xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i810e1c4dab4f4d1399314ac6b5f6c4c2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Co-Chief Executive Officer of Blackstone Secured Lending Fund (the &#8220;Company&#8221;), does hereby certify that to the undersigned&#8217;s knowledge&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the Company&#8217;s Form 10-K for the year ended December&#160;31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the information contained in the Company&#8217;s Form 10-K for the year ended December&#160;31, 2023 fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2024 </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.436%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brad Marshall</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brad Marshall</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer</font></td></tr></table></div><div style="margin-top:12pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>bxsl-20231231xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ic11a169e517d474f8a2e1a1f960604d0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Co-Chief Executive Officer of Blackstone Secured Lending Fund (the &#8220;Company&#8221;), does hereby certify that to the undersigned&#8217;s knowledge&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the Company&#8217;s Form 10-K for the year ended December&#160;31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the information contained in the Company&#8217;s Form 10-K for the year ended December&#160;31, 2023 fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2024</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.436%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jonathan Bock</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan Bock</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer</font></td></tr></table></div><div style="margin-top:12pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.3
<SEQUENCE>10
<FILENAME>bxsl-20231231xex323.htm
<DESCRIPTION>EX-32.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i4314876db665466cb63d3f040b926e75_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 32.3</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Financial Officer of Blackstone Secured Lending Fund (the &#8220;Company&#8221;), does hereby certify that to the undersigned&#8217;s knowledge&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the Company&#8217;s Form 10-K for the year ended December&#160;31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the information contained in the Company&#8217;s Form 10-K for the year ended December&#160;31, 2023 fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2024</font></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.436%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Teddy Desloge</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teddy Desloge</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-top:9pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>11
<FILENAME>bxsl-20231231xex971.htm
<DESCRIPTION>EX-97.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ib5b39bbe79b54689a7ca980317ca25cc_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 97.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">APPENDIX II</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Incentive Compensation Clawback Policies and Procedures</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Blackstone Secured Lending Fund</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Overview</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Board of Trustees (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of Blackstone Secured Lending Fund, a Delaware statutory trust (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), has adopted this Incentive Compensation Clawback Policy (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) which requires the recoupment of certain incentive-based compensation in accordance with the terms herein and is intended to comply with Section 303A.14 of The New York Stock Exchange Listed Company Manual, as such section may be amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Listing Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The Company, as an externally-managed business development company regulated under the Investment Company Act of 1940, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">1940 Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), currently neither pays nor has any plans to pay or otherwise award Incentive Compensation to Covered Executives, but nevertheless has designed and implemented this Policy to comply with the Listing Rules. The Listing Rules require the Company to adopt this Policy regardless of whether Incentive Compensation is paid or otherwise awarded by the Company to Covered Executives. Capitalized terms not otherwise defined herein shall have the meanings assigned to such terms under Section 12 of this Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Interpretation and Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Board or, if designated by the Board, a committee thereof (the Board or such committee charged with administration of this Policy, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Policy Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall have full authority to interpret and enforce the Policy&#59; provided, however, that the Policy shall be interpreted in a manner consistent with its intent to meet the requirements of the Listing Rules.  As further set forth in Section 10 below, this Policy is intended to supplement any other clawback policies and procedures that the Company may have in place from time to time pursuant to other applicable law, plans, policies or agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Covered Executives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Policy applies to each current and former Executive Officer of the Company who serves or served as an Executive O&#64259;cer at any time during a performance period in respect of which Incentive Compensation is Received, to the extent that any portion of such Incentive Compensation is (a) Received by the Executive Officer during the last three completed Fiscal Years or any applicable Transition Period preceding the date that the Company is required to prepare a Restatement (regardless of whether any such Restatement is actually filed) and (b) determined to have included Erroneously Awarded Compensation.  For purposes of determining the relevant recovery period referenced in the preceding clause (a), the date that the Company is required to prepare a Restatement under the Policy is the earlier to occur of (i) the date that the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare a Restatement or (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare a Restatement.  Executive Officers subject to this Policy pursuant to this Section 3 are referred to herein as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Covered Executives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Recovery of Erroneously Awarded Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If any Erroneously Awarded Compensation is Received by a Covered Executive, the Company shall reasonably promptly take steps to recover such Erroneously Awarded Compensation in a manner described under Section 5 of this Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Forms of Recovery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Policy Administrator shall determine, in its sole discretion and in a manner that effectuates the purpose of the Listing Rules, one or more methods for recovering any Erroneously Awarded Compensation hereunder in accordance with Section 4 above, which may include, without limitation&#58; (a) requiring cash reimbursement&#59; (b) seeking </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">APII-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 97.1</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">recovery or forfeiture of any gain realized on the vesting, exercise, settlement, sale, transfer or other disposition of any equity-based awards&#59; (c) offsetting the amount to be recouped from any compensation otherwise owed by the Company to the Covered Executive&#59; (d) cancelling outstanding vested or unvested equity awards&#59; or (e) taking any other remedial and recovery action permitted by law, as determined by the Policy Administrator. To the extent the Covered Executive refuses to pay to the Company an amount equal to the Erroneously Awarded Compensation, the Company shall have the right to sue for repayment and&#47;or enforce the Covered Executive&#8217;s obligation to make payment through the reduction or cancellation of outstanding and future compensation. Any reduction, cancellation or forfeiture of compensation shall be done in compliance with Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">No Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall not indemnify any Covered Executive against the loss of any Erroneously Awarded Compensation for which the Policy Administrator has determined to seek recoupment pursuant to this Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Exceptions to the Recovery Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything in this Policy to the contrary, Erroneously Awarded Compensation need not be recovered pursuant to this Policy if the Policy Administrator (or, if the Policy Administrator is not composed solely of Independent Directors, a majority of the Independent Directors serving on the Board) determines that recovery would be impracticable as a result of any of the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">the direct expense paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered&#59; provided that, before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on expense of enforcement, the Company must make a reasonable attempt to recover such Erroneously Awarded Compensation, document such reasonable attempt(s) to recover, and provide that documentation to the Exchange&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">recovery would violate home country law where that law was adopted prior to November 28, 2022&#59; provided that, before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on violation of home country law, the Company must obtain an opinion of home country counsel, acceptable to the Exchange, that recovery would result in such a violation, and must provide such opinion to the Exchange&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and the regulations thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Policy Administrator Determination Final</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any determination by the Policy Administrator with respect to the Policy shall be final, conclusive and binding on all interested parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Policy may be amended by the Policy Administrator from time to time, to the extent permitted under the Listing Rules.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Non-Exclusivity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Nothing in the Policy shall be viewed as limiting the right of the Company or the Policy Administrator to pursue additional remedies or recoupment under or as required by any similar policy adopted by the Company or under the Company&#8217;s compensation plans, award agreements, employment agreements or similar agreements or the applicable provisions of any law, rule or regulation which may require or permit recoupment to a greater degree or with respect to additional compensation as compared to this Policy (but without duplication as to any recoupment already made with respect to Erroneously Awarded </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">APII-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 97.1</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Compensation pursuant to this Policy).  This Policy shall be interpreted in all respects to comply with the Listing Rules.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Covered Executives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in Section 3 of this Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Erroneously Awarded Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the amount of Incentive Compensation actually Received that exceeds the amount of Incentive Compensation that otherwise would have been Received had it been determined based on the restated amounts, and computed without regard to any taxes paid. For Incentive Compensation based on stock price or total shareholder return, where the amount of erroneously awarded Incentive Compensation is not subject to mathematical recalculation directly from the information in a Restatement&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">The calculation of Erroneously Awarded Compensation shall be based on a reasonable estimate of the effect of the Restatement on the stock price or total shareholder return upon which the Incentive Compensation was Received&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The Company shall maintain documentation of the determination of that reasonable estimate and provide such documentation to the Exchange.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean The New York Stock Exchange.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Company&#8217;s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the Company. Executive officers of the Company&#8217;s parent(s) or subsidiaries shall be deemed executive officers of the Company if they perform such policy-making functions for the Company. For the avoidance of doubt, &#8220;Executive Officer&#8221; does not include the Company&#8217;s investment adviser (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Adviser</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or any of the Adviser&#8217;s directors, partners, officers or employees, solely in their capacity as such.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Financial Reporting Measures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean measures that are determined and presented in accordance with the accounting principles used in preparing the Company&#8217;s financial statements, and any measures that are derived wholly or in part from such measures, including, without limitation&#58; stock price&#59; total shareholder return&#59; net asset value&#59; net investment income&#59; net income&#59; net realized or unrealized gains&#59; profitability&#59; financial ratios&#59; earnings before interest, taxes, depreciation and amortization&#59; funds from operations and adjusted funds from operations&#59; liquidity measures&#59; return measures (e.g., return on investments, return on assets)&#59; earnings measures (e.g., earnings per share) and any of such financial reporting measures relative to a peer group (in each case, regardless of whether such measures are presented within the Company&#8217;s financial statements or included in a filing with the Securities and Exchange Commission).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Fiscal Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Company&#8217;s fiscal year&#59; provided that a Transition Period between the last day of the Company&#8217;s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months will be deemed a completed fiscal year.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">APII-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 97.1</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean any compensation (whether cash or equity-based) that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure, and may include, but shall not be limited to, performance bonuses and long-term incentive awards such as stock options, stock appreciation rights, restricted stock, restricted stock units, performance share units or other equity-based awards.  For the avoidance of doubt, Incentive Compensation does not include (i) awards that are granted, earned and vested exclusively upon completion of a specified employment period, without any performance condition, and (ii) bonus awards that are discretionary or based on subjective goals or goals unrelated to Financial Reporting Measures. Notwithstanding the foregoing, compensation amounts shall not be considered &#8220;Incentive Compensation&#8221; for purposes of the Policy unless such compensation is Received (1) while the Company has a class of securities listed on a national securities exchange or a national securities association and (2) on or after October 2, 2023, the effective date of the Listing Rules.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Independent Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean a director who is determined by the Board to be &#8220;independent&#8221; for Board or Policy Administrator membership, as applicable, under the rules of the Exchange, as of any determination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Listing Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in Section 1 of this Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Incentive Compensation shall be deemed &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Received</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; in the Company&#8217;s fiscal period during which the Financial Reporting Measure specified in the Incentive Compensation award is attained, even if the payment or grant of the Incentive Compensation occurs after the end of that period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Restatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the Company&#8217;s previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Transition Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean any transition period that results from a change in the Company&#8217;s Fiscal Year within or immediately following the three completed Fiscal Years immediately preceding the Company&#8217;s requirement to prepare a Restatement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">APII-4</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>12
<FILENAME>bxsl-20231231xex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="if850e36fd04449f1a7efbe841b100dfa_41"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Section&#160;13(r) Disclosure</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">The disclosure reproduced below was initially included in the Annual Report on Form 10-K filed with the Securities and Exchange Commission by Blackstone Inc. (&#8220;Blackstone&#8221;) with respect to its fiscal year ended December 31, 2023, in accordance with Section 13(r) of the Securities Exchange Act of 1934, as amended, in regard to Mundys S.p.A. (formerly, Atlantia S.PA.).  Mundys S.p.A. may be, or may have been at the time considered to be, an affiliate of Blackstone, and therefore an affiliate of Blackstone Secured Lending Fund (&#8220;BXSL&#8221;).  BXSL did not independently verify or participate in the preparation of the disclosure reproduced below.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Blackstone included the following disclosure in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023&#58;</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mundys S.p.A. (formerly &#8220;Atlantia S.p.A.&#8221;) provided the disclosure reproduced below in connection with activities during the fiscal year ended December&#160;31, 2023. We have not independently verified or participated in the preparation of this disclosure.</font></div><div style="margin-top:6pt;padding-left:45.6pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Disclosure pursuant to Section&#160;13(r) of the Securities Exchange Act of 1934. Funds affiliated with Blackstone first invested in Mundys S.p.A. on November&#160;18, 2022 in connection with the voluntary public tender offer by Schema Alfa S.p.A. for all of the shares of Mundys S.p.A., pursuant to which such funds obtained a minority&#160;non-controlling&#160;interest in Mundys S.p.A. Mundys S.p.A. owns and controls Aeroporti di Roma S.p.A. (&#8220;ADR&#8221;), an operator of airports in Italy including Leonardo da Vinci-Fiumicino Airport. Iran Air has historically operated periodic flights to and from Leonardo da Vinci-Fiumicino Airport as authorized, from time to time, by an aviation-related bilateral agreement between Italy and Iran, scheduled in compliance with European Regulation 95&#47;93, and approved by the Italian Civil Aviation Authority. ADR, as airport operator, is under a mandatory obligation to provide airport services to all air carriers (including Iran Air) authorized by the applicable Italian authority. The relevant turnover attributable to these activities (whose consideration is calculated on the basis of general tariffs determined by such independent Italian authority) in the fiscal year ended December&#160;31, 2023 was less than &#8364;210,000. Mundys S.p.A. does not track profits specifically attributable to these activities.&#8221;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>bxsl-20231231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:c9da10f3-9ca1-46ab-8b82-2faa6d8e78e0,g:d2995a14-2db1-4369-b86a-a80f43cbbba9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bxsl="http://www.bxsl.com/20231231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bxsl.com/20231231">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.org/2006/xbrldi" schemaLocation="http://www.xbrl.org/2006/xbrldi-2006.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cef-pre/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bxsl-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bxsl-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bxsl-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bxsl-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.bxsl.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.bxsl.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofAssetsandLiabilities" roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities">
        <link:definition>0000003 - Statement - Consolidated Statements of Assets and Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofAssetsandLiabilitiesParenthetical" roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical">
        <link:definition>0000004 - Statement - Consolidated Statements of Assets and Liabilities (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofOperations">
        <link:definition>0000005 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinNetAssets" roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets">
        <link:definition>0000006 - Statement - Consolidated Statements of Changes in Net Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedScheduleofInvestments" roleURI="http://www.bxsl.com/role/ConsolidatedScheduleofInvestments">
        <link:definition>0000008 - Statement - Consolidated Schedule of Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedScheduleofInvestments_1" roleURI="http://www.bxsl.com/role/ConsolidatedScheduleofInvestments_1">
        <link:definition>0000008 - Statement - Consolidated Schedule of Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedScheduleofInvestmentsParenthetical" roleURI="http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical">
        <link:definition>0000009 - Statement - Consolidated Schedule of Investments (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedScheduleofInvestmentsParenthetical_1" roleURI="http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical_1">
        <link:definition>0000009 - Statement - Consolidated Schedule of Investments (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Organization" roleURI="http://www.bxsl.com/role/Organization">
        <link:definition>0000010 - Disclosure - Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.bxsl.com/role/SignificantAccountingPolicies">
        <link:definition>0000011 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AgreementsandRelatedPartyTransactions" roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactions">
        <link:definition>0000012 - Disclosure - Agreements and Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.bxsl.com/role/Investments">
        <link:definition>0000013 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.bxsl.com/role/FairValueMeasurements">
        <link:definition>0000014 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Borrowings" roleURI="http://www.bxsl.com/role/Borrowings">
        <link:definition>0000015 - Disclosure - Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingencies" roleURI="http://www.bxsl.com/role/CommitmentandContingencies">
        <link:definition>0000016 - Disclosure - Commitment and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetAssets" roleURI="http://www.bxsl.com/role/NetAssets">
        <link:definition>0000017 - Disclosure - Net Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.bxsl.com/role/EarningsPerShare">
        <link:definition>0000018 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.bxsl.com/role/IncomeTaxes">
        <link:definition>0000019 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialHighlightsandSeniorSecurities" roleURI="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecurities">
        <link:definition>0000020 - Disclosure - Financial Highlights and Senior Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.bxsl.com/role/SubsequentEvents">
        <link:definition>0000021 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>9954701 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.bxsl.com/role/InvestmentsTables">
        <link:definition>9954702 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.bxsl.com/role/FairValueMeasurementsTables">
        <link:definition>9954703 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsTables" roleURI="http://www.bxsl.com/role/BorrowingsTables">
        <link:definition>9954704 - Disclosure - Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetAssetsTables" roleURI="http://www.bxsl.com/role/NetAssetsTables">
        <link:definition>9954705 - Disclosure - Net Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.bxsl.com/role/EarningsPerShareTables">
        <link:definition>9954706 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.bxsl.com/role/IncomeTaxesTables">
        <link:definition>9954707 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialHighlightsandSeniorSecuritiesTables" roleURI="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesTables">
        <link:definition>9954708 - Disclosure - Financial Highlights and Senior Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesRevenueRecognitionIncomeTaxDetails" roleURI="http://www.bxsl.com/role/SignificantAccountingPoliciesRevenueRecognitionIncomeTaxDetails">
        <link:definition>9954709 - Disclosure - Significant Accounting Policies - Revenue Recognition / Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails" roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails">
        <link:definition>9954710 - Disclosure - Agreements and Related Party Transactions - Investment Advisory Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails" roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails">
        <link:definition>9954711 - Disclosure - Agreements and Related Party Transactions - Base Management Fee (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AgreementsandRelatedPartyTransactionsIncentiveFeesDetails" roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails">
        <link:definition>9954712 - Disclosure - Agreements and Related Party Transactions - Incentive Fees (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails" roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails">
        <link:definition>9954713 - Disclosure - Agreements and Related Party Transactions - Administration Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails" roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails">
        <link:definition>9954714 - Disclosure - Agreements and Related Party Transactions - Sub-Administration and Expense Support (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails" roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails">
        <link:definition>9954715 - Disclosure - Agreements and Related Party Transactions - Expense Payments and Reimbursement Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInvestmentPortfolioatCostandFairValueDetails" roleURI="http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails">
        <link:definition>9954716 - Disclosure - Investments - Investment Portfolio at Cost and Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInvestmentsatFairValuePercentDetails" roleURI="http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails">
        <link:definition>9954717 - Disclosure - Investments - Investments at Fair Value Percent (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsGeographicInvestmentDetails" roleURI="http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails">
        <link:definition>9954718 - Disclosure - Investments - Geographic Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAdditionalInformationDetails" roleURI="http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails">
        <link:definition>9954719 - Disclosure - Investments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails" roleURI="http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails">
        <link:definition>9954720 - Disclosure - Fair Value Measurements - Fair Value Hierarchy of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails" roleURI="http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails">
        <link:definition>9954721 - Disclosure - Fair Value Measurements - Summary of Changes in Fair Value of Investments Measured Using Level 3 Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsUnobservableInputsDetails" roleURI="http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails">
        <link:definition>9954722 - Disclosure - Fair Value Measurements - Unobservable Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9954723 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails" roleURI="http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails">
        <link:definition>9954724 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurements of Unsecured Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsJacksonHoleFundingFacilityDetails" roleURI="http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails">
        <link:definition>9954725 - Disclosure - Borrowings - Jackson Hole Funding Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsBreckenridgeFundingFacilityDetails" roleURI="http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails">
        <link:definition>9954726 - Disclosure - Borrowings - Breckenridge Funding Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsBigSkyFundingFacilityDetails" roleURI="http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails">
        <link:definition>9954727 - Disclosure - Borrowings - Big Sky Funding Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsRevolvingCreditFacilityDetails" roleURI="http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails">
        <link:definition>9954728 - Disclosure - Borrowings - Revolving Credit Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsUnsecuredDebtDetails" roleURI="http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails">
        <link:definition>9954729 - Disclosure - Borrowings - Unsecured Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsOutstandingDebtObligationsDetails" roleURI="http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails">
        <link:definition>9954730 - Disclosure - Borrowings - Outstanding Debt Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsAdditionalInformationDetails" roleURI="http://www.bxsl.com/role/BorrowingsAdditionalInformationDetails">
        <link:definition>9954731 - Disclosure - Borrowings - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsInterestExpenseDetails" roleURI="http://www.bxsl.com/role/BorrowingsInterestExpenseDetails">
        <link:definition>9954732 - Disclosure - Borrowings - Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesDetails" roleURI="http://www.bxsl.com/role/CommitmentandContingenciesDetails">
        <link:definition>9954733 - Disclosure - Commitment and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetAssetsSubscriptionsandDrawdownsDetails" roleURI="http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails">
        <link:definition>9954734 - Disclosure - Net Assets - Subscriptions and Drawdowns (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails" roleURI="http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails">
        <link:definition>9954735 - Disclosure - Net Assets - Schedule of Shares Issued and Proceeds Received (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetAssetsDistributionsDeclaredDetails" roleURI="http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails">
        <link:definition>9954736 - Disclosure - Net Assets - Distributions Declared (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetAssetsDividendReinvestmentDetails" roleURI="http://www.bxsl.com/role/NetAssetsDividendReinvestmentDetails">
        <link:definition>9954737 - Disclosure - Net Assets - Dividend Reinvestment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetAssetsScheduledofAmountsReceivedandSharesIssuedDetails" roleURI="http://www.bxsl.com/role/NetAssetsScheduledofAmountsReceivedandSharesIssuedDetails">
        <link:definition>9954738 - Disclosure - Net Assets - Scheduled of Amounts Received and Shares Issued (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetAssetsShareRepurchasePlanDetails" roleURI="http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails">
        <link:definition>9954739 - Disclosure - Net Assets - Share Repurchase Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetAssetsShareRepurchasesDetails" roleURI="http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails">
        <link:definition>9954740 - Disclosure - Net Assets - Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetAssetsShareholderTransferRestrictionsDetails" roleURI="http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails">
        <link:definition>9954741 - Disclosure - Net Assets - Shareholder Transfer Restrictions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.bxsl.com/role/EarningsPerShareDetails">
        <link:definition>9954742 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofPermanentDifferencesDetails" roleURI="http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails">
        <link:definition>9954743 - Disclosure - Income Taxes - Schedule of Permanent Differences (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.bxsl.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>9954744 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofChangesinNetAssetsDetails" roleURI="http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails">
        <link:definition>9954745 - Disclosure - Income Taxes - Schedule of Changes in Net Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails" roleURI="http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails">
        <link:definition>9954746 - Disclosure - Income Taxes - Schedule of Accumulated Gains (Losses) as Calculated on Tax Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofTaxBasisofInvestmentsDetails" roleURI="http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails">
        <link:definition>9954747 - Disclosure - Income Taxes - Schedule of Tax Basis of Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialHighlightsandSeniorSecuritiesDetails" roleURI="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails">
        <link:definition>9954748 - Disclosure - Financial Highlights and Senior Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.bxsl.com/role/SubsequentEventsDetails">
        <link:definition>9954749 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember" abstract="true" name="ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage" abstract="false" name="IncomeBasedIncentiveFeesCatchUpAmountPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_AerospaceAndDefenseSectorMember" abstract="true" name="AerospaceAndDefenseSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_CapitalGainsIncentiveFeeExpense" abstract="false" name="CapitalGainsIncentiveFeeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_Company10b51PlanMember" abstract="true" name="Company10b51PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentsUnrealizedGainLossMember" abstract="true" name="InvestmentsUnrealizedGainLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember" abstract="true" name="WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ElectronicEquipmentInstrumentsComponentsMember" abstract="true" name="ElectronicEquipmentInstrumentsComponentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_Scenario2Member" abstract="true" name="Scenario2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_SpecialtyRetailMember" abstract="true" name="SpecialtyRetailMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_A3625NotesDue2026Member" abstract="true" name="A3625NotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_CommitmentFeeScenarioAxis" abstract="true" name="CommitmentFeeScenarioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bxsl_VariableRateScenarioDomain" abstract="true" name="VariableRateScenarioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount" abstract="false" name="InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_InvestmentPortfolioMember" abstract="true" name="InvestmentPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember" abstract="true" name="WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember" abstract="true" name="WeGenerallyDoNotControlOurPortfolioCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember" abstract="true" name="OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember" abstract="true" name="JacksonHoleFundingFacilityForeignCurrencyAdvancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember" abstract="true" name="SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember" abstract="true" name="FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember" abstract="true" name="TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_IndustrialConglomeratesMember" abstract="true" name="IndustrialConglomeratesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_DebtIssuanceCostsIncurredButNotYetPaid" abstract="false" name="DebtIssuanceCostsIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_InterestPayableInterestExpense" abstract="false" name="InterestPayableInterestExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_DividendsOrdinaryIncomeMember" abstract="true" name="DividendsOrdinaryIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember" abstract="true" name="ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_PaidInKindInterestNoncash" abstract="false" name="PaidInKindInterestNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_BlackstoneDonegalHoldingsLPMember" abstract="true" name="BlackstoneDonegalHoldingsLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_Scenario3Member" abstract="true" name="Scenario3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_DividendsCapitalGainsMember" abstract="true" name="DividendsCapitalGainsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember" abstract="true" name="ForceMajeureEventsMayAdverselyAffectOurOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_Dividends3Member" abstract="true" name="Dividends3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable" abstract="false" name="IncreaseDecreaseInIncomeBasedIncentiveFeePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_IncomeBasedIncentiveFeesScenarioAxis" abstract="true" name="IncomeBasedIncentiveFeesScenarioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock" abstract="false" name="InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="bxsl_UnsecuredDebtRealizedGainLossMember" abstract="true" name="UnsecuredDebtRealizedGainLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_Dividends9Member" abstract="true" name="Dividends9Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember" abstract="true" name="AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember" abstract="true" name="WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_WeMayInvestThroughVariousJointVenturesMember" abstract="true" name="WeMayInvestThroughVariousJointVenturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ScheduleOfSharesRepurchasedTableTextBlock" abstract="false" name="ScheduleOfSharesRepurchasedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome" abstract="false" name="InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock" abstract="false" name="ScheduleOfDividendReinvestmentPlanTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="bxsl_InvestmentCompanyPerShareDataAbstract" abstract="true" name="InvestmentCompanyPerShareDataAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember" abstract="true" name="TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember" abstract="true" name="InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_RelatedPartyTransactionTerminationNoticePeriod" abstract="false" name="RelatedPartyTransactionTerminationNoticePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember" abstract="true" name="OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember" abstract="true" name="ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_QualifyingAssetsMember" abstract="true" name="QualifyingAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_OilGasConsumableFuelsMember" abstract="true" name="OilGasConsumableFuelsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_RealEstateManagementDevelopmentSectorMember" abstract="true" name="RealEstateManagementDevelopmentSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_EquitySecuritiesRealizedGainLossMember" abstract="true" name="EquitySecuritiesRealizedGainLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember" abstract="true" name="InitialPublicOfferingShareholderTransferRestrictionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember" abstract="true" name="RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_NonQualifyingAssetsMember" abstract="true" name="NonQualifyingAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember" abstract="true" name="OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember" abstract="true" name="ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember" abstract="true" name="WeAreSubjectToRisksRelatedToESGInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage" abstract="false" name="LineOfCreditFacilityMinimumCapacityUtilizationPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements" abstract="false" name="PaymentsOfDebtIssuanceCostsLineOfCreditArrangements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage" abstract="false" name="IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_A2750NotesDue2026Member" abstract="true" name="A2750NotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember" abstract="true" name="OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember" abstract="true" name="WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember" abstract="true" name="WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_RetainedEarningsAccumulatedDeficitAudited" abstract="false" name="RetainedEarningsAccumulatedDeficitAudited" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember" abstract="true" name="OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_DebtSecuritiesFirstLienRealizedGainLossMember" abstract="true" name="DebtSecuritiesFirstLienRealizedGainLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_StockRepurchasedDuringPeriodAverageCostPerShare" abstract="false" name="StockRepurchasedDuringPeriodAverageCostPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="bxsl_DiversifiedTelecommunicationServicesSectorMember" abstract="true" name="DiversifiedTelecommunicationServicesSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_SubAdministrationAgreementMember" abstract="true" name="SubAdministrationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_A3650NotesDue2023Member" abstract="true" name="A3650NotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" abstract="false" name="InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember" abstract="true" name="TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember" abstract="true" name="WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TechnologyHardwareStorageAndPeripheralsMember" abstract="true" name="TechnologyHardwareStorageAndPeripheralsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember" abstract="true" name="OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_DebtSecuritiesFirstLienMember" abstract="true" name="DebtSecuritiesFirstLienMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_BERMUDAAndCAYMANISLANDMember" abstract="true" name="BERMUDAAndCAYMANISLANDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_ValuationAssetRecoverabilityMember" abstract="true" name="ValuationAssetRecoverabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember" abstract="true" name="WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember" abstract="true" name="WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_Dividends8Member" abstract="true" name="Dividends8Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember" abstract="true" name="ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ElectricalEquipmentSectorMember" abstract="true" name="ElectricalEquipmentSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_IncomeBasedIncentiveFeesRate" abstract="false" name="IncomeBasedIncentiveFeesRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_A2023NotesMember" abstract="true" name="A2023NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember" abstract="true" name="WeMayHaveDifficultySourcingInvestmentOpportunitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_VariableRateScenarioAxis" abstract="true" name="VariableRateScenarioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bxsl_Dividends1Member" abstract="true" name="Dividends1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InternetAndDirectMarketingRetailMember" abstract="true" name="InternetAndDirectMarketingRetailMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember" abstract="true" name="ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ValuationYieldAnalysisApproachMember" abstract="true" name="ValuationYieldAnalysisApproachMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome" abstract="false" name="InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_DistributorsSectorMember" abstract="true" name="DistributorsSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ExciseTaxesPaid" abstract="false" name="ExciseTaxesPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member" abstract="true" name="CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember" abstract="true" name="HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier" abstract="false" name="LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bxsl_InvestmentOwnedNonaccrualNumberOfLoans" abstract="false" name="InvestmentOwnedNonaccrualNumberOfLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" abstract="false" name="InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold" abstract="false" name="IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember" abstract="true" name="WeMayExperienceFluctuationsInOurQuarterlyResultsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn" abstract="false" name="IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember" abstract="true" name="WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_Scenario1Member" abstract="true" name="Scenario1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_A2125SeniorNotesDue2027Member" abstract="true" name="A2125SeniorNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember" abstract="true" name="PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_A2028NotesMember" abstract="true" name="A2028NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_AirFreightLogisticsSectorMember" abstract="true" name="AirFreightLogisticsSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember" abstract="true" name="PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentTypeConcentrationRiskMember" abstract="true" name="InvestmentTypeConcentrationRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_IncomeBasedIncentiveFeeExpense" abstract="false" name="IncomeBasedIncentiveFeeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember" abstract="true" name="InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_DebtSecuritiesSecondLienMember" abstract="true" name="DebtSecuritiesSecondLienMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember" abstract="true" name="ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_MediaSectorMember" abstract="true" name="MediaSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember" abstract="true" name="VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember" abstract="true" name="OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_MeasurementInputMarketMultipleMember" abstract="true" name="MeasurementInputMarketMultipleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_RelatedPartyTransactionRenewalTerm" abstract="false" name="RelatedPartyTransactionRenewalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bxsl_InvestmentPercentageOfPortfolioAboveFloorRate" abstract="false" name="InvestmentPercentageOfPortfolioAboveFloorRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare" abstract="false" name="DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable" abstract="false" name="IncreaseDecreaseInCapitalGainsIncentiveFeePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_ExpenseSupportReimbursementRelatedParty" abstract="false" name="ExpenseSupportReimbursementRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract" abstract="true" name="InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bxsl_AtTheMarketOfferingOffering1Member" abstract="true" name="AtTheMarketOfferingOffering1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" abstract="false" name="AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_SubscriptionFacilityMember" abstract="true" name="SubscriptionFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_JacksonHoleFundingFacilityDollarAdvancesMember" abstract="true" name="JacksonHoleFundingFacilityDollarAdvancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_CitiBankRevolvingCreditFacilityMember" abstract="true" name="CitiBankRevolvingCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ConstructionEngineeringSectorMember" abstract="true" name="ConstructionEngineeringSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_A2850NotesDue2028Member" abstract="true" name="A2850NotesDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TransferRestrictionsAxis" abstract="true" name="TransferRestrictionsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember" abstract="true" name="WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember" abstract="true" name="ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_GroundTransportationMember" abstract="true" name="GroundTransportationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember" abstract="true" name="AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome" abstract="false" name="IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember" abstract="true" name="ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod" abstract="false" name="RelatedPartyTransactionVoluntaryWaiverPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bxsl_CapitalGainsBasedIncentiveFeesRate" abstract="false" name="CapitalGainsBasedIncentiveFeesRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember" abstract="true" name="ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember" abstract="true" name="PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_Dividends7Member" abstract="true" name="Dividends7Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_VoluntaryWaiverScenarioDomain" abstract="true" name="VoluntaryWaiverScenarioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction" abstract="false" name="InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember" abstract="true" name="CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember" abstract="true" name="UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember" abstract="true" name="OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_BigSkyFundingFacilityMember" abstract="true" name="BigSkyFundingFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember" abstract="true" name="InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentCompanySupplementalDataAbstract" abstract="true" name="InvestmentCompanySupplementalDataAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome" abstract="false" name="InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_VoluntaryWaiverInPlaceMember" abstract="true" name="VoluntaryWaiverInPlaceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue" abstract="false" name="SaleOfStockNumberOfSharesIssuedInTransactionValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee" abstract="false" name="InterestPayableDebtInstrumentUnusedBorrowingCapacityFee" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember" abstract="true" name="AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember" abstract="true" name="DebtSecuritiesSecondLienUnrealizedGainLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_Dividends5Member" abstract="true" name="Dividends5Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember" abstract="true" name="GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember" abstract="true" name="RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_DelayedDrawTermLoansAndRevolversMember" abstract="true" name="DelayedDrawTermLoansAndRevolversMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember" abstract="true" name="TheImpactOfFinancialReformLegislationOnUsIsUncertainMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember" abstract="true" name="InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock" abstract="false" name="InvestmentCompanyChangeInNetAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="bxsl_ElectronicEquipmentInstrumentsAndComponentsMember" abstract="true" name="ElectronicEquipmentInstrumentsAndComponentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember" abstract="true" name="OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember" abstract="true" name="WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TransferRestrictionsDomain" abstract="true" name="TransferRestrictionsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_NumberOfEquityDistributionAgreements" abstract="false" name="NumberOfEquityDistributionAgreements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember" abstract="true" name="DebtSecuritiesFirstLienUnrealizedGainLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember" abstract="true" name="WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentsAtFairValueMember" abstract="true" name="InvestmentsAtFairValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ExpenseSupportAgreementExcessOperatingFundsMember" abstract="true" name="ExpenseSupportAgreementExcessOperatingFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_OilGasAndConsumableFuelsMember" abstract="true" name="OilGasAndConsumableFuelsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_VoluntaryWaiverNotInPlaceMember" abstract="true" name="VoluntaryWaiverNotInPlaceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_StockIssuedDuringPeriodValueNewIssuesGross" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesGross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember" abstract="true" name="WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member" abstract="true" name="CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome" abstract="false" name="InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember" abstract="true" name="TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentOwnedAtFairValueMember" abstract="true" name="InvestmentOwnedAtFairValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_SaleOfStockRemainingAuthorizedAmount" abstract="false" name="SaleOfStockRemainingAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember" abstract="true" name="WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember" abstract="true" name="AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome" abstract="false" name="InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_PharmaceuticalsSectorMember" abstract="true" name="PharmaceuticalsSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ITServicesSectorMember" abstract="true" name="ITServicesSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember" abstract="true" name="WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_A2027NotesMember" abstract="true" name="A2027NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember" abstract="true" name="InvestingInOurSharesInvolvesAHighDegreeOfRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_IncomeBasedIncentiveFeesScenarioDomain" abstract="true" name="IncomeBasedIncentiveFeesScenarioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember" abstract="true" name="SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember" abstract="true" name="WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_VoluntaryWaiverScenarioAxis" abstract="true" name="VoluntaryWaiverScenarioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bxsl_DebtSecuritiesSecondLienRealizedGainLossMember" abstract="true" name="DebtSecuritiesSecondLienRealizedGainLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_Dividends6Member" abstract="true" name="Dividends6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ProfessionalServicesSectorMember" abstract="true" name="ProfessionalServicesSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction" abstract="false" name="DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_ExpenseSupportAgreementMember" abstract="true" name="ExpenseSupportAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember" abstract="true" name="AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember" abstract="true" name="NoShareholderApprovalIsRequiredForCertainMergersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember" abstract="true" name="PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember" abstract="true" name="TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ElectricUtilitiesMember" abstract="true" name="ElectricUtilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember" abstract="true" name="ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember" abstract="true" name="ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_IncentiveFeePayableIncome" abstract="false" name="IncentiveFeePayableIncome" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember" abstract="true" name="WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_DistributionCostsIncurredButNotYetPaid" abstract="false" name="DistributionCostsIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_LineOfCreditFacilityUnusedCapacityPercentage" abstract="false" name="LineOfCreditFacilityUnusedCapacityPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_DebtSecuritiesFixedRateMember" abstract="true" name="DebtSecuritiesFixedRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember" abstract="true" name="IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember" abstract="true" name="WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_RelatedPartyTransactionInitialTerm" abstract="false" name="RelatedPartyTransactionInitialTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bxsl_Dividends4Member" abstract="true" name="Dividends4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract" abstract="true" name="InvestmentCompanyRatioToAverageNetAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bxsl_Scenario4Member" abstract="true" name="Scenario4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TransportationInfrastructureSectorMember" abstract="true" name="TransportationInfrastructureSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_A2026NotesMember" abstract="true" name="A2026NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_AbilityToAchieveInvestmentObjectivesMember" abstract="true" name="AbilityToAchieveInvestmentObjectivesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentsRealizedGainLossMember" abstract="true" name="InvestmentsRealizedGainLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember" abstract="true" name="WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_NetRealizedGainsLossesAbstract" abstract="true" name="NetRealizedGainsLossesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember" abstract="true" name="OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember" abstract="true" name="WeMayEnterIntoSecuritiesLendingAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember" abstract="true" name="WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember" abstract="true" name="OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_DebtSecuritiesVariableRateMember" abstract="true" name="DebtSecuritiesVariableRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_BuildingProductsSectorMember" abstract="true" name="BuildingProductsSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions" abstract="false" name="InvestmentCompanyDistributableEarningsLossBeforeDeductions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember" abstract="true" name="EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember" abstract="true" name="ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember" abstract="true" name="TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember" abstract="true" name="LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember" abstract="true" name="PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember" abstract="true" name="TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_Company10b18PlanMember" abstract="true" name="Company10b18PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_UnsecuredDebtUnrealizedGainLossMember" abstract="true" name="UnsecuredDebtUnrealizedGainLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_WeMayDefaultUnderOurCreditFacilitiesMember" abstract="true" name="WeMayDefaultUnderOurCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_New2026NotesMember" abstract="true" name="New2026NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_JacksonHoleFundingFacilityMember" abstract="true" name="JacksonHoleFundingFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember" abstract="true" name="OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_HealthCareTechnologySectorMember" abstract="true" name="HealthCareTechnologySectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember" abstract="true" name="TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_MarineMember" abstract="true" name="MarineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TradingCompaniesDistributorsSectorMember" abstract="true" name="TradingCompaniesDistributorsSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_IncentiveFeePayableCapitalGains" abstract="false" name="IncentiveFeePayableCapitalGains" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences" abstract="false" name="InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember" abstract="true" name="WeMayNotRealizeGainsFromOurEquityInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember" abstract="true" name="TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember" abstract="true" name="ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember" abstract="true" name="WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember" abstract="true" name="TheNAVOfOurSharesMayFluctuateSignificantlyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember" abstract="true" name="InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember" abstract="true" name="WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember" abstract="true" name="WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_AdministrationAgreementMember" abstract="true" name="AdministrationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember" abstract="true" name="ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_CommitmentFeeScenarioDomain" abstract="true" name="CommitmentFeeScenarioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember" abstract="true" name="AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit" abstract="false" name="LineOfCreditFacilityAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome" abstract="false" name="InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_SoftwareSectorMember" abstract="true" name="SoftwareSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_EquitySecuritiesUnrealizedGainLossMember" abstract="true" name="EquitySecuritiesUnrealizedGainLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember" abstract="true" name="FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember" abstract="true" name="EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember" abstract="true" name="WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentAdvisoryAgreementMember" abstract="true" name="InvestmentAdvisoryAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" abstract="false" name="InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bxsl_RoadAndRailMember" abstract="true" name="RoadAndRailMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" abstract="false" name="InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember" abstract="true" name="CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio" abstract="false" name="DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bxsl_HealthCareProvidersServicesSectorMember" abstract="true" name="HealthCareProvidersServicesSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_RelatedPartyTransactionExpensePaymentPeriod" abstract="false" name="RelatedPartyTransactionExpensePaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bxsl_CommercialServicesSuppliesSectorMember" abstract="true" name="CommercialServicesSuppliesSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember" abstract="true" name="AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage" abstract="false" name="ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_BreckenridgeFundingFacilityMember" abstract="true" name="BreckenridgeFundingFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_Dividends2Member" abstract="true" name="Dividends2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember" abstract="true" name="TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate" abstract="false" name="RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="bxsl_HealthCareEquipmentSuppliesSectorMember" abstract="true" name="HealthCareEquipmentSuppliesSectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_PaperAndForestProductsMember" abstract="true" name="PaperAndForestProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember" abstract="true" name="OurPortfolioCompaniesMayBeHighlyLeveragedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember" abstract="true" name="SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember" abstract="true" name="AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_PaperForestProductsMember" abstract="true" name="PaperForestProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember" abstract="true" name="FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember" abstract="true" name="WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember" abstract="true" name="ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember" abstract="true" name="OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember" abstract="true" name="TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember" abstract="true" name="AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_MachineryMember" abstract="true" name="MachineryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bxsl_MeasurementInputPerformanceMultipleMember" abstract="true" name="MeasurementInputPerformanceMultipleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>14
<FILENAME>bxsl-20231231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:c9da10f3-9ca1-46ab-8b82-2faa6d8e78e0,g:d2995a14-2db1-4369-b86a-a80f43cbbba9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedStatementsofAssetsandLiabilities"/>
  <link:calculationLink xlink:role="http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d705cfc7-6da7-4813-86ba-5d5341f9346c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f5138d71-ee8b-4dc1-8c53-13caeccbd804" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d705cfc7-6da7-4813-86ba-5d5341f9346c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f5138d71-ee8b-4dc1-8c53-13caeccbd804" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a9c47bf3-218e-4eac-956c-45fac9911111" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d705cfc7-6da7-4813-86ba-5d5341f9346c" xlink:to="loc_us-gaap_StockholdersEquity_a9c47bf3-218e-4eac-956c-45fac9911111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bc1821b3-f003-45f0-b83b-9947113db61e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d705cfc7-6da7-4813-86ba-5d5341f9346c" xlink:to="loc_us-gaap_Liabilities_bc1821b3-f003-45f0-b83b-9947113db61e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7417b6f3-8ddb-4db1-95de-96e76a98d464" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6fb04714-c2ce-4174-8cca-31069f00d802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7417b6f3-8ddb-4db1-95de-96e76a98d464" xlink:to="loc_us-gaap_CommonStockValue_6fb04714-c2ce-4174-8cca-31069f00d802" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3269833a-ab8a-4e4b-b359-ab05edc59b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7417b6f3-8ddb-4db1-95de-96e76a98d464" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3269833a-ab8a-4e4b-b359-ab05edc59b8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_eac7e244-e096-40a9-9b1e-a3f2e5d8dbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7417b6f3-8ddb-4db1-95de-96e76a98d464" xlink:to="loc_us-gaap_AdditionalPaidInCapital_eac7e244-e096-40a9-9b1e-a3f2e5d8dbf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_45478ab2-7a55-412b-9c16-f0967a4a07d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncentiveFeePayableCapitalGains_07c0638d-2433-47e9-8fab-f98f660c894b" xlink:href="bxsl-20231231.xsd#bxsl_IncentiveFeePayableCapitalGains"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_45478ab2-7a55-412b-9c16-f0967a4a07d0" xlink:to="loc_bxsl_IncentiveFeePayableCapitalGains_07c0638d-2433-47e9-8fab-f98f660c894b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1af6c043-9f9c-4a65-96d0-f4bb838a3875" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_45478ab2-7a55-412b-9c16-f0967a4a07d0" xlink:to="loc_us-gaap_LongTermDebt_1af6c043-9f9c-4a65-96d0-f4bb838a3875" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncentiveFeePayableIncome_e7b262f3-840c-4073-a3e7-b3a063eeb997" xlink:href="bxsl-20231231.xsd#bxsl_IncentiveFeePayableIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_45478ab2-7a55-412b-9c16-f0967a4a07d0" xlink:to="loc_bxsl_IncentiveFeePayableIncome_e7b262f3-840c-4073-a3e7-b3a063eeb997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_162058df-d794-4eec-8403-fa5ddf3b62e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_45478ab2-7a55-412b-9c16-f0967a4a07d0" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_162058df-d794-4eec-8403-fa5ddf3b62e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionPayable_972ab25c-3d24-4032-8869-d32760d8d217" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DistributionPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_45478ab2-7a55-412b-9c16-f0967a4a07d0" xlink:to="loc_us-gaap_DistributionPayable_972ab25c-3d24-4032-8869-d32760d8d217" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeePayable_8262c4be-3a2d-4f59-ab08-b1f74f3109e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeePayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_45478ab2-7a55-412b-9c16-f0967a4a07d0" xlink:to="loc_us-gaap_ManagementFeePayable_8262c4be-3a2d-4f59-ab08-b1f74f3109e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_b18f8708-9af2-4bd2-ad03-1e44690f73f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_45478ab2-7a55-412b-9c16-f0967a4a07d0" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_b18f8708-9af2-4bd2-ad03-1e44690f73f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayableInvestmentPurchase_44e9fd39-5a8e-4009-94dd-1d53392a3904" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayableInvestmentPurchase"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_45478ab2-7a55-412b-9c16-f0967a4a07d0" xlink:to="loc_us-gaap_PayableInvestmentPurchase_44e9fd39-5a8e-4009-94dd-1d53392a3904" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_676cd257-36ba-4328-9161-5ce849f44844" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_45478ab2-7a55-412b-9c16-f0967a4a07d0" xlink:to="loc_us-gaap_OtherLiabilities_676cd257-36ba-4328-9161-5ce849f44844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2a7437fe-4639-4251-a10f-509818709dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendAndInterestReceivable_99b137da-9754-426e-8730-2a9823ba79d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendAndInterestReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2a7437fe-4639-4251-a10f-509818709dd8" xlink:to="loc_us-gaap_DividendAndInterestReceivable_99b137da-9754-426e-8730-2a9823ba79d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_63ea2ee5-9764-4cf1-a37b-0b2a06f350af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2a7437fe-4639-4251-a10f-509818709dd8" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_63ea2ee5-9764-4cf1-a37b-0b2a06f350af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d85924d5-ed2d-4f17-a4be-21c4891414f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2a7437fe-4639-4251-a10f-509818709dd8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d85924d5-ed2d-4f17-a4be-21c4891414f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableInvestmentSale_66aac194-7310-4fbd-9975-e9e7c96d42e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableInvestmentSale"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2a7437fe-4639-4251-a10f-509818709dd8" xlink:to="loc_us-gaap_ReceivableInvestmentSale_66aac194-7310-4fbd-9975-e9e7c96d42e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_83bd5a07-1647-4037-a73d-717ff52b35b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2a7437fe-4639-4251-a10f-509818709dd8" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_83bd5a07-1647-4037-a73d-717ff52b35b6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.bxsl.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_77e06998-492c-4fe1-9dde-610ebb21d98a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_d1df96d6-63b1-4ec7-b712-c278d84cb5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense_77e06998-492c-4fe1-9dde-610ebb21d98a" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_d1df96d6-63b1-4ec7-b712-c278d84cb5bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense_483ded45-3595-4f93-8f5c-429770443518" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense_77e06998-492c-4fe1-9dde-610ebb21d98a" xlink:to="loc_us-gaap_ManagementFeeExpense_483ded45-3595-4f93-8f5c-429770443518" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_ac4748d1-cd3a-4600-9254-66020fd07cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense_77e06998-492c-4fe1-9dde-610ebb21d98a" xlink:to="loc_us-gaap_ProfessionalFees_ac4748d1-cd3a-4600-9254-66020fd07cf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_170e8f0f-3016-4700-919d-5dee1719559c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense_77e06998-492c-4fe1-9dde-610ebb21d98a" xlink:to="loc_us-gaap_InterestExpense_170e8f0f-3016-4700-919d-5dee1719559c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrusteeFees_8d80dd02-c8f9-4525-a7dd-89de1d7e6af3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrusteeFees"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense_77e06998-492c-4fe1-9dde-610ebb21d98a" xlink:to="loc_us-gaap_TrusteeFees_8d80dd02-c8f9-4525-a7dd-89de1d7e6af3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeeExpense_1696204f-4821-4dc4-95d7-c4500c984cfa" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense_77e06998-492c-4fe1-9dde-610ebb21d98a" xlink:to="loc_bxsl_IncomeBasedIncentiveFeeExpense_1696204f-4821-4dc4-95d7-c4500c984cfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CapitalGainsIncentiveFeeExpense_3e353630-ae5e-4f3d-bc88-5e7b1f217ca3" xlink:href="bxsl-20231231.xsd#bxsl_CapitalGainsIncentiveFeeExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense_77e06998-492c-4fe1-9dde-610ebb21d98a" xlink:to="loc_bxsl_CapitalGainsIncentiveFeeExpense_3e353630-ae5e-4f3d-bc88-5e7b1f217ca3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdministrativeFeesExpense_efcd9c32-8bd4-4289-a8e1-d693037efb45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdministrativeFeesExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense_77e06998-492c-4fe1-9dde-610ebb21d98a" xlink:to="loc_us-gaap_AdministrativeFeesExpense_efcd9c32-8bd4-4289-a8e1-d693037efb45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_13065b0e-3938-4e8c-9244-6c67352164db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_57ba7d80-a4ec-445e-b0b1-f4037ce6f638" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_13065b0e-3938-4e8c-9244-6c67352164db" xlink:to="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_57ba7d80-a4ec-445e-b0b1-f4037ce6f638" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax_2f9db92a-79cf-4770-ad23-430fdaf4c9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_13065b0e-3938-4e8c-9244-6c67352164db" xlink:to="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax_2f9db92a-79cf-4770-ad23-430fdaf4c9e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_4b1d6794-7f11-4f2c-841e-df8b5cadece7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_2d01e894-b5bf-43e9-8cef-7d4c75095bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_4b1d6794-7f11-4f2c-841e-df8b5cadece7" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_2d01e894-b5bf-43e9-8cef-7d4c75095bc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_25a41772-1d28-4db0-ba79-881218038a25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_4b1d6794-7f11-4f2c-841e-df8b5cadece7" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_25a41772-1d28-4db0-ba79-881218038a25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_78f330a6-3c2f-4004-a3dd-d6d3c415abaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_191cff81-10f6-45c7-856e-8abc2208c790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_78f330a6-3c2f-4004-a3dd-d6d3c415abaf" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_191cff81-10f6-45c7-856e-8abc2208c790" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax_821f8efb-6ea8-4b85-97cf-00c3f6cfa640" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_78f330a6-3c2f-4004-a3dd-d6d3c415abaf" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax_821f8efb-6ea8-4b85-97cf-00c3f6cfa640" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax_76321c35-15e3-4187-96c8-b9260d00283f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_696d5e71-8106-476f-964b-820efc130681" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax_76321c35-15e3-4187-96c8-b9260d00283f" xlink:to="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_696d5e71-8106-476f-964b-820efc130681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_aeaa120a-f10a-4ff9-bdec-e97c182e0ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax_76321c35-15e3-4187-96c8-b9260d00283f" xlink:to="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_aeaa120a-f10a-4ff9-bdec-e97c182e0ac2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_8926f175-24bb-49d6-ba17-b10688b3120b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_dd33964d-f602-443d-8f05-1c527de4caf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_8926f175-24bb-49d6-ba17-b10688b3120b" xlink:to="loc_us-gaap_NetInvestmentIncome_dd33964d-f602-443d-8f05-1c527de4caf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_4147faee-92b4-4837-aae7-ea53abd4844a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_8926f175-24bb-49d6-ba17-b10688b3120b" xlink:to="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_4147faee-92b4-4837-aae7-ea53abd4844a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossInvestmentIncomeOperating_659e7d98-990b-47bc-8ddd-9b8888c8b545" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossInvestmentIncomeOperating"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FeeIncome_b31777a4-2daa-4bee-8cb0-ceb0929c630f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FeeIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossInvestmentIncomeOperating_659e7d98-990b-47bc-8ddd-9b8888c8b545" xlink:to="loc_us-gaap_FeeIncome_b31777a4-2daa-4bee-8cb0-ceb0929c630f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendIncomeOperating_1ba0f437-0b87-467b-9856-f5281e27f403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossInvestmentIncomeOperating_659e7d98-990b-47bc-8ddd-9b8888c8b545" xlink:to="loc_us-gaap_DividendIncomeOperating_1ba0f437-0b87-467b-9856-f5281e27f403" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingPaidInCash_58806804-1bff-4327-85c5-2522a6758ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOperatingPaidInCash"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossInvestmentIncomeOperating_659e7d98-990b-47bc-8ddd-9b8888c8b545" xlink:to="loc_us-gaap_InterestIncomeOperatingPaidInCash_58806804-1bff-4327-85c5-2522a6758ef4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingPaidInKind_5b284c38-b5d8-4066-b858-2dc992b833e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOperatingPaidInKind"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossInvestmentIncomeOperating_659e7d98-990b-47bc-8ddd-9b8888c8b545" xlink:to="loc_us-gaap_InterestIncomeOperatingPaidInKind_5b284c38-b5d8-4066-b858-2dc992b833e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_73c635d6-c506-47dc-acbe-46cca8daddc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossInvestmentIncomeOperating_aba1bdab-d983-46a6-a9bc-8ebcab73ceeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossInvestmentIncomeOperating"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetInvestmentIncome_73c635d6-c506-47dc-acbe-46cca8daddc1" xlink:to="loc_us-gaap_GrossInvestmentIncomeOperating_aba1bdab-d983-46a6-a9bc-8ebcab73ceeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement_9772f3dc-7eb5-4ced-a1db-4a4a42de9d17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetInvestmentIncome_73c635d6-c506-47dc-acbe-46cca8daddc1" xlink:to="loc_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement_9772f3dc-7eb5-4ced-a1db-4a4a42de9d17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement_f743cc3a-e5de-4e71-b8cc-996ed9c92be0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyVoluntaryFeeWaived_2054a3aa-0477-4b42-9903-c092d5ee3056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyVoluntaryFeeWaived"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement_f743cc3a-e5de-4e71-b8cc-996ed9c92be0" xlink:to="loc_us-gaap_InvestmentCompanyVoluntaryFeeWaived_2054a3aa-0477-4b42-9903-c092d5ee3056" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_24905056-d1dd-4376-80a4-58d4a87cdcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement_f743cc3a-e5de-4e71-b8cc-996ed9c92be0" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_24905056-d1dd-4376-80a4-58d4a87cdcbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyContractualFeeWaived_5655e229-adfa-4b1f-b5d4-347c8b3938ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyContractualFeeWaived"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement_f743cc3a-e5de-4e71-b8cc-996ed9c92be0" xlink:to="loc_us-gaap_InvestmentCompanyContractualFeeWaived_5655e229-adfa-4b1f-b5d4-347c8b3938ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1f6462cd-ccaa-48ef-9b98-de8764468563" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fe482add-1a15-48ce-81c4-3758eafca3db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1f6462cd-ccaa-48ef-9b98-de8764468563" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fe482add-1a15-48ce-81c4-3758eafca3db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e870060d-3480-4c5d-aea7-f5f20a3270e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1f6462cd-ccaa-48ef-9b98-de8764468563" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e870060d-3480-4c5d-aea7-f5f20a3270e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_0809e1a8-66d7-4331-a288-3e2ce1a7ca9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_0809e1a8-66d7-4331-a288-3e2ce1a7ca9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable_d0319860-8c65-4b06-8072-d0db37ad80b6" xlink:href="bxsl-20231231.xsd#bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable_d0319860-8c65-4b06-8072-d0db37ad80b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8b41fcb0-30ef-473a-b107-ff9279cb50c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8b41fcb0-30ef-473a-b107-ff9279cb50c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueToAffiliates_d67ff42b-d793-4edf-b8c7-53d1a02afb42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToAffiliates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_IncreaseDecreaseInDueToAffiliates_d67ff42b-d793-4edf-b8c7-53d1a02afb42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5d3edffb-205b-4710-9163-f8fd76ece5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_NetIncomeLoss_5d3edffb-205b-4710-9163-f8fd76ece5b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInterestPayableNet_f6554f88-d728-44be-9734-d28d304fa7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_IncreaseDecreaseInInterestPayableNet_f6554f88-d728-44be-9734-d28d304fa7e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_13ae4ef3-671a-46e6-aedb-96610ab33a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_13ae4ef3-671a-46e6-aedb-96610ab33a1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold_4711d5b8-ae99-4529-98cd-afe2c17f1931" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivableForInvestmentSold"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold_4711d5b8-ae99-4529-98cd-afe2c17f1931" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_770db9b6-ca6a-454d-82e0-b0548e1120c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_770db9b6-ca6a-454d-82e0-b0548e1120c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity_655901a9-268d-4dfe-a17f-e0797f54f317" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity_655901a9-268d-4dfe-a17f-e0797f54f317" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable_5656c9f4-facf-48d9-b74f-4600ea8320aa" xlink:href="bxsl-20231231.xsd#bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable_5656c9f4-facf-48d9-b74f-4600ea8320aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaidInKindInterestNoncash_39dbbf93-f657-477b-9634-a1e37bf3ced1" xlink:href="bxsl-20231231.xsd#bxsl_PaidInKindInterestNoncash"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_bxsl_PaidInKindInterestNoncash_39dbbf93-f657-477b-9634-a1e37bf3ced1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased_720ff40e-bcda-4572-9234-24969203d7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased_720ff40e-bcda-4572-9234-24969203d7c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInManagementFeePayable_fc1668e9-afd4-4131-b51e-bf11e3d50b42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInManagementFeePayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_IncreaseDecreaseInManagementFeePayable_fc1668e9-afd4-4131-b51e-bf11e3d50b42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_29bb1459-4787-45e1-b5da-d87656c46844" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_29bb1459-4787-45e1-b5da-d87656c46844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_2104fe86-675d-4dea-8da4-fdcd57e3e65e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_2104fe86-675d-4dea-8da4-fdcd57e3e65e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements_46dc7e36-ee77-49e3-8c19-57fb86bc5d7d" xlink:href="bxsl-20231231.xsd#bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements_46dc7e36-ee77-49e3-8c19-57fb86bc5d7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity_bceaa12a-47b3-4417-a35a-1522bcc222b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity_bceaa12a-47b3-4417-a35a-1522bcc222b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5f816bbf-94c4-4960-a5c1-718f83cba0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5f816bbf-94c4-4960-a5c1-718f83cba0c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable_da75fccc-a855-4170-85e9-86acb3ba9884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0de5e2fc-c37c-4988-8472-86aea6d28ca4" xlink:to="loc_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable_da75fccc-a855-4170-85e9-86acb3ba9884" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27d32c03-f95f-46da-8b05-6bfaca610247" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_fad1fa64-c822-4062-bb6b-7c2e0b4bc212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27d32c03-f95f-46da-8b05-6bfaca610247" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_fad1fa64-c822-4062-bb6b-7c2e0b4bc212" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_47d64460-6b3a-4ad8-9fad-f09131276b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27d32c03-f95f-46da-8b05-6bfaca610247" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_47d64460-6b3a-4ad8-9fad-f09131276b0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_35e2fc9c-4ee2-4583-8896-c71309a0a916" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27d32c03-f95f-46da-8b05-6bfaca610247" xlink:to="loc_us-gaap_RepaymentsOfDebt_35e2fc9c-4ee2-4583-8896-c71309a0a916" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_121c65dd-3fa8-4495-b8ef-2bc2e2dd9bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27d32c03-f95f-46da-8b05-6bfaca610247" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_121c65dd-3fa8-4495-b8ef-2bc2e2dd9bbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_2bd4eb93-7fbd-4a94-8ab4-f91ed04bb25b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27d32c03-f95f-46da-8b05-6bfaca610247" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_2bd4eb93-7fbd-4a94-8ab4-f91ed04bb25b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements_a12472d4-3613-44fb-ac95-5343387c0b53" xlink:href="bxsl-20231231.xsd#bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27d32c03-f95f-46da-8b05-6bfaca610247" xlink:to="loc_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements_a12472d4-3613-44fb-ac95-5343387c0b53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_609a57c1-8209-4d9f-9fe7-79c1b9040864" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27d32c03-f95f-46da-8b05-6bfaca610247" xlink:to="loc_us-gaap_PaymentsOfDividends_609a57c1-8209-4d9f-9fe7-79c1b9040864" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f51142e5-96dc-406b-b97e-db0dae176c78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27d32c03-f95f-46da-8b05-6bfaca610247" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f51142e5-96dc-406b-b97e-db0dae176c78" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsInterestExpenseDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsInterestExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.bxsl.com/role/BorrowingsInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_816994e9-dda8-42ae-b7b7-69206b2d8a57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_48da1914-9614-4d17-b99a-81961b975550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_816994e9-dda8-42ae-b7b7-69206b2d8a57" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_48da1914-9614-4d17-b99a-81961b975550" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_6521d52f-961a-4257-a020-be1057a6af87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_816994e9-dda8-42ae-b7b7-69206b2d8a57" xlink:to="loc_us-gaap_InterestExpenseBorrowings_6521d52f-961a-4257-a020-be1057a6af87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee_288bd643-0cb6-49a5-9e1d-13f9c7f19755" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityFee"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_816994e9-dda8-42ae-b7b7-69206b2d8a57" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee_288bd643-0cb6-49a5-9e1d-13f9c7f19755" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements_98a2e131-9fa6-4fe1-957f-4f1ad4c616cb" xlink:href="bxsl-20231231.xsd#bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_816994e9-dda8-42ae-b7b7-69206b2d8a57" xlink:to="loc_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements_98a2e131-9fa6-4fe1-957f-4f1ad4c616cb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#IncomeTaxesScheduleofChangesinNetAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions_26395158-422f-4915-b3d0-c56a9b2c811a" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome_59a0a716-ddce-4060-957e-2962705fd4e1" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions_26395158-422f-4915-b3d0-c56a9b2c811a" xlink:to="loc_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome_59a0a716-ddce-4060-957e-2962705fd4e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome_83f131bd-3a3b-4a51-a1a4-c0f7eecec2c7" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions_26395158-422f-4915-b3d0-c56a9b2c811a" xlink:to="loc_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome_83f131bd-3a3b-4a51-a1a4-c0f7eecec2c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome_256b30e2-3796-462c-8f6f-6c4114912f64" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions_26395158-422f-4915-b3d0-c56a9b2c811a" xlink:to="loc_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome_256b30e2-3796-462c-8f6f-6c4114912f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome_d050426b-a92c-45c5-8e65-f0465448c4c5" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions_26395158-422f-4915-b3d0-c56a9b2c811a" xlink:to="loc_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome_d050426b-a92c-45c5-8e65-f0465448c4c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e74bfaf5-fb43-4603-a851-e9bae8d10f89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions_26395158-422f-4915-b3d0-c56a9b2c811a" xlink:to="loc_us-gaap_NetIncomeLoss_e74bfaf5-fb43-4603-a851-e9bae8d10f89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome_b3858132-186b-4e41-968f-320e9aa07c5c" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions_26395158-422f-4915-b3d0-c56a9b2c811a" xlink:to="loc_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome_b3858132-186b-4e41-968f-320e9aa07c5c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails"/>
  <link:calculationLink xlink:role="http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_88834e07-c7f8-442b-89db-98d6315efd37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss_8f6d0ccb-a514-4981-b214-4c7dd9d0334d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_88834e07-c7f8-442b-89db-98d6315efd37" xlink:to="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss_8f6d0ccb-a514-4981-b214-4c7dd9d0334d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences_c49b922a-15cc-44b7-be16-49bb84c0419a" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_88834e07-c7f8-442b-89db-98d6315efd37" xlink:to="loc_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences_c49b922a-15cc-44b7-be16-49bb84c0419a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss_b0308a11-6e27-4e7f-8c8e-3bd3ca52751c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_88834e07-c7f8-442b-89db-98d6315efd37" xlink:to="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss_b0308a11-6e27-4e7f-8c8e-3bd3ca52751c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation_ee47342f-27ab-436c-9283-d45c4cc3035a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_88834e07-c7f8-442b-89db-98d6315efd37" xlink:to="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation_ee47342f-27ab-436c-9283-d45c4cc3035a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RetainedEarningsAccumulatedDeficitAudited_56e73b00-87ee-4d0e-8533-99877c97597d" xlink:href="bxsl-20231231.xsd#bxsl_RetainedEarningsAccumulatedDeficitAudited"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation_200ee7f7-676b-42c3-be4c-47f63a8f7700" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bxsl_RetainedEarningsAccumulatedDeficitAudited_56e73b00-87ee-4d0e-8533-99877c97597d" xlink:to="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation_200ee7f7-676b-42c3-be4c-47f63a8f7700" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss_4f4ca810-92ed-4482-b2a6-7cf6e16b35ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bxsl_RetainedEarningsAccumulatedDeficitAudited_56e73b00-87ee-4d0e-8533-99877c97597d" xlink:to="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss_4f4ca810-92ed-4482-b2a6-7cf6e16b35ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss_01c582ce-8e72-42cc-a4a0-3c1bc3657dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bxsl_RetainedEarningsAccumulatedDeficitAudited_56e73b00-87ee-4d0e-8533-99877c97597d" xlink:to="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss_01c582ce-8e72-42cc-a4a0-3c1bc3657dcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences_8c73c872-69ea-4af7-9d01-1bab2f1e07ec" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bxsl_RetainedEarningsAccumulatedDeficitAudited_56e73b00-87ee-4d0e-8533-99877c97597d" xlink:to="loc_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences_8c73c872-69ea-4af7-9d01-1bab2f1e07ec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#IncomeTaxesScheduleofTaxBasisofInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet_9508a165-0af2-4a92-a291-65da315aabe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation_90232706-8631-40ea-a046-fc308b86c7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet_9508a165-0af2-4a92-a291-65da315aabe9" xlink:to="loc_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation_90232706-8631-40ea-a046-fc308b86c7c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation_f442c5c4-0590-4130-ae65-711055d81bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet_9508a165-0af2-4a92-a291-65da315aabe9" xlink:to="loc_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation_f442c5c4-0590-4130-ae65-711055d81bb5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FinancialHighlightsandSeniorSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare_17836c20-6636-4e58-a6eb-df7ffd53c3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_0fe1fa0b-31af-4b4d-afb9-720eb7e7cb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare_17836c20-6636-4e58-a6eb-df7ffd53c3ae" xlink:to="loc_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_0fe1fa0b-31af-4b4d-afb9-720eb7e7cb5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare_24228542-b641-43aa-9ce2-7ae9387ec3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare_17836c20-6636-4e58-a6eb-df7ffd53c3ae" xlink:to="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare_24228542-b641-43aa-9ce2-7ae9387ec3c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_6b026ee8-2758-4b87-b377-d2422f3f7df2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare_9d809808-578e-4d01-a9f6-eca6be8a4589" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_6b026ee8-2758-4b87-b377-d2422f3f7df2" xlink:to="loc_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare_9d809808-578e-4d01-a9f6-eca6be8a4589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare_42038133-00f4-4ee5-a49d-8441540cb4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_6b026ee8-2758-4b87-b377-d2422f3f7df2" xlink:to="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare_42038133-00f4-4ee5-a49d-8441540cb4a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare_4ea3e464-8e01-4f9b-856f-6c35e865ce7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributionToShareholdersPerShare"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_6b026ee8-2758-4b87-b377-d2422f3f7df2" xlink:to="loc_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare_4ea3e464-8e01-4f9b-856f-6c35e865ce7e" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>15
<FILENAME>bxsl-20231231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:c9da10f3-9ca1-46ab-8b82-2faa6d8e78e0,g:d2995a14-2db1-4369-b86a-a80f43cbbba9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedStatementsofAssetsandLiabilities"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_56f4c862-efba-46f6-a9ee-dafac35a8c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_StatementTable_56f4c862-efba-46f6-a9ee-dafac35a8c2b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis_134b3c0b-3235-48c7-837b-141d34600569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_56f4c862-efba-46f6-a9ee-dafac35a8c2b" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationAxis_134b3c0b-3235-48c7-837b-141d34600569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_134b3c0b-3235-48c7-837b-141d34600569_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_134b3c0b-3235-48c7-837b-141d34600569" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_134b3c0b-3235-48c7-837b-141d34600569_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_dc550d10-26fe-4636-b792-5402e051e360" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_134b3c0b-3235-48c7-837b-141d34600569" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_dc550d10-26fe-4636-b792-5402e051e360" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_dd95c732-7897-4d2e-a621-2fe1fdab9463" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_dc550d10-26fe-4636-b792-5402e051e360" xlink:to="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_dd95c732-7897-4d2e-a621-2fe1fdab9463" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_43390f8e-d4c5-4de8-aed9-3a3a6b560a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_dc550d10-26fe-4636-b792-5402e051e360" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_43390f8e-d4c5-4de8-aed9-3a3a6b560a1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37078504-ebe3-484f-b994-9a87f9ecefc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_56f4c862-efba-46f6-a9ee-dafac35a8c2b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37078504-ebe3-484f-b994-9a87f9ecefc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_37078504-ebe3-484f-b994-9a87f9ecefc6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37078504-ebe3-484f-b994-9a87f9ecefc6" xlink:to="loc_us-gaap_RelatedPartyDomain_37078504-ebe3-484f-b994-9a87f9ecefc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d2bc879a-3c32-4093-b3e7-1c76bdcf4393" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37078504-ebe3-484f-b994-9a87f9ecefc6" xlink:to="loc_us-gaap_RelatedPartyDomain_d2bc879a-3c32-4093-b3e7-1c76bdcf4393" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_c5f38c69-37a8-4f9e-930d-4601aa0264a8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d2bc879a-3c32-4093-b3e7-1c76bdcf4393" xlink:to="loc_srt_AffiliatedEntityMember_c5f38c69-37a8-4f9e-930d-4601aa0264a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_d4a660d2-ae70-4d8a-b53a-f99f688ea0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_d4a660d2-ae70-4d8a-b53a-f99f688ea0bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e7a90e4a-92c3-447b-b3ed-d550b2dc08f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e7a90e4a-92c3-447b-b3ed-d550b2dc08f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendAndInterestReceivable_9e988633-8911-4f02-974d-ca4116eee1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendAndInterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:to="loc_us-gaap_DividendAndInterestReceivable_9e988633-8911-4f02-974d-ca4116eee1c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_567aa406-1951-4961-877d-3fcc7e8a7929" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_567aa406-1951-4961-877d-3fcc7e8a7929" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableInvestmentSale_c10b6cc3-2224-44c0-925f-1e8b50c3fd25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableInvestmentSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:to="loc_us-gaap_ReceivableInvestmentSale_c10b6cc3-2224-44c0-925f-1e8b50c3fd25" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_60795b97-d7d0-4d0b-958d-754ec4951481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:to="loc_us-gaap_Assets_60795b97-d7d0-4d0b-958d-754ec4951481" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_21a6c236-17ce-48fe-8ece-98dffe4accc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_LongTermDebt_21a6c236-17ce-48fe-8ece-98dffe4accc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayableInvestmentPurchase_9641e552-864c-48a4-930f-c03fd849e301" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayableInvestmentPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_PayableInvestmentPurchase_9641e552-864c-48a4-930f-c03fd849e301" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_4fb5df57-ecc9-4c48-9526-21d16334ce82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_OtherLiabilities_4fb5df57-ecc9-4c48-9526-21d16334ce82" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeePayable_287fd904-809c-4ffb-b680-a27ed305d5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeePayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_ManagementFeePayable_287fd904-809c-4ffb-b680-a27ed305d5f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncentiveFeePayableIncome_0e68e135-1780-406a-bb2a-2dceab961d11" xlink:href="bxsl-20231231.xsd#bxsl_IncentiveFeePayableIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_bxsl_IncentiveFeePayableIncome_0e68e135-1780-406a-bb2a-2dceab961d11" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncentiveFeePayableCapitalGains_bec5da0a-001f-43f3-830b-89465560e499" xlink:href="bxsl-20231231.xsd#bxsl_IncentiveFeePayableCapitalGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_bxsl_IncentiveFeePayableCapitalGains_bec5da0a-001f-43f3-830b-89465560e499" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_275d9afc-2112-4707-8930-32963bef1c87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_275d9afc-2112-4707-8930-32963bef1c87" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionPayable_2e4d3fb0-e7c4-4c3a-8ece-3fb2ed9803d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DistributionPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_DistributionPayable_2e4d3fb0-e7c4-4c3a-8ece-3fb2ed9803d6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3659df5f-3cdb-4268-bc4f-28f004c6e8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3659df5f-3cdb-4268-bc4f-28f004c6e8a2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_031718f6-bdf3-42da-a020-ad45eca469c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_Liabilities_031718f6-bdf3-42da-a020-ad45eca469c9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3d0e3f60-f92f-4640-ab2b-8c5b055307e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3d0e3f60-f92f-4640-ab2b-8c5b055307e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3f9b14fe-97a7-4772-9ff5-41c526b48fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3f9b14fe-97a7-4772-9ff5-41c526b48fe3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d1c50d51-0f7f-4763-b5cc-21638df562c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f9b14fe-97a7-4772-9ff5-41c526b48fe3" xlink:to="loc_us-gaap_CommonStockValue_d1c50d51-0f7f-4763-b5cc-21638df562c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ccad5ad6-788d-4b64-be80-48641f7d45b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f9b14fe-97a7-4772-9ff5-41c526b48fe3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ccad5ad6-788d-4b64-be80-48641f7d45b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8154d329-2ed5-42a5-9d58-69b0896d3e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f9b14fe-97a7-4772-9ff5-41c526b48fe3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8154d329-2ed5-42a5-9d58-69b0896d3e9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_49edcf51-b7dc-453d-9d73-a4bf06c6c05a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f9b14fe-97a7-4772-9ff5-41c526b48fe3" xlink:to="loc_us-gaap_StockholdersEquity_49edcf51-b7dc-453d-9d73-a4bf06c6c05a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_083e3ca8-aef8-4e0d-9853-8d390d8dfc78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_083e3ca8-aef8-4e0d-9853-8d390d8dfc78" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAssetValuePerShare_20313876-3aa7-4d5d-95e4-a9bf838cd138" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetAssetValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_NetAssetValuePerShare_20313876-3aa7-4d5d-95e4-a9bf838cd138" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedStatementsofAssetsandLiabilitiesParenthetical"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6212e9c4-e63e-44ef-8eb8-95c73995b66b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_StatementTable_6212e9c4-e63e-44ef-8eb8-95c73995b66b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis_8326b372-438e-474d-93d3-624a8403f5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6212e9c4-e63e-44ef-8eb8-95c73995b66b" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationAxis_8326b372-438e-474d-93d3-624a8403f5b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_8326b372-438e-474d-93d3-624a8403f5b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_8326b372-438e-474d-93d3-624a8403f5b0" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_8326b372-438e-474d-93d3-624a8403f5b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_7ff6867a-ccad-4f7f-bf78-94aaf5f9b710" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_8326b372-438e-474d-93d3-624a8403f5b0" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_7ff6867a-ccad-4f7f-bf78-94aaf5f9b710" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_b292d7dc-f77c-4d85-8cee-f1e90de22c54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_7ff6867a-ccad-4f7f-bf78-94aaf5f9b710" xlink:to="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_b292d7dc-f77c-4d85-8cee-f1e90de22c54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_54ac3081-d89e-4986-9cea-e13d5bf68688" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_7ff6867a-ccad-4f7f-bf78-94aaf5f9b710" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_54ac3081-d89e-4986-9cea-e13d5bf68688" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtCost_f91c0d09-d5fb-42b3-b824-6e272ce7b26f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_InvestmentOwnedAtCost_f91c0d09-d5fb-42b3-b824-6e272ce7b26f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_7e677f82-3226-438a-bcbc-e3e462bf4042" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_7e677f82-3226-438a-bcbc-e3e462bf4042" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2b38d5c3-4b1d-4b4e-8962-fc2d47eb4547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2b38d5c3-4b1d-4b4e-8962-fc2d47eb4547" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_44b161a7-1789-4070-a1f8-60101e99f2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_44b161a7-1789-4070-a1f8-60101e99f2e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_53df1892-5cd2-4bf9-80b1-e0033f31828e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_CommonStockSharesIssued_53df1892-5cd2-4bf9-80b1-e0033f31828e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f9097b87-c555-4586-b53b-713e20ab24e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f9097b87-c555-4586-b53b-713e20ab24e1" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0a5e7119-06fa-4587-bef8-91c42fe9df81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_StatementTable_0a5e7119-06fa-4587-bef8-91c42fe9df81" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis_df963779-4905-4631-88dc-bcc6d95a710b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0a5e7119-06fa-4587-bef8-91c42fe9df81" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationAxis_df963779-4905-4631-88dc-bcc6d95a710b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_df963779-4905-4631-88dc-bcc6d95a710b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_df963779-4905-4631-88dc-bcc6d95a710b" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_df963779-4905-4631-88dc-bcc6d95a710b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_1ff698e0-6d36-4346-a529-31c494cea51b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_df963779-4905-4631-88dc-bcc6d95a710b" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_1ff698e0-6d36-4346-a529-31c494cea51b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_f890043b-ef08-4f6f-b2d1-5ca4de8b9639" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_1ff698e0-6d36-4346-a529-31c494cea51b" xlink:to="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_f890043b-ef08-4f6f-b2d1-5ca4de8b9639" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_8591c1f7-2d20-4900-a33b-1fe89f368a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_1ff698e0-6d36-4346-a529-31c494cea51b" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_8591c1f7-2d20-4900-a33b-1fe89f368a1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingPaidInCash_9e5675c9-6247-4b61-ac16-8efba003de04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOperatingPaidInCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:to="loc_us-gaap_InterestIncomeOperatingPaidInCash_9e5675c9-6247-4b61-ac16-8efba003de04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingPaidInKind_ad024643-f8ad-4935-a99b-22a982d3634d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOperatingPaidInKind"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:to="loc_us-gaap_InterestIncomeOperatingPaidInKind_ad024643-f8ad-4935-a99b-22a982d3634d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendIncomeOperating_4bcc7b00-a6eb-461e-a17e-2d944ec56f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:to="loc_us-gaap_DividendIncomeOperating_4bcc7b00-a6eb-461e-a17e-2d944ec56f9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FeeIncome_de677115-fe31-4d42-8a20-6d588ea9ba32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FeeIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:to="loc_us-gaap_FeeIncome_de677115-fe31-4d42-8a20-6d588ea9ba32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossInvestmentIncomeOperating_baa95c57-35dd-4fa3-8245-95d03b8e571c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossInvestmentIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:to="loc_us-gaap_GrossInvestmentIncomeOperating_baa95c57-35dd-4fa3-8245-95d03b8e571c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_92c10d99-1655-4a05-8aa8-89bbe544e317" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_InterestExpense_92c10d99-1655-4a05-8aa8-89bbe544e317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense_2177ade3-9ae1-42d4-be75-d5b57fc0535a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_ManagementFeeExpense_2177ade3-9ae1-42d4-be75-d5b57fc0535a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeeExpense_b4ef3971-c465-433e-bf37-2c8bac86bdd3" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_bxsl_IncomeBasedIncentiveFeeExpense_b4ef3971-c465-433e-bf37-2c8bac86bdd3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CapitalGainsIncentiveFeeExpense_ed687eee-4840-4fb6-8123-f40c2a460252" xlink:href="bxsl-20231231.xsd#bxsl_CapitalGainsIncentiveFeeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_bxsl_CapitalGainsIncentiveFeeExpense_ed687eee-4840-4fb6-8123-f40c2a460252" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_b4b6fdb7-4a03-4c28-8296-faca30c013f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_ProfessionalFees_b4b6fdb7-4a03-4c28-8296-faca30c013f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrusteeFees_873944bf-d1f5-463d-9281-4d8f65d10eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrusteeFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_TrusteeFees_873944bf-d1f5-463d-9281-4d8f65d10eb1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdministrativeFeesExpense_cdc83c91-fbb2-407c-8dcb-6324614e2d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdministrativeFeesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_AdministrativeFeesExpense_cdc83c91-fbb2-407c-8dcb-6324614e2d2a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_db0dc43f-af95-44ee-bd65-d78e84711404" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_db0dc43f-af95-44ee-bd65-d78e84711404" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_77272ba1-136e-4dc6-a2e1-9b5d9643e120" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_77272ba1-136e-4dc6-a2e1-9b5d9643e120" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyContractualFeeWaived_8e50019a-02c3-4c0c-b659-d61ba346c22a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyContractualFeeWaived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_InvestmentCompanyContractualFeeWaived_8e50019a-02c3-4c0c-b659-d61ba346c22a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyVoluntaryFeeWaived_e6464b80-fc6d-4e10-9bd6-336033ac5cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyVoluntaryFeeWaived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_InvestmentCompanyVoluntaryFeeWaived_e6464b80-fc6d-4e10-9bd6-336033ac5cb5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement_480ee98b-f513-477d-bb9b-e82855071603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement_480ee98b-f513-477d-bb9b-e82855071603" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_4ca87aa6-f541-4c53-949b-a1edb4f419fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_NetInvestmentIncome_4ca87aa6-f541-4c53-949b-a1edb4f419fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_7522186e-98d6-4941-b56b-7b4961666e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_7522186e-98d6-4941-b56b-7b4961666e7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_2ca88b7a-2c65-4172-997b-34d45cf4c725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_2ca88b7a-2c65-4172-997b-34d45cf4c725" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract_aa868e96-b948-451e-b394-42a4cdcfed8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract_aa868e96-b948-451e-b394-42a4cdcfed8a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_86b7f9c5-36c4-49ad-9d8e-4e1d6824e104" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract_aa868e96-b948-451e-b394-42a4cdcfed8a" xlink:to="loc_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_86b7f9c5-36c4-49ad-9d8e-4e1d6824e104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_0446095f-5e31-425c-931b-4bf7e676ae3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_86b7f9c5-36c4-49ad-9d8e-4e1d6824e104" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_0446095f-5e31-425c-931b-4bf7e676ae3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_0616593e-fde9-4c26-95b3-9d693f575bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_86b7f9c5-36c4-49ad-9d8e-4e1d6824e104" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_0616593e-fde9-4c26-95b3-9d693f575bc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_0b1bf5f8-5ed6-455b-a30c-8e29fbc3b761" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_86b7f9c5-36c4-49ad-9d8e-4e1d6824e104" xlink:to="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_0b1bf5f8-5ed6-455b-a30c-8e29fbc3b761" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NetRealizedGainsLossesAbstract_8432a868-c725-4ccf-ad27-860525910b4c" xlink:href="bxsl-20231231.xsd#bxsl_NetRealizedGainsLossesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract_aa868e96-b948-451e-b394-42a4cdcfed8a" xlink:to="loc_bxsl_NetRealizedGainsLossesAbstract_8432a868-c725-4ccf-ad27-860525910b4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7af8df91-e111-4ca6-be71-a581be07403d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_NetRealizedGainsLossesAbstract_8432a868-c725-4ccf-ad27-860525910b4c" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7af8df91-e111-4ca6-be71-a581be07403d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax_3116754e-28fd-4ebd-a3ec-00c533ca72c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_NetRealizedGainsLossesAbstract_8432a868-c725-4ccf-ad27-860525910b4c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax_3116754e-28fd-4ebd-a3ec-00c533ca72c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_a151d1ad-3a4e-489d-9a11-595871f0579e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_NetRealizedGainsLossesAbstract_8432a868-c725-4ccf-ad27-860525910b4c" xlink:to="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_a151d1ad-3a4e-489d-9a11-595871f0579e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax_94e2e048-8563-4834-9a23-1dc95ffee9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract_aa868e96-b948-451e-b394-42a4cdcfed8a" xlink:to="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax_94e2e048-8563-4834-9a23-1dc95ffee9c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ccbce20c-95fd-428f-a2e3-a82126d2bf48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_NetIncomeLoss_ccbce20c-95fd-428f-a2e3-a82126d2bf48" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare_1ded5cc2-87cd-4c57-bb0f-4f5dbce4a96f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare_1ded5cc2-87cd-4c57-bb0f-4f5dbce4a96f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1d466af2-aa0e-4117-9afc-d90868dd21b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_EarningsPerShareBasic_1d466af2-aa0e-4117-9afc-d90868dd21b4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3db5b050-a7df-4821-b9b9-7b82383e1a37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3db5b050-a7df-4821-b9b9-7b82383e1a37" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2d4e8f2a-c3b9-42e8-8823-664df4151213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2d4e8f2a-c3b9-42e8-8823-664df4151213" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b2ebe191-c6b5-45c1-9d1d-895526c57d20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b2ebe191-c6b5-45c1-9d1d-895526c57d20" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedStatementsofChangesinNetAssets"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_aa7e30a2-afc4-4c0b-abf9-ce0a468201c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_308ce3a0-e1c0-4478-b3d2-d1063090a153" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_aa7e30a2-afc4-4c0b-abf9-ce0a468201c4" xlink:to="loc_us-gaap_StatementTable_308ce3a0-e1c0-4478-b3d2-d1063090a153" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9cd923e4-3f71-4ec1-9726-33259e3ec41e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_308ce3a0-e1c0-4478-b3d2-d1063090a153" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9cd923e4-3f71-4ec1-9726-33259e3ec41e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9cd923e4-3f71-4ec1-9726-33259e3ec41e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9cd923e4-3f71-4ec1-9726-33259e3ec41e" xlink:to="loc_us-gaap_EquityComponentDomain_9cd923e4-3f71-4ec1-9726-33259e3ec41e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_75b70e82-0c3c-4d1d-8de3-ca35674869ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9cd923e4-3f71-4ec1-9726-33259e3ec41e" xlink:to="loc_us-gaap_EquityComponentDomain_75b70e82-0c3c-4d1d-8de3-ca35674869ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f62fcfab-4d62-48ed-a771-48f8c59ef397" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_75b70e82-0c3c-4d1d-8de3-ca35674869ee" xlink:to="loc_us-gaap_CommonStockMember_f62fcfab-4d62-48ed-a771-48f8c59ef397" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_22f4d1b9-d9c1-4da0-bc7b-4cb4da185200" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_75b70e82-0c3c-4d1d-8de3-ca35674869ee" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_22f4d1b9-d9c1-4da0-bc7b-4cb4da185200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3cbb653e-dc9c-4cf3-b5a2-50ac6e604278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_75b70e82-0c3c-4d1d-8de3-ca35674869ee" xlink:to="loc_us-gaap_RetainedEarningsMember_3cbb653e-dc9c-4cf3-b5a2-50ac6e604278" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyNetAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_aa7e30a2-afc4-4c0b-abf9-ce0a468201c4" xlink:to="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_27e7dbcf-df3e-4eaa-ad39-ba84c814dcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_StockholdersEquity_27e7dbcf-df3e-4eaa-ad39-ba84c814dcd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a6726ee9-3504-4229-81c5-397d03a5ce4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a6726ee9-3504-4229-81c5-397d03a5ce4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan_df9aa553-e3f9-477e-a071-48a4b6d5d21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan_df9aa553-e3f9-477e-a071-48a4b6d5d21e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_52a57a1d-e432-4072-a02a-480d7bf83775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_52a57a1d-e432-4072-a02a-480d7bf83775" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_36cf091d-fe64-46f8-ba0c-5022295e274f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_36cf091d-fe64-46f8-ba0c-5022295e274f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_a5efc1a6-d109-4ae8-95bb-a5ab2e6d5c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_a5efc1a6-d109-4ae8-95bb-a5ab2e6d5c50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_9f8730e9-6674-4df4-9abc-5c937a37e57e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_9f8730e9-6674-4df4-9abc-5c937a37e57e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDividendDistribution_6c96d145-1228-49ab-ae85-dce40e885760" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDividendDistribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_InvestmentCompanyDividendDistribution_6c96d145-1228-49ab-ae85-dce40e885760" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_0cbb9800-5a40-4d8b-8f57-87ec06dae0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_0cbb9800-5a40-4d8b-8f57-87ec06dae0bc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_644555c4-93c9-47f0-a277-9b80810454b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedScheduleofInvestments" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedScheduleofInvestments"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/ConsolidatedScheduleofInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesByIndustryAxis_06d74faf-71d1-4e0c-9057-f887b71fc633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesByIndustryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:to="loc_us-gaap_EquitySecuritiesByIndustryAxis_06d74faf-71d1-4e0c-9057-f887b71fc633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember_06d74faf-71d1-4e0c-9057-f887b71fc633_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis_06d74faf-71d1-4e0c-9057-f887b71fc633" xlink:to="loc_us-gaap_EquitySecuritiesIndustryMember_06d74faf-71d1-4e0c-9057-f887b71fc633_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis_06d74faf-71d1-4e0c-9057-f887b71fc633" xlink:to="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AerospaceAndDefenseSectorMember_613dd741-76d2-4dd7-860b-202a1ab08b29" xlink:href="bxsl-20231231.xsd#bxsl_AerospaceAndDefenseSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_AerospaceAndDefenseSectorMember_613dd741-76d2-4dd7-860b-202a1ab08b29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AirFreightLogisticsSectorMember_d3176380-cee1-4b95-a1df-e4f11cf665e6" xlink:href="bxsl-20231231.xsd#bxsl_AirFreightLogisticsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_AirFreightLogisticsSectorMember_d3176380-cee1-4b95-a1df-e4f11cf665e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BuildingProductsSectorMember_f6566efb-7b18-4cec-ad0c-3945ba94541a" xlink:href="bxsl-20231231.xsd#bxsl_BuildingProductsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_BuildingProductsSectorMember_f6566efb-7b18-4cec-ad0c-3945ba94541a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChemicalsSectorMember_dba0de09-b88c-4c22-97a5-813cf83d65ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChemicalsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_ChemicalsSectorMember_dba0de09-b88c-4c22-97a5-813cf83d65ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommercialServicesSuppliesSectorMember_b569dc0d-fc52-473d-8464-6716863aa62f" xlink:href="bxsl-20231231.xsd#bxsl_CommercialServicesSuppliesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_CommercialServicesSuppliesSectorMember_b569dc0d-fc52-473d-8464-6716863aa62f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ConstructionEngineeringSectorMember_536ef2b0-397d-4dc5-8f63-3ae8514248fb" xlink:href="bxsl-20231231.xsd#bxsl_ConstructionEngineeringSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ConstructionEngineeringSectorMember_536ef2b0-397d-4dc5-8f63-3ae8514248fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContainerAndPackagingSectorMember_0d0a65d3-52ee-46dc-8924-7dd4cc30b60b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContainerAndPackagingSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_ContainerAndPackagingSectorMember_0d0a65d3-52ee-46dc-8924-7dd4cc30b60b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DistributorsSectorMember_4554238b-3f62-4928-a864-e56c289d17e4" xlink:href="bxsl-20231231.xsd#bxsl_DistributorsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_DistributorsSectorMember_4554238b-3f62-4928-a864-e56c289d17e4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsumerSectorMember_08e88259-d315-4657-8b14-673b233418d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsumerSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_ConsumerSectorMember_08e88259-d315-4657-8b14-673b233418d8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DiversifiedTelecommunicationServicesSectorMember_ee66fb06-734c-4c4a-8360-331c0883c754" xlink:href="bxsl-20231231.xsd#bxsl_DiversifiedTelecommunicationServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_DiversifiedTelecommunicationServicesSectorMember_ee66fb06-734c-4c4a-8360-331c0883c754" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServicesSectorMember_27af04a6-e3a3-4d22-ae65-9f715dea0843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_FinancialServicesSectorMember_27af04a6-e3a3-4d22-ae65-9f715dea0843" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectricalEquipmentSectorMember_b4a18b2e-b01d-463d-bf3f-8e14d540a27b" xlink:href="bxsl-20231231.xsd#bxsl_ElectricalEquipmentSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ElectricalEquipmentSectorMember_b4a18b2e-b01d-463d-bf3f-8e14d540a27b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectronicEquipmentInstrumentsComponentsMember_2fd873bc-7abe-47e3-86aa-34175beed8b0" xlink:href="bxsl-20231231.xsd#bxsl_ElectronicEquipmentInstrumentsComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ElectronicEquipmentInstrumentsComponentsMember_2fd873bc-7abe-47e3-86aa-34175beed8b0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnergySectorMember_d806fa9c-bf97-420f-a90a-4bbc572452ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EnergySectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_EnergySectorMember_d806fa9c-bf97-420f-a90a-4bbc572452ef" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareEquipmentSuppliesSectorMember_5834ee28-3810-4371-bf4d-105a75c8e599" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareEquipmentSuppliesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_HealthCareEquipmentSuppliesSectorMember_5834ee28-3810-4371-bf4d-105a75c8e599" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareProvidersServicesSectorMember_2e2f0b88-435f-4719-8cc8-1936f8243bd7" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareProvidersServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_HealthCareProvidersServicesSectorMember_2e2f0b88-435f-4719-8cc8-1936f8243bd7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareTechnologySectorMember_ae6108b0-a711-4a16-8286-9a00e08e7f90" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareTechnologySectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_HealthCareTechnologySectorMember_ae6108b0-a711-4a16-8286-9a00e08e7f90" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSectorMember_5c9c6664-1d57-4687-8c0b-2bc9e56b0a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_InsuranceSectorMember_5c9c6664-1d57-4687-8c0b-2bc9e56b0a7b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ITServicesSectorMember_1db7ffe6-ea28-471f-a20f-067f6b147490" xlink:href="bxsl-20231231.xsd#bxsl_ITServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ITServicesSectorMember_1db7ffe6-ea28-471f-a20f-067f6b147490" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MachineryMember_0eda4eda-b876-41df-b0ef-79613b8390ac" xlink:href="bxsl-20231231.xsd#bxsl_MachineryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_MachineryMember_0eda4eda-b876-41df-b0ef-79613b8390ac" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OilGasConsumableFuelsMember_98d9ad67-7935-47c0-8ee7-17a4ff704018" xlink:href="bxsl-20231231.xsd#bxsl_OilGasConsumableFuelsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_OilGasConsumableFuelsMember_98d9ad67-7935-47c0-8ee7-17a4ff704018" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaperForestProductsMember_087845d8-25c5-4c17-8d91-4f53a55ed02e" xlink:href="bxsl-20231231.xsd#bxsl_PaperForestProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_PaperForestProductsMember_087845d8-25c5-4c17-8d91-4f53a55ed02e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PharmaceuticalsSectorMember_9086587e-64f2-4aa2-860c-8f87b5287bd6" xlink:href="bxsl-20231231.xsd#bxsl_PharmaceuticalsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_PharmaceuticalsSectorMember_9086587e-64f2-4aa2-860c-8f87b5287bd6" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ProfessionalServicesSectorMember_c3ee7307-d58d-4f99-a21d-12768e2c8bb2" xlink:href="bxsl-20231231.xsd#bxsl_ProfessionalServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ProfessionalServicesSectorMember_c3ee7307-d58d-4f99-a21d-12768e2c8bb2" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RealEstateManagementDevelopmentSectorMember_1b46f80e-4871-4892-a1d5-4d659d2fd4cb" xlink:href="bxsl-20231231.xsd#bxsl_RealEstateManagementDevelopmentSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_RealEstateManagementDevelopmentSectorMember_1b46f80e-4871-4892-a1d5-4d659d2fd4cb" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SoftwareSectorMember_418f812b-f9b9-45bf-a4ad-e5a169813f5f" xlink:href="bxsl-20231231.xsd#bxsl_SoftwareSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_SoftwareSectorMember_418f812b-f9b9-45bf-a4ad-e5a169813f5f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TradingCompaniesDistributorsSectorMember_6b087e94-c9d8-435b-a54b-639f38554df4" xlink:href="bxsl-20231231.xsd#bxsl_TradingCompaniesDistributorsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_TradingCompaniesDistributorsSectorMember_6b087e94-c9d8-435b-a54b-639f38554df4" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransportationInfrastructureSectorMember_58e93d97-7660-4442-a156-234b1dd986e8" xlink:href="bxsl-20231231.xsd#bxsl_TransportationInfrastructureSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_TransportationInfrastructureSectorMember_58e93d97-7660-4442-a156-234b1dd986e8" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectricUtilitiesMember_b31dad5c-926f-444c-82a3-ef746a061fb8" xlink:href="bxsl-20231231.xsd#bxsl_ElectricUtilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ElectricUtilitiesMember_b31dad5c-926f-444c-82a3-ef746a061fb8" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_GroundTransportationMember_dcbb48d4-cf14-4cbb-b1c7-07ef6575e7e9" xlink:href="bxsl-20231231.xsd#bxsl_GroundTransportationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_GroundTransportationMember_dcbb48d4-cf14-4cbb-b1c7-07ef6575e7e9" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:to="loc_us-gaap_InvestmentTypeAxis_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:to="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienMember_ed0a89a1-c412-44c5-8599-bb266fff30a3" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:to="loc_bxsl_DebtSecuritiesFirstLienMember_ed0a89a1-c412-44c5-8599-bb266fff30a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienMember_f1877936-306b-43b5-8bb7-722139b5616c" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:to="loc_bxsl_DebtSecuritiesSecondLienMember_f1877936-306b-43b5-8bb7-722139b5616c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_1985c505-803e-4efd-8ed3-be1fb7b64a45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:to="loc_us-gaap_EquitySecuritiesMember_1985c505-803e-4efd-8ed3-be1fb7b64a45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_a6ed9294-8968-403b-8a9b-549c4bcd2231" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:to="loc_us-gaap_UnsecuredDebtMember_a6ed9294-8968-403b-8a9b-549c4bcd2231" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_0f854d32-dd24-4d75-8030-6ba812993aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_0f854d32-dd24-4d75-8030-6ba812993aaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis_bd54ae9f-9cab-4a66-956e-9128a3b89570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationAxis_bd54ae9f-9cab-4a66-956e-9128a3b89570" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_bd54ae9f-9cab-4a66-956e-9128a3b89570_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_bd54ae9f-9cab-4a66-956e-9128a3b89570" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_bd54ae9f-9cab-4a66-956e-9128a3b89570_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_df2b61d4-0112-49ef-9030-bdf1ed59a384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_bd54ae9f-9cab-4a66-956e-9128a3b89570" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_df2b61d4-0112-49ef-9030-bdf1ed59a384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_093bfb1d-7c06-42ff-a206-530378cf9fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_df2b61d4-0112-49ef-9030-bdf1ed59a384" xlink:to="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_093bfb1d-7c06-42ff-a206-530378cf9fa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_bc6aab4b-37c3-4523-9411-7221e0df1fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_df2b61d4-0112-49ef-9030-bdf1ed59a384" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_bc6aab4b-37c3-4523-9411-7221e0df1fbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIdentifierAxis_d559b7aa-d84e-4950-b963-ef92b000e781" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:to="loc_us-gaap_InvestmentIdentifierAxis_d559b7aa-d84e-4950-b963-ef92b000e781" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBasisSpreadVariableRate_9d475db8-9afa-47f7-ba8b-a357d54bc91d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBasisSpreadVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentBasisSpreadVariableRate_9d475db8-9afa-47f7-ba8b-a357d54bc91d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRatePaidInKind_7db4f701-b8d9-4850-80d5-eaf47a1a9480" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRatePaidInKind"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentInterestRatePaidInKind_7db4f701-b8d9-4850-80d5-eaf47a1a9480" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRate_161d6fc8-4194-4b90-b1e2-f3eb53fa6f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentInterestRate_161d6fc8-4194-4b90-b1e2-f3eb53fa6f9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount_97fc024f-cca6-41d1-897b-65e7bb8bf014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount_97fc024f-cca6-41d1-897b-65e7bb8bf014" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_c619dbed-e6d8-4c00-829d-fd6e33c49002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_c619dbed-e6d8-4c00-829d-fd6e33c49002" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtCost_7a07ea32-42c9-4bf9-81a4-86cb654b4a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedAtCost_7a07ea32-42c9-4bf9-81a4-86cb654b4a9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_08b0ab67-5535-4fcc-bcff-e3e1d33f1a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_08b0ab67-5535-4fcc-bcff-e3e1d33f1a2a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_12a9d080-0a26-4c64-9f27-d160161f510f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_12a9d080-0a26-4c64-9f27-d160161f510f" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedScheduleofInvestments_1" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedScheduleofInvestments_1"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/ConsolidatedScheduleofInvestments_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesByIndustryAxis_06d74faf-71d1-4e0c-9057-f887b71fc633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesByIndustryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:to="loc_us-gaap_EquitySecuritiesByIndustryAxis_06d74faf-71d1-4e0c-9057-f887b71fc633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember_06d74faf-71d1-4e0c-9057-f887b71fc633_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis_06d74faf-71d1-4e0c-9057-f887b71fc633" xlink:to="loc_us-gaap_EquitySecuritiesIndustryMember_06d74faf-71d1-4e0c-9057-f887b71fc633_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis_06d74faf-71d1-4e0c-9057-f887b71fc633" xlink:to="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AerospaceAndDefenseSectorMember_613dd741-76d2-4dd7-860b-202a1ab08b29" xlink:href="bxsl-20231231.xsd#bxsl_AerospaceAndDefenseSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_AerospaceAndDefenseSectorMember_613dd741-76d2-4dd7-860b-202a1ab08b29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AirFreightLogisticsSectorMember_d3176380-cee1-4b95-a1df-e4f11cf665e6" xlink:href="bxsl-20231231.xsd#bxsl_AirFreightLogisticsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_AirFreightLogisticsSectorMember_d3176380-cee1-4b95-a1df-e4f11cf665e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BuildingProductsSectorMember_f6566efb-7b18-4cec-ad0c-3945ba94541a" xlink:href="bxsl-20231231.xsd#bxsl_BuildingProductsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_BuildingProductsSectorMember_f6566efb-7b18-4cec-ad0c-3945ba94541a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChemicalsSectorMember_dba0de09-b88c-4c22-97a5-813cf83d65ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChemicalsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_ChemicalsSectorMember_dba0de09-b88c-4c22-97a5-813cf83d65ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommercialServicesSuppliesSectorMember_b569dc0d-fc52-473d-8464-6716863aa62f" xlink:href="bxsl-20231231.xsd#bxsl_CommercialServicesSuppliesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_CommercialServicesSuppliesSectorMember_b569dc0d-fc52-473d-8464-6716863aa62f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ConstructionEngineeringSectorMember_536ef2b0-397d-4dc5-8f63-3ae8514248fb" xlink:href="bxsl-20231231.xsd#bxsl_ConstructionEngineeringSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ConstructionEngineeringSectorMember_536ef2b0-397d-4dc5-8f63-3ae8514248fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContainerAndPackagingSectorMember_0d0a65d3-52ee-46dc-8924-7dd4cc30b60b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContainerAndPackagingSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_ContainerAndPackagingSectorMember_0d0a65d3-52ee-46dc-8924-7dd4cc30b60b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DistributorsSectorMember_4554238b-3f62-4928-a864-e56c289d17e4" xlink:href="bxsl-20231231.xsd#bxsl_DistributorsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_DistributorsSectorMember_4554238b-3f62-4928-a864-e56c289d17e4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsumerSectorMember_08e88259-d315-4657-8b14-673b233418d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsumerSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_ConsumerSectorMember_08e88259-d315-4657-8b14-673b233418d8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DiversifiedTelecommunicationServicesSectorMember_ee66fb06-734c-4c4a-8360-331c0883c754" xlink:href="bxsl-20231231.xsd#bxsl_DiversifiedTelecommunicationServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_DiversifiedTelecommunicationServicesSectorMember_ee66fb06-734c-4c4a-8360-331c0883c754" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServicesSectorMember_27af04a6-e3a3-4d22-ae65-9f715dea0843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_FinancialServicesSectorMember_27af04a6-e3a3-4d22-ae65-9f715dea0843" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectricalEquipmentSectorMember_b4a18b2e-b01d-463d-bf3f-8e14d540a27b" xlink:href="bxsl-20231231.xsd#bxsl_ElectricalEquipmentSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ElectricalEquipmentSectorMember_b4a18b2e-b01d-463d-bf3f-8e14d540a27b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectronicEquipmentInstrumentsComponentsMember_2fd873bc-7abe-47e3-86aa-34175beed8b0" xlink:href="bxsl-20231231.xsd#bxsl_ElectronicEquipmentInstrumentsComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ElectronicEquipmentInstrumentsComponentsMember_2fd873bc-7abe-47e3-86aa-34175beed8b0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnergySectorMember_d806fa9c-bf97-420f-a90a-4bbc572452ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EnergySectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_EnergySectorMember_d806fa9c-bf97-420f-a90a-4bbc572452ef" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareEquipmentSuppliesSectorMember_5834ee28-3810-4371-bf4d-105a75c8e599" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareEquipmentSuppliesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_HealthCareEquipmentSuppliesSectorMember_5834ee28-3810-4371-bf4d-105a75c8e599" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareProvidersServicesSectorMember_2e2f0b88-435f-4719-8cc8-1936f8243bd7" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareProvidersServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_HealthCareProvidersServicesSectorMember_2e2f0b88-435f-4719-8cc8-1936f8243bd7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareTechnologySectorMember_ae6108b0-a711-4a16-8286-9a00e08e7f90" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareTechnologySectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_HealthCareTechnologySectorMember_ae6108b0-a711-4a16-8286-9a00e08e7f90" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSectorMember_5c9c6664-1d57-4687-8c0b-2bc9e56b0a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_InsuranceSectorMember_5c9c6664-1d57-4687-8c0b-2bc9e56b0a7b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ITServicesSectorMember_1db7ffe6-ea28-471f-a20f-067f6b147490" xlink:href="bxsl-20231231.xsd#bxsl_ITServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ITServicesSectorMember_1db7ffe6-ea28-471f-a20f-067f6b147490" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MachineryMember_0eda4eda-b876-41df-b0ef-79613b8390ac" xlink:href="bxsl-20231231.xsd#bxsl_MachineryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_MachineryMember_0eda4eda-b876-41df-b0ef-79613b8390ac" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OilGasConsumableFuelsMember_98d9ad67-7935-47c0-8ee7-17a4ff704018" xlink:href="bxsl-20231231.xsd#bxsl_OilGasConsumableFuelsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_OilGasConsumableFuelsMember_98d9ad67-7935-47c0-8ee7-17a4ff704018" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaperForestProductsMember_087845d8-25c5-4c17-8d91-4f53a55ed02e" xlink:href="bxsl-20231231.xsd#bxsl_PaperForestProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_PaperForestProductsMember_087845d8-25c5-4c17-8d91-4f53a55ed02e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PharmaceuticalsSectorMember_9086587e-64f2-4aa2-860c-8f87b5287bd6" xlink:href="bxsl-20231231.xsd#bxsl_PharmaceuticalsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_PharmaceuticalsSectorMember_9086587e-64f2-4aa2-860c-8f87b5287bd6" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ProfessionalServicesSectorMember_c3ee7307-d58d-4f99-a21d-12768e2c8bb2" xlink:href="bxsl-20231231.xsd#bxsl_ProfessionalServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ProfessionalServicesSectorMember_c3ee7307-d58d-4f99-a21d-12768e2c8bb2" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RealEstateManagementDevelopmentSectorMember_1b46f80e-4871-4892-a1d5-4d659d2fd4cb" xlink:href="bxsl-20231231.xsd#bxsl_RealEstateManagementDevelopmentSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_RealEstateManagementDevelopmentSectorMember_1b46f80e-4871-4892-a1d5-4d659d2fd4cb" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SoftwareSectorMember_418f812b-f9b9-45bf-a4ad-e5a169813f5f" xlink:href="bxsl-20231231.xsd#bxsl_SoftwareSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_SoftwareSectorMember_418f812b-f9b9-45bf-a4ad-e5a169813f5f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TradingCompaniesDistributorsSectorMember_6b087e94-c9d8-435b-a54b-639f38554df4" xlink:href="bxsl-20231231.xsd#bxsl_TradingCompaniesDistributorsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_TradingCompaniesDistributorsSectorMember_6b087e94-c9d8-435b-a54b-639f38554df4" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransportationInfrastructureSectorMember_58e93d97-7660-4442-a156-234b1dd986e8" xlink:href="bxsl-20231231.xsd#bxsl_TransportationInfrastructureSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_TransportationInfrastructureSectorMember_58e93d97-7660-4442-a156-234b1dd986e8" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectricUtilitiesMember_b31dad5c-926f-444c-82a3-ef746a061fb8" xlink:href="bxsl-20231231.xsd#bxsl_ElectricUtilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ElectricUtilitiesMember_b31dad5c-926f-444c-82a3-ef746a061fb8" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_GroundTransportationMember_dcbb48d4-cf14-4cbb-b1c7-07ef6575e7e9" xlink:href="bxsl-20231231.xsd#bxsl_GroundTransportationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_GroundTransportationMember_dcbb48d4-cf14-4cbb-b1c7-07ef6575e7e9" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:to="loc_us-gaap_InvestmentTypeAxis_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:to="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienMember_ed0a89a1-c412-44c5-8599-bb266fff30a3" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:to="loc_bxsl_DebtSecuritiesFirstLienMember_ed0a89a1-c412-44c5-8599-bb266fff30a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienMember_f1877936-306b-43b5-8bb7-722139b5616c" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:to="loc_bxsl_DebtSecuritiesSecondLienMember_f1877936-306b-43b5-8bb7-722139b5616c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_1985c505-803e-4efd-8ed3-be1fb7b64a45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:to="loc_us-gaap_EquitySecuritiesMember_1985c505-803e-4efd-8ed3-be1fb7b64a45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_a6ed9294-8968-403b-8a9b-549c4bcd2231" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:to="loc_us-gaap_UnsecuredDebtMember_a6ed9294-8968-403b-8a9b-549c4bcd2231" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_0f854d32-dd24-4d75-8030-6ba812993aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_0f854d32-dd24-4d75-8030-6ba812993aaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis_bd54ae9f-9cab-4a66-956e-9128a3b89570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationAxis_bd54ae9f-9cab-4a66-956e-9128a3b89570" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_bd54ae9f-9cab-4a66-956e-9128a3b89570_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_bd54ae9f-9cab-4a66-956e-9128a3b89570" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_bd54ae9f-9cab-4a66-956e-9128a3b89570_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_df2b61d4-0112-49ef-9030-bdf1ed59a384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_bd54ae9f-9cab-4a66-956e-9128a3b89570" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_df2b61d4-0112-49ef-9030-bdf1ed59a384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_093bfb1d-7c06-42ff-a206-530378cf9fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_df2b61d4-0112-49ef-9030-bdf1ed59a384" xlink:to="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_093bfb1d-7c06-42ff-a206-530378cf9fa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_bc6aab4b-37c3-4523-9411-7221e0df1fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_df2b61d4-0112-49ef-9030-bdf1ed59a384" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_bc6aab4b-37c3-4523-9411-7221e0df1fbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBasisSpreadVariableRate_9d475db8-9afa-47f7-ba8b-a357d54bc91d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBasisSpreadVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentBasisSpreadVariableRate_9d475db8-9afa-47f7-ba8b-a357d54bc91d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRatePaidInKind_7db4f701-b8d9-4850-80d5-eaf47a1a9480" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRatePaidInKind"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentInterestRatePaidInKind_7db4f701-b8d9-4850-80d5-eaf47a1a9480" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRate_161d6fc8-4194-4b90-b1e2-f3eb53fa6f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentInterestRate_161d6fc8-4194-4b90-b1e2-f3eb53fa6f9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount_97fc024f-cca6-41d1-897b-65e7bb8bf014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount_97fc024f-cca6-41d1-897b-65e7bb8bf014" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_c619dbed-e6d8-4c00-829d-fd6e33c49002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_c619dbed-e6d8-4c00-829d-fd6e33c49002" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtCost_7a07ea32-42c9-4bf9-81a4-86cb654b4a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedAtCost_7a07ea32-42c9-4bf9-81a4-86cb654b4a9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_08b0ab67-5535-4fcc-bcff-e3e1d33f1a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_08b0ab67-5535-4fcc-bcff-e3e1d33f1a2a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_12a9d080-0a26-4c64-9f27-d160161f510f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_12a9d080-0a26-4c64-9f27-d160161f510f" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedScheduleofInvestmentsParenthetical"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIdentifierAxis_86667ecb-2fd9-4367-b792-bf1ec44ecc72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_us-gaap_InvestmentIdentifierAxis_86667ecb-2fd9-4367-b792-bf1ec44ecc72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ec9054d-b989-41fc-becc-72cbac6b914c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_srt_RangeAxis_1ec9054d-b989-41fc-becc-72cbac6b914c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1ec9054d-b989-41fc-becc-72cbac6b914c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1ec9054d-b989-41fc-becc-72cbac6b914c" xlink:to="loc_srt_RangeMember_1ec9054d-b989-41fc-becc-72cbac6b914c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_59167211-c517-439f-94a5-16cabb289bd7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1ec9054d-b989-41fc-becc-72cbac6b914c" xlink:to="loc_srt_RangeMember_59167211-c517-439f-94a5-16cabb289bd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b5910acf-6c06-4b93-ad2f-8f5936bc2e02" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_59167211-c517-439f-94a5-16cabb289bd7" xlink:to="loc_srt_MinimumMember_b5910acf-6c06-4b93-ad2f-8f5936bc2e02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_b9d38609-e50d-44b7-9da7-e87ba2dbbf02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_us-gaap_InvestmentTypeAxis_b9d38609-e50d-44b7-9da7-e87ba2dbbf02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_b9d38609-e50d-44b7-9da7-e87ba2dbbf02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_b9d38609-e50d-44b7-9da7-e87ba2dbbf02" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_b9d38609-e50d-44b7-9da7-e87ba2dbbf02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_dfff5101-57cd-47bc-bef8-fa47503c744a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_b9d38609-e50d-44b7-9da7-e87ba2dbbf02" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_dfff5101-57cd-47bc-bef8-fa47503c744a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_QualifyingAssetsMember_5a43a1cd-d298-4802-83d8-33a132596190" xlink:href="bxsl-20231231.xsd#bxsl_QualifyingAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_dfff5101-57cd-47bc-bef8-fa47503c744a" xlink:to="loc_bxsl_QualifyingAssetsMember_5a43a1cd-d298-4802-83d8-33a132596190" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NonQualifyingAssetsMember_da3cf3df-4dd7-41fa-a44c-dff0ed7ee640" xlink:href="bxsl-20231231.xsd#bxsl_NonQualifyingAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_dfff5101-57cd-47bc-bef8-fa47503c744a" xlink:to="loc_bxsl_NonQualifyingAssetsMember_da3cf3df-4dd7-41fa-a44c-dff0ed7ee640" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis_8a3c5293-589a-4512-989d-51a68c0e2bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationAxis_8a3c5293-589a-4512-989d-51a68c0e2bf2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_8a3c5293-589a-4512-989d-51a68c0e2bf2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_8a3c5293-589a-4512-989d-51a68c0e2bf2" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_8a3c5293-589a-4512-989d-51a68c0e2bf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_8a3c5293-589a-4512-989d-51a68c0e2bf2" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_df7d97a8-70b7-4701-92d5-338e9a4514ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:to="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_df7d97a8-70b7-4701-92d5-338e9a4514ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_7fd2735e-e36f-44a3-953a-cb933cc0d37e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_7fd2735e-e36f-44a3-953a-cb933cc0d37e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerMember_74d04c0e-9996-4897-bd22-39350ac10d32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerMember_74d04c0e-9996-4897-bd22-39350ac10d32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerNameAxis_9848620b-ec1b-4b7f-853a-5d02ee38ea64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_us-gaap_InvestmentIssuerNameAxis_9848620b-ec1b-4b7f-853a-5d02ee38ea64" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerNameDomain_9848620b-ec1b-4b7f-853a-5d02ee38ea64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentIssuerNameAxis_9848620b-ec1b-4b7f-853a-5d02ee38ea64" xlink:to="loc_us-gaap_InvestmentIssuerNameDomain_9848620b-ec1b-4b7f-853a-5d02ee38ea64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerNameDomain_b6d73b39-02ab-494d-9c1d-17a4a5e5bc76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentIssuerNameAxis_9848620b-ec1b-4b7f-853a-5d02ee38ea64" xlink:to="loc_us-gaap_InvestmentIssuerNameDomain_b6d73b39-02ab-494d-9c1d-17a4a5e5bc76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BlackstoneDonegalHoldingsLPMember_8f930d71-340e-4cde-8739-2590b1437dbf" xlink:href="bxsl-20231231.xsd#bxsl_BlackstoneDonegalHoldingsLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerNameDomain_b6d73b39-02ab-494d-9c1d-17a4a5e5bc76" xlink:to="loc_bxsl_BlackstoneDonegalHoldingsLPMember_8f930d71-340e-4cde-8739-2590b1437dbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_063fbe06-a8a7-4502-a4c0-6bf2362fc86a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_063fbe06-a8a7-4502-a4c0-6bf2362fc86a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_8ef47f16-968d-4011-b54b-d94eeb6f5ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_8ef47f16-968d-4011-b54b-d94eeb6f5ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue_cff38432-2c36-4d2a-9528-9ddf104aab8b" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue_cff38432-2c36-4d2a-9528-9ddf104aab8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRateFloor_e42e507b-5567-4211-8b93-1c7e799bf8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InvestmentInterestRateFloor_e42e507b-5567-4211-8b93-1c7e799bf8ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate_b79a7b4b-f2b8-4043-be0a-49129a5d3057" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentPercentageOfPortfolioAboveFloorRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate_b79a7b4b-f2b8-4043-be0a-49129a5d3057" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_61fc31cf-58f9-4b96-9f62-781b08b0954d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_61fc31cf-58f9-4b96-9f62-781b08b0954d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions_12ab10e0-16a3-4c30-b724-f46e4c082ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions_12ab10e0-16a3-4c30-b724-f46e4c082ce4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions_5f6d2dc2-7567-4756-8065-d1342c44fe00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions_5f6d2dc2-7567-4756-8065-d1342c44fe00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease_e8f4406b-dbbe-481b-b096-ee3b8153576a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease_e8f4406b-dbbe-481b-b096-ee3b8153576a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax_03cdd0c6-4a04-42ba-a3ff-2112bf705ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax_03cdd0c6-4a04-42ba-a3ff-2112bf705ee7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_eca5c3e4-2ec7-45a6-b2c2-31bc1feda839" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeSecurities_e285e578-41d5-495e-8c86-a33e9b3ed58e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndDividendIncomeSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InterestAndDividendIncomeSecurities_e285e578-41d5-495e-8c86-a33e9b3ed58e" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical_1" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedScheduleofInvestmentsParenthetical_1"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ec9054d-b989-41fc-becc-72cbac6b914c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_srt_RangeAxis_1ec9054d-b989-41fc-becc-72cbac6b914c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1ec9054d-b989-41fc-becc-72cbac6b914c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1ec9054d-b989-41fc-becc-72cbac6b914c" xlink:to="loc_srt_RangeMember_1ec9054d-b989-41fc-becc-72cbac6b914c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_59167211-c517-439f-94a5-16cabb289bd7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1ec9054d-b989-41fc-becc-72cbac6b914c" xlink:to="loc_srt_RangeMember_59167211-c517-439f-94a5-16cabb289bd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b5910acf-6c06-4b93-ad2f-8f5936bc2e02" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_59167211-c517-439f-94a5-16cabb289bd7" xlink:to="loc_srt_MinimumMember_b5910acf-6c06-4b93-ad2f-8f5936bc2e02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_b9d38609-e50d-44b7-9da7-e87ba2dbbf02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_us-gaap_InvestmentTypeAxis_b9d38609-e50d-44b7-9da7-e87ba2dbbf02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_b9d38609-e50d-44b7-9da7-e87ba2dbbf02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_b9d38609-e50d-44b7-9da7-e87ba2dbbf02" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_b9d38609-e50d-44b7-9da7-e87ba2dbbf02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_dfff5101-57cd-47bc-bef8-fa47503c744a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_b9d38609-e50d-44b7-9da7-e87ba2dbbf02" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_dfff5101-57cd-47bc-bef8-fa47503c744a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_QualifyingAssetsMember_5a43a1cd-d298-4802-83d8-33a132596190" xlink:href="bxsl-20231231.xsd#bxsl_QualifyingAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_dfff5101-57cd-47bc-bef8-fa47503c744a" xlink:to="loc_bxsl_QualifyingAssetsMember_5a43a1cd-d298-4802-83d8-33a132596190" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NonQualifyingAssetsMember_da3cf3df-4dd7-41fa-a44c-dff0ed7ee640" xlink:href="bxsl-20231231.xsd#bxsl_NonQualifyingAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_dfff5101-57cd-47bc-bef8-fa47503c744a" xlink:to="loc_bxsl_NonQualifyingAssetsMember_da3cf3df-4dd7-41fa-a44c-dff0ed7ee640" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis_8a3c5293-589a-4512-989d-51a68c0e2bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationAxis_8a3c5293-589a-4512-989d-51a68c0e2bf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_8a3c5293-589a-4512-989d-51a68c0e2bf2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_8a3c5293-589a-4512-989d-51a68c0e2bf2" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_8a3c5293-589a-4512-989d-51a68c0e2bf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_8a3c5293-589a-4512-989d-51a68c0e2bf2" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_df7d97a8-70b7-4701-92d5-338e9a4514ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:to="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_df7d97a8-70b7-4701-92d5-338e9a4514ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_7fd2735e-e36f-44a3-953a-cb933cc0d37e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_7fd2735e-e36f-44a3-953a-cb933cc0d37e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerMember_74d04c0e-9996-4897-bd22-39350ac10d32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerMember_74d04c0e-9996-4897-bd22-39350ac10d32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerNameAxis_9848620b-ec1b-4b7f-853a-5d02ee38ea64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_us-gaap_InvestmentIssuerNameAxis_9848620b-ec1b-4b7f-853a-5d02ee38ea64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerNameDomain_9848620b-ec1b-4b7f-853a-5d02ee38ea64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentIssuerNameAxis_9848620b-ec1b-4b7f-853a-5d02ee38ea64" xlink:to="loc_us-gaap_InvestmentIssuerNameDomain_9848620b-ec1b-4b7f-853a-5d02ee38ea64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerNameDomain_b6d73b39-02ab-494d-9c1d-17a4a5e5bc76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentIssuerNameAxis_9848620b-ec1b-4b7f-853a-5d02ee38ea64" xlink:to="loc_us-gaap_InvestmentIssuerNameDomain_b6d73b39-02ab-494d-9c1d-17a4a5e5bc76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BlackstoneDonegalHoldingsLPMember_8f930d71-340e-4cde-8739-2590b1437dbf" xlink:href="bxsl-20231231.xsd#bxsl_BlackstoneDonegalHoldingsLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerNameDomain_b6d73b39-02ab-494d-9c1d-17a4a5e5bc76" xlink:to="loc_bxsl_BlackstoneDonegalHoldingsLPMember_8f930d71-340e-4cde-8739-2590b1437dbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_063fbe06-a8a7-4502-a4c0-6bf2362fc86a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_063fbe06-a8a7-4502-a4c0-6bf2362fc86a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_8ef47f16-968d-4011-b54b-d94eeb6f5ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_8ef47f16-968d-4011-b54b-d94eeb6f5ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue_cff38432-2c36-4d2a-9528-9ddf104aab8b" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue_cff38432-2c36-4d2a-9528-9ddf104aab8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRateFloor_e42e507b-5567-4211-8b93-1c7e799bf8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InvestmentInterestRateFloor_e42e507b-5567-4211-8b93-1c7e799bf8ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate_b79a7b4b-f2b8-4043-be0a-49129a5d3057" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentPercentageOfPortfolioAboveFloorRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate_b79a7b4b-f2b8-4043-be0a-49129a5d3057" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_61fc31cf-58f9-4b96-9f62-781b08b0954d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_61fc31cf-58f9-4b96-9f62-781b08b0954d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions_12ab10e0-16a3-4c30-b724-f46e4c082ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions_12ab10e0-16a3-4c30-b724-f46e4c082ce4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions_5f6d2dc2-7567-4756-8065-d1342c44fe00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions_5f6d2dc2-7567-4756-8065-d1342c44fe00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease_e8f4406b-dbbe-481b-b096-ee3b8153576a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease_e8f4406b-dbbe-481b-b096-ee3b8153576a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax_03cdd0c6-4a04-42ba-a3ff-2112bf705ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax_03cdd0c6-4a04-42ba-a3ff-2112bf705ee7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_eca5c3e4-2ec7-45a6-b2c2-31bc1feda839" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeSecurities_e285e578-41d5-495e-8c86-a33e9b3ed58e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndDividendIncomeSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InterestAndDividendIncomeSecurities_e285e578-41d5-495e-8c86-a33e9b3ed58e" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_64884165-31b1-4bfd-8f4d-a295e95e59fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_64884165-31b1-4bfd-8f4d-a295e95e59fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_3b7ffe09-0d5e-464a-a540-a7ed446b5c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_64884165-31b1-4bfd-8f4d-a295e95e59fa" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_3b7ffe09-0d5e-464a-a540-a7ed446b5c3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3b7ffe09-0d5e-464a-a540-a7ed446b5c3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_3b7ffe09-0d5e-464a-a540-a7ed446b5c3f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3b7ffe09-0d5e-464a-a540-a7ed446b5c3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_bff4a410-f013-4111-836c-be4593812fed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_3b7ffe09-0d5e-464a-a540-a7ed446b5c3f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_bff4a410-f013-4111-836c-be4593812fed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentAdvisoryAgreementMember_e18bc190-e8c5-4f22-aab2-279b9bc6a4a7" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentAdvisoryAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_bff4a410-f013-4111-836c-be4593812fed" xlink:to="loc_bxsl_InvestmentAdvisoryAgreementMember_e18bc190-e8c5-4f22-aab2-279b9bc6a4a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a9e0de64-f5f8-4fa4-becf-7a6a7dc853f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_64884165-31b1-4bfd-8f4d-a295e95e59fa" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a9e0de64-f5f8-4fa4-becf-7a6a7dc853f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a9e0de64-f5f8-4fa4-becf-7a6a7dc853f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a9e0de64-f5f8-4fa4-becf-7a6a7dc853f2" xlink:to="loc_us-gaap_RelatedPartyDomain_a9e0de64-f5f8-4fa4-becf-7a6a7dc853f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_1f6bb62c-b63d-461f-9f43-d4201e8c4680" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a9e0de64-f5f8-4fa4-becf-7a6a7dc853f2" xlink:to="loc_us-gaap_RelatedPartyDomain_1f6bb62c-b63d-461f-9f43-d4201e8c4680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_a348f0ee-8e31-4c29-ba76-adda0788ee62" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1f6bb62c-b63d-461f-9f43-d4201e8c4680" xlink:to="loc_srt_AffiliatedEntityMember_a348f0ee-8e31-4c29-ba76-adda0788ee62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioAxis_31f74c5f-7bf3-4420-828b-2738f1e93fe0" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_64884165-31b1-4bfd-8f4d-a295e95e59fa" xlink:to="loc_bxsl_VoluntaryWaiverScenarioAxis_31f74c5f-7bf3-4420-828b-2738f1e93fe0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioDomain_31f74c5f-7bf3-4420-828b-2738f1e93fe0_default" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bxsl_VoluntaryWaiverScenarioAxis_31f74c5f-7bf3-4420-828b-2738f1e93fe0" xlink:to="loc_bxsl_VoluntaryWaiverScenarioDomain_31f74c5f-7bf3-4420-828b-2738f1e93fe0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioDomain_843b301d-ee83-4b95-bade-9e2f85dc7521" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bxsl_VoluntaryWaiverScenarioAxis_31f74c5f-7bf3-4420-828b-2738f1e93fe0" xlink:to="loc_bxsl_VoluntaryWaiverScenarioDomain_843b301d-ee83-4b95-bade-9e2f85dc7521" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverNotInPlaceMember_66a1d67c-ca68-4c59-af45-ef1fdb7b8763" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverNotInPlaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_VoluntaryWaiverScenarioDomain_843b301d-ee83-4b95-bade-9e2f85dc7521" xlink:to="loc_bxsl_VoluntaryWaiverNotInPlaceMember_66a1d67c-ca68-4c59-af45-ef1fdb7b8763" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverInPlaceMember_e590d8fe-9318-403a-99bc-1017bd7152d9" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverInPlaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_VoluntaryWaiverScenarioDomain_843b301d-ee83-4b95-bade-9e2f85dc7521" xlink:to="loc_bxsl_VoluntaryWaiverInPlaceMember_e590d8fe-9318-403a-99bc-1017bd7152d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate_692ca169-56d2-4998-9a9c-ddf42f62e2e5" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate_692ca169-56d2-4998-9a9c-ddf42f62e2e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionInitialTerm_e8925a63-9585-430c-a10a-6d3ac60279d1" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionInitialTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_bxsl_RelatedPartyTransactionInitialTerm_e8925a63-9585-430c-a10a-6d3ac60279d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionRenewalTerm_655eb6a4-f585-422c-9a97-41781e454b09" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_bxsl_RelatedPartyTransactionRenewalTerm_655eb6a4-f585-422c-9a97-41781e454b09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod_0e1c4b6f-b21b-4f44-8f27-68394fa618ff" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod_0e1c4b6f-b21b-4f44-8f27-68394fa618ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesBaseRate_a433aa83-0ea5-4f60-a32b-fd0ef4581e44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesBaseRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_us-gaap_ManagementAndServiceFeesBaseRate_a433aa83-0ea5-4f60-a32b-fd0ef4581e44" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesIncentiveRate_7a1c5394-1ebd-4a01-83a1-32360807470c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesIncentiveRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_us-gaap_ManagementAndServiceFeesIncentiveRate_7a1c5394-1ebd-4a01-83a1-32360807470c" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c68dc4d5-b432-45bb-af91-01103452299d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c68dc4d5-b432-45bb-af91-01103452299d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioAxis_fe51be53-063e-4e79-88e8-c947065f754e" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c68dc4d5-b432-45bb-af91-01103452299d" xlink:to="loc_bxsl_VoluntaryWaiverScenarioAxis_fe51be53-063e-4e79-88e8-c947065f754e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioDomain_fe51be53-063e-4e79-88e8-c947065f754e_default" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bxsl_VoluntaryWaiverScenarioAxis_fe51be53-063e-4e79-88e8-c947065f754e" xlink:to="loc_bxsl_VoluntaryWaiverScenarioDomain_fe51be53-063e-4e79-88e8-c947065f754e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioDomain_107979b1-49b7-4165-b1ad-9a177399c491" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bxsl_VoluntaryWaiverScenarioAxis_fe51be53-063e-4e79-88e8-c947065f754e" xlink:to="loc_bxsl_VoluntaryWaiverScenarioDomain_107979b1-49b7-4165-b1ad-9a177399c491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverInPlaceMember_303c7534-cac8-4ea4-a83b-096ebeb0971d" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverInPlaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_VoluntaryWaiverScenarioDomain_107979b1-49b7-4165-b1ad-9a177399c491" xlink:to="loc_bxsl_VoluntaryWaiverInPlaceMember_303c7534-cac8-4ea4-a83b-096ebeb0971d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_82fa461b-3c10-49eb-a984-963f8a8ce77d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c68dc4d5-b432-45bb-af91-01103452299d" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_82fa461b-3c10-49eb-a984-963f8a8ce77d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_82fa461b-3c10-49eb-a984-963f8a8ce77d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_82fa461b-3c10-49eb-a984-963f8a8ce77d" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_82fa461b-3c10-49eb-a984-963f8a8ce77d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_2f98c78c-a807-4703-9e53-e7f915617622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_82fa461b-3c10-49eb-a984-963f8a8ce77d" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_2f98c78c-a807-4703-9e53-e7f915617622" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentAdvisoryAgreementMember_b321610e-f024-4a35-940a-85dbb424593c" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentAdvisoryAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_2f98c78c-a807-4703-9e53-e7f915617622" xlink:to="loc_bxsl_InvestmentAdvisoryAgreementMember_b321610e-f024-4a35-940a-85dbb424593c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesRate_79683f9f-f2d4-4561-b8dc-1a7600552abd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:to="loc_us-gaap_ManagementAndServiceFeesRate_79683f9f-f2d4-4561-b8dc-1a7600552abd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesBaseRate_2adc30a7-cdc8-40e1-bf3e-89d7520477af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesBaseRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:to="loc_us-gaap_ManagementAndServiceFeesBaseRate_2adc30a7-cdc8-40e1-bf3e-89d7520477af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense_b1f3228e-5997-4c45-9210-fdf5c0db3fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:to="loc_us-gaap_ManagementFeeExpense_b1f3228e-5997-4c45-9210-fdf5c0db3fd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyContractualFeeWaived_02d1c1a7-2554-4459-8357-0d0ebefb36e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyContractualFeeWaived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:to="loc_us-gaap_InvestmentCompanyContractualFeeWaived_02d1c1a7-2554-4459-8357-0d0ebefb36e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeePayable_2cddfc95-9aa6-44ad-8277-6ee3f49ee863" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeePayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:to="loc_us-gaap_ManagementFeePayable_2cddfc95-9aa6-44ad-8277-6ee3f49ee863" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_f8230e3c-1c5f-4a6f-b8d7-bd7cf461c083" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_f8230e3c-1c5f-4a6f-b8d7-bd7cf461c083" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_f8230e3c-1c5f-4a6f-b8d7-bd7cf461c083_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_f8230e3c-1c5f-4a6f-b8d7-bd7cf461c083" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_f8230e3c-1c5f-4a6f-b8d7-bd7cf461c083_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_62336bc6-fc5e-4297-81f8-6bc00ca858fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_f8230e3c-1c5f-4a6f-b8d7-bd7cf461c083" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_62336bc6-fc5e-4297-81f8-6bc00ca858fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember_01994a3e-7f57-4fa8-afe6-8865de822740" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_62336bc6-fc5e-4297-81f8-6bc00ca858fe" xlink:to="loc_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember_01994a3e-7f57-4fa8-afe6-8865de822740" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember_5cb20996-a29b-4284-80f4-d0495e27ed42" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_62336bc6-fc5e-4297-81f8-6bc00ca858fe" xlink:to="loc_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember_5cb20996-a29b-4284-80f4-d0495e27ed42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentAdvisoryAgreementMember_b96f6bb5-5459-44e2-8db3-48f058936142" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentAdvisoryAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_62336bc6-fc5e-4297-81f8-6bc00ca858fe" xlink:to="loc_bxsl_InvestmentAdvisoryAgreementMember_b96f6bb5-5459-44e2-8db3-48f058936142" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesScenarioAxis_3f9a38fa-44c9-4c1e-99ff-992c8e7d808c" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesScenarioAxis_3f9a38fa-44c9-4c1e-99ff-992c8e7d808c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesScenarioDomain_3f9a38fa-44c9-4c1e-99ff-992c8e7d808c_default" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesScenarioAxis_3f9a38fa-44c9-4c1e-99ff-992c8e7d808c" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesScenarioDomain_3f9a38fa-44c9-4c1e-99ff-992c8e7d808c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesScenarioDomain_ef4f0084-6a30-481d-a77e-9fa04684846f" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesScenarioAxis_3f9a38fa-44c9-4c1e-99ff-992c8e7d808c" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesScenarioDomain_ef4f0084-6a30-481d-a77e-9fa04684846f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember_33d00825-a3bb-4a1e-b606-05dee986834e" xlink:href="bxsl-20231231.xsd#bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesScenarioDomain_ef4f0084-6a30-481d-a77e-9fa04684846f" xlink:to="loc_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember_33d00825-a3bb-4a1e-b606-05dee986834e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember_b1516fc8-5ffe-4f0e-aba1-cdf3d7fac5cf" xlink:href="bxsl-20231231.xsd#bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesScenarioDomain_ef4f0084-6a30-481d-a77e-9fa04684846f" xlink:to="loc_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember_b1516fc8-5ffe-4f0e-aba1-cdf3d7fac5cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioAxis_9d8c24f1-6d87-4031-8f9f-7f126ad18c93" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:to="loc_bxsl_VoluntaryWaiverScenarioAxis_9d8c24f1-6d87-4031-8f9f-7f126ad18c93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioDomain_9d8c24f1-6d87-4031-8f9f-7f126ad18c93_default" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bxsl_VoluntaryWaiverScenarioAxis_9d8c24f1-6d87-4031-8f9f-7f126ad18c93" xlink:to="loc_bxsl_VoluntaryWaiverScenarioDomain_9d8c24f1-6d87-4031-8f9f-7f126ad18c93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioDomain_6259e9db-78e8-4ba6-b2da-62a71e465180" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bxsl_VoluntaryWaiverScenarioAxis_9d8c24f1-6d87-4031-8f9f-7f126ad18c93" xlink:to="loc_bxsl_VoluntaryWaiverScenarioDomain_6259e9db-78e8-4ba6-b2da-62a71e465180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverInPlaceMember_a3e2c43a-86eb-453f-9f28-d54213490f4b" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverInPlaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_VoluntaryWaiverScenarioDomain_6259e9db-78e8-4ba6-b2da-62a71e465180" xlink:to="loc_bxsl_VoluntaryWaiverInPlaceMember_a3e2c43a-86eb-453f-9f28-d54213490f4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverNotInPlaceMember_8daf9079-14f4-46de-b839-a659bd4ce1fb" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverNotInPlaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_VoluntaryWaiverScenarioDomain_6259e9db-78e8-4ba6-b2da-62a71e465180" xlink:to="loc_bxsl_VoluntaryWaiverNotInPlaceMember_8daf9079-14f4-46de-b839-a659bd4ce1fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8e4b52bf-7ba8-48a8-9dc2-126c80bbee8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8e4b52bf-7ba8-48a8-9dc2-126c80bbee8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8e4b52bf-7ba8-48a8-9dc2-126c80bbee8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8e4b52bf-7ba8-48a8-9dc2-126c80bbee8e" xlink:to="loc_us-gaap_RelatedPartyDomain_8e4b52bf-7ba8-48a8-9dc2-126c80bbee8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_969476b0-39b2-41f4-bdc4-a9e1d2641449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8e4b52bf-7ba8-48a8-9dc2-126c80bbee8e" xlink:to="loc_us-gaap_RelatedPartyDomain_969476b0-39b2-41f4-bdc4-a9e1d2641449" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_e14953b6-8935-4c52-ad9d-bdb016024de5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_969476b0-39b2-41f4-bdc4-a9e1d2641449" xlink:to="loc_srt_AffiliatedEntityMember_e14953b6-8935-4c52-ad9d-bdb016024de5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesIncentiveRate_9a70b6ed-ae26-4fb2-9578-6609e5c7b2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesIncentiveRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_us-gaap_ManagementAndServiceFeesIncentiveRate_9a70b6ed-ae26-4fb2-9578-6609e5c7b2c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate_f5715d2b-069d-431a-b469-d2e9dc01e5b5" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate_f5715d2b-069d-431a-b469-d2e9dc01e5b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesRate_a35b8c38-ba68-45b3-ab0c-537b429dad6a" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesRate_a35b8c38-ba68-45b3-ab0c-537b429dad6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage_3fd4608c-5536-4c89-89ad-df1e621c46a1" xlink:href="bxsl-20231231.xsd#bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage_3fd4608c-5536-4c89-89ad-df1e621c46a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold_1e77753f-f677-4a9c-b9b0-24eef2160b56" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold_1e77753f-f677-4a9c-b9b0-24eef2160b56" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome_5c184ace-2dd7-4d4c-8566-f05e8497ee29" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome_5c184ace-2dd7-4d4c-8566-f05e8497ee29" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage_a3b32bb4-76a0-4f63-a71a-c1f2467af914" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage_a3b32bb4-76a0-4f63-a71a-c1f2467af914" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage_037d544c-3f3f-437e-8717-ed7f51ca4018" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage_037d544c-3f3f-437e-8717-ed7f51ca4018" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn_0a40b241-b453-4f61-8b43-f067ff5dc6f8" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn_0a40b241-b453-4f61-8b43-f067ff5dc6f8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CapitalGainsBasedIncentiveFeesRate_c4587d60-5ba8-4d72-b018-1763dadfaaf0" xlink:href="bxsl-20231231.xsd#bxsl_CapitalGainsBasedIncentiveFeesRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_CapitalGainsBasedIncentiveFeesRate_c4587d60-5ba8-4d72-b018-1763dadfaaf0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeeExpense_e5d32ff4-63df-4b6f-a4b7-d7314fcc7f08" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeeExpense_e5d32ff4-63df-4b6f-a4b7-d7314fcc7f08" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyVoluntaryFeeWaived_f6e323f2-552c-4162-817d-b52c95dae486" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyVoluntaryFeeWaived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_us-gaap_InvestmentCompanyVoluntaryFeeWaived_f6e323f2-552c-4162-817d-b52c95dae486" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncentiveFeePayableIncome_cca73ded-e56d-4ca8-8a2e-ebd679cfb39a" xlink:href="bxsl-20231231.xsd#bxsl_IncentiveFeePayableIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncentiveFeePayableIncome_cca73ded-e56d-4ca8-8a2e-ebd679cfb39a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CapitalGainsIncentiveFeeExpense_7335c947-4f23-4b52-966b-57df1c42d4c6" xlink:href="bxsl-20231231.xsd#bxsl_CapitalGainsIncentiveFeeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_CapitalGainsIncentiveFeeExpense_7335c947-4f23-4b52-966b-57df1c42d4c6" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_940ab3cd-3f73-458d-86fe-5ee6b149f611" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_afd7463d-4e5e-4005-9d9f-6b3e64df4e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_940ab3cd-3f73-458d-86fe-5ee6b149f611" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_afd7463d-4e5e-4005-9d9f-6b3e64df4e4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_b6724fcc-d0cc-4fc7-9c08-fd381655da04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_afd7463d-4e5e-4005-9d9f-6b3e64df4e4b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_b6724fcc-d0cc-4fc7-9c08-fd381655da04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_b6724fcc-d0cc-4fc7-9c08-fd381655da04_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b6724fcc-d0cc-4fc7-9c08-fd381655da04" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_b6724fcc-d0cc-4fc7-9c08-fd381655da04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_96ab14d4-0aea-4cd2-992a-7957565959ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b6724fcc-d0cc-4fc7-9c08-fd381655da04" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_96ab14d4-0aea-4cd2-992a-7957565959ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AdministrationAgreementMember_e5e28487-5d65-468f-8900-412b0a908e45" xlink:href="bxsl-20231231.xsd#bxsl_AdministrationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_96ab14d4-0aea-4cd2-992a-7957565959ff" xlink:to="loc_bxsl_AdministrationAgreementMember_e5e28487-5d65-468f-8900-412b0a908e45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f7fbbf9f-1c79-4c10-95ab-360d13c50171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_afd7463d-4e5e-4005-9d9f-6b3e64df4e4b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f7fbbf9f-1c79-4c10-95ab-360d13c50171" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f7fbbf9f-1c79-4c10-95ab-360d13c50171_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f7fbbf9f-1c79-4c10-95ab-360d13c50171" xlink:to="loc_us-gaap_RelatedPartyDomain_f7fbbf9f-1c79-4c10-95ab-360d13c50171_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8f688f05-ffa2-405c-bc40-0f35caa15381" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f7fbbf9f-1c79-4c10-95ab-360d13c50171" xlink:to="loc_us-gaap_RelatedPartyDomain_8f688f05-ffa2-405c-bc40-0f35caa15381" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_21981f90-de8d-409c-a11f-e870071c94af" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_8f688f05-ffa2-405c-bc40-0f35caa15381" xlink:to="loc_srt_AffiliatedEntityMember_21981f90-de8d-409c-a11f-e870071c94af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionInitialTerm_04ae6eeb-8513-4c81-9b01-36fe5a41ee58" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionInitialTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_940ab3cd-3f73-458d-86fe-5ee6b149f611" xlink:to="loc_bxsl_RelatedPartyTransactionInitialTerm_04ae6eeb-8513-4c81-9b01-36fe5a41ee58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdministrativeFeesExpense_2624da99-2868-4b21-b999-7b768f72bef3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdministrativeFeesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_940ab3cd-3f73-458d-86fe-5ee6b149f611" xlink:to="loc_us-gaap_AdministrativeFeesExpense_2624da99-2868-4b21-b999-7b768f72bef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_64d71e35-121b-4f3c-8770-8339776fd653" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_940ab3cd-3f73-458d-86fe-5ee6b149f611" xlink:to="loc_us-gaap_OtherLiabilities_64d71e35-121b-4f3c-8770-8339776fd653" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_df3eda44-637f-4c95-be8f-c68671ac41b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3dff632c-26f5-4a4b-bbf4-77ff39dde57c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df3eda44-637f-4c95-be8f-c68671ac41b5" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3dff632c-26f5-4a4b-bbf4-77ff39dde57c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_d5536db4-96d4-48d3-a35f-19e2144001f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3dff632c-26f5-4a4b-bbf4-77ff39dde57c" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_d5536db4-96d4-48d3-a35f-19e2144001f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d5536db4-96d4-48d3-a35f-19e2144001f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_d5536db4-96d4-48d3-a35f-19e2144001f1" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d5536db4-96d4-48d3-a35f-19e2144001f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_17d435d1-da6e-481e-9acf-2f6be8a34338" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_d5536db4-96d4-48d3-a35f-19e2144001f1" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_17d435d1-da6e-481e-9acf-2f6be8a34338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SubAdministrationAgreementMember_ebf04531-1ae3-4907-9256-2b4ad49be4b4" xlink:href="bxsl-20231231.xsd#bxsl_SubAdministrationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_17d435d1-da6e-481e-9acf-2f6be8a34338" xlink:to="loc_bxsl_SubAdministrationAgreementMember_ebf04531-1ae3-4907-9256-2b4ad49be4b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionInitialTerm_e7b0eddb-20d3-46d7-a1b1-ff0d1fc9d859" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionInitialTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df3eda44-637f-4c95-be8f-c68671ac41b5" xlink:to="loc_bxsl_RelatedPartyTransactionInitialTerm_e7b0eddb-20d3-46d7-a1b1-ff0d1fc9d859" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionRenewalTerm_573e15ba-e867-4a2a-9410-8895760b5f1a" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df3eda44-637f-4c95-be8f-c68671ac41b5" xlink:to="loc_bxsl_RelatedPartyTransactionRenewalTerm_573e15ba-e867-4a2a-9410-8895760b5f1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionTerminationNoticePeriod_e5e9de50-b3a9-4797-a525-a83587c3b433" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionTerminationNoticePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df3eda44-637f-4c95-be8f-c68671ac41b5" xlink:to="loc_bxsl_RelatedPartyTransactionTerminationNoticePeriod_e5e9de50-b3a9-4797-a525-a83587c3b433" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_eb37bf95-86db-420d-bea6-265ea6348b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_78e2bbee-b20d-4611-8ddc-ddf96435b359" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb37bf95-86db-420d-bea6-265ea6348b5b" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_78e2bbee-b20d-4611-8ddc-ddf96435b359" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_5278afca-6a29-4329-9996-f1964014691b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_78e2bbee-b20d-4611-8ddc-ddf96435b359" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_5278afca-6a29-4329-9996-f1964014691b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_5278afca-6a29-4329-9996-f1964014691b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_5278afca-6a29-4329-9996-f1964014691b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_5278afca-6a29-4329-9996-f1964014691b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_e7d5896e-016c-4bb6-854f-152411bd9a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_5278afca-6a29-4329-9996-f1964014691b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_e7d5896e-016c-4bb6-854f-152411bd9a4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExpenseSupportAgreementMember_a900e9e7-583d-4742-94c5-e230017eed5a" xlink:href="bxsl-20231231.xsd#bxsl_ExpenseSupportAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_e7d5896e-016c-4bb6-854f-152411bd9a4f" xlink:to="loc_bxsl_ExpenseSupportAgreementMember_a900e9e7-583d-4742-94c5-e230017eed5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember_56c20d79-071d-47b3-80d5-5e2abc917b03" xlink:href="bxsl-20231231.xsd#bxsl_ExpenseSupportAgreementExcessOperatingFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_e7d5896e-016c-4bb6-854f-152411bd9a4f" xlink:to="loc_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember_56c20d79-071d-47b3-80d5-5e2abc917b03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_29b915d1-6f8c-4c16-8dcd-0350023bc6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_78e2bbee-b20d-4611-8ddc-ddf96435b359" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_29b915d1-6f8c-4c16-8dcd-0350023bc6f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_29b915d1-6f8c-4c16-8dcd-0350023bc6f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_29b915d1-6f8c-4c16-8dcd-0350023bc6f2" xlink:to="loc_us-gaap_RelatedPartyDomain_29b915d1-6f8c-4c16-8dcd-0350023bc6f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_473efda5-8127-45ea-bba6-61c6f07d7518" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_29b915d1-6f8c-4c16-8dcd-0350023bc6f2" xlink:to="loc_us-gaap_RelatedPartyDomain_473efda5-8127-45ea-bba6-61c6f07d7518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_9bda8b71-a938-452a-8e48-3b06e9a46d62" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_473efda5-8127-45ea-bba6-61c6f07d7518" xlink:to="loc_srt_AffiliatedEntityMember_9bda8b71-a938-452a-8e48-3b06e9a46d62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionExpensePaymentPeriod_b2a0dea0-a66a-46a2-8626-59197984a979" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionExpensePaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb37bf95-86db-420d-bea6-265ea6348b5b" xlink:to="loc_bxsl_RelatedPartyTransactionExpensePaymentPeriod_b2a0dea0-a66a-46a2-8626-59197984a979" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_34debe0b-1b6d-4161-b5d5-3c3a674c921e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb37bf95-86db-420d-bea6-265ea6348b5b" xlink:to="loc_us-gaap_OtherLiabilities_34debe0b-1b6d-4161-b5d5-3c3a674c921e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExpenseSupportReimbursementRelatedParty_edd058b2-b904-492e-83c1-96319a010adb" xlink:href="bxsl-20231231.xsd#bxsl_ExpenseSupportReimbursementRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb37bf95-86db-420d-bea6-265ea6348b5b" xlink:to="loc_bxsl_ExpenseSupportReimbursementRelatedParty_edd058b2-b904-492e-83c1-96319a010adb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#InvestmentsInvestmentPortfolioatCostandFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_ea2b1c75-d790-4d59-be18-bc99c6fcacdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_d9db997b-1cae-4e7d-9943-2554b4da6cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_ea2b1c75-d790-4d59-be18-bc99c6fcacdc" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_d9db997b-1cae-4e7d-9943-2554b4da6cc8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_bfd41081-7e91-419f-9a6a-ac1baa908661" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_d9db997b-1cae-4e7d-9943-2554b4da6cc8" xlink:to="loc_us-gaap_InvestmentTypeAxis_bfd41081-7e91-419f-9a6a-ac1baa908661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_bfd41081-7e91-419f-9a6a-ac1baa908661_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_bfd41081-7e91-419f-9a6a-ac1baa908661" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_bfd41081-7e91-419f-9a6a-ac1baa908661_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_56288b30-1e62-4791-a44e-32f08ce6f743" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_bfd41081-7e91-419f-9a6a-ac1baa908661" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_56288b30-1e62-4791-a44e-32f08ce6f743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienMember_c556b469-f63a-48dd-a39c-1da28e6dee3d" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_56288b30-1e62-4791-a44e-32f08ce6f743" xlink:to="loc_bxsl_DebtSecuritiesFirstLienMember_c556b469-f63a-48dd-a39c-1da28e6dee3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienMember_397dcd52-cdd4-47fb-9b71-4c93e9169a49" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_56288b30-1e62-4791-a44e-32f08ce6f743" xlink:to="loc_bxsl_DebtSecuritiesSecondLienMember_397dcd52-cdd4-47fb-9b71-4c93e9169a49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_6edbc7b5-c6c5-4b2f-97fe-b3254d726214" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_56288b30-1e62-4791-a44e-32f08ce6f743" xlink:to="loc_us-gaap_UnsecuredDebtMember_6edbc7b5-c6c5-4b2f-97fe-b3254d726214" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_54069474-e789-4bc1-85f5-aa22ef96ed28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_56288b30-1e62-4791-a44e-32f08ce6f743" xlink:to="loc_us-gaap_EquitySecuritiesMember_54069474-e789-4bc1-85f5-aa22ef96ed28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d0da0b20-ac9f-4837-aaac-5a5ef752e98a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_d9db997b-1cae-4e7d-9943-2554b4da6cc8" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d0da0b20-ac9f-4837-aaac-5a5ef752e98a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d0da0b20-ac9f-4837-aaac-5a5ef752e98a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d0da0b20-ac9f-4837-aaac-5a5ef752e98a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d0da0b20-ac9f-4837-aaac-5a5ef752e98a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b6484afa-a404-41a6-b2c9-d658e261bb90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d0da0b20-ac9f-4837-aaac-5a5ef752e98a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b6484afa-a404-41a6-b2c9-d658e261bb90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedAtFairValueMember_3704021c-6025-4122-97dc-c4da29ccb0f7" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b6484afa-a404-41a6-b2c9-d658e261bb90" xlink:to="loc_bxsl_InvestmentOwnedAtFairValueMember_3704021c-6025-4122-97dc-c4da29ccb0f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_57f66911-7933-4f96-b81d-db8745f2cfc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_d9db997b-1cae-4e7d-9943-2554b4da6cc8" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_57f66911-7933-4f96-b81d-db8745f2cfc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_57f66911-7933-4f96-b81d-db8745f2cfc1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_57f66911-7933-4f96-b81d-db8745f2cfc1" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_57f66911-7933-4f96-b81d-db8745f2cfc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_00606969-fa71-4443-ba13-51a580b4f9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_57f66911-7933-4f96-b81d-db8745f2cfc1" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_00606969-fa71-4443-ba13-51a580b4f9cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTypeConcentrationRiskMember_4372b16d-ec55-472c-8143-fe1b01bd0e66" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTypeConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_00606969-fa71-4443-ba13-51a580b4f9cb" xlink:to="loc_bxsl_InvestmentTypeConcentrationRiskMember_4372b16d-ec55-472c-8143-fe1b01bd0e66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtCost_63dec866-2a8b-44a1-b8c1-69664f4bb4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_ea2b1c75-d790-4d59-be18-bc99c6fcacdc" xlink:to="loc_us-gaap_InvestmentOwnedAtCost_63dec866-2a8b-44a1-b8c1-69664f4bb4ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_c849c725-2468-4410-a969-7d2bade7e4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_ea2b1c75-d790-4d59-be18-bc99c6fcacdc" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_c849c725-2468-4410-a969-7d2bade7e4d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_48c9a568-6b35-46f5-b31b-b304cbb2ac86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_ea2b1c75-d790-4d59-be18-bc99c6fcacdc" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_48c9a568-6b35-46f5-b31b-b304cbb2ac86" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#InvestmentsInvestmentsatFairValuePercentDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_527b2a10-b687-43bb-9026-45f3838f4098" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_078a18dc-b614-40ca-a5de-faa906ad4311" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_527b2a10-b687-43bb-9026-45f3838f4098" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_078a18dc-b614-40ca-a5de-faa906ad4311" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesByIndustryAxis_6f9f595d-cf18-4a6a-bccb-fb195e58e5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesByIndustryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_078a18dc-b614-40ca-a5de-faa906ad4311" xlink:to="loc_us-gaap_EquitySecuritiesByIndustryAxis_6f9f595d-cf18-4a6a-bccb-fb195e58e5b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember_6f9f595d-cf18-4a6a-bccb-fb195e58e5b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis_6f9f595d-cf18-4a6a-bccb-fb195e58e5b4" xlink:to="loc_us-gaap_EquitySecuritiesIndustryMember_6f9f595d-cf18-4a6a-bccb-fb195e58e5b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis_6f9f595d-cf18-4a6a-bccb-fb195e58e5b4" xlink:to="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AerospaceAndDefenseSectorMember_ca9ff15d-285e-4c9c-abe8-8caa2ac61292" xlink:href="bxsl-20231231.xsd#bxsl_AerospaceAndDefenseSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_AerospaceAndDefenseSectorMember_ca9ff15d-285e-4c9c-abe8-8caa2ac61292" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AirFreightLogisticsSectorMember_2770acdf-1e02-44a8-a0ae-deee530b775e" xlink:href="bxsl-20231231.xsd#bxsl_AirFreightLogisticsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_AirFreightLogisticsSectorMember_2770acdf-1e02-44a8-a0ae-deee530b775e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BuildingProductsSectorMember_c6ad9e56-6164-468b-a6f6-756f86474add" xlink:href="bxsl-20231231.xsd#bxsl_BuildingProductsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_BuildingProductsSectorMember_c6ad9e56-6164-468b-a6f6-756f86474add" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChemicalsSectorMember_6aaf69de-0e5b-4aad-88b2-b194baf9de29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChemicalsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_us-gaap_ChemicalsSectorMember_6aaf69de-0e5b-4aad-88b2-b194baf9de29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommercialServicesSuppliesSectorMember_271b7ecd-30cb-486c-a29a-9e6f94cfab22" xlink:href="bxsl-20231231.xsd#bxsl_CommercialServicesSuppliesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_CommercialServicesSuppliesSectorMember_271b7ecd-30cb-486c-a29a-9e6f94cfab22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ConstructionEngineeringSectorMember_1c942783-e5e1-4022-9f4b-1dd0306893e7" xlink:href="bxsl-20231231.xsd#bxsl_ConstructionEngineeringSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_ConstructionEngineeringSectorMember_1c942783-e5e1-4022-9f4b-1dd0306893e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContainerAndPackagingSectorMember_f35cdd74-5fb2-4fa0-a109-862160726527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContainerAndPackagingSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_us-gaap_ContainerAndPackagingSectorMember_f35cdd74-5fb2-4fa0-a109-862160726527" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DistributorsSectorMember_be7e3298-0051-4d61-9c65-63cd2e47d3bd" xlink:href="bxsl-20231231.xsd#bxsl_DistributorsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_DistributorsSectorMember_be7e3298-0051-4d61-9c65-63cd2e47d3bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsumerSectorMember_92b15555-1f87-4c19-bd1b-04240e48362c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsumerSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_us-gaap_ConsumerSectorMember_92b15555-1f87-4c19-bd1b-04240e48362c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServicesSectorMember_c309bacc-30b4-484b-82a5-7a8101f079c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_us-gaap_FinancialServicesSectorMember_c309bacc-30b4-484b-82a5-7a8101f079c3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DiversifiedTelecommunicationServicesSectorMember_5cddc666-6839-4eb5-bf8f-4ef0c6fb85c4" xlink:href="bxsl-20231231.xsd#bxsl_DiversifiedTelecommunicationServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_DiversifiedTelecommunicationServicesSectorMember_5cddc666-6839-4eb5-bf8f-4ef0c6fb85c4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectricalEquipmentSectorMember_81651cfa-5a2a-4d24-960a-3f115f9e0a9c" xlink:href="bxsl-20231231.xsd#bxsl_ElectricalEquipmentSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_ElectricalEquipmentSectorMember_81651cfa-5a2a-4d24-960a-3f115f9e0a9c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember_38a418b0-25a6-4e91-a02c-2db099290010" xlink:href="bxsl-20231231.xsd#bxsl_ElectronicEquipmentInstrumentsAndComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember_38a418b0-25a6-4e91-a02c-2db099290010" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectricUtilitiesMember_9c15550e-92a6-4a14-8de2-24b6dcc6b1d9" xlink:href="bxsl-20231231.xsd#bxsl_ElectricUtilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_ElectricUtilitiesMember_9c15550e-92a6-4a14-8de2-24b6dcc6b1d9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnergySectorMember_8f19db5a-72e9-472c-910e-34a5ea8de328" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EnergySectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_us-gaap_EnergySectorMember_8f19db5a-72e9-472c-910e-34a5ea8de328" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_GroundTransportationMember_ceb936ce-e0a4-4db8-ac52-2f6f7a8c4246" xlink:href="bxsl-20231231.xsd#bxsl_GroundTransportationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_GroundTransportationMember_ceb936ce-e0a4-4db8-ac52-2f6f7a8c4246" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareEquipmentSuppliesSectorMember_1fb94312-1eff-4d0c-8981-e38f0c918c69" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareEquipmentSuppliesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_HealthCareEquipmentSuppliesSectorMember_1fb94312-1eff-4d0c-8981-e38f0c918c69" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareProvidersServicesSectorMember_fd81e808-1af5-43dc-96a8-1547a35fb0c7" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareProvidersServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_HealthCareProvidersServicesSectorMember_fd81e808-1af5-43dc-96a8-1547a35fb0c7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareTechnologySectorMember_f242cc00-5608-4613-b215-c4a33f065b38" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareTechnologySectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_HealthCareTechnologySectorMember_f242cc00-5608-4613-b215-c4a33f065b38" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IndustrialConglomeratesMember_0e08060f-cb8b-46ad-9bdd-79c712f8d7e5" xlink:href="bxsl-20231231.xsd#bxsl_IndustrialConglomeratesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_IndustrialConglomeratesMember_0e08060f-cb8b-46ad-9bdd-79c712f8d7e5" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSectorMember_74979468-de56-4174-a2a9-9fa25ae5a3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_us-gaap_InsuranceSectorMember_74979468-de56-4174-a2a9-9fa25ae5a3f7" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InternetAndDirectMarketingRetailMember_0fb83bb3-15d2-40f0-b8d4-95792c918b50" xlink:href="bxsl-20231231.xsd#bxsl_InternetAndDirectMarketingRetailMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_InternetAndDirectMarketingRetailMember_0fb83bb3-15d2-40f0-b8d4-95792c918b50" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ITServicesSectorMember_3895b084-2c0c-492a-bb6a-b05556a96a47" xlink:href="bxsl-20231231.xsd#bxsl_ITServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_ITServicesSectorMember_3895b084-2c0c-492a-bb6a-b05556a96a47" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MachineryMember_40373f9d-c4bd-4f41-a2ed-9001289bad24" xlink:href="bxsl-20231231.xsd#bxsl_MachineryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_MachineryMember_40373f9d-c4bd-4f41-a2ed-9001289bad24" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MarineMember_bbbf9fef-f914-414d-8468-b13ae11e9890" xlink:href="bxsl-20231231.xsd#bxsl_MarineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_MarineMember_bbbf9fef-f914-414d-8468-b13ae11e9890" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MediaSectorMember_40d27179-9ff6-42c2-bc48-2307806e6755" xlink:href="bxsl-20231231.xsd#bxsl_MediaSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_MediaSectorMember_40d27179-9ff6-42c2-bc48-2307806e6755" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OilGasAndConsumableFuelsMember_c4ad86ac-ab4b-4856-882c-5fdd61ad4a8e" xlink:href="bxsl-20231231.xsd#bxsl_OilGasAndConsumableFuelsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_OilGasAndConsumableFuelsMember_c4ad86ac-ab4b-4856-882c-5fdd61ad4a8e" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaperAndForestProductsMember_ac11ada4-f0c5-4ac7-8dd0-5b6b21266fd6" xlink:href="bxsl-20231231.xsd#bxsl_PaperAndForestProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_PaperAndForestProductsMember_ac11ada4-f0c5-4ac7-8dd0-5b6b21266fd6" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PharmaceuticalsSectorMember_fc14da21-2ecc-480b-98aa-7631a09f3d62" xlink:href="bxsl-20231231.xsd#bxsl_PharmaceuticalsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_PharmaceuticalsSectorMember_fc14da21-2ecc-480b-98aa-7631a09f3d62" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ProfessionalServicesSectorMember_4eedc49a-94ff-4002-a0a4-b1cec1433d60" xlink:href="bxsl-20231231.xsd#bxsl_ProfessionalServicesSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_ProfessionalServicesSectorMember_4eedc49a-94ff-4002-a0a4-b1cec1433d60" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RealEstateManagementDevelopmentSectorMember_8acbf54c-b6eb-4226-85c8-06bce5847aec" xlink:href="bxsl-20231231.xsd#bxsl_RealEstateManagementDevelopmentSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_RealEstateManagementDevelopmentSectorMember_8acbf54c-b6eb-4226-85c8-06bce5847aec" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RoadAndRailMember_d1e4f390-0d5e-4909-94c2-7757bc47cb05" xlink:href="bxsl-20231231.xsd#bxsl_RoadAndRailMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_RoadAndRailMember_d1e4f390-0d5e-4909-94c2-7757bc47cb05" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SoftwareSectorMember_e811abde-1821-4e20-91fd-a8d7a8877070" xlink:href="bxsl-20231231.xsd#bxsl_SoftwareSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_SoftwareSectorMember_e811abde-1821-4e20-91fd-a8d7a8877070" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SpecialtyRetailMember_46e7c78d-ae61-4d35-8e3d-821d02ec5dad" xlink:href="bxsl-20231231.xsd#bxsl_SpecialtyRetailMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_SpecialtyRetailMember_46e7c78d-ae61-4d35-8e3d-821d02ec5dad" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TechnologyHardwareStorageAndPeripheralsMember_01b2746a-db08-40e6-bb15-e6a469aab0ca" xlink:href="bxsl-20231231.xsd#bxsl_TechnologyHardwareStorageAndPeripheralsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_TechnologyHardwareStorageAndPeripheralsMember_01b2746a-db08-40e6-bb15-e6a469aab0ca" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TradingCompaniesDistributorsSectorMember_a6cdfed1-382e-4c7d-b96b-a17cd3a9bf71" xlink:href="bxsl-20231231.xsd#bxsl_TradingCompaniesDistributorsSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_TradingCompaniesDistributorsSectorMember_a6cdfed1-382e-4c7d-b96b-a17cd3a9bf71" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransportationInfrastructureSectorMember_20c85841-2a0b-4656-8647-db70f78cb1e7" xlink:href="bxsl-20231231.xsd#bxsl_TransportationInfrastructureSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_TransportationInfrastructureSectorMember_20c85841-2a0b-4656-8647-db70f78cb1e7" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_159433cc-7d88-4e90-8ac9-c00ea9de3612" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_078a18dc-b614-40ca-a5de-faa906ad4311" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_159433cc-7d88-4e90-8ac9-c00ea9de3612" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_159433cc-7d88-4e90-8ac9-c00ea9de3612_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_159433cc-7d88-4e90-8ac9-c00ea9de3612" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_159433cc-7d88-4e90-8ac9-c00ea9de3612_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e41a9857-e41a-4f3b-a9e2-123d4324ac72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_159433cc-7d88-4e90-8ac9-c00ea9de3612" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e41a9857-e41a-4f3b-a9e2-123d4324ac72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedAtFairValueMember_73543297-5a73-47a5-add0-cfa7c6c00b01" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e41a9857-e41a-4f3b-a9e2-123d4324ac72" xlink:to="loc_bxsl_InvestmentOwnedAtFairValueMember_73543297-5a73-47a5-add0-cfa7c6c00b01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_0cbd0cd7-c1a5-4ec7-8a15-d1ade84b4d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_078a18dc-b614-40ca-a5de-faa906ad4311" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_0cbd0cd7-c1a5-4ec7-8a15-d1ade84b4d2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0cbd0cd7-c1a5-4ec7-8a15-d1ade84b4d2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_0cbd0cd7-c1a5-4ec7-8a15-d1ade84b4d2c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_0cbd0cd7-c1a5-4ec7-8a15-d1ade84b4d2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_fb9ebc2e-d277-4fd3-b149-30eaed1cc058" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_0cbd0cd7-c1a5-4ec7-8a15-d1ade84b4d2c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_fb9ebc2e-d277-4fd3-b149-30eaed1cc058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTypeConcentrationRiskMember_a527bfdf-320b-4d44-a2ac-3c15b17311f6" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTypeConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_fb9ebc2e-d277-4fd3-b149-30eaed1cc058" xlink:to="loc_bxsl_InvestmentTypeConcentrationRiskMember_a527bfdf-320b-4d44-a2ac-3c15b17311f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ea3f4a54-01c1-4739-b451-afb208471a56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_527b2a10-b687-43bb-9026-45f3838f4098" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ea3f4a54-01c1-4739-b451-afb208471a56" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#InvestmentsGeographicInvestmentDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e94e9cb-748c-49a3-a974-cbe80f98e73c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_3ecd7492-8f9a-4060-921c-7f955d34db59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e94e9cb-748c-49a3-a974-cbe80f98e73c" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_3ecd7492-8f9a-4060-921c-7f955d34db59" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ee660568-c657-47c6-a74b-4552a88cd570" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3ecd7492-8f9a-4060-921c-7f955d34db59" xlink:to="loc_srt_StatementGeographicalAxis_ee660568-c657-47c6-a74b-4552a88cd570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ee660568-c657-47c6-a74b-4552a88cd570_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ee660568-c657-47c6-a74b-4552a88cd570" xlink:to="loc_srt_SegmentGeographicalDomain_ee660568-c657-47c6-a74b-4552a88cd570_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ec1bedf1-e933-43d9-978f-8a7134136e8f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ee660568-c657-47c6-a74b-4552a88cd570" xlink:to="loc_srt_SegmentGeographicalDomain_ec1bedf1-e933-43d9-978f-8a7134136e8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_00c5c3c3-13cf-4fe2-8b19-8d7f71361192" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ec1bedf1-e933-43d9-978f-8a7134136e8f" xlink:to="loc_country_US_00c5c3c3-13cf-4fe2-8b19-8d7f71361192" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_8a5fdd0a-85d2-484c-884d-834dd2442897" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ec1bedf1-e933-43d9-978f-8a7134136e8f" xlink:to="loc_country_CA_8a5fdd0a-85d2-484c-884d-834dd2442897" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BERMUDAAndCAYMANISLANDMember_e4455a06-3c32-4c8c-aa3f-33bbfbab7dfe" xlink:href="bxsl-20231231.xsd#bxsl_BERMUDAAndCAYMANISLANDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ec1bedf1-e933-43d9-978f-8a7134136e8f" xlink:to="loc_bxsl_BERMUDAAndCAYMANISLANDMember_e4455a06-3c32-4c8c-aa3f-33bbfbab7dfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_8221d327-5075-4a8f-9785-503af51579e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ec1bedf1-e933-43d9-978f-8a7134136e8f" xlink:to="loc_srt_EuropeMember_8221d327-5075-4a8f-9785-503af51579e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_662b3781-752a-4b76-8226-e024a4a88cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3ecd7492-8f9a-4060-921c-7f955d34db59" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_662b3781-752a-4b76-8226-e024a4a88cf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662b3781-752a-4b76-8226-e024a4a88cf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_662b3781-752a-4b76-8226-e024a4a88cf3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662b3781-752a-4b76-8226-e024a4a88cf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84c7b6ad-8379-4774-90b1-21d02a71eccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_662b3781-752a-4b76-8226-e024a4a88cf3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84c7b6ad-8379-4774-90b1-21d02a71eccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedAtFairValueMember_ff94aca2-f0a7-443e-87f7-1f63542cda85" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84c7b6ad-8379-4774-90b1-21d02a71eccd" xlink:to="loc_bxsl_InvestmentOwnedAtFairValueMember_ff94aca2-f0a7-443e-87f7-1f63542cda85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d1c48361-c364-4127-9774-340861ad3a52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3ecd7492-8f9a-4060-921c-7f955d34db59" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d1c48361-c364-4127-9774-340861ad3a52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_d1c48361-c364-4127-9774-340861ad3a52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d1c48361-c364-4127-9774-340861ad3a52" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_d1c48361-c364-4127-9774-340861ad3a52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3cb46201-e6cc-462c-8bd6-67a27f8c4110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d1c48361-c364-4127-9774-340861ad3a52" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3cb46201-e6cc-462c-8bd6-67a27f8c4110" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTypeConcentrationRiskMember_c75e1d3c-9184-4e88-942f-c02e4d64f852" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTypeConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3cb46201-e6cc-462c-8bd6-67a27f8c4110" xlink:to="loc_bxsl_InvestmentTypeConcentrationRiskMember_c75e1d3c-9184-4e88-942f-c02e4d64f852" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtCost_96edff60-aa59-41de-9f69-560eebce63dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e94e9cb-748c-49a3-a974-cbe80f98e73c" xlink:to="loc_us-gaap_InvestmentOwnedAtCost_96edff60-aa59-41de-9f69-560eebce63dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_70746e06-49c5-4970-ab0c-09ec05de4d19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e94e9cb-748c-49a3-a974-cbe80f98e73c" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_70746e06-49c5-4970-ab0c-09ec05de4d19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_867e1174-e73c-427b-bafc-30af3a318384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e94e9cb-748c-49a3-a974-cbe80f98e73c" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_867e1174-e73c-427b-bafc-30af3a318384" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_3da5da9f-265f-4a52-a74f-9258ccee8ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e94e9cb-748c-49a3-a974-cbe80f98e73c" xlink:to="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_3da5da9f-265f-4a52-a74f-9258ccee8ec9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#InvestmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_e49fdb91-8b5d-4461-87a0-3ddc651843a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_c44a03de-e998-429c-a173-d8606015f832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_e49fdb91-8b5d-4461-87a0-3ddc651843a7" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_c44a03de-e998-429c-a173-d8606015f832" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_645ec33b-d056-402c-9345-9518ed0dd78d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c44a03de-e998-429c-a173-d8606015f832" xlink:to="loc_us-gaap_InvestmentTypeAxis_645ec33b-d056-402c-9345-9518ed0dd78d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_645ec33b-d056-402c-9345-9518ed0dd78d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_645ec33b-d056-402c-9345-9518ed0dd78d" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_645ec33b-d056-402c-9345-9518ed0dd78d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_e7cc99b0-b28d-4ac2-8a9c-df622a2aaa54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_645ec33b-d056-402c-9345-9518ed0dd78d" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_e7cc99b0-b28d-4ac2-8a9c-df622a2aaa54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesVariableRateMember_28d9b546-98ee-4c7a-8df3-331b965c4c23" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesVariableRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e7cc99b0-b28d-4ac2-8a9c-df622a2aaa54" xlink:to="loc_bxsl_DebtSecuritiesVariableRateMember_28d9b546-98ee-4c7a-8df3-331b965c4c23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFixedRateMember_05029b9c-e483-4587-aa8e-1ef6d0ddab30" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFixedRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e7cc99b0-b28d-4ac2-8a9c-df622a2aaa54" xlink:to="loc_bxsl_DebtSecuritiesFixedRateMember_05029b9c-e483-4587-aa8e-1ef6d0ddab30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf099bb8-6e08-4ff1-8ea6-3765af5a5533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c44a03de-e998-429c-a173-d8606015f832" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf099bb8-6e08-4ff1-8ea6-3765af5a5533" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_bf099bb8-6e08-4ff1-8ea6-3765af5a5533_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf099bb8-6e08-4ff1-8ea6-3765af5a5533" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_bf099bb8-6e08-4ff1-8ea6-3765af5a5533_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f7cc211-9d2c-41dc-bee0-cda79228044b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf099bb8-6e08-4ff1-8ea6-3765af5a5533" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f7cc211-9d2c-41dc-bee0-cda79228044b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentsAtFairValueMember_c1254168-345e-4448-875e-e3c4a7ab7edb" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentsAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f7cc211-9d2c-41dc-bee0-cda79228044b" xlink:to="loc_bxsl_InvestmentsAtFairValueMember_c1254168-345e-4448-875e-e3c4a7ab7edb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_976161db-b85f-428d-bd59-35778c2852c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c44a03de-e998-429c-a173-d8606015f832" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_976161db-b85f-428d-bd59-35778c2852c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_976161db-b85f-428d-bd59-35778c2852c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_976161db-b85f-428d-bd59-35778c2852c8" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_976161db-b85f-428d-bd59-35778c2852c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_97e01951-7ebc-4940-b327-2e0bd5614609" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_976161db-b85f-428d-bd59-35778c2852c8" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_97e01951-7ebc-4940-b327-2e0bd5614609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTypeConcentrationRiskMember_b60d8203-02f1-4a56-b940-7427bc9f15ec" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTypeConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_97e01951-7ebc-4940-b327-2e0bd5614609" xlink:to="loc_bxsl_InvestmentTypeConcentrationRiskMember_b60d8203-02f1-4a56-b940-7427bc9f15ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedNonaccrualNumberOfLoans_d877c7a7-e232-4fef-b5bd-473f31b8f0bd" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedNonaccrualNumberOfLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_e49fdb91-8b5d-4461-87a0-3ddc651843a7" xlink:to="loc_bxsl_InvestmentOwnedNonaccrualNumberOfLoans_d877c7a7-e232-4fef-b5bd-473f31b8f0bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_38cec2b5-d6b2-4e58-b5ab-12b06505c828" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_e49fdb91-8b5d-4461-87a0-3ddc651843a7" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_38cec2b5-d6b2-4e58-b5ab-12b06505c828" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f51b4f8f-4e5b-4ac1-9497-fa030cd137b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_29680023-a54e-4594-9f11-507071bf2f52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f51b4f8f-4e5b-4ac1-9497-fa030cd137b8" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_29680023-a54e-4594-9f11-507071bf2f52" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1c532f67-25ad-4719-b28e-8576031eb55b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_29680023-a54e-4594-9f11-507071bf2f52" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1c532f67-25ad-4719-b28e-8576031eb55b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1c532f67-25ad-4719-b28e-8576031eb55b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1c532f67-25ad-4719-b28e-8576031eb55b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1c532f67-25ad-4719-b28e-8576031eb55b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ed63fef6-ca24-4249-8b2b-c6727af601fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1c532f67-25ad-4719-b28e-8576031eb55b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ed63fef6-ca24-4249-8b2b-c6727af601fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f6dc47b9-706b-443e-9594-0f5001312bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ed63fef6-ca24-4249-8b2b-c6727af601fa" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f6dc47b9-706b-443e-9594-0f5001312bfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f2566451-995e-4d20-834a-94622472c495" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ed63fef6-ca24-4249-8b2b-c6727af601fa" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f2566451-995e-4d20-834a-94622472c495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_77e30596-6b09-4669-a697-174aea849248" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ed63fef6-ca24-4249-8b2b-c6727af601fa" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_77e30596-6b09-4669-a697-174aea849248" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_34f82351-6524-44b9-b1da-6d3b774cad66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_29680023-a54e-4594-9f11-507071bf2f52" xlink:to="loc_us-gaap_FinancialInstrumentAxis_34f82351-6524-44b9-b1da-6d3b774cad66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34f82351-6524-44b9-b1da-6d3b774cad66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_34f82351-6524-44b9-b1da-6d3b774cad66" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_34f82351-6524-44b9-b1da-6d3b774cad66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a005ec0a-4e33-48a7-9c52-cf5acdd1f2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_34f82351-6524-44b9-b1da-6d3b774cad66" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a005ec0a-4e33-48a7-9c52-cf5acdd1f2f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienMember_78feb959-dd4a-411b-8e0b-6127343308cb" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a005ec0a-4e33-48a7-9c52-cf5acdd1f2f0" xlink:to="loc_bxsl_DebtSecuritiesFirstLienMember_78feb959-dd4a-411b-8e0b-6127343308cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienMember_8780c4c9-951d-4e37-945f-7e134cb11888" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a005ec0a-4e33-48a7-9c52-cf5acdd1f2f0" xlink:to="loc_bxsl_DebtSecuritiesSecondLienMember_8780c4c9-951d-4e37-945f-7e134cb11888" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_f3987c2c-35d1-4cfc-85e9-446dc6a3696b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a005ec0a-4e33-48a7-9c52-cf5acdd1f2f0" xlink:to="loc_us-gaap_EquitySecuritiesMember_f3987c2c-35d1-4cfc-85e9-446dc6a3696b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_856b65b1-94e9-4fa8-9220-c94de6ab61d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a005ec0a-4e33-48a7-9c52-cf5acdd1f2f0" xlink:to="loc_us-gaap_UnsecuredDebtMember_856b65b1-94e9-4fa8-9220-c94de6ab61d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_0c95f668-5fa8-46ac-8f98-8ddb9ca8dac7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f51b4f8f-4e5b-4ac1-9497-fa030cd137b8" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_0c95f668-5fa8-46ac-8f98-8ddb9ca8dac7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1fd33e75-f879-4d98-be16-077b0fc7ac6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e4de16e6-7c22-45ee-8cb2-f0a5796fefbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1fd33e75-f879-4d98-be16-077b0fc7ac6c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e4de16e6-7c22-45ee-8cb2-f0a5796fefbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_0070839d-b5e0-4a14-99e6-3970f2327a46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e4de16e6-7c22-45ee-8cb2-f0a5796fefbb" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_0070839d-b5e0-4a14-99e6-3970f2327a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0070839d-b5e0-4a14-99e6-3970f2327a46_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_0070839d-b5e0-4a14-99e6-3970f2327a46" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0070839d-b5e0-4a14-99e6-3970f2327a46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_65dd326a-e35f-451a-90d2-8b7101cbf012" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_0070839d-b5e0-4a14-99e6-3970f2327a46" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_65dd326a-e35f-451a-90d2-8b7101cbf012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_65dd326a-e35f-451a-90d2-8b7101cbf012" xlink:to="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentsRealizedGainLossMember_03e1960a-4711-40bd-8313-e28c783afac4" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentsRealizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:to="loc_bxsl_InvestmentsRealizedGainLossMember_03e1960a-4711-40bd-8313-e28c783afac4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentsUnrealizedGainLossMember_5de2a136-5555-4788-b5c8-eb3b8e396dc8" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentsUnrealizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:to="loc_bxsl_InvestmentsUnrealizedGainLossMember_5de2a136-5555-4788-b5c8-eb3b8e396dc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienMember_b93222ee-890d-4787-bb99-8d3fa1f8cf60" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:to="loc_bxsl_DebtSecuritiesFirstLienMember_b93222ee-890d-4787-bb99-8d3fa1f8cf60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember_1871cb82-9425-42cc-ab63-ad564f8656bd" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienRealizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_DebtSecuritiesFirstLienMember_b93222ee-890d-4787-bb99-8d3fa1f8cf60" xlink:to="loc_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember_1871cb82-9425-42cc-ab63-ad564f8656bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember_97757b07-e77e-48f8-a61d-37cb0a67446f" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_DebtSecuritiesFirstLienMember_b93222ee-890d-4787-bb99-8d3fa1f8cf60" xlink:to="loc_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember_97757b07-e77e-48f8-a61d-37cb0a67446f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienMember_f73ea104-8f88-4c95-821d-47e196c86b44" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:to="loc_bxsl_DebtSecuritiesSecondLienMember_f73ea104-8f88-4c95-821d-47e196c86b44" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember_4bb7ff07-4ac9-441a-9759-8e07935a4ed2" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienRealizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_DebtSecuritiesSecondLienMember_f73ea104-8f88-4c95-821d-47e196c86b44" xlink:to="loc_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember_4bb7ff07-4ac9-441a-9759-8e07935a4ed2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember_c862ff6d-5c7d-4f69-87cc-f336cf250aed" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_DebtSecuritiesSecondLienMember_f73ea104-8f88-4c95-821d-47e196c86b44" xlink:to="loc_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember_c862ff6d-5c7d-4f69-87cc-f336cf250aed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_c92a62a9-7b64-4c90-82b4-4cfb39b33524" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:to="loc_us-gaap_UnsecuredDebtMember_c92a62a9-7b64-4c90-82b4-4cfb39b33524" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_UnsecuredDebtRealizedGainLossMember_f13526f6-44af-430f-9714-622f7d804600" xlink:href="bxsl-20231231.xsd#bxsl_UnsecuredDebtRealizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnsecuredDebtMember_c92a62a9-7b64-4c90-82b4-4cfb39b33524" xlink:to="loc_bxsl_UnsecuredDebtRealizedGainLossMember_f13526f6-44af-430f-9714-622f7d804600" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_UnsecuredDebtUnrealizedGainLossMember_4a6e602d-6349-47e6-ad77-19a68388b08a" xlink:href="bxsl-20231231.xsd#bxsl_UnsecuredDebtUnrealizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnsecuredDebtMember_c92a62a9-7b64-4c90-82b4-4cfb39b33524" xlink:to="loc_bxsl_UnsecuredDebtUnrealizedGainLossMember_4a6e602d-6349-47e6-ad77-19a68388b08a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_4c9354ec-635f-4e30-bf10-439b6d5b26c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:to="loc_us-gaap_EquitySecuritiesMember_4c9354ec-635f-4e30-bf10-439b6d5b26c0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_EquitySecuritiesRealizedGainLossMember_f2dcdeba-36ef-415a-a5ef-0ca39ba2bce3" xlink:href="bxsl-20231231.xsd#bxsl_EquitySecuritiesRealizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_4c9354ec-635f-4e30-bf10-439b6d5b26c0" xlink:to="loc_bxsl_EquitySecuritiesRealizedGainLossMember_f2dcdeba-36ef-415a-a5ef-0ca39ba2bce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_EquitySecuritiesUnrealizedGainLossMember_55ffd150-9b35-468d-ac1d-3e1211b3b1d7" xlink:href="bxsl-20231231.xsd#bxsl_EquitySecuritiesUnrealizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_4c9354ec-635f-4e30-bf10-439b6d5b26c0" xlink:to="loc_bxsl_EquitySecuritiesUnrealizedGainLossMember_55ffd150-9b35-468d-ac1d-3e1211b3b1d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1fd33e75-f879-4d98-be16-077b0fc7ac6c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_d1776db7-2af7-4522-88c0-560a8972b4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_d1776db7-2af7-4522-88c0-560a8972b4bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_330f4cb6-2c7e-4bb0-ac03-5c18d05a8661" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_330f4cb6-2c7e-4bb0-ac03-5c18d05a8661" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1c072793-4968-4ac3-979b-252a3775b427" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1c072793-4968-4ac3-979b-252a3775b427" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium_5a55244c-bc60-4200-a670-9369ac235aef" xlink:href="bxsl-20231231.xsd#bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium_5a55244c-bc60-4200-a670-9369ac235aef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_fa1d436f-199e-4f45-8496-856a4f3c529f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_fa1d436f-199e-4f45-8496-856a4f3c529f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_bb141cd2-0fc0-4966-adab-c3d3adf08c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_bb141cd2-0fc0-4966-adab-c3d3adf08c50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_ff611dae-23ab-4e5b-84e2-11f354bdd74a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_ff611dae-23ab-4e5b-84e2-11f354bdd74a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_c1030ab1-cfe7-489b-a039-5e2c3f352691" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_85f9c48b-b8dc-4452-b00b-34e309ff1ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1fd33e75-f879-4d98-be16-077b0fc7ac6c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_85f9c48b-b8dc-4452-b00b-34e309ff1ee9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FairValueMeasurementsUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b00b88e4-55a9-4fdd-995e-cd6d29f0e22e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b00b88e4-55a9-4fdd-995e-cd6d29f0e22e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8cbe1c24-8043-4f35-b4b9-642e07b470d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8cbe1c24-8043-4f35-b4b9-642e07b470d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8cbe1c24-8043-4f35-b4b9-642e07b470d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8cbe1c24-8043-4f35-b4b9-642e07b470d6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8cbe1c24-8043-4f35-b4b9-642e07b470d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea57a7a9-b2ba-4800-a26d-90fa0e38bfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8cbe1c24-8043-4f35-b4b9-642e07b470d6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea57a7a9-b2ba-4800-a26d-90fa0e38bfbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienMember_ca984e89-78bf-4c13-9670-dd5cf6914b12" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea57a7a9-b2ba-4800-a26d-90fa0e38bfbd" xlink:to="loc_bxsl_DebtSecuritiesFirstLienMember_ca984e89-78bf-4c13-9670-dd5cf6914b12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienMember_591d7b65-dc69-49f1-833e-ea886bc6d8ff" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea57a7a9-b2ba-4800-a26d-90fa0e38bfbd" xlink:to="loc_bxsl_DebtSecuritiesSecondLienMember_591d7b65-dc69-49f1-833e-ea886bc6d8ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_f084222c-e362-4505-a9f7-c0973257226b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea57a7a9-b2ba-4800-a26d-90fa0e38bfbd" xlink:to="loc_us-gaap_UnsecuredDebtMember_f084222c-e362-4505-a9f7-c0973257226b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_b499c28b-6403-4843-8362-89ae46153ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea57a7a9-b2ba-4800-a26d-90fa0e38bfbd" xlink:to="loc_us-gaap_EquitySecuritiesMember_b499c28b-6403-4843-8362-89ae46153ad2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5fe57a95-ef84-40cd-a125-9a636e775615" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:to="loc_srt_RangeAxis_5fe57a95-ef84-40cd-a125-9a636e775615" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5fe57a95-ef84-40cd-a125-9a636e775615_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5fe57a95-ef84-40cd-a125-9a636e775615" xlink:to="loc_srt_RangeMember_5fe57a95-ef84-40cd-a125-9a636e775615_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e7fb2096-7644-422e-ae6c-5fbf895d548d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5fe57a95-ef84-40cd-a125-9a636e775615" xlink:to="loc_srt_RangeMember_e7fb2096-7644-422e-ae6c-5fbf895d548d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d54c5f1c-c24f-426f-bc67-cb54cf401ba2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e7fb2096-7644-422e-ae6c-5fbf895d548d" xlink:to="loc_srt_MinimumMember_d54c5f1c-c24f-426f-bc67-cb54cf401ba2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e5e3222a-403f-4ed2-b4fd-414e725b9599" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e7fb2096-7644-422e-ae6c-5fbf895d548d" xlink:to="loc_srt_MaximumMember_e5e3222a-403f-4ed2-b4fd-414e725b9599" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_9096fb43-49e0-4015-997a-fe986a099ea5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e7fb2096-7644-422e-ae6c-5fbf895d548d" xlink:to="loc_srt_WeightedAverageMember_9096fb43-49e0-4015-997a-fe986a099ea5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_f1b7bcc1-927a-4175-9e38-33c0859fac36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:to="loc_us-gaap_ValuationTechniqueAxis_f1b7bcc1-927a-4175-9e38-33c0859fac36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_f1b7bcc1-927a-4175-9e38-33c0859fac36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_f1b7bcc1-927a-4175-9e38-33c0859fac36" xlink:to="loc_us-gaap_ValuationTechniqueDomain_f1b7bcc1-927a-4175-9e38-33c0859fac36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_d930c2ec-7ec8-4cbb-baef-e4d909312859" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_f1b7bcc1-927a-4175-9e38-33c0859fac36" xlink:to="loc_us-gaap_ValuationTechniqueDomain_d930c2ec-7ec8-4cbb-baef-e4d909312859" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ValuationYieldAnalysisApproachMember_c75a2bb8-3345-45db-9f6a-49cf9305e2ae" xlink:href="bxsl-20231231.xsd#bxsl_ValuationYieldAnalysisApproachMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_d930c2ec-7ec8-4cbb-baef-e4d909312859" xlink:to="loc_bxsl_ValuationYieldAnalysisApproachMember_c75a2bb8-3345-45db-9f6a-49cf9305e2ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ValuationAssetRecoverabilityMember_60d51afe-680e-4cd1-a805-aaec621b7b28" xlink:href="bxsl-20231231.xsd#bxsl_ValuationAssetRecoverabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_d930c2ec-7ec8-4cbb-baef-e4d909312859" xlink:to="loc_bxsl_ValuationAssetRecoverabilityMember_60d51afe-680e-4cd1-a805-aaec621b7b28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketApproachValuationTechniqueMember_5b408fa7-8504-4aff-b43d-f7b2df54c3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketApproachValuationTechniqueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_d930c2ec-7ec8-4cbb-baef-e4d909312859" xlink:to="loc_us-gaap_MarketApproachValuationTechniqueMember_5b408fa7-8504-4aff-b43d-f7b2df54c3ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_4b92b1ca-cb14-4527-9e2c-205b231429ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_d930c2ec-7ec8-4cbb-baef-e4d909312859" xlink:to="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_4b92b1ca-cb14-4527-9e2c-205b231429ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ca42fb4d-8373-4b9f-8543-f60afa354a29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ca42fb4d-8373-4b9f-8543-f60afa354a29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ca42fb4d-8373-4b9f-8543-f60afa354a29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ca42fb4d-8373-4b9f-8543-f60afa354a29" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ca42fb4d-8373-4b9f-8543-f60afa354a29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9f7f2348-1b7b-440b-9823-9f2cdb186177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ca42fb4d-8373-4b9f-8543-f60afa354a29" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9f7f2348-1b7b-440b-9823-9f2cdb186177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_fbe88c3e-79e5-43d8-8004-5a66eeb9148a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9f7f2348-1b7b-440b-9823-9f2cdb186177" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_fbe88c3e-79e5-43d8-8004-5a66eeb9148a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_3238580f-1e80-4205-ac63-bb7daded99ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_3238580f-1e80-4205-ac63-bb7daded99ad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_3238580f-1e80-4205-ac63-bb7daded99ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_3238580f-1e80-4205-ac63-bb7daded99ad" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_3238580f-1e80-4205-ac63-bb7daded99ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_3238580f-1e80-4205-ac63-bb7daded99ad" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_d02bb084-83fb-45e8-a460-c7ca6a819024" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_d02bb084-83fb-45e8-a460-c7ca6a819024" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MeasurementInputMarketMultipleMember_95602ab6-f968-451a-a0f4-ce00fc934544" xlink:href="bxsl-20231231.xsd#bxsl_MeasurementInputMarketMultipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:to="loc_bxsl_MeasurementInputMarketMultipleMember_95602ab6-f968-451a-a0f4-ce00fc934544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputQuotedPriceMember_87a77103-a608-4890-939e-3fc4607bc74a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputQuotedPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:to="loc_us-gaap_MeasurementInputQuotedPriceMember_87a77103-a608-4890-939e-3fc4607bc74a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MeasurementInputPerformanceMultipleMember_87051039-9490-48d0-bf3f-2fe7ac3043bf" xlink:href="bxsl-20231231.xsd#bxsl_MeasurementInputPerformanceMultipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:to="loc_bxsl_MeasurementInputPerformanceMultipleMember_87051039-9490-48d0-bf3f-2fe7ac3043bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_3bb57d34-7fad-4ed5-81e1-15d18f6587e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_3bb57d34-7fad-4ed5-81e1-15d18f6587e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_3a11fc1b-2421-4c1e-8db5-8639fcee7355" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b00b88e4-55a9-4fdd-995e-cd6d29f0e22e" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_3a11fc1b-2421-4c1e-8db5-8639fcee7355" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput_5b750cb4-766a-4e77-8fd9-6579a8540351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b00b88e4-55a9-4fdd-995e-cd6d29f0e22e" xlink:to="loc_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput_5b750cb4-766a-4e77-8fd9-6579a8540351" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_48a8c63a-90b7-4179-a724-b09749d05597" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa5fc01f-56e5-42a4-9657-4037803c4bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_48a8c63a-90b7-4179-a724-b09749d05597" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa5fc01f-56e5-42a4-9657-4037803c4bb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_13132883-eff1-488b-8677-72c596cecc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa5fc01f-56e5-42a4-9657-4037803c4bb2" xlink:to="loc_us-gaap_DebtInstrumentAxis_13132883-eff1-488b-8677-72c596cecc3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_13132883-eff1-488b-8677-72c596cecc3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_13132883-eff1-488b-8677-72c596cecc3c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_13132883-eff1-488b-8677-72c596cecc3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_13132883-eff1-488b-8677-72c596cecc3c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2023NotesMember_5ba851b5-e4c1-457b-8006-22e3b3421c91" xlink:href="bxsl-20231231.xsd#bxsl_A2023NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:to="loc_bxsl_A2023NotesMember_5ba851b5-e4c1-457b-8006-22e3b3421c91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2026NotesMember_ae9f8bc9-c555-41de-9c69-46858d92230d" xlink:href="bxsl-20231231.xsd#bxsl_A2026NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:to="loc_bxsl_A2026NotesMember_ae9f8bc9-c555-41de-9c69-46858d92230d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_New2026NotesMember_f545015e-c434-4126-9f35-94d2a345a461" xlink:href="bxsl-20231231.xsd#bxsl_New2026NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:to="loc_bxsl_New2026NotesMember_f545015e-c434-4126-9f35-94d2a345a461" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2027NotesMember_0fdbf861-b8f4-4445-bf05-d5173d0bca72" xlink:href="bxsl-20231231.xsd#bxsl_A2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:to="loc_bxsl_A2027NotesMember_0fdbf861-b8f4-4445-bf05-d5173d0bca72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2028NotesMember_7ddc0cc8-a035-4d0c-bdd8-27e4d9398b53" xlink:href="bxsl-20231231.xsd#bxsl_A2028NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:to="loc_bxsl_A2028NotesMember_7ddc0cc8-a035-4d0c-bdd8-27e4d9398b53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d572bdbe-f4ae-4f7b-92a5-da1f8d5f8ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa5fc01f-56e5-42a4-9657-4037803c4bb2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d572bdbe-f4ae-4f7b-92a5-da1f8d5f8ad5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d572bdbe-f4ae-4f7b-92a5-da1f8d5f8ad5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d572bdbe-f4ae-4f7b-92a5-da1f8d5f8ad5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d572bdbe-f4ae-4f7b-92a5-da1f8d5f8ad5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_897c2e33-315d-48c8-a9c9-8095f61d844a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d572bdbe-f4ae-4f7b-92a5-da1f8d5f8ad5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_897c2e33-315d-48c8-a9c9-8095f61d844a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0a235e30-9aa1-4cda-b8a2-edb1b707b21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_897c2e33-315d-48c8-a9c9-8095f61d844a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0a235e30-9aa1-4cda-b8a2-edb1b707b21e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_07f2b1be-a33c-4c83-b22a-735acedcc268" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa5fc01f-56e5-42a4-9657-4037803c4bb2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_07f2b1be-a33c-4c83-b22a-735acedcc268" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_07f2b1be-a33c-4c83-b22a-735acedcc268_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_07f2b1be-a33c-4c83-b22a-735acedcc268" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_07f2b1be-a33c-4c83-b22a-735acedcc268_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9acd2e9a-b635-4e8e-9417-09cca12bfdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_07f2b1be-a33c-4c83-b22a-735acedcc268" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9acd2e9a-b635-4e8e-9417-09cca12bfdc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_555eef60-938b-43ef-b2bb-539c64a57517" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9acd2e9a-b635-4e8e-9417-09cca12bfdc3" xlink:to="loc_us-gaap_UnsecuredDebtMember_555eef60-938b-43ef-b2bb-539c64a57517" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_34c1dda5-c079-4aac-9b58-ecc1a8ff5b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_48a8c63a-90b7-4179-a724-b09749d05597" xlink:to="loc_us-gaap_LongTermDebtFairValue_34c1dda5-c079-4aac-9b58-ecc1a8ff5b52" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_fa65e360-58dc-41e4-9730-7250d9670e91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06c3875b-7a37-41e0-8df3-ea6b7fa2ef7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_fa65e360-58dc-41e4-9730-7250d9670e91" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06c3875b-7a37-41e0-8df3-ea6b7fa2ef7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_04b05082-3a6a-44b2-b78d-8a26eafaf351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06c3875b-7a37-41e0-8df3-ea6b7fa2ef7e" xlink:to="loc_us-gaap_DebtInstrumentAxis_04b05082-3a6a-44b2-b78d-8a26eafaf351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_04b05082-3a6a-44b2-b78d-8a26eafaf351_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_04b05082-3a6a-44b2-b78d-8a26eafaf351" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_04b05082-3a6a-44b2-b78d-8a26eafaf351_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_04b05082-3a6a-44b2-b78d-8a26eafaf351" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2023NotesMember_525cdde9-7bc9-494e-97ab-58a226d337c7" xlink:href="bxsl-20231231.xsd#bxsl_A2023NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:to="loc_bxsl_A2023NotesMember_525cdde9-7bc9-494e-97ab-58a226d337c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2026NotesMember_0385b550-18a0-4bfd-9089-20643ab8f29f" xlink:href="bxsl-20231231.xsd#bxsl_A2026NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:to="loc_bxsl_A2026NotesMember_0385b550-18a0-4bfd-9089-20643ab8f29f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_New2026NotesMember_bf860780-c2e9-497b-ac34-f5ee718aa712" xlink:href="bxsl-20231231.xsd#bxsl_New2026NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:to="loc_bxsl_New2026NotesMember_bf860780-c2e9-497b-ac34-f5ee718aa712" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2027NotesMember_70c7ae12-4c7a-4b04-817c-c90356401c98" xlink:href="bxsl-20231231.xsd#bxsl_A2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:to="loc_bxsl_A2027NotesMember_70c7ae12-4c7a-4b04-817c-c90356401c98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2028NotesMember_c80b881d-5733-44f4-a61f-ec9829d39843" xlink:href="bxsl-20231231.xsd#bxsl_A2028NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:to="loc_bxsl_A2028NotesMember_c80b881d-5733-44f4-a61f-ec9829d39843" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17fb24da-6a8c-47de-9f0f-f5b47d1655ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06c3875b-7a37-41e0-8df3-ea6b7fa2ef7e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17fb24da-6a8c-47de-9f0f-f5b47d1655ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_17fb24da-6a8c-47de-9f0f-f5b47d1655ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17fb24da-6a8c-47de-9f0f-f5b47d1655ec" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_17fb24da-6a8c-47de-9f0f-f5b47d1655ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2768df13-6641-46fd-b6b2-a391a0181e39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17fb24da-6a8c-47de-9f0f-f5b47d1655ec" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2768df13-6641-46fd-b6b2-a391a0181e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5cf6b5ac-c896-405b-a3a1-e0fd7cd3e3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2768df13-6641-46fd-b6b2-a391a0181e39" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5cf6b5ac-c896-405b-a3a1-e0fd7cd3e3e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_03e48e42-0ac4-4098-8b81-12d5dea9ef8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2768df13-6641-46fd-b6b2-a391a0181e39" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_03e48e42-0ac4-4098-8b81-12d5dea9ef8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_41d3ce08-c778-4729-b62f-1e3622045c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06c3875b-7a37-41e0-8df3-ea6b7fa2ef7e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_41d3ce08-c778-4729-b62f-1e3622045c0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_41d3ce08-c778-4729-b62f-1e3622045c0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41d3ce08-c778-4729-b62f-1e3622045c0a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_41d3ce08-c778-4729-b62f-1e3622045c0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fa754b28-495b-4aba-8974-348c411a2e09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41d3ce08-c778-4729-b62f-1e3622045c0a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fa754b28-495b-4aba-8974-348c411a2e09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_2223adc3-66c3-45cb-b8bb-30dde8a07d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fa754b28-495b-4aba-8974-348c411a2e09" xlink:to="loc_us-gaap_UnsecuredDebtMember_2223adc3-66c3-45cb-b8bb-30dde8a07d1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_972f83d3-930f-4d8c-be13-0e96df299fad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_fa65e360-58dc-41e4-9730-7250d9670e91" xlink:to="loc_us-gaap_LongTermDebtFairValue_972f83d3-930f-4d8c-be13-0e96df299fad" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsJacksonHoleFundingFacilityDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:to="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9bf94ed2-917d-4c29-b02c-cde7af4ee8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:to="loc_us-gaap_DebtInstrumentAxis_9bf94ed2-917d-4c29-b02c-cde7af4ee8ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9bf94ed2-917d-4c29-b02c-cde7af4ee8ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9bf94ed2-917d-4c29-b02c-cde7af4ee8ef" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9bf94ed2-917d-4c29-b02c-cde7af4ee8ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_29412104-2d9a-4f7d-9036-0c89ed15c64f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9bf94ed2-917d-4c29-b02c-cde7af4ee8ef" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_29412104-2d9a-4f7d-9036-0c89ed15c64f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember_58b20985-3059-4762-aab0-7aae7920f4f4" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_29412104-2d9a-4f7d-9036-0c89ed15c64f" xlink:to="loc_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember_58b20985-3059-4762-aab0-7aae7920f4f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember_5cf0531d-036a-4dcc-a94d-4891feec5a8a" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityDollarAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_29412104-2d9a-4f7d-9036-0c89ed15c64f" xlink:to="loc_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember_5cf0531d-036a-4dcc-a94d-4891feec5a8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityMember_b8811df7-1062-49cc-8a15-5e23969b79cd" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_29412104-2d9a-4f7d-9036-0c89ed15c64f" xlink:to="loc_bxsl_JacksonHoleFundingFacilityMember_b8811df7-1062-49cc-8a15-5e23969b79cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_46e4f3ae-474e-4b22-9f66-794c01f077b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_46e4f3ae-474e-4b22-9f66-794c01f077b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_46e4f3ae-474e-4b22-9f66-794c01f077b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_46e4f3ae-474e-4b22-9f66-794c01f077b1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_46e4f3ae-474e-4b22-9f66-794c01f077b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6c96d667-0ca4-4f93-a45d-7388ba8a63b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_46e4f3ae-474e-4b22-9f66-794c01f077b1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6c96d667-0ca4-4f93-a45d-7388ba8a63b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_ecf09027-ca44-4f32-a937-bfcf95d42b42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6c96d667-0ca4-4f93-a45d-7388ba8a63b8" xlink:to="loc_us-gaap_LineOfCreditMember_ecf09027-ca44-4f32-a937-bfcf95d42b42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_735c7abe-02d7-486a-a1d3-004f2af20759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:to="loc_us-gaap_CreditFacilityAxis_735c7abe-02d7-486a-a1d3-004f2af20759" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_735c7abe-02d7-486a-a1d3-004f2af20759_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_735c7abe-02d7-486a-a1d3-004f2af20759" xlink:to="loc_us-gaap_CreditFacilityDomain_735c7abe-02d7-486a-a1d3-004f2af20759_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8d0cc217-ee48-430e-b9df-70e1a3200432" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_735c7abe-02d7-486a-a1d3-004f2af20759" xlink:to="loc_us-gaap_CreditFacilityDomain_8d0cc217-ee48-430e-b9df-70e1a3200432" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_fbf18607-7939-4e96-97aa-89053e26eede" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_8d0cc217-ee48-430e-b9df-70e1a3200432" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_fbf18607-7939-4e96-97aa-89053e26eede" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_fb968f03-e101-486a-b0b9-244e5a51f41a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:to="loc_us-gaap_VariableRateAxis_fb968f03-e101-486a-b0b9-244e5a51f41a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_fb968f03-e101-486a-b0b9-244e5a51f41a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_fb968f03-e101-486a-b0b9-244e5a51f41a" xlink:to="loc_us-gaap_VariableRateDomain_fb968f03-e101-486a-b0b9-244e5a51f41a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9369c72b-8a36-4972-ae75-b1ae9a3f1be7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_fb968f03-e101-486a-b0b9-244e5a51f41a" xlink:to="loc_us-gaap_VariableRateDomain_9369c72b-8a36-4972-ae75-b1ae9a3f1be7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_492ac99c-f5fe-47b5-98fd-ebe0a1a123fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_9369c72b-8a36-4972-ae75-b1ae9a3f1be7" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_492ac99c-f5fe-47b5-98fd-ebe0a1a123fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio_6e159ff7-4d6d-48dd-a904-5e457f4e37fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:to="loc_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio_6e159ff7-4d6d-48dd-a904-5e457f4e37fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8f4a02bc-d13f-4510-8fdb-d54c6e4114f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8f4a02bc-d13f-4510-8fdb-d54c6e4114f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_30fa373b-4a0f-4384-ac0c-b2a48b6bb6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_30fa373b-4a0f-4384-ac0c-b2a48b6bb6a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_78032569-357e-4ff1-b679-c8c0bacd02bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_78032569-357e-4ff1-b679-c8c0bacd02bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit_a0774a6a-9dd9-494d-a0d3-f626d25fd06d" xlink:href="bxsl-20231231.xsd#bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:to="loc_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit_a0774a6a-9dd9-494d-a0d3-f626d25fd06d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsBreckenridgeFundingFacilityDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_62ce36a7-48c4-4568-a814-53cdfd32be28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_62ce36a7-48c4-4568-a814-53cdfd32be28" xlink:to="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_984a287a-570e-4e2a-b5a0-b239eafd20a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_us-gaap_CreditFacilityAxis_984a287a-570e-4e2a-b5a0-b239eafd20a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_984a287a-570e-4e2a-b5a0-b239eafd20a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_984a287a-570e-4e2a-b5a0-b239eafd20a1" xlink:to="loc_us-gaap_CreditFacilityDomain_984a287a-570e-4e2a-b5a0-b239eafd20a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_24ad077c-9c7d-4761-8c6e-e1bcbde536c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_984a287a-570e-4e2a-b5a0-b239eafd20a1" xlink:to="loc_us-gaap_CreditFacilityDomain_24ad077c-9c7d-4761-8c6e-e1bcbde536c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_64440e47-451a-4775-b614-a220fa96fa29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_24ad077c-9c7d-4761-8c6e-e1bcbde536c3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_64440e47-451a-4775-b614-a220fa96fa29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_59f1024e-2fd8-4403-98da-15e355f64b81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_us-gaap_DebtInstrumentAxis_59f1024e-2fd8-4403-98da-15e355f64b81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_59f1024e-2fd8-4403-98da-15e355f64b81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_59f1024e-2fd8-4403-98da-15e355f64b81" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_59f1024e-2fd8-4403-98da-15e355f64b81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ece117c3-814b-4405-8629-491fa7f23ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_59f1024e-2fd8-4403-98da-15e355f64b81" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ece117c3-814b-4405-8629-491fa7f23ef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BreckenridgeFundingFacilityMember_dff3e9ff-c8b2-4cb8-8ea0-986f3e7fee21" xlink:href="bxsl-20231231.xsd#bxsl_BreckenridgeFundingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ece117c3-814b-4405-8629-491fa7f23ef0" xlink:to="loc_bxsl_BreckenridgeFundingFacilityMember_dff3e9ff-c8b2-4cb8-8ea0-986f3e7fee21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_af2f3337-00fa-4d3a-9174-4aa70395b23a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_af2f3337-00fa-4d3a-9174-4aa70395b23a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_af2f3337-00fa-4d3a-9174-4aa70395b23a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_af2f3337-00fa-4d3a-9174-4aa70395b23a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_af2f3337-00fa-4d3a-9174-4aa70395b23a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b9dfc952-4398-42a8-ad8c-87fcf99aa954" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_af2f3337-00fa-4d3a-9174-4aa70395b23a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b9dfc952-4398-42a8-ad8c-87fcf99aa954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e8492c88-08b6-44e9-af00-c19e1988893e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b9dfc952-4398-42a8-ad8c-87fcf99aa954" xlink:to="loc_us-gaap_LineOfCreditMember_e8492c88-08b6-44e9-af00-c19e1988893e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_681f732f-f2ca-4c9d-804f-678d5e7e1ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_us-gaap_VariableRateAxis_681f732f-f2ca-4c9d-804f-678d5e7e1ddb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_681f732f-f2ca-4c9d-804f-678d5e7e1ddb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_681f732f-f2ca-4c9d-804f-678d5e7e1ddb" xlink:to="loc_us-gaap_VariableRateDomain_681f732f-f2ca-4c9d-804f-678d5e7e1ddb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7c28556d-a91f-489b-a1c3-ca4e04a27861" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_681f732f-f2ca-4c9d-804f-678d5e7e1ddb" xlink:to="loc_us-gaap_VariableRateDomain_7c28556d-a91f-489b-a1c3-ca4e04a27861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_39a978b9-e799-47ed-8f2a-138a58c298d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_7c28556d-a91f-489b-a1c3-ca4e04a27861" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_39a978b9-e799-47ed-8f2a-138a58c298d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariableRateScenarioAxis_9aa52d76-9ef0-4874-b381-4dfba795c984" xlink:href="bxsl-20231231.xsd#bxsl_VariableRateScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_bxsl_VariableRateScenarioAxis_9aa52d76-9ef0-4874-b381-4dfba795c984" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariableRateScenarioDomain_9aa52d76-9ef0-4874-b381-4dfba795c984_default" xlink:href="bxsl-20231231.xsd#bxsl_VariableRateScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bxsl_VariableRateScenarioAxis_9aa52d76-9ef0-4874-b381-4dfba795c984" xlink:to="loc_bxsl_VariableRateScenarioDomain_9aa52d76-9ef0-4874-b381-4dfba795c984_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariableRateScenarioDomain_1a1c8a28-838c-4fe6-b929-c280362a27d1" xlink:href="bxsl-20231231.xsd#bxsl_VariableRateScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bxsl_VariableRateScenarioAxis_9aa52d76-9ef0-4874-b381-4dfba795c984" xlink:to="loc_bxsl_VariableRateScenarioDomain_1a1c8a28-838c-4fe6-b929-c280362a27d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario1Member_206063a8-7438-4f6a-b1ef-10b9b14bb71c" xlink:href="bxsl-20231231.xsd#bxsl_Scenario1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_VariableRateScenarioDomain_1a1c8a28-838c-4fe6-b929-c280362a27d1" xlink:to="loc_bxsl_Scenario1Member_206063a8-7438-4f6a-b1ef-10b9b14bb71c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario2Member_db2a44f4-2aca-4211-95b1-bfc44cdf7b4f" xlink:href="bxsl-20231231.xsd#bxsl_Scenario2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_VariableRateScenarioDomain_1a1c8a28-838c-4fe6-b929-c280362a27d1" xlink:to="loc_bxsl_Scenario2Member_db2a44f4-2aca-4211-95b1-bfc44cdf7b4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario3Member_4589eb30-8042-4a80-b9ee-1bef5d1426aa" xlink:href="bxsl-20231231.xsd#bxsl_Scenario3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_VariableRateScenarioDomain_1a1c8a28-838c-4fe6-b929-c280362a27d1" xlink:to="loc_bxsl_Scenario3Member_4589eb30-8042-4a80-b9ee-1bef5d1426aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_daad6449-aae0-4333-a932-0da507e26be5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_srt_RangeAxis_daad6449-aae0-4333-a932-0da507e26be5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_daad6449-aae0-4333-a932-0da507e26be5_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_daad6449-aae0-4333-a932-0da507e26be5" xlink:to="loc_srt_RangeMember_daad6449-aae0-4333-a932-0da507e26be5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_99766266-cf27-4654-add3-70fa4db20662" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_daad6449-aae0-4333-a932-0da507e26be5" xlink:to="loc_srt_RangeMember_99766266-cf27-4654-add3-70fa4db20662" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_848b96d4-bd15-499f-829b-4835f3127b52" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_99766266-cf27-4654-add3-70fa4db20662" xlink:to="loc_srt_MaximumMember_848b96d4-bd15-499f-829b-4835f3127b52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cb91d52b-29fe-4a88-ac51-59387ec5cc36" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_99766266-cf27-4654-add3-70fa4db20662" xlink:to="loc_srt_MinimumMember_cb91d52b-29fe-4a88-ac51-59387ec5cc36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommitmentFeeScenarioAxis_1eb23646-a633-47bc-ad25-3fbfbbc14d3e" xlink:href="bxsl-20231231.xsd#bxsl_CommitmentFeeScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_bxsl_CommitmentFeeScenarioAxis_1eb23646-a633-47bc-ad25-3fbfbbc14d3e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommitmentFeeScenarioDomain_1eb23646-a633-47bc-ad25-3fbfbbc14d3e_default" xlink:href="bxsl-20231231.xsd#bxsl_CommitmentFeeScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bxsl_CommitmentFeeScenarioAxis_1eb23646-a633-47bc-ad25-3fbfbbc14d3e" xlink:to="loc_bxsl_CommitmentFeeScenarioDomain_1eb23646-a633-47bc-ad25-3fbfbbc14d3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommitmentFeeScenarioDomain_d88a35b8-0a69-4600-a001-02b065d14c2a" xlink:href="bxsl-20231231.xsd#bxsl_CommitmentFeeScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bxsl_CommitmentFeeScenarioAxis_1eb23646-a633-47bc-ad25-3fbfbbc14d3e" xlink:to="loc_bxsl_CommitmentFeeScenarioDomain_d88a35b8-0a69-4600-a001-02b065d14c2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario1Member_ead40779-6957-4b10-8924-4e06322e3700" xlink:href="bxsl-20231231.xsd#bxsl_Scenario1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_CommitmentFeeScenarioDomain_d88a35b8-0a69-4600-a001-02b065d14c2a" xlink:to="loc_bxsl_Scenario1Member_ead40779-6957-4b10-8924-4e06322e3700" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario2Member_3145bef1-f686-43e4-bfe9-b078591e6e66" xlink:href="bxsl-20231231.xsd#bxsl_Scenario2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_CommitmentFeeScenarioDomain_d88a35b8-0a69-4600-a001-02b065d14c2a" xlink:to="loc_bxsl_Scenario2Member_3145bef1-f686-43e4-bfe9-b078591e6e66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5c1f95f4-1b3e-46c0-be1b-72a4789a4371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_62ce36a7-48c4-4568-a814-53cdfd32be28" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5c1f95f4-1b3e-46c0-be1b-72a4789a4371" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_7c25eb57-a397-4603-b009-f4ebd39f7036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_62ce36a7-48c4-4568-a814-53cdfd32be28" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_7c25eb57-a397-4603-b009-f4ebd39f7036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LineOfCreditFacilityUnusedCapacityPercentage_1c2aaf53-6eab-4cb8-a65e-8094778212a8" xlink:href="bxsl-20231231.xsd#bxsl_LineOfCreditFacilityUnusedCapacityPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_62ce36a7-48c4-4568-a814-53cdfd32be28" xlink:to="loc_bxsl_LineOfCreditFacilityUnusedCapacityPercentage_1c2aaf53-6eab-4cb8-a65e-8094778212a8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsBigSkyFundingFacilityDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_30ae2f8b-c9fe-41bd-8fbd-15c2de969faf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30ae2f8b-c9fe-41bd-8fbd-15c2de969faf" xlink:to="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f05474c9-3949-482a-9ecd-49f506a2e16b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_us-gaap_CreditFacilityAxis_f05474c9-3949-482a-9ecd-49f506a2e16b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f05474c9-3949-482a-9ecd-49f506a2e16b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f05474c9-3949-482a-9ecd-49f506a2e16b" xlink:to="loc_us-gaap_CreditFacilityDomain_f05474c9-3949-482a-9ecd-49f506a2e16b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e7d269cb-76c7-478b-b74d-c5e8427cf418" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f05474c9-3949-482a-9ecd-49f506a2e16b" xlink:to="loc_us-gaap_CreditFacilityDomain_e7d269cb-76c7-478b-b74d-c5e8427cf418" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_874f809f-de96-4c75-8c2e-2917e8a5a468" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e7d269cb-76c7-478b-b74d-c5e8427cf418" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_874f809f-de96-4c75-8c2e-2917e8a5a468" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_31bcede2-b7a6-4e84-9643-b389e14a03be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_us-gaap_DebtInstrumentAxis_31bcede2-b7a6-4e84-9643-b389e14a03be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_31bcede2-b7a6-4e84-9643-b389e14a03be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_31bcede2-b7a6-4e84-9643-b389e14a03be" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_31bcede2-b7a6-4e84-9643-b389e14a03be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1b1cc931-941c-4b00-a845-697225eec0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_31bcede2-b7a6-4e84-9643-b389e14a03be" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1b1cc931-941c-4b00-a845-697225eec0ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BigSkyFundingFacilityMember_cc496675-4825-4193-9687-653b7be01523" xlink:href="bxsl-20231231.xsd#bxsl_BigSkyFundingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b1cc931-941c-4b00-a845-697225eec0ee" xlink:to="loc_bxsl_BigSkyFundingFacilityMember_cc496675-4825-4193-9687-653b7be01523" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a17a3e57-df70-4eea-aa00-ee8a25b18dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a17a3e57-df70-4eea-aa00-ee8a25b18dc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a17a3e57-df70-4eea-aa00-ee8a25b18dc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a17a3e57-df70-4eea-aa00-ee8a25b18dc0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a17a3e57-df70-4eea-aa00-ee8a25b18dc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e15deb65-998d-4f45-a52f-658c212d56ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a17a3e57-df70-4eea-aa00-ee8a25b18dc0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e15deb65-998d-4f45-a52f-658c212d56ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9977272e-d90d-49ed-8e84-b709de8da0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e15deb65-998d-4f45-a52f-658c212d56ec" xlink:to="loc_us-gaap_LineOfCreditMember_9977272e-d90d-49ed-8e84-b709de8da0cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_8664cfc0-898f-4ae2-abbb-0287e581bc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_us-gaap_VariableRateAxis_8664cfc0-898f-4ae2-abbb-0287e581bc4f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8664cfc0-898f-4ae2-abbb-0287e581bc4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_8664cfc0-898f-4ae2-abbb-0287e581bc4f" xlink:to="loc_us-gaap_VariableRateDomain_8664cfc0-898f-4ae2-abbb-0287e581bc4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_cbd43820-072c-4066-9017-1018628f439a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_8664cfc0-898f-4ae2-abbb-0287e581bc4f" xlink:to="loc_us-gaap_VariableRateDomain_cbd43820-072c-4066-9017-1018628f439a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_b45d60a1-2d93-414e-902d-ff7ed0c85030" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_cbd43820-072c-4066-9017-1018628f439a" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_b45d60a1-2d93-414e-902d-ff7ed0c85030" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommitmentFeeScenarioAxis_6fedc5ac-7e80-42ef-b1b1-f5ac0acfc689" xlink:href="bxsl-20231231.xsd#bxsl_CommitmentFeeScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_bxsl_CommitmentFeeScenarioAxis_6fedc5ac-7e80-42ef-b1b1-f5ac0acfc689" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommitmentFeeScenarioDomain_6fedc5ac-7e80-42ef-b1b1-f5ac0acfc689_default" xlink:href="bxsl-20231231.xsd#bxsl_CommitmentFeeScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bxsl_CommitmentFeeScenarioAxis_6fedc5ac-7e80-42ef-b1b1-f5ac0acfc689" xlink:to="loc_bxsl_CommitmentFeeScenarioDomain_6fedc5ac-7e80-42ef-b1b1-f5ac0acfc689_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommitmentFeeScenarioDomain_0b1e51d9-8c76-46d3-beb5-10ed4fbcc31f" xlink:href="bxsl-20231231.xsd#bxsl_CommitmentFeeScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bxsl_CommitmentFeeScenarioAxis_6fedc5ac-7e80-42ef-b1b1-f5ac0acfc689" xlink:to="loc_bxsl_CommitmentFeeScenarioDomain_0b1e51d9-8c76-46d3-beb5-10ed4fbcc31f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario1Member_e6b0a1f2-912d-430a-9a43-676e4fd45b29" xlink:href="bxsl-20231231.xsd#bxsl_Scenario1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_CommitmentFeeScenarioDomain_0b1e51d9-8c76-46d3-beb5-10ed4fbcc31f" xlink:to="loc_bxsl_Scenario1Member_e6b0a1f2-912d-430a-9a43-676e4fd45b29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario2Member_e4af2809-1d89-4e5a-a4f1-2d918f3c99d7" xlink:href="bxsl-20231231.xsd#bxsl_Scenario2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_CommitmentFeeScenarioDomain_0b1e51d9-8c76-46d3-beb5-10ed4fbcc31f" xlink:to="loc_bxsl_Scenario2Member_e4af2809-1d89-4e5a-a4f1-2d918f3c99d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d608b4a6-71fa-433d-8f44-ddf27dcf4961" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_srt_RangeAxis_d608b4a6-71fa-433d-8f44-ddf27dcf4961" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d608b4a6-71fa-433d-8f44-ddf27dcf4961_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d608b4a6-71fa-433d-8f44-ddf27dcf4961" xlink:to="loc_srt_RangeMember_d608b4a6-71fa-433d-8f44-ddf27dcf4961_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16bce18f-4394-43ec-b47d-4e68cc6f208e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d608b4a6-71fa-433d-8f44-ddf27dcf4961" xlink:to="loc_srt_RangeMember_16bce18f-4394-43ec-b47d-4e68cc6f208e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0667b3e1-9cc1-40c4-aee5-6fc7d89a180f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_16bce18f-4394-43ec-b47d-4e68cc6f208e" xlink:to="loc_srt_MinimumMember_0667b3e1-9cc1-40c4-aee5-6fc7d89a180f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6a85e88b-8505-4ecf-8244-b59b1bc7169a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_16bce18f-4394-43ec-b47d-4e68cc6f208e" xlink:to="loc_srt_MaximumMember_6a85e88b-8505-4ecf-8244-b59b1bc7169a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d22169a7-ea28-4dbf-9d62-5c2e34c0c212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30ae2f8b-c9fe-41bd-8fbd-15c2de969faf" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d22169a7-ea28-4dbf-9d62-5c2e34c0c212" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage_c53343e1-8a8b-49b1-a5c5-f21648ca36fc" xlink:href="bxsl-20231231.xsd#bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30ae2f8b-c9fe-41bd-8fbd-15c2de969faf" xlink:to="loc_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage_c53343e1-8a8b-49b1-a5c5-f21648ca36fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_aac52845-b7c2-46bd-98bc-8ce44b8bc3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30ae2f8b-c9fe-41bd-8fbd-15c2de969faf" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_aac52845-b7c2-46bd-98bc-8ce44b8bc3e7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsRevolvingCreditFacilityDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:to="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ac88c3f4-c075-4225-a2e3-86661e4891aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:to="loc_us-gaap_CreditFacilityAxis_ac88c3f4-c075-4225-a2e3-86661e4891aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ac88c3f4-c075-4225-a2e3-86661e4891aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ac88c3f4-c075-4225-a2e3-86661e4891aa" xlink:to="loc_us-gaap_CreditFacilityDomain_ac88c3f4-c075-4225-a2e3-86661e4891aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c2713826-55e0-4c8b-9efd-9f5aab6cef67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ac88c3f4-c075-4225-a2e3-86661e4891aa" xlink:to="loc_us-gaap_CreditFacilityDomain_c2713826-55e0-4c8b-9efd-9f5aab6cef67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_8dd90ca6-9a07-4d7c-a5fe-8e27c716f67e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c2713826-55e0-4c8b-9efd-9f5aab6cef67" xlink:to="loc_us-gaap_SecuredDebtMember_8dd90ca6-9a07-4d7c-a5fe-8e27c716f67e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_a4b83294-fb22-4463-aa29-4fba4827b2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c2713826-55e0-4c8b-9efd-9f5aab6cef67" xlink:to="loc_us-gaap_LetterOfCreditMember_a4b83294-fb22-4463-aa29-4fba4827b2b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_5c2a9435-bc51-4e75-9bdf-b5330a518bda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c2713826-55e0-4c8b-9efd-9f5aab6cef67" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_5c2a9435-bc51-4e75-9bdf-b5330a518bda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cd49f36c-9383-449f-ab97-489540decbfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cd49f36c-9383-449f-ab97-489540decbfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cd49f36c-9383-449f-ab97-489540decbfc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cd49f36c-9383-449f-ab97-489540decbfc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cd49f36c-9383-449f-ab97-489540decbfc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_37bbd841-a599-4e53-b181-49781c236ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cd49f36c-9383-449f-ab97-489540decbfc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_37bbd841-a599-4e53-b181-49781c236ec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_8b2e6fec-fd06-4a93-a0db-7e90eca9cab9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_37bbd841-a599-4e53-b181-49781c236ec2" xlink:to="loc_us-gaap_LineOfCreditMember_8b2e6fec-fd06-4a93-a0db-7e90eca9cab9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_91986535-96eb-4581-b382-e4a38877f525" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:to="loc_us-gaap_VariableRateAxis_91986535-96eb-4581-b382-e4a38877f525" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_91986535-96eb-4581-b382-e4a38877f525_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_91986535-96eb-4581-b382-e4a38877f525" xlink:to="loc_us-gaap_VariableRateDomain_91986535-96eb-4581-b382-e4a38877f525_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_92004450-e2a6-46d6-9b28-2f0db5d90be9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_91986535-96eb-4581-b382-e4a38877f525" xlink:to="loc_us-gaap_VariableRateDomain_92004450-e2a6-46d6-9b28-2f0db5d90be9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_6a11aa28-1ea2-4567-9cb3-148560d40959" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_92004450-e2a6-46d6-9b28-2f0db5d90be9" xlink:to="loc_us-gaap_BaseRateMember_6a11aa28-1ea2-4567-9cb3-148560d40959" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_5e9e3b0c-67ce-4ab0-9e97-53c88cf48a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_92004450-e2a6-46d6-9b28-2f0db5d90be9" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_5e9e3b0c-67ce-4ab0-9e97-53c88cf48a3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariableRateScenarioAxis_36d9c0f6-2cfa-426b-93d1-0916e5827676" xlink:href="bxsl-20231231.xsd#bxsl_VariableRateScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:to="loc_bxsl_VariableRateScenarioAxis_36d9c0f6-2cfa-426b-93d1-0916e5827676" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariableRateScenarioDomain_36d9c0f6-2cfa-426b-93d1-0916e5827676_default" xlink:href="bxsl-20231231.xsd#bxsl_VariableRateScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bxsl_VariableRateScenarioAxis_36d9c0f6-2cfa-426b-93d1-0916e5827676" xlink:to="loc_bxsl_VariableRateScenarioDomain_36d9c0f6-2cfa-426b-93d1-0916e5827676_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariableRateScenarioDomain_3bc7b620-a054-4f13-a584-d48464462314" xlink:href="bxsl-20231231.xsd#bxsl_VariableRateScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bxsl_VariableRateScenarioAxis_36d9c0f6-2cfa-426b-93d1-0916e5827676" xlink:to="loc_bxsl_VariableRateScenarioDomain_3bc7b620-a054-4f13-a584-d48464462314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario1Member_29bccf0f-770f-4516-aa17-e77d8ae1719b" xlink:href="bxsl-20231231.xsd#bxsl_Scenario1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_VariableRateScenarioDomain_3bc7b620-a054-4f13-a584-d48464462314" xlink:to="loc_bxsl_Scenario1Member_29bccf0f-770f-4516-aa17-e77d8ae1719b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario2Member_05d874a0-458b-4af7-88ae-a9afc4170183" xlink:href="bxsl-20231231.xsd#bxsl_Scenario2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_VariableRateScenarioDomain_3bc7b620-a054-4f13-a584-d48464462314" xlink:to="loc_bxsl_Scenario2Member_05d874a0-458b-4af7-88ae-a9afc4170183" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario3Member_01ef34f3-df33-441d-be68-0a94766bb979" xlink:href="bxsl-20231231.xsd#bxsl_Scenario3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_VariableRateScenarioDomain_3bc7b620-a054-4f13-a584-d48464462314" xlink:to="loc_bxsl_Scenario3Member_01ef34f3-df33-441d-be68-0a94766bb979" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario4Member_c5e58679-cd72-4da7-a17c-979cd84231fe" xlink:href="bxsl-20231231.xsd#bxsl_Scenario4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_VariableRateScenarioDomain_3bc7b620-a054-4f13-a584-d48464462314" xlink:to="loc_bxsl_Scenario4Member_c5e58679-cd72-4da7-a17c-979cd84231fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4e15c649-a2bc-4381-89e2-27b2033dacbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:to="loc_us-gaap_DebtInstrumentAxis_4e15c649-a2bc-4381-89e2-27b2033dacbd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4e15c649-a2bc-4381-89e2-27b2033dacbd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4e15c649-a2bc-4381-89e2-27b2033dacbd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4e15c649-a2bc-4381-89e2-27b2033dacbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_62a44bce-9037-4f9e-9559-de4d115d0b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4e15c649-a2bc-4381-89e2-27b2033dacbd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_62a44bce-9037-4f9e-9559-de4d115d0b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityMember_f6fcc9e1-7027-47e0-9c6d-03aaac7102ee" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62a44bce-9037-4f9e-9559-de4d115d0b5d" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityMember_f6fcc9e1-7027-47e0-9c6d-03aaac7102ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member_e32cd33c-a298-4256-a2e8-930b45e00f05" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62a44bce-9037-4f9e-9559-de4d115d0b5d" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member_e32cd33c-a298-4256-a2e8-930b45e00f05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member_5b428f92-515a-415c-b374-893c6e977fef" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62a44bce-9037-4f9e-9559-de4d115d0b5d" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member_5b428f92-515a-415c-b374-893c6e977fef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_81cc3ded-388e-47d4-970e-93cff00b21f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_81cc3ded-388e-47d4-970e-93cff00b21f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_15b5190e-c60f-49e0-a293-b4671403f80f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_15b5190e-c60f-49e0-a293-b4671403f80f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier_7541c532-9dbe-4a08-9706-33ea7b8d2f16" xlink:href="bxsl-20231231.xsd#bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:to="loc_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier_7541c532-9dbe-4a08-9706-33ea7b8d2f16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_bc727c82-410a-4769-a70f-5790729524b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_bc727c82-410a-4769-a70f-5790729524b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio_83a3166a-30cd-4dbe-8884-565b3122f4ce" xlink:href="bxsl-20231231.xsd#bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:to="loc_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio_83a3166a-30cd-4dbe-8884-565b3122f4ce" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsUnsecuredDebtDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4e1e6e47-ea35-4585-bd01-abb6c9c9874c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_75fe88c0-bcef-4be6-8b95-baca5eb3caf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e1e6e47-ea35-4585-bd01-abb6c9c9874c" xlink:to="loc_us-gaap_DebtInstrumentTable_75fe88c0-bcef-4be6-8b95-baca5eb3caf1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_156ec6e8-ab82-438c-a4a9-82a5c335efef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_75fe88c0-bcef-4be6-8b95-baca5eb3caf1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_156ec6e8-ab82-438c-a4a9-82a5c335efef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_156ec6e8-ab82-438c-a4a9-82a5c335efef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_156ec6e8-ab82-438c-a4a9-82a5c335efef" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_156ec6e8-ab82-438c-a4a9-82a5c335efef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d7d12aa4-66ef-45fd-8f0d-86cb60322c98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_156ec6e8-ab82-438c-a4a9-82a5c335efef" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d7d12aa4-66ef-45fd-8f0d-86cb60322c98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_35bfdafc-e13d-4671-9207-9b269d7fc0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d7d12aa4-66ef-45fd-8f0d-86cb60322c98" xlink:to="loc_us-gaap_UnsecuredDebtMember_35bfdafc-e13d-4671-9207-9b269d7fc0b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_38b1df1c-49c2-4a6c-8163-ff43bf05453e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_75fe88c0-bcef-4be6-8b95-baca5eb3caf1" xlink:to="loc_us-gaap_DebtInstrumentAxis_38b1df1c-49c2-4a6c-8163-ff43bf05453e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_38b1df1c-49c2-4a6c-8163-ff43bf05453e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_38b1df1c-49c2-4a6c-8163-ff43bf05453e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_38b1df1c-49c2-4a6c-8163-ff43bf05453e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_38b1df1c-49c2-4a6c-8163-ff43bf05453e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3650NotesDue2023Member_7576e9e8-147f-4ddd-8bac-68687ca5476c" xlink:href="bxsl-20231231.xsd#bxsl_A3650NotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:to="loc_bxsl_A3650NotesDue2023Member_7576e9e8-147f-4ddd-8bac-68687ca5476c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3625NotesDue2026Member_2e447d21-8e99-4347-a6ba-33533ae437f6" xlink:href="bxsl-20231231.xsd#bxsl_A3625NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:to="loc_bxsl_A3625NotesDue2026Member_2e447d21-8e99-4347-a6ba-33533ae437f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2750NotesDue2026Member_21c1eee2-52c3-43dc-8369-4c64f1244689" xlink:href="bxsl-20231231.xsd#bxsl_A2750NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:to="loc_bxsl_A2750NotesDue2026Member_21c1eee2-52c3-43dc-8369-4c64f1244689" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2125SeniorNotesDue2027Member_b5978767-4984-4a1e-9fb2-1a1a49747b68" xlink:href="bxsl-20231231.xsd#bxsl_A2125SeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:to="loc_bxsl_A2125SeniorNotesDue2027Member_b5978767-4984-4a1e-9fb2-1a1a49747b68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2850NotesDue2028Member_c0d01479-a3ba-4f29-8423-13d0d49436dd" xlink:href="bxsl-20231231.xsd#bxsl_A2850NotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:to="loc_bxsl_A2850NotesDue2028Member_c0d01479-a3ba-4f29-8423-13d0d49436dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_d2dc802e-d25c-44a5-a1cf-ae45d0c817b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e1e6e47-ea35-4585-bd01-abb6c9c9874c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_d2dc802e-d25c-44a5-a1cf-ae45d0c817b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_878b3e1e-3a42-49cd-87d7-9785fb9cc95b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e1e6e47-ea35-4585-bd01-abb6c9c9874c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_878b3e1e-3a42-49cd-87d7-9785fb9cc95b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4301624d-09c2-43a0-be42-d202761caa0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e1e6e47-ea35-4585-bd01-abb6c9c9874c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4301624d-09c2-43a0-be42-d202761caa0b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsOutstandingDebtObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4c25d650-09a3-45f0-af1b-d02fd1c778f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_DebtInstrumentTable_4c25d650-09a3-45f0-af1b-d02fd1c778f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3126b81b-4ab9-45b8-80d5-0843ef5b3ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4c25d650-09a3-45f0-af1b-d02fd1c778f0" xlink:to="loc_us-gaap_DebtInstrumentAxis_3126b81b-4ab9-45b8-80d5-0843ef5b3ec8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3126b81b-4ab9-45b8-80d5-0843ef5b3ec8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3126b81b-4ab9-45b8-80d5-0843ef5b3ec8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3126b81b-4ab9-45b8-80d5-0843ef5b3ec8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3126b81b-4ab9-45b8-80d5-0843ef5b3ec8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityMember_9d21d4e4-6f9f-4553-a099-836161c36a98" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_JacksonHoleFundingFacilityMember_9d21d4e4-6f9f-4553-a099-836161c36a98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BreckenridgeFundingFacilityMember_00949c82-f279-498b-ba6a-79ee68f17a58" xlink:href="bxsl-20231231.xsd#bxsl_BreckenridgeFundingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_BreckenridgeFundingFacilityMember_00949c82-f279-498b-ba6a-79ee68f17a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BigSkyFundingFacilityMember_4209df60-6214-4446-92b6-266f4701575e" xlink:href="bxsl-20231231.xsd#bxsl_BigSkyFundingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_BigSkyFundingFacilityMember_4209df60-6214-4446-92b6-266f4701575e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityMember_e249556c-3c9b-4d07-916a-8da9920468bf" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityMember_e249556c-3c9b-4d07-916a-8da9920468bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3650NotesDue2023Member_a0d29edf-bfc9-40dd-9f46-a1438a9c31c3" xlink:href="bxsl-20231231.xsd#bxsl_A3650NotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_A3650NotesDue2023Member_a0d29edf-bfc9-40dd-9f46-a1438a9c31c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3625NotesDue2026Member_465b9062-323e-4db3-b591-e58beedcf2e3" xlink:href="bxsl-20231231.xsd#bxsl_A3625NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_A3625NotesDue2026Member_465b9062-323e-4db3-b591-e58beedcf2e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2750NotesDue2026Member_a13418f0-9eab-4a01-a21a-ede646d03743" xlink:href="bxsl-20231231.xsd#bxsl_A2750NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_A2750NotesDue2026Member_a13418f0-9eab-4a01-a21a-ede646d03743" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2125SeniorNotesDue2027Member_45eb0922-ef2b-4cd2-8c44-43ae5b9673d9" xlink:href="bxsl-20231231.xsd#bxsl_A2125SeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_A2125SeniorNotesDue2027Member_45eb0922-ef2b-4cd2-8c44-43ae5b9673d9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2850NotesDue2028Member_d8e2746a-3900-4b32-aa4a-787185638c27" xlink:href="bxsl-20231231.xsd#bxsl_A2850NotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_A2850NotesDue2028Member_d8e2746a-3900-4b32-aa4a-787185638c27" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d1fdc02b-2319-4dcc-960a-e2745feb4792" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4c25d650-09a3-45f0-af1b-d02fd1c778f0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d1fdc02b-2319-4dcc-960a-e2745feb4792" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d1fdc02b-2319-4dcc-960a-e2745feb4792_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d1fdc02b-2319-4dcc-960a-e2745feb4792" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d1fdc02b-2319-4dcc-960a-e2745feb4792_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_50791554-1162-4e04-9ccd-94ee9c226b73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d1fdc02b-2319-4dcc-960a-e2745feb4792" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_50791554-1162-4e04-9ccd-94ee9c226b73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_aabc712f-5582-4c2d-91fd-ace028b4c5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_50791554-1162-4e04-9ccd-94ee9c226b73" xlink:to="loc_us-gaap_LineOfCreditMember_aabc712f-5582-4c2d-91fd-ace028b4c5d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_202595ca-20ac-41c4-861a-1f1e8977ba31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_50791554-1162-4e04-9ccd-94ee9c226b73" xlink:to="loc_us-gaap_UnsecuredDebtMember_202595ca-20ac-41c4-861a-1f1e8977ba31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_fbc73966-dd7b-4b87-ad0f-19c086850df2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4c25d650-09a3-45f0-af1b-d02fd1c778f0" xlink:to="loc_us-gaap_CreditFacilityAxis_fbc73966-dd7b-4b87-ad0f-19c086850df2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fbc73966-dd7b-4b87-ad0f-19c086850df2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_fbc73966-dd7b-4b87-ad0f-19c086850df2" xlink:to="loc_us-gaap_CreditFacilityDomain_fbc73966-dd7b-4b87-ad0f-19c086850df2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a696b11c-ebf7-48dc-927d-89f0159c9619" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_fbc73966-dd7b-4b87-ad0f-19c086850df2" xlink:to="loc_us-gaap_CreditFacilityDomain_a696b11c-ebf7-48dc-927d-89f0159c9619" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_00c1c40e-1252-4fc1-bd2a-77a769698e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a696b11c-ebf7-48dc-927d-89f0159c9619" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_00c1c40e-1252-4fc1-bd2a-77a769698e7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_94d433aa-6d02-4b85-b9c6-73a71498430a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_94d433aa-6d02-4b85-b9c6-73a71498430a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a70b0795-6e44-4853-a94e-93b8673ca580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a70b0795-6e44-4853-a94e-93b8673ca580" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d681f861-2427-4f76-b92d-35a61a84342a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d681f861-2427-4f76-b92d-35a61a84342a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_fbc5f1c1-1e21-4046-8a55-6657e15c6ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_LongTermDebt_fbc5f1c1-1e21-4046-8a55-6657e15c6ddf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_46114acd-6a6d-4148-85e2-40eef7dd6b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_46114acd-6a6d-4148-85e2-40eef7dd6b0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_cda65454-164c-4c64-bf80-eb1e42dd5b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_cda65454-164c-4c64-bf80-eb1e42dd5b9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_458be5c5-e930-46f7-ae53-3a7c35b84efc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_458be5c5-e930-46f7-ae53-3a7c35b84efc" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#CommitmentandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/CommitmentandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_50d60308-e6bc-4035-adbd-b6ebba0f8414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_51894571-1dbb-4542-8bc5-b163b8930403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_50d60308-e6bc-4035-adbd-b6ebba0f8414" xlink:to="loc_us-gaap_OtherCommitmentsTable_51894571-1dbb-4542-8bc5-b163b8930403" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_a8884db7-c555-4545-a334-66ac24af1dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_51894571-1dbb-4542-8bc5-b163b8930403" xlink:to="loc_us-gaap_OtherCommitmentsAxis_a8884db7-c555-4545-a334-66ac24af1dd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_a8884db7-c555-4545-a334-66ac24af1dd8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_a8884db7-c555-4545-a334-66ac24af1dd8" xlink:to="loc_us-gaap_OtherCommitmentsDomain_a8884db7-c555-4545-a334-66ac24af1dd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_b39106be-25f6-48e8-8a62-38956ee94b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_a8884db7-c555-4545-a334-66ac24af1dd8" xlink:to="loc_us-gaap_OtherCommitmentsDomain_b39106be-25f6-48e8-8a62-38956ee94b8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DelayedDrawTermLoansAndRevolversMember_54ca41ee-7d82-4093-8019-e6b3d1d0759f" xlink:href="bxsl-20231231.xsd#bxsl_DelayedDrawTermLoansAndRevolversMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_b39106be-25f6-48e8-8a62-38956ee94b8d" xlink:to="loc_bxsl_DelayedDrawTermLoansAndRevolversMember_54ca41ee-7d82-4093-8019-e6b3d1d0759f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_550c2172-76b9-4fee-822f-463b8cebdb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_50d60308-e6bc-4035-adbd-b6ebba0f8414" xlink:to="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_550c2172-76b9-4fee-822f-463b8cebdb8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount_bc54536d-7b8b-44f2-878b-02ca464910c5" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_50d60308-e6bc-4035-adbd-b6ebba0f8414" xlink:to="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount_bc54536d-7b8b-44f2-878b-02ca464910c5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsSubscriptionsandDrawdownsDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_540308ea-a327-4c77-93e6-ded45a48c412" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_540308ea-a327-4c77-93e6-ded45a48c412" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e26a9010-4a96-4638-88fd-4eab8c0f2975" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_540308ea-a327-4c77-93e6-ded45a48c412" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e26a9010-4a96-4638-88fd-4eab8c0f2975" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e26a9010-4a96-4638-88fd-4eab8c0f2975_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e26a9010-4a96-4638-88fd-4eab8c0f2975" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e26a9010-4a96-4638-88fd-4eab8c0f2975_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_75c8a154-606f-4623-8b22-be5b2ac22a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e26a9010-4a96-4638-88fd-4eab8c0f2975" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_75c8a154-606f-4623-8b22-be5b2ac22a5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_1651ca89-b125-499d-8526-8b333cfcb81b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_75c8a154-606f-4623-8b22-be5b2ac22a5a" xlink:to="loc_us-gaap_OverAllotmentOptionMember_1651ca89-b125-499d-8526-8b333cfcb81b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_eebbdb70-1c46-4592-b31b-449d938d270f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_75c8a154-606f-4623-8b22-be5b2ac22a5a" xlink:to="loc_us-gaap_IPOMember_eebbdb70-1c46-4592-b31b-449d938d270f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9098807d-d10a-4216-8a9b-cd3a920b940e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_540308ea-a327-4c77-93e6-ded45a48c412" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9098807d-d10a-4216-8a9b-cd3a920b940e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9098807d-d10a-4216-8a9b-cd3a920b940e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9098807d-d10a-4216-8a9b-cd3a920b940e" xlink:to="loc_us-gaap_RelatedPartyDomain_9098807d-d10a-4216-8a9b-cd3a920b940e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_669fca33-a515-4037-befc-97cc249fa5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9098807d-d10a-4216-8a9b-cd3a920b940e" xlink:to="loc_us-gaap_RelatedPartyDomain_669fca33-a515-4037-befc-97cc249fa5c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_a3036224-aeea-4431-a8f9-692be2b9c9fd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_669fca33-a515-4037-befc-97cc249fa5c6" xlink:to="loc_srt_AffiliatedEntityMember_a3036224-aeea-4431-a8f9-692be2b9c9fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3d77a608-afa8-4e05-867d-04fed227b035" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3d77a608-afa8-4e05-867d-04fed227b035" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_018fd52c-6658-443f-87c8-db4a2616b24c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_018fd52c-6658-443f-87c8-db4a2616b24c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_0f5391be-8b4c-4648-bde4-f67eb8a3713f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_0f5391be-8b4c-4648-bde4-f67eb8a3713f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_5fab2244-a3f8-488b-8b63-e54a396dd1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_5fab2244-a3f8-488b-8b63-e54a396dd1ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyCommittedCapital_964ea01e-3add-441d-94e4-185aeccc1283" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyCommittedCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_InvestmentCompanyCommittedCapital_964ea01e-3add-441d-94e4-185aeccc1283" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_82e71e56-815d-4a52-af2c-9cbaae615204" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_82e71e56-815d-4a52-af2c-9cbaae615204" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_c31b31e7-3485-4098-98ee-a233c8e09db9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_c31b31e7-3485-4098-98ee-a233c8e09db9" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_4e880cd8-5957-430c-a5e9-b59e1204a511" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_4e880cd8-5957-430c-a5e9-b59e1204a511" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_0eb9bc56-01e7-46f2-b616-81326ff7ed5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_4e880cd8-5957-430c-a5e9-b59e1204a511" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_0eb9bc56-01e7-46f2-b616-81326ff7ed5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0eb9bc56-01e7-46f2-b616-81326ff7ed5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_0eb9bc56-01e7-46f2-b616-81326ff7ed5d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0eb9bc56-01e7-46f2-b616-81326ff7ed5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1c5b1033-d96a-4008-879e-d2ae78cbcef5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_0eb9bc56-01e7-46f2-b616-81326ff7ed5d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1c5b1033-d96a-4008-879e-d2ae78cbcef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AtTheMarketOfferingOffering1Member_1385ef66-259b-4b42-963d-6598476057e2" xlink:href="bxsl-20231231.xsd#bxsl_AtTheMarketOfferingOffering1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1c5b1033-d96a-4008-879e-d2ae78cbcef5" xlink:to="loc_bxsl_AtTheMarketOfferingOffering1Member_1385ef66-259b-4b42-963d-6598476057e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NumberOfEquityDistributionAgreements_308ddb21-b7d7-4d1b-a504-578168df34ed" xlink:href="bxsl-20231231.xsd#bxsl_NumberOfEquityDistributionAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_bxsl_NumberOfEquityDistributionAgreements_308ddb21-b7d7-4d1b-a504-578168df34ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue_6b56c2b2-2aa9-4f65-bde5-2d8f6cb71f76" xlink:href="bxsl-20231231.xsd#bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue_6b56c2b2-2aa9-4f65-bde5-2d8f6cb71f76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SaleOfStockRemainingAuthorizedAmount_5331410a-ca9e-490e-a8e2-a6e7f985eb95" xlink:href="bxsl-20231231.xsd#bxsl_SaleOfStockRemainingAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_bxsl_SaleOfStockRemainingAuthorizedAmount_5331410a-ca9e-490e-a8e2-a6e7f985eb95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_66f3ba8a-6765-4315-956f-0432851d48f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_66f3ba8a-6765-4315-956f-0432851d48f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_223ce843-dffd-434b-bc41-a1b40f95ae7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_223ce843-dffd-434b-bc41-a1b40f95ae7a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_7f2a0511-c4eb-4383-9377-2817f948885d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_7f2a0511-c4eb-4383-9377-2817f948885d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_56c4ae14-3990-4d31-9818-2983791ba3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_56c4ae14-3990-4d31-9818-2983791ba3a4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_63079c95-e867-4eac-acbe-bcfd34fa8ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_63079c95-e867-4eac-acbe-bcfd34fa8ddb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_881fc687-873d-48f4-8c01-96631ecc52bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_881fc687-873d-48f4-8c01-96631ecc52bc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_StockIssuedDuringPeriodValueNewIssuesGross_0e2b3b50-6894-4641-97f7-9b9d447b0096" xlink:href="bxsl-20231231.xsd#bxsl_StockIssuedDuringPeriodValueNewIssuesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_bxsl_StockIssuedDuringPeriodValueNewIssuesGross_0e2b3b50-6894-4641-97f7-9b9d447b0096" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsDistributionsDeclaredDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_f2abfb56-2949-46a6-9bd1-625bb3c51103" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_7a83f0c2-df4a-47b8-a4fc-36b12aff7b91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DividendsPayableLineItems_f2abfb56-2949-46a6-9bd1-625bb3c51103" xlink:to="loc_us-gaap_DividendsPayableTable_7a83f0c2-df4a-47b8-a4fc-36b12aff7b91" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_46777f65-04d0-471e-ba60-359fa3e4daea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_7a83f0c2-df4a-47b8-a4fc-36b12aff7b91" xlink:to="loc_us-gaap_DividendsAxis_46777f65-04d0-471e-ba60-359fa3e4daea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_46777f65-04d0-471e-ba60-359fa3e4daea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DividendsAxis_46777f65-04d0-471e-ba60-359fa3e4daea" xlink:to="loc_us-gaap_DividendsDomain_46777f65-04d0-471e-ba60-359fa3e4daea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DividendsAxis_46777f65-04d0-471e-ba60-359fa3e4daea" xlink:to="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends1Member_fc6a31ca-2635-42a8-8093-4bc3b9be7899" xlink:href="bxsl-20231231.xsd#bxsl_Dividends1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends1Member_fc6a31ca-2635-42a8-8093-4bc3b9be7899" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends2Member_ea946389-847a-4afa-9b88-8461d9d7e001" xlink:href="bxsl-20231231.xsd#bxsl_Dividends2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends2Member_ea946389-847a-4afa-9b88-8461d9d7e001" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends3Member_bde8673c-d917-4787-bdc3-67c298add9d3" xlink:href="bxsl-20231231.xsd#bxsl_Dividends3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends3Member_bde8673c-d917-4787-bdc3-67c298add9d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends4Member_12757238-f33d-4f37-a9f6-bf821c28a303" xlink:href="bxsl-20231231.xsd#bxsl_Dividends4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends4Member_12757238-f33d-4f37-a9f6-bf821c28a303" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends5Member_1951fa21-6c23-4180-8c05-5308416d28c7" xlink:href="bxsl-20231231.xsd#bxsl_Dividends5Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends5Member_1951fa21-6c23-4180-8c05-5308416d28c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends6Member_f5b7afdb-1919-432c-9485-cf76d8f6de74" xlink:href="bxsl-20231231.xsd#bxsl_Dividends6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends6Member_f5b7afdb-1919-432c-9485-cf76d8f6de74" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends7Member_a21aae99-56a0-493c-bfcc-aacce4bb8d11" xlink:href="bxsl-20231231.xsd#bxsl_Dividends7Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends7Member_a21aae99-56a0-493c-bfcc-aacce4bb8d11" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends8Member_be0495d6-890a-4137-869a-5c4fc75b61ed" xlink:href="bxsl-20231231.xsd#bxsl_Dividends8Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends8Member_be0495d6-890a-4137-869a-5c4fc75b61ed" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends9Member_c4a4c153-f2e5-4c96-a525-fefa19c36780" xlink:href="bxsl-20231231.xsd#bxsl_Dividends9Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends9Member_c4a4c153-f2e5-4c96-a525-fefa19c36780" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_67eb2fb4-385a-4cbd-93ce-ec4e07d0a628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_f2abfb56-2949-46a6-9bd1-625bb3c51103" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_67eb2fb4-385a-4cbd-93ce-ec4e07d0a628" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_faae0297-3ba8-4e73-a3d3-230b48c1b4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_f2abfb56-2949-46a6-9bd1-625bb3c51103" xlink:to="loc_us-gaap_DividendsCommonStock_faae0297-3ba8-4e73-a3d3-230b48c1b4e6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsShareRepurchasePlanDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e326d85f-0040-4e5a-9d0a-79114cf85281" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_66f54c97-606e-4fca-b9d0-594a1a8352ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e326d85f-0040-4e5a-9d0a-79114cf85281" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_66f54c97-606e-4fca-b9d0-594a1a8352ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_c024704e-f91d-4254-a70a-1362c97e9d47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_66f54c97-606e-4fca-b9d0-594a1a8352ca" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_c024704e-f91d-4254-a70a-1362c97e9d47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_c024704e-f91d-4254-a70a-1362c97e9d47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_c024704e-f91d-4254-a70a-1362c97e9d47" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_c024704e-f91d-4254-a70a-1362c97e9d47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f5dc6fb2-7c0c-4d12-9dc7-53779863a1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_c024704e-f91d-4254-a70a-1362c97e9d47" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f5dc6fb2-7c0c-4d12-9dc7-53779863a1a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Company10b51PlanMember_06830fbf-879b-4e1c-af72-60bfa771a35d" xlink:href="bxsl-20231231.xsd#bxsl_Company10b51PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f5dc6fb2-7c0c-4d12-9dc7-53779863a1a4" xlink:to="loc_bxsl_Company10b51PlanMember_06830fbf-879b-4e1c-af72-60bfa771a35d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Company10b18PlanMember_3ea3e81a-2ac4-488d-a3fe-0faaeca90afb" xlink:href="bxsl-20231231.xsd#bxsl_Company10b18PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f5dc6fb2-7c0c-4d12-9dc7-53779863a1a4" xlink:to="loc_bxsl_Company10b18PlanMember_3ea3e81a-2ac4-488d-a3fe-0faaeca90afb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1099b109-21a3-4c5a-970b-0bf59b9ebce3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e326d85f-0040-4e5a-9d0a-79114cf85281" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1099b109-21a3-4c5a-970b-0bf59b9ebce3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_6688c6bf-6f7a-41d6-b8da-f590da35b615" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e326d85f-0040-4e5a-9d0a-79114cf85281" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_6688c6bf-6f7a-41d6-b8da-f590da35b615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_36b2a961-c74d-492c-bf4c-c8a5860d18c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e326d85f-0040-4e5a-9d0a-79114cf85281" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_36b2a961-c74d-492c-bf4c-c8a5860d18c6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_55498abe-594e-4041-a385-c4202d272952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_dba70c7d-2558-4f20-84c0-3af55b0b8207" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_55498abe-594e-4041-a385-c4202d272952" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_dba70c7d-2558-4f20-84c0-3af55b0b8207" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_4cb6cb1c-9bd0-439c-80f2-3188f4f0b16e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_dba70c7d-2558-4f20-84c0-3af55b0b8207" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_4cb6cb1c-9bd0-439c-80f2-3188f4f0b16e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_4cb6cb1c-9bd0-439c-80f2-3188f4f0b16e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4cb6cb1c-9bd0-439c-80f2-3188f4f0b16e" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_4cb6cb1c-9bd0-439c-80f2-3188f4f0b16e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5b4a0bf6-653e-4643-93f5-bbcf1ea23fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4cb6cb1c-9bd0-439c-80f2-3188f4f0b16e" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5b4a0bf6-653e-4643-93f5-bbcf1ea23fdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Company10b51PlanMember_b7c7c298-ba5f-4046-9e0b-0a7b3aabf568" xlink:href="bxsl-20231231.xsd#bxsl_Company10b51PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5b4a0bf6-653e-4643-93f5-bbcf1ea23fdc" xlink:to="loc_bxsl_Company10b51PlanMember_b7c7c298-ba5f-4046-9e0b-0a7b3aabf568" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0ed9a1e6-528f-4dc5-b863-fd35ba60de1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_55498abe-594e-4041-a385-c4202d272952" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0ed9a1e6-528f-4dc5-b863-fd35ba60de1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare_775e1b72-773a-43b8-823a-9165ce5b2169" xlink:href="bxsl-20231231.xsd#bxsl_StockRepurchasedDuringPeriodAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_55498abe-594e-4041-a385-c4202d272952" xlink:to="loc_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare_775e1b72-773a-43b8-823a-9165ce5b2169" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9e36b165-ac81-414e-a2f9-2506aa5b0abf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_55498abe-594e-4041-a385-c4202d272952" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9e36b165-ac81-414e-a2f9-2506aa5b0abf" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsShareholderTransferRestrictionsDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_f2293a4b-0753-4859-a043-dad8aed734ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_d331d527-d5e1-449b-805f-1668d6c53f26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_f2293a4b-0753-4859-a043-dad8aed734ef" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_d331d527-d5e1-449b-805f-1668d6c53f26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransferRestrictionsAxis_dcde6026-ab2f-41a5-8bb8-81278d76785f" xlink:href="bxsl-20231231.xsd#bxsl_TransferRestrictionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_d331d527-d5e1-449b-805f-1668d6c53f26" xlink:to="loc_bxsl_TransferRestrictionsAxis_dcde6026-ab2f-41a5-8bb8-81278d76785f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransferRestrictionsDomain_dcde6026-ab2f-41a5-8bb8-81278d76785f_default" xlink:href="bxsl-20231231.xsd#bxsl_TransferRestrictionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bxsl_TransferRestrictionsAxis_dcde6026-ab2f-41a5-8bb8-81278d76785f" xlink:to="loc_bxsl_TransferRestrictionsDomain_dcde6026-ab2f-41a5-8bb8-81278d76785f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransferRestrictionsDomain_f0c9c1ee-d8a4-4ae3-83fa-410f14959728" xlink:href="bxsl-20231231.xsd#bxsl_TransferRestrictionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bxsl_TransferRestrictionsAxis_dcde6026-ab2f-41a5-8bb8-81278d76785f" xlink:to="loc_bxsl_TransferRestrictionsDomain_f0c9c1ee-d8a4-4ae3-83fa-410f14959728" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember_171be826-1cd8-4cfa-9fa3-e579ca862ffc" xlink:href="bxsl-20231231.xsd#bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bxsl_TransferRestrictionsDomain_f0c9c1ee-d8a4-4ae3-83fa-410f14959728" xlink:to="loc_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember_171be826-1cd8-4cfa-9fa3-e579ca862ffc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction_a51c1536-4c03-4a5e-a0ca-a84c5c651e18" xlink:href="bxsl-20231231.xsd#bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_f2293a4b-0753-4859-a043-dad8aed734ef" xlink:to="loc_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction_a51c1536-4c03-4a5e-a0ca-a84c5c651e18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_df77e67d-0c0f-481d-b349-e3f3b777d081" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_f2293a4b-0753-4859-a043-dad8aed734ef" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_df77e67d-0c0f-481d-b349-e3f3b777d081" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#IncomeTaxesScheduleofPermanentDifferencesDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems_91ed1d4c-b55b-4438-8199-ca46b83c173b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyChangesInNetAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyChangesInNetAssetsTable_4ecb0bf0-b62c-4876-9a4c-5646a8f76675" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyChangesInNetAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems_91ed1d4c-b55b-4438-8199-ca46b83c173b" xlink:to="loc_us-gaap_InvestmentCompanyChangesInNetAssetsTable_4ecb0bf0-b62c-4876-9a4c-5646a8f76675" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4a686bbb-9054-43e4-933e-b42a2424f251" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InvestmentCompanyChangesInNetAssetsTable_4ecb0bf0-b62c-4876-9a4c-5646a8f76675" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4a686bbb-9054-43e4-933e-b42a2424f251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4a686bbb-9054-43e4-933e-b42a2424f251_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4a686bbb-9054-43e4-933e-b42a2424f251" xlink:to="loc_us-gaap_EquityComponentDomain_4a686bbb-9054-43e4-933e-b42a2424f251_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3671f8e2-affc-444c-a2ce-b68d0ba0138d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4a686bbb-9054-43e4-933e-b42a2424f251" xlink:to="loc_us-gaap_EquityComponentDomain_3671f8e2-affc-444c-a2ce-b68d0ba0138d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9a7ceeeb-d0bb-434c-9af5-05ca4b7ce15d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3671f8e2-affc-444c-a2ce-b68d0ba0138d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9a7ceeeb-d0bb-434c-9af5-05ca4b7ce15d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cfbc85d9-e0f7-4435-8332-6bc3e8c42588" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3671f8e2-affc-444c-a2ce-b68d0ba0138d" xlink:to="loc_us-gaap_RetainedEarningsMember_cfbc85d9-e0f7-4435-8332-6bc3e8c42588" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ee195553-3eca-42bb-bf62-c524c7559895" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3671f8e2-affc-444c-a2ce-b68d0ba0138d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ee195553-3eca-42bb-bf62-c524c7559895" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease_4de30ddf-ba13-4617-8b6e-32164c7c2f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems_91ed1d4c-b55b-4438-8199-ca46b83c173b" xlink:to="loc_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease_4de30ddf-ba13-4617-8b6e-32164c7c2f8a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_fee81da8-4c19-45ee-8b6a-6faf29554f91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxNoteTable_b0247b5d-7186-44b8-a087-86a4f251312b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxNoteTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_fee81da8-4c19-45ee-8b6a-6faf29554f91" xlink:to="loc_us-gaap_FederalIncomeTaxNoteTable_b0247b5d-7186-44b8-a087-86a4f251312b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_3f488c9a-2e53-411a-88db-48e00f1eca0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_b0247b5d-7186-44b8-a087-86a4f251312b" xlink:to="loc_us-gaap_DividendsAxis_3f488c9a-2e53-411a-88db-48e00f1eca0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_3f488c9a-2e53-411a-88db-48e00f1eca0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DividendsAxis_3f488c9a-2e53-411a-88db-48e00f1eca0a" xlink:to="loc_us-gaap_DividendsDomain_3f488c9a-2e53-411a-88db-48e00f1eca0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_afa51df0-0e69-4ebd-8ba8-9a8cdbd3c73d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DividendsAxis_3f488c9a-2e53-411a-88db-48e00f1eca0a" xlink:to="loc_us-gaap_DividendsDomain_afa51df0-0e69-4ebd-8ba8-9a8cdbd3c73d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DividendsOrdinaryIncomeMember_e8fd2423-e7af-4d4e-a6ca-4f9098494d26" xlink:href="bxsl-20231231.xsd#bxsl_DividendsOrdinaryIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_afa51df0-0e69-4ebd-8ba8-9a8cdbd3c73d" xlink:to="loc_bxsl_DividendsOrdinaryIncomeMember_e8fd2423-e7af-4d4e-a6ca-4f9098494d26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DividendsCapitalGainsMember_70f8ed4f-0f2e-439a-aace-e1c954863dc7" xlink:href="bxsl-20231231.xsd#bxsl_DividendsCapitalGainsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_afa51df0-0e69-4ebd-8ba8-9a8cdbd3c73d" xlink:to="loc_bxsl_DividendsCapitalGainsMember_70f8ed4f-0f2e-439a-aace-e1c954863dc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_51890d6b-8901-4e2d-9699-45c65945f52e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_fee81da8-4c19-45ee-8b6a-6faf29554f91" xlink:to="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_51890d6b-8901-4e2d-9699-45c65945f52e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome_fce0cd74-c8e4-4710-81fe-d8a55af9b3c6" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_fee81da8-4c19-45ee-8b6a-6faf29554f91" xlink:to="loc_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome_fce0cd74-c8e4-4710-81fe-d8a55af9b3c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_38b9f175-258d-4b30-a521-988ca4ed863f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_fee81da8-4c19-45ee-8b6a-6faf29554f91" xlink:to="loc_us-gaap_DividendsCommonStock_38b9f175-258d-4b30-a521-988ca4ed863f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FinancialHighlightsandSeniorSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_cbc087b4-12f1-4597-b4d7-e92f441d9357" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_4072f5e1-2f6b-4a19-b82a-2ef06a0fce88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_cbc087b4-12f1-4597-b4d7-e92f441d9357" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_4072f5e1-2f6b-4a19-b82a-2ef06a0fce88" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_79fca4be-9676-4d03-ad53-6c39a2ed19ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4072f5e1-2f6b-4a19-b82a-2ef06a0fce88" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_79fca4be-9676-4d03-ad53-6c39a2ed19ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_79fca4be-9676-4d03-ad53-6c39a2ed19ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_79fca4be-9676-4d03-ad53-6c39a2ed19ec" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_79fca4be-9676-4d03-ad53-6c39a2ed19ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d3579f1e-5b5a-4e29-9874-2cf3417cd35b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_79fca4be-9676-4d03-ad53-6c39a2ed19ec" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d3579f1e-5b5a-4e29-9874-2cf3417cd35b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_6e1576ec-2261-4107-9ad3-38e60d36e48b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d3579f1e-5b5a-4e29-9874-2cf3417cd35b" xlink:to="loc_us-gaap_IPOMember_6e1576ec-2261-4107-9ad3-38e60d36e48b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_b6227fd7-2209-414a-b2b7-c9a5e39a89a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_cbc087b4-12f1-4597-b4d7-e92f441d9357" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_b6227fd7-2209-414a-b2b7-c9a5e39a89a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements_9a2537e1-4d9e-4741-b13e-66efb0ceff77" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_cbc087b4-12f1-4597-b4d7-e92f441d9357" xlink:to="loc_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements_9a2537e1-4d9e-4741-b13e-66efb0ceff77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements_c27e92b5-8d64-43cc-a069-de2b02d3c3e2" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_cbc087b4-12f1-4597-b4d7-e92f441d9357" xlink:to="loc_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements_c27e92b5-8d64-43cc-a069-de2b02d3c3e2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.bxsl.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_304a0ac1-2911-4ddd-8a88-def11aad550d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_57358bff-cfca-4658-9b94-c36def93ca9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_304a0ac1-2911-4ddd-8a88-def11aad550d" xlink:to="loc_us-gaap_SubsequentEventTable_57358bff-cfca-4658-9b94-c36def93ca9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bdde6fb0-1a85-4d7f-b066-e88cff9cddd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_57358bff-cfca-4658-9b94-c36def93ca9b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bdde6fb0-1a85-4d7f-b066-e88cff9cddd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bdde6fb0-1a85-4d7f-b066-e88cff9cddd2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bdde6fb0-1a85-4d7f-b066-e88cff9cddd2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bdde6fb0-1a85-4d7f-b066-e88cff9cddd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e6a0835f-b9dc-4813-8cd9-ab2da1dac240" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bdde6fb0-1a85-4d7f-b066-e88cff9cddd2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e6a0835f-b9dc-4813-8cd9-ab2da1dac240" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_51f167ec-8cfc-4793-a16f-6c5c669a7e66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e6a0835f-b9dc-4813-8cd9-ab2da1dac240" xlink:to="loc_us-gaap_SubsequentEventMember_51f167ec-8cfc-4793-a16f-6c5c669a7e66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_44d1b2d9-4b7e-44e3-b7d9-14d7fc06a8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_304a0ac1-2911-4ddd-8a88-def11aad550d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_44d1b2d9-4b7e-44e3-b7d9-14d7fc06a8cf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#SecurityOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2023NotesMember_284736e2-dea7-49dc-834b-9924a4d91486" xlink:href="bxsl-20231231.xsd#bxsl_A2023NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2023NotesMember_284736e2-dea7-49dc-834b-9924a4d91486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2026NotesMember_342580ea-7806-4038-8f73-b0ed3008fc70" xlink:href="bxsl-20231231.xsd#bxsl_A2026NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2026NotesMember_342580ea-7806-4038-8f73-b0ed3008fc70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_New2026NotesMember_7d5eab47-2c6d-407b-8889-a44d86c54755" xlink:href="bxsl-20231231.xsd#bxsl_New2026NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_New2026NotesMember_7d5eab47-2c6d-407b-8889-a44d86c54755" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2027NotesMember_92c4c6e2-7771-40d7-bb46-c5951084cf67" xlink:href="bxsl-20231231.xsd#bxsl_A2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2027NotesMember_92c4c6e2-7771-40d7-bb46-c5951084cf67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2028NotesMember_4ddf96a5-bb61-44b4-a8b0-b3b98588f141" xlink:href="bxsl-20231231.xsd#bxsl_A2028NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2028NotesMember_4ddf96a5-bb61-44b4-a8b0-b3b98588f141" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember_9a9e6016-6ebe-42c0-8502-a2d13fa3f45b" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember_9a9e6016-6ebe-42c0-8502-a2d13fa3f45b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember_a82d3ec6-0c59-443f-8d4a-7eb7f243a782" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityDollarAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember_a82d3ec6-0c59-443f-8d4a-7eb7f243a782" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityMember_673f6938-f33f-4351-a68d-e8c65bd73cdf" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_JacksonHoleFundingFacilityMember_673f6938-f33f-4351-a68d-e8c65bd73cdf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BreckenridgeFundingFacilityMember_5ae52b71-cb9e-455e-93e6-ce1c2bddaa81" xlink:href="bxsl-20231231.xsd#bxsl_BreckenridgeFundingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_BreckenridgeFundingFacilityMember_5ae52b71-cb9e-455e-93e6-ce1c2bddaa81" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BigSkyFundingFacilityMember_94495c4b-244d-4cb2-941e-3f78bacc8d24" xlink:href="bxsl-20231231.xsd#bxsl_BigSkyFundingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_BigSkyFundingFacilityMember_94495c4b-244d-4cb2-941e-3f78bacc8d24" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityMember_c9c1ed35-3230-4b0a-9f1c-b679fe333aa1" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityMember_c9c1ed35-3230-4b0a-9f1c-b679fe333aa1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member_554cb158-298f-457b-8dec-b1ce6d2a47d5" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member_554cb158-298f-457b-8dec-b1ce6d2a47d5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member_f6b427f1-f7a9-4155-9da4-ae92937f19e9" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member_f6b427f1-f7a9-4155-9da4-ae92937f19e9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3650NotesDue2023Member_a0e9c444-02ca-4e78-81bf-53f87b2c260c" xlink:href="bxsl-20231231.xsd#bxsl_A3650NotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A3650NotesDue2023Member_a0e9c444-02ca-4e78-81bf-53f87b2c260c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3625NotesDue2026Member_f3e58558-bd5a-4ab6-99f5-8d6d78ed9b41" xlink:href="bxsl-20231231.xsd#bxsl_A3625NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A3625NotesDue2026Member_f3e58558-bd5a-4ab6-99f5-8d6d78ed9b41" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2750NotesDue2026Member_dd1602ae-4f70-4aac-99ab-310ac9e4126a" xlink:href="bxsl-20231231.xsd#bxsl_A2750NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2750NotesDue2026Member_dd1602ae-4f70-4aac-99ab-310ac9e4126a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2125SeniorNotesDue2027Member_050bd4c2-eb19-48bd-8818-b4dfb26b370b" xlink:href="bxsl-20231231.xsd#bxsl_A2125SeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2125SeniorNotesDue2027Member_050bd4c2-eb19-48bd-8818-b4dfb26b370b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2850NotesDue2028Member_792e2fc5-43a2-4cb5-9890-49698d4cc29c" xlink:href="bxsl-20231231.xsd#bxsl_A2850NotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2850NotesDue2028Member_792e2fc5-43a2-4cb5-9890-49698d4cc29c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SubscriptionFacilityMember_6ef64a5d-e442-4a23-ae01-05cfd428df1e" xlink:href="bxsl-20231231.xsd#bxsl_SubscriptionFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_SubscriptionFacilityMember_6ef64a5d-e442-4a23-ae01-05cfd428df1e" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="20"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#RiskOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cef_AllRisksMember" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember_a1198c28-81a4-4814-a679-2042cd2e3c8e" xlink:href="bxsl-20231231.xsd#bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember_a1198c28-81a4-4814-a679-2042cd2e3c8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AbilityToAchieveInvestmentObjectivesMember_7284ab2e-f63a-4888-b7db-f36ebfd43723" xlink:href="bxsl-20231231.xsd#bxsl_AbilityToAchieveInvestmentObjectivesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AbilityToAchieveInvestmentObjectivesMember_7284ab2e-f63a-4888-b7db-f36ebfd43723" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember_be81516a-a1b1-441a-a188-cc617faf1c31" xlink:href="bxsl-20231231.xsd#bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember_be81516a-a1b1-441a-a188-cc617faf1c31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember_9b26473f-60d4-45a1-aea0-cbdc128b2f56" xlink:href="bxsl-20231231.xsd#bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember_9b26473f-60d4-45a1-aea0-cbdc128b2f56" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember_664ac9ae-32c4-4d4b-af2d-dd5b6c9c06e9" xlink:href="bxsl-20231231.xsd#bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember_664ac9ae-32c4-4d4b-af2d-dd5b6c9c06e9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember_e5fc2d07-fa74-4603-9b9a-51e7f8524105" xlink:href="bxsl-20231231.xsd#bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember_e5fc2d07-fa74-4603-9b9a-51e7f8524105" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember_249b7686-2ea6-4c85-b095-37e29130e585" xlink:href="bxsl-20231231.xsd#bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember_249b7686-2ea6-4c85-b095-37e29130e585" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember_69311e27-7434-4afc-9bed-70d50f1cffe4" xlink:href="bxsl-20231231.xsd#bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember_69311e27-7434-4afc-9bed-70d50f1cffe4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember_11dcfe2d-aa02-4eb0-a595-eaea10b18b3d" xlink:href="bxsl-20231231.xsd#bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember_11dcfe2d-aa02-4eb0-a595-eaea10b18b3d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember_5f4e934c-e827-4bcd-adfa-58f518e845a7" xlink:href="bxsl-20231231.xsd#bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember_5f4e934c-e827-4bcd-adfa-58f518e845a7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember_52aa6302-1c85-4769-b8c6-64b2cf4a42c2" xlink:href="bxsl-20231231.xsd#bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember_52aa6302-1c85-4769-b8c6-64b2cf4a42c2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember_b5a30c2b-802c-49dd-88ed-b66246ccfa46" xlink:href="bxsl-20231231.xsd#bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember_b5a30c2b-802c-49dd-88ed-b66246ccfa46" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember_99ad6499-b3de-4b6c-91cb-fe3a94d8a3b8" xlink:href="bxsl-20231231.xsd#bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember_99ad6499-b3de-4b6c-91cb-fe3a94d8a3b8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember_df5f397a-ab05-4727-8ec6-651a90ef4bfc" xlink:href="bxsl-20231231.xsd#bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember_df5f397a-ab05-4727-8ec6-651a90ef4bfc" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember_07653b16-7f8c-4872-8690-e60b14a51ff9" xlink:href="bxsl-20231231.xsd#bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember_07653b16-7f8c-4872-8690-e60b14a51ff9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember_63b515a3-9a97-4233-a9f0-d1ebcffb0c44" xlink:href="bxsl-20231231.xsd#bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember_63b515a3-9a97-4233-a9f0-d1ebcffb0c44" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember_e7656c7b-71e0-4cdb-a00f-1a25b989d4e9" xlink:href="bxsl-20231231.xsd#bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember_e7656c7b-71e0-4cdb-a00f-1a25b989d4e9" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember_f4bfbe77-6871-40b3-a55c-a9e4f446b6da" xlink:href="bxsl-20231231.xsd#bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember_f4bfbe77-6871-40b3-a55c-a9e4f446b6da" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember_881aa60e-ff77-4641-ab82-b23624d8ce36" xlink:href="bxsl-20231231.xsd#bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember_881aa60e-ff77-4641-ab82-b23624d8ce36" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember_8a8272df-1560-4873-a3f9-c32343a5e66c" xlink:href="bxsl-20231231.xsd#bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember_8a8272df-1560-4873-a3f9-c32343a5e66c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember_83bbff84-75ee-4988-9fe1-229b51abbaa5" xlink:href="bxsl-20231231.xsd#bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember_83bbff84-75ee-4988-9fe1-229b51abbaa5" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember_9a196b29-914c-40cb-8185-1d4315d290c5" xlink:href="bxsl-20231231.xsd#bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember_9a196b29-914c-40cb-8185-1d4315d290c5" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember_3f8d6205-1435-465a-8f61-715d30d472ac" xlink:href="bxsl-20231231.xsd#bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember_3f8d6205-1435-465a-8f61-715d30d472ac" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember_b3cb98da-420b-4837-9658-e9937ffd0d8e" xlink:href="bxsl-20231231.xsd#bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember_b3cb98da-420b-4837-9658-e9937ffd0d8e" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember_4d259329-9458-44d2-b6d9-26d0583db508" xlink:href="bxsl-20231231.xsd#bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember_4d259329-9458-44d2-b6d9-26d0583db508" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember_7f62d10f-ef3c-4771-8d81-613c296c79d6" xlink:href="bxsl-20231231.xsd#bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember_7f62d10f-ef3c-4771-8d81-613c296c79d6" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember_6d1799b7-e2f4-47dd-a573-fe41227026c1" xlink:href="bxsl-20231231.xsd#bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember_6d1799b7-e2f4-47dd-a573-fe41227026c1" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember_8ce50c66-dc94-4709-ba72-4a058f15b3e9" xlink:href="bxsl-20231231.xsd#bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember_8ce50c66-dc94-4709-ba72-4a058f15b3e9" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember_3c3e07e1-b03a-48fb-a158-e37541858000" xlink:href="bxsl-20231231.xsd#bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember_3c3e07e1-b03a-48fb-a158-e37541858000" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember_d4b574ac-c2c3-466e-94c7-0d3f2cd98465" xlink:href="bxsl-20231231.xsd#bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember_d4b574ac-c2c3-466e-94c7-0d3f2cd98465" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember_99f06dd2-3dd0-4fd1-8eb1-e049a3468165" xlink:href="bxsl-20231231.xsd#bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember_99f06dd2-3dd0-4fd1-8eb1-e049a3468165" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember_4bdec8a0-d7d4-465f-ac64-e3d98e080433" xlink:href="bxsl-20231231.xsd#bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember_4bdec8a0-d7d4-465f-ac64-e3d98e080433" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember_49923da7-6f91-4c0c-bbcb-43aa00e01d6b" xlink:href="bxsl-20231231.xsd#bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember_49923da7-6f91-4c0c-bbcb-43aa00e01d6b" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember_5ebbc2e5-4a8e-420e-86b8-18d47b6df083" xlink:href="bxsl-20231231.xsd#bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember_5ebbc2e5-4a8e-420e-86b8-18d47b6df083" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember_7e294ddf-3d00-406e-91e1-d6ac797f52f3" xlink:href="bxsl-20231231.xsd#bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember_7e294ddf-3d00-406e-91e1-d6ac797f52f3" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember_3ab64e8c-f3ee-4af1-b2bd-a55aa0a9161d" xlink:href="bxsl-20231231.xsd#bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember_3ab64e8c-f3ee-4af1-b2bd-a55aa0a9161d" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember_12aaba3a-0bb8-4649-9a33-96cb0628cb3a" xlink:href="bxsl-20231231.xsd#bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember_12aaba3a-0bb8-4649-9a33-96cb0628cb3a" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember_54c439fa-e7f9-4ea9-89db-ebff709f7b34" xlink:href="bxsl-20231231.xsd#bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember_54c439fa-e7f9-4ea9-89db-ebff709f7b34" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember_e18f2246-b66b-492b-8e37-c943bad8fb22" xlink:href="bxsl-20231231.xsd#bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember_e18f2246-b66b-492b-8e37-c943bad8fb22" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember_bccca0d0-d2f7-4189-97b9-f3d1b1d74e87" xlink:href="bxsl-20231231.xsd#bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember_bccca0d0-d2f7-4189-97b9-f3d1b1d74e87" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember_8001a112-e2b8-4bc9-88a5-e5082d66bc22" xlink:href="bxsl-20231231.xsd#bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember_8001a112-e2b8-4bc9-88a5-e5082d66bc22" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember_8e93e153-f272-4c36-98af-0e28f30aed68" xlink:href="bxsl-20231231.xsd#bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember_8e93e153-f272-4c36-98af-0e28f30aed68" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember_60b7fd2e-bd5f-4cbb-b515-dee42d03f653" xlink:href="bxsl-20231231.xsd#bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember_60b7fd2e-bd5f-4cbb-b515-dee42d03f653" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember_f24472a0-3e6d-425f-9dec-470e1085ac9a" xlink:href="bxsl-20231231.xsd#bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember_f24472a0-3e6d-425f-9dec-470e1085ac9a" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember_80d92bb5-f3be-4262-951e-008e2f395538" xlink:href="bxsl-20231231.xsd#bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember_80d92bb5-f3be-4262-951e-008e2f395538" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember_4adafd46-a353-4a7d-bc97-5b9a700f1bab" xlink:href="bxsl-20231231.xsd#bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember_4adafd46-a353-4a7d-bc97-5b9a700f1bab" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember_c968f3c5-ca06-4dc7-891c-bdf77302d6bd" xlink:href="bxsl-20231231.xsd#bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember_c968f3c5-ca06-4dc7-891c-bdf77302d6bd" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember_596f8dd7-36a1-4640-8539-d14430aa6598" xlink:href="bxsl-20231231.xsd#bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember_596f8dd7-36a1-4640-8539-d14430aa6598" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember_b7d88ec0-b878-41d4-bb6b-f1d8269f6f1c" xlink:href="bxsl-20231231.xsd#bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember_b7d88ec0-b878-41d4-bb6b-f1d8269f6f1c" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember_91647460-a2f6-48f9-aac1-7d1be9f7909e" xlink:href="bxsl-20231231.xsd#bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember_91647460-a2f6-48f9-aac1-7d1be9f7909e" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember_253188fd-873f-4682-930f-847329b52898" xlink:href="bxsl-20231231.xsd#bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember_253188fd-873f-4682-930f-847329b52898" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember_beb8c286-a75f-4d7b-8546-61aa3604b23b" xlink:href="bxsl-20231231.xsd#bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember_beb8c286-a75f-4d7b-8546-61aa3604b23b" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember_82c37b9c-dd0d-4520-b047-b1496978c6a4" xlink:href="bxsl-20231231.xsd#bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember_82c37b9c-dd0d-4520-b047-b1496978c6a4" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember_a2269d2b-4d53-4d1b-bfd5-2dbe59f452a2" xlink:href="bxsl-20231231.xsd#bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember_a2269d2b-4d53-4d1b-bfd5-2dbe59f452a2" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember_f2d8dc7a-c181-4216-8771-ecafe782c8bc" xlink:href="bxsl-20231231.xsd#bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember_f2d8dc7a-c181-4216-8771-ecafe782c8bc" xlink:type="arc" order="56"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember_9e5a724d-4301-4b1b-89ba-16dec4b2cd03" xlink:href="bxsl-20231231.xsd#bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember_9e5a724d-4301-4b1b-89ba-16dec4b2cd03" xlink:type="arc" order="57"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember_831a5ae3-14ab-4650-8419-67442a9c55c6" xlink:href="bxsl-20231231.xsd#bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember_831a5ae3-14ab-4650-8419-67442a9c55c6" xlink:type="arc" order="58"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember_fa84c9d7-50cd-4bb2-9007-4ec2013497a4" xlink:href="bxsl-20231231.xsd#bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember_fa84c9d7-50cd-4bb2-9007-4ec2013497a4" xlink:type="arc" order="59"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember_a3206949-265c-462c-9cc0-130915fd3c05" xlink:href="bxsl-20231231.xsd#bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember_a3206949-265c-462c-9cc0-130915fd3c05" xlink:type="arc" order="60"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember_20ed5bcf-eccd-4496-8ae6-234e31e6efb1" xlink:href="bxsl-20231231.xsd#bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember_20ed5bcf-eccd-4496-8ae6-234e31e6efb1" xlink:type="arc" order="61"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember_6da60d84-48ad-4031-b275-2a3f6da9bdde" xlink:href="bxsl-20231231.xsd#bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember_6da60d84-48ad-4031-b275-2a3f6da9bdde" xlink:type="arc" order="62"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember_4572c037-6569-4f50-a123-c725c20c2f98" xlink:href="bxsl-20231231.xsd#bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember_4572c037-6569-4f50-a123-c725c20c2f98" xlink:type="arc" order="63"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember_1693bdac-a9e4-4361-a44d-af2bac94702d" xlink:href="bxsl-20231231.xsd#bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember_1693bdac-a9e4-4361-a44d-af2bac94702d" xlink:type="arc" order="64"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember_0f98482c-e283-4afb-991d-3e126826087f" xlink:href="bxsl-20231231.xsd#bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember_0f98482c-e283-4afb-991d-3e126826087f" xlink:type="arc" order="65"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayInvestThroughVariousJointVenturesMember_64ade5bd-4f2a-451f-afec-72b09e6dc000" xlink:href="bxsl-20231231.xsd#bxsl_WeMayInvestThroughVariousJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayInvestThroughVariousJointVenturesMember_64ade5bd-4f2a-451f-afec-72b09e6dc000" xlink:type="arc" order="66"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember_0e492c2a-a99c-4e85-8526-f146f36b05e0" xlink:href="bxsl-20231231.xsd#bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember_0e492c2a-a99c-4e85-8526-f146f36b05e0" xlink:type="arc" order="67"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember_fe99a3ca-932e-4f46-8b54-d2a6f9c682e4" xlink:href="bxsl-20231231.xsd#bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember_fe99a3ca-932e-4f46-8b54-d2a6f9c682e4" xlink:type="arc" order="68"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember_d0387326-ccd3-4cf8-9744-a4c308356867" xlink:href="bxsl-20231231.xsd#bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember_d0387326-ccd3-4cf8-9744-a4c308356867" xlink:type="arc" order="69"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember_567c2476-580f-4acb-808d-891d703b55cb" xlink:href="bxsl-20231231.xsd#bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember_567c2476-580f-4acb-808d-891d703b55cb" xlink:type="arc" order="70"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember_4d776fd1-b87f-4751-84fc-b2f51d392768" xlink:href="bxsl-20231231.xsd#bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember_4d776fd1-b87f-4751-84fc-b2f51d392768" xlink:type="arc" order="71"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember_cd5bb1b6-43e2-4c36-9b5c-172198180bad" xlink:href="bxsl-20231231.xsd#bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember_cd5bb1b6-43e2-4c36-9b5c-172198180bad" xlink:type="arc" order="72"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember_9549da07-bf08-4f71-954e-350adf4d2aaa" xlink:href="bxsl-20231231.xsd#bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember_9549da07-bf08-4f71-954e-350adf4d2aaa" xlink:type="arc" order="73"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember_c88fb7ad-11a9-4675-bede-dc79f0d411d3" xlink:href="bxsl-20231231.xsd#bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember_c88fb7ad-11a9-4675-bede-dc79f0d411d3" xlink:type="arc" order="74"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember_ea73fd9c-1a63-4048-bac9-b1498516e071" xlink:href="bxsl-20231231.xsd#bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember_ea73fd9c-1a63-4048-bac9-b1498516e071" xlink:type="arc" order="75"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember_f63ca2ee-44b6-4273-80c7-d2ae300d3d6f" xlink:href="bxsl-20231231.xsd#bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember_f63ca2ee-44b6-4273-80c7-d2ae300d3d6f" xlink:type="arc" order="76"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember_43758406-0f0e-4bb2-8c95-d1eed6a23582" xlink:href="bxsl-20231231.xsd#bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember_43758406-0f0e-4bb2-8c95-d1eed6a23582" xlink:type="arc" order="77"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember_30549ae2-0b7a-4930-a1b6-b1bdc10ab76e" xlink:href="bxsl-20231231.xsd#bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember_30549ae2-0b7a-4930-a1b6-b1bdc10ab76e" xlink:type="arc" order="78"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember_a111e4ab-b302-4f4a-87f5-3525bfe2dffe" xlink:href="bxsl-20231231.xsd#bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember_a111e4ab-b302-4f4a-87f5-3525bfe2dffe" xlink:type="arc" order="79"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember_b2382538-a051-4e31-b55a-c58d6db52305" xlink:href="bxsl-20231231.xsd#bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember_b2382538-a051-4e31-b55a-c58d6db52305" xlink:type="arc" order="80"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember_dad8be72-194d-42d5-a76f-273c50ed422e" xlink:href="bxsl-20231231.xsd#bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember_dad8be72-194d-42d5-a76f-273c50ed422e" xlink:type="arc" order="81"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember_900bb35e-633c-406d-9881-b95c887a53b3" xlink:href="bxsl-20231231.xsd#bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember_900bb35e-633c-406d-9881-b95c887a53b3" xlink:type="arc" order="82"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember_2af8cef9-2da3-4c93-8589-f78d8ed08ced" xlink:href="bxsl-20231231.xsd#bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember_2af8cef9-2da3-4c93-8589-f78d8ed08ced" xlink:type="arc" order="83"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember_27abb0ed-2695-45dc-ac3d-35f4ceafb00d" xlink:href="bxsl-20231231.xsd#bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember_27abb0ed-2695-45dc-ac3d-35f4ceafb00d" xlink:type="arc" order="84"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember_3c9ef5a6-ef86-4c0b-b148-25f87b828f51" xlink:href="bxsl-20231231.xsd#bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember_3c9ef5a6-ef86-4c0b-b148-25f87b828f51" xlink:type="arc" order="85"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember_1bc9e89a-e78e-449b-83af-a6e47c9614a8" xlink:href="bxsl-20231231.xsd#bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember_1bc9e89a-e78e-449b-83af-a6e47c9614a8" xlink:type="arc" order="86"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember_15b7431f-a541-4926-82b5-f837a107f3e5" xlink:href="bxsl-20231231.xsd#bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember_15b7431f-a541-4926-82b5-f837a107f3e5" xlink:type="arc" order="87"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember_a7398e5e-a3b6-47f1-908f-27a454a196aa" xlink:href="bxsl-20231231.xsd#bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember_a7398e5e-a3b6-47f1-908f-27a454a196aa" xlink:type="arc" order="88"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayDefaultUnderOurCreditFacilitiesMember_dc976ba8-e57a-4d13-9d3c-11f663c8b63b" xlink:href="bxsl-20231231.xsd#bxsl_WeMayDefaultUnderOurCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayDefaultUnderOurCreditFacilitiesMember_dc976ba8-e57a-4d13-9d3c-11f663c8b63b" xlink:type="arc" order="89"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember_718b09a7-5b61-409f-8b5b-a1b9d2837591" xlink:href="bxsl-20231231.xsd#bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember_718b09a7-5b61-409f-8b5b-a1b9d2837591" xlink:type="arc" order="90"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember_e2be876d-5c8e-4b6a-813e-ef3ad18017aa" xlink:href="bxsl-20231231.xsd#bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember_e2be876d-5c8e-4b6a-813e-ef3ad18017aa" xlink:type="arc" order="91"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember_1a01cce4-3f41-4680-8a56-dfbc73817071" xlink:href="bxsl-20231231.xsd#bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember_1a01cce4-3f41-4680-8a56-dfbc73817071" xlink:type="arc" order="92"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember_aa55ee91-adb0-4800-b786-32c97e372ac2" xlink:href="bxsl-20231231.xsd#bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember_aa55ee91-adb0-4800-b786-32c97e372ac2" xlink:type="arc" order="93"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember_c1bea3e7-be53-424f-bd04-b56b20b00f64" xlink:href="bxsl-20231231.xsd#bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember_c1bea3e7-be53-424f-bd04-b56b20b00f64" xlink:type="arc" order="94"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember_279105cb-ae38-45aa-bedc-11050857abcb" xlink:href="bxsl-20231231.xsd#bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember_279105cb-ae38-45aa-bedc-11050857abcb" xlink:type="arc" order="95"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember_be5a82de-4d58-4b6a-b59b-5156658a2282" xlink:href="bxsl-20231231.xsd#bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember_be5a82de-4d58-4b6a-b59b-5156658a2282" xlink:type="arc" order="96"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember_e3e4ea53-775e-4f59-8681-6f55a7f9d9f7" xlink:href="bxsl-20231231.xsd#bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember_e3e4ea53-775e-4f59-8681-6f55a7f9d9f7" xlink:type="arc" order="97"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember_06815fa5-d65c-489f-b1b0-e968995cc08b" xlink:href="bxsl-20231231.xsd#bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember_06815fa5-d65c-489f-b1b0-e968995cc08b" xlink:type="arc" order="98"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember_d767fe76-aaaf-41ec-a0cc-cb8a29131d91" xlink:href="bxsl-20231231.xsd#bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember_d767fe76-aaaf-41ec-a0cc-cb8a29131d91" xlink:type="arc" order="99"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember_0b565352-7dbf-4adb-9585-6bc4b7a9f678" xlink:href="bxsl-20231231.xsd#bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember_0b565352-7dbf-4adb-9585-6bc4b7a9f678" xlink:type="arc" order="100"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember_3fbdea6c-bc55-4df3-b350-cfe5997f73b5" xlink:href="bxsl-20231231.xsd#bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember_3fbdea6c-bc55-4df3-b350-cfe5997f73b5" xlink:type="arc" order="101"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember_a757ff60-c6c0-452c-b4bc-6870772af794" xlink:href="bxsl-20231231.xsd#bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember_a757ff60-c6c0-452c-b4bc-6870772af794" xlink:type="arc" order="102"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember_de80818b-50ca-4c4c-b6c3-7931691e05fa" xlink:href="bxsl-20231231.xsd#bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember_de80818b-50ca-4c4c-b6c3-7931691e05fa" xlink:type="arc" order="103"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember_70b4b4b7-0557-46ef-b948-2eba5ad5fbd7" xlink:href="bxsl-20231231.xsd#bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember_70b4b4b7-0557-46ef-b948-2eba5ad5fbd7" xlink:type="arc" order="104"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember_6c392d95-cafa-4b8a-9360-e033443171ec" xlink:href="bxsl-20231231.xsd#bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember_6c392d95-cafa-4b8a-9360-e033443171ec" xlink:type="arc" order="105"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember_64af7e73-eb4d-4af2-96e6-4f60cc5687a0" xlink:href="bxsl-20231231.xsd#bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember_64af7e73-eb4d-4af2-96e6-4f60cc5687a0" xlink:type="arc" order="106"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember_fb350529-4441-4caf-b6ba-a3415193d152" xlink:href="bxsl-20231231.xsd#bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember_fb350529-4441-4caf-b6ba-a3415193d152" xlink:type="arc" order="107"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember_758681bb-cd63-437a-9d7d-528caaf287a8" xlink:href="bxsl-20231231.xsd#bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember_758681bb-cd63-437a-9d7d-528caaf287a8" xlink:type="arc" order="108"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember_2ae65154-99f6-4ab5-9c9b-617096f598d4" xlink:href="bxsl-20231231.xsd#bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember_2ae65154-99f6-4ab5-9c9b-617096f598d4" xlink:type="arc" order="109"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember_d15b03cc-447a-4e07-b9cf-0a45172a0515" xlink:href="bxsl-20231231.xsd#bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember_d15b03cc-447a-4e07-b9cf-0a45172a0515" xlink:type="arc" order="110"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember_3e41120d-0876-45dc-a278-6058b94afdaf" xlink:href="bxsl-20231231.xsd#bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember_3e41120d-0876-45dc-a278-6058b94afdaf" xlink:type="arc" order="111"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember_39c5fd57-55aa-4247-ab50-afe9bd1178cb" xlink:href="bxsl-20231231.xsd#bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember_39c5fd57-55aa-4247-ab50-afe9bd1178cb" xlink:type="arc" order="112"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember_6e682a98-a965-4a90-b2bb-f9d65f80e255" xlink:href="bxsl-20231231.xsd#bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember_6e682a98-a965-4a90-b2bb-f9d65f80e255" xlink:type="arc" order="113"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember_d921ecb4-4190-4b51-8ef9-f24a1dc38244" xlink:href="bxsl-20231231.xsd#bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember_d921ecb4-4190-4b51-8ef9-f24a1dc38244" xlink:type="arc" order="114"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>bxsl-20231231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:c9da10f3-9ca1-46ab-8b82-2faa6d8e78e0,g:d2995a14-2db1-4369-b86a-a80f43cbbba9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction_b2384822-4aa4-46f5-affc-73bef6b86cbb_terseLabel_en-US" xlink:label="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of shares restriction</link:label>
    <link:label id="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction_label_en-US" xlink:label="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering, Shareholder Transfer Restrictions, Percentage Of Share Transfer Restriction</link:label>
    <link:label id="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction_documentation_en-US" xlink:label="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering, Shareholder Transfer Restrictions, Percentage Of Share Transfer Restriction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction" xlink:href="bxsl-20231231.xsd#bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction" xlink:to="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_b741226d-62e8-4548-bcf8-726f3bf2094f_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_4a565d27-8b03-4f2a-ae9e-92f9bde55489_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_c54c06c7-bfee-4a0b-9a63-1a142475d7d7_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_5ff983fb-e517-4fdd-84dd-70fa4a1a5968_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TransferRestrictionsAxis_c295b0dd-3f3c-4cf0-9344-16049f4ff84f_terseLabel_en-US" xlink:label="lab_bxsl_TransferRestrictionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Restrictions [Axis]</link:label>
    <link:label id="lab_bxsl_TransferRestrictionsAxis_label_en-US" xlink:label="lab_bxsl_TransferRestrictionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Restrictions [Axis]</link:label>
    <link:label id="lab_bxsl_TransferRestrictionsAxis_documentation_en-US" xlink:label="lab_bxsl_TransferRestrictionsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Restrictions, Scenario</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransferRestrictionsAxis" xlink:href="bxsl-20231231.xsd#bxsl_TransferRestrictionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TransferRestrictionsAxis" xlink:to="lab_bxsl_TransferRestrictionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember_label_en-US" xlink:label="lab_bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may have difficulty paying distributions and the tax character of any distributions is uncertain. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember_documentation_en-US" xlink:label="lab_bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may have difficulty paying distributions and the tax character of any distributions is uncertain.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember" xlink:to="lab_bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_234c1573-db27-4152-ae7e-bb44819b9b3e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d386a067-c630-4ca2-8c94-160236129b60_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Principal Committed</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_071103e2-03a8-4809-9a46-b9ed8a61a9e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare_ad085e57-0bcd-42e0-8a72-3671b4705233_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in net assets from capital share transactions (in usd per share)</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Tax Return of Capital Distribution, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare" xlink:to="lab_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_1113a545-b123-435a-a212-675e269f33ac_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_cdeb93ee-b549-43da-aedb-3251cfbef531_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise tax expense</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Operating, Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit" xlink:to="lab_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_f452911a-049b-4c5b-a2e7-c8225151050e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from principal repayments and sales of investments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentsAtFairValueMember_9e9bccb8-41c0-47f2-8e1b-22d1ce3202fe_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentsAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments At Fair Value</link:label>
    <link:label id="lab_bxsl_InvestmentsAtFairValueMember_label_en-US" xlink:label="lab_bxsl_InvestmentsAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments At Fair Value [Member]</link:label>
    <link:label id="lab_bxsl_InvestmentsAtFairValueMember_documentation_en-US" xlink:label="lab_bxsl_InvestmentsAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments At Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentsAtFairValueMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentsAtFairValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentsAtFairValueMember" xlink:to="lab_bxsl_InvestmentsAtFairValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_6e115644-5ec0-455f-9924-a723b4c50b34_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxNoteTextBlock_60005da4-c6c2-461e-bfd2-0d12b7bc89aa_terseLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Note</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Note [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTextBlock" xlink:to="lab_us-gaap_FederalIncomeTaxNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxNoteTable_8f0af8e6-a770-4602-9332-d4df29882eb3_terseLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxNoteTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Note [Table]</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxNoteTable_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxNoteTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Note [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxNoteTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxNoteTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable" xlink:to="lab_us-gaap_FederalIncomeTaxNoteTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_2f56db07-f069-4aac-affa-7c00dd16a9b4_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayDefaultUnderOurCreditFacilitiesMember_label_en-US" xlink:label="lab_bxsl_WeMayDefaultUnderOurCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may default under our credit facilities. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayDefaultUnderOurCreditFacilitiesMember_documentation_en-US" xlink:label="lab_bxsl_WeMayDefaultUnderOurCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may default under our credit facilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayDefaultUnderOurCreditFacilitiesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayDefaultUnderOurCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayDefaultUnderOurCreditFacilitiesMember" xlink:to="lab_bxsl_WeMayDefaultUnderOurCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayInvestThroughVariousJointVenturesMember_label_en-US" xlink:label="lab_bxsl_WeMayInvestThroughVariousJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may invest through various joint ventures. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayInvestThroughVariousJointVenturesMember_documentation_en-US" xlink:label="lab_bxsl_WeMayInvestThroughVariousJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may invest through various joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayInvestThroughVariousJointVenturesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayInvestThroughVariousJointVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayInvestThroughVariousJointVenturesMember" xlink:to="lab_bxsl_WeMayInvestThroughVariousJointVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ValuationYieldAnalysisApproachMember_b69e0509-01a5-4de2-a261-7d7575736fae_terseLabel_en-US" xlink:label="lab_bxsl_ValuationYieldAnalysisApproachMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield Analysis</link:label>
    <link:label id="lab_bxsl_ValuationYieldAnalysisApproachMember_label_en-US" xlink:label="lab_bxsl_ValuationYieldAnalysisApproachMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation, Yield Analysis Approach [Member]</link:label>
    <link:label id="lab_bxsl_ValuationYieldAnalysisApproachMember_documentation_en-US" xlink:label="lab_bxsl_ValuationYieldAnalysisApproachMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation, Yield Analysis Approach</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ValuationYieldAnalysisApproachMember" xlink:href="bxsl-20231231.xsd#bxsl_ValuationYieldAnalysisApproachMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ValuationYieldAnalysisApproachMember" xlink:to="lab_bxsl_ValuationYieldAnalysisApproachMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss_7653895d-c441-40ee-8036-63e31b58c1eb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributable ordinary income</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Distributable Earnings (Loss), Accumulated Ordinary Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss" xlink:to="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1f939a98-5fde-4d0f-bf73-5a2f186a0138_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember_8f2b925d-d801-4212-80cc-b40ba4af7dd3_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Management Agreement - Incentive Rate, Annualized Hurdle Rate Member</link:label>
    <link:label id="lab_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember_label_en-US" xlink:label="lab_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Management Agreement - Incentive Rate, Annualized Hurdle Rate Member [Member]</link:label>
    <link:label id="lab_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember_documentation_en-US" xlink:label="lab_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Management Agreement - Incentive Rate, Annualized Hurdle Rate Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember" xlink:to="lab_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember_label_en-US" xlink:label="lab_bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember_documentation_en-US" xlink:label="lab_bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember" xlink:to="lab_bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember_label_en-US" xlink:label="lab_bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The incentive fee based on income takes into account our past performance. [Member]</link:label>
    <link:label id="lab_bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember_documentation_en-US" xlink:label="lab_bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The incentive fee based on income takes into account our past performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember" xlink:href="bxsl-20231231.xsd#bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember" xlink:to="lab_bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_beb9d6f6-eeeb-41d0-9d71-1df5ad1995a1_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_d282fa61-ab71-4398-906b-68c01e87b75b_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio_38a01606-c334-41b5-9fed-81b4a53ec1ad_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of net investment income to average net assets</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Investment Income (Loss) Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio" xlink:to="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_3d573552-eadb-40f0-987f-c67d4317e59b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 7)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_2b664b5e-2431-4924-8d52-ab1576995015_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_CapitalGainsIncentiveFeeExpense_469f794e-5f70-4fa2-b223-f13610745da0_terseLabel_en-US" xlink:label="lab_bxsl_CapitalGainsIncentiveFeeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital gains incentive fees (Note 3)</link:label>
    <link:label id="lab_bxsl_CapitalGainsIncentiveFeeExpense_label_en-US" xlink:label="lab_bxsl_CapitalGainsIncentiveFeeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Gains Incentive Fee Expense</link:label>
    <link:label id="lab_bxsl_CapitalGainsIncentiveFeeExpense_documentation_en-US" xlink:label="lab_bxsl_CapitalGainsIncentiveFeeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Gains Incentive Fee Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CapitalGainsIncentiveFeeExpense" xlink:href="bxsl-20231231.xsd#bxsl_CapitalGainsIncentiveFeeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_CapitalGainsIncentiveFeeExpense" xlink:to="lab_bxsl_CapitalGainsIncentiveFeeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_MachineryMember_5d50dba9-6781-4020-9615-4e7d17d89f80_terseLabel_en-US" xlink:label="lab_bxsl_MachineryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery</link:label>
    <link:label id="lab_bxsl_MachineryMember_label_en-US" xlink:label="lab_bxsl_MachineryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery [Member]</link:label>
    <link:label id="lab_bxsl_MachineryMember_documentation_en-US" xlink:label="lab_bxsl_MachineryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MachineryMember" xlink:href="bxsl-20231231.xsd#bxsl_MachineryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_MachineryMember" xlink:to="lab_bxsl_MachineryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember_label_en-US" xlink:label="lab_bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face conflicts of interest caused by compensation arrangements with us and our affiliates, which could result in actions that are not in the best interests of our shareholders. [Member]</link:label>
    <link:label id="lab_bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember_documentation_en-US" xlink:label="lab_bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face conflicts of interest caused by compensation arrangements with us and our affiliates, which could result in actions that are not in the best interests of our shareholders.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember" xlink:href="bxsl-20231231.xsd#bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember" xlink:to="lab_bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_CitiBankRevolvingCreditFacilityMember_7bd9d3cd-b9d5-420d-b218-99f75c5cbf90_terseLabel_en-US" xlink:label="lab_bxsl_CitiBankRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_bxsl_CitiBankRevolvingCreditFacilityMember_label_en-US" xlink:label="lab_bxsl_CitiBankRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CitiBank, Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_bxsl_CitiBankRevolvingCreditFacilityMember_documentation_en-US" xlink:label="lab_bxsl_CitiBankRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CitiBank, Revolving Credit Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityMember" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_CitiBankRevolvingCreditFacilityMember" xlink:to="lab_bxsl_CitiBankRevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c90b7c94-ce05-41f4-94e9-d32c852d014d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Assets</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_41ca045b-b743-4b17-b5c2-4d177f1c32ca_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common shares, net of offering and underwriting costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_e3cb7b00-443d-49d8-869a-ac07062879ee_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Proceeds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember_label_en-US" xlink:label="lab_bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">If we issue preferred shares or convertible debt securities, the net asset value of our common shares may become more volatile. [Member]</link:label>
    <link:label id="lab_bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember_documentation_en-US" xlink:label="lab_bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">If we issue preferred shares or convertible debt securities, the net asset value of our common shares may become more volatile.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember" xlink:href="bxsl-20231231.xsd#bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember" xlink:to="lab_bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_4533d3c7-a886-4001-86a6-e0a6305f33b4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_8950cfc4-ce52-4719-9a26-fd5bb0863007_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_RelatedPartyTransactionTerminationNoticePeriod_ee627a8d-9079-4a30-809d-eaa13506fb21_terseLabel_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionTerminationNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination notice period</link:label>
    <link:label id="lab_bxsl_RelatedPartyTransactionTerminationNoticePeriod_label_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionTerminationNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Termination Notice Period</link:label>
    <link:label id="lab_bxsl_RelatedPartyTransactionTerminationNoticePeriod_documentation_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionTerminationNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Termination Notice Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionTerminationNoticePeriod" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionTerminationNoticePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_RelatedPartyTransactionTerminationNoticePeriod" xlink:to="lab_bxsl_RelatedPartyTransactionTerminationNoticePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AuditInformationAbstract_label_en-US" xlink:label="lab_bxsl_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_bxsl_AuditInformationAbstract_documentation_en-US" xlink:label="lab_bxsl_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AuditInformationAbstract" xlink:href="bxsl-20231231.xsd#bxsl_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AuditInformationAbstract" xlink:to="lab_bxsl_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_5bcd3fc5-50ac-4744-b2ee-1238fa197d29_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesIndustryMember_62eb2154-730d-496c-bcad-2576812c3b2b_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesIndustryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industry Sector [Domain]</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesIndustryMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesIndustryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industry Sector [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember" xlink:to="lab_us-gaap_EquitySecuritiesIndustryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_MediaSectorMember_67a36188-480a-44d9-9651-d38a344e8c69_terseLabel_en-US" xlink:label="lab_bxsl_MediaSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Media</link:label>
    <link:label id="lab_bxsl_MediaSectorMember_label_en-US" xlink:label="lab_bxsl_MediaSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Media Sector [Member]</link:label>
    <link:label id="lab_bxsl_MediaSectorMember_documentation_en-US" xlink:label="lab_bxsl_MediaSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Media Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MediaSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_MediaSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_MediaSectorMember" xlink:to="lab_bxsl_MediaSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_MarineMember_73cce70b-b3da-4907-b5d7-7f83491b4ee9_terseLabel_en-US" xlink:label="lab_bxsl_MarineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marine</link:label>
    <link:label id="lab_bxsl_MarineMember_label_en-US" xlink:label="lab_bxsl_MarineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marine [Member]</link:label>
    <link:label id="lab_bxsl_MarineMember_documentation_en-US" xlink:label="lab_bxsl_MarineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MarineMember" xlink:href="bxsl-20231231.xsd#bxsl_MarineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_MarineMember" xlink:to="lab_bxsl_MarineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyVoluntaryFeeWaived_ff45f546-d1b8-4b98-a274-e65dbc6e614e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyVoluntaryFeeWaived" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive fees waived (Note 3)</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyVoluntaryFeeWaived_c5ed4b05-13ea-4267-a105-857ea736b58c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyVoluntaryFeeWaived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive fees waived</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyVoluntaryFeeWaived_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyVoluntaryFeeWaived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Voluntary Fee Waived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyVoluntaryFeeWaived" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyVoluntaryFeeWaived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyVoluntaryFeeWaived" xlink:to="lab_us-gaap_InvestmentCompanyVoluntaryFeeWaived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentUnaffiliatedIssuerMember_40220f0a-5786-4eec-b2b5-995c3a980aee_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentUnaffiliatedIssuerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlled/non-affiliated investments</link:label>
    <link:label id="lab_us-gaap_InvestmentUnaffiliatedIssuerMember_label_en-US" xlink:label="lab_us-gaap_InvestmentUnaffiliatedIssuerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Unaffiliated Issuer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentUnaffiliatedIssuerMember" xlink:to="lab_us-gaap_InvestmentUnaffiliatedIssuerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeeExpense_1408669e-74d3-4dc2-b5b7-fd862e45834e_terseLabel_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income based incentive fees (Note 3)</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeeExpense_5727d093-17b5-46cd-b3fa-ae4e6398fa4f_verboseLabel_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income based incentive fee expense</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeeExpense_label_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fee Expense</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeeExpense_documentation_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fee Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeeExpense" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncomeBasedIncentiveFeeExpense" xlink:to="lab_bxsl_IncomeBasedIncentiveFeeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare_b589786c-13f7-4ff9-a1e0-7dfeaba31897_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in net assets resulting from operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Investment Income (Loss) from Operations, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare" xlink:to="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_daa8a2cd-36b0-4d36-941c-d906682232bb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AirFreightLogisticsSectorMember_c851579d-f1e8-41dd-b62f-6797d5b9cf5e_terseLabel_en-US" xlink:label="lab_bxsl_AirFreightLogisticsSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Air Freight &amp; Logistics</link:label>
    <link:label id="lab_bxsl_AirFreightLogisticsSectorMember_label_en-US" xlink:label="lab_bxsl_AirFreightLogisticsSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Air Freight &amp; Logistics Sector [Member]</link:label>
    <link:label id="lab_bxsl_AirFreightLogisticsSectorMember_documentation_en-US" xlink:label="lab_bxsl_AirFreightLogisticsSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Air Freight &amp; Logistics Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AirFreightLogisticsSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_AirFreightLogisticsSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AirFreightLogisticsSectorMember" xlink:to="lab_bxsl_AirFreightLogisticsSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_abf93a0a-26fb-464e-8c3c-76f7e944657f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments, included in net unrealized appreciation (depreciation) on the Consolidated Statements of Operations</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_A2028NotesMember_8e446437-d0d5-475b-b378-8bc4a63e50ec_terseLabel_en-US" xlink:label="lab_bxsl_A2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Notes</link:label>
    <link:label id="lab_bxsl_A2028NotesMember_label_en-US" xlink:label="lab_bxsl_A2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Notes [Member]</link:label>
    <link:label id="lab_bxsl_A2028NotesMember_documentation_en-US" xlink:label="lab_bxsl_A2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2028NotesMember" xlink:href="bxsl-20231231.xsd#bxsl_A2028NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_A2028NotesMember" xlink:to="lab_bxsl_A2028NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_SaleOfStockRemainingAuthorizedAmount_0d5057a3-861c-44de-9d16-d4deb72021f0_terseLabel_en-US" xlink:label="lab_bxsl_SaleOfStockRemainingAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining available for issuance</link:label>
    <link:label id="lab_bxsl_SaleOfStockRemainingAuthorizedAmount_label_en-US" xlink:label="lab_bxsl_SaleOfStockRemainingAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Remaining Authorized Amount</link:label>
    <link:label id="lab_bxsl_SaleOfStockRemainingAuthorizedAmount_documentation_en-US" xlink:label="lab_bxsl_SaleOfStockRemainingAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Remaining Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SaleOfStockRemainingAuthorizedAmount" xlink:href="bxsl-20231231.xsd#bxsl_SaleOfStockRemainingAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_SaleOfStockRemainingAuthorizedAmount" xlink:to="lab_bxsl_SaleOfStockRemainingAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_b95d1309-11c9-4b94-b696-594efbba4417_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AdministrationAgreementMember_f9c4ed8c-d0b9-4ef1-a5a3-ecd99dcafe07_terseLabel_en-US" xlink:label="lab_bxsl_AdministrationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administration Agreement</link:label>
    <link:label id="lab_bxsl_AdministrationAgreementMember_label_en-US" xlink:label="lab_bxsl_AdministrationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administration Agreement [Member]</link:label>
    <link:label id="lab_bxsl_AdministrationAgreementMember_documentation_en-US" xlink:label="lab_bxsl_AdministrationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administration Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AdministrationAgreementMember" xlink:href="bxsl-20231231.xsd#bxsl_AdministrationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AdministrationAgreementMember" xlink:to="lab_bxsl_AdministrationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember_label_en-US" xlink:label="lab_bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We generally do not control our portfolio companies. [Member]</link:label>
    <link:label id="lab_bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember_documentation_en-US" xlink:label="lab_bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We generally do not control our portfolio companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember" xlink:to="lab_bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2d4e2ac2-262e-4b9d-af67-8291f4652129_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss), diluted, per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_32fd71b4-4550-4a5b-a348-62a1576a445c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_9c6faacc-ffee-4938-99cd-c14a709833d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DistributionPayable_57ac1215-6d8c-4360-ac2b-f7f2bc8d8483_terseLabel_en-US" xlink:label="lab_us-gaap_DistributionPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution payable (Note 8)</link:label>
    <link:label id="lab_us-gaap_DistributionPayable_label_en-US" xlink:label="lab_us-gaap_DistributionPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DistributionPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DistributionPayable" xlink:to="lab_us-gaap_DistributionPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TechnologyHardwareStorageAndPeripheralsMember_bf424bb4-00d5-4bbd-9f91-9cfcb5a5b91d_terseLabel_en-US" xlink:label="lab_bxsl_TechnologyHardwareStorageAndPeripheralsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology Hardware, Storage &amp; Peripherals</link:label>
    <link:label id="lab_bxsl_TechnologyHardwareStorageAndPeripheralsMember_label_en-US" xlink:label="lab_bxsl_TechnologyHardwareStorageAndPeripheralsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology Hardware, Storage and Peripherals [Member]</link:label>
    <link:label id="lab_bxsl_TechnologyHardwareStorageAndPeripheralsMember_documentation_en-US" xlink:label="lab_bxsl_TechnologyHardwareStorageAndPeripheralsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology Hardware, Storage and Peripherals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TechnologyHardwareStorageAndPeripheralsMember" xlink:href="bxsl-20231231.xsd#bxsl_TechnologyHardwareStorageAndPeripheralsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TechnologyHardwareStorageAndPeripheralsMember" xlink:to="lab_bxsl_TechnologyHardwareStorageAndPeripheralsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember_label_en-US" xlink:label="lab_bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in laws or regulations governing our operations may adversely affect our business or cause us to alter our business strategy. [Member]</link:label>
    <link:label id="lab_bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember_documentation_en-US" xlink:label="lab_bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in laws or regulations governing our operations may adversely affect our business or cause us to alter our business strategy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember" xlink:href="bxsl-20231231.xsd#bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember" xlink:to="lab_bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_47561236-561f-4f5c-aaa4-e3f67901903b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember_label_en-US" xlink:label="lab_bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">As a Delaware statutory trust, we are subject to the control share acquisition statute contained in the Delaware Statutory Trust Act. [Member]</link:label>
    <link:label id="lab_bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember_documentation_en-US" xlink:label="lab_bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">As a Delaware statutory trust, we are subject to the control share acquisition statute contained in the Delaware Statutory Trust Act.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember" xlink:href="bxsl-20231231.xsd#bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember" xlink:to="lab_bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_b1450c93-5db3-4c6b-8de3-5019c46d62f5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyCommittedCapital_598a407f-aa7d-4bff-a614-520ce31a88fd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyCommittedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital commitments</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyCommittedCapital_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyCommittedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Committed Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyCommittedCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyCommittedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyCommittedCapital" xlink:to="lab_us-gaap_InvestmentCompanyCommittedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock_236fc360-b273-479e-8272-b3592e8eefac_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Net Assets</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock_label_en-US" xlink:label="lab_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Change In Net Assets [Table Text Block]</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock_documentation_en-US" xlink:label="lab_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Change In Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock" xlink:to="lab_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember_label_en-US" xlink:label="lab_bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may not realize gains from our equity investments. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember_documentation_en-US" xlink:label="lab_bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may not realize gains from our equity investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember" xlink:to="lab_bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn_8bde9908-9b4d-4c81-a25e-89cb45792c32_terseLabel_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre incentive fee cap percentage</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn_label_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Cap, Percentage Of Cumulative Net Return</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn_documentation_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Cap, Percentage Of Cumulative Net Return</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn" xlink:to="lab_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_03b4f7c2-ee5d-4456-8075-7825010c3e81_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdministrativeFeesExpense_9a0d7255-1a00-4f9f-a9ad-7a9f970df089_terseLabel_en-US" xlink:label="lab_us-gaap_AdministrativeFeesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administrative service expenses (Note 3)</link:label>
    <link:label id="lab_us-gaap_AdministrativeFeesExpense_1e4c3bd6-8c86-4fd9-bf6f-0564506de7f7_verboseLabel_en-US" xlink:label="lab_us-gaap_AdministrativeFeesExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administrative service expenses</link:label>
    <link:label id="lab_us-gaap_AdministrativeFeesExpense_label_en-US" xlink:label="lab_us-gaap_AdministrativeFeesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administrative Fees Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdministrativeFeesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdministrativeFeesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdministrativeFeesExpense" xlink:to="lab_us-gaap_AdministrativeFeesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketApproachValuationTechniqueMember_f1c0acc9-1596-4f26-bbb2-9a5cd122dff7_terseLabel_en-US" xlink:label="lab_us-gaap_MarketApproachValuationTechniqueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Approach</link:label>
    <link:label id="lab_us-gaap_MarketApproachValuationTechniqueMember_label_en-US" xlink:label="lab_us-gaap_MarketApproachValuationTechniqueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation, Market Approach [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketApproachValuationTechniqueMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketApproachValuationTechniqueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketApproachValuationTechniqueMember" xlink:to="lab_us-gaap_MarketApproachValuationTechniqueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_1dde55a6-178d-4cb1-b6ad-e6bcffc67aa0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_7c77c637-35df-401b-837c-4045e5523c91_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_1cd8ba25-e868-401a-95a4-be811ed736d9_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in net assets resulting from operations</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_0bc6525b-7497-4f2c-b045-4cfc3a03b495_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in net assets resulting from operations</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember_label_en-US" xlink:label="lab_bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We and our investment adviser could be the target of litigation or regulatory investigations. [Member]</link:label>
    <link:label id="lab_bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember_documentation_en-US" xlink:label="lab_bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We and our investment adviser could be the target of litigation or regulatory investigations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember" xlink:to="lab_bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_af725749-39bf-4752-9720-b1fee43d84e6_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember_label_en-US" xlink:label="lab_bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may be subject to risks associated with our investments in the software industry. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember_documentation_en-US" xlink:label="lab_bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may be subject to risks associated with our investments in the software industry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember" xlink:to="lab_bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_f4ac8bcd-696b-499b-bbb2-373ff285e70d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIssuerAffiliationDomain_441317a1-9342-4845-8f3f-fa92ff6b943d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIssuerAffiliationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Issuer Affiliation [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentIssuerAffiliationDomain_label_en-US" xlink:label="lab_us-gaap_InvestmentIssuerAffiliationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Issuer Affiliation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain" xlink:to="lab_us-gaap_InvestmentIssuerAffiliationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_CapitalGainsBasedIncentiveFeesRate_962740f1-b924-49eb-b65e-c542e1ffe0af_terseLabel_en-US" xlink:label="lab_bxsl_CapitalGainsBasedIncentiveFeesRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital gains based incentive rate</link:label>
    <link:label id="lab_bxsl_CapitalGainsBasedIncentiveFeesRate_label_en-US" xlink:label="lab_bxsl_CapitalGainsBasedIncentiveFeesRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Gains Based Incentive Fees, Rate</link:label>
    <link:label id="lab_bxsl_CapitalGainsBasedIncentiveFeesRate_documentation_en-US" xlink:label="lab_bxsl_CapitalGainsBasedIncentiveFeesRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Gains Based Incentive Fees, Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CapitalGainsBasedIncentiveFeesRate" xlink:href="bxsl-20231231.xsd#bxsl_CapitalGainsBasedIncentiveFeesRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_CapitalGainsBasedIncentiveFeesRate" xlink:to="lab_bxsl_CapitalGainsBasedIncentiveFeesRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_bcd97e4a-1b1d-4a7c-839d-3ef14b421d2b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_cd3e41eb-2903-45ef-893f-c5a07165ebc1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET ASSETS</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_8cbf631b-e8a4-45f6-a47e-cbcc42659768_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_201f746e-43f8-4d3e-91bb-51738b624103_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax reclassification of shareholders' equity in accordance with GAAP</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember_label_en-US" xlink:label="lab_bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may enter into repurchase agreements or reverse repurchase agreements. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember_documentation_en-US" xlink:label="lab_bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may enter into repurchase agreements or reverse repurchase agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember" xlink:to="lab_bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b99f385c-a352-4049-9e0f-2d6b7057fe6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember_label_en-US" xlink:label="lab_bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing in large private U.S. borrowers may limit the Company&#8217;s ability to achieve high growth rates during times of economic expansion. [Member]</link:label>
    <link:label id="lab_bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember_documentation_en-US" xlink:label="lab_bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing in large private U.S. borrowers may limit the Company&#8217;s ability to achieve high growth rates during times of economic expansion.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember" xlink:to="lab_bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetAssetValuePerShare_d4291b1b-a953-4d42-83cd-e56bd4a224ac_terseLabel_en-US" xlink:label="lab_us-gaap_NetAssetValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET ASSET VALUE PER SHARE (in usd per share)</link:label>
    <link:label id="lab_us-gaap_NetAssetValuePerShare_cb9bcb54-72e7-4889-987f-e3930e12cd34_periodStartLabel_en-US" xlink:label="lab_us-gaap_NetAssetValuePerShare" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net asset value, beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_NetAssetValuePerShare_2e36105f-30f3-456a-92b2-02880a40c9e4_periodEndLabel_en-US" xlink:label="lab_us-gaap_NetAssetValuePerShare" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net asset value, ending of period (in usd per share)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAssetValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetAssetValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetAssetValuePerShare" xlink:to="lab_us-gaap_NetAssetValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4a29580e-3ae9-44d8-b970-b62e43d54afd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in Fair Value of Investments Measured Using Level 3 Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_88f65b71-8d67-4848-a350-e588e44b2442_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_09047478-978f-4431-a864-d211454eb3dc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlled/non-affiliated investments</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_e83f441c-76b6-420a-96d5-4d673ce48f42_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized (gain) loss on investments</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDomain_e26b302f-b5b1-4bfc-ae55-2558b20be800_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Domain]</link:label>
    <link:label id="lab_us-gaap_DividendsDomain_label_en-US" xlink:label="lab_us-gaap_DividendsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDomain" xlink:to="lab_us-gaap_DividendsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember_label_en-US" xlink:label="lab_bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may enter into securities lending agreements. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember_documentation_en-US" xlink:label="lab_bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may enter into securities lending agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember" xlink:to="lab_bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_dd82c7c6-2d3c-4291-bc35-c3a606d24d15_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0f10746c-b98c-4508-a7b6-c0ed77475242_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements_13383948-7bdd-456d-8c64-b04be0fe445b_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of expenses to average net assets, before waivers</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements_label_en-US" xlink:label="lab_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Expense Ratio Before Fee Waiver And Reimbursements</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements_documentation_en-US" xlink:label="lab_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Expense Ratio Before Fee Waiver And Reimbursements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" xlink:to="lab_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_d9f33214-ad88-4cc5-904d-321a50adf783_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeSecurities_503b5b50-3cb0-4007-bb2f-0a22e70abb44_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend and Interest Income</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeSecurities_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividend Income, Securities, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndDividendIncomeSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendIncomeSecurities" xlink:to="lab_us-gaap_InterestAndDividendIncomeSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_ba8b471a-72c1-4a92-b47f-2e9e2e6f7655_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperatingPaidInKind_6342e5a4-aa79-45bd-a708-f307ad78b979_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperatingPaidInKind" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment-in-kind interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperatingPaidInKind_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperatingPaidInKind" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Operating, Paid in Kind</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingPaidInKind" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOperatingPaidInKind"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperatingPaidInKind" xlink:to="lab_us-gaap_InterestIncomeOperatingPaidInKind" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5e4ec694-b715-43c4-ad82-d4ef1f844f1c_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_RelatedPartyTransactionExpensePaymentPeriod_ea50e9eb-3c38-4713-8dfa-4e0c1cb57df7_terseLabel_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionExpensePaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense payment period</link:label>
    <link:label id="lab_bxsl_RelatedPartyTransactionExpensePaymentPeriod_label_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionExpensePaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expense Payment Period</link:label>
    <link:label id="lab_bxsl_RelatedPartyTransactionExpensePaymentPeriod_documentation_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionExpensePaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expense Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionExpensePaymentPeriod" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionExpensePaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_RelatedPartyTransactionExpensePaymentPeriod" xlink:to="lab_bxsl_RelatedPartyTransactionExpensePaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember_3508991f-8bc0-4e14-8c16-a655cf90255b_terseLabel_en-US" xlink:label="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering, Shareholder Transfer Restrictions</link:label>
    <link:label id="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember_label_en-US" xlink:label="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering, Shareholder Transfer Restrictions [Member]</link:label>
    <link:label id="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember_documentation_en-US" xlink:label="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering, Shareholder Transfer Restrictions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember" xlink:href="bxsl-20231231.xsd#bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember" xlink:to="lab_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_CommitmentFeeScenarioDomain_74d218f3-a777-4f99-b39b-8d6ad7645631_terseLabel_en-US" xlink:label="lab_bxsl_CommitmentFeeScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment Fee Scenario [Domain]</link:label>
    <link:label id="lab_bxsl_CommitmentFeeScenarioDomain_label_en-US" xlink:label="lab_bxsl_CommitmentFeeScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment Fee Scenario [Domain]</link:label>
    <link:label id="lab_bxsl_CommitmentFeeScenarioDomain_documentation_en-US" xlink:label="lab_bxsl_CommitmentFeeScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment Fee Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommitmentFeeScenarioDomain" xlink:href="bxsl-20231231.xsd#bxsl_CommitmentFeeScenarioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_CommitmentFeeScenarioDomain" xlink:to="lab_bxsl_CommitmentFeeScenarioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_a3e77a30-cea1-4b2a-9ddb-1ec2997e4dca_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Dividends3Member_3b5d71ed-024c-4aea-b930-763a19417712_terseLabel_en-US" xlink:label="lab_bxsl_Dividends3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 3</link:label>
    <link:label id="lab_bxsl_Dividends3Member_label_en-US" xlink:label="lab_bxsl_Dividends3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 3 [Member]</link:label>
    <link:label id="lab_bxsl_Dividends3Member_documentation_en-US" xlink:label="lab_bxsl_Dividends3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends3Member" xlink:href="bxsl-20231231.xsd#bxsl_Dividends3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Dividends3Member" xlink:to="lab_bxsl_Dividends3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_464e6511-077f-40c8-849e-9219763c72a8_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_d80a49b9-8bca-46e8-85bc-c026d93c3360_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_c31906ad-56e3-4495-a136-cc650b329508_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedPercentOfNetAssets_ce6d202f-cb34-4159-9b69-edc8c57578d9_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">% of Net Assets</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedPercentOfNetAssets_550b7d44-b745-4c73-93e0-f235273ce14d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as % of Net Assets</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedPercentOfNetAssets_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Net Assets, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:to="lab_us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_2c3442c5-4089-4413-bc3b-a373f6594471_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_e217dfe2-4e51-4357-bdf0-b8d5b0d17bc8_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_6b989dc2-3ebd-4a59-af81-4e0dad530733_netLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per Share Amount (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_571b745e-cda4-4fd7-a359-70138a4e88d6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions declared and payable per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember_label_en-US" xlink:label="lab_bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">There is a risk that investors in our shares may not receive distributions or that our distributions may decrease over time. [Member]</link:label>
    <link:label id="lab_bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember_documentation_en-US" xlink:label="lab_bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">There is a risk that investors in our shares may not receive distributions or that our distributions may decrease over time.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember" xlink:href="bxsl-20231231.xsd#bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember" xlink:to="lab_bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember_label_en-US" xlink:label="lab_bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compliance with SEC Rule 18f-4 governing derivatives and use of leverage may limit our investment discretion. [Member]</link:label>
    <link:label id="lab_bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember_documentation_en-US" xlink:label="lab_bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compliance with SEC Rule 18f-4 governing derivatives and use of leverage may limit our investment discretion.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember" xlink:href="bxsl-20231231.xsd#bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember" xlink:to="lab_bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DistributorsSectorMember_4b04fae8-c8ba-49e9-9b76-1b39d94a13bb_terseLabel_en-US" xlink:label="lab_bxsl_DistributorsSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors</link:label>
    <link:label id="lab_bxsl_DistributorsSectorMember_label_en-US" xlink:label="lab_bxsl_DistributorsSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors Sector [Member]</link:label>
    <link:label id="lab_bxsl_DistributorsSectorMember_documentation_en-US" xlink:label="lab_bxsl_DistributorsSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DistributorsSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_DistributorsSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DistributorsSectorMember" xlink:to="lab_bxsl_DistributorsSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DebtSecuritiesVariableRateMember_4f5579fc-d143-4dda-94a4-99f030eb11b2_terseLabel_en-US" xlink:label="lab_bxsl_DebtSecuritiesVariableRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Variable Rate</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesVariableRateMember_label_en-US" xlink:label="lab_bxsl_DebtSecuritiesVariableRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Variable Rate [Member]</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesVariableRateMember_documentation_en-US" xlink:label="lab_bxsl_DebtSecuritiesVariableRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesVariableRateMember" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesVariableRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DebtSecuritiesVariableRateMember" xlink:to="lab_bxsl_DebtSecuritiesVariableRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedAtCost_b5b3d423-7a56-4234-930b-d9b34d532def_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments at cost</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedAtCost_a2ef773b-83cf-4d54-b566-a46c94eb82c0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedAtCost_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedAtCost" xlink:to="lab_us-gaap_InvestmentOwnedAtCost" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare_fe2d68ae-1763-4481-bb39-21f68cdb35b2_terseLabel_en-US" xlink:label="lab_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Price Paid per Share (in usd per share)</link:label>
    <link:label id="lab_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare_label_en-US" xlink:label="lab_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Average Cost Per Share</link:label>
    <link:label id="lab_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare_documentation_en-US" xlink:label="lab_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare" xlink:href="bxsl-20231231.xsd#bxsl_StockRepurchasedDuringPeriodAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare" xlink:to="lab_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_7d476be8-ee67-4f03-a7e0-0c1951018a11_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred offering costs paid on issuance of common shares</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_46332b9f-c9f1-48d5-b735-341370c1d37c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering expenses</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_180e9c88-b053-4634-b6aa-836adface582_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Placement Fees/Offering Expenses</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_8f56dabc-e22e-48ec-ab37-2f741d901b89_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a5f56770-66bf-4cf4-8255-4b9c5ca91bdc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember_label_en-US" xlink:label="lab_bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our portfolio investments may present special tax issues. [Member]</link:label>
    <link:label id="lab_bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember_documentation_en-US" xlink:label="lab_bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our portfolio investments may present special tax issues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember" xlink:href="bxsl-20231231.xsd#bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember" xlink:to="lab_bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee_be9be28f-9fab-43aa-a470-a61833c40a30_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility unused fees</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee" xlink:to="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_VoluntaryWaiverNotInPlaceMember_c1f52c77-05ee-4228-9b60-de0fdf46b54f_terseLabel_en-US" xlink:label="lab_bxsl_VoluntaryWaiverNotInPlaceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Waiver Not In Place</link:label>
    <link:label id="lab_bxsl_VoluntaryWaiverNotInPlaceMember_label_en-US" xlink:label="lab_bxsl_VoluntaryWaiverNotInPlaceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Waiver Not In Place [Member]</link:label>
    <link:label id="lab_bxsl_VoluntaryWaiverNotInPlaceMember_documentation_en-US" xlink:label="lab_bxsl_VoluntaryWaiverNotInPlaceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Waiver Not In Place</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverNotInPlaceMember" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverNotInPlaceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_VoluntaryWaiverNotInPlaceMember" xlink:to="lab_bxsl_VoluntaryWaiverNotInPlaceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_86d7c288-4d43-4827-b457-eede52840fe7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_e4e360fc-226b-46c0-8c16-98ced77df1d3_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized appreciation (depreciation):</link:label>
    <link:label id="lab_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_label_en-US" xlink:label="lab_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Recognized Unrealized Appreciation (Depreciation), Net [Abstract]</link:label>
    <link:label id="lab_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_documentation_en-US" xlink:label="lab_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Recognized Unrealized Appreciation (Depreciation), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract" xlink:to="lab_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_5b05f0a8-d099-4423-875a-b1c4e4f28f88_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock_5ce5966f-4c2d-494d-8685-9170219dd8d3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Highlights</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Financial Highlights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock" xlink:to="lab_us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Scenario3Member_6b6656e3-908b-4846-a0f4-b68a607abd95_terseLabel_en-US" xlink:label="lab_bxsl_Scenario3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario 3</link:label>
    <link:label id="lab_bxsl_Scenario3Member_label_en-US" xlink:label="lab_bxsl_Scenario3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario 3 [Member]</link:label>
    <link:label id="lab_bxsl_Scenario3Member_documentation_en-US" xlink:label="lab_bxsl_Scenario3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario3Member" xlink:href="bxsl-20231231.xsd#bxsl_Scenario3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Scenario3Member" xlink:to="lab_bxsl_Scenario3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_New2026NotesMember_dea092cc-ec2a-472e-87c7-0bb44544008e_terseLabel_en-US" xlink:label="lab_bxsl_New2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New 2026 Notes</link:label>
    <link:label id="lab_bxsl_New2026NotesMember_label_en-US" xlink:label="lab_bxsl_New2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New 2026 Notes [Member]</link:label>
    <link:label id="lab_bxsl_New2026NotesMember_documentation_en-US" xlink:label="lab_bxsl_New2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New 2026 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_New2026NotesMember" xlink:href="bxsl-20231231.xsd#bxsl_New2026NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_New2026NotesMember" xlink:to="lab_bxsl_New2026NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_9130a23f-79e2-49bd-afe2-2de8c8f16166_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManagementAndServiceFeesIncentiveRate_27db7975-0a06-450b-9a15-79a5a95fd277_terseLabel_en-US" xlink:label="lab_us-gaap_ManagementAndServiceFeesIncentiveRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive fees rate</link:label>
    <link:label id="lab_us-gaap_ManagementAndServiceFeesIncentiveRate_label_en-US" xlink:label="lab_us-gaap_ManagementAndServiceFeesIncentiveRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management and Service Fees, Incentive Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesIncentiveRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesIncentiveRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManagementAndServiceFeesIncentiveRate" xlink:to="lab_us-gaap_ManagementAndServiceFeesIncentiveRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity_775dcd9b-ed86-496a-a725-cd6944018221_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of investments and principal repayments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Disposition of Investment, Operating Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity" xlink:to="lab_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueOptionPricingModelMember_e656128e-6d98-4827-a381-88c301fa5b86_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Pricing Model</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueOptionPricingModelMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Option Pricing Model [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="lab_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_d7f5352c-6adc-4354-873d-1931f3e47940_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_96053a6e-a3ee-4b72-b7eb-ee95189dc4c4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f81522b6-28ab-4124-a035-4c35ed7cd736_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManagementFeeExpense_a398b112-1a41-4351-b436-d7757a4c7f29_terseLabel_en-US" xlink:label="lab_us-gaap_ManagementFeeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fees (Note 3)</link:label>
    <link:label id="lab_us-gaap_ManagementFeeExpense_602a63a3-2211-46aa-a563-17e6e2e34844_verboseLabel_en-US" xlink:label="lab_us-gaap_ManagementFeeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fees</link:label>
    <link:label id="lab_us-gaap_ManagementFeeExpense_label_en-US" xlink:label="lab_us-gaap_ManagementFeeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Fee Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManagementFeeExpense" xlink:to="lab_us-gaap_ManagementFeeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentOwnedNonaccrualNumberOfLoans_172cae81-daae-431c-b2c0-877047e49ba3_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentOwnedNonaccrualNumberOfLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of loans in non-accrual status</link:label>
    <link:label id="lab_bxsl_InvestmentOwnedNonaccrualNumberOfLoans_label_en-US" xlink:label="lab_bxsl_InvestmentOwnedNonaccrualNumberOfLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Nonaccrual, Number Of Loans</link:label>
    <link:label id="lab_bxsl_InvestmentOwnedNonaccrualNumberOfLoans_documentation_en-US" xlink:label="lab_bxsl_InvestmentOwnedNonaccrualNumberOfLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Nonaccrual, Number Of Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedNonaccrualNumberOfLoans" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedNonaccrualNumberOfLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentOwnedNonaccrualNumberOfLoans" xlink:to="lab_bxsl_InvestmentOwnedNonaccrualNumberOfLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Dividends1Member_6c785716-7cc2-48b3-897c-8147d8a26d71_terseLabel_en-US" xlink:label="lab_bxsl_Dividends1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 1</link:label>
    <link:label id="lab_bxsl_Dividends1Member_label_en-US" xlink:label="lab_bxsl_Dividends1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 1 [Member]</link:label>
    <link:label id="lab_bxsl_Dividends1Member_documentation_en-US" xlink:label="lab_bxsl_Dividends1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends1Member" xlink:href="bxsl-20231231.xsd#bxsl_Dividends1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Dividends1Member" xlink:to="lab_bxsl_Dividends1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember_label_en-US" xlink:label="lab_bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terms relating to redemption may materially adversely affect our noteholders return on any debt securities that we may issue. [Member]</link:label>
    <link:label id="lab_bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember_documentation_en-US" xlink:label="lab_bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terms relating to redemption may materially adversely affect our noteholders return on any debt securities that we may issue.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember" xlink:href="bxsl-20231231.xsd#bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember" xlink:to="lab_bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember_bdfa4c0e-75eb-4e6f-9235-1a25c9509b18_terseLabel_en-US" xlink:label="lab_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Second Lien, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember_label_en-US" xlink:label="lab_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Second Lien, Unrealized Gain (Loss) [Member]</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember_documentation_en-US" xlink:label="lab_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Second Lien, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember" xlink:to="lab_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChemicalsSectorMember_56c0597e-5dca-4bc9-b1d0-d238acf3ba1d_terseLabel_en-US" xlink:label="lab_us-gaap_ChemicalsSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chemicals</link:label>
    <link:label id="lab_us-gaap_ChemicalsSectorMember_label_en-US" xlink:label="lab_us-gaap_ChemicalsSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chemicals Sector [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChemicalsSectorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChemicalsSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChemicalsSectorMember" xlink:to="lab_us-gaap_ChemicalsSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember_label_en-US" xlink:label="lab_bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our investments in CLOs may be riskier than a direct investment in the debt or other securities of the underlying companies. [Member]</link:label>
    <link:label id="lab_bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember_documentation_en-US" xlink:label="lab_bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our investments in CLOs may be riskier than a direct investment in the debt or other securities of the underlying companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember" xlink:href="bxsl-20231231.xsd#bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember" xlink:to="lab_bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_PaidInKindInterestNoncash_8e313c44-5a62-4a9d-aeb1-f0e7150c0110_negatedTerseLabel_en-US" xlink:label="lab_bxsl_PaidInKindInterestNoncash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment-in-kind interest capitalized</link:label>
    <link:label id="lab_bxsl_PaidInKindInterestNoncash_label_en-US" xlink:label="lab_bxsl_PaidInKindInterestNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid In Kind Interest, Noncash</link:label>
    <link:label id="lab_bxsl_PaidInKindInterestNoncash_documentation_en-US" xlink:label="lab_bxsl_PaidInKindInterestNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid In Kind Interest, Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaidInKindInterestNoncash" xlink:href="bxsl-20231231.xsd#bxsl_PaidInKindInterestNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_PaidInKindInterestNoncash" xlink:to="lab_bxsl_PaidInKindInterestNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences_513e2db0-a39a-493e-8976-7e605aac4735_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other temporary book/tax differences</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences_label_en-US" xlink:label="lab_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Distributable Earnings (Loss), Accumulated Other Temporary Differences</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences_documentation_en-US" xlink:label="lab_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Distributable Earnings (Loss), Accumulated Other Temporary Differences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences" xlink:to="lab_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Company10b18PlanMember_9ca114c5-a6e7-4f3a-be9a-6438e011abec_terseLabel_en-US" xlink:label="lab_bxsl_Company10b18PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company 10b-18 Plan</link:label>
    <link:label id="lab_bxsl_Company10b18PlanMember_label_en-US" xlink:label="lab_bxsl_Company10b18PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company 10b-18 Plan [Member]</link:label>
    <link:label id="lab_bxsl_Company10b18PlanMember_documentation_en-US" xlink:label="lab_bxsl_Company10b18PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company 10b-18 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Company10b18PlanMember" xlink:href="bxsl-20231231.xsd#bxsl_Company10b18PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Company10b18PlanMember" xlink:to="lab_bxsl_Company10b18PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_QualifyingAssetsMember_3de5c9b5-d5ad-4e96-ab23-5124d87aa50b_terseLabel_en-US" xlink:label="lab_bxsl_QualifyingAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualifying Assets</link:label>
    <link:label id="lab_bxsl_QualifyingAssetsMember_label_en-US" xlink:label="lab_bxsl_QualifyingAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualifying Assets [Member]</link:label>
    <link:label id="lab_bxsl_QualifyingAssetsMember_documentation_en-US" xlink:label="lab_bxsl_QualifyingAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualifying Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_QualifyingAssetsMember" xlink:href="bxsl-20231231.xsd#bxsl_QualifyingAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_QualifyingAssetsMember" xlink:to="lab_bxsl_QualifyingAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentCompanyPerShareDataAbstract_af2b1c36-adb2-4d12-b968-67e4f5a53677_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentCompanyPerShareDataAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Per Share Data [Abstract]</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyPerShareDataAbstract_label_en-US" xlink:label="lab_bxsl_InvestmentCompanyPerShareDataAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Per Share Data [Abstract]</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyPerShareDataAbstract_documentation_en-US" xlink:label="lab_bxsl_InvestmentCompanyPerShareDataAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Per Share Data</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyPerShareDataAbstract" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyPerShareDataAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentCompanyPerShareDataAbstract" xlink:to="lab_bxsl_InvestmentCompanyPerShareDataAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes_3b358314-98fb-4542-9166-614363e14b47_terseLabel_en-US" xlink:label="lab_us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax cost of investments</link:label>
    <link:label id="lab_us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes_label_en-US" xlink:label="lab_us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes" xlink:to="lab_us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DividendsOrdinaryIncomeMember_819a5e5b-055c-4d3a-baaf-7d77d741a141_terseLabel_en-US" xlink:label="lab_bxsl_DividendsOrdinaryIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Ordinary Income</link:label>
    <link:label id="lab_bxsl_DividendsOrdinaryIncomeMember_label_en-US" xlink:label="lab_bxsl_DividendsOrdinaryIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Ordinary Income [Member]</link:label>
    <link:label id="lab_bxsl_DividendsOrdinaryIncomeMember_documentation_en-US" xlink:label="lab_bxsl_DividendsOrdinaryIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Ordinary Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DividendsOrdinaryIncomeMember" xlink:href="bxsl-20231231.xsd#bxsl_DividendsOrdinaryIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DividendsOrdinaryIncomeMember" xlink:to="lab_bxsl_DividendsOrdinaryIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_440c1e63-7cdc-4ebd-84c7-1562ccfb5a3c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_7ec263f4-a06b-44ea-ae3a-462c04140728_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan_638ea03a-7537-4b0c-b02c-c3dfaccad0ce_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DRIP Shares Issued (in share)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Dividend Reinvestment Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_381277c9-7089-43e5-a5f4-b0ab1fa37621_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amount</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_a52a7ce9-8035-41d0-92e5-8f9a0e9b480a_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember_59c7cad0-ca8b-4c67-9a4c-8ff8610b9129_terseLabel_en-US" xlink:label="lab_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, First Lien, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember_label_en-US" xlink:label="lab_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, First Lien, Unrealized Gain (Loss) [Member]</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember_documentation_en-US" xlink:label="lab_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, First Lien, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember" xlink:to="lab_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8aded306-0b3d-4e40-a58c-13ce99c1dc3c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_9205bfea-8027-41ad-be3f-fbb49ef10e94_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements_f2cfd099-3546-479c-b348-35f5c87a5383_negatedTerseLabel_en-US" xlink:label="lab_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs paid</link:label>
    <link:label id="lab_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements_label_en-US" xlink:label="lab_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Of Debt Issuance Costs, Line Of Credit Arrangements</link:label>
    <link:label id="lab_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements_documentation_en-US" xlink:label="lab_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Of Debt Issuance Costs, Line Of Credit Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements" xlink:href="bxsl-20231231.xsd#bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements" xlink:to="lab_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember_label_en-US" xlink:label="lab_bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We are uncertain of our sources for funding our future capital needs; our ability to acquire investments and to expand our operations will be adversely affected. [Member]</link:label>
    <link:label id="lab_bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember_documentation_en-US" xlink:label="lab_bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We are uncertain of our sources for funding our future capital needs; our ability to acquire investments and to expand our operations will be adversely affected.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember" xlink:to="lab_bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember_label_en-US" xlink:label="lab_bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may experience fluctuations in our quarterly results. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember_documentation_en-US" xlink:label="lab_bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may experience fluctuations in our quarterly results.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember" xlink:to="lab_bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_2e73a675-e20d-4ecc-9087-098206b78cce_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared</link:label>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:to="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_30e160a0-5d66-46a7-9bec-c32d6ab96ee6_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreements and Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperatingPaidInCash_9427732b-2815-4c5b-b858-fe7cab4812b8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperatingPaidInCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperatingPaidInCash_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperatingPaidInCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Operating, Paid in Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingPaidInCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOperatingPaidInCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperatingPaidInCash" xlink:to="lab_us-gaap_InterestIncomeOperatingPaidInCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContainerAndPackagingSectorMember_391e043e-5e50-4706-98b5-df843d4b25ac_terseLabel_en-US" xlink:label="lab_us-gaap_ContainerAndPackagingSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Containers &amp; Packaging</link:label>
    <link:label id="lab_us-gaap_ContainerAndPackagingSectorMember_label_en-US" xlink:label="lab_us-gaap_ContainerAndPackagingSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Container and Packaging Sector [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContainerAndPackagingSectorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContainerAndPackagingSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContainerAndPackagingSectorMember" xlink:to="lab_us-gaap_ContainerAndPackagingSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyContractualFeeWaived_26e18e6f-782e-4188-8b4e-d3f4626dc5f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyContractualFeeWaived" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fees waived (Note 3)</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyContractualFeeWaived_f44158d1-4440-42eb-9a9c-7e9561f283c9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyContractualFeeWaived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fees waived</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyContractualFeeWaived_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyContractualFeeWaived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Contractual Fee Waived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyContractualFeeWaived" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyContractualFeeWaived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyContractualFeeWaived" xlink:to="lab_us-gaap_InvestmentCompanyContractualFeeWaived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_14912a61-b165-4d19-8eec-4805e9d6da87_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsumerSectorMember_c9596304-7751-4862-bfbf-475f8c78cd4c_terseLabel_en-US" xlink:label="lab_us-gaap_ConsumerSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified Consumer Services</link:label>
    <link:label id="lab_us-gaap_ConsumerSectorMember_label_en-US" xlink:label="lab_us-gaap_ConsumerSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Sector [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsumerSectorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsumerSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsumerSectorMember" xlink:to="lab_us-gaap_ConsumerSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_4f380059-cdb0-454b-a6a1-47cf1fe98fef_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OilGasAndConsumableFuelsMember_b824616c-5942-4aaf-9d89-d522b68d2f07_terseLabel_en-US" xlink:label="lab_bxsl_OilGasAndConsumableFuelsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oil, Gas &amp; Consumable Fuels</link:label>
    <link:label id="lab_bxsl_OilGasAndConsumableFuelsMember_label_en-US" xlink:label="lab_bxsl_OilGasAndConsumableFuelsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oil, Gas and Consumable Fuels [Member]</link:label>
    <link:label id="lab_bxsl_OilGasAndConsumableFuelsMember_documentation_en-US" xlink:label="lab_bxsl_OilGasAndConsumableFuelsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oil, Gas and Consumable Fuels</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OilGasAndConsumableFuelsMember" xlink:href="bxsl-20231231.xsd#bxsl_OilGasAndConsumableFuelsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OilGasAndConsumableFuelsMember" xlink:to="lab_bxsl_OilGasAndConsumableFuelsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember_label_en-US" xlink:label="lab_bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may syndicate co-investment opportunities, which may be costly. [Member]</link:label>
    <link:label id="lab_bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember_documentation_en-US" xlink:label="lab_bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may syndicate co-investment opportunities, which may be costly.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember" xlink:to="lab_bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_47d7d3d1-8b94-4804-b141-207fe3748eac_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Act File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions_764585e5-8879-410c-8af7-e31cb32139ff_totalLabel_en-US" xlink:label="lab_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxable/distributable income</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions_label_en-US" xlink:label="lab_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Distributable Earnings (Loss), Before Deductions</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions_documentation_en-US" xlink:label="lab_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Distributable Earnings (Loss), Before Deductions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions" xlink:to="lab_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DistributionCostsIncurredButNotYetPaid_a6b983ed-549c-4468-b216-696d03626304_terseLabel_en-US" xlink:label="lab_bxsl_DistributionCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution payable</link:label>
    <link:label id="lab_bxsl_DistributionCostsIncurredButNotYetPaid_label_en-US" xlink:label="lab_bxsl_DistributionCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Costs Incurred But Not Yet Paid</link:label>
    <link:label id="lab_bxsl_DistributionCostsIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_bxsl_DistributionCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Costs Incurred But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DistributionCostsIncurredButNotYetPaid" xlink:href="bxsl-20231231.xsd#bxsl_DistributionCostsIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DistributionCostsIncurredButNotYetPaid" xlink:to="lab_bxsl_DistributionCostsIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_1d456c70-2e82-485b-8a92-c91ade2ea7e9_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentBasisSpreadVariableRate_62c86f45-9038-4fa7-b29b-4263b8d5a2f9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentBasisSpreadVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reference Rate and Spread</link:label>
    <link:label id="lab_us-gaap_InvestmentBasisSpreadVariableRate_label_en-US" xlink:label="lab_us-gaap_InvestmentBasisSpreadVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Basis Spread, Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBasisSpreadVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBasisSpreadVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentBasisSpreadVariableRate" xlink:to="lab_us-gaap_InvestmentBasisSpreadVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_61a3e3fd-b494-43a8-a300-a930a849c170_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_13d8fef5-ae21-4648-ad82-cecf46e4e41f_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember_label_en-US" xlink:label="lab_bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An investment strategy focused primarily on privately-held companies presents certain challenges, including, but not limited to, the lack of available information about these companies. [Member]</link:label>
    <link:label id="lab_bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember_documentation_en-US" xlink:label="lab_bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An investment strategy focused primarily on privately-held companies presents certain challenges, including, but not limited to, the lack of available information about these companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember" xlink:href="bxsl-20231231.xsd#bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember" xlink:to="lab_bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate_964ff683-056f-484a-b95a-78b9a77c57fb_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of portfolio above floor rate</link:label>
    <link:label id="lab_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate_label_en-US" xlink:label="lab_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Percentage Of Portfolio Above Floor Rate</link:label>
    <link:label id="lab_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate_documentation_en-US" xlink:label="lab_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Percentage Of Portfolio Above Floor Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentPercentageOfPortfolioAboveFloorRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate" xlink:to="lab_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_UnsecuredDebtRealizedGainLossMember_b76a6fb4-78cd-49d1-83ae-e33e97229a88_terseLabel_en-US" xlink:label="lab_bxsl_UnsecuredDebtRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt, Realized Gain (Loss)</link:label>
    <link:label id="lab_bxsl_UnsecuredDebtRealizedGainLossMember_label_en-US" xlink:label="lab_bxsl_UnsecuredDebtRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt, Realized Gain (Loss) [Member]</link:label>
    <link:label id="lab_bxsl_UnsecuredDebtRealizedGainLossMember_documentation_en-US" xlink:label="lab_bxsl_UnsecuredDebtRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_UnsecuredDebtRealizedGainLossMember" xlink:href="bxsl-20231231.xsd#bxsl_UnsecuredDebtRealizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_UnsecuredDebtRealizedGainLossMember" xlink:to="lab_bxsl_UnsecuredDebtRealizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_630d79b1-187e-413a-a580-8e5406a1d9ee_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TransportationInfrastructureSectorMember_f2210bcb-17d1-42c0-980c-a0ef3bf1e69f_terseLabel_en-US" xlink:label="lab_bxsl_TransportationInfrastructureSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transportation Infrastructure</link:label>
    <link:label id="lab_bxsl_TransportationInfrastructureSectorMember_label_en-US" xlink:label="lab_bxsl_TransportationInfrastructureSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transportation Infrastructure Sector [Member]</link:label>
    <link:label id="lab_bxsl_TransportationInfrastructureSectorMember_documentation_en-US" xlink:label="lab_bxsl_TransportationInfrastructureSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transportation Infrastructure Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransportationInfrastructureSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_TransportationInfrastructureSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TransportationInfrastructureSectorMember" xlink:to="lab_bxsl_TransportationInfrastructureSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable_e0780f5a-c746-4503-90ad-283b272f2424_terseLabel_en-US" xlink:label="lab_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income based incentive fee payable</link:label>
    <link:label id="lab_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable_label_en-US" xlink:label="lab_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Income Based Incentive Fee Payable</link:label>
    <link:label id="lab_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable_documentation_en-US" xlink:label="lab_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Income Based Incentive Fee Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable" xlink:href="bxsl-20231231.xsd#bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable" xlink:to="lab_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InternetAndDirectMarketingRetailMember_a2b4e107-1a41-4cfe-94a3-b94737d835e7_terseLabel_en-US" xlink:label="lab_bxsl_InternetAndDirectMarketingRetailMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internet &amp; Direct Marketing Retail</link:label>
    <link:label id="lab_bxsl_InternetAndDirectMarketingRetailMember_label_en-US" xlink:label="lab_bxsl_InternetAndDirectMarketingRetailMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internet and Direct Marketing Retail [Member]</link:label>
    <link:label id="lab_bxsl_InternetAndDirectMarketingRetailMember_documentation_en-US" xlink:label="lab_bxsl_InternetAndDirectMarketingRetailMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internet and Direct Marketing Retail</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InternetAndDirectMarketingRetailMember" xlink:href="bxsl-20231231.xsd#bxsl_InternetAndDirectMarketingRetailMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InternetAndDirectMarketingRetailMember" xlink:to="lab_bxsl_InternetAndDirectMarketingRetailMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_45975ffb-7812-4a2d-971e-63b423f61a59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentInterestRate_3d20ee98-bfb4-4dc4-a822-93dd05c05a20_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate</link:label>
    <link:label id="lab_us-gaap_InvestmentInterestRate_label_en-US" xlink:label="lab_us-gaap_InvestmentInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentInterestRate" xlink:to="lab_us-gaap_InvestmentInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ef3bd17-d2e8-4645-9487-c1546615d9f2_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ab331d8d-1e09-4e8f-92a0-1b4092184450_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_0513d74a-c870-41e4-8a49-ce486d2ea98f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable_1f535004-a76c-4e8d-a23b-47251ccf39b0_terseLabel_en-US" xlink:label="lab_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital gains incentive fee payable</link:label>
    <link:label id="lab_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable_label_en-US" xlink:label="lab_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Capital Gains Incentive Fee Payable</link:label>
    <link:label id="lab_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable_documentation_en-US" xlink:label="lab_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Capital Gains Incentive Fee Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable" xlink:href="bxsl-20231231.xsd#bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable" xlink:to="lab_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DividendsCapitalGainsMember_81ca0d92-bd43-424c-9b1c-d637fcda516c_terseLabel_en-US" xlink:label="lab_bxsl_DividendsCapitalGainsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Capital Gains</link:label>
    <link:label id="lab_bxsl_DividendsCapitalGainsMember_label_en-US" xlink:label="lab_bxsl_DividendsCapitalGainsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Capital Gains [Member]</link:label>
    <link:label id="lab_bxsl_DividendsCapitalGainsMember_documentation_en-US" xlink:label="lab_bxsl_DividendsCapitalGainsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Capital Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DividendsCapitalGainsMember" xlink:href="bxsl-20231231.xsd#bxsl_DividendsCapitalGainsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DividendsCapitalGainsMember" xlink:to="lab_bxsl_DividendsCapitalGainsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember_label_en-US" xlink:label="lab_bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may have difficulty sourcing investment opportunities. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember_documentation_en-US" xlink:label="lab_bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may have difficulty sourcing investment opportunities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember" xlink:to="lab_bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_d18da1e6-ab69-4038-bc1b-c93f06ca9522_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_512a0bfd-9c6b-4ec3-a5dd-81bfa7992ba5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_bcc72ca3-3818-4dfe-a076-92ac18a454e7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_SubAdministrationAgreementMember_c7346715-1ef7-47a1-b399-a54019c749bc_terseLabel_en-US" xlink:label="lab_bxsl_SubAdministrationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub-Administration Agreement</link:label>
    <link:label id="lab_bxsl_SubAdministrationAgreementMember_label_en-US" xlink:label="lab_bxsl_SubAdministrationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub-Administration Agreement [Member]</link:label>
    <link:label id="lab_bxsl_SubAdministrationAgreementMember_documentation_en-US" xlink:label="lab_bxsl_SubAdministrationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub-Administration Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SubAdministrationAgreementMember" xlink:href="bxsl-20231231.xsd#bxsl_SubAdministrationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_SubAdministrationAgreementMember" xlink:to="lab_bxsl_SubAdministrationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DebtSecuritiesFixedRateMember_7f2a6750-1c68-4ce3-877c-fb5eec859023_terseLabel_en-US" xlink:label="lab_bxsl_DebtSecuritiesFixedRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Fixed Rate</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesFixedRateMember_label_en-US" xlink:label="lab_bxsl_DebtSecuritiesFixedRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Fixed Rate [Member]</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesFixedRateMember_documentation_en-US" xlink:label="lab_bxsl_DebtSecuritiesFixedRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Fixed Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFixedRateMember" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFixedRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DebtSecuritiesFixedRateMember" xlink:to="lab_bxsl_DebtSecuritiesFixedRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember_label_en-US" xlink:label="lab_bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions in a credit facility may limit our investment discretion. [Member]</link:label>
    <link:label id="lab_bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember_documentation_en-US" xlink:label="lab_bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions in a credit facility may limit our investment discretion.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember" xlink:href="bxsl-20231231.xsd#bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember" xlink:to="lab_bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2f05ae35-8d52-468a-a276-de161ec7c8e0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_ab98a73a-2171-4162-9ed7-7c4629d7ebef_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt (net of unamortized debt issuance costs of $25,953 and $35,289 at December&#160;31, 2023 and December&#160;31, 2022, respectively)</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_51144198-1340-49cc-8502-914f8dc37ada_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract_ed8ba03c-3a71-4ea8-bd33-86b999777dc9_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized and unrealized gain (loss):</link:label>
    <link:label id="lab_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract_label_en-US" xlink:label="lab_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss), Investment and Derivative, Operating, and Foreign Currency Transaction, after Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract" xlink:to="lab_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_A2026NotesMember_ebffecfb-311e-4936-8473-e7f64856f870_terseLabel_en-US" xlink:label="lab_bxsl_A2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Notes</link:label>
    <link:label id="lab_bxsl_A2026NotesMember_label_en-US" xlink:label="lab_bxsl_A2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Notes [Member]</link:label>
    <link:label id="lab_bxsl_A2026NotesMember_documentation_en-US" xlink:label="lab_bxsl_A2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2026NotesMember" xlink:href="bxsl-20231231.xsd#bxsl_A2026NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_A2026NotesMember" xlink:to="lab_bxsl_A2026NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation_7c9abf76-c44b-4120-ab6a-a90887115a63_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized appreciation/(depreciation) on investments</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Distributable Earnings (Loss), Accumulated Appreciation (Depreciation)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation" xlink:to="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d351a91b-253a-4613-adee-4fed518eccfa_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from offering</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d66a3c45-1166-463f-84d4-53a72ff6983b_verboseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Proceeds</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_11113086-e1cc-484a-b7e9-5b090331321a_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_label_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableLineItems" xlink:to="lab_us-gaap_DividendsPayableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_bee6e201-22c1-4937-bb39-b3f54bc95841_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments/Receivables/Payables From Investments Sold/Purchased</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember_label_en-US" xlink:label="lab_bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technological innovations and industry disruptions may negatively impact us. [Member]</link:label>
    <link:label id="lab_bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember_documentation_en-US" xlink:label="lab_bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technological innovations and industry disruptions may negatively impact us.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember" xlink:href="bxsl-20231231.xsd#bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember" xlink:to="lab_bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier_93ce6a6a-0c9b-4b3f-80a6-ea267146cbc3_terseLabel_en-US" xlink:label="lab_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined revolving debt amount multiplier</link:label>
    <link:label id="lab_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier_label_en-US" xlink:label="lab_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Combined Revolving Debt Amount, Multiplier</link:label>
    <link:label id="lab_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier_documentation_en-US" xlink:label="lab_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Combined Revolving Debt Amount, Multiplier</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier" xlink:href="bxsl-20231231.xsd#bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier" xlink:to="lab_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendAndInterestReceivable_645d281f-251b-4577-841c-aa148b82c61b_terseLabel_en-US" xlink:label="lab_us-gaap_DividendAndInterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable from non-controlled/non-affiliated investments</link:label>
    <link:label id="lab_us-gaap_DividendAndInterestReceivable_label_en-US" xlink:label="lab_us-gaap_DividendAndInterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend and Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendAndInterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendAndInterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendAndInterestReceivable" xlink:to="lab_us-gaap_DividendAndInterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember_label_en-US" xlink:label="lab_bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We face risks associated with the deployment of our capital [Member]</link:label>
    <link:label id="lab_bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember_documentation_en-US" xlink:label="lab_bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We face risks associated with the deployment of our capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember" xlink:href="bxsl-20231231.xsd#bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember" xlink:to="lab_bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember_label_en-US" xlink:label="lab_bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No shareholder approval is required for certain mergers. [Member]</link:label>
    <link:label id="lab_bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember_documentation_en-US" xlink:label="lab_bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No shareholder approval is required for certain mergers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember" xlink:href="bxsl-20231231.xsd#bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember" xlink:to="lab_bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_15ddb0d2-d7c8-4b9b-8934-ebf058b5b3be_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember_label_en-US" xlink:label="lab_bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may be impacted by general European economic conditions. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember_documentation_en-US" xlink:label="lab_bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may be impacted by general European economic conditions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember" xlink:to="lab_bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember_label_en-US" xlink:label="lab_bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A lack of liquidity in certain of our investments may adversely affect our business. [Member]</link:label>
    <link:label id="lab_bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember_documentation_en-US" xlink:label="lab_bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A lack of liquidity in certain of our investments may adversely affect our business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember" xlink:href="bxsl-20231231.xsd#bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember" xlink:to="lab_bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ConstructionEngineeringSectorMember_b7f44487-87ba-41a0-8bd8-d3d5da0704bd_terseLabel_en-US" xlink:label="lab_bxsl_ConstructionEngineeringSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction &amp; Engineering</link:label>
    <link:label id="lab_bxsl_ConstructionEngineeringSectorMember_label_en-US" xlink:label="lab_bxsl_ConstructionEngineeringSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction &amp; Engineering Sector [Member]</link:label>
    <link:label id="lab_bxsl_ConstructionEngineeringSectorMember_documentation_en-US" xlink:label="lab_bxsl_ConstructionEngineeringSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction &amp; Engineering Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ConstructionEngineeringSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_ConstructionEngineeringSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ConstructionEngineeringSectorMember" xlink:to="lab_bxsl_ConstructionEngineeringSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction_1321e56d-9626-427a-af48-435bdc0d00f5_negatedTerseLabel_en-US" xlink:label="lab_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash deferred financing costs activity</link:label>
    <link:label id="lab_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction_label_en-US" xlink:label="lab_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Line Of Credit Arrangements, Incurred During Noncash Or Partial Noncash Transaction</link:label>
    <link:label id="lab_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction_documentation_en-US" xlink:label="lab_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Line Of Credit Arrangements, Incurred During Noncash Or Partial Noncash Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="bxsl-20231231.xsd#bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="lab_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3bb35992-83e7-4c8b-a59f-76c5a29a004f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember_label_en-US" xlink:label="lab_bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We are a non-diversified investment company and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer. [Member]</link:label>
    <link:label id="lab_bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember_documentation_en-US" xlink:label="lab_bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We are a non-diversified investment company and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember" xlink:to="lab_bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee_bae055db-7b92-4911-960b-0696f60be1fa_terseLabel_en-US" xlink:label="lab_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused commitment fees</link:label>
    <link:label id="lab_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee_label_en-US" xlink:label="lab_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Debt Instrument Unused Borrowing Capacity Fee</link:label>
    <link:label id="lab_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee_documentation_en-US" xlink:label="lab_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Debt Instrument Unused Borrowing Capacity Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee" xlink:href="bxsl-20231231.xsd#bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee" xlink:to="lab_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember_fb598a2b-931f-4515-8d1c-c95a9683cb42_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Management Agreement - Incentive Rate, Quarterly Hurdle Rate Member</link:label>
    <link:label id="lab_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember_label_en-US" xlink:label="lab_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Management Agreement - Incentive Rate, Quarterly Hurdle Rate Member [Member]</link:label>
    <link:label id="lab_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember_documentation_en-US" xlink:label="lab_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Management Agreement - Incentive Rate, Quarterly Hurdle Rate Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember" xlink:to="lab_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax_96d217d5-2bc0-4c33-919c-4c3f450d58e8_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Realized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax_label_en-US" xlink:label="lab_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Gain (Loss), Investment, Derivative, and Foreign Currency Transaction Price Change, Operating, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax" xlink:to="lab_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember_label_en-US" xlink:label="lab_bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our portfolio may be concentrated in a limited number of industries, which may subject us to a risk of significant loss if there is a downturn in a particular industry. [Member]</link:label>
    <link:label id="lab_bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember_documentation_en-US" xlink:label="lab_bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our portfolio may be concentrated in a limited number of industries, which may subject us to a risk of significant loss if there is a downturn in a particular industry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember" xlink:href="bxsl-20231231.xsd#bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember" xlink:to="lab_bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember_label_en-US" xlink:label="lab_bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies. [Member]</link:label>
    <link:label id="lab_bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember_documentation_en-US" xlink:label="lab_bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember" xlink:href="bxsl-20231231.xsd#bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember" xlink:to="lab_bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember_d49cc0a9-14c1-46fb-a1ac-4f1fea408f81_terseLabel_en-US" xlink:label="lab_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Support Agreement, Excess Operating Funds</link:label>
    <link:label id="lab_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember_label_en-US" xlink:label="lab_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Support Agreement, Excess Operating Funds [Member]</link:label>
    <link:label id="lab_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember_documentation_en-US" xlink:label="lab_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Support Agreement, Excess Operating Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember" xlink:href="bxsl-20231231.xsd#bxsl_ExpenseSupportAgreementExcessOperatingFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember" xlink:to="lab_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e47db39e-b6db-4180-ba87-9921279f1199_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_6888a2cf-045e-465d-af09-b32d1ca9442a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_NumberOfEquityDistributionAgreements_e793b643-3b9e-40bf-a980-92e32d7f625b_terseLabel_en-US" xlink:label="lab_bxsl_NumberOfEquityDistributionAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of agreements</link:label>
    <link:label id="lab_bxsl_NumberOfEquityDistributionAgreements_label_en-US" xlink:label="lab_bxsl_NumberOfEquityDistributionAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Equity Distribution Agreements</link:label>
    <link:label id="lab_bxsl_NumberOfEquityDistributionAgreements_documentation_en-US" xlink:label="lab_bxsl_NumberOfEquityDistributionAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Equity Distribution Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NumberOfEquityDistributionAgreements" xlink:href="bxsl-20231231.xsd#bxsl_NumberOfEquityDistributionAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_NumberOfEquityDistributionAgreements" xlink:to="lab_bxsl_NumberOfEquityDistributionAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_41535c8a-35ab-461d-9d9e-4fa3bd3d24ab_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities and Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_MeasurementInputMarketMultipleMember_06355078-82ba-48bc-be7e-78512fd6d909_terseLabel_en-US" xlink:label="lab_bxsl_MeasurementInputMarketMultipleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Multiple</link:label>
    <link:label id="lab_bxsl_MeasurementInputMarketMultipleMember_label_en-US" xlink:label="lab_bxsl_MeasurementInputMarketMultipleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Market Multiple [Member]</link:label>
    <link:label id="lab_bxsl_MeasurementInputMarketMultipleMember_documentation_en-US" xlink:label="lab_bxsl_MeasurementInputMarketMultipleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Market Multiple</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MeasurementInputMarketMultipleMember" xlink:href="bxsl-20231231.xsd#bxsl_MeasurementInputMarketMultipleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_MeasurementInputMarketMultipleMember" xlink:to="lab_bxsl_MeasurementInputMarketMultipleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember_label_en-US" xlink:label="lab_bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of any distributions we may make is uncertain. Our distributions may exceed our earnings. [Member]</link:label>
    <link:label id="lab_bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember_documentation_en-US" xlink:label="lab_bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of any distributions we may make is uncertain. Our distributions may exceed our earnings.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember" xlink:href="bxsl-20231231.xsd#bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember" xlink:to="lab_bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Dividends5Member_30ec54c0-f2bb-44c1-9efb-51d3c1a791ca_terseLabel_en-US" xlink:label="lab_bxsl_Dividends5Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 5</link:label>
    <link:label id="lab_bxsl_Dividends5Member_label_en-US" xlink:label="lab_bxsl_Dividends5Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 5 [Member]</link:label>
    <link:label id="lab_bxsl_Dividends5Member_documentation_en-US" xlink:label="lab_bxsl_Dividends5Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends5Member" xlink:href="bxsl-20231231.xsd#bxsl_Dividends5Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Dividends5Member" xlink:to="lab_bxsl_Dividends5Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome_f2e05438-56ae-4abc-a3ec-940a83002718_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-deductible expenses and excise taxes</link:label>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome_label_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis Reconciliation, Other Non-Deductible Tax Expense, Increase (Decrease) In Taxable Income</link:label>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome_documentation_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis Reconciliation, Other Non-Deductible Tax Expense, Increase (Decrease) In Taxable Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome" xlink:to="lab_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_1b7a7c78-9e63-4d40-8af5-115e251111a3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_LineOfCreditFacilityUnusedCapacityPercentage_62c10cfa-db03-42fa-9a4b-cdbfd508dd5a_terseLabel_en-US" xlink:label="lab_bxsl_LineOfCreditFacilityUnusedCapacityPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capacity percentage</link:label>
    <link:label id="lab_bxsl_LineOfCreditFacilityUnusedCapacityPercentage_label_en-US" xlink:label="lab_bxsl_LineOfCreditFacilityUnusedCapacityPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Percentage</link:label>
    <link:label id="lab_bxsl_LineOfCreditFacilityUnusedCapacityPercentage_documentation_en-US" xlink:label="lab_bxsl_LineOfCreditFacilityUnusedCapacityPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LineOfCreditFacilityUnusedCapacityPercentage" xlink:href="bxsl-20231231.xsd#bxsl_LineOfCreditFacilityUnusedCapacityPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_LineOfCreditFacilityUnusedCapacityPercentage" xlink:to="lab_bxsl_LineOfCreditFacilityUnusedCapacityPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_f6605934-166a-4aeb-bb8d-efc8fc7a06b3_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7ce7f29a-2e0a-49c0-9eae-37867677f68b_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod_1284fbf7-b2b0-4290-9681-b6e3cc0e92e8_terseLabel_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Waiver period</link:label>
    <link:label id="lab_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod_label_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Voluntary Waiver Period</link:label>
    <link:label id="lab_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod_documentation_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Voluntary Waiver Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod" xlink:to="lab_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_5b65d9ae-67c3-458c-a94f-b9718aa38ecb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_9efb4cd3-5edb-40e6-bcd7-721b29b8e837_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember_label_en-US" xlink:label="lab_bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us. [Member]</link:label>
    <link:label id="lab_bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember_documentation_en-US" xlink:label="lab_bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember" xlink:href="bxsl-20231231.xsd#bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember" xlink:to="lab_bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AbilityToAchieveInvestmentObjectivesMember_label_en-US" xlink:label="lab_bxsl_AbilityToAchieveInvestmentObjectivesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ability to Achieve Investment Objectives [Member]</link:label>
    <link:label id="lab_bxsl_AbilityToAchieveInvestmentObjectivesMember_documentation_en-US" xlink:label="lab_bxsl_AbilityToAchieveInvestmentObjectivesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ability to Achieve Investment Objectives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AbilityToAchieveInvestmentObjectivesMember" xlink:href="bxsl-20231231.xsd#bxsl_AbilityToAchieveInvestmentObjectivesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AbilityToAchieveInvestmentObjectivesMember" xlink:to="lab_bxsl_AbilityToAchieveInvestmentObjectivesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedBalancePrincipalAmount_8edcc86d-5e16-46c2-a132-11febb6d450c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Par Amounts/Units</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedBalancePrincipalAmount_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:to="lab_us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome_266fa2b2-50b5-47bd-8dd2-a34dd96d5195_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net post-October capital loss deferral (reversal)</link:label>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome_label_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis Reconciliation, Capital Loss Carryover, Increase (Decrease) In Taxable Income</link:label>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome_documentation_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis Reconciliation, Capital Loss Carryover, Increase (Decrease) In Taxable Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome" xlink:to="lab_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceShares_f16081dd-4a42-4c8e-81ca-3d1c0a8fdd5a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment owned (in shares)</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceShares_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedBalanceShares" xlink:to="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_261e1eb4-33aa-4322-8f70-77a0c3923f53_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember_label_en-US" xlink:label="lab_bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price declines in the medium- and large-sized U.S. corporate debt market may adversely affect the fair value of our portfolio, reducing our NAV through increased net unrealized depreciation. [Member]</link:label>
    <link:label id="lab_bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember_documentation_en-US" xlink:label="lab_bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price declines in the medium- and large-sized U.S. corporate debt market may adversely affect the fair value of our portfolio, reducing our NAV through increased net unrealized depreciation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember" xlink:href="bxsl-20231231.xsd#bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember" xlink:to="lab_bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_32e52912-bb06-4fd0-a677-7a2f7aa92073_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember_label_en-US" xlink:label="lab_bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our investments may include original issue discount and payment-in-kind instruments. [Member]</link:label>
    <link:label id="lab_bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember_documentation_en-US" xlink:label="lab_bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our investments may include original issue discount and payment-in-kind instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember" xlink:href="bxsl-20231231.xsd#bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember" xlink:to="lab_bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4338db04-8e77-485c-a90b-859c852a7c5a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_10b5361b-57b8-4974-95a7-5028a06dea2e_totalLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income before excise tax</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9005b815-2c32-4844-bb40-58f015b86db7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_48c4614d-e6bd-4ce0-85de-1a89f027517e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Dividends4Member_d33b59ae-aa62-44c9-b946-db4e32d5b33f_terseLabel_en-US" xlink:label="lab_bxsl_Dividends4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 4</link:label>
    <link:label id="lab_bxsl_Dividends4Member_label_en-US" xlink:label="lab_bxsl_Dividends4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 4 [Member]</link:label>
    <link:label id="lab_bxsl_Dividends4Member_documentation_en-US" xlink:label="lab_bxsl_Dividends4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends4Member" xlink:href="bxsl-20231231.xsd#bxsl_Dividends4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Dividends4Member" xlink:to="lab_bxsl_Dividends4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyFinancialHighlightsTextBlock_36946664-87f4-49e4-bb30-6111b9c3cce4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyFinancialHighlightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Highlights and Senior Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyFinancialHighlightsTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyFinancialHighlightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Financial Highlights [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialHighlightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialHighlightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyFinancialHighlightsTextBlock" xlink:to="lab_us-gaap_InvestmentCompanyFinancialHighlightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentAdvisoryAgreementMember_92433330-716d-428e-8d3d-d3066be1b08a_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentAdvisoryAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Advisory Agreement</link:label>
    <link:label id="lab_bxsl_InvestmentAdvisoryAgreementMember_label_en-US" xlink:label="lab_bxsl_InvestmentAdvisoryAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Advisory Agreement [Member]</link:label>
    <link:label id="lab_bxsl_InvestmentAdvisoryAgreementMember_documentation_en-US" xlink:label="lab_bxsl_InvestmentAdvisoryAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Advisory Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentAdvisoryAgreementMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentAdvisoryAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentAdvisoryAgreementMember" xlink:to="lab_bxsl_InvestmentAdvisoryAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax_25e5ebf0-46ae-4fbe-885e-773f9097d59a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transactions</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Gain (Loss), Foreign Currency Transaction, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_f58eae9c-f3ca-47d7-bb1c-66beae5cca32_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_UnsecuredDebtUnrealizedGainLossMember_f25ee4ae-f3ba-4643-be80-36f3412971a9_terseLabel_en-US" xlink:label="lab_bxsl_UnsecuredDebtUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_bxsl_UnsecuredDebtUnrealizedGainLossMember_label_en-US" xlink:label="lab_bxsl_UnsecuredDebtUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt, Unrealized Gain (Loss) [Member]</link:label>
    <link:label id="lab_bxsl_UnsecuredDebtUnrealizedGainLossMember_documentation_en-US" xlink:label="lab_bxsl_UnsecuredDebtUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_UnsecuredDebtUnrealizedGainLossMember" xlink:href="bxsl-20231231.xsd#bxsl_UnsecuredDebtUnrealizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_UnsecuredDebtUnrealizedGainLossMember" xlink:to="lab_bxsl_UnsecuredDebtUnrealizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_8f7a415b-f6a7-4b09-b8f6-341148618e88_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Expenses and Offering Expenses</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_RetainedEarningsAccumulatedDeficitAudited_5217dc9d-b038-4721-8902-2fa70824a7cc_totalLabel_en-US" xlink:label="lab_bxsl_RetainedEarningsAccumulatedDeficitAudited" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accumulated under-distributed (over-distributed) earnings</link:label>
    <link:label id="lab_bxsl_RetainedEarningsAccumulatedDeficitAudited_label_en-US" xlink:label="lab_bxsl_RetainedEarningsAccumulatedDeficitAudited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit), Audited</link:label>
    <link:label id="lab_bxsl_RetainedEarningsAccumulatedDeficitAudited_documentation_en-US" xlink:label="lab_bxsl_RetainedEarningsAccumulatedDeficitAudited" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit), Audited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RetainedEarningsAccumulatedDeficitAudited" xlink:href="bxsl-20231231.xsd#bxsl_RetainedEarningsAccumulatedDeficitAudited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_RetainedEarningsAccumulatedDeficitAudited" xlink:to="lab_bxsl_RetainedEarningsAccumulatedDeficitAudited" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember_label_en-US" xlink:label="lab_bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Of Distributions Exceeding Taxable Earnings And Profits, Causing Return Of Capital [Member]</link:label>
    <link:label id="lab_bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember_documentation_en-US" xlink:label="lab_bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Of Distributions Exceeding Taxable Earnings And Profits, Causing Return Of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember" xlink:href="bxsl-20231231.xsd#bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember" xlink:to="lab_bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_b9a280c7-067f-417d-a376-9a84dea15fef_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_SpecialtyRetailMember_1676f94c-b482-469b-b623-e7dd9c0c0e2f_terseLabel_en-US" xlink:label="lab_bxsl_SpecialtyRetailMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Retail</link:label>
    <link:label id="lab_bxsl_SpecialtyRetailMember_label_en-US" xlink:label="lab_bxsl_SpecialtyRetailMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Retail [Member]</link:label>
    <link:label id="lab_bxsl_SpecialtyRetailMember_documentation_en-US" xlink:label="lab_bxsl_SpecialtyRetailMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Retail</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SpecialtyRetailMember" xlink:href="bxsl-20231231.xsd#bxsl_SpecialtyRetailMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_SpecialtyRetailMember" xlink:to="lab_bxsl_SpecialtyRetailMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation_4958119d-d9f2-43c9-9d48-96045918010b_terseLabel_en-US" xlink:label="lab_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized appreciation</link:label>
    <link:label id="lab_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation_label_en-US" xlink:label="lab_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis, Unrealized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation" xlink:to="lab_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember_label_en-US" xlink:label="lab_bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulations governing our operation as a BDC and RIC will affect our ability to raise additional capital or borrow for investment purposes, which may have a negative effect on our growth. [Member]</link:label>
    <link:label id="lab_bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember_documentation_en-US" xlink:label="lab_bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulations governing our operation as a BDC and RIC will affect our ability to raise additional capital or borrow for investment purposes, which may have a negative effect on our growth.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember" xlink:href="bxsl-20231231.xsd#bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember" xlink:to="lab_bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ValuationAssetRecoverabilityMember_041f24e9-12c9-43be-a2b3-fd948e729258_terseLabel_en-US" xlink:label="lab_bxsl_ValuationAssetRecoverabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Recoverability</link:label>
    <link:label id="lab_bxsl_ValuationAssetRecoverabilityMember_label_en-US" xlink:label="lab_bxsl_ValuationAssetRecoverabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation, Asset Recoverability [Member]</link:label>
    <link:label id="lab_bxsl_ValuationAssetRecoverabilityMember_documentation_en-US" xlink:label="lab_bxsl_ValuationAssetRecoverabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation, Asset Recoverability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ValuationAssetRecoverabilityMember" xlink:href="bxsl-20231231.xsd#bxsl_ValuationAssetRecoverabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ValuationAssetRecoverabilityMember" xlink:to="lab_bxsl_ValuationAssetRecoverabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableTable_877c6a34-85aa-46e7-b4b2-3416ae708c69_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableTable_label_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableTable" xlink:to="lab_us-gaap_DividendsPayableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_9dcc3f12-0191-4854-beaa-612477874aba_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_f087bd7e-8fdd-439c-ac44-52c6913bbd78_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember_label_en-US" xlink:label="lab_bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Force Majeure events may adversely affect our operations. [Member]</link:label>
    <link:label id="lab_bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember_documentation_en-US" xlink:label="lab_bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Force Majeure events may adversely affect our operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember" xlink:href="bxsl-20231231.xsd#bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember" xlink:to="lab_bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember_label_en-US" xlink:label="lab_bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We cannot assure you that the market price of common shares will not decline below the IPO price or below our NAV. The market price of common shares may be volatile and may fluctuate substantially. [Member]</link:label>
    <link:label id="lab_bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember_documentation_en-US" xlink:label="lab_bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We cannot assure you that the market price of common shares will not decline below the IPO price or below our NAV. The market price of common shares may be volatile and may fluctuate substantially.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember" xlink:href="bxsl-20231231.xsd#bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember" xlink:to="lab_bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember_label_en-US" xlink:label="lab_bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A shareholder&#8217;s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us. [Member]</link:label>
    <link:label id="lab_bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember_documentation_en-US" xlink:label="lab_bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A shareholder&#8217;s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember" xlink:href="bxsl-20231231.xsd#bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember" xlink:to="lab_bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember_label_en-US" xlink:label="lab_bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our portfolio companies may be highly leveraged. [Member]</link:label>
    <link:label id="lab_bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember_documentation_en-US" xlink:label="lab_bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our portfolio companies may be highly leveraged.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember" xlink:href="bxsl-20231231.xsd#bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember" xlink:to="lab_bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_2338dcac-4687-465a-9b0b-0fb116744070_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesByIndustryAxis_234570c3-0895-444c-92f8-28a5b8b95723_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesByIndustryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industry Sector [Axis]</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesByIndustryAxis_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesByIndustryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industry Sector [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesByIndustryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesByIndustryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis" xlink:to="lab_us-gaap_EquitySecuritiesByIndustryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember_label_en-US" xlink:label="lab_bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our investments in prospective portfolio companies may be risky, and we could lose all or part of our investment. [Member]</link:label>
    <link:label id="lab_bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember_documentation_en-US" xlink:label="lab_bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our investments in prospective portfolio companies may be risky, and we could lose all or part of our investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember" xlink:href="bxsl-20231231.xsd#bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember" xlink:to="lab_bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_91ed6069-d6a3-49a9-8812-ae8570dbf98a_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyDividendDistribution_04254309-fae7-49fb-b242-20cb87e25c70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyDividendDistribution" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared from net investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyDividendDistribution_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyDividendDistribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Dividend Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDividendDistribution" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDividendDistribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyDividendDistribution" xlink:to="lab_us-gaap_InvestmentCompanyDividendDistribution" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_eecedce3-97f6-4714-add6-fe8f8aba4db2_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue_809de7bf-02bd-429a-b5cf-7d8f397c1b07_terseLabel_en-US" xlink:label="lab_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate sales price</link:label>
    <link:label id="lab_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue_label_en-US" xlink:label="lab_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction, Value</link:label>
    <link:label id="lab_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue_documentation_en-US" xlink:label="lab_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue" xlink:href="bxsl-20231231.xsd#bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue" xlink:to="lab_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_BreckenridgeFundingFacilityMember_90f043c4-78a7-4c80-9cee-011f1d191708_terseLabel_en-US" xlink:label="lab_bxsl_BreckenridgeFundingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breckenridge Funding Facility</link:label>
    <link:label id="lab_bxsl_BreckenridgeFundingFacilityMember_label_en-US" xlink:label="lab_bxsl_BreckenridgeFundingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breckenridge Funding Facility [Member]</link:label>
    <link:label id="lab_bxsl_BreckenridgeFundingFacilityMember_documentation_en-US" xlink:label="lab_bxsl_BreckenridgeFundingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breckenridge Funding Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BreckenridgeFundingFacilityMember" xlink:href="bxsl-20231231.xsd#bxsl_BreckenridgeFundingFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_BreckenridgeFundingFacilityMember" xlink:to="lab_bxsl_BreckenridgeFundingFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DelayedDrawTermLoansAndRevolversMember_22f58f08-fcfb-48b9-a5a4-50cacc69a3c6_terseLabel_en-US" xlink:label="lab_bxsl_DelayedDrawTermLoansAndRevolversMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loans And Revolvers</link:label>
    <link:label id="lab_bxsl_DelayedDrawTermLoansAndRevolversMember_label_en-US" xlink:label="lab_bxsl_DelayedDrawTermLoansAndRevolversMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loans And Revolvers [Member]</link:label>
    <link:label id="lab_bxsl_DelayedDrawTermLoansAndRevolversMember_documentation_en-US" xlink:label="lab_bxsl_DelayedDrawTermLoansAndRevolversMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loans And Revolvers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DelayedDrawTermLoansAndRevolversMember" xlink:href="bxsl-20231231.xsd#bxsl_DelayedDrawTermLoansAndRevolversMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DelayedDrawTermLoansAndRevolversMember" xlink:to="lab_bxsl_DelayedDrawTermLoansAndRevolversMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_d67c75d3-e9e3-4f98-8115-e9554b9c8dfc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemptions paid in cash</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate_75203b47-3b05-423d-b184-59003bba8a07_terseLabel_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly hurdle rate</link:label>
    <link:label id="lab_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate_label_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Income Based Incentive Fee, Quarterly Hurdle Rate</link:label>
    <link:label id="lab_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate_documentation_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Income Based Incentive Fee, Quarterly Hurdle Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate" xlink:to="lab_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_51b8f0e7-3d19-4094-9e4d-f430ea88fd35_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_fb75b339-a111-4b4c-8cc9-2aa47eb45bb1_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member_a06c6fe1-dffc-4dd1-a371-470b7f5277dc_terseLabel_en-US" xlink:label="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2027</link:label>
    <link:label id="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member_label_en-US" xlink:label="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2027 [Member]</link:label>
    <link:label id="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member_documentation_en-US" xlink:label="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member" xlink:to="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_VoluntaryWaiverScenarioDomain_e8fa3031-d4b8-4220-95a5-ad8dd19b376e_terseLabel_en-US" xlink:label="lab_bxsl_VoluntaryWaiverScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Waiver Scenario [Domain]</link:label>
    <link:label id="lab_bxsl_VoluntaryWaiverScenarioDomain_label_en-US" xlink:label="lab_bxsl_VoluntaryWaiverScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Waiver Scenario [Domain]</link:label>
    <link:label id="lab_bxsl_VoluntaryWaiverScenarioDomain_documentation_en-US" xlink:label="lab_bxsl_VoluntaryWaiverScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Waiver Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioDomain" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_VoluntaryWaiverScenarioDomain" xlink:to="lab_bxsl_VoluntaryWaiverScenarioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember_label_en-US" xlink:label="lab_bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may be subject to additional potential conflicts of interests as a consequence of Blackstone&#8217;s status as a public company [Member]</link:label>
    <link:label id="lab_bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember_documentation_en-US" xlink:label="lab_bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may be subject to additional potential conflicts of interests as a consequence of Blackstone&#8217;s status as a public company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember" xlink:to="lab_bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5cf058ec-e3d2-488b-aa53-d42afeac9de7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Dividends6Member_50153b30-c067-4558-973f-46391f21bdf8_terseLabel_en-US" xlink:label="lab_bxsl_Dividends6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 6</link:label>
    <link:label id="lab_bxsl_Dividends6Member_label_en-US" xlink:label="lab_bxsl_Dividends6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 6 [Member]</link:label>
    <link:label id="lab_bxsl_Dividends6Member_documentation_en-US" xlink:label="lab_bxsl_Dividends6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends6Member" xlink:href="bxsl-20231231.xsd#bxsl_Dividends6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Dividends6Member" xlink:to="lab_bxsl_Dividends6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_PaperAndForestProductsMember_5582e0bc-cc4c-4ec0-9aaa-4e1c456a190a_terseLabel_en-US" xlink:label="lab_bxsl_PaperAndForestProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paper &amp; Forest Products</link:label>
    <link:label id="lab_bxsl_PaperAndForestProductsMember_label_en-US" xlink:label="lab_bxsl_PaperAndForestProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paper and Forest Products [Member]</link:label>
    <link:label id="lab_bxsl_PaperAndForestProductsMember_documentation_en-US" xlink:label="lab_bxsl_PaperAndForestProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paper and Forest Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaperAndForestProductsMember" xlink:href="bxsl-20231231.xsd#bxsl_PaperAndForestProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_PaperAndForestProductsMember" xlink:to="lab_bxsl_PaperAndForestProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ddc1bf75-893e-4e3e-9694-ace2f7cfe07d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributable earnings (loss)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e5df45e5-875a-4883-a6fd-109f061be4ef_totalLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accumulated under-distributed (over-distributed) earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember_653e5aad-f3f1-4ccc-ba12-afb07f918b0b_terseLabel_en-US" xlink:label="lab_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electronic Equipment, Instruments &amp; Components</link:label>
    <link:label id="lab_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember_label_en-US" xlink:label="lab_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electronic Equipment, Instruments and Components [Member]</link:label>
    <link:label id="lab_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember_documentation_en-US" xlink:label="lab_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electronic Equipment, Instruments and Components</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember" xlink:href="bxsl-20231231.xsd#bxsl_ElectronicEquipmentInstrumentsAndComponentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember" xlink:to="lab_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput_57a1da39-d9d8-4807-9fe8-a618e7f6c872_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement input</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Investment Owned, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" xlink:to="lab_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease_9a3c4d0d-75e6-4c5d-a79d-e34be325a094_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Tax Reclassification, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease" xlink:to="lab_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_6d3ec8bc-6ede-4a17-9218-31e9315e9a81_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers into Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentCompanySupplementalDataAbstract_d4e7c6e3-d7f9-4212-ad6e-76b41d82cfec_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentCompanySupplementalDataAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Data:</link:label>
    <link:label id="lab_bxsl_InvestmentCompanySupplementalDataAbstract_label_en-US" xlink:label="lab_bxsl_InvestmentCompanySupplementalDataAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Supplemental Data [Abstract]</link:label>
    <link:label id="lab_bxsl_InvestmentCompanySupplementalDataAbstract_documentation_en-US" xlink:label="lab_bxsl_InvestmentCompanySupplementalDataAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Supplemental Data</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanySupplementalDataAbstract" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanySupplementalDataAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentCompanySupplementalDataAbstract" xlink:to="lab_bxsl_InvestmentCompanySupplementalDataAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_e23c60ab-fb44-4af4-b57a-1923b28057c2_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_de3c0fe0-8b52-46f5-bb4e-e896cf965956_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Principal Committed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InterestPayableInterestExpense_df438d32-a990-419b-a02d-1d7aca5154ba_terseLabel_en-US" xlink:label="lab_bxsl_InterestPayableInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_bxsl_InterestPayableInterestExpense_label_en-US" xlink:label="lab_bxsl_InterestPayableInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Interest Expense</link:label>
    <link:label id="lab_bxsl_InterestPayableInterestExpense_documentation_en-US" xlink:label="lab_bxsl_InterestPayableInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InterestPayableInterestExpense" xlink:href="bxsl-20231231.xsd#bxsl_InterestPayableInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InterestPayableInterestExpense" xlink:to="lab_bxsl_InterestPayableInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_af527e5d-95c5-4ddc-a3a0-272d951d7eae_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember_label_en-US" xlink:label="lab_bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transactions denominated in foreign currencies subject us to foreign currency risks. [Member]</link:label>
    <link:label id="lab_bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember_documentation_en-US" xlink:label="lab_bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transactions denominated in foreign currencies subject us to foreign currency risks.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember" xlink:href="bxsl-20231231.xsd#bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember" xlink:to="lab_bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue_c4501bc1-e0c6-4d98-8e63-e850bcd19421_negatedTerseLabel_en-US" xlink:label="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue_label_en-US" xlink:label="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Financial Commitment to Investee, Future Amount, Fair Value</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue_documentation_en-US" xlink:label="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Financial Commitment to Investee, Future Amount, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" xlink:to="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Dividends9Member_c23ec287-1ee9-40b8-a5bd-1b7be8ae40dc_terseLabel_en-US" xlink:label="lab_bxsl_Dividends9Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 9</link:label>
    <link:label id="lab_bxsl_Dividends9Member_label_en-US" xlink:label="lab_bxsl_Dividends9Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 9 [Member]</link:label>
    <link:label id="lab_bxsl_Dividends9Member_documentation_en-US" xlink:label="lab_bxsl_Dividends9Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 9</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends9Member" xlink:href="bxsl-20231231.xsd#bxsl_Dividends9Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Dividends9Member" xlink:to="lab_bxsl_Dividends9Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_788b04d9-5d0b-479b-a420-f8cdbf929596_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome_5d5f68f8-d17a-4e23-b787-782542bcaf26_terseLabel_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of pre incentive rate investment income, percentage</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome_label_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Percentage Of Pre-Incentive Fee Net Investment Income</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome_documentation_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Percentage Of Pre-Incentive Fee Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome" xlink:to="lab_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember_label_en-US" xlink:label="lab_bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial regulatory changes in the United States could adversely affect our business [Member]</link:label>
    <link:label id="lab_bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember_documentation_en-US" xlink:label="lab_bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial regulatory changes in the United States could adversely affect our business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember" xlink:href="bxsl-20231231.xsd#bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember" xlink:to="lab_bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4f01b5f5-6e7f-4c1e-a499-59e7f228f26e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements_bc18491f-eb66-41e1-a28b-857223f1cdee_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of net expenses to average net assets</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements_label_en-US" xlink:label="lab_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Expense Ratio Including Fee Waiver And Reimbursements</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements_documentation_en-US" xlink:label="lab_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Expense Ratio Including Fee Waiver And Reimbursements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" xlink:to="lab_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_2aac7d9f-f0fe-4119-83a1-0bf5d792f7f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_d6e07022-521b-4ea5-8cbf-a5d48ef24058_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments/Forward Purchase Agreement</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea8dd04c-d119-43d4-b972-e78efa857e1d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_063bf87f-d197-43d9-9b9c-4f73516abd51_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember_label_en-US" xlink:label="lab_bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders may experience dilution in the net asset value of their shares if they do not participate in our dividend reinvestment plan and if our shares are trading at a discount to net asset value. [Member]</link:label>
    <link:label id="lab_bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember_documentation_en-US" xlink:label="lab_bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders may experience dilution in the net asset value of their shares if they do not participate in our dividend reinvestment plan and if our shares are trading at a discount to net asset value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember" xlink:href="bxsl-20231231.xsd#bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember" xlink:to="lab_bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_01272d13-a576-455a-a503-5bf4e101c4e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInterestPayableNet_3dbd5d34-b2c2-4a83-8087-b051e63925f3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInterestPayableNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Interest Payable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="lab_us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions_30f11ce7-c64c-41a7-95b3-1e05b2070abf_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Additions</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Affiliates, at Fair Value, Gross Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:to="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_708aa266-440e-4350-88e3-3baccf3faa0a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember_f4bde9e9-58a9-410d-98ea-422028cb9b4e_terseLabel_en-US" xlink:label="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Less Than Or Equal To Catch-Up Amount</link:label>
    <link:label id="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember_label_en-US" xlink:label="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Less Than Or Equal To Catch-Up Amount [Member]</link:label>
    <link:label id="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember_documentation_en-US" xlink:label="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Less Than Or Equal To Catch-Up Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember" xlink:href="bxsl-20231231.xsd#bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember" xlink:to="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember_label_en-US" xlink:label="lab_bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may use a wide range of investment techniques that could expose us to a diverse range of risks. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember_documentation_en-US" xlink:label="lab_bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may use a wide range of investment techniques that could expose us to a diverse range of risks.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember" xlink:to="lab_bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember_label_en-US" xlink:label="lab_bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second priority liens on collateral securing debt investments that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. [Member]</link:label>
    <link:label id="lab_bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember_documentation_en-US" xlink:label="lab_bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second priority liens on collateral securing debt investments that we make to our portfolio companies may be subject to control by senior creditors with first priority liens.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember" xlink:href="bxsl-20231231.xsd#bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember" xlink:to="lab_bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_A2027NotesMember_d352e267-1a75-4aa8-a13e-7ac73b481974_terseLabel_en-US" xlink:label="lab_bxsl_A2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Notes</link:label>
    <link:label id="lab_bxsl_A2027NotesMember_label_en-US" xlink:label="lab_bxsl_A2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Notes [Member]</link:label>
    <link:label id="lab_bxsl_A2027NotesMember_documentation_en-US" xlink:label="lab_bxsl_A2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2027NotesMember" xlink:href="bxsl-20231231.xsd#bxsl_A2027NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_A2027NotesMember" xlink:to="lab_bxsl_A2027NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyPortfolioTurnover_a2a5ad61-f785-4a3c-8057-9d3ce1190e72_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyPortfolioTurnover" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portfolio turnover rate</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyPortfolioTurnover_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyPortfolioTurnover" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Portfolio Turnover</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyPortfolioTurnover" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyPortfolioTurnover"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyPortfolioTurnover" xlink:to="lab_us-gaap_InvestmentCompanyPortfolioTurnover" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsMember_550ba21c-d959-475a-84bf-8f8d1a21e1aa_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsMember_label_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsMember" xlink:to="lab_us-gaap_InvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_cfb930e7-c851-45a0-8c7a-c4a977a29584_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1b47e1af-54fa-4bd7-a025-58b872daa4d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash debt issuance costs activity</link:label>
    <link:label id="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_label_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember_label_en-US" xlink:label="lab_bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our Board may amend our Declaration of Trust without prior shareholder approval. [Member]</link:label>
    <link:label id="lab_bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember_documentation_en-US" xlink:label="lab_bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our Board may amend our Declaration of Trust without prior shareholder approval.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember" xlink:href="bxsl-20231231.xsd#bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember" xlink:to="lab_bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable_416c606e-5a0a-494d-982d-82c55b294524_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Interest and Dividends Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputQuotedPriceMember_7c58b9f4-1957-404b-866c-193826e787ac_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputQuotedPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Broker quoted price</link:label>
    <link:label id="lab_us-gaap_MeasurementInputQuotedPriceMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputQuotedPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Quoted Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputQuotedPriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputQuotedPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputQuotedPriceMember" xlink:to="lab_us-gaap_MeasurementInputQuotedPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_26bd1308-ea03-4bec-b2b2-8e32c5cfc31b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_17217ff5-ffb4-4848-91c8-8b95c40c7148_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_f8d7bc38-e5e8-40f8-ace5-1aaa72a2a200_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_3415d3dc-8f61-462a-8915-bcfbd46d2d5c_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income after excise tax</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_60af9b26-31d5-49da-8945-93bb72ddbe17_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Operating, after Expense and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax" xlink:to="lab_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember_label_en-US" xlink:label="lab_bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compliance with the SEC&#8217;s Regulation Best Interest by participating broker-dealers may negatively impact our ability to raise capital in a public offering [Member]</link:label>
    <link:label id="lab_bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember_documentation_en-US" xlink:label="lab_bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compliance with the SEC&#8217;s Regulation Best Interest by participating broker-dealers may negatively impact our ability to raise capital in a public offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember" xlink:href="bxsl-20231231.xsd#bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember" xlink:to="lab_bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ElectricalEquipmentSectorMember_bfb86903-f233-4d08-8e66-08d6f2551f2f_terseLabel_en-US" xlink:label="lab_bxsl_ElectricalEquipmentSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electrical Equipment</link:label>
    <link:label id="lab_bxsl_ElectricalEquipmentSectorMember_label_en-US" xlink:label="lab_bxsl_ElectricalEquipmentSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electrical Equipment Sector [Member]</link:label>
    <link:label id="lab_bxsl_ElectricalEquipmentSectorMember_documentation_en-US" xlink:label="lab_bxsl_ElectricalEquipmentSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electrical Equipment Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectricalEquipmentSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_ElectricalEquipmentSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ElectricalEquipmentSectorMember" xlink:to="lab_bxsl_ElectricalEquipmentSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember_label_en-US" xlink:label="lab_bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember_documentation_en-US" xlink:label="lab_bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember" xlink:to="lab_bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalFees_bdef8195-5d1b-489c-b718-c3da17d6e4f1_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_ProfessionalFees_label_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalFees" xlink:to="lab_us-gaap_ProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember_label_en-US" xlink:label="lab_bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in interest rates may affect our cost of capital and net investment income. [Member]</link:label>
    <link:label id="lab_bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember_documentation_en-US" xlink:label="lab_bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in interest rates may affect our cost of capital and net investment income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember" xlink:href="bxsl-20231231.xsd#bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember" xlink:to="lab_bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_368ed774-d9ef-4ba0-b2b2-4d0c74a37188_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyAbstract" xlink:to="lab_us-gaap_InvestmentCompanyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_041833c7-1337-4952-bfb8-79f87e4c97c3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock" xlink:to="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Dividends8Member_4c51ca00-e6fd-4326-a26b-5ce7c8f3379b_terseLabel_en-US" xlink:label="lab_bxsl_Dividends8Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 8</link:label>
    <link:label id="lab_bxsl_Dividends8Member_label_en-US" xlink:label="lab_bxsl_Dividends8Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 8 [Member]</link:label>
    <link:label id="lab_bxsl_Dividends8Member_documentation_en-US" xlink:label="lab_bxsl_Dividends8Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 8</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends8Member" xlink:href="bxsl-20231231.xsd#bxsl_Dividends8Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Dividends8Member" xlink:to="lab_bxsl_Dividends8Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_f9603925-cfac-4157-abff-0db2ecc038d6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments on debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_fe060c22-123d-46f4-a472-294c8bb63087_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments at fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_0d7445d3-a143-40e3-90db-e996b0371a67_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_c684ccfc-729b-4e99-908d-4e5d89380bfd_periodStartLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_b00b43c9-8d5f-4ca6-b22b-6842aebeac11_periodEndLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:to="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount_043e731d-97eb-4ec2-aefc-2c4866dfc1b8_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future amount</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount_label_en-US" xlink:label="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Financial Commitment to Investee, Estimated Future Amount</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount_documentation_en-US" xlink:label="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Financial Commitment to Investee, Estimated Future Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount" xlink:to="lab_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceSectorMember_1057faed-e470-4839-aeec-8bc2e22eb2f1_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance</link:label>
    <link:label id="lab_us-gaap_InsuranceSectorMember_label_en-US" xlink:label="lab_us-gaap_InsuranceSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Sector [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSectorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceSectorMember" xlink:to="lab_us-gaap_InsuranceSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncentiveFeePayableCapitalGains_b409a3c8-7726-424e-9551-cd9f84065165_terseLabel_en-US" xlink:label="lab_bxsl_IncentiveFeePayableCapitalGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital gains incentive fees payable (Note 3)</link:label>
    <link:label id="lab_bxsl_IncentiveFeePayableCapitalGains_label_en-US" xlink:label="lab_bxsl_IncentiveFeePayableCapitalGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Fee Payable, Capital Gains</link:label>
    <link:label id="lab_bxsl_IncentiveFeePayableCapitalGains_documentation_en-US" xlink:label="lab_bxsl_IncentiveFeePayableCapitalGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Fee Payable, Capital Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncentiveFeePayableCapitalGains" xlink:href="bxsl-20231231.xsd#bxsl_IncentiveFeePayableCapitalGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncentiveFeePayableCapitalGains" xlink:to="lab_bxsl_IncentiveFeePayableCapitalGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_f509eab4-12c7-4680-ae4b-30ed5b8e2af9_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_720b6615-4716-4d20-ac75-e136285d0ce3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized (appreciation) depreciation on investments</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_e177ea3a-eca3-4cf1-a447-a023c89f71fc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized (appreciation) depreciation on investments</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_7806b0ee-af17-45dd-a8ad-d1cb7c5b7e7b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember_label_en-US" xlink:label="lab_bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing in private companies involves a number of significant risks, any one of which could have a material adverse effect on our operating results. [Member]</link:label>
    <link:label id="lab_bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember_documentation_en-US" xlink:label="lab_bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing in private companies involves a number of significant risks, any one of which could have a material adverse effect on our operating results.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember" xlink:to="lab_bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock_a627bd06-9629-4888-a341-ef4778d1427c_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Gains (Losses) as Calculated on Tax Basis</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock_label_en-US" xlink:label="lab_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Components Of Distributable Earnings (Accumulated Losses) [Table Text Block]</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock_documentation_en-US" xlink:label="lab_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Components Of Distributable Earnings (Accumulated Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock" xlink:to="lab_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_7428a402-f8c7-44e5-bc53-bf6d00770d3d_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_093b1bc0-88a0-4d21-8cd1-37719ce6cbe2_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyNetAssetsRollForward_dd10ded7-ba25-4e0c-9717-45e13822c0ad_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyNetAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Net Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyNetAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyNetAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Net Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyNetAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyNetAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward" xlink:to="lab_us-gaap_InvestmentCompanyNetAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5a932678-acc9-4ea7-9755-cc3180e9cfd5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed net investment income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_A2023NotesMember_19225ced-c6cf-4059-8a92-3286c68c7c49_terseLabel_en-US" xlink:label="lab_bxsl_A2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Notes</link:label>
    <link:label id="lab_bxsl_A2023NotesMember_label_en-US" xlink:label="lab_bxsl_A2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Notes [Member]</link:label>
    <link:label id="lab_bxsl_A2023NotesMember_documentation_en-US" xlink:label="lab_bxsl_A2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2023NotesMember" xlink:href="bxsl-20231231.xsd#bxsl_A2023NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_A2023NotesMember" xlink:to="lab_bxsl_A2023NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember_label_en-US" xlink:label="lab_bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Any material adverse change in its financial condition or our relationship with the Adviser could have a material adverse effect on our business and ability to achieve our investment objectives [Member]</link:label>
    <link:label id="lab_bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember_documentation_en-US" xlink:label="lab_bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Any material adverse change in its financial condition or our relationship with the Adviser could have a material adverse effect on our business and ability to achieve our investment objectives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember" xlink:href="bxsl-20231231.xsd#bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember" xlink:to="lab_bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember_label_en-US" xlink:label="lab_bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We are subject to risks associated with investing alongside other third parties. [Member]</link:label>
    <link:label id="lab_bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember_documentation_en-US" xlink:label="lab_bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We are subject to risks associated with investing alongside other third parties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember" xlink:to="lab_bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_A2750NotesDue2026Member_894aeff5-baf0-46b2-bf2d-637ea82803ed_terseLabel_en-US" xlink:label="lab_bxsl_A2750NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New 2026 Notes</link:label>
    <link:label id="lab_bxsl_A2750NotesDue2026Member_label_en-US" xlink:label="lab_bxsl_A2750NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% Notes Due 2026 [Member]</link:label>
    <link:label id="lab_bxsl_A2750NotesDue2026Member_documentation_en-US" xlink:label="lab_bxsl_A2750NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% Notes Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2750NotesDue2026Member" xlink:href="bxsl-20231231.xsd#bxsl_A2750NotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_A2750NotesDue2026Member" xlink:to="lab_bxsl_A2750NotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome_69f3d8b3-9578-48c3-aeda-d041d0b6937e_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized gains (losses) for tax not included in book income</link:label>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome_label_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis Reconciliation, Other Realized Gains (Losses) Differences, Increase (Decrease) In Taxable Income</link:label>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome_documentation_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis Reconciliation, Other Realized Gains (Losses) Differences, Increase (Decrease) In Taxable Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome" xlink:to="lab_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_BigSkyFundingFacilityMember_5def8bd6-de95-494e-a512-39a4cc005478_terseLabel_en-US" xlink:label="lab_bxsl_BigSkyFundingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Big Sky Funding Facility</link:label>
    <link:label id="lab_bxsl_BigSkyFundingFacilityMember_label_en-US" xlink:label="lab_bxsl_BigSkyFundingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Big Sky Funding Facility [Member]</link:label>
    <link:label id="lab_bxsl_BigSkyFundingFacilityMember_documentation_en-US" xlink:label="lab_bxsl_BigSkyFundingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Big Sky Funding Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BigSkyFundingFacilityMember" xlink:href="bxsl-20231231.xsd#bxsl_BigSkyFundingFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_BigSkyFundingFacilityMember" xlink:to="lab_bxsl_BigSkyFundingFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome_450b523b-9109-45d5-8917-54f73c5d4acf_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible offering costs</link:label>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome_label_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis Reconciliation, Non-Deductible Tax Expense, Offering Costs, Increase (Decrease) In Taxable Income</link:label>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome_documentation_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis Reconciliation, Non-Deductible Tax Expense, Offering Costs, Increase (Decrease) In Taxable Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome" xlink:to="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock_445ad4a1-9ec8-4f6d-a1a2-8099f30528cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shares Issued and Proceeds Received</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Sale of Stock by Subsidiary or Equity Method Investee Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:to="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_EquitySecuritiesRealizedGainLossMember_912dd696-69da-4e7b-b57c-384d33828697_terseLabel_en-US" xlink:label="lab_bxsl_EquitySecuritiesRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, Realized Gain (Loss)</link:label>
    <link:label id="lab_bxsl_EquitySecuritiesRealizedGainLossMember_label_en-US" xlink:label="lab_bxsl_EquitySecuritiesRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, Realized Gain (Loss) [Member]</link:label>
    <link:label id="lab_bxsl_EquitySecuritiesRealizedGainLossMember_documentation_en-US" xlink:label="lab_bxsl_EquitySecuritiesRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_EquitySecuritiesRealizedGainLossMember" xlink:href="bxsl-20231231.xsd#bxsl_EquitySecuritiesRealizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_EquitySecuritiesRealizedGainLossMember" xlink:to="lab_bxsl_EquitySecuritiesRealizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Dividends7Member_39eb1622-f5ef-4516-941f-1e6c7538b450_terseLabel_en-US" xlink:label="lab_bxsl_Dividends7Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 7</link:label>
    <link:label id="lab_bxsl_Dividends7Member_label_en-US" xlink:label="lab_bxsl_Dividends7Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 7 [Member]</link:label>
    <link:label id="lab_bxsl_Dividends7Member_documentation_en-US" xlink:label="lab_bxsl_Dividends7Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 7</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends7Member" xlink:href="bxsl-20231231.xsd#bxsl_Dividends7Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Dividends7Member" xlink:to="lab_bxsl_Dividends7Member" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_c6272a84-22a8-4d90-879c-76e5630ad311_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_2f473243-93ff-4bfc-ba8b-010ab19dcbde_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialServicesSectorMember_994e70a3-9a07-4fee-aa63-3ede813e817b_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified Financial Services</link:label>
    <link:label id="lab_us-gaap_FinancialServicesSectorMember_label_en-US" xlink:label="lab_us-gaap_FinancialServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Services Sector [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServicesSectorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialServicesSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialServicesSectorMember" xlink:to="lab_us-gaap_FinancialServicesSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_0dba8b60-903a-43f6-8446-6014d119c3f3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ffe1bee7-d74e-411d-91d9-2b07f713da75_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, $0.001 par value (unlimited shares authorized; 185,782,408 and 160,362,861 shares issued and outstanding at December&#160;31, 2023 and December&#160;31, 2022, respectively)</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_7668991b-3c9b-461f-a668-4e7dc3f38451_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_f3eab48a-af69-4319-ad38-a61e5fa454f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member_46b12c35-15ac-4fba-95e8-901fb62e18c6_terseLabel_en-US" xlink:label="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2026</link:label>
    <link:label id="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member_label_en-US" xlink:label="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2026 [Member]</link:label>
    <link:label id="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member_documentation_en-US" xlink:label="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member" xlink:to="lab_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember_label_en-US" xlink:label="lab_bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">There may be conflicts of interest related to obligations that the Adviser&#8217;s senior management and Investment Team have to other clients. [Member]</link:label>
    <link:label id="lab_bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember_documentation_en-US" xlink:label="lab_bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">There may be conflicts of interest related to obligations that the Adviser&#8217;s senior management and Investment Team have to other clients.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember" xlink:href="bxsl-20231231.xsd#bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember" xlink:to="lab_bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare_2cd23a46-4809-4014-9339-23a7df47110a_terseLabel_en-US" xlink:label="lab_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock, percent of market price</link:label>
    <link:label id="lab_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare_label_en-US" xlink:label="lab_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Reinvestment Plan, Minimum Share Issuance Price, Percentage Of Current Market Price Per Share</link:label>
    <link:label id="lab_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare_documentation_en-US" xlink:label="lab_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Reinvestment Plan, Minimum Share Issuance Price, Percentage Of Current Market Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare" xlink:href="bxsl-20231231.xsd#bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare" xlink:to="lab_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember_label_en-US" xlink:label="lab_bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our ability to enter into transactions with our affiliates is restricted. [Member]</link:label>
    <link:label id="lab_bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember_documentation_en-US" xlink:label="lab_bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our ability to enter into transactions with our affiliates is restricted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember" xlink:href="bxsl-20231231.xsd#bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember" xlink:to="lab_bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember_label_en-US" xlink:label="lab_bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We are subject to risks related to ESG investments. [Member]</link:label>
    <link:label id="lab_bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember_documentation_en-US" xlink:label="lab_bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We are subject to risks related to ESG investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember" xlink:to="lab_bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_RelatedPartyTransactionInitialTerm_b71155e1-4f8c-465e-abfc-71ed0fdbaf36_terseLabel_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionInitialTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, initial term</link:label>
    <link:label id="lab_bxsl_RelatedPartyTransactionInitialTerm_label_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionInitialTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Initial Term</link:label>
    <link:label id="lab_bxsl_RelatedPartyTransactionInitialTerm_documentation_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionInitialTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Initial Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionInitialTerm" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionInitialTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_RelatedPartyTransactionInitialTerm" xlink:to="lab_bxsl_RelatedPartyTransactionInitialTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncentiveFeePayableIncome_ee81be5e-3432-45c7-b156-cff9a1fe33df_terseLabel_en-US" xlink:label="lab_bxsl_IncentiveFeePayableIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income based incentive fees payable (Note 3)</link:label>
    <link:label id="lab_bxsl_IncentiveFeePayableIncome_bba2f0da-9c5f-4708-b3f4-dbab106588a4_verboseLabel_en-US" xlink:label="lab_bxsl_IncentiveFeePayableIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income based incentive fees payable</link:label>
    <link:label id="lab_bxsl_IncentiveFeePayableIncome_label_en-US" xlink:label="lab_bxsl_IncentiveFeePayableIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Fee Payable, Income</link:label>
    <link:label id="lab_bxsl_IncentiveFeePayableIncome_documentation_en-US" xlink:label="lab_bxsl_IncentiveFeePayableIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Fee Payable, Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncentiveFeePayableIncome" xlink:href="bxsl-20231231.xsd#bxsl_IncentiveFeePayableIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncentiveFeePayableIncome" xlink:to="lab_bxsl_IncentiveFeePayableIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_b0f38c52-0e6e-45c3-bc13-368a1044a9b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsidiary or Equity Method Investee [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsidiary or Equity Method Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_7f8b3dd9-a752-4428-a1c7-910fa9a12151_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payable</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnergySectorMember_86af786c-de34-42e0-af2f-508fb90dcc66_terseLabel_en-US" xlink:label="lab_us-gaap_EnergySectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy Equipment &amp; Services</link:label>
    <link:label id="lab_us-gaap_EnergySectorMember_label_en-US" xlink:label="lab_us-gaap_EnergySectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy Sector [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnergySectorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EnergySectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnergySectorMember" xlink:to="lab_us-gaap_EnergySectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember_label_en-US" xlink:label="lab_bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay to the Adviser will be determined without independent assessment on our behalf, and these terms may be less advantageous to us than if such terms had been the subject of arm&#8217;s-length negotiations. [Member]</link:label>
    <link:label id="lab_bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember_documentation_en-US" xlink:label="lab_bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay to the Adviser will be determined without independent assessment on our behalf, and these terms may be less advantageous to us than if such terms had been the subject of arm&#8217;s-length negotiations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember" xlink:href="bxsl-20231231.xsd#bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember" xlink:to="lab_bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage_412cd557-0d3b-438e-8b3d-da626d00fcec_terseLabel_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual catch up amount prior to the waiver period</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage_label_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Catch-Up Amount, Annualized Percentage</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage_documentation_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Catch-Up Amount, Annualized Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage" xlink:to="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_b3211496-8a0b-446b-b585-3ecfdfa55de7_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_d7a39aa7-755d-4069-9d5d-489831c0e073_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember_label_en-US" xlink:label="lab_bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The requirement that we invest a sufficient portion of our assets in Qualifying Assets could preclude us from investing in accordance with our current business strategy [Member]</link:label>
    <link:label id="lab_bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember_documentation_en-US" xlink:label="lab_bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The requirement that we invest a sufficient portion of our assets in Qualifying Assets could preclude us from investing in accordance with our current business strategy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember" xlink:href="bxsl-20231231.xsd#bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember" xlink:to="lab_bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_52d448a0-a0b3-4c19-b4b6-dd00a8e89498_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental information and non-cash activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember_label_en-US" xlink:label="lab_bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations could have an adverse effect on the ability of Blackstone Credit and its MiFID-authorized EEA affiliates to obtain and research in connection with the provision of an investment service. [Member]</link:label>
    <link:label id="lab_bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember_documentation_en-US" xlink:label="lab_bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations could have an adverse effect on the ability of Blackstone Credit and its MiFID-authorized EEA affiliates to obtain and research in connection with the provision of an investment service.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember" xlink:href="bxsl-20231231.xsd#bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember" xlink:to="lab_bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember_label_en-US" xlink:label="lab_bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enter into credit default swaps or other derivative transactions which expose us to certain risks associated with the use of leverage. [Member]</link:label>
    <link:label id="lab_bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember_documentation_en-US" xlink:label="lab_bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enter into credit default swaps or other derivative transactions which expose us to certain risks associated with the use of leverage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember" xlink:href="bxsl-20231231.xsd#bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember" xlink:to="lab_bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ScheduleOfSharesRepurchasedTableTextBlock_d7ab26fb-5c01-4cd7-bf92-a5d65b8eff44_terseLabel_en-US" xlink:label="lab_bxsl_ScheduleOfSharesRepurchasedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shares Repurchased</link:label>
    <link:label id="lab_bxsl_ScheduleOfSharesRepurchasedTableTextBlock_label_en-US" xlink:label="lab_bxsl_ScheduleOfSharesRepurchasedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Shares Repurchased [Table Text Block]</link:label>
    <link:label id="lab_bxsl_ScheduleOfSharesRepurchasedTableTextBlock_documentation_en-US" xlink:label="lab_bxsl_ScheduleOfSharesRepurchasedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ScheduleOfSharesRepurchasedTableTextBlock" xlink:href="bxsl-20231231.xsd#bxsl_ScheduleOfSharesRepurchasedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ScheduleOfSharesRepurchasedTableTextBlock" xlink:to="lab_bxsl_ScheduleOfSharesRepurchasedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_020ecd56-c730-4ffa-b2d6-a645c88b5a28_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Company10b51PlanMember_e8bb30aa-a1f7-4df7-827b-959f50994d31_terseLabel_en-US" xlink:label="lab_bxsl_Company10b51PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company 10b5-1 Plan</link:label>
    <link:label id="lab_bxsl_Company10b51PlanMember_label_en-US" xlink:label="lab_bxsl_Company10b51PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company 10b5-1 Plan [Member]</link:label>
    <link:label id="lab_bxsl_Company10b51PlanMember_documentation_en-US" xlink:label="lab_bxsl_Company10b51PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company 10b5-1 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Company10b51PlanMember" xlink:href="bxsl-20231231.xsd#bxsl_Company10b51PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Company10b51PlanMember" xlink:to="lab_bxsl_Company10b51PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_HealthCareEquipmentSuppliesSectorMember_504c2953-28ab-407a-9bcc-10e7fab316de_terseLabel_en-US" xlink:label="lab_bxsl_HealthCareEquipmentSuppliesSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Equipment &amp; Supplies</link:label>
    <link:label id="lab_bxsl_HealthCareEquipmentSuppliesSectorMember_label_en-US" xlink:label="lab_bxsl_HealthCareEquipmentSuppliesSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Equipment &amp; Supplies Sector [Member]</link:label>
    <link:label id="lab_bxsl_HealthCareEquipmentSuppliesSectorMember_documentation_en-US" xlink:label="lab_bxsl_HealthCareEquipmentSuppliesSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Equipment &amp; Supplies Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareEquipmentSuppliesSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareEquipmentSuppliesSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_HealthCareEquipmentSuppliesSectorMember" xlink:to="lab_bxsl_HealthCareEquipmentSuppliesSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_6e79c8f2-0c2b-493d-a1e5-dbc263861e46_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to affiliates</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4708db84-0fad-495d-b392-757801e67ea3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock_bb128ddc-ebd5-4f5f-9ab0-5b26414c5ec6_terseLabel_en-US" xlink:label="lab_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Received and Shares Issued to Shareholders</link:label>
    <link:label id="lab_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock_label_en-US" xlink:label="lab_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Dividend Reinvestment Plan [Table Text Block]</link:label>
    <link:label id="lab_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock_documentation_en-US" xlink:label="lab_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Dividend Reinvestment Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock" xlink:href="bxsl-20231231.xsd#bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock" xlink:to="lab_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentInterestRateFloor_48b7005f-d731-4b27-96c6-0acc8b16d45a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, floor</link:label>
    <link:label id="lab_us-gaap_InvestmentInterestRateFloor_label_en-US" xlink:label="lab_us-gaap_InvestmentInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Interest Rate, Floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRateFloor" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentInterestRateFloor" xlink:to="lab_us-gaap_InvestmentInterestRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3e980cc7-9b51-42bb-b2de-545734a6ddf1_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_HealthCareProvidersServicesSectorMember_a6d4859b-8372-469a-bae9-fef695dac952_terseLabel_en-US" xlink:label="lab_bxsl_HealthCareProvidersServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Providers &amp; Services</link:label>
    <link:label id="lab_bxsl_HealthCareProvidersServicesSectorMember_label_en-US" xlink:label="lab_bxsl_HealthCareProvidersServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Providers &amp; Services Sector [Member]</link:label>
    <link:label id="lab_bxsl_HealthCareProvidersServicesSectorMember_documentation_en-US" xlink:label="lab_bxsl_HealthCareProvidersServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Providers &amp; Services Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareProvidersServicesSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareProvidersServicesSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_HealthCareProvidersServicesSectorMember" xlink:to="lab_bxsl_HealthCareProvidersServicesSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation_3d641a6a-1b6f-4371-be51-ebb23eaf197d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized depreciation</link:label>
    <link:label id="lab_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation_label_en-US" xlink:label="lab_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis, Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation" xlink:to="lab_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b01598e6-5381-43cb-b8c6-3cbcf93b91ea_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OilGasConsumableFuelsMember_113f82f3-f4dd-4382-b719-d4388237e8fe_terseLabel_en-US" xlink:label="lab_bxsl_OilGasConsumableFuelsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oil, Gas &amp; Consumable Fuels</link:label>
    <link:label id="lab_bxsl_OilGasConsumableFuelsMember_label_en-US" xlink:label="lab_bxsl_OilGasConsumableFuelsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oil, Gas &amp; Consumable Fuels [Member]</link:label>
    <link:label id="lab_bxsl_OilGasConsumableFuelsMember_documentation_en-US" xlink:label="lab_bxsl_OilGasConsumableFuelsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oil, Gas &amp; Consumable Fuels</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OilGasConsumableFuelsMember" xlink:href="bxsl-20231231.xsd#bxsl_OilGasConsumableFuelsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OilGasConsumableFuelsMember" xlink:to="lab_bxsl_OilGasConsumableFuelsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember_label_en-US" xlink:label="lab_bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims. [Member]</link:label>
    <link:label id="lab_bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember_documentation_en-US" xlink:label="lab_bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember" xlink:href="bxsl-20231231.xsd#bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember" xlink:to="lab_bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_e758b541-9ea5-4b6c-8d90-17a3194294b5_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_f401bdc3-b343-45c5-9430-62e913f27118_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Number of Shares Repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_BuildingProductsSectorMember_2cad3946-24c9-4aba-9af9-4ff335e4efa3_terseLabel_en-US" xlink:label="lab_bxsl_BuildingProductsSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Products</link:label>
    <link:label id="lab_bxsl_BuildingProductsSectorMember_label_en-US" xlink:label="lab_bxsl_BuildingProductsSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Products Sector [Member]</link:label>
    <link:label id="lab_bxsl_BuildingProductsSectorMember_documentation_en-US" xlink:label="lab_bxsl_BuildingProductsSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Products Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BuildingProductsSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_BuildingProductsSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_BuildingProductsSectorMember" xlink:to="lab_bxsl_BuildingProductsSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_d8966e83-271f-4747-b3e9-c3f205bc67a0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">% of Total Investments at Fair Value</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_acb04c3c-abb1-4dbf-ad68-fe7a7f5a4c61_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_3201b4dc-4844-4477-8eb2-2c2da6c4af2f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity_cfbe1f57-9baa-43c9-97d0-002a58233bd6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity_label_en-US" xlink:label="lab_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Purchase, Investment, Operating Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity" xlink:to="lab_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_a65c9742-26e1-495d-a848-0fe527e3da50_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Financing Costs and Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_641bf154-a854-499b-b1da-d73489f53301_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIssuerNameAxis_acff7452-ec74-4a03-b983-8c0331ed71b4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIssuerNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Issuer Name [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentIssuerNameAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentIssuerNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Issuer Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIssuerNameAxis" xlink:to="lab_us-gaap_InvestmentIssuerNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f9bb28a8-ae1b-457f-a636-92354adff908_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAverageAmountOutstanding_691e20fa-fa37-4e5d-85ea-1bca18fd65c3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAverageAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average principal debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAverageAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAverageAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Average Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAverageAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAverageAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAverageAmountOutstanding" xlink:to="lab_us-gaap_LongTermDebtAverageAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesRate_05aecaa4-bf4d-4f5e-9a3a-15c3128e56b0_terseLabel_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income based incentive rate</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesRate_label_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Rate</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesRate_documentation_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesRate" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesRate" xlink:to="lab_bxsl_IncomeBasedIncentiveFeesRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_6070bdb3-d9d0-446c-bd20-438f0c21ecf7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Dividends2Member_829e886d-83bb-42f4-916c-5480e48ad0bb_terseLabel_en-US" xlink:label="lab_bxsl_Dividends2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 2</link:label>
    <link:label id="lab_bxsl_Dividends2Member_label_en-US" xlink:label="lab_bxsl_Dividends2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 2 [Member]</link:label>
    <link:label id="lab_bxsl_Dividends2Member_documentation_en-US" xlink:label="lab_bxsl_Dividends2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends2Member" xlink:href="bxsl-20231231.xsd#bxsl_Dividends2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Dividends2Member" xlink:to="lab_bxsl_Dividends2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio_13809ad0-fd8a-4038-8f17-da14939e66d9_terseLabel_en-US" xlink:label="lab_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset coverage ratio</link:label>
    <link:label id="lab_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio_label_en-US" xlink:label="lab_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Required Asset Coverage Ratio</link:label>
    <link:label id="lab_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio_documentation_en-US" xlink:label="lab_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Required Asset Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio" xlink:href="bxsl-20231231.xsd#bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio" xlink:to="lab_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember_label_en-US" xlink:label="lab_bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may be obligated to pay the Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember_documentation_en-US" xlink:label="lab_bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may be obligated to pay the Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember" xlink:to="lab_bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_d7ae1d99-0e33-4e27-8c14-fd1c46a8bfc4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_VariableRateScenarioAxis_8ade8627-a393-443c-99ac-dfa8ffbcb8db_terseLabel_en-US" xlink:label="lab_bxsl_VariableRateScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Scenario [Axis]</link:label>
    <link:label id="lab_bxsl_VariableRateScenarioAxis_label_en-US" xlink:label="lab_bxsl_VariableRateScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Scenario [Axis]</link:label>
    <link:label id="lab_bxsl_VariableRateScenarioAxis_documentation_en-US" xlink:label="lab_bxsl_VariableRateScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Scenario</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariableRateScenarioAxis" xlink:href="bxsl-20231231.xsd#bxsl_VariableRateScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_VariableRateScenarioAxis" xlink:to="lab_bxsl_VariableRateScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember_label_en-US" xlink:label="lab_bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">There may be trademark risk, as we do not own the Blackstone name. [Member]</link:label>
    <link:label id="lab_bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember_documentation_en-US" xlink:label="lab_bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">There may be trademark risk, as we do not own the Blackstone name.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember" xlink:href="bxsl-20231231.xsd#bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember" xlink:to="lab_bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_98927a21-da8b-4476-bacd-0a432773a30e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2fe33be6-8047-4e7b-8689-69e03f99556f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_3eff4baa-3bce-4841-b2d8-a67f965497ec_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5e9d095b-f85c-4ace-bf20-5e8ddf5ce82b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyChangesInNetAssetsTable_20bf51a5-7f04-4bf5-bf04-951467b93d08_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyChangesInNetAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Changes in Net Assets [Table]</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyChangesInNetAssetsTable_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyChangesInNetAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Change in Net Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyChangesInNetAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyChangesInNetAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyChangesInNetAssetsTable" xlink:to="lab_us-gaap_InvestmentCompanyChangesInNetAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_f08450f6-85cc-40a6-a1ff-45241778e129_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FeeIncome_22646e14-d12d-45fa-90e6-3ca53b92e36b_terseLabel_en-US" xlink:label="lab_us-gaap_FeeIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee income</link:label>
    <link:label id="lab_us-gaap_FeeIncome_label_en-US" xlink:label="lab_us-gaap_FeeIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FeeIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FeeIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FeeIncome" xlink:to="lab_us-gaap_FeeIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_b4404fa1-44f8-440f-9f42-a4091f215b15_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease_d162daf1-79ba-4283-b971-5cfc8144792e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gains (Losses)</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease" xlink:to="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_e05de0f0-14bc-4c37-9667-492d81c715db_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_SoftwareSectorMember_02e41453-392c-4678-a12e-9f3a18aeef5a_terseLabel_en-US" xlink:label="lab_bxsl_SoftwareSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_bxsl_SoftwareSectorMember_label_en-US" xlink:label="lab_bxsl_SoftwareSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Sector [Member]</link:label>
    <link:label id="lab_bxsl_SoftwareSectorMember_documentation_en-US" xlink:label="lab_bxsl_SoftwareSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SoftwareSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_SoftwareSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_SoftwareSectorMember" xlink:to="lab_bxsl_SoftwareSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium_e4abf8e5-6fdf-4487-96ba-5467c6fd89ae_terseLabel_en-US" xlink:label="lab_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of discount/amortization of premium</link:label>
    <link:label id="lab_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium_label_en-US" xlink:label="lab_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Accretion Of Discount/Amortization Of Premium</link:label>
    <link:label id="lab_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium_documentation_en-US" xlink:label="lab_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Accretion Of Discount/Amortization Of Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" xlink:href="bxsl-20231231.xsd#bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" xlink:to="lab_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome_f53b25d9-f504-4cc2-9774-5785c872befe_verboseLabel_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible capital gains incentive fees</link:label>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome_label_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis Reconciliation, Non-Deductible Tax Expense, Capital Gains Incentive Fee, Increase (Decrease) In Taxable Income</link:label>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome_documentation_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis Reconciliation, Non-Deductible Tax Expense, Capital Gains Incentive Fee, Increase (Decrease) In Taxable Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome" xlink:to="lab_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember_label_en-US" xlink:label="lab_bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Failure to maintain our status as a BDC would reduce our operating flexibility. [Member]</link:label>
    <link:label id="lab_bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember_documentation_en-US" xlink:label="lab_bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Failure to maintain our status as a BDC would reduce our operating flexibility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember" xlink:href="bxsl-20231231.xsd#bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember" xlink:to="lab_bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember_label_en-US" xlink:label="lab_bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We are exposed to risks associated with changes in interest rates. [Member]</link:label>
    <link:label id="lab_bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember_documentation_en-US" xlink:label="lab_bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We are exposed to risks associated with changes in interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember" xlink:to="lab_bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ExpenseSupportReimbursementRelatedParty_42bcbd4a-8eea-4d8a-be3d-909389481b75_terseLabel_en-US" xlink:label="lab_bxsl_ExpenseSupportReimbursementRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recoupment of expense support (Note 3)</link:label>
    <link:label id="lab_bxsl_ExpenseSupportReimbursementRelatedParty_label_en-US" xlink:label="lab_bxsl_ExpenseSupportReimbursementRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Support Reimbursement, Related Party</link:label>
    <link:label id="lab_bxsl_ExpenseSupportReimbursementRelatedParty_documentation_en-US" xlink:label="lab_bxsl_ExpenseSupportReimbursementRelatedParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Support Reimbursement, Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExpenseSupportReimbursementRelatedParty" xlink:href="bxsl-20231231.xsd#bxsl_ExpenseSupportReimbursementRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ExpenseSupportReimbursementRelatedParty" xlink:to="lab_bxsl_ExpenseSupportReimbursementRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentOwnedAtFairValueMember_ce235f64-394e-4928-abf6-7da1290e3706_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentOwnedAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, At Fair Value</link:label>
    <link:label id="lab_bxsl_InvestmentOwnedAtFairValueMember_label_en-US" xlink:label="lab_bxsl_InvestmentOwnedAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, At Fair Value [Member]</link:label>
    <link:label id="lab_bxsl_InvestmentOwnedAtFairValueMember_documentation_en-US" xlink:label="lab_bxsl_InvestmentOwnedAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, At Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedAtFairValueMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedAtFairValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentOwnedAtFairValueMember" xlink:to="lab_bxsl_InvestmentOwnedAtFairValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayableInvestmentPurchase_359c443d-1f5b-4f11-854b-85ca41e89429_terseLabel_en-US" xlink:label="lab_us-gaap_PayableInvestmentPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payable for investments purchased</link:label>
    <link:label id="lab_us-gaap_PayableInvestmentPurchase_label_en-US" xlink:label="lab_us-gaap_PayableInvestmentPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payable, Investment, Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayableInvestmentPurchase" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayableInvestmentPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayableInvestmentPurchase" xlink:to="lab_us-gaap_PayableInvestmentPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember_c0e72240-3c0c-4fbb-a61c-72c055089c66_terseLabel_en-US" xlink:label="lab_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jackson Hole Funding Facility, Dollar Advances</link:label>
    <link:label id="lab_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember_label_en-US" xlink:label="lab_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jackson Hole Funding Facility, Dollar Advances [Member]</link:label>
    <link:label id="lab_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember_documentation_en-US" xlink:label="lab_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jackson Hole Funding Facility, Dollar Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityDollarAdvancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember" xlink:to="lab_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7d653b45-bf70-4faa-b661-c18e9dea2910_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_06874a01-c8c7-4e20-a912-2934d524d15d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember_label_en-US" xlink:label="lab_bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We have formed CLOs and may form additional CLOs in the future, which may subject us to certain structured financing risks. [Member]</link:label>
    <link:label id="lab_bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember_documentation_en-US" xlink:label="lab_bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We have formed CLOs and may form additional CLOs in the future, which may subject us to certain structured financing risks.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember" xlink:href="bxsl-20231231.xsd#bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember" xlink:to="lab_bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember_label_en-US" xlink:label="lab_bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We are subject to regulatory oversight, which could negatively impact our operations, cash flow or financial condition, impose additional costs on us or otherwise adversely affect our business [Member]</link:label>
    <link:label id="lab_bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember_documentation_en-US" xlink:label="lab_bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We are subject to regulatory oversight, which could negatively impact our operations, cash flow or financial condition, impose additional costs on us or otherwise adversely affect our business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember" xlink:to="lab_bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManagementAndServiceFeesBaseRate_805b26e5-db98-4f84-8fb0-d99b72c32335_terseLabel_en-US" xlink:label="lab_us-gaap_ManagementAndServiceFeesBaseRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base management fee</link:label>
    <link:label id="lab_us-gaap_ManagementAndServiceFeesBaseRate_label_en-US" xlink:label="lab_us-gaap_ManagementAndServiceFeesBaseRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management and Service Fees, Base Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesBaseRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesBaseRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManagementAndServiceFeesBaseRate" xlink:to="lab_us-gaap_ManagementAndServiceFeesBaseRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_eabb476e-ac01-4eae-83c7-b4a68f7e8ba4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentAffiliatedIssuerMember_53b961b7-8641-45fc-8fef-df95e973ed8e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentAffiliatedIssuerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Affiliated Issuer</link:label>
    <link:label id="lab_us-gaap_InvestmentAffiliatedIssuerMember_label_en-US" xlink:label="lab_us-gaap_InvestmentAffiliatedIssuerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Affiliated Issuer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentAffiliatedIssuerMember" xlink:to="lab_us-gaap_InvestmentAffiliatedIssuerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_PaperForestProductsMember_26e9590a-3aa7-4c34-86ab-56c6870f3161_terseLabel_en-US" xlink:label="lab_bxsl_PaperForestProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paper &amp; Forest Products</link:label>
    <link:label id="lab_bxsl_PaperForestProductsMember_label_en-US" xlink:label="lab_bxsl_PaperForestProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paper &amp; Forest Products [Member]</link:label>
    <link:label id="lab_bxsl_PaperForestProductsMember_documentation_en-US" xlink:label="lab_bxsl_PaperForestProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paper &amp; Forest Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaperForestProductsMember" xlink:href="bxsl-20231231.xsd#bxsl_PaperForestProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_PaperForestProductsMember" xlink:to="lab_bxsl_PaperForestProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a0f0a17c-aacf-4b9d-bd36-14ba69739bda_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_877375d0-96f9-4235-ba3f-12170f44f934_terseLabel_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_label_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Line of Credit Arrangements, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:to="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember_label_en-US" xlink:label="lab_bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquire various financial instruments for purposes of &#8220;hedging&#8221; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders. [Member]</link:label>
    <link:label id="lab_bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember_documentation_en-US" xlink:label="lab_bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquire various financial instruments for purposes of &#8220;hedging&#8221; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember" xlink:href="bxsl-20231231.xsd#bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember" xlink:to="lab_bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_ed22bca6-4bac-4150-b4e9-8bf977288132_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net of unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_PharmaceuticalsSectorMember_f1ef776d-b96c-49cf-9043-23f10c34472a_terseLabel_en-US" xlink:label="lab_bxsl_PharmaceuticalsSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals Sector</link:label>
    <link:label id="lab_bxsl_PharmaceuticalsSectorMember_label_en-US" xlink:label="lab_bxsl_PharmaceuticalsSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals Sector [Member]</link:label>
    <link:label id="lab_bxsl_PharmaceuticalsSectorMember_documentation_en-US" xlink:label="lab_bxsl_PharmaceuticalsSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PharmaceuticalsSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_PharmaceuticalsSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_PharmaceuticalsSectorMember" xlink:to="lab_bxsl_PharmaceuticalsSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ProfessionalServicesSectorMember_f119b378-483d-4c8c-98dd-42d8a372678c_terseLabel_en-US" xlink:label="lab_bxsl_ProfessionalServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Services</link:label>
    <link:label id="lab_bxsl_ProfessionalServicesSectorMember_label_en-US" xlink:label="lab_bxsl_ProfessionalServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Services Sector [Member]</link:label>
    <link:label id="lab_bxsl_ProfessionalServicesSectorMember_documentation_en-US" xlink:label="lab_bxsl_ProfessionalServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Services Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ProfessionalServicesSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_ProfessionalServicesSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ProfessionalServicesSectorMember" xlink:to="lab_bxsl_ProfessionalServicesSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements_f89f4157-f5b9-4322-bf0b-71f3e642f305_terseLabel_en-US" xlink:label="lab_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements_label_en-US" xlink:label="lab_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Issuance Costs, Line Of Credit Arrangements</link:label>
    <link:label id="lab_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements_documentation_en-US" xlink:label="lab_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Issuance Costs, Line Of Credit Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" xlink:href="bxsl-20231231.xsd#bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" xlink:to="lab_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TradingCompaniesDistributorsSectorMember_414eee34-3b4b-4b45-bc3f-f948e1c7e1ab_terseLabel_en-US" xlink:label="lab_bxsl_TradingCompaniesDistributorsSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Companies &amp; Distributors</link:label>
    <link:label id="lab_bxsl_TradingCompaniesDistributorsSectorMember_label_en-US" xlink:label="lab_bxsl_TradingCompaniesDistributorsSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Companies &amp; Distributors Sector [Member]</link:label>
    <link:label id="lab_bxsl_TradingCompaniesDistributorsSectorMember_documentation_en-US" xlink:label="lab_bxsl_TradingCompaniesDistributorsSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Companies &amp; Distributors Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TradingCompaniesDistributorsSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_TradingCompaniesDistributorsSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TradingCompaniesDistributorsSectorMember" xlink:to="lab_bxsl_TradingCompaniesDistributorsSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember_label_en-US" xlink:label="lab_bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">When we use leverage, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us. [Member]</link:label>
    <link:label id="lab_bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember_documentation_en-US" xlink:label="lab_bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">When we use leverage, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember" xlink:href="bxsl-20231231.xsd#bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember" xlink:to="lab_bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesScenarioAxis_7a64f2ea-d32d-4266-9419-6177e1a0849c_terseLabel_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Scenario [Axis]</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesScenarioAxis_label_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Scenario [Axis]</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesScenarioAxis_documentation_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Scenario</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesScenarioAxis" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesScenarioAxis" xlink:to="lab_bxsl_IncomeBasedIncentiveFeesScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIdentifierAxis_069880a0-7685-4192-b30d-ab2fa93b87f5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIdentifierAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Identifier [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentIdentifierAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentIdentifierAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Identifier [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIdentifierAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIdentifierAxis" xlink:to="lab_us-gaap_InvestmentIdentifierAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_d6c41350-d72a-4ec6-bf10-2b24cbe5bd7e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_44389164-f20e-43fb-bdfe-619893907540_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Available</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ExpenseSupportAgreementMember_e55e0ab9-e7be-4488-b632-ac5a890ad133_terseLabel_en-US" xlink:label="lab_bxsl_ExpenseSupportAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Support Agreement</link:label>
    <link:label id="lab_bxsl_ExpenseSupportAgreementMember_label_en-US" xlink:label="lab_bxsl_ExpenseSupportAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Support Agreement [Member]</link:label>
    <link:label id="lab_bxsl_ExpenseSupportAgreementMember_documentation_en-US" xlink:label="lab_bxsl_ExpenseSupportAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Support Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExpenseSupportAgreementMember" xlink:href="bxsl-20231231.xsd#bxsl_ExpenseSupportAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ExpenseSupportAgreementMember" xlink:to="lab_bxsl_ExpenseSupportAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember_b140b13f-21c2-4c2c-b7ec-66419272631f_terseLabel_en-US" xlink:label="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Greater Than Catch-Up Amount</link:label>
    <link:label id="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember_label_en-US" xlink:label="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Greater Than Catch-Up Amount [Member]</link:label>
    <link:label id="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember_documentation_en-US" xlink:label="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Greater Than Catch-Up Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember" xlink:href="bxsl-20231231.xsd#bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember" xlink:to="lab_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_dde94c7a-459b-4ab9-ad44-12253bdf6058_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_0e5ce950-5cd0-41b4-ab0b-864b85f25def_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized and realized gain (loss) (in usd per share)</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Gain (Loss) on Investment, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:to="lab_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_eae82de9-b978-4d37-9145-2291f0870f27_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit_385b939b-7348-41cf-9881-3c2be5c94d7a_terseLabel_en-US" xlink:label="lab_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity including the accordion feature</link:label>
    <link:label id="lab_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit_label_en-US" xlink:label="lab_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:label id="lab_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit_documentation_en-US" xlink:label="lab_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:href="bxsl-20231231.xsd#bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:to="lab_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_GroundTransportationMember_741299c1-9c13-4e2f-98cb-b1fcfc0ee452_terseLabel_en-US" xlink:label="lab_bxsl_GroundTransportationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ground Transportation</link:label>
    <link:label id="lab_bxsl_GroundTransportationMember_label_en-US" xlink:label="lab_bxsl_GroundTransportationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ground Transportation [Member]</link:label>
    <link:label id="lab_bxsl_GroundTransportationMember_documentation_en-US" xlink:label="lab_bxsl_GroundTransportationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ground Transportation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_GroundTransportationMember" xlink:href="bxsl-20231231.xsd#bxsl_GroundTransportationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_GroundTransportationMember" xlink:to="lab_bxsl_GroundTransportationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_3bf2dea6-91eb-4497-8318-e8b3106125b3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Par Amount</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember_label_en-US" xlink:label="lab_bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusive forum and jury trial waiver provisions that could limit a shareholder&#8217;s ability to bring a claim, may cause the Company to incur additional costs associated with such action. [Member]</link:label>
    <link:label id="lab_bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember_documentation_en-US" xlink:label="lab_bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusive forum and jury trial waiver provisions that could limit a shareholder&#8217;s ability to bring a claim, may cause the Company to incur additional costs associated with such action.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember" xlink:href="bxsl-20231231.xsd#bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember" xlink:to="lab_bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_5570197b-9366-48f1-b062-50d8437fa2ff_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase plan (in years)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5cf7dcb3-5969-45cc-acb7-44db12fbbd21_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f566b812-2015-4fe0-af85-3c28bd84b618_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_f38023fc-0ac4-49d7-a957-9fa2ee4591c0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember_label_en-US" xlink:label="lab_bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We have not established any limit on the amount of funds we may use from available sources, such as borrowings, if any, or proceeds from securities offerings, to fund distributions [Member]</link:label>
    <link:label id="lab_bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember_documentation_en-US" xlink:label="lab_bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We have not established any limit on the amount of funds we may use from available sources, such as borrowings, if any, or proceeds from securities offerings, to fund distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember" xlink:to="lab_bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IndustrialConglomeratesMember_8cafdffa-a138-49cb-860f-29f9cab125b1_terseLabel_en-US" xlink:label="lab_bxsl_IndustrialConglomeratesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial Conglomerates</link:label>
    <link:label id="lab_bxsl_IndustrialConglomeratesMember_label_en-US" xlink:label="lab_bxsl_IndustrialConglomeratesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial Conglomerates [Member]</link:label>
    <link:label id="lab_bxsl_IndustrialConglomeratesMember_documentation_en-US" xlink:label="lab_bxsl_IndustrialConglomeratesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial Conglomerates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IndustrialConglomeratesMember" xlink:href="bxsl-20231231.xsd#bxsl_IndustrialConglomeratesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IndustrialConglomeratesMember" xlink:to="lab_bxsl_IndustrialConglomeratesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome_a760909b-762f-4b9b-8f4d-684d5baa0e94_verboseLabel_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized (appreciation) depreciation</link:label>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome_label_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis Reconciliation, Net Unrealized Depreciation (Appreciation) On Investments, Increase (Decrease) In Taxable Income</link:label>
    <link:label id="lab_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome_documentation_en-US" xlink:label="lab_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis Reconciliation, Net Unrealized Depreciation (Appreciation) On Investments, Increase (Decrease) In Taxable Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome" xlink:to="lab_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems_9ee0fdc7-442d-4e68-8a5c-60ec35fb53ef_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Changes in Net Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Change in Net Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyChangesInNetAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems" xlink:to="lab_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_f2ddeffc-f36f-421b-8931-fa4c8acbf100_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_c72d5905-7dd9-4781-9a40-c07a12db73f4_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIssuerNameDomain_7f0add41-d099-4f32-b7ee-cdb1c0435c3f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIssuerNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Issuer Name [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentIssuerNameDomain_label_en-US" xlink:label="lab_us-gaap_InvestmentIssuerNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Issuer Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIssuerNameDomain" xlink:to="lab_us-gaap_InvestmentIssuerNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_VoluntaryWaiverScenarioAxis_bad59af7-93fb-4b99-9434-c68a93437a49_terseLabel_en-US" xlink:label="lab_bxsl_VoluntaryWaiverScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Waiver Scenario [Axis]</link:label>
    <link:label id="lab_bxsl_VoluntaryWaiverScenarioAxis_label_en-US" xlink:label="lab_bxsl_VoluntaryWaiverScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Waiver Scenario [Axis]</link:label>
    <link:label id="lab_bxsl_VoluntaryWaiverScenarioAxis_documentation_en-US" xlink:label="lab_bxsl_VoluntaryWaiverScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Waiver Scenario</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioAxis" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_VoluntaryWaiverScenarioAxis" xlink:to="lab_bxsl_VoluntaryWaiverScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Scenario2Member_a07b63fe-4f9e-480a-9cbc-30f0a083ddd9_terseLabel_en-US" xlink:label="lab_bxsl_Scenario2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario 2</link:label>
    <link:label id="lab_bxsl_Scenario2Member_label_en-US" xlink:label="lab_bxsl_Scenario2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario 2 [Member]</link:label>
    <link:label id="lab_bxsl_Scenario2Member_documentation_en-US" xlink:label="lab_bxsl_Scenario2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario2Member" xlink:href="bxsl-20231231.xsd#bxsl_Scenario2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Scenario2Member" xlink:to="lab_bxsl_Scenario2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_bedbdea5-476e-4f00-ba5e-ba239b1ec29d_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Low</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_ade12b3b-1a39-4f33-99d6-27477afd561a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesScenarioDomain_2ad55462-0aae-4ab6-b82e-21ece3bc7487_terseLabel_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Scenario [Domain]</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesScenarioDomain_label_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Scenario [Domain]</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesScenarioDomain_documentation_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesScenarioDomain" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesScenarioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesScenarioDomain" xlink:to="lab_bxsl_IncomeBasedIncentiveFeesScenarioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_SubscriptionFacilityMember_label_en-US" xlink:label="lab_bxsl_SubscriptionFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription Facility [Member]</link:label>
    <link:label id="lab_bxsl_SubscriptionFacilityMember_documentation_en-US" xlink:label="lab_bxsl_SubscriptionFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SubscriptionFacilityMember" xlink:href="bxsl-20231231.xsd#bxsl_SubscriptionFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_SubscriptionFacilityMember" xlink:to="lab_bxsl_SubscriptionFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_475a8dbb-41bf-4a49-9574-415e91e5f606_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_b54a6045-6e06-4162-8398-8d153229abea_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_HealthCareTechnologySectorMember_7bd2a5ef-394b-4342-8b66-a285712e4af7_terseLabel_en-US" xlink:label="lab_bxsl_HealthCareTechnologySectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Technology</link:label>
    <link:label id="lab_bxsl_HealthCareTechnologySectorMember_label_en-US" xlink:label="lab_bxsl_HealthCareTechnologySectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Technology Sector [Member]</link:label>
    <link:label id="lab_bxsl_HealthCareTechnologySectorMember_documentation_en-US" xlink:label="lab_bxsl_HealthCareTechnologySectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Technology Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareTechnologySectorMember" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareTechnologySectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_HealthCareTechnologySectorMember" xlink:to="lab_bxsl_HealthCareTechnologySectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember_label_en-US" xlink:label="lab_bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The NAV of our shares may fluctuate significantly. [Member]</link:label>
    <link:label id="lab_bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember_documentation_en-US" xlink:label="lab_bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The NAV of our shares may fluctuate significantly.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember" xlink:href="bxsl-20231231.xsd#bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember" xlink:to="lab_bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ElectronicEquipmentInstrumentsComponentsMember_d4f8badf-8307-47d3-8b17-640f52bd3145_terseLabel_en-US" xlink:label="lab_bxsl_ElectronicEquipmentInstrumentsComponentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electronic Equipment, Instruments &amp; Components</link:label>
    <link:label id="lab_bxsl_ElectronicEquipmentInstrumentsComponentsMember_label_en-US" xlink:label="lab_bxsl_ElectronicEquipmentInstrumentsComponentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electronic Equipment, Instruments &amp; Components [Member]</link:label>
    <link:label id="lab_bxsl_ElectronicEquipmentInstrumentsComponentsMember_documentation_en-US" xlink:label="lab_bxsl_ElectronicEquipmentInstrumentsComponentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electronic Equipment, Instruments &amp; Components</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectronicEquipmentInstrumentsComponentsMember" xlink:href="bxsl-20231231.xsd#bxsl_ElectronicEquipmentInstrumentsComponentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ElectronicEquipmentInstrumentsComponentsMember" xlink:to="lab_bxsl_ElectronicEquipmentInstrumentsComponentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_e45ea006-ce93-42a0-ae0f-a3adcf650e70_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyFinancialHighlightsRollForward_1762672e-28d6-4617-9fa2-8f1264bff564_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyFinancialHighlightsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Financial Highlights [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyFinancialHighlightsRollForward_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyFinancialHighlightsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Financial Highlights [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialHighlightsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialHighlightsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyFinancialHighlightsRollForward" xlink:to="lab_us-gaap_InvestmentCompanyFinancialHighlightsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_6fb9b7fb-bfba-4e42-af32-eedcdba29e6e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_JacksonHoleFundingFacilityMember_4e436560-f1a5-482f-9585-3f9bdbebf7b2_terseLabel_en-US" xlink:label="lab_bxsl_JacksonHoleFundingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jackson Hole Funding Facility</link:label>
    <link:label id="lab_bxsl_JacksonHoleFundingFacilityMember_label_en-US" xlink:label="lab_bxsl_JacksonHoleFundingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jackson Hole Funding Facility [Member]</link:label>
    <link:label id="lab_bxsl_JacksonHoleFundingFacilityMember_documentation_en-US" xlink:label="lab_bxsl_JacksonHoleFundingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jackson Hole Funding Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityMember" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_JacksonHoleFundingFacilityMember" xlink:to="lab_bxsl_JacksonHoleFundingFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_74a0d021-6710-48d6-a178-f37989a8ef89_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember_label_en-US" xlink:label="lab_bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The inability of the Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business. [Member]</link:label>
    <link:label id="lab_bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember_documentation_en-US" xlink:label="lab_bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The inability of the Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember" xlink:href="bxsl-20231231.xsd#bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember" xlink:to="lab_bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a4a2a6f7-fa7d-48ff-ad19-19959cb536e2_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_d3c413d0-1802-443a-8aa5-05d2e1a6d950_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributable Earnings (Loss)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_a346dfaa-2a99-42f6-b056-6d13ecf006c9_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated net realized gain (loss)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember_label_en-US" xlink:label="lab_bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Any unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available for distribution. [Member]</link:label>
    <link:label id="lab_bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember_documentation_en-US" xlink:label="lab_bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Any unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available for distribution.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember" xlink:href="bxsl-20231231.xsd#bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember" xlink:to="lab_bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_MeasurementInputPerformanceMultipleMember_f2d20243-6b99-4e16-b6a1-253c00973f00_terseLabel_en-US" xlink:label="lab_bxsl_MeasurementInputPerformanceMultipleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Multiple</link:label>
    <link:label id="lab_bxsl_MeasurementInputPerformanceMultipleMember_label_en-US" xlink:label="lab_bxsl_MeasurementInputPerformanceMultipleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Performance Multiple [Member]</link:label>
    <link:label id="lab_bxsl_MeasurementInputPerformanceMultipleMember_documentation_en-US" xlink:label="lab_bxsl_MeasurementInputPerformanceMultipleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Performance Multiple</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MeasurementInputPerformanceMultipleMember" xlink:href="bxsl-20231231.xsd#bxsl_MeasurementInputPerformanceMultipleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_MeasurementInputPerformanceMultipleMember" xlink:to="lab_bxsl_MeasurementInputPerformanceMultipleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_3fabc2be-e80c-46b1-b4c9-5bf945bd4040_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net accretion of discount and amortization of premium</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_86c319e6-dafd-49d8-a57e-09a1a6c460cb_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and net assets</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_0d9c9b7a-7455-489f-8e5d-4d562cab5f06_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss), basic, per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_5ace1a42-f712-4cef-a9c9-6fcf318085fe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_6e77a95e-b180-4996-911e-727c532c442f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_dc61d4a4-c726-496f-af46-137dd1114dad_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased_f9139c27-3ecd-44fd-a68c-935ed32f4627_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payable for investments purchased</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Payable for Investment Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased" xlink:to="lab_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableInvestmentSale_d85e29a4-b3d6-48d6-8fa4-9710b16dfc0d_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableInvestmentSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable for investments sold</link:label>
    <link:label id="lab_us-gaap_ReceivableInvestmentSale_label_en-US" xlink:label="lab_us-gaap_ReceivableInvestmentSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable, Investment, Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableInvestmentSale" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableInvestmentSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableInvestmentSale" xlink:to="lab_us-gaap_ReceivableInvestmentSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax_103526ec-d62f-4d84-b205-6bb21b1db1a4_totalLabel_en-US" xlink:label="lab_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized and change in unrealized gain (loss)</link:label>
    <link:label id="lab_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax_label_en-US" xlink:label="lab_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss), Investment and Derivative, Operating, and Foreign Currency Transaction, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax" xlink:to="lab_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember_label_en-US" xlink:label="lab_bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cybersecurity risks and data protection could result in the loss of data, interruptions in our business, damage to our reputation, and subject us to regulatory actions [Member]</link:label>
    <link:label id="lab_bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember_documentation_en-US" xlink:label="lab_bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cybersecurity risks and data protection could result in the loss of data, interruptions in our business, damage to our reputation, and subject us to regulatory actions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember" xlink:href="bxsl-20231231.xsd#bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember" xlink:to="lab_bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember_label_en-US" xlink:label="lab_bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holders of any preferred shares that we may issue will have the right to elect certain members of our Board and have class voting rights on certain matters. [Member]</link:label>
    <link:label id="lab_bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember_documentation_en-US" xlink:label="lab_bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holders of any preferred shares that we may issue will have the right to elect certain members of our Board and have class voting rights on certain matters.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember" xlink:href="bxsl-20231231.xsd#bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember" xlink:to="lab_bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember_label_en-US" xlink:label="lab_bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">It may be difficult to bring suit or foreclosure in non-U.S. countries [Member]</link:label>
    <link:label id="lab_bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember_documentation_en-US" xlink:label="lab_bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">It may be difficult to bring suit or foreclosure in non-U.S. countries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember" xlink:href="bxsl-20231231.xsd#bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember" xlink:to="lab_bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_CommercialServicesSuppliesSectorMember_f1e8bc80-dd6d-41e8-831f-24ba249f2fad_terseLabel_en-US" xlink:label="lab_bxsl_CommercialServicesSuppliesSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Services &amp; Supplies</link:label>
    <link:label id="lab_bxsl_CommercialServicesSuppliesSectorMember_label_en-US" xlink:label="lab_bxsl_CommercialServicesSuppliesSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Services &amp; Supplies Sector [Member]</link:label>
    <link:label id="lab_bxsl_CommercialServicesSuppliesSectorMember_documentation_en-US" xlink:label="lab_bxsl_CommercialServicesSuppliesSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Services &amp; Supplies Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommercialServicesSuppliesSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_CommercialServicesSuppliesSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_CommercialServicesSuppliesSectorMember" xlink:to="lab_bxsl_CommercialServicesSuppliesSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_5f2ccd26-d11c-4c10-a53c-c8076b9468ac_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expenses before excise tax</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Investment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_711d3164-c853-4d8f-aa0f-57854e8429ab_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DebtIssuanceCostsIncurredButNotYetPaid_cb62eae3-7762-4473-88c3-1a7019ed43d7_terseLabel_en-US" xlink:label="lab_bxsl_DebtIssuanceCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued but unpaid debt issuing costs</link:label>
    <link:label id="lab_bxsl_DebtIssuanceCostsIncurredButNotYetPaid_label_en-US" xlink:label="lab_bxsl_DebtIssuanceCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs Incurred But Not Yet Paid</link:label>
    <link:label id="lab_bxsl_DebtIssuanceCostsIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_bxsl_DebtIssuanceCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs Incurred But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtIssuanceCostsIncurredButNotYetPaid" xlink:href="bxsl-20231231.xsd#bxsl_DebtIssuanceCostsIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DebtIssuanceCostsIncurredButNotYetPaid" xlink:to="lab_bxsl_DebtIssuanceCostsIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember_e2de47ac-2fba-40eb-991c-aff039fafebd_terseLabel_en-US" xlink:label="lab_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, First Lien, Realized Gain (Loss)</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember_label_en-US" xlink:label="lab_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, First Lien, Realized Gain (Loss) [Member]</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember_documentation_en-US" xlink:label="lab_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, First Lien, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienRealizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember" xlink:to="lab_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentInterestRatePaidInKind_e1816d53-0e48-4475-bb7f-8bd0e78fb230_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentInterestRatePaidInKind" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid in Kind</link:label>
    <link:label id="lab_us-gaap_InvestmentInterestRatePaidInKind_label_en-US" xlink:label="lab_us-gaap_InvestmentInterestRatePaidInKind" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Interest Rate, Paid in Kind</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRatePaidInKind" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRatePaidInKind"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentInterestRatePaidInKind" xlink:to="lab_us-gaap_InvestmentInterestRatePaidInKind" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_617eba65-8fdf-4991-be8d-72ad16eabd82_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinvestment of distributions during the period</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ElectricUtilitiesMember_b798c541-2bce-431f-b009-dd89b71d4f16_terseLabel_en-US" xlink:label="lab_bxsl_ElectricUtilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electric Utilities</link:label>
    <link:label id="lab_bxsl_ElectricUtilitiesMember_label_en-US" xlink:label="lab_bxsl_ElectricUtilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electric Utilities [Member]</link:label>
    <link:label id="lab_bxsl_ElectricUtilitiesMember_documentation_en-US" xlink:label="lab_bxsl_ElectricUtilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electric Utilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectricUtilitiesMember" xlink:href="bxsl-20231231.xsd#bxsl_ElectricUtilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ElectricUtilitiesMember" xlink:to="lab_bxsl_ElectricUtilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_ffc122f1-0144-4e8a-889c-05a1cca3ba33_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_c3a9c32d-6041-4bb3-a134-4ffe936e5dbb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings on debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_fca5ba05-d57c-4809-8002-27e08780cb81_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total increase (decrease) in net assets (in usd per share)</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Net Asset Value Per Share, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:to="lab_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_172f2acd-e886-4125-9501-5511f8e6ffeb_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DebtSecuritiesSecondLienMember_4facd788-ebd6-423e-ba8e-4e27a36e4034_terseLabel_en-US" xlink:label="lab_bxsl_DebtSecuritiesSecondLienMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second lien debt</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesSecondLienMember_label_en-US" xlink:label="lab_bxsl_DebtSecuritiesSecondLienMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Second Lien [Member]</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesSecondLienMember_documentation_en-US" xlink:label="lab_bxsl_DebtSecuritiesSecondLienMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Second Lien</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienMember" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DebtSecuritiesSecondLienMember" xlink:to="lab_bxsl_DebtSecuritiesSecondLienMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Scenario4Member_a2553a84-ba01-4114-a834-8615078e28e0_terseLabel_en-US" xlink:label="lab_bxsl_Scenario4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario 4</link:label>
    <link:label id="lab_bxsl_Scenario4Member_label_en-US" xlink:label="lab_bxsl_Scenario4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario 4 [Member]</link:label>
    <link:label id="lab_bxsl_Scenario4Member_documentation_en-US" xlink:label="lab_bxsl_Scenario4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario 4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario4Member" xlink:href="bxsl-20231231.xsd#bxsl_Scenario4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Scenario4Member" xlink:to="lab_bxsl_Scenario4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_b493f157-e09f-46c2-aa00-66b7b4d7ac06_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_f0ed8390-0483-478d-8989-3e7cb30e2e9d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_label_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseBorrowings" xlink:to="lab_us-gaap_InterestExpenseBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AerospaceAndDefenseSectorMember_1e3a6a1b-de44-4e91-9b05-b5a86bc84c12_terseLabel_en-US" xlink:label="lab_bxsl_AerospaceAndDefenseSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aerospace &amp; Defense</link:label>
    <link:label id="lab_bxsl_AerospaceAndDefenseSectorMember_label_en-US" xlink:label="lab_bxsl_AerospaceAndDefenseSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aerospace And Defense Sector [Member]</link:label>
    <link:label id="lab_bxsl_AerospaceAndDefenseSectorMember_documentation_en-US" xlink:label="lab_bxsl_AerospaceAndDefenseSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aerospace And Defense Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AerospaceAndDefenseSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_AerospaceAndDefenseSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AerospaceAndDefenseSectorMember" xlink:to="lab_bxsl_AerospaceAndDefenseSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_e806e268-d37a-4a38-ad51-0944aa99d08d_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_StockIssuedDuringPeriodValueNewIssuesGross_231247d2-49c4-4091-9cf7-6ac311a91a99_terseLabel_en-US" xlink:label="lab_bxsl_StockIssuedDuringPeriodValueNewIssuesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Proceeds</link:label>
    <link:label id="lab_bxsl_StockIssuedDuringPeriodValueNewIssuesGross_label_en-US" xlink:label="lab_bxsl_StockIssuedDuringPeriodValueNewIssuesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues, Gross</link:label>
    <link:label id="lab_bxsl_StockIssuedDuringPeriodValueNewIssuesGross_documentation_en-US" xlink:label="lab_bxsl_StockIssuedDuringPeriodValueNewIssuesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_StockIssuedDuringPeriodValueNewIssuesGross" xlink:href="bxsl-20231231.xsd#bxsl_StockIssuedDuringPeriodValueNewIssuesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_StockIssuedDuringPeriodValueNewIssuesGross" xlink:to="lab_bxsl_StockIssuedDuringPeriodValueNewIssuesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_3cedbab5-e0bd-4126-9cbf-496a046bfac2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_68b6b889-65c6-412e-a895-ea0e9cf2a3c5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlled/affiliated investments</link:label>
    <link:label id="lab_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_label_en-US" xlink:label="lab_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Affiliated Issuer, Noncontrolled [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember" xlink:to="lab_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan_2a09ac3a-88a0-46b6-9bb2-b51cd95689b2_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinvestment of dividends</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan_076d8a88-b8e0-44dd-ad9e-ee97fee46ae6_netLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DRIP Shares Value</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Dividend Reinvestment Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract" xlink:to="lab_us-gaap_ScheduleOfInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember_label_en-US" xlink:label="lab_bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General economic conditions could adversely affect the performance of our investments and operations [Member]</link:label>
    <link:label id="lab_bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember_documentation_en-US" xlink:label="lab_bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General economic conditions could adversely affect the performance of our investments and operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember" xlink:href="bxsl-20231231.xsd#bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember" xlink:to="lab_bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_0a89d66c-be97-4899-a40c-bd9ad8b7b5f8_totalLabel_en-US" xlink:label="lab_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized gain (loss)</link:label>
    <link:label id="lab_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_e24e8eee-b391-4a0a-ba3b-fb57bf55e8b7_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized gain (loss) on investments</link:label>
    <link:label id="lab_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_label_en-US" xlink:label="lab_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Gain (Loss), Investment, Derivative, and Foreign Currency Transaction Price Change, Operating, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" xlink:to="lab_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_9474898d-cba4-40f3-84f8-e75043cb2a3f_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet_8e2664ba-809d-4875-a644-18aa086bbd6d_totalLabel_en-US" xlink:label="lab_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized appreciation (depreciation)</link:label>
    <link:label id="lab_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet_label_en-US" xlink:label="lab_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Tax Basis, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet" xlink:to="lab_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_RelatedPartyTransactionRenewalTerm_d780b022-3945-425a-8caf-1dc9484e39e7_terseLabel_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, renewal term</link:label>
    <link:label id="lab_bxsl_RelatedPartyTransactionRenewalTerm_label_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Renewal Term</link:label>
    <link:label id="lab_bxsl_RelatedPartyTransactionRenewalTerm_documentation_en-US" xlink:label="lab_bxsl_RelatedPartyTransactionRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionRenewalTerm" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_RelatedPartyTransactionRenewalTerm" xlink:to="lab_bxsl_RelatedPartyTransactionRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_ad75cedd-db27-4d99-99f1-a946316adf3b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions_971b2a3c-749f-4283-87c7-dd21c8a2fc9a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Reductions</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Affiliates, at Fair Value, Gross Reductions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions" xlink:to="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_Scenario1Member_c9608a5f-0002-46b2-a4ef-edd1200f4028_terseLabel_en-US" xlink:label="lab_bxsl_Scenario1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario 1</link:label>
    <link:label id="lab_bxsl_Scenario1Member_label_en-US" xlink:label="lab_bxsl_Scenario1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario 1 [Member]</link:label>
    <link:label id="lab_bxsl_Scenario1Member_documentation_en-US" xlink:label="lab_bxsl_Scenario1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario1Member" xlink:href="bxsl-20231231.xsd#bxsl_Scenario1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_Scenario1Member" xlink:to="lab_bxsl_Scenario1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9303abe-fe54-414f-a39c-b70953b086ab_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_a59436e1-0031-4ab3-b29b-3aed466fa242_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember_label_en-US" xlink:label="lab_bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Adviser relies on key personnel, the loss of any of whom could impair its ability to successfully manage us. [Member]</link:label>
    <link:label id="lab_bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember_documentation_en-US" xlink:label="lab_bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Adviser relies on key personnel, the loss of any of whom could impair its ability to successfully manage us.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember" xlink:href="bxsl-20231231.xsd#bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember" xlink:to="lab_bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_0dd1b547-a0ee-4453-bc35-f1f469023295_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings, Schedule of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:to="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember_label_en-US" xlink:label="lab_bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Some of our investments may be subject to corporate-level income tax. [Member]</link:label>
    <link:label id="lab_bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember_documentation_en-US" xlink:label="lab_bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Some of our investments may be subject to corporate-level income tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember" xlink:href="bxsl-20231231.xsd#bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember" xlink:to="lab_bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract_bdd37e35-15d2-4cd0-a3c9-9d7f131ad1cc_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratios:</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract_label_en-US" xlink:label="lab_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Ratio To Average Net Assets [Abstract]</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract_documentation_en-US" xlink:label="lab_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Ratio To Average Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract" xlink:to="lab_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInManagementFeePayable_d85e72c9-3d70-4e90-9d5d-a4968eea600a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInManagementFeePayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInManagementFeePayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInManagementFeePayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Management Fee Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInManagementFeePayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInManagementFeePayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInManagementFeePayable" xlink:to="lab_us-gaap_IncreaseDecreaseInManagementFeePayable" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ITServicesSectorMember_4c10bbb3-4365-41f5-92dd-22651f2fd4ee_terseLabel_en-US" xlink:label="lab_bxsl_ITServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IT Services</link:label>
    <link:label id="lab_bxsl_ITServicesSectorMember_label_en-US" xlink:label="lab_bxsl_ITServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IT Services Sector [Member]</link:label>
    <link:label id="lab_bxsl_ITServicesSectorMember_documentation_en-US" xlink:label="lab_bxsl_ITServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IT Services Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ITServicesSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_ITServicesSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ITServicesSectorMember" xlink:to="lab_bxsl_ITServicesSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyTotalReturn_091d029f-8eec-4583-8ea4-9b36d6ebf7b9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyTotalReturn" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total return based on NAV</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyTotalReturn_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyTotalReturn" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Total Return</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyTotalReturn" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTotalReturn"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyTotalReturn" xlink:to="lab_us-gaap_InvestmentCompanyTotalReturn" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrusteeFees_f2aaa0d7-4752-4025-b8bf-9f6ba692a51c_terseLabel_en-US" xlink:label="lab_us-gaap_TrusteeFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board of Trustees' fees</link:label>
    <link:label id="lab_us-gaap_TrusteeFees_label_en-US" xlink:label="lab_us-gaap_TrusteeFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trustee Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrusteeFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrusteeFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrusteeFees" xlink:to="lab_us-gaap_TrusteeFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_b41befed-a0fb-41ec-9b14-07db7a062e41_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_718eef11-dd88-4ff1-85e3-d3bcca9a7235_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember_label_en-US" xlink:label="lab_bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legislative or regulatory tax changes could adversely affect investors. [Member]</link:label>
    <link:label id="lab_bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember_documentation_en-US" xlink:label="lab_bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legislative or regulatory tax changes could adversely affect investors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember" xlink:href="bxsl-20231231.xsd#bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember" xlink:to="lab_bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember_label_en-US" xlink:label="lab_bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing in our shares involves a high degree of risk. [Member]</link:label>
    <link:label id="lab_bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember_documentation_en-US" xlink:label="lab_bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing in our shares involves a high degree of risk.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember" xlink:to="lab_bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_85fb9fa5-32ec-41e4-add8-e1b1ca240c33_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused portion</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:to="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember_label_en-US" xlink:label="lab_bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terrorist attacks, acts of war or natural disasters may adversely affect our operations. [Member]</link:label>
    <link:label id="lab_bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember_documentation_en-US" xlink:label="lab_bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terrorist attacks, acts of war or natural disasters may adversely affect our operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember" xlink:href="bxsl-20231231.xsd#bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember" xlink:to="lab_bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_f8301267-d2ae-4e7c-ad4d-0e4497ec95de_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember_label_en-US" xlink:label="lab_bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inflation and supply chain risks have had and may continue to have an adverse impact on our financial condition and results of operations. [Member]</link:label>
    <link:label id="lab_bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember_documentation_en-US" xlink:label="lab_bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inflation and supply chain risks have had and may continue to have an adverse impact on our financial condition and results of operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember" xlink:href="bxsl-20231231.xsd#bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember" xlink:to="lab_bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_f63a4935-387a-44c3-9a0c-a420d444e3f6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_4ae976f2-b5b1-4728-a464-eb70679921ac_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio_bed7881c-e53f-4e6d-8169-faedb748d84c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset coverage ratio</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Senior Security, Indebtedness, Asset Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" xlink:to="lab_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TransferRestrictionsDomain_4efe2fdb-d22e-49db-b3d4-ed1b7172f9cf_terseLabel_en-US" xlink:label="lab_bxsl_TransferRestrictionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Restrictions [Domain]</link:label>
    <link:label id="lab_bxsl_TransferRestrictionsDomain_label_en-US" xlink:label="lab_bxsl_TransferRestrictionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Restrictions [Domain]</link:label>
    <link:label id="lab_bxsl_TransferRestrictionsDomain_documentation_en-US" xlink:label="lab_bxsl_TransferRestrictionsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Restrictions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransferRestrictionsDomain" xlink:href="bxsl-20231231.xsd#bxsl_TransferRestrictionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TransferRestrictionsDomain" xlink:to="lab_bxsl_TransferRestrictionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement_dbc5164b-3ff9-477f-a61f-c28edcab5704_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net expenses before excise tax</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Expense, after Reduction of Fee Waiver and Reimbursement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement" xlink:to="lab_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember_label_en-US" xlink:label="lab_bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Adviser&#8217;s influence on conducting our operations gives it the ability to increase its fees, which may reduce the amount of cash flow available for distribution to our shareholders. [Member]</link:label>
    <link:label id="lab_bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember_documentation_en-US" xlink:label="lab_bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Adviser&#8217;s influence on conducting our operations gives it the ability to increase its fees, which may reduce the amount of cash flow available for distribution to our shareholders.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember" xlink:href="bxsl-20231231.xsd#bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember" xlink:to="lab_bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember_label_en-US" xlink:label="lab_bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may enter into a TRS agreement that exposes us to certain risks, including market risk, liquidity risk and other risks similar to those associated with the use of leverage. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember_documentation_en-US" xlink:label="lab_bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may enter into a TRS agreement that exposes us to certain risks, including market risk, liquidity risk and other risks similar to those associated with the use of leverage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember" xlink:to="lab_bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManagementAndServiceFeesRate_844bcab2-4707-4b8b-b691-6ef161e98ea7_terseLabel_en-US" xlink:label="lab_us-gaap_ManagementAndServiceFeesRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee rate</link:label>
    <link:label id="lab_us-gaap_ManagementAndServiceFeesRate_label_en-US" xlink:label="lab_us-gaap_ManagementAndServiceFeesRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management and Service Fees, Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManagementAndServiceFeesRate" xlink:to="lab_us-gaap_ManagementAndServiceFeesRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare_5559d962-2512-49e3-90e0-ca715ccfdd7d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (in usd per share)</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Investment Income (Loss), Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare" xlink:to="lab_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherGeneralAndAdministrativeExpense_78beecfe-128c-48ca-b032-16bf3dd18368_terseLabel_en-US" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other general and administrative</link:label>
    <link:label id="lab_us-gaap_OtherGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember_label_en-US" xlink:label="lab_bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of substantial amounts of our common shares in the public market may have an adverse effect on the market price of our common shares. [Member]</link:label>
    <link:label id="lab_bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember_documentation_en-US" xlink:label="lab_bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of substantial amounts of our common shares in the public market may have an adverse effect on the market price of our common shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember" xlink:href="bxsl-20231231.xsd#bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember" xlink:to="lab_bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember_label_en-US" xlink:label="lab_bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our credit ratings may not reflect all risks of an investment in our debt securities. [Member]</link:label>
    <link:label id="lab_bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember_documentation_en-US" xlink:label="lab_bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our credit ratings may not reflect all risks of an investment in our debt securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember" xlink:href="bxsl-20231231.xsd#bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember" xlink:to="lab_bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6733c47d-e24d-4a03-ab6f-6c2a0be9715e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember_label_en-US" xlink:label="lab_bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The impact of financial reform legislation on us is uncertain. [Member]</link:label>
    <link:label id="lab_bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember_documentation_en-US" xlink:label="lab_bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The impact of financial reform legislation on us is uncertain.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember" xlink:href="bxsl-20231231.xsd#bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember" xlink:to="lab_bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_964313f9-95dd-4213-8906-3dc42c4873b6_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember_label_en-US" xlink:label="lab_bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders will experience dilution in their ownership percentage if they do not participate in our dividend reinvestment plan. [Member]</link:label>
    <link:label id="lab_bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember_documentation_en-US" xlink:label="lab_bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders will experience dilution in their ownership percentage if they do not participate in our dividend reinvestment plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember" xlink:href="bxsl-20231231.xsd#bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember" xlink:to="lab_bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a6d2f155-f774-4562-9fe2-e6e665fdb003_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_VoluntaryWaiverInPlaceMember_84e3f08b-68bc-4d68-b290-326e6cef6ce2_terseLabel_en-US" xlink:label="lab_bxsl_VoluntaryWaiverInPlaceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Waiver In Place</link:label>
    <link:label id="lab_bxsl_VoluntaryWaiverInPlaceMember_label_en-US" xlink:label="lab_bxsl_VoluntaryWaiverInPlaceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Waiver In Place [Member]</link:label>
    <link:label id="lab_bxsl_VoluntaryWaiverInPlaceMember_documentation_en-US" xlink:label="lab_bxsl_VoluntaryWaiverInPlaceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Waiver In Place</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverInPlaceMember" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverInPlaceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_VoluntaryWaiverInPlaceMember" xlink:to="lab_bxsl_VoluntaryWaiverInPlaceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIssuerAffiliationAxis_50afe033-e3ad-4ddc-8f77-159551849bd6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIssuerAffiliationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Issuer Affiliation [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentIssuerAffiliationAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentIssuerAffiliationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Issuer Affiliation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis" xlink:to="lab_us-gaap_InvestmentIssuerAffiliationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_2871824a-f082-4250-9b9c-17f5eb49316f_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_EquitySecuritiesUnrealizedGainLossMember_4df53df8-9915-433e-b891-88568841896b_terseLabel_en-US" xlink:label="lab_bxsl_EquitySecuritiesUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_bxsl_EquitySecuritiesUnrealizedGainLossMember_label_en-US" xlink:label="lab_bxsl_EquitySecuritiesUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, Unrealized Gain (Loss) [Member]</link:label>
    <link:label id="lab_bxsl_EquitySecuritiesUnrealizedGainLossMember_documentation_en-US" xlink:label="lab_bxsl_EquitySecuritiesUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_EquitySecuritiesUnrealizedGainLossMember" xlink:href="bxsl-20231231.xsd#bxsl_EquitySecuritiesUnrealizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_EquitySecuritiesUnrealizedGainLossMember" xlink:to="lab_bxsl_EquitySecuritiesUnrealizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f4f9e872-b4ea-4e07-a838-dd1de89a672d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyDistributionPolicyTextBlock_622077e2-8db4-41d3-891c-d0645efd1078_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyDistributionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyDistributionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyDistributionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Distribution [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyDistributionPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentCompanyDistributionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare_f58112ab-86b0-4f3b-8eec-1098073c6290_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions declared (in usd per share)</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Distribution to Shareholders, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributionToShareholdersPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare" xlink:to="lab_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_1ad3bf5d-0f86-46f3-9b6e-a3e62541263c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded commitment</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_51ba358b-a93e-4cac-944d-7610080080d4_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining undrawn</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" xlink:to="lab_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_dd4f2fde-cfc3-474d-9568-f88cdea4e9c7_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_0dcb802c-eb61-48d6-aaa9-15c7daad77f9_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of original issue discount and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1ce05f64-7690-4b3a-8e02-397fdee2da1e_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of original issue discount and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_A2850NotesDue2028Member_4bbb54d9-32d6-4617-ad8a-aa350c816630_terseLabel_en-US" xlink:label="lab_bxsl_A2850NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.850% Notes Due 2028</link:label>
    <link:label id="lab_bxsl_A2850NotesDue2028Member_10ccebad-aad5-4392-9946-b76452cdad32_verboseLabel_en-US" xlink:label="lab_bxsl_A2850NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Notes</link:label>
    <link:label id="lab_bxsl_A2850NotesDue2028Member_label_en-US" xlink:label="lab_bxsl_A2850NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.850% Notes Due 2028 [Member]</link:label>
    <link:label id="lab_bxsl_A2850NotesDue2028Member_documentation_en-US" xlink:label="lab_bxsl_A2850NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.850% Notes Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2850NotesDue2028Member" xlink:href="bxsl-20231231.xsd#bxsl_A2850NotesDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_A2850NotesDue2028Member" xlink:to="lab_bxsl_A2850NotesDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManagementFeePayable_516d6d14-8130-44dd-9413-3e71e83a4773_terseLabel_en-US" xlink:label="lab_us-gaap_ManagementFeePayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fees payable (Note 3)</link:label>
    <link:label id="lab_us-gaap_ManagementFeePayable_b9eaca28-ee63-45e7-bb22-d85e6023259a_verboseLabel_en-US" xlink:label="lab_us-gaap_ManagementFeePayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fees payable</link:label>
    <link:label id="lab_us-gaap_ManagementFeePayable_label_en-US" xlink:label="lab_us-gaap_ManagementFeePayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Fee Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeePayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeePayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManagementFeePayable" xlink:to="lab_us-gaap_ManagementFeePayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_8f4cc82f-7a7e-4153-b34e-e8cbea029514_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized gain (loss)</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_NonQualifyingAssetsMember_67558cbc-5108-4543-9ed4-92feab7bf856_terseLabel_en-US" xlink:label="lab_bxsl_NonQualifyingAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-qualifying Assets</link:label>
    <link:label id="lab_bxsl_NonQualifyingAssetsMember_label_en-US" xlink:label="lab_bxsl_NonQualifyingAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Qualifying Assets [Member]</link:label>
    <link:label id="lab_bxsl_NonQualifyingAssetsMember_documentation_en-US" xlink:label="lab_bxsl_NonQualifyingAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Qualifying Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NonQualifyingAssetsMember" xlink:href="bxsl-20231231.xsd#bxsl_NonQualifyingAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_NonQualifyingAssetsMember" xlink:to="lab_bxsl_NonQualifyingAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember_label_en-US" xlink:label="lab_bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may not be able to obtain and maintain all required state licenses. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember_documentation_en-US" xlink:label="lab_bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may not be able to obtain and maintain all required state licenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember" xlink:to="lab_bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember_1973f9c9-3bed-498f-9a39-a19ead33276f_terseLabel_en-US" xlink:label="lab_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jackson Hole Funding Facility, Foreign Currency Advances</link:label>
    <link:label id="lab_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember_label_en-US" xlink:label="lab_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jackson Hole Funding Facility, Foreign Currency Advances [Member]</link:label>
    <link:label id="lab_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember_documentation_en-US" xlink:label="lab_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jackson Hole Funding Facility, Foreign Currency Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember" xlink:to="lab_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_BERMUDAAndCAYMANISLANDMember_ce626163-542b-46c5-bff3-cd2e37a6cbb5_terseLabel_en-US" xlink:label="lab_bxsl_BERMUDAAndCAYMANISLANDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bermuda/Cayman Islands</link:label>
    <link:label id="lab_bxsl_BERMUDAAndCAYMANISLANDMember_label_en-US" xlink:label="lab_bxsl_BERMUDAAndCAYMANISLANDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BERMUDA and CAYMAN ISLAND [Member]</link:label>
    <link:label id="lab_bxsl_BERMUDAAndCAYMANISLANDMember_documentation_en-US" xlink:label="lab_bxsl_BERMUDAAndCAYMANISLANDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BERMUDA and CAYMAN ISLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BERMUDAAndCAYMANISLANDMember" xlink:href="bxsl-20231231.xsd#bxsl_BERMUDAAndCAYMANISLANDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_BERMUDAAndCAYMANISLANDMember" xlink:to="lab_bxsl_BERMUDAAndCAYMANISLANDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember_label_en-US" xlink:label="lab_bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our shares may be purchased by the Adviser or its affiliates. [Member]</link:label>
    <link:label id="lab_bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember_documentation_en-US" xlink:label="lab_bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our shares may be purchased by the Adviser or its affiliates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember" xlink:href="bxsl-20231231.xsd#bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember" xlink:to="lab_bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage_0ad7d45e-211e-4145-8219-ff9bcc498efb_terseLabel_en-US" xlink:label="lab_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum utilization percentage</link:label>
    <link:label id="lab_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage_label_en-US" xlink:label="lab_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Minimum Capacity Utilization, Percentage</link:label>
    <link:label id="lab_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage_documentation_en-US" xlink:label="lab_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Minimum Capacity Utilization, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage" xlink:href="bxsl-20231231.xsd#bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage" xlink:to="lab_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_7912bd74-0f84-4e87-8900-662b9ed9fabf_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_2193b1b6-e77d-4a8b-b763-5ec3253c99d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendIncomeOperating_2337055d-874e-4b91-84d3-46ebf79c6319_terseLabel_en-US" xlink:label="lab_us-gaap_DividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend income</link:label>
    <link:label id="lab_us-gaap_DividendIncomeOperating_label_en-US" xlink:label="lab_us-gaap_DividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendIncomeOperating" xlink:to="lab_us-gaap_DividendIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyTotalReturnMarketValue_f094ffdc-c494-4b55-9a21-1cdffbe86f21_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyTotalReturnMarketValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total return based on market value</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyTotalReturnMarketValue_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyTotalReturnMarketValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Total Return, Market Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyTotalReturnMarketValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTotalReturnMarketValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyTotalReturnMarketValue" xlink:to="lab_us-gaap_InvestmentCompanyTotalReturnMarketValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_ac0adb00-7193-4b53-bb5c-2da785bf7a33_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common shares, net of offering and underwriting costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DiversifiedTelecommunicationServicesSectorMember_9253b593-e0b0-44aa-bba8-a5b1d9108ef7_terseLabel_en-US" xlink:label="lab_bxsl_DiversifiedTelecommunicationServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified Telecommunication Services</link:label>
    <link:label id="lab_bxsl_DiversifiedTelecommunicationServicesSectorMember_label_en-US" xlink:label="lab_bxsl_DiversifiedTelecommunicationServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified Telecommunication Services Sector [Member]</link:label>
    <link:label id="lab_bxsl_DiversifiedTelecommunicationServicesSectorMember_documentation_en-US" xlink:label="lab_bxsl_DiversifiedTelecommunicationServicesSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified Telecommunication Services Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DiversifiedTelecommunicationServicesSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_DiversifiedTelecommunicationServicesSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DiversifiedTelecommunicationServicesSectorMember" xlink:to="lab_bxsl_DiversifiedTelecommunicationServicesSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_f5a7405a-deab-47c7-9af9-1082591ea4da_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c2cd6862-a9ca-44d0-ac79-bc7f0e5b16ef_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember_label_en-US" xlink:label="lab_bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity. [Member]</link:label>
    <link:label id="lab_bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember_documentation_en-US" xlink:label="lab_bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember" xlink:href="bxsl-20231231.xsd#bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember" xlink:to="lab_bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_A3650NotesDue2023Member_bed083cf-3d79-4145-bd3a-c775fcac7672_terseLabel_en-US" xlink:label="lab_bxsl_A3650NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.650% Notes Due 2023</link:label>
    <link:label id="lab_bxsl_A3650NotesDue2023Member_8d6042c6-4f6e-4e3b-80cd-8536c445ec14_verboseLabel_en-US" xlink:label="lab_bxsl_A3650NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Notes</link:label>
    <link:label id="lab_bxsl_A3650NotesDue2023Member_label_en-US" xlink:label="lab_bxsl_A3650NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.650% Notes Due 2023 [Member]</link:label>
    <link:label id="lab_bxsl_A3650NotesDue2023Member_documentation_en-US" xlink:label="lab_bxsl_A3650NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.650% Notes Due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3650NotesDue2023Member" xlink:href="bxsl-20231231.xsd#bxsl_A3650NotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_A3650NotesDue2023Member" xlink:to="lab_bxsl_A3650NotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_RoadAndRailMember_15f4fa02-7a75-4f65-aa7d-245c5aecdfa0_terseLabel_en-US" xlink:label="lab_bxsl_RoadAndRailMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Road &amp; Rail</link:label>
    <link:label id="lab_bxsl_RoadAndRailMember_label_en-US" xlink:label="lab_bxsl_RoadAndRailMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Road and Rail [Member]</link:label>
    <link:label id="lab_bxsl_RoadAndRailMember_documentation_en-US" xlink:label="lab_bxsl_RoadAndRailMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Road and Rail</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RoadAndRailMember" xlink:href="bxsl-20231231.xsd#bxsl_RoadAndRailMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_RoadAndRailMember" xlink:to="lab_bxsl_RoadAndRailMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ExciseTaxesPaid_e46174b0-52ca-4d75-ac9d-2a62a27a65cf_terseLabel_en-US" xlink:label="lab_bxsl_ExciseTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise taxes paid</link:label>
    <link:label id="lab_bxsl_ExciseTaxesPaid_label_en-US" xlink:label="lab_bxsl_ExciseTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise Taxes Paid</link:label>
    <link:label id="lab_bxsl_ExciseTaxesPaid_documentation_en-US" xlink:label="lab_bxsl_ExciseTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExciseTaxesPaid" xlink:href="bxsl-20231231.xsd#bxsl_ExciseTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ExciseTaxesPaid" xlink:to="lab_bxsl_ExciseTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_466e5cdd-99be-4d46-89c5-9df19ad8644b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage_6759140a-1af1-42bb-93e2-88a029564cce_terseLabel_en-US" xlink:label="lab_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive rate, catch up, percentage</link:label>
    <link:label id="lab_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage_label_en-US" xlink:label="lab_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management And Service Fees, Income Based Incentive Rate, Catch up, Percentage</link:label>
    <link:label id="lab_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage_documentation_en-US" xlink:label="lab_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management And Service Fees, Income Based Incentive Rate, Catch up, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage" xlink:href="bxsl-20231231.xsd#bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage" xlink:to="lab_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember_label_en-US" xlink:label="lab_bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain provisions of our Declaration of Trust could deter takeover attempts and have an adverse impact on the value of our common shares. [Member]</link:label>
    <link:label id="lab_bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember_documentation_en-US" xlink:label="lab_bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain provisions of our Declaration of Trust could deter takeover attempts and have an adverse impact on the value of our common shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember" xlink:href="bxsl-20231231.xsd#bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember" xlink:to="lab_bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_6ee325aa-b2d5-459f-b702-27f1c5c50eec_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid during the period</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_204a9360-d013-4b28-ad59-d52ce2684cb9_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest expense</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_RealEstateManagementDevelopmentSectorMember_3773e094-9fb3-4b12-82c5-515c83c14be8_terseLabel_en-US" xlink:label="lab_bxsl_RealEstateManagementDevelopmentSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Management &amp; Development</link:label>
    <link:label id="lab_bxsl_RealEstateManagementDevelopmentSectorMember_label_en-US" xlink:label="lab_bxsl_RealEstateManagementDevelopmentSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Management &amp; Development Sector [Member]</link:label>
    <link:label id="lab_bxsl_RealEstateManagementDevelopmentSectorMember_documentation_en-US" xlink:label="lab_bxsl_RealEstateManagementDevelopmentSectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Management &amp; Development Sector</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RealEstateManagementDevelopmentSectorMember" xlink:href="bxsl-20231231.xsd#bxsl_RealEstateManagementDevelopmentSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_RealEstateManagementDevelopmentSectorMember" xlink:to="lab_bxsl_RealEstateManagementDevelopmentSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_A2125SeniorNotesDue2027Member_49e2804a-b02a-4773-a8af-1ea4c570d777_terseLabel_en-US" xlink:label="lab_bxsl_A2125SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% Senior Notes Due 2027</link:label>
    <link:label id="lab_bxsl_A2125SeniorNotesDue2027Member_ae586aa4-c3a7-41d4-86e5-faf659e4e98d_verboseLabel_en-US" xlink:label="lab_bxsl_A2125SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Notes</link:label>
    <link:label id="lab_bxsl_A2125SeniorNotesDue2027Member_label_en-US" xlink:label="lab_bxsl_A2125SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% Senior Notes Due 2027 [Member]</link:label>
    <link:label id="lab_bxsl_A2125SeniorNotesDue2027Member_documentation_en-US" xlink:label="lab_bxsl_A2125SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% Senior Notes Due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2125SeniorNotesDue2027Member" xlink:href="bxsl-20231231.xsd#bxsl_A2125SeniorNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_A2125SeniorNotesDue2027Member" xlink:to="lab_bxsl_A2125SeniorNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_1aa01ca6-96fa-4e9a-aa0c-029bc9db4285_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage_8c5be3e7-f9be-4fc5-af5c-ab9b57101b14_terseLabel_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catch-up amount prior to the waiver period</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage_label_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Catch-Up Amount, Percentage</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage_documentation_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Catch-Up Amount, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage" xlink:to="lab_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_VariableRateScenarioDomain_78b3dbb6-8cf9-4081-8e4b-2191b52658db_terseLabel_en-US" xlink:label="lab_bxsl_VariableRateScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Scenario [Domain]</link:label>
    <link:label id="lab_bxsl_VariableRateScenarioDomain_label_en-US" xlink:label="lab_bxsl_VariableRateScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Scenario [Domain]</link:label>
    <link:label id="lab_bxsl_VariableRateScenarioDomain_documentation_en-US" xlink:label="lab_bxsl_VariableRateScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariableRateScenarioDomain" xlink:href="bxsl-20231231.xsd#bxsl_VariableRateScenarioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_VariableRateScenarioDomain" xlink:to="lab_bxsl_VariableRateScenarioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8a711bd0-82c5-44be-9fc4-a94fd54f12a8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember_label_en-US" xlink:label="lab_bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our investments in securities or assets of publicly-traded companies are subject to the risks inherent in investing in public securities. [Member]</link:label>
    <link:label id="lab_bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember_documentation_en-US" xlink:label="lab_bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our investments in securities or assets of publicly-traded companies are subject to the risks inherent in investing in public securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember" xlink:href="bxsl-20231231.xsd#bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember" xlink:to="lab_bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_A3625NotesDue2026Member_93b669fe-a5bc-4297-ad86-fc7d3cc66a99_terseLabel_en-US" xlink:label="lab_bxsl_A3625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% Notes Due 2026</link:label>
    <link:label id="lab_bxsl_A3625NotesDue2026Member_c7bc82e3-cfce-45e5-af17-c00ba909a6e8_verboseLabel_en-US" xlink:label="lab_bxsl_A3625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Notes</link:label>
    <link:label id="lab_bxsl_A3625NotesDue2026Member_label_en-US" xlink:label="lab_bxsl_A3625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% Notes Due 2026 [Member]</link:label>
    <link:label id="lab_bxsl_A3625NotesDue2026Member_documentation_en-US" xlink:label="lab_bxsl_A3625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% Notes Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3625NotesDue2026Member" xlink:href="bxsl-20231231.xsd#bxsl_A3625NotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_A3625NotesDue2026Member" xlink:to="lab_bxsl_A3625NotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_121f5fde-9d0b-47a3-97aa-9d0c0dc098d7_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation of assets and liabilities in foreign currencies</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss), Foreign Currency Transaction, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements_10363052-7f94-400a-be6e-1a5f771898fc_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of expenses to average net assets, waivers</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements_label_en-US" xlink:label="lab_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Expense Ratio, Fee Waiver And Reimbursements</link:label>
    <link:label id="lab_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements_documentation_en-US" xlink:label="lab_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Expense Ratio, Fee Waiver And Reimbursements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" xlink:to="lab_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0fcd092f-2597-4227-8adc-4481eb4ce797_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding diluted (in share)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember_label_en-US" xlink:label="lab_bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Another pandemic or global health crisis like the COVID-19 pandemic may adversely impact our performance and results of operations [Member]</link:label>
    <link:label id="lab_bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember_documentation_en-US" xlink:label="lab_bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Another pandemic or global health crisis like the COVID-19 pandemic may adversely impact our performance and results of operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember" xlink:href="bxsl-20231231.xsd#bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember" xlink:to="lab_bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDueToAffiliates_fe30a32b-3242-4cdc-8768-3762c9bc1fdd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDueToAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to affiliates</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDueToAffiliates_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDueToAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Due to Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueToAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDueToAffiliates" xlink:to="lab_us-gaap_IncreaseDecreaseInDueToAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember_label_en-US" xlink:label="lab_bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our Board may change our operating policies and strategies without prior notice or shareholder approval, the effects of which may be adverse to our results of operations and financial condition. [Member]</link:label>
    <link:label id="lab_bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember_documentation_en-US" xlink:label="lab_bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Our Board may change our operating policies and strategies without prior notice or shareholder approval, the effects of which may be adverse to our results of operations and financial condition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember" xlink:href="bxsl-20231231.xsd#bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember" xlink:to="lab_bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember_label_en-US" xlink:label="lab_bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We will be subject to corporate-level income tax if we are unable to qualify as a RIC under Subchapter M of the Code or to satisfy RIC distribution requirements. [Member]</link:label>
    <link:label id="lab_bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember_documentation_en-US" xlink:label="lab_bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We will be subject to corporate-level income tax if we are unable to qualify as a RIC under Subchapter M of the Code or to satisfy RIC distribution requirements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember" xlink:to="lab_bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DebtSecuritiesFirstLienMember_968e6faa-6c8c-4044-9683-70d891c6717f_terseLabel_en-US" xlink:label="lab_bxsl_DebtSecuritiesFirstLienMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First lien debt</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesFirstLienMember_label_en-US" xlink:label="lab_bxsl_DebtSecuritiesFirstLienMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, First Lien [Member]</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesFirstLienMember_documentation_en-US" xlink:label="lab_bxsl_DebtSecuritiesFirstLienMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, First Lien</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienMember" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DebtSecuritiesFirstLienMember" xlink:to="lab_bxsl_DebtSecuritiesFirstLienMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold_3a64f0b8-7345-44b9-9e84-0cfb72a516ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable for investments</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivable for Investment Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivableForInvestmentSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_bf27cf16-cb26-4cef-a964-29357911afce_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_BlackstoneDonegalHoldingsLPMember_35fdaeb0-77b7-4395-bcfe-16ecd83cc26b_terseLabel_en-US" xlink:label="lab_bxsl_BlackstoneDonegalHoldingsLPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blackstone Donegal Holdings LP</link:label>
    <link:label id="lab_bxsl_BlackstoneDonegalHoldingsLPMember_label_en-US" xlink:label="lab_bxsl_BlackstoneDonegalHoldingsLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blackstone Donegal Holdings LP [Member]</link:label>
    <link:label id="lab_bxsl_BlackstoneDonegalHoldingsLPMember_documentation_en-US" xlink:label="lab_bxsl_BlackstoneDonegalHoldingsLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blackstone Donegal Holdings LP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BlackstoneDonegalHoldingsLPMember" xlink:href="bxsl-20231231.xsd#bxsl_BlackstoneDonegalHoldingsLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_BlackstoneDonegalHoldingsLPMember" xlink:to="lab_bxsl_BlackstoneDonegalHoldingsLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_32b94b49-8a99-4000-a334-061ccd074041_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_bd61a950-d8e4-4d16-98f1-966291ad2f0c_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_d9c63b62-8c1c-4a3e-b354-4cc3739fb86f_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_0022ef09-450f-451e-b5cd-77e8b811940f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Owned, Federal Income Tax Note [Line Items]</link:label>
    <link:label id="lab_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_label_en-US" xlink:label="lab_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Owned, Federal Income Tax Note [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems" xlink:to="lab_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_1e8eb5b3-dd4f-4551-9342-5a406be48196_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember_label_en-US" xlink:label="lab_bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Economic recessions or downturns or restrictions on trade could impair our portfolio companies and adversely affect our operating results. [Member]</link:label>
    <link:label id="lab_bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember_documentation_en-US" xlink:label="lab_bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Economic recessions or downturns or restrictions on trade could impair our portfolio companies and adversely affect our operating results.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember" xlink:href="bxsl-20231231.xsd#bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember" xlink:to="lab_bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_9cfbef14-f130-46a1-9fe9-0092b2032480_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentsUnrealizedGainLossMember_8285c6b7-10ab-4650-a930-0bd264d8e145_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentsUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_bxsl_InvestmentsUnrealizedGainLossMember_label_en-US" xlink:label="lab_bxsl_InvestmentsUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Unrealized Gain (Loss) [Member]</link:label>
    <link:label id="lab_bxsl_InvestmentsUnrealizedGainLossMember_documentation_en-US" xlink:label="lab_bxsl_InvestmentsUnrealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentsUnrealizedGainLossMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentsUnrealizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentsUnrealizedGainLossMember" xlink:to="lab_bxsl_InvestmentsUnrealizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_edcde0d3-dab3-43e1-b2ff-f0ca18a3b632_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember_label_en-US" xlink:label="lab_bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The trading market or market value of our issued debt securities may fluctuate. [Member]</link:label>
    <link:label id="lab_bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember_documentation_en-US" xlink:label="lab_bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The trading market or market value of our issued debt securities may fluctuate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember" xlink:href="bxsl-20231231.xsd#bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember" xlink:to="lab_bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_ae15d382-c9e2-4307-8187-63a166b9a30a_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold_2b9ad242-f81f-4dd1-b671-4f68436bc819_terseLabel_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive rate, threshold</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold_label_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Voluntary Waiver, Incentive Rate Threshold</link:label>
    <link:label id="lab_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold_documentation_en-US" xlink:label="lab_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Based Incentive Fees, Voluntary Waiver, Incentive Rate Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold" xlink:to="lab_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_cb08b535-498e-4450-ac6c-c939bbd6a5b3_totalLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized appreciation (depreciation)</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_bf6472e6-2a78-44df-8944-8c6c9b6bc4c1_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized appreciation (depreciation) on investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss), Investment, Derivative, and Foreign Currency Transaction Price Change, Operating, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" xlink:to="lab_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85ecc4d0-8927-4e0a-93cb-cecb0c11dfe5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_3e9cdf16-9421-47b1-95a4-4310416d31a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid in cash</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember_label_en-US" xlink:label="lab_bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adviser are not prohibited from raising money for or managing other entities that make the same types of investments that we target. [Member]</link:label>
    <link:label id="lab_bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember_documentation_en-US" xlink:label="lab_bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adviser are not prohibited from raising money for or managing other entities that make the same types of investments that we target.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember" xlink:href="bxsl-20231231.xsd#bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember" xlink:to="lab_bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_NetRealizedGainsLossesAbstract_deef476c-4d4a-4ca9-9bca-0b15f04b14f2_terseLabel_en-US" xlink:label="lab_bxsl_NetRealizedGainsLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized gain (loss):</link:label>
    <link:label id="lab_bxsl_NetRealizedGainsLossesAbstract_label_en-US" xlink:label="lab_bxsl_NetRealizedGainsLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Realized Gains (Losses) [Abstract]</link:label>
    <link:label id="lab_bxsl_NetRealizedGainsLossesAbstract_documentation_en-US" xlink:label="lab_bxsl_NetRealizedGainsLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Realized Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NetRealizedGainsLossesAbstract" xlink:href="bxsl-20231231.xsd#bxsl_NetRealizedGainsLossesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_NetRealizedGainsLossesAbstract" xlink:to="lab_bxsl_NetRealizedGainsLossesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_637e38d7-c306-4829-bb8b-d67631c87f8c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_label_en-US" xlink:label="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, over Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtWeightedAverageInterestRateOverTime"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:to="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_d69275ad-619c-460d-b484-5bc8a038af97_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_eb80f420-2f75-4d83-89f0-e0507f302df4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward" xlink:to="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_91e734b8-c859-4a8b-9bc1-7f559ceb1341_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8e71e751-e2e1-4f13-a75a-e77128917922_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember_label_en-US" xlink:label="lab_bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">As a public company, we are subject to regulations. Efforts to comply with such regulations will involve significant expenditures, and non-compliance with such regulations may adversely affect us. [Member]</link:label>
    <link:label id="lab_bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember_documentation_en-US" xlink:label="lab_bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">As a public company, we are subject to regulations. Efforts to comply with such regulations will involve significant expenditures, and non-compliance with such regulations may adversely affect us.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember" xlink:href="bxsl-20231231.xsd#bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember" xlink:to="lab_bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_CommitmentFeeScenarioAxis_ed486c7e-6d7e-4eb2-b50b-53361946d5a6_terseLabel_en-US" xlink:label="lab_bxsl_CommitmentFeeScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment Fee Scenario [Axis]</link:label>
    <link:label id="lab_bxsl_CommitmentFeeScenarioAxis_label_en-US" xlink:label="lab_bxsl_CommitmentFeeScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment Fee Scenario [Axis]</link:label>
    <link:label id="lab_bxsl_CommitmentFeeScenarioAxis_documentation_en-US" xlink:label="lab_bxsl_CommitmentFeeScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment Fee Scenario</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommitmentFeeScenarioAxis" xlink:href="bxsl-20231231.xsd#bxsl_CommitmentFeeScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_CommitmentFeeScenarioAxis" xlink:to="lab_bxsl_CommitmentFeeScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_db559af2-0737-4f02-a5ec-2fe87f91a0da_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossInvestmentIncomeOperating_263e2cb4-e670-423e-8004-b726f612b7ef_totalLabel_en-US" xlink:label="lab_us-gaap_GrossInvestmentIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investment income</link:label>
    <link:label id="lab_us-gaap_GrossInvestmentIncomeOperating_label_en-US" xlink:label="lab_us-gaap_GrossInvestmentIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Investment Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossInvestmentIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossInvestmentIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossInvestmentIncomeOperating" xlink:to="lab_us-gaap_GrossInvestmentIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentPortfolioMember_37c67578-a484-454a-9d7e-4ff13d4042e3_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Portfolio</link:label>
    <link:label id="lab_bxsl_InvestmentPortfolioMember_label_en-US" xlink:label="lab_bxsl_InvestmentPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Portfolio [Member]</link:label>
    <link:label id="lab_bxsl_InvestmentPortfolioMember_documentation_en-US" xlink:label="lab_bxsl_InvestmentPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentPortfolioMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentPortfolioMember" xlink:to="lab_bxsl_InvestmentPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_7bb687dc-3f3f-4bac-91b1-d19b9f0fc37e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember_label_en-US" xlink:label="lab_bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">operations. Our investments in the healthcare providers and services industry face considerable uncertainties. [Member]</link:label>
    <link:label id="lab_bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember_documentation_en-US" xlink:label="lab_bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">operations. Our investments in the healthcare providers and services industry face considerable uncertainties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember" xlink:href="bxsl-20231231.xsd#bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember" xlink:to="lab_bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember_label_en-US" xlink:label="lab_bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A covenant breach or other default by our portfolio companies may adversely affect our operating results. [Member]</link:label>
    <link:label id="lab_bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember_documentation_en-US" xlink:label="lab_bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A covenant breach or other default by our portfolio companies may adversely affect our operating results.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember" xlink:href="bxsl-20231231.xsd#bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember" xlink:to="lab_bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentsRealizedGainLossMember_ae5348c2-8256-4e10-9b2f-ca80994e66c5_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentsRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Realized Gain (Loss)</link:label>
    <link:label id="lab_bxsl_InvestmentsRealizedGainLossMember_label_en-US" xlink:label="lab_bxsl_InvestmentsRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Realized Gain (Loss) [Member]</link:label>
    <link:label id="lab_bxsl_InvestmentsRealizedGainLossMember_documentation_en-US" xlink:label="lab_bxsl_InvestmentsRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentsRealizedGainLossMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentsRealizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentsRealizedGainLossMember" xlink:to="lab_bxsl_InvestmentsRealizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_8f47a470-bd02-4b0c-9ef2-5d22eeb35556_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0a165774-3588-40f7-a787-5fe1db2fb36a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding basic (in share)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_bbd75f1c-3f87-43dc-8cb3-b351601547b5_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_9ad0559b-601c-42e2-ac22-5bc5aa6d00e0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_a6a0760a-c152-436a-a138-49bf884ec43e_terseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_3e68f147-119f-4b1d-8560-e6ff42ff3400_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_InvestmentTypeConcentrationRiskMember_c51afd07-faff-4dae-b2bb-bae714faf9d3_terseLabel_en-US" xlink:label="lab_bxsl_InvestmentTypeConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type Concentration Risk</link:label>
    <link:label id="lab_bxsl_InvestmentTypeConcentrationRiskMember_label_en-US" xlink:label="lab_bxsl_InvestmentTypeConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type Concentration Risk [Member]</link:label>
    <link:label id="lab_bxsl_InvestmentTypeConcentrationRiskMember_documentation_en-US" xlink:label="lab_bxsl_InvestmentTypeConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type Concentration Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTypeConcentrationRiskMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTypeConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_InvestmentTypeConcentrationRiskMember" xlink:to="lab_bxsl_InvestmentTypeConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_AtTheMarketOfferingOffering1Member_0048991e-f1d6-41de-a4bb-8475cc78287b_terseLabel_en-US" xlink:label="lab_bxsl_AtTheMarketOfferingOffering1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-the-Market Offering</link:label>
    <link:label id="lab_bxsl_AtTheMarketOfferingOffering1Member_label_en-US" xlink:label="lab_bxsl_AtTheMarketOfferingOffering1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-the-Market Offering, Offering 1 [Member]</link:label>
    <link:label id="lab_bxsl_AtTheMarketOfferingOffering1Member_documentation_en-US" xlink:label="lab_bxsl_AtTheMarketOfferingOffering1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-the-Market Offering, Offering 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AtTheMarketOfferingOffering1Member" xlink:href="bxsl-20231231.xsd#bxsl_AtTheMarketOfferingOffering1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_AtTheMarketOfferingOffering1Member" xlink:to="lab_bxsl_AtTheMarketOfferingOffering1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_45950724-b1b2-4cd7-9c7c-a74ab182a10c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_428c49a0-c2e9-42eb-ab3c-e7257a120024_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember_53e616ad-98ea-4945-a329-8f6f74c18ea8_terseLabel_en-US" xlink:label="lab_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Second Lien, Realized Gain (Loss)</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember_label_en-US" xlink:label="lab_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Second Lien, Realized Gain (Loss) [Member]</link:label>
    <link:label id="lab_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember_documentation_en-US" xlink:label="lab_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Second Lien, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienRealizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember" xlink:to="lab_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss_c960e3d2-b8c1-47fe-93ee-8c8ef279fe36_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributable capital gains</link:label>
    <link:label id="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss_label_en-US" xlink:label="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Company, Distributable Earnings (Loss), Accumulated Long-Term Capital Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss" xlink:to="lab_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_a375d0ca-a9e8-4fce-9224-4c03911240db_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_774b0e15-9a63-4630-97c6-6c92a506d1c2_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capacity, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d3da0645-e639-4e45-aed7-a01631eb2478_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember_label_en-US" xlink:label="lab_bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may face increasing competition for investment opportunities, which could delay deployment of our capital, reduce returns and result in losses. [Member]</link:label>
    <link:label id="lab_bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember_documentation_en-US" xlink:label="lab_bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">We may face increasing competition for investment opportunities, which could delay deployment of our capital, reduce returns and result in losses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember" xlink:to="lab_bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsAxis_54d2ae92-5199-4e1e-ab4f-2eb74bd59a44_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Axis]</link:label>
    <link:label id="lab_us-gaap_DividendsAxis_label_en-US" xlink:label="lab_us-gaap_DividendsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsAxis" xlink:to="lab_us-gaap_DividendsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember_label_en-US" xlink:label="lab_bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertainty as to the value of our portfolio investments. [Member]</link:label>
    <link:label id="lab_bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember_documentation_en-US" xlink:label="lab_bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertainty as to the value of our portfolio investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember" xlink:href="bxsl-20231231.xsd#bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember" xlink:to="lab_bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>17
<FILENAME>bxsl-20231231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:c9da10f3-9ca1-46ab-8b82-2faa6d8e78e0,g:d2995a14-2db1-4369-b86a-a80f43cbbba9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bxsl.com/role/Cover" xlink:type="simple" xlink:href="bxsl-20231231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_67e0aab8-b929-4fc9-affe-ed1c55a9d236" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_DocumentType_67e0aab8-b929-4fc9-affe-ed1c55a9d236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_95fa4165-f680-413d-9005-ab73611a33b9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_DocumentAnnualReport_95fa4165-f680-413d-9005-ab73611a33b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6f0a7a7b-97be-41e5-8c2e-282369fed57a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_DocumentPeriodEndDate_6f0a7a7b-97be-41e5-8c2e-282369fed57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f8b391ed-acf2-44cf-9417-973b4e59152e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_CurrentFiscalYearEndDate_f8b391ed-acf2-44cf-9417-973b4e59152e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_338a06cd-0d84-42f4-b1a3-bb3744c635a4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_DocumentTransitionReport_338a06cd-0d84-42f4-b1a3-bb3744c635a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7dfcdea9-8188-47c1-8468-0f40ae3dd990" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityFileNumber_7dfcdea9-8188-47c1-8468-0f40ae3dd990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4d2515fc-2de4-40f4-ac4f-e4b28c349726" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityRegistrantName_4d2515fc-2de4-40f4-ac4f-e4b28c349726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c2bb12dd-8dcc-4d1f-8857-a0f29b1c57d8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c2bb12dd-8dcc-4d1f-8857-a0f29b1c57d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2c9514a3-8232-49e7-8f5c-617c6ecabfbd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityTaxIdentificationNumber_2c9514a3-8232-49e7-8f5c-617c6ecabfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b40153ba-fb0a-4192-b2a7-704f6ea52f96" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityAddressAddressLine1_b40153ba-fb0a-4192-b2a7-704f6ea52f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_46d03c0f-d176-49f7-b1b1-f0ed239c9627" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityAddressAddressLine2_46d03c0f-d176-49f7-b1b1-f0ed239c9627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a177a4a4-da3b-4167-afe2-f19fb45a0366" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityAddressCityOrTown_a177a4a4-da3b-4167-afe2-f19fb45a0366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_58f7d8b8-2101-4a79-b1ea-51a38b3e7f4e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityAddressStateOrProvince_58f7d8b8-2101-4a79-b1ea-51a38b3e7f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4c037b1b-bbfc-46ad-b12f-9df636d84be0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityAddressPostalZipCode_4c037b1b-bbfc-46ad-b12f-9df636d84be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3aff2fd3-2a23-42bf-8471-3d42fc253777" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_CityAreaCode_3aff2fd3-2a23-42bf-8471-3d42fc253777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_60f6218c-b522-42dc-a314-323c24e05426" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_LocalPhoneNumber_60f6218c-b522-42dc-a314-323c24e05426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_846a2d31-710b-46a7-b63e-891f81f193db" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_Security12bTitle_846a2d31-710b-46a7-b63e-891f81f193db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f2235291-66f7-42cc-ae18-96d55d64729b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_TradingSymbol_f2235291-66f7-42cc-ae18-96d55d64729b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_84f4ce2c-b2d8-4996-aed3-fc9052a6a487" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_SecurityExchangeName_84f4ce2c-b2d8-4996-aed3-fc9052a6a487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_24d6ed17-8ff2-49bf-8f27-aea5056a4590" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_24d6ed17-8ff2-49bf-8f27-aea5056a4590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_0d27dc60-ef0f-428a-b6a5-17b1d0ded19f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityVoluntaryFilers_0d27dc60-ef0f-428a-b6a5-17b1d0ded19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_905086ed-273e-4038-8990-599f788991f5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityCurrentReportingStatus_905086ed-273e-4038-8990-599f788991f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_793ec71e-8fe9-4b44-bf78-e54224485f1a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityInteractiveDataCurrent_793ec71e-8fe9-4b44-bf78-e54224485f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_58e5feb3-73bd-44b4-bf5e-de0cfafd4029" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityFilerCategory_58e5feb3-73bd-44b4-bf5e-de0cfafd4029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6e16aeab-8f43-4c59-926f-2e01d8f7265f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntitySmallBusiness_6e16aeab-8f43-4c59-926f-2e01d8f7265f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_68b4eb1b-0f75-4495-b561-d4ecc9d15ff2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityEmergingGrowthCompany_68b4eb1b-0f75-4495-b561-d4ecc9d15ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_0a87cd7e-0eb3-4262-afc9-d06010cba610" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_IcfrAuditorAttestationFlag_0a87cd7e-0eb3-4262-afc9-d06010cba610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b766920f-4ad6-4b0b-b6ed-4737b76a62fd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityShellCompany_b766920f-4ad6-4b0b-b6ed-4737b76a62fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_30245fd3-b9d4-48a8-93b6-2d1068acb6f1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_30245fd3-b9d4-48a8-93b6-2d1068acb6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_7258587a-b1db-434a-9b9a-8e6d8f8f1fc3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityPublicFloat_7258587a-b1db-434a-9b9a-8e6d8f8f1fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_41f81033-74f5-464c-bb9b-cf1b7ea07167" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_41f81033-74f5-464c-bb9b-cf1b7ea07167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_6b6a12f7-bcb8-4c72-af3f-f481022931b6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_EntityCentralIndexKey_6b6a12f7-bcb8-4c72-af3f-f481022931b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_2d6e03cf-764a-43c0-a70b-d94fa3f95f21" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_DocumentFiscalYearFocus_2d6e03cf-764a-43c0-a70b-d94fa3f95f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_c3b212de-3476-46fe-8501-7648eeb2aaa3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_DocumentFiscalPeriodFocus_c3b212de-3476-46fe-8501-7648eeb2aaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a57fff49-94e3-4163-9a97-7e8bbecd8993" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0be088a-db76-4af0-a252-027f0a82aceb" xlink:to="loc_dei_AmendmentFlag_a57fff49-94e3-4163-9a97-7e8bbecd8993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AuditInformation" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AuditInformationAbstract_d34235c0-cf9d-4caa-9b57-a6174b3a0ae6" xlink:href="bxsl-20231231.xsd#bxsl_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_b2287e2e-3416-40e0-871c-c821f6d3a19b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_AuditInformationAbstract_d34235c0-cf9d-4caa-9b57-a6174b3a0ae6" xlink:to="loc_dei_AuditorName_b2287e2e-3416-40e0-871c-c821f6d3a19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_f01cbf8b-4eaa-4390-8522-112ca7d20be6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_AuditInformationAbstract_d34235c0-cf9d-4caa-9b57-a6174b3a0ae6" xlink:to="loc_dei_AuditorLocation_f01cbf8b-4eaa-4390-8522-112ca7d20be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_2fe0c34b-eb73-435e-8c06-d3f120d94eb4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_AuditInformationAbstract_d34235c0-cf9d-4caa-9b57-a6174b3a0ae6" xlink:to="loc_dei_AuditorFirmId_2fe0c34b-eb73-435e-8c06-d3f120d94eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedStatementsofAssetsandLiabilities"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ae25f571-8572-403c-9bdb-e10ba696822d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_56f4c862-efba-46f6-a9ee-dafac35a8c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ae25f571-8572-403c-9bdb-e10ba696822d" xlink:to="loc_us-gaap_StatementTable_56f4c862-efba-46f6-a9ee-dafac35a8c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis_134b3c0b-3235-48c7-837b-141d34600569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_56f4c862-efba-46f6-a9ee-dafac35a8c2b" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationAxis_134b3c0b-3235-48c7-837b-141d34600569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_dc550d10-26fe-4636-b792-5402e051e360" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_134b3c0b-3235-48c7-837b-141d34600569" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_dc550d10-26fe-4636-b792-5402e051e360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_dd95c732-7897-4d2e-a621-2fe1fdab9463" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_dc550d10-26fe-4636-b792-5402e051e360" xlink:to="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_dd95c732-7897-4d2e-a621-2fe1fdab9463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_43390f8e-d4c5-4de8-aed9-3a3a6b560a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_dc550d10-26fe-4636-b792-5402e051e360" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_43390f8e-d4c5-4de8-aed9-3a3a6b560a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37078504-ebe3-484f-b994-9a87f9ecefc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_56f4c862-efba-46f6-a9ee-dafac35a8c2b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37078504-ebe3-484f-b994-9a87f9ecefc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d2bc879a-3c32-4093-b3e7-1c76bdcf4393" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37078504-ebe3-484f-b994-9a87f9ecefc6" xlink:to="loc_us-gaap_RelatedPartyDomain_d2bc879a-3c32-4093-b3e7-1c76bdcf4393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_c5f38c69-37a8-4f9e-930d-4601aa0264a8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d2bc879a-3c32-4093-b3e7-1c76bdcf4393" xlink:to="loc_srt_AffiliatedEntityMember_c5f38c69-37a8-4f9e-930d-4601aa0264a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_56f4c862-efba-46f6-a9ee-dafac35a8c2b" xlink:to="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_d4a660d2-ae70-4d8a-b53a-f99f688ea0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_d4a660d2-ae70-4d8a-b53a-f99f688ea0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e7a90e4a-92c3-447b-b3ed-d550b2dc08f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e7a90e4a-92c3-447b-b3ed-d550b2dc08f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendAndInterestReceivable_9e988633-8911-4f02-974d-ca4116eee1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendAndInterestReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:to="loc_us-gaap_DividendAndInterestReceivable_9e988633-8911-4f02-974d-ca4116eee1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_567aa406-1951-4961-877d-3fcc7e8a7929" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_567aa406-1951-4961-877d-3fcc7e8a7929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableInvestmentSale_c10b6cc3-2224-44c0-925f-1e8b50c3fd25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableInvestmentSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:to="loc_us-gaap_ReceivableInvestmentSale_c10b6cc3-2224-44c0-925f-1e8b50c3fd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_60795b97-d7d0-4d0b-958d-754ec4951481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d7f6eb34-90da-4d00-b4ce-0e157aa8cead" xlink:to="loc_us-gaap_Assets_60795b97-d7d0-4d0b-958d-754ec4951481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_21a6c236-17ce-48fe-8ece-98dffe4accc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_LongTermDebt_21a6c236-17ce-48fe-8ece-98dffe4accc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayableInvestmentPurchase_9641e552-864c-48a4-930f-c03fd849e301" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayableInvestmentPurchase"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_PayableInvestmentPurchase_9641e552-864c-48a4-930f-c03fd849e301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_4fb5df57-ecc9-4c48-9526-21d16334ce82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_OtherLiabilities_4fb5df57-ecc9-4c48-9526-21d16334ce82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeePayable_287fd904-809c-4ffb-b680-a27ed305d5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeePayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_ManagementFeePayable_287fd904-809c-4ffb-b680-a27ed305d5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncentiveFeePayableIncome_0e68e135-1780-406a-bb2a-2dceab961d11" xlink:href="bxsl-20231231.xsd#bxsl_IncentiveFeePayableIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_bxsl_IncentiveFeePayableIncome_0e68e135-1780-406a-bb2a-2dceab961d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncentiveFeePayableCapitalGains_bec5da0a-001f-43f3-830b-89465560e499" xlink:href="bxsl-20231231.xsd#bxsl_IncentiveFeePayableCapitalGains"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_bxsl_IncentiveFeePayableCapitalGains_bec5da0a-001f-43f3-830b-89465560e499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_275d9afc-2112-4707-8930-32963bef1c87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_275d9afc-2112-4707-8930-32963bef1c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionPayable_2e4d3fb0-e7c4-4c3a-8ece-3fb2ed9803d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DistributionPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_DistributionPayable_2e4d3fb0-e7c4-4c3a-8ece-3fb2ed9803d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3659df5f-3cdb-4268-bc4f-28f004c6e8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3659df5f-3cdb-4268-bc4f-28f004c6e8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_031718f6-bdf3-42da-a020-ad45eca469c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_2946b68d-b137-4e7e-b7f3-3c9656019b5c" xlink:to="loc_us-gaap_Liabilities_031718f6-bdf3-42da-a020-ad45eca469c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3d0e3f60-f92f-4640-ab2b-8c5b055307e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3d0e3f60-f92f-4640-ab2b-8c5b055307e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3f9b14fe-97a7-4772-9ff5-41c526b48fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3f9b14fe-97a7-4772-9ff5-41c526b48fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d1c50d51-0f7f-4763-b5cc-21638df562c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f9b14fe-97a7-4772-9ff5-41c526b48fe3" xlink:to="loc_us-gaap_CommonStockValue_d1c50d51-0f7f-4763-b5cc-21638df562c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ccad5ad6-788d-4b64-be80-48641f7d45b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f9b14fe-97a7-4772-9ff5-41c526b48fe3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ccad5ad6-788d-4b64-be80-48641f7d45b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8154d329-2ed5-42a5-9d58-69b0896d3e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f9b14fe-97a7-4772-9ff5-41c526b48fe3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8154d329-2ed5-42a5-9d58-69b0896d3e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_49edcf51-b7dc-453d-9d73-a4bf06c6c05a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f9b14fe-97a7-4772-9ff5-41c526b48fe3" xlink:to="loc_us-gaap_StockholdersEquity_49edcf51-b7dc-453d-9d73-a4bf06c6c05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_083e3ca8-aef8-4e0d-9853-8d390d8dfc78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_083e3ca8-aef8-4e0d-9853-8d390d8dfc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAssetValuePerShare_20313876-3aa7-4d5d-95e4-a9bf838cd138" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetAssetValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_72f3c4de-a819-47ea-ab8e-c294dd4c7646" xlink:to="loc_us-gaap_NetAssetValuePerShare_20313876-3aa7-4d5d-95e4-a9bf838cd138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedStatementsofAssetsandLiabilitiesParenthetical"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f9dcb3fd-1dbe-4392-bbe3-46943e0dbceb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6212e9c4-e63e-44ef-8eb8-95c73995b66b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f9dcb3fd-1dbe-4392-bbe3-46943e0dbceb" xlink:to="loc_us-gaap_StatementTable_6212e9c4-e63e-44ef-8eb8-95c73995b66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis_8326b372-438e-474d-93d3-624a8403f5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6212e9c4-e63e-44ef-8eb8-95c73995b66b" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationAxis_8326b372-438e-474d-93d3-624a8403f5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_7ff6867a-ccad-4f7f-bf78-94aaf5f9b710" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_8326b372-438e-474d-93d3-624a8403f5b0" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_7ff6867a-ccad-4f7f-bf78-94aaf5f9b710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_b292d7dc-f77c-4d85-8cee-f1e90de22c54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_7ff6867a-ccad-4f7f-bf78-94aaf5f9b710" xlink:to="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_b292d7dc-f77c-4d85-8cee-f1e90de22c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_54ac3081-d89e-4986-9cea-e13d5bf68688" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_7ff6867a-ccad-4f7f-bf78-94aaf5f9b710" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_54ac3081-d89e-4986-9cea-e13d5bf68688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6212e9c4-e63e-44ef-8eb8-95c73995b66b" xlink:to="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtCost_f91c0d09-d5fb-42b3-b824-6e272ce7b26f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_InvestmentOwnedAtCost_f91c0d09-d5fb-42b3-b824-6e272ce7b26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_7e677f82-3226-438a-bcbc-e3e462bf4042" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_7e677f82-3226-438a-bcbc-e3e462bf4042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2b38d5c3-4b1d-4b4e-8962-fc2d47eb4547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2b38d5c3-4b1d-4b4e-8962-fc2d47eb4547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_44b161a7-1789-4070-a1f8-60101e99f2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_44b161a7-1789-4070-a1f8-60101e99f2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_53df1892-5cd2-4bf9-80b1-e0033f31828e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_CommonStockSharesIssued_53df1892-5cd2-4bf9-80b1-e0033f31828e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f9097b87-c555-4586-b53b-713e20ab24e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c3f59480-3f5a-43e6-bdd2-98d4adfb5dd1" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f9097b87-c555-4586-b53b-713e20ab24e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_0dee56a4-9977-4dd8-8865-b0b7c625ec7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0a5e7119-06fa-4587-bef8-91c42fe9df81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0dee56a4-9977-4dd8-8865-b0b7c625ec7e" xlink:to="loc_us-gaap_StatementTable_0a5e7119-06fa-4587-bef8-91c42fe9df81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis_df963779-4905-4631-88dc-bcc6d95a710b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0a5e7119-06fa-4587-bef8-91c42fe9df81" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationAxis_df963779-4905-4631-88dc-bcc6d95a710b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_1ff698e0-6d36-4346-a529-31c494cea51b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_df963779-4905-4631-88dc-bcc6d95a710b" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_1ff698e0-6d36-4346-a529-31c494cea51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_f890043b-ef08-4f6f-b2d1-5ca4de8b9639" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_1ff698e0-6d36-4346-a529-31c494cea51b" xlink:to="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_f890043b-ef08-4f6f-b2d1-5ca4de8b9639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_8591c1f7-2d20-4900-a33b-1fe89f368a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_1ff698e0-6d36-4346-a529-31c494cea51b" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_8591c1f7-2d20-4900-a33b-1fe89f368a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0a5e7119-06fa-4587-bef8-91c42fe9df81" xlink:to="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingPaidInCash_9e5675c9-6247-4b61-ac16-8efba003de04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOperatingPaidInCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:to="loc_us-gaap_InterestIncomeOperatingPaidInCash_9e5675c9-6247-4b61-ac16-8efba003de04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingPaidInKind_ad024643-f8ad-4935-a99b-22a982d3634d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOperatingPaidInKind"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:to="loc_us-gaap_InterestIncomeOperatingPaidInKind_ad024643-f8ad-4935-a99b-22a982d3634d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendIncomeOperating_4bcc7b00-a6eb-461e-a17e-2d944ec56f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendIncomeOperating"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:to="loc_us-gaap_DividendIncomeOperating_4bcc7b00-a6eb-461e-a17e-2d944ec56f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FeeIncome_de677115-fe31-4d42-8a20-6d588ea9ba32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FeeIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:to="loc_us-gaap_FeeIncome_de677115-fe31-4d42-8a20-6d588ea9ba32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossInvestmentIncomeOperating_baa95c57-35dd-4fa3-8245-95d03b8e571c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossInvestmentIncomeOperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a081c13d-8eec-4382-9041-7eabe2489d58" xlink:to="loc_us-gaap_GrossInvestmentIncomeOperating_baa95c57-35dd-4fa3-8245-95d03b8e571c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_92c10d99-1655-4a05-8aa8-89bbe544e317" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_InterestExpense_92c10d99-1655-4a05-8aa8-89bbe544e317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense_2177ade3-9ae1-42d4-be75-d5b57fc0535a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_ManagementFeeExpense_2177ade3-9ae1-42d4-be75-d5b57fc0535a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeeExpense_b4ef3971-c465-433e-bf37-2c8bac86bdd3" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_bxsl_IncomeBasedIncentiveFeeExpense_b4ef3971-c465-433e-bf37-2c8bac86bdd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CapitalGainsIncentiveFeeExpense_ed687eee-4840-4fb6-8123-f40c2a460252" xlink:href="bxsl-20231231.xsd#bxsl_CapitalGainsIncentiveFeeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_bxsl_CapitalGainsIncentiveFeeExpense_ed687eee-4840-4fb6-8123-f40c2a460252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_b4b6fdb7-4a03-4c28-8296-faca30c013f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_ProfessionalFees_b4b6fdb7-4a03-4c28-8296-faca30c013f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrusteeFees_873944bf-d1f5-463d-9281-4d8f65d10eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrusteeFees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_TrusteeFees_873944bf-d1f5-463d-9281-4d8f65d10eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdministrativeFeesExpense_cdc83c91-fbb2-407c-8dcb-6324614e2d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdministrativeFeesExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_AdministrativeFeesExpense_cdc83c91-fbb2-407c-8dcb-6324614e2d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_db0dc43f-af95-44ee-bd65-d78e84711404" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_db0dc43f-af95-44ee-bd65-d78e84711404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_77272ba1-136e-4dc6-a2e1-9b5d9643e120" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_77272ba1-136e-4dc6-a2e1-9b5d9643e120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyContractualFeeWaived_8e50019a-02c3-4c0c-b659-d61ba346c22a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyContractualFeeWaived"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_InvestmentCompanyContractualFeeWaived_8e50019a-02c3-4c0c-b659-d61ba346c22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyVoluntaryFeeWaived_e6464b80-fc6d-4e10-9bd6-336033ac5cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyVoluntaryFeeWaived"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_InvestmentCompanyVoluntaryFeeWaived_e6464b80-fc6d-4e10-9bd6-336033ac5cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement_480ee98b-f513-477d-bb9b-e82855071603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0cf94d36-7b70-4e9d-a96e-25782ad0ba11" xlink:to="loc_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement_480ee98b-f513-477d-bb9b-e82855071603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_4ca87aa6-f541-4c53-949b-a1edb4f419fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_NetInvestmentIncome_4ca87aa6-f541-4c53-949b-a1edb4f419fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_7522186e-98d6-4941-b56b-7b4961666e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_7522186e-98d6-4941-b56b-7b4961666e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_2ca88b7a-2c65-4172-997b-34d45cf4c725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_2ca88b7a-2c65-4172-997b-34d45cf4c725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract_aa868e96-b948-451e-b394-42a4cdcfed8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract_aa868e96-b948-451e-b394-42a4cdcfed8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_86b7f9c5-36c4-49ad-9d8e-4e1d6824e104" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract_aa868e96-b948-451e-b394-42a4cdcfed8a" xlink:to="loc_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_86b7f9c5-36c4-49ad-9d8e-4e1d6824e104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_0446095f-5e31-425c-931b-4bf7e676ae3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_86b7f9c5-36c4-49ad-9d8e-4e1d6824e104" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_0446095f-5e31-425c-931b-4bf7e676ae3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_0616593e-fde9-4c26-95b3-9d693f575bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_86b7f9c5-36c4-49ad-9d8e-4e1d6824e104" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_0616593e-fde9-4c26-95b3-9d693f575bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_0b1bf5f8-5ed6-455b-a30c-8e29fbc3b761" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract_86b7f9c5-36c4-49ad-9d8e-4e1d6824e104" xlink:to="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_0b1bf5f8-5ed6-455b-a30c-8e29fbc3b761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NetRealizedGainsLossesAbstract_8432a868-c725-4ccf-ad27-860525910b4c" xlink:href="bxsl-20231231.xsd#bxsl_NetRealizedGainsLossesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract_aa868e96-b948-451e-b394-42a4cdcfed8a" xlink:to="loc_bxsl_NetRealizedGainsLossesAbstract_8432a868-c725-4ccf-ad27-860525910b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7af8df91-e111-4ca6-be71-a581be07403d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_NetRealizedGainsLossesAbstract_8432a868-c725-4ccf-ad27-860525910b4c" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_7af8df91-e111-4ca6-be71-a581be07403d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax_3116754e-28fd-4ebd-a3ec-00c533ca72c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_NetRealizedGainsLossesAbstract_8432a868-c725-4ccf-ad27-860525910b4c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax_3116754e-28fd-4ebd-a3ec-00c533ca72c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_a151d1ad-3a4e-489d-9a11-595871f0579e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_NetRealizedGainsLossesAbstract_8432a868-c725-4ccf-ad27-860525910b4c" xlink:to="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_a151d1ad-3a4e-489d-9a11-595871f0579e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax_94e2e048-8563-4834-9a23-1dc95ffee9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract_aa868e96-b948-451e-b394-42a4cdcfed8a" xlink:to="loc_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax_94e2e048-8563-4834-9a23-1dc95ffee9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ccbce20c-95fd-428f-a2e3-a82126d2bf48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_NetIncomeLoss_ccbce20c-95fd-428f-a2e3-a82126d2bf48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare_1ded5cc2-87cd-4c57-bb0f-4f5dbce4a96f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare_1ded5cc2-87cd-4c57-bb0f-4f5dbce4a96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1d466af2-aa0e-4117-9afc-d90868dd21b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_EarningsPerShareBasic_1d466af2-aa0e-4117-9afc-d90868dd21b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3db5b050-a7df-4821-b9b9-7b82383e1a37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3db5b050-a7df-4821-b9b9-7b82383e1a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2d4e8f2a-c3b9-42e8-8823-664df4151213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2d4e8f2a-c3b9-42e8-8823-664df4151213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b2ebe191-c6b5-45c1-9d1d-895526c57d20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eb0f4f71-b52e-436c-9a16-ed8c32136fec" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b2ebe191-c6b5-45c1-9d1d-895526c57d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedStatementsofChangesinNetAssets"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_66baca05-3c1f-40e3-8d9e-aab8b1395c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_308ce3a0-e1c0-4478-b3d2-d1063090a153" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_66baca05-3c1f-40e3-8d9e-aab8b1395c2a" xlink:to="loc_us-gaap_StatementTable_308ce3a0-e1c0-4478-b3d2-d1063090a153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9cd923e4-3f71-4ec1-9726-33259e3ec41e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_308ce3a0-e1c0-4478-b3d2-d1063090a153" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9cd923e4-3f71-4ec1-9726-33259e3ec41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_75b70e82-0c3c-4d1d-8de3-ca35674869ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9cd923e4-3f71-4ec1-9726-33259e3ec41e" xlink:to="loc_us-gaap_EquityComponentDomain_75b70e82-0c3c-4d1d-8de3-ca35674869ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f62fcfab-4d62-48ed-a771-48f8c59ef397" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_75b70e82-0c3c-4d1d-8de3-ca35674869ee" xlink:to="loc_us-gaap_CommonStockMember_f62fcfab-4d62-48ed-a771-48f8c59ef397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_22f4d1b9-d9c1-4da0-bc7b-4cb4da185200" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_75b70e82-0c3c-4d1d-8de3-ca35674869ee" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_22f4d1b9-d9c1-4da0-bc7b-4cb4da185200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3cbb653e-dc9c-4cf3-b5a2-50ac6e604278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_75b70e82-0c3c-4d1d-8de3-ca35674869ee" xlink:to="loc_us-gaap_RetainedEarningsMember_3cbb653e-dc9c-4cf3-b5a2-50ac6e604278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_aa7e30a2-afc4-4c0b-abf9-ce0a468201c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_308ce3a0-e1c0-4478-b3d2-d1063090a153" xlink:to="loc_us-gaap_StatementLineItems_aa7e30a2-afc4-4c0b-abf9-ce0a468201c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyNetAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_aa7e30a2-afc4-4c0b-abf9-ce0a468201c4" xlink:to="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_27e7dbcf-df3e-4eaa-ad39-ba84c814dcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_StockholdersEquity_27e7dbcf-df3e-4eaa-ad39-ba84c814dcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a6726ee9-3504-4229-81c5-397d03a5ce4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a6726ee9-3504-4229-81c5-397d03a5ce4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan_df9aa553-e3f9-477e-a071-48a4b6d5d21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan_df9aa553-e3f9-477e-a071-48a4b6d5d21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_52a57a1d-e432-4072-a02a-480d7bf83775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_52a57a1d-e432-4072-a02a-480d7bf83775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_36cf091d-fe64-46f8-ba0c-5022295e274f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax_36cf091d-fe64-46f8-ba0c-5022295e274f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_a5efc1a6-d109-4ae8-95bb-a5ab2e6d5c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_a5efc1a6-d109-4ae8-95bb-a5ab2e6d5c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_9f8730e9-6674-4df4-9abc-5c937a37e57e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax_9f8730e9-6674-4df4-9abc-5c937a37e57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDividendDistribution_6c96d145-1228-49ab-ae85-dce40e885760" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDividendDistribution"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_InvestmentCompanyDividendDistribution_6c96d145-1228-49ab-ae85-dce40e885760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_0cbb9800-5a40-4d8b-8f57-87ec06dae0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_0cbb9800-5a40-4d8b-8f57-87ec06dae0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_644555c4-93c9-47f0-a277-9b80810454b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyNetAssetsRollForward_adb8fb94-6086-4dda-9baf-16e5bb982184" xlink:to="loc_us-gaap_StockholdersEquity_644555c4-93c9-47f0-a277-9b80810454b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_bdef5d4c-28a9-45ec-a4b0-fc4c03ef2963" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_70b0d40f-414b-45e8-8242-8c3a400ea9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bdef5d4c-28a9-45ec-a4b0-fc4c03ef2963" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_70b0d40f-414b-45e8-8242-8c3a400ea9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5cc6fa87-4077-4788-982f-63341e27dbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_70b0d40f-414b-45e8-8242-8c3a400ea9fc" xlink:to="loc_us-gaap_NetIncomeLoss_5cc6fa87-4077-4788-982f-63341e27dbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b65ca33f-b28d-4fc7-a76a-70105e2b9abf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_70b0d40f-414b-45e8-8242-8c3a400ea9fc" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b65ca33f-b28d-4fc7-a76a-70105e2b9abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_75160ccf-0e2f-4de9-8920-d830d5c84734" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b65ca33f-b28d-4fc7-a76a-70105e2b9abf" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_75160ccf-0e2f-4de9-8920-d830d5c84734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_a81b5561-ddb1-4b88-93d6-1a55a45be733" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b65ca33f-b28d-4fc7-a76a-70105e2b9abf" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_a81b5561-ddb1-4b88-93d6-1a55a45be733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_b3b88373-0e64-4731-b504-2cd5d8dac841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b65ca33f-b28d-4fc7-a76a-70105e2b9abf" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_b3b88373-0e64-4731-b504-2cd5d8dac841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_da52a055-4780-45f5-887c-bb8500d1ab84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b65ca33f-b28d-4fc7-a76a-70105e2b9abf" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_da52a055-4780-45f5-887c-bb8500d1ab84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaidInKindInterestNoncash_4c398c28-265b-40c7-8b25-7de29949e0ab" xlink:href="bxsl-20231231.xsd#bxsl_PaidInKindInterestNoncash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b65ca33f-b28d-4fc7-a76a-70105e2b9abf" xlink:to="loc_bxsl_PaidInKindInterestNoncash_4c398c28-265b-40c7-8b25-7de29949e0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements_ad126531-1715-4250-980c-0f6395d68a99" xlink:href="bxsl-20231231.xsd#bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b65ca33f-b28d-4fc7-a76a-70105e2b9abf" xlink:to="loc_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements_ad126531-1715-4250-980c-0f6395d68a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_388b5a69-86c1-4ad7-99d5-ca9b3c5df69e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b65ca33f-b28d-4fc7-a76a-70105e2b9abf" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_388b5a69-86c1-4ad7-99d5-ca9b3c5df69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity_63d97a09-2bf6-4475-96e2-f73480197deb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b65ca33f-b28d-4fc7-a76a-70105e2b9abf" xlink:to="loc_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity_63d97a09-2bf6-4475-96e2-f73480197deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity_64bee18c-e04f-4aa1-9348-2f97ec95eb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b65ca33f-b28d-4fc7-a76a-70105e2b9abf" xlink:to="loc_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity_64bee18c-e04f-4aa1-9348-2f97ec95eb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca3f7f79-4c4f-49b5-897b-57689daafba5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b65ca33f-b28d-4fc7-a76a-70105e2b9abf" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca3f7f79-4c4f-49b5-897b-57689daafba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable_5ff4db34-429b-498d-acd2-6271ef3ebd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca3f7f79-4c4f-49b5-897b-57689daafba5" xlink:to="loc_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable_5ff4db34-429b-498d-acd2-6271ef3ebd0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold_49985e50-190b-4675-b775-7e67b774e176" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivableForInvestmentSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca3f7f79-4c4f-49b5-897b-57689daafba5" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold_49985e50-190b-4675-b775-7e67b774e176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3ac95e33-b127-4e36-ab14-9f0dbe4c4b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca3f7f79-4c4f-49b5-897b-57689daafba5" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3ac95e33-b127-4e36-ab14-9f0dbe4c4b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased_4dc60f70-af92-400f-8369-7d115e546400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca3f7f79-4c4f-49b5-897b-57689daafba5" xlink:to="loc_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased_4dc60f70-af92-400f-8369-7d115e546400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueToAffiliates_40ded260-a2f9-4ff5-90c9-5c589ab7765f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToAffiliates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca3f7f79-4c4f-49b5-897b-57689daafba5" xlink:to="loc_us-gaap_IncreaseDecreaseInDueToAffiliates_40ded260-a2f9-4ff5-90c9-5c589ab7765f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInManagementFeePayable_7a9db2cc-0070-4ad0-bf48-a2897ee4f813" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInManagementFeePayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca3f7f79-4c4f-49b5-897b-57689daafba5" xlink:to="loc_us-gaap_IncreaseDecreaseInManagementFeePayable_7a9db2cc-0070-4ad0-bf48-a2897ee4f813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable_e02e4894-a26f-4e25-a8ce-8ae184cc855a" xlink:href="bxsl-20231231.xsd#bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca3f7f79-4c4f-49b5-897b-57689daafba5" xlink:to="loc_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable_e02e4894-a26f-4e25-a8ce-8ae184cc855a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable_5680aa40-71bd-468e-a899-a996ec567099" xlink:href="bxsl-20231231.xsd#bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca3f7f79-4c4f-49b5-897b-57689daafba5" xlink:to="loc_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable_5680aa40-71bd-468e-a899-a996ec567099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInterestPayableNet_991163e3-89a0-4e06-bee3-480eef69f064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca3f7f79-4c4f-49b5-897b-57689daafba5" xlink:to="loc_us-gaap_IncreaseDecreaseInInterestPayableNet_991163e3-89a0-4e06-bee3-480eef69f064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_75c99f4a-4de4-480b-9236-476c1f113125" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca3f7f79-4c4f-49b5-897b-57689daafba5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_75c99f4a-4de4-480b-9236-476c1f113125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5770437a-434d-461f-8d1a-6dffc9ca8b86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_70b0d40f-414b-45e8-8242-8c3a400ea9fc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5770437a-434d-461f-8d1a-6dffc9ca8b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_465f91f4-854e-4223-990c-faf171459bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bdef5d4c-28a9-45ec-a4b0-fc4c03ef2963" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_465f91f4-854e-4223-990c-faf171459bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_9d2a566d-8a56-4889-b4b5-75cecb777db6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_465f91f4-854e-4223-990c-faf171459bb2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_9d2a566d-8a56-4889-b4b5-75cecb777db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_f1c333f0-53c0-4341-b1fd-0ae73f193424" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_465f91f4-854e-4223-990c-faf171459bb2" xlink:to="loc_us-gaap_RepaymentsOfDebt_f1c333f0-53c0-4341-b1fd-0ae73f193424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements_2e6ceea8-a28e-4b83-a036-0723739ed899" xlink:href="bxsl-20231231.xsd#bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_465f91f4-854e-4223-990c-faf171459bb2" xlink:to="loc_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements_2e6ceea8-a28e-4b83-a036-0723739ed899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_5512d1c7-c158-4bc9-90e3-1171530753cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_465f91f4-854e-4223-990c-faf171459bb2" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_5512d1c7-c158-4bc9-90e3-1171530753cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_7884a5bd-597d-40b6-bb81-f5a60a48da99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_465f91f4-854e-4223-990c-faf171459bb2" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_7884a5bd-597d-40b6-bb81-f5a60a48da99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_0ecc6c2a-2564-45e1-91e9-7aefd82e6f80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_465f91f4-854e-4223-990c-faf171459bb2" xlink:to="loc_us-gaap_PaymentsOfDividends_0ecc6c2a-2564-45e1-91e9-7aefd82e6f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e3b93088-9a9d-438e-b679-de43ee378b14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_465f91f4-854e-4223-990c-faf171459bb2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e3b93088-9a9d-438e-b679-de43ee378b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3028f529-a4b9-40b0-8ca0-d8d979d24062" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_465f91f4-854e-4223-990c-faf171459bb2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3028f529-a4b9-40b0-8ca0-d8d979d24062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a43d1bbf-cbab-4d3d-b40a-61d92a910ced" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_465f91f4-854e-4223-990c-faf171459bb2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a43d1bbf-cbab-4d3d-b40a-61d92a910ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_9609843a-1fef-4461-a2da-4ff825750b91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bdef5d4c-28a9-45ec-a4b0-fc4c03ef2963" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_9609843a-1fef-4461-a2da-4ff825750b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_fc64edca-81eb-43af-b907-09848f504aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bdef5d4c-28a9-45ec-a4b0-fc4c03ef2963" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_fc64edca-81eb-43af-b907-09848f504aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_214ce2ae-a991-4eab-9fbd-7e9fe35f7fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bdef5d4c-28a9-45ec-a4b0-fc4c03ef2963" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_214ce2ae-a991-4eab-9fbd-7e9fe35f7fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e0c56fe6-8b73-4f17-9f52-42f37aba168a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bdef5d4c-28a9-45ec-a4b0-fc4c03ef2963" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e0c56fe6-8b73-4f17-9f52-42f37aba168a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_cb860a54-6b09-43bb-b5d3-51f1bca9d503" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bdef5d4c-28a9-45ec-a4b0-fc4c03ef2963" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_cb860a54-6b09-43bb-b5d3-51f1bca9d503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_6f38017f-c322-4bc7-bdb5-5741a9a6d596" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cb860a54-6b09-43bb-b5d3-51f1bca9d503" xlink:to="loc_us-gaap_InterestPaidNet_6f38017f-c322-4bc7-bdb5-5741a9a6d596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DistributionCostsIncurredButNotYetPaid_abac2520-7700-4f3f-9fa9-428b91b12dfd" xlink:href="bxsl-20231231.xsd#bxsl_DistributionCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cb860a54-6b09-43bb-b5d3-51f1bca9d503" xlink:to="loc_bxsl_DistributionCostsIncurredButNotYetPaid_abac2520-7700-4f3f-9fa9-428b91b12dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_6f65e0a2-7cd0-4962-948c-0d94d42f3d33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cb860a54-6b09-43bb-b5d3-51f1bca9d503" xlink:to="loc_us-gaap_StockIssued1_6f65e0a2-7cd0-4962-948c-0d94d42f3d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction_7c72022d-1cd0-4ac3-841b-144d8229c42b" xlink:href="bxsl-20231231.xsd#bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cb860a54-6b09-43bb-b5d3-51f1bca9d503" xlink:to="loc_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction_7c72022d-1cd0-4ac3-841b-144d8229c42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_7069c806-3192-420c-8007-2e306909798e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cb860a54-6b09-43bb-b5d3-51f1bca9d503" xlink:to="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_7069c806-3192-420c-8007-2e306909798e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtIssuanceCostsIncurredButNotYetPaid_7fbd256e-603f-4529-93c7-586156def22c" xlink:href="bxsl-20231231.xsd#bxsl_DebtIssuanceCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cb860a54-6b09-43bb-b5d3-51f1bca9d503" xlink:to="loc_bxsl_DebtIssuanceCostsIncurredButNotYetPaid_7fbd256e-603f-4529-93c7-586156def22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExciseTaxesPaid_586fbb5d-0e9c-489b-8900-55af80d36de6" xlink:href="bxsl-20231231.xsd#bxsl_ExciseTaxesPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cb860a54-6b09-43bb-b5d3-51f1bca9d503" xlink:to="loc_bxsl_ExciseTaxesPaid_586fbb5d-0e9c-489b-8900-55af80d36de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedScheduleofInvestments" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedScheduleofInvestments"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/ConsolidatedScheduleofInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract_4fb91f17-84fc-4d09-b8f1-c6675c965fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_4fb91f17-84fc-4d09-b8f1-c6675c965fe7" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesByIndustryAxis_06d74faf-71d1-4e0c-9057-f887b71fc633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesByIndustryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:to="loc_us-gaap_EquitySecuritiesByIndustryAxis_06d74faf-71d1-4e0c-9057-f887b71fc633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis_06d74faf-71d1-4e0c-9057-f887b71fc633" xlink:to="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AerospaceAndDefenseSectorMember_613dd741-76d2-4dd7-860b-202a1ab08b29" xlink:href="bxsl-20231231.xsd#bxsl_AerospaceAndDefenseSectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_AerospaceAndDefenseSectorMember_613dd741-76d2-4dd7-860b-202a1ab08b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AirFreightLogisticsSectorMember_d3176380-cee1-4b95-a1df-e4f11cf665e6" xlink:href="bxsl-20231231.xsd#bxsl_AirFreightLogisticsSectorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_AirFreightLogisticsSectorMember_d3176380-cee1-4b95-a1df-e4f11cf665e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BuildingProductsSectorMember_f6566efb-7b18-4cec-ad0c-3945ba94541a" xlink:href="bxsl-20231231.xsd#bxsl_BuildingProductsSectorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_BuildingProductsSectorMember_f6566efb-7b18-4cec-ad0c-3945ba94541a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChemicalsSectorMember_dba0de09-b88c-4c22-97a5-813cf83d65ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChemicalsSectorMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_ChemicalsSectorMember_dba0de09-b88c-4c22-97a5-813cf83d65ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommercialServicesSuppliesSectorMember_b569dc0d-fc52-473d-8464-6716863aa62f" xlink:href="bxsl-20231231.xsd#bxsl_CommercialServicesSuppliesSectorMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_CommercialServicesSuppliesSectorMember_b569dc0d-fc52-473d-8464-6716863aa62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ConstructionEngineeringSectorMember_536ef2b0-397d-4dc5-8f63-3ae8514248fb" xlink:href="bxsl-20231231.xsd#bxsl_ConstructionEngineeringSectorMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ConstructionEngineeringSectorMember_536ef2b0-397d-4dc5-8f63-3ae8514248fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContainerAndPackagingSectorMember_0d0a65d3-52ee-46dc-8924-7dd4cc30b60b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContainerAndPackagingSectorMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_ContainerAndPackagingSectorMember_0d0a65d3-52ee-46dc-8924-7dd4cc30b60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DistributorsSectorMember_4554238b-3f62-4928-a864-e56c289d17e4" xlink:href="bxsl-20231231.xsd#bxsl_DistributorsSectorMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_DistributorsSectorMember_4554238b-3f62-4928-a864-e56c289d17e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsumerSectorMember_08e88259-d315-4657-8b14-673b233418d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsumerSectorMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_ConsumerSectorMember_08e88259-d315-4657-8b14-673b233418d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DiversifiedTelecommunicationServicesSectorMember_ee66fb06-734c-4c4a-8360-331c0883c754" xlink:href="bxsl-20231231.xsd#bxsl_DiversifiedTelecommunicationServicesSectorMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_DiversifiedTelecommunicationServicesSectorMember_ee66fb06-734c-4c4a-8360-331c0883c754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServicesSectorMember_27af04a6-e3a3-4d22-ae65-9f715dea0843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialServicesSectorMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_FinancialServicesSectorMember_27af04a6-e3a3-4d22-ae65-9f715dea0843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectricalEquipmentSectorMember_b4a18b2e-b01d-463d-bf3f-8e14d540a27b" xlink:href="bxsl-20231231.xsd#bxsl_ElectricalEquipmentSectorMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ElectricalEquipmentSectorMember_b4a18b2e-b01d-463d-bf3f-8e14d540a27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectronicEquipmentInstrumentsComponentsMember_2fd873bc-7abe-47e3-86aa-34175beed8b0" xlink:href="bxsl-20231231.xsd#bxsl_ElectronicEquipmentInstrumentsComponentsMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ElectronicEquipmentInstrumentsComponentsMember_2fd873bc-7abe-47e3-86aa-34175beed8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnergySectorMember_d806fa9c-bf97-420f-a90a-4bbc572452ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EnergySectorMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_EnergySectorMember_d806fa9c-bf97-420f-a90a-4bbc572452ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareEquipmentSuppliesSectorMember_5834ee28-3810-4371-bf4d-105a75c8e599" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareEquipmentSuppliesSectorMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_HealthCareEquipmentSuppliesSectorMember_5834ee28-3810-4371-bf4d-105a75c8e599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareProvidersServicesSectorMember_2e2f0b88-435f-4719-8cc8-1936f8243bd7" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareProvidersServicesSectorMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_HealthCareProvidersServicesSectorMember_2e2f0b88-435f-4719-8cc8-1936f8243bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareTechnologySectorMember_ae6108b0-a711-4a16-8286-9a00e08e7f90" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareTechnologySectorMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_HealthCareTechnologySectorMember_ae6108b0-a711-4a16-8286-9a00e08e7f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSectorMember_5c9c6664-1d57-4687-8c0b-2bc9e56b0a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceSectorMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_us-gaap_InsuranceSectorMember_5c9c6664-1d57-4687-8c0b-2bc9e56b0a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ITServicesSectorMember_1db7ffe6-ea28-471f-a20f-067f6b147490" xlink:href="bxsl-20231231.xsd#bxsl_ITServicesSectorMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ITServicesSectorMember_1db7ffe6-ea28-471f-a20f-067f6b147490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MachineryMember_0eda4eda-b876-41df-b0ef-79613b8390ac" xlink:href="bxsl-20231231.xsd#bxsl_MachineryMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_MachineryMember_0eda4eda-b876-41df-b0ef-79613b8390ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OilGasConsumableFuelsMember_98d9ad67-7935-47c0-8ee7-17a4ff704018" xlink:href="bxsl-20231231.xsd#bxsl_OilGasConsumableFuelsMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_OilGasConsumableFuelsMember_98d9ad67-7935-47c0-8ee7-17a4ff704018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaperForestProductsMember_087845d8-25c5-4c17-8d91-4f53a55ed02e" xlink:href="bxsl-20231231.xsd#bxsl_PaperForestProductsMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_PaperForestProductsMember_087845d8-25c5-4c17-8d91-4f53a55ed02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PharmaceuticalsSectorMember_9086587e-64f2-4aa2-860c-8f87b5287bd6" xlink:href="bxsl-20231231.xsd#bxsl_PharmaceuticalsSectorMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_PharmaceuticalsSectorMember_9086587e-64f2-4aa2-860c-8f87b5287bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ProfessionalServicesSectorMember_c3ee7307-d58d-4f99-a21d-12768e2c8bb2" xlink:href="bxsl-20231231.xsd#bxsl_ProfessionalServicesSectorMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ProfessionalServicesSectorMember_c3ee7307-d58d-4f99-a21d-12768e2c8bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RealEstateManagementDevelopmentSectorMember_1b46f80e-4871-4892-a1d5-4d659d2fd4cb" xlink:href="bxsl-20231231.xsd#bxsl_RealEstateManagementDevelopmentSectorMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_RealEstateManagementDevelopmentSectorMember_1b46f80e-4871-4892-a1d5-4d659d2fd4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SoftwareSectorMember_418f812b-f9b9-45bf-a4ad-e5a169813f5f" xlink:href="bxsl-20231231.xsd#bxsl_SoftwareSectorMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_SoftwareSectorMember_418f812b-f9b9-45bf-a4ad-e5a169813f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TradingCompaniesDistributorsSectorMember_6b087e94-c9d8-435b-a54b-639f38554df4" xlink:href="bxsl-20231231.xsd#bxsl_TradingCompaniesDistributorsSectorMember"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_TradingCompaniesDistributorsSectorMember_6b087e94-c9d8-435b-a54b-639f38554df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransportationInfrastructureSectorMember_58e93d97-7660-4442-a156-234b1dd986e8" xlink:href="bxsl-20231231.xsd#bxsl_TransportationInfrastructureSectorMember"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_TransportationInfrastructureSectorMember_58e93d97-7660-4442-a156-234b1dd986e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectricUtilitiesMember_b31dad5c-926f-444c-82a3-ef746a061fb8" xlink:href="bxsl-20231231.xsd#bxsl_ElectricUtilitiesMember"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_ElectricUtilitiesMember_b31dad5c-926f-444c-82a3-ef746a061fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_GroundTransportationMember_dcbb48d4-cf14-4cbb-b1c7-07ef6575e7e9" xlink:href="bxsl-20231231.xsd#bxsl_GroundTransportationMember"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_1d1de1ea-01f3-4f96-8088-b2097d90b3c8" xlink:to="loc_bxsl_GroundTransportationMember_dcbb48d4-cf14-4cbb-b1c7-07ef6575e7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:to="loc_us-gaap_InvestmentTypeAxis_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_8fa1ecd8-e934-4e00-bb59-5f10ae1125fa" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:to="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienMember_ed0a89a1-c412-44c5-8599-bb266fff30a3" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:to="loc_bxsl_DebtSecuritiesFirstLienMember_ed0a89a1-c412-44c5-8599-bb266fff30a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienMember_f1877936-306b-43b5-8bb7-722139b5616c" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:to="loc_bxsl_DebtSecuritiesSecondLienMember_f1877936-306b-43b5-8bb7-722139b5616c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_1985c505-803e-4efd-8ed3-be1fb7b64a45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_InvestmentPortfolioMember_ea2c8327-4a78-4394-8378-73fc26ee5b69" xlink:to="loc_us-gaap_EquitySecuritiesMember_1985c505-803e-4efd-8ed3-be1fb7b64a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_a6ed9294-8968-403b-8a9b-549c4bcd2231" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:to="loc_us-gaap_UnsecuredDebtMember_a6ed9294-8968-403b-8a9b-549c4bcd2231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_0f854d32-dd24-4d75-8030-6ba812993aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c270e3df-54a9-4839-a4b6-713611f30df2" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_0f854d32-dd24-4d75-8030-6ba812993aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis_bd54ae9f-9cab-4a66-956e-9128a3b89570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationAxis_bd54ae9f-9cab-4a66-956e-9128a3b89570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_df2b61d4-0112-49ef-9030-bdf1ed59a384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_bd54ae9f-9cab-4a66-956e-9128a3b89570" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_df2b61d4-0112-49ef-9030-bdf1ed59a384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_093bfb1d-7c06-42ff-a206-530378cf9fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_df2b61d4-0112-49ef-9030-bdf1ed59a384" xlink:to="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_093bfb1d-7c06-42ff-a206-530378cf9fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_bc6aab4b-37c3-4523-9411-7221e0df1fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_df2b61d4-0112-49ef-9030-bdf1ed59a384" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_bc6aab4b-37c3-4523-9411-7221e0df1fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIdentifierAxis_d559b7aa-d84e-4950-b963-ef92b000e781" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:to="loc_us-gaap_InvestmentIdentifierAxis_d559b7aa-d84e-4950-b963-ef92b000e781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_efdbe020-1343-46d6-bf5a-e3f19e009254" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBasisSpreadVariableRate_9d475db8-9afa-47f7-ba8b-a357d54bc91d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBasisSpreadVariableRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentBasisSpreadVariableRate_9d475db8-9afa-47f7-ba8b-a357d54bc91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRatePaidInKind_7db4f701-b8d9-4850-80d5-eaf47a1a9480" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRatePaidInKind"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentInterestRatePaidInKind_7db4f701-b8d9-4850-80d5-eaf47a1a9480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRate_161d6fc8-4194-4b90-b1e2-f3eb53fa6f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentInterestRate_161d6fc8-4194-4b90-b1e2-f3eb53fa6f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount_97fc024f-cca6-41d1-897b-65e7bb8bf014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount_97fc024f-cca6-41d1-897b-65e7bb8bf014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_c619dbed-e6d8-4c00-829d-fd6e33c49002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_c619dbed-e6d8-4c00-829d-fd6e33c49002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtCost_7a07ea32-42c9-4bf9-81a4-86cb654b4a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedAtCost_7a07ea32-42c9-4bf9-81a4-86cb654b4a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_08b0ab67-5535-4fcc-bcff-e3e1d33f1a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_08b0ab67-5535-4fcc-bcff-e3e1d33f1a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_12a9d080-0a26-4c64-9f27-d160161f510f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_275c5d3d-cf59-4285-94b4-c4a74523732c" xlink:to="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_12a9d080-0a26-4c64-9f27-d160161f510f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedScheduleofInvestments_1" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedScheduleofInvestments_1"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/ConsolidatedScheduleofInvestments_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedScheduleofInvestmentsParenthetical"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract_1999408a-cb83-4c53-8dbf-b8707017e886" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_1999408a-cb83-4c53-8dbf-b8707017e886" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIdentifierAxis_86667ecb-2fd9-4367-b792-bf1ec44ecc72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_us-gaap_InvestmentIdentifierAxis_86667ecb-2fd9-4367-b792-bf1ec44ecc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ec9054d-b989-41fc-becc-72cbac6b914c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_srt_RangeAxis_1ec9054d-b989-41fc-becc-72cbac6b914c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_59167211-c517-439f-94a5-16cabb289bd7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1ec9054d-b989-41fc-becc-72cbac6b914c" xlink:to="loc_srt_RangeMember_59167211-c517-439f-94a5-16cabb289bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b5910acf-6c06-4b93-ad2f-8f5936bc2e02" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_59167211-c517-439f-94a5-16cabb289bd7" xlink:to="loc_srt_MinimumMember_b5910acf-6c06-4b93-ad2f-8f5936bc2e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_b9d38609-e50d-44b7-9da7-e87ba2dbbf02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_us-gaap_InvestmentTypeAxis_b9d38609-e50d-44b7-9da7-e87ba2dbbf02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_dfff5101-57cd-47bc-bef8-fa47503c744a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_b9d38609-e50d-44b7-9da7-e87ba2dbbf02" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_dfff5101-57cd-47bc-bef8-fa47503c744a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_QualifyingAssetsMember_5a43a1cd-d298-4802-83d8-33a132596190" xlink:href="bxsl-20231231.xsd#bxsl_QualifyingAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_dfff5101-57cd-47bc-bef8-fa47503c744a" xlink:to="loc_bxsl_QualifyingAssetsMember_5a43a1cd-d298-4802-83d8-33a132596190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NonQualifyingAssetsMember_da3cf3df-4dd7-41fa-a44c-dff0ed7ee640" xlink:href="bxsl-20231231.xsd#bxsl_NonQualifyingAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_dfff5101-57cd-47bc-bef8-fa47503c744a" xlink:to="loc_bxsl_NonQualifyingAssetsMember_da3cf3df-4dd7-41fa-a44c-dff0ed7ee640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationAxis_8a3c5293-589a-4512-989d-51a68c0e2bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationAxis_8a3c5293-589a-4512-989d-51a68c0e2bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerAffiliationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationAxis_8a3c5293-589a-4512-989d-51a68c0e2bf2" xlink:to="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_df7d97a8-70b7-4701-92d5-338e9a4514ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentUnaffiliatedIssuerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:to="loc_us-gaap_InvestmentUnaffiliatedIssuerMember_df7d97a8-70b7-4701-92d5-338e9a4514ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_7fd2735e-e36f-44a3-953a-cb933cc0d37e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember_7fd2735e-e36f-44a3-953a-cb933cc0d37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentAffiliatedIssuerMember_74d04c0e-9996-4897-bd22-39350ac10d32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAffiliatedIssuerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerAffiliationDomain_cd7e6775-a5ad-4130-88d8-9fc72de1aad3" xlink:to="loc_us-gaap_InvestmentAffiliatedIssuerMember_74d04c0e-9996-4897-bd22-39350ac10d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerNameAxis_9848620b-ec1b-4b7f-853a-5d02ee38ea64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_us-gaap_InvestmentIssuerNameAxis_9848620b-ec1b-4b7f-853a-5d02ee38ea64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerNameDomain_b6d73b39-02ab-494d-9c1d-17a4a5e5bc76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIssuerNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerNameAxis_9848620b-ec1b-4b7f-853a-5d02ee38ea64" xlink:to="loc_us-gaap_InvestmentIssuerNameDomain_b6d73b39-02ab-494d-9c1d-17a4a5e5bc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BlackstoneDonegalHoldingsLPMember_8f930d71-340e-4cde-8739-2590b1437dbf" xlink:href="bxsl-20231231.xsd#bxsl_BlackstoneDonegalHoldingsLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentIssuerNameDomain_b6d73b39-02ab-494d-9c1d-17a4a5e5bc76" xlink:to="loc_bxsl_BlackstoneDonegalHoldingsLPMember_8f930d71-340e-4cde-8739-2590b1437dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f3df03fd-4c03-438d-8599-97a3f053706c" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_063fbe06-a8a7-4502-a4c0-6bf2362fc86a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_063fbe06-a8a7-4502-a4c0-6bf2362fc86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_8ef47f16-968d-4011-b54b-d94eeb6f5ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_8ef47f16-968d-4011-b54b-d94eeb6f5ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue_cff38432-2c36-4d2a-9528-9ddf104aab8b" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue_cff38432-2c36-4d2a-9528-9ddf104aab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentInterestRateFloor_e42e507b-5567-4211-8b93-1c7e799bf8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInterestRateFloor"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InvestmentInterestRateFloor_e42e507b-5567-4211-8b93-1c7e799bf8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate_b79a7b4b-f2b8-4043-be0a-49129a5d3057" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentPercentageOfPortfolioAboveFloorRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate_b79a7b4b-f2b8-4043-be0a-49129a5d3057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_61fc31cf-58f9-4b96-9f62-781b08b0954d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_61fc31cf-58f9-4b96-9f62-781b08b0954d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions_12ab10e0-16a3-4c30-b724-f46e4c082ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions_12ab10e0-16a3-4c30-b724-f46e4c082ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions_5f6d2dc2-7567-4756-8065-d1342c44fe00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions_5f6d2dc2-7567-4756-8065-d1342c44fe00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease_e8f4406b-dbbe-481b-b096-ee3b8153576a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease_e8f4406b-dbbe-481b-b096-ee3b8153576a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax_03cdd0c6-4a04-42ba-a3ff-2112bf705ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax_03cdd0c6-4a04-42ba-a3ff-2112bf705ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_eca5c3e4-2ec7-45a6-b2c2-31bc1feda839" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3f228c3d-7d6b-46c8-ae82-45831f785d0a" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_eca5c3e4-2ec7-45a6-b2c2-31bc1feda839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeSecurities_e285e578-41d5-495e-8c86-a33e9b3ed58e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndDividendIncomeSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_7ea1312e-830a-49c0-82ed-655f35b3c0c9" xlink:to="loc_us-gaap_InterestAndDividendIncomeSecurities_e285e578-41d5-495e-8c86-a33e9b3ed58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical_1" xlink:type="simple" xlink:href="bxsl-20231231.xsd#ConsolidatedScheduleofInvestmentsParenthetical_1"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bxsl.com/role/Organization" xlink:type="simple" xlink:href="bxsl-20231231.xsd#Organization"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/Organization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_de81f2fa-efbc-42ee-b0b3-dd2b2bbd3974" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0490645e-10c0-43d5-9706-776a77a84eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_de81f2fa-efbc-42ee-b0b3-dd2b2bbd3974" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0490645e-10c0-43d5-9706-776a77a84eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="bxsl-20231231.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_92b1daad-5b32-4bd7-b8d9-f41b89ac881e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_3c73cb33-23f4-4244-adfe-82b14c7374f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_92b1daad-5b32-4bd7-b8d9-f41b89ac881e" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_3c73cb33-23f4-4244-adfe-82b14c7374f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactions" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_1f6c5450-6a4e-4e90-ae87-0092ad2899e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_5f8c14a0-ef61-4d89-80c1-9da269e45d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_1f6c5450-6a4e-4e90-ae87-0092ad2899e8" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_5f8c14a0-ef61-4d89-80c1-9da269e45d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/Investments" xlink:type="simple" xlink:href="bxsl-20231231.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract_406cc61b-1518-45cb-9a0e-c63ed815807e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_d38104a2-cbf1-4d34-bd84-383cd497abd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_406cc61b-1518-45cb-9a0e-c63ed815807e" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_d38104a2-cbf1-4d34-bd84-383cd497abd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_accd59d4-8719-45c3-8af4-12a0fee72f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_fe6afc4f-c0f4-4171-ac04-9ce41b75a718" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_accd59d4-8719-45c3-8af4-12a0fee72f3c" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_fe6afc4f-c0f4-4171-ac04-9ce41b75a718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/Borrowings" xlink:type="simple" xlink:href="bxsl-20231231.xsd#Borrowings"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/Borrowings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8d9faad9-7823-409b-b9b2-dc958f0ce20a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_14c7a45a-d295-48c3-977a-c0b61fb0b6db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8d9faad9-7823-409b-b9b2-dc958f0ce20a" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_14c7a45a-d295-48c3-977a-c0b61fb0b6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/CommitmentandContingencies" xlink:type="simple" xlink:href="bxsl-20231231.xsd#CommitmentandContingencies"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/CommitmentandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_38d6d1c5-6103-4130-8c1f-c9e3d1232c26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1ffb7b98-56e8-4507-97a3-319495257c68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_38d6d1c5-6103-4130-8c1f-c9e3d1232c26" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1ffb7b98-56e8-4507-97a3-319495257c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssets" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssets"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/NetAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e7ce2831-59a6-41f7-8a6c-36283d1f74b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e421a327-6f22-40c0-8083-1d5721614395" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e7ce2831-59a6-41f7-8a6c-36283d1f74b9" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e421a327-6f22-40c0-8083-1d5721614395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/EarningsPerShare" xlink:type="simple" xlink:href="bxsl-20231231.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5a2b266b-b55e-4fd0-aab8-d4f22acfe56e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_aa3df680-b61b-4102-98ff-f715657603df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5a2b266b-b55e-4fd0-aab8-d4f22acfe56e" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_aa3df680-b61b-4102-98ff-f715657603df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/IncomeTaxes" xlink:type="simple" xlink:href="bxsl-20231231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0e8bf7a6-5ac9-4833-a7ec-b98ec449bc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1b8f7cd8-22ed-48ac-a6bf-216d42a152df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0e8bf7a6-5ac9-4833-a7ec-b98ec449bc5f" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1b8f7cd8-22ed-48ac-a6bf-216d42a152df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecurities" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FinancialHighlightsandSeniorSecurities"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyAbstract_6f199c7b-3679-43f8-92e8-dcdd543f9630" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialHighlightsTextBlock_5cf6ab7c-beb0-48fc-a34c-1706181b65c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialHighlightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyAbstract_6f199c7b-3679-43f8-92e8-dcdd543f9630" xlink:to="loc_us-gaap_InvestmentCompanyFinancialHighlightsTextBlock_5cf6ab7c-beb0-48fc-a34c-1706181b65c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/SubsequentEvents" xlink:type="simple" xlink:href="bxsl-20231231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_bf3980df-f21d-4efd-9d39-66dae44dbd13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_b45fce0c-bc86-4b26-b702-6328027ae68a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_bf3980df-f21d-4efd-9d39-66dae44dbd13" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_b45fce0c-bc86-4b26-b702-6328027ae68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="bxsl-20231231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_bfdce99b-83cd-43ba-ac5c-7f5013706f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_bfdce99b-83cd-43ba-ac5c-7f5013706f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_919705b0-75d9-4136-975d-a1b1f55c2688" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_UseOfEstimates_919705b0-75d9-4136-975d-a1b1f55c2688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_6cc90a3c-f708-42df-9519-c1baa0d0899a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_6cc90a3c-f708-42df-9519-c1baa0d0899a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6de0acf8-478c-46d7-b4c1-93b3cddcbc83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6de0acf8-478c-46d7-b4c1-93b3cddcbc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_6bf6743b-7e31-4853-92ad-ff6a48fe94b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_6bf6743b-7e31-4853-92ad-ff6a48fe94b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_b248beac-1b7d-4bb6-9a54-b26d4a8f9a73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_b248beac-1b7d-4bb6-9a54-b26d4a8f9a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_fb2f0f36-d055-454b-b889-13a77ab99a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_fb2f0f36-d055-454b-b889-13a77ab99a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_0b516e6e-c6d1-4905-9630-4078d60bf4f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_0b516e6e-c6d1-4905-9630-4078d60bf4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock_a3da7efb-6e26-4a2c-80f2-0e7aac3672f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_StockholdersEquityPolicyTextBlock_a3da7efb-6e26-4a2c-80f2-0e7aac3672f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_2d1c93da-c185-41a7-a641-7838aebba9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_DebtPolicyTextBlock_2d1c93da-c185-41a7-a641-7838aebba9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_0fe597f2-294a-46c3-8097-c3e3f77b3a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_0fe597f2-294a-46c3-8097-c3e3f77b3a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributionPolicyTextBlock_15eda6e4-165c-41c3-9a59-bb9983fdafde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributionPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_InvestmentCompanyDistributionPolicyTextBlock_15eda6e4-165c-41c3-9a59-bb9983fdafde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d8afc4b7-33b5-41e8-9685-b50635091530" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d8afc4b7-33b5-41e8-9685-b50635091530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_a3da7d57-90b5-4e78-af30-cb65bc968ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08b9346-7406-403a-ba4e-09ae38b81b52" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_a3da7d57-90b5-4e78-af30-cb65bc968ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/InvestmentsTables" xlink:type="simple" xlink:href="bxsl-20231231.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract_166bcb96-3895-43df-b502-009acbd8afc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_54368d60-a3c6-4b76-84a5-11ce2d224c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_166bcb96-3895-43df-b502-009acbd8afc3" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_54368d60-a3c6-4b76-84a5-11ce2d224c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_84f6a0b4-c2b3-4d05-bfd4-d69bfda70917" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_aa0173f3-8142-4e27-9dfe-82f44d57158c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_84f6a0b4-c2b3-4d05-bfd4-d69bfda70917" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_aa0173f3-8142-4e27-9dfe-82f44d57158c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_df4e4360-eaaa-470b-a7f3-5e59aec58649" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_84f6a0b4-c2b3-4d05-bfd4-d69bfda70917" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_df4e4360-eaaa-470b-a7f3-5e59aec58649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_74b12c82-d9f9-4665-b51d-2de16476840e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_84f6a0b4-c2b3-4d05-bfd4-d69bfda70917" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_74b12c82-d9f9-4665-b51d-2de16476840e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_db68023d-8081-432d-83d9-62e4119ae096" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_84f6a0b4-c2b3-4d05-bfd4-d69bfda70917" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_db68023d-8081-432d-83d9-62e4119ae096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsTables" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsTables"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/BorrowingsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_de034e9a-605e-4cf5-a0fc-d18bf649c0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_4a278c05-461d-4357-a7d3-d805598519b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_de034e9a-605e-4cf5-a0fc-d18bf649c0a0" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_4a278c05-461d-4357-a7d3-d805598519b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsTables" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsTables"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/NetAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_684ad430-22ff-4464-94d3-d93db2ed6789" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock_0712387a-d495-4afb-b463-9aa029c1aa6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_684ad430-22ff-4464-94d3-d93db2ed6789" xlink:to="loc_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock_0712387a-d495-4afb-b463-9aa029c1aa6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_e9d8aa1f-b821-412a-ac83-d3ef1a1ae4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_684ad430-22ff-4464-94d3-d93db2ed6789" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_e9d8aa1f-b821-412a-ac83-d3ef1a1ae4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock_cf20fd96-68f2-4711-8d1e-c09fe2b1dac2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_684ad430-22ff-4464-94d3-d93db2ed6789" xlink:to="loc_us-gaap_DividendsDeclaredTableTextBlock_cf20fd96-68f2-4711-8d1e-c09fe2b1dac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock_0415eaae-8f02-4413-89f1-f01b262b05bd" xlink:href="bxsl-20231231.xsd#bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_684ad430-22ff-4464-94d3-d93db2ed6789" xlink:to="loc_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock_0415eaae-8f02-4413-89f1-f01b262b05bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ScheduleOfSharesRepurchasedTableTextBlock_2cf2de88-1b80-45a8-b28d-24f1d5eca10a" xlink:href="bxsl-20231231.xsd#bxsl_ScheduleOfSharesRepurchasedTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_684ad430-22ff-4464-94d3-d93db2ed6789" xlink:to="loc_bxsl_ScheduleOfSharesRepurchasedTableTextBlock_2cf2de88-1b80-45a8-b28d-24f1d5eca10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="bxsl-20231231.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6bcf1221-71c1-4094-b5ef-9341ff990fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_890fa11d-c292-4d40-9ec6-2d4d1474cc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6bcf1221-71c1-4094-b5ef-9341ff990fdb" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_890fa11d-c292-4d40-9ec6-2d4d1474cc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bxsl-20231231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_063f5640-ae81-435b-b1e2-ea61f2568ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock_09355f1f-f7f1-433f-aa0a-f6e0e6acefbf" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_063f5640-ae81-435b-b1e2-ea61f2568ce0" xlink:to="loc_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock_09355f1f-f7f1-433f-aa0a-f6e0e6acefbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxNoteTextBlock_83e0278d-74cf-42f5-9cfe-e0bd7b406c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxNoteTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_063f5640-ae81-435b-b1e2-ea61f2568ce0" xlink:to="loc_us-gaap_FederalIncomeTaxNoteTextBlock_83e0278d-74cf-42f5-9cfe-e0bd7b406c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock_d1178c50-8bec-4ec9-9abc-3b1d09b5f910" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_063f5640-ae81-435b-b1e2-ea61f2568ce0" xlink:to="loc_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock_d1178c50-8bec-4ec9-9abc-3b1d09b5f910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesTables" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FinancialHighlightsandSeniorSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyAbstract_99a91272-31d6-423d-82ea-36b36507326b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock_e1cfea28-7b2f-44f4-b392-6840dc09d96a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyAbstract_99a91272-31d6-423d-82ea-36b36507326b" xlink:to="loc_us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock_e1cfea28-7b2f-44f4-b392-6840dc09d96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/SignificantAccountingPoliciesRevenueRecognitionIncomeTaxDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#SignificantAccountingPoliciesRevenueRecognitionIncomeTaxDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/SignificantAccountingPoliciesRevenueRecognitionIncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c79a3fff-d249-4ab5-b2e1-f1a148d83623" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_3fb460fc-ed87-484f-9307-3abef2411d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c79a3fff-d249-4ab5-b2e1-f1a148d83623" xlink:to="loc_us-gaap_InvestmentIncomeInterest_3fb460fc-ed87-484f-9307-3abef2411d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_60d9946d-2273-4264-9b86-bc2d7b464c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c79a3fff-d249-4ab5-b2e1-f1a148d83623" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_60d9946d-2273-4264-9b86-bc2d7b464c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_fd6ab96b-9e8f-452f-b8c4-491d203b71f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c79a3fff-d249-4ab5-b2e1-f1a148d83623" xlink:to="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_fd6ab96b-9e8f-452f-b8c4-491d203b71f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_a43f12da-a7c3-41ba-899d-2397f1cc7ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_64884165-31b1-4bfd-8f4d-a295e95e59fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_a43f12da-a7c3-41ba-899d-2397f1cc7ffe" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_64884165-31b1-4bfd-8f4d-a295e95e59fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_3b7ffe09-0d5e-464a-a540-a7ed446b5c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_64884165-31b1-4bfd-8f4d-a295e95e59fa" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_3b7ffe09-0d5e-464a-a540-a7ed446b5c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_bff4a410-f013-4111-836c-be4593812fed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_3b7ffe09-0d5e-464a-a540-a7ed446b5c3f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_bff4a410-f013-4111-836c-be4593812fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentAdvisoryAgreementMember_e18bc190-e8c5-4f22-aab2-279b9bc6a4a7" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentAdvisoryAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_bff4a410-f013-4111-836c-be4593812fed" xlink:to="loc_bxsl_InvestmentAdvisoryAgreementMember_e18bc190-e8c5-4f22-aab2-279b9bc6a4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a9e0de64-f5f8-4fa4-becf-7a6a7dc853f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_64884165-31b1-4bfd-8f4d-a295e95e59fa" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a9e0de64-f5f8-4fa4-becf-7a6a7dc853f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_1f6bb62c-b63d-461f-9f43-d4201e8c4680" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a9e0de64-f5f8-4fa4-becf-7a6a7dc853f2" xlink:to="loc_us-gaap_RelatedPartyDomain_1f6bb62c-b63d-461f-9f43-d4201e8c4680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_a348f0ee-8e31-4c29-ba76-adda0788ee62" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1f6bb62c-b63d-461f-9f43-d4201e8c4680" xlink:to="loc_srt_AffiliatedEntityMember_a348f0ee-8e31-4c29-ba76-adda0788ee62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioAxis_31f74c5f-7bf3-4420-828b-2738f1e93fe0" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_64884165-31b1-4bfd-8f4d-a295e95e59fa" xlink:to="loc_bxsl_VoluntaryWaiverScenarioAxis_31f74c5f-7bf3-4420-828b-2738f1e93fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioDomain_843b301d-ee83-4b95-bade-9e2f85dc7521" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VoluntaryWaiverScenarioAxis_31f74c5f-7bf3-4420-828b-2738f1e93fe0" xlink:to="loc_bxsl_VoluntaryWaiverScenarioDomain_843b301d-ee83-4b95-bade-9e2f85dc7521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverNotInPlaceMember_66a1d67c-ca68-4c59-af45-ef1fdb7b8763" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverNotInPlaceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VoluntaryWaiverScenarioDomain_843b301d-ee83-4b95-bade-9e2f85dc7521" xlink:to="loc_bxsl_VoluntaryWaiverNotInPlaceMember_66a1d67c-ca68-4c59-af45-ef1fdb7b8763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverInPlaceMember_e590d8fe-9318-403a-99bc-1017bd7152d9" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverInPlaceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VoluntaryWaiverScenarioDomain_843b301d-ee83-4b95-bade-9e2f85dc7521" xlink:to="loc_bxsl_VoluntaryWaiverInPlaceMember_e590d8fe-9318-403a-99bc-1017bd7152d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_64884165-31b1-4bfd-8f4d-a295e95e59fa" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate_692ca169-56d2-4998-9a9c-ddf42f62e2e5" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate_692ca169-56d2-4998-9a9c-ddf42f62e2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionInitialTerm_e8925a63-9585-430c-a10a-6d3ac60279d1" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionInitialTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_bxsl_RelatedPartyTransactionInitialTerm_e8925a63-9585-430c-a10a-6d3ac60279d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionRenewalTerm_655eb6a4-f585-422c-9a97-41781e454b09" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_bxsl_RelatedPartyTransactionRenewalTerm_655eb6a4-f585-422c-9a97-41781e454b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod_0e1c4b6f-b21b-4f44-8f27-68394fa618ff" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod_0e1c4b6f-b21b-4f44-8f27-68394fa618ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesBaseRate_a433aa83-0ea5-4f60-a32b-fd0ef4581e44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesBaseRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_us-gaap_ManagementAndServiceFeesBaseRate_a433aa83-0ea5-4f60-a32b-fd0ef4581e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesIncentiveRate_7a1c5394-1ebd-4a01-83a1-32360807470c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesIncentiveRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9493891a-8a5b-4552-ba6f-729c2973af3e" xlink:to="loc_us-gaap_ManagementAndServiceFeesIncentiveRate_7a1c5394-1ebd-4a01-83a1-32360807470c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_8724a3d2-fad9-4a19-8d82-e448493c2b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c68dc4d5-b432-45bb-af91-01103452299d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_8724a3d2-fad9-4a19-8d82-e448493c2b7e" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c68dc4d5-b432-45bb-af91-01103452299d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioAxis_fe51be53-063e-4e79-88e8-c947065f754e" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c68dc4d5-b432-45bb-af91-01103452299d" xlink:to="loc_bxsl_VoluntaryWaiverScenarioAxis_fe51be53-063e-4e79-88e8-c947065f754e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioDomain_107979b1-49b7-4165-b1ad-9a177399c491" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VoluntaryWaiverScenarioAxis_fe51be53-063e-4e79-88e8-c947065f754e" xlink:to="loc_bxsl_VoluntaryWaiverScenarioDomain_107979b1-49b7-4165-b1ad-9a177399c491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverInPlaceMember_303c7534-cac8-4ea4-a83b-096ebeb0971d" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverInPlaceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VoluntaryWaiverScenarioDomain_107979b1-49b7-4165-b1ad-9a177399c491" xlink:to="loc_bxsl_VoluntaryWaiverInPlaceMember_303c7534-cac8-4ea4-a83b-096ebeb0971d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_82fa461b-3c10-49eb-a984-963f8a8ce77d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c68dc4d5-b432-45bb-af91-01103452299d" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_82fa461b-3c10-49eb-a984-963f8a8ce77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_2f98c78c-a807-4703-9e53-e7f915617622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_82fa461b-3c10-49eb-a984-963f8a8ce77d" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_2f98c78c-a807-4703-9e53-e7f915617622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentAdvisoryAgreementMember_b321610e-f024-4a35-940a-85dbb424593c" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentAdvisoryAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_2f98c78c-a807-4703-9e53-e7f915617622" xlink:to="loc_bxsl_InvestmentAdvisoryAgreementMember_b321610e-f024-4a35-940a-85dbb424593c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c68dc4d5-b432-45bb-af91-01103452299d" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesRate_79683f9f-f2d4-4561-b8dc-1a7600552abd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:to="loc_us-gaap_ManagementAndServiceFeesRate_79683f9f-f2d4-4561-b8dc-1a7600552abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesBaseRate_2adc30a7-cdc8-40e1-bf3e-89d7520477af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesBaseRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:to="loc_us-gaap_ManagementAndServiceFeesBaseRate_2adc30a7-cdc8-40e1-bf3e-89d7520477af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense_b1f3228e-5997-4c45-9210-fdf5c0db3fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:to="loc_us-gaap_ManagementFeeExpense_b1f3228e-5997-4c45-9210-fdf5c0db3fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyContractualFeeWaived_02d1c1a7-2554-4459-8357-0d0ebefb36e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyContractualFeeWaived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:to="loc_us-gaap_InvestmentCompanyContractualFeeWaived_02d1c1a7-2554-4459-8357-0d0ebefb36e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeePayable_2cddfc95-9aa6-44ad-8277-6ee3f49ee863" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementFeePayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d4dcea2-fab8-487a-9c43-24aaab9e9d82" xlink:to="loc_us-gaap_ManagementFeePayable_2cddfc95-9aa6-44ad-8277-6ee3f49ee863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_89bb91f3-c05e-4a74-b802-8b5713c73543" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_89bb91f3-c05e-4a74-b802-8b5713c73543" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_f8230e3c-1c5f-4a6f-b8d7-bd7cf461c083" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_f8230e3c-1c5f-4a6f-b8d7-bd7cf461c083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_62336bc6-fc5e-4297-81f8-6bc00ca858fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_f8230e3c-1c5f-4a6f-b8d7-bd7cf461c083" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_62336bc6-fc5e-4297-81f8-6bc00ca858fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember_01994a3e-7f57-4fa8-afe6-8865de822740" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_62336bc6-fc5e-4297-81f8-6bc00ca858fe" xlink:to="loc_bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember_01994a3e-7f57-4fa8-afe6-8865de822740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember_5cb20996-a29b-4284-80f4-d0495e27ed42" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_62336bc6-fc5e-4297-81f8-6bc00ca858fe" xlink:to="loc_bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember_5cb20996-a29b-4284-80f4-d0495e27ed42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentAdvisoryAgreementMember_b96f6bb5-5459-44e2-8db3-48f058936142" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentAdvisoryAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_62336bc6-fc5e-4297-81f8-6bc00ca858fe" xlink:to="loc_bxsl_InvestmentAdvisoryAgreementMember_b96f6bb5-5459-44e2-8db3-48f058936142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesScenarioAxis_3f9a38fa-44c9-4c1e-99ff-992c8e7d808c" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesScenarioAxis_3f9a38fa-44c9-4c1e-99ff-992c8e7d808c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesScenarioDomain_ef4f0084-6a30-481d-a77e-9fa04684846f" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesScenarioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesScenarioAxis_3f9a38fa-44c9-4c1e-99ff-992c8e7d808c" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesScenarioDomain_ef4f0084-6a30-481d-a77e-9fa04684846f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember_33d00825-a3bb-4a1e-b606-05dee986834e" xlink:href="bxsl-20231231.xsd#bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesScenarioDomain_ef4f0084-6a30-481d-a77e-9fa04684846f" xlink:to="loc_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember_33d00825-a3bb-4a1e-b606-05dee986834e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember_b1516fc8-5ffe-4f0e-aba1-cdf3d7fac5cf" xlink:href="bxsl-20231231.xsd#bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_IncomeBasedIncentiveFeesScenarioDomain_ef4f0084-6a30-481d-a77e-9fa04684846f" xlink:to="loc_bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember_b1516fc8-5ffe-4f0e-aba1-cdf3d7fac5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioAxis_9d8c24f1-6d87-4031-8f9f-7f126ad18c93" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:to="loc_bxsl_VoluntaryWaiverScenarioAxis_9d8c24f1-6d87-4031-8f9f-7f126ad18c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverScenarioDomain_6259e9db-78e8-4ba6-b2da-62a71e465180" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverScenarioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VoluntaryWaiverScenarioAxis_9d8c24f1-6d87-4031-8f9f-7f126ad18c93" xlink:to="loc_bxsl_VoluntaryWaiverScenarioDomain_6259e9db-78e8-4ba6-b2da-62a71e465180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverInPlaceMember_a3e2c43a-86eb-453f-9f28-d54213490f4b" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverInPlaceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VoluntaryWaiverScenarioDomain_6259e9db-78e8-4ba6-b2da-62a71e465180" xlink:to="loc_bxsl_VoluntaryWaiverInPlaceMember_a3e2c43a-86eb-453f-9f28-d54213490f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VoluntaryWaiverNotInPlaceMember_8daf9079-14f4-46de-b839-a659bd4ce1fb" xlink:href="bxsl-20231231.xsd#bxsl_VoluntaryWaiverNotInPlaceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VoluntaryWaiverScenarioDomain_6259e9db-78e8-4ba6-b2da-62a71e465180" xlink:to="loc_bxsl_VoluntaryWaiverNotInPlaceMember_8daf9079-14f4-46de-b839-a659bd4ce1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8e4b52bf-7ba8-48a8-9dc2-126c80bbee8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8e4b52bf-7ba8-48a8-9dc2-126c80bbee8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_969476b0-39b2-41f4-bdc4-a9e1d2641449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8e4b52bf-7ba8-48a8-9dc2-126c80bbee8e" xlink:to="loc_us-gaap_RelatedPartyDomain_969476b0-39b2-41f4-bdc4-a9e1d2641449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_e14953b6-8935-4c52-ad9d-bdb016024de5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_969476b0-39b2-41f4-bdc4-a9e1d2641449" xlink:to="loc_srt_AffiliatedEntityMember_e14953b6-8935-4c52-ad9d-bdb016024de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a5ad1422-51cd-48db-b795-93f7aa182dc6" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementAndServiceFeesIncentiveRate_9a70b6ed-ae26-4fb2-9578-6609e5c7b2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementAndServiceFeesIncentiveRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_us-gaap_ManagementAndServiceFeesIncentiveRate_9a70b6ed-ae26-4fb2-9578-6609e5c7b2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate_f5715d2b-069d-431a-b469-d2e9dc01e5b5" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate_f5715d2b-069d-431a-b469-d2e9dc01e5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesRate_a35b8c38-ba68-45b3-ab0c-537b429dad6a" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesRate_a35b8c38-ba68-45b3-ab0c-537b429dad6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage_3fd4608c-5536-4c89-89ad-df1e621c46a1" xlink:href="bxsl-20231231.xsd#bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage_3fd4608c-5536-4c89-89ad-df1e621c46a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold_1e77753f-f677-4a9c-b9b0-24eef2160b56" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold_1e77753f-f677-4a9c-b9b0-24eef2160b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome_5c184ace-2dd7-4d4c-8566-f05e8497ee29" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome_5c184ace-2dd7-4d4c-8566-f05e8497ee29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage_a3b32bb4-76a0-4f63-a71a-c1f2467af914" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage_a3b32bb4-76a0-4f63-a71a-c1f2467af914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage_037d544c-3f3f-437e-8717-ed7f51ca4018" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage_037d544c-3f3f-437e-8717-ed7f51ca4018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn_0a40b241-b453-4f61-8b43-f067ff5dc6f8" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn_0a40b241-b453-4f61-8b43-f067ff5dc6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CapitalGainsBasedIncentiveFeesRate_c4587d60-5ba8-4d72-b018-1763dadfaaf0" xlink:href="bxsl-20231231.xsd#bxsl_CapitalGainsBasedIncentiveFeesRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_CapitalGainsBasedIncentiveFeesRate_c4587d60-5ba8-4d72-b018-1763dadfaaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncomeBasedIncentiveFeeExpense_e5d32ff4-63df-4b6f-a4b7-d7314fcc7f08" xlink:href="bxsl-20231231.xsd#bxsl_IncomeBasedIncentiveFeeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncomeBasedIncentiveFeeExpense_e5d32ff4-63df-4b6f-a4b7-d7314fcc7f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyVoluntaryFeeWaived_f6e323f2-552c-4162-817d-b52c95dae486" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyVoluntaryFeeWaived"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_us-gaap_InvestmentCompanyVoluntaryFeeWaived_f6e323f2-552c-4162-817d-b52c95dae486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IncentiveFeePayableIncome_cca73ded-e56d-4ca8-8a2e-ebd679cfb39a" xlink:href="bxsl-20231231.xsd#bxsl_IncentiveFeePayableIncome"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_IncentiveFeePayableIncome_cca73ded-e56d-4ca8-8a2e-ebd679cfb39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CapitalGainsIncentiveFeeExpense_7335c947-4f23-4b52-966b-57df1c42d4c6" xlink:href="bxsl-20231231.xsd#bxsl_CapitalGainsIncentiveFeeExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_496aee31-2236-4ef8-a7b2-5a56d5156ad8" xlink:to="loc_bxsl_CapitalGainsIncentiveFeeExpense_7335c947-4f23-4b52-966b-57df1c42d4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_b9956517-aed7-47e3-b6d1-51bed2ec44c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_afd7463d-4e5e-4005-9d9f-6b3e64df4e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_b9956517-aed7-47e3-b6d1-51bed2ec44c8" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_afd7463d-4e5e-4005-9d9f-6b3e64df4e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_b6724fcc-d0cc-4fc7-9c08-fd381655da04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_afd7463d-4e5e-4005-9d9f-6b3e64df4e4b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_b6724fcc-d0cc-4fc7-9c08-fd381655da04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_96ab14d4-0aea-4cd2-992a-7957565959ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b6724fcc-d0cc-4fc7-9c08-fd381655da04" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_96ab14d4-0aea-4cd2-992a-7957565959ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AdministrationAgreementMember_e5e28487-5d65-468f-8900-412b0a908e45" xlink:href="bxsl-20231231.xsd#bxsl_AdministrationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_96ab14d4-0aea-4cd2-992a-7957565959ff" xlink:to="loc_bxsl_AdministrationAgreementMember_e5e28487-5d65-468f-8900-412b0a908e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f7fbbf9f-1c79-4c10-95ab-360d13c50171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_afd7463d-4e5e-4005-9d9f-6b3e64df4e4b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f7fbbf9f-1c79-4c10-95ab-360d13c50171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8f688f05-ffa2-405c-bc40-0f35caa15381" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f7fbbf9f-1c79-4c10-95ab-360d13c50171" xlink:to="loc_us-gaap_RelatedPartyDomain_8f688f05-ffa2-405c-bc40-0f35caa15381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_21981f90-de8d-409c-a11f-e870071c94af" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_8f688f05-ffa2-405c-bc40-0f35caa15381" xlink:to="loc_srt_AffiliatedEntityMember_21981f90-de8d-409c-a11f-e870071c94af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_940ab3cd-3f73-458d-86fe-5ee6b149f611" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_afd7463d-4e5e-4005-9d9f-6b3e64df4e4b" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_940ab3cd-3f73-458d-86fe-5ee6b149f611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionInitialTerm_04ae6eeb-8513-4c81-9b01-36fe5a41ee58" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionInitialTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_940ab3cd-3f73-458d-86fe-5ee6b149f611" xlink:to="loc_bxsl_RelatedPartyTransactionInitialTerm_04ae6eeb-8513-4c81-9b01-36fe5a41ee58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdministrativeFeesExpense_2624da99-2868-4b21-b999-7b768f72bef3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdministrativeFeesExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_940ab3cd-3f73-458d-86fe-5ee6b149f611" xlink:to="loc_us-gaap_AdministrativeFeesExpense_2624da99-2868-4b21-b999-7b768f72bef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_64d71e35-121b-4f3c-8770-8339776fd653" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_940ab3cd-3f73-458d-86fe-5ee6b149f611" xlink:to="loc_us-gaap_OtherLiabilities_64d71e35-121b-4f3c-8770-8339776fd653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_5ecb8210-0161-46d2-8835-88bd69ea403d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3dff632c-26f5-4a4b-bbf4-77ff39dde57c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_5ecb8210-0161-46d2-8835-88bd69ea403d" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3dff632c-26f5-4a4b-bbf4-77ff39dde57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_d5536db4-96d4-48d3-a35f-19e2144001f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3dff632c-26f5-4a4b-bbf4-77ff39dde57c" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_d5536db4-96d4-48d3-a35f-19e2144001f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_17d435d1-da6e-481e-9acf-2f6be8a34338" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_d5536db4-96d4-48d3-a35f-19e2144001f1" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_17d435d1-da6e-481e-9acf-2f6be8a34338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SubAdministrationAgreementMember_ebf04531-1ae3-4907-9256-2b4ad49be4b4" xlink:href="bxsl-20231231.xsd#bxsl_SubAdministrationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_17d435d1-da6e-481e-9acf-2f6be8a34338" xlink:to="loc_bxsl_SubAdministrationAgreementMember_ebf04531-1ae3-4907-9256-2b4ad49be4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_df3eda44-637f-4c95-be8f-c68671ac41b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3dff632c-26f5-4a4b-bbf4-77ff39dde57c" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_df3eda44-637f-4c95-be8f-c68671ac41b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionInitialTerm_e7b0eddb-20d3-46d7-a1b1-ff0d1fc9d859" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionInitialTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df3eda44-637f-4c95-be8f-c68671ac41b5" xlink:to="loc_bxsl_RelatedPartyTransactionInitialTerm_e7b0eddb-20d3-46d7-a1b1-ff0d1fc9d859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionRenewalTerm_573e15ba-e867-4a2a-9410-8895760b5f1a" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df3eda44-637f-4c95-be8f-c68671ac41b5" xlink:to="loc_bxsl_RelatedPartyTransactionRenewalTerm_573e15ba-e867-4a2a-9410-8895760b5f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionTerminationNoticePeriod_e5e9de50-b3a9-4797-a525-a83587c3b433" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionTerminationNoticePeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df3eda44-637f-4c95-be8f-c68671ac41b5" xlink:to="loc_bxsl_RelatedPartyTransactionTerminationNoticePeriod_e5e9de50-b3a9-4797-a525-a83587c3b433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_61375eb8-2348-43c2-936f-676e63645cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_78e2bbee-b20d-4611-8ddc-ddf96435b359" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_61375eb8-2348-43c2-936f-676e63645cf9" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_78e2bbee-b20d-4611-8ddc-ddf96435b359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_5278afca-6a29-4329-9996-f1964014691b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_78e2bbee-b20d-4611-8ddc-ddf96435b359" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_5278afca-6a29-4329-9996-f1964014691b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_e7d5896e-016c-4bb6-854f-152411bd9a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_5278afca-6a29-4329-9996-f1964014691b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_e7d5896e-016c-4bb6-854f-152411bd9a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExpenseSupportAgreementMember_a900e9e7-583d-4742-94c5-e230017eed5a" xlink:href="bxsl-20231231.xsd#bxsl_ExpenseSupportAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_e7d5896e-016c-4bb6-854f-152411bd9a4f" xlink:to="loc_bxsl_ExpenseSupportAgreementMember_a900e9e7-583d-4742-94c5-e230017eed5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember_56c20d79-071d-47b3-80d5-5e2abc917b03" xlink:href="bxsl-20231231.xsd#bxsl_ExpenseSupportAgreementExcessOperatingFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_e7d5896e-016c-4bb6-854f-152411bd9a4f" xlink:to="loc_bxsl_ExpenseSupportAgreementExcessOperatingFundsMember_56c20d79-071d-47b3-80d5-5e2abc917b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_29b915d1-6f8c-4c16-8dcd-0350023bc6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_78e2bbee-b20d-4611-8ddc-ddf96435b359" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_29b915d1-6f8c-4c16-8dcd-0350023bc6f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_473efda5-8127-45ea-bba6-61c6f07d7518" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_29b915d1-6f8c-4c16-8dcd-0350023bc6f2" xlink:to="loc_us-gaap_RelatedPartyDomain_473efda5-8127-45ea-bba6-61c6f07d7518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_9bda8b71-a938-452a-8e48-3b06e9a46d62" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_473efda5-8127-45ea-bba6-61c6f07d7518" xlink:to="loc_srt_AffiliatedEntityMember_9bda8b71-a938-452a-8e48-3b06e9a46d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_eb37bf95-86db-420d-bea6-265ea6348b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_78e2bbee-b20d-4611-8ddc-ddf96435b359" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_eb37bf95-86db-420d-bea6-265ea6348b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RelatedPartyTransactionExpensePaymentPeriod_b2a0dea0-a66a-46a2-8626-59197984a979" xlink:href="bxsl-20231231.xsd#bxsl_RelatedPartyTransactionExpensePaymentPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb37bf95-86db-420d-bea6-265ea6348b5b" xlink:to="loc_bxsl_RelatedPartyTransactionExpensePaymentPeriod_b2a0dea0-a66a-46a2-8626-59197984a979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_34debe0b-1b6d-4161-b5d5-3c3a674c921e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb37bf95-86db-420d-bea6-265ea6348b5b" xlink:to="loc_us-gaap_OtherLiabilities_34debe0b-1b6d-4161-b5d5-3c3a674c921e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExpenseSupportReimbursementRelatedParty_edd058b2-b904-492e-83c1-96319a010adb" xlink:href="bxsl-20231231.xsd#bxsl_ExpenseSupportReimbursementRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb37bf95-86db-420d-bea6-265ea6348b5b" xlink:to="loc_bxsl_ExpenseSupportReimbursementRelatedParty_edd058b2-b904-492e-83c1-96319a010adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#InvestmentsInvestmentPortfolioatCostandFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract_ded16555-4a79-4da5-953c-c366089b5774" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_d9db997b-1cae-4e7d-9943-2554b4da6cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_ded16555-4a79-4da5-953c-c366089b5774" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_d9db997b-1cae-4e7d-9943-2554b4da6cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_bfd41081-7e91-419f-9a6a-ac1baa908661" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_d9db997b-1cae-4e7d-9943-2554b4da6cc8" xlink:to="loc_us-gaap_InvestmentTypeAxis_bfd41081-7e91-419f-9a6a-ac1baa908661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_56288b30-1e62-4791-a44e-32f08ce6f743" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_bfd41081-7e91-419f-9a6a-ac1baa908661" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_56288b30-1e62-4791-a44e-32f08ce6f743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienMember_c556b469-f63a-48dd-a39c-1da28e6dee3d" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_56288b30-1e62-4791-a44e-32f08ce6f743" xlink:to="loc_bxsl_DebtSecuritiesFirstLienMember_c556b469-f63a-48dd-a39c-1da28e6dee3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienMember_397dcd52-cdd4-47fb-9b71-4c93e9169a49" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_56288b30-1e62-4791-a44e-32f08ce6f743" xlink:to="loc_bxsl_DebtSecuritiesSecondLienMember_397dcd52-cdd4-47fb-9b71-4c93e9169a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_6edbc7b5-c6c5-4b2f-97fe-b3254d726214" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_56288b30-1e62-4791-a44e-32f08ce6f743" xlink:to="loc_us-gaap_UnsecuredDebtMember_6edbc7b5-c6c5-4b2f-97fe-b3254d726214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_54069474-e789-4bc1-85f5-aa22ef96ed28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_56288b30-1e62-4791-a44e-32f08ce6f743" xlink:to="loc_us-gaap_EquitySecuritiesMember_54069474-e789-4bc1-85f5-aa22ef96ed28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d0da0b20-ac9f-4837-aaac-5a5ef752e98a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_d9db997b-1cae-4e7d-9943-2554b4da6cc8" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d0da0b20-ac9f-4837-aaac-5a5ef752e98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b6484afa-a404-41a6-b2c9-d658e261bb90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d0da0b20-ac9f-4837-aaac-5a5ef752e98a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b6484afa-a404-41a6-b2c9-d658e261bb90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedAtFairValueMember_3704021c-6025-4122-97dc-c4da29ccb0f7" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedAtFairValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b6484afa-a404-41a6-b2c9-d658e261bb90" xlink:to="loc_bxsl_InvestmentOwnedAtFairValueMember_3704021c-6025-4122-97dc-c4da29ccb0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_57f66911-7933-4f96-b81d-db8745f2cfc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_d9db997b-1cae-4e7d-9943-2554b4da6cc8" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_57f66911-7933-4f96-b81d-db8745f2cfc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_00606969-fa71-4443-ba13-51a580b4f9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_57f66911-7933-4f96-b81d-db8745f2cfc1" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_00606969-fa71-4443-ba13-51a580b4f9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTypeConcentrationRiskMember_4372b16d-ec55-472c-8143-fe1b01bd0e66" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTypeConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_00606969-fa71-4443-ba13-51a580b4f9cb" xlink:to="loc_bxsl_InvestmentTypeConcentrationRiskMember_4372b16d-ec55-472c-8143-fe1b01bd0e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_ea2b1c75-d790-4d59-be18-bc99c6fcacdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_d9db997b-1cae-4e7d-9943-2554b4da6cc8" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_ea2b1c75-d790-4d59-be18-bc99c6fcacdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtCost_63dec866-2a8b-44a1-b8c1-69664f4bb4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_ea2b1c75-d790-4d59-be18-bc99c6fcacdc" xlink:to="loc_us-gaap_InvestmentOwnedAtCost_63dec866-2a8b-44a1-b8c1-69664f4bb4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_c849c725-2468-4410-a969-7d2bade7e4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_ea2b1c75-d790-4d59-be18-bc99c6fcacdc" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_c849c725-2468-4410-a969-7d2bade7e4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_48c9a568-6b35-46f5-b31b-b304cbb2ac86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_ea2b1c75-d790-4d59-be18-bc99c6fcacdc" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_48c9a568-6b35-46f5-b31b-b304cbb2ac86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#InvestmentsInvestmentsatFairValuePercentDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a47b9976-4edc-470f-895f-39e02099ae57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_078a18dc-b614-40ca-a5de-faa906ad4311" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a47b9976-4edc-470f-895f-39e02099ae57" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_078a18dc-b614-40ca-a5de-faa906ad4311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesByIndustryAxis_6f9f595d-cf18-4a6a-bccb-fb195e58e5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesByIndustryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_078a18dc-b614-40ca-a5de-faa906ad4311" xlink:to="loc_us-gaap_EquitySecuritiesByIndustryAxis_6f9f595d-cf18-4a6a-bccb-fb195e58e5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis_6f9f595d-cf18-4a6a-bccb-fb195e58e5b4" xlink:to="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AerospaceAndDefenseSectorMember_ca9ff15d-285e-4c9c-abe8-8caa2ac61292" xlink:href="bxsl-20231231.xsd#bxsl_AerospaceAndDefenseSectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_AerospaceAndDefenseSectorMember_ca9ff15d-285e-4c9c-abe8-8caa2ac61292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AirFreightLogisticsSectorMember_2770acdf-1e02-44a8-a0ae-deee530b775e" xlink:href="bxsl-20231231.xsd#bxsl_AirFreightLogisticsSectorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_AirFreightLogisticsSectorMember_2770acdf-1e02-44a8-a0ae-deee530b775e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BuildingProductsSectorMember_c6ad9e56-6164-468b-a6f6-756f86474add" xlink:href="bxsl-20231231.xsd#bxsl_BuildingProductsSectorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_BuildingProductsSectorMember_c6ad9e56-6164-468b-a6f6-756f86474add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChemicalsSectorMember_6aaf69de-0e5b-4aad-88b2-b194baf9de29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChemicalsSectorMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_us-gaap_ChemicalsSectorMember_6aaf69de-0e5b-4aad-88b2-b194baf9de29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommercialServicesSuppliesSectorMember_271b7ecd-30cb-486c-a29a-9e6f94cfab22" xlink:href="bxsl-20231231.xsd#bxsl_CommercialServicesSuppliesSectorMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_CommercialServicesSuppliesSectorMember_271b7ecd-30cb-486c-a29a-9e6f94cfab22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ConstructionEngineeringSectorMember_1c942783-e5e1-4022-9f4b-1dd0306893e7" xlink:href="bxsl-20231231.xsd#bxsl_ConstructionEngineeringSectorMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_ConstructionEngineeringSectorMember_1c942783-e5e1-4022-9f4b-1dd0306893e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContainerAndPackagingSectorMember_f35cdd74-5fb2-4fa0-a109-862160726527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContainerAndPackagingSectorMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_us-gaap_ContainerAndPackagingSectorMember_f35cdd74-5fb2-4fa0-a109-862160726527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DistributorsSectorMember_be7e3298-0051-4d61-9c65-63cd2e47d3bd" xlink:href="bxsl-20231231.xsd#bxsl_DistributorsSectorMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_DistributorsSectorMember_be7e3298-0051-4d61-9c65-63cd2e47d3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsumerSectorMember_92b15555-1f87-4c19-bd1b-04240e48362c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsumerSectorMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_us-gaap_ConsumerSectorMember_92b15555-1f87-4c19-bd1b-04240e48362c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServicesSectorMember_c309bacc-30b4-484b-82a5-7a8101f079c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialServicesSectorMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_us-gaap_FinancialServicesSectorMember_c309bacc-30b4-484b-82a5-7a8101f079c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DiversifiedTelecommunicationServicesSectorMember_5cddc666-6839-4eb5-bf8f-4ef0c6fb85c4" xlink:href="bxsl-20231231.xsd#bxsl_DiversifiedTelecommunicationServicesSectorMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_DiversifiedTelecommunicationServicesSectorMember_5cddc666-6839-4eb5-bf8f-4ef0c6fb85c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectricalEquipmentSectorMember_81651cfa-5a2a-4d24-960a-3f115f9e0a9c" xlink:href="bxsl-20231231.xsd#bxsl_ElectricalEquipmentSectorMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_ElectricalEquipmentSectorMember_81651cfa-5a2a-4d24-960a-3f115f9e0a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember_38a418b0-25a6-4e91-a02c-2db099290010" xlink:href="bxsl-20231231.xsd#bxsl_ElectronicEquipmentInstrumentsAndComponentsMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_ElectronicEquipmentInstrumentsAndComponentsMember_38a418b0-25a6-4e91-a02c-2db099290010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ElectricUtilitiesMember_9c15550e-92a6-4a14-8de2-24b6dcc6b1d9" xlink:href="bxsl-20231231.xsd#bxsl_ElectricUtilitiesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_ElectricUtilitiesMember_9c15550e-92a6-4a14-8de2-24b6dcc6b1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnergySectorMember_8f19db5a-72e9-472c-910e-34a5ea8de328" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EnergySectorMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_us-gaap_EnergySectorMember_8f19db5a-72e9-472c-910e-34a5ea8de328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_GroundTransportationMember_ceb936ce-e0a4-4db8-ac52-2f6f7a8c4246" xlink:href="bxsl-20231231.xsd#bxsl_GroundTransportationMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_GroundTransportationMember_ceb936ce-e0a4-4db8-ac52-2f6f7a8c4246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareEquipmentSuppliesSectorMember_1fb94312-1eff-4d0c-8981-e38f0c918c69" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareEquipmentSuppliesSectorMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_HealthCareEquipmentSuppliesSectorMember_1fb94312-1eff-4d0c-8981-e38f0c918c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareProvidersServicesSectorMember_fd81e808-1af5-43dc-96a8-1547a35fb0c7" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareProvidersServicesSectorMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_HealthCareProvidersServicesSectorMember_fd81e808-1af5-43dc-96a8-1547a35fb0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HealthCareTechnologySectorMember_f242cc00-5608-4613-b215-c4a33f065b38" xlink:href="bxsl-20231231.xsd#bxsl_HealthCareTechnologySectorMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_HealthCareTechnologySectorMember_f242cc00-5608-4613-b215-c4a33f065b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IndustrialConglomeratesMember_0e08060f-cb8b-46ad-9bdd-79c712f8d7e5" xlink:href="bxsl-20231231.xsd#bxsl_IndustrialConglomeratesMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_IndustrialConglomeratesMember_0e08060f-cb8b-46ad-9bdd-79c712f8d7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSectorMember_74979468-de56-4174-a2a9-9fa25ae5a3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceSectorMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_us-gaap_InsuranceSectorMember_74979468-de56-4174-a2a9-9fa25ae5a3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InternetAndDirectMarketingRetailMember_0fb83bb3-15d2-40f0-b8d4-95792c918b50" xlink:href="bxsl-20231231.xsd#bxsl_InternetAndDirectMarketingRetailMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_InternetAndDirectMarketingRetailMember_0fb83bb3-15d2-40f0-b8d4-95792c918b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ITServicesSectorMember_3895b084-2c0c-492a-bb6a-b05556a96a47" xlink:href="bxsl-20231231.xsd#bxsl_ITServicesSectorMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_ITServicesSectorMember_3895b084-2c0c-492a-bb6a-b05556a96a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MachineryMember_40373f9d-c4bd-4f41-a2ed-9001289bad24" xlink:href="bxsl-20231231.xsd#bxsl_MachineryMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_MachineryMember_40373f9d-c4bd-4f41-a2ed-9001289bad24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MarineMember_bbbf9fef-f914-414d-8468-b13ae11e9890" xlink:href="bxsl-20231231.xsd#bxsl_MarineMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_MarineMember_bbbf9fef-f914-414d-8468-b13ae11e9890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MediaSectorMember_40d27179-9ff6-42c2-bc48-2307806e6755" xlink:href="bxsl-20231231.xsd#bxsl_MediaSectorMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_MediaSectorMember_40d27179-9ff6-42c2-bc48-2307806e6755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OilGasAndConsumableFuelsMember_c4ad86ac-ab4b-4856-882c-5fdd61ad4a8e" xlink:href="bxsl-20231231.xsd#bxsl_OilGasAndConsumableFuelsMember"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_OilGasAndConsumableFuelsMember_c4ad86ac-ab4b-4856-882c-5fdd61ad4a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PaperAndForestProductsMember_ac11ada4-f0c5-4ac7-8dd0-5b6b21266fd6" xlink:href="bxsl-20231231.xsd#bxsl_PaperAndForestProductsMember"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_PaperAndForestProductsMember_ac11ada4-f0c5-4ac7-8dd0-5b6b21266fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PharmaceuticalsSectorMember_fc14da21-2ecc-480b-98aa-7631a09f3d62" xlink:href="bxsl-20231231.xsd#bxsl_PharmaceuticalsSectorMember"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_PharmaceuticalsSectorMember_fc14da21-2ecc-480b-98aa-7631a09f3d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ProfessionalServicesSectorMember_4eedc49a-94ff-4002-a0a4-b1cec1433d60" xlink:href="bxsl-20231231.xsd#bxsl_ProfessionalServicesSectorMember"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_ProfessionalServicesSectorMember_4eedc49a-94ff-4002-a0a4-b1cec1433d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RealEstateManagementDevelopmentSectorMember_8acbf54c-b6eb-4226-85c8-06bce5847aec" xlink:href="bxsl-20231231.xsd#bxsl_RealEstateManagementDevelopmentSectorMember"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_RealEstateManagementDevelopmentSectorMember_8acbf54c-b6eb-4226-85c8-06bce5847aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RoadAndRailMember_d1e4f390-0d5e-4909-94c2-7757bc47cb05" xlink:href="bxsl-20231231.xsd#bxsl_RoadAndRailMember"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_RoadAndRailMember_d1e4f390-0d5e-4909-94c2-7757bc47cb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SoftwareSectorMember_e811abde-1821-4e20-91fd-a8d7a8877070" xlink:href="bxsl-20231231.xsd#bxsl_SoftwareSectorMember"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_SoftwareSectorMember_e811abde-1821-4e20-91fd-a8d7a8877070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SpecialtyRetailMember_46e7c78d-ae61-4d35-8e3d-821d02ec5dad" xlink:href="bxsl-20231231.xsd#bxsl_SpecialtyRetailMember"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_SpecialtyRetailMember_46e7c78d-ae61-4d35-8e3d-821d02ec5dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TechnologyHardwareStorageAndPeripheralsMember_01b2746a-db08-40e6-bb15-e6a469aab0ca" xlink:href="bxsl-20231231.xsd#bxsl_TechnologyHardwareStorageAndPeripheralsMember"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_TechnologyHardwareStorageAndPeripheralsMember_01b2746a-db08-40e6-bb15-e6a469aab0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TradingCompaniesDistributorsSectorMember_a6cdfed1-382e-4c7d-b96b-a17cd3a9bf71" xlink:href="bxsl-20231231.xsd#bxsl_TradingCompaniesDistributorsSectorMember"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_TradingCompaniesDistributorsSectorMember_a6cdfed1-382e-4c7d-b96b-a17cd3a9bf71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransportationInfrastructureSectorMember_20c85841-2a0b-4656-8647-db70f78cb1e7" xlink:href="bxsl-20231231.xsd#bxsl_TransportationInfrastructureSectorMember"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_2b006fbc-f8b2-4d9f-a749-3ddc65879260" xlink:to="loc_bxsl_TransportationInfrastructureSectorMember_20c85841-2a0b-4656-8647-db70f78cb1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_159433cc-7d88-4e90-8ac9-c00ea9de3612" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_078a18dc-b614-40ca-a5de-faa906ad4311" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_159433cc-7d88-4e90-8ac9-c00ea9de3612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e41a9857-e41a-4f3b-a9e2-123d4324ac72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_159433cc-7d88-4e90-8ac9-c00ea9de3612" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e41a9857-e41a-4f3b-a9e2-123d4324ac72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedAtFairValueMember_73543297-5a73-47a5-add0-cfa7c6c00b01" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedAtFairValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e41a9857-e41a-4f3b-a9e2-123d4324ac72" xlink:to="loc_bxsl_InvestmentOwnedAtFairValueMember_73543297-5a73-47a5-add0-cfa7c6c00b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_0cbd0cd7-c1a5-4ec7-8a15-d1ade84b4d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_078a18dc-b614-40ca-a5de-faa906ad4311" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_0cbd0cd7-c1a5-4ec7-8a15-d1ade84b4d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_fb9ebc2e-d277-4fd3-b149-30eaed1cc058" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_0cbd0cd7-c1a5-4ec7-8a15-d1ade84b4d2c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_fb9ebc2e-d277-4fd3-b149-30eaed1cc058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTypeConcentrationRiskMember_a527bfdf-320b-4d44-a2ac-3c15b17311f6" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTypeConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_fb9ebc2e-d277-4fd3-b149-30eaed1cc058" xlink:to="loc_bxsl_InvestmentTypeConcentrationRiskMember_a527bfdf-320b-4d44-a2ac-3c15b17311f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_527b2a10-b687-43bb-9026-45f3838f4098" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_078a18dc-b614-40ca-a5de-faa906ad4311" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_527b2a10-b687-43bb-9026-45f3838f4098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ea3f4a54-01c1-4739-b451-afb208471a56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_527b2a10-b687-43bb-9026-45f3838f4098" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ea3f4a54-01c1-4739-b451-afb208471a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#InvestmentsGeographicInvestmentDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract_67562a2e-36d2-4ac9-967a-1a0c66685116" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_3ecd7492-8f9a-4060-921c-7f955d34db59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_67562a2e-36d2-4ac9-967a-1a0c66685116" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_3ecd7492-8f9a-4060-921c-7f955d34db59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ee660568-c657-47c6-a74b-4552a88cd570" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3ecd7492-8f9a-4060-921c-7f955d34db59" xlink:to="loc_srt_StatementGeographicalAxis_ee660568-c657-47c6-a74b-4552a88cd570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ec1bedf1-e933-43d9-978f-8a7134136e8f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ee660568-c657-47c6-a74b-4552a88cd570" xlink:to="loc_srt_SegmentGeographicalDomain_ec1bedf1-e933-43d9-978f-8a7134136e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_00c5c3c3-13cf-4fe2-8b19-8d7f71361192" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ec1bedf1-e933-43d9-978f-8a7134136e8f" xlink:to="loc_country_US_00c5c3c3-13cf-4fe2-8b19-8d7f71361192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_8a5fdd0a-85d2-484c-884d-834dd2442897" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ec1bedf1-e933-43d9-978f-8a7134136e8f" xlink:to="loc_country_CA_8a5fdd0a-85d2-484c-884d-834dd2442897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BERMUDAAndCAYMANISLANDMember_e4455a06-3c32-4c8c-aa3f-33bbfbab7dfe" xlink:href="bxsl-20231231.xsd#bxsl_BERMUDAAndCAYMANISLANDMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ec1bedf1-e933-43d9-978f-8a7134136e8f" xlink:to="loc_bxsl_BERMUDAAndCAYMANISLANDMember_e4455a06-3c32-4c8c-aa3f-33bbfbab7dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_8221d327-5075-4a8f-9785-503af51579e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ec1bedf1-e933-43d9-978f-8a7134136e8f" xlink:to="loc_srt_EuropeMember_8221d327-5075-4a8f-9785-503af51579e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_662b3781-752a-4b76-8226-e024a4a88cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3ecd7492-8f9a-4060-921c-7f955d34db59" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_662b3781-752a-4b76-8226-e024a4a88cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84c7b6ad-8379-4774-90b1-21d02a71eccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_662b3781-752a-4b76-8226-e024a4a88cf3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84c7b6ad-8379-4774-90b1-21d02a71eccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedAtFairValueMember_ff94aca2-f0a7-443e-87f7-1f63542cda85" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedAtFairValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84c7b6ad-8379-4774-90b1-21d02a71eccd" xlink:to="loc_bxsl_InvestmentOwnedAtFairValueMember_ff94aca2-f0a7-443e-87f7-1f63542cda85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d1c48361-c364-4127-9774-340861ad3a52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3ecd7492-8f9a-4060-921c-7f955d34db59" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d1c48361-c364-4127-9774-340861ad3a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3cb46201-e6cc-462c-8bd6-67a27f8c4110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d1c48361-c364-4127-9774-340861ad3a52" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3cb46201-e6cc-462c-8bd6-67a27f8c4110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTypeConcentrationRiskMember_c75e1d3c-9184-4e88-942f-c02e4d64f852" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTypeConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3cb46201-e6cc-462c-8bd6-67a27f8c4110" xlink:to="loc_bxsl_InvestmentTypeConcentrationRiskMember_c75e1d3c-9184-4e88-942f-c02e4d64f852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e94e9cb-748c-49a3-a974-cbe80f98e73c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3ecd7492-8f9a-4060-921c-7f955d34db59" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e94e9cb-748c-49a3-a974-cbe80f98e73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtCost_96edff60-aa59-41de-9f69-560eebce63dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e94e9cb-748c-49a3-a974-cbe80f98e73c" xlink:to="loc_us-gaap_InvestmentOwnedAtCost_96edff60-aa59-41de-9f69-560eebce63dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_70746e06-49c5-4970-ab0c-09ec05de4d19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e94e9cb-748c-49a3-a974-cbe80f98e73c" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_70746e06-49c5-4970-ab0c-09ec05de4d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_867e1174-e73c-427b-bafc-30af3a318384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e94e9cb-748c-49a3-a974-cbe80f98e73c" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_867e1174-e73c-427b-bafc-30af3a318384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_3da5da9f-265f-4a52-a74f-9258ccee8ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e94e9cb-748c-49a3-a974-cbe80f98e73c" xlink:to="loc_us-gaap_InvestmentOwnedPercentOfNetAssets_3da5da9f-265f-4a52-a74f-9258ccee8ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#InvestmentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract_f30194ed-9689-4c83-b7c6-3dc756441f22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_c44a03de-e998-429c-a173-d8606015f832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_f30194ed-9689-4c83-b7c6-3dc756441f22" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_c44a03de-e998-429c-a173-d8606015f832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_645ec33b-d056-402c-9345-9518ed0dd78d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c44a03de-e998-429c-a173-d8606015f832" xlink:to="loc_us-gaap_InvestmentTypeAxis_645ec33b-d056-402c-9345-9518ed0dd78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_e7cc99b0-b28d-4ac2-8a9c-df622a2aaa54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_645ec33b-d056-402c-9345-9518ed0dd78d" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_e7cc99b0-b28d-4ac2-8a9c-df622a2aaa54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesVariableRateMember_28d9b546-98ee-4c7a-8df3-331b965c4c23" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesVariableRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e7cc99b0-b28d-4ac2-8a9c-df622a2aaa54" xlink:to="loc_bxsl_DebtSecuritiesVariableRateMember_28d9b546-98ee-4c7a-8df3-331b965c4c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFixedRateMember_05029b9c-e483-4587-aa8e-1ef6d0ddab30" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFixedRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e7cc99b0-b28d-4ac2-8a9c-df622a2aaa54" xlink:to="loc_bxsl_DebtSecuritiesFixedRateMember_05029b9c-e483-4587-aa8e-1ef6d0ddab30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf099bb8-6e08-4ff1-8ea6-3765af5a5533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c44a03de-e998-429c-a173-d8606015f832" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf099bb8-6e08-4ff1-8ea6-3765af5a5533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f7cc211-9d2c-41dc-bee0-cda79228044b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf099bb8-6e08-4ff1-8ea6-3765af5a5533" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f7cc211-9d2c-41dc-bee0-cda79228044b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentsAtFairValueMember_c1254168-345e-4448-875e-e3c4a7ab7edb" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentsAtFairValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f7cc211-9d2c-41dc-bee0-cda79228044b" xlink:to="loc_bxsl_InvestmentsAtFairValueMember_c1254168-345e-4448-875e-e3c4a7ab7edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_976161db-b85f-428d-bd59-35778c2852c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c44a03de-e998-429c-a173-d8606015f832" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_976161db-b85f-428d-bd59-35778c2852c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_97e01951-7ebc-4940-b327-2e0bd5614609" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_976161db-b85f-428d-bd59-35778c2852c8" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_97e01951-7ebc-4940-b327-2e0bd5614609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTypeConcentrationRiskMember_b60d8203-02f1-4a56-b940-7427bc9f15ec" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTypeConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_97e01951-7ebc-4940-b327-2e0bd5614609" xlink:to="loc_bxsl_InvestmentTypeConcentrationRiskMember_b60d8203-02f1-4a56-b940-7427bc9f15ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_e49fdb91-8b5d-4461-87a0-3ddc651843a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c44a03de-e998-429c-a173-d8606015f832" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_e49fdb91-8b5d-4461-87a0-3ddc651843a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentOwnedNonaccrualNumberOfLoans_d877c7a7-e232-4fef-b5bd-473f31b8f0bd" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentOwnedNonaccrualNumberOfLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_e49fdb91-8b5d-4461-87a0-3ddc651843a7" xlink:to="loc_bxsl_InvestmentOwnedNonaccrualNumberOfLoans_d877c7a7-e232-4fef-b5bd-473f31b8f0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_38cec2b5-d6b2-4e58-b5ab-12b06505c828" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_e49fdb91-8b5d-4461-87a0-3ddc651843a7" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_38cec2b5-d6b2-4e58-b5ab-12b06505c828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_604c3a1f-beff-47cc-b878-9f7a3afb0734" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_29680023-a54e-4594-9f11-507071bf2f52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_604c3a1f-beff-47cc-b878-9f7a3afb0734" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_29680023-a54e-4594-9f11-507071bf2f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1c532f67-25ad-4719-b28e-8576031eb55b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_29680023-a54e-4594-9f11-507071bf2f52" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1c532f67-25ad-4719-b28e-8576031eb55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ed63fef6-ca24-4249-8b2b-c6727af601fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1c532f67-25ad-4719-b28e-8576031eb55b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ed63fef6-ca24-4249-8b2b-c6727af601fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f6dc47b9-706b-443e-9594-0f5001312bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ed63fef6-ca24-4249-8b2b-c6727af601fa" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f6dc47b9-706b-443e-9594-0f5001312bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f2566451-995e-4d20-834a-94622472c495" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ed63fef6-ca24-4249-8b2b-c6727af601fa" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f2566451-995e-4d20-834a-94622472c495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_77e30596-6b09-4669-a697-174aea849248" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ed63fef6-ca24-4249-8b2b-c6727af601fa" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_77e30596-6b09-4669-a697-174aea849248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_34f82351-6524-44b9-b1da-6d3b774cad66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_29680023-a54e-4594-9f11-507071bf2f52" xlink:to="loc_us-gaap_FinancialInstrumentAxis_34f82351-6524-44b9-b1da-6d3b774cad66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a005ec0a-4e33-48a7-9c52-cf5acdd1f2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_34f82351-6524-44b9-b1da-6d3b774cad66" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a005ec0a-4e33-48a7-9c52-cf5acdd1f2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienMember_78feb959-dd4a-411b-8e0b-6127343308cb" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a005ec0a-4e33-48a7-9c52-cf5acdd1f2f0" xlink:to="loc_bxsl_DebtSecuritiesFirstLienMember_78feb959-dd4a-411b-8e0b-6127343308cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienMember_8780c4c9-951d-4e37-945f-7e134cb11888" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a005ec0a-4e33-48a7-9c52-cf5acdd1f2f0" xlink:to="loc_bxsl_DebtSecuritiesSecondLienMember_8780c4c9-951d-4e37-945f-7e134cb11888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_f3987c2c-35d1-4cfc-85e9-446dc6a3696b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a005ec0a-4e33-48a7-9c52-cf5acdd1f2f0" xlink:to="loc_us-gaap_EquitySecuritiesMember_f3987c2c-35d1-4cfc-85e9-446dc6a3696b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_856b65b1-94e9-4fa8-9220-c94de6ab61d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a005ec0a-4e33-48a7-9c52-cf5acdd1f2f0" xlink:to="loc_us-gaap_UnsecuredDebtMember_856b65b1-94e9-4fa8-9220-c94de6ab61d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f51b4f8f-4e5b-4ac1-9497-fa030cd137b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_29680023-a54e-4594-9f11-507071bf2f52" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f51b4f8f-4e5b-4ac1-9497-fa030cd137b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_0c95f668-5fa8-46ac-8f98-8ddb9ca8dac7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f51b4f8f-4e5b-4ac1-9497-fa030cd137b8" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_0c95f668-5fa8-46ac-8f98-8ddb9ca8dac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_db9d9757-2f9a-40e4-a543-c3f529a7621f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e4de16e6-7c22-45ee-8cb2-f0a5796fefbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_db9d9757-2f9a-40e4-a543-c3f529a7621f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e4de16e6-7c22-45ee-8cb2-f0a5796fefbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_0070839d-b5e0-4a14-99e6-3970f2327a46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e4de16e6-7c22-45ee-8cb2-f0a5796fefbb" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_0070839d-b5e0-4a14-99e6-3970f2327a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_65dd326a-e35f-451a-90d2-8b7101cbf012" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_0070839d-b5e0-4a14-99e6-3970f2327a46" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_65dd326a-e35f-451a-90d2-8b7101cbf012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_65dd326a-e35f-451a-90d2-8b7101cbf012" xlink:to="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentsRealizedGainLossMember_03e1960a-4711-40bd-8313-e28c783afac4" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentsRealizedGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:to="loc_bxsl_InvestmentsRealizedGainLossMember_03e1960a-4711-40bd-8313-e28c783afac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentsUnrealizedGainLossMember_5de2a136-5555-4788-b5c8-eb3b8e396dc8" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentsUnrealizedGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:to="loc_bxsl_InvestmentsUnrealizedGainLossMember_5de2a136-5555-4788-b5c8-eb3b8e396dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienMember_b93222ee-890d-4787-bb99-8d3fa1f8cf60" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:to="loc_bxsl_DebtSecuritiesFirstLienMember_b93222ee-890d-4787-bb99-8d3fa1f8cf60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember_1871cb82-9425-42cc-ab63-ad564f8656bd" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienRealizedGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_DebtSecuritiesFirstLienMember_b93222ee-890d-4787-bb99-8d3fa1f8cf60" xlink:to="loc_bxsl_DebtSecuritiesFirstLienRealizedGainLossMember_1871cb82-9425-42cc-ab63-ad564f8656bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember_97757b07-e77e-48f8-a61d-37cb0a67446f" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_DebtSecuritiesFirstLienMember_b93222ee-890d-4787-bb99-8d3fa1f8cf60" xlink:to="loc_bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember_97757b07-e77e-48f8-a61d-37cb0a67446f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienMember_f73ea104-8f88-4c95-821d-47e196c86b44" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:to="loc_bxsl_DebtSecuritiesSecondLienMember_f73ea104-8f88-4c95-821d-47e196c86b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember_4bb7ff07-4ac9-441a-9759-8e07935a4ed2" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienRealizedGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_DebtSecuritiesSecondLienMember_f73ea104-8f88-4c95-821d-47e196c86b44" xlink:to="loc_bxsl_DebtSecuritiesSecondLienRealizedGainLossMember_4bb7ff07-4ac9-441a-9759-8e07935a4ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember_c862ff6d-5c7d-4f69-87cc-f336cf250aed" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_DebtSecuritiesSecondLienMember_f73ea104-8f88-4c95-821d-47e196c86b44" xlink:to="loc_bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember_c862ff6d-5c7d-4f69-87cc-f336cf250aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_c92a62a9-7b64-4c90-82b4-4cfb39b33524" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:to="loc_us-gaap_UnsecuredDebtMember_c92a62a9-7b64-4c90-82b4-4cfb39b33524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_UnsecuredDebtRealizedGainLossMember_f13526f6-44af-430f-9714-622f7d804600" xlink:href="bxsl-20231231.xsd#bxsl_UnsecuredDebtRealizedGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnsecuredDebtMember_c92a62a9-7b64-4c90-82b4-4cfb39b33524" xlink:to="loc_bxsl_UnsecuredDebtRealizedGainLossMember_f13526f6-44af-430f-9714-622f7d804600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_UnsecuredDebtUnrealizedGainLossMember_4a6e602d-6349-47e6-ad77-19a68388b08a" xlink:href="bxsl-20231231.xsd#bxsl_UnsecuredDebtUnrealizedGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnsecuredDebtMember_c92a62a9-7b64-4c90-82b4-4cfb39b33524" xlink:to="loc_bxsl_UnsecuredDebtUnrealizedGainLossMember_4a6e602d-6349-47e6-ad77-19a68388b08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_4c9354ec-635f-4e30-bf10-439b6d5b26c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsMember_5c917303-9aee-46ca-ac3b-1eda63bfe1c0" xlink:to="loc_us-gaap_EquitySecuritiesMember_4c9354ec-635f-4e30-bf10-439b6d5b26c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_EquitySecuritiesRealizedGainLossMember_f2dcdeba-36ef-415a-a5ef-0ca39ba2bce3" xlink:href="bxsl-20231231.xsd#bxsl_EquitySecuritiesRealizedGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_4c9354ec-635f-4e30-bf10-439b6d5b26c0" xlink:to="loc_bxsl_EquitySecuritiesRealizedGainLossMember_f2dcdeba-36ef-415a-a5ef-0ca39ba2bce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_EquitySecuritiesUnrealizedGainLossMember_55ffd150-9b35-468d-ac1d-3e1211b3b1d7" xlink:href="bxsl-20231231.xsd#bxsl_EquitySecuritiesUnrealizedGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_4c9354ec-635f-4e30-bf10-439b6d5b26c0" xlink:to="loc_bxsl_EquitySecuritiesUnrealizedGainLossMember_55ffd150-9b35-468d-ac1d-3e1211b3b1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1fd33e75-f879-4d98-be16-077b0fc7ac6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e4de16e6-7c22-45ee-8cb2-f0a5796fefbb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1fd33e75-f879-4d98-be16-077b0fc7ac6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1fd33e75-f879-4d98-be16-077b0fc7ac6c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_d1776db7-2af7-4522-88c0-560a8972b4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_d1776db7-2af7-4522-88c0-560a8972b4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_330f4cb6-2c7e-4bb0-ac03-5c18d05a8661" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_330f4cb6-2c7e-4bb0-ac03-5c18d05a8661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1c072793-4968-4ac3-979b-252a3775b427" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1c072793-4968-4ac3-979b-252a3775b427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium_5a55244c-bc60-4200-a670-9369ac235aef" xlink:href="bxsl-20231231.xsd#bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium_5a55244c-bc60-4200-a670-9369ac235aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_fa1d436f-199e-4f45-8496-856a4f3c529f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_fa1d436f-199e-4f45-8496-856a4f3c529f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_bb141cd2-0fc0-4966-adab-c3d3adf08c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_bb141cd2-0fc0-4966-adab-c3d3adf08c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_ff611dae-23ab-4e5b-84e2-11f354bdd74a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_ff611dae-23ab-4e5b-84e2-11f354bdd74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_c1030ab1-cfe7-489b-a039-5e2c3f352691" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_46551a37-5877-4717-a54f-047752fa5262" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_c1030ab1-cfe7-489b-a039-5e2c3f352691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_85f9c48b-b8dc-4452-b00b-34e309ff1ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1fd33e75-f879-4d98-be16-077b0fc7ac6c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_85f9c48b-b8dc-4452-b00b-34e309ff1ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FairValueMeasurementsUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bec70ca5-2f96-475d-ae7c-338cad380dad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bec70ca5-2f96-475d-ae7c-338cad380dad" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8cbe1c24-8043-4f35-b4b9-642e07b470d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8cbe1c24-8043-4f35-b4b9-642e07b470d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea57a7a9-b2ba-4800-a26d-90fa0e38bfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8cbe1c24-8043-4f35-b4b9-642e07b470d6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea57a7a9-b2ba-4800-a26d-90fa0e38bfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesFirstLienMember_ca984e89-78bf-4c13-9670-dd5cf6914b12" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesFirstLienMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea57a7a9-b2ba-4800-a26d-90fa0e38bfbd" xlink:to="loc_bxsl_DebtSecuritiesFirstLienMember_ca984e89-78bf-4c13-9670-dd5cf6914b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtSecuritiesSecondLienMember_591d7b65-dc69-49f1-833e-ea886bc6d8ff" xlink:href="bxsl-20231231.xsd#bxsl_DebtSecuritiesSecondLienMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea57a7a9-b2ba-4800-a26d-90fa0e38bfbd" xlink:to="loc_bxsl_DebtSecuritiesSecondLienMember_591d7b65-dc69-49f1-833e-ea886bc6d8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_f084222c-e362-4505-a9f7-c0973257226b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea57a7a9-b2ba-4800-a26d-90fa0e38bfbd" xlink:to="loc_us-gaap_UnsecuredDebtMember_f084222c-e362-4505-a9f7-c0973257226b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_b499c28b-6403-4843-8362-89ae46153ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea57a7a9-b2ba-4800-a26d-90fa0e38bfbd" xlink:to="loc_us-gaap_EquitySecuritiesMember_b499c28b-6403-4843-8362-89ae46153ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5fe57a95-ef84-40cd-a125-9a636e775615" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:to="loc_srt_RangeAxis_5fe57a95-ef84-40cd-a125-9a636e775615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e7fb2096-7644-422e-ae6c-5fbf895d548d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5fe57a95-ef84-40cd-a125-9a636e775615" xlink:to="loc_srt_RangeMember_e7fb2096-7644-422e-ae6c-5fbf895d548d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d54c5f1c-c24f-426f-bc67-cb54cf401ba2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e7fb2096-7644-422e-ae6c-5fbf895d548d" xlink:to="loc_srt_MinimumMember_d54c5f1c-c24f-426f-bc67-cb54cf401ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e5e3222a-403f-4ed2-b4fd-414e725b9599" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e7fb2096-7644-422e-ae6c-5fbf895d548d" xlink:to="loc_srt_MaximumMember_e5e3222a-403f-4ed2-b4fd-414e725b9599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_9096fb43-49e0-4015-997a-fe986a099ea5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e7fb2096-7644-422e-ae6c-5fbf895d548d" xlink:to="loc_srt_WeightedAverageMember_9096fb43-49e0-4015-997a-fe986a099ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_f1b7bcc1-927a-4175-9e38-33c0859fac36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:to="loc_us-gaap_ValuationTechniqueAxis_f1b7bcc1-927a-4175-9e38-33c0859fac36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_d930c2ec-7ec8-4cbb-baef-e4d909312859" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_f1b7bcc1-927a-4175-9e38-33c0859fac36" xlink:to="loc_us-gaap_ValuationTechniqueDomain_d930c2ec-7ec8-4cbb-baef-e4d909312859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ValuationYieldAnalysisApproachMember_c75a2bb8-3345-45db-9f6a-49cf9305e2ae" xlink:href="bxsl-20231231.xsd#bxsl_ValuationYieldAnalysisApproachMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_d930c2ec-7ec8-4cbb-baef-e4d909312859" xlink:to="loc_bxsl_ValuationYieldAnalysisApproachMember_c75a2bb8-3345-45db-9f6a-49cf9305e2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ValuationAssetRecoverabilityMember_60d51afe-680e-4cd1-a805-aaec621b7b28" xlink:href="bxsl-20231231.xsd#bxsl_ValuationAssetRecoverabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_d930c2ec-7ec8-4cbb-baef-e4d909312859" xlink:to="loc_bxsl_ValuationAssetRecoverabilityMember_60d51afe-680e-4cd1-a805-aaec621b7b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketApproachValuationTechniqueMember_5b408fa7-8504-4aff-b43d-f7b2df54c3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketApproachValuationTechniqueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_d930c2ec-7ec8-4cbb-baef-e4d909312859" xlink:to="loc_us-gaap_MarketApproachValuationTechniqueMember_5b408fa7-8504-4aff-b43d-f7b2df54c3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_4b92b1ca-cb14-4527-9e2c-205b231429ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_d930c2ec-7ec8-4cbb-baef-e4d909312859" xlink:to="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_4b92b1ca-cb14-4527-9e2c-205b231429ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ca42fb4d-8373-4b9f-8543-f60afa354a29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ca42fb4d-8373-4b9f-8543-f60afa354a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9f7f2348-1b7b-440b-9823-9f2cdb186177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ca42fb4d-8373-4b9f-8543-f60afa354a29" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9f7f2348-1b7b-440b-9823-9f2cdb186177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_fbe88c3e-79e5-43d8-8004-5a66eeb9148a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9f7f2348-1b7b-440b-9823-9f2cdb186177" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_fbe88c3e-79e5-43d8-8004-5a66eeb9148a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_3238580f-1e80-4205-ac63-bb7daded99ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_3238580f-1e80-4205-ac63-bb7daded99ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_3238580f-1e80-4205-ac63-bb7daded99ad" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_d02bb084-83fb-45e8-a460-c7ca6a819024" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_d02bb084-83fb-45e8-a460-c7ca6a819024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MeasurementInputMarketMultipleMember_95602ab6-f968-451a-a0f4-ce00fc934544" xlink:href="bxsl-20231231.xsd#bxsl_MeasurementInputMarketMultipleMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:to="loc_bxsl_MeasurementInputMarketMultipleMember_95602ab6-f968-451a-a0f4-ce00fc934544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputQuotedPriceMember_87a77103-a608-4890-939e-3fc4607bc74a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputQuotedPriceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:to="loc_us-gaap_MeasurementInputQuotedPriceMember_87a77103-a608-4890-939e-3fc4607bc74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_MeasurementInputPerformanceMultipleMember_87051039-9490-48d0-bf3f-2fe7ac3043bf" xlink:href="bxsl-20231231.xsd#bxsl_MeasurementInputPerformanceMultipleMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:to="loc_bxsl_MeasurementInputPerformanceMultipleMember_87051039-9490-48d0-bf3f-2fe7ac3043bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_3bb57d34-7fad-4ed5-81e1-15d18f6587e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5e2cefaf-bd82-42be-8e6f-442891b71f75" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_3bb57d34-7fad-4ed5-81e1-15d18f6587e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b00b88e4-55a9-4fdd-995e-cd6d29f0e22e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_079311a6-f052-4e7f-9042-96892ddf945b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b00b88e4-55a9-4fdd-995e-cd6d29f0e22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_3a11fc1b-2421-4c1e-8db5-8639fcee7355" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b00b88e4-55a9-4fdd-995e-cd6d29f0e22e" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_3a11fc1b-2421-4c1e-8db5-8639fcee7355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput_5b750cb4-766a-4e77-8fd9-6579a8540351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b00b88e4-55a9-4fdd-995e-cd6d29f0e22e" xlink:to="loc_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput_5b750cb4-766a-4e77-8fd9-6579a8540351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7a12c7b3-3b1c-4455-bf69-bd02318ae827" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa5fc01f-56e5-42a4-9657-4037803c4bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7a12c7b3-3b1c-4455-bf69-bd02318ae827" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa5fc01f-56e5-42a4-9657-4037803c4bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_13132883-eff1-488b-8677-72c596cecc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa5fc01f-56e5-42a4-9657-4037803c4bb2" xlink:to="loc_us-gaap_DebtInstrumentAxis_13132883-eff1-488b-8677-72c596cecc3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_13132883-eff1-488b-8677-72c596cecc3c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2023NotesMember_5ba851b5-e4c1-457b-8006-22e3b3421c91" xlink:href="bxsl-20231231.xsd#bxsl_A2023NotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:to="loc_bxsl_A2023NotesMember_5ba851b5-e4c1-457b-8006-22e3b3421c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2026NotesMember_ae9f8bc9-c555-41de-9c69-46858d92230d" xlink:href="bxsl-20231231.xsd#bxsl_A2026NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:to="loc_bxsl_A2026NotesMember_ae9f8bc9-c555-41de-9c69-46858d92230d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_New2026NotesMember_f545015e-c434-4126-9f35-94d2a345a461" xlink:href="bxsl-20231231.xsd#bxsl_New2026NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:to="loc_bxsl_New2026NotesMember_f545015e-c434-4126-9f35-94d2a345a461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2027NotesMember_0fdbf861-b8f4-4445-bf05-d5173d0bca72" xlink:href="bxsl-20231231.xsd#bxsl_A2027NotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:to="loc_bxsl_A2027NotesMember_0fdbf861-b8f4-4445-bf05-d5173d0bca72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2028NotesMember_7ddc0cc8-a035-4d0c-bdd8-27e4d9398b53" xlink:href="bxsl-20231231.xsd#bxsl_A2028NotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4244f636-1166-40dc-911e-7cc7d75e1aa7" xlink:to="loc_bxsl_A2028NotesMember_7ddc0cc8-a035-4d0c-bdd8-27e4d9398b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d572bdbe-f4ae-4f7b-92a5-da1f8d5f8ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa5fc01f-56e5-42a4-9657-4037803c4bb2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d572bdbe-f4ae-4f7b-92a5-da1f8d5f8ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_897c2e33-315d-48c8-a9c9-8095f61d844a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d572bdbe-f4ae-4f7b-92a5-da1f8d5f8ad5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_897c2e33-315d-48c8-a9c9-8095f61d844a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0a235e30-9aa1-4cda-b8a2-edb1b707b21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_897c2e33-315d-48c8-a9c9-8095f61d844a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0a235e30-9aa1-4cda-b8a2-edb1b707b21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_07f2b1be-a33c-4c83-b22a-735acedcc268" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa5fc01f-56e5-42a4-9657-4037803c4bb2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_07f2b1be-a33c-4c83-b22a-735acedcc268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9acd2e9a-b635-4e8e-9417-09cca12bfdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_07f2b1be-a33c-4c83-b22a-735acedcc268" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9acd2e9a-b635-4e8e-9417-09cca12bfdc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_555eef60-938b-43ef-b2bb-539c64a57517" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9acd2e9a-b635-4e8e-9417-09cca12bfdc3" xlink:to="loc_us-gaap_UnsecuredDebtMember_555eef60-938b-43ef-b2bb-539c64a57517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_48a8c63a-90b7-4179-a724-b09749d05597" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa5fc01f-56e5-42a4-9657-4037803c4bb2" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_48a8c63a-90b7-4179-a724-b09749d05597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_34c1dda5-c079-4aac-9b58-ecc1a8ff5b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_48a8c63a-90b7-4179-a724-b09749d05597" xlink:to="loc_us-gaap_LongTermDebtFairValue_34c1dda5-c079-4aac-9b58-ecc1a8ff5b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f1506b57-b67f-4a00-a5f5-495852d0a8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06c3875b-7a37-41e0-8df3-ea6b7fa2ef7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f1506b57-b67f-4a00-a5f5-495852d0a8ec" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06c3875b-7a37-41e0-8df3-ea6b7fa2ef7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_04b05082-3a6a-44b2-b78d-8a26eafaf351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06c3875b-7a37-41e0-8df3-ea6b7fa2ef7e" xlink:to="loc_us-gaap_DebtInstrumentAxis_04b05082-3a6a-44b2-b78d-8a26eafaf351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_04b05082-3a6a-44b2-b78d-8a26eafaf351" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2023NotesMember_525cdde9-7bc9-494e-97ab-58a226d337c7" xlink:href="bxsl-20231231.xsd#bxsl_A2023NotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:to="loc_bxsl_A2023NotesMember_525cdde9-7bc9-494e-97ab-58a226d337c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2026NotesMember_0385b550-18a0-4bfd-9089-20643ab8f29f" xlink:href="bxsl-20231231.xsd#bxsl_A2026NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:to="loc_bxsl_A2026NotesMember_0385b550-18a0-4bfd-9089-20643ab8f29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_New2026NotesMember_bf860780-c2e9-497b-ac34-f5ee718aa712" xlink:href="bxsl-20231231.xsd#bxsl_New2026NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:to="loc_bxsl_New2026NotesMember_bf860780-c2e9-497b-ac34-f5ee718aa712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2027NotesMember_70c7ae12-4c7a-4b04-817c-c90356401c98" xlink:href="bxsl-20231231.xsd#bxsl_A2027NotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:to="loc_bxsl_A2027NotesMember_70c7ae12-4c7a-4b04-817c-c90356401c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2028NotesMember_c80b881d-5733-44f4-a61f-ec9829d39843" xlink:href="bxsl-20231231.xsd#bxsl_A2028NotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afaa6482-0a96-4af9-93eb-ed7b5569bc6d" xlink:to="loc_bxsl_A2028NotesMember_c80b881d-5733-44f4-a61f-ec9829d39843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17fb24da-6a8c-47de-9f0f-f5b47d1655ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06c3875b-7a37-41e0-8df3-ea6b7fa2ef7e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17fb24da-6a8c-47de-9f0f-f5b47d1655ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2768df13-6641-46fd-b6b2-a391a0181e39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17fb24da-6a8c-47de-9f0f-f5b47d1655ec" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2768df13-6641-46fd-b6b2-a391a0181e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5cf6b5ac-c896-405b-a3a1-e0fd7cd3e3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2768df13-6641-46fd-b6b2-a391a0181e39" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5cf6b5ac-c896-405b-a3a1-e0fd7cd3e3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_03e48e42-0ac4-4098-8b81-12d5dea9ef8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2768df13-6641-46fd-b6b2-a391a0181e39" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_03e48e42-0ac4-4098-8b81-12d5dea9ef8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_41d3ce08-c778-4729-b62f-1e3622045c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06c3875b-7a37-41e0-8df3-ea6b7fa2ef7e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_41d3ce08-c778-4729-b62f-1e3622045c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fa754b28-495b-4aba-8974-348c411a2e09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41d3ce08-c778-4729-b62f-1e3622045c0a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fa754b28-495b-4aba-8974-348c411a2e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_2223adc3-66c3-45cb-b8bb-30dde8a07d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fa754b28-495b-4aba-8974-348c411a2e09" xlink:to="loc_us-gaap_UnsecuredDebtMember_2223adc3-66c3-45cb-b8bb-30dde8a07d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_fa65e360-58dc-41e4-9730-7250d9670e91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_06c3875b-7a37-41e0-8df3-ea6b7fa2ef7e" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_fa65e360-58dc-41e4-9730-7250d9670e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_972f83d3-930f-4d8c-be13-0e96df299fad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_fa65e360-58dc-41e4-9730-7250d9670e91" xlink:to="loc_us-gaap_LongTermDebtFairValue_972f83d3-930f-4d8c-be13-0e96df299fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsJacksonHoleFundingFacilityDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_33070621-9a75-45d1-a20e-b7d546129c92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_33070621-9a75-45d1-a20e-b7d546129c92" xlink:to="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9bf94ed2-917d-4c29-b02c-cde7af4ee8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:to="loc_us-gaap_DebtInstrumentAxis_9bf94ed2-917d-4c29-b02c-cde7af4ee8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_29412104-2d9a-4f7d-9036-0c89ed15c64f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9bf94ed2-917d-4c29-b02c-cde7af4ee8ef" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_29412104-2d9a-4f7d-9036-0c89ed15c64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember_58b20985-3059-4762-aab0-7aae7920f4f4" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_29412104-2d9a-4f7d-9036-0c89ed15c64f" xlink:to="loc_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember_58b20985-3059-4762-aab0-7aae7920f4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember_5cf0531d-036a-4dcc-a94d-4891feec5a8a" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityDollarAdvancesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_29412104-2d9a-4f7d-9036-0c89ed15c64f" xlink:to="loc_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember_5cf0531d-036a-4dcc-a94d-4891feec5a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityMember_b8811df7-1062-49cc-8a15-5e23969b79cd" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_29412104-2d9a-4f7d-9036-0c89ed15c64f" xlink:to="loc_bxsl_JacksonHoleFundingFacilityMember_b8811df7-1062-49cc-8a15-5e23969b79cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_46e4f3ae-474e-4b22-9f66-794c01f077b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_46e4f3ae-474e-4b22-9f66-794c01f077b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6c96d667-0ca4-4f93-a45d-7388ba8a63b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_46e4f3ae-474e-4b22-9f66-794c01f077b1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6c96d667-0ca4-4f93-a45d-7388ba8a63b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_ecf09027-ca44-4f32-a937-bfcf95d42b42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6c96d667-0ca4-4f93-a45d-7388ba8a63b8" xlink:to="loc_us-gaap_LineOfCreditMember_ecf09027-ca44-4f32-a937-bfcf95d42b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_735c7abe-02d7-486a-a1d3-004f2af20759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:to="loc_us-gaap_CreditFacilityAxis_735c7abe-02d7-486a-a1d3-004f2af20759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8d0cc217-ee48-430e-b9df-70e1a3200432" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_735c7abe-02d7-486a-a1d3-004f2af20759" xlink:to="loc_us-gaap_CreditFacilityDomain_8d0cc217-ee48-430e-b9df-70e1a3200432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_fbf18607-7939-4e96-97aa-89053e26eede" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_8d0cc217-ee48-430e-b9df-70e1a3200432" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_fbf18607-7939-4e96-97aa-89053e26eede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_fb968f03-e101-486a-b0b9-244e5a51f41a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:to="loc_us-gaap_VariableRateAxis_fb968f03-e101-486a-b0b9-244e5a51f41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9369c72b-8a36-4972-ae75-b1ae9a3f1be7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_fb968f03-e101-486a-b0b9-244e5a51f41a" xlink:to="loc_us-gaap_VariableRateDomain_9369c72b-8a36-4972-ae75-b1ae9a3f1be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_492ac99c-f5fe-47b5-98fd-ebe0a1a123fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_9369c72b-8a36-4972-ae75-b1ae9a3f1be7" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_492ac99c-f5fe-47b5-98fd-ebe0a1a123fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75b49c74-0fbc-45d5-b897-4d17c37f81a7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio_6e159ff7-4d6d-48dd-a904-5e457f4e37fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:to="loc_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio_6e159ff7-4d6d-48dd-a904-5e457f4e37fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8f4a02bc-d13f-4510-8fdb-d54c6e4114f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8f4a02bc-d13f-4510-8fdb-d54c6e4114f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_30fa373b-4a0f-4384-ac0c-b2a48b6bb6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_30fa373b-4a0f-4384-ac0c-b2a48b6bb6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_78032569-357e-4ff1-b679-c8c0bacd02bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_78032569-357e-4ff1-b679-c8c0bacd02bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit_a0774a6a-9dd9-494d-a0d3-f626d25fd06d" xlink:href="bxsl-20231231.xsd#bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c73bdd79-f107-4eda-860a-c93bf4c31c6c" xlink:to="loc_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit_a0774a6a-9dd9-494d-a0d3-f626d25fd06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsBreckenridgeFundingFacilityDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d3b7b7e4-1ea5-4c9f-970c-4e6fcc5a7f97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d3b7b7e4-1ea5-4c9f-970c-4e6fcc5a7f97" xlink:to="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_984a287a-570e-4e2a-b5a0-b239eafd20a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_us-gaap_CreditFacilityAxis_984a287a-570e-4e2a-b5a0-b239eafd20a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_24ad077c-9c7d-4761-8c6e-e1bcbde536c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_984a287a-570e-4e2a-b5a0-b239eafd20a1" xlink:to="loc_us-gaap_CreditFacilityDomain_24ad077c-9c7d-4761-8c6e-e1bcbde536c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_64440e47-451a-4775-b614-a220fa96fa29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_24ad077c-9c7d-4761-8c6e-e1bcbde536c3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_64440e47-451a-4775-b614-a220fa96fa29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_59f1024e-2fd8-4403-98da-15e355f64b81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_us-gaap_DebtInstrumentAxis_59f1024e-2fd8-4403-98da-15e355f64b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ece117c3-814b-4405-8629-491fa7f23ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_59f1024e-2fd8-4403-98da-15e355f64b81" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ece117c3-814b-4405-8629-491fa7f23ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BreckenridgeFundingFacilityMember_dff3e9ff-c8b2-4cb8-8ea0-986f3e7fee21" xlink:href="bxsl-20231231.xsd#bxsl_BreckenridgeFundingFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ece117c3-814b-4405-8629-491fa7f23ef0" xlink:to="loc_bxsl_BreckenridgeFundingFacilityMember_dff3e9ff-c8b2-4cb8-8ea0-986f3e7fee21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_af2f3337-00fa-4d3a-9174-4aa70395b23a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_af2f3337-00fa-4d3a-9174-4aa70395b23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b9dfc952-4398-42a8-ad8c-87fcf99aa954" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_af2f3337-00fa-4d3a-9174-4aa70395b23a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b9dfc952-4398-42a8-ad8c-87fcf99aa954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e8492c88-08b6-44e9-af00-c19e1988893e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b9dfc952-4398-42a8-ad8c-87fcf99aa954" xlink:to="loc_us-gaap_LineOfCreditMember_e8492c88-08b6-44e9-af00-c19e1988893e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_681f732f-f2ca-4c9d-804f-678d5e7e1ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_us-gaap_VariableRateAxis_681f732f-f2ca-4c9d-804f-678d5e7e1ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7c28556d-a91f-489b-a1c3-ca4e04a27861" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_681f732f-f2ca-4c9d-804f-678d5e7e1ddb" xlink:to="loc_us-gaap_VariableRateDomain_7c28556d-a91f-489b-a1c3-ca4e04a27861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_39a978b9-e799-47ed-8f2a-138a58c298d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_7c28556d-a91f-489b-a1c3-ca4e04a27861" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_39a978b9-e799-47ed-8f2a-138a58c298d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariableRateScenarioAxis_9aa52d76-9ef0-4874-b381-4dfba795c984" xlink:href="bxsl-20231231.xsd#bxsl_VariableRateScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_bxsl_VariableRateScenarioAxis_9aa52d76-9ef0-4874-b381-4dfba795c984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariableRateScenarioDomain_1a1c8a28-838c-4fe6-b929-c280362a27d1" xlink:href="bxsl-20231231.xsd#bxsl_VariableRateScenarioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VariableRateScenarioAxis_9aa52d76-9ef0-4874-b381-4dfba795c984" xlink:to="loc_bxsl_VariableRateScenarioDomain_1a1c8a28-838c-4fe6-b929-c280362a27d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario1Member_206063a8-7438-4f6a-b1ef-10b9b14bb71c" xlink:href="bxsl-20231231.xsd#bxsl_Scenario1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VariableRateScenarioDomain_1a1c8a28-838c-4fe6-b929-c280362a27d1" xlink:to="loc_bxsl_Scenario1Member_206063a8-7438-4f6a-b1ef-10b9b14bb71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario2Member_db2a44f4-2aca-4211-95b1-bfc44cdf7b4f" xlink:href="bxsl-20231231.xsd#bxsl_Scenario2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VariableRateScenarioDomain_1a1c8a28-838c-4fe6-b929-c280362a27d1" xlink:to="loc_bxsl_Scenario2Member_db2a44f4-2aca-4211-95b1-bfc44cdf7b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario3Member_4589eb30-8042-4a80-b9ee-1bef5d1426aa" xlink:href="bxsl-20231231.xsd#bxsl_Scenario3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VariableRateScenarioDomain_1a1c8a28-838c-4fe6-b929-c280362a27d1" xlink:to="loc_bxsl_Scenario3Member_4589eb30-8042-4a80-b9ee-1bef5d1426aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_daad6449-aae0-4333-a932-0da507e26be5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_srt_RangeAxis_daad6449-aae0-4333-a932-0da507e26be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_99766266-cf27-4654-add3-70fa4db20662" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_daad6449-aae0-4333-a932-0da507e26be5" xlink:to="loc_srt_RangeMember_99766266-cf27-4654-add3-70fa4db20662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_848b96d4-bd15-499f-829b-4835f3127b52" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_99766266-cf27-4654-add3-70fa4db20662" xlink:to="loc_srt_MaximumMember_848b96d4-bd15-499f-829b-4835f3127b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cb91d52b-29fe-4a88-ac51-59387ec5cc36" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_99766266-cf27-4654-add3-70fa4db20662" xlink:to="loc_srt_MinimumMember_cb91d52b-29fe-4a88-ac51-59387ec5cc36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommitmentFeeScenarioAxis_1eb23646-a633-47bc-ad25-3fbfbbc14d3e" xlink:href="bxsl-20231231.xsd#bxsl_CommitmentFeeScenarioAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_bxsl_CommitmentFeeScenarioAxis_1eb23646-a633-47bc-ad25-3fbfbbc14d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommitmentFeeScenarioDomain_d88a35b8-0a69-4600-a001-02b065d14c2a" xlink:href="bxsl-20231231.xsd#bxsl_CommitmentFeeScenarioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_CommitmentFeeScenarioAxis_1eb23646-a633-47bc-ad25-3fbfbbc14d3e" xlink:to="loc_bxsl_CommitmentFeeScenarioDomain_d88a35b8-0a69-4600-a001-02b065d14c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario1Member_ead40779-6957-4b10-8924-4e06322e3700" xlink:href="bxsl-20231231.xsd#bxsl_Scenario1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_CommitmentFeeScenarioDomain_d88a35b8-0a69-4600-a001-02b065d14c2a" xlink:to="loc_bxsl_Scenario1Member_ead40779-6957-4b10-8924-4e06322e3700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario2Member_3145bef1-f686-43e4-bfe9-b078591e6e66" xlink:href="bxsl-20231231.xsd#bxsl_Scenario2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_CommitmentFeeScenarioDomain_d88a35b8-0a69-4600-a001-02b065d14c2a" xlink:to="loc_bxsl_Scenario2Member_3145bef1-f686-43e4-bfe9-b078591e6e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_62ce36a7-48c4-4568-a814-53cdfd32be28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_72226ec4-79d8-44c7-ab5a-54c37acfdc25" xlink:to="loc_us-gaap_DebtInstrumentLineItems_62ce36a7-48c4-4568-a814-53cdfd32be28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5c1f95f4-1b3e-46c0-be1b-72a4789a4371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_62ce36a7-48c4-4568-a814-53cdfd32be28" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5c1f95f4-1b3e-46c0-be1b-72a4789a4371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_7c25eb57-a397-4603-b009-f4ebd39f7036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_62ce36a7-48c4-4568-a814-53cdfd32be28" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_7c25eb57-a397-4603-b009-f4ebd39f7036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LineOfCreditFacilityUnusedCapacityPercentage_1c2aaf53-6eab-4cb8-a65e-8094778212a8" xlink:href="bxsl-20231231.xsd#bxsl_LineOfCreditFacilityUnusedCapacityPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_62ce36a7-48c4-4568-a814-53cdfd32be28" xlink:to="loc_bxsl_LineOfCreditFacilityUnusedCapacityPercentage_1c2aaf53-6eab-4cb8-a65e-8094778212a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsBigSkyFundingFacilityDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_af7838cd-b0dc-4dbf-befc-afea9e93ef83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_af7838cd-b0dc-4dbf-befc-afea9e93ef83" xlink:to="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f05474c9-3949-482a-9ecd-49f506a2e16b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_us-gaap_CreditFacilityAxis_f05474c9-3949-482a-9ecd-49f506a2e16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e7d269cb-76c7-478b-b74d-c5e8427cf418" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f05474c9-3949-482a-9ecd-49f506a2e16b" xlink:to="loc_us-gaap_CreditFacilityDomain_e7d269cb-76c7-478b-b74d-c5e8427cf418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_874f809f-de96-4c75-8c2e-2917e8a5a468" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e7d269cb-76c7-478b-b74d-c5e8427cf418" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_874f809f-de96-4c75-8c2e-2917e8a5a468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_31bcede2-b7a6-4e84-9643-b389e14a03be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_us-gaap_DebtInstrumentAxis_31bcede2-b7a6-4e84-9643-b389e14a03be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1b1cc931-941c-4b00-a845-697225eec0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_31bcede2-b7a6-4e84-9643-b389e14a03be" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1b1cc931-941c-4b00-a845-697225eec0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BigSkyFundingFacilityMember_cc496675-4825-4193-9687-653b7be01523" xlink:href="bxsl-20231231.xsd#bxsl_BigSkyFundingFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b1cc931-941c-4b00-a845-697225eec0ee" xlink:to="loc_bxsl_BigSkyFundingFacilityMember_cc496675-4825-4193-9687-653b7be01523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a17a3e57-df70-4eea-aa00-ee8a25b18dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a17a3e57-df70-4eea-aa00-ee8a25b18dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e15deb65-998d-4f45-a52f-658c212d56ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a17a3e57-df70-4eea-aa00-ee8a25b18dc0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e15deb65-998d-4f45-a52f-658c212d56ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9977272e-d90d-49ed-8e84-b709de8da0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e15deb65-998d-4f45-a52f-658c212d56ec" xlink:to="loc_us-gaap_LineOfCreditMember_9977272e-d90d-49ed-8e84-b709de8da0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_8664cfc0-898f-4ae2-abbb-0287e581bc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_us-gaap_VariableRateAxis_8664cfc0-898f-4ae2-abbb-0287e581bc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_cbd43820-072c-4066-9017-1018628f439a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_8664cfc0-898f-4ae2-abbb-0287e581bc4f" xlink:to="loc_us-gaap_VariableRateDomain_cbd43820-072c-4066-9017-1018628f439a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_b45d60a1-2d93-414e-902d-ff7ed0c85030" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_cbd43820-072c-4066-9017-1018628f439a" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_b45d60a1-2d93-414e-902d-ff7ed0c85030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommitmentFeeScenarioAxis_6fedc5ac-7e80-42ef-b1b1-f5ac0acfc689" xlink:href="bxsl-20231231.xsd#bxsl_CommitmentFeeScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_bxsl_CommitmentFeeScenarioAxis_6fedc5ac-7e80-42ef-b1b1-f5ac0acfc689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CommitmentFeeScenarioDomain_0b1e51d9-8c76-46d3-beb5-10ed4fbcc31f" xlink:href="bxsl-20231231.xsd#bxsl_CommitmentFeeScenarioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_CommitmentFeeScenarioAxis_6fedc5ac-7e80-42ef-b1b1-f5ac0acfc689" xlink:to="loc_bxsl_CommitmentFeeScenarioDomain_0b1e51d9-8c76-46d3-beb5-10ed4fbcc31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario1Member_e6b0a1f2-912d-430a-9a43-676e4fd45b29" xlink:href="bxsl-20231231.xsd#bxsl_Scenario1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_CommitmentFeeScenarioDomain_0b1e51d9-8c76-46d3-beb5-10ed4fbcc31f" xlink:to="loc_bxsl_Scenario1Member_e6b0a1f2-912d-430a-9a43-676e4fd45b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario2Member_e4af2809-1d89-4e5a-a4f1-2d918f3c99d7" xlink:href="bxsl-20231231.xsd#bxsl_Scenario2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_CommitmentFeeScenarioDomain_0b1e51d9-8c76-46d3-beb5-10ed4fbcc31f" xlink:to="loc_bxsl_Scenario2Member_e4af2809-1d89-4e5a-a4f1-2d918f3c99d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d608b4a6-71fa-433d-8f44-ddf27dcf4961" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_srt_RangeAxis_d608b4a6-71fa-433d-8f44-ddf27dcf4961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16bce18f-4394-43ec-b47d-4e68cc6f208e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d608b4a6-71fa-433d-8f44-ddf27dcf4961" xlink:to="loc_srt_RangeMember_16bce18f-4394-43ec-b47d-4e68cc6f208e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0667b3e1-9cc1-40c4-aee5-6fc7d89a180f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16bce18f-4394-43ec-b47d-4e68cc6f208e" xlink:to="loc_srt_MinimumMember_0667b3e1-9cc1-40c4-aee5-6fc7d89a180f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6a85e88b-8505-4ecf-8244-b59b1bc7169a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16bce18f-4394-43ec-b47d-4e68cc6f208e" xlink:to="loc_srt_MaximumMember_6a85e88b-8505-4ecf-8244-b59b1bc7169a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_30ae2f8b-c9fe-41bd-8fbd-15c2de969faf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f6e0cb8f-2e0c-4fb5-929a-ac69481fc221" xlink:to="loc_us-gaap_DebtInstrumentLineItems_30ae2f8b-c9fe-41bd-8fbd-15c2de969faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d22169a7-ea28-4dbf-9d62-5c2e34c0c212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30ae2f8b-c9fe-41bd-8fbd-15c2de969faf" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d22169a7-ea28-4dbf-9d62-5c2e34c0c212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage_c53343e1-8a8b-49b1-a5c5-f21648ca36fc" xlink:href="bxsl-20231231.xsd#bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30ae2f8b-c9fe-41bd-8fbd-15c2de969faf" xlink:to="loc_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage_c53343e1-8a8b-49b1-a5c5-f21648ca36fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_aac52845-b7c2-46bd-98bc-8ce44b8bc3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30ae2f8b-c9fe-41bd-8fbd-15c2de969faf" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_aac52845-b7c2-46bd-98bc-8ce44b8bc3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsRevolvingCreditFacilityDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b11ba5bb-1acb-4e77-8db9-32a70279fe54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b11ba5bb-1acb-4e77-8db9-32a70279fe54" xlink:to="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ac88c3f4-c075-4225-a2e3-86661e4891aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:to="loc_us-gaap_CreditFacilityAxis_ac88c3f4-c075-4225-a2e3-86661e4891aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c2713826-55e0-4c8b-9efd-9f5aab6cef67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ac88c3f4-c075-4225-a2e3-86661e4891aa" xlink:to="loc_us-gaap_CreditFacilityDomain_c2713826-55e0-4c8b-9efd-9f5aab6cef67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_8dd90ca6-9a07-4d7c-a5fe-8e27c716f67e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c2713826-55e0-4c8b-9efd-9f5aab6cef67" xlink:to="loc_us-gaap_SecuredDebtMember_8dd90ca6-9a07-4d7c-a5fe-8e27c716f67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_a4b83294-fb22-4463-aa29-4fba4827b2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c2713826-55e0-4c8b-9efd-9f5aab6cef67" xlink:to="loc_us-gaap_LetterOfCreditMember_a4b83294-fb22-4463-aa29-4fba4827b2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_5c2a9435-bc51-4e75-9bdf-b5330a518bda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c2713826-55e0-4c8b-9efd-9f5aab6cef67" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_5c2a9435-bc51-4e75-9bdf-b5330a518bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cd49f36c-9383-449f-ab97-489540decbfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cd49f36c-9383-449f-ab97-489540decbfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_37bbd841-a599-4e53-b181-49781c236ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cd49f36c-9383-449f-ab97-489540decbfc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_37bbd841-a599-4e53-b181-49781c236ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_8b2e6fec-fd06-4a93-a0db-7e90eca9cab9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_37bbd841-a599-4e53-b181-49781c236ec2" xlink:to="loc_us-gaap_LineOfCreditMember_8b2e6fec-fd06-4a93-a0db-7e90eca9cab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_91986535-96eb-4581-b382-e4a38877f525" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:to="loc_us-gaap_VariableRateAxis_91986535-96eb-4581-b382-e4a38877f525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_92004450-e2a6-46d6-9b28-2f0db5d90be9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_91986535-96eb-4581-b382-e4a38877f525" xlink:to="loc_us-gaap_VariableRateDomain_92004450-e2a6-46d6-9b28-2f0db5d90be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_6a11aa28-1ea2-4567-9cb3-148560d40959" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_92004450-e2a6-46d6-9b28-2f0db5d90be9" xlink:to="loc_us-gaap_BaseRateMember_6a11aa28-1ea2-4567-9cb3-148560d40959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_5e9e3b0c-67ce-4ab0-9e97-53c88cf48a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_92004450-e2a6-46d6-9b28-2f0db5d90be9" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_5e9e3b0c-67ce-4ab0-9e97-53c88cf48a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariableRateScenarioAxis_36d9c0f6-2cfa-426b-93d1-0916e5827676" xlink:href="bxsl-20231231.xsd#bxsl_VariableRateScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:to="loc_bxsl_VariableRateScenarioAxis_36d9c0f6-2cfa-426b-93d1-0916e5827676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariableRateScenarioDomain_3bc7b620-a054-4f13-a584-d48464462314" xlink:href="bxsl-20231231.xsd#bxsl_VariableRateScenarioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VariableRateScenarioAxis_36d9c0f6-2cfa-426b-93d1-0916e5827676" xlink:to="loc_bxsl_VariableRateScenarioDomain_3bc7b620-a054-4f13-a584-d48464462314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario1Member_29bccf0f-770f-4516-aa17-e77d8ae1719b" xlink:href="bxsl-20231231.xsd#bxsl_Scenario1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VariableRateScenarioDomain_3bc7b620-a054-4f13-a584-d48464462314" xlink:to="loc_bxsl_Scenario1Member_29bccf0f-770f-4516-aa17-e77d8ae1719b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario2Member_05d874a0-458b-4af7-88ae-a9afc4170183" xlink:href="bxsl-20231231.xsd#bxsl_Scenario2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VariableRateScenarioDomain_3bc7b620-a054-4f13-a584-d48464462314" xlink:to="loc_bxsl_Scenario2Member_05d874a0-458b-4af7-88ae-a9afc4170183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario3Member_01ef34f3-df33-441d-be68-0a94766bb979" xlink:href="bxsl-20231231.xsd#bxsl_Scenario3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VariableRateScenarioDomain_3bc7b620-a054-4f13-a584-d48464462314" xlink:to="loc_bxsl_Scenario3Member_01ef34f3-df33-441d-be68-0a94766bb979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Scenario4Member_c5e58679-cd72-4da7-a17c-979cd84231fe" xlink:href="bxsl-20231231.xsd#bxsl_Scenario4Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_VariableRateScenarioDomain_3bc7b620-a054-4f13-a584-d48464462314" xlink:to="loc_bxsl_Scenario4Member_c5e58679-cd72-4da7-a17c-979cd84231fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4e15c649-a2bc-4381-89e2-27b2033dacbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:to="loc_us-gaap_DebtInstrumentAxis_4e15c649-a2bc-4381-89e2-27b2033dacbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_62a44bce-9037-4f9e-9559-de4d115d0b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4e15c649-a2bc-4381-89e2-27b2033dacbd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_62a44bce-9037-4f9e-9559-de4d115d0b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityMember_f6fcc9e1-7027-47e0-9c6d-03aaac7102ee" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62a44bce-9037-4f9e-9559-de4d115d0b5d" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityMember_f6fcc9e1-7027-47e0-9c6d-03aaac7102ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member_e32cd33c-a298-4256-a2e8-930b45e00f05" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62a44bce-9037-4f9e-9559-de4d115d0b5d" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member_e32cd33c-a298-4256-a2e8-930b45e00f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member_5b428f92-515a-415c-b374-893c6e977fef" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62a44bce-9037-4f9e-9559-de4d115d0b5d" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member_5b428f92-515a-415c-b374-893c6e977fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ec6b0c60-6966-45c3-b9d1-74dd8d67a533" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_81cc3ded-388e-47d4-970e-93cff00b21f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_81cc3ded-388e-47d4-970e-93cff00b21f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_15b5190e-c60f-49e0-a293-b4671403f80f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_15b5190e-c60f-49e0-a293-b4671403f80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier_7541c532-9dbe-4a08-9706-33ea7b8d2f16" xlink:href="bxsl-20231231.xsd#bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:to="loc_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier_7541c532-9dbe-4a08-9706-33ea7b8d2f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_bc727c82-410a-4769-a70f-5790729524b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_bc727c82-410a-4769-a70f-5790729524b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio_83a3166a-30cd-4dbe-8884-565b3122f4ce" xlink:href="bxsl-20231231.xsd#bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a8efd0d-141f-4756-a51a-38b75894ec34" xlink:to="loc_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio_83a3166a-30cd-4dbe-8884-565b3122f4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsUnsecuredDebtDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d7e3cac0-f666-4353-90fc-a0fdaba47f28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_75fe88c0-bcef-4be6-8b95-baca5eb3caf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d7e3cac0-f666-4353-90fc-a0fdaba47f28" xlink:to="loc_us-gaap_DebtInstrumentTable_75fe88c0-bcef-4be6-8b95-baca5eb3caf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_156ec6e8-ab82-438c-a4a9-82a5c335efef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75fe88c0-bcef-4be6-8b95-baca5eb3caf1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_156ec6e8-ab82-438c-a4a9-82a5c335efef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d7d12aa4-66ef-45fd-8f0d-86cb60322c98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_156ec6e8-ab82-438c-a4a9-82a5c335efef" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d7d12aa4-66ef-45fd-8f0d-86cb60322c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_35bfdafc-e13d-4671-9207-9b269d7fc0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d7d12aa4-66ef-45fd-8f0d-86cb60322c98" xlink:to="loc_us-gaap_UnsecuredDebtMember_35bfdafc-e13d-4671-9207-9b269d7fc0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_38b1df1c-49c2-4a6c-8163-ff43bf05453e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75fe88c0-bcef-4be6-8b95-baca5eb3caf1" xlink:to="loc_us-gaap_DebtInstrumentAxis_38b1df1c-49c2-4a6c-8163-ff43bf05453e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_38b1df1c-49c2-4a6c-8163-ff43bf05453e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3650NotesDue2023Member_7576e9e8-147f-4ddd-8bac-68687ca5476c" xlink:href="bxsl-20231231.xsd#bxsl_A3650NotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:to="loc_bxsl_A3650NotesDue2023Member_7576e9e8-147f-4ddd-8bac-68687ca5476c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3625NotesDue2026Member_2e447d21-8e99-4347-a6ba-33533ae437f6" xlink:href="bxsl-20231231.xsd#bxsl_A3625NotesDue2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:to="loc_bxsl_A3625NotesDue2026Member_2e447d21-8e99-4347-a6ba-33533ae437f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2750NotesDue2026Member_21c1eee2-52c3-43dc-8369-4c64f1244689" xlink:href="bxsl-20231231.xsd#bxsl_A2750NotesDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:to="loc_bxsl_A2750NotesDue2026Member_21c1eee2-52c3-43dc-8369-4c64f1244689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2125SeniorNotesDue2027Member_b5978767-4984-4a1e-9fb2-1a1a49747b68" xlink:href="bxsl-20231231.xsd#bxsl_A2125SeniorNotesDue2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:to="loc_bxsl_A2125SeniorNotesDue2027Member_b5978767-4984-4a1e-9fb2-1a1a49747b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2850NotesDue2028Member_c0d01479-a3ba-4f29-8423-13d0d49436dd" xlink:href="bxsl-20231231.xsd#bxsl_A2850NotesDue2028Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c838e23f-de94-485b-a501-3e82470b5cfa" xlink:to="loc_bxsl_A2850NotesDue2028Member_c0d01479-a3ba-4f29-8423-13d0d49436dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4e1e6e47-ea35-4585-bd01-abb6c9c9874c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75fe88c0-bcef-4be6-8b95-baca5eb3caf1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4e1e6e47-ea35-4585-bd01-abb6c9c9874c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_d2dc802e-d25c-44a5-a1cf-ae45d0c817b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e1e6e47-ea35-4585-bd01-abb6c9c9874c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_d2dc802e-d25c-44a5-a1cf-ae45d0c817b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_878b3e1e-3a42-49cd-87d7-9785fb9cc95b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e1e6e47-ea35-4585-bd01-abb6c9c9874c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_878b3e1e-3a42-49cd-87d7-9785fb9cc95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4301624d-09c2-43a0-be42-d202761caa0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e1e6e47-ea35-4585-bd01-abb6c9c9874c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4301624d-09c2-43a0-be42-d202761caa0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsOutstandingDebtObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_336be736-5198-427f-afca-abe4f91f2e70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4c25d650-09a3-45f0-af1b-d02fd1c778f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_336be736-5198-427f-afca-abe4f91f2e70" xlink:to="loc_us-gaap_DebtInstrumentTable_4c25d650-09a3-45f0-af1b-d02fd1c778f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3126b81b-4ab9-45b8-80d5-0843ef5b3ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4c25d650-09a3-45f0-af1b-d02fd1c778f0" xlink:to="loc_us-gaap_DebtInstrumentAxis_3126b81b-4ab9-45b8-80d5-0843ef5b3ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3126b81b-4ab9-45b8-80d5-0843ef5b3ec8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityMember_9d21d4e4-6f9f-4553-a099-836161c36a98" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_JacksonHoleFundingFacilityMember_9d21d4e4-6f9f-4553-a099-836161c36a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BreckenridgeFundingFacilityMember_00949c82-f279-498b-ba6a-79ee68f17a58" xlink:href="bxsl-20231231.xsd#bxsl_BreckenridgeFundingFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_BreckenridgeFundingFacilityMember_00949c82-f279-498b-ba6a-79ee68f17a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BigSkyFundingFacilityMember_4209df60-6214-4446-92b6-266f4701575e" xlink:href="bxsl-20231231.xsd#bxsl_BigSkyFundingFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_BigSkyFundingFacilityMember_4209df60-6214-4446-92b6-266f4701575e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityMember_e249556c-3c9b-4d07-916a-8da9920468bf" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityMember_e249556c-3c9b-4d07-916a-8da9920468bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3650NotesDue2023Member_a0d29edf-bfc9-40dd-9f46-a1438a9c31c3" xlink:href="bxsl-20231231.xsd#bxsl_A3650NotesDue2023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_A3650NotesDue2023Member_a0d29edf-bfc9-40dd-9f46-a1438a9c31c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3625NotesDue2026Member_465b9062-323e-4db3-b591-e58beedcf2e3" xlink:href="bxsl-20231231.xsd#bxsl_A3625NotesDue2026Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_A3625NotesDue2026Member_465b9062-323e-4db3-b591-e58beedcf2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2750NotesDue2026Member_a13418f0-9eab-4a01-a21a-ede646d03743" xlink:href="bxsl-20231231.xsd#bxsl_A2750NotesDue2026Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_A2750NotesDue2026Member_a13418f0-9eab-4a01-a21a-ede646d03743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2125SeniorNotesDue2027Member_45eb0922-ef2b-4cd2-8c44-43ae5b9673d9" xlink:href="bxsl-20231231.xsd#bxsl_A2125SeniorNotesDue2027Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_A2125SeniorNotesDue2027Member_45eb0922-ef2b-4cd2-8c44-43ae5b9673d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2850NotesDue2028Member_d8e2746a-3900-4b32-aa4a-787185638c27" xlink:href="bxsl-20231231.xsd#bxsl_A2850NotesDue2028Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35addd27-6e58-42e7-a39c-bdb0add3ef23" xlink:to="loc_bxsl_A2850NotesDue2028Member_d8e2746a-3900-4b32-aa4a-787185638c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d1fdc02b-2319-4dcc-960a-e2745feb4792" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4c25d650-09a3-45f0-af1b-d02fd1c778f0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d1fdc02b-2319-4dcc-960a-e2745feb4792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_50791554-1162-4e04-9ccd-94ee9c226b73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d1fdc02b-2319-4dcc-960a-e2745feb4792" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_50791554-1162-4e04-9ccd-94ee9c226b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_aabc712f-5582-4c2d-91fd-ace028b4c5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_50791554-1162-4e04-9ccd-94ee9c226b73" xlink:to="loc_us-gaap_LineOfCreditMember_aabc712f-5582-4c2d-91fd-ace028b4c5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_202595ca-20ac-41c4-861a-1f1e8977ba31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_50791554-1162-4e04-9ccd-94ee9c226b73" xlink:to="loc_us-gaap_UnsecuredDebtMember_202595ca-20ac-41c4-861a-1f1e8977ba31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_fbc73966-dd7b-4b87-ad0f-19c086850df2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4c25d650-09a3-45f0-af1b-d02fd1c778f0" xlink:to="loc_us-gaap_CreditFacilityAxis_fbc73966-dd7b-4b87-ad0f-19c086850df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a696b11c-ebf7-48dc-927d-89f0159c9619" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_fbc73966-dd7b-4b87-ad0f-19c086850df2" xlink:to="loc_us-gaap_CreditFacilityDomain_a696b11c-ebf7-48dc-927d-89f0159c9619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_00c1c40e-1252-4fc1-bd2a-77a769698e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a696b11c-ebf7-48dc-927d-89f0159c9619" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_00c1c40e-1252-4fc1-bd2a-77a769698e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4c25d650-09a3-45f0-af1b-d02fd1c778f0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_94d433aa-6d02-4b85-b9c6-73a71498430a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_94d433aa-6d02-4b85-b9c6-73a71498430a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a70b0795-6e44-4853-a94e-93b8673ca580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a70b0795-6e44-4853-a94e-93b8673ca580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d681f861-2427-4f76-b92d-35a61a84342a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d681f861-2427-4f76-b92d-35a61a84342a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_fbc5f1c1-1e21-4046-8a55-6657e15c6ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_LongTermDebt_fbc5f1c1-1e21-4046-8a55-6657e15c6ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_46114acd-6a6d-4148-85e2-40eef7dd6b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_46114acd-6a6d-4148-85e2-40eef7dd6b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_cda65454-164c-4c64-bf80-eb1e42dd5b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_cda65454-164c-4c64-bf80-eb1e42dd5b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_458be5c5-e930-46f7-ae53-3a7c35b84efc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b6833efa-c3a3-46de-9f50-baa6becd3b39" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_458be5c5-e930-46f7-ae53-3a7c35b84efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsAdditionalInformationDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/BorrowingsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4c3902e3-2aff-4061-bd57-0adfae61a404" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InterestPayableInterestExpense_e16de853-b910-43b4-bf69-4d34d23d9e86" xlink:href="bxsl-20231231.xsd#bxsl_InterestPayableInterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4c3902e3-2aff-4061-bd57-0adfae61a404" xlink:to="loc_bxsl_InterestPayableInterestExpense_e16de853-b910-43b4-bf69-4d34d23d9e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee_d253f5e2-d6f0-47cd-a798-079cfddfbe1d" xlink:href="bxsl-20231231.xsd#bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4c3902e3-2aff-4061-bd57-0adfae61a404" xlink:to="loc_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee_d253f5e2-d6f0-47cd-a798-079cfddfbe1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_d5e4a071-c04e-4ba8-939b-9963cc64a127" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtWeightedAverageInterestRateOverTime"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4c3902e3-2aff-4061-bd57-0adfae61a404" xlink:to="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_d5e4a071-c04e-4ba8-939b-9963cc64a127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAverageAmountOutstanding_2aab46f3-87b1-4b74-9bae-14bee39d141a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAverageAmountOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4c3902e3-2aff-4061-bd57-0adfae61a404" xlink:to="loc_us-gaap_LongTermDebtAverageAmountOutstanding_2aab46f3-87b1-4b74-9bae-14bee39d141a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/BorrowingsInterestExpenseDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#BorrowingsInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/BorrowingsInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bc3f85bd-1a5a-49fc-948d-807069de1aed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_9525aa7c-3212-47e0-84ee-9ababfdbdaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bc3f85bd-1a5a-49fc-948d-807069de1aed" xlink:to="loc_us-gaap_InterestExpenseBorrowings_9525aa7c-3212-47e0-84ee-9ababfdbdaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee_1d87475c-7be9-4537-915d-1061f59e8a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityFee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bc3f85bd-1a5a-49fc-948d-807069de1aed" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee_1d87475c-7be9-4537-915d-1061f59e8a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements_c5946eba-3e0c-4de7-ac02-3f2066ac65bd" xlink:href="bxsl-20231231.xsd#bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bc3f85bd-1a5a-49fc-948d-807069de1aed" xlink:to="loc_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements_c5946eba-3e0c-4de7-ac02-3f2066ac65bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d308b9f3-10aa-48d2-afca-3be396f50897" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bc3f85bd-1a5a-49fc-948d-807069de1aed" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d308b9f3-10aa-48d2-afca-3be396f50897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_bf5a361b-99fa-4efb-b6d7-5f8e861b7ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bc3f85bd-1a5a-49fc-948d-807069de1aed" xlink:to="loc_us-gaap_InterestExpense_bf5a361b-99fa-4efb-b6d7-5f8e861b7ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_803eac1b-04da-4791-b181-b904dbabbeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bc3f85bd-1a5a-49fc-948d-807069de1aed" xlink:to="loc_us-gaap_InterestPaidNet_803eac1b-04da-4791-b181-b904dbabbeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#CommitmentandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/CommitmentandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_10b70ed0-ab59-4839-a418-f16149020b26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_51894571-1dbb-4542-8bc5-b163b8930403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_10b70ed0-ab59-4839-a418-f16149020b26" xlink:to="loc_us-gaap_OtherCommitmentsTable_51894571-1dbb-4542-8bc5-b163b8930403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_a8884db7-c555-4545-a334-66ac24af1dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_51894571-1dbb-4542-8bc5-b163b8930403" xlink:to="loc_us-gaap_OtherCommitmentsAxis_a8884db7-c555-4545-a334-66ac24af1dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_b39106be-25f6-48e8-8a62-38956ee94b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_a8884db7-c555-4545-a334-66ac24af1dd8" xlink:to="loc_us-gaap_OtherCommitmentsDomain_b39106be-25f6-48e8-8a62-38956ee94b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DelayedDrawTermLoansAndRevolversMember_54ca41ee-7d82-4093-8019-e6b3d1d0759f" xlink:href="bxsl-20231231.xsd#bxsl_DelayedDrawTermLoansAndRevolversMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_b39106be-25f6-48e8-8a62-38956ee94b8d" xlink:to="loc_bxsl_DelayedDrawTermLoansAndRevolversMember_54ca41ee-7d82-4093-8019-e6b3d1d0759f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_50d60308-e6bc-4035-adbd-b6ebba0f8414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_51894571-1dbb-4542-8bc5-b163b8930403" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_50d60308-e6bc-4035-adbd-b6ebba0f8414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_550c2172-76b9-4fee-822f-463b8cebdb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_50d60308-e6bc-4035-adbd-b6ebba0f8414" xlink:to="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_550c2172-76b9-4fee-822f-463b8cebdb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount_bc54536d-7b8b-44f2-878b-02ca464910c5" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_50d60308-e6bc-4035-adbd-b6ebba0f8414" xlink:to="loc_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount_bc54536d-7b8b-44f2-878b-02ca464910c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsSubscriptionsandDrawdownsDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_50a83b08-3267-4589-82a1-20b076fa6399" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_540308ea-a327-4c77-93e6-ded45a48c412" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_50a83b08-3267-4589-82a1-20b076fa6399" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_540308ea-a327-4c77-93e6-ded45a48c412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e26a9010-4a96-4638-88fd-4eab8c0f2975" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_540308ea-a327-4c77-93e6-ded45a48c412" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e26a9010-4a96-4638-88fd-4eab8c0f2975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_75c8a154-606f-4623-8b22-be5b2ac22a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e26a9010-4a96-4638-88fd-4eab8c0f2975" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_75c8a154-606f-4623-8b22-be5b2ac22a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_1651ca89-b125-499d-8526-8b333cfcb81b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_75c8a154-606f-4623-8b22-be5b2ac22a5a" xlink:to="loc_us-gaap_OverAllotmentOptionMember_1651ca89-b125-499d-8526-8b333cfcb81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_eebbdb70-1c46-4592-b31b-449d938d270f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_75c8a154-606f-4623-8b22-be5b2ac22a5a" xlink:to="loc_us-gaap_IPOMember_eebbdb70-1c46-4592-b31b-449d938d270f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9098807d-d10a-4216-8a9b-cd3a920b940e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_540308ea-a327-4c77-93e6-ded45a48c412" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9098807d-d10a-4216-8a9b-cd3a920b940e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_669fca33-a515-4037-befc-97cc249fa5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9098807d-d10a-4216-8a9b-cd3a920b940e" xlink:to="loc_us-gaap_RelatedPartyDomain_669fca33-a515-4037-befc-97cc249fa5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_a3036224-aeea-4431-a8f9-692be2b9c9fd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_669fca33-a515-4037-befc-97cc249fa5c6" xlink:to="loc_srt_AffiliatedEntityMember_a3036224-aeea-4431-a8f9-692be2b9c9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_540308ea-a327-4c77-93e6-ded45a48c412" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3d77a608-afa8-4e05-867d-04fed227b035" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3d77a608-afa8-4e05-867d-04fed227b035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_018fd52c-6658-443f-87c8-db4a2616b24c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_018fd52c-6658-443f-87c8-db4a2616b24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_0f5391be-8b4c-4648-bde4-f67eb8a3713f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_0f5391be-8b4c-4648-bde4-f67eb8a3713f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_5fab2244-a3f8-488b-8b63-e54a396dd1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_5fab2244-a3f8-488b-8b63-e54a396dd1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyCommittedCapital_964ea01e-3add-441d-94e4-185aeccc1283" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyCommittedCapital"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_InvestmentCompanyCommittedCapital_964ea01e-3add-441d-94e4-185aeccc1283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_82e71e56-815d-4a52-af2c-9cbaae615204" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount_82e71e56-815d-4a52-af2c-9cbaae615204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_c31b31e7-3485-4098-98ee-a233c8e09db9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_98327459-549e-4f7f-b3bb-e938f7a39060" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_c31b31e7-3485-4098-98ee-a233c8e09db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_31641433-55eb-481c-b2e9-3d28dc3714a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_4e880cd8-5957-430c-a5e9-b59e1204a511" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_31641433-55eb-481c-b2e9-3d28dc3714a2" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_4e880cd8-5957-430c-a5e9-b59e1204a511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_0eb9bc56-01e7-46f2-b616-81326ff7ed5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_4e880cd8-5957-430c-a5e9-b59e1204a511" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_0eb9bc56-01e7-46f2-b616-81326ff7ed5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1c5b1033-d96a-4008-879e-d2ae78cbcef5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_0eb9bc56-01e7-46f2-b616-81326ff7ed5d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1c5b1033-d96a-4008-879e-d2ae78cbcef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AtTheMarketOfferingOffering1Member_1385ef66-259b-4b42-963d-6598476057e2" xlink:href="bxsl-20231231.xsd#bxsl_AtTheMarketOfferingOffering1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1c5b1033-d96a-4008-879e-d2ae78cbcef5" xlink:to="loc_bxsl_AtTheMarketOfferingOffering1Member_1385ef66-259b-4b42-963d-6598476057e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_4e880cd8-5957-430c-a5e9-b59e1204a511" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NumberOfEquityDistributionAgreements_308ddb21-b7d7-4d1b-a504-578168df34ed" xlink:href="bxsl-20231231.xsd#bxsl_NumberOfEquityDistributionAgreements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_bxsl_NumberOfEquityDistributionAgreements_308ddb21-b7d7-4d1b-a504-578168df34ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue_6b56c2b2-2aa9-4f65-bde5-2d8f6cb71f76" xlink:href="bxsl-20231231.xsd#bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue_6b56c2b2-2aa9-4f65-bde5-2d8f6cb71f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SaleOfStockRemainingAuthorizedAmount_5331410a-ca9e-490e-a8e2-a6e7f985eb95" xlink:href="bxsl-20231231.xsd#bxsl_SaleOfStockRemainingAuthorizedAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_bxsl_SaleOfStockRemainingAuthorizedAmount_5331410a-ca9e-490e-a8e2-a6e7f985eb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_66f3ba8a-6765-4315-956f-0432851d48f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_66f3ba8a-6765-4315-956f-0432851d48f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_223ce843-dffd-434b-bc41-a1b40f95ae7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_223ce843-dffd-434b-bc41-a1b40f95ae7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_7f2a0511-c4eb-4383-9377-2817f948885d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_7f2a0511-c4eb-4383-9377-2817f948885d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_56c4ae14-3990-4d31-9818-2983791ba3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_56c4ae14-3990-4d31-9818-2983791ba3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_63079c95-e867-4eac-acbe-bcfd34fa8ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_63079c95-e867-4eac-acbe-bcfd34fa8ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_881fc687-873d-48f4-8c01-96631ecc52bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_881fc687-873d-48f4-8c01-96631ecc52bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_StockIssuedDuringPeriodValueNewIssuesGross_0e2b3b50-6894-4641-97f7-9b9d447b0096" xlink:href="bxsl-20231231.xsd#bxsl_StockIssuedDuringPeriodValueNewIssuesGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_ffc156fc-d33f-4974-8ebb-a2faf3280786" xlink:to="loc_bxsl_StockIssuedDuringPeriodValueNewIssuesGross_0e2b3b50-6894-4641-97f7-9b9d447b0096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsDistributionsDeclaredDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_50249737-9f88-48a9-9fb8-1cfd1fab5a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_7a83f0c2-df4a-47b8-a4fc-36b12aff7b91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_50249737-9f88-48a9-9fb8-1cfd1fab5a2c" xlink:to="loc_us-gaap_DividendsPayableTable_7a83f0c2-df4a-47b8-a4fc-36b12aff7b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_46777f65-04d0-471e-ba60-359fa3e4daea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_7a83f0c2-df4a-47b8-a4fc-36b12aff7b91" xlink:to="loc_us-gaap_DividendsAxis_46777f65-04d0-471e-ba60-359fa3e4daea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsAxis_46777f65-04d0-471e-ba60-359fa3e4daea" xlink:to="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends1Member_fc6a31ca-2635-42a8-8093-4bc3b9be7899" xlink:href="bxsl-20231231.xsd#bxsl_Dividends1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends1Member_fc6a31ca-2635-42a8-8093-4bc3b9be7899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends2Member_ea946389-847a-4afa-9b88-8461d9d7e001" xlink:href="bxsl-20231231.xsd#bxsl_Dividends2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends2Member_ea946389-847a-4afa-9b88-8461d9d7e001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends3Member_bde8673c-d917-4787-bdc3-67c298add9d3" xlink:href="bxsl-20231231.xsd#bxsl_Dividends3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends3Member_bde8673c-d917-4787-bdc3-67c298add9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends4Member_12757238-f33d-4f37-a9f6-bf821c28a303" xlink:href="bxsl-20231231.xsd#bxsl_Dividends4Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends4Member_12757238-f33d-4f37-a9f6-bf821c28a303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends5Member_1951fa21-6c23-4180-8c05-5308416d28c7" xlink:href="bxsl-20231231.xsd#bxsl_Dividends5Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends5Member_1951fa21-6c23-4180-8c05-5308416d28c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends6Member_f5b7afdb-1919-432c-9485-cf76d8f6de74" xlink:href="bxsl-20231231.xsd#bxsl_Dividends6Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends6Member_f5b7afdb-1919-432c-9485-cf76d8f6de74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends7Member_a21aae99-56a0-493c-bfcc-aacce4bb8d11" xlink:href="bxsl-20231231.xsd#bxsl_Dividends7Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends7Member_a21aae99-56a0-493c-bfcc-aacce4bb8d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends8Member_be0495d6-890a-4137-869a-5c4fc75b61ed" xlink:href="bxsl-20231231.xsd#bxsl_Dividends8Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends8Member_be0495d6-890a-4137-869a-5c4fc75b61ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Dividends9Member_c4a4c153-f2e5-4c96-a525-fefa19c36780" xlink:href="bxsl-20231231.xsd#bxsl_Dividends9Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_850e2c08-1eca-4fb6-90b4-f43be1570465" xlink:to="loc_bxsl_Dividends9Member_c4a4c153-f2e5-4c96-a525-fefa19c36780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_f2abfb56-2949-46a6-9bd1-625bb3c51103" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_7a83f0c2-df4a-47b8-a4fc-36b12aff7b91" xlink:to="loc_us-gaap_DividendsPayableLineItems_f2abfb56-2949-46a6-9bd1-625bb3c51103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_67eb2fb4-385a-4cbd-93ce-ec4e07d0a628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_f2abfb56-2949-46a6-9bd1-625bb3c51103" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_67eb2fb4-385a-4cbd-93ce-ec4e07d0a628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_faae0297-3ba8-4e73-a3d3-230b48c1b4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_f2abfb56-2949-46a6-9bd1-625bb3c51103" xlink:to="loc_us-gaap_DividendsCommonStock_faae0297-3ba8-4e73-a3d3-230b48c1b4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsDividendReinvestmentDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsDividendReinvestmentDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/NetAssetsDividendReinvestmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b99b29ce-8cae-45e0-b688-b88d9e9a21ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare_22b05058-32f5-427a-bd35-a5d69d2cdbe4" xlink:href="bxsl-20231231.xsd#bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b99b29ce-8cae-45e0-b688-b88d9e9a21ed" xlink:to="loc_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare_22b05058-32f5-427a-bd35-a5d69d2cdbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsScheduledofAmountsReceivedandSharesIssuedDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsScheduledofAmountsReceivedandSharesIssuedDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/NetAssetsScheduledofAmountsReceivedandSharesIssuedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_271ee7ba-1bdc-4272-a308-9af9a1e568dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan_4012dcf7-0b50-46e7-9c59-215d8b8e6487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_271ee7ba-1bdc-4272-a308-9af9a1e568dd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan_4012dcf7-0b50-46e7-9c59-215d8b8e6487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan_cd1068be-7fe8-4fab-9403-577fbad19051" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_271ee7ba-1bdc-4272-a308-9af9a1e568dd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan_cd1068be-7fe8-4fab-9403-577fbad19051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsShareRepurchasePlanDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_dd2ef166-4d70-456f-9c63-9668e10dad68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_66f54c97-606e-4fca-b9d0-594a1a8352ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dd2ef166-4d70-456f-9c63-9668e10dad68" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_66f54c97-606e-4fca-b9d0-594a1a8352ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_c024704e-f91d-4254-a70a-1362c97e9d47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_66f54c97-606e-4fca-b9d0-594a1a8352ca" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_c024704e-f91d-4254-a70a-1362c97e9d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f5dc6fb2-7c0c-4d12-9dc7-53779863a1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_c024704e-f91d-4254-a70a-1362c97e9d47" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f5dc6fb2-7c0c-4d12-9dc7-53779863a1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Company10b51PlanMember_06830fbf-879b-4e1c-af72-60bfa771a35d" xlink:href="bxsl-20231231.xsd#bxsl_Company10b51PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f5dc6fb2-7c0c-4d12-9dc7-53779863a1a4" xlink:to="loc_bxsl_Company10b51PlanMember_06830fbf-879b-4e1c-af72-60bfa771a35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Company10b18PlanMember_3ea3e81a-2ac4-488d-a3fe-0faaeca90afb" xlink:href="bxsl-20231231.xsd#bxsl_Company10b18PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f5dc6fb2-7c0c-4d12-9dc7-53779863a1a4" xlink:to="loc_bxsl_Company10b18PlanMember_3ea3e81a-2ac4-488d-a3fe-0faaeca90afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e326d85f-0040-4e5a-9d0a-79114cf85281" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_66f54c97-606e-4fca-b9d0-594a1a8352ca" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e326d85f-0040-4e5a-9d0a-79114cf85281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1099b109-21a3-4c5a-970b-0bf59b9ebce3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e326d85f-0040-4e5a-9d0a-79114cf85281" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1099b109-21a3-4c5a-970b-0bf59b9ebce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_6688c6bf-6f7a-41d6-b8da-f590da35b615" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e326d85f-0040-4e5a-9d0a-79114cf85281" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_6688c6bf-6f7a-41d6-b8da-f590da35b615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_36b2a961-c74d-492c-bf4c-c8a5860d18c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e326d85f-0040-4e5a-9d0a-79114cf85281" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_36b2a961-c74d-492c-bf4c-c8a5860d18c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_02116e85-c874-447f-a570-813790339e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_dba70c7d-2558-4f20-84c0-3af55b0b8207" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_02116e85-c874-447f-a570-813790339e6b" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_dba70c7d-2558-4f20-84c0-3af55b0b8207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_4cb6cb1c-9bd0-439c-80f2-3188f4f0b16e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_dba70c7d-2558-4f20-84c0-3af55b0b8207" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_4cb6cb1c-9bd0-439c-80f2-3188f4f0b16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5b4a0bf6-653e-4643-93f5-bbcf1ea23fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4cb6cb1c-9bd0-439c-80f2-3188f4f0b16e" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5b4a0bf6-653e-4643-93f5-bbcf1ea23fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_Company10b51PlanMember_b7c7c298-ba5f-4046-9e0b-0a7b3aabf568" xlink:href="bxsl-20231231.xsd#bxsl_Company10b51PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5b4a0bf6-653e-4643-93f5-bbcf1ea23fdc" xlink:to="loc_bxsl_Company10b51PlanMember_b7c7c298-ba5f-4046-9e0b-0a7b3aabf568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_55498abe-594e-4041-a385-c4202d272952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_dba70c7d-2558-4f20-84c0-3af55b0b8207" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_55498abe-594e-4041-a385-c4202d272952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0ed9a1e6-528f-4dc5-b863-fd35ba60de1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_55498abe-594e-4041-a385-c4202d272952" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0ed9a1e6-528f-4dc5-b863-fd35ba60de1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare_775e1b72-773a-43b8-823a-9165ce5b2169" xlink:href="bxsl-20231231.xsd#bxsl_StockRepurchasedDuringPeriodAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_55498abe-594e-4041-a385-c4202d272952" xlink:to="loc_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare_775e1b72-773a-43b8-823a-9165ce5b2169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9e36b165-ac81-414e-a2f9-2506aa5b0abf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_55498abe-594e-4041-a385-c4202d272952" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9e36b165-ac81-414e-a2f9-2506aa5b0abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#NetAssetsShareholderTransferRestrictionsDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_29557308-6bbe-4a10-99da-c335cc986a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_d331d527-d5e1-449b-805f-1668d6c53f26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_29557308-6bbe-4a10-99da-c335cc986a8b" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_d331d527-d5e1-449b-805f-1668d6c53f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransferRestrictionsAxis_dcde6026-ab2f-41a5-8bb8-81278d76785f" xlink:href="bxsl-20231231.xsd#bxsl_TransferRestrictionsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_d331d527-d5e1-449b-805f-1668d6c53f26" xlink:to="loc_bxsl_TransferRestrictionsAxis_dcde6026-ab2f-41a5-8bb8-81278d76785f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransferRestrictionsDomain_f0c9c1ee-d8a4-4ae3-83fa-410f14959728" xlink:href="bxsl-20231231.xsd#bxsl_TransferRestrictionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_TransferRestrictionsAxis_dcde6026-ab2f-41a5-8bb8-81278d76785f" xlink:to="loc_bxsl_TransferRestrictionsDomain_f0c9c1ee-d8a4-4ae3-83fa-410f14959728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember_171be826-1cd8-4cfa-9fa3-e579ca862ffc" xlink:href="bxsl-20231231.xsd#bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_TransferRestrictionsDomain_f0c9c1ee-d8a4-4ae3-83fa-410f14959728" xlink:to="loc_bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember_171be826-1cd8-4cfa-9fa3-e579ca862ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_f2293a4b-0753-4859-a043-dad8aed734ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_d331d527-d5e1-449b-805f-1668d6c53f26" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_f2293a4b-0753-4859-a043-dad8aed734ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction_a51c1536-4c03-4a5e-a0ca-a84c5c651e18" xlink:href="bxsl-20231231.xsd#bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_f2293a4b-0753-4859-a043-dad8aed734ef" xlink:to="loc_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction_a51c1536-4c03-4a5e-a0ca-a84c5c651e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_df77e67d-0c0f-481d-b349-e3f3b777d081" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_f2293a4b-0753-4859-a043-dad8aed734ef" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_df77e67d-0c0f-481d-b349-e3f3b777d081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5bf7bdd5-9b8b-46ac-96e4-05fbb924dff3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6a3c88cc-5bc8-4a69-aa49-d8a084d0d301" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5bf7bdd5-9b8b-46ac-96e4-05fbb924dff3" xlink:to="loc_us-gaap_NetIncomeLoss_6a3c88cc-5bc8-4a69-aa49-d8a084d0d301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b0770ad2-5ebb-4dad-bb10-3a2264c8b88b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5bf7bdd5-9b8b-46ac-96e4-05fbb924dff3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b0770ad2-5ebb-4dad-bb10-3a2264c8b88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2d84e9cd-6938-40cc-97eb-be61e09089d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5bf7bdd5-9b8b-46ac-96e4-05fbb924dff3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2d84e9cd-6938-40cc-97eb-be61e09089d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d6271061-c357-4ceb-ab70-88dadb4a9d02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5bf7bdd5-9b8b-46ac-96e4-05fbb924dff3" xlink:to="loc_us-gaap_EarningsPerShareBasic_d6271061-c357-4ceb-ab70-88dadb4a9d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_097c783e-03fe-47ca-b913-15ea43b52b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5bf7bdd5-9b8b-46ac-96e4-05fbb924dff3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_097c783e-03fe-47ca-b913-15ea43b52b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#IncomeTaxesScheduleofPermanentDifferencesDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_21f3b10a-a577-4718-a7fe-44547d28f152" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyChangesInNetAssetsTable_4ecb0bf0-b62c-4876-9a4c-5646a8f76675" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyChangesInNetAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_21f3b10a-a577-4718-a7fe-44547d28f152" xlink:to="loc_us-gaap_InvestmentCompanyChangesInNetAssetsTable_4ecb0bf0-b62c-4876-9a4c-5646a8f76675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4a686bbb-9054-43e4-933e-b42a2424f251" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyChangesInNetAssetsTable_4ecb0bf0-b62c-4876-9a4c-5646a8f76675" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4a686bbb-9054-43e4-933e-b42a2424f251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3671f8e2-affc-444c-a2ce-b68d0ba0138d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4a686bbb-9054-43e4-933e-b42a2424f251" xlink:to="loc_us-gaap_EquityComponentDomain_3671f8e2-affc-444c-a2ce-b68d0ba0138d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9a7ceeeb-d0bb-434c-9af5-05ca4b7ce15d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3671f8e2-affc-444c-a2ce-b68d0ba0138d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9a7ceeeb-d0bb-434c-9af5-05ca4b7ce15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cfbc85d9-e0f7-4435-8332-6bc3e8c42588" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3671f8e2-affc-444c-a2ce-b68d0ba0138d" xlink:to="loc_us-gaap_RetainedEarningsMember_cfbc85d9-e0f7-4435-8332-6bc3e8c42588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ee195553-3eca-42bb-bf62-c524c7559895" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3671f8e2-affc-444c-a2ce-b68d0ba0138d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ee195553-3eca-42bb-bf62-c524c7559895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems_91ed1d4c-b55b-4438-8199-ca46b83c173b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyChangesInNetAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyChangesInNetAssetsTable_4ecb0bf0-b62c-4876-9a4c-5646a8f76675" xlink:to="loc_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems_91ed1d4c-b55b-4438-8199-ca46b83c173b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease_4de30ddf-ba13-4617-8b6e-32164c7c2f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems_91ed1d4c-b55b-4438-8199-ca46b83c173b" xlink:to="loc_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease_4de30ddf-ba13-4617-8b6e-32164c7c2f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_15cd90f7-2b5c-4663-846d-27a2cd6c81dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxNoteTable_b0247b5d-7186-44b8-a087-86a4f251312b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxNoteTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_15cd90f7-2b5c-4663-846d-27a2cd6c81dc" xlink:to="loc_us-gaap_FederalIncomeTaxNoteTable_b0247b5d-7186-44b8-a087-86a4f251312b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_3f488c9a-2e53-411a-88db-48e00f1eca0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_b0247b5d-7186-44b8-a087-86a4f251312b" xlink:to="loc_us-gaap_DividendsAxis_3f488c9a-2e53-411a-88db-48e00f1eca0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_afa51df0-0e69-4ebd-8ba8-9a8cdbd3c73d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsAxis_3f488c9a-2e53-411a-88db-48e00f1eca0a" xlink:to="loc_us-gaap_DividendsDomain_afa51df0-0e69-4ebd-8ba8-9a8cdbd3c73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DividendsOrdinaryIncomeMember_e8fd2423-e7af-4d4e-a6ca-4f9098494d26" xlink:href="bxsl-20231231.xsd#bxsl_DividendsOrdinaryIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_afa51df0-0e69-4ebd-8ba8-9a8cdbd3c73d" xlink:to="loc_bxsl_DividendsOrdinaryIncomeMember_e8fd2423-e7af-4d4e-a6ca-4f9098494d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_DividendsCapitalGainsMember_70f8ed4f-0f2e-439a-aace-e1c954863dc7" xlink:href="bxsl-20231231.xsd#bxsl_DividendsCapitalGainsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_afa51df0-0e69-4ebd-8ba8-9a8cdbd3c73d" xlink:to="loc_bxsl_DividendsCapitalGainsMember_70f8ed4f-0f2e-439a-aace-e1c954863dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_fee81da8-4c19-45ee-8b6a-6faf29554f91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_b0247b5d-7186-44b8-a087-86a4f251312b" xlink:to="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_fee81da8-4c19-45ee-8b6a-6faf29554f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_51890d6b-8901-4e2d-9699-45c65945f52e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_fee81da8-4c19-45ee-8b6a-6faf29554f91" xlink:to="loc_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit_51890d6b-8901-4e2d-9699-45c65945f52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome_fce0cd74-c8e4-4710-81fe-d8a55af9b3c6" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_fee81da8-4c19-45ee-8b6a-6faf29554f91" xlink:to="loc_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome_fce0cd74-c8e4-4710-81fe-d8a55af9b3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_38b9f175-258d-4b30-a521-988ca4ed863f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_fee81da8-4c19-45ee-8b6a-6faf29554f91" xlink:to="loc_us-gaap_DividendsCommonStock_38b9f175-258d-4b30-a521-988ca4ed863f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#IncomeTaxesScheduleofChangesinNetAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_357e3bbf-1b8a-4903-b6da-c66e5ececd68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5d4b64e1-22ff-4603-8aee-e18627d110e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_357e3bbf-1b8a-4903-b6da-c66e5ececd68" xlink:to="loc_us-gaap_NetIncomeLoss_5d4b64e1-22ff-4603-8aee-e18627d110e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome_49ce57bf-e0e0-4a29-8bad-8ff7a1929900" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_357e3bbf-1b8a-4903-b6da-c66e5ececd68" xlink:to="loc_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome_49ce57bf-e0e0-4a29-8bad-8ff7a1929900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome_c3f788e2-2d43-4735-b240-e2eb8bc41f4d" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_357e3bbf-1b8a-4903-b6da-c66e5ececd68" xlink:to="loc_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome_c3f788e2-2d43-4735-b240-e2eb8bc41f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome_aa46fcc8-67ad-4c0b-bd48-7b34a4e33988" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_357e3bbf-1b8a-4903-b6da-c66e5ececd68" xlink:to="loc_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome_aa46fcc8-67ad-4c0b-bd48-7b34a4e33988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome_b3303107-4471-4d58-a394-598f6078331b" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_357e3bbf-1b8a-4903-b6da-c66e5ececd68" xlink:to="loc_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome_b3303107-4471-4d58-a394-598f6078331b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome_5f9d3f34-c6ce-4549-9aaf-f1b6a0accd20" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_357e3bbf-1b8a-4903-b6da-c66e5ececd68" xlink:to="loc_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome_5f9d3f34-c6ce-4549-9aaf-f1b6a0accd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions_60dc9777-7564-44a6-885d-a91623bee7fe" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_357e3bbf-1b8a-4903-b6da-c66e5ececd68" xlink:to="loc_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions_60dc9777-7564-44a6-885d-a91623bee7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b63d783e-8698-4957-86e6-0c7b9918ef54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss_ac693c76-0cd1-4c78-bf8a-8b89c9e8033a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b63d783e-8698-4957-86e6-0c7b9918ef54" xlink:to="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss_ac693c76-0cd1-4c78-bf8a-8b89c9e8033a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss_da24e92c-8b32-428d-af17-60c621fa4c59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b63d783e-8698-4957-86e6-0c7b9918ef54" xlink:to="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss_da24e92c-8b32-428d-af17-60c621fa4c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences_aaf45791-de10-4979-9013-155e404e5eaf" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b63d783e-8698-4957-86e6-0c7b9918ef54" xlink:to="loc_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences_aaf45791-de10-4979-9013-155e404e5eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation_32d2be98-525f-4e9b-bb6f-cefbaa6bbda8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b63d783e-8698-4957-86e6-0c7b9918ef54" xlink:to="loc_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation_32d2be98-525f-4e9b-bb6f-cefbaa6bbda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0435d19f-8dcd-40f3-b144-ce3d9dc4579f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b63d783e-8698-4957-86e6-0c7b9918ef54" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0435d19f-8dcd-40f3-b144-ce3d9dc4579f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RetainedEarningsAccumulatedDeficitAudited_d89a119e-a161-41f9-b31e-96044eec22af" xlink:href="bxsl-20231231.xsd#bxsl_RetainedEarningsAccumulatedDeficitAudited"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b63d783e-8698-4957-86e6-0c7b9918ef54" xlink:to="loc_bxsl_RetainedEarningsAccumulatedDeficitAudited_d89a119e-a161-41f9-b31e-96044eec22af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#IncomeTaxesScheduleofTaxBasisofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4e871a2c-bf1c-432f-9718-8da170d94fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation_aef49253-3613-47fb-acb9-3237c96795a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4e871a2c-bf1c-432f-9718-8da170d94fb9" xlink:to="loc_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation_aef49253-3613-47fb-acb9-3237c96795a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation_6cdd0493-dc56-4b0b-b9de-08861bfada07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4e871a2c-bf1c-432f-9718-8da170d94fb9" xlink:to="loc_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation_6cdd0493-dc56-4b0b-b9de-08861bfada07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet_04b3823a-49c7-4476-8625-2d67539dfa45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4e871a2c-bf1c-432f-9718-8da170d94fb9" xlink:to="loc_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet_04b3823a-49c7-4476-8625-2d67539dfa45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes_330a2f49-3263-4094-a172-4c2237802739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4e871a2c-bf1c-432f-9718-8da170d94fb9" xlink:to="loc_us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes_330a2f49-3263-4094-a172-4c2237802739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#FinancialHighlightsandSeniorSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyAbstract_aaa55b16-11f1-4af6-8353-80cb5315698b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyPerShareDataAbstract_fbea4763-57e4-4b43-96e7-e6e897af6253" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyPerShareDataAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyAbstract_aaa55b16-11f1-4af6-8353-80cb5315698b" xlink:to="loc_bxsl_InvestmentCompanyPerShareDataAbstract_fbea4763-57e4-4b43-96e7-e6e897af6253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyFinancialHighlightsRollForward_e2e7a7af-e533-4f49-9a7b-aa6617c63c20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyFinancialHighlightsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_InvestmentCompanyPerShareDataAbstract_fbea4763-57e4-4b43-96e7-e6e897af6253" xlink:to="loc_us-gaap_InvestmentCompanyFinancialHighlightsRollForward_e2e7a7af-e533-4f49-9a7b-aa6617c63c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAssetValuePerShare_50d65747-0e90-4c2a-b179-9f5bdda61fee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetAssetValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyFinancialHighlightsRollForward_e2e7a7af-e533-4f49-9a7b-aa6617c63c20" xlink:to="loc_us-gaap_NetAssetValuePerShare_50d65747-0e90-4c2a-b179-9f5bdda61fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare_30ad692a-5725-4585-a57a-8f664db797f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyFinancialHighlightsRollForward_e2e7a7af-e533-4f49-9a7b-aa6617c63c20" xlink:to="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare_30ad692a-5725-4585-a57a-8f664db797f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_81efeece-d9b9-408d-a0c1-e6dbc1a013fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyFinancialHighlightsRollForward_e2e7a7af-e533-4f49-9a7b-aa6617c63c20" xlink:to="loc_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_81efeece-d9b9-408d-a0c1-e6dbc1a013fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare_13a25da4-ce17-41a7-8d0b-97a6b25bd8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyFinancialHighlightsRollForward_e2e7a7af-e533-4f49-9a7b-aa6617c63c20" xlink:to="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare_13a25da4-ce17-41a7-8d0b-97a6b25bd8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare_8e5e72cc-5001-4ea5-8ca4-e8814659d48a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyDistributionToShareholdersPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyFinancialHighlightsRollForward_e2e7a7af-e533-4f49-9a7b-aa6617c63c20" xlink:to="loc_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare_8e5e72cc-5001-4ea5-8ca4-e8814659d48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare_0b7341f6-173f-4857-960d-35b0e04cdfb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyFinancialHighlightsRollForward_e2e7a7af-e533-4f49-9a7b-aa6617c63c20" xlink:to="loc_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare_0b7341f6-173f-4857-960d-35b0e04cdfb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_e4a00574-922f-4388-bf98-f79549343f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyFinancialHighlightsRollForward_e2e7a7af-e533-4f49-9a7b-aa6617c63c20" xlink:to="loc_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_e4a00574-922f-4388-bf98-f79549343f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAssetValuePerShare_af3aa465-18ef-46da-a2ca-4665bbef355e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetAssetValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyFinancialHighlightsRollForward_e2e7a7af-e533-4f49-9a7b-aa6617c63c20" xlink:to="loc_us-gaap_NetAssetValuePerShare_af3aa465-18ef-46da-a2ca-4665bbef355e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3857bc2a-b530-414d-bff3-0811d59d22c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyAbstract_aaa55b16-11f1-4af6-8353-80cb5315698b" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3857bc2a-b530-414d-bff3-0811d59d22c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyTotalReturn_e5b701a3-1a04-46b6-9091-4e71df6563a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTotalReturn"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyAbstract_aaa55b16-11f1-4af6-8353-80cb5315698b" xlink:to="loc_us-gaap_InvestmentCompanyTotalReturn_e5b701a3-1a04-46b6-9091-4e71df6563a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyTotalReturnMarketValue_e58a0905-1a05-418f-b494-84055b7070dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyTotalReturnMarketValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyAbstract_aaa55b16-11f1-4af6-8353-80cb5315698b" xlink:to="loc_us-gaap_InvestmentCompanyTotalReturnMarketValue_e58a0905-1a05-418f-b494-84055b7070dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract_68b7e758-4160-4ad1-a5dc-0478dfb392a3" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyAbstract_aaa55b16-11f1-4af6-8353-80cb5315698b" xlink:to="loc_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract_68b7e758-4160-4ad1-a5dc-0478dfb392a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements_50807665-4e1a-4b36-acd7-c5d4108e74ce" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract_68b7e758-4160-4ad1-a5dc-0478dfb392a3" xlink:to="loc_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements_50807665-4e1a-4b36-acd7-c5d4108e74ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio_8734e80b-2ccd-46bc-8c31-1bb03e5cac66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract_68b7e758-4160-4ad1-a5dc-0478dfb392a3" xlink:to="loc_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio_8734e80b-2ccd-46bc-8c31-1bb03e5cac66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanyPortfolioTurnover_e16f2242-d892-4a7d-8fcd-a34a2488d5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanyPortfolioTurnover"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract_68b7e758-4160-4ad1-a5dc-0478dfb392a3" xlink:to="loc_us-gaap_InvestmentCompanyPortfolioTurnover_e16f2242-d892-4a7d-8fcd-a34a2488d5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanySupplementalDataAbstract_ace2b4c0-b1a4-49db-8564-029a644e6e9b" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanySupplementalDataAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyAbstract_aaa55b16-11f1-4af6-8353-80cb5315698b" xlink:to="loc_bxsl_InvestmentCompanySupplementalDataAbstract_ace2b4c0-b1a4-49db-8564-029a644e6e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cc0a051d-096f-4e36-a883-cd7a5bffc576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_InvestmentCompanySupplementalDataAbstract_ace2b4c0-b1a4-49db-8564-029a644e6e9b" xlink:to="loc_us-gaap_StockholdersEquity_cc0a051d-096f-4e36-a883-cd7a5bffc576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio_38e0c0e3-81a7-4ab4-925c-4c9b7417a37d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bxsl_InvestmentCompanySupplementalDataAbstract_ace2b4c0-b1a4-49db-8564-029a644e6e9b" xlink:to="loc_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio_38e0c0e3-81a7-4ab4-925c-4c9b7417a37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_4072f5e1-2f6b-4a19-b82a-2ef06a0fce88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentCompanyAbstract_aaa55b16-11f1-4af6-8353-80cb5315698b" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_4072f5e1-2f6b-4a19-b82a-2ef06a0fce88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_79fca4be-9676-4d03-ad53-6c39a2ed19ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4072f5e1-2f6b-4a19-b82a-2ef06a0fce88" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_79fca4be-9676-4d03-ad53-6c39a2ed19ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d3579f1e-5b5a-4e29-9874-2cf3417cd35b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_79fca4be-9676-4d03-ad53-6c39a2ed19ec" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d3579f1e-5b5a-4e29-9874-2cf3417cd35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_6e1576ec-2261-4107-9ad3-38e60d36e48b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d3579f1e-5b5a-4e29-9874-2cf3417cd35b" xlink:to="loc_us-gaap_IPOMember_6e1576ec-2261-4107-9ad3-38e60d36e48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_cbc087b4-12f1-4597-b4d7-e92f441d9357" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4072f5e1-2f6b-4a19-b82a-2ef06a0fce88" xlink:to="loc_us-gaap_ClassOfStockLineItems_cbc087b4-12f1-4597-b4d7-e92f441d9357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_b6227fd7-2209-414a-b2b7-c9a5e39a89a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_cbc087b4-12f1-4597-b4d7-e92f441d9357" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_b6227fd7-2209-414a-b2b7-c9a5e39a89a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements_9a2537e1-4d9e-4741-b13e-66efb0ceff77" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_cbc087b4-12f1-4597-b4d7-e92f441d9357" xlink:to="loc_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements_9a2537e1-4d9e-4741-b13e-66efb0ceff77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements_c27e92b5-8d64-43cc-a069-de2b02d3c3e2" xlink:href="bxsl-20231231.xsd#bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_cbc087b4-12f1-4597-b4d7-e92f441d9357" xlink:to="loc_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements_c27e92b5-8d64-43cc-a069-de2b02d3c3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bxsl.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="bxsl-20231231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.bxsl.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0097c929-0a79-40be-99fb-fe448182a2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_57358bff-cfca-4658-9b94-c36def93ca9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0097c929-0a79-40be-99fb-fe448182a2bb" xlink:to="loc_us-gaap_SubsequentEventTable_57358bff-cfca-4658-9b94-c36def93ca9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bdde6fb0-1a85-4d7f-b066-e88cff9cddd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_57358bff-cfca-4658-9b94-c36def93ca9b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bdde6fb0-1a85-4d7f-b066-e88cff9cddd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e6a0835f-b9dc-4813-8cd9-ab2da1dac240" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bdde6fb0-1a85-4d7f-b066-e88cff9cddd2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e6a0835f-b9dc-4813-8cd9-ab2da1dac240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_51f167ec-8cfc-4793-a16f-6c5c669a7e66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e6a0835f-b9dc-4813-8cd9-ab2da1dac240" xlink:to="loc_us-gaap_SubsequentEventMember_51f167ec-8cfc-4793-a16f-6c5c669a7e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_304a0ac1-2911-4ddd-8a88-def11aad550d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_57358bff-cfca-4658-9b94-c36def93ca9b" xlink:to="loc_us-gaap_SubsequentEventLineItems_304a0ac1-2911-4ddd-8a88-def11aad550d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_44d1b2d9-4b7e-44e3-b7d9-14d7fc06a8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_304a0ac1-2911-4ddd-8a88-def11aad550d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_44d1b2d9-4b7e-44e3-b7d9-14d7fc06a8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#N2"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/cef/role/N2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cef_AllRisksMember" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember" xlink:href="bxsl-20231231.xsd#bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AbilityToAchieveInvestmentObjectivesMember" xlink:href="bxsl-20231231.xsd#bxsl_AbilityToAchieveInvestmentObjectivesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AbilityToAchieveInvestmentObjectivesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember" xlink:href="bxsl-20231231.xsd#bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember" xlink:href="bxsl-20231231.xsd#bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember" xlink:href="bxsl-20231231.xsd#bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember" xlink:href="bxsl-20231231.xsd#bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember" xlink:href="bxsl-20231231.xsd#bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember" xlink:href="bxsl-20231231.xsd#bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember" xlink:href="bxsl-20231231.xsd#bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember" xlink:href="bxsl-20231231.xsd#bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember" xlink:href="bxsl-20231231.xsd#bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember" xlink:href="bxsl-20231231.xsd#bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember" xlink:href="bxsl-20231231.xsd#bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember" xlink:href="bxsl-20231231.xsd#bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember" xlink:href="bxsl-20231231.xsd#bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember" xlink:href="bxsl-20231231.xsd#bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember" xlink:href="bxsl-20231231.xsd#bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember" xlink:href="bxsl-20231231.xsd#bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember" xlink:href="bxsl-20231231.xsd#bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember" xlink:href="bxsl-20231231.xsd#bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember" xlink:href="bxsl-20231231.xsd#bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember" xlink:href="bxsl-20231231.xsd#bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember" xlink:href="bxsl-20231231.xsd#bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember" xlink:href="bxsl-20231231.xsd#bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember" xlink:href="bxsl-20231231.xsd#bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember" xlink:href="bxsl-20231231.xsd#bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember" xlink:href="bxsl-20231231.xsd#bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember" xlink:href="bxsl-20231231.xsd#bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember" xlink:href="bxsl-20231231.xsd#bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember" xlink:href="bxsl-20231231.xsd#bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember" xlink:href="bxsl-20231231.xsd#bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember" xlink:href="bxsl-20231231.xsd#bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember" xlink:href="bxsl-20231231.xsd#bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember" xlink:href="bxsl-20231231.xsd#bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember" xlink:href="bxsl-20231231.xsd#bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember" xlink:href="bxsl-20231231.xsd#bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember" xlink:href="bxsl-20231231.xsd#bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember" xlink:href="bxsl-20231231.xsd#bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember"/>
    <link:presentationArc order="53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember" xlink:href="bxsl-20231231.xsd#bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember"/>
    <link:presentationArc order="54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember" xlink:href="bxsl-20231231.xsd#bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember"/>
    <link:presentationArc order="56" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember" xlink:href="bxsl-20231231.xsd#bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember"/>
    <link:presentationArc order="57" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember"/>
    <link:presentationArc order="58" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember"/>
    <link:presentationArc order="59" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember"/>
    <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember" xlink:href="bxsl-20231231.xsd#bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember"/>
    <link:presentationArc order="61" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember" xlink:href="bxsl-20231231.xsd#bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember"/>
    <link:presentationArc order="62" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember" xlink:href="bxsl-20231231.xsd#bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember"/>
    <link:presentationArc order="63" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember" xlink:href="bxsl-20231231.xsd#bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember"/>
    <link:presentationArc order="64" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayInvestThroughVariousJointVenturesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayInvestThroughVariousJointVenturesMember"/>
    <link:presentationArc order="65" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayInvestThroughVariousJointVenturesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember"/>
    <link:presentationArc order="66" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember"/>
    <link:presentationArc order="67" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember"/>
    <link:presentationArc order="68" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember" xlink:href="bxsl-20231231.xsd#bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember"/>
    <link:presentationArc order="69" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember"/>
    <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember" xlink:href="bxsl-20231231.xsd#bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember"/>
    <link:presentationArc order="71" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember" xlink:href="bxsl-20231231.xsd#bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember"/>
    <link:presentationArc order="72" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember" xlink:href="bxsl-20231231.xsd#bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember"/>
    <link:presentationArc order="73" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember" xlink:href="bxsl-20231231.xsd#bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember"/>
    <link:presentationArc order="74" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember" xlink:href="bxsl-20231231.xsd#bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember"/>
    <link:presentationArc order="75" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember" xlink:href="bxsl-20231231.xsd#bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember"/>
    <link:presentationArc order="76" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember" xlink:href="bxsl-20231231.xsd#bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember"/>
    <link:presentationArc order="77" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember" xlink:href="bxsl-20231231.xsd#bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember"/>
    <link:presentationArc order="78" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember" xlink:href="bxsl-20231231.xsd#bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember"/>
    <link:presentationArc order="79" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember"/>
    <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember" xlink:href="bxsl-20231231.xsd#bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember"/>
    <link:presentationArc order="81" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember" xlink:href="bxsl-20231231.xsd#bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember"/>
    <link:presentationArc order="82" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember" xlink:href="bxsl-20231231.xsd#bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember"/>
    <link:presentationArc order="83" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember" xlink:href="bxsl-20231231.xsd#bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember"/>
    <link:presentationArc order="84" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember"/>
    <link:presentationArc order="85" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember" xlink:href="bxsl-20231231.xsd#bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember"/>
    <link:presentationArc order="86" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember" xlink:href="bxsl-20231231.xsd#bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember"/>
    <link:presentationArc order="87" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayDefaultUnderOurCreditFacilitiesMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayDefaultUnderOurCreditFacilitiesMember"/>
    <link:presentationArc order="88" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayDefaultUnderOurCreditFacilitiesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember" xlink:href="bxsl-20231231.xsd#bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember"/>
    <link:presentationArc order="89" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember" xlink:href="bxsl-20231231.xsd#bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember"/>
    <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember" xlink:href="bxsl-20231231.xsd#bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember"/>
    <link:presentationArc order="91" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember" xlink:href="bxsl-20231231.xsd#bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember"/>
    <link:presentationArc order="92" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember" xlink:href="bxsl-20231231.xsd#bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember"/>
    <link:presentationArc order="93" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember" xlink:href="bxsl-20231231.xsd#bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember"/>
    <link:presentationArc order="94" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember" xlink:href="bxsl-20231231.xsd#bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember"/>
    <link:presentationArc order="95" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember" xlink:href="bxsl-20231231.xsd#bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember"/>
    <link:presentationArc order="96" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember" xlink:href="bxsl-20231231.xsd#bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember"/>
    <link:presentationArc order="97" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember" xlink:href="bxsl-20231231.xsd#bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember"/>
    <link:presentationArc order="98" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember"/>
    <link:presentationArc order="99" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember" xlink:href="bxsl-20231231.xsd#bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember"/>
    <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember" xlink:href="bxsl-20231231.xsd#bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember"/>
    <link:presentationArc order="101" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember" xlink:href="bxsl-20231231.xsd#bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember"/>
    <link:presentationArc order="102" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember" xlink:href="bxsl-20231231.xsd#bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember"/>
    <link:presentationArc order="103" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember" xlink:href="bxsl-20231231.xsd#bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember"/>
    <link:presentationArc order="104" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember" xlink:href="bxsl-20231231.xsd#bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember"/>
    <link:presentationArc order="105" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember" xlink:href="bxsl-20231231.xsd#bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember"/>
    <link:presentationArc order="106" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember" xlink:href="bxsl-20231231.xsd#bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember"/>
    <link:presentationArc order="107" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember" xlink:href="bxsl-20231231.xsd#bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember"/>
    <link:presentationArc order="108" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember" xlink:href="bxsl-20231231.xsd#bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember"/>
    <link:presentationArc order="109" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember" xlink:href="bxsl-20231231.xsd#bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember"/>
    <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember" xlink:href="bxsl-20231231.xsd#bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember"/>
    <link:presentationArc order="111" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember" xlink:href="bxsl-20231231.xsd#bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember"/>
    <link:presentationArc order="112" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember" xlink:href="bxsl-20231231.xsd#bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember"/>
    <link:presentationArc order="113" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember" xlink:to="loc_bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2023NotesMember" xlink:href="bxsl-20231231.xsd#bxsl_A2023NotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2023NotesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2026NotesMember" xlink:href="bxsl-20231231.xsd#bxsl_A2026NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2026NotesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_New2026NotesMember" xlink:href="bxsl-20231231.xsd#bxsl_New2026NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_New2026NotesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2027NotesMember" xlink:href="bxsl-20231231.xsd#bxsl_A2027NotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2027NotesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2028NotesMember" xlink:href="bxsl-20231231.xsd#bxsl_A2028NotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2028NotesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityDollarAdvancesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_JacksonHoleFundingFacilityDollarAdvancesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_JacksonHoleFundingFacilityMember" xlink:href="bxsl-20231231.xsd#bxsl_JacksonHoleFundingFacilityMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_JacksonHoleFundingFacilityMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BreckenridgeFundingFacilityMember" xlink:href="bxsl-20231231.xsd#bxsl_BreckenridgeFundingFacilityMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_BreckenridgeFundingFacilityMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_BigSkyFundingFacilityMember" xlink:href="bxsl-20231231.xsd#bxsl_BigSkyFundingFacilityMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_BigSkyFundingFacilityMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityMember" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member" xlink:href="bxsl-20231231.xsd#bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3650NotesDue2023Member" xlink:href="bxsl-20231231.xsd#bxsl_A3650NotesDue2023Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A3650NotesDue2023Member" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A3625NotesDue2026Member" xlink:href="bxsl-20231231.xsd#bxsl_A3625NotesDue2026Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A3625NotesDue2026Member" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2750NotesDue2026Member" xlink:href="bxsl-20231231.xsd#bxsl_A2750NotesDue2026Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2750NotesDue2026Member" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2125SeniorNotesDue2027Member" xlink:href="bxsl-20231231.xsd#bxsl_A2125SeniorNotesDue2027Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2125SeniorNotesDue2027Member" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_A2850NotesDue2028Member" xlink:href="bxsl-20231231.xsd#bxsl_A2850NotesDue2028Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_A2850NotesDue2028Member" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_bxsl_SubscriptionFacilityMember" xlink:href="bxsl-20231231.xsd#bxsl_SubscriptionFacilityMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_bxsl_SubscriptionFacilityMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>bxsl-20231231_g1.jpg
<TEXT>
begin 644 bxsl-20231231_g1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #1 TT# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#\MO[9U#_G
M^N?^_P W^-']LZA_S_7/_?YO\:IT4 7/[9U#_G^N?^_S?XT?VSJ'_/\ 7/\
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MV4J6RB*)I&S)(%S\J'&T'F@#Z%HHHH _E7HHHH **** "BBB@ HHHH ****
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M_P""HGQ2M-,A6RTSQ-X1&O6]NB;4#274(FV^WFI*?^!8K[OH **** "BBB@
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MES[YH _HD\._&[PIKGP;T_XH75]_8'A&\TY=4^U:P5@,,##(,G) )&. 3DD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=%FCT6U3/$:0( X'UE,I_P"!5^[/PATNWT7X3^"]/M(Q%;6NBV4,: 8 58$
M'Z5_/Q^W-I-QHO[7_P 7+>Z3RY'\0W-R ?[DK>:A_%74_C7[G?L;_$RU^+G[
M,7PZ\16\JR2-I$-I=!3G9<0*(95/_ T)^A% 'L]%%% !7Y._\%QO^0W\(O\
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MT_\ $T7O@?P;)IWP5T^.:.Z\3Z\K0W.J7&,1K9QC^%6'S%L\'G:<*?(/@/\
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MQ@*.]?,>H_\ !%/3_$&H76IZS\9-8U'5;R9Y[J[FTE'>:1B2SLS3$DDG))-
M'V+^Q+>0WW[(_P )9;>198_^$=M(]RGC<J!6'U# C\*]MKX2^'/_  3?\?\
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ME?']V*,L[?@#7YJ77_!$/QVNIE+;XD^'9=/SQ/+:3I+C_KF,C_Q^OH+X#_\
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M!]6?\$NO^3W/ '^[??\ I'-7[^5^ ?\ P2Z_Y/<\ ?[M]_Z1S5^_E !1110
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M:I;P75G=7LMPFHK)*JM%(K,=^[) /4$@CF@#^C&BBB@ HHHH **** "BBB@
MHHHH **** /Y5Z*** "BBB@#[4_X)#_\GE:;_P!@:_\ _0%K]U*_"O\ X)#_
M /)Y6F_]@:__ /0%K]U* /Y<O''_ ".OB#_L(7'_ *,:L2OT=\4?\$F1JGB3
M5+V'XZ^#(X[BZDF"3+M=-S$[2!*>1G'X5W7PI_X(S>%;S4(;CQ5\6D\06BD,
M]CX;@CC+]\>:SO@?1,T >%?\$D?@?J/Q#_:6M?&DEI)_PCW@Z&2YENF4[&NI
M(VCAB![M\S/[!/<5^J_[7'[4GAS]E7X57_B+5)X9]=GC:'1=(+CS+RYQ\O'7
MRU)!=NPXZD \WXQ\">/OV>?A7!X0_9J^&_A=K>",E9=4U1HG$A&&D:,J/.D/
M!W/*.GH,5^,'[6'A/X]1>.KGQ#\<-)UY-6N6\M+_ %"+=:;<DB.!TS$%'.%0
MXZ\=: /&?$6OWWBOQ!J6M:I.UUJ6HW,EW<SMUDED8L['ZDFL^BB@#])?^"(G
M_)7/B1_V X?_ $H%?=O_  4B_P"3)OBC_P!>=O\ ^E<-?"7_  1$_P"2N?$C
M_L!P_P#I0*^[?^"D7_)DWQ1_Z\[?_P!*X: /Y[:6.-I9%1%+NQPJJ,DD] !2
M5]?_ /!*\> E_:PTV7QU+90F'3YI-$.HLJP_VB&3R^6XW;/-*Y_B QSB@#H/
MV=_^"3?Q6^,5E:ZSXIEA^'.@3A9$_M*(RW\J'G*VX(V\?\]&4^QKT7Q)^S7^
MP]\"?$,WA?QY\4?$GB#Q);.(;Q+#<T5M)W#>1 P4CNI=B.AK[+_;_P#VUM#_
M &=/A+J.G:!K5K=?$36H6M=,M;697DLPPPUTX&=H09VY^\V.H!Q^"<\\EU-)
M--(TLTC%WDD8LS,3DDD]230!^P>E_P#!*C]G3XX>"+;Q+\,O'.O+IUXK?9]0
MMKR*\@W X(:-HU<,#P5+*1WQ7Y__ +7W[%/C/]D+Q%:0ZU+#K?AK4F9=.UZS
M0K'*P&3'(AYCD YVY((Y!.#C[?\ ^"'OB>]N?#_Q6\/22,VGV=SI]]#&6)"2
M2K.CD#MD0I^5?1G_  50\.V6O?L5^,[B[B#S:7/97MJY'*2?:8X\C_@$CCZ&
M@#\#J**[/X-_"G6?C=\3_#O@?0$W:GK5TMNCL"5B7J\K?[*(&8^RT ;'P(_9
MS\??M(^*_P"P? FA2:G/& US>2'R[6S0_P 4TIX4=<#EC@X!K[>U#_@FS\$O
MV=="LM1_:"^-+6-]<+O72M#18V?U$89))9%[;A&H^E?>-SIO@3_@G;^R?JUW
MH]C']AT"R\UF?"S:K?OA$:1N[22%1_LKP.%K\$/BE\4?$OQF\=:KXO\ %NI2
MZIK>I2F26:0_*@_AC1?X44<!1P * /TC^$/[+_["G[0&J?\ "/>#O&GB :_(
M"L-K=W[VES,1WB6:$*Y[X )]J=\8/^")QM]/GO/AEX[DN;I 632_$D*KYG'W
M1<1@ 'ZICW%?EM8WUSI=];WEG<2VEW;R++#/"Y1XW4Y5E8<@@@$$5^OG[*?_
M  5S\%WGP[M=)^,UY=Z1XKTV(1-J\%F\\.I*!@.1&"4E/\0QM)Y!&<  _)_X
MB?#GQ'\)_&6I>%?%FDSZ+KVGR>7<6EP.1QD,".&4C!# D$$$&O5?V#_^3Q/A
M+_V'H?ZUH?MX_M(:5^U%^T%J'B[0+*:ST*WM(=-L6N4"33QQ[CYK@="S.V!G
MA=O>L_\ 8/\ ^3Q/A+_V'H?ZT ?T85_+S\1O^2A>*/\ L*77_HYJ_J&K^7GX
MC?\ )0O%'_84NO\ T<U 'J'[+_PL^$?Q.O-<@^*GQ0?X;"W$/]G.MF9UNBQ?
MS 3@A=N$ZX^]7W-X#_X) _"OXH>%[3Q'X3^-.H:_H=UN$-]8V4#QN58JPSNX
M((((/(Q7Q]^Q7^Q#XG_:W\7;U\S1? NGRJ-5UQD_$PP9&'E(_!0<GL#]6_M<
M?MU^&?V=O \?P$_9R,5A;Z5$UE?^(K.0N+8Y/F1P29^>8L27FR<$G;SRH!R_
MQ+_X)[_LV?!_4I=.\7?M)_V3J47$EC]EAFN(SZ-%&693]17P5\3M%\.^'?B!
MKVF>$M<?Q+X:M;IHM/U>2$Q-=PC[LA0@%<^A%<Y<7$MY<2SSRO//*Q>221BS
M.Q.223U)/>HZ .J^&'PM\4_&7QII_A3P=H\^MZ[?,1%;0 <*/O.['A$ Y+,0
M!7Z&:3_P2O\ AK\$_!L'B?\ :(^+4>A1/@&RTATA3?@$QI)(K/,W7A(P?YU[
MS_P1]^!VF^"_V?)/B%+:JWB#Q;<R@7+ ;H[.&0QI&I[ NCN?7*^@KX7_ ."L
M'C3Q#XB_;!\0Z1J\LRZ7H=M:VVE6K$^6D+P)(SJ.F7=V)(] /X: /8]+^$O_
M  3R\37B:7;?$7Q!IMQ*?+2[NKB>! >F2\MOL'KEL"O7]'_X(P_"?5=4L=8L
MOB'XAU+PM,JS);P-;.;A",@K<*N-I]0AZ\&OQVK]1?\ @C+^T1JTGB+7_@_J
MU[)=:4;-M6T9)6+?9G1U$\2>BL'#XZ JQ_B- 'YJ^.-)M]!\:>(-,M PM;+4
M+BVA#G)V)(RKD]S@"OTP_P""?_\ P2^:[;2/B7\8+.-K0JEYI'A5R'$H(#)-
M=8XVXP1%W_B_NG\XOC#&L7Q;\;H@VJNN7P ] +AZ]L_89\?>,-8_:R^$^ER>
M)]9N+$ZU K6DVHRM$8D!)4J6QC:IXQ0!_08JK&JJJA548"@8 'I7Y4:E_P $
M1=2U#4KNZ_X6W:IY\SR[?[!8XW,3C_7^]?JS7\Q?B+XD>+D\0:HJ^*=:51=2
M@ :A-@?.?]J@#[B^,/\ P1[O_A+\*?%WC63XH6VI)X?TNXU,V:Z*T9G$49?9
MN\\[<XQG!^E?G36_=?$#Q1?6LMM<^)-7N+>92DD,M_*R.IZ@@M@CVK0^$?PM
MUWXU?$C0/!/ANW^T:QK%RMO%G[L:]7D<]E10S$^BF@!WPI^$'C'XW>+;?PUX
M)T&ZU_5YN?*MU^6)>[R.<*B#^\Q K] ?"_\ P21\,?#;PC_PE'Q\^+%GX6L$
MQYMOI;QQ1QL1G9]HF'S-_LK'VXS7Z'_LW_LW^"?V1?A6-$T..-&CB^U:QKEP
MH$UY(JY>61NR@9VKT4>^2?P\_;/_ &JM=_:H^+VI:Q<7<T?A6RF>WT+2]Q$<
M%N#@2%>GF. &9NO..@% 'U;8_"'_ ()X:A=+I*?$O7H[@_NQ?SW%Q$A;INWM
M;",?4@"M?XC?\$;=,\1>&T\0_!;XE0Z[:3Q>=:VVL&.2&Y7MLNH!MY]TQ[BO
MR]K[!_X)S?MDZM^SI\5],\-ZOJ$DOPZ\072VU]:3.3'93.0J748_A(8C?CJN
M<\@8 /F[XJ_"#QC\$?%UQX:\;:#=:!K$//DW"_+*N<!XW&5=#V9217'U_27^
MTU^S+X0_:D^'%UX8\3VB+<JK/INKQH#<:?/CB1&].FY>C#@]B/YX_BY\+==^
M"OQ(U_P3XDM_L^L:/<M;R[?N2#JDB'NK*58'T84 ?1/PS_X);?'GXG:'I.MV
MND:1I&CZI:PWMK>:GJD8#PR('1MD>]QE6!P0#S7TO\-_^"(D[21S>/OB1&D?
M\5GX=LB2?^VTI&/^_9KX%\ _M5_%_P"&5UI\WAWXC>(K**Q"+#9OJ$DML$7
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M6VHH!+' )P!VKY:\>?\ !7KX!^$XY5T>ZUSQA<+PJZ9IS11L?=YS'@?0'Z4
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M=R8^[<PKP<GJZ@-W.[H0#\*=<UJ[\2:UJ&K:A()K^_N)+JXD5 @>1V+,=H
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MS?\ R17F?Q*_X)%^-_B[K2ZUXP^/]QXDUF.!;9+S4M%:1Q&I)5,_:.@+-^=
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MFFR2*";:-8U>9E]&?S$7/HI'\1K\K-4\/ZIH=Q)!J6FWFGSQG#QW4#Q,OU#
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M_P G9:M_V*EY_P"E%K7VQ_P6"UVUTS]D&:QFN%CN=2UNRA@BW -)M+2-@=P
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M%\:/@]I_QO\ "*>'=3USQ!H%HMTERUQX<U%K*X?:&&QI "2AW<KWP/2N]HH
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MH9TGPQI&@Z'9:+IVF6EEI-E$L%M8PPJL,4:C 55 P !5/4OA_P"%M8A:*_\
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M "BBB@#ZL_X)=?\ )[G@#_=OO_2.:OW\K\ _^"77_)[G@#_=OO\ TCFK]_*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /I/_@G1_R=_P""
M/]V\_P#266OVUHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>bxsl-20231231_g2.jpg
<TEXT>
begin 644 bxsl-20231231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Z L<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#&^%OPMT;X
MB^'+W6];U#5!>"_>$M!,@# (C9.Y&).7/.:[C_AG'P?_ -!+7/\ O_#_ /&J
M/V<?^2>:A_V%9/\ T5%7L% 'C_\ PSCX/_Z"6N?]_P"'_P"-4?\ #./@_P#Z
M"6N?]_X?_C5>P44 >/\ _#./@_\ Z"6N?]_X?_C5'_#./@__ *"6N?\ ?^'_
M .-5[!10!X__ ,,X^#_^@EKG_?\ A_\ C5'_  SCX/\ ^@EKG_?^'_XU7L%%
M 'C_ /PSCX/_ .@EKG_?^'_XU1_PSCX/_P"@EKG_ '_A_P#C5>P44 >/_P##
M./@__H):Y_W_ (?_ (U1_P ,X^#_ /H):Y_W_A_^-5[!10!X_P#\,X^#_P#H
M):Y_W_A_^-4?\,X^#_\ H):Y_P!_X?\ XU7L%% 'C_\ PSCX/_Z"6N?]_P"'
M_P"-4?\ #./@_P#Z"6N?]_X?_C5>P44 >/\ _#./@_\ Z"6N?]_X?_C5>7ZC
M\-]+\&^-DTWQE-?IH5V2+/5+-E4 _P#30,K=.A Z=>17UA69X@\/Z;XGT:?2
MM5MQ-:S#D=&0]F4]F'K0!YA'^SKX,EC62/5=:>-P&5EN(2&!Z$'RNE._X9Q\
M'_\ 02US_O\ P_\ QJJ&AZYJOP>UZ+PQXGF>Y\,7#$:=J14_N?\ 9;T'J.W4
M<5[;'(DL:R1NKQN RLIR&!Z$'TH \A_X9Q\'_P#02US_ +_P_P#QJC_AG'P?
M_P!!+7/^_P##_P#&J]@HH \?_P"&<?!__02US_O_  __ !JC_AG'P?\ ]!+7
M/^_\/_QJO8** /'_ /AG'P?_ -!+7/\ O_#_ /&J/^&<?!__ $$M<_[_ ,/_
M ,:KV"B@#Q__ (9Q\'_]!+7/^_\ #_\ &J/^&<?!_P#T$M<_[_P__&J]@HH
M\?\ ^&<?!_\ T$M<_P"_\/\ \:H_X9Q\'_\ 02US_O\ P_\ QJO8** /'_\
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MU7L%% 'C_P#PSCX/_P"@EKG_ '_A_P#C5'_#./@__H):Y_W_ (?_ (U7L%%
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MOCC5/!^BS/XA\,VS,R7:G MN,C#'@@ME<#@D%EXS10!L_LX_\D\U#_L*R?\
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M^N07UY8WT4'V9VMRA6:+<'V.KJPQD'E<'D\UM44 <Y/X/A.H7UWI^K:GI1U
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M7FE[A:W5LR;U5DV,I#JR,",=5Z@8Q6[10 B@JBJ6+$#!8XR??BEHHH ****
M"BBCH,F@ Z#)KQ?Q7XKU7XDZ[+X)\$3;-/7C5-77.P)W52/X3R./O'@?+DD\
M5^*]5^).NR^"?!$VS3T.W5-77.P+W56'53@CC[_0?+DGTSPIX3TKP;H<6E:5
M#MC7YI)6QOF?NS'N?Y=!Q0 >%/">E>#=#BTK2H=L:_-)*V-\S]V8]S_+H.**
MW** /#/@'XET'1O M];ZIK>FV,[:G(ZQW5TD3%?*B&0&(.,@\^QKU/\ X3OP
M?_T->A_^#&'_ .*KXOUN-(M?U&.-%2-+J5551@* QP /2J% 'V__ ,)WX/\
M^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT
M/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8
MP_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\
MQ5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_
M  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_  G?
M@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_  G?@_\
MZ&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q5>0^,O'\7Q#\0?\
M(EI.NV6D>'E/^GZG<W"Q"=0>53<1N7T ^]WP*^?J* /LKP[K/P\\+:+!I6D^
M(]!AMHA_T$82SMW9CNY8^O\ 2M7_ (3OP?\ ]#7H?_@QA_\ BJ^(** /M_\
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MKT/_ ,&,/_Q5?$%% 'V__P )WX/_ .AKT/\ \&,/_P 51_PG?@__ *&O0_\
MP8P__%5\044 ?9^N?%#P?HND7%^->T^]:)?DMK.ZCEDD;L %)_/H*\M\+7&D
M>.?$8\9>/O$6BQ1Q,1IVC2W\06( \%U+=/8\L>3Q@'P*B@#[?_X3KP>!@>*M
M"_\ !C#_ /%4?\)WX/\ ^AKT/_P8P_\ Q5?$%% 'V_\ \)WX/_Z&O0__  8P
M_P#Q5'_"=^#_ /H:]#_\&,/_ ,57Q!10!]O_ /"=^#_^AKT/_P &,/\ \51_
MPG?@_P#Z&O0__!C#_P#%5\044 ?;_P#PG?@__H:]#_\ !C#_ /%4?\)WX/\
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MT/\ \&,/_P 57Q!10!]O_P#"=^#_ /H:]#_\&,/_ ,51_P )WX/_ .AKT/\
M\&,/_P 57Q!10!]O_P#"=^#_ /H:]#_\&,/_ ,51_P )WX/_ .AKT/\ \&,/
M_P 57Q!10!]O_P#"=^#_ /H:]#_\&,/_ ,51_P )WX/_ .AKT/\ \&,/_P 5
M7Q!10!]O_P#"=^#_ /H:]#_\&,/_ ,57FWBKQ9JGQ+UR7P5X(F"Z:!C4]74D
MIL[JI'53R./O]!\H)/S37UE\!8(8OA;:2QQ1I)+/,9'50"Y#D D]^ !^% '8
F^%/">E>#=#BTK2H=L:_-)*V-\S]V8]S_ "Z#BMRBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>bxsl-20231231_g3.jpg
<TEXT>
begin 644 bxsl-20231231_g3.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1"H17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0?.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %1A>6QO<BP@
M06QE>&%N9&5R   !ZAP !P  " P   AN     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$=M-L%8<MN91DD MM)9F&T!@@KM]/O[;5=-MM0T^59K6ZB6:&1>CHPR#^1H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC_B7\0[7X:^&[?6+ZQFO8
MY[M;41PN%()1VSSV^0_G785XE^U7_P DLTW_ +#47_HB>@#VVBBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "O$OVJ_^26:;_P!AJ+_T1/7MM>)?M5_\
MDLTW_L-1?^B)Z /;:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\2_
M:K_Y)9IO_8:B_P#1$]>VUXE^U7_R2S3?^PU%_P"B)Z /;:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\2_:K_Y)9IO
M_8:B_P#1$]>VUXE^U7_R2S3?^PU%_P"B)Z /;:*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KQ+PO_R>3XS_ .P+'_Z!9U[;7B7A?_D\GQG_ -@6/_T"SH ]
MMHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q+]E3_DEFI?]AJ7_P!$05[;
M7B7[*G_)+-2_[#4O_HB"O;: "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHKY0\.?M(^(O#.N75AXDA77-.CN'16)"7$2AB
M.&Z-CT89/]X4 ?5]%<GX+^)OA7Q[ #X?U-&N=N7LI_W<Z>OR'J!ZKD>]=90
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MOB#_ ,"(/_C-'_#*G@C_ *"OB#_P(@_^,U[;10!XE_PRIX(_Z"OB#_P(@_\
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M  RIX(_Z"OB#_P "(/\ XS7MM% 'B7_#*G@C_H*^(/\ P(@_^,T?\,J>"/\
MH*^(/_ B#_XS7MM% 'B7_#*G@C_H*^(/_ B#_P",T?\ #*G@C_H*^(/_  (@
M_P#C->VT4 >)?\,J>"/^@KX@_P# B#_XS1_PRIX(_P"@KX@_\"(/_C->VT4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7B7A?\ Y/)\
M9_\ 8%C_ /0+.O;:\2\+_P#)Y/C/_L"Q_P#H%G0![;1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'B7[*G_ "2S4O\ L-2_^B(*]MKQ+]E3_DEFI?\ 8:E_
M]$05[;0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7B7[5?_)+--_[#47_ *(GKVVO$OVJ_P#D
MEFF_]AJ+_P!$3T >VT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7B7A?_D\
MGQG_ -@6/_T"SKVVO$O"_P#R>3XS_P"P+'_Z!9T >VT444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!XE^RI_R2S4O^PU+_Z(@KVVO$OV5/\ DEFI?]AJ7_T1
M!7MM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %>)?M5_\DLTW_L-1?^B)Z]MKQ+]JO_DEFF_]
MAJ+_ -$3T >VT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7B7A?_D\GQG_V
M!8__ $"SKVVO$O"__)Y/C/\ [ L?_H%G0![;1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% 'B7[*G_)+-2_[#4O_ *(@KVVO$OV5/^26:E_V&I?_ $1!7MM
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %>)?M5_\ )+--_P"PU%_Z(GKVVO$OVJ_^26:;_P!A
MJ+_T1/0![;1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>)>%_\ D\GQG_V!
M8_\ T"SKVVO$O"__ ">3XS_[ L?_ *!9T >VT444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!XE^RI_R2S4O^PU+_ .B(*]MKQ+]E3_DEFI?]AJ7_ -$05[;0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7/>-/ ^C>/M%BTOQ%'-):PW"W""*4H=X5E'([8<U
MT-% !1110 451U?6M,T#3GO];O[>PM8_O2W$@1?H,]3[#FJ7A/Q;I7C716U7
M0)9)K+SGA65XRF\KU(!YQ]<&@#;HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN8\+?$7PQXPGF
MMM%U2-KV!F26RE^29"IP?E/WA[KD>]=/0 5XEX7_ .3R?&?_ &!8_P#T"SKU
MO2]7_M+4=9M?(\K^R[U;3=OSYN;>&;=C''^NVXY^[GO@>2>%_P#D\GQG_P!@
M6/\ ] LZ /;:**@O;ZUTVSDN]0N8;6VB&Z2:>0(B#U)/ H GHKG?"GCK0?&S
M7Y\-W37D-A*(I)PA5&8C/RYY(]\8],UT5 !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%8GBOQ=I/@
MK1TU3Q!,\%DTZPM*D9?86S@D#G''8&K^E:OIVNZ='?Z-?6]]:2?=FMY ZGVR
M._MVH N4444 >)?LJ?\ )+-2_P"PU+_Z(@KVVO$OV5/^26:E_P!AJ7_T1!7M
MM !161XC\5Z'X2TXWWB/4[>P@YVF5OF<^BJ.6/L :E\/:[9^)O#]GK.F>9]D
MO$\R(R+M8KDC)';I0!I4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%+I0+2R<E?)A'(9U_P">C9R<\J,+V).U7@^LF5?$VM>:&/C0^*;;^RN#Y_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 9&C:5/IVK>(+J=HV34M02ZA"$DJHM8(<-D<
M'=$QXSP1]!YAX9LKI/VO/%]V]M,MM)H\:I.8R$8[+3@-T)X/Y&O9J* "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /&?V7[*ZL/ACJ,5];36TAUB5@DT90
MD>3#S@]N#7LU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
84 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>bxsl-20231231_g4.jpg
<TEXT>
begin 644 bxsl-20231231_g4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +1!+D# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KP6/]G._\5_&+X@^*_%GC3QN-$OKRUBT+P_H_B[4--L;:VCL+=9)
M!':SQD.]QY^1G'RAL?,2?>J* /R,_P""6NN>+?VDO&OCW3OB'\0_B#KUCINF
M036NWQKJUL8)7D92P,-PF[('1LCCI7W_ /"/3_\ AF?PAXILOB3\1IKG1O\
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MQEJGB3]M;]G+X67_ )DO@:ZU32=1N[%B?L][-/J9MV$BXP^R./ SG F;INY
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNWQL\#^)OB3\/]4\,^&_$NG>%FU:VFL;R]OM)DU!OL\L;(PB5+F#9)\V0Y+
M8^[W'>T4 ?'W[&O["_BK]CG4M6CTKXHZ;XC\/ZS+#+J.GWGA5H9F\L.%,,ZW
MI\MOG.=R...%!YK%\1?\$VKC2OVGI_C1\+/B8/AMJ,UP;M](_L :A;&5U*W
MYN(_W<N6)3'REV*E?EV_;=% 'QI\6?\ @G;-XO\ C59_%_P)\3KSX8?$9U1M
M3OM-TH7%I=3B(1R2QV[S Q[Q]Y&>12.H))8^SZ]^S78>-/@CXJ^'_BSQ-K'B
M:[\40%-4\1WGE)=22@+L:..-%BBCC9%*1(H48).YF=F]DHH ^<_V2?V1[_\
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M'/V)10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%<=\/\ XQ>!OBM/K$/@SQ=HWBB3
M1YE@OUTF]CN/L[,"4W;2>&PV&Z$HX!RK =!I/B+2O$$FH1Z7J=GJ3Z==-8WJ
MVEPDIM;A55FAD"D[) KH2K8(#*<<B@#1HK/M?$&EWUUJ=K;:E9W%SI;K%?PQ
M3HSVCM&LJK*H.8R8W1P&QE64]"#5/P=XZ\-?$31_[6\*>(=*\3:5YC0_;M'O
M8KN#>N-R[XV*Y&1D9R,B@#<HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P?'S:2O
M@7Q&=>N9+/0QIMR;^XB+!XK?RF\UUV@G(3<> 3QQ6]10!\B_LVRK\/\ XSMX
M#UE=.\4W,-K>Q>%?&&GRHMP=)CM]*#V]U;H B_=M LT>4<Q'"1=&O?!N&_\
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MG^=JG_/G9_\ @6__ ,:H\[5/^?.S_P# M_\ XU6A10!G^=JG_/G9_P#@6_\
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M_P :H\[5/^?.S_\  M__ (U6A10!G^=JG_/G9_\ @6__ ,:H\[5/^?.S_P#
MM_\ XU6A10!G^=JG_/G9_P#@6_\ \:H\[5/^?.S_ / M_P#XU6A10!G^=JG_
M #YV?_@6_P#\:H\[5/\ GSL__ M__C5:%% &?YVJ?\^=G_X%O_\ &J/.U3_G
MSL__  +?_P"-5H44 9_G:I_SYV?_ (%O_P#&J/.U3_GSL_\ P+?_ .-5H44
M9_G:I_SYV?\ X%O_ /&J/.U3_GSL_P#P+?\ ^-5H44 9_G:I_P ^=G_X%O\
M_&J/.U3_ )\[/_P+?_XU6A10!G^=JG_/G9_^!;__ !JCSM4_Y\[/_P "W_\
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M\[/_ ,"W_P#C5:%% &?YVJ?\^=G_ .!;_P#QJCSM4_Y\[/\ \"W_ /C5:%%
M&?YVJ?\ /G9_^!;_ /QJCSM4_P"?.S_\"W_^-5H44 9_G:I_SYV?_@6__P :
MH\[5/^?.S_\  M__ (U6A10!G^=JG_/G9_\ @6__ ,:H\[5/^?.S_P# M_\
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MJ/.U3_GSL_\ P+?_ .-5H44 9_G:I_SYV?\ X%O_ /&J/.U3_GSL_P#P+?\
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M@LS,<  =2345C?6VJ6<5W9W$5W:S+OCG@<.CJ>X8<$?2@5U>Q/1110,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$?\ ^.T>3JG_ #^6?_@(_P#\=K0HH$9_DZI_S^6?_@(__P =H\G5/^?RS_\
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M.UH44 9_DZI_S^6?_@(__P =H\G5/^?RS_\  1__ ([6A10!G^3JG_/Y9_\
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M_P#CM:%% &?Y.J?\_EG_ . C_P#QVCR=4_Y_+/\ \!'_ /CM:%% &?Y.J?\
M/Y9_^ C_ /QVCR=4_P"?RS_\!'_^.UH44 9_DZI_S^6?_@(__P =H\G5/^?R
MS_\  1__ ([6A10!G^3JG_/Y9_\ @(__ ,=H\G5/^?RS_P# 1_\ X[6A10!G
M^3JG_/Y9_P#@(_\ \=H\G5/^?RS_ / 1_P#X[6A10!G^3JG_ #^6?_@(_P#\
M=H\G5/\ G\L__ 1__CM:%% &?Y.J?\_EG_X"/_\ ':/)U3_G\L__  $?_P".
MUH44 9_DZI_S^6?_ ("/_P#':/)U3_G\L_\ P$?_ ..UH44 9_DZI_S^6?\
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M^ C_ /QVCR=4_P"?RS_\!'_^.UH44 9_DZI_S^6?_@(__P =H\G5/^?RS_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHJMJ6I6>CV4MY?W4%C:1#,EQ<R".
M-!G&2Q( Y(_.@3=E=EFOFC]H3X]7?@[XC:'IVD7$D<6C2"YU%$D(2?>H'E.
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M^6?_ ("/_P#':T** ,_R=4_Y_+/_ ,!'_P#CM'DZI_S^6?\ X"/_ /':T**
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M/\G5/^?RS_\  1__ ([1Y.J?\_EG_P" C_\ QVM"B@#/\G5/^?RS_P# 1_\
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MT>3JG_/Y9_\ @(__ ,=K0HH S_)U3_G\L_\ P$?_ ..T>3JG_/Y9_P#@(_\
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M:T** ,_R=4_Y_+/_ ,!'_P#CM'DZI_S^6?\ X"/_ /':T** ,_R=4_Y_+/\
M\!'_ /CM'DZI_P _EG_X"/\ _':T** ,_P G5/\ G\L__ 1__CM'DZI_S^6?
M_@(__P =K0HH S_)U3_G\L__  $?_P".T>3JG_/Y9_\ @(__ ,=K0HH S_)U
M3_G\L_\ P$?_ ..T>3JG_/Y9_P#@(_\ \=K0HH S_)U3_G\L_P#P$?\ ^.T>
M3JG_ #^6?_@(_P#\=K0HH S_ "=4_P"?RS_\!'_^.T>3JG_/Y9_^ C__ !VM
M"B@#/\G5/^?RS_\  1__ ([1Y.J?\_EG_P" C_\ QVM"B@#/\G5/^?RS_P#
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M^ C_ /QVCR=4_P"?RS_\!'_^.UH44 9_DZI_S^6?_@(__P =H\G5/^?RS_\
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M\@Y.YP!R0?F +#OCV:EL=5"O#$4U4A_P4^S\T%%%%(Z HHHH **** "BBB@
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M4=?F )P1P>A&""00:WJ!1DI*\7=!1110,**** "BBB@ HHHH **** "BBB@
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M<F(< Y/]YS(^1P=P->VTY;Z'G9?&3INO-6E-W^71?<%%%%2>F%%%% !1110
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M_A['T-=\,OQ=354W\U;\SS:N:8&CI.M'[[_D?7-%?!L?_!0SQ]X^NI;+X?\
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M=244 9_DZI_S^6?_ ("/_P#':/)U3_G\L_\ P$?_ ..UH44",_R=4_Y_+/\
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M/\G5/^?RS_\  1__ ([1Y.J?\_EG_P" C_\ QVM"B@#/\G5/^?RS_P# 1_\
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MT>3JG_/Y9_\ @(__ ,=K0HH S_)U3_G\L_\ P$?_ ..T>3JG_/Y9_P#@(_\
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M:T** ,_R=4_Y_+/_ ,!'_P#CM'DZI_S^6?\ X"/_ /':T** ,_R=4_Y_+/\
M\!'_ /CM'DZI_P _EG_X"/\ _':T** ,_P G5/\ G\L__ 1__CM'DZI_S^6?
M_@(__P =K0HH S_)U3_G\L__  $?_P".T>3JG_/Y9_\ @(__ ,=K0HH S_)U
M3_G\L_\ P$?_ ..T>3JG_/Y9_P#@(_\ \=K0HH S_)U3_G\L_P#P$?\ ^.T>
M3JG_ #^6?_@(_P#\=K0HH S_ "=4_P"?RS_\!'_^.T>3JG_/Y9_^ C__ !VM
M"B@#/\G5/^?RS_\  1__ ([1Y.J?\_EG_P" C_\ QVM"B@#/\G5/^?RS_P#
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M_P#QVCR=4_Y_+/\ \!'_ /CM:%%2>T9_DZI_S^6?_@(__P =H\G5/^?RS_\
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M6 _>F;CG!P!GMC)!KZIAX?Q:Z_[=3?\ DOQ)^O8FI_ PTO\ MYJ/^;_ ]?\
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MTWPCX&U^^EL_AS\//%_Q5OHV*RWVK*;:U#A<EB(,-C@<.Z$[N2,_/]N?"O\
M8=^&?@'2[)]5T5?%&N"-'NKK5I6N(FFVCS"L1 3:6R?F4G'7/->_Z?I]KI-E
M#9V-K#9VD*[8K>WC$<:+Z*H& /I7PDLRQ$4XPF_E:/\ Z38_3(Y+"K[]2*5^
M]YO[Y-K[D?GUX?\ V#?B)X[V-X@'A?X=:66&VRTN W=U'APP;S&9G)^]R9\\
MY/).?<O G[ GP^\'W*WE^K>++\-O\[6T9T5L_P *(Z@CV?=U-?3=%>?4Q%6K
M\4F>K1RK"4-5"[_KIM^!@Z+X:/AO3X['2(M)TJQCX2VLM-\F->W"K( *O>3J
MG_/Y9_\ @(__ ,=K0HKE/644E9&?Y.J?\_EG_P" C_\ QVCR=4_Y_+/_ ,!'
M_P#CM:%%,#/\G5/^?RS_ / 1_P#X[1Y.J?\ /Y9_^ C_ /QVM"B@#/\ )U3_
M )_+/_P$?_X[1Y.J?\_EG_X"/_\ ':T** ,_R=4_Y_+/_P !'_\ CM'DZI_S
M^6?_ ("/_P#':T*\I^-OQ-L]%T&YT6PN5GU6[*P2K&-XAC8X?<>@8KE0N0WS
M9';.%:K&C!SD:TJ3JS4(G<>#?%UEXPTN2ZLK@7'DS/!(?*,?(/!VDD@,I5AS
MT/.#D#>KY8_9_P#&O_"-^*X].E.;#552'Y0,)+NVHW )P6+#D\[\Y.,#ZGK'
M!XCZQ2YGOU-\50^KU'%;!1117:<@4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **R?%'BK2O!>BSZKK%Y'9640Y>0\LV#A5'\3''
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M#3_"NCZ+:Z[%:[)-:=YB)%WC(@BP<+)LPV7R#D #.:R=>_X*0:/'9W%WX?\
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M>/G!)QL;&*^4OVIOB1\5KK6W\&?$CQ19:D+41W%QINB21K#;R%>$<*JEG"R
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M;W4KQ_+M+.%YY6]$52Q/Y"O#_P!F/1;KQ!>^)?B-JD02]URYDAMP4*E(@^7
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M[H;JTE66*1<XRK*2"..QKXH_;V_:3T/4_ -GX,\'Z_8:Y_:[^;J-QI-ZDZ)
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M3@9..<4O@[P+X:^'>C_V3X4\/:5X9TKS&F^PZ/916D&]L;FV1J%R<#)QDX%
M&Y4=PLK0L(72.7LTB%E'X C^=244 9_DZI_S^6?_ ("/_P#':/)U3_G\L_\
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MV,HMQ6THM2^_9_.Q^AODZI_S^6?_ ("/_P#':/)U3_G\L_\ P$?_ ..U\?\
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M:/)U3_G\L_\ P$?_ ..UH44 9_DZI_S^6?\ X"/_ /':/)U3_G\L_P#P$?\
M^.UH44 9_DZI_P _EG_X"/\ _':/)U3_ )_+/_P$?_X[7A'A']M3PEXO^.UU
M\.+:RN$B$LEI9ZYYJM!=7$9(=0H'"$@A),D,0.!D5]#UO6P]3#M*K&UU?Y'-
M0Q-'%)NC*]G9^J,_R=4_Y_+/_P !'_\ CM'DZI_S^6?_ ("/_P#':T**P.DS
M_)U3_G\L_P#P$?\ ^.T>3JG_ #^6?_@(_P#\=J/6?%&C>'%W:MJ]CI:[2^;R
MY2'Y1U/S$<>]<%KW[47PE\.!S>?$'0FV<,+.[6Z*GT(BW<]>.O!]*UA1J5?X
M<6_1-F-2M2I?Q)I>KL>@^3JG_/Y9_P#@(_\ \=H\G5/^?RS_ / 1_P#X[7@&
ML?\ !0+X/::2+/5-4ULYP/[/TN8;NO0RA,]&_P"^37+?\/";+7L?\(A\+_%W
MB/< 4'E*A/KGR_-Q[=SZ#(SVQRW%R5_9M+ST_.QYT\WR^#LZR?H[_E<^J/)U
M3_G\L_\ P$?_ ..T>3JG_/Y9_P#@(_\ \=KY4/[2/[0OB=6_X1WX$OIA)8)_
M;3R#_=)\PP<<C.<?S E3_AK_ ,7/AF\)^"E?(SMBD\O.>>MQDCCCG.#SW-?V
M?*/\2I"/K)?I<C^U:4OX5.<O2+_6Q]3>3JG_ #^6?_@(_P#\=H\G5/\ G\L_
M_ 1__CM?*T7[-O[0/B8K_P )+\=9M+5CN<:&)0>HXR@@XQD<;>QQ0O\ P3ST
M_7 !XO\ B9XJ\1\*&^=%S@YS^]\[OCKZ8Z<4?5<-'XZZ^2;_ ,@^N8N?\/"R
MM_>E%?DVSZ!UGXG>'O#A(U;QWX5TLC@_;+B.'OC^*<=R/SKS_6OVQ?A;H:MY
MWQ'T6Y89 2PL+BZ+$'&!Y;-U/3M^%8VA_P#!/OX.:24-UI.H:UM& -0U!P.A
M[1;/7\3R<FO0M#_9A^%'AT@VG@'0W(  -Y:BZ(QC'^MW<\#GV%'+@(]9R^Y?
MYCYLSGM&$?5RE^27YGBVN?\ !1CX?:6'^QMJVKD D-;:-Y:' R"3+<(0#E>V
M?F'%?GS\0/&VJ_$?QQK/B75F)U'4KIKF15!*Q'<46-1G.Q,A%*\XYSD8K]#?
MVXOAKXCO?A3I>@?#?PDK6%U?*=4CT*T59MB &%2B#)CW@,< X,2=,U\)77[.
M_P 2[69(IO 6M6\EU(8X(I-.=3(XRP"C!#$!7; #$+GJ,E?K<H^I4Z;JP]UO
M365W9?=_5CX#B"6/J55AZOO1CKI%I7?WWL>_?LT_&7X\>/?"-OX$^'TOA^*W
M\/6ZJ+[450W*P-(RH#N<JX3#+E8^BIG.X5[!/^S?\>O%5O-/XT^.\FBVP1FF
M&C;UC5,$MNV"W  X]@ >QQ7S3^S_ *#\0/V>_C!H?B?6/#FK>']&)>UOWU&!
MH$GLV3+H-^-[*P5E7/!1<DJ,C[!AM?&?[35^DMV\WA7P!$XD2./(EO,9Q[,1
MZG* J/E)!SY>95_JU?\ V?DL];V3?GJ[]=3T,M;Q&'4,1[251:*/,XJVEF[6
MLEW9\T7'[,.C>/O&"Z-X8UK6/B!?*0MWK-[(L=I$#D,V/F8*-K8.[EL@*< C
MZB^&G[$?@3P%9Q/=Z5I?B'4OE9IM5LVN(T8$MA(VDVX!)Y*YZ] <5[AX1\':
M1X%T6#2M%LTL[2( <<O(0 -SL>6; ')K:KPJF/Q516E4=O7_ "/IL'DF&H/V
MM2"<_O2]+Z_-ZG.Z'X2B\+VHM]&M-&TB #'E6.F"%,#H-JN.E:9AU/M=V@_[
M=6_^.5?HKSW>3NV?0J*BK)6,_P G5/\ G\L__ 1__CM'DZI_S^6?_@(__P =
MK0HH&9_DZI_S^6?_ ("/_P#':/)U3_G\L_\ P$?_ ..UH44 9_DZI_S^6?\
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MZ\UT_B#XX:)H\J:5X?LY]>U#'EP6UC$1$2,C:K8P?N\;?EY'(R*QJ5J%#?\
M'_(UIX;&XI_%RKRU_%Z?@>%-^S3\<_C(K-\3_BF=#TR<-YNB^'2VPK@81@OE
MIUW'+>9T7N21JZ3^S_\ !3X$E6N+6P\2:Q$6+?VE;F]F8@@L/+WB%""-V"HP
M1D= !Z2?#OQ&^(V#J^HIX7TF0?-:VZ8D=2!P5#$D'D,KL#\W0$8KL/"GP?\
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M>KG'E>@D[[#J***S*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "H;N9K>UFE2-IGC1F6->KD#.!]:FHH \!NI[B\N
M[B>;=),[F1]NY5+'+# ],DK@!NV342+A@=K$91]Y3DYSSC;P3C!Z87TKZ#HK
M?VOD9\ASF@:59:MX?M)KS2K:*>6+$F(5!)Z;@0!C/48QUJ>3P5HDLC.;! S'
M<=K,H)SGH#_D<=*W**RYFF[%<JZG,3_#G0Y@0EN\.1_!(2 <YW8;(SU_/Z8K
M#X6Z.K;EDNE.<G:ZC/7K\O/4UV%%',QV.*C^'4MOC[-KEW" <CKN'/J& ^N
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M3@AL$X!QU.C^RS^U):?M$V&LPW&GC1]<TV8N;52626U<DQ2*?[P!"N,G!P>
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MCJ>X]16#>?\ !0OX/VN[RKW5[U0,AH--<9^7=T;:>G<CL:S-+\<_LX6JH8_
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MTO=;?YGJY^$/[5'B;8VK?%C1M&C9!^[TV,!D;&/X+=,^O+'KCL#0W[#?BKQ
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M\&ZE&T<=E-81MPR6LQV_=VX ?< -O'&*])HK&5&G4^**?R-HUJD/ADT>/M\
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MW\/AZ&'4%=9(CY<?F AM@  R#SUSU[8KH**4I\W02C8****S+"BBB@ HHHH
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M57R27+-='^G='1T445!V'Y*_%[X)_&CQM\4?$VMZMX'UZ^U*\OY)/-MK626
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HILDBPQL[LJ(H+,S'
M '4DUYEXT_:;^%OP_60:QXXTA;B,$M:VEP+F<8&<%(MS D=,@=_0TTF]B)U(
M4U>;L>GT5\FZE_P4*T/5KYM.\ > O$_CC4UW 00PB') 7C"^9(.ISNC&,=^2
M*4?C;]K'XH*HT?PGH7PYL),;;S4L&=>F<K(7/3UA&"0.><:>S?70XOKU%Z4[
MR]%?_@'U_7GOC+]H3X:^ 2R:[XVT:SG4X:U2Z6:<?]LH]S_I7@:?L5^//B!M
MD^)_QEUG5D;_ %NG:666WY/S%0Y$8XX_U6.^.U>A>"?V&O@]X+6$CPU_;EQ'
MC$^L3M-NXP08QMC(.3D;,<GMQ1:"W=_Z_KH+VN*J+W*:C_B?Z*_YG':U_P %
M#_!LUU]B\'>%_$OC2_8;D2ULS$C#YA_M2=5/_+/U]#CBOB!^TI^T8O@G4?$\
M?@+3/AWX>M(MTEUK.3=J^  JI*P+%F;"KY)Y&2<<'[0T+PWI'A>S%IHVE66D
M6H  @L;=(4X&!\J@#BL;XD_"WPS\7?#Z:'XKT^34]+6=;C[.EW-;@N%91N,3
MJ6&';Y22.AQD##4X)_"14P^)G%WJZ]+:+[]6?BMX@U[4O$^O:CJ^KWDU[JFH
M7#3W-U+G+L6.7;C 7>PPN., #&%W?H]^Q+\*_A+XL^$ND>*++P?87'B.%VM-
M2EU%3=/#=IM+;1)E4!4QN H^4,!DD$UT-U^R-\ +/Q99>'G\$R#4+J$S1LNJ
M7NT* >"WGY!(1OK@YY->C^"?AG\-/V<+/4Y- M(?#,&IE'N(Y+Z>?SC&"%V)
M([G(#G[@[C/0553%4IP:3M;^M=3S\%E-?#UE.JE)/U;^6AZ9'&L4:HBA$485
M5& !Z"F7-U#9V[SW$J00QC<\DC!54>I)Z5Y+=_'"^\37#6?@;09M7F&-UW<+
M^Y7.<' 8#!^4Y9EX/?%,A^#>O^,)4NO&WB2XF'WEL;%]JHQ'][ 4$<#Y5YP3
MG)X\KZU[32C'F\^GW_Y'U_U?D_C2Y?+=_=_F:OB;X\:+IEQ]AT6&;Q'J;L8X
MH;,'RW<?PA\?,<X'RY&2!D&L<Z#\1/B5DZIJ">%M'DW+]EMT9960C'S+G+9Q
M@ABHPW XR?3/#G@[1?"-OY.D:;!8KC!9!ER,YP6.21[9K9I>PJ5/X\ODM%_F
MQ^VA3_@Q^;U?^2.(\+?!SPQX6Q(EB-0O#MW75]^]8X'& >!CD],Y).<UV]%%
M=<(1IKE@K(YIU)5'S3=V%%%%60%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 445RVN^/+>P<6]A&=1N
MGPJ^5\R!CP!\N23G' ]>HII-["N=#?:A;:;;F:ZF2"(?Q.<9XS@>IX/ YKC9
M_$6L^+97MM#A>RM""KWDPV%2.&&[G!Y&  3QG(%26/@J[UR47GB68S/R!9HW
MR@8Q@E3C'7@#T/7-=E!;Q6L2Q0QI%&O1(U"@?@*K2/F+<P_#_@NPT%A-@W5[
MWN)0,_0 <#'..IY/-=!114W;W'9+8****0PHHHH **** "BBB@ HHHH ****
M "BBN.^'?QB\#?%R/4G\$^+M&\5IILP@NVTB]CN!"QSMW%2>&PV&Z-M."<&@
M#L:*Y;PK\5/!7CK3]2OO#?C#0?$-EII*WUSI6IP7,=J0"Q$K(Q"< GYL< UH
M>$?&GA[Q_HL>L>%]=TSQ)I$C,B:AI%Y'=6[,IPP$D;%20>",\4 ;-%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5R?B;PE-)/_:FBM]FU1&,FU2 LAP>Q'WB<=P#
MSGJ:ZRBFG81SOAGQ?%K;-:W""UU*,E9(,G!(ZXST.,$J>1[XS715SGB?PFNL
M,EW:.+74HV4K-D@-CH#@'IUR.> .E0>&?%[W5Q_96K)]FU6/Y26&U9<!>0.Q
M.>@R/0\X%6O\(EO9EKQIX'TOQUI+66I0!F ;R;E !+ Q&"R-U!QUQUKS31/%
MFN_"#5;?0O%9:^T27:MIJD8.U !RH&2<#'*'D#[NX#GVNJ&N:#I_B339M/U.
MUCO+248:.0?D0>H([$<CM7#5HN3]I3=I+\?)G73K<JY)J\?ZV+5K=07UND]M
M-'<0.,I)$P96'J".#4M>',NL_ +5 5\W5O!,[]-PW6N2!@YX4CC&,*WS#"G!
MKV#P_P"(+#Q1I4.HZ;<)<VLG\2D$JPX*MZ,#P1V-52K*HW"2M);K^MT*K1]F
ME*+O%]2Y=6T-[;RV]Q$D]O,ACDBE4,KJ1@J0>"".,&OCWQ]^S;XK_9Y\43_$
M3X#B66%SNU/P6Q9XKB,=HUW#<H^;"\NN?D./E'V/179&3CL>=6P\*Z5]&MFM
MT>0?L_?M->%_C]I#_8G72O$=J2M[H5S)^^C(."Z9 ,D?^T ".C!3Q7K]?.?[
M0'[)-IX^U5/&O@2\'@[XCVL@G34+?*17C Y_>@?=?TD R<D,&!XS/@7^UI>7
M?B+_ (5Y\7=._P"$/\?P!(XI)U"0:@2!@C&51SGC!*-SM(^[5.*DN:'W'-3Q
M$Z4E2Q._1]'_ ),^GZ***R/2"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***^(OVO/VN-0^'OQI\):
M)X8O));3P[.NH:[#:S%5NMV%-JY!P0(V/RD$AWC(!*BKA!U'9'+B,1#"P]I/
M8^W:*^1)_P!O+4_&<\EK\,/A+XD\5R9*?:KI#%%&P."6$2R<9]67M47V?]K?
MXJ+B2X\/?#'3IN<Q*KSJO8<^<P;D?W#Q_#TJO9O[3L8?7Z4OX2<_1?KL?75W
M>06%O)<7,T=O!&,O+,X55'J2>!7E'C3]K3X2> _-74?'&F7$\;!7M]-D-Y(I
MR1@B(-M(P<YQC'TKR&V_8'N?%]PE[\3/BCXC\6W).XPQ2E8T^8,%4RF3C(/1
M5X/ !&:]8\&_LA?"+P.L36?@K3[ZXC.X7&K WK[L#YL2EE!^4'@#GGJ2:+06
M[N/GQ<_A@HKS=_P7^9Y3>?\ !02W\2W,EE\./AEXH\9WJG;\T/E(#U#8B$S;
M<<_,%/TY(A&L?M:_%(#[)IN@?#.PEP%DG1'G"]]VYI6!QGHBD9'H37UQ9V5O
MIMK%:VEO%:VT2[8X84"(@] !P!4]'/'I$7U:M/\ BU7\K+_-GR#'^PGK_CH+
M)\4/B[XA\2[P1+9V<C)%CDC:9"RCG!P(P./7FO3O!G[%OP>\%X>+P?:ZO<#K
M-K1-WD?-P4?]W_&W\/<>@Q[A12=2<NI<,#AX._+=]WK^93TO1[#0[-+33;*W
MT^T3[L%K$L4:_15 %7**;)(L,;.[*B*"S,QP !U)-9G<.HKA?$GQJ\)^&@1)
MJ'VZ48_=V*^:#DX'S\)G) QNS[5RQ^(GC[QHH'AKPNVEVCJ,7U]AC@AOF7<5
M4@8 X#]?3FN26*I1?*G=]EJ=,</4DN9JR[O0]?N+B*UA:6:1(8EZO(P51VZF
MN"\1?'3PIX?=HH[W^U)P=NRQ*NN[C WDA3DL!P3R<=:P;?X(:GXBF\_QGXEN
M-3Y;_1+5B(SG/4L/0XPJJ!D^VW:U[X*:/=>&9-)T98='>5E\ZZ: 7$DJ@?<+
M.<C)"Y(/;%92GBIQO3@EZ[_Y+[S6,,/&5IROZ;?U\CYN\0>+K_7O%LOB$M)!
M=O.&A:'.Z, #"KQG/R#O\NW)(^[7M_P[^$NB>*M,M/$^M:C<>)KR^B5G:8E(
M^%"E",EG"L' W,1@\#%97_#+/!/_  DBE\$ _P!G#YL\'<?,YXQQT![$8%>D
M?#'X>3?#G3;NQ;5CJ=O-(LJ*8/+\M@NTG[S9R%3T&5)Q\QKSL+A:T:MZ\;I^
M:W[VN=^)Q5*5-*A*S7D]O6QUMG8V^G6R6]I;Q6MNF=L4*!$7)R< <#DD_C4]
M%%?0GA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9T][FTD+V< C6WM(;QY80SB&*[^8KO.?JSX>;O\ AJ+XP_8#$=(_LS0?MOE
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M_+/_ ,!'_P#CM:%% &?Y.J?\_EG_ . C_P#QVCR=4_Y_+/\ \!'_ /CM:%%
M&?Y.J?\ /Y9_^ C_ /QVCR=4_P"?RS_\!'_^.UH44 9_DZI_S^6?_@(__P =
MH\G5/^?RS_\  1__ ([6A10!G^3JG_/Y9_\ @(__ ,=H\G5/^?RS_P# 1_\
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M<Q7EM%<0.)(94$B..C*1D'\JEHL!G^3JG_/Y9_\ @(__ ,=H\G5/^?RS_P#
M1_\ X[6A10!G^3JG_/Y9_P#@(_\ \=H\G5/^?RS_ / 1_P#X[6A10!G^3JG_
M #^6?_@(_P#\=H\G5/\ G\L__ 1__CM:%% &?Y.J?\_EG_X"/_\ ':/)U3_G
M\L__  $?_P".UH44 9_DZI_S^6?_ ("/_P#':/)U3_G\L_\ P$?_ ..UH44
M9_DZI_S^6?\ X"/_ /':/)U3_G\L_P#P$?\ ^.UH44 9_DZI_P _EG_X"/\
M_':/)U3_ )_+/_P$?_X[6A10!G^3JG_/Y9_^ C__ !VCR=4_Y_+/_P !'_\
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MT>3JG_/Y9_\ @(__ ,=K0HH S_)U3_G\L_\ P$?_ ..T>3JG_/Y9_P#@(_\
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M%3H/N*H/4Y))/K%%3*HY*VR-:>$IPESR]Z7=Z_=V^04V2188V=V5$4%F9C@
M#J2:YW7/'5CI<@M[8?VE?,=BP6[K]_LK'L>^ "<#ITSE?\(]KGBUQ+K%T;&R
M(RMI!\K=%[9.#][DG(STJ5'N=EP\6?$2U@MKBSTR3S[IU,:W"D!%;T4Y!9O3
M'''7@BO--Z%ERRF(,FUM_4$':?O=VXSWSC&.:]"\577@/0;,6NI:C;6#P'GR
M9B9UQAB7"Y..!DL,#..,UX1XF^(2+K,\>AQNNFJ/E%YDRGIN)VL ,L2HQD@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\L7KV>C^XZ^BBBLSJ"BBB@ HJKJFJV6B:?/?:C>6]A90+NEN;J58XXQZLS$
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKCOAW\8O
MWQ<CU)_!/B[1O%::;,(+MM(O8[@0L<[=Q4GAL-ANC;3@G!H [&BN3\*?%KP-
MX\M=4N?#7C/P]XBM]*&=0FTG5(+I+/(8CS3&Y$?",?FQ]T^AK3\(^-/#WC_1
M8]8\+Z[IGB32)&9$U#2+R.ZMV93A@)(V*D@\$9XH V:*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** ..\2>$9(KHZQHI^SWT?SO
M#&H D/ +#C[V,\=&K3\,^+(=>C:&1?LVH1%EEMV]5."1^/8\CH:WJYCQ5X1&
MJ.E_8-]FU2'E63"^9[$]CP.?8 \=+3YE9DVML7]0\'Z#J]U)<WVB:=>W$@VO
M+<6L<C,!@<D@^@_(>E0_\(#X8.<^'-).3N_X\8NN,9^[Z<5EZ3X^2.QN8M50
MQ:G9J/,C7_EH3V' ^;U'IR!@\3^"?&<GB1Y[>ZBCANHT655CSAD/!.#TP>.>
MOIQ63HQUDXHT526R9T\$$=K!'##&L,,:A$CC4*JJ!@  = !4E%%429&L>$=$
MU_)U'2K2[?:5$DD*F10<_=?&X?>;H>YKC=7_ &??!^J<QVUQIYR#_HLY(!!!
M& X8#D X  X%>DT5C.C2J?'%,VC6J0^&31X]'\&?$_A^,'0/&UPFU@1;7(=8
MSSUX8KG'^QC@= !3EU+XN>'6/VFPT_Q# " \L>T-U RBJ5..IP0>"/0BO7Z*
MP^J1C\$G'T?^=S7ZS*7QI/U7^5CR"/X_RZ443Q'X3U+2'Q\Q )'! +#S%C&W
MG(YR0#W!%=+I?QM\&ZIM7^UULY3C,=Y&T6W(SRQ&W\0Q'!YX-=Q)&LT;(ZJZ
M,"K*PR"#U!%<[JWPW\,:T=UUHEH7W;C)"GDN3[LF"?Q-')B(_#-/U7ZK_(?/
M0E\4&O1_Y_YFUI^J66K0^;8WD%Y%_?MY5D7\P:M5Y1JG[.F@S,TFF:AJ6E3<
M;-LYE10 !QN^;L.=V>O-0-\/_B1H/F'1_&B7R;BP74%8G!SQ\XDZ9X *_='.
M&X/;5H_'3OZ._P"=@]E2E\-3[U_PYZKJ6F6>LV$]CJ%I!?64Z[);:YC62.1?
M1E8$$?6OF_XB?L#^ O$5X-6\'W%[\.O$$>6BO-&=C"K$8SY18;>W$;)^?-=V
MOC?XF>'U#ZMX0CU2 'DZ>09""3_<9SQZ;.X'/)J6S_:+T9&:/5]+U'2YER6Q
M'YJ =O1B3QP%YR,9JHXVG%ZMQ?FFO^ <U;+O;KWHJ7H[_EJ>(_V[^TW^SS(%
MU/3[;XQ>%(GP+JW;%\D>0?F('F XW9)24#^]TKT#X7_MT?#+XA3"QU&_E\&:
MT&\M['7E$*A\D$"7[G!!'S%3D'C@UZ[I?Q2\)ZPP6VUZS#,VQ5G<PEF] ' R
M>#P/0^E>'_MS:?\ #G2_@[JOB+Q'X>TW4M>N%6TTJZQY=PUPP.QO,1E=E107
MQN(PN,<UWTZL*]E&SOU7]6/)K4:^"BYQGHNDO\]RQH?[:'AN]_:$\2^!K^]T
MRP\-Z?9EK/6GG 6:YBR;A&?<5"@!MO .86Y;< ,+QC^W(/$.M'PU\&?"E]\0
M=>W;6O3 ZV4(Y&[@AF&<<DQKA@=W!Q^>]_\ #G4M&\"Z?XJD$<EK=3;6MF0[
M4"_-&QZ9#?=X!Z*.2V%_57X(^-/ACI?PAT#5_#%OI7A71M1MEG&GPLGFB0#:
MZMMRTKJ5*EN2=M7.=&,?:1=TM/*ZW./#5,9B9.C/W&_>VN[/M_GO]S/']+_9
M'^('QJU"#6_CGXWN)XE*R1^&M&E @A.0=IP/+4\ ':KD@G]YG!'TQ\/_ (6^
M$OA7I*:;X3T"RT.U48/V:/\ >2>[R'+N> ,L2< #L*Y&^_: LKVX-IX8T:_\
M0W9!*[(RB,,'!  +=0>JKC'..*K_ &7XJ>-F)GFL_"FGMLS'&2)F&6R01E@P
MPO=01QM')KSI8V,_=IIR]-O\CZ"CEL:+YY:-]9/7_,]3U36].T.$2ZC?VMA$
MV</=3+&#@9."Q%>>ZU^T%X=L91;Z;%=ZU=O_ *N.WB**QSC'S#<>>/E4G)%5
M['X!Z);R-J'B/5;S7+G'[^6XD\F.3W;!W=>>7_0D5J66K:7I+'3_  9H<!N,
M!'GC@"H!P<O@AF.6ZL1U)SZREB:NBM'\7_E^9U?[-3W;D_N7^9S.H>*OB7XA
MMWDAL+3PA8%F47%XP$@^4\88%F]L(I/..F#SEG\.;[QAJ@EN]5O/$4J@-YLS
M%;=<LQ')R2N-N#@'CA<YSZU8^!9-1G%[K]Q)=W'\,*RG:HZD<8QSV7 ^4=17
M706\5K$L4,:11KT2-0H'X"J^JT[WJ-S?GM]VQ/UF=K02CZ;_ 'G'>%_A;IF@
M6\8F1;AD VQ@;8DX7C QNZ=6_(5VB@*  , < "EHKKNSFZW84444@"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *X7XI:P(]/32D#,UP/-E 4G]
MVK# Z'.3V[[<=#7=5FZMX=T[7&C:^M5G:/A6)(/7/8^OY5<6D[L3/#9(V);Y
M-S9<J<9^;C:>4[*,9_#FNY^%NK1V]Y/I[*J^<!)%\N",#[N,9 VKWP,H>.:Z
MK_A7_A_C_B7)P<_??KG.>OKS5W3/#&EZ/-YMI9I%)_>R6(SG.,DXZFM95$U8
MA1:-2BBBN<T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH Y3XL6V@WGPK\96_BJ\?3O"\NC7D>JW
MD;%6@M# XGD! ."L>XYP>G0U\M?#/5K'P9K/C'P3X\M[?7I--\-:[/8>,-"/
MEWL^C1R6Z745Q;(-D$K.(VC9"4?8Y58B"K?:%<A\/?A#X'^$L.H1>"O".B^%
M(]0E$UVNCV,=L)F&=N[8!D+N;:.B@D "@#X/FLM1TSP5+I7BY+'41)X0\+#3
M]7T<J;-_!L>K6PO(KV(8VSB*60RRC,#PKF-8B)@WUO\ #S=_PU%\8?L!B.D?
MV9H/VWR@/^0ILNO,W8_Y:?9/L&[/.SR.V*[_ ,*_"OP5X$M]3@\->#]!\/0:
MH=U_'I6F06JW9P1F41J-_#-][/WCZUH>$?!?A[P!HL>C^%]!TSPWI$;,Z:?I
M%G':VZLQRQ$<:A02>2<<T ;-1W"RM"PA=(Y>S2(64?@"/YU)10!G^3JG_/Y9
M_P#@(_\ \=H\G5/^?RS_ / 1_P#X[6A10(S_ "=4_P"?RS_\!'_^.T>3JG_/
MY9_^ C__ !VM"B@#/\G5/^?RS_\  1__ ([1Y.J?\_EG_P" C_\ QVM"B@#/
M\G5/^?RS_P# 1_\ X[1Y.J?\_EG_ . C_P#QVM"B@#/\G5/^?RS_ / 1_P#X
M[1Y.J?\ /Y9_^ C_ /QVM"B@#/\ )U3_ )_+/_P$?_X[1Y.J?\_EG_X"/_\
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M=K0HH S_ "=4_P"?RS_\!'_^.T>3JG_/Y9_^ C__ !VM"B@#/\G5/^?RS_\
M 1__ ([1Y.J?\_EG_P" C_\ QVM"B@#/\G5/^?RS_P# 1_\ X[1Y.J?\_EG_
M . C_P#QVM"B@#/\G5/^?RS_ / 1_P#X[1Y.J?\ /Y9_^ C_ /QVM"B@#/\
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M]J]^HPR]L]1Z=.:5?%?B"W8)=>&W=O[T+L1W]%8>@Z]B<]J.1ZAH=%Y.J?\
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MG^3JG_/Y9_\ @(__ ,=H\G5/^?RS_P# 1_\ X[6A10!G^3JG_/Y9_P#@(_\
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M_P =H\G5/^?RS_\  1__ ([6A10!G^3JG_/Y9_\ @(__ ,=H\G5/^?RS_P#
M1_\ X[6A10!G^3JG_/Y9_P#@(_\ \=H\G5/^?RS_ / 1_P#X[6A10!G^3JG_
M #^6?_@(_P#\=H\G5/\ G\L__ 1__CM:%% &?Y.J?\_EG_X"/_\ ':/)U3_G
M\L__  $?_P".UH44 9_DZI_S^6?_ ("/_P#':/)U3_G\L_\ P$?_ ..UH44
M9_DZI_S^6?\ X"/_ /':/)U3_G\L_P#P$?\ ^.UH44 9_DZI_P _EG_X"/\
M_':/)U3_ )_+/_P$?_X[6A10!G^3JG_/Y9_^ C__ !VCR=4_Y_+/_P !'_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=K0HH S_ "=4_P"?RS_\!'_^.T>3JG_/Y9_^ C__ !VM"B@#/\G5/^?RS_\
M 1__ ([1Y.J?\_EG_P" C_\ QVM"B@#/\G5/^?RS_P# 1_\ X[1Y.J?\_EG_
M . C_P#QVM"B@#/\G5/^?RS_ / 1_P#X[1Y.J?\ /Y9_^ C_ /QVM"B@#/\
M)U3_ )_+/_P$?_X[1Y.J?\_EG_X"/_\ ':T** ,_R=4_Y_+/_P !'_\ CM'D
MZI_S^6?_ ("/_P#':T** ,_R=4_Y_+/_ ,!'_P#CM'DZI_S^6?\ X"/_ /':
MT** ,_R=4_Y_+/\ \!'_ /CM'DZI_P _EG_X"/\ _':T** ,_P G5/\ G\L_
M_ 1__CM'DZI_S^6?_@(__P =K0HH S_)U3_G\L__  $?_P".T>3JG_/Y9_\
M@(__ ,=K0HH S_)U3_G\L_\ P$?_ ..T>3JG_/Y9_P#@(_\ \=K0HH S_)U3
M_G\L_P#P$?\ ^.T>3JG_ #^6?_@(_P#\=K0HH S_ "=4_P"?RS_\!'_^.T>3
MJG_/Y9_^ C__ !VM"B@#/\G5/^?RS_\  1__ ([1Y.J?\_EG_P" C_\ QVM"
MB@#/\G5/^?RS_P# 1_\ X[1Y.J?\_EG_ . C_P#QVM"B@#/\G5/^?RS_ / 1
M_P#X[1Y.J?\ /Y9_^ C_ /QVM"B@#/\ )U3_ )_+/_P$?_X[1Y.J?\_EG_X"
M/_\ ':T** ,_R=4_Y_+/_P !'_\ CM'DZI_S^6?_ ("/_P#':T** ,_R=4_Y
M_+/_ ,!'_P#CM'DZI_S^6?\ X"/_ /':T** ,_R=4_Y_+/\ \!'_ /CM'DZI
M_P _EG_X"/\ _':T** ,_P G5/\ G\L__ 1__CM'DZI_S^6?_@(__P =K0HH
M S_)U3_G\L__  $?_P".T>3JG_/Y9_\ @(__ ,=K0HH S_)U3_G\L_\ P$?_
M ..T>3JG_/Y9_P#@(_\ \=K0HH S_)U3_G\L_P#P$?\ ^.T>3JG_ #^6?_@(
M_P#\=K0HH S_ "=4_P"?RS_\!'_^.T>3JG_/Y9_^ C__ !VM"B@#/\G5/^?R
MS_\  1__ ([1Y.J?\_EG_P" C_\ QVM"B@#/\G5/^?RS_P# 1_\ X[1Y.J?\
M_EG_ . C_P#QVM"B@#/\G5/^?RS_ / 1_P#X[1Y.J?\ /Y9_^ C_ /QVM"B@
M#/\ )U3_ )_+/_P$?_X[1Y.J?\_EG_X"/_\ ':T** ,_R=4_Y_+/_P !'_\
MCM'DZI_S^6?_ ("/_P#':T** ,_R=4_Y_+/_ ,!'_P#CM'DZI_S^6?\ X"/_
M /':T** ,_R=4_Y_+/\ \!'_ /CM'DZI_P _EG_X"/\ _':T** ,_P G5/\
MG\L__ 1__CM'DZI_S^6?_@(__P =K0HH S_)U3_G\L__  $?_P".T>3JG_/Y
M9_\ @(__ ,=K0HH S_)U3_G\L_\ P$?_ ..T>3JG_/Y9_P#@(_\ \=K0HH S
M_)U3_G\L_P#P$?\ ^.T>3JG_ #^6?_@(_P#\=K0HH S_ "=4_P"?RS_\!'_^
M.T>3JG_/Y9_^ C__ !VM"B@#/\G5/^?RS_\  1__ ([1Y.J?\_EG_P" C_\
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MK0HH S_)U3_G\L__  $?_P".T>3JG_/Y9_\ @(__ ,=K0HH S_)U3_G\L_\
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M'_\ CM'DZI_S^6?_ ("/_P#':T** ,_R=4_Y_+/_ ,!'_P#CM'DZI_S^6?\
MX"/_ /':T** ,_R=4_Y_+/\ \!'_ /CM'DZI_P _EG_X"/\ _':T** ,_P G
M5/\ G\L__ 1__CM'DZI_S^6?_@(__P =K0HH S_)U3_G\L__  $?_P".T>3J
MG_/Y9_\ @(__ ,=K0HH S_)U3_G\L_\ P$?_ ..T>3JG_/Y9_P#@(_\ \=K0
MHH S_)U3_G\L_P#P$?\ ^.T>3JG_ #^6?_@(_P#\=K0HH S_ "=4_P"?RS_\
M!'_^.T>3JG_/Y9_^ C__ !VM"B@#/\G5/^?RS_\  1__ ([1Y.J?\_EG_P"
MC_\ QVM"B@"&U6X6,BXDCE?/#11E!CTP6/\ .IJ**!A1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !117'?#OXQ>!OBY'J3^"?%VC>*
MTTV807;:1>QW A8YV[BI/#8;#=&VG!.#0!V-%<Z?B-X37Q-J'AP^*-&'B'3K
M0W][I/\ :$/VNUMAMS/)%NWI'\Z?.P ^9>>15GPCXT\/>/\ 18]8\+Z[IGB3
M2)&9$U#2+R.ZMV93A@)(V*D@\$9XH V:*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#/\ )U3_ )_+/_P$?_X[1Y.J?\_EG_X"/_\ ':T** ,_R=4_Y_+/_P !'_\
MCM'DZI_S^6?_ ("/_P#':T** ,_R=4_Y_+/_ ,!'_P#CM'DZI_S^6?\ X"/_
M /':T** ,_R=4_Y_+/\ \!'_ /CM'DZI_P _EG_X"/\ _':T** ,_P G5/\
MG\L__ 1__CM'DZI_S^6?_@(__P =K0HH S_)U3_G\L__  $?_P".T>3JG_/Y
M9_\ @(__ ,=K0HH S_)U3_G\L_\ P$?_ ..T>3JG_/Y9_P#@(_\ \=K0HH S
M_)U3_G\L_P#P$?\ ^.T>3JG_ #^6?_@(_P#\=K0HH S_ "=4_P"?RS_\!'_^
M.T>3JG_/Y9_^ C__ !VM"B@#/\G5/^?RS_\  1__ ([1Y.J?\_EG_P" C_\
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MK0HH S_)U3_G\L__  $?_P".T>3JG_/Y9_\ @(__ ,=K0HH S_)U3_G\L_\
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M'_\ CM'DZI_S^6?_ ("/_P#':T** ,_R=4_Y_+/_ ,!'_P#CM'DZI_S^6?\
MX"/_ /':T** ,_R=4_Y_+/\ \!'_ /CM'DZI_P _EG_X"/\ _':T** ,_P G
M5/\ G\L__ 1__CM'DZI_S^6?_@(__P =K0HH S_)U3_G\L__  $?_P".T>3J
MG_/Y9_\ @(__ ,=K0HH S_)U3_G\L_\ P$?_ ..T>3JG_/Y9_P#@(_\ \=K0
MHH S_)U3_G\L_P#P$?\ ^.T>3JG_ #^6?_@(_P#\=K0HH S_ "=4_P"?RS_\
M!'_^.T>3JG_/Y9_^ C__ !VM"B@#/\G5/^?RS_\  1__ ([1Y.J?\_EG_P"
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M/\G5/^?RS_\  1__ ([1Y.J?\_EG_P" C_\ QVM"B@#/\G5/^?RS_P# 1_\
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MU[QYX4/CKP?J_A_^U[_0EU*W:V>_TL0_:(T;A]GG1R)DKE<E#@,<8."/-_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%9/AOQ5I7B^QFO-'O$OK:*XDMGD
M16 $B-M8<@9&>A'!!!!((- N97Y;ZFM117D'[0WQE\3_  :A\)W&A^$M)\3V
MVO:Y9>'RVH:])ISV]S=S+# VU;2??'N;YR"&4#A6YP#/7Z*\2T/X^^(M+^-.
M@_#7Q_X)M/#NJ>(K*ZO=&U+0M:;5;*Y^S*C31N7MK>2)E5P<LFT\ -DXJ7]F
M7XQ>)?B];_$M?%%AI.GWWA7QI?>&HH]&>62)HH(;=PS/)@LY:5\D*@P -O!)
M /:***\R_:6^(VO_  A^!/C/QIX9L=-U'5]"T][]+?5I7CMV2/#29V#<QV!M
MJY7+8&X9S0!Z;16+X)UJ?Q)X,T#5KI8TN;_3[>ZE6)2J!WC5F"@DD#)/!)-+
MXS\7:7X \):QXDUNZ2RTC2;62\NIY&"A8T4L>I SQ@#/)(% &S16?X?UJ'Q)
MH.FZM;QR16]_;174<<P =5= P#8)&<'G!(]ZT* "BBB@ HKR7Q5\9M>3XL7G
M@#P7X6L/$>K:9I$&M:G+JFM'3HXH9I98XHX=L$S2RGR7.&"(!MRX+8KK?A9X
MZG^)'@NVUVYT2Z\.7,ES=VLNE7TB//;O!<RV[*Y0E=V8B3M++SPS##$ ZVBB
MB@ HHHH ***\?^ OQ4\4_$'Q1\5-&\566CV5QX3\1#2;4:,TLB26[6L$Z/(\
MA&Z0^=R JA?N_-C<0#V"BO$]6^-GC:S_ &DM/^%UIX'T.YT^\TM]>&NR^)I8
MY$L([B&"8FV%DW[X-,-L?F;6 YD3G'ME !1110 45Y#\6OBAXJ\"?%KX2:%I
MUEH\WAGQ9JL^F:C<W32M>Q.EG/<((47"X/D\NQ..FTYW+Z!X5_X2?S-<_P"$
ME.DE/[2E_LG^RA*#]@VIY?VCS/\ EMN\S=L^7&W'>@#>HHHH **\@_:&^,OB
M?X-0^$[C0_"6D^)[;7M<LO#Y;4->DTY[>YNYEA@;:MI/OCW-\Y!#*!PK<XV/
M 7C?QSK'B^^T;Q5X3T#2;:WMC(+_ ,/^(YM519P8R;>97LK?RG\N6.0 D[E8
M$ C) !Z/1110 45Y9^T]\1O$WPC^!/C#QIX2L])O]7T*QDOQ!K4DBVYCC4LY
M_=_,S #A<KN/&Y<YKT70[Y]4T73[R0*'N+>.9MHP,LH)P,G'7U- %ZBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **P?!?CO0?B)I,NJ>'=2CU2PCN9K-IXE8 2Q.4=?F )P1P>A&""0
M0:WJ!1DI*\7=!17FGQ:^+UWX"\0^#?"VA:+;Z_XN\6W-Q#IMG?:@;"T5+>$S
M3RS3K%*RA4  "Q.2S*.!EAB7/[1B^#_ _P 1O$OC_P -3>$H/ T:M?11WT5T
M+TF!91]D<[ ZN76.,OY;,YPRH010,]FHHHH ***\?^$GQ3\5^+_C)\7?"'B/
M3]'LK/PG=6*:9+I<DLKSP7,<DJM.[X DV"+**HVDM\S@JU 'L%%%% !17C_[
M-/Q3\5_%/0?&,GC+3]'TS6=!\47N@&'0Y)9;8K;K&-PDDPTA+,_S;4[ J"#6
MK\:OC%-\*CX2L;#1X-9UOQ3JW]D:?%?7_P!@LXY!!+.SSS^7(44)"V-L;L20
M * /2Z*XWX0?$*3XI?#[3O$DNG)I<MS+<PM!#<_:H&,-Q) 98)MJ^=!)Y7F1
MR;5WQNC8&<5S'[27QA\1? WP/#XHT;PKIWBFR2]M;*\BO=:?3I(6N;F&VA9-
MMM,)!YDPW9*E0,C=T &YZS17BO@3]H#5[_XU77PJ\<^$;?PIXJ.C_P!NZ=-I
M>KG4[&_M1*8I"LK00NCJVWY7C&02>PS[50 445!?7#VMC<3QPM<21QLZPI]Z
M0@$A1[GI0!/17%?!3XBS?%[X1^$/&TVD-H3^(-,@U,:<TWG&!94#J-^U=PVD
M$':,@]*W_%5UK5CX?O)_#NFV6KZU&H-M8ZC?-902G(R&F6*4IQDC]VV2 . <
M@ UJ*^3[/]LKQM;_  #TSXTZO\*]+C^']S:1ZA<G2?%CW6I6ENSA-[6\EC"C
M8)R0LI.!QFN\^('QS\>>'_C#X3\$^&_ 6@Z]:>*;"[U#3-6U#Q//8;8[5(&F
M$\*Z?*8SNN(PNTOGJ=O0 'NE%>)^"_VBK^;XN0?#+X@^#G\">+-0LGO]%DAU
M)-1T_6(XQF=;><)&WF1CEHWC1MHW8Q@F+PK^T!XE^+-UJ5_\-? ]GK_@W3[V
M:P/B'6M<;31J$L+;)C8Q+;3&9%8,@>1HE9E(!P-U 'N-%<;\(_B#/\4/ \'B
M"Z\/WWA:Y>\OK*72=29&N+=[:[FMF#E"4))A+?*6&&&&8<GA_A'\:?&WQ ^*
MGCSPAKG@?1/#]MX/G@M+S4;+Q)+?-/+/;1W,7E1-9197RY5W%F4@\ -U ![5
M117C_P"U9\4_%?P7^#=_XO\ ".GZ/J5Y875NES%K,DH18)9!$6C2/F20.\>$
M+)D%L-D!6 /8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOZ,T4!L?FI^TAXD^',FO?M-ZCI5W;6ECKWP[TR^M-6T@S6UMJ-\)KW9)]JA
M24R-Y &7VS8"X< XZ3XT>'_ WP]^$OPL\3(=1TOX4^(I(I_&VM>'+*UU57N1
M81PVMQ=6]Q#<0O%NC=9,0'+E2?GP&_0>B@#\]=';X=^&? OPM2TUKQ%XC_9N
MU#Q3J-SK.J^,;!;73F9K)7LT,*P6ZIIWVG>JJ\(B\U=N-FRO9?V,[CP_:_$#
MX]:3X9A>/0X_%-O<:>T-M*EG]G.FVB*L#E?*V H0JHQ^0*0 FPGZEHH ^2_&
M7QN^'GA']OC33KOCSPWHJ:?\/;^QO&U'5X+=+>YDU&RD2!R[@+*T:,X0X8J,
MX(JE^TM\=]/^)WP9\0:IX(O]0USP!X>\1:?:>)=<\(K!?236>-]V+=)8WBF2
M+S+5G($B,ID4@!68?8-% 'YN75O\'+?]B_\ : UKX=^-O%&L>%;W3XYXKS4K
M9=!TR+4T618H;&*VM;-=YD$/F1JAC=FB!R6>MW1?$7@GPG\8/AR/AIJ?AZV\
M7>(/A/J$.W3[V(RZGJ CLVL%F;S 99<I*$+Y8A6 .!\OZ#44 ?G1X1UOX7_V
MA^S#K/AU%?QM_;T:>,OL]M-<:M_:$FE72R?VF%C:0S"X=P&E^Z#(4P@8KYEX
MK\3?#\_ /XVV2>-+606OQOCFLD_X2.7S)K21K*/<Q$Y::(PPW6'?>N('9<%,
MK^LE% 'P%XGU[P%X9^)O[3WA_P "^,=#\$_;OAU;ZGY^C705([Y$OFN+O9;L
M9#.(V@9VC4R$,K$,2-VS^R;)X(\1?'JSO_!9\.^"=*T_PR+>Y\*>'_&UI=-J
MVIAE5KY[33KN2*>-(FE0S7*^:S/&Q4%05^N_BAX+G^(G@'6?#=OJSZ*^I0B!
MKM;:.X'EE@9(WBD!5TD0-&PX)5VP5.&'F/PG_95T+P!XDTWQ#?Z%\.XM<TIY
M'L;[P7X(BT&0%X6A?S7\^=GRDC\*R+\W(.!@ XO_ (*">,O".C>#_AQH_B7Q
M+::']L\=Z%<21G5#8W(LXKQ#<7".DB21K&IR94(V':<J<&I/C3\ M!B_9'^.
M-GX?EN/&5GXDT^Y\2Z=_:5Y<:S,9H]-MTA,5Q-)++,Q-HCQMN."ZJO %?4]%
M 'PYX!\6> -;_:.^!_B#07L[_P#M+X<ZA87NM:':O,I>+^SP$FN84.SR1YBE
MG*>46"LRE@I\'\+ZY\*-!_9[7Q/#KF@_V_H_QB7^R=8N=5%S?6]D-6AW&.>6
M3S?+:S7<QSAT&YL_>'ZMT4QW/SD^.6I>"O$W@C]II?&WV:X^*J?;W\*/=9FO
M'T0V<9M'TTC/^CN'E\WR3@DR&3C 'WYX!U6'7/ _A_4+=9D@N;""1%N(98I
M"@ZI*JN#_O*#[5OT4A!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!\O\ CSX??M3W_C+6KCPM\3?#.G^')KJ1
M]/M;BUC$D,!8E(VS92$L%P"V\Y(S[5XI\?O$G[3/P1\(I>>*OBMH$]MJ;O90
MVFFVT#7,F48NP'V!,*J_>8,-N1W-?H76!XJ^'_A?QT;4^)/#>D>(3:;OL_\
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M/L_Q!XRT;P?X6G\1>)-2M/#NCVT2RW5YJDZP16X8@ .[D '<P7GJ2!U-;5%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 445YUXNT+XCWVOW$V@>(K&PTH[?)MY8T+#Y%#;B8
M7/+;B#NXXX/(K*I/V:ORM^AI3@INS:7J>BUG:'XAT_Q):R7.FW*W4$<K0,ZJ
M0-Z]1R!D=,$<$$$9%>%>/M1^)O@?2$FU3Q;9O'<GR%BM?+$Q^7EE/V=2/<CH
M2F,=*X?X9>(O$UKJ4.@:!KD.C_;ICL^U*OE,X0\ ,C[23P .A"J3T2O-GF"C
M55/D?X7\NIZ,<"Y4W4YU^-O/H?7U<7\3OBIIOPOM-'^TV-_K6JZU?+INE:-I
M*QM=WUP4>0HGFO'&H5(W9G=U50IR1Q7*#PS\8L\^+-+Q@=$3/4_].O8'\=HZ
M9-<O\?/!NB>,?"'@#PM\1?%UUX:\976L-)X>\5:'<BT:TU2.&=XV4G:"#%YB
M;&!#9V\,5-=].LZCMR->MO\ ,X:E)06DD_3_ (8]%\)_&S1_$DWB:VO=,U?P
MM>^&;.&\UBVUZV6+[(LHF8#S$=XY0%A9B\3O'R '+!@O;Z3JEMKFE6>I64AF
ML[R%+B"0HR[HW4,IPP!&01P0#7P9\4+SQQ??!?\ :3^&?Q&O[#QQJ_A?P='J
M=OXW\/QM83WL&RY:.WOHH7PDD;Q3.8BY1DD)*$,=VWXF2SCT+P3X+\+^*_%%
MU/8^ [G6)-#L_&EWIJ6CM]F5+VZU4SF;;&7:..V"2H-X)1%5<]!@?<=%?"]S
M\0O%OC+X<_L?:K)X_P!<M=0\2W]E8^((M*NH[8W_ )NG-.S3 1EBP*H>H7$A
M.,E&4U#XF:W\/=+^(WA.#QAK$'AJS^*6E>&7U_4]4FO+S0]*N[>UDF(O)RSK
M^]=HUDE9_+\WKA0: /IKP?\ &2[\3_'#QO\ #RY\+76C+X<L++4(=4N;J.0:
MA'</,@=(X]VQ08' WL&/=%KTZO@OQ=K>@?!GXM?M 6=M\1=2T.6#X>Z0;/5+
MB[.LZK:LUS>+B,SRF69]\\6/,E&TSQ_,J!"N%XP\6>-/!>B_M*^'[7Q7XF\'
MQZ+X0L==T>"Y\7MK6H6EUMNS(GVJ=9&A>1;9=\$<C;=K-&XW95C['Z(UYC\&
MOC)=_%;6?B!IU[X6NO"MQX3US^QFAO+J.>6X!MXIUF/E91-RS*0H=^,9(/%>
M%ZPM_P"&;SX.Z#J'CWQ=%X>^)UP)M;U.\UN2.6":'2Q+%:6US\K6BW$B%F$;
M*S,K*A7<173?LB2:5IGQ0_:&T"RUL:M<6'BZ $7%Z+F[6(:;:1J97)+N0T;Q
MEW8LS1MN._<2@/:OBI\4M-^$V@V6HZA9:AJMQJ%_#I>GZ9I42/<WEU*3Y<2;
MW1 3M8[G=5 !R15KX=^/[3XC^'Y-2MK"^TF:WNY["\T[4EC%Q:W$,A22-S$[
MQL01]Y'92",$U\P?M-?;_P!IGQ7\1_A#I.KP>$]6^'^E:?XKTF[:=8;N\U,^
M9+!+%-N#000E$225,.&N!\R 8=?V3?$7A3XSR:-\3M-U?5/!VCZ-9V_AU_ U
MKXAFCL4UIY&:YFN+9)=LSM)-L1I@6EPTK@DHP1-SZ!^//QJL_P!G_P"'E]XT
MU7P[K>OZ+IXWWQT,6K2VL73S66>>+<N2!A-S<YQC)&9X1_:*TO7OB9'\/M=\
M,>(O ?B^YLGU&QT_Q%%;%;^W0@2-!/:SSPN4R-R;PX'.W'-<M^W]-'#^QK\6
M&D8(IT9E!+;>2Z #.>Y(&._2JWB;X*^+[+QY?_&3Q!XAM/&_BOPIX=U&#PGX
M=T?0GL;2&>2-F9F4W,TLTLFU(^'5<=%!.:8SZ*HKXG\'>)-0A\._LW>/_"7Q
M!\0>)]:\<:I9Z?XBT^^U>6^M-1CELY9KUUM&8QVKVS1,W[A8@@5E8'(%8+>.
M_$6N?L^O\7M-\:^((/BY9>+QIESX<75)FL?.;6/L@T=]++M"/W+JJD)YV0KF
M0\DH6I][5QWPC^*&F?&;X?Z;XOT:TOK+3KY[B..#4HECG4PSR0-N5688+1,0
M03E2#WKP&XT/6O''[:?COPE=_$/QA::#;^&M'UVUL-*U7[+'9SB\D#1J(T V
M.L(#*^XNLCY)&W96_:8O-8^'&MZ=:>$(=0NO#^B>&[[4+C0/#/B)M+U+3@TA
MSJL<#;8]06+#_P"CRR%0S ["6&6,^N*\7\*_M/V'C3XP3^!-)\ ^/+FSAN;F
MU;QK_8JCPZ9( XE"WGF?-B2-H>%/[P$= 37I?@_7K76? VB:U'=O-8W6G07B
MW=TOE,T;1*X=P3\I(.2">.:^;/ GP%L/V>?V@O!(^%.OZDO@OQ/!?MK_ (0N
MM4FO[:.(0M-%JD!E=F0^?Y,+,2=_GKC^+(!ZHO[3/AEO$TEC_9VL?\(\FKKX
M?/C#R83I']I%_+%KO\WS<^;^Z\SRO*$GR>9N(%.\9?M*^&_!GB+6]/ETW6-3
MTWPXL+>)-?TZ*&2QT+S0&07.Z5920A61O)CD\M&#OM7FOFG9+'^P2/ ;2>5X
MZ?Q<= %FZDW#:K_PD(F,JH?FSM(NPW.$(?G'/4W6J6G@WX/_ +7NF>(=BZE)
MK&KW M9XR6OHK[385L5C5C^]\P 0* ?F>)E&,4"/L)KJ%+4W+31K;A/,,Q8;
M N,[L],8YS7CF@_M2:'KMEH.JKX5\5VGAKQ%>6MEH7B":RA:TU)KB58XW41S
M-)!&=VX/<I$&4?)N9E5NV\!Z?=^%?@[X=L=>\R\OM-T&WAO_ .)Y9([=1+UQ
MDDAO3K7Q_H-KJ/[/OAWP)XF^&'C:V^(_P(\0ZMIEK:> ?$#)<WFF_:+B,1-I
MUSEGD>&5T?R&!*",G.06 ,^WM/\ $VF:IK6JZ1:W2S:AI?E?;855OW)D7>@+
M8P25YP#D @G&1G4K\\M2FG^".K?MD^+_  Q=:K;>+-/O[?["LFJ7=UY4<UA;
MRSW?V625HYFAC>2=6=6V+&0 L8VU[EH;3>"OVC/AE9>"?&FM>*/!_C'0M2OM
M5L-4UBXUB,+ L+0:A#),[M KO,(B$*Q'>H"AL4 ?3$TC10NZQM,RJ2(TQN8X
MZ#) R?<@5YE^SS\:IOCMX+U+7KCPY-X5GL=:OM&ETVXNTN9$>VE,3EFC&S.X
M'A2PXX9NM?.GP&^*WA[XEZEX8\0W_P :=1T?XJ0^);RQUWP1>:E(_P!I3SY8
M!8II'F;(T0-"XN4C+*L;-(YPY7A?V<M<MO$GB:Y\!>*;[6O"'A74O''B2]T;
M6/#NMW&G#6]16^E5]/EGM9D:(+$1(L1),W!5U\HK(>H>I]H_'CXT6GP!^'M]
MXSU/PYKGB'1=/'F7_P#80MFEM8O^>K+//%N7.!A-S<YQ@$CK_"^LW/B#0++4
M;O1;_P .W%PF]],U0PFY@Y( ?R9)(\XP?E=NHS@Y \1_;V1+7]C#XJQ^841-
M$9 TKEB?F0 %B<DG@<GDGO6;^UAJ6N6?Q'^ 4&D>+]<T&PUGQ8=+O['1[I(4
MO('M99,N=A=MIC &#MPY)PVUE8SZ5KS'P?\ &2[\3_'#QO\ #RY\+76C+X<L
M++4(=4N;J.0:A'</,@=(X]VQ08' WL&/=%KYEU#XE:Y\/=+^(WA6'QAK$/AF
MT^*6E>&7U[4]3EO+S0]+N[>UDF(O)F:1?WLC1K)*6$?F]3MR,KQ]XJ7X!_%+
MX_MX2\37-SJ^G> =#N+6;5+Y]7OK2$7EW]IF)FD::<0QS><0[Y 9!]W9A"/O
MVBOA?X<VOASQA9>,6F_:N77_  U?^'WOI;?PGJNI6MUH<L<B8O\ [3/J=W-;
MG][M^S/MCDXQ&=C ]#^R/)K"_$J70OBAXB\66_Q(T/1[>/3-'U'6+Y+#6-,$
M>Q=5-O)<.DUTY8K.&'[IU7Y%8;B ?8]%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>_O8M-LYKF8XCB4L>F3
M[#/<]![FN;OM+\6RWD[6^L6\5NTC>6GEKE4R=HYC.2 1W[?6N/\ %VH:W9L=
M/U+4A=+M\Z1;= 0H!) .V,$GI\I[8(Y%6HMDN5CO?"OBZ+Q.+A1#]GFA()C+
M9RI) 8< ]5/;TK?KP72]4N=$OUFMIOLLB(58[5(53DL!D#*CY/7H. >:]&73
M/&C*A&LV;@@<X7D CG_5=QG\ACUJI0L]-@3(OB9\6K'X:W&@:?\ V1JGB7Q!
MK]S);:7H>BB#[5<F.,RRN#/+%$B(BY9GD4<J!DL :.D?'GPW>>'_ !GK&JPZ
MEX7MO!P)UU-:M?*>SVP+._"%_, C8'=&75L_(SUPO[2'@GPU\1-8^'/AS5_&
M.I> _B.7NKSPIXGTFX6&2.[BCB6>$*Q E$J2\PD8=$D&1W^8/VAM>\:^+_V4
M?VD?!/Q"-CK_ (C\!S:9(/%WA<M:PZTLAC8?:H(I !-"@/F1/\B[HV"':C-D
M4?I!17Q#^T==C3[CQ?H?@WQEXOO7\)>!Y;Z*TM?%UW90Z1<"XN@;RYOS.]Q?
M3LT?E);2)*B_9V#%#(M:?B+Q1XC\8_$K]D13XVUZST[QAI5^=;L=+U!;:*[D
MBT=IBS^6 Y?S&8'!PI52H1P&H#H?9=>8?#3XS7/Q ^*'Q+\'77A>Y\//X,N;
M2!;FZNXI6U!)TD=)E2/(1"B*RY8MA\,J,I6OF/3?B9K.E>&D\&7OC#7+7PK/
M\8]2\&W&OW&IROJ-GIJI+/%:F^=C*A>;9")F<R")L*ZMM*T=2\0:/\.?'W[3
M.BV7CW6-.NC+X3L[6XL[U=1UHHVR![>-YIE;>YD%O]HFD#1M,KN_R D ^^:*
M_-7XK^./&W@_X._M2:;8>,O$GABZ\*3Z/>Z1#'XNEU6\LTF5$GA^VS@S $L&
M9%<E'.U7/1OH;QUHQ\-_&_P-\-;[QOXO@\*>,YM7UZXGG\07$-Q/>Q):+#IM
MM=QE98(/FGG\F-U);Y5(C'E$ ]5^ ?QFNOC5HOB>]O?"MWX/NM#\07>@R:??
M7,<\VZ 1[G9H\Q@[G(PCNOR\.<\:_P 4/BUIOPMCT**XTW4M<U?7K_\ LW2M
M'TB.-KF\G\MY656EDCB0+'&[%I'50%ZYP*\?_8AU'39+?XT:?9Z['K=Q:?$7
M56ED-PDTWEL(A$[E2<[@APQZ[6Z8*CS3]IC4-4_:0OOBQX=T34K?1-8^#5U8
M:QI%FMY]ENM0O#;F61I9UD5HH)());=-K)\[EF;Y0H/4-MSZ_P#AYX[L?B1X
M3M]=L+>[LHY)KBTFL[]%2>UN;>>2WN() K,NZ.:*1"49E)7*LRD$\S\=?C?;
M_ 7PS;>(-0\*>(/$FER7,-I--H/V,FUDFFCAA$@N+B$X>255!3< <[MHP3XU
M^RGKG@SXJ7FG_%7P_KVJ>'O#MU##X?T3P"->FCLM/N889!<"6Q63RA.VU]J%
M2"D*S ;I,CJOV]R3^S'K<:2QPS2:SH"1-(F\;O[9LB/DR-V,$[0>0#0!V?@'
M]H+2?&?Q$U#P%J6@:]X)\:6E@NJ#1?$45N'N;0OL,\$MO--#(JMA3M?()P1P
M<>I5\L_$/X5^,_APOQ(^/&J>);;QG\2M)\%WFF^';+2-#:PL+&-5,W$#37$D
MTC2J&):3&,J  01CZ+JEUX0\9? G6_ ?C77O&=IXYM;@ZUIFJ:U<ZG%?P+8/
M<B^B29V6T99D1"(A''F=4*C"@ 'U]4%]>)I]C<74@9HX(VE8(,L0H).!W/%?
M#/A'QEKVH?!SX._%K2/'&O7WQ%\0>);#3-<T2XU2YEL;UI[KR;ZR&G22>3;&
MW3>P:-$9%@+,QRS'O/ .A:SXY_:\^..BZEX_\8C2_"]YX6UG2[.TU@PP0%X[
MJ:6V,2 (UO(!L>-U)9<$DLJ. #Z'^%GQ$T_XN?#GPYXTTFVO+/3-=LH[^V@U
M"-4G6.0;EWJK,H.,=&(]ZZJOB[]I#4=1^#_B">V\.MJZ> _"G@6V0Z?X4\0O
M9WOA:W#7D/\ :)L7=(]0B:.-(PK2%XS:EE",P>OL"^N["Z\/W%S=7'V?2Y+5
MI);AY6M]D)3+.7RICPN3NR".O&* /*/AI^T]8_%3XCW_ (6TCX?>/K;3K4W!
MC\8:AHJP:#>+$^S?;W1E_>AS]S"_,.> "1=T/]ICPQKWB'3[.+3]7AT+5-4F
MT32O%<T,7]E:E?1&17AA=93(/FAE59'C2.0IB-WRN?*OAG\"8OV??CE;^&_A
M7XDU > M;\.WUQJ'A.^U22]MM&N$: 6EU;EV:2+S#)(I!;YPA/S;,IPVA,E[
M^QG^SYX,L8S!XLB\4:!I#Z<NU;FTOM.OTDU#<F[*F%;6X=S@D 9P,\&@:=SZ
M.US]ICPQH/B+5;*73]7N-#T?48='U;Q5;PQ-I>G7TOE[()7\T2Y!FB#ND;1Q
ME\2.A# >B^*M:N?#OA^\U*ST34/$=S;J&32]*: 7,_(!">?+%'D D_,XX!QD
MX!^+?$#1Z7^QM^T-X/NXMWBV;Q1K^E?V:<?:+J\U*^:33]JLP+F:.ZMG0]2#
MP#CG[=L4>PTJW2[G#R0PJ)IW;J0HW,2<>A.: T/$? W[6'_"?^%_"_BG3_A3
MX\B\)^(KFSM[36YO[):)%N9T@CEDBCU!IUC#N"Q$9*J"<<5ZUX>UC7=1USQ)
M:ZKX>&CZ;8W4<.EWXODG_M.$PH[3>6H!AVR,\>ULD^7NZ$5\J_L'_#'6;KX%
M_ OQ8OCO5]3T6QTV9V\-WD=FEG;L\<L0:$Q6R2LZL6'[V1^'?GL?,_C?X^\<
M:+\+?VP9K#XD^)HKKPIK^GG2KR&^2&:UBFB@+VR$(!'&#.P!CVN=B_,3G<#]
M#]%:*^=?#=[<> ?VP-9\-CQ-K=]H-[X"CU^\M-9U*:\C2ZBOWB-Q"KEA!NC<
MATB$<9VH0A(R/#OA#XLU^X^*GP9:'QQXKO-&\=:-K N]<UC7R9-7?RM\%]%I
M3--!8+OYA5"#AMKQ@@B@1]]T5^?'P:\5>)S\"OV>/']WX]\5:GXCUCXB2Z)>
M3:EK4LEO>64M_J,#036^[R9/D12K%&9&5 C(J@#J/ WQ8T#X@>--0NM=^-E_
MX(^*>A^/YM/G\*3ZE(L-W80WC11:?;Z4SJLPN+;ROWZQR2B5RP;C90(^O_#N
MLZ]J6N>)+;5?#HT;3K&[2'2[_P"W)/\ VG"84=IO+49AVR,\>UB2?+W="*P/
MCU\5)?@C\(_$OCF/0+CQ*NAVIO)=/MKF*W9HEY=R\A  5<M@!F.,!23BOEZZ
M\?:WI _:<L-3^(_B>*&P\7Z/IVE7EOLN;JV6Y%JQLK0;H8X3(TK0!RR"/>'9
MB5+'E_$7B'6;/X0_MC^$=9U'4([#1]#CFTW2]6\1SZ[-8B?3V,L7VJ;]XV7"
M;DW.J,Y4,PZ@S[R\)ZT_B7PKHVKRVWV*34+*&[:VWE_*,D:L4W%5)QG&2!TZ
M#I2^*-8NO#^@W>H66B7_ (CN8%#)I>EM MQ/E@"$,\L4>0"3\SKP#C)P#\5?
M%[QEXA\'V.D:M:7NLW?AK2/AMI]U>0^%?$36=[X<61;I)-4:P9HX=0B=45 K
M.7C-L60(S!Z^XX;Z">Q2[60"V>,2B1P5^4C.3G&./6@#@_@3\9K;X]_#VP\9
MZ;X;USP[HVHJ);#^WEMDENH2.)56">7:I.0-^UCC.,$$^AU^=?AG5-:TO]BO
M]D67P]XMUKPXM]XMT+1[U='NDMQ=03W3+*DGRY8#81M!VG+;U<=/54\<>(_A
M#+^UC;>'=3U;Q ?!VFV>KZ'9:YJ-QJSVT\NF-*X4S.TGE&2,/Y>_ ._:%!&0
M#V_Q=\9[SPK\>/ ?P[/A2ZN+#Q5:WDZ>(_M<:P0/;Q/(\/E#+EL"+E@BXE&&
M8J5KU"OA^23PYX5^-G[,>L6'CS4/%0UG3M9OXY?$'B!KR34;B73XUC>$2,PB
M\UF*B.!%C!X1%.0W+?LY^,&^,>L^#-?U7]I*T3Q'K4<UCX@^'EF=3M=1GGEA
M*W%L+=]486C0,K%+FTMH-OEE@0": /T)HKX)^&23Z#\9O#WAKQ=\0O'%_P##
M6ZU>[N/ GB^;Q'J"+XCNF,.=/O9Q<8E1/+;[."BI<*DC(2&83?>U !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M %#5- TS7/*_M+3;34/*),?VJ!9=F1@XW XS5.U\$^';&X2>VT#2[>:,J4DB
MLXU92OW2"%XQV]*NZYKEAX9T:^U;5+J.QTVQA:XN+F8X6.-1EF/T K@O@G^T
M)X0^/VGZG<^%I[K?ILJQW-K?0^5,JMDQR;<GY'"L0<YX.0*KZNZD75Y+I;NQ
MF\3&G.-%SM)[*^YZ76?K7A_2_$=F]IJVFV>J6KJR-!>P),C*PPP*L""".".]
M:%>>?%SX_>!O@5%ID_CG5;K0[+49EMX+\Z7=SVBR,0%26>*)HX22>/,9<@$C
M@$B30Z#P[\-_"7@_PU<>'=!\+:+HGA^X\SSM)T[3X;>TEWC;)NB10IW#@Y'(
MZU2C^#O@&%_#[Q^!_#:/X>5DT9ETFW!TQ6.6%M\G[D$]=F*Z36-7L_#^DWVJ
M:C<)::?90/<W-Q)]V*-%+.Q]@ 3^%<M\)_C%X5^.'A5/$G@Z[O=1T.1ML-]=
M:5=V*3_[47VB*,R+VWIE<@C.010!#=? 7X97MCH=E<?#KPG/9:$6.DV\NAVK
M1Z?N<.WV=3'B++@,=F,D9ZU+I_P0^'.DMKAL? 'A>R.O(T>K&WT:VC_M%68L
MRW&$_>@DDD/G))-=M11YAL[G'Z;\'? .CZ/=:38>!_#=CI=U9G3KBQMM)MXX
M)K4LS&!T"!6C+.YV$;<NQQR:IW7P#^&-]IZV%Q\./"5Q8K:1Z>+:70[5HA;)
M(94@VF/'EK(2X3H&)(&>:WO'7BP^!O">HZZ-%U;Q#]C0/_9FA6WVF]GRP7$4
M>X;B,YQGH#6]0!S-]\,?!VJ>#H_"5YX3T.[\*1JJIH4^FPO8J%.5 @*[  >1
MQP:N^'/!OA_P=%-%H&A:;H<<PC$B:;:1VX?8@C3<$ SM1549Z!0!P*V:* .6
M\5?"OP5XZU;3]4\2^#]!\0ZGIW_'E>ZKID%S-;<[OW;NI*<@'Y2.14G_  K/
MP?\ \)DOB[_A%-#_ .$K6(0C7?[.A^W",+M">?MW[=O&,XQQ6Y>ZE:::(#=W
M4-J)Y5@B\Z0)YDC<*BY/+'L!R:LT#U.=\;?#GPG\2].@T_Q?X7T;Q5802^?%
M:ZWI\-Y%')@KO5958!L,PR.<$^M7O#/A?1O!>AVNB^'M(L="T>U!6WT_3+9+
M>WA!8L0D: *N6)/ ZDFM2O/OBQ\>/!OP2&E-XONM4L8]4N%M+.6RT*_U".2=
MF"I#NMH) LCDX5&(9N=H.#0(VM#^%_@WPSXCO_$&C^$="TG7[_\ X_-4L=-A
MANKG_KI*JAG_ !)H_P"%7^#?^$R_X2[_ (1'0O\ A*]NS^W?[-A^W;?3S]N_
M'MFMS2=3AUK2K/4+=+B.WNX4GC2[MI+:9590P#Q2*KQM@\HZAE.00""*\YTO
M]IOX;:QJ%E:VWB"0#4+J.QTZ[N-,NX+/4YWD$:QV=R\0BNFW'D0N^T*S'"JQ
M !U5G\+_  ;IWC*Z\76GA'0K7Q7=#%QKL.FPI?3#:%P\X7>WR@#D] !4OB[X
M<^$_'\"P^*/"^B^)(5>.01ZOI\-TH:/=Y;8D4\KYCX/;>V.IKS[7_P!K;X:^
M&=2EL;V\\0M)'JKZ&)K/PAK%U;RWZNR-;13Q6K1RR;D9=J,Q)4^E=S\/?B;H
M'Q0T_4;S0);YDTZ\;3[R#4M,NM.N+>X$<<I1X+F..13LEC8$K@AQB@#I9K6&
MXMGMI88Y;>1#&\+J"C*1@J0>",<8K \$_#7PA\-+.XM/"'A71/"MI<.))H-$
MTZ&S21@,!F6)5!..YJ/P'\3?#'Q.CUR3POJ\6KQZ'JMQH>H-"CJ(+V#;YL)W
M 9*[EY7*G(P34OQ ^(&C?"_PK>^)/$+WL.CV2F2YFL=-N;YH4 ):1H[>-W"*
M 2S[=J@9) H >/A[X57QD?%P\,Z./%AA^S'7OL$7VXQ8QY?G[=^W'\.<4:O\
M/?"OB#Q+I?B+5/#.CZEX@TH$:?JUY812W=GG)/E2LI:/J?ND=:PM.^-_A75O
MA@WQ!M#K<_A81K,LZ^'=1^T21,5VRQVI@\^2,APV]8RNW+9V@D9\G[1W@6/P
MQX?UW[7K#VWB R?V59Q^'-2?4+U44,\D5D+<W#1A2K&01[=K*<X8$@'I<D:S
M1LCJKHP*LK#((/4$5RUC\)_!&E^+%\46?@WP_:>)EB\E=:@TN!+P1[=NP3!-
M^W;QC.,<5/X%^(WAOXEZ?>7WAG58M6M;.Z:RN)(E9?)N%1'>)@P!#J)%#*>5
M;<K896 Y?4OVB_ ^E?%2W^'%Q/K@\87 5XK&+PSJ<J/$75//$ZVYB\E6=0TV
M_P M"3N88. #LH?!/AVW\27_ (ABT#2X]?O[=;6\U5+.,75S"N-L<DNW<Z#
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MILDYE=%!<Y)/S$\FNFHH YFQ^&/@[2_&%UXLL_">AVGBJZ4K<:Y!IL*7TRD
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M-8/+Y,9CVQ[V 9MH&XC)R:] HHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI>XNA-Y\Q*QQJ2\AW*BJ<@8J'7OV;? /B:'P3%J.GZI,O@N03:$4U_4(VM'
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M?%3X%^$/C0VCMXLM]5NQI%REY9)8:]?Z>D-PC!HYMMM/&#(C %7(+)SM(R:
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M-7B:Z^'/P\UZ_P#"NFQ7'C+6)%M-*M8$B62]U*5%AA9M[(KE%16.]@/+@P6
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
0@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171134224304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Feb. 20, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">814-01299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Blackstone Secured Lending Fund<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-7020632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">345 Park Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">31st Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(212)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">503-2100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares of Beneficial Interest, $0.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BXSL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,600,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001736035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171134226064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">DELOITTE & TOUCHE LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171133289136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Assets and Liabilities - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investments at fair value</a></td>
<td class="nump">$ 9,868,440<span></span>
</td>
<td class="nump">$ 9,617,248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">154,857<span></span>
</td>
<td class="nump">131,272<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet', window );">Deferred financing costs</a></td>
<td class="nump">16,450<span></span>
</td>
<td class="nump">13,332<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivableInvestmentSale', window );">Receivable for investments sold</a></td>
<td class="nump">1,295<span></span>
</td>
<td class="nump">49,269<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">10,134,618<span></span>
</td>
<td class="nump">9,908,995<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt (net of unamortized debt issuance costs of $25,953 and $35,289 at December&#160;31, 2023 and December&#160;31, 2022, respectively)</a></td>
<td class="nump">4,911,930<span></span>
</td>
<td class="nump">5,527,715<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayableInvestmentPurchase', window );">Payable for investments purchased</a></td>
<td class="nump">8,566<span></span>
</td>
<td class="nump">20,273<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeePayable', window );">Management fees payable (Note 3)</a></td>
<td class="nump">23,034<span></span>
</td>
<td class="nump">18,595<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncentiveFeePayableIncome', window );">Income based incentive fees payable (Note 3)</a></td>
<td class="nump">34,373<span></span>
</td>
<td class="nump">24,773<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncentiveFeePayableCapitalGains', window );">Capital gains incentive fees payable (Note 3)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,506<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Interest payable</a></td>
<td class="nump">39,880<span></span>
</td>
<td class="nump">45,289<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DistributionPayable', window );">Distribution payable (Note 8)</a></td>
<td class="nump">143,052<span></span>
</td>
<td class="nump">96,218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">12,817<span></span>
</td>
<td class="nump">851<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,182,577<span></span>
</td>
<td class="nump">5,750,029<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>NET ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common shares, $0.001 par value (unlimited shares authorized; 185,782,408 and 160,362,861 shares issued and outstanding at December&#160;31, 2023 and December&#160;31, 2022, respectively)</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">4,701,827<span></span>
</td>
<td class="nump">4,033,113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Distributable earnings (loss)</a></td>
<td class="nump">250,028<span></span>
</td>
<td class="nump">125,693<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total net assets</a></td>
<td class="nump">4,952,041<span></span>
</td>
<td class="nump">4,158,966<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and net assets</a></td>
<td class="nump">$ 10,134,618<span></span>
</td>
<td class="nump">$ 9,908,995<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">NET ASSET VALUE PER SHARE (in usd per share)</a></td>
<td class="nump">$ 26.66<span></span>
</td>
<td class="nump">$ 25.93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to affiliates</a></td>
<td class="nump">$ 8,925<span></span>
</td>
<td class="nump">$ 10,809<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember', window );">Non-controlled/non-affiliated investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investments at fair value</a></td>
<td class="nump">9,862,650<span></span>
</td>
<td class="nump">9,560,664<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendAndInterestReceivable', window );">Interest receivable from non-controlled/non-affiliated investments</a></td>
<td class="nump">93,576<span></span>
</td>
<td class="nump">97,874<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember', window );">Non-controlled/affiliated investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investments at fair value</a></td>
<td class="nump">$ 5,790<span></span>
</td>
<td class="nump">$ 56,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Unless otherwise indicated, all debt and equity investments held by the Company (which such term &#8220;Company&#8221; shall include the Company&#8217;s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December&#160;31, 2022, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in </span><div style="margin-top:2pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><br/><br/><br/><br/><br/>thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company&#8217;s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.</span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncentiveFeePayableCapitalGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incentive Fee Payable, Capital Gains</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncentiveFeePayableCapitalGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncentiveFeePayableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incentive Fee Payable, Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncentiveFeePayableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 835<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479359/835-30-S45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DistributionPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution payable to ownership interest holder from investment income and return of capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(10)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480191/946-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DistributionPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendAndInterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of dividend and interest receivable from investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480833/946-310-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendAndInterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in security owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fee payable for management of fund or trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 54B<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-54B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 59<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-59<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6A<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayableInvestmentPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payable for purchase of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(10)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480191/946-405-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayableInvestmentPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivableInvestmentSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable from sale of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480833/946-310-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivableInvestmentSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171133552640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investments at cost</a></td>
<td class="nump">$ 9,934,159<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,657,872<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Net of unamortized debt issuance costs</a></td>
<td class="nump">$ 25,953<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 35,289<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">185,782,408<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">160,362,861<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">185,782,408<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">160,362,861<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember', window );">Non-controlled/non-affiliated investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investments at cost</a></td>
<td class="nump">$ 9,934,158<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 9,621,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember', window );">Non-controlled/affiliated investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investments at cost</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 36,639<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Unless otherwise indicated, all debt and equity investments held by the Company (which such term &#8220;Company&#8221; shall include the Company&#8217;s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December&#160;31, 2022, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in </span><div style="margin-top:2pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><br/><br/><br/><br/><br/>thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company&#8217;s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.</span></div></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171129129552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Investment income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperatingPaidInCash', window );">Interest income</a></td>
<td class="nump">$ 1,089,044<span></span>
</td>
<td class="nump">$ 796,499<span></span>
</td>
<td class="nump">$ 610,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendIncomeOperating', window );">Dividend income</a></td>
<td class="nump">387<span></span>
</td>
<td class="nump">9,307<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeeIncome', window );">Fee income</a></td>
<td class="nump">7,010<span></span>
</td>
<td class="nump">4,162<span></span>
</td>
<td class="nump">5,785<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossInvestmentIncomeOperating', window );">Total investment income</a></td>
<td class="nump">1,143,517<span></span>
</td>
<td class="nump">850,292<span></span>
</td>
<td class="nump">624,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">266,420<span></span>
</td>
<td class="nump">203,579<span></span>
</td>
<td class="nump">120,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeeExpense', window );">Management fees (Note 3)</a></td>
<td class="nump">98,122<span></span>
</td>
<td class="nump">101,707<span></span>
</td>
<td class="nump">62,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeeExpense', window );">Income based incentive fees (Note 3)</a></td>
<td class="nump">134,230<span></span>
</td>
<td class="nump">97,154<span></span>
</td>
<td class="nump">67,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_CapitalGainsIncentiveFeeExpense', window );">Capital gains incentive fees (Note 3)</a></td>
<td class="num">(5,506)<span></span>
</td>
<td class="num">(11,883)<span></span>
</td>
<td class="nump">16,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">6,077<span></span>
</td>
<td class="nump">4,011<span></span>
</td>
<td class="nump">2,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TrusteeFees', window );">Board of Trustees' fees</a></td>
<td class="nump">907<span></span>
</td>
<td class="nump">853<span></span>
</td>
<td class="nump">571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdministrativeFeesExpense', window );">Administrative service expenses (Note 3)</a></td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">2,672<span></span>
</td>
<td class="nump">2,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Other general and administrative</a></td>
<td class="nump">6,115<span></span>
</td>
<td class="nump">6,343<span></span>
</td>
<td class="nump">4,794<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInvestmentExpense', window );">Total expenses before excise tax</a></td>
<td class="nump">508,615<span></span>
</td>
<td class="nump">404,436<span></span>
</td>
<td class="nump">277,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyContractualFeeWaived', window );">Management fees waived (Note 3)</a></td>
<td class="num">(20,194)<span></span>
</td>
<td class="num">(25,427)<span></span>
</td>
<td class="num">(4,195)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyVoluntaryFeeWaived', window );">Incentive fees waived (Note 3)</a></td>
<td class="num">(15,604)<span></span>
</td>
<td class="num">(13,879)<span></span>
</td>
<td class="num">(2,333)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement', window );">Net expenses before excise tax</a></td>
<td class="nump">472,817<span></span>
</td>
<td class="nump">365,130<span></span>
</td>
<td class="nump">270,586<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income before excise tax</a></td>
<td class="nump">670,700<span></span>
</td>
<td class="nump">485,162<span></span>
</td>
<td class="nump">354,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit', window );">Excise tax expense</a></td>
<td class="nump">16,795<span></span>
</td>
<td class="nump">1,386<span></span>
</td>
<td class="nump">2,438<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax', window );">Net investment income after excise tax</a></td>
<td class="nump">653,905<span></span>
</td>
<td class="nump">483,776<span></span>
</td>
<td class="nump">351,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract', window );"><strong>Net change in unrealized appreciation (depreciation):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss', window );">Net unrealized (appreciation) depreciation on investments</a></td>
<td class="num">(50,841)<span></span>
</td>
<td class="num">(126,493)<span></span>
</td>
<td class="nump">104,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax', window );">Translation of assets and liabilities in foreign currencies</a></td>
<td class="num">(3,732)<span></span>
</td>
<td class="nump">4,344<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax', window );">Net change in unrealized appreciation (depreciation)</a></td>
<td class="num">(54,573)<span></span>
</td>
<td class="num">(122,149)<span></span>
</td>
<td class="nump">104,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_NetRealizedGainsLossesAbstract', window );"><strong>Net realized gain (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss', window );">Non-controlled/non-affiliated investments</a></td>
<td class="num">(6,205)<span></span>
</td>
<td class="nump">37,402<span></span>
</td>
<td class="nump">7,785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax', window );">Foreign currency transactions</a></td>
<td class="nump">18,824<span></span>
</td>
<td class="nump">5,527<span></span>
</td>
<td class="num">(3,217)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax', window );">Net realized gain (loss)</a></td>
<td class="nump">12,619<span></span>
</td>
<td class="nump">42,929<span></span>
</td>
<td class="nump">4,568<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax', window );">Net realized and change in unrealized gain (loss)</a></td>
<td class="num">(41,954)<span></span>
</td>
<td class="num">(79,220)<span></span>
</td>
<td class="nump">108,746<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net increase (decrease) in net assets resulting from operations</a></td>
<td class="nump">$ 611,951<span></span>
</td>
<td class="nump">$ 404,556<span></span>
</td>
<td class="nump">$ 460,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare', window );">Net investment income (in usd per share)</a></td>
<td class="nump">$ 3.90<span></span>
</td>
<td class="nump">$ 2.91<span></span>
</td>
<td class="nump">$ 2.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings (loss), basic, per share (in usd per share)</a></td>
<td class="nump">3.65<span></span>
</td>
<td class="nump">2.44<span></span>
</td>
<td class="nump">3.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings (loss), diluted, per share (in usd per share)</a></td>
<td class="nump">$ 3.65<span></span>
</td>
<td class="nump">$ 2.44<span></span>
</td>
<td class="nump">$ 3.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding basic (in share)</a></td>
<td class="nump">167,615,433<span></span>
</td>
<td class="nump">166,072,919<span></span>
</td>
<td class="nump">144,510,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding diluted (in share)</a></td>
<td class="nump">167,615,433<span></span>
</td>
<td class="nump">166,072,919<span></span>
</td>
<td class="nump">144,510,122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember', window );">Non-controlled/non-affiliated investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Investment income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperatingPaidInKind', window );">Payment-in-kind interest income</a></td>
<td class="nump">$ 47,076<span></span>
</td>
<td class="nump">$ 40,324<span></span>
</td>
<td class="nump">$ 8,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract', window );"><strong>Net change in unrealized appreciation (depreciation):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss', window );">Net unrealized (appreciation) depreciation on investments</a></td>
<td class="num">(36,685)<span></span>
</td>
<td class="num">(143,515)<span></span>
</td>
<td class="nump">101,804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_NetRealizedGainsLossesAbstract', window );"><strong>Net realized gain (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss', window );">Non-controlled/non-affiliated investments</a></td>
<td class="num">(14,488)<span></span>
</td>
<td class="nump">37,402<span></span>
</td>
<td class="nump">7,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember', window );">Non-controlled/affiliated investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract', window );"><strong>Net change in unrealized appreciation (depreciation):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss', window );">Net unrealized (appreciation) depreciation on investments</a></td>
<td class="num">(14,156)<span></span>
</td>
<td class="nump">17,022<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_NetRealizedGainsLossesAbstract', window );"><strong>Net realized gain (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss', window );">Non-controlled/non-affiliated investments</a></td>
<td class="nump">$ 8,283<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_CapitalGainsIncentiveFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Gains Incentive Fee Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_CapitalGainsIncentiveFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncomeBasedIncentiveFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Based Incentive Fee Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncomeBasedIncentiveFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Recognized Unrealized Appreciation (Depreciation), Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_NetRealizedGainsLossesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Realized Gains (Losses)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_NetRealizedGainsLossesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdministrativeFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdministrativeFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column C)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column C)(Footnote 6)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column D)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column D)(Footnote 6)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating dividend income on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480228/946-830-45-39<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FeeIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fee income including, but not limited to, managerial assistance, servicing of investment, and origination and commitment fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FeeIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of realized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480228/946-830-45-38<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480228/946-830-45-38<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossInvestmentIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossInvestmentIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperatingPaidInCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from investment paid in cash, classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperatingPaidInCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperatingPaidInKind">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from investment paid in kind, classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperatingPaidInKind</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyContractualFeeWaived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fee contractually waived by investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyContractualFeeWaived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reimbursement and fee waiver, of expense for generation of investment income classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit amount, after investment expense, of dividend and interest investment income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyVoluntaryFeeWaived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fee voluntarily waived by investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyVoluntaryFeeWaived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInvestmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the generation of investment income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInvestmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after expense and tax, of investment income classified as operating. Excludes realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) on investment income classified as operating. Excludes realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483580/946-220-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 220<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of realized and unrealized gain (loss) on investment and derivative, classified as operating, and foreign currency transaction. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480228/946-830-45-37<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of realized gain (loss) on investment, derivative, and foreign currency transaction on investment and derivative from change in market price, classified as operating. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 37<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480228/946-830-45-37<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TrusteeFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fees charged annually for the professional services of a trustee, usually quoted as a percentage of the funds being managed. The fee for appointing an offshore Trustee is included in the trust price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TrusteeFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of unrealized gain (loss) on investment, derivative, and foreign currency transaction on investment and derivative from change in market price, classified as operating. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 37<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480228/946-830-45-37<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171134443824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Net Assets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetsRollForward', window );"><strong>Investment Company, Net Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 4,158,966<span></span>
</td>
<td class="nump">$ 4,447,479<span></span>
</td>
<td class="nump">$ 3,267,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common shares, net of offering and underwriting costs</a></td>
<td class="nump">665,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">976,101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan', window );">Reinvestment of dividends</a></td>
<td class="nump">20,651<span></span>
</td>
<td class="nump">52,382<span></span>
</td>
<td class="nump">38,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Common shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(263,017)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax', window );">Net investment income</a></td>
<td class="nump">653,905<span></span>
</td>
<td class="nump">483,776<span></span>
</td>
<td class="nump">351,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax', window );">Net realized gain (loss) on investments</a></td>
<td class="nump">12,619<span></span>
</td>
<td class="nump">42,929<span></span>
</td>
<td class="nump">4,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax', window );">Net change in unrealized appreciation (depreciation) on investments</a></td>
<td class="num">(54,573)<span></span>
</td>
<td class="num">(122,149)<span></span>
</td>
<td class="nump">104,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyDividendDistribution', window );">Dividends declared from net investment income</a></td>
<td class="num">(504,787)<span></span>
</td>
<td class="num">(482,434)<span></span>
</td>
<td class="num">(295,792)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Tax reclassification of shareholders' equity in accordance with GAAP</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">4,952,041<span></span>
</td>
<td class="nump">4,158,966<span></span>
</td>
<td class="nump">4,447,479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Par Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetsRollForward', window );"><strong>Investment Company, Net Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common shares, net of offering and underwriting costs</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan', window );">Reinvestment of dividends</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Common shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetsRollForward', window );"><strong>Investment Company, Net Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">4,033,113<span></span>
</td>
<td class="nump">4,245,125<span></span>
</td>
<td class="nump">3,232,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common shares, net of offering and underwriting costs</a></td>
<td class="nump">665,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">976,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan', window );">Reinvestment of dividends</a></td>
<td class="nump">20,650<span></span>
</td>
<td class="nump">52,380<span></span>
</td>
<td class="nump">38,938<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Common shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(263,006)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Tax reclassification of shareholders' equity in accordance with GAAP</a></td>
<td class="num">(17,171)<span></span>
</td>
<td class="num">(1,386)<span></span>
</td>
<td class="num">(2,438)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">4,701,827<span></span>
</td>
<td class="nump">4,033,113<span></span>
</td>
<td class="nump">4,245,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Distributable Earnings (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetsRollForward', window );"><strong>Investment Company, Net Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">125,693<span></span>
</td>
<td class="nump">202,185<span></span>
</td>
<td class="nump">35,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax', window );">Net investment income</a></td>
<td class="nump">653,905<span></span>
</td>
<td class="nump">483,776<span></span>
</td>
<td class="nump">351,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax', window );">Net realized gain (loss) on investments</a></td>
<td class="nump">12,619<span></span>
</td>
<td class="nump">42,929<span></span>
</td>
<td class="nump">4,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax', window );">Net change in unrealized appreciation (depreciation) on investments</a></td>
<td class="num">(54,573)<span></span>
</td>
<td class="num">(122,149)<span></span>
</td>
<td class="nump">104,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyDividendDistribution', window );">Dividends declared from net investment income</a></td>
<td class="num">(504,787)<span></span>
</td>
<td class="num">(482,434)<span></span>
</td>
<td class="num">(295,792)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Tax reclassification of shareholders' equity in accordance with GAAP</a></td>
<td class="nump">17,171<span></span>
</td>
<td class="nump">1,386<span></span>
</td>
<td class="nump">2,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 250,028<span></span>
</td>
<td class="nump">$ 125,693<span></span>
</td>
<td class="nump">$ 202,185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyDividendDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of dividend distribution from ordinary income and capital gain. Excludes distribution for tax return of capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyDividendDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyNetAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyNetAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after expense and tax, of investment income classified as operating. Excludes realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of realized gain (loss) on investment, derivative, and foreign currency transaction on investment and derivative from change in market price, classified as operating. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 37<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480228/946-830-45-37<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the holder of the stock to reinvest dividends paid to them by the entity on new issues of stock by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480348/946-230-55-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of unrealized gain (loss) on investment, derivative, and foreign currency transaction on investment and derivative from change in market price, classified as operating. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 37<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480228/946-830-45-37<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171130049360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net increase (decrease) in net assets resulting from operations</a></td>
<td class="nump">$ 611,951<span></span>
</td>
<td class="nump">$ 404,556<span></span>
</td>
<td class="nump">$ 460,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss', window );">Net change in unrealized (appreciation) depreciation on investments</a></td>
<td class="nump">50,841<span></span>
</td>
<td class="nump">126,493<span></span>
</td>
<td class="num">(104,727)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies</a></td>
<td class="nump">3,732<span></span>
</td>
<td class="num">(4,344)<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss', window );">Net realized (gain) loss on investments</a></td>
<td class="nump">6,205<span></span>
</td>
<td class="num">(37,402)<span></span>
</td>
<td class="num">(7,785)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Net accretion of discount and amortization of premium</a></td>
<td class="num">(52,865)<span></span>
</td>
<td class="num">(47,429)<span></span>
</td>
<td class="num">(62,799)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_PaidInKindInterestNoncash', window );">Payment-in-kind interest capitalized</a></td>
<td class="num">(51,558)<span></span>
</td>
<td class="num">(40,324)<span></span>
</td>
<td class="num">(9,152)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements', window );">Amortization of deferred financing costs</a></td>
<td class="nump">5,471<span></span>
</td>
<td class="nump">4,008<span></span>
</td>
<td class="nump">2,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of original issue discount and debt issuance costs</a></td>
<td class="nump">9,336<span></span>
</td>
<td class="nump">10,405<span></span>
</td>
<td class="nump">7,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity', window );">Purchases of investments</a></td>
<td class="num">(1,483,303)<span></span>
</td>
<td class="num">(961,768)<span></span>
</td>
<td class="num">(6,824,327)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity', window );">Proceeds from sale of investments and principal repayments</a></td>
<td class="nump">1,305,234<span></span>
</td>
<td class="nump">1,174,176<span></span>
</td>
<td class="nump">2,734,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable', window );">Interest receivable</a></td>
<td class="nump">4,298<span></span>
</td>
<td class="num">(35,215)<span></span>
</td>
<td class="num">(41,203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold', window );">Receivable for investments</a></td>
<td class="nump">47,974<span></span>
</td>
<td class="nump">93,609<span></span>
</td>
<td class="num">(28,341)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased', window );">Payable for investments purchased</a></td>
<td class="num">(11,707)<span></span>
</td>
<td class="num">(15,944)<span></span>
</td>
<td class="num">(12,365)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToAffiliates', window );">Due to affiliates</a></td>
<td class="num">(1,884)<span></span>
</td>
<td class="nump">4,168<span></span>
</td>
<td class="nump">1,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInManagementFeePayable', window );">Management fee payable</a></td>
<td class="nump">4,439<span></span>
</td>
<td class="nump">783<span></span>
</td>
<td class="nump">7,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable', window );">Income based incentive fee payable</a></td>
<td class="nump">9,600<span></span>
</td>
<td class="nump">4,964<span></span>
</td>
<td class="nump">4,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable', window );">Capital gains incentive fee payable</a></td>
<td class="num">(5,506)<span></span>
</td>
<td class="num">(11,883)<span></span>
</td>
<td class="nump">16,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Interest payable</a></td>
<td class="num">(5,409)<span></span>
</td>
<td class="nump">6,145<span></span>
</td>
<td class="nump">24,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">11,966<span></span>
</td>
<td class="num">(2,244)<span></span>
</td>
<td class="nump">2,529<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">458,815<span></span>
</td>
<td class="nump">672,948<span></span>
</td>
<td class="num">(3,828,514)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Borrowings on debt</a></td>
<td class="nump">1,440,343<span></span>
</td>
<td class="nump">920,827<span></span>
</td>
<td class="nump">5,778,952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments on debt</a></td>
<td class="num">(2,091,209)<span></span>
</td>
<td class="num">(877,152)<span></span>
</td>
<td class="num">(2,780,121)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements', window );">Deferred financing costs paid</a></td>
<td class="num">(8,589)<span></span>
</td>
<td class="num">(3,789)<span></span>
</td>
<td class="num">(9,359)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,398)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Deferred offering costs paid on issuance of common shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,607)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid in cash</a></td>
<td class="num">(437,966)<span></span>
</td>
<td class="num">(423,441)<span></span>
</td>
<td class="num">(253,776)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common shares, net of offering and underwriting costs</a></td>
<td class="nump">665,260<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">981,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Redemptions paid in cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(263,017)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(432,161)<span></span>
</td>
<td class="num">(648,179)<span></span>
</td>
<td class="nump">3,713,400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">26,654<span></span>
</td>
<td class="nump">24,769<span></span>
</td>
<td class="num">(115,114)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of foreign exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(3,069)<span></span>
</td>
<td class="nump">3,624<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">131,272<span></span>
</td>
<td class="nump">102,879<span></span>
</td>
<td class="nump">217,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">154,857<span></span>
</td>
<td class="nump">131,272<span></span>
</td>
<td class="nump">102,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental information and non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid during the period</a></td>
<td class="nump">256,478<span></span>
</td>
<td class="nump">182,152<span></span>
</td>
<td class="nump">94,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_DistributionCostsIncurredButNotYetPaid', window );">Distribution payable</a></td>
<td class="nump">143,052<span></span>
</td>
<td class="nump">96,218<span></span>
</td>
<td class="nump">89,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Reinvestment of distributions during the period</a></td>
<td class="nump">20,651<span></span>
</td>
<td class="nump">52,382<span></span>
</td>
<td class="nump">38,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Non-cash deferred financing costs activity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Non-cash debt issuance costs activity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_DebtIssuanceCostsIncurredButNotYetPaid', window );">Accrued but unpaid debt issuing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_ExciseTaxesPaid', window );">Excise taxes paid</a></td>
<td class="nump">$ 5,245<span></span>
</td>
<td class="nump">$ 4,106<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Debt Issuance Costs, Line Of Credit Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_DebtIssuanceCostsIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Issuance Costs Incurred But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_DebtIssuanceCostsIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Issuance Costs, Line Of Credit Arrangements, Incurred During Noncash Or Partial Noncash Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_DistributionCostsIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Distribution Costs Incurred But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_DistributionCostsIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_ExciseTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Excise Taxes Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_ExciseTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Capital Gains Incentive Fee Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Income Based Incentive Fee Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_PaidInKindInterestNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Paid In Kind Interest, Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_PaidInKindInterestNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments Of Debt Issuance Costs, Line Of Credit Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column C)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column C)(Footnote 6)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column D)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column D)(Footnote 6)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in obligations owed to an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount due to the entity in the form of unpaid interest and dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInManagementFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in fee payable for management of fund or trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480369/946-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInManagementFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in payable for purchase of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480369/946-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivableForInvestmentSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivable from sale of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480369/946-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivableForInvestmentSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for acquisition of investment, classified as operating activity. Includes, but is not limited to, funding, origination, drawdown, and participation in investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480369/946-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment, classified as operating activity. Includes, but is not limited to, repayment, principal payment, paydown, and maturity of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480369/946-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<HTML>
<HEAD><TITLE>NOPE</TITLE></HEAD>
<BODY>NOT TODAY FRIEND</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140170883370016">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Schedule of Investments (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">199.30%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">231.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 690,256<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3,057)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate', window );">Percentage of portfolio above floor rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">93.70%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">93.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,617,248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,868,440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,617,248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember', window );">Non-controlled/non-affiliated investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">199.19%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">229.90%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 985,936<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,560,664<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,862,650<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,560,664<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember', window );">Non-controlled/affiliated investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.36%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 56,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 56,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember', window );">Non-controlled/affiliated investments | Blackstone Donegal Holdings LP</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">56,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">35,683<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions', window );">Gross Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,879<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions', window );">Gross Reductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(44,921)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease', window );">Change in Unrealized Gains (Losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14,156)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,022<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax', window );">Net Realized Gain (Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,283<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">56,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeSecurities', window );">Dividend and Interest Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerMember', window );">Investment, Affiliated Issuer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">56,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">35,683<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions', window );">Gross Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,879<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions', window );">Gross Reductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(44,921)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease', window );">Change in Unrealized Gains (Losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14,156)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,022<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax', window );">Net Realized Gain (Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,283<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">56,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeSecurities', window );">Dividend and Interest Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=bxsl_QualifyingAssetsMember', window );">Qualifying Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=bxsl_NonQualifyingAssetsMember', window );">Non-qualifying Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Low | Qualifying Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">70.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=123Dentist, Inc.', window );">Investment, Identifier [Axis]: 123Dentist, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[7]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
<td class="nump">$ 1,220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 1,220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=123Dentist, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: 123Dentist, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">276<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">270<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(68)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (18)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc.', window );">Investment, Identifier [Axis]: ACI Group Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.48%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 103,013<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 103,013<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc. 1', window );">Investment, Identifier [Axis]: ACI Group Holdings, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">2.31%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 114,347<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc. 2', window );">Investment, Identifier [Axis]: ACI Group Holdings, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 1,619<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: ACI Group Holdings, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,182<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,295<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc., Revolver', window );">Investment, Identifier [Axis]: ACI Group Holdings, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,832<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,295<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC', window );">Investment, Identifier [Axis]: ADCS Clinics Intermediate Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 8,419<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,419<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC 1', window );">Investment, Identifier [Axis]: ADCS Clinics Intermediate Holdings, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.14%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 6,849<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC 2', window );">Investment, Identifier [Axis]: ADCS Clinics Intermediate Holdings, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">$ 1,615<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: ADCS Clinics Intermediate Holdings, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">468<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC, Revolver', window );">Investment, Identifier [Axis]: ADCS Clinics Intermediate Holdings, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,301<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,301<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (26)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (26)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=AGI Group Holdings LP - A2 Units', window );">Investment, Identifier [Axis]: AGI Group Holdings LP - A2 Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 724<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">507<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 724<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=AGI-CFI Holdings, Inc.', window );">Investment, Identifier [Axis]: AGI-CFI Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.29%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 95,431<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 95,431<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=AGI-CFI Holdings, Inc. 1', window );">Investment, Identifier [Axis]: AGI-CFI Holdings, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">1.50%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 74,470<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=AGI-CFI Holdings, Inc. 2', window );">Investment, Identifier [Axis]: AGI-CFI Holdings, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.36%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 17,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=AI Altius Bidco, Inc. 1', window );">Investment, Identifier [Axis]: AI Altius Bidco, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[15]</sup></td>
<td class="nump">0.13%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 960<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[15]</sup></td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=AI Altius Bidco, Inc. 2', window );">Investment, Identifier [Axis]: AI Altius Bidco, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.13%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[16]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[16]</sup></td>
<td class="nump">$ 808<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,612<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 808<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=AI Altius Bidco, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: AI Altius Bidco, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">158<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,446<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ALKU, LLC', window );">Investment, Identifier [Axis]: ALKU, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 796<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ALKU, LLC 1', window );">Investment, Identifier [Axis]: ALKU, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.80%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">74,904<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 74,904<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ALKU, LLC 2', window );">Investment, Identifier [Axis]: ALKU, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.92%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 38,118<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 38,118<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ASP Endeavor Acquisition, LLC', window );">Investment, Identifier [Axis]: ASP Endeavor Acquisition, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[17]</sup></td>
<td class="nump">0.31%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[18]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[18]</sup></td>
<td class="nump">$ 13,042<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 12,467<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[17]</sup></td>
<td class="nump">$ 13,042<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[18]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=AVE Holdings I Corp.', window );">Investment, Identifier [Axis]: AVE Holdings I Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 638<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 596<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 638<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Abaco Energy Technologies, LLC', window );">Investment, Identifier [Axis]: Abaco Energy Technologies, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.35%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[19]</sup></td>
<td class="nump">0.88%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[20]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[20]</sup></td>
<td class="nump">$ 36,437<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[19]</sup></td>
<td class="nump">$ 36,437<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[20]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Albireo Energy, LLC', window );">Investment, Identifier [Axis]: Albireo Energy, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.45%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="nump">$ 101,953<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 101,953<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Albireo Energy, LLC 1', window );">Investment, Identifier [Axis]: Albireo Energy, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[14]</sup></td>
<td class="nump">1.43%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[14]</sup></td>
<td class="nump">$ 70,722<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Albireo Energy, LLC 2', window );">Investment, Identifier [Axis]: Albireo Energy, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[14]</sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[14]</sup></td>
<td class="nump">$ 5,726<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Albireo Energy, LLC 3', window );">Investment, Identifier [Axis]: Albireo Energy, LLC 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[14]</sup></td>
<td class="nump">0.43%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[14]</sup></td>
<td class="nump">$ 21,227<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Alera Group, Inc.', window );">Investment, Identifier [Axis]: Alera Group, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.07%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.09%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 3,629<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,659<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 3,629<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Alera Group, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Alera Group, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,291<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings LLC', window );">Investment, Identifier [Axis]: Amerilife Holdings LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 2,145<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings LLC, Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: Amerilife Holdings LLC, Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings LLC, Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: Amerilife Holdings LLC, Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">488<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings LLC, Revolver', window );">Investment, Identifier [Axis]: Amerilife Holdings LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">243<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings, LLC', window );">Investment, Identifier [Axis]: Amerilife Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">2,076<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,076<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Amerilife Holdings, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings, LLC, Revolver', window );">Investment, Identifier [Axis]: Amerilife Holdings, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">243<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc.', window );">Investment, Identifier [Axis]: Amerivet Partners Management, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.13%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc. 1', window );">Investment, Identifier [Axis]: Amerivet Partners Management, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 1,341<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc. 2', window );">Investment, Identifier [Axis]: Amerivet Partners Management, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.09%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 4,259<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Amerivet Partners Management, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,605<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc., Revolver', window );">Investment, Identifier [Axis]: Amerivet Partners Management, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Anaplan, Inc.', window );">Investment, Identifier [Axis]: Anaplan, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
<td class="nump">$ 1,747<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,794<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 1,747<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Anaplan, Inc., Revolver', window );">Investment, Identifier [Axis]: Anaplan, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">161<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">179<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (21)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Apex Companies, LLC', window );">Investment, Identifier [Axis]: Apex Companies, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Apex Companies, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Apex Companies, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">369<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Armada Parent, Inc.', window );">Investment, Identifier [Axis]: Armada Parent, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.61%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 25,209<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 25,209<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Armada Parent, Inc. ', window );">Investment, Identifier [Axis]: Armada Parent, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.51%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 25,435<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Armada Parent, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Armada Parent, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Armada Parent, Inc., Revolver', window );">Investment, Identifier [Axis]: Armada Parent, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (30)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (83)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Ascend Buyer, LLC 1', window );">Investment, Identifier [Axis]: Ascend Buyer, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.37%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">0.45%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 18,678<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 18,415<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">$ 18,678<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Ascend Buyer, LLC 2', window );">Investment, Identifier [Axis]: Ascend Buyer, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 1,975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,945<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">$ 1,975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Ascend Buyer, LLC 3', window );">Investment, Identifier [Axis]: Ascend Buyer, LLC 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">$ 624<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Ascend Buyer, LLC, Revolver', window );">Investment, Identifier [Axis]: Ascend Buyer, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,293<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,940<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (19)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=AxiomSL Group, Inc.', window );">Investment, Identifier [Axis]: AxiomSL Group, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 41,635<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 41,635<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=AxiomSL Group, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: AxiomSL Group, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,949<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(29)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=AxiomSL Group, Inc., Revolver', window );">Investment, Identifier [Axis]: AxiomSL Group, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BP Purchaser, LLC', window );">Investment, Identifier [Axis]: BP Purchaser, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.14%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">0.17%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 7,094<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,968<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">$ 7,094<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BPPH2 Limited', window );">Investment, Identifier [Axis]: BPPH2 Limited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.67%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[15]</sup></td>
<td class="nump">0.76%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
<td class="nump">$ 31,794<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 33,272<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[15]</sup></td>
<td class="nump">$ 31,794<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Bamboo US BidCo LLC 1', window );">Investment, Identifier [Axis]: Bamboo US BidCo LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[14]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[14]</sup></td>
<td class="nump">$ 667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Bamboo US BidCo LLC 2', window );">Investment, Identifier [Axis]: Bamboo US BidCo LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[14]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[14]</sup></td>
<td class="nump">$ 373<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Bamboo US BidCo LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Bamboo US BidCo LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">99<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Bamboo US BidCo LLC, Revolver', window );">Investment, Identifier [Axis]: Bamboo US BidCo LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">142<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Barbri Holdings, Inc.', window );">Investment, Identifier [Axis]: Barbri Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.53%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 63,820<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 63,820<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Barbri Holdings, Inc. 1', window );">Investment, Identifier [Axis]: Barbri Holdings, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">1.17%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">$ 58,055<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Bazaarvoice, Inc.', window );">Investment, Identifier [Axis]: Bazaarvoice, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5.49%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[16]</sup></td>
<td class="nump">$ 228,477<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 228,477<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Bazaarvoice, Inc. 1', window );">Investment, Identifier [Axis]: Bazaarvoice, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[15]</sup></td>
<td class="nump">4.57%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[15]</sup></td>
<td class="nump">$ 226,169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Bazaarvoice, Inc. 2', window );">Investment, Identifier [Axis]: Bazaarvoice, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[15]</sup></td>
<td class="nump">0.31%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[15]</sup></td>
<td class="nump">$ 15,244<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Bazaarvoice, Inc., Revolver', window );">Investment, Identifier [Axis]: Bazaarvoice, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,662<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">28,662<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Beeline, LLC 1', window );">Investment, Identifier [Axis]: Beeline, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 4,939<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Beeline, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Beeline, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">514<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Beeline, LLC, Revolver', window );">Investment, Identifier [Axis]: Beeline, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">591<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Benefytt Technologies, Inc.', window );">Investment, Identifier [Axis]: Benefytt Technologies, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.26%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">10,896<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 10,896<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Benefytt Technologies, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Benefytt Technologies, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">397<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD)', window );">Investment, Identifier [Axis]: Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.36%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 56,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 56,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD) ', window );">Investment, Identifier [Axis]: Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5],[21]</sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5],[21]</sup></td>
<td class="nump">$ 5,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc.', window );">Investment, Identifier [Axis]: BlueCat Networks USA, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
<td class="nump">$ 1,913<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,913<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc. 1', window );">Investment, Identifier [Axis]: BlueCat Networks USA, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 1,913<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc. 2', window );">Investment, Identifier [Axis]: BlueCat Networks USA, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc. 3', window );">Investment, Identifier [Axis]: BlueCat Networks USA, Inc. 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 61<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: BlueCat Networks USA, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">277<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc., Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: BlueCat Networks USA, Inc., Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">309<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc., Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: BlueCat Networks USA, Inc., Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">341<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Bluefin Holding, LLC', window );">Investment, Identifier [Axis]: Bluefin Holding, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[14]</sup></td>
<td class="nump">0.45%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[14]</sup></td>
<td class="nump">$ 22,381<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Bluefin Holding, LLC, Revolver', window );">Investment, Identifier [Axis]: Bluefin Holding, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,244<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(34)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Box Co-Invest Blocker, LLC', window );">Investment, Identifier [Axis]: Box Co-Invest Blocker, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 625<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 625<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Box Co-Invest Blocker, LLC - Class A Units', window );">Investment, Identifier [Axis]: Box Co-Invest Blocker, LLC - Class A Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 358<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Box Co-Invest Blocker, LLC - Class C Units', window );">Investment, Identifier [Axis]: Box Co-Invest Blocker, LLC - Class C Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 92<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BradyIFS Holdings, LLC 1', window );">Investment, Identifier [Axis]: BradyIFS Holdings, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">1.81%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">$ 89,599<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BradyIFS Holdings, LLC 2', window );">Investment, Identifier [Axis]: BradyIFS Holdings, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">$ 2,372<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BradyIFS Holdings, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: BradyIFS Holdings, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,613<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=BradyIFS Holdings, LLC, Revolver', window );">Investment, Identifier [Axis]: BradyIFS Holdings, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,758<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (155)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Brave Parent Holdings, Inc.', window );">Investment, Identifier [Axis]: Brave Parent Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">1.28%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">$ 63,346<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Brave Parent Holdings, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Brave Parent Holdings, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,282<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(55)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Brave Parent Holdings, Inc., Revolver', window );">Investment, Identifier [Axis]: Brave Parent Holdings, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,641<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (36)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Bution Holdco 2, Inc.', window );">Investment, Identifier [Axis]: Bution Holdco 2, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.42%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">1.75%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 72,809<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 70,143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">$ 72,809<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CCBlue Bidco, Inc.', window );">Investment, Identifier [Axis]: CCBlue Bidco, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.18%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.24%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 9,853<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,046<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 9,853<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CCBlue Bidco, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: CCBlue Bidco, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,408<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CFCo LLC (Benefytt Technologies, Inc.)', window );">Investment, Identifier [Axis]: CFCo LLC (Benefytt Technologies, Inc.)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[15],[22],[23]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[15],[22],[23]</sup></td>
<td class="nump">$ 68<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CFCo LLC (Benefytt Technologies, Inc.) - Class B Units', window );">Investment, Identifier [Axis]: CFCo LLC (Benefytt Technologies, Inc.) - Class B Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CFGI Holdings, LLC', window );">Investment, Identifier [Axis]: CFGI Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.14%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.18%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 7,565<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,942<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 7,565<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CFGI Holdings, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: CFGI Holdings, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CFGI Holdings, LLC, Revolver', window );">Investment, Identifier [Axis]: CFGI Holdings, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,050<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,050<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (21)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (21)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CFS Brands, LLC', window );">Investment, Identifier [Axis]: CFS Brands, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[14]</sup></td>
<td class="nump">2.34%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[14]</sup></td>
<td class="nump">$ 115,897<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CFS Brands, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: CFS Brands, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,118<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CFS Brands, LLC, Revolver', window );">Investment, Identifier [Axis]: CFS Brands, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (364)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=COP Home Services TopCo IV, Inc.', window );">Investment, Identifier [Axis]: COP Home Services TopCo IV, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.76%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[14]</sup></td>
<td class="nump">0.51%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 21,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">37,541<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[14]</sup></td>
<td class="nump">$ 21,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=COP Home Services TopCo IV, Inc. 2', window );">Investment, Identifier [Axis]: COP Home Services TopCo IV, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.17%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="nump">7,178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 7,178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=COP Home Services TopCo IV, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: COP Home Services TopCo IV, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,730<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(131)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=COP Home Services TopCo IV, Inc., Revolver', window );">Investment, Identifier [Axis]: COP Home Services TopCo IV, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,509<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,941<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(38)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (21)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CPI Buyer, LLC', window );">Investment, Identifier [Axis]: CPI Buyer, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.70%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 29,089<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 29,089<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CPI Buyer, LLC 1', window );">Investment, Identifier [Axis]: CPI Buyer, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.61%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 30,063<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CPI Buyer, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: CPI Buyer, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,778<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CPI Buyer, LLC, Revolver', window );">Investment, Identifier [Axis]: CPI Buyer, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (64)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (64)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CPI Intermediate Holdings Inc', window );">Investment, Identifier [Axis]: CPI Intermediate Holdings Inc</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.08%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[7]</sup></td>
<td class="nump">0.09%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 3,943<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,924<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[7]</sup></td>
<td class="nump">$ 3,943<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CPI Intermediate Holdings Inc, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: CPI Intermediate Holdings Inc, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">966<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">966<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Caerus Midco 2 S.&#192;. R.L - Additional Vehicle Units', window );">Investment, Identifier [Axis]: Caerus Midco 2 S.&#192;. R.L - Additional Vehicle Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11]</sup></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Caerus Midco 2 S.&#192;. R.L - Vehicle Units', window );">Investment, Identifier [Axis]: Caerus Midco 2 S.&#192;. R.L - Vehicle Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11]</sup></td>
<td class="nump">$ 53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 54<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="nump">$ 53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc. 1', window );">Investment, Identifier [Axis]: Caerus US 1, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[6],[7]</sup></td>
<td class="nump">0.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
<td class="nump">$ 10,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,788<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[6],[7]</sup></td>
<td class="nump">$ 10,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc. 2', window );">Investment, Identifier [Axis]: Caerus US 1, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.06%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
<td class="nump">$ 2,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,163<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 2,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc. 3', window );">Investment, Identifier [Axis]: Caerus US 1, Inc. 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 791<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: Caerus US 1, Inc., Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">836<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,506<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(15)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: Caerus US 1, Inc., Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">320<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Revolver', window );">Investment, Identifier [Axis]: Caerus US 1, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">322<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Revolver 1', window );">Investment, Identifier [Axis]: Caerus US 1, Inc., Revolver 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">732<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Revolver 2', window );">Investment, Identifier [Axis]: Caerus US 1, Inc., Revolver 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Cambium Holdings, LLC - Senior Preferred Interests', window );">Investment, Identifier [Axis]: Cambium Holdings, LLC - Senior Preferred Interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.32%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.36%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 15,135<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 15,955<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 15,135<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Cambium Learning Group, Inc.', window );">Investment, Identifier [Axis]: Cambium Learning Group, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5.84%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">7.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 292,101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">289,143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">$ 292,101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Cambium Learning Group, Inc., Revolver', window );">Investment, Identifier [Axis]: Cambium Learning Group, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">43,592<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">43,592<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd.', window );">Investment, Identifier [Axis]: Canadian Hospital Specialties Ltd.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.55%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[12],[13]</sup></td>
<td class="nump">$ 22,786<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 22,786<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd. 1', window );">Investment, Identifier [Axis]: Canadian Hospital Specialties Ltd. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[14]</sup></td>
<td class="nump">0.51%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[14]</sup></td>
<td class="nump">$ 25,356<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd. 2', window );">Investment, Identifier [Axis]: Canadian Hospital Specialties Ltd. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[7]</sup></td>
<td class="nump">0.17%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
<td class="nump">$ 7,171<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,683<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 7,171<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd. 4', window );">Investment, Identifier [Axis]: Canadian Hospital Specialties Ltd. 4</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">0.14%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 7,075<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Canadian Hospital Specialties Ltd., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,647<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd., Revolver', window );">Investment, Identifier [Axis]: Canadian Hospital Specialties Ltd., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,376<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Capstone Logistics, LLC', window );">Investment, Identifier [Axis]: Capstone Logistics, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.13%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 5,350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,501<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 5,350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Castle Management Borrower, LLC', window );">Investment, Identifier [Axis]: Castle Management Borrower, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">0.46%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">$ 22,940<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Castle Management Borrower, LLC, Revolver', window );">Investment, Identifier [Axis]: Castle Management Borrower, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,917<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (44)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Circana Group, L.P. 1', window );">Investment, Identifier [Axis]: Circana Group, L.P. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">2.43%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 120,332<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Circana Group, L.P. 2', window );">Investment, Identifier [Axis]: Circana Group, L.P. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">1.56%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 77,153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Circana Group, L.P. 3', window );">Investment, Identifier [Axis]: Circana Group, L.P. 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 2,484<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Circana Group, L.P., Revolver', window );">Investment, Identifier [Axis]: Circana Group, L.P., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,316<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Clearview Buyer, Inc.', window );">Investment, Identifier [Axis]: Clearview Buyer, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.18%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.22%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 9,001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,909<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 9,001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Clearview Buyer, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Clearview Buyer, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,668<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,668<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Clearview Buyer, Inc., Revolver', window );">Investment, Identifier [Axis]: Clearview Buyer, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">898<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">898<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (18)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (18)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Color Intermediate LLC', window );">Investment, Identifier [Axis]: Color Intermediate LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.41%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.48%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 19,906<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 20,160<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 19,906<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Community Brands ParentCo, LLC', window );">Investment, Identifier [Axis]: Community Brands ParentCo, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 4,850<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,893<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 4,850<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Community Brands ParentCo, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Community Brands ParentCo, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">588<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">588<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Community Brands ParentCo, LLC, Revolver', window );">Investment, Identifier [Axis]: Community Brands ParentCo, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">345<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">345<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Confine Visual Bidco', window );">Investment, Identifier [Axis]: Confine Visual Bidco</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.28%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">0.36%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
<td class="nump">$ 15,092<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,936<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 15,092<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Confine Visual Bidco, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Confine Visual Bidco, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,043<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,046<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Connatix Buyer, Inc.', window );">Investment, Identifier [Axis]: Connatix Buyer, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.39%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.51%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 21,220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,362<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 21,220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Connatix Buyer, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Connatix Buyer, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(109)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Connatix Buyer, Inc., Revolver', window );">Investment, Identifier [Axis]: Connatix Buyer, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,431<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,431<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (448)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (109)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Connatix Parent, LLC - Class L Common Units', window );">Investment, Identifier [Axis]: Connatix Parent, LLC - Class L Common Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 256<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 117<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 256<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Corfin Holdings, Inc. 1', window );">Investment, Identifier [Axis]: Corfin Holdings, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.88%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">4.70%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 195,405<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 192,311<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 195,405<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Corfin Holdings, Inc. 2', window );">Investment, Identifier [Axis]: Corfin Holdings, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.34%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">1.63%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 67,874<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 66,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 67,874<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Coupa Software Inc.', window );">Investment, Identifier [Axis]: Coupa Software Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[7]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 1,819<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Coupa Software Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Coupa Software Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Coupa Software Inc., Revolver', window );">Investment, Identifier [Axis]: Coupa Software Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Crewline Buyer, Inc.', window );">Investment, Identifier [Axis]: Crewline Buyer, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[14]</sup></td>
<td class="nump">1.18%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[14]</sup></td>
<td class="nump">$ 58,282<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Crewline Buyer, Inc., Revolver', window );">Investment, Identifier [Axis]: Crewline Buyer, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,438<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(156)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Cross Country Healthcare, Inc.', window );">Investment, Identifier [Axis]: Cross Country Healthcare, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.16%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 6,582<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 6,582<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Cumming Group, Inc. 1', window );">Investment, Identifier [Axis]: Cumming Group, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.59%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">1.71%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 71,088<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 78,670<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">$ 71,088<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Cumming Group, Inc. 2', window );">Investment, Identifier [Axis]: Cumming Group, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.19%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 970<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,448<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">$ 970<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Cumming Group, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Cumming Group, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,063<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,896<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(60)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(79)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Cumming Group, Inc., Revolver', window );">Investment, Identifier [Axis]: Cumming Group, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,695<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (190)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CustomInk, LLC', window );">Investment, Identifier [Axis]: CustomInk, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.30%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14],[23]</sup></td>
<td class="nump">3.93%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 163,594<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 163,594<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14],[23]</sup></td>
<td class="nump">$ 163,594<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=CustomInk, LLC - Series A Preferred Units', window );">Investment, Identifier [Axis]: CustomInk, LLC - Series A Preferred Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.14%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.16%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 6,521<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,171<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 6,521<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC', window );">Investment, Identifier [Axis]: DCA Investment Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.79%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 32,749<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 32,749<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC 1', window );">Investment, Identifier [Axis]: DCA Investment Holdings, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.66%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 32,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC 2', window );">Investment, Identifier [Axis]: DCA Investment Holdings, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 990<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC, Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: DCA Investment Holdings, LLC, Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC, Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: DCA Investment Holdings, LLC, Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (15)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Dana Kepner Company, LLC', window );">Investment, Identifier [Axis]: Dana Kepner Company, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">$ 49,700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Dana Kepner Company, LLC 1', window );">Investment, Identifier [Axis]: Dana Kepner Company, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.51%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">62,975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 62,975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Dana Kepner Company, LLC 2', window );">Investment, Identifier [Axis]: Dana Kepner Company, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 1,985<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,985<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Daylight Beta Parent LLC (Benefytt Technologies, Inc.)', window );">Investment, Identifier [Axis]: Daylight Beta Parent LLC (Benefytt Technologies, Inc.)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[15]</sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[15]</sup></td>
<td class="nump">$ 5,419<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Denali Bidco Ltd 1', window );">Investment, Identifier [Axis]: Denali Bidco Ltd 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[7]</sup></td>
<td class="nump">0.06%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 2,783<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Denali Bidco Ltd 2', window );">Investment, Identifier [Axis]: Denali Bidco Ltd 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 1,268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Denali Bidco Ltd, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Denali Bidco Ltd, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,761<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Deneb Ultimate Topco, LLC - Class A Units', window );">Investment, Identifier [Axis]: Deneb Ultimate Topco, LLC - Class A Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 168<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 168<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Descartes Holdings, Inc', window );">Investment, Identifier [Axis]: Descartes Holdings, Inc</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 102<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Diligent Corporation', window );">Investment, Identifier [Axis]: Diligent Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.18%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">1.38%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 57,182<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">58,350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 57,182<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc.', window );">Investment, Identifier [Axis]: Discovery Education, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.61%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 25,565<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 25,565<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc. 1', window );">Investment, Identifier [Axis]: Discovery Education, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.07%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 3,575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc. 2', window );">Investment, Identifier [Axis]: Discovery Education, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.64%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 31,648<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Discovery Education, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,773<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc., Revolver', window );">Investment, Identifier [Axis]: Discovery Education, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,960<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,960<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (118)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (104)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Doc Generici (Diocle S.p.A.)', window );">Investment, Identifier [Axis]: Doc Generici (Diocle S.p.A.)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[15]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[16]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[16]</sup></td>
<td class="nump">$ 1,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,349<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 1,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Doc Generici (Diocle S.p.A.), Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Doc Generici (Diocle S.p.A.), Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,682<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,195<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (591)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (141)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Donuts, Inc.', window );">Investment, Identifier [Axis]: Donuts, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6.45%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">7.68%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 319,245<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">319,179<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 319,245<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Dreambox Learning Holding LLC', window );">Investment, Identifier [Axis]: Dreambox Learning Holding LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.16%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
<td class="nump">$ 6,661<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 6,661<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=EIS Acquisition Holdings, LP - Class A Common Units', window );">Investment, Identifier [Axis]: EIS Acquisition Holdings, LP - Class A Common Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.27%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.32%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 13,282<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 13,455<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 13,282<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ENV BIDCO AB, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: ENV BIDCO AB, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">260<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ENV Bidco AB 1', window );">Investment, Identifier [Axis]: ENV Bidco AB 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[6],[7]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
<td class="nump">$ 981<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[6],[7]</sup></td>
<td class="nump">$ 981<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ENV Bidco AB 2', window );">Investment, Identifier [Axis]: ENV Bidco AB 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[15]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[16]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[16]</sup></td>
<td class="nump">$ 1,179<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,079<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 1,179<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ENV Bidco AB, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: ENV Bidco AB, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">433<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (153)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Eagle Midstream Canada Finance, Inc.', window );">Investment, Identifier [Axis]: Eagle Midstream Canada Finance, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.31%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[6],[7]</sup></td>
<td class="nump">1.77%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
<td class="nump">$ 73,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 65,109<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[6],[7]</sup></td>
<td class="nump">$ 73,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Edifecs, Inc. 1', window );">Investment, Identifier [Axis]: Edifecs, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.27%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.32%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 13,449<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 13,447<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 13,449<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Edifecs, Inc. 2', window );">Investment, Identifier [Axis]: Edifecs, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4.38%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">5.38%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 223,544<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 216,910<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 223,544<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Emergency Power Holdings, LLC', window );">Investment, Identifier [Axis]: Emergency Power Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.93%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[14]</sup></td>
<td class="nump">1.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="nump">$ 43,486<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,064<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[14]</sup></td>
<td class="nump">$ 43,486<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Emergency Power Holdings, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Emergency Power Holdings, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,456<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18,700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (165)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (187)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Endeavor Schools Holdings LLC 1', window );">Investment, Identifier [Axis]: Endeavor Schools Holdings LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">0.44%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">$ 21,796<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Endeavor Schools Holdings LLC 2', window );">Investment, Identifier [Axis]: Endeavor Schools Holdings LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">0.08%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">$ 3,944<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Endeavor Schools Holdings LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Endeavor Schools Holdings LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,776<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Episerver, Inc.', window );">Investment, Identifier [Axis]: Episerver, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.18%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">0.22%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="nump">$ 9,117<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,081<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">$ 9,117<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Episerver, Inc., Revolver', window );">Investment, Identifier [Axis]: Episerver, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,064<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,064<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (83)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (93)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Epoch Acquisition, Inc.', window );">Investment, Identifier [Axis]: Epoch Acquisition, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.48%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.58%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 24,185<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 23,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 24,185<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Ergomed Plc', window );">Investment, Identifier [Axis]: Ergomed Plc</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">0.43%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 21,260<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Ergomed Plc, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Ergomed Plc, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Expedition Holdco, LLC - Class A Units', window );">Investment, Identifier [Axis]: Expedition Holdco, LLC - Class A Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Expedition Holdco, LLC - Class B Units', window );">Investment, Identifier [Axis]: Expedition Holdco, LLC - Class B Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 21<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 21<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Experity, Inc.', window );">Investment, Identifier [Axis]: Experity, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.30%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.35%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 14,677<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,664<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 14,677<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Experity, Inc., Revolver', window );">Investment, Identifier [Axis]: Experity, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,495<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,495<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (15)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (30)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Fencing Supply Group Acquisition, LLC', window );">Investment, Identifier [Axis]: Fencing Supply Group Acquisition, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.06%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">1.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="nump">$ 52,187<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">52,735<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">$ 52,187<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Fencing Supply Group Acquisition, LLC, Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: Fencing Supply Group Acquisition, LLC, Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,910<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Fencing Supply Group Acquisition, LLC, Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: Fencing Supply Group Acquisition, LLC, Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,637<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Formulations Parent Corp.', window );">Investment, Identifier [Axis]: Formulations Parent Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">0.17%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 8,386<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Formulations Parent Corp., Revolver', window );">Investment, Identifier [Axis]: Formulations Parent Corp., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,429<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (26)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Foundation Risk Partners Corp.', window );">Investment, Identifier [Axis]: Foundation Risk Partners Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.32%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.65%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 26,881<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,880<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 26,881<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Foundation Risk Partners Corp., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Foundation Risk Partners Corp., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,920<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(69)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Foundation Risk Partners Corp., Revolver', window );">Investment, Identifier [Axis]: Foundation Risk Partners Corp., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,382<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,401<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(36)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Freya Bidco Limited, Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: Freya Bidco Limited, Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">257<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Freya Bidco Limited, Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: Freya Bidco Limited, Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">257<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Freya Bidco Limited, Term Loan 1', window );">Investment, Identifier [Axis]: Freya Bidco Limited, Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,009<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Freya Bidco Limited, Term Loan 2', window );">Investment, Identifier [Axis]: Freya Bidco Limited, Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,107<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Frontgrade Technologies Holdings, Inc.', window );">Investment, Identifier [Axis]: Frontgrade Technologies Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 2,370<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Frontgrade Technologies Holdings, Inc., Revolver', window );">Investment, Identifier [Axis]: Frontgrade Technologies Holdings, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">516<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Frontline Road Safety Investments, LLC - Class A Common Units', window );">Investment, Identifier [Axis]: Frontline Road Safety Investments, LLC - Class A Common Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.08%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 1,920<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,776<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 1,920<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Frontline Road Safety, LLC', window );">Investment, Identifier [Axis]: Frontline Road Safety, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 84,648<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 84,648<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Frontline Road Safety, LLC 1', window );">Investment, Identifier [Axis]: Frontline Road Safety, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">1.77%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 87,637<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Frontline Road Safety, LLC 2', window );">Investment, Identifier [Axis]: Frontline Road Safety, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.22%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 10,831<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Frontline Road Safety, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Frontline Road Safety, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,996<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (137)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=FusionSite Midco, LLC 1', window );">Investment, Identifier [Axis]: FusionSite Midco, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">0.51%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">$ 25,334<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=FusionSite Midco, LLC 2', window );">Investment, Identifier [Axis]: FusionSite Midco, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">$ 2,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=FusionSite Midco, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: FusionSite Midco, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,800<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=FusionSite Midco, LLC, Revolver', window );">Investment, Identifier [Axis]: FusionSite Midco, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,791<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(63)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GCX Corporation Buyer, LLC', window );">Investment, Identifier [Axis]: GCX Corporation Buyer, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.64%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 26,661<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 26,661<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GCX Corporation Buyer, LLC 1', window );">Investment, Identifier [Axis]: GCX Corporation Buyer, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.43%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 21,182<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GCX Corporation Buyer, LLC 2', window );">Investment, Identifier [Axis]: GCX Corporation Buyer, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 5,363<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GCX Corporation Buyer, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: GCX Corporation Buyer, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GCX Corporation Group Holdings, L.P. - Class A-2 Units', window );">Investment, Identifier [Axis]: GCX Corporation Group Holdings, L.P. - Class A-2 Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 324<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 302<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 324<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GI Consilio Parent, LLC', window );">Investment, Identifier [Axis]: GI Consilio Parent, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[15]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[15]</sup></td>
<td class="nump">$ 554<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GI Consilio Parent, LLC, Revolver', window );">Investment, Identifier [Axis]: GI Consilio Parent, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">561<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC', window );">Investment, Identifier [Axis]: GI Ranger Intermediate, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.38%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 15,725<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 15,725<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC 1', window );">Investment, Identifier [Axis]: GI Ranger Intermediate, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.32%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 15,726<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC 2', window );">Investment, Identifier [Axis]: GI Ranger Intermediate, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 720<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: GI Ranger Intermediate, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,040<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,040<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC, Revolver', window );">Investment, Identifier [Axis]: GI Ranger Intermediate, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">480<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,080<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GTCR Investors LP - A-1 Units', window );">Investment, Identifier [Axis]: GTCR Investors LP - A-1 Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 417<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Galway Borrower, LLC', window );">Investment, Identifier [Axis]: Galway Borrower, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.24%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.52%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 21,577<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,032<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 21,577<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Galway Borrower, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Galway Borrower, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">274<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Galway Borrower, LLC, Revolver', window );">Investment, Identifier [Axis]: Galway Borrower, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,120<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (53)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Genuine Cable Group, LLC', window );">Investment, Identifier [Axis]: Genuine Cable Group, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.31%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">4.24%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 176,389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 164,014<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">$ 176,389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Gigamon Inc.', window );">Investment, Identifier [Axis]: Gigamon Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.15%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.18%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 7,293<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,308<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 7,293<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Gigamon Inc., Revolver', window );">Investment, Identifier [Axis]: Gigamon Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">437<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">437<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Go Car Wash Management Corp.', window );">Investment, Identifier [Axis]: Go Car Wash Management Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.44%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">0.53%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 21,954<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 21,941<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">$ 21,954<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Go Car Wash Management Corp., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Go Car Wash Management Corp., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,057<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GovernmentJobs.com, Inc.', window );">Investment, Identifier [Axis]: GovernmentJobs.com, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 4,828<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,156<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 4,828<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GovernmentJobs.com, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: GovernmentJobs.com, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,144<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GovernmentJobs.com, Inc., Revolver', window );">Investment, Identifier [Axis]: GovernmentJobs.com, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">677<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">677<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC', window );">Investment, Identifier [Axis]: GraphPAD Software, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.63%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 26,222<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 26,222<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC 1', window );">Investment, Identifier [Axis]: GraphPAD Software, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.27%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 13,518<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC 2', window );">Investment, Identifier [Axis]: GraphPAD Software, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.26%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 12,797<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC 3', window );">Investment, Identifier [Axis]: GraphPAD Software, LLC 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.13%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 6,429<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC 4', window );">Investment, Identifier [Axis]: GraphPAD Software, LLC 4</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">$ 1,030<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: GraphPAD Software, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,429<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(64)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC, Revolver', window );">Investment, Identifier [Axis]: GraphPAD Software, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,062<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,124<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Groundworks, LLC', window );">Investment, Identifier [Axis]: Groundworks, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">$ 802<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Groundworks, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Groundworks, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">37<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Groundworks, LLC, Revolver', window );">Investment, Identifier [Axis]: Groundworks, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Gruden Acquisition, Inc.', window );">Investment, Identifier [Axis]: Gruden Acquisition, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.39%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="nump">16,167<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 16,167<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Gruden Acquisition, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Gruden Acquisition, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(26)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Gruden Acquisition, Inc., Revolver', window );">Investment, Identifier [Axis]: Gruden Acquisition, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (38)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Guidehouse Holding Corp. - Preferred Equity', window );">Investment, Identifier [Axis]: Guidehouse Holding Corp. - Preferred Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.40%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 16,637<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 16,637<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Guidehouse, Inc.', window );">Investment, Identifier [Axis]: Guidehouse, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6.13%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">7.67%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
<td class="nump">$ 319,027<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">303,558<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 319,027<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc.', window );">Investment, Identifier [Axis]: HIG Orca Acquisition Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.56%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="nump">$ 23,239<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 23,239<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc. 1', window );">Investment, Identifier [Axis]: HIG Orca Acquisition Holdings, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">0.39%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">$ 19,091<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc. 2', window );">Investment, Identifier [Axis]: HIG Orca Acquisition Holdings, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">0.06%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">$ 2,877<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: HIG Orca Acquisition Holdings, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,241<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,390<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc., Revolver', window );">Investment, Identifier [Axis]: HIG Orca Acquisition Holdings, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,961<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,542<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC', window );">Investment, Identifier [Axis]: Healthcomp Holding Company, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[15]</sup></td>
<td class="nump">0.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[15]</sup></td>
<td class="nump">$ 9,924<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC - Preferred Interest', window );">Investment, Identifier [Axis]: Healthcomp Holding Company, LLC - Preferred Interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 985<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC 1', window );">Investment, Identifier [Axis]: Healthcomp Holding Company, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.83%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="nump">$ 76,247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 76,247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC 2', window );">Investment, Identifier [Axis]: Healthcomp Holding Company, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.97%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.77%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="nump">$ 32,085<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">97,515<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 32,085<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Healthcomp Holding Company, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,952<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Helix TS, LLC', window );">Investment, Identifier [Axis]: Helix TS, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 42,083<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 42,083<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Helix TS, LLC 1', window );">Investment, Identifier [Axis]: Helix TS, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.90%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 44,672<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Helix TS, LLC 2', window );">Investment, Identifier [Axis]: Helix TS, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 973<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Helix TS, LLC, Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: Helix TS, LLC, Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">138<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Helix TS, LLC, Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: Helix TS, LLC, Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">767<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc.', window );">Investment, Identifier [Axis]: High Street Buyer, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.47%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 61,282<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 61,282<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc. 1', window );">Investment, Identifier [Axis]: High Street Buyer, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">1.06%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 52,366<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc. 2', window );">Investment, Identifier [Axis]: High Street Buyer, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.23%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 11,146<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: High Street Buyer, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,396<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc., Revolver', window );">Investment, Identifier [Axis]: High Street Buyer, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,254<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,254<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (45)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (45)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=IG Investments Holdings, LLC', window );">Investment, Identifier [Axis]: IG Investments Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.93%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">1.15%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 47,915<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,011<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 47,915<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=IG Investments Holdings, LLC, Revolver', window );">Investment, Identifier [Axis]: IG Investments Holdings, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,583<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (18)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ISQ Hawkey Holdco, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: ISQ Hawkey Holdco, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">90<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ISQ Hawkey Holdco, Inc., Revolver', window );">Investment, Identifier [Axis]: ISQ Hawkey Holdco, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">91<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ISQ Hawkeye Holdco, Inc.', window );">Investment, Identifier [Axis]: ISQ Hawkeye Holdco, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 893<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">$ 893<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ISQ Hawkeye Holdco, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: ISQ Hawkeye Holdco, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=ISQ Hawkeye Holdco, Inc., Revolver', window );">Investment, Identifier [Axis]: ISQ Hawkeye Holdco, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">91<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Icefall Parent Inc, Revolver', window );">Investment, Identifier [Axis]: Icefall Parent Inc, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,042<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Icefall Parent Inc, Term Loan', window );">Investment, Identifier [Axis]: Icefall Parent Inc, Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">31,940<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Infostretch Corporation', window );">Investment, Identifier [Axis]: Infostretch Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.09%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 4,776<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,408<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 4,776<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Inova Pharmaceutical, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Inova Pharmaceutical, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">102<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Inova Pharmaceutical, Term Loan', window );">Investment, Identifier [Axis]: Inova Pharmaceutical, Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">661<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Inovalon Holdings, Inc.', window );">Investment, Identifier [Axis]: Inovalon Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.21%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">2.52%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 104,979<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 109,329<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 104,979<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Inovalon Holdings, Inc. 2', window );">Investment, Identifier [Axis]: Inovalon Holdings, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
<td class="nump">$ 10,359<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,293<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 10,359<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Inovalon Holdings, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Inovalon Holdings, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,060<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,060<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(138)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (138)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC', window );">Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3.39%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 141,089<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 141,089<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC 1', window );">Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">2.79%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 138,022<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC 2', window );">Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 1,862<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC 3', window );">Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 1,098<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC 5', window );">Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.08%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 3,998<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,064<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">347<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC, Revolver', window );">Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,381<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Investment  One', window );">Investment, Identifier [Axis]: Investment One</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRateFloor', window );">Interest rate, floor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Investment Five', window );">Investment, Identifier [Axis]: Investment Five</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRateFloor', window );">Interest rate, floor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Investment Four', window );">Investment, Identifier [Axis]: Investment Four</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRateFloor', window );">Interest rate, floor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Investment One', window );">Investment, Identifier [Axis]: Investment One</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRateFloor', window );">Interest rate, floor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Investment Seven', window );">Investment, Identifier [Axis]: Investment Seven</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRateFloor', window );">Interest rate, floor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Investment Six', window );">Investment, Identifier [Axis]: Investment Six</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRateFloor', window );">Interest rate, floor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.50%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.50%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Investment Three', window );">Investment, Identifier [Axis]: Investment Three</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRateFloor', window );">Interest rate, floor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.75%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.75%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Investment Two', window );">Investment, Identifier [Axis]: Investment Two</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRateFloor', window );">Interest rate, floor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.50%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.50%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Iris Buyer, LLC', window );">Investment, Identifier [Axis]: Iris Buyer, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">0.51%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">$ 25,377<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Iris Buyer, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Iris Buyer, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,318<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Iris Buyer, LLC, Revolver', window );">Investment, Identifier [Axis]: Iris Buyer, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (101)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Italian Motorway Holdings S.&#224;.r.l', window );">Investment, Identifier [Axis]: Italian Motorway Holdings S.&#224;.r.l</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.74%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">1.96%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[16]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[16]</sup></td>
<td class="nump">$ 81,376<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 86,349<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 81,376<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=JSS Holdings, Inc. 1', window );">Investment, Identifier [Axis]: JSS Holdings, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5.72%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">6.88%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 285,912<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 283,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">$ 285,912<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=JSS Holdings, Inc. 2', window );">Investment, Identifier [Axis]: JSS Holdings, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 4,938<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,888<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">$ 4,938<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Jacuzzi Brands, LLC', window );">Investment, Identifier [Axis]: Jacuzzi Brands, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.28%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 94,817<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 94,817<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Jacuzzi Brands, LLC 1', window );">Investment, Identifier [Axis]: Jacuzzi Brands, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.21%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 10,215<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Jacuzzi Brands, LLC 2', window );">Investment, Identifier [Axis]: Jacuzzi Brands, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">1.42%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 70,275<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc.', window );">Investment, Identifier [Axis]: Java Buyer, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 4,815<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4,815<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc. 1', window );">Investment, Identifier [Axis]: Java Buyer, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">$ 5,919<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc. 2', window );">Investment, Identifier [Axis]: Java Buyer, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">$ 353<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Java Buyer, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,897<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc., Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: Java Buyer, Inc., Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">930<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc., Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: Java Buyer, Inc., Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,276<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Jayhawk Buyer, LLC', window );">Investment, Identifier [Axis]: Jayhawk Buyer, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.96%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">3.70%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 153,720<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">146,766<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 153,720<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Jayhawk Buyer, LLC 2', window );">Investment, Identifier [Axis]: Jayhawk Buyer, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 5,144<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5,144<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Jayhawk Buyer, LLC 3', window );">Investment, Identifier [Axis]: Jayhawk Buyer, LLC 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 4,950<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Jayhawk Buyer, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Jayhawk Buyer, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">30<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Jayhawk Holdings, LP - A-1 Common Units', window );">Investment, Identifier [Axis]: Jayhawk Holdings, LP - A-1 Common Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 627<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 172<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 627<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Jayhawk Holdings, LP - A-2 Common Units', window );">Investment, Identifier [Axis]: Jayhawk Holdings, LP - A-2 Common Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 338<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 338<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Jones Deslauriers Insurance Management, Inc.', window );">Investment, Identifier [Axis]: Jones Deslauriers Insurance Management, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[10],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.44%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[10],[11],[12]</sup></td>
<td class="nump">$ 59,917<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[10],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 59,917<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=KKR Alberta Midstream Finance Inc.', window );">Investment, Identifier [Axis]: KKR Alberta Midstream Finance Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.72%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[6],[7]</sup></td>
<td class="nump">0.96%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
<td class="nump">$ 40,002<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35,421<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[6],[7]</sup></td>
<td class="nump">$ 40,002<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=KPSKY Acquisition, Inc.', window );">Investment, Identifier [Axis]: KPSKY Acquisition, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.51%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 21,240<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 21,240<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=KPSKY Acquisition, Inc. 1', window );">Investment, Identifier [Axis]: KPSKY Acquisition, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[7],[23]</sup></td>
<td class="nump">0.40%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[7],[23]</sup></td>
<td class="nump">$ 20,014<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=KPSKY Acquisition, Inc. 2', window );">Investment, Identifier [Axis]: KPSKY Acquisition, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[7]</sup></td>
<td class="nump">$ 2,305<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=KPSKY Acquisition, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: KPSKY Acquisition, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Kaufman Hall &amp; Associates, LLC', window );">Investment, Identifier [Axis]: Kaufman Hall &amp; Associates, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.49%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.58%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 24,131<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 24,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 24,131<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Knowledge Pro Buyer, Inc.', window );">Investment, Identifier [Axis]: Knowledge Pro Buyer, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">0.14%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 5,858<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,078<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">$ 5,858<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Knowledge Pro Buyer, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Knowledge Pro Buyer, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,633<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,032<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Knowledge Pro Buyer, Inc., Revolver', window );">Investment, Identifier [Axis]: Knowledge Pro Buyer, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">784<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,145<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Kwol Acquisition, Inc.', window );">Investment, Identifier [Axis]: Kwol Acquisition, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">0.13%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 6,685<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Kwol Acquisition, Inc., Revolver', window );">Investment, Identifier [Axis]: Kwol Acquisition, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">628<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=L&amp;S Mechanical Acquisition, LLC', window );">Investment, Identifier [Axis]: L&amp;S Mechanical Acquisition, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.24%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.29%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
<td class="nump">$ 11,869<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 12,006<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 11,869<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=LD Lower Holdings, Inc.', window );">Investment, Identifier [Axis]: LD Lower Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.83%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">2.19%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 91,072<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 90,602<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 91,072<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=LD Lower Holdings, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: LD Lower Holdings, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15,684<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Legacy Intermediate, LLC', window );">Investment, Identifier [Axis]: Legacy Intermediate, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.14%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 5,080<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,766<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 5,080<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Legacy Intermediate, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Legacy Intermediate, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(20)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Legacy Intermediate, LLC, Revolver', window );">Investment, Identifier [Axis]: Legacy Intermediate, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">958<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Lightbox Intermediate, LP', window );">Investment, Identifier [Axis]: Lightbox Intermediate, LP</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[15]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[16]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[16]</sup></td>
<td class="nump">$ 1,920<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,886<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[15]</sup></td>
<td class="nump">$ 1,920<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Lindstrom, LLC', window );">Investment, Identifier [Axis]: Lindstrom, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.40%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">2.90%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 120,758<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 119,016<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 120,758<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Linquest Corp.', window );">Investment, Identifier [Axis]: Linquest Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.19%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.23%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 9,395<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,592<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 9,395<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Linquest Corp., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Linquest Corp., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (50)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Livingston International, Inc.', window );">Investment, Identifier [Axis]: Livingston International, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.44%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[6],[7]</sup></td>
<td class="nump">3.07%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
<td class="nump">$ 127,563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 120,848<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[6],[7]</sup></td>
<td class="nump">$ 127,563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Lobos Parent, Inc. - Series A Preferred Shares', window );">Investment, Identifier [Axis]: Lobos Parent, Inc. - Series A Preferred Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 1,641<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,819<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 1,641<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Lytx, Inc.', window );">Investment, Identifier [Axis]: Lytx, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.71%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">1.95%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 81,076<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 84,454<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 81,076<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MAG DS Corp.', window );">Investment, Identifier [Axis]: MAG DS Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.56%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6],[14]</sup></td>
<td class="nump">1.80%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 74,813<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 77,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6],[14]</sup></td>
<td class="nump">$ 74,813<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MHE Intermediate Holdings 1', window );">Investment, Identifier [Axis]: MHE Intermediate Holdings 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="nump">$ 4,331<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,559<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">$ 4,331<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MHE Intermediate Holdings 2', window );">Investment, Identifier [Axis]: MHE Intermediate Holdings 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="nump">$ 208<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">249<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">$ 208<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MHE Intermediate Holdings, LLC, Revolver', window );">Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">230<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MPG Parent Holdings LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: MPG Parent Holdings LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,679<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MPG Parent Holdings LLC, Revolver', window );">Investment, Identifier [Axis]: MPG Parent Holdings LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,313<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MPG Parent Holdings LLC, Term Loan', window );">Investment, Identifier [Axis]: MPG Parent Holdings LLC, Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,763<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MRI Software, LLC', window );">Investment, Identifier [Axis]: MRI Software, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[6],[14]</sup></td>
<td class="nump">0.63%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[12],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[12],[13]</sup></td>
<td class="nump">$ 26,405<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50,422<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[6],[14]</sup></td>
<td class="nump">$ 26,405<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[12],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: MRI Software, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">40,238<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(201)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Revolver 1', window );">Investment, Identifier [Axis]: MRI Software, LLC, Revolver 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,516<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,516<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(28)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(55)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Revolver 2', window );">Investment, Identifier [Axis]: MRI Software, LLC, Revolver 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,822<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (347)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Revolver 3', window );">Investment, Identifier [Axis]: MRI Software, LLC, Revolver 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(40)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Revolver 4', window );">Investment, Identifier [Axis]: MRI Software, LLC, Revolver 4</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,086<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (34)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Magnesium BorrowerCo, Inc. 1', window );">Investment, Identifier [Axis]: Magnesium BorrowerCo, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 4,079<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,203<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 4,079<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Magnesium BorrowerCo, Inc. 2', window );">Investment, Identifier [Axis]: Magnesium BorrowerCo, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.09%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 5,177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,345<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 5,177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Magnesium BorrowerCo, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Magnesium BorrowerCo, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (12)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (12)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Magneto Components BuyCo, LLC', window );">Investment, Identifier [Axis]: Magneto Components BuyCo, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">0.65%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 32,273<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Magneto Components BuyCo, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Magneto Components BuyCo, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,610<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Magneto Components BuyCo, LLC, Revolver', window );">Investment, Identifier [Axis]: Magneto Components BuyCo, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,508<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (138)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Holdings, Inc. - Series A Preferred Shares', window );">Investment, Identifier [Axis]: Mandolin Technology Holdings, Inc. - Series A Preferred Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.07%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.08%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 3,408<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,568<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 3,408<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc.', window );">Investment, Identifier [Axis]: Mandolin Technology Intermediate Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[18]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.22%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[18]</sup></td>
<td class="nump">$ 9,120<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[18]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,120<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc. 1', window );">Investment, Identifier [Axis]: Mandolin Technology Intermediate Holdings, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[17]</sup></td>
<td class="nump">0.16%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[17]</sup></td>
<td class="nump">$ 7,887<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc. 2', window );">Investment, Identifier [Axis]: Mandolin Technology Intermediate Holdings, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.14%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[17]</sup></td>
<td class="nump">0.08%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[18]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[18]</sup></td>
<td class="nump">$ 3,426<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,965<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[17]</sup></td>
<td class="nump">$ 3,426<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[18]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc. 3', window );">Investment, Identifier [Axis]: Mandolin Technology Intermediate Holdings, Inc. 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[15]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[15]</sup></td>
<td class="nump">$ 194<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc. 4', window );">Investment, Identifier [Axis]: Mandolin Technology Intermediate Holdings, Inc. 4</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[17]</sup></td>
<td class="nump">0.07%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[17]</sup></td>
<td class="nump">$ 3,319<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc., Revolver', window );">Investment, Identifier [Axis]: Mandolin Technology Intermediate Holdings, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">916<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">349<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Marcone Yellowstone Buyer, Inc. 1', window );">Investment, Identifier [Axis]: Marcone Yellowstone Buyer, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.09%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[7]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 1,524<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,606<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[7]</sup></td>
<td class="nump">$ 1,524<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Marcone Yellowstone Buyer, Inc. 2', window );">Investment, Identifier [Axis]: Marcone Yellowstone Buyer, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[7]</sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
<td class="nump">$ 4,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,471<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[7]</sup></td>
<td class="nump">$ 4,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Marcone Yellowstone Buyer, Inc. 3', window );">Investment, Identifier [Axis]: Marcone Yellowstone Buyer, Inc. 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[7]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
<td class="nump">$ 1,534<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,483<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[7]</sup></td>
<td class="nump">$ 1,534<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Marcone Yellowstone Buyer, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Marcone Yellowstone Buyer, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">342<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">342<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (17)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Material Holdings, LLC', window );">Investment, Identifier [Axis]: Material Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.45%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.57%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 23,687<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22,431<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 23,687<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Material Holdings, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Material Holdings, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,802<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Material Holdings, LLC, Revolver', window );">Investment, Identifier [Axis]: Material Holdings, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">848<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">918<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Maverick Acquisition, Inc.', window );">Investment, Identifier [Axis]: Maverick Acquisition, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.28%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.41%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 17,004<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,763<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 17,004<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Medallia, Inc.', window );">Investment, Identifier [Axis]: Medallia, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8.26%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 343,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 343,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Medallia, Inc. 1', window );">Investment, Identifier [Axis]: Medallia, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">7.21%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 356,796<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Medallia, Inc. 2', window );">Investment, Identifier [Axis]: Medallia, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 2,094<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mercury Bidco Globe Limited, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Mercury Bidco Globe Limited, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mercury Bidco Globe Limited, Term Loan', window );">Investment, Identifier [Axis]: Mercury Bidco Globe Limited, Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">59,287<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Micross Topco, Inc.', window );">Investment, Identifier [Axis]: Micross Topco, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.09%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 4,767<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,699<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 4,767<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mimecast Limited', window );">Investment, Identifier [Axis]: Mimecast Limited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 638<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 674<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 638<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Minotaur Acquisition, Inc.', window );">Investment, Identifier [Axis]: Minotaur Acquisition, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[6],[15]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[16]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[16]</sup></td>
<td class="nump">$ 1,903<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,967<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[6],[15]</sup></td>
<td class="nump">$ 1,903<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mode Holdings, L.P. - Class A-2 Common Units', window );">Investment, Identifier [Axis]: Mode Holdings, L.P. - Class A-2 Common Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.26%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 10,699<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,822<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 10,699<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mode Purchaser, Inc. 1', window );">Investment, Identifier [Axis]: Mode Purchaser, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.89%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">4.17%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 173,421<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 143,110<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 173,421<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Mode Purchaser, Inc. 2', window );">Investment, Identifier [Axis]: Mode Purchaser, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.08%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 4,950<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,085<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 4,950<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monk Holding Co.', window );">Investment, Identifier [Axis]: Monk Holding Co.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 4,929<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4,929<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monk Holding Co. 1', window );">Investment, Identifier [Axis]: Monk Holding Co. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7],[23]</sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7],[23]</sup></td>
<td class="nump">$ 4,804<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monk Holding Co. 2', window );">Investment, Identifier [Axis]: Monk Holding Co. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monk Holding Co., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Monk Holding Co., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,038<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l 1', window );">Investment, Identifier [Axis]: Monterey Financing S.&#224;.r.l 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[16]</sup></td>
<td class="nump">704<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 704<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l 2', window );">Investment, Identifier [Axis]: Monterey Financing S.&#224;.r.l 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[16]</sup></td>
<td class="nump">674<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 674<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l 3', window );">Investment, Identifier [Axis]: Monterey Financing S.&#224;.r.l 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[18]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[18]</sup></td>
<td class="nump">510<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[18]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 510<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l 4', window );">Investment, Identifier [Axis]: Monterey Financing S.&#224;.r.l 4</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[16]</sup></td>
<td class="nump">$ 196<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 196<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Monterey Financing S.&#224;.r.l, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">467<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 1', window );">Investment, Identifier [Axis]: Monterey Financing, S.A.R.L 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 206<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 2', window );">Investment, Identifier [Axis]: Monterey Financing, S.A.R.L 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 721<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 3', window );">Investment, Identifier [Axis]: Monterey Financing, S.A.R.L 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[15]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 4', window );">Investment, Identifier [Axis]: Monterey Financing, S.A.R.L 4</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 708<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 5', window );">Investment, Identifier [Axis]: Monterey Financing, S.A.R.L 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[17]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[17]</sup></td>
<td class="nump">$ 503<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Monterey Financing, S.A.R.L, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">283<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=More Cowbell II, LLC 1', window );">Investment, Identifier [Axis]: More Cowbell II, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">0.16%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">$ 7,866<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=More Cowbell II, LLC 2', window );">Investment, Identifier [Axis]: More Cowbell II, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">$ 192<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=More Cowbell II, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: More Cowbell II, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">871<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(11)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=More Cowbell II, LLC, Revolver', window );">Investment, Identifier [Axis]: More Cowbell II, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">968<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=NAVEX TopCo, Inc.', window );">Investment, Identifier [Axis]: NAVEX TopCo, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">1.21%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 59,969<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=NAVEX TopCo, Inc., Revolver', window );">Investment, Identifier [Axis]: NAVEX TopCo, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,394<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (108)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=NC Ocala Co-Invest Beta, L.P. - LP Interest', window );">Investment, Identifier [Axis]: NC Ocala Co-Invest Beta, L.P. - LP Interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.06%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.07%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 2,854<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,054<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 2,854<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=NDC Acquisition Corp.', window );">Investment, Identifier [Axis]: NDC Acquisition Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.33%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 13,735<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 13,735<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=NDC Acquisition Corp. 1', window );">Investment, Identifier [Axis]: NDC Acquisition Corp. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">0.27%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">$ 13,288<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=NDC Acquisition Corp. 2', window );">Investment, Identifier [Axis]: NDC Acquisition Corp. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">$ 480<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=NDC Acquisition Corp., Revolver', window );">Investment, Identifier [Axis]: NDC Acquisition Corp., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,911<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,911<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=NMC Crimson Holdings, Inc.', window );">Investment, Identifier [Axis]: NMC Crimson Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.80%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 74,829<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 74,829<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=NMC Crimson Holdings, Inc. 1', window );">Investment, Identifier [Axis]: NMC Crimson Holdings, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">1.44%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 71,173<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=NMC Crimson Holdings, Inc. 2', window );">Investment, Identifier [Axis]: NMC Crimson Holdings, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.30%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 14,719<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=NMC Crimson Holdings, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: NMC Crimson Holdings, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,617<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,585<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Navigator Acquiror, Inc.', window );">Investment, Identifier [Axis]: Navigator Acquiror, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4.42%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[17]</sup></td>
<td class="nump">4.78%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[18]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[18]</sup></td>
<td class="nump">$ 198,728<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">218,854<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[17]</sup></td>
<td class="nump">$ 198,728<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[18]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Navigator Acquiror, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Navigator Acquiror, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,746<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">49,175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Ncp Helix Holdings, LLC. - Preferred Shares', window );">Investment, Identifier [Axis]: Ncp Helix Holdings, LLC. - Preferred Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 472<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 536<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 472<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Neptune Holdings, Inc.', window );">Investment, Identifier [Axis]: Neptune Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">0.14%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">$ 6,841<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Neptune Holdings, Inc., Revolver', window );">Investment, Identifier [Axis]: Neptune Holdings, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">933<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (19)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Nintex Topco Limited', window );">Investment, Identifier [Axis]: Nintex Topco Limited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.66%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[6],[7]</sup></td>
<td class="nump">0.77%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
<td class="nump">$ 31,987<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 32,511<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[6],[7]</sup></td>
<td class="nump">$ 31,987<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=OHCP V TC COI, LP. - LP Interest', window );">Investment, Identifier [Axis]: OHCP V TC COI, LP. - LP Interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 4,410<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,055<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 4,410<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Odyssey Holding Company, LLC', window );">Investment, Identifier [Axis]: Odyssey Holding Company, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.45%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 18,672<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 18,672<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Odyssey Holding Company, LLC 1', window );">Investment, Identifier [Axis]: Odyssey Holding Company, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.34%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 17,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Odyssey Holding Company, LLC 2', window );">Investment, Identifier [Axis]: Odyssey Holding Company, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 1,635<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc.', window );">Investment, Identifier [Axis]: Onex Baltimore Buyer, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.67%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 27,720<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 27,720<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc. 1', window );">Investment, Identifier [Axis]: Onex Baltimore Buyer, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[7],[23]</sup></td>
<td class="nump">0.22%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[7],[23]</sup></td>
<td class="nump">$ 10,804<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc. 2', window );">Investment, Identifier [Axis]: Onex Baltimore Buyer, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">0.18%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[7]</sup></td>
<td class="nump">$ 9,091<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Onex Baltimore Buyer, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc., Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: Onex Baltimore Buyer, Inc., Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc., Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: Onex Baltimore Buyer, Inc., Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,729<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Oranje Holdco Inc', window );">Investment, Identifier [Axis]: Oranje Holdco Inc</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Oranje Holdco Inc, Revolver', window );">Investment, Identifier [Axis]: Oranje Holdco Inc, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Other Cash and Cash Equivalents', window );">Investment, Identifier [Axis]: Other Cash and Cash Equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.72%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3.16%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 131,272<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">134,896<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 131,272<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC', window );">Investment, Identifier [Axis]: PGIS Intermediate Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11],[12]</sup></td>
<td class="nump">$ 4,470<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4,470<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC 1', window );">Investment, Identifier [Axis]: PGIS Intermediate Holdings, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.09%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 4,522<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC 2', window );">Investment, Identifier [Axis]: PGIS Intermediate Holdings, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 249<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: PGIS Intermediate Holdings, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,007<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC, Revolver', window );">Investment, Identifier [Axis]: PGIS Intermediate Holdings, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">469<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">330<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=PPV Intermediate Holdings, LLC', window );">Investment, Identifier [Axis]: PPV Intermediate Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
<td class="nump">$ 1,775<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,971<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 1,775<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=PPV Intermediate Holdings, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: PPV Intermediate Holdings, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">78<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=PPV Intermediate Holdings, LLC, Revolver', window );">Investment, Identifier [Axis]: PPV Intermediate Holdings, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">159<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">116<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Pavion Corp.', window );">Investment, Identifier [Axis]: Pavion Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">1.62%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 80,138<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Pavion Corp., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Pavion Corp., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,279<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(183)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Pavion Corp., Revolver', window );">Investment, Identifier [Axis]: Pavion Corp., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,565<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Petrus Buyer Inc', window );">Investment, Identifier [Axis]: Petrus Buyer Inc</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 1,831<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,882<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 1,831<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Petrus Buyer Inc, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Petrus Buyer Inc, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">595<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">595<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Petrus Buyer Inc, Revolver', window );">Investment, Identifier [Axis]: Petrus Buyer Inc, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">272<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">272<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Phoenix 1 Buyer Corp.', window );">Investment, Identifier [Axis]: Phoenix 1 Buyer Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[15]</sup></td>
<td class="nump">0.52%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[15]</sup></td>
<td class="nump">$ 25,573<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Phoenix 1 Buyer Corp., Revolver', window );">Investment, Identifier [Axis]: Phoenix 1 Buyer Corp., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,009<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(50)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Acquisition, LLC', window );">Investment, Identifier [Axis]: Point Broadband Acquisition, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.44%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 101,470<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 101,470<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Acquisition, LLC 1', window );">Investment, Identifier [Axis]: Point Broadband Acquisition, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">1.73%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">$ 85,486<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Acquisition, LLC 2', window );">Investment, Identifier [Axis]: Point Broadband Acquisition, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">0.79%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">$ 38,969<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Acquisition, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Point Broadband Acquisition, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20,703<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Holdings, LLC - Class A Units', window );">Investment, Identifier [Axis]: Point Broadband Holdings, LLC - Class A Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.14%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.13%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 5,285<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 7,049<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 5,285<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Holdings, LLC - Class Additional A Units', window );">Investment, Identifier [Axis]: Point Broadband Holdings, LLC - Class Additional A Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,515<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Holdings, LLC - Class Additional B Units', window );">Investment, Identifier [Axis]: Point Broadband Holdings, LLC - Class Additional B Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 1,136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 536<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 1,136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Holdings, LLC - Class B Units', window );">Investment, Identifier [Axis]: Point Broadband Holdings, LLC - Class B Units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 762<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,492<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 762<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Porcelain Acquisition Corp.', window );">Investment, Identifier [Axis]: Porcelain Acquisition Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.06%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">1.32%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 54,829<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 52,267<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 54,829<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Porcelain Acquisition Corp., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Porcelain Acquisition Corp., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,481<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Profile Products, LLC 1', window );">Investment, Identifier [Axis]: Profile Products, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.15%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 6,186<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,189<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 6,186<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Profile Products, LLC 2', window );">Investment, Identifier [Axis]: Profile Products, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 1,214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,857<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 1,214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Profile Products, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Profile Products, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">413<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Profile Products, LLC, Revolver', window );">Investment, Identifier [Axis]: Profile Products, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">237<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Profile Products, LLC, Revolver 1', window );">Investment, Identifier [Axis]: Profile Products, LLC, Revolver 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">520<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(17)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Profile Products, LLC, Revolver 2', window );">Investment, Identifier [Axis]: Profile Products, LLC, Revolver 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">353<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Progress Residential PM Holdings, LLC 1', window );">Investment, Identifier [Axis]: Progress Residential PM Holdings, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.37%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">1.69%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 70,324<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 67,900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 70,324<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Progress Residential PM Holdings, LLC 2', window );">Investment, Identifier [Axis]: Progress Residential PM Holdings, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 833<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">833<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 833<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,623<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,623<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">333<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">333<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Project Boost Purchaser, LLC', window );">Investment, Identifier [Axis]: Project Boost Purchaser, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 4,763<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4,763<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Project Boost Purchaser, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Project Boost Purchaser, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">905<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Project Boost Purchaser, LLC, Revolver', window );">Investment, Identifier [Axis]: Project Boost Purchaser, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">591<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Project Ruby Ultimate Parent Corp.', window );">Investment, Identifier [Axis]: Project Ruby Ultimate Parent Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.17%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[6],[7]</sup></td>
<td class="nump">0.19%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8]</sup></td>
<td class="nump">$ 8,019<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,201<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[6],[7]</sup></td>
<td class="nump">$ 8,019<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Pye-Barker Fire &amp; Safety LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Pye-Barker Fire &amp; Safety LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,278<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (183)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC 1', window );">Investment, Identifier [Axis]: Quality Distribution LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">$ 681<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC 2', window );">Investment, Identifier [Axis]: Quality Distribution LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[14]</sup></td>
<td class="nump">0.37%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[14]</sup></td>
<td class="nump">$ 18,220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC, Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: Quality Distribution LLC, Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC, Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: Quality Distribution LLC, Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,931<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC, Revolver 1', window );">Investment, Identifier [Axis]: Quality Distribution LLC, Revolver 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">94<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC, Revolver 2', window );">Investment, Identifier [Axis]: Quality Distribution LLC, Revolver 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (135)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Qualus Power Services Corp.', window );">Investment, Identifier [Axis]: Qualus Power Services Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.65%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">0.80%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 33,092<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 31,962<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">$ 33,092<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Qualus Power Services Corp. 2', window );">Investment, Identifier [Axis]: Qualus Power Services Corp. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">0.64%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[14]</sup></td>
<td class="nump">$ 31,515<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Qualus Power Services Corp., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Qualus Power Services Corp., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,737<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,259<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=RPBLS Midco, LLC', window );">Investment, Identifier [Axis]: RPBLS Midco, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.22%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 9,329<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,329<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=RPBLS Midco, LLC 1', window );">Investment, Identifier [Axis]: RPBLS Midco, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.15%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 7,388<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=RPBLS Midco, LLC 2', window );">Investment, Identifier [Axis]: RPBLS Midco, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[17]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[17]</sup></td>
<td class="nump">$ 1,961<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=RPBLS Midco, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: RPBLS Midco, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=RWL Holdings, LLC', window );">Investment, Identifier [Axis]: RWL Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.58%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.57%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 23,827<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,656<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 23,827<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=RWL Holdings, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: RWL Holdings, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,452<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (65)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc.', window );">Investment, Identifier [Axis]: Rally Buyer, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 699<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 699<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc. 1', window );">Investment, Identifier [Axis]: Rally Buyer, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 824<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc. 2', window );">Investment, Identifier [Axis]: Rally Buyer, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 42<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Rally Buyer, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">205<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc., Revolver', window );">Investment, Identifier [Axis]: Rally Buyer, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">66<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">110<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Razor Holdco, LLC', window );">Investment, Identifier [Axis]: Razor Holdco, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.74%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.88%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 36,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 36,693<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 36,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Red River Technology, LLC', window );">Investment, Identifier [Axis]: Red River Technology, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.61%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">1.93%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 80,180<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 79,967<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 80,180<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Red River Technology, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Red River Technology, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,880<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Redwood Services Group, LLC', window );">Investment, Identifier [Axis]: Redwood Services Group, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.09%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.06%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 2,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,430<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 2,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Redwood Services Group, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Redwood Services Group, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">133<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Redwood Services Group, LLC, Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: Redwood Services Group, LLC, Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Redwood Services Group, LLC, Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: Redwood Services Group, LLC, Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">139<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Relativity ODA, LLC', window );">Investment, Identifier [Axis]: Relativity ODA, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.43%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">0.50%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 20,631<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,087<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">$ 20,631<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Relativity ODA, LLC, Revolver', window );">Investment, Identifier [Axis]: Relativity ODA, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,292<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,292<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(49)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (49)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Relay Purchaser, LLC', window );">Investment, Identifier [Axis]: Relay Purchaser, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.88%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 36,415<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 36,415<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Relay Purchaser, LLC, Revolver', window );">Investment, Identifier [Axis]: Relay Purchaser, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (71)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=RoadOne Inc', window );">Investment, Identifier [Axis]: RoadOne Inc</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 1,024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,075<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">$ 1,024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=RoadOne Inc, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: RoadOne Inc, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">163<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">255<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=RoadOne Inc, Revolver', window );">Investment, Identifier [Axis]: RoadOne Inc, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">275<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc.', window );">Investment, Identifier [Axis]: Roadsafe Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.23%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 51,336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 51,336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc. 1', window );">Investment, Identifier [Axis]: Roadsafe Holdings, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.57%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 28,339<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc. 2', window );">Investment, Identifier [Axis]: Roadsafe Holdings, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.40%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 19,820<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc. 3', window );">Investment, Identifier [Axis]: Roadsafe Holdings, Inc. 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.08%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 4,040<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Roadsafe Holdings, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=S&amp;P Global Engineering Solutions', window );">Investment, Identifier [Axis]: S&amp;P Global Engineering Solutions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">$ 1,596<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=S&amp;P Global Engineering Solutions, Revolver', window );">Investment, Identifier [Axis]: S&amp;P Global Engineering Solutions, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">249<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC 1', window );">Investment, Identifier [Axis]: SEKO Global Logistics Network, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[13]</sup></td>
<td class="nump">$ 1,978<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">$ 1,978<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC 2', window );">Investment, Identifier [Axis]: SEKO Global Logistics Network, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">0.15%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="nump">$ 6,214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 167<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">$ 6,214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC 3', window );">Investment, Identifier [Axis]: SEKO Global Logistics Network, LLC 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">$ 775<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC 4', window );">Investment, Identifier [Axis]: SEKO Global Logistics Network, LLC 4</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">$ 1,985<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: SEKO Global Logistics Network, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">399<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC, Revolver', window );">Investment, Identifier [Axis]: SEKO Global Logistics Network, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">432<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">294<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SG Acquisition, Inc.', window );">Investment, Identifier [Axis]: SG Acquisition, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.09%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[17]</sup></td>
<td class="nump">2.52%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[18]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[18]</sup></td>
<td class="nump">$ 104,974<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">103,662<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[17]</sup></td>
<td class="nump">$ 104,974<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[18]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Safety Borrower Holdings LP', window );">Investment, Identifier [Axis]: Safety Borrower Holdings LP</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="nump">$ 5,028<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5,028<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Safety Borrower Holdings LP 1', window );">Investment, Identifier [Axis]: Safety Borrower Holdings LP 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">$ 5,032<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Safety Borrower Holdings LP 2', window );">Investment, Identifier [Axis]: Safety Borrower Holdings LP 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">$ 276<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Safety Borrower Holdings LP, Revolver', window );">Investment, Identifier [Axis]: Safety Borrower Holdings LP, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">373<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc.', window );">Investment, Identifier [Axis]: Sam Holding Co, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.99%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 41,306<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 41,306<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc. 1', window );">Investment, Identifier [Axis]: Sam Holding Co, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">0.75%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">$ 37,206<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc. 2', window );">Investment, Identifier [Axis]: Sam Holding Co, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.23%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 11,378<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc. 3', window );">Investment, Identifier [Axis]: Sam Holding Co, Inc. 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.32%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 15,761<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Sam Holding Co, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">29,731<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc., Revolver', window );">Investment, Identifier [Axis]: Sam Holding Co, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (75)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SelectQuote, Inc.', window );">Investment, Identifier [Axis]: SelectQuote, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.34%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[7]</sup></td>
<td class="nump">1.62%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 67,243<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 66,538<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[7]</sup></td>
<td class="nump">$ 67,243<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Shelf Bidco Ltd', window );">Investment, Identifier [Axis]: Shelf Bidco Ltd</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[7],[23]</sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[10]</sup></td>
<td class="nump">$ 4,938<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,053<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[7],[23]</sup></td>
<td class="nump">$ 4,938<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Shelf Holdco Ltd Common Equity', window );">Investment, Identifier [Axis]: Shelf Holdco Ltd Common Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11]</sup></td>
<td class="nump">$ 50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 88<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="nump">$ 50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Sherlock Buyer Corp.', window );">Investment, Identifier [Axis]: Sherlock Buyer Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.17%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 8,223<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,267<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 8,223<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Sherlock Buyer Corp., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Sherlock Buyer Corp., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,794<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,794<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(28)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(28)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Sherlock Buyer Corp., Revolver', window );">Investment, Identifier [Axis]: Sherlock Buyer Corp., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (22)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (22)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Shoals Holdings, LLC', window );">Investment, Identifier [Axis]: Shoals Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.24%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">2.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 83,921<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 61,350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">$ 83,921<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Smile Doctors, LLC', window );">Investment, Identifier [Axis]: Smile Doctors, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.21%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.27%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 11,218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,571<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 11,218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Smile Doctors, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Smile Doctors, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,607<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(39)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Smile Doctors, LLC, Revolver', window );">Investment, Identifier [Axis]: Smile Doctors, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">710<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (31)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Snoopy Bidco, Inc.', window );">Investment, Identifier [Axis]: Snoopy Bidco, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">7.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 293,329<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">302,719<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 293,329<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Snoopy Bidco, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Snoopy Bidco, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,786<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15,786<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(237)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (237)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc.', window );">Investment, Identifier [Axis]: SpecialtyCare, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.29%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="nump">$ 12,209<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12,209<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc. 1', window );">Investment, Identifier [Axis]: SpecialtyCare, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">0.23%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[14]</sup></td>
<td class="nump">$ 11,592<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc. 2', window );">Investment, Identifier [Axis]: SpecialtyCare, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[15]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[15]</sup></td>
<td class="nump">$ 146<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: SpecialtyCare, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,155<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,155<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc., Revolver', window );">Investment, Identifier [Axis]: SpecialtyCare, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">865<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">614<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Spitfire Parent, Inc. 1', window );">Investment, Identifier [Axis]: Spitfire Parent, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.59%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">1.30%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 53,960<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 78,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 53,960<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Spitfire Parent, Inc. 2', window );">Investment, Identifier [Axis]: Spitfire Parent, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.24%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.26%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="nump">$ 10,845<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,128<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 10,845<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Spitfire Parent, Inc. 3', window );">Investment, Identifier [Axis]: Spitfire Parent, Inc. 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.48%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 20,059<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 20,059<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Spitfire Parent, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Spitfire Parent, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,689<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Stamps.com, Inc.', window );">Investment, Identifier [Axis]: Stamps.com, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5.62%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">6.75%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
<td class="nump">$ 280,899<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 278,069<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 280,899<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=State Street Institutional U.S. Government Money Market Fund', window );">Investment, Identifier [Axis]: State Street Institutional U.S. Government Money Market Fund</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.40%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 19,961<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Stepping Stones Healthcare Services, LLC', window );">Investment, Identifier [Axis]: Stepping Stones Healthcare Services, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.06%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 2,690<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,626<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 2,690<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Stepping Stones Healthcare Services, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Stepping Stones Healthcare Services, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">155<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">441<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Stepping Stones Healthcare Services, LLC, Revolver', window );">Investment, Identifier [Axis]: Stepping Stones Healthcare Services, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">74<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (13)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=TCFI AEVEX, LLC', window );">Investment, Identifier [Axis]: TCFI AEVEX, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.23%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">2.44%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 101,373<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 110,230<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 101,373<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=THL Fund IX Investors (Plymouth II), LP', window );">Investment, Identifier [Axis]: THL Fund IX Investors (Plymouth II), LP</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 249<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=TPG IX Newark CI, L.P. - LP Interests', window );">Investment, Identifier [Axis]: TPG IX Newark CI, L.P. - LP Interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="nump">$ 1,965<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=TRP Infrastructure Services, LLC', window );">Investment, Identifier [Axis]: TRP Infrastructure Services, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.70%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">0.88%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 36,464<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34,608<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[14]</sup></td>
<td class="nump">$ 36,464<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=TRP Infrastructure Services, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: TRP Infrastructure Services, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (71)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Tailwind Colony Holding Corporation', window );">Investment, Identifier [Axis]: Tailwind Colony Holding Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 42,132<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 42,132<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Tailwind Colony Holding Corporation 1', window );">Investment, Identifier [Axis]: Tailwind Colony Holding Corporation 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">$ 5,581<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Tailwind Colony Holding Corporation 2', window );">Investment, Identifier [Axis]: Tailwind Colony Holding Corporation 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">0.84%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">$ 41,465<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Tennessee Bidco Limited 1', window );">Investment, Identifier [Axis]: Tennessee Bidco Limited 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">0.46%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
<td class="nump">$ 19,134<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 19,134<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Tennessee Bidco Limited 2', window );">Investment, Identifier [Axis]: Tennessee Bidco Limited 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">0.81%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
<td class="nump">$ 33,693<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 54,303<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 33,693<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Tennessee Bidco Limited 3', window );">Investment, Identifier [Axis]: Tennessee Bidco Limited 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.33%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">1.28%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
<td class="nump">$ 53,088<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 16,176<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 53,088<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Tennessee Bidco Limited 4', window );">Investment, Identifier [Axis]: Tennessee Bidco Limited 4</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">0.38%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
<td class="nump">$ 15,718<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 55,366<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 15,718<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Tetra Technologies, Inc.', window );">Investment, Identifier [Axis]: Tetra Technologies, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.36%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[14]</sup></td>
<td class="nump">0.43%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[13]</sup></td>
<td class="nump">$ 17,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5],[14]</sup></td>
<td class="nump">$ 17,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The Action Environmental Group, Inc. 1', window );">Investment, Identifier [Axis]: The Action Environmental Group, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[24]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3.17%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[24]</sup></td>
<td class="nump">132,022<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[24]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 132,022<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The Action Environmental Group, Inc. 2', window );">Investment, Identifier [Axis]: The Action Environmental Group, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[24]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.26%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[24]</sup></td>
<td class="nump">10,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[24]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 10,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The Cook &amp; Boardman Group, LLC', window );">Investment, Identifier [Axis]: The Cook &amp; Boardman Group, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[13]</sup></td>
<td class="nump">$ 41,998<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 41,998<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc. 1', window );">Investment, Identifier [Axis]: The Fertility Partners, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[7]</sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11],[12]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[10],[11],[12]</sup></td>
<td class="nump">$ 4,776<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,913<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 4,776<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[10],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc. 2', window );">Investment, Identifier [Axis]: The Fertility Partners, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.07%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[7]</sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11],[12]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11],[12]</sup></td>
<td class="nump">$ 4,287<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,512<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 4,287<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11],[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc. 3', window );">Investment, Identifier [Axis]: The Fertility Partners, Inc. 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[7]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 121<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: The Fertility Partners, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">315<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc., Revolver', window );">Investment, Identifier [Axis]: The Fertility Partners, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">127<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">28<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The GI Alliance Management, LLC', window );">Investment, Identifier [Axis]: The GI Alliance Management, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
<td class="nump">$ 3,998<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,942<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 3,998<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The GI Alliance Management, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: The GI Alliance Management, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">883<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (26)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The NPD Group L.P. 1', window );">Investment, Identifier [Axis]: The NPD Group L.P. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.78%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">74,210<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 74,210<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The NPD Group L.P. 2', window );">Investment, Identifier [Axis]: The NPD Group L.P. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.93%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 121,859<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 121,859<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The NPD Group L.P., Revolver 1', window );">Investment, Identifier [Axis]: The NPD Group L.P., Revolver 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,729<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=The NPD Group L.P., Revolver 2', window );">Investment, Identifier [Axis]: The NPD Group L.P., Revolver 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,416<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (44)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Thevelia US, LLC', window );">Investment, Identifier [Axis]: Thevelia US, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[6],[17]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[12],[18]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[12],[18]</sup></td>
<td class="nump">$ 1,273<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,299<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[6],[17]</sup></td>
<td class="nump">$ 1,273<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[12],[18]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Thevelia US, LLC 2', window );">Investment, Identifier [Axis]: Thevelia US, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[17]</sup></td>
<td class="nump">0.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[18]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[18]</sup></td>
<td class="nump">$ 4,810<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,908<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[17]</sup></td>
<td class="nump">$ 4,810<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[18]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Titan Investment Company, Inc.', window );">Investment, Identifier [Axis]: Titan Investment Company, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.79%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[15]</sup></td>
<td class="nump">0.97%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[16]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[16]</sup></td>
<td class="nump">$ 40,136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 39,206<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[15]</sup></td>
<td class="nump">$ 40,136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Trader Corp.', window );">Investment, Identifier [Axis]: Trader Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.15%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[7]</sup></td>
<td class="nump">0.17%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
<td class="nump">$ 7,185<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[7]</sup></td>
<td class="nump">$ 7,185<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[10],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Trader Corp., Revolver', window );">Investment, Identifier [Axis]: Trader Corp., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (190)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (11)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Tricor Horizon, LP', window );">Investment, Identifier [Axis]: Tricor Horizon, LP</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 382<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">386<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="nump">$ 382<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp.', window );">Investment, Identifier [Axis]: Trinity Air Consultants Holdings Corp.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.61%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 67,079<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 67,079<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp. 1', window );">Investment, Identifier [Axis]: Trinity Air Consultants Holdings Corp. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">1.13%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 55,812<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp. 2', window );">Investment, Identifier [Axis]: Trinity Air Consultants Holdings Corp. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.45%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 22,390<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,916<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">402<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,274<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(113)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp., Revolver', window );">Investment, Identifier [Axis]: Trinity Air Consultants Holdings Corp., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,881<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,881<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (69)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Trinity Partners Holdings, LLC', window );">Investment, Identifier [Axis]: Trinity Partners Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 4,694<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,742<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 4,694<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Trinity Partners Holdings, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Trinity Partners Holdings, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,433<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,433<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Triple Lift, Inc.', window );">Investment, Identifier [Axis]: Triple Lift, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.54%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 63,876<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 63,876<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Triple Lift, Inc. 1', window );">Investment, Identifier [Axis]: Triple Lift, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">1.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 59,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Triple Lift, Inc. 2', window );">Investment, Identifier [Axis]: Triple Lift, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 2,681<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Triple Lift, Inc., Revolver', window );">Investment, Identifier [Axis]: Triple Lift, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,747<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,747<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc. 1', window );">Investment, Identifier [Axis]: Turing Holdco, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.17%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">0.41%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[12],[16]</sup></td>
<td class="nump">$ 17,160<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 8,546<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 17,160<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc. 2', window );">Investment, Identifier [Axis]: Turing Holdco, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.08%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[15]</sup></td>
<td class="nump">0.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
<td class="nump">$ 8,310<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[4],[5],[6],[15]</sup></td>
<td class="nump">$ 8,310<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc. 3', window );">Investment, Identifier [Axis]: Turing Holdco, Inc. 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5],[6],[15]</sup></td>
<td class="nump">0.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5],[6],[15]</sup></td>
<td class="nump">$ 12,165<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc. 4', window );">Investment, Identifier [Axis]: Turing Holdco, Inc. 4</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5],[6],[15]</sup></td>
<td class="nump">0.09%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5],[6],[15]</sup></td>
<td class="nump">$ 4,509<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Turing Holdco, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,239<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc., Delayed Draw Term Loan 1', window );">Investment, Identifier [Axis]: Turing Holdco, Inc., Delayed Draw Term Loan 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">31,468<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc., Delayed Draw Term Loan 2', window );">Investment, Identifier [Axis]: Turing Holdco, Inc., Delayed Draw Term Loan 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,901<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=UMP Holdings, LLC 1', window );">Investment, Identifier [Axis]: UMP Holdings, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 1,068<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=UMP Holdings, LLC 2', window );">Investment, Identifier [Axis]: UMP Holdings, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 1,463<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=UMP Holdings, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: UMP Holdings, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC', window );">Investment, Identifier [Axis]: US Oral Surgery Management Holdco, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.99%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 41,169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 41,169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC 1', window );">Investment, Identifier [Axis]: US Oral Surgery Management Holdco, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.63%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 31,065<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC 2', window );">Investment, Identifier [Axis]: US Oral Surgery Management Holdco, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">0.32%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">$ 15,734<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: US Oral Surgery Management Holdco, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,867<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC, Revolver', window );">Investment, Identifier [Axis]: US Oral Surgery Management Holdco, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (73)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Unified Door &amp; Hardware Group, LLC', window );">Investment, Identifier [Axis]: Unified Door &amp; Hardware Group, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">1.87%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[14]</sup></td>
<td class="nump">$ 92,486<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Unified Door &amp; Hardware Group, LLC 1', window );">Investment, Identifier [Axis]: Unified Door &amp; Hardware Group, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.02%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">953<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 953<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Unified Door &amp; Hardware Group, LLC 2', window );">Investment, Identifier [Axis]: Unified Door &amp; Hardware Group, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.23%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11],[13]</sup></td>
<td class="nump">51,064<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 51,064<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Unified Door &amp; Hardware Group, LLC 3', window );">Investment, Identifier [Axis]: Unified Door &amp; Hardware Group, LLC 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11],[13]</sup></td>
<td class="nump">$ 41,733<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 41,733<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Unified Physician Management, LLC', window );">Investment, Identifier [Axis]: Unified Physician Management, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[17]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[18]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[11],[18]</sup></td>
<td class="nump">$ 2,046<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,102<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[17]</sup></td>
<td class="nump">$ 2,046<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[9],[11],[18]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Unified Physician Management, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Unified Physician Management, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">77<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Unified Physician Management, LLC, Revolver', window );">Investment, Identifier [Axis]: Unified Physician Management, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">241<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">241<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=United Mutual Acquisition Holdings, LLC', window );">Investment, Identifier [Axis]: United Mutual Acquisition Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 1,738<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,738<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=United Mutual Acquisition Holdings, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: United Mutual Acquisition Holdings, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,275<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Veregy Consolidated, Inc.', window );">Investment, Identifier [Axis]: Veregy Consolidated, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.38%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="nump">0.41%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
<td class="nump">$ 17,126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 18,680<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="nump">$ 17,126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Victory Buyer, LLC', window );">Investment, Identifier [Axis]: Victory Buyer, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.18%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[17]</sup></td>
<td class="nump">0.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[18]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[18]</sup></td>
<td class="nump">$ 8,248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,970<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[6],[17]</sup></td>
<td class="nump">$ 8,248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[18]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc.', window );">Investment, Identifier [Axis]: WHCG Purchaser III, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.83%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="nump">$ 34,563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 34,563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc. 1', window );">Investment, Identifier [Axis]: WHCG Purchaser III, Inc. 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">0.53%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5],[6],[7]</sup></td>
<td class="nump">$ 26,419<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc. 2', window );">Investment, Identifier [Axis]: WHCG Purchaser III, Inc. 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.08%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 4,084<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc., Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: WHCG Purchaser III, Inc., Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,490<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc., Revolver', window );">Investment, Identifier [Axis]: WHCG Purchaser III, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,454<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=WPEngine, Inc.', window );">Investment, Identifier [Axis]: WPEngine, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">1.32%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 65,133<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=WPEngine, Inc., Revolver', window );">Investment, Identifier [Axis]: WPEngine, Inc., Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(200)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC', window );">Investment, Identifier [Axis]: West Monroe Partners, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.35%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 14,524<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 14,524<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC 1', window );">Investment, Identifier [Axis]: West Monroe Partners, LLC 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">0.29%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6],[7]</sup></td>
<td class="nump">$ 14,377<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC 2', window );">Investment, Identifier [Axis]: West Monroe Partners, LLC 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[7]</sup></td>
<td class="nump">$ 281<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: West Monroe Partners, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,848<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC, Revolver', window );">Investment, Identifier [Axis]: West Monroe Partners, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,155<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,443<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Westland Insurance Group LTD 1', window );">Investment, Identifier [Axis]: Westland Insurance Group LTD 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.99%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[13]</sup></td>
<td class="nump">41,209<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10],[11],[12],[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 41,209<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Westland Insurance Group LTD 2', window );">Investment, Identifier [Axis]: Westland Insurance Group LTD 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[12],[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.84%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[12],[16]</sup></td>
<td class="nump">$ 118,210<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9],[10],[11],[12],[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 118,210<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Westland Insurance Group LTD, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Westland Insurance Group LTD, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">572<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Windows Acquisition Holdings, Inc.', window );">Investment, Identifier [Axis]: Windows Acquisition Holdings, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">1.29%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
<td class="nump">$ 53,729<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 49,997<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[5],[6],[14]</sup></td>
<td class="nump">$ 53,729<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11],[12],[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=World Insurance Associates, LLC', window );">Investment, Identifier [Axis]: World Insurance Associates, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">0.75%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[5],[6],[14]</sup></td>
<td class="nump">$ 36,914<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=World Insurance Associates, LLC, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: World Insurance Associates, LLC, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">47,025<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(470)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=World Insurance Associates, LLC, Revolver', window );">Investment, Identifier [Axis]: World Insurance Associates, LLC, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,939<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (59)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Zendesk Inc', window );">Investment, Identifier [Axis]: Zendesk Inc</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
<td class="nump">$ 1,542<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,614<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3],[5],[6],[7]</sup></td>
<td class="nump">$ 1,542<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[8],[9],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Zendesk Inc, Delayed Draw Term Loan', window );">Investment, Identifier [Axis]: Zendesk Inc, Delayed Draw Term Loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">361<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">361<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Zendesk Inc, Revolver', window );">Investment, Identifier [Axis]: Zendesk Inc, Revolver</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Zoro Common Equity', window );">Investment, Identifier [Axis]: Zoro Common Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 21<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 21<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 21<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=Zoro Series A Preferred Shares', window );">Investment, Identifier [Axis]: Zoro Series A Preferred Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.01%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
<td class="nump">$ 362<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 418<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 362<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[11]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Unless otherwise indicated, all debt and equity investments held by the Company (which such term &#8220;Company&#8221; shall include the Company&#8217;s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December&#160;31, 2022, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in </span><div style="margin-top:2pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><br/><br/><br/><br/><br/>thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company&#8217;s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.</span></div></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Position or portion thereof is an unfunded commitment, and no interest is being earned on the unfunded portion, although the investment may be subject to unused commitment fees. Negative cost and fair value results from unamortized fees, which are capitalized to the investment cost. The unfunded commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. See below for more information on the Company&#8217;s unfunded commitments:</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:26.68pt">These investments are not pledged as collateral under any of the Company's credit facilities. For other debt investments that are pledged to the Company's credit facilities, a single investment may be divided into parts that are individually pledged as collateral to separate credit facilities. Any other debt investments listed above are pledged to financing facilities and are not available to satisfy the creditors of the Company.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">The investment is not a qualifying asset under Section 55(a) of the Investment Company Act of 1940, as amended (together with the rules and regulations promulgated thereunder, the &#8220;1940 Act&#8221;). The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70% of the Company&#8217;s total assets. As of December&#160;31, 2023, non-qualifying assets represented 11.0% of total assets as calculated in accordance with regulatory requirements.<br/><br/></span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">These investments were valued using unobservable inputs and are considered Level 3 investments. Fair value was determined in good faith by or under the direction of the Board of Trustees (see Note 2), pursuant to the Company&#8217;s valuation policy.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">Unless otherwise indicated, all debt and equity investments held by the Company (which such term &#8220;Company&#8221; shall include the Company&#8217;s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December&#160;31, 2023, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company&#8217;s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">The interest rate floor on these investments as of December&#160;31, 2023 was 0.75%.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was 0.75%</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion, although the investment may be subject to unused commitment fees. Negative cost and fair value results from unamortized fees, which are capitalized to the investment cost. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. See below for more information on the Company&#8217;s unfunded commitments:</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">The investment is not a qualifying asset under Section 55(a) of the 1940 Act. The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70% of the Company&#8217;s total assets. As of December&#160;31, 2022, non-qualifying assets represented 11.0% of total assets as calculated in accordance with regulatory requirements.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">These investments were valued using unobservable inputs and are considered Level 3 investments. Fair value was determined in good faith by or under the direction of the Board of Trustees (see Note 2 and Note 5), pursuant to the Company&#8217;s valuation policy.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:26.68pt">These debt investments are not pledged as collateral under any of the Company's credit facilities. For other debt investments that are pledged to the Company's credit facilities, a single investment may be divided into parts that are individually pledged as collateral to separate credit facilities. Any other debt investments listed above are pledged to financing facilities and are not available to satisfy the creditors of the Company.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[13]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was 1.00%</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[14]</td>
<td style="vertical-align: top;" valign="top">The interest rate floor on these investments as of December&#160;31, 2023 was 1.00%</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[15]</td>
<td style="vertical-align: top;" valign="top">There are no interest rate floors on these investments.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[16]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">There are no interest rate floors on these investments.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[17]</td>
<td style="vertical-align: top;" valign="top">The interest rate floor on these investments as of December&#160;31, 2023 was 0.50%.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[18]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was 0.50%</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[19]</td>
<td style="vertical-align: top;" valign="top">The interest rate floor on these investments as of December&#160;31, 2023 was 1.50%.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[20]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was 1.50%</span><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was 2.00%</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">For unsettled positions the interest rate does not include the base rate.</span></div></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[21]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">Under the 1940 Act, the Company would be deemed to &#8220;control&#8221; a portfolio company if the Company owned more than 25% of its outstanding voting securities and/or held the power to exercise control over the management or policies of the portfolio company. As of December&#160;31, 2023, the Company does not &#8220;control&#8221; any of these portfolio companies. Under the 1940 Act, the Company would be deemed an &#8220;affiliated person&#8221; of a portfolio company if the Company owns 5% or more of the portfolio company&#8217;s outstanding voting securities. As of December&#160;31, 2023, the Company&#8217;s non-controlled/affiliated investments were as follows:</span><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.901%"><tr><td style="width:1.0%"></td><td style="width:28.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.136%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.988%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value as of December&#160;31, 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Reductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net change in Unrealized Gains (Losses)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Realized Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value as of December&#160;31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend and Interest Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlled/Affiliated Investments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Blackstone Donegal Holdings LP</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(44,921)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,156)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">56,584</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(44,921)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14,156)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,283</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[22]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">Loan was on non-accrual status as of December&#160;31, 2023.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[23]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">These loans are &#8220;last-out&#8221; portions of loans. The &#8220;last-out&#8221; portion of the Company's loan investment generally earns a higher interest rate than the &#8220;first-out&#8221; portion, and in exchange the &#8220;first-out&#8221; portion would generally receive priority with respect to payment principal, interest and any other amounts due thereunder over the &#8220;last-out&#8221; portion.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[24]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was 1.25%.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Company, Financial Commitment to Investee, Future Amount, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentPercentageOfPortfolioAboveFloorRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment, Percentage Of Portfolio Above Floor Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentPercentageOfPortfolioAboveFloorRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating dividend and interest income, including amortization and accretion of premiums and discounts, on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of financial support committed by investment company to investee that is contractually required but not provided.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in security owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedPercentOfNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of investment owned to net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedPercentOfNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross additions to the investment in and advance to the affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross reductions to the investment in and advance to the affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the investments in and advances to affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized gain (loss) on investment, derivative, and foreign currency transaction on investment and derivative from change in market price, classified as operating. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480228/946-830-45-36<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIssuerNameAxis=bxsl_BlackstoneDonegalHoldingsLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIssuerNameAxis=bxsl_BlackstoneDonegalHoldingsLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=bxsl_QualifyingAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=bxsl_QualifyingAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=bxsl_NonQualifyingAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=bxsl_NonQualifyingAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=123Dentist, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=123Dentist, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=123Dentist, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=123Dentist, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ACI Group Holdings, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ADCS Clinics Intermediate Holdings, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=AGI Group Holdings LP - A2 Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=AGI Group Holdings LP - A2 Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=AGI-CFI Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=AGI-CFI Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=AGI-CFI Holdings, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=AGI-CFI Holdings, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=AGI-CFI Holdings, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=AGI-CFI Holdings, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=AI Altius Bidco, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=AI Altius Bidco, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=AI Altius Bidco, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=AI Altius Bidco, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=AI Altius Bidco, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=AI Altius Bidco, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ALKU, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ALKU, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ALKU, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ALKU, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ALKU, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ALKU, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ASP Endeavor Acquisition, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ASP Endeavor Acquisition, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=AVE Holdings I Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=AVE Holdings I Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Abaco Energy Technologies, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Abaco Energy Technologies, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Albireo Energy, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Albireo Energy, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Albireo Energy, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Albireo Energy, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Albireo Energy, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Albireo Energy, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Albireo Energy, LLC 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Albireo Energy, LLC 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Alera Group, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Alera Group, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Alera Group, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Alera Group, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Amerilife Holdings LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings LLC, Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Amerilife Holdings LLC, Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings LLC, Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Amerilife Holdings LLC, Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Amerilife Holdings LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Amerilife Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Amerilife Holdings, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Amerilife Holdings, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Amerilife Holdings, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Amerivet Partners Management, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Anaplan, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Anaplan, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Anaplan, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Anaplan, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Apex Companies, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Apex Companies, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Apex Companies, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Apex Companies, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Armada Parent, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Armada Parent, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Armada Parent, Inc. ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Armada Parent, Inc. </td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Armada Parent, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Armada Parent, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Armada Parent, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Armada Parent, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Ascend Buyer, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Ascend Buyer, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Ascend Buyer, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Ascend Buyer, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Ascend Buyer, LLC 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Ascend Buyer, LLC 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Ascend Buyer, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Ascend Buyer, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=AxiomSL Group, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=AxiomSL Group, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=AxiomSL Group, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=AxiomSL Group, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=AxiomSL Group, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=AxiomSL Group, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BP Purchaser, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BP Purchaser, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BPPH2 Limited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BPPH2 Limited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Bamboo US BidCo LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Bamboo US BidCo LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Bamboo US BidCo LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Bamboo US BidCo LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Bamboo US BidCo LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Bamboo US BidCo LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Bamboo US BidCo LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Bamboo US BidCo LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Barbri Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Barbri Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Barbri Holdings, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Barbri Holdings, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Bazaarvoice, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Bazaarvoice, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Bazaarvoice, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Bazaarvoice, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Bazaarvoice, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Bazaarvoice, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Bazaarvoice, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Bazaarvoice, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Beeline, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Beeline, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Beeline, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Beeline, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Beeline, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Beeline, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Benefytt Technologies, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Benefytt Technologies, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Benefytt Technologies, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Benefytt Technologies, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD)">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD)</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD) ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD) </td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc. 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc. 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc., Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc., Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc., Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BlueCat Networks USA, Inc., Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Bluefin Holding, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Bluefin Holding, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Bluefin Holding, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Bluefin Holding, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Box Co-Invest Blocker, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Box Co-Invest Blocker, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Box Co-Invest Blocker, LLC - Class A Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Box Co-Invest Blocker, LLC - Class A Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Box Co-Invest Blocker, LLC - Class C Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Box Co-Invest Blocker, LLC - Class C Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BradyIFS Holdings, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BradyIFS Holdings, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BradyIFS Holdings, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BradyIFS Holdings, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BradyIFS Holdings, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BradyIFS Holdings, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=BradyIFS Holdings, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=BradyIFS Holdings, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Brave Parent Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Brave Parent Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Brave Parent Holdings, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Brave Parent Holdings, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Brave Parent Holdings, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Brave Parent Holdings, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Bution Holdco 2, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Bution Holdco 2, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CCBlue Bidco, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CCBlue Bidco, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CCBlue Bidco, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CCBlue Bidco, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CFCo LLC (Benefytt Technologies, Inc.)">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CFCo LLC (Benefytt Technologies, Inc.)</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CFCo LLC (Benefytt Technologies, Inc.) - Class B Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CFCo LLC (Benefytt Technologies, Inc.) - Class B Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CFGI Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CFGI Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CFGI Holdings, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CFGI Holdings, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CFGI Holdings, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CFGI Holdings, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CFS Brands, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CFS Brands, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CFS Brands, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CFS Brands, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CFS Brands, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CFS Brands, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=COP Home Services TopCo IV, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=COP Home Services TopCo IV, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=COP Home Services TopCo IV, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=COP Home Services TopCo IV, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=COP Home Services TopCo IV, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=COP Home Services TopCo IV, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=COP Home Services TopCo IV, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=COP Home Services TopCo IV, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CPI Buyer, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CPI Buyer, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CPI Buyer, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CPI Buyer, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CPI Buyer, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CPI Buyer, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CPI Buyer, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CPI Buyer, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CPI Intermediate Holdings Inc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CPI Intermediate Holdings Inc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CPI Intermediate Holdings Inc, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CPI Intermediate Holdings Inc, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Caerus Midco 2 S.&#192;. R.L - Additional Vehicle Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Caerus Midco 2 S.&#192;. R.L - Additional Vehicle Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Caerus Midco 2 S.&#192;. R.L - Vehicle Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Caerus Midco 2 S.&#192;. R.L - Vehicle Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc. 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc. 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Revolver 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Revolver 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Revolver 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Caerus US 1, Inc., Revolver 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Cambium Holdings, LLC - Senior Preferred Interests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Cambium Holdings, LLC - Senior Preferred Interests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Cambium Learning Group, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Cambium Learning Group, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Cambium Learning Group, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Cambium Learning Group, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd. 4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd. 4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Canadian Hospital Specialties Ltd., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Capstone Logistics, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Capstone Logistics, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Castle Management Borrower, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Castle Management Borrower, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Castle Management Borrower, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Castle Management Borrower, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Circana Group, L.P. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Circana Group, L.P. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Circana Group, L.P. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Circana Group, L.P. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Circana Group, L.P. 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Circana Group, L.P. 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Circana Group, L.P., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Circana Group, L.P., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Clearview Buyer, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Clearview Buyer, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Clearview Buyer, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Clearview Buyer, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Clearview Buyer, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Clearview Buyer, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Color Intermediate LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Color Intermediate LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Community Brands ParentCo, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Community Brands ParentCo, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Community Brands ParentCo, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Community Brands ParentCo, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Community Brands ParentCo, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Community Brands ParentCo, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Confine Visual Bidco">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Confine Visual Bidco</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Confine Visual Bidco, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Confine Visual Bidco, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Connatix Buyer, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Connatix Buyer, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Connatix Buyer, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Connatix Buyer, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Connatix Buyer, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Connatix Buyer, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Connatix Parent, LLC - Class L Common Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Connatix Parent, LLC - Class L Common Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Corfin Holdings, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Corfin Holdings, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Corfin Holdings, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Corfin Holdings, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Coupa Software Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Coupa Software Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Coupa Software Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Coupa Software Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Coupa Software Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Coupa Software Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Crewline Buyer, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Crewline Buyer, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Crewline Buyer, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Crewline Buyer, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Cross Country Healthcare, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Cross Country Healthcare, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Cumming Group, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Cumming Group, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Cumming Group, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Cumming Group, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Cumming Group, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Cumming Group, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Cumming Group, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Cumming Group, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CustomInk, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CustomInk, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=CustomInk, LLC - Series A Preferred Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=CustomInk, LLC - Series A Preferred Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC, Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC, Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC, Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=DCA Investment Holdings, LLC, Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Dana Kepner Company, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Dana Kepner Company, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Dana Kepner Company, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Dana Kepner Company, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Dana Kepner Company, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Dana Kepner Company, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Daylight Beta Parent LLC (Benefytt Technologies, Inc.)">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Daylight Beta Parent LLC (Benefytt Technologies, Inc.)</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Denali Bidco Ltd 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Denali Bidco Ltd 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Denali Bidco Ltd 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Denali Bidco Ltd 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Denali Bidco Ltd, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Denali Bidco Ltd, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Deneb Ultimate Topco, LLC - Class A Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Deneb Ultimate Topco, LLC - Class A Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Descartes Holdings, Inc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Descartes Holdings, Inc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Diligent Corporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Diligent Corporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Discovery Education, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Doc Generici (Diocle S.p.A.)">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Doc Generici (Diocle S.p.A.)</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Doc Generici (Diocle S.p.A.), Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Doc Generici (Diocle S.p.A.), Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Donuts, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Donuts, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Dreambox Learning Holding LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Dreambox Learning Holding LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=EIS Acquisition Holdings, LP - Class A Common Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=EIS Acquisition Holdings, LP - Class A Common Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ENV BIDCO AB, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ENV BIDCO AB, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ENV Bidco AB 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ENV Bidco AB 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ENV Bidco AB 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ENV Bidco AB 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ENV Bidco AB, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ENV Bidco AB, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Eagle Midstream Canada Finance, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Eagle Midstream Canada Finance, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Edifecs, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Edifecs, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Edifecs, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Edifecs, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Emergency Power Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Emergency Power Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Emergency Power Holdings, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Emergency Power Holdings, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Endeavor Schools Holdings LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Endeavor Schools Holdings LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Endeavor Schools Holdings LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Endeavor Schools Holdings LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Endeavor Schools Holdings LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Endeavor Schools Holdings LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Episerver, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Episerver, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Episerver, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Episerver, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Epoch Acquisition, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Epoch Acquisition, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Ergomed Plc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Ergomed Plc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Ergomed Plc, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Ergomed Plc, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Expedition Holdco, LLC - Class A Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Expedition Holdco, LLC - Class A Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Expedition Holdco, LLC - Class B Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Expedition Holdco, LLC - Class B Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Experity, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Experity, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Experity, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Experity, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Fencing Supply Group Acquisition, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Fencing Supply Group Acquisition, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Fencing Supply Group Acquisition, LLC, Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Fencing Supply Group Acquisition, LLC, Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Fencing Supply Group Acquisition, LLC, Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Fencing Supply Group Acquisition, LLC, Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Formulations Parent Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Formulations Parent Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Formulations Parent Corp., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Formulations Parent Corp., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Foundation Risk Partners Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Foundation Risk Partners Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Foundation Risk Partners Corp., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Foundation Risk Partners Corp., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Foundation Risk Partners Corp., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Foundation Risk Partners Corp., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Freya Bidco Limited, Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Freya Bidco Limited, Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Freya Bidco Limited, Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Freya Bidco Limited, Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Freya Bidco Limited, Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Freya Bidco Limited, Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Freya Bidco Limited, Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Freya Bidco Limited, Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Frontgrade Technologies Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Frontgrade Technologies Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Frontgrade Technologies Holdings, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Frontgrade Technologies Holdings, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Frontline Road Safety Investments, LLC - Class A Common Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Frontline Road Safety Investments, LLC - Class A Common Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Frontline Road Safety, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Frontline Road Safety, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Frontline Road Safety, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Frontline Road Safety, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Frontline Road Safety, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Frontline Road Safety, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Frontline Road Safety, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Frontline Road Safety, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=FusionSite Midco, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=FusionSite Midco, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=FusionSite Midco, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=FusionSite Midco, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=FusionSite Midco, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=FusionSite Midco, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=FusionSite Midco, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=FusionSite Midco, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GCX Corporation Buyer, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GCX Corporation Buyer, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GCX Corporation Buyer, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GCX Corporation Buyer, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GCX Corporation Buyer, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GCX Corporation Buyer, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GCX Corporation Buyer, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GCX Corporation Buyer, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GCX Corporation Group Holdings, L.P. - Class A-2 Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GCX Corporation Group Holdings, L.P. - Class A-2 Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GI Consilio Parent, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GI Consilio Parent, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GI Consilio Parent, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GI Consilio Parent, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GI Ranger Intermediate, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GTCR Investors LP - A-1 Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GTCR Investors LP - A-1 Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Galway Borrower, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Galway Borrower, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Galway Borrower, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Galway Borrower, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Galway Borrower, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Galway Borrower, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Genuine Cable Group, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Genuine Cable Group, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Gigamon Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Gigamon Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Gigamon Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Gigamon Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Go Car Wash Management Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Go Car Wash Management Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Go Car Wash Management Corp., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Go Car Wash Management Corp., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GovernmentJobs.com, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GovernmentJobs.com, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GovernmentJobs.com, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GovernmentJobs.com, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GovernmentJobs.com, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GovernmentJobs.com, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC 4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC 4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=GraphPAD Software, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Groundworks, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Groundworks, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Groundworks, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Groundworks, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Groundworks, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Groundworks, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Gruden Acquisition, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Gruden Acquisition, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Gruden Acquisition, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Gruden Acquisition, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Gruden Acquisition, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Gruden Acquisition, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Guidehouse Holding Corp. - Preferred Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Guidehouse Holding Corp. - Preferred Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Guidehouse, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Guidehouse, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=HIG Orca Acquisition Holdings, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC - Preferred Interest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC - Preferred Interest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Healthcomp Holding Company, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Helix TS, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Helix TS, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Helix TS, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Helix TS, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Helix TS, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Helix TS, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Helix TS, LLC, Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Helix TS, LLC, Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Helix TS, LLC, Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Helix TS, LLC, Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=High Street Buyer, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=IG Investments Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=IG Investments Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=IG Investments Holdings, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=IG Investments Holdings, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ISQ Hawkey Holdco, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ISQ Hawkey Holdco, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ISQ Hawkey Holdco, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ISQ Hawkey Holdco, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ISQ Hawkeye Holdco, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ISQ Hawkeye Holdco, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ISQ Hawkeye Holdco, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ISQ Hawkeye Holdco, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=ISQ Hawkeye Holdco, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=ISQ Hawkeye Holdco, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Icefall Parent Inc, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Icefall Parent Inc, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Icefall Parent Inc, Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Icefall Parent Inc, Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Infostretch Corporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Infostretch Corporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Inova Pharmaceutical, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Inova Pharmaceutical, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Inova Pharmaceutical, Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Inova Pharmaceutical, Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Inovalon Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Inovalon Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Inovalon Holdings, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Inovalon Holdings, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Inovalon Holdings, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Inovalon Holdings, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC 5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC 5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Integrity Marketing Acquisition, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Investment  One">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Investment  One</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Investment Five">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Investment Five</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Investment Four">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Investment Four</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Investment One">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Investment One</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Investment Seven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Investment Seven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Investment Six">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Investment Six</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Investment Three">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Investment Three</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Investment Two">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Investment Two</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Iris Buyer, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Iris Buyer, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Iris Buyer, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Iris Buyer, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Iris Buyer, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Iris Buyer, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Italian Motorway Holdings S.&#224;.r.l">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Italian Motorway Holdings S.&#224;.r.l</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=JSS Holdings, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=JSS Holdings, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=JSS Holdings, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=JSS Holdings, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Jacuzzi Brands, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Jacuzzi Brands, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Jacuzzi Brands, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Jacuzzi Brands, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Jacuzzi Brands, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Jacuzzi Brands, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc., Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc., Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc., Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Java Buyer, Inc., Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Jayhawk Buyer, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Jayhawk Buyer, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Jayhawk Buyer, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Jayhawk Buyer, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Jayhawk Buyer, LLC 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Jayhawk Buyer, LLC 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Jayhawk Buyer, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Jayhawk Buyer, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Jayhawk Holdings, LP - A-1 Common Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Jayhawk Holdings, LP - A-1 Common Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Jayhawk Holdings, LP - A-2 Common Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Jayhawk Holdings, LP - A-2 Common Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Jones Deslauriers Insurance Management, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Jones Deslauriers Insurance Management, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=KKR Alberta Midstream Finance Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=KKR Alberta Midstream Finance Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=KPSKY Acquisition, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=KPSKY Acquisition, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=KPSKY Acquisition, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=KPSKY Acquisition, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=KPSKY Acquisition, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=KPSKY Acquisition, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=KPSKY Acquisition, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=KPSKY Acquisition, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Kaufman Hall &amp; Associates, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Kaufman Hall &amp; Associates, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Knowledge Pro Buyer, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Knowledge Pro Buyer, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Knowledge Pro Buyer, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Knowledge Pro Buyer, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Knowledge Pro Buyer, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Knowledge Pro Buyer, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Kwol Acquisition, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Kwol Acquisition, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Kwol Acquisition, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Kwol Acquisition, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=L&amp;S Mechanical Acquisition, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=L&amp;S Mechanical Acquisition, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=LD Lower Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=LD Lower Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=LD Lower Holdings, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=LD Lower Holdings, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Legacy Intermediate, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Legacy Intermediate, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Legacy Intermediate, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Legacy Intermediate, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Legacy Intermediate, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Legacy Intermediate, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Lightbox Intermediate, LP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Lightbox Intermediate, LP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Lindstrom, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Lindstrom, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Linquest Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Linquest Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Linquest Corp., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Linquest Corp., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Livingston International, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Livingston International, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Lobos Parent, Inc. - Series A Preferred Shares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Lobos Parent, Inc. - Series A Preferred Shares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Lytx, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Lytx, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MAG DS Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MAG DS Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MHE Intermediate Holdings 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MHE Intermediate Holdings 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MHE Intermediate Holdings 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MHE Intermediate Holdings 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MHE Intermediate Holdings, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MHE Intermediate Holdings, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MPG Parent Holdings LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MPG Parent Holdings LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MPG Parent Holdings LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MPG Parent Holdings LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MPG Parent Holdings LLC, Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MPG Parent Holdings LLC, Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MRI Software, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MRI Software, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Revolver 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Revolver 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Revolver 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Revolver 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Revolver 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Revolver 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Revolver 4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=MRI Software, LLC, Revolver 4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Magnesium BorrowerCo, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Magnesium BorrowerCo, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Magnesium BorrowerCo, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Magnesium BorrowerCo, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Magnesium BorrowerCo, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Magnesium BorrowerCo, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Magneto Components BuyCo, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Magneto Components BuyCo, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Magneto Components BuyCo, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Magneto Components BuyCo, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Magneto Components BuyCo, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Magneto Components BuyCo, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Holdings, Inc. - Series A Preferred Shares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mandolin Technology Holdings, Inc. - Series A Preferred Shares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc. 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc. 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc. 4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc. 4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mandolin Technology Intermediate Holdings, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Marcone Yellowstone Buyer, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Marcone Yellowstone Buyer, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Marcone Yellowstone Buyer, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Marcone Yellowstone Buyer, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Marcone Yellowstone Buyer, Inc. 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Marcone Yellowstone Buyer, Inc. 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Marcone Yellowstone Buyer, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Marcone Yellowstone Buyer, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Material Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Material Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Material Holdings, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Material Holdings, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Material Holdings, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Material Holdings, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Maverick Acquisition, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Maverick Acquisition, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Medallia, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Medallia, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Medallia, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Medallia, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Medallia, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Medallia, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mercury Bidco Globe Limited, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mercury Bidco Globe Limited, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mercury Bidco Globe Limited, Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mercury Bidco Globe Limited, Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Micross Topco, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Micross Topco, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mimecast Limited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mimecast Limited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Minotaur Acquisition, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Minotaur Acquisition, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mode Holdings, L.P. - Class A-2 Common Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mode Holdings, L.P. - Class A-2 Common Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mode Purchaser, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mode Purchaser, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Mode Purchaser, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Mode Purchaser, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monk Holding Co.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monk Holding Co.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monk Holding Co. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monk Holding Co. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monk Holding Co. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monk Holding Co. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monk Holding Co., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monk Holding Co., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l 4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l 4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monterey Financing S.&#224;.r.l, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L 5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Monterey Financing, S.A.R.L, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=More Cowbell II, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=More Cowbell II, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=More Cowbell II, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=More Cowbell II, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=More Cowbell II, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=More Cowbell II, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=More Cowbell II, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=More Cowbell II, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=NAVEX TopCo, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=NAVEX TopCo, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=NAVEX TopCo, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=NAVEX TopCo, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=NC Ocala Co-Invest Beta, L.P. - LP Interest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=NC Ocala Co-Invest Beta, L.P. - LP Interest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=NDC Acquisition Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=NDC Acquisition Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=NDC Acquisition Corp. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=NDC Acquisition Corp. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=NDC Acquisition Corp. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=NDC Acquisition Corp. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=NDC Acquisition Corp., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=NDC Acquisition Corp., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=NMC Crimson Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=NMC Crimson Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=NMC Crimson Holdings, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=NMC Crimson Holdings, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=NMC Crimson Holdings, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=NMC Crimson Holdings, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=NMC Crimson Holdings, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=NMC Crimson Holdings, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Navigator Acquiror, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Navigator Acquiror, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Navigator Acquiror, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Navigator Acquiror, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Ncp Helix Holdings, LLC. - Preferred Shares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Ncp Helix Holdings, LLC. - Preferred Shares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Neptune Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Neptune Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Neptune Holdings, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Neptune Holdings, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Nintex Topco Limited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Nintex Topco Limited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=OHCP V TC COI, LP. - LP Interest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=OHCP V TC COI, LP. - LP Interest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Odyssey Holding Company, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Odyssey Holding Company, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Odyssey Holding Company, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Odyssey Holding Company, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Odyssey Holding Company, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Odyssey Holding Company, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc., Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc., Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc., Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Onex Baltimore Buyer, Inc., Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Oranje Holdco Inc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Oranje Holdco Inc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Oranje Holdco Inc, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Oranje Holdco Inc, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Other Cash and Cash Equivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Other Cash and Cash Equivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=PGIS Intermediate Holdings, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=PPV Intermediate Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=PPV Intermediate Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=PPV Intermediate Holdings, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=PPV Intermediate Holdings, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=PPV Intermediate Holdings, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=PPV Intermediate Holdings, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Pavion Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Pavion Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Pavion Corp., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Pavion Corp., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Pavion Corp., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Pavion Corp., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Petrus Buyer Inc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Petrus Buyer Inc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Petrus Buyer Inc, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Petrus Buyer Inc, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Petrus Buyer Inc, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Petrus Buyer Inc, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Phoenix 1 Buyer Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Phoenix 1 Buyer Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Phoenix 1 Buyer Corp., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Phoenix 1 Buyer Corp., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Acquisition, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Point Broadband Acquisition, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Acquisition, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Point Broadband Acquisition, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Acquisition, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Point Broadband Acquisition, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Acquisition, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Point Broadband Acquisition, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Holdings, LLC - Class A Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Point Broadband Holdings, LLC - Class A Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Holdings, LLC - Class Additional A Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Point Broadband Holdings, LLC - Class Additional A Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Holdings, LLC - Class Additional B Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Point Broadband Holdings, LLC - Class Additional B Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Point Broadband Holdings, LLC - Class B Units">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Point Broadband Holdings, LLC - Class B Units</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Porcelain Acquisition Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Porcelain Acquisition Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Porcelain Acquisition Corp., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Porcelain Acquisition Corp., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Profile Products, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Profile Products, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Profile Products, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Profile Products, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Profile Products, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Profile Products, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Profile Products, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Profile Products, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Profile Products, LLC, Revolver 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Profile Products, LLC, Revolver 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Profile Products, LLC, Revolver 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Profile Products, LLC, Revolver 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Progress Residential PM Holdings, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Progress Residential PM Holdings, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Progress Residential PM Holdings, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Progress Residential PM Holdings, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Project Boost Purchaser, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Project Boost Purchaser, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Project Boost Purchaser, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Project Boost Purchaser, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Project Boost Purchaser, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Project Boost Purchaser, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Project Ruby Ultimate Parent Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Project Ruby Ultimate Parent Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Pye-Barker Fire &amp; Safety LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Pye-Barker Fire &amp; Safety LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC, Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC, Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC, Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC, Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC, Revolver 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC, Revolver 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC, Revolver 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Quality Distribution LLC, Revolver 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Qualus Power Services Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Qualus Power Services Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Qualus Power Services Corp. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Qualus Power Services Corp. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Qualus Power Services Corp., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Qualus Power Services Corp., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=RPBLS Midco, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=RPBLS Midco, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=RPBLS Midco, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=RPBLS Midco, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=RPBLS Midco, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=RPBLS Midco, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=RPBLS Midco, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=RPBLS Midco, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=RWL Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=RWL Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=RWL Holdings, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=RWL Holdings, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Rally Buyer, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Razor Holdco, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Razor Holdco, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Red River Technology, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Red River Technology, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Red River Technology, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Red River Technology, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Redwood Services Group, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Redwood Services Group, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Redwood Services Group, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Redwood Services Group, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Redwood Services Group, LLC, Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Redwood Services Group, LLC, Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Redwood Services Group, LLC, Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Redwood Services Group, LLC, Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Relativity ODA, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Relativity ODA, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Relativity ODA, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Relativity ODA, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Relay Purchaser, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Relay Purchaser, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Relay Purchaser, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Relay Purchaser, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=RoadOne Inc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=RoadOne Inc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=RoadOne Inc, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=RoadOne Inc, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=RoadOne Inc, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=RoadOne Inc, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc. 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc. 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Roadsafe Holdings, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=S&amp;P Global Engineering Solutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=S&amp;P Global Engineering Solutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=S&amp;P Global Engineering Solutions, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=S&amp;P Global Engineering Solutions, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC 4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC 4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SEKO Global Logistics Network, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SG Acquisition, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SG Acquisition, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Safety Borrower Holdings LP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Safety Borrower Holdings LP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Safety Borrower Holdings LP 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Safety Borrower Holdings LP 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Safety Borrower Holdings LP 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Safety Borrower Holdings LP 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Safety Borrower Holdings LP, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Safety Borrower Holdings LP, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc. 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc. 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Sam Holding Co, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SelectQuote, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SelectQuote, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Shelf Bidco Ltd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Shelf Bidco Ltd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Shelf Holdco Ltd Common Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Shelf Holdco Ltd Common Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Sherlock Buyer Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Sherlock Buyer Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Sherlock Buyer Corp., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Sherlock Buyer Corp., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Sherlock Buyer Corp., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Sherlock Buyer Corp., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Shoals Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Shoals Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Smile Doctors, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Smile Doctors, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Smile Doctors, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Smile Doctors, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Smile Doctors, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Smile Doctors, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Snoopy Bidco, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Snoopy Bidco, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Snoopy Bidco, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Snoopy Bidco, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=SpecialtyCare, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Spitfire Parent, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Spitfire Parent, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Spitfire Parent, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Spitfire Parent, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Spitfire Parent, Inc. 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Spitfire Parent, Inc. 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Spitfire Parent, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Spitfire Parent, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Stamps.com, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Stamps.com, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=State Street Institutional U.S. Government Money Market Fund">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=State Street Institutional U.S. Government Money Market Fund</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Stepping Stones Healthcare Services, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Stepping Stones Healthcare Services, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Stepping Stones Healthcare Services, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Stepping Stones Healthcare Services, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Stepping Stones Healthcare Services, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Stepping Stones Healthcare Services, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=TCFI AEVEX, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=TCFI AEVEX, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=THL Fund IX Investors (Plymouth II), LP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=THL Fund IX Investors (Plymouth II), LP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=TPG IX Newark CI, L.P. - LP Interests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=TPG IX Newark CI, L.P. - LP Interests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=TRP Infrastructure Services, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=TRP Infrastructure Services, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=TRP Infrastructure Services, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=TRP Infrastructure Services, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Tailwind Colony Holding Corporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Tailwind Colony Holding Corporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Tailwind Colony Holding Corporation 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Tailwind Colony Holding Corporation 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Tailwind Colony Holding Corporation 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Tailwind Colony Holding Corporation 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Tennessee Bidco Limited 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Tennessee Bidco Limited 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Tennessee Bidco Limited 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Tennessee Bidco Limited 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Tennessee Bidco Limited 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Tennessee Bidco Limited 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Tennessee Bidco Limited 4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Tennessee Bidco Limited 4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Tetra Technologies, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Tetra Technologies, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The Action Environmental Group, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The Action Environmental Group, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The Action Environmental Group, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The Action Environmental Group, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The Cook &amp; Boardman Group, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The Cook &amp; Boardman Group, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc. 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc. 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The Fertility Partners, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The GI Alliance Management, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The GI Alliance Management, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The GI Alliance Management, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The GI Alliance Management, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The NPD Group L.P. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The NPD Group L.P. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The NPD Group L.P. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The NPD Group L.P. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The NPD Group L.P., Revolver 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The NPD Group L.P., Revolver 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=The NPD Group L.P., Revolver 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=The NPD Group L.P., Revolver 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Thevelia US, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Thevelia US, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Thevelia US, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Thevelia US, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Titan Investment Company, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Titan Investment Company, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Trader Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Trader Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Trader Corp., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Trader Corp., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Tricor Horizon, LP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Tricor Horizon, LP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Trinity Air Consultants Holdings Corp., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Trinity Partners Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Trinity Partners Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Trinity Partners Holdings, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Trinity Partners Holdings, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Triple Lift, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Triple Lift, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Triple Lift, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Triple Lift, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Triple Lift, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Triple Lift, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Triple Lift, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Triple Lift, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc. 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc. 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc. 4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc. 4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc., Delayed Draw Term Loan 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc., Delayed Draw Term Loan 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc., Delayed Draw Term Loan 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Turing Holdco, Inc., Delayed Draw Term Loan 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=UMP Holdings, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=UMP Holdings, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=UMP Holdings, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=UMP Holdings, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=UMP Holdings, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=UMP Holdings, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=US Oral Surgery Management Holdco, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Unified Door &amp; Hardware Group, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Unified Door &amp; Hardware Group, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Unified Door &amp; Hardware Group, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Unified Door &amp; Hardware Group, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Unified Door &amp; Hardware Group, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Unified Door &amp; Hardware Group, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Unified Door &amp; Hardware Group, LLC 3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Unified Door &amp; Hardware Group, LLC 3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Unified Physician Management, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Unified Physician Management, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Unified Physician Management, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Unified Physician Management, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Unified Physician Management, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Unified Physician Management, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=United Mutual Acquisition Holdings, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=United Mutual Acquisition Holdings, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=United Mutual Acquisition Holdings, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=United Mutual Acquisition Holdings, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Veregy Consolidated, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Veregy Consolidated, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Victory Buyer, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Victory Buyer, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc. 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc. 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc. 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc. 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc., Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc., Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=WHCG Purchaser III, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=WPEngine, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=WPEngine, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=WPEngine, Inc., Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=WPEngine, Inc., Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=West Monroe Partners, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Westland Insurance Group LTD 1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Westland Insurance Group LTD 1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Westland Insurance Group LTD 2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Westland Insurance Group LTD 2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Westland Insurance Group LTD, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Westland Insurance Group LTD, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Windows Acquisition Holdings, Inc.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Windows Acquisition Holdings, Inc.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=World Insurance Associates, LLC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=World Insurance Associates, LLC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=World Insurance Associates, LLC, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=World Insurance Associates, LLC, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=World Insurance Associates, LLC, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=World Insurance Associates, LLC, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Zendesk Inc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Zendesk Inc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Zendesk Inc, Delayed Draw Term Loan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Zendesk Inc, Delayed Draw Term Loan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Zendesk Inc, Revolver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Zendesk Inc, Revolver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Zoro Common Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Zoro Common Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=Zoro Series A Preferred Shares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=Zoro Series A Preferred Shares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171131081104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization</a></td>
<td class="text">Organization<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Secured Lending Fund (together with its consolidated subsidiaries, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Company&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), is a Delaware statutory trust formed on March 26, 2018, and structured as an externally managed, non-diversified closed-end management investment company.&#160;On October 26, 2018, the Company elected to be regulated as a business development company (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BDC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) under the Investment Company Act of 1940, as amended (together with the&#160;rules and regulations promulgated thereunder, the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;1940 Act&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). In addition, the Company has elected to be treated for U.S. federal income tax purposes, and intends to qualify annually, as a regulated investment company (a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;RIC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), under Subchapter M of the Internal Revenue Code of 1986, as amended (together with the&#160;rules and regulations promulgated thereunder, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Code&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is externally managed by Blackstone Credit BDC Advisors LLC (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Adviser&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) an affiliate of Blackstone Alternative Credit Advisors LP (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Administrator&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and, collectively with its affiliates in the credit, asset based finance, and insurance asset management business unit of Blackstone Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Blackstone&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Blackstone Credit &amp; Insurance,&#8221; or &#8220;BXCI&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Administration Agreement&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).&#160;References herein to information about Blackstone Credit &amp; Insurance from December 31, 2023 or prior refers solely to the Adviser and Blackstone Alternative Credit Advisors LP, collectively with their credit-focused affiliates within Blackstone Credit &amp; Insurance.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation.&#160;The Company seeks to achieve its investment objectives primarily through originated loans and other securities, including syndicated loans, of private U.S. companies, typically in the form of first lien senior secured and unitranche loans (including first out/last out loans), and to a lesser extent, second lien, third lien, unsecured and subordinated loans and other debt and equity securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company commenced its loan origination and investment activities on November 20, 2018.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 28, 2021, the Company priced its initial public offering (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;IPO&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">), and the Company's common shares of beneficial interest (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Common Shares&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) began trading on the New York Stock Exchange (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;NYSE&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">). See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 8&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171130881440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;GAAP&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and pursuant to the requirements for reporting on Form 10-K and Article 6 of Regulation S-X. As an investment company, the Company applies the accounting and reporting guidance in Accounting Standards Codification (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ASC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Topic 946, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Services &#8211; Investment Companies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ASC 946&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) issued by the Financial Accounting Standards Board (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;FASB&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, all adjustments considered necessary for the fair presentation of the consolidated financial statements for the periods presented have been included.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intercompany balances and transactions have been eliminated.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period information has been reclassified to conform to the current period presentation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Such amounts could differ from those estimates and such differences could be material.&#160;Assumptions and estimates regarding the valuation of investments involve a higher degree of judgment and complexity and these assumptions and estimates may be significant to the consolidated financial statements. Actual results may ultimately differ from those estimates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Consolidation</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As provided under ASC 946, the Company will not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidated the results of the Company&#8217;s wholly-owned subsidiaries which are considered to be investment companies.&#160;As of December&#160;31, 2023, the Company's consolidated subsidiaries were BGSL Jackson Hole Funding LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Jackson Hole Funding&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), BGSL Breckenridge Funding LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Breckenridge Funding&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), BGSL Big Sky Funding LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Big Sky Funding&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), BGSL Investments LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BGSL Investments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), BXSL Associates GP (Lux) S.&#224; r.l, BXSL Direct Lending (Lux) SCSp, BXSL C-1 LLC, and BXSL C-2 Funding LLC.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of demand deposits and highly liquid investments, such as money market funds, with original maturities of three months or less. Cash and cash equivalents are carried at cost, which approximates fair value. The Company deposits its cash and cash equivalents with financial institutions and, at times, may exceed the Federal Deposit Insurance Corporation insured limit.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment transactions are recorded on a trade date basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gains or losses are measured by the difference between the net proceeds received (excluding prepayment fees, if any) and the amortized cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include investments charged off during the period, net of recoveries, and is recorded within Net realized gain (loss) on the Consolidated Statements of Operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in unrealized gains or losses primarily reflects the change in investment values, including the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period, and is recorded within Net change in unrealized appreciation (depreciation) on the Consolidated Statements of Operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of Investments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to report its investments, including those for which current market values are not readily available, at fair value.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company values its investments in accordance with ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ASC 820&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the applicable measurement date, and Rule 2a-5 under the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on observable market prices or parameters or derived from such prices or parameters when such quotations are readily available.&#160;In accordance with&#160;Rule 2a-5 under the 1940 Act, a market quotation is &#8220;readily available&#8221; only when it is a quoted price (unadjusted) in active markets for identical instruments that a fund can access at the measurement date, provided that such a quotation is not considered to be readily available if it is not reliable.&#160;The Company utilizes mid-market pricing (i.e., mid-point of average bid and ask prices) to value these investments.&#160;These market quotations are obtained from independent pricing services, if available; otherwise generally from at least two principal market makers or primary market dealers.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where prices or inputs are not available or, in the judgment of the Board, not reliable, valuation techniques based on the facts and circumstances of the particular investment will be utilized. These valuation approaches involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments&#8217; complexity. In the absence of observable, reliable market prices, the Company values its investments using various valuation methodologies applied on a consistent basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An enterprise value (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;EV&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) analysis is generally performed to determine the value of equity investments, control debt investments and non-control debt investments that are credit-impaired, and to determine if debt investments are credit impaired. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser will generally utilize approaches including the market approach, the income approach or both approaches, as appropriate, when calculating EV.&#160;The primary method for determining EV for non-control investments, and control investments without reliable projections, uses a multiple analysis whereby appropriate multiples are applied to the portfolio company&#8217;s earnings before interest, taxes, depreciation and amortization (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;EBITDA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or another key financial metric (e.g., such as revenues, cash flows or net income) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Performance Multiple&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).&#160;Performance Multiples are typically determined based upon a review of publicly traded comparable companies and market comparable transactions, if any.&#160;The second method for determining EV (and primary method for control investments with reliable projections) uses a discounted cash flow analysis whereby future expected cash flows and the anticipated terminal value of the portfolio company are discounted to determine a present value using estimated discount rates.&#160;The income approach is generally used when the Adviser has visibility into the long term projected cash flows of a portfolio company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If debt investments are credit-impaired, which occurs when there is insufficient coverage under the enterprise value analysis through the respective investment&#8217;s position in the capital structure, the Adviser generally uses the enterprise value &#8220;waterfall&#8221; approach or a recovery method (if a liquidation or restructuring is deemed likely) to determine fair value. For debt investments that are not determined to be credit-impaired, the Adviser generally uses a market interest rate yield analysis to determine fair value. To determine fair value using a yield analysis, the expected cash flows are projected based on the contractual terms of the debt security and discounted back to the measurement date based on a market yield.&#160;A market yield is determined based upon an assessment of current and expected market yields for similar investments and risk profiles.&#160;The Company considers the current contractual interest rate, the maturity and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the enterprise value of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, the Company depends on primary market data, including newly funded transactions, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable.&#160;The fair value of loans with call protection is generally capped at par plus applicable prepayment premium in effect at the measurement date.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820 prioritizes the use of observable market prices derived from such prices. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The levels used for classifying investments are not necessarily an indication of the risk associated with investing in these securities. The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 1:&#160;Inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date. The types of financial instruments included in Level 1 include unrestricted securities, including equities and derivatives, listed in active markets.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 2:&#160;Inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. The types of financial instruments in this category include less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities and certain over-the-counter derivatives where the fair value is based on observable inputs.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 3:&#160;Inputs to the valuation methodology are unobservable and significant to overall fair value measurement. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in this category include debt and equity investments in privately held entities, collateralized loan obligations (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;CLOs&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and certain over-the-counter derivatives where the fair value is based on unobservable inputs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment&#8217;s level within the fair value hierarchy is based on the lowest level of input that is significant to the overall fair value measurement. The Adviser&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.&#160;Transfers between levels, if any, are recognized at the beginning of the quarter in which the transfer occurs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the source of the inputs, including any markets in which its investments are trading (or any markets in which securities with similar attributes are trading), in determining fair value. When an investment is valued based on prices provided by reputable dealers or pricing services (that is, broker quotes), the Company subjects those prices to various criteria in making the determination as to whether a particular investment would qualify for treatment as a Level 2 or Level 3 investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company&#8217;s investments may fluctuate from period to period, and these differences could be material. Additionally, the fair value of the Company&#8217;s investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that the Company may ultimately realize. Further, such investments are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If the Company was required to liquidate a portfolio investment in a forced or liquidation sale, it could realize significantly less than the value at which the Company has recorded it. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected in the valuations currently assigned.&#160;See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations&#8212;Critical Accounting Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables/Payables From Investments Sold/Purchased</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables/payables from investments sold/purchased consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes all derivative instruments as assets or liabilities at fair value in its consolidated financial statements. Derivative contracts entered into by the Company are not designated in hedge accounting relationships and all changes in fair value are recognized through current period gains or losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company has commitments and risks resulting from its investment transactions, which may include those involving derivative instruments. Derivative instruments are measured in terms of the notional contract amount and derive their value based upon one or more underlying instruments. While the notional amount gives some indication of the Company&#8217;s derivative activity, it generally is not exchanged, but is only used as the basis on which interest and other payments are exchanged. Derivative instruments are subject to various risks similar to non-derivative instruments including market, credit, liquidity, and operational risks. The Company manages these risks on an aggregate basis as part of its risk management process.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Purchase Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward purchase agreements are recognized at fair value through current period gains or losses on the date on which the contract is entered into and are subsequently re-measured at fair value. All forward purchase agreements are carried as assets when fair value is positive and as liabilities when fair value is negative.&#160;A forward purchase agreement is derecognized when the obligation specified in the contract is discharged, canceled or expired.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Transactions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts denominated in foreign currencies are translated into U.S. dollars on the following basis: (i)&#160;investments and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates effective on the last business day of the period; and (ii)&#160;purchases and sales of investments, borrowings and repayments of such borrowings, income, and expenses denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates prevailing on the transaction dates.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes net changes in fair values on investments held resulting from foreign exchange rate fluctuations in Translation of assets and liabilities in foreign currencies on the Consolidated Statements of Operations, if any. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign security and currency translations may involve certain considerations and risks not typically associated with investing in U.S. companies and U.S. government securities. These risks include, but are not limited to, currency fluctuations and revaluations and future adverse political, social and economic developments, which could cause investments in foreign markets to be less liquid and prices more volatile than those of comparable U.S. companies or U.S. government securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income is recorded on an accrual basis and includes the accretion of discounts and amortizations of premiums.&#160;Discounts from and premiums to par value on debt investments purchased are accreted/amortized into interest income over the life of the respective security using the effective interest method.&#160;The amortized cost of debt investments represents the original cost, including loan origination fees and upfront fees received that are deemed to be an adjustment to yield, adjusted for the accretion of discounts and amortization of premiums, if any.&#160;Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income in the current period. For the years ended December&#160;31, 2023, 2022 and 2021 the Company recorded $19.3 million, $4.9 million and $60.9 million, respectively, in non-recurring interest income (e.g., prepayment premiums, accelerated accretion of upfront loan origination fees and unamortized discounts). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PIK Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has loans in its portfolio that contain payment-in-kind (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;PIK&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) provisions.&#160;PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity.&#160;Such income is included in payment-in-kind interest income in the Consolidated Statements of Operations.&#160;If at any point the Company believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status.&#160;When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through payment-in-kind interest income.&#160;To satisfy the Company&#8217;s annual RIC distribution requirements, this non-cash source of income must be included in determining the amounts to be paid out to shareholders in the form of dividends, even though the Company has not yet collected cash.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend income on preferred equity securities is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fee Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may receive various fees in the ordinary course of business such as structuring, consent, waiver, amendment, syndication and other miscellaneous fees as well as fees for managerial assistance rendered by the Company to the portfolio companies.&#160;Such fees are recognized as income when earned or the services are rendered.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Accrual Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans are generally placed on non-accrual status when there is reasonable doubt whether principal or interest will be collected in full.&#160;Accrued interest is generally reversed when a loan is placed on non-accrual status. Additionally, any original issue discount and market discount are no longer accreted to interest income as of the date the loan is placed on non-accrual status.&#160;Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management&#8217;s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management&#8217;s judgment, are likely to remain current. Management may make exceptions to this treatment and&#160;determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Organization Expenses and Offering Expenses</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records expenses related to public equity offerings as a reduction of capital upon completion of an offering of registered securities. The costs associated with any renewals of a shelf registration statement will be expensed as incurred. For the year ended December&#160;31, 2023, the Company incurred $0.4 million of offering costs in connection with its follow-on offering which were charged as a reduction of paid-in-capital. For the year ended December&#160;31, 2022, the Company incurred no offering costs. For the year ended December&#160;31, 2021, the Company incurred $1.6 million of offering costs relating to its IPO which were charged as a reduction of paid-in-capital. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Financing Costs and Debt Issuance Costs</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred financing and debt issuance costs represent fees and other direct incremental costs incurred in connection with the Company&#8217;s borrowings.&#160;These expenses are deferred and amortized into interest expense over the life of the related debt instrument. Deferred financing costs related to revolving credit facilities are presented separately as an asset on the Company&#8217;s Consolidated Statements of Assets and Liabilities.&#160;Debt issuance costs related to any issuance of installment debt or notes are presented net against the outstanding debt balance of the related security.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to be treated as a BDC under the 1940 Act.&#160;The Company also has elected to be treated as a RIC under the Code.&#160;So long as the Company maintains its status as a RIC, it generally will not pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that it distributes at least annually to its shareholders as dividends. Rather, any tax liability related to income earned and distributed by the Company would represent obligations of the Company&#8217;s investors and would not be reflected in the consolidated financial statements of the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are &#8220;more-likely-than-not&#8221; to be sustained by the applicable tax authority. Tax positions not deemed to meet the &#8220;more-likely-than-not&#8221; threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To qualify for and maintain qualification as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to qualify for RIC tax treatment, the Company must distribute to its shareholders, for each taxable year, at least 90% of the sum of (i) its &#8220;investment company taxable income&#8221; for that year (without regard to the deduction for dividends paid), which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses and (ii) its net tax-exempt income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, based on the excise tax distribution requirements, the Company is subject to a 4% nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner in each taxable year an amount at least equal to the sum of (i) 98% of its ordinary income for the calendar year, (ii) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October&#160;31 in that calendar year and (iii)&#160;any income realized, but not distributed, in prior years. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to corporate income tax is considered to have been distributed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, the Company incurred $16.8 million, $1.4 million and $2.4 million, respectively, of U.S. federal excise tax.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributions</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that the Company has taxable income available, the Company intends to make quarterly distributions to its shareholders.&#160;Distributions to shareholders are recorded on the record date.&#160;All distributions will be paid at the discretion of the Board and will depend on the Company&#8217;s earnings, financial condition, maintenance of the Company's tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Reference Rate Reform (Topic 848)&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional expedients and exceptions for applying </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Interbank Offered Rate (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LIBOR&#8221;</span>) or another reference rate expected to be discontinued because of reference rate reform. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848), which expanded the scope of Topic 848 to include derivative instruments impacted by discounting transition. ASU 2020-04 and ASU 2021-01 are effective for all entities through December 31, 2022. The expedients and exceptions provided by the amendments do not apply to contract modifications and hedging relationships entered into or evaluated after December 31, 2022, except for hedging transactions as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which deferred the sunset day of this guidance to December 31, 2024. There has been no material impact of these standards on the Company&#8217;s financial position, results of operations or cash flows<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171130459216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreements and Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Agreements and Related Party Transactions</a></td>
<td class="text">Agreements and Related Party Transactions<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Advisory Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, the Company entered into the original investment advisory agreement with the Adviser. The Adviser is responsible for originating prospective investments, conducting research and due diligence investigations on potential investments, analyzing investment opportunities, negotiating and structuring the Company&#8217;s investments and monitoring its investments and portfolio companies on an ongoing basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2021, the Company entered into an amended and restated investment advisory agreement (as amended and restated, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Investment Advisory Agreement&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), pursuant to which the Adviser manages the Company on a day-to-day basis. The Investment Advisory Agreement is substantially the same as the prior investment advisory agreement except, following the IPO, the incentive fee on income became subject to a twelve-quarter lookback quarterly hurdle rate of 1.50% as opposed to a single quarter measurement and became subject to an Incentive Fee Cap (as defined below) based on the Company&#8217;s Cumulative Net Return (as defined below). The amendment to the Investment Advisory Agreement does not result in higher fees (on a cumulative basis) payable to the Adviser than the fees that would have otherwise been payable to the Adviser under the original investment advisory agreement.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company pays the Adviser a fee for its services under the Investment Advisory Agreement consisting of two components: a management fee and an incentive fee. The cost of both the management fee and the incentive fee is borne by the shareholders. The initial term of the Investment Advisory Agreement was two years from October 1, 2018, and on May 6, 2020 and May 6, 2021, it was renewed and approved by the Board, including a majority of trustees who are not parties to the Investment Advisory Agreement or &#8220;interested persons&#8221; (as such term is defined in Section 2(a)(19) of the 1940 Act) (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Independent Trustees&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), for a one-year period. On October 18, 2021, the Board approved the amended and restated Investment Advisory Agreement for an initial term ending May 31, 2022. Unless earlier terminated, the Investment Advisory Agreement will renew automatically for successive annual periods, provided that such continuance is specifically approved at least annually by the vote of the Board and by the vote of a majority of the Independent Trustees. The Investment Advisory Agreement was most recently renewed and approved by the Board, including majority of the Independent Trustees, on May 2, 2023 for a one-year period ending on May 31, 2024.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser implemented a waiver effective from the consummation of the IPO to extend the Company&#8217;s pre-IPO fee structure for a period of two years. With the waiver in place, instead of having the base management fee and each incentive fee increase to 1.00% and 17.5%, respectively, following the IPO, each such fee remained at 0.75% and 15.0% for a period of two years following the IPO (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Waiver Period&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). As a result of the fee waiver, the pre-listing management fee and incentive fee rates paid by the Company to the Adviser did not increase during the Waiver Period. Amounts waived by the Adviser are not subject to recoupment by the Adviser. The Waiver Period ended on October 28, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Base Management Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting from the consummation of the IPO, the management fee pursuant to the Investment Advisory Agreement is payable quarterly in arrears at an annual rate of 1.0% of the average value of the Company&#8217;s gross assets at the end of the two most recently completed calendar quarters. For purposes of the Investment Advisory Agreement, "gross assets" means the Company&#8217;s total assets determined on a consolidated basis in accordance with GAAP, excluding undrawn commitments but including assets purchased with borrowed amounts. The management fee was calculated for the quarter ended December 31, 2021, and the quarter ended December 31, 2023, at a weighted rate calculated based on the fee rates applicable before and after the consummation of the IPO and the expiration of the Waiver Period based on the number of days in the calendar quarter before and after the consummation of the IPO and the expiration of the Waiver Period.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the consummation of the IPO, the management fee was 0.75% of the average value of the Company&#8217;s gross assets at the end of the two most recently completed calendar quarters. In order to maintain the same management fee arrangement that the Company had in place prior to the IPO for a period of time following the consummation of the IPO, the Adviser voluntarily waived its right to receive the base management fee in excess of 0.75% of the average value of the Company&#8217;s gross assets at the end of the two most recently completed calendar quarters during the Waiver Period. Amounts waived by the Adviser are not subject to recoupment by the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, base management fees were $98.1 million, $101.7 million and $62.4 million, respectively, of which $20.2 million, $25.4 million and $4.2 million, respectively, were waived. As of December&#160;31, 2023 and December&#160;31, 2022, $23.0 million and $18.6 million, respectively, was payable to the Adviser relating to management fees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Fees</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The incentive fees consist of two components that are determined independently of each other, with the result that one component may be payable even if the other is not. One component is based on income and the other component is based on capital gains, each as described below:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(i) Income based incentive fees:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first part of the incentive fee, an income based incentive fee, is calculated and payable quarterly in arrears based on the Company&#8217;s Pre-Incentive Fee Net Investment Income Returns as defined in the Investment Advisory Agreement.&#160;Pre-Incentive Fee Net Investment Income Returns means, as the context requires, either the dollar value of, or percentage rate of return on the value of the Company&#8217;s net assets at the end of the immediately preceding quarter from, interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies) accrued during the calendar quarter, minus the Company&#8217;s operating expenses accrued for the quarter (including the management fee, expenses payable under the Administration Agreement, and any interest expense or fees on any credit facilities or outstanding debt and dividends paid on any issued and outstanding preferred shares, but excluding the incentive fee.&#160;Pre-Incentive Fee Net Investment Income Returns includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with PIK interest and zero-coupon securities)), accrued income that the Company has not yet received in cash.&#160;Pre-incentive fee net investment income excludes any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The Company excludes the impact of expense support payments and recoupments from pre-incentive fee net investment income. Shareholders may be charged a fee on an income amount that is higher than the income they may ultimately receive.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-Incentive Fee Net Investment Income Returns, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, is compared to a &#8220;hurdle rate&#8221; of return of 1.5% per quarter (6.0% annualized). </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Investment Advisory Agreement, the Company is required to pay an income based incentive fee of 17.5% (15% prior to the consummation of the IPO), with a 1.5% hurdle and 100% catch-up. However, the Adviser has implemented a voluntary waiver with respect to the income based incentive fee during the Waiver Period. The Adviser has voluntarily waived its right to receive an income based incentive fee above 15% during the Waiver Period and amounts waived by the Adviser are not subject to recoupment by the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company pays the Adviser an income based incentive fee based on its aggregate pre-incentive fee net investment income, as adjusted as described above, from the calendar quarter then ending and the eleven preceding calendar quarters (such period, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Trailing Twelve Quarters&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The hurdle amount for the income based incentive fee is determined on a quarterly basis and is equal to 1.5% multiplied by the Company&#8217;s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters. The hurdle amount is calculated after making appropriate adjustments for issuances by the Company of common shares, including issuances pursuant to its dividend reinvestment plan and distributions that occurred during the relevant Trailing Twelve Quarters. The income based incentive fee for any partial period will be appropriately prorated.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the income based incentive fee, the Company will pay the Adviser a quarterly incentive fee based on the amount by which (A) aggregate pre-incentive fee net investment income in respect of the relevant Trailing Twelve Quarters exceeds (B) the hurdle amount for such Trailing Twelve Quarters. The amount of the excess of (A) over (B) described in this paragraph for such Trailing Twelve Quarters is referred to as the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Excess Income Amount&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The income based incentive fee for each quarter will be determined as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:32.5pt">No income based incentive fee is payable to the Adviser for any calendar quarter for which there is no Excess Income Amount.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:32.5pt">The Adviser will be paid 100% of the pre-incentive fee net investment income in respect of the Trailing Twelve Quarters, if any, that exceeds the hurdle amount for such Trailing Twelve Quarters, but is less than or equal to an amount, which we refer to as the &#8220;Catch-up Amount,&#8221; determined as the sum of 1.82% (7.27% annualized) (1.76% (7.06% annualized) during the Waiver Period), multiplied by the Company&#8217;s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters that is included in the calculation of the incentive fee based on income.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt">The Adviser will be paid 17.5% (15% during the Waiver Period), of the pre-incentive fee net investment income in respect of the Trailing Twelve Quarters that exceeds the Catch-up Amount.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amount of the income based incentive fee that will be paid to the Adviser for a particular quarter will equal the excess of (a) the income based incentive fee so calculated over (b) the aggregate income based incentive fee that was paid in respect of the first eleven calendar quarters included in the relevant Trailing Twelve Quarters subject to the Incentive Fee Cap as described below.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The income based incentive fee that will be paid to the Adviser for a particular quarter is subject to a cap (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Incentive Fee Cap&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">). The Incentive Fee Cap for any quarter is an amount equal to (a) 17.5% (15% prior to the end of the Waiver Period) of the Cumulative Net Return (as defined below) during the relevant Trailing Twelve Quarters minus (b) the aggregate income based incentive fee that was paid in respect of the first eleven calendar quarters (or the portion thereof) included in the relevant Trailing Twelve Quarters.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Cumulative Net Return&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> means (x) the pre-incentive fee net investment income in respect of the relevant Trailing Twelve Quarters minus (y) any Net Capital Loss (as defined below), if any, in respect of the relevant Trailing Twelve Quarters. If, in any quarter, the Incentive Fee Cap is zero or a negative value, the Company will pay no income based incentive fee to the Adviser for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is a positive value but is less than the income based incentive fee that is payable to the Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company will pay an income based incentive fee to the Adviser equal to the Incentive Fee Cap for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is equal to or greater than the income based incentive fee that is payable to the Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company will pay an income based incentive fee to the Adviser equal to the incentive fee calculated as described above for such quarter without regard to the Incentive Fee Cap.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Net Capital Loss&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in respect of a particular period means the difference, if positive, between (i) aggregate capital losses, whether realized or unrealized, in such period and (ii) aggregate capital gains, whether realized or unrealized, in such period.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These calculations are prorated for any period of less than three months and adjusted for any share issuances or repurchases during the relevant quarter. As the consummation of the IPO occurred on a date other than the first day of a calendar quarter, the income based incentive fee with respect to the Company&#8217;s pre-incentive fee net investment income was calculated for such calendar quarter at a weighted rate calculated based on the fee rates applicable before and after the consummation of the IPO based on the number of days in such calendar quarter before and after the consummation of the IPO. In no event will the amendments to the income based incentive fee include the incentive fee cap and allow the Adviser to receive greater cumulative income based incentive fees under the Investment Advisory Agreement than it would have under the prior investment advisory agreement. Amounts waived by the Adviser are not subject to recoupment by the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(ii) Capital gains based incentive fee:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting from the completion of the IPO, the second part of the incentive fee, a capital gains incentive fee, is determined and payable in arrears as of the end of each calendar year in an amount equal to 17.5% of realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees as calculated in accordance with GAAP. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, the second part of the incentive fee, a capital gains incentive fee, was determined and payable in arrears as of the end of each calendar year in an amount equal to 15.0% of realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees as calculated in accordance with GAAP. However, similar to the voluntary waivers referenced above, the Adviser voluntarily waived its right to receive a capital gains based incentive fee above 15% from the date of consummation of the IPO through the Waiver Period. The Company will accrue, but will not pay, a capital gains incentive fee with respect to unrealized appreciation because a capital gains incentive fee would be owed to the Adviser if the Company were to sell the relevant investment and realize a capital gain. Amounts waived by the Adviser are not subject to recoupment by the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, the Company accrued income based incentive fees of $134.2 million, $97.2 million and $67.3 million, respectively, of which $15.6 million $13.9 million and $2.3 million, respectively, were waived. As of December&#160;31, 2023 and December&#160;31, 2022, $34.4 million and $24.8 million, respectively, was payable to the Adviser for income based incentive fees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023 and 2022, the Company reversed previously accrued capital gains incentive fees of $(5.5) million and $(11.9) million, respectively. For the year ended December&#160;31, 2021, the Company accrued $16.3 million of capital gains incentive fees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administration Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, the Company entered into an Administration Agreement with the Administrator. Under the terms of the Administration Agreement, the Administrator provides, or oversees the performance of, administrative and compliance services, including, but not limited to, maintaining financial records, overseeing the calculation of NAV, compliance monitoring (including diligence and oversight of the Company&#8217;s other service providers), preparing reports to shareholders and reports filed with the United States Securities and Exchange Commission (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;SEC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), preparing materials and coordinating meetings of the Company&#8217;s Board, managing the payment of expenses and the performance of administrative and professional services rendered by others and providing office space, equipment and office services. The Administrator may also offer to provide, on the Company&#8217;s behalf, managerial assistance to the Company&#8217;s portfolio companies. The initial term of the agreement was two years from October 1, 2018. Unless earlier terminated, the Administration Agreement will renew automatically for successive annual periods, provided that such continuance is approved at least annually by (i) the vote of the Board or by a majority vote of the outstanding voting securities of the Company and (ii) the vote of a majority of the Independent Trustees. The Administration Agreement was most recently renewed and approved by the Board, including a majority of the Independent Trustees, on May 2, 2023, for a one-year period.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For providing these services, the Company will reimburse the Administrator for its costs, expenses and allocable portion of overhead (including rent, office equipment and utilities) and other expenses incurred by the Administrator in performing its administrative obligations under the Administration Agreement, including but not limited to: (i) the Company&#8217;s chief compliance officer, chief financial officer and their respective staffs; (ii) investor relations, legal, operations and other non-investment professionals (including information technology professionals) at the Administrator that perform duties for the Company; and (iii) any internal audit group personnel of Blackstone or any of its affiliates. The Administrator has elected to forgo any reimbursement for rent and other occupancy costs for the years ended December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, the Company incurred $2.2 million, $2.7 million and $2.4 million, respectively, in expenses under the Administration Agreement, which were recorded in Administrative service expenses in the Company&#8217;s Consolidated Statements of Operations. As of December&#160;31, 2023 and December&#160;31, 2022, $1.1 million and $1.2 million, respectively, was unpaid and included in &#8220;Due to affiliates&#8221; in the Consolidated Statements of Assets and Liabilities.</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sub-Administration and Custody Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, the Administrator entered into a sub-administration agreement (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Sub-Administration Agreement&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) with State Street Bank and Trust Company (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Sub-Administrator&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) under which the Sub-Administrator provides various accounting and administrative services to the Company.&#160;The Sub-Administrator also serves as the Company&#8217;s custodian (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Custodian&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).&#160;The initial term of the Sub-Administration Agreement is two years from the effective date and after expiration of the initial term and the Sub-Administration Agreement shall automatically renew for successive one-year periods, unless a written notice of non-renewal is delivered prior to 120 days prior to the expiration of the initial term or renewal term.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expense Support and Conditional Reimbursement Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2018, the Company entered into an Expense Support and Conditional Reimbursement Agreement (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Expense Support Agreement&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) with the Adviser pursuant to which the Adviser was able to elect to pay certain expenses of the Company on the Company&#8217;s behalf (each, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Expense Payment&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), provided that no portion of the payment was used to pay any interest of the Company. Any Expense Payment that the Adviser committed to pay was to be paid by the Adviser to the Company in any combination of cash or other immediately available funds no later than forty-five days after such commitment was made in writing, and/or offset against amounts due from the Company to the Adviser or its affiliates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Expense Support Agreement, following any calendar quarter in which Available Operating Funds (as defined below) exceeded the cumulative distributions accrued to the Company&#8217;s shareholders based on distributions declared with respect to record dates occurring in such calendar quarter (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Excess Operating Funds&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), the Company was required to pay such Excess Operating Funds, or a portion thereof, to the Adviser until such time as all Expense Payments made by the Adviser to the Company within three years prior to the last business day of such calendar quarter were reimbursed. Any payments required to be made by the Company to the Adviser are referred to herein as a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Reimbursement Payment&#8221;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Available Operating Funds means the sum of (i) the Company&#8217;s net investment company taxable income (including net short-term capital gains reduced by net long-term capital losses), (ii) the Company&#8217;s net capital gains (including the excess of net long-term capital gains over net short-term capital losses) and (iii) dividends and other distributions paid to the Company on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Expense Support Agreement terminated by its own terms on October 28, 2021. The Company&#8217;s obligation to make Reimbursement Payments survived the termination of the Expense Support Agreement and may be made for a period of up to three years, in accordance with the terms of the Expense Support Agreement. The Company&#8217;s obligation to make a Reimbursement Payment becomes a liability of the Company on the last business day of the applicable calendar quarter. As of December&#160;31, 2023, there are no amounts subject to the Reimbursement Payment obligation.</span></div>As of December&#160;31, 2023 and December&#160;31, 2022, there was no unreimbursed Expense Payments. For the years ended December&#160;31, 2023, 2022 and 2021, the Adviser made no Expense Payments. For the years ended December&#160;31, 2023, 2022 and 2021, the Company made no Reimbursement Payments related to Expense Payments by the Adviser.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171136892336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of the Company&#8217;s investment portfolio at cost and fair value was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total Investments at Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total Investments at Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First lien debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,817,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,722,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,497,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,419,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second lien debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,934,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,868,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,657,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,617,248&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The industry composition of investments at fair value was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aerospace &amp; Defense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Air Freight &amp; Logistics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Services &amp; Supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction &amp; Engineering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Containers &amp; Packaging</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diversified Consumer Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diversified Financial Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diversified Telecommunication Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrical Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electronic Equipment, Instruments &amp; Components</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electric Utilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Energy Equipment &amp; Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ground Transportation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Equipment &amp; Supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Providers &amp; Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial Conglomerates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet &amp; Direct Marketing Retail</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Media</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oil, Gas &amp; Consumable Fuels</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paper &amp; Forest Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceuticals </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate Management &amp; Development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Road &amp; Rail</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Retail</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology Hardware, Storage &amp; Peripherals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Companies &amp; Distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transportation Infrastructure</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Amount rounds to less than 0.1% as of December&#160;31, 2022.</span></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Amount rounds to less than 0.1% as of December&#160;31, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The geographic composition of investments at cost and fair value was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total Investments at Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as % of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,381,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,317,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda/Cayman Islands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,934,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,868,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total<br/>Investments at<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>as % of Net<br/>Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,934,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,893,051&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,657,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,617,248&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, one borrower (one loan) and no borrowers in the portfolio were on non-accrual status, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, on a fair value basis, 99.9% and 99.9%, respectively, of our performing debt investments bore interest at a floating rate and 0.1% and 0.1%, respectively, of our performing debt investments bore interest at a fixed rate.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments owned by investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//946-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171131097136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of financial instruments:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First lien debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,722,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second lien debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,710,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,868,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First lien debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,419,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second lien debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,452&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,472,796&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,617,248&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the fair value of financial instruments for which Level 3 inputs were used to determine the fair value:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second Lien Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unsecured Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,472,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,492,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from principal repayments and sales of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,114,974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,351)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,187,790)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of discount/amortization of premium</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,095)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,739)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,941)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,515&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,940&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,710,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments still held as of December&#160;31, 2023 included in change in net unrealized appreciation (depreciation) on the Consolidated Statements of Operations</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,013)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,437)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,082)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First&#160;Lien&#160;Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second Lien Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,288,184&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,501,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from principal repayments and sales of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(980,395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,967)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,042,362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of discount/amortization of premium</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,465)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,235)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,330)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,472,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments still held as of December&#160;31, 2022 included in net change in unrealized appreciation (depreciation) on the Consolidated Statements of Operations</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,180)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,629)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,528&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,281)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">For the years ended December&#160;31, 2023 and 2022, transfers into or out of Level 3 were primarily due to decreased or increased price transparency.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents quantitative information about the significant unobservable inputs of the Company&#8217;s Level 3 financial instruments. The table is not intended to be all-inclusive but instead captures the significant unobservable inputs relevant to the Company&#8217;s determination of fair value.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Low</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">High</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in first lien debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,533,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield Analysis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Recoverability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market Multiple</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50x</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in second lien debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield Analysis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in unsecured debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield Analysis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.90%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market Approach</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance Multiple</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.40x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.00x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.47x</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option Pricing Model </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield Analysis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,940&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,710,582&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Low</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">High</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in first lien debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,037,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield analysis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market quotations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker quoted price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.19</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in second lien debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield analysis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance multiple</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.00x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.41x</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option pricing model</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield analysis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,949&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,472,796&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Weighted averages are calculated based on fair value of investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant unobservable input used in the yield analysis is the discount rate based on comparable market yields. The significant unobservable input used for market quotations are broker quoted prices provided by independent pricing services. The significant unobservable input used under the market approach is the Performance Multiple. Significant increases in discount rates would result in a significantly lower fair value measurement. Significant decreases in quoted prices or Performance Multiples would result in a significantly lower fair value measurement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments Not Carried at Fair Value</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s SPV Financing Facilities (as defined in Note 6) and Revolving Credit Facility (as defined in Note 6), as of December&#160;31, 2023 and December&#160;31, 2022, approximates their carrying value as the credit facilities have variable interest based on selected short term rates. These financial instruments would be categorized as Level 3 within the hierarchy.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value measurements of the Company's Unsecured Notes (as defined in Note 6) had they been accounted for at fair value. These financial instruments would be categorized as Level 3 as of December&#160;31, 2023 and as Level 2 as of December&#160;31, 2022 within the hierarchy.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New 2026 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551,661&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,825,722&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div>The carrying amounts of the Company&#8217;s other assets and liabilities approximate fair value. These financial instruments are categorized as Level 3 within the hierarchy.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171131178768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings</a></td>
<td class="text">Borrowings<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the 1940 Act, with certain limitations, the Company is allowed to borrow amounts such that its asset coverage, as defined in the 1940 Act, is at least 150% after such borrowing. As of December&#160;31, 2023 and December&#160;31, 2022, the Company&#8217;s asset coverage was 200.3% and 174.8%, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SPV Financing Facilities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following wholly-owned subsidiaries of the Company have entered into secured financing facilities, as described below: Jackson Hole Funding, Breckenridge Funding and Big Sky Funding which are collectively referred to as the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;SPVs&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and such secured financing facilities described below are collectively referred to as the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;SPV Financing Facilities&#8221;.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of each SPV to the lenders under the applicable SPV Financing Facility are secured by a first priority security interest in all of the applicable SPV&#8217;s portfolio investments and cash. The obligations of each SPV under the applicable SPV Financing Facility are non-recourse to the Company, and the Company&#8217;s exposure to the credit facility is limited to the value of its investment in the applicable SPV.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the SPV Financing Facilities, the applicable SPV has made certain customary representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar facilities. Each SPV Financing Facility contains customary events of default for similar financing transactions, including if a change of control of the applicable SPV occurs. Upon the occurrence and during the continuation of an event of default, the lenders under the applicable SPV Financing Facility may declare the outstanding advances and all other obligations under the applicable SPV Financing Facility immediately due and payable. The occurrence of an event of default triggers a requirement that the applicable SPV obtain the consent of the lenders under the applicable SPV Financing Facility prior to entering into any sale or disposition with respect to portfolio investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, the Company was in compliance with all covenants and other requirements of each of the SPV Financing Facilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jackson Hole Funding Facility</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 16, 2018, Jackson Hole Funding, the Company&#8217;s wholly-owned subsidiary that holds primarily originated loan investments, entered into a senior secured revolving credit facility (which was subsequently amended and restated on December 16, 2021, and amended effective as of September 16, 2022, November 15, 2023 and December 18, 2023, and as further amended from time to time, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#8220;Jackson Hole Funding Facility&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) with JPMorgan Chase Bank, National Association (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#8220;JPM&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">). JPM serves as administrative agent, Citibank, N.A., serves as collateral agent and securities intermediary, Virtus Group, LP serves as collateral administrator and the Company serves as portfolio manager under the Jackson Hole Funding Facility.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advances under the Jackson Hole Funding Facility bear interest at a per annum rate equal to the benchmark in effect for the currency of the applicable advances (which is the three-month Term SOFR for dollar advances), plus the applicable margin of 2.375% per annum for certain foreign currency advances to 2.525% per annum for dollar advances. Jackson Hole Funding pays a commitment fee of 0.48% per annum on the average daily unused amount of the financing commitments until November 28, 2025. Jackson Hole Funding also pays to JPM an administrative agency fee, in addition to certain other fees, each as agreed between Jackson Hole Funding and JPM.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum commitment amount of the Jackson Hole Funding Facility as of December&#160;31, 2023 was $500.0 million. The Jackson Hole Funding Facility has an accordion feature, subject to the satisfaction of various conditions, which could bring total commitments under the Jackson Hole Funding Facility to up to $900.0 million. Proceeds from borrowings under the Jackson Hole Funding Facility may be used to fund portfolio investments by Jackson Hole Funding and to make advances under delayed draw term loans where Jackson Hole Funding is a lender. The period during which Jackson Hole Funding may make borrowings under the Jackson Hole Funding Facility expires on November 28, 2025 and the Jackson Hole Funding Facility is scheduled to mature on May 17, 2027.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breckenridge Funding Facility</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 21, 2018, Breckenridge Funding, the Company&#8217;s wholly-owned subsidiary that holds primarily syndicated loan investments, entered into a senior secured revolving credit facility (which was subsequently amended on June 11, 2019, August 2, 2019, September 27, 2019, April 13, 2020, October 5, 2021, February 28, 2022, May 19, 2022, November 1, 2023 and January 17, 2024, and as further amended from time to time, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Breckenridge Funding Facility&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) with BNP Paribas (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;BNP&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">). BNP serves as administrative agent, Wells Fargo Bank, National Association (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Wells Fargo&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) serves as collateral agent and the Company serves as servicer under the Breckenridge Funding Facility.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advances under the Breckenridge Funding Facility bear interest at a per annum rate equal to the three-month Term SOFR (or other base rate) in effect, plus an applicable margin of 1.70%, 2.05% or 2.30% per annum, as applicable, depending on the nature of the advances being requested under the facility. Breckenridge Funding pays a commitment fee of 0.70% per annum if the unused facility amount is greater than 50% or 0.35% per annum if the unused facility amount is less than or equal to 50% and greater than 25%, based on the average daily unused amount of the financing commitments until December 21, 2024, in addition to certain other fees as agreed between Breckenridge Funding and BNP.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from borrowings under the Breckenridge Funding Facility may be used to fund portfolio investments by Breckenridge Funding and to make advances under delayed draw and revolving loans where Breckenridge Funding is a lender. The period during which Breckenridge Funding may make borrowings under the Breckenridge Funding Facility for the remaining commitment amounts expires on December 21, 2024 and the Breckenridge Funding Facility is scheduled to mature on December 21, 2026.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Big Sky Funding Facility</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 10, 2019, Big Sky Funding, the Company&#8217;s wholly-owned subsidiary, entered into a senior secured revolving credit facility (which was subsequently amended on December 30, 2020 and September 30, 2021 and amended and restated on June 29, 2022, and amended on March 30, 2023 and as further amended from time to time, the (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Big Sky Funding Facility&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) with Bank of America, N.A. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Bank of America&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">). Bank of America serves as administrative agent, Wells Fargo serves as collateral administrator and the Company serves as manager under the Big Sky Funding Facility.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advances under the Big Sky Funding Facility bear interest at a per annum rate equal to the one-month Term SOFR in effect, plus the applicable margin of (a) until September 25, 2024, 1.80% per annum, and (b) from and after September 25, 2024, a range between 2.10% and 2.45% per annum depending on the nature of the collateral securing the advances. Big Sky Funding is required to utilize a minimum percentage of 80% of the financing commitments. Unused amounts below such minimum utilization amount accrue a fee at a rate of 1.60% per annum. In addition, Big Sky Funding pays an unused fee of 0.45% per annum on the daily unused amount of the financing commitments in excess of the minimum utilization amount, commencing three months after the closing date of the Big Sky Funding Facility.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from borrowings under the Big Sky Funding Facility may be used to fund portfolio investments by Big Sky Funding and to make advances under revolving loans or delayed draw term loans where Big Sky Funding is a lender. The period during which Big Sky Funding may make borrowings under the Big Sky Funding Facility expires on March 30, 2026 and the Big Sky Funding Facility is scheduled to mature on September 30, 2026.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Revolving Credit Facility</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 15, 2020, the Company entered into a senior secured revolving credit facility (which was most recently amended on June 9, 2023 and as further amended from time to time, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Revolving Credit Facility&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) with Citibank, N.A. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8220;Citi&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) serving as administrative agent and collateral agent.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility provides for borrowings in U.S. dollars and certain agreed upon foreign currencies. Borrowings under the Revolving Credit Facility are subject to compliance with a borrowing base. A portion of the Revolving Credit Facility consists of funded term loans in the aggregate principal amount of $385.0 million and the Revolving Credit Facility provides for the issuance of letters of credit on behalf of the Company in an aggregate face amount not to exceed $175.0 million. Proceeds from the borrowings under the Revolving Credit Facility may be used for general corporate purposes of the Company and its subsidiaries in the ordinary course of business. Availability of the revolver under the Revolving Credit Facility will terminate on June 28, 2027 (other than with respect to the foreign currency commitments of certain lenders in the amount of $200.0 million, which expire on June 28, 2026) and all amounts outstanding under the Revolving Credit Facility must be repaid by June 28, 2028 (other than with respect to the foreign currency commitments of certain lenders in the amount of $200.0 million which mature on June 28, 2027) pursuant to an amortization schedule.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans under the Revolving Credit Facility bear interest at a per annum rate equal to, (x) for loans for which the Company elects the base rate option, the &#8220;alternate base rate&#8221; (which is the greatest of (a) the prime rate as publicly announced by Citi, (b) the sum of (i) the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System plus (ii) 0.5% and (c) one month adjusted Term SOFR plus 1% per annum) plus (A) if the gross borrowing base is equal to or greater than 1.6 times the combined revolving debt amount, 0.75%, or (B) if the gross borrowing base is less than 1.6 times the combined revolving debt amount, 0.875%, and (y) for all other loans, the applicable benchmark rate for the related interest period for such borrowing plus (A) if the gross borrowing base is equal to or greater than 1.6 times the combined revolving debt amount, 1.75%, or (B) if the gross borrowing base is less than 1.6 times the combined revolving debt amount, 1.875%. The Company will pay an unused fee of 0.375% per annum on the daily unused amount of the revolver commitments. The Company will pay letter of credit participation fees and a fronting fee on the average daily amount of any lender&#8217;s exposure with respect to any letters of credit issued under the Revolving Credit Facility.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations to the lenders under the Revolving Credit Facility are secured by a first priority security interest in substantially all of the Company&#8217;s assets.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Revolving Credit Facility, the Company has made certain customary representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar facilities. In addition, the Company must comply with the following financial covenants: (a) the Company must maintain a minimum shareholders&#8217; equity, measured as of each fiscal quarter end; and (b) the Company must maintain at all times a 150% asset coverage ratio.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility contains customary events of default for similar financing transactions. Upon the occurrence and during the continuation of an event of default, Citi may terminate the commitments and declare the outstanding advances and all other obligations under the Revolving Credit Facility immediately due and payable.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, the Company was in compliance with all covenants and other requirements of the Revolving Credit Facility.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Unsecured Notes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued unsecured notes, as further described below: 2023 Notes, 2026 Notes, New 2026 Notes, 2027 Notes and 2028 Notes (each as defined below) which are collectively referred to herein as the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Unsecured Notes&#8221;.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Unsecured Notes contain certain covenants, including covenants requiring the Company to comply with the asset coverage requirements of Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the 1940 Act, whether or not it is subject to those requirements, and to provide financial information to the holders of the Unsecured Notes and the Trustee (as defined below) if the Company is no longer subject to the reporting requirements under the Exchange Act. These covenants are subject to important limitations and exceptions that are described in each respective indenture governing the Unsecured Notes (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Unsecured Notes Indentures&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on the occurrence of a &#8220;change of control repurchase event,&#8221; as defined in each respective Unsecured Notes Indenture, the Company will generally be required to make an offer to purchase the outstanding Unsecured Notes at a price equal to 100% of the principal amount of such Unsecured Notes plus accrued and unpaid interest to the repurchase date.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, the Company was in compliance with all covenants and other requirements of each of the Unsecured Notes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Notes</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2020, the Company issued $400.0 million aggregate principal amount of 3.650% notes due July 14, 2023 (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2023 Notes&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) pursuant to an indenture (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Base Indenture&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and a supplemental indenture, each dated as of July 15, 2020 (and together with the Base Indenture, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2023 Notes Indenture&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), between the Company and U.S. Bank National Association (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Trustee&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes bore interest at a rate of 3.650% per year payable semi-annually on January 14 and July 14 of each year, which commenced on January 14, 2021. The 2023 Notes were general unsecured obligations of the Company that ranked senior in right of payment to all of the Company&#8217;s existing and future indebtedness that was expressly subordinated in right of payment to the 2023 Notes, ranked pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, ranked effectively junior to any of the Company&#8217;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and ranked structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#8217;s subsidiaries, financing vehicles or similar facilities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes matured on July 14, 2023 and were paid off consistent with the terms of the 2023 Notes Indenture. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2026 Notes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 23, 2020 and December 1, 2020, the Company issued $500.0 million aggregate principal amount and $300.0 million aggregate principal amount, respectively, of 3.625% notes due 2026 (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2026 Notes&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) pursuant to a supplemental indenture, dated as of October 23, 2020 (and together with the Base Indenture, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2026 Notes Indenture&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), to the Base Indenture between the Company and the Trustee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2026 Notes will mature on January 15, 2026 and may be redeemed in whole or in part at the Company&#8217;s option at any time or from time to time at the redemption prices set forth in the 2026 Notes Indenture. The 2026 Notes bear interest at a rate of 3.625% per year payable semi-annually on January 15 and July 15 of each year, commencing on July 15, 2021. The 2026 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2026 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company&#8217;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New 2026 Notes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 16, 2021 and April 27, 2021, the Company issued $400.0 million aggregate principal amount and $300.0 million aggregate principal amount, respectively, of 2.750% notes due 2026 (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;New 2026 Notes&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) pursuant to a supplemental indenture, dated as of March 16, 2021 (and together with the Base Indenture, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;New 2026 Notes Indenture&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), to the Base Indenture between the Company and the Trustee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The New 2026 Notes will mature on September 16, 2026 and may be redeemed in whole or in part at the Company&#8217;s option at any time or from time to time at the redemption prices set forth in the New 2026 Notes Indenture. The New 2026 Notes bear interest at a rate of 2.750% per year payable semi-annually on March 16 and September 16 of each year, commencing on September 16, 2021. The New 2026 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company&#8217;s existing and future indebtedness that is expressly subordinated in right of payment to the New 2026 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company&#8217;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#8217;s subsidiaries, financing vehicles or similar facilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2027 Notes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company issued $650.0 million aggregate principal amount of 2.125% notes due 2027 (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2027 Notes&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) pursuant to a supplemental indenture, dated as of July 23, 2021 (and together with the Base Indenture, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2027 Notes Indenture&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), to the Base Indenture between the Company and the Trustee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2027 Notes will mature on February 15, 2027 and may be redeemed in whole or in part at the Company&#8217;s option at any time or from time to time at the redemption prices set forth in the 2027 Notes Indenture. The 2027 Notes bear interest at a rate of 2.125% per year payable semi-annually on February 15 and August 15 of each year, commencing on February 15, 2022. The 2027 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company&#8217;s existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company&#8217;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#8217;s subsidiaries, financing vehicles or similar facilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Notes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2021, the Company issued $650.0 million in aggregate principal amount of its 2.850% notes due 2028 (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2028 Notes&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) pursuant to a supplemental indenture, dated as of September 30, 2021 (and together with the Base Indenture, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;2028 Notes Indenture&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), to the Base Indenture between the Company and the Trustee. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2028 Notes will mature on September 30, 2028 and may be redeemed in whole or in part at the Company&#8217;s option at any time or from time to time at the redemption prices set forth in the 2028 Notes Indenture. The 2028 Notes bear interest at a rate of 2.850% per year payable semi-annually on March 30 and September 30 of each year, commencing on March 30, 2022. The 2028 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company&#8217;s existing and future indebtedness that is expressly subordinated in right of payment to the 2028 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company&#8217;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#8217;s subsidiaries, financing vehicles or similar facilities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s outstanding debt obligations were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Principal<br/>Committed</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding<br/>Principal</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Debt Issuance Costs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unused</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jackson Hole Funding Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breckenridge Funding Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Big Sky Funding Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,092,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,092,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New 2026 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,600,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,937,883&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,911,930&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,662,117&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,662,037&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The unused portion is the amount upon which commitment fees, if any, are based.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The amount available reflects any limitations related to each respective credit facility&#8217;s borrowing base.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Under the Jackson Hole Funding Facility, the Company may borrow in U.S. dollars (USD) or certain other permitted currencies. As of December&#160;31, 2023, the Company had no borrowings denominated in currencies other than USD. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Under the Revolving Credit Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2023, the Company had non-USD borrowings denominated in the following currencies:</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">Canadian Dollars (CAD) 1.0 million</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">Euros (EUR) 94.4 million</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">British Pounds (GBP) 66.9 million</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Principal Committed</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Principal</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Debt Issuance Costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unused</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jackson Hole Funding Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breckenridge Funding Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Big Sky Funding Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New 2026 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,550,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,563,003&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,527,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986,997&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976,379&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The unused portion is the amount upon which commitment fees, if any, are based.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The amount available reflects any limitations related to each respective credit facility&#8217;s borrowing base.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Under the Jackson Hole Funding Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2022, the Company had no borrowings denominated in currencies other than USD.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Under the Revolving Credit Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2022, the Company had borrowings denominated in the following currencies:</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">Canadian Dollars (CAD) 355.9 million</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">Euros (EUR) 97.9 million</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">British Pounds (GBP) 66.6 million</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of&#160;December&#160;31, 2023 and December&#160;31, 2022,&#160;$38.7 million and $44.5 million, respectively, of interest expense and $1.2 million and $0.8 million, respectively, of unused commitment fees were included in interest payable. For the years ended December&#160;31, 2023, 2022 and 2021, the weighted average interest rate on all borrowings outstanding was 4.93%, 3.46%, and 2.92% (including unused fees and accretion of net discounts on unsecured debt), respectively, and the average principal debt outstanding was $5,275.4 million, $5,732.6 million and $4,000.8 million, respectively. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of interest expense were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility unused fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of original issue discount and debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Interest Expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,478&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,152&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,552&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171131067680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Portfolio Company Commitments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment portfolio may contain debt investments which are in the form of lines of credit or delayed draw commitments, which require us to provide funding when requested by portfolio companies in accordance with underlying loan agreements.&#160;As of December&#160;31, 2023 and December&#160;31, 2022 the Company had unfunded commitments, including delayed draw terms loans and revolvers, with an aggregate amount of $985.9 million and $690.3 million, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, from time to time, the Adviser and its affiliates may commit to an investment on behalf of the investment vehicles it manages, including the Company. Certain terms of these investments are not finalized at the time of the commitment and each respective investment vehicle's allocation may change prior to the date of funding. In this regard, as of December&#160;31, 2023 and December&#160;31, 2022, the Company estimates that $221.3 million and $16.5 million, respectively, of investments that were committed but not yet funded. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Commitments and Contingencies</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become a party to certain legal proceedings incidental to the normal course of its business. At December&#160;31, 2023 and December&#160;31, 2022, management is not aware of any material pending legal proceedings.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171130970016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Net Assets</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8. Net Assets</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Issued</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the authority to issue an unlimited number of common shares of beneficial interest at $0.001 per share par value.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2023, the Company completed a follow-on offering under its shelf registration statement, issuing 6,500,000 of its common shares of beneficial interest at a price to the underwriters of $26.78 per share. Net of underwriting fees, the Company received cash proceeds, before offering expenses, of $174.1 million. On August 18, 2023, the underwriters exercised, in full, their option to purchase an additional 975,000 shares of common shares, which resulted in cash proceeds, before offering expenses, of $26.1 million. The Company incurred offering expenses of $0.4 million in connection with the follow-on offering.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, the Company is party to five separate equity distribution agreements&#160;with sales agents (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Distribution Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), pursuant to which the Company may sell, from time to time, up to an aggregate sales price of $400.0&#160;million of its common shares of beneficial interest. Sales of common shares made pursuant to the Equity Distribution Agreements may be made in negotiated transactions or transactions that are deemed to be &#8220;at-the-market&#8221; offerings as defined in Rule 415(a)(5) under the Securities Act of 1933, as amended. Actual sales depend on a variety of factors including market conditions, the trading price of the Company&#8217;s common shares, the Company&#8217;s capital needs, and the Company&#8217;s determination of the appropriate sources of funding to meet such needs. As of December&#160;31, 2023, common shares with an aggregate sales price of $328.9 million remained available for issuance under the Equity Distribution Agreements.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total common shares issued and proceeds received, for the year ended December&#160;31, 2023, through the &#8220;at-the-market&#8221; offering program (dollars in thousands except per share amounts):</span></div><div style="margin-bottom:8pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.554%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuances of Common Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Proceeds</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Placement Fees/Offering Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Share Price </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;At-the-market&#8221; Offering</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,144,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Represents the net offering price per share after deducting placement fees and commissions and offering expenses.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No common shares were issued for the year ended December&#160;31, 2022, other than those issued through the Company's dividend reinvestment program.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the Company priced its IPO, issuing 9,180,000 of its common shares of beneficial interest at a public offering price of $26.15 per share. Net of underwriting fees, the Company received cash proceeds, before offering expenses, of $230.6 million. On November 4, 2021, the underwriters exercised their option to purchase an additional 1,377,000 shares of common shares, which resulted in cash proceeds, before offering expenses, of $33.8 million. The Company&#8217;s common shares began trading on the NYSE under the symbol &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BXSL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; on October 28, 2021.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the listing of the Company&#8217;s common shares on the NYSE, the Board decided to eliminate any outstanding fractional common shares (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Fractional Shares&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), as permitted by Delaware law by rounding down the number of Fractional Shares held by each of our shareholders to the nearest whole share and paying each shareholder cash for such Fractional Shares.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to September 8, 2021, the Company entered into additional subscription agreements (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Subscription Agreements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) with investors providing for the private placement of the Company&#8217;s shares. Under the terms of the Subscription Agreements, investors are required to fund drawdowns to purchase the Company&#8217;s shares up to the amount of their respective Capital Commitment on an as-needed basis each time the Company delivers a drawdown notice to its investors. As of September 8, 2021, all Capital Commitments in the amount of $3,926.3 million ($80.0 million from affiliates of the Adviser) had been drawn. As of December&#160;31, 2021, the Company had received Capital Commitments totaling $3,926.3 million ($713.3 million remaining undrawn), of which $80.0 million ($8.0 million remaining undrawn) were from affiliates of the Adviser.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total common shares issued and proceeds received related to the Company&#8217;s capital drawdowns and IPO for the year ended December&#160;31, 2021 (dollars in millions except share amounts):</span></div><div style="margin-bottom:8pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Share Issuance Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Proceeds</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 8, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,869,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 8, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,723,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,557,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,149,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Includes proceeds (net of any underwriting fees) from our initial public offering and the underwriter's exercise of the over-allotment option.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distributions </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s distributions declared and payable for the year ended December&#160;31, 2023 (dollars in thousands except per share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.186%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date Declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 20, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 26, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Reinvestment</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted a dividend reinvestment plan (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;DRIP&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), pursuant to which it reinvests all cash dividends declared by the Board on behalf of its shareholders who do not elect to receive their dividends in cash. As a result, if the Board and the Company declares, a cash dividend or other distribution, then the Company&#8217;s shareholders who have not opted out of its dividend reinvestment plan will have their cash distributions automatically reinvested in additional shares as described below, rather than receiving the cash dividend or other distribution. Starting from the consummation of the IPO, the number of shares to be issued to a shareholder is determined by dividing the total dollar amount of the cash dividend or distribution payable to a shareholder by the market price per common share at the close of regular trading on the NYSE on the payment date of a distribution, or if no sale is reported for such day, the average of the reported bid and ask prices. However, if the market price per share on the payment date of a cash dividend or distribution exceeds the most recently computed NAV per share, the Company will issue shares at the greater of (i) the most recently computed NAV per share and (ii) 95% of the current market price per share (or such lesser discount to the current market price per share that still exceeded the most recently computed NAV per share). For example, if the most recently computed NAV per share is $25.00 and the market price on the payment date of a cash dividend is $24.00 per share, the Company will issue shares at $24.00 per share. If the most recently computed NAV per share is $25.00 and the market price on the payment date of a cash dividend is $27.00 per share, the Company will issue shares at $25.65 per share (95% of the current market price). If the most recently computed NAV per share is $25.00 and the market price on the payment date of a cash dividend is $26.00 per share, the Company will issue shares at $25.00 per share.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders who receive distributions in the form of shares will generally be subject to the same U.S. federal, state and local tax consequences as if they received cash distributions; however, since their cash distributions will be reinvested, those shareholders will not receive cash with which to pay any applicable taxes. The Company intends to use newly issued shares to implement the plan.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our dividend reinvestment plan, the following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company&#8217;s DRIP during the year ended December&#160;31, 2023 (dollars in thousands except share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Issued</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company's DRIP during the year ended December&#160;31, 2022 (dollars in thousands except share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Issued</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 14, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,382&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054,845&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company's DRIP during the year ended December&#160;31, 2021 (dollars in thousands except share amounts):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Issued</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 29, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 14, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 13, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 12, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plan</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2021, the Board approved a share repurchase plan (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Company 10b5-1 Plan&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), to acquire up to approximately $262 million (representing the net proceeds from the IPO) in the aggregate of our common shares at prices below our NAV per share over a specified period, in accordance with the guidelines specified in Rule 10b-18 and Rule 10b5-1 of the Exchange Act.&#160;The Company 10b5-1 Plan terminated by its own terms in November 2022. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Board authorized a share repurchase plan, under which we may repurchase up to $250 million in the aggregate of our outstanding common shares in the open market at prices below our NAV per share for a one-year term, in accordance with the guidelines specified in Rule 10b-18 of the Exchange Act (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Company 10b-18 Plan&#8221;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and together with the Company 10b5-1 Plan, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Share Repurchase Plans&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023 and December&#160;31, 2021, the Company did not repurchase any of its shares under the Share Repurchase Plans.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the shares repurchased under the Company 10b5-1 Plan during the year ended December&#160;31, 2022 (dollars in thousands except share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total Number of Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1 - April 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1 - May 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1 - June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1 - July 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1 - August 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,223,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,223,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1 - September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1 - October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Repurchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,959,931</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,959,931</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholder Transfer Restrictions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For shareholders who held common shares prior to the IPO, without the consent of the Adviser:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to January 3, 2022, a shareholder was not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber any common share held by such shareholder prior to the IPO (and any DRIP shares received with respect to such common shares);</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to March 1, 2022, a shareholder was not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber 90% of the common shares held by such shareholder prior to the IPO (and any DRIP shares received with respect to such common shares);</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to May 1, 2022, a shareholder was not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber 75% of the common shares held by such shareholder prior to the IPO (and any DRIP shares received with respect to such common shares); and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to July 1, 2022, a shareholder was not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber 50% of the common shares held by such shareholder prior to the date of the IPO (and any DRIP shares received with respect to such common shares).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This means that, as a result of these transfer restrictions, without the consent of the Adviser, a shareholder who owned 100 common shares on the date of the IPO could not sell any of such shares until January 3, 2022; prior to March 1, 2022, such shareholder could only sell up to 10 of such shares; prior to May 1, 2022, such shareholder could only sell up to 25 of such shares; prior to July 1, 2022, such shareholder could only sell up to 50 of such shares; and after July 1, 2022, such shareholder could sell all of such shares. Consent by the Adviser to waive any of the foregoing transfer restrictions is subject to the consent of the representatives on behalf of the underwriters in the IPO. In addition, the Company&#8217;s trustees have agreed for a period of 180 days after the date of the IPO and the Company&#8217;s executive officers who are not trustees have agreed for a period of 180 days after the date of the IPO, not to transfer (whether by sale, gift, merger, by operation of law or otherwise) their common shares without the prior written consent of the representatives on behalf of the underwriters in the IPO, subject to certain exceptions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171130890960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in net assets resulting from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding (basic and diluted)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,615,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,072,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,510,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share (basic and diluted)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171130940448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments, as gains and losses are generally not included in taxable income until they are realized; (2) income or loss recognition on exited investments; (3) non-deductible U.S federal excise taxes; and (4) other non-deductible expenses.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes certain adjustments to the classification of net assets as a result of permanent book-to-tax differences, which include differences in the book and tax basis of certain assets and liabilities, and non-deductible federal taxes or losses among other items. To the extent these differences are permanent, they are charged or credited to additional paid in capital, undistributed net investment income or undistributed net realized gains on investments, as appropriate. For the years ended December&#160;31, 2023, 2022 and 2021, permanent differences were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undistributed net investment income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,895&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,556)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated net realized gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,911)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid In Capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,984)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, permanent differences were principally related to $16.8 million, $1.4 million and $2.4 million, respectively, of U.S. federal excise taxes and $0.2 million, $0.2 million and $0.0 million, respectively, of non-deductible offering costs.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For tax purposes, the Company may elect to defer any portion of a post-October capital loss or late-year ordinary loss to the first day of the following fiscal year. As of December&#160;31, 2023, 2022 and 2021, there were none. </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following reconciles the increase in net assets resulting from operations to taxable income for the years ended December&#160;31, 2023, 2022 and 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net increase (decrease) in net assets resulting from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized (appreciation) depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Realized gains (losses) for tax not included in book income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible capital gains incentive fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-deductible expenses and excise taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net post-October capital loss deferral (reversal)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Taxable/distributable income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677,085&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,304&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,985&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Tax information for the fiscal year ended December&#160;31, 2023 is estimated and is not considered final until the Company files its tax return.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated gains (losses) as calculated on a tax basis for the years ended December&#160;31, 2023, 2022 and 2021 were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributable ordinary income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributable capital gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other temporary book/tax differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,389)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation/(depreciation) on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,065)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total accumulated under-distributed (over-distributed) earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,861&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and unrealized gain (loss) of the Company&#8217;s investments, as calculated on a tax basis, at December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrealized appreciation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrealized depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146,095)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,232)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in unrealized appreciation (depreciation)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,338)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,943)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax cost of investments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,927,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,658,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,855,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, $456.8 million and $47.9 million of the dividends declared were derived from ordinary income and capital gains, respectively, as determined on a tax basis.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, $470.0 million and $12.4 million of the dividends declared were derived from ordinary income and capital gains, respectively, as determined on a tax basis.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the dividends declared during the year ended December&#160;31, 2021 were derived from ordinary income, as determined on a tax basis. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BGSL Investments, a wholly-owned subsidiary that was formed in 2019, is a Delaware LLC which has elected to be treated as a corporation for U.S. tax purposes. As such, BGSL Investments is subject to U.S. Federal, state and local taxes. For the Company's tax year ended December&#160;31, 2023, BGSL Investments activity did not result in a material provision for income taxes.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management has analyzed the Company&#8217;s tax positions taken, or to be taken, on federal income tax returns for all open tax years, and has concluded that no provision for income tax is required in the Company&#8217;s financial statements. The Company&#8217;s federal tax returns are subject to examination by the Internal Revenue Service for a period of three fiscal years after they are filed.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171139005712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Highlights and Senior Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyAbstract', window );"><strong>Investment Company [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialHighlightsTextBlock', window );">Financial Highlights and Senior Securities</a></td>
<td class="text">Financial Highlights and Senior Securities<div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the financial highlights for the years ended December&#160;31, 2023, 2022, 2021, 2020, 2019 and for the period ended December 31, 2018:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per Share Data </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net asset value, beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized and realized gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in net assets resulting from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions declared </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.00)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in net assets from capital share transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.09)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total increase (decrease) in net assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.82)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net asset value, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.02&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,782,408&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,362,861&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,274,033&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,661,586&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,289,742&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,621,319&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return based on NAV </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return based on market value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ratio of net expenses to average net assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ratio of net investment income to average net assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portfolio turnover rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets, end of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,952,041</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,158,966</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,447,479</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,267,809</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673,117</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,365</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset coverage ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The per share data was derived by using the weighted average shares outstanding during the period.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The per share data for distributions was derived by using the actual shares outstanding at the date of the relevant transactions (refer to Note 8).</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Total return is calculated as the change in NAV per share during the period, plus distributions per share (assuming dividends and distributions are reinvested in accordance with the Company's dividend reinvestment plan) divided by the beginning NAV per share. Total return does not include sales load.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Total return based on market value is calculated as the change in market value per share during the respective periods, taking into account distributions, if any, reinvested in accordance with the Company&#8217;s dividend reinvestment plan. The beginning market value per share is based on the initial public offering price of $26.15 per share and not annualized.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Amounts are annualized except for expense support amounts relating to organizational costs and management fee and income based incentive fee waivers by the Adviser (refer to Note 3). For the years ended December&#160;31, 2023, 2022, 2021, 2020, 2019 and the period ended December 31, 2018, the ratio of total operating expenses to average net assets was 11.7%, 9.3%, 7.4%, 6.4%, 8.5%, and 14.1% respectively, on an annualized basis, excluding the effect of expense support/(recoupment) and management fee and income based incentive fee waivers by the Adviser which represented (0.8)%, (0.9)%, (0.2)%, (0.1)%, (0.0)% and 5.2%, respectively, of average net assets.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The period ended December 31, 2018 represents the period from November 20, 2018 (commencement of operations) to December 31, 2018.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is information about the Company&#8217;s senior securities as of the dates indicated in the below table:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.761%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class and Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount Outstanding Exclusive of Treasury Securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($ in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Coverage per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($ in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Involuntary Liquidating Preference per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Market Value per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subscription Facility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jackson Hole Funding Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,151</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,278</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Breckenridge Funding Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,151</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,278</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Big Sky Funding facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.761%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class and Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount Outstanding Exclusive of Treasury Securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($ in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Coverage per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($ in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Involuntary Liquidating Preference per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Market Value per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">New 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Total amount of each class of senior securities outstanding at the end of the period presented.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Asset coverage per unit is the ratio of the carrying value of our total assets, less all liabilities excluding indebtedness represented by senior securities in this table, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The amount to which such class of senior security would be entitled upon our involuntary liquidation in preference to any security junior to it. The &#8220;-&#8221; in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Not applicable because the senior securities are not registered for public trading.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The Subscription Facility was terminated on November 3, 2020.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The 2023 Notes matured on July 14, 2023 and were paid off consistent with the terms of the 2023 Notes Indenture.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyFinancialHighlightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of financial highlights reported by investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyFinancialHighlightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171130935856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management evaluated subsequent events through the date of issuance of the consolidated financial statements.&#160;There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of December&#160;31, 2023, except as discussed below.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;28, 2024 the Board declared a distribution of $0.77 per share, which is payable on April 26, 2024, to shareholders of record as of March 31, 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171034255776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>N-2 - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="9">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0001736035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">814-01299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Blackstone Secured Lending Fund<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">345 Park Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">31st Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(212)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">503-2100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesTableTextBlock', window );">Senior Securities [Table Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is information about the Company&#8217;s senior securities as of the dates indicated in the below table:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.761%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class and Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount Outstanding Exclusive of Treasury Securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($ in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Coverage per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($ in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Involuntary Liquidating Preference per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Market Value per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subscription Facility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jackson Hole Funding Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,151</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,278</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Breckenridge Funding Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,151</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,278</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Big Sky Funding facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.761%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class and Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount Outstanding Exclusive of Treasury Securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($ in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Coverage per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($ in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Involuntary Liquidating Preference per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Market Value per Unit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">New 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Total amount of each class of senior securities outstanding at the end of the period presented.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Asset coverage per unit is the ratio of the carrying value of our total assets, less all liabilities excluding indebtedness represented by senior securities in this table, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The amount to which such class of senior security would be entitled upon our involuntary liquidation in preference to any security junior to it. The &#8220;-&#8221; in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Not applicable because the senior securities are not registered for public trading.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The Subscription Facility was terminated on November 3, 2020.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The 2023 Notes matured on July 14, 2023 and were paid off consistent with the terms of the 2023 Notes Indenture.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InvestmentObjectivesAndPracticesTextBlock', window );">Investment Objectives and Practices [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. We believe that Blackstone&#8217;s investment platform provides us with a competitive advantage in selecting investments, and to achieve our investment objectives, we will leverage the Adviser&#8217;s investment team&#8217;s and Blackstone&#8217;s extensive network of relationships with other sophisticated institutions to source, evaluate and, as appropriate, partner with on transactions. There are no assurances that we will achieve our investment objectives.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under normal market conditions, we generally invest at least 80% of our total assets (net assets plus borrowings for investment purposes) in secured debt investments. Our portfolio is composed primarily of first lien senior secured and unitranche loans. To a lesser extent, we have and may continue to also invest in second lien, third lien, unsecured or subordinated loans and other debt and equity securities. In limited instances we may retain the &#8220;last out&#8221; portion of a first-lien loan. In such cases, the &#8220;first out&#8221; portion of the first lien loan would receive priority with respect to payment over our &#8220;last out&#8221; position. In exchange for the higher risk of loss associated with such &#8220;last out&#8221; portion, we would earn a higher rate of interest than the &#8220;first out&#8221; position. We do not currently expect to focus on investments in issuers that are distressed or in need of rescue financing. Subject to the limitations of the 1940 Act, we may invest in loans or other securities, the proceeds of which may refinance or otherwise repay debt or securities of companies whose debt is owned by other Blackstone Credit &amp; Insurance funds.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a BDC, at least 70% of our assets must be the type of &#8220;qualifying&#8221; assets listed in Section 55(a) of the 1940 Act, as described herein, which are generally privately-offered securities issued by U.S. private or thinly-traded companies. We may also invest up to 30% of our portfolio opportunistically in &#8220;non-qualifying&#8221; portfolio investments, such as investments in non-U.S. companies. We generally intend to distribute substantially all of our available earnings annually by making quarterly cash distributions. We use leverage and intend to continue to use leverage for our investment activities. We use and intend to continue to use leverage, which is permitted up to the maximum amount allowed by the 1940 Act (currently limited to a debt-to-equity ratio of 2:1), to enhance potential returns. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Financial Condition, Liquidity and Capital Resources&#8212;Borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the Company priced its initial public offering (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;IPO&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), and the Company's common shares of beneficial interest (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Common Shares&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) began trading on the New York Stock Exchange (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;NYSE&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 8. Consolidated Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 8. Net Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity and capital resources are generated primarily from cash flows from interest, dividends and fees earned from our investments and principal repayments, our credit facilities, debt securitization transactions, and other secured and unsecured debt. We may also generate cash flow from operations, future borrowings and future offerings of securities including public and/or private issuances of debt and/or equity securities through both registered offerings and private offerings. The primary uses of our cash and cash equivalents are for (i) originating loans and purchasing senior secured debt investments, (ii) funding the costs of our operations (including fees paid to our Adviser and expense reimbursements paid to our Administrator), (iii) debt service, repayment and other financing costs of our borrowings and (iv) cash distributions to the holders of our shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To&#160;facilitate public issuances of debt and/or equity securities, in July 2022, we filed a shelf registration statement with the SEC that is effective for a term of three years and expires in July 2025. The amount of securities to be issued pursuant to the shelf registration statement filed in July 2022 was not specified when it was filed and there is no specific dollar limit on the amount of securities we may issue. The securities covered by the registration statement filed in July 2022 include: (i) common shares; (ii) preferred shares; (iii) debt securities; (iv) subscription rights; and (v) warrants. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of any offering.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, our debt consisted of asset based leverage facilities, a revolving credit facility, and unsecured note issuances. We may from time to time enter into additional credit facilities, increase the size of our existing credit facilities or issue further debt securities. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors. In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. As of December&#160;31, 2023 and December&#160;31, 2022, we had an aggregate amount of $4,937.9 million and $5,563.0 million of senior securities outstanding, respectively, and our asset coverage ratio was 200.3% and 174.8%, respectively. We seek to carefully consider our unfunded commitments for the purpose of planning our ongoing financial leverage. Further, we maintain sufficient borrowing capacity within the 150% asset coverage limitation to cover any outstanding unfunded commitments we are required to fund. From time to time we may also repurchase our outstanding debt. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, and other factors. The amounts involved in any such purchase transactions, individually or in the aggregate, may be material.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents as of December&#160;31, 2023, taken together with our $1,662.1 million of unused capacity under our credit facilities (subject to borrowing base availability, $1,662.0 million is available to borrow) is expected to be sufficient for our investing activities and to conduct our operations in the near term. Additionally, we held $157.9 million of Level 2 debt investments as of December&#160;31, 2023, which could provide additional liquidity if necessary.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have historically been able to obtain sufficient borrowing capacity, a deterioration in economic conditions or any other negative economic developments could restrict our access to financing in the future. We may not be able to find new financing for future investments or liquidity needs and, even if we are able to obtain such financing, such financing may not be on as favorable terms as we have previously obtained. These factors may limit our ability to make new investments and adversely impact our results of operations. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we had </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$154.9 million in cash and cash equivalents. During the year ended December&#160;31, 2023, cash provided by operating activities was $458.8 million, primarily from receipt of interest payments from our investments, partially offset by purchases of investments, net of sales of investments and principal repayments, of $178.1 million.&#160;Cash used in financing activities was $432.2 million during the year, which was primarily as a result of net repayments on our credit facilities and Unsecured Notes of $650.9 million and dividends paid in cash of $438.0 million partially offset by $665.3 million of proceeds from the issuance of our common shares.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskFactorsTableTextBlock', window );">Risk Factors [Table Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in our shares involves a number of significant risks. In addition to the other information contained in this annual report, shareholders should consider carefully the following information before making an investment in our Common Shares. The risks set forth below are not the only risks we face. Such additional risks and uncertainties not presently known to us or not presently deemed material by us may also impair our operations and performance. If any of the following events occur, our business, financial condition and results of operations could be materially and adversely affected. In such cases, the NAV of our Common Shares could decline, and shareholders may lose all or part of their investment.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">Risks Related to Our Business and Structure</span><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Price declines in the medium- and large-sized U.S. corporate debt market may adversely affect the fair value of our portfolio, reducing our NAV through increased net unrealized depreciation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conditions in the medium- and large-sized U.S. corporate debt market may deteriorate, as seen during the recent financial crisis, which may cause pricing levels to similarly decline or be volatile. During the 2008-2009 financial crisis, many institutions were forced to raise cash by selling their interests in performing assets in order to satisfy margin requirements or the equivalent of margin requirements imposed by their lenders and/or, in the case of hedge funds and other investment vehicles, to satisfy widespread redemption requests. This resulted in a forced deleveraging cycle of price declines, compulsory sales, and further price declines, with falling underlying credit values, and other constraints resulting from the credit crisis generating further selling pressure. If similar events occurred in the medium- and large-sized U.S. corporate debt market, our NAV could decline through an increase in unrealized depreciation and incurrence of realized losses in connection with the sale of our investments, which could have a material adverse impact on our business, financial condition and results of operations and the market price of our shares.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to achieve our investment objectives depends on the ability of the Adviser to manage and support our investment process. If the Adviser or Blackstone Credit &amp; Insurance were to lose any members of their respective senior management teams, our ability to achieve our investment objectives could be significantly harmed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we have no employees, we depend on the investment expertise, skill and network of business contacts of the broader networks of the Adviser and its affiliates. The Adviser evaluates, negotiates, structures, executes, monitors and services our investments. Our future success depends to a significant extent on the continued service and coordination of Blackstone Credit &amp; Insurance and its senior management team. The departure of any members of Blackstone Credit &amp; Insurance&#8217;s senior management team could have a material adverse effect on our ability to achieve our investment objectives.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to achieve our investment objectives depends on the Adviser&#8217;s ability to identify and analyze, and to invest in, finance and monitor companies that meet our investment criteria. The Adviser&#8217;s capabilities in structuring the investment process, providing competent, attentive and efficient services to us, and facilitating access to financing on acceptable terms depend on the employment of investment professionals in an adequate number and of adequate sophistication to match the corresponding flow of transactions. To achieve our investment objectives, the Adviser may need to hire, train, supervise and manage new investment professionals to participate in our investment selection and monitoring process. The Adviser may not be able to find investment professionals in a timely manner or at all. Failure to support our investment process could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investment Advisory Agreement has been approved pursuant to Section 15 of the 1940 Act. In addition, the Investment Advisory Agreement has termination provisions that allow the parties to terminate the agreement. The Investment Advisory Agreement may be terminated at any time, without penalty, by us or by the Adviser, upon 60 days&#8217; written notice. If the Investment Advisory Agreement is terminated, it may adversely affect the quality of our investment opportunities. In addition, in the event the Investment Advisory Agreement is terminated, it may be difficult for us to replace the Adviser. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because our business model depends to a significant extent upon relationships with private equity sponsors, investment banks and commercial banks, the inability of the Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser depends on its broader organization&#8217;s relationships with private equity sponsors, investment banks and commercial banks, and we rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the Adviser or its broader organization fail to maintain their existing relationships or develop new relationships with other sponsors or sources of investment opportunities, we may not be able to grow our investment portfolio. In addition, individuals with whom the Adviser or its broader organizations have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face increasing competition for investment opportunities, which could delay deployment of our capital, reduce returns and result in losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete for investments with other BDCs and investment funds (including private equity funds, mezzanine funds, performing and other credit funds, and funds that invest in CLOs, structured notes, derivatives and other types of collateralized securities and structured products), as well as traditional financial services companies such as commercial banks and other sources of funding. These other BDCs and investment funds might be reasonable investment alternatives to us and may be less costly or complex with fewer and/or different risks than we have. Moreover, alternative investment vehicles, such as hedge funds, have begun to invest in areas in which they have not traditionally invested, including making investments in U.S. private companies. As a result of these new competitors entering the financing markets in which we operate, competition for investment opportunities in U.S. private companies may intensify. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of capital and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have. These characteristics could allow our competitors to consider a wider variety of investments, establish more relationships and offer better pricing and more flexible structuring than we are able to do. We may lose investment opportunities if we do not match our competitors&#8217; pricing, terms or structure. If we are forced to match our competitors&#8217; pricing, terms or structure, we may not be able to achieve acceptable returns on our investments or may bear substantial risk of capital loss. A significant part of our competitive advantage stems from the fact that the market for investments in U.S. private companies is underserved by traditional commercial banks and other financial sources. A significant increase in the number and/or the size of our competitors in this target market could force us to accept less attractive investment terms. Furthermore, many of our competitors have greater experience operating under, or are not subject to, the regulatory restrictions that the 1940 Act imposes on us as a BDC.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulty sourcing investment opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure investors that we will be able to locate a sufficient number of suitable investment opportunities to allow us to deploy all available capital successfully. In addition, privately-negotiated investments in loans and illiquid securities of private middle market companies require substantial due diligence and structuring, and we cannot assure investors that we will achieve our anticipated investment pace. As a result, investors will be unable to evaluate any future portfolio company investments prior to purchasing our shares. Our shareholders will have no input with respect to investment decisions. These factors increase the uncertainty, and thus the risk, of investing in our shares. To the extent we are unable to deploy all available capital, our investment income and, in turn, our results of operations, will likely be materially adversely affected.&#160;There is no assurance that we will be able to consummate investment transactions or that such transactions will be successful.&#160;Blackstone Credit &amp; Insurance, the Company and their affiliates may also face certain conflicts of interests in connection with any transaction, including any warehousing transaction, involving an affiliate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks associated with the deployment of our capital.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the nature of our periodic public offerings in relation to our investment strategy and the need to be able to deploy potentially large amounts of capital quickly to capitalize on potential investment opportunities, if we have difficulty identifying suitable investments on attractive terms, there could be a delay between the time we receive net proceeds from the sale of shares of our Common Shares in any periodic public offering and the time we invest the net proceeds. Our proportion of privately-negotiated investments may be lower than expected. We may also from time to time hold cash pending deployment into investments or have less than our targeted leverage, which cash or shortfall in target leverage may at times be significant, particularly at times when we are receiving high amounts of offering proceeds and/or times when there are few attractive investment opportunities. Such cash may be held in an account for the benefit of our shareholders that may be invested in money market accounts or other similar temporary investments, each of which is subject to management fees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event we are unable to find suitable investments such cash may be maintained for longer periods which would be dilutive to overall investment returns. This could cause a substantial delay in the time it takes for your investment to realize its full potential return and could adversely affect our ability to pay regular distributions of cash flow from operations to you. It is not anticipated that the temporary investment of such cash into money market accounts or other similar temporary investments pending deployment into investments will generate significant interest, and investors should understand that such low interest payments on the temporarily invested cash may adversely affect overall returns. In the event we fail to timely invest the net proceeds of sales of our Common Shares or do not deploy sufficient capital to meet our targeted leverage, our results of operations and financial condition may be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As required by the 1940 Act, a significant portion of our investment portfolio is and will be recorded at fair value as determined in good faith and, as a result, there is and will be uncertainty as to the value of our portfolio investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, we are required to carry our portfolio investments at market value or, if there is no readily available market value, at fair value as determined pursuant to policies adopted by, and subject to the oversight of, our Board. There is not a public market for the securities of the privately-held companies in which we invest. Many of our investments are not publicly-traded or actively traded on a secondary market. As a result, we value these securities quarterly at fair value as determined in good faith as required by the 1940 Act. In connection with striking a NAV as of a date other than quarter end for share issuances and repurchases, the Company will consider whether there has been a material change to such investments as to affect their fair value, but such analysis will be more limited than the quarter end process.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our valuation process, we will take into account relevant factors in determining the fair value of the Company&#8217;s investments, without market quotations, many of which are loans, including and in combination, as relevant: (i) the estimated enterprise value of a portfolio company, (ii) the nature and realizable value of any collateral, (iii) the portfolio company&#8217;s ability to make payments based on its earnings and cash flow, (iv) the markets in which the portfolio company does business, (v) a comparison of the portfolio company&#8217;s securities to any similar publicly traded securities, and (vi) overall changes in the interest rate environment and the credit markets that may affect the price at which similar investments may be made in the future. Our determinations of fair value may differ materially from the values that would have been used if a ready market for these non-traded securities existed. Due to this uncertainty, our fair value determinations may cause our NAV on a given date to materially differ from the value that we may ultimately realize upon the sale of one or more of our investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There is a risk that investors in our shares may not receive distributions or that our distributions may decrease over time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not achieve investment results that will allow us to make a specified or stable level of cash distributions and our distributions may decrease over time. In addition, due to the asset coverage test applicable to us as a BDC, we may be limited in our ability to make distributions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The amount of any distributions we may make is uncertain. Our distributions may exceed our earnings, particularly during the period before we have substantially invested the net proceeds from any securities offering. Therefore, portions of the distributions that we make may represent a return of capital to a shareholder that will lower such shareholder&#8217;s tax basis in its shares and reduce the amount of funds we have for investment in targeted assets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may fund our cash distributions to shareholders from any sources of funds available to us, including offering proceeds, borrowings, net investment income from operations, capital gains proceeds from the sale of assets, non-capital gains proceeds from the sale of assets, dividends or other distributions paid to us on account of preferred and common equity investments in portfolio companies and fee and expense reimbursement waivers from the Adviser or the Administrator, if any. Our ability to pay distributions, if any, might be adversely affected by, among other things, the impact of one or more of the risk factors described in this annual report. In addition, the inability to satisfy the asset coverage test applicable to us as a BDC may limit our ability to pay distributions. All distributions are and will be paid at the discretion of our Board and will depend on our earnings, our financial condition, maintenance of our RIC status, compliance with applicable BDC regulations and such other factors as our Board may deem relevant from time to time. We cannot assure shareholders that we will continue to pay distributions to our shareholders in the future. In the event that we encounter delays in locating suitable investment opportunities, we may pay all or a substantial portion of our distributions from the proceeds of our prior offerings or from borrowings or sources other than cash flow from operations in anticipation of future cash flow, which may constitute a return of shareholders&#8217; capital. A return of capital is a return of a shareholder&#8217;s investment, rather than a return of earnings or gains derived from our investment activities. A shareholder will not be subject to immediate taxation on the amount of any distribution treated as a return of capital to the extent of the shareholder&#8217;s basis in its shares; however, the shareholder&#8217;s basis in its shares will be reduced (but not below zero) by the amount of the return of capital, which will result in the shareholder recognizing additional gain (or a lower loss) when the shares are sold. To the extent that the amount of the return of capital exceeds the shareholder&#8217;s basis in its shares, such excess amount will be treated as gain from the sale of the shareholder&#8217;s shares. Distributions from the proceeds of our prior offerings or from borrowings also could reduce the amount of capital we ultimately invest in our portfolio companies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have not established any limit on the amount of funds we may use from available sources, such as borrowings, if any, or proceeds from securities offerings, to fund distributions (which may reduce the amount of capital we ultimately invest in assets).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any distributions made from sources other than cash flow from operations or relying on fee or expense reimbursement waivers, if any, from the Adviser or the Administrator are not based on our investment performance, and can only be sustained if we achieve positive investment performance in future periods and/or the Adviser or the Administrator continues to make such expense reimbursements, if any. The extent to which we pay distributions from sources other than cash flow from operations will depend on various factors, including the level of participation in our dividend reinvestment plan, how quickly we invest the proceeds from this and any future offering and the performance of our investments. Shareholders should also understand that our future repayments to the Adviser will reduce the distributions that they would otherwise receive. There can be no assurance that we will achieve such performance in order to sustain these distributions, or be able to pay distributions at all. The Adviser and the Administrator have no obligation to waive fees or receipt of expense reimbursements, if any.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a public reporting company, we are subject to regulations not applicable to private companies, such as provisions of the Sarbanes-Oxley Act. Efforts to comply with such regulations will involve significant expenditures, and non-compliance with such regulations may adversely affect us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public reporting company, we are subject to the Sarbanes-Oxley Act, and the related rules and regulations promulgated by the SEC. Our management is required to report on our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. We are required to review on an annual basis our internal control over financial reporting, and on a quarterly and annual basis to evaluate and disclose changes in our internal control over financial reporting. Developing and maintaining an effective system of internal controls may require significant expenditures, which may negatively impact our financial performance and our ability to make distributions. This process also will result in a diversion of our management&#8217;s time and attention. We cannot be certain of when our evaluation, testing and remediation actions will be completed or the impact of the same on our operations. In addition, we may be unable to ensure that the process is effective or that our internal controls over financial reporting are or will be effective in a timely manner. In the event that we are unable to develop or maintain an effective system of internal controls and maintain or achieve compliance with the Sarbanes-Oxley Act and related rules, we may be adversely affected. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in laws or regulations governing our operations may adversely affect our business or cause us to alter our business strategy. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, our portfolio companies and other counterparties are subject to regulation at the local, state and federal level. New legislation may be enacted or new interpretations, rulings or regulations could be adopted, including those governing the types of investments we are permitted to make, any of which could harm us and our shareholders, potentially with retroactive effect.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President Biden may support an enhanced regulatory agenda that imposes greater costs on all sectors and on financial services companies in particular. In addition, uncertainty regarding legislation and regulations affecting the financial services industry or taxation could also adversely impact our business or the business of our portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, any changes to or repeal of the laws and regulations governing our operations relating to permitted investments may cause us to alter our investment strategy to avail ourselves of new or different opportunities. Such changes could result in material differences to our strategies and plans as set forth in this annual report and may result in our investment focus shifting from the areas of expertise of the Adviser to other types of investments in which the Adviser may have less expertise or little or no experience. Thus, any such changes, if they occur, could have a material adverse effect on our financial condition and results of operations and the value of a shareholder&#8217;s investment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial regulatory changes in the United States could adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial services industry continues to be the subject of heightened regulatory scrutiny in the United States. There has been active debate over the appropriate extent of regulation and oversight of investment funds and their managers. We may be adversely affected as a result of new or revised regulations imposed by the SEC or other U.S. governmental regulatory authorities or self-regulatory organizations that supervise the financial markets. We also may be adversely affected by changes in the interpretation or enforcement of existing laws and regulations by these governmental authorities and self-regulatory organizations. Further, new regulations or interpretations of existing laws may result in enhanced disclosure obligations, including with respect to climate change or environmental, social and governance factors, which could negatively affect us and materially increase our regulatory burden. Increased regulations generally increase our costs, and we could continue to experience higher costs if new laws require us to spend more time or buy new technology to comply effectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any changes in the regulatory framework applicable to our business, including the changes described above, may impose additional compliance and other costs, increase regulatory investigations of the investment activities of our funds, require the attention of our senior management, affect the manner in which we conduct our business and adversely affect our profitability. The full extent of the impact on us of any new laws, regulations or initiatives that may be proposed is impossible to determine.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We, the Adviser and its affiliates are subject to regulatory oversight, which could negatively impact our operations, cash flow or financial condition, impose additional costs on us or otherwise adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and the businesses of the Adviser and its affiliates are subject to&#160;extensive regulation, including periodic examinations, inquiries and investigations which may result in enforcement and other proceedings, by governmental agencies&#160;and self-regulatory organizations in the jurisdictions in which we and they operate around the world, including the SEC and various other U.S. federal, state&#160;and local agencies. These&#160;authorities have regulatory powers dealing with many aspects of financial services, including the authority to&#160;grant, and in specific circumstances to cancel, permissions to carry on particular activities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the Adviser and its respective affiliates have received, and may in the future receive, requests for information, inquiries and informal or formal investigations or subpoenas from such regulators from time to time in connection with such inquiries and proceedings and otherwise in the ordinary course of business. These requests could relate to a broad range of matters, including specific practices of our business, the Adviser, our investments or other investments the Adviser or its affiliates make on behalf of their clients, potential conflicts of interest between us and the Adviser or its affiliates, or industry wide practices. SEC actions and initiatives can have an adverse effect on our financial results,&#160;including as a result of the imposition of a sanction, a limitation on our, Blackstone&#8217;s or our personnel&#8217;s&#160;activities, or changing our historic practices. Any adverse publicity relating to an investigation, proceeding or imposition of these sanctions could&#160;harm our or Blackstone&#8217;s reputation and have an&#160;adverse effect on our future fundraising or operations. The costs of responding to legal or regulatory&#160;information requests, any increased reporting, registration and compliance requirements will be borne by us&#160;in the form of legal or other expenses, litigation, regulatory proceedings or penalties, may divert the attention of our management, may cause negative publicity that adversely affects investor sentiment, and may place us at a competitive disadvantage, including to the extent that we, the Adviser or any of its affiliates are required to disclose sensitive business information or alter business practices.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, efforts by the current administration or future administrations could have further impacts on our industry if previously enacted laws are amended or if new legislative or regulatory reforms are adopted. In addition, a future change in administration may lead to leadership changes at a number of U.S. federal regulatory agencies with oversight over the U.S. financial services industry. Such changes would pose uncertainty with respect to such agencies&#8217; ongoing policy priorities and could lead to increased regulatory enforcement activity in the financial services industry. Any changes or reforms may impose additional costs on our current or future investments, require the attention of senior management or result in other limitations on our business or investments. We are unable to predict at this time the likelihood or effect of any such changes or reforms.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The impact of financial reform legislation on us is uncertain.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of past market conditions in the U.S. and global financial markets, the U.S. and global economy, legislators, the presidential administration and regulators have increased their focus on the regulation of the financial services industry, including the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Dodd-Frank Act,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which instituted a wide range of reforms that have impacted all financial institutions to varying degrees. Because these requirements are relatively new and evolving, the full impact such requirements will have on our business, results of operations or financial condition is unclear. While we cannot predict what effect any changes in the laws or regulations or their interpretations would have on us, these changes could be materially adverse to us and our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any changes in the regulatory framework applicable to our business, including the changes described above, may impose additional compliance and other costs, increase regulatory investigations of the investment activities of our funds, require the attention of our senior management, affect the manner in which we conduct our business and adversely affect our profitability. The full extent of the impact on us of any new laws, regulations or initiatives that may be proposed is impossible to determine.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience fluctuations in our quarterly results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could experience fluctuations in our quarterly operating results due to a number of factors, including our ability or inability to make investments in companies that meet our investment criteria, the interest rate payable on the loans or other debt securities we originate or acquire, the level of our expenses (including our borrowing costs), variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our markets and general economic conditions. As a result of these factors, results for any previous period should not be relied upon as being indicative of performance in future periods.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transactions denominated in foreign currencies subject us to foreign currency risks.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold assets and have made borrowings denominated in foreign currencies and may acquire assets or make borrowings denominated in other foreign currencies, which exposes us to foreign currency risk. As a result, a change in foreign currency exchange rates may have an adverse impact on the valuation of our assets or liabilities, as well as our income and cash flows. As a result of foreign currency fluctuations, the value of our liabilities and expenses may increase or the value of our assets and income may decrease due to factors outside of our control, which can have a negative effect on our NAV and cash available for distribution. Any such changes in foreign currency exchange rates may impact the measurement of such assets or liabilities for purposes of maintaining RIC tax treatment or the requirements under the 1940 Act. We may seek to hedge against currency exchange rate fluctuations by using financial instruments such as futures, options, swaps and forward contracts, subject to the requirements of the 1940 Act, but there is no guarantee such efforts will be successful and such hedging strategies create additional costs. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;We may acquire various financial instruments for purposes of &#8220;hedging&#8221; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General economic conditions could adversely affect the performance of our investments and operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our portfolio companies are susceptible to the effects of economic slowdowns or recessions. The global growth cycle is in a mature phase and signs of slowdown are evident in certain regions around the world, although most economists continue to expect moderate economic growth in the near term, with limited signals of an imminent recession in the U.S. as consumer and government spending remain healthy. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of non&#8209;performing loans on the balance sheets of European banks, the effect of the United Kingdom (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;U.K.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) leaving the European Union (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;E.U.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), instability in the Chinese capital markets and the COVID-19 pandemic. Although the broader outlook remains constructive, geopolitical instability continues to pose risk. In particular, the current U.S. political environment and the resulting uncertainties regarding actual and potential shifts in U.S. foreign investment, trade, taxation, economic, environmental and other policies under the current Administration, as well as the impact of geopolitical tension, such as a deterioration in the bilateral relationship between the U.S. and China or the current ongoing conflict between Russia and Ukraine and the escalating conflict in the Middle East, and the rapidly evolving measures in response, could lead to disruption, instability and volatility in the global markets. Certain of our portfolio companies may operate in, or have dealings with, countries subject to sanctions or embargoes imposed by the U.S. government, foreign governments, or the United Nations or other international organizations. U.S. debt ceiling and budget deficit concerns have increased the possibility of additional credit-rating downgrades and economic slowdowns or a recession in the United States. A decreased U.S. government credit rating, any default by the U.S. government on its obligations, or any prolonged U.S. government shutdown, could create broader financial turmoil and uncertainty, which may weigh heavily on our financial performance and the value of our common shares. Unfavorable economic conditions would be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events may limit our investment originations, and limit our ability to grow and could have a material negative impact on our operating results, financial condition, results of operations and cash flows and the fair values of our debt and equity investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any deterioration of general economic conditions may lead to significant declines in corporate earnings or loan performance, and the ability of corporate borrowers to service their debt, any of which could trigger a period of global economic slowdown, and have an adverse impact on the performance and financial results of the Company, and the value and the liquidity of the shares. In an economic downturn, we may have non-performing assets or non-performing assets may increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions&#160;impacted&#160;the value of any collateral securing our senior secured debt in 2023 and may continue to impact such collateral in 2024. A severe recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income, assets and net worth. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on favorable terms or at all. These events could prevent us from increasing investments and harm our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the failure of certain financial institutions, namely banks, may increase the possibility of a sustained deterioration of financial market liquidity, or illiquidity at clearing, cash management and/or custodial financial institutions. The failure of a bank (or banks) with which we and/or our portfolio companies have a commercial relationship could adversely affect, among other things, our and/or our portfolio companies&#8217; ability to pursue key strategic initiatives, including by affecting our or our portfolio company&#8217;s ability to access deposits or borrow from financial institutions on favorable terms. Additionally, if a portfolio company or its sponsor has a commercial relationship with a bank that has failed or is otherwise distressed, the portfolio company may experience issues receiving financial support from a sponsor to support its operations or consummate transactions, to the detriment of their business, financial condition and/or results of operations. In addition, such bank failure(s) could affect, in certain circumstances, the ability of both affiliated and unaffiliated co-lenders, including syndicate banks or other fund vehicles, to undertake and/or execute co-investment transactions with the Company, which in turn may result in fewer co-investment opportunities being made available to the Company or impact the Company&#8217;s ability to provide additional follow-on support to portfolio companies. The ability of the Company, its subsidiaries and portfolio companies to spread banking relationships among multiple institutions may be limited by certain contractual arrangements, including liens placed on their respective assets as a result of a bank agreeing to provide financing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inflation and supply chain risks have had and may continue to have an adverse impact on our financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflation in the United States remained elevated throughout 2022 and 2023 and may continue to remain high in the future. While inflation has shown signs of moderating, it remains uncertain whether substantial inflation in the United States will be sustained over an extended period of time or have a significant effect on the United States or other economies. Elevated inflation could have an adverse impact on our operating costs, credit facilities, and general and administrative expenses, as these costs could increase at a rate higher than our revenue. Certain of our portfolio companies are in industries that have been impacted by inflation and global supply chain issues. Recent inflationary pressures have increased the costs of labor, energy and raw materials and have adversely affected consumer spending, economic growth and our portfolio companies&#8217; operations and such pressures and related volatility may continue during 2024. If such portfolio companies are unable to pass any increases in their costs of operations along to their customers, it could adversely affect their operating results and impact their ability to pay interest and principal on our loans, particularly if interest rates rise in response to inflation. In addition, any projected future decreases in our portfolio companies&#8217; operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of our investments could result in future realized or unrealized losses and therefore reduce our net assets resulting from operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be impacted by general European economic conditions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our investment activities could be affected by general economic and market conditions in Europe and in the rest of the world, as well as by changes in applicable laws and regulations (including laws relating to taxation of our investments), trade barriers, currency exchange controls, rate of inflation, currency depreciation, asset re-investment, resource self-sufficiency and national and international political and socioeconomic circumstances in respect of the European and other non-U.S. countries in which we may invest. These factors will affect the level and volatility of securities prices and the liquidity of the Company&#8217;s investments, which could impair our profitability or result in losses. General fluctuations in the market prices of securities and interest rates may affect our investment opportunities and the value of our investments. We may maintain substantial trading positions that can be adversely affected by the level of volatility in the financial markets; the larger the positions, the greater the potential for loss. Declines in the performance of national economies or the credit markets in certain jurisdictions have had a negative impact on general economic and market conditions globally, and as a result, could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser&#8217;s financial condition may be adversely affected by a significant general economic downturn and it may be subject to legal, regulatory, reputational and other unforeseen risks that could have a material adverse effect on the Adviser&#8217;s businesses and operations (including those of the Company). A recession, slowdown and/or sustained downturn in the global economy (or any particular segment thereof) could have a pronounced impact on the Company and could adversely affect the Company&#8217;s profitability, impede the ability of the Company&#8217;s portfolio companies to perform under or refinance their existing obligations and impair the Company&#8217;s ability to effectively deploy its capital or realize its investments on favorable terms.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, economic problems in a single country are increasingly affecting other markets and economies. A continuation of this trend could result in problems in one country adversely affecting regional and even global economic conditions and markets. For example, concerns about the fiscal stability and growth prospects of certain European countries in the last economic downturn had a negative impact on most economies of the Eurozone and global markets and the current ongoing conflict between Russia and Ukraine could have a negative impact on those countries and others in the region. The occurrence of similar crises in the future could cause increased volatility in the economies and financial markets of countries throughout a region, or even globally.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of the foregoing events could result in substantial or total losses to the Company in respect of certain investments, which losses will likely be exacerbated by the presence of leverage in a portfolio company&#8217;s capital structure. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">It may be difficult to bring suit or foreclosure in non-U.S. countries.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the effectiveness of the judicial systems in the countries in which the Company may invest varies, the Company (or any portfolio company) may have difficulty in foreclosing or successfully pursuing claims in the courts of such countries, as compared to the United States or other countries. Further, to the extent the Company or a portfolio company may obtain a judgment but is required to seek its enforcement in the courts of one of these countries in which the Company invests, there can be no assurance that such courts will enforce such judgment. The laws of other countries often lack the sophistication and consistency found in the United States with respect to foreclosure, bankruptcy, corporate reorganization or creditors&#8217; rights. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MiFID II obligations could have an adverse effect on the ability of Blackstone Credit &amp; Insurance and its MiFID-authorized EEA affiliates to obtain and research in connection with the provision of an investment service.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Recast European Union Directive on Markets in Financial Instruments (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;MiFID II&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) came into effect on January 3, 2018, and imposes regulatory obligations in respect of providing financial services in the European Economic Area (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;EEA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by EEA banks and EEA investment firms providing regulated services (each an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Investment Firm&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The Adviser is a non-EEA investment company and is, therefore, not subject to MiFID II but can be indirectly affected. The regulatory obligations imposed by MiFID II may impact, and constrain the implementation of, the investment strategy of the Company. MiFID II restricts Investment Firms&#8217; ability to obtain research in connection with the provision of an investment service. For example, Investment Firms providing portfolio management or independent investment advice may purchase investment research only at their own expense or out of specifically dedicated research payment accounts agreed upon with their clients. Research will also have to be unbundled and paid separately from the trading commission. EEA broker-dealers will unbundle research costs and invoice them to Investment Firms separated from dealing commissions. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Therefore, in light of the above, MiFID II could have an adverse effect on the ability of Blackstone Credit &amp; Insurance and its MiFID-authorized EEA affiliates to obtain and to provide research. The new requirements regarding the unbundling of research costs under MiFID II are not consistent with market practice in the United States and the regulatory framework concerning the use of commissions to acquire research developed by the SEC, although the SEC has issued temporary no-action letters to facilitate compliance by firms with the research requirements under MiFID II in a manner that is consistent with the U.S. federal securities laws. Blackstone Credit &amp; Insurance&#8217;s access to third-party research may nonetheless be significantly limited. Some EEA jurisdictions extend certain MiFID II obligations also to other market participants (e.g., Alternative Investment Fund Managers) under national law. There is very little guidance, and limited market practice, that has developed in preparation for MiFID II. As such, the precise impact of MiFID II on Blackstone Credit &amp; Insurance and the Company cannot be fully predicted at this stage. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available for distribution.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at the fair value as determined in good faith pursuant to procedures adopted by, and under oversight of, our Board. Decreases in the market value or fair value of our investments relative to amortized cost will be recorded as unrealized depreciation. Any unrealized losses in our portfolio could be an indication of a portfolio company&#8217;s inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods. In addition, decreases in the market value or fair value of our investments will reduce our NAV.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terrorist attacks, acts of war or natural disasters may adversely affect our operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Terrorist acts, acts of war or natural disasters may disrupt our operations, as well as the operations of the businesses in which we invest. Such acts, including the current ongoing conflict between Russia and Ukraine and the escalating conflict in the Middle East, have created, and continue to create, economic and political uncertainties and have contributed to recent global economic instability. Future terrorist activities, military or security operations, or natural disasters could further weaken the domestic/global economies and create additional uncertainties, which may negatively impact the businesses in which we invest directly or indirectly and, in turn, could have a material adverse impact on our business, operating results and financial condition. Losses from terrorist attacks and natural disasters are generally uninsurable. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Force Majeure events may adversely affect our operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be affected by force majeure events (e.g., acts of God, fire, flood, earthquakes, outbreaks of an infectious disease, pandemic or any other serious public health concern, war, terrorism, nationalization of industry and labor strikes). Force Majeure events could adversely affect the ability of the Company or a counterparty to perform its obligations. The liability and cost arising out of a failure to perform obligations as a result of a force majeure event could be considerable and could be borne by the Company. Certain Force Majeure events, such as war or an outbreak of an infectious disease, could have a broader negative impact on the global or local economy, thereby affecting us. Additionally, a major governmental intervention into industry, including the nationalization of an industry or the assertion of control, could result in a loss to the Company if an investment is affected, and any compensation provided by the relevant government may not be adequate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Another pandemic or global health crisis like the COVID-19 pandemic may adversely impact our performance and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From 2020 to 2022, in response to the COVID-19 pandemic, many countries instituted quarantine restrictions and took other measures to limit the spread of the virus. This resulted in labor shortages and disruption of supply chains and contributed to prolonged disruption of the global economy. A widespread reoccurrence of another pandemic or global health crisis could increase the possibility of periods of increased restrictions on business operations, which may adversely impact our business, financial condition, results of operations, liquidity and prospects materially and exacerbate many of the other risks discussed in this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Risk Factors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of another pandemic or global health crisis like the COVID-19 pandemic, our portfolio companies may experience decreased revenues and earnings, which may adversely impact our ability to realize value from such investments and in turn reduce our performance revenues. Investments in certain sectors, including hospitality, location-based entertainment, retail, travel, leisure and events, and in certain geographies, office and residential, could be particularly negatively impacted, as was the case during the COVID-19 pandemic. Our portfolio companies may also face increased credit and liquidity risk due to volatility in financial markets, reduced revenue streams and limited access or higher cost of financing, which may result in potential impairment of our investments. In addition, borrowers of loans, notes and other credit instruments may be unable to meet their principal or interest payment obligations or satisfy financial covenants, resulting in a decrease in value of our investments. In the event of significant credit market contraction as a result of a pandemic or similar global health crisis, we may be limited in our ability to sell assets at attractive prices or in a timely manner in order to avoid losses and margin calls from credit providers. Shareholders may also be negatively impacted if we experience a decline in the pace of capital deployment or fundraising.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a pandemic or global health crisis may pose enhanced operational risks. For example, the employees of our Adviser and/or its affiliates may become sick or otherwise unable to perform their duties for an extended period, and extended public health restrictions and remote working arrangements may affect our Adviser and/or its affiliates by impacting employee morale, integration of new employees and preservation of their culture. Remote working environments may also be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts. Moreover, our third-party service providers could be impacted by an inability to perform due to pandemic-related restrictions or by failures of, or attacks on, their technology platforms.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity and data protection risks could result in the loss of data, interruptions in our business, and damage to our reputation, and subject us to regulatory actions&#160;, increased costs and financial losses, each of which could have a material adverse effect on our business and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are highly dependent on technology platforms and we rely heavily on Blackstone&#8217;s and its affiliates&#8217; analytical, financial, accounting, communications and other data processing systems. Blackstone&#8217;s and its affiliates&#8217; systems face ongoing cybersecurity threats and attacks, which could result in the loss of confidentiality, integrity or availability of such systems and the data held by such systems. Attacks on Blackstone&#8217;s and/or its affiliates&#8217; systems could involve, and in some instances have in the past involved, attempts intended to obtain unauthorized access to our proprietary information, destroy data or disable, degrade or sabotage our systems, or divert or otherwise steal funds, including through the introduction of computer viruses, &#8220;phishing&#8221; attempts and other forms of social engineering. Attacks on Blackstone&#8217;s and/or its affiliates&#8217; systems could also involve ransomware or other forms of cyber extortion. Cyberattacks and other data security threats could originate from a wide variety of external sources, including cyber criminals, nation state hackers, hacktivists and other outside parties. Cyberattacks and other security threats could also originate from the malicious or accidental acts of insiders, such as employees, consultants, independent contractors or other service providers.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been an increase in the frequency and sophistication of the cyber and data security threats, with attacks ranging from those common to businesses generally to those that are more advanced and persistent, which may target Blackstone and/or its affiliates because they hold a significant amount of confidential and sensitive information about investors, portfolio companies and potential investments. As a result, Blackstone&#8217;s and its affiliates&#8217; may face a heightened risk of a security breach or disruption with respect to this information. Measures taken by Blackstone&#8217;s and/or its affiliates&#8217; to ensure the integrity of their systems may not provide adequate protection, especially because cyberattack techniques are continually evolving, may persist undetected over extended periods of time, and may not be mitigated in a timely manner to prevent or minimize the impact of an attack on Blackstone and/or its affiliates&#8217;, our investors, our portfolio companies or potential investments. If Blackstone&#8217;s and/or its affiliates&#8217; systems or those of third party service providers are compromised either as a result of malicious activity or through inadvertent transmittal or other loss of data, do not operate properly or are disabled, or we fail to provide the appropriate regulatory or other notifications in a timely manner, we could suffer financial loss, increased costs, a disruption of our businesses, liability to our counterparties, portfolio companies or fund investors, regulatory intervention or reputational damage. The costs related to cyber or other data security threats or disruptions may not be fully insured or indemnified by other means.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we could also suffer losses in connection with updates to, or the failure to timely update, the technology platforms on which we rely. We are reliant on third party service providers for certain aspects of our business, including for our administration, as well as for certain technology platforms, including cloud-based services. These third-party service providers could also face ongoing cybersecurity threats and compromises of their systems and as a result, unauthorized individuals could gain, and in some past instances have gained, access to certain confidential data.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybersecurity and data protection have become top priorities for regulators around the world. Many jurisdictions in which we, Blackstone and/or its affiliates operate have laws and regulations relating to privacy, data protection and cybersecurity, including, as examples, the General Data Protection Regulation (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;GDPR&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in the European Union, the U.K. Data Protection Act, and the California Privacy Rights Act (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;CPRA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). For example, in February 2022, the SEC proposed rules regarding registered investment advisers' and funds' cybersecurity risk management requiring the adoption and implementation of cybersecurity policies and procedures, enhanced disclosure in regulatory filings and prompt reporting of incidents to the SEC, which, if adopted, could increase our compliance costs and potential regulatory liability related to cybersecurity. Some jurisdictions have also enacted or proposed laws requiring companies to notify individuals and government agencies of data security breaches involving certain types of personal data.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breaches in our, Blackstone&#8217;s and/or its affiliates&#8217; security or in the security of third party service providers, whether malicious in nature or through inadvertent transmittal or other loss of data, could potentially jeopardize our, Blackstone&#8217;s and/or its affiliates&#8217;, including the Adviser&#8217;s, employees or our shareholders' or counterparties' confidential, proprietary and other information processed and stored in, and transmitted through, computer systems and networks, or otherwise cause interruptions or malfunctions in our, Blackstone&#8217;s and/or its affiliates&#8217;, including the Adviser&#8217;s, employees', our shareholders', our counterparties' or third parties' business and operations, which could result in significant financial losses, increased costs, liability to our shareholders and other counterparties, regulatory intervention and reputational damage. Furthermore, if we, Blackstone and/or its affiliates fail to comply with the relevant laws and regulations or fail to provide the appropriate regulatory or other notifications of breach in a timely matter, it could result in regulatory investigations and penalties, which could lead to negative publicity and reputational harm and may cause our shareholders to lose confidence in the effectiveness of our security measures and Blackstone more generally.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio companies also rely on data processing systems and the secure processing, storage and transmission of information, including payment and health information, which in some instances are provided by third parties. A disruption or compromise of these systems could have a material adverse effect on the value of these businesses. We may invest in strategic assets having a national or regional profile or in infrastructure, the nature of which could expose them to a greater risk of being subject to a terrorist attack or a security breach than other assets or businesses. Such an event may have material adverse consequences on our investment or assets of the same type or may require portfolio companies to increase preventative security measures or expand insurance coverage.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, Blackstone&#8217;s and/or its affiliates&#8217; and our portfolio companies' technology platforms, data and intellectual property are also subject to a heightened risk of theft or compromise to the extent they engage in operations outside the United States, in particular in those jurisdictions that do not have comparable levels of protection of proprietary information and assets such as intellectual property, trademarks, trade secrets, know-how and customer information and records. In addition, they may be required to compromise protections or forego rights to technology, data and intellectual property in order to operate in or access markets in a foreign jurisdiction. Any such direct or indirect compromise of these assets could have a material adverse impact on us and our portfolio companies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to obtain and maintain all required state licenses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to obtain various state licenses in order to, among other things, originate commercial loans. Applying for, obtaining and maintaining required licenses can be costly and take several months. There is no assurance that we will obtain, and maintain, all of the licenses that we need on a timely basis. Furthermore, we will be subject to various information and other requirements in order to obtain and maintain these licenses, and there is no assurance that we will satisfy those requirements. Our failure to obtain or maintain licenses might restrict investment options and have other adverse consequences.</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with the SEC&#8217;s Regulation Best Interest by participating broker-dealers may negatively impact our ability to raise capital in a public offering, which could harm our ability to achieve our investment objectives.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Broker-dealers are required to comply with Regulation Best Interest, which, among other requirements, establishes a new standard of conduct for broker-dealers and their associated persons when making a recommendation of any securities transaction or investment strategy involving securities to a retail customer. The full impact of Regulation Best Interest on participating broker-dealers cannot be determined at this time, and it may negatively impact whether participating broker-dealers and their associated persons recommend the offering to certain retail customers. In particular, under SEC guidance concerning Regulation Best Interest, a broker-dealer recommending an investment in our shares should consider a number of factors, under the care obligation of Regulation Best Interest, including but not limited to cost and complexity of the investment and reasonably available alternatives in determining whether there is a reasonable basis for the recommendation. As a result, high cost, high risk and complex products may be subject to greater scrutiny by broker-dealers. Broker-dealers may recommend a more costly or complex product as long as they have a reasonable basis to believe is in the best interest of a particular retail customer. However, if broker-dealers choose alternatives to our shares, many of which likely exist, such as an investment in listed entities, which may be a reasonable alternative to an investment in us as such investments may feature characteristics like lower cost, nominal commissions at the time of initial purchase, less complexity and lesser or different risks, our ability to raise capital will be adversely affected. If compliance by broker-dealers with Regulation Best Interest negatively impacts our ability to raise capital in a public offering, it may harm our ability to create a diversified portfolio of investments and achieve our investment objectives.</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a Delaware statutory trust, we are subject to the control share acquisition statute contained in the Delaware Statutory Trust Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is organized as a Delaware statutory trust and thus is subject to the control share acquisition statute contained in Subchapter III of the Delaware Statutory Trust Act (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;DSTA Control Share Statute&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The DSTA Control Share Statute applies to any closed-end management investment company that has elected to be regulated as a business development company under the 1940 Act organized as a Delaware statutory trust and listed on a national securities exchange, such as the Company. The DSTA Control Share Statute became automatically applicable to the Company on August 1, 2022.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSTA Control Share Statute defines &#8220;control beneficial interests&#8221; (referred to as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;control shares&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein) by reference to a series of voting power thresholds and provides that a holder of control shares acquired in a control share acquisition has no voting rights under the Delaware Statutory Trust Act (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;DSTA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or the Company&#8217;s governing documents with respect to the control shares acquired in the control share acquisition, except to the extent approved by the Company&#8217;s shareholders by the affirmative vote of two&#8211;thirds of all the votes entitled to be cast on the matter, excluding all interested shares (generally, shares held by the acquiring person and their associates and shares held by Company insiders).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSTA Control Share Statute provides for a series of voting power thresholds above which shares are considered control shares. Whether one of these thresholds of voting power is met is determined by aggregating the holdings of the acquiring person as well as those of his, her or its &#8220;associates.&#8221; These thresholds are:</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) 10% or more, but less than 15% of all voting power;</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) 15% or more, but less than 20% of all voting power;</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) 20% or more, but less than 25% of all voting power;</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) 25% or more, but less than 30% of all voting power;</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5) 30% or more, but less than a majority of all voting power; or</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6) a majority or more of all voting power.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the DSTA Control Share Statute, once a threshold is reached, an acquirer has no voting rights with respect to shares in excess of that threshold (i.e., the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;control shares&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) until approved by a vote of shareholders, as described above, or otherwise exempted by the Board of Trustees. The DSTA Control Share Statute contains a statutory process for an acquiring person to request a shareholder meeting for the purpose of considering the voting rights to be accorded control shares. An acquiring person must repeat this process at each threshold level.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the DSTA Control Share Statute, an acquiring person&#8217;s &#8220;associates&#8221; are broadly defined to include, among others, relatives of the acquiring person, anyone in a control relationship with the acquiring person, any investment fund or other collective investment vehicle that has the same investment adviser as the acquiring person, any investment adviser of an acquiring person that is an investment fund or other collective investment vehicle and any other person acting or intending to act jointly or in concert with the acquiring person.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Voting power under the DSTA Control Share Statute is the power (whether such power is direct or indirect or through any contract, arrangement, understanding, relationship or otherwise) to directly or indirectly exercise or direct the exercise of the voting power of shares of the Company in the election of the Trustees (either generally or with respect to any subset, series or class of trustees, including any Trustees elected solely by a particular series or class of shares, such as the preferred shares).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any control shares of the Company acquired before August 1, 2022 are not subject to the DSTA Control Share Statute; however, any further acquisitions on or after August 1, 2022 are considered control shares subject to the DSTA Control Share Statute.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSTA Control Share Statute requires shareholders to disclose to the Company any control share acquisition within 10 days of such acquisition, and also permits the Company to require a shareholder or an associate of such person to disclose the number of shares owned or with respect to which such person or an associate thereof can directly or indirectly exercise voting power. Further, the DSTA Control Share Statute requires a shareholder or an associate of such person to provide to the Company within 10 days of receiving a request therefor from the Company any information that the Trustees reasonably believe is necessary or desirable to determine whether a control share acquisition has occurred.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSTA Control Share Statute permits the Board, through a provision in the Company&#8217;s governing documents or by Board action alone, to eliminate the application of the DSTA Control Share Statute to the acquisition of control shares in the Company specifically, generally, or generally by types, as to specifically identified or unidentified existing or future beneficial owners or their affiliates or associates or as to any series or classes of shares. The DSTA Control Share Statute does not provide that the Company can generally &#8220;opt out&#8221; of the application of the DSTA Control Share Statute; rather, specific acquisitions or classes of acquisitions may be exempted by the Board, either in advance or retroactively, but other aspects of the DSTA Control Share Statute, which are summarized above, would continue to apply. The DSTA Control Share Statute further provides that the Board of Trustees is under no obligation to grant any such exemptions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing is only a summary of the material terms of the DSTA Control Share Statute. Shareholders should consult their own counsel with respect to the application of the DSTA Control Share Statute to any particular circumstance.</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Declaration of Trust includes exclusive forum and jury trial waiver provisions that could limit a shareholder&#8217;s ability to bring a claim or, if such provisions are deemed inapplicable or unenforceable by a court, may cause the Company to incur additional costs associated with such action.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Declaration of Trust provides that, to the fullest extent permitted by law, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of a duty owed by any trustee, officer or other agent of the Company to the Company or our shareholders, (iii) any action asserting a claim arising pursuant to any provision of Title 12 of the Delaware Code, Delaware statutory or common law, our Declaration of Trust, or (iv) any action asserting a claim governed by the internal affairs doctrine (for the avoidance of doubt, including any claims brought to interpret, apply or enforce the federal securities laws of the United States, including, without limitation, the 1940 Act or the securities or anti-fraud laws of any international, national, state, provincial, territorial, local or other governmental or regulatory authority, including, in each case, the applicable rules and regulations promulgated thereunder) shall be the Court of Chancery of the State of Delaware or, if such court does not have subject matter jurisdiction thereof, any other court in the State of Delaware with subject matter jurisdiction. In addition, our Declaration of Trust provides that no shareholder may maintain a derivative action on behalf of the Company unless holders of at least ten percent (10%) of the outstanding shares join in the bringing of such action. These provisions of our Declaration of Trust may make it more difficult for shareholders to bring a derivative action than a company without such provisions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Declaration of Trust also includes an irrevocable waiver of the right to trial by jury in all such claims, suits, actions and proceedings. Any person purchasing or otherwise acquiring any of our Common Shares shall be deemed to have notice of and to have consented to these provisions of our Declaration of Trust. These provisions may limit a shareholder&#8217;s ability to bring a claim in a judicial forum or in a manner that it finds favorable for disputes with the Company or the Company&#8217;s trustees or officers, which may discourage such lawsuits. Alternatively, if a court were to find the exclusive forum provision or the jury trial waiver provision to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions or in other manners, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any of the foregoing, neither we nor any of our investors are permitted to waive compliance with any provision of the U.S. federal securities laws and the rules and regulations promulgated thereunder.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Board may change our operating policies and strategies without prior notice or shareholder approval, the effects of which may be adverse to our results of operations and financial condition.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board has the authority to modify or waive our current operating policies, investment criteria and strategies without prior notice and without shareholder approval, unless required by the 1940 Act or applicable law. We cannot predict the effect any changes to our current operating policies, investment criteria and strategies would have on our business, NAV, operating results and value of our shares. However, the effects might be adverse, which could negatively impact our ability to pay shareholders distributions and cause shareholders to lose all or part of their investment. Moreover, we have significant flexibility in investing the net proceeds from our continuous offering and may use the net proceeds from our continuous offering in ways with which investors may not agree or for purposes other than those contemplated in this annual report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Board may amend our Declaration of Trust without prior shareholder approval.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board may, without shareholder vote, subject to certain exceptions, amend or otherwise supplement the Declaration of Trust by making an amendment, a Declaration of Trust supplemental thereto or an amended and restated Declaration of Trust, including without limitation to classify the Board, to impose advance notice bylaw provisions for Trustee nominations or for shareholder proposals, to require super-majority approval of transactions with significant shareholders or other provisions that may be characterized as anti-takeover in nature.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain provisions of our Declaration of Trust could deter takeover attempts and have an adverse impact on the value of our common shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Declaration of Trust contains anti-takeover provisions that could have the effect of limiting the ability of other entities or persons to acquire control of the Company or to change the composition of our Board of Trustees. Our Board of Trustees is divided into three classes of trustees serving staggered three-year terms. This provision could delay for up to two years the replacement of a majority of our Board of Trustees. These provisions could have the effect of depriving shareholders of an opportunity to sell their common shares at a premium over prevailing market prices by discouraging a third party from seeking to obtain control over the Company.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt">Risks Related to Our Investments</span><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in prospective portfolio companies may be risky, and we could lose all or part of our investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in senior secured loans, senior secured bonds, subordinated debt and equity of private U.S. companies, including middle market companies, may be risky and, subject to compliance with our 80% policy, there is no limit on the amount of any such investments in which we may invest.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Loans and Senior Secured Bonds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a risk that any collateral pledged by portfolio companies in which we have taken a security interest may decrease in value over time or lose its entire value, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. Such risks have become more pronounced due to rising interest rates and market volatility.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent our debt investment is collateralized by the securities of a portfolio company&#8217;s subsidiaries, such securities may lose some or all of their value in the event of the bankruptcy or insolvency of the portfolio company. Also, in some circumstances, our security interest may be contractually or structurally subordinated to claims of other creditors. In addition, deterioration in a portfolio company&#8217;s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the debt. Secured debt that is under-collateralized involves a greater risk of loss. In addition, second lien debt is granted a second priority security interest in collateral, which means that any realization of collateral will generally be applied to pay senior secured debt in full before second lien debt is paid. Similarly, investments in &#8220;last out&#8221; pieces of unitranche loans will be similar to second lien loans in that such investments will be junior in priority to the &#8220;first out&#8221; piece of the same unitranche loan with respect to payment of principal, interest and other amounts. Consequently, the fact that debt is secured does not guarantee that we will receive principal and interest payments according to the debt&#8217;s terms, or at all, or that we will be able to collect on the debt should we be forced to enforce our remedies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subordinated Debt. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our subordinated debt investments will generally rank junior in priority of payment to senior debt and will generally be unsecured. This may result in a heightened level of risk and volatility or a loss of principal, which could lead to the loss of the entire investment. These investments may involve additional risks that could adversely affect our investment returns. To the extent interest payments associated with such debt are deferred, such debt may be subject to greater fluctuations in valuations, and such debt could subject us and our shareholders to non-cash income. Because we will not receive any principal repayments prior to the maturity of some of our subordinated debt investments, such investments will be of greater risk than amortizing loans.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may make select equity investments. In addition, in connection with our debt investments, we on occasion may receive equity interests such as warrants or options as additional consideration. The equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in preferred securities involve certain risks. Certain preferred securities contain provisions that allow an issuer under certain conditions to skip or defer distributions. If the Company owns a preferred security that is deferring its distribution, the Company may be required to include the amount of the deferred distribution in its taxable income for tax purposes although it does not currently receive such amount in cash. In order to receive the special treatment accorded to RICs and their shareholders under the Code and to avoid U.S. federal income and/or excise taxes at the Company level, the Company may be required to distribute this income to shareholders in the tax year in which the income is recognized (without a corresponding receipt of cash). Therefore, the Company may be required to pay out as an income distribution in any such tax year an amount greater than the total amount of cash income the Company actually received, and to sell portfolio securities, including at potentially disadvantageous times or prices, to obtain cash needed for these income distributions. Preferred securities often are subject to legal provisions that allow for redemption in the event of certain tax or legal changes or at the issuer&#8217;s call. In the event of redemption, the Company may not be able to reinvest the proceeds at comparable rates of return. Preferred securities are subordinated to bonds and other debt securities in an issuer&#8217;s capital structure in terms of priority for corporate income and liquidation payments, and therefore will be subject to greater credit risk than those debt securities. Preferred securities may trade less frequently and in a more limited volume and may be subject to more abrupt or erratic price movements than many other securities, such as common stocks, corporate debt securities and U.S. government securities. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-U.S. Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may invest in non-U.S. securities, which may include securities denominated in U.S. dollars or in non-U.S. currencies, to the extent permitted by the 1940 Act. Because evidence of ownership of such securities usually is held outside the United States, we would be subject to additional risks if we invested in non-U.S. securities, which include possible adverse political and economic developments, seizure or nationalization of foreign deposits and adoption of governmental restrictions, which might adversely affect or restrict the payment of principal and interest on the non-U.S. securities to shareholders located outside the country of the issuer, whether from currency blockage or otherwise. Because non-U.S. securities may be purchased with and payable in foreign currencies, the value of these assets as measured in U.S. dollars may be affected unfavorably by changes in currency rates and exchange control regulations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loans Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The loans that the Company may invest in include loans that are first lien, second lien, third lien or that are unsecured. In addition, the loans the Company will invest in will usually be rated below investment grade or may also be unrated. Loans are subject to a number of risks described elsewhere in the prospectus, including credit risk, liquidity risk, below investment grade instruments risk and management risk. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although certain loans in which the Company may invest will be secured by collateral, there can be no assurance that such collateral could be readily liquidated or that the liquidation of such collateral would satisfy the borrower&#8217;s obligation in the event of non-payment of scheduled interest or principal. In the event of the bankruptcy or insolvency of a borrower, the Company could experience delays or limitations with respect to its ability to realize the benefits of the collateral securing a loan. In the event of a decline in the value of the already pledged collateral, if the terms of a loan do not require the borrower to pledge additional collateral, the Company will be exposed to the risk that the value of the collateral will not at all times equal or exceed the amount of the borrower&#8217;s obligations under the loans. To the extent that a loan is collateralized by stock in the borrower or its subsidiaries, such stock may lose some or all of its value in the event of the bankruptcy or insolvency of the borrower. Those loans that are under-collateralized involve a greater risk of loss. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, there is a risk that any collateral pledged by portfolio companies in which the Company has taken a security interest may decrease in value over time or lose its entire value, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. To the extent the Company&#8217;s debt investment is collateralized by the securities of a portfolio company&#8217;s subsidiaries, such securities may lose some or all of their value in the event of the bankruptcy or insolvency of the portfolio company. Also, in some circumstances, the Company&#8217;s security interest may be contractually or structurally subordinated to claims of other creditors. In addition, deterioration in a portfolio company&#8217;s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the debt. Secured debt that is under-collateralized involves a greater risk of loss. In addition, second lien debt is granted a second priority security interest in collateral, which means that any realization of collateral will generally be applied to pay senior secured debt in full before second lien debt is paid. Consequently, the fact that debt is secured does not guarantee that the Company will receive principal and interest payments according to the debt&#8217;s terms, or at all, or that the Company will be able to collect on the debt should it be forced to enforce remedies. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans are not registered with the SEC, or any state securities commission, and are not listed on any national securities exchange. There is less readily available or reliable information about most loans than is the case for many other types of securities, including securities issued in transactions registered under the Securities Act or registered under the Exchange Act. No active trading market may exist for some loans, and some loans may be subject to restrictions on resale. A secondary market may be subject to irregular trading activity, wide bid/ask spreads and extended trade settlement periods, which may impair the ability to realize full value and thus cause a material decline in the Company&#8217;s NAV. In addition, the Company may not be able to readily dispose of its loans at prices that approximate those at which the Company could sell such loans if they were more widely-traded and, as a result of such illiquidity, the Company may have to sell other investments or engage in borrowing transactions if necessary to raise cash to meet its obligations. During periods of limited supply and liquidity of loans, the Company&#8217;s yield may be lower. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some loans are subject to the risk that a court, pursuant to fraudulent conveyance or other similar laws, could subordinate the loans to presently existing or future indebtedness of the borrower or take other action detrimental to lenders, including the Company. Such court action could under certain circumstances include invalidation of loans. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If legislation of state or federal regulations impose additional requirements or restrictions on the ability of financial institutions to make loans, the availability of loans for investment by the Company may be adversely affected. In addition, such requirements or restrictions could reduce or eliminate sources of financing for certain borrowers. This would increase the risk of default. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If legislation or federal or state regulations require financial institutions to increase their capital requirements this may cause financial institutions to dispose of loans that are considered highly levered transactions. Such sales could result in prices that, in the opinion of the Adviser, do not represent fair value. If the Company attempts to sell a loan at a time when a financial institution is engaging in such a sale, the price the Company could get for the loan may be adversely affected. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may acquire loans through assignments or participations. The Company will typically acquire loans through assignment. The purchaser of an assignment typically succeeds to all the rights and obligations of the assigning institution and becomes a lender under the credit agreement with respect to the debt obligation; however, the purchaser&#8217;s rights can be more restricted than those of the assigning institution, and the Company may not be able to unilaterally enforce all rights and remedies under the loan and with regard to any associated collateral. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A participation typically results in a contractual relationship only with the institution selling the participation interest, not with the borrower. Sellers of participations typically include banks, broker-dealers, other financial institutions and lending institutions. Certain participation agreements also include the option to convert the participation to a full assignment under agreed upon circumstances. The Adviser has adopted best execution procedures and guidelines to mitigate credit and counterparty risk in the atypical situation when the Company must acquire a loan through a participation. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In purchasing participations, the Company generally will have no right to enforce compliance by the borrower with the terms of the loan agreement against the borrower, and the Company may not directly benefit from the collateral supporting the debt obligation in which it has purchased the participation. As a result, the Company will be exposed to the credit risk of both the borrower and the institution selling the participation. Further, in purchasing participations in lending syndicates, the Company will not be able to conduct the due diligence on the borrower or the quality of the loan with respect to which it is buying a participation that the Company would otherwise conduct if it were investing directly in the loan, which may result in the Company being exposed to greater credit or fraud risk with respect to the borrower or the loan than the Company expected when initially purchasing the participation. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also may originate loans or acquire loans by participating in the initial issuance of the loan as part of a syndicate of banks and financial institutions, or receive its interest in a loan directly from the borrower. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser has established a counterparty and liquidity sub-committee that regularly reviews each broker-dealer counterparty for, among other things, its quality and the quality of its execution. The established procedures and guidelines require trades to be placed for execution only with broker counterparties approved by the counterparty and liquidity sub-committee of the Adviser. The factors considered by the sub-committee when selecting and approving brokers and dealers include, but are not limited to: (i) quality, accuracy, and timeliness of execution, (ii) review of the reputation, financial strength and stability of the financial institution, (iii) willingness and ability of the counterparty to commit capital, (iv) ongoing reliability and (v) access to underwritten offerings and secondary markets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Junior, Unsecured Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our strategy may entail acquiring securities that are junior or unsecured instruments. While this approach can facilitate obtaining control and then adding value through active management, it also means that certain of the Company&#8217;s investments may be unsecured. If a portfolio company becomes financially distressed or insolvent and does not successfully reorganize, we will have no assurance (compared to those distressed securities investors that acquire only fully collateralized positions) that we will recover any of the principal that we have invested. Similarly, investments in &#8220;last out&#8221; pieces of unitranche loans will be similar to second lien loans in that such investments will be junior in priority to the &#8220;first out&#8221; piece of the same unitranche loan with respect to payment of principal, interest and other amounts. Consequently, the fact that debt is secured does not guarantee that we will receive principal and interest payments according to the debt&#8217;s terms, or at all, or that we will be able to collect on the debt should it be forced to enforce its remedies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While such junior or unsecured investments may benefit from the same or similar financial and other covenants as those enjoyed by the indebtedness ranking more senior to such investments and may benefit from cross-default provisions and security over the issuer&#8217;s assets, some or all of such terms may not be part of particular Investments. Moreover, our ability to influence an issuer&#8217;s affairs, especially during periods of financial distress or following insolvency, is likely to be substantially less than that of senior creditors. For example, under typical subordination terms, senior creditors are able to block the acceleration of the junior debt or the exercise by junior debt holders of other rights they may have as creditors. Accordingly, we may not be able to take steps to protect investments in a timely manner or at all, and there can be no assurance that our rate of return objectives or any particular investment will be achieved. In addition, the debt securities in which we will invest may not be protected by financial covenants or limitations upon additional indebtedness, may have limited liquidity and are not expected to be rated by a credit rating agency.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early repayments of our investments may have a material adverse effect on our investment objectives. In addition, depending on fluctuations of the equity markets and other factors, warrants and other equity investments may become worthless.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that attempts to provide downside protection through contractual or structural terms with respect to our investments will achieve their desired effect and potential investors should regard an investment in us as being speculative and having a high degree of risk. Furthermore, we have limited flexibility to negotiate terms when purchasing newly issued investments in connection with a syndication of mezzanine or certain other junior or subordinated investments or in the secondary market.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Below Investment Grade Risk. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as &#8220;junk,&#8221; have predominantly speculative characteristics with respect to the issuer&#8217;s capacity to pay interest and repay principal. They may also be difficult to value and illiquid. The major risks of below investment grade securities include:</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Below investment grade securities may be issued by less creditworthy issuers. Issuers of below investment grade securities may have a larger amount of outstanding debt relative to their assets than issuers of investment grade securities. In the event of an issuer&#8217;s bankruptcy, claims of other creditors may have priority over the claims of holders of below investment grade securities, leaving few or no assets available to repay holders of below investment grade securities.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Prices of below investment grade securities are subject to extreme price fluctuations. Adverse changes in an issuer&#8217;s industry and general economic conditions may have a greater impact on the prices of below investment grade securities than on other higher-rated fixed-income securities.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Issuers of below investment grade securities may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments, or the unavailability of additional financing.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Below investment grade securities frequently have redemption features that permit an issuer to repurchase the security from us before it matures. If the issuer redeems below investment grade securities, we may have to invest the proceeds in securities with lower yields and may lose income.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Below investment grade securities may be less liquid than higher-rated fixed-income securities, even under normal economic conditions. There are fewer dealers in the below investment grade securities market, and there may be significant differences in the prices quoted by the dealers. Judgment may play a greater role in valuing these securities and we may be unable to sell these securities at an advantageous time or price.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit rating of a high-yield security does not necessarily address its market value risk. Ratings and market value may change from time to time, positively or negatively, to reflect new developments regarding the issuer.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mezzanine Loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Our mezzanine loans generally will be subordinated to senior secured loans on a payment basis, are typically unsecured and rank</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pari passu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with other unsecured creditors.&#160;As such, other creditors may rank senior to us in the event of insolvency.&#160;This may result in an above average amount of risk and loss of principal. Our mezzanine debt securities generally will have ratings or implied or imputed ratings below investment grade. They will be obligations of corporations, partnerships or other entities that are generally unsecured, typically are subordinated to other obligations of the obligor and generally have greater credit and liquidity risk than is typically associated with investment grade corporate obligations. Accordingly, the risks associated with mezzanine debt securities include a greater possibility that adverse changes in the financial condition of the obligor or in general economic conditions (including a sustained period of rising interest rates or an economic downturn) may adversely affect the obligor&#8217;s ability to pay principal and interest on its debt. Many obligors on mezzanine debt securities are highly leveraged, and specific developments affecting such obligors, including reduced cash flow from operations or the inability to refinance debt at maturity, may also adversely affect such obligors&#8217; ability to meet debt service obligations. Mezzanine debt securities are often issued in connection with leveraged acquisitions or recapitalizations, in which the issuers incur a substantially higher amount of indebtedness than the level at which they had previously operated. Default rates for mezzanine debt securities have historically been higher than has been the case for investment grade securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Retention Vehicles</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We may invest in CLO debt and equity tranches and warehouse investments directly or indirectly through an investment in U.S. and/or European vehicles (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Retention Vehicles</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) established for the purpose of satisfying U.S. and/or E.U. regulations that require eligible risk retainers to purchase and retain specified amounts of the credit risk associated with certain CLOs, which vehicles themselves are invested in CLO securities, warehouse investments and/or senior secured obligations. Risk Retention Vehicles will be structured to satisfy the retention requirements by purchasing and retaining the percentage of CLO notes prescribed under the applicable retention requirements (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retention Notes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and will not include Risk Retention Vehicles that are deemed to be controlled by the Adviser or its affiliates (other than Risk Retention Vehicles we control).</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indirect investments in CLO equity securities (and in some instances more senior CLO securities) and warehouse investments through entities that have been established to satisfy the U.S. retention requirements and/or the European retention requirements may allow for better economics for us (including through fee rebate arrangements) by creating stronger negotiating positions with CLO managers and underwriting banks who are incentivized to issue CLOs and who require the participation of a Risk Retention Vehicle to enable the CLO securities to be issued. However, Retention Notes differ from other securities of the same ranking since the retention requirements prescribe that such Retention Notes must be held by the relevant risk retainer for a specified period. In the case of European Risk Retention Vehicles, the prescribed holding period is the lifetime of the CLO, and in the case of U.S. Risk Retention Vehicles it is the longer of (x) the period until the CLO has paid down its securities to 33% of their original principal amount, (y) the period until the CLO has sold down its assets to 33% of their original principal amount and (z) two years after the closing of the CLO. In addition, Retention Notes are subject to other restrictions not imposed on other securities of the same ranking; for example, Retention Notes may not be subject to credit risk mitigation, and breach of the retention requirements may result in the imposition of regulatory sanctions or, in the case of the European retention requirements, in claims being brought against the retaining party.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Covenant-lite&#8221; Obligations.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We may invest in, or obtain exposure to, obligations that may be &#8220;covenant-lite,&#8221; which means such obligations lack certain financial maintenance covenants. While these loans may still contain other collateral protections, a covenant-lite loan may carry more risk than a covenant-heavy loan made by the same borrower, as it does not require the borrower to provide affirmation that certain specific financial tests have been satisfied on a routine basis as is required under a covenant-heavy loan agreement. Should a loan we hold begin to deteriorate in quality, our ability to negotiate with the borrower may be delayed under a covenant-lite loan compared to a loan with full maintenance covenants. This may in turn delay our ability to seek to recover its investment.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consumer Loans.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We may invest in, or obtain exposure to, consumer lending, which involves risk elements in addition to normal credit risk. Consumer loan terms vary according to the type and value of collateral and creditworthiness of the borrower. In underwriting consumer loans, a thorough analysis of the borrower&#8217;s financial ability to repay the loan as agreed is typically performed. The ability to repay shall be determined by, among others, the borrower&#8217;s employment history, current financial conditions, and credit background. While these loans typically have higher yields than many other loans, such loans involve risk elements in addition to normal credit risk. Consumer loans may entail greater credit risk than other loans particularly in the case of unsecured consumer loans or consumer loans secured by rapidly depreciable assets, such as automobiles. In such cases, any repossessed collateral for a defaulted consumer loan may not provide an adequate source of repayment of the outstanding loan balance as a result of the greater likelihood of damage, loss or depreciation. In addition, consumer loan collections are dependent on the borrower&#8217;s continuing financial stability, and thus are more likely to be affected by adverse personal circumstances. During periods of deteriorating economic conditions, such as recessions or periods of rising unemployment, delinquencies and losses generally increase, sometimes dramatically, with respect to consumer loans. Furthermore, the application of various federal and state laws, including bankruptcy and insolvency laws, and/or state consumer protection laws may limit the amount which can be recovered on such loans.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bridge Financings.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> From time to time, we may lend to portfolio companies on a short-term, unsecured basis or otherwise invest on an interim basis in portfolio companies in anticipation of a future issuance of equity or long-term debt securities or other refinancing or syndication. Such bridge loans would typically be convertible into a more permanent, long-term security; however, for reasons not always in the Company&#8217;s control, such long-term securities issuance or other refinancing or syndication may not occur and such bridge loans and interim investments may remain outstanding. In such event, the interest rate on such loans or the terms of such interim investments may not adequately reflect the risk associated with the position taken by the Company.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructurings.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in companies operating in workout or bankruptcy modes present additional legal risks, including fraudulent conveyance, voidable preference and equitable subordination risks. The level of analytical sophistication, both financial and legal, necessary for successful investment in companies experiencing significant business and financial difficulties is unusually high. There is no assurance that we will correctly evaluate the value of the assets collateralizing our loans or the prospects for a successful reorganization or similar action.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to risks associated with changes in interest rates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to financial market risks, including changes in interest rates. General interest rate fluctuations may have a substantial negative impact on our investments and investment opportunities and, accordingly, have a material adverse effect on our investment objectives and our rate of return on invested capital. In addition, an increase in interest rates would make it more expensive to use debt for our financing needs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During periods of falling interest rates, payments under the floating rate debt instruments that we hold would generally decrease, resulting in less revenue to us. In the event of a sharply rising interest rate environment, such as during 2022 and 2023, payments under floating rate debt instruments generally would rise and there may be a significant number of issuers of such floating rate debt instruments that would be unable or unwilling to pay such increased interest costs and may otherwise be unable to repay their loans. Investments in floating rate debt instruments may also decline in value in response to rising interest rates if the interest rates of such investments do not rise as much, or as quickly, as market interest rates in general. Similarly, during periods of rising interest rates, fixed-rate debt instruments may decline in value because the fixed rates of interest paid thereunder may be below market interest rates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, an increase in interest rates would make it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase in the amount of incentive fees payable to the Adviser with respect to pre-incentive fee net investment income.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio companies may have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt in which we invest. By their terms, such debt instruments may entitle the holders to receive payment of interest or principal on or before the dates on which we are entitled to receive payments with respect to the debt instruments in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any proceeds. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt instruments in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If one of our portfolio companies were to file for bankruptcy, depending on the facts and circumstances, including the extent to which we actually provided managerial assistance to that portfolio company, a bankruptcy court might re-characterize our debt investment and subordinate all or a portion of our claim to that of other creditors. We may also be subject to lender liability claims for actions taken by us with respect to a borrower&#8217;s business or instances where we exercise control over the borrower.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We generally do not control our portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not expect to control most of our portfolio companies, even though we may have board representation or board observation rights, and our debt agreements with such portfolio companies may contain certain restrictive covenants. As a result, we are subject to the risk that a portfolio company in which we invest may make business decisions with which we disagree and the management of such company, as representatives of the holders of the company&#8217;s common equity, may take risks or otherwise act in ways that do not serve our interests as debt investors. Due to the lack of liquidity for our investments in non-traded companies, we may not be able to dispose of our interests in our portfolio companies as readily as we would like or at an appropriate valuation. As a result, a portfolio company may make decisions that could decrease the value of our portfolio holdings.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks related to ESG matters.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Adviser&#8217;s consideration of ESG factors is intended to aid the Adviser in evaluating the return and risk profile of a given investment and is not expected to by itself determine an investment decision for us, the Adviser&#8217;s consideration of ESG factors could, to the extent material economic risks associated with an investment are identified, cause the Adviser to consider taking action with respect to a company differently than may have been taken in the absence of such consideration, which could cause us to perform differently compared to funds that do not have such considerations. Further, although the Adviser views application of its ESG framework to be an opportunity to potentially enhance or protect the performance of investments over the long-term, the Adviser cannot guarantee that any consideration of ESG factors or engagement with portfolio companies on ESG, which depends in part on skill and qualitative judgments, will positively impact the performance of any individual portfolio company or us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors and other stakeholders have become more focused on understanding how companies address a variety of ESG factors. As they evaluate investment decisions, many investors look not only at company disclosures but also to ESG rating systems that have been developed by third parties to allow ESG comparisons among companies. The criteria used in these ratings systems may conflict and change frequently, and we cannot predict how these third parties will score us, nor can we have any assurance that they score us accurately or other companies accurately or that other companies have provided them with accurate data. If our ESG ratings, disclosures or practices do not meet the standards set by such investors or our shareholders, they may choose not to invest in our shares. Relatedly, we risk damage to our reputation, if we do not, or are perceived to not, act responsibly in a number of areas, such as greenhouse gas emissions, energy management, human rights, community relations, workforce health and safety, and business ethics and transparency. Adverse incidents with respect to ESG matters or negative ESG ratings or assessments by third-party ESG raters could impact the value of our brand, or the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a growing regulatory interest across jurisdictions in improving transparency regarding the definition, measurement and disclosure of ESG factors in order to allow investors to validate and better understand sustainability claims. New regulatory initiatives related to ESG that are applicable to us could adversely affect our business. For example, the SEC has proposed rules that would require additional disclosures about ESG investment practices by investment advisers and certain funds, including BDCs. These changing rules, regulations and stakeholder expectations have resulted in, and are likely to continue to result in, increased general and administrative expenses and increased management time and attention spent complying with or meeting such regulations and expectations. If we fail or are perceived to fail to comply with applicable rules, regulations and stakeholder expectations, it could negatively impact our reputation and our business results. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our investment adviser could be the target of litigation or regulatory investigations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We as well as our investment adviser and its affiliates participate in a highly regulated industry and are each subject to regulatory examinations in the ordinary course of business. There can be no assurance that we and our investment adviser and/or any of its affiliates will avoid regulatory investigation and possible enforcement actions stemming therefrom. Our investment adviser is a registered investment adviser and, as such, is subject to the provisions of the Advisers Act. We and our investment adviser are each, from time to time, subject to formal and informal examinations, investigations, inquiries, audits and reviews from numerous regulatory authorities both in response to issues and questions raised in such examinations or investigations and in connection with the changing priorities of the applicable regulatory authorities across the market in general.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment adviser, its affiliates and/or any of their respective principals and employees could also be named as defendants in, or otherwise become involved in, litigation. Litigation and regulatory actions can be time-consuming and expensive and can lead to unexpected losses, which expenses and losses are often subject to indemnification by us. Legal proceedings could continue without resolution for long periods of time and their outcomes, which could materially and adversely affect the value of us or the ability of our investment adviser to manage us, are often impossible to anticipate. Our investment adviser would likely be required to expend significant resources responding to any litigation or regulatory action related to it, and these actions could be a distraction to the activities of our investment adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment activities are subject to the normal risks of becoming involved in litigation by third parties. This risk would be somewhat greater if we were to exercise control or significant influence over a portfolio company&#8217;s direction. The expense of defending against claims by third parties and paying any amounts pursuant to settlements or judgments would, absent willful misfeasance, bad faith, gross negligence, or reckless disregard of the duties involved by our investment adviser, our administrator, or any of our officers, be borne by us and would reduce our net assets. Our investment adviser and others are indemnified by us in connection with such litigation, subject to certain conditions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Second priority liens on collateral securing debt investments that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. If there is a default, the value of the collateral may not be sufficient to repay in full both the first priority creditors and us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain debt investments that we make to portfolio companies may be secured on a second priority basis by the same collateral securing first priority debt of such companies. The first priority liens on the collateral will secure the portfolio company&#8217;s obligations under any outstanding senior debt and may secure certain other future debt that may be permitted to be incurred by the company under the agreements governing the loans. The holders of obligations secured by the first priority liens on the collateral will generally control the liquidation of and be entitled to receive proceeds from any realization of the collateral to repay their obligations in full before us. In addition, the value of the collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from the sale or sales of all of the collateral would be sufficient to satisfy the debt obligations secured by the second priority liens after payment in full of all obligations secured by the first priority liens on the collateral. If such proceeds are not sufficient to repay amounts outstanding under the debt obligations secured by the second priority liens, then we, to the extent not repaid from the proceeds of the sale of the collateral, will only have an unsecured claim against the company&#8217;s remaining assets, if any.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also make unsecured debt investments in portfolio companies, meaning that such investments will not benefit from any interest in collateral of such companies. Liens on such portfolio companies&#8217; collateral, if any, will secure the portfolio company&#8217;s obligations under its outstanding secured debt and may secure certain future debt that is permitted to be incurred by the portfolio company under its secured debt agreements. The holders of obligations secured by such liens will generally control the liquidation of, and be entitled to receive proceeds from, any realization of such collateral to repay their obligations in full before we are so entitled. In addition, the value of such collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from sales of such collateral would be sufficient to satisfy its unsecured debt obligations after payment in full of all secured debt obligations. If such proceeds were not sufficient to repay the outstanding secured debt obligations, then its unsecured claims would rank equally with the unpaid portion of such secured creditors&#8217; claims against the portfolio company&#8217;s remaining assets, if any.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights we may have with respect to the collateral securing the debt investments we make to our portfolio companies with senior debt outstanding may also be limited pursuant to the terms of one or more intercreditor agreements that we enter into with the holders of senior debt. Under such an intercreditor agreement, at any time that obligations that have the benefit of the first priority liens are outstanding, any of the following actions that may be taken in respect of the collateral will be at the direction of the holders of the obligations secured by the first priority liens: the ability to cause the commencement of enforcement proceedings against the collateral; the ability to control the conduct of such proceedings; the approval of amendments to collateral documents; releases of liens on the collateral; and waivers of past defaults under collateral documents. We may not have the ability to control or direct such actions, even if our rights are adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic recessions or downturns or restrictions on trade could impair our portfolio companies and adversely affect our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks associated with our and our portfolio companies&#8217; businesses are more severe during periods of economic slowdown or recession. In recent years, we have experienced periods of economic slowdown and in some instances, contraction, as countries and industries around the globe grappled with the short- and long-term economic impacts of the COVID-19 pandemic, elevated inflation, supply chain challenges, labor shortages, high interest rates, foreign currency exchange volatility and volatility in global capital markets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our portfolio companies may be susceptible to economic recessions or downturns and may be unable to repay our debt investments during these periods. Therefore, our non-performing assets are likely to increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions may also decrease the value of any collateral securing our senior secured debt. A prolonged recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income and NAV. Certain of our portfolio companies may also be impacted by tariffs or other matters affecting international trade. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on terms we deem acceptable. These events could prevent us from increasing investments and adversely affect our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portfolio company&#8217;s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, acceleration of the time when the loans are due and foreclosure on its assets representing collateral for its obligations, which could trigger cross defaults under other agreements and jeopardize our portfolio company&#8217;s ability to meet its obligations under the debt investments that we hold and the value of any equity securities we own. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting portfolio company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in CLOs may be riskier than a direct investment in the debt or other securities of the underlying companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When investing in CLOs, we may invest in any level of a CLO&#8217;s subordination chain, including subordinated (lower-rated) tranches and residual interests (the lowest tranche). CLOs are typically highly levered and therefore, the junior debt and equity tranches that we may invest in are subject to a higher risk of total loss and deferral or nonpayment of interest than the more senior tranches to which they are subordinated. In addition, we will generally have the right to receive payments only from the CLOs, and will generally not have direct rights against the underlying borrowers or entities that sponsored the CLOs. Furthermore, the investments we make in CLOs are at times thinly traded or have only a limited trading market. As a result, investments in such CLOs may be characterized as illiquid securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A covenant breach or other default by our portfolio companies may adversely affect our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portfolio company&#8217;s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, termination of its loans and foreclosure on its secured assets, which could trigger cross-defaults under other agreements and jeopardize a portfolio company&#8217;s ability to meet its obligations under the debt or equity securities that we hold. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms, which may include the waiver of certain financial covenants, with a defaulting portfolio company. In addition, lenders in certain cases can be subject to lender liability claims for actions taken by them when they become too involved in the borrower&#8217;s business or exercise control over a borrower. It is possible that we could become subject to a lender&#8217;s liability claim, including as a result of actions taken if we render significant managerial assistance to the borrower. Furthermore, if one of our portfolio companies were to file for bankruptcy protection, a bankruptcy court might re-characterize our debt holding and subordinate all or a portion of our claim to claims of other creditors, even though we may have structured our investment as senior secured debt. The likelihood of such a re-characterization would depend on the facts and circumstances, including the extent to which we provided managerial assistance to that portfolio company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our portfolio companies may be highly leveraged.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our portfolio companies may be highly leveraged, which may have adverse consequences to these companies and to us as an investor. These companies may be subject to restrictive financial and operating covenants and the leverage may impair these companies&#8217; ability to finance their future operations and capital needs. As a result, these companies&#8217; flexibility to respond to changing business and economic conditions and to take advantage of business opportunities may be limited. Further, a leveraged company&#8217;s income and net assets will tend to increase or decrease at a greater rate than if borrowed money were not used.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our portfolio may be concentrated in a limited number of industries, which may subject us to a risk of significant loss if there is a downturn in a particular industry in which a number of our investments are concentrated.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio may be concentrated in a limited number of industries. Our portfolio will be considered to be concentrated in a particular industry when 25% or greater of its total assets are invested in issuers that are a part of that industry. A downturn in any industry in which we are invested could significantly impact the aggregate returns we realize. We anticipate that we may concentrate our investments in issuers that are part of the software industry, which currently represent close to 25% of our total assets, as a result of additional investments in the software industry and/or fluctuations in the fair value of our investments in the software industry and other industries.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an industry in which we have significant investments suffers from adverse business or economic conditions, as individual industries have historically experienced to varying degrees, a material portion of our investment portfolio could be affected adversely, which, in turn, could adversely affect our financial position and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to risks associated with our investments in the software industry.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue, income (or losses) and valuations of software and other technology-related companies can and often do fluctuate suddenly and dramatically. In addition, because of rapid technological change, the average selling prices of software products have historically decreased over their productive lives. As a result, the average selling prices of software offered by our portfolio companies may decrease over time, which could adversely affect their operating results and, correspondingly, the value of any securities that we may hold. Additionally, companies operating in the software industry are subject to vigorous competition, changing technology, changing client and end-consumer needs, evolving industry standards and frequent introductions of new products and services. Our portfolio companies in the software industry could compete with companies that are larger and could be engaged in a greater range of businesses or have greater financial, technical, sales or other resources than our portfolio companies do. Our portfolio companies could lose market share if their competitors introduce or acquire new products that compete with their software and related services or add new features to existing products. Any deterioration in the results of our portfolio companies due to competition or otherwise could, in turn, materially adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in the healthcare providers and services industry face considerable uncertainties.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and rules governing the business of healthcare companies and interpretations of those laws and rules are subject to frequent change. Broad latitude is given to the agencies administering those regulations. Existing or future laws and rules could force our portfolio companies engaged in healthcare to change how they do business, restrict revenue, increase costs, change reserve levels and change business practices.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare companies often must obtain and maintain regulatory approvals to market many of their products, change prices for certain regulated products and consummate some of their acquisitions and divestitures. Delays in obtaining or failing to obtain or maintain these approvals could reduce revenue or increase costs. Policy changes on the local, state and federal level, such as the expansion of the government&#8217;s role in the healthcare arena and alternative assessments and tax increases specific to the healthcare industry or healthcare products as part of federal health care reform initiatives, could fundamentally change the dynamics of the healthcare industry.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing in large private U.S. borrowers may limit the Company&#8217;s ability to achieve high growth rates during times of economic expansion. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing in originated assets made to large private U.S. borrowers may result in us underperforming in other segments of the market, particularly during times of economic expansion, because large private U.S. borrowers may be less responsive to competitive challenges and opportunities in the financial markets. As a result, our value may not rise at the same rate, if at all, as other funds that invest in smaller market capitalization companies that are more capable of responding to economic and industrial changes. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing in private companies involves a number of significant risks, any one of which could have a material adverse effect on our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks include that:</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing on any guarantees we may have obtained in connection with our investment; </span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies frequently have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tends to render them more vulnerable to competitors&#8217; actions and changing market conditions, as well as general economic downturns; </span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us; </span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, Trustees and members of the Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and </span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not realize gains from our equity investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain investments that we may make could include warrants or other equity securities. In addition, we may make direct equity investments in portfolio companies. Our goal is ultimately to realize gains upon our disposition of such equity interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. We also may be unable to realize any value if a portfolio company does not have a liquidity event, such as a sale of the business, recapitalization or public offering, which would allow us to sell the underlying equity interests. We intend to seek puts or similar rights to give us the right to sell our equity securities back to the portfolio company issuer. We may be unable to exercise these put rights for the consideration provided in our investment documents if the issuer is in financial distress.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An investment strategy focused primarily on privately-held companies presents certain challenges, including, but not limited to, the lack of available information about these companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest primarily in privately-held companies. Investments in private companies pose significantly greater risks than investments in public companies. First, private companies have reduced access to the capital markets, resulting in diminished capital resources and the ability to withstand financial distress. Second, the depth and breadth of experience of management in private companies tends to be less than that at public companies, which makes such companies more likely to depend on the management talents and efforts of a smaller group of persons and/or persons. Therefore, the decisions made by such management teams and/or the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our investments and, in turn, on us. Third, the investments themselves tend to be less liquid. As such, we may have difficulty exiting an investment promptly or at a desired price prior to maturity or outside of a normal amortization schedule. As a result, the relative lack of liquidity and the potential diminished capital resources of our target portfolio companies may affect our investment returns. Fourth, limited public information generally exists about private companies. Fifth, these companies may not have third-party debt ratings or audited financial statements. We must therefore rely on the ability of the Adviser to obtain adequate information through due diligence to evaluate the creditworthiness and potential returns from investing in these companies. The Adviser typically assesses an investment in a portfolio company based on the Adviser&#8217;s estimate of the portfolio company&#8217;s earnings and enterprise value, among other things, and these estimates may be based on limited information and may otherwise be inaccurate, causing the Adviser to make different investment decisions than it may have made with more complete information. These private companies and their financial information are not subject to the Sarbanes-Oxley Act and other rules that govern public companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in securities or assets of publicly-traded companies are subject to the risks inherent in investing in public securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may invest a portion of our portfolio in publicly-traded assets. For example, it is not expected that we will be able to negotiate additional financial covenants or other contractual rights, which we might otherwise be able to obtain in making privately negotiated investments. In addition, by investing in publicly-traded securities or assets, we will be subject to U.S. federal and state securities laws, as well as non-U.S. securities laws, that may, among other things, restrict or prohibit our ability to make or sell an investment. Moreover, we may not have the same access to information in connection with investments in public securities, either when investigating a potential investment or after making an investment, as compared to privately negotiated investments. Furthermore, we may be limited in our ability to make investments and to sell existing investments in public securities because the Firm may be deemed to have material, non-public information regarding the issuers of those securities or as a result of other internal policies. The inability to sell public securities in these circumstances could materially adversely affect our investment results. In addition, an investment may be sold by us to a public company where the consideration received is a combination of cash and stock of the public company, which may, depending on the securities laws of the relevant jurisdiction, be subject to lock-up periods. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A lack of liquidity in certain of our investments may adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally invest in companies whose securities are not publicly-traded or actively traded on the secondary market, and whose securities are subject to legal and other restrictions on resale or will otherwise be less liquid than publicly-traded securities. The illiquidity of certain of our investments may make it difficult for us to sell these investments when desired. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we had previously recorded these investments. The reduced liquidity of our investments may make it difficult for us to dispose of them at a favorable price, and, as a result, we may suffer losses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments. After our initial investment in a portfolio company, we may be called upon from time to time to provide additional funds to such company or have the opportunity to increase our investment through the exercise of a warrant to purchase shares. There is no assurance that we will make, or will have sufficient funds to make, follow-on investments. Any decisions not to make a follow-on investment or any inability on our part to make such an investment may have a negative impact on a portfolio company in need of such an investment, may result in a missed opportunity for us to increase our participation in a successful operation or may reduce the expected return on the investment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments may include original issue discount and payment-in-kind instruments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we invest in original issue discount or payment-in-kind (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;PIK&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) instruments and the accretion of original issue discount or PIK interest income constitutes a portion of our income, we will be exposed to risks associated with the requirement to include such non-cash income in taxable and accounting income prior to receipt of cash, including the following:&#160;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the higher interest rates on PIK instruments reflect the payment deferral and increased credit risk associated with these instruments, and PIK instruments generally represent a significantly higher credit risk than coupon loans;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">original issue discount and PIK instruments may have unreliable valuations because the accruals require judgments about collectability of the deferred payments and the value of any associated collateral;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">an election to defer PIK interest payments by adding them to the principal on such instruments increases our future investment income which increases our gross assets and, as such, increases the Adviser&#8217;s future base management fees which, thus, increases the Adviser&#8217;s future income incentive fees at a compounding rate;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">market prices of PIK instruments and other zero-coupon instruments are affected to a greater extent by interest rate changes, and may be more volatile than instruments that pay interest periodically in cash. While PIK instruments are usually less volatile than zero-coupon debt instruments, PIK instruments are generally more volatile than cash pay securities;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the deferral of PIK interest on an instrument increases the loan-to-value ratio, which is a measure of the riskiness of a loan, with respect to such instrument;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">even if the conditions for income accrual under GAAP are satisfied, a borrower could still default when actual payment is due upon the maturity of such loan;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">for accounting purposes, cash distributions to investors representing original issue discount income do not come from paid-in capital, although they may be paid from the offering proceeds. Thus, although a distribution of original issue discount income may come from the cash invested by investors, the 1940 Act does not require that investors be given notice of this fact;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the required recognition of original issue discount or PIK interest for U.S. federal income tax purposes may have a negative impact on liquidity, as it represents a non-cash component of our investment company taxable income that may require cash distributions to shareholders in order to maintain our ability to be subject to tax as a RIC; and</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">original issue discount may create a risk of non-refundable cash payments to the Adviser based on non-cash accruals that may never be realized.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may enter into a TRS agreement that exposes us to certain risks, including market risk, liquidity risk and other risks similar to those associated with the use of leverage.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total return swap (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;TRS&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is a contract in which one party agrees to make periodic payments to another party based on the change in the market value of the assets underlying the TRS, which may include a specified security, basket of securities or securities indices during a specified period, in return for periodic payments based on a fixed or variable interest rate. A TRS effectively adds leverage to a portfolio by providing investment exposure to a security or market without owning or taking physical custody of such security or investing directly in such market. Because of the unique structure of a TRS, a TRS often offers lower financing costs than are offered through more traditional borrowing arrangements. The Company would typically have to post collateral to cover this potential obligation. To the extent the Company complied with the applicable requirements of Rule 18f-4, the leverage incurred through TRS will not be considered a borrowing for purposes of the Company&#8217;s overall leverage limitation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A TRS is subject to market risk, liquidity risk and risk of imperfect correlation between the value of the TRS and the loans underlying the TRS. In addition, we may incur certain costs in connection with the TRS that could in the aggregate be significant. A TRS is also subject to the risk that a counterparty will default on its payment obligations thereunder or that we will not be able to meet our obligations to the counterparty.</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may enter into repurchase agreements or reverse repurchase agreements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to our investment objectives and policies, we may invest in repurchase agreements as a buyer for investment purposes. Repurchase agreements typically involve the acquisition by us of debt securities from a selling financial institution such as a bank, savings and loan association or broker-dealer. The agreement provides that we will sell the securities back to the institution at a fixed time in the future for the purchase price plus premium (which often reflects the interests). We do not bear the risk of a decline in the value of the underlying security unless the seller defaults under its repurchase obligation. In the event of the bankruptcy or other default of a seller of a repurchase agreement, we could experience both delays in liquidating the underlying securities and losses, including (1) possible decline in the value of the underlying security during the period in which we seek to enforce its rights thereto; (2) possible lack of access to income on the underlying security during this period; and (3) expenses of enforcing its rights. In addition, as described above, the value of the collateral underlying the repurchase agreement will be at least equal to the repurchase price, including any accrued interest earned on the repurchase agreement. In the event of a default or bankruptcy by a selling financial institution, we generally will seek to liquidate such collateral. However, the exercise of our right to liquidate such collateral could involve certain costs or delays and, to the extent that proceeds from any sale upon a default of the obligation to repurchase were less than the repurchase price, we could suffer a loss.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to our investment objectives and policies, we invest in repurchase agreements as a seller, also known as a &#8220;reverse repurchase agreement.&#8221; Our use of reverse repurchase agreements involves many of the same risks involved in our use of leverage, as the proceeds from reverse repurchase agreements are generally invested in additional portfolio investments. There is a risk that the market value of the securities acquired from the proceeds received in connection with a reverse repurchase agreement may decline below the price of the securities underlying the reverse repurchase agreement that we have sold but remain obligated to repurchase. Reverse repurchase agreements also involve the risk that the counterparty liquidates the securities we delivered to it under the reverse repurchase agreements following the occurrence of an event of default under the applicable repurchase agreement by us. In addition, there is a risk that the market value of the securities we retain may decline. If the buyer of securities under a reverse repurchase agreement were to file for bankruptcy or experiences insolvency, we may be adversely affected. Furthermore, our counterparty may require us to provide additional margin in the form of cash, securities or other forms of collateral under the terms of the derivative contract. Also, in entering into reverse repurchase agreements, we bear the risk of loss to the extent that the proceeds of the reverse repurchase agreement are less than the value of the underlying securities. In addition, the interest costs associated with reverse repurchase agreements transactions, may adversely affect our results of operations and financial condition, and, in some cases, we may be worse off than if we had not used such instruments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may enter into securities lending agreements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may from time to time make secured loans of our marginable securities to brokers, dealers and other financial institutions if our asset coverage, as defined in the 1940 Act, is at or above 150% immediately after each such loan. The risks in lending portfolio securities, as with other extensions of credit, consist of possible delay in recovery of the securities or possible loss of rights in the collateral should the borrower fail financially. However, such loans will be made only to brokers and other financial institutions that are believed by the Adviser to be of high credit standing. Securities loans are made to broker-dealers pursuant to agreements requiring that loans be continuously secured by collateral consisting of U.S. government securities, cash or cash equivalents (e.g., negotiable certificates of deposit, bankers&#8217; acceptances or letters of credit) maintained on a daily mark-to-market basis in an amount at least equal at all times to the market value of the securities lent. If the Company enters into a securities lending arrangement, the Adviser, as part of its responsibilities under the Investment Advisory Agreement, will invest the Company&#8217;s cash collateral in accordance with the Company&#8217;s investment objectives and strategies. The Company will pay the borrower of the securities a fee based on the amount of the cash collateral posted in connection with the securities lending program. The borrower will pay to the Company, as the lender, an amount equal to any dividends or interest received on the securities lent.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may invest the cash collateral received only in accordance with its investment objectives, subject to the Company&#8217;s agreement with the borrower of the securities. In the case of cash collateral, the Company expects to pay a rebate to the borrower. The reinvestment of cash collateral will result in a form of effective leverage for the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although voting rights or rights to consent with respect to the loaned securities pass to the borrower, the Company, as the lender, will retain the right to call the loans and obtain the return of the securities loaned at any time on reasonable notice, and it will do so in order that the securities may be voted by the Company if the holders of such securities are asked to vote upon or consent to matters materially affecting the investment. The Company may also call such loans in order to sell the securities involved. When engaged in securities lending, the Company&#8217;s performance will continue to reflect changes in the value of the securities loaned and will also reflect the receipt of interest through investment of cash collateral by the Company in permissible investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may from time to time enter into credit default swaps or other derivative transactions which expose us to certain risks, including credit risk, market risk, liquidity risk and other risks similar to those associated with the use of leverage.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may from time to time enter into credit default swaps or other derivative transactions that seek to modify or replace the investment performance of a particular reference security or other asset. These transactions are typically individually negotiated, non-standardized agreements between two parties to exchange payments, with payments generally calculated by reference to a notional amount or quantity. Swap contracts and similar derivative contracts are not traded on exchanges; rather, banks and dealers act as principals in these markets. These investments may present risks in excess of those resulting from the referenced security or other asset. Because these transactions are not an acquisition of the referenced security or other asset itself, the investor has no right directly to enforce compliance with the terms of the referenced security or other asset and has no voting or other consensual rights of ownership with respect to the referenced security or other asset. In the event of insolvency of a counterparty, we will be treated as a general creditor of the counterparty and will have no claim of title with respect to the referenced security or other asset.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A credit default swap is a contract in which one party buys or sells protection against a credit event with respect to an issuer, such as an issuer&#8217;s failure to make timely payments of interest or principal on its debt obligations, bankruptcy or restructuring during a specified period. Generally, if we sell credit protection using a credit default swap, we will receive fixed payments from the swap counterparty and if a credit event occurs with respect to the applicable issuer, we will pay the swap counterparty par for the issuer&#8217;s defaulted debt securities and the swap counterparty will deliver the defaulted debt securities to us. Generally, if we buy credit protection using a credit default swap, we will make fixed payments to the counterparty and if a credit event occurs with respect to the applicable issuer, we will deliver the issuer&#8217;s defaulted securities underlying the swap to the swap counterparty and the counterparty will pay us par for the defaulted securities. Alternatively, a credit default swap may be cash settled and the buyer of protection would receive the difference between the par value and the market value of the issuer&#8217;s defaulted debt securities from the seller of protection.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit default swaps are subject to the credit risk of the underlying issuer. If we are selling credit protection, there is a risk that we will not properly assess the risk of the underlying issuer, a credit event will occur and we will have to pay the counterparty. If we are buying credit protection, there is a risk that we will not properly assess the risk of the underlying issuer, no credit event will occur and we will receive no benefit for the premium paid.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A derivative transaction is also subject to the risk that a counterparty will default on its payment obligations thereunder or that we will not be able to meet our obligations to the counterparty. In some cases, we may post collateral to secure our obligations to the counterparty, and we may be required to post additional collateral upon the occurrence of certain events such as a decrease in the value of the reference security or other asset. In some cases, the counterparty may not collateralize any of its obligations to us. Derivative investments effectively add leverage to a portfolio by providing investment exposure to a security or market without owning or taking physical custody of such security or investing directly in such market. In addition to the risks described above, such arrangements are subject to risks similar to those associated with the use of leverage. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain categories of credit default swaps are subject to mandatory clearing, and more categories may be subject to mandatory clearing in the future. The counterparty risk for cleared derivatives is generally lower than for uncleared over-the-counter derivative transactions because generally a clearing organization becomes substituted for each counterparty to a cleared derivative contract and, in effect, guarantees the parties&#8217; performance under the contract as each party to a trade looks only to the clearing house for performance of financial obligations. However, there can be no assurance that a clearing house, or its members, will satisfy the clearing house&#8217;s obligations (including, but not limited to, financial obligations and legal obligations to segregate margins collected by the clearing house) to the Company. Counterparty risk with respect to certain exchange-traded and over-the-counter derivatives are considered as part of the value at risk provisions of Rule 18f-4. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Risk Factors&#8212;Risks Related to Debt Financing.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may acquire various financial instruments for purposes of &#8220;hedging&#8221; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek to hedge against interest rate and currency exchange rate fluctuations and credit risk by using financial instruments such as futures, options, swaps and forward contracts, subject to the requirements of the 1940 Act. These financial instruments may be purchased on exchanges or may be individually negotiated and traded in over-the-counter markets. Use of such financial instruments for hedging purposes may present significant risks, including the risk of loss of the amounts invested. Defaults by the other party to a hedging transaction can result in losses in the hedging transaction. Hedging activities also involve the risk of an imperfect correlation between the hedging instrument and the asset being hedged, which could result in losses both on the hedging transaction and on the instrument being hedged. Use of hedging activities may not prevent significant losses and could increase our losses. Further, hedging transactions may reduce cash available to pay distributions to our shareholders.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the risk that the investments we make in our portfolio companies may be repaid prior to maturity. When this occurs, we will generally reinvest these proceeds in temporary investments, pending their future investment in new portfolio companies. These temporary investments will typically have substantially lower yields than the debt being prepaid and we could experience significant delays in reinvesting these amounts. Any future investment in a new portfolio company may also be at lower yields than the debt that was repaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Additionally, prepayments, net of prepayment fees, could negatively impact our return on equity.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technological or other innovations and industry disruptions may negatively impact us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent trends in the market generally have been toward disrupting the industry with technological or other innovations, and multiple young companies have been successful in capitalizing on this trend toward disruption. In this period of rapid technological and commercial innovation, new businesses and approaches may be created that could affect the Company and/or its portfolio companies or alter the market practices that help frame its strategy. Any of these new approaches could damage the Company&#8217;s investments, significantly disrupt the market in which it operates and subject it to increased competition, which could materially and adversely affect its business, financial condition and results of investments. Moreover, given the pace of innovation in recent years, the impact on a particular investment may not have been foreseeable at the time we made the investment. Furthermore, we could base investment decisions on views about the direction or degree of innovation that prove inaccurate and lead to losses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may invest through various joint ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may hold a portion of its investments through partnerships, joint ventures, securitization vehicles or other entities with third-party investors (collectively, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">joint ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Joint venture investments involve various risks, including the risk that we will not be able to implement investment decisions or exit strategies because of limitations on our control under applicable agreements with joint venture partners, the risk that a joint venture partner may become bankrupt or may at any time have economic or business interests or goals that are inconsistent with those of the Company, the risk that a joint venture partner may be in a position to take action contrary to the Company&#8217;s objectives, the risk of liability based upon the actions of a joint venture partner and the risk of disputes or litigation with such partner and the inability to enforce fully all rights (or the incurrence of additional risk in connection with enforcement of rights) one partner may have against the other, including in connection with foreclosure on partner loans, because of risks arising under state law. In addition, we may, in certain cases, be liable for actions of our joint venture partners. The joint ventures in which we participate may sometimes be allocated investment opportunities that might have otherwise gone entirely to the Company, which may reduce our return on equity. Additionally, our joint venture investments may be held on an unconsolidated basis and at times may be highly leveraged. Such leverage would not count toward the investment limits imposed on us by the 1940 Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks associated with investing alongside other third parties.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We may invest in joint ventures alongside third parties through joint ventures, partnerships or other entities in the future. Such investments may involve risks not present in investments where a third party is not involved, including the possibility that such third party may at any time have economic or business interests or goals which are inconsistent with ours, or may be in a position to take action contrary to our investment objectives. In addition, we may in certain circumstances be liable for actions of such third party.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More specifically, joint ventures involve a third party that has approval rights over activity of the joint venture. The third party may take actions that are inconsistent with our interests. For example, the third party may decline to approve an investment for the joint venture that we otherwise want the joint venture to make. A joint venture may also use investment leverage which magnifies the potential for gain or loss on amounts invested. Generally, the amount of borrowing by the joint venture is not included when calculating our total borrowing and related leverage ratios and is not subject to asset coverage requirements imposed by the 1940 Act. If the activities of the joint venture were required to be consolidated with our activities because of a change in GAAP rules or SEC staff interpretations, it is likely that we would have to reorganize any such joint venture.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may syndicate co-investment opportunities, which may be costly.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may make an investment with the expectation of offering a portion of its interests therein as a co-investment opportunity to third-party investors. There can be no assurance that we will be successful in syndicating any such co-investment, in whole or in part, that the closing of such co-investment will be consummated in a timely manner, that any syndication will take place on terms and conditions that will be preferable for the Company or that expenses incurred by us with respect to any such syndication will not be substantial. In the event that we are not successful in syndicating any such co-investment, in whole or in part, we may consequently hold a greater concentration and have more exposure in the related investment than initially was intended, which could make the Company more susceptible to fluctuations in value resulting from adverse economic and/or business conditions with respect thereto. Moreover, an investment by the Company that is not syndicated to co-investors as originally anticipated could significantly reduce our overall investment returns.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may use a wide range of investment techniques that could expose us to a diverse range of risks.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser may employ investment techniques or invest in instruments that it believes will help achieve our investment objectives, whether or not such investment techniques or instruments are specifically defined herein, so long as such investments are consistent with our investment strategies and objectives and subject to applicable law. Such investment techniques or instruments may not be thoroughly tested in the market before being employed and may have operational or theoretical shortcomings which could result in unsuccessful investments and, ultimately, losses to us. In addition, any such investment technique or instrument may be more speculative than other investment techniques or instruments specifically described herein and may involve material and unanticipated risks. There can be no assurance that the Adviser will be successful in implementing any such investment technique. Furthermore, the diversification and type of investments may differ substantially from our prior investments.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">Risks Related to the Adviser and Its Affiliates</span><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Adviser and its affiliates, including our officers and some of our trustees, face conflicts of interest caused by compensation arrangements with us and our affiliates, which could result in actions that are not in the best interests of our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser and its affiliates receive substantial fees from us in return for their services, and these fees could influence the advice provided to us. We pay to the Adviser an incentive fee that is based on the performance of our portfolio and an annual base management fee that is based on the average value of our gross assets at the end of the two most recently completed calendar quarters. Because the incentive fee is based on the performance of our portfolio, the Adviser may be incentivized to make investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The way in which the incentive fee is determined may also encourage the Adviser to use leverage to increase the return on our investments. In addition, because the base management fee is based on the average value of our gross assets at the end of the two most recently completed calendar quarters, which includes any borrowings for investment purposes, the Adviser may be incentivized to recommend the use of leverage or the issuance of additional equity to make additional investments and increase the average value of our gross assets at the end of the two most recently completed calendar quarters. Under certain circumstances, the use of leverage may increase the likelihood of default, which could disfavor our shareholders. Our compensation arrangements could therefore result in our making riskier or more speculative investments, or relying more on leverage to make investments, than would otherwise be the case. This could result in higher investment losses, particularly during cyclical economic downturns. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be obligated to pay the Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Investment Advisory Agreement entitles the Adviser to receive Pre-Incentive Fee Net Investment Income Returns regardless of any capital losses. In such case, we may be required to pay the Adviser incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or if we incur a net loss for that quarter.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any Pre-Incentive Fee Net Investment Income Returns may be computed and paid on income that may include interest that has been accrued but not yet received. If a portfolio company defaults on a loan that is structured to provide accrued interest, it is possible that accrued interest previously included in the calculation of the incentive fee will become uncollectible. The Adviser is not under any obligation to reimburse us for any part of the incentive fee it received that was based on accrued income that we never received as a result of a default by an entity on the obligation that resulted in the accrual of such income, and such circumstances would result in our paying an incentive fee on income we never received.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The incentive fee based on income takes into account our past performance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Incentive Fee based on income is determined and paid quarterly in arrears at the end of each calendar quarter by reference to our aggregate net investment income, as adjusted, from the calendar quarter then ending and the Trailing Twelve Quarters. The effect of calculating the incentive fee using reference to the Trailing Twelve Quarters is that, in certain circumstances, an incentive fee based on income is payable to the Adviser although our net income for such quarter did not exceed the hurdle rate or the incentive fee will be higher than it would have been if calculated based on our performance for the applicable quarter without taking into account the Trailing Twelve Quarters. For example, if we experience a net loss for any particular quarter, an incentive fee may still be paid to the Adviser if such net loss is less than the net loss for the most recent quarter that preceded the Trailing Twelve Quarters. In such circumstances, the Adviser would be entitled to an incentive fee whereas it would not have been entitled to an incentive fee if calculated solely on the basis of our performance for the applicable quarter.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There may be conflicts of interest related to obligations that the Adviser&#8217;s senior management and Investment Team have to Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The members of the senior management and Investment Team of the Adviser serve or may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do, or of investment funds managed by the same personnel. In serving in these multiple capacities, they may have obligations to Other Clients or investors in those entities, the fulfillment of which may not be in our best interests or in the best interest of our shareholders. Our investment objectives may overlap with the investment objectives of such investment funds, accounts or other investment vehicles. In particular, we will rely on the Adviser to manage our day-to-day activities and to implement our investment strategy. The Adviser and certain of its affiliates are presently, and plan in the future to continue to be, involved with activities that are unrelated to us. As a result of these activities, the Adviser, its officers and employees and certain of its affiliates will have conflicts of interest in allocating their time between us and other activities in which they are or may become involved, including the management of its affiliated equipment funds. The Adviser and its officers and employees will devote only as much of its or their time to our business as the Adviser and its officers and employees, in their judgment, determine is reasonably required, which may be substantially less than their full time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely, in part, on the Adviser to assist with identifying investment opportunities and making investment recommendations to the Adviser. The Adviser and its affiliates are not restricted from forming additional investment funds, entering into other investment advisory relationships or engaging in other business activities. These activities could be viewed as creating a conflict of interest in that the time and effort of the members of the Adviser, its affiliates and their officers and employees will not be devoted exclusively to our business, but will be allocated between us and such other business activities of the Adviser and its affiliates in a manner that the Adviser deems necessary and appropriate consistent with its fiduciary duties and the 1940 Act. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The time and resources that individuals employed by the Adviser devote to us may be diverted and we may face additional competition due to the fact that individuals employed by the Adviser are not prohibited from raising money for or managing other entities that make the same types of investments that we target.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser and individuals employed by the Adviser are generally not prohibited from raising capital for and managing other investment entities that make the same types of investments as those we target. As a result, the time and resources that these individuals may devote to us may be diverted. In addition, we may compete with any such investment entity for the same investors and investment opportunities. We may participate in certain transactions originated by the Adviser or its affiliates under our exemptive relief from the SEC that allows us to engage in co-investment transactions with the Adviser and its affiliates, subject to certain terms and conditions. However, while the terms of the exemptive relief require that the Adviser will be given the opportunity to cause us to participate in certain transactions originated by affiliates of the Adviser, the Adviser may determine that we not participate in those transactions and for certain other transactions (as set forth in guidelines approved by the Board) the Adviser may not have the opportunity to cause us to participate. Affiliates of the Adviser, whose primary business includes the origination of investments or investing in non-originated assets, engage in investment advisory business with accounts that compete with us. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us."</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our shares may be purchased by the Adviser or its affiliates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Affiliates of the Adviser have purchased and in the future expect to purchase our shares. The Adviser and its affiliates will not acquire any shares with the intention to resell or re-distribute such shares. The purchase of shares by the Adviser and its affiliates could create certain risks, including, but not limited to, the following:</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Adviser and its affiliates may have an interest in disposing of our assets at an earlier date so as to recover their investment in our shares; and</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">substantial purchases of shares by the Adviser and its affiliates may limit the Adviser&#8217;s ability to fulfill any financial obligations that it may have to us or incurred on our behalf.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Adviser relies on key personnel, the loss of any of whom could impair its ability to successfully manage us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends, to a significant extent, on the continued services of the officers and employees of the Adviser or its affiliates. The loss of services of one or more members of the Adviser&#8217;s management team, including members of the Investment Committee, could adversely affect our financial condition, business and results of operations. The Adviser does not have an employment agreement with any of these key personnel and we cannot guarantee that all, or any particular one, will remain affiliated with us and/or the Adviser. Further, we do not intend to separately maintain key person life insurance on any of these individuals.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on the Adviser to select our investments and otherwise conduct our business, and any material adverse change in its financial condition or our relationship with the Adviser could have a material adverse effect on our business and ability to achieve our investment objectives.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success is dependent upon our relationship with, and the performance of, the Adviser in the acquisition and management of our portfolio investments, and our corporate operations, as well as the persons and firms the Adviser retains to provide services on our behalf. The Adviser may suffer or become distracted by adverse financial or operational problems in connection with Blackstone&#8217;s business and activities unrelated to us and over which we have no control. Should the Adviser fail to allocate sufficient resources to perform its responsibilities to us for any reason, we may be unable to achieve our investment objectives or to pay distributions to our shareholders.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The compensation we pay to the Adviser will be determined without independent assessment on our behalf, and these terms may be less advantageous to us than if such terms had been the subject of arm&#8217;s-length negotiations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investment Advisory Agreement will not be entered into on an arm&#8217;s-length basis with an unaffiliated third party. As a result, the form and amount of compensation we pay the Adviser may be less favorable to us than they might have been had an investment advisory agreement been entered into through arm&#8217;s-length transactions with an unaffiliated third party.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Adviser&#8217;s influence on conducting our operations gives it the ability to increase its fees, which may reduce the amount of cash flow available for distribution to our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser is paid a base management fee calculated as a percentage of our gross assets and unrelated to net income or any other performance base or measure. The Adviser may advise us to consummate transactions or conduct our operations in a manner that, in the Adviser&#8217;s reasonable discretion, is in the best interests of our shareholders. These transactions, however, may increase the amount of fees paid to the Adviser. The Adviser&#8217;s ability to influence the base management fee paid to it by us could reduce the amount of cash flow available for distribution to our shareholders.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There may be trademark risk, as we do not own the Blackstone name.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not own the Blackstone name, but we are permitted to use it as part of our corporate name pursuant to the Investment Advisory Agreement. Use of the name by other parties or the termination of the Investment Advisory Agreement may harm our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to additional potential conflicts of interests as a consequence of Blackstone&#8217;s status as a public company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a consequence of Blackstone&#8217;s status as a public company, our officers and trustees, and the employees&#160;of the Adviser may take into account certain considerations and other factors in connection with the management of the business and affairs of us and our affiliates that would not necessarily be taken into account if Blackstone were not a public company. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">Risks Related to Business Development Companies</span><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The requirement that we invest a sufficient portion of our assets in Qualifying Assets could preclude us from investing in accordance with our current business strategy; conversely, the failure to invest a sufficient portion of our assets in Qualifying Assets could result in our failure to maintain our status as a BDC.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, a BDC may not acquire any asset other than assets of the type listed in section 55(a) of the 1940 Act described as &#8220;qualifying&#8221; assets (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Qualifying Assets&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), unless, at the time of and after giving effect to such acquisition, at least 70% of our total assets are Qualifying Assets. Therefore, we may be precluded from investing in what we believe are attractive investments if such investments are not Qualifying Assets. Conversely, if we fail to invest a sufficient portion of our assets in Qualifying Assets, we could lose our status as a BDC, which would have a material adverse effect on our business, financial condition and results of operations. Similarly, these rules could prevent us from making additional investments in existing portfolio companies, which could result in the dilution of our position, or could require us to dispose of investments at an inopportune time to comply with the 1940 Act. If we were forced to sell non-qualifying investments in the portfolio for compliance purposes, the proceeds from such sale could be significantly less than the current value of such investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to maintain our status as a BDC would reduce our operating flexibility.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not remain a BDC, we might be regulated as a registered closed-end management investment company under the 1940 Act, which would subject us to substantially more regulatory restrictions under the 1940 Act and correspondingly decrease our operating flexibility.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulations governing our operation as a BDC and RIC will affect our ability to raise, and the way in which we raise, additional capital or borrow for investment purposes, which may have a negative effect on our growth.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of meeting the annual distribution requirement to avoid paying U.S. federal corporate income tax, as a RIC, we may need to periodically access the capital markets to raise cash in order to fund new investments. We may issue &#8220;senior securities,&#8221; as defined under the 1940 Act, including borrowing money from banks or other financial institutions only in amounts such that our asset coverage meets the threshold set forth in the 1940 Act immediately after each such issuance. The 1940 Act currently requires an asset coverage of at least 150% (i.e., the amount of debt may not exceed two-thirds of the value of our assets). Our ability to issue different types of securities is also limited. Compliance with these requirements may unfavorably limit our investment opportunities and reduce our ability in comparison to other companies to profit from favorable spreads between the rates at which we can borrow and the rates at which we can lend. As a BDC, therefore, we intend to continuously issue equity at a rate more frequent than our privately-owned competitors, which may lead to greater shareholder dilution. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. federal income tax purposes, we are required to recognize taxable income (which may include deferred interest that is accrued as original issue discount) in some circumstances in which we do not receive a corresponding payment in cash and to make distributions with respect to such income in order to avoid corporate income tax as a RIC. Under such circumstances, we may have difficulty meeting the annual distribution requirement necessary to eliminate any corporate income tax as a RIC under the Code. This difficulty in making the required distribution may be amplified to the extent that we are required to pay an incentive fee with respect to such accrued income. As a result, we may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital, or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may not meet the distribution requirements prescribed by the Code for a RIC and as such may become subject to corporate income tax.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We borrow for investment purposes. If the value of our assets declines, we may be unable to satisfy the asset coverage test, which would prohibit us from paying distributions and could result in a corporate income tax to the Company. If we cannot satisfy the asset coverage test, we may be required to sell a portion of our investments and, depending on the nature of our debt financing, repay a portion of our indebtedness at a time when such sales may be disadvantageous.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, we generally are prohibited from issuing or selling our shares at a price per share, after deducting selling commissions and dealer manager fees, that is below our NAV per share, which may be a disadvantage as compared with other public companies. We may, however, sell our shares, or warrants, options or rights to acquire our shares, at a price below the current NAV of our shares if our Board, including our independent trustees, determine that such sale is in our best interests and the best interests of our shareholders, and our shareholders, as well as those shareholders that are not affiliated with us, approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board, closely approximates the fair value of such securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to enter into transactions with our affiliates is restricted.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are prohibited under the 1940 Act from participating in certain transactions with certain of our affiliates (including portfolio companies of Other Clients) without the prior approval of a majority of the independent members of our Board and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of our outstanding voting securities will be our affiliate for purposes of the 1940 Act and generally we will be prohibited from buying or selling any securities from or to such affiliate, absent the prior approval of our Board. However, we may under certain circumstances purchase any such affiliate's loans or securities in the secondary market, which could create a conflict for the Adviser between our interests and the interests of such affiliate, in that the ability of the Adviser to recommend actions in our best interest may be limited. The 1940 Act also prohibits certain &#8220;joint&#8221; transactions with certain of our affiliates, which could include investments in the same portfolio company (whether at the same or closely related times), without prior approval of our Board and, in some cases, the SEC. If a person acquires more than 25% of our voting securities, we will be prohibited from buying or selling any security from or to such person or certain of that person&#8217;s affiliates, or entering into prohibited joint transactions (including certain co-investments) with such persons, absent the prior approval of the SEC. Similar restrictions limit our ability to transact business with our officers, trustees, investment advisers, sub-advisers or their affiliates. As a result of these restrictions, we may be prohibited from buying or selling any security from or to any fund or any portfolio company of a fund managed by the Adviser, or entering into joint arrangements such as certain co-investments with these companies or funds without the prior approval of the SEC, which may limit the scope of investment opportunities that would otherwise be available to us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have obtained exemptive relief from the SEC that allows us to engage in co-investment transactions with the Adviser and its affiliates, subject to certain terms and conditions. However, while the terms of the exemptive relief require that the Adviser will be given the opportunity to cause us to participate in certain transactions originated by affiliates of the Adviser, the Adviser may determine that we not participate in those transactions and for certain other transactions (as set forth in guidelines approved by the Board) the Adviser may not have the opportunity to cause us to participate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are uncertain of our sources for funding our future capital needs; if we cannot obtain debt or equity financing on acceptable terms, our ability to acquire investments and to expand our operations will be adversely affected.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the sale of shares will be used for our investment opportunities, operating expenses and for payment of various fees and expenses such as base management fees, incentive fees and other expenses. Any working capital reserves we maintain may not be sufficient for investment purposes, and we may require debt or equity financing to operate. Accordingly, in the event that we develop a need for additional capital in the future for investments or for any other reason, these sources of funding may not be available to us. Consequently, if we cannot obtain debt or equity financing on acceptable terms, our ability to acquire investments and to expand our operations will be adversely affected. As a result, we would be less able to create and maintain a broad portfolio of investments and achieve our investment objectives, which may negatively impact our results of operations and reduce our ability to make distributions to our shareholders.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a non-diversified investment company within the meaning of the 1940 Act, and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are classified as a non-diversified investment company within the meaning of the 1940 Act, which means that we are not limited by the 1940 Act with respect to the proportion of our assets that we may invest in securities of a single issuer. Under the 1940 Act, a &#8220;diversified&#8221; investment company is required to invest at least 75% of the value of its total assets in cash and cash items, government securities, securities of other investment companies and other securities limited in respect of any one issuer to an amount not greater than 5% of the value of the total assets of such company and no more than 10% of the outstanding voting securities of such issuer. As a non-diversified investment company, we are not subject to this requirement. To the extent that we assume large positions in the securities of a small number of issuers, or within a particular industry, our NAV may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market&#8217;s assessment of the issuer. We may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company or to a general downturn in the economy. However, we will be subject to the diversification requirements applicable to RICs under Subchapter M of the Code.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt">Risks Related to Debt Financing</span><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">When we use leverage, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us. Leverage may also adversely affect the return on our assets, reduce cash available for distribution to our shareholders, and result in losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of borrowings, also known as leverage, increases the volatility of investments by magnifying the potential for loss on invested equity capital. When we use leverage to partially finance our investments, through borrowing from banks and other lenders, shareholders will experience increased risks of investing in our shares. If the value of our assets decreases, leveraging would cause NAV to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Such a decline could negatively affect our ability to make distributions to our shareholders. In addition, our shareholders will bear the burden of any increase in our expenses as a result of our use of leverage, including interest expenses and any increase in the management or incentive fees payable to the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use and intend to continue to use leverage to finance our investments. The amount of leverage that we employ will depend on the Adviser&#8217;s and our Board&#8217;s assessment of market and other factors at the time of any proposed borrowing. There can be no assurance that leveraged financing will be available to us on favorable terms or at all. However, to the extent that we use leverage to finance our assets, our financing costs will reduce cash available for distributions to shareholders. Moreover, we may not be able to meet our financing obligations and, to the extent that we cannot, we risk the loss of some or all of our assets to liquidation or sale to satisfy the obligations. In such an event, we may be forced to sell assets at significantly depressed prices due to market conditions or otherwise, which may result in losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a BDC, we generally are required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred shares that we may issue in the future, of at least 150%. If this ratio were to fall below 150%, we could not incur additional debt and could be required to sell a portion of our investments to repay some debt when it is disadvantageous to do so. This could have a material adverse effect on our operations and investment activities. Moreover, our ability to make distributions to shareholders may be significantly restricted or we may not be able to make any such distributions whatsoever. The amount of leverage that we will employ will be subject to oversight by our Board of Trustees, a majority of whom are independent Trustees with no material interests in such transactions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into reverse repurchase agreements. Transactions under such agreements constitute leverage. When the Company enters into a reverse repurchase agreement, any fluctuations in the market value of either the securities transferred to another party or the securities in which the proceeds may be invested would affect the market value of the Company&#8217;s assets. As a result, the use of such leverage transactions may increase fluctuations in the market value of the Company&#8217;s assets compared to what would occur without the use of such transactions. Because reverse repurchase agreements may be considered to be the practical equivalent of borrowing funds, they constitute a form of leverage. If the Company reinvests the proceeds of a reverse repurchase agreement at a rate lower than the cost of the agreement, transacting under such agreement will lower the Company&#8217;s yield. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although leverage has the potential to enhance overall returns that exceed the Company&#8217;s cost of funds, they will further diminish returns (or increase losses on capital) to the extent overall returns are less than the Company&#8217;s cost of funds. In addition, borrowings and reverse repurchase agreements or similar arrangements in which the Company may engage may be secured by the shareholders&#8217; investments as well as by the Company&#8217;s assets and the documentation relating to such transactions may provide that during the continuance of a default under such arrangement, the interests of the holders of Common Shares may be subordinated to the interests of the Company&#8217;s lenders or debt-holders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit facilities and unsecured notes impose financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a regulated investment company under the 1940 Act. A failure to renew our facilities or to add new or replacement debt facilities or issue additional debt securities or other evidences of indebtedness could have a material adverse effect on our business, financial condition, results of operations and/or liquidity.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8212; Financial Condition, Liquidity and Capital Resources&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information regarding our borrowings.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may default under our credit facilities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event we default under our credit facilities or other borrowings, our business could be adversely affected as we may be forced to sell a portion of our investments quickly and prematurely at what may be disadvantageous prices to us in order to meet our outstanding payment obligations and/or support working capital requirements under such borrowing facility, any of which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, following any such default, the agent for the lenders under such borrowing facility could assume control of the disposition of any or all of our assets, including the selection of such assets to be disposed and the timing of such disposition, which would have a material adverse effect on our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our current or future credit ratings may not reflect all risks of an investment in our debt securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any current or future credit ratings of us are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our current or future credit ratings will generally affect the market value of our debt securities. Our current or future credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of or trading market for the publicly issued debt securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The trading market or market value of our issued debt securities may fluctuate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our issued debt securities may or may not have an established trading market. We cannot assure our noteholders that a trading market for our issued debt securities will ever develop or be maintained if developed. In addition to our creditworthiness, many factors may materially adversely affect the trading market for, and market value of, our issued debt securities. These factors include, but are not limited to, the following:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the time remaining to the maturity of these debt securities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outstanding principal amount of debt securities with terms identical to these debt securities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ratings assigned by national statistical ratings agencies;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the general economic environment;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the supply of debt securities trading in the secondary market, if any;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the redemption or repayment features, if any, of these debt securities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level, direction and volatility of market interest rates generally; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market rates of interest higher or lower than rates borne by the debt securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our noteholders should also be aware that there may be a limited number of buyers when they decide to sell their debt securities. This too may materially adversely affect the market value of the debt securities or the trading market for the debt securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms relating to redemption may materially adversely affect our noteholders return on any debt securities that we may issue.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our noteholders&#8217; debt securities are redeemable at our option, we may choose to redeem their debt securities at times when prevailing interest rates are lower than the interest rate paid on their debt securities. In addition, if our noteholders&#8217; debt securities are subject to mandatory redemption, we may be required to redeem their debt securities also at times when prevailing interest rates are lower than the interest rate paid on their debt securities. In this circumstance, our noteholders may not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as their debt securities being redeemed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we issue preferred shares or convertible debt securities, the net asset value of our common shares may become more volatile.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that the issuance of preferred shares and/or convertible debt securities would result in a higher yield or return to the holders of our common shares. The issuance of preferred shares or convertible debt would likely cause the NAV of our common shares to become more volatile. If the dividend rate on the preferred shares, or the interest rate on the convertible debt securities, were to approach the net rate of return on our investment portfolio, the benefit of such leverage to the holders of our common shares would be reduced. If the dividend rate on the preferred shares, or the interest rate on the convertible debt securities, were to exceed the net rate of return on our portfolio, the use of leverage would result in a lower rate of return to the holders of common shares than if we had not issued the preferred shares or convertible debt securities. Any decline in the NAV of our investment would be borne entirely by the holders of our common shares. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in NAV to the holders of our common shares than if we were not leveraged through the issuance of preferred shares or debt securities. This decline in NAV would also tend to cause a greater decline in the market price, if any, for our common shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also a risk that, in the event of a sharp decline in the value of our net assets, we would be in danger of failing to maintain required asset coverage ratios, which may be required by the preferred shares or convertible debt, or our current investment income might not be sufficient to meet the dividend requirements on the preferred shares or the interest payments on the debt securities. In order to counteract such an event, we might need to liquidate investments in order to fund the redemption of some or all of the preferred shares or convertible debt. In addition, we would pay (and the holders of our common shares would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred shares, debt securities, convertible debt, or any combination of these securities. Holders of preferred shares or convertible debt may have different interests than holders of common shares and may at times have disproportionate influence over our affairs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders of any preferred shares that we may issue will have the right to elect certain members of our Board and have class voting rights on certain matters.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 1940 Act requires that holders of preferred shares must be entitled as a class to elect two trustees at all times and to elect a majority of the trustees if dividends on such preferred shares are in arrears by two years or more, until such arrearage is eliminated. In addition, certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred shares, including changes in fundamental investment restrictions and conversion to open-end status and, accordingly, preferred shareholders could veto any such changes. Restrictions imposed on the declarations and payment of dividends or other distributions to the holders of our common shares and preferred shares, both by the 1940 Act and by requirements imposed by rating agencies, might impair our ability to maintain our tax treatment as a RIC for U.S. federal income tax purposes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in a credit facility may limit our investment discretion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A credit facility may be backed by all or a portion of our loans and securities on which the lenders will have a security interest. We may pledge up to 100% of our assets and may grant a security interest in all of our assets under the terms of any debt instrument we enter into with lenders. We expect that any security interests we grant will be set forth in a pledge and security agreement and evidenced by the filing of financing statements by the agent for the lenders. In addition, we expect that the custodian for our securities serving as collateral for such loan would include in its electronic systems notices indicating the existence of such security interests and, following notice of occurrence of an event of default, if any, and during its continuance, will only accept transfer instructions with respect to any such securities from the lender or its designee. If we were to default under the terms of any debt instrument, the agent for the applicable lenders would be able to assume control of the timing of disposition of any or all of our assets securing such debt, which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In connection with one or more credit facilities entered into by the Company, distributions to shareholders may be subordinated to payments required in connection with any indebtedness contemplated thereby.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any security interests and/or negative covenants required by a credit facility may limit our ability to create liens on assets to secure additional debt and may make it difficult for us to restructure or refinance indebtedness at or prior to maturity or obtain additional debt or equity financing. In addition, if our borrowing base under a credit facility were to decrease, we may be required to secure additional assets in an amount sufficient to cure any borrowing base deficiency. In the event that all of our assets are secured at the time of such a borrowing base deficiency, we could be required to repay advances under a credit facility or make deposits to a collection account, either of which could have a material adverse impact on our ability to fund future investments and to make distributions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may be subject to limitations as to how borrowed funds may be used, which may include restrictions on geographic and industry concentrations, loan size, payment frequency and status, average life, collateral interests and investment ratings, as well as regulatory restrictions on leverage which may affect the amount of funding that may be obtained. There may also be certain requirements relating to portfolio performance, including required minimum portfolio yield and limitations on delinquencies and charge-offs, a violation of which could limit further advances and, in some cases, result in an event of default. An event of default under a credit facility could result in an accelerated maturity date for all amounts outstanding thereunder, which could have a material adverse effect on our business and financial condition. This could reduce our liquidity and cash flow and impair our ability to grow our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the effect of leverage on returns from an investment in our shares assuming various annual returns on our portfolio, net of expenses. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.626%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assumed Return on Our Portfolio (Net of Expenses)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corresponding return to common stockholder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#160;(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-25.52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-15.28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-5.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Based on (i) $10.1 billion in total assets as of December&#160;31, 2023, (ii) $4.9 billion in outstanding indebtedness, at par, as of December&#160;31, 2023, (iii) $5.0 billion in net assets as of December&#160;31, 2023 and (iv)&#160;an annualized average interest rate, including fees (such as fees on undrawn amounts and amortization of financing costs), on our indebtedness, as of December&#160;31, 2023, of 5.05%.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on an outstanding indebtedness, at par, of&#160;$4.9 billion&#160;as of&#160;December&#160;31, 2023 and the weighted average effective annual interest rate, including fees (such as fees on undrawn amounts and amortization of financing costs), of 5.05% as of that date, our investment portfolio at fair value would have had to produce an annual return of approximately 2.46% to cover annual interest payments on the outstanding debt. For more information on our indebtedness, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Financial Condition, Liquidity and Capital Resources.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in interest rates may affect our cost of capital and net investment income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we use debt to finance a portion of our investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In periods of rising interest rates when we have debt outstanding, our cost of funds will increase, which could reduce our net investment income. We expect that our long-term fixed-rate investments will be financed primarily with equity and long-term debt. We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. These techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. These activities may limit our ability to participate in the benefits of lower interest rates with respect to the hedged portfolio. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations. Also, we have limited experience in entering into hedging transactions, and we will initially have to purchase or develop such expertise.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with SEC Rule 18f-4 governing derivatives and use of leverage may limit our investment discretion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, Rule 18f-4 under the 1940 Act, eliminates the asset segregation framework arising from prior SEC guidance for covering positions in derivatives and certain financial instruments. Rule 18f-4 also limits a fund&#8217;s derivatives exposure through a value-at-risk test and requires the adoption and implementation of a derivatives risk management program for certain derivatives users. Subject to certain conditions, limited derivatives users (as defined in Rule 18f-4), such as the Company, however, would not be subject to the full requirements of Rule 18f-4. Under Rule 18f-4, a fund may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the fund has, among other things, a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. The Company has adopted policies and procedures to comply with the requirements of the rule. Compliance with Rule 18f-4 may limit our ability to use derivatives and/or enter into certain other financial contracts.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may form CLOs in the future, which may subject us to certain structured financing risks.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To finance investments, we may securitize certain of our secured loans or other investments, including through the formation of one or more CLOs, while retaining all or most of the exposure to the performance of these investments. This would involve contributing a pool of assets to a special purpose entity, and selling debt interests in such entity on a non-recourse or limited-recourse basis to purchasers. Depending on how these CLOs are structured, an interest in any such CLO held by us may be considered a &#8220;non-qualifying&#8221; portfolio investment for purposes of the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the CLOs we may in the future create we will depend in part on distributions from the CLO&#8217;s assets out of its earnings and cash flows to enable us to make distributions to shareholders. The ability of a CLO to make distributions will be subject to various limitations, including the terms and covenants of the debt it issues. Also, a CLO may take actions that delay distributions in order to preserve ratings and to keep the cost of present and future financings lower or the CLO may be obligated to retain cash or other assets to satisfy over-collateralization requirements commonly provided for holders of the CLO&#8217;s debt, which could impact our ability to receive distributions from the CLO. If we do not receive cash flow from any such CLO that is necessary to satisfy the annual distribution requirement for maintaining RIC status, and we are unable to obtain cash from other sources necessary to satisfy this requirement, we may not maintain our qualification as a RIC, which would have a material adverse effect on an investment in the shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a decline in the credit quality of loans in a CLO due to poor operating results of the relevant borrowers, declines in the value of loan collateral or increases in defaults, among other things, may force a CLO to sell certain assets at a loss, reducing their earnings and, in turn, cash potentially available for distribution to us for distribution to shareholders. To the extent that any losses are incurred by the CLO in respect of any collateral, such losses will be borne first by us as owner of equity interests in the CLO.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manager for a CLO that we create may be the Company, the Adviser or an affiliate, and such manager may be entitled to receive compensation for structuring and/or management services. To the extent the Adviser or an affiliate other than the Company serves as manager and the Company is obligated to compensate the Adviser or the affiliate for such services, we, the Adviser or the affiliate will implement offsetting arrangements to assure that we, and indirectly, our shareholders, pay no additional management fees to the Adviser or the affiliate in connection therewith. To the extent we serve as manager, we will waive any right to receive fees for such services from the Company (and indirectly its shareholders) or any affiliate.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.4pt">Federal Income Tax Risks</span><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will be subject to corporate-level income tax if we are unable to maintain RIC tax treatment under Subchapter M of the Code or satisfy RIC distribution requirements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain and maintain RIC tax treatment under Subchapter M of the Code, we must, among other things, meet annual distribution, income source and quarterly asset diversification requirements. If we do not qualify for or maintain RIC tax treatment for any reason and are subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For federal income tax purposes, we may be required to recognize taxable income in circumstances in which we do not receive a corresponding payment in cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount (such as zero-coupon securities, debt instruments with PIK interest or, in certain cases, increasing interest rates or debt instruments that were issued with warrants), we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. We may also have to include in income other amounts that we have not yet received in cash, such as deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. We anticipate that a portion of our income may constitute original issue discount or other income required to be included in taxable income prior to receipt of cash. Furthermore, we have elected to amortize market discount and include such amounts in our taxable income on a current basis, instead of upon disposition of the applicable debt obligation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because any original issue discount, market discount or other amounts accrued will be included in our investment company taxable income for the year of the accrual, we may be required to make a distribution to our shareholders in order to satisfy the annual distribution requirement, even though we will not have received any corresponding cash amount. As a result, we may have difficulty meeting the annual distribution requirement necessary to eliminate any corporate income tax as a RIC under Subchapter M of the Code. We may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may not qualify for or maintain RIC tax treatment and thus we may become subject to corporate-level income tax.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our investments may be subject to corporate-level income tax.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may invest in certain debt and equity investments through taxable subsidiaries and the taxable income of these taxable subsidiaries will be subject to federal and state corporate income taxes. We may invest in certain foreign debt and equity investments which could be subject to foreign taxes (such as income tax, withholding and value added taxes).</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our portfolio investments may present special tax issues.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to invest in debt securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Investments in these types of instruments may present special tax issues for the Company. U.S. federal income tax rules are not entirely clear about issues such as when the Company may cease to accrue interest, original issue discount or market discount, when and to what extent deductions may be taken for bad debts or worthless instruments, how payments received on obligations in default should be allocated between principal and income and whether exchanges of debt obligations in a bankruptcy or workout context are taxable. These and other issues will be addressed by the Company, to the extent necessary, to preserve its status as a RIC and to distribute sufficient income to not become subject to U.S. federal income tax.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legislative or regulatory tax changes could adversely affect investors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any time, the federal income tax laws governing RICs or the administrative interpretations of those laws or regulations may be amended. Any of those new laws, regulations or interpretations may take effect retroactively and could adversely affect the taxation of us or our shareholders. Therefore, changes in tax laws, regulations or administrative interpretations or any amendments thereto could diminish the value of an investment in our shares or the value or the resale potential of our investments.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.73pt">Risks Related to an Investment in the Common Shares</span><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot assure you that the market price of common shares will not decline below the IPO price or below our NAV. The market price of common shares may be volatile and may fluctuate substantially.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently list our common shares on the NYSE under the symbol &#8220;BXSL.&#8221; We cannot assure you that the trading market can be sustained. In addition, we cannot predict the prices at which our common shares will trade. Shares of closed-end management investment companies, including BDCs, frequently trade at a discount from their NAV and our shares may also be discounted in the market. This characteristic of closed-end management investment companies is separate and distinct from the risk that our NAV per share may decline. We cannot predict whether our common shares will trade at, above or below NAV. The risk of loss associated with this characteristic of closed-end management investment companies may be greater for investors expecting to sell common shares purchased in the offering soon after the offering. In addition, if our common shares trades below its NAV, we will generally not be able to sell additional common shares to the public at its market price without first obtaining the approval of a majority of our shareholders (including a majority of our unaffiliated shareholders) and our independent directors for such issuance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price and liquidity of the market for our common shares may be si</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gnificantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant volatility in the market price and trading volume of securities of BDCs or other companies in the sector in which we operate, which are not necessarily related to the operating performance of these companies;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of RIC or BDC status;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in earnings or variations in operating results;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the value of our portfolio of investments;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting guidelines governing valuation of our investments;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any shortfall in revenue or net income or any increase in losses from levels expected by shareholders or securities analysts;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">departure of either of the Adviser or certain of its respective key personnel;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating performance of companies comparable to us;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic trends and other external factors; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of a major funding source.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A shareholder&#8217;s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our shareholders do not have preemptive rights to purchase any shares we issue in the future. Our charter authorizes us to issue an unlimited number of shares. Our Board may elect to sell additional shares in the future or issue equity interests in private offerings. To the extent we issue additional equity interests at or below NAV, your percentage ownership interest in us may be diluted. In addition, depending upon the terms and pricing of any additional offerings and the value of our investments, you may also experience dilution in the book value and fair value of your shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, we generally are prohibited from issuing or selling our common shares at a price below NAV per share, which may be a disadvantage as compared with certain public companies. We may, however, sell our common shares, or warrants, options, or rights to acquire our common shares, at a price below the current NAV of our common shares if our Board and independent directors determine that such sale is in our best interests and the best interests of our shareholders, and our shareholders, including a majority of those shareholders that are not affiliated with us, approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board, closely approximates the fair value of such securities (less any distributing commission or discount). If we raise additional funds by issuing common shares or senior securities convertible into, or exchangeable for, our common shares, then the percentage ownership of our shareholders at that time will decrease and you will experience dilution.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulty paying distributions and the tax character of any distributions is uncertain.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally intend to distribute substantially all of our available earnings annually by paying distributions on a quarterly basis, as determined by the Board in its discretion. We cannot assure shareholders that we will achieve investment results that will allow us to make a specified level of cash distributions (particularly during the early stages of our operations) or year-to-year increases in cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this annual report. Due to the asset coverage test applicable to us under the 1940 Act as a BDC, we may be limited in our ability to make distributions. In addition, if we enter into a credit facility or any other borrowing facility, for so long as such facility is outstanding, we anticipate that we may be required by its terms to use all payments of interest and principal that we receive from our current investments as well as any proceeds received from the sale of our current investments to repay amounts outstanding thereunder, which could adversely affect our ability to make distributions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the tax treatment and characterization of our distributions may vary significantly from time to time due to the nature of our investments. The ultimate tax characterization of our distributions made during a taxable year may not finally be determined until after the end of that taxable year. We may make distributions during a taxable year that exceed our investment company taxable income and net capital gains for that taxable year. In such a situation, the amount by which our total distributions exceed investment company taxable income and net capital gains generally would be treated as a return of capital up to the amount of a shareholder&#8217;s tax basis in the shares, with any amounts exceeding such tax basis treated as a gain from the sale or exchange of such shares. A return of capital generally is a return of a shareholder&#8217;s investment rather than a return of earnings or gains derived from our investment activities. Moreover, we may pay all or a substantial portion of our distributions from the proceeds of the sale of our shares or from borrowings or sources other than cash flow from operations in anticipation of future cash flow, which could constitute a return of shareholders&#8217; capital and will lower such shareholders&#8217; tax basis in our shares, which may result in increased tax liability to shareholders when they sell such shares.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributions on our common shares may exceed our taxable earnings and profits. Therefore, portions of the distributions that we pay may represent a return of capital to you. A return of capital is a return of a portion of your original investment in common shares. As a result, a return of capital will (i) lower your tax basis in your shares and thereby increase the amount of capital gain (or decrease the amount of capital loss) realized upon a subsequent sale or redemption of such shares, and (ii) reduce the amount of funds we have for investment in portfolio companies. We have not established any limit on the extent to which we may use offering proceeds to fund distributions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may pay our distributions from offering proceeds in anticipation of future cash flow, which may constitute a return of your capital and will lower your tax basis in your shares, thereby increasing the amount of capital gain (or decreasing the amount of capital loss) realized upon a subsequent sale or redemption of such shares, even if such shares have not increased in value or have, in fact, lost value.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders will experience dilution in their ownership percentage if they do not participate in our dividend reinvestment plan.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All distributions declared in cash payable to shareholders that are participants in our dividend reinvestment plan will generally be automatically reinvested in common shares if the investor opts in to the plan. As a result, shareholders that do not elect to participate in our dividend reinvestment plan may experience dilution over time.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders may experience dilution in the net asset value of their shares if they do not participate in our dividend reinvestment plan and if our shares are trading at a discount to net asset value.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All distributions declared in cash payable to shareholders that are participants in our dividend reinvestment plan will generally be automatically reinvested in common shares if the investor opts in to the plan. As a result, shareholders that do not elect to participate in our dividend reinvestment plan may experience accretion to the NAV of their shares if our shares are trading at a premium to NAV and dilution if our shares are trading at a discount to NAV. The level of accretion or discount would depend on various factors, including the proportion of our shareholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to shareholders.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">No shareholder approval is required for certain mergers.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board may undertake to approve mergers between us and certain other funds or vehicles.&#160;Subject to the requirements of the 1940 Act and NYSE rules, such mergers will not require shareholder approval so shareholders will not be given an opportunity to vote on these matters unless such mergers are reasonably anticipated to result in a material dilution of the NAV per share of the Company.&#160;These mergers may involve funds managed by affiliates of Blackstone Credit &amp; Insurance.&#160;The Board may also convert the form and/or jurisdiction of organization, including to take advantage of laws that are more favorable to maintaining board control in the face of dissident shareholders.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing in our shares involves a high degree of risk.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The investments we make in accordance with our investment objectives may result in a higher amount of risk than alternative investment options and volatility or loss of principal. Our investments in portfolio companies may be highly speculative and aggressive and, therefore, an investment in our shares may not be suitable for someone with lower risk tolerance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The NAV of our shares may fluctuate significantly.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NAV and liquidity, if any, of the market for our shares may be significantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant volatility in the market price and trading volume of securities of BDCs or other companies in the sector in which we operate, which are not necessarily related to the operating performance of these companies;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of RIC or BDC status;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in earnings or variations in operating results;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the value of our portfolio of investments;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting guidelines governing valuation of our investments;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any shortfall in revenue or net income or any increase in losses from levels expected by shareholders or securities analysts;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">departure of either of the Adviser or certain of its respective key personnel;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating performance of companies comparable to us;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic trends and other external factors; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of a major funding source.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of substantial amounts of our common shares in the public market may have an adverse effect on the market price of our common shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of substantial amounts of our common shares, or the availability of such common shares for sale, could adversely affect the prevailing market prices for our common shares. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser, Blackstone Credit &amp; Insurance, Blackstone and their respective affiliates will be subject to certain conflicts of interest with respect to the services the Adviser and the Administrator provide to us. These conflicts will arise primarily from the involvement of Blackstone Credit &amp; Insurance, Blackstone and their respective affiliates (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Firm&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), in other activities that may conflict with our activities. You should be aware that individual conflicts will not necessarily be resolved in favor of your interest. The foregoing list of conflicts does not purport to be a complete enumeration or explanation of the actual and potential conflicts involved in an investment in the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this discussion and ease of reference, the following terms shall have the meanings as set forth below:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Blackstone Credit &amp; Insurance Clients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means, collectively, the investment funds, client accounts (including managed accounts) and proprietary accounts and/or other similar arrangements (including such arrangements in which the Company or one or more Other Blackstone Credit &amp; Insurance Clients own interests) that Blackstone Credit &amp; Insurance may establish, advise or sub-advise from time to time and to which Blackstone Credit &amp; Insurance provides investment management or sub-advisory services (other than the Company and any such funds and accounts in which the Company has an interest), in each case including any alternative investment vehicles and additional capital vehicles relating thereto and any vehicles established by Blackstone Credit &amp; Insurance to exercise its side-by-side or other general partner investment rights as set forth in their respective governing documents; provided, that for the avoidance of doubt, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Other Blackstone Credit &amp; Insurance Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not include Blackstone Credit &amp; Insurance in its role as principal of any account, including any such accounts for which Blackstone Credit &amp; Insurance or an affiliate thereof acts as an advisor.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blackstone Clients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means, collectively, the investment funds, client accounts (including managed accounts) and proprietary accounts and/or other similar arrangements (including such arrangements in which the Company or one or more Blackstone Clients own interests) that Blackstone may establish, advise or sub-advise from time to time and to which Blackstone provides investment management or sub-advisory services (other than the Company, any such funds and accounts in which the Company has an interest and Other Blackstone Credit &amp; Insurance Clients), in each case including any alternative investment vehicles and additional capital vehicles relating thereto and any vehicles established by Blackstone to exercise its side-by-side or other general partner investment rights as set forth in their respective governing documents; provided that, for the avoidance of doubt, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Blackstone Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not include Blackstone in its role as principal of any account, including any accounts for which Blackstone or an affiliate thereof acts as an advisor.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Clients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means, collectively, Other Blackstone Credit &amp; Insurance Clients and Blackstone Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Based Compensation and Management Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The existence of the incentive fees payable to Blackstone Credit &amp; Insurance may create a greater incentive for Blackstone Credit &amp; Insurance to make more speculative investments on behalf of the Company, or to time the purchase or sale of investments in a manner motivated by the personal interests of Blackstone Credit &amp; Insurance and/or Blackstone personnel. However, the fact that the hurdle rate for the incentive fee based on income is calculated on an aggregate basis each quarter and that realized and unrealized losses are netted against realized gains for the incentive fee based on capital gains should reduce the incentives for the Adviser to make more speculative investments or otherwise time the purchase or sale of investments. Our Board of Trustees will seek to monitor these conflicts but there can be no assurances that such monitoring will fully mitigate any such conflicts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the manner in which the Adviser&#8217;s entitlement to incentive fees is determined may result in a conflict between its interests and the interests of shareholders with respect to the sequence and timing of disposals of investments, as the Adviser may want to dispose of lower yielding investments in favor of higher yielding ones. With respect to the Adviser&#8217;s entitlement to incentive fees on capital gains, the Adviser may be incentivized to realize capital gains prior to a year end if such gains, net of realized and unrealized losses, would result in an incentive fee on capital gains.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Firm&#8217;s Policies and Procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm has implemented policies and procedures to address conflicts that arise as a result of its various activities, as well as regulatory and other legal considerations. Specified policies and procedures implemented by the Firm to mitigate potential conflicts of interest and address certain regulatory requirements and contractual restrictions are expected to reduce the synergies across the Firm&#8217;s various businesses that the Company expects to draw on for purposes of pursuing attractive investment opportunities. Because the Firm has many different asset management and advisory businesses, including private equity, a credit business, a hedge fund business, a capital markets group, a life sciences business and a real estate advisory business, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would otherwise be subject if it had just one line of business. In addressing these conflicts and regulatory, legal and contractual requirements across its various businesses and to protect against the inappropriate sharing and/or use of information between the Company and the other business units at the Firm, the Firm has implemented certain policies and procedures (e.g., information wall policy) regarding the sharing of information that could reduce the positive synergies that the Company expects to utilize for purposes of identifying and managing attractive investments. For example, the Firm will from time to time come into possession of material non-public information with respect to companies, including companies in which the Company has investments or might be considering making an investment or companies that are clients of the Firm. As a consequence, that information, which could be of benefit to the Company, might become restricted to those other respective businesses and otherwise be unavailable to the Company. It is also possible that the Company could be restricted from trading despite the fact that the Company did not receive such information. There can be no assurance, however, that any such policies and/or procedures will be effective in accomplishing their stated purpose and/or that they will not otherwise adversely affect the ability of the Company to effectively achieve its investment objective by unduly limiting the investment flexibility of the Company and/or the flow of otherwise appropriate information between Blackstone Credit &amp; Insurance and other business units at the Firm. Personnel of the Firm could be unable, for example, to assist with the activities of the Company as a result of these walls. There can be no assurance that additional restrictions will not be imposed that would further limit the ability of the Firm to share information internally.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to the extent that the Firm is in possession of material non-public information or is otherwise restricted from trading in certain securities, the Company and the Adviser could also be deemed to be in possession of such information or otherwise restricted. Additionally, the terms of confidentiality or other agreements with or related to companies in which any Other Client has or has considered making an investment or which is otherwise a client of the Firm will from time to time restrict or otherwise limit the ability of the Company and/or its portfolio companies and their affiliates to make investments in or otherwise engage in businesses or activities competitive with such companies. The Firm could enter into one or more strategic relationships in certain regions or with respect to certain types of investments that, although intended to provide greater opportunities for the Company, could require the Company to share such opportunities or otherwise limit the amount of an opportunity the Company can otherwise take.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allocation of Personnel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser and its members, officers and employees will devote as much of their time to the activities of the Company as they deem necessary to conduct its business affairs in an appropriate manner. By the terms of the Investment Advisory Agreement, the Firm is not restricted from forming additional investment funds, from entering into other investment advisory relationships or from engaging in other business activities, even though such activities have the potential to be in competition with the Company and/or to involve substantial time and resources of the Adviser. Firm personnel, including members of the investment committee, will work on other projects, serve on other committees (including boards of directors) and source potential investments for and otherwise assist the investment programs of Other Clients and their portfolio companies, including other investment programs to be developed in the future. Certain members of Blackstone Credit &amp; Insurance&#8217;s investment team are also members of Other Clients&#8217; investment teams and will continue to serve in those roles (which could be their primary responsibility) and as a result, not all of their business time will be devoted to Blackstone or the Company. Certain non-investment professionals are not dedicated solely to the Company and are permitted to perform work for Other Clients which is expected to detract from the time such persons devote to the Company. These activities could be viewed as creating a conflict of interest in that the time and effort of the members of the Adviser and its officers and employees will not be devoted exclusively to the business of the Company, but will be allocated between the business of the Company and the management of the monies of such other advisees of the Adviser. Time spent on these other initiatives diverts attention from the activities of the Company, which could negatively impact the Company and shareholders. Furthermore, Blackstone Credit &amp; Insurance and Blackstone Credit &amp; Insurance personnel derive financial benefit from these other activities, including fees and performance-based compensation. Firm personnel outside of Blackstone Credit &amp; Insurance can share in the fees and performance-based compensation from the Company; similarly, Blackstone Credit &amp; Insurance personnel can share in the fees and performance-based compensation generated by Other Clients. These and other factors create conflicts of interest in the allocation of time by Firm personnel. Blackstone Credit &amp; Insurance&#8217;s determination of the amount of time necessary to conduct the Company&#8217;s activities will be conclusive, and shareholders rely on Blackstone Credit &amp; Insurance&#8217;s judgment in this regard.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Outside Activities of Principals and Other Personnel and their Related Parties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain of the principals and employees of the Adviser will, in certain circumstances, be subject to a variety of conflicts of interest relating to their responsibilities to the Company, Other Clients and their respective portfolio companies, and their outside personal or business activities, including as members of investment or advisory committees or boards of directors of or advisors to investment funds, corporations, foundations or other organizations. Such positions create a conflict if such other entities have interests that are adverse to those of the Company, including if such other entities compete with the Company for investment opportunities or other resources. The other managed accounts and/or investment funds in which such individuals may become involved may have investment objectives that overlap with the Company. Furthermore, certain principals and employees of the Adviser are likely to have a greater financial interest in the performance of such other funds or accounts than the performance of the Company. Such involvement is expected to create conflicts of interest in making investments on behalf of the Company and such other funds and accounts. Although such principals and employees will seek to limit any such conflicts in a manner that is in accordance with their fiduciary duties to the Company, there can be no assurance they will be resolved favorably for the Company. Also, Blackstone personnel, Firm employees, including employees of the Adviser, are generally permitted to invest in alternative investment funds, private equity funds, credit funds, real estate funds, hedge funds and other investment vehicles, as well as engage in other personal trading activities relating to companies, assets, securities or instruments (subject to the Firm&#8217;s Code of Ethics requirements), some of which will involve conflicts of interests. Such personal securities transactions will, in certain circumstances, relate to securities or instruments which can be expected to also be held or acquired by Other Clients, the Company, or otherwise relate to portfolio companies in which the Company has or acquires a different principal investment (including, for example, with respect to seniority), which is expected to give rise to conflicts of interest related to misaligned interests between the Company and such persons. There could be situations in which such alternative investment funds invest in the same portfolio companies as the Company and there could be situations in which such alternative investment funds purchase securities from, or sell securities to, the Company if permitted under the 1940 Act and other applicable law. There can be no assurance that conflicts of interest arising out of such activities will be resolved in favor of the Company. Shareholders will not receive any benefit from any such investments, and the financial incentives of Firm personnel in such other investments could be greater than their financial incentives in relation to the Company and are not expected to receive notice should the Company make investments in which such persons hold direct or indirect interests.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain employees and other professionals of the Firm have family members or relatives employed by such advisers and service providers (or their affiliates) or otherwise actively involved in industries and sectors in which the Company invests, and/or have business, financial, personal or other relationships with companies in such industries and sectors (including the advisors and service providers described above) or other industries, which gives rise to potential or actual conflicts of interest. For example, such family members or relatives might be employees, officers, directors, personnel or owners of companies or assets that are actual or potential investments of the Company or other counterparties of the Company and its portfolio companies and/or assets. Moreover, in certain instances, the Company or its portfolio companies can be expected to issue loans to or acquire securities from, or otherwise transact with, companies that are owned by such family members or relatives or in respect of which such family members or relatives have other involvement. These relationships have the potential to influence Blackstone, the Adviser and/or Blackstone Credit &amp; Insurance in deciding whether to select, recommend or create such service providers to perform services for the Company or portfolio companies (the cost of which will generally be borne directly or indirectly by the Company or such portfolio companies, as applicable). Notwithstanding the foregoing, investment transactions relating to the Company that require the use of a service provider will generally be allocated to service providers on the basis of best execution, the evaluation of which includes, among other considerations, such service provider&#8217;s provision of certain investment-related services and research that the Adviser believes to be of benefit to the Company. To the extent that the Firm determines appropriate, conflict mitigation strategies can be expected to be put in place with respect to a particular circumstance, such as internal information barriers or recusal, disclosure or other steps determined appropriate by the Firm. The shareholders rely on the Firm to manage these conflicts in its sole discretion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Secondments and Internships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain personnel of Blackstone and its affiliates, including consultants, will, in certain circumstances, be seconded to one or more portfolio companies, vendors and service providers and vendors or shareholders or other investors of the Company and Other Clients to provide finance, accounting, operational support, data management and other similar services, including the sourcing of investments for the Company or other parties. The salaries, benefits, overhead and other similar expenses for such personnel during the secondment could be borne by Blackstone and its affiliates or the organization for which the personnel are working or both. In addition, personnel of portfolio companies, vendors, service providers (including law firms and accounting firms) and shareholders or other investors of the Company and Other Clients will, in certain circumstances, be seconded to, serve internships at or otherwise provide consulting services to, Blackstone, the Company, Other Clients and portfolio companies of the Company and Other Clients. While often the Company, Other Clients and their respective portfolio companies are the beneficiaries of these types of arrangements, Blackstone is from time to time a beneficiary of these arrangements as well, including in circumstances where the vendor, personnel or service provider or otherwise also provides services to the Company, Other Clients, their respective portfolio companies or Blackstone in the ordinary course. Blackstone, the Company, Other Clients or their portfolio companies could receive benefits from these arrangements at no cost, or alternatively could pay all or a portion of the fees, compensation or other expenses in respect of these arrangements. If a portfolio company pays the cost it will be borne directly or indirectly by the Company. To the extent such fees, compensation or other expenses are borne by the Company, including indirectly through its portfolio companies or reimbursement of Blackstone for such costs, the management fee will not be reduced as a result of these arrangements or any fees, expense reimbursements or other costs related thereto. The personnel described above may provide services in respect of multiple matters, including in respect of matters related to Blackstone, the Company, Other Clients, portfolio companies, each of their respective affiliates and related parties, and any costs of such personnel may be allocated accordingly, Blackstone will endeavor in good faith to allocate the costs of these arrangements, if any, to Blackstone, the Company, Other Clients, portfolio companies and other parties based on time spent by the personnel or another methodology Blackstone deems appropriate in a particular circumstance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone Credit &amp; Insurance and its personnel and related parties will receive intangible and other benefits, discounts and perquisites arising or resulting from their activities on behalf of the Company, the value of which will not reduce the management fees or incentive fees or otherwise be shared with the Company or its portfolio companies. For example, airline travel or hotel stays incurred as Fund expenses, as set forth in the Investment Advisory Agreement and Administration Agreement (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Fund Expenses&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), often result in &#8220;miles&#8221; or &#8220;points&#8221; or credit in loyalty or status programs, and certain purchases made by credit card will result in &#8220;credit card points, &#8220;cash back&#8221; or rebates in addition to such loyalty or status program miles or points. Such benefits and/or amounts will, whether or not de minimis or difficult to value, inure exclusively to the benefit of Blackstone Credit &amp; Insurance, its affiliates or their personnel (and not the Company and/or portfolio companies) even though the cost of the underlying service is borne by the Company and/or portfolio companies. (See also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Service Providers, Vendors and Other Counterparties Generally&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Portfolio Company Relationships Generally&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein.) Similarly, Blackstone Credit &amp; Insurance, its affiliates and their personnel and related parties, and third parties designated by the foregoing, also receive discounts on products and services provided by portfolio companies and customers or suppliers of such portfolio companies. Such other benefits or fees have the potential to give rise to conflicts of interest in connection with the Company&#8217;s investment activities, and while the Adviser and Blackstone Credit &amp; Insurance will seek to resolve any such conflicts in a fair and equitable manner, there is no assurance that any such conflicts will be resolved in favor of the Company. See also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Service Providers, Vendors and Other Counterparties Generally&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Portfolio Company Relationships Generally&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Advisors, Industry Experts and Operating Partners</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blackstone Credit &amp; Insurance is expected to engage and retain strategic advisors, consultants, senior advisors, executive advisors, industry experts, operating partners, deal sourcers, consultants and other similar professionals (which is expected to include current and former executives or other personnel of Blackstone and/or Blackstone Credit &amp; Insurance, as well as current and former executives or other personnel of Blackstone&#8217;s and/or Blackstone Credit &amp; Insurance&#8217;s portfolio companies) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Senior and Other Advisors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) who are not employees or affiliates of Blackstone Credit &amp; Insurance and who will, from time to time, receive payments from, or allocations of a profits interest with respect to, portfolio companies (as well as from Blackstone Credit &amp; Insurance or the Company). In particular, in some cases, consultants, including those with a &#8220;Senior Advisor&#8221; title, have been and will be engaged with the responsibility to source, diligence and recommend transactions to Blackstone Credit &amp; Insurance or to undertake a build-up strategy to originate, acquire and develop assets and businesses in a particular sector or involving a particular strategy, potentially on a full-time and/or exclusive basis and notwithstanding any overlap with the responsibilities of Blackstone Credit &amp; Insurance under the Investment Advisory Agreement, the compensation to such consultants is expected to be borne fully by the Company and/or portfolio companies (with no reduction or offset to management fee payable by the Company) and not Blackstone Credit &amp; Insurance. Similarly, the Company, Other Clients and their portfolio companies are expected to retain and pay compensation to Senior and Other Advisors to provide services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any amounts paid by the Company or a portfolio company to Senior and Other Advisors in connection with the above services, including cash fees, profits, or equity interests in a portfolio company, discretionary bonus awards, performance-based compensation (e.g., promote), sourcing fees, retainers and expense reimbursements, will be treated as Company Expenses or expenses of the portfolio company, as the case may be, and will not, even if they have the effect of reducing any retainers or minimum amounts otherwise payable by Blackstone Credit &amp; Insurance, be chargeable to Blackstone Credit &amp; Insurance or be deemed paid to or received by Blackstone Credit &amp; Insurance, and such amounts will not reduce the management fees or incentive fees payable. Amounts charged by Senior and Other Advisors will not necessarily be confirmed as being comparable to market rates for such services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent permitted by applicable law and/or any applicable SEC granted exemptive or no action relief, these Senior and Other Advisors often have the right or could be offered the ability to (i) co-invest alongside the Company, including in the specific investments in which they are involved (and for which they can be entitled to receive performance-related incentive fees, which will reduce the Company&#8217;s returns), (ii) otherwise participate in equity plans for management of any such portfolio company, or (iii) invest directly in the Company or in a vehicle controlled by the Company subject to reduced or waived advisory fees and/or incentive fees, including after the termination of their engagement by or other status with the Firm. Such co-investment and/or participation (which generally will result in the Company being allocated a smaller share of the applicable investment) will not be considered as part of the Firm&#8217;s side-by-side co-investment rights. Such co-investment and/or participation could vary by transaction (and such participation can, depending on its structure, reduce the Company&#8217;s returns. Additionally, and notwithstanding the foregoing, these Senior and Other Advisors, as well as other Blackstone Clients could be (or could have the preferred right to be) investors in Blackstone Credit &amp; Insurance&#8217;s portfolio companies (which, in some cases, can involve agreements to pay performance fees, or allocate profits interests, to such persons in connection with the Company&#8217;s investment therein, which will reduce the Company&#8217;s returns) and/or Other Clients. Such Senior and Other Advisors, as well as other Blackstone Clients, could also, subject to applicable law, have rights to co-invest with the Company on a side-by-side basis, which rights are generally offered on a no-fee/no-carried interest basis and generally result in the Company being allocated a smaller share of an investment than would otherwise be the case in the absence of such side-by-side participation. Senior and Other Advisors&#8217; benefits described in this paragraph will, in certain circumstances, continue after termination of status as a Senior and Other Advisors.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The time, dedication and scope of work of, and the nature of the relationship with, each of the Senior and Other Advisors vary considerably. In certain cases, they could advise the Adviser and/or Blackstone Credit &amp; Insurance on transactions, provide the Adviser and/or Blackstone with industry-specific insights and feedback on investment themes, assist in transaction due diligence, or make introductions to and provide reference checks on management teams. In other cases, they take on more extensive roles (and could be exclusive service providers to Blackstone Credit &amp; Insurance) and serve as executives or directors on the boards of portfolio companies or contribute to the identification and origination of new investment opportunities. The Company expects to rely on these Senior and Other Advisors to recommend Blackstone as a preferred investment partner, identify investments, source opportunities, and otherwise carry out its investment program, but there is no assurance that these advisers will continue to be involved with the Company for any length of time. In certain instances, Blackstone Credit &amp; Insurance can be expected to have formal or informal arrangements with these Senior and Other Advisors (which may or may not be terminable upon notice by any party), and in other cases the relationships are more informal. They are either compensated (including pursuant to retainers and expense reimbursement, and, in any event, pursuant to negotiated arrangements that will not be confirmed as being comparable to the market rates for such services) by Blackstone, the Company, and/or portfolio companies or otherwise uncompensated or entitled to deferred compensation until occurrence of a future event, such as commencement of a formal engagement. In certain cases, they have certain attributes of Blackstone Credit &amp; Insurance &#8220;employees&#8221; (e.g., they can be expected to have dedicated offices at Blackstone Credit &amp; Insurance, receive administrative support from Blackstone Credit &amp; Insurance personnel, participate in general meetings and events for Blackstone Credit &amp; Insurance personnel, work on Blackstone Credit &amp; Insurance matters as their primary or sole business activity, service Blackstone exclusively, have Blackstone-related e-mail addresses and/or business cards and participate in certain benefit arrangements typically reserved for Blackstone employees, etc.) even though they are not considered Blackstone Credit &amp; Insurance employees, affiliates or personnel for purposes of the Investment Advisory Agreement between the Company and Blackstone Credit &amp; Insurance. Under many of these arrangements, there can be no assurance that the amount of compensation paid in a particular period of time will be proportional to the amount of hours worked or the amount or tangible work product generated by the Senior and Other Advisors during such time. Some Senior and Other Advisors work only for the Company and its portfolio companies, while others may have other clients. In particular, in some cases, Senior and Other Advisors, including those with a &#8220;Senior Advisor&#8221; or &#8220;Operating Advisor&#8221; title, have been and will be engaged with the responsibility to source and recommend transactions to the Adviser potentially on a full-time and/or exclusive basis and, notwithstanding any overlap with the responsibilities of the Adviser under the Investment Advisory Agreement, the compensation to such Senior and Other Advisors will be borne fully portfolio companies (with no reduction to management fees) and not the Adviser. Senior and Other </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advisors could have conflicts of interest between their work for the Company and its portfolio companies, on the one hand, and themselves or other clients, on the other hand, and Blackstone Credit &amp; Insurance is limited in its ability to monitor and mitigate these conflicts. Blackstone Credit &amp; Insurance expects, where applicable, to allocate the costs of such Senior and Other Advisors to the Company and/or applicable portfolio companies, and to the extent any such costs are allocated to the Company, they would be treated as Company Expenses. Payments or allocations to Senior and Other Advisors will not be reduced by the management fee, and can be expected to increase the overall costs and expenses borne indirectly by investors in the Company. There can be no assurance that any of the Senior and Other Advisors, to the extent engaged, will continue to serve in such roles and/or continue their arrangements with Blackstone Credit &amp; Insurance, the Company and/or any portfolio companies for the duration of the relevant investments or throughout the term of the Company. Additionally, from time to time, Senior and Other Advisors provide services on behalf of both the Company and Other Clients, and any work performed by Senior and Other Advisors retained on behalf of the Company could benefit the Other Clients (and alternatively, work performed by Senior and Other Advisors on behalf of Other Clients could benefit the Company), and Blackstone Credit &amp; Insurance shall have no obligation to allocate any portion of the costs to be borne by the Company in respect of such Senior and Other Advisors to the Other Clients, except as described below.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of the foregoing, in certain investments including involving a &#8220;platform company,&#8221; the Company will, in certain circumstances, enter into an arrangement with one or more individuals (who could be former personnel of the Firm or current or former personnel of portfolio companies of the Company or Other Clients, generally will have experience or capability in sourcing or managing investments, and could form a management team) to undertake a new business line or a build-up strategy to acquire and develop assets and businesses in a particular sector or involving a particular strategy. The services provided by such individuals or relevant portfolio company, as the case may be, could include the following with respect to investments: origination or sourcing, due diligence, evaluation, negotiation, servicing, development, management (including turnaround) and disposition. The individuals or relevant portfolio company could be compensated with a salary and equity incentive plan, including a portion of profits derived from the Company or a portfolio company or asset of the Company (which, to the extent permitted by applicable law and/or any applicable SEC granted exemptive or no action relief, can take the form of a management fee and/or profits allocation (whether paid directly to such individuals or to an affiliate entity controlled by such individuals), or other long-term incentive plans. Compensation could also be based on assets under management, a waterfall similar to a carried interest, respectively, or another similar metric. The Company could initially bear the cost of overhead (including rent, utilities, benefits, salary or retainers for the individuals or their affiliates entities) and the sourcing, diligence and analysis of investments, as well as the compensation for the individuals and entity undertaking the build-up strategy. Such expenses could be borne directly by the Company as Company Expenses (or broken deal expenses, if applicable) or indirectly through expenditures by a portfolio company. None the fees, costs or expenses described above will reduce the management fee.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Adviser will, in certain circumstances, engage third parties as Senior and Other Advisors (or in another similar capacity) in order to advise it with respect to existing investments, specific investment opportunities, and economic and industry trends. Such Senior and Other Advisors can receive reimbursement of reasonable related expenses by portfolio companies or the Company and could have the opportunity to invest in a portion of the equity and/or debt available to the Company for investment that would otherwise be taken by the Adviser and its affiliates. If such Senior and Other Advisors generate investment opportunities on the Company&#8217;s behalf, such Senior and Other Advisors are permitted to receive special additional fees or allocations which have the potential to not be comparable to those received by a third party in an arm&#8217;s length transaction and such additional fees or allocations would be borne fully by the Company and/or portfolio companies (with no reduction or offset to management fees) and not Blackstone Credit &amp; Insurance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Minority Investments in Asset Management Firms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone and Other Clients, including Blackstone Strategic Capital Holdings (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BSCH&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and its related parties, regularly make minority investments in alternative asset management firms that are not affiliated with Blackstone, the Company, Other Clients and their respective portfolio companies, and which from time to time engage in similar investment transactions, including with respect to purchase and sale of investments, with these asset management firms and their advised funds and portfolio companies. Typically, the Blackstone related party with an interest in the asset management firm would be entitled to receive a share of carried interest/performance based incentive compensation and net fee income or revenue share generated by the various products, vehicles, funds and accounts managed by that third party asset management firm that are included in the transaction or activities of the third party asset management firm, or a subset of such activities such as transactions with a Blackstone related party. In addition, while such minority investments are generally structured so that Blackstone does not &#8220;control&#8221; such third party asset management firms, Blackstone could nonetheless be afforded certain governance rights in relation to such investments (typically in the nature of &#8220;protective&#8221; rights, negative control rights or anti-dilution arrangements, as well as certain reporting and consultation rights) that afford Blackstone the ability to influence the firm. Although Blackstone and Other Clients, including BSCH, do not intend to control such third </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">party asset management firms, there can be no assurance that all third parties will similarly conclude that such investments are non-control investments or that, due to the provisions of the governing documents of such third party asset management firms or the interpretation of applicable law or regulations, investments by Blackstone and Other Clients, including BSCH, will not be deemed to have control elements for certain contractual, regulatory or other purposes. While such third party asset managers will not be deemed affiliated with the Company within the meaning of the 1940 Act, Blackstone expects to, under certain circumstances, be in a position to influence the management and operations of such asset managers and the existence of its economic/revenue sharing interest therein can give rise to conflicts of interest. Participation rights in a third party asset management firm (or other similar business), negotiated governance arrangements and/or the interpretation of applicable law or regulations could expose the investments of the Company to claims by third parties in connection with such investments (as indirect owners of such asset management firms or similar businesses) that would have an adverse financial or reputational impact on the performance of the Company. The Company, its affiliates and their respective portfolio companies are expected to, from time to time engage in transactions with, and buy and sell investments from, any such third party asset managers and their sponsored funds and transactions and other commercial arrangements between such third party asset managers and the Company and its portfolio companies are not subject to approval by the Board of Trustees. There can be no assurance that the terms of these transactions between parties related to Blackstone, on the one hand, and the Company and its portfolio companies, on the other hand, will be at arm&#8217;s length or that Blackstone will not receive a benefit from such transactions, which can be expected to incentivize Blackstone to cause these transactions to occur. Such conflicts related to investments in and arrangements with other asset management firms will not necessarily be resolved in favor of the Company. Shareholders will not be entitled to receive notice or disclosure of the terms or occurrence of either the investments in alternative asset management firms or transactions therewith and will not receive any benefit from such transactions. By executing a subscription agreement with respect to the Company, each shareholder acknowledges these conflicts related to investments in and arrangements with other asset management firms, acknowledges that these conflicts will not necessarily be resolved in favor of the Company, agrees that shareholders will not be entitled to receive notice or disclosure of the terms or occurrence of either the investments in alternative asset management firms or transactions therewith, otherwise understands that shareholders will not receive any benefit from such transactions, consents to all such transactions and arrangements to the fullest extent permitted by law, and waives any claim against Blackstone and releases Blackstone from any liability arising from the existence of any such conflict of interest.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, certain advisors and service providers (including law firms) temporarily provide their personnel to Blackstone, Other Clients or their portfolio companies pursuant to various arrangements including at cost or at no cost. (See also &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Secondments and Internships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; herein.) While often the Company, Other Clients and their portfolio companies are the beneficiaries of these types of arrangements, Blackstone is from time to time a beneficiary of these arrangements as well, including in circumstances where the advisor or service provider also provides services to the Company, Other Clients or Blackstone in the ordinary course. Blackstone, the Company, Other Clients or their portfolio companies could receive benefits from these arrangements at no cost, or alternatively could pay all or a portion of the fees, compensation or other expenses in respect of these arrangements. The management fee will not be offset or reduced as a result of these arrangements or any fees, expense reimbursements or other costs related thereto. The personnel described above could provide services in respect of multiple matters, including in respect of matters related to Blackstone, the Company, Other Clients, portfolio companies, each of their respective affiliates and related parties, and Blackstone will endeavor in good faith to allocate the costs of these arrangements, if any, to Blackstone, the Company, Other Clients, portfolio companies and other parties based on time spent by the personnel or another methodology the Firm deems appropriate in a particular circumstance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Multiple Blackstone Business Lines. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone has multiple business lines, including the Blackstone Capital Markets Group, which Blackstone Credit &amp; Insurance, the Company, Other Clients, portfolio companies of the Company and Other Clients and third parties will, in certain circumstances, engage for debt and equity financings and to provide other investment banking, brokerage, investment advisory or other services. As a result of these activities, Blackstone is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than if it had one line of business. For example, from time to time, Blackstone could come into possession of information that limits the Company&#8217;s ability to engage in potential transactions. Similarly, other Blackstone businesses and their personnel could be prohibited by law or contract from sharing information with Blackstone that would be relevant to monitoring the investments and other activities. These types of restrictions from time to time will negatively impact the ability of the Company to implement its investment program. Finally, Blackstone personnel who are members of the investment team or investment committee could be excluded from participating in certain investment decisions due to conflicts involving other Blackstone businesses or for other reasons, including other business activities, in which case the Company will not benefit from their experience. The shareholders will not receive a benefit from any fees earned by Blackstone or its personnel from these other businesses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone is under no obligation to decline any engagements or investments in order to make an investment opportunity available to the Company. Blackstone has long-term relationships with a significant number of corporations and their senior management. Blackstone will consider those relationships when evaluating an investment opportunity, which has the potential to result in Blackstone choosing not to make such an investment due to such relationships (e.g., investments in a competitor of a client or other person with whom Blackstone has a relationship). The Company could be required to sell or hold existing investments as a result of investment banking relationships or other relationships that Blackstone has or will have or transactions or investments that Blackstone makes or has made. (See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Allocation of Investment Opportunities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Portfolio Company Relationships&#8221;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Therefore, there can be no assurance that all potentially suitable investment opportunities that come to the attention of Blackstone will be made available to the Company. The Company is also permitted to co-invest with Other Clients or other persons with whom Blackstone has a relationship in particular investment opportunities, and other aspects of these Blackstone relationships could influence the decisions made by Blackstone with respect to the investments and otherwise result in a conflict (see also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Other Clients; Allocation of Investment Opportunities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein). Company would otherwise have to buy or sell certain assets, and may require that the Company dispose of an investment at an inopportune time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blackstone Policies and Procedures; Information Walls.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blackstone has implemented policies and procedures to address conflicts that arise as a result of its various activities, as well as regulatory and other legal considerations. Some of these policies and procedures, such as Blackstone&#8217;s information wall policy, are implemented by Blackstone to mitigate potential conflicts of interest and address certain regulatory requirements and contractual restrictions will reduce the synergies and collaboration across Blackstone&#8217;s various businesses that the Company expects to draw on for purposes of identifying, pursuing and managing attractive investment opportunities. Because Blackstone has many different asset management and advisory businesses, including private equity, growth equity, a credit business, a hedge fund business, a capital markets group, a life sciences business and a real estate advisory business, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would otherwise be subject if it had just one line of business. In addressing these conflicts and regulatory, legal and contractual requirements across its various businesses and to protect against the inappropriate sharing and/or use of information between the Company and the other business units at Blackstone, Blackstone has implemented certain policies and procedures (e.g., Blackstone&#8217;s information wall policy) regarding the sharing of information that have the potential to reduce the positive synergies and collaborations that the Company could otherwise expect to utilize for purposes of identifying and managing attractive investments. For example, Blackstone will from time to time come into possession of material non-public information with respect to companies in which Other Clients have investments or might be considering making an investment or companies that are clients of Blackstone. As a consequence, that information, which could be of benefit to the Company, might become restricted to those other respective businesses and otherwise be unavailable to the Company. It is also possible that the Company could be restricted from trading despite the fact that the Company did not receive such information. There can be no assurance, however, that any such policies and/or procedures will be effective in accomplishing their stated purpose and/or that they will not otherwise adversely affect the ability of the Company to effectively achieve its investment objective by unduly limiting the investment flexibility of the Company and/or the flow of otherwise appropriate information between Blackstone Credit &amp; Insurance and other business units at Blackstone. For example, in some instances, personnel of Blackstone would be unable to assist with the activities of the Company as a result of these walls. There can be no assurance that additional restrictions will not be imposed that would further limit the ability of Blackstone to share information internally. In addition, due to these restrictions, it is possible that the Company will not be able to initiate a transaction that it otherwise might have initiated and will not be able to purchase or sell an investment that it otherwise might have purchased or sold, which could negatively affect its operations or performance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to the extent that Blackstone is in possession of material non-public information or is otherwise restricted from making certain investments, the Company and the Adviser would also be deemed to be in possession of such information or otherwise restricted. Additionally, the terms of confidentiality or other agreements with or related to companies in which any Blackstone fund has or has considered making an investment or which is otherwise a client of Blackstone will from time to time restrict or otherwise limit the ability of the Company and/or its portfolio companies and their affiliates to make investments in or otherwise engage in businesses or activities competitive with such companies. Blackstone has in the past entered into, and reserves the right to enter into in the future, one or more strategic relationships in certain regions or with respect to certain types of investments that, although intended to provide greater opportunities for the Company, require the Company to share such opportunities or otherwise limit the amount of an opportunity the Company can otherwise take. (See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Allocation of Investment Opportunities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm receives, generates and/or obtains various kinds of data and information from the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and limited partners in Other Clients and service providers, including but not limited to data and information relating to or created in connection with business operations, financial information results, trends, budgets, energy usage, plans, ESG, carbon emissions and related metrics, customer and user data, employee and contractor data, supplier and cost data, and other related data and information, some of which is sometimes referred to as &#8220;alternative data&#8221; or &#8220;big data&#8221;. The Firm can be expected to be better able to anticipate macroeconomic and other trends, and otherwise develop investment themes or identify specific investment, trading or business opportunities, as a result of its access to (and rights regarding, including use, ownership, distribution and derived works rights over) this data and information from the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and limited partners in Other Clients, related parties and service providers. The Firm has entered and will continue to enter into information sharing and use, measurement and other arrangements, which will give the Firm access to (and rights regarding, including ownership, use, distribution and derived works rights over) data that it would not otherwise obtain in the ordinary course, with the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and in Other Clients, as well as with related parties and service providers. Further, this alternative data is expected to be aggregated across the Company, Other Clients and their respective portfolio companies. Although the Firm believes that these activities improve the Firm&#8217;s investment management activities on behalf of the Company and Other Clients, information obtained from the Company and its portfolio companies, and investors in the Company and in Other Clients also provides material benefits to Blackstone or Other Clients without compensation or other benefit accruing to the Company or its shareholders. For example, information from a portfolio company in which the Company holds an interest can be expected to enable the Firm to better understand a particular industry, enhance the Firm&#8217;s ability to provide advice or direction to a portfolio company&#8217;s management team on strategy or operations and enable the Firm to execute trading and investment strategies in reliance on that understanding for Blackstone and Other Clients that do not own an interest in the portfolio company, typically without compensation or benefit to the Company or its portfolio companies. Blackstone would serve as the repository for data described in this paragraph, including with ownership and use rights therein. The Firm is also permitted to share data from a portfolio company (on an anonymized basis) with a portfolio company of an Other Client, which has the potential to increase a competitive disadvantage for, and indirectly harm, such portfolio company (although the opposite may be true as well, in which case a portfolio company of the Company may receive data from a portfolio company of an Other Client). In addition, the Firm could have an incentive to pursue an investment in a particular company based on the data and information expected to be received or generated in connection with such investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, except for contractual obligations to third parties to maintain confidentiality of certain information or otherwise limit the scope and purpose of its use or distribution, and regulatory limitations on the use of material nonpublic information, the Firm is generally free to use and distribute data and information from the Company&#8217;s activities to assist in the pursuit of the Firm&#8217;s various other activities, including but not limited to trading activities or use for the benefit of the Firm and/or an Other Client. Any confidentiality obligations in the operative documents do not limit the Firm&#8217;s ability to do so. For example, the Firm&#8217;s ability to trade in securities of an issuer relating to a specific industry can, subject to applicable law, be enhanced by information of a portfolio company in the same or related industry. Such trading or other business activities is expected to provide a material benefit to the Firm without compensation or other benefit to the Company or shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sharing and use of &#8220;big data&#8221; and other information presents potential conflicts of interest and the shareholders acknowledge and agree that any benefits received by the Firm or its personnel (including fees (in cash or in kind), costs and expenses) will not reduce the management fees or incentive fees payable to the Adviser or otherwise shared with the Company or its shareholders. As a result, the Adviser has an incentive to pursue investments that have data and information that can be utilized in a manner that benefits the Firm or Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data Management Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone or an affiliate of Blackstone formed in the future may provide data management services to portfolio companies and investors in the Company and in Other Clients and will provide such services directly to the Company and Other Clients (collectively,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Data Holders&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Such services are expected to include assistance with obtaining, analyzing, curating, processing, packaging, organizing, mapping, holding, transforming, enhancing, marketing and selling such data (among other related data management and consulting services) for monetization through licensing or sale arrangements with third parties and, subject to applicable law and the limitations in the Investment Advisory Agreement and any other applicable contractual limitations, with the Company, Other Clients, portfolio companies, investors in the Company and in Other Clients, and other Blackstone affiliates and associated entities (including funds in which Blackstone and Other Clients make investments, and portfolio companies thereof). If Blackstone enters into data services arrangements with portfolio companies and receives compensation from such portfolio companies for such data services, the Company will indirectly bear its share of such compensation based on its pro rata ownership of such portfolio companies. Where Blackstone believes appropriate, data from one Data Holder will be aggregated or pooled with data from other Data Holders. Any revenues arising </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from such aggregated or pooled data sets would be allocated between applicable Data Holders on a fair and reasonable basis as determined by Blackstone Credit &amp; Insurance in its sole discretion, with Blackstone Credit &amp; Insurance able to make corrective allocations should it determine subsequently that such corrections were necessary or advisable. Blackstone is expected to receive compensation for such data management services, which is expected to include a percentage of the revenues generated through any licensing or sale arrangements with respect to the relevant data, and which compensation is also expected to include fees, royalties and cost and expense reimbursement (including start-up costs and allocable overhead associated with personnel working on relevant matters (including salaries, benefits and other similar expenses)). Additionally, Blackstone is expected to share and distribute the products from such data management services within Blackstone or its affiliates (including Other Clients or their portfolio companies) at no charge and, in such cases, the Data Holders will not receive any financial or other benefit from having provided such data to Blackstone. The potential receipt of such compensation by Blackstone creates incentives for Blackstone to cause the Company to invest in portfolio companies with a significant amount of data that it might not otherwise have invested in or on terms less favorable than it otherwise would have sought to obtain.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blackstone and Blackstone Credit &amp; Insurance Strategic Relationships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone and Blackstone Credit &amp; Insurance have entered, and it can be expected that Blackstone and Blackstone Credit &amp; Insurance in the future will enter, into both (i) strategic relationships with investors (and/or one or more of their affiliates) that involve an overall relationship with Blackstone or Blackstone Credit &amp; Insurance (which will afford such investor special rights and benefits) that could (but is not required to) incorporate one or more strategies (including, but not limited to, a different sector and/or geographical focus within the same or a different Blackstone business unit) in addition to the Company&#8217;s strategy and (ii) arrangements that involve an agreement or understanding to make an investment in or a capital commitment to (as applicable) the Company and one or more Other Clients, as applicable (which can include a subscription or capital commitment, as applicable, already made recently to another Other Client) (any such overall relationship and/or multi-fund arrangement in the foregoing (i) and (ii), (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Strategic Relationships&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), with terms and conditions applicable solely to such investor and its investment in multiple Blackstone or Blackstone Credit &amp; Insurance strategies that would not apply to any other investor&#8217;s investment in the Company. A Strategic Relationship often involves (but is not required to involve) an investor agreeing to make a capital commitment to or investment in (as applicable) multiple Blackstone or Blackstone Credit &amp; Insurance Clients, one of which could include the Company. Shareholders will not receive a copy of any agreement memorializing such a Strategic Relationship program (even if in the form of a side letter) or receive any other disclosure or reporting of the terms of or existence of any Strategic Relationship and will be unable to elect in the &#8220;most-favored-nations&#8221; election process (if any) any rights or benefits afforded through a Strategic Relationship (for the avoidance of doubt, no further disclosure or reporting information will be shared with the shareholders about any Strategic Relationship). Specific examples of such additional rights and benefits have included and can be expected to include, among others, specialized reporting, discounts or reductions on and/or reimbursements or rebates of management fees or carried interest (as applicable), secondment of personnel from the investor to Blackstone or Blackstone Credit &amp; Insurance (or vice versa), rights to participate in the investment review and evaluation process, as well as priority rights or targeted amounts for co-investments alongside Blackstone Credit &amp; Insurance or Blackstone funds (including, without limitation, preferential or favorable allocation of co-investment and preferential terms and conditions related to co-investment or other participation in Blackstone or Blackstone Credit &amp; Insurance Clients (including in respect of any carried interest (as applicable) and/or management fees to be charged with respect thereto, as well as any additional discounts, reductions, reimbursements or rebates with respect thereto or other penalties that may result if certain target co-investment allocations or other conditions under such arrangements are not achieved)). Any co-investment that is part of a Strategic Relationship could include co-investment in investments made by the Company. Blackstone, including its personnel (including Blackstone Credit &amp; Insurance personnel), reserves the right to receive compensation from Strategic Relationships and could be incentivized to allocate investment opportunities away from the Company to or source investment opportunities for Strategic Relationships. Strategic Relationships will in certain circumstances, result in fewer co-investment opportunities (or reduced or no allocations) being made available to shareholders, subject to the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blackstone Credit &amp; Insurance Value Creation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone Credit &amp; Insurance Value Creation is a global platform that is part of Blackstone&#8217;s Portfolio Operations Group (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Portfolio Operations Group&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and seeks to provide access to a range of cost-saving, revenue-generating and best-practice sharing opportunities for Blackstone Credit &amp; Insurance portfolio companies. The Portfolio Operations Group is organized into seven functional areas, across geographic regions and industry verticals:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Procurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Blackstone&#8217;s group purchasing program harnesses spending from portfolio companies across more than 75 categories, including IT hardware and software, office supplies, shipping, energy and telecommunications.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Cost Containment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Blackstone&#8217;s Equity Healthcare team partners with portfolio companies to optimize the strategy and value of healthcare spending by reducing cost and improving the quality of healthcare services received by employees and their dependents. Equity Healthcare is one of the largest private sector purchasers of healthcare services in the United States and has helped drive cumulative healthcare cost savings to portfolio companies and strengthened portfolio companies&#8217; ability to attract and retain talent.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lean Process</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The lean process team seeks to drive transformational improvements focused on material and information flows by reducing waste and non-value add activities across manufacturing functions. It develops prescriptive solutions for portfolio companies and aligns with senior leadership to support tailored strategies and guide management teams in executing and sustaining improved workflow processes.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leadership and Talent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Portfolio Operations Group employs the following strategies to optimize leadership and organizational performance: (i) delivering fit-for-purpose resources to portfolio companies, which include non-executive chairpersons, board members, advisors, and operating specialists, (ii) strengthening company teams and organizational practices through assisting with restructuring, integrations and growth actions, and (iii) convening conferences for portfolio company executives to share best practices and improve alignment to the Firm.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sustainability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: By improving the operation and maintenance of mechanical systems, the Portfolio Operations Group seeks to reduce energy spend while improving productivity, safety, and environmental performance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Technology / BPO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Blackstone&#8217;s Technology / BPO team helps the portfolio management teams recruit/upgrade their information technology leadership teams; import contemporary operating systems and application software to address their respective business priorities; leverage portfolio investments in technology companies to promote and serve the overall portfolio interests; and evaluate and negotiate preferred partnerships with digital/technology suppliers, advisors, and consultants from around the world.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Science</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Firm has invested in a team of data scientists and engineers to help the portfolio companies realize operational efficiencies and drive new revenue through data and analytics. This team focuses on (i) building predictive models to enhance decision making; (ii) leveraging big data within operations; (iii) data visualization to democratize access to information; and (iv) data monetization.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of Blackstone&#8217;s Portfolio Operations Group (including Blackstone Credit &amp; Insurance Value Creation), who are Blackstone employees, are permitted to provide services to the Company&#8217;s portfolio companies, including without limitation those related to the functional areas described above and other similar management consulting, operational and financial matters and are permitted to participate in the Firm co-investment rights. Any payments made or fees paid (which fees or payments will also in certain instances be structured as a reimbursement of internal compensation costs for time spent) by such portfolio companies to Blackstone for services rendered to such portfolio companies will generally be no greater than what would be paid in an arm&#8217;s-length transaction for similar overalls services, and such payments or fees received will not reduce the management fee payable by the Company. As a result, Blackstone is likely to be incentivized to cause members of the Portfolio Operations Group to spend more time on the Company&#8217;s portfolio companies as compared to portfolio companies of Other Clients that do reduce the management fee. On the other hand, there can be no assurance that members of the Portfolio Operations Group will be able to provide their services to portfolio companies and/or that any individuals within the Portfolio Operations Group will remain employed by Blackstone through the life of the Company. The level of involvement and role of Blackstone&#8217;s Portfolio Operations Group within each part of Blackstone with respect to any of the Company&#8217;s portfolio companies are expected to vary, including having no involvement or role at all. In addition, the Portfolio Operations Group will provide services to the Company&#8217;s portfolio companies as described in more detail in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Firm Affiliated Service Providers&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including facilitation of arrangements for Portfolio Companies relating to group procurement (such as the group purchasing organization) and other operational, administrative or management related matters from third parties or Firm affiliates, and other similar operational initiatives. These services can result in commissions or similar payments, including related to a portion of the savings achieved by the portfolio companies. See also </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Other Fees&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Group Procurement; Discounts&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Firm Affiliated Service Providers&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information regarding such programs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Buying and Selling Investments or Assets from Certain Related Parties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company and its portfolio companies may purchase investments or assets from or sell investments or assets to shareholders, other portfolio companies of the Company, portfolio companies of Other Clients or their respective related parties. Purchases and sales of investments or assets between the Company or its portfolio companies, on the one hand, and shareholders, other portfolio companies of the Company, portfolio companies of Other Clients or their respective related parties, on the other hand, are not, unless required by applicable law, subject to the approval of the Board of Trustees or any shareholder. These transactions involve conflicts of interest, as the Firm may receive fees and other benefits, directly or indirectly, from or otherwise have interests in both parties to the transaction, including different financial incentives Blackstone could have with respect to the parties to the transaction. For example, there can be no assurance that any investment or asset sold by the Company to a shareholder, other portfolio companies of the Company, portfolio company of Other Clients or any of their respective related parties will not be valued or allocated a sale price that is lower than might otherwise have been the case if such asset were sold to a third party rather than to a shareholder, portfolio company of Other Clients or any of their respective related parties. The Firm will not be required to solicit third party bids or obtain a third party valuation prior to causing the Company or any of its portfolio companies to purchase or sell any asset or investment from or to a shareholder, other portfolio companies of the Company, portfolio company of Other Clients or any of their respective related parties as provided above.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Firm Businesses, Activities and Relationships. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its regular business, Blackstone provides a broad range of investment banking, advisory and other services. In addition, from time to time, the Firm will provide services in the future beyond those currently provided. Shareholders will not receive any benefit from any fees relating to such services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the regular course of its capital markets, investment banking, real estate advisory and other businesses, Blackstone represents potential purchasers, sellers and other involved parties, including corporations, financial buyers, management, shareholders and institutions, with respect to transactions that could give rise to other transactions that are suitable for the Company. In such a case, a Blackstone advisory client would typically require Blackstone to act exclusively on its behalf. Such advisory client requests have the potential to preclude all Blackstone-affiliated clients, including the Company, from participating in related transactions that would otherwise be suitable. Blackstone will be under no obligation to decline any such engagements in order to make an investment opportunity available to the Company. In connection with its capital markets, investment banking, advisory, real estate and other businesses, Blackstone comes into possession of information that limits its ability to engage in potential transactions. The Company&#8217;s activities are expected to be constrained as a result of the inability of Blackstone personnel to use such information. For example, employees of Blackstone from time to time are prohibited by law or contract from sharing information with members of the Company&#8217;s investment team. Additionally, there are expected to be circumstances in which one or more individuals associated with Blackstone affiliates (including clients) will be precluded from providing services related to the Company&#8217;s activities because of certain confidential information available to those individuals or to other parts of Blackstone (e.g., trading can be restricted). Where Blackstone affiliates are engaged to find buyers or financing sources for potential sellers of assets, the seller can permit the Company to act as a participant in such transactions (as a buyer or financing partner), which would raise certain conflicts of interest inherent in such a situation (including as to the negotiation of the purchase price).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may invest in securities of the same issuers as Other Clients, other investment vehicles, accounts and clients of the Firm and the Adviser. To the extent that the Company holds interests that are different (or more senior or junior) than those held by such Other Clients, Blackstone Credit &amp; Insurance may be presented with decisions involving circumstances where the interests of such Other Clients are in conflict with those of the Company. Furthermore, it is possible the Company&#8217;s interest could be subordinated or otherwise adversely affected by virtue of such Other Clients&#8217; involvement and actions relating to its investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the 1940 Act limits the Company&#8217;s ability to undertake certain transactions with its affiliates that are registered under the 1940 Act or regulated as BDCs under the 1940 Act. As a result of these restrictions, the Company could be prohibited from executing &#8220;joint&#8221; transactions with such affiliates, which could include investments in the same portfolio company (whether at the same or different times). These limitations have the potential to limit the scope of investment opportunities that would otherwise be available to the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance has received an exemptive order that permits certain funds, among other things, to co-invest with certain other persons, including certain affiliates of Blackstone Credit &amp; Insurance, and certain funds managed and controlled by Blackstone Credit &amp; Insurance and its affiliates subject to certain terms and conditions. In addition, other present and future activities of the Firm and its affiliates (including Blackstone Credit &amp; Insurance and the Adviser) will from time to time give rise to additional conflicts of interest relating to the Firm and its investment activities. In the event that any such conflict of interest arises, the Adviser will attempt to resolve such conflicts in a fair and equitable manner. Investors should be aware that, subject to applicable law, conflicts will not necessarily be resolved in favor of the Company&#8217;s interests.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transactions with Clients of Blackstone Insurance Solutions and Asset Based Finance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone Insurance Solutions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BIS&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is the business segment of Blackstone Credit &amp; Insurance that provides investment advisory services to insurers, including among others, (i) Fidelity Life Insurance Company and certain of its affiliates (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;FGL&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), (ii) Everlake Life Insurance Company and certain of its affiliates (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Everlake&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), (iii) certain subsidiaries of Corebridge Financial, Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Corebridge&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and (iv) certain subsidiaries of Resolution Life Group Holdings Ltd. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Resolution Life&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Certain of the insurers for which BIS provides services are, or may be in the future, owned, directly or indirectly, by Blackstone, the Company, or Other Clients, in whole or in part. Actual or potential conflicts of interest will likely arise in relation to the funds, vehicles or accounts BIS advises or sub-advises, including accounts where an insurer (including, without limitation, each of FGL, Everlake, Corebridge and Resolution Life) participates in investments directly and there is no separate vehicle controlled by Blackstone (for the purposes of this paragraph only, collectively, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BIS Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Blackstone Credit &amp; Insurance also advises funds and accounts focused on asset-based finance, including insurers and other types of investors (for the purposes of this paragraph only, collectively, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ABF Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and each BIS Client and ABF Client is an Other Client for&#160;purposes other than this paragraph). BIS Clients have invested and are expected to continue investing in Other Clients and/or the Company. For greater clarity, any references herein to Blackstone Credit &amp; Insurance or Other Blackstone Credit &amp; Insurance Clients do not include BIS, BIS Clients or ABF Clients. Certain BIS Clients and certain ABF Clients have investment objectives that overlap with those of the Company (and Blackstone Credit &amp; Insurance, or a business segment thereof, has entered into sub-management agreements with BIS to manage (for a fee, which such fees may be shared with BIS) the assets of certain such BIS Clients with respect to investments that overlap in part with the Company&#8217;s investment directive) or its portfolio companies and such BIS Clients and ABF Clients may invest, as permitted by applicable law and the Company&#8217;s co-investment exemptive relief, alongside (or in lieu of) the Company or such portfolio companies in certain investments, which will reduce the investment opportunities otherwise available to the Company or such portfolio companies. BIS Clients and ABF Clients will also engage in a variety of activities, including participating in transactions related to the Company and/or its portfolio companies (e.g., as originators, co-originators, counterparties or otherwise). Other transactions in which BIS Clients or ABF Clients will participate include, without limitation, investments in debt or other securities issued by portfolio companies or other forms of financing to portfolio companies (including special purpose vehicles established by the Company or such portfolio companies). When investing alongside the Company or its portfolio companies or in other transactions related to the Company or its portfolio companies, BIS Clients or ABF Clients may not invest or divest at the same time or on the same terms as the Company or the applicable portfolio companies or at a different time or on different terms. BIS Clients and ABF Clients will also from time to time acquire investments and portfolio companies directly or indirectly from the Company, as permitted by applicable law and the Company&#8217;s co-investment exemptive relief. In circumstances where Blackstone Credit &amp; Insurance determines in good faith that the conflict of interest is mitigated in whole or in part through various measures that Blackstone, Blackstone Credit &amp; Insurance or the Adviser implements, the Adviser may determine to proceed with the applicable transaction (subject to oversight by the Board of Trustees and the applicable law to which the Company is subject). In order to seek to mitigate any potential conflicts of interest with respect to such transactions (or other transactions involving BIS Clients or ABF Clients), Blackstone reserves the right, in its sole discretion, to involve independent members of the board of a portfolio company or a third party stakeholder in the transaction to negotiate price and terms on behalf of the BIS Clients or ABF Clients or otherwise cause the BIS Clients or ABF Clients to &#8220;follow the vote&#8221; thereof, and/or cause an independent client representative or other third party to approve the investment or otherwise represent the interests of one or more of the parties to the transaction. In addition, Blackstone or the Adviser may limit the percentage interest of the BIS Clients or ABF Clients participating in such transaction, or obtain appropriate price quotes or other benchmarks, or, alternatively, a third-party price opinion or other document to support the reasonableness of the price and terms of the transaction. From time to time, the applicable BIS Clients or ABF Clients participating in a transaction will be required to consent thereto (including in circumstances where the Adviser does not seek the consent of the Board of Trustees). There can be no assurance that any such measures or other measures that may be implemented by Blackstone will be effective at mitigating any actual or potential conflicts of interest. Moreover, under certain circumstances (e.g., where a BIS Client or ABF Client participates in a transaction directly (and not through a vehicle controlled by Blackstone) and independently consents to participating in a transaction), a BIS Client or ABF Client (or any other Blackstone Client participating via a similar arrangement) will not be an &#8220;Affiliate&#8221; as defined under the 1940 Act. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allocation of Portfolios</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm will, in certain circumstances, have an opportunity to acquire a portfolio or pool of assets, securities and instruments that it determines should be divided and allocated among the Company and Other Clients. Such allocations generally would be based on the Firm&#8217;s assessment of the expected returns and risk profile of each of the assets. For example, some of the assets in a pool will have an opportunistic return profile, while others will have a return profile not appropriate for the Company. Also, a pool can contain both debt and equity instruments that the Firm determines should be allocated to different funds. In all of these situations, the combined purchase price paid to a seller would be allocated among the multiple assets, securities and instruments in the pool and therefore among the Company and Other Clients acquiring any of the assets, securities and instruments, although the Firm could, in certain circumstances, allocate value to the Company and such Other Clients on a different basis than the contractual purchase price. Similarly, there will likely be circumstances in which the Company and Other Clients will sell assets in a single or related transactions to a buyer. In some cases, a counterparty will require an allocation of value in the purchase or sale contract, though the Firm could determine such allocation of value is not accurate and should not be relied upon. The Firm will generally rely upon internal analysis to determine the ultimate allocation of value, though it could also obtain third party valuation reports. Regardless of the methodology for allocating value, the Firm will have conflicting duties to the Company and Other Clients when they buy or sell assets together in a portfolio, including as a result of different financial incentives the Firm has with respect to different vehicles, most clearly when the fees and compensation, including performance-based compensation, earned from the different vehicles differ. There can be no assurance that an investment of the Company will not be valued or allocated a purchase price that is higher or lower than it might otherwise have been allocated if such investment were acquired or sold independently rather than as a component of a portfolio shared with Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holding Entities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Firm may determine that for legal, tax, regulatory, accounting, administrative or other reasons the Company should hold a particular investment (or a portion of an investment or pool of assets) through a single holding entity through which the Company and one or more Other Clients hold different investments (or a different portion of such investment or pool of assets), including where such investment or pool has been divided and allocated among the Company and such Other Clients. Over time, it is possible that the Company and/or Other Clients may make different decisions with respect to the investments held through such holding entities and therefore may have differing economic rights, obligations or liabilities with respect to a holding entity. In such circumstances, the economic rights, liabilities and obligations in respect of the investment (or portion of an investment or pool of assets) that is indirectly held by the Company would be specifically attributed to the Company, and the Company would be deemed to hold its investment (or portion of an investment or pool of assets) separately from, and not jointly with, such Other Clients (and vice versa in respect of the investments (or portion of an investment or pool of assets) held indirectly through such holding entity by such Other Clients).&#160;Furthermore, certain holding structures may require a newly-established manager, advisor, service provider or other entity intended to address certain legal, tax, regulatory, accounting, administrative or other considerations applicable to the Company and/or Other Clients. It is possible that the Company or an affiliate will be initially responsible for the costs and expenses of establishing such holding structure (including any such newly-established entities) prior to, and/or, in anticipation of, Other Clients participating through such structure for their investments and it is expected that such Other Clients reimburse the Company or the Company would reimburse such affiliate for any such costs and expenses on a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> basis. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Affiliate Transactions and Investments in Different Levels of Capital Structure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company and the Other Clients may make investments at different levels of an issuer&#8217;s capital structure or otherwise in different classes of an issuer&#8217;s securities or loans, subject to the limitations of the 1940 Act. While less common, subject to applicable law, from time to time the Company could hold an investment in a different layer of the capital structure than an investor or another party with which Blackstone has a material relationship, in which case Blackstone could have an incentive to cause the Company or the portfolio company to offer more favorable terms to such parties (including, for instance, financing arrangements). Certain such investments inherently give rise to conflicts of interest or perceived conflicts of interest between or among the various classes of securities or loans that are expected to be held by such entities. To the extent the Company holds securities or loans that are different (including with respect to their relative seniority) than those held by an Other Client, the Adviser and its affiliates will be presented with decisions when the interests of the funds are in conflict. For example, conflicts could arise where the Company lends funds to a portfolio company while an Other Client invests in equity securities of such portfolio company. In this circumstance, for example, if such portfolio company were to go into bankruptcy, become insolvent or otherwise be unable to meet its payment obligations or comply with its debt covenants, conflicts of interest could arise between the holders of different types of securities or loans as to what actions the portfolio company should take. In addition, purchases or sales of securities or loans for the account of the Company (particularly marketable securities) will be bunched or aggregated with orders for Other Clients, including other funds. It is frequently not possible to receive the same price or execution on the entire volume of securities sold, and the various prices could be averaged, which has the potential to be disadvantageous to the Company. Further conflicts could arise after the Company and Other Clients have made their respective initial investments. For example, if additional financing is necessary as a result of financial or other difficulties, it is not always </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the best interests of the Company to provide such additional financing. If the Other Clients were to lose their respective investments as a result of such difficulties, the ability of the Adviser to recommend actions in the best interests of the Company might be impaired. Any applicable co-investment exemptive order issued by the SEC may restrict the Company&#8217;s ability to participate in follow-on financings. Blackstone Credit &amp; Insurance may in its sole discretion take steps to reduce the potential for adversity between the Company and the Other Clients, including causing the Company and/or such Other Clients to take certain actions that, in the absence of such conflict, it would not take. Such conflicts will be more difficult if the Company and Other Clients hold significant or controlling interests in competing or different tranches of a portfolio company&#8217;s capital structure. Equity holders and debt holders have different (and often competing) motives, incentives, liquidity goals and other interests with respect to a portfolio company. In addition, there could be circumstances where Blackstone Credit &amp; Insurance agrees to implement certain procedures to ameliorate conflicts of interest that involve a forbearance of rights relating to the Company or Other Clients, such as where Blackstone Credit &amp; Insurance is expected to cause the Company or Other Clients to decline to exercise certain control-and/or foreclosure-related rights with respect to a portfolio company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the Company is prohibited under the 1940 Act from participating in certain transactions with certain of affiliates (including portfolio companies of Other Clients) without the prior approval of a majority of the independent members of the Board of Trustees and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of the outstanding voting securities may be an affiliate of the Company for purposes of the 1940 Act and generally the Company will be prohibited from buying or selling any securities from or to such affiliate, absent the prior approval of the Board of Trustees. However, the Company may under certain circumstances purchase any such affiliate&#8217;s loans or securities in the secondary market, which could create a conflict for the Adviser between the Company&#8217;s interests and the interests of such affiliate, in that the ability of the Adviser to recommend actions in the Company&#8217;s best interest may be limited. The 1940 Act also prohibits certain &#8220;joint&#8221; transactions with certain affiliates, which could include investments in the same portfolio company (whether at the same or closely related times), without prior approval of the Board of Trustees and, in some cases, the SEC.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, conflicts may arise in determining the amount of an investment, if any, to be allocated among potential investors and the respective terms thereof. There can be no assurance that any conflict will be resolved in favor of the Company, and each shareholder acknowledges and agrees that in some cases, subject to applicable law, a decision by Blackstone Credit &amp; Insurance to take any particular action could have the effect of benefiting an Other Client and therefore may not have been in the best interests of, and may be adverse to, the Company. There can be no assurance that the return on the Company&#8217;s investment will be equivalent to or better than the returns obtained by the Other Clients participating in the same or similar transactions. The shareholders will not receive any benefit from fees paid to any affiliate of the Adviser in respect of any Other Client&#8217;s investment in a portfolio company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Financing Counterparties. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may invest in companies or other entities in which Other Clients make an investment in a different part of the capital structure (and vice versa) subject to the requirements of the 1940 Act and the Company&#8217;s co-investment exemptive order. The Adviser requests in the ordinary course proposals from lenders and other sources to provide financing to the Company and its portfolio companies. Blackstone Credit &amp; Insurance takes into account various facts and circumstances it deems relevant in selecting financing sources, including whether a potential lender has expressed an interest in evaluating debt financing opportunities, whether a potential lender has a history of participating in debt financing opportunities generally and with the Firm in particular, the size of the potential lender&#8217;s loan amount, the timing of the relevant cash requirement, the availability of other sources of financing, the creditworthiness of the lender, whether the potential lender has demonstrated a long-term or continuing commitment to the success of Blackstone, Blackstone Credit &amp; Insurance and their funds, and such other factors that Blackstone and Blackstone Credit &amp; Insurance deem relevant under the circumstances. The cost of debt alone is not determinative.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that shareholders, Other Clients, their portfolio companies, co-investors and other parties with material relationships with the Firm, such as shareholders of and lenders to the Firm and lenders to Other Clients and their portfolio companies (as well as Blackstone itself), could provide additional financing to portfolio companies of the Company, subject to the requirements of the 1940 Act. The Firm could have incentives to cause the Company and its portfolio companies to accept less favorable financing terms from a shareholder, Other Clients, their portfolio companies, Blackstone, and other parties with material relationships with the Firm than it would from a third party. If the Company occupies a different, and in particular, a more senior, position in the capital structure than a shareholder, Other Client, their portfolio companies and other parties with material relationships with Blackstone, Blackstone could have an incentive to cause the Company or portfolio company to offer financing terms that are more favorable to such parties. In the case of a related party financing between the Company or its portfolio companies, on the one hand, and Blackstone or Other Clients&#8217; portfolio companies, on the other hand, to the extent permitted by the 1940 Act, the Adviser could, but is not obligated to, rely on a third party agent to confirm the terms offered by the counterparty are consistent with market terms, or the Adviser could instead rely on its own internal analysis, which the </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adviser believes is often superior to third party analysis given the Firm&#8217;s scale in the market. If however any of the Firm, the Company, an Other Client or any of their portfolio companies delegates to a third party, such as another member of a financing syndicate or a joint venture partner, the negotiation of the terms of the financing, the transaction will be assumed to be conducted on an arms-length basis, even though the participation of the Firm related vehicle impacts the market terms. For example, in the case of a loan extended to the Company or a portfolio company by a financing syndicate in which an Other Client has agreed to participate on terms negotiated by a third party participant in the syndicate, it might have been necessary to offer better terms to the financing provider to fully subscribe the syndicate if the Other Client had not participated. It is also possible that the frequent participation of Other Clients in such syndicates could dampen interest among other potential financing providers, thereby lowering demand to participate in the syndicate and increasing the financing costs to the Company. The Adviser does not believe either of these effects is significant, but no assurance can be given to shareholders that these effects will not be significant in any circumstance. Unless required by applicable law, the Adviser will not seek any consent or approvals from shareholders or the Board of Trustees in the case of any of these conflicts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm could cause actions adverse to the Company to be taken for the benefit of Other Clients that have made an investment more senior in the capital structure of a portfolio company than the Company (e.g., provide financing to a portfolio company, the equity of which is owned by the Company) and, vice versa, actions may be taken for the benefit of the Company and its portfolio companies that are adverse to Other Clients. The Firm could seek to implement procedures to mitigate conflicts of interest in these situations such as (i) a forbearance of rights, including some or all non-economic rights, by the Company or relevant Other Client (or their respective portfolio companies, as the case may be) by, for example, agreeing to follow the vote of a third party in the same tranche of the capital structure, or otherwise deciding to recuse itself with respect to both normal course ongoing matters (such as consent rights with respect to loan modifications in intercreditor agreements) and also decisions on defaults, foreclosures, workouts, restructurings and other similar matters, (ii) causing the Company or relevant Other Client (or their respective portfolio companies, as the case may be) to hold only a non-controlling interest in any such portfolio company, (iii) retaining a third party loan servicer, administrative agent or other agent to make decisions on behalf of the Company or relevant Other Client (or their respective portfolio companies, as the case may be), or (iv) create groups of personnel within the Firm separated by information barriers (which may be temporary and limited purpose in nature), each of which would advise one of the clients that has a conflicting position with other clients. As an example, to the extent an Other Client holds an interest in a loan or security that is different (including with respect to relative seniority) than those held by the Company or its portfolio companies, the Firm can decline to exercise, or delegate to a third party, certain control, foreclosure and other similar governance rights of the Other Client. In these cases, the Firm would generally act on behalf of one of its clients, though the other client would generally retain certain control rights, such as the right to consent to certain actions taken by the trustee or administrative or other agent of the investment, including a release, waiver, forgiveness or reduction of any claim for principal or interest; extension of maturity date or due date of any payment of any principal or interest; release or substitution of any material collateral; release, waiver, termination or modification of any material provision of any guaranty or indemnity; subordination of any lien; and release, waiver or permission with respect to any covenants. The efficacy of following the vote of third-party creditors will be limited in circumstances where the Company or Other Client acquires all or substantially all of a relevant instrument, tranche or class of securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with negotiating loans and bank financings in respect of Blackstone Credit &amp; Insurance-sponsored transactions, Blackstone Credit &amp; Insurance will generally obtain the right to participate (for its own account or an Other Client) in a portion of the financings with respect to such Blackstone Credit &amp; Insurance-sponsored transactions on the same terms negotiated by third parties with the Firm or other terms the Adviser determines to be consistent with the market. Although the Firm could rely on third parties to verify market terms, the Firm may nonetheless have influence on such third parties. No assurance can be given that negotiating with a third party, or verification of market terms by a third party, will ensure that the Company and its portfolio companies receive market terms.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, it is anticipated that in a bankruptcy proceeding the Company&#8217;s interests will likely be subordinated or otherwise adverse to the interests of Other Clients with ownership positions that are more senior to those of the Company. For example, an Other Client that has provided debt financing to an investment of the Company will be permitted to take actions for its benefit, particularly if the Company&#8217;s investment is in financial distress, which adversely impact the value of the Company&#8217;s subordinated interests.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Other Clients can be expected to provide financing to the Company and its portfolio companies subject to the requirements of the 1940 Act, there can be no assurance that any Other Client will indeed provide any such financing with respect to any particular investment. Participation by Other Clients in some but not all financings of the Company and its portfolio companies has the potential to adversely impact the ability of the Company and its portfolio companies to obtain financing from third parties when Other Clients do not participate, as it could serve as a negative signal to market participants.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any financing provided by a shareholder or an affiliate to the Company or a portfolio company is not an investment in the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The respective investment programs of the Company and the Other Clients may or may not be substantially similar. Blackstone Credit &amp; Insurance and/or Blackstone may give advice to, and recommend securities for, Other Clients that may differ from advice given to, or securities recommended or bought for, the Company, even though their investment objectives may be the same as or similar to those of the Company. While Blackstone Credit &amp; Insurance will seek to manage potential conflicts of interest in a fair and equitable manner, the portfolio strategies employed by Blackstone Credit &amp; Insurance and Blackstone in managing their respective Other Clients are likely to conflict from time to time with the transactions and strategies employed by the Adviser in managing the Company and may affect the prices and availability of the securities and instruments in which the Company invests. Participation in specific investment opportunities may be appropriate, at times, for both the Company and Other Clients. In any event, it is the policy of Blackstone Credit &amp; Insurance to allocate investment opportunities and sale opportunities on a basis deemed by Blackstone Credit &amp; Insurance, in its sole discretion, to be fair and equitable over time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conflicting Fiduciary Duties to Debt Funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Other Clients include funds and accounts that make investments in senior secured loans, distressed debt, subordinated debt, high-yield securities, commercial mortgage-backed securities and other debt instruments. As discussed above, it is expected that these Other Clients or investors therein will be offered the opportunity, subject to applicable law, to provide financing with respect to investments made by the Company and its portfolio companies. The Firm owes a fiduciary duty and/or other obligations to these Other Clients as well as to the Company and will encounter conflicts in the exercise of these duties and/or obligations. For example, if an Other Client purchases high-yield securities or other debt instruments of a portfolio company of the Company, or otherwise occupies a senior (or other different) position in the capital structure of an investment relative to the Company, the Firm will encounter conflicts in providing advice to the Company and to these Other Clients with regard to appropriate terms of such high-yield securities or other instruments, the enforcement of covenants, the terms of recapitalizations and the resolution of workouts or bankruptcies, among other matters. For example, in a bankruptcy proceeding, in circumstances where the Company holds an equity investment in a portfolio company, the holders of such portfolio company&#8217;s debt instruments (which can include one or more Other Clients) could take actions for their benefit (particularly in circumstances where such portfolio company faces financial difficulties or distress) that subordinate or adversely impact the value of the Company&#8217;s investment in such portfolio company. More commonly, the Company could hold an investment that is senior in the capital structure, such as a debt instrument, to an Other Client. Although measures described in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Financing Counterparties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; above can mitigate these conflicts, they cannot completely eliminate them. These conflicts related to fiduciary duties to such Other Clients will not necessarily be resolved in favor of the Company, and investors will not always be entitled to receive notice or disclosure of the occurrence of these conflicts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, certain Other Clients can be expected to invest in securities of publicly traded companies that are actual or potential investments of the Company or its portfolio companies. The trading activities of those vehicles can differ from or be inconsistent with activities that are undertaken for the account of the Company or its portfolio companies in any such securities or related securities. In addition, the Company could not pursue an investment in a portfolio company otherwise within the investment mandate of the Company as a result of such trading activities by Other Clients. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Blackstone and Blackstone Credit &amp; Insurance Clients; Allocation of Investment Opportunities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain inherent conflicts of interest arise from the fact that the Adviser, Blackstone Credit &amp; Insurance and Blackstone provide investment management, advisory and sub-advisory services to the Company and Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance and/or Blackstone may give advice to, and recommend securities for, Other Clients that may differ from advice given to, or securities recommended or bought for, the Company, even though their investment objectives may be the same as or similar to those of the Company. Blackstone Credit &amp; Insurance has adopted guidelines and policies, which can be expected to be updated from time to time, regarding allocation of investment opportunities. While Blackstone Credit &amp; Insurance will seek to manage potential conflicts of interest in a fair and equitable manner, the portfolio strategies employed by Blackstone Credit &amp; Insurance and Blackstone in managing their respective Other Clients are likely to conflict from time to time with the transactions and strategies employed by the Adviser in managing the Company and may affect the prices and availability of the securities and instruments in which the Company invests. Participation in specific investment opportunities may be appropriate, at times, for both the Company and Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance provides investment management services to Other Blackstone Credit &amp; Insurance Clients. In addition, Blackstone provides investment management services to Blackstone Clients. Blackstone Credit &amp; Insurance will share appropriate investment opportunities (and sale opportunities) (including, without limitation, secondary market transactions and certain syndicated primary issuance transactions (which generally will not be originated investments)) with Other Clients and the Company in accordance with Firm-wide allocation policies, which generally provide for sharing pro rata based on targeted acquisition size (generally based on available capacity) or targeted sale size (or, in some sales cases, the aggregate positions held by the Company and the applicable Other Clients), taking into account actual and anticipated investments and capital commitments (as appropriate), available cash, asset-based leverage and relative capital of the Company and the applicable Other Clients and such other factors as Blackstone Credit &amp; Insurance determines in good faith to be appropriate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent an opportunity is shared with one or more Other Clients, Blackstone Credit &amp; Insurance expects that such Other Clients generally will invest on substantially the same economic terms available to the Company (including sharing of transaction fees and expenses) and generally will exit investments at the same time and on substantially the same economic terms as the Company, and on a pro rata basis with the Company subject to legal, tax, regulatory, accounting or applicable considerations (including the terms of the governing agreements of, or portfolio management considerations applicable to, the Company or such Other Clients); provided that the Company may syndicate a portion of an investment where Other Clients do not also syndicate a portion of the investment. (See also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Transactions with Clients of Blackstone Insurance Solutions and Asset Based Finance.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allocation Methodology Considerations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, Blackstone Credit &amp; Insurance may also consider the following factors in making any allocation determinations, and such factors may result in a different allocation of investment and/or sale opportunities: (i)&#160;the risk-return and target return profile of the proposed investment relative to the Company&#8217;s and the Other Clients&#8217; current risk profiles; (ii)&#160;the Company&#8217;s and/or the Other Clients&#8217; investment strategies, mandates, guidelines, limitations, restrictions, terms and objectives (including whether such objectives are considered solely in light of the specific investment under consideration or in the context of the respective portfolios&#8217; overall holdings), other contractual provisions (including Other Clients with minimum allocation provisions), focus (including investment focus on a classification attributable to an investment, such as maturity), parameters and investor preferences of the Company and the Other Clients (including, without limitation, with respect to Other Clients that expect to invest in or alongside other funds or across asset classes based on expected return (such as certain managed accounts or other investment vehicles (whether now in existence or which may be established in the future)) with similar investment strategies and objectives); (iii) diversification and concentration considerations in the Company&#8217;s or the Other Clients&#8217; portfolios (including the potential for the proposed investment to create an industry, sector, geography, region, location, market or issuer imbalance in the Company&#8217;s and Other Clients&#8217; portfolios, as applicable) and taking into account any existing non-pro rata investment positions in the portfolio of the Company and Other Clients; (iv)&#160;liquidity considerations of the Company and the relevant Other Clients (including warehouse vehicles or arrangements (such as CLO warehouses and Blackstone-controlled or third party warehouse arrangements) established for the benefit of current Other Clients or potential future Other Clients), including during a ramp-up (which includes the period prior to or after the initial closing of an Other Client during which its manager is deploying funds already invested or committed (or that its manager anticipates will be invested or committed) and can continue for a period during an Other Client&#8217;s fundraising and/or acceptance of future subscriptions as deemed appropriate by the Firm, including to protect against zero or de minimis allocations or in anticipation of future subscriptions) or wind-down of one or more of the Company or such Other Clients, proximity to the end of the Company&#8217;s or Other Clients&#8217; specified term or investment period, any redemption/withdrawal requests, anticipated future contributions and available cash; (v)&#160;legal, tax, accounting and other considerations or consequences; (vi)&#160;regulatory or contractual provisions, obligations, terms, limitations, restrictions or consequences relating to the Company or Other Clients (including, without limitation, requirements under the 1940 Act and any related rules, orders, guidance or other authority applicable to the Company or Other Clients); (vii) avoiding a de minimis or odd lot allocation; (viii)&#160;availability and degree of leverage and any requirements or other terms of the investment, or of any existing leverage facilities; (ix)&#160;the Company&#8217;s or Other Clients&#8217; investment focus on a classification attributable to an investment or issuer of an investment, including, without limitation, investment strategy, geography, location, industry or business sector; (x)&#160;the nature and extent of involvement in the transaction on the part of the respective teams of investment professionals dedicated to the Company or such Other Clients; (xi)&#160;the management of any actual or potential conflict of interest; (xii)&#160;with respect to investments that are made available to Blackstone Credit &amp; Insurance by counterparties pursuant to negotiated trading platforms (e.g., ISDA contracts), the absence of such relationships which may not be available for the Company and all Other Clients; (xiii)&#160;co-investment arrangements, (xiv)&#160;available capital of the Company and such Other Clients, (xv) sourcing of the investment, (xvi)&#160;the specific nature (including size, type, amount, liquidity, holding period, anticipated maturity and minimum investment criteria) of the investment, (xvii)&#160;expected investment return, (xviii)&#160;expected cash characteristics (such as cash-on-cash yield, distribution rates or volatility of cash flows), (xix) capital expenditure required </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as part of the investment, (xx)&#160;portfolio diversification and concentration concerns (including, but not limited to, whether a particular fund already has its desired exposure to the investment, sector, industry, geographic region or markets in question), (xxi) relation to existing investments in a fund, if applicable (e.g., &#8220;follow on&#8221; to existing investment, joint venture or other partner to existing investment, or same security as existing investment), (xxii) timing expected to be necessary to execute an investment, (xxiii) whether Blackstone Credit &amp; Insurance believes that allocating investment opportunities to an investor will help establish, recognize, strengthen and/or cultivate relationships that may provide indirectly longer-term benefits (including strategic, sourcing or similar benefits) to the Company, Other Clients and/or Blackstone and (xxiv) any other considerations deemed relevant by Blackstone Credit &amp; Insurance in good faith.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the requirements of the 1940 Act and the Company&#8217;s co-investment exemptive order, Blackstone Credit &amp; Insurance shall not have any obligation to present any investment opportunity (or portion of any investment opportunity) to the Company if Blackstone Credit &amp; Insurance determines in good faith that such opportunity (or portion thereof) should not be presented to the Company, including for any one or a combination of the reasons described above, or if Blackstone Credit &amp; Insurance is otherwise restricted from presenting such investment opportunity to the Company. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Alongside Regulated Funds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition,&#160;Blackstone Credit &amp; Insurance has received an exemptive order from the SEC that permits certain existing and future Other Blackstone Credit &amp; Insurance Clients that are closed-end management investment companies that have elected to be regulated as a BDC or are registered under the 1940 Act and who intend to rely on the exemptive order (each a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Regulated Fund&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and collectively, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Regulated Funds&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), including the Company, among other things, to co-invest with certain other persons, including certain affiliates of Blackstone Credit &amp; Insurance, and certain funds managed and controlled by Blackstone Credit &amp; Insurance and its affiliates, including the Company and Other Blackstone Credit &amp; Insurance Clients, subject to certain terms and conditions. For so long as any privately negotiated investment opportunity falls within certain established investment criteria of one or more Regulated Funds, such investment opportunity shall also be offered to such Regulated Fund(s). In the event that the aggregate targeted investment sizes of the Company, such Other Blackstone Credit &amp; Insurance Clients and such Regulated Fund(s) that are allocated an investment opportunity exceed the amount of such investment opportunity, allocation of such investment opportunity to each of the Company, such Other Blackstone Credit &amp; Insurance Clients and Regulated Fund(s) will be reduced proportionately based on their respective &#8220;available capital&#8221; as defined in the co-investment exemptive order, which may result in allocation to the Company in an amount less than what it would otherwise have been if such Other Blackstone Credit &amp; Insurance Client(s) and Regulated Fund(s) did not participate in such investment opportunity. The co-investment exemptive order also restricts the ability of the Company (or any such Other Blackstone Credit &amp; Insurance Client) from investing in any privately negotiated investment opportunity alongside a Regulated Fund except at the same time and on same terms, as described in the exemptive order. As a result, the Company risks being unable to make investments in different parts of the capital structure of the same issuer in which a Regulated Fund has invested or seeks to invest, and Regulated Funds risk being unable to make investments in different parts of the capital structure of the same issuer in which the Company has invested or seeks to invest. The Company may be unable to participate in or effect certain transactions, or take certain actions in respect of certain investments, on account of applicable restrictions under the 1940 Act, related guidance from the SEC and/or the Company&#8217;s exemptive order.&#160;For example, the Company may be restricted from participating in certain transactions or taking certain actions in respect of portfolio companies in which certain funds managed and controlled by Blackstone Credit &amp; Insurance and its affiliates and/or a Regulated Fund has also invested, which may include, but is not limited to declining to vote, participating in a potential co-investment opportunity (as such participation may not comply with the conditions of the co-investment exemptive order), exercising rights with respect to any such investment, and/or declining to participate in follow-on investments. The Company may also be required to sell an investment to avoid potential violations of the 1940 Act and/or related rules thereunder or for other reasons. In such cases, the Company&#8217;s interests in an investment may be adversely affected, including by resulting in the dilution of or decrease in the value of the Company&#8217;s investment, or otherwise by resulting in the Company being put in a disadvantageous position with respect to the investment as compared to Other Blackstone Credit &amp; Insurance Clients, including other Regulated Funds. Whether the Company participates or declines to participate in any such action or transaction will be made by the Adviser in its sole discretion and will take into account the Adviser&#8217;s fiduciary duties and applicable law, including the 1940 Act, the rules thereunder and/or the exemptive order. There is no assurance that any such determination will be resolved in favor of the Company&#8217;s interests. The rules promulgated by the SEC under the 1940 Act, as well as any related guidance from the SEC and/or the terms of the exemptive order itself, are subject to change, and Blackstone Credit &amp; Insurance could undertake to amend the exemptive order (subject to SEC approval), obtain additional exemptive relief, or otherwise be subject to other requirements in respect of co-investments involving the Company, any Other Blackstone Credit &amp; Insurance Client and any Regulated Funds, any of which could impact the amount of any allocation made available to Regulated Funds and thereby affect (and potentially decrease) the allocation made to the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, with respect to Blackstone Credit &amp; Insurance&#8217;s ability to allocate investment opportunities, including where such opportunities are within the common objectives and guidelines of the Company and one or more Other Clients (which allocations are to be made on a basis that Blackstone Credit &amp; Insurance believes in good faith to be fair and reasonable), Blackstone Credit &amp; Insurance and Blackstone have established general guidelines and policies, which it can be expected to update from time to time, for determining how such allocations are to be made, which, among other things, set forth principles regarding what constitutes &#8220;debt&#8221; or &#8220;debt-like&#8221; investments, criteria for defining &#8220;control-oriented equity&#8221; or &#8220;infrastructure&#8221; investments, guidance regarding allocation for certain types of investments (e.g., distressed assets) and other matters. In addition, certain Other Clients can receive certain priority or other allocation rights with respect to certain investments, subject to various conditions set forth in such Other Clients&#8217; respective governing agreements. The application of those guidelines and conditions could result in the Company or Other Clients not participating (and/or not participating to the same extent) in certain investment opportunities in which they would have otherwise participated had the related allocations been determined without regard to such guidelines and conditions and based only on the circumstances of those particular investments. Additionally, investment opportunities sourced by Blackstone Credit &amp; Insurance will be allocated in accordance with Blackstone&#8217;s and Blackstone Credit &amp; Insurance&#8217;s allocation policies, which provide that investment opportunities will be allocated in whole or in part to other business units of the Firm on a basis that Blackstone and Blackstone Credit &amp; Insurance believe in good faith to be fair and reasonable, based on various factors, including the involvement of the respective teams from Blackstone Credit &amp; Insurance and such other business units. It should also be noted that investment opportunities sourced by business units of the Firm other than Blackstone Credit &amp; Insurance will be allocated in accordance with such business units&#8217; allocation policies, which will result in such investment opportunities being allocated, in whole or in part, away from Blackstone Credit &amp; Insurance, the Company and Other Blackstone Credit &amp; Insurance Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Blackstone Credit &amp; Insurance determines not to pursue some or all of an investment opportunity for the Company that would otherwise be within the Company&#8217;s objectives and strategies, and Blackstone or Blackstone Credit &amp; Insurance provides the opportunity or offers the opportunity to Other Clients (or other parties, including portfolio companies), Blackstone or Blackstone Credit &amp; Insurance, including their personnel (including Blackstone Credit &amp; Insurance personnel), will, in certain circumstances, receive compensation from the Other Clients and/or other parties, whether or not in respect of a particular investment, including an allocation of carried interest or referral fees, and any such compensation could be greater than amounts paid by the Company to Blackstone Credit &amp; Insurance. As a result, Blackstone Credit &amp; Insurance (including Blackstone Credit &amp; Insurance personnel who receive such compensation) could be incentivized to allocate investment opportunities away from the Company to or source investment opportunities for Other Clients and/or other parties. In addition, in some cases Blackstone or Blackstone Credit &amp; Insurance can be expected to earn greater fees when Other Clients participate alongside or instead of the Company in an investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance makes good faith determinations for allocation decisions based on expectations that will, in certain circumstances, prove inaccurate. Information unavailable to Blackstone Credit &amp; Insurance, or circumstances not foreseen by Blackstone Credit &amp; Insurance at the time of allocation, can cause an investment opportunity to yield a different return than expected. Conversely, an investment that Blackstone Credit &amp; Insurance expects to be consistent with the Company&#8217;s return objectives will, in certain circumstances, fail to achieve them.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser is permitted, but will be under no obligation to, provide co-investment opportunities relating to investments made by the Company to Fund shareholders, Other Clients, investors in such Other Clients, subject to the Company&#8217;s exemptive relief and the 1940 Act. Such co-investment opportunities may be offered to such parties in the Adviser&#8217;s discretion subject to the Company&#8217;s exemptive relief. From time to time, Blackstone Credit &amp; Insurance may form one or more funds or accounts to co-invest in transactions with the Company (or transactions alongside any of the Company and one or more Other Clients). Furthermore, for the avoidance of doubt, to the extent that the Company has received its target amount in respect of an investment opportunity, any remaining portion of such investment opportunity initially allocated to the Company may be allocated to Other Clients or to co-investors in Blackstone Credit &amp; Insurance&#8217;s discretion pursuant to the Company&#8217;s exemptive relief.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Orders may be combined for the Company and other participating Other Clients, and if any order is not filled at the same price, they may be allocated on an average price basis. Similarly, if an order on behalf of more than one account cannot be fully executed under prevailing market conditions, securities may be allocated among the different accounts on a basis that Blackstone Credit &amp; Insurance or its affiliates consider equitable.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, it can be expected that the Firm will, from time to time, enter into arrangements or strategic relationships with third parties, including other asset managers, financial firms or other businesses or companies, that, among other things, provide for referral, sourcing or sharing of investment opportunities. Blackstone or Blackstone Credit &amp; Insurance may pay management fees and performance-based compensation in connection with such arrangements. Blackstone or Blackstone Credit &amp; Insurance may also provide for or receive reimbursement of certain expenses incurred or received in connection with these arrangements, including diligence expenses and general overhead, administrative, deal sourcing and related corporate expenses. The amount of these rebates may relate to allocations of co-investment opportunities and increase if certain co-investment allocations are not made. While it is possible that the Company will, along with the Firm itself, benefit from the existence of those arrangements and/or relationships, it is also possible that investment opportunities that would otherwise be presented to or made by the Company would instead be referred (in whole or in part) to such third party, or, as indicated above, to other third parties, either as a contractual obligation or otherwise, resulting in fewer opportunities (or reduced allocations) being made available to the Company and/or shareholders. This means that co-investment opportunities that are sourced by the Company may be allocated to investors that are not shareholders. For example, a firm with which the Firm has entered into a strategic relationship may be afforded with &#8220;first-call&#8221; rights on a particular category of investment opportunities, although there is not expected to be substantial overlap in the investment strategies and/or objectives between the Company and any such firm. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Investments Inside the Company&#8217;s Mandate that are not Pursued by the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under certain circumstances, Blackstone or Blackstone Credit &amp; Insurance can be expected to determine not to pursue some or all of an investment opportunity within the Company&#8217;s mandate, including without limitation, as a result of business, reputational or other reasons applicable to the Company, Other Clients, their respective portfolio companies or Blackstone. In addition, Blackstone Credit &amp; Insurance will, in certain circumstances, determine that the Company should not pursue some or all of an investment opportunity, including, by way of example and without limitation, because the Company has already invested sufficient capital in the investment, sector, industry, geographic region or markets in question, as determined by Blackstone Credit &amp; Insurance in its good faith discretion, or the investment is not appropriate for the Company for other reasons as determined by Blackstone Credit &amp; Insurance in its good faith reasonable sole discretion. In any such case Blackstone or Blackstone Credit &amp; Insurance could, thereafter, offer such opportunity to other parties, including Other Clients or portfolio companies or limited partners or shareholders of the Company or Other Clients, joint venture partners, related parties or third parties. Any such Other Clients could be advised by a different Blackstone or Blackstone Credit &amp; Insurance business group with a different investment committee, which could determine an investment opportunity to be more attractive than Blackstone Credit &amp; Insurance believes to be the case. In any event, there can be no assurance that Blackstone Credit &amp; Insurance&#8217;s assessment will prove correct or that the performance of any investments actually pursued by the Company will be comparable to any investment opportunities that are not pursued by the Company. Blackstone and Blackstone Credit &amp; Insurance, including their personnel, are permitted to receive compensation from any such party that makes the investment, including an allocation of carried interest or referral fees, and any such compensation could be greater than amounts paid by the Company to Blackstone Credit &amp; Insurance. In some cases, Blackstone or Blackstone Credit &amp; Insurance earns greater fees when Other Clients participate alongside or instead of the Company in an investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Situations can arise where certain assets held by the Company are transferred to Other Clients and vice versa. Such transactions will be conducted in accordance with, and subject to, the Adviser&#8217;s contractual obligations to the Company and applicable law, including the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Co-Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will co-invest with its shareholders, limited partners and/or shareholders of the Other Clients, the Firm&#8217;s affiliates and other parties with whom Blackstone Credit &amp; Insurance has a material relationship. The allocation of co-investment opportunities is entirely and solely in the discretion of Blackstone Credit &amp; Insurance, subject to applicable law. In addition to participation by Consultants in specific transactions or investment opportunities, Consultants and/or other Firm employees may be permitted to participate in the Firm&#8217;s side-by-side co-investment rights. Such rights generally do not provide for an advisory fee or carried interest payable by participants therein and generally result in the Company being allocated a smaller share of an investment than would otherwise be the case in the absence of such side-by-side. Furthermore, Other Clients will be permitted (or have a preferred right) to participate in the Firm&#8217;s side-by-side co-investment rights.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain circumstances, Blackstone Credit &amp; Insurance will determine that a co-investment opportunity should be offered to one or more third parties (such investors, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Co-Investors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and will maintain sole discretion with respect to which Co-Investors are offered any such opportunity. It is expected that many investors who will, in certain circumstances, have expressed an interest in co-investment opportunities will not be allocated any co-investment opportunities or will, in certain circumstances, receive a smaller amount of co-investment opportunities than the amount requested. Any co-investments offered by Blackstone Credit &amp; Insurance will be on such terms and conditions (including with respect to advisory fees, performance-based compensation and related arrangements and/or other fees applicable to co-investors) as Blackstone Credit &amp; Insurance determines to be appropriate in its sole discretion on a case-by-case basis, which may differ amongst co-investors with respect to the same co-investment. In addition, the performance of Other Clients co-investing with the Company is not considered for purposes of calculating the incentive fee payable by the Company to the Adviser. Furthermore, the Company and co-investors will often have different investment objectives and limitations, such as return objectives and maximum hold period. Blackstone Credit &amp; Insurance, as a result, will have conflicting incentives in making decisions with respect to such opportunities. Even if the Company and any such parties invest in the same securities on similar terms, conflicts of interest will still arise as a result of differing investment profiles of the investors, among other items.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">General Co-Investment Considerations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There are expected to be circumstances where an amount that would otherwise have been invested by the Company is instead allocated to co-investors (who could be shareholders of the Company or limited partners of Other Clients) or supplemental capital vehicles, and there is no guarantee that any shareholders will be offered any particular co-investment opportunity. Each co-investment opportunity (should any exist) is likely to be different, and allocation of each such opportunity will depend on the facts and circumstances specific to that unique situation (e.g., timing, industry, size, geography, asset class, projected holding period, exit strategy and counterparty). Different situations will require that the various facts and circumstances of each opportunity be weighted differently, as Blackstone Credit &amp; Insurance deems relevant to such opportunity. Such factors are likely to include, among others, whether a co-investor adds strategic value, industry expertise or other similar synergies; whether a potential co-investor has expressed an interest in evaluating co-investment opportunities; whether a potential co-investor has an overall strategic relationship with the Firm; whether a potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of Blackstone, Blackstone Credit &amp; Insurance, the Company, Other Clients or other co-investments (including whether a potential co-investor will help establish, recognize, strengthen and/or cultivate relationships that can provide indirectly longer-term benefits to the Company or Other Clients and their respective underlying portfolio companies, or whether the potential co-investor has significant capital under management by the Firm or intends to increase such amount); the ability of a potential co-investor to commit to a co-investment opportunity within the required timeframe of the particular transaction; Blackstone Credit &amp; Insurance&#8217;s assessment of a potential co-investor&#8217;s ability to invest an amount of capital that fits the needs of the investment (taking into account the amount of capital needed as well as the maximum number of investors that can realistically participate in the transaction); whether the co-investor is considered &#8220;strategic&#8221; to the investment because it is able to offer the Company certain benefits, including but not limited to, the ability to help consummate the investment, the ability to aid in operating or monitoring the portfolio company or the possession of certain expertise; the transparency, speed and predictability of the potential co-investor&#8217;s investment process; whether the Firm has previously expressed a general intention to seek to offer co-investment opportunities to such potential co-investor; whether a potential co-investor has the financial and operational resources and other relevant wherewithal to evaluate and participate in a co-investment opportunity; the familiarity the Firm has with the personnel and professionals of the investor in working together in investment contexts (which may include such potential co-investor&#8217;s history of investment in other Firm co-investment opportunities); the extent to which a potential co-investor has committed to an Other Client; the size of such potential co-investor&#8217;s interest to be held in the underlying portfolio company as a result of the Company&#8217;s investment (which is likely to be based on the size of the potential co-investor&#8217;s capital commitment or investment in the Company); the extent to which a potential co-investor has been provided a greater amount of co-investment opportunities relative to others; the ability of a potential co-investor to invest in potential add-on acquisitions for the portfolio company or participate in defensive investments; the likelihood that the potential co-investor would require governance rights that would complicate or jeopardize the transaction (or, alternatively, whether the investor would be willing to defer to the Firm and assume a more passive role in governing the portfolio company); any interests a potential co-investor might have in any competitors of the underlying portfolio company; the tax profile of the potential co-investor and the tax characteristics of the investment (including whether the potential co-investor would require particular structuring implementation or covenants that would not otherwise be required but for its participation or whether such co-investor&#8217;s participation is beneficial to the overall structuring of the investment); whether a potential co-investor&#8217;s participation in the transaction would subject the Company and/or the portfolio company to additional regulatory requirements, review and/or scrutiny, including any necessary governmental approvals required to consummate the investment; the potential co-investor&#8217;s interaction with the potential management team of the </span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">portfolio company; whether the potential co-investor has any existing positions in the portfolio company (whether in the same security in which the Company is investing or otherwise); whether there is any evidence to suggest that there is a heightened risk with respect to the potential co-investor maintaining confidentiality; whether the potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of the Company, other affiliated funds and/or other co-investments, including the size of such commitment; whether the potential co-investor has any known investment policies and restrictions, guideline limitations or investment objectives that are relevant to the transaction, including the need for distributions; whether the expected holding period and risk-return profile of the investment is consistent with the stated goals of the investor; and such other factors as the Adviser deems relevant and believes to be appropriate under the circumstances. Furthermore, in connection with any such co-investment by third-party co-investors, the Adviser can establish one or more investment vehicles managed or advised by the Firm to facilitate such co-investors&#8217; investment alongside the Company. The factors listed in the foregoing sentence are neither presented in order of importance nor weighted, except that Blackstone Credit &amp; Insurance has historically primarily relied upon the following two factors in making the determination to offer co-investment opportunities to co-investors: (i) whether the potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of the Company (including whether a potential co-investor will help establish, recognize, strengthen and/or cultivate relationships that can provide indirectly longer-term benefits to the Company or Other Clients and their respective underlying portfolio companies), other affiliated funds, and/or other co-investments, including the size of any such commitment and fee revenue or profits generated for the benefit of Blackstone Credit &amp; Insurance or Blackstone as a result thereof and (ii) the ability of a potential co-investor to process a co-investment decision within the required timeline of the particular transaction. Except as otherwise described herein, co-investors generally will not share Broken Deal Expenses with the Company and Other Clients, with the result that the Company and such Other Clients will bear all such Broken Deal Expenses, and such expenses can be significant. However, the Adviser does not intend to offer any such co-investment opportunities to shareholders in their capacity as shareholders. Blackstone Credit &amp; Insurance may (but is not required to) establish co-investment vehicles (including dedicated or &#8220;standing&#8221; co-investment vehicles) for one or more investors (including third party investors and investors in the Company) in order to co-invest alongside the Company in one or more future investments. The existence of these vehicles could reduce the opportunity for other shareholders to receive allocations of co-investment. In addition, the allocation of investments to Other Clients, including as described under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Other Blackstone and Blackstone Credit &amp; Insurance Clients; Allocation of Investment Opportunities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein, may result in fewer co-investment opportunities (or reduced allocations) being made available to shareholders.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Additional Potential Conflicts of Interest with respect to Co-Investment; Strategic Relationships Involving Co-Investment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition, the Adviser and/or its affiliates will in certain circumstances be incentivized to offer certain potential co-investors (including, by way of example, as a part of an overall strategic relationship with the Firm) opportunities to co-invest because the extent to which any such co-investor participates in (or is offered) co-investment opportunities can impact the amount of performance-based compensation and/or management fees or other fees paid by the co-investor. The amount of carried interest or expenses charged and/or management fees paid by the Company may be less than or exceed such amounts charged or paid by co-investment vehicles pursuant to the terms of such vehicles&#8217; partnership agreements and/or other agreements with co-investors, and such variation in the amount of fees and expenses may create an economic incentive for Blackstone Credit &amp; Insurance to allocate a greater or lesser percentage of an investment opportunity to the Company or such co-investment vehicles or co-investors, as the case may be. In addition, other terms of existing and future co-investment vehicles may differ materially, and in some instances may be more favorable to Blackstone Credit &amp; Insurance, than the terms of the Company, and such different terms may create an incentive for Blackstone Credit &amp; Insurance to manage such vehicles, which could result in the Company receiving a lesser percentage of an investment opportunity than if such co-investment vehicles did not exist. Such relationships will from time to time give rise to conflicts of interest, and there can be no assurance that such conflicts of interest will be resolved in favor of the Company. Accordingly, any investment opportunities that would have otherwise been offered or allocated, in whole or in part, to the Company can be reduced and made available to co-investment vehicles. Co-investments may be offered by the Adviser on such terms and conditions as the Adviser determines in its discretion on a case-by-case basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fund Co-Investment Opportunities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a BDC regulated under the 1940 Act, the Company is subject to certain limitations relating to co-investments and joint transactions with affiliates, which likely will in certain circumstances limit the Company&#8217;s ability to make investments or enter into other transactions alongside the Other Clients. There can be no assurance that such regulatory restrictions will not adversely affect the Company&#8217;s ability to capitalize on attractive investment opportunities. However, subject to the 1940 Act and any applicable co-investment exemptive order issued by the SEC, the Company may co-invest with Other Clients (including co-investment or other vehicles in which the Firm or its personnel invest and that co-invest with such Other Clients) in investments that are suitable for the Company and one or more of such Other Clients. Even if the Company and any such Other Clients and/or co-investment or other vehicles invest in the same securities, conflicts of interest may still arise.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions. Such order may restrict our ability to enter into follow-on investments or other transactions. Pursuant to such order, we may co-invest in a negotiated deal with certain affiliates of the Adviser or certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions. We may also receive an allocation in such a deal alongside affiliates pursuant to other mechanisms to the extent permitted by the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Portfolio Companies Alongside Other Clients. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company will co-invest with Other Clients (including co-investment or other vehicles in which the Firm or its personnel invest and that co-invest with such Other Clients) in investments that are suitable for both the Company and such Other Clients, as permitted by applicable law and/or any applicable SEC-granted order. Even if the Company and any such Other Clients invest in the same securities or loans, conflicts of interest are still expected to arise. For example, it is possible that as a result of legal, tax, regulatory, accounting, political, national security or other considerations, the terms of such investment (and divestment thereof) (including with respect to price and timing) for the Company and such other funds and vehicles are not the same. Additionally, the Company and such Other Clients and/or vehicles will generally have different investment periods and/or investment objectives (including return profiles) and Blackstone Credit &amp; Insurance, as a result, could have conflicting goals with respect to the amount, price and timing of disposition opportunities. As such, subject to applicable law and any applicable order issued by the SEC, the Company and/or such Other Clients may dispose of any such shared investment at different times and on different terms.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Firm Involvement in Financing of Third Party Dispositions by the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company is permitted from time to time dispose of all or a portion of an investment by way of accepting a third-party purchaser&#8217;s bid where the Firm or one or more Other Clients is providing financing as part of such bid or acquisition of the investment or underlying assets thereof. This generally would include the circumstance where the Firm or one or more Other Clients is making commitments to provide financing at or prior to the time such third-party purchaser commits to purchase such investments or assets from the Company. Such involvement of the Firm or one or more Other Clients as such a provider of debt financing in connection with the potential acquisition of portfolio investments by third parties from the Company may give rise to potential or actual conflicts of interest.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Self-Administration of the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance expects to provide certain fund administration services to the Company rather than engage or rely on a third party administrator to perform such services. The costs for providing these services are not included in the management fee under the Investment Advisory Agreement and will be paid separately by the Company. Blackstone Credit &amp; Insurance also reserves the right to charge the Company a reduced rate for these services, or to reduce or waive such charges entirely, subject to the 1940 Act. Blackstone Credit &amp; Insurance&#8217;s ability to determine the reimbursement obligation from the Company creates a conflict of interest. Blackstone Credit &amp; Insurance addresses this conflict by reviewing its fund administration costs to ensure that it is comparable and fair with regard to equivalent services performed by a non-affiliated third party at a rate negotiated on an arm&#8217;s length basis. The Board of Trustees periodically reviews the reimbursement obligation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Outsourcing. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the oversight and, in certain circumstances, approval by the Board of Trustees of the Company, Blackstone may outsource to third parties several of the services performed for the Company and/or its portfolio entities, including services (such as administrative, legal, accounting, tax, diligence, modeling, ongoing monitoring, preparation of internal templates and/or memos or other related services) that may be or historically have been performed in-house by Blackstone and its personnel. For certain third-party service providers, the fees, costs and expenses of such service providers will be borne by the Company, and in other circumstances, the fees, costs and expenses of such service providers will be borne by Blackstone. Certain third-party service providers and/or their employees will dedicate substantially all of their business time to the Company, Other Clients and/or their respective portfolio entities, while others will have other clients. In certain cases, third-party service providers and/or their employees may spend a significant amount of time at Blackstone offices, have dedicated office space at Blackstone, receive administrative support from Blackstone personnel or participate in meetings and events for Blackstone personnel, even though they are not Blackstone employees or affiliates. This creates a conflict of interest because Blackstone will have an incentive to outsource services to third parties due to a number of factors, including because retaining third parties will reduce Blackstone&#8217;s internal overhead and compensation costs for employees who would otherwise perform such services in-house.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The involvement of third-party service providers may present a number of risks due to Blackstone&#8217;s reduced control over the functions that are outsourced. There can be no assurances that Blackstone will be able to identify, prevent or mitigate the risks of engaging third-party service providers. The Company may suffer adverse consequences from actions, errors or failures to act by such third parties, and will have obligations, including indemnity obligations, and limited recourse against them. Outsourcing may not occur uniformly for all Blackstone managed vehicles and accounts and, accordingly, certain costs may be incurred by (or allocated to) the Company through the use of third-party service providers that are not incurred by (or allocated to) Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material, Non-Public Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance will come into possession of confidential information with respect to an issuer and other actual or prospective portfolio companies. Blackstone Credit &amp; Insurance can be restricted from buying, originating or selling securities, loans, or derivatives on behalf of the Company until such time as the information becomes public or is no longer deemed material such that it would preclude the Company from participating in an investment. Disclosure of such information to the Adviser&#8217;s personnel responsible for the affairs of the Company will be on a need-to-know basis only, and the Company might not be free to act upon any such information. Therefore, the Company will not always have access to confidential information in the possession of Blackstone Credit &amp; Insurance that might be relevant to an investment decision to be made for the Company. In addition, Blackstone Credit &amp; Insurance, in an effort to avoid buying or selling restrictions on behalf of the Company or Other Clients, can choose to forego an opportunity to receive (or elect not to receive) information that other market participants or counterparties, including those with the same positions in the issuer as the Company, are eligible to receive or have received, even if possession of such information would otherwise be advantageous to the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Break-up and other Similar Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Break-up or topping fees with respect to the Company&#8217;s investments can be paid to Blackstone Credit &amp; Insurance. Alternatively, the Company could receive the break-up or topping fees directly. Break-up or topping fees paid to Blackstone Credit &amp; Insurance or the Company in connection with a transaction could be allocated, or not, to Other Clients or co-investment vehicles that invest (or are expected to invest) alongside the Company, as determined by Blackstone Credit &amp; Insurance to be appropriate in the circumstances. Generally, Blackstone Credit &amp; Insurance would not allocate break-up or topping fees with respect to a potential investment to the Company, an Other Client or co-investment vehicle unless such person would also share in Broken Deal Expenses related to the potential investment. With respect to fees received by Blackstone Credit &amp; Insurance relating to the Company&#8217;s investments or from unconsummated transactions, shareholders will not receive the benefit of any fees relating to the Company&#8217;s investments (including, without limitation, as described above). In the case of fees for services as a director of a portfolio company, the management fee will not be reduced to the extent any Firm personnel continues to serve as a director after the Company has exited (or is in the process of exiting) the applicable portfolio company and/or following the termination of such employee&#8217;s employment with the Firm. For the avoidance of doubt, although the financial advisory and restructuring business of Blackstone has been spun out, to the extent any investment banking fees, consulting (including management consulting) fees, syndication fees, capital markets syndication and advisory fees (including underwriting fees), origination fees, servicing fees, healthcare consulting / brokerage fees, fees relating to group purchasing, financial advisory fees and similar fees for arranging acquisitions and other major financial restructurings, loan servicing and/or other types of insurance fees, operations fees, financing fees, fees for asset services, title insurance fees, and other similar fees and annual retainers (whether in cash or in kind) are received by Blackstone, such fees will not be required to be shared with the Company or the shareholders and will not reduce the management fee payable by the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Broken Deal Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any expenses that may be incurred by the Company for actual investments as described herein may also be incurred by the Company with respect to broken deals (i.e., investments that are not consummated) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Broken Deal Expenses&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Unless required by law or regulation, Blackstone Credit &amp; Insurance is not required to and, in most circumstances, will not seek reimbursement of Broken Deal Expenses (i.e., expenses incurred in pursuit of an investment that is not consummated) from third parties, including counterparties to the potential transaction or potential co-investors. Examples of such Broken Deal Expenses include, but are not limited to, reverse termination fees, extraordinary expenses such as litigation costs and judgments, meal, travel and entertainment expenses incurred, deposits or down payments which are forfeited in connection with unconsummated transactions, costs from onboarding (i.e., KYC) investment entities with a financial institution, commitment fees that become payable in connection with a proposed investment, consulting fees and expenses (including all expenses incurred in connection with any tax audit or investigation settlement), printing and publishing expenses, costs of negotiating co-investment documentation (including non-disclosure agreements with counterparties), and legal, accounting, tax and other due diligence and pursuit costs and expenses and broken deal expenses associated with services provided by portfolio companies, which may include expenses incurred prior to the commencement of the Company&#8217;s investment activities. Any such Broken Deal Expenses could, in the sole discretion of Blackstone Credit &amp; Insurance, be allocated solely to the Company and not to Other Clients or co-investment vehicles that could have made the investment, even when the Other Client or co-investment vehicle commonly invests alongside the Company in its investments or the Firm or Other Clients in their investments. In such cases, the Company&#8217;s shares of expenses would increase. The Adviser expects that until a potential investment of the Company is formally allocated to an Other Client (it being understood that final allocation decisions are typically made shortly prior to closing an investment), the Company is expected to bear the broken deal expenses for such investment, which may result in substantial amounts of broken deal expenses. In the event Broken Deal Expenses are allocated to an Other Client or a co-investment vehicle, Blackstone Credit &amp; Insurance or the Company will, in certain circumstances, advance such fees and expenses without charging interest until paid by the Other Client or co-investment vehicle, as applicable. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Firm Business Activities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm, Other Clients, their portfolio companies, and personnel and related parties of the foregoing will receive fees and compensation, including performance-based and other incentive fees, for products and services provided to the Company and its portfolio companies, such as fees for asset management (including, without limitation, management fees and carried interest/incentive arrangements), development and property management; portfolio operations support (such as those provided by Blackstone&#8217;s Portfolio Operations Group); arranging, underwriting (including without limitation, evaluation regarding value creation opportunities and ESG risk mitigation); syndication or refinancing of a loan or investment (or other additional fees, including acquisition fees, loan modification or restructuring fees); servicing; loan servicing; special servicing; administrative services; advisory services on purchase or sale of an asset or company; investment banking and capital markets services; placement agent services; fund administration; internal legal and tax planning services; information technology products and services; insurance procurement; brokerage; solutions and risk management services; data extraction and management products and services; fees for monitoring and oversight of loans or title insurance provided to portfolio companies or third parties; and other products and services. For example, the Firm or Other Clients may, directly or indirectly through a portfolio entity, from time to time acquire loans or other assets for the purpose of syndicating some or all the assets to the Company and/or Other Clients, and may receive syndication or other fees in connection therewith. Such parties will also provide products and services for fees to the Firm, Other Clients and their portfolio companies, and their personnel and related parties, as well as third parties. Through its innovations group, Blackstone incubates (or otherwise invests in) businesses that are expected to provide goods and services to the Company (subject to the requirements of the 1940 Act and applicable guidance) and Other Clients and their portfolio companies, as well as other Firm-related parties and third parties. By contracting for a product or service from a business related to the Firm, the Company and its portfolio companies would provide not only current income to the business and its stakeholders, but could also create significant enterprise value in them, which would not be shared with the Company or shareholders and could benefit the Firm directly and indirectly. Also, the Firm, Other Clients and their portfolio companies, and their personnel and related parties may receive compensation or other benefits, such as through additional ownership interests or otherwise, directly related to the consumption of products and services by the Company and its portfolio companies. The Company and its portfolio companies will incur expenses in negotiating for any such fees and services, which will be treated as Fund Expenses. In addition, the Firm may receive fees associated with capital invested by co-investors relating to investments in which the Company participates or otherwise, in connection with a joint venture in which the Company participates (subject to the 1940 Act) or otherwise with respect to assets or other interests retained by a seller or other commercial counterparty with respect to which the Firm performs services. Finally, the Firm and its personnel and related parties will, in certain circumstances, also receive compensation in connection with origination activities, referrals and other related activities of such business, and unconsummated transactions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will, as determined by Blackstone Credit &amp; Insurance and as permitted by the governing fund documents, bear the cost of fund administration, compliance and accounting (including, without limitation, maintaining financial records, filing of the Company&#8217;s tax returns, overseeing the calculation of the Company&#8217;s net asset value, compliance monitoring (including diligence and oversight of the Company&#8217;s other service providers), preparing reports to the Company&#8217;s shareholders and reports filed with the SEC and other regulators, preparing materials and coordinating meetings of the Board, managing the payment of expenses, the payment and receipt of funds for investments and the performance of administrative and professional services rendered by others, providing office space, equipment and office services), in house legal, tax planning and other related services provided by Firm personnel and related parties to the Company and its portfolio companies, including the allocation of their compensation and related overhead otherwise payable by the Firm, or pay for their services at market rates, as discussed above in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Self-Administration of the Company.&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such allocations or charges can be based on any of the following methodologies: (i) requiring personnel to periodically record or allocate their historical time spent with respect to the Company or the Firm approximating the proportion of certain personnel&#8217;s time spent with respect to the Company, and in each case allocating their compensation (including, without limitation, salary, bonus and benefits) and allocable overhead based on time spent, or charging their time spent at market rates, (ii) the assessment of an overall dollar amount (based on a fixed fee or percentage of assets under management) that the Firm believes represents a fair recoupment of expenses and a market rate for such services or (iii) any other similar methodology determined by the Firm to be appropriate under the circumstances. Certain Firm personnel will provide services to few, or only one, of the Company and Other Clients, in which case the Firm could rely upon rough approximations of time spent by the employee for purposes of allocating the salary and overhead of the person if the market rate for services is clearly higher than allocable salary and overhead. However, any methodology (including the choice thereof) involves inherent conflicts and may result in incurrence of greater expenses by the Company and its portfolio companies than would be the case if such services were provided by third parties.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance, Other Clients and their portfolio companies, and their affiliates, personnel and related parties could continue to receive fees, including performance-based or incentive fees, for the services described in the preceding paragraphs with respect to investments sold by the Company or a portfolio company to a third party buyer after the sale is consummated. Such post-disposition involvement will give rise to potential or actual conflicts of interest, particularly in the sale process. Moreover, Blackstone Credit &amp; Insurance, Other Clients and their portfolio companies, and their affiliates, personnel and related parties could acquire a stake in the relevant asset as part of the overall service relationship, at the time of the sale or thereafter.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance does not have any obligation to ensure that fees for products and services contracted by the Company or its portfolio companies are at market rates unless the counterparty is considered an affiliate of the Firm and given the breadth of the Firm&#8217;s investments and activities Blackstone Credit &amp; Insurance may not be aware of every commercial arrangement between the Company and its portfolio companies, on the one hand, and the Firm, Other Clients and their portfolio companies, and personnel and related parties of the foregoing, on the other hand.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as set forth above, the Company and shareholders will not receive the benefit (e.g., through a reduction to the management fee or otherwise) of any fees or other compensation or benefit received by Blackstone Credit &amp; Insurance, its affiliates or their personnel and related parties. (See also </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Service Providers, Vendors and Other Counterparties Generally&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Other Firm Business Activities.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities and Lending Activities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone, its affiliates and their related parties and personnel will from time to time participate in underwriting or lending syndicates with respect to current or potential portfolio companies, or will otherwise act as arrangers of financing, including with respect to the public offering and/or private placement of debt or equity securities issued by, or loan proceeds borrowed by the Company and its portfolio companies, or otherwise in arranging financing (including loans) for such portfolio companies or advise on such transactions. Such underwritings or engagements can be on a firm commitment basis or can be on an uncommitted &#8220;best efforts&#8221; basis, and the underwriting or financing parties are under no duty to provide any commitment unless specifically set forth in the relevant contract. Blackstone may also provide placement or other similar services to purchasers or sellers of securities, including loans or instruments issued by portfolio companies. There could also be circumstances in which the Company commits to purchase any portion of such issuance from the portfolio company that a Blackstone broker-dealer intends to syndicate to third parties. As a result thereof, subject to the limitations of the 1940 Act, Blackstone may be permitted to receive commissions or other compensation, thereby creating a potential conflict of interest. This could include, by way of example, fees and/ or commissions for equity syndications to co-investment vehicles. In certain cases, subject to the limitations of the 1940 Act, a Blackstone broker-dealer will, from time to time, act as the managing underwriter, or a member of the underwriting syndicate or broker for the Company or its portfolio companies, or as dealer, broker or advisor to a counterparty to the Company or a portfolio company, and purchase securities from or sell securities to the Company, Other Clients or portfolio companies of the Company or Other Clients or advise on such </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transactions. Blackstone will also from time to time, on behalf of the Company or other parties to a transaction involving the Company or its portfolio companies, effect transactions, including transactions in the secondary markets that result in commissions or other compensation paid to Blackstone by the Company or its portfolio companies or the counterparty to the transaction, thereby creating a potential conflict of interest. This could include, by way of example, fees and/or commissions for equity syndications to co-investment vehicles. Subject to applicable law, Blackstone will from time to time receive underwriting fees, discounts, placement commissions, loan modification or restructuring fees, servicing fees, capital markets advisory fees, lending arrangement fees, asset/property management fees, insurance (including title insurance) incentive fees and consulting fees, monitoring fees, commitment fees, syndication fees, origination fees, organizational fees, operational fees, loan servicing fees, and financing and divestment fees (or, in each case, rebates in lieu of any such fees, whether in the form of purchase price discounts or otherwise, even in cases where Blackstone, an Other Client or its portfolio companies are purchasing debt) or other compensation with respect to the foregoing activities, which are not required to be shared with the Company. In addition, the management fee with respect to a shareholder generally will not be reduced by such amounts. Therefore, Blackstone will from time to time have a potential conflict of interest regarding the Company and the other parties to those transactions to the extent it receives commissions, discounts or other compensation from such other parties. The Board of Trustees, in its sole discretion, will approve any transactions, subject to the limitations of the 1940 Act, in which a Blackstone broker-dealer acts as an underwriter, as broker for the Company, or as dealer, broker or advisor, on the other side of a transaction with the Company only where the Board of Trustees believes in good faith that such transactions are appropriate for the Company and, by executing a subscription agreement for shares in the Company, a shareholder consents to all such transactions, along with the other transactions involving conflicts of interest described herein, to the fullest extent permitted by law.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Blackstone serves as underwriter with respect to securities of the Company or its portfolio companies, the Company and such portfolio companies could from time to time be subject to a &#8220;lock-up&#8221; period following the offering under applicable regulations during which time the Company or portfolio company would be unable to sell any securities subject to the &#8220;lock-up.&#8221; This could prejudice the ability of the Company and its portfolio companies to dispose of such securities at an opportune time. In addition, Blackstone Capital Markets can serve as underwriter in connection with the sale of securities by the Company or its portfolio companies. Conflicts would be expected to arise because such engagement would result in Blackstone Capital Markets receiving selling commissions or other compensation in connection with such sale. (See also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Portfolio Company Relationships Generally&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone and Blackstone Credit &amp; Insurance employees are generally permitted to invest in alternative investment funds, real estate funds, hedge funds or other investment vehicles, including potential competitors of the Company. The Company will not receive any benefit from any such investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PJT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On October 1, 2015, Blackstone spun off its financial and strategic advisory services, restructuring and reorganization advisory services, and its Park Hill fund placement businesses and combined these businesses with PJT Partners Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;PJT&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), an independent financial advisory firm founded by Paul J. Taubman. While PJT operates independently from Blackstone and is not an affiliate thereof, it is expected that there will be substantial overlapping ownership between Blackstone and PJT for a considerable period of time going forward. Therefore, conflicts of interest will arise in connection with transactions between or involving the Company and its portfolio companies, on the one hand, and PJT, on the other. The pre-existing relationship between Blackstone and its former personnel, the overlapping ownership and co-investment and other continuing arrangements between PJT and Blackstone can be expected to influence Blackstone Credit &amp; Insurance to select or recommend PJT to perform services for the Company or its portfolio companies, the cost of which will generally be borne directly or indirectly by the Company. Given that PJT is no longer an affiliate of Blackstone, Blackstone and its affiliates will be free to cause the Company and portfolio companies to transact with PJT generally without restriction under the applicable governing documents, notwithstanding the relationship between Blackstone and PJT. In addition, one or more investment vehicles controlled by Blackstone may be established to facilitate participation in Blackstone&#8217;s side-by-side investment program by employees and/or partners of PJT. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Portfolio Company Relationships Generally</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company&#8217;s portfolio companies, including special purpose vehicles that might be formed in connection with investments, are expected to be counterparties to or participants in agreements, transactions or other arrangements with the Company, Other Clients, and/or portfolio companies of the Company and Other Clients or other Blackstone affiliates and/or any portfolio companies of the foregoing for the provision of goods and services, purchase and sale of assets and other matters (including information-sharing and/or consulting). For example, from time to time, certain portfolio companies of the Company or Other Clients will provide or recommend goods or services to Blackstone, the Company, Other Clients, or other portfolio companies of the Company or Other Clients (including &#8220;platform&#8221; investments of the Company and Other Clients). As another example, it can also be expected that the management of one or more portfolio </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies may consult with one another (or with one or more portfolio companies of an Other Client) in respect of seeking its expertise, industry view, or otherwise on a particular topic including but not limited to an asset and/or the purchase and /or sale thereof. Moreover, the Company and/or an Other Client can consult with a portfolio company or a portfolio company of an Other Client as part of the investment diligence for a potential investment by the Company or such Other Client. As a result of, or as part of such interactions or otherwise, personnel (including one or more members of the management team) at one portfolio company may also transfer to or become employed by another portfolio company (or a portfolio company of an Other Client), the Company, Blackstone or their respective affiliates (or vice versa). Any such transfer may result in payments by the entity that such personnel is going to, to the entity such personnel is departing from. Although the Firm might determine that such agreements, transactions or other arrangements are consistent with the requirements of such Other Clients&#8217; offering and/or governing agreements, such agreements, transactions or other arrangements might not have otherwise been entered into but for the affiliation with Blackstone Credit &amp; Insurance and/or Blackstone. These agreements, transactions or other agreements involve fees, commissions, servicing payments and/or discounts to Blackstone Credit &amp; Insurance, any Blackstone affiliate (including personnel) or a portfolio company, none of which reduce the management fee payable by the Company. This may give rise to actual or potential conflicts of interest for the Adviser, the Company and/or their respective affiliates, as such agreements, transactions and arrangements may be more favorable for one portfolio company than another, thus benefiting the Company or Other Clients at the expense of the other. For example, the Firm reserves the right to cause, or offer the opportunity to, portfolio companies to enter into agreements regarding group procurement (such as the group purchasing organization), benefits management, purchase of title and/or other insurance policies (which could be pooled across portfolio companies and discounted due to scale) and other operational, administrative or management related matters from a third party or a Firm affiliate, and other similar operational initiatives that can result in commissions or similar payments, including related to a portion of the savings achieved by the portfolio company. Such agreements, transactions or other arrangements will generally be entered into without the consent or direct involvement of the Company and/or such Other Client or the consent of the Board of Trustees and/or the shareholders of the Company or such Other Client (including, without limitation, in the case of minority and/or non-controlling investments by the Company in such portfolio companies or the sale of assets from one portfolio company to another) and/or such Other Client. In any such case, the Company might not be involved in the negotiation process, and there can be no assurance that the terms of any such agreement, transaction or other arrangement will be as favorable to the Company as otherwise would be the case if the counterparty were not related to the Firm.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, it is possible that certain portfolio companies of Other Clients or companies in which Other Clients have an interest will compete with the Company for one or more investment opportunities. It is also possible that certain portfolio companies of Other Clients will engage in activities that will have adverse consequences on the Company and/or its portfolio companies. As an example of the latter, the laws and regulations of certain jurisdictions (e.g., bankruptcy, environmental, consumer protection and/or labor laws) would not recognize the segregation of assets and liabilities as between separate entities and could permit recourse against the assets of not just the entity that has incurred the liabilities, but also the other entities that are under common control with, or part of the same economic group as, such entity. In such circumstances, the assets of the Company and/or its portfolio companies potentially will be used to satisfy the obligations or liabilities of one or more Other Clients, their portfolio companies and/or affiliates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, Blackstone and affiliates of Blackstone and Blackstone portfolio companies could also establish other investment products, vehicles and platforms focusing on specific asset classes or industry sectors that fall within the Company&#8217;s investment strategy, which would possibly compete with the Company for investment opportunities (it being understood that such arrangements would give rise to conflicts of interest that would not necessarily be resolved in favor of the Company).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain portfolio companies have established or invested in, or can be expected to in the future establish or invest in, vehicles that are managed exclusively by the portfolio company (and not the Company or the Firm or any of its affiliates) and that invest in asset classes or industry sectors (such as cyber security) that fall within the Company&#8217;s investment strategy. Such vehicles, which would not be considered affiliates of the Firm and would not be subject to the Firm&#8217;s policies and procedures, have the potential to compete with the Company for investment opportunities. Portfolio companies and affiliates of the Firm will also establish other investment products, vehicles and platforms focusing on specific asset classes or industry sectors (such as reinsurance) that can be expected to compete with the Company for investment opportunities (it being understood that such arrangements can give rise to conflicts of interest that would not necessarily be resolved in favor of the Company). In addition, the Company reserves the right to hold non-controlling interests in certain portfolio companies and, as a result, such portfolio companies could engage in activities outside of the Company&#8217;s control that would have adverse consequences on the Company and/or its other portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone has also entered into certain investment management arrangements whereby it provides investment management services for compensation to insurance companies including (i) FGL and certain of its affiliates, (ii) Everlake and certain of its affiliates and (iii) certain subsidiaries of Corebridge and (iv) certain subsidiaries of Resolution Life. As of the date of the date hereof, Blackstone owns a 9.9% equity interest in the parent company of Everlake and Blackstone Clients own the remaining equity interests in the parent company of Everlake, and Blackstone owns a 9.9% equity interest in Corebridge. The foregoing insurance company investment management arrangements will involve investments by such insurance company clients across a variety of asset classes (including investments that would otherwise be appropriate for the Company). As a result, in addition to the compensation Blackstone receives for providing investment management services to insurance companies in which Blackstone or an Other Client owns an interest, in certain instances Blackstone receives additional compensation in its capacity as an indirect owner of such insurance companies and/or Other Clients. In the future Blackstone will likely enter into similar arrangements with other portfolio companies of the Company, Other Clients or other insurance companies. Such arrangements have the potential to reduce the allocations of investments to the Company, and Blackstone could be incentivized to allocate investments away from the Company to such insurance company client under such investment management arrangements or other vehicles/accounts to the extent the economic arrangements related thereto are more favorable to Blackstone relative to the terms of the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, portfolio companies with respect to which the Firm can elect members of the board of directors or a managing member could, as a result, subject the Company and/or such directors or managing member to fiduciary obligations to make decisions that they believe to be in the best interests of any such portfolio company. Although in most cases the interests of the Company and any such portfolio company will be aligned, this will not always be the case. This has the potential to create conflicts of interest between the relevant director&#8217;s or managing member&#8217;s obligations to any such portfolio company and its stakeholders, on the one hand, and the interests of the Company, on the other hand. Although Blackstone Credit &amp; Insurance will generally seek to minimize the impact of any such conflicts, there can be no assurance they will be resolved favorably for the Company. For instance, such positions could impair the ability of the Company to sell the securities of an issuer in the event a director receives material non- public information by virtue of their role, which would have an adverse effect on the Company. Furthermore, an employee of Blackstone serving as a director to a portfolio company owes a fiduciary duty and/or other obligations to the portfolio company, on the one hand, and the Company, on the other hand, and such employee could be in a position where they must make a decision that is either not in the best interest of the Company, or is not in the best interest of the portfolio company. Blackstone personnel serving as directors can make decisions for a portfolio company that negatively impact returns received by the Company as an investor in the portfolio company. In addition, to the extent an employee serves as a director on the board of more than one portfolio company, such employees&#8217; fiduciaries duties among the two portfolio companies can be expected to create a conflict of interest. In general, the Adviser and Blackstone personnel will be entitled to indemnification from the Company. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Portfolio Company Service Providers and Vendors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to applicable law, the Company, Other Clients, portfolio companies of each of the foregoing and Blackstone Credit &amp; Insurance can be expected to engage portfolio companies of the Company and Other Clients to provide some or all of the following services: (a)&#160;corporate support services (including, without limitation, accounts payable, accounts receivable, accounting/audit (e.g., valuation support services), account management (e.g., treasury, customer due diligence), insurance, procurement, placement, brokerage and consulting services, cash management, accounts receivable financing, corporate secretarial and executive assistant services, domiciliation, data management, directorship services, finance/budget, human resources (e.g., the onboarding and ongoing development of personnel), communication, public relations and publicity, information technology and software systems support, corporate governance and entity management (e.g., liquidation, dissolution and/or otherwise end of term services), risk management and compliance, internal compliance, know-your-client reviews and refreshes, judicial processes, legal, environmental due diligence support(e.g., review of property condition reports, energy consumption), climate accounting services, ESG program management services, engineering services, services related to the sourcing, development and implementation of renewable energy, ESG data collection and reporting services, capital planning services, operational coordination (i.e., coordination with joint venture partners, property managers), risk management, reporting (such as tax reporting, debt reporting or other reporting), tax and treasury, tax analysis and compliance (e.g., CIT and VAT compliance), transfer pricing and internal risk control, treasury and valuation services) and other services; (b) loan services (including, without limitation, monitoring, restructuring and work-out of performing, sub-performing and nonperforming loans, administrative services, and cash management); (c) management services (i.e., management by a portfolio company, Blackstone affiliate or third party (e.g., a third-party manager or operating partner) of operational services); (d) operational services (i.e., general management of day to day operations), including, without limitation, personnel, construction management (such as management of general contractors on capital projects), leasing services (such as leasing strategy, management of third party brokers, negotiation of major leases and negotiation of leases), project management (such as management of development projects, project design and execution, vendor management, and turnkey services); (e) risk management (tax and treasury); (f) transaction support services (including, without </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">limitation, acquisition support; customer due diligence and related onboarding; liquidation; reporting; managing relationships with brokers, banks and other potential sources of investments, identifying potential investments, coordinating with investors, assembling relevant information, conducting financial and market analyses and modelling, coordinating closing/post-closing procedures for acquisitions, dispositions and other transactions, coordinating design and development works (such as recommending and implementing design decisions); and providing diligence and negotiation support to acquire the same; marketing and distribution, overseeing brokers, lawyers, accountants and other advisors, working with consultants and third parties to pursue entitlements; providing in-house legal, ESG and accounting services, assisting with due diligence, preparation of project feasibilities, site visits, transaction consulting and specification of technical analysis and review of (i) design and structural work, (ii) certifications, (iii) operations and maintenance manuals and (iv) statutory documents); (g) insurance procurement, placement, brokerage and consulting services; and (h)&#160;other services. Similarly, Blackstone Credit &amp; Insurance, Other Clients and their portfolio companies can be expected to engage portfolio companies of the Company to provide some or all of these services. Some of the services performed by portfolio company service providers could also be performed by Blackstone Credit &amp; Insurance from time to time and vice versa. Fees paid by the Company or its portfolio companies to or value created by other portfolio company service providers do not reduce the management fee payable by the Company and are not otherwise shared with the Company. In certain circumstances, Blackstone can be expected to play a substantial role in overseeing the personnel of portfolio company service providers that provide services to the Company, Other Clients and/or their portfolio companies on an ongoing basis, including with respect to the selection, hiring, retention and compensation of such personnel. For example, Blackstone expects that certain portfolio company service providers, as described below, with Blackstone&#8217;s oversight, will establish a team of personnel to provide support services exclusively to the Company and its portfolio companies (and/or other investment funds or accounts managed or controlled by Blackstone). Further, Blackstone has multiple business lines, which may result in competition with a portfolio company for high performing executive talent and presents actual and potential conflicts of interest. For example, Blackstone may &#8220;poach&#8221; a portfolio company executive, or such executive may interview with Blackstone during the applicable contractual period with respect to such person&#8217;s existing position and later be hired by Blackstone after such period. A portfolio company may want to retain such executives or other employees, and regardless, Blackstone is under no obligation to avoid interviewing or hiring such employees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portfolio companies of the Company and Other Clients some of which can be expected to provide services to the Company and its portfolio companies include, without limitation, the following, and could include additional portfolio companies that might be formed or acquired in the future: </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BTIG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. BTIG, LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BTIG&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is a global financial services firm in which certain Blackstone entities own a strategic minority investment. BTIG provides institutional trading, investment banking, research and related brokerage services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CoreTrust</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On September 30, 2022, certain Blackstone private equity funds and related entities closed the previously announced acquisition of a majority interest in CoreTrust (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;CoreTrust Acquisition&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), a group purchasing organization that provides purchasing services to member companies, which includes portfolio companies owned, in whole or in part, by certain Blackstone-managed funds. CoreTrust is expected to provide group purchasing services to the Company, portfolio companies, Other Clients and Blackstone. Generally, CoreTrust generates revenue from vendors based on a percentage of the amount of products or services purchased by its member companies and benefit plans maintained by its member companies. CoreTrust has historically shared a portion of the revenue generated through purchases made by Blackstone portfolio companies and paid Blackstone a consulting fee. Blackstone stopped accepting such revenue sharing arrangements and consulting fee upon the closing of the CoreTrust Acquisition. However, Blackstone may in its sole discretion reinstitute such or similar revenue sharing arrangements with CoreTrust in the future. In addition, prior to the CoreTrust Acquisition, CoreTrust generated revenue in respect of certain portfolio companies (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Applicable Portfolio Companies&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) from certain health and welfare benefit plan-related vendors (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Applicable Vendors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). For legal and regulatory reasons</span><span style="background-color:#dddddd;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">following the CoreTrust Acquisition, CoreTrust is limited in its ability to generate revenue from the Applicable Vendors in respect of portfolio companies&#8217; health benefit plans based on a percentage of the amount of products or services purchased by such plans. As a result, for Applicable Portfolio Companies and other portfolio companies that become CoreTrust members, CoreTrust intends to rebate all revenue received from Applicable Vendors to each such Portfolio Company&#8217;s applicable benefit plan. CoreTrust also intends to enter into with each Applicable Portfolio Company (and with other portfolio companies that become CoreTrust members) a separate agreement that will include the payment of an access fee in return for allowing such portfolio companies to use the goods and services provided by the Applicable Vendors through CoreTrust. The amount of the access fee will generally be determined either as a percentage of total company revenues or as a fixed fee (in each case subject to periodic review by CoreTrust and the Applicable Portfolio Company) and might not be subject to benchmarking, and the access fee could be greater or less than the amount of the revenue that CoreTrust previously generated from Applicable Vendors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Optiv</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Optiv Security, Inc. is a portfolio company held by certain Blackstone private equity funds that provides a full slate of information security services and solutions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PSAV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. PSAV, Inc. is a portfolio company held by certain Blackstone private equity funds that provides outsourced audiovisual services and event production.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refinitiv</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On October 1, 2018, a consortium led by Blackstone announced that private equity funds managed by Blackstone had completed an acquisition of Thomson Reuters&#8217; Financial &amp; Risk business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Refinitiv&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). On January 29, 2021, Refinitiv was sold to London Stock Exchange Group (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LSEG&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), with Blackstone private equity funds receiving a minority stake in LSEG. Refinitiv operates a pricing service that provides valuation services and may provide goods and services for the Company and its portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Kryalos. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone through one or more of its funds has made a minority investment in Kryalos, an operating partner in certain real estate investments made by Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Peridot Financial Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Peridot&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> and Global Supply Chain Finance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;GSCF&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone through one or more of its funds has made majority investments into Peridot and GSCF, which provide supply chain financing and accounts receivable services globally.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RE Tech Advisors </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;RE Tech&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Blackstone through one or more of its funds has made a majority investment in RE Tech, an energy audit/consulting firm that identifies and implements energy efficiency programs, calculates return on investment and tracks performance post-completion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legence (f.k.a Therma Holdings) (&#8220;Legence&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Legence is a portfolio company held by certain Blackstone private equity funds that provides carbon reduction and energy management services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revantage.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revantage is a portfolio entity of certain Blackstone Clients that provides corporate support services, including, without limitation, accounting, legal, tax, treasury, information technology and human resources and operational services and management services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There may be instances where current and former employees of Other Clients&#8217; portfolio companies are seconded to or temporarily hired by the Company&#8217;s portfolio companies or, at times, the Company&#8217;s investments directly. Such secondments or temporary hiring of current and former employees of Other Clients&#8217; portfolio companies by the Company&#8217;s portfolio companies (or its investments) may result in a potential conflict of interest between the Company&#8217;s portfolio companies and those of such Other Clients. The costs of such employees are expected to be borne by the Company or its relevant portfolio companies, as applicable, and the fees paid by the Company or such portfolio companies to, other portfolio company service providers or vendors do not offset or reduce the management fee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its portfolio companies will compensate one or more of these service providers and vendors owned by the Company or Other Clients, including through incentive based compensation payable to their management teams and other related parties. The incentive based compensation paid with respect to a portfolio company or asset of the Company or Other Clients will vary from the incentive based compensation paid with respect to other portfolio companies and assets of the Company and Other Clients; as a result the management team or other related parties can be expected to have greater incentives with respect to certain assets and portfolio companies relative to others, and the performance of certain assets and portfolio companies can be expected to provide incentives to retain management that also service other assets and portfolio companies. Some of these service providers and vendors owned or controlled by the Company or Other Clients may charge the Company and its portfolio companies for goods and services at rates generally consistent with those available in the market for similar goods and services. The discussion regarding the determination of market rates under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Firm Affiliated Service Providers&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein applies equally in respect of the fees and expenses of the portfolio company service providers, if charged at rates generally consistent with those available in the market. Other service providers and vendors owned and/or controlled by the Company or Other Clients pass through expenses on a cost reimbursement, no-profit or break-even basis, in which case the service provider allocates costs and expenses directly associated with work performed for the benefit of the Company and its portfolio companies to them, along with any related tax costs and an allocation of the service provider&#8217;s overhead, including any of the following: salaries, wages, benefits and travel expenses; marketing and advertising fees and expenses; legal, accounting and other professional fees and disbursements; office space and equipment; insurance premiums; technology expenditures, including hardware and software costs; costs to engage recruitment firms to hire employees; diligence expenses; one-time costs, including costs related to building-out and winding-down a portfolio company; costs that are of a limited </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">duration or non-recurring (such as start-up or technology build-up costs, one-time technology and systems implementation costs, employee on-boarding and severance payments, and readiness of initial public offerings and other infrastructure costs); taxes; and other operating and capital expenditures. Any of the foregoing costs (including in prior periods, such as where any such costs are amortized over an extended period), although allocated in a particular period, will, in certain circumstances, relate to activities occurring outside the period, and further will, in certain circumstances, be of a general and administrative nature that is not specifically related to particular services, and therefore the Company could pay more than its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> portion of fees for services. In addition, in certain circumstances, Blackstone also relies on the management team of a portfolio company with respect to the determination of costs and expenses and allocation thereof and does not oversee or participate in such determinations or allocations. Moreover, to the extent a portfolio company uses an allocated cost model with respect to fees, costs and expenses, such fees, costs and expenses are typically estimated and/or accrued quarterly (or on another regular periodic basis) but not finalized until year-end and as a result, such year-end true-up is subject to fluctuation and increases such that for a given year, the year-end cumulative amount with respect to fees, costs and expenses may be greater than the sum of the quarterly estimates (or other periodic estimates where applicable) and/or accruals and therefore the Company could bear more fees, costs and expenses at year-end than had been anticipated throughout the year. The allocation of overhead among the entities and assets to which services are provided can be expected to be based on any of a number of different methodologies, including, without limitation, &#8220;cost&#8221; basis as described above, &#8220;time-allocation&#8221; basis, &#8220;per unit&#8221; basis, &#8220;per square footage&#8221; basis or &#8220;fixed percentage&#8221; basis, and the particular methodology used to allocate such overhead among the entities and assets to which services are provided are expected to vary depending on the types of services provided and the applicable asset class involved, and could, in certain circumstances, change from one period to another. There can be no assurance that a different manner of allocation would result in the Company and its portfolio companies bearing less or more costs and expenses. In addition, a portfolio company that uses a &#8220;cost&#8221; basis methodology may, in certain circumstances, change its allocation methodology, for example, to charging a flat fee for a particular service or instance (or vice versa) or to another methodology described herein or otherwise, and such changes may increase or reduce the amounts received by such portfolio companies for the same services, and shareholders will not necessarily be entitled to receive notice or disclosure of such changes in allocation methodology. In certain instances, particularly where such service providers and vendors are located in Europe or Asia, such service providers and vendors will charge the Company and its portfolio companies for goods and services at cost plus a percentage of cost for transfer pricing or other tax, legal, regulatory, accounting or other reasons or even decide to amortize any costs or expenses to address accounting or operational considerations. Further, the Company and its portfolio companies may compensate one or more of these service providers and vendors owned by the Company or Other Clients through incentive-based compensation payable to their management teams and other related parties. The incentive-based compensation paid with respect to a portfolio company or asset of the Company or Other Clients will vary from the incentive based compensation paid with respect to other portfolio companies and assets of the Company and Other Clients; as a result the management team or other related parties can be expected to have greater incentives with respect to certain assets and portfolio companies relative to others, and the performance of certain assets and portfolio companies could provide incentives to retain management that also service other assets and portfolio companies. Blackstone Credit &amp; Insurance will not always perform or obtain benchmarking analysis or third-party verification of expenses with respect to services provided on a cost reimbursement, no profit or break even basis, or in respect of incentive-based compensation. There can be no assurances that amounts charged by portfolio company service providers that are not controlled by the Company or Other Clients will be consistent with market rates or that any benchmarking, verification or other analysis will be performed with respect to such charges. If benchmarking is performed, the related expenses will be borne by the Company, Other Clients and their respective portfolio companies and will not reduce the management fee. A portfolio company service provider will, in certain circumstances, subcontract certain of its responsibilities to other portfolio companies. In such circumstances, the relevant subcontractor could invoice the portfolio company for fees (or in the case of a cost reimbursement arrangement, for allocable costs and expenses) in respect of the services provided by the subcontractor. The portfolio company, if charging on a cost reimbursement, no-profit or break-even basis, would in turn allocate those costs and expenses as it allocates other fees and expenses as described above. Similarly, Other Clients, their portfolio companies and Blackstone Credit &amp; Insurance can be expected to engage portfolio companies of the Company to provide services, and these portfolio companies will generally charge for services in the same manner described above, but the Company and its portfolio companies generally will not be reimbursed for any costs (such as start-up costs or technology build-up costs) relating to such portfolio companies incurred prior to such engagement. Some of the services performed by these service providers could also be performed by Blackstone Credit &amp; Insurance from time to time and vice versa. Fees paid by the Company or its portfolio companies to these service providers do not the management fee payable to the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where compensation paid to an affiliated service provider from the Company or its portfolio company is based on market rates, such compensation will not be based on the cost incurred by the applicable service provider and therefore will likely result in a profit to such service provider. In the event the service provider is an affiliate of Blackstone Credit &amp; Insurance, Blackstone Credit &amp; Insurance experiences a conflict of interest in determining the terms of any such engagement. There can be no assurance that an unaffiliated third party would not charge a lesser rate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Providers, Vendors and Other Counterparties Generally</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain third party advisors and other service providers and vendors or their affiliates to the Company and its portfolio companies (including accountants, administrators, paying agents, depositories, lenders, bankers, brokers, attorneys, consultants, title agents and investment or commercial banking firms) are owned by the Firm, the Company or Other Clients or provide goods or services to, or have other business, personal, financial or other relationships with, the Firm, the Other Clients and their respective portfolio companies and affiliates and personnel. Such advisors and service providers referred to above could be investors in the Company, affiliates of the Adviser, sources of financing and investment opportunities or co-investors or commercial counterparties or entities in which the Firm and/or Other Clients have an investment, and payments by the Company and/or such entities can be expected to indirectly benefit the Firm, the Other Clients and their respective portfolio companies or any affiliates or personnel. Also, advisors, lenders, investors, commercial counterparties, vendors and service providers (including any of their affiliates or personnel) to the Company and its portfolio companies could have other commercial or personal relationships with the Firm, Other Clients and their respective portfolio companies, or any affiliates, personnel or family members of personnel of the foregoing. Although the Firm selects service providers and vendors it believes are most appropriate in the circumstances based on its knowledge of such service providers and vendors (which knowledge is generally greater in the case of service providers and vendors that have other relationships to the Firm), the relationship of service providers and vendors to the Firm as described above will influence the Firm in deciding whether to select, recommend or form such an advisor or service provider to perform services for the Company, subject to applicable law, or a portfolio company, the cost of which will generally be borne directly or indirectly by the Company and can be expected to incentivize the Firm to engage such service provider over a third party, utilize the services of such service providers and vendors more frequently than would be the case absent the conflict, or to pay such service providers and vendors higher fees or commissions, resulting in higher fees and expenses being borne by the Company, than would be the case absent the conflict. The incentive could be created by current income and/or the generation of enterprise value in a service provider or vendor; the Firm can be expected to also have an incentive to invest in or create service providers and vendors to realize on these opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm has a practice of not entering into any arrangements with advisors, vendors or service providers that provide lower rates or discounts to the Firm itself compared to those it enters into on behalf of the Company and its portfolio companies for the same services. However, legal fees for unconsummated transactions are often charged at a discounted rate, such that if the Company and its portfolio companies consummate a higher percentage of transactions with a particular law firm than the Firm, the Company, Other Clients and their portfolio companies, the shareholders could indirectly pay a higher net effective rate for the services of that law firm than the Firm, the Company or Other Clients or their portfolio companies. Also, advisors, vendors and service providers often charge different rates or have different arrangements for different types of services. For example, advisors, vendors and service providers often charge fees based on the complexity of the matter as well as the expertise and time required to handle it. Therefore, to the extent the types of services used by the Company and its portfolio companies are different from those used by the Firm, Other Clients and their portfolio companies, and their affiliates and personnel, the Company and its portfolio companies can be expected to pay different amounts or rates than those paid by such other persons. Similarly, the Firm, the Company, the Other Clients and their portfolio companies and affiliates can be expected to enter into agreements or other arrangements with vendors and other similar counterparties (whether such counterparties are affiliated or unaffiliated with the Firm) from time to time whereby such counterparty will, in certain circumstances, charge lower rates (or no fee) or provide discounts or rebates for such counterparty&#8217;s products or services depending on certain factors, including without limitation the volume of transactions entered into with such counterparty by the Firm, the Company and its investment and/or portfolio companies in the aggregate or other factors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to applicable law, the Company, Other Clients and their portfolio companies are expected to enter into joint ventures with third parties to which the service providers and vendors described above will, in certain circumstances, provide services. In some of these cases, the third party joint venture partner may be permitted to negotiate to not pay its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> share of fees, costs and expenses to be allocated as described above, in which case the Company, Other Clients and their portfolio companies that also use the services of the portfolio company service provider will, directly or indirectly, pay the difference, or the portfolio company service provider will bear a loss equal to the difference.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm might, from time to time, encourage service providers to funds and investments to use, generally at market rates and/or on arm&#8217;s length terms (and/or on the basis of best execution, if applicable), the Firm-affiliated service providers in connection with the business of the Company, portfolio companies, and unaffiliated entities. This practice creates a conflict of interest because it provides an indirect benefit to the Firm in the form of added business for the Firm-affiliated service providers without any reduction to the Company&#8217;s management fee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain portfolio companies that provide services to the Company, Other Clients and/or portfolio companies or assets of the Company and/or Other Clients could be transferred between and among the Company and/or Other Clients (where the Company may be a seller or a buyer in any such transfer) for minimal or no consideration (based on a third-party valuation confirming the same). Such transfers may give rise to actual or potential conflicts of interest for Blackstone Credit &amp; Insurance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Firm Affiliated Service Providers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s, the Firm&#8217;s and/or portfolio companies&#8217; advisers and other service providers, or their affiliates (including accountants, administrators, lenders, bankers, brokers, attorneys, consultants, and investment or commercial banking firms) also provide goods or services to, or have business, personal, financial or other relationships with, the Firm, its affiliates and portfolio companies. Such advisers and service providers (or their affiliates) may be investors in the Company, affiliates of the Firm, sources of investment opportunities, co-investors, commercial counterparties and/or portfolio companies in which the Firm and/or the Company has an investment. Accordingly, payments by the Company and/or such entities may indirectly benefit the Company and/or its affiliates, including the Firm and Other Clients. No fees charged by these service providers and vendors will reduce the management fees payable to the Adviser. Furthermore, the Firm, the Other Clients and their portfolio companies and their affiliates and related parties will use the services of these Firm affiliates, including at different rates. Although the Firm believes the services provided by its affiliates are equal or better than those of third parties, the Firm directly benefits from the engagement of these affiliates, and there is therefore an inherent conflict of interest such as those described above.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Firm has many different businesses, including the Blackstone Capital Markets Group, which Blackstone investment teams and portfolio companies can engage to provide underwriting and capital market advisory services, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would be subject if it had just one line of business. To the extent Blackstone determines appropriate, conflict mitigation strategies would be put in place with respect to a particular circumstance, such as internal information barriers or recusal, disclosure or other steps determined appropriate by the Adviser. Service providers affiliated with the Firm, which are generally expected to receive competitive market rate fees (as determined by the Adviser or its affiliates) with respect to certain investments, include:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.07pt">Aquicore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Aquicore is a cloud-based platform that tracks, analyzes and predicts key metrics in real estate, focused on the reduction of energy consumption. Blackstone holds a minority investment in Aquicore.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Equity Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Equity Healthcare LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Equity Healthcare&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is a Blackstone affiliate that negotiates with providers of standard administrative services and insurance carriers for health benefit plans and other related services for cost discounts, quality of service monitoring, data services and clinical consulting. Because of the combined purchasing power of its client participants, which include unaffiliated third parties, Equity Healthcare is able to negotiate pricing terms that are believed to be more favorable than those that the portfolio companies could obtain for themselves on an individual basis. The fees received by Equity Healthcare in connection with services provided to investments will not reduce the management fee payable by the Company.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.07pt">LNLS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lexington National Land Services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LNLS&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is a Blackstone affiliate that (i) acts as a title agent in facilitating and issuing title insurance, (ii) provides title support services for title insurance underwriters and (iii) acts as escrow agent in connection with investments by the Company, Other Clients and their portfolio companies, affiliates and related parties, and third parties. In exchange for such services LNLS earns fees which would have otherwise been paid to third parties. If LNLS is involved in a transaction in which the Company participates, Blackstone will benchmark the relevant costs to the extent market data is available except when LNLS is providing such services in a state where the insurance premium or escrow fee, as applicable, is regulated by the state or when LNLS is part of a syndicate of title insurance companies where the insurance premium is negotiated by other title insurance underwriters or their agents.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Refinitiv</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Portfolio Company Service Providers and Vendors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; above.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Blackstone acquired a 9.9% interest in Corebridge, and in connection therewith has entered into a long-term asset management partnership with certain subsidiaries and/or affiliates of Corebridge to serve as the exclusive external manager with respect to certain asset classes within their investment portfolio, for compensation. While Blackstone will not control Corebridge, the aforementioned investment in Corebridge and asset management arrangements could incentivize Blackstone to cause (and Blackstone will benefit indirectly from causing) the Company and/or its portfolio companies to engage Corebridge or its affiliates (including Corebridge Financial, Inc. and its other affiliates and subsidiaries) to provide various services and engage in other transactions and otherwise present conflicts of interests as a result of Blackstone&#8217;s interest and relationship therewith.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain Blackstone-affiliated service providers and their respective personnel will receive a management promote, an incentive fee and other performance-based compensation in respect of investments, sales or other transaction volume. Furthermore, Blackstone-affiliated service providers can be expected to charge costs and expenses based on allocable overhead associated with personnel working on relevant matters (including salaries, benefits and other similar expenses).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with such relationships, Blackstone Credit &amp; Insurance and, if required by applicable law, the Board of Trustees, will make determinations of competitive market rates based on its consideration of a number of factors, which are generally expected to include Blackstone Credit &amp; Insurance&#8217;s experience with non-affiliated service providers, benchmarking data and other methodologies determined by Blackstone Credit &amp; Insurance to be appropriate under the circumstances (i.e., rates that fall within a range that Blackstone Credit &amp; Insurance has determined is reflective of rates in the applicable market and certain similar markets, though not necessarily equal to or lower than the median rate of comparable firms and in certain circumstances, is expected to be in the top of the range). In respect of benchmarking, while Blackstone Credit &amp; Insurance often obtains benchmarking data regarding the rates charged or quoted by third parties for services similar to those provided by Blackstone Credit &amp; Insurance affiliates in the applicable market or certain similar markets, relevant comparisons would not be available for a number of reasons, including, without limitation, as a result of a lack of a substantial market of providers or users of such services or the confidential or bespoke nature of such services (e.g., different assets could receive different services). In addition, benchmarking data is based on general market and broad industry overviews, rather than determined on an asset by asset basis. As a result, benchmarking data does not take into account specific characteristics of individual assets then invested in by the Company (such as location or size), or the particular characteristics of services provided. Further, it could be difficult to identify comparable third-party service providers that provide services of a similar scope and scale as the Firm-affiliated service providers that are the subject of the benchmarking analysis or to obtain detailed information about pricing of a service comparable to that being provided to the Company from third-party service providers if such service providers anticipate that Blackstone will not in fact engage their services. For these reasons, such market comparisons would not necessarily result in precise market terms for comparable services. Expenses to obtain benchmarking data will be borne by the Company, Other Clients and their respective portfolio companies and will not reduce the management fee. Finally, in certain circumstances Blackstone Credit &amp; Insurance may determine that third party benchmarking is unnecessary, including in circumstances where the price for a particular good or service is mandated by law (e.g., title insurance in rate regulated states) or because in Blackstone Credit &amp; Insurance&#8217;s view no comparable service provider offering such good or service (or an insufficient number of comparable service providers for a reasonable comparison) exists or because Blackstone Credit &amp; Insurance has access to adequate market data (including from third party clients of the Firm-affiliated service provider that is the subject of the benchmarking analysis) to make the determination without reference to third party benchmarking. For example, in certain circumstances a Firm-affiliated service provider or a portfolio company service provider could provide services to third parties, in which case if the rates charged to such third parties are consistent with the rates charged to the Company, Other Clients and their respective portfolio companies, then a separate benchmarking analysis of such rates is not expected to be prepared. Some of the services performed by Firm-affiliated service providers could also be performed by the Firm from time to time and vice versa. Fees paid by the Company or its portfolio companies to or value created in Firm affiliated service providers or vendors do not reduce the management fee. These conflicts related to Firm-affiliated service providers will not necessarily be resolved in favor of the Company, and shareholders might not be entitled to receive notice or disclosure of the occurrence of these conflicts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advisers and service providers, or their affiliates, often charge different rates, including below-market or no fee, or have different arrangements for different types of services. With respect to service providers, for example, the fee for a given type of work could vary depending on the complexity of the matter as well as the expertise required and demands placed on the service provider. Therefore, to the extent the types of services used by the Company and/or portfolio companies differ from those used by the Firm and its affiliates (including personnel), Blackstone Credit &amp; Insurance and/or Blackstone or their respective affiliates (including personnel) potentially will pay different amounts or rates than those paid by the Company and/or portfolio companies. However, Blackstone Credit &amp; Insurance and its affiliates have a longstanding practice of not entering into any arrangements with advisers or service providers that could provide for lower rates or discounts than those available to the Company, Other Clients and/or portfolio companies for the same services. Furthermore, it is possible that certain advisers and service providers will provide services exclusively to the Firm and its affiliates, including the Company, Other Clients and their portfolio companies, although such advisers and service providers would not be considered employees of Blackstone or Blackstone Credit &amp; Insurance. Similarly, Blackstone, Blackstone Credit &amp; Insurance, each of their respective affiliates, the Company, the Other Clients and/or their portfolio companies, can enter into agreements or other arrangements with vendors and other similar counterparties (whether such counterparties are affiliated or unaffiliated with the Firm) from time to time whereby such counterparty would charge lower rates (or no fee) and/or provide discounts or rebates for such counterparty&#8217;s products and/or services depending on certain factors, including volume of transactions entered into with such counterparty by the Firm, its affiliates, the Company, the Other Clients and their portfolio companies in the aggregate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, investment banks or other financial institutions, as well as certain Blackstone employees, are expected to also be investors in the Company. These institutions and employees are a potential source of information and ideas that could benefit the Company. Blackstone has procedures in place reasonably designed to prevent the inappropriate use of such information by the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transactions with Portfolio Companies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm and portfolio companies of the Company and Other Clients operate in multiple industries and provide products and services to or otherwise contract with the Company and its portfolio companies, among others. In the alternative, the Firm could form a joint venture with such a company to implement such referral arrangement. For example, such arrangements could include the establishment of a joint venture or other business arrangement between the Firm, on the one hand, and a portfolio company of the Company, portfolio company of an Other Client or third party, on the other hand, pursuant to which the joint venture or business provides services (including, without limitation, corporate support services, loan management services, management services, operational services, ongoing account services (e.g., interacting and coordinating with banks generally and with regard to their know your client requirements), risk management services, data management services, consulting services, brokerage services, sustainability and clean energy consulting services, insurance procurement, placement, brokerage and consulting services, and other services) to portfolio companies of the Company (and portfolio companies of Other Clients) that are referred to the joint venture or business by the Firm. The Firm, the Company and Other Clients and their respective portfolio companies and personnel and related parties of the foregoing can be expected to make referrals or introductions to the Company or portfolio companies of the Company or Other Clients in an effort, in part, to increase the customer base of such companies or businesses (and therefore the value of the investment held by the Company or Other Client, which would also benefit the Firm financially through its participation in such joint venture or business) or because such referrals or introductions will, in certain circumstances, result in financial benefits, such as cash payments, additional equity ownership, participation in revenue share and/or milestones benefiting the referring or introducing party that are tied or related to participation by the portfolio companies of the Company and/or of Other Clients, accruing to the party making the introduction. Such joint venture or business could use data obtained from such portfolio companies (see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Data&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">elsewhere herein). Furthermore, such introductions or referrals could involve the transfer of certain personnel or employees among Blackstone and the Company&#8217;s portfolio companies and Other Clients which might result in a termination fee or similar payments being due and payable from one such entity to another. The Company and the shareholders typically will not share in any fees, economics, equity or other benefits accruing to the Firm, Other Clients and their portfolio companies as a result of the introduction of the Company and its portfolio companies. Moreover, payments made to the Firm in connection with such arrangements will not reduce the management fee payable to the Adviser. There could, however, be instances in which the applicable arrangements provide that the Company or its portfolio companies share in some or all of any resulting financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) based on structures and allocation methodologies determined in the sole discretion of the Firm. Conversely, where the Company or one of its portfolio companies is the referring or introducing party, rather than receiving all of the financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) for similar types of referrals and/or introductions, such financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) could be similarly shared with the participating Other Clients or their respective portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm is also permitted to enter into commercial relationships with third party companies, including those in which the Company considered making an investment (but ultimately chose not to pursue). For example, the Firm could enter into an introducer engagement with such company, pursuant to which the Firm introduces the company to unaffiliated third parties (which can include current and former portfolio companies and portfolio companies of Other Clients and/or their respective employees) in exchange for a fee from, or equity interest in, such company. Even though the Firm could benefit financially from this commercial relationship, the Firm will be under no obligation to reimburse the Company for Broken Deal Expenses incurred in connection with its consideration of the prospective investment and such arrangements will not be subject to the management fee payable to the Adviser and otherwise described herein.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Firm or an affiliate thereof will from time to time hold equity or other investments in companies or businesses (even if they are not &#8220;affiliates&#8221; of the Firm) that provide services to or otherwise contract with portfolio companies. Blackstone and Blackstone Credit &amp; Insurance have in the past entered (and can be expected in the future to enter) into relationships with companies in the information technology, corporate services and related industries whereby Blackstone acquires an equity or similar interest in such company. In connection with such relationships, Blackstone and/or Blackstone Credit &amp; Insurance reserves the right to also make referrals and/or introductions to portfolio companies (which could result in financial incentives (including additional equity ownership) and/or milestones benefitting Blackstone and/or Blackstone Credit &amp; Insurance that are tied or related to participation by portfolio companies). Such joint venture or business could use data obtained from portfolio companies of the Company and/or portfolio companies of Other Clients. These arrangements are expected to be entered into without the consent or direct involvement of the Company. The Company and the shareholders will not share in any fees or economics accruing to Blackstone and/or Blackstone Credit &amp; Insurance as a result of these relationships and/or participation by portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to transactions or agreements with portfolio companies (including, for the avoidance of doubt, long-term incentive plans), at times if officers unrelated to the Firm have not yet been appointed to represent a portfolio company, the Firm is permitted to negotiate and execute agreements between the Firm and/or the Company on the one hand, and the portfolio company or its affiliates, on the other hand, without arm&#8217;s length representation of the portfolio company, which could entail a conflict of interest in relation to efforts to enter into terms that are arm&#8217;s length. Among the measures the Firm can be expected to use to mitigate such conflicts are to involve outside counsel to review and advise on such agreements and provide insights into commercially reasonable terms, or establish separate groups with information barriers within the Firm to advise on each side of the negotiation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Leasing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to applicable law, the Company and its portfolio companies may lease property to or from Blackstone, Other Clients and their portfolio companies and affiliates and other related parties. The leases are generally expected to, but might not always, be at market rates. Blackstone can be expected to confirm market rates by reference to other leases it is aware of in the market, which Blackstone expects to be generally indicative of the market given the scale of Blackstone&#8217;s real estate business. Blackstone can be expected to, but might not always, nonetheless have conflicts of interest in making these determinations, and with regard to other decisions related to such assets and investments. There can be no assurance that the Company and its portfolio companies will lease to or from any such related parties on terms as favorable to the Company and its portfolio companies as would apply if the counterparties were unrelated.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-Guarantees and Cross-Collateralization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. While Blackstone Credit &amp; Insurance generally seeks to use reasonable efforts to avoid cross-guarantees and other similar arrangements, a counterparty, lender or other participant in any transaction to be pursued by the Company other than alternative investment vehicles and/or the Other Clients could require or prefer facing only one fund entity or group of entities, which can result in any of the Company, such Other Clients, the portfolio companies, such Other Clients&#8217; portfolio companies and/or other vehicles being jointly and severally liable for such applicable obligation (subject to any limitations set forth in the applicable governing documents thereof), which in each case could result in the Company, such Other Clients, such portfolio companies and portfolio companies, and/or vehicles entering into a back-to-back or other similar reimbursement agreement, subject to applicable law. In such situation, better financing terms could be available through a cross-collateralized arrangement, but it is not expected that any of the Company or such Other Clients or vehicles would be compensated (or provide compensation to the other) for being primarily liable vis-&#224;-vis such third party counterparty. Also, it is expected that cross-collateralization will generally occur at portfolio companies rather than the Company for obligations that are not recourse to the Company except in limited circumstances such as &#8220;bad boy&#8221; events. Any cross-collateralization arrangements with Other Clients could result in the Company losing its interests in otherwise performing investments due to poorly performing or non-performing investments of Other Clients in the collateral pool.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, a lender could require that it face only one portfolio company of the Company and Other Clients, even though multiple portfolio companies of the Company and Other Clients benefit from the lending, which will typically result in (i) the portfolio company facing the lender being solely liable with respect to the entire obligation, and therefore being required to contribute amounts in respect of the shortfall attributable to other portfolio companies, and (ii) portfolio companies of the Company and Other Clients being jointly and severally liable for the full amount of the obligation, liable on a cross-collateralized basis or liable for an equity cushion (which cushion amount can vary depending upon the type of financing or refinancing (e.g., cushions for refinancings could be smaller)). The portfolio companies of the Company and Other Clients benefiting from a financing may enter into a back-to-back or other similar reimbursement agreements whereby each agrees that no portfolio company bears more than its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> portion of the debt and related obligations. It is not expected that the portfolio companies would be compensated (or provide compensation to other portfolio companies) for being primarily liable, or jointly liable, for other portfolio companies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> share of any financing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint Venture Partners</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company will from time to time enter into one or more joint venture arrangements with third party joint venture partners. Investments made with joint venture partners will often involve performance-based compensation and other fees payable to such joint venture partners, as determined by the Adviser in its sole discretion. The joint venture partners could provide services similar to those provided by the Adviser to the Company. Yet, no compensation or fees paid to the joint venture partners would reduce the management fees payable by the Company. Additional conflicts would arise if a joint venture partner is related to the Firm in any way, such as a limited partner investor in, lender to, a shareholder of, or a service provider to the Firm, the Company, Other Clients, or their respective portfolio companies, or any affiliate, personnel, officer or agent of any of the foregoing.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Group Procurement; Discounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company, subject to applicable law, and certain portfolio companies will enter into agreements regarding group procurement (including, but not limited to, CoreTrust, an independent group purchasing organization), benefits management, purchase of title and/or other insurance policies (which can be expected to include brokerage and/or placement thereof, and will from time to time be pooled across portfolio companies and discounted due to scale, including through sharing of deductibles and other forms of shared risk retention) from a third party or an affiliate of Blackstone Credit &amp; Insurance and/or Blackstone, and other operational, administrative or management related initiatives. The Firm will allocate the cost of these various services and products purchased on a group basis among the Company, Other Clients and their portfolio companies. Some of these arrangements result in commissions, discounts, rebates or similar payments to Blackstone Credit &amp; Insurance and/or Blackstone or their affiliates (including personnel), or Other Clients and their portfolio companies, including as a result of transactions entered into by the Company and its portfolio companies and/or related to a portion of the savings achieved by the portfolio companies. Such commissions or payment will not reduce the management fee. The Firm can be expected to also receive consulting, usage or other fees from the parties to these group procurement arrangements. To the extent that a portfolio company of an Other Client is providing such a service, such portfolio company and such Other Client will benefit. Further, the benefits received by a particular portfolio company providing the service could be greater than those received by the Company and its portfolio companies receiving the service. Conflicts exist in the allocation of the costs and benefits of these arrangements, and shareholders rely on the Adviser to handle them in its sole discretion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diverse Shareholder Group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s shareholders are expected to be based in a wide variety of jurisdictions and take a wide variety of forms. The shareholders may have conflicting investment, tax and other interests with respect to their investments in the Company and with respect to the interests of investors in other investment vehicles managed or advised by the Adviser and Blackstone Credit &amp; Insurance that may participate in the same investments as the Company. The conflicting interests of individual shareholders with respect to other shareholders and relative to investors in other investment vehicles would generally relate to or arise from, among other things, the nature of investments made by the Company and such other partnerships, the structuring or the acquisition of investments and the timing of disposition of investments. As a consequence, conflicts of interest may arise in connection with the decisions made by the Adviser or Blackstone Credit &amp; Insurance, including with respect to the nature or structuring of investments that may be more beneficial for one investor than for another investor, especially with respect to investors&#8217; individual tax situations. In addition, the Company may make investments that may have a negative impact on related investments made by the shareholders in separate transactions, such as credit investments that, by consequence of the exercise of remedies related to such investments, adversely impact equity-like investments in respect of those same issuers. In selecting and structuring investments appropriate for the Company, the Adviser or Blackstone Credit &amp; Insurance will consider the investment and tax objectives of the Company and the shareholders (and those of investors in other investment vehicles managed or advised by the Adviser or Blackstone Credit &amp; Insurance) as a whole, not the investment, tax or other objectives of any shareholder individually.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain shareholders also may be investors in Other Clients, including supplemental capital vehicles and co-investment vehicles that invest alongside the Company in one or more investments, consistent with applicable law and/or any applicable SEC-granted order. Shareholders also might include affiliates of the Firm, such as Other Clients, affiliates of portfolio companies of the Company or Other Clients, charities, foundations or other entities or programs associated with Firm personnel and/or current or former Firm employees, the Firm&#8217;s senior advisors and/or operating partners and any affiliates, funds or persons may also invest in the Company through the vehicles established in connection with the Firm&#8217;s side-by-side co-investment rights, subject to applicable law, in each case, without being subject to management fees, and shareholders will not be afforded the benefits of such arrangements. Some of the foregoing Firm related parties are sponsors of feeder vehicles that could invest in the Company as shareholders. The Firm related sponsors of feeder vehicles generally charge their investors additional fees, including performance based fees, which could provide the Firm current income and increase the value of its ownership position in them. The Firm will therefore have incentives to refer potential investors to these feeder vehicles. All of these Firm related shareholders will have equivalent rights to vote and withhold consents as nonrelated shareholders. Nonetheless, the Firm could have the ability to influence, directly or indirectly, these Firm related shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is also possible that the Company or its portfolio companies will be a counterparty (such counterparties dealt with on an arm&#8217;s-length basis) or participant in agreements, transactions or other arrangements with a shareholder or an affiliate of a shareholder. Such transactions may include agreements to pay performance fees to operating partners, a management team and other related persons in connection with the Company&#8217;s investment therein, which will reduce the Company&#8217;s returns. Such shareholders described in the previous sentences may therefore have different information about the Firm and the Company than shareholders not similarly positioned. In addition, conflicts of interest may arise in dealing with any such shareholders, and the Adviser and its affiliates may not be motivated to act solely in accordance with its interests relating to the Company. Similar information disparity may occur as a result of shareholders monitoring their investments in vehicles such as the Company differently. For example, certain shareholders may periodically request from the Adviser information regarding the Company, its investments and/or portfolio companies that is not otherwise set forth in (or has yet to be set forth) in the reporting and other information required to be delivered to all shareholders. In such circumstances, the Adviser may provide such information to such shareholders, subject to applicable law and regulations. Unless required by applicable law, the Adviser will not be obligated to affirmatively provide such information to all shareholders (although the Adviser will generally provide the same information upon request and treat shareholders equally in that regard). As a result, certain shareholders may have more information about the Company than other shareholders, and, unless required by applicable law, the Adviser will have no duty to ensure all shareholders seek, obtain or process the same information regarding the Company, its investments and/or portfolio companies. Therefore, certain shareholders may be able to take actions on the basis of such information which, in the absence of such information, other shareholders do not take. Furthermore, at certain times the Firm may be restricted from disclosing to the shareholders material non-public information regarding any assets in which the Company invests, particularly those investments in which an Other Client or portfolio company that is publicly registered co-invests with the Company. In addition, investment banks or other financial institutions, as well as Firm personnel, may also be shareholders. These institutions and personnel are a potential source of information and ideas that could benefit the Company, and may receive information about the Company and its portfolio companies in their capacity as a service provider or vendor to the Company and its portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Possible Future Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm and its affiliates are expected to expand the range of services that it provides over time. Except as provided herein, the Firm and its affiliates will not be restricted in the scope of its business or in the performance of any such services (whether now offered or undertaken in the future) even if such activities could give rise to conflicts of interest, and whether or not such conflicts are described herein. The Firm and its affiliates have, and will continue to develop, relationships with a significant number of companies, financial sponsors and their senior managers, including relationships with clients who might hold or might have held investments similar to those intended to be made by the Company. These clients could themselves represent appropriate investment opportunities for the Company or could compete with the Company for investment opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restrictions Arising under the Securities Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm&#8217;s activities and the activities of Other Clients (including the holding of securities positions or having one of its employees on the board of directors of a portfolio company) could result in securities law restrictions on transactions in securities held by the Company, affect the prices of such securities or the ability of such entities to purchase, retain or dispose of such investments, or otherwise create conflicts of interest, any of which could have an adverse impact on the performance of the Company and thus the return to the shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 1940 Act may limit the Company&#8217;s ability to undertake certain transactions with or alongside its affiliates that are registered under the 1940 Act. As a result of these restrictions, the Company may be prohibited from executing &#8220;joint&#8221; transactions with the Company&#8217;s 1940 Act registered affiliates, which could include investments in the same portfolio company (whether at the same or different times) or buying investments from, or selling them to, Other Clients. These limitations have the potential to limit the scope of investment opportunities that would otherwise be available to the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders&#8217; Outside Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A shareholder shall be entitled to and can be expected to have business interests and engage in activities in addition to those relating to the Company, including business interests and activities in direct competition with the Company and its portfolio companies, and can engage in transactions with, and provide services to, the Company or its portfolio companies (which will, in certain circumstances, include providing leverage or other financing to the Company or its portfolio companies as determined by the Adviser in its sole discretion). None of the Company, any shareholder or any other person shall have any rights by virtue of the Company&#8217;s operative documents or any related agreements in any business ventures of any shareholder. The shareholder, and in certain cases the Adviser, will have conflicting loyalties in these situations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser will cause the Company to purchase, and/or bear premiums, fees, costs and expenses (including any expenses or fees of insurance brokers) for insurance to insure the Company and the Board of Trustees against liability in connection with the activities of the Company. This includes a portion of any premiums, fees, costs and expenses for one or more &#8220;umbrella,&#8221; group or other insurance policies maintained by the Firm that cover the Company and one or more of the Other Clients, the Adviser, Blackstone Credit &amp; Insurance and/or Blackstone (including their respective directors, officers, employees, agents, representatives, independent client representative (if any) and other indemnified parties). The Adviser will make judgments about the allocation of premiums, fees, costs and expenses for such &#8220;umbrella,&#8221; group or other insurance policies among the Company, one or more Other Clients, the Adviser, Blackstone Credit &amp; Insurance and/or Blackstone on a fair and reasonable basis, subject to approval by the Board of Trustees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technological and Scientific Innovations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recent technological and scientific innovations have disrupted numerous established industries and those with incumbent power in them.&#160;As technological and scientific innovation continues to advance rapidly, it could impact one or more of the Company&#8217;s strategies.&#160;Moreover, given the pace of innovation in recent years, the impact on a particular portfolio company might not have been foreseeable at the time the Company made such investment and could adversely impact the Company and/or its portfolio companies. Furthermore, Blackstone Credit &amp; Insurance could base investment decisions on views about the direction or degree of innovation that prove inaccurate and lead to losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Potential Conflicts of Interest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The officers, directors, members, managers, employees and personnel of the Adviser may trade in securities for their own accounts, subject to restrictions and reporting requirements as may be required by law or the Firm&#8217;s policies, or otherwise determined from time to time by the Adviser. In addition, certain Other Clients may be subject to the 1940 Act or other regulations that, due to the role of the Firm, could restrict the ability of the Company to buy investments from, to sell investments to or to invest in the same securities as, such Other Clients. Such regulations may have the effect of limiting the investment opportunities available to the Company. In addition, as a consequence of Blackstone&#8217;s status as a public company, the officers, directors, members, managers and personnel of the Adviser may take into account certain considerations and other factors in connection with the management of the business and affairs of the Company and its affiliates that would not necessarily be taken into account if Blackstone were not a public company. The directors of Blackstone have fiduciary duties to shareholders of the public company that may conflict with their duties to the Company. Finally, although the Firm believes its positive reputation in the marketplace provides benefit to the Company and Other Clients, the Adviser could decline to undertake investment activity or transact with a counterparty on behalf of the Company for reputational reasons, and this decision could result in the Company foregoing a profit or suffering a loss.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity and capital resources are generated primarily from cash flows from interest, dividends and fees earned from our investments and principal repayments, our credit facilities, debt securitization transactions, and other secured and unsecured debt. We may also generate cash flow from operations, future borrowings and future offerings of securities including public and/or private issuances of debt and/or equity securities through both registered offerings and private offerings. The primary uses of our cash and cash equivalents are for (i) originating loans and purchasing senior secured debt investments, (ii) funding the costs of our operations (including fees paid to our Adviser and expense reimbursements paid to our Administrator), (iii) debt service, repayment and other financing costs of our borrowings and (iv) cash distributions to the holders of our shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To&#160;facilitate public issuances of debt and/or equity securities, in July 2022, we filed a shelf registration statement with the SEC that is effective for a term of three years and expires in July 2025. The amount of securities to be issued pursuant to the shelf registration statement filed in July 2022 was not specified when it was filed and there is no specific dollar limit on the amount of securities we may issue. The securities covered by the registration statement filed in July 2022 include: (i) common shares; (ii) preferred shares; (iii) debt securities; (iv) subscription rights; and (v) warrants. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of any offering.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, our debt consisted of asset based leverage facilities, a revolving credit facility, and unsecured note issuances. We may from time to time enter into additional credit facilities, increase the size of our existing credit facilities or issue further debt securities. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors. In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. As of December&#160;31, 2023 and December&#160;31, 2022, we had an aggregate amount of $4,937.9 million and $5,563.0 million of senior securities outstanding, respectively, and our asset coverage ratio was 200.3% and 174.8%, respectively. We seek to carefully consider our unfunded commitments for the purpose of planning our ongoing financial leverage. Further, we maintain sufficient borrowing capacity within the 150% asset coverage limitation to cover any outstanding unfunded commitments we are required to fund. From time to time we may also repurchase our outstanding debt. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, and other factors. The amounts involved in any such purchase transactions, individually or in the aggregate, may be material.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents as of December&#160;31, 2023, taken together with our $1,662.1 million of unused capacity under our credit facilities (subject to borrowing base availability, $1,662.0 million is available to borrow) is expected to be sufficient for our investing activities and to conduct our operations in the near term. Additionally, we held $157.9 million of Level 2 debt investments as of December&#160;31, 2023, which could provide additional liquidity if necessary.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have historically been able to obtain sufficient borrowing capacity, a deterioration in economic conditions or any other negative economic developments could restrict our access to financing in the future. We may not be able to find new financing for future investments or liquidity needs and, even if we are able to obtain such financing, such financing may not be on as favorable terms as we have previously obtained. These factors may limit our ability to make new investments and adversely impact our results of operations. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we had </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$154.9 million in cash and cash equivalents. During the year ended December&#160;31, 2023, cash provided by operating activities was $458.8 million, primarily from receipt of interest payments from our investments, partially offset by purchases of investments, net of sales of investments and principal repayments, of $178.1 million.&#160;Cash used in financing activities was $432.2 million during the year, which was primarily as a result of net repayments on our credit facilities and Unsecured Notes of $650.9 million and dividends paid in cash of $438.0 million partially offset by $665.3 million of proceeds from the issuance of our common shares.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_EffectsOfLeverageTextBlock', window );">Effects of Leverage [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity and capital resources are generated primarily from cash flows from interest, dividends and fees earned from our investments and principal repayments, our credit facilities, debt securitization transactions, and other secured and unsecured debt. We may also generate cash flow from operations, future borrowings and future offerings of securities including public and/or private issuances of debt and/or equity securities through both registered offerings and private offerings. The primary uses of our cash and cash equivalents are for (i) originating loans and purchasing senior secured debt investments, (ii) funding the costs of our operations (including fees paid to our Adviser and expense reimbursements paid to our Administrator), (iii) debt service, repayment and other financing costs of our borrowings and (iv) cash distributions to the holders of our shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To&#160;facilitate public issuances of debt and/or equity securities, in July 2022, we filed a shelf registration statement with the SEC that is effective for a term of three years and expires in July 2025. The amount of securities to be issued pursuant to the shelf registration statement filed in July 2022 was not specified when it was filed and there is no specific dollar limit on the amount of securities we may issue. The securities covered by the registration statement filed in July 2022 include: (i) common shares; (ii) preferred shares; (iii) debt securities; (iv) subscription rights; and (v) warrants. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of any offering.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, our debt consisted of asset based leverage facilities, a revolving credit facility, and unsecured note issuances. We may from time to time enter into additional credit facilities, increase the size of our existing credit facilities or issue further debt securities. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors. In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. As of December&#160;31, 2023 and December&#160;31, 2022, we had an aggregate amount of $4,937.9 million and $5,563.0 million of senior securities outstanding, respectively, and our asset coverage ratio was 200.3% and 174.8%, respectively. We seek to carefully consider our unfunded commitments for the purpose of planning our ongoing financial leverage. Further, we maintain sufficient borrowing capacity within the 150% asset coverage limitation to cover any outstanding unfunded commitments we are required to fund. From time to time we may also repurchase our outstanding debt. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, and other factors. The amounts involved in any such purchase transactions, individually or in the aggregate, may be material.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents as of December&#160;31, 2023, taken together with our $1,662.1 million of unused capacity under our credit facilities (subject to borrowing base availability, $1,662.0 million is available to borrow) is expected to be sufficient for our investing activities and to conduct our operations in the near term. Additionally, we held $157.9 million of Level 2 debt investments as of December&#160;31, 2023, which could provide additional liquidity if necessary.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have historically been able to obtain sufficient borrowing capacity, a deterioration in economic conditions or any other negative economic developments could restrict our access to financing in the future. We may not be able to find new financing for future investments or liquidity needs and, even if we are able to obtain such financing, such financing may not be on as favorable terms as we have previously obtained. These factors may limit our ability to make new investments and adversely impact our results of operations. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we had </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$154.9 million in cash and cash equivalents. During the year ended December&#160;31, 2023, cash provided by operating activities was $458.8 million, primarily from receipt of interest payments from our investments, partially offset by purchases of investments, net of sales of investments and principal repayments, of $178.1 million.&#160;Cash used in financing activities was $432.2 million during the year, which was primarily as a result of net repayments on our credit facilities and Unsecured Notes of $650.9 million and dividends paid in cash of $438.0 million partially offset by $665.3 million of proceeds from the issuance of our common shares.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_EffectsOfLeverageTableTextBlock', window );">Effects of Leverage [Table Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the effect of leverage on returns from an investment in our shares assuming various annual returns on our portfolio, net of expenses. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.626%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assumed Return on Our Portfolio (Net of Expenses)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corresponding return to common stockholder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#160;(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-25.52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-15.28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-5.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Based on (i) $10.1 billion in total assets as of December&#160;31, 2023, (ii) $4.9 billion in outstanding indebtedness, at par, as of December&#160;31, 2023, (iii) $5.0 billion in net assets as of December&#160;31, 2023 and (iv)&#160;an annualized average interest rate, including fees (such as fees on undrawn amounts and amortization of financing costs), on our indebtedness, as of December&#160;31, 2023, of 5.05%.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ReturnAtMinusTenPercent', window );">Return at Minus Ten [Percent]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25.52%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ReturnAtMinusFivePercent', window );">Return at Minus Five [Percent]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.28%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ReturnAtZeroPercent', window );">Return at Zero [Percent]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.03%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ReturnAtPlusFivePercent', window );">Return at Plus Five [Percent]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ReturnAtPlusTenPercent', window );">Return at Plus Ten [Percent]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_EffectsOfLeveragePurposeTextBlock', window );">Effects of Leverage, Purpose [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the effect of leverage on returns from an investment in our shares assuming various annual returns on our portfolio, net of expenses. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SharePriceTableTextBlock', window );">Share Price [Table Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the net asset value per share of our common stock, the range of high and low closing sales prices of our common stock reported on the NYSE, the closing sales price as a premium (discount) to net asset value and the dividends declared by us in each fiscal quarter since we began trading on the NYSE.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price Range</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Asset Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High Sales Price Premium (Discount) to Net Asset Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low Sales Price Premium (Discount) to Net Asset Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Dividend Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.26</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Quarter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$27.51</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23.95</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28.77</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26.67</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth Quarter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28.63</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26.06</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Quarter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$31.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$27.88</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28.99</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23.30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Quarter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth Quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24.68</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.35</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth Quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$37.64</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$27.63</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low closing sales prices. The NAV shown are based on outstanding shares at the end of the relevant quarter.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Calculated as the respective high or low closing sales price less NAV, divided by NAV (in each case, as of the applicable quarter). </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents the dividend or distribution declared and payable in the relevant quarter.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity and capital resources are generated primarily from cash flows from interest, dividends and fees earned from our investments and principal repayments, our credit facilities, debt securitization transactions, and other secured and unsecured debt. We may also generate cash flow from operations, future borrowings and future offerings of securities including public and/or private issuances of debt and/or equity securities through both registered offerings and private offerings. The primary uses of our cash and cash equivalents are for (i) originating loans and purchasing senior secured debt investments, (ii) funding the costs of our operations (including fees paid to our Adviser and expense reimbursements paid to our Administrator), (iii) debt service, repayment and other financing costs of our borrowings and (iv) cash distributions to the holders of our shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To&#160;facilitate public issuances of debt and/or equity securities, in July 2022, we filed a shelf registration statement with the SEC that is effective for a term of three years and expires in July 2025. The amount of securities to be issued pursuant to the shelf registration statement filed in July 2022 was not specified when it was filed and there is no specific dollar limit on the amount of securities we may issue. The securities covered by the registration statement filed in July 2022 include: (i) common shares; (ii) preferred shares; (iii) debt securities; (iv) subscription rights; and (v) warrants. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of any offering.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, our debt consisted of asset based leverage facilities, a revolving credit facility, and unsecured note issuances. We may from time to time enter into additional credit facilities, increase the size of our existing credit facilities or issue further debt securities. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors. In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. As of December&#160;31, 2023 and December&#160;31, 2022, we had an aggregate amount of $4,937.9 million and $5,563.0 million of senior securities outstanding, respectively, and our asset coverage ratio was 200.3% and 174.8%, respectively. We seek to carefully consider our unfunded commitments for the purpose of planning our ongoing financial leverage. Further, we maintain sufficient borrowing capacity within the 150% asset coverage limitation to cover any outstanding unfunded commitments we are required to fund. From time to time we may also repurchase our outstanding debt. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, and other factors. The amounts involved in any such purchase transactions, individually or in the aggregate, may be material.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents as of December&#160;31, 2023, taken together with our $1,662.1 million of unused capacity under our credit facilities (subject to borrowing base availability, $1,662.0 million is available to borrow) is expected to be sufficient for our investing activities and to conduct our operations in the near term. Additionally, we held $157.9 million of Level 2 debt investments as of December&#160;31, 2023, which could provide additional liquidity if necessary.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have historically been able to obtain sufficient borrowing capacity, a deterioration in economic conditions or any other negative economic developments could restrict our access to financing in the future. We may not be able to find new financing for future investments or liquidity needs and, even if we are able to obtain such financing, such financing may not be on as favorable terms as we have previously obtained. These factors may limit our ability to make new investments and adversely impact our results of operations. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we had </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$154.9 million in cash and cash equivalents. During the year ended December&#160;31, 2023, cash provided by operating activities was $458.8 million, primarily from receipt of interest payments from our investments, partially offset by purchases of investments, net of sales of investments and principal repayments, of $178.1 million.&#160;Cash used in financing activities was $432.2 million during the year, which was primarily as a result of net repayments on our credit facilities and Unsecured Notes of $650.9 million and dividends paid in cash of $438.0 million partially offset by $665.3 million of proceeds from the issuance of our common shares.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBid', window );">Lowest Price or Bid</a></td>
<td class="nump">$ 26.06<span></span>
</td>
<td class="nump">$ 26.67<span></span>
</td>
<td class="nump">$ 23.95<span></span>
</td>
<td class="nump">$ 22.26<span></span>
</td>
<td class="nump">$ 22.35<span></span>
</td>
<td class="nump">$ 22.11<span></span>
</td>
<td class="nump">$ 23.30<span></span>
</td>
<td class="nump">$ 27.88<span></span>
</td>
<td class="nump">$ 27.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBid', window );">Highest Price or Bid</a></td>
<td class="nump">$ 28.63<span></span>
</td>
<td class="nump">$ 28.77<span></span>
</td>
<td class="nump">$ 27.51<span></span>
</td>
<td class="nump">$ 26.25<span></span>
</td>
<td class="nump">$ 24.68<span></span>
</td>
<td class="nump">$ 25.24<span></span>
</td>
<td class="nump">$ 28.99<span></span>
</td>
<td class="nump">$ 31.75<span></span>
</td>
<td class="nump">$ 37.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent', window );">Highest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="nump">7.40%<span></span>
</td>
<td class="nump">8.40%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="num">(4.80%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">21.50%<span></span>
</td>
<td class="nump">43.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent', window );">Lowest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="num">(2.30%)<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="num">(8.90%)<span></span>
</td>
<td class="num">(14.70%)<span></span>
</td>
<td class="num">(13.80%)<span></span>
</td>
<td class="num">(14.20%)<span></span>
</td>
<td class="num">(10.00%)<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">NAV Per Share</a></td>
<td class="nump">$ 26.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.27<span></span>
</td>
<td class="nump">$ 26.66<span></span>
</td>
<td class="nump">$ 25.20<span></span>
</td>
<td class="nump">$ 26.02<span></span>
</td>
<td class="nump">$ 24.57<span></span>
</td>
<td class="nump">$ 25.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember', window );">Price declines in the medium- and large-sized U.S. corporate debt market may adversely affect the fair value of our portfolio, reducing our NAV through increased net unrealized depreciation. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Price declines in the medium- and large-sized U.S. corporate debt market may adversely affect the fair value of our portfolio, reducing our NAV through increased net unrealized depreciation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conditions in the medium- and large-sized U.S. corporate debt market may deteriorate, as seen during the recent financial crisis, which may cause pricing levels to similarly decline or be volatile. During the 2008-2009 financial crisis, many institutions were forced to raise cash by selling their interests in performing assets in order to satisfy margin requirements or the equivalent of margin requirements imposed by their lenders and/or, in the case of hedge funds and other investment vehicles, to satisfy widespread redemption requests. This resulted in a forced deleveraging cycle of price declines, compulsory sales, and further price declines, with falling underlying credit values, and other constraints resulting from the credit crisis generating further selling pressure. If similar events occurred in the medium- and large-sized U.S. corporate debt market, our NAV could decline through an increase in unrealized depreciation and incurrence of realized losses in connection with the sale of our investments, which could have a material adverse impact on our business, financial condition and results of operations and the market price of our shares.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_AbilityToAchieveInvestmentObjectivesMember', window );">Ability to Achieve Investment Objectives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to achieve our investment objectives depends on the ability of the Adviser to manage and support our investment process. If the Adviser or Blackstone Credit &amp; Insurance were to lose any members of their respective senior management teams, our ability to achieve our investment objectives could be significantly harmed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we have no employees, we depend on the investment expertise, skill and network of business contacts of the broader networks of the Adviser and its affiliates. The Adviser evaluates, negotiates, structures, executes, monitors and services our investments. Our future success depends to a significant extent on the continued service and coordination of Blackstone Credit &amp; Insurance and its senior management team. The departure of any members of Blackstone Credit &amp; Insurance&#8217;s senior management team could have a material adverse effect on our ability to achieve our investment objectives.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to achieve our investment objectives depends on the Adviser&#8217;s ability to identify and analyze, and to invest in, finance and monitor companies that meet our investment criteria. The Adviser&#8217;s capabilities in structuring the investment process, providing competent, attentive and efficient services to us, and facilitating access to financing on acceptable terms depend on the employment of investment professionals in an adequate number and of adequate sophistication to match the corresponding flow of transactions. To achieve our investment objectives, the Adviser may need to hire, train, supervise and manage new investment professionals to participate in our investment selection and monitoring process. The Adviser may not be able to find investment professionals in a timely manner or at all. Failure to support our investment process could have a material adverse effect on our business, financial condition and results of operations.</span></div>The Investment Advisory Agreement has been approved pursuant to Section 15 of the 1940 Act. In addition, the Investment Advisory Agreement has termination provisions that allow the parties to terminate the agreement. The Investment Advisory Agreement may be terminated at any time, without penalty, by us or by the Adviser, upon 60 days&#8217; written notice. If the Investment Advisory Agreement is terminated, it may adversely affect the quality of our investment opportunities. In addition, in the event the Investment Advisory Agreement is terminated, it may be difficult for us to replace the Adviser.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember', window );">The inability of the Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because our business model depends to a significant extent upon relationships with private equity sponsors, investment banks and commercial banks, the inability of the Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser depends on its broader organization&#8217;s relationships with private equity sponsors, investment banks and commercial banks, and we rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the Adviser or its broader organization fail to maintain their existing relationships or develop new relationships with other sponsors or sources of investment opportunities, we may not be able to grow our investment portfolio. In addition, individuals with whom the Adviser or its broader organizations have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember', window );">We may face increasing competition for investment opportunities, which could delay deployment of our capital, reduce returns and result in losses. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face increasing competition for investment opportunities, which could delay deployment of our capital, reduce returns and result in losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete for investments with other BDCs and investment funds (including private equity funds, mezzanine funds, performing and other credit funds, and funds that invest in CLOs, structured notes, derivatives and other types of collateralized securities and structured products), as well as traditional financial services companies such as commercial banks and other sources of funding. These other BDCs and investment funds might be reasonable investment alternatives to us and may be less costly or complex with fewer and/or different risks than we have. Moreover, alternative investment vehicles, such as hedge funds, have begun to invest in areas in which they have not traditionally invested, including making investments in U.S. private companies. As a result of these new competitors entering the financing markets in which we operate, competition for investment opportunities in U.S. private companies may intensify. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of capital and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have. These characteristics could allow our competitors to consider a wider variety of investments, establish more relationships and offer better pricing and more flexible structuring than we are able to do. We may lose investment opportunities if we do not match our competitors&#8217; pricing, terms or structure. If we are forced to match our competitors&#8217; pricing, terms or structure, we may not be able to achieve acceptable returns on our investments or may bear substantial risk of capital loss. A significant part of our competitive advantage stems from the fact that the market for investments in U.S. private companies is underserved by traditional commercial banks and other financial sources. A significant increase in the number and/or the size of our competitors in this target market could force us to accept less attractive investment terms. Furthermore, many of our competitors have greater experience operating under, or are not subject to, the regulatory restrictions that the 1940 Act imposes on us as a BDC.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember', window );">We may have difficulty sourcing investment opportunities. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulty sourcing investment opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure investors that we will be able to locate a sufficient number of suitable investment opportunities to allow us to deploy all available capital successfully. In addition, privately-negotiated investments in loans and illiquid securities of private middle market companies require substantial due diligence and structuring, and we cannot assure investors that we will achieve our anticipated investment pace. As a result, investors will be unable to evaluate any future portfolio company investments prior to purchasing our shares. Our shareholders will have no input with respect to investment decisions. These factors increase the uncertainty, and thus the risk, of investing in our shares. To the extent we are unable to deploy all available capital, our investment income and, in turn, our results of operations, will likely be materially adversely affected.&#160;There is no assurance that we will be able to consummate investment transactions or that such transactions will be successful.&#160;Blackstone Credit &amp; Insurance, the Company and their affiliates may also face certain conflicts of interests in connection with any transaction, including any warehousing transaction, involving an affiliate.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember', window );">We face risks associated with the deployment of our capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks associated with the deployment of our capital.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the nature of our periodic public offerings in relation to our investment strategy and the need to be able to deploy potentially large amounts of capital quickly to capitalize on potential investment opportunities, if we have difficulty identifying suitable investments on attractive terms, there could be a delay between the time we receive net proceeds from the sale of shares of our Common Shares in any periodic public offering and the time we invest the net proceeds. Our proportion of privately-negotiated investments may be lower than expected. We may also from time to time hold cash pending deployment into investments or have less than our targeted leverage, which cash or shortfall in target leverage may at times be significant, particularly at times when we are receiving high amounts of offering proceeds and/or times when there are few attractive investment opportunities. Such cash may be held in an account for the benefit of our shareholders that may be invested in money market accounts or other similar temporary investments, each of which is subject to management fees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event we are unable to find suitable investments such cash may be maintained for longer periods which would be dilutive to overall investment returns. This could cause a substantial delay in the time it takes for your investment to realize its full potential return and could adversely affect our ability to pay regular distributions of cash flow from operations to you. It is not anticipated that the temporary investment of such cash into money market accounts or other similar temporary investments pending deployment into investments will generate significant interest, and investors should understand that such low interest payments on the temporarily invested cash may adversely affect overall returns. In the event we fail to timely invest the net proceeds of sales of our Common Shares or do not deploy sufficient capital to meet our targeted leverage, our results of operations and financial condition may be adversely affected.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember', window );">Uncertainty as to the value of our portfolio investments. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As required by the 1940 Act, a significant portion of our investment portfolio is and will be recorded at fair value as determined in good faith and, as a result, there is and will be uncertainty as to the value of our portfolio investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, we are required to carry our portfolio investments at market value or, if there is no readily available market value, at fair value as determined pursuant to policies adopted by, and subject to the oversight of, our Board. There is not a public market for the securities of the privately-held companies in which we invest. Many of our investments are not publicly-traded or actively traded on a secondary market. As a result, we value these securities quarterly at fair value as determined in good faith as required by the 1940 Act. In connection with striking a NAV as of a date other than quarter end for share issuances and repurchases, the Company will consider whether there has been a material change to such investments as to affect their fair value, but such analysis will be more limited than the quarter end process.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our valuation process, we will take into account relevant factors in determining the fair value of the Company&#8217;s investments, without market quotations, many of which are loans, including and in combination, as relevant: (i) the estimated enterprise value of a portfolio company, (ii) the nature and realizable value of any collateral, (iii) the portfolio company&#8217;s ability to make payments based on its earnings and cash flow, (iv) the markets in which the portfolio company does business, (v) a comparison of the portfolio company&#8217;s securities to any similar publicly traded securities, and (vi) overall changes in the interest rate environment and the credit markets that may affect the price at which similar investments may be made in the future. Our determinations of fair value may differ materially from the values that would have been used if a ready market for these non-traded securities existed. Due to this uncertainty, our fair value determinations may cause our NAV on a given date to materially differ from the value that we may ultimately realize upon the sale of one or more of our investments.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember', window );">There is a risk that investors in our shares may not receive distributions or that our distributions may decrease over time. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There is a risk that investors in our shares may not receive distributions or that our distributions may decrease over time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not achieve investment results that will allow us to make a specified or stable level of cash distributions and our distributions may decrease over time. In addition, due to the asset coverage test applicable to us as a BDC, we may be limited in our ability to make distributions.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember', window );">The amount of any distributions we may make is uncertain. Our distributions may exceed our earnings. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The amount of any distributions we may make is uncertain. Our distributions may exceed our earnings, particularly during the period before we have substantially invested the net proceeds from any securities offering. Therefore, portions of the distributions that we make may represent a return of capital to a shareholder that will lower such shareholder&#8217;s tax basis in its shares and reduce the amount of funds we have for investment in targeted assets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may fund our cash distributions to shareholders from any sources of funds available to us, including offering proceeds, borrowings, net investment income from operations, capital gains proceeds from the sale of assets, non-capital gains proceeds from the sale of assets, dividends or other distributions paid to us on account of preferred and common equity investments in portfolio companies and fee and expense reimbursement waivers from the Adviser or the Administrator, if any. Our ability to pay distributions, if any, might be adversely affected by, among other things, the impact of one or more of the risk factors described in this annual report. In addition, the inability to satisfy the asset coverage test applicable to us as a BDC may limit our ability to pay distributions. All distributions are and will be paid at the discretion of our Board and will depend on our earnings, our financial condition, maintenance of our RIC status, compliance with applicable BDC regulations and such other factors as our Board may deem relevant from time to time. We cannot assure shareholders that we will continue to pay distributions to our shareholders in the future. In the event that we encounter delays in locating suitable investment opportunities, we may pay all or a substantial portion of our distributions from the proceeds of our prior offerings or from borrowings or sources other than cash flow from operations in anticipation of future cash flow, which may constitute a return of shareholders&#8217; capital. A return of capital is a return of a shareholder&#8217;s investment, rather than a return of earnings or gains derived from our investment activities. A shareholder will not be subject to immediate taxation on the amount of any distribution treated as a return of capital to the extent of the shareholder&#8217;s basis in its shares; however, the shareholder&#8217;s basis in its shares will be reduced (but not below zero) by the amount of the return of capital, which will result in the shareholder recognizing additional gain (or a lower loss) when the shares are sold. To the extent that the amount of the return of capital exceeds the shareholder&#8217;s basis in its shares, such excess amount will be treated as gain from the sale of the shareholder&#8217;s shares. Distributions from the proceeds of our prior offerings or from borrowings also could reduce the amount of capital we ultimately invest in our portfolio companies.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember', window );">We have not established any limit on the amount of funds we may use from available sources, such as borrowings, if any, or proceeds from securities offerings, to fund distributions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have not established any limit on the amount of funds we may use from available sources, such as borrowings, if any, or proceeds from securities offerings, to fund distributions (which may reduce the amount of capital we ultimately invest in assets).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any distributions made from sources other than cash flow from operations or relying on fee or expense reimbursement waivers, if any, from the Adviser or the Administrator are not based on our investment performance, and can only be sustained if we achieve positive investment performance in future periods and/or the Adviser or the Administrator continues to make such expense reimbursements, if any. The extent to which we pay distributions from sources other than cash flow from operations will depend on various factors, including the level of participation in our dividend reinvestment plan, how quickly we invest the proceeds from this and any future offering and the performance of our investments. Shareholders should also understand that our future repayments to the Adviser will reduce the distributions that they would otherwise receive. There can be no assurance that we will achieve such performance in order to sustain these distributions, or be able to pay distributions at all. The Adviser and the Administrator have no obligation to waive fees or receipt of expense reimbursements, if any.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember', window );">As a public company, we are subject to regulations. Efforts to comply with such regulations will involve significant expenditures, and non-compliance with such regulations may adversely affect us. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a public reporting company, we are subject to regulations not applicable to private companies, such as provisions of the Sarbanes-Oxley Act. Efforts to comply with such regulations will involve significant expenditures, and non-compliance with such regulations may adversely affect us.</span></div>As a public reporting company, we are subject to the Sarbanes-Oxley Act, and the related rules and regulations promulgated by the SEC. Our management is required to report on our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. We are required to review on an annual basis our internal control over financial reporting, and on a quarterly and annual basis to evaluate and disclose changes in our internal control over financial reporting. Developing and maintaining an effective system of internal controls may require significant expenditures, which may negatively impact our financial performance and our ability to make distributions. This process also will result in a diversion of our management&#8217;s time and attention. We cannot be certain of when our evaluation, testing and remediation actions will be completed or the impact of the same on our operations. In addition, we may be unable to ensure that the process is effective or that our internal controls over financial reporting are or will be effective in a timely manner. In the event that we are unable to develop or maintain an effective system of internal controls and maintain or achieve compliance with the Sarbanes-Oxley Act and related rules, we may be adversely affected.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember', window );">Changes in laws or regulations governing our operations may adversely affect our business or cause us to alter our business strategy. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in laws or regulations governing our operations may adversely affect our business or cause us to alter our business strategy. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, our portfolio companies and other counterparties are subject to regulation at the local, state and federal level. New legislation may be enacted or new interpretations, rulings or regulations could be adopted, including those governing the types of investments we are permitted to make, any of which could harm us and our shareholders, potentially with retroactive effect.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President Biden may support an enhanced regulatory agenda that imposes greater costs on all sectors and on financial services companies in particular. In addition, uncertainty regarding legislation and regulations affecting the financial services industry or taxation could also adversely impact our business or the business of our portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, any changes to or repeal of the laws and regulations governing our operations relating to permitted investments may cause us to alter our investment strategy to avail ourselves of new or different opportunities. Such changes could result in material differences to our strategies and plans as set forth in this annual report and may result in our investment focus shifting from the areas of expertise of the Adviser to other types of investments in which the Adviser may have less expertise or little or no experience. Thus, any such changes, if they occur, could have a material adverse effect on our financial condition and results of operations and the value of a shareholder&#8217;s investment.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember', window );">Financial regulatory changes in the United States could adversely affect our business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial regulatory changes in the United States could adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial services industry continues to be the subject of heightened regulatory scrutiny in the United States. There has been active debate over the appropriate extent of regulation and oversight of investment funds and their managers. We may be adversely affected as a result of new or revised regulations imposed by the SEC or other U.S. governmental regulatory authorities or self-regulatory organizations that supervise the financial markets. We also may be adversely affected by changes in the interpretation or enforcement of existing laws and regulations by these governmental authorities and self-regulatory organizations. Further, new regulations or interpretations of existing laws may result in enhanced disclosure obligations, including with respect to climate change or environmental, social and governance factors, which could negatively affect us and materially increase our regulatory burden. Increased regulations generally increase our costs, and we could continue to experience higher costs if new laws require us to spend more time or buy new technology to comply effectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any changes in the regulatory framework applicable to our business, including the changes described above, may impose additional compliance and other costs, increase regulatory investigations of the investment activities of our funds, require the attention of our senior management, affect the manner in which we conduct our business and adversely affect our profitability. The full extent of the impact on us of any new laws, regulations or initiatives that may be proposed is impossible to determine.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember', window );">We are subject to regulatory oversight, which could negatively impact our operations, cash flow or financial condition, impose additional costs on us or otherwise adversely affect our business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We, the Adviser and its affiliates are subject to regulatory oversight, which could negatively impact our operations, cash flow or financial condition, impose additional costs on us or otherwise adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and the businesses of the Adviser and its affiliates are subject to&#160;extensive regulation, including periodic examinations, inquiries and investigations which may result in enforcement and other proceedings, by governmental agencies&#160;and self-regulatory organizations in the jurisdictions in which we and they operate around the world, including the SEC and various other U.S. federal, state&#160;and local agencies. These&#160;authorities have regulatory powers dealing with many aspects of financial services, including the authority to&#160;grant, and in specific circumstances to cancel, permissions to carry on particular activities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the Adviser and its respective affiliates have received, and may in the future receive, requests for information, inquiries and informal or formal investigations or subpoenas from such regulators from time to time in connection with such inquiries and proceedings and otherwise in the ordinary course of business. These requests could relate to a broad range of matters, including specific practices of our business, the Adviser, our investments or other investments the Adviser or its affiliates make on behalf of their clients, potential conflicts of interest between us and the Adviser or its affiliates, or industry wide practices. SEC actions and initiatives can have an adverse effect on our financial results,&#160;including as a result of the imposition of a sanction, a limitation on our, Blackstone&#8217;s or our personnel&#8217;s&#160;activities, or changing our historic practices. Any adverse publicity relating to an investigation, proceeding or imposition of these sanctions could&#160;harm our or Blackstone&#8217;s reputation and have an&#160;adverse effect on our future fundraising or operations. The costs of responding to legal or regulatory&#160;information requests, any increased reporting, registration and compliance requirements will be borne by us&#160;in the form of legal or other expenses, litigation, regulatory proceedings or penalties, may divert the attention of our management, may cause negative publicity that adversely affects investor sentiment, and may place us at a competitive disadvantage, including to the extent that we, the Adviser or any of its affiliates are required to disclose sensitive business information or alter business practices.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, efforts by the current administration or future administrations could have further impacts on our industry if previously enacted laws are amended or if new legislative or regulatory reforms are adopted. In addition, a future change in administration may lead to leadership changes at a number of U.S. federal regulatory agencies with oversight over the U.S. financial services industry. Such changes would pose uncertainty with respect to such agencies&#8217; ongoing policy priorities and could lead to increased regulatory enforcement activity in the financial services industry. Any changes or reforms may impose additional costs on our current or future investments, require the attention of senior management or result in other limitations on our business or investments. We are unable to predict at this time the likelihood or effect of any such changes or reforms.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember', window );">The impact of financial reform legislation on us is uncertain. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The impact of financial reform legislation on us is uncertain.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of past market conditions in the U.S. and global financial markets, the U.S. and global economy, legislators, the presidential administration and regulators have increased their focus on the regulation of the financial services industry, including the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Dodd-Frank Act,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which instituted a wide range of reforms that have impacted all financial institutions to varying degrees. Because these requirements are relatively new and evolving, the full impact such requirements will have on our business, results of operations or financial condition is unclear. While we cannot predict what effect any changes in the laws or regulations or their interpretations would have on us, these changes could be materially adverse to us and our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any changes in the regulatory framework applicable to our business, including the changes described above, may impose additional compliance and other costs, increase regulatory investigations of the investment activities of our funds, require the attention of our senior management, affect the manner in which we conduct our business and adversely affect our profitability. The full extent of the impact on us of any new laws, regulations or initiatives that may be proposed is impossible to determine.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember', window );">We may experience fluctuations in our quarterly results. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience fluctuations in our quarterly results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could experience fluctuations in our quarterly operating results due to a number of factors, including our ability or inability to make investments in companies that meet our investment criteria, the interest rate payable on the loans or other debt securities we originate or acquire, the level of our expenses (including our borrowing costs), variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our markets and general economic conditions. As a result of these factors, results for any previous period should not be relied upon as being indicative of performance in future periods.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember', window );">Transactions denominated in foreign currencies subject us to foreign currency risks. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transactions denominated in foreign currencies subject us to foreign currency risks.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold assets and have made borrowings denominated in foreign currencies and may acquire assets or make borrowings denominated in other foreign currencies, which exposes us to foreign currency risk. As a result, a change in foreign currency exchange rates may have an adverse impact on the valuation of our assets or liabilities, as well as our income and cash flows. As a result of foreign currency fluctuations, the value of our liabilities and expenses may increase or the value of our assets and income may decrease due to factors outside of our control, which can have a negative effect on our NAV and cash available for distribution. Any such changes in foreign currency exchange rates may impact the measurement of such assets or liabilities for purposes of maintaining RIC tax treatment or the requirements under the 1940 Act. We may seek to hedge against currency exchange rate fluctuations by using financial instruments such as futures, options, swaps and forward contracts, subject to the requirements of the 1940 Act, but there is no guarantee such efforts will be successful and such hedging strategies create additional costs. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;We may acquire various financial instruments for purposes of &#8220;hedging&#8221; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders.&#8221;</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember', window );">General economic conditions could adversely affect the performance of our investments and operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General economic conditions could adversely affect the performance of our investments and operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our portfolio companies are susceptible to the effects of economic slowdowns or recessions. The global growth cycle is in a mature phase and signs of slowdown are evident in certain regions around the world, although most economists continue to expect moderate economic growth in the near term, with limited signals of an imminent recession in the U.S. as consumer and government spending remain healthy. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of non&#8209;performing loans on the balance sheets of European banks, the effect of the United Kingdom (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;U.K.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) leaving the European Union (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;E.U.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), instability in the Chinese capital markets and the COVID-19 pandemic. Although the broader outlook remains constructive, geopolitical instability continues to pose risk. In particular, the current U.S. political environment and the resulting uncertainties regarding actual and potential shifts in U.S. foreign investment, trade, taxation, economic, environmental and other policies under the current Administration, as well as the impact of geopolitical tension, such as a deterioration in the bilateral relationship between the U.S. and China or the current ongoing conflict between Russia and Ukraine and the escalating conflict in the Middle East, and the rapidly evolving measures in response, could lead to disruption, instability and volatility in the global markets. Certain of our portfolio companies may operate in, or have dealings with, countries subject to sanctions or embargoes imposed by the U.S. government, foreign governments, or the United Nations or other international organizations. U.S. debt ceiling and budget deficit concerns have increased the possibility of additional credit-rating downgrades and economic slowdowns or a recession in the United States. A decreased U.S. government credit rating, any default by the U.S. government on its obligations, or any prolonged U.S. government shutdown, could create broader financial turmoil and uncertainty, which may weigh heavily on our financial performance and the value of our common shares. Unfavorable economic conditions would be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events may limit our investment originations, and limit our ability to grow and could have a material negative impact on our operating results, financial condition, results of operations and cash flows and the fair values of our debt and equity investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any deterioration of general economic conditions may lead to significant declines in corporate earnings or loan performance, and the ability of corporate borrowers to service their debt, any of which could trigger a period of global economic slowdown, and have an adverse impact on the performance and financial results of the Company, and the value and the liquidity of the shares. In an economic downturn, we may have non-performing assets or non-performing assets may increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions&#160;impacted&#160;the value of any collateral securing our senior secured debt in 2023 and may continue to impact such collateral in 2024. A severe recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income, assets and net worth. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on favorable terms or at all. These events could prevent us from increasing investments and harm our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the failure of certain financial institutions, namely banks, may increase the possibility of a sustained deterioration of financial market liquidity, or illiquidity at clearing, cash management and/or custodial financial institutions. The failure of a bank (or banks) with which we and/or our portfolio companies have a commercial relationship could adversely affect, among other things, our and/or our portfolio companies&#8217; ability to pursue key strategic initiatives, including by affecting our or our portfolio company&#8217;s ability to access deposits or borrow from financial institutions on favorable terms. Additionally, if a portfolio company or its sponsor has a commercial relationship with a bank that has failed or is otherwise distressed, the portfolio company may experience issues receiving financial support from a sponsor to support its operations or consummate transactions, to the detriment of their business, financial condition and/or results of operations. In addition, such bank failure(s) could affect, in certain circumstances, the ability of both affiliated and unaffiliated co-lenders, including syndicate banks or other fund vehicles, to undertake and/or execute co-investment transactions with the Company, which in turn may result in fewer co-investment opportunities being made available to the Company or impact the Company&#8217;s ability to provide additional follow-on support to portfolio companies. The ability of the Company, its subsidiaries and portfolio companies to spread banking relationships among multiple institutions may be limited by certain contractual arrangements, including liens placed on their respective assets as a result of a bank agreeing to provide financing.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember', window );">Inflation and supply chain risks have had and may continue to have an adverse impact on our financial condition and results of operations. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inflation and supply chain risks have had and may continue to have an adverse impact on our financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflation in the United States remained elevated throughout 2022 and 2023 and may continue to remain high in the future. While inflation has shown signs of moderating, it remains uncertain whether substantial inflation in the United States will be sustained over an extended period of time or have a significant effect on the United States or other economies. Elevated inflation could have an adverse impact on our operating costs, credit facilities, and general and administrative expenses, as these costs could increase at a rate higher than our revenue. Certain of our portfolio companies are in industries that have been impacted by inflation and global supply chain issues. Recent inflationary pressures have increased the costs of labor, energy and raw materials and have adversely affected consumer spending, economic growth and our portfolio companies&#8217; operations and such pressures and related volatility may continue during 2024. If such portfolio companies are unable to pass any increases in their costs of operations along to their customers, it could adversely affect their operating results and impact their ability to pay interest and principal on our loans, particularly if interest rates rise in response to inflation. In addition, any projected future decreases in our portfolio companies&#8217; operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of our investments could result in future realized or unrealized losses and therefore reduce our net assets resulting from operations.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember', window );">We may be impacted by general European economic conditions. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be impacted by general European economic conditions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our investment activities could be affected by general economic and market conditions in Europe and in the rest of the world, as well as by changes in applicable laws and regulations (including laws relating to taxation of our investments), trade barriers, currency exchange controls, rate of inflation, currency depreciation, asset re-investment, resource self-sufficiency and national and international political and socioeconomic circumstances in respect of the European and other non-U.S. countries in which we may invest. These factors will affect the level and volatility of securities prices and the liquidity of the Company&#8217;s investments, which could impair our profitability or result in losses. General fluctuations in the market prices of securities and interest rates may affect our investment opportunities and the value of our investments. We may maintain substantial trading positions that can be adversely affected by the level of volatility in the financial markets; the larger the positions, the greater the potential for loss. Declines in the performance of national economies or the credit markets in certain jurisdictions have had a negative impact on general economic and market conditions globally, and as a result, could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser&#8217;s financial condition may be adversely affected by a significant general economic downturn and it may be subject to legal, regulatory, reputational and other unforeseen risks that could have a material adverse effect on the Adviser&#8217;s businesses and operations (including those of the Company). A recession, slowdown and/or sustained downturn in the global economy (or any particular segment thereof) could have a pronounced impact on the Company and could adversely affect the Company&#8217;s profitability, impede the ability of the Company&#8217;s portfolio companies to perform under or refinance their existing obligations and impair the Company&#8217;s ability to effectively deploy its capital or realize its investments on favorable terms.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, economic problems in a single country are increasingly affecting other markets and economies. A continuation of this trend could result in problems in one country adversely affecting regional and even global economic conditions and markets. For example, concerns about the fiscal stability and growth prospects of certain European countries in the last economic downturn had a negative impact on most economies of the Eurozone and global markets and the current ongoing conflict between Russia and Ukraine could have a negative impact on those countries and others in the region. The occurrence of similar crises in the future could cause increased volatility in the economies and financial markets of countries throughout a region, or even globally.</span></div>Any of the foregoing events could result in substantial or total losses to the Company in respect of certain investments, which losses will likely be exacerbated by the presence of leverage in a portfolio company&#8217;s capital structure.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember', window );">It may be difficult to bring suit or foreclosure in non-U.S. countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">It may be difficult to bring suit or foreclosure in non-U.S. countries.</span></div>Because the effectiveness of the judicial systems in the countries in which the Company may invest varies, the Company (or any portfolio company) may have difficulty in foreclosing or successfully pursuing claims in the courts of such countries, as compared to the United States or other countries. Further, to the extent the Company or a portfolio company may obtain a judgment but is required to seek its enforcement in the courts of one of these countries in which the Company invests, there can be no assurance that such courts will enforce such judgment. The laws of other countries often lack the sophistication and consistency found in the United States with respect to foreclosure, bankruptcy, corporate reorganization or creditors&#8217; rights.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember', window );">Obligations could have an adverse effect on the ability of Blackstone Credit and its MiFID-authorized EEA affiliates to obtain and research in connection with the provision of an investment service. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MiFID II obligations could have an adverse effect on the ability of Blackstone Credit &amp; Insurance and its MiFID-authorized EEA affiliates to obtain and research in connection with the provision of an investment service.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Recast European Union Directive on Markets in Financial Instruments (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;MiFID II&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) came into effect on January 3, 2018, and imposes regulatory obligations in respect of providing financial services in the European Economic Area (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;EEA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by EEA banks and EEA investment firms providing regulated services (each an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Investment Firm&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The Adviser is a non-EEA investment company and is, therefore, not subject to MiFID II but can be indirectly affected. The regulatory obligations imposed by MiFID II may impact, and constrain the implementation of, the investment strategy of the Company. MiFID II restricts Investment Firms&#8217; ability to obtain research in connection with the provision of an investment service. For example, Investment Firms providing portfolio management or independent investment advice may purchase investment research only at their own expense or out of specifically dedicated research payment accounts agreed upon with their clients. Research will also have to be unbundled and paid separately from the trading commission. EEA broker-dealers will unbundle research costs and invoice them to Investment Firms separated from dealing commissions. </span></div>Therefore, in light of the above, MiFID II could have an adverse effect on the ability of Blackstone Credit &amp; Insurance and its MiFID-authorized EEA affiliates to obtain and to provide research. The new requirements regarding the unbundling of research costs under MiFID II are not consistent with market practice in the United States and the regulatory framework concerning the use of commissions to acquire research developed by the SEC, although the SEC has issued temporary no-action letters to facilitate compliance by firms with the research requirements under MiFID II in a manner that is consistent with the U.S. federal securities laws. Blackstone Credit &amp; Insurance&#8217;s access to third-party research may nonetheless be significantly limited. Some EEA jurisdictions extend certain MiFID II obligations also to other market participants (e.g., Alternative Investment Fund Managers) under national law. There is very little guidance, and limited market practice, that has developed in preparation for MiFID II. As such, the precise impact of MiFID II on Blackstone Credit &amp; Insurance and the Company cannot be fully predicted at this stage.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember', window );">Any unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available for distribution. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available for distribution.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at the fair value as determined in good faith pursuant to procedures adopted by, and under oversight of, our Board. Decreases in the market value or fair value of our investments relative to amortized cost will be recorded as unrealized depreciation. Any unrealized losses in our portfolio could be an indication of a portfolio company&#8217;s inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods. In addition, decreases in the market value or fair value of our investments will reduce our NAV.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember', window );">Terrorist attacks, acts of war or natural disasters may adversely affect our operations. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terrorist attacks, acts of war or natural disasters may adversely affect our operations.</span></div>Terrorist acts, acts of war or natural disasters may disrupt our operations, as well as the operations of the businesses in which we invest. Such acts, including the current ongoing conflict between Russia and Ukraine and the escalating conflict in the Middle East, have created, and continue to create, economic and political uncertainties and have contributed to recent global economic instability. Future terrorist activities, military or security operations, or natural disasters could further weaken the domestic/global economies and create additional uncertainties, which may negatively impact the businesses in which we invest directly or indirectly and, in turn, could have a material adverse impact on our business, operating results and financial condition. Losses from terrorist attacks and natural disasters are generally uninsurable.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember', window );">Force Majeure events may adversely affect our operations. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Force Majeure events may adversely affect our operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be affected by force majeure events (e.g., acts of God, fire, flood, earthquakes, outbreaks of an infectious disease, pandemic or any other serious public health concern, war, terrorism, nationalization of industry and labor strikes). Force Majeure events could adversely affect the ability of the Company or a counterparty to perform its obligations. The liability and cost arising out of a failure to perform obligations as a result of a force majeure event could be considerable and could be borne by the Company. Certain Force Majeure events, such as war or an outbreak of an infectious disease, could have a broader negative impact on the global or local economy, thereby affecting us. Additionally, a major governmental intervention into industry, including the nationalization of an industry or the assertion of control, could result in a loss to the Company if an investment is affected, and any compensation provided by the relevant government may not be adequate.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember', window );">Another pandemic or global health crisis like the COVID-19 pandemic may adversely impact our performance and results of operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Another pandemic or global health crisis like the COVID-19 pandemic may adversely impact our performance and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From 2020 to 2022, in response to the COVID-19 pandemic, many countries instituted quarantine restrictions and took other measures to limit the spread of the virus. This resulted in labor shortages and disruption of supply chains and contributed to prolonged disruption of the global economy. A widespread reoccurrence of another pandemic or global health crisis could increase the possibility of periods of increased restrictions on business operations, which may adversely impact our business, financial condition, results of operations, liquidity and prospects materially and exacerbate many of the other risks discussed in this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Risk Factors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of another pandemic or global health crisis like the COVID-19 pandemic, our portfolio companies may experience decreased revenues and earnings, which may adversely impact our ability to realize value from such investments and in turn reduce our performance revenues. Investments in certain sectors, including hospitality, location-based entertainment, retail, travel, leisure and events, and in certain geographies, office and residential, could be particularly negatively impacted, as was the case during the COVID-19 pandemic. Our portfolio companies may also face increased credit and liquidity risk due to volatility in financial markets, reduced revenue streams and limited access or higher cost of financing, which may result in potential impairment of our investments. In addition, borrowers of loans, notes and other credit instruments may be unable to meet their principal or interest payment obligations or satisfy financial covenants, resulting in a decrease in value of our investments. In the event of significant credit market contraction as a result of a pandemic or similar global health crisis, we may be limited in our ability to sell assets at attractive prices or in a timely manner in order to avoid losses and margin calls from credit providers. Shareholders may also be negatively impacted if we experience a decline in the pace of capital deployment or fundraising.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a pandemic or global health crisis may pose enhanced operational risks. For example, the employees of our Adviser and/or its affiliates may become sick or otherwise unable to perform their duties for an extended period, and extended public health restrictions and remote working arrangements may affect our Adviser and/or its affiliates by impacting employee morale, integration of new employees and preservation of their culture. Remote working environments may also be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts. Moreover, our third-party service providers could be impacted by an inability to perform due to pandemic-related restrictions or by failures of, or attacks on, their technology platforms.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember', window );">Cybersecurity risks and data protection could result in the loss of data, interruptions in our business, damage to our reputation, and subject us to regulatory actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity and data protection risks could result in the loss of data, interruptions in our business, and damage to our reputation, and subject us to regulatory actions&#160;, increased costs and financial losses, each of which could have a material adverse effect on our business and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are highly dependent on technology platforms and we rely heavily on Blackstone&#8217;s and its affiliates&#8217; analytical, financial, accounting, communications and other data processing systems. Blackstone&#8217;s and its affiliates&#8217; systems face ongoing cybersecurity threats and attacks, which could result in the loss of confidentiality, integrity or availability of such systems and the data held by such systems. Attacks on Blackstone&#8217;s and/or its affiliates&#8217; systems could involve, and in some instances have in the past involved, attempts intended to obtain unauthorized access to our proprietary information, destroy data or disable, degrade or sabotage our systems, or divert or otherwise steal funds, including through the introduction of computer viruses, &#8220;phishing&#8221; attempts and other forms of social engineering. Attacks on Blackstone&#8217;s and/or its affiliates&#8217; systems could also involve ransomware or other forms of cyber extortion. Cyberattacks and other data security threats could originate from a wide variety of external sources, including cyber criminals, nation state hackers, hacktivists and other outside parties. Cyberattacks and other security threats could also originate from the malicious or accidental acts of insiders, such as employees, consultants, independent contractors or other service providers.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been an increase in the frequency and sophistication of the cyber and data security threats, with attacks ranging from those common to businesses generally to those that are more advanced and persistent, which may target Blackstone and/or its affiliates because they hold a significant amount of confidential and sensitive information about investors, portfolio companies and potential investments. As a result, Blackstone&#8217;s and its affiliates&#8217; may face a heightened risk of a security breach or disruption with respect to this information. Measures taken by Blackstone&#8217;s and/or its affiliates&#8217; to ensure the integrity of their systems may not provide adequate protection, especially because cyberattack techniques are continually evolving, may persist undetected over extended periods of time, and may not be mitigated in a timely manner to prevent or minimize the impact of an attack on Blackstone and/or its affiliates&#8217;, our investors, our portfolio companies or potential investments. If Blackstone&#8217;s and/or its affiliates&#8217; systems or those of third party service providers are compromised either as a result of malicious activity or through inadvertent transmittal or other loss of data, do not operate properly or are disabled, or we fail to provide the appropriate regulatory or other notifications in a timely manner, we could suffer financial loss, increased costs, a disruption of our businesses, liability to our counterparties, portfolio companies or fund investors, regulatory intervention or reputational damage. The costs related to cyber or other data security threats or disruptions may not be fully insured or indemnified by other means.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we could also suffer losses in connection with updates to, or the failure to timely update, the technology platforms on which we rely. We are reliant on third party service providers for certain aspects of our business, including for our administration, as well as for certain technology platforms, including cloud-based services. These third-party service providers could also face ongoing cybersecurity threats and compromises of their systems and as a result, unauthorized individuals could gain, and in some past instances have gained, access to certain confidential data.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybersecurity and data protection have become top priorities for regulators around the world. Many jurisdictions in which we, Blackstone and/or its affiliates operate have laws and regulations relating to privacy, data protection and cybersecurity, including, as examples, the General Data Protection Regulation (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;GDPR&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in the European Union, the U.K. Data Protection Act, and the California Privacy Rights Act (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;CPRA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). For example, in February 2022, the SEC proposed rules regarding registered investment advisers' and funds' cybersecurity risk management requiring the adoption and implementation of cybersecurity policies and procedures, enhanced disclosure in regulatory filings and prompt reporting of incidents to the SEC, which, if adopted, could increase our compliance costs and potential regulatory liability related to cybersecurity. Some jurisdictions have also enacted or proposed laws requiring companies to notify individuals and government agencies of data security breaches involving certain types of personal data.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breaches in our, Blackstone&#8217;s and/or its affiliates&#8217; security or in the security of third party service providers, whether malicious in nature or through inadvertent transmittal or other loss of data, could potentially jeopardize our, Blackstone&#8217;s and/or its affiliates&#8217;, including the Adviser&#8217;s, employees or our shareholders' or counterparties' confidential, proprietary and other information processed and stored in, and transmitted through, computer systems and networks, or otherwise cause interruptions or malfunctions in our, Blackstone&#8217;s and/or its affiliates&#8217;, including the Adviser&#8217;s, employees', our shareholders', our counterparties' or third parties' business and operations, which could result in significant financial losses, increased costs, liability to our shareholders and other counterparties, regulatory intervention and reputational damage. Furthermore, if we, Blackstone and/or its affiliates fail to comply with the relevant laws and regulations or fail to provide the appropriate regulatory or other notifications of breach in a timely matter, it could result in regulatory investigations and penalties, which could lead to negative publicity and reputational harm and may cause our shareholders to lose confidence in the effectiveness of our security measures and Blackstone more generally.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio companies also rely on data processing systems and the secure processing, storage and transmission of information, including payment and health information, which in some instances are provided by third parties. A disruption or compromise of these systems could have a material adverse effect on the value of these businesses. We may invest in strategic assets having a national or regional profile or in infrastructure, the nature of which could expose them to a greater risk of being subject to a terrorist attack or a security breach than other assets or businesses. Such an event may have material adverse consequences on our investment or assets of the same type or may require portfolio companies to increase preventative security measures or expand insurance coverage.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, Blackstone&#8217;s and/or its affiliates&#8217; and our portfolio companies' technology platforms, data and intellectual property are also subject to a heightened risk of theft or compromise to the extent they engage in operations outside the United States, in particular in those jurisdictions that do not have comparable levels of protection of proprietary information and assets such as intellectual property, trademarks, trade secrets, know-how and customer information and records. In addition, they may be required to compromise protections or forego rights to technology, data and intellectual property in order to operate in or access markets in a foreign jurisdiction. Any such direct or indirect compromise of these assets could have a material adverse impact on us and our portfolio companies.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember', window );">We may not be able to obtain and maintain all required state licenses. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to obtain and maintain all required state licenses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to obtain various state licenses in order to, among other things, originate commercial loans. Applying for, obtaining and maintaining required licenses can be costly and take several months. There is no assurance that we will obtain, and maintain, all of the licenses that we need on a timely basis. Furthermore, we will be subject to various information and other requirements in order to obtain and maintain these licenses, and there is no assurance that we will satisfy those requirements. Our failure to obtain or maintain licenses might restrict investment options and have other adverse consequences.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember', window );">Compliance with the SEC&#8217;s Regulation Best Interest by participating broker-dealers may negatively impact our ability to raise capital in a public offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with the SEC&#8217;s Regulation Best Interest by participating broker-dealers may negatively impact our ability to raise capital in a public offering, which could harm our ability to achieve our investment objectives.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Broker-dealers are required to comply with Regulation Best Interest, which, among other requirements, establishes a new standard of conduct for broker-dealers and their associated persons when making a recommendation of any securities transaction or investment strategy involving securities to a retail customer. The full impact of Regulation Best Interest on participating broker-dealers cannot be determined at this time, and it may negatively impact whether participating broker-dealers and their associated persons recommend the offering to certain retail customers. In particular, under SEC guidance concerning Regulation Best Interest, a broker-dealer recommending an investment in our shares should consider a number of factors, under the care obligation of Regulation Best Interest, including but not limited to cost and complexity of the investment and reasonably available alternatives in determining whether there is a reasonable basis for the recommendation. As a result, high cost, high risk and complex products may be subject to greater scrutiny by broker-dealers. Broker-dealers may recommend a more costly or complex product as long as they have a reasonable basis to believe is in the best interest of a particular retail customer. However, if broker-dealers choose alternatives to our shares, many of which likely exist, such as an investment in listed entities, which may be a reasonable alternative to an investment in us as such investments may feature characteristics like lower cost, nominal commissions at the time of initial purchase, less complexity and lesser or different risks, our ability to raise capital will be adversely affected. If compliance by broker-dealers with Regulation Best Interest negatively impacts our ability to raise capital in a public offering, it may harm our ability to create a diversified portfolio of investments and achieve our investment objectives.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember', window );">As a Delaware statutory trust, we are subject to the control share acquisition statute contained in the Delaware Statutory Trust Act. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a Delaware statutory trust, we are subject to the control share acquisition statute contained in the Delaware Statutory Trust Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is organized as a Delaware statutory trust and thus is subject to the control share acquisition statute contained in Subchapter III of the Delaware Statutory Trust Act (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;DSTA Control Share Statute&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The DSTA Control Share Statute applies to any closed-end management investment company that has elected to be regulated as a business development company under the 1940 Act organized as a Delaware statutory trust and listed on a national securities exchange, such as the Company. The DSTA Control Share Statute became automatically applicable to the Company on August 1, 2022.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSTA Control Share Statute defines &#8220;control beneficial interests&#8221; (referred to as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;control shares&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein) by reference to a series of voting power thresholds and provides that a holder of control shares acquired in a control share acquisition has no voting rights under the Delaware Statutory Trust Act (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;DSTA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or the Company&#8217;s governing documents with respect to the control shares acquired in the control share acquisition, except to the extent approved by the Company&#8217;s shareholders by the affirmative vote of two&#8211;thirds of all the votes entitled to be cast on the matter, excluding all interested shares (generally, shares held by the acquiring person and their associates and shares held by Company insiders).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSTA Control Share Statute provides for a series of voting power thresholds above which shares are considered control shares. Whether one of these thresholds of voting power is met is determined by aggregating the holdings of the acquiring person as well as those of his, her or its &#8220;associates.&#8221; These thresholds are:</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) 10% or more, but less than 15% of all voting power;</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) 15% or more, but less than 20% of all voting power;</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) 20% or more, but less than 25% of all voting power;</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) 25% or more, but less than 30% of all voting power;</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5) 30% or more, but less than a majority of all voting power; or</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6) a majority or more of all voting power.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the DSTA Control Share Statute, once a threshold is reached, an acquirer has no voting rights with respect to shares in excess of that threshold (i.e., the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;control shares&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) until approved by a vote of shareholders, as described above, or otherwise exempted by the Board of Trustees. The DSTA Control Share Statute contains a statutory process for an acquiring person to request a shareholder meeting for the purpose of considering the voting rights to be accorded control shares. An acquiring person must repeat this process at each threshold level.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the DSTA Control Share Statute, an acquiring person&#8217;s &#8220;associates&#8221; are broadly defined to include, among others, relatives of the acquiring person, anyone in a control relationship with the acquiring person, any investment fund or other collective investment vehicle that has the same investment adviser as the acquiring person, any investment adviser of an acquiring person that is an investment fund or other collective investment vehicle and any other person acting or intending to act jointly or in concert with the acquiring person.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Voting power under the DSTA Control Share Statute is the power (whether such power is direct or indirect or through any contract, arrangement, understanding, relationship or otherwise) to directly or indirectly exercise or direct the exercise of the voting power of shares of the Company in the election of the Trustees (either generally or with respect to any subset, series or class of trustees, including any Trustees elected solely by a particular series or class of shares, such as the preferred shares).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any control shares of the Company acquired before August 1, 2022 are not subject to the DSTA Control Share Statute; however, any further acquisitions on or after August 1, 2022 are considered control shares subject to the DSTA Control Share Statute.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSTA Control Share Statute requires shareholders to disclose to the Company any control share acquisition within 10 days of such acquisition, and also permits the Company to require a shareholder or an associate of such person to disclose the number of shares owned or with respect to which such person or an associate thereof can directly or indirectly exercise voting power. Further, the DSTA Control Share Statute requires a shareholder or an associate of such person to provide to the Company within 10 days of receiving a request therefor from the Company any information that the Trustees reasonably believe is necessary or desirable to determine whether a control share acquisition has occurred.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSTA Control Share Statute permits the Board, through a provision in the Company&#8217;s governing documents or by Board action alone, to eliminate the application of the DSTA Control Share Statute to the acquisition of control shares in the Company specifically, generally, or generally by types, as to specifically identified or unidentified existing or future beneficial owners or their affiliates or associates or as to any series or classes of shares. The DSTA Control Share Statute does not provide that the Company can generally &#8220;opt out&#8221; of the application of the DSTA Control Share Statute; rather, specific acquisitions or classes of acquisitions may be exempted by the Board, either in advance or retroactively, but other aspects of the DSTA Control Share Statute, which are summarized above, would continue to apply. The DSTA Control Share Statute further provides that the Board of Trustees is under no obligation to grant any such exemptions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing is only a summary of the material terms of the DSTA Control Share Statute. Shareholders should consult their own counsel with respect to the application of the DSTA Control Share Statute to any particular circumstance.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember', window );">Exclusive forum and jury trial waiver provisions that could limit a shareholder&#8217;s ability to bring a claim, may cause the Company to incur additional costs associated with such action. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Declaration of Trust includes exclusive forum and jury trial waiver provisions that could limit a shareholder&#8217;s ability to bring a claim or, if such provisions are deemed inapplicable or unenforceable by a court, may cause the Company to incur additional costs associated with such action.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Declaration of Trust provides that, to the fullest extent permitted by law, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of a duty owed by any trustee, officer or other agent of the Company to the Company or our shareholders, (iii) any action asserting a claim arising pursuant to any provision of Title 12 of the Delaware Code, Delaware statutory or common law, our Declaration of Trust, or (iv) any action asserting a claim governed by the internal affairs doctrine (for the avoidance of doubt, including any claims brought to interpret, apply or enforce the federal securities laws of the United States, including, without limitation, the 1940 Act or the securities or anti-fraud laws of any international, national, state, provincial, territorial, local or other governmental or regulatory authority, including, in each case, the applicable rules and regulations promulgated thereunder) shall be the Court of Chancery of the State of Delaware or, if such court does not have subject matter jurisdiction thereof, any other court in the State of Delaware with subject matter jurisdiction. In addition, our Declaration of Trust provides that no shareholder may maintain a derivative action on behalf of the Company unless holders of at least ten percent (10%) of the outstanding shares join in the bringing of such action. These provisions of our Declaration of Trust may make it more difficult for shareholders to bring a derivative action than a company without such provisions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Declaration of Trust also includes an irrevocable waiver of the right to trial by jury in all such claims, suits, actions and proceedings. Any person purchasing or otherwise acquiring any of our Common Shares shall be deemed to have notice of and to have consented to these provisions of our Declaration of Trust. These provisions may limit a shareholder&#8217;s ability to bring a claim in a judicial forum or in a manner that it finds favorable for disputes with the Company or the Company&#8217;s trustees or officers, which may discourage such lawsuits. Alternatively, if a court were to find the exclusive forum provision or the jury trial waiver provision to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions or in other manners, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any of the foregoing, neither we nor any of our investors are permitted to waive compliance with any provision of the U.S. federal securities laws and the rules and regulations promulgated thereunder.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember', window );">Our Board may change our operating policies and strategies without prior notice or shareholder approval, the effects of which may be adverse to our results of operations and financial condition. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Board may change our operating policies and strategies without prior notice or shareholder approval, the effects of which may be adverse to our results of operations and financial condition.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board has the authority to modify or waive our current operating policies, investment criteria and strategies without prior notice and without shareholder approval, unless required by the 1940 Act or applicable law. We cannot predict the effect any changes to our current operating policies, investment criteria and strategies would have on our business, NAV, operating results and value of our shares. However, the effects might be adverse, which could negatively impact our ability to pay shareholders distributions and cause shareholders to lose all or part of their investment. Moreover, we have significant flexibility in investing the net proceeds from our continuous offering and may use the net proceeds from our continuous offering in ways with which investors may not agree or for purposes other than those contemplated in this annual report.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember', window );">Our Board may amend our Declaration of Trust without prior shareholder approval. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Board may amend our Declaration of Trust without prior shareholder approval.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board may, without shareholder vote, subject to certain exceptions, amend or otherwise supplement the Declaration of Trust by making an amendment, a Declaration of Trust supplemental thereto or an amended and restated Declaration of Trust, including without limitation to classify the Board, to impose advance notice bylaw provisions for Trustee nominations or for shareholder proposals, to require super-majority approval of transactions with significant shareholders or other provisions that may be characterized as anti-takeover in nature.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember', window );">Certain provisions of our Declaration of Trust could deter takeover attempts and have an adverse impact on the value of our common shares. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain provisions of our Declaration of Trust could deter takeover attempts and have an adverse impact on the value of our common shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Declaration of Trust contains anti-takeover provisions that could have the effect of limiting the ability of other entities or persons to acquire control of the Company or to change the composition of our Board of Trustees. Our Board of Trustees is divided into three classes of trustees serving staggered three-year terms. This provision could delay for up to two years the replacement of a majority of our Board of Trustees. These provisions could have the effect of depriving shareholders of an opportunity to sell their common shares at a premium over prevailing market prices by discouraging a third party from seeking to obtain control over the Company.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember', window );">Our investments in prospective portfolio companies may be risky, and we could lose all or part of our investment. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in prospective portfolio companies may be risky, and we could lose all or part of our investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in senior secured loans, senior secured bonds, subordinated debt and equity of private U.S. companies, including middle market companies, may be risky and, subject to compliance with our 80% policy, there is no limit on the amount of any such investments in which we may invest.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Loans and Senior Secured Bonds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a risk that any collateral pledged by portfolio companies in which we have taken a security interest may decrease in value over time or lose its entire value, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. Such risks have become more pronounced due to rising interest rates and market volatility.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent our debt investment is collateralized by the securities of a portfolio company&#8217;s subsidiaries, such securities may lose some or all of their value in the event of the bankruptcy or insolvency of the portfolio company. Also, in some circumstances, our security interest may be contractually or structurally subordinated to claims of other creditors. In addition, deterioration in a portfolio company&#8217;s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the debt. Secured debt that is under-collateralized involves a greater risk of loss. In addition, second lien debt is granted a second priority security interest in collateral, which means that any realization of collateral will generally be applied to pay senior secured debt in full before second lien debt is paid. Similarly, investments in &#8220;last out&#8221; pieces of unitranche loans will be similar to second lien loans in that such investments will be junior in priority to the &#8220;first out&#8221; piece of the same unitranche loan with respect to payment of principal, interest and other amounts. Consequently, the fact that debt is secured does not guarantee that we will receive principal and interest payments according to the debt&#8217;s terms, or at all, or that we will be able to collect on the debt should we be forced to enforce our remedies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subordinated Debt. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our subordinated debt investments will generally rank junior in priority of payment to senior debt and will generally be unsecured. This may result in a heightened level of risk and volatility or a loss of principal, which could lead to the loss of the entire investment. These investments may involve additional risks that could adversely affect our investment returns. To the extent interest payments associated with such debt are deferred, such debt may be subject to greater fluctuations in valuations, and such debt could subject us and our shareholders to non-cash income. Because we will not receive any principal repayments prior to the maturity of some of our subordinated debt investments, such investments will be of greater risk than amortizing loans.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may make select equity investments. In addition, in connection with our debt investments, we on occasion may receive equity interests such as warrants or options as additional consideration. The equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in preferred securities involve certain risks. Certain preferred securities contain provisions that allow an issuer under certain conditions to skip or defer distributions. If the Company owns a preferred security that is deferring its distribution, the Company may be required to include the amount of the deferred distribution in its taxable income for tax purposes although it does not currently receive such amount in cash. In order to receive the special treatment accorded to RICs and their shareholders under the Code and to avoid U.S. federal income and/or excise taxes at the Company level, the Company may be required to distribute this income to shareholders in the tax year in which the income is recognized (without a corresponding receipt of cash). Therefore, the Company may be required to pay out as an income distribution in any such tax year an amount greater than the total amount of cash income the Company actually received, and to sell portfolio securities, including at potentially disadvantageous times or prices, to obtain cash needed for these income distributions. Preferred securities often are subject to legal provisions that allow for redemption in the event of certain tax or legal changes or at the issuer&#8217;s call. In the event of redemption, the Company may not be able to reinvest the proceeds at comparable rates of return. Preferred securities are subordinated to bonds and other debt securities in an issuer&#8217;s capital structure in terms of priority for corporate income and liquidation payments, and therefore will be subject to greater credit risk than those debt securities. Preferred securities may trade less frequently and in a more limited volume and may be subject to more abrupt or erratic price movements than many other securities, such as common stocks, corporate debt securities and U.S. government securities. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-U.S. Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may invest in non-U.S. securities, which may include securities denominated in U.S. dollars or in non-U.S. currencies, to the extent permitted by the 1940 Act. Because evidence of ownership of such securities usually is held outside the United States, we would be subject to additional risks if we invested in non-U.S. securities, which include possible adverse political and economic developments, seizure or nationalization of foreign deposits and adoption of governmental restrictions, which might adversely affect or restrict the payment of principal and interest on the non-U.S. securities to shareholders located outside the country of the issuer, whether from currency blockage or otherwise. Because non-U.S. securities may be purchased with and payable in foreign currencies, the value of these assets as measured in U.S. dollars may be affected unfavorably by changes in currency rates and exchange control regulations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loans Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The loans that the Company may invest in include loans that are first lien, second lien, third lien or that are unsecured. In addition, the loans the Company will invest in will usually be rated below investment grade or may also be unrated. Loans are subject to a number of risks described elsewhere in the prospectus, including credit risk, liquidity risk, below investment grade instruments risk and management risk. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although certain loans in which the Company may invest will be secured by collateral, there can be no assurance that such collateral could be readily liquidated or that the liquidation of such collateral would satisfy the borrower&#8217;s obligation in the event of non-payment of scheduled interest or principal. In the event of the bankruptcy or insolvency of a borrower, the Company could experience delays or limitations with respect to its ability to realize the benefits of the collateral securing a loan. In the event of a decline in the value of the already pledged collateral, if the terms of a loan do not require the borrower to pledge additional collateral, the Company will be exposed to the risk that the value of the collateral will not at all times equal or exceed the amount of the borrower&#8217;s obligations under the loans. To the extent that a loan is collateralized by stock in the borrower or its subsidiaries, such stock may lose some or all of its value in the event of the bankruptcy or insolvency of the borrower. Those loans that are under-collateralized involve a greater risk of loss. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, there is a risk that any collateral pledged by portfolio companies in which the Company has taken a security interest may decrease in value over time or lose its entire value, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. To the extent the Company&#8217;s debt investment is collateralized by the securities of a portfolio company&#8217;s subsidiaries, such securities may lose some or all of their value in the event of the bankruptcy or insolvency of the portfolio company. Also, in some circumstances, the Company&#8217;s security interest may be contractually or structurally subordinated to claims of other creditors. In addition, deterioration in a portfolio company&#8217;s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the debt. Secured debt that is under-collateralized involves a greater risk of loss. In addition, second lien debt is granted a second priority security interest in collateral, which means that any realization of collateral will generally be applied to pay senior secured debt in full before second lien debt is paid. Consequently, the fact that debt is secured does not guarantee that the Company will receive principal and interest payments according to the debt&#8217;s terms, or at all, or that the Company will be able to collect on the debt should it be forced to enforce remedies. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans are not registered with the SEC, or any state securities commission, and are not listed on any national securities exchange. There is less readily available or reliable information about most loans than is the case for many other types of securities, including securities issued in transactions registered under the Securities Act or registered under the Exchange Act. No active trading market may exist for some loans, and some loans may be subject to restrictions on resale. A secondary market may be subject to irregular trading activity, wide bid/ask spreads and extended trade settlement periods, which may impair the ability to realize full value and thus cause a material decline in the Company&#8217;s NAV. In addition, the Company may not be able to readily dispose of its loans at prices that approximate those at which the Company could sell such loans if they were more widely-traded and, as a result of such illiquidity, the Company may have to sell other investments or engage in borrowing transactions if necessary to raise cash to meet its obligations. During periods of limited supply and liquidity of loans, the Company&#8217;s yield may be lower. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some loans are subject to the risk that a court, pursuant to fraudulent conveyance or other similar laws, could subordinate the loans to presently existing or future indebtedness of the borrower or take other action detrimental to lenders, including the Company. Such court action could under certain circumstances include invalidation of loans. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If legislation of state or federal regulations impose additional requirements or restrictions on the ability of financial institutions to make loans, the availability of loans for investment by the Company may be adversely affected. In addition, such requirements or restrictions could reduce or eliminate sources of financing for certain borrowers. This would increase the risk of default. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If legislation or federal or state regulations require financial institutions to increase their capital requirements this may cause financial institutions to dispose of loans that are considered highly levered transactions. Such sales could result in prices that, in the opinion of the Adviser, do not represent fair value. If the Company attempts to sell a loan at a time when a financial institution is engaging in such a sale, the price the Company could get for the loan may be adversely affected. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may acquire loans through assignments or participations. The Company will typically acquire loans through assignment. The purchaser of an assignment typically succeeds to all the rights and obligations of the assigning institution and becomes a lender under the credit agreement with respect to the debt obligation; however, the purchaser&#8217;s rights can be more restricted than those of the assigning institution, and the Company may not be able to unilaterally enforce all rights and remedies under the loan and with regard to any associated collateral. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A participation typically results in a contractual relationship only with the institution selling the participation interest, not with the borrower. Sellers of participations typically include banks, broker-dealers, other financial institutions and lending institutions. Certain participation agreements also include the option to convert the participation to a full assignment under agreed upon circumstances. The Adviser has adopted best execution procedures and guidelines to mitigate credit and counterparty risk in the atypical situation when the Company must acquire a loan through a participation. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In purchasing participations, the Company generally will have no right to enforce compliance by the borrower with the terms of the loan agreement against the borrower, and the Company may not directly benefit from the collateral supporting the debt obligation in which it has purchased the participation. As a result, the Company will be exposed to the credit risk of both the borrower and the institution selling the participation. Further, in purchasing participations in lending syndicates, the Company will not be able to conduct the due diligence on the borrower or the quality of the loan with respect to which it is buying a participation that the Company would otherwise conduct if it were investing directly in the loan, which may result in the Company being exposed to greater credit or fraud risk with respect to the borrower or the loan than the Company expected when initially purchasing the participation. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also may originate loans or acquire loans by participating in the initial issuance of the loan as part of a syndicate of banks and financial institutions, or receive its interest in a loan directly from the borrower. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser has established a counterparty and liquidity sub-committee that regularly reviews each broker-dealer counterparty for, among other things, its quality and the quality of its execution. The established procedures and guidelines require trades to be placed for execution only with broker counterparties approved by the counterparty and liquidity sub-committee of the Adviser. The factors considered by the sub-committee when selecting and approving brokers and dealers include, but are not limited to: (i) quality, accuracy, and timeliness of execution, (ii) review of the reputation, financial strength and stability of the financial institution, (iii) willingness and ability of the counterparty to commit capital, (iv) ongoing reliability and (v) access to underwritten offerings and secondary markets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Junior, Unsecured Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our strategy may entail acquiring securities that are junior or unsecured instruments. While this approach can facilitate obtaining control and then adding value through active management, it also means that certain of the Company&#8217;s investments may be unsecured. If a portfolio company becomes financially distressed or insolvent and does not successfully reorganize, we will have no assurance (compared to those distressed securities investors that acquire only fully collateralized positions) that we will recover any of the principal that we have invested. Similarly, investments in &#8220;last out&#8221; pieces of unitranche loans will be similar to second lien loans in that such investments will be junior in priority to the &#8220;first out&#8221; piece of the same unitranche loan with respect to payment of principal, interest and other amounts. Consequently, the fact that debt is secured does not guarantee that we will receive principal and interest payments according to the debt&#8217;s terms, or at all, or that we will be able to collect on the debt should it be forced to enforce its remedies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While such junior or unsecured investments may benefit from the same or similar financial and other covenants as those enjoyed by the indebtedness ranking more senior to such investments and may benefit from cross-default provisions and security over the issuer&#8217;s assets, some or all of such terms may not be part of particular Investments. Moreover, our ability to influence an issuer&#8217;s affairs, especially during periods of financial distress or following insolvency, is likely to be substantially less than that of senior creditors. For example, under typical subordination terms, senior creditors are able to block the acceleration of the junior debt or the exercise by junior debt holders of other rights they may have as creditors. Accordingly, we may not be able to take steps to protect investments in a timely manner or at all, and there can be no assurance that our rate of return objectives or any particular investment will be achieved. In addition, the debt securities in which we will invest may not be protected by financial covenants or limitations upon additional indebtedness, may have limited liquidity and are not expected to be rated by a credit rating agency.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early repayments of our investments may have a material adverse effect on our investment objectives. In addition, depending on fluctuations of the equity markets and other factors, warrants and other equity investments may become worthless.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that attempts to provide downside protection through contractual or structural terms with respect to our investments will achieve their desired effect and potential investors should regard an investment in us as being speculative and having a high degree of risk. Furthermore, we have limited flexibility to negotiate terms when purchasing newly issued investments in connection with a syndication of mezzanine or certain other junior or subordinated investments or in the secondary market.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Below Investment Grade Risk. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as &#8220;junk,&#8221; have predominantly speculative characteristics with respect to the issuer&#8217;s capacity to pay interest and repay principal. They may also be difficult to value and illiquid. The major risks of below investment grade securities include:</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Below investment grade securities may be issued by less creditworthy issuers. Issuers of below investment grade securities may have a larger amount of outstanding debt relative to their assets than issuers of investment grade securities. In the event of an issuer&#8217;s bankruptcy, claims of other creditors may have priority over the claims of holders of below investment grade securities, leaving few or no assets available to repay holders of below investment grade securities.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Prices of below investment grade securities are subject to extreme price fluctuations. Adverse changes in an issuer&#8217;s industry and general economic conditions may have a greater impact on the prices of below investment grade securities than on other higher-rated fixed-income securities.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Issuers of below investment grade securities may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments, or the unavailability of additional financing.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Below investment grade securities frequently have redemption features that permit an issuer to repurchase the security from us before it matures. If the issuer redeems below investment grade securities, we may have to invest the proceeds in securities with lower yields and may lose income.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Below investment grade securities may be less liquid than higher-rated fixed-income securities, even under normal economic conditions. There are fewer dealers in the below investment grade securities market, and there may be significant differences in the prices quoted by the dealers. Judgment may play a greater role in valuing these securities and we may be unable to sell these securities at an advantageous time or price.</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit rating of a high-yield security does not necessarily address its market value risk. Ratings and market value may change from time to time, positively or negatively, to reflect new developments regarding the issuer.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mezzanine Loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Our mezzanine loans generally will be subordinated to senior secured loans on a payment basis, are typically unsecured and rank</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pari passu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with other unsecured creditors.&#160;As such, other creditors may rank senior to us in the event of insolvency.&#160;This may result in an above average amount of risk and loss of principal. Our mezzanine debt securities generally will have ratings or implied or imputed ratings below investment grade. They will be obligations of corporations, partnerships or other entities that are generally unsecured, typically are subordinated to other obligations of the obligor and generally have greater credit and liquidity risk than is typically associated with investment grade corporate obligations. Accordingly, the risks associated with mezzanine debt securities include a greater possibility that adverse changes in the financial condition of the obligor or in general economic conditions (including a sustained period of rising interest rates or an economic downturn) may adversely affect the obligor&#8217;s ability to pay principal and interest on its debt. Many obligors on mezzanine debt securities are highly leveraged, and specific developments affecting such obligors, including reduced cash flow from operations or the inability to refinance debt at maturity, may also adversely affect such obligors&#8217; ability to meet debt service obligations. Mezzanine debt securities are often issued in connection with leveraged acquisitions or recapitalizations, in which the issuers incur a substantially higher amount of indebtedness than the level at which they had previously operated. Default rates for mezzanine debt securities have historically been higher than has been the case for investment grade securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Retention Vehicles</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We may invest in CLO debt and equity tranches and warehouse investments directly or indirectly through an investment in U.S. and/or European vehicles (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Retention Vehicles</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) established for the purpose of satisfying U.S. and/or E.U. regulations that require eligible risk retainers to purchase and retain specified amounts of the credit risk associated with certain CLOs, which vehicles themselves are invested in CLO securities, warehouse investments and/or senior secured obligations. Risk Retention Vehicles will be structured to satisfy the retention requirements by purchasing and retaining the percentage of CLO notes prescribed under the applicable retention requirements (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retention Notes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and will not include Risk Retention Vehicles that are deemed to be controlled by the Adviser or its affiliates (other than Risk Retention Vehicles we control).</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indirect investments in CLO equity securities (and in some instances more senior CLO securities) and warehouse investments through entities that have been established to satisfy the U.S. retention requirements and/or the European retention requirements may allow for better economics for us (including through fee rebate arrangements) by creating stronger negotiating positions with CLO managers and underwriting banks who are incentivized to issue CLOs and who require the participation of a Risk Retention Vehicle to enable the CLO securities to be issued. However, Retention Notes differ from other securities of the same ranking since the retention requirements prescribe that such Retention Notes must be held by the relevant risk retainer for a specified period. In the case of European Risk Retention Vehicles, the prescribed holding period is the lifetime of the CLO, and in the case of U.S. Risk Retention Vehicles it is the longer of (x) the period until the CLO has paid down its securities to 33% of their original principal amount, (y) the period until the CLO has sold down its assets to 33% of their original principal amount and (z) two years after the closing of the CLO. In addition, Retention Notes are subject to other restrictions not imposed on other securities of the same ranking; for example, Retention Notes may not be subject to credit risk mitigation, and breach of the retention requirements may result in the imposition of regulatory sanctions or, in the case of the European retention requirements, in claims being brought against the retaining party.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Covenant-lite&#8221; Obligations.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We may invest in, or obtain exposure to, obligations that may be &#8220;covenant-lite,&#8221; which means such obligations lack certain financial maintenance covenants. While these loans may still contain other collateral protections, a covenant-lite loan may carry more risk than a covenant-heavy loan made by the same borrower, as it does not require the borrower to provide affirmation that certain specific financial tests have been satisfied on a routine basis as is required under a covenant-heavy loan agreement. Should a loan we hold begin to deteriorate in quality, our ability to negotiate with the borrower may be delayed under a covenant-lite loan compared to a loan with full maintenance covenants. This may in turn delay our ability to seek to recover its investment.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consumer Loans.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We may invest in, or obtain exposure to, consumer lending, which involves risk elements in addition to normal credit risk. Consumer loan terms vary according to the type and value of collateral and creditworthiness of the borrower. In underwriting consumer loans, a thorough analysis of the borrower&#8217;s financial ability to repay the loan as agreed is typically performed. The ability to repay shall be determined by, among others, the borrower&#8217;s employment history, current financial conditions, and credit background. While these loans typically have higher yields than many other loans, such loans involve risk elements in addition to normal credit risk. Consumer loans may entail greater credit risk than other loans particularly in the case of unsecured consumer loans or consumer loans secured by rapidly depreciable assets, such as automobiles. In such cases, any repossessed collateral for a defaulted consumer loan may not provide an adequate source of repayment of the outstanding loan balance as a result of the greater likelihood of damage, loss or depreciation. In addition, consumer loan collections are dependent on the borrower&#8217;s continuing financial stability, and thus are more likely to be affected by adverse personal circumstances. During periods of deteriorating economic conditions, such as recessions or periods of rising unemployment, delinquencies and losses generally increase, sometimes dramatically, with respect to consumer loans. Furthermore, the application of various federal and state laws, including bankruptcy and insolvency laws, and/or state consumer protection laws may limit the amount which can be recovered on such loans.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bridge Financings.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> From time to time, we may lend to portfolio companies on a short-term, unsecured basis or otherwise invest on an interim basis in portfolio companies in anticipation of a future issuance of equity or long-term debt securities or other refinancing or syndication. Such bridge loans would typically be convertible into a more permanent, long-term security; however, for reasons not always in the Company&#8217;s control, such long-term securities issuance or other refinancing or syndication may not occur and such bridge loans and interim investments may remain outstanding. In such event, the interest rate on such loans or the terms of such interim investments may not adequately reflect the risk associated with the position taken by the Company.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructurings.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in companies operating in workout or bankruptcy modes present additional legal risks, including fraudulent conveyance, voidable preference and equitable subordination risks. The level of analytical sophistication, both financial and legal, necessary for successful investment in companies experiencing significant business and financial difficulties is unusually high. There is no assurance that we will correctly evaluate the value of the assets collateralizing our loans or the prospects for a successful reorganization or similar action.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember', window );">We are exposed to risks associated with changes in interest rates. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to risks associated with changes in interest rates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to financial market risks, including changes in interest rates. General interest rate fluctuations may have a substantial negative impact on our investments and investment opportunities and, accordingly, have a material adverse effect on our investment objectives and our rate of return on invested capital. In addition, an increase in interest rates would make it more expensive to use debt for our financing needs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During periods of falling interest rates, payments under the floating rate debt instruments that we hold would generally decrease, resulting in less revenue to us. In the event of a sharply rising interest rate environment, such as during 2022 and 2023, payments under floating rate debt instruments generally would rise and there may be a significant number of issuers of such floating rate debt instruments that would be unable or unwilling to pay such increased interest costs and may otherwise be unable to repay their loans. Investments in floating rate debt instruments may also decline in value in response to rising interest rates if the interest rates of such investments do not rise as much, or as quickly, as market interest rates in general. Similarly, during periods of rising interest rates, fixed-rate debt instruments may decline in value because the fixed rates of interest paid thereunder may be below market interest rates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, an increase in interest rates would make it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase in the amount of incentive fees payable to the Adviser with respect to pre-incentive fee net investment income.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember', window );">Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio companies may have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt in which we invest. By their terms, such debt instruments may entitle the holders to receive payment of interest or principal on or before the dates on which we are entitled to receive payments with respect to the debt instruments in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any proceeds. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt instruments in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember', window );">There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If one of our portfolio companies were to file for bankruptcy, depending on the facts and circumstances, including the extent to which we actually provided managerial assistance to that portfolio company, a bankruptcy court might re-characterize our debt investment and subordinate all or a portion of our claim to that of other creditors. We may also be subject to lender liability claims for actions taken by us with respect to a borrower&#8217;s business or instances where we exercise control over the borrower.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember', window );">We generally do not control our portfolio companies. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We generally do not control our portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not expect to control most of our portfolio companies, even though we may have board representation or board observation rights, and our debt agreements with such portfolio companies may contain certain restrictive covenants. As a result, we are subject to the risk that a portfolio company in which we invest may make business decisions with which we disagree and the management of such company, as representatives of the holders of the company&#8217;s common equity, may take risks or otherwise act in ways that do not serve our interests as debt investors. Due to the lack of liquidity for our investments in non-traded companies, we may not be able to dispose of our interests in our portfolio companies as readily as we would like or at an appropriate valuation. As a result, a portfolio company may make decisions that could decrease the value of our portfolio holdings.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember', window );">We are subject to risks related to ESG investments. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks related to ESG matters.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Adviser&#8217;s consideration of ESG factors is intended to aid the Adviser in evaluating the return and risk profile of a given investment and is not expected to by itself determine an investment decision for us, the Adviser&#8217;s consideration of ESG factors could, to the extent material economic risks associated with an investment are identified, cause the Adviser to consider taking action with respect to a company differently than may have been taken in the absence of such consideration, which could cause us to perform differently compared to funds that do not have such considerations. Further, although the Adviser views application of its ESG framework to be an opportunity to potentially enhance or protect the performance of investments over the long-term, the Adviser cannot guarantee that any consideration of ESG factors or engagement with portfolio companies on ESG, which depends in part on skill and qualitative judgments, will positively impact the performance of any individual portfolio company or us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors and other stakeholders have become more focused on understanding how companies address a variety of ESG factors. As they evaluate investment decisions, many investors look not only at company disclosures but also to ESG rating systems that have been developed by third parties to allow ESG comparisons among companies. The criteria used in these ratings systems may conflict and change frequently, and we cannot predict how these third parties will score us, nor can we have any assurance that they score us accurately or other companies accurately or that other companies have provided them with accurate data. If our ESG ratings, disclosures or practices do not meet the standards set by such investors or our shareholders, they may choose not to invest in our shares. Relatedly, we risk damage to our reputation, if we do not, or are perceived to not, act responsibly in a number of areas, such as greenhouse gas emissions, energy management, human rights, community relations, workforce health and safety, and business ethics and transparency. Adverse incidents with respect to ESG matters or negative ESG ratings or assessments by third-party ESG raters could impact the value of our brand, or the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations.</span></div>There is a growing regulatory interest across jurisdictions in improving transparency regarding the definition, measurement and disclosure of ESG factors in order to allow investors to validate and better understand sustainability claims. New regulatory initiatives related to ESG that are applicable to us could adversely affect our business. For example, the SEC has proposed rules that would require additional disclosures about ESG investment practices by investment advisers and certain funds, including BDCs. These changing rules, regulations and stakeholder expectations have resulted in, and are likely to continue to result in, increased general and administrative expenses and increased management time and attention spent complying with or meeting such regulations and expectations. If we fail or are perceived to fail to comply with applicable rules, regulations and stakeholder expectations, it could negatively impact our reputation and our business results.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember', window );">We and our investment adviser could be the target of litigation or regulatory investigations. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our investment adviser could be the target of litigation or regulatory investigations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We as well as our investment adviser and its affiliates participate in a highly regulated industry and are each subject to regulatory examinations in the ordinary course of business. There can be no assurance that we and our investment adviser and/or any of its affiliates will avoid regulatory investigation and possible enforcement actions stemming therefrom. Our investment adviser is a registered investment adviser and, as such, is subject to the provisions of the Advisers Act. We and our investment adviser are each, from time to time, subject to formal and informal examinations, investigations, inquiries, audits and reviews from numerous regulatory authorities both in response to issues and questions raised in such examinations or investigations and in connection with the changing priorities of the applicable regulatory authorities across the market in general.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment adviser, its affiliates and/or any of their respective principals and employees could also be named as defendants in, or otherwise become involved in, litigation. Litigation and regulatory actions can be time-consuming and expensive and can lead to unexpected losses, which expenses and losses are often subject to indemnification by us. Legal proceedings could continue without resolution for long periods of time and their outcomes, which could materially and adversely affect the value of us or the ability of our investment adviser to manage us, are often impossible to anticipate. Our investment adviser would likely be required to expend significant resources responding to any litigation or regulatory action related to it, and these actions could be a distraction to the activities of our investment adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment activities are subject to the normal risks of becoming involved in litigation by third parties. This risk would be somewhat greater if we were to exercise control or significant influence over a portfolio company&#8217;s direction. The expense of defending against claims by third parties and paying any amounts pursuant to settlements or judgments would, absent willful misfeasance, bad faith, gross negligence, or reckless disregard of the duties involved by our investment adviser, our administrator, or any of our officers, be borne by us and would reduce our net assets. Our investment adviser and others are indemnified by us in connection with such litigation, subject to certain conditions.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember', window );">Second priority liens on collateral securing debt investments that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Second priority liens on collateral securing debt investments that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. If there is a default, the value of the collateral may not be sufficient to repay in full both the first priority creditors and us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain debt investments that we make to portfolio companies may be secured on a second priority basis by the same collateral securing first priority debt of such companies. The first priority liens on the collateral will secure the portfolio company&#8217;s obligations under any outstanding senior debt and may secure certain other future debt that may be permitted to be incurred by the company under the agreements governing the loans. The holders of obligations secured by the first priority liens on the collateral will generally control the liquidation of and be entitled to receive proceeds from any realization of the collateral to repay their obligations in full before us. In addition, the value of the collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from the sale or sales of all of the collateral would be sufficient to satisfy the debt obligations secured by the second priority liens after payment in full of all obligations secured by the first priority liens on the collateral. If such proceeds are not sufficient to repay amounts outstanding under the debt obligations secured by the second priority liens, then we, to the extent not repaid from the proceeds of the sale of the collateral, will only have an unsecured claim against the company&#8217;s remaining assets, if any.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also make unsecured debt investments in portfolio companies, meaning that such investments will not benefit from any interest in collateral of such companies. Liens on such portfolio companies&#8217; collateral, if any, will secure the portfolio company&#8217;s obligations under its outstanding secured debt and may secure certain future debt that is permitted to be incurred by the portfolio company under its secured debt agreements. The holders of obligations secured by such liens will generally control the liquidation of, and be entitled to receive proceeds from, any realization of such collateral to repay their obligations in full before we are so entitled. In addition, the value of such collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from sales of such collateral would be sufficient to satisfy its unsecured debt obligations after payment in full of all secured debt obligations. If such proceeds were not sufficient to repay the outstanding secured debt obligations, then its unsecured claims would rank equally with the unpaid portion of such secured creditors&#8217; claims against the portfolio company&#8217;s remaining assets, if any.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights we may have with respect to the collateral securing the debt investments we make to our portfolio companies with senior debt outstanding may also be limited pursuant to the terms of one or more intercreditor agreements that we enter into with the holders of senior debt. Under such an intercreditor agreement, at any time that obligations that have the benefit of the first priority liens are outstanding, any of the following actions that may be taken in respect of the collateral will be at the direction of the holders of the obligations secured by the first priority liens: the ability to cause the commencement of enforcement proceedings against the collateral; the ability to control the conduct of such proceedings; the approval of amendments to collateral documents; releases of liens on the collateral; and waivers of past defaults under collateral documents. We may not have the ability to control or direct such actions, even if our rights are adversely affected.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember', window );">Economic recessions or downturns or restrictions on trade could impair our portfolio companies and adversely affect our operating results. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic recessions or downturns or restrictions on trade could impair our portfolio companies and adversely affect our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks associated with our and our portfolio companies&#8217; businesses are more severe during periods of economic slowdown or recession. In recent years, we have experienced periods of economic slowdown and in some instances, contraction, as countries and industries around the globe grappled with the short- and long-term economic impacts of the COVID-19 pandemic, elevated inflation, supply chain challenges, labor shortages, high interest rates, foreign currency exchange volatility and volatility in global capital markets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our portfolio companies may be susceptible to economic recessions or downturns and may be unable to repay our debt investments during these periods. Therefore, our non-performing assets are likely to increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions may also decrease the value of any collateral securing our senior secured debt. A prolonged recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income and NAV. Certain of our portfolio companies may also be impacted by tariffs or other matters affecting international trade. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on terms we deem acceptable. These events could prevent us from increasing investments and adversely affect our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portfolio company&#8217;s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, acceleration of the time when the loans are due and foreclosure on its assets representing collateral for its obligations, which could trigger cross defaults under other agreements and jeopardize our portfolio company&#8217;s ability to meet its obligations under the debt investments that we hold and the value of any equity securities we own. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting portfolio company.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember', window );">Our investments in CLOs may be riskier than a direct investment in the debt or other securities of the underlying companies. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in CLOs may be riskier than a direct investment in the debt or other securities of the underlying companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When investing in CLOs, we may invest in any level of a CLO&#8217;s subordination chain, including subordinated (lower-rated) tranches and residual interests (the lowest tranche). CLOs are typically highly levered and therefore, the junior debt and equity tranches that we may invest in are subject to a higher risk of total loss and deferral or nonpayment of interest than the more senior tranches to which they are subordinated. In addition, we will generally have the right to receive payments only from the CLOs, and will generally not have direct rights against the underlying borrowers or entities that sponsored the CLOs. Furthermore, the investments we make in CLOs are at times thinly traded or have only a limited trading market. As a result, investments in such CLOs may be characterized as illiquid securities.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember', window );">A covenant breach or other default by our portfolio companies may adversely affect our operating results. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A covenant breach or other default by our portfolio companies may adversely affect our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portfolio company&#8217;s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, termination of its loans and foreclosure on its secured assets, which could trigger cross-defaults under other agreements and jeopardize a portfolio company&#8217;s ability to meet its obligations under the debt or equity securities that we hold. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms, which may include the waiver of certain financial covenants, with a defaulting portfolio company. In addition, lenders in certain cases can be subject to lender liability claims for actions taken by them when they become too involved in the borrower&#8217;s business or exercise control over a borrower. It is possible that we could become subject to a lender&#8217;s liability claim, including as a result of actions taken if we render significant managerial assistance to the borrower. Furthermore, if one of our portfolio companies were to file for bankruptcy protection, a bankruptcy court might re-characterize our debt holding and subordinate all or a portion of our claim to claims of other creditors, even though we may have structured our investment as senior secured debt. The likelihood of such a re-characterization would depend on the facts and circumstances, including the extent to which we provided managerial assistance to that portfolio company.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember', window );">Our portfolio companies may be highly leveraged. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our portfolio companies may be highly leveraged.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our portfolio companies may be highly leveraged, which may have adverse consequences to these companies and to us as an investor. These companies may be subject to restrictive financial and operating covenants and the leverage may impair these companies&#8217; ability to finance their future operations and capital needs. As a result, these companies&#8217; flexibility to respond to changing business and economic conditions and to take advantage of business opportunities may be limited. Further, a leveraged company&#8217;s income and net assets will tend to increase or decrease at a greater rate than if borrowed money were not used.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember', window );">Our portfolio may be concentrated in a limited number of industries, which may subject us to a risk of significant loss if there is a downturn in a particular industry. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our portfolio may be concentrated in a limited number of industries, which may subject us to a risk of significant loss if there is a downturn in a particular industry in which a number of our investments are concentrated.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio may be concentrated in a limited number of industries. Our portfolio will be considered to be concentrated in a particular industry when 25% or greater of its total assets are invested in issuers that are a part of that industry. A downturn in any industry in which we are invested could significantly impact the aggregate returns we realize. We anticipate that we may concentrate our investments in issuers that are part of the software industry, which currently represent close to 25% of our total assets, as a result of additional investments in the software industry and/or fluctuations in the fair value of our investments in the software industry and other industries.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an industry in which we have significant investments suffers from adverse business or economic conditions, as individual industries have historically experienced to varying degrees, a material portion of our investment portfolio could be affected adversely, which, in turn, could adversely affect our financial position and results of operations.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember', window );">We may be subject to risks associated with our investments in the software industry. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to risks associated with our investments in the software industry.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue, income (or losses) and valuations of software and other technology-related companies can and often do fluctuate suddenly and dramatically. In addition, because of rapid technological change, the average selling prices of software products have historically decreased over their productive lives. As a result, the average selling prices of software offered by our portfolio companies may decrease over time, which could adversely affect their operating results and, correspondingly, the value of any securities that we may hold. Additionally, companies operating in the software industry are subject to vigorous competition, changing technology, changing client and end-consumer needs, evolving industry standards and frequent introductions of new products and services. Our portfolio companies in the software industry could compete with companies that are larger and could be engaged in a greater range of businesses or have greater financial, technical, sales or other resources than our portfolio companies do. Our portfolio companies could lose market share if their competitors introduce or acquire new products that compete with their software and related services or add new features to existing products. Any deterioration in the results of our portfolio companies due to competition or otherwise could, in turn, materially adversely affect our business, financial condition and results of operations.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember', window );">operations. Our investments in the healthcare providers and services industry face considerable uncertainties. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in the healthcare providers and services industry face considerable uncertainties.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and rules governing the business of healthcare companies and interpretations of those laws and rules are subject to frequent change. Broad latitude is given to the agencies administering those regulations. Existing or future laws and rules could force our portfolio companies engaged in healthcare to change how they do business, restrict revenue, increase costs, change reserve levels and change business practices.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare companies often must obtain and maintain regulatory approvals to market many of their products, change prices for certain regulated products and consummate some of their acquisitions and divestitures. Delays in obtaining or failing to obtain or maintain these approvals could reduce revenue or increase costs. Policy changes on the local, state and federal level, such as the expansion of the government&#8217;s role in the healthcare arena and alternative assessments and tax increases specific to the healthcare industry or healthcare products as part of federal health care reform initiatives, could fundamentally change the dynamics of the healthcare industry.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember', window );">Investing in large private U.S. borrowers may limit the Company&#8217;s ability to achieve high growth rates during times of economic expansion. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing in large private U.S. borrowers may limit the Company&#8217;s ability to achieve high growth rates during times of economic expansion. </span></div>Investing in originated assets made to large private U.S. borrowers may result in us underperforming in other segments of the market, particularly during times of economic expansion, because large private U.S. borrowers may be less responsive to competitive challenges and opportunities in the financial markets. As a result, our value may not rise at the same rate, if at all, as other funds that invest in smaller market capitalization companies that are more capable of responding to economic and industrial changes.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember', window );">Investing in private companies involves a number of significant risks, any one of which could have a material adverse effect on our operating results. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing in private companies involves a number of significant risks, any one of which could have a material adverse effect on our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks include that:</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing on any guarantees we may have obtained in connection with our investment; </span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies frequently have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tends to render them more vulnerable to competitors&#8217; actions and changing market conditions, as well as general economic downturns; </span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us; </span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">these companies generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, Trustees and members of the Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span>these companies may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember', window );">We may not realize gains from our equity investments. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not realize gains from our equity investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain investments that we may make could include warrants or other equity securities. In addition, we may make direct equity investments in portfolio companies. Our goal is ultimately to realize gains upon our disposition of such equity interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. We also may be unable to realize any value if a portfolio company does not have a liquidity event, such as a sale of the business, recapitalization or public offering, which would allow us to sell the underlying equity interests. We intend to seek puts or similar rights to give us the right to sell our equity securities back to the portfolio company issuer. We may be unable to exercise these put rights for the consideration provided in our investment documents if the issuer is in financial distress.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember', window );">An investment strategy focused primarily on privately-held companies presents certain challenges, including, but not limited to, the lack of available information about these companies. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An investment strategy focused primarily on privately-held companies presents certain challenges, including, but not limited to, the lack of available information about these companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest primarily in privately-held companies. Investments in private companies pose significantly greater risks than investments in public companies. First, private companies have reduced access to the capital markets, resulting in diminished capital resources and the ability to withstand financial distress. Second, the depth and breadth of experience of management in private companies tends to be less than that at public companies, which makes such companies more likely to depend on the management talents and efforts of a smaller group of persons and/or persons. Therefore, the decisions made by such management teams and/or the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our investments and, in turn, on us. Third, the investments themselves tend to be less liquid. As such, we may have difficulty exiting an investment promptly or at a desired price prior to maturity or outside of a normal amortization schedule. As a result, the relative lack of liquidity and the potential diminished capital resources of our target portfolio companies may affect our investment returns. Fourth, limited public information generally exists about private companies. Fifth, these companies may not have third-party debt ratings or audited financial statements. We must therefore rely on the ability of the Adviser to obtain adequate information through due diligence to evaluate the creditworthiness and potential returns from investing in these companies. The Adviser typically assesses an investment in a portfolio company based on the Adviser&#8217;s estimate of the portfolio company&#8217;s earnings and enterprise value, among other things, and these estimates may be based on limited information and may otherwise be inaccurate, causing the Adviser to make different investment decisions than it may have made with more complete information. These private companies and their financial information are not subject to the Sarbanes-Oxley Act and other rules that govern public companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember', window );">Our investments in securities or assets of publicly-traded companies are subject to the risks inherent in investing in public securities. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in securities or assets of publicly-traded companies are subject to the risks inherent in investing in public securities.</span></div>We may invest a portion of our portfolio in publicly-traded assets. For example, it is not expected that we will be able to negotiate additional financial covenants or other contractual rights, which we might otherwise be able to obtain in making privately negotiated investments. In addition, by investing in publicly-traded securities or assets, we will be subject to U.S. federal and state securities laws, as well as non-U.S. securities laws, that may, among other things, restrict or prohibit our ability to make or sell an investment. Moreover, we may not have the same access to information in connection with investments in public securities, either when investigating a potential investment or after making an investment, as compared to privately negotiated investments. Furthermore, we may be limited in our ability to make investments and to sell existing investments in public securities because the Firm may be deemed to have material, non-public information regarding the issuers of those securities or as a result of other internal policies. The inability to sell public securities in these circumstances could materially adversely affect our investment results. In addition, an investment may be sold by us to a public company where the consideration received is a combination of cash and stock of the public company, which may, depending on the securities laws of the relevant jurisdiction, be subject to lock-up periods.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember', window );">A lack of liquidity in certain of our investments may adversely affect our business. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A lack of liquidity in certain of our investments may adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally invest in companies whose securities are not publicly-traded or actively traded on the secondary market, and whose securities are subject to legal and other restrictions on resale or will otherwise be less liquid than publicly-traded securities. The illiquidity of certain of our investments may make it difficult for us to sell these investments when desired. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we had previously recorded these investments. The reduced liquidity of our investments may make it difficult for us to dispose of them at a favorable price, and, as a result, we may suffer losses.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember', window );">We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments. After our initial investment in a portfolio company, we may be called upon from time to time to provide additional funds to such company or have the opportunity to increase our investment through the exercise of a warrant to purchase shares. There is no assurance that we will make, or will have sufficient funds to make, follow-on investments. Any decisions not to make a follow-on investment or any inability on our part to make such an investment may have a negative impact on a portfolio company in need of such an investment, may result in a missed opportunity for us to increase our participation in a successful operation or may reduce the expected return on the investment.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember', window );">Our investments may include original issue discount and payment-in-kind instruments. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments may include original issue discount and payment-in-kind instruments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we invest in original issue discount or payment-in-kind (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;PIK&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) instruments and the accretion of original issue discount or PIK interest income constitutes a portion of our income, we will be exposed to risks associated with the requirement to include such non-cash income in taxable and accounting income prior to receipt of cash, including the following:&#160;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the higher interest rates on PIK instruments reflect the payment deferral and increased credit risk associated with these instruments, and PIK instruments generally represent a significantly higher credit risk than coupon loans;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">original issue discount and PIK instruments may have unreliable valuations because the accruals require judgments about collectability of the deferred payments and the value of any associated collateral;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">an election to defer PIK interest payments by adding them to the principal on such instruments increases our future investment income which increases our gross assets and, as such, increases the Adviser&#8217;s future base management fees which, thus, increases the Adviser&#8217;s future income incentive fees at a compounding rate;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">market prices of PIK instruments and other zero-coupon instruments are affected to a greater extent by interest rate changes, and may be more volatile than instruments that pay interest periodically in cash. While PIK instruments are usually less volatile than zero-coupon debt instruments, PIK instruments are generally more volatile than cash pay securities;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the deferral of PIK interest on an instrument increases the loan-to-value ratio, which is a measure of the riskiness of a loan, with respect to such instrument;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">even if the conditions for income accrual under GAAP are satisfied, a borrower could still default when actual payment is due upon the maturity of such loan;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">for accounting purposes, cash distributions to investors representing original issue discount income do not come from paid-in capital, although they may be paid from the offering proceeds. Thus, although a distribution of original issue discount income may come from the cash invested by investors, the 1940 Act does not require that investors be given notice of this fact;</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the required recognition of original issue discount or PIK interest for U.S. federal income tax purposes may have a negative impact on liquidity, as it represents a non-cash component of our investment company taxable income that may require cash distributions to shareholders in order to maintain our ability to be subject to tax as a RIC; and</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">original issue discount may create a risk of non-refundable cash payments to the Adviser based on non-cash accruals that may never be realized.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember', window );">We may enter into a TRS agreement that exposes us to certain risks, including market risk, liquidity risk and other risks similar to those associated with the use of leverage. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may enter into a TRS agreement that exposes us to certain risks, including market risk, liquidity risk and other risks similar to those associated with the use of leverage.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total return swap (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;TRS&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is a contract in which one party agrees to make periodic payments to another party based on the change in the market value of the assets underlying the TRS, which may include a specified security, basket of securities or securities indices during a specified period, in return for periodic payments based on a fixed or variable interest rate. A TRS effectively adds leverage to a portfolio by providing investment exposure to a security or market without owning or taking physical custody of such security or investing directly in such market. Because of the unique structure of a TRS, a TRS often offers lower financing costs than are offered through more traditional borrowing arrangements. The Company would typically have to post collateral to cover this potential obligation. To the extent the Company complied with the applicable requirements of Rule 18f-4, the leverage incurred through TRS will not be considered a borrowing for purposes of the Company&#8217;s overall leverage limitation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A TRS is subject to market risk, liquidity risk and risk of imperfect correlation between the value of the TRS and the loans underlying the TRS. In addition, we may incur certain costs in connection with the TRS that could in the aggregate be significant. A TRS is also subject to the risk that a counterparty will default on its payment obligations thereunder or that we will not be able to meet our obligations to the counterparty.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember', window );">We may enter into repurchase agreements or reverse repurchase agreements. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may enter into repurchase agreements or reverse repurchase agreements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to our investment objectives and policies, we may invest in repurchase agreements as a buyer for investment purposes. Repurchase agreements typically involve the acquisition by us of debt securities from a selling financial institution such as a bank, savings and loan association or broker-dealer. The agreement provides that we will sell the securities back to the institution at a fixed time in the future for the purchase price plus premium (which often reflects the interests). We do not bear the risk of a decline in the value of the underlying security unless the seller defaults under its repurchase obligation. In the event of the bankruptcy or other default of a seller of a repurchase agreement, we could experience both delays in liquidating the underlying securities and losses, including (1) possible decline in the value of the underlying security during the period in which we seek to enforce its rights thereto; (2) possible lack of access to income on the underlying security during this period; and (3) expenses of enforcing its rights. In addition, as described above, the value of the collateral underlying the repurchase agreement will be at least equal to the repurchase price, including any accrued interest earned on the repurchase agreement. In the event of a default or bankruptcy by a selling financial institution, we generally will seek to liquidate such collateral. However, the exercise of our right to liquidate such collateral could involve certain costs or delays and, to the extent that proceeds from any sale upon a default of the obligation to repurchase were less than the repurchase price, we could suffer a loss.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to our investment objectives and policies, we invest in repurchase agreements as a seller, also known as a &#8220;reverse repurchase agreement.&#8221; Our use of reverse repurchase agreements involves many of the same risks involved in our use of leverage, as the proceeds from reverse repurchase agreements are generally invested in additional portfolio investments. There is a risk that the market value of the securities acquired from the proceeds received in connection with a reverse repurchase agreement may decline below the price of the securities underlying the reverse repurchase agreement that we have sold but remain obligated to repurchase. Reverse repurchase agreements also involve the risk that the counterparty liquidates the securities we delivered to it under the reverse repurchase agreements following the occurrence of an event of default under the applicable repurchase agreement by us. In addition, there is a risk that the market value of the securities we retain may decline. If the buyer of securities under a reverse repurchase agreement were to file for bankruptcy or experiences insolvency, we may be adversely affected. Furthermore, our counterparty may require us to provide additional margin in the form of cash, securities or other forms of collateral under the terms of the derivative contract. Also, in entering into reverse repurchase agreements, we bear the risk of loss to the extent that the proceeds of the reverse repurchase agreement are less than the value of the underlying securities. In addition, the interest costs associated with reverse repurchase agreements transactions, may adversely affect our results of operations and financial condition, and, in some cases, we may be worse off than if we had not used such instruments.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember', window );">We may enter into securities lending agreements. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may enter into securities lending agreements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may from time to time make secured loans of our marginable securities to brokers, dealers and other financial institutions if our asset coverage, as defined in the 1940 Act, is at or above 150% immediately after each such loan. The risks in lending portfolio securities, as with other extensions of credit, consist of possible delay in recovery of the securities or possible loss of rights in the collateral should the borrower fail financially. However, such loans will be made only to brokers and other financial institutions that are believed by the Adviser to be of high credit standing. Securities loans are made to broker-dealers pursuant to agreements requiring that loans be continuously secured by collateral consisting of U.S. government securities, cash or cash equivalents (e.g., negotiable certificates of deposit, bankers&#8217; acceptances or letters of credit) maintained on a daily mark-to-market basis in an amount at least equal at all times to the market value of the securities lent. If the Company enters into a securities lending arrangement, the Adviser, as part of its responsibilities under the Investment Advisory Agreement, will invest the Company&#8217;s cash collateral in accordance with the Company&#8217;s investment objectives and strategies. The Company will pay the borrower of the securities a fee based on the amount of the cash collateral posted in connection with the securities lending program. The borrower will pay to the Company, as the lender, an amount equal to any dividends or interest received on the securities lent.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may invest the cash collateral received only in accordance with its investment objectives, subject to the Company&#8217;s agreement with the borrower of the securities. In the case of cash collateral, the Company expects to pay a rebate to the borrower. The reinvestment of cash collateral will result in a form of effective leverage for the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although voting rights or rights to consent with respect to the loaned securities pass to the borrower, the Company, as the lender, will retain the right to call the loans and obtain the return of the securities loaned at any time on reasonable notice, and it will do so in order that the securities may be voted by the Company if the holders of such securities are asked to vote upon or consent to matters materially affecting the investment. The Company may also call such loans in order to sell the securities involved. When engaged in securities lending, the Company&#8217;s performance will continue to reflect changes in the value of the securities loaned and will also reflect the receipt of interest through investment of cash collateral by the Company in permissible investments.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember', window );">Enter into credit default swaps or other derivative transactions which expose us to certain risks associated with the use of leverage. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may from time to time enter into credit default swaps or other derivative transactions which expose us to certain risks, including credit risk, market risk, liquidity risk and other risks similar to those associated with the use of leverage.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may from time to time enter into credit default swaps or other derivative transactions that seek to modify or replace the investment performance of a particular reference security or other asset. These transactions are typically individually negotiated, non-standardized agreements between two parties to exchange payments, with payments generally calculated by reference to a notional amount or quantity. Swap contracts and similar derivative contracts are not traded on exchanges; rather, banks and dealers act as principals in these markets. These investments may present risks in excess of those resulting from the referenced security or other asset. Because these transactions are not an acquisition of the referenced security or other asset itself, the investor has no right directly to enforce compliance with the terms of the referenced security or other asset and has no voting or other consensual rights of ownership with respect to the referenced security or other asset. In the event of insolvency of a counterparty, we will be treated as a general creditor of the counterparty and will have no claim of title with respect to the referenced security or other asset.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A credit default swap is a contract in which one party buys or sells protection against a credit event with respect to an issuer, such as an issuer&#8217;s failure to make timely payments of interest or principal on its debt obligations, bankruptcy or restructuring during a specified period. Generally, if we sell credit protection using a credit default swap, we will receive fixed payments from the swap counterparty and if a credit event occurs with respect to the applicable issuer, we will pay the swap counterparty par for the issuer&#8217;s defaulted debt securities and the swap counterparty will deliver the defaulted debt securities to us. Generally, if we buy credit protection using a credit default swap, we will make fixed payments to the counterparty and if a credit event occurs with respect to the applicable issuer, we will deliver the issuer&#8217;s defaulted securities underlying the swap to the swap counterparty and the counterparty will pay us par for the defaulted securities. Alternatively, a credit default swap may be cash settled and the buyer of protection would receive the difference between the par value and the market value of the issuer&#8217;s defaulted debt securities from the seller of protection.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit default swaps are subject to the credit risk of the underlying issuer. If we are selling credit protection, there is a risk that we will not properly assess the risk of the underlying issuer, a credit event will occur and we will have to pay the counterparty. If we are buying credit protection, there is a risk that we will not properly assess the risk of the underlying issuer, no credit event will occur and we will receive no benefit for the premium paid.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A derivative transaction is also subject to the risk that a counterparty will default on its payment obligations thereunder or that we will not be able to meet our obligations to the counterparty. In some cases, we may post collateral to secure our obligations to the counterparty, and we may be required to post additional collateral upon the occurrence of certain events such as a decrease in the value of the reference security or other asset. In some cases, the counterparty may not collateralize any of its obligations to us. Derivative investments effectively add leverage to a portfolio by providing investment exposure to a security or market without owning or taking physical custody of such security or investing directly in such market. In addition to the risks described above, such arrangements are subject to risks similar to those associated with the use of leverage. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain categories of credit default swaps are subject to mandatory clearing, and more categories may be subject to mandatory clearing in the future. The counterparty risk for cleared derivatives is generally lower than for uncleared over-the-counter derivative transactions because generally a clearing organization becomes substituted for each counterparty to a cleared derivative contract and, in effect, guarantees the parties&#8217; performance under the contract as each party to a trade looks only to the clearing house for performance of financial obligations. However, there can be no assurance that a clearing house, or its members, will satisfy the clearing house&#8217;s obligations (including, but not limited to, financial obligations and legal obligations to segregate margins collected by the clearing house) to the Company. Counterparty risk with respect to certain exchange-traded and over-the-counter derivatives are considered as part of the value at risk provisions of Rule 18f-4. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Risk Factors&#8212;Risks Related to Debt Financing.&#8221;</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember', window );">Acquire various financial instruments for purposes of &#8220;hedging&#8221; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may acquire various financial instruments for purposes of &#8220;hedging&#8221; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek to hedge against interest rate and currency exchange rate fluctuations and credit risk by using financial instruments such as futures, options, swaps and forward contracts, subject to the requirements of the 1940 Act. These financial instruments may be purchased on exchanges or may be individually negotiated and traded in over-the-counter markets. Use of such financial instruments for hedging purposes may present significant risks, including the risk of loss of the amounts invested. Defaults by the other party to a hedging transaction can result in losses in the hedging transaction. Hedging activities also involve the risk of an imperfect correlation between the hedging instrument and the asset being hedged, which could result in losses both on the hedging transaction and on the instrument being hedged. Use of hedging activities may not prevent significant losses and could increase our losses. Further, hedging transactions may reduce cash available to pay distributions to our shareholders.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember', window );">Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the risk that the investments we make in our portfolio companies may be repaid prior to maturity. When this occurs, we will generally reinvest these proceeds in temporary investments, pending their future investment in new portfolio companies. These temporary investments will typically have substantially lower yields than the debt being prepaid and we could experience significant delays in reinvesting these amounts. Any future investment in a new portfolio company may also be at lower yields than the debt that was repaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Additionally, prepayments, net of prepayment fees, could negatively impact our return on equity.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember', window );">Technological innovations and industry disruptions may negatively impact us. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technological or other innovations and industry disruptions may negatively impact us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent trends in the market generally have been toward disrupting the industry with technological or other innovations, and multiple young companies have been successful in capitalizing on this trend toward disruption. In this period of rapid technological and commercial innovation, new businesses and approaches may be created that could affect the Company and/or its portfolio companies or alter the market practices that help frame its strategy. Any of these new approaches could damage the Company&#8217;s investments, significantly disrupt the market in which it operates and subject it to increased competition, which could materially and adversely affect its business, financial condition and results of investments. Moreover, given the pace of innovation in recent years, the impact on a particular investment may not have been foreseeable at the time we made the investment. Furthermore, we could base investment decisions on views about the direction or degree of innovation that prove inaccurate and lead to losses.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayInvestThroughVariousJointVenturesMember', window );">We may invest through various joint ventures. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may invest through various joint ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may hold a portion of its investments through partnerships, joint ventures, securitization vehicles or other entities with third-party investors (collectively, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">joint ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Joint venture investments involve various risks, including the risk that we will not be able to implement investment decisions or exit strategies because of limitations on our control under applicable agreements with joint venture partners, the risk that a joint venture partner may become bankrupt or may at any time have economic or business interests or goals that are inconsistent with those of the Company, the risk that a joint venture partner may be in a position to take action contrary to the Company&#8217;s objectives, the risk of liability based upon the actions of a joint venture partner and the risk of disputes or litigation with such partner and the inability to enforce fully all rights (or the incurrence of additional risk in connection with enforcement of rights) one partner may have against the other, including in connection with foreclosure on partner loans, because of risks arising under state law. In addition, we may, in certain cases, be liable for actions of our joint venture partners. The joint ventures in which we participate may sometimes be allocated investment opportunities that might have otherwise gone entirely to the Company, which may reduce our return on equity. Additionally, our joint venture investments may be held on an unconsolidated basis and at times may be highly leveraged. Such leverage would not count toward the investment limits imposed on us by the 1940 Act.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember', window );">We are subject to risks associated with investing alongside other third parties. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks associated with investing alongside other third parties.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We may invest in joint ventures alongside third parties through joint ventures, partnerships or other entities in the future. Such investments may involve risks not present in investments where a third party is not involved, including the possibility that such third party may at any time have economic or business interests or goals which are inconsistent with ours, or may be in a position to take action contrary to our investment objectives. In addition, we may in certain circumstances be liable for actions of such third party.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More specifically, joint ventures involve a third party that has approval rights over activity of the joint venture. The third party may take actions that are inconsistent with our interests. For example, the third party may decline to approve an investment for the joint venture that we otherwise want the joint venture to make. A joint venture may also use investment leverage which magnifies the potential for gain or loss on amounts invested. Generally, the amount of borrowing by the joint venture is not included when calculating our total borrowing and related leverage ratios and is not subject to asset coverage requirements imposed by the 1940 Act. If the activities of the joint venture were required to be consolidated with our activities because of a change in GAAP rules or SEC staff interpretations, it is likely that we would have to reorganize any such joint venture.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember', window );">We may syndicate co-investment opportunities, which may be costly. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may syndicate co-investment opportunities, which may be costly.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may make an investment with the expectation of offering a portion of its interests therein as a co-investment opportunity to third-party investors. There can be no assurance that we will be successful in syndicating any such co-investment, in whole or in part, that the closing of such co-investment will be consummated in a timely manner, that any syndication will take place on terms and conditions that will be preferable for the Company or that expenses incurred by us with respect to any such syndication will not be substantial. In the event that we are not successful in syndicating any such co-investment, in whole or in part, we may consequently hold a greater concentration and have more exposure in the related investment than initially was intended, which could make the Company more susceptible to fluctuations in value resulting from adverse economic and/or business conditions with respect thereto. Moreover, an investment by the Company that is not syndicated to co-investors as originally anticipated could significantly reduce our overall investment returns.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember', window );">We may use a wide range of investment techniques that could expose us to a diverse range of risks. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may use a wide range of investment techniques that could expose us to a diverse range of risks.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser may employ investment techniques or invest in instruments that it believes will help achieve our investment objectives, whether or not such investment techniques or instruments are specifically defined herein, so long as such investments are consistent with our investment strategies and objectives and subject to applicable law. Such investment techniques or instruments may not be thoroughly tested in the market before being employed and may have operational or theoretical shortcomings which could result in unsuccessful investments and, ultimately, losses to us. In addition, any such investment technique or instrument may be more speculative than other investment techniques or instruments specifically described herein and may involve material and unanticipated risks. There can be no assurance that the Adviser will be successful in implementing any such investment technique. Furthermore, the diversification and type of investments may differ substantially from our prior investments.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember', window );">Face conflicts of interest caused by compensation arrangements with us and our affiliates, which could result in actions that are not in the best interests of our shareholders. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Adviser and its affiliates, including our officers and some of our trustees, face conflicts of interest caused by compensation arrangements with us and our affiliates, which could result in actions that are not in the best interests of our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser and its affiliates receive substantial fees from us in return for their services, and these fees could influence the advice provided to us. We pay to the Adviser an incentive fee that is based on the performance of our portfolio and an annual base management fee that is based on the average value of our gross assets at the end of the two most recently completed calendar quarters. Because the incentive fee is based on the performance of our portfolio, the Adviser may be incentivized to make investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The way in which the incentive fee is determined may also encourage the Adviser to use leverage to increase the return on our investments. In addition, because the base management fee is based on the average value of our gross assets at the end of the two most recently completed calendar quarters, which includes any borrowings for investment purposes, the Adviser may be incentivized to recommend the use of leverage or the issuance of additional equity to make additional investments and increase the average value of our gross assets at the end of the two most recently completed calendar quarters. Under certain circumstances, the use of leverage may increase the likelihood of default, which could disfavor our shareholders. Our compensation arrangements could therefore result in our making riskier or more speculative investments, or relying more on leverage to make investments, than would otherwise be the case. This could result in higher investment losses, particularly during cyclical economic downturns. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.&#8221;</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember', window );">We may be obligated to pay the Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be obligated to pay the Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Investment Advisory Agreement entitles the Adviser to receive Pre-Incentive Fee Net Investment Income Returns regardless of any capital losses. In such case, we may be required to pay the Adviser incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or if we incur a net loss for that quarter.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any Pre-Incentive Fee Net Investment Income Returns may be computed and paid on income that may include interest that has been accrued but not yet received. If a portfolio company defaults on a loan that is structured to provide accrued interest, it is possible that accrued interest previously included in the calculation of the incentive fee will become uncollectible. The Adviser is not under any obligation to reimburse us for any part of the incentive fee it received that was based on accrued income that we never received as a result of a default by an entity on the obligation that resulted in the accrual of such income, and such circumstances would result in our paying an incentive fee on income we never received.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember', window );">The incentive fee based on income takes into account our past performance. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The incentive fee based on income takes into account our past performance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Incentive Fee based on income is determined and paid quarterly in arrears at the end of each calendar quarter by reference to our aggregate net investment income, as adjusted, from the calendar quarter then ending and the Trailing Twelve Quarters. The effect of calculating the incentive fee using reference to the Trailing Twelve Quarters is that, in certain circumstances, an incentive fee based on income is payable to the Adviser although our net income for such quarter did not exceed the hurdle rate or the incentive fee will be higher than it would have been if calculated based on our performance for the applicable quarter without taking into account the Trailing Twelve Quarters. For example, if we experience a net loss for any particular quarter, an incentive fee may still be paid to the Adviser if such net loss is less than the net loss for the most recent quarter that preceded the Trailing Twelve Quarters. In such circumstances, the Adviser would be entitled to an incentive fee whereas it would not have been entitled to an incentive fee if calculated solely on the basis of our performance for the applicable quarter.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember', window );">There may be conflicts of interest related to obligations that the Adviser&#8217;s senior management and Investment Team have to other clients. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There may be conflicts of interest related to obligations that the Adviser&#8217;s senior management and Investment Team have to Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The members of the senior management and Investment Team of the Adviser serve or may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do, or of investment funds managed by the same personnel. In serving in these multiple capacities, they may have obligations to Other Clients or investors in those entities, the fulfillment of which may not be in our best interests or in the best interest of our shareholders. Our investment objectives may overlap with the investment objectives of such investment funds, accounts or other investment vehicles. In particular, we will rely on the Adviser to manage our day-to-day activities and to implement our investment strategy. The Adviser and certain of its affiliates are presently, and plan in the future to continue to be, involved with activities that are unrelated to us. As a result of these activities, the Adviser, its officers and employees and certain of its affiliates will have conflicts of interest in allocating their time between us and other activities in which they are or may become involved, including the management of its affiliated equipment funds. The Adviser and its officers and employees will devote only as much of its or their time to our business as the Adviser and its officers and employees, in their judgment, determine is reasonably required, which may be substantially less than their full time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely, in part, on the Adviser to assist with identifying investment opportunities and making investment recommendations to the Adviser. The Adviser and its affiliates are not restricted from forming additional investment funds, entering into other investment advisory relationships or engaging in other business activities. These activities could be viewed as creating a conflict of interest in that the time and effort of the members of the Adviser, its affiliates and their officers and employees will not be devoted exclusively to our business, but will be allocated between us and such other business activities of the Adviser and its affiliates in a manner that the Adviser deems necessary and appropriate consistent with its fiduciary duties and the 1940 Act. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.&#8221;</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember', window );">Adviser are not prohibited from raising money for or managing other entities that make the same types of investments that we target. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The time and resources that individuals employed by the Adviser devote to us may be diverted and we may face additional competition due to the fact that individuals employed by the Adviser are not prohibited from raising money for or managing other entities that make the same types of investments that we target.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser and individuals employed by the Adviser are generally not prohibited from raising capital for and managing other investment entities that make the same types of investments as those we target. As a result, the time and resources that these individuals may devote to us may be diverted. In addition, we may compete with any such investment entity for the same investors and investment opportunities. We may participate in certain transactions originated by the Adviser or its affiliates under our exemptive relief from the SEC that allows us to engage in co-investment transactions with the Adviser and its affiliates, subject to certain terms and conditions. However, while the terms of the exemptive relief require that the Adviser will be given the opportunity to cause us to participate in certain transactions originated by affiliates of the Adviser, the Adviser may determine that we not participate in those transactions and for certain other transactions (as set forth in guidelines approved by the Board) the Adviser may not have the opportunity to cause us to participate. Affiliates of the Adviser, whose primary business includes the origination of investments or investing in non-originated assets, engage in investment advisory business with accounts that compete with us. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us."</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember', window );">Our shares may be purchased by the Adviser or its affiliates. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our shares may be purchased by the Adviser or its affiliates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Affiliates of the Adviser have purchased and in the future expect to purchase our shares. The Adviser and its affiliates will not acquire any shares with the intention to resell or re-distribute such shares. The purchase of shares by the Adviser and its affiliates could create certain risks, including, but not limited to, the following:</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Adviser and its affiliates may have an interest in disposing of our assets at an earlier date so as to recover their investment in our shares; and</span></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">substantial purchases of shares by the Adviser and its affiliates may limit the Adviser&#8217;s ability to fulfill any financial obligations that it may have to us or incurred on our behalf.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember', window );">The Adviser relies on key personnel, the loss of any of whom could impair its ability to successfully manage us. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Adviser relies on key personnel, the loss of any of whom could impair its ability to successfully manage us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends, to a significant extent, on the continued services of the officers and employees of the Adviser or its affiliates. The loss of services of one or more members of the Adviser&#8217;s management team, including members of the Investment Committee, could adversely affect our financial condition, business and results of operations. The Adviser does not have an employment agreement with any of these key personnel and we cannot guarantee that all, or any particular one, will remain affiliated with us and/or the Adviser. Further, we do not intend to separately maintain key person life insurance on any of these individuals.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember', window );">Any material adverse change in its financial condition or our relationship with the Adviser could have a material adverse effect on our business and ability to achieve our investment objectives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on the Adviser to select our investments and otherwise conduct our business, and any material adverse change in its financial condition or our relationship with the Adviser could have a material adverse effect on our business and ability to achieve our investment objectives.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success is dependent upon our relationship with, and the performance of, the Adviser in the acquisition and management of our portfolio investments, and our corporate operations, as well as the persons and firms the Adviser retains to provide services on our behalf. The Adviser may suffer or become distracted by adverse financial or operational problems in connection with Blackstone&#8217;s business and activities unrelated to us and over which we have no control. Should the Adviser fail to allocate sufficient resources to perform its responsibilities to us for any reason, we may be unable to achieve our investment objectives or to pay distributions to our shareholders.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember', window );">Pay to the Adviser will be determined without independent assessment on our behalf, and these terms may be less advantageous to us than if such terms had been the subject of arm&#8217;s-length negotiations. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The compensation we pay to the Adviser will be determined without independent assessment on our behalf, and these terms may be less advantageous to us than if such terms had been the subject of arm&#8217;s-length negotiations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investment Advisory Agreement will not be entered into on an arm&#8217;s-length basis with an unaffiliated third party. As a result, the form and amount of compensation we pay the Adviser may be less favorable to us than they might have been had an investment advisory agreement been entered into through arm&#8217;s-length transactions with an unaffiliated third party.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember', window );">The Adviser&#8217;s influence on conducting our operations gives it the ability to increase its fees, which may reduce the amount of cash flow available for distribution to our shareholders. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Adviser&#8217;s influence on conducting our operations gives it the ability to increase its fees, which may reduce the amount of cash flow available for distribution to our shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser is paid a base management fee calculated as a percentage of our gross assets and unrelated to net income or any other performance base or measure. The Adviser may advise us to consummate transactions or conduct our operations in a manner that, in the Adviser&#8217;s reasonable discretion, is in the best interests of our shareholders. These transactions, however, may increase the amount of fees paid to the Adviser. The Adviser&#8217;s ability to influence the base management fee paid to it by us could reduce the amount of cash flow available for distribution to our shareholders.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember', window );">There may be trademark risk, as we do not own the Blackstone name. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There may be trademark risk, as we do not own the Blackstone name.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not own the Blackstone name, but we are permitted to use it as part of our corporate name pursuant to the Investment Advisory Agreement. Use of the name by other parties or the termination of the Investment Advisory Agreement may harm our business.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember', window );">We may be subject to additional potential conflicts of interests as a consequence of Blackstone&#8217;s status as a public company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to additional potential conflicts of interests as a consequence of Blackstone&#8217;s status as a public company.</span></div>As a consequence of Blackstone&#8217;s status as a public company, our officers and trustees, and the employees&#160;of the Adviser may take into account certain considerations and other factors in connection with the management of the business and affairs of us and our affiliates that would not necessarily be taken into account if Blackstone were not a public company.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember', window );">The requirement that we invest a sufficient portion of our assets in Qualifying Assets could preclude us from investing in accordance with our current business strategy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The requirement that we invest a sufficient portion of our assets in Qualifying Assets could preclude us from investing in accordance with our current business strategy; conversely, the failure to invest a sufficient portion of our assets in Qualifying Assets could result in our failure to maintain our status as a BDC.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, a BDC may not acquire any asset other than assets of the type listed in section 55(a) of the 1940 Act described as &#8220;qualifying&#8221; assets (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Qualifying Assets&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), unless, at the time of and after giving effect to such acquisition, at least 70% of our total assets are Qualifying Assets. Therefore, we may be precluded from investing in what we believe are attractive investments if such investments are not Qualifying Assets. Conversely, if we fail to invest a sufficient portion of our assets in Qualifying Assets, we could lose our status as a BDC, which would have a material adverse effect on our business, financial condition and results of operations. Similarly, these rules could prevent us from making additional investments in existing portfolio companies, which could result in the dilution of our position, or could require us to dispose of investments at an inopportune time to comply with the 1940 Act. If we were forced to sell non-qualifying investments in the portfolio for compliance purposes, the proceeds from such sale could be significantly less than the current value of such investments.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember', window );">Failure to maintain our status as a BDC would reduce our operating flexibility. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to maintain our status as a BDC would reduce our operating flexibility.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not remain a BDC, we might be regulated as a registered closed-end management investment company under the 1940 Act, which would subject us to substantially more regulatory restrictions under the 1940 Act and correspondingly decrease our operating flexibility.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember', window );">Regulations governing our operation as a BDC and RIC will affect our ability to raise additional capital or borrow for investment purposes, which may have a negative effect on our growth. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulations governing our operation as a BDC and RIC will affect our ability to raise, and the way in which we raise, additional capital or borrow for investment purposes, which may have a negative effect on our growth.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of meeting the annual distribution requirement to avoid paying U.S. federal corporate income tax, as a RIC, we may need to periodically access the capital markets to raise cash in order to fund new investments. We may issue &#8220;senior securities,&#8221; as defined under the 1940 Act, including borrowing money from banks or other financial institutions only in amounts such that our asset coverage meets the threshold set forth in the 1940 Act immediately after each such issuance. The 1940 Act currently requires an asset coverage of at least 150% (i.e., the amount of debt may not exceed two-thirds of the value of our assets). Our ability to issue different types of securities is also limited. Compliance with these requirements may unfavorably limit our investment opportunities and reduce our ability in comparison to other companies to profit from favorable spreads between the rates at which we can borrow and the rates at which we can lend. As a BDC, therefore, we intend to continuously issue equity at a rate more frequent than our privately-owned competitors, which may lead to greater shareholder dilution. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. federal income tax purposes, we are required to recognize taxable income (which may include deferred interest that is accrued as original issue discount) in some circumstances in which we do not receive a corresponding payment in cash and to make distributions with respect to such income in order to avoid corporate income tax as a RIC. Under such circumstances, we may have difficulty meeting the annual distribution requirement necessary to eliminate any corporate income tax as a RIC under the Code. This difficulty in making the required distribution may be amplified to the extent that we are required to pay an incentive fee with respect to such accrued income. As a result, we may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital, or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may not meet the distribution requirements prescribed by the Code for a RIC and as such may become subject to corporate income tax.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We borrow for investment purposes. If the value of our assets declines, we may be unable to satisfy the asset coverage test, which would prohibit us from paying distributions and could result in a corporate income tax to the Company. If we cannot satisfy the asset coverage test, we may be required to sell a portion of our investments and, depending on the nature of our debt financing, repay a portion of our indebtedness at a time when such sales may be disadvantageous.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, we generally are prohibited from issuing or selling our shares at a price per share, after deducting selling commissions and dealer manager fees, that is below our NAV per share, which may be a disadvantage as compared with other public companies. We may, however, sell our shares, or warrants, options or rights to acquire our shares, at a price below the current NAV of our shares if our Board, including our independent trustees, determine that such sale is in our best interests and the best interests of our shareholders, and our shareholders, as well as those shareholders that are not affiliated with us, approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board, closely approximates the fair value of such securities.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember', window );">Our ability to enter into transactions with our affiliates is restricted. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to enter into transactions with our affiliates is restricted.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are prohibited under the 1940 Act from participating in certain transactions with certain of our affiliates (including portfolio companies of Other Clients) without the prior approval of a majority of the independent members of our Board and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of our outstanding voting securities will be our affiliate for purposes of the 1940 Act and generally we will be prohibited from buying or selling any securities from or to such affiliate, absent the prior approval of our Board. However, we may under certain circumstances purchase any such affiliate's loans or securities in the secondary market, which could create a conflict for the Adviser between our interests and the interests of such affiliate, in that the ability of the Adviser to recommend actions in our best interest may be limited. The 1940 Act also prohibits certain &#8220;joint&#8221; transactions with certain of our affiliates, which could include investments in the same portfolio company (whether at the same or closely related times), without prior approval of our Board and, in some cases, the SEC. If a person acquires more than 25% of our voting securities, we will be prohibited from buying or selling any security from or to such person or certain of that person&#8217;s affiliates, or entering into prohibited joint transactions (including certain co-investments) with such persons, absent the prior approval of the SEC. Similar restrictions limit our ability to transact business with our officers, trustees, investment advisers, sub-advisers or their affiliates. As a result of these restrictions, we may be prohibited from buying or selling any security from or to any fund or any portfolio company of a fund managed by the Adviser, or entering into joint arrangements such as certain co-investments with these companies or funds without the prior approval of the SEC, which may limit the scope of investment opportunities that would otherwise be available to us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have obtained exemptive relief from the SEC that allows us to engage in co-investment transactions with the Adviser and its affiliates, subject to certain terms and conditions. However, while the terms of the exemptive relief require that the Adviser will be given the opportunity to cause us to participate in certain transactions originated by affiliates of the Adviser, the Adviser may determine that we not participate in those transactions and for certain other transactions (as set forth in guidelines approved by the Board) the Adviser may not have the opportunity to cause us to participate.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember', window );">We are uncertain of our sources for funding our future capital needs; our ability to acquire investments and to expand our operations will be adversely affected. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are uncertain of our sources for funding our future capital needs; if we cannot obtain debt or equity financing on acceptable terms, our ability to acquire investments and to expand our operations will be adversely affected.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the sale of shares will be used for our investment opportunities, operating expenses and for payment of various fees and expenses such as base management fees, incentive fees and other expenses. Any working capital reserves we maintain may not be sufficient for investment purposes, and we may require debt or equity financing to operate. Accordingly, in the event that we develop a need for additional capital in the future for investments or for any other reason, these sources of funding may not be available to us. Consequently, if we cannot obtain debt or equity financing on acceptable terms, our ability to acquire investments and to expand our operations will be adversely affected. As a result, we would be less able to create and maintain a broad portfolio of investments and achieve our investment objectives, which may negatively impact our results of operations and reduce our ability to make distributions to our shareholders.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember', window );">We are a non-diversified investment company and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a non-diversified investment company within the meaning of the 1940 Act, and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are classified as a non-diversified investment company within the meaning of the 1940 Act, which means that we are not limited by the 1940 Act with respect to the proportion of our assets that we may invest in securities of a single issuer. Under the 1940 Act, a &#8220;diversified&#8221; investment company is required to invest at least 75% of the value of its total assets in cash and cash items, government securities, securities of other investment companies and other securities limited in respect of any one issuer to an amount not greater than 5% of the value of the total assets of such company and no more than 10% of the outstanding voting securities of such issuer. As a non-diversified investment company, we are not subject to this requirement. To the extent that we assume large positions in the securities of a small number of issuers, or within a particular industry, our NAV may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market&#8217;s assessment of the issuer. We may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company or to a general downturn in the economy. However, we will be subject to the diversification requirements applicable to RICs under Subchapter M of the Code.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember', window );">When we use leverage, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">When we use leverage, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us. Leverage may also adversely affect the return on our assets, reduce cash available for distribution to our shareholders, and result in losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of borrowings, also known as leverage, increases the volatility of investments by magnifying the potential for loss on invested equity capital. When we use leverage to partially finance our investments, through borrowing from banks and other lenders, shareholders will experience increased risks of investing in our shares. If the value of our assets decreases, leveraging would cause NAV to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Such a decline could negatively affect our ability to make distributions to our shareholders. In addition, our shareholders will bear the burden of any increase in our expenses as a result of our use of leverage, including interest expenses and any increase in the management or incentive fees payable to the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use and intend to continue to use leverage to finance our investments. The amount of leverage that we employ will depend on the Adviser&#8217;s and our Board&#8217;s assessment of market and other factors at the time of any proposed borrowing. There can be no assurance that leveraged financing will be available to us on favorable terms or at all. However, to the extent that we use leverage to finance our assets, our financing costs will reduce cash available for distributions to shareholders. Moreover, we may not be able to meet our financing obligations and, to the extent that we cannot, we risk the loss of some or all of our assets to liquidation or sale to satisfy the obligations. In such an event, we may be forced to sell assets at significantly depressed prices due to market conditions or otherwise, which may result in losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a BDC, we generally are required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred shares that we may issue in the future, of at least 150%. If this ratio were to fall below 150%, we could not incur additional debt and could be required to sell a portion of our investments to repay some debt when it is disadvantageous to do so. This could have a material adverse effect on our operations and investment activities. Moreover, our ability to make distributions to shareholders may be significantly restricted or we may not be able to make any such distributions whatsoever. The amount of leverage that we will employ will be subject to oversight by our Board of Trustees, a majority of whom are independent Trustees with no material interests in such transactions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into reverse repurchase agreements. Transactions under such agreements constitute leverage. When the Company enters into a reverse repurchase agreement, any fluctuations in the market value of either the securities transferred to another party or the securities in which the proceeds may be invested would affect the market value of the Company&#8217;s assets. As a result, the use of such leverage transactions may increase fluctuations in the market value of the Company&#8217;s assets compared to what would occur without the use of such transactions. Because reverse repurchase agreements may be considered to be the practical equivalent of borrowing funds, they constitute a form of leverage. If the Company reinvests the proceeds of a reverse repurchase agreement at a rate lower than the cost of the agreement, transacting under such agreement will lower the Company&#8217;s yield. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although leverage has the potential to enhance overall returns that exceed the Company&#8217;s cost of funds, they will further diminish returns (or increase losses on capital) to the extent overall returns are less than the Company&#8217;s cost of funds. In addition, borrowings and reverse repurchase agreements or similar arrangements in which the Company may engage may be secured by the shareholders&#8217; investments as well as by the Company&#8217;s assets and the documentation relating to such transactions may provide that during the continuance of a default under such arrangement, the interests of the holders of Common Shares may be subordinated to the interests of the Company&#8217;s lenders or debt-holders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit facilities and unsecured notes impose financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a regulated investment company under the 1940 Act. A failure to renew our facilities or to add new or replacement debt facilities or issue additional debt securities or other evidences of indebtedness could have a material adverse effect on our business, financial condition, results of operations and/or liquidity.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8212; Financial Condition, Liquidity and Capital Resources&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information regarding our borrowings.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayDefaultUnderOurCreditFacilitiesMember', window );">We may default under our credit facilities. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may default under our credit facilities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event we default under our credit facilities or other borrowings, our business could be adversely affected as we may be forced to sell a portion of our investments quickly and prematurely at what may be disadvantageous prices to us in order to meet our outstanding payment obligations and/or support working capital requirements under such borrowing facility, any of which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, following any such default, the agent for the lenders under such borrowing facility could assume control of the disposition of any or all of our assets, including the selection of such assets to be disposed and the timing of such disposition, which would have a material adverse effect on our business, financial condition, results of operations and cash flows.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember', window );">Our credit ratings may not reflect all risks of an investment in our debt securities. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our current or future credit ratings may not reflect all risks of an investment in our debt securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any current or future credit ratings of us are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our current or future credit ratings will generally affect the market value of our debt securities. Our current or future credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of or trading market for the publicly issued debt securities.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember', window );">The trading market or market value of our issued debt securities may fluctuate. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The trading market or market value of our issued debt securities may fluctuate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our issued debt securities may or may not have an established trading market. We cannot assure our noteholders that a trading market for our issued debt securities will ever develop or be maintained if developed. In addition to our creditworthiness, many factors may materially adversely affect the trading market for, and market value of, our issued debt securities. These factors include, but are not limited to, the following:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the time remaining to the maturity of these debt securities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outstanding principal amount of debt securities with terms identical to these debt securities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ratings assigned by national statistical ratings agencies;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the general economic environment;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the supply of debt securities trading in the secondary market, if any;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the redemption or repayment features, if any, of these debt securities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level, direction and volatility of market interest rates generally; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market rates of interest higher or lower than rates borne by the debt securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our noteholders should also be aware that there may be a limited number of buyers when they decide to sell their debt securities. This too may materially adversely affect the market value of the debt securities or the trading market for the debt securities.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember', window );">Terms relating to redemption may materially adversely affect our noteholders return on any debt securities that we may issue. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms relating to redemption may materially adversely affect our noteholders return on any debt securities that we may issue.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our noteholders&#8217; debt securities are redeemable at our option, we may choose to redeem their debt securities at times when prevailing interest rates are lower than the interest rate paid on their debt securities. In addition, if our noteholders&#8217; debt securities are subject to mandatory redemption, we may be required to redeem their debt securities also at times when prevailing interest rates are lower than the interest rate paid on their debt securities. In this circumstance, our noteholders may not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as their debt securities being redeemed.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember', window );">If we issue preferred shares or convertible debt securities, the net asset value of our common shares may become more volatile. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we issue preferred shares or convertible debt securities, the net asset value of our common shares may become more volatile.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that the issuance of preferred shares and/or convertible debt securities would result in a higher yield or return to the holders of our common shares. The issuance of preferred shares or convertible debt would likely cause the NAV of our common shares to become more volatile. If the dividend rate on the preferred shares, or the interest rate on the convertible debt securities, were to approach the net rate of return on our investment portfolio, the benefit of such leverage to the holders of our common shares would be reduced. If the dividend rate on the preferred shares, or the interest rate on the convertible debt securities, were to exceed the net rate of return on our portfolio, the use of leverage would result in a lower rate of return to the holders of common shares than if we had not issued the preferred shares or convertible debt securities. Any decline in the NAV of our investment would be borne entirely by the holders of our common shares. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in NAV to the holders of our common shares than if we were not leveraged through the issuance of preferred shares or debt securities. This decline in NAV would also tend to cause a greater decline in the market price, if any, for our common shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also a risk that, in the event of a sharp decline in the value of our net assets, we would be in danger of failing to maintain required asset coverage ratios, which may be required by the preferred shares or convertible debt, or our current investment income might not be sufficient to meet the dividend requirements on the preferred shares or the interest payments on the debt securities. In order to counteract such an event, we might need to liquidate investments in order to fund the redemption of some or all of the preferred shares or convertible debt. In addition, we would pay (and the holders of our common shares would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred shares, debt securities, convertible debt, or any combination of these securities. Holders of preferred shares or convertible debt may have different interests than holders of common shares and may at times have disproportionate influence over our affairs.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember', window );">Holders of any preferred shares that we may issue will have the right to elect certain members of our Board and have class voting rights on certain matters. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders of any preferred shares that we may issue will have the right to elect certain members of our Board and have class voting rights on certain matters.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 1940 Act requires that holders of preferred shares must be entitled as a class to elect two trustees at all times and to elect a majority of the trustees if dividends on such preferred shares are in arrears by two years or more, until such arrearage is eliminated. In addition, certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred shares, including changes in fundamental investment restrictions and conversion to open-end status and, accordingly, preferred shareholders could veto any such changes. Restrictions imposed on the declarations and payment of dividends or other distributions to the holders of our common shares and preferred shares, both by the 1940 Act and by requirements imposed by rating agencies, might impair our ability to maintain our tax treatment as a RIC for U.S. federal income tax purposes.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember', window );">Provisions in a credit facility may limit our investment discretion. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in a credit facility may limit our investment discretion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A credit facility may be backed by all or a portion of our loans and securities on which the lenders will have a security interest. We may pledge up to 100% of our assets and may grant a security interest in all of our assets under the terms of any debt instrument we enter into with lenders. We expect that any security interests we grant will be set forth in a pledge and security agreement and evidenced by the filing of financing statements by the agent for the lenders. In addition, we expect that the custodian for our securities serving as collateral for such loan would include in its electronic systems notices indicating the existence of such security interests and, following notice of occurrence of an event of default, if any, and during its continuance, will only accept transfer instructions with respect to any such securities from the lender or its designee. If we were to default under the terms of any debt instrument, the agent for the applicable lenders would be able to assume control of the timing of disposition of any or all of our assets securing such debt, which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In connection with one or more credit facilities entered into by the Company, distributions to shareholders may be subordinated to payments required in connection with any indebtedness contemplated thereby.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any security interests and/or negative covenants required by a credit facility may limit our ability to create liens on assets to secure additional debt and may make it difficult for us to restructure or refinance indebtedness at or prior to maturity or obtain additional debt or equity financing. In addition, if our borrowing base under a credit facility were to decrease, we may be required to secure additional assets in an amount sufficient to cure any borrowing base deficiency. In the event that all of our assets are secured at the time of such a borrowing base deficiency, we could be required to repay advances under a credit facility or make deposits to a collection account, either of which could have a material adverse impact on our ability to fund future investments and to make distributions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may be subject to limitations as to how borrowed funds may be used, which may include restrictions on geographic and industry concentrations, loan size, payment frequency and status, average life, collateral interests and investment ratings, as well as regulatory restrictions on leverage which may affect the amount of funding that may be obtained. There may also be certain requirements relating to portfolio performance, including required minimum portfolio yield and limitations on delinquencies and charge-offs, a violation of which could limit further advances and, in some cases, result in an event of default. An event of default under a credit facility could result in an accelerated maturity date for all amounts outstanding thereunder, which could have a material adverse effect on our business and financial condition. This could reduce our liquidity and cash flow and impair our ability to grow our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the effect of leverage on returns from an investment in our shares assuming various annual returns on our portfolio, net of expenses. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.626%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assumed Return on Our Portfolio (Net of Expenses)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corresponding return to common stockholder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#160;(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-25.52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-15.28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-5.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Based on (i) $10.1 billion in total assets as of December&#160;31, 2023, (ii) $4.9 billion in outstanding indebtedness, at par, as of December&#160;31, 2023, (iii) $5.0 billion in net assets as of December&#160;31, 2023 and (iv)&#160;an annualized average interest rate, including fees (such as fees on undrawn amounts and amortization of financing costs), on our indebtedness, as of December&#160;31, 2023, of 5.05%.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on an outstanding indebtedness, at par, of&#160;$4.9 billion&#160;as of&#160;December&#160;31, 2023 and the weighted average effective annual interest rate, including fees (such as fees on undrawn amounts and amortization of financing costs), of 5.05% as of that date, our investment portfolio at fair value would have had to produce an annual return of approximately 2.46% to cover annual interest payments on the outstanding debt. For more information on our indebtedness, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item 7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Financial Condition, Liquidity and Capital Resources.&#8221;</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember', window );">Changes in interest rates may affect our cost of capital and net investment income. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in interest rates may affect our cost of capital and net investment income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we use debt to finance a portion of our investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In periods of rising interest rates when we have debt outstanding, our cost of funds will increase, which could reduce our net investment income. We expect that our long-term fixed-rate investments will be financed primarily with equity and long-term debt. We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. These techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. These activities may limit our ability to participate in the benefits of lower interest rates with respect to the hedged portfolio. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations. Also, we have limited experience in entering into hedging transactions, and we will initially have to purchase or develop such expertise.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember', window );">Compliance with SEC Rule 18f-4 governing derivatives and use of leverage may limit our investment discretion. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with SEC Rule 18f-4 governing derivatives and use of leverage may limit our investment discretion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, Rule 18f-4 under the 1940 Act, eliminates the asset segregation framework arising from prior SEC guidance for covering positions in derivatives and certain financial instruments. Rule 18f-4 also limits a fund&#8217;s derivatives exposure through a value-at-risk test and requires the adoption and implementation of a derivatives risk management program for certain derivatives users. Subject to certain conditions, limited derivatives users (as defined in Rule 18f-4), such as the Company, however, would not be subject to the full requirements of Rule 18f-4. Under Rule 18f-4, a fund may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the fund has, among other things, a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. The Company has adopted policies and procedures to comply with the requirements of the rule. Compliance with Rule 18f-4 may limit our ability to use derivatives and/or enter into certain other financial contracts.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember', window );">We have formed CLOs and may form additional CLOs in the future, which may subject us to certain structured financing risks. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may form CLOs in the future, which may subject us to certain structured financing risks.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To finance investments, we may securitize certain of our secured loans or other investments, including through the formation of one or more CLOs, while retaining all or most of the exposure to the performance of these investments. This would involve contributing a pool of assets to a special purpose entity, and selling debt interests in such entity on a non-recourse or limited-recourse basis to purchasers. Depending on how these CLOs are structured, an interest in any such CLO held by us may be considered a &#8220;non-qualifying&#8221; portfolio investment for purposes of the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the CLOs we may in the future create we will depend in part on distributions from the CLO&#8217;s assets out of its earnings and cash flows to enable us to make distributions to shareholders. The ability of a CLO to make distributions will be subject to various limitations, including the terms and covenants of the debt it issues. Also, a CLO may take actions that delay distributions in order to preserve ratings and to keep the cost of present and future financings lower or the CLO may be obligated to retain cash or other assets to satisfy over-collateralization requirements commonly provided for holders of the CLO&#8217;s debt, which could impact our ability to receive distributions from the CLO. If we do not receive cash flow from any such CLO that is necessary to satisfy the annual distribution requirement for maintaining RIC status, and we are unable to obtain cash from other sources necessary to satisfy this requirement, we may not maintain our qualification as a RIC, which would have a material adverse effect on an investment in the shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a decline in the credit quality of loans in a CLO due to poor operating results of the relevant borrowers, declines in the value of loan collateral or increases in defaults, among other things, may force a CLO to sell certain assets at a loss, reducing their earnings and, in turn, cash potentially available for distribution to us for distribution to shareholders. To the extent that any losses are incurred by the CLO in respect of any collateral, such losses will be borne first by us as owner of equity interests in the CLO.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manager for a CLO that we create may be the Company, the Adviser or an affiliate, and such manager may be entitled to receive compensation for structuring and/or management services. To the extent the Adviser or an affiliate other than the Company serves as manager and the Company is obligated to compensate the Adviser or the affiliate for such services, we, the Adviser or the affiliate will implement offsetting arrangements to assure that we, and indirectly, our shareholders, pay no additional management fees to the Adviser or the affiliate in connection therewith. To the extent we serve as manager, we will waive any right to receive fees for such services from the Company (and indirectly its shareholders) or any affiliate.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember', window );">We will be subject to corporate-level income tax if we are unable to qualify as a RIC under Subchapter M of the Code or to satisfy RIC distribution requirements. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will be subject to corporate-level income tax if we are unable to maintain RIC tax treatment under Subchapter M of the Code or satisfy RIC distribution requirements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain and maintain RIC tax treatment under Subchapter M of the Code, we must, among other things, meet annual distribution, income source and quarterly asset diversification requirements. If we do not qualify for or maintain RIC tax treatment for any reason and are subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember', window );">We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For federal income tax purposes, we may be required to recognize taxable income in circumstances in which we do not receive a corresponding payment in cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount (such as zero-coupon securities, debt instruments with PIK interest or, in certain cases, increasing interest rates or debt instruments that were issued with warrants), we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. We may also have to include in income other amounts that we have not yet received in cash, such as deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. We anticipate that a portion of our income may constitute original issue discount or other income required to be included in taxable income prior to receipt of cash. Furthermore, we have elected to amortize market discount and include such amounts in our taxable income on a current basis, instead of upon disposition of the applicable debt obligation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because any original issue discount, market discount or other amounts accrued will be included in our investment company taxable income for the year of the accrual, we may be required to make a distribution to our shareholders in order to satisfy the annual distribution requirement, even though we will not have received any corresponding cash amount. As a result, we may have difficulty meeting the annual distribution requirement necessary to eliminate any corporate income tax as a RIC under Subchapter M of the Code. We may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may not qualify for or maintain RIC tax treatment and thus we may become subject to corporate-level income tax.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember', window );">Some of our investments may be subject to corporate-level income tax. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our investments may be subject to corporate-level income tax.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may invest in certain debt and equity investments through taxable subsidiaries and the taxable income of these taxable subsidiaries will be subject to federal and state corporate income taxes. We may invest in certain foreign debt and equity investments which could be subject to foreign taxes (such as income tax, withholding and value added taxes).</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember', window );">Our portfolio investments may present special tax issues. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our portfolio investments may present special tax issues.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to invest in debt securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Investments in these types of instruments may present special tax issues for the Company. U.S. federal income tax rules are not entirely clear about issues such as when the Company may cease to accrue interest, original issue discount or market discount, when and to what extent deductions may be taken for bad debts or worthless instruments, how payments received on obligations in default should be allocated between principal and income and whether exchanges of debt obligations in a bankruptcy or workout context are taxable. These and other issues will be addressed by the Company, to the extent necessary, to preserve its status as a RIC and to distribute sufficient income to not become subject to U.S. federal income tax.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember', window );">Legislative or regulatory tax changes could adversely affect investors. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legislative or regulatory tax changes could adversely affect investors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any time, the federal income tax laws governing RICs or the administrative interpretations of those laws or regulations may be amended. Any of those new laws, regulations or interpretations may take effect retroactively and could adversely affect the taxation of us or our shareholders. Therefore, changes in tax laws, regulations or administrative interpretations or any amendments thereto could diminish the value of an investment in our shares or the value or the resale potential of our investments.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember', window );">We cannot assure you that the market price of common shares will not decline below the IPO price or below our NAV. The market price of common shares may be volatile and may fluctuate substantially. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot assure you that the market price of common shares will not decline below the IPO price or below our NAV. The market price of common shares may be volatile and may fluctuate substantially.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently list our common shares on the NYSE under the symbol &#8220;BXSL.&#8221; We cannot assure you that the trading market can be sustained. In addition, we cannot predict the prices at which our common shares will trade. Shares of closed-end management investment companies, including BDCs, frequently trade at a discount from their NAV and our shares may also be discounted in the market. This characteristic of closed-end management investment companies is separate and distinct from the risk that our NAV per share may decline. We cannot predict whether our common shares will trade at, above or below NAV. The risk of loss associated with this characteristic of closed-end management investment companies may be greater for investors expecting to sell common shares purchased in the offering soon after the offering. In addition, if our common shares trades below its NAV, we will generally not be able to sell additional common shares to the public at its market price without first obtaining the approval of a majority of our shareholders (including a majority of our unaffiliated shareholders) and our independent directors for such issuance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price and liquidity of the market for our common shares may be si</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gnificantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant volatility in the market price and trading volume of securities of BDCs or other companies in the sector in which we operate, which are not necessarily related to the operating performance of these companies;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of RIC or BDC status;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in earnings or variations in operating results;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the value of our portfolio of investments;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting guidelines governing valuation of our investments;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any shortfall in revenue or net income or any increase in losses from levels expected by shareholders or securities analysts;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">departure of either of the Adviser or certain of its respective key personnel;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating performance of companies comparable to us;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic trends and other external factors; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of a major funding source.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember', window );">A shareholder&#8217;s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A shareholder&#8217;s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our shareholders do not have preemptive rights to purchase any shares we issue in the future. Our charter authorizes us to issue an unlimited number of shares. Our Board may elect to sell additional shares in the future or issue equity interests in private offerings. To the extent we issue additional equity interests at or below NAV, your percentage ownership interest in us may be diluted. In addition, depending upon the terms and pricing of any additional offerings and the value of our investments, you may also experience dilution in the book value and fair value of your shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 1940 Act, we generally are prohibited from issuing or selling our common shares at a price below NAV per share, which may be a disadvantage as compared with certain public companies. We may, however, sell our common shares, or warrants, options, or rights to acquire our common shares, at a price below the current NAV of our common shares if our Board and independent directors determine that such sale is in our best interests and the best interests of our shareholders, and our shareholders, including a majority of those shareholders that are not affiliated with us, approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board, closely approximates the fair value of such securities (less any distributing commission or discount). If we raise additional funds by issuing common shares or senior securities convertible into, or exchangeable for, our common shares, then the percentage ownership of our shareholders at that time will decrease and you will experience dilution.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember', window );">We may have difficulty paying distributions and the tax character of any distributions is uncertain. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulty paying distributions and the tax character of any distributions is uncertain.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally intend to distribute substantially all of our available earnings annually by paying distributions on a quarterly basis, as determined by the Board in its discretion. We cannot assure shareholders that we will achieve investment results that will allow us to make a specified level of cash distributions (particularly during the early stages of our operations) or year-to-year increases in cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this annual report. Due to the asset coverage test applicable to us under the 1940 Act as a BDC, we may be limited in our ability to make distributions. In addition, if we enter into a credit facility or any other borrowing facility, for so long as such facility is outstanding, we anticipate that we may be required by its terms to use all payments of interest and principal that we receive from our current investments as well as any proceeds received from the sale of our current investments to repay amounts outstanding thereunder, which could adversely affect our ability to make distributions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the tax treatment and characterization of our distributions may vary significantly from time to time due to the nature of our investments. The ultimate tax characterization of our distributions made during a taxable year may not finally be determined until after the end of that taxable year. We may make distributions during a taxable year that exceed our investment company taxable income and net capital gains for that taxable year. In such a situation, the amount by which our total distributions exceed investment company taxable income and net capital gains generally would be treated as a return of capital up to the amount of a shareholder&#8217;s tax basis in the shares, with any amounts exceeding such tax basis treated as a gain from the sale or exchange of such shares. A return of capital generally is a return of a shareholder&#8217;s investment rather than a return of earnings or gains derived from our investment activities. Moreover, we may pay all or a substantial portion of our distributions from the proceeds of the sale of our shares or from borrowings or sources other than cash flow from operations in anticipation of future cash flow, which could constitute a return of shareholders&#8217; capital and will lower such shareholders&#8217; tax basis in our shares, which may result in increased tax liability to shareholders when they sell such shares.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember', window );">Risk Of Distributions Exceeding Taxable Earnings And Profits, Causing Return Of Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributions on our common shares may exceed our taxable earnings and profits. Therefore, portions of the distributions that we pay may represent a return of capital to you. A return of capital is a return of a portion of your original investment in common shares. As a result, a return of capital will (i) lower your tax basis in your shares and thereby increase the amount of capital gain (or decrease the amount of capital loss) realized upon a subsequent sale or redemption of such shares, and (ii) reduce the amount of funds we have for investment in portfolio companies. We have not established any limit on the extent to which we may use offering proceeds to fund distributions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may pay our distributions from offering proceeds in anticipation of future cash flow, which may constitute a return of your capital and will lower your tax basis in your shares, thereby increasing the amount of capital gain (or decreasing the amount of capital loss) realized upon a subsequent sale or redemption of such shares, even if such shares have not increased in value or have, in fact, lost value.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember', window );">Shareholders will experience dilution in their ownership percentage if they do not participate in our dividend reinvestment plan. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders will experience dilution in their ownership percentage if they do not participate in our dividend reinvestment plan.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All distributions declared in cash payable to shareholders that are participants in our dividend reinvestment plan will generally be automatically reinvested in common shares if the investor opts in to the plan. As a result, shareholders that do not elect to participate in our dividend reinvestment plan may experience dilution over time.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember', window );">Shareholders may experience dilution in the net asset value of their shares if they do not participate in our dividend reinvestment plan and if our shares are trading at a discount to net asset value. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders may experience dilution in the net asset value of their shares if they do not participate in our dividend reinvestment plan and if our shares are trading at a discount to net asset value.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All distributions declared in cash payable to shareholders that are participants in our dividend reinvestment plan will generally be automatically reinvested in common shares if the investor opts in to the plan. As a result, shareholders that do not elect to participate in our dividend reinvestment plan may experience accretion to the NAV of their shares if our shares are trading at a premium to NAV and dilution if our shares are trading at a discount to NAV. The level of accretion or discount would depend on various factors, including the proportion of our shareholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to shareholders.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember', window );">No shareholder approval is required for certain mergers. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">No shareholder approval is required for certain mergers.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board may undertake to approve mergers between us and certain other funds or vehicles.&#160;Subject to the requirements of the 1940 Act and NYSE rules, such mergers will not require shareholder approval so shareholders will not be given an opportunity to vote on these matters unless such mergers are reasonably anticipated to result in a material dilution of the NAV per share of the Company.&#160;These mergers may involve funds managed by affiliates of Blackstone Credit &amp; Insurance.&#160;The Board may also convert the form and/or jurisdiction of organization, including to take advantage of laws that are more favorable to maintaining board control in the face of dissident shareholders.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember', window );">Investing in our shares involves a high degree of risk. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing in our shares involves a high degree of risk.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The investments we make in accordance with our investment objectives may result in a higher amount of risk than alternative investment options and volatility or loss of principal. Our investments in portfolio companies may be highly speculative and aggressive and, therefore, an investment in our shares may not be suitable for someone with lower risk tolerance.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember', window );">The NAV of our shares may fluctuate significantly. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The NAV of our shares may fluctuate significantly.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NAV and liquidity, if any, of the market for our shares may be significantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant volatility in the market price and trading volume of securities of BDCs or other companies in the sector in which we operate, which are not necessarily related to the operating performance of these companies;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of RIC or BDC status;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in earnings or variations in operating results;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the value of our portfolio of investments;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting guidelines governing valuation of our investments;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any shortfall in revenue or net income or any increase in losses from levels expected by shareholders or securities analysts;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">departure of either of the Adviser or certain of its respective key personnel;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating performance of companies comparable to us;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic trends and other external factors; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of a major funding source.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember', window );">Sales of substantial amounts of our common shares in the public market may have an adverse effect on the market price of our common shares. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of substantial amounts of our common shares in the public market may have an adverse effect on the market price of our common shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of substantial amounts of our common shares, or the availability of such common shares for sale, could adversely affect the prevailing market prices for our common shares. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember', window );">Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser, Blackstone Credit &amp; Insurance, Blackstone and their respective affiliates will be subject to certain conflicts of interest with respect to the services the Adviser and the Administrator provide to us. These conflicts will arise primarily from the involvement of Blackstone Credit &amp; Insurance, Blackstone and their respective affiliates (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Firm&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), in other activities that may conflict with our activities. You should be aware that individual conflicts will not necessarily be resolved in favor of your interest. The foregoing list of conflicts does not purport to be a complete enumeration or explanation of the actual and potential conflicts involved in an investment in the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this discussion and ease of reference, the following terms shall have the meanings as set forth below:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Blackstone Credit &amp; Insurance Clients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means, collectively, the investment funds, client accounts (including managed accounts) and proprietary accounts and/or other similar arrangements (including such arrangements in which the Company or one or more Other Blackstone Credit &amp; Insurance Clients own interests) that Blackstone Credit &amp; Insurance may establish, advise or sub-advise from time to time and to which Blackstone Credit &amp; Insurance provides investment management or sub-advisory services (other than the Company and any such funds and accounts in which the Company has an interest), in each case including any alternative investment vehicles and additional capital vehicles relating thereto and any vehicles established by Blackstone Credit &amp; Insurance to exercise its side-by-side or other general partner investment rights as set forth in their respective governing documents; provided, that for the avoidance of doubt, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Other Blackstone Credit &amp; Insurance Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not include Blackstone Credit &amp; Insurance in its role as principal of any account, including any such accounts for which Blackstone Credit &amp; Insurance or an affiliate thereof acts as an advisor.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blackstone Clients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means, collectively, the investment funds, client accounts (including managed accounts) and proprietary accounts and/or other similar arrangements (including such arrangements in which the Company or one or more Blackstone Clients own interests) that Blackstone may establish, advise or sub-advise from time to time and to which Blackstone provides investment management or sub-advisory services (other than the Company, any such funds and accounts in which the Company has an interest and Other Blackstone Credit &amp; Insurance Clients), in each case including any alternative investment vehicles and additional capital vehicles relating thereto and any vehicles established by Blackstone to exercise its side-by-side or other general partner investment rights as set forth in their respective governing documents; provided that, for the avoidance of doubt, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Blackstone Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not include Blackstone in its role as principal of any account, including any accounts for which Blackstone or an affiliate thereof acts as an advisor.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Clients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means, collectively, Other Blackstone Credit &amp; Insurance Clients and Blackstone Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Based Compensation and Management Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The existence of the incentive fees payable to Blackstone Credit &amp; Insurance may create a greater incentive for Blackstone Credit &amp; Insurance to make more speculative investments on behalf of the Company, or to time the purchase or sale of investments in a manner motivated by the personal interests of Blackstone Credit &amp; Insurance and/or Blackstone personnel. However, the fact that the hurdle rate for the incentive fee based on income is calculated on an aggregate basis each quarter and that realized and unrealized losses are netted against realized gains for the incentive fee based on capital gains should reduce the incentives for the Adviser to make more speculative investments or otherwise time the purchase or sale of investments. Our Board of Trustees will seek to monitor these conflicts but there can be no assurances that such monitoring will fully mitigate any such conflicts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the manner in which the Adviser&#8217;s entitlement to incentive fees is determined may result in a conflict between its interests and the interests of shareholders with respect to the sequence and timing of disposals of investments, as the Adviser may want to dispose of lower yielding investments in favor of higher yielding ones. With respect to the Adviser&#8217;s entitlement to incentive fees on capital gains, the Adviser may be incentivized to realize capital gains prior to a year end if such gains, net of realized and unrealized losses, would result in an incentive fee on capital gains.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Firm&#8217;s Policies and Procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm has implemented policies and procedures to address conflicts that arise as a result of its various activities, as well as regulatory and other legal considerations. Specified policies and procedures implemented by the Firm to mitigate potential conflicts of interest and address certain regulatory requirements and contractual restrictions are expected to reduce the synergies across the Firm&#8217;s various businesses that the Company expects to draw on for purposes of pursuing attractive investment opportunities. Because the Firm has many different asset management and advisory businesses, including private equity, a credit business, a hedge fund business, a capital markets group, a life sciences business and a real estate advisory business, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would otherwise be subject if it had just one line of business. In addressing these conflicts and regulatory, legal and contractual requirements across its various businesses and to protect against the inappropriate sharing and/or use of information between the Company and the other business units at the Firm, the Firm has implemented certain policies and procedures (e.g., information wall policy) regarding the sharing of information that could reduce the positive synergies that the Company expects to utilize for purposes of identifying and managing attractive investments. For example, the Firm will from time to time come into possession of material non-public information with respect to companies, including companies in which the Company has investments or might be considering making an investment or companies that are clients of the Firm. As a consequence, that information, which could be of benefit to the Company, might become restricted to those other respective businesses and otherwise be unavailable to the Company. It is also possible that the Company could be restricted from trading despite the fact that the Company did not receive such information. There can be no assurance, however, that any such policies and/or procedures will be effective in accomplishing their stated purpose and/or that they will not otherwise adversely affect the ability of the Company to effectively achieve its investment objective by unduly limiting the investment flexibility of the Company and/or the flow of otherwise appropriate information between Blackstone Credit &amp; Insurance and other business units at the Firm. Personnel of the Firm could be unable, for example, to assist with the activities of the Company as a result of these walls. There can be no assurance that additional restrictions will not be imposed that would further limit the ability of the Firm to share information internally.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to the extent that the Firm is in possession of material non-public information or is otherwise restricted from trading in certain securities, the Company and the Adviser could also be deemed to be in possession of such information or otherwise restricted. Additionally, the terms of confidentiality or other agreements with or related to companies in which any Other Client has or has considered making an investment or which is otherwise a client of the Firm will from time to time restrict or otherwise limit the ability of the Company and/or its portfolio companies and their affiliates to make investments in or otherwise engage in businesses or activities competitive with such companies. The Firm could enter into one or more strategic relationships in certain regions or with respect to certain types of investments that, although intended to provide greater opportunities for the Company, could require the Company to share such opportunities or otherwise limit the amount of an opportunity the Company can otherwise take.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allocation of Personnel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser and its members, officers and employees will devote as much of their time to the activities of the Company as they deem necessary to conduct its business affairs in an appropriate manner. By the terms of the Investment Advisory Agreement, the Firm is not restricted from forming additional investment funds, from entering into other investment advisory relationships or from engaging in other business activities, even though such activities have the potential to be in competition with the Company and/or to involve substantial time and resources of the Adviser. Firm personnel, including members of the investment committee, will work on other projects, serve on other committees (including boards of directors) and source potential investments for and otherwise assist the investment programs of Other Clients and their portfolio companies, including other investment programs to be developed in the future. Certain members of Blackstone Credit &amp; Insurance&#8217;s investment team are also members of Other Clients&#8217; investment teams and will continue to serve in those roles (which could be their primary responsibility) and as a result, not all of their business time will be devoted to Blackstone or the Company. Certain non-investment professionals are not dedicated solely to the Company and are permitted to perform work for Other Clients which is expected to detract from the time such persons devote to the Company. These activities could be viewed as creating a conflict of interest in that the time and effort of the members of the Adviser and its officers and employees will not be devoted exclusively to the business of the Company, but will be allocated between the business of the Company and the management of the monies of such other advisees of the Adviser. Time spent on these other initiatives diverts attention from the activities of the Company, which could negatively impact the Company and shareholders. Furthermore, Blackstone Credit &amp; Insurance and Blackstone Credit &amp; Insurance personnel derive financial benefit from these other activities, including fees and performance-based compensation. Firm personnel outside of Blackstone Credit &amp; Insurance can share in the fees and performance-based compensation from the Company; similarly, Blackstone Credit &amp; Insurance personnel can share in the fees and performance-based compensation generated by Other Clients. These and other factors create conflicts of interest in the allocation of time by Firm personnel. Blackstone Credit &amp; Insurance&#8217;s determination of the amount of time necessary to conduct the Company&#8217;s activities will be conclusive, and shareholders rely on Blackstone Credit &amp; Insurance&#8217;s judgment in this regard.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Outside Activities of Principals and Other Personnel and their Related Parties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain of the principals and employees of the Adviser will, in certain circumstances, be subject to a variety of conflicts of interest relating to their responsibilities to the Company, Other Clients and their respective portfolio companies, and their outside personal or business activities, including as members of investment or advisory committees or boards of directors of or advisors to investment funds, corporations, foundations or other organizations. Such positions create a conflict if such other entities have interests that are adverse to those of the Company, including if such other entities compete with the Company for investment opportunities or other resources. The other managed accounts and/or investment funds in which such individuals may become involved may have investment objectives that overlap with the Company. Furthermore, certain principals and employees of the Adviser are likely to have a greater financial interest in the performance of such other funds or accounts than the performance of the Company. Such involvement is expected to create conflicts of interest in making investments on behalf of the Company and such other funds and accounts. Although such principals and employees will seek to limit any such conflicts in a manner that is in accordance with their fiduciary duties to the Company, there can be no assurance they will be resolved favorably for the Company. Also, Blackstone personnel, Firm employees, including employees of the Adviser, are generally permitted to invest in alternative investment funds, private equity funds, credit funds, real estate funds, hedge funds and other investment vehicles, as well as engage in other personal trading activities relating to companies, assets, securities or instruments (subject to the Firm&#8217;s Code of Ethics requirements), some of which will involve conflicts of interests. Such personal securities transactions will, in certain circumstances, relate to securities or instruments which can be expected to also be held or acquired by Other Clients, the Company, or otherwise relate to portfolio companies in which the Company has or acquires a different principal investment (including, for example, with respect to seniority), which is expected to give rise to conflicts of interest related to misaligned interests between the Company and such persons. There could be situations in which such alternative investment funds invest in the same portfolio companies as the Company and there could be situations in which such alternative investment funds purchase securities from, or sell securities to, the Company if permitted under the 1940 Act and other applicable law. There can be no assurance that conflicts of interest arising out of such activities will be resolved in favor of the Company. Shareholders will not receive any benefit from any such investments, and the financial incentives of Firm personnel in such other investments could be greater than their financial incentives in relation to the Company and are not expected to receive notice should the Company make investments in which such persons hold direct or indirect interests.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain employees and other professionals of the Firm have family members or relatives employed by such advisers and service providers (or their affiliates) or otherwise actively involved in industries and sectors in which the Company invests, and/or have business, financial, personal or other relationships with companies in such industries and sectors (including the advisors and service providers described above) or other industries, which gives rise to potential or actual conflicts of interest. For example, such family members or relatives might be employees, officers, directors, personnel or owners of companies or assets that are actual or potential investments of the Company or other counterparties of the Company and its portfolio companies and/or assets. Moreover, in certain instances, the Company or its portfolio companies can be expected to issue loans to or acquire securities from, or otherwise transact with, companies that are owned by such family members or relatives or in respect of which such family members or relatives have other involvement. These relationships have the potential to influence Blackstone, the Adviser and/or Blackstone Credit &amp; Insurance in deciding whether to select, recommend or create such service providers to perform services for the Company or portfolio companies (the cost of which will generally be borne directly or indirectly by the Company or such portfolio companies, as applicable). Notwithstanding the foregoing, investment transactions relating to the Company that require the use of a service provider will generally be allocated to service providers on the basis of best execution, the evaluation of which includes, among other considerations, such service provider&#8217;s provision of certain investment-related services and research that the Adviser believes to be of benefit to the Company. To the extent that the Firm determines appropriate, conflict mitigation strategies can be expected to be put in place with respect to a particular circumstance, such as internal information barriers or recusal, disclosure or other steps determined appropriate by the Firm. The shareholders rely on the Firm to manage these conflicts in its sole discretion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Secondments and Internships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain personnel of Blackstone and its affiliates, including consultants, will, in certain circumstances, be seconded to one or more portfolio companies, vendors and service providers and vendors or shareholders or other investors of the Company and Other Clients to provide finance, accounting, operational support, data management and other similar services, including the sourcing of investments for the Company or other parties. The salaries, benefits, overhead and other similar expenses for such personnel during the secondment could be borne by Blackstone and its affiliates or the organization for which the personnel are working or both. In addition, personnel of portfolio companies, vendors, service providers (including law firms and accounting firms) and shareholders or other investors of the Company and Other Clients will, in certain circumstances, be seconded to, serve internships at or otherwise provide consulting services to, Blackstone, the Company, Other Clients and portfolio companies of the Company and Other Clients. While often the Company, Other Clients and their respective portfolio companies are the beneficiaries of these types of arrangements, Blackstone is from time to time a beneficiary of these arrangements as well, including in circumstances where the vendor, personnel or service provider or otherwise also provides services to the Company, Other Clients, their respective portfolio companies or Blackstone in the ordinary course. Blackstone, the Company, Other Clients or their portfolio companies could receive benefits from these arrangements at no cost, or alternatively could pay all or a portion of the fees, compensation or other expenses in respect of these arrangements. If a portfolio company pays the cost it will be borne directly or indirectly by the Company. To the extent such fees, compensation or other expenses are borne by the Company, including indirectly through its portfolio companies or reimbursement of Blackstone for such costs, the management fee will not be reduced as a result of these arrangements or any fees, expense reimbursements or other costs related thereto. The personnel described above may provide services in respect of multiple matters, including in respect of matters related to Blackstone, the Company, Other Clients, portfolio companies, each of their respective affiliates and related parties, and any costs of such personnel may be allocated accordingly, Blackstone will endeavor in good faith to allocate the costs of these arrangements, if any, to Blackstone, the Company, Other Clients, portfolio companies and other parties based on time spent by the personnel or another methodology Blackstone deems appropriate in a particular circumstance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone Credit &amp; Insurance and its personnel and related parties will receive intangible and other benefits, discounts and perquisites arising or resulting from their activities on behalf of the Company, the value of which will not reduce the management fees or incentive fees or otherwise be shared with the Company or its portfolio companies. For example, airline travel or hotel stays incurred as Fund expenses, as set forth in the Investment Advisory Agreement and Administration Agreement (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Fund Expenses&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), often result in &#8220;miles&#8221; or &#8220;points&#8221; or credit in loyalty or status programs, and certain purchases made by credit card will result in &#8220;credit card points, &#8220;cash back&#8221; or rebates in addition to such loyalty or status program miles or points. Such benefits and/or amounts will, whether or not de minimis or difficult to value, inure exclusively to the benefit of Blackstone Credit &amp; Insurance, its affiliates or their personnel (and not the Company and/or portfolio companies) even though the cost of the underlying service is borne by the Company and/or portfolio companies. (See also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Service Providers, Vendors and Other Counterparties Generally&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Portfolio Company Relationships Generally&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein.) Similarly, Blackstone Credit &amp; Insurance, its affiliates and their personnel and related parties, and third parties designated by the foregoing, also receive discounts on products and services provided by portfolio companies and customers or suppliers of such portfolio companies. Such other benefits or fees have the potential to give rise to conflicts of interest in connection with the Company&#8217;s investment activities, and while the Adviser and Blackstone Credit &amp; Insurance will seek to resolve any such conflicts in a fair and equitable manner, there is no assurance that any such conflicts will be resolved in favor of the Company. See also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Service Providers, Vendors and Other Counterparties Generally&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Portfolio Company Relationships Generally&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Advisors, Industry Experts and Operating Partners</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blackstone Credit &amp; Insurance is expected to engage and retain strategic advisors, consultants, senior advisors, executive advisors, industry experts, operating partners, deal sourcers, consultants and other similar professionals (which is expected to include current and former executives or other personnel of Blackstone and/or Blackstone Credit &amp; Insurance, as well as current and former executives or other personnel of Blackstone&#8217;s and/or Blackstone Credit &amp; Insurance&#8217;s portfolio companies) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Senior and Other Advisors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) who are not employees or affiliates of Blackstone Credit &amp; Insurance and who will, from time to time, receive payments from, or allocations of a profits interest with respect to, portfolio companies (as well as from Blackstone Credit &amp; Insurance or the Company). In particular, in some cases, consultants, including those with a &#8220;Senior Advisor&#8221; title, have been and will be engaged with the responsibility to source, diligence and recommend transactions to Blackstone Credit &amp; Insurance or to undertake a build-up strategy to originate, acquire and develop assets and businesses in a particular sector or involving a particular strategy, potentially on a full-time and/or exclusive basis and notwithstanding any overlap with the responsibilities of Blackstone Credit &amp; Insurance under the Investment Advisory Agreement, the compensation to such consultants is expected to be borne fully by the Company and/or portfolio companies (with no reduction or offset to management fee payable by the Company) and not Blackstone Credit &amp; Insurance. Similarly, the Company, Other Clients and their portfolio companies are expected to retain and pay compensation to Senior and Other Advisors to provide services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any amounts paid by the Company or a portfolio company to Senior and Other Advisors in connection with the above services, including cash fees, profits, or equity interests in a portfolio company, discretionary bonus awards, performance-based compensation (e.g., promote), sourcing fees, retainers and expense reimbursements, will be treated as Company Expenses or expenses of the portfolio company, as the case may be, and will not, even if they have the effect of reducing any retainers or minimum amounts otherwise payable by Blackstone Credit &amp; Insurance, be chargeable to Blackstone Credit &amp; Insurance or be deemed paid to or received by Blackstone Credit &amp; Insurance, and such amounts will not reduce the management fees or incentive fees payable. Amounts charged by Senior and Other Advisors will not necessarily be confirmed as being comparable to market rates for such services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent permitted by applicable law and/or any applicable SEC granted exemptive or no action relief, these Senior and Other Advisors often have the right or could be offered the ability to (i) co-invest alongside the Company, including in the specific investments in which they are involved (and for which they can be entitled to receive performance-related incentive fees, which will reduce the Company&#8217;s returns), (ii) otherwise participate in equity plans for management of any such portfolio company, or (iii) invest directly in the Company or in a vehicle controlled by the Company subject to reduced or waived advisory fees and/or incentive fees, including after the termination of their engagement by or other status with the Firm. Such co-investment and/or participation (which generally will result in the Company being allocated a smaller share of the applicable investment) will not be considered as part of the Firm&#8217;s side-by-side co-investment rights. Such co-investment and/or participation could vary by transaction (and such participation can, depending on its structure, reduce the Company&#8217;s returns. Additionally, and notwithstanding the foregoing, these Senior and Other Advisors, as well as other Blackstone Clients could be (or could have the preferred right to be) investors in Blackstone Credit &amp; Insurance&#8217;s portfolio companies (which, in some cases, can involve agreements to pay performance fees, or allocate profits interests, to such persons in connection with the Company&#8217;s investment therein, which will reduce the Company&#8217;s returns) and/or Other Clients. Such Senior and Other Advisors, as well as other Blackstone Clients, could also, subject to applicable law, have rights to co-invest with the Company on a side-by-side basis, which rights are generally offered on a no-fee/no-carried interest basis and generally result in the Company being allocated a smaller share of an investment than would otherwise be the case in the absence of such side-by-side participation. Senior and Other Advisors&#8217; benefits described in this paragraph will, in certain circumstances, continue after termination of status as a Senior and Other Advisors.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The time, dedication and scope of work of, and the nature of the relationship with, each of the Senior and Other Advisors vary considerably. In certain cases, they could advise the Adviser and/or Blackstone Credit &amp; Insurance on transactions, provide the Adviser and/or Blackstone with industry-specific insights and feedback on investment themes, assist in transaction due diligence, or make introductions to and provide reference checks on management teams. In other cases, they take on more extensive roles (and could be exclusive service providers to Blackstone Credit &amp; Insurance) and serve as executives or directors on the boards of portfolio companies or contribute to the identification and origination of new investment opportunities. The Company expects to rely on these Senior and Other Advisors to recommend Blackstone as a preferred investment partner, identify investments, source opportunities, and otherwise carry out its investment program, but there is no assurance that these advisers will continue to be involved with the Company for any length of time. In certain instances, Blackstone Credit &amp; Insurance can be expected to have formal or informal arrangements with these Senior and Other Advisors (which may or may not be terminable upon notice by any party), and in other cases the relationships are more informal. They are either compensated (including pursuant to retainers and expense reimbursement, and, in any event, pursuant to negotiated arrangements that will not be confirmed as being comparable to the market rates for such services) by Blackstone, the Company, and/or portfolio companies or otherwise uncompensated or entitled to deferred compensation until occurrence of a future event, such as commencement of a formal engagement. In certain cases, they have certain attributes of Blackstone Credit &amp; Insurance &#8220;employees&#8221; (e.g., they can be expected to have dedicated offices at Blackstone Credit &amp; Insurance, receive administrative support from Blackstone Credit &amp; Insurance personnel, participate in general meetings and events for Blackstone Credit &amp; Insurance personnel, work on Blackstone Credit &amp; Insurance matters as their primary or sole business activity, service Blackstone exclusively, have Blackstone-related e-mail addresses and/or business cards and participate in certain benefit arrangements typically reserved for Blackstone employees, etc.) even though they are not considered Blackstone Credit &amp; Insurance employees, affiliates or personnel for purposes of the Investment Advisory Agreement between the Company and Blackstone Credit &amp; Insurance. Under many of these arrangements, there can be no assurance that the amount of compensation paid in a particular period of time will be proportional to the amount of hours worked or the amount or tangible work product generated by the Senior and Other Advisors during such time. Some Senior and Other Advisors work only for the Company and its portfolio companies, while others may have other clients. In particular, in some cases, Senior and Other Advisors, including those with a &#8220;Senior Advisor&#8221; or &#8220;Operating Advisor&#8221; title, have been and will be engaged with the responsibility to source and recommend transactions to the Adviser potentially on a full-time and/or exclusive basis and, notwithstanding any overlap with the responsibilities of the Adviser under the Investment Advisory Agreement, the compensation to such Senior and Other Advisors will be borne fully portfolio companies (with no reduction to management fees) and not the Adviser. Senior and Other </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advisors could have conflicts of interest between their work for the Company and its portfolio companies, on the one hand, and themselves or other clients, on the other hand, and Blackstone Credit &amp; Insurance is limited in its ability to monitor and mitigate these conflicts. Blackstone Credit &amp; Insurance expects, where applicable, to allocate the costs of such Senior and Other Advisors to the Company and/or applicable portfolio companies, and to the extent any such costs are allocated to the Company, they would be treated as Company Expenses. Payments or allocations to Senior and Other Advisors will not be reduced by the management fee, and can be expected to increase the overall costs and expenses borne indirectly by investors in the Company. There can be no assurance that any of the Senior and Other Advisors, to the extent engaged, will continue to serve in such roles and/or continue their arrangements with Blackstone Credit &amp; Insurance, the Company and/or any portfolio companies for the duration of the relevant investments or throughout the term of the Company. Additionally, from time to time, Senior and Other Advisors provide services on behalf of both the Company and Other Clients, and any work performed by Senior and Other Advisors retained on behalf of the Company could benefit the Other Clients (and alternatively, work performed by Senior and Other Advisors on behalf of Other Clients could benefit the Company), and Blackstone Credit &amp; Insurance shall have no obligation to allocate any portion of the costs to be borne by the Company in respect of such Senior and Other Advisors to the Other Clients, except as described below.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of the foregoing, in certain investments including involving a &#8220;platform company,&#8221; the Company will, in certain circumstances, enter into an arrangement with one or more individuals (who could be former personnel of the Firm or current or former personnel of portfolio companies of the Company or Other Clients, generally will have experience or capability in sourcing or managing investments, and could form a management team) to undertake a new business line or a build-up strategy to acquire and develop assets and businesses in a particular sector or involving a particular strategy. The services provided by such individuals or relevant portfolio company, as the case may be, could include the following with respect to investments: origination or sourcing, due diligence, evaluation, negotiation, servicing, development, management (including turnaround) and disposition. The individuals or relevant portfolio company could be compensated with a salary and equity incentive plan, including a portion of profits derived from the Company or a portfolio company or asset of the Company (which, to the extent permitted by applicable law and/or any applicable SEC granted exemptive or no action relief, can take the form of a management fee and/or profits allocation (whether paid directly to such individuals or to an affiliate entity controlled by such individuals), or other long-term incentive plans. Compensation could also be based on assets under management, a waterfall similar to a carried interest, respectively, or another similar metric. The Company could initially bear the cost of overhead (including rent, utilities, benefits, salary or retainers for the individuals or their affiliates entities) and the sourcing, diligence and analysis of investments, as well as the compensation for the individuals and entity undertaking the build-up strategy. Such expenses could be borne directly by the Company as Company Expenses (or broken deal expenses, if applicable) or indirectly through expenditures by a portfolio company. None the fees, costs or expenses described above will reduce the management fee.</span></div><div style="margin-top:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Adviser will, in certain circumstances, engage third parties as Senior and Other Advisors (or in another similar capacity) in order to advise it with respect to existing investments, specific investment opportunities, and economic and industry trends. Such Senior and Other Advisors can receive reimbursement of reasonable related expenses by portfolio companies or the Company and could have the opportunity to invest in a portion of the equity and/or debt available to the Company for investment that would otherwise be taken by the Adviser and its affiliates. If such Senior and Other Advisors generate investment opportunities on the Company&#8217;s behalf, such Senior and Other Advisors are permitted to receive special additional fees or allocations which have the potential to not be comparable to those received by a third party in an arm&#8217;s length transaction and such additional fees or allocations would be borne fully by the Company and/or portfolio companies (with no reduction or offset to management fees) and not Blackstone Credit &amp; Insurance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Minority Investments in Asset Management Firms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone and Other Clients, including Blackstone Strategic Capital Holdings (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BSCH&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and its related parties, regularly make minority investments in alternative asset management firms that are not affiliated with Blackstone, the Company, Other Clients and their respective portfolio companies, and which from time to time engage in similar investment transactions, including with respect to purchase and sale of investments, with these asset management firms and their advised funds and portfolio companies. Typically, the Blackstone related party with an interest in the asset management firm would be entitled to receive a share of carried interest/performance based incentive compensation and net fee income or revenue share generated by the various products, vehicles, funds and accounts managed by that third party asset management firm that are included in the transaction or activities of the third party asset management firm, or a subset of such activities such as transactions with a Blackstone related party. In addition, while such minority investments are generally structured so that Blackstone does not &#8220;control&#8221; such third party asset management firms, Blackstone could nonetheless be afforded certain governance rights in relation to such investments (typically in the nature of &#8220;protective&#8221; rights, negative control rights or anti-dilution arrangements, as well as certain reporting and consultation rights) that afford Blackstone the ability to influence the firm. Although Blackstone and Other Clients, including BSCH, do not intend to control such third </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">party asset management firms, there can be no assurance that all third parties will similarly conclude that such investments are non-control investments or that, due to the provisions of the governing documents of such third party asset management firms or the interpretation of applicable law or regulations, investments by Blackstone and Other Clients, including BSCH, will not be deemed to have control elements for certain contractual, regulatory or other purposes. While such third party asset managers will not be deemed affiliated with the Company within the meaning of the 1940 Act, Blackstone expects to, under certain circumstances, be in a position to influence the management and operations of such asset managers and the existence of its economic/revenue sharing interest therein can give rise to conflicts of interest. Participation rights in a third party asset management firm (or other similar business), negotiated governance arrangements and/or the interpretation of applicable law or regulations could expose the investments of the Company to claims by third parties in connection with such investments (as indirect owners of such asset management firms or similar businesses) that would have an adverse financial or reputational impact on the performance of the Company. The Company, its affiliates and their respective portfolio companies are expected to, from time to time engage in transactions with, and buy and sell investments from, any such third party asset managers and their sponsored funds and transactions and other commercial arrangements between such third party asset managers and the Company and its portfolio companies are not subject to approval by the Board of Trustees. There can be no assurance that the terms of these transactions between parties related to Blackstone, on the one hand, and the Company and its portfolio companies, on the other hand, will be at arm&#8217;s length or that Blackstone will not receive a benefit from such transactions, which can be expected to incentivize Blackstone to cause these transactions to occur. Such conflicts related to investments in and arrangements with other asset management firms will not necessarily be resolved in favor of the Company. Shareholders will not be entitled to receive notice or disclosure of the terms or occurrence of either the investments in alternative asset management firms or transactions therewith and will not receive any benefit from such transactions. By executing a subscription agreement with respect to the Company, each shareholder acknowledges these conflicts related to investments in and arrangements with other asset management firms, acknowledges that these conflicts will not necessarily be resolved in favor of the Company, agrees that shareholders will not be entitled to receive notice or disclosure of the terms or occurrence of either the investments in alternative asset management firms or transactions therewith, otherwise understands that shareholders will not receive any benefit from such transactions, consents to all such transactions and arrangements to the fullest extent permitted by law, and waives any claim against Blackstone and releases Blackstone from any liability arising from the existence of any such conflict of interest.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, certain advisors and service providers (including law firms) temporarily provide their personnel to Blackstone, Other Clients or their portfolio companies pursuant to various arrangements including at cost or at no cost. (See also &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Secondments and Internships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; herein.) While often the Company, Other Clients and their portfolio companies are the beneficiaries of these types of arrangements, Blackstone is from time to time a beneficiary of these arrangements as well, including in circumstances where the advisor or service provider also provides services to the Company, Other Clients or Blackstone in the ordinary course. Blackstone, the Company, Other Clients or their portfolio companies could receive benefits from these arrangements at no cost, or alternatively could pay all or a portion of the fees, compensation or other expenses in respect of these arrangements. The management fee will not be offset or reduced as a result of these arrangements or any fees, expense reimbursements or other costs related thereto. The personnel described above could provide services in respect of multiple matters, including in respect of matters related to Blackstone, the Company, Other Clients, portfolio companies, each of their respective affiliates and related parties, and Blackstone will endeavor in good faith to allocate the costs of these arrangements, if any, to Blackstone, the Company, Other Clients, portfolio companies and other parties based on time spent by the personnel or another methodology the Firm deems appropriate in a particular circumstance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Multiple Blackstone Business Lines. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone has multiple business lines, including the Blackstone Capital Markets Group, which Blackstone Credit &amp; Insurance, the Company, Other Clients, portfolio companies of the Company and Other Clients and third parties will, in certain circumstances, engage for debt and equity financings and to provide other investment banking, brokerage, investment advisory or other services. As a result of these activities, Blackstone is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than if it had one line of business. For example, from time to time, Blackstone could come into possession of information that limits the Company&#8217;s ability to engage in potential transactions. Similarly, other Blackstone businesses and their personnel could be prohibited by law or contract from sharing information with Blackstone that would be relevant to monitoring the investments and other activities. These types of restrictions from time to time will negatively impact the ability of the Company to implement its investment program. Finally, Blackstone personnel who are members of the investment team or investment committee could be excluded from participating in certain investment decisions due to conflicts involving other Blackstone businesses or for other reasons, including other business activities, in which case the Company will not benefit from their experience. The shareholders will not receive a benefit from any fees earned by Blackstone or its personnel from these other businesses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone is under no obligation to decline any engagements or investments in order to make an investment opportunity available to the Company. Blackstone has long-term relationships with a significant number of corporations and their senior management. Blackstone will consider those relationships when evaluating an investment opportunity, which has the potential to result in Blackstone choosing not to make such an investment due to such relationships (e.g., investments in a competitor of a client or other person with whom Blackstone has a relationship). The Company could be required to sell or hold existing investments as a result of investment banking relationships or other relationships that Blackstone has or will have or transactions or investments that Blackstone makes or has made. (See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Allocation of Investment Opportunities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Portfolio Company Relationships&#8221;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Therefore, there can be no assurance that all potentially suitable investment opportunities that come to the attention of Blackstone will be made available to the Company. The Company is also permitted to co-invest with Other Clients or other persons with whom Blackstone has a relationship in particular investment opportunities, and other aspects of these Blackstone relationships could influence the decisions made by Blackstone with respect to the investments and otherwise result in a conflict (see also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Other Clients; Allocation of Investment Opportunities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein). Company would otherwise have to buy or sell certain assets, and may require that the Company dispose of an investment at an inopportune time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blackstone Policies and Procedures; Information Walls.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blackstone has implemented policies and procedures to address conflicts that arise as a result of its various activities, as well as regulatory and other legal considerations. Some of these policies and procedures, such as Blackstone&#8217;s information wall policy, are implemented by Blackstone to mitigate potential conflicts of interest and address certain regulatory requirements and contractual restrictions will reduce the synergies and collaboration across Blackstone&#8217;s various businesses that the Company expects to draw on for purposes of identifying, pursuing and managing attractive investment opportunities. Because Blackstone has many different asset management and advisory businesses, including private equity, growth equity, a credit business, a hedge fund business, a capital markets group, a life sciences business and a real estate advisory business, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would otherwise be subject if it had just one line of business. In addressing these conflicts and regulatory, legal and contractual requirements across its various businesses and to protect against the inappropriate sharing and/or use of information between the Company and the other business units at Blackstone, Blackstone has implemented certain policies and procedures (e.g., Blackstone&#8217;s information wall policy) regarding the sharing of information that have the potential to reduce the positive synergies and collaborations that the Company could otherwise expect to utilize for purposes of identifying and managing attractive investments. For example, Blackstone will from time to time come into possession of material non-public information with respect to companies in which Other Clients have investments or might be considering making an investment or companies that are clients of Blackstone. As a consequence, that information, which could be of benefit to the Company, might become restricted to those other respective businesses and otherwise be unavailable to the Company. It is also possible that the Company could be restricted from trading despite the fact that the Company did not receive such information. There can be no assurance, however, that any such policies and/or procedures will be effective in accomplishing their stated purpose and/or that they will not otherwise adversely affect the ability of the Company to effectively achieve its investment objective by unduly limiting the investment flexibility of the Company and/or the flow of otherwise appropriate information between Blackstone Credit &amp; Insurance and other business units at Blackstone. For example, in some instances, personnel of Blackstone would be unable to assist with the activities of the Company as a result of these walls. There can be no assurance that additional restrictions will not be imposed that would further limit the ability of Blackstone to share information internally. In addition, due to these restrictions, it is possible that the Company will not be able to initiate a transaction that it otherwise might have initiated and will not be able to purchase or sell an investment that it otherwise might have purchased or sold, which could negatively affect its operations or performance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to the extent that Blackstone is in possession of material non-public information or is otherwise restricted from making certain investments, the Company and the Adviser would also be deemed to be in possession of such information or otherwise restricted. Additionally, the terms of confidentiality or other agreements with or related to companies in which any Blackstone fund has or has considered making an investment or which is otherwise a client of Blackstone will from time to time restrict or otherwise limit the ability of the Company and/or its portfolio companies and their affiliates to make investments in or otherwise engage in businesses or activities competitive with such companies. Blackstone has in the past entered into, and reserves the right to enter into in the future, one or more strategic relationships in certain regions or with respect to certain types of investments that, although intended to provide greater opportunities for the Company, require the Company to share such opportunities or otherwise limit the amount of an opportunity the Company can otherwise take. (See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Allocation of Investment Opportunities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm receives, generates and/or obtains various kinds of data and information from the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and limited partners in Other Clients and service providers, including but not limited to data and information relating to or created in connection with business operations, financial information results, trends, budgets, energy usage, plans, ESG, carbon emissions and related metrics, customer and user data, employee and contractor data, supplier and cost data, and other related data and information, some of which is sometimes referred to as &#8220;alternative data&#8221; or &#8220;big data&#8221;. The Firm can be expected to be better able to anticipate macroeconomic and other trends, and otherwise develop investment themes or identify specific investment, trading or business opportunities, as a result of its access to (and rights regarding, including use, ownership, distribution and derived works rights over) this data and information from the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and limited partners in Other Clients, related parties and service providers. The Firm has entered and will continue to enter into information sharing and use, measurement and other arrangements, which will give the Firm access to (and rights regarding, including ownership, use, distribution and derived works rights over) data that it would not otherwise obtain in the ordinary course, with the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and in Other Clients, as well as with related parties and service providers. Further, this alternative data is expected to be aggregated across the Company, Other Clients and their respective portfolio companies. Although the Firm believes that these activities improve the Firm&#8217;s investment management activities on behalf of the Company and Other Clients, information obtained from the Company and its portfolio companies, and investors in the Company and in Other Clients also provides material benefits to Blackstone or Other Clients without compensation or other benefit accruing to the Company or its shareholders. For example, information from a portfolio company in which the Company holds an interest can be expected to enable the Firm to better understand a particular industry, enhance the Firm&#8217;s ability to provide advice or direction to a portfolio company&#8217;s management team on strategy or operations and enable the Firm to execute trading and investment strategies in reliance on that understanding for Blackstone and Other Clients that do not own an interest in the portfolio company, typically without compensation or benefit to the Company or its portfolio companies. Blackstone would serve as the repository for data described in this paragraph, including with ownership and use rights therein. The Firm is also permitted to share data from a portfolio company (on an anonymized basis) with a portfolio company of an Other Client, which has the potential to increase a competitive disadvantage for, and indirectly harm, such portfolio company (although the opposite may be true as well, in which case a portfolio company of the Company may receive data from a portfolio company of an Other Client). In addition, the Firm could have an incentive to pursue an investment in a particular company based on the data and information expected to be received or generated in connection with such investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, except for contractual obligations to third parties to maintain confidentiality of certain information or otherwise limit the scope and purpose of its use or distribution, and regulatory limitations on the use of material nonpublic information, the Firm is generally free to use and distribute data and information from the Company&#8217;s activities to assist in the pursuit of the Firm&#8217;s various other activities, including but not limited to trading activities or use for the benefit of the Firm and/or an Other Client. Any confidentiality obligations in the operative documents do not limit the Firm&#8217;s ability to do so. For example, the Firm&#8217;s ability to trade in securities of an issuer relating to a specific industry can, subject to applicable law, be enhanced by information of a portfolio company in the same or related industry. Such trading or other business activities is expected to provide a material benefit to the Firm without compensation or other benefit to the Company or shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sharing and use of &#8220;big data&#8221; and other information presents potential conflicts of interest and the shareholders acknowledge and agree that any benefits received by the Firm or its personnel (including fees (in cash or in kind), costs and expenses) will not reduce the management fees or incentive fees payable to the Adviser or otherwise shared with the Company or its shareholders. As a result, the Adviser has an incentive to pursue investments that have data and information that can be utilized in a manner that benefits the Firm or Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data Management Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone or an affiliate of Blackstone formed in the future may provide data management services to portfolio companies and investors in the Company and in Other Clients and will provide such services directly to the Company and Other Clients (collectively,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Data Holders&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Such services are expected to include assistance with obtaining, analyzing, curating, processing, packaging, organizing, mapping, holding, transforming, enhancing, marketing and selling such data (among other related data management and consulting services) for monetization through licensing or sale arrangements with third parties and, subject to applicable law and the limitations in the Investment Advisory Agreement and any other applicable contractual limitations, with the Company, Other Clients, portfolio companies, investors in the Company and in Other Clients, and other Blackstone affiliates and associated entities (including funds in which Blackstone and Other Clients make investments, and portfolio companies thereof). If Blackstone enters into data services arrangements with portfolio companies and receives compensation from such portfolio companies for such data services, the Company will indirectly bear its share of such compensation based on its pro rata ownership of such portfolio companies. Where Blackstone believes appropriate, data from one Data Holder will be aggregated or pooled with data from other Data Holders. Any revenues arising </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from such aggregated or pooled data sets would be allocated between applicable Data Holders on a fair and reasonable basis as determined by Blackstone Credit &amp; Insurance in its sole discretion, with Blackstone Credit &amp; Insurance able to make corrective allocations should it determine subsequently that such corrections were necessary or advisable. Blackstone is expected to receive compensation for such data management services, which is expected to include a percentage of the revenues generated through any licensing or sale arrangements with respect to the relevant data, and which compensation is also expected to include fees, royalties and cost and expense reimbursement (including start-up costs and allocable overhead associated with personnel working on relevant matters (including salaries, benefits and other similar expenses)). Additionally, Blackstone is expected to share and distribute the products from such data management services within Blackstone or its affiliates (including Other Clients or their portfolio companies) at no charge and, in such cases, the Data Holders will not receive any financial or other benefit from having provided such data to Blackstone. The potential receipt of such compensation by Blackstone creates incentives for Blackstone to cause the Company to invest in portfolio companies with a significant amount of data that it might not otherwise have invested in or on terms less favorable than it otherwise would have sought to obtain.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blackstone and Blackstone Credit &amp; Insurance Strategic Relationships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone and Blackstone Credit &amp; Insurance have entered, and it can be expected that Blackstone and Blackstone Credit &amp; Insurance in the future will enter, into both (i) strategic relationships with investors (and/or one or more of their affiliates) that involve an overall relationship with Blackstone or Blackstone Credit &amp; Insurance (which will afford such investor special rights and benefits) that could (but is not required to) incorporate one or more strategies (including, but not limited to, a different sector and/or geographical focus within the same or a different Blackstone business unit) in addition to the Company&#8217;s strategy and (ii) arrangements that involve an agreement or understanding to make an investment in or a capital commitment to (as applicable) the Company and one or more Other Clients, as applicable (which can include a subscription or capital commitment, as applicable, already made recently to another Other Client) (any such overall relationship and/or multi-fund arrangement in the foregoing (i) and (ii), (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Strategic Relationships&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), with terms and conditions applicable solely to such investor and its investment in multiple Blackstone or Blackstone Credit &amp; Insurance strategies that would not apply to any other investor&#8217;s investment in the Company. A Strategic Relationship often involves (but is not required to involve) an investor agreeing to make a capital commitment to or investment in (as applicable) multiple Blackstone or Blackstone Credit &amp; Insurance Clients, one of which could include the Company. Shareholders will not receive a copy of any agreement memorializing such a Strategic Relationship program (even if in the form of a side letter) or receive any other disclosure or reporting of the terms of or existence of any Strategic Relationship and will be unable to elect in the &#8220;most-favored-nations&#8221; election process (if any) any rights or benefits afforded through a Strategic Relationship (for the avoidance of doubt, no further disclosure or reporting information will be shared with the shareholders about any Strategic Relationship). Specific examples of such additional rights and benefits have included and can be expected to include, among others, specialized reporting, discounts or reductions on and/or reimbursements or rebates of management fees or carried interest (as applicable), secondment of personnel from the investor to Blackstone or Blackstone Credit &amp; Insurance (or vice versa), rights to participate in the investment review and evaluation process, as well as priority rights or targeted amounts for co-investments alongside Blackstone Credit &amp; Insurance or Blackstone funds (including, without limitation, preferential or favorable allocation of co-investment and preferential terms and conditions related to co-investment or other participation in Blackstone or Blackstone Credit &amp; Insurance Clients (including in respect of any carried interest (as applicable) and/or management fees to be charged with respect thereto, as well as any additional discounts, reductions, reimbursements or rebates with respect thereto or other penalties that may result if certain target co-investment allocations or other conditions under such arrangements are not achieved)). Any co-investment that is part of a Strategic Relationship could include co-investment in investments made by the Company. Blackstone, including its personnel (including Blackstone Credit &amp; Insurance personnel), reserves the right to receive compensation from Strategic Relationships and could be incentivized to allocate investment opportunities away from the Company to or source investment opportunities for Strategic Relationships. Strategic Relationships will in certain circumstances, result in fewer co-investment opportunities (or reduced or no allocations) being made available to shareholders, subject to the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blackstone Credit &amp; Insurance Value Creation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone Credit &amp; Insurance Value Creation is a global platform that is part of Blackstone&#8217;s Portfolio Operations Group (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Portfolio Operations Group&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and seeks to provide access to a range of cost-saving, revenue-generating and best-practice sharing opportunities for Blackstone Credit &amp; Insurance portfolio companies. The Portfolio Operations Group is organized into seven functional areas, across geographic regions and industry verticals:</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Procurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Blackstone&#8217;s group purchasing program harnesses spending from portfolio companies across more than 75 categories, including IT hardware and software, office supplies, shipping, energy and telecommunications.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Cost Containment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Blackstone&#8217;s Equity Healthcare team partners with portfolio companies to optimize the strategy and value of healthcare spending by reducing cost and improving the quality of healthcare services received by employees and their dependents. Equity Healthcare is one of the largest private sector purchasers of healthcare services in the United States and has helped drive cumulative healthcare cost savings to portfolio companies and strengthened portfolio companies&#8217; ability to attract and retain talent.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lean Process</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The lean process team seeks to drive transformational improvements focused on material and information flows by reducing waste and non-value add activities across manufacturing functions. It develops prescriptive solutions for portfolio companies and aligns with senior leadership to support tailored strategies and guide management teams in executing and sustaining improved workflow processes.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leadership and Talent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Portfolio Operations Group employs the following strategies to optimize leadership and organizational performance: (i) delivering fit-for-purpose resources to portfolio companies, which include non-executive chairpersons, board members, advisors, and operating specialists, (ii) strengthening company teams and organizational practices through assisting with restructuring, integrations and growth actions, and (iii) convening conferences for portfolio company executives to share best practices and improve alignment to the Firm.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sustainability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: By improving the operation and maintenance of mechanical systems, the Portfolio Operations Group seeks to reduce energy spend while improving productivity, safety, and environmental performance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Technology / BPO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Blackstone&#8217;s Technology / BPO team helps the portfolio management teams recruit/upgrade their information technology leadership teams; import contemporary operating systems and application software to address their respective business priorities; leverage portfolio investments in technology companies to promote and serve the overall portfolio interests; and evaluate and negotiate preferred partnerships with digital/technology suppliers, advisors, and consultants from around the world.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Science</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Firm has invested in a team of data scientists and engineers to help the portfolio companies realize operational efficiencies and drive new revenue through data and analytics. This team focuses on (i) building predictive models to enhance decision making; (ii) leveraging big data within operations; (iii) data visualization to democratize access to information; and (iv) data monetization.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of Blackstone&#8217;s Portfolio Operations Group (including Blackstone Credit &amp; Insurance Value Creation), who are Blackstone employees, are permitted to provide services to the Company&#8217;s portfolio companies, including without limitation those related to the functional areas described above and other similar management consulting, operational and financial matters and are permitted to participate in the Firm co-investment rights. Any payments made or fees paid (which fees or payments will also in certain instances be structured as a reimbursement of internal compensation costs for time spent) by such portfolio companies to Blackstone for services rendered to such portfolio companies will generally be no greater than what would be paid in an arm&#8217;s-length transaction for similar overalls services, and such payments or fees received will not reduce the management fee payable by the Company. As a result, Blackstone is likely to be incentivized to cause members of the Portfolio Operations Group to spend more time on the Company&#8217;s portfolio companies as compared to portfolio companies of Other Clients that do reduce the management fee. On the other hand, there can be no assurance that members of the Portfolio Operations Group will be able to provide their services to portfolio companies and/or that any individuals within the Portfolio Operations Group will remain employed by Blackstone through the life of the Company. The level of involvement and role of Blackstone&#8217;s Portfolio Operations Group within each part of Blackstone with respect to any of the Company&#8217;s portfolio companies are expected to vary, including having no involvement or role at all. In addition, the Portfolio Operations Group will provide services to the Company&#8217;s portfolio companies as described in more detail in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Firm Affiliated Service Providers&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including facilitation of arrangements for Portfolio Companies relating to group procurement (such as the group purchasing organization) and other operational, administrative or management related matters from third parties or Firm affiliates, and other similar operational initiatives. These services can result in commissions or similar payments, including related to a portion of the savings achieved by the portfolio companies. See also </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Other Fees&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Group Procurement; Discounts&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Firm Affiliated Service Providers&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information regarding such programs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Buying and Selling Investments or Assets from Certain Related Parties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company and its portfolio companies may purchase investments or assets from or sell investments or assets to shareholders, other portfolio companies of the Company, portfolio companies of Other Clients or their respective related parties. Purchases and sales of investments or assets between the Company or its portfolio companies, on the one hand, and shareholders, other portfolio companies of the Company, portfolio companies of Other Clients or their respective related parties, on the other hand, are not, unless required by applicable law, subject to the approval of the Board of Trustees or any shareholder. These transactions involve conflicts of interest, as the Firm may receive fees and other benefits, directly or indirectly, from or otherwise have interests in both parties to the transaction, including different financial incentives Blackstone could have with respect to the parties to the transaction. For example, there can be no assurance that any investment or asset sold by the Company to a shareholder, other portfolio companies of the Company, portfolio company of Other Clients or any of their respective related parties will not be valued or allocated a sale price that is lower than might otherwise have been the case if such asset were sold to a third party rather than to a shareholder, portfolio company of Other Clients or any of their respective related parties. The Firm will not be required to solicit third party bids or obtain a third party valuation prior to causing the Company or any of its portfolio companies to purchase or sell any asset or investment from or to a shareholder, other portfolio companies of the Company, portfolio company of Other Clients or any of their respective related parties as provided above.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Firm Businesses, Activities and Relationships. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its regular business, Blackstone provides a broad range of investment banking, advisory and other services. In addition, from time to time, the Firm will provide services in the future beyond those currently provided. Shareholders will not receive any benefit from any fees relating to such services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the regular course of its capital markets, investment banking, real estate advisory and other businesses, Blackstone represents potential purchasers, sellers and other involved parties, including corporations, financial buyers, management, shareholders and institutions, with respect to transactions that could give rise to other transactions that are suitable for the Company. In such a case, a Blackstone advisory client would typically require Blackstone to act exclusively on its behalf. Such advisory client requests have the potential to preclude all Blackstone-affiliated clients, including the Company, from participating in related transactions that would otherwise be suitable. Blackstone will be under no obligation to decline any such engagements in order to make an investment opportunity available to the Company. In connection with its capital markets, investment banking, advisory, real estate and other businesses, Blackstone comes into possession of information that limits its ability to engage in potential transactions. The Company&#8217;s activities are expected to be constrained as a result of the inability of Blackstone personnel to use such information. For example, employees of Blackstone from time to time are prohibited by law or contract from sharing information with members of the Company&#8217;s investment team. Additionally, there are expected to be circumstances in which one or more individuals associated with Blackstone affiliates (including clients) will be precluded from providing services related to the Company&#8217;s activities because of certain confidential information available to those individuals or to other parts of Blackstone (e.g., trading can be restricted). Where Blackstone affiliates are engaged to find buyers or financing sources for potential sellers of assets, the seller can permit the Company to act as a participant in such transactions (as a buyer or financing partner), which would raise certain conflicts of interest inherent in such a situation (including as to the negotiation of the purchase price).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may invest in securities of the same issuers as Other Clients, other investment vehicles, accounts and clients of the Firm and the Adviser. To the extent that the Company holds interests that are different (or more senior or junior) than those held by such Other Clients, Blackstone Credit &amp; Insurance may be presented with decisions involving circumstances where the interests of such Other Clients are in conflict with those of the Company. Furthermore, it is possible the Company&#8217;s interest could be subordinated or otherwise adversely affected by virtue of such Other Clients&#8217; involvement and actions relating to its investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the 1940 Act limits the Company&#8217;s ability to undertake certain transactions with its affiliates that are registered under the 1940 Act or regulated as BDCs under the 1940 Act. As a result of these restrictions, the Company could be prohibited from executing &#8220;joint&#8221; transactions with such affiliates, which could include investments in the same portfolio company (whether at the same or different times). These limitations have the potential to limit the scope of investment opportunities that would otherwise be available to the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance has received an exemptive order that permits certain funds, among other things, to co-invest with certain other persons, including certain affiliates of Blackstone Credit &amp; Insurance, and certain funds managed and controlled by Blackstone Credit &amp; Insurance and its affiliates subject to certain terms and conditions. In addition, other present and future activities of the Firm and its affiliates (including Blackstone Credit &amp; Insurance and the Adviser) will from time to time give rise to additional conflicts of interest relating to the Firm and its investment activities. In the event that any such conflict of interest arises, the Adviser will attempt to resolve such conflicts in a fair and equitable manner. Investors should be aware that, subject to applicable law, conflicts will not necessarily be resolved in favor of the Company&#8217;s interests.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transactions with Clients of Blackstone Insurance Solutions and Asset Based Finance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Blackstone Insurance Solutions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BIS&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is the business segment of Blackstone Credit &amp; Insurance that provides investment advisory services to insurers, including among others, (i) Fidelity Life Insurance Company and certain of its affiliates (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;FGL&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), (ii) Everlake Life Insurance Company and certain of its affiliates (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Everlake&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), (iii) certain subsidiaries of Corebridge Financial, Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Corebridge&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and (iv) certain subsidiaries of Resolution Life Group Holdings Ltd. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Resolution Life&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Certain of the insurers for which BIS provides services are, or may be in the future, owned, directly or indirectly, by Blackstone, the Company, or Other Clients, in whole or in part. Actual or potential conflicts of interest will likely arise in relation to the funds, vehicles or accounts BIS advises or sub-advises, including accounts where an insurer (including, without limitation, each of FGL, Everlake, Corebridge and Resolution Life) participates in investments directly and there is no separate vehicle controlled by Blackstone (for the purposes of this paragraph only, collectively, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BIS Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Blackstone Credit &amp; Insurance also advises funds and accounts focused on asset-based finance, including insurers and other types of investors (for the purposes of this paragraph only, collectively, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ABF Clients&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and each BIS Client and ABF Client is an Other Client for&#160;purposes other than this paragraph). BIS Clients have invested and are expected to continue investing in Other Clients and/or the Company. For greater clarity, any references herein to Blackstone Credit &amp; Insurance or Other Blackstone Credit &amp; Insurance Clients do not include BIS, BIS Clients or ABF Clients. Certain BIS Clients and certain ABF Clients have investment objectives that overlap with those of the Company (and Blackstone Credit &amp; Insurance, or a business segment thereof, has entered into sub-management agreements with BIS to manage (for a fee, which such fees may be shared with BIS) the assets of certain such BIS Clients with respect to investments that overlap in part with the Company&#8217;s investment directive) or its portfolio companies and such BIS Clients and ABF Clients may invest, as permitted by applicable law and the Company&#8217;s co-investment exemptive relief, alongside (or in lieu of) the Company or such portfolio companies in certain investments, which will reduce the investment opportunities otherwise available to the Company or such portfolio companies. BIS Clients and ABF Clients will also engage in a variety of activities, including participating in transactions related to the Company and/or its portfolio companies (e.g., as originators, co-originators, counterparties or otherwise). Other transactions in which BIS Clients or ABF Clients will participate include, without limitation, investments in debt or other securities issued by portfolio companies or other forms of financing to portfolio companies (including special purpose vehicles established by the Company or such portfolio companies). When investing alongside the Company or its portfolio companies or in other transactions related to the Company or its portfolio companies, BIS Clients or ABF Clients may not invest or divest at the same time or on the same terms as the Company or the applicable portfolio companies or at a different time or on different terms. BIS Clients and ABF Clients will also from time to time acquire investments and portfolio companies directly or indirectly from the Company, as permitted by applicable law and the Company&#8217;s co-investment exemptive relief. In circumstances where Blackstone Credit &amp; Insurance determines in good faith that the conflict of interest is mitigated in whole or in part through various measures that Blackstone, Blackstone Credit &amp; Insurance or the Adviser implements, the Adviser may determine to proceed with the applicable transaction (subject to oversight by the Board of Trustees and the applicable law to which the Company is subject). In order to seek to mitigate any potential conflicts of interest with respect to such transactions (or other transactions involving BIS Clients or ABF Clients), Blackstone reserves the right, in its sole discretion, to involve independent members of the board of a portfolio company or a third party stakeholder in the transaction to negotiate price and terms on behalf of the BIS Clients or ABF Clients or otherwise cause the BIS Clients or ABF Clients to &#8220;follow the vote&#8221; thereof, and/or cause an independent client representative or other third party to approve the investment or otherwise represent the interests of one or more of the parties to the transaction. In addition, Blackstone or the Adviser may limit the percentage interest of the BIS Clients or ABF Clients participating in such transaction, or obtain appropriate price quotes or other benchmarks, or, alternatively, a third-party price opinion or other document to support the reasonableness of the price and terms of the transaction. From time to time, the applicable BIS Clients or ABF Clients participating in a transaction will be required to consent thereto (including in circumstances where the Adviser does not seek the consent of the Board of Trustees). There can be no assurance that any such measures or other measures that may be implemented by Blackstone will be effective at mitigating any actual or potential conflicts of interest. Moreover, under certain circumstances (e.g., where a BIS Client or ABF Client participates in a transaction directly (and not through a vehicle controlled by Blackstone) and independently consents to participating in a transaction), a BIS Client or ABF Client (or any other Blackstone Client participating via a similar arrangement) will not be an &#8220;Affiliate&#8221; as defined under the 1940 Act. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allocation of Portfolios</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm will, in certain circumstances, have an opportunity to acquire a portfolio or pool of assets, securities and instruments that it determines should be divided and allocated among the Company and Other Clients. Such allocations generally would be based on the Firm&#8217;s assessment of the expected returns and risk profile of each of the assets. For example, some of the assets in a pool will have an opportunistic return profile, while others will have a return profile not appropriate for the Company. Also, a pool can contain both debt and equity instruments that the Firm determines should be allocated to different funds. In all of these situations, the combined purchase price paid to a seller would be allocated among the multiple assets, securities and instruments in the pool and therefore among the Company and Other Clients acquiring any of the assets, securities and instruments, although the Firm could, in certain circumstances, allocate value to the Company and such Other Clients on a different basis than the contractual purchase price. Similarly, there will likely be circumstances in which the Company and Other Clients will sell assets in a single or related transactions to a buyer. In some cases, a counterparty will require an allocation of value in the purchase or sale contract, though the Firm could determine such allocation of value is not accurate and should not be relied upon. The Firm will generally rely upon internal analysis to determine the ultimate allocation of value, though it could also obtain third party valuation reports. Regardless of the methodology for allocating value, the Firm will have conflicting duties to the Company and Other Clients when they buy or sell assets together in a portfolio, including as a result of different financial incentives the Firm has with respect to different vehicles, most clearly when the fees and compensation, including performance-based compensation, earned from the different vehicles differ. There can be no assurance that an investment of the Company will not be valued or allocated a purchase price that is higher or lower than it might otherwise have been allocated if such investment were acquired or sold independently rather than as a component of a portfolio shared with Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holding Entities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Firm may determine that for legal, tax, regulatory, accounting, administrative or other reasons the Company should hold a particular investment (or a portion of an investment or pool of assets) through a single holding entity through which the Company and one or more Other Clients hold different investments (or a different portion of such investment or pool of assets), including where such investment or pool has been divided and allocated among the Company and such Other Clients. Over time, it is possible that the Company and/or Other Clients may make different decisions with respect to the investments held through such holding entities and therefore may have differing economic rights, obligations or liabilities with respect to a holding entity. In such circumstances, the economic rights, liabilities and obligations in respect of the investment (or portion of an investment or pool of assets) that is indirectly held by the Company would be specifically attributed to the Company, and the Company would be deemed to hold its investment (or portion of an investment or pool of assets) separately from, and not jointly with, such Other Clients (and vice versa in respect of the investments (or portion of an investment or pool of assets) held indirectly through such holding entity by such Other Clients).&#160;Furthermore, certain holding structures may require a newly-established manager, advisor, service provider or other entity intended to address certain legal, tax, regulatory, accounting, administrative or other considerations applicable to the Company and/or Other Clients. It is possible that the Company or an affiliate will be initially responsible for the costs and expenses of establishing such holding structure (including any such newly-established entities) prior to, and/or, in anticipation of, Other Clients participating through such structure for their investments and it is expected that such Other Clients reimburse the Company or the Company would reimburse such affiliate for any such costs and expenses on a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> basis. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Affiliate Transactions and Investments in Different Levels of Capital Structure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company and the Other Clients may make investments at different levels of an issuer&#8217;s capital structure or otherwise in different classes of an issuer&#8217;s securities or loans, subject to the limitations of the 1940 Act. While less common, subject to applicable law, from time to time the Company could hold an investment in a different layer of the capital structure than an investor or another party with which Blackstone has a material relationship, in which case Blackstone could have an incentive to cause the Company or the portfolio company to offer more favorable terms to such parties (including, for instance, financing arrangements). Certain such investments inherently give rise to conflicts of interest or perceived conflicts of interest between or among the various classes of securities or loans that are expected to be held by such entities. To the extent the Company holds securities or loans that are different (including with respect to their relative seniority) than those held by an Other Client, the Adviser and its affiliates will be presented with decisions when the interests of the funds are in conflict. For example, conflicts could arise where the Company lends funds to a portfolio company while an Other Client invests in equity securities of such portfolio company. In this circumstance, for example, if such portfolio company were to go into bankruptcy, become insolvent or otherwise be unable to meet its payment obligations or comply with its debt covenants, conflicts of interest could arise between the holders of different types of securities or loans as to what actions the portfolio company should take. In addition, purchases or sales of securities or loans for the account of the Company (particularly marketable securities) will be bunched or aggregated with orders for Other Clients, including other funds. It is frequently not possible to receive the same price or execution on the entire volume of securities sold, and the various prices could be averaged, which has the potential to be disadvantageous to the Company. Further conflicts could arise after the Company and Other Clients have made their respective initial investments. For example, if additional financing is necessary as a result of financial or other difficulties, it is not always </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the best interests of the Company to provide such additional financing. If the Other Clients were to lose their respective investments as a result of such difficulties, the ability of the Adviser to recommend actions in the best interests of the Company might be impaired. Any applicable co-investment exemptive order issued by the SEC may restrict the Company&#8217;s ability to participate in follow-on financings. Blackstone Credit &amp; Insurance may in its sole discretion take steps to reduce the potential for adversity between the Company and the Other Clients, including causing the Company and/or such Other Clients to take certain actions that, in the absence of such conflict, it would not take. Such conflicts will be more difficult if the Company and Other Clients hold significant or controlling interests in competing or different tranches of a portfolio company&#8217;s capital structure. Equity holders and debt holders have different (and often competing) motives, incentives, liquidity goals and other interests with respect to a portfolio company. In addition, there could be circumstances where Blackstone Credit &amp; Insurance agrees to implement certain procedures to ameliorate conflicts of interest that involve a forbearance of rights relating to the Company or Other Clients, such as where Blackstone Credit &amp; Insurance is expected to cause the Company or Other Clients to decline to exercise certain control-and/or foreclosure-related rights with respect to a portfolio company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the Company is prohibited under the 1940 Act from participating in certain transactions with certain of affiliates (including portfolio companies of Other Clients) without the prior approval of a majority of the independent members of the Board of Trustees and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of the outstanding voting securities may be an affiliate of the Company for purposes of the 1940 Act and generally the Company will be prohibited from buying or selling any securities from or to such affiliate, absent the prior approval of the Board of Trustees. However, the Company may under certain circumstances purchase any such affiliate&#8217;s loans or securities in the secondary market, which could create a conflict for the Adviser between the Company&#8217;s interests and the interests of such affiliate, in that the ability of the Adviser to recommend actions in the Company&#8217;s best interest may be limited. The 1940 Act also prohibits certain &#8220;joint&#8221; transactions with certain affiliates, which could include investments in the same portfolio company (whether at the same or closely related times), without prior approval of the Board of Trustees and, in some cases, the SEC.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, conflicts may arise in determining the amount of an investment, if any, to be allocated among potential investors and the respective terms thereof. There can be no assurance that any conflict will be resolved in favor of the Company, and each shareholder acknowledges and agrees that in some cases, subject to applicable law, a decision by Blackstone Credit &amp; Insurance to take any particular action could have the effect of benefiting an Other Client and therefore may not have been in the best interests of, and may be adverse to, the Company. There can be no assurance that the return on the Company&#8217;s investment will be equivalent to or better than the returns obtained by the Other Clients participating in the same or similar transactions. The shareholders will not receive any benefit from fees paid to any affiliate of the Adviser in respect of any Other Client&#8217;s investment in a portfolio company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Financing Counterparties. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may invest in companies or other entities in which Other Clients make an investment in a different part of the capital structure (and vice versa) subject to the requirements of the 1940 Act and the Company&#8217;s co-investment exemptive order. The Adviser requests in the ordinary course proposals from lenders and other sources to provide financing to the Company and its portfolio companies. Blackstone Credit &amp; Insurance takes into account various facts and circumstances it deems relevant in selecting financing sources, including whether a potential lender has expressed an interest in evaluating debt financing opportunities, whether a potential lender has a history of participating in debt financing opportunities generally and with the Firm in particular, the size of the potential lender&#8217;s loan amount, the timing of the relevant cash requirement, the availability of other sources of financing, the creditworthiness of the lender, whether the potential lender has demonstrated a long-term or continuing commitment to the success of Blackstone, Blackstone Credit &amp; Insurance and their funds, and such other factors that Blackstone and Blackstone Credit &amp; Insurance deem relevant under the circumstances. The cost of debt alone is not determinative.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that shareholders, Other Clients, their portfolio companies, co-investors and other parties with material relationships with the Firm, such as shareholders of and lenders to the Firm and lenders to Other Clients and their portfolio companies (as well as Blackstone itself), could provide additional financing to portfolio companies of the Company, subject to the requirements of the 1940 Act. The Firm could have incentives to cause the Company and its portfolio companies to accept less favorable financing terms from a shareholder, Other Clients, their portfolio companies, Blackstone, and other parties with material relationships with the Firm than it would from a third party. If the Company occupies a different, and in particular, a more senior, position in the capital structure than a shareholder, Other Client, their portfolio companies and other parties with material relationships with Blackstone, Blackstone could have an incentive to cause the Company or portfolio company to offer financing terms that are more favorable to such parties. In the case of a related party financing between the Company or its portfolio companies, on the one hand, and Blackstone or Other Clients&#8217; portfolio companies, on the other hand, to the extent permitted by the 1940 Act, the Adviser could, but is not obligated to, rely on a third party agent to confirm the terms offered by the counterparty are consistent with market terms, or the Adviser could instead rely on its own internal analysis, which the </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adviser believes is often superior to third party analysis given the Firm&#8217;s scale in the market. If however any of the Firm, the Company, an Other Client or any of their portfolio companies delegates to a third party, such as another member of a financing syndicate or a joint venture partner, the negotiation of the terms of the financing, the transaction will be assumed to be conducted on an arms-length basis, even though the participation of the Firm related vehicle impacts the market terms. For example, in the case of a loan extended to the Company or a portfolio company by a financing syndicate in which an Other Client has agreed to participate on terms negotiated by a third party participant in the syndicate, it might have been necessary to offer better terms to the financing provider to fully subscribe the syndicate if the Other Client had not participated. It is also possible that the frequent participation of Other Clients in such syndicates could dampen interest among other potential financing providers, thereby lowering demand to participate in the syndicate and increasing the financing costs to the Company. The Adviser does not believe either of these effects is significant, but no assurance can be given to shareholders that these effects will not be significant in any circumstance. Unless required by applicable law, the Adviser will not seek any consent or approvals from shareholders or the Board of Trustees in the case of any of these conflicts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm could cause actions adverse to the Company to be taken for the benefit of Other Clients that have made an investment more senior in the capital structure of a portfolio company than the Company (e.g., provide financing to a portfolio company, the equity of which is owned by the Company) and, vice versa, actions may be taken for the benefit of the Company and its portfolio companies that are adverse to Other Clients. The Firm could seek to implement procedures to mitigate conflicts of interest in these situations such as (i) a forbearance of rights, including some or all non-economic rights, by the Company or relevant Other Client (or their respective portfolio companies, as the case may be) by, for example, agreeing to follow the vote of a third party in the same tranche of the capital structure, or otherwise deciding to recuse itself with respect to both normal course ongoing matters (such as consent rights with respect to loan modifications in intercreditor agreements) and also decisions on defaults, foreclosures, workouts, restructurings and other similar matters, (ii) causing the Company or relevant Other Client (or their respective portfolio companies, as the case may be) to hold only a non-controlling interest in any such portfolio company, (iii) retaining a third party loan servicer, administrative agent or other agent to make decisions on behalf of the Company or relevant Other Client (or their respective portfolio companies, as the case may be), or (iv) create groups of personnel within the Firm separated by information barriers (which may be temporary and limited purpose in nature), each of which would advise one of the clients that has a conflicting position with other clients. As an example, to the extent an Other Client holds an interest in a loan or security that is different (including with respect to relative seniority) than those held by the Company or its portfolio companies, the Firm can decline to exercise, or delegate to a third party, certain control, foreclosure and other similar governance rights of the Other Client. In these cases, the Firm would generally act on behalf of one of its clients, though the other client would generally retain certain control rights, such as the right to consent to certain actions taken by the trustee or administrative or other agent of the investment, including a release, waiver, forgiveness or reduction of any claim for principal or interest; extension of maturity date or due date of any payment of any principal or interest; release or substitution of any material collateral; release, waiver, termination or modification of any material provision of any guaranty or indemnity; subordination of any lien; and release, waiver or permission with respect to any covenants. The efficacy of following the vote of third-party creditors will be limited in circumstances where the Company or Other Client acquires all or substantially all of a relevant instrument, tranche or class of securities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with negotiating loans and bank financings in respect of Blackstone Credit &amp; Insurance-sponsored transactions, Blackstone Credit &amp; Insurance will generally obtain the right to participate (for its own account or an Other Client) in a portion of the financings with respect to such Blackstone Credit &amp; Insurance-sponsored transactions on the same terms negotiated by third parties with the Firm or other terms the Adviser determines to be consistent with the market. Although the Firm could rely on third parties to verify market terms, the Firm may nonetheless have influence on such third parties. No assurance can be given that negotiating with a third party, or verification of market terms by a third party, will ensure that the Company and its portfolio companies receive market terms.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, it is anticipated that in a bankruptcy proceeding the Company&#8217;s interests will likely be subordinated or otherwise adverse to the interests of Other Clients with ownership positions that are more senior to those of the Company. For example, an Other Client that has provided debt financing to an investment of the Company will be permitted to take actions for its benefit, particularly if the Company&#8217;s investment is in financial distress, which adversely impact the value of the Company&#8217;s subordinated interests.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Other Clients can be expected to provide financing to the Company and its portfolio companies subject to the requirements of the 1940 Act, there can be no assurance that any Other Client will indeed provide any such financing with respect to any particular investment. Participation by Other Clients in some but not all financings of the Company and its portfolio companies has the potential to adversely impact the ability of the Company and its portfolio companies to obtain financing from third parties when Other Clients do not participate, as it could serve as a negative signal to market participants.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any financing provided by a shareholder or an affiliate to the Company or a portfolio company is not an investment in the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The respective investment programs of the Company and the Other Clients may or may not be substantially similar. Blackstone Credit &amp; Insurance and/or Blackstone may give advice to, and recommend securities for, Other Clients that may differ from advice given to, or securities recommended or bought for, the Company, even though their investment objectives may be the same as or similar to those of the Company. While Blackstone Credit &amp; Insurance will seek to manage potential conflicts of interest in a fair and equitable manner, the portfolio strategies employed by Blackstone Credit &amp; Insurance and Blackstone in managing their respective Other Clients are likely to conflict from time to time with the transactions and strategies employed by the Adviser in managing the Company and may affect the prices and availability of the securities and instruments in which the Company invests. Participation in specific investment opportunities may be appropriate, at times, for both the Company and Other Clients. In any event, it is the policy of Blackstone Credit &amp; Insurance to allocate investment opportunities and sale opportunities on a basis deemed by Blackstone Credit &amp; Insurance, in its sole discretion, to be fair and equitable over time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conflicting Fiduciary Duties to Debt Funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Other Clients include funds and accounts that make investments in senior secured loans, distressed debt, subordinated debt, high-yield securities, commercial mortgage-backed securities and other debt instruments. As discussed above, it is expected that these Other Clients or investors therein will be offered the opportunity, subject to applicable law, to provide financing with respect to investments made by the Company and its portfolio companies. The Firm owes a fiduciary duty and/or other obligations to these Other Clients as well as to the Company and will encounter conflicts in the exercise of these duties and/or obligations. For example, if an Other Client purchases high-yield securities or other debt instruments of a portfolio company of the Company, or otherwise occupies a senior (or other different) position in the capital structure of an investment relative to the Company, the Firm will encounter conflicts in providing advice to the Company and to these Other Clients with regard to appropriate terms of such high-yield securities or other instruments, the enforcement of covenants, the terms of recapitalizations and the resolution of workouts or bankruptcies, among other matters. For example, in a bankruptcy proceeding, in circumstances where the Company holds an equity investment in a portfolio company, the holders of such portfolio company&#8217;s debt instruments (which can include one or more Other Clients) could take actions for their benefit (particularly in circumstances where such portfolio company faces financial difficulties or distress) that subordinate or adversely impact the value of the Company&#8217;s investment in such portfolio company. More commonly, the Company could hold an investment that is senior in the capital structure, such as a debt instrument, to an Other Client. Although measures described in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Financing Counterparties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; above can mitigate these conflicts, they cannot completely eliminate them. These conflicts related to fiduciary duties to such Other Clients will not necessarily be resolved in favor of the Company, and investors will not always be entitled to receive notice or disclosure of the occurrence of these conflicts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, certain Other Clients can be expected to invest in securities of publicly traded companies that are actual or potential investments of the Company or its portfolio companies. The trading activities of those vehicles can differ from or be inconsistent with activities that are undertaken for the account of the Company or its portfolio companies in any such securities or related securities. In addition, the Company could not pursue an investment in a portfolio company otherwise within the investment mandate of the Company as a result of such trading activities by Other Clients. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Blackstone and Blackstone Credit &amp; Insurance Clients; Allocation of Investment Opportunities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain inherent conflicts of interest arise from the fact that the Adviser, Blackstone Credit &amp; Insurance and Blackstone provide investment management, advisory and sub-advisory services to the Company and Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance and/or Blackstone may give advice to, and recommend securities for, Other Clients that may differ from advice given to, or securities recommended or bought for, the Company, even though their investment objectives may be the same as or similar to those of the Company. Blackstone Credit &amp; Insurance has adopted guidelines and policies, which can be expected to be updated from time to time, regarding allocation of investment opportunities. While Blackstone Credit &amp; Insurance will seek to manage potential conflicts of interest in a fair and equitable manner, the portfolio strategies employed by Blackstone Credit &amp; Insurance and Blackstone in managing their respective Other Clients are likely to conflict from time to time with the transactions and strategies employed by the Adviser in managing the Company and may affect the prices and availability of the securities and instruments in which the Company invests. Participation in specific investment opportunities may be appropriate, at times, for both the Company and Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance provides investment management services to Other Blackstone Credit &amp; Insurance Clients. In addition, Blackstone provides investment management services to Blackstone Clients. Blackstone Credit &amp; Insurance will share appropriate investment opportunities (and sale opportunities) (including, without limitation, secondary market transactions and certain syndicated primary issuance transactions (which generally will not be originated investments)) with Other Clients and the Company in accordance with Firm-wide allocation policies, which generally provide for sharing pro rata based on targeted acquisition size (generally based on available capacity) or targeted sale size (or, in some sales cases, the aggregate positions held by the Company and the applicable Other Clients), taking into account actual and anticipated investments and capital commitments (as appropriate), available cash, asset-based leverage and relative capital of the Company and the applicable Other Clients and such other factors as Blackstone Credit &amp; Insurance determines in good faith to be appropriate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent an opportunity is shared with one or more Other Clients, Blackstone Credit &amp; Insurance expects that such Other Clients generally will invest on substantially the same economic terms available to the Company (including sharing of transaction fees and expenses) and generally will exit investments at the same time and on substantially the same economic terms as the Company, and on a pro rata basis with the Company subject to legal, tax, regulatory, accounting or applicable considerations (including the terms of the governing agreements of, or portfolio management considerations applicable to, the Company or such Other Clients); provided that the Company may syndicate a portion of an investment where Other Clients do not also syndicate a portion of the investment. (See also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Transactions with Clients of Blackstone Insurance Solutions and Asset Based Finance.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allocation Methodology Considerations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, Blackstone Credit &amp; Insurance may also consider the following factors in making any allocation determinations, and such factors may result in a different allocation of investment and/or sale opportunities: (i)&#160;the risk-return and target return profile of the proposed investment relative to the Company&#8217;s and the Other Clients&#8217; current risk profiles; (ii)&#160;the Company&#8217;s and/or the Other Clients&#8217; investment strategies, mandates, guidelines, limitations, restrictions, terms and objectives (including whether such objectives are considered solely in light of the specific investment under consideration or in the context of the respective portfolios&#8217; overall holdings), other contractual provisions (including Other Clients with minimum allocation provisions), focus (including investment focus on a classification attributable to an investment, such as maturity), parameters and investor preferences of the Company and the Other Clients (including, without limitation, with respect to Other Clients that expect to invest in or alongside other funds or across asset classes based on expected return (such as certain managed accounts or other investment vehicles (whether now in existence or which may be established in the future)) with similar investment strategies and objectives); (iii) diversification and concentration considerations in the Company&#8217;s or the Other Clients&#8217; portfolios (including the potential for the proposed investment to create an industry, sector, geography, region, location, market or issuer imbalance in the Company&#8217;s and Other Clients&#8217; portfolios, as applicable) and taking into account any existing non-pro rata investment positions in the portfolio of the Company and Other Clients; (iv)&#160;liquidity considerations of the Company and the relevant Other Clients (including warehouse vehicles or arrangements (such as CLO warehouses and Blackstone-controlled or third party warehouse arrangements) established for the benefit of current Other Clients or potential future Other Clients), including during a ramp-up (which includes the period prior to or after the initial closing of an Other Client during which its manager is deploying funds already invested or committed (or that its manager anticipates will be invested or committed) and can continue for a period during an Other Client&#8217;s fundraising and/or acceptance of future subscriptions as deemed appropriate by the Firm, including to protect against zero or de minimis allocations or in anticipation of future subscriptions) or wind-down of one or more of the Company or such Other Clients, proximity to the end of the Company&#8217;s or Other Clients&#8217; specified term or investment period, any redemption/withdrawal requests, anticipated future contributions and available cash; (v)&#160;legal, tax, accounting and other considerations or consequences; (vi)&#160;regulatory or contractual provisions, obligations, terms, limitations, restrictions or consequences relating to the Company or Other Clients (including, without limitation, requirements under the 1940 Act and any related rules, orders, guidance or other authority applicable to the Company or Other Clients); (vii) avoiding a de minimis or odd lot allocation; (viii)&#160;availability and degree of leverage and any requirements or other terms of the investment, or of any existing leverage facilities; (ix)&#160;the Company&#8217;s or Other Clients&#8217; investment focus on a classification attributable to an investment or issuer of an investment, including, without limitation, investment strategy, geography, location, industry or business sector; (x)&#160;the nature and extent of involvement in the transaction on the part of the respective teams of investment professionals dedicated to the Company or such Other Clients; (xi)&#160;the management of any actual or potential conflict of interest; (xii)&#160;with respect to investments that are made available to Blackstone Credit &amp; Insurance by counterparties pursuant to negotiated trading platforms (e.g., ISDA contracts), the absence of such relationships which may not be available for the Company and all Other Clients; (xiii)&#160;co-investment arrangements, (xiv)&#160;available capital of the Company and such Other Clients, (xv) sourcing of the investment, (xvi)&#160;the specific nature (including size, type, amount, liquidity, holding period, anticipated maturity and minimum investment criteria) of the investment, (xvii)&#160;expected investment return, (xviii)&#160;expected cash characteristics (such as cash-on-cash yield, distribution rates or volatility of cash flows), (xix) capital expenditure required </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as part of the investment, (xx)&#160;portfolio diversification and concentration concerns (including, but not limited to, whether a particular fund already has its desired exposure to the investment, sector, industry, geographic region or markets in question), (xxi) relation to existing investments in a fund, if applicable (e.g., &#8220;follow on&#8221; to existing investment, joint venture or other partner to existing investment, or same security as existing investment), (xxii) timing expected to be necessary to execute an investment, (xxiii) whether Blackstone Credit &amp; Insurance believes that allocating investment opportunities to an investor will help establish, recognize, strengthen and/or cultivate relationships that may provide indirectly longer-term benefits (including strategic, sourcing or similar benefits) to the Company, Other Clients and/or Blackstone and (xxiv) any other considerations deemed relevant by Blackstone Credit &amp; Insurance in good faith.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the requirements of the 1940 Act and the Company&#8217;s co-investment exemptive order, Blackstone Credit &amp; Insurance shall not have any obligation to present any investment opportunity (or portion of any investment opportunity) to the Company if Blackstone Credit &amp; Insurance determines in good faith that such opportunity (or portion thereof) should not be presented to the Company, including for any one or a combination of the reasons described above, or if Blackstone Credit &amp; Insurance is otherwise restricted from presenting such investment opportunity to the Company. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Alongside Regulated Funds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition,&#160;Blackstone Credit &amp; Insurance has received an exemptive order from the SEC that permits certain existing and future Other Blackstone Credit &amp; Insurance Clients that are closed-end management investment companies that have elected to be regulated as a BDC or are registered under the 1940 Act and who intend to rely on the exemptive order (each a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Regulated Fund&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and collectively, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Regulated Funds&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), including the Company, among other things, to co-invest with certain other persons, including certain affiliates of Blackstone Credit &amp; Insurance, and certain funds managed and controlled by Blackstone Credit &amp; Insurance and its affiliates, including the Company and Other Blackstone Credit &amp; Insurance Clients, subject to certain terms and conditions. For so long as any privately negotiated investment opportunity falls within certain established investment criteria of one or more Regulated Funds, such investment opportunity shall also be offered to such Regulated Fund(s). In the event that the aggregate targeted investment sizes of the Company, such Other Blackstone Credit &amp; Insurance Clients and such Regulated Fund(s) that are allocated an investment opportunity exceed the amount of such investment opportunity, allocation of such investment opportunity to each of the Company, such Other Blackstone Credit &amp; Insurance Clients and Regulated Fund(s) will be reduced proportionately based on their respective &#8220;available capital&#8221; as defined in the co-investment exemptive order, which may result in allocation to the Company in an amount less than what it would otherwise have been if such Other Blackstone Credit &amp; Insurance Client(s) and Regulated Fund(s) did not participate in such investment opportunity. The co-investment exemptive order also restricts the ability of the Company (or any such Other Blackstone Credit &amp; Insurance Client) from investing in any privately negotiated investment opportunity alongside a Regulated Fund except at the same time and on same terms, as described in the exemptive order. As a result, the Company risks being unable to make investments in different parts of the capital structure of the same issuer in which a Regulated Fund has invested or seeks to invest, and Regulated Funds risk being unable to make investments in different parts of the capital structure of the same issuer in which the Company has invested or seeks to invest. The Company may be unable to participate in or effect certain transactions, or take certain actions in respect of certain investments, on account of applicable restrictions under the 1940 Act, related guidance from the SEC and/or the Company&#8217;s exemptive order.&#160;For example, the Company may be restricted from participating in certain transactions or taking certain actions in respect of portfolio companies in which certain funds managed and controlled by Blackstone Credit &amp; Insurance and its affiliates and/or a Regulated Fund has also invested, which may include, but is not limited to declining to vote, participating in a potential co-investment opportunity (as such participation may not comply with the conditions of the co-investment exemptive order), exercising rights with respect to any such investment, and/or declining to participate in follow-on investments. The Company may also be required to sell an investment to avoid potential violations of the 1940 Act and/or related rules thereunder or for other reasons. In such cases, the Company&#8217;s interests in an investment may be adversely affected, including by resulting in the dilution of or decrease in the value of the Company&#8217;s investment, or otherwise by resulting in the Company being put in a disadvantageous position with respect to the investment as compared to Other Blackstone Credit &amp; Insurance Clients, including other Regulated Funds. Whether the Company participates or declines to participate in any such action or transaction will be made by the Adviser in its sole discretion and will take into account the Adviser&#8217;s fiduciary duties and applicable law, including the 1940 Act, the rules thereunder and/or the exemptive order. There is no assurance that any such determination will be resolved in favor of the Company&#8217;s interests. The rules promulgated by the SEC under the 1940 Act, as well as any related guidance from the SEC and/or the terms of the exemptive order itself, are subject to change, and Blackstone Credit &amp; Insurance could undertake to amend the exemptive order (subject to SEC approval), obtain additional exemptive relief, or otherwise be subject to other requirements in respect of co-investments involving the Company, any Other Blackstone Credit &amp; Insurance Client and any Regulated Funds, any of which could impact the amount of any allocation made available to Regulated Funds and thereby affect (and potentially decrease) the allocation made to the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, with respect to Blackstone Credit &amp; Insurance&#8217;s ability to allocate investment opportunities, including where such opportunities are within the common objectives and guidelines of the Company and one or more Other Clients (which allocations are to be made on a basis that Blackstone Credit &amp; Insurance believes in good faith to be fair and reasonable), Blackstone Credit &amp; Insurance and Blackstone have established general guidelines and policies, which it can be expected to update from time to time, for determining how such allocations are to be made, which, among other things, set forth principles regarding what constitutes &#8220;debt&#8221; or &#8220;debt-like&#8221; investments, criteria for defining &#8220;control-oriented equity&#8221; or &#8220;infrastructure&#8221; investments, guidance regarding allocation for certain types of investments (e.g., distressed assets) and other matters. In addition, certain Other Clients can receive certain priority or other allocation rights with respect to certain investments, subject to various conditions set forth in such Other Clients&#8217; respective governing agreements. The application of those guidelines and conditions could result in the Company or Other Clients not participating (and/or not participating to the same extent) in certain investment opportunities in which they would have otherwise participated had the related allocations been determined without regard to such guidelines and conditions and based only on the circumstances of those particular investments. Additionally, investment opportunities sourced by Blackstone Credit &amp; Insurance will be allocated in accordance with Blackstone&#8217;s and Blackstone Credit &amp; Insurance&#8217;s allocation policies, which provide that investment opportunities will be allocated in whole or in part to other business units of the Firm on a basis that Blackstone and Blackstone Credit &amp; Insurance believe in good faith to be fair and reasonable, based on various factors, including the involvement of the respective teams from Blackstone Credit &amp; Insurance and such other business units. It should also be noted that investment opportunities sourced by business units of the Firm other than Blackstone Credit &amp; Insurance will be allocated in accordance with such business units&#8217; allocation policies, which will result in such investment opportunities being allocated, in whole or in part, away from Blackstone Credit &amp; Insurance, the Company and Other Blackstone Credit &amp; Insurance Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Blackstone Credit &amp; Insurance determines not to pursue some or all of an investment opportunity for the Company that would otherwise be within the Company&#8217;s objectives and strategies, and Blackstone or Blackstone Credit &amp; Insurance provides the opportunity or offers the opportunity to Other Clients (or other parties, including portfolio companies), Blackstone or Blackstone Credit &amp; Insurance, including their personnel (including Blackstone Credit &amp; Insurance personnel), will, in certain circumstances, receive compensation from the Other Clients and/or other parties, whether or not in respect of a particular investment, including an allocation of carried interest or referral fees, and any such compensation could be greater than amounts paid by the Company to Blackstone Credit &amp; Insurance. As a result, Blackstone Credit &amp; Insurance (including Blackstone Credit &amp; Insurance personnel who receive such compensation) could be incentivized to allocate investment opportunities away from the Company to or source investment opportunities for Other Clients and/or other parties. In addition, in some cases Blackstone or Blackstone Credit &amp; Insurance can be expected to earn greater fees when Other Clients participate alongside or instead of the Company in an investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance makes good faith determinations for allocation decisions based on expectations that will, in certain circumstances, prove inaccurate. Information unavailable to Blackstone Credit &amp; Insurance, or circumstances not foreseen by Blackstone Credit &amp; Insurance at the time of allocation, can cause an investment opportunity to yield a different return than expected. Conversely, an investment that Blackstone Credit &amp; Insurance expects to be consistent with the Company&#8217;s return objectives will, in certain circumstances, fail to achieve them.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser is permitted, but will be under no obligation to, provide co-investment opportunities relating to investments made by the Company to Fund shareholders, Other Clients, investors in such Other Clients, subject to the Company&#8217;s exemptive relief and the 1940 Act. Such co-investment opportunities may be offered to such parties in the Adviser&#8217;s discretion subject to the Company&#8217;s exemptive relief. From time to time, Blackstone Credit &amp; Insurance may form one or more funds or accounts to co-invest in transactions with the Company (or transactions alongside any of the Company and one or more Other Clients). Furthermore, for the avoidance of doubt, to the extent that the Company has received its target amount in respect of an investment opportunity, any remaining portion of such investment opportunity initially allocated to the Company may be allocated to Other Clients or to co-investors in Blackstone Credit &amp; Insurance&#8217;s discretion pursuant to the Company&#8217;s exemptive relief.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Orders may be combined for the Company and other participating Other Clients, and if any order is not filled at the same price, they may be allocated on an average price basis. Similarly, if an order on behalf of more than one account cannot be fully executed under prevailing market conditions, securities may be allocated among the different accounts on a basis that Blackstone Credit &amp; Insurance or its affiliates consider equitable.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, it can be expected that the Firm will, from time to time, enter into arrangements or strategic relationships with third parties, including other asset managers, financial firms or other businesses or companies, that, among other things, provide for referral, sourcing or sharing of investment opportunities. Blackstone or Blackstone Credit &amp; Insurance may pay management fees and performance-based compensation in connection with such arrangements. Blackstone or Blackstone Credit &amp; Insurance may also provide for or receive reimbursement of certain expenses incurred or received in connection with these arrangements, including diligence expenses and general overhead, administrative, deal sourcing and related corporate expenses. The amount of these rebates may relate to allocations of co-investment opportunities and increase if certain co-investment allocations are not made. While it is possible that the Company will, along with the Firm itself, benefit from the existence of those arrangements and/or relationships, it is also possible that investment opportunities that would otherwise be presented to or made by the Company would instead be referred (in whole or in part) to such third party, or, as indicated above, to other third parties, either as a contractual obligation or otherwise, resulting in fewer opportunities (or reduced allocations) being made available to the Company and/or shareholders. This means that co-investment opportunities that are sourced by the Company may be allocated to investors that are not shareholders. For example, a firm with which the Firm has entered into a strategic relationship may be afforded with &#8220;first-call&#8221; rights on a particular category of investment opportunities, although there is not expected to be substantial overlap in the investment strategies and/or objectives between the Company and any such firm. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Investments Inside the Company&#8217;s Mandate that are not Pursued by the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under certain circumstances, Blackstone or Blackstone Credit &amp; Insurance can be expected to determine not to pursue some or all of an investment opportunity within the Company&#8217;s mandate, including without limitation, as a result of business, reputational or other reasons applicable to the Company, Other Clients, their respective portfolio companies or Blackstone. In addition, Blackstone Credit &amp; Insurance will, in certain circumstances, determine that the Company should not pursue some or all of an investment opportunity, including, by way of example and without limitation, because the Company has already invested sufficient capital in the investment, sector, industry, geographic region or markets in question, as determined by Blackstone Credit &amp; Insurance in its good faith discretion, or the investment is not appropriate for the Company for other reasons as determined by Blackstone Credit &amp; Insurance in its good faith reasonable sole discretion. In any such case Blackstone or Blackstone Credit &amp; Insurance could, thereafter, offer such opportunity to other parties, including Other Clients or portfolio companies or limited partners or shareholders of the Company or Other Clients, joint venture partners, related parties or third parties. Any such Other Clients could be advised by a different Blackstone or Blackstone Credit &amp; Insurance business group with a different investment committee, which could determine an investment opportunity to be more attractive than Blackstone Credit &amp; Insurance believes to be the case. In any event, there can be no assurance that Blackstone Credit &amp; Insurance&#8217;s assessment will prove correct or that the performance of any investments actually pursued by the Company will be comparable to any investment opportunities that are not pursued by the Company. Blackstone and Blackstone Credit &amp; Insurance, including their personnel, are permitted to receive compensation from any such party that makes the investment, including an allocation of carried interest or referral fees, and any such compensation could be greater than amounts paid by the Company to Blackstone Credit &amp; Insurance. In some cases, Blackstone or Blackstone Credit &amp; Insurance earns greater fees when Other Clients participate alongside or instead of the Company in an investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Situations can arise where certain assets held by the Company are transferred to Other Clients and vice versa. Such transactions will be conducted in accordance with, and subject to, the Adviser&#8217;s contractual obligations to the Company and applicable law, including the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Co-Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will co-invest with its shareholders, limited partners and/or shareholders of the Other Clients, the Firm&#8217;s affiliates and other parties with whom Blackstone Credit &amp; Insurance has a material relationship. The allocation of co-investment opportunities is entirely and solely in the discretion of Blackstone Credit &amp; Insurance, subject to applicable law. In addition to participation by Consultants in specific transactions or investment opportunities, Consultants and/or other Firm employees may be permitted to participate in the Firm&#8217;s side-by-side co-investment rights. Such rights generally do not provide for an advisory fee or carried interest payable by participants therein and generally result in the Company being allocated a smaller share of an investment than would otherwise be the case in the absence of such side-by-side. Furthermore, Other Clients will be permitted (or have a preferred right) to participate in the Firm&#8217;s side-by-side co-investment rights.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain circumstances, Blackstone Credit &amp; Insurance will determine that a co-investment opportunity should be offered to one or more third parties (such investors, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Co-Investors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and will maintain sole discretion with respect to which Co-Investors are offered any such opportunity. It is expected that many investors who will, in certain circumstances, have expressed an interest in co-investment opportunities will not be allocated any co-investment opportunities or will, in certain circumstances, receive a smaller amount of co-investment opportunities than the amount requested. Any co-investments offered by Blackstone Credit &amp; Insurance will be on such terms and conditions (including with respect to advisory fees, performance-based compensation and related arrangements and/or other fees applicable to co-investors) as Blackstone Credit &amp; Insurance determines to be appropriate in its sole discretion on a case-by-case basis, which may differ amongst co-investors with respect to the same co-investment. In addition, the performance of Other Clients co-investing with the Company is not considered for purposes of calculating the incentive fee payable by the Company to the Adviser. Furthermore, the Company and co-investors will often have different investment objectives and limitations, such as return objectives and maximum hold period. Blackstone Credit &amp; Insurance, as a result, will have conflicting incentives in making decisions with respect to such opportunities. Even if the Company and any such parties invest in the same securities on similar terms, conflicts of interest will still arise as a result of differing investment profiles of the investors, among other items.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">General Co-Investment Considerations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There are expected to be circumstances where an amount that would otherwise have been invested by the Company is instead allocated to co-investors (who could be shareholders of the Company or limited partners of Other Clients) or supplemental capital vehicles, and there is no guarantee that any shareholders will be offered any particular co-investment opportunity. Each co-investment opportunity (should any exist) is likely to be different, and allocation of each such opportunity will depend on the facts and circumstances specific to that unique situation (e.g., timing, industry, size, geography, asset class, projected holding period, exit strategy and counterparty). Different situations will require that the various facts and circumstances of each opportunity be weighted differently, as Blackstone Credit &amp; Insurance deems relevant to such opportunity. Such factors are likely to include, among others, whether a co-investor adds strategic value, industry expertise or other similar synergies; whether a potential co-investor has expressed an interest in evaluating co-investment opportunities; whether a potential co-investor has an overall strategic relationship with the Firm; whether a potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of Blackstone, Blackstone Credit &amp; Insurance, the Company, Other Clients or other co-investments (including whether a potential co-investor will help establish, recognize, strengthen and/or cultivate relationships that can provide indirectly longer-term benefits to the Company or Other Clients and their respective underlying portfolio companies, or whether the potential co-investor has significant capital under management by the Firm or intends to increase such amount); the ability of a potential co-investor to commit to a co-investment opportunity within the required timeframe of the particular transaction; Blackstone Credit &amp; Insurance&#8217;s assessment of a potential co-investor&#8217;s ability to invest an amount of capital that fits the needs of the investment (taking into account the amount of capital needed as well as the maximum number of investors that can realistically participate in the transaction); whether the co-investor is considered &#8220;strategic&#8221; to the investment because it is able to offer the Company certain benefits, including but not limited to, the ability to help consummate the investment, the ability to aid in operating or monitoring the portfolio company or the possession of certain expertise; the transparency, speed and predictability of the potential co-investor&#8217;s investment process; whether the Firm has previously expressed a general intention to seek to offer co-investment opportunities to such potential co-investor; whether a potential co-investor has the financial and operational resources and other relevant wherewithal to evaluate and participate in a co-investment opportunity; the familiarity the Firm has with the personnel and professionals of the investor in working together in investment contexts (which may include such potential co-investor&#8217;s history of investment in other Firm co-investment opportunities); the extent to which a potential co-investor has committed to an Other Client; the size of such potential co-investor&#8217;s interest to be held in the underlying portfolio company as a result of the Company&#8217;s investment (which is likely to be based on the size of the potential co-investor&#8217;s capital commitment or investment in the Company); the extent to which a potential co-investor has been provided a greater amount of co-investment opportunities relative to others; the ability of a potential co-investor to invest in potential add-on acquisitions for the portfolio company or participate in defensive investments; the likelihood that the potential co-investor would require governance rights that would complicate or jeopardize the transaction (or, alternatively, whether the investor would be willing to defer to the Firm and assume a more passive role in governing the portfolio company); any interests a potential co-investor might have in any competitors of the underlying portfolio company; the tax profile of the potential co-investor and the tax characteristics of the investment (including whether the potential co-investor would require particular structuring implementation or covenants that would not otherwise be required but for its participation or whether such co-investor&#8217;s participation is beneficial to the overall structuring of the investment); whether a potential co-investor&#8217;s participation in the transaction would subject the Company and/or the portfolio company to additional regulatory requirements, review and/or scrutiny, including any necessary governmental approvals required to consummate the investment; the potential co-investor&#8217;s interaction with the potential management team of the </span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">portfolio company; whether the potential co-investor has any existing positions in the portfolio company (whether in the same security in which the Company is investing or otherwise); whether there is any evidence to suggest that there is a heightened risk with respect to the potential co-investor maintaining confidentiality; whether the potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of the Company, other affiliated funds and/or other co-investments, including the size of such commitment; whether the potential co-investor has any known investment policies and restrictions, guideline limitations or investment objectives that are relevant to the transaction, including the need for distributions; whether the expected holding period and risk-return profile of the investment is consistent with the stated goals of the investor; and such other factors as the Adviser deems relevant and believes to be appropriate under the circumstances. Furthermore, in connection with any such co-investment by third-party co-investors, the Adviser can establish one or more investment vehicles managed or advised by the Firm to facilitate such co-investors&#8217; investment alongside the Company. The factors listed in the foregoing sentence are neither presented in order of importance nor weighted, except that Blackstone Credit &amp; Insurance has historically primarily relied upon the following two factors in making the determination to offer co-investment opportunities to co-investors: (i) whether the potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of the Company (including whether a potential co-investor will help establish, recognize, strengthen and/or cultivate relationships that can provide indirectly longer-term benefits to the Company or Other Clients and their respective underlying portfolio companies), other affiliated funds, and/or other co-investments, including the size of any such commitment and fee revenue or profits generated for the benefit of Blackstone Credit &amp; Insurance or Blackstone as a result thereof and (ii) the ability of a potential co-investor to process a co-investment decision within the required timeline of the particular transaction. Except as otherwise described herein, co-investors generally will not share Broken Deal Expenses with the Company and Other Clients, with the result that the Company and such Other Clients will bear all such Broken Deal Expenses, and such expenses can be significant. However, the Adviser does not intend to offer any such co-investment opportunities to shareholders in their capacity as shareholders. Blackstone Credit &amp; Insurance may (but is not required to) establish co-investment vehicles (including dedicated or &#8220;standing&#8221; co-investment vehicles) for one or more investors (including third party investors and investors in the Company) in order to co-invest alongside the Company in one or more future investments. The existence of these vehicles could reduce the opportunity for other shareholders to receive allocations of co-investment. In addition, the allocation of investments to Other Clients, including as described under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Other Blackstone and Blackstone Credit &amp; Insurance Clients; Allocation of Investment Opportunities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein, may result in fewer co-investment opportunities (or reduced allocations) being made available to shareholders.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Additional Potential Conflicts of Interest with respect to Co-Investment; Strategic Relationships Involving Co-Investment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition, the Adviser and/or its affiliates will in certain circumstances be incentivized to offer certain potential co-investors (including, by way of example, as a part of an overall strategic relationship with the Firm) opportunities to co-invest because the extent to which any such co-investor participates in (or is offered) co-investment opportunities can impact the amount of performance-based compensation and/or management fees or other fees paid by the co-investor. The amount of carried interest or expenses charged and/or management fees paid by the Company may be less than or exceed such amounts charged or paid by co-investment vehicles pursuant to the terms of such vehicles&#8217; partnership agreements and/or other agreements with co-investors, and such variation in the amount of fees and expenses may create an economic incentive for Blackstone Credit &amp; Insurance to allocate a greater or lesser percentage of an investment opportunity to the Company or such co-investment vehicles or co-investors, as the case may be. In addition, other terms of existing and future co-investment vehicles may differ materially, and in some instances may be more favorable to Blackstone Credit &amp; Insurance, than the terms of the Company, and such different terms may create an incentive for Blackstone Credit &amp; Insurance to manage such vehicles, which could result in the Company receiving a lesser percentage of an investment opportunity than if such co-investment vehicles did not exist. Such relationships will from time to time give rise to conflicts of interest, and there can be no assurance that such conflicts of interest will be resolved in favor of the Company. Accordingly, any investment opportunities that would have otherwise been offered or allocated, in whole or in part, to the Company can be reduced and made available to co-investment vehicles. Co-investments may be offered by the Adviser on such terms and conditions as the Adviser determines in its discretion on a case-by-case basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fund Co-Investment Opportunities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a BDC regulated under the 1940 Act, the Company is subject to certain limitations relating to co-investments and joint transactions with affiliates, which likely will in certain circumstances limit the Company&#8217;s ability to make investments or enter into other transactions alongside the Other Clients. There can be no assurance that such regulatory restrictions will not adversely affect the Company&#8217;s ability to capitalize on attractive investment opportunities. However, subject to the 1940 Act and any applicable co-investment exemptive order issued by the SEC, the Company may co-invest with Other Clients (including co-investment or other vehicles in which the Firm or its personnel invest and that co-invest with such Other Clients) in investments that are suitable for the Company and one or more of such Other Clients. Even if the Company and any such Other Clients and/or co-investment or other vehicles invest in the same securities, conflicts of interest may still arise.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions. Such order may restrict our ability to enter into follow-on investments or other transactions. Pursuant to such order, we may co-invest in a negotiated deal with certain affiliates of the Adviser or certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions. We may also receive an allocation in such a deal alongside affiliates pursuant to other mechanisms to the extent permitted by the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Portfolio Companies Alongside Other Clients. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company will co-invest with Other Clients (including co-investment or other vehicles in which the Firm or its personnel invest and that co-invest with such Other Clients) in investments that are suitable for both the Company and such Other Clients, as permitted by applicable law and/or any applicable SEC-granted order. Even if the Company and any such Other Clients invest in the same securities or loans, conflicts of interest are still expected to arise. For example, it is possible that as a result of legal, tax, regulatory, accounting, political, national security or other considerations, the terms of such investment (and divestment thereof) (including with respect to price and timing) for the Company and such other funds and vehicles are not the same. Additionally, the Company and such Other Clients and/or vehicles will generally have different investment periods and/or investment objectives (including return profiles) and Blackstone Credit &amp; Insurance, as a result, could have conflicting goals with respect to the amount, price and timing of disposition opportunities. As such, subject to applicable law and any applicable order issued by the SEC, the Company and/or such Other Clients may dispose of any such shared investment at different times and on different terms.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Firm Involvement in Financing of Third Party Dispositions by the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company is permitted from time to time dispose of all or a portion of an investment by way of accepting a third-party purchaser&#8217;s bid where the Firm or one or more Other Clients is providing financing as part of such bid or acquisition of the investment or underlying assets thereof. This generally would include the circumstance where the Firm or one or more Other Clients is making commitments to provide financing at or prior to the time such third-party purchaser commits to purchase such investments or assets from the Company. Such involvement of the Firm or one or more Other Clients as such a provider of debt financing in connection with the potential acquisition of portfolio investments by third parties from the Company may give rise to potential or actual conflicts of interest.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Self-Administration of the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance expects to provide certain fund administration services to the Company rather than engage or rely on a third party administrator to perform such services. The costs for providing these services are not included in the management fee under the Investment Advisory Agreement and will be paid separately by the Company. Blackstone Credit &amp; Insurance also reserves the right to charge the Company a reduced rate for these services, or to reduce or waive such charges entirely, subject to the 1940 Act. Blackstone Credit &amp; Insurance&#8217;s ability to determine the reimbursement obligation from the Company creates a conflict of interest. Blackstone Credit &amp; Insurance addresses this conflict by reviewing its fund administration costs to ensure that it is comparable and fair with regard to equivalent services performed by a non-affiliated third party at a rate negotiated on an arm&#8217;s length basis. The Board of Trustees periodically reviews the reimbursement obligation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Outsourcing. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the oversight and, in certain circumstances, approval by the Board of Trustees of the Company, Blackstone may outsource to third parties several of the services performed for the Company and/or its portfolio entities, including services (such as administrative, legal, accounting, tax, diligence, modeling, ongoing monitoring, preparation of internal templates and/or memos or other related services) that may be or historically have been performed in-house by Blackstone and its personnel. For certain third-party service providers, the fees, costs and expenses of such service providers will be borne by the Company, and in other circumstances, the fees, costs and expenses of such service providers will be borne by Blackstone. Certain third-party service providers and/or their employees will dedicate substantially all of their business time to the Company, Other Clients and/or their respective portfolio entities, while others will have other clients. In certain cases, third-party service providers and/or their employees may spend a significant amount of time at Blackstone offices, have dedicated office space at Blackstone, receive administrative support from Blackstone personnel or participate in meetings and events for Blackstone personnel, even though they are not Blackstone employees or affiliates. This creates a conflict of interest because Blackstone will have an incentive to outsource services to third parties due to a number of factors, including because retaining third parties will reduce Blackstone&#8217;s internal overhead and compensation costs for employees who would otherwise perform such services in-house.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The involvement of third-party service providers may present a number of risks due to Blackstone&#8217;s reduced control over the functions that are outsourced. There can be no assurances that Blackstone will be able to identify, prevent or mitigate the risks of engaging third-party service providers. The Company may suffer adverse consequences from actions, errors or failures to act by such third parties, and will have obligations, including indemnity obligations, and limited recourse against them. Outsourcing may not occur uniformly for all Blackstone managed vehicles and accounts and, accordingly, certain costs may be incurred by (or allocated to) the Company through the use of third-party service providers that are not incurred by (or allocated to) Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material, Non-Public Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance will come into possession of confidential information with respect to an issuer and other actual or prospective portfolio companies. Blackstone Credit &amp; Insurance can be restricted from buying, originating or selling securities, loans, or derivatives on behalf of the Company until such time as the information becomes public or is no longer deemed material such that it would preclude the Company from participating in an investment. Disclosure of such information to the Adviser&#8217;s personnel responsible for the affairs of the Company will be on a need-to-know basis only, and the Company might not be free to act upon any such information. Therefore, the Company will not always have access to confidential information in the possession of Blackstone Credit &amp; Insurance that might be relevant to an investment decision to be made for the Company. In addition, Blackstone Credit &amp; Insurance, in an effort to avoid buying or selling restrictions on behalf of the Company or Other Clients, can choose to forego an opportunity to receive (or elect not to receive) information that other market participants or counterparties, including those with the same positions in the issuer as the Company, are eligible to receive or have received, even if possession of such information would otherwise be advantageous to the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Break-up and other Similar Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Break-up or topping fees with respect to the Company&#8217;s investments can be paid to Blackstone Credit &amp; Insurance. Alternatively, the Company could receive the break-up or topping fees directly. Break-up or topping fees paid to Blackstone Credit &amp; Insurance or the Company in connection with a transaction could be allocated, or not, to Other Clients or co-investment vehicles that invest (or are expected to invest) alongside the Company, as determined by Blackstone Credit &amp; Insurance to be appropriate in the circumstances. Generally, Blackstone Credit &amp; Insurance would not allocate break-up or topping fees with respect to a potential investment to the Company, an Other Client or co-investment vehicle unless such person would also share in Broken Deal Expenses related to the potential investment. With respect to fees received by Blackstone Credit &amp; Insurance relating to the Company&#8217;s investments or from unconsummated transactions, shareholders will not receive the benefit of any fees relating to the Company&#8217;s investments (including, without limitation, as described above). In the case of fees for services as a director of a portfolio company, the management fee will not be reduced to the extent any Firm personnel continues to serve as a director after the Company has exited (or is in the process of exiting) the applicable portfolio company and/or following the termination of such employee&#8217;s employment with the Firm. For the avoidance of doubt, although the financial advisory and restructuring business of Blackstone has been spun out, to the extent any investment banking fees, consulting (including management consulting) fees, syndication fees, capital markets syndication and advisory fees (including underwriting fees), origination fees, servicing fees, healthcare consulting / brokerage fees, fees relating to group purchasing, financial advisory fees and similar fees for arranging acquisitions and other major financial restructurings, loan servicing and/or other types of insurance fees, operations fees, financing fees, fees for asset services, title insurance fees, and other similar fees and annual retainers (whether in cash or in kind) are received by Blackstone, such fees will not be required to be shared with the Company or the shareholders and will not reduce the management fee payable by the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Broken Deal Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any expenses that may be incurred by the Company for actual investments as described herein may also be incurred by the Company with respect to broken deals (i.e., investments that are not consummated) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Broken Deal Expenses&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Unless required by law or regulation, Blackstone Credit &amp; Insurance is not required to and, in most circumstances, will not seek reimbursement of Broken Deal Expenses (i.e., expenses incurred in pursuit of an investment that is not consummated) from third parties, including counterparties to the potential transaction or potential co-investors. Examples of such Broken Deal Expenses include, but are not limited to, reverse termination fees, extraordinary expenses such as litigation costs and judgments, meal, travel and entertainment expenses incurred, deposits or down payments which are forfeited in connection with unconsummated transactions, costs from onboarding (i.e., KYC) investment entities with a financial institution, commitment fees that become payable in connection with a proposed investment, consulting fees and expenses (including all expenses incurred in connection with any tax audit or investigation settlement), printing and publishing expenses, costs of negotiating co-investment documentation (including non-disclosure agreements with counterparties), and legal, accounting, tax and other due diligence and pursuit costs and expenses and broken deal expenses associated with services provided by portfolio companies, which may include expenses incurred prior to the commencement of the Company&#8217;s investment activities. Any such Broken Deal Expenses could, in the sole discretion of Blackstone Credit &amp; Insurance, be allocated solely to the Company and not to Other Clients or co-investment vehicles that could have made the investment, even when the Other Client or co-investment vehicle commonly invests alongside the Company in its investments or the Firm or Other Clients in their investments. In such cases, the Company&#8217;s shares of expenses would increase. The Adviser expects that until a potential investment of the Company is formally allocated to an Other Client (it being understood that final allocation decisions are typically made shortly prior to closing an investment), the Company is expected to bear the broken deal expenses for such investment, which may result in substantial amounts of broken deal expenses. In the event Broken Deal Expenses are allocated to an Other Client or a co-investment vehicle, Blackstone Credit &amp; Insurance or the Company will, in certain circumstances, advance such fees and expenses without charging interest until paid by the Other Client or co-investment vehicle, as applicable. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Firm Business Activities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm, Other Clients, their portfolio companies, and personnel and related parties of the foregoing will receive fees and compensation, including performance-based and other incentive fees, for products and services provided to the Company and its portfolio companies, such as fees for asset management (including, without limitation, management fees and carried interest/incentive arrangements), development and property management; portfolio operations support (such as those provided by Blackstone&#8217;s Portfolio Operations Group); arranging, underwriting (including without limitation, evaluation regarding value creation opportunities and ESG risk mitigation); syndication or refinancing of a loan or investment (or other additional fees, including acquisition fees, loan modification or restructuring fees); servicing; loan servicing; special servicing; administrative services; advisory services on purchase or sale of an asset or company; investment banking and capital markets services; placement agent services; fund administration; internal legal and tax planning services; information technology products and services; insurance procurement; brokerage; solutions and risk management services; data extraction and management products and services; fees for monitoring and oversight of loans or title insurance provided to portfolio companies or third parties; and other products and services. For example, the Firm or Other Clients may, directly or indirectly through a portfolio entity, from time to time acquire loans or other assets for the purpose of syndicating some or all the assets to the Company and/or Other Clients, and may receive syndication or other fees in connection therewith. Such parties will also provide products and services for fees to the Firm, Other Clients and their portfolio companies, and their personnel and related parties, as well as third parties. Through its innovations group, Blackstone incubates (or otherwise invests in) businesses that are expected to provide goods and services to the Company (subject to the requirements of the 1940 Act and applicable guidance) and Other Clients and their portfolio companies, as well as other Firm-related parties and third parties. By contracting for a product or service from a business related to the Firm, the Company and its portfolio companies would provide not only current income to the business and its stakeholders, but could also create significant enterprise value in them, which would not be shared with the Company or shareholders and could benefit the Firm directly and indirectly. Also, the Firm, Other Clients and their portfolio companies, and their personnel and related parties may receive compensation or other benefits, such as through additional ownership interests or otherwise, directly related to the consumption of products and services by the Company and its portfolio companies. The Company and its portfolio companies will incur expenses in negotiating for any such fees and services, which will be treated as Fund Expenses. In addition, the Firm may receive fees associated with capital invested by co-investors relating to investments in which the Company participates or otherwise, in connection with a joint venture in which the Company participates (subject to the 1940 Act) or otherwise with respect to assets or other interests retained by a seller or other commercial counterparty with respect to which the Firm performs services. Finally, the Firm and its personnel and related parties will, in certain circumstances, also receive compensation in connection with origination activities, referrals and other related activities of such business, and unconsummated transactions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will, as determined by Blackstone Credit &amp; Insurance and as permitted by the governing fund documents, bear the cost of fund administration, compliance and accounting (including, without limitation, maintaining financial records, filing of the Company&#8217;s tax returns, overseeing the calculation of the Company&#8217;s net asset value, compliance monitoring (including diligence and oversight of the Company&#8217;s other service providers), preparing reports to the Company&#8217;s shareholders and reports filed with the SEC and other regulators, preparing materials and coordinating meetings of the Board, managing the payment of expenses, the payment and receipt of funds for investments and the performance of administrative and professional services rendered by others, providing office space, equipment and office services), in house legal, tax planning and other related services provided by Firm personnel and related parties to the Company and its portfolio companies, including the allocation of their compensation and related overhead otherwise payable by the Firm, or pay for their services at market rates, as discussed above in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Self-Administration of the Company.&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such allocations or charges can be based on any of the following methodologies: (i) requiring personnel to periodically record or allocate their historical time spent with respect to the Company or the Firm approximating the proportion of certain personnel&#8217;s time spent with respect to the Company, and in each case allocating their compensation (including, without limitation, salary, bonus and benefits) and allocable overhead based on time spent, or charging their time spent at market rates, (ii) the assessment of an overall dollar amount (based on a fixed fee or percentage of assets under management) that the Firm believes represents a fair recoupment of expenses and a market rate for such services or (iii) any other similar methodology determined by the Firm to be appropriate under the circumstances. Certain Firm personnel will provide services to few, or only one, of the Company and Other Clients, in which case the Firm could rely upon rough approximations of time spent by the employee for purposes of allocating the salary and overhead of the person if the market rate for services is clearly higher than allocable salary and overhead. However, any methodology (including the choice thereof) involves inherent conflicts and may result in incurrence of greater expenses by the Company and its portfolio companies than would be the case if such services were provided by third parties.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance, Other Clients and their portfolio companies, and their affiliates, personnel and related parties could continue to receive fees, including performance-based or incentive fees, for the services described in the preceding paragraphs with respect to investments sold by the Company or a portfolio company to a third party buyer after the sale is consummated. Such post-disposition involvement will give rise to potential or actual conflicts of interest, particularly in the sale process. Moreover, Blackstone Credit &amp; Insurance, Other Clients and their portfolio companies, and their affiliates, personnel and related parties could acquire a stake in the relevant asset as part of the overall service relationship, at the time of the sale or thereafter.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone Credit &amp; Insurance does not have any obligation to ensure that fees for products and services contracted by the Company or its portfolio companies are at market rates unless the counterparty is considered an affiliate of the Firm and given the breadth of the Firm&#8217;s investments and activities Blackstone Credit &amp; Insurance may not be aware of every commercial arrangement between the Company and its portfolio companies, on the one hand, and the Firm, Other Clients and their portfolio companies, and personnel and related parties of the foregoing, on the other hand.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as set forth above, the Company and shareholders will not receive the benefit (e.g., through a reduction to the management fee or otherwise) of any fees or other compensation or benefit received by Blackstone Credit &amp; Insurance, its affiliates or their personnel and related parties. (See also </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Service Providers, Vendors and Other Counterparties Generally&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Other Firm Business Activities.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities and Lending Activities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone, its affiliates and their related parties and personnel will from time to time participate in underwriting or lending syndicates with respect to current or potential portfolio companies, or will otherwise act as arrangers of financing, including with respect to the public offering and/or private placement of debt or equity securities issued by, or loan proceeds borrowed by the Company and its portfolio companies, or otherwise in arranging financing (including loans) for such portfolio companies or advise on such transactions. Such underwritings or engagements can be on a firm commitment basis or can be on an uncommitted &#8220;best efforts&#8221; basis, and the underwriting or financing parties are under no duty to provide any commitment unless specifically set forth in the relevant contract. Blackstone may also provide placement or other similar services to purchasers or sellers of securities, including loans or instruments issued by portfolio companies. There could also be circumstances in which the Company commits to purchase any portion of such issuance from the portfolio company that a Blackstone broker-dealer intends to syndicate to third parties. As a result thereof, subject to the limitations of the 1940 Act, Blackstone may be permitted to receive commissions or other compensation, thereby creating a potential conflict of interest. This could include, by way of example, fees and/ or commissions for equity syndications to co-investment vehicles. In certain cases, subject to the limitations of the 1940 Act, a Blackstone broker-dealer will, from time to time, act as the managing underwriter, or a member of the underwriting syndicate or broker for the Company or its portfolio companies, or as dealer, broker or advisor to a counterparty to the Company or a portfolio company, and purchase securities from or sell securities to the Company, Other Clients or portfolio companies of the Company or Other Clients or advise on such </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transactions. Blackstone will also from time to time, on behalf of the Company or other parties to a transaction involving the Company or its portfolio companies, effect transactions, including transactions in the secondary markets that result in commissions or other compensation paid to Blackstone by the Company or its portfolio companies or the counterparty to the transaction, thereby creating a potential conflict of interest. This could include, by way of example, fees and/or commissions for equity syndications to co-investment vehicles. Subject to applicable law, Blackstone will from time to time receive underwriting fees, discounts, placement commissions, loan modification or restructuring fees, servicing fees, capital markets advisory fees, lending arrangement fees, asset/property management fees, insurance (including title insurance) incentive fees and consulting fees, monitoring fees, commitment fees, syndication fees, origination fees, organizational fees, operational fees, loan servicing fees, and financing and divestment fees (or, in each case, rebates in lieu of any such fees, whether in the form of purchase price discounts or otherwise, even in cases where Blackstone, an Other Client or its portfolio companies are purchasing debt) or other compensation with respect to the foregoing activities, which are not required to be shared with the Company. In addition, the management fee with respect to a shareholder generally will not be reduced by such amounts. Therefore, Blackstone will from time to time have a potential conflict of interest regarding the Company and the other parties to those transactions to the extent it receives commissions, discounts or other compensation from such other parties. The Board of Trustees, in its sole discretion, will approve any transactions, subject to the limitations of the 1940 Act, in which a Blackstone broker-dealer acts as an underwriter, as broker for the Company, or as dealer, broker or advisor, on the other side of a transaction with the Company only where the Board of Trustees believes in good faith that such transactions are appropriate for the Company and, by executing a subscription agreement for shares in the Company, a shareholder consents to all such transactions, along with the other transactions involving conflicts of interest described herein, to the fullest extent permitted by law.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Blackstone serves as underwriter with respect to securities of the Company or its portfolio companies, the Company and such portfolio companies could from time to time be subject to a &#8220;lock-up&#8221; period following the offering under applicable regulations during which time the Company or portfolio company would be unable to sell any securities subject to the &#8220;lock-up.&#8221; This could prejudice the ability of the Company and its portfolio companies to dispose of such securities at an opportune time. In addition, Blackstone Capital Markets can serve as underwriter in connection with the sale of securities by the Company or its portfolio companies. Conflicts would be expected to arise because such engagement would result in Blackstone Capital Markets receiving selling commissions or other compensation in connection with such sale. (See also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;&#8212;Portfolio Company Relationships Generally&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone and Blackstone Credit &amp; Insurance employees are generally permitted to invest in alternative investment funds, real estate funds, hedge funds or other investment vehicles, including potential competitors of the Company. The Company will not receive any benefit from any such investments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PJT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On October 1, 2015, Blackstone spun off its financial and strategic advisory services, restructuring and reorganization advisory services, and its Park Hill fund placement businesses and combined these businesses with PJT Partners Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;PJT&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), an independent financial advisory firm founded by Paul J. Taubman. While PJT operates independently from Blackstone and is not an affiliate thereof, it is expected that there will be substantial overlapping ownership between Blackstone and PJT for a considerable period of time going forward. Therefore, conflicts of interest will arise in connection with transactions between or involving the Company and its portfolio companies, on the one hand, and PJT, on the other. The pre-existing relationship between Blackstone and its former personnel, the overlapping ownership and co-investment and other continuing arrangements between PJT and Blackstone can be expected to influence Blackstone Credit &amp; Insurance to select or recommend PJT to perform services for the Company or its portfolio companies, the cost of which will generally be borne directly or indirectly by the Company. Given that PJT is no longer an affiliate of Blackstone, Blackstone and its affiliates will be free to cause the Company and portfolio companies to transact with PJT generally without restriction under the applicable governing documents, notwithstanding the relationship between Blackstone and PJT. In addition, one or more investment vehicles controlled by Blackstone may be established to facilitate participation in Blackstone&#8217;s side-by-side investment program by employees and/or partners of PJT. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Portfolio Company Relationships Generally</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company&#8217;s portfolio companies, including special purpose vehicles that might be formed in connection with investments, are expected to be counterparties to or participants in agreements, transactions or other arrangements with the Company, Other Clients, and/or portfolio companies of the Company and Other Clients or other Blackstone affiliates and/or any portfolio companies of the foregoing for the provision of goods and services, purchase and sale of assets and other matters (including information-sharing and/or consulting). For example, from time to time, certain portfolio companies of the Company or Other Clients will provide or recommend goods or services to Blackstone, the Company, Other Clients, or other portfolio companies of the Company or Other Clients (including &#8220;platform&#8221; investments of the Company and Other Clients). As another example, it can also be expected that the management of one or more portfolio </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies may consult with one another (or with one or more portfolio companies of an Other Client) in respect of seeking its expertise, industry view, or otherwise on a particular topic including but not limited to an asset and/or the purchase and /or sale thereof. Moreover, the Company and/or an Other Client can consult with a portfolio company or a portfolio company of an Other Client as part of the investment diligence for a potential investment by the Company or such Other Client. As a result of, or as part of such interactions or otherwise, personnel (including one or more members of the management team) at one portfolio company may also transfer to or become employed by another portfolio company (or a portfolio company of an Other Client), the Company, Blackstone or their respective affiliates (or vice versa). Any such transfer may result in payments by the entity that such personnel is going to, to the entity such personnel is departing from. Although the Firm might determine that such agreements, transactions or other arrangements are consistent with the requirements of such Other Clients&#8217; offering and/or governing agreements, such agreements, transactions or other arrangements might not have otherwise been entered into but for the affiliation with Blackstone Credit &amp; Insurance and/or Blackstone. These agreements, transactions or other agreements involve fees, commissions, servicing payments and/or discounts to Blackstone Credit &amp; Insurance, any Blackstone affiliate (including personnel) or a portfolio company, none of which reduce the management fee payable by the Company. This may give rise to actual or potential conflicts of interest for the Adviser, the Company and/or their respective affiliates, as such agreements, transactions and arrangements may be more favorable for one portfolio company than another, thus benefiting the Company or Other Clients at the expense of the other. For example, the Firm reserves the right to cause, or offer the opportunity to, portfolio companies to enter into agreements regarding group procurement (such as the group purchasing organization), benefits management, purchase of title and/or other insurance policies (which could be pooled across portfolio companies and discounted due to scale) and other operational, administrative or management related matters from a third party or a Firm affiliate, and other similar operational initiatives that can result in commissions or similar payments, including related to a portion of the savings achieved by the portfolio company. Such agreements, transactions or other arrangements will generally be entered into without the consent or direct involvement of the Company and/or such Other Client or the consent of the Board of Trustees and/or the shareholders of the Company or such Other Client (including, without limitation, in the case of minority and/or non-controlling investments by the Company in such portfolio companies or the sale of assets from one portfolio company to another) and/or such Other Client. In any such case, the Company might not be involved in the negotiation process, and there can be no assurance that the terms of any such agreement, transaction or other arrangement will be as favorable to the Company as otherwise would be the case if the counterparty were not related to the Firm.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, it is possible that certain portfolio companies of Other Clients or companies in which Other Clients have an interest will compete with the Company for one or more investment opportunities. It is also possible that certain portfolio companies of Other Clients will engage in activities that will have adverse consequences on the Company and/or its portfolio companies. As an example of the latter, the laws and regulations of certain jurisdictions (e.g., bankruptcy, environmental, consumer protection and/or labor laws) would not recognize the segregation of assets and liabilities as between separate entities and could permit recourse against the assets of not just the entity that has incurred the liabilities, but also the other entities that are under common control with, or part of the same economic group as, such entity. In such circumstances, the assets of the Company and/or its portfolio companies potentially will be used to satisfy the obligations or liabilities of one or more Other Clients, their portfolio companies and/or affiliates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, Blackstone and affiliates of Blackstone and Blackstone portfolio companies could also establish other investment products, vehicles and platforms focusing on specific asset classes or industry sectors that fall within the Company&#8217;s investment strategy, which would possibly compete with the Company for investment opportunities (it being understood that such arrangements would give rise to conflicts of interest that would not necessarily be resolved in favor of the Company).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain portfolio companies have established or invested in, or can be expected to in the future establish or invest in, vehicles that are managed exclusively by the portfolio company (and not the Company or the Firm or any of its affiliates) and that invest in asset classes or industry sectors (such as cyber security) that fall within the Company&#8217;s investment strategy. Such vehicles, which would not be considered affiliates of the Firm and would not be subject to the Firm&#8217;s policies and procedures, have the potential to compete with the Company for investment opportunities. Portfolio companies and affiliates of the Firm will also establish other investment products, vehicles and platforms focusing on specific asset classes or industry sectors (such as reinsurance) that can be expected to compete with the Company for investment opportunities (it being understood that such arrangements can give rise to conflicts of interest that would not necessarily be resolved in favor of the Company). In addition, the Company reserves the right to hold non-controlling interests in certain portfolio companies and, as a result, such portfolio companies could engage in activities outside of the Company&#8217;s control that would have adverse consequences on the Company and/or its other portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone has also entered into certain investment management arrangements whereby it provides investment management services for compensation to insurance companies including (i) FGL and certain of its affiliates, (ii) Everlake and certain of its affiliates and (iii) certain subsidiaries of Corebridge and (iv) certain subsidiaries of Resolution Life. As of the date of the date hereof, Blackstone owns a 9.9% equity interest in the parent company of Everlake and Blackstone Clients own the remaining equity interests in the parent company of Everlake, and Blackstone owns a 9.9% equity interest in Corebridge. The foregoing insurance company investment management arrangements will involve investments by such insurance company clients across a variety of asset classes (including investments that would otherwise be appropriate for the Company). As a result, in addition to the compensation Blackstone receives for providing investment management services to insurance companies in which Blackstone or an Other Client owns an interest, in certain instances Blackstone receives additional compensation in its capacity as an indirect owner of such insurance companies and/or Other Clients. In the future Blackstone will likely enter into similar arrangements with other portfolio companies of the Company, Other Clients or other insurance companies. Such arrangements have the potential to reduce the allocations of investments to the Company, and Blackstone could be incentivized to allocate investments away from the Company to such insurance company client under such investment management arrangements or other vehicles/accounts to the extent the economic arrangements related thereto are more favorable to Blackstone relative to the terms of the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, portfolio companies with respect to which the Firm can elect members of the board of directors or a managing member could, as a result, subject the Company and/or such directors or managing member to fiduciary obligations to make decisions that they believe to be in the best interests of any such portfolio company. Although in most cases the interests of the Company and any such portfolio company will be aligned, this will not always be the case. This has the potential to create conflicts of interest between the relevant director&#8217;s or managing member&#8217;s obligations to any such portfolio company and its stakeholders, on the one hand, and the interests of the Company, on the other hand. Although Blackstone Credit &amp; Insurance will generally seek to minimize the impact of any such conflicts, there can be no assurance they will be resolved favorably for the Company. For instance, such positions could impair the ability of the Company to sell the securities of an issuer in the event a director receives material non- public information by virtue of their role, which would have an adverse effect on the Company. Furthermore, an employee of Blackstone serving as a director to a portfolio company owes a fiduciary duty and/or other obligations to the portfolio company, on the one hand, and the Company, on the other hand, and such employee could be in a position where they must make a decision that is either not in the best interest of the Company, or is not in the best interest of the portfolio company. Blackstone personnel serving as directors can make decisions for a portfolio company that negatively impact returns received by the Company as an investor in the portfolio company. In addition, to the extent an employee serves as a director on the board of more than one portfolio company, such employees&#8217; fiduciaries duties among the two portfolio companies can be expected to create a conflict of interest. In general, the Adviser and Blackstone personnel will be entitled to indemnification from the Company. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Portfolio Company Service Providers and Vendors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to applicable law, the Company, Other Clients, portfolio companies of each of the foregoing and Blackstone Credit &amp; Insurance can be expected to engage portfolio companies of the Company and Other Clients to provide some or all of the following services: (a)&#160;corporate support services (including, without limitation, accounts payable, accounts receivable, accounting/audit (e.g., valuation support services), account management (e.g., treasury, customer due diligence), insurance, procurement, placement, brokerage and consulting services, cash management, accounts receivable financing, corporate secretarial and executive assistant services, domiciliation, data management, directorship services, finance/budget, human resources (e.g., the onboarding and ongoing development of personnel), communication, public relations and publicity, information technology and software systems support, corporate governance and entity management (e.g., liquidation, dissolution and/or otherwise end of term services), risk management and compliance, internal compliance, know-your-client reviews and refreshes, judicial processes, legal, environmental due diligence support(e.g., review of property condition reports, energy consumption), climate accounting services, ESG program management services, engineering services, services related to the sourcing, development and implementation of renewable energy, ESG data collection and reporting services, capital planning services, operational coordination (i.e., coordination with joint venture partners, property managers), risk management, reporting (such as tax reporting, debt reporting or other reporting), tax and treasury, tax analysis and compliance (e.g., CIT and VAT compliance), transfer pricing and internal risk control, treasury and valuation services) and other services; (b) loan services (including, without limitation, monitoring, restructuring and work-out of performing, sub-performing and nonperforming loans, administrative services, and cash management); (c) management services (i.e., management by a portfolio company, Blackstone affiliate or third party (e.g., a third-party manager or operating partner) of operational services); (d) operational services (i.e., general management of day to day operations), including, without limitation, personnel, construction management (such as management of general contractors on capital projects), leasing services (such as leasing strategy, management of third party brokers, negotiation of major leases and negotiation of leases), project management (such as management of development projects, project design and execution, vendor management, and turnkey services); (e) risk management (tax and treasury); (f) transaction support services (including, without </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">limitation, acquisition support; customer due diligence and related onboarding; liquidation; reporting; managing relationships with brokers, banks and other potential sources of investments, identifying potential investments, coordinating with investors, assembling relevant information, conducting financial and market analyses and modelling, coordinating closing/post-closing procedures for acquisitions, dispositions and other transactions, coordinating design and development works (such as recommending and implementing design decisions); and providing diligence and negotiation support to acquire the same; marketing and distribution, overseeing brokers, lawyers, accountants and other advisors, working with consultants and third parties to pursue entitlements; providing in-house legal, ESG and accounting services, assisting with due diligence, preparation of project feasibilities, site visits, transaction consulting and specification of technical analysis and review of (i) design and structural work, (ii) certifications, (iii) operations and maintenance manuals and (iv) statutory documents); (g) insurance procurement, placement, brokerage and consulting services; and (h)&#160;other services. Similarly, Blackstone Credit &amp; Insurance, Other Clients and their portfolio companies can be expected to engage portfolio companies of the Company to provide some or all of these services. Some of the services performed by portfolio company service providers could also be performed by Blackstone Credit &amp; Insurance from time to time and vice versa. Fees paid by the Company or its portfolio companies to or value created by other portfolio company service providers do not reduce the management fee payable by the Company and are not otherwise shared with the Company. In certain circumstances, Blackstone can be expected to play a substantial role in overseeing the personnel of portfolio company service providers that provide services to the Company, Other Clients and/or their portfolio companies on an ongoing basis, including with respect to the selection, hiring, retention and compensation of such personnel. For example, Blackstone expects that certain portfolio company service providers, as described below, with Blackstone&#8217;s oversight, will establish a team of personnel to provide support services exclusively to the Company and its portfolio companies (and/or other investment funds or accounts managed or controlled by Blackstone). Further, Blackstone has multiple business lines, which may result in competition with a portfolio company for high performing executive talent and presents actual and potential conflicts of interest. For example, Blackstone may &#8220;poach&#8221; a portfolio company executive, or such executive may interview with Blackstone during the applicable contractual period with respect to such person&#8217;s existing position and later be hired by Blackstone after such period. A portfolio company may want to retain such executives or other employees, and regardless, Blackstone is under no obligation to avoid interviewing or hiring such employees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portfolio companies of the Company and Other Clients some of which can be expected to provide services to the Company and its portfolio companies include, without limitation, the following, and could include additional portfolio companies that might be formed or acquired in the future: </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BTIG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. BTIG, LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BTIG&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is a global financial services firm in which certain Blackstone entities own a strategic minority investment. BTIG provides institutional trading, investment banking, research and related brokerage services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CoreTrust</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On September 30, 2022, certain Blackstone private equity funds and related entities closed the previously announced acquisition of a majority interest in CoreTrust (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;CoreTrust Acquisition&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), a group purchasing organization that provides purchasing services to member companies, which includes portfolio companies owned, in whole or in part, by certain Blackstone-managed funds. CoreTrust is expected to provide group purchasing services to the Company, portfolio companies, Other Clients and Blackstone. Generally, CoreTrust generates revenue from vendors based on a percentage of the amount of products or services purchased by its member companies and benefit plans maintained by its member companies. CoreTrust has historically shared a portion of the revenue generated through purchases made by Blackstone portfolio companies and paid Blackstone a consulting fee. Blackstone stopped accepting such revenue sharing arrangements and consulting fee upon the closing of the CoreTrust Acquisition. However, Blackstone may in its sole discretion reinstitute such or similar revenue sharing arrangements with CoreTrust in the future. In addition, prior to the CoreTrust Acquisition, CoreTrust generated revenue in respect of certain portfolio companies (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Applicable Portfolio Companies&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) from certain health and welfare benefit plan-related vendors (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8220;Applicable Vendors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). For legal and regulatory reasons</span><span style="background-color:#dddddd;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">following the CoreTrust Acquisition, CoreTrust is limited in its ability to generate revenue from the Applicable Vendors in respect of portfolio companies&#8217; health benefit plans based on a percentage of the amount of products or services purchased by such plans. As a result, for Applicable Portfolio Companies and other portfolio companies that become CoreTrust members, CoreTrust intends to rebate all revenue received from Applicable Vendors to each such Portfolio Company&#8217;s applicable benefit plan. CoreTrust also intends to enter into with each Applicable Portfolio Company (and with other portfolio companies that become CoreTrust members) a separate agreement that will include the payment of an access fee in return for allowing such portfolio companies to use the goods and services provided by the Applicable Vendors through CoreTrust. The amount of the access fee will generally be determined either as a percentage of total company revenues or as a fixed fee (in each case subject to periodic review by CoreTrust and the Applicable Portfolio Company) and might not be subject to benchmarking, and the access fee could be greater or less than the amount of the revenue that CoreTrust previously generated from Applicable Vendors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Optiv</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Optiv Security, Inc. is a portfolio company held by certain Blackstone private equity funds that provides a full slate of information security services and solutions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PSAV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. PSAV, Inc. is a portfolio company held by certain Blackstone private equity funds that provides outsourced audiovisual services and event production.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refinitiv</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On October 1, 2018, a consortium led by Blackstone announced that private equity funds managed by Blackstone had completed an acquisition of Thomson Reuters&#8217; Financial &amp; Risk business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Refinitiv&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). On January 29, 2021, Refinitiv was sold to London Stock Exchange Group (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LSEG&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), with Blackstone private equity funds receiving a minority stake in LSEG. Refinitiv operates a pricing service that provides valuation services and may provide goods and services for the Company and its portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Kryalos. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone through one or more of its funds has made a minority investment in Kryalos, an operating partner in certain real estate investments made by Other Clients.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Peridot Financial Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Peridot&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> and Global Supply Chain Finance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;GSCF&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackstone through one or more of its funds has made majority investments into Peridot and GSCF, which provide supply chain financing and accounts receivable services globally.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RE Tech Advisors </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;RE Tech&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Blackstone through one or more of its funds has made a majority investment in RE Tech, an energy audit/consulting firm that identifies and implements energy efficiency programs, calculates return on investment and tracks performance post-completion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legence (f.k.a Therma Holdings) (&#8220;Legence&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Legence is a portfolio company held by certain Blackstone private equity funds that provides carbon reduction and energy management services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revantage.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revantage is a portfolio entity of certain Blackstone Clients that provides corporate support services, including, without limitation, accounting, legal, tax, treasury, information technology and human resources and operational services and management services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There may be instances where current and former employees of Other Clients&#8217; portfolio companies are seconded to or temporarily hired by the Company&#8217;s portfolio companies or, at times, the Company&#8217;s investments directly. Such secondments or temporary hiring of current and former employees of Other Clients&#8217; portfolio companies by the Company&#8217;s portfolio companies (or its investments) may result in a potential conflict of interest between the Company&#8217;s portfolio companies and those of such Other Clients. The costs of such employees are expected to be borne by the Company or its relevant portfolio companies, as applicable, and the fees paid by the Company or such portfolio companies to, other portfolio company service providers or vendors do not offset or reduce the management fee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its portfolio companies will compensate one or more of these service providers and vendors owned by the Company or Other Clients, including through incentive based compensation payable to their management teams and other related parties. The incentive based compensation paid with respect to a portfolio company or asset of the Company or Other Clients will vary from the incentive based compensation paid with respect to other portfolio companies and assets of the Company and Other Clients; as a result the management team or other related parties can be expected to have greater incentives with respect to certain assets and portfolio companies relative to others, and the performance of certain assets and portfolio companies can be expected to provide incentives to retain management that also service other assets and portfolio companies. Some of these service providers and vendors owned or controlled by the Company or Other Clients may charge the Company and its portfolio companies for goods and services at rates generally consistent with those available in the market for similar goods and services. The discussion regarding the determination of market rates under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212;Firm Affiliated Service Providers&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herein applies equally in respect of the fees and expenses of the portfolio company service providers, if charged at rates generally consistent with those available in the market. Other service providers and vendors owned and/or controlled by the Company or Other Clients pass through expenses on a cost reimbursement, no-profit or break-even basis, in which case the service provider allocates costs and expenses directly associated with work performed for the benefit of the Company and its portfolio companies to them, along with any related tax costs and an allocation of the service provider&#8217;s overhead, including any of the following: salaries, wages, benefits and travel expenses; marketing and advertising fees and expenses; legal, accounting and other professional fees and disbursements; office space and equipment; insurance premiums; technology expenditures, including hardware and software costs; costs to engage recruitment firms to hire employees; diligence expenses; one-time costs, including costs related to building-out and winding-down a portfolio company; costs that are of a limited </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">duration or non-recurring (such as start-up or technology build-up costs, one-time technology and systems implementation costs, employee on-boarding and severance payments, and readiness of initial public offerings and other infrastructure costs); taxes; and other operating and capital expenditures. Any of the foregoing costs (including in prior periods, such as where any such costs are amortized over an extended period), although allocated in a particular period, will, in certain circumstances, relate to activities occurring outside the period, and further will, in certain circumstances, be of a general and administrative nature that is not specifically related to particular services, and therefore the Company could pay more than its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> portion of fees for services. In addition, in certain circumstances, Blackstone also relies on the management team of a portfolio company with respect to the determination of costs and expenses and allocation thereof and does not oversee or participate in such determinations or allocations. Moreover, to the extent a portfolio company uses an allocated cost model with respect to fees, costs and expenses, such fees, costs and expenses are typically estimated and/or accrued quarterly (or on another regular periodic basis) but not finalized until year-end and as a result, such year-end true-up is subject to fluctuation and increases such that for a given year, the year-end cumulative amount with respect to fees, costs and expenses may be greater than the sum of the quarterly estimates (or other periodic estimates where applicable) and/or accruals and therefore the Company could bear more fees, costs and expenses at year-end than had been anticipated throughout the year. The allocation of overhead among the entities and assets to which services are provided can be expected to be based on any of a number of different methodologies, including, without limitation, &#8220;cost&#8221; basis as described above, &#8220;time-allocation&#8221; basis, &#8220;per unit&#8221; basis, &#8220;per square footage&#8221; basis or &#8220;fixed percentage&#8221; basis, and the particular methodology used to allocate such overhead among the entities and assets to which services are provided are expected to vary depending on the types of services provided and the applicable asset class involved, and could, in certain circumstances, change from one period to another. There can be no assurance that a different manner of allocation would result in the Company and its portfolio companies bearing less or more costs and expenses. In addition, a portfolio company that uses a &#8220;cost&#8221; basis methodology may, in certain circumstances, change its allocation methodology, for example, to charging a flat fee for a particular service or instance (or vice versa) or to another methodology described herein or otherwise, and such changes may increase or reduce the amounts received by such portfolio companies for the same services, and shareholders will not necessarily be entitled to receive notice or disclosure of such changes in allocation methodology. In certain instances, particularly where such service providers and vendors are located in Europe or Asia, such service providers and vendors will charge the Company and its portfolio companies for goods and services at cost plus a percentage of cost for transfer pricing or other tax, legal, regulatory, accounting or other reasons or even decide to amortize any costs or expenses to address accounting or operational considerations. Further, the Company and its portfolio companies may compensate one or more of these service providers and vendors owned by the Company or Other Clients through incentive-based compensation payable to their management teams and other related parties. The incentive-based compensation paid with respect to a portfolio company or asset of the Company or Other Clients will vary from the incentive based compensation paid with respect to other portfolio companies and assets of the Company and Other Clients; as a result the management team or other related parties can be expected to have greater incentives with respect to certain assets and portfolio companies relative to others, and the performance of certain assets and portfolio companies could provide incentives to retain management that also service other assets and portfolio companies. Blackstone Credit &amp; Insurance will not always perform or obtain benchmarking analysis or third-party verification of expenses with respect to services provided on a cost reimbursement, no profit or break even basis, or in respect of incentive-based compensation. There can be no assurances that amounts charged by portfolio company service providers that are not controlled by the Company or Other Clients will be consistent with market rates or that any benchmarking, verification or other analysis will be performed with respect to such charges. If benchmarking is performed, the related expenses will be borne by the Company, Other Clients and their respective portfolio companies and will not reduce the management fee. A portfolio company service provider will, in certain circumstances, subcontract certain of its responsibilities to other portfolio companies. In such circumstances, the relevant subcontractor could invoice the portfolio company for fees (or in the case of a cost reimbursement arrangement, for allocable costs and expenses) in respect of the services provided by the subcontractor. The portfolio company, if charging on a cost reimbursement, no-profit or break-even basis, would in turn allocate those costs and expenses as it allocates other fees and expenses as described above. Similarly, Other Clients, their portfolio companies and Blackstone Credit &amp; Insurance can be expected to engage portfolio companies of the Company to provide services, and these portfolio companies will generally charge for services in the same manner described above, but the Company and its portfolio companies generally will not be reimbursed for any costs (such as start-up costs or technology build-up costs) relating to such portfolio companies incurred prior to such engagement. Some of the services performed by these service providers could also be performed by Blackstone Credit &amp; Insurance from time to time and vice versa. Fees paid by the Company or its portfolio companies to these service providers do not the management fee payable to the Adviser.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where compensation paid to an affiliated service provider from the Company or its portfolio company is based on market rates, such compensation will not be based on the cost incurred by the applicable service provider and therefore will likely result in a profit to such service provider. In the event the service provider is an affiliate of Blackstone Credit &amp; Insurance, Blackstone Credit &amp; Insurance experiences a conflict of interest in determining the terms of any such engagement. There can be no assurance that an unaffiliated third party would not charge a lesser rate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Providers, Vendors and Other Counterparties Generally</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain third party advisors and other service providers and vendors or their affiliates to the Company and its portfolio companies (including accountants, administrators, paying agents, depositories, lenders, bankers, brokers, attorneys, consultants, title agents and investment or commercial banking firms) are owned by the Firm, the Company or Other Clients or provide goods or services to, or have other business, personal, financial or other relationships with, the Firm, the Other Clients and their respective portfolio companies and affiliates and personnel. Such advisors and service providers referred to above could be investors in the Company, affiliates of the Adviser, sources of financing and investment opportunities or co-investors or commercial counterparties or entities in which the Firm and/or Other Clients have an investment, and payments by the Company and/or such entities can be expected to indirectly benefit the Firm, the Other Clients and their respective portfolio companies or any affiliates or personnel. Also, advisors, lenders, investors, commercial counterparties, vendors and service providers (including any of their affiliates or personnel) to the Company and its portfolio companies could have other commercial or personal relationships with the Firm, Other Clients and their respective portfolio companies, or any affiliates, personnel or family members of personnel of the foregoing. Although the Firm selects service providers and vendors it believes are most appropriate in the circumstances based on its knowledge of such service providers and vendors (which knowledge is generally greater in the case of service providers and vendors that have other relationships to the Firm), the relationship of service providers and vendors to the Firm as described above will influence the Firm in deciding whether to select, recommend or form such an advisor or service provider to perform services for the Company, subject to applicable law, or a portfolio company, the cost of which will generally be borne directly or indirectly by the Company and can be expected to incentivize the Firm to engage such service provider over a third party, utilize the services of such service providers and vendors more frequently than would be the case absent the conflict, or to pay such service providers and vendors higher fees or commissions, resulting in higher fees and expenses being borne by the Company, than would be the case absent the conflict. The incentive could be created by current income and/or the generation of enterprise value in a service provider or vendor; the Firm can be expected to also have an incentive to invest in or create service providers and vendors to realize on these opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm has a practice of not entering into any arrangements with advisors, vendors or service providers that provide lower rates or discounts to the Firm itself compared to those it enters into on behalf of the Company and its portfolio companies for the same services. However, legal fees for unconsummated transactions are often charged at a discounted rate, such that if the Company and its portfolio companies consummate a higher percentage of transactions with a particular law firm than the Firm, the Company, Other Clients and their portfolio companies, the shareholders could indirectly pay a higher net effective rate for the services of that law firm than the Firm, the Company or Other Clients or their portfolio companies. Also, advisors, vendors and service providers often charge different rates or have different arrangements for different types of services. For example, advisors, vendors and service providers often charge fees based on the complexity of the matter as well as the expertise and time required to handle it. Therefore, to the extent the types of services used by the Company and its portfolio companies are different from those used by the Firm, Other Clients and their portfolio companies, and their affiliates and personnel, the Company and its portfolio companies can be expected to pay different amounts or rates than those paid by such other persons. Similarly, the Firm, the Company, the Other Clients and their portfolio companies and affiliates can be expected to enter into agreements or other arrangements with vendors and other similar counterparties (whether such counterparties are affiliated or unaffiliated with the Firm) from time to time whereby such counterparty will, in certain circumstances, charge lower rates (or no fee) or provide discounts or rebates for such counterparty&#8217;s products or services depending on certain factors, including without limitation the volume of transactions entered into with such counterparty by the Firm, the Company and its investment and/or portfolio companies in the aggregate or other factors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to applicable law, the Company, Other Clients and their portfolio companies are expected to enter into joint ventures with third parties to which the service providers and vendors described above will, in certain circumstances, provide services. In some of these cases, the third party joint venture partner may be permitted to negotiate to not pay its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> share of fees, costs and expenses to be allocated as described above, in which case the Company, Other Clients and their portfolio companies that also use the services of the portfolio company service provider will, directly or indirectly, pay the difference, or the portfolio company service provider will bear a loss equal to the difference.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm might, from time to time, encourage service providers to funds and investments to use, generally at market rates and/or on arm&#8217;s length terms (and/or on the basis of best execution, if applicable), the Firm-affiliated service providers in connection with the business of the Company, portfolio companies, and unaffiliated entities. This practice creates a conflict of interest because it provides an indirect benefit to the Firm in the form of added business for the Firm-affiliated service providers without any reduction to the Company&#8217;s management fee.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain portfolio companies that provide services to the Company, Other Clients and/or portfolio companies or assets of the Company and/or Other Clients could be transferred between and among the Company and/or Other Clients (where the Company may be a seller or a buyer in any such transfer) for minimal or no consideration (based on a third-party valuation confirming the same). Such transfers may give rise to actual or potential conflicts of interest for Blackstone Credit &amp; Insurance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Firm Affiliated Service Providers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s, the Firm&#8217;s and/or portfolio companies&#8217; advisers and other service providers, or their affiliates (including accountants, administrators, lenders, bankers, brokers, attorneys, consultants, and investment or commercial banking firms) also provide goods or services to, or have business, personal, financial or other relationships with, the Firm, its affiliates and portfolio companies. Such advisers and service providers (or their affiliates) may be investors in the Company, affiliates of the Firm, sources of investment opportunities, co-investors, commercial counterparties and/or portfolio companies in which the Firm and/or the Company has an investment. Accordingly, payments by the Company and/or such entities may indirectly benefit the Company and/or its affiliates, including the Firm and Other Clients. No fees charged by these service providers and vendors will reduce the management fees payable to the Adviser. Furthermore, the Firm, the Other Clients and their portfolio companies and their affiliates and related parties will use the services of these Firm affiliates, including at different rates. Although the Firm believes the services provided by its affiliates are equal or better than those of third parties, the Firm directly benefits from the engagement of these affiliates, and there is therefore an inherent conflict of interest such as those described above.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Firm has many different businesses, including the Blackstone Capital Markets Group, which Blackstone investment teams and portfolio companies can engage to provide underwriting and capital market advisory services, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would be subject if it had just one line of business. To the extent Blackstone determines appropriate, conflict mitigation strategies would be put in place with respect to a particular circumstance, such as internal information barriers or recusal, disclosure or other steps determined appropriate by the Adviser. Service providers affiliated with the Firm, which are generally expected to receive competitive market rate fees (as determined by the Adviser or its affiliates) with respect to certain investments, include:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.07pt">Aquicore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Aquicore is a cloud-based platform that tracks, analyzes and predicts key metrics in real estate, focused on the reduction of energy consumption. Blackstone holds a minority investment in Aquicore.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Equity Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Equity Healthcare LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Equity Healthcare&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is a Blackstone affiliate that negotiates with providers of standard administrative services and insurance carriers for health benefit plans and other related services for cost discounts, quality of service monitoring, data services and clinical consulting. Because of the combined purchasing power of its client participants, which include unaffiliated third parties, Equity Healthcare is able to negotiate pricing terms that are believed to be more favorable than those that the portfolio companies could obtain for themselves on an individual basis. The fees received by Equity Healthcare in connection with services provided to investments will not reduce the management fee payable by the Company.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.07pt">LNLS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lexington National Land Services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LNLS&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is a Blackstone affiliate that (i) acts as a title agent in facilitating and issuing title insurance, (ii) provides title support services for title insurance underwriters and (iii) acts as escrow agent in connection with investments by the Company, Other Clients and their portfolio companies, affiliates and related parties, and third parties. In exchange for such services LNLS earns fees which would have otherwise been paid to third parties. If LNLS is involved in a transaction in which the Company participates, Blackstone will benchmark the relevant costs to the extent market data is available except when LNLS is providing such services in a state where the insurance premium or escrow fee, as applicable, is regulated by the state or when LNLS is part of a syndicate of title insurance companies where the insurance premium is negotiated by other title insurance underwriters or their agents.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Refinitiv</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Portfolio Company Service Providers and Vendors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; above.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Blackstone acquired a 9.9% interest in Corebridge, and in connection therewith has entered into a long-term asset management partnership with certain subsidiaries and/or affiliates of Corebridge to serve as the exclusive external manager with respect to certain asset classes within their investment portfolio, for compensation. While Blackstone will not control Corebridge, the aforementioned investment in Corebridge and asset management arrangements could incentivize Blackstone to cause (and Blackstone will benefit indirectly from causing) the Company and/or its portfolio companies to engage Corebridge or its affiliates (including Corebridge Financial, Inc. and its other affiliates and subsidiaries) to provide various services and engage in other transactions and otherwise present conflicts of interests as a result of Blackstone&#8217;s interest and relationship therewith.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain Blackstone-affiliated service providers and their respective personnel will receive a management promote, an incentive fee and other performance-based compensation in respect of investments, sales or other transaction volume. Furthermore, Blackstone-affiliated service providers can be expected to charge costs and expenses based on allocable overhead associated with personnel working on relevant matters (including salaries, benefits and other similar expenses).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with such relationships, Blackstone Credit &amp; Insurance and, if required by applicable law, the Board of Trustees, will make determinations of competitive market rates based on its consideration of a number of factors, which are generally expected to include Blackstone Credit &amp; Insurance&#8217;s experience with non-affiliated service providers, benchmarking data and other methodologies determined by Blackstone Credit &amp; Insurance to be appropriate under the circumstances (i.e., rates that fall within a range that Blackstone Credit &amp; Insurance has determined is reflective of rates in the applicable market and certain similar markets, though not necessarily equal to or lower than the median rate of comparable firms and in certain circumstances, is expected to be in the top of the range). In respect of benchmarking, while Blackstone Credit &amp; Insurance often obtains benchmarking data regarding the rates charged or quoted by third parties for services similar to those provided by Blackstone Credit &amp; Insurance affiliates in the applicable market or certain similar markets, relevant comparisons would not be available for a number of reasons, including, without limitation, as a result of a lack of a substantial market of providers or users of such services or the confidential or bespoke nature of such services (e.g., different assets could receive different services). In addition, benchmarking data is based on general market and broad industry overviews, rather than determined on an asset by asset basis. As a result, benchmarking data does not take into account specific characteristics of individual assets then invested in by the Company (such as location or size), or the particular characteristics of services provided. Further, it could be difficult to identify comparable third-party service providers that provide services of a similar scope and scale as the Firm-affiliated service providers that are the subject of the benchmarking analysis or to obtain detailed information about pricing of a service comparable to that being provided to the Company from third-party service providers if such service providers anticipate that Blackstone will not in fact engage their services. For these reasons, such market comparisons would not necessarily result in precise market terms for comparable services. Expenses to obtain benchmarking data will be borne by the Company, Other Clients and their respective portfolio companies and will not reduce the management fee. Finally, in certain circumstances Blackstone Credit &amp; Insurance may determine that third party benchmarking is unnecessary, including in circumstances where the price for a particular good or service is mandated by law (e.g., title insurance in rate regulated states) or because in Blackstone Credit &amp; Insurance&#8217;s view no comparable service provider offering such good or service (or an insufficient number of comparable service providers for a reasonable comparison) exists or because Blackstone Credit &amp; Insurance has access to adequate market data (including from third party clients of the Firm-affiliated service provider that is the subject of the benchmarking analysis) to make the determination without reference to third party benchmarking. For example, in certain circumstances a Firm-affiliated service provider or a portfolio company service provider could provide services to third parties, in which case if the rates charged to such third parties are consistent with the rates charged to the Company, Other Clients and their respective portfolio companies, then a separate benchmarking analysis of such rates is not expected to be prepared. Some of the services performed by Firm-affiliated service providers could also be performed by the Firm from time to time and vice versa. Fees paid by the Company or its portfolio companies to or value created in Firm affiliated service providers or vendors do not reduce the management fee. These conflicts related to Firm-affiliated service providers will not necessarily be resolved in favor of the Company, and shareholders might not be entitled to receive notice or disclosure of the occurrence of these conflicts.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advisers and service providers, or their affiliates, often charge different rates, including below-market or no fee, or have different arrangements for different types of services. With respect to service providers, for example, the fee for a given type of work could vary depending on the complexity of the matter as well as the expertise required and demands placed on the service provider. Therefore, to the extent the types of services used by the Company and/or portfolio companies differ from those used by the Firm and its affiliates (including personnel), Blackstone Credit &amp; Insurance and/or Blackstone or their respective affiliates (including personnel) potentially will pay different amounts or rates than those paid by the Company and/or portfolio companies. However, Blackstone Credit &amp; Insurance and its affiliates have a longstanding practice of not entering into any arrangements with advisers or service providers that could provide for lower rates or discounts than those available to the Company, Other Clients and/or portfolio companies for the same services. Furthermore, it is possible that certain advisers and service providers will provide services exclusively to the Firm and its affiliates, including the Company, Other Clients and their portfolio companies, although such advisers and service providers would not be considered employees of Blackstone or Blackstone Credit &amp; Insurance. Similarly, Blackstone, Blackstone Credit &amp; Insurance, each of their respective affiliates, the Company, the Other Clients and/or their portfolio companies, can enter into agreements or other arrangements with vendors and other similar counterparties (whether such counterparties are affiliated or unaffiliated with the Firm) from time to time whereby such counterparty would charge lower rates (or no fee) and/or provide discounts or rebates for such counterparty&#8217;s products and/or services depending on certain factors, including volume of transactions entered into with such counterparty by the Firm, its affiliates, the Company, the Other Clients and their portfolio companies in the aggregate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, investment banks or other financial institutions, as well as certain Blackstone employees, are expected to also be investors in the Company. These institutions and employees are a potential source of information and ideas that could benefit the Company. Blackstone has procedures in place reasonably designed to prevent the inappropriate use of such information by the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transactions with Portfolio Companies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm and portfolio companies of the Company and Other Clients operate in multiple industries and provide products and services to or otherwise contract with the Company and its portfolio companies, among others. In the alternative, the Firm could form a joint venture with such a company to implement such referral arrangement. For example, such arrangements could include the establishment of a joint venture or other business arrangement between the Firm, on the one hand, and a portfolio company of the Company, portfolio company of an Other Client or third party, on the other hand, pursuant to which the joint venture or business provides services (including, without limitation, corporate support services, loan management services, management services, operational services, ongoing account services (e.g., interacting and coordinating with banks generally and with regard to their know your client requirements), risk management services, data management services, consulting services, brokerage services, sustainability and clean energy consulting services, insurance procurement, placement, brokerage and consulting services, and other services) to portfolio companies of the Company (and portfolio companies of Other Clients) that are referred to the joint venture or business by the Firm. The Firm, the Company and Other Clients and their respective portfolio companies and personnel and related parties of the foregoing can be expected to make referrals or introductions to the Company or portfolio companies of the Company or Other Clients in an effort, in part, to increase the customer base of such companies or businesses (and therefore the value of the investment held by the Company or Other Client, which would also benefit the Firm financially through its participation in such joint venture or business) or because such referrals or introductions will, in certain circumstances, result in financial benefits, such as cash payments, additional equity ownership, participation in revenue share and/or milestones benefiting the referring or introducing party that are tied or related to participation by the portfolio companies of the Company and/or of Other Clients, accruing to the party making the introduction. Such joint venture or business could use data obtained from such portfolio companies (see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Data&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">elsewhere herein). Furthermore, such introductions or referrals could involve the transfer of certain personnel or employees among Blackstone and the Company&#8217;s portfolio companies and Other Clients which might result in a termination fee or similar payments being due and payable from one such entity to another. The Company and the shareholders typically will not share in any fees, economics, equity or other benefits accruing to the Firm, Other Clients and their portfolio companies as a result of the introduction of the Company and its portfolio companies. Moreover, payments made to the Firm in connection with such arrangements will not reduce the management fee payable to the Adviser. There could, however, be instances in which the applicable arrangements provide that the Company or its portfolio companies share in some or all of any resulting financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) based on structures and allocation methodologies determined in the sole discretion of the Firm. Conversely, where the Company or one of its portfolio companies is the referring or introducing party, rather than receiving all of the financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) for similar types of referrals and/or introductions, such financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) could be similarly shared with the participating Other Clients or their respective portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm is also permitted to enter into commercial relationships with third party companies, including those in which the Company considered making an investment (but ultimately chose not to pursue). For example, the Firm could enter into an introducer engagement with such company, pursuant to which the Firm introduces the company to unaffiliated third parties (which can include current and former portfolio companies and portfolio companies of Other Clients and/or their respective employees) in exchange for a fee from, or equity interest in, such company. Even though the Firm could benefit financially from this commercial relationship, the Firm will be under no obligation to reimburse the Company for Broken Deal Expenses incurred in connection with its consideration of the prospective investment and such arrangements will not be subject to the management fee payable to the Adviser and otherwise described herein.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Firm or an affiliate thereof will from time to time hold equity or other investments in companies or businesses (even if they are not &#8220;affiliates&#8221; of the Firm) that provide services to or otherwise contract with portfolio companies. Blackstone and Blackstone Credit &amp; Insurance have in the past entered (and can be expected in the future to enter) into relationships with companies in the information technology, corporate services and related industries whereby Blackstone acquires an equity or similar interest in such company. In connection with such relationships, Blackstone and/or Blackstone Credit &amp; Insurance reserves the right to also make referrals and/or introductions to portfolio companies (which could result in financial incentives (including additional equity ownership) and/or milestones benefitting Blackstone and/or Blackstone Credit &amp; Insurance that are tied or related to participation by portfolio companies). Such joint venture or business could use data obtained from portfolio companies of the Company and/or portfolio companies of Other Clients. These arrangements are expected to be entered into without the consent or direct involvement of the Company. The Company and the shareholders will not share in any fees or economics accruing to Blackstone and/or Blackstone Credit &amp; Insurance as a result of these relationships and/or participation by portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to transactions or agreements with portfolio companies (including, for the avoidance of doubt, long-term incentive plans), at times if officers unrelated to the Firm have not yet been appointed to represent a portfolio company, the Firm is permitted to negotiate and execute agreements between the Firm and/or the Company on the one hand, and the portfolio company or its affiliates, on the other hand, without arm&#8217;s length representation of the portfolio company, which could entail a conflict of interest in relation to efforts to enter into terms that are arm&#8217;s length. Among the measures the Firm can be expected to use to mitigate such conflicts are to involve outside counsel to review and advise on such agreements and provide insights into commercially reasonable terms, or establish separate groups with information barriers within the Firm to advise on each side of the negotiation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Leasing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to applicable law, the Company and its portfolio companies may lease property to or from Blackstone, Other Clients and their portfolio companies and affiliates and other related parties. The leases are generally expected to, but might not always, be at market rates. Blackstone can be expected to confirm market rates by reference to other leases it is aware of in the market, which Blackstone expects to be generally indicative of the market given the scale of Blackstone&#8217;s real estate business. Blackstone can be expected to, but might not always, nonetheless have conflicts of interest in making these determinations, and with regard to other decisions related to such assets and investments. There can be no assurance that the Company and its portfolio companies will lease to or from any such related parties on terms as favorable to the Company and its portfolio companies as would apply if the counterparties were unrelated.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-Guarantees and Cross-Collateralization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. While Blackstone Credit &amp; Insurance generally seeks to use reasonable efforts to avoid cross-guarantees and other similar arrangements, a counterparty, lender or other participant in any transaction to be pursued by the Company other than alternative investment vehicles and/or the Other Clients could require or prefer facing only one fund entity or group of entities, which can result in any of the Company, such Other Clients, the portfolio companies, such Other Clients&#8217; portfolio companies and/or other vehicles being jointly and severally liable for such applicable obligation (subject to any limitations set forth in the applicable governing documents thereof), which in each case could result in the Company, such Other Clients, such portfolio companies and portfolio companies, and/or vehicles entering into a back-to-back or other similar reimbursement agreement, subject to applicable law. In such situation, better financing terms could be available through a cross-collateralized arrangement, but it is not expected that any of the Company or such Other Clients or vehicles would be compensated (or provide compensation to the other) for being primarily liable vis-&#224;-vis such third party counterparty. Also, it is expected that cross-collateralization will generally occur at portfolio companies rather than the Company for obligations that are not recourse to the Company except in limited circumstances such as &#8220;bad boy&#8221; events. Any cross-collateralization arrangements with Other Clients could result in the Company losing its interests in otherwise performing investments due to poorly performing or non-performing investments of Other Clients in the collateral pool.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, a lender could require that it face only one portfolio company of the Company and Other Clients, even though multiple portfolio companies of the Company and Other Clients benefit from the lending, which will typically result in (i) the portfolio company facing the lender being solely liable with respect to the entire obligation, and therefore being required to contribute amounts in respect of the shortfall attributable to other portfolio companies, and (ii) portfolio companies of the Company and Other Clients being jointly and severally liable for the full amount of the obligation, liable on a cross-collateralized basis or liable for an equity cushion (which cushion amount can vary depending upon the type of financing or refinancing (e.g., cushions for refinancings could be smaller)). The portfolio companies of the Company and Other Clients benefiting from a financing may enter into a back-to-back or other similar reimbursement agreements whereby each agrees that no portfolio company bears more than its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> portion of the debt and related obligations. It is not expected that the portfolio companies would be compensated (or provide compensation to other portfolio companies) for being primarily liable, or jointly liable, for other portfolio companies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> share of any financing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint Venture Partners</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company will from time to time enter into one or more joint venture arrangements with third party joint venture partners. Investments made with joint venture partners will often involve performance-based compensation and other fees payable to such joint venture partners, as determined by the Adviser in its sole discretion. The joint venture partners could provide services similar to those provided by the Adviser to the Company. Yet, no compensation or fees paid to the joint venture partners would reduce the management fees payable by the Company. Additional conflicts would arise if a joint venture partner is related to the Firm in any way, such as a limited partner investor in, lender to, a shareholder of, or a service provider to the Firm, the Company, Other Clients, or their respective portfolio companies, or any affiliate, personnel, officer or agent of any of the foregoing.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Group Procurement; Discounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company, subject to applicable law, and certain portfolio companies will enter into agreements regarding group procurement (including, but not limited to, CoreTrust, an independent group purchasing organization), benefits management, purchase of title and/or other insurance policies (which can be expected to include brokerage and/or placement thereof, and will from time to time be pooled across portfolio companies and discounted due to scale, including through sharing of deductibles and other forms of shared risk retention) from a third party or an affiliate of Blackstone Credit &amp; Insurance and/or Blackstone, and other operational, administrative or management related initiatives. The Firm will allocate the cost of these various services and products purchased on a group basis among the Company, Other Clients and their portfolio companies. Some of these arrangements result in commissions, discounts, rebates or similar payments to Blackstone Credit &amp; Insurance and/or Blackstone or their affiliates (including personnel), or Other Clients and their portfolio companies, including as a result of transactions entered into by the Company and its portfolio companies and/or related to a portion of the savings achieved by the portfolio companies. Such commissions or payment will not reduce the management fee. The Firm can be expected to also receive consulting, usage or other fees from the parties to these group procurement arrangements. To the extent that a portfolio company of an Other Client is providing such a service, such portfolio company and such Other Client will benefit. Further, the benefits received by a particular portfolio company providing the service could be greater than those received by the Company and its portfolio companies receiving the service. Conflicts exist in the allocation of the costs and benefits of these arrangements, and shareholders rely on the Adviser to handle them in its sole discretion.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diverse Shareholder Group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s shareholders are expected to be based in a wide variety of jurisdictions and take a wide variety of forms. The shareholders may have conflicting investment, tax and other interests with respect to their investments in the Company and with respect to the interests of investors in other investment vehicles managed or advised by the Adviser and Blackstone Credit &amp; Insurance that may participate in the same investments as the Company. The conflicting interests of individual shareholders with respect to other shareholders and relative to investors in other investment vehicles would generally relate to or arise from, among other things, the nature of investments made by the Company and such other partnerships, the structuring or the acquisition of investments and the timing of disposition of investments. As a consequence, conflicts of interest may arise in connection with the decisions made by the Adviser or Blackstone Credit &amp; Insurance, including with respect to the nature or structuring of investments that may be more beneficial for one investor than for another investor, especially with respect to investors&#8217; individual tax situations. In addition, the Company may make investments that may have a negative impact on related investments made by the shareholders in separate transactions, such as credit investments that, by consequence of the exercise of remedies related to such investments, adversely impact equity-like investments in respect of those same issuers. In selecting and structuring investments appropriate for the Company, the Adviser or Blackstone Credit &amp; Insurance will consider the investment and tax objectives of the Company and the shareholders (and those of investors in other investment vehicles managed or advised by the Adviser or Blackstone Credit &amp; Insurance) as a whole, not the investment, tax or other objectives of any shareholder individually.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain shareholders also may be investors in Other Clients, including supplemental capital vehicles and co-investment vehicles that invest alongside the Company in one or more investments, consistent with applicable law and/or any applicable SEC-granted order. Shareholders also might include affiliates of the Firm, such as Other Clients, affiliates of portfolio companies of the Company or Other Clients, charities, foundations or other entities or programs associated with Firm personnel and/or current or former Firm employees, the Firm&#8217;s senior advisors and/or operating partners and any affiliates, funds or persons may also invest in the Company through the vehicles established in connection with the Firm&#8217;s side-by-side co-investment rights, subject to applicable law, in each case, without being subject to management fees, and shareholders will not be afforded the benefits of such arrangements. Some of the foregoing Firm related parties are sponsors of feeder vehicles that could invest in the Company as shareholders. The Firm related sponsors of feeder vehicles generally charge their investors additional fees, including performance based fees, which could provide the Firm current income and increase the value of its ownership position in them. The Firm will therefore have incentives to refer potential investors to these feeder vehicles. All of these Firm related shareholders will have equivalent rights to vote and withhold consents as nonrelated shareholders. Nonetheless, the Firm could have the ability to influence, directly or indirectly, these Firm related shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is also possible that the Company or its portfolio companies will be a counterparty (such counterparties dealt with on an arm&#8217;s-length basis) or participant in agreements, transactions or other arrangements with a shareholder or an affiliate of a shareholder. Such transactions may include agreements to pay performance fees to operating partners, a management team and other related persons in connection with the Company&#8217;s investment therein, which will reduce the Company&#8217;s returns. Such shareholders described in the previous sentences may therefore have different information about the Firm and the Company than shareholders not similarly positioned. In addition, conflicts of interest may arise in dealing with any such shareholders, and the Adviser and its affiliates may not be motivated to act solely in accordance with its interests relating to the Company. Similar information disparity may occur as a result of shareholders monitoring their investments in vehicles such as the Company differently. For example, certain shareholders may periodically request from the Adviser information regarding the Company, its investments and/or portfolio companies that is not otherwise set forth in (or has yet to be set forth) in the reporting and other information required to be delivered to all shareholders. In such circumstances, the Adviser may provide such information to such shareholders, subject to applicable law and regulations. Unless required by applicable law, the Adviser will not be obligated to affirmatively provide such information to all shareholders (although the Adviser will generally provide the same information upon request and treat shareholders equally in that regard). As a result, certain shareholders may have more information about the Company than other shareholders, and, unless required by applicable law, the Adviser will have no duty to ensure all shareholders seek, obtain or process the same information regarding the Company, its investments and/or portfolio companies. Therefore, certain shareholders may be able to take actions on the basis of such information which, in the absence of such information, other shareholders do not take. Furthermore, at certain times the Firm may be restricted from disclosing to the shareholders material non-public information regarding any assets in which the Company invests, particularly those investments in which an Other Client or portfolio company that is publicly registered co-invests with the Company. In addition, investment banks or other financial institutions, as well as Firm personnel, may also be shareholders. These institutions and personnel are a potential source of information and ideas that could benefit the Company, and may receive information about the Company and its portfolio companies in their capacity as a service provider or vendor to the Company and its portfolio companies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Possible Future Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Firm and its affiliates are expected to expand the range of services that it provides over time. Except as provided herein, the Firm and its affiliates will not be restricted in the scope of its business or in the performance of any such services (whether now offered or undertaken in the future) even if such activities could give rise to conflicts of interest, and whether or not such conflicts are described herein. The Firm and its affiliates have, and will continue to develop, relationships with a significant number of companies, financial sponsors and their senior managers, including relationships with clients who might hold or might have held investments similar to those intended to be made by the Company. These clients could themselves represent appropriate investment opportunities for the Company or could compete with the Company for investment opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restrictions Arising under the Securities Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Firm&#8217;s activities and the activities of Other Clients (including the holding of securities positions or having one of its employees on the board of directors of a portfolio company) could result in securities law restrictions on transactions in securities held by the Company, affect the prices of such securities or the ability of such entities to purchase, retain or dispose of such investments, or otherwise create conflicts of interest, any of which could have an adverse impact on the performance of the Company and thus the return to the shareholders.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 1940 Act may limit the Company&#8217;s ability to undertake certain transactions with or alongside its affiliates that are registered under the 1940 Act. As a result of these restrictions, the Company may be prohibited from executing &#8220;joint&#8221; transactions with the Company&#8217;s 1940 Act registered affiliates, which could include investments in the same portfolio company (whether at the same or different times) or buying investments from, or selling them to, Other Clients. These limitations have the potential to limit the scope of investment opportunities that would otherwise be available to the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders&#8217; Outside Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A shareholder shall be entitled to and can be expected to have business interests and engage in activities in addition to those relating to the Company, including business interests and activities in direct competition with the Company and its portfolio companies, and can engage in transactions with, and provide services to, the Company or its portfolio companies (which will, in certain circumstances, include providing leverage or other financing to the Company or its portfolio companies as determined by the Adviser in its sole discretion). None of the Company, any shareholder or any other person shall have any rights by virtue of the Company&#8217;s operative documents or any related agreements in any business ventures of any shareholder. The shareholder, and in certain cases the Adviser, will have conflicting loyalties in these situations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser will cause the Company to purchase, and/or bear premiums, fees, costs and expenses (including any expenses or fees of insurance brokers) for insurance to insure the Company and the Board of Trustees against liability in connection with the activities of the Company. This includes a portion of any premiums, fees, costs and expenses for one or more &#8220;umbrella,&#8221; group or other insurance policies maintained by the Firm that cover the Company and one or more of the Other Clients, the Adviser, Blackstone Credit &amp; Insurance and/or Blackstone (including their respective directors, officers, employees, agents, representatives, independent client representative (if any) and other indemnified parties). The Adviser will make judgments about the allocation of premiums, fees, costs and expenses for such &#8220;umbrella,&#8221; group or other insurance policies among the Company, one or more Other Clients, the Adviser, Blackstone Credit &amp; Insurance and/or Blackstone on a fair and reasonable basis, subject to approval by the Board of Trustees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technological and Scientific Innovations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recent technological and scientific innovations have disrupted numerous established industries and those with incumbent power in them.&#160;As technological and scientific innovation continues to advance rapidly, it could impact one or more of the Company&#8217;s strategies.&#160;Moreover, given the pace of innovation in recent years, the impact on a particular portfolio company might not have been foreseeable at the time the Company made such investment and could adversely impact the Company and/or its portfolio companies. Furthermore, Blackstone Credit &amp; Insurance could base investment decisions on views about the direction or degree of innovation that prove inaccurate and lead to losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Potential Conflicts of Interest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The officers, directors, members, managers, employees and personnel of the Adviser may trade in securities for their own accounts, subject to restrictions and reporting requirements as may be required by law or the Firm&#8217;s policies, or otherwise determined from time to time by the Adviser. In addition, certain Other Clients may be subject to the 1940 Act or other regulations that, due to the role of the Firm, could restrict the ability of the Company to buy investments from, to sell investments to or to invest in the same securities as, such Other Clients. Such regulations may have the effect of limiting the investment opportunities available to the Company. In addition, as a consequence of Blackstone&#8217;s status as a public company, the officers, directors, members, managers and personnel of the Adviser may take into account certain considerations and other factors in connection with the management of the business and affairs of the Company and its affiliates that would not necessarily be taken into account if Blackstone were not a public company. The directors of Blackstone have fiduciary duties to shareholders of the public company that may conflict with their duties to the Company. Finally, although the Firm believes its positive reputation in the marketplace provides benefit to the Company and Other Clients, the Adviser could decline to undertake investment activity or transact with a counterparty on behalf of the Company for reputational reasons, and this decision could result in the Company foregoing a profit or suffering a loss.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2023NotesMember', window );">2023 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 400.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,802<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2026NotesMember', window );">2026 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="nump">$ 800.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800.0<span></span>
</td>
<td class="nump">$ 800.0<span></span>
</td>
<td class="nump">$ 800.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,802<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_New2026NotesMember', window );">New 2026 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="nump">$ 700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700.0<span></span>
</td>
<td class="nump">$ 700.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,802<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2027NotesMember', window );">2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="nump">$ 650.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650.0<span></span>
</td>
<td class="nump">$ 650.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,802<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2028NotesMember', window );">2028 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="nump">$ 650.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650.0<span></span>
</td>
<td class="nump">$ 650.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,802<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityMember', window );">Jackson Hole Funding Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="nump">$ 233.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 360.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 361.0<span></span>
</td>
<td class="nump">$ 233.0<span></span>
</td>
<td class="nump">$ 362.3<span></span>
</td>
<td class="nump">$ 514.2<span></span>
</td>
<td class="nump">$ 120.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,802<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 2,151<span></span>
</td>
<td class="nump">$ 2,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_BreckenridgeFundingFacilityMember', window );">Breckenridge Funding Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="nump">$ 741.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 825.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 568.7<span></span>
</td>
<td class="nump">$ 741.7<span></span>
</td>
<td class="nump">$ 569.0<span></span>
</td>
<td class="nump">$ 820.3<span></span>
</td>
<td class="nump">$ 65.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,802<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 2,151<span></span>
</td>
<td class="nump">$ 2,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_BigSkyFundingFacilityMember', window );">Big Sky Funding Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="nump">$ 480.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 499.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 499.6<span></span>
</td>
<td class="nump">$ 480.9<span></span>
</td>
<td class="nump">$ 200.3<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,802<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_SubscriptionFacilityMember', window );">Subscription Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 119.8<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,151<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="nump">$ 682.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 678.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 915.0<span></span>
</td>
<td class="nump">$ 682.3<span></span>
</td>
<td class="nump">$ 182.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,802<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_EffectsOfLeveragePurposeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_EffectsOfLeveragePurposeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_EffectsOfLeverageTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_EffectsOfLeverageTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_EffectsOfLeverageTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_EffectsOfLeverageTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FinancialHighlightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FinancialHighlightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InvestmentObjectivesAndPracticesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 2<br> -Paragraph b, d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InvestmentObjectivesAndPracticesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtMinusFivePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtMinusFivePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtMinusTenPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtMinusTenPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtPlusFivePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtPlusFivePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtPlusTenPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtPlusTenPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtZeroPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtZeroPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskFactorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskFactorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesCvgPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br> -Paragraph 3<br> -Subparagraph Instruction 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesCvgPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SharePriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SharePriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 54B<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-54B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 59<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-59<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6A<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_AbilityToAchieveInvestmentObjectivesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_AbilityToAchieveInvestmentObjectivesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayInvestThroughVariousJointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayInvestThroughVariousJointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayDefaultUnderOurCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayDefaultUnderOurCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2023NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2023NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2026NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2026NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_New2026NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_New2026NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2028NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2028NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_BreckenridgeFundingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_BreckenridgeFundingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_BigSkyFundingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_BigSkyFundingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_SubscriptionFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_SubscriptionFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140170881895696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;GAAP&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and pursuant to the requirements for reporting on Form 10-K and Article 6 of Regulation S-X. As an investment company, the Company applies the accounting and reporting guidance in Accounting Standards Codification (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ASC&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Topic 946, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Services &#8211; Investment Companies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ASC 946&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) issued by the Financial Accounting Standards Board (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;FASB&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, all adjustments considered necessary for the fair presentation of the consolidated financial statements for the periods presented have been included.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intercompany balances and transactions have been eliminated.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period information has been reclassified to conform to the current period presentation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Such amounts could differ from those estimates and such differences could be material.&#160;Assumptions and estimates regarding the valuation of investments involve a higher degree of judgment and complexity and these assumptions and estimates may be significant to the consolidated financial statements. Actual results may ultimately differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Consolidation</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As provided under ASC 946, the Company will not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidated the results of the Company&#8217;s wholly-owned subsidiaries which are considered to be investment companies.&#160;As of December&#160;31, 2023, the Company's consolidated subsidiaries were BGSL Jackson Hole Funding LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Jackson Hole Funding&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), BGSL Breckenridge Funding LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Breckenridge Funding&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), BGSL Big Sky Funding LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Big Sky Funding&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), BGSL Investments LLC (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;BGSL Investments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), BXSL Associates GP (Lux) S.&#224; r.l, BXSL Direct Lending (Lux) SCSp, BXSL C-1 LLC, and BXSL C-2 Funding LLC.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of demand deposits and highly liquid investments, such as money market funds, with original maturities of three months or less. Cash and cash equivalents are carried at cost, which approximates fair value. The Company deposits its cash and cash equivalents with financial institutions and, at times, may exceed the Federal Deposit Insurance Corporation insured limit.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments/Receivables/Payables From Investments Sold/Purchased</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment transactions are recorded on a trade date basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gains or losses are measured by the difference between the net proceeds received (excluding prepayment fees, if any) and the amortized cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include investments charged off during the period, net of recoveries, and is recorded within Net realized gain (loss) on the Consolidated Statements of Operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in unrealized gains or losses primarily reflects the change in investment values, including the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period, and is recorded within Net change in unrealized appreciation (depreciation) on the Consolidated Statements of Operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of Investments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to report its investments, including those for which current market values are not readily available, at fair value.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company values its investments in accordance with ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;ASC 820&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the applicable measurement date, and Rule 2a-5 under the 1940 Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on observable market prices or parameters or derived from such prices or parameters when such quotations are readily available.&#160;In accordance with&#160;Rule 2a-5 under the 1940 Act, a market quotation is &#8220;readily available&#8221; only when it is a quoted price (unadjusted) in active markets for identical instruments that a fund can access at the measurement date, provided that such a quotation is not considered to be readily available if it is not reliable.&#160;The Company utilizes mid-market pricing (i.e., mid-point of average bid and ask prices) to value these investments.&#160;These market quotations are obtained from independent pricing services, if available; otherwise generally from at least two principal market makers or primary market dealers.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where prices or inputs are not available or, in the judgment of the Board, not reliable, valuation techniques based on the facts and circumstances of the particular investment will be utilized. These valuation approaches involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments&#8217; complexity. In the absence of observable, reliable market prices, the Company values its investments using various valuation methodologies applied on a consistent basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An enterprise value (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;EV&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) analysis is generally performed to determine the value of equity investments, control debt investments and non-control debt investments that are credit-impaired, and to determine if debt investments are credit impaired. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Adviser will generally utilize approaches including the market approach, the income approach or both approaches, as appropriate, when calculating EV.&#160;The primary method for determining EV for non-control investments, and control investments without reliable projections, uses a multiple analysis whereby appropriate multiples are applied to the portfolio company&#8217;s earnings before interest, taxes, depreciation and amortization (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;EBITDA&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or another key financial metric (e.g., such as revenues, cash flows or net income) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Performance Multiple&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).&#160;Performance Multiples are typically determined based upon a review of publicly traded comparable companies and market comparable transactions, if any.&#160;The second method for determining EV (and primary method for control investments with reliable projections) uses a discounted cash flow analysis whereby future expected cash flows and the anticipated terminal value of the portfolio company are discounted to determine a present value using estimated discount rates.&#160;The income approach is generally used when the Adviser has visibility into the long term projected cash flows of a portfolio company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If debt investments are credit-impaired, which occurs when there is insufficient coverage under the enterprise value analysis through the respective investment&#8217;s position in the capital structure, the Adviser generally uses the enterprise value &#8220;waterfall&#8221; approach or a recovery method (if a liquidation or restructuring is deemed likely) to determine fair value. For debt investments that are not determined to be credit-impaired, the Adviser generally uses a market interest rate yield analysis to determine fair value. To determine fair value using a yield analysis, the expected cash flows are projected based on the contractual terms of the debt security and discounted back to the measurement date based on a market yield.&#160;A market yield is determined based upon an assessment of current and expected market yields for similar investments and risk profiles.&#160;The Company considers the current contractual interest rate, the maturity and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the enterprise value of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, the Company depends on primary market data, including newly funded transactions, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable.&#160;The fair value of loans with call protection is generally capped at par plus applicable prepayment premium in effect at the measurement date.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820 prioritizes the use of observable market prices derived from such prices. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The levels used for classifying investments are not necessarily an indication of the risk associated with investing in these securities. The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 1:&#160;Inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date. The types of financial instruments included in Level 1 include unrestricted securities, including equities and derivatives, listed in active markets.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 2:&#160;Inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. The types of financial instruments in this category include less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities and certain over-the-counter derivatives where the fair value is based on observable inputs.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 3:&#160;Inputs to the valuation methodology are unobservable and significant to overall fair value measurement. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in this category include debt and equity investments in privately held entities, collateralized loan obligations (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;CLOs&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and certain over-the-counter derivatives where the fair value is based on unobservable inputs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment&#8217;s level within the fair value hierarchy is based on the lowest level of input that is significant to the overall fair value measurement. The Adviser&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.&#160;Transfers between levels, if any, are recognized at the beginning of the quarter in which the transfer occurs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the source of the inputs, including any markets in which its investments are trading (or any markets in which securities with similar attributes are trading), in determining fair value. When an investment is valued based on prices provided by reputable dealers or pricing services (that is, broker quotes), the Company subjects those prices to various criteria in making the determination as to whether a particular investment would qualify for treatment as a Level 2 or Level 3 investment.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company&#8217;s investments may fluctuate from period to period, and these differences could be material. Additionally, the fair value of the Company&#8217;s investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that the Company may ultimately realize. Further, such investments are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If the Company was required to liquidate a portfolio investment in a forced or liquidation sale, it could realize significantly less than the value at which the Company has recorded it. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected in the valuations currently assigned.&#160;See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations&#8212;Critical Accounting Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables/Payables From Investments Sold/Purchased</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables/payables from investments sold/purchased consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Instruments/Forward Purchase Agreement</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes all derivative instruments as assets or liabilities at fair value in its consolidated financial statements. Derivative contracts entered into by the Company are not designated in hedge accounting relationships and all changes in fair value are recognized through current period gains or losses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company has commitments and risks resulting from its investment transactions, which may include those involving derivative instruments. Derivative instruments are measured in terms of the notional contract amount and derive their value based upon one or more underlying instruments. While the notional amount gives some indication of the Company&#8217;s derivative activity, it generally is not exchanged, but is only used as the basis on which interest and other payments are exchanged. Derivative instruments are subject to various risks similar to non-derivative instruments including market, credit, liquidity, and operational risks. The Company manages these risks on an aggregate basis as part of its risk management process.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Purchase Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward purchase agreements are recognized at fair value through current period gains or losses on the date on which the contract is entered into and are subsequently re-measured at fair value. All forward purchase agreements are carried as assets when fair value is positive and as liabilities when fair value is negative.&#160;A forward purchase agreement is derecognized when the obligation specified in the contract is discharged, canceled or expired.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Transactions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts denominated in foreign currencies are translated into U.S. dollars on the following basis: (i)&#160;investments and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates effective on the last business day of the period; and (ii)&#160;purchases and sales of investments, borrowings and repayments of such borrowings, income, and expenses denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates prevailing on the transaction dates.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes net changes in fair values on investments held resulting from foreign exchange rate fluctuations in Translation of assets and liabilities in foreign currencies on the Consolidated Statements of Operations, if any. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign security and currency translations may involve certain considerations and risks not typically associated with investing in U.S. companies and U.S. government securities. These risks include, but are not limited to, currency fluctuations and revaluations and future adverse political, social and economic developments, which could cause investments in foreign markets to be less liquid and prices more volatile than those of comparable U.S. companies or U.S. government securities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income is recorded on an accrual basis and includes the accretion of discounts and amortizations of premiums.&#160;Discounts from and premiums to par value on debt investments purchased are accreted/amortized into interest income over the life of the respective security using the effective interest method.&#160;The amortized cost of debt investments represents the original cost, including loan origination fees and upfront fees received that are deemed to be an adjustment to yield, adjusted for the accretion of discounts and amortization of premiums, if any.&#160;Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income in the current period. For the years ended December&#160;31, 2023, 2022 and 2021 the Company recorded $19.3 million, $4.9 million and $60.9 million, respectively, in non-recurring interest income (e.g., prepayment premiums, accelerated accretion of upfront loan origination fees and unamortized discounts). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PIK Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has loans in its portfolio that contain payment-in-kind (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;PIK&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) provisions.&#160;PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity.&#160;Such income is included in payment-in-kind interest income in the Consolidated Statements of Operations.&#160;If at any point the Company believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status.&#160;When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through payment-in-kind interest income.&#160;To satisfy the Company&#8217;s annual RIC distribution requirements, this non-cash source of income must be included in determining the amounts to be paid out to shareholders in the form of dividends, even though the Company has not yet collected cash.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend income on preferred equity securities is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fee Income</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may receive various fees in the ordinary course of business such as structuring, consent, waiver, amendment, syndication and other miscellaneous fees as well as fees for managerial assistance rendered by the Company to the portfolio companies.&#160;Such fees are recognized as income when earned or the services are rendered.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Accrual Income</span></div>Loans are generally placed on non-accrual status when there is reasonable doubt whether principal or interest will be collected in full.&#160;Accrued interest is generally reversed when a loan is placed on non-accrual status. Additionally, any original issue discount and market discount are no longer accreted to interest income as of the date the loan is placed on non-accrual status.&#160;Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management&#8217;s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management&#8217;s judgment, are likely to remain current. Management may make exceptions to this treatment and&#160;determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Organization Expenses and Offering Expenses</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Organization Expenses and Offering Expenses</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Deferred Financing Costs and Debt Issuance Costs</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Financing Costs and Debt Issuance Costs</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred financing and debt issuance costs represent fees and other direct incremental costs incurred in connection with the Company&#8217;s borrowings.&#160;These expenses are deferred and amortized into interest expense over the life of the related debt instrument. Deferred financing costs related to revolving credit facilities are presented separately as an asset on the Company&#8217;s Consolidated Statements of Assets and Liabilities.&#160;Debt issuance costs related to any issuance of installment debt or notes are presented net against the outstanding debt balance of the related security.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to be treated as a BDC under the 1940 Act.&#160;The Company also has elected to be treated as a RIC under the Code.&#160;So long as the Company maintains its status as a RIC, it generally will not pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that it distributes at least annually to its shareholders as dividends. Rather, any tax liability related to income earned and distributed by the Company would represent obligations of the Company&#8217;s investors and would not be reflected in the consolidated financial statements of the Company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are &#8220;more-likely-than-not&#8221; to be sustained by the applicable tax authority. Tax positions not deemed to meet the &#8220;more-likely-than-not&#8221; threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To qualify for and maintain qualification as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to qualify for RIC tax treatment, the Company must distribute to its shareholders, for each taxable year, at least 90% of the sum of (i) its &#8220;investment company taxable income&#8221; for that year (without regard to the deduction for dividends paid), which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses and (ii) its net tax-exempt income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, based on the excise tax distribution requirements, the Company is subject to a 4% nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner in each taxable year an amount at least equal to the sum of (i) 98% of its ordinary income for the calendar year, (ii) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October&#160;31 in that calendar year and (iii)&#160;any income realized, but not distributed, in prior years. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to corporate income tax is considered to have been distributed.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyDistributionPolicyTextBlock', window );">Distributions</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributions</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that the Company has taxable income available, the Company intends to make quarterly distributions to its shareholders.&#160;Distributions to shareholders are recorded on the record date.&#160;All distributions will be paid at the discretion of the Board and will depend on the Company&#8217;s earnings, financial condition, maintenance of the Company's tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Reference Rate Reform (Topic 848)&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional expedients and exceptions for applying </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Interbank Offered Rate (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LIBOR&#8221;</span>) or another reference rate expected to be discontinued because of reference rate reform. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848), which expanded the scope of Topic 848 to include derivative instruments impacted by discounting transition. ASU 2020-04 and ASU 2021-01 are effective for all entities through December 31, 2022. The expedients and exceptions provided by the amendments do not apply to contract modifications and hedging relationships entered into or evaluated after December 31, 2022, except for hedging transactions as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which deferred the sunset day of this guidance to December 31, 2024. There has been no material impact of these standards on the Company&#8217;s financial position, results of operations or cash flows<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant unobservable input used in the yield analysis is the discount rate based on comparable market yields. The significant unobservable input used for market quotations are broker quoted prices provided by independent pricing services. The significant unobservable input used under the market approach is the Performance Multiple. Significant increases in discount rates would result in a significantly lower fair value measurement. Significant decreases in quoted prices or Performance Multiples would result in a significantly lower fair value measurement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyDistributionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for distribution to ownership interest holder. Includes, but is not limited to, dividend distribution and tax return of capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyDistributionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140170881879584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock', window );">Schedule of Investments</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of the Company&#8217;s investment portfolio at cost and fair value was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total Investments at Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total Investments at Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First lien debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,817,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,722,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,497,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,419,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second lien debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,934,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,868,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,657,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,617,248&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The industry composition of investments at fair value was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aerospace &amp; Defense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Air Freight &amp; Logistics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Services &amp; Supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction &amp; Engineering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Containers &amp; Packaging</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diversified Consumer Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diversified Financial Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diversified Telecommunication Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrical Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electronic Equipment, Instruments &amp; Components</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electric Utilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Energy Equipment &amp; Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ground Transportation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Equipment &amp; Supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Providers &amp; Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial Conglomerates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet &amp; Direct Marketing Retail</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Media</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oil, Gas &amp; Consumable Fuels</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paper &amp; Forest Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceuticals </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate Management &amp; Development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Road &amp; Rail</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Retail</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology Hardware, Storage &amp; Peripherals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Companies &amp; Distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transportation Infrastructure</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Amount rounds to less than 0.1% as of December&#160;31, 2022.</span></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Amount rounds to less than 0.1% as of December&#160;31, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The geographic composition of investments at cost and fair value was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total Investments at Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as % of Net Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,381,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,317,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda/Cayman Islands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,934,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,868,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total<br/>Investments at<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>as % of Net<br/>Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,934,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,893,051&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,657,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,617,248&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140170708803424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Assets Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of financial instruments:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First lien debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,722,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second lien debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,710,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,868,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First lien debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,419,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second lien debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,452&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,472,796&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,617,248&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of Changes in Fair Value of Investments Measured Using Level 3 Inputs</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the fair value of financial instruments for which Level 3 inputs were used to determine the fair value:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First Lien Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second Lien Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unsecured Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,472,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,492,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from principal repayments and sales of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,114,974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,351)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,187,790)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of discount/amortization of premium</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,095)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,739)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,941)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,515&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,940&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,710,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments still held as of December&#160;31, 2023 included in change in net unrealized appreciation (depreciation) on the Consolidated Statements of Operations</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,013)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,437)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,082)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First&#160;Lien&#160;Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second Lien Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,288,184&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,501,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from principal repayments and sales of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(980,395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,967)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,042,362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of discount/amortization of premium</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,465)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,235)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,330)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,472,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments still held as of December&#160;31, 2022 included in net change in unrealized appreciation (depreciation) on the Consolidated Statements of Operations</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,180)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,629)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,528&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,281)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">For the years ended December&#160;31, 2023 and 2022, transfers into or out of Level 3 were primarily due to decreased or increased price transparency.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents quantitative information about the significant unobservable inputs of the Company&#8217;s Level 3 financial instruments. The table is not intended to be all-inclusive but instead captures the significant unobservable inputs relevant to the Company&#8217;s determination of fair value.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Low</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">High</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in first lien debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,533,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield Analysis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Recoverability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market Multiple</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50x</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in second lien debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield Analysis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in unsecured debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield Analysis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.90%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market Approach</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance Multiple</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.40x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.00x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.47x</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option Pricing Model </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield Analysis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,940&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,710,582&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Low</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">High</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in first lien debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,037,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield analysis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market quotations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker quoted price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.19</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in second lien debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield analysis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance multiple</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.00x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.41x</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option pricing model</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yield analysis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,949&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,472,796&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Weighted averages are calculated based on fair value of investments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value measurements of the Company's Unsecured Notes (as defined in Note 6) had they been accounted for at fair value. These financial instruments would be categorized as Level 3 as of December&#160;31, 2023 and as Level 2 as of December&#160;31, 2022 within the hierarchy.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New 2026 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551,661&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,825,722&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171142494000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-Term Debt Instruments</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s outstanding debt obligations were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Principal<br/>Committed</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding<br/>Principal</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Debt Issuance Costs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unused</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jackson Hole Funding Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breckenridge Funding Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Big Sky Funding Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,092,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,092,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New 2026 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,600,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,937,883&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,911,930&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,662,117&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,662,037&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The unused portion is the amount upon which commitment fees, if any, are based.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The amount available reflects any limitations related to each respective credit facility&#8217;s borrowing base.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Under the Jackson Hole Funding Facility, the Company may borrow in U.S. dollars (USD) or certain other permitted currencies. As of December&#160;31, 2023, the Company had no borrowings denominated in currencies other than USD. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Under the Revolving Credit Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2023, the Company had non-USD borrowings denominated in the following currencies:</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">Canadian Dollars (CAD) 1.0 million</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">Euros (EUR) 94.4 million</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">British Pounds (GBP) 66.9 million</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Principal Committed</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Principal</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Debt Issuance Costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unused</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jackson Hole Funding Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breckenridge Funding Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Big Sky Funding Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New 2026 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,550,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,563,003&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,527,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986,997&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976,379&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The unused portion is the amount upon which commitment fees, if any, are based.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The amount available reflects any limitations related to each respective credit facility&#8217;s borrowing base.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Under the Jackson Hole Funding Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2022, the Company had no borrowings denominated in currencies other than USD.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Under the Revolving Credit Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2022, the Company had borrowings denominated in the following currencies:</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">Canadian Dollars (CAD) 355.9 million</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">Euros (EUR) 97.9 million</span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt">British Pounds (GBP) 66.6 million</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of interest expense were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility unused fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of original issue discount and debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Interest Expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,478&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,152&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,552&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-8<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171130126768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock', window );">Schedule of Shares Issued and Proceeds Received</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total common shares issued and proceeds received, for the year ended December&#160;31, 2023, through the &#8220;at-the-market&#8221; offering program (dollars in thousands except per share amounts):</span></div><div style="margin-bottom:8pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.554%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuances of Common Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Proceeds</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Placement Fees/Offering Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Share Price </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;At-the-market&#8221; Offering</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,144,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Represents the net offering price per share after deducting placement fees and commissions and offering expenses.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Schedule of Stock by Class</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total common shares issued and proceeds received related to the Company&#8217;s capital drawdowns and IPO for the year ended December&#160;31, 2021 (dollars in millions except share amounts):</span></div><div style="margin-bottom:8pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Share Issuance Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Proceeds</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 8, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,869,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 8, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,723,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,557,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,149,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Includes proceeds (net of any underwriting fees) from our initial public offering and the underwriter's exercise of the over-allotment option.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsDeclaredTableTextBlock', window );">Dividends Declared</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s distributions declared and payable for the year ended December&#160;31, 2023 (dollars in thousands except per share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.186%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date Declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 20, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 26, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s distributions declared and payable for the year ended December&#160;31, 2022 (dollars in thousands except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date Declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 18, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 18, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 18, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 18, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 16, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 18, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 18, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 14, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 14, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="30" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:17.68pt">Represents a special distribution.</span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s distributions declared and payable for the year ended December&#160;31, 2021 (dollars in thousands except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.186%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date Declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 14, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 13, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 13, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 12, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 12, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 18, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,792&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock', window );">Schedule of Amounts Received and Shares Issued to Shareholders</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our dividend reinvestment plan, the following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company&#8217;s DRIP during the year ended December&#160;31, 2023 (dollars in thousands except share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Issued</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company's DRIP during the year ended December&#160;31, 2022 (dollars in thousands except share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Issued</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 14, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,382&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054,845&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company's DRIP during the year ended December&#160;31, 2021 (dollars in thousands except share amounts):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DRIP Shares Issued</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 29, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 14, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 13, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 12, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total distributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_ScheduleOfSharesRepurchasedTableTextBlock', window );">Schedule of Shares Repurchased</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the shares repurchased under the Company 10b5-1 Plan during the year ended December&#160;31, 2022 (dollars in thousands except share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total Number of Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1 - April 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1 - May 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1 - June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1 - July 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1 - August 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,223,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,223,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1 - September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1 - October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Repurchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,959,931</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,959,931</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Dividend Reinvestment Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_ScheduleOfSharesRepurchasedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_ScheduleOfSharesRepurchasedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsDeclaredTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsDeclaredTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-5<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481142/505-10-45-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-10<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-8<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171131172800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in net assets resulting from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding (basic and diluted)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,615,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,072,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,510,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share (basic and diluted)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171132079488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock', window );">Schedule of Changes in Net Assets</a></td>
<td class="text">For the years ended December&#160;31, 2023, 2022 and 2021, permanent differences were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undistributed net investment income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,895&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,556)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated net realized gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,911)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid In Capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,984)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxNoteTextBlock', window );">Federal Income Tax Note</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following reconciles the increase in net assets resulting from operations to taxable income for the years ended December&#160;31, 2023, 2022 and 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net increase (decrease) in net assets resulting from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized (appreciation) depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Realized gains (losses) for tax not included in book income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible capital gains incentive fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-deductible expenses and excise taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net post-October capital loss deferral (reversal)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Taxable/distributable income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677,085&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,304&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,985&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Tax information for the fiscal year ended December&#160;31, 2023 is estimated and is not considered final until the Company files its tax return.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and unrealized gain (loss) of the Company&#8217;s investments, as calculated on a tax basis, at December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrealized appreciation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrealized depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146,095)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,232)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in unrealized appreciation (depreciation)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,338)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,943)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax cost of investments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,927,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,658,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,855,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock', window );">Schedule of Accumulated Gains (Losses) as Calculated on Tax Basis</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated gains (losses) as calculated on a tax basis for the years ended December&#160;31, 2023, 2022 and 2021 were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributable ordinary income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributable capital gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other temporary book/tax differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,389)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation/(depreciation) on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,065)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total accumulated under-distributed (over-distributed) earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,861&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Company, Change In Net Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Company, Components Of Distributable Earnings (Accumulated Losses)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the federal tax basis of investment holdings. This item captures the aggregate cost of securities, aggregate gross unrealized appreciation for all securities in which there is an excess of value over tax cost, aggregate gross unrealized depreciation for all securities in which there is an excess of tax cost over value, net unrealized appreciation (depreciation), and an explanation of the differences between tax and book.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171131153568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Highlights and Senior Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyAbstract', window );"><strong>Investment Company [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock', window );">Schedule of Financial Highlights</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the financial highlights for the years ended December&#160;31, 2023, 2022, 2021, 2020, 2019 and for the period ended December 31, 2018:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For The Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per Share Data </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net asset value, beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized and realized gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in net assets resulting from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions declared </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.00)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in net assets from capital share transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.09)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total increase (decrease) in net assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.82)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net asset value, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.02&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,782,408&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,362,861&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,274,033&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,661,586&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,289,742&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,621,319&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return based on NAV </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return based on market value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ratio of net expenses to average net assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ratio of net investment income to average net assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portfolio turnover rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets, end of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,952,041</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,158,966</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,447,479</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,267,809</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673,117</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,365</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset coverage ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The per share data was derived by using the weighted average shares outstanding during the period.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The per share data for distributions was derived by using the actual shares outstanding at the date of the relevant transactions (refer to Note 8).</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Total return is calculated as the change in NAV per share during the period, plus distributions per share (assuming dividends and distributions are reinvested in accordance with the Company's dividend reinvestment plan) divided by the beginning NAV per share. Total return does not include sales load.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Total return based on market value is calculated as the change in market value per share during the respective periods, taking into account distributions, if any, reinvested in accordance with the Company&#8217;s dividend reinvestment plan. The beginning market value per share is based on the initial public offering price of $26.15 per share and not annualized.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Amounts are annualized except for expense support amounts relating to organizational costs and management fee and income based incentive fee waivers by the Adviser (refer to Note 3). For the years ended December&#160;31, 2023, 2022, 2021, 2020, 2019 and the period ended December 31, 2018, the ratio of total operating expenses to average net assets was 11.7%, 9.3%, 7.4%, 6.4%, 8.5%, and 14.1% respectively, on an annualized basis, excluding the effect of expense support/(recoupment) and management fee and income based incentive fee waivers by the Adviser which represented (0.8)%, (0.9)%, (0.2)%, (0.1)%, (0.0)% and 5.2%, respectively, of average net assets.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">The period ended December 31, 2018 represents the period from November 20, 2018 (commencement of operations) to December 31, 2018.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial highlights. Includes, but is not limited to, per share information, income and expense ratios, total return, capital commitment and fee waiver.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171138673408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Revenue Recognition / Income Tax (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">$ 19,300,000<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="nump">$ 60,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Offering costs</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit', window );">Excise tax expense</a></td>
<td class="nump">$ 16,795,000<span></span>
</td>
<td class="nump">$ 1,386,000<span></span>
</td>
<td class="nump">$ 2,438,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) on investment income classified as operating. Excludes realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483580/946-220-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171129710608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Agreements and Related Party Transactions - Investment Advisory Agreement (Details) - Investment Advisory Agreement<br></strong></div></th>
<th class="th"><div>May 02, 2023</div></th>
<th class="th"><div>Oct. 28, 2021</div></th>
<th class="th"><div>Oct. 18, 2021</div></th>
<th class="th"><div>May 06, 2021</div></th>
<th class="th"><div>May 06, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate', window );">Quarterly hurdle rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Voluntary Waiver In Place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementAndServiceFeesBaseRate', window );">Base management fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate', window );">Quarterly hurdle rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionInitialTerm', window );">Related party transaction, initial term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionRenewalTerm', window );">Related party transaction, renewal term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod', window );">Waiver period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Affiliated Entity | Voluntary Waiver Not In Place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementAndServiceFeesBaseRate', window );">Base management fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementAndServiceFeesIncentiveRate', window );">Incentive fees rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Affiliated Entity | Voluntary Waiver In Place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementAndServiceFeesBaseRate', window );">Base management fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementAndServiceFeesIncentiveRate', window );">Incentive fees rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Income Based Incentive Fee, Quarterly Hurdle Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_RelatedPartyTransactionInitialTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Initial Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_RelatedPartyTransactionInitialTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_RelatedPartyTransactionRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Renewal Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_RelatedPartyTransactionRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Voluntary Waiver Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementAndServiceFeesBaseRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Base rate for management and service fees under arrangement to manage operations, including, but not limited to, investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementAndServiceFeesBaseRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementAndServiceFeesIncentiveRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate based on performance for management and service fees under arrangement to manage operations, including, but not limited to, investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementAndServiceFeesIncentiveRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_VoluntaryWaiverScenarioAxis=bxsl_VoluntaryWaiverInPlaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_VoluntaryWaiverScenarioAxis=bxsl_VoluntaryWaiverInPlaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_VoluntaryWaiverScenarioAxis=bxsl_VoluntaryWaiverNotInPlaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_VoluntaryWaiverScenarioAxis=bxsl_VoluntaryWaiverNotInPlaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171138992896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreements and Related Party Transactions - Base Management Fee (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">14 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2021</div></th>
<th class="th"><div>Oct. 18, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeeExpense', window );">Management fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98,122<span></span>
</td>
<td class="nump">$ 101,707<span></span>
</td>
<td class="nump">$ 62,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyContractualFeeWaived', window );">Management fees waived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,194<span></span>
</td>
<td class="nump">25,427<span></span>
</td>
<td class="nump">$ 4,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeePayable', window );">Management fees payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,034<span></span>
</td>
<td class="nump">$ 18,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Investment Advisory Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementAndServiceFeesRate', window );">Management fee rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_VoluntaryWaiverScenarioAxis=bxsl_VoluntaryWaiverInPlaceMember', window );">Voluntary Waiver In Place | Investment Advisory Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementAndServiceFeesBaseRate', window );">Base management fee</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyContractualFeeWaived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fee contractually waived by investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyContractualFeeWaived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementAndServiceFeesBaseRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Base rate for management and service fees under arrangement to manage operations, including, but not limited to, investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementAndServiceFeesBaseRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementAndServiceFeesRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate for management and service fees under arrangement to manage operations, including, but not limited to, investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementAndServiceFeesRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fee payable for management of fund or trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_VoluntaryWaiverScenarioAxis=bxsl_VoluntaryWaiverInPlaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_VoluntaryWaiverScenarioAxis=bxsl_VoluntaryWaiverInPlaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171132227200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreements and Related Party Transactions - Incentive Fees (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">26 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2021</div></th>
<th class="th"><div>Oct. 18, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeeExpense', window );">Income based incentive fee expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,230<span></span>
</td>
<td class="nump">$ 97,154<span></span>
</td>
<td class="nump">$ 67,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyVoluntaryFeeWaived', window );">Incentive fees waived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,604<span></span>
</td>
<td class="nump">13,879<span></span>
</td>
<td class="nump">2,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncentiveFeePayableIncome', window );">Income based incentive fees payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,373<span></span>
</td>
<td class="nump">24,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_CapitalGainsIncentiveFeeExpense', window );">Capital gains incentive fees (Note 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,506)<span></span>
</td>
<td class="num">$ (11,883)<span></span>
</td>
<td class="nump">$ 16,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember', window );">Investment Management Agreement - Incentive Rate, Quarterly Hurdle Rate Member | Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementAndServiceFeesIncentiveRate', window );">Incentive fees rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember', window );">Investment Management Agreement - Incentive Rate, Annualized Hurdle Rate Member | Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementAndServiceFeesIncentiveRate', window );">Incentive fees rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Investment Advisory Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate', window );">Quarterly hurdle rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeesRate', window );">Income based incentive rate</a></td>
<td class="nump">17.50%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage', window );">Incentive rate, catch up, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold', window );">Incentive rate, threshold</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_CapitalGainsBasedIncentiveFeesRate', window );">Capital gains based incentive rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Investment Advisory Agreement | Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate', window );">Quarterly hurdle rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Investment Advisory Agreement | Voluntary Waiver In Place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn', window );">Pre incentive fee cap percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_CapitalGainsBasedIncentiveFeesRate', window );">Capital gains based incentive rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Investment Advisory Agreement | Voluntary Waiver In Place | Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementAndServiceFeesIncentiveRate', window );">Incentive fees rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Investment Advisory Agreement | Voluntary Waiver Not In Place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn', window );">Pre incentive fee cap percentage</a></td>
<td class="nump">17.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Investment Advisory Agreement | Voluntary Waiver Not In Place | Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementAndServiceFeesIncentiveRate', window );">Incentive fees rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Investment Advisory Agreement | Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Less Than Or Equal To Catch-Up Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome', window );">Payment of pre incentive rate investment income, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Investment Advisory Agreement | Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Less Than Or Equal To Catch-Up Amount | Voluntary Waiver In Place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage', window );">Catch-up amount prior to the waiver period</a></td>
<td class="nump">1.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage', window );">Annual catch up amount prior to the waiver period</a></td>
<td class="nump">7.06%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Investment Advisory Agreement | Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Less Than Or Equal To Catch-Up Amount | Voluntary Waiver Not In Place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage', window );">Catch-up amount prior to the waiver period</a></td>
<td class="nump">1.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage', window );">Annual catch up amount prior to the waiver period</a></td>
<td class="nump">7.27%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Investment Advisory Agreement | Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Greater Than Catch-Up Amount | Voluntary Waiver In Place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome', window );">Payment of pre incentive rate investment income, percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember', window );">Investment Advisory Agreement | Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Greater Than Catch-Up Amount | Voluntary Waiver Not In Place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome', window );">Payment of pre incentive rate investment income, percentage</a></td>
<td class="nump">17.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_CapitalGainsBasedIncentiveFeesRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Gains Based Incentive Fees, Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_CapitalGainsBasedIncentiveFeesRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_CapitalGainsIncentiveFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Gains Incentive Fee Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_CapitalGainsIncentiveFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncentiveFeePayableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incentive Fee Payable, Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncentiveFeePayableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncomeBasedIncentiveFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Based Incentive Fee Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncomeBasedIncentiveFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Based Incentive Fees, Cap, Percentage Of Cumulative Net Return</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Based Incentive Fees, Catch-Up Amount, Annualized Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Based Incentive Fees, Catch-Up Amount, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Based Incentive Fees, Percentage Of Pre-Incentive Fee Net Investment Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncomeBasedIncentiveFeesRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Based Incentive Fees, Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncomeBasedIncentiveFeesRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Based Incentive Fees, Voluntary Waiver, Incentive Rate Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Management And Service Fees, Income Based Incentive Rate, Catch up, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Income Based Incentive Fee, Quarterly Hurdle Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyVoluntaryFeeWaived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fee voluntarily waived by investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyVoluntaryFeeWaived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementAndServiceFeesIncentiveRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate based on performance for management and service fees under arrangement to manage operations, including, but not limited to, investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementAndServiceFeesIncentiveRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=bxsl_InvestmentAdvisoryAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_VoluntaryWaiverScenarioAxis=bxsl_VoluntaryWaiverInPlaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_VoluntaryWaiverScenarioAxis=bxsl_VoluntaryWaiverInPlaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_VoluntaryWaiverScenarioAxis=bxsl_VoluntaryWaiverNotInPlaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_VoluntaryWaiverScenarioAxis=bxsl_VoluntaryWaiverNotInPlaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncomeBasedIncentiveFeesScenarioAxis=bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncomeBasedIncentiveFeesScenarioAxis=bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_IncomeBasedIncentiveFeesScenarioAxis=bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_IncomeBasedIncentiveFeesScenarioAxis=bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171129080864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreements and Related Party Transactions - Administration Agreement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 01, 2018</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdministrativeFeesExpense', window );">Administrative service expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="nump">$ 2,672<span></span>
</td>
<td class="nump">$ 2,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,925<span></span>
</td>
<td class="nump">10,809<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_AdministrationAgreementMember', window );">Administration Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionInitialTerm', window );">Related party transaction, initial term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_AdministrationAgreementMember', window );">Administration Agreement | Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_RelatedPartyTransactionInitialTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Initial Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_RelatedPartyTransactionInitialTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdministrativeFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdministrativeFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=bxsl_AdministrationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=bxsl_AdministrationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171138553872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Agreements and Related Party Transactions - Sub-Administration and Expense Support (Details) - Sub-Administration Agreement<br></strong></div></th>
<th class="th"><div>Oct. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionInitialTerm', window );">Related party transaction, initial term</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionRenewalTerm', window );">Related party transaction, renewal term</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionTerminationNoticePeriod', window );">Termination notice period</a></td>
<td class="text">120 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_RelatedPartyTransactionInitialTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Initial Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_RelatedPartyTransactionInitialTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_RelatedPartyTransactionRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Renewal Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_RelatedPartyTransactionRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_RelatedPartyTransactionTerminationNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Termination Notice Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_RelatedPartyTransactionTerminationNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=bxsl_SubAdministrationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=bxsl_SubAdministrationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171129420864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreements and Related Party Transactions - Expense Payments and Reimbursement Payments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 12, 2018</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_ExpenseSupportReimbursementRelatedParty', window );">Recoupment of expense support (Note 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,925,000<span></span>
</td>
<td class="nump">10,809,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_ExpenseSupportAgreementMember', window );">Expense Support Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionExpensePaymentPeriod', window );">Expense payment period</a></td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_ExpenseSupportAgreementMember', window );">Expense Support Agreement | Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=bxsl_ExpenseSupportAgreementExcessOperatingFundsMember', window );">Expense Support Agreement, Excess Operating Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RelatedPartyTransactionExpensePaymentPeriod', window );">Expense payment period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_ExpenseSupportReimbursementRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense Support Reimbursement, Related Party</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_ExpenseSupportReimbursementRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_RelatedPartyTransactionExpensePaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Expense Payment Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_RelatedPartyTransactionExpensePaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=bxsl_ExpenseSupportAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=bxsl_ExpenseSupportAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=bxsl_ExpenseSupportAgreementExcessOperatingFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=bxsl_ExpenseSupportAgreementExcessOperatingFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140170882746800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Investment Portfolio at Cost and Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost</a></td>
<td class="nump">$ 9,934,159<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,657,872<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 9,868,440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,617,248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=bxsl_InvestmentOwnedAtFairValueMember', window );">Investment Owned, At Fair Value | Investment Type Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost</a></td>
<td class="nump">$ 9,817,402<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">$ 9,497,570<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 9,722,061<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 9,419,963<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | Investment Owned, At Fair Value | Investment Type Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">98.50%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">97.90%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesSecondLienMember', window );">Second lien debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost</a></td>
<td class="nump">$ 43,347<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">$ 48,753<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 41,515<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 46,336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesSecondLienMember', window );">Second lien debt | Investment Owned, At Fair Value | Investment Type Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.50%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost</a></td>
<td class="nump">$ 9,930<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 9,924<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt | Investment Owned, At Fair Value | Investment Type Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost</a></td>
<td class="nump">$ 63,480<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 111,549<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 94,940<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 150,949<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equity | Investment Owned, At Fair Value | Investment Type Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.60%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">Unless otherwise indicated, all debt and equity investments held by the Company (which such term &#8220;Company&#8221; shall include the Company&#8217;s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December&#160;31, 2023, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company&#8217;s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Unless otherwise indicated, all debt and equity investments held by the Company (which such term &#8220;Company&#8221; shall include the Company&#8217;s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December&#160;31, 2022, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in </span><div style="margin-top:2pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><br/><br/><br/><br/><br/>thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company&#8217;s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.</span></div></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in security owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=bxsl_InvestmentOwnedAtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=bxsl_InvestmentOwnedAtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=bxsl_InvestmentTypeConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=bxsl_InvestmentTypeConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesFirstLienMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesFirstLienMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesSecondLienMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesSecondLienMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171140585312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Investments at Fair Value Percent (Details) - Investment Owned, At Fair Value - Investment Type Concentration Risk<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_AerospaceAndDefenseSectorMember', window );">Aerospace &amp; Defense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">5.20%<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_AirFreightLogisticsSectorMember', window );">Air Freight &amp; Logistics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_BuildingProductsSectorMember', window );">Building Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_ChemicalsSectorMember', window );">Chemicals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_CommercialServicesSuppliesSectorMember', window );">Commercial Services &amp; Supplies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">7.80%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ConstructionEngineeringSectorMember', window );">Construction &amp; Engineering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_ContainerAndPackagingSectorMember', window );">Containers &amp; Packaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_DistributorsSectorMember', window );">Distributors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">5.70%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_ConsumerSectorMember', window );">Diversified Consumer Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_FinancialServicesSectorMember', window );">Diversified Financial Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_DiversifiedTelecommunicationServicesSectorMember', window );">Diversified Telecommunication Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ElectricalEquipmentSectorMember', window );">Electrical Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ElectronicEquipmentInstrumentsAndComponentsMember', window );">Electronic Equipment, Instruments &amp; Components</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ElectricUtilitiesMember', window );">Electric Utilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_EnergySectorMember', window );">Energy Equipment &amp; Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_GroundTransportationMember', window );">Ground Transportation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_HealthCareEquipmentSuppliesSectorMember', window );">Health Care Equipment &amp; Supplies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_HealthCareProvidersServicesSectorMember', window );">Health Care Providers &amp; Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">10.70%<span></span>
</td>
<td class="nump">11.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_HealthCareTechnologySectorMember', window );">Health Care Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_IndustrialConglomeratesMember', window );">Industrial Conglomerates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_InsuranceSectorMember', window );">Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="nump">8.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_InternetAndDirectMarketingRetailMember', window );">Internet &amp; Direct Marketing Retail</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ITServicesSectorMember', window );">IT Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_MachineryMember', window );">Machinery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_MarineMember', window );">Marine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_MediaSectorMember', window );">Media</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_OilGasAndConsumableFuelsMember', window );">Oil, Gas &amp; Consumable Fuels</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_PaperAndForestProductsMember', window );">Paper &amp; Forest Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_PharmaceuticalsSectorMember', window );">Pharmaceuticals Sector</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ProfessionalServicesSectorMember', window );">Professional Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">7.80%<span></span>
</td>
<td class="nump">8.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_RealEstateManagementDevelopmentSectorMember', window );">Real Estate Management &amp; Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_RoadAndRailMember', window );">Road &amp; Rail</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_SoftwareSectorMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">17.40%<span></span>
</td>
<td class="nump">14.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_SpecialtyRetailMember', window );">Specialty Retail</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_TechnologyHardwareStorageAndPeripheralsMember', window );">Technology Hardware, Storage &amp; Peripherals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_TradingCompaniesDistributorsSectorMember', window );">Trading Companies &amp; Distributors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_TransportationInfrastructureSectorMember', window );">Transportation Infrastructure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=bxsl_InvestmentOwnedAtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=bxsl_InvestmentOwnedAtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=bxsl_InvestmentTypeConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=bxsl_InvestmentTypeConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_AerospaceAndDefenseSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_AerospaceAndDefenseSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_AirFreightLogisticsSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_AirFreightLogisticsSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_BuildingProductsSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_BuildingProductsSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_ChemicalsSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_ChemicalsSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_CommercialServicesSuppliesSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_CommercialServicesSuppliesSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ConstructionEngineeringSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ConstructionEngineeringSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_ContainerAndPackagingSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_ContainerAndPackagingSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_DistributorsSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_DistributorsSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_ConsumerSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_ConsumerSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_FinancialServicesSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_FinancialServicesSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_DiversifiedTelecommunicationServicesSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_DiversifiedTelecommunicationServicesSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ElectricalEquipmentSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ElectricalEquipmentSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ElectronicEquipmentInstrumentsAndComponentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ElectronicEquipmentInstrumentsAndComponentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ElectricUtilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ElectricUtilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_EnergySectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_EnergySectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_GroundTransportationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_GroundTransportationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_HealthCareEquipmentSuppliesSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_HealthCareEquipmentSuppliesSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_HealthCareProvidersServicesSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_HealthCareProvidersServicesSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_HealthCareTechnologySectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_HealthCareTechnologySectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_IndustrialConglomeratesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_IndustrialConglomeratesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_InsuranceSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_InsuranceSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_InternetAndDirectMarketingRetailMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_InternetAndDirectMarketingRetailMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ITServicesSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ITServicesSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_MachineryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_MachineryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_MarineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_MarineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_MediaSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_MediaSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_OilGasAndConsumableFuelsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_OilGasAndConsumableFuelsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_PaperAndForestProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_PaperAndForestProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_PharmaceuticalsSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_PharmaceuticalsSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ProfessionalServicesSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_ProfessionalServicesSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_RealEstateManagementDevelopmentSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_RealEstateManagementDevelopmentSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_RoadAndRailMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_RoadAndRailMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_SoftwareSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_SoftwareSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_SpecialtyRetailMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_SpecialtyRetailMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_TechnologyHardwareStorageAndPeripheralsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_TechnologyHardwareStorageAndPeripheralsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_TradingCompaniesDistributorsSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_TradingCompaniesDistributorsSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=bxsl_TransportationInfrastructureSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=bxsl_TransportationInfrastructureSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171138957104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Geographic Investment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost</a></td>
<td class="nump">$ 9,934,159<span></span>
</td>
<td class="nump">$ 9,657,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 9,868,440<span></span>
</td>
<td class="nump">$ 9,617,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="nump">199.30%<span></span>
</td>
<td class="nump">231.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=bxsl_InvestmentOwnedAtFairValueMember', window );">Investment Owned, At Fair Value | Investment Type Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost</a></td>
<td class="nump">$ 9,381,707<span></span>
</td>
<td class="nump">$ 8,934,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 9,317,684<span></span>
</td>
<td class="nump">$ 8,893,051<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="nump">188.20%<span></span>
</td>
<td class="nump">213.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Investment Owned, At Fair Value | Investment Type Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">94.40%<span></span>
</td>
<td class="nump">92.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost</a></td>
<td class="nump">$ 275,579<span></span>
</td>
<td class="nump">$ 510,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 278,103<span></span>
</td>
<td class="nump">$ 520,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | Investment Owned, At Fair Value | Investment Type Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bxsl_BERMUDAAndCAYMANISLANDMember', window );">Bermuda/Cayman Islands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost</a></td>
<td class="nump">$ 436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bxsl_BERMUDAAndCAYMANISLANDMember', window );">Bermuda/Cayman Islands | Investment Owned, At Fair Value | Investment Type Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost</a></td>
<td class="nump">$ 276,437<span></span>
</td>
<td class="nump">$ 212,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 272,180<span></span>
</td>
<td class="nump">$ 203,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Fair Value as % of Net Assets</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe | Investment Owned, At Fair Value | Investment Type Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Total Investments at Fair Value</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in security owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedPercentOfNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of investment owned to net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedPercentOfNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=bxsl_InvestmentOwnedAtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=bxsl_InvestmentOwnedAtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=bxsl_InvestmentTypeConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=bxsl_InvestmentTypeConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bxsl_BERMUDAAndCAYMANISLANDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bxsl_BERMUDAAndCAYMANISLANDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171140536528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Additional Information (Details) - loan<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentOwnedNonaccrualNumberOfLoans', window );">Number of loans in non-accrual status</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesVariableRateMember', window );">Debt Securities, Variable Rate | Investments At Fair Value | Investment Type Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">99.90%<span></span>
</td>
<td class="nump">99.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesFixedRateMember', window );">Debt Securities, Fixed Rate | Investments At Fair Value | Investment Type Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentOwnedNonaccrualNumberOfLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Nonaccrual, Number Of Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentOwnedNonaccrualNumberOfLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesVariableRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesVariableRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=bxsl_InvestmentsAtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=bxsl_InvestmentsAtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=bxsl_InvestmentTypeConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=bxsl_InvestmentTypeConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesFixedRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=bxsl_DebtSecuritiesFixedRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171140544112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Hierarchy of Financial Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 9,868,440<span></span>
</td>
<td class="nump">$ 9,617,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">9,722,061<span></span>
</td>
<td class="nump">9,419,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesSecondLienMember', window );">Second lien debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">41,515<span></span>
</td>
<td class="nump">46,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">94,940<span></span>
</td>
<td class="nump">150,949<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">9,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | First lien debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Second lien debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Investments in equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">157,858<span></span>
</td>
<td class="nump">144,452<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | First lien debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">157,858<span></span>
</td>
<td class="nump">144,452<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Second lien debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Investments in equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">9,710,582<span></span>
</td>
<td class="nump">9,472,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | First lien debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">9,564,203<span></span>
</td>
<td class="nump">9,275,511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Second lien debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">41,515<span></span>
</td>
<td class="nump">46,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Investments in equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">94,940<span></span>
</td>
<td class="nump">$ 150,949<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 9,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesSecondLienMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesSecondLienMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171129148832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Changes in Fair Value of Investments Measured Using Level 3 Inputs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_InvestmentsMember', window );">Total Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value, beginning of period</a></td>
<td class="nump">$ 9,472,796<span></span>
</td>
<td class="nump">$ 9,501,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases of investments</a></td>
<td class="nump">1,508,759<span></span>
</td>
<td class="nump">952,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Proceeds from principal repayments and sales of investments</a></td>
<td class="num">(1,187,790)<span></span>
</td>
<td class="num">(1,042,362)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium', window );">Accretion of discount/amortization of premium</a></td>
<td class="nump">50,580<span></span>
</td>
<td class="nump">45,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level 3</a></td>
<td class="nump">4,938<span></span>
</td>
<td class="nump">108,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level 3</a></td>
<td class="num">(91,939)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value, end of period</a></td>
<td class="nump">9,710,582<span></span>
</td>
<td class="nump">9,472,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments, included in net unrealized appreciation (depreciation) on the Consolidated Statements of Operations</a></td>
<td class="num">(44,082)<span></span>
</td>
<td class="num">(97,281)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bxsl_InvestmentsRealizedGainLossMember', window );">Investments, Realized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Net realized gain (loss)</a></td>
<td class="num">(1,662)<span></span>
</td>
<td class="nump">39,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bxsl_InvestmentsUnrealizedGainLossMember', window );">Investments, Unrealized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Net realized gain (loss)</a></td>
<td class="num">(45,100)<span></span>
</td>
<td class="num">(132,330)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value, beginning of period</a></td>
<td class="nump">9,275,511<span></span>
</td>
<td class="nump">9,288,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases of investments</a></td>
<td class="nump">1,492,985<span></span>
</td>
<td class="nump">934,505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Proceeds from principal repayments and sales of investments</a></td>
<td class="num">(1,114,974)<span></span>
</td>
<td class="num">(980,395)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium', window );">Accretion of discount/amortization of premium</a></td>
<td class="nump">50,516<span></span>
</td>
<td class="nump">45,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level 3</a></td>
<td class="nump">4,938<span></span>
</td>
<td class="nump">108,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level 3</a></td>
<td class="num">(91,939)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value, end of period</a></td>
<td class="nump">9,564,203<span></span>
</td>
<td class="nump">9,275,511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments, included in net unrealized appreciation (depreciation) on the Consolidated Statements of Operations</a></td>
<td class="num">(38,013)<span></span>
</td>
<td class="num">(119,180)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesFirstLienRealizedGainLossMember', window );">Debt Securities, First Lien, Realized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Net realized gain (loss)</a></td>
<td class="num">(15,095)<span></span>
</td>
<td class="num">(2,125)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember', window );">Debt Securities, First Lien, Unrealized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Net realized gain (loss)</a></td>
<td class="num">(37,739)<span></span>
</td>
<td class="num">(118,465)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesSecondLienMember', window );">Second lien debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value, beginning of period</a></td>
<td class="nump">46,336<span></span>
</td>
<td class="nump">42,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases of investments</a></td>
<td class="nump">1,935<span></span>
</td>
<td class="nump">5,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Proceeds from principal repayments and sales of investments</a></td>
<td class="num">(7,351)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium', window );">Accretion of discount/amortization of premium</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value, end of period</a></td>
<td class="nump">41,515<span></span>
</td>
<td class="nump">46,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments, included in net unrealized appreciation (depreciation) on the Consolidated Statements of Operations</a></td>
<td class="nump">374<span></span>
</td>
<td class="num">(2,629)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesSecondLienRealizedGainLossMember', window );">Debt Securities, Second Lien, Realized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Net realized gain (loss)</a></td>
<td class="num">(49)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember', window );">Debt Securities, Second Lien, Unrealized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Net realized gain (loss)</a></td>
<td class="nump">586<span></span>
</td>
<td class="num">(2,630)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases of investments</a></td>
<td class="nump">9,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Proceeds from principal repayments and sales of investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium', window );">Accretion of discount/amortization of premium</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value, end of period</a></td>
<td class="nump">9,924<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments, included in net unrealized appreciation (depreciation) on the Consolidated Statements of Operations</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bxsl_UnsecuredDebtRealizedGainLossMember', window );">Unsecured Debt, Realized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Net realized gain (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bxsl_UnsecuredDebtUnrealizedGainLossMember', window );">Unsecured Debt, Unrealized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Net realized gain (loss)</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value, beginning of period</a></td>
<td class="nump">150,949<span></span>
</td>
<td class="nump">170,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases of investments</a></td>
<td class="nump">3,915<span></span>
</td>
<td class="nump">12,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Proceeds from principal repayments and sales of investments</a></td>
<td class="num">(65,465)<span></span>
</td>
<td class="num">(61,967)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium', window );">Accretion of discount/amortization of premium</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value, end of period</a></td>
<td class="nump">94,940<span></span>
</td>
<td class="nump">150,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments, included in net unrealized appreciation (depreciation) on the Consolidated Statements of Operations</a></td>
<td class="num">(6,437)<span></span>
</td>
<td class="nump">24,528<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bxsl_EquitySecuritiesRealizedGainLossMember', window );">Equity Securities, Realized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Net realized gain (loss)</a></td>
<td class="nump">13,482<span></span>
</td>
<td class="nump">41,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bxsl_EquitySecuritiesUnrealizedGainLossMember', window );">Equity Securities, Unrealized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Net realized gain (loss)</a></td>
<td class="num">$ (7,941)<span></span>
</td>
<td class="num">$ (11,235)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Accretion Of Discount/Amortization Of Premium</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_InvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_InvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bxsl_InvestmentsRealizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bxsl_InvestmentsRealizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bxsl_InvestmentsUnrealizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bxsl_InvestmentsUnrealizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesFirstLienMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesFirstLienMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesFirstLienRealizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesFirstLienRealizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesSecondLienMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesSecondLienMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesSecondLienRealizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesSecondLienRealizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bxsl_UnsecuredDebtRealizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bxsl_UnsecuredDebtRealizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bxsl_UnsecuredDebtUnrealizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bxsl_UnsecuredDebtUnrealizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bxsl_EquitySecuritiesRealizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bxsl_EquitySecuritiesRealizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bxsl_EquitySecuritiesUnrealizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bxsl_EquitySecuritiesUnrealizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140170881653952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Unobservable Inputs (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 9,868,440<span></span>
</td>
<td class="nump">$ 9,617,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">9,710,582<span></span>
</td>
<td class="nump">9,472,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">9,564,203<span></span>
</td>
<td class="nump">9,275,511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | Yield Analysis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">9,533,700<span></span>
</td>
<td class="nump">9,037,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | Asset Recoverability | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 30,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | Market Approach | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 238,378<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | Low | Yield Analysis | Level 3 | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.0768<span></span>
</td>
<td class="nump">0.0683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | Low | Asset Recoverability | Level 3 | Market Multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | Low | Market Approach | Level 3 | Broker quoted price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | High | Yield Analysis | Level 3 | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.3089<span></span>
</td>
<td class="nump">0.1984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | High | Asset Recoverability | Level 3 | Market Multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | High | Market Approach | Level 3 | Broker quoted price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | Weighted Average | Yield Analysis | Level 3 | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.1031<span></span>
</td>
<td class="nump">0.1013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | Weighted Average | Asset Recoverability | Level 3 | Market Multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember', window );">First lien debt | Weighted Average | Market Approach | Level 3 | Broker quoted price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94.19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesSecondLienMember', window );">Second lien debt | Yield Analysis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 41,515<span></span>
</td>
<td class="nump">$ 46,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesSecondLienMember', window );">Second lien debt | Low | Yield Analysis | Level 3 | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.1018<span></span>
</td>
<td class="nump">0.1043<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesSecondLienMember', window );">Second lien debt | High | Yield Analysis | Level 3 | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.1438<span></span>
</td>
<td class="nump">0.1425<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesSecondLienMember', window );">Second lien debt | Weighted Average | Yield Analysis | Level 3 | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.1269<span></span>
</td>
<td class="nump">0.1260<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt | Yield Analysis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 9,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt | Low | Yield Analysis | Level 3 | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">14.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt | High | Yield Analysis | Level 3 | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">14.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt | Weighted Average | Yield Analysis | Level 3 | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">14.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 94,940<span></span>
</td>
<td class="nump">$ 150,949<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | Yield Analysis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">6,402<span></span>
</td>
<td class="nump">22,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | Market Approach | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">60,007<span></span>
</td>
<td class="nump">105,782<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | Option Pricing Model | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 28,531<span></span>
</td>
<td class="nump">$ 22,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | Low | Yield Analysis | Level 3 | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.1075<span></span>
</td>
<td class="nump">0.1131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | Low | Market Approach | Level 3 | Performance Multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">6.4<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | Low | Option Pricing Model | Level 3 | Expected Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.3200<span></span>
</td>
<td class="nump">0.3000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | High | Yield Analysis | Level 3 | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.1792<span></span>
</td>
<td class="nump">0.1375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | High | Market Approach | Level 3 | Performance Multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | High | Option Pricing Model | Level 3 | Expected Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.5500<span></span>
</td>
<td class="nump">0.5000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | Weighted Average | Yield Analysis | Level 3 | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.1417<span></span>
</td>
<td class="nump">0.1274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | Weighted Average | Market Approach | Level 3 | Performance Multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">11.47<span></span>
</td>
<td class="nump">13.41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Investments in equity | Weighted Average | Option Pricing Model | Level 3 | Expected Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.4286<span></span>
</td>
<td class="nump">0.4346<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure investment owned by investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in security owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesFirstLienMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=bxsl_ValuationYieldAnalysisApproachMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=bxsl_ValuationYieldAnalysisApproachMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=bxsl_ValuationAssetRecoverabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=bxsl_ValuationAssetRecoverabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=bxsl_MeasurementInputMarketMultipleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=bxsl_MeasurementInputMarketMultipleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputQuotedPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputQuotedPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesSecondLienMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bxsl_DebtSecuritiesSecondLienMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=bxsl_MeasurementInputPerformanceMultipleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=bxsl_MeasurementInputPerformanceMultipleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171139100560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - Level 2 - Unsecured debt<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">$ 2,825,722<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2023NotesMember', window );">2023 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">397,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2026NotesMember', window );">2026 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">740,171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_New2026NotesMember', window );">New 2026 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">619,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2027NotesMember', window );">2027 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">546,117<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2028NotesMember', window );">2028 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">$ 522,809<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2023NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2023NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2026NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2026NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_New2026NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_New2026NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2028NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2028NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171129379072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value Measurements of Unsecured Notes (Details) - Unsecured debt - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">$ 2,551,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,825,722<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2023NotesMember', window );">2023 Notes | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2023NotesMember', window );">2023 Notes | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">397,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2026NotesMember', window );">2026 Notes | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">763,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2026NotesMember', window );">2026 Notes | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">740,171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_New2026NotesMember', window );">New 2026 Notes | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">643,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_New2026NotesMember', window );">New 2026 Notes | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">619,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2027NotesMember', window );">2027 Notes | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">583,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2027NotesMember', window );">2027 Notes | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546,117<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2028NotesMember', window );">2028 Notes | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">$ 561,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2028NotesMember', window );">2028 Notes | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 522,809<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2023NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2023NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2026NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2026NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_New2026NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_New2026NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2028NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2028NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171138626944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Jackson Hole Funding Facility (Details)<br></strong></div></th>
<th class="th"><div>Sep. 16, 2022</div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio', window );">Asset coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.30%<span></span>
</td>
<td class="nump">200.30%<span></span>
</td>
<td class="nump">174.80%<span></span>
</td>
<td class="nump">174.80%<span></span>
</td>
<td class="nump">180.20%<span></span>
</td>
<td class="nump">230.00%<span></span>
</td>
<td class="nump">215.10%<span></span>
</td>
<td class="nump">227.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember', window );">Jackson Hole Funding Facility, Foreign Currency Advances | Line of Credit | Revolving Credit Facility | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityDollarAdvancesMember', window );">Jackson Hole Funding Facility, Dollar Advances | Line of Credit | Revolving Credit Facility | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.525%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityMember', window );">Jackson Hole Funding Facility | Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit', window );">Maximum borrowing capacity including the accordion feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Increase Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of total assets less all liabilities and indebtedness not represented by senior security, to senior security representing indebtedness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Investment Company Act of 1940<br> -Section 61<br> -Paragraph a<br> -Subparagraph (1)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityDollarAdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityDollarAdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171133269616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Breckenridge Funding Facility (Details) - Revolving Credit Facility - Breckenridge Funding Facility - Line of Credit<br></strong></div></th>
<th class="th"><div>May 19, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Scenario 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Scenario 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">High | Scenario 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_LineOfCreditFacilityUnusedCapacityPercentage', window );">Unused capacity percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">High | Scenario 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_LineOfCreditFacilityUnusedCapacityPercentage', window );">Unused capacity percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Low | Scenario 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_LineOfCreditFacilityUnusedCapacityPercentage', window );">Unused capacity percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">SOFR | Scenario 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">SOFR | Scenario 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.05%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">SOFR | Scenario 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_LineOfCreditFacilityUnusedCapacityPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Unused Capacity, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_LineOfCreditFacilityUnusedCapacityPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_BreckenridgeFundingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_BreckenridgeFundingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_CommitmentFeeScenarioAxis=bxsl_Scenario1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_CommitmentFeeScenarioAxis=bxsl_Scenario1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_CommitmentFeeScenarioAxis=bxsl_Scenario2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_CommitmentFeeScenarioAxis=bxsl_Scenario2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_VariableRateScenarioAxis=bxsl_Scenario1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_VariableRateScenarioAxis=bxsl_Scenario1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_VariableRateScenarioAxis=bxsl_Scenario2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_VariableRateScenarioAxis=bxsl_Scenario2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_VariableRateScenarioAxis=bxsl_Scenario3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_VariableRateScenarioAxis=bxsl_Scenario3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171132193904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Big Sky Funding Facility (Details) - Revolving Credit Facility - Big Sky Funding Facility - Line of Credit<br></strong></div></th>
<th class="th"><div>Mar. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage', window );">Minimum utilization percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Scenario 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Scenario 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.45%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">SOFR | Low</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">SOFR | High</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.45%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Minimum Capacity Utilization, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_BigSkyFundingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_BigSkyFundingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_CommitmentFeeScenarioAxis=bxsl_Scenario1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_CommitmentFeeScenarioAxis=bxsl_Scenario1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_CommitmentFeeScenarioAxis=bxsl_Scenario2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_CommitmentFeeScenarioAxis=bxsl_Scenario2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140170708611456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Revolving Credit Facility (Details) - Line of Credit<br> &#8364; in Millions, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Jun. 28, 2022</div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Jun. 09, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>GBP (&#163;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember', window );">Term loan | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 385,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio', window );">Asset coverage ratio</a></td>
<td class="nump">1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,775,000,000<span></span>
</td>
<td class="nump">&#8364; 94.4<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">&#163; 66.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,625,000,000<span></span>
</td>
<td class="nump">&#8364; 97.9<span></span>
</td>
<td class="nump">$ 355.9<span></span>
</td>
<td class="nump">&#163; 66.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Scenario 1 | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier', window );">Combined revolving debt amount multiplier</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Scenario 2 | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier', window );">Combined revolving debt amount multiplier</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Scenario 3 | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier', window );">Combined revolving debt amount multiplier</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Scenario 4 | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier', window );">Combined revolving debt amount multiplier</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Base Rate | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | SOFR | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Compliance, Required Asset Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Combined Revolving Debt Amount, Multiplier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_CitiBankRevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_CitiBankRevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_VariableRateScenarioAxis=bxsl_Scenario1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_VariableRateScenarioAxis=bxsl_Scenario1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_VariableRateScenarioAxis=bxsl_Scenario2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_VariableRateScenarioAxis=bxsl_Scenario2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_VariableRateScenarioAxis=bxsl_Scenario3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_VariableRateScenarioAxis=bxsl_Scenario3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_VariableRateScenarioAxis=bxsl_Scenario4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_VariableRateScenarioAxis=bxsl_Scenario4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171132238800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Unsecured Debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jul. 23, 2021</div></th>
<th class="th"><div>Apr. 27, 2021</div></th>
<th class="th"><div>Mar. 16, 2021</div></th>
<th class="th"><div>Dec. 01, 2020</div></th>
<th class="th"><div>Oct. 23, 2020</div></th>
<th class="th"><div>Jul. 15, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 6,600,000,000<span></span>
</td>
<td class="nump">$ 6,550,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt | 3.650% Notes Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.65%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt | 3.625% Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt | New 2026 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">700,000,000<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt | 2.125% Senior Notes Due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">650,000,000<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured debt | 2.850% Notes Due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -SubTopic 470<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A3650NotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A3650NotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A3625NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A3625NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2750NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2750NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2125SeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2125SeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2850NotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2850NotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171132271392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Outstanding Debt Obligations (Details)<br> &#163; in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 23, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 16, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 23, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 15, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate Principal Committed</a></td>
<td class="nump">$ 6,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,550,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding Principal</a></td>
<td class="nump">4,937,883,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,563,003,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">4,911,930,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,527,715,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Costs</a></td>
<td class="nump">25,953,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,289,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Unused portion</a></td>
<td class="nump">1,662,117,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">986,997,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Amount Available</a></td>
<td class="nump">1,662,037,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">976,379,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityMember', window );">Jackson Hole Funding Facility | Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate Principal Committed</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding Principal</a></td>
<td class="nump">233,019,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,019,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">233,019,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,019,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Unused portion</a></td>
<td class="nump">266,981,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,981,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Amount Available</a></td>
<td class="nump">266,981,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,981,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_BreckenridgeFundingFacilityMember', window );">Breckenridge Funding Facility | Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate Principal Committed</a></td>
<td class="nump">1,025,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">825,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding Principal</a></td>
<td class="nump">741,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">825,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">741,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">825,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Unused portion</a></td>
<td class="nump">283,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Amount Available</a></td>
<td class="nump">283,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_BigSkyFundingFacilityMember', window );">Big Sky Funding Facility | Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate Principal Committed</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding Principal</a></td>
<td class="nump">480,906,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499,606,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">480,906,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499,606,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Unused portion</a></td>
<td class="nump">19,094,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Amount Available</a></td>
<td class="nump">19,094,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_CitiBankRevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate Principal Committed</a></td>
<td class="nump">1,775,000,000<span></span>
</td>
<td class="nump">&#8364; 94,400,000<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">&#163; 66.9<span></span>
</td>
<td class="nump">1,625,000,000<span></span>
</td>
<td class="nump">&#8364; 97,900,000<span></span>
</td>
<td class="nump">$ 355.9<span></span>
</td>
<td class="nump">&#163; 66.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding Principal</a></td>
<td class="nump">682,258,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">678,378,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">682,258,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">678,378,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Unused portion</a></td>
<td class="nump">1,092,742,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">946,622,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Amount Available</a></td>
<td class="nump">1,092,662,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,004,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A3650NotesDue2023Member', window );">2023 Notes | Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate Principal Committed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">398,850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A3625NotesDue2026Member', window );">2026 Notes | Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate Principal Committed</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding Principal</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">796,343,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">794,559,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Costs</a></td>
<td class="nump">3,657,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,441,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2750NotesDue2026Member', window );">New 2026 Notes | Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate Principal Committed</a></td>
<td class="nump">700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding Principal</a></td>
<td class="nump">700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">695,206,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">693,432,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Costs</a></td>
<td class="nump">4,794,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,568,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2125SeniorNotesDue2027Member', window );">2027 Notes | Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate Principal Committed</a></td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding Principal</a></td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">641,412,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">638,669,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Costs</a></td>
<td class="nump">8,588,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,332,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bxsl_A2850NotesDue2028Member', window );">2028 Notes | Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate Principal Committed</a></td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding Principal</a></td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">641,086,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">639,202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Costs</a></td>
<td class="nump">$ 8,914,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,798,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_JacksonHoleFundingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_BreckenridgeFundingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_BreckenridgeFundingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_BigSkyFundingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_BigSkyFundingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_CitiBankRevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_CitiBankRevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A3650NotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A3650NotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A3625NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A3625NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2750NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2750NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2125SeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2125SeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bxsl_A2850NotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bxsl_A2850NotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171131812976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InterestPayableInterestExpense', window );">Interest expense</a></td>
<td class="nump">$ 38.7<span></span>
</td>
<td class="nump">$ 44.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee', window );">Unused commitment fees</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime', window );">Weighted average interest rate</a></td>
<td class="nump">4.93%<span></span>
</td>
<td class="nump">3.46%<span></span>
</td>
<td class="nump">2.92%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAverageAmountOutstanding', window );">Average principal debt outstanding</a></td>
<td class="nump">$ 5,275.4<span></span>
</td>
<td class="nump">$ 5,732.6<span></span>
</td>
<td class="nump">$ 4,000.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Payable, Debt Instrument Unused Borrowing Capacity Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InterestPayableInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Payable, Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InterestPayableInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAverageAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average amount outstanding of long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (b)<br> -Subparagraph (1)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAverageAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated over time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtWeightedAverageInterestRateOverTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171129077344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Interest Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Borrowing interest expense</a></td>
<td class="nump">$ 246,642<span></span>
</td>
<td class="nump">$ 187,035<span></span>
</td>
<td class="nump">$ 107,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee', window );">Facility unused fees</a></td>
<td class="nump">4,971<span></span>
</td>
<td class="nump">2,131<span></span>
</td>
<td class="nump">2,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements', window );">Amortization of deferred financing costs</a></td>
<td class="nump">5,471<span></span>
</td>
<td class="nump">4,008<span></span>
</td>
<td class="nump">2,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of original issue discount and debt issuance costs</a></td>
<td class="nump">9,336<span></span>
</td>
<td class="nump">10,405<span></span>
</td>
<td class="nump">7,102<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total Interest Expense</a></td>
<td class="nump">266,420<span></span>
</td>
<td class="nump">203,579<span></span>
</td>
<td class="nump">120,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest expense</a></td>
<td class="nump">$ 256,478<span></span>
</td>
<td class="nump">$ 182,152<span></span>
</td>
<td class="nump">$ 94,552<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Debt Issuance Costs, Line Of Credit Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment fees for the unused borrowing capacity under the long-term financing arrangement that is available to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnusedBorrowingCapacityFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171131960016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 690,256<span></span>
</td>
<td class="nump">$ 713,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount', window );">Estimated future amount</a></td>
<td class="nump">$ 221,300<span></span>
</td>
<td class="nump">16,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=bxsl_DelayedDrawTermLoansAndRevolversMember', window );">Delayed Draw Term Loans And Revolvers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Unfunded commitment</a></td>
<td class="nump">$ 985,900<span></span>
</td>
<td class="nump">$ 690,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Company, Financial Commitment to Investee, Estimated Future Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of financial support committed by investment company to investee that is contractually required but not provided.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=bxsl_DelayedDrawTermLoansAndRevolversMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=bxsl_DelayedDrawTermLoansAndRevolversMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171136973120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Assets - Subscriptions and Drawdowns (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 18, 2023</div></th>
<th class="th"><div>Aug. 14, 2023</div></th>
<th class="th"><div>Nov. 04, 2021</div></th>
<th class="th"><div>Oct. 28, 2021</div></th>
<th class="th"><div>Sep. 08, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyCommittedCapital', window );">Capital commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,926,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Remaining undrawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 690,256<span></span>
</td>
<td class="nump">$ 713,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,607<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyCommittedCapital', window );">Capital commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount', window );">Remaining undrawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="nump">975,000<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="nump">1,377,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price per share (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from offering</a></td>
<td class="nump">$ 26,100<span></span>
</td>
<td class="nump">$ 174,100<span></span>
</td>
<td class="nump">$ 33,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering expenses</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price per share (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyCommittedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funds committed to investment company from investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyCommittedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of financial support committed by investment company to investee that is contractually required but not provided.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140170882748336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Assets - Schedule of Shares Issued and Proceeds Received (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 08, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 08, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>equity_distribution_agreement </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_NumberOfEquityDistributionAgreements', window );">Number of agreements | equity_distribution_agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue', window );">Aggregate sales price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_SaleOfStockRemainingAuthorizedAmount', window );">Remaining available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">328,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Placement Fees/Offering Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,607,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net Proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 665,260,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 981,102,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common shares issued (in shares) | shares</a></td>
<td class="nump">13,723,035<span></span>
</td>
<td class="nump">13,869,637<span></span>
</td>
<td class="nump">10,557,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,149,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_StockIssuedDuringPeriodValueNewIssuesGross', window );">Aggregate Proceeds</a></td>
<td class="nump">$ 356,300,000<span></span>
</td>
<td class="nump">$ 357,000,000.0<span></span>
</td>
<td class="nump">$ 264,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 977,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=bxsl_AtTheMarketOfferingOffering1Member', window );">At-the-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,144,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross Proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 466,821,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Placement Fees/Offering Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,297,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net Proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 465,524,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_NumberOfEquityDistributionAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Equity Distribution Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_NumberOfEquityDistributionAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Number of Shares Issued in Transaction, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_SaleOfStockRemainingAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Remaining Authorized Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_SaleOfStockRemainingAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_StockIssuedDuringPeriodValueNewIssuesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, New Issues, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_StockIssuedDuringPeriodValueNewIssuesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=bxsl_AtTheMarketOfferingOffering1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=bxsl_AtTheMarketOfferingOffering1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171134314000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Assets - Distributions Declared (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 08, 2023</div></th>
<th class="th"><div>Jun. 20, 2023</div></th>
<th class="th"><div>May 10, 2023</div></th>
<th class="th"><div>Feb. 27, 2023</div></th>
<th class="th"><div>Nov. 02, 2022</div></th>
<th class="th"><div>Aug. 30, 2022</div></th>
<th class="th"><div>May 02, 2022</div></th>
<th class="th"><div>Feb. 23, 2022</div></th>
<th class="th"><div>Oct. 18, 2021</div></th>
<th class="th"><div>Sep. 07, 2021</div></th>
<th class="th"><div>Jun. 07, 2021</div></th>
<th class="th"><div>Feb. 24, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Per Share Amount (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.9400<span></span>
</td>
<td class="nump">$ 2.9100<span></span>
</td>
<td class="nump">$ 2.0300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 504,787<span></span>
</td>
<td class="nump">$ 482,434<span></span>
</td>
<td class="nump">$ 295,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=bxsl_Dividends1Member', window );">Dividends 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Per Share Amount (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=bxsl_Dividends2Member', window );">Dividends 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Per Share Amount (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=bxsl_Dividends3Member', window );">Dividends 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Per Share Amount (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=bxsl_Dividends4Member', window );">Dividends 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Per Share Amount (in usd per share)</a></td>
<td class="nump">$ 0.7700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2000<span></span>
</td>
<td class="nump">$ 0.3750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Total Amount</a></td>
<td class="nump">$ 143,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,995<span></span>
</td>
<td class="nump">$ 54,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=bxsl_Dividends5Member', window );">Dividends 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Per Share Amount (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=bxsl_Dividends6Member', window );">Dividends 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Per Share Amount (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=bxsl_Dividends7Member', window );">Dividends 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Per Share Amount (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=bxsl_Dividends8Member', window );">Dividends 8</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Per Share Amount (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=bxsl_Dividends9Member', window );">Dividends 9</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Per Share Amount (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481071/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=bxsl_Dividends1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=bxsl_Dividends1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=bxsl_Dividends2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=bxsl_Dividends2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=bxsl_Dividends3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=bxsl_Dividends3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=bxsl_Dividends4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=bxsl_Dividends4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=bxsl_Dividends5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=bxsl_Dividends5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=bxsl_Dividends6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=bxsl_Dividends6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=bxsl_Dividends7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=bxsl_Dividends7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=bxsl_Dividends8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=bxsl_Dividends8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=bxsl_Dividends9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=bxsl_Dividends9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171131170272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Assets - Dividend Reinvestment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare', window );">Purchase price of common stock, percent of market price</a></td>
<td class="nump">95.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividend Reinvestment Plan, Minimum Share Issuance Price, Percentage Of Current Market Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171139124736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Assets - Scheduled of Amounts Received and Shares Issued (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 26, 2023</div></th>
<th class="th"><div>Jul. 27, 2023</div></th>
<th class="th"><div>Apr. 27, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Nov. 14, 2022</div></th>
<th class="th"><div>Aug. 12, 2022</div></th>
<th class="th"><div>May 13, 2022</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Nov. 12, 2021</div></th>
<th class="th"><div>Aug. 13, 2021</div></th>
<th class="th"><div>May 14, 2021</div></th>
<th class="th"><div>Jan. 29, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan', window );">DRIP Shares Value</a></td>
<td class="nump">$ 5,445<span></span>
</td>
<td class="nump">$ 4,635<span></span>
</td>
<td class="nump">$ 5,439<span></span>
</td>
<td class="nump">$ 5,132<span></span>
</td>
<td class="nump">$ 12,942<span></span>
</td>
<td class="nump">$ 11,470<span></span>
</td>
<td class="nump">$ 16,501<span></span>
</td>
<td class="nump">$ 11,469<span></span>
</td>
<td class="nump">$ 9,944<span></span>
</td>
<td class="nump">$ 9,142<span></span>
</td>
<td class="nump">$ 8,674<span></span>
</td>
<td class="nump">$ 11,179<span></span>
</td>
<td class="nump">$ 20,651<span></span>
</td>
<td class="nump">$ 52,382<span></span>
</td>
<td class="nump">$ 38,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan', window );">DRIP Shares Issued (in share)</a></td>
<td class="nump">205,149<span></span>
</td>
<td class="nump">172,888<span></span>
</td>
<td class="nump">213,130<span></span>
</td>
<td class="nump">208,510<span></span>
</td>
<td class="nump">541,489<span></span>
</td>
<td class="nump">455,148<span></span>
</td>
<td class="nump">640,829<span></span>
</td>
<td class="nump">417,379<span></span>
</td>
<td class="nump">327,082<span></span>
</td>
<td class="nump">352,656<span></span>
</td>
<td class="nump">339,398<span></span>
</td>
<td class="nump">443,639<span></span>
</td>
<td class="nump">799,677<span></span>
</td>
<td class="nump">2,054,845<span></span>
</td>
<td class="nump">1,462,775<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the shareholders to reinvest dividends paid to them by the entity on new issues of stock by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the holder of the stock to reinvest dividends paid to them by the entity on new issues of stock by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480348/946-230-55-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140170708775392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Assets - Share Repurchase Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Oct. 18, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,002,432<span></span>
</td>
<td class="nump">2,251,657<span></span>
</td>
<td class="nump">2,223,389<span></span>
</td>
<td class="nump">2,394,113<span></span>
</td>
<td class="nump">1,313,782<span></span>
</td>
<td class="nump">774,558<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,959,931<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=bxsl_Company10b51PlanMember', window );">Company 10b5-1 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,002,432<span></span>
</td>
<td class="nump">2,251,657<span></span>
</td>
<td class="nump">2,223,389<span></span>
</td>
<td class="nump">2,394,113<span></span>
</td>
<td class="nump">1,313,782<span></span>
</td>
<td class="nump">774,558<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,959,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=bxsl_Company10b18PlanMember', window );">Company 10b-18 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program authorized amount</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Stock repurchase plan (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=bxsl_Company10b51PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=bxsl_Company10b51PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=bxsl_Company10b18PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=bxsl_Company10b18PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171129139760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Assets - Share Repurchases (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="7">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Total Number of Shares Repurchased (in shares)</a></td>
<td class="nump">2,002,432<span></span>
</td>
<td class="nump">2,251,657<span></span>
</td>
<td class="nump">2,223,389<span></span>
</td>
<td class="nump">2,394,113<span></span>
</td>
<td class="nump">1,313,782<span></span>
</td>
<td class="nump">774,558<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,959,931<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare', window );">Average Price Paid per Share (in usd per share)</a></td>
<td class="nump">$ 23.67<span></span>
</td>
<td class="nump">$ 24.14<span></span>
</td>
<td class="nump">$ 24.22<span></span>
</td>
<td class="nump">$ 23.20<span></span>
</td>
<td class="nump">$ 24.49<span></span>
</td>
<td class="nump">$ 25.24<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=bxsl_Company10b51PlanMember', window );">Company 10b5-1 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Total Number of Shares Repurchased (in shares)</a></td>
<td class="nump">2,002,432<span></span>
</td>
<td class="nump">2,251,657<span></span>
</td>
<td class="nump">2,223,389<span></span>
</td>
<td class="nump">2,394,113<span></span>
</td>
<td class="nump">1,313,782<span></span>
</td>
<td class="nump">774,558<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,959,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 46,527<span></span>
</td>
<td class="nump">$ 100,886<span></span>
</td>
<td class="nump">$ 154,736<span></span>
</td>
<td class="nump">$ 210,275<span></span>
</td>
<td class="nump">$ 242,447<span></span>
</td>
<td class="nump">$ 262,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_StockRepurchasedDuringPeriodAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchased During Period, Average Cost Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_StockRepurchasedDuringPeriodAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=bxsl_Company10b51PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=bxsl_Company10b51PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171133435808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Assets - Shareholder Transfer Restrictions (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">2 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Jan. 03, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction', window );">Percentage of shares restriction</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_TransferRestrictionsAxis=bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember', window );">Initial Public Offering, Shareholder Transfer Restrictions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Investment owned (in shares)</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial Public Offering, Shareholder Transfer Restrictions, Percentage Of Share Transfer Restriction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of investment owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_TransferRestrictionsAxis=bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_TransferRestrictionsAxis=bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171133435680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net increase (decrease) in net assets resulting from operations</a></td>
<td class="nump">$ 611,951<span></span>
</td>
<td class="nump">$ 404,556<span></span>
</td>
<td class="nump">$ 460,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding basic (in share)</a></td>
<td class="nump">167,615,433<span></span>
</td>
<td class="nump">166,072,919<span></span>
</td>
<td class="nump">144,510,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding diluted (in share)</a></td>
<td class="nump">167,615,433<span></span>
</td>
<td class="nump">166,072,919<span></span>
</td>
<td class="nump">144,510,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings (loss), basic, per share (in usd per share)</a></td>
<td class="nump">$ 3.65<span></span>
</td>
<td class="nump">$ 2.44<span></span>
</td>
<td class="nump">$ 3.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings (loss) diluted (in usd per share)</a></td>
<td class="nump">$ 3.65<span></span>
</td>
<td class="nump">$ 2.44<span></span>
</td>
<td class="nump">$ 3.19<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171140632576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Permanent Differences (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Undistributed net investment income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems', window );"><strong>Investment Company, Changes in Net Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease', window );">Reclassification</a></td>
<td class="nump">$ 32,895<span></span>
</td>
<td class="nump">$ 60,532<span></span>
</td>
<td class="num">$ (17,556)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated net realized gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems', window );"><strong>Investment Company, Changes in Net Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease', window );">Reclassification</a></td>
<td class="num">(15,911)<span></span>
</td>
<td class="num">(58,963)<span></span>
</td>
<td class="nump">19,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Paid In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems', window );"><strong>Investment Company, Changes in Net Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease', window );">Reclassification</a></td>
<td class="num">$ (16,984)<span></span>
</td>
<td class="nump">$ 1,569<span></span>
</td>
<td class="num">$ (2,438)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyChangesInNetAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyChangesInNetAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from reclassification to paid-in capital of permanent difference for distribution to ownership interest holder by investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171133576704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems', window );"><strong>Investments, Owned, Federal Income Tax Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit', window );">Excise tax expense</a></td>
<td class="nump">$ 16,795<span></span>
</td>
<td class="nump">$ 1,386<span></span>
</td>
<td class="nump">$ 2,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome', window );">Non-deductible offering costs</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared</a></td>
<td class="nump">504,787<span></span>
</td>
<td class="nump">482,434<span></span>
</td>
<td class="nump">$ 295,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=bxsl_DividendsOrdinaryIncomeMember', window );">Dividends, Ordinary Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems', window );"><strong>Investments, Owned, Federal Income Tax Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared</a></td>
<td class="nump">456,800<span></span>
</td>
<td class="nump">470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=bxsl_DividendsCapitalGainsMember', window );">Dividends, Capital Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems', window );"><strong>Investments, Owned, Federal Income Tax Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared</a></td>
<td class="nump">$ 47,900<span></span>
</td>
<td class="nump">$ 12,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment, Tax Basis Reconciliation, Non-Deductible Tax Expense, Offering Costs, Increase (Decrease) In Taxable Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481071/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) on investment income classified as operating. Excludes realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483580/946-220-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=bxsl_DividendsOrdinaryIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=bxsl_DividendsOrdinaryIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=bxsl_DividendsCapitalGainsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=bxsl_DividendsCapitalGainsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171141227360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Changes in Net Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net increase (decrease) in net assets resulting from operations</a></td>
<td class="nump">$ 611,951<span></span>
</td>
<td class="nump">$ 404,556<span></span>
</td>
<td class="nump">$ 460,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome', window );">Net change in unrealized (appreciation) depreciation</a></td>
<td class="nump">54,573<span></span>
</td>
<td class="nump">122,149<span></span>
</td>
<td class="num">(104,178)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome', window );">Realized gains (losses) for tax not included in book income</a></td>
<td class="num">(917)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome', window );">Non-deductible capital gains incentive fees</a></td>
<td class="num">(5,506)<span></span>
</td>
<td class="num">(11,883)<span></span>
</td>
<td class="nump">16,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome', window );">Other non-deductible expenses and excise taxes</a></td>
<td class="nump">16,984<span></span>
</td>
<td class="nump">1,542<span></span>
</td>
<td class="nump">2,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome', window );">Net post-October capital loss deferral (reversal)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,293)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions', window );">Taxable/distributable income</a></td>
<td class="nump">$ 677,085<span></span>
</td>
<td class="nump">$ 516,304<span></span>
</td>
<td class="nump">$ 370,985<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Company, Distributable Earnings (Loss), Before Deductions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment, Tax Basis Reconciliation, Capital Loss Carryover, Increase (Decrease) In Taxable Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment, Tax Basis Reconciliation, Net Unrealized Depreciation (Appreciation) On Investments, Increase (Decrease) In Taxable Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment, Tax Basis Reconciliation, Non-Deductible Tax Expense, Capital Gains Incentive Fee, Increase (Decrease) In Taxable Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment, Tax Basis Reconciliation, Other Non-Deductible Tax Expense, Increase (Decrease) In Taxable Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment, Tax Basis Reconciliation, Other Realized Gains (Losses) Differences, Increase (Decrease) In Taxable Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171131814080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Accumulated Gains (Losses) as Calculated on Tax Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss', window );">Distributable ordinary income</a></td>
<td class="nump">$ 281,140<span></span>
</td>
<td class="nump">$ 104,577<span></span>
</td>
<td class="nump">$ 104,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss', window );">Distributable capital gains</a></td>
<td class="nump">26,953<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="nump">3,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences', window );">Other temporary book/tax differences</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,506)<span></span>
</td>
<td class="num">(17,389)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation', window );">Net change in unrealized appreciation/(depreciation) on investments</a></td>
<td class="num">(58,065)<span></span>
</td>
<td class="num">(10,194)<span></span>
</td>
<td class="nump">109,941<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Total accumulated under-distributed (over-distributed) earnings</a></td>
<td class="nump">$ 250,028<span></span>
</td>
<td class="nump">125,693<span></span>
</td>
<td class="nump">$ 199,861<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_RetainedEarningsAccumulatedDeficitAudited', window );">Total accumulated under-distributed (over-distributed) earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Company, Distributable Earnings (Loss), Accumulated Other Temporary Differences</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_RetainedEarningsAccumulatedDeficitAudited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Retained Earnings (Accumulated Deficit), Audited</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_RetainedEarningsAccumulatedDeficitAudited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit) from unrealized appreciation (depreciation) of investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit) from long-term capital gain (loss) of investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit) from ordinary income (loss) of investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171130275792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Tax Basis of Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation', window );">Gross unrealized appreciation</a></td>
<td class="nump">$ 86,757<span></span>
</td>
<td class="nump">$ 88,353<span></span>
</td>
<td class="nump">$ 132,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation', window );">Gross unrealized depreciation</a></td>
<td class="num">(146,095)<span></span>
</td>
<td class="num">(129,296)<span></span>
</td>
<td class="num">(22,232)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet', window );">Net change in unrealized appreciation (depreciation)</a></td>
<td class="num">(59,338)<span></span>
</td>
<td class="num">(40,943)<span></span>
</td>
<td class="nump">109,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes', window );">Tax cost of investments</a></td>
<td class="nump">$ 9,927,777<span></span>
</td>
<td class="nump">$ 9,658,192<span></span>
</td>
<td class="nump">$ 9,855,692<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost of investment for federal income tax purpose.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(2)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase in investment from unrealized gain when value exceeds cost for federal income tax purpose.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative decrease in investment from unrealized loss when cost for federal income tax purpose exceeds value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in investment from unrealized gain (loss) when value exceeds (is less than) cost for federal income tax purpose.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(2)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171134447408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Highlights and Senior Securities (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Oct. 28, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyFinancialHighlightsRollForward', window );"><strong>Investment Company, Financial Highlights [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net asset value, beginning of period (in usd per share)</a></td>
<td class="nump">$ 25.93<span></span>
</td>
<td class="nump">$ 26.27<span></span>
</td>
<td class="nump">$ 25.20<span></span>
</td>
<td class="nump">$ 26.02<span></span>
</td>
<td class="nump">$ 24.57<span></span>
</td>
<td class="nump">$ 25.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare', window );">Net investment income (in usd per share)</a></td>
<td class="nump">3.90<span></span>
</td>
<td class="nump">2.91<span></span>
</td>
<td class="nump">2.43<span></span>
</td>
<td class="nump">2.51<span></span>
</td>
<td class="nump">2.18<span></span>
</td>
<td class="nump">0.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare', window );">Net unrealized and realized gain (loss) (in usd per share)</a></td>
<td class="num">(0.24)<span></span>
</td>
<td class="num">(0.47)<span></span>
</td>
<td class="nump">0.76<span></span>
</td>
<td class="num">(0.22)<span></span>
</td>
<td class="nump">0.96<span></span>
</td>
<td class="num">(0.57)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare', window );">Net increase (decrease) in net assets resulting from operations (in usd per share)</a></td>
<td class="nump">3.66<span></span>
</td>
<td class="nump">2.44<span></span>
</td>
<td class="nump">3.19<span></span>
</td>
<td class="nump">2.29<span></span>
</td>
<td class="nump">3.14<span></span>
</td>
<td class="num">(0.40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare', window );">Distributions declared (in usd per share)</a></td>
<td class="num">(2.94)<span></span>
</td>
<td class="num">(2.91)<span></span>
</td>
<td class="num">(2.03)<span></span>
</td>
<td class="num">(2.30)<span></span>
</td>
<td class="num">(2.00)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare', window );">Net increase (decrease) in net assets from capital share transactions (in usd per share)</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="nump">0.13<span></span>
</td>
<td class="num">(0.09)<span></span>
</td>
<td class="num">(0.81)<span></span>
</td>
<td class="nump">0.31<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease', window );">Total increase (decrease) in net assets (in usd per share)</a></td>
<td class="nump">0.73<span></span>
</td>
<td class="num">(0.34)<span></span>
</td>
<td class="nump">1.07<span></span>
</td>
<td class="num">(0.82)<span></span>
</td>
<td class="nump">1.45<span></span>
</td>
<td class="num">(0.43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net asset value, ending of period (in usd per share)</a></td>
<td class="nump">$ 26.66<span></span>
</td>
<td class="nump">$ 25.93<span></span>
</td>
<td class="nump">$ 26.27<span></span>
</td>
<td class="nump">$ 25.20<span></span>
</td>
<td class="nump">$ 26.02<span></span>
</td>
<td class="nump">$ 24.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">185,782,408<span></span>
</td>
<td class="nump">160,362,861<span></span>
</td>
<td class="nump">169,274,033<span></span>
</td>
<td class="nump">129,661,586<span></span>
</td>
<td class="nump">64,289,742<span></span>
</td>
<td class="nump">9,621,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyTotalReturn', window );">Total return based on NAV</a></td>
<td class="nump">14.70%<span></span>
</td>
<td class="nump">10.30%<span></span>
</td>
<td class="nump">12.60%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">14.40%<span></span>
</td>
<td class="num">(1.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyTotalReturnMarketValue', window );">Total return based on market value</a></td>
<td class="nump">37.40%<span></span>
</td>
<td class="num">(26.10%)<span></span>
</td>
<td class="nump">32.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract', window );"><strong>Ratios:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements', window );">Ratio of net expenses to average net assets</a></td>
<td class="nump">10.90%<span></span>
</td>
<td class="nump">8.40%<span></span>
</td>
<td class="nump">7.20%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">8.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio', window );">Ratio of net investment income to average net assets</a></td>
<td class="nump">14.60%<span></span>
</td>
<td class="nump">11.10%<span></span>
</td>
<td class="nump">9.30%<span></span>
</td>
<td class="nump">10.40%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">6.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyPortfolioTurnover', window );">Portfolio turnover rate</a></td>
<td class="nump">13.40%<span></span>
</td>
<td class="nump">9.90%<span></span>
</td>
<td class="nump">35.40%<span></span>
</td>
<td class="nump">46.80%<span></span>
</td>
<td class="nump">31.50%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanySupplementalDataAbstract', window );"><strong>Supplemental Data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total net assets</a></td>
<td class="nump">$ 4,952,041<span></span>
</td>
<td class="nump">$ 4,158,966<span></span>
</td>
<td class="nump">$ 4,447,479<span></span>
</td>
<td class="nump">$ 3,267,809<span></span>
</td>
<td class="nump">$ 1,673,117<span></span>
</td>
<td class="nump">$ 236,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio', window );">Asset coverage ratio</a></td>
<td class="nump">200.30%<span></span>
</td>
<td class="nump">174.80%<span></span>
</td>
<td class="nump">180.20%<span></span>
</td>
<td class="nump">230.00%<span></span>
</td>
<td class="nump">215.10%<span></span>
</td>
<td class="nump">227.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements', window );">Ratio of expenses to average net assets, before waivers</a></td>
<td class="nump">11.70%<span></span>
</td>
<td class="nump">9.30%<span></span>
</td>
<td class="nump">7.40%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">14.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements', window );">Ratio of expenses to average net assets, waivers</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="num">(0.90%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">(0.00%)<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price per share (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Company, Expense Ratio Before Fee Waiver And Reimbursements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Company, Expense Ratio, Fee Waiver And Reimbursements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Company, Expense Ratio Including Fee Waiver And Reimbursements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Company, Ratio To Average Net Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bxsl_InvestmentCompanySupplementalDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Company, Supplemental Data</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bxsl_InvestmentCompanySupplementalDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bxsl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyDistributionToShareholdersPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit amount of distribution to shareholders. Includes, but is not limited to, dividend and capital gain. Excludes distribution for tax return of capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyDistributionToShareholdersPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyFinancialHighlightsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyFinancialHighlightsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit amount of investment income (loss) and realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit amount, after investment expense, of dividend and interest investment income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of investment income (loss) to average net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyInvestmentIncomeLossRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit amount of increase (decrease) in net asset value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyPortfolioTurnover">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of lesser of purchase or sale of portfolio securities to average value of portfolio securities owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyPortfolioTurnover</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of total assets less all liabilities and indebtedness not represented by senior security, to senior security representing indebtedness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Investment Company Act of 1940<br> -Section 61<br> -Paragraph a<br> -Subparagraph (1)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit amount of capital distribution in excess of tax basis earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyTotalReturn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyTotalReturn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyTotalReturnMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage increase (decrease) in portfolio market value assuming reinvestment of dividend and capital gain distribution.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyTotalReturnMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 54B<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-54B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 59<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-59<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6A<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140171136916736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Distributions declared and payable per share (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.9400<span></span>
</td>
<td class="nump">$ 2.9100<span></span>
</td>
<td class="nump">$ 2.0300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Distributions declared and payable per share (in usd per share)</a></td>
<td class="nump">$ 0.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>94
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MCM;S193F?\ER=6W':Q _2Y6(U\'P!'&8K/ZSYS6(5P'=3D4 70?0-P%NNR+
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MTH42_M/19@7C2Z9@6LNW08VT;&;X@[5:]U7[W#.XV#D[[6X;N49Q"#/@%6;
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MWW'%D&WT\UKE'A;;LITFY+88#MRN/,-U5<:]%1%J5L0S5I*[&-P< 7:(B0_
M)RU<MF/ON'(-ORU&'+_3XW7%Q?TE=T*7B=[*7H"#RT_AMUO FA%N$'%=R^N
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M ALV(!UEC,'.J($-ZH>-S[)]XWBD+B-P02,'H $="P-BK]T)H*,"!U$X8,U
M!_5#A[;F; G.] B! C[&^KU'5\>CP-WS #H6\,$Y1PUY4#]Y?#C8\'$OA;A
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M6$[EY=VK2^VV5%_MURPUX;=%FY=+M*BK-:H.OV:"WAGP2X[R;B_0@$[MC8/
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M)":C53NFD8FYD>E>K,1NWSW#NQA>&VLL*Q@@A<PG5J*ZVAIZT7S$_A(?8?"
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M:I1F!(<8;FA39'P7AXSO8C9)A&:!KC*,TC*4EJ,TB](<2O,HK4!I)4JK4%I
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ML:3Z?=75]?WFK;WW;)=:L2> 6*85>PJ(Y5JQ9X"8U8I= 6).*_8<$/-:L6M
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MNPGHY3KM/C]A ] H+F=QEL4Y%N=97,'B2A97L;C XFH69R0K&&%>DP2@-XT
M]"8>9-:D< 2$Z&";WM5B9[.D$R745F;JREQ=:=653EWIU96%\"D/;G,45[&X
MP.)J%F>DIAG>YA2OU>:-J/ F'O8=D<*9]_<RNV RBLM87,[B+(MS+,ZSN(+%
ME2RN8G&!Q=4LSDCF,,+.)LD.;QK9X4TZ30IGPRZ5C.(R%I>S.,OB'(OS+*Y@
M<26+JUA<8'$UBS,&YG$FT+*O1B9Z$\]$#TOA"#!5"N>!(:9P='69LBY7UEEE
MG5/6>65=(7RVP]N<S0JCN,#B:A9GI*89T>:39(4WC:SP)AKG4Z1P!( ZA?/
MZ211EMTG+,K*3%V9JRNMNM*I*[VZLA ^[>'-3N(J%A=87,WBC-0Z(YH=XK6:
MO9&LW<3#L+H4C@"1'Z4N.R^#TOEBN>RT.;O,,(K+69QE<8[%>197L+B2Q54L
M+K"XFL49R1)&F-@DN>%-(S>\B<=^3\9PA'&Z&,X#9'5D7NFZ>XW"+C*,XG(6
M9UF<8W&>Q14LKF1Q%8L++*YF<4:R@A'F-4D.>M/(06_B$68AAR.,EB^]N@'H
M-$F[">BXSG#W8A/0*,ZR.,?B/(LK6%S)XBH6%UA<S>*,Y 4CW&N2!/2FD8#>
MQ)/,JB".,@Q]TL)Z5PZ>S;K+X6@K,W5EKJZTZDJGKO3JRD+XE(>W.1L61G&!
MQ=4LSDA-,Z+-)PD+;QIAX4T\[BL&<6X^O;W(/GW\_;>[___#SW_L[V,RA7C)
MXC(6E[,XR^(<B_,LKF!Q)8NK6%Q@<36+,Y(QC+"R2:+#VT9T>#N;)H2S)=.5
MERPN8W$YB[,LSK$XS^(*%E>RN(K%!197LSAC8!YG BW[:D2BM_%(]) 0SFX/
M$P(ECR71GY*'6[3%W=^KKV_U^SU-)?>$D<N4<D\9N5PI]XR1LTJY*T;.*>6>
M,W)>*7?-R!5*N1>BW/;^;='L_A\/>VKW6[9*[26B5BG57B%J0:GV&E&KE6IO
M$#5CE'+F$:.G]6<C&[2@USK=I(W337RM:BD,MML#Q'V]'DM21ZV\%$XT2M$G
MG&BF%GW*B>9JT6><J%6+7G&B3BWZG!/U:M%K3K0X)3I;I)W3D2#::?N[?]S_
M ,GRQ(E)J?P25J[4RJ]@Y:!6?@TKUVKE-["R,6KI^U,9JWWRC-#5ED\):NW6
M":XQJ6$;GX>@"4#N]I#F6_3Y:M4]PPES'HXO5OO/;.P"[R@N9W&6Q3D6YUE<
MT7L,K6?SCN4+QY#R#H2=TH'B HNK69R1+&/$0Z-)IG1L&U,Z[OX<.VA.!"1W
M^W&K(U^;+SN^%L=W;L*34^86Y0PW-Q*7LSC+XAR+\RRNZ#^0UEUS$PZDOO-]
M[T5TR?X"%8L++*YF<4;RBQ$.!_%:#M>8Q[*-3T&)IBAW^]''UV_+;<?GA'DN
MFNLW=@H+BLM9G&5QCL5Y%E?T'T/IMF-QPC&DO'YC)[B@N,#B:A9G)*\8X6Z3
M3'#9-B:X;.,35>24Y6Z/Z"0%9^N.RPFS8C0NIQ1[<KY8IA9[>KY8KA9[=KZ8
M58M=G2_FU&+/SQ?S:K'K\\6*TV)=<Q;$E.:LU'N)Z%5JO5>(7E#KO4;T:K7>
M&T3/&+7@_=-10C'BSFU%V9Z'O>IK3$3:QJ<221G?7V\^W;Z__=O-Q=./[]_=
M?OC[Y_OU]OI/1>0LATL6E[&XG,59%N=8G&=Q!8LK65S%X@*+JUF<D=QAQ$7S
M)%.3MHVI2=MOLR+XH"\Y>^.2Q64L+F=QEL4Y%N=97,'B2A97L;C XFH69PS,
MXTR@95^-*5?;^)2K8:OM";"O=U'IORNBDKL]JGVINEQWENO15F;JREQ=:=65
M3EWIU96%\($/[WUVCA**"RRN9G%&ZJ01O3_%'*5T=IBC=/_G^*V8L 2?!.CT
M>S21MMOC.C&X9-'J>75EIJ[,U9567>G4E5Y=60@?^M">9W$5BPLLKF9Q1NJ@
MP3V/\5H]GS1Z/A[A5JW$)T%ZSO/]_9YTWF6ER;+;[.@^!RPN9W&6Q3D6YUE<
MP>)*%E>QN,#B:A9G)&,88653['.0SM*&E<5CNZ?6XY/&]=ZE]&?)=GO6T;)\
M2=+>'5.0'&YAZ%X'+,ZR.,?B/(LK6%S)XBH6%UA<S>*,9 @C+&R*O0[2V;QA
M8?&8=7Q5/FFT^C*L&PE/DT7[.8N@-MS#T#D!+,ZR.,?B/(LK6%S)XBH6%UA<
MS>*,Y @C/&R*U'\Z6S0\+)JZU:S-)R'41K8X$6_HWE(J*S-U9:ZNM.I*IZ[T
MZLI"^+"'=SN)JUA<8'$UBS-2[XSH=HC7ZO9EH]OCP>+!\9T_G,KO"$I#7X"S
MN(S%Y2S.LCC'XCR+*UA<R>(J%A=87,WBC&0/(PQMBM![.ELU#&TU27YGS\7L
M"]W7@<7E+,ZR.,?B/(LK6%S)XBH6%UA<S>*,@7F<";3L:]VPKWB<>E!^1X*I
M8N8[@3+<^=#@-8O+69QE<8[%>197['%BSJE45U;JRJ"NK-65QNA+=YK25MMO
M&FT?W\U $=T1MD,8MM[.3N -;WHTKLSB<A9G69QC<9[%%7M<^[#?SI).TRLK
M*W5E4%?6ZDIC]*4[36FKZ;>-IH_':Y79'2&CJSS'H[LHL+B,Q>4LSK(XQ^(\
MBROVN..7BSV]CB:/65Q@<36+,Y(OC+AKF21YG#22QTD\.'PRNB.,TZ_<LQ-0
M@QT,Q64L+F=QEL4Y%N=97+'''46\9NU=HTM6M6)Q@<75+,Y(?C#<P2A>R\$:
M.>HD'H$6DCO":.5%6)PRW,+8G#6*RUF<97&.Q7D65^QQ1Q=AL_6J8V%L?AK%
M!197LS@C&<(("YLD/YVD#0N+YZ UP1T!H?4Q,K=YR>(R%I>S.,OB'(OS+*[8
MX[HAI^[5F+*R4E<&=66MKC1&7[K3E+::O9$T3N)984UNYQ]W7G#]]M.7#S>?
M/E^XMQ_>_OWF8<")O38%T>&-S2:045S.XBR+<RS.L[B"Q94LKF)Q@<75+,Y(
M3C'B0F:2!'+22" GBVDB/ F9SKQD<1F+RUF<97&.Q7D65["XDL55+"ZPN)K%
M&0/S.!-HV5<C4IW$(]7#(CP"K/<)^>:$_;$!;!27L;B<Q5D6YUB<9W'%'M=)
MLG3ORG2%E;8P: MK;:$QZLJ=HK+5](W8<1)?7U4.\ B 6( GTO)L:!G%92PN
M9W&6Q3D6YUE<L<=U=E=+YYV>5U96ZLJ@KJS5E<;H2W>:TE;G-Q*[23QDJTOQ
M")!!IWDVKHOB,A:7LSC+XAR+\RRNV..:;Y&6F^6ZT_#H^L<L+K"XFL49R1Q&
MW+U,L?YQFC22R$D\2'PZRC,B@+R.V1@;0$9Q&8O+69QE<8[%>197[''-/,]R
MG2XZ-H:N@\SB HNK69R13&&$C4VQ#G*:-++523P6+>5YAH:J(S[&)JM17,;B
M<A9G69QC<9[%%7O<T>78:C;K^!B;K$9Q@<75+,Y(KC#"QR9)5J>-9'4:3TAK
M0CT"8HB9Q5&#S0S%92PN9W&6Q3D6YUE<L<=ULBU)YWF2MK)25P9U9:VN-$9?
MNM.4MCJ^D41.XUGBLY,]%TE_:[/A8Q27L;B<Q5D6YUB<9W$%BRM97,7B HNK
M69R1O&+X]0S%:[E;(Z2<IM-D>U(V<XSB,A:7LSC+XAR+\RRN8'$EBZM87&!Q
M-8LS!N9Q)M"RKT;L.HW'KH=E>P38@.VU]B@IY'"I+<RTA;FVT&H+G;;0:PL+
MX9,>WO1L'AG%!197LS@CM="(II\DCYPV\LAI-#*HR/8(@*'[:CW@[F>4->,*
M2:?75769LBY7UEEEG5/6>65=(7S,P[N<Q%4L+K"XFL49J6=&=#G$:W5Y([:;
MQI.VNAR/ -&N?/Z :;X+2.:+;H.S$5P4E[,XR^(<B_,LKF!Q)8NK6%Q@<36+
M,Y(QC+"R2=9 3AMAY#2>)3Z9X1'&#=I)ZX&U.K*PV;IC86RD&,7E+,ZR.,?B
M/(LK6%S)XBH6%UA<S>*,9 @C+&R2=9#31JHZC0>BA?R.,%I]&=9-R/9>AK$1
M:127LSC+XAR+\RRN8'$EBZM87&!Q-8LSDB.,\+!)HM1I(TJ=QB/1JNR.D*K6
M&EG_,K6SV;SC9<K*3%V9JRNMNM*I*[VZLA ^[.'=SB:.45Q@<36+,U+OC.CV
M21+':2-QG,8SP^?G=M+^UF;SQ2@N8W$YB[,LSK$XS^(*%E>RN(K%!197LS@C
M><4(=YLDASQOY)#GLVER.W,V48SB,A:7LSC+XAR+\RRN8'$EBZM87&!Q-8LS
M!N9Q)M"RKT:H>AX/50_+[0@P;6;G =-)K\P[H1UM9::NS-655EWIU)5>75D(
M'_;POF?CQB@NL+B:Q1FIBT;T_21QXWDC;CR/+V@L1W<$P)#8S@-*C.WHZC)E
M7:ZLL\HZIZSSRKI"^(B'=SB;R$5Q@<75+,Y(_3*BPR=)Y,X;B=QY/$2KB^T(
M$,TCU@=$\UW1(EUN.\W-KGF,XG(69UF<8W&>Q14LKF1Q%8L++*YF<48RA1$V
M-DG&>-[(&,^C^<;3D1UAG#JN\\!9'=E7>U^W2T%NN'V1N)S%61;G6)QG<06+
M*UE<Q>("BZM9G)',8(1]0;R6?37"T_-X[EF(ZPBC59=?W<1T[^47FYA&<3F+
MLRS.L3C/X@H65[*XBL4%%E>S.".YP0C_FB0Q/6\DIN?QY+,FJB,@5";6NP[M
M;#;K^IBR,E-7YNI*JZYTZDJOKBR$#WIXI[/!8A076%S-XHS4-R,Z?9)@\;P1
M+)['H\%23.?#V]_>O_T0V2,KSA_^0IO-%J.XG,59%N=8G&=Q!8LK65S%X@*+
MJUF<D4QAA(U-DBV>-[+%\\U$>1QVV644E[&XG,59%N=8G&=Q!8LK65S%X@*+
MJUF<,3"/,X&6?37"TO-X6'I('F>WA[5O'5:M+,EC256_X,ZE5O,)IYEI-9]R
MFKE6\QFG:;6:5YRFTVH^YS2]5O.:TRRTFB]$S<.JP4E\/_!2J_F2TZRTFJ\X
MS:#5?,UIUEK--YRF,5I1\PA45=N\D7U>HWI\[EHTHO"+^'K:4J9LMP>TMYM*
M-IT3EB U;.&H2[7P$U8X4PL_985SM? S5MBJA:]88:<6?LX*>[7P-2M<G!*>
M;=+V.4T2[O>%PT:+O6<WK?S+*>0KM?RK*>2#6O[U%/*U6O[-%/+&J/7O3H53
M_  GSR7='T ^F0S[ 5KGQ\9<BT5\>H0FD;G;0XZ6WMC,%IT3I# 50S4__E+
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M @XKD49/:CKYEY/(5UKY5Y/(!ZW\ZTGD:ZW\FTGDC='JWY_WIO@!3IXV.C^
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M"-?1D(<=\A]0L;B:Q34LSDC>,>*%%L1KN=W&<[MX]TA/CO/D]3@_?WE8+M/
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M//[>']3\<=R;)3PW^XXHNJ*KY:W%19*:[%9F*"YG<9;%%2S.L;BR^VK:+,-
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M8Y]87,+B4A9G69QC<1F+RUG<GL45+*YD<16+,Y(K#%@73]'TMIUO/!_[WMM
M1W8/7,R^T(.?6%S*XBR+<RPN8W$YB]NSN(+%E2RN8G'&P#S.!&KVM?7L*]Q
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M='"T#AG7KI&Z6>[B^;)A7.PVPR@N97&6Q3D6E[&XG,7M65S!XDH65[$X(]G
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M/3T@FIN?+1JFIV@A4IN>4O4<5$W4JA>@:JI6O015K5KU"E1U:M5K4#53J]Z
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M'F:&XA(6E[(XR^(<B\M87,[B]BRN8'$EBZM8G)%L8<!R=Y)>LIW72[;[WC_
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M#DFTA[:/?VWQ>K_(R:07_LX93D7WXU6.U*65OK36EUI]J=.7-OI2+YWTQ4;
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MM7N]]GM:.^BU/]#:QNC%'^YTK/KLO6)"77&S4*L/;W]Q&^<^W:.CC!P_4N)
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M \0-5X?T_C92#/0[D;!TA<)KB9@Q_N%>+917PSP+\QS,:V">O_!&\<UR.S8
M96FG+^WUI4%?:LR"VFM5[= &XD:E0SIHKHG#?2=2]!. )"?# $A>!?-JF&=A
MGH-Y#<SS%]Z3=9T.^]-N//Q)X0[F]3 OP#PC^D3.4PX$')I;W.IR2 >*9T)O
MWXD'+ECW\%J"99@:O%T5RJMAGH5Y#N8U,,]?>$]6YSR4AV)L:O ^5"BOAWD!
MYAG1'W),;9U]J YQ \,A'0-/IMJ^$P_73]7(%/0-S*M@7@WS+,QS,*^!>?["
M>SI5*\MR[&IP?P+*ZV%>@'E&-(@<5UNG/^$0]R<<TFEO.;OVG<C06QL9=KZ!
M>17,JV&>A7D.YC4PSU]XHPC.L(>KU9=V^M)>7QKTI<8LJ+U6U0Z'?QS5/Z1S
MSUGQH:MB9GB3V=X;F%?!O!KF69CG8%X#\SS,:V%>!_-ZF!=@GA'-(F>"LTXX
M_Q"'\P_GM0)$Y*X0-S"O@GDUS+,PS\&\!N9YF-?"O [F]3 OP#QC:"#H" ,[
M.\9Y[V,Z[[TP0"30+CT;\_MY7E\@4G3B1EU9J2MK=:555SIU9:.N]-*I7C[\
M45X'\WJ8%V">$4=2QO"G@,/A'\>AC^G%[A7I(8'P9"VM]+"?7*._*(:O%F_T
MI96^M-:76GVITY<V^E(OG?6,T0^GAU%>#_,"S#/B0,H9_>NDAX]Q>OB8SOLJ
M0T,"Y>( \R._''U2*+;[XC0>]W .&.75,,_"/ ?S&ICG85X+\SJ8U\.\ /.,
M:! YKK;.%A3'.!%]3.>9Y]-"PH$7(TMLNGM]H1R>N-EN._'T J>:45X-\RS,
M<S"O@7D>YK4PKX-Y/<P+,,^(QI#C9NOL0'&,@]W'9+Y2C D)ARLF9SOMY(Q,
MEE8PKX9Y%N8YF-? / _S6IC7P;P>Y@689T1GR+$S"#BTLSC*?4PGLE7Y((&A
M\+3IQ:PWY7'L:LK22E]:ZTNMOM3I2QM]J9?.=L:XA]/.**^'>0'F&7$(Y8S[
M==+.QSCM?$S'E?."0>7,\(8CS2BO@GDUS+,PS\&\!N9YF-?"O [F]3 OP#PC
MFD6.PZV3?#[&R>?C<:5@T!&.,:.\"N;5,,_"/ ?S&ICG85X+\SJ8U\.\ /.,
MH8&@(PSM+$YR']-)[J7!(&$];%TPZ*0.!NDJ*W5EK:ZTZDJGKFS4E5XZU1G#
M'XXYH[P>Y@689\21E#/\UXDY'^.8\S&]Q*PF&"0L4JL/!DVNC%L4Q7D\[I6E
ME;ZTUI=:?:G3ES;Z4B^=]8S1#Z>"45X/\P+,,^) RAG]ZZ2"3W$J^)3.\2J#
M00)%?D_["'CR[>G;WW_\EC:MM/R1!N75,,_"/ ?S&ICG85X+\SJ8U\.\ /.,
M:! 9KD8!AZX6AYU/Z:CR?#!(.% 9#'JD/ D&E8=S,78S>.EGE%?#/ OS',QK
M8)Z'>2W,ZV!>#_,"S#.B,>2XV3KA[5,9NUDZ=BT%@X3#%9.SB=3V].0,3FVC
MO!KF69CG8%X#\SS,:V%>!_-ZF!=@GA&=(<?.UDEMG^+4]BD=OE8%@P2&PM,F
M%^'=;,K#V-64I96^M-:76GVITY<V^E(OG>V,<0_GFU%>#_,"S#/B$,H9]^OD
MFT]QOOF4#!UF!H.V,\.;3$S>P+P*YM4PS\(\!_,:F.=A7@OS.IC7P[P \XQH
M%CD.!P&'#A='GD_[E8)!)WA!:I17P;P:YEF8YV!> _,\S&MA7@?S>I@78)XQ
M-!!TA*&=Q4GN4SK)O3 8)-!TP:!'B"(8I*RLU)6UNM*J*YVZLE%7>NE49PQ_
M..:,\GJ8%V">$4=2SO!?)^9\BF/.I_3BS(I@D$#0!X-.DVO5%D6Q'8][96FE
M+ZWUI59?ZO2EC;[42V<]8_3#J6"4U\.\ /.,.)!R1O\ZJ>!3G H^I7.\VF"0
M,@T\/_)/HV]/AUTYS@.FA3*>:. EG5&>A7D.YC4PS\.\%N9U,*^'>0'F&=$?
M<DQMG:SS*<XZG]))Y40N2!EQ%G)!YU$NZ+ ]39@9O* SRJMAGH5Y#N8U,,_#
MO!;F=3"OAWD!YAG1%W+,;)WH]CF.;I_3H6LI%B0<+D_-SN/,]N34+"VTW,U0
M7@WS+,QS,*^!>1[FM3"O@WD]S LPSXC&D.%F%'#H9G%D^YQ.7JM200)#86F3
MZS)O-A/OF;2EE;ZTUI=:?:G3ES;Z4B^=[8QQ#X>;45X/\P+,,^(0RAGWZX2;
MSW&X^9Q.)^>E@G8SPYN,2][ O KFU3#/PCP'\QJ8YV%>"_,ZF-?#O #SC&@6
M.0ZW3M[Y'.>=S]N54D%G,@5Z _,JF%?#/ OS',QK8)Z'>2W,ZV!>#_,"S#.&
M!H*.,+2S.,9]3@8IEZ:"!-J?BF^/:ZIDT".H* ;IF/&#FZJPTA;6VD*K+73:
MPD9;Z*7SG#'V25X'\WJ8%V">$8=1SMB'@,.Q'P><S^GUF!61(('P9+R+L:#S
MY-K&Q<0.',K*2EU9JRNMNM*I*QMUI9=.><;0A\/ **^'>0'F&7$4Y0S]=<+
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M3B_[&I1M]+)WH*R?E=T,5XU^(\O&'B#EB[6R;T'93B_[#I3M];+O0=F@E_T
MRAJCUWVXCV'"\W>#L;#B=J 1'M[;XA[-?;K_1ID@?J0\62GM/'5S$[I]-*M,
MI1D9;X[@71)1GH5Y#N8U,,_/7$M33Q^:SK'TTP>\?R+*ZV%>@'E&-(^<=TKK
M[)^XC]L"]^G&C/D(\>.!3Y;#/>TG3$[H_%"OKYP&93@=O($BRK,PS\&\!N;Y
MF0OJ-#&CU;02R1EB].=W,*^'>0'F&=$Y<NQNG?T5]W&+V#[=;B-EB/?CII[=
M;MC5\[THHYO9P0UB**^&>1;F.9C7P#P_?2T=C^/EY*5K23&S@YO#4%X/\P+,
M,Z)KY%C=.LUA^[@Y;)]NN-&%B">W1MIL-N-EDP4YG>4IY5X <I5>[B4@5^OE
M7@%R5B]W"\@YO=QK0*[1R]T!<GY>;KB?PAM93N'72K&WSQ;K]&+OGBW6Z\7>
M/ULLZ,4^/%O,&+W:P_O39\HEG'DDI[!F_7? N!UOG^YP$M/#7_[OQY^^?'Y8
M??C3Y[_\G%I_."V5$;>#>_107@WS+,QS,*^!>1[FM3"O@WD]S LPSXA>D3.!
M7J<+[Q!WX1U^Z[S@T\,'<CNJ&YA7P;P:YEF8YV!> _,\S&MA7@?S>I@78)XQ
M-!!TA*&=Q=U>AW2WU\+T\"--7-7R>U'XTMPII8>UDB\@R4HO^1*2K/62KR!)
MJY>\A22=7O(U)-GH)>\@2:^7?"-+*MN2M8IO&<5.K_B.4>SUBN\9Q:!7_, H
M&J.7O'^=@&@N\'2C,/5E;<F',KY1I7=.NOOXZ8>K3Y^O[*?/<_>FZ6V:RHG.
M%D'KR4B7\L5:V1>@;*67?0G*UGK95Z"LU<O>@K).+_L:E&WTLG>@K-?+MOK2
M3E_:ZTN#OM28!;4Z$QF:6-RK=Y"V9Q.[) Z3G1Y%<1POX".(+7,QI>P+4+;2
MR[X$96N]["M0UNIE;T%9IY=]#<HV>MD[4-;/RF[.$[-O3:?4DJ78M=IO:>U.
MK_V.UN[UVN]I[:#7_D!K&Z,7?YBOL^KS]XJQNN)FD;L4^R%N$OSVA_0<7M5(
M\4B)(U+?_D['73&^ Z;U!D_L,W>^)"/C-3K)JV&>A7D.YC4PS\]<38?B>![?
M#H2K2?LRAOP+=#"OAWD!YAG117+>LT/ H?7%/62'="?.?$?%XX&')]?G\;2=
M>&NAW$5-[*E(@S(L#^X>0WD6YCF8U\ \/W-);4^G\7K%TB6U9'EV]&_1P;P>
MY@689T0+R?&]=3K)#G$GV2'=ER.U5CP>/ICK;<MQTE@0TLWUX&8RE%?#/ OS
M',QK8)Z?N9IVYZFYWM*=J68\#VXG0WD]S LPSXCVD>-YZ[23'>)VLD.Z-T?5
M8_'(&+UH+B>><I5[CB6=3RGW I"K]'(O ;E:+_<*D+-ZN5M SNGE7@-RC5[N
M#I#S\W+[\2+NDIS6M)6*;QG%3J_XCE'L]8KO&<6@5_S *!JCEWQX^TIH)GQ[
MI*DP[H5IB;C-[Y!N[LAKP[@J9^Y5Y+Y1-S"O@GDUS+,PS\&\!N9YF-?"O [F
M]3 OP#PCND7.+'N=C=\.<:?9X;=FCQ4:,>"^,I17P;P:YEF8YV!> _,\S&MA
M7@?S>I@78)XQ-!!TA(&='>.^LF-Z1Y^%C1C'R;V$BLWXJY&@J^K!4*J] -0J
MM=I+0*U6J[T"U*Q:[190<VJUUX!:HU:[ ]2\6NV-K#98.NPT\]I *?B6$>S4
M@N\8P5XM^)X1#&K!#XR@,6K%^S<&B*3>JHW"JP7)X>TG[@,\ICLWY/:*XV2;
M2+$_CS>0%[34H62MY M(LM)+OH0D:[WD*TC2ZB5O(4FGEWP-239ZR3M(TL]+
M#EX.MNK*3EW9JRN#NM(8?6G"(OY5.G2H,G:H="N+HG?B.-F\,6U10M^,VJ*4
MDB\@R4HO^1*2K/62KR!)JY>\A22=7O(U)-GH)>\@23\O.?[<)BEJY\TZP;>,
M8*<6?,<(]FK!]XQ@4 M^8 2-42L^S)L)R82;3WQH>Z;D\*X4=_0=TWT3RI:&
M1\J38%)9GG?C^Y+0IB'E/-+'+W\7C?)JF&=AGH-Y#<SSTQ?29KL?KY<N74A:
M\R9_?P?S>I@78)X1_2/C734%')I>W,?U[0^IBV>^F>'QP"?)\W)SF'@KG5;0
M]3&D(1EF1_)JF&=AGH-Y#<SSTU?3IA@NO/]&OIJT9D?^_@[F]3 OP#PC^D:.
MV4' H=G%G5O'= ^,U,%P'&_5=#^UVXXM3^BU$:=V<-<6RJMAGH5Y#N8U,,]/
M7TC?IG;CW@7I0M*Z'=ROA?)ZF!=@GA&-(\?MUNG7.L;]6L=TXXNJ=^&1,5J%
M?&(52$%.-CVEU(MG2E5ZJ9?/E*KU4J^>*67U4K?/E')ZJ=?/E&KT4G?/E/)Z
MJ3>RE-:8E8IO&<5.K_B.4>SUBN\9Q:!7_, H&J.7?'AK2F@N\&:C,.>%KTWC
M%KECNO5![$_XY<>_?/WTRS^NW,>O__GC+Y\^_^7*_/F_?_WT\Z=?/GWY_(>K
MV]OKF5L3N6?3#<RK8%X-\RS,<S"O@7D>YK4PKX-Y/<P+,,^(QI$SJ5YGT[5C
MW(UU_*T=@F]5.,*=5RBO@GDUS+,PS\&\!N9YF-?"O [F]3 OP#QC:"#H"$,[
MBSNOCND]OI:T*GPGTB;7&)J<WEY+K P_A%NW4%X-\RS,<S"O@7G^PANM;3\,
M7[?ZTDY?VNM+@[[4F 6UUZK:@1F<XKZE4SJ3+L4ROQ,)J:5'$U:0IBZW I17
MP;P:YEF8YV!> _/\A3=:CKH\C:Q 6]KI2WM]:="7&K.@]EI5.[2"N(?D)/60
MR%FX[T3*HOE FI5A B2O@GDUS+,PS\&\!N;Y"^_)-];=87<ZCCV 5.Y@7@_S
M LPSHEED//E0P*'#E;'#I8/$,\&W[\0#9Q9233E;$ICA;"2O@GDUS+,PS\&\
M!N;Y"^])5FZW+S;CSC-4N8-Y/<P+,,^()I'C;!!PZ&QQ'\,IG0=/IMR^$P]?
M-FDC(]$W,*^">37,LS#/P;P&YOD+[^FDK=B<SF-K@[L54%X/\P+,,Z)+Y%C;
M.MT*I[A;X90,"2LB;=^)C&7^!H66+_Y&\BJ85\,\"_,<S&M@GK_PAB]HM]L)
M@U.6=OK27E\:]*7&+*B]5M4.+2#.\)_2D6@@;G15S QV,@1\ _,JF%?#/ OS
M',QK8)Z'>2W,ZV!>#_,"S#.B=>1,>=9)\9_B%/_IL%+@Z$3NQW #\RJ85\,\
M"_,<S&M@GH=Y+<SK8%X/\P+,,X8&@HXPM+,X+7Y*I\47!HX$VL.N%/=/<>(J
MD]<7EABTN-&75OK26E]J]:5.7]KH2[UTXC/,  Y3H[P>Y@689\1QE6,&ZX2I
M3W&8^B1M;2$'CM*$D0$DE\RZOO!&L8G];FP"RM)*7UKK2ZV^U.E+&WVIETY^
MA@G $624U\.\ /.,.)YR3&"="/(ICB"?TJ%A;=1(B!Z/9P(S!G >?X'8GG?;
MS7C\PX%BE%?#/ OS',QK8)Z'>2W,ZV!>#_,"S#.B4>2XVSI[09SC3/4YG8B>
MCQD)!TX^VDPOGW5]@3V)C&Q/V_UQY&IIV>6NAO)JF&=AGH-Y#<SS,*^%>1W,
MZV%>@'E&-(@,5Z. 0U>+X^'G=+!;BA@)AZLG:^>)C._VM"G+L:W!:6^45\,\
M"_,<S&M@GH=Y+<SK8%X/\P+,,Z)#Y-C:.IGP<QG;6CK:K8H7"0R]MTVNB;TI
MASO<W^A+*WUIK2^U^E*G+VWTI5XZZ1G#'PY.H[P>Y@689\21E#/\UPE.G^/@
M]#F=?":B13/;+J>5EW^+1WD5S*MAGH5Y#N8U,,_#O!;F=3"OAWD!YAG1.G+\
M;ITT]3E.4Y]W*T6+SF1L]@;F53"OAGD6YCF8U\ \#_-:F-?!O![F!9AG# T$
M'6%H9W$R_)Q.AB^,%@DT=:SHD3,.U4R\I%*65OK26E]J]:5.7]KH2[UTTC.,
M (Y,H[P>Y@689\0QE6,$ZT2FSW%D^IQ>[%81*Q((BR)%Y\EE>HMB5XP-0%E:
MZ4MK?:G5ESI]::,O]=*)SS  .&2,\GJ8%V">$<=2C@&L$S(^QR'C<SH6K(P4
M"13=6]SC^ O5Z30.$Z6U,IYPX,6G49Z%>0[F-3#/P[P6YG4PKX=Y >89T2)R
M?&V=O/0YSDN?TVGG1)A(B$GK@T2G<9#HM#^,_0Q>?1KEU3#/PCP'\QJ8YV%>
M"_,ZF-?#O #SC&@-.7ZV3O3['$>_S^G0MA@C$C+?J@G:1-[[=)AX-P.GO5%>
M#?,LS',PKX%Y'N:U,*^#>3W,"S#/B-Z08VBKI+WWFRCM??^'YP:()(;&U7YG
MC+:&VHS:V-2EE;ZTUI=:?:G3ES;Z4B^=\,5#G^5U,*^'>0'F&7$4+1_Z&' X
M](MXZ*<SS41X:#LSV-F5L5E>!?-JF&=AGH-Y#<SS,*^%>1W,ZV%>@'E&M(X<
MOULE*[W?E+'?E>N$AWX'<W;&+H?-\FJ89V&>@WD-S/,PKX5Y'<SK85Z ><;0
M0- 1AG:VC>TLG?U>%AZ2:$O6)?J=512#^,SX24Y56&D+:VVAU18Z;6&C+?32
MJ<X8_FP4FN7U,"_ /"..I)SAOTH4>K_9Q<,_F4]41(8DPM*5B'[GC4(SPR5U
M;_2EE;ZTUI=:?:G3ES;Z4B^=_ P3('D=S.MA7H!Y1AQ/.28  8<FL(]-(!WY
MU<6&)(JV ?1WSI,O4^5I%!H4]#*>;]AEI%F>A7D.YC4PS\.\%N9U,*^'>0'F
M&=$F<KQME4ST?G.(O2V=:)Z-#DD'+EJ'Z'?8D_A0<9[X*,6N)<WR:IAG89Z#
M>0W,\S"OA7D=S.MA7H!Y1K2''$];)>:]WQQC3TL'M(7XD'2X?J(VD?'>G$]C
M4V,SWBROAGD6YCF8U\ \#_-:F-?!O![F!9AG1'_(,;55,M[[S2DVM7146Q<A
M6K@J]JRS3:X%O=F,>U?5I96^M-:76GVITY<V^E(OG?2,X<]&HEE>#_,"S#/B
M2,H9_JM$HO>;<SS\TYEF(D:TGQGL9.#R!N95,*^&>1;F.9C7P#P/\UJ8U\&\
M'N8%F&=$Z\CQNW42TT6<F"XV*\6("C)$>@/S*IA7PSP+\QS,:V">AWDMS.M@
M7@_S LPSA@:"CC"TLS@%7J13X MC1 )-'2%ZY(Q7X-F.GN.TI96^M-:76GVI
MTY<V^E(OG?0,(X#CT2BOAWD!YAEQ3.48P3KQZ"*.1Q?I9: 5@2*!L"A,5$PN
MI5P4^_&+'&UII2^M]:567^KTI8V^U$LG/L, X$ QRNMA7H!Y1AQ+.0:P3J"X
MB /%13H"K P3"1356]Q'1OQ]:K>9B!&FM3*><-A%HUF>A7D.YC4PS\.\%N9U
M,*^'>0'F&=$B<GQMG:1T$2>EBV00,Q$D$@[4AX@>08<G?C;1#Y$6S/ SDE?#
M/ OS',QK8)Z'>2W,ZV!>#_,"S#.B->3X&00<^ED<^B[2<6TI1"0<KIN@C9/>
MV_-$@"BME6%H<-(;Y5F8YV!> _,\S&MA7@?S>I@78)X1O2''T-9)>A=QTKM(
M![95 2*!H7.UR56?-YO-A+$I2RM]::TOM?I2IR]M]*5>.N$90Q\.1*.\'N8%
MF&?$490S]-<)1!=Q(+I()YJE\-#73S]????K/W[\^I 3FAG59*;R!N95,*^&
M>1;F.9C7P#P/\UJ8U\&\'N8%F&=$C\@QMG5"T44<BBY.:Z6$R(SH#<RK8%X-
M\RS,<S"O@7D>YK4PKX-Y/<P+,,\8&@@ZPM#.XI!WD0YY+TT)"<M@%X\/:\?[
MKH_-G!&>IP,RY7[\M*8LK?2EM;[4ZDN=OK31EWKIC&>X !Q]1GD]S LPSX@#
M*L<%UHD^EW'TN4PO]*R(" F$R\C?2Z._G%PMN2C&']64E96ZLE976G6E4U<V
MZDHOG>[EPQ[E=3"OAWD!YAEQ!&4,>PHX'/9Q1+A,AWJ5P2"!<AGZ\T.^&'UT
M*@_E;AP(3"LM?Z1!>37,LS#/P;P&YGF8U\*\#N;U,"_ /",:1(ZKK9-W+N.\
M<YE.*\_'@H0#+T96'))N5HXR0>5^MQF''--R&6X&KP:-\BS,<S"O@7D>YK4P
MKX-Y/<P+,,^(QI#C9NN$M\LXO%VF8]=2*$@X7#$Y&T>VR_WV>!S;&9S91GDU
MS+,PS\&\!N9YF-?"O [F]3 OP#PC.D..G:V3V2[CS':9S%'J(D$"0^%IN^DT
MS'Z\I*VVM-*7UOI2JR]U^M)&7^JELYTQ[DE>!_-ZF!=@GA&'4,ZXAX##<1]G
MF\MT.%G* _WR\:=/'S]?N2^_?/GZ]X__N'KYY:<?/GW^R\]7[1__Y_\HR]W_
M]\>O?_QI9K"3R<D;F%?!O!KF69CG8%X#\SS,:V%>!_-ZF!=@GA&M(\?OUHD^
MEW'TN3RL%!,JR33H#<RK8%X-\RS,<S"O@7D>YK4PKX-Y/<P+,,\8&@@ZPM#.
MXCAWF8YS+XD)75]HPZ>/_3#?\KTH_*3]XSY7<+I_[BNFO/-&K_N"U*WTNB])
MW5JO^XK4M7K=6U+7Z75?D[J-7O>.U/5ZW3>R;G'_TJ2X5R\>7IV44Y*M7O(M
M)-GI)=]!DKU>\CTD&?22'R!)8_2:YCM*=('Y&X7[2Z+#6UH<Y"_3*Y-+F;?K
M"V'X-SEO)VYCPC+HPQ6TY%N94OL%K5WIM5_2VK5>^Q6M;?7:M[2VTVN_IK4;
MO?8=K>UGM8]#[3>R]L LBOO?4.R3-SNE^%M<O-.+O\/%>[WX>UP\Z,4_X.+&
MZ-4?;HJP_/Q-92RON*OHY8<WRKA%I$PW=8Q2HE?_O/J?_^.T/>RF'EBO)5[&
M&ZS';HEM=,:.IU.Q&=\)A?:4V)W2=T!X P"49V&>@WD-S/,PKU5?4F_E2TK]
MD /WR:"\ /.,Z"HYK\'6Z9/9QGTRVW27RTRT]/IR8)RB.A7;8C=Z4! 41A;U
M6Q9U[BDA35O^<A_EU3#/PCP'\QJ8YV<NJ\W0IM[(E]5PIG!,38O1OT4'\WJ8
M%V">$6TDP_LHX-#[XF:A;;K-)QE$O;X<_N12/6QWY[$#+MAI(/F*) W*,#^X
M6PCE69CG8%X#\_ST%55LCX>Q^4D-:LIWW^A?H(-Y/<P+,,^(%I+C>^NT$VW+
MV/?274%R8O7ZPA@^U!?'B0G@@KT6TO:GU/S_:7NWYKB1-,OVK_#I6+=9=5G<
M+W:>/"D2!$$0!(,@"):=!W6FIDIVLJ0>9=;4U%C_^"$IBNG$Q;\=CH4RF[;2
MM,=:(36P@8C8'_R<<B:Z\X)RIKKSDG)FNO.*<N:Z\YIR%KKSAG*6P\Y]3[!;
M WMJL(O*.TA9Z<I[2%GKR@=(V>C*1TCIG.Y\_OZ6D08"OB,5$O[('S67_K38
M,CSN9=2L+P^'MV;UTX(O/__Y9#YP02-G3\Y@7@+S4IB7P;P<YA4PKX1Y!YA7
MP;P:YC4PSYE!$7,K/LWPV-(?'GOZP[.#+U6_@KDX(WD)S$MA7@;S<IA7P+P2
MYAU@7@7S:IC7P#SG:""8".TX\V?BEN&9N"-+U:^TYQTE_5O03?<;!F.?D.>;
MSL$=',]4T?E(4:**+D:*4E5T.5*4J:*KD:)<%5V/%!6JZ&:DJ%1%M[9H[WVZ
M&DAC274W6E6IJOO1JEI5/8Q6-:KJ<;3*.=7U\F%_I$S.6">$[+"L?<7PIPJ7
MX<U0A,[RLG<CD/E\M>U>)XR=5WX\SC-XK1!UYX NT747@"[5=9> +M-U5X N
MUW77@*[0=3> KAS4S9:K[A7%T/GG\A\MRX%KBZB] [65KKT'M;6N?0"UC:Y]
M!+7.Z=Z7JQ$F'D[UKEB(=47<OD;YHZ++\,R.\E#9TS?*N\>.[9:=:M,'T_=Z
M8SEP>8*W_$%Y*<S+8%X.\PJ85PX<1>O]?-'->.,H$CXUP-L!H;P:YC4PSYG!
M$?,=SC3; 2W]*<)E> 0CT C^_L)WCXG=S3:+13?@C"F/'Y^<^W>I/K, $2D'
M[P2$\C*8E\.\ N:5 X?28K>?=U/..)1:U_[>>^<#_!>H8%X-\QJ8Y\S4B(FZ
M:;8*6OIS8,OPJ(M9 -[+=W3&3$WPCHX<*TE@7@KS,IB7P[P"YI4#1U'_'9UQ
M% EW=/!>2"BOAGD-S'-F8L3$W#0S7BM_QFL5'I61^KZKWHU\9NMM]^[.T 7#
M3M6<C] DNN9BA";5-9<C-)FNN1JAR77-]0A-H6MN1FC*0<UFM^ODKJ6Q<U>5
MW8V65;KL?K2LUF4/HV6-+GL<+7-.MSU_]SE6-YRP79T0L?)O<2M_'FX5GBHZ
MOFJ[&+B6D$,S9S O@7DIS,M@7@[S"IA7PKP#S*M@7@WS&ICGS*"(N NF@.UT
M6_CI]GU(@:_:KLA->,Y@7@+S4IB7P;P<YA4PKX1Y!YA7P;P:YC4PSSD:""9"
M.\[\N:A5>"[JR*KM*\VNVAI:LVJKB<Y'BA)5=#%2E*JBRY&B3!5=C13EJNAZ
MI*A013<C1:4JNK5%PD=]274W6E6IJOO1JEI5/8Q6-:KJ<;3*.=7U\@%_I$S.
M6">$K/[QWI\U>_I#^..]6;5])2A56T,F56U5W3F@2W3=!:!+==TEH,MTW16@
MRW7=-: K=-T-H"L'=7U56TMW3-56U=Z!VDK7WH/:6M<^@-I&USZ"6N=T[\O5
M"!,/IWIOU980MZ]1_@#A*CQD(E9M7RG^3^JK7?M[] ^F+?Q+);QI'LI+85X&
M\W*85\"\LO\8VB][?AP</9R'OO,*YM4PKX%YS@R-F.]OIME.;^4/OJW"0PO#
M-=O7%V[>A5O/!AV&P"[9A@$1"0?OHX?R,IB7P[P"YI4#!U+[.6BW]H$D5FS1
MMU_!O!KF-3#/F8D1$W/3;+.W\F>G5N$I%*MBN^J.N_3?R8T8F0J_-B+GX)$I
ME)?!O!SF%3"O[#^&>N_D1@],H>^\@GDUS&M@GC/3(B;BIAF86OD#4ZOP"(I6
MK^W?(V<V[R:=-#LUD'2:Y7R$)9$M%R,LJ6RY'&')9,O5"$LN6ZY'6 K9<C/"
M4@8LW7D&2R,$KBB[&RVK=-G]:%FMRQY&RQI=]CA:YIQN>_FB<Z0N%*UMG1"N
M^@]O_IC9*CRW8_5J/_[\C__S?SZ?_/3MXY=??OO3R=75Z< U!-Z%#.4E,"^%
M>1G,RV%> ?-*F'> >17,JV%> _.<F1,Q=[_3#)>M_>&R]?=1!+Y6NR:W%#J#
M>0G,2V%>!O-RF%? O!+F'6!>!?-JF-? /.=H()@([3CS9Z#6X1FH8VJU/YDT
M_VOS_5 ,PL-2*"^!>2G,RV!>#O,*F%>^\8R6X4%=6*D+:W5AHRYT3EYY*JQL
MG_4+_ZP/;V!B52-_,@F]>U8/G_/P1!'*2V!>"O,RF)?#O +FE6^\;H-KT3WK
MQ:65OK36ES;Z4N>.6'LJK6TG@#].LPY7KI7BV4\F1;K>P_L0H;P$YJ4P+X-Y
M.<PK8%[YQO-_W=RO=O-M]\R'-QA">37,:V">,R,BYO/,-!L,K?VACW6XL#M0
M,_O)?&%[:^WA/ MR(O*,Y"4P+X5Y&<S+85X!\\HWWN9=GLTWNVZ>D>(*YM4P
MKX%YSHR&F#R#@.T\\P<$UN&Z=;!/]I/Y<ND&C6P;G\&\!.:E,"^#>3G,*V!>
M^<83;M#@.0"45\.\!N8Y,QMB FV:.8"U/P>P#K>K[?;83R9#2C6R7'P&\Q*8
ME\*\#.;E,*^ >>4;K]VJ62QZ;M3$I96^M-:7-OI2YXY8>RJM;9_Y?C5^'>X;
M'U\+&MK:.BR*.+?APCS*2V%>!O-RF%? O!+F'6!>!?-JF-? /&<F1<R-S32U
M^+5?BU_OIBH&D5L-G,&\!.:E,"^#>3G,*V!>"?,.,*^">37,:V"><S003(1V
MG/DE[G6XQ'UL,4C8$&05>@C-Z1O#Z$:<J0L3=6&J+LS4A;FZL% 7EM8_<<1I
M#]>;45X-\QJ8Y\PS*.:TGZ;>O/'KS9OPD]:%9I!!>#O5@\^<.GWC=!YQU7[T
MPYF^--&7IOK23%^:ZTL+?6EI_:,??_*CO KFU3"O@7G./(\B3GX*V#[Y_3+P
M)ES?%4M!!L6[U@^<^//.#PA/Q_Q\USWMX6HORDMA7@;S<IA7P+P2YAU@7@7S
M:IC7P#QGYD-,J$VS#\+&[SIOPDWEX4:0\<)WGUGZ'RIU^@;9O NS17MOIS/+
M%A%F<&<9Y64P+X=Y!<PK8=X!YE4PKX9Y#<QS9B[$A-DTNR!L_-KV)ERXMNI
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M-LGN%INYWZ&>AQO0@=*149T6GKUU^D9YWR-9=':"-VP180:WHE%>!O-RF%?
MO!+F'6!>!?-JF-? /&?F0DR83;*WQ6;N%\/GX4JWV3L2]P,83K-NOW>U7\^Z
M:0;WO%%>"O,RF)?#O +FE3#O /,JF%?#O ;F.3,88M)LFC[XPN^#+\*U;JEU
M9##L2%OT/U"[NY>JNC*15Z;RRDQ>F<LK"WEE:?TS'W_"H[P*YM4PKX%YSCQW
M(DYX"M@^X?W:]"+<>Q;+1A=??_WE\Y>__O:GDZN;D_\X<?\Q/SG]^O>_?_UR
M$GB^?%A]_ _V*"^!>2G,RV!>#O,*F%?"O /,JV!>#?,:F.?,[(@)O&EZU0N_
M5[U83-0_6L!-:927P+P4YF4P+X=Y!<PK8=X!YE4PKX9Y#<QSC@:"B=".,[\L
MOE#+XB=?__GETR\G__;YR\EO?_OXY/OWD_]^_6\#>;;L?$V^6+0_AWPPW\'3
MQ[V!?%/XYY'\1.1?1/)3D7\9R<]$_E4D/Q?YUY'\0N3?1/)+D7]K\W\,00VD
MJF*Y&V6I1,O]*$LM6AY&61K1\CC*XIRH>7X:\1B/&H-.R,%^3SO;_:K\(MA?
M#>QF]/I"_S>!Y;Z[E9'!?_FB;KX9BF^RK9O O!3F93 OAWD%S"NU8^C6/H;>
M[5PT$+'D.Z]@7@WS&ICGS)R(N7&%@.UP\XOSBW#5W=JTZ/7E[W::V?9$G%FH
M'T@W^-'I*"^%>1G,RV%> ?/*WL-GL^CN@F$=/L:](US81WDUS&M@GC,S(B;8
MIBGL+_S"_B)<MY?V)GIE/#]GXH]? ;OA9A;[!\+-II]'TA.)?A%)3R7Z920]
MD^A7D?1<HE]'T@N)?A-)+_^@MW^7GO7<$AH*(S1%T=TH4:6+[D>):EWT,$K4
MZ*+'42+G=-/+Y^\1JM,C5$(@:A_!_?F+17AR(O;G\87R\SC\W'B4E\"\%.9E
M,"^'>07,*V'> >95,*^&>0W,<V9VQ-R]3C.;L?!G,Q:[J7X>AY]9C_(2F)?"
MO SFY3"O@'DES#O O KFU3"O@7G.T4 P$=IQYD]G+,+C%6-^'M]W?A>:SW?K
M[H=T<\!C(-\4_GDD/Q'Y%Y'\5.1?1O(SD7\5R<]%_G4DOQ#Y-Y'\4N3?VGSC
MT[IBN1MEJ43+_2A++5H>1ED:T?(XRN*<J'GY>#["H\:@$W)0^FR^]&=5EE%[
M%YR^O=#_\G\Q[Q:;#'[XY_'PBX^_/45Y*<S+8%X.\PJ85VK'T*U]# D_CZ/O
MO()Y-<QK8)XS<R+BQI4"ML/-G\M9CMC.X/3MY?[AN5]V$\[8]&#HWC3\NHAP
M@R=M4%X&\W*85\"\LO?H62YWW7 3]\P8R#5X_ ;EU3"O@7G.C(B87)MF_&:Y
M\'-M[+8&IV\,X]=QPS0<;C;]/)*>2/2+2'HJT2\CZ9E$OXJDYQ+].I)>2/2;
M2'KY![WS(V7/':&X)\= :(JBNU&B2A?=CQ+5NNAAE*C118^C1,[IIN>/WV-4
MIT>HA$#4/H'[PT?+<3M5?/WRZ;>3#Y]^^_7C/[X]_2]^.TF__/:/;Q^?GY:<
M?_SR\:^?7E_ZY><_#UP(X!TL4%X"\U*8E\&\'.85,*^$>0>85\&\&N8U,,^9
M 1)S"SO-#A9+?RSGZ0_3_$3^"N;BC.0E,"^%>1G,RV%> ?-*F'> >17,JV%>
M _.<HX%@(K3CS!_$6:([6!BTO^R?[S'GS__CCV^^=T-Y2-;_SV!> O-2F)?!
MO!SF%3"O?..U/PRM%JV?(P_ZTDI?6NM+&WVI<T>L/976ML/ 'UY9CMYMPB#T
M!L#+,YO7P2@@']Y_!O,2F)?"O SFY3"O@'GE&Z^S9\]NWHT"<6FE+ZWUI8V^
MU+DCUIY*:]M1X(\^+)&M)PS*<?<#\$0$RDM@7@KS,IB7P[P"YI4P[P#S*IA7
MO_'\GVUW3RFP[28./>K  L%3O1UP_JC#,G8;"N.%O9FV#08;/!N!\A*8E\*\
M#.;E,*^ >>4;[]W3"W:+^:9[;P,//:"\&N8U,,^9&1$3;-,,/2S]H8?EN"TI
MC)<?=\M&/@3_#.8E,"^%>1G,RV%> ?/*-]Z[C>;V^_FVFVSP]A0HKX9Y#<QS
M9DC$)-LTVU.L_,K_"MB>PF <%6]AUO'QAO(2F)?"O SFY3"O@'GE&Z_]E<Q\
MM>H$G+JTTI?6^M)&7^K<$6M/I;7M"/"+\:M1&U9DV>V)^_4_/WW[_>-)_OF7
MWW[_]NGCWT_./W]Y:1T--XW"UH@3'6[0H[P4YF4P+X=Y!<PK8=X!YE4PKX9Y
M#<QS9FQ$W.Y0P';6+?RLFVJOBA6\5P7*2V!>"O,RF)?#O +FE3#O /,JF%?#
MO ;F.4<#P41HQYE?%U^%Z^+'-(U.WVCM^\A-NQ7QP12_[4CXO&WT\Q?UO1_W
MSG3E.:1,=.4%I$QUY26DS'3E%:3,=>4UI"QTY0VD+'7EK:WL?"\R$.VB\8XQ
M5KKQGC'6NO&!,3:Z\9$Q.J<KGZ>8$.<1F>Z$4#><[0N5W_!?!6NW9@ON](W0
M^HO,YYON$+XA>SO5U\H%2M2>@]I$UUZ VE377H+:3-=>@=I<UUZ#VD+7WH#:
M<E [6W>?-VUI XW3@4N8Z+ZCW97NOJ?=M>Y^H-V-[GZDW<[I\I=+'6L?OE9T
M[<+%0K:W+W_^1,@J/,.A-#]/WRCO'B*R7BVZS]DR=._N=0<O?/!H!\I+85X&
M\W*85\"\LO=@6LTV/0_<L@XF]5,,O'4+RJMA7@/SG)DA,5]03;-UR\J??EF%
M9U>&GRCX^L+-NZR;S;O[41F&5M8%GB\8!D4$'CS @O(RF)?#O +FE;U'U&HV
M6_7<_4;,6PT]:A#]2U0PKX9Y#<QS9H#$I!X$;*>>/^BS"H_H6(\:7'6G#@;N
M\XQ1(.D^#Q[907DIS,M@7@[S"IA7]AY,J]Y-IJR#2;W/@T=Z4%X-\QJ8Y\SP
MB$F\:29_5O[DSRH\P",]A/"5T7GR5L\FI(9."SY1=P[H$EUW >A277<)Z#)=
M=P7H<EUW#>@*77<#Z,IAW7Z]?_>?;H0?.T8W$.%1_CO&7\7Z[QE_'>M_8/Q-
MK/^1\3L7^P9>OLLEWD'@6F"\ ^'2<.2/F/X4V$K=^J:_*'USR)H3]_/__,?G
MWS[__OGKE]!S&,.JB#HA/.6%\E*8E\&\'.85,*^$>0>85\&\&N8U,,^961%S
M%S_-,-C:'P9;?Q\DX=O1:WBJ"^4E,"^%>1G,RV%> ?-*F'> >17,JV%> _.<
MHX%@(K3CS!]L6X<'VXY\#J-!^WYC.0O?VIY:F(@HA.?>4%X*\S*8E\.\ N:5
M;[SV)Z%U]PF,XLI*7EG+*QMYI7/ZTE-E:3L %GX A)_/+SQ[T2!T3_I@-^G4
M D:<_O"<&,I+85X&\W*85\"\\HW7/@'VNWWW_!>75OK26E_:Z$N=.V+MJ;2V
MG0+^D-0Z7&L7'[MH4.3+/[S!!LI+8%X*\S*8E\.\ N:5;[QWNV(NUCU/MT#%
M%<RK85X#\YP9$S$?<:;9.6/MS]6LP^WEX2<N&B_LO;'I+3F=6JR(3"-Y"<Q+
M85X&\W*85\"\\HVW>9=I\TW/'0TIKF!>#?,:F.?,>(C)- C8SC1_6&(=+IQ;
M#ULT7B[?J,%;9:"\!.:E,"^#>3G,*V!>^<9[OWWY8C7KAAH\"('R:IC7P#QG
MYD-,J$TS"+'V!R'6X5*Y])Q%@R$G&[SS!\I+8%X*\S*8E\.\ N:5;[Q.%V?=
MW?E#75KI2VM]::,O=>Z(M:?2VO;9[P\$K,/=ZKCFT,E\X/R&-_5 >0G,2V%>
M!O-RF%? O!+F'6!>!?-JF-? /&>F1<P-SC03 &M_ F"]FZH[!&_E@?(2F)?"
MO SFY3"O@'DES#O O KFU3"O@7G.T4 P$=IQYG>]U^&N]['=(6,#D*7W_)[%
M?B@(]_U=B&6K-W&F+TWTI:F^--.7YOK20E]:6O_B$2D %Z)17@WS&ICGS!,J
M)@6F*41O_$+T)KRSA5 @,@@O9_Y:.?LWO0_YG\^VR\[9KRY-]*6IOC33E^;Z
MTD)?6EK_ZL>?_2BO@GDUS&M@GC-/I(BSGP*VSWZ_/[P)-W[%XI!!>;OV#Y_Y
M\^XO"[/.WG1GENGX3S8H+X5Y&<S+85X!\TJ8=X!Y%<RK85X#\YP9$#&I-LT6
M&!N_%+T)5YJ'*T/&"]^";!Y.LT6G_#'?[Y>[;IK!S6:4E\*\#.;E,*^ >27,
M.\"\"N;5,*^!><X,AI@TFV8'C(U?[MZ$:]E66<AXN7!SUM//G<WFJVZ<P45M
ME)?"O SFY3"O@'DES#O O KFU3"O@7G.3(:8.)NFS[WQ^]R;8+]2JPD9#"'3
M5OUEAYY0TU8F\LI47IG)*W-Y92&O+*U_YH@3GN15,*^&>0W,<^:Y$W/"0\#V
M">^7G3?AMG)D,V@Q<&+#G6:4E\"\%.9E,"^'>07,*V'> >95,*^&>0W,<V9:
MQ$3<--7GC5]]WFPF:@9MX"(SRDM@7@KS,IB7P[P"YI4P[P#S*IA7P[P&YCE'
M \%$:,>9W^7>A+O<1S:##)K7#!K(P&U_)::]O]^9OC31EZ;ZTDQ?FNM+"WUI
M:?UC1P0 W'1&>37,:V">,\^EF "8INF\\9O.F_ 39I52D/"0Z+5UXO<^(7<^
MV_;T L2EB;XTU9=F^M)<7UKH2TOK'SSBQ(<[P2BOAGD-S'/F.11SXD_3"=[X
MG>!-N,6K]H&D+O# 2;_O_MJT7/3\=@X_[AGEI3 O@WDYS"M@7@GS#C"O@GDU
MS&M@GC.C(2;/IFDW;_UV\S;<31YN ADO])M _3GV"GC_!)C]MI-C8='Q.8;R
M4IB7P;P<YA4PKX1Y!YA7P;P:YC4PSYF1$)%C%+"=8WY/>QMN6%L=(./EP1NR
M;4\W>SGK?O<2=D0$&5S-1GD9S,MA7@'S2IAW@'D5S*MA7@/SG)D),4$V335[
MN_"#+-RPEMH_!B.<9OT/VIWU!9JX--&7IOK23%^:ZTL+?6EI_4-'G/)P?QGE
MU3"O@7G./'MB3OEI^LM;O[^\#1>0K?[/QW_\C[]__')R\?'77T_^GX]__Z__
M]SD;OO[\^>/OGW[[T\G5U>G B0X_A1KE)3 OA7D9S,MA7@'S2IAW@'D5S*MA
M7@/SG!D;,5DW3;EYZY>;MZN)BD!;LOEY!O,2F)?"O SFY3"O@'DES#O O KF
MU3"O@7G.T4 P$=IQYE>WM^'J]C%%H-,WFEEC^6"*W^TQW5L?.--UYX NT747
M@"[5=9> +M-U5X NUW77@*[0=3> KM1UM[9.>2#R03?>,<9*-]XSQEHW/C#&
M1C<^,D;G=.7S3N6(\XC<=D)P&\[VQ<@OV6_#SP:W2FFG;X1NG6K>O0 9#R+_
M<9H'.VQGNO(<4B:Z\@)2IKKR$E)FNO(*4N:Z\AI2%KKR!E*60\K9?K/L7IR.
M?5I_<.O(@^Z^H]V5[KZGW;7N?J#=C>Y^I-W.Z?*7RQEK'[P>]-B%"X)L;U_B
M_,&+;7A40JE?GKY1WOUBOYKM%MV+G#"9L1KZ,>W,>GW$ETCP8_-17@;S<IA7
MP+QRX$!:MI_\<FL?2.JG%'C8!.75,*^!><[,CY@OF:89-MGZPR;;\*C(0$?S
M].V%[RJ6R^VJYV9>&$;Y\9F]O]!Y9D$BP@Y^J#[*RV!>#O,*F%<.'$V[]:X;
M=L;1).\K>H#_$A7,JV%> _.<&1XQB3?-E,W6G[+9AN=C@FW.T[>7"_=WPAQ.
M\/X.GK%!>2G,RV!>#O,*F%<.'$CSY;P;><:!I-[?P3,X**^&>0W,<V9PQ*3=
M-#,X.W\&9Q<>I;$KGZ=OC.XSR_:=T#-T9NBIJO.1JD1778Q4I;KJ<J0JTU57
M(U6YKKH>J2ITU<U(53FLZKD7M51B,*O&.\98Z<9[QECKQ@?&V.C&1\;HG*Y\
M_CX5<0:RN>,4POFXGP=W_HC4+CSC9-6,OWS]YZ^??OGKIY.;;U]/?OK'OSY]
M^_Z@P8'K$3E[<0;S$IB7PKP,YN4PKX!Y)<P[P+P*YM4PKX%YSDR+B#MI"MB.
MN(4?<=^G-?AV\8Z<*SF#>0G,2V%>!O-RF%? O!+F'6!>!?-JF-? /.=H()@(
M[3CS!\-VX<&P(]O%K[1.2VW;;1<;XK_,G^X]@T\E/--UYX NT747@"[5=9>
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M\ >AT\W:MJ]-ENO=F6X\Q5"UGH/61+9>@-94MEZ"UDRV7H'67+9>@]9"MMZ
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M/"YV9/WXE68^7_.#*5:>ERSKS@%=HNLN %VJZRX!7:;KK@!=KNNN 5VAZVX
M7:GK;FW=RRQHZR/9T "SJKT#M96NO0>UM:Y] +6-KGT$M<[IWI<O%C#Q$:GN
MA%A7Q.WKE3_]-P]OK28TE.>]6XK-Y^TY[0^F3'YNLJH\AY2)KKR E*FNO(24
MF:Z\@I2YKKR&E(6NO(&4Y:!RMMATKU^&LN^,MQ^5K+Z!NTG>0*6_@?M)WD"M
MOX&'2=Y H[^!QTG>@'/Z.WBYXDWP%H:O%MVW(%PNCGL+[:N@/S0Z#\\ B;7E
M5\J[C9.WF^[S]0R;^8BI\.LCOHEB-R-D>1G,RV%> ?/*WN-H/=]TGRAJ'4='
M?=)A-RQD>37,:V">,R,DYMNJ238LW,[]^<1Y>"@DT%O^_D*_:+K9;+M/U#,$
MVB.4PY"(O&-W*V1Y&<S+85X!\\K>@VD]:W?@;^V#J2_O@H]11O\B%<RK85X#
M\YR9'S&A-\FVAMNY/Z,V#X_ZF,7E[DA1_UV>.)LVF'KP:!K*2V%>!O-RF%?
MO++W.%K/=CVC&LJ^:>I='CR=AO)JF-? /&=F1TS@33.=MO"GTQ;A81^IN;SH
MW?MHUMG[Z(.I,X-/59V/5"6ZZF*D*M55ER-5F:ZZ&JG*==7U2%6AJVY&JLJ
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MD=Y*]]Z3WEKW/I#>1O<^DE[G=/'+E8LS#\=_URSDOV1N7\W\":VG/X0$XC,
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MF>K*2TB9Z<HK2)GKRFM(6>C*&TA9#BO;-9U;6WE,]5C5WH':2M?>@]I:USZ
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M6K950EQ*G]27_C3(,CS'$?$S_,L4V=\__?+Y>83T_6_R_9>+\%LX_H<JE)?
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M!]BZG;5>[2=*; 4;M<F%9NT?\':1/Z#7_P'O%OD#@OX/>+_('Q#U?\"'1?X
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M[H[Y30PR38'#^ /';BKAQ2U <N4 >*X=RFM@GH5Y#N9YF-<J3Z(W\DFDJ03
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MTCC+][$U/2&)H<BTW73C8;,=IYI26NNEC5YJ]5*GEWJ]M)5^[8)QSQ:>65Z
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MTI;S-K\VLZ(8)!!&"; 34V!RS=IJ4XV[ EIIK9<V>JG52YU>ZO725OKU"U(
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M5_=..K @P>"2-\JS,,_!/ _SVIE3J%H?!E]6WBA.H<=7 M7DPC4=_'?W,"_
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MY3OAJJ45!88ZVDZ3&UNLJOUX+6RMM-9+&[W4ZJ5.+_5Z:2O]Z)</?Y37P[P
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ME[R')+U>\@&2#'K)C[*D9F7E@U[QD5%L](I/C&*K5WQF%#N]X@NC:(Q>TGR
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MM/Y,=%..?",2=NK2+(NLE;L&Y"J]W T@5^OE;@$YJY>[ ^2<7NX>D/-ZN0=
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MJ6V"TDH^0I*-7O()DFSUDL^09*>7?($DC=%K?NN$8D1/,'BC</@36Z%6<;/
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M0-/GA=Y <EY(5UAI"VMMH=46.FVAUQ8&Z7?.&/LDKX%Y+<SK8)X1AU'.V(>
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M0>A5>K%:15Y(( P<0,P,K4;7VBW*[8@+*$LK?6FM+[7Z4J<O]?K2(/WZ&2X
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M8%X#\UJ8U\$\(UI%Q@2* O;]+0YX;XJ9(E ;,NYZ!?,JF%?#/ OS',SS,"_
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MEKS>Q GR33K[+>61A,.5D[1A#OBKI8V]EH$#X2BOAGD6YCF8YV%>@'D'F-?
MO!;F=3#/B.Z08VGSY,8W<6Y\DXY_J\)( D/I:Z-K52\6(ZMU:TLK?6FM+[7Z
M4J<O]?K2(/WB&6,?CE>CO!;F=3#/B,,H9^S/$Z_>Q/'J33H?G9,3FMAP+:V4
M\6$=3E"CO!KF69CG8)Z'>0'F'6!> _-:F-?!/"-:18Z_S1.TWL1!Z\U^KIP0
MG)I&>17,JV&>A7D.YGF8%V#> >8U,*^%>1W,,X8&@H[0L[-M'.O>IF/=)^:$
M!)HN(_0&D3-"NL)*6UAK"ZVVT&D+O;8P2+_QZ>,>Y34PKX5Y'<PSXA#*&/<4
ML#_NX[CS-KT6M2(C)!#T^:#MZ%K.13%\1Z.LK-25M;K2JBN=NM*K*X/T<V<,
M>S@6C/):F-?!/"..H)QA/T\L>!O'@K?I(*\R&"10Y/>R;X#X>]/7:[XLAR,>
M7KX:Y=4PS\(\!_,\S LP[P#S&IC7PKP.YAG1(')<;9[ \S8./&_3<>7I4)!P
MH#(0]$;9R&X&KUZ-\FJ89V&>@WD>Y@68=X!Y#<QK85X'\XQH##EN-D]X>QN'
MM[?)&*48"!(.5TS.5B.3L^5VF&],*V78&<FK89Z%>0[F>9@78-X!YC4PKX5Y
M'<PSHC/DV!D$[-M9G-C>IH/7JC"0P%!XVOB2OXMR.70U96FE+ZWUI59?ZO2E
M7E\:I%\[8]S#N6:4U\*\#N89<0CEC/MY<LW;.->\30>3<X) RXG!#:]ZC?(J
MF%?#/ OS',SS,"_ O /,:V!>"_,ZF&=$J\CQMWE"SMLXY+S=SA0$VL+K7:.\
M"N;5,,_"/ ?S/,P+,.\ \QJ8U\*\#N890P-!1^C;69S;WJ9SVZ<&@815LG5!
MH)TV"*0JK+2%M;;0:@N=MM!K"X/T&V>,>SC/C/):F-?!/",.H9QQ/T^>>1OG
MF;?I19\U02!AV6A]$&ATO=JB6&^'(UY96NE+:WVIU9<Z?:G7EP;I5\\8_7#\
M%^6U,*^#>48<2#FC?Y[X[RZ._^[2@5UE'DB@R*]GWP#O/CFM]YO%8-RGE4Y_
MED%Y-<RS,,_!/ _S LP[P+P&YK4PKX-Y1C2(#%>C@'U7B\/-NW0T>3H/)!RH
MS .]4=[E@=:;S?!34UHNP\W@I9Q1GH5Y#N9YF!=@W@'F-3"OA7D=S#.B,>2X
MV3R9[5T9NUDZ;2WE@83#%9.SD;#V>KLIAG8&A[517@WS+,QS,,_#O #S#C"O
M@7DMS.M@GA&=(<?.Y@EK[^*P]BZ=N5;E@02&PM-&5V1>+);#T+:VM-*7UOI2
MJR]U^E*O+PW2KYTQ[N%8,\IK85X'\\S_3]O;]L:M9&FV?T7  (-NH&XAR7S'
M!08(I26*8H:8=(JBJ$)],,YQ5PE]2C[7Q]6-&O2/OY(LIT-\B;T97"R@>]J#
MR+7"+O())G/O"/$6"KGOIREKWKAES1MOK:%8#_3YM\^_?"O^^>7;Y^_%0#WW
M-5DA>0'S$IB7PKP,YEF8E\.\ N8=85X)\RJ85\,\(Z9$2+1!P&:TN27.F^5$
MI4 ;LO#S N8E,"^%>1G,LS OAWD%S#O"O!+F53"OAGG&T$ P$9IQYE9N;_R5
MVT-*@78G6O.+QK:QQ<4'T?N7^&W+U]5K(4%/PNELEX M4=NN %NJMET#MDQM
MVP,VJ[;= +9<;3L MN*GK5'1U6BH_"C+ML[YZSV!K5+=CE:56M7=:%6E5=V/
M5M5:U<-HE3%:ESD?+]NI98H8[I<U%Q6W7'[CW\_[\.GQU[/'I[/L\:EO'5EW
M_@7F[65$V#G\QRV[E)82E? 2$B9:X14D3+7":TB8:85[2&BUPAM(F&N%!TA8
M] H;;W&/VH&E=F"E'5AK!QJC'MD?!S]'-L/(+7;?2)N4^XM>=R="LU)SL5VU
M\TBHA5?GD5)Y"2D3O?(*4J9ZY36DS/3*/:2T>N4-I,SUR@.D+'J5\2)N/_H*
M2O>AX_E_O19A+?L>@I7:6U!;ZK5WH+;2:^]!;:W7/H!:8_3>U\=F3-R?^&VQ
M(O(UXN;ZY39M;/PM%YJR[=V)XA;VK.?;>=1>P80.CY]?@GM6+G@K>I27PKP,
MYEF8E\.\HOM"6JR;F]A^E"\DQ0L.N$T%Y54PKX9Y1HR.D#?2T[2I;-TVE:V_
MP:2GH'MW^N#J7<2MHEDKX@3#N_=\45_.^2'#<P[EI3 O@WD6YN4PK^BYFK:;
M12OGI*NIL?YW/C\?X?F7,*^">37,,V)N!(0=!6R&G=N]LO4WH7CKO7>GC[N+
M\6JUG&_:D2<TNTA/=?[/!Z0=W+V"\C*89V%>#O.*[@MI'2_F[;03+B3YJ0Z=
M>@GS*IA7PSPC9D9(T$W3V+*-W:#S=Z;(E>"[$Z/Y2VXT7[3S3FB$$?-.J;H<
MJ4KTJJN1JE2ONAZIRO2J_4B5U:MN1JIRO>HP4E7TJU;M]ZF22I')2MGM:%FI
ME]V-EE5ZV?UH6:V7/8R6&:.WO;P=':OSI&]+IXA?=5G!UNTFVOH[@:2N@K]_
M_NT_SLX??_WER]G^6T_A@5\QO @7Y24P+X5Y&<RS,"^'>07,.\*\$N95,*^&
M>4;,B)"'XVG:I;9NN]3S'UX<?$_!&YB+,Y*7P+P4YF4PS\*\'.85,.\(\TJ8
M5\&\&N890P/!1&C&F=LBM?6?X#"PIV#;?9C!JNM;OW!TQ(_O7(M3+<N?_K)Y
M_I]XV_<:0.F^I-V)WGU%NU.]^YIV9WKWGG9;O?N&=N=Z]X%V%S_=_GUH/\KF
MUR]VD?=5@TIU.UI5:E5WHU655G4_6E5K50^C5<9H7:\O&$;*=FJ9(N?[9<UE
MRVV%VTJ'F(B%PMO.5J,H6L?MI4K9:_1C,UW=<J7T7T[A3_3^JRG\J=Y_/84_
MT_OW4_BMWG\SA3_7^P]3^(L^_VRU;E>G27XW0J0:9*WV%M26>NT=J*WTVGM0
M6^NU#Z#6&+WW=1'$Q+V+28=8L9IHQ,VET6WHVTH-?:H:Y#>*6V2PG*VW[;51
MV2[UX_'6OR;")^*@O!3F93#/PKP<YA4P[PCSRA,OBM]=]=NHG='"5:_X$@(?
MEH/RC!@C(6^SICDL9^OV#V[]_1V>>N3O'W0K2!?;Q;H==\H.+#?NOF]*W9MY
MY.$D"<Q+85X&\RS,RV%><>(MWUU9S:K/C_*5U7@LZ"U-A@\+0GD5S*MAGA$C
M)"3WICDL:.OVG6W]_3MB:7*[3V@Y6[9W<! T Q_VX.8SE)?"O SF69B7P[RB
M\Z+J#CY-[YG_-37<>X;R*IA7PSPCQD=(YDW2>[:>.;UG+W_P73>:*N4?C-9F
MRZU66\DV*/JTVDM2FZBU5Z0V56NO26VFUNY)K55K;TAMKM8>2&WAT;8JGT6O
MF/-JV>UH6:F7W8V657K9_6A9K9<]C)89H[>9\_$Z7Z*W*Y]'Z)KK4N2N2_ZN
M*U7E\]67W]Y*G\]V7_[QCR]/9Q?_WS\?O_VK9Q4CFXPN8%X"\U*8E\$\"_-R
MF%? O"/,*V%>!?-JF&?$R!C^_(T!FSD7NSGWO6\$+X3^ >;BC#W^BN6E,"^#
M>1;FY3"O@'E'F%?"O KFU3#/&!H()D(SSN9NG&D;ULZ^_/?3YU_/_NWQZ>R/
MOW]Z]OW[V?^\_5\]>39O_;:TG#W_I_V.07%ZUJ;OE8)*<CE"DF@E5R,DJ59R
M/4*2:27[$1*KE=R,D.1:R6&$I-!*/LJ2[U^G?/W-2M?M>%>I==V-=U5:U_UX
M5ZUU/8QW&:.5O7Z_'VM3IZE1Q*G'UEPH%NY"L0BK,?CQP?>_LK47 3_^[3;M
MW^Q,  0\[I*\%.9E,,_"O!SF%:K+Z*-\&;V[^/OK"=C9ES"O@GDUS#-B7(0\
M#$/ 9L8MW8SS-VT(]00_/NY>HIO6/F>2Q/^XRQZ8QO)2F)?!/ OS<IA7=%Y!
M72$G7$&:ITWV)#665\&\&N89,2I"\FV2D]36LY6;;_X:?%WM0-?!/>V0$ZK]
MO2$G&RY'&!*5X6J$(549KD<8,I5A/\)@58:;$89<93B,,!0JPT?9H E4670[
M7E2J1'?C195*=#]>5*M$#^-%QJA,K]_7QZIT,6D4.3G@R_K:#7I_HX;\8_S7
MW[[\\I]GY__\U_/_]^[+U]^[SS<7/ &_6;&=4"POA7D9S+,P+X=Y!<P[PKP2
MYE4PKX9Y1@R*D,?82=J=UK.-FVZ;J7Z")YL@+F!> O-2F)?!/ OS<IA7P+PC
MS"MA7@7S:IAG# T$$Z$99ULWSOR=(,/V(OM!:U:"+IL]^1]$\5^BOS;W:.J)
M.:7R$E(F>N45I$SURFM(F>F5>TAI]<H;2)GKE0=(6>B5'V7E:[7T3'X_H#3>
M,L92;[QCC)7>>,\8:[WQ@3$:HU>^OD@@G ,RW2A"77 V%JK(;3V+_(T#\NYC
M/PBMW9=:FX])KG=WNG!2L=9Z"5H3M?4*M*9JZS5HS=36/6BU:NL-:,W5U@-H
M+7JMLT6KLUC4MA) V#Q,[;ZEW:7>?4>[*[W[GG;7>O<#[39&+W]9XV![_R+1
MMBN6";6]N>ZYK6V1O[5-M[78#\J[ZI#%IK77CF1K/./VK'AP*QO*2V%>!O,L
MS,MA7M%]+2W7K:/PQ&M)^>4%G7X)\RJ85\,\(R9(P'LI"MB,O=B-/?\)2?T5
MOV\?=&N5-_-Y:U\=2=#Z-M];^^L'!<0=W.J&\C*89V%>#O.*G@MJT]KZ7;R@
MNIX&^BJ T;]#"?,JF%?#/"/&1TCF3=,.%[GM<)&_>4*J '[[^+MU.5YU/.-)
M/1J:9SSVW#:6E\*\#.99F)?#O*+G6HH[GO&$:TG[C,<>Z\;R*IA7PSPC1D=(
MWDURK-LZ<KNZGO_@NWA4%<%OC/;>,QVYY]?I<D^INP1TB5YW!>A2O>X:T&5Z
MW1[06;WN!M#E>MT!T!7]NO:F8))-F]DZX2TC+-7".T98J87WC+!6"Q\8H3%J
MX^N[5D+I2>R.S<)&*IMKC]MM%_G;F,0BY2^??OOC=<NPQZ>__?&GL_U^U[,^
MD:TZ%S O@7DIS,M@GH5Y.<PK8-X1YI4PKX)Y-<PS8E"$/%E/TVL7N;UVT??.
M#KY(.?*VC 3$&<E+8%X*\S*89V%>#O,*F'>$>27,JV!>#?.,H8%@(C3CS.TH
MB_P=90.+E-]HFB)E0?SZI>SEU+UXUO>^0.FZ'.M*]*ZKL:Y4[[H>Z\KTKOU8
ME]6[;L:Z<KWK,-95]+KF<;OF6'(Y/U]U[E!^U-MNQ]M*O>UNO*W2V^['VVJ]
M[6&\S1B][O5]P%A??Q2W?8HL]OB::XO;SQ?YSX#2U!5ONOX2412WM]\19*_W
M\5)<4Y2^2\*7Z'U7A"_5^ZX)7Z;W[0F?U?MN"%^N]QT(7]'GFZV747NM$7SM
MPDG?JJ/TWI+>4N^]([V5WGM/>FN]]X'T&J,7OZY.G+DWXCO,BHQ7F9LKEMNR
M&?F;;+05P>VCPE;1O&-S3$'WF@G]:Q5[X!S+2V%>!O,LS,MA7M%Y%6V>+Z)%
M.^FEYDG%MPKVR#F65\&\&N89,3A"WOU,<^1<[/;]Q?XFB_Y"X+</NG6;J]ER
MNVH%G&!X#;COYPGWI9R?,#SE4%X*\S*89V%>#O.*SDMI$T<=Y7#2I?2N]-<3
M=>A?H(1Y%<RK89X14R,@ZBA@,^K<5J_8WS CU?_&[;Z<[B<ZP>-_HO-_."#K
MX.XNE)?!/ OS<IA7=%Y%F_DV;G]WEZXBQ1,=.O<2YE4PKX9Y1DR,D)B;IK4K
MCMV8\S?*J,I^WQC-+^11O&BGG="7XT\[I>=RC"?1>Z[&>%*]YWJ,)]-[]F,\
M5N^Y&>/)]9[#&$_1ZXD[RG@ECR9_E;;;\;92;[L;;ZOTMOOQMEIO>QAO,T:O
M>WD3.MK7'[=MGR)O];_3Q6YS7*P]*ZZ[8/<?C[]]/OOPY9=O7[[ZRG7]EN'U
M;2@O@7DIS,M@GH5Y.<PK8-X1YI4PKX)Y-<PS8DR$/!%/TP@7NXUPSW]X<?#E
MNF]@+LY(7@+S4IB7P3P+\W*85\"\(\PK85X%\VJ89PP-!!.A&6=N;U7L[ZT:
M6*[[1FN526[;W_2EHZG^JMM26&F\A(R)VG@%&5.U\1HR9FKC'C):M?$&,N9J
MXP$R%OW&CLV$):6R[U=KO&6,I=YXQQ@KO?&>,=9ZXP-C-$:O?'V)0#@]8=ZU
MF?!(9W.%<OOC8O_)1XJBWS="JZBRO=&8X!JTF;#2>@E:$[7U"K2F:NLU:,W4
MUCUHM6KK#6C-U=8#:"U^6J.&M;U>"=+!6PGKS+>TN=2:[VASI37?T^9::WZ@
MS<9HU:_K&NO>J=V*A2%T^^#8;9V,_5TSRF+A-XI;%!#--LMV@XN@4^VQY&<$
MO&2"S^%#>1G,LS OAWE%]\44+58=OW *%Y/V"PM\3A_*JV!>#?.,F"$A+Z&F
M.:<O=OOZ8G\;AJ=N^/L'5^^R;C7O**.3&CW^JMQ!V \*"#SXI#Z4E\$\"_-R
MF%=T7U%1O.PH'Q:NJ"%;"*-_B1+F53"OAGE&#)"0U)OF.+_8[0V+_6TV8@EQ
MNYTGFBW743O[!IV%UA-[<&\8RDMA7@;S+,S+85[1?3%%<=0^,TBZF+3/>7!_
M&,JK8%X-\XP8'B&)-TU_V-SM#YO[6VY4U<3SSD-_9K-FU?L'4:<*/JWN$M E
M>MT5H$OUNFM E^EU>T!G];H;0)?K=0= 5WATZU9H2SIE:&N-MXRQU!OO&&.E
M-]XSQEIO?&",QNB5+V]=$:<OMYM.17 /^S5Q[O;MS?V=4%)I\M.7+[__Z^S\
M\==?OCP/>/KESSV+%-GK<P'S$IB7PKP,YEF8E\.\ N8=85X)\RJ85\,\(\9$
MP.,U!6QF6^QFV_=N#KXT>4Z>T'0!\Q*8E\*\#.99F)?#O +F'6%>"?,JF%?#
M/&-H()@(S3ASN\CF_BZR@:7);[3F\^>J8R=A0:RN3=8J+R%EHE=>0<I4K[R&
ME)E>N8>45J^\@92Y7GF E,5/9=10MM\H,&?)Z7RWC*_4^NX87Z7UW3.^6NM[
M8'S&:(6O[Q$(XTYM5,3XP+<(;A/@\Q]\Z,.GQU_/'I_.LL>GKM7H7 3HBS1W
M)U:S-#1>-7+B0C\TT0]-]4,S_5"K'YKKAQ;2/WS HRG)*V%>!?-JF&?$6RGD
MT10"-N]_MVMN+IU(YN]).!<) XM9=Q(PX#LZ?'@9RDMA7@;S+,S+85YQXC4S
M<[9NK*1'_=!2/[32#ZWU0XT9,':G&MM, ;<S:>XO"E?6:[]1W-*+>33?+MJ[
M8PD^W>_9\"%>*"^%>1G,LS OAWE%]]4T6\11>Y=GZ6K2?H6#3_E">17,JV&>
M$5,DY %HFE.^YFZKRMQ?[M]?L?WVP=6[ZW.[VL3MM!O4GN(IV?:# B(/[E%!
M>1G,LS OAWE%YR45;S?;5<=;JZ%-*IZ:;?1O4<*\"N;5,,^($1*2>]-TJLS=
M3I6YO^I?JME^^_C[U?EE;_YV^@UJ6.D)/KA7!>6E,"^#>1;FY3"OZ+R:XNU\
M'F_;P3>T6:4G\^ ^%917P;P:YADQ/D(R;YH^E;G;IS+WE_SKJK:WW;]E-7NM
M/X@Z7?(I=9> +M'KK@!=JM== [I,K]L#.JO7W0"Z7*\[ +JB5[>>+;;N?]H)
MSO3=!.EO&7T9J+]C]%6@_I[1UX'Z!T9O3*#_];=;8@+]JX P <6:,.RGW(7;
MD[3PUYI+!>&_?_[E\=-OW_ZU^_3ULZ\BW*\9_O,,RDM@7@KS,IAG85X.\PJ8
M=X1Y)<RK8%X-\XR8$P&/[A2P&6YNM\OB>]4Y7Q&^@!M<4%X"\U*8E\$\"_-R
MF%? O"/,*V%>!?-JF&<,#003H1EGL1MG_N-*AE2$GXNTUB\!FY?_U7GLRDZ"
M!00BW"*#\E*8E\$\"_-RF%><>.+FND?]T%(_M-(/K?5#C1DP=J<:VTP#MS]D
M(9TR)!;A"82^ CPQ"^"#B5!> O-2F)?!/ OS<IA7G'C-^V"[7LV<_T3M8 CY
M7!GXN2KP<W7@YXP)_>!N^ >;,>/6^B^\]<2J*K]SD3+P88.LF;Z >0G,2V%>
M!O,LS,MA7G'BO=O=*UXM.A*%%)<PKX)Y-<PS8EB$?*V"@,V$<[L9%OY>A)YB
MOG/Q@QVU5&*RP5T,*"^!>2G,RV">A7DYS"M.O'?;M<;S>4>RD>(2YE4PKX9Y
M1@R)D&2#@,UD<SLT%OX:=V^YWKGX\8$/;62=]P7,2V!>"O,RF&=A7@[SBA/O
M_4-;/-NVHPWNP$!Y%<RK89X14R(DVJ;IP%BX'1@+?RV[7)5W+C(&YAM9SWT!
M\Q*8E\*\#.99F)?#O.+$:V\(V9%PRJ&E?FBE'UKKAQHS8.Q.-;:9 6XWPL)?
MUCV\=NDLZKFWR;KE"YB7P+P4YF4PS\*\'.85,.\(\TJ85\&\&N89,2E"'G&F
M:3Q8N(T'B^U4U4ODYOD7,"^!>2G,RV">A7DYS"M@WA'FE3"O@GDUS#.&!H*)
MT(BSI5MIOO17F@^L7A)HK\THL=.0\O+N/9[U!.*R>W/V5M7&A7YHHA^:ZH=F
M^J%6/S37#RVD?_GA:8#R2IA7P;P:YAGQQ@I( PK83 .W-'LI'40@5B\)A%8"
M+,44B+KN@2AJ_E!\H1^:Z(>F^J&9?JC5#\WU0POI7S\@!>"*9I17P;P:YAGQ
MA@I)@6DJFI=N1?/27X.L+"X2**TDZ$^ N.,WA]ERT;[_X?)DE)?"O SF69B7
MP[P"YAUA7@GS*IA7PSPC!D5(NDVS@__2K=!>^NNK^PN+A ^V BU:>5-MWBX2
MB3;1O)UJ<*$URDMA7@;S+,S+85X!\XXPKX1Y%<RK89X1 R(DU2!@,]7<@O"E
MMR13+"H2/C[@86W1?EB+EMNX'6MD46H"\U*8E\$\"_-RF%? O"/,*V%>!?-J
MF&?$A B)-0C8C#6W"GSI+^96%10)C '9UKDS]VP6=SRT*8<F^J&I?FBF'VKU
M0W/]T$+Z5P^X_^%::917P;P:YAGQ5@JY_Z>IE5ZZM=)+?[%S0#%1W'-OPX70
M*"^!>2G,RV">A7DYS"M@WA'FE3"O@GDUS#-B4H3$VS3UTDNW7GJYGJB8: G7
M/:.\!.:E,"^#>1;FY3"O@'E'F%?"O KFU3#/&!H()D(SSMS2[Z6_]'MH,9%B
MM_E6,5'4%XC?8<T3&CM^1%0-3+0#4^W 3#O0:@?FVH&%]&\=</_#M=$HKX)Y
M-<PSXJT4<O]/4QN]=&NCE_X=<37E0XK=K#O+AWKO^^[=?;>+5?O.5PY-]$-3
M_=!,/]3JA^;ZH87TKQ^0 G!),<JK8%X-\XQX0X6DP#0EQ2NWI'CE+P)6E@\)
ME/9;V[X$> .]^T6J>;+7A>0;_@T'Y:4P+X-Y%N;E,*^ >4>85\*\"N;5,,^(
M,1&0;12PF6UN@?3*7][<7SPD?+"G>*@WTZ)V\=!JW<XT> -KE)?"O SF69B7
MP[P"YAUA7@GS*IA7PSPCQD-(IDU3[KV*W4SS%VI+I4/"QP<\J'74>7=\3?/[
M D(-KO)&>1G,LS OAWD%S#O"O!+F53"OAGE&S(>04)NFRGOE5GFO_,7:JL(A
M@3$@V>8=KV';P2:/2E2C4M6H3#7*JD;EJE&%]$\:<'/#Q<XHKX)Y-<PSXGT2
M<G-/4^R\<HN=5][*0[DJZ/';?SQ^_7QV^/3U^QC/)D-^U? ?TE%> O-2F)?!
M/ OS<IA7P+PCS"MA7@7S:IAGQ*P("3@(V PXM^QYM9RH+F@%;V6-\A*8E\*\
M#.99F)?#O +F'6%>"?,JF%?#/&-H()@(S3ASJ[A7_BKN(75!NQ.MM2M.8U.<
M#Z)7L0W1A5IW2>@2M>Z*T*5JW36AR]2Z/:&S:MT-H<O5N@.A*W[J&M5=C5>F
M'V6;LYMRYT;*1ZWK=KRKU+KNQKLJK>M^O*O6NA[&NXS1REX.4A]MVZEMBDSV
MV)I+C%M)O_+O&BZ5GNU.A.8V2[/MJKVN"%N4ZS:WNM [+REGHG=>4<Y4[[RF
MG)G>N:><5N^\H9RYWGF@G$6?<[:-UUOW/^V%2-K;O^M8R]XE*602M^0DRL!)
MW)&3J (G<4].H@Z<Q ,Y"6,"9_&Z"G+3Z%U,I&DHEA;5-)H+I=NCL?)W56BJ
M,W<GBOM;_7JSBF?MI5)HXO WW5](@( W3/"N_"@O@WD6YN4PK^B\DI;+V2IJ
MKQU2.Y#B2PS<E8+R*IA7PSPCAD?(VZ=INE)6;E?*RM]3TE.SN3M]T*VR7*^W
MLW4[Y(2N%<6.<!<2)2#IX W[45X&\RS,RV%>T7DY+1?QJN,I66J":AQ>VAMW
M</L-RJM@7@WSC)@<(7$W3?O-VFV_6?L;9[SEG+O3Q^4G.\$C/]GY </S#N6E
M,"^#>1;FY3"OZ+R2EO/M:M;*.^E*4CS9H7,O85X%\VJ89\34"(@Z"MB,.K<;
M9^UOJI&+/'<G1O.;>K3<MA-/Z.&1$T_INASK2O2NJ[&N5.^Z'NO*]*[]6)?5
MNV[&NG*]ZS#65?2[YNUHEMK6%-&LD]V.EY5JV=UX6:66W8^7U6K9PWB9,6K;
MRXO3T3I/"#=UBA#6_WZXCMVEQ-_%%%12W+/5H%\UO 8/Y24P+X5Y&<RS,"^'
M>07,.\*\$N95,*^&>4;,BI!GY6D:HM9N0]3Z>U\&7U*\)CM(+F!> O-2F)?!
M/ OS<IA7P+PCS"MA7@7S:IAG# T$$Z$99VX+V/,??,]K TN*WVB*DF+!JRLI
M5NHN"5VBUET1NE2MNR9TF5JW)W16K;LA=+E:=R!TQ4^=6%(LV9RO81OOVP&5
M\!82EEKA'22LM,)[2%AKA0^0T!BM\?5E :+<J96*Q):4S57([=-;^X\6450=
MK[M/U-C.%^VE1SC'1%UUK'5>4LY$[[RBG*G>>4TY,[US3SFMWGE#.7.]\T Y
MBU[G>M.Q/$EG_G254?H7*J7\%I>7>OD=+J_T\GM<7NOE#[C<&+W]=6F#]?V+
M0UNO6!WT^N:"YW9RKOW=.ZWJX;/_.?O?_VLS7RVZOBON)%[ RZ.W/J2Y\R\6
MS>+YIKVR*3OP^E<T^$0>E)?!/ OS<IA7P+QCWZ4T;];KW<J7DOJK"7QF#\JK
M89X1TR3DS=,T9_:LW4[#M;]#H[^<^.V#[\^QC^=1^T%?V:;E+R?V4P+>H\-'
M]J"\#.99F)?#O*+G<IHO.\KK]"U%:_DQ&#[8!^55,*^&>4:,CY#,F^9@G[7;
M-+;V]]Z(-<7M'I\HCN)-._G&=HOY 0&A!W>+H;P,YEF8E\.\HOM*FFT6RW;H
MZ;O%_'D'MXRAO KFU3#/B-$1DG?3M(RMW9:QM;\#1U=8W'WNSBSN>+.K[!_K
MCSVEZW*L*]&[KL:Z4KWK>JPKT[OV8UU6[[H9Z\KUKL-85^%Q=;RAU3>Y^0-:
MJ;R%E*5>>0<I*[WR'E+6>N4#I#1&[WQ]WXI(?4'=]99UI+2QZ&S<QKV-OPTJ
MJ 1YWKTV^57#7[NBO 3FI3 O@WD6YN4PKX!Y1YA7PKP*YM4PSXA9$?!430&;
M >>VZVV^MV[P)<@;\MB="YB7P+P4YF4PS\*\'.85,.\(\TJ85\&\&N890P/!
M1&C&6>S&F;]E;.!IYP+M+]'LY7E2Z*7;29R +(2[RU!>"O,RF&=A7@[SBA-/
M**0\:@>6VH&5=F"M'6B,>N1.,;)YZ[O-5!O_R5"*@\X%0NMV%_8<W$G$@!L?
M[L-">2G,RV">A7DYS"M.O-:^L?&\?>LKAY;ZH95^:*T?:LR L3O5V&8,N$U(
M&W]IN?*D<X&B7_F]G(  ('D)S$MA7@;S+,S+85YQXKF_I<:S9=?*3XI+F%?!
MO!KF&3$G0K[>0,!FN+F]+1M_07'_4>?"!UMYUK^'X4Z"!80:?& 5RDMA7@;S
M+,S+85YQXJW>A5HT7[=##3Z)"N55,*^&>4;,AY!0F^8DJHW;O[#QEVI+9YT+
M']<_JL%M#R@O@7DIS,M@GH5Y.<PK3KSWCVJSYM9P1UA<PKP*YM4PSX@!$9)J
MT[0D;-R6A(V_PEMUV+G T$<;6=]\ ?,2F)?"O SF69B7P[SBQ&M5WRPV[7!3
M#BWU0RO]T%H_U)@!8W>JL<W;WZW.W_AKG:7"H6^?_O'['W_^Y<L_OM<,]=S6
M9!GO!<Q+8%X*\S*89V%>#O,*F'>$>27,JV!>#?.,&!(A#S;3U.%OW#K\S7:J
MBB'R9(<+F)? O!3F93#/PKP<YA4P[PCS2IA7P;P:YAE# \%$:,39UJWPWOHK
MO =N6OA&:VT-MV[O6BB(3XT=J]<M>+HC3JN[!'2)7G<%Z%*][AK097K='M!9
MO>X&T.5ZW0'0%7K=1UFW=5YR=">W5G8[6E;J97>C995>=C]:5NME#Z-EQNAM
M+WU%8W4#DMDHHKE?UUQIW%+[K?^4!,7&A-O.(QFBJ%E&\T&4O=O@S;O"*)67
MD#+1*Z\@9:I77D/*3*_<0TJK5]Y RERO/$#*HE?9=9*.I'3O\Y_UGCUKD%)[
M"VI+O?8.U%9Z[3VHK?7:!U!KC-[[NE9AXO[$[SR%AQ WUZ_87;_\W1#*4\K?
M*.]^-MTLH^:YZQ]$G_,8VK-TP5T2*"^%>1G,LS OAWE%SY6T>;XWVCDO7$F*
M;QCP^3PHKX)Y-<PS8G@$O!NB@,W$<UM*MOZ&D/YM!=\^^*[B;1/-H_;N6H+B
MW7?MJ#?IX+80E)?"O SF69B7P[RBYW*:SYNU1A_ERZGQ#-#Y#'V$_P(ES*M@
M7@WSC)@<(7$WS?D]6[=UYOD/OHM'VE'P[>/OUN/U9M;<G/>#*)*?[+R?#\@[
MDI?"O SF69B7P[RB^TK:S#;-[P@?Y2M)\61'SKV$>17,JV&>$5,C).H@8#/J
MW$::K;\?1K69X+;[)(#E*FX'GO*XC=[ 4ZHN1ZH2O>IJI"K5JZY'JC*]:C]2
M9?6JFY&J7*\ZC%05O:I5U^]Y@DJ1R4K9[6A9J9?=C995>MG]:%FMESV,EAFC
MM[V^(QVIZT_?MDX1O_K?\]R^I:V_\4@N\?WV^?E_?_W\O,RD3W]\>_SVSV^/
M7YX^_796_OGXY[/DRW]]_OKT\O$S^^7I\[_.[*>O__D\]/*?3WVU)W #$\I+
M8%X*\S*89V%>#O,*F'>$>27,JV!>#?.,&"@A3]+3]#EMW3ZG[?<^";X<> LW
M+:&\!.:E,"^#>1;FY3"O@'E'F%?"O KFU3#/&!H()D(SSMR^K:V_;ZM_APWA
M@ST_WNQ.'WQW?,9VNVK\BGDA&0("#&[/0GD9S+,P+X=Y!<P[PKP2YE4PKX9Y
M1LR"D ";ICUKZ[9G;?V[X8L_XFRU:01W5Z&\%.9E,,_"O!SF%3#O"/-*F%?!
MO!KF&?'&#DFC2;JK-C.GN^KE#V-_9_G!:'?B-S-).S)1CTS5(S/U2*L>F:M'
M%M*_].#[E>65,*^">37,,^*E/_Q^Q8#-^S5R[U>I1T5XI_WY]]\?G_[V_']\
M>?K\Q]G5YT^_??O[+Y^^?CX[/L_G\9?/?_SI;+_?]=SG[(D1+"^!>2G,RV">
MA7DYS"M@WA'FE3"O@GDUS#-B>(0DWB0G1FQFL9MX\33OKW^ N3ACVQE87@KS
M,IAG85X.\PJ8=X1Y)<RK8%X-\XRA@6 B-.-L[L:9OP!\V'86/VB*[2PD\5^B
MO_Y)LZ6%6GD)*1.]\@I2IGKE-:3,],H]I+1ZY0VDS/7* Z0L],J/LO*U$&G6
M6XUTBG:E\98QEGKC'6.L],9[QECKC0^,T1B]TIQ#S@&9;A2A+CB;"]7"7:B\
M5=Z*W3!^$-I["[37)K_KW9TN;(BAM5Z"UD1MO0*MJ=IZ#5HSM74/6JW:>@-:
M<[7U %J+7NMLV6J=%K6M!!#VR5"[;VEWJ7??T>Y*[[ZGW;7>_4"[C='+7]<X
MUMZ_2+3MBF5";6^N>TMWW?/7HNMVT?A!>=]K&4?ME4\Z]^?=,V[/BL<>S\/R
M4IB7P3P+\W*85_1<2^M%>RG0=%$HOKRPA_RPO KFU3#/B D2\EYJDD-^-K.5
M&WO^9IG>K31^?/#=W@>K=6LC#4G0^C;?MYF&  J(.[;MA>5E,,_"O!SF%=T7
MU#J.VW$G7%!=3P,]^VFP?X<2YE4PKX9Y1HR/D,R;I#5F,UN[F><_OD<HQ?SQ
M\7?K\BI>M9-/.B5(\XS'-L>PO!3F93#/PKP<YA4]U])VU@X]X5K2/N.QO3,L
MKX)Y-<PS8G2$Y-TDO3.;V<;-.W\+C*[8<]/Y=GHVZ_C%4>JXT>2>4G<)Z!*]
M[@K0I7K=-:#+]+H]H+-ZW0V@R_6Z Z K?+KM^_^T,URP:S,\; *WS 3*X G<
M,1.H@B=PSTR@#I[  S,!8X)G\/HNEYB"=T7P3T&Q0@S\^7+KKG7^-BNA4/IV
M=YF>F8N[BWM?/31['A;+2V!>"O,RF&=A7@[S"IAWA'DES*M@7@WSC)@1(0_Q
MTW1L16['5O2]RX2OAX[(?I@+F)? O!3F93#/PKP<YA4P[PCS2IA7P;P:YAE#
M \%$:,:9V] 6^1O:!M9#O]%>_A_W6;3]3E;0GK[]K9__)Y[UO)S0V2X)6Z*U
M71&V5&N[)FR9UK8G;%9KNR%LN=9V(&R%UO91MCF_FFU[WD#H7+?C7:76=3?>
M56E=]^-=M=;U,-YEC%;V\G)@M$T=QD:1QAY;<VV)W;7%?ZR,HH3YC= J_UQT
MK"C*TY"6XJJB=%Y2SD3OO**<J=YY33DSO7-/.:W>>4,Y<[WS0#F+7N=LOFFO
M/8*S7;_I6X64WEO26^J]=Z2WTGOO26^M]SZ07F/TXM=UBS/WQW_;K,A_E;FY
MFKF=HY&_UT=9F/Q&>;=_6#2+Y[/V@J8\^:I_(6-/O6)Y*<S+8)Z%>3G,*WHN
MI6C>\8NG="EIOFNP)UZQO KFU3#/B/$1\G9HDA.O-I';A/C\!]^%TU^5_/9!
MMX@TFFWGS8JJ#Z+B%'/1RIMU7DI UI&\%.9E,,_"O!SF%=W74S2+5JTSJ\7K
MZ5TULB_PR+]!"?,JF%?#/"-F1TC@0<!FX+G=9Y&_AT<J28[:K4)]3W?*\X;Z
M$P_N.D-Y*<S+8)Z%>3G,*[HOI5DT7W<DGM3#J'BZ@WO.4%X%\VJ89\3<" F[
M:7K.(K?G+/)W\*CJD=\8S>JS.)ZW(T]H&)(C3^FZ'.M*]*ZKL:Y4[[H>Z\KT
MKOU8E]6[;L:Z<KWK,-95]+L6[9Y@R:7)9J7M=KRMU-ONQMLJO>U^O*W6VQ[&
MVXS1ZU[?FX[U>:*XY5-D\8!?_-R.OLC?'B55_5[M7X_O.TOOWVKGOGS]X^S?
M#K_]ZQ]?_OGM[V=I^N]_.ML?>A8B]C@LEI? O!3F93#/PKP<YA4P[PCS2IA7
MP;P:YADQ.T(>H:=IZ8O<EK[H>P?%!-7 Y-DZ%S O@7DIS,M@GH5Y.<PK8-X1
MYI4PKX)Y-<PSA@:"B=",,[=K*])V;9U]^>^GS[^>_=OCT]D??__T[/OWL_]Y
M^[\ZIG\NDO_2V=ZV.WWNW6XDB\UZTRBDN5"/3-0C4_7(3#W2JD?FZI&%]*\;
M</?#K4THKX)Y-<PSXHT4<O=/T]H4NZU-L?\PJMZS/:4/OKY1Z3O?\\>'WVV]
ML=BV;F^_8_@##,I+85X&\RS,RV%> ?..,*^$>17,JV&>$=,@(,(H8#/"W':F
MV%_)[OW]]ES\>.]3RMOGQ R#3]Q">2G,RV">A7DYS"M@WA'FE3"O@GDUS#-B
M'(1DV#0G;L6QFV'^2F;Y9]ESD=$?9)T5U[/9K'7 L7IHHA^:ZH=F^J%6/S37
M#RVD?^2 VQT^D0KE53"OAGE&O'-";O=I3J2*W;Z"V%^<+?UF=DA>?BZ[^?S?
MG[[^Y]DN_=/9_L^'/Y_]/V?[P]F/!KN>T@V_>/@K9I27P+P4YF4PS\*\'.85
M,.\(\TJ85\&\&N89,3E"XFZ:EH+8;2F(%Q/]8A:3]<87,"^!>2G,RV">A7DY
MS"M@WA'FE3"O@GDUS#.&!H*)T(PSMV$@]A=?C_C%3""_OE3?]&7ALO7+4;1=
M+=?QNOTU3CDTT0]-]4,S_5"K'YKKAQ;2/W1 $,#%]"BO@GDUS#/B/142!-,4
MT\=N,7T<=(#+N?C!M_O<]P/:JO7R^>52;]_I\,$M*"^%>1G,LS OAWD%S#O"
MO!+F53"OAGE&C(20')OF4);8+>&.1QS*<BY^W/_4TCZ$HSO(X-)LE)?"O SF
M69B7P[P"YAUA7@GS*IA7PSPC9D)(D$U3FAV[I=GQV--6SD6&/\WZ]N5?M --
M.331#TWU0S/]4*L?FNN'%M(_=, M#Y<OH[P*YM4PSXAW3\@M/TWY<NR6+\?C
M#IWX^/*3V7]\_?3'MZ___.7;/[]^/CL^S^/QE\]_>$ZA\#L#7CO#IU"@O!3F
M93#/PKP<YA4P[PCS2IA7P;P:YADQ-$*2;II2[;E;JCV?ZA2*.7P*!<I+8%X*
M\S*89V%>#O,*F'>$>27,JV!>#?.,H8%@(C3CS"W;GJ.G4+S1FM\[ENTC,@6O
M[A@*I>Z2T"5JW16A2]6Z:T*7J75[0F?5NAM"EZMU!T)7J'4?95WS(/>^S6J4
MQEO(6*J-=Y"Q4AOO(6.M-CY 1F/4RI>]:QBG/K>-(K@E9W,QBMW%:/2Q%?.>
M[?]G[4W1!)G^V JM\Y)R)GKG%>5,]<YKRIGIG7O*:?7.&\J9ZYT'REGT.F>S
M]K$5DK-YT\MG5VCEM[B\U,OO<'FEE]_C\EHO?\#EQNCMKVL;K.]?'-IZQ>J@
MUS<7/+<#98Z<;#%O'T<PWVPVZ_:2-_9@"S\@X)T2W&B"\C*89V%>#O.*[BMI
M&V\ZOK5(YUIHO[7 G2@HKX)Y-<PS8H*$O'2:IA-E[G:BS+WEX9[#+=X^N'J7
M=(MYU$XZOT%YMH6?$A!W)"^%>1G,LS OAWE%S^6T6LS:<2=<3LVX\YYO@?XM
M2IA7P;P:YADQ/D(R#P(V,\]M5YF/.]]BWCZ48+Y8-9]</X@>Q3,>?+P%RDMA
M7@;S+,S+85[1?26M%JOV#NK2E:1^QH.[<E!>!?-JF&?$Z C)NVFZ<N9N5\X<
M..)BWKVO^JSCF^W8$RZ4JLNQJD2MNAJK2M6JZ[&J3*W:CU59M>IFK"I7JPYC
M546_:K.9N?^)VCDMG2B@S>F@"=Q"$RA#)W '3: *G< ]-($Z= (/T 2,"9W!
MZPM;9 J>U!>FH%@%AOXVZ79GS<<=L/'I\;?_?GSZ]6SWY;<O3_\ZN_KRVZ^/
M3W][_N/7W[]\_?3M\<M3SQ(('ZZ!\A*8E\*\#.99F)?#O +F'6%>"?,JF%?#
M/"/F1LC#^S0=7'.W@VL^U>$:<_AP#927P+P4YF4PS\*\'.85,.\(\TJ85\&\
M&N890P/!1&C&F=N=-O=WIPTI<CX7:;H'W9W$"<A"N'\-Y:4P+X-Y%N;E,*\X
M\9K?BU9QX^?YHWYHJ1]:Z8?6^J'&#!B[4XUM!,'";=Y:^(_+D I,ST7"T+*D
MG40<'@,H+X%Y*<S+8)Z%>3G,*TZ\5A7;=M.* >W04C^TT@^M]4.-&3!VIQK;
MC &WZ6GAKV'7E-V=BQ3U<X"?$Q  \%D7*"^%>1G,LS OAWG%B>?^@+N(U^M%
M^_:'#[% >17,JV&>$7,BX,L.!6R&6^R&F[]RN7\[1.&# XJ<=A(L(-1(7@+S
M4IB7P3P+\W*85YQXJW>AMMATA!I\5 ?*JV!>#?.,F \AH3;-41T+MU%BX:\W
ME_9&%#ZN?U2##^Y >0G,2V%>!O,LS,MA7G'BO7]4B^9Q.]7@/@B45\&\&N89
M,2!"4FV:/HB%VP>Q\-8=ZS9*%!CZ:(-JH$_11O(2F)?"O SF69B7P[SBQ&N^
MB8V:=3E'_=!2/[32#ZWU0XT9,':G&MN\_=V6@(7V!(O0DJ*SJ.=>)PN*+V!>
M O-2F)?!/ OS<IA7P+PCS"MA7@7S:IAGQ.0(>=J9IB-@X78$+%83%14MR-W^
M+V!> O-2F)?!/ OS<IA7P+PCS"MA7@7S:IAG# T$$Z$99VY!^,)?$#ZPJ$B@
MO;:/]._FLSL!6I41[4,\E",3]<A4/3)3C[3JD;EZ9"'],P?<^G!Y-,JK8%X-
M\XQX%X7<^M.41R_<\NB%_W *31F1XG@+_P9>NQ.DM6E8LV+B0C\TT0]-]4,S
M_5"K'YKKAQ;2OWC G0]7$J.\"N;5,,^(-U'(G3]-)?'"K21>^&M_M95#0@7Q
MW'O7;UN_*2Q7VXYE'BX'1GDIS,M@GH5Y.<PK8-X1YI4PKX)Y-<PS8C:$!-HT
MQUDLW8KHI;^>N;]:2/C@:X9Y=M?:G0ANR<=RN6R?T>4W#0\RE)?"O SF69B7
MP[P"YAUA7@GS*IA7PSPC9D) D%' 9I"Y-=U+?S6V5"$D?-S_2+9L5^0NEYNH
MG61P93;*2V%>!O,LS,MA7@'SCC"OA'D5S*MAGA%#(23)IBG@7L9NDOGKL%55
M00)#B+/.?;)GLZ@CT91#$_W05#\TTP^U^J&Y?F@A_4L'W/-P?3/*JV!>#?.,
M>/N$W//3U#<OW?KFI;] &2@%BGON=;BB&>4E,"^%>1G,LS OAWD%S#O"O!+F
M53"OAGE&3(Z0N)NF\'GI%CXO%Q.5 BW)*M<+F)? O!3F93#/PKP<YA4P[PCS
M2IA7P;P:YAE# \%$:,:96\B]]!=R#RP%$FAR*= ;0%$*I!R9J$>FZI&9>J15
MC\S5(POIGSG@UH>+FE%>!?-JF&?$NRCDUI^FJ'GI%C4O_5O.*DJ!!(*N%&C9
MN6=N9RF0=FBB'YKJAV;ZH58_--</+:1_\8 ['Z[_17D5S*MAGA%OHI [?YKZ
MWZ5;_[OT5^PJ2X$$BO"B=MWZW6D1SZ.X?<_#NSZCO!3F93#/PKP<YA4P[PCS
M2IA7P;P:YADQ'$(2;9JRYJ5;UKST%R5[:H$4U<Q"+="F50NTB*/UMIUD\(;/
M*"^%>1G,LS OAWD%S#O"O!+F53"OAGE&#(60))NF3'OIEFDO_0768C'0F/KL
M9;L^>Q$MNEZ^P 7:*"^%>1G,LS OAWD%S#O"O!+F53"OAGE&3(60*)NF0'OE
M%FBO_'76JFH@@>'/LU7G7KNSV6:^??>?5KZ%?3 )_6 :^L$L](,V](-YZ <+
MZ;_+X:F"\DJ85\&\&N89\08-2!4*V$P5MUIZY2]WENJ-/C\]?7[.F\]GYX^_
M_O+E;/_XC\=OGW_MVV[(+QO^HSS*2V!>"O,RF&=A7@[S"IAWA'DES*M@7@WS
MC)@6(1$W31GURBVC7L43U1BMX*VM45X"\U*8E\$\"_-RF%? O"/,*V%>!?-J
MF&<,#003H1EG;H7XRE\A/J3&:'>B1='[KQ_KF>^(W0_B+/[RLL_LCY.N7PH6
M-B_?+*.>,]>#)G%)3B()G,05.8DT<!+7Y"2RP$GLR4G8P$G<D)/( R=Q("=1
M_)Q$XPW!.FX4M'R4O5'T?@_H5V_<<PR\UGM+>DN]]X[T5GKO/>FM]=X'TFN,
M7OQRJ#MHW@TP*U8:E;FYH+H]""MO8?#_.7QZ_/7L\>DL>WSJJ=,5 ._N]A\%
M?/UW_.X$;/[S-,]!O%"/3-0C4_7(3#W2JD?FZI&%],\>\#A-\DJ85\&\&N89
M\48*>9R&@,V[WRW97TE[K_OK=G<G0OL,PG7[J5FHZ!^6%!=Z]R7M3O3N*]J=
MZMW7M#O3N_>TV^K=-[0[U[L/M+OH<\\VBW7[&5AP-Y\7?A[,ZW\:5L[@=IH9
ME/H9W$TS@TH_@_MI9E#K9_ PS0R,T4_A]:EYBCGT+CD=<U"L.0/GT%Q+W1Z8
ME;^#15,)OY,H :_5WQI"YLX_5K29+]LKI-" XZ:6?V6$]_E'>1G,LS OAWD%
MS#O"O/+G%1J[5^@JVL[:P2Y<HL->>,#M0"C/B'D2\H5BFG:@E=L.M/(W\O04
MS^].'W3K1:-MLX?G@RAHQ=3W@OO>;Q!P1Q#*2V%>!O,LS,MA7M%Y5<71=K%J
M/S<+EU4S6M;R(S/</(3R*IA7PSPC1DE(_DW3/+1RFX=6_AX@;\G][O3Q=]?K
M+)JU4U!H-=(]K%U(H(  A!N)4%X&\RS,RV%>T7E!/2^K\T4[ (4K:MB/9W"[
M$<JK8%X-\XP8(R'9-TV[T<IM-UKY^X7D&OW=B=$J")\MVADHM"?I,U#IO*2<
MB=YY13E3O?.:<F9ZYYYR6KWSAG+F>N>!<A;]SJ['6\$Y+-V5WEO26^J]=Z2W
MTGOO26^M]SZ07F/TXM>7O)S9$_\MLR+_0THCUF[/V=K?+Q;8'=*S ZU?-OR]
M+\I+8%X*\S*89V%>#O,*F'>$>27,JV!>#?.,F!8!C^P4L!EQ;@/<^GL'"M\=
MLH:;W5!> O-2F)?!/ OS<IA7P+PCS"MA7@7S:IAG# T$$Z$99[$;9_[S/@9V
MAZR[C[]8SWR]Z1_$60SK#@F:Q"4YB21P$E?D)-+ 25R3D\@")[$G)V$#)W%#
M3B(/G,2!G$3Q<Q*#6E0^RI,8]#XD:!*WY"3*P$G<D9.H B=Q3TZB#IS$ SD)
M8P)G\?)"!9S&+G0:BD4LZ.V*V\FY]G>VR(TG F!XX\FZNR^GH_%$.3)1CTS5
M(S/U2*L>F:M'%M(_>\"3.GST#<JK8%X-\XQX(X4\J4]S],W:;3M[_H/_W:K8
M>/)&:!;DQ\MY^X'<+QO>>*)U7]+N1.^^HMVIWGU-NS.]>T^[K=Y]0[MSO?M
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MLH&[\U!> O-2F)?!/ OS<IA7P+PCS"MA7@7S:IAG# T$$Z$99VYWWL9_/-W
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M+2]G[H__MEF1_T&U$6X+Y<;?VA+8>;+H6?C(H],N8%X"\U*8E\$\"_-RF%?
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M%T__]?CUR]/+T$^_G25?O_SS]^^%R6=1SU)%]B)=P+P$YJ4P+X-Y%N;E,*^
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MZO4CMUX_6DQ42A1YZST#XHSD)3 OA7D9S+,P+X=Y!<P[PKP2YE4PKX9YQM!
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M_[KJWYW1^5N8E\.\ N8=85X)\ZK.ZVFY6<S:D:WICQSR70?]BQ@Q3P)>N%'
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MH]IH<=5YF$)K>ZT/HDV5>TK;)6!+U+8KP):J;=> +5/;]H#-JFTW@"U7VPZ
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MM7$/&:W:> ,9<[7Q !F+?F.S%NRCK-3LQ7S4&V\98ZDWWC'&2F^\9XRUWOC
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M,>UY.693]6+B_9%(N'#J;Z8N_VI5U>.YKRQM]*6MOM3J2YV^U.M+@_3-%S@
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MGS$HKX5Y%N8YF.=A7H!Y)YC7P;P>YD689T1S*'&T92+0VS0"O<T'F.=C0L+
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M'G.6R4'OTQST?KU0-F@/)YM17@/S6IAG89Z#>1[F!9AW@GD=S.MA7H1YQM!
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M"S#O!/,ZF-?#O CSC*&!H",,[:Q.[2R?X[XD!G1[IHU""?4@P/!8%/YK]?4
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MF-?"/ OS',SS,"^<>0\-[E!7J['!P<EWE-?#O CSC.@5)0:W3/+]D";?#_D
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M?_SP^Z>/O_WV_I?_Y\.7O[[[C_^X_^W^W>_O?[FY_]>+ZYD[099^^;MJE-?
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M5>J,*U7V&;42WFZOA#^?36[7R^GM>-8[_]MF^E0L75%7X]O1AR]?07D^F!>
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M\U(P+P/S<C!/"#00Z @E._/4)(K'3:)X=3?PMXQJB;9&H?U*2?O&AYL8E!>
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M%X)Y$9@7@WD)F#<"\U(P+P/S<C!/:&V!,S'M)"!@]X>JEW44$'@&X^P,&Q#
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MP;P$S!N!>2F8EX%Y.9@GM!;!F:1VDUTQU>R*V55VQ01G5Z \'\P+P+P0S(O
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M ,H+P+P0S(O O!C,2\"\$9B7@GD9F)>#>4)K#AQ'ZR8Y,%"3 X.ND@,#<'(
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M2D)6(5BA]JJ(&B6QVZ,DRE61 ^[/U YE+":" R-07@#FA6!>!.;%8%X"YHW
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M$9@7@WD)F#<"\U(P+P/S<C!/:*V",\7N)A#AJH$(^4LW5WKV8)R=(7D^F!>
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M_-(0%W?;CQ_O7_]6L=^8#3+WK_-KL(8\2#LL;=/&GZ0]/DE;J'OL ;+?G?L
M+7N *[=LNOCO[XZ_O\O^_K>;W=U>_?WX]M)D/FUWSS_L^ZGM8OW]]J?-XH>'
M[7:WV.U[K=C3=;QM++\<7+<D_S!!>TI\Q\2?HC\^19\M?UKR^YYRWTDNOGK_
MT_KQ;O.T>-XNOOKAA_N'^_U3//UVL7Y>D%KYV[?;AX?%?O#\>;U['^TA>LD_
MH5"PB4;#4:,A^Y=^L_EP__AX__AA;Q$>7J2)/>W VMC0FL[Z/O@S9E-5/HA9
MG@;39?91]H,8>(Y#@,F#]&WO_3)XD-@'@R>>_D@RXIOLC_SW[>/5W7[0W>U;
MV.;][Q[W_W4]ML/W^U9Z;+'1WY^-/;?9246;*F%/2EB5P?D05DH$H6A3$4X&
MQ62'__D#]"$>&Z'-$#;AR ?MEW8(/K<"/_!OYN^Y!ST9$9-W(H5C^R'*M$*;
MP;7ATV6SU?[93D;%Y)U*?GP_?+FE8W+;MJR3$3(RTV<X61337FIT-*(.1RK:
M5*>3%3)Y+U0R0KX!,5@5'73J6$,9FG;9MCYL*MGPM1*<?)3)6I"2D;6/C:RV
M;5BCCWPP]L@K\)- OW2R/R;O?X+Q>,98+&1V#K)H6"=[LDYVJ3(6VZPCFRN"
M5+2I""=K9O/6;/98?(@7O+;LWVYLT.@3'S3AL+8"OS#?Z.W)>MF\]5+L^JVH
M.Y.*-M7IY,YLWOP4=?T@1J+K/WR+]H--V_1AQY\/7BO R;79O&O#'?\A !W"
MFFX(>WW+;5WD:5?@UX#F?W)O-N_>BOK\Q?]>O'E8W_WCZ7F[[P)O]O_R8?VP
M^-/VX461I\4W;Z-JB,Y-246;RG0RB/9B!M&*&D2I:%.=3@;1GF\0KRVW>M%Z
MYQ]S3=N[^+2#/3DXF[=+?]QMGY[V?[[W]R]+2O'1K&>I61GSC[B^&Q(_[N3!
M;-Z#_?KCOMT[D+OTKQOX.Y7W@PUG$B.?6\9_GSNY(Y>?6+K^<?WX8?-2 ]\]
M[C;KA_O_M>\J_KB^?WQ:_.:;_4_?//U+=!5AR7^R\:8)WV4CGS/=ZP)(]&>?
M_(P#4TU[\_(M_;F__MKX;S7L-_2V#Z?]\PDK"\V=;(O+#O<%H]$A !B-8I^:
MU.+T]Y'5IOQ0?W/_T_W[S;Z;?.DJOWY\WNQ%>-[_A[OMQ_BO=;#BLA^9_LS3
MH.[RP^BI7__MJ1/?_^"GI\^;7?1W"DVV'!Y)8^K&G09_UUQJ5'.BH[]4M*E.
MI]'?Y9>PBD:U0PPTJD4^EAG5W&GD=?F1MV!4<WQ 9346&7.3HYH[#;FN9,C-
MCVJ.#ZC142WRN50W<!IU77[4K1W5(@-Q=%3CG\N,:OXT&/O\8#QG5/-\9(V,
M:OF$M2OTIV':YX=I/*IY/CA'1K78I]*CFC^-NCX_ZLX=U0[AFDS%93\R_9FG
MP=?G!]__]_.^3?SPRXN4F>T-HCL[I*)-GYCL[? JDW9>=#B7BC85X32<^]*5
MF-(=+K_&,V8R%]>%+51C\/6GP=?G!]^7&8K_*FK0HB_24M&F3WT:SGVGTZ"%
M5D<.(FBLM?B3;?!YVS"_0?>Q!FU""P$_-OV])QOA\S;BF_T7_O>BK/<573*1
MBC;=JG;R(8W.DDDCNF0B%6TJPLF[-,)+)OEXLY_>Y/ORZ5.='$^3=SST!?GK
MO?5YOO_A?K-;_.VK?]X__?U?%\:ZFY?_\>GE_WZ\^S+ZG*++(%+1IGJ<K%6C
MLXVV$75;4M&F(IS<5B.\E;:);))]61U<!N\?-R#QW^S??_LWM_^GW_^SV?^S
MW?^SBPE^6YIRA5*:?8I^_\]A_T^S?/F7[-)+0W;X7FSVI9'=%ZQA )N3 6S.
MGWUY V(4_!4/RO$]Q,;:\*4MGZU6D9,Y;/)S/?@UN>'S.,;U0UAM8*?.C&KK
M"F1;H7QS2^UD))N\D9PYBOUV<;-Y6/^R>;^XV:U_7OQEL_NX^&:[?HPJ+;K]
M62K:5*>3@6T&G=%-U,U*19L>5SBYV38_JU:X/;/E$VJV"V?^HA]*S.^T)ZO9
MEEK-Z _CDU]7;;@]_?"AR5D)D]C1W9[<8GN66_SJ^NO%'W?;SY^.>P?2KC&?
M:?;)$ W7V)Y<8ZOC&EM1UR@5;2K"R36VLJ[Q#8@W'2Y>_HNQ<15%)_G:N+%,
MGH=H3X:PO9@A;$4-H52TJ4[D0)F (00QRAM/Q! NW=*$*R?Y?+6:G"QA>Z8E
M? ,"E LB.L/81HSC5-ZI("?+UYYE^5)#T<)$GUG4Y$E%FRIS,GFMCLEK14V>
M5+3IF<Z3R>OR)F_V8 3B'=^5LN])UX<H;/!P[!2HQF1F=W*8G;G44-2)3GM*
M19OJ=#*\W9G;L-Z  *7MAJ\2&^.=#]?J\MEJY3CYW"Z_\%S;Z=KH,XN:7ZEH
M4V5.YK?36:#N1+VK5+2I"">#V\DN4+\!\4J+IRF;"K[-IZN5Y^1KNXMM,N]$
MU\:EHDUU(A<RG.MU08#2=A/QIBT[7)S/52O&R>=V*CYWSA1G_A?,;CP:[K<[
MN=].Q_UVHNY7*MKT+I"3^^U%ICC[R&Y\;_KP2%_D8[:U0Y.XL>1D0OMSICE[
M/LT9+M-D/S+]42?'UZM,<?YV\>WFI^W#3_%=Y?F<L^]0T3"!_<D$]CJ3G;VH
MWY.*-A7AY/?Z_.1D:85YUD*'WK$"XY\RRW2!G?Q8?\[5#3V_NH$5&+\R*E5@
M)Q?4YV?F4('=7+];7.^_='_W].L6W(^;]R^NB!3<-]]<1Q](U 1)19O*=#)!
MO<X&P5YT^DXJVE0$<JF5[ ;!-R#>ZR3H:0+4Q164O?"JC[^<) X']">CT^>-
MCN:-7Z)>2"K:],ZODQ<:\EZH:#4!Q"AJ-P._2*OW['4BGZE6C9/G&LX\@?$&
M!"B30G0.<.!KV1-AIU*<G-YPGM,K&XCB"PKYU+,%T#!\P\GP#3J&;Q U?%+1
MIB*<#-\@O+H-XAWG)HR/BY?8WVC" X?Y/+6ZG#SF<+%%[4%T45LJVE2GD^T=
M\K:WH.,%*]JHP?"%[+;W;/C1<+7#R=4.^9DYH3XWNIZ03SV[N6@XW^'D?(?\
M?:[5?:ZH>96*-A6!W->:/V\SO\_-QWN=%T9E-!0N)N1S5=\ 2Z^ S9_*T;S4
M<"EZ<D<L7* 5N8EV>:[M11%*VLX8(UA1:(*6 U)5RV&)'/\GK.^<-0;PB^:W
M*)6[;)?D,MNECBD>XXH)H6&+S9)<=KL4F0D%8>8_-Y\S]6WJRNHEN>UV>=9U
MM_EOSW^*W!QL\ SDMMOE_XDIUOR2!O@-\Y50N?EV2:Z^7>I,N(YQQ810N?]V
M22[ 7>8G28L+FE_48AS#'<"/!;^3W&:[+'6'\9_';_*_LNQN;?"IX.9[8L[
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M+(F%"]0B3MHIS8/*(I+$PDV%(!RE)D\?*IX_D64BC>$FF'N_[.-'7AO".FH
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MJ+=*<Y)Y*L]\(53\+T'^] #Y4S%\Q4_4&.=9:0'7#$!)R4QMB"*#F4J+BX"
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M>H#@F?]2! *R0V$)N.X8A\W6L9L70<9JD8A! S@>S3<B66*/6+BI5H38TP/
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M;:X*QFD@&*?!*:WD2X&51B%4C"[A- UYNE'-(%5ZLBNZ0?YZ_#X_;\*FJE3
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M9,,R/+%_ U/-*$5N<[E^*YQP?AT.U.&>AU,+QKX\1 TEFU]X*ABU?5CJ8I5
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M,[\ZN"='<4\.@)KJNF.?>&YA>ZR#?7(4^^0Z+7LLS'$2BQ>*0>TQP#W5=,?
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MF2<Z50U3A=LDHN]RU\?OL_F4'IT;T(%3>0JG\OT%SWSEP5@5S4MGJP0%9'D
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MY#IL7!,B@ 8"[V'E_/3]_N7U^?[U[L?-U?[YY_WS[1M+.W'-RA.X-AR@ 3E
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M6!8IVXYG*2XV=.>$@[1\.$L<)*7%0IIELVFU(EO)35:M5F62DEJ\4 RTTGE
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M5R2^D&O'XQ>5%GIR@O=BP]FGUW_F7MFTJ%ZS3#8K-) 2-A%*V(JA2MD\VR#
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M41E1]IY&_-SV^=SRV<Y3!:FUY/E0%8+RO7BA5F@D+P@@:Y0!9&KQ0KW06*H
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M>7_[^/KPTQOT^/W'3_>Y?:,D6\4=8V.3$7#6M58V61E=IA8O% -M<IX(5O5
M5CA$C 2ID#)AO=V8>O]$IEG77M JYP%C%5+86&5DF'5Y[E=I6X=$*;R3I&-N
MQ[&5TQ$VK+(.664=H8P5#58%H#(NBK*/C@'0SD0.1$%B64<P7]4C5JJUD\^W
M_.*UXH4:H6_N\GWE^C%+F52F%B\4 RUR'@!6,V:1B)\=X'CXGS;5+3T&D+@3
MV4&VP9=UB"_KNOR:"]/Q2AE1IA8OU M-<Y[]5?1<)B$*;J%>OD1LIZWL#=J
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MA)KYDFW<%!)O>D*\J:\X99R-6KQ0#+1)A$53,4'&Z#8GE$(SI&3LXR]N0Z2
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M3@@2&@E(J/#MC40IO95Z\1P=FJX3)Z:1=/7"H%7+<WB*)A9(B%)5E#N0G>Q
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M3GT=_SP_]97]4/CET"D2V%=5*>;GG+6@7_.EV]A'A(A-O1&H85(&AJG%"\5
MMYCG<"THOE'<LVX;*S[YN6%(4E4FY'E-Q3ROQ%>4NZK>19J2D8^EOQXZJ3R
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M$ZG%"\5 MY0'_M0LONGBAW8>WM+%C#])3MH!-^E<X@0,FJIT?Y1'E)'O+G=
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MY'3S8"*5"X&T.YZJD.WGD17EW07M:9[CM/QFTXH7ZH7VE&"B"NTIB4))FJ<
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M5.=[QB)F!Y+%,U2"[$"6BQW(B-F!9/%,,: ;1DA_T3,E5.R^X=X=UGC&O6D
M&7\LS,5#ITJ(,7U]O)@U> ;9>PP!YYV2SAX;2@71&VX]CPV%4#[&<]E08@ ?
M63Q3#&A#PUR[$>E,[!NY/?$I)?/.%T*.'HOFZ'ENA=CW<<?,IY3>.X%V+@Q]
MBTCHCXWRO\6O[_R+^$@;";>;Q\U!4!WCN68]J3!R@QAY9CTAEHXAY+;QB_A]
M1/L='^L5.ZSQ8;=J=P*S;RTQMKUKO+VG(RF[XY>K\'HB)-0Q<<9Y46)@'5D\
M4R_H!,,<N-AG320*]H4. CH0&GQF'32$-)<N#+23",PM9B5?. ZWY28!^Q)M
M*B[]G(V9VEWCC8W,/>A<PTRWL87.YU:)271D\4QEH%L5N=PJ%2=N$"./6X7<
M.8:0V1)*G7#/3]K[U;"V;=Z -]U\37([X\:1Z+",@R99G'%FE9A)1Q;/U M:
M\3#J+;K:C4-(>*N=XT""RK$,F(=/QR"?CB&XMJAJ9T]BROFDLE-P+(W.FX*.
M!BW]KO$&1^8?=.UA<AM:\1;;>@4&_.*B?7BL5Y\#R ^DQ82LRS/U"MES3.::
M>J4BP_5BY"'-,4B:8PB++:'Z'2):I6@VG\#_V<4P!D2'@7>\K<^M-\G1]HX/
MWD2H.PP2Z-@!XG:60D@,I".+9^H%K7J8\Q9;")$HV!<Z".@XB6#"3&+-%=9>
MNC+0JB.PMIA*> AQO*N:3RP"#]969 +:K3G4N\9;&YE^T-*'J6UH'5S7M^JO
M%^WZT5/UB"ES9/%,3: WEV%O?D+5(S;>>9AR##+E&$)=2ZEZ,\\#6&FG&>+7
MHU_(OPHTZRAW8S9@3%S[#4Q%H6.7X=GSO!6/>((]#W>.0>X<"^/<HBO>F*W$
MSN]TT-!F5LQ85=HU+X]!AQ@ZAM#98FK>(<31RKV86-PKK*E1N5C:A_W:$E[C
M;8Y.1,B?8V%FVYC:A[PCC[0T/NWRT.88I,VQ,FS,TZL@%1!N$"./ZX: .8:@
MV*+7Z1V4N4K8$T>.CTVY=Q,*)+LQA.R&K;Z7MB=]R6RJG_MSOL/9&:2IL3"D
M#$^[Q4V[+KYMUXM_M:L7Q0]O/3=";#SSH-481*NQ,I?Q)$:CD<4SQ8#&,\P<
M2S&>I<<!.B98D,8/1<XC3F0SUW@S+*:D06]9GM%;4I'0!AWS>$M(5F,(%BW2
M6T;"U3RRV7925!9G#FDC60W(4V,(3RW&34YM-RDJ>_X$:2F87U/;/%J"7>--
MQ.06Y*>Q,)8LHFZM].%*KQ?:,ZXVN^6VUFGX;;O4JFY"DRC$@#6R>*9:T#Y.
M<]G'*;%]I(IGB@'M8Y@\EO*V$1(Q[FT(8L!:'\]Z,W;J-8:0G<:FX;T668L7
M%0%MD"+/=@Q(5&,(#BVR>,5 U?">9"/0IK/)S'[9B(J]9NH";32"5(MYV0@)
M$2D*L>N>VCN9CT4V18%V.@PEHZE>OK>.B %K9/%,O:"3GN;:XTR,2B.+9XH!
M;7*80994OQ#+S/$C=OL85KDQ42176'/)(D&(&IN=<0,S%12MURL/9(U!R!H[
M';*&A8CJ10XV6EE6YF[ *ZRQ=$V@:SZ1M18W2GNVYQ)3U\CBF7I!8YV+NL:(
MJ6MD\4PQH'\FIJZ]02/&Y9=T3X=)>\4LW%RZ2- TGQ&FQHAA:F3Q3+V@F48P
M:%&C= 2? >U%MO?E7#@6)O(PU!ADJ#$$-$8R2H\[ 3%\10D]*X_#ACPU-LOE
ML(FQ:63Q3#&@PP[3R.(7&(DI:7T\ R'O?Q,8XL]8-/[,?2_A7Q]_+Y4]-^U=
M4X70,18&=>7-=]\S-3&,C"R>J2-TMU6N.6$J4-@@1A[K"L%C#*%S16=\9>\5
MD!/[Z27<7/HM00.*T,#0?)>!_!SN(X]'A+PN%L9@9<YWS],9,>J++)ZI(_2.
M5:[]#%3\K4&,/*81\KQ8F($U(M]G=D5F?";M3,GCX2!TBR'$+#3C*^M>7KJF
M[_)0LABD9+$3*5F121_>)TA,R"*+9^@&"5DL%R&+$1.RR.*98D"G2$3(8@ZB
MU;2J+'P<^CGS6J$;.PU]U?]Z$*?C^M#+J7?!"A*MV(E$JT,^]BRK(1$#1_$0
MDZS(XIDJ0<N5BV3%B$E69/%,,:!O0TA6"5L&Y]'G$R!MXY-<5X'6[)V#6'/!
M!6I30^C9YF<\F" ,^$KH<WEL'>1^,83[%;D) XD2M]]@[CB68#JWC6$>SA>#
MG"\6QF=%;26<V^90SAPX':2IN,QSG$A@27>-MS4J[:#[1 !9)U6[<5/)X2M)
M2,(L'I1#"!A'(&#)59 3$[[(XIEB,"@&C0?MXQP]:$IA/9RAGS.OE<-K/<F#
M<@=QZR6S!CSN@&7!CYD7*. %GNI"'U6W^V'Q81LX&@1I)*&793&>'/*K>"Y^
M%2?F5Y'%,\4HH1C4- $L8I0A0((D2.GVIZSTY](4JG0^:\F)>5ID\4R]9E O
M"FN)18GL2;:UG(IJ9AWT@;26KDL%=3D9)H"%B!2%=IVYC^<7V11E#D4YU4 >
M%RK/LB/23,(]YW&'D+C%$>)6>JDBQFF1Q3/%@.X0 6$EE"H,K85L[>E_WZHJ
MUAHFTE*Z/M"1LO.=1\6)45ID\4R]H$%&B%LQ@S$2 N] ]BE4Y;PTC["XPAI*
MUP/ZXC"\:OPX[%X.1II)Z"IY7#)D;G$6WGIYPCA,['.IXIEB0#,<QE$EC<.G
M;[/L8]COKEN;=9'FTD6"#OB ICK/8$R[I9(LGJD7=,:G8[:P$'&]R#:R?&JO
M7B)MI4L"??&)C"US/$96\)'F$GI-'G\, 5L\%V"+$P.VR.*98D!_3 38X@X@
MEIS)F94#V.?,:X5>]31P5O_KP17\\(?,BX/&\$0:UFZMARJ]CG'3AA])B2%8
M9/%,<:!+S 7!XL00++)XIAC0%R(0K/'+]GU$]*S'2[1Q^U!SS[$DWC:EM7B/
MMLF,(^WB#G;ED,+%^1DG6XD17F3Q3+V@U4187Y&3K4B4Z&]V4-)!<9VI&[.'
MZ3SN$F*_>)BF%;.FWX> ]U.5TCH?"&MJ1%8Z *VV@-=XBZDY";TH0L]**(F>
MV8%P0PD)F,>%0OX71_A?Z261&.Y%%L\4 [I0!,N54!*%Y[1_F_.!->X\Z=6;
M@+YVK0.[T&;9^.R#7# NSCBS&V9W)?3!/#.[$ K&$2A89$5$HD1]JX.*]D1O
M)6SN#M)FNCK0P8=Y6U'%\!#BF#8PMS:X84V-S$>[45O#:[S1E&R$IA]A:R74
M0N%1F7ARF"J>*0XT[P@=[(1:2.S,\Z"_.$1_<03:E3!3CF' \$2Z&(+8A<V>
M*L_# >.0 \;%^4Y^Y6%.5T*ORC,O# %@' & Q4R5(R$BNY%]_"OC;.KH1'D\
M..1]\3!&*V50ENZ[)N9_D<4SQ8&>_ #!HA^4PW2M!#'R;). V"X>1EVE#,I(
MQ+AL.@2QGW*LDRB1]M)5@A9:AH^GRCHH4R&W!KWRF&J(\.*G(KS>H"$BNY%M
MDF7IZD-Y9L<AH8N?2.BRQ^11KX,@S2=THSSV&0*\>"Z %R<&>)'%,\6 ]AF!
M644O:(;C)-R[?8Z!-CF^M46(T.)A[!2Z\$E,P>KC1:V10K051Z!4=+GM6SNE
M8E0-2N0QJ9!YQ<M<$\5AVM1X,:CBF6) 4XHPK**SN[2W(6B^8&65O#SH*0[1
M4SQ,=$+3N[3?"K/G"/-0HSBD1G&$&D68WIYUH/ %)/3H/!X0 JQXF6MK1)B,
ME2!&'O,'65D<867%IW=II02?S,UC#*ZP!M-O"MJS,#T*3V_[*%!'>N=Q5I!0
MQ1%Z$Y+>O_[X]O@U;5^-#C>3T&_SS$9"#A5'.%0G)#&Q=<L#F>(0,L41/%3"
M7 D&G(+X:=\FW=)]>KZU,GN%-9<L$F1/\>GY3L_G8534^$Y%%<_4"QH_A$85
M,U6"A(CJ15/[]'PV<=C&/,@I/H6V<7K2X?GV>.PQ5>%F$GI+'B<* 51\FNF<
M?$Z,D"*+9XH!'6:8S90R'B,1AQ5Z-)ND9TRV3]W( YCB$##%I^<[*Y]3@:(&
MO?(86PB>XJ>#I[ 0\3W)-LGJ<=[1C?+X9(B>XJ>AIZQQ>=S\-3%[BBR>*1AT
MS[G84YR8/446SQ0#NF>$%!7]"#RU3[*7TGYPS$.*XI 4Q<-T)?0!>!8ZQ[Z_
MCSP$)PX)3AS!+V&)_:[XZ[I>%N]VZ[MF_;GXL5[5=XW^^##GY3NJ$VEY?$?.
MPW;BD.W$9YE.O^?$X":R>*88T)"&>4@I'@R)&'>D"S'VJ8]G&;KY? +_YSNP
MET.^$Y^%9T:SVC$J--,@3![["E%//(Q'BMW C$2)[%<V'U4R-K5W%.1!.G&(
M=.*G(YVP$)&B$*^F.QA1QR*;HD"3>AK3*:Z6^69XB>E-9/%,O:!'S45OXL3T
M)K)XIAC0HR+TII1JALSP8L]_,\_LKN,1D H990@$25"\.N/L+C%&BBR>J1=T
MU@AQ*F:(1D*@/:BR9W8%FS@V)N<A1W%(CN)A(!/1Z.R9[R6&2Y'%,_6"]KK*
M-=]+A9$:Q,@SWPNQ5#P:2Q4].B,1CP[)8=(GI6>R5]@+<'F@5QQ"KWAUQLE>
M8K@563Q3+^BBP\RHN"%ZQ(E=_F[DF.DM9\(^!3L/Y(I#R!5'(%<DX_2X^5\J
M"M:@8AYO#:E:O,KEK:DX6H,8>;PUY')QA,L5/?];.>9_I]74/I')\4$QG7I/
MX84P+!YF3*$SN_.8F=W@A\R+@Z82@5,1)6?X?+3P-8SO@53Q3-V@^9SGFK@-
M$[@2Q,CC+"&6BR-8KNATG-O84OWBOMW;D<^9UPJ-7Y@YA6>CM"KKRYGC"AT?
M Q[.O$#HN1"*$Y:1*_UW50;;=EW\L7YX_+KX5GDLY;.:XIMUNWL,+*"$6T[H
M>GD<%T13<01-=4(>$D]$YN%.<<B=X@@Q*N&A!F-0E2$7.G>_#<\JN[[FP4]Q
MB)_B\S.^#1]F1"7TICPF"^*G.(*?BGF804(@W<=^"W[.967S)?+0I 2D28DP
MI(EF5/8L!2!MC^X\9/%,O1C4*].+\2),LDH0(XM9%)!H):*)5K'C,A9Q?Q)/
M]Q_ATY'69_;Q0EO'38D$E.A\;\4+8M0663Q3+PGU"MO8N'5L+$I,-Y*6%9^7
MEA]&&DJ7I(22A(US1+W"0L3H0>NA^WBE1U]3CRG4(SR32%.RW.LC2-L),F1Q
MSP*BM<0D#!8XH6313C>2Q3/%J* 8L6_3QY<L[##5<%[1&N@^G@T8\N?6',HS
M/V.YHGT_GRR>H1?$;8DPQ2JV7"%1D"[$[#G2DDVFUJ((TDRZ(- ?(X"LF&*%
M,;80-8A]-+.W!ARK:ZH!#7(82D54JMQG02)M)PB19<)50,"68)F6\@45#6L0
M(X\5AG0M@="U$DH5$A'++-IML7T\G6!'I<J;6= 4(WRMK(6*&,%%%L_4"YIF
M!)@56ZBPK;#A#N3:LSJSUT&09M(%@:XXC*B**U08 "&L!K%[9C8^X5A=4PUH
MBQ$25F2A>GO_>;.X6=0KL&#J7Y=!&DU0(,ODL8"(+<'"!OF$"D7L?O/ M 2$
M:8DPHRKAY/X^HCW;9KC92[1QZ^U1YMS\>15HT]C^>8VWR9Y> U#_J8)'A N(
MXA(\/*^<M9Z%,6#CNQY5/%,OZ*P1'%AD/4.B(-_GH)^-#>,3$_1RA;66K@MT
MT B)+.*H_C[$T?E)S#PIY1)M:D0"VJ@#6[]KO,%QV0>M=IC\=7+Y&[6+#[F8
MA'3,,T<-L6:"9\+=BC ^+$&,/%X;XLA$&.$5O6T(B9-P[U,KL6<^^** P#"!
MH+Z0S47(KR?<B'V<JF]7H(!4+X& KT[/\^"&0*3Y!!WR&%[(\1(\E^$EYG:1
MQ3/$@-PN$<9AQ6>VL*=LN<E.O$(_9EXI])/14"W/!=I'I%J;<_L/Q1P%+""=
M2H2)3A%IN%4:_[C;[NIE\?KF'[O%9K%=M*OCHU,\-T8\*YH'3B4@G$J(7+.B
M5.RH08P\LZ*012405E/"K&@,_0E[OQL)DB"E1!^$396@'Q-GG!XEAE"1Q3/U
M@I8MS':*?9Q$HD3V),<[3C-AG3*(-)8N"_1]"#PJ9I(4XT_%:4)L((4+-0LT
M-C6!'C(,;"(J7N.>&(F95&3Q3!FAKQ2Y?"45.VH0(X^OA"PJ@;"HHGTE,6JJ
MCP=M(..STI<G$"$EPF0FU($2@Z+Z>%%F%=*?!,)J0O+]OYMU<_>YN&A7FW:Y
MN%4U]79_O+WGKHGM:1[PDX#@)X& G](SF9CJ1!;/% /:4P3)E+ D(CU.T+0$
MEVCCGE<2KOQMF,^DUQ%M>+>2FK)!ORK/Z%>)J4]D\4R]H%\-PY1B_2H2)6);
ML'295<;MM8\\]"<!Z4\"H3_%K'U(AS&LIM7$3C7,UGI3S64]+<6N(UJ(3C3H
M7A&:%%;-%C?;=OVY>+/[W*P#LRS$T"FR>*8RT)#*7(:4F#M%%L\0 W*G1!CG
ME%+&2L\J.[/+&-(XOJ#H:XM;288UQ6*7$R&H2I1G7,RG8E8-6N99S(<,+($P
ML"*K&1(E\%T.VMD+^167]M1+'IZ6@#PM@?"T8HI9:2_D5_.97<N0IB+RS5[
MMW6[QAN*SS9HN<-L*JRD_>W;BV^*M[OUS7VMOJGBN^^^"SV?$7.UR.*9^D!O
M7>9:FZ?B9PUBY#'.D,<EHGE<T<L'2$1S@E/]A_OT)%[O/\2SRF#EW1,*D5^B
M#+\WEK>*$4_XYN& "<@!$V&\5G05PUXGB^].-JE5/9O:AZ(B3::+ ]TU0O&*
M64G 0& CE"%VY*5]HL.QTH8R$ 8FP@"MU/+E.W.!&/]%%L]4"-KI::XS%ZA
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M@N7;H!)N+N'>\_A/R-X2\US^,PSU2A CC_^$G"^!<+X22A82$7V6._R^_3J
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ME6L^_$4W\*E=_]9)])?_!5!+ P04    " #5-5Q8'I;7?E$&   A#P  &0
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MXTH5'@O<886E#?B>&X30O)"![E9\]A]02P,$%     @ U35<6&J'%W29(
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M>M>LBD]M[4IG_?=/>E@$7WU2RH1O>,*S Q.>GA4_MDV_]L6[IK)5/L$3@"Z
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MWBF\=QG!90A=BCV8$&>(DSKO!\#R8D?PQWDG@7S3PC]QLO?G5V_"3'-8F>8
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M29=2G,G2=>6P@=B0XE^9E45^J$V7VBX*XH 'A)R5(CPN1[Z?*=<V1KV^W5A
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MP)&Y$JZ*!""G'M%7HY7XC@WR\U>%H.H["'%IUZ(HIB)1GB0G4)+S^1<24R;
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M )RF]XM0.-<N*=63=I@RJ*R9Y$$(B8-NRM38@'GXJ3. Q Q:\^+TSW&[/-8
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MAAWQXMK,^"0&DK(I+KE</GI3&&F,C3-EJMEXJO678(%W0B<"P,E"-QJ<3HR
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MXDJ>_-Z -<):"PAT*Y%]2NP7P."VT3DHO@;I)M4Z6<P?GGV'S*+R&9 ^D3'
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MA1/=Y3KON-2^[B;O83QT[_*.7@I_$_5BUU0B:QUGK^2II=JM&FWD@-]V[S;
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M$L/JYVA4JA2U/3 R KV1IE0PU@PYJDIIU[1G?=?!KY9EXQQ/!M 6=NB'/C'
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MYM[8IU\..!\]3[0.&/H&FVN#*1C;K^BKUJ)][<%;O3VB0=3/I[LA%+N8VUM
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M9,!18O$L='$/#XN<>@*!(JCT.\M1[&24J/DV':RA<4<&/UIB4)20*@&SN[
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M;,#7LL=7M8NONQ&^PAY??1N!#>$+?)+L4ZIQGR:P=-JKECI'[)WZM]4 >7^
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M_(:H@7AE;-$FK&D C.55G$@_G>9)UI!UIVO0W>0ZSJ]HCW"&LAC14E8DH-3
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M84,0K WXC7S\O6C:8Y=W%8"TB.Z/4IA^XH8BO#Y*CC$G$+$9(-&O#56=3')
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M<"4X3$,;\'VAE-U/Z(#V_?[JOU!+ P04    " #5-5Q8O/-;"KX*  !&(P
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MQ<P@LKU>TKB[TM<]HH=1^0+U@'5W799W:O!PF)>A'_*'#V7=()^"!P%1@I9
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MW3YOY4>Q+ML<),BRC6IRD&LKL"!#J)T-,]]LF/@&3:KMGDE'+,7CEN _6V:
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M5).8=!^0#.$0P9]!%2KRAW<HRX$ZL$I)25K!0&<I2<S]Z!?R5Z7)4\+2LZO
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M47.IN.B=J0+9:3NWV:7N*ZT)<8/*ZC%=A(7,.-E3!&@JSM11M:"5P=MR:+B
M K^JB8O]]9"Q6'A=9PG7F/12BO!6YWHU4I-?%L]$7JU-?<C7U"WY;87$O%B/
MW7;0OM=.S>,%K=B%GW/RKU*_-9NYN+\4PZX#&NCPT@;3,'VJUX>NG"0/650U
M*T& RM>=XS(:HHM"8I8X3^XI .I)XNJ\%L:>R=2_99"O><%J 0G:"H(<L,0R
M6>D\D=W.IXWBW,_,(Y#40J80%C:D;E76CT>Y?LPU<##AEL4-7$:NEPM\?_'.
M^W-8]D!B5$WAH)";2@ *JP_(-;?/ZWZ#5,);E2Q5.27WF9!>6V*BDR?RM.V=
M*M/TY\85S79,SNM/PL4J''I1MF_]S1&%',A>E**ZD"'%:O.!9:>=8C7+R#AH
M(N!H)6S0#\DO!2TW3HAGRSUDC<W(EP@\#<2JN\(O;6B+3=?B"%R[./=-"1(
MWKVFYFEP"7F]4+WWZ<)WJ7*F7+!UC'F)E)(AS2)"RL1-*VE4++ZB*C*.D6.5
M>UPAMUC3TY0Z7F0%7U5B2K!B->85?L@W",V;X:($]8,*\(4&CK#N4VB#,VC.
MH1O?PR9P/Q0^A$'#*B>F^W(K+9)=.&](D@OW$/8Z[G0<&3%#*AJ852-69;0Z
MFU#1+F+7\Z/#I):6'__JMRNY]VOT=K)O+-.%GDA2786'8]Y Z%ER-2\;VR;-
M;'IO\[QAAU,I(N%E@%#"#\6,"<^K4JMF23@LJP_^G;Q9(W&+LD!,P;#PK4?)
MDP'#* UCYBVV.+B[Z$,$Y,;%79#Y<L\U.6WOBR^ NECGER\ ;565/B7>1OBT
M;].UL/J"":/#!Y#J#']M4:_O$7&,T7%U=R+$"LW^%>#E(1?'?-P7L7!SQO^K
M*=-J;K*M?;J6I3(M0U &+!I9/N $V;Q]WO$BQ9>,:=Z[445[]!5*TC#M@$UB
MK'\-2>$@._X5.A^1G<29O0PHI#>F"X&CC#;DH?8HS1?67 :)4L(DZM?V=)RE
MY:Q9HOE=9.X9_I3U6%6H*A.F("D"O@+6ZAG=?;B\:JP>F<E\R18_[UE9/0A]
M,']G)D8)IAS"9:O(;Q(:_8GB&>2G-N>D6@NK I1WXYCQS,&%C2;R<_PZLEHE
M^-S_MD>KCH+IS,JDN)8IR:JH-T5>=5=#$7:>1C_*).0TYGI34<EW/Q:QQOH;
MP8;;'5U1$M[,707NTO(VJ)T*[05X^;]L><]:W()LD53-_S'.%L)>0(X%885]
M#2Y%K#-EV.:2-HY=;?U:CR\ D?BQC(F;:I]/I-<0T;\IT,O#^E&^5R\232@(
ME-\HR,,L.S5W*:A%\+9$T/O=YQB]YV5B6Z5)FH/!*:N0N#(7WFX/%4V8) NC
MU9L>6_[$49@QDV)G!3>'<TJ_[:X@QZ#G$2NM:3 9%IC-A"K?B$176]DU&TSP
MJ)V^LV>Q^7BCA()%X&44[2J9ME>P5_T4JU' A9MY1C46CUQC"7.&6'%./2G5
M^AJ"CK,2G&C$L: LO+'UWA=EGD@]2L.B"N[M:X?#1T=\;O!UK&AKEMMG[!Z;
MP, "*G9)>\W1\K!>=;>PYDMISF!C.Z"YK>=Z12U!P6CII,OER-?,94!Q8%1)
MLF%G9%!1!A056U0FN%XVXUZ>6S> Z=2VZ)(Q?">2]>-4*&O09ZT0XV\M I)E
MRO[5.P:!+3 15Z*HO5S&'1?%NE,%3T@Q_$-0"M94KV?ISJOD(WPH7?C]UHQ1
MF+511%YROS(\9J+,&(LDNR*"8C X5WF/K<.M><4V^(VU0'09A'.BP$[L,$!'
M!4L48NDFJY_0_KKB+;[ TC;>DFS%-?:<]<)8/?C%[0:9EKV/O? DY?IFVK:.
MR_YB^;:)TS.M0RDQ<,T12$YWYYTR,T[;2BE.)I MF;DZ26/7%'PUD7:*MV>;
M2E=YC=&$X#H;!.Y0RC:KBA>E)R4SCW'WB_V>;W,.@BY^:7N=5I@5A!Z@FFVF
M+.F@31F+FJ2/F"Z(M@5AV(L-\Z.W$LRGG>O.OT2)/_K&=U9FP@P(OQ['"AOM
M;O0\M:8YI#<R;63%?5#F4,Q+O<['N"WDNF='0J80]@R*1X-MI<$9\JQ(MN23
MHRR6<-AX7 3& W>![J*KMI!^4<SG[T8@V7V.?D%_R*>ZQ'SH'WD)<2P?J3 ,
M[/P/)8A3+(927(%X&/"D'!Y\ZP'A7^FW@V]-*0,3%SN7$G!.EC1T34R<)TM;
MFE ].6\J03<7H"50?M:< H\5C"M7?;BVTJR]2F-;3(YT962$%-DO55YZ(O=C
M9 ?3D\CE[=N8QK=1A+O;?-VM;PL- LLHX7P\IEGBE6\RQ^,9UT(.0;QI+>KR
M@?)FI)LV02^WC0Y!3]8G=(9T5A/R"F6V/7=_6K'^?VO%DCPQ:S)=9%B-S-DZ
M<-0NC$;.AI3215)[\:NNJ)TY8))?Y\L0'5&)?L0*3;<=OM)RE[VBB83)@O&S
M7U?QFJA;N#$7@7/I2JW.]%@1M4P?N(@]A4X0;?7"6$J*;!%AWB\B3#3CNA<C
ML;_MD1G(3UBPI8HXV4O.)D6<&\JU[83P::\+$2<)%*540.9A,8<-XDQ=!HA?
MUE6VT"3]TE7()OFN9LI;:LW:'36[OA!1W@BZ)N]0HC@E. C8.^9X4GHK.<VX
M=MN<NEH\<<>J70&[<+;\BF9P.1>F44!*!6N3]"$7T6K&Y8S93LD>@=8#:]/P
M\!>ITB2]PZQZ2N'37MSZ_N\9;4DHQB 2[_F\"TO2C380C2D9"(WB(W9,I%49
M(O8T@(WGDR_RQ]*6<&LKY(Y=&?]N[+-4-S/@[Z8[2U!SFH^G*9[GC-R;-+4Q
M/)_G]$+_,J)Z7_23_TSM8>-5*C??]'98AA;D# OO,EE?15.C!&A>EM J5WO+
MF(R\)N.!%8-J8IBINY2"11&F2_$]'4C0+]PSV2.ZQ& "36F=GA)7V[%']/E5
M4TK9T$40T8A9<YA#2\DB1KM@UN2)6<U&R1A[YU1)@F6+I69V3*RJWC*'\&HA
MVPE%60329-EX%;'0(MM(M&2Q$O*HGF,I/ PS>\8$/=HH5,5[[=#;L/=?V!V%
M"X#47L&:![CF8F"@)MQ?3 :;A11=VB#.FTRM+B1E1B%-&XH@Z+^)%<Q-"3EA
M&S:<OW,IVALH&/)I(]23[.EUHR1>YP>9WB>FG#H?!Q=6Z+1F"9^WB<[;B;@K
M3[%OQG*Y_8+9%MQ1[\T78(G2,PG^XH)A.\/_R&]58:E?(S.1?4J,7^B7-\.K
M@$W-BV>3"C/C3D*BS8KBB#TCZD=IM9A*CZ$EUS)981T;)@HXPEP#2R!I&,D3
MA\JA8"/QLFAQY,39MELISK"$RP.6VX:C)&-D%T#H'H=5PSXN7.[#3$6&:6HG
M)U2MK%Q*<T=3R "'B0TM2"S%E$$@A[QV4P^5[$H*D8H/Q_G<V.?.TB"R%3@.
M./JU'_1C! ]7R<,%K=@BA>M ?I057\:SLK 3XW:0;?W$=LC]JU3/K'!PQ$A1
MRC,UP:H9U;?#2F.\]165$\LX,K240,)A ])V8OQAP#7*![^"?N L[)D.J1AM
MPYU>#MY_ZW6*$)F3UQ&F0U1=/28)#X"_A;DFKB>.,[%XL4<W #8OEM$;3Z__
MN7]CS]I;-'4]F?6PL/ V?-M_:=C_V;W4(PYCA'#9[8^/J/BXTLN^S$A_G_YC
M?/%N\![$:[@18%,P$UR(E69I.J T=584GX4HF'JH/C*Y[AZ2 @UW-97R]T<1
M1&R19LEBSMCW,/8"\RT7)[=H745O7%_2L+6S"PB-\5)BGNZ<4Q0$Z J@F]O9
M3_"E8C,]&P;:LX>P%P;B^.YK4\K,7:EF*A\"BU/8S2.PJ07K1[YXZC,@]V7L
MM0+V#C(L,1=4BOSZ_4'A5FLI0S*(C2!@[99B<S5.._OJCPUPC)A>_/DS-HRS
MOO,HP6,7U\%K,IX[KK8]C"L_&0;H;HXF<U/H5X0<*;=+S7^27LO "Y=2V:R,
M[]=1$_GBN46Q1^*6M4@$VD>7OK#M'L&[TP0!8#L\DW8EGGBVB/<\3N+)(,YG
MAA;4Y3VP*"P>U8K!:X7=]2RUN=^Y9E?"%B;.=F!<M-+>A$2.5L :?8'4WEF2
M9B8?X[Z98^%8X8NX1W! \B[S9L26!]NPRQ=NJ*C4.[$*X)7W@.=")/7.&S;N
MN&C"0,L/5D:?MU?'5+'B#[)/#V80HV[1O9ZF_E<05F?UUX)JJVY^IGIL:ARQ
MH3<1ZPR/<Z(:2 #+(LU$:_<*2SG1ZQF#3?%R?,)ZB!L.YG9ZSX8:(Z523&;V
MS_DB?BI*DLNZ1"Q;&-;4+/8=(=:(9JT5/;_NA^UY0H>_=1$$KH?8%G;'=3?M
ML:G]C40)S<U>U=P8A4,:I*]S6&_D;]_4W_WMF[2"_YE]][=95/[]J]O#PZ^B
MZN]?'7\5U7__*LVQ9_.GNOSJN[_A8W7T99G]M<+:^'__BHH+E4_)5]_]YW\,
M3@^^[4"[4T6;J*)-M="^ >'ON[]A<S- /3SZ2O _P(\[\+\;.I'XUA21_M=/
ML(71]UDQ^_R_.X;\_6[(5R[ 1U6T"U6TH2K:2!7M4A7M2A5MK(IVK8IVL^=
M3,GHA,U"C"1A.*%K-H5ZG2GDC+%>Z9)++5.TF#-^\;]=<6=7/4O*67%=RN[J
M+R:.#'AWNN(\%DE^YU@MTX..>Q>GW%?.LVU++T:_+43/DT;I,6MO-O]"A+#(
MO:U7O;4^0<\8;OVJ'SB_L#* J%[6\.Y%C7).M11H,(GCKF0LO$<SDP=,TTRO
MD.9C27K(?4$!!!C.D^!LW*=E*0G8_I95?-X]J@=B_4QL_S#6//P@7,G6<8GF
M$"R&:OP&3N.CS[@^*N**\A<W]/Q3751S']=^E%,K:<MS.1#9F#)K^)@?8MF=
MY-]ZW"LB\-;46!72(>=TS]&:1S"NJUPPR-:F4SW5[CIY.#]3\,'XZEP/%]N#
MV\0NO8( J%G+=0,'\/#@\)"25Q=I1KYM4+JS11CB18&X7-#$YL0./[*O*<@,
M)C\'65!8+4>?RQH.K#5$IZ*>F$^?M.L_AL5>[YFH6Q6N\?L[1\E3\6<8/<<L
M;+E2FI1_G=;T%YD["Y/6P&D#0N=88+?<5B,G=(V1X1G'S#/S_DBEY9P:\_*Q
M,R4G7$\X$&Z_Y?/@*@5ZOW8D:D;P+=,:EBF;E>F*H_TP? 3^PN5RWV(_&33J
MRDDW*V ]LFT.A?:WPL17XZP:#LSURQYU%<C$F&5C* YJ^($ZCIF1)# #"$4V
M89)ALUIEXINV.IRMH&+\_E7/I"1S2LM"XN=,1<X/-)X+T*;(=G8TZ.$"']'D
MV[\]Y#N#M4"LKTTE0$UA1RG-8YN(^'<*ZFM&)0^O'"G$[BX/[&[J3JTKG[D1
M0DUUHR,NA]U6)H./!TVB_,YO-JMJXR7R,"/%VE"]%MUX'AB 9V=%8M[B5'FC
M0GG*//HZ8]:>-Z*2>N*H,C*#[WCH60>%,3-M:_?F<5IV27&PWPR["(09_%[M
M?OR5L2H;^RZ6!#/^$LD,IVI*5(K7ZH,!Z^[)DK6=XW8MO3-9@U9 2:>VV!P9
M\FLQ:3EON+>DTN@.N0.QTH(L8^RQ>L/M;^A7ONO**XV4YCBP9(Z1&6^)BNAI
M_]?1*D-'],8P*<8Q2S":;'!R\)=7GQJJ%CLG7^G# YH-:Y]9?GW<>W]TUG\?
M+;'!G,2*?7W2.SD]ZA_87[I(/G]IFYJ*'$D(LLF*R.1460>FJ^')RX<,_O#@
MH'_T%WIN<';</_]+B$ GSSCG9K#_U#_/U=5'["9'L2/A2JQI[9Q-9/!AAQ.Q
MOBS.71:YV &=]<*P#"\M\MDUL/$;?'A1$C'(ZJG$>XH)"/>F/5\O<)X2]YX2
MB2!V*]<]C8Z.%O@4C'&#$SU[DJ[K2L"3]3[#8O$GCD'S>A>80FBM"ETZS,+G
M#KTN]N!D#0KGQ@)(TCI)^)N=3Z@$N*[FF03DL Q@"+SGRKSS3=2//FX7B+O/
M4X]:'N#./7 3!PX=AJE_/>B=GA[V!_[Q:'*J\&XI@RWDG5I.],;CRHZH[LD)
MQQY+N9SD0^X<IJTBS/SV6Q+Z/&,9,7Y+MXO"+WT@+@,3ED8R5A%$D(7%2@,_
M7+NNP[-TN_IZ<.+S$+'$9-'AAL:P?;7])$333MZ[6QV]4=@YVOEBBFDV+AQ3
M%=NDE!!ML,?.1 K>[S_2O2X71)>5TB0#$&FXB KSI!3#X3G;ZA!T&EJ62J>5
MM.KD>H7JO7IKU(4+ _'<>XO.J&P.I#"+EIN&9SVR8)I:A%X#8[LZL L6N]?Z
MMS\BCHIRMESN*QR[^N1>&@&#2PM)KX?FUK+-%(#$96A"<T)GB9+.<-FM-Z6]
M$X%LCSVR3?/M:C-V8+!5ZE&%BC@-H@.<N^<Q!9-VX:(.O8.'M^#7QR?G_7/S
M_5[;#..5OMMLD]5E;Y&Z^LP5%PN2B]>6A[;K>G!9]L)K>/5"TPU(#8.S<\?_
MA+ERBXO<(Y:-Z1X=]@_M<L_#!;5U;JF^GEF(C<H0M3<6FYVPP6+)GV?%^DE1
M\P2_/CTY:,DZSJ)%)@9# R0:'9U[O+=K:;\^/3WI'_E\;[, O17*.[TAG9X#
M36/AG2K:1!5MJH46>@Z.G>?@^#=X#HB9[?,?[ 1^M?] $^U"%6VHBC921;M4
M1;M211NKHEVKHMWL.18_^9%)D53>S[*&HP2K5K"/M;E0KBIU7S0]1/QX]["I
M#Q:GI3@C$SMH2UTQ0-$JFVWO*A,\*RFU<39SI8&D<22-E^NLHWSSN%ZAD$8!
M)ZR$6.V$OV7:MG*=%@I4MVUSN8!=O%K!!>6):-XW4,K X+)Y]*,41<^I:L4/
M-A;CS82'/I2AOXW>#4!7?'?REPC^ _^+__H(DJA+"Y;ZZESMA6X+- 9(I?<W
M T X/.F?'$: ,CCI'Y[C#R?]@R/X+_QS /^!7Q^?P'_QX>]-V6JT5WX].(";
M^]Z)/($I8ZMT3G;-KU%:\E[U%4S?E$%FOQ5>Z;OP$! &[0/B)N\>B3/1V_JL
MG'0@1!@D4OCA=N1T>&/C<JFZ<!Y1QC:&.8H22N2QQ+SJ7UU[AM!M\+;GI<SZ
M4]XV5?@M3//D+]UWO>;!OE-%FZBB3;70PKO^Q-WU)SN9FIQ.(,R[%'1UN.#S
MZ%\_).4,F%/W%;\3[]57O";:A2K:4!5MI(IVJ8IVI8HV5D6[5D6[V7,:WM#]
M\9>WG2Q)<R!WJF@35;2I%EK(DDX=2SI]%4L:H05I-T_:"?AJGJ2)=J&*-E1%
M&ZFB7:JB7:FBC571KE71;O8<AS<DRF[A29H#N5-%FZBB3;700IYTYGC2V0MY
MTO]*RF(/-]H)]6INI(EVH8HV5$4;J:)=JJ)=J:*-5=&N5=%N]AR$-ZA/;V%&
MFN.X4T6;J*)-M=!"9G3NF-'Y"YG1#]G+Y*.=>*_F2)IH%ZIH0U6TD2K:I2K:
ME2K:6!7M6A7M1M &!P27 \S3=P?]@Y/#P=^^>0H8D.9G[U31)JIH4RVTD &]
M=PSH_6L8T'Z;T4ZX5_,?3;0+5;2A*MI(%>U2%>U*%6VLBG:MBG8C:"W^,S@Y
M/FGS'\W/WJFB3531IEIH ?\Y.K#\!WY\I8.Z%_T@L8W[<MQV8[^6&:FB7:BB
M#5711JIHEZIH5ZIH8U6T:U6TFSTGXT\?]6M\U%U:K.IVW:FB3531IEIH(1,?
M."8^V$FJU"<X^J%,9R^-+MH-^&K.K8EVH8HV5$4;J:)=JJ)=J:*-5=&N5=%N
M]AR'+LY-$1_<^X[CS24,1.I(K!)ARNT82DZ1X<P<*?Z++%)ZE#Q'6(6=TE@I
MPG55^DTD? PIIL]1,@@W^>>GH=3JV83@H%18BF7:+*,W6.T=HT<HKZ<]=%,0
MPX69SI-9%DO>(9??3V(*L:8J3U*K-()OSBBYXSYYB"D'>BX-[LWP^L)2?J29
M_\ %+#'4Z -]_A_T>0S_N<(5N875H!\^T3SXU1_,%"[\*6Q@'+ZEUW_;FQ0:
M?&%ZML,PN6]Z].;H;322;)U_8CSUL#N>.AJE955'_[>LR]?1X6E_<!!]#?\Y
M/('_'/8/3Z.#_BG%.AWWS]["#U_#+\X.L MT =\,7CW"5\_Z)P/XSU'__4ET
MS*^>]]][;_[TF):M%T^.X8WS_MD9??KT+#KO'\,+!_T3\]H9S =3B,+W3D_I
MO=,C>N_@-#JC]]X<]H_>^F_N78G#SI4 V*-!_^R$9G5^'AT.:$"G_3,#?MZQ
M#B?]\_<TK/?O:1U@50:89X)K>- _L ,[VER)D_X9SNBD?WA,JS\8X%SH%5S_
M0_/N^4''<ISTW^,ZP)J?T\M')]&;X_XYOWS$/^#+IP<O69%!YX(?P@X=G?5/
MCVE)8-V/87Z ._GF V&?'-&IP&J7CJ^DE:M(/)=0+JZ+#2L^=XU\R@1$24Q[
M-N?4YBACT2.;'0'_S$Q9P/!#<H#GG,;/&>7[.!;+D8A3/9J:?/<FIL^/P3."
M*W^84KD6G</NR]%DR91G+-7&3&\C&A4+FIT\D'(>84RF)@3Q,QSC&\/19C&6
MNW)KZ97MEF&\[1,;^#&A:\5TYS&L,FK7;+2<DW(3I$;REHWAUF%_5L'XLPK&
MGU4P_JR"\6<5C#^K8/Q9!>//*AA_5L'XLPK&GU4P_JR"\6<5C#^K8/Q9!>//
M*AA_5L'XLPK&GU4P_GM6P5!U2MVIHDU4T:9::*%_^M#YIW?6Y_[N%K0).%/L
MV,%NV.F\TRG-*&=><!@Y-,+8L(_=CYV>A8]==#V&_ICPL6'78^CQ"1\;=3]V
MU$*[['YLT JOO>H>VU'XU+CK*73!A(]==S]VVD*[V;U'KZ2H6U6T.U6TB2K:
M5 LM/#NN]OS1[E+;Z%)]T>$YVJ2"\PTJ^-C]V-G&X>EX#'V:[</3\1AZ3=N'
MI^,Q]-"U#T_'8^@%;!^>SBF\?]\^/9N/D1^S?7HZ'D/?7OOT:%8ENE5%NU-%
MFZBB3;70PM/CZB\=[2XTTW5Z>MMB"S[\8W?LO7RKG3UQ=MP^8]W/G1\?^/\W
M:!^Y[K>.3]MGKONY]C4YVK,RZ!4_Z,P^N]SW)FC*W6]>F;$-POCNP_;1[)S"
MX6#C;'8^=WRT<;7M'/"K#Z<FVITJVD05;:J%%AY.5S#E:'>)B ZQ\+>?S7W5
M*/I'W33[4=[<.$\G[?.YYPMP!75_8;CO30PJZGYUM/?5H^VG>/]7#[<=XWVO
M'FSC .,MJ]F6SJ]W?^+5 8&::+>J:'>J:!-5M*D66L@ 7'F2H]WU&/!4VWB]
MSE-]VJGJ;6B$JF5&5-&&JFBCK@7!D+>V)*U:/T05;:R*=MU-(8=G;0GA181T
MV[V\+?'EKAOLH/78I.NQX_Y):VA3>>PD^*9])CQ9KLC&T>[: GRG8C@;_,'Z
M%] +VRS?<2@@=H-]5U%I.VKM-RO*54'Q6^1+$'<4^;RZ>A$OXK0,F_!Y:2I!
MHV4\Y2;NRC5-1 MCDY>)5->;8X3>+(VY__>_[LC8VWW3J]8$446[4$4;JJ*-
M5-$N5=&N5-'&JFC7JF@WJFBWJFAWJF@35;2I%EK(3UV=D",N W"TA9^:ANT7
MB0LA [;WH\2RY77TKP_W%3GDNYF6:MD05;0+5;2A*MI(%>U2%>U*%6VLBG:M
MBG:CBG:KBG:GBC9119MJH85,R]46.=I36R2M/N_/X5<M****=J&*-E1%&ZFB
M7:JB7:FBC571KE71;O:<@/_A:M!'%P;U^X;N(JTX7ZK"<"TO+@0C8"@&WT1K
M@I!3I97?HGT68X@[9F91$@N&75%8594N4QA)MC;+C);<^R1Z*K B098$ 3V'
M!P?G[^!_WG=\:HEA7FE>U6DMF2#/":?0S#C:KHS32I*+[C&R/LL$-BUMW XM
ME+2+I\@8CAS&L@LE!@KB@&%8U6*-R_.0YD%49211K2X>"3>UZ\%TB6&O)J<!
M!F#:NW/B2<_LURSFX-C'9([1\HW)Z.)P-J\PQ%,"*YUAI*@WQ.=TGE1 $#$&
MM<V3I:0NP$!PJACCE582M"/QG&:YYHG$VU+,W1J0.6C&/PX80[I<-5F% >84
MF]23;"R.AF\_37&9BYB7G>(NL[476$^'( @_Q3!B$(E37# >)471F8 =>8_W
MWV2/T1,R +/%R @J"M4;+PR]470=[MB, O/GO_V ].SIY/!!0\;FK%)4N207
MI/FVPTH?]+,$,$E'GLN*JF+N RN2)Q1<ZV+T<>4-[PBBQOQ 38KSBVV8K>%%
M-C:/X[/NFRKE5@'>\3(\1%(*.@+X; JY< S>^##QJE.04RW2I(HV446;:J$%
M@MRQ*])TO+L4S0<7K_EA]I@"Z4=CQSJF%.2<PK]WVLUV?^.U@IXJVH4JVE 5
M;:2*=JF*=J6*-E9%NU9%NU%%NU5%NU-%FZBB3;700L[E*A,=#_Y0N]FQ:ITB
M5;0+5;2A*MI(%>U2%>U*%6VLBG:MBG:CBG:KBG:GBC9119MJH85,RX6K'^\.
M5W^1W6PWQJLYDR;:A2K:4!5MI(IVJ8IVI8HV5D6[5D6[V7,"IF&26"Q*1ZBB
M1H53/#BCM;)%(N1=J<MCZHY0OEF.&;NH<6)M@Z*LVZB4V5-5I.S[+V. 8!;/
M/E=U =KY1S8>_&>\7'T+RE#5E)SYCB8C^$Q&!2OS=;0DA<A4"$I+OP"1I%KS
MD.C;=1(O)>_V5=.?V3H Z4..A2- LLG6H+672\S%^V1*K9$:GQ=1LEQEQ3I)
M.._>I0-3'I/[ N::EG6*18ZJSY@X'%-.8OU<E)]Q1D;?IV3@6,KX4FI]6<1S
MRI>D9ZOV1I"Q I//%@N8)98SY1QA\_<$C3GX:\Q=>RCJE'\&0:V98?XC_)Q\
M268-_799Y"DE&=*F<F&8JFW.X&I)DCU9-9R5::@&U]A?.@"O:87%B :S2W.L
MAB+HG#E8%.6<BNJP3+F?.,RLN_>=5P"&%)=2ZZ--0'N_\)__<7XX./MVVQ?V
MV'),,=G\U?3'B_M[#JQLO)V AX59>W6ZX )7,*%L_6O2,_G,# [_,28G7F4A
M"3(PQCD77HIK6,MDX[B#6D#K$!"@'0>F"]LZ#Y@U*Q1H#,J;?*,G*:%<?FBY
M2FHJGA+7^%\\]521QV8F6WJ%R33& &H*#'%NY68"<4'5-I)5[>7CAH>8#_A2
M+,CA*!> 1[G6%:?@ P$D_\;3%N4-I;C&7%;-_KHJ5IAL#4?#E#@ VID]RMGP
MN[I2T2T\ZUX6/]5,VDL0O8 _4/9QPF;WQ[3$JAQHQ\4LY14N6"7;S,P\3!]N
M31$KHF!&)^:WUHDI@.P]7B69F$0]RF&SKUP$/[5'UI&IO7.)J8)#AB;_/.>;
M!(@QSK)^-(K3K.$K8_=U]*JS^QOML)U&5M5[_TX5;:**-M5""Z5^EVAWO#O1
M[B=B)[LD%RE5@D4#N>H /D(EU*3X]F.ZJGK&B;00TF*D]F.(: OF^2>2B+#)
MI:P14]V&Y]$GLMW1DKLG_6HU11/M0A5MJ(HV4D6[5$6[4D4;JZ)=JZ+=J*+=
MJJ+=J:)-5-&F6F@A*W59E\?'?ZS55S/+[:,JVH4JVE 5;:2*=JF*=J6*-E9%
MNU9%NU%%NU5%NU-%FZBB3;700J;ELE&/=V<UOLSJJYE^]U$5[4(5;:B*-E)%
MNU1%NU)%&ZNB7:NBW>PY =\G'.3G:Q>@D,^3;*^EKEE18)JOX%" DZFD;0HQ
MPV-545)E0:ORW,?YYTI,>LME4I*Z3+_LB8WG?Z)2YALM/&,;VA^-=;8H'^)<
MJJ];B]<?L(CXVV>:ZGKW!FY9$E,EL#'C*<B61G55N]>HRWB_;>:T)\%>LJ'>
M%NX-Q^-M--J=.I9+JM;+*N$+IAA_:(IK[>IS9QG ![Q'VB8A$^'+=7>E=J)?
M+5-&\OPHH8XO6(:*;4OA?+!N( ZHN,_2AUBJ3K:W8_N4J RA[1W1"XI\8^\Q
M-HN3:;;BBJ7A8F;9_N- 51&;+;8KU41Z5;2)*MI4"RV475PB_?'N1'I3/QN^
M8()5G?V;K8Z+HMQ%_%ZL*?!["AGW+=C<ZH":6TA8>V([QSE[)AI;.=AUCU%*
M,P7\HRK:A2K:4!5MI(IVJ8IVI8HV5D6[5D6[446[546[4T6;J*)-M=!"'NE*
M(AR?_;%&*=6Z ZIH%ZIH0U6TD2K:I2K:E2K:6!7M6A7M1A7M5A7M3A5MHHHV
MU4(+F9:K.W"\,T7XA48IU>("JF@7JFA#5;21*MJE*MJ5*MI8%>U:%>UFSPGX
M;ZC:_)*8R*+6IP,#Q/<7'RO)"K1#XP10KT5;R[1#?^]%R^377^,<%L+\PL]H
M=>F54HV='^',3;+147LR$Y@5?;R=^J%[W'R)6@#2MRD:S('6ZQ4;2F;8^ZM&
MB8ER&+U^-!3FY^!698$M+:JW/>Y)@&&*%;>3E982+@C&1ENYP# R/,35AMG*
M;T#HS#?2 <^T-]BWTDOL\H7F'"0;& NW<[0/Q1E,,)<UH  P"6NBGB89A_U4
M-?<^P2%GR1=)@TV>.5#K&VHA2:V] + $=EUQ)R*)]NQ'=T698$>:GO^Y[M1?
MLQ9>MG"/S4+WR4.3!P%W:!N**;R)"1Q68FWB2VM_^;&# [V$O<<<Y2WCS]P+
MPQ$O8%&:K"%*NTG4X<%O#\"&0K2_F7.(EC9JUF4B\_Q6%IA5Z@T5EH:#GI+>
MB\_Q]L%QYSGX=%ZEBS6L-_<^,ST [.AB"CR]QTX]TE^ \H,YW(X6SK0] C)9
M1P^PO+5K9HC,H4YFCSDV/!$JP6FQ@=)0J-GY>=&G]K+)EQB)!G:V6";!:'#0
M$DR&O;9*(C0Z=])"E*(M7>RA='[T/E1;ZV#0JJ:I6E9)^G3'>M@18!]6& #2
M+@!D22FM%-N$3<GT5;64-JH^C?-IG#W&J#T!#6"PH@F9HV9B&U_G7CC<92JF
M1'<LHU"F"9OY@T1H^ EFEU:/T;(H-TRDN73OA#-2UY*V;A@E/;^ 4YM2#_ @
M>)3'[W=FP5V3ZX;BQ[?3XH(WF5:?8S%;\Q-SOAE,3X)$T19M."?9R&4$KLC!
M;T7;9K\V@9]>O*JYW(IV*"8A,O.+2_^L\/9[Q(DW(3"%P)& 49YM.J-XVSEV
MS<4X46!!2Z]A!_:F84+V<L_;%^KV8Y]67(2 ! RNQ.#=.3NN$^\ZXM/4GHF?
M[D]MF6Q8[C?B1O(;#/I432_ P&KD++8"!Y\#VF.\8FA7<#?XAHEKLCFT+@7:
M8=LK;4GF^^46SD:GV/ KRAE(N0:![8=#"T5.,,,S7&NLGNG*V=EKT.Z/:24H
MI2^(?)J*^\; !=QM_U>M]*2*-E%%FVJAA6JBJ_1TO+O.C7 M(@1DVND,+NHU
MTW=XR[?]=#O-]*JEH531+E31AJIH(U6T2U6T*U6TL2K:M2K:C2K:K2K:G2K:
M1!5MJH46L+(35^ODY. /-=.?J)8Y446[4$4;JJ*-5-$N5=&N5-'&JFC7JF@W
MJFBWJFAWJF@35;2I%EK(M%R9DY.=%0E>9J;?C?%JSJ1:RT05;:B*-E)%NU1%
MNU)%&ZNB7:NBW>PY ;]= T%K>IR3'8NJ_,FC9"1"Y?,YX4@TSZ@!1XRZJ_LM
MAD5)QS:K35JW+;VA_08U<+)*L3;._@#\E6=*,Z8.R56GQN@MRYK8)++U.YLD
M/V\;+[(B%C\"]B[%+L%!:_>%-6PLT_D\2YS)P)@YI.QD8(Z9-[C(6?J0F(1K
MS[1EXSU?M*I^8C"B<YINF$\+-!)8@'L>F-F:)C>;8VH'4/:\)/S;B$F9V#I8
MIA66)J7(1NZ@:RJF2NE!2FZGGQ^+C(ILTD=-+84T7S4U6^5+KNW@[.0T_GDR
M2RO)A Z:(EL[#]HW&EC*$L-/J3<U%41$ZD#3"##WGC-*2@=I?X _%9STS:&T
M8M-S*[*+OGKMX%(8%!IL*703S4E-F?>V]UZ6AO)9^CG)@D;LV6:]6ND*O2T"
MM..<H86V62Y;X9]^<CG'59OXT> O!LP=H/[^"@ILC/HH1")U*=/2*U3!I7BS
MJF"7H&P:#G61I5("(Z@&VZZYB<#>0'V?"/[IF>BL(2)L/?949$_\F!M/I]U+
ME?/>J:)-5-&F6FBAW'7HY*[==6I^29@*V.\&!%W,F O;ZJI;?;T[+5^[/_MJ
M44VUN),JVE 5;:2*=JF*=J6*-E9%NU9%NU%%NU5%NU-%FZBB3;700F;F"E"<
M'/VQEB_54@^J:!>J:$-5M)$JVJ4JVI4JVE@5[5H5[485[585[4X5;:**-M5"
M"YF6*_4 /_Y^R]=.C%=S)DVT"U6TH2K:2!7M4A7M2A5MK(IVK8IVL^<$_ X=
MA.Q)&<4H2FIS'IO:@]1*!INVS--9M&KN0;GE."?00$FO-6%0J*BW2ZK5&%SW
M8!5H6\O-T^W%*&%S>4T\7!0OL>MVY8?[_+M)9Y\Y>5A^1?$O^0LR@7L2+-4V
M#)JJ@A34MFFPH_ 2+S*&PF%, JNMMAE+0.]]4C]C1QN<*I9ZXVSG68)OYHG4
M<$OF7NR1:;K!%ARSWA^+Y1*^^XE_2<7YUELWP2ZN^:*$9O)ZNX^R_0K^A:LB
M,MU>RZ$)0:700(I5P[@>MN&(J95M(#0A' #L#?T7;63<) =SSG&<'OFE>6 :
M(_,-[0Q%(M%W<!TX? D[EW 3F<1&42,NAIT]HD$/#5IHHN)@)_,L#ZZFT52M
MFJ@]J078<,<@^]3S8V*C\7CC<. 8F.B3HUUYNY\F),N!,(503%WRO"6VJF6
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MSDW1)J9H4U.T"U.T2U.TF2G:E2G:M2G:C2G:K2G:W!1M8866*JU(-_+#46:
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M1*8R6._8\3X#[R4Y_R*])78Y1ZD@:C1VXT9]Y =2^;<=AS[WX[ )QVD_*4V
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MR>ZKW#70PR,O,)PC9&W>V"Z?Z*V)Z8W( -?@_EL[<K O2PAQ(A*_R)@^[/=
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MSA7DQXU1(*1'!%)-5ZR>V(T,<M<H<D<,!N*\AO.M.P-CXFR4J0*G//:ZH2F
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M:T?63N7D.%_C<?V(W+X[3CQ":<,"J7NR#N#[NMF4/-#CHXH(=GEGW3%\30=
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M-B7,/8;#S L3Y%=& R?4#/8HE+KSU[UZ#\76*Q:#$D]+S("G?[8PN?+78<7
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M[9:NCQ7FA_>?T@^OF,<' W*0OT E$3HTF K(ZR.;5G9G:@0QX[-7,'IK=40
M]]*!A6'9@X^%K7W@HW2Z"#W5TC5@6\B)3;JR3<Y_&?+&@5PLP=3!B +E5_BW
M!;X)L%&H$5Q5%N"<DWL/1@TEJ8"V(<P6)6AP5D](5<%T'\P,>[PK>1N"_.8/
MF)P EW0X2G #TR3?E0F;09K[AW>G88F@:#1=&^]<9P%9!NDH/!M=2F)X5^+I
MSLOG?9,2,24Y Q).KO."T_T/+$[8ERJ1H?M43,+UGT".HJ6H!W\\9DPD$K0G
M+F:F="69;\&QB2>9'V<0F0.[1VH5@LX CV(,!TMMY"[?.+I7;V12QT*"I1^'
M@GQHHU(R)V40HB#Y+[SZ\EJT&3S.J_M\%Y8-TVJS?(W&)K$U) OY_OU_Q-IT
M3G/<:;L2SX_QZ-73B8?XNYMZB/B3G_L RM#Z_;7J=)AMFN %+FN^[/,3.X&5
MK@QT'*X<?-:E1ZAZ]Y2!&GR:Q\7S)TX5Y"A[3^XT<V=L?Z#.6\XW#W4.RPH3
M)4,NW4%]E*;1YDGG2K88RLHK9:]YQ>@<=Z7J&;J/.&#)XTZQOB6JMC0S/)Z@
MF(9W)@?>1PY%O_'6MI/#;J&/]ZYEATY69A_$;&"H[VO*<7)OQ8W.CBQ^TDH_
M*<2<=+5[O @PRBY;?0[V3;P![C.X,M%%(X328^*=JW79;]W F2V4IY(W$TE!
M0CP7O"JC9)"Q2&GESX8G+H^)I+[QTW<N>WB2CZ]#(C_*H<K)KQ,VT8.$-1QS
M!F- RK>3!+]PJXM3TB -;3QQZ8C-N:I\Y 6B@5L">H]P'"&[5FREX;<)909G
MHT\4;.8T90@*EQB]W.98#1*)&=#)&=)4.RDZT7/8*Y()/"? 3C0TKK@F.E,P
M4QEK6)!R0#R";PK&"ZDAU*VU,SYT?1)O*X:S*$L[<G1#6EN[]W^XH2+19^^.
ME7R1ZPPB/QYS3:!@N9V+N3"L*(GX&EWA2B^IH5 >/3IA'\"#VTN#@UI^XBX7
MH@RU [!^)D8R\Z$2753<B4&ST@_'K=/<E7)'RW9/(&>'&(Y4*IOV'8!GI%%)
M]EQ'E'BN_#D&G 92(=C[?GV7T:4#Q7&/[IWE4Y*VS@=_;U3.'Q E.5GIW@S1
M3R+\'?(^,<D K\C2:ZJM?_UB/:2'XOCY6HZ7<(ZV=&DOI1^0*HAG%J0_)R&U
MSG$^2!*JQJ RI6*MB!Q,RI.</@393)/?* :W*KO/UY!XYXC_&_D@)360*3ZS
MMBGWI5]8#E83!YM_+,XX)BHAAW:=E/VQ5<C1A^ZPPC$?="M,'I!SA:IE.I55
MGBOZ\50('G&6V0[UR@ EDDPIY@3F=R5Y%-?9WE\)QNSBKL*;AVJR: ZE(^8$
M5$JQQ(LDY$SAV(IA 88S+B\PM*2S^GF/2*2K)3AF;U7IBX&L<?D4.3JQ53>(
M55K'UV<U4+P\4"74=[[&!:XPM"-N-H7!WM>VB%L1<L5V>0&AUY6$R)A"/?K!
MI:";TDN)>&U=97!TXJX;]U)54@GMY#LIKX&8:UZM@C<N5)YSB00<1TB-$.^5
MB@V*+@F!#HH^*?X4_'(8ALHJ@X]1]!7;:N%@R-;FKA*4ML;G$QWP45><C7ZN
M<J"[FTJ0&]ZN'_SB,".<16AR#/"AH>%0>Z7>O %5.E9;GLP(S3XJ!V!)B0_@
MT<[W_#E(3!_F6P-O:7JO%;H(57<ES<XJO#OA6'K>SA"&$0\TLT^H;#(NM%_2
M]'#^/5HT43N3BP8J7G/BST'S@KI5^<=F!4ID'(:$+569-;%C9[7<5K+=(U M
M'B!A8>]-T/8=8&'725DY#K]C4'/E"GW2TF0C>>D0<O +U,V5]%<*M)*CVHLJ
M& -^8W;ZJ_A(*H 2%P@5JYQ=/OP\G"'6PYB#2E%7"2WU?)UXE95K%/'RI307
M_@KNQ-](PM]IHJ#DFV(95/3G39_/0) $SJ.X@_?EFMV*6-\24TB(U1RC7WKS
M#]*IC$= TX]''75 X 1U]HKC'])L;^[A\&N(#V RC#>JB"ZY+N_O, 6/+Z58
M(IN6!^#XQBJHC_Q(H22GXT./<Q(X0LFO$Q,A$K) G23/"7HDJ5Y%"+\MV#B*
MK:J?92M)T\C^CSY^1PUBZ$*4DH*26T)7]:#PMU4J=(%R3GQ$\8U#"5)@$9'"
M"B+B.!ON5&O9G?+6%FYN"[<P@^MTJGVG.M6^.]J=\Q^4T*-*C(?CRRHTG$9J
MST;_Y]8!$?*!'K=''__R'K>6<.>V<!-;N*DMW(4MW*4MW,P6[LH6[MH6[L86
M[M86;FX+MS"#Z^BX]TK'O<<GO#^@XRXX/>4<PPZA4<$OR(((%2VC__-A66,]
MR0$E]MY6B5G"G=O"36SAIK9P%[9PE[9P,UNX*UNX:UNX&UNX6UNXN2W<P@RN
MH\2^54KLVZ.&&H8Y_\^O[DLS^AFJ3@]HJJ,@+]=4EG#GMG 36[BI+=R%+=RE
M+=S,%N[*%N[ZU%XPN+0PA(H_ZU@G)K3W7 U'X,3$2+TT29FMJC!2:8LA"5Z5
M&W6+5<E[%$M\D2@,V"/8.SN.T2=PO/Z)FN&1-('M5G1+"B"FIW(_@<213KW_
M0E>&3C8O.?V04A4*;DI:/%?47%G72I,T\"' \Z.W#?KL#7J_-QGQCZ6/&D=F
MBIB/MMF5Y'6*;<MT'YW .@+!U4>FS11'M_2:&'/H@9U73 7^X(J6WV"HZPKT
MH +"X:$<YY$K'O*J+,CE+HYZID=X]\V[=[@8_A_O>^]TXGU4IC[5*DO/BJ3F
M)DN<3;&9D:IIQ$$]:_*DJI8+:)!V@QF* B<^.25I-E4&]JJL%?]%]&XGY3@A
M4IF'^$''R7ABF"$5NMO@%OY!K3!KQYID(!T]W_2=L-K5JI)IF1,6YQQRK+#*
M \I&1_]L\]5GV*%9J*GI/B;DTB>D-WW.C,%1CKG"Z_ ,]%Y>2O\HW?\+%6TX
M+F@-5"\YBPY)'\L/574,O@?P@584H: P'6O'X%GMO#;'5S2)@K3PYKAMYPLJ
MP92+^[O-ESN%$R]13_Y#.:>\M75(AD_["4DVH<-DQKNV6G.ORR#(NK>YUO=Z
M&"K0A).B,.O0)([S"21KM<<25+DWZ6@*ES9QH6+"81/>\MB^M86;V\(MS. Z
M)OQWRH3_[JC9 O550U&Y6"@8VZ14F+R*K:R89@^U2*@*&_>L!&&%#KBG/+-'
M!_ORJX(EW+DMW,06;FH+=V$+=VD+-[.%N[*%N[:%N[&%N[6%F]O"+<S@.AKQ
M>Z41O__*GMGO;968)=RY+=S$%FYJ"W=A"W=I"S>SA;NRA;NVA;NQA;NUA9O;
MPBW,X#I*[+^4$OLO"\_L49"7:RI+N'-;N(DMW-06[L(6[M(6;F8+=V4+=WUJ
M+_R/7W&./1 <H6/IZKUT3!/$#@8<C?!OO&10S5UPKD0N2AKEV>AG<5()>R@,
M=] 5@W6;7#0HO%I4 T&TNS$I>IC(B1*JF,4(QT2.&S4H])'38]8#V,-L<KW!
M#KUF:*9Z@)5DK)MZCX'7U?^%Z<O[66&ZF^L@)?98,X_U!AAJ(@-C2L>_+6S.
M?:KM@634(Q,VZK3P?'3A$TARREQ/?GJP'@]]EH'QH<LCR[+1'Y/D:)(;OY $
M46H*+*6"+3,'A&>D3? Z'FDI("!&.YXN+>//676B$<<)"WW][I#N ?./J>LV
M%SL5S%B>+UM5KMOENI'B3[U).A[TPDBHDM+6?G?@82O*4G/>VL+-;>$69G =
M*^H'947]</3D^%7')M*>@8_XIR$O+S<Y&V!U.LRAZ&4#:_CC%R4"R.V_8B\$
M CGE1SOZ7B\W["SASFWA)K9P4UNX"UNX2UNXF2W<E2W<M2W<C2W<K2W<W!9N
M80;749X_*N7YXU?VH_UHJ\0LX<YMX2:V<%-;N M;N$M;N)DMW)4MW+4MW(TM
MW*TMW-P6;F$&ERJQ[[Z)2LS_^\_[T8Z#O%A3F<*=V\)-;.&FMG 7MG"7MG S
M6[@K6[CK4WOA7_DV-/,HA9..)4/.-VR;@"F5.W)3:';[I!%)PSVJ* $L>=%N
MVWDF30[-.L'!A0U =D]",; 6-C!,>ZSKG*#(M37D  (.#>4HH%[V>^P66[DW
ML?G"[X,3SL6^8:JIPU+%'BRVP>![.'-A%/U5")0FTH3A]#)0M25S%82JW+;O
MT\OZI 6AL)1:R25R]:AZ%$FCO-!C(%"3#)Z6ICODUA9N;@NW,(/KG)9OU6EY
MM#04<J!5DBHE'88%&]Z7)QP9QQ_X\I/5$N[<%FYB"S>UA;NPA;NTA9O9PEW9
MPEW;PMW8PMW:PLUMX19F<!VM]DYIM7=?UY'QG6V]N2G<N2W<Q!9N:@MW80MW
M:0LWLX6[LH6[MH6[L86[M86;V\(MS. Z2DS5FW]WM!CTN8X,VZ)R4[AS6[B)
M+=S4%N["%N[2%FYF"W=E"W=]:B_\H6O*/YQ\E$J"F#X.O[0OZ^:([X&;635W
M2(NI&W,M2VC863E\JZ*)B0+X^W()KRI<4-![=QR*(:FE@K"R\A5[,'M#,H^$
M^E;88RLA5'Y(Z%$_1$;#L23LJ*M_H.0B9ON!7)%^E@8^'BN9PBU_[5;<-AH'
M'KZPSFM\*2D-5+WN0V5;])/4R=0]1.)GE9J#N28]NK7]OBR848Y:DF!78FX>
MJ?GLLA4E50%Y&_4L)R% (>2D'DJ%0CY=Y8U!'\IY&XJED,38#RAVY9'"TDXZ
M65$6;QIHN;'6(C3<3-G/ES2F2,>2%P<]83AMV1H[:M4Q@09((*7/<@'5;%5Y
M7R%#+_%Q(7=>(AU#JQ^6.JXP<1;C,Z1P-:7V2@?*&3CU 8>.+<&#*=S<%FYA
M!M>Q&A3!@__W"4W9V?^T1; #*;EQ)Y\NTAK'X_Z<H\][N8%A"7=N"S>QA9O:
MPEW8PEW:PLULX:YLX:YMX6YLX6YMX>:V< LSN(Y24R6OWWWWE?TYME6JIG#G
MMG 36[BI+=R%+=RE+=S,%N[*%N[:%N[&%N[6%FYN"[<P@^LH,56E^MW1$K+G
M^G-L2U%-X<YMX2:V<%-;N M;N$M;N)DMW)4MW/6IO?#,6\H^@VYPX.+8L2M&
M<9AH*O8Z7W-[4^P?YK\*Z2"0F8(L]@UD/U#+&2*A"3PHT.N%+\N<(,)<5=B[
M$':LOU1C @K6%&US< MU<C?R6CF9N&/@$Y32N-TF=C/I-,"4RS83Q(Q?_F9X
M/Q]WFH$'NJ[0QV&8TRP=#':V@PX5V)9M/(IL/C)/W'DA1RZL#"M_,M6+-<D4
M$<>"M&"G+J#<RB,V.J)T$^&O6=:.NP:PQTB]N33<(8\$#8XX=;BI3/(HW6%H
MTQ;KU N$S^\_(G:2&(^R 6$;/>3NL>XVEX!R*5R2*ML[(**7AAR%HE>CWL$E
M-@!#_Z4K[J0M '>/D$9O\"[2/$&[F$+J3.@SD,@+,!_!NVW;#(QAQSSML 9'
M)0C(B(JM..MP(0^TD_#?DD6@Q"OJ#9%52 17?P8Z>-@*U#N*F.A^:]=;;G.&
M=/&J:SN3U V\-;DCU_E#OH9"L+ZW"G>+T':5W+"1N\F!1(D?D>4,2(N(*6Y3
MKEIN/H<$5*$[S)T_RI6KC3O69]@YQ#5/G4E#AUH#S7X#Z?W KJ['U!<H^!7]
MRI6?J<%# 5Z\1NV2&MKMM?ZIHV7;4/(6ZS_N<E _U8W;]WIS<F=H:4F:5VOJ
M^T-]!JFG)J#0ALBQL05U4U).\E^Q1VV.6F/4$J4:=T"2QNOR>'9);_P.(,5'
M3(9>^AUT>6EVW*D&,@%)(.\A-<U_&*:8,--AHES4*U@>4(%%B:*,)'I2MMCI
M/8 S+]\ PL*VH@84H<>&6LKDKY0TU_D(/B:D_?D_[ED]\E>A'#:C7,6V4DM2
MCY-UPYT,^A RX%C1(-T7MI(#0<NJ-;13:F"I%-D;[T( QRI(EMXQO2=.^%T)
MWF) Q')C:=(<O@)M?.G4Q'8Y[.NGYD52Q5JY^[9A59IOT&N/@R1*N8K[\OJ]
MN:9^5. I7C5":)<OJ8E4INC],G *1[Y!"  4U%UVFT%#KKSF;0 W]^V3"@J,
M1W?M/HOA$?#LDYK$PY^^!;K4JX45=!4%=4PYDMG&23>D$)9P7J)6I 7 $U"#
MZB]63V>@&Y&O$BJ=UX-URLK"@'D(%)IJF8ER#UI6A?[&*,%OL!6C?-+)::P5
M6^(K7U9(L,G-+E8J^*3ZLE.[9)Z#N_R>1QPD94R9H9OD-.SU9,?'Z9X?Y/NG
MM-WPL .N>EO&#U.XN2W<P@RN<R%4C!_?'6<Y^(<+L4%MB\F9+LG4V),GJ[:N
MH5B4]#2E3O>A&2E!Q.:?QYWZMC0BIG#GMG 36[BI+=R%+=RE+=S,%N[*%N[:
M%N[&%N[6%FYN"[<P@^NH/U6J_]T/7]FI;ULR;PIW;@LWL86;VL)=V,)=VL+-
M;.&N;.&N;>%N;.%N;>'FMG +,[B.$E,E\]\=K6=]KE/?MB[>%.[<%FYB"S>U
MA;NPA;NTA9O9PEW9PEV?V@M?]S[S#T>Y;^!IK \]!-WQD->WV>2['*G,J!4V
MM*IUY,0 +GCL6(J/0H?7NO5V!K7]1;:S#)BV5&PBCLI]R?;<[#.TAJ7"S8H*
M/RFS3R[@TD>3J>D'>VD>F3-N.8Q^STWWQ=!YED&'TH/3AMC0<QN;XKH"72KT
M!*[Y!,_>GD,?E=M4Y9[(\ 8&DU,B(5AGV+UX>+R8XUECNX*\[J:AHJ>-^T=O
MM >['GU8-;3&1V:#EV8\VO3;(NL6+-1/G?J=\ ]ZW<8=V8*?_]GF%29M9NTZ
M;\1Q0DY_?%H!W9ZAD;2:ZZQM[DIN]HNM7#M-(+ '1LV.<7@@O'B5Y>QEI=Z\
M6J#*JC,T?@EPNQ9.Q5O0BP3>5VSH -V[N9OR1O? AD4_,-QL54%;<\K7Y=X+
ML6G$L 2,NQ*8BB<Q%K)_#?GNA&607H-:@T-/ O9<<95RD>W]?& F[L85ZXQR
M:L=I4B][\OV@@,9MC1^(JN-L=),G,J_?FB6=MR!(RQOJWHU!+!A8Z"&#3NVL
M"&TCVB($]:AUN01!Z"MI5W,DL=LTKM"RZ'6+VU-[%!P<5E?[X6(78J;Z0T<C
MQ[:H$;S#58:NQGXZF9T. X40_]$-/' /<.)U#G[D!J:I3@-F$A/<L8;K>@P3
M;V4;6O)*I7A(5.YM2&AJ@7Y=]-[']\_W0>= ($):A;N#JB6F,Q-[(@04<@[A
MX52ODRXS,"EM!;YVVFUK[@\#@GCP/.%PI8HPY\U8YH[2QDE.Y)S*B'R0O\<:
M#'YZ"'MM>%[ZKQF_-)";7Y"&XDSV#8DZM64)PJY?JQOL@3/&JUIT^X<..K47
M@T<X8+:5@^5GM[]0*O2+\ZMDAKW>]/* ,3D(/0ZDC8<8]3JO2#-1+(EW!O%$
M;IBB(=MFP! @I .]<!4>4\1 B3$?;&;BCVY_G+89L374KFEV7#GA!QN"B_3*
M8PH@-W@H0M/H?5YO7%93%^^EW\V;#$E8MZCV"K?=Y5N'?T0I67W&3DQ^P;W$
M8"$'*=)U2_VQ927\R(?7G%AFL[5?.!0:+W(47"G"!BJAX38&=Y;(@5 XYEK
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M<G)4/B/>I2&V?( E[H7FR7\G>0UPA0MUSE"%!O%@H:W3N5(Z32,]UF7</_6
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MKO,S&KBA?+CN -'>.EQP7)Z1]T&AY@!!S%U6D[0AD8[.JB#<%=RZK4M12%T
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M_P#G%S@ICJWM0 >E],&2[G[D8P/^'%>+H/*E"1GFT9"X*#HJPQI1@U@QTXG
MOGZG+#HD.U]CHZ<Q%S0QK"4$%+?&XC8P7.?Q*;"$L/]][2=C'M8W82V;EC&5
MN![\^>TO;X/R%71V(%5VN5K%9</':/>0F$?)A!_<VV_;6<2EKGTM9JY7$58
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M CYW(5D2DU;ZJH[R[DVJ29J81Z,.^NR$%NT>Z*\NQW.1\& X7L[B54UYN-:
MYK)1)UYK$)N][<)X((+;<%"2=Q;),&67*E_N#ZCR5RZ;!%XNENC;W/)2DV@J
ME[++*8Z_//L6G$?9EN26G*,+*9J&0YHZ+G];0QF86E] QDE+<_J43F_.+W9^
M]LOV&Q7;YY667NWR@_UR>:%N9)VUA*R@J[)X."!1AR0^BJ_2 H]JR=^*Q_.*
M5]_MM^_>";('%W?' 5=<-C/*O!?A,SJQ,P?HZ7?K9X'O(1>\YRSM^!_J+)2
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MC<5M8+C.)A8D:GZX7@KWF5(*-AL3BAMA<6,L;H+%3;&X&18WQ^(66-SRUEH
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M;1WM\NFH&\+2=Z$>@O\EMQ1W[OV"U=7N*G?@UN,&4'(-CL[Z.]%IG>'5IWW
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MTH<>D]_4,$T3G2V=1O^?QU_8X_R7JZ]7G4VZYEV\=K/2XX=301\^YZ+"RL=
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M8$;>8^K)C9@(!\DN>$SNTIQXU$62E=5\JBZGJ9&SSIER>J?6QO31'T+Y@2S
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M: 1YOJ5"PO6P<'TLW  +-\3"C;!P8RS<! LWO307>K%+OUXHP7,]&8>.=U%
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M.*G!;T[P99I^XV_G^^PH10K.U;>GH_9.K!(:?LH.468:Z7-]F!4!40$@ \/
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M<4[V1HR(*:0-8IM6#YDK:4#K.O:WS'H4.:>];0\*6,J.QY1D>6@H/>;%-_(
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MA1]X:=KN<C-<^7NX5K[8<P[8D#K#BP^?7ED>.VR]LU;,OR4Q^[.KSF=J,GV
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M[3/4XG^XOTAFL3(2VIB'AES;:KY?/EL>N1D6#X76;C 2XN4J/\BE%XN*;%Q
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MA1MAX<98N D6;HJ%FV'AYEBX!19N"8.++-<[SW+!E3$-),QN03F>6+@^%FZ
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MQ@EG&JR&#>27"]][MA6"PO6Q<(,6#3+$?G*$A1MCX28M&F3:XIE9BV?FYIG
M<W%]_>GJ8WSNN0RVA+5#-!$]=N;U=U'--+#-<Q)+NX3"];%P@Q8-,L1^<H2%
M&V/A)BT:9-KBF5F+9^9US]0Q)RY#+6&M$,U(CW=XW<P[_'/ZD&\?B##QI4C7
MV;&E-Z(9]=F[>BA<#PO7Q\(-L'!#+-P("S?&PDVP<%,LW P+-\?"+;!P2QA<
M9+H\5N8U7#O30,+L%I:Y"87K8^$&6+@A%FZ$A1MCX298N"D6;H:%FV/A%EBX
M)0PNLEL>4_6ZD5'V3&_$V^KY[_W'BE; EPL??;XI0L+UL7"#^E;Y\/'J;>4,
MA/SN" LWQL)-#)S?*)^NWU5.0>U&U*SVP6OU8"7:H^:[E6O9R\\L8<T1S4R/
MB7G]790T#>PETD3SUY\_1;$L2RC<H*Y-ZD@3T*^.L'!C+-RDMDUJ2!.MAM.L
M]K$:TD3-8]79>5E,$]86,CM_+._3]-A+CLF?_KA+B[OT2[K=EIT5+83_^0/Y
M+^QO.T6Z49/W^@^?;W[XL?+[GZ__,+FFW__H8/[TQX.:L_.DN,OV96>;;A3D
MZZL/J@(%G1+,#\?\H,S;#YW;_'C,=_S/^S19IP4]H/Z^R?.C^8$^\)@7W[C8
M?_I_ 5!+ P04    " #5-5Q8KW2%I; ?   C9@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6R]7>N3VS:2_U=8WL?-5$F:AQW'CA-7C<?VKF^=C6O&
M2;;JZCY )"0A0Y$*0(Y&]]=?O_"B*'F2[-V'Q))( (U&H_O7#V"^W;;VSJVT
M[HJ'==VX[YZLNF[SS=F9*U=ZK=RLW>@&GBQ:NU8=?+7+,[>Q6E74:%V?79Z?
M/S];*],\>?TM_?;)OOZV[;O:-/J3+5R_7BN[>Z/K=OO=DXLG_H<;LUQU^,/9
MZV\W:JEO=??CYI.%;V>AE\JL=>-,VQ16+[Y[<G7QS9N+K[$!O?&3T5N7?"YP
M*O.VO<,O'ZKOGIPC1;K698==*/CG7E_KNL:>@(Y?I=,G84QLF'[VO;^GR<-D
MYLKIZ[;^V53=ZKLG+YX4E5ZHONYNVNW?M4SH*^RO;&M'_R^V_.[SKYX49>^Z
M=BV-@8*U:?A?]2",2!J\.#_0X%(:7!+=/!!1^59UZO6WMMT6%M^&WO #395:
M W&FP56Y[2P\-="N>WUKEHU9F%(U77%5EFW?=*99%I_:VI1&N^+$?SK]]JR#
M\;#562E]O^&^+P_T?7%9?-\VW<H5[YI*5WD'9T!HH/;24_OF\FB/;W4Y*YY>
M3(K+\\NG1_I[&F;_E/I[>J"_L1G_U]7<=1:DY;_'9LS]/1OO#[?0-VZC2OW=
M$]@C3MM[_>3U7_]T\?S\U1%JGP5JGQWK_?4;Y8PKVD7Q"?MN.H5R/4;D[^BF
M^+S21=DV#MA0J4Y7Q<(TJBF-J@L'KVC8B9TK5NI>%W.MFP+FMU$6WH.V';15
M96E[>'GN>U>1MZ:A;[:"#C4(>+=*GVZL@7$V-?!^J1MM55WO\+G>(!F&N_^Q
M,?CM%DD!J2S^^J<7EY?GK_YV=?6)/EZ\*DX+U53%IK>N1VGN6FIH]:^]L4(^
M:#'X8=-:&A@HQYU=7)Q/_T%MK^#WLM;%<Z3_1B_[FGES._W7K+AR\ Z0<Z]=
MA[T!M]8;U>PF-,PU?RG49E.C% E+_!RQ]SCPLC?,"IA<(H(PN:92MG+06T6;
MDD8/D[VZO8YS_=QN3%F\?/9\4KP/*W4+$F=*&![?NX#W/D1RF4*3<@\ZQ!YB
MI\:Y'K@\WQ']L=]1(M^T\$_L[/W5[9O0TPQ&ICZ R@8G 0Q=JP;T/-(R*6"-
M"U7]TC-MCB3/5!KEJ=$P 0<6@E8+^U@H8XM-*JS06_<H>?5=;+0U+= LO<#K
M49)!^NH>]!,L,5!EX*F5I05AKG&='*T?*(7&*3(FZ4;0M0&]C"3,BFMM.["$
M*-(P, \*/;+Q1,)7RG$KJ\M:.0>K#+2 J,)4\"TOM65O+2Z:=)%.?G9$DWP5
M-,E71U7 CTXC#]^YSJQQ0XTID3_20T;4\T#4\Z-=7H?5/*#6?D-SW*T;V]Z#
M3%5%#];'%B+L^7;=&ECRINU242H,"$ZRSU%[^<U>M- :10I4P:@V '@S!TDV
M*+\@ MBPZ6Q;UZ@I8345;2+_\G;5 A_GO8.Y.-D%KB/UR=3CR\YO:I$-H7U&
M*MM/)-L*K/<< !/GMXJ\1WKAZU<.1P8U.VVW#;P?:$;ML%V9$O2SU>FFA*'G
M>G^Z\#XI1A@$3+->SX$WWCQGC/X/EU.8CPA#%&_^=ONQ^$]5WCE8O;^WH(7?
MP[KA_#]^O(Y:9NR-H'4FW,L;V%QWNK&F6A[H9>R-O5X,*+N[W8$.\H?#ME'M
MND&[P=.TX;_@T95S+>@PM'%_^U2<?.P?3HO;V5__='GY[%5A9[6\]A8L6MD5
M'S63)N]=WV[D^?7T L>=D-Z27R[3F1Q3(E^'_?KU\0VGW(H&H _OP,S>JQHG
M-;9W?V=717A2X@>=/)'-@K)7@:<"KU1@8!UN7ORR C@..*(VT*1*)-=-0/A0
MP%VQ;AN] [-D[\#[60!SX!F!D]::):CT&IYUO34="BGM(ZLUMD)("YL;$ N(
M_V$*:0\I:U'%*]PR#BR?;*\-[.\'5IULWZ!1K_,]'>:#_Y4'AR&2H_4S#>CD
MKF<S!0TF.#9H:0VS6ZM=H1]*+3KBO:X0;L'>I8% ,%UO"9A<MQ; "JM2@[]"
M"[1SW3'!>1$$Y\71U4[D_^P&U ;,9 Z\//ND=O2A>&_;=;:';MNZ.OO4VQ+L
MY]"18/EZ](@I),HL.JX6["I J0QJ%3ZN=$$F@5#M##"AJLW_P/,E6'F6@=8Y
MS8W76C&C!#X!A%N 9D-VSG6W1:N//S<@;+#XN @.!X3I0YL36!9 (8R' 5GO
MB,"%QE4S *:;'<-;PI5KQ)%(!HI41-SX+%'1:%66]*/;Z!+Q9 ':'%!<0)9K
MW:T 7:  @<,.Q"P1T8&N[QM[:*9 W;UI>P=["[D%WB.\Q8I&@%2ZV0I8,;M$
MABY@F\)>$HH8UTR(&4 Y]G2OT1A(3RXN!5(')OB?&@E,B"I.D*)3[W]<I^;E
M-B) Z/T'MKOP N\O'!3H:I8$P(_.%7:H-335!<81&-?'M@FW:?_B8C5^'=D*
MP[0<;#&RZ!GG+$.3@X/3M@8KOD%-#VN2<C4T&F'I$?Z-3AI5D4:;0[X&Z)SP
M[;?R]B=@0<#GZ99+E1J11BX921H[10/(-6 C8B0$\JPZ/306O<U\IPV(. XC
M4[A@ZEZ9&K4)J;]#&E8:#T8?\U<1/;ZX/ =G"[O"F>KB>][PW"9SJN#-Q+(S
MW95>(,I+:$$;)/NY1VVT DJW;5]7B+6"9@ F.8WN$A %@M&AB&R4H0>DP$#)
M@+*JC9J;VG0[HAZ6 !;? B,2'1?4D+ ._'?P=PUP HU5Q[2@_UHBX[P^(^G&
MI6?1NNGAT:6:?B6P&AM=O'QV#CYB-V/N\.1@H3%<1KJTG2.(Y5YE;$N0EN9B
M%2@BV";X#;JD62_0!)"A'GUSNX)IT.-?^Y;](J_!!^M/GNAP-8]- J;IB0Q]
MXV1D>?<&\ O=-O6.Z0)+"N\K:JXKGD!QTC?L\.KJE 4,PY$R$CNJK)U+L>&V
M9\$BL5"$3\#VTUS05Y#UVE^DX/900\8Z^4R\OY-A^[UYH=GAF?"^0@&K!_L'
M4 8J$8!2IIHF*TN@U,ST;$)/-BUXU103 FVH0 /-07Q1F)2[D_4]13)8<&!:
M+C,B-*;3>ZO"*][.T>7V(F-@/3< B\EY%DJ\ \66U,_O%?MR6P,]Q[@3=0)\
MJX&OP.%MZ\-3A 9I_+6Z$V%E^Q @9 4J%9[,BI]7Z-%$P37-IN^BCHHL;NW$
M![A^Z:LEK:(8<HJN3#+>3XA!O(R=+E<-8%N=[#*.E90"@$MCRW[M.@Y@2*^\
MY?M:V=1VD1<,,B#+67F&Q^$(KZIRI4E1MC5(KFO7&MATK^L\N%-HC@E0,Z##
M3XS]P4HO$41#"]:*(%YQP60.O&%(<6&(L2EC*"C5TO"3,-X#(Y,[5N#HDI]:
MZP?0BR$DI4 9H28 &J)>F@0NYQHJ#Q<<L!>,M.X!*H!Y3[C&^*JMVR5Z$!P:
M%&PIW@O.6K#E55-@9,K"N,)Z'8W*NY_2**>J=PCY3!HP!3N, 23>SQ5JR37L
M"J*>^X+IHMTE Y$86HE/0)-YETT*F=JTS?3@"ZR8T,<!+6*ZJ0$>H5EG.Y%1
M818C_8>6A6_)RN6JN@<.6);*.$$1SEP44ZSEA4&>3T0D2I13_R,*S;SM5DDO
M$S3#]!4X3QJ4E#BHX9+BO]#[NY^8LK#?&3<OR%[Q'/DU^BEE6L9JVI7[#Q+\
M+1((M/S"62MHU9-_4:S[NL,@>5S^+6J9^2ZE/;S%[/42)X$C1%H+P'&MCS^%
M:)!6%F> L4F8@>8@J$9WM5,/R*(4%K+F9A]D$*%^]^;#Y[=7450Q M9PR.P.
M7.WHI ('87N!US-;SJ)#CFBY(11-3NZB;K>TS1&P\T*>QK$^L<"34?]>IIW$
MG\<>,U>ZW0:-;+V+ EJ)$NTWM#D1J.LM8?9^#G"(851%#M<:40@N4HB $3]$
M^)+GJ7/I?3@6(P?0')L<E*(32F3L"]LAX1F5G%,O.95Q%+W7563KOA0M^@YP
M1*$?T-](7W71[VP8+E*(D>B%E0S*953"B.$) 9E64#ZN+9VP&A7S@<Z-M"LL
MADF8=\/]G.G 'M>0=F^7Z!&,N<,G$^"Q;(>Z1<4!M'BNY;-&N+(_(; B1W59
MH@79P+4E."PN4&4)&&-(9;' ?".%4@4512RZ9PC"<G4KV_;+E0_QXF(AC(S$
MA#U-(1V.W[#7JC:FH^R([4M<ZTG&I8R+;IP*V7E;6 Z[@'?]=DNUJ_+.?)#<
M$Y1]"<2)>XA9.$\')0@1!>@U!9GN=+T[S04E==_>TW8Y9(H0+B6[FJ'MWLH<
MF7? _EX%DO 5.Z/K*EF%0]1]'G\@HJT&_3 EHUO.ZD0J,X1'2@#T"B9;<:2
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M[A[DB'\O$%&U!!>I1%2-)-;2S/5DI,.Q>KUT$-)B-09/T#\AT"YUHC"/M R
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M") )D79,;!I9H))CK%<_K*+"(Z^A80QYY$:<KF0S/F[W>7>7\$J;>F5!5,U
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M2D,$V%]H[38_2,#VGGOR#U!+ P04    " #5-5Q83,6VB'()  "]&P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6S-66MOVS@6_2N$IYU- *TCDGIV
MD@!)'Y@"[6S0UV"PV ^TS,1"9<D5J:297S_GDK*L.(Z;:1?8_6)2?%S>Q[D/
MTL<W3?O9++2V[.NRJLW)9&'MZMG1D2D6>JG,M%GI&C.73;M4%I_MU9%9M5K-
MW:9E=23",#E:JK*>G!Z[L8OV]+CI;%76^J)EIELN57M[KJOFYF3")^N!=^75
MPM+ T>GQ2EWI]]I^7%VT^#H:J,S+I:Y-V=2LU9<GDS/^[#RE]6[!IU+?F%&?
MD22SIOE,'Z_G)Y.0&-*5+BQ14&BN]7-=540(;'SI:4Z&(VGCN+^F_LK)#EEF
MRNCG3?5[.;>+DTDV87-]J;K*OFMN?M6]/#'1*YK*N%]VX]>F6%QTQC;+?C,X
M6):U;]777@^C#5GXP ;1;Q".;W^0X_*%LNKTN&UN6$NK08TZ3E2W&\R5-1GE
MO6TQ6V*?/7VERI9]4E6GV5NM3-=J:-P:=O!!S2IM#H^/+$ZAM4=%3_'<4Q0/
M4.2"O6UJNS#L93W7\[L$CL#>P*-8\W@N]E)\H8LIDSQ@(A1R#STYR"P=/?EM
MF5^4IJ@:$MNP?Y_-C&T!D__L$MJ3C':3)-=Y9E:JT"<3^(;1[;6>G/[\$T_"
M7_8P' T,1_NHCQ@.V)DQ&O;IC35G0/8[771M6]97[%R9TNSB?B_]W=Q_6&AV
MV53P6J)L"0[,S1(\+$T25]=.C8M2MZHM%K>LN6279:WJHE05*VLHM'. >L9@
M1;V<Z7:P)'NCKW7%>-^*OI7L0V.Q^579&LNJ4M?PLIEE3]C//V6"BU_0XW$:
M9'&&7A[$212(4+I^*D00)IR]UT53ST>;UUO7;<2#F,?KYF-M2(70YL[%>9"+
MJ/]]^:4K[2TDN];&>E>YMSP*\BA<-UZ8AYA/>1C$F7#]+,F""#NV%25^1%%1
M%$2QIR_2&-)RUX\XQ$GD(Q25!%(FZ^81TO,XA-SYT.Z0?\13E(H@S1/73W@:
MB"AC>QPF'APFWNLP[WV*(30^7ZCZ"MY=UFSD]YAX/1)B\*:/AL"^UN_K>M79
MG?ZT__B]KE-L&-KRHH=\![1:=K,HB\7 6>DX8S>ZU:PS8-PVL)_5+5*$WJ+[
MC"%_N;$_M&I]5-[AC1Y&;P@)+P@)/30V QLO<9\]%L9J]+8>C[P:N C83%^5
M=4T:@: KW9;-? N7/<KN.HN'T1@L%QU"#3*Q(4)C+/(@RD609S%ZN8Q[EY5!
MSFDD#K,@C7-VT3:%UG.HM6V6L$L)A:_ =ZM7ZM834A#<J.K^"0<\X!R.G4:'
M[" -9,P/!V8/DCB(DOC0+<I2L!H>LK.B:+6K/T!ICFS3=+4]4LNFM>6?:CT!
M<"S+;LD@;,P3AN"0#&1I+ O9;RC04'55Y9\PP!6J+7: Q&7HM#@(<SHVRC?,
M<!E$B"M@)4G$H=OM@4>XZ^J!DEKA; #.<7(PUYLO$)000H)HG"60SDF<1YQ.
MB@,>0KH/K:K-I6X)S4#@&IT'6 ,ER>Q>=!C"BIO=;$>Y2'H8$SC(R8@CD;;;
M8<$89!J6NPNO37[HH_V3'A=/UB%Z'(B_2U% 4-615V$+7(PP;F"L2EGOF;N]
MVMBRJMA"5R#N@';?)\>$-US5X/&1G#4^R#QO:M-4Y=PQ]-ZB\2S@T']!56ZQ
M@1X.9!:$7!ZB*U/2$%F=?H-(IJZ'V!UF -0C0HKX=DCY[\60+(//$<>1"+*,
M;,K3,!")-W<<\D"*_.'(D<L(BV(6^]PE@BA$!H]!*XY^+&#D61A(<L]-F !L
MD]2%B1#<2O+/OQ<FR/VDA(^G&X>*$4?W10D1<#'B KX0P:MECO/Y=X8'SK,^
MX(D@D:$;"81T$5!",+D_0G#$XP0HNU=!].-[H\-#06'=[H\).U+.KD3S_Q0,
MQ!W"]?=P]G># 4>1R+/0^3TL+'+J"3B*H.+U($>YEE&@YIMP< N)#2E\9XE!
M7D*B!,S>A05V;]G8539P-91Q977+YBB/7(D#-U%4[V ']-%_8%VA/<V5:G5=
MW$[W%)')4$0FC[QUC:_&?5'H9*%)K^D/NEC4Y9=.[ZP6]Y^SMUK\TJG:EC!2
M>4VF]J\P[CEC1AHCG9ORJBXORP(+@81F1O<W1Z0O$J%5;_;E2M6WSD'27\R@
MZ9UXG#+BRO-2&E8WE@SE[0H[S#135?5/ATA#G,TZZ[9K-6>%6EEWH7X,<W ,
M?4V3H+J+RW51.\3 35T[W8&P=\XE1I;;82(4LB,^G#G9&T#CU_)JP7YWSSB0
M\NP:K@!:A.YQ-H*[7=Z[<"'#2!FDR!E_E.3"9[6J;G$5=^\+%,K!F-4LG289
M>\ID.,URM#R<2NZ^D7NDO]G39;ZAHV=E1:GQK6H_8_1M5]ER!7:Q)PZ_;C6;
M(F>+4[-]O>M+H+U<@B@G-GDTE:X5TX38W:+=W;TT^YIJ/^%HFH=/MYHMJMI7
M!$D8A&&ZEOX,0:U1N/Y<Z-9Y0 UW'U223"/H $H-22-\&J5?F<A@$8YXYDQ_
M@?A OO6VF0/R+[^N=$$F_M0@*'LU2X'=D#&.?1N)*;+C4X;")Q3?5%<:DYK2
M:2Z\VGB*=NO^ORDQ[T?V_QEJ0U3X5$EX =4] 5L2,)EFDN3*IRBP'&HY?0O4
MBC+-UC;ZTC6V3QWG;?,9XM'($)PSI^ \(5WET% ^RL+?!*W/T7N9!%>1]-H7
M<0_:\#YH>WCQ, Y2F*+G7>W"UW*-K]CYF,@]ON0TXOA"A9@-^%KU^%K>Q=?U
M"%]ACZ^^C4"&\ 4Z2?8MT;@/$S@Z[45+G2&V7E@V=0M9?X"$\I! QD)&+515
M=+X4F?D\6F^]0(R*UWU)-!V2:+K_):98Z'E7.=+/5=O>DIX<R'T*?8G"9^GX
MV<"_KW]FE&N'C+0KK^X]^L=?-9?C!_&[6?0?9O0<\AMPCDI?4;9"-O45&@TR
MW)X6R(C8>(N<J>E/"&=8+*$W'67OI#/P9O0#]>%-TP$A,[*@U5=-ZXN]319_
MZ 9).AZ6B0=KRYO2+OH'J>$M=U=^W7''VT2M4=<M]GH9O^9(U(SD-YA.^NDT
MD;A1QBR-PH"G=!6Y&4\GD0PR'K&$:M$HHJFTGXHSB6N'9#'B T?(Q52VGL(=
MB^.^%\._LG#C(B*(8WH1X:Z?B9A>C'<^.!Z-_E)9ZO;*_7%DF+.>_W=E&!W^
MFSKS?\ELEOL_MA!D<&DUK-*7V$K98L):_V>1_[#-ROU!,VNL;9:NNT AI5M:
M@/G+!D+U'W3 \(_=Z5]02P,$%     @ U35<6 BTY2F*!@  Q1(  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL[5AK;^.X%?TK%]YB,0&TMMZ/3!(@
M3F:Z4W2WP239HBCZ@99HFX@DNB2=3/KK>T@][!D[;A?H]D/1+R(E\1[>2]U[
M#JF+%ZF>])IS0U^:NM67D[4QF_/93)=KWC ]E1O>XLU2JH89W*K53&\49Y4S
M:NI9Z/OIK&&BG5Q=N&=WZNI";DTM6GZG2&^;AJG7.:_ER^4DF P//HO5VM@'
MLZN+#5OQ>VX>-W<*=[,1I1(-;[60+2F^O)Q<!^?SV(YW WX1_$7O]<E&LI#R
MR=Y\JBXGOG6(U[PT%H&A>>8WO*XM$-SX>X\Y&:>TAOO] ?VCBQVQ+)CF-[+^
MLZC,^G*23ZCB2[:MS6?Y\B/OXTDL7BEK[:[TTHV-B@F56VUDTQO#@T:T7<N^
M].NP9Y#[;QB$O4'H_.XF<E[>,L.N+I1\(65' \UV7*C.&LZ)UGZ4>Z/P5L#.
M7,VE@H5H5YK>/;!%S?79Q<P V+Z>E3W(O ,)WP )0OI)MF:MZ4-;\>IK@!GP
M1[?"P:UY>!+QEI=3B@*/0C^,3N!%8YB1PXO>Q%L8NA6ZK*7>*DY_O5YHHY 2
M?SL6;8<5'\>R97*N-ZSDEQ/4@>;JF4^NOO\N2/WW)SR-1T_C4^A7]RB[:EMS
MDDOZHVQ7/SQPU9#S_U,+G[>H"*./>7T2][C7#VM.-[+9L/;U^^_R,,C>:T+E
M:L/:"CF!],:T<E&+%;,UI.F%8_&8IJ6L4<[Z'(Z5O%EP-7XLNEZM%,=X3G_:
M0[IA2KW:SF/+&JF,^ >O^JBTWK*VM(YHH_%^J_'JSHY!U;X+SNBZD=O6T/4S
M$[5-47H7GM$?6/FD,>!'B0<?M]TL'UDI:F%>Z5UT1K^CQ/<]W_?1"Z/(\X/B
MJYZ+.'QOGZ6I5^3!7F^N>/G$6R6JU1'TP//#Q"%G<>!E>^V &>:1%^%^:.=B
M1?=/KX=0@XMQ[GN%GX[M !04GE_$0_.9/\OZV:VGXI4P>P''9W KRSJWTCST
MPB0?VQ$-**&7Q6'?2]/0?K24?I:&:\I[9X8V*U(OBB.*O#3)1I"A_1F4NV><
M#49]FQ:)%]J(O R>?VL,PZPW3)/>8&BQEC$H)?>2/#]FF)\P]/,4AD5P...#
M-*S&)TZ]=$R+V"NBS,OSJ.L' >Y=NB1>D=B'@5TB+PBRL>]'F4M*6SK;+E<W
M?:X*309/69>NVPT>O:Q%N:92-HTPMG!IR;GV2"P))><10S593:FF+J<?=M9L
M3':HE)4P;2VH%@#J:U'Q&E56D9'$&69!56^X$SDJN^Q8]MDQUO9B8'LWZ]25
MR2,H6SG'3Y:4YX;T9 $%>NW!2+3T.+V?4@5*8 HR\GA_>T924<F5P:Z ) P5
M;4!CPEA_RZU2O"T%UU.ZUI;G#DCDZ\G6K*)6[IS7X*560@Q=^)AAA]A/9M8,
M7MW?3EU=[")\LWY.1G=_^QN$T_Y@<=^.R5IT+&O=W4UR[A(Z3-^#4EM6"01Z
M.ZS\S356/ICZV"C4M<W(8>B'K9)X_^'Q\QD5\30^&#!7P@B]!NWBLV/D[^=W
M9Y2FTV(<^6U0X1[1WRD!WS8HKQN7Z3:$??+?>S_(P"^LWO+_JAC$8]5'J=]+
MP*ZW$X.HZ+6@[YR6@KP7@F_;;]EG:/^U$!0%""H=V\$P HE&_X8$I+T#:99[
M49:/[8!3Q"! ?+TB2C$N[C2[X]-AA88V*G(O3WR !LEA1"=U(_:2I*#$B^/@
MU^M&Y,51")Y.TJ/T_Z9N1#D8NB"P> 3[7R,<^-1X38$/K3J<<Z<<23+D4 +O
ML)'PHZX?9EX6)#9I('JY3:@BQTZBL+I19%#1K/B_:ORG>37\WY*)(^'\!O(0
M)<D>JQ\5B.S(@+<$(AU'VC1$RB)_[0'%!BA:@^."-L2_;'",YX>G!QRL721_
MX4QU9\<C!PHG-KB BL=$/(#&GLT2&W:VV*CE&;9IMAH#/\-NVM]Q9%][MI[L
MAB\+"+N[R%ZS(K#:8L7(58H- *=[CH7%>"P\EM>NM-,E$!M,8]1_#M,T2P],
MI1(K&-4H;PVAJW#T["JTK;I3E1B4KD,LP%FI):#83RCS K!11SN?AD@_["+%
M(24.W3[5C[PDLW03A# %^=TP?*0-$_ 9:WMLF1(80P_L,B'VQ"Z8H^N0CIU>
M9WN_%AJN5NX'BB873/>787PZ_J.Y[GY-[(9W/WA^8@I+HJGF2YCZTRR9D.I^
MFG0W1F[<CXJ%-$8VKKOF#$5I!^#]4H*]^QL[P?CGZNJ?4$L#!!0    ( -4U
M7%C7TR]UIP@  !(<   9    >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;,U9
M:8_;.!+]*X1G,), :END[O0!.-=N!DAB))E9+!;[@99H6X@L>BBJ.[V_?A^I
MTT<['6P&V2^V>-1CL>I5L2A=W4GUN=H(H<F7;5%6UY.-UKMGLUF5;L265U.Y
M$R5&5E)MN493K6?53@F>6:%M,6.N&\ZV/"\G-U>V;Z%NKF2MB[P4"T6J>KOE
MZOZY*.3=]81.NHX/^7JC3<?LYFK'U^*CT+_O%@JM68^2Y5M15KDLB1*KZ\F<
M/GL>F_EVPA^YN*M&S\3L9"GE9]-XDUU/7*.0*$2J#0+'WZUX(8K" $&-/UO,
M2;^D$1P_=^BO[=ZQER6OQ M9_"//].9Z$D]()E:\+O0'>?=WT>XG,'BI+"K[
M2^Z:N:$W(6E=:;EMA:'!-B^;?_ZEM<-(('8?$&"M +-Z-PM9+5]RS6^NE+PC
MRLP&FGFP6[724"XOC5,^:H71''+ZYAW\/J\JH2ORY!-?%J)Z>C73 #;#L[0%
M>=Z L = *"-O9:DW%7E59B+;!YA!HUXMUJGUG)U%?"G2*?&H0YC+O#-X7K]-
MS^)Y#^"]^K/.]3WYUWQ9:04F_/O4)AL(_S2$B8YGU8ZGXGH"^E="W8K)S2\_
MT="]/*.@WROHGT._^8AHR^I"$+DB'S<<"Y W556+C/ R(PLE4R&RBGP0J0"+
MLU/JGU_@TT:0E2P0A'FY)MJXNHW$_#]83&-82\T+DLKM%N%2-4KD@Q*[3@G5
M*N$ 4%G)>\$5$<;W!)X3VZ50O?<<S%"R7F_LS%]^BAES+[F^0.L"JW\6VO;1
M2VQ])931#BNM%=^2)QD4Y@I:E!"6=04U*B*^I&*GR0YK6"4)W\JZU-739]9D
MO$RA-\SXHME(:\UWM=7JJ+^U\M^4K*K!SHL"CD;NT>2U$-7L?:?9JR_(AI6!
M0]STL^>W0B&#-9#HSE-!GM"GW6;GIS;;0]+(H;[OQ)%+?B9^&#HQHWBB#DLB
MVQ,X ?/QQ*(I#2SN!V$9B#U;FY;0960[L_K(."N-9WBF1OXSX_W.5MB9=:SQ
M./R,)-FT>RS1[G9ZAN!!3_#@\037,OU,EO?D1<&KZA27SV/]!5S&0\$U_K6T
M\B#)CI?WQELTNJQ(RG>Y0<P4O\OD76NI-XOWCXD!NL?D;5X4UM8MD0])/.9G
MSVB"["Z^1N+Y>JW$VDSLJ?E;70H2MUI0SXG#Q D]0RPOB*8N^0@-&EU'DR)$
MK>L%F!)./?).WC8SFIV ?]1U@B!R7-<E+/2G/OEDK>W%8#+@(P;X)(JFD9W]
MIDR+.H.6O=&?-(R%">])#8NI.Y5;<AI*/B4K);=$U@K&0C> =_6RR-.!E\;T
MQN2]K%"_&G,*E>:599@9A=KJ@H,EVM)=[DP9<([*84_E\"S]7N:W>29,*H*C
MX=73Z?@LQNG3Y!&\/N1EEN- RY>UMHS*6GT:CO-[B_"8)/WMJ=;RL=N_.9>D
MRIK.!;^W!F\:$&V8/+>B+57:QFNQ5#5J0>2V5H^W7*6;0:TYTEDQC/Y,W&ED
M:(?\2)GCX^DMOS=\;,8MV[VA58R06TE* R>*VZFLFSJ$02_]/M72LCX< "(#
MX'E@/QO"(F['CXWZ&R^;W340?@_A([X T=ABWX7(\]/$MUL,7!^J1N2'T8+]
M(%ITIJ==3NH,V7:PQNM>VS"LH"TK0B=A3=HY FFH1<-3$  (3#8+'#_PK?A
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MA_8WXY$@[K$.\AH:KFJ.KZ+/86.%0E(4M2)+AK,?21OOZ/%H[TF%PLJ-YC?
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M'^O16$^R_S+U7'W 8DZ91"446M*[N-11B7I6U1O%E[9[S[C2L\ N%WJ\@S
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M$TKSH30*I3$HC:-HNGR4^VF;W<_6:U SI[-:G%8K6A_:*H72&)3&431=!\H
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M?+@0P5RD10'Y_EV2Y,]/B@:V-Y2=_ ]02P,$%     @ U35<6#;B= O( P
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M/#'V79]\2N>.IS."#!*I$41];>$.LDR35!Y_5U"G?J86-H_W](]F\&HP3T3
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MXM8/PPW?M8 ^@/=7UM++Q/=_?WOG?P!02P,$%     @ U35<6#F\KL<5!
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MMTQZ1EA[>MC51J^9BVQ.#@24NRESY:A\A*6F.J'7?<A-F2O7GQ([C=RS=NK
M@6ER.],\K A?2[]L1=?9PWNB,\&X=JBHV1LL-;5I$A!1X:;,5: "$Y::Z@0
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MC+PZ_5-="+8O#]!\84*PM/RXHR2B>6$@O[]E3#Q>% ,T9[#6_P-02P,$%
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MFD%"6/[$#X40>P%^]TA 4 0$AP&=(P'M(J!M$\V9V;0F6.&P+_@6">.MT<S
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MSE?#T.<XD^7F)I]1@R^!=%PA'8=W"[\YX>7FUJ Q'K\$9W'%61SFK/&),8<
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M V[T9LDJ>ZB4B*4FVP@HT4/(*GO*_'"-]F'/UW4%N>8>P -2\\RDIO!VA.R
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MUCO:IT#' - QF"7%&Z#B(Y::;"/ Q^"<K<!M9>D.@4>#LT(4Q5R/U"4U1S$
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M3]%ZPV6#/1UOR9K.*?^\?<K%G5VA+*.$IBS*4I#3U<3Z%=[-<" #BC>^1/3
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M[RN^')"6"; C?C!8RK4R,DL9<?YL*K=)WPL,(T@A5@:"ZL\"KB!-#9+F\:<
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MILK"U%=9?%IO<GFW?XN=E1.8UXNYXEY*\22S1?FXG-&TO?MJO(K2OHN#\\'
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MS,[K9&*>)W+7D3YJA<T\KINQAK*O=5F@?^2'HB8_ENBMF0WMR$(U"M5LJ.9
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M9ZV; -FK>X!J%*K94,V!:BY4\Z :@VH^2FMNE+KO2DQLG0]MPT(U"M5LJ.9
M-1>J>5"-034?I36W1]W.)>IV;L\ZW^I:0S]T'TJ[#[751],[9Z$-5JCF034&
MU7R4ULS9NL%*U+_\^G:=#^VH0C5::A?GNF?F>:I#FZ50S85J'E1C4,U':<=4
M'YU<Z"SBZ;JXL%ZF+?//V^,USZI'JXOWW167K!O5PX]7_OL0I.LPSK0M?Y:A
M^G J/S[3X\7TCG=$LBLNF_:4")%$Q<T-#U8\S0?(YY\3^4^%\DX^075)P\7_
M4$L#!!0    ( -4U7%A1XNG#(Q(  #4\ 0 9    >&PO=V]R:W-H965T<R]S
M:&5E=#4R+GAM;+7=6V_;2)K&\:]"> :#'F V%H^2NA,#B<7SJ=!!9B\6>Z'8
MC"-$EKP2G4P/YL,O9=.B:U@JD=W_R46W[9"_DE]%#V3Q4?GMC^WNV_YK5=7&
M/^[7F_V[BZ]U_?#SY>7^YFMUO]R_V3Y4F^9OOFQW]\NZ^71W=[E_V%7+VZ>3
M[M>7UF3B7=XO5YN+J[=/7Q.[J[?;QWJ]VE1B9^P?[^^7N]\^5.OMCW<7YL7+
M%WY=W7VM#U^XO'K[L+RK/E;UIP>Q:SZ[/"JWJ_MJLU]M-\:N^O+NXKWYL_"\
MPPE/1_Q]5?W8O_K8.'PKG[?;;X=/XMMW%Y/#+:K6U4U]();-_[Y7U]5Z?9":
MV_%_+7IQ7/-PXNN/7_3@Z9MOOIG/RWUUO5W_]^JV_OKN8G9AW%9?EH_K^M?M
MCZAJOR'WX-ULU_NG_QH_VF,G%\;-X[[>WK<G-[?@?K5Y_O_R'^T@7IU@62=.
ML-H3K*$GV.T)]M 3G/8$9^@);GN"._0$KSW!&WK"M#UA.O2$67O";.@)\_:$
M^= 3S,G+/3<9?,KQSAY\;YLO=[<Y^/XV7^YP<_ ];K[<Y>;@^]Q\N=/-P?>Z
M^7*WFT_W^^7S@^3I$;98ULNKM[OM#V-W.+[Q#A\\/4R?SF\>6*O-(5$^UKOF
M;U?->?75A^VN.6.UN=L;_V64C_6^7FYNFT^-1?6Y-LK/Z]7=\O#0WQL_+:IZ
MN5KO_VK\Y4^F9_]BK#9&OEJO#W_Y-^//KS]]>UDW-^VPP.5->S,^/-\,Z\3-
M6%0W;PS;_)MA32S;^/1Q8?STY[\JF.LQC/_I5^.GO_QI9GO.+RIL,0:[?G_J
M-OECF/"#.-RFPP!55C#<LC1C"L<PY\84C<%.CRD>PYP94Z*W/E8/C35YLDS-
MF%(]DSRNWQB6?9;)],S[AUW#3,\RN9[)EPUC>F>98L"<)\]SGFB84L^4-_5Q
M-CI&#!BQZ>J8RR:?CK%F'6/->G+MD]]EDU[Q9E_O'ING/[7Q/UES@!'7U?W^
M?U7I]*PY:NWPK.[G_</RIGIWT3QMVU>[[]7%U>%?Y^0754:1V(+$?!(+2"PD
ML8C$8A)+2"PEL8S$<A(K2*PD,0%A4L+9QX2S=?K5^[N[7=4\-ZL,L5MM;E8/
MR[5QO;V_7]5U=:N*N&?.?>(./V=^O_*\2?OG[>7WUP&F77EL@)&83V*!8B*N
MJYQ(2*X;D5A,8@F)I226D5A.8@6)E20F($R*)^<83XXVGE[_*'D,*%4L/3/>
MJP>A,[>GLYG=CR7MBF-CB<1\$@OZ$W%=KQE'?R(AN6Y$8C&))226DEA&8CF)
M%216DIB ,"F6W&,LN=I8NE[N=K\=,NGOR_5CI<HC5Y%'ICFW%4^3M$N-S2,2
M\TDLZ$_$=:WIU'3[>42N&Y%83&()B:4DEI%83F(%B94D)B!,RB/OF$>>-H\^
M;9;WVUV]^F=U^_R*>[S?/RXW-U7SL]R^5KZ0[O4>CI8[=Q5/E[0KCXTG$O-)
M+.C/PW:MV;P?3N2J$8G%)):06$IB&8GE)%:06$EB L*D<)H>PVEZ)IP>]TTN
M/1P":KM19=&T]]@S/<\RS6D_C;1+C4TC$O-)+.A/9#[SYO/^0$)RV8C$8A)+
M2"PEL8S$<A(K2*PD,0%A4AS-CG$TT[_B?;]]W-3&^^_+U7KY>:W\Z6VF#*2)
MK0@D[6)C XG$?!(+^A.93SU[JGA^1"X;D5A,8@F)I226D5A.8@6)E20F($P*
MI/DQD.;:0$J6-]_VVXT1;=>5$3P^O]@=+&]6ZU7]F_$OXZESL/UB7.^JVU7=
M?.'7ZOMV_?UP5/NEEX-54:9=>VPE@<06).:36$!B(8E%)!:36$)B*8EE)):3
M6$%B)8D)")/RT)P< _%0V 5K5RT'A1RJ+5#-1[4 U4)4BU M1K4$U5)4RU M
M1[4"U4I4$Y0F1]ZK_KS)]K!:3[J>=J*'U1YJVJ^._;=C%OJ;-SJF2"U0?*N.
M^EL-!WRK$7KC8E1+4"U%M0S5<E0K4*U$-4%I<K)87;)H^Z/#*U2M(UT2M.V)
MV7^-YUJ_Y.BG2&@Y'=4"Q5!L;Z(:2H@N'*%:C&H)JJ6HEJ%:CFH%JI6H)BA-
M3JFNAF[J>^CG&U4M,"B>T.8YJOFH%BB&<C*>T/(YJL6HEJ!:BFH9JN6H5J!:
MB6J"TN1XZFKHA[==_Z$.0PM(\>1Y\YFIB"?M6J/CB=1\5 L40['GJIF$Z+H1
MJL6HEJ!:BFH9JN6H5J!:B6J"TN1TZMKHIKZ./J328/;[UR?S"6VDHYJ/:H%B
M**?R">VDHUJ,:@FJI:B6H5J.:@6JE:@F*$W.IZZ=;NKKZ1]VU<VW:K-;W=[]
M!QH.^L5'7_U#^^ZHYJ-:@&HAJD6H%J-:@FHIJF6HEJ-:@6HEJ@E*DP.R:\B;
M4[;P0+9QKU%M@6H^J@6H%J):A&HQJB6HEJ):AFHYJA6H5J*:H#0Y\KH6OGFF
MAC^Z\* HY4\L5]UX0%OYJ.:C6J"8RDP]E!!=.$*U&-425$M1+4.U'-4*5"M1
M35":'%==1]_4E_2'MRCFO0?DU'EZ)V,_I= Z/:KYJ!8HAG(RI="^/*K%J):@
M6HIJ&:KEJ%:@6HEJ@M+DW4J[XKRE;:D.:%&TP)!XTJ\U-IY0S4>U0#&44_&$
M+ARA6HQJ":JEJ):A6HYJ!:J5J"8H38ZGKN1NZ4ONYUL45K_J;<UL6QE/9$EW
M@6H^J@6*H?1BB5PP0K48U1)42U$M0[4<U0I4*U%-4)H<2U872_J&_)#ZA*4H
MQY\*)G;C=G;G=G;K]OY0>L'$[LC.;LG.[LG.;LK.[LK.;LO.[LO.;LS.[LS^
MGRC%6UTIWM*7XC^L[HR/WW[C*Q/Z=<=>/T2U!:KYJ!:@6HAJ$:K%J):@6HIJ
M&:KEJ%:@6HEJ@M+D;.P:^<V'9&6BY:C(([4%JOFH%J!:B&H1JL6HEJ!:BFH9
MJN6H5J!:B6J"TN3(ZVK^UIF:_]C*A*78<_W$'A'ZI4<'&MKY1[5@^%!"=.$(
MU6)42U M1;4,U7)4*U"M1#5!:7):=:5_2U_Z']R8L/I;KSNSR7SB*5(*+>>C
MFH]J@6HH\[FG&$J(+ARA6HQJ":JEJ):A6HYJ!:J5J"8H34ZIKGEOZ3>G']"8
MZ._%?C*>T"(]JOFH%JB&<BJ>T)8\JL6HEJ!:BFH9JN6H5J!:B6J"TN1XZEKR
MEKXE/Z QH:C%SR=S1Y%.:"D>U7Q4"Q0SL143"=%5(U2+42U!M135,E3+4:U
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M#J5]4565P0-8L;UD=\TE4C]\UP\8C,T&HNF].&RS\QOOSM_KV6$G+Y1]XAL
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MC4NUU[Z^V>B8#JJYJ.:AFH]J :J%J!:AFJ"T:J*5%Q&H[ULMO[W\Z.A"+QE
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MT_SESGJ IW3U8[/;Y_\'4$L#!!0    ( -4U7%CF[[]D/ (  +<$   9
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M!GRR\=*0O]+# RGSR0-<TY#EO^!0:@T-K%/&:53"(H(HB(M_[V?Y'4X B!L
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M@=+&H+0)*,V'HI6CW7R/=O/,:$]/2JEB]HT2KJ]E/T#B5*K]RE<*SXY[2-H
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M3R*VI1"@,T*+_G->59)<S=EK%#WKJ.4\A]C'_>8YI'VDXE5!GC!YK.;>I),
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ML]F PA-[@0E/V/3@D1)\;'"2<[S*QKY?+L:QPZW).!XP.J22.!P0G@J%\6N
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M4A*\.Q2[CF1U>TS,F52'3MO,U7<$< U0]Q>,R<>./GF&+Y/X+U!+ P04
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MQ[NT^"Q>(][<T+CD6XI45O_):X.U!F2YDX78-,&J!ILDJS_C;TU#' 10]T0
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M4(@7#RH9:1O^0EFIU>ZL+:VPOXM2J_/2]I.N*0PL1S Q1%"J86PX,2(P.K3
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MMKE1MH51MM H6V2*[?AG&*TGQOIX8OKYNJ$X?(SH3,;,<J!1B0'5OGD";98
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M'Y]E9YO^+9^-_YH\?P%02P$"% ,4    " #4-5Q8!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( -0U
M7%@2G"_-[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( -0U7%B97)PC$ 8  )PG   3              "
M <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ U#5<6*URA3YO
M!P  R2\  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( -0U7%BS#2U5/0(  +X%   8              "
M@;,/  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #4-5Q8
M"\/8IWT(  #$(@  &               @($F$@  >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ U#5<6*WM9KBJ!0  HA(  !@
M     ("!V1H  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M -0U7%B;!,+I- D   \S   8              " @;D@  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    " #4-5Q8&C6O>Q0'  !G)P  &
M            @($C*@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ U#5<6&KO(8'O"0  C2\  !@              ("!;3$  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( -4U7%ASNS>VT\X# .^0
M1  8              " @9([  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    " #5-5Q8]ZA G_<H 0"YA@X &               @(&;"@0
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ U35<6!Z6UWY1
M!@  (0\  !D              ("!R#,% 'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    " #5-5Q8:H<7=)D@  #K90  &0
M@(%0.@4 >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( -4U
M7%C W.6B9Q@  ,]=   9              " @2!;!0!X;"]W;W)K<VAE971S
M+W-H965T,3(N>&UL4$L! A0#%     @ U35<6$F$#H'I!@  B1   !D
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M=#$W+GAM;%!+ 0(4 Q0    ( -4U7%CE%G]_R@(  #P&   9
M  " @?VR!0!X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @
MU35<6/!/3I'."   RQ<  !D              ("!_K4% 'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6Q02P$"% ,4    " #5-5Q8O/-;"KX*  !&(P  &0
M            @($#OP4 >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4
M Q0    ( -4U7%B3S(4#_0(  *L&   9              " @?C)!0!X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ U35<6(G"?3$HP@$
MY5 , !D              ("!+,T% 'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6Q02P$"% ,4    " #5-5Q8KW2%I; ?   C9@  &0              @(&+
MCP< >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( -4U7%CX
MNA:B;08  /,.   9              " @7*O!P!X;"]W;W)K<VAE971S+W-H
M965T,C0N>&UL4$L! A0#%     @ U35<6$S%MHAR"0  O1L  !D
M     ("!%K8' 'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -4U7%AF=+L<-@<  ,<1   9              "
M@7C8!P!X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ U35<
M6'IQ>R?* @  / @  !D              ("!Y=\' 'AL+W=O<FMS:&5E=',O
M<VAE970S,2YX;6Q02P$"% ,4    " #5-5Q8.7?,&;0$  !L)P  &0
M        @('FX@< >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0
M   ( -4U7%@N!1KB+00  %(:   9              " @='G!P!X;"]W;W)K
M<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ U35<6)%J<N8'"@  7'8
M !D              ("!->P' 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q0
M2P$"% ,4    " #5-5Q8-N)T"\@#  !Y%0  &0              @(%S]@<
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( -4U7%B@0]HH
M2P(  ,D%   9              " @7+Z!P!X;"]W;W)K<VAE971S+W-H965T
M,S8N>&UL4$L! A0#%     @ U35<6#F\KL<5!   /!H  !D
M ("!]/P' 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " #5
M-5Q80+Z9[C@(  "9+0  &0              @(%  0@ >&PO=V]R:W-H965T
M<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( -4U7%BH*/_GA0L  +5J   9
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M970T,RYX;6Q02P$"% ,4    " #5-5Q8O$I^I:L*  #B;   &0
M    @('A+P@ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (
M -4U7%CF=^&*+P,  %4.   9              " @<,Z" !X;"]W;W)K<VAE
M971S+W-H965T-#4N>&UL4$L! A0#%     @ U35<6+%)^?'Q!   O28  !D
M             ("!*3X( 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"
M% ,4    " #5-5Q8N0  544%  " +0  &0              @(%10P@ >&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( -4U7%@=W2XC?@,
M  T2   9              " @<U(" !X;"]W;W)K<VAE971S+W-H965T-#@N
M>&UL4$L! A0#%     @ U35<6$5\?WPR P  F@T  !D              ("!
M@DP( 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " #5-5Q8
M:IWY$/X)  ".D@  &0              @('K3P@ >&PO=V]R:W-H965T<R]S
M:&5E=#4P+GAM;%!+ 0(4 Q0    ( -4U7%B49H#,Y08  -Y0   9
M      " @2!:" !X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%
M  @ U35<6%'BZ<,C$@  -3P! !D              ("!/&$( 'AL+W=O<FMS
M:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " #5-5Q8,;[,"@P#  !="0
M&0              @(&6<P@ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+
M 0(4 Q0    ( -4U7%B/$HG?;0,  ,T*   9              " @=EV" !X
M;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ U35<6 &L:HO2
M @  D0H  !D              ("!?7H( 'AL+W=O<FMS:&5E=',O<VAE970U
M-2YX;6Q02P$"% ,4    " #5-5Q8\*\=HU0&  "-.P  &0
M@(&&?0@ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( -4U
M7%@OD;@8D 4  (LD   9              " @1&$" !X;"]W;W)K<VAE971S
M+W-H965T-3<N>&UL4$L! A0#%     @ U35<6 $V<K3+"P  .,,  !D
M         ("!V(D( 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4
M    " #5-5Q8YN^_9#P"  "W!   &0              @(':E0@ >&PO=V]R
M:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( -4U7%C6]DA[4 0  /83
M   9              " @4V8" !X;"]W;W)K<VAE971S+W-H965T-C N>&UL
M4$L! A0#%     @ U35<6+LKRT5:!0  ]RT  !D              ("!U)P(
M 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " #5-5Q8HB7A
M_N,$  !2&P  &0              @(%EH@@ >&PO=V]R:W-H965T<R]S:&5E
M=#8R+GAM;%!+ 0(4 Q0    ( -4U7%B>8X.<(0,  /\+   9
M  " @7^G" !X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @
MU35<6%:J@=Y% P  > H  !D              ("!UZH( 'AL+W=O<FMS:&5E
M=',O<VAE970V-"YX;6Q02P$"% ,4    " #5-5Q89!'NUH,#  #M#@  &0
M            @(%3K@@ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4
M Q0    ( -4U7%C6@C.LCP,  ' /   9              " @0VR" !X;"]W
M;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ U35<6(JK#J[_ P
M)PP  !D              ("!T[4( 'AL+W=O<FMS:&5E=',O<VAE970V-RYX
M;6Q02P$"% ,4    " #5-5Q8F8*Q.W8#   )"P  &0              @($)
MN@@ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( -4U7%C=
MM5KBYP(  *4(   9              " @;:]" !X;"]W;W)K<VAE971S+W-H
M965T-CDN>&UL4$L! A0#%     @ U35<6$1:7<2-"   _38  !D
M     ("!U, ( 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4
M" #5-5Q8E%F7_^8"  !8#   &0              @(&8R0@ >&PO=V]R:W-H
M965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( -4U7%A)410WP0,  (\<   -
M              "  ;7," !X;"]S='EL97,N>&UL4$L! A0#%     @ U35<
M6)>*NQS     $P(   L              ( !H= ( %]R96QS+RYR96QS4$L!
M A0#%     @ U35<6,D%4 =\!0  T"X   \              ( !BM$( 'AL
M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( -4U7%BP!0"]-@(  !PJ   :
M          "  3/7" !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( -4U7%CART;(_0$  #TI   3              "  :'9" !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@    !/ $\ H!4  ,_;"     $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1713</ContextCount>
  <ElementCount>322</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>277</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities</Role>
      <ShortName>Consolidated Statements of Assets and Liabilities</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements of Assets and Liabilities (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical</Role>
      <ShortName>Consolidated Statements of Assets and Liabilities (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Changes in Net Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets</Role>
      <ShortName>Consolidated Statements of Changes in Net Assets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Schedule of Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/ConsolidatedScheduleofInvestments</Role>
      <ShortName>Consolidated Schedule of Investments</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Schedule of Investments (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical</Role>
      <ShortName>Consolidated Schedule of Investments (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/Organization</Role>
      <ShortName>Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Agreements and Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/AgreementsandRelatedPartyTransactions</Role>
      <ShortName>Agreements and Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/Borrowings</Role>
      <ShortName>Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Commitment and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/CommitmentandContingencies</Role>
      <ShortName>Commitment and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Net Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/NetAssets</Role>
      <ShortName>Net Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Financial Highlights and Senior Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/FinancialHighlightsandSeniorSecurities</Role>
      <ShortName>Financial Highlights and Senior Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9954701 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bxsl.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9954702 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bxsl.com/role/Investments</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954703 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bxsl.com/role/FairValueMeasurements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954704 - Disclosure - Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/BorrowingsTables</Role>
      <ShortName>Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bxsl.com/role/Borrowings</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954705 - Disclosure - Net Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/NetAssetsTables</Role>
      <ShortName>Net Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bxsl.com/role/NetAssets</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954706 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bxsl.com/role/EarningsPerShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954707 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bxsl.com/role/IncomeTaxes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954708 - Disclosure - Financial Highlights and Senior Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesTables</Role>
      <ShortName>Financial Highlights and Senior Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bxsl.com/role/FinancialHighlightsandSeniorSecurities</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954709 - Disclosure - Significant Accounting Policies - Revenue Recognition / Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/SignificantAccountingPoliciesRevenueRecognitionIncomeTaxDetails</Role>
      <ShortName>Significant Accounting Policies - Revenue Recognition / Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954710 - Disclosure - Agreements and Related Party Transactions - Investment Advisory Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails</Role>
      <ShortName>Agreements and Related Party Transactions - Investment Advisory Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954711 - Disclosure - Agreements and Related Party Transactions - Base Management Fee (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails</Role>
      <ShortName>Agreements and Related Party Transactions - Base Management Fee (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954712 - Disclosure - Agreements and Related Party Transactions - Incentive Fees (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails</Role>
      <ShortName>Agreements and Related Party Transactions - Incentive Fees (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954713 - Disclosure - Agreements and Related Party Transactions - Administration Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails</Role>
      <ShortName>Agreements and Related Party Transactions - Administration Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954714 - Disclosure - Agreements and Related Party Transactions - Sub-Administration and Expense Support (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails</Role>
      <ShortName>Agreements and Related Party Transactions - Sub-Administration and Expense Support (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954715 - Disclosure - Agreements and Related Party Transactions - Expense Payments and Reimbursement Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails</Role>
      <ShortName>Agreements and Related Party Transactions - Expense Payments and Reimbursement Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954716 - Disclosure - Investments - Investment Portfolio at Cost and Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails</Role>
      <ShortName>Investments - Investment Portfolio at Cost and Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954717 - Disclosure - Investments - Investments at Fair Value Percent (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails</Role>
      <ShortName>Investments - Investments at Fair Value Percent (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954718 - Disclosure - Investments - Geographic Investment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails</Role>
      <ShortName>Investments - Geographic Investment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954719 - Disclosure - Investments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails</Role>
      <ShortName>Investments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954720 - Disclosure - Fair Value Measurements - Fair Value Hierarchy of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value Hierarchy of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954721 - Disclosure - Fair Value Measurements - Summary of Changes in Fair Value of Investments Measured Using Level 3 Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Changes in Fair Value of Investments Measured Using Level 3 Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954722 - Disclosure - Fair Value Measurements - Unobservable Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails</Role>
      <ShortName>Fair Value Measurements - Unobservable Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954723 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954724 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurements of Unsecured Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value Measurements of Unsecured Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954725 - Disclosure - Borrowings - Jackson Hole Funding Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails</Role>
      <ShortName>Borrowings - Jackson Hole Funding Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954726 - Disclosure - Borrowings - Breckenridge Funding Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails</Role>
      <ShortName>Borrowings - Breckenridge Funding Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954727 - Disclosure - Borrowings - Big Sky Funding Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails</Role>
      <ShortName>Borrowings - Big Sky Funding Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954728 - Disclosure - Borrowings - Revolving Credit Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails</Role>
      <ShortName>Borrowings - Revolving Credit Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954729 - Disclosure - Borrowings - Unsecured Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails</Role>
      <ShortName>Borrowings - Unsecured Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954730 - Disclosure - Borrowings - Outstanding Debt Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails</Role>
      <ShortName>Borrowings - Outstanding Debt Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954731 - Disclosure - Borrowings - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/BorrowingsAdditionalInformationDetails</Role>
      <ShortName>Borrowings - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954732 - Disclosure - Borrowings - Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/BorrowingsInterestExpenseDetails</Role>
      <ShortName>Borrowings - Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954733 - Disclosure - Commitment and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/CommitmentandContingenciesDetails</Role>
      <ShortName>Commitment and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bxsl.com/role/CommitmentandContingencies</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954734 - Disclosure - Net Assets - Subscriptions and Drawdowns (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails</Role>
      <ShortName>Net Assets - Subscriptions and Drawdowns (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954735 - Disclosure - Net Assets - Schedule of Shares Issued and Proceeds Received (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails</Role>
      <ShortName>Net Assets - Schedule of Shares Issued and Proceeds Received (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954736 - Disclosure - Net Assets - Distributions Declared (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails</Role>
      <ShortName>Net Assets - Distributions Declared (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954737 - Disclosure - Net Assets - Dividend Reinvestment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/NetAssetsDividendReinvestmentDetails</Role>
      <ShortName>Net Assets - Dividend Reinvestment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954738 - Disclosure - Net Assets - Scheduled of Amounts Received and Shares Issued (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/NetAssetsScheduledofAmountsReceivedandSharesIssuedDetails</Role>
      <ShortName>Net Assets - Scheduled of Amounts Received and Shares Issued (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954739 - Disclosure - Net Assets - Share Repurchase Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails</Role>
      <ShortName>Net Assets - Share Repurchase Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954740 - Disclosure - Net Assets - Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails</Role>
      <ShortName>Net Assets - Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954741 - Disclosure - Net Assets - Shareholder Transfer Restrictions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails</Role>
      <ShortName>Net Assets - Shareholder Transfer Restrictions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954742 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bxsl.com/role/EarningsPerShareTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954743 - Disclosure - Income Taxes - Schedule of Permanent Differences (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails</Role>
      <ShortName>Income Taxes - Schedule of Permanent Differences (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954744 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954745 - Disclosure - Income Taxes - Schedule of Changes in Net Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails</Role>
      <ShortName>Income Taxes - Schedule of Changes in Net Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954746 - Disclosure - Income Taxes - Schedule of Accumulated Gains (Losses) as Calculated on Tax Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails</Role>
      <ShortName>Income Taxes - Schedule of Accumulated Gains (Losses) as Calculated on Tax Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954747 - Disclosure - Income Taxes - Schedule of Tax Basis of Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails</Role>
      <ShortName>Income Taxes - Schedule of Tax Basis of Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954748 - Disclosure - Financial Highlights and Senior Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails</Role>
      <ShortName>Financial Highlights and Senior Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="bxsl-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954749 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bxsl.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bxsl.com/role/SubsequentEvents</ParentRole>
      <Position>71</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="bxsl-20231231.htm">bxsl-20231231.htm</File>
    <File>bxsl-20231231.xsd</File>
    <File>bxsl-20231231_cal.xml</File>
    <File>bxsl-20231231_def.xml</File>
    <File>bxsl-20231231_lab.xml</File>
    <File>bxsl-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>bxsl-20231231_g1.jpg</File>
    <File>bxsl-20231231_g2.jpg</File>
    <File>bxsl-20231231_g3.jpg</File>
    <File>bxsl-20231231_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="5289">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="280">http://xbrl.sec.gov/cef/2023</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>101
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bxsl-20231231.htm": {
   "nsprefix": "bxsl",
   "nsuri": "http://www.bxsl.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "bxsl-20231231.htm"
     ]
    },
    "schema": {
     "local": [
      "bxsl-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "bxsl-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bxsl-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "bxsl-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bxsl-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 259,
   "keyCustom": 63,
   "axisStandard": 27,
   "axisCustom": 5,
   "memberStandard": 42,
   "memberCustom": 223,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/dei/2023": 4,
    "http://fasb.org/us-gaap/2023": 2
   },
   "contextCount": 1713,
   "entityCount": 1,
   "segmentCount": 277,
   "elementCount": 876,
   "unitCount": 12,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 5289,
    "http://xbrl.sec.gov/cef/2023": 280,
    "http://xbrl.sec.gov/dei/2023": 38
   },
   "report": {
    "R1": {
     "role": "http://www.bxsl.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentAnnualReport",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.bxsl.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
     "longName": "0000003 - Statement - Consolidated Statements of Assets and Liabilities",
     "shortName": "Consolidated Statements of Assets and Liabilities",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentOwnedAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical",
     "longName": "0000004 - Statement - Consolidated Statements of Assets and Liabilities (Parenthetical)",
     "shortName": "Consolidated Statements of Assets and Liabilities (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentOwnedAtCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.bxsl.com/role/ConsolidatedStatementsofOperations",
     "longName": "0000005 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestIncomeOperatingPaidInCash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestIncomeOperatingPaidInCash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets",
     "longName": "0000006 - Statement - Consolidated Statements of Changes in Net Assets",
     "shortName": "Consolidated Statements of Changes in Net Assets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "0000007 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossUnrealized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
     "longName": "0000008 - Statement - Consolidated Schedule of Investments",
     "shortName": "Consolidated Schedule of Investments",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentInterestRatePaidInKind",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-277",
      "name": "us-gaap:InvestmentOwnedBalancePrincipalAmount",
      "unitRef": "cad",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
     "longName": "0000009 - Statement - Consolidated Schedule of Investments (Parenthetical)",
     "shortName": "Consolidated Schedule of Investments (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentOwnedPercentOfNetAssets",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.bxsl.com/role/Organization",
     "longName": "0000010 - Disclosure - Organization",
     "shortName": "Organization",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.bxsl.com/role/SignificantAccountingPolicies",
     "longName": "0000011 - Disclosure - Significant Accounting Policies",
     "shortName": "Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactions",
     "longName": "0000012 - Disclosure - Agreements and Related Party Transactions",
     "shortName": "Agreements and Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.bxsl.com/role/Investments",
     "longName": "0000013 - Disclosure - Investments",
     "shortName": "Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.bxsl.com/role/FairValueMeasurements",
     "longName": "0000014 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.bxsl.com/role/Borrowings",
     "longName": "0000015 - Disclosure - Borrowings",
     "shortName": "Borrowings",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.bxsl.com/role/CommitmentandContingencies",
     "longName": "0000016 - Disclosure - Commitment and Contingencies",
     "shortName": "Commitment and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.bxsl.com/role/NetAssets",
     "longName": "0000017 - Disclosure - Net Assets",
     "shortName": "Net Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.bxsl.com/role/EarningsPerShare",
     "longName": "0000018 - Disclosure - Earnings Per Share",
     "shortName": "Earnings Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.bxsl.com/role/IncomeTaxes",
     "longName": "0000019 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecurities",
     "longName": "0000020 - Disclosure - Financial Highlights and Senior Securities",
     "shortName": "Financial Highlights and Senior Securities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.bxsl.com/role/SubsequentEvents",
     "longName": "0000021 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityFileNumber",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cef:SeniorSecuritiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies",
     "longName": "9954701 - Disclosure - Significant Accounting Policies (Policies)",
     "shortName": "Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.bxsl.com/role/InvestmentsTables",
     "longName": "9954702 - Disclosure - Investments (Tables)",
     "shortName": "Investments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.bxsl.com/role/FairValueMeasurementsTables",
     "longName": "9954703 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.bxsl.com/role/BorrowingsTables",
     "longName": "9954704 - Disclosure - Borrowings (Tables)",
     "shortName": "Borrowings (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.bxsl.com/role/NetAssetsTables",
     "longName": "9954705 - Disclosure - Net Assets (Tables)",
     "shortName": "Net Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.bxsl.com/role/EarningsPerShareTables",
     "longName": "9954706 - Disclosure - Earnings Per Share (Tables)",
     "shortName": "Earnings Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.bxsl.com/role/IncomeTaxesTables",
     "longName": "9954707 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "bxsl:InvestmentCompanyChangeInNetAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "bxsl:InvestmentCompanyChangeInNetAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesTables",
     "longName": "9954708 - Disclosure - Financial Highlights and Senior Securities (Tables)",
     "shortName": "Financial Highlights and Senior Securities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.bxsl.com/role/SignificantAccountingPoliciesRevenueRecognitionIncomeTaxDetails",
     "longName": "9954709 - Disclosure - Significant Accounting Policies - Revenue Recognition / Income Tax (Details)",
     "shortName": "Significant Accounting Policies - Revenue Recognition / Income Tax (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentIncomeInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentIncomeInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails",
     "longName": "9954710 - Disclosure - Agreements and Related Party Transactions - Investment Advisory Agreement (Details)",
     "shortName": "Agreements and Related Party Transactions - Investment Advisory Agreement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1245",
      "name": "bxsl:RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1233",
      "name": "bxsl:RelatedPartyTransactionInitialTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
     "longName": "9954711 - Disclosure - Agreements and Related Party Transactions - Base Management Fee (Details)",
     "shortName": "Agreements and Related Party Transactions - Base Management Fee (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ManagementFeeExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1241",
      "name": "us-gaap:ManagementAndServiceFeesRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
     "longName": "9954712 - Disclosure - Agreements and Related Party Transactions - Incentive Fees (Details)",
     "shortName": "Agreements and Related Party Transactions - Incentive Fees (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "bxsl:IncomeBasedIncentiveFeeExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1243",
      "name": "us-gaap:ManagementAndServiceFeesIncentiveRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails",
     "longName": "9954713 - Disclosure - Agreements and Related Party Transactions - Administration Agreement (Details)",
     "shortName": "Agreements and Related Party Transactions - Administration Agreement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdministrativeFeesExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1253",
      "name": "bxsl:RelatedPartyTransactionInitialTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails",
     "longName": "9954714 - Disclosure - Agreements and Related Party Transactions - Sub-Administration and Expense Support (Details)",
     "shortName": "Agreements and Related Party Transactions - Sub-Administration and Expense Support (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1256",
      "name": "bxsl:RelatedPartyTransactionInitialTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1256",
      "name": "bxsl:RelatedPartyTransactionInitialTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails",
     "longName": "9954715 - Disclosure - Agreements and Related Party Transactions - Expense Payments and Reimbursement Payments (Details)",
     "shortName": "Agreements and Related Party Transactions - Expense Payments and Reimbursement Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "bxsl:ExpenseSupportReimbursementRelatedParty",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "bxsl:ExpenseSupportReimbursementRelatedParty",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails",
     "longName": "9954716 - Disclosure - Investments - Investment Portfolio at Cost and Fair Value (Details)",
     "shortName": "Investments - Investment Portfolio at Cost and Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentOwnedAtCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1261",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails",
     "longName": "9954717 - Disclosure - Investments - Investments at Fair Value Percent (Details)",
     "shortName": "Investments - Investments at Fair Value Percent (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1272",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1274",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails",
     "longName": "9954718 - Disclosure - Investments - Geographic Investment (Details)",
     "shortName": "Investments - Geographic Investment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentOwnedAtCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1348",
      "name": "us-gaap:InvestmentOwnedAtCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails",
     "longName": "9954719 - Disclosure - Investments - Additional Information (Details)",
     "shortName": "Investments - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "bxsl:InvestmentOwnedNonaccrualNumberOfLoans",
      "unitRef": "loan",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "bxsl:InvestmentOwnedNonaccrualNumberOfLoans",
      "unitRef": "loan",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
     "longName": "9954720 - Disclosure - Fair Value Measurements - Fair Value Hierarchy of Financial Instruments (Details)",
     "shortName": "Fair Value Measurements - Fair Value Hierarchy of Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails",
     "longName": "9954721 - Disclosure - Fair Value Measurements - Summary of Changes in Fair Value of Investments Measured Using Level 3 Inputs (Details)",
     "shortName": "Fair Value Measurements - Summary of Changes in Fair Value of Investments Measured Using Level 3 Inputs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1404",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1428",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails",
     "longName": "9954722 - Disclosure - Fair Value Measurements - Unobservable Inputs (Details)",
     "shortName": "Fair Value Measurements - Unobservable Inputs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentOwnedAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1384",
      "name": "us-gaap:InvestmentOwnedAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
     "longName": "9954723 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1504",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R46": {
     "role": "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails",
     "longName": "9954724 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurements of Unsecured Notes (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value Measurements of Unsecured Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1503",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1503",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
     "longName": "9954725 - Disclosure - Borrowings - Jackson Hole Funding Facility (Details)",
     "shortName": "Borrowings - Jackson Hole Funding Facility (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1505",
      "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
     "longName": "9954726 - Disclosure - Borrowings - Breckenridge Funding Facility (Details)",
     "shortName": "Borrowings - Breckenridge Funding Facility (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1512",
      "name": "us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1512",
      "name": "us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
     "longName": "9954727 - Disclosure - Borrowings - Big Sky Funding Facility (Details)",
     "shortName": "Borrowings - Big Sky Funding Facility (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1520",
      "name": "bxsl:LineOfCreditFacilityMinimumCapacityUtilizationPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1520",
      "name": "bxsl:LineOfCreditFacilityMinimumCapacityUtilizationPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails",
     "longName": "9954728 - Disclosure - Borrowings - Revolving Credit Facility (Details)",
     "shortName": "Borrowings - Revolving Credit Facility (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1523",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1523",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails",
     "longName": "9954729 - Disclosure - Borrowings - Unsecured Debt (Details)",
     "shortName": "Borrowings - Unsecured Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1539",
      "name": "us-gaap:DebtInstrumentRedemptionPricePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
     "longName": "9954730 - Disclosure - Borrowings - Outstanding Debt Obligations (Details)",
     "shortName": "Borrowings - Outstanding Debt Obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.bxsl.com/role/BorrowingsAdditionalInformationDetails",
     "longName": "9954731 - Disclosure - Borrowings - Additional Information (Details)",
     "shortName": "Borrowings - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "bxsl:InterestPayableInterestExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "bxsl:InterestPayableInterestExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.bxsl.com/role/BorrowingsInterestExpenseDetails",
     "longName": "9954732 - Disclosure - Borrowings - Interest Expense (Details)",
     "shortName": "Borrowings - Interest Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestExpenseBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestExpenseBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.bxsl.com/role/CommitmentandContingenciesDetails",
     "longName": "9954733 - Disclosure - Commitment and Contingencies (Details)",
     "shortName": "Commitment and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "bxsl:InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails",
     "longName": "9954734 - Disclosure - Net Assets - Subscriptions and Drawdowns (Details)",
     "shortName": "Net Assets - Subscriptions and Drawdowns (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1572",
      "name": "us-gaap:InvestmentCompanyCommittedCapital",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails",
     "longName": "9954735 - Disclosure - Net Assets - Schedule of Shares Issued and Proceeds Received (Details)",
     "shortName": "Net Assets - Schedule of Shares Issued and Proceeds Received (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "bxsl:NumberOfEquityDistributionAgreements",
      "unitRef": "equity_distribution_agreement",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "bxsl:NumberOfEquityDistributionAgreements",
      "unitRef": "equity_distribution_agreement",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails",
     "longName": "9954736 - Disclosure - Net Assets - Distributions Declared (Details)",
     "shortName": "Net Assets - Distributions Declared (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1578",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.bxsl.com/role/NetAssetsDividendReinvestmentDetails",
     "longName": "9954737 - Disclosure - Net Assets - Dividend Reinvestment (Details)",
     "shortName": "Net Assets - Dividend Reinvestment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "bxsl:DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "bxsl:DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.bxsl.com/role/NetAssetsScheduledofAmountsReceivedandSharesIssuedDetails",
     "longName": "9954738 - Disclosure - Net Assets - Scheduled of Amounts Received and Shares Issued (Details)",
     "shortName": "Net Assets - Scheduled of Amounts Received and Shares Issued (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1599",
      "name": "us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bxsl:ScheduleOfDividendReinvestmentPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1599",
      "name": "us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bxsl:ScheduleOfDividendReinvestmentPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails",
     "longName": "9954739 - Disclosure - Net Assets - Share Repurchase Plan (Details)",
     "shortName": "Net Assets - Share Repurchase Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1629",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bxsl:ScheduleOfSharesRepurchasedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1608",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails",
     "longName": "9954740 - Disclosure - Net Assets - Share Repurchases (Details)",
     "shortName": "Net Assets - Share Repurchases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-1629",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bxsl:ScheduleOfSharesRepurchasedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1629",
      "name": "bxsl:StockRepurchasedDuringPeriodAverageCostPerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bxsl:ScheduleOfSharesRepurchasedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails",
     "longName": "9954741 - Disclosure - Net Assets - Shareholder Transfer Restrictions (Details)",
     "shortName": "Net Assets - Shareholder Transfer Restrictions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-1635",
      "name": "bxsl:InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1635",
      "name": "bxsl:InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.bxsl.com/role/EarningsPerShareDetails",
     "longName": "9954742 - Disclosure - Earnings Per Share (Details)",
     "shortName": "Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R65": {
     "role": "http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails",
     "longName": "9954743 - Disclosure - Income Taxes - Schedule of Permanent Differences (Details)",
     "shortName": "Income Taxes - Schedule of Permanent Differences (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-1640",
      "name": "us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1640",
      "name": "us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.bxsl.com/role/IncomeTaxesNarrativeDetails",
     "longName": "9954744 - Disclosure - Income Taxes - Narrative (Details)",
     "shortName": "Income Taxes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails",
     "longName": "9954745 - Disclosure - Income Taxes - Schedule of Changes in Net Assets (Details)",
     "shortName": "Income Taxes - Schedule of Changes in Net Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "bxsl:InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FederalIncomeTaxNoteTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails",
     "longName": "9954746 - Disclosure - Income Taxes - Schedule of Accumulated Gains (Losses) as Calculated on Tax Basis (Details)",
     "shortName": "Income Taxes - Schedule of Accumulated Gains (Losses) as Calculated on Tax Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bxsl:InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bxsl:InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails",
     "longName": "9954747 - Disclosure - Income Taxes - Schedule of Tax Basis of Investments (Details)",
     "shortName": "Income Taxes - Schedule of Tax Basis of Investments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:TaxBasisOfInvestmentsGrossUnrealizedAppreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:TaxBasisOfInvestmentsGrossUnrealizedAppreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails",
     "longName": "9954748 - Disclosure - Financial Highlights and Senior Securities (Details)",
     "shortName": "Financial Highlights and Senior Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:NetAssetValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1650",
      "name": "us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.bxsl.com/role/SubsequentEventsDetails",
     "longName": "9954749 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1713",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bxsl-20231231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "bxsl_A2023NotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "A2023NotesMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Notes",
        "label": "2023 Notes [Member]",
        "documentation": "2023 Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_A2026NotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "A2026NotesMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026 Notes",
        "label": "2026 Notes [Member]",
        "documentation": "2026 Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_A2027NotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "A2027NotesMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027 Notes",
        "label": "2027 Notes [Member]",
        "documentation": "2027 Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_A2028NotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "A2028NotesMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028 Notes",
        "label": "2028 Notes [Member]",
        "documentation": "2028 Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_A2125SeniorNotesDue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "A2125SeniorNotesDue2027Member",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2.125% Senior Notes Due 2027",
        "verboseLabel": "2027 Notes",
        "label": "2.125% Senior Notes Due 2027 [Member]",
        "documentation": "2.125% Senior Notes Due 2027"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_A2750NotesDue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "A2750NotesDue2026Member",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New 2026 Notes",
        "label": "2.750% Notes Due 2026 [Member]",
        "documentation": "2.750% Notes Due 2026"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_A2850NotesDue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "A2850NotesDue2028Member",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2.850% Notes Due 2028",
        "verboseLabel": "2028 Notes",
        "label": "2.850% Notes Due 2028 [Member]",
        "documentation": "2.850% Notes Due 2028"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_A3625NotesDue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "A3625NotesDue2026Member",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "3.625% Notes Due 2026",
        "verboseLabel": "2026 Notes",
        "label": "3.625% Notes Due 2026 [Member]",
        "documentation": "3.625% Notes Due 2026"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_A3650NotesDue2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "A3650NotesDue2023Member",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "3.650% Notes Due 2023",
        "verboseLabel": "2023 Notes",
        "label": "3.650% Notes Due 2023 [Member]",
        "documentation": "3.650% Notes Due 2023"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "A covenant breach or other default by our portfolio companies may adversely affect our operating results. [Member]",
        "documentation": "A covenant breach or other default by our portfolio companies may adversely affect our operating results."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "A lack of liquidity in certain of our investments may adversely affect our business. [Member]",
        "documentation": "A lack of liquidity in certain of our investments may adversely affect our business."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "A shareholder\u2019s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us. [Member]",
        "documentation": "A shareholder\u2019s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_AbilityToAchieveInvestmentObjectivesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AbilityToAchieveInvestmentObjectivesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ability to Achieve Investment Objectives [Member]",
        "documentation": "Ability to Achieve Investment Objectives"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net accretion of discount and amortization of premium",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Accrued Liabilities and Other Liabilities",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Undistributed net investment income (loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r9",
      "r27",
      "r325",
      "r328",
      "r355",
      "r424",
      "r425",
      "r837",
      "r838",
      "r839",
      "r850",
      "r851",
      "r852"
     ]
    },
    "bxsl_AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquire various financial instruments for purposes of \u201chedging\u201d or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders. [Member]",
        "documentation": "Acquire various financial instruments for purposes of \u201chedging\u201d or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r715",
      "r907"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets",
      "http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid in Capital",
        "verboseLabel": "Paid In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r460",
      "r850",
      "r851",
      "r852",
      "r872",
      "r923"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesRevenueRecognitionIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r102"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_AdministrationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AdministrationAgreementMember",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Administration Agreement",
        "label": "Administration Agreement [Member]",
        "documentation": "Administration Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdministrativeFeesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdministrativeFeesExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Administrative service expenses (Note 3)",
        "verboseLabel": "Administrative service expenses",
        "label": "Administrative Fees Expense",
        "documentation": "Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r525",
      "r918"
     ]
    },
    "bxsl_AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adviser are not prohibited from raising money for or managing other entities that make the same types of investments that we target. [Member]",
        "documentation": "Adviser are not prohibited from raising money for or managing other entities that make the same types of investments that we target."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_AerospaceAndDefenseSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AerospaceAndDefenseSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aerospace &amp; Defense",
        "label": "Aerospace And Defense Sector [Member]",
        "documentation": "Aerospace And Defense Sector"
       }
      }
     },
     "auth_ref": []
    },
    "srt_AffiliatedEntityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "AffiliatedEntityMember",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliated Entity",
        "label": "Affiliated Entity [Member]"
       }
      }
     },
     "auth_ref": [
      "r525",
      "r690",
      "r721",
      "r870",
      "r878",
      "r879",
      "r880"
     ]
    },
    "bxsl_AirFreightLogisticsSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AirFreightLogisticsSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Air Freight &amp; Logistics",
        "label": "Air Freight &amp; Logistics Sector [Member]",
        "documentation": "Air Freight &amp; Logistics Sector"
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_AmortizationOfDebtIssuanceCostsLineOfCreditArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AmortizationOfDebtIssuanceCostsLineOfCreditArrangements",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/BorrowingsInterestExpenseDetails": {
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsInterestExpenseDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of deferred financing costs",
        "label": "Amortization Of Debt Issuance Costs, Line Of Credit Arrangements",
        "documentation": "Amortization Of Debt Issuance Costs, Line Of Credit Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/BorrowingsInterestExpenseDetails": {
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsInterestExpenseDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization of original issue discount and debt issuance costs",
        "terseLabel": "Amortization of original issue discount and debt issuance costs",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r353",
      "r707",
      "r708",
      "r845"
     ]
    },
    "bxsl_AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "An investment strategy focused primarily on privately-held companies presents certain challenges, including, but not limited to, the lack of available information about these companies. [Member]",
        "documentation": "An investment strategy focused primarily on privately-held companies presents certain challenges, including, but not limited to, the lack of available information about these companies."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "bxsl_AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Another pandemic or global health crisis like the COVID-19 pandemic may adversely impact our performance and results of operations [Member]",
        "documentation": "Another pandemic or global health crisis like the COVID-19 pandemic may adversely impact our performance and results of operations"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Any material adverse change in its financial condition or our relationship with the Adviser could have a material adverse effect on our business and ability to achieve our investment objectives [Member]",
        "documentation": "Any material adverse change in its financial condition or our relationship with the Adviser could have a material adverse effect on our business and ability to achieve our investment objectives"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Any unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available for distribution. [Member]",
        "documentation": "Any unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available for distribution."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "As a Delaware statutory trust, we are subject to the control share acquisition statute contained in the Delaware Statutory Trust Act. [Member]",
        "documentation": "As a Delaware statutory trust, we are subject to the control share acquisition statute contained in the Delaware Statutory Trust Act."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "As a public company, we are subject to regulations. Efforts to comply with such regulations will involve significant expenditures, and non-compliance with such regulations may adversely affect us. [Member]",
        "documentation": "As a public company, we are subject to regulations. Efforts to comply with such regulations will involve significant expenditures, and non-compliance with such regulations may adversely affect us."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r124",
      "r144",
      "r177",
      "r181",
      "r183",
      "r218",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r320",
      "r322",
      "r343",
      "r411",
      "r518",
      "r715",
      "r732",
      "r864",
      "r865",
      "r881"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_AtTheMarketOfferingOffering1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AtTheMarketOfferingOffering1Member",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-the-Market Offering",
        "label": "At-the-Market Offering, Offering 1 [Member]",
        "documentation": "At-the-Market Offering, Offering 1"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.bxsl.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r737",
      "r738",
      "r739"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.bxsl.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r737",
      "r738",
      "r739"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://www.bxsl.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r737",
      "r738",
      "r739"
     ]
    },
    "bxsl_BERMUDAAndCAYMANISLANDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "BERMUDAAndCAYMANISLANDMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bermuda/Cayman Islands",
        "label": "BERMUDA and CAYMAN ISLAND [Member]",
        "documentation": "BERMUDA and CAYMAN ISLAND"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BaseRateMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base Rate",
        "label": "Base Rate [Member]",
        "documentation": "Minimum rate investor will accept."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r774"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_BigSkyFundingFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "BigSkyFundingFacilityMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Big Sky Funding Facility",
        "label": "Big Sky Funding Facility [Member]",
        "documentation": "Big Sky Funding Facility"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_BlackstoneDonegalHoldingsLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "BlackstoneDonegalHoldingsLPMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Blackstone Donegal Holdings LP",
        "label": "Blackstone Donegal Holdings LP [Member]",
        "documentation": "Blackstone Donegal Holdings LP"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_BreckenridgeFundingFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "BreckenridgeFundingFacilityMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Breckenridge Funding Facility",
        "label": "Breckenridge Funding Facility [Member]",
        "documentation": "Breckenridge Funding Facility"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_BuildingProductsSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "BuildingProductsSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building Products",
        "label": "Building Products Sector [Member]",
        "documentation": "Building Products Sector"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r738",
      "r739"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "country_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "CA",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Canada",
        "label": "CANADA"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_CapitalGainsBasedIncentiveFeesRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "CapitalGainsBasedIncentiveFeesRate",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital gains based incentive rate",
        "label": "Capital Gains Based Incentive Fees, Rate",
        "documentation": "Capital Gains Based Incentive Fees, Rate"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_CapitalGainsIncentiveFeeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "CapitalGainsIncentiveFeeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital gains incentive fees (Note 3)",
        "label": "Capital Gains Incentive Fee Expense",
        "documentation": "Capital Gains Incentive Fee Expense"
       }
      }
     },
     "auth_ref": []
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r742"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r123",
      "r695"
     ]
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents [Member]",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r92",
      "r140"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r92"
     ]
    },
    "bxsl_CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Certain provisions of our Declaration of Trust could deter takeover attempts and have an adverse impact on the value of our common shares. [Member]",
        "documentation": "Certain provisions of our Declaration of Trust could deter takeover attempts and have an adverse impact on the value of our common shares."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in interest rates may affect our cost of capital and net investment income. [Member]",
        "documentation": "Changes in interest rates may affect our cost of capital and net investment income."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in laws or regulations governing our operations may adversely affect our business or cause us to alter our business strategy. [Member]",
        "documentation": "Changes in laws or regulations governing our operations may adversely affect our business or cause us to alter our business strategy."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChemicalsSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChemicalsSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chemicals",
        "label": "Chemicals Sector [Member]",
        "documentation": "Sector of economy consisting of companies engaged in business activity related to chemicals."
       }
      }
     },
     "auth_ref": [
      "r926",
      "r930",
      "r933",
      "r937"
     ]
    },
    "bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2026",
        "label": "CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2026 [Member]",
        "documentation": "CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2026"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2027",
        "label": "CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2027 [Member]",
        "documentation": "CitiBank, Revolving Credit Facility, Foreign Currency Commitments 2027"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_CitiBankRevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "CitiBankRevolvingCreditFacilityMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "CitiBank, Revolving Credit Facility [Member]",
        "documentation": "CitiBank, Revolving Credit Facility"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r125",
      "r126",
      "r127",
      "r144",
      "r164",
      "r165",
      "r167",
      "r169",
      "r175",
      "r176",
      "r218",
      "r235",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r274",
      "r275",
      "r278",
      "r281",
      "r288",
      "r343",
      "r441",
      "r442",
      "r443",
      "r444",
      "r460",
      "r463",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r476",
      "r504",
      "r532",
      "r564",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r827",
      "r846",
      "r853"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r175",
      "r274",
      "r275",
      "r276",
      "r278",
      "r281",
      "r286",
      "r288",
      "r441",
      "r442",
      "r443",
      "r444",
      "r709",
      "r827",
      "r846"
     ]
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfTreasuryStockTable",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails",
      "http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Treasury Stock [Table]",
        "label": "Class of Treasury Stock [Table]",
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r53",
      "r54"
     ]
    },
    "bxsl_CommercialServicesSuppliesSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "CommercialServicesSuppliesSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial Services &amp; Supplies",
        "label": "Commercial Services &amp; Supplies Sector [Member]",
        "documentation": "Commercial Services &amp; Supplies Sector"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_CommitmentFeeScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "CommitmentFeeScenarioAxis",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitment Fee Scenario [Axis]",
        "label": "Commitment Fee Scenario [Axis]",
        "documentation": "Commitment Fee Scenario"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_CommitmentFeeScenarioDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "CommitmentFeeScenarioDomain",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitment Fee Scenario [Domain]",
        "label": "Commitment Fee Scenario [Domain]",
        "documentation": "Commitment Fee Scenario [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 7)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r75",
      "r412",
      "r503"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/CommitmentandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r229",
      "r230",
      "r680",
      "r863"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails",
      "http://www.bxsl.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Per Share Amount (in usd per share)",
        "terseLabel": "Distributions declared and payable per share (in usd per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Par Amount",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r717",
      "r718",
      "r719",
      "r722",
      "r723",
      "r724",
      "r725",
      "r850",
      "r851",
      "r872",
      "r896",
      "r923"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in usd per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r504"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical",
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r81",
      "r504",
      "r524",
      "r923",
      "r924"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common shares, $0.001 par value (unlimited shares authorized; 185,782,408 and 160,362,861 shares issued and outstanding at December\u00a031, 2023 and December\u00a031, 2022, respectively)",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r413",
      "r715"
     ]
    },
    "bxsl_Company10b18PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Company10b18PlanMember",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company 10b-18 Plan",
        "label": "Company 10b-18 Plan [Member]",
        "documentation": "Company 10b-18 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Company10b51PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Company10b51PlanMember",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails",
      "http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company 10b5-1 Plan",
        "label": "Company 10b5-1 Plan [Member]",
        "documentation": "Company 10b5-1 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compliance with SEC Rule 18f-4 governing derivatives and use of leverage may limit our investment discretion. [Member]",
        "documentation": "Compliance with SEC Rule 18f-4 governing derivatives and use of leverage may limit our investment discretion."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compliance with the SEC\u2019s Regulation Best Interest by participating broker-dealers may negatively impact our ability to raise capital in a public offering [Member]",
        "documentation": "Compliance with the SEC\u2019s Regulation Best Interest by participating broker-dealers may negatively impact our ability to raise capital in a public offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails",
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r65",
      "r66",
      "r187",
      "r679"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails",
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r65",
      "r66",
      "r187",
      "r429",
      "r679"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails",
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r65",
      "r66",
      "r187",
      "r679",
      "r828"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails",
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "% of Total Investments at Fair Value",
        "verboseLabel": "Concentration percentage",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r65",
      "r66",
      "r187"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails",
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r65",
      "r66",
      "r187",
      "r679"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r696"
     ]
    },
    "bxsl_ConstructionEngineeringSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ConstructionEngineeringSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction &amp; Engineering",
        "label": "Construction &amp; Engineering Sector [Member]",
        "documentation": "Construction &amp; Engineering Sector"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsumerSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsumerSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diversified Consumer Services",
        "label": "Consumer Sector [Member]",
        "documentation": "Sector of economy consisting of companies engaged in business activity related to consumer product and service."
       }
      }
     },
     "auth_ref": [
      "r926",
      "r930",
      "r933",
      "r937"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContainerAndPackagingSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContainerAndPackagingSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Containers &amp; Packaging",
        "label": "Container and Packaging Sector [Member]",
        "documentation": "Sector of economy consisting of companies engaged in business activity related to container and packaging."
       }
      }
     },
     "auth_ref": [
      "r926",
      "r930",
      "r933",
      "r937"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity risks and data protection could result in the loss of data, interruptions in our business, damage to our reputation, and subject us to regulatory actions [Member]",
        "documentation": "Cybersecurity risks and data protection could result in the loss of data, interruptions in our business, damage to our reputation, and subject us to regulatory actions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtAndEquitySecuritiesRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtAndEquitySecuritiesRealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlled/non-affiliated investments",
        "negatedTerseLabel": "Net realized (gain) loss on investments",
        "label": "Debt and Equity Securities, Realized Gain (Loss)",
        "documentation": "Amount of realized gain (loss) on investment in debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r545",
      "r546",
      "r642",
      "r643",
      "r644",
      "r840",
      "r841"
     ]
    },
    "us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtAndEquitySecuritiesUnrealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net unrealized (appreciation) depreciation on investments",
        "negatedTerseLabel": "Net change in unrealized (appreciation) depreciation on investments",
        "label": "Debt and Equity Securities, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) on investment in debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r551",
      "r552",
      "r645",
      "r646",
      "r647",
      "r840",
      "r841"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/Borrowings"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r142",
      "r244",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r260",
      "r267",
      "r268",
      "r270"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r78",
      "r79",
      "r106",
      "r107",
      "r147",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r354",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r847"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Principal",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r107",
      "r271"
     ]
    },
    "bxsl_DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset coverage ratio",
        "label": "Debt Instrument, Covenant Compliance, Required Asset Coverage Ratio",
        "documentation": "Debt Instrument, Covenant Compliance, Required Asset Coverage Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Aggregate principal amount",
        "terseLabel": "Aggregate Principal Committed",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r70",
      "r245",
      "r354",
      "r705",
      "r706"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r246"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r269",
      "r354",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r847"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r147",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r354",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r847"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption percentage",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-Term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r47",
      "r50",
      "r67",
      "r68",
      "r70",
      "r76",
      "r100",
      "r101",
      "r147",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r269",
      "r354",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r847"
     ]
    },
    "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnusedBorrowingCapacityAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unused portion",
        "label": "Debt Instrument, Unused Borrowing Capacity, Amount",
        "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_DebtInstrumentUnusedBorrowingCapacityFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnusedBorrowingCapacityFee",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/BorrowingsInterestExpenseDetails": {
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Facility unused fees",
        "label": "Debt Instrument, Unused Borrowing Capacity, Fee",
        "documentation": "Amount of commitment fees for the unused borrowing capacity under the long-term financing arrangement that is available to the entity."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "bxsl_DebtIssuanceCostsIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DebtIssuanceCostsIncurredButNotYetPaid",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued but unpaid debt issuing costs",
        "label": "Debt Issuance Costs Incurred But Not Yet Paid",
        "documentation": "Debt Issuance Costs Incurred But Not Yet Paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-cash debt issuance costs activity",
        "label": "Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction",
        "documentation": "The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r35"
     ]
    },
    "bxsl_DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-cash deferred financing costs activity",
        "label": "Debt Issuance Costs, Line Of Credit Arrangements, Incurred During Noncash Or Partial Noncash Transaction",
        "documentation": "Debt Issuance Costs, Line Of Credit Arrangements, Incurred During Noncash Or Partial Noncash Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtIssuanceCostsLineOfCreditArrangementsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred financing costs",
        "label": "Debt Issuance Costs, Line of Credit Arrangements, Net",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_DebtPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Financing Costs and Debt Issuance Costs",
        "label": "Debt, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "bxsl_DebtSecuritiesFirstLienMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DebtSecuritiesFirstLienMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First lien debt",
        "label": "Debt Securities, First Lien [Member]",
        "documentation": "Debt Securities, First Lien"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_DebtSecuritiesFirstLienRealizedGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DebtSecuritiesFirstLienRealizedGainLossMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, First Lien, Realized Gain (Loss)",
        "label": "Debt Securities, First Lien, Realized Gain (Loss) [Member]",
        "documentation": "Debt Securities, First Lien, Realized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_DebtSecuritiesFirstLienUnrealizedGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DebtSecuritiesFirstLienUnrealizedGainLossMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, First Lien, Unrealized Gain (Loss)",
        "label": "Debt Securities, First Lien, Unrealized Gain (Loss) [Member]",
        "documentation": "Debt Securities, First Lien, Unrealized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_DebtSecuritiesFixedRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DebtSecuritiesFixedRateMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Fixed Rate",
        "label": "Debt Securities, Fixed Rate [Member]",
        "documentation": "Debt Securities, Fixed Rate"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_DebtSecuritiesSecondLienMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DebtSecuritiesSecondLienMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Second lien debt",
        "label": "Debt Securities, Second Lien [Member]",
        "documentation": "Debt Securities, Second Lien"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_DebtSecuritiesSecondLienRealizedGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DebtSecuritiesSecondLienRealizedGainLossMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Second Lien, Realized Gain (Loss)",
        "label": "Debt Securities, Second Lien, Realized Gain (Loss) [Member]",
        "documentation": "Debt Securities, Second Lien, Realized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_DebtSecuritiesSecondLienUnrealizedGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DebtSecuritiesSecondLienUnrealizedGainLossMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Second Lien, Unrealized Gain (Loss)",
        "label": "Debt Securities, Second Lien, Unrealized Gain (Loss) [Member]",
        "documentation": "Debt Securities, Second Lien, Unrealized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_DebtSecuritiesVariableRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DebtSecuritiesVariableRateMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Variable Rate",
        "label": "Debt Securities, Variable Rate [Member]",
        "documentation": "Debt Securities, Variable Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFinanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net of unamortized debt issuance costs",
        "label": "Debt Issuance Costs, Net",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r867"
     ]
    },
    "bxsl_DelayedDrawTermLoansAndRevolversMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DelayedDrawTermLoansAndRevolversMember",
     "presentation": [
      "http://www.bxsl.com/role/CommitmentandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Delayed Draw Term Loans And Revolvers",
        "label": "Delayed Draw Term Loans And Revolvers [Member]",
        "documentation": "Delayed Draw Term Loans And Revolvers"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r740",
      "r741",
      "r811"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments/Forward Purchase Agreement",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r56",
      "r57",
      "r58",
      "r59",
      "r146"
     ]
    },
    "bxsl_DistributionCostsIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DistributionCostsIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distribution payable",
        "label": "Distribution Costs Incurred But Not Yet Paid",
        "documentation": "Distribution Costs Incurred But Not Yet Paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DistributionPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DistributionPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distribution payable (Note 8)",
        "label": "Distribution Payable",
        "documentation": "Amount of distribution payable to ownership interest holder from investment income and return of capital."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r666"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "bxsl_DistributorsSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DistributorsSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributors",
        "label": "Distributors Sector [Member]",
        "documentation": "Distributors Sector"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_DiversifiedTelecommunicationServicesSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DiversifiedTelecommunicationServicesSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diversified Telecommunication Services",
        "label": "Diversified Telecommunication Services Sector [Member]",
        "documentation": "Diversified Telecommunication Services Sector"
       }
      }
     },
     "auth_ref": []
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "us-gaap_DividendAndInterestReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendAndInterestReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest receivable from non-controlled/non-affiliated investments",
        "label": "Dividend and Interest Receivable",
        "documentation": "Amount of dividend and interest receivable from investment."
       }
      }
     },
     "auth_ref": [
      "r513",
      "r572",
      "r732"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "us-gaap_DividendIncomeOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendIncomeOperating",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_GrossInvestmentIncomeOperating",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend income",
        "label": "Dividend Income, Operating",
        "documentation": "Amount of operating dividend income on securities."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r457",
      "r533",
      "r648",
      "r650",
      "r729",
      "r730",
      "r940"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r740",
      "r741",
      "r811"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "bxsl_DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDividendReinvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price of common stock, percent of market price",
        "label": "Dividend Reinvestment Plan, Minimum Share Issuance Price, Percentage Of Current Market Price Per Share",
        "documentation": "Dividend Reinvestment Plan, Minimum Share Issuance Price, Percentage Of Current Market Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Dividends1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Dividends1Member",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends 1",
        "label": "Dividends 1 [Member]",
        "documentation": "Dividends 1"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Dividends2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Dividends2Member",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends 2",
        "label": "Dividends 2 [Member]",
        "documentation": "Dividends 2"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Dividends3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Dividends3Member",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends 3",
        "label": "Dividends 3 [Member]",
        "documentation": "Dividends 3"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Dividends4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Dividends4Member",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends 4",
        "label": "Dividends 4 [Member]",
        "documentation": "Dividends 4"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Dividends5Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Dividends5Member",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends 5",
        "label": "Dividends 5 [Member]",
        "documentation": "Dividends 5"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Dividends6Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Dividends6Member",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends 6",
        "label": "Dividends 6 [Member]",
        "documentation": "Dividends 6"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Dividends7Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Dividends7Member",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends 7",
        "label": "Dividends 7 [Member]",
        "documentation": "Dividends 7"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Dividends8Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Dividends8Member",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends 8",
        "label": "Dividends 8 [Member]",
        "documentation": "Dividends 8"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Dividends9Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Dividends9Member",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends 9",
        "label": "Dividends 9 [Member]",
        "documentation": "Dividends 9"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsAxis",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesNarrativeDetails",
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends [Axis]",
        "label": "Dividends [Axis]",
        "documentation": "Information about distribution of earnings to shareholders including, but not limited to, cash, property or capital stock."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_DividendsCapitalGainsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DividendsCapitalGainsMember",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends, Capital Gains",
        "label": "Dividends, Capital Gains [Member]",
        "documentation": "Dividends, Capital Gains"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesNarrativeDetails",
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Amount",
        "verboseLabel": "Dividends declared",
        "label": "Dividends, Common Stock",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r102"
     ]
    },
    "us-gaap_DividendsDeclaredTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsDeclaredTableTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends Declared",
        "label": "Dividends Declared [Table Text Block]",
        "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsDomain",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesNarrativeDetails",
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends [Domain]",
        "label": "Dividends [Domain]",
        "documentation": "Distributions of earnings to shareholders including but not limited to cash, property or capital stock."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_DividendsOrdinaryIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "DividendsOrdinaryIncomeMember",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends, Ordinary Income",
        "label": "Dividends, Ordinary Income [Member]",
        "documentation": "Dividends, Ordinary Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsPayableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableLineItems",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends Payable [Line Items]",
        "label": "Dividends Payable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsPayableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableTable",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsDistributionsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends Payable [Table]",
        "label": "Dividends Payable [Table]",
        "documentation": "A table that contains information regarding dividends that have been declared but not paid as of the financial reporting date. This information may contain the amount, amount per share, declared date, and date to be paid."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r737",
      "r738",
      "r739"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r737",
      "r738",
      "r739",
      "r814"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations",
      "http://www.bxsl.com/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings (loss), basic, per share (in usd per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r162",
      "r164",
      "r167",
      "r168",
      "r169",
      "r173",
      "r333",
      "r334",
      "r409",
      "r421",
      "r698"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations",
      "http://www.bxsl.com/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings (loss), diluted, per share (in usd per share)",
        "verboseLabel": "Earnings (loss) diluted (in usd per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r164",
      "r167",
      "r168",
      "r169",
      "r173",
      "r333",
      "r334",
      "r409",
      "r421",
      "r698"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/EarningsPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r170",
      "r171",
      "r172"
     ]
    },
    "bxsl_EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Economic recessions or downturns or restrictions on trade could impair our portfolio companies and adversely affect our operating results. [Member]",
        "documentation": "Economic recessions or downturns or restrictions on trade could impair our portfolio companies and adversely affect our operating results."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of foreign exchange rate changes on cash and cash equivalents",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "bxsl_ElectricUtilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ElectricUtilitiesMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Electric Utilities",
        "label": "Electric Utilities [Member]",
        "documentation": "Electric Utilities"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ElectricalEquipmentSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ElectricalEquipmentSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Electrical Equipment",
        "label": "Electrical Equipment Sector [Member]",
        "documentation": "Electrical Equipment Sector"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ElectronicEquipmentInstrumentsAndComponentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ElectronicEquipmentInstrumentsAndComponentsMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Electronic Equipment, Instruments &amp; Components",
        "label": "Electronic Equipment, Instruments and Components [Member]",
        "documentation": "Electronic Equipment, Instruments and Components"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ElectronicEquipmentInstrumentsComponentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ElectronicEquipmentInstrumentsComponentsMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Electronic Equipment, Instruments &amp; Components",
        "label": "Electronic Equipment, Instruments &amp; Components [Member]",
        "documentation": "Electronic Equipment, Instruments &amp; Components"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EnergySectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EnergySectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Energy Equipment &amp; Services",
        "label": "Energy Sector [Member]",
        "documentation": "Sector of economy consisting of companies engaged in business activity related to energy."
       }
      }
     },
     "auth_ref": [
      "r926",
      "r930",
      "r933",
      "r937"
     ]
    },
    "bxsl_EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Enter into credit default swaps or other derivative transactions which expose us to certain risks associated with the use of leverage. [Member]",
        "documentation": "Enter into credit default swaps or other derivative transactions which expose us to certain risks associated with the use of leverage."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r735"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r735"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "terseLabel": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r735"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r735"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r735"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r735"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r735"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityClassOfTreasuryStockLineItems",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails",
      "http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets",
      "http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r121",
      "r131",
      "r132",
      "r133",
      "r148",
      "r149",
      "r150",
      "r152",
      "r158",
      "r160",
      "r174",
      "r219",
      "r220",
      "r289",
      "r302",
      "r303",
      "r304",
      "r314",
      "r315",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r332",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r355",
      "r424",
      "r425",
      "r426",
      "r460",
      "r564"
     ]
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquitySecuritiesByIndustryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesByIndustryAxis",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Industry Sector [Axis]",
        "label": "Industry Sector [Axis]",
        "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r483",
      "r486",
      "r584",
      "r601",
      "r623",
      "r657",
      "r702",
      "r719"
     ]
    },
    "us-gaap_EquitySecuritiesIndustryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesIndustryMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Industry Sector [Domain]",
        "label": "Industry Sector [Domain]",
        "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r483",
      "r486",
      "r584",
      "r601",
      "r623",
      "r657",
      "r719"
     ]
    },
    "us-gaap_EquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in equity",
        "verboseLabel": "Equity",
        "label": "Equity Securities [Member]",
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r726",
      "r727",
      "r728",
      "r927"
     ]
    },
    "bxsl_EquitySecuritiesRealizedGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "EquitySecuritiesRealizedGainLossMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Securities, Realized Gain (Loss)",
        "label": "Equity Securities, Realized Gain (Loss) [Member]",
        "documentation": "Equity Securities, Realized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_EquitySecuritiesUnrealizedGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "EquitySecuritiesUnrealizedGainLossMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Securities, Unrealized Gain (Loss)",
        "label": "Equity Securities, Unrealized Gain (Loss) [Member]",
        "documentation": "Equity Securities, Unrealized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EuropeMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Europe",
        "label": "Europe [Member]"
       }
      }
     },
     "auth_ref": [
      "r926",
      "r930",
      "r933",
      "r937"
     ]
    },
    "bxsl_ExciseTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ExciseTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Excise taxes paid",
        "label": "Excise Taxes Paid",
        "documentation": "Excise Taxes Paid"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exclusive forum and jury trial waiver provisions that could limit a shareholder\u2019s ability to bring a claim, may cause the Company to incur additional costs associated with such action. [Member]",
        "documentation": "Exclusive forum and jury trial waiver provisions that could limit a shareholder\u2019s ability to bring a claim, may cause the Company to incur additional costs associated with such action."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "bxsl_ExpenseSupportAgreementExcessOperatingFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ExpenseSupportAgreementExcessOperatingFundsMember",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense Support Agreement, Excess Operating Funds",
        "label": "Expense Support Agreement, Excess Operating Funds [Member]",
        "documentation": "Expense Support Agreement, Excess Operating Funds"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ExpenseSupportAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ExpenseSupportAgreementMember",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense Support Agreement",
        "label": "Expense Support Agreement [Member]",
        "documentation": "Expense Support Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ExpenseSupportReimbursementRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ExpenseSupportReimbursementRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recoupment of expense support (Note 3)",
        "label": "Expense Support Reimbursement, Related Party",
        "documentation": "Expense Support Reimbursement, Related Party"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Face conflicts of interest caused by compensation arrangements with us and our affiliates, which could result in actions that are not in the best interests of our shareholders. [Member]",
        "documentation": "Face conflicts of interest caused by compensation arrangements with us and our affiliates, which could result in actions that are not in the best interests of our shareholders."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Failure to maintain our status as a BDC would reduce our operating flexibility. [Member]",
        "documentation": "Failure to maintain our status as a BDC would reduce our operating flexibility."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments, included in net unrealized appreciation (depreciation) on the Consolidated Statements of Operations",
        "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held."
       }
      }
     },
     "auth_ref": [
      "r342"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r104"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Domain]",
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r62"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Changes in Fair Value of Investments Measured Using Level 3 Inputs",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r62"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Axis]",
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r62"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r63",
      "r64"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r337",
      "r368",
      "r369",
      "r370",
      "r705",
      "r706",
      "r711",
      "r712",
      "r713"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r291",
      "r296",
      "r337",
      "r368",
      "r711",
      "r712",
      "r713"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r291",
      "r296",
      "r337",
      "r369",
      "r705",
      "r706",
      "r711",
      "r712",
      "r713"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r337",
      "r370",
      "r705",
      "r706",
      "r711",
      "r712",
      "r713"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accretion of discount/amortization of premium",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Accretion Of Discount/Amortization Of Premium",
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Accretion Of Discount/Amortization Of Premium"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net realized gain (loss)",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of investments",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Proceeds from principal repayments and sales of investments",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transfers into Level 3",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Transfers out of Level 3",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value, beginning of period",
        "periodEndLabel": "Fair value, end of period",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r368",
      "r369",
      "r370",
      "r705",
      "r706",
      "r711",
      "r712",
      "r713"
     ]
    },
    "us-gaap_FederalIncomeTaxNoteTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FederalIncomeTaxNoteTable",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal Income Tax Note [Table]",
        "label": "Federal Income Tax Note [Table]",
        "documentation": "Table of federal income tax note for schedule of investments. The federal income tax note may be qualified for security investments, non-security investments and/or for the combination of security and non-security investments."
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "us-gaap_FederalIncomeTaxNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FederalIncomeTaxNoteTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal Income Tax Note",
        "label": "Federal Income Tax Note [Table Text Block]",
        "documentation": "Tabular disclosure of the federal tax basis of investment holdings. This item captures the aggregate cost of securities, aggregate gross unrealized appreciation for all securities in which there is an excess of value over tax cost, aggregate gross unrealized depreciation for all securities in which there is an excess of tax cost over value, net unrealized appreciation (depreciation), and an explanation of the differences between tax and book."
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "us-gaap_FeeIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FeeIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_GrossInvestmentIncomeOperating",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fee income",
        "label": "Fee Income",
        "documentation": "Amount of fee income including, but not limited to, managerial assistance, servicing of investment, and origination and commitment fees."
       }
      }
     },
     "auth_ref": [
      "r915"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r269",
      "r286",
      "r330",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r417",
      "r703",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r857",
      "r858",
      "r859",
      "r860"
     ]
    },
    "bxsl_FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial regulatory changes in the United States could adversely affect our business [Member]",
        "documentation": "Financial regulatory changes in the United States could adversely affect our business"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialServicesSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialServicesSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diversified Financial Services",
        "label": "Financial Services Sector [Member]",
        "documentation": "Sector of the economy consisting of companies engaged in financial services."
       }
      }
     },
     "auth_ref": [
      "r719",
      "r926",
      "r930",
      "r933",
      "r937"
     ]
    },
    "bxsl_ForceMajeureEventsMayAdverselyAffectOurOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ForceMajeureEventsMayAdverselyAffectOurOperationsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Force Majeure events may adversely affect our operations. [Member]",
        "documentation": "Force Majeure events may adversely affect our operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealizedAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossRealizedAfterTax",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency transactions",
        "label": "Realized Gain (Loss), Foreign Currency Transaction, after Tax",
        "documentation": "Amount, after tax, of realized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r676",
      "r677",
      "r912",
      "r922"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies",
        "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r529",
      "r730",
      "r875",
      "r876",
      "r921"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossUnrealizedAfterTax",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Translation of assets and liabilities in foreign currencies",
        "label": "Unrealized Gain (Loss), Foreign Currency Transaction, after Tax",
        "documentation": "Amount, after tax, of unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r676",
      "r731",
      "r914",
      "r922"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Transactions",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "bxsl_GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General economic conditions could adversely affect the performance of our investments and operations [Member]",
        "documentation": "General economic conditions could adversely affect the performance of our investments and operations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossInvestmentIncomeOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossInvestmentIncomeOperating",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetInvestmentIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total investment income",
        "label": "Gross Investment Income, Operating",
        "documentation": "Amount, before investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r730",
      "r916"
     ]
    },
    "bxsl_GroundTransportationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "GroundTransportationMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ground Transportation",
        "label": "Ground Transportation [Member]",
        "documentation": "Ground Transportation"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_HealthCareEquipmentSuppliesSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "HealthCareEquipmentSuppliesSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Health Care Equipment &amp; Supplies",
        "label": "Health Care Equipment &amp; Supplies Sector [Member]",
        "documentation": "Health Care Equipment &amp; Supplies Sector"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_HealthCareProvidersServicesSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "HealthCareProvidersServicesSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Health Care Providers &amp; Services",
        "label": "Health Care Providers &amp; Services Sector [Member]",
        "documentation": "Health Care Providers &amp; Services Sector"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_HealthCareTechnologySectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "HealthCareTechnologySectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Health Care Technology",
        "label": "Health Care Technology Sector [Member]",
        "documentation": "Health Care Technology Sector"
       }
      }
     },
     "auth_ref": []
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "bxsl_HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Holders of any preferred shares that we may issue will have the right to elect certain members of our Board and have class voting rights on certain matters. [Member]",
        "documentation": "Holders of any preferred shares that we may issue will have the right to elect certain members of our Board and have class voting rights on certain matters."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IPOMember",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IPO",
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ITServicesSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ITServicesSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IT Services",
        "label": "IT Services Sector [Member]",
        "documentation": "IT Services Sector"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r737",
      "r738",
      "r739"
     ]
    },
    "bxsl_IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "If we issue preferred shares or convertible debt securities, the net asset value of our common shares may become more volatile. [Member]",
        "documentation": "If we issue preferred shares or convertible debt securities, the net asset value of our common shares may become more volatile."
       }
      }
     },
     "auth_ref": []
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "bxsl_IncentiveFeePayableCapitalGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncentiveFeePayableCapitalGains",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital gains incentive fees payable (Note 3)",
        "label": "Incentive Fee Payable, Capital Gains",
        "documentation": "Incentive Fee Payable, Capital Gains"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_IncentiveFeePayableIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncentiveFeePayableIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income based incentive fees payable (Note 3)",
        "verboseLabel": "Income based incentive fees payable",
        "label": "Incentive Fee Payable, Income",
        "documentation": "Incentive Fee Payable, Income"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "bxsl_IncomeBasedIncentiveFeeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncomeBasedIncentiveFeeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income based incentive fees (Note 3)",
        "verboseLabel": "Income based incentive fee expense",
        "label": "Income Based Incentive Fee Expense",
        "documentation": "Income Based Incentive Fee Expense"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre incentive fee cap percentage",
        "label": "Income Based Incentive Fees, Cap, Percentage Of Cumulative Net Return",
        "documentation": "Income Based Incentive Fees, Cap, Percentage Of Cumulative Net Return"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual catch up amount prior to the waiver period",
        "label": "Income Based Incentive Fees, Catch-Up Amount, Annualized Percentage",
        "documentation": "Income Based Incentive Fees, Catch-Up Amount, Annualized Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_IncomeBasedIncentiveFeesCatchUpAmountPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncomeBasedIncentiveFeesCatchUpAmountPercentage",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Catch-up amount prior to the waiver period",
        "label": "Income Based Incentive Fees, Catch-Up Amount, Percentage",
        "documentation": "Income Based Incentive Fees, Catch-Up Amount, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment of pre incentive rate investment income, percentage",
        "label": "Income Based Incentive Fees, Percentage Of Pre-Incentive Fee Net Investment Income",
        "documentation": "Income Based Incentive Fees, Percentage Of Pre-Incentive Fee Net Investment Income"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_IncomeBasedIncentiveFeesRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncomeBasedIncentiveFeesRate",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income based incentive rate",
        "label": "Income Based Incentive Fees, Rate",
        "documentation": "Income Based Incentive Fees, Rate"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_IncomeBasedIncentiveFeesScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncomeBasedIncentiveFeesScenarioAxis",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Based Incentive Fees, Scenario [Axis]",
        "label": "Income Based Incentive Fees, Scenario [Axis]",
        "documentation": "Income Based Incentive Fees, Scenario"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_IncomeBasedIncentiveFeesScenarioDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncomeBasedIncentiveFeesScenarioDomain",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Based Incentive Fees, Scenario [Domain]",
        "label": "Income Based Incentive Fees, Scenario [Domain]",
        "documentation": "Income Based Incentive Fees, Scenario [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incentive rate, threshold",
        "label": "Income Based Incentive Fees, Voluntary Waiver, Incentive Rate Threshold",
        "documentation": "Income Based Incentive Fees, Voluntary Waiver, Incentive Rate Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r305",
      "r308",
      "r309",
      "r312",
      "r316",
      "r317",
      "r318",
      "r319",
      "r450"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r306",
      "r307",
      "r309",
      "r310",
      "r311",
      "r313",
      "r436"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "bxsl_IncreaseDecreaseInCapitalGainsIncentiveFeePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncreaseDecreaseInCapitalGainsIncentiveFeePayable",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital gains incentive fee payable",
        "label": "Increase (Decrease) In Capital Gains Incentive Fee Payable",
        "documentation": "Increase (Decrease) In Capital Gains Incentive Fee Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInDueToAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDueToAffiliates",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due to affiliates",
        "label": "Increase (Decrease) in Due to Affiliates",
        "documentation": "The increase (decrease) in obligations owed to an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "bxsl_IncreaseDecreaseInIncomeBasedIncentiveFeePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IncreaseDecreaseInIncomeBasedIncentiveFeePayable",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income based incentive fee payable",
        "label": "Increase (Decrease) In Income Based Incentive Fee Payable",
        "documentation": "Increase (Decrease) In Income Based Incentive Fee Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInterestAndDividendsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest receivable",
        "label": "Increase (Decrease) in Interest and Dividends Receivable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount due to the entity in the form of unpaid interest and dividends."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInInterestPayableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInterestPayableNet",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest payable",
        "label": "Increase (Decrease) in Interest Payable, Net",
        "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInManagementFeePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInManagementFeePayable",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management fee payable",
        "label": "Increase (Decrease) in Management Fee Payable",
        "documentation": "Amount of increase (decrease) in fee payable for management of fund or trust."
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInPayableForInvestmentPurchased": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPayableForInvestmentPurchased",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payable for investments purchased",
        "label": "Increase (Decrease) in Payable for Investment Purchased",
        "documentation": "Amount of increase (decrease) in payable for purchase of investment."
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "us-gaap_IncreaseDecreaseInReceivableForInvestmentSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInReceivableForInvestmentSold",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Receivable for investments",
        "label": "Increase (Decrease) in Receivable for Investment Sold",
        "documentation": "Amount of increase (decrease) in receivable from sale of investment."
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "bxsl_IndustrialConglomeratesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "IndustrialConglomeratesMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Industrial Conglomerates",
        "label": "Industrial Conglomerates [Member]",
        "documentation": "Industrial Conglomerates"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inflation and supply chain risks have had and may continue to have an adverse impact on our financial condition and results of operations. [Member]",
        "documentation": "Inflation and supply chain risks have had and may continue to have an adverse impact on our financial condition and results of operations."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InitialPublicOfferingShareholderTransferRestrictionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InitialPublicOfferingShareholderTransferRestrictionsMember",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Public Offering, Shareholder Transfer Restrictions",
        "label": "Initial Public Offering, Shareholder Transfer Restrictions [Member]",
        "documentation": "Initial Public Offering, Shareholder Transfer Restrictions"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of shares restriction",
        "label": "Initial Public Offering, Shareholder Transfer Restrictions, Percentage Of Share Transfer Restriction",
        "documentation": "Initial Public Offering, Shareholder Transfer Restrictions, Percentage Of Share Transfer Restriction"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InsuranceSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InsuranceSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance",
        "label": "Insurance Sector [Member]",
        "documentation": "Sector of economy consisting of companies engaged in business activity related to insurance."
       }
      }
     },
     "auth_ref": [
      "r926",
      "r930",
      "r933",
      "r937"
     ]
    },
    "us-gaap_InterestAndDividendIncomeSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestAndDividendIncomeSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend and Interest Income",
        "label": "Interest and Dividend Income, Securities, Operating",
        "documentation": "Amount of operating dividend and interest income, including amortization and accretion of premiums and discounts, on securities."
       }
      }
     },
     "auth_ref": [
      "r916",
      "r939"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.bxsl.com/role/BorrowingsInterestExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsInterestExpenseDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "totalLabel": "Total Interest Expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r112",
      "r134",
      "r179",
      "r352",
      "r541",
      "r730",
      "r909"
     ]
    },
    "us-gaap_InterestExpenseBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseBorrowings",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/BorrowingsInterestExpenseDetails": {
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowing interest expense",
        "label": "Interest Expense, Borrowings",
        "documentation": "Aggregate amount of interest expense on all borrowings."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "us-gaap_InterestIncomeOperatingPaidInCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeOperatingPaidInCash",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_GrossInvestmentIncomeOperating",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Operating, Paid in Cash",
        "documentation": "Amount of interest income from investment paid in cash, classified as operating."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r648",
      "r651"
     ]
    },
    "us-gaap_InterestIncomeOperatingPaidInKind": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeOperatingPaidInKind",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_GrossInvestmentIncomeOperating",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment-in-kind interest income",
        "label": "Interest Income, Operating, Paid in Kind",
        "documentation": "Amount of interest income from investment paid in kind, classified as operating."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r648",
      "r651",
      "r653"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsInterestExpenseDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest paid during the period",
        "verboseLabel": "Cash paid for interest expense",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r138",
      "r139"
     ]
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest payable",
        "label": "Interest Payable",
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r889"
     ]
    },
    "bxsl_InterestPayableDebtInstrumentUnusedBorrowingCapacityFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InterestPayableDebtInstrumentUnusedBorrowingCapacityFee",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unused commitment fees",
        "label": "Interest Payable, Debt Instrument Unused Borrowing Capacity Fee",
        "documentation": "Interest Payable, Debt Instrument Unused Borrowing Capacity Fee"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InterestPayableInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InterestPayableInterestExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Payable, Interest Expense",
        "documentation": "Interest Payable, Interest Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]",
        "documentation": "The risk associated with changes in interest rates that effect the value of an interest-bearing asset or liability, and a servicing asset or liability."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InternetAndDirectMarketingRetailMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InternetAndDirectMarketingRetailMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Internet &amp; Direct Marketing Retail",
        "label": "Internet and Direct Marketing Retail [Member]",
        "documentation": "Internet and Direct Marketing Retail"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "bxsl_InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investing in large private U.S. borrowers may limit the Company\u2019s ability to achieve high growth rates during times of economic expansion. [Member]",
        "documentation": "Investing in large private U.S. borrowers may limit the Company\u2019s ability to achieve high growth rates during times of economic expansion."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestingInOurSharesInvolvesAHighDegreeOfRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestingInOurSharesInvolvesAHighDegreeOfRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investing in our shares involves a high degree of risk. [Member]",
        "documentation": "Investing in our shares involves a high degree of risk."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investing in private companies involves a number of significant risks, any one of which could have a material adverse effect on our operating results. [Member]",
        "documentation": "Investing in private companies involves a number of significant risks, any one of which could have a material adverse effect on our operating results."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentAdvisoryAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentAdvisoryAgreementMember",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Advisory Agreement",
        "label": "Investment Advisory Agreement [Member]",
        "documentation": "Investment Advisory Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentAffiliatedIssuerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentAffiliatedIssuerMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Affiliated Issuer",
        "label": "Investment, Affiliated Issuer [Member]",
        "documentation": "Affiliated issuer of investment."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r537",
      "r546",
      "r552",
      "r643",
      "r646",
      "r894"
     ]
    },
    "us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentAffiliatedIssuerNoncontrolledMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlled/affiliated investments",
        "label": "Investment, Affiliated Issuer, Noncontrolled [Member]",
        "documentation": "Noncontrolled affiliated issuer of investment."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r457",
      "r499",
      "r501",
      "r508",
      "r523",
      "r534",
      "r535",
      "r631",
      "r642",
      "r643",
      "r645",
      "r646",
      "r650",
      "r651",
      "r655",
      "r656",
      "r657"
     ]
    },
    "us-gaap_InvestmentBasisSpreadVariableRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentBasisSpreadVariableRate",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reference Rate and Spread",
        "label": "Investment, Basis Spread, Variable Rate",
        "documentation": "Percentage added to reference rate used to compute variable rate on investment."
       }
      }
     },
     "auth_ref": [
      "r579",
      "r600",
      "r604",
      "r639"
     ]
    },
    "us-gaap_InvestmentCompanyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r741",
      "r808",
      "r809",
      "r810"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "bxsl_InvestmentCompanyChangeInNetAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentCompanyChangeInNetAssetsTableTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Net Assets",
        "label": "Investment Company, Change In Net Assets [Table Text Block]",
        "documentation": "Investment Company, Change In Net Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentCompanyChangesInNetAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyChangesInNetAssetsLineItems",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Company, Changes in Net Assets [Line Items]",
        "label": "Investment Company, Change in Net Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r475",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671"
     ]
    },
    "us-gaap_InvestmentCompanyChangesInNetAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyChangesInNetAssetsTable",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Company, Changes in Net Assets [Table]",
        "label": "Investment Company, Change in Net Assets [Table]",
        "documentation": "Disclosure of information about change in net assets (equity) of investment company."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r475",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671"
     ]
    },
    "us-gaap_InvestmentCompanyCommittedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyCommittedCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital commitments",
        "label": "Investment Company, Committed Capital",
        "documentation": "Amount of funds committed to investment company from investors."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "bxsl_InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accumulated Gains (Losses) as Calculated on Tax Basis",
        "label": "Investment Company, Components Of Distributable Earnings (Accumulated Losses) [Table Text Block]",
        "documentation": "Investment Company, Components Of Distributable Earnings (Accumulated Losses)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentCompanyContractualFeeWaived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyContractualFeeWaived",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Management fees waived (Note 3)",
        "terseLabel": "Management fees waived",
        "label": "Investment Company, Contractual Fee Waived",
        "documentation": "Amount of fee contractually waived by investment company."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r535"
     ]
    },
    "us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails": {
       "parentTag": "us-gaap_RetainedEarningsAccumulatedDeficit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net change in unrealized appreciation/(depreciation) on investments",
        "label": "Investment Company, Distributable Earnings (Loss), Accumulated Appreciation (Depreciation)",
        "documentation": "Amount of accumulated undistributed earnings (deficit) from unrealized appreciation (depreciation) of investment company."
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails": {
       "parentTag": "us-gaap_RetainedEarningsAccumulatedDeficit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributable capital gains",
        "label": "Investment Company, Distributable Earnings (Loss), Accumulated Long-Term Capital Gain (Loss)",
        "documentation": "Amount of accumulated undistributed earnings (deficit) from long-term capital gain (loss) of investment company."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails": {
       "parentTag": "bxsl_RetainedEarningsAccumulatedDeficitAudited",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributable ordinary income",
        "label": "Investment Company, Distributable Earnings (Loss), Accumulated Ordinary Income (Loss)",
        "documentation": "Amount of accumulated undistributed earnings (deficit) from ordinary income (loss) of investment company."
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "bxsl_InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails": {
       "parentTag": "bxsl_RetainedEarningsAccumulatedDeficitAudited",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other temporary book/tax differences",
        "label": "Investment Company, Distributable Earnings (Loss), Accumulated Other Temporary Differences",
        "documentation": "Investment Company, Distributable Earnings (Loss), Accumulated Other Temporary Differences"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentCompanyDistributableEarningsLossBeforeDeductions",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Taxable/distributable income",
        "label": "Investment Company, Distributable Earnings (Loss), Before Deductions",
        "documentation": "Investment Company, Distributable Earnings (Loss), Before Deductions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentCompanyDistributionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyDistributionPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributions",
        "label": "Investment Company, Distribution [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for distribution to ownership interest holder. Includes, but is not limited to, dividend distribution and tax return of capital."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "us-gaap_InvestmentCompanyDistributionToShareholdersPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyDistributionToShareholdersPerShare",
     "calculation": {
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails": {
       "parentTag": "us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Distributions declared (in usd per share)",
        "label": "Investment Company, Distribution to Shareholders, Per Share",
        "documentation": "Per share or unit amount of distribution to shareholders. Includes, but is not limited to, dividend and capital gain. Excludes distribution for tax return of capital."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r471"
     ]
    },
    "us-gaap_InvestmentCompanyDividendDistribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyDividendDistribution",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends declared from net investment income",
        "label": "Investment Company, Dividend Distribution",
        "documentation": "Amount of dividend distribution from ordinary income and capital gain. Excludes distribution for tax return of capital."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r459",
      "r460",
      "r563"
     ]
    },
    "us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetInvestmentIncome",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net expenses before excise tax",
        "label": "Investment Company, Expense, after Reduction of Fee Waiver and Reimbursement",
        "documentation": "Amount, after reimbursement and fee waiver, of expense for generation of investment income classified as operating."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "bxsl_InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ratio of expenses to average net assets, before waivers",
        "label": "Investment Company, Expense Ratio Before Fee Waiver And Reimbursements",
        "documentation": "Investment Company, Expense Ratio Before Fee Waiver And Reimbursements"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ratio of expenses to average net assets, waivers",
        "label": "Investment Company, Expense Ratio, Fee Waiver And Reimbursements",
        "documentation": "Investment Company, Expense Ratio, Fee Waiver And Reimbursements"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ratio of net expenses to average net assets",
        "label": "Investment Company, Expense Ratio Including Fee Waiver And Reimbursements",
        "documentation": "Investment Company, Expense Ratio Including Fee Waiver And Reimbursements"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/CommitmentandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated future amount",
        "label": "Investment Company, Financial Commitment to Investee, Estimated Future Amount",
        "documentation": "Investment Company, Financial Commitment to Investee, Estimated Future Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/CommitmentandContingenciesDetails",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unfunded commitment",
        "verboseLabel": "Remaining undrawn",
        "label": "Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount",
        "documentation": "Amount of financial support committed by investment company to investee that is contractually required but not provided."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "bxsl_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Fair Value",
        "label": "Investment Company, Financial Commitment to Investee, Future Amount, Fair Value",
        "documentation": "Investment Company, Financial Commitment to Investee, Future Amount, Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentCompanyFinancialHighlightsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyFinancialHighlightsRollForward",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Company, Financial Highlights [Roll Forward]",
        "label": "Investment Company, Financial Highlights [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyFinancialHighlightsTableTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Highlights",
        "label": "Investment Company, Financial Highlights [Table Text Block]",
        "documentation": "Tabular disclosure of financial highlights. Includes, but is not limited to, per share information, income and expense ratios, total return, capital commitment and fee waiver."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "us-gaap_InvestmentCompanyFinancialHighlightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyFinancialHighlightsTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Highlights and Senior Securities",
        "label": "Investment Company, Financial Highlights [Text Block]",
        "documentation": "The entire disclosure of financial highlights reported by investment company."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r461",
      "r464",
      "r469"
     ]
    },
    "us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyGainLossOnInvestmentPerShare",
     "calculation": {
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails": {
       "parentTag": "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net unrealized and realized gain (loss) (in usd per share)",
        "label": "Investment Company, Gain (Loss) on Investment, Per Share",
        "documentation": "Per share or unit amount of realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r469"
     ]
    },
    "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare",
     "calculation": {
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails": {
       "parentTag": "us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in net assets resulting from operations (in usd per share)",
        "label": "Investment Company, Investment Income (Loss) from Operations, Per Share",
        "documentation": "Per share or unit amount of investment income (loss) and realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r470"
     ]
    },
    "us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyInvestmentIncomeLossPerShare",
     "calculation": {
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails": {
       "parentTag": "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations",
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment income (in usd per share)",
        "label": "Investment Company, Investment Income (Loss), Per Share",
        "documentation": "Per share or unit amount, after investment expense, of dividend and interest investment income (loss)."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_InvestmentCompanyInvestmentIncomeLossRatio": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyInvestmentIncomeLossRatio",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ratio of net investment income to average net assets",
        "label": "Investment Company, Investment Income (Loss) Ratio",
        "documentation": "Percentage of investment income (loss) to average net assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyInvestmentOwnedFairValueMeasurementInput",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement input",
        "label": "Investment Company, Investment Owned, Measurement Input",
        "documentation": "Value of input used to measure investment owned by investment company."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease",
     "calculation": {
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total increase (decrease) in net assets (in usd per share)",
        "label": "Investment Company, Net Asset Value Per Share, Period Increase (Decrease)",
        "documentation": "Per share or unit amount of increase (decrease) in net asset value."
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "us-gaap_InvestmentCompanyNetAssetsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyNetAssetsRollForward",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Company, Net Assets [Roll Forward]",
        "label": "Investment Company, Net Assets [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentCompanyPerShareDataAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentCompanyPerShareDataAbstract",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Company, Per Share Data [Abstract]",
        "label": "Investment Company, Per Share Data [Abstract]",
        "documentation": "Investment Company, Per Share Data"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentCompanyPortfolioTurnover": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyPortfolioTurnover",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portfolio turnover rate",
        "label": "Investment Company, Portfolio Turnover",
        "documentation": "Percentage of lesser of purchase or sale of portfolio securities to average value of portfolio securities owned."
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "bxsl_InvestmentCompanyRatioToAverageNetAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentCompanyRatioToAverageNetAssetsAbstract",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ratios:",
        "label": "Investment Company, Ratio To Average Net Assets [Abstract]",
        "documentation": "Investment Company, Ratio To Average Net Assets"
       }
      }
     },
     "auth_ref": []
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "us-gaap_InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset coverage ratio",
        "label": "Investment Company, Senior Security, Indebtedness, Asset Coverage Ratio",
        "documentation": "Percentage of total assets less all liabilities and indebtedness not represented by senior security, to senior security representing indebtedness."
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "bxsl_InvestmentCompanySupplementalDataAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentCompanySupplementalDataAbstract",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Data:",
        "label": "Investment Company, Supplemental Data [Abstract]",
        "documentation": "Investment Company, Supplemental Data"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentCompanyTaxReclassificationIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyTaxReclassificationIncreaseDecrease",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification",
        "label": "Investment Company, Tax Reclassification, Increase (Decrease)",
        "documentation": "Amount of increase (decrease) from reclassification to paid-in capital of permanent difference for distribution to ownership interest holder by investment company."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyTaxReturnOfCapitalDistributionPerShare",
     "calculation": {
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails": {
       "parentTag": "us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net increase (decrease) in net assets from capital share transactions (in usd per share)",
        "label": "Investment Company, Tax Return of Capital Distribution, Per Share",
        "documentation": "Per share or unit amount of capital distribution in excess of tax basis earnings."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r471"
     ]
    },
    "us-gaap_InvestmentCompanyTotalReturn": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyTotalReturn",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total return based on NAV",
        "label": "Investment Company, Total Return",
        "documentation": "Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r462",
      "r466"
     ]
    },
    "us-gaap_InvestmentCompanyTotalReturnMarketValue": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyTotalReturnMarketValue",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total return based on market value",
        "label": "Investment Company, Total Return, Market Value",
        "documentation": "Percentage increase (decrease) in portfolio market value assuming reinvestment of dividend and capital gain distribution."
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_InvestmentCompanyVoluntaryFeeWaived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentCompanyVoluntaryFeeWaived",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Incentive fees waived (Note 3)",
        "terseLabel": "Incentive fees waived",
        "label": "Investment Company, Voluntary Fee Waived",
        "documentation": "Amount of fee voluntarily waived by investment company."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r535"
     ]
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments",
        "label": "Investment Holdings, Schedule of Investments [Table Text Block]",
        "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments."
       }
      }
     },
     "auth_ref": [
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905"
     ]
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/Investments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Schedule of Investments [Text Block]",
        "documentation": "The entire disclosure for investments owned by investment company."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r575",
      "r592",
      "r610",
      "r620",
      "r656"
     ]
    },
    "us-gaap_InvestmentIdentifierAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIdentifierAxis",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Identifier [Axis]",
        "label": "Investment, Identifier [Axis]",
        "documentation": "Identification of investment in security, including, but not limited to, name, title, and other identifying information."
       }
      }
     },
     "auth_ref": [
      "r477",
      "r478",
      "r479",
      "r484",
      "r485",
      "r486",
      "r490",
      "r491",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r592",
      "r593",
      "r594",
      "r596",
      "r598",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r620",
      "r621",
      "r622",
      "r625",
      "r626",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r643",
      "r644",
      "r646",
      "r647",
      "r648",
      "r649",
      "r651",
      "r652",
      "r653",
      "r654",
      "r656",
      "r658",
      "r659",
      "r660",
      "r719"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesRevenueRecognitionIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r178"
     ]
    },
    "us-gaap_InvestmentIncomeInvestmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeInvestmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total expenses before excise tax",
        "label": "Investment Income, Investment Expense",
        "documentation": "Amount of expenses related to the generation of investment income."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r730",
      "r891"
     ]
    },
    "us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeOperatingAfterExpenseAndTax",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net investment income after excise tax",
        "terseLabel": "Net investment income",
        "label": "Investment Income, Operating, after Expense and Tax",
        "documentation": "Amount, after expense and tax, of investment income classified as operating. Excludes realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r544",
      "r559",
      "r731"
     ]
    },
    "us-gaap_InvestmentIncomeOperatingTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeOperatingTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations",
      "http://www.bxsl.com/role/IncomeTaxesNarrativeDetails",
      "http://www.bxsl.com/role/SignificantAccountingPoliciesRevenueRecognitionIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Excise tax expense",
        "label": "Investment Income, Operating, Tax Expense (Benefit)",
        "documentation": "Amount of tax expense (benefit) on investment income classified as operating. Excludes realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r527",
      "r531",
      "r543"
     ]
    },
    "us-gaap_InvestmentInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentInterestRate",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate",
        "label": "Investment Interest Rate",
        "documentation": "Rate of interest on investment."
       }
      }
     },
     "auth_ref": [
      "r578",
      "r579",
      "r599",
      "r600",
      "r604",
      "r605",
      "r638",
      "r639",
      "r719",
      "r855",
      "r856"
     ]
    },
    "us-gaap_InvestmentInterestRateFloor": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentInterestRateFloor",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate, floor",
        "label": "Investment, Interest Rate, Floor",
        "documentation": "Minimum rate of interest on investment."
       }
      }
     },
     "auth_ref": [
      "r928",
      "r931",
      "r934",
      "r938"
     ]
    },
    "us-gaap_InvestmentInterestRatePaidInKind": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentInterestRatePaidInKind",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paid in Kind",
        "label": "Investment, Interest Rate, Paid in Kind",
        "documentation": "Rate of interest paid in kind on investment."
       }
      }
     },
     "auth_ref": [
      "r579",
      "r600",
      "r604",
      "r639"
     ]
    },
    "us-gaap_InvestmentIssuerAffiliationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIssuerAffiliationAxis",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Issuer Affiliation [Axis]",
        "label": "Investment, Issuer Affiliation [Axis]",
        "documentation": "Information by affiliation of issuer of investment."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r457",
      "r482",
      "r492",
      "r507",
      "r508",
      "r534",
      "r535",
      "r536",
      "r537",
      "r545",
      "r546",
      "r551",
      "r552",
      "r584",
      "r585",
      "r591",
      "r619",
      "r623",
      "r624",
      "r642",
      "r643",
      "r645",
      "r646",
      "r650",
      "r651",
      "r655",
      "r656",
      "r657"
     ]
    },
    "us-gaap_InvestmentIssuerAffiliationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIssuerAffiliationDomain",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Issuer Affiliation [Domain]",
        "label": "Investment, Issuer Affiliation [Domain]",
        "documentation": "Affiliation of issuer of investment."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r457",
      "r482",
      "r492",
      "r507",
      "r508",
      "r534",
      "r535",
      "r536",
      "r537",
      "r545",
      "r546",
      "r551",
      "r552",
      "r584",
      "r585",
      "r591",
      "r619",
      "r623",
      "r624",
      "r642",
      "r643",
      "r645",
      "r646",
      "r650",
      "r651",
      "r655",
      "r656",
      "r657"
     ]
    },
    "us-gaap_InvestmentIssuerNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIssuerNameAxis",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Issuer Name [Axis]",
        "label": "Investment, Issuer Name [Axis]",
        "documentation": "Information by name of issuer of investment."
       }
      }
     },
     "auth_ref": [
      "r929",
      "r932",
      "r935",
      "r941"
     ]
    },
    "us-gaap_InvestmentIssuerNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIssuerNameDomain",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Issuer Name [Domain]",
        "label": "Investment, Issuer Name [Domain]",
        "documentation": "Name of issuer of investment."
       }
      }
     },
     "auth_ref": [
      "r929",
      "r932",
      "r935",
      "r941"
     ]
    },
    "bxsl_InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Management Agreement - Incentive Rate, Annualized Hurdle Rate Member",
        "label": "Investment Management Agreement - Incentive Rate, Annualized Hurdle Rate Member [Member]",
        "documentation": "Investment Management Agreement - Incentive Rate, Annualized Hurdle Rate Member"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Management Agreement - Incentive Rate, Quarterly Hurdle Rate Member",
        "label": "Investment Management Agreement - Incentive Rate, Quarterly Hurdle Rate Member [Member]",
        "documentation": "Investment Management Agreement - Incentive Rate, Quarterly Hurdle Rate Member"
       }
      }
     },
     "auth_ref": []
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "us-gaap_InvestmentOwnedAtCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentOwnedAtCost",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical",
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investments at cost",
        "terseLabel": "Cost",
        "label": "Investment Owned, Cost",
        "documentation": "Cost of the investment."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r484",
      "r485",
      "r588",
      "r598",
      "r616",
      "r656",
      "r719",
      "r732",
      "r903"
     ]
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentOwnedAtFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails",
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments at fair value",
        "verboseLabel": "Fair Value",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Investment Owned, Fair Value",
        "documentation": "Fair value of investment in security owned."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r477",
      "r478",
      "r479",
      "r481",
      "r483",
      "r484",
      "r485",
      "r487",
      "r492",
      "r495",
      "r507",
      "r508",
      "r575",
      "r584",
      "r585",
      "r594",
      "r608",
      "r609",
      "r623",
      "r624",
      "r625",
      "r633",
      "r636",
      "r655",
      "r657",
      "r660",
      "r719",
      "r732",
      "r903"
     ]
    },
    "bxsl_InvestmentOwnedAtFairValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentOwnedAtFairValueMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Owned, At Fair Value",
        "label": "Investment Owned, At Fair Value [Member]",
        "documentation": "Investment Owned, At Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentOwnedBalancePrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentOwnedBalancePrincipalAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Par Amounts/Units",
        "label": "Investment Owned, Balance, Principal Amount",
        "documentation": "Amount of principal of investment owned."
       }
      }
     },
     "auth_ref": [
      "r477",
      "r487",
      "r582",
      "r613",
      "r641",
      "r719"
     ]
    },
    "us-gaap_InvestmentOwnedBalanceShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentOwnedBalanceShares",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment owned (in shares)",
        "label": "Investment Owned, Balance, Shares",
        "documentation": "Number of shares of investment owned."
       }
      }
     },
     "auth_ref": [
      "r477",
      "r487",
      "r582",
      "r613",
      "r641",
      "r719"
     ]
    },
    "bxsl_InvestmentOwnedNonaccrualNumberOfLoans": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentOwnedNonaccrualNumberOfLoans",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of loans in non-accrual status",
        "label": "Investment Owned, Nonaccrual, Number Of Loans",
        "documentation": "Investment Owned, Nonaccrual, Number Of Loans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentOwnedPercentOfNetAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentOwnedPercentOfNetAssets",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "% of Net Assets",
        "terseLabel": "Fair Value as % of Net Assets",
        "label": "Investment Owned, Net Assets, Percentage",
        "documentation": "Percentage of investment owned to net assets."
       }
      }
     },
     "auth_ref": [
      "r480",
      "r484",
      "r485",
      "r584",
      "r608",
      "r623",
      "r626",
      "r657",
      "r719",
      "r903"
     ]
    },
    "bxsl_InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentOwnedRecognizedUnrealizedAppreciationDepreciationNetAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net change in unrealized appreciation (depreciation):",
        "label": "Investment Owned, Recognized Unrealized Appreciation (Depreciation), Net [Abstract]",
        "documentation": "Investment Owned, Recognized Unrealized Appreciation (Depreciation), Net"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentPercentageOfPortfolioAboveFloorRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentPercentageOfPortfolioAboveFloorRate",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of portfolio above floor rate",
        "label": "Investment, Percentage Of Portfolio Above Floor Rate",
        "documentation": "Investment, Percentage Of Portfolio Above Floor Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments/Receivables/Payables From Investments Sold/Purchased",
        "label": "Investment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r422",
      "r432",
      "r433",
      "r434",
      "r435",
      "r595",
      "r597"
     ]
    },
    "bxsl_InvestmentPortfolioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentPortfolioMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Portfolio",
        "label": "Investment Portfolio [Member]",
        "documentation": "Investment Portfolio"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails": {
       "parentTag": "bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net post-October capital loss deferral (reversal)",
        "label": "Investment, Tax Basis Reconciliation, Capital Loss Carryover, Increase (Decrease) In Taxable Income",
        "documentation": "Investment, Tax Basis Reconciliation, Capital Loss Carryover, Increase (Decrease) In Taxable Income"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails": {
       "parentTag": "bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net change in unrealized (appreciation) depreciation",
        "label": "Investment, Tax Basis Reconciliation, Net Unrealized Depreciation (Appreciation) On Investments, Increase (Decrease) In Taxable Income",
        "documentation": "Investment, Tax Basis Reconciliation, Net Unrealized Depreciation (Appreciation) On Investments, Increase (Decrease) In Taxable Income"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails": {
       "parentTag": "bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-deductible capital gains incentive fees",
        "label": "Investment, Tax Basis Reconciliation, Non-Deductible Tax Expense, Capital Gains Incentive Fee, Increase (Decrease) In Taxable Income",
        "documentation": "Investment, Tax Basis Reconciliation, Non-Deductible Tax Expense, Capital Gains Incentive Fee, Increase (Decrease) In Taxable Income"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-deductible offering costs",
        "label": "Investment, Tax Basis Reconciliation, Non-Deductible Tax Expense, Offering Costs, Increase (Decrease) In Taxable Income",
        "documentation": "Investment, Tax Basis Reconciliation, Non-Deductible Tax Expense, Offering Costs, Increase (Decrease) In Taxable Income"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails": {
       "parentTag": "bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-deductible expenses and excise taxes",
        "label": "Investment, Tax Basis Reconciliation, Other Non-Deductible Tax Expense, Increase (Decrease) In Taxable Income",
        "documentation": "Investment, Tax Basis Reconciliation, Other Non-Deductible Tax Expense, Increase (Decrease) In Taxable Income"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails": {
       "parentTag": "bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Realized gains (losses) for tax not included in book income",
        "label": "Investment, Tax Basis Reconciliation, Other Realized Gains (Losses) Differences, Increase (Decrease) In Taxable Income",
        "documentation": "Investment, Tax Basis Reconciliation, Other Realized Gains (Losses) Differences, Increase (Decrease) In Taxable Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Type [Axis]",
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r480",
      "r481",
      "r484",
      "r487",
      "r575",
      "r584",
      "r601",
      "r609",
      "r623",
      "r627",
      "r628",
      "r657",
      "r661",
      "r662",
      "r663",
      "r664",
      "r719"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments [Domain]",
        "label": "Investments [Domain]",
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r480",
      "r481",
      "r484",
      "r487",
      "r575",
      "r584",
      "r601",
      "r609",
      "r623",
      "r627",
      "r628",
      "r657",
      "r661",
      "r662",
      "r663",
      "r664",
      "r719"
     ]
    },
    "bxsl_InvestmentTypeConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentTypeConcentrationRiskMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails",
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Type Concentration Risk",
        "label": "Investment Type Concentration Risk [Member]",
        "documentation": "Investment Type Concentration Risk"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentUnaffiliatedIssuerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentUnaffiliatedIssuerMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlled/non-affiliated investments",
        "label": "Investment, Unaffiliated Issuer [Member]",
        "documentation": "Unaffiliated issuer of investment."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r492",
      "r523",
      "r534",
      "r535",
      "r536",
      "r545",
      "r551",
      "r575",
      "r580",
      "r584",
      "r585",
      "r591",
      "r611",
      "r619",
      "r623",
      "r624"
     ]
    },
    "bxsl_InvestmentsAtFairValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentsAtFairValueMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments At Fair Value",
        "label": "Investments At Fair Value [Member]",
        "documentation": "Investments At Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Investments, Fair Value Disclosure",
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method."
       }
      }
     },
     "auth_ref": [
      "r336"
     ]
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Additions",
        "label": "Investments in and Advances to Affiliates, at Fair Value, Gross Additions",
        "documentation": "Gross additions to the investment in and advance to the affiliate."
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gross Reductions",
        "label": "Investments in and Advances to Affiliates, at Fair Value, Gross Reductions",
        "documentation": "Gross reductions to the investment in and advance to the affiliate."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Unrealized Gains (Losses)",
        "label": "Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in the investments in and advances to affiliates."
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in and Advances to Affiliates, at Fair Value [Roll Forward]",
        "label": "Investments in and Advances to Affiliates, at Fair Value [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Investments",
        "label": "Investments [Member]",
        "documentation": "Assets held for their financial return, rather than for the entity's operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsOwnedFederalIncomeTaxNoteLineItems",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, Owned, Federal Income Tax Note [Line Items]",
        "label": "Investments, Owned, Federal Income Tax Note [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "bxsl_InvestmentsRealizedGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentsRealizedGainLossMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, Realized Gain (Loss)",
        "label": "Investments, Realized Gain (Loss) [Member]",
        "documentation": "Investments, Realized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_InvestmentsUnrealizedGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "InvestmentsUnrealizedGainLossMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, Unrealized Gain (Loss)",
        "label": "Investments, Unrealized Gain (Loss) [Member]",
        "documentation": "Investments, Unrealized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "It may be difficult to bring suit or foreclosure in non-U.S. countries [Member]",
        "documentation": "It may be difficult to bring suit or foreclosure in non-U.S. countries"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_JacksonHoleFundingFacilityDollarAdvancesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "JacksonHoleFundingFacilityDollarAdvancesMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Jackson Hole Funding Facility, Dollar Advances",
        "label": "Jackson Hole Funding Facility, Dollar Advances [Member]",
        "documentation": "Jackson Hole Funding Facility, Dollar Advances"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_JacksonHoleFundingFacilityForeignCurrencyAdvancesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "JacksonHoleFundingFacilityForeignCurrencyAdvancesMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Jackson Hole Funding Facility, Foreign Currency Advances",
        "label": "Jackson Hole Funding Facility, Foreign Currency Advances [Member]",
        "documentation": "Jackson Hole Funding Facility, Foreign Currency Advances"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_JacksonHoleFundingFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "JacksonHoleFundingFacilityMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Jackson Hole Funding Facility",
        "label": "Jackson Hole Funding Facility [Member]",
        "documentation": "Jackson Hole Funding Facility"
       }
      }
     },
     "auth_ref": []
    },
    "cef_LatestNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "cef_LatestSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestSharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "bxsl_LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legislative or regulatory tax changes could adversely affect investors. [Member]",
        "documentation": "Legislative or regulatory tax changes could adversely affect investors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of Credit",
        "label": "Letter of Credit [Member]",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r144",
      "r218",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r321",
      "r322",
      "r323",
      "r343",
      "r502",
      "r699",
      "r732",
      "r864",
      "r881",
      "r882"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and net assets",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r108",
      "r415",
      "r715",
      "r848",
      "r861",
      "r874"
     ]
    },
    "bxsl_LineOfCreditFacilityAccordionFeatureIncreaseLimit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "LineOfCreditFacilityAccordionFeatureIncreaseLimit",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowing capacity including the accordion feature",
        "label": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "documentation": "Line of Credit Facility, Accordion Feature, Increase Limit"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Combined revolving debt amount multiplier",
        "label": "Line Of Credit Facility, Combined Revolving Debt Amount, Multiplier",
        "documentation": "Line Of Credit Facility, Combined Revolving Debt Amount, Multiplier"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, maximum borrowing capacity",
        "verboseLabel": "Aggregate Principal Committed",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "bxsl_LineOfCreditFacilityMinimumCapacityUtilizationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "LineOfCreditFacilityMinimumCapacityUtilizationPercentage",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum utilization percentage",
        "label": "Line of Credit Facility, Minimum Capacity Utilization, Percentage",
        "documentation": "Line of Credit Facility, Minimum Capacity Utilization, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount Available",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unused capacity, commitment fee percentage",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_LineOfCreditFacilityUnusedCapacityPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "LineOfCreditFacilityUnusedCapacityPercentage",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unused capacity percentage",
        "label": "Line of Credit Facility, Unused Capacity, Percentage",
        "documentation": "Line of Credit Facility, Unused Capacity, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.bxsl.com/role/Cover",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt (net of unamortized debt issuance costs of $25,953 and $35,289 at December\u00a031, 2023 and December\u00a031, 2022, respectively)",
        "verboseLabel": "Carrying Value",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r107",
      "r257",
      "r272",
      "r705",
      "r706",
      "r890"
     ]
    },
    "us-gaap_LongTermDebtAverageAmountOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtAverageAmountOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average principal debt outstanding",
        "label": "Long-Term Debt, Average Amount Outstanding",
        "documentation": "Average amount outstanding of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r120",
      "r541"
     ]
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "us-gaap_LongTermDebtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of debt",
        "label": "Long-Term Debt, Fair Value",
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r755"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r756"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r755"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r755"
     ]
    },
    "us-gaap_LongTermDebtWeightedAverageInterestRateOverTime": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtWeightedAverageInterestRateOverTime",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average interest rate",
        "label": "Long-Term Debt, Weighted Average Interest Rate, over Time",
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated over time."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r42"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "bxsl_MachineryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "MachineryMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery",
        "label": "Machinery [Member]",
        "documentation": "Machinery"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ManagementAndServiceFeesBaseRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ManagementAndServiceFeesBaseRate",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base management fee",
        "label": "Management and Service Fees, Base Rate",
        "documentation": "Base rate for management and service fees under arrangement to manage operations, including, but not limited to, investment."
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "us-gaap_ManagementAndServiceFeesIncentiveRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ManagementAndServiceFeesIncentiveRate",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incentive fees rate",
        "label": "Management and Service Fees, Incentive Rate",
        "documentation": "Rate based on performance for management and service fees under arrangement to manage operations, including, but not limited to, investment."
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "bxsl_ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incentive rate, catch up, percentage",
        "label": "Management And Service Fees, Income Based Incentive Rate, Catch up, Percentage",
        "documentation": "Management And Service Fees, Income Based Incentive Rate, Catch up, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ManagementAndServiceFeesRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ManagementAndServiceFeesRate",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management fee rate",
        "label": "Management and Service Fees, Rate",
        "documentation": "Rate for management and service fees under arrangement to manage operations, including, but not limited to, investment."
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "us-gaap_ManagementFeeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ManagementFeeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management fees (Note 3)",
        "verboseLabel": "Management fees",
        "label": "Management Fee Expense",
        "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r535",
      "r730",
      "r908"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r778"
     ]
    },
    "us-gaap_ManagementFeePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ManagementFeePayable",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management fees payable (Note 3)",
        "verboseLabel": "Management fees payable",
        "label": "Management Fee Payable",
        "documentation": "Amount of fee payable for management of fund or trust."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "bxsl_MarineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "MarineMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marine",
        "label": "Marine [Member]",
        "documentation": "Marine"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketApproachValuationTechniqueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketApproachValuationTechniqueMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Approach",
        "label": "Valuation, Market Approach [Member]",
        "documentation": "Valuation approach using price and other relevant information generated by market transaction involving identical or comparable asset, liability, or group of assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "High",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r234",
      "r298",
      "r395",
      "r423",
      "r488",
      "r489",
      "r578",
      "r599",
      "r605",
      "r606",
      "r638",
      "r691",
      "r692",
      "r701",
      "r709",
      "r714",
      "r716",
      "r866",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888"
     ]
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputDiscountRateMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount Rate",
        "label": "Measurement Input, Discount Rate [Member]",
        "documentation": "Measurement input using interest rate to determine present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "bxsl_MeasurementInputMarketMultipleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "MeasurementInputMarketMultipleMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Multiple",
        "label": "Measurement Input, Market Multiple [Member]",
        "documentation": "Measurement Input, Market Multiple"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_MeasurementInputPerformanceMultipleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "MeasurementInputPerformanceMultipleMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Multiple",
        "label": "Measurement Input, Performance Multiple [Member]",
        "documentation": "Measurement Input, Performance Multiple"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected Volatility",
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "us-gaap_MeasurementInputQuotedPriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputQuotedPriceMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Broker quoted price",
        "label": "Measurement Input, Quoted Price [Member]",
        "documentation": "Measurement input using quoted price."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r338"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_MediaSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "MediaSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Media",
        "label": "Media Sector [Member]",
        "documentation": "Media Sector"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Low",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r234",
      "r298",
      "r395",
      "r423",
      "r488",
      "r489",
      "r578",
      "r599",
      "r605",
      "r606",
      "r638",
      "r691",
      "r692",
      "r701",
      "r709",
      "r714",
      "r716",
      "r866",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888"
     ]
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share",
        "terseLabel": "NET ASSET VALUE PER SHARE (in usd per share)",
        "periodStartLabel": "Net asset value, beginning of period (in usd per share)",
        "periodEndLabel": "Net asset value, ending of period (in usd per share)",
        "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r467",
      "r474",
      "r476",
      "r506",
      "r524",
      "r667",
      "r732"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93",
      "r94"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails": {
       "parentTag": "bxsl_InvestmentCompanyDistributableEarningsLossBeforeDeductions",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations",
      "http://www.bxsl.com/role/EarningsPerShareDetails",
      "http://www.bxsl.com/role/IncomeTaxesScheduleofChangesinNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in net assets resulting from operations",
        "terseLabel": "Net increase (decrease) in net assets resulting from operations",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r94",
      "r109",
      "r122",
      "r128",
      "r129",
      "r133",
      "r144",
      "r151",
      "r153",
      "r154",
      "r155",
      "r156",
      "r159",
      "r160",
      "r166",
      "r177",
      "r180",
      "r182",
      "r184",
      "r218",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r334",
      "r343",
      "r416",
      "r530",
      "r558",
      "r562",
      "r700",
      "r730",
      "r864"
     ]
    },
    "us-gaap_NetInvestmentIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetInvestmentIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentIncomeOperatingAfterExpenseAndTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net investment income before excise tax",
        "label": "Net Investment Income",
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r419",
      "r420",
      "r542",
      "r730"
     ]
    },
    "bxsl_NetRealizedGainsLossesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "NetRealizedGainsLossesAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net realized gain (loss):",
        "label": "Net Realized Gains (Losses) [Abstract]",
        "documentation": "Net Realized Gains (Losses)"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_New2026NotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "New2026NotesMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New 2026 Notes",
        "label": "New 2026 Notes [Member]",
        "documentation": "New 2026 Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r741",
      "r808",
      "r809",
      "r810"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "bxsl_NoShareholderApprovalIsRequiredForCertainMergersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "NoShareholderApprovalIsRequiredForCertainMergersMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No shareholder approval is required for certain mergers. [Member]",
        "documentation": "No shareholder approval is required for certain mergers."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "bxsl_NonQualifyingAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "NonQualifyingAssetsMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-qualifying Assets",
        "label": "Non-Qualifying Assets [Member]",
        "documentation": "Non-Qualifying Assets"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_NumberOfEquityDistributionAgreements": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "NumberOfEquityDistributionAgreements",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of agreements",
        "label": "Number Of Equity Distribution Agreements",
        "documentation": "Number Of Equity Distribution Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Obligations could have an adverse effect on the ability of Blackstone Credit and its MiFID-authorized EEA affiliates to obtain and research in connection with the provision of an investment service. [Member]",
        "documentation": "Obligations could have an adverse effect on the ability of Blackstone Credit and its MiFID-authorized EEA affiliates to obtain and research in connection with the provision of an investment service."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OilGasAndConsumableFuelsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OilGasAndConsumableFuelsMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Oil, Gas &amp; Consumable Fuels",
        "label": "Oil, Gas and Consumable Fuels [Member]",
        "documentation": "Oil, Gas and Consumable Fuels"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OilGasConsumableFuelsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OilGasConsumableFuelsMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Oil, Gas &amp; Consumable Fuels",
        "label": "Oil, Gas &amp; Consumable Fuels [Member]",
        "documentation": "Oil, Gas &amp; Consumable Fuels"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "operations. Our investments in the healthcare providers and services industry face considerable uncertainties. [Member]",
        "documentation": "operations. Our investments in the healthcare providers and services industry face considerable uncertainties."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/Organization"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r103",
      "r430",
      "r431"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "us-gaap_OtherCommitmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsAxis",
     "presentation": [
      "http://www.bxsl.com/role/CommitmentandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Axis]",
        "label": "Other Commitments [Axis]",
        "documentation": "Information by type of other commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsDomain",
     "presentation": [
      "http://www.bxsl.com/role/CommitmentandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Domain]",
        "label": "Other Commitments [Domain]",
        "documentation": "Other future obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.bxsl.com/role/CommitmentandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Line Items]",
        "label": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://www.bxsl.com/role/CommitmentandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Table]",
        "label": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other general and administrative",
        "label": "Other General and Administrative Expense",
        "documentation": "Amount of general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r918"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due to affiliates",
        "label": "Other Liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r410",
      "r498",
      "r499",
      "r732",
      "r906"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "bxsl_OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our ability to enter into transactions with our affiliates is restricted. [Member]",
        "documentation": "Our ability to enter into transactions with our affiliates is restricted."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our Board may amend our Declaration of Trust without prior shareholder approval. [Member]",
        "documentation": "Our Board may amend our Declaration of Trust without prior shareholder approval."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our Board may change our operating policies and strategies without prior notice or shareholder approval, the effects of which may be adverse to our results of operations and financial condition. [Member]",
        "documentation": "Our Board may change our operating policies and strategies without prior notice or shareholder approval, the effects of which may be adverse to our results of operations and financial condition."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our credit ratings may not reflect all risks of an investment in our debt securities. [Member]",
        "documentation": "Our credit ratings may not reflect all risks of an investment in our debt securities."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our investments in CLOs may be riskier than a direct investment in the debt or other securities of the underlying companies. [Member]",
        "documentation": "Our investments in CLOs may be riskier than a direct investment in the debt or other securities of the underlying companies."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our investments in prospective portfolio companies may be risky, and we could lose all or part of our investment. [Member]",
        "documentation": "Our investments in prospective portfolio companies may be risky, and we could lose all or part of our investment."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our investments in securities or assets of publicly-traded companies are subject to the risks inherent in investing in public securities. [Member]",
        "documentation": "Our investments in securities or assets of publicly-traded companies are subject to the risks inherent in investing in public securities."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our investments may include original issue discount and payment-in-kind instruments. [Member]",
        "documentation": "Our investments may include original issue discount and payment-in-kind instruments."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OurPortfolioCompaniesMayBeHighlyLeveragedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurPortfolioCompaniesMayBeHighlyLeveragedMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our portfolio companies may be highly leveraged. [Member]",
        "documentation": "Our portfolio companies may be highly leveraged."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies. [Member]",
        "documentation": "Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our portfolio investments may present special tax issues. [Member]",
        "documentation": "Our portfolio investments may present special tax issues."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our portfolio may be concentrated in a limited number of industries, which may subject us to a risk of significant loss if there is a downturn in a particular industry. [Member]",
        "documentation": "Our portfolio may be concentrated in a limited number of industries, which may subject us to a risk of significant loss if there is a downturn in a particular industry."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Our shares may be purchased by the Adviser or its affiliates. [Member]",
        "documentation": "Our shares may be purchased by the Adviser or its affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r761"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r763"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r765"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over-Allotment Option",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_PaidInKindInterestNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "PaidInKindInterestNoncash",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment-in-kind interest capitalized",
        "label": "Paid In Kind Interest, Noncash",
        "documentation": "Paid In Kind Interest, Noncash"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_PaperAndForestProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "PaperAndForestProductsMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paper &amp; Forest Products",
        "label": "Paper and Forest Products [Member]",
        "documentation": "Paper and Forest Products"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_PaperForestProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "PaperForestProductsMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paper &amp; Forest Products",
        "label": "Paper &amp; Forest Products [Member]",
        "documentation": "Paper &amp; Forest Products"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay to the Adviser will be determined without independent assessment on our behalf, and these terms may be less advantageous to us than if such terms had been the subject of arm\u2019s-length negotiations. [Member]",
        "documentation": "Pay to the Adviser will be determined without independent assessment on our behalf, and these terms may be less advantageous to us than if such terms had been the subject of arm\u2019s-length negotiations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PayableInvestmentPurchase": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayableInvestmentPurchase",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payable for investments purchased",
        "label": "Payable, Investment, Purchase",
        "documentation": "Amount of payable for purchase of investment."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r665",
      "r732"
     ]
    },
    "us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForPurchaseOfInvestmentOperatingActivity",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of investments",
        "label": "Payment for Purchase, Investment, Operating Activity",
        "documentation": "Amount of cash outflow for acquisition of investment, classified as operating activity. Includes, but is not limited to, funding, origination, drawdown, and participation in investment."
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Redemptions paid in cash",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Debt issuance costs paid",
        "label": "Payments of Debt Issuance Costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "bxsl_PaymentsOfDebtIssuanceCostsLineOfCreditArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "PaymentsOfDebtIssuanceCostsLineOfCreditArrangements",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred financing costs paid",
        "label": "Payments Of Debt Issuance Costs, Line Of Credit Arrangements",
        "documentation": "Payments Of Debt Issuance Costs, Line Of Credit Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividends",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends paid in cash",
        "label": "Payments of Dividends",
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred offering costs paid on issuance of common shares",
        "terseLabel": "Offering expenses",
        "verboseLabel": "Placement Fees/Offering Expenses",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "bxsl_PharmaceuticalsSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "PharmaceuticalsSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pharmaceuticals Sector",
        "label": "Pharmaceuticals Sector [Member]",
        "documentation": "Pharmaceuticals Sector"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Greater Than Catch-Up Amount",
        "label": "Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Greater Than Catch-Up Amount [Member]",
        "documentation": "Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Greater Than Catch-Up Amount"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Less Than Or Equal To Catch-Up Amount",
        "label": "Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Less Than Or Equal To Catch-Up Amount [Member]",
        "documentation": "Pre-Incentive Fee Net Investment Income For Trailing Twelve Quarters Less Than Or Equal To Catch-Up Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference",
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r80",
      "r846",
      "r868"
     ]
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r751"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "bxsl_PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity. [Member]",
        "documentation": "Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Price declines in the medium- and large-sized U.S. corporate debt market may adversely affect the fair value of our portfolio, reducing our NAV through increased net unrealized depreciation. [Member]",
        "documentation": "Price declines in the medium- and large-sized U.S. corporate debt market may adversely affect the fair value of our portfolio, reducing our NAV through increased net unrealized depreciation."
       }
      }
     },
     "auth_ref": []
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "us-gaap_ProceedsFromDispositionOfInvestmentOperatingActivity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromDispositionOfInvestmentOperatingActivity",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of investments and principal repayments",
        "label": "Proceeds from Disposition of Investment, Operating Activity",
        "documentation": "Amount of cash inflow from sale of investment, classified as operating activity. Includes, but is not limited to, repayment, principal payment, paydown, and maturity of investment."
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common shares, net of offering and underwriting costs",
        "verboseLabel": "Net Proceeds",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings on debt",
        "label": "Proceeds from Issuance of Debt",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees",
        "label": "Professional Fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r730",
      "r910",
      "r918"
     ]
    },
    "bxsl_ProfessionalServicesSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ProfessionalServicesSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional Services",
        "label": "Professional Services Sector [Member]",
        "documentation": "Professional Services Sector"
       }
      }
     },
     "auth_ref": []
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "bxsl_ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provisions in a credit facility may limit our investment discretion. [Member]",
        "documentation": "Provisions in a credit facility may limit our investment discretion."
       }
      }
     },
     "auth_ref": []
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "bxsl_QualifyingAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "QualifyingAssetsMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Qualifying Assets",
        "label": "Qualifying Assets [Member]",
        "documentation": "Qualifying Assets"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r234",
      "r290",
      "r298",
      "r299",
      "r300",
      "r301",
      "r371",
      "r395",
      "r423",
      "r488",
      "r489",
      "r578",
      "r599",
      "r605",
      "r606",
      "r638",
      "r691",
      "r692",
      "r701",
      "r709",
      "r714",
      "r716",
      "r719",
      "r862",
      "r866",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r234",
      "r290",
      "r298",
      "r299",
      "r300",
      "r301",
      "r371",
      "r395",
      "r423",
      "r488",
      "r489",
      "r578",
      "r599",
      "r605",
      "r606",
      "r638",
      "r691",
      "r692",
      "r701",
      "r709",
      "r714",
      "r716",
      "r719",
      "r862",
      "r866",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888"
     ]
    },
    "bxsl_RealEstateManagementDevelopmentSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "RealEstateManagementDevelopmentSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Management &amp; Development",
        "label": "Real Estate Management &amp; Development Sector [Member]",
        "documentation": "Real Estate Management &amp; Development Sector"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net realized and change in unrealized gain (loss)",
        "label": "Gain (Loss), Investment and Derivative, Operating, and Foreign Currency Transaction, after Tax",
        "documentation": "Amount, after tax, of realized and unrealized gain (loss) on investment and derivative, classified as operating, and foreign currency transaction. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity."
       }
      }
     },
     "auth_ref": [
      "r557",
      "r895",
      "r922",
      "r942"
     ]
    },
    "us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTaxAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Realized and unrealized gain (loss):",
        "label": "Gain (Loss), Investment and Derivative, Operating, and Foreign Currency Transaction, after Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net realized gain (loss)",
        "terseLabel": "Net realized gain (loss) on investments",
        "label": "Realized Gain (Loss), Investment, Derivative, and Foreign Currency Transaction Price Change, Operating, after Tax",
        "documentation": "Amount, after tax, of realized gain (loss) on investment, derivative, and foreign currency transaction on investment and derivative from change in market price, classified as operating. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r560",
      "r674",
      "r911"
     ]
    },
    "us-gaap_RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Realized Gain (Loss)",
        "label": "Realized Gain (Loss), Investment, Derivative, and Foreign Currency Transaction Price Change, Operating, before Tax",
        "documentation": "Amount, before tax, of realized gain (loss) on investment, derivative, and foreign currency transaction on investment and derivative from change in market price, classified as operating. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r673",
      "r920"
     ]
    },
    "us-gaap_ReceivableInvestmentSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivableInvestmentSale",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable for investments sold",
        "label": "Receivable, Investment, Sale",
        "documentation": "Amount of receivable from sale of investment."
       }
      }
     },
     "auth_ref": [
      "r512",
      "r573",
      "r732"
     ]
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Tax reclassification of shareholders' equity in accordance with GAAP",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r27"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "bxsl_RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Regulations governing our operation as a BDC and RIC will affect our ability to raise additional capital or borrow for investment purposes, which may have a negative effect on our growth. [Member]",
        "documentation": "Regulations governing our operation as a BDC and RIC will affect our ability to raise additional capital or borrow for investment purposes, which may have a negative effect on our growth."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Domain]",
        "label": "Related Party, Type [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r359",
      "r360",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r523",
      "r525",
      "r574"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r360",
      "r880"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_RelatedPartyTransactionExpensePaymentPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "RelatedPartyTransactionExpensePaymentPeriod",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense payment period",
        "label": "Related Party Transaction, Expense Payment Period",
        "documentation": "Related Party Transaction, Expense Payment Period"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Quarterly hurdle rate",
        "label": "Related Party Transaction, Income Based Incentive Fee, Quarterly Hurdle Rate",
        "documentation": "Related Party Transaction, Income Based Incentive Fee, Quarterly Hurdle Rate"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_RelatedPartyTransactionInitialTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "RelatedPartyTransactionInitialTerm",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party transaction, initial term",
        "label": "Related Party Transaction, Initial Term",
        "documentation": "Related Party Transaction, Initial Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r536",
      "r537",
      "r540"
     ]
    },
    "bxsl_RelatedPartyTransactionRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "RelatedPartyTransactionRenewalTerm",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party transaction, renewal term",
        "label": "Related Party Transaction, Renewal Term",
        "documentation": "Related Party Transaction, Renewal Term"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_RelatedPartyTransactionTerminationNoticePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "RelatedPartyTransactionTerminationNoticePeriod",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination notice period",
        "label": "Related Party Transaction, Termination Notice Period",
        "documentation": "Related Party Transaction, Termination Notice Period"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_RelatedPartyTransactionVoluntaryWaiverPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "RelatedPartyTransactionVoluntaryWaiverPeriod",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Waiver period",
        "label": "Related Party Transaction, Voluntary Waiver Period",
        "documentation": "Related Party Transaction, Voluntary Waiver Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Axis]",
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r359",
      "r360",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r523",
      "r525",
      "r574",
      "r880"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agreements and Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r358",
      "r360",
      "r361",
      "r452",
      "r453",
      "r454",
      "r538",
      "r539",
      "r540",
      "r569",
      "r571"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments on debt",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributable earnings (loss)",
        "totalLabel": "Total accumulated under-distributed (over-distributed) earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r102",
      "r414",
      "r427",
      "r428",
      "r446",
      "r505",
      "r715"
     ]
    },
    "bxsl_RetainedEarningsAccumulatedDeficitAudited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "RetainedEarningsAccumulatedDeficitAudited",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofAccumulatedGainsLossesasCalculatedonTaxBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total accumulated under-distributed (over-distributed) earnings",
        "label": "Retained Earnings (Accumulated Deficit), Audited",
        "documentation": "Retained Earnings (Accumulated Deficit), Audited"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets",
      "http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributable Earnings (Loss)",
        "verboseLabel": "Accumulated net realized gain (loss)",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r148",
      "r149",
      "r150",
      "r152",
      "r158",
      "r160",
      "r219",
      "r220",
      "r302",
      "r303",
      "r304",
      "r314",
      "r315",
      "r324",
      "r326",
      "r327",
      "r329",
      "r332",
      "r424",
      "r426",
      "r460",
      "r923"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r693",
      "r697"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment income:",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r753"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "bxsl_RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Of Distributions Exceeding Taxable Earnings And Profits, Causing Return Of Capital [Member]",
        "documentation": "Risk Of Distributions Exceeding Taxable Earnings And Profits, Causing Return Of Capital"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_RoadAndRailMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "RoadAndRailMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Road &amp; Rail",
        "label": "Road and Rail [Member]",
        "documentation": "Road and Rail"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from offering",
        "verboseLabel": "Gross Proceeds",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails",
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_SaleOfStockNumberOfSharesIssuedInTransactionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransactionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate sales price",
        "label": "Sale of Stock, Number of Shares Issued in Transaction, Value",
        "documentation": "Sale of Stock, Number of Shares Issued in Transaction, Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails",
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering price per share (in usd per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_SaleOfStockRemainingAuthorizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "SaleOfStockRemainingAuthorizedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining available for issuance",
        "label": "Sale of Stock, Remaining Authorized Amount",
        "documentation": "Sale of Stock, Remaining Authorized Amount"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "bxsl_SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales of substantial amounts of our common shares in the public market may have an adverse effect on the market price of our common shares. [Member]",
        "documentation": "Sales of substantial amounts of our common shares in the public market may have an adverse effect on the market price of our common shares."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Scenario1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Scenario1Member",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario 1",
        "label": "Scenario 1 [Member]",
        "documentation": "Scenario 1"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Scenario2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Scenario2Member",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario 2",
        "label": "Scenario 2 [Member]",
        "documentation": "Scenario 2"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Scenario3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Scenario3Member",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario 3",
        "label": "Scenario 3 [Member]",
        "documentation": "Scenario 3"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_Scenario4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "Scenario4Member",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario 4",
        "label": "Scenario 4 [Member]",
        "documentation": "Scenario 4"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-Term Debt Instruments",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r47",
      "r50",
      "r67",
      "r68",
      "r70",
      "r76",
      "r100",
      "r101",
      "r705",
      "r707",
      "r849"
     ]
    },
    "bxsl_ScheduleOfDividendReinvestmentPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ScheduleOfDividendReinvestmentPlanTableTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Amounts Received and Shares Issued to Shareholders",
        "label": "Schedule Of Dividend Reinvestment Plan [Table Text Block]",
        "documentation": "Schedule Of Dividend Reinvestment Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Earnings Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "us-gaap_ScheduleOfInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentsLineItems",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails",
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments [Line Items]",
        "label": "Schedule of Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r596",
      "r598",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660"
     ]
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentsTable",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestmentsParenthetical",
      "http://www.bxsl.com/role/InvestmentsAdditionalInformationDetails",
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments [Table]",
        "label": "Schedule of Investments [Table]",
        "documentation": "Disclosure of information about investments owned by investment company."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r596",
      "r598",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r629",
      "r630",
      "r631",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsAdministrationAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsExpensePaymentsandReimbursementPaymentsDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72",
      "r536",
      "r537",
      "r540"
     ]
    },
    "us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Shares Issued and Proceeds Received",
        "label": "Schedule of Sale of Stock by Subsidiary or Equity Method Investee Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ScheduleOfSharesRepurchasedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ScheduleOfSharesRepurchasedTableTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Shares Repurchased",
        "label": "Schedule Of Shares Repurchased [Table Text Block]",
        "documentation": "Schedule Of Shares Repurchased"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Schedule of Stock by Class [Table]",
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r100",
      "r101",
      "r102",
      "r125",
      "r126",
      "r127",
      "r175",
      "r274",
      "r275",
      "r276",
      "r278",
      "r281",
      "r286",
      "r288",
      "r441",
      "r442",
      "r443",
      "r444",
      "r709",
      "r827",
      "r846"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r43",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r80",
      "r81",
      "r100",
      "r101",
      "r102"
     ]
    },
    "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails",
      "http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Subsidiary or Equity Method Investee [Table]",
        "label": "Schedule of Subsidiary or Equity Method Investee [Table]",
        "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second priority liens on collateral securing debt investments that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. [Member]",
        "documentation": "Second priority liens on collateral securing debt investments that we make to our portfolio companies may be subject to control by senior creditors with first priority liens."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredDebtMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term loan",
        "label": "Secured Debt [Member]",
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOFR",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg."
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r734"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r186",
      "r479",
      "r483",
      "r485",
      "r584",
      "r601",
      "r623",
      "r657",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r694",
      "r710",
      "r719",
      "r869",
      "r892"
     ]
    },
    "cef_SeniorSecuritiesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r786"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r786"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r787"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r787"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r792"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r783",
      "r790"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r784",
      "r790"
     ]
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r782",
      "r790"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r785"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r801"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareRepurchaseProgramAxis",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails",
      "http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Axis]",
        "label": "Share Repurchase Program [Axis]",
        "documentation": "Information by share repurchase program."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareRepurchaseProgramDomain",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails",
      "http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Domain]",
        "label": "Share Repurchase Program [Domain]",
        "documentation": "Name of the share repurchase program."
       }
      }
     },
     "auth_ref": []
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "bxsl_ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders may experience dilution in the net asset value of their shares if they do not participate in our dividend reinvestment plan and if our shares are trading at a discount to net asset value. [Member]",
        "documentation": "Shareholders may experience dilution in the net asset value of their shares if they do not participate in our dividend reinvestment plan and if our shares are trading at a discount to net asset value."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders will experience dilution in their ownership percentage if they do not participate in our dividend reinvestment plan. [Member]",
        "documentation": "Shareholders will experience dilution in their ownership percentage if they do not participate in our dividend reinvestment plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r141"
     ]
    },
    "bxsl_SoftwareSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "SoftwareSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software",
        "label": "Software Sector [Member]",
        "documentation": "Software Sector"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Some of our investments may be subject to corporate-level income tax. [Member]",
        "documentation": "Some of our investments may be subject to corporate-level income tax."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_SpecialtyRetailMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "SpecialtyRetailMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Specialty Retail",
        "label": "Specialty Retail [Member]",
        "documentation": "Specialty Retail"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r125",
      "r126",
      "r127",
      "r144",
      "r164",
      "r165",
      "r167",
      "r169",
      "r175",
      "r176",
      "r218",
      "r235",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r274",
      "r275",
      "r278",
      "r281",
      "r288",
      "r343",
      "r441",
      "r442",
      "r443",
      "r444",
      "r460",
      "r463",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r476",
      "r504",
      "r532",
      "r564",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r827",
      "r846",
      "r853"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets",
      "http://www.bxsl.com/role/IncomeTaxesScheduleofPermanentDifferencesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r26",
      "r121",
      "r131",
      "r132",
      "r133",
      "r148",
      "r149",
      "r150",
      "r152",
      "r158",
      "r160",
      "r174",
      "r219",
      "r220",
      "r289",
      "r302",
      "r303",
      "r304",
      "r314",
      "r315",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r332",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r355",
      "r424",
      "r425",
      "r426",
      "r460",
      "r564"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r186",
      "r479",
      "r483",
      "r485",
      "r584",
      "r601",
      "r623",
      "r657",
      "r678",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r694",
      "r710",
      "r719",
      "r869",
      "r892"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical",
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r174",
      "r396",
      "r432",
      "r476",
      "r492",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r504",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r514",
      "r515",
      "r516",
      "r517",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r534",
      "r535",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r564",
      "r721"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilitiesParenthetical",
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r174",
      "r396",
      "r432",
      "r476",
      "r492",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r504",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r514",
      "r515",
      "r516",
      "r517",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r534",
      "r535",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r564",
      "r721"
     ]
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reinvestment of distributions during the period",
        "label": "Stock Issued",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r35"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesDividendReinvestmentPlan",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsScheduledofAmountsReceivedandSharesIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DRIP Shares Issued (in share)",
        "label": "Stock Issued During Period, Shares, Dividend Reinvestment Plan",
        "documentation": "Number of shares issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the shareholders to reinvest dividends paid to them by the entity on new issues of stock by the entity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r564",
      "r669"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of common shares issued (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r80",
      "r81",
      "r102",
      "r441",
      "r564",
      "r668"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueDividendReinvestmentPlan",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets",
      "http://www.bxsl.com/role/NetAssetsScheduledofAmountsReceivedandSharesIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Reinvestment of dividends",
        "netLabel": "DRIP Shares Value",
        "label": "Stock Issued During Period, Value, Dividend Reinvestment Plan",
        "documentation": "Value of stock issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the holder of the stock to reinvest dividends paid to them by the entity on new issues of stock by the entity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r460",
      "r564",
      "r669",
      "r720",
      "r731"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common shares, net of offering and underwriting costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r80",
      "r81",
      "r102",
      "r460",
      "r564",
      "r668",
      "r731"
     ]
    },
    "bxsl_StockIssuedDuringPeriodValueNewIssuesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "StockIssuedDuringPeriodValueNewIssuesGross",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Proceeds",
        "label": "Stock Issued During Period, Value, New Issues, Gross",
        "documentation": "Stock Issued During Period, Value, New Issues, Gross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program authorized amount",
        "label": "Stock Repurchase Program, Authorized Amount",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase plan (in years)",
        "label": "Stock Repurchase Program, Period in Force",
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "documentation": "Amount remaining of a stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_StockRepurchasedDuringPeriodAverageCostPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "StockRepurchasedDuringPeriodAverageCostPerShare",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average Price Paid per Share (in usd per share)",
        "label": "Stock Repurchased During Period, Average Cost Per Share",
        "documentation": "Stock Repurchased During Period, Average Cost Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareRepurchasePlanDetails",
      "http://www.bxsl.com/role/NetAssetsShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares repurchased (in shares)",
        "verboseLabel": "Total Number of Shares Repurchased (in shares)",
        "label": "Stock Repurchased During Period, Shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r80",
      "r81",
      "r102",
      "r444",
      "r564",
      "r670"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Common shares repurchased",
        "label": "Stock Repurchased During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r80",
      "r81",
      "r102",
      "r460",
      "r564",
      "r670",
      "r731"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities",
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets",
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total net assets",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "terseLabel": "Total net assets",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r84",
      "r85",
      "r96",
      "r506",
      "r524",
      "r565",
      "r566",
      "r715",
      "r732",
      "r848",
      "r861",
      "r874",
      "r923"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NET ASSETS",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/NetAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Assets",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r143",
      "r273",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r287",
      "r289",
      "r331",
      "r567",
      "r570",
      "r672"
     ]
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityPolicyTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization Expenses and Offering Expenses",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r568"
     ]
    },
    "bxsl_SubAdministrationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "SubAdministrationAgreementMember",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsSubAdministrationandExpenseSupportDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sub-Administration Agreement",
        "label": "Sub-Administration Agreement [Member]",
        "documentation": "Sub-Administration Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_SubscriptionFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "SubscriptionFacilityMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription Facility [Member]",
        "documentation": "Subscription Facility"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.bxsl.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r363"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.bxsl.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r363"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.bxsl.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r363"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.bxsl.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r363"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.bxsl.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r363"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.bxsl.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r364"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiaryOrEquityMethodInvesteeLineItems",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails",
      "http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary or Equity Method Investee [Line Items]",
        "label": "Subsidiary or Equity Method Investee [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.bxsl.com/role/FinancialHighlightsandSeniorSecuritiesDetails",
      "http://www.bxsl.com/role/NetAssetsScheduleofSharesIssuedandProceedsReceivedDetails",
      "http://www.bxsl.com/role/NetAssetsSubscriptionsandDrawdownsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental information and non-cash activities:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxBasisOfInvestmentsCostForIncomeTaxPurposes",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax cost of investments",
        "label": "Investment, Tax Basis, Cost",
        "documentation": "Amount of cost of investment for federal income tax purpose."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxBasisOfInvestmentsGrossUnrealizedAppreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails": {
       "parentTag": "us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross unrealized appreciation",
        "label": "Investment, Tax Basis, Unrealized Gain",
        "documentation": "Amount of cumulative increase in investment from unrealized gain when value exceeds cost for federal income tax purpose."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxBasisOfInvestmentsGrossUnrealizedDepreciation",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails": {
       "parentTag": "us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gross unrealized depreciation",
        "label": "Investment, Tax Basis, Unrealized Loss",
        "documentation": "Amount of cumulative decrease in investment from unrealized loss when cost for federal income tax purpose exceeds value."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/IncomeTaxesScheduleofTaxBasisofInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in unrealized appreciation (depreciation)",
        "label": "Investment, Tax Basis, Unrealized Gain (Loss)",
        "documentation": "Amount of cumulative increase (decrease) in investment from unrealized gain (loss) when value exceeds (is less than) cost for federal income tax purpose."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "bxsl_TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Technological innovations and industry disruptions may negatively impact us. [Member]",
        "documentation": "Technological innovations and industry disruptions may negatively impact us."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TechnologyHardwareStorageAndPeripheralsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TechnologyHardwareStorageAndPeripheralsMember",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Technology Hardware, Storage &amp; Peripherals",
        "label": "Technology Hardware, Storage and Peripherals [Member]",
        "documentation": "Technology Hardware, Storage and Peripherals"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Terms relating to redemption may materially adversely affect our noteholders return on any debt securities that we may issue. [Member]",
        "documentation": "Terms relating to redemption may materially adversely affect our noteholders return on any debt securities that we may issue."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Terrorist attacks, acts of war or natural disasters may adversely affect our operations. [Member]",
        "documentation": "Terrorist attacks, acts of war or natural disasters may adversely affect our operations."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Adviser relies on key personnel, the loss of any of whom could impair its ability to successfully manage us. [Member]",
        "documentation": "The Adviser relies on key personnel, the loss of any of whom could impair its ability to successfully manage us."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Adviser\u2019s influence on conducting our operations gives it the ability to increase its fees, which may reduce the amount of cash flow available for distribution to our shareholders. [Member]",
        "documentation": "The Adviser\u2019s influence on conducting our operations gives it the ability to increase its fees, which may reduce the amount of cash flow available for distribution to our shareholders."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The amount of any distributions we may make is uncertain. Our distributions may exceed our earnings. [Member]",
        "documentation": "The amount of any distributions we may make is uncertain. Our distributions may exceed our earnings."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TheImpactOfFinancialReformLegislationOnUsIsUncertainMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TheImpactOfFinancialReformLegislationOnUsIsUncertainMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The impact of financial reform legislation on us is uncertain. [Member]",
        "documentation": "The impact of financial reform legislation on us is uncertain."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The inability of the Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business. [Member]",
        "documentation": "The inability of the Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The incentive fee based on income takes into account our past performance. [Member]",
        "documentation": "The incentive fee based on income takes into account our past performance."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TheNAVOfOurSharesMayFluctuateSignificantlyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TheNAVOfOurSharesMayFluctuateSignificantlyMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The NAV of our shares may fluctuate significantly. [Member]",
        "documentation": "The NAV of our shares may fluctuate significantly."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The requirement that we invest a sufficient portion of our assets in Qualifying Assets could preclude us from investing in accordance with our current business strategy [Member]",
        "documentation": "The requirement that we invest a sufficient portion of our assets in Qualifying Assets could preclude us from investing in accordance with our current business strategy"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The trading market or market value of our issued debt securities may fluctuate. [Member]",
        "documentation": "The trading market or market value of our issued debt securities may fluctuate."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "There is a risk that investors in our shares may not receive distributions or that our distributions may decrease over time. [Member]",
        "documentation": "There is a risk that investors in our shares may not receive distributions or that our distributions may decrease over time."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims. [Member]",
        "documentation": "There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "There may be conflicts of interest related to obligations that the Adviser\u2019s senior management and Investment Team have to other clients. [Member]",
        "documentation": "There may be conflicts of interest related to obligations that the Adviser\u2019s senior management and Investment Team have to other clients."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "There may be trademark risk, as we do not own the Blackstone name. [Member]",
        "documentation": "There may be trademark risk, as we do not own the Blackstone name."
       }
      }
     },
     "auth_ref": []
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "bxsl_TradingCompaniesDistributorsSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TradingCompaniesDistributorsSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Companies &amp; Distributors",
        "label": "Trading Companies &amp; Distributors Sector [Member]",
        "documentation": "Trading Companies &amp; Distributors Sector"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.bxsl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions denominated in foreign currencies subject us to foreign currency risks. [Member]",
        "documentation": "Transactions denominated in foreign currencies subject us to foreign currency risks."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TransferRestrictionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TransferRestrictionsAxis",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transfer Restrictions [Axis]",
        "label": "Transfer Restrictions [Axis]",
        "documentation": "Transfer Restrictions, Scenario"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_TransferRestrictionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TransferRestrictionsDomain",
     "presentation": [
      "http://www.bxsl.com/role/NetAssetsShareholderTransferRestrictionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transfer Restrictions [Domain]",
        "label": "Transfer Restrictions [Domain]",
        "documentation": "Transfer Restrictions [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r269",
      "r286",
      "r330",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r417",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r857",
      "r858",
      "r859",
      "r860"
     ]
    },
    "bxsl_TransportationInfrastructureSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "TransportationInfrastructureSectorMember",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/InvestmentsInvestmentsatFairValuePercentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transportation Infrastructure",
        "label": "Transportation Infrastructure Sector [Member]",
        "documentation": "Transportation Infrastructure Sector"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TrusteeFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TrusteeFees",
     "crdr": "debit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Board of Trustees' fees",
        "label": "Trustee Fees",
        "documentation": "Fees charged annually for the professional services of a trustee, usually quoted as a percentage of the funds being managed. The fee for appointing an offshore Trustee is included in the trust price."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://www.bxsl.com/role/InvestmentsGeographicInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnamortizedDebtIssuanceExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unamortized Debt Issuance Costs",
        "label": "Unamortized Debt Issuance Expense",
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uncertainty as to the value of our portfolio investments. [Member]",
        "documentation": "Uncertainty as to the value of our portfolio investments."
       }
      }
     },
     "auth_ref": []
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "us-gaap_UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax",
     "crdr": "credit",
     "calculation": {
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofChangesinNetAssets",
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in unrealized appreciation (depreciation)",
        "terseLabel": "Net change in unrealized appreciation (depreciation) on investments",
        "label": "Unrealized Gain (Loss), Investment, Derivative, and Foreign Currency Transaction Price Change, Operating, after Tax",
        "documentation": "Amount, after tax, of unrealized gain (loss) on investment, derivative, and foreign currency transaction on investment and derivative from change in market price, classified as operating. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r561",
      "r675",
      "r913"
     ]
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsOutstandingDebtObligationsDetails",
      "http://www.bxsl.com/role/BorrowingsUnsecuredDebtDetails",
      "http://www.bxsl.com/role/ConsolidatedScheduleofInvestments",
      "http://www.bxsl.com/role/FairValueMeasurementsFairValueHierarchyofFinancialInstrumentsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsScheduleofFairValueMeasurementsofUnsecuredNotesDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails",
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails",
      "http://www.bxsl.com/role/InvestmentsInvestmentPortfolioatCostandFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured debt",
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_UnsecuredDebtRealizedGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "UnsecuredDebtRealizedGainLossMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured Debt, Realized Gain (Loss)",
        "label": "Unsecured Debt, Realized Gain (Loss) [Member]",
        "documentation": "Unsecured Debt, Realized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_UnsecuredDebtUnrealizedGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "UnsecuredDebtUnrealizedGainLossMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsSummaryofChangesinFairValueofInvestmentsMeasuredUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured Debt, Unrealized Gain (Loss)",
        "label": "Unsecured Debt, Unrealized Gain (Loss) [Member]",
        "documentation": "Unsecured Debt, Unrealized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.bxsl.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r115",
      "r116",
      "r117",
      "r118"
     ]
    },
    "bxsl_ValuationAssetRecoverabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ValuationAssetRecoverabilityMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Recoverability",
        "label": "Valuation, Asset Recoverability [Member]",
        "documentation": "Valuation, Asset Recoverability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Axis]",
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Domain]",
        "label": "Valuation Approach and Technique [Domain]",
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ValuationTechniqueOptionPricingModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueOptionPricingModelMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option Pricing Model",
        "label": "Valuation Technique, Option Pricing Model [Member]",
        "documentation": "Valuation technique calculating price of option."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "bxsl_ValuationYieldAnalysisApproachMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "ValuationYieldAnalysisApproachMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Yield Analysis",
        "label": "Valuation, Yield Analysis Approach [Member]",
        "documentation": "Valuation, Yield Analysis Approach"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBigSkyFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsJacksonHoleFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_VariableRateScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "VariableRateScenarioAxis",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate Scenario [Axis]",
        "label": "Variable Rate Scenario [Axis]",
        "documentation": "Variable Rate Scenario"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_VariableRateScenarioDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "VariableRateScenarioDomain",
     "presentation": [
      "http://www.bxsl.com/role/BorrowingsBreckenridgeFundingFacilityDetails",
      "http://www.bxsl.com/role/BorrowingsRevolvingCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate Scenario [Domain]",
        "label": "Variable Rate Scenario [Domain]",
        "documentation": "Variable Rate Scenario [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us. [Member]",
        "documentation": "Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_VoluntaryWaiverInPlaceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "VoluntaryWaiverInPlaceMember",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Voluntary Waiver In Place",
        "label": "Voluntary Waiver In Place [Member]",
        "documentation": "Voluntary Waiver In Place"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_VoluntaryWaiverNotInPlaceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "VoluntaryWaiverNotInPlaceMember",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Voluntary Waiver Not In Place",
        "label": "Voluntary Waiver Not In Place [Member]",
        "documentation": "Voluntary Waiver Not In Place"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_VoluntaryWaiverScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "VoluntaryWaiverScenarioAxis",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Voluntary Waiver Scenario [Axis]",
        "label": "Voluntary Waiver Scenario [Axis]",
        "documentation": "Voluntary Waiver Scenario"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_VoluntaryWaiverScenarioDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "VoluntaryWaiverScenarioDomain",
     "presentation": [
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsBaseManagementFeeDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsIncentiveFeesDetails",
      "http://www.bxsl.com/role/AgreementsandRelatedPartyTransactionsInvestmentAdvisoryAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Voluntary Waiver Scenario [Domain]",
        "label": "Voluntary Waiver Scenario [Domain]",
        "documentation": "Voluntary Waiver Scenario [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "bxsl_WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We and our investment adviser could be the target of litigation or regulatory investigations. [Member]",
        "documentation": "We and our investment adviser could be the target of litigation or regulatory investigations."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We are a non-diversified investment company and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer. [Member]",
        "documentation": "We are a non-diversified investment company and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We are exposed to risks associated with changes in interest rates. [Member]",
        "documentation": "We are exposed to risks associated with changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We are subject to regulatory oversight, which could negatively impact our operations, cash flow or financial condition, impose additional costs on us or otherwise adversely affect our business [Member]",
        "documentation": "We are subject to regulatory oversight, which could negatively impact our operations, cash flow or financial condition, impose additional costs on us or otherwise adversely affect our business"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We are subject to risks associated with investing alongside other third parties. [Member]",
        "documentation": "We are subject to risks associated with investing alongside other third parties."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeAreSubjectToRisksRelatedToESGInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeAreSubjectToRisksRelatedToESGInvestmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We are subject to risks related to ESG investments. [Member]",
        "documentation": "We are subject to risks related to ESG investments."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We are uncertain of our sources for funding our future capital needs; our ability to acquire investments and to expand our operations will be adversely affected. [Member]",
        "documentation": "We are uncertain of our sources for funding our future capital needs; our ability to acquire investments and to expand our operations will be adversely affected."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We cannot assure you that the market price of common shares will not decline below the IPO price or below our NAV. The market price of common shares may be volatile and may fluctuate substantially. [Member]",
        "documentation": "We cannot assure you that the market price of common shares will not decline below the IPO price or below our NAV. The market price of common shares may be volatile and may fluctuate substantially."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We face risks associated with the deployment of our capital [Member]",
        "documentation": "We face risks associated with the deployment of our capital"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeGenerallyDoNotControlOurPortfolioCompaniesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeGenerallyDoNotControlOurPortfolioCompaniesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We generally do not control our portfolio companies. [Member]",
        "documentation": "We generally do not control our portfolio companies."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We have formed CLOs and may form additional CLOs in the future, which may subject us to certain structured financing risks. [Member]",
        "documentation": "We have formed CLOs and may form additional CLOs in the future, which may subject us to certain structured financing risks."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We have not established any limit on the amount of funds we may use from available sources, such as borrowings, if any, or proceeds from securities offerings, to fund distributions [Member]",
        "documentation": "We have not established any limit on the amount of funds we may use from available sources, such as borrowings, if any, or proceeds from securities offerings, to fund distributions"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may be impacted by general European economic conditions. [Member]",
        "documentation": "We may be impacted by general European economic conditions."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may be obligated to pay the Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio. [Member]",
        "documentation": "We may be obligated to pay the Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may be subject to additional potential conflicts of interests as a consequence of Blackstone\u2019s status as a public company [Member]",
        "documentation": "We may be subject to additional potential conflicts of interests as a consequence of Blackstone\u2019s status as a public company"
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may be subject to risks associated with our investments in the software industry. [Member]",
        "documentation": "We may be subject to risks associated with our investments in the software industry."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayDefaultUnderOurCreditFacilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayDefaultUnderOurCreditFacilitiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may default under our credit facilities. [Member]",
        "documentation": "We may default under our credit facilities."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may enter into a TRS agreement that exposes us to certain risks, including market risk, liquidity risk and other risks similar to those associated with the use of leverage. [Member]",
        "documentation": "We may enter into a TRS agreement that exposes us to certain risks, including market risk, liquidity risk and other risks similar to those associated with the use of leverage."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may enter into repurchase agreements or reverse repurchase agreements. [Member]",
        "documentation": "We may enter into repurchase agreements or reverse repurchase agreements."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayEnterIntoSecuritiesLendingAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayEnterIntoSecuritiesLendingAgreementsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may enter into securities lending agreements. [Member]",
        "documentation": "We may enter into securities lending agreements."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayExperienceFluctuationsInOurQuarterlyResultsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayExperienceFluctuationsInOurQuarterlyResultsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may experience fluctuations in our quarterly results. [Member]",
        "documentation": "We may experience fluctuations in our quarterly results."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may face increasing competition for investment opportunities, which could delay deployment of our capital, reduce returns and result in losses. [Member]",
        "documentation": "We may face increasing competition for investment opportunities, which could delay deployment of our capital, reduce returns and result in losses."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may have difficulty paying distributions and the tax character of any distributions is uncertain. [Member]",
        "documentation": "We may have difficulty paying distributions and the tax character of any distributions is uncertain."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income. [Member]",
        "documentation": "We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayHaveDifficultySourcingInvestmentOpportunitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayHaveDifficultySourcingInvestmentOpportunitiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may have difficulty sourcing investment opportunities. [Member]",
        "documentation": "We may have difficulty sourcing investment opportunities."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayInvestThroughVariousJointVenturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayInvestThroughVariousJointVenturesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may invest through various joint ventures. [Member]",
        "documentation": "We may invest through various joint ventures."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may not be able to obtain and maintain all required state licenses. [Member]",
        "documentation": "We may not be able to obtain and maintain all required state licenses."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments. [Member]",
        "documentation": "We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayNotRealizeGainsFromOurEquityInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayNotRealizeGainsFromOurEquityInvestmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may not realize gains from our equity investments. [Member]",
        "documentation": "We may not realize gains from our equity investments."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may syndicate co-investment opportunities, which may be costly. [Member]",
        "documentation": "We may syndicate co-investment opportunities, which may be costly."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We may use a wide range of investment techniques that could expose us to a diverse range of risks. [Member]",
        "documentation": "We may use a wide range of investment techniques that could expose us to a diverse range of risks."
       }
      }
     },
     "auth_ref": []
    },
    "bxsl_WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "We will be subject to corporate-level income tax if we are unable to qualify as a RIC under Subchapter M of the Code or to satisfy RIC distribution requirements. [Member]",
        "documentation": "We will be subject to corporate-level income tax if we are unable to qualify as a RIC under Subchapter M of the Code or to satisfy RIC distribution requirements."
       }
      }
     },
     "auth_ref": []
    },
    "srt_WeightedAverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "WeightedAverageMember",
     "presentation": [
      "http://www.bxsl.com/role/FairValueMeasurementsUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average",
        "label": "Weighted Average [Member]"
       }
      }
     },
     "auth_ref": [
      "r691",
      "r692",
      "r883",
      "r885",
      "r888"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations",
      "http://www.bxsl.com/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average shares outstanding diluted (in share)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r169"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.bxsl.com/role/ConsolidatedStatementsofOperations",
      "http://www.bxsl.com/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average shares outstanding basic (in share)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r169"
     ]
    },
    "bxsl_WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bxsl.com/20231231",
     "localname": "WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "When we use leverage, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us. [Member]",
        "documentation": "When we use leverage, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "59",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-59"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "e",
   "SubTopic": "470",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "835",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479359/835-30-S45-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(CFRR 211.02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.7,8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//946-320/tableOfContent"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "220",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-5"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(2)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(2)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-10"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-12"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-12"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-12"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-16"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-7"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-8"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-9"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-18"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-24"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-25"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-3"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(10)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(10)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-4"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column C)(Footnote 6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column D)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column D)(Footnote 6)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-36"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "37",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-37"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "37",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-37"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-38"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480348/946-230-55-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-39"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "4",
   "Subparagraph": "Instruction 3"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Investment Company Act of 1940",
   "Section": "61",
   "Paragraph": "a",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-9"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-18"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480369/946-230-45-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-37"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>102
<FILENAME>0001736035-24-000006-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001736035-24-000006-xbrl.zip
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MF=A11(4="BEG<WFU R,I1$F#^7DD]R)PMQ_T<N4"<W 4 9+E!D?27\452+-
M4#V'8.DDD1L/:\8!I'K5(C N+RV'63KU9-GWI8#S#7PVNNO3!^8*)&M1Q,:3
M9%UX[0+CRIZ6>6^9=+<$I-A%@&&K"_HMI[J9I-NM%Q@[G9IYLJFEGNPFFUF%
M/[-THG?U<4)TM8ONGQ4(8,I:!'"61.#-)U>\&-K\Z>4&P$6U:Y:>W;JU*4S!
MB@# \LM&>7M+HF'7 <-%UK=4/ICFKS$5Z8X$&T Q::?/)"Q:,6,7(B_?!E+5
M(A"M9*=@XC4]KH-XG+:.-)_=P]U4UYQLB3^MN\19Z3 MK.NK)$]R4W#2OBA9
M8U;:=/7<_=:7>7;;WDZFVWS>IR%](:;V14!CG]F\,D?,&LHF/',&LM[0(54J
M L-ZMHG 391)<Q)G>DW_"GV_=;4(^.FS6ZY;F>'F[6?F'M!ZV;YK'&7#S[;-
M_-/ZG<7V+:5GZ0NSPAY,(8L C7QFOW289/SV&[:YO;0K/26<O5E'F6Z>E<-G
MTZ*+?-S2T$.*?UY)2Q8V//>S]5D:&RVF3!<P77)MHI7/QQP,18!$6:&JZY%@
M4LZ@&^I1)OU^G/6Z>J=T2;8K^YJ&:<#C6 +7:\>!]1*OEG'((?+>D9,B<*7G
M.8K7[BZ)@OT0:^>RUN#:ZK:\;KXD=!_--]SE-]@G&S5#MR]HWG@*-Y8Z*0)+
MJGEJRB2545TS&HSFBC78@%K#J\]>\]W[:K-%X$BOS[?7?#@2LS:SVM$A"S$E
M*AHY2E&#D@&3R;I;V)*U9"66A3=)&]WNH"7#V"2[#++5M5PQ5-+2J#O(];-P
M55:M0=;Q*)N?71%&4LQA VP]?T?,;@8G1<!,\SU!JVGL*N]]/OFZ4ATUB%RA
M!;9^14!%RX7L-3*EQ:Z!%2I9D4M**60XWPAB,O%<GS]K^,8][W8,++O)P89$
M1<!+<_+@6F,FO:UM[CFU/_C.3[M(I:5OB8=>EL"8YZV0W51[9:^.1LDB32-)
MDEV'.!L#9UE4\\F^U*!6/9P4 5/EM)[+O(B8YGVB3"V;A7,S[+S:>=:5;%[Q
MLMQYUG%@A%/Q; /:WH3(18!:6=7R?$_7E?6Y22LXU_SOU]A^:72&?%($VK2R
MB7+>?BLY2(HY'CFFF@MK@7.[%;-K)L*%]?8T,\GZ7#JC>B,J!$M7SP,1N[/T
MZG%D1\ \TDXJ7MLTL('T8@-?2RY.:*O=JSA*NJ!C(XO3(C*I'%[2-H!FKLPP
M+3<7LX1!+D?%LQ+GQ(VWI$N4'+7*3P;)ZY?OC*EV(0!5:I5M;OURF'CFN4D_
M;VSR9F,_3/V*0*.RJ=;%1NY,"=>PM;O<)N*6B):%XRMVO99C=77:F]4^>2<'
M]@]W%,Q]E#LC"E/J@E"M57M,YUK6U7S(G;K&Q*ZO=G*.J,V'>W26+A=\Y#)L
M29L2Q\ *%@9*-5UU84M&JM:_]6M#S9A[0[>BFQ8G&D<=YTYX/H/.0ZKTQ"?W
MV,)=)Q]@S=6M*B07^S;@$E2[^==5H3X_X>#.V(PJ(]28 Z$(=&MU(+A]N#H8
M4:M7-AR2U=YDMEWW)*9P18!7J\(M UA7:.BV<(%+5 3FM% G+7.9K[7ZCW1B
M%LNO24[+;<24Z]V8<*;4!3_WP/OH1HO F9)]LYI]HO9WQ6:QW2T7ZUPJW8MU
M,JUV!]<L'+I^Y3IW$&*B[W)3G=M:*=Q6CI9D29+#W9Z=<+43D>N._%H?HJ0>
M*[_'$W-T%(%O]32;I"%PMEUKI8;NE>J+U9:?BXWWZW=8+H9$>B9;5Z9X$U+S
MLR+ JSX+1E()->2!\P-231=:9<N"UEJSQBAK>BR GC5Q5@06E017J87.#Z>=
M>_:?%)?1)R:3(T0P]2D&:WJQ,6 U,EH0WII0<N@6WI-XJS_B.DR*8U#5*P(^
M2JS+GZ6-%VV@\]9!I+E8"%.PPM BFVG4/MLWODT:2@R6HB4S'?\U9LL&(\OD
MI=;@*3Q(7X7;7OZL"+1G7H@TL*]P$62VO3AI\Q+69\GYP#8-359"M7:2)0&J
M\ZAW)MWGL^R5F^^,FC9^FS=I<\/ ^N<;E1:(Y_M,I?$O?%9R5AB"5&?SKLIN
M:;Q'9\OCPUM)H:JUWORH<"TY6X//+.T#=,.2$M2&:UI?<STHN&2MU482R^I7
M2)V+@*&2\^'G6EXR5J?6UKLR;6+LFH.89 D@2!9KG&+41+EFG)BZ%8$IY?:G
MOW39BWVPN:;HSN\N[=>D6^PZ5-+4C2>9YW+2IN-DI5:E>]<%AV7%9T5 1'/1
MTFFSI]6(W[MR)5>KYAHLNC4W)=GL4NEN*JF#ADZYIOM)/(V]DFV8(^93:]BS
M"3/Y*&V^4S/=BPNI\WD1L%#^#.HZZ\T7U&SLM33<KFY%9AEF86I5! JTE,1Z
M6U>2(C^RF9T:C3L/0BRZ'+ORX,'GD1KGML Z!;/*%S\.W";:02QL#IMX8U"T
M=UX$=&35>E:XG79;:DFKV<L^A5V=,/7Y2;,C/IFON^6;''RA&CPK37,[H)]M
M'E@II.DF.,L&::"CHPAHRF5 :BFO.T:ZSI(V>F/7 W?>%K$E0^9.DG9!E3LC
MQ"3R)5JS$176(X1)#7'?OBQU]&VG?SBE,K+FKV+35W=N0K:YE&L&E5QW3<,Z
M8\G>KQ1L6L]B'VXS.8Q&-VRH(@[<(N.\"!PL%UR[8]WB]% 9YROB('I^_O25
ML^16M#R/*.F>JYF=[IVG84O F:[=Y0Z[SPZ]W>^EW?,B$+5EDI94H(^I?DBN
M,)]9TEBJ^Y@@L,5!5#<V-L=4JT#(:[%RM"Q([JG(?5(R\S_/M4W-U-SV3?9K
M:O&Y<\5,T@C=79!N))CO$L14N""P:WX*15;+ZF"E"[%J?NQ.^G.<PT')I%6N
MX]G)1I*6_#FF@@]<LY+TD22RZ[E3 ./0!NPN$<]M&W&X3(?9T0JN$B<Y/S?*
M8KUL%Q/F0"@"/;NT4V>LF=MXD)Y/XJ;,S%CK#>_S2B'58L?FI6!//)VO,;4K
M @Q;GE%BKESK:ODLMDH5=%5/+<^%Z(M=0*N'DN3.*4B/)^GJ=&>W#:>6:5=6
ME9=%8TDVEQ7CY-*X=),WY*"X* @Y6\C;S"IK5\IF4T^\)&<MD_4I VV!<U$$
MBI;4ZBPZ7J3KORK6 7,EL6Z'5VK<Z=F;<T.]82PT><'G];6KQYO;<> :*X0K
M:5>:LC_;((BJ?Q& 6Z)_[4;)M!+$O7%N'6H>,*?$1+.!TBQYP7+'MC-K:\>3
M;"]O3ZO)B_@M7?UP1V\G[^P^(=^,KN;;0298LB]-8PZ%(M"USR,F/[LM"]F&
M!2=GEGA9;Y#P=)E2$+-4\FYNU!V:].5@87+JW"RC*?/]W=EB5Q*?@Q+VBR)0
MLB3)GF]V25I NO0HV0%S20/GSU&++R^* *P68MPF^8[)^J,,A'6P[@Q'5Z&W
M>JYYLD/;[5D ;Y-P402$Y?II:[K<A.O* =Q_ER57R2P7/M.+SBY%'$2QO3>8
MVA4"3KEUGG0Q40[=Z;:A.Y')]06CBT5)L::YA370C/1GVWMJ<K:J<-:(>Y;(
MCZEQ$;A34AWI).C9:)9I=QIN4N_1U9ZR'M4&KO>"/9>.W;!D)3%ZY00N%]FZ
M<KV.#8\_*3=^!*C$1<!3UZDI)I4?SU1>M4(7ML[;H=SRX<CF+TTWR\XW]*:?
ME59$)R?RS4]F\P0UYI-*^L>Y5[DV_/-7T"A"7>TK'1<!0BW/W6O)VDI0.\MZ
M1:[4=+@F*)K!'GA9.BX"@7KE.#6ZG&#=!B.W[)[ )VN&UAWGP]_$]6+J5P2"
MM'J.N=_T;F/!2N>#ZF)Q8-E'P7'!U9X(>VF6A:!!S,UVETJ/6>B.FTBICOMW
M;N'&/I[L*$GQ\)JNZ/.IT8^T2V^L1Y[7\+G)$W6O6>FX&!PHQ7:YPW_T1+EU
M<6>;(MN \N0BYF2)P%4Z]=5\(;YF:K<M+^%']@V"$9U8W]U)SA7QE&LUUE>^
MM7@SF-G+\L51N>5_5/6+P)F2*-@9>(.[LHM81+,>G<U;G:02A7G9C!L&MS;+
M&4K^&TL'1SU9#^CJ>=FE.XR(3]UQ,M2,;MDD[?QJ_^UJ**%GZ2* *=_>_C6M
M.K]L_Z":%0%(Y3=HKLHV;ZOL3Y@KAW=>VB6TJ ZU"&"IS8;<B"3(S1^?:*69
MYS>K_8+2W"855<$R@R+@HL_,HU(J!_AL?/IO%<_W::;<OJ>Y*RG-XSX7-MVH
M:+ZANLZ$>G1[>'O=]%J=/.*P<.W36V^3.-^,%LZ#ZVP-P/IDJU&R[@K:6*-4
M*@)/JN6K^#,\L5SQ;G 1NR7PC"DO$Z/Y2,FU8)CO(>A.DV.-YR!Y=1D/=%6\
M5"H"A7HU(%Z)@M-"F-2I:QI$[CP2M]:S$BF;13D5J)Y%H%)IS<F*,,VG@#&W
M-&OU<\ELDR9TRHG:TVK (^,ZK23GPB2K>!EQ!%6Q"! J[W^=SVT^N=_HMGDD
MOM>^+,%/7'<?I;UDQ"<]IETS#3IDR=%[Z?GQZ8%[?&)O5EHMP=UA8*XM(U\6
M&@N*:J]%P%$K^^7H[!6AGRW$)M*G<^WO4-MUW%CT.W)GDLPK-VI1+>N.WU<K
MGP@Z/HH K&Y4;H34)A.MINXD@XQ572J]6+?50]A5V%(14%.NT'-A78M3W-R!
M? WFVI^G[>9 =2H"7G+^M/9IV?)MI0PM=\H>; I:!*[D4^%*Y'-$8%Z _:(,
M*9D@TWVN*73(=DO)9TTOGE.)Y^5,F&(7@47-VQ@OBNY=3Q)GCNNV/2<[Z[3;
M1S??G&$#F,5E\PT7-ABJLU;V'4,')HUSP^YLZPZ5-F2^I%.ETY4]5/Q0_N:D
MZ9O>B./*[[X1KE-O<A=B$]J\*#'OQ;T(DZ@X?^E-/';;M-1B+(\9=4ST1VY4
MM5PZ^^'.;V2?E#V5_7OMZ]V##>;.V)7KWG;^ZQ.G\];[KKS%]ZO?/G?9:_)_
M<_KT.^2O;B[_Z8?*\?O8P3?'-K_C1IQM?B,NWNU&?'/R\?4WHG2\#<_XS<'
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MS@GO[$D\.^Z$[4W7<>"LNBF'7#)[T^6P:!X8EOK43,!DF%N&@LI:8'G/2]F
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MNE#!0[;6M7#&<&K"[K':0$T/3<T2[#ZK9LM?Z<60"Y9Z.>O$#)1*A:K(V8E
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M; G,5VI:!M(4=E]4HNF416YK5"29-J1#)1TR]PK<%/0,%@K5))T(*H&EPV5
M$_8T[R28-!Y[P[<"R8D+@_28AG1ER^D>R(G+@=;)">A><9F/"9@,23V>S4]$
MA90/EO#4Z?A>*7+G.V27MNS< W<*RWC6R@EHC[" ITY_HU1/%0\8\&P(RW+J
MC+G=:K@3(2RQ654.?08\AR4U=1$SCT;DAD6/2C\8.Q?6]B5-/(>%.$[5 9<9
M(8?UK^>PW*:N:3AK7?KX]1WGL+#F-0WA_2HLO;&*3MF<ONU===TY+M5Y2U9
MCPO+<^:'G-WYI/2V52*5>IS#TITU<@):(RS=V=P:@8ITSF&1CT?']SRVBC&J
MI3MO<*70%<\P+V"ACT=-)%BNQHK4E=;J$7A)\@*6]7B75RU\2G !2WJ\2Y_8
M!$2&P.+!(IX7XJ%#@ M8MN-Q'=@),8MJ7,-P2%N$I3B>L('IE+/'K+H*-C#%
MY3?K)81WJK@$1XW'L;2_:#Y+SB&KI_9ENL2%.U]0%M#MXI(=)0>N:?@G;F(J
MLMWHX+9Y>HS+=[)#.+$#H=-C7*C3[9%K-68D.^"6]-7$4Z3U"5A-7,3S137A
M?2TN 5+QA)+L6)M]D1.7 JV3$]#7XE*@7@M[=]WI,2[^L=JM;6[F[' /O"HN
M!M+L,3F6"CTAP<4]\7B,7_-Q>HS+>-8)B.Y12["(I\$D%3Q%=:0=A7N@)2SL
M:7 3N(,Q9J09QD%RO ^NARW!4IZ&"L@5D_9F!)S\M<%5(!CQCR9'M:._[8%Y
MPA*>YICI(9/!C/1<B>2>[>8Z+<&RGJ8,&9TJ3?Q@I)0P&S64!!(6E@$U;S[-
M(Z-:?0]TA.5!S0DW3$^1B4$)EODT]5"-K=GUQ!Z@NQ(L^&D^N1L1S8!-$);Y
M7-JHU3$?/YY,Q&Q^*$PM^#7FAJ=9YGYT0S\MPW*@/R8QSK[+TS(L'KI4>AR+
M! ME59;$4WH"Z8S+L'CH4L4R3%0DM]P\+%O=XVH)BX2^I"5ZN%N&94*7FLUH
MMJS"QSQBX=]!8R)8_+-6PST(<F$YT!>,$BF*A<5!7V.42(+"@J%+;7_I4-.0
M6>6"D51"#3DS^/W33LNXP,AIFA3JW2H:$I\.F"-_>[$<5L%E1+%[2]^Z7-))
MM_;MAZ"X1&B]H'B>M@)+@ZZH>*0S^+Y;IQ58!G35(IZR;RNX6IS'A2HB+.ZQ
M(MY2.;3OG]]W@BLD+/-Y4TCX2 >6_%SQ(1TK"9M*5F!YSY6K:)?N^9_4O3D*
MU!@7"%1@(<^5II-1K]98[(C&G1IAH8ZK"9%A<KK3GLR'55B4\U)+/$NLPG*;
MZ]85Z>J Y@NT]H"75V$ISD:"PGM;6,1SS8<CXD>:L0B]<T$5%O&\*B*\7<+"
MGE; !E2(K!@V:0Z#*" LUEDG(*!/A84[-NQ97F+@3Q\YK<("GI944TIZ(ZK'
M-&!QQ ,J,)TI+-]9+R%Z=',"RW@2/<4>)I(GL.#'K4D.W2Y:TJ'Z@45NQ][+
M37IX\^8)+/G93%%XBX5%/RW-#7@?V1-8Y/-"/'@[Q$4]_L_DFCX^L%G:#=@5
MNZ(RV!-<WO.JBO"6"<N ?J(VZ]P J"-ML3R!Y4 ;JPFT-^\$%@E]E.I1L'#(
M2$\K]*7+4U@2](:,Z//F*2P+^OBHQ"HJ@#5,6/K3H4/)#(_'BPU<WMY$M*>P
MS"=1-5+$4^.)DLRM;%J?BWNBZ>DI+ 'Z@I3P-@K+@SI4ADIPN>PY,2-KCXP"
MGE9A,5&':OM;&?DW$T(]FD@]/S$*WFYA:5''VJ;F5.#7"IW",J(.TT&L9_,F
M3E="W;,U[;B E(3E0V\JB>YDSV!Y4>>Z^5HP!.ILSV Q44?)ATP_F\;L0?!S
MAHN+W _5;$8NN:1)O_:_$_^H=G1[U-X#67%YD=+,FN;CO4U72*NU)VSA#!<:
MK=43<-+$I4.]JVQ/T>I9;HAVB(N!7E,1T!1Q@<]K(L+/C[C\Y[;U6A\@I"*O
M,USL\X: 0'5=Y[B YZ6 Z.[T')?PO&&-%2 !<;'.&P)6@02$!3@WM4_-7TA?
M33S@727GL+SFAD[YD$9*I^646NU-G< Y+,&Y:7@KS=1@#T<\A\4W-VP2Q7(?
M*K'.8>G-3<<CGN9CLX=M*,YA 4Y7LB=2IR+B8[?4L6>;]\YAN<[OT!4(]US
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MB9! \L'"E]SI<T!RP=*6V\_MU:XF.**=PVY'^O)I1TA!RCDL/ME 1Z"0Y;P
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MPT*>AF960?6T%# +;Z$H71D6\%PIXE%-/E,S(ATJZ9"Y:]&RR_+.'NOT%94
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M4%W$S*,1N6'1H](/AMSY-3CU8*F/I\;C..$^=4UE:.8]+CRT#HDGL-3'4W+
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MYEW83N,8=6KL-'/I3N,8=4KL-'/I3N,8=2KL-'/I3N.8>0I\>#/7[C2.F:?
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M0AZ$5G:FD-FI;F/,3IGW:AW8^,N@'7DSQNQ4$3+FP0AVP[BI682-=H;,BF(
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M6=K*B$4RI;W)I4@\L]?2B3*ES-)6R"M2L>U-X\@]E $+Z]5 H)TARXQ9:EQ
MS%;EXQ GL 29(PTM26$@9B5R#..V1K:OM;8-,2?:^6 $#LBL[/TAL]0:/L3)
M6$%F+:D0:"MPD*1B!8X:=<3>I$*8K6!7LQMM50U S*-QLPN9K2,A>C6T=M U
M>F&]V1N]OTG9FS!'.K34AK.M4?O,8;:R"F&VLC=AMG9V<3OH*7"0HI]$9BL1
MYLD,0F@K>R-#2UVT6Y*^K0A-F*T(72,3W+OCJ-E"]^XX:HXJC7,!J6]8A^_$
MLPJIG4]D=G2W(+2D8868)5&V;=P>&C)OI&!7HWJ=XQM6]B;,UFZ4,"N[T2G6
MU6@,]AX)$U6O$;0TEV ;*"#-F*U;Z)I=4HYS2+K&0Y&88V_DJ!&0[DTK->JD
MO8NP**T$04LANB85]N[M:O9)O8LP3]<80EL;4L)L16@D;"8MPD#]:,1L[?MK
MLG>.;XS2)4>BMOB0J"V.H*VL0IBMR!$H+8Z8K>UHH!PZ8[;.5XG:X@C:BAQQ
M>NB4V=IT(&EQ*=S5I._&E\+U:JQI=&O=<B#FM;(*)^B:)IM>0Z,&+"G<[>(\
M&C(GVOF.<[3>)XVHD2(1>I1"1TWW1Z]'!_9!(F8K<B!A+6?CS^PLE50Q:*EY
M<ZRIB.Z-=J@BVEJ&1;FP]8S%H ,-+57J(F;I)7E$5:^*0U-H:W=74ZO;>P"O
MJ>/NW77$Y4+([!RQ*+3DT#7EF+V!HZ9I)<?.FD/7=(#T[I.*\G>.H:T0'1<Y
M(+/ET(1YE/RY*-KUG@H#ZXL1L[4(D9VM"!U8CXF8K2M29&?KBA1!2Q7&"%J2
M]1GS2I0@M'4+1IBE'OM=8$$F8M8V2FA\N12B ZM(=V012L( B-D*'#7UF+W^
M3)@E.3#$K.PXQMT1E9 JAQ4*+4V50M#6_"YF:6E2&H.6YG<=T:;#\FFTZ[!\
M&D$KD]*H>RC]"13Z=B&VCI9ET,J198)&5V%6R$/0UMX#05L9$4%;R07=.EK)
M!5W^)T)K[H&@K>B!H*TXC:"MD(>>:*41X SZ*$4/5&ULA3Q4;JR4'5!H*TXC
M:$6SED*OI)"'.ED.TG$+S:A3I- AM)81$?3M0FP<HT"AK9"'H*U='HH>5AHG
M_=5:G$9-X9&6MC9,"-J*'@A:V3"M5YLX00G(;.D<(&BE.608]X19*II S)*V
M$F*V*H\9M%.=@I@E$8Q]D3A#KW/$"4)10TO1KJ:3O=?.@2H'C-G:<L1U[T%F
M2VQD3QJLI58XQ&Q%CJ+N^][-76#W_::H3S('VO+HQ*YP!!UI:,FAR?N]))Z#
MF!5I1,BL+<) R0#$+#7^,CM+/;0(VKKG*-IS](:[HK;PWG@7.!EP'S?\#3)K
MQY5 M1'$K#3^3HLPKBL<,EMRC@A:4F5CAK8B1U$N[(W1B;DP3O-G\FC416M=
MH-?,Z<DQM.701>&N-W($*G<@9LLY J>2(6;K0:@H0O?N.>*BW;AC646JR&30
MRNT,A9:JC!GTWKB\@]!6:30[&=Y"M_;=L*-AI*6EOAMFZ=NVK-:^&V9IJ86%
M05O)A4!;#7#LO<**'D5Z([WN@:"M-%XDDI+CT]HN+U%O!$%K&R9DZ:,4/1+U
M1ABTM<M+E*-!I8Y:R$/05D9$T-;>HTA#IS>Y($M;>P\T*S 2VEJ("-H*>:CJ
MV%J(R-)6R"-=%H-U&D?0BI(^A1XEGT9-.)*JW"91H U!6](=#-HZ;B'WD&3#
M$+1V:UHD.MCZ-+ZJT6=HK9M@S%(- H/>&2X-H:W"B2*ELQQH;6-:I)/8N_,H
MDASL#1X(6HH=18HTK66$#-K*X0AZ9VSQ(+34?,@,+<6[1)%$!FV=M- .3YH\
MQ"QMO<;E2:Q.P:-&A*LWLQ0)6O7F\$#E,,1L;?"0G7=2"B?OA\J1!3);BY 4
M3$BBL(@YT<Y[*:L@.RN7'1#:.J^@.E[+T 3:BAPUO=:]D:.FISW'H:UH5]--
MVVMGU+4@72@19BMNH.8A*T#7M+3W!CO"; 4.U"UI.4=-JW5OM"/,5N0@S)$.
M[=Q$CZC/6BJ^8]#2PRR#EI[ $;15;#"B!"X]5#!HJ<P105OO6 Q:>A)BT-(S
MYUC49YT#K67$HI;EWNA1U++<&Z>+>E)SH+6%6-1(V^O3"-J*'D5-A[V6+FKO
M[/7IHI;EWNB!H"V?+NI)S8'6#@'(TM;6M*B1MO?D@MQ#ZG5"T%:OTYC82,N@
MK32>V/V+H+6]1V)[)X+6,F)B]R^SM'5KFMB3N@[L247,RG 9R"Q-2V*^H?3^
M3JLPL5$206LY/*^[DT)+A1[KFOZ]WH!7U)*:8VBIZ7 L:CKL789%766] :^H
M?R_(/:R %]A6AIBM(%W4<]CK'.3"0QKE@Y@MYT 72](B1,R27-$:7:5;JQ!!
M2]Y!F*U5F#>$&T)++=:(6:JF9\YA73G6M%CW1HZX>=:0.='.UC5IXE#Y==%H
MZ!QH*W_'C8:FS))^YCIPDBYBUE9AX)AEQFQY=."<9<9L'5=JAD/WKL*:YM\@
MAU94K,;=+G&0+H*V*HX9M#3XBT%+]54,6BJ_8]"WA_#6BN-=8O\O@KX3/7K=
M([%IF5E:*K%BT%;(0]"WT:-U=CB#7DDAKZAIN=<]BIJ6>Q=BXNQP9FDKC1<-
M/.]-XT4][;UIO*AIN3=Z) Z'1M!:]$"6MJ)'XD1K!FUEQ**)UD'04ETI@Y:Z
M4A&T57:\2YRSC*"M]G &;67$Q-GA#%J:THZ@[Z@']$8/U--N9<3$GG9F:2LC
M)NHT[(K:PWO=HZ@]O-<]BG0:>J-'HDX#L[25QE$WK95<$CO$$;26$?.:K2?H
MO(9)"FTMQ,1^6@3M+,1A'.)FRT-FJRN.03LEFT.<Z %DMAR:,$M]R\PWI +U
M(5 ]@#%;T2Y0\F"HZ<1O;?-$S)9#%W7BYSB'U4^+H*5FZP'=_TO.4:,>D&-G
M+7\'2DL,13(-O=Y1(WG0NPH#U0.&FJ[V7CL7=;7W.G2@Y,&0V(F/H*VS;*!Z
M ',.R:&+FMI[G2.PJ1TQ6PX=.+,8,5N^@9BMDVRB> ""5H[?XVZ;.&D905M/
MX,S2TFLR@Y8>9K=%_;^][E'4X-GK'D7]O[W1HZBGO=>GBSKX>BV=V/^+H*V:
M069IJ:^,00_&$6""3NR51-#:0D26EAJ'F*6MA5C42MNJB,&@I4YK!#U::;QH
MTG)O]$#0UD(L:J4-<@\KC1?U__:F<50K(4D>,&@K3B?V_S)+2Q)B#-I*+L@]
M)"V_;=%,ZUY+(V@KC1?U__8NQ*).Z]Z0ARQM[3U0@V<BM.8>B2//&;05/1"T
M%:>+^G][+5W4_]N[$(LF1/<N1 1M';<0=.1"M,Z(14W+0="6>Q!H[=846?HV
M>AQRH"69:02M9<2B8>V]&1%9^O9)KO&A:+U:(>B5X1X06BFKA\Q*%?+$'"<?
M )D=AQ[&L<8Y6EL!$+-4[LV8%6G*R:/1[8$4H=&%6**AUU9>J1&7:&U@& .E
M=!BSXM$46FIO0="24 -B5OJUILA1(_'2&^W0.YR55VJ41WK#75$"[UV%@8I6
MB%F2>$',UIXC+W) :.M<&*C"A9@56=B).5#^AS%;BY! )SJ'%3A0U;'E'#7:
M4+W.$:@-A9CW@0ZM/(%/9Y4:]9_>R\8B::C>DRR!EO311]1T:$7H&E6YWL@1
M*-"&F)5MTK0(B=J!L@@ALQ;M:C2X>AT:I14E?U/H1$-;::4F?_>FE9K-76/]
M&F0>I+12)-"6 VWM_ FSE;\)LZ0).P;*?B)F*T#7;)-Z=QQ(,4RZ 4/^;.TX
MBK)*KT?79)4@0QO1;K-&S(YN'X1VM"BII97*" JM:%'NCWG%NHQ9N6QDR$IU
MTN3.>2*V$%H+''DBMA3:2H;H%NR8"&TMQ"+1K=Z%6"2Z%61I*WH@:"MZH*H[
M10\60CO*!M322D,UM;324 VA1RM.(TLK+3<3-"I"MT)>D>A6KT\7B6X%N8>U
M$/.DH"BTHIT)H;60EZ>J1*&M-%XDF]/KTT6R.4&6MI)+D5)88YS>'VOJ#EJO
M>>,>XABRDE88LJ,^LS_&%4@S9.7-@B%;KUFH44BI56+,2D,60Y:\.:]7;[W*
M>YR%S)&&EEI!$//6681Q@\T9LK1Q+JH5;"V,/M;H$36^!D%FQ3<@L],C!*&5
M4 >9I380YAS2EK^F12@&V3ISQW6/3>Y,7H&LL)&H0XJ@$YU#$D!$S$I.V5?Y
M<VNLJW&-WB58([R6PVP) R!HZ=@=IXK/D+4S;(V&6>\:),S6'@E5%BMQ8Y_G
M&PQ96X/DGM_RYYH7H-ZX42,5UYNZT1N0HG*Q9WLD:?\<MQ=ER)8[HP=Z:_M,
MH*WX7%-OTNG/A[PY&HQ9*6!DR,KD#^@93D)!S,I=W68])*HN(&BKB)A96NH%
M8M".OL4A;_0F8W;J-Q"RLMV8W+E(WZ)W#1)HJUT305MM0 Q::@-BT%*7&%N(
M4EO]@"13K86(H*UM1Z+\";.TU"4VH-L9*R,B:*F;%T%K&1%!6QD105L9$36K
M6'$:/558<1I9VDKC"-I*+HG:6@@ZTM*:3R<*@@U%VEJ]EBX23\JQM!8]B@3!
M>J-'D0Y1[]:T2/&IUSV*M+5Z%V*1BEF.3VNWIL@]K&NQ(IFJ7I\N4C'KC1Y%
MVEJ]/EVDK=4;/8H4GWK=HT@0K#>-%\E4Y;B'=@%9)+W6^BY>TS;;Z-$,6:H/
M"^ST1<Q235O1X-/68IJ:Z<.M9BY2!&OUYL#:W;BYE@Q9ZLA"S%(ZJ1$C:@US
M>8,+&;,C;X>0'4G,0UZ7$$*6<G9@_]BA1DZD-<SER;8P9BG,U2ASM"Y 4E\@
MQ8R:WM[6]5<D[]KJS'%MW_M#GB0 8PXTLQ(S-NLMVC3?0K>^L"%HZ]4805L/
ML,S2MP^P^QAHZ]V'0:^-@$>AI<>J;5';2A#T7O)I!&WY=%&#4&^<+FH0ZLV(
MJ"]!N7Z&T)&6OO,^W[L0D7M86]/$KB8&;:7QHEZ;WH6(VE:L-%[4BM4;IXNZ
MFG)\6MLP%74U]2[$HEZ;7I\NZFKJ]6D$;84\!&TMQ*)6K%[W*&K%ZEV("'J0
M?+JH?ZPW3A?UC_4NQ,0&(09MG5P2NYJ8I2-]^C;D];X$)+87,FBIZ6U;U/36
MNQ 1M)7&BSKU>GVZJ.FM-^05M1?VIO'$IC<$;?6/,6AK(2:V%S)H*WH@Z,%)
MX[LB4>;6A<B@I32.H*WHP2PM+40&+:7Q76*)&X*.M+06\A*5F1FT%*<WB;,5
M$+0EC,*@)=T<!BVIN6R*XG2O>Q1EQ-Z%6!2G@]S#6HA%99N]EBXJ1>[-B*C6
M5+J?1M#60Q&SM'0(8#XM;4TW166;O>Y1)$;?&_**ZJ>#W,/*B$42Z;V6+BK;
M[,V(106RO0LQL7Z:04L/19M$!7T$K<7I1-E_!FTEET1==P8=:6G+IQ-G%6Q0
MX=51<H^B$K?>M_'$)SD&;96X)3XS,TM;W1<(6NESV:-2TYWAT0S94<!&R([.
M.*M!5E8@8QZ,G#*,1Q(TMH9K0&9%Y@HRW_'G'.=00ATUM!,W2)GWK9D;G[,8
MLI11"+*TU4"=%J.SUT ]"XH(*#.S%#/RU"D1\L&)&>06*1!9<@S4QZ+LC1BS
M(\^,D'>.,Q-DQ9G7JR+F1C-#9N4*%S([LV,FZ)JM?J]SU.SU>YVC:$O7F%(@
MM'*]/XP'M H-YX#,TIT78I;NO)AO2'=>"%JY\YH"1\W]?F^$+KK@[TW?-6\_
MO9$#I4(I0M=L.7JC7=Z6 T);J;!FF]1X70Z9K:Q2,[6N]ZR"RKZ40F@(G>@<
MSITYA%9&5$^1 ^V3I/1=LQ\-LK.5O@FTE;X#ZZ=(3<'!\&>&[ P#1\C6*39N
MXAYDUNY&X]Z[(;,R*'>*SFA?)VTWBC;]O2?"N)G@D/EV$38J,$-F:XM4=+CJ
MW8O6'*YZ3[%QHY0A\QWGZ/5HM.>0TDK>/@E"*[7$D%F)')#92BN)AQ4B?&)%
M:*0P8T5HE%:D"%V3OGOWT$7INS>K$&@EVNWS @=#5JK-IUB'9.VD^$R8K2),
MI,2GE,M,8:-F#>8P:_$904O)FS!+.86D0>D=J&:+%&-E*Z40Q6+KF(+TK*UC
M2DWN[HW.-7NDWOL-M-^0,@IAMNYD\O9U>Q0XI#2(%.6=-)B84O)43BBTM>%
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M%R*"7DG[:0(])B[$07EEF:"1(HZ57-",2LL]$+25$1&TM6%"PI)6G$;05O1
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M^L%SH+6%6-0/WNO310V_O>Z1.%R&6=IRCZ(VU!QH2RZ 04M]>PQ::A<Z)K;
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MJN,= K5S$+,U7 U!6]&N1N^G-ZL$JFX-@=HYB-D*'(396H-%,^1[@UV@@-5
M[APMYZA1D^C=C@9J02%F*]BA.W0K< 0*6 V!>C^(V5J$16/O>QTZ4%@),5N9
ML&B$?*]S!(H4(6;KIC%0[P<Q)RY"2;:#^8:UAPX4HD',5K CS-8B1+YA94)4
M(2UEE1K5K<; ,6RW-6I]K?*3B%GJ9!\"Q: 8L_7F%JCW@YBE23=#H$818M8<
MND8[)\<YK&A7HS42Q&PY=(T03:]#$V8KVA%F97+3M+6K8>[=C@8**XTU)6"M
M_LR8E8)H"*U(7T#FC9-4QIHJGUZ'KJFF"K*SM0A1R8RU"FMJP'H]NF@668YW
M#-(RC*NG&K:[FG#7N @A\YW(T3I2B$$[FVC$/$B!HZ8VJ3="(V8K%096"")F
M*ZL433%LU8_>U:3"'.:=%#GRINM!:.FND1DZT#F4]#TMPK@IAI#9"AR!0]\0
MLQ;L JL:$;-44(68E<>@*7#4E'#G,%L!FC K]P63/P<6CR)FZ4$6,5N),'%:
M)()6DLH4.&H286^ #BS$' /K Q&SU)& F*U@EUCPRJ #%Z&UZP\L>$7,EF\0
MYD3?L()=8C'TB :128:NJ0]L;8)$S-8B3"R&1M!65D&&MO:C<>7]T_FJ)JWD
M,"L5W./A6#0ILE66%D$/D@ P@U82"X6V?#IQO"6"MB;;,.A1BAX(>I 68M&<
MV=Z0AR[O)!U_!#TH[U@4>C#VI11:FIB H*V)"0S:RHA%<V8;;P\F:"3>8B67
MHIF<O3Z-H*V]1]%$W][DDC@[^5@T_;1W(2;.F666EB;Z,FAKEX?<0QIOR2RM
M/%Q,T(G#<1&TEA$3)_HR:"N-(VAK:YHX_11!:^Z!H!/=0PMY16.(>T->XD1?
M!#THK:@46AI#S*"MJU[4>6^=7!"TM9]&N@P'R:>+QA#W1H_$@<\(6GLH0G-F
MK>2"H*WDDC>&F%I:$H3:U,Q.;JTC1,Q2!3)BMM3"&+0DH,.@G2K339R*%626
MY$80LZ2\Q7Q#*O7>! HZ,F8K1-<H0O4Z1XT830ZSYAQQHGW#=D\<6E)%1\Q2
M;_BF1KRC-WW7B*3T!HY A3/&; 6[&D6H7D/7B$KT.G217%BO<P3*T2!FRZ$1
MLY56:N8O]J["(JVBWE48./L-,6O';U1)'^@<5KBKT1S)8;;V'$7Z';T.7:.%
MT6OH&N6 7H<NTL)HE0[8QPU2@\S*U<QFW*,VVKVQ"B&T\_Q-+:TLPPD:;93V
MQI840CL2'M325O0H:ECNC1[D:.C45D%HISV+0N^-:R4(K267HC;:WCB-+'U;
M ]M8;3Q!%_5)]KI'4>]O;_1 T-;>HZAAN3>YH/<LI8T60FL9,:^-EEK:2BX(
MVMI[Y/5)4F@K3A?U2?8NQ*+>W]XX7=0GF0.MN4=1RV%O]$#05O1 ==*63^<U
MPDW0>9U.$%IS#P(]6KL\Y!X')^0=BB2F6WT:05L^?2AZW<J!OG,:[_7IQ">Y
M79%/MUH:06=:6GIS0>,+K/TT@G;D>"&T]23'W$,ZN3#WL*)'GEHSA-9"7E&]
M1V_(*WK\[+5TT=MXCJ6UA8B@CU*<+GK\['6/HF?FWH68)S$]02>^(R)HS3V*
MWA%[%V+1.V*OI?.4;:FE+?=(?"A"T-H9$3U^6J?Q/&5;ZM/6:;Q(4+/7IXL>
M/WNC1^+CYZ[H';'7TNA)SCIN)3XS,_>P&AD2WUP8=**E+9]F\\!VCGL$S@.C
MEI9\FLU.VB5"2Y4U;+26=')!T*-TL V<<3=!HVLQ*TXG7D &3EZ;H!,O( -'
M:U%HZ;C%W,.*'NB&*1%:\^F\V4D3=.(-4]5$GQQ+:PL17=;LI#A==,.48VFK
MX8Q96FHX.R36Y2%HK2<@\88)06N6+AHIWFOI1-6)0^(N#T%K"['H;;RWHZCH
MF;EUPX2@-?<HFD7:>M6+H*UR(.;3TG[ZD%B%P* M]TBL0C@FOHTS:,FG$72D
M>VCWTXE=<@A:6XB)^M/'Q"XY!FVY1]X-TQ%=Y6WRD-=KPZ$9LW+E<43O6DK8
M8,C*' :&?,>9&W<<C'EP8D;-?.O&2P.&?,<S6KVY9B1W:\Q 9E:&W#%F:<,_
M)IX'$;3U>,^@I;WSF'@>9-"6>R1>%XR)LUL8M%0F@:"MUUEF::E>:2P:[=/K
MTXFU'0Q:FMV"H*WN(0:M[*8I],HX'4[013TMO98N:@_I]>FBV2V](:^H>Z@W
MN23VM"!H+7H4->+DN(>67(JZAWI#7E'W4*^E$X6B$+26$1,'SHQ%U8Z]EDZL
MP6/0B>ZAA;S$[B$$'6EIS:?S.N+6 ROO4%X"(/1HG &HH0V/ALQ*40IDWACA
M[H@*':5"&O2L)56%H?=#:0765-+TKL":>HG&%0B9M32(H)W*,/)TJ/@S0[9J
M!A'SZ*04]*HLA>>XJEW(;&U$:TJ-&U^4(?,@I4'D&];)"D%;N9L\5"@ETI#9
MBASH04A:A<C.B0XM-;"@(FGI$$N8I=8F@JPTO4W>3 HZK#,L8=X&VGEMW9D3
M:"MW(T,[<:/&S#'(:VN+1!3"K%B'5,VD'1)BMF(=@;:2"F&6VD_1EE^ZRZTY
MPO:N0=2;$,ALQ6=D9RO6H18AZ9:1,%OQF3!+\1GYLQ2?:\S<&^MJW@=[CU;H
ML2W0SEI\)M!6K"/,2O(^%FV?6T,=.EI)-[EH()D4-E#9EQ4V$'2@H0<I#Q)F
M*SP39NMLA?S9.J?4U+CN&P,T4N1V\B"3:W=JU9A:NY*Z$;+S"(OTPR5G#E0>
M1<R29\15(C%D2:P1,3MBC0C9$5AFGN'H2[*Y05*<JRE\;EV -37$K2VE0Y&X
M9&M#.H.6FG<1M-7;S2PMS<$:T-6&LN&'T)96$K/T*M ]+/5 !&U-'&/NL3=V
M_A-THC0M@[;B=**>+H+6TGBBRBN#/@9:6MM[%,U*[HW312JOO2&//,EJR05!
M6\D%05O))7&4]I H HR@-?=(% %FT%;T2%0N1M#6S!4&+<U<&8KT='LM3:"M
M^10(6EN("%J::<]\VMI/%^GI]B[$(N7B7I\NTM/MC1ZHP$.:_XV@-9\N4B[N
M]>DBY>+6=W'T(N>43*"73T<K#C$[,H+,S%)I9I'*:ZL[YXGI'FH:;F*0+<\H
M$N=H78'H>B;/S)(WUZ@]M:83\M I)>V:WMY67R[2_FWUC,!6=<2LQ(S-N$TL
M<V30TBTC@K:>L)BEI;D[VZ(RQUY+%Y4Y]OIT415L;_1 T)9/%U4,ME[W(VCK
M-0A!6Z6[#%JZ&F4^+<UF9=#2L^RV:"Y\KZ6+BN]ZHT=1;6;O0BPJW>WUZ:(R
MQ]Z,6%0QV+L0BRH&>WT:6=J*T\C2THCU;6*9(X.VDDMB%2RSM+7W**H8S('6
MW*.HH+1W(2)H*^05E3GVN@>"/CJ6WI!;4^O> T%;^VD$;5W6,&AI/\W<0]I/
M,VCIN+5)? E T%9R89:6TCB#EK:FF\3[:02MA3QD:>D*@5G:BM.)3W*;Q$MU
M!FW%Z<0W%P2MI?&BJ]Y>2R=J!R#H3/>P0E[B52^"UGPZ\26 05LA+U'P@$%;
M-TQ%]],Y[J$=MXJ>+WH/ 01:NY\NT@X(@K;B=.)#$;.TM?=(5&E T%J<1I:V
MKL60I:TT7B27TIL1B_0P>MT#05LAKT@/H]>GBY1'.AM56;&8T_6)F)U^8(3L
M] .S.C&GMQ8Q._WXK*K>46I S(XD#3.S%#30VY"S  .U4A"S%#1J)ARV+L"B
M"8>M<0[M0AUG1F:6XES-M+(89"O.%0W,;8T:-7.)6UT#W6PXGI&G(\?4.Z0%
MB$K!\I ESPC4L6*J/Y(WU^B2=KH&JO%Q;F$0LG.ER,J_G 6(*F4DSPB\N47,
MDC>3=!*(;'E&GF FJH*6/*/FXC;&RLH40X8L776A]WAI-U=TG]'JS46WH*WN
M7'/9'&-FYQ(455M*"Q!5M3J.4?2HW;K^:J['8Y EST W^E+,*'J%:-UHY$T-
M8DH<@6:6T@E!=B93()6%6RLW%K$RY#O.W.H92,PBSS/62E$V8U;:#(Y[D@&=
MF(&0UZL\,SO99(]N!R0SYUW"(&1I >9-P$+(EC/GS4;;HXY7)6<CY$ K2^L/
M71M)ZR_PJADQ2]X<5R,\'E?H0N-HV!E"#\IAFUI:.5-12P]&'J302F_N!%VD
MA]KK'N@V9B.Y1Y%<;F_(0]#*Q=<$721XV6OI/.59:NE(]["B1Y$>:J]/(VC+
M/1#T-M ]M.A1)'C9:VE46WZ0#@'(TEMI(1+HT0IYR-*W(:]1AI'ZM!4]BO10
M>]VC2"XWR-)61D30UMX#U3-:<;I(6K37/1#T(*7Q/&%B"FU=]19)B_9:NDAY
M-L?26IQ&T%9&+!*\['4/!&VY!X).= \MY!7IH?;Z=)%*9Y"EK5M3!.W4[>[)
M,^(N#_E@+$*&/!K;?X:\-:(&0U9BQG&/;M*5C,*8]WEF=EH*$;+3-[9'%[M2
MU2!BEFI@\S22$++3.(:0I<T<J9^1<C9!/CC+CR K@UX8LI3_2-V,9&6"+/ER
MC0Q5C&,X06Y'+G"=$RM"=A(V0@YT#*7PG"$[%T:[&H7J5BNCZW'GQ@@Q2U&.
M($LAHZ9GNK'BBR%+(8-<Y4N.09"=W2="=G:?"-DYENR*Y'%;G3E/AW]7<\<<
M@VQY1N#H ,0LN0:Y,7+4 1&R) " F!VMV76-.%D,\MH1U4;,SF,V,[/SF+U&
MFR/GS1(Q.^EDC;*VY!IYRJT(V3E0K?-DLQ"R%3-(7X1SH8&0UXK""6.6LG:-
MJGWK LR;D8*0K9B1=Z.Q#BQ!0\R2F6OFC;2&N;P;?81L;9KSKO37-8_P,<A2
MU2IBEA9@7A$,\PPI9A1)E\<P2W$NK]@!B5PZ6R.F@.J\3R'=1><5@BF).H\]
MB-EY4V,"4XYG!([C1LQ2G"L:Q]VY!67,T@I$RE+."JRYTF]=@($U4HA9"AIY
M-XI,ZU3RC+RY2DP/1C)ST<21&&;)-?)&_C 5.LDSR,V1M#<JF@?<NM.HN5/L
M](R1I$#GX@@A2U>*B-G9-H]YUP,(68H9B-G)@&-@+2ABEN)<GK #0G:>+L<\
ME02$+/ER42EV:\C(VS0C9&D#&KC/'_/N8!"R=&H= Z_T$;.43@)?>Q"S=#C)
MN^I"R%;0R+L$1<B6F?.ZD1"RM&T.;*T;T%!,)9L@Y$0S._6K"-E9@ AYKX2Y
M(?!ZG#$[DFB(6?+F&G7W&&]V)-$0LI0 $_<9>=LYA.QLFH>\=Q.$'&AE:_W5
MW&>TFKE(=2#&S,Y$%H0LQ8R:AY-69\[KN43(UOHCS-+Z(R4EDF?4C+V)L;+E
MS#7%1JUACKST2,Y,D*5C-D&6[E^*E+I:UU_-ZW!KF*L9L-!JY2+-@=8%6%-2
M$N,94F2N>1QN#7.!0D&(.= S)-4=Q"P-M$=RZ8,2FRGT:#@TA=X9'@VAU\K\
MTQ&*TQ\EGT92[\JT$PJM1&GJ'GLI>B!+KXRMT@BGX5C1 ]5+67$:05L9$4%;
M>P]436!9&D$G6EJ+'LC25O1 K<6*R#>%7B5:>I#2.'I9L39,R-+6?AJUT5C[
M:73Q?SL-L[$FD%HZT3VTA8B>LJR]!W*/VSB]SX&VSHBH!LSR:33'Q=I[(&@K
MY"%H:\.$H)7]]+!#SX?*N18R*\VEDW.@$1C6,D25@M:5.K*TM9M&T%821^YA
M)7%DZ4$ZMZ!:&LO2J&;)2N((VKH40]!6<D'0UFX:%7M8[H&J:JSH@2QM^32"
MMD(>@E86XG0&(!>]UKDE3F1T8B:E0):=XV9:C<<M*KF2KM,1]+ .M+2U[V#N
M(:5P!&V] 3#WV#LI?)M8W(:@!Z6FGD(K;6446M&6G*!1G9@B24NAK>A15+#9
M&ST0]%&*'D6UC[T+L:@BK]<]4$6>%?(0M)5<BJI,>Q=B41EA$+3E'@C:6HAY
MM8_K$0V>4_H](;.C>DZAC=A!F4?C?@E"*[?ID/GV\K&QA! R6WFEJ"JV-X,C
MZ*,4HU'Q@13N:DK$>J,=8596(62V]APU6CJ]6:5H<%#K&RV:J*&,AX',SK0C
M"*T(RDT>G:="2:&E<!<GG0F9+8>.DPB&S)8_QRE>4SM;UXU%!9J]Q\*B4MC>
MZ\:B\NX@]U!*PZ:%&"?]"9FM<R&ZZ CT#45]E]I922S3<25N!B=DEO1_MN18
MJ-7?)=;](VBM>K>HEZ5WJU34K-!;8)77@#.EEKS)"A#:.H0C0P<ZAW4(SQO)
M2:&M76G<[$7(;+T8QDT2I0XM/0H%-NXAYIV45>*&ED-F:PW&32V'S%KV1M!2
ML*M)A+W!CC!;P2YN0"YDMHY7>5-]*;04.$BP4Q8A9+:"'6%6)&@F?T;]ZU*
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MK:$YO[-9F)FG/*N.NA$7D%ER^#-!2Q6Z;W#U!IVY>)LM'(47G(C9*G9]#ZA
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MI+5CL3[_-(6V?'E]]OI-TR$K\NR*^,Y%6NNQ;;1M(F@GTKO#2N3Q<,L\.%4
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MG4;._[/TY8(>F;V5ZC2!UHYZ4:2MSRVD:2L1T4O@5LE#O7N5D;8N/U$/K74
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M2*#W4H$F-C;ESAXR[Z7"@>R"RI4]A98J!V&V*C0R=4MQ)LQ6$A+F2FU8A8-
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MJT)GAIO-GNBB"452M4,YJ.RAU_7<. H*05M=*RS24B\%@U;,\KOC+?&\GHU
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M/6_7^_\RM_O[_R3;[[K_<;S^C_>2VNVN_YUV^ZOJ[FO:;G=[+\S#[EY@AZO
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M#[H"$_L[%[)JS;9&ZO50!$ 'L9NXJ@R*7?#N- VHL:>AQ><<PG:@ZK@LZ<#
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M >(E7MF&;#>3\%:#L*2..R YCB).QA=(L!0F19B,SJ^S5Z>@P*2OE7-/NMD
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M.]6%<!-S-UO^(RY=E]&!.I'PRP3)+I8P/Q/;7[UM\$TNK$\N@XGG?-M87"[
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MRP;V7Q9'GZWYR]; Q=H:!$P9(\/,7FB($P-+/;'['KB(2@QM6LZ8$Y[)U*,
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MJH$OFS[;PN5?*^7=>ABG!"U&]#%.4GKKB;/ZK:B+=S0 7[/FL]PFD%C>G7(
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MN!3'^3&Q4VY]-S?S>4:_.WP2W1\>K[M_JU6C>ETP,X-FS:Z+H^<-$4.4.2Z
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MXX!L:GUO.S[A_QIG->1=Z&".!UT:U85ZM>L>&Q@34H+Y>2V0F8%6A-A2M.E
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M@3IF .+%(0EC50KM J,]&\BOI?)).Z!X1K-8E<(3V8'EL=AD!Y^S=:0"I;*
MN0 #COI2DS$B\;(;+,<D&E*',QEL2%O-KXL"'Y!'D:3*F_KY" NSF,:NQ1>@
MK,X\3KRN*T3P)+B\U+::-F;:)1YXPG6+F9*0B< QXW+8I=Y2I(55DKZ9M"X.
M=[+WCY[G$S@E6B-&QV%<)+F[T_.@4W7,]*FV&;7\PFBO>RZ@X 9+VFZ50<N*
MC26)O DT>W7C\,93[FBI5D:GJBI.4F[G8D7^DUDJ[EJ(ZJ>Q=B]OUHQVR_+
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M\).PI-J_C8\>F9N"B5X&71]Y7FNZA!L8 >; 84L12=N(%G_]P%/+68T>--8
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M6!,R#Z.LMG'1G9W; =#+.-* _W&P0XY,V-E>U>B=42X@T%@;1R2(+6WL<*(
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MHS"ZL&(U1'GZ2I[1LHWO5PBG_G7ZYMTF?)_:U%LKPX1/-%UZK'*S!@7LII>
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MI42?UZS*-["OE08Q$3<ZD?#8W>[M$]B4+UZ>2JJ19EH:?%KV,0G"U@L6?V;
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MK!$=18".P[MY=!!# 1Q45!7T=IT:?%P\V6_.1U!AZ-\ ,G\&I@/^&Z'SE^2
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MK^^2=D2&GQ@HZ*SPP%'BF1%&^O$=,);TC%4:^AL^<9J:'(F_D'A)^,U":,9
M9"$ZJ?1'3H+.A)P#Y(22JDI_R9O'_%1$3"IFV*[0+3AMVKK0'&E47S_ =WK'
M*H5ABGWICOL#?*"])B-YK:0UEF^09@G<DI2!;%L0G^30?=%N&H)%G)\]_#<M
MUN$/5(=^>/;UDW\+="W8 :]_.M&\:"ZUL0C>>0GR669KU7(9H6I4=<FM93#&
M,"=LM>%*&+J$J%A+?#@ZYNYL\A(4*.VJZ8K;IM^EY&3'H3"L94$H2AIEW_3,
M5E6P#I&"3D#0$<'JF)1X)'LK'=S<%@7@)3&YA/XI8KP &9_ #_[N(FM"J?7
MI1\"-N@_GC]_?0C8H(P/*G8=:D*]*H<B1T[3M:4QE9>F158AKYP"@D8X?BXC
M\]*A>3>DE[R\91E#[,OMAWDV9AAOH#90S:2#B3;,A)^"*)YI@YA/(^9(^G7+
M'+JAFCPM%HW4%AA6HH.(?LH("80D^:;S/63IOMAZM4.TQ?L:QSRCCE?9PPF3
M+X=G5=M2*86[(K0?W0*H2_!'@R4SME@X?W/"*94-6R)R*GT13K\6E^Y(=HP
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M^X7_D>W:)./@TV5M8;54J[R.!8D#Y;C6Z*VUO>4$['C3* ?#T+6LSL2&6Q>
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M+1T,MG?P)@\B12:<4^DB4Y?53*QW)()O0?OOXRWLB_5RS> /5*BX'@7"567
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M5!O[5L%+$Q7WS0J,GU_[+F^\9J; +W)^3FR)O!].$1$7 D,GIHH6T@@R6>=
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M/T4I0HYQ L[3$X^W6RED)$TYI%LNFSC7FK<9D70_LEON$&?PCL"UMZ81X\?
M1?7<>RE_,)D.S?7S\*H#>V H!/KVLOUEOV'5C[N8/N,JXH5B*+1HZ*@O48/6
M.L(1V\._&T&UC R+_DD8&O<H(O#BYTI8^B6P2N 3@#M'-@:_X48O3_]F^]YV
M_M[6\;:%\B/S<A(U HURH7TK> UA< W4BO2<@;PD=9Z84/F7=6T8E<DX>FD
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M'B,1820>WV,D#F(L7S!&8F^&78NNMN)L<+\3*E%+J(O,NF3CT8Y/!5S6N5A
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MK5"<ZZ.')5-YPQMB[MV$P7J@^&SL7)QNE%@D]\DN+=L#:&&=7*N:VC=_F;Q
M1NU%R*C]Q!FU;/*=\Z_?=SVA75\P?)\R*:( V4W^^M<7V>31XR>3UWG[?O+<
MA1%K]TR/SMU-7U9-XRY 4_K?3?O>_==_3\X?GC]Y?%_%B:HX3^ZK. <QEM^[
MBO,'I;%^5/I(L$:\E#3VJYH<DLF[_ ,]43BEC\[TOKNZH[*E(@LP'9K5+WDZ
M>C<=D=/265]24F'*A>A\UK*S=]RB=>F5+CEI36A):=U"DH4,/1R$+0/2F"X
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M\944-]/LC#1;-C-G0K*HNSTS_H+G-U(VO'7%N$!S2^]NZD@K[5I#UP#$,A;
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M/-Y2^UW#XE5F.5V4_B6=3=#*+QO7.U5TTJG9H#,-&5W-PH3,"!</S5#=U'"
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M5R+^B#\A7JMO42/*)+A/71)%/"$),SQ[$0Z92 [AFY8V/)8YEWSYM.AO"-%
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MU/5C]-VPNJS)*O6;1R=7 2%CHEZ:"G@5$P?PI8L:^PRMS)6+K1B*.&/(^UZ
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MNF):L=U=*^4N#R4@AN>9)'ER<I8):1LREV%)A:I7R?VW2H(M>J62T)V&3E-
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MX:^'Y_- 7LE;1-T^*A73_EP5>:4N! QR.OE;+3)G=^BE-&8_IHCT<9,\1EE
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MVT&QC^YD:G%^Z!-$.-&,\RO<0-S49,\>?O.M;#BT8''JAN?1/0XV87=5%#P
MOA=Q >;U>W&L0DG7M 3^I[O8O%E.'AQ(&>KO9_^96N\_8O.?$*+@6I>!GTTW
M:6[*::[^R*G2@_>'L[\?Q%QE\!(T<RE[^\45I?L+3U]K$VWX_*=_O/K^]/R;
MB1OQO'!;D(CUQ31A31-X$\WV?=4T[\4$L*UP)RL<AFQR630$"^G+F?@J.HJH
M;1;U% Z<7EGL<!:!@V"-PM7&=.XXD*%E$5 LM+L#"T1.;BY[B0''B59ZV "&
MS8B_;_G2H2^7>>Z'S)O<+.Z&M&!U%5L-3KH^RO.H'![%:K:&LHCG#\A[^KIZ
MX#F70TI)Y.BK=5/,&HI2%W5OA"!&BDN-ROBT#'(-+3PJ1A ]BF_U/WVS=N=#
MCA_^_7U+K+E^ZLFK$E"F_YF,Y\=R/G>GY@]Y9UG7W+J;$R!+ZK0:-N$U,!2R
M*Y0C0.%#SK%LURN%28?5!-!]0[>W2]P?)-(&_"+P9&WS&LC_5;1_6:/^CY-+
M@/:,M\K,N6&BF@ J)7S.<NH.)-*+3!JAD][GS*^V\+?.XP[D$/A;J)@IFAG4
M4Q+$)%W#N -J!;.BK)3X:[IV86"OIR"]([=!ZC'LQ83K;5+T6$3A$G0D3Z64
M0@[.)>T+B?U'_:E\Q*V(N]V?^ZA_GLZ."E?R#1GEZIX@IVS%^'RJY&?4V^R3
M_L[BNI!W>)ON:MW3B'6]2:"H-BZ$6\[?6S9E):4.HR49PB?88G*%KDFQ>8#%
M3GGD!HD149Y1HON_UXO\VFUP\F''_/\;K?&S3UA$,#M?.O8EGLS*J"!H5L\X
M/0@B8!M9FAF(,&G>JP(,RBB7P!OMJ25:WA6 !8K^9[<MD6^Q,A]2O^+WA(:8
M,947<FM-])E2AOBD3\B4F4:Q4/3+QEO$MG.(A$R9?U=!,-37YK'7L ,&:D%'
M%U6!]3TZ5' *;8\_+9[5\BRZ]4)7EZIHNVHX4#'R(N0B#ZG9@6P(QB?\E#.V
MT*MI%/,EN!AZ :/\7,Y&7UY2W*)UOA!>#*Q59F']6W*OZ>8=M%BH]_Y"Z4CC
M+:[_JDJW4N;RB/0'W>VOF&U0QT;C(BD.3P0HC-SUJ0DU0FYQ_ .;BDT'-#@*
M76@+H.F&P18^&ZN*<UTH<A+LG;L>ALM".@<$[<7_BNX:BSU+55LR4H)CP=^(
ML8*VEUM%%P\O'OFTOHV&+:[+7)-_\AC*-!3O%>8D8M6T5LKJ\I31 -.K!;*A
M";2+M(>2?S#0 0&*)EQ:/F_)'JX++YE&>>_,IL+ISS?$#;7?\!O=DC_<W(.N
MS8^6,@Y\]@>F^7 6\)!7+;-PKJ4[31Z!"^UQCBKTY:3V_+[.?L<Z^Z/[.OM!
MC.5WKK-_,U9G/W^XG6B;\N3'X*T,Y :==U:Q6(A/M8ZCC#.4#T@!AA-P4;UR
M+ @R.C$#_RC%RH?SG?L[JW#>.Y,(@##"&;B7II=$!&1F[D[-O,RW(:0%>QD>
M-<=30 <,CW/"Z5[;R/YG;<L<"7K%G:; HVC%FS%Y@_$*P[B<),Z9G7?3KB&K
MX4BDY\7D?;'QQ;J9A8;:K.]T8\@ZI5ES[$X;W[=I;B0GX+R Z<81Q5XEGT%;
M\.C#LXU<'TM[20(GPQ%HMR]2&4@D=#MFF;4@^44*7K[#.Y;>M,YT7Z.^1BP.
M<VFU&-PZ@8&67;=&&HR:S^/*KI*WLJZ6'RR:O?@3S%2$?>=Z $C!>@-:R=2W
M<!ND+;7^S2YZ0%IO87+\LW= DD LZ;"#7X99D@WPP"UW6:*R,$V=)2(NR-+@
MPAWE5Z%-4P&,Y@^SYE2<GZ@K?<-0P()W6TC+0#WLNG#;#N3=O4@-]= %YT<L
M/CBO%EH3IR8,MK,8*,)]$*&-%A/(\L5$&8OB!LA)>[F(P53@BT#01!*_YA;2
M)ZT(AA?;MQ $,>91#9V+,*>4LY 5@Y3ND-L69LM,?_2,V"GK:>?,9!X("$:L
M%2C86HHX:?;9&PS[J!.SM*0\\ J:HF8K)Y+GQ/JG"T6 "D@.M^A@6:85)R(
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M@MD:UL/2"#1B9[$5/MJ(93OL3X[K&6PESR8*I$V;1;D_&LM31A8/U\]].*4
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M@U^@M9#D:#I56L@DS>=+[DNW"BY%-&&0*T0I4;*>[804#Y94,Y#&7.D.HFY
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M5W6%_Y5*1_8%AV075F)9'4=DG[11WL6;"A]J! :UZZTU#B 7XJ:1?<L(LQH
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MVTG"W5D'Y*? I.<N?^3X>)F!3^8 W-2.VAEU)R1=EXF+/.#BQ<]YM#B'[YS
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M=O5R)<2#>JZC2AHS(RB)HLCZHNVBL*OZVC^8X\O\UV*8&SFLJRQ$DJ'[7T/
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M9UINVU\H)[H]Z$C#CL!SFJQQ&^YBKD.B"4K+V@J/@VXRBLLQ(&!NIZ!?[A.
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M -%@*R"C)P?VDFC/;&$7EXLT\7"G"8F!7S-DN@<)'>YLNL:T"KM%XGZU05:
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M\&ZZ-J%_PHXLSJ0_ ':J@UA[S%P,_[YO$W*S<6]@?Y S#$"&=EC!II]\6U)
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MJ2&7N=7Z05/.80_@7E$T1ZC8S.YIY/Z=G#6&]K6]T\(J72CC8HOC&'R*K+1
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M6G-J?IJ%TU*W4DN!BIR42/7;!Q4DH$'R .82O6ERYR/WA5VI# CAC<KX['H
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M#2KO:!4-F!WOR'^')J5_U@UWYO3*@Q?^"/0_N5DIJ+R(0.>R]\&\01,C\78
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M5E3MNG:;IXTV#RHOV'T*@[S/Z6WH2\2"0%R45;DHJ"L_L#9:?./><_V<,Q-
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M]+C2HU]6._5H96G?^*Y2MZ,,Y];/MLWG"+#^:(^.:P['Z<_RW'U1J=%+@B$
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MF3X:O=?J9Q/+H, *88H\"K+DJ=<C2PQQ=8T9'M9)21 W:)3KHX_,\"J$#X7
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MMH1P5:W/OK1QL=#J;01,B"IGG?(W$PQ3'C4=H"BHYR1$49B&0,H$P/2LN.L
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ML.*; -$-=#O )# <G3#7<ACDYH$:'J8/R.N@'^-8".J2Q6/0MC.H>%DP=,2
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M[M(=S"=#"4<VH(%^>(30RQEB8ZMZF&'XR$P)KY'('I>NLVFD\ #8ZEO\LGQ
M^BJM=%IA-I$CUC*728C4@PT*1_6O2->W,>'DM@F/6Y$2PSJRQJ#C+5]GWPC-
MD\0VR.%SL&']Q"YY(#Z9(ZQZI$01/JM[:K1A(\I7D -5^):B$]1!.F@HL*59
MK/BWL:5P"X)RX3_A<.A8(T&2)2=W=9 HYL)U>/_)!D1:5S$MFW\U_^B,B-8E
M8GPU\C0#4&)[A07H(7@1U )K^(#:_00E4'RH< *982$Q$/L2*Y)6WZ11I&4(
MPD6%&0O1WVZ?YNIL[=)[!9\^AIHQ:;/OPH9%R/Q'I?=4JY6DM&&7K%&?[AYP
MB?OZ724=@$B;P* 4)E-(>8XIOJ<TEJ^ZL &%=*MV:R/[B=E+F"6P3,/)"4B]
MT[G);O#E\\"3#%8!_%S^??E2LSE+;[IPF/'DVO(,#3+^S@PW/1OY@)VN!)[^
ML;\!*X:G[Q)'.O<<[F8_/C4]9P2SEMZD)YJ3R7XJ8'\@54=\Y=B>7&)FLY.%
MS=&R"#@ZMT!M+'6PMP;?AI:'O@T_&>Z>;@N>-"I75(9O!'-\FY8Z88D7+2&;
M3S9$I'])O#*,$](OLD_&_6*^&&&$]#V*GG0;^;)M3+;9E/6DK=S9?&VSADKP
MFCEI0+VT71SR<FN5EOKB U8 ,<'/XTY/VGHN';[@"KD:2=\+=Q/V[L+M&I:E
M*OFUF*9$[F.HB=63LSI</"Z<0S.GXQOQ6.[@G]\13,LUQHM?+P]0O9.!F18E
MKMXUSYOCK2W.$XBG5QJ:2B"U@K'MHQ'E<:&@W8I9V%D<3$;PS]AHR.S"%XIJ
MHBE;%B$<B57YX80IP7QO;!/0G#H1U9-[/#S"&"Q)$VG 8-3Z#EPJ0B;J#"KI
M=#;UCFU#"@'Y_(O1F2O7GU30,&*K=Y*$Q@U6)9O5)ZG=9HH#62NI:%K3)^L;
MH7HP984CH7(Y)=""/\CQH[X+GMSZV'V73VIXU^LB2(<# '[BOWM8TX/ N#HM
M#WR*OB9M*2V+S%S_'FR%'SR>Z0]ZM_\9Q&&H487YM-[(WKZN'?-QF1I'ZJW6
M&8-_C[A2SC3LC6>UT=F'RPV)<B(^A]<CVAI7FV\M+&FYP31H^4&6EP>BP!K2
M=@E/L>6UX)LXEL_^ABE,S"F G A$O1,MM3GJR<[4TH0%[CYO?<IK4R-Q$PTE
MGPJ*+>4!1-93[R+9%?D@@@J,]<<'C$=53+PW7*!5S(8A(6Z9FQB_DY,0446K
M8+IS0 I @>#U* #!7F*Z@+'*K\IEC**PC21K1$&1\UH9#*&5OS'M/4F, 2>>
MB*O"->P:P\N0H*XGY 72!)0_(ES?,.L:F0@NRVS&PM:;*1--PMOFB)7DYLYY
MG5)*I\FO,.1.7N O"6):SF&BQ#NR/P5?K$C[E$#[/5RLT-UO2.+*C$^:B7+P
MFKVT*:5\3DF5(BX/9PIQ:2,"0^9JT\"SZ(FJ[^.W)Q4JTM8%VD8D/4^5!4_S
M542;'ID>(/@_-NZBC:QC;\?^FI),H-;4$60>Z!S[P^-^">UD#9 SPG$ =%B*
M6$*>2G%KMTVS)P JJ1VED21\'4<K^#&LH2R[)U"4W@_5R-ZW$VTY[X7MU*4N
MM1NGM$V))PY%!R,S9\ER<#(%\&L)E.I1&?HY(3[Z9>)S<["0=3O$%,WFR)R:
M.(_Q69'Q<''8+1\X WE_#PHQNK$1C4C?EG7VR0%D3#37EM!-7B,_*EHH""1C
MH-$I4_!>69P(9-4+=Q0X[TQ&$:Q&#\BYS8&*=V8B($\9(V2Q5?@L.3S(O(0"
MRRM!\#_4LB:&X@G+G4.(Z6H$I\%S4LY2CB!'SB>B)4YDT_&VV491:L/ES4&5
M-?&)60A'RY!^Q L#2AU,;W%,\^TQRQYQ:RVH]T*M GL#]EHJ09S'"ZSF8EC-
M;UY@-5<QE@\.J_EU&5;SFTE834YA!3_]U22LYB/M;"[/+H@*-'%D#'^KDLD3
M1W9NHL*%L"Z$4N(1;+JA:!!-?.6M&GZ1MV-X"T:N9.O T7438IS&$$^>]6Y4
M3B.<:0VU,5)<-L'16+\%X?=C(Q$\]<UWWW)RD0@5[5>5""$3*6A"D=^",K',
MZW!.8S*UW)40^>A[A$W5/ XT2=K3%F]&S$(A[2<F6 MR0,4PV=&#%90X."%9
M2)W!I6M),"V]>27+%BZ'!CL^UIY6"N^S9ZWRDV_UQA-/B;]#BJZRB>!V/7%W
M0W@[A.L&D_;DHPH,E\"T1DT'R\E[$ANUGB,LR0/']+E/.)XFN)M]1XZZI=]'
MUU9^8 HN&!IAK2/<-&8L\_#.6&>O3,T=*B3AT2MX^'V'Y-E&.$!>*:_)E,,#
MQX#:-]$'>[^N(^RC)58A07KKQL"NG15!PL. MDT8"T(]RAX^E6>X_:2&?;UH
M:NX;6G.U*.-,,^%_LKU%8/;<-W%9XY$,0W80A(8?R.??A>@]8;.&K7?+)PD*
M;\M@2,-\W IRAU_JG+6[PFSI=.J.7'&?L&L'RT1;(,(MJRF,T^T:PJ0RM]\Y
M"F5S[47=4Q\(6%2C( :9J[]C;B*6RT:;HXI=9F@6+12+;QNZK8BPD?9_][R;
MD G[S?].NW_"J.'(XKL^=7OBO]?HBYLP7(THN4&1(-X15)CE $,3H589,*9
M++P@Q4&&(6FA* [):#+Y<DI%=\;8(A3G]F[VI^ZY>4JW&;SV5!>(8G:T>E/;
MU@8T\!2^=[[MF)M>H82]@EB. G;/AKQ$=@>$WW"[I>0 Q-TIW-$YG:'>VCGS
MN)FR=A>+@N_A7*7?[IPMV3V8I ;/ZF>W-0 <)ZL?BZ7GT4GG?*3_+D9IL+@-
MP00)*XF\TK'[_,R--GF(/S73[+R >!?#<BMYDV"5Q"VLMY*^<O4#RGD "((2
M-"ET)KJID1='-K:))#@73^V69_6@&:)]:9N;)@PU)#)&)2D<B+>[[GG3K.X9
M?2(.#3DC;KTGJB^UII;/8\(5'QI[A2-*B_O+3.$#\VO8(0?OPY)=9%9]QC@'
M^(!_'>&%8^$4S8M<%"0?@!5[EU@[L2*TG BL[\;L6L0R2N-?<&K#F>,&S0[M
MXC[2\\@3!X;@QC!M"B]@K008;^YNRU6 ALOTT1"PJL#ZW3&_4+6IW8%KX*-V
MO*4)\=C<:_;X+JR/BY#P]YH)_=9QC'S<XO+/B<<0)54*5"(*I--J95ITSF2V
MDM*J2 Z6*ZL)1&N>5HH9[\3JOP4WK73H)G,?= QDUZI0&A\@TA?ICR*;!QTR
MW0#!)QX'*&QY C01'#+9)L>ZDH;N(PPEY^1+P'*R3)B45:2PL*Z7PD[E.R[V
M",;#^+%Y$O6B!EG7PO@RW:0$04J>A;G-Z/V)9>H=%!F'ABOK*EHT:[A/ +#\
MD >(7^)8B*I37U#/'EJX.=&SRZS=U*.-[PY3HNP9B$AF?@^Z>5@'*IP>;8=/
MAN(<8W8'Z*^"2X7?O.:-RA,<+LT'NVTY TA$2^JI^LUCJ7JXQPFWP'-XIX?6
M=NO3H.+<E8:,L[=JMJ3@1G!]X-ZY!7=#DD/M[D JB]O@Y0I; $[&8;GD+[R,
MY(1/8]LKB;]@AKD"%_8H^$$)?\KL+.(SW,9QDF,([?8[G6V I&%=%)O4-O!0
MKB2)=X<EGVN\:*;]UP(JTBN8)ZD@6HTB'Y*:R,Y9LZ@ #8IY)=S*X(]3S#<Y
MQP(]@)6:RY3HW_P\HPX<'S6*K#U3EX_=,<&D-IOUO&+_4<QPL20YPH.5^LP7
MW$*F1<OXK[9UJ)14F[@*J'UVV3SN"005H3OF-3!P( 5;K_!\_A:PI_N?V $S
M:?&A[#:/R?2-:8U%$XK+Y>$14>_13:BX^]'9YMH*I($D-55@Y:X>PVF-3\C$
M?+S/%(S8QTOQ6Q/8K73%%6J4@KH\G$OU,A!:AJD\J\A]-,\M%4ZFB-0XSB%T
MVXXQ#IYBIZBS-ODP_ -ZW-X!L!S3F#UU'@G%;;&+@V(&&'N#.>V*FB6[5)N]
MON=K#S4O>VJH$Q*<-5)H\K>Z_M&Z)T(9T#7;[6670$*,_KA*:88DMQ,^#T+:
M1L.W>RZT;U:FG^@%\W IYN&W+YB'JQC+!\<\_*:,>?CM).8AYQ^!G_[Z&C$/
M,8L>#.L3DH%R&74X!#-)#2?>ODD_.*!P"UP6PQ):VODR)0N&=_4#U18L6P&Y
M>DE:T2?B.OL'(W?LJMD@>H]1H6:PT8\47#75E^CR,G'J<;=JD>  &R4QWSX#
M8"9<_ZRU2P,MB.$Z@K,DX"I1DD&V;VL5L5<'+)-V" :OP\-N@R=['^P_MG94
M*$\U,\P )FJ-HT"G2:YCH<T"',>2I3CM99(B[=)K':-2O"Q714+4$O06<,7%
M*=4<3[JV&(Y#@GB5PC\ZT2U3,D/"+;N-F*@G8Y0I7UK%[O"8M(VH0?6$)$DJ
MZ'6WA+'!#;2A#Q#X@Y+'LF\7C?\Z05,DKT>H#/-B*X&*4KTGZT03!&F^Q#Z@
M$7R\#D"@F:L:VOICXL0JWAF02_:& P,80/\<.NPIS;+%P"E#YOA7)P\;ZG2*
M>HG/ISZN%%AJ4V5*J\<6:-:T.%KE::%\/1HF@T8AM\SESCF?SF:I\Z&C3+%Y
MH&4CL#@7;*H[NA3 W>R_=A@U*9U@1E%;$(53LD NL0QBT+@^-D1M^1CB]B,E
ML_2,JE$<# +DDTL^)$$N4X)*SY?63YS](;L):<N=%H.ENI"=%%SW"$/V.64K
ME#T:_8TPLVI=1<'G1(983-<6'L#MVX1R"M]!)K(=2(DFZ:*>4\4T9K0KG22N
M-8U.Q]GI 8D!S:PG_;/)8@E5;X0J>8B24OB."='S[HU$3'I;@V+:"&;)YI*)
MW@H91,)AV]UFS? YL;CF^IRIOM$&6%-&+<:6#*7'8TA3/P_?DC2%X*7&2Y^0
MX=)VLM>8K;$Q7FZTL%'Y1A&HDJ[X>_H&]%8X:Y5AH)!>:P<4,!NI082+H8._
MW8)V)0BLR.2+I1J!4Z%OL.U6:"X5_X#+2NEE;*@0/8@Y<T ,G6D7 M+/9ET?
M-K!&!LD%06K7OP443D6P47QM%,4RM1&N0O+ 61"NA+K\-ZVW,!" W RTS(>=
M5P)&RD52[@\2R;6^@7(LUJ#=ML!IYD[[/FN)IR2#UM,TYT"D%W:B/>/SOW=F
M<'N2\AG!=NY!V R//:&R=LT&]U,;XP8E8D";U^Z0IPB]GD7=]RWN3+*-8NF:
M;1@/]GY SI?@-*HO$)Z\J^&HS*-,%>M84.\*7M#$HL*'S-\4@\$:$>2-TX/4
M&81SM12+^!IE<O3<^RQ3YNYBJU]2UF)?.R*CCC,AUCBK[^_,CK]S\W"Z*N!,
M%>"8N,(2;Q7"K02MZ4YWX0C? \<P"D*)M>ER1UK2CH.#"A'7%ZZIJ<L!3,#N
M>5YGQ%3%Y+5&4G8YLX?1R4Q?2>\6,9>8R<=(PU),=SF@&V]H7HL]N75X>8V0
M7? 13QE%'-D8'N(:EN6Y;A&X%^8;'6"LM?6$<8_<(T?H:VVW!%,,=A5\^@W!
M(FE+OJ+-._!?;.$HP9Y<<6R\.C3\WVM&VQR%Z O_67XFCY*UZ(9]N/#MF#09
M#LI=\-_UYE7^9EIC(U)R>P-E#T(G;#"_N3^ '[$7"&BS!4;15S :*LW;I\!N
M>$5\FWX,W%2\;8=!#8+%&:.7SXV7Y"TU@+:OE^C@D2,@5Y3X I9X7:[/B-D7
MZS9!3SZ"IQ9ZLX%(+WGBZQT3F3 39FTK^$(1644WI*<^:-^%^,D%&3_@X=TU
MRVC'-8T3EH/[6,-Z0XNNZ39)P$<GJ\FW2 [3]0F)Y#E5[H2&46D2C6FQ03@J
M:DFJ7YMA^_3*F4<PE,D4F1<L"F>\[WL65&Q\^B;>%%H'4TNN9D_!BS%#$+E>
M-67FRB0VT?BZ3&ZJ]1$_AO"\)]A3QZ34HG],R+\=H"(P_N<J['ISH'X<$6:P
M3[V;_>=X6@+N=KOY\ 622S3,!8[*6#<[O"P35M'V:5!'<59B2!N-^@2AYY*#
MG^#YC@C<EL4+->4V$_!I;5KP10,GB1@*P/&$>C;>&-0Z;D3/?+;" <U3)EKP
M)$.8WT/55SW,M [+B0E\7B[MEZ1P4V=3O5G.1ZQ2:!->6(Z+K,#5N6A,K511
MMGS<Q09QLJ$R1?8P5[Z_K C41 ,;.[97X 2%0R:52IY0>!:FL>G>1+;;KOQP
MMSBZ )_<?E8;YK<-&Q+;5O7/8 ,O0:-H>]L4B-SM/]P^,)6-@<Y(,!R'6_*A
MBCR;=[.?7$I\<2RDQ"$=1&GA/7HXYJ:[(!-6I$LH;L:D1^1,% Y?[G$2F';7
M78Y J.)?D(5&C1N ,;CR*Z,N%74.[R \PZ"PO=_1^-G FYI)>BY>8 "G80!?
MO<  KF(L'QP&\-LR#."K21A SI< /_W-M2B*3-]!NV->)N0BK.WX23DSSZL5
M"P5+BO"W_LVG=FO__.":L,R+A=F[[^MM\1)*DUU4T.EZ[3DBG].$[IP[.TNC
MG7JES0?AJ<B>!GG092-DHJ:GT3:7=BGR<Z9B9)2<9%PF/4L*KU72YZG/)H]Y
M :[-GA[NH!\)S,&QD5KI:\D#2ZA9#ZXW:<Q=)@+ ,T-QE:$D!>M3 I087:SK
MEMC3L*B'1B?\N2)'#&$\XN?O86Z:X+UWQTS-;0(+;Q'*.QH?!S$^9Y\@H/M&
M@AA#F5>@.=2 >I^R;XZ,VD;JR8#<1L=^2&J]P]D@SBHL#B5-#+BPDZHI!3U1
M8GA+O41P"IEVVFTFU]8AW7I1MZ;"OE<P#E38P^I9^D(IN3 5>V 3[R4*I64/
M,WT\*W^$?J8HK8P.%]<"(%:)^C8%N #,8J+L<[;4I'CIHBGMZ4ZXV:_10E_8
M4O>M*?1\WZX.(0[MC[,_J%;('R!F_A[Z3CZN;E8:ZE _-W,K8B,ZI@#5/K_-
MFKTYF8#G*NP-)E"5D)O3 Y6/H.E'H+UQ>VR;C;T;*FSQ@9I0L(G;L WOT>D-
MNZU9I8>7:=A@*LTYQN(9;+@#=7LMPKZJBGS35/I)M(7D<J#6GV"%VPBP$Y@U
M5GBB@-ADRW$QF$ZC4SNG""=)*FN3G7B*GNB>L4EAK?MM==@K0Q!-EN5X)(\J
MFP'3M%*(^3DAR AS<VNQDZ7T*HHA8H$<&48<0(&5+\DU1?[&XEXQ5'S)'AC#
MUJ1],R[/9OH\>%-'<6<MF<[/:.O(V/BUEII*$L1ZX\2TTO;!LISX5KFW5UY+
MWF<@>L1[4Q74%%Q*'/+3\^MDOG"9H9R^;"2_9VA!]Q:X&CPTFIWV'W6\\"DI
MA*$Y9Z$%G(%NG.12"0Q@<(:,R\@QIB,)V.J<\I86SU4:[D3#-[VBZ1PKPS T
M=YCMS1NA4=ZIP1W57IES#B;+CY);)G LST\Z\M8C=++K&CYBLZ61#HY(M\B4
MLS"',>0SI32[))?J)WB,(1=T@IE/F]7:3I-D"[[A!/#.8+?3Q:DX>^U1 IHV
M5>GD54-@72R@,I?*=1'"G^KI_YANA^H2P]6,YT 1?7L/.\6%/\)'(&)%1N(&
ME54:*&#O^"^V> ?:OXL\,IV_#MG]*M#E*;!6P-PMU67.(RR)/H,^AVE@%T2\
MN]_0:*0N%C[!/+W@JC".1<BB0&NO%UZ^_2>.Q#6:BX)<.5E^B!P/GD_[\1#<
MAR7$FGV]8K&Y%&5:T"*W[E6.5YMTK."+\.J%X%?'08D E;!#3)/)6R!)"ACW
MI)YL'J+CQ=RC!]F.D%"/#]4! OW]+0?!H"PR>L'$LF(QX- /AR)31L&I4@_*
M(/ L&#H<D *C68F*M##;:3WFER-(<C&G ,_ JYG78([J);,?;>3^<2-+D5L0
M=861!!<Q6:D^Y)I<" 8:</KG7#8'\RD)N?PVK.^9XH(5IT0G;G&K/V!@[&E!
MST_.#K]D=2_*ZIZ>+H3TKKI',*_WA[#;-@@E@OG!W%QKZ/+R*PZT&!Y7M3(R
M>OD<BMG0%+JS/I:\>\E"OV2A_YU9Z)>*_J45_=^]5/2O8BP?O*+_5;FB_[O)
MBG[.!@ __>TG4=$_;=C9&QO*[ICSN3+7>-H73H*9W ,\YSOMM\ECS[U('S#F
M-'G543M\4ZZOS9V6F?#=1L6Y*N,QSN\NB:NU=QJ@<>T6_@24$Z@$:/^(4Y 1
M%VY;EKN^O5>HHP;.\WE!B#RE-$1/(42O_8JG*/P!Y+=OGQ&F%UV9U$&*(]%B
M"3AI8789)8)RF#.2F$?!A?Z^0:HXZ$;@A#SRXMW$1^FG^0K>8#*P7F(O$\3:
M\A!<%?IK%C]%Q!\I1IG6()5S,M#:4B.4S(JI!?FL+LC4ON66OLB.R*D+=!H,
MS#B53I6$9N3"(ZHQLPO#%]AW'AXJD@&^I2D!8440<I)>%"I.R'-'P"1C+S/&
MF^=)ST9I\A2"'V;]ONM6X&>".](E3LLG%V_]G/;LF8HA9JG!=(@NV%C^_YS0
MEZ**0=+S668S.>6<6\,. PO_T0!)FYVIC!,W4A(2F^9!.:BP=0PQR9HIN55K
MEYIVDP$U[UHO*F^YP=%K)WGZ<\<[Y.E9Q#!8*]*:-A%Y'U/$/:TES70+4;[&
M"4B;J7'U,/@'M29B:*?-S$CP[*C5S%4U)4[M\W=%(9CYJXBRRUHX(#@PC!OC
M@N)40BH"A[$'>^0A/A5X-[MYTS3X!]=5+9$:#A:IOGSE!()QGR@\P*%MXAE\
MP\5,VNZOP=;.OD%;2P68YHZ+'A\S*3>_1AMZ8>K4I#[_T@1?:15&<G\$?]V<
MD8]+6/V?W1[VC.I]8%XS6'9D13C'H&,N 0Z5G'Q^A+1YR@V+^8BW(MYAO"O#
M&XMM@GI#RU^R>A;*-7GZZ]%TDPA-90[L[X%4XS_^5PAR7F%AOQW>WC+)/+H.
MZ&0)[7RP1.MV$]F+D:[:^3AC8(DH[%4"MPIM(Q7.]C@*^;+A%1(YQ"$6GO@9
MEUZ*#S6#BUFB2NH:X;]B]J^R6M&5*I31O_A^@OLHIB=O<@9K<J;B1Y3!<87H
M(T#4495_@RV<DE,J9()87<4>CIFIC$.0^TX?4.)ET#F 2PLZ7Z#L#GTO0,FP
M9PW/,"?DN6IWM'NM B0%&M.WAZV+"/1OYY"56A[<,\P[T>_P1L<>XMC.6._#
M9"\.>W%6$@D,J?I+[_D<&\N"![$7BG35RW[L&SP/RXQK=P1;?2J&2P%?A30Y
MN7&^^HD4-%V8;HB(C# L_F+9=\- ?KVJ2FO(HZEF/GB1A(5C17(P#,+/@'UT
MKK7"J;HMN^X9!A9\-JAK4@7;L6B$/PWSWPX/5#)'RW5 W@P.("7S7CQ5R>F8
MOV(RDU6+RGEQJ7<HO@TI/M[6B9<THIPS=<SCID_]-Z_B-V:X(//,HD*P\5:'
M\%I'#-_W$%7>-P#6?WPXHDN)NT(V?R61?<=2A^'_;1?UA@3/RF^2Y6CSU\ V
MKN@NSMD>%P)/P!?#BL)O@'5&767;;* A+X\H.JN%(^*&]@JY6\@ 1Y&\9,5&
MSEF13<:;36P:.=B"/!P/H_X>=_^W?_XQ?GY(*@Y*MD.5)TN:$[_#J<J[W5[@
MR)+K*,.8FAV%AR/+#\376R%/$=3*@YMP>WB4Y UCQQ@,#HR:*Y9)(IF6**,L
MBL@ ,^$H+45:\I?PDQ&%"N:A1[J8!LHAZ'@0+G@3=OE*BA(T5Y2+@'\0ST^]
M=T^)Z8Q(05'\\SEG.'::#B7A3'E!F0P_?#T4,,"^;@?Z#-[J1$TN5%\\V\RV
M^,@NNR+;;2*/<SI$)6KL >)Y]V"JZ_L:*C>S?S1]1_0U=+$A#:.<;884QRE@
MUZHT$LQ*!1=O=;L"_@6AF?%2<I/!'M+$O8.+YZBD0:A?.68-BR:$70D(&%F"
MP=H!7(D*C49P1U"LI-M]!K8]S/TS4H^32$GETEC\PGC&X);6:,EGJH*M4%-A
MHG 3>4?H=VI!Z"?(=+E$M^])W+X8Q*O::.:S5!:<7 ECPZ@_EW[=V9J7)YT%
MUS!=4%^D!&$42^L/&V0G[XEO$[S1FJ]F9OPYA"]!NAV7/)@<Y1RG#^CRGCI&
M']L-#L]> =S?A@ST)S+GKO!),JN0\(#-Z!*0]"JV1]Q3=A28B@B%YZXM?62(
M<> K6_+[WTWX_6/;_Y]W-LU%7I!BFU[]W"\Z.N<A.@WB8R!, DCJ@$B$W(WP
MZO;-B;F,4W%[!FVSAJMMD;3).R9=L7I(3@J.^PY].^*Z00HCH"!=-5*+R'=:
M;KA@P#9&,_DO7ND2L$\K_0:M@$^21TTU6D12#"3PM&G.TS'ZXFA9]L%S1<A<
M37Z@H:<12-MC.*M 03<(G^</;_[P6BT1E@0><CWF1,5!'6TNU<1!B_-AW2>(
MU_))UKGQLE/6KZG@<T_^&&\F"P2EF^CFW=.<)(.,[I ]".$#=LDU@.7=:O/+
M[3^ !>_XV%2J::2.9"5!J;F:XK6C3&.(TN"XT[QWN'R1VVL^-D(9HD94+E<!
MP15_+OL@2BLM'VI8X/ 5P4XM+1MF^.TM,#S"I[#U@MNF^'($!YQ<V7!,PR80
M_ A^?KWIGF'/A'5Z-]>%P31[F!*8/244?H%N7 K=^/H%NG$58_G@T(W?E:$;
M7T]"-W(&!_CI5]>HR5 /[CKWED[\A1C6GY5T63;]SKNT0I0C'(-0I3+:>9&$
M!Z(UC28?D'(&6VO0; 5;1DT12GME,GF<4HE)%O&/@*(9DRO$= !)%<Q78$ 2
M?HPF\QVRX]+%2ARD[$,FK:TUCI Z$Z/?S-<W5XR8A;G;J8IR\7E5(OV@+BYK
M0(S^&:;<MTTD<44IP^R#_%[AQ5CF+X&:.H6"YEUXV+Y)_5)\0'B"K-493I!H
M>Y KQ7& 3]=Z$(QUE#MFLW]H-H\QD5(A /A^AS<^=)Z!8$6SDW >&].>(#[W
MKI$BC2/R6]79(8/:]"0GR,D9ET"2]..R,NY*A C+G\RS]LT,!Y' I^' P*P^
MS6?:*)$&K9QYT#3764A9AY6XQJK>=$?0OULS]9PBV_!0,^2)E<^.)ORG+$\S
M-)P<+>[G(^:Z7,5\[)/IU@&3\L^ 8Q3I,38:V&E-MP[^]X/V] #G'KU3%I/9
M!!?FVV V=BQ:L^RV"\-D2TM6#[1YI0^2V^PA[CWGU2"#L)>V(<FJ"!2>1XE'
M\X"9SN+LI^(?5W@,+BQNFTZ>UUKV^2NEK@!* .G7CUO;MFA+<A?.ZY/@MD?L
MV$T.:VS^>?/=M[2UB1HRUJKTP@-KX!+F9P-%8[0/6?!F==L@:%^3##8B]$V%
M:!Y0@EAOTUZ7!)O8OOG#MU1QP-] 80P<F)'$W?-#AZF*';>#"GMLD\W+#=+,
MUQ]FN<L;4KP<OP>O ,K"ONAF0^DH:1'_F'-5G*KA"N;*59,\-,Z0*T#GYOU0
M4?\,WZU4L)53R XKZBTXM10EI!>RMA0G-4819+'+5%O2JC2%&E*-.[M]"*Q&
M',;(BYL"Y=GVPW&\R)@CH ,0VJUA-1DZ]#I)( [IZ\%G#6?=9 9'KK5U\$L&
M::55"^BJZEGR*BT5)9NPFKQ'R1-"P)'EN.$N>?^HFV&N8JW(2!4AA1$<K;AJ
MF\H.&[:D6ZQIP_,MN>8;LZ&9+G!FNTHI(NQ[-^^6#9/Y4$Y1LZ[E/Z@2<-0)
MWT1$0OXU+YR_J]1148F!R'#9^Z.=%K'R:>\<6ZHLL:N\#.#8K=M=1'"<\+9C
M7MJ RN)<I;XOR1'2E"/Y.>J*/%/1F-4RHG<89?;:]?O,WPVCCO,97+69CIY2
MDI37503;)V:##I*XM -G]8MTOC?L:;_'2\W):Z)A4,1]L:&)R*(ZF1P\&H_[
M<2"V$O%7M%D,&TK!DR$Y&]X;'K$,.#W@R(!7..RD_%+B&8L015@N-25%]B4=
MM(!I5"@R?5',.AD@ C3&#K%05!5VSD#@P@\V9CM=)X9+V]-BNZ'+6(>8[',@
M4:*.5;W/G+@$=LB$ETKU9KQXQ5+[_/7542C;D%B8Y)DKH.<><J4U;2UBN^C
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MKMA'";DJ<FC;JFV*%(TU6VU\L9GOQ"5(WP@20D1*#^P$[0)EK9*\@!:A?)6
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M1+B--S(/#VN?Q-437KE(UR,9QHRFRCH'?TM> -]*H>YG+8)ML#EUO#K&RH<
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ML.[K^[Y^?,A;!*U/.72;##K<]:7&,6HNM/27B\.QL5U>6&(D D])TDB1)41
MMY8JWK+;$%O^>S$>5YRR"QY[CS"I. [N*+N;_:4+QP_/Z_7L"*F:U93-EX%K
M^SZ%5H8<''ZK\L0<%%G9S6K&MQ::4^&QJS>"T GF Y;IEW>(P^W?$#B9R:XL
MZ4Y*"ZOEVG)67BI!.9@^H_J+UA4!5MYID9Y9BOU-+I?/1DM16&WT@!Q7.0P*
MSL..X63AUH&,:OQ$L:64L@>:03T]<T(P!,[$<TW<''"Q'6TNVB!*P@?WSTVS
M._?BJ694;IU1RR.R$'$$^YX%H,MP0O'[\7M@!)_<_O_N'0@2($%]V%W L_%
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M= 42'6>=AY1)5ALH@Q6Z21AD-29(IPU/9-4ZRRL4HS#7M S: P(EDC11GCB
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M?@7,AOVV''H++YK,SUFCK^4^;&"(];D/"FCA@WLP[NG*#UG>XSH9MGSLV]G
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MGFI]02^39Z-9[]C7B6%'!4]EC!Z+_"KGLY5;*A?%O/B]5;+;U%:"CLJS=A1
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MTQ?,)$Z89=0SRA5@G(QM/UM9'Y<5F("4[1J3WFG'DQG0D2@XA 7H:-#[=?A
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M?'Q53<H.#E]A@BZ:!G'^GZ\^?OY@9VG1'15Y05[(E^RW*(0U@]G"7P]-HG9
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M%Z;T+X'KE!<ZJ/N@TSGI':\PGS>S-(^**(7-%7%01#?B#<*L#H;T[>I6![G
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M$+/C9RTP"(YL#JR6J8D;Z8B2:]F_RMX._LQ-[FSJB)D,E/40(#B.0V^8\&8
MN$'V!K"S+&3^B&6'T@B@'6ENZ#UB9TSVT[E3:]&,4\2R/3FDWCM7HO0B6'&%
M;7OBG3\A_N878]"RY)91SU#@W\"W21AR$A8)=\U:]RW<'C;CA0'XSZF73!%L
M&4S1!/N;L"UH!*27?47)#.@-/YT$#D(G>T!, 4S-1&]1XCO3 ,P+=A2Y7C2B
MOA!=8_&H]0([1_(<](O=&J0+]GB#$; +O#Z]>HYS<OU3&2MD2S^]'=?>YS8Y
M6BN<KA"F-34<!<1YNV5PI'F[U?N54VY.AQ31YT^.AG\R&IP\BH&03MG SB=@
M+=Z9ER*@.]1_Q^)G)(AHP<MUX!$'.B/2@:A4<BP>(;4DO\VWT175UNE1\L%#
MK&(O*B@*KH()I'WL/()%'H(H>B"^(V2OHLZ5)'>34-)Q _4U3D+X95A\9"KA
M O6=MS?*YLL'6#9<,4+H>=BDD3/#=CR^2MJ] .T]XGF#@O'9O<.96ZR;?C(.
M&8,+HP=M/ F>^%:"1O)B[:\$7$[.&R/PD7&:$SC;8?#$@$N>'KS1 SPXF;BY
MNWFAY@P]N@H>2"#SH+?\D3>#)3AY$4UUE?9AK$4)W&O):VO!")0V/,E'W0V7
MP/*?O/@!F%>TE,+Z0.O[P=0;@0EP?O@LBM!&@[<&;^0&3Z1.(;IXBA]TVJGT
M-0C;O/<:E_82KL#OTD9.O#UAQ*,EQM;-(5LD(7-;VGN^;[H6@8/NC2&6  X
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MXNA[[3H#6TO\!*<*IM"! ?4.N6P8:V//=_P1_D@>F;[0YQ OS6ZW9:?H@3M
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M840RYH4YUP0XR1F/<^_F!_Y-SEW.[TW$'3?Q3F!!8H]\O)!V8MW0LP+5B'=
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M.;V<M># [*1-[QG(\SPH>_-E<@&52Y=9^R%X//"Q0P@,!+B2HMY1 E2,Q29
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M,ARD1V/XQ.>0AZ)#9<5;!FG9@)Z?]^W3G/,HQ5I+<52C#(E;("[%H/UD+E0
MK, ]O< 5IU@+B\S0V^3Z?/(/KPG<14 +.;Q)21 MPUR+"LTY2,$6!,P">X*8
M5I_#C,N]KX ,HNGP$HYB,LE02P1P731_"^E2S$%2;K +V9L2&@;M(_[/,:A.
ML+_4"N1)I#XGJ\:=A<"(W@R9[9[Y!#W[C-^S6<RAP/ 1?_A>FAGGU7947>LL
MMA4U61E,HD!JA*5H[Q( +)($%_7+<NMS=<R?$=X$GR/,P76!2B\T7M[\0E\
M?A80LECA' 83 OS-,5U(%=4<]J64S3(0-FT4>L3"B-@,_H47/? ]VTL'V@;
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M3D2DRU>N_V/G!XBS@WOW]!!,,A!PAPNVT!CI>F3JJ90KB!%T(;X<6CIB,X>
MX^964WX#%&X_KY@7]R80N+5>++>R:<9]00D8'0IH,V5]HWTD6&%+>X_8@_\D
M[,'?0=7!*_)?R&CW*Z:Y\*7?!T&,J2_-I WJK#)_#2%'Q8D]I5H2;%D$K#*+
MFQ_9&28'I'1IQ4.>5*%Q0)U5^J.0ZM$>V,35?AGH/:.M=_IF"H@X;^Y'$_#_
M>* /LCL1W)1#LISFN6F)6T#*)F*%&PMG0_,F'("=!U;P&,+/Q)4D_@3#/'"E
MX'L(-;/(BRNO##<>8J\P<$8/J4<5LBRR)'HLAZ_'K_FIV3.'JLS5.?FN5+8Y
MIXP?^J)Z"N#"8 @;^$A^0[8>SY\E<>/4Q=+(#;WAF.]Q7* KD$?NN%>L_W*6
MZ-5[,#B<Y*FER>P50J)S,I+)3GEH_K@A8A,VD@LHW65RT7%EP4Q&'H6MD!OP
M_<&+,D/N: _PXG#AO8CP'#ZK(5TKW9?]C!';71[0(%IX$,;S:_09=P,D?^0D
M0EADX-W*+'#9!0>6 GENQ%I.;X)5Q9S_?T$40<:PU!/X$_3;G>N*;+=P?^@7
MIZ#/TX1$/K*79YK"/5BKX=-,0 $X6L<4"6+98ZP=O:IX"O)/AEE 9]L)@OSP
M8SMU6A@\B2CB^:J\?R5@D\;/Q0F=1O\84.-&']Z1CI"[^YG3N-$2YN9TVJ@^
MR4_ ')K@"? ]@78ZSNL4X]YB.N4F#Y*?(P.C@.GD,:B/&40,+_E)4,2/@C9A
MQ:+=Q<Q?>ND2-V'*X'<N4.K>V]Q3J,HZQ^43DH7C\@DL82F?B+PD2P]&PF 6
M>O"!9(-XI?>.F;<23E![5-L>O<>,$ OIM*0@:T^ID&<I9\H0]%Y'W)Y$HNIC
MG1\_EYM>&2B)S,\,DWD8L 7D@]/1<10DX0@#/EPR%_B%%1/3$*=!I,HC.RHB
M D.XL5>N6&D/K"3TKLA4XM3__$&LC*C3[&RV5Q2H$T.D64[Q6^"-$LZ47]?,
M)HI+]F84LCG?(F$/VQK^8, 5CVGJ!0^4/7%V[L_9C$4COY%5W\!?;XHS3S'Q
MR^AE]=&3G^"#;/#DX.KV[;N/GS]\__Y.^U_.=/9:^_[YCS?_]4[[^/'+_#S*
MDZ=795I]#/C9AZ27V6Y?W>)B_CL(?^B:_->&A#KTZRZ4:9W\!LIR2)1DGG+.
M):U3?2_S=A&"!,"+&_T5)CT'S6"8ZT,_5.>K*_XW[7Q!T:NTG$W:#2X[0VBK
M#&$CUJ*:BRHV%S50U5Y8"Q&]<ZZ%:*'NF_)*65/15UF=W*SW6FTV\RU%FY?R
MU]P]= ZM 1SZXG1: SB^3LVM ==O/G_[O*252=813"'PQ^!?=JV4=RZEB>#+
M:C Y=2["_6]8X>,:_7?,+JI"0V-Y!1_OX?3=PK2VY<UQ\YU]M;;JX%G*VB4W
M;/?/JS5G(:[-4IL:U:V(3IL)HY>3JK9PLE9%H0J^HUIU*NK/5^TOG-5M?&,]
M.R[VLIK*M)OY]\5\K<1E*?'"/B_QPG9I/DJ?NSFM%ON25%M2L2VIX3(FS4))
M5U)3FY*VD6DL7,]<L*4>6*Y/)1-6OC*N&7@))+VCB @JB#]7)O*H#SMS1&5[
MMI GYOP@Q<)^XM&*3L>,4BG-G17RVH)UI00+ZRL4?/(EP=^XFH7NH@B[AGC'
M2*Y(ACIKR"1Z+DFQS_"\$VVKT&N%XM$5C26RKR0ZE\:2MPPVGD\;X!@V$%AD
M^N-<0FG#P,)J;;2UU:#.%'E,SMF8*WO99U2J!8I=:"&3@SVH&7>9(:?9"B'O
M>1 E,*4N)QW6R]/T61+.0)>5MF66S%<H[5EK:3M1R$_!?E&ISL#Y'$F;,]_S
MATTT,W&T+"PBJ3KFR[/;$'.3+O\YN?LY^KH,+ISH^!()!ED3[C_S*1OPPS$=
M$M/4BAQ(KFS^D\GQU!:(P2OB+T& U]2/LW)SZ4V*3R!' !?.#S@R+8.,PG 0
MQD8[N\,>RA$@CFBGFXD35_"D,.D3TQX47Y77U#.\#W4E!OZDU#%Q$MC9,)]=
MR#FUG+CPR#@(%VE)_4W6&GIFP@(TPK-B(A$$4Z #8$6PZUE-6.++U1 AP&KS
M3=6Q%D 7#3_S8U3F>5ML/!$+2#EQ1:29V39NFE9U/S5,QY<[2[^QD9-$3$Z#
M\7PPC[AIDTS9ZQ4D?>H\4\>8V":B-FU.H6<8U0G$[-3*]2\V2ID&.8X5:@.+
M#@"(RCA!/A4#9KA8B:8WJ2TR3R2M.\15#4'XINAD 1__A24)^(E\]=S@FZS^
M@'B%2S+Y)[)_@+KJO*(7F:JTH.!<X(/Q_6&QJ(U.@B.P^F!%[4#S7Z#L(+_Y
MJUY_JG_9A\"=>N92]M5<RG,X.F[@H7'5@]*FK;\RD&GCW^B: GC>X8K'43_1
M.^9'WS(W(/_B0T#FD9DW>;$#X];W6]V^716WOMMO]<U.+;CUAM7J=+N5;K7\
M\XY=_I"M%C58>:OM![/SG5XZP;M>QC8WFM'-\0E29MUJ+/DA7VN^S6MQTBM/
M-\T=A55XP0WG])\D'<P"'=8P\A",T'T(VLR]$<L=C1A$4:^WG5!_8,5-%+C[
M]NW=]V\;;/_2MQ6*F.HM4>>C8=/DPC=DFK6DW/;ZC197LD\$"W"DC=I8$57F
MSS']OX;R9_EK%V!QXEPCR58L.T> REQ5\_47PW@[*L9EG4%HPX]$E4^!?R.2
M7A/FOO3A3V<\!G?=X8.3,ZZ]'@41%0'\(IHGWH<\4ZTEOL=;)Y+(O9KOI3 '
M5QK$=][4F43_>75CR=Z*)+JY=YS9JTPP/N/ N+OX#3SF"H\CIDX, ?K/^)6?
M3&_<@,)$O WL#]"6T4[)9@SCZG:@#RQ;-SI]V8,AU\?!FJJMVFH?8M4FKKIK
M&KJ)(RT65AUKY;!9]#[EP%.Z/,GU'MGD>3XX$2JF"GNWM5/0KK_,:]%*K]AL
MO;5?:<-Q7S3MJS+S6LB\_:ZI=SOM!>8M#S<JZE6MTN[4XY0IV3A;V:BLT[>7
M#1MEH]-MZ]VNW1#9.+23O=37,5IFIRGN3KVNCF5LY30LLD_GZM:HQ8LQ#^'%
M=*]NK:[>1=S8@[DP*0>;U3BX5&6?NEZKRG;;Z[7>U6U'[PUVMO?ENF5O]GZ3
M<%<Q4G5UL3TC]8&1NGJGO[-UK(F3CI ). Y#? ]B9U(<TIG/1FUI^CJ'L#.#
M+,8O,S55K6/W &LVVA3A=WIZOV<VS3RN2RUOJ>^FGNM.V GHNZI,N[6V,PP>
M*O=UVZXK5-YLUS97A6+7:C[94.Q7G_[9GOUXFM'HZ::]F!QM&OM=PF'0&T1&
M3"$2L4L(C&]A3O[!PIR3$9<UVAI)>N>[^#_O,GJ"U7;"$+L+MY,<"P+QCJWW
M.[VC^JG5E?-1(YZ3X:DU*G@_/(78\^#,F24.X7%XZKS*0Y8=OV._;211H:@
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M[MFT_'-;_L'I2FV(@'I-2=$K_CE*=>2V_(,0/V9;M[M-X9]+.^+YW?&=>YK
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M_K^X7F1]S[*8.^JW^ZS7-^V!W1\.[*'9'3"W9UC.P!K\CV%BZ,>O>@CE2\Q
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M]JCM.4QV\FBCS^RV=75K]RV]UYC19XJW#IJ.VB=OV4WCK4M(-JFQ>LTQMRH
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MR?:KH+B;6TX]F,+\  9CIUAERW'BO4ZBC9.[;__:@DC(P@M%Z(*D?;6?_LT
ME"V9E$1@!L2 .%6[N8FD(0'TF4;/Z=/=Y]F\!(;^R(NJ598WK7IEJ9\VBB+Z
MVVFCC2CBX?YCMSOPZYZLO1?#T83Y@AD?-]'+Q4TG_P1UURJVRO(;QGGW+5T
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M#N76>\2*A-\_$Q!$01!ET?W&;7 C@FMN1&QW=(>FYC"&-.!&A,X(TS&!FLU
M$'4B3VC @M8>V+ 2>#O/('$7W$@TFE"?B2/22@!232'5D!H1)83,#[2 T#%
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M)$#B,H'/ ^.B&&#H&##4G &1E1)$0%+4=R"9!G4U*) X@!*D,P#\1_(IN:5
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MM&J5Z@IFAB4*^6V1_LM3<<@JN\J+%)-=H OI$1O2Q_NM[7%)&VP(M=LV=8C
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M5]CX6W)U_=+[<?%1_9GZM,5'%ZA=K,=ZK#^"]<.J\WCUX4QYTEF:?,J+^UU
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MTH06J1JD"ABON?&B$\HP&:;EPT?<!2VB<[*^=":]!DAU"*F&I(C4$(H96CL
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M,7-+=&QCA(TF'&H.8.0;(F,;*%P!)49[H;X#Q33FJD%4\+"4:QC7/$&NT0
M?R39_'.VF'FGZOL6-][/^5S?14E8Y$6B[>!0,K!'K 6T&]!N6/.ZK!7*(D)#
MCTX-:4)95$U.K5$60S1>>$(89K^T?+9@'8@W>*R,ZT<[A$U(EPX.4LVT&UQJ
M"(4AIG4 0B;2C3 H<12CH4??<60:T=4@1,*RR2EQ!3/#4FZT18@,7L8!#0<T
M'-:\+F^#$ GM=C@=(G#-#&E B(3,+B$R1.,1LF%$.%0<[9T]> >,2*BSLM1G
M!$,[@*F&E$@8EA@BPI7A"\!0IQAJSHE$"DC$YY$Q/PL@]3RJJT.*E%U.8U<D
M:,-2B?RYR"ZR=.:]R?/"^UMR=?W2^SDI9I^3(O5^4K=Y[7OOWY^BRP>4(@X3
M(WV\W]J>-VR%&-$)57L358<(7#-#FA C5:=3"IF/2:=3%FA>)(12I+WS1]@!
M+Q(%HXGD/A-H\P%,->1%(J(PQ'S!C;DU8.@8,-28%XFH A+U>8Q!5'T'DFE0
M5X,7B73B:QP?2YL/TT0;UF/]T:W?@U0^SXM96CQ?Y=<O]+9=YO-LYMTZP"/R
MK#M?T=$APCS=Z90+/V*V*.B]3=:#G ;@=Y (,=089'X4&H>(P&!O,?A0<!FU
M$%Q&#W7&<1!N9>AYLM)$MOK?6?9I\H/ZQ^TU;9XMIV.NG_]U7G5F>U&D\V25
M?4I??LYFJ\O;9W]GX7F^6N57+X*O2Y)S=>'KU<-+MLA,VP@BP5,08E(+NC0G
ML;%0^3SN_O.RN+V<Z^1C^OR\2)._GB<7ZFI?)///R<U2/],[-W65+9Y_\Q"_
MO?\'[_+BHK6[K "B@+\19[]0J$L+_5?JFA)GKL6[+/0^_;>,L70VC8,X%3'E
MDL?GDI_32*8S05@BF?P?H37H"L->?N&=ZBV^6"U_.$DF]RW9*=K$M_=.-0)>
MS]6VKR9@?DBGZR*=>>_312F>?ZL>A//7KQYVZ9"2E;KR#]/+=+:NK/#5=2Y_
M."].)F_2::I=<.4#&?$]&NA&T8[?W[-LX:TN\[7ZC-GR^ZW+K2YJ4MYAC5_N
M=;NE4_[J4,N7@+KM>7*]3%_<_LO+6;:\GB<W+[)%>?'EHI=72?%1>9Z-%PZO
MMUX Y?=5O]XX)"G'0@CMDS9$Q.:+-^YJK![&R?;/*1U3PG;^*AB3FC\/6;U/
M>NBBU,M7B,C2145"6KFH<$P#WM$G'>+N(N[:-8DQ(76_^Z&?L[@>GAZZIG@<
MZDWFU#5%ZHF[]IQ<O":U[TCXZ"=M>-QOHF<6J9/90P>[/2DP_!G^K-,_>RI%
M484GFX#CR6/J4^K"ZG/NGP\W'_%<_[W:<5JDV#;'L!42EH>VNY'M)JJS>A7*
MS^QQ'3L.XYHA>$['\7:X=YXLT^ITYSTCWT2QC\AR]N7GFQM_MVSIB_D[L.[;
M/%\M\E6ZW$.V].CSB0ZY.5H_+NWW\'Y/+](B74Q33ROK/'5F\BJQI->_G?*,
MNK11>@:$6X%EA8->&O\9"5T"@'N>\I=DM2ZRU8WW1MG8U%L.<9.<)85723!/
M_EQDB":&9G^=4>^CS9E+-G?/+^I,M5>FJIUPBNX]H.]T?N#7=.55.=1[3\E2
MB>#>Y6LN'C#?9H6*G-YGZ<)[DYZOO.?>(E\\UYGK(I_/T]F)_L_DXB*;9V7:
MY9G^5;98I[/]-V;K-2I8C_58?P3K;7:R<ZFV>+?O?:/"H&)9%6[KW/;Z*BV\
M#VGQ*9ON10GU4RN+]5B/]8==/ZQF&*_/SGZF*J:]RG3$ZE 1M7/OI8=[7H3?
M/XN^?Q:C\<7>C2_0]>(1Z;-HH^M%)'0[4'2]Z,R0!ETOHKCL>K&C3@+&VW^D
M*]5-+V)[#^PI*6F#&M6=M1RNO?%^>GUF4H>[=Q&$6WO\X_GU$QO\4%T^Y&A"
M(Y\%QF,IW2FL/[H]\N\#W"$[JPGK[9!FQ:PB4.X]]$5\1".2L".P(PSK:P51
MVX+Y5*"5S[$6R>Y[P*A1)"NH[DP;.=&!I1,C?&>6]GXDR>(^&7B:7)UGZROO
M?9H4"UWJN&F'^VXQ'5N9WS*\04'B^V<DP*P@S JRY/+C-LA!P71+7,P*ZLR0
M!N2@X"4Y&&Q'>3#>OL83)S1HS@X^\L3J/*4C.\;MND.G []ZQ[BX ^I/A*,)
MC:5/N'&'WT?B*H>;(AW1D<X"J!JR99$&D?!IY,KT$8"H4Q U)Y@$W-&Q(,DT
M2JW#,)7S-S#[J!, _+B8I<FGO- MH7)UM[<3H9=ZY)%#8H(>,3R8>(2)1];\
MK6R%WI%:^T6A_>K*D ;T3AR4],Z.\9(PWO[T#HDUO2,Q\:B]8X?L@!")B3J!
M4)]0XY:^2''W'U/-^)"8*@P1/R).I+R!H:XQU)@.B5D))"$Q\:CO0#(-ZFJP
M(3'7>AMNS(8X,O%HZ&P(]"[-"9$A9IZA=WG<Y?*@#4(D#JT2(D,$KIDA30B1
MJ")$MM^8,-YA"!%DS_8Y>-P'_*$($3&:<#\PGP"-A&S_(=60#XE'$^9+8EPU
M @@= X2:TR&RQ)'YR18XZGE$5X,-D8%F0P);$_J@#:E5V)][ITGA_5>RO/1^
M21;)QU1;SSO-B^N&U3_0AD ; FV(+7]+VJ!")($VI%-#&E ADI94B" P7F/C
M$7K"B.9"(HA#VCMUD ZX$,E*<4@8&),AR,?V'U/-R!#)2PQ1<D2M98"AYAAJ
MS(;(L!2'2+[]K@:0^@4DTZBN#AT201S2'1U2WLKGO/AKZ4,/8M ;&9(02$)L
M.EK:"@]2]D=&"Y3.#&G"@U3]D26,9](?F? 3&K  DI#VCAO4"@VR?;B0HTD<
M(-$*S'RA.;[%B/KF8#01SE3= R2=@N0.C[$#*42[$^A_^HX4T[!K?Z)"74C9
M-M89T)@*-YP9\H?U6._*^CUHWLTX9#VNFCPZ"[GGKG7G2YBUGY!2E\7464T0
M/Q2VZI7WMED/T@S WP&26>K:N 9AX,?25N,%@+!_('PHOF1MQ)>A.KV.N>P#
MW(8[F/EMMD@6TRR98S(SUF,]UMM=/ZQRC-=)<5YD7UI2F$QA01U&PQ$L0U1$
MHP[CB?B6MZ _4)<2Z;;(&-#<F26;"Q#4MXM2@4!1B='<>OR$QI9'- ]:I[J3
M(^*'+\10EZD[OL>^9+:.[STCA  J&\2W+$%$8H ((#)BKTE0(BD(4=33=R29
M!G9U*&A"5(PW=J9-\+"*,7[)B]0[S3^?I_.Y]^X="C(PD-9]-J2/]UO;U8:M
ML"&$ZG*, (K^KBQIPH805O6EV"Z\A_7VM9X\(2C':/G($79!AA ^F@A?2N,X
MTI)4%ICJ$%,-N1"BU3 V)DT 0\> (0,J)-) BB, J>] ,@WJ:C$A0A=[$%=
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M ]1H.\R"]0["B2"!MM?)@W?!B42Z_2GW1>A*1WV JD-0->1$(EZ"*!3;+TB
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M>)#<K'20\OH@>(@SF;LV<[3#8R3,AX^IA@0/(1)#E%)@"!C2(7@(G<R9S3F
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M].I5PAEU9#M0U*MT==H@O; @_F1.'9N%VC1(2W)?@*I'4#6E00(%(G'; !%
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M6P0/IXK@*<GX-R=XJF.P!L'#65<$SQC]J!;!@P1GI8.4UU$+5>Y.YLQ%ST.
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M\-*(VUDO4_%CZU.\N%R+O_GY]D$I$+JDM*2"X5# 0 '3DA<..V%] D\<):"
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M_;"J'89K20T5!G,*%8:[VU$/UJO>J8-)28./4I7N2"'2BZ1!SK'UF>UQ4X8
M E4]HJHAV4VD,,:GMN>C]RU0I$58$P*'="A0T@WMZI#.A$H1*SO$OJ4F'>7+
M:>5/\>)R+?[4YUOK]RA;?HVRV+8^YFD6?8ZM?T17UR\L8<;D^C+.A,U!.F,]
MUF,]2.?:K]K3V_P_F)"E1S@;].#,)GU -C\3Q]).R&8BNX=@0E9_EM0AFXF4
M_=$I;:LM]!BM1V<TQ(BLCAD=V@?;3+S)/'1MUP.W U U)IM] 2)F!ZXI7 ]
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MJ77$QNVW9.[.4LF[O3@M\Q[ 3Y)8_&><6T7*Y\%3:"J3JIVQ,5]#]3%>I"(
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M7D+LH*T0NVV3#H G!'Q;A*]&B!ZV%:(#PZ/%<'F(_P.,VPKQ>3LAO@EP54>
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M(M46)=6N.U2YGXB&&%TWI\8Q08S'>-3VO<I<]+KJB&T;=<2 2%5RZZ".^#"
MM(6DZCSJB&VWYW7$[;N_/2V<=!'%Z932^@@J+L9C/"KK2F]2&TT(N8[R).3"
M[@T(K(3 _1FOH^9RKB,;U2LE ,/.PG!;I83!@2\[6B[JZITX5M$OS[=3/[F1
MF)E%]A=6;'Q'UR],$VBX&(_Q^XT_(#<UH2^N7^UC+U,_)=)E&A.2,N^A-$@7
M["7JSZ0_AI=#Z6M$+S;,-)%?HY \2+_Z\0_ZHU_H!$ ;P7B,WR\E."#67YA\
MFHW('ZQ:VI5=2Y1F?0!1JR"JH& 80-*!(&F;"&'R$"%,MFE7F^8EDLH@/G7]
M/;TAL02M >,Q'C4<I8B%U0@[967'NB$[;N4&Y*_$:50"=09%%>BI#2@="I2V
M\5.+!S]U!IXVM%%4UEY1V6,EV?HY![EFVMH%40SC,7Z/\3MNV^?'F(YU&ATF
MT>)J1AXW>*H57XB6]/Y]S[*&.N:GF^_;0NIF-Y( N)2U*;+BN+*B5B9NM:]G
M2[(D'F@\T.T_T/OG8JZ2/]6:+FNNC:=Z[W)(7D]X=Y"\+16T.:2"KDI3044;
M&GKW(=O**O[T;(*R5':4^O2&Z7\GP9WW,_UC=4FW?GP=A-FM/R:I03BARW1\
MI-)?M[P#[^>KF*7%R\]]XU.64W;$WF#'NO7R<]E7&I\9W66]MM3')EL46=,H
M2L,H)3GRPB.51=C\2]\B=E4W:3H_'HWN[^^'?UW%LV$47X\T1=%',?WV:/6S
M;=S*\RG6K*&5K=4?X8PDB12Q_:;[(*%W%DXH*%,RD25_-J//ZE6:Y?(D;T01
MK!D:W)#91+IZD.A8Z32ZI7?T(+V[OPG&-U*RH'^D)+Z5_O$W1].4#\OO9_]2
M/TC)#?OP(!S/%A.R_@'L!U3[0\+B1O94L4NA'W>5!)/ CP,Z&_2=)LT7\3Q*
MZ#^B*1T=)'3XVH]?CF_(9$$?5_K=-67BO>3'A-Y1&-T&8?:#04@?[-G,CY.A
M=))]V"<R)BQPY7%#5V5)8V_#9_=XXT^>S<.+3SSU0Y]>:RA]RC]:>G=Z\NF]
M+'U>Q!']Q^<_OM%_?(R#-$ANI L6?>A7OWZ\H%_]Y(?LB_^,66N]=Y_^^4_Z
MM<M[,EE]T9?>77YF7V0K\EL4WY-K]HN6/__;[_]\3^]CM6KKE\ANG,YV=$ND
M>1Q-%F.*!!JKMZU]_BD%2\X^A[E8O/U9#.?T<TYID//II,P?I:+Q<A9??BQ=
MX_]+QJF41MD[@P7PA3^36 _!.,B".?UX^LS0Z$]7ZSM=CS03H>9^+/FW=!I3
MZ1W]1>E-M* /R82N-H7%G ZGOX$N#$/-RVF1)8K668Z__'W%($"Q&3-DQ=G+
M+,D^]?Z&/K_+7T,_.6(OI\W/WYRPH?39IT]"AM)-C*]/ ?NP&9E<TX_R&?HI
M=.CSX\]D>A43=F%TA>FON(WB#-;LPL8Q148J3?UQ,*-HHM?\RHH^1N*U,%80
ME\4-Q-IC(!8E=A:]$;1]WPA_TN#&WKA2S(I69Q&]5O8H,-B\?';82E\1"OM@
MV6-3\NG_\H'I#?U[P&(2B[X!@RF-T#&9TA]DC3?I1Y)@65SP+$Q)OT_9STRD
M;^QCWJW"]J??OZUB-D7?ZJO++['H1'_-C 6 WUDM+9NQO//GE1_^D$[HU_QK
M\OPC+W__[>QD\S,OGSZ3!<JU3\DN[/EGT)\(* 7;_)3/:U=&Q@MV/T\7]H7&
MZ#"+5B\NZ,NW]1N*QC_HTW[[\@I>3LWE][./19-S^?WIPTZC.0EOZ!2$;WW:
M:?&'G9X]?=A3O'_CLWXK_JS?GCZ*?I%^C#^C'\->6]*5GRR!]XY"[#8*9P_9
MUR8LXC((?B$3%HRRTNCD^6_[LOI8]JGL9[/:ZHN8/GW/?_!B]8/OL[A+PR*=
M%_:I,P901NZE.7TX(Q:QZ->&TA<64EGX9$_#RU=P\A3;LN\\03R[CP6[>/:6
MI*^HNV"R_*&$QFL__SK[Y^/SDPVA89YR?_8*\E^A D.I\$E]F.=7_<AIZ/P^
M??SS:YO.(GIG4^*G%*!O$8^R"=9Z>O4H%5S]E<S6<JME6D5Q^?OT<0_GY"JZ
M(U_8I;%5*\ZSF&6T/MP4!GY:O>&R-^Q3O/+9VRF(I3NF1F2\Z=FT/$V&SWZY
M]!\21\,,--FK_O%U2AG (G]+QF3YQDV>D03Z J-K3%<U7HT=KWA'-O?L$5E^
M&J6-048FAL]?A=+65$7<5Z+^6FZB=SXW81QO'&7/S^.J,Y!%-'\.V"F.[)O^
MY/\NDA4#8]^F+(TFUO_QL\>%XI*RYW'&VY;Q@-P&BUO*_>A3[L_G,_K<TH=9
M9J#9H,V+A+TMV(?FD2&X6PL:MX1RS8SQ^^-Q%$^RQM;W].6:_9O^0C9V'M.
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M"D-7&4.O%0:87%2:/G.DP6R3-WT0I_>'JS.'+,5"[X^. *TD>^#>_*, 4L;
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MA']E/:VZ]O/#1O*X2U37Q3&PU,V!Y\B.4OF8)U2*#@&M%94"!I8'PB]ZK4_
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M64291&DAHEK_+"2(.X5QCG:6!0%<'7A6];.@D!HZA*0VI 8;?I6'01EZK3#
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M10:.?3E$K^4(U%"4WO'0X2O)F3-P])4L".'FP',-05)" *E>2L#=.+( 3];
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M)Q1#\"4.%Y_#:_K5?+-"H$2Y(_.' HCR1S,,',W@3!3$L;FT5=8JU,+)C*X
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MS+:ZDE5T$"OS;1^:FV](K-ZNJZ=J(W?_-BO8,MLIUS#;T$$LM@UKZS2#A24
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M&S:WC23;@G\%P;T]H8Z%25054(6R)QAARVVW;]O3>G;WO?L^;4 D;.$U16I
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MF+91EP#!G W,V6C$OZI6") P:+13Q1!A2[,DA0 )V;9.8S?##^M5Z%3!E"%
M(A1JM'?04%T0("$OSAS<CP/MB,X5H.H05#49D%!8$#'Z]#^ Z!A 5)\""4.X
MHR-!$C6RJ\*!A";+559)W<]:C1Z=WU\FR\3[+;U:IKEWNKHL+N &.I##TB!#
M3,FB9^</O&S<#A,B#1/2V,31(2*79DD2$Z*V3,AN4T)8KX(4A&O#A$A(0=H[
M;\2=,"%QX=N$S[4K(^P!J@Y!59<),4VMN1^&Y/,K0'0,(*K/A$2!15(#72N
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M0;U*BPR1ZD+=$(7&NJ$?EU3C02$^.%359+RCR*"(^U'05"\FH*C7*"*PU])
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M"$E(>Z<-U@D/8F9'AKX(R%UMD8;M/ZCJ\B"Q!1$/,.P'(*+Q(-HBB<6NM*X
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M089H/#EA<2NBIX&FZ<H.&_<!?R@B)#2Y7^X7#XD+:3SD?KL%54T>)!061$(
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M8=7;G_[S/#=V^O:*.MTU]?VN<7,K+Q8%0M>;U3+U/J2SZSR=>V_3I8&F]ZI
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M*I^G^9/-ZNJI>6S7JT4V]XP'/":_6OJ"9H<(\L)@-.61]B--[KQ7R6 ]R%P
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MJM3H*=-68JS(-7I-@*83*_Q$R]L_4IOH.%WUVV_OO>>+ FB;Y!L>\)8 Q.R
M@_-_[6R<V^=P"O_7Q_NM[/+C=O@_V2C_-T3DTBQ)XO]4L_S?$*U'X__056*O
MLT_<"6,6CZ9AX,O&QOFA54F/05678](61$%(YI@ HF, 47U6)@ZV2**SE4!2
MSP.[*JQ,S$SG)"T= 0U5%^5,1V^LQWI7UN_!:0]BU'?I&UH?(LR+>7&29L*7
M8=@0_=W]D'D@[\#((\2&8@N_2)#/JH!?#^'W4$"IVP@HP]&4C]7NR%'7@#:
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MIP:NO,$&I <Y2S?Y]=I[<7V3YH;Y<"BKV(?M0W,0R$":=K!Q*_R'MBU3(\A
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MF?[(-L5W?K6:=[JZ+*[B!IU ZK=&13\0*$$:<;6L'28DAA*D4TN2F)!M3]0
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M+ ]2DCF ]2KP( *M0EH^;X1=\""Q2<9&ON;D(@=D8_L/JII$2"PLB*( *7V
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MWOXS<!BA+2I297L=-$0C!$C)L4(5!F3D?I7(K_8?-'<,1PE(X@(D)8I'@&2
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M'X<0VO4=2=0XM1*IHXVRA;LR) [*%F>2I7W80V*UTA"SS!"W_,#+JE9X'1Y
MW-*I)2F\#F?-3AH>HO6@;CG <4-U081P;C7U44 .(I%.[C^H:A(A7%@0,<S8
M 8AH1 C?5AP&$712?4<2-;"K0H3PR! AH2N-PX:D;MDDEU?K\6QU"6%+W>H>
M#-5!NY9&7&O<#OLA&^TH.T38_O_L?7]SVSB6[5=!::?G)56R1(*_G2Y5)78G
M[1UWMS=.S[ZW_VS1$FQS(Y,:DHK;^^D?0$FV;%&V*!(D*)ZJ74]:-B@0.+@X
M]^#BWG(S64K]<#+U0Z]*_>CB[.G:T-H_I2R.R';R,=Q&U ^7NQNNV]<UI!0
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MXD0()T(XT1XAG))\'J,^GT?7Q5$L]4IO-14%O@!-U7)9HX[S?,Z!1D;?L#2
M"" J=3;/OVJD&WWJPAZU'4I;'29#AL-D"H?)4 4U"-]4YBW0_K#:(XSIM9W:
MK(7N62(WHF95)4\A?JY[P"M!$>V,(GI:5:DY ;\VP6\KK31ET$HGHY559=Y
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MX2&I<+C3H@%$'72TAZKWEE=DU>@5V9S,NK1OVIX*>A_P5#F=M2HJ7> Y&5*
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M?BV$WU823&608+L:$HP;(-7? *D^?JT-$AS:HSTBH"6%X-=#GYV*M=WF^0N
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M>H&4\:)#:D$OD&W<[5IY@ML;6:X'O: =4"JJ%VS!DE2]0 0CECDJ@&#0- V
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MS "90-)XF4/J0"60S0R4J1[A:HOJ$;0T,X"(H"8SJ+]ZA*MYO9%!(2*TC!E
M0H"$4!-/Z*Q?5]!X2ZP?49 GZ%IO9/=-ZD%!: ?2BO($Z?4E<C"E<TR5.6R
M@K [3YA/6$@^CO\U#Q9W/1%J@-H1M8R>,RP14-I9-Z^@]=Z2T+\)HI"5CM!1
M.J(M2"M*%+9 32I1,$HF@H:@T Q1Z)BD4.JPH8,BPI(:V- 0)%(#B44@BE(#
M,TO:6)X:0$-0DQK47R/"U2V.*1<:0@UH^)7YT_1VS&>/_!I-LZQ!RZE$. *D
MA%KB%NFR:@3$!)F,09FJ$:XNXA:-OF=MGB9#33A@J#5Q!5)'V8@F.,4T^(M\
MNT38 L(6ZA@]=UBBCG5G_<""1EUBF8@<L^UR7ICC 4)2.& H-<(/4 >BE?P
M"@,4AIU'SQ[JIB ()@0&B5:]UK(05.N-'!M)$CH%I28( M4A(-1/$,Z^D#_B
ML;\>L; ZGD@0NH#0!6E"@H[[#]*MNSJ9)6F66=(R2Q]$0&AH$](:X1'(Q7A
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MQ,6G\TOR6S 91X@UP%6%.D;/'.H0&V3;=8F9$W,L-Q4I$!1Q_X"D6I#4"$-
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MB%60:>#5J47AV'S.^ZZ+# LM05I1#4)Z,8H<3#D<4YO!+] @Y#&%U5V'1XJ
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M S'R10?MC9.>^L=ZX[ PVS4^3?WQ]R2-0D8N!?@Y6,_98DU\YN94^?Z?\(U
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MC8)C!-+YW0EG=X8UQ![_WM@D>1'!AV8QW0JB)_H@<$#V^8[G/0J$P+E)F'1
M:"R,W(6+<P"!;< =PTYY!44PPZ=+,0.Y!_39-S[/X@ !!K(?5U'WF,=F,8=.
MG#*)SBA69$R3"#8=1>!0_F1>L%1_P'C1 EIX_?9-&^C 2)K!R>1WMC58YC$O
MH@:H\ZC7T8%;,!Q1#Y(G]SLX_SS)Q^!\D",8A,8?G6\=8\'@7,%P<2DJ8L3.
M+V.9A."WH0S$6T&W$@P$_/Z?"9@MBT=X&70$\"V_7X6-RHQIO'#:($6_?F@%
MYYB"=;XET]F=LP3Y9_PND3\I4@7BT/@*T@=L ;C$.>.<-!X^#2>UX69PEVVX
MFOHH2!Z[CPR>EAI WQ76!U5=5K#&]-%0K*0WH(S=V "U8MS,?[H13N+Z^/$-
M$%@[:(,6A3B3QR</-%A2A%SD2N48;SPZ9XR(R2/-CO-+BT[SWO5=,,,<L-E:
M<*8HJ4Q,):&"@K,#,DWM\O2H(X.\5&;,Z&!1#D8L)F1T&<UD4D^!@X5_BH\H
M]F)JV&$NH7!Y'_Q9IQW&7;JF%MP-:*I6'8GDJ_]P[I>OX,[$59LIYG8H+;/7
M__7F0QL.$/4NYIO QV1A[+AHHJ7\AY(":98"* ;\Q$]WAD#F#/X;.>!0H7FF
M&G)@? 5+1I,"P#J+$@>H&EYS\D\%S\NY#1DG^A<M,95O\@N\D0MLPR4)M_$K
M6X!=A(5+!AI(*'$"D"<\+4BG.@V2N$)S%LC16("M5<*XLPGU/G3AOR'^4(2Y
M-)1V\"-XQT++$4%LK%6J!"<\S V%H+Q:!+,$9:0B2?%#L+>UVS@S4R@%O%>\
MDV#ZO_SL>/8,;N*6^9R_9DD8\B #.42DI)#5##"N\9K0JO)!$7F!?WL%5W1O
MS)PEIO ,9[D,V<PEDA&4I5ID$6,_R(UR9G<NV/BDZ*K7!-0"Y^HBC=R%07)[
M!R3DPC&3$>\%<"XY\2$SV::8'D*S 1[]N3O+OF"BWH/G_L0]DN>73D& _3TN
M,5,+OR>T+9(^?F'AAE%L>"Z#"V0^DG D(FOX^ZA.D6+@"WQ1+[+?Y]\$MOG-
M<_@_^&<NN;:N.E%X= !OX:^A>^*&\M\X0B7[U2C!U'3-8<S9-*8_V9^)&S^J
M(Q+6476+21COZAX%U)R(!C>=4@3))S_G>V-!PD\^K@/>_!3\Y/+(ZO*0V"F=
M!"&@JV&],<<>SL<Y@*[EV8"NB3$1LTRFGCL#&@:)B_1X+!./-B!4X8<OGX^K
M]6@QD@.S\_L_$1$8T KE? BI=0KR<.%23BN=5-2&,WS#%_J-%MJ&TX23NH6?
M!4%(<H\/%J.G_W<0_C"^Q<'LA_'NEP );L,1?OKO;^_:<'(=XQM+1Q\]\4HV
MK[2AM5&2<"R]BV.>$GH"BR04R@T<":^HR:KG?VV8_QMV+]J=J;6VS=1^<V]]
M%R07N$@WLQDFKX$MOXBA4U7Y5ZLJ_VJ5\Z_*@XWLR89\].J4;&URE7ZHZO>M
MM!1RPXV_=B(W^KPH;/J1_[=JXW9QAT<A@5K.K"D@P5VB@E*S[B=DT*2FW=JZ
M/./. 2=ARL#V!K]BZ80\MQKS(L P@0]/Y6$X&3UBI '^"N?DD9)CJ+P+EA+\
MSA(3!=SC0:,?WF=+GK^AQ_\!-A3.)XK);6Q#<.QO-S=?VA P(,M)C<#0N#_T
M-4)Q:0MR\W&,F[ &WJ,KU>M>_2=]]P9K8CUF#/'6OJ9I&N/;U7_1##>JXRPF
MT?+&+KB9'IKV@A#DS?*\C_SAV\3E! !7J@BK;SA!S@GG$6:72)C1K[?ABF^^
MM2)%9WP/P!<V)OWADX= MZS^58K,9,"00AN]5^4T/.FC(X;V6T)0>(VM("HW
MBA*>?D.NS6ZRDC5?!_ _K3C"]S??7K?A_$XI8D$K_L 5*8@2'^4KR/HL'07N
MM^<9SOQ_$SEC$TT!=\Y0P9=3  N<H;)4C!U9,+#>@)"/6%+?;22? A_/3 LQ
M;WA^<D=\XXG(A*PTF3H>-1_SZ$8(C^:-.:HAQ3SWGD<.3VZ_;T0:B6<2^)7F
MDA18[$.;#-G,<R)101?C)%GZE#179(!;/$(EK0K/4O5HMG)'_HC8Y\6[*';O
MT8I4W(Y^E;_3+_M;I^"-P":1'=-MKCZ_]A-9O9^*%T1^"_=%4DFT7@H!S0H*
MQ( \.21HSDNS.5(S]4"B]\X/!I0@#E24FD?)_5*.3G=B3&JQ62R,;S1Y,37
M"]7)&\(" /Y5SW6FKI>.KC;F:2FV6#SJ7HJ9UWR'_\I<5'UL)'<[QK=D=I<N
M:$8CI,':7K"09PCCNR J[C'"K_ /\4SD3$Z>QL^$\ LBI72C' 8E.M+'A.S6
M"2D(B<O$L5OI+:D3G>'?@8<):.,.;I["2IB3Q8_];S*_Y1D$?T[.A\=^X:6)
M>''$<E>1__5[YQ%7&RE1$BEPUA_8S2Q&?Q:H(?%B_BSX!ST9_-,59]<IA[^,
M3<)CS[K#;5S?X?9TDZ<W%N&ZAVW['C;=!Z;[P)KM \LZP&!KSL[M7ROBWC5Q
M=WO;N'>N':L^VCTX,?N2LC^YO9V:QW(3R2*XN:A[%R&9?#SSP05/#BA(M1.*
MM3$8U$Y;"GBE!QB"?G6X-&OD>L32*\?(IDN**CH4,_+##V10I"6BY(M'W([D
MJZ=J&AEQ$R:-6'O'.+4[R1>5***+V]+<_!*&;K%^"D[*\QZO @3AR37+P3LN
M&KPA4T,9O.&D=#U8BB,M674D+']-ULR9I?J$FD8]XP%^S'C]MV\?C?^'*@5D
MS-\#4(BH1?#FJ)Z]!:&TJL6U(;1F\K-[';+9#^:'[ORV?6=7M;@VG9U[:WS[
M\=B^8\NOJT4GIN &MN>T"@MKR7']%ZP*7/Y@QFMX__;%>/$Q^75I? ,A:EG]
M5T;8\<3'WKHA1D6D'2T^]^;;4KS_YJJ'I\W+O\0KEDJU38;_WCC1W8T_Q_]Y
M]V?B_G0\/-1Z\VQX8N89C\G"[N@TZ1_*/D_-+$@W,L-_L&PCTAY"33UG]Q1"
M8Q3SX&X AI"\1\-SX2MJ#2HX$A31 C?A'IP\[$ +?[#86"3D9% 44%2P>ACA
M$D6ZW/3 :!1\*[Z+T'[#*N&.4;]",CN<,,1HMX-61A2;TB)9@@GW2P2H%NDP
M^HZAFD'I?@@0H/9G:,E9],KUH]B-DS029E*H$._$I/ 5NE'"K'HO6FS?\A]2
M^@7>!.%2N/^\?PDKFMU[-VZ2$S.95L]]HRI?;'2:,?FJJ?$GPH9*'C^7P$(2
M#S%2-.<U0 Z5FXJP-!4!G5PZZRN#Z_P7;.?6 <HG/@^B2/1CW#.',X-(F&=Q
M<7 IX@=,<N'+/@@48'!D-(Q^SYC[$]NC@?5$$P+E*A[I/!>,^B,6P*N/EVD!
MM'./]3*X#!0;63T5OJ=X+N@<\JAZM&0S#&\;""489Q4T]RR^"^8D)+#5@8?B
MT05*_+!NI["ZGVZ01" _\7)O??R4;&:DK&PN;C^[@YO$^U^ *$Y"N2*>QC/I
M,&#E^*2?C$.8T).BC')$ ] GA@M4%F6\P!5=RNJR7$@K"V3ATS]S]QD^<'($
M]UT0C"C$=OW55R,;<$*VP#8K7FZ5?5<A#E(IN=X;[DLCB@E(?8HCY"XZY &1
MVA\G30.^^))R7$&."-(O55# BNNNW+3:KV2\ #68_O5$I- :(,5_J+FQ$]87
MA89_D5$EN</SHH4X6H%*,?"%-2+<6))U <)2XV1-XAB#<T U<^0'YZ?C>IAR
M((-'L:E.^>S$7@N'555*BQ',,392M:PV$.^!(+&-W[GNS-'SLZX!A.MJAR_/
MV6S.%AAI5E@'G21AC"1H^6&%PX/,_J=F#?!TQ+!PS!< !U@%Y+CT!AF+F")W
MTN(%:N6D-D',*CZJ]F1J0PE.1[Q8=^;"H<1IP0,5&<\HM7B?$109G%S1?$W@
M+<NY&BAH4!(5Z>1DP?OL+D",<G )5 Y3C/OS0Q!'%5(6@(X^!"\KQG;N $LH
M0KHD*E$@Q[?RDP]WV$B+;_^9!+&C&O<%Z2I"Y!]*$DATK*\X?;@?N=ST5W!;
M@B5*/Y5B*/C82(XK!!^5D-[PZVS.MV*\2'Q>L\CFEUPR4FLZ_R5>:\AMXIGP
MCL.$2U%>L4.>/WC5M"%,M A"*U-7FC.B+_(H0GXG,EF42S24]H7&/M\)UU_(
M&>G!JM(?G'@TB"+CWIU?*1=-032WPSHFO;,,7)],; <L.P>LJ:D[%ZG0'^*Z
M+W$MG(YXN8RB3;(?CECI?C@5!%.L\)-DA&RQ9,0;Z7)D'HI[,G*GKY14;-;5
M00^!$_08-F#'#X%L_J"("_T^UEIQ N8&;QJFF8.-".^<'"/_$_$;%-YS_642
M9T9,1AM!:,INE[3H2?A]5'YMYHC&5*JI8C:[\]T_T5Y(!06OTYV)F-C,#6?)
M?13S:E3Q5"YD$\\)5=^!<I] O(($YQ29BM3B+0IA.;,[EA5N18A+X"%&8;ZP
M6%9%R8YPN3&>2\NJO+@><A'G4-*7V /G=%(5V&_DS[(R9-4N@I<$G4@_VLW'
MS7NC5TKY& '4D5(!>8IR#-:0B58S/>6\D,TGB6LL-.Z8_P17#=PKY=2X.PY$
M=TM%?-0Q(R(G(J!)N$ G&3FY\0TJ%X%C$I1RO+9BU=9Z]X\VF%E DH[WB&$<
M5VUQ V=5P)."A)ZC-KZ'[Z:%DD23 C(BYRZ)T@&.*Z%2'E(^HI76?H"KO5 B
M5UVY0,CHG*7X%]DJW$7%\]-O&O*;Q6J#4L.IKG0L5CI.=*6CKG34E8ZZTO&(
ME8ZCZ@[_D>SPKZN/M*OK(_LG@<7^70$V(R,W4\7"ULU;MFKH7-J6XGU36)@<
MCDN\B#8H:*8[Y2D<(Q?_!,N(/$ER9L$=G5&7-3S]W3\4]R]U>7CJ9D%N/%?)
M_+/TDJKC<Y8!;Y$HO:&D@(15"PLB8*\ 0;@22G$9]]C= .9Q9JT\H.<R?50W
MD'Y*C/@15JPH0<3P[@+X,9"5C&F='G-"W %V@\$.6(K?8R*Z,YZ3&NKG),[3
M8.UI!G_W^L/WMS>ML">Q@M3G):<_V*-2 0!T@]GW%ZQSV\FJ'4*.WHRF(U80
M++S@@1PF3#UQ&KYLQ0E_X08QQ95^%W36AO,6#%JU/('5EV+5I0;T7'CBR9(\
M/,RVP6HP\48@8#SZ.6>\I<D)B2O38E1B "%RE/?5_+O,&RO"0V#5U<N.%X04
M418Q=2*C4EY<2GF!;6L8'&;SC*S*LF.1X'P%T&M+#OFN4&":\/9YJ)=*?FF]
M0,FI!U0I5^C4E07D7!=']H^*AW"'7+9GS=/O&2%U:V4'6)3G.6^-D"M)>JL
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M/%1@5.%GK^!95]P-"%6^X-&*HK2N*;OB^D@SS-,RC+TEP^1,!C)N\Z _%%@
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MU/CON;<D607J?%J$Z(,TPA"<FULU&9Z.]_@O#H^7;B98(IH&IM]<A-'RV6T
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M3DRE-J;9K.,K5^OIE>OD2,IUTFNP-F)0!Y'PY+NPMLSV7II/9SR4;8:"ZCX
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MG6U 8BZMBI*AD%0TQ_-G?1!6[B .0$'9QX26(R4(9BG9VH8\@),ZU#=@"FQ
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M>L/)L9&%A6MM209K*[)Y@FDX.3:RD6#:$I,_>RORK0M+B=R%R^;4(8,=>VE
M51N2JVE_TG ^:M3'Q'!3]8_:D&P?P30,/SD:G% EP3D8DIFP5#H(]Y&6S\A2
MF#2<;QH-$7NU+?$F;5HV3S -YYM&HS81S+,R+;\SC\V"^WNX\QGO%-8VYH9,
MT'!:9S1NA FTC=E:@FDXK3/"(0NM&1MY]C;F.Q"4<8A+,7#2UA)Q!K1EN8;D
M&T[HC+N-D+RV+%M+, TG=,8T!J(M4>ZSMRRYC S ELQDI&E\H.HACLO",^)O
M$+C%SV'[:"NSFB$:3ON,+60(NR5&@[8RFR>8AM,^8UM;F4>P,HT_8M=SXUVK
MY9^/R6!W&\[UC*GWJ"V3H[2-V3S!-)SK&0^08/96J=K&W%!"^BR\?<SL2]E<
MI,.6FU%_P\F>\;"1XF)M4+:68!I.]HQ'C>C7TS(HCWKE?Z,-&-]#>,8R"&.Z
M*FU6KB'[AM,[XW$CI<7:K&PMP>R3WMFBI7T\T2WM!Z:%OS/'B^^,-XCE7;([
M=5/[9NS1<"IHTFV3&:'MSN8)IN%4T*37)H(Y^T"F*C._A,%/=YXU1.K"S U9
MH.'DSP23/]W6I$.U$=H\Q32<_9E@]D<GT(\B-;^SV9T/OWO[J&W+U53?:S@%
M-.DWTNJF;<O6$DS#*:#)H$W]81HPZ=AB_ .?4(5-2$!+MUYPSX"8M,&[EB\;
M3DY-AAI']+P)IN'DU&34)H(Y>W/W@Q\EH0-WI"W<-73><#9J0F.K=-;^? FF
MX6:CR>3B>MP:ETA;N,>7W#$+?2:S8&_=D,UBXW<G_,%BG'GRE<6.ZVE[=PV7
M-IL4L[K=1B:>:'NWM033;%+,ZO:08'3MZJ&DYG==I[HII3>;^[*ZUL6UU9H0
MG;9XFR>89E-?5M=&@FG+U 1M\:JR>^[^/ Y5_N[,[A#:^=&0!-#H*H:=P0;+
M>+4,(A=I\67(/*#GG^P5SM*]LNG;11)R(H8/N+A^85VF5$L'J*WR:DEB-9M.
MM+K44=9MB9&EK?+F":;9=*+5'>@H]$&%>@BO:8-\#9$WFYNSNL-&VB:U0=Y:
M@FDV-V=U1VTBF+./\/[.YJZC [AK:+S9O)S5';=)\VM3L7F":38O9W4G;2*8
MLS<5/[N>:?S-R7"L$)C?F7K,>)^P'>=$/R>3H.%\5X_P /?VK+4-V5J":3C?
MU2,\0#W@Z4#W_<59LE#(RO=!R*(8>\'FR6Q'X+_G9"@TG/_J66TR%+1EV3S!
M-)S_ZMEM(ICSRW_M8_H>+?_UY<X)[YT92VA-T2EFP7K[9,&>D>EE-YP%Z_7;
M-%M3V^K-$TS#6;#>H)&TJ;;5-Q3M8;!@400GK$=G;4[S#2?%>L.+Z]'^14?:
M2F\MP32<%.N-L"^C+01S]O'?KPS'OT2Q$S/C=\>':U&@P-ZRG\P+=A\,\YQL
MA8;S9CW*F^GJWO,EF(;S9CW*F^V-:Z.-RPWE9N#,A93\JOO"UE/[/GFRS;%$
M+:O;-BQ1;7(V3TP-Y]"L7IN0C,_>Y/P6+.(')]3UJ>O(O.&$F85@B2.-D7#&
M%--PQLQ"L,2^-BH/)AF7<'F.%S]JM(&-Z+W?<$;'ZK=IN*:V')LGF(8S.M8
M"48'*P]TWQF K/%W)YRC$6D:W^(@A L2SCC<F+N\8Z&C:U?7,D/#J1Z+^I_:
MTE^NS<OF":;A5(\UTB'+0TK/T,&%TJQJQW=9E$)=(;+K- $YJM/CZUB@X32/
M16F>04L,"&UQ-D\P#:=YK$DC#2+:XMQ89BHC!HT/_B)T0%HFLSC1 <RUM-]P
M<Y3=O;CNMZ9^3AN8S1-,PXD=F\  ]82LQN][5"TL@]C9*V8Y#<(Y"Z_XD;VT
MX8SG08*]J'+MX@-8%H\W$ 6>.Z<WGP-[6*.<P_[AT_O]&83F9S4'Y=30!6[-
M7<>YP+_4TOH!C&?-*ZMYQ6Z<5VS-*TWQ"JG"WV+$&9!=2_ ?N:9[)[QU?=HX
M'(O<[14JNY?62)*JZ\_ANEY>X2M-;VJ\;D\6[DGIO#KXK^=/I3?J#,=X##?W
M0&FQ0?06&7%@>"R"_[V#U74[O;\83F0$"^,MFS%D&TZX=L\TK*YE=?)M9*=X
M(=8Y78A=N! 4.RCF7#\AH57UBG)I8FU]JS/"_L%R<^&#.X_OI'Q5OB@D4C?[
MBC,%X9/$]5]11 _*4!#(!Y<R]@36U)MT"V>F_!?7B\+<M6TVGXV[8S8:6_U)
M?SR=]*?6<,+FHY[M3.S)_]A6?W AOW87RETL03=<34/F_+AR%K#)EX[WX#Q&
MJ+Q59@%.$8L:CJAUL^[4%+;J6:MX9K%XFC-#LJ6K TT9<$WX$NB4A;RS]*].
M:]9BW(6HV?]M_=V-P \A_!I@JS=H%/@(S>!<UPJWP]-NR7LBX?7: TLAB@.?
M&=_8+ G9W/C(?(K8OX>#:/WZ/P4Q(PF'&$)HJS@Q;.&]ZSL^%K48W[#'Y)Y?
M1\NW\L+U040'"3QC'ID&^S5C8&4A\D=TAX-,86N.B7\+@S$RX(,DRN,[%CZX
M$3-\.(UYL3&;_EN0V>E &FMX95^L>'L$QN@J\9%3PO:P>1V\$0\#]]TQXY8%
MMZ&SO'-G8)C?2SV"+.GZ/UD4$QD83@SO1C$=WL)Q0^.GXR7,>("#A/^W"#PO
M>(A>RC,D:S'3460;PYX\9QFQE_(?KR2*@>O3RNA+K\1)"<56T4U/1\??SJ1U
MI\LEM@C9B%\6;W?@K=_*K_<GG=%H5/D6JONJU^L>U>MV!I/!5H^J?WU@5__(
M#HL:]:WV+:J5)S7LKO[Q-0'!U1&"7NES%8X\EZ*'<02+1G)UC%!:NH8T<LM^
MX8XGHL1<ZASG"M^YW:?U!L3C)D&F33;\; [M/:J2?Z JT4>WY=']!54TA?&-
M#WE%K0^U 7I$LX:.^!.+C9LH8@74N+-/I__AN^@4D"M0JC5:M\N-*:(RIEUU
M$$>-B/[[T^V_W:'@VEA^$LTK<L*Y+BAPD0IQ_$Q.?7[PV?PF1IV9[QGUD_NK
M>4"1!7Q,&MVWE>!^_^)Z8MKCGCGJ-E60N(T$.T;U@>8WS6\-\!NJ-])NVS/=
M@)BN-S*'XZ:Z$MO.=-N4_.S'@"=$B+7U0 WW,]I#(+A^8QVP3T=K;<C1:F(_
M,+&O;O<NR%U!ZI\7X$IP3Z*:XD<7U[WQN#&4RO,F^3.JT*O>[AO'=^9Z!LXJ
M^V?0/8B_,;ZXMD8#<S#:&^)+]WZ<!QWM84=/D)C&9J_;EKGGFI@:-P\&#;>N
M][N-3(/6!--:@ED-CK&;/=GO75P/]N^HT.UGFUWZ:Q;>)W/GMS?.(SS+^!!Y
M6)&B^\Y6Z5UK)_NMK%7[UL5UWVY+\Y#N-CLRF2CF606MV$ KH[9,<M6TTKPR
M;1CZHM]OTR@(33#-$\QJ<)T=K2\]0.20E_XN"8/E;EW^9^AG5*O1_B&B9?TA
M!CB&9M_6V'R:CO:,EO5'2$R6V1NW!45%$U/SZK=AV)W^6$?+SIM@5@-[[6BO
M33!:UA9TKS.*EFV!/[)A1OM)<!3.I@9N[],Y46E18:L,#F'P#KI8&3>Q^V9O
MT-0,J&/A31RT6%6SL6;C)V'CW?V-00]Y>3P<F_U^4Z&;T^;E'<H"-<S1H2#!
M!DU!@AV95-M03ZAYI3V\LCH@L)M_-T!(L,FDTU3B[SGSRL:08 (JYQG"06CD
MA9->E(:#6 \'86DX" T'H>$@6G)T&1S$7Z?A;]=Y2 AZ21]N$W2))ZE 0]#?
M&AY"PT/H=O7UA0/#@\3C^Q?78XK'3ZRF*H+;WJFN^4WS6P/\MD?@?(!,-Y[8
M9G?0>R9,MT.X[_EVS \:'A<S0'@(:_]ZC6?1*Z^)_<#$OGJ8UHX!;*R%[-F-
M#6T];Y(_^X)W#0^QWOXY"!P=_,KUH-<U!Q,-#Z'I:%\[&JM0K:YI#W7]\LD3
M4ZUYT#!4VK"+I<M[(Z5I@FDMP3P%W-BP=W'=:\"#TA7O3]ZA>(:]N)6*=G@0
M/*^AA8Z49=K]IM"#3RP8I>FH.8-M: ,Q=6US;#55^Z^)J77Z=]@PGM>PCQV*
M3<7)-<&TCV"> L]K.+BX[G?:(F;.*,#61(>BV)UN;3K$Z9RHM*BP50Y2$3'$
M7)DY'(S,\6AO<.EFK_)( 0;-QIJ-C\G&>_@;(^+EWLBT^DV%B$^;E[<)%NJN
MJ]4=BG;3'8K#<4,=BD<FU3:DM#6OM(=7GJ+ 8XC0\'9O__D?FE>J.A1_*TSK
M+D\S+\_COJ;R_M4ST(\_Q?LFPF8$V9[%B46.[*6!W95O6::!\^N!",+@@87&
MBUH6\ +'7]FBJVB*Z:_(*]+_I\!W9K,P<;Q/Q$R?%Q_AB5'.]H&]S]#^>0":
MC)B?,L@PXX]1]^(:5ESB#@/7=TD;W6H+PP-MH:MLH7=Q[0?E'<A+B R:9L^,
M91#&"^#'P(!7&5R4 9^_$DL ^G+B)#*-D$5+!H_XR;S'SK94>O:T;3CJI/JI
M$[EP9-N'\E:#PVYM$8TL,. G%6&\OZRFX-KU-8QV##9@S?KR]&;BO01):"Q9
MB$P Z@+6,8V!@K/.,Z!K!B_$0,-1C*.)X4J %6/\,"R)[;CEU?AOVV^9 )[+
MX?A=;Z1A/,/1H&9Y#5V(^XO-Z38*(J1:8>*J7-MF\]FX.V:CL=6?],?327\*
M]@N;CWJV,[$G_]-#8V83:( #1W9)IGP*@/(&'7FS(-'A.;/B/1;O+?79W[K1
MS NB!([P.WS^M1?,?BBW->04 :>&GKY\$9_'X'*7*%I#</S54=._,P<?1U<D
MKUFLJB"@=ULQ-SK%K\P_^U_9+ E#()#7*!2K-C&JVL2HO(F_%FA$.0;\<-5!
M@/Q;01*O6J)WOH,2!@7L!0_(1QS 8@DW3ER$&EI1+7<N"YUP=O>('+AP?<>?
MN:"E73^"0Z)+?;F.LXJ7O@6G36S[0B&/ZML85=_&B&YCQ1U:U7=HK[S#@R-^
M@+X:#^RM 3\&G=%@.Y2.6L2(7F=H;X<=L@K&0B_J\(OJ:\"/=8 ?M@;\6'%:
M'QE8849/8ROL=&Z6/K>=SLW6Y[;EN97K.LZ^]/B]&X*WY[G,)X]0HW5H]( -
MBF@W3FI'%:YQ/K%-,8:K?[$PJ,IIC\87U__Q;V.K9[UJ?6^KQNO0'/=D'#=J
MCN,V*"4932ZN>U@4-FA_2[EF.\UV3\9V&[?W-L)V8YH7,1CV36O_&?":\33C
MM6CC6S+>Y+",1\,=1I9E=H<G@5%U1BT6U>3RC0%)S.L=T^?:!U[)+:.-FQKW
M]<?&5F/^F,84:"<M]0Y&2[:FI3.G)>NP6KQ_<=WOF8->6X K-#TU3$_V8>EI
MT#)Z.OMLQ!]^A/5';+Z[S7>&K>35O+#QJ.V]]?2PZ1A\"\(.FI946MIXC.+>
MM#32M'3FM-1@;G 3'3VF$;O6WA!WFIS:24Z'37R-)^TBI[./\[W[,W'C1[41
M04?Z5K%#@PFIU9IZTM71F3.GI09S+&MHJ:=IZ;QI:=Q@!F(#-3W!3LF^.=E_
M$KNFIW;24X-9B$WHR6X9/9U1I*\)"+U-!FL_4^"M)H_FK"1(@[FG-=9-_XEJ
ME/>ZS':7<VD6UBR\GH4/F^Z;#)ZHZ%GSL>;C9\W'#:8J-^%CPK0=X=RM\=Z
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MO X9R]XCN*Q&/+'31:MYT5I7[!M>SO;LAN.KS5ZO;TY&9>/C<MMH1PMBCYH
MC^2"[4B PXOKD6D/RO4@FOA:1WRM];PJ:&]U\M32T(,G1WW;BK[#^5P[BK[Q
MQ?5P8/:'98=+R[Z3I[[#.5L[4M^$++_QR!Q-RI/2#TZ 9Y_*NIG-0D:$ P[4
MW(UFL)GX-^<^@/7]RY%O+($2W.1>Y[=V<*JFOR*O2;Y*;^SSXJVXKQOENCXO
MOO#+VIKU[.[%]:!K#GIM@9/7D;;#)+Z.1Z$51-@#(FP*.T<38,L(L,;U:A4!
M6F#^:OH[3_JK\;W:H:)7AP9L/8WJW*FSQC=K!W5N8D#VN0$Y+CMN.D/V) 3V
MB<5&R& 5_V)SX]9Q?>.%%T11R4W601"5T7JECM0(M@#_>L)HR-_@<C["U7SP
M9UXR9_,/_CLGQ';JJ+<]GV%V;&!V)SI"=X;$6>K!/#)Q5M ?=F&6JR T[;6.
M]K8DO<.U%6XL#M<8Q3I?=NXT>;@VND95-#;7V69_O/=<!DV7+=73I;:Q$S,B
M*=$V')8)5"?9GL)-XR"KB+&:^*G+YBR7(5P1S[.]F+/LK]U<N-,-E6S+?:5D
MVVEQ7[][<6V/S)&]CQFMXWCM-%D.5]RXI>/6I^2:SFZ<"MUM*Q1+Z;76A0[Z
ME=DU+?).GO1*F;43T\<VUGM/^OO4>VO:;"EMEO)J)T:;_8OK_L"$O1^?. ^:
M4:/A$,<@L.\A?'G!0AR)$0?IB MYV(TN:4@3FM:MJ6)Z%F*W7-F=BK$64R=B
M?(#2BUYQ LSS2 BVMATNI:P/0%A$5_;V\F  \L"<V'M7R>G08CO)\7#^XUIR
M7)U^Z0]U^N7,:?%PS7+[TJ).!9X[+1ZN<VY?6AQK6CQS6CQ<'UTC)N.D72;C
M@3)^*4&UP),,DA@[Z9ZK+_ELHDW'<"8_)_'GQ8ZB8="]N)X@TJ#.1)X ,;;?
MDZREQ=4FTZ"GVUO.G!B/X$KN2HR6)L8S)\8C^)*[$J-N_#LY8FPO*DLS-F._
M/3;C&?7XU4Q:5H9P,G^NQV_J\2;;R!:K[>,W!S1^<S#LFU;7/H7Q)GH2D6;5
MIV'5MH_?'&#C9\\<[(_%KOE4\VF+-KXEGQYU_.8F?#IJ:&Z'9E/-IBW:^)9L
M>KC6X1W9= QLVC<G_;WQ<C2?:CYMT<:WY-.V#^ <T #.40^AK9KJYS^' 9S'
M+Z_8I;$:/LE[,O K3'1E&%0* :_%@;%P?0>HR/'@ U$<)GS23!2[GF?<,0\>
M3M-FWK(9NY^RD-^_W3,-JVO9N:=G2_-AH1LN#UZ)[YCQ)O")*&A5WV+X'[X.
M^.7/2Q;2AZ/J@HQUURQHCU_?2QL(;!XDP$0I_2G$6?'N.0OB)SBA=HOJO:M;
MUO52D=R-A.B>?RY(Y3?$(1_\/U+>D)U36TOI(;;4C\UNKQQ$W#HIT>#]'RG!
MIF6 E@%'+BK:G?,KF+N'>!E-S2'5[*W9^_FP][8J?FL4B489O1F ",WAFL,U
MAV]<_-8>(]X&]C?[]DB+ "T"M @X8,5A>T0 PIWTS6Y%J/749 #%87^+,4"=
MQNA@2W@9KI]0".]:;O)3<@\W/Z-@*IV%:]ML/AMWQVPTMOJ3_G@ZZ4^MX83-
M1SW;F=B3_[&ZO?&%?'#AN>EQ]OI7O8O:MZW1\&K R0/>8O.;.'UYR .[\HSO
MG?#6]7G V@(1!>>/^TJO@!\D'+_G+"/V4O[CU=R-EI[S^-+UB6CI2Z_$P\2]
M5+2=T1GSMU\]N//X#LF\T^7NJHALBU\6;W?@K=_*K_='G?%H6/E6M].K?+WN
M4;U>IS>N?JON4?6OV^.^7M1&KP_L[9ZT<E&K*6%-WF1U(7NO]+D*E3IC((?#
MPVB.\6;EQ4%(^8;_9DYHO/,Q<R$S&X9(:E@YL;O/(2F&T!;YKY8?H!M&,8]#
M?729S__UEDWC6@3?+4_AV9SD-TS?S@T\14,?X X'^.[/Q(T?C0_^3Q;%E"[4
M1[CE$7X/8L>K/<$S:C:I=B/49I,I QL-L^.ZY407]&Q5T',X"(3="GJ&U')B
MC<=F;ZQK9#6K/F-6/1Q"Q(ZLBBTGECG>?Z:DYE/-IRW:^)9\>CCPC!WY='1Q
MW1MU36NH>\,THSYC1CT<L,B.C#JF=NMNS[2M,GQ#"UGU[*>#?4G"V9T3,:KM
M=C>(W9PG9LJ6?'8XR)3T?K;G-6P<L?O ;7LK10W=TTHRM ^'KK$[&8ZZ%]<#
M<U(QLED3X5D0X>%P(_8@PAXX");9KYABHZGP+*CP<*@(>U"A!1IY8)GC05.]
M!!J_;)UY&P:PXGED+,+@WEC"3<[<I>,9(5LZC[RGT?'AG.&J&K& 3Q>"?LL:
MO@.:P-_P<K9G-AN8;=PU[4G9_#WXD&D] >%D+=\*ZEL-F3KJZ_D;IT9]6PJ_
M ]J\.PJ_P<7UL&=.AONT,FCJ:RGU'<[6W9'ZAN!MF=V^9=K#?>KH3VO>R_&,
MW)O9+&1$.&#!SMUH!IN)?W/N UC?OQSYQA(HP4WN=6!W!ZMV^BORFN2K],8^
M+]Z*^[I1KNOSX@N_K.U9;\3']=I[@]GJ0$<K*;3.\CT>A580X1CD?T47I:;
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M7+SRES2;QOW)7F&#Y97=J<!+G#H1PP< J_0R"LE-A=$^]W%JIU/*^@"$M>/
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M]=CMQ*AHG(/MVQ]9YFAR$CKUV>3*=NDD@4_RRD;\"A.UC0;EM>"U.# 6KN\
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M6M<W%FX8Q8;G,M^8LVE)KNIF!=VL4 ')NZ;R):.QSP\^!DC3$._VF>PAMAV
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M)W*7[/T#V_K'>-C"[W@1U?Q8]-'$KCB6^\"? =>&S&E(\X3J$P>#_5/"QDL
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M=_APSO!YNL('=H3_VI$+S!.K<XG5)I],P#.D>88TSY ^:H:T69PA;9U"AC0
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M: A,\]^^EQ]H+=*/O/.?5GB.3\Y+?!B"NQ3^''\=@TSU/"<(A:L_O[Z_%OQ
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M);QA]8@?1D?H$W\Z#%/,+C3#)DO>SXMLXY%W2-5L6O9=$#C+!Y99V)QU9#K
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M X7.QL4MD6=,YHR%/U/]E^T6)Y000<R\'#DA;E5))1X6'=">CLA_X9:-5KZ
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M88C%[EM\B;(S?[G<N3LK1BL1X^HQHF"FI()U9XFR9HN&V?&([5:G?"2OXF@
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M&84R= /)^\!_")RGNW7TZ&/"Z?R.)G'*]:2FL9&:EC2:*$;>:Q& :!XN^PJ
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MK1:WEB1Q<<O%[5#YI- 54)2AN *6)(,CK6NBJ;;NS\MO!1JW6\?""?9C*W>
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ML^!#J=]YHV0<3V,TL?-%YK\D]O:VJ7X\4XE;^/USX\M%\J(V'%X$JZB@S=
M>!$U)^?' WO<M ?2!3*D/AR&M$83O6/E.*>$6W3'G./7,69)%/;07/CMT0T!
MF#A\$^=*(MX Z["OM9?$_ !3*;2#S+'6B1/F&.?1%_SG)6D^W=ZHG![_<?D#
M5H>^TV=\PUO' Y^*)!<"!3%_FQ:0Y<?!;\/*7Q;B9N:O 6XH!$+B><G<^ WV
M<'!\Y'J[@;LW0IGYG8,M>X._!#%$7[%>X;>:T\WLF&Z*A'3+DVU[^UL;?3G
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M'%ARQO1P$\P@')]\X )VQ@"8IW L?&-;A=/!M;/"SNS2$(GIWL0-.F>@"1\
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M8UUW"URB/)B6EJ6J@E"'=BQO@5J4$;.5<5>G1:^'%+=^Q'L-+U=RMTF&/K8
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MCKIEZENE;U6)-OZ\33B[C1TUX3RZVAK/@0MT3*'AQU$861ZN>84I\XF^@A8
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M.63!TO2N]NK,2,00GAN97.R+IG*S>R#ZM.NEZ W[//#_VT*3FL[MW06^9A/
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M*]J.;<U.R]]^\*G20Z\:G&E9U\&EC=,N6GG!@9H,3'QWQ(+P_;]B)WI<K\%
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MH].$-%+O#ZG[AT;J#B!ULZ=%S(PAXV5D#5TF*^K #[DFL;T+M$V\:O8D_CD
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M;MQC-KH[XK1'9^.O%G(LX;2':-QC-GJZ&:UVX52-TQZ13JN;T>Z5TVY:!+.
MT_:U3GODG';[JI#K<-J!;D:K==JJ<=HCTFEU,]J]<MJ]U6LT31T<>53(LX03
M[[E>HVGJX,@JL2^M66O-NCS=,K1FK9+J38O6;4"D=7#D42'/$GZ_?5&[%:BD
M@R.KQ+ZT?J_U>]V/H00D>XY4]QJ;EL[;@$BWCUDI.SWD6<CO<TBT*WZO&-G-
MSC&CTM&IJUJ_+X=^7Q(^O[ ?0T_W8]#O;YL(<3RBKN['L%]1=^O:E:;9??&F
MV]'AF55'CB6B["%J5YIF3_=CT$+F<0B9E>2TNA_#7CGMUK4K3;._(TY[=/;]
M:B''$DY[B-J5ICG0_1BT^Z9JG/:(=%K=CV&OG';3VI7SG+;9T#KMD7/:[6M3
MKL%IFZ;NQZ!UVJIQVB/2:74_AKURVOU5C6SJP,BC0IXEG'C?52.;.C"R2NQ+
M:]9:L]9=(4I L@M(]:9E\S8@TCHP\JB09PF_W[ZLW@I4TH&156)?6K_7^KWN
M"E$"DEU JC<MWK<!D>X>LU)V>LBSA-]O7]QO!2KUCAF5CDY=U?I].?3[DO#Y
MA8D0?=T10K^_;2+$\8BZNB/$?D7=[:MG-G5XYK$'C1RD>F9SH#M":"'S.(3,
M2G):W1%BKYQVT^J9\YRVI<,SCYW3;E\=<PU.VS)U1PCMOJD:ISTBG59WA-@K
MI]VT;F4!IVUJG?;(.>WV=2G7X;0MW1%"Z[15X[1'I-/JCA#[Y+3F_BI&MG1@
MY%$ASV).;.ZE8J2*2CHPLDKL2VO66K/6'2%*0+(+2/6F9?,V(-(Z,/*HD&<)
MO]^^K-X*5-*!D55B7UJ_U_J][@A1 I)=0*HW+=ZW 9'N'[-2=GK(LX3?;U_<
M;P4J#8X9E8Y.7=7Z_2[X_<O(&KH,_ATY]V_^#C_DJJ96<.=X%Y$_>V4V87RQ
MUPMDY:^:"7]WO!'L]-4%?K+K??57;:N)VSHSS^6V#CY[%BIFK][M(QAN_<AR
M#6L**!,9_MA@ECTQ;-<*0_PK)&H%_TAR9?AQ%$:6AR,95F1$$V8P;X3/XJ\S
M6)@_,F8!"Q&I1O7D%/-G5MXS:I;NC"[#D$5PV^&&6G<$9.)#AA,2T ,+Z+X\
M =L*@D<\G'O+C1E^ZL>!$?%3QG'"FN$R.%W+=0W7L8:.RP^6_;3=F(X5SV (
MA^?A8P%+#M,8/A8@A./!O+@2O)PUF(F68=W=!>S.BIB"6O/O)H/GIZT;2_;,
M?N);(2P(YV;!E%!UY+NN%8CI0GKA%[,&AX5?9K8$V(O# *FS8]?"C0%CMY")
MA[[KC.B3H14Z816QMU4Z[+V=)$@ R/$P<8# A/%B*O-H//BQ"T> E"5R(A>.
M(Y[!$2$B.]Z][\)05O (V/NO&(\+Y3+ !$"*,0N89S.<Q_(>TP'_BFD"^-B)
MZ@8N"#ERL_'Z@OXU7R=8#("*ISC<"%AA1.C-I3*<))H(BG?S_DIBH?L(F ?/
M>7X$Z P+"FAZ6/S("6W71S2%$0P;N*N%LSS.6#%IK2*VM4N';5_@'*S9S(7C
M WH$YV!;<<CHU.;I#PCOXN#NG! HB3BK63R$]XTHL'""*IY+IW3G@I?N)AZ&
M=N#,Z#)=6S:R'KCM5DA4W/$D+?X"5)];/'A 0Q5/H%O*$\#D0IYL:P!-BP,.
M[]]BH&)FF^<>$GM\@+M@S"P'!;LQ<4:\'T#!'YQH0I<IX;M1=MB/!'H8.7=H
MJ*6BFNQXL26BP>8^40Y6;*?=K/<Z*-'[H8//O H8<&SGGKU^<$;11"KIRHM<
M;7G52%^QAL#6XVCQ*W.JT.&5GM: ,J$'.9@I/W&]J/T[K18;V?U&G_7ZS?:@
MW1\.VL-F=\!&/;-E#5J#_S4'C1?RK4F0WI0[=C$,F/7CPAK#'E]9[H/U&*(F
MJ6I2H$:)-75[=83\(J#E=*[%(!N/]P,R1'0ZN1&S?1*!O5>@]K( GX+E6*59
MBS$)T##T'ZN/K@>WE-@6W*LKM"F!)/OWE]:;A?3O\*@[E\1/Y.ZM:]D_PLCW
M@,@C>P6Z\HEQ)?$: %'Z]7/:!7+;E:H$7 -+\FP'-*>;"#Z8\N,H^5;.2)3U
M8QAC!+H>J'5L%I$Z%**QTH"M637\&U<)1('K0\"#?:#DP8,3DDC$1N=%M.@I
M!&#O!V>8S;HA#+5?XBD,9.<MLM("&X<7=Y8U>X62" CK ('W]WBJM_#L6]>W
M?Z0FUG:#VW6!/;'1920_Q+%8:%LS//(@!DJ3CF7PP:1%5JPE=WMS7$^9#X9>
M:M9219M6]P @+Q9M4(ZX\J<P\R/9-7NO49CP )7P@A@,#0]T?<(4,(P  W@9
M^/$=%R#PBI%J'H:QA4J;-&"H-W"<W, PN8%U;N"&90 V3ZQ[%/*9!TA;."%H
M;+X-% E)T@CD?J!(I'P*2Q4]P/5-J;T)O0V(&"A_-0/T@40?%8^,A(87 +6_
M\P!T(WIRK=7331L;TJG']R+K/B37%1["9<1DY1@RUW]8+ .7%$V^@HC/AD$,
MFCK?9+-/FVP3G-[Z5C!"'XEK(3PMW&X4.,.8[@0 Z)<G>EXRS1X^?KG.WWS
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MY3G_3N>Y W4BMJA+-?**=P"=J1^#&'CEPV;OJ).LPIV,W^KO!&N">>]Q79\
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M@4:WV6K(C@"WPXYB;!X,_!KTEHALD-*N#J)0R(PS;/)(G9U_>/Z#1P>7>4#
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MF'L<X:N/W[X*:S872>=I4"ZN2L9GBW#P2[3T*;%!;V72$ ]\D $_PLN=6,A
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M],"DWY&'=&-I,SDD(P:?%DJ6D=6IZZ>61!*A[RT2=:AH2.HOK-C7:TMHJO%
M3E?1AGS%_J44Q0'@!/-=GT"FXSWKLD)=YBBY<%<\2-WX9(5\=ZN6S%WGV,!/
M1%;Y7@YHF=7- G3/V3+(28V!3WM,"5M0S@B4MR0!&F C (01?S*(73%NZOZD
MO[F G3Q>(YEW.72>LHNEJ#T1:1^\TT'BNJ3FAYFQ[:3%62A#HV6,ES@I&0:N
M>O.5LH!IG:2 _PD2:RI8+V?MQO,+I2O\EM-I["6FT>R1C2O0+F<Q"2^B6=R0
MQJLBJO$!&""$FR?G +9!3] TY'6_0ZF: C;)6X7**$6PV(RN/<FC(C('V\-A
MM\,8*SD*]3&CHHDTT,2+R"-W/<9&&'""VJ*,W.$A,MRVC%)JVKT2M<*,T0\D
M8?+MRP EW&(:=U,Y:\6-J@BF.0JJ.(\A+XQ'_J,IF'(>O*3Q\AGR7<J3(-_/
M>59)'F+(EN,"E:$(!7$/6)HGD1Q4)JTG[0$7T%>BPVI@9&E"$M,*DA6G*MS#
M),*!,-E$1@OEKAT?5EIOBZ9=/B5NC#D$*NR[363+B5R1[R!FY787H4$AGB1O
MH]+VLJA "59_$P(*ILQ?U8Q6N\/K+E[>,R\&/M RP\BX=GT?=#B9Y@>__=,P
M&V8'6[U[CPJHA55 \+F93P9Y;(Y(S6(5AFHIM?GG3/\*9I"Q'%^0>0]DD!C*
MY+(4TGGOIW&IQ/](=9#?*@]KFBA1^!1R1Q'/(D;:SI+0(2_Y"3\>4G%@*B>6
M9\[.PO,2&"Q6\(81X=7[:.+8E6,!?Z*(@-%=PI:)+4;Y?ACM!S-APAC+T<'1
MH%_7,'M_79@9IS+7[44:2XCU:K'[4:C$DO,ZN80HEFOD:_,@E0H<]*)()TWR
MJ-+E-)M5^RW!.AE0AG(-7E1:OYV$12&?4D81_=B=PN7(&Y0)V%*70 %F%CIX
M$"XV"%=LQ+/?7"*4,=I9?>I C'Q*$"=EMY33.:*<B;R%F;/-45IA2/6BUH%&
MQ#0UW2[YK').PEA[\_XJ&>"!#4.'IS,_/#S482/U._^^[/?IG>]B;.9W:I",
M]XK7M%>:>[UE'L."TR0.?'WPN%PNL_0K=P5O*;<<4]F(#))F00F[@*L"+T8<
M)H&$B:CSKZ!FSD8W5$'D2Q#1_1 <S.!I;-=L&,16\"B</XT:5K-IOY(P%*N1
MYK( +OT%EFVV9B%[)7]Y/7)"K*_URO%H=_32:P%M86-#H](]%KNT+5?8SPC\
M_.O4WE1O<)M3%,#_1W)F\74=OGHY_WFW56_TS<*O&O7BSQ<-97;JG6YWHZ$6
M?]YI%4^R\:)Z]5:SM72HEP0O#C,X%CR\__NB]2(U XZ0EKUJ&":@^<M5CS5G
M/_'!UXJQTV7CN0/D9W=@^VA_%1%I%!"1A22A),N=HW%E7["P,$ERLY=:*)UZ
M<XVU%)C[D<!?-.O]>9(S!(;-#<AGYOE9\SQG>8U&^@+I"W3("R0+<LU<]K.R
MM^BL57215K"D(>C-J*![HPNQ1]MF;#Q^O>$=@F66P5/=X'$CB<EESB2XF+8L
MA(20MTA>G468%>R,#+FO-2G22C _]?W-%K<Q,HSI?Z5"AJ5'GZEJ\J1#7[UC
M3J\6,I'GV#:5T/@%?J_!/+O8]L;H>&1@.P:JN73K?S@_L V#<6,]3#SVN U]
MK-:9?U%J!FZSVVT)?C6@M<,;4D)6LK%<,5\%I S$=F?O'SW54V+Z3H?B;2\<
M:-)W=*1OZ=8ST:ZG(T4_630X2>%Y#EI'SSW4H.G381]:8#[LK:@:L\AF/VAN
MH;F%-K5DMIY+!=*<0W..]3G'2XKB*'"@B<U=(*Z_:O9R<307^,F^76K%<31G
MYOE>/&CKS/XZ Q6S5^_V$0SOE+@=43HO%+$^X2LL7,!J0)LH <\T7R.90BI5
M$[\H7W3D%YW<%X*P40YOAM0M#O,J[P$V2WZ #]@*1"GY@X7D>#:0%\O&3926
M*T(%\< +(K&615[5C"E6GIRY3IH!GL_S]E@DVB3SZH0S)K*!Q<COF$V1W'SD
MEDDCMZJ($*W2(00&ZXE\6=5W+U-E*;$VC/+Q>#4U3CS7J1*'X0E/JYO:B%9>
M[T4KK] X4]X1;<VN79\G:7W'26XQ29=/H3SZR8>-W4PP/EO,]-&S_2F;?_*&
M]PAR;'6Y%+6K/)2=\CVO9#]2QSS/OW+I4GPZ)8]\1HR_$#,]TO,ZV3>;[#M8
MG.R+ZW5&__?%ZOS3IME^H5.$GV$MATX1?J;(;:Q.9YAFW7B?Y(6I^7YE#SPO
M7O7:J8EE"2?_HE2-+4@A%DDZU"%8)/QD$T&ICD@LB[C\R>0;SG08!R'+9UGS
M? K1(8628K$269H3G4U@M1RE4K@Z!N:@95IFAN=4B7Q5+P/^95H)3?V.YWE@
M5IDH81Q&,'RHUB 3"5%*TO@]4S*:SH:6Z/@F*M@A&[!X##[UR,FEGV$QC'NJ
M8$T9T9@-0UU18=-6B-WDQ):*&GZ=*V5C9!7&PD:@LE:KS*SBVTQ!(!/_DCJK
M22,C%!$Q>2QR>8Z7E3^L6>"/\128%7AS-=UE*PM1.R^D_+LQYL+-K$<Z>IDV
M)FJAISE"*#$7[68^D;]FN @7+"[IA50JEG+>Y^K+\R0A+"A(I92C,"W^EDZ[
M=*;*Y7E>\QXT26EJ.*R),W3R)3Y%-A9=8TP1I)Q;'AZ+3;^]N;3R3+)3Y-L_
MJ V/C^5F^)]8^ !K1Q&F!+BBL)8D;6&[$OZ4)WY+L%S2G)J2C$N%!'C/@&6=
M0LK!$42L1=7Y098&8YLB),/BD)*$5ID5O:@:4%A3:M02W5NWE)RHG%E8@_=]
M4E]>ZL-&LU43+;4?,$=;I"T5Y*F_HL8[OYC<.$)J,/9O,,[@9@2\T:;($J8$
M:""-^/5YC??.^:59Z\!;28*O;!91E(9N8**L1SGG\"Y-2E,F+Z<9QO)U^0:\
MD-;_X'F\V7F(@F:K>2BELBG5WO?FWAIQ%LD[ =V?2]-1"@21Z#C7&7HNI_=/
M69\?&S/S*A'_YNP!84^M A@V\.9B:1Q=^..+&5QS6%="I3$E;<$A92@X1YOD
M"U27/5$R*LF!',<N5J*3#4*PZY?H+YCV(:3LSKFI-B$GE4ALZ\%;@_YN<LB:
M]4&K4[;$-EQ43R>V;9 W<NM'0,<R#$D(:TE389F4A13@V@EA6\8_D2*@$;"*
M.2:%V24:'=9!ATQZT;'@0UMG&^ELH_)D&RTS?1XNY6@_%[E+EMY52UETD5OU
M N$HDSQ83-@W.::&L2D1?XZC^B5_,3?:HKHU4K]+M3=R2S9?<W5NFWWBQ=YH
MO[M)7-#8IK%M36P[J)#Q;'PEEZ%W$IREX*".[:X7;?$8[WKQG=L;9UDBX&IL
MT]BV+\Y2PF!]G=3ZC$FMSR8M%&2V5D=0,!;6@-*TNTJTVQPTT)FG)872G,@Q
M8UNKUW\^;#L&2>'I.>#:6%.EBV+VGT*6M6E08]N3R'*7@G).P#3X/%;!Q34(
MM/A2I7MB]EI:6"[5B1PSMK7:O2=092TL[Z(&AI9?JG13M+2LL4U+R\<A+:\H
MO:)%F"I=E:<19BTP:VP['&'>I<"L2_]L,OOB0B$ASZQ2,NF29#OJ#BSRZ&JR
M$;3,RIY/QU;3.D1>UUQH/T\#3K)@L>^O;$%=P<HOY2L%]%&F/6?;7H<K,^PJ
M"/URUMV1-V#DPUQX87CG2I&U?H$ED# U<N9:'N\;G%RWW 7C;4L]WIX8*P1$
MHL^BJ-:$O?=RUZZ*I]@NY2D^H<K1JMI!1J9VD#SM&74[5NZJ2+)-6P1G:C35
M5]1HXFBW:-"B:*;\!/,HM&[=GMZ+ L0K1XX\+_K2K,O>6[PC9Q!.G!D5L1$=
M7=.>G>)[.M3/2==M^O,[QNX F[S!,@*\HS4\0CV**U>M87E73V3^19=SH<9]
MJ&4OJTR'N)R6LZ-B=LDY\RQX3/1.\[%KA=7KYFO2U/C;O,R \<.#@?%:Q906
M+R?<"RE;$RBR=I_1^1ORBREVKA9WVX^C, +<I>(95/JO)FO/%%7?R7 E3&3G
M3<JIG[%26Z80RDYH).5HS(%9ZS8:M4&_*RL.JBOA=0!+B6#%R/6<IULYTO)V
M 78HE2D7])<.8C=E2S?OKP@?DWH^]SXO?!&H+;%G_@-081I!5%*2+(_C75VA
M]XZ'!7F$WD(J"3!R63Z$"HSDJV'F;A06)!'HG&![/,/1' ##79C4D$C&E#N3
MF^$%G=2%^$-D0#(C6GV[9CACP[JW'!>ILRXY*'",EQQL-K+P4'_JXH%'7#RP
M+%3N'QY5 J,+_>"$C,JLV2@?4F&@(7,==L]XH5V2'_),$\4MT4-=%$+C4M@$
M[2X^_"+H':>!.8*''^*#1.BL*<,2/@%5; NS2L-7M882FGNH%AR18*23#S[G
M\*%(+U&,07S>1&VH&Q^+#$7+*C+)@DRYYN_"0B1+I5E%%9H,69S)R-=E,I8!
MGDK]"4C BYAXODK* 4+>:G>,;U;PP[B\9UX,<F'+#".L&NL'-4*7?_K!C_0W
MPVR8G?;15?/I].N=]F WA7.Z]79[>4?X9ZCF8]:[YF;[V_^B@-TTEZ]I[Q6&
M#EGR?\VJ,8\S8A*)Y+9&WM4QPN%+4K7]A@N=")#1B0(CU4"/KDL*C:@+ZQSY
MXHX^V._Y>HP_8^-45(E&+U.31QE2A"L MV:C56OVVQI::T'K_QP=R],]V)?4
M>-"]P33 #@BP8Q!,-A:AC[RXQW._?_0\JJ"NR$'X4]5%W>>BNL\'-[-5Z[8;
M&EB'D'1+R)F>7DQBK\I,Z:20LFM_&F!5!]C1RR3+:B"<EDI3=@:K 59U@!V]
M:+(\=?^T.(=FM1I@)2,G59--5F2<GQ;ST-Q6 ZQD]*2$XLF&-OVT/_97&>CY
MY\0W+@-F?/$CXYWL\5H&1G4T[Q\]W_K-]ZQH O.^]>VG2<%'0U,T$=8 TUQK
MJTU?68'K(U\"KO;CB4:Z2NH\U8Z3>]Z".[7^H*/!5>I8N6?=\2T;C1Z-=RQT
M_3NM6&N.JP%6?1'E6??]NX6YE?"Q\3T>,B^,F.-I447SWG5$E=9 @TN+*@N]
M %8$I.7!N'1M9Z1E%<UZ-<"J+ZL\GSGE:P!SOA^RPV8;ENZ<-9/5 "L9):F:
MF^=/QW4=:VI\9YXUL9ZF[1P-W]",5@.L9/2D:I+)382)'7]:WMWIB";:</)D
MT UJO49?@ZO4AI-#$)/BTD>7KIL6[<;B=06A3E2L]P.6\C/.S(ZLP'=>!C9U
M&FRNV6K76MUN&0!>#8 =7ZKGA@&+UW"!+T19,U[AC=>4+P,?.)KW#\H<EE4*
MWNM=HJ#Z!\>>&'\ ,L4!,ZZL&2*B\>G356&A]:U7UJ5"R:N65E"-&LNE7;3J
M!:5,L: VKV^L-$P258&/7A&O=GF%YVV UZQU!IW:8/ TW^-)PJQ;[_[M^1CP
MLQ'*__YX:5Q__&!\<*TP-'X%?@MK-SXY4P?+:5:04#:W(9255/ZTF6&;4C2]
M9JO6:.EXTK5AUJLW"PBE[$&YTQ6MUS?M_QB74X!J%!H$7&QW0@7Q*4O%_%N6
M')2\$5RC]YS=,6'VUQFH)(W@BEO8*%U;U&9'ZN<VS&?)7@;4^,6>L%'L,L-L
M?7AYB8UB^$NRSY!AMGF+(>,OW_$B]Q%[R"P7Y\]$PX6YIT2_A?.:\<FWXS#"
MOG.,1<9E&/JPEPA@]N%;+3-&YD'Y/N]]!@-;S#5^MX)9W;BD;CW(*V5W';&O
MFI%*7[)%#O:6A"V*HN78(F+"W)$QH@R\!3NLY];LB-X6V ACRF0=]/G7>)^F
MST&=%KK@M<S0^9EHL_+]J07+8\:(L2D;J?V]DHY HI.%LL%U-B>Z<R9H45S:
MW7 =WGICZ&,;R'!N=O@.QD]6BZ!5P"\[;=UC1Z0)SI\\24U%\.N1;"M"?41X
M,["-A\!.%22NP"II'-P@-MYPU)Z#<JPBI% W6DOG2*"(EI#0:-6:/5A7K[MR
M7;E^*04+O,VV!J&6+**W" <WH([9Z#:-3Y9G6["Z(&D'<A.#=&BT&F]KQMO@
MT3,^6P\ N6^7ACEHF(UJM=[D%/>YVM<NIKCJ\6!OKN6".IS55Q\PT?>-6^J'
M<_8V=O@C9AOHWZ5KO+/&GB7O^)GXM]\PU6_/_A\VT^SB9^_\B04G'6%734"+
M_[8B*]@01E<@K0P#9Y&X8:YU-+K-EX"&:/-E+F[SM4&'TF8CZ5"JFX,=<7.P
M9VTRVZHG[62I4RR  N7&,-,[]C: >2SJ<25:<<K"!$J/7GM)M[]R[%C=!N]R
M*#?XC7L>GW_]ZWMC^!FF+=:H,YD/LOGE7<"H_>]K^ P( 0@M',73;ZK6G/-/
MQMN2$U5/VL!1A^@E^T\;6<JN;;,X"&,LT@^O<X'L@5'WZ4QK-Y"GDP[*8P8<
M'L5M^,^+09<)!*\]<\Z-6>!@6S@?OW[_$S0/[XX!MP]1HJL9#6!Y?^.WY<R!
MI]/&Q86/8[.M&DK:O.LOZ&F)I ?R(_:PO;?<..GH>1?XU#B/VA_#"JDW+O;J
MY.]@C[RI'_+V[*2A88-MER&RVY8+3UJ!\2_0Y2+J%8R+M/"EBQE\A-U+X264
M0W'_B<Z(>Z8%D2J/0CT'(JYG%K"+[&L>*D3I^<"7_I1A7_@X\+!CL<U0EC9L
M07V$;C>)@Q$05 2S[,270!#GL85.>0?OA!D)OI8YWM78(3L*+[HDU!'QP7'A
MS)DS'<+8+(LG\+[R+F "BH!R.^PGMC-GLK<A*$*V'0?8T3OI/;CG_KR;DA)B
M!W7C;1S"=Z'LK;@4AK7G;#$LT:-*T%R(:V4 )")TE8#YS7HDO,2F>T 9WLL;
M1Y+<0@*0N[:98PCK93B']XJ6OQT)(S/#D#$@DK-9X-]S2PR^\=:W@E'2EI19
M(/DBS*C5->]*RG:W"D%$IT@7D32.Q]CQ&JFEA3%?CL_9%K"L1UA)R)M*XX@C
M9+8./.H$P,J&S,:FL?QUY#(X\8*Q<00<#$29"_P7AP.E"34F:E MP<&Y.K>
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M2,,&0K'E>H9&+P/ @LNU<I-F-W=CMD!HSY=JY@H4S:[JQ#!U*5$$*,0!FDN
M_,P1O6:]5T0N<D0D3ZQ2T7J)UBP,*P$J^^B Y0Y$2WD!#@9 <^_8 GD<3UTX
MB?>]UR&:5*D]+9GHR,M!0CH)_" W<F/E-D33K)L%0##GH#7/FV-O9CG\XCF*
MEW04$XY:X['C.B2\RITMW,FE,.' 2)\<:PCO;20 EL84>>5?*&K"=P8*Q;AJ
M%T_:&<6IS2S0.FS_@ENQ4"GBYTU?CF.*<4#?>_)(C9L<I0TH08-0*A2"<(D
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M"H52CE8IY&X\CAO: VGJV=\WPK:*L_J>3O?=,:NG\B3A^3O/M=(>AA[O=5?
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MAGJXX!@KF>LU* &@B@C5R'9I3<<G71OV1@,=CM\QAFKF^)T4F3(8M' 8+ D
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MPR$9JA[G&3T0?TQ<*SC[X\VQWN.GZ*JJKVNO6 /VDY9O34&UB8T2Z@JJ>I-
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MHTLRLTW3L=8$HDI2A)23%4U_6(O$1S\*0LO*17D^2$VU8:Y/DUF=DL8JMSL
M!-\\EX14Z54NO,F/TG+(DF4X.N;?OD]A;9A[SZ131XXKN?%CU>:^IYTM#40
M4!\MTWQ7KJS \9Z+U(&&P2IBZF+3M),5'=6J@JFE+5HE2:C>D%&1V<F=/8C5
M7:J ^)V$X90^[MR9V.;NV+L6%CA*B_/)Q(O<$/SHL;A@%K9%H %81G@L7KM"
M>I1N@I>VL+NB.8F^-4??.LP.0/9?]@\,LCV0UZEKO3=SF_,^R28Y)_9. -)%
M>2A>_NZ-Z8B4"Q($DH^;QL>-W_QZRVJIA=5U9]$7ZI/)NW+I.?3KAK)OD[%;
M;G_->5RB=UUWEMG0DQ^V<ATYSBZ;K1[3*C09O.7N[S9&(6W]C=*1"#SPN@WG
MZO@5R$>2J'/@G"*Y_S77+*3.6->=Q>"V/9E:5&50?O,MRSU,G4GE%J+) "X)
M8 6?+^DIN::GTR&;J%6G7YJ>78_,S[%GOM-_IN',^?7_ 5!+ P04    " #7
M-5Q89B:JWJ P  "/W@$ $0   &)X<VPM,C R,S$R,S$N>'-D[7UK<]NXDO;W
M\ROTYM/9JM>3V+E,DIJ9+?J6Z*QM>25[O.?3*9B$)*PI4@.0MK6_?KL;O(JB
M ,IRC*R\=;;&$8G&I4&@KT__]N^/L[!WSZ42<?3[F_U?WKWI\<B/ Q%-?G]S
M?76Z]_G-O__QM[_]]O_V]O[K<'C6.X[]=,:CI'<D.4MXT'L0R;273'GO)I9W
MXI[U+D.6C&,YV]O[@YH=Q?.%%)-ITCMX=_ A?RU_*K_Z7P*V_V[\?N^+S_;W
M/GQBMWN?;S\?[!V,&?L4?.:_?N;O_O_D:W#PY<M'MO]A[R"XA=?>?_JR=_OY
M$]MCG]^-/[SW;V]OV1<B^JB^*G_*9ZP'4XO4UT?U^YMIDLR_OGW[\/#PR\/[
M7V(Y>7OP[MW^V_\Z/QO1JV^R=T,1W=7>?KR58?[^^[?X^)8IGK]^^ZC"VNOX
MPR]^/(/7#][OP__R-Y&.6$-91"IAD5]0#A*YERSF7.VO;@3/W^)S[.C=WKO]
MO8-:5T%2-*OV\_&M?MCHQ=S)P=Z[]WLX'Y8D4MRF"3\%'A_S,4M#Z"R-_DI9
M*,:"!["!0HY;I/9"Y7'"Y(0G%VS&U9SYW+" ?_RMUT.>BMD\EDDO:C0;,W5+
MPU4RH69O>IK_9['/$MK6^*;*UZ+Q_EL>)@K_M8?_^N51!6_>VO>:JKT)8_-.
M/5?;Z-ZS7[J,H+*9][]\^?+V$7?GZA&LW'+T_A[^N;=_ *SMT&W;WK7O&_ZU
ME[?;QAC*+[/;&/)V3QS#RL^Q;2^86M*_U5.'47RPG8>1M>PTC-6GC"4O\@;(
MA(\;=/A)MQ?6'>8-L,-/73I4W/]E$M^_]?EX;RZYS4=?::*_=VR+?_P+"&S4
M=YQ&B5QTZKO2)/]'EZ.F1BS@HDO?^>OXQXH^613%";7'7[+?YG,1C6/] _R$
M'^G7_$L=\G%^T35NZQ7'(?WG*Y.^C$/#V?EV+N,YEXG@JGK3$X&IY./?W^#M
MM)??3)I_LS!_I=%!_;C!Q] #5W STGS/R@GE)/"+^_V- CZ$7"^1R_,/^+CK
M_*&)B,3_B=F'[+;K[*$)#W_ZB?LL[#IQ:.*GX2:['IM?P?.>"'Y_<Q2#HO*F
MA[]=#_NKY4;J3[^84\IIE9OOCW?T?_N]O5*?V>M1J]_>+K^[1"55/!A$?]#?
MRY]SUCA[94W#I06Q;E?_?E8VRW[,%V[-<GII())^A+H:C<1F91MMC(M\4%]D
M(M"K4-BA!3^*(Q6'(D"]>023("U)Q6-/*9XH%@5G@MV*4."G:+?-.] S,NH]
M<*>@0I]#2;U\H'KQN*<[Z$$/O4H7KYQ<N?*73,+#*4\$#'W;;*T3-_+XPU-Y
MW/M[K<=_>^7Y> "7)PWM2=]LA8J1BQ_MN5B2?>74^&C*H@E7(KK@B=[>3^'8
M"FI&SGVRYUQ&OB>B'G20?8ZO3!P?,34]#>.'I_&N(&)DV:\=6 94>T1V5_GD
M3WF0ACP>]Z-[KA):F<Y\6DG$R*?/:_F4T40N5:B^LJE<BW_M;X51_]I_9=5S
ML^II$J69HI&!7S9@X*OD:+G\6_H0EVF^,G6[3!W("8O$_UA;3FKOFYBQ_PZM
M)D+Y8:Q2R>$?U>8[M,HC,8G$&/96E'@^>2Y$-+F$;>E;VDC6$S#R87^9#Q5Z
MO9)@+Z>X0ZSQ)I)KV9=%P9"'>$[ :9 LKB2+%/.M56([0D96'2RSJJ1+5HR,
M<H](]ZJT=XAI'>7R+A+X_OME!NRF^';*A/R3A2D_YPP7PGJQ5S<T+ON'Y65'
M.CTBU*M2VB$6',92Q@]P+ENM>^5MXV)_7%[LLO$.K>]1/)L)^K#A8 4Y$:]
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M.>/W/'S?C^;IT_?,U@9@W$P-JV'[9LH&M02S4'E_*<LQ'UR/1M>CX?7>]_0
M7S=;OK+747RKN+Q'_]QV=D\[1>-V:-@1V[=#M9=7IBZQX())M(C<=]''[ @9
M66@=R;77*XB_,JXX>8NL\)6/X_%UI-"KSH.+..ED_=]F=\9-8)O>AL=Z)4F]
M[2UX5 RD1R/9R1U31N3]@_EW*HZ^P]/3-$+<]U/F(]K7HL..Z$+.R/$U.7;P
MCZR#'O;0R[KHY7WL."\/)??O>"1%,-D*,RWH&;G9,*'5N%GMX96;2]P4D]'=
M8BM\7$?)R,&&A:S.03'I ?%7YM69-^3W<7@/?QW!12.2)['/0,O(P(9MK,;
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M";C?R%Q$)F//AZ'BL\$855Z<-\Q>)EFQX<'X$LB+=-:ZT"\REB?(OL_+F14
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M[6# M:#CQ/2]-!!)I<Z&R7K1_OY+&RS.1,3A=*V5;SH7D9BE,SARX8=D<9W
MKSK-R0+G87.";@ ^7++%+/.W+D<M5J=6#51>$RJU 2UG39A6"!Y>%*5:#-P6
M)LAJBFYL%N_@UX_O.N0FM[WNQ*'6EC5!P;JX@3'8>\BB.P62/V9>462VU D4
ME'11MXNDZ'FSRN;Z$3T[L<1TW9T\HD,QR*X[$ -C'V6? "?58O@PWZ&;$W5D
M84@HRJJ.X3S@["REQ.)TJ.:*8!@<9D[2+O$N>()*)WQ85[&'-2/@@*5$$$H
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MG'D9U%6,A.MK9I!IG1VP$PR]XOXTBL-XLOC.9/  5R3<VW@WHT,"AC*?(O2
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MQG?HN)4I64MUI'Y>!_B8S6#Z).PC&*S6[H!R%O!XK:KEBSV;^D,.#M2%6Z
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MVB4?R$6<;.(Z:39S8G+D[=#^C6J=9/K +OB#KH\-/:KVV[,+"6>=8R0E>N@
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MD%ZT/C]&-;^4"EC(0%(M($)>"$'_JCP:$7[#Q(1"_$*C<8(5@]M03/2\2M"
M: DM "ORZ;C?JM,G$Q6CH _ZJSCM'Y=NN),3#U:&K.@<5F)PBQ</)>,HSD#W
M[4='<11I@)@L/J^ 7*T[+S*9W1 T]7--P@G&KZ@N80;*;&OAM+MUM-!B)*@Y
M%0<Y2?-I1(?C,I2JA:EG<Z).<+\J%.<@#J3E':;)19S\DR>73+1C1=HV=U83
MK"J[>:223MK/<_5+O+#65>A&Q UHL>58]T<>#(WA-89&3NSHPE=^*?F8XU[4
M/@JXD&/X0"4AF-0GTD2119SD> ;[2+>EKQ=/N',0#_^,42HP%?SZX<-P8O'S
M0O*@M%/AN^*N/$?8,OPS#'--%$-%^!E<AY$R2;%/)NO$XK0 ZV8@AIM45JLU
M?7DDWL)D_,'2M/S!*?XTHH2'V"/([SI7I$A3[0PY9:3STLA3N9O&P+?&:TZP
MK5ZDH!^-)5-Y2(&-9\"^O1/3Q0B#3Y:1")_<BT183HRO",UDA &UPC2Q#A2<
MF'+%6=[-OVC1T(D)TO6,NO:Q #W93T,0>-DB*U&17<M534&A<%24KLL"*R@7
M8R"S'&]XR@4E$3 U':(E4Z'.&4VP>+-N82$RO-B8G& +7#35;:.TK\1T>YE:
MO?1=5=K?ZG$H9'+_#B-/ICX(RV2!H;KA49#[>W-L5=#1$!!,X7.<2@FL:RYK
M_(-Z=V(#U6-92D7EC!,TP&8A,19DW)G\M>+>#3!JB)9AC( OPH2Y/XW$7RDO
M2];KW&4R^.K4L[R554#ELW3FQ$)6H#VTA;V*.7L9AP)=,/B=:+,X6LPJ.!\@
MP<#',UB%]P%?G+;IJ@SM5GN+M;4W PTG1%M0I(O/%CHJ8)$*=#1K;!+7)^ $
MP^M6#:QOA4/J:EU:U<Z)Z1VF(L1S"\YX!,2UBCY:W\:):36TUD(ZPJ&=,/)_
MD32@Q:(,#AAVI#WB4P>2SEJ,<[0NE 8IGDP-9([D3E[#$@9F@+"X :<#&S'9
MA*RZ\@M(;_BBFW[$;H#A+SPH)S:P=Q3?<S@8DT/)F3\=2(($.>9C!D,]7*R<
MY4H7;K>E?_9NG5A<=)H&]T(ASE&(.>[1?W#T:BCT?(9%.0\$GX>K+)Y5ME<_
M*='P0%/"#3I.PW!QSB(VX:8$N1_0L1,+7( SWO,B] "!B=EC%I:P"L!5'["Q
M*21L.[2=6*8G%+CZ!M\G_!=K7/V8BEJF#IU84-(MXC">8.9>/XI +LW%S%QA
MA5L[K\ZSHCR;\0/>7@=.+%@FRNR_N]W_C"4C#3%%+6\[,97KB$HV:3B$KF!I
MEHU=2/DF[3J[D:^C@(*Q:MYZH]FG"P4G6'O!'RS]!*O>=&(*_\#0K#CZ'B/R
M58?*0^9V3DROBJ%9&,>J,:MH1,"7BM S#.+6<KP)V',[M)U8)FU3/<(Z??E%
MLK#1N,WMG)C>%9<REJ 6>TF"^];3QB F!_*"@?;&0K@<F4HTRG2KTF"L"[#]
M?IQ8OG,F160P*]7?<6+8&491H0\6=A$0MRU=UI;MG9CNBH#1:N7E+H&F]7:N
MAIO:&[X\WT]G*07WD-W@BL\P/01E8BRMA1E1V["OV77CZG+FX5^97Y*8?RKC
M&9Q+&I?8NH3F)I2<^(0PQ$M1%!BJF9@&!!PDRS];Y*7]PA7G-HIU&;K0D*,U
M<!!YL$^6X@Y90@M#\8K&>^0'C\.-Y4>PR+P>Z#(>5A:<AV&)1?H!SJ4T7<&A
M' DXE,GPA)1)^2W=>VR&D0I  +_-HU"8-_(+#L@)ABPCE^G2ES6LYQ4.^E$\
M3K#NEUTMV.WVX<2R88BQ]Z=&^L]#B@OHPTHE45/J0W<Z3DR_#Y^*ANW"&M+S
M>8@.W0QC'#?\=Q9H*",L%R>B%+Z 6@I15E@'4Y2;/EB=$;3LKC5%>+W8@)Q@
MR T(=%$48T!L*OD_XS0[IG1B+*74#L;5$'B$Q8.[),NS/>1A_( %CRX'^EU)
MO^3)L>UDZ,/.(^@S]*IB^^)D&8$?FC. ?I+A.\)LCRJ"E"=F=AN1^^$0P0NO
M,%,Z&8S/8 /KBZOJL,B@IR8V7]8S=>;$0GK!3$0HZNNCPPZ^PM#(B8E5P3#Q
M4REA(0@(D\*S@7%"(JRM5%,Q+Q.KJ*[ZXCB&STM74Q=S^!H(I"S/-QAR49;'
M,YKN7V@P3C"B1.<&U=L.'VUM$R<FY<%)#>+L)8M :1'^0'X+8]!@,TNA%$JH
M,W&')\/1X,_^\?Z7_,VJ12R[<5-Y65;.W.3F?Z'!N.".694NZ?E^+ /HZ)2C
M.9+GD!8$RM\I\=) R54;APF!EC2QEBKLSX5Z^Z0^G0W@RA4T&T/KZG>=.,VT
MO:JTGG3UW]JW=V*ZIPPN70GZ3Y[RB:IG#C9^>'QT4T-_*JL!A?Q1W%IX#;='
MWXGE*KQ^^G#,7->C!S97180:U3$5][SF&,0PY#*XO%J$ZREEOUYL.$XPHS47
MJ9: I&O2Z* L7$$LN^=%BWJ2DFT5X&?MTHE%75+L0&.S5(0L&CHVP<R[4['P
MY*+V508ZPC.4;1U@5F"'V7N.-J'MJB@UC,EJ-H03??U.6/&BFYS/9"[*(]>A
M\J!C:81=$O?%[#8%A8",T/8\[T;5#=B2[ 8H\)44V:";I8+)RG/,,?R2W7&$
M[_*2!%U5>.:M-*'"0=B"NK$^P._E!N3$7B7XV**&=1X+CSL,E CXV/-<6X(\
MP,=X.].66X](NR')YZE$.T<]LDNL4I'_V06BV+JY$XQO@23)#A40-LBP16/J
M"FNRFL;+XYO@1P@GE:@@2*//1MBQU[:U$]RMH=9E>(6GL8^85I=2S)@4X6(
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M<H!X0O&>P/9U$.29!3+$1-9Y&)-M11]".J=&.S=U=+XJHDCZD0: LW WO>S
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M#1T(_-@)__86YJO\*9^Q/_[VOU!+ P04    " #7-5Q8]R1FG#4;  !-$@$
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M\1Z[Y8N;YE2OO;6O3.I-P!OE3U\M .?;)U>___SI/4[) [86F?'>@?(BT9J
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M^6X97;CXO'Z)U*4?__)_4$L#!!0    ( -<U7%BBQ=*0S,,  (7E"  5
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M %^*!L63%B;60&+KN_7M:)X]!QH)>H#(367G?+;&=Y$11,]E67-@Q1(EK9%
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M=@#IZNM+@-8**VB9P"6M6^5D( CR.'S4V1LED8L!Z^@W@SH6AK25_@!]P*\
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M_KJ@[@]DH)?)ZM1J(;@SZQ&I!I17508FTEM2)Y@;8] .E[+Z$+IGSXV!%#%
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MRW5_S(WG?Y*TETAF(6N7ZY(]G?^<O'EAC4.17(RBFYX?>-(1*;NE3#=H?+]
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MM3FJ8AF'Z'*-#A"''<L:,!1E P]>N0&]Y(V8CI0A#10P['ER#=\II\/4E.1
M<:]J$VO:VC@**!*CEB48,ID.0HMO@ R]A#UH(.WW/V>8?PC36KK\>C&9I<FG
M,#WY.#^;K4Z]+8D)52"EL"Z5Y."\C6 TVAA=+(P/Y_/> ^Q("=)*%8,&UJZ#
M?/LA$*%/D^&>3*T,:&I&=V*TG0F?H62#4B;E&1LNB^8NGF^ '3L(?E!C=(WM
M9/5BOER=VL LACI87=3A?[%X<#PH<"9%0]:/"GZX7,QK0(Z9!CN(>H"FU'=
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ML14]Z2-,W^'BXRDZ+W0PM:N4TZ D2Q X"V"R#,DP87WN9@H\_*QO@A>[2?9
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MY2^X7+[[$&:_+W[\+S*(WLU?A%7Z\,>G\^G>EUG",M/2A(8@(]E"@607#3/
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M,TA'KLFFTP'S?&LZ>NGDX9J./@(]T.WAS6CWQ7U&%(%E# R",8&.PR# &6%
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MHZ)$,\$_4J;F,ER1^ )ZZPS->QXQ1&9FUQ4=)B-3"TMZIMT@&F=!R1C!,V&
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M+QZR<[L\Z/!N3DNES >2:.N\S9/)XM4")^\_K'Z9OY\L5Y.TO(%-6,O(?RO
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M.!]#%MUN86Y]\/%H<1^);5#??DEWM$L0ELL<@!B++UB@^%IFQ%4&5\^+R&5
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MZ8B4W5*F&S2^7Q[:&PS3'Y>KL,)?PRR\7_=&>(F?<3K?D!\34BQ:U3I]K#,
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M1 NCU6GZ4H:BN;8>.\5K'C@PKS_S.2MV+_D=XO;F]@VV,2)*ZSA871N@1FO
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M@H]:0"P:8TJ<7NG6G77.7U,/^6WGKJA]2!VW:N7-;+FZ_G66-UG\UI4<R&6
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M[EX,7I*4V6HHKG;W3J2X(7,#S-K 2K083>M&E8V7T"P6/PC.;=PQTWG!339
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MSK^>4:9C TT9L^'*@SSN_YY=?WJRF-7CU3Q>^EHPMU/$$[?6I&!!8*'U:"'
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M'7Y%:7"T,8#3!E6140M_QF[!,RO[\>J<LRHUO T<897WK1U^F5\O;NN@/X3
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MWZ9O@.0:6@O;<$@%@V#>@#6JSF,5&3";"+J$XKQ.6KE.CNNI"=SC:[;GKX_
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MG[I.J;'D6 =?2-')Q2Z&84&I%8K1"DR>1?;#F]T_)[(5H1,5ZZ^>XKU[%;N
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M(;9O1W40U,7KQSCB;ST4=!O=[WE9%LO/."=TC[786:9Y[<OD%0%4+M4I&K*
M*-EBE$S)[6[X'7>'O8^\>!484<(C7 0\ 5I5]%^+VASMP9VH#$';)!78@JDF
M3&IP/'/@.G%7C'8VM\YBZP3LXI5E/!I&B-Y_FZCU]M_SG%Y=W[OV'R1R7B(/
M()3@M925UIX"P3/2EYBSE;JU[[$?S<E;C)U7KYI&M(T0-ON&[/7B\Q><?]V"
MNBNVN'X]/NA@-8N!W@13<W&RM>!*\F"T]>BT8E*W;A]X--@?ZG@"TD_4^NXW
M7"Y):G_FUAWOGGSP&(WNGD??NK_=3WA5[:'WGW*^_NMR<?.%5.^^'/;]-?G0
M:R7!=0K% ^53#ETT$L&S8&MVIP>T0D%@WBJ?F-9^M"N[(S$W3-?8A> V%EY0
ME\AX 6WJ'8A !9Y>C5KD8AV3484PVLRV9W!-WB]N"KUZ)OVB#4'GTM>M=AO8
MZJK#)9?".0FY%#(:G MD+]!>;$74WL0<HXR-]>PIBI/?9C4C>M%4X".$DAXC
M^@T_;QR>+KA&NHW:A^DT=U%#.7M6!08*?$J%4$*I8J0!SHTA;4\1/">?PL9H
MD]69([8^F:=5A /W3U/I01\YMRY%>54I^&UQ?=]31 >RO3DYC9G\1U#:AIIZ
M88!< !DD^95QNY/[GA#A]B=/[S>U$?BBE;1:WP=5,.8A&,R^N! ]1*WIG.(I
M@U]WG#).N^2%D"QUILZ\0.J.EE;KM^ZW_.]M.$4KS7AUNI54!$<8\+7#H5=)
MH%0:U?;4SCWD/?WLET#?0(FUOG*IVF0?@F$EA>(,A^ *@5%*0RA,0]+<RL1"
M)-^C\[MG7QAY@Z35\);D'HQ[",:F%%F,KDXLH8T@L0@A)0?"UB(1Z5W0LC-U
M[@52=[2TQBPY>#Z7.6DK0B(?L"BL0]GH7/8"2<&0%Y=T<9A:7V!<2*7+6([N
M",2,4&'7+[VY"]@?%2LM&1]45G ,72>O6''>1G(6)$BN$WF4=6?U9)4ZYG4Q
M/#DUR1BYBZQ8F4ZU^K T4<6*V-A2**3.DH%'K)>^"<FJ0@$Y!1XLLT'PT>;_
M/(5S[A4KO8CL4+%R# LC7+W_NIA_O,[+S]4 O$^39K8(>GH&E#(2)B<AU#9I
M5FJ,.<4HC&NL&;MPO%B39[#01T@ V\9TI_9=4(UDR>Q&=!J393AC!U1@@+A'
M.#;VH/,8D\B>=BA37;CL,GC%+3 ?(W(12HKR@I7@@&TQE0[TD?)$7?^UUCD7
M4U.370 E<ZG-R -HZ:-1J*WFK2]TSJ+K?PN&.O3O[R/>D6R ?]RM\D%.H(H\
M)3**(ZOC31$C^* =Y!@YNE)TT*W32'8".:%A>(H,DN%D[-60<5/>WL=/.=U<
MY479^>-%N=?\=52P=6+<D8\?(WVNA23.)<FNH"'OA+8FO1XSS#.9N9:\%2LT
M2W5*41YO/O<Y)]DQ$Z6S.H"M@^))+@Q<*A(RFF +BESL:,[S2TBRZZ-71R79
M]2'HC)/LF I,,R= 8LUU5D% L"Z!0V$R%BSM$]PO+,FN%]&'D^SZ"'S*G*HN
MN+[7)+M>G'5-KCI&X%,J!$% HP@?0V]JRTE/[D,.D),-6AM?Y\-=M"+T3[(;
M10_ZR'G\)#NA8TK9@ZT)2,HK\CPMDJ=(2Q0F26FC/60^GWN272^!/Y]DUT-:
MHR?9,>G(2],,N$,&*I0ZP<UYXL8HB<$5X;N54)]QDMT@ZHZ6U@1)=C7IB%G'
M((I<-<D&P"@5%)VS)8AH.X['/>LDNZ/I&RBQT9/L+(L6,Q>@8AT$$)@"QVV$
MZ)G41C$>?;?NZ&><9#?HW3M:6J,GV4572TQY FVEI#.]*$##"V0"(7R2WJF+
M3[(;1-W1TCI=DAVO Y]40C#HR/FW-8.ZL$)[0Z!ON-$ZMZX<>P%)=D,<W1&(
M.7F271>P/Y+L6C(^*!/J&+I.GF0GK*%WC$LP1G%0ALS08,BM1.DY,NYXEJ,U
MOK_T)+OI5*L/2Q.WA=:QF*"1C"=7CW9&VS=*Y)!9238FF65NW7CQ@MM"]R*R
M1UOH/BR,<,'^;/X?/=IE56V_6"<(>P<N. Y<))TR^ES<CRS,T13D&!8FR+=:
M[Y^*)QDS<Q"M=;1_"D]K%;5WK31",*4C:YW@?7%9F$-LXL%"GRX+LPNJ[S4+
MLQ=CW3+PCA'W=%F8!:U601 P3XJO," X;Q5(Y:+BG)2>M;9)SST+<P0=Z"/E
MB;(PA1 24ZR''_U!BPH07 @@64K9(2.CNG78Y)RS,'LQU"$+LX]X)\O"]%84
M)Y,$+\EU4HD\J9#)_F'9FU2$]Z7YX)"7DH4Y),5H.!GC9V'^M%@N%_\F8:S^
M"^,?J\7\;_2W;V[FJ<H'X[IA[( LRSX?/S"+\NB5-,J2?!R8_Z9!T<J0DO50
M.+.USR[M,(8A1"]#45'R:,;M</9KJYS&QQ][:SN3V:Q\I V3E1#K1&--^YVG
M=29NH[3%\9&[-$V:L=B"X^=S1OI+]8SS#GTHGH0AP'.;0,5J43$1(:9LL:B<
M76X]5_A\\@X'\WHXS;"/?*?,*NN"ZWM-,^S%6=?TLF,$/J5""*^XX$R!2!YK
MJ7Q-Q)$&6'0^)ZZC4>-N!.>79CB*'O21<^N$I_U6UYO%,L\^SE_?+)=Y'K^^
M2G]64_P^O\X%P;S3Y")I3VZW$8 8R,)&S-8+5E3I-C/H2 !GE,+1B[[%Q+)O
MG=OXC)6^N+K"Y3;46)B6/ $)A&238@3TJC91\+SD'#5NCT;MK2:[GONRM6.P
MI*?;1#89@<YQGHH%SDA9R9B*X)!KT%E(;WRP/G;K,GGH22^;^".D.4*JSNXP
MK,FJR-I1QRKZ(P@Z(HLQ8+VJK3*8M:%UL=(YW5BU=AL&RW@"WC<W)AU0?;<7
M5'T8ZWA!=82XI[N@,M&;9(RE70X5;7I> I+F@Y7.!3J!C QCMP\ZNPNJ]CK0
M1\IC<#^;Y[?E]3*GV>8")9/UX9FP0( J(DDFJ9<60HG%ZZ1$4,T[1CQ!<3;7
M4[WXV:9\F'!'N)VZQ;*Q0=8Z;:6.EGX3F$ATH#FR.)$G"8RI(K (9G7K>^BG
M*%[*63]0OB.DHCQ&=*?473"-=,[OPG.:4WXH5\]2/T#0(^SR.[&YQ&(4W$+.
MRH&2+$/PJ8!EF:,4!%&VWN>G(__ Z3X%]WWD.P+G[_*?BZL_R>-\#&[3/#\4
M7BO[R'21'E3VIM;4UM0+IF46)N?4.E_U64#3G_?#.5N,)? 1#OY_X7)63[<Z
MRWZM[B5XXPJ3D#GCM^H>6/ @E,H:-2^*MTY+W<;P4@[]0;(=H7SO(9Y-DE4'
M1",=^$_1G.:X'\;2,Y0/$/$(V_X.9%X:4FT1P*$TM8:;?(YL2<$Y9H^R\)!;
M9XA,1?J!8WYLSOM(=@2NW]\F/[[],R_GLX^?KN_2Z>8?*\3WB[*\_\DO\Y3_
M\_[?^*7^Y.Y$4EY@]#Y"T:5&-((&[TJ"'#)#CES(TOH$& 1X>A-A*..+4]$U
M@@'Q9,[S^SR?+9;K-9&54Q&'ZYSF>;5:CZE^O:#%X,<JN]GB@\E<^U+J>6KJ
M/59*@)XIT%EI6U2F$[:UK@T"?.J[IU^;)+9-Q]D("O=8(.LAYN^_+#.FM_.'
M[R7_X(I")LAJ2UP6,MTXJW/$ R2MHLF*<_+?1DUMV8_M9:C1*$R,',O>>%__
MG-^L<GJ-7^C[ZZ_T&GR>K5^(-SG_3AX#?47Z_D&R@I(D!(2?@$NG &.=;"50
MN6!",#AFR+L7V)>A4]-P-<;-Z0[@?\?_S#[??+[/?]\LX4,=(2&T\2"UK0-J
M"H=@2&#1118PIOJR3*!7^_"]7%5JPDCKIDB[@+Z*D3Z;9/XFXS59A[_,(^VL
MJ_SKC)3_ S)K56V"Z%-:=[ZC(Y@E"<4(DX0NB6TWA]R3:]/[T9>M&A.(>V_<
M9H3"H)^6.?Z1Y\M9^CA*95"'SV]6&M1W+2/7!AD1LS18 _ZU8X V#M!Q,G)E
M3"5)$;)HG>0P96V0$,)D6ICUR8%2T0(&C4#VF+082XJB]1C,,ZP-ZL-QI]J@
M'E(]E]J@'1=>WBD4SA)NR^@HS *!5L'(D)(^8TF"8>LTOS._^._#Z^&+_S[R
MG>K.MPNF[_'BOQ=772Y_CQ'T5$H@%":R="+X6 M?K.'@R#^'S$,,*6MIFL__
M.N>+_^;<]Y'OY!?_1BG%LK(U/(,$KL:N#1V&* 0YUMX4%*W3O2[AXK\79[TN
M_OL(?/0PZEKAM2=72J@,HJS/.2;!.W*KN,Y2ZV)4<"]W&$GK@W^@?$>(4.VM
M8NF"ZWLM"N[%6==BT&,$/F51<(Z9U_06(&\H5'P:G!$U\L$+VB)D+NRB%:%_
M4? H>M!'SJWK^9Z)M]P=4*D4F7TI$%VHS>*# Y?)_O'.T ]LR5EL'0=[@HP'
M'W7JH.*QE"Q&D^=(#:B>%*Y@$45*:8&1S0$JU:&6W*HZ@M(RZ379NB^Y"67K
M0W^PC*?K.=D%U?=:TM>+L6[E7,>(>[J2OIK+'+VF74EZ5Z?=.\#:_LS96G[D
M$;UNW<;ZW$OZ1M"!/E*>J*3/*2^B<\!<,+3790]8&(/(?>;>.>=EZVS_IRC.
MIJ2O%S\=2OIZ"'>*S'[C>+%2%"@BDD9'G\ Q5<!8EW2VF:<4OJ?,_@'G_"#9
M3I/9WP71]Y;9WXNEPUG>QXAXFLQ^&X73VM3$3%YJ>Y@ R,FIB:@R4RBL,ZTC
M>>>:V=^8\SZ2/;O,?NG16Q<\9.MK4ZE,LB@"@4N'VD7A76I]P7/YF?V]&&^:
MV=^'KM8]P!X*XGW,<_IV<7LKAJA%L@9\+HS$029QD(Z3A5P"6J^C=]V:PNU[
MPJ7;".W$]Y13W9S3S;5T!UB[K84>[)["%FC(QB%^!XBR=7#W&7B<-B^'PH&3
M=6Q7R0:"%QYHEV/2"-K/4K>H[M0,[SGXIR>XCP1;$[N!PC=##9AA1I*C:I6D
M#:K4ND6>"W 6?. J!+L],V(/FUL?/-W)VU3:BT:B:GV:;K!LYE&E6I10I[<*
MK$:IX!R\#KQV^Z%#)A4;MKON'J!M\OE>H]-VC*C&>MLV<^:4=CX'R:H'(4"A
M8[2HG(&'7'3B2ACLUNETZX-?$&W'B*IAKL-J>?WA'<X_WOI^"3$9I3P@9MK]
MI92UJ98 EE SFX4)N5.:,WWJ U^'OOOFYSQZX*6;KL=+[RF%9C"%FPV@ XP^
M@:PN9+9_+0];J@.$OTW? ,DUW$*WX7AOC1'&0"S"@C): :8DP;*"BK9Y1C^]
M! +W&*+M^>LCL,:\W=7)W0%QR@5O$MG.B6M0WA=PP@>RIZ4N=+39H%LP]^BA
MTYV)@\2^:"&SAN;F&@B)ZAN0&#Q/6@00OO:'0.< H^:@O70V1QVC-"W(>_C0
M"R3O:)FU-CH?U3<_<F9Y#D(:90 -;2?*ADAK$QID"26$R%7:OJW=8W[N?<2E
M&S -!?B45MN>UHW5W0%7K^C;,P\[0?BM$2$'.1X@S4E>XCM\R3F4.CA@:#QM
M48P!,L:!B<!,]8VBZ.9%3L[R<R&XB4GN(\2Q@W 9DV+6>C!>TYD3:GL3+Q2H
MS(P4(DO+6"="3QN$:R;NYZ)P?60U=A1.<J5#+AR*<89L]$S&6LEUVI-UVO-L
MLC&]>#M-%&Y4WHZ1U>BE"L^T&M*1%Z^+ AXD66XFLCK#-8 5J*SSJ*0=MX;I
M$IH^M2M\;\3$&.GN1S<2LF18YD"[$\K:Z-4P25K./!250Y*^6-;-8?J^FCX-
MT:EIN&IM!AQ&_0 HIXT6BY9@,H;;XH\ZOQH<\\I:)[A U^FLZ?/4R]:.<86\
M]])AC#X]LX_O__@Z2H>>YSZY76^>SOA'[LHC&6917("XCLOP4#.BZ ^NHTC9
M&U]PW&FEOX[9E:>8S$AG"PCZ+ZA2.[D*CX#1>.5XB6*[X.XE=N7IPW&7KCQ]
MI'K&77D*T\JJZ$%Z19:\$P@^QP3*%\T,BLQ-Z^S]\^[*TXO7PUUY^LAWJH8L
M73!]CUUY>G'5I3/+,8*>2@FR3<+X2(Z3B60_6=H9@U4)HLY."1N+XJT[T9US
M5Y[FW/>1[^1=>9Q5A:S7 O7D(XO6:G!19!">V^Q0HS*MR;^$KCR]..O5E:>/
MP*?IRB-YB#EE02M$0D0+!&^4K'FL/G.%3(;6-9KGW95GR,$_4+Y3=N7I@NM[
M[<K3B[.NW5B.$?B477EXX#%ZR<$K3GH?:BS?*0W&6R%TSI'E<3>"\^O*,XH>
M])%S\ZX\NR(MFZ24J+PQ=""1T4-_<"]IL<Z"T3+8D!G78JMZ;U\_GOT/.77$
M\%@:%B/(<+(>/-RBS-I"*I:1$F<ZRI!6F\G>$#IPEV+K;EOGWH-GR!$_6,83
M]N#I@.J[[<'3A[&./7B.$/=T/7@RURD'0YKN';FSA;8ZU*+0UD0."!=)F]Q\
M)LBY]^!IKP-]I#Q-#Q[OK1667,SD60UCU"KO:L@$RWS*+B&+8\Z".;,>/+WX
M.=R#IX]PI^C!XXQ1L<2:]$2GFT(R73&$ $PXF[4C<W:[\.]%]^ 9<LX/DNTT
M/7BZ(/K>>O#T8NEP/Y9C1#Q-#YX8DI).,&!6D&XS8\ S;H$S[HQP14D_YB#M
M<^K!TYCS/I(]NQX\0>ED&'(0B9Q/Q54F\")!*38G%IUFLK6W=_D]>'HQWK0'
M3Q^Z6N<K[T^I-R6GJ#&"S8X,8Y$+!!XX%/H[AO2J&;<UK.&2*X&.L1(:"K!U
M&Y[G\K6[X'J1E4"]".E:)'*,-*>L!&*!9\V3!Q>M 662A)!)NSG+B=0\1LF[
MM0&YD$J@44CN(\31*X%,H+.B"/#DJH*2#*$FNH.Q)JN2E [;0W0NKA*HE[B?
MK03J(:NQ*X&RPB(<\\"3\Z"RIL-%E?6ASUV1T?MD>_%V?I5 @WD[1E9C=).X
M;:]@F L*#5A>NW-+69-$E8*4BK I%N6[-3B]Q,XNQYA#QTMOS,XN'6"\P,XN
M?82_K[/+$9(;L;,+-R%F7EU[Z54M#HP05!V7EHV+T13!7*?,A%,3V*VS2P/^
M^@BL=6>71XTNR).V068./D9.CG54@#EK,"5:VMZ1.]8I'GT9S4%ZB7UO<Y ^
M,FO=V>51BQF#3F?G CC--"TBUA8SI(E!>S*KH^6F6X3Q,MKR'$W>T3([91US
MHD.<H%C(M1N?2J& 3T: CB)+%5F]#!LUV>L2ZIC;E0HU8J*UG_+KCNK'N\UH
M4_[XSVOZV__%2L"#2LBHI51UCW)(XE&DVX Z:BBT%N4B2MJL.CDTQR*X;"69
M3O@CYQCTJZ9&C%K4'+M@HR ?D:3D78CD,F:E GTELVV\Z1P-]K(5;%JNIJQU
MWE->T:3:^<!G-ZMW[K.&D2N>-;I<$B-M4G7ZA-6&]A*.(%VPVGDR8&3KR6P3
M5CSG: *+AH'QQH#244+PB8-5*;ED+-)..NKJSJ+BN0_'72J>^TCUC"N>,3H7
M95$064W8%D(#DLD%SAC#LW*>;W?;?N$5S[UX/5SQW$>^4Q6[=L'T/58\]^*J
M2]7K,8*>2@FBL%PZ84#KVCLYDFGE:8,$7S1B,#$7T]H,/>>*Y^;<]Y'O>/E3
M=8?;%-VFY%E$ QZ9)1?;1CH R99V6=@:DB$\K2O;GH XD\KF7MSLSG0Z4K!C
ME#OEZ^N\W$K)1O).I/ *2A#DN"@C ;%.6"\!E1,VB-"\W&D'CA? ]V#Q3M[.
M@#QB]$J2TUJ[::M,^YD/J4 @RX61S>M":FW274([@R%*T$[@(Q2W[ZSJB4GY
M(DT$+YTD#?4%,-3N?<YKQ5*.83LV^>+K'8=8]H-E/ 'O&SWO@.I[K7?LQ5BW
M6K=CQ#U=O:.T(22G:FS<K_.(2.=Y'<WGK>-12)-CZQNN<Z]W'$$'^DAYFGI'
M%T0V)4<HB=%>AYX,%)8"V.Q9CN@C+7G$2X8SJW?LQ<_A>L<^PIVBWM%S[XPF
M^\.;'.A@HY4%LG0@*Y3.65NTZ#2![874.PXYYP?)=H2>!CO*=+H@^M[J'7NQ
M=+CV[1@13U/OZ 5C2FD&6> ZP=B0JR$<B$(;D$Z>A=QZ7S_7>L?6G/>0[ A<
M_X2K_* BSB#G6%-A>$916WE;\#%(X,IIPY)B7K?F^3&"LZA([,7)HIE 1SBS
MA]5'ZNRSI#,-C(UU4EI@X#.9K%K6J'51#F4:)W1[P>6L0Y1G.KI:%TOM'=(N
M3?*1%0,BUHQJ80(Y0&05,<]-UDY88[O-X=GWA$LW =N)KV'?BT.CI+O ZE7*
MNO]9)ZAD;</&(7X'B'**MW<#+T0;C*BCI;0"53@YG=HI2,HIHY0A%M59,OQ<
M%>NT!/>0X-@UK,*'& LK8"W]H30W@,@M9&N3P\PM]Z$3FZ>M86TE[>=*6/N(
M:NP25J:3LPI9=3?(Y\!BP1$&0(\E*FX9=]VZ@YZVA'5,VHX1U5AOF]Q@X;E(
M522D4H=C*IX@9%/G]7EEC0G!VWX5X_+%T7:,J!K>:3W"HC9]9#5M]<9ZB,F2
MSY;0 KWX$0A"3$[1FDJW4<Q;'_R":#M&5".$*7=TC5:9ZVB4!Q0A@I*.@_-9
M0$V.8%(FC*&USWK>'?6'A*4'RK=A<YW=B!YTE.Z"ZWOMJ-^+LZZ=U(\1^)0=
M]8U I4*L+;VDI3W.TU=:>Q*@2ISKQ((>=R,XOX[ZH^A!'SDW[[]$8OP)YW\\
MGR=53(G19]KRF*@#93(#'TT")A$Q6L[$]FR%?9V8NCSNU+5KQU*S&%6NS=OG
M/8_PS6*99Q_GKV^6RSR/#^KL5L2JV32[D2(F*2.]#MZ1LU]+<T1VY/&SH'1F
MK##=0B^Z@/D.M*8Y)Q/O)L_BMYL8?%#"%2] <XV@:+^%(*VB?59&D[VU)7?L
M^C8<S/>N4\=P,D:^Y*Y2\]N^%?=5J9N"X ^.QRA33B"=R[2G)D6^%"-IR5@*
M8T'P,F8"U2%\IU:I7YO458[&R @WN)U;67 =-/<$C'R]4KOAL[J'DK.GC.6*
MR=*QV\_1]NXE-!5I5XW;B(G69]@NU:9=,=!?I_L]M*[DU>?%S?SZ[^2<S;Y<
MS6B7M%KQJ*4 GT*]/6:NZKD!*3/:X)(HO-M%[=$0+EM-)A3_1(=4MUX5(5IA
MHQ-TL#(Z7:TA][+>F&CKF15>"S5JRN^%]A5I?7RUYZIAN';]:CR6Q.O%GWF.
M];^?2?]Q'O.[_#\W,UK3J]4JKW^\),3O:ON=#TZBY,:0=%@=!EQ?$.>< FUT
MH,U'%!6[.?#'8[ALS9F2@+U9*"/TH_GG?/6M++9)%YJ=G]BL]\QAO"-WG%&9
M9Y-5[7<F=;TBU1 2XW5BAXD^>F=5Z_*\"3O.6%VR<Y$!>9KT:H1LP 5/2\2(
M.@<9L71J''STZLZBXTP?CKMTG.DCU7/I.+.S HO7^6(F.Y)$/0*EBX */3B!
M.DJI\Y/8S(NO3>W%;9?:U#XRGJX<L0NJ[[4VM1=CW>H2CQ'W=,J0;.("48$Q
M5>=UJ2W]R)YR)@;#I!"T15ZP$AQ3FSJ"#O21\@C</[*T[N+ 4H>2L$3(7)(5
M:RP'+YBMZ?G&)ULB"ZV+DG? .)OJU%X,+=J*=_1 Z6TVKPL\E3I@W-<VFF@B
M.&XDE*)D*$PK+5NW'CKO7* AQ_U ^8X0L]I[V]0%U_>:"]2+LZXY(,<(?,I<
MH.BDRT(6DEAM+^]T -3D$LGLA+(LZ%A:MR8Z]UR@4?2@CYQ;WWR\DD:SWQ;7
M>?7S3:YTW!U+5EN3/=DV7%G:\U*B$X[V.S#..$O;GK*F6[?T/0\X=63P6/$O
M&LNN=88/81+Z :9-AHC(2MDD.+A<FVI(90%-0" S54K,2MK2[9YJSP->")^#
M9=?\_13VD8[=8^*1YYP%:!$E84JT$4E#Z*)1A0NENHX[W?. %\%G ]FUKIIX
M);C0[_-\ME@^0+;)N0G:6V>-I>/%T5*19_ E".#(47FK;#"N(ZO//.9E<-M*
MCJUO[%X)]TCKW*;H@R5&!X('E+1WJ"(\U%(/(+>/)>65-"EUY';G UX&J\-E
MU[">>_="W^64/W]9#SA9SN+#B^(D4G1,D*,I-)F("C4@CP7HC-!U,C:WH75K
MIX[03JT<8]RSM.%A])C*&XSY-F_E@[.N3DG+(%&)ZD*086B3!=JL= D^1J_#
MJ/KQ#<M+5(@C)3VZ2_W+_#HO\^IZ75)X37^D![JJ).-&J 1L[5%*9! R84[U
M.#,\(K)Q=>(Y="]12YJQL=<T'"%EX^W-]>H:Y^DN#^YMN)I]7,_86C7)WSC\
M\<V2.7JN9.3,#K(#I<P%(4J4M>U0-10UD8[DX>689)"MT_ FS.Q04>AD:#G,
MU]7IP@ +#Y"8*(E':UUIW5?^##,[^G#<);.CCU3/);-C5RB3"Q,<K]T> OF^
M.CAP+&E@3I&T-!V?L?6%[GE?\_3BM<,U3P_Y3AG5[X+KN[WFZ<-9YVN>(P0^
MJ4)H3"D)"[57$RB1+;G9/I)]%1C]A#"*<2?.G>$USRAZT$/.K</(_X7QC]5B
M_C>2S)N;M?&U597LD^!)906F^)K6H&N7;.]K8)23W2L-;J?W[(E.'7K2J5V*
M8PE9C"7-UC= /RUS_"//E[/T<0\ZQCQYQ$Y $=;7$&D@6\@@6)^S<85;U-VX
M/OBHET!V6WFV?K%_FGU\_\?7W;B48#Z5VL-&< 5**0->! /"F*(LX]KJ;@4@
MSSSD13#<2(:M[XJZ]9/(0GFM3009/1U8J>:.<=(^E]![P91QH4GM_,OAN[U<
MF]\A[<DL0):$SW5858FTT[!4!V*12B)7TJ&/DLZ6%Y*5<32[+637NB?POLP"
M973PS B00N9:(28A:,^!EAQR3K&(W)G/,\_*&,+G8-DU;*GV;&8!<JFX*[6#
M.%;GH0:H!4?(*1ME$I-6=>3S[+,RCN>S@>R>\FE&S,I0.@?FA0!:$R&+28"+
M2M7K@4PZ:*Q,77-M+B,K8P"WK>3XE&$[2E9&JG-?5:W1]8R!"E( HB+;W5GN
MM)$N"MN1VW//RAC ZG#9/>73C5*MF'A)D9%Z$3ETRJ<8P1M&NP@AU24'9?W8
M(_1>4EQ[L(S':+JQIS"G ZKOM5JQ%V,=*]6.$/=TU8J:6<^U5L Y68@J,P4^
M1K+X5<X^"F&";1W3/O=JQ1%TH(^4Q^#^Z;!'Q! M%P6TKB6941 86C=@S'1N
M!15U:IV!]Q3%V=0J]N+G\"3-/L(=(:UN5_4DL:&]CDBT8 3%HP)GR&G@A6?G
MK0TH6_>N..?BU"&$#Q7O""_XX[C<>A<KI(*RMF1/R9(/$1P9L8D5X#XR9\A.
M3:6U??<4Q4NQ[@;*=X31!(\1W6EU%TPC67:[\)S&KAO*U;/4#Q#TZ*_]'38T
MW@3.(^10ZOCO1.:+L F<+XQK'[WAK3/UIB/_@#TW!?=]Y#L"Y\_?Q3 6Z>QA
M&;C0=*Z5R"$D@6 M6L+M7;:M>Q"=V2W8<,X68PE\!%/OUSZMAKU*2DI$,'3F
MU5=!0_#1@)5H>2T DZQUF7H??*>. /[:)!%V-$:FK+]!RP)9R!I,5NNZ- E(
MIC%X&9RQ,J)VX^9#GV/]3;OTZ",E/7JNXVM<+K^2?MYA2\;Q0FX,"%4'<!1K
M2#O)EY4:R;<AY51BW+86C_&\1$T8(/&1 L;_N'.6J^&D"Z?SC&?!03%EP*$F
M137:K@?]I#1&.\/-\U\&VT=+= 27\9]S_+Q87L_^]S9R\<MJ=5/[\O[E/U_(
MNB;_V'"N,"8P:!(HKAPXG>E48CD7FY()S:V#YQ&]# UH*/71"[9ONWP_,5/N
M-J>8T&A58V9&Q74/" C%,;*I>58B)1W\N,?!L_!>AK:,Q4?#O)[G#-UWN4J.
MH#XU=>N\W*RCANPE(ZF0'X:9K!VR=*/4P:E<6K>&[H?P92C0B*SLS25J5L;[
M;:X SM/KQ?R:H.9YG.4AQ;N'/W1@R6Y/U(T*==]>?\K+!P.IOJF/9LDPR1QD
M4\<P,JD!4T@03 X!67'JV_3=1F_:7C!#-YGM#[X-Y6ONO-*6#*D4 M 6*,"1
M;06!&W*;2)-IT2.O<-*"W39<;V\5PV5[+D6[VRM9!WZQCI!(P4+4NC9"4"0:
M*6L[6HQ"8>$IM2[;W87C5%=@#=@]H"^]I3Q"_&(;TR;>VP'52!=ANQ&=YBIL
M.&,'5&" N*=3!K*6."/#"80N!I3+Y&)A38=W7IN<O0JN]:3F*97@P)785#K0
M1\JM:_M^SE?XE?SK)?Z[!EM^7>!\]6I^-Q$M+U>;09TJHN(Y@TTU+8=Y"8YQ
M7\].F7AB5OMN!6#=GC>]0]&"FL6X<AWA%N.7^9]Y=7T[=.KS%YQ_?3.;(]G?
M>/5-%/]8W/Y6SF]NKF^6F^B[UBP*;@584\O7"ZW!"5'($:+3,.:0VF\-QZ,]
MO3ZUL3LGXJMUN7@_V']97<\^UYY9C_"3J:6T- EL<&1^J4+FEZ6OF* WR"AZ
M36.WD> -P%RZ.IV$E+TG5[,8R&_Y>CTA;_7^)JSB<K;NV[C"^7H73HM_#VID
MUOW#!\9$CEQ%H]A(?>@LS7#Y]>WR+_]SL\[6N/ZT2!L]^*9XWLF:U>U!*Y_K
MA5N!(,DSREZZ8E%Z9EI?='<&-_1<?!\_Y71SE=^60X^\\PU5?04SDBE8+Q^C
MM>!E-N1F)*51N:AXZXS1GA"GBK>,HS_;Y^"8_)Q+9.;;RM[C>J77B_C'V@7)
MPJ!GG(%";^H!3D:I*PE41CK*61'>MBY V OF5#&:435@6]N:,#&"U_X 3JW!
M?%O^L20W V,EX,Z!Z8)PI'#.872G">TTHG-;2<;AXC1:8W5TR+4"PTQU$02Y
MI4$("%D'@5$(U*WOJT^E+0=B0"=3ECX4C!$0_#,O7UU=+=9NP-NU#7H7LN!&
M\XC.0^!"@_(^@=.BCBN34L82:T^[UC'!?6"F=\1:,[<=(6PB]C$B1;^_W?0L
M(K\R!<N 1T5ZKSVM3-8VALHG,MV2L*QU<MO]PU\<W\>)=93:B*MUFW)<7G]]
ML,353U\?_F2]\7GFG6,V0>(,00E><_%\@)@D>L&"5ZSU[,;NZ+X'>W0DKD;(
MBGV(Y^YMZ8)H)(/T*9K3&*!C\?>,F@P0_LB;S1TR8WR)*"6@YKJ&,2WMGR6"
MMS$*Y0OJ:"Y4'0Y8F*?3ACXR;Z@%J^7UAU>ES*YF%=!?YM??2L)0,FF$4("9
MMD:E) =TQ8/Q(F01?/2ETZ42/>*!!M!WW]C?__3IC8NAG"R:"G0$J['>)"SF
M:^N)%OEV>3L+Y5]X=5-'*;W_A,O\029KT3 '6-#5?@(:G"$=9ZKD)(0-3+:.
M9G6 =0)+<Y+(:6M&1E":AR;W3949?5-QK6H!0"9Y/-@E/S!./K<6L5:"N*K@
M!9R-#E)0* PW0:C6N=%]\+U4-1J-HW'C79LA;K=ZSHJ6GI-]7_O*D..F'(24
M%11C<W H+9>M/=E]6+X#/3E>]B,X)@]PO29;:T:?NAX0]2['//LSI[>/%%@7
M)(=>T2DJ"RFP<X%@&PE9*UJ^28F7$17E,,#O0'L:LS1"C>"3?(K;- HZ75_C
ME]DU7GWP1F5DZX&!*=$^R-=-DQ1PIS''&+EPK7/O#X)ZJ:K3EHT1R@<'I'(Y
MD2W/FIP_K@DY:D&6&AVO/@;$;+@6K'65RB6EWIU(P<;A;X3JP]_QZSJ'[&YG
MW935OEZLKE<?HN1!\FQ!*E?]3^_ NYP!A9319>93:-T"Z3D\+U5[FG$P?F7A
MMWRTNQ#WXI&IC_/T^W(1<TZKS;'<),NN[\.:9=T-6N7D67BE1*Y-B9 DN55U
M[CRX3$J(HF"1PC'K6L=-SS8+3V7G6$P.M-<6E&014&=?1S9D3GLJ:MZZ4>?%
M9^'UT9^A67A]^#G_+#R6@P^13G%6MVIEBH!@:D2>2V%*L3GIU@40%Y^%UTL#
M.F?A]6'B-/E471#^R,([AL[^B57'<'$:K>%1!\ZDA.0-DAW('#A+IF82F*V+
M(>;2/,_WTK+P1E:6/A2T+LU\=?V/3_GON/PC7[\M)2]G\X^;__)-4IAT.A=C
M0.@Z/RXH =[(!$9[IZQAVF9QR.3N^*RS3+WJ1<]B/-FV+IC;W*G<GJ0_SU;7
MRUFX68O[XS*O+9S5!\E<2D%P"#:1ZB=.5IMF"K1UW+A4I,JI$_E=GG;.CO@Q
M-NPX8FZM!WVNV=9WN!],T":*($ @UC)/H^N]B@:17#$Q6%ZLZ:04O1_](C5D
M7 ):GQ@/T-XWKGIU0R)9UAYZFT)@*;FJ^4,1:]C*LPSHL@ TV19/>U[PW0II
MNSSMI2M%&S&/>\%Y^(+>F"(#.@1C25V5Y!H\20:8(C%HGA2I[H\DBO;QD[$X
M&N%VL]]5K! R9J?(+BNU(D:J "$J#LB#8L5KLLY&K!^Z[ OS1AK5F*41;D"?
MO0.Q12#3G$-4F:QOZ21X:2T(QVG[5,ZYYM&U2[V'&J(PS3@8XY[R[L+E#<EF
M ^QM>9# ^($L+869*Y#>,S+-)0?ON /AG;2>!Y38^B+\(*@7JRE-V=A[;3E"
MFI^1S/KH-61G;"W/C( Q9-KK2I*J8'7O?J3YM3IWCI?]4YTX>ASS/:[-II;3
MSS<UN$/ 9HMT:V7]EO^]_M'J@W.\1.,L."OI('2%EAX9J:\QDN<8M0C-DX@[
M(7NQ^M*>EZ?:<_3PYULG;S?$M9-_C_"OR\6JQJ!%D$$S,,ZKFLM*"&VQX(-/
M2MG F.\8<^G\S)>F&&.*_*EF^+%29!Z&$%<_YWB%RS;I,,]^<*O4E^[H&Z6Y
M_#S[DUR4>5J1&5KOAQ_HD,!0@C9D/"A/_*(A:A,'(W0(,I)1VKQ-]5XP@P=%
M;'WP[56X12<+BX*<+X5 *NL %;TTT@0NL!0;?.MDE9U IDI):</UDZ$/@V5[
M+HDF]RM97VLJ8ZVML6.F$MG2EI/)A(:!U+Z@S"IA;CXPY"& DTV?'<[G/@WI
M+=<Q9H9MP-S=7W:!,U)>R!:4TR2!#"!G'\T#)#L!X4Z3Y1*9 S)?29-+H+V.
M!05%R9"YMDR9UBD=DQ!](']C/)[["+1Y[^P-EDW* #DK*'D=96ZD!B70@:LM
MG56(,OB0K?.^DR.P_<DG&+ S1,Z+5D)J?9]^#T9LNNZ@KYV[/#AE:5E8D&P/
M1XB4X<DGFQGC_1@3+X>Q8X0TVCLF[\"$E-?3/2%Y;FGS<!9"BA*,C<([3 1(
M]F-,OAS&CA%2P\OGQV#4)I%*6&V%=%!DC>(4:0%],77BFN!1N-JCHA]CZN4P
M=HR0&E[O/@:C-V"\Y@4%N6!1T,;,':MQ-PU:,J>X2<)%VX\Q_7(8.T9(#6]/
M'X,QFT-5!XLE!>">DP\M:S5A+1Z+Q9J:>)2R5?T8,R^'L6.$U/ ^\S$8N^G,
M(SAB]AZT03*"/6W6H<0(B#%F%8)+V\5*AQBS+X>Q8X34\$KQ,1BW.50S4UXG
M \[7[EN<MFAG/(*.JD2K@^$=\VVW/_DE,':,D!I>^#T&X^_ 1(4J<BVAB$RN
M1O0&4 L-A?Q^[J,TUK%^C/F7P]@Q0FIXR;99V(,,@F_!O[OKX\T=Q(?:%$84
M6IYTFE8;0P+:"S+DJ#*SB:$1K0<2=L%U0C5H&D5OSL$(7<'N@3U,.2ET.C#A
M+=342%#92D"9) A)[X*+/*C<.G%U%XZ7H@>#93SEC)^JG._REYME_(2K_/L5
MSIOT'=C_L<TZ#'1$WNB2]?:R_O45KE:UA"KCZF;Y=4WM-Z7)4I %K LPILC.
MRO2">WJCP7K.52Q."]?Z,K(#K,%'RXX/O[U0,J9H.NEL;=E=6W?0$1IHP:"]
M0HY.:A%;7Z_M!3/5!6QK/7ARB#21]KE<QVZ_I,O%QR5^7E]?1"84V5<9BN<)
ME- *T)*0N#2"5IE]4K:Q\NQ'<ZJ+VD9L;^>%M9'Z&.7:.Y'=&>-=L(U5WO\,
MKA,5]C?BL)-J#"!@:B4I.D53@@ ;6:QUI(+VUFA!2VN],Y)>CM;)ZM,KQZ$Z
M_A/H1A^YM[Z]NFL-QUG0O-IY=RXW,TZR$FH;W%I:GGD$+%;0CAD*6LM1;A>W
M[(E+[/[\$R2'-B-@T59ZK2^0OT'B[@$DF5%FQQ$$1E5;CZ;:A#0#J\Y31,^P
MA)Z$/OS\ET?HT=(;8]>^+>3=WI2V"GKY!\Z\#_0'"%(Q4+$:QY8%(+73/O@<
M8FZ=D]H1VO3Z,;8S,08G8[2JWPGS-FW]E_F;Q3)F3@:Q<]'0?F5*39_@R4!P
M"8$0LD2;53"\>1N?#KB^%Z49P,;XF\V.\I</T@2!WG"(5I$EY$6]]%(1HD/M
M#$O<-1^%<QC5B]>6H4SL3:,9/?399JKYGL\<*>@YZ@SS+IJCM?*._FD-2V10
MK):]RYH+H$@^25CA=>N)W2>->*9 WE2T"82N,SB*8.!49""Q:!U8<(*U#EI=
M1,2SCQYTCWCVD?8%1#Q5#"8&\K-\J G;TD=PK B0W+FB"IGSIO7$QTN*>/9B
MNWO$LX_4IPYF=<'V(^+9D\,^4:UC")A:27102(Z8 :-EKD6ZM7](T1!"+#RC
MD"4U+ZN_H(CG:+K11^X313R#C>O4<PA(UCH=LP9\KGXZVB 1R5LW[I"M>CD1
MSUX$=(AX]I'>^%&.79X2R\DCSP;(XR*$*=)BG9%0$GG42*Y2YLTG9%VHSSK$
MXFS,1/-VI<_ >_5G7N+'=6>I^^XPUNK,@Q5@K43: 8,#)^@KSXV.=7HZ-]WJ
MY7H^^.4HQNABGRS>OJ.3YK??V81[?:XEWT8#1L=!<56'XA1/AC<SB&1KTUXX
M22BU"]J7HV43,S=U*.W3XHJ>LNZ,6/+R7:Y=4.)=$Y1&D;7#CV@::.NYHNFG
M%@GA)2JR8*R6H)SV@*PVHL3D,"<K56[^'I_KU*(D)4]:6$BT*X-2/I ;0&8>
M-\8E$[4LHGFX_^*G%O70GZ%3B_KP<^I8WMH<V/7:KQW.%%,V3!C (,@TY*C!
MA7KX<V%=LL8Z73J96_N><"ECB'I1NF@MVM8N]\YM_M81[0)K=YBN!_.G"+TU
M9.,0OP-$.2'3A44?>:;7Q:$"A5F"DZ5><+/"E=?>;E=(G0G#>^)GTQ/<1X*M
MB?VE2A*O?K\)5[.X&41SP)+;E*%;'K(C4? Z5TW%VIRC8)UZ;7U$9T0IL1/Q
MQV.8SM%IRN%B>@):!UR.@?T[G:MD8N#'?#=N8,<O?4#-:TVHH?4P64<4D[O&
M(@(Z%74TFF?>;3L9"^%9-T ]PCH]'SI'""!_FY7]]M_SG'["J]H]_"Y@F8JU
MV=@$+#+:RQU/$*3RD&61P5J;6//:L^?PO#3%:L[!^#6>O\SI2S+5_Y,?3&,F
M/?^,<X+_\ZR^&)G #PG/]'[&P/C,L#4U"M \F5G_^A/./^;5+_/[\-$W9?,\
M)YY4A*!U("=)5O/*>XBH3' R<BM;M\WO@Z_=GK3W69N9M3&P4!@$(R*]&]:
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M _02]*"=Q$>8!?S$I/X'_N==;>NV6LW*+*XGA-+&5?.%:KNW]7\_J)0E2ZE
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M//?,.^55VDZ//M3#?==C3M_0O1<#.QNZ#Q;?:-.V[KSAO](Z-Q$2R\C53JH
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MMT/.W*42]\""OT3!7Z(89200+%NN3"$+SU(_V1%X:6*CT\O8#FA$ ^=.[D"
M>_$WSJ'9VWH$2FP[[3DD<SZKO3WI2O/<"4-\AHUNRB=$IQH3T0Q> "43GDP#
MMIE%1G1:\WI"'=&'>46N_5Z6?<4.@1J"4V/0]UE5?[47_]BH50>C $YJ6"02
M7,\#>\'H;?=G.OZ25"FM,D6HAGLVY[DD$+AE1'*C*4^%T=FT88R7IS4ZS8KL
M>$;4[P00<>$>/2\;L_G:KL-.XSO\\K+C<(^!<,.>87X./KT;?[JM0ZX!_0>L
M3W?-B773+IO^0C[;I?,^XDZ"YF/9XQ!WOSBX!;G),^D5<867)'=*$B&M)DY[
M7U#I"YT=@1X7 4?1J7(L@CGJJ$<4?E[)[,[U<P:KIP\UA/Q]?GG<SOM!O43X
M-,TY8F] K"41E,-E!3$RS[2RPNMT&NC0\9\=G1*]L/A&8+WG#NP<H H@=P&Z
M'+7YXN:W'_$ZM3%&44N)37U!\D3 ;5QH";Z!371B"W 4IL*R'??)$1[U"XIN
MY*#GE5?NL)'IX+GM$>[[FPENOUO<_P$QP4>0:]=[OX7SJ9NG[A>'IORAND]I
MHI(D)2[%MUD;N*J$8L0Q*E(+^FPFF_X+D!>CRKSQ(8SHU;P"Q(TS=65#7@[>
ML8^EJ]IE=5ZOT!#@&NQ0_JK[9Z\G>H786?)7EQW^2>BZ-:[^%CU[ZOS&[<N*
MSN1EV;3K@\\?Q.)DYA*6$9]BOXG).)%">4)=*GQ&E;-\6G-NM"Q&I]_12NHH
M91BQD7D%A6%4$P&)VRZ;V'RHOU=A)0*:-XY5=+UTR^JV4;9S%S%C6#:C$H%K
MY*==U=7],S0.J@MO4X=+:CVN8]0$X3F(=2Y/+<T\9]/R;6_*1G2Z_GX.=42?
MYU4ZGD?MYQ^7NUQCZ1!BNUI\*!O@8/=S?0>*7O=84OOXKP&XS2*03+]Z9-\_
M]FF.8T249(Y;DJ? K\1E]WE!74(%P\41OY0O?E&RH]/7> ]M1#]G;L8^K[^Y
M2E7KL\8I\]#3_L%Y!19T]O2S-V:R\0EJ(4K3##QWC24:GA+)$D<H%2[UF60L
MF^99O#"AT>E@3 <SHG7S*A<_=UU^+^\?5D\?'7"A[IT=BM7**F\A[E<9^"6Y
M*BP!U[T@3$M54.H3K2;W!ASSP=%IQ4L*;N243U>/Z)*%=67@IFPZK*M%:#US
M]M,&25WZJ\INV@#%,/3%[$U2A!T62[\'[8PC&E=^6'$QN!/89QSZE2$*;/J_
M..#@&LG!@36,&$4YR:TIB)") ;_ %T5&(?[3TRI>D3$6M99&()^C#G[$"DXP
M;G/V+/MU6%)\[F]@0W[MU]A__(P3)KD7UA8DXRK! @\E@F62V"3/(313G,EI
MS^DIJ8I._]Y,Y"/*,Z_$L&L!'"&X&]@T0'+HO0F]NY7MX3;:@0U<,P;VU^+W
M$9Q@MWQJYX+JP@KA#"5:%(+DB<V)UEP3GUB1<NFY3Z9A4;P.O=$I7(3'-++Z
M<5[YH\^GXGK"L/WZNBF_@35]N>E6EW3C0.%FWS6)M\]W'J.7\AO\]/HA=$U\
M"#DNW"$%0=*0);CX&WZUW6L:3WA>Y)P2E7J.(T*2*&424MA$.^D+2>4TI(FW
MXB Z=7T71SFBP#/QUG9<]PQO/>A^<4B[&%R2/7>C'QA^6E:N[]C>H2S]@<G:
M4JV>@2W]/.I*698(X2T1N,$UYP*BKHQZ(O(B0X"Q5$Q\OR-@)F:U?A<'/*+A
M\PI,PP!RCU?T&\@T[(\"<B_^L0'C'2FT.BU,*B! +# Y:@L-W@W$BSQ1*N,T
MUVDV+;(^_K.CTY\7%M_(<<]%,]L#6>M7OES69M,ZK"M]54VY J7N36'U]+M;
MV:U!7#>N#;TYG9-Q_J!6*]?U-9K5QN*D[V8-LNA#M3 _^5$9B,2V*%=75<#]
M"$>FZ\TZ+'-_GMP4J<D*+0VQEEJ2LQ2<%YH71">YY+(0AJMIO5CO@-GH%/H=
MR.PH!1FQH--69_9R]@W$BPZGL+JQ]=53J$OMY/-LMC@<Q56%20DL!>P_1>'W
M=W^YYUNEX+';5,.E@9DY<("(]I:1U&K'I =!J&GM(&_'0W3Z_DZ.<T2-9Q9Q
M.L/[6,(K9<,[U5OM<R#W?[I0;%N.LL*:0A&3B(3D:<+!ERD2XHSRK@!S%7HB
M+N4)J8I.U=Y,Y"/*<X+]+W"1H[\+FA_VE2YW(![8:[(;\CXPK]%BQ++I5I/"
M-[]4'OZ/LU@4Q>FM\L!UDHZI(LWASL\H,*W!8H34BB3<.H-+%2V=UFOQ1@Q$
MIY+OX2!'M'=VC>G0V#KWQ"V;\KY$/MMV@VO-#<)\+RI[K9ZZ8OU_EI6]JMIU
ML]GG162)8LIE),F5QF%J"I%;(@DO\CQ5TC!FIB$-GI:NZ'3M#<4^HD(G*-!<
MX##75;6N%[>?;Q;WC7-('[;;=;-@+=:B^BN^=PYZ-_@/U?SE0A)A^QC@/[![
M%2OVX8=OP$E>J09="YPI/*A$8&](Z^ IZ4NWPYN@1&ZD+0BC!DQ+ZY1(2@N2
M.Y/2),ME,3%PBI*]Z!0Z2BD=I00C=C%WO&5?) AQV)@'!90/@@FM>\&U&?OF
MX!AG*>4R1WQ:9L"T4T.D,90D&94)\S8S=!H6T$G(B5SO7D/(/^H)/\$BFRT+
MN\@(Y[800.@YL2EUEFGCP;U%I88PGPCE.$FSW&6)X\[K:<BG1WYPY&=_6L&-
MG/),S+&!SJZ)O&]$N_FN'MMM;UI())7@?>ZMMPL)]>[Z?'Y[3KH"N56<6I&3
M7"A@FF8X45U 8*TR#]^3VMIIU;\W8B ZK7L/!SFBO?,J(P'NKW%_JJ:L-^T6
M2VG/$[VLF^M-$U[YI?_=V7M<QMZ$#0_=6O; Z0ZQ">'.5@@6<56Y$-:7"&!B
M#_="X +AGVV%" ,<^[AK0\L>*U)#LX)PQB7)/?C""C29F")E\.J;U$\L$;X?
MGJ.SD?<CNJ/49<2LYE6@KAOWV$5V ^C/P;323]J4#Q=0;G%CQW'/ML+Y[+#-
M;UEUI;@!\(#+3%O5K9TD><83HO+<$N53K8S,"YI.:^E\:TZB,X&W%LA11SNB
MV'/7Y9B'JE[5]Z5!LZ_J;UNJAX8M,,X!%GX$!_G+8)\4["\7X)"[5& 'MM=$
MRL22S"4I%RFGHO"3-/1D)$6G:F\C[!&=F5>%">Y\9R*W#TV]N7_HWX__J$%N
M?SIL4][6BWBNK&,:'"&?*I*SQ(-B.T.*5%/IN#530<Z/^=3H3O[%1#9RN"?
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M?_^W_LOX/UJU[M__[?\#4$L#!!0    ( -<U7%A8R8!HTV<  $!U   4
M8GAS;"TR,#(S,3(S,5]G,2YJ<&?LNP=44]&7/GJ1W@Q(KT&Z5%$0!"0@TD40
M%*1&!:2)B(B A@1!Z1 !044I2A<AT@61T!$0D")5(! 414I""1?27OR]F?F_
M_YN9M][,^Z\U[[TU=^7<E97<<O;9>W_[^\X]ESY%QP%\UN96Y@ 38U-C4@,
M^BQ@"C ?.O3WP]A8&!]6#E96%A96+G9V-@X>+AX>;BYN;M[#1_AX#_,?YN;F
M$^;C%Q 4$A+B@8B("@N*'A$4$OQ[$29FQCDLK)RLK)R"O-R\@O_AC=X&\',
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MC@[$>*#Z-B*8J;.;5+D<+$J5 *%QAM$!I28<9"\8NY,60*44'$I2+H!H4=_
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MA;N"^?@+>).D_!]J9565UUOK<V;"%G@^CS2OB#D<M_CAP.CC,RCA(@14BN_
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M)6D=L[\GLAN.^?"^.SXM&QD8+'G-ZU+/J<?,@%<]$ %MP\[.XAK7.<N[B\#
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M:RQ%(4WG.LY:4&NM@9U@\"B&$D7QI@.A5K3PK-U2BN"&3S))%DS]@+_OHGQ
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MDW8D+UH[(PK7$;CRZ.[2";:F"+5QW=F+2%0F9]$3/F2K3I,N58>F.=P$HYK
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MZIL@Q@T.K'!N\A:5E_&8#XNF0JW7)X3/@2KK;3IU>F4N%[X5?4?5#Q;EOQ?
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MYB1#'?:/((?%QF&[U[\XA$KF_7 5IZ=E(QP:>7 Y ?H^SO=:G3SU\PT#7;8
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MZT-:'U\E7[0+YZO"Z9=IK"4NM*/)GV=HS#]SV<D-<." 2,?1J[IN2A77;%V
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M8Q,\<?ZND#3A'>VKY_,ST;_B*G/>A>!O)>7-.D8%#O,%Z9[=?Q^P=P@=%9&
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M393G4X8#.CQ6/%VEMM G4Y7*EE*7G!DUE)W8D/E- (+_E25AJA+JMN)UDA
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M7J'M?2/:]V:"[)3NM;DYIL98%6 N3&I!"\ZJFKRQ\8(),Z1U4Z=2D4*HQW)
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M9<#S@3]16B<-I2]B18OC.;N:>08BR]T#GAHMC8P6(/?09="?UA#P;Z8ID==
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M*YT[(5,S)S8761C%%=^+*_L=K#7I1=NL?/$?YK3=.=]_GGERD<VN3:A)QVD
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M,.6\!3,[CYKII(RN@>0=!HR83O1)['#)Q\^%<M'OYMBO=#]^>\0U#B'VVNF
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M32 ="^$M^,=:8)8GFY2.M@7?"+-$GL<3.@&6-V)_0%,GKZG*=C.O57^N;D"
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M'1;>LIB'H*KJW\FW,;\Z;N9RWGLU<II31ZQ^=>Z-,I:S9V@2)HXQTWXL<VB
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M.4BLP+7C*]/ENV'(8)-QIVJV<L)IMB^IK,8F@A'+#[MJ:1EXR5ID9 &*R8+
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M/5C477*.]6,<0#:. U*^G\Q0BIQJ5=145M=]#IV>EPH5F!A&%GX@(CAM"F"
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MNP>50U<N,W5"8]\LV&9>&<GEY(B(UE^X$675T"OP*)67P(GD>4!B;)/'Q,]
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M2VVMT?*SK7YWK?9E?AA%JE]XFKOS=QMP5R'M]O Q*S3S4L5OCF@)WG4/W-X
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M=&C;[VN (^8T]EE6DLC6J&]U'9=]YZ,R%QD6W:0==K0FY9U>KU,0#1H1WF0
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M<%3]-_<3V/I-AC;U,?FWW2'NC:_221P:&O:S-E%%-574:6MNJRYIECW0D8P
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MHU# Q3=8+"W]:ZJFKHEDF%N1K\VB<K)69:1N771>J(;WD(: [5FZ&8^SYEQ
MQ!"\&\P&M9^$?L!4["R_?-"<5\AZ8305E22Q135/X]4'N"U$R<WL++43.W3W
M)N8'0WFKT%?!:UT3N<Z%:K8LDTR^B4&5"KSR_70;,\6Z/.LZ_ <]<!AM@F[6
MSZW\QV<5T]> Y)3#*:%'[<NYFN]M2(75FB=A6*+1;[H])9=08VS*#S !E .C
M',Y82SPC_]ZI2XV*],U7XE6"S(TWUX#@DDMMKQEJ-W"(OF3P7D[WXW'VL^'
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M[5F;BZEF#;HE<M[^?*FY"5C2C8*'XFQ1?F+"K!]VOG(X7()^/3UBSGCO( 0
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M[>!9&3)8, ",1S);=O:.ON]5:GR62@DDA%4[((%/^1=@(O/?M#B_@V%O9W^
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MT%@&[<NOIUFHBW5V')8P>U?-!^G\85R*_/E/EO"Z6WX-N',;*Y<7+W#R1LM
MNA4_.++.W' L^F50Z1K0\L9E$8U.%?S,C@Z#"F,\P\X ;[U??;G8Z#MRWIN[
M((\Z10IV]4*FJYJ.<;O>H_V'6%F9W@M9O"ZHX!\5MF_Q(^ JX?!Q!(H52WUA
MPAT(LP<&78U .XA8HC;8_Y)HX9FN 5V#(8XD6%X(IZQI0M^ ]XYSO-1*VM+1
MW.0I-!OWZFML<?*6"[C:6@W[?D-8!3&!'%OX]X<4PJ]X*8$? CWFO^%68>2'
MJFJS^NX0;J*"E2</5QA9['>=7]R@-?#XRNG6\@U*9_!AV$F9-Q0'*%PO%V5;
M9"[,\FE\=>^QQS2</[X&](#J(S/1Z(K:LUS:<XG!G^Z9X0ML:!2G#F8QV*U"
M"FQ7%\.&Q?,B7< R1U>VIUU8@U]%WHM4QP9)C+<$!(2$(N\[!ZQ5NLO)^M%&
MW^!R&PA/8<U];R*AP-9 "3 F3D3P:X]N$-)YZ&([5 6>#D4IAZI(9-P:FO,'
M2"9E;4:9L>]XNK9N3&GV^<=^Z-N'K(/L!CXK49VX)*\FKWO5U-\,* /6-S?T
MDMEFIA[P=6)&,BF4X&&"8/M]"MT:/Y,N/RA.'E-3A&%',@V&NW_BT1PK_;&N
M^/95IR>-WIBE[(-'-'"I#6D&^-#B;"0*'G;@1[/E0]0!(^'7,X+PCG,.E=!^
MFO)G>)]%_OW,'PE8ZDQ_!B$Q\ANX!E#O?5+)0]-5.W*/A4AQ)*B[BTKU ;()
M16X9E1'<K]\6U=UQB2W4RMONF'=\8^%I<0;3 1&$<<<6:IML7P['-"CF>IXM
M(!%^_6!&/Z#76;L$GA#K*QRZ7(L^:2AH&=.^]Z=U1/2G;%K1EPXA'5!$R@#*
MN V\NXC9Z=(YTEC1B#FTJFECS&.2.(G6(JS9"YP#2)T"V)"T1QJ[UX"?./FK
M#/Q3*S^>":!TD1=,B7O/<5$SX*?J[K3HIN3*9_X[%H9H39=74;%E)M68S#UQ
MO_CYI@5:-*$ZE\I*3](1([*2:MO%O^!<E0AD; '9'K\&3)\+G#0G^/DTGHP=
MBTY@&-S)E:L2%;-BGT74)#E,5!A-'RDB=SNRO2Z[R;*]S/0G0 \AO&2>Q0L]
MY3,O*10D0)]()6HH]@T>\K9R;@N'9):S!P#O6#Z8W]*'A+D+)_ZPU^DOY50B
MK*&62'"XQ1-?OS/$HEOGI=PVHQS@IB=60M<OL,<!<.[KD2=P+5]+!;C8VC3Q
M?<=I*UJ_]SBY!G!NE7D_9@HZK7Z8AC]N%H;W;[LVL'_)0C<7U Z7B-ES $36
M]+8":5HW)8IB$O-,QBZ-9B@OW1WQTKJ;<+D%];W,%UE9Q8E1_RR3_8_.>/G?
M.0?HTZZQ4X%M'(,7R8'8:CC]E-PQ^+/&Z.*>+N"")E96XW(J+VNA4]TI#RYI
M[@/^]Y]SLO?@T@(JCRWKGES::$]7>!OQ^O>._CKU-*6Z1UG4?==$T=6/J\Z!
ML Y1G"VVLU^R"QSQ)L>Z0F+E)]:--=B;V;"T:X!X9]UMI[?$-UFX<]?IROD]
MGI %=U-FR7U>YMD37(+=(&XUG'ESSZ\)9CEE(#?>:[<DU+/*K:Z!,6TR]YN&
M4/D]>3T$?82U=B\U>%#M;F\Z_*N6YZ'[A]=F0']]S6WY6^7;?H17,?C[4+[J
M2P,KNHMB# #R#O.@I*UU\U49E1"E-#&%]TZ_&_XA%I5E=9B7B+J4/ME38#.D
MFQ"AHN+DM*EYZG? [&>LS,E17J@??.\:P'XHGA_2O9S9]:>I&F><&8!Z<RF&
M<\7V%"\^P/.F4[Y.DTS-PKK5M-<Q*)&MY1LA!=?=C%?CBG+P-U:[ R),M(TT
MH*2VI:(3O,IU</QD2BP ;%ZF>1@]Q?=425F>*">3 J>$C0XJVN9%^3Y^?J0_
MF\?E_M#IO0@7FP)_&5A27HF_#)W?=@T@PRH^KQGM6FN]!B2G+C]."/JJI'1K
MT.G66:EN6*>N3CZ;WAEL#6]I!&PD"86.0X W55K7UADG$L2Q8\R!C4-O:)4W
M#BV- NGH)#)>Q"NN9]6)9.W9521K_X&STL:0Z<8JVSI: FI#B/?VXB6B##KN
MZXV(J=,\898G_.COD49>JPAOL2IE.H?N5*UI7RVBD44*C*3L=[@:O&>K!Q-:
MJ+%L["P08_D?8Q<2Y399VE9:GU49_Y3S/,25(JV7[L\)W;4=NP:@C*!*P^!5
MJA7WIIFGX*K:FU)[A@(C)/4G81)1=K+-;Z/'H!48Z7.F"RFD%4E(@ULX# P>
M WVKX9$S0IC'L7G;&'[[(YK299$.0&F^M!0GZUWE7S=.3];1J6_ <[H8O%\U
M57>/9RIG(T^%_(]4+UYXD!,TJ6A[XHU<*L![?#*>H<9NP1.'5R\@R&9*S5BW
MA@H]G\AH"27D'^8$EF(BHGI\XMC6@M3HB2&9(XU5Z5J-MSVC\CR26?^M:\^>
M@4SME^,WWBG5K!S=ITI&(:I[PYD,G"&<G(5;.X:EN6B>MH; FGF1W1SNV%1;
M9XZR'NEN58;>0?6?FG:O?;JN=G!(?#]/)21\LMCG6P2CH]VTGOG3:M.;R8JH
M:ODW4[>I&S*]O/!'_H(]_,2>NS)MGUQ9CB:O'0R,2C.+XL1*+L>$-EX^ZTJZ
M^"8E'7/$W+O[OD&:Y5009Z0^1++WN^OS\6)O/O[%J5@N>NQR'_'W^!_B'EP$
M)(#-_R4Q>T ^LUW^A&>@LDTPB@*0(-4[?^:BI"3Z!#)#;#U:[+,1[/Y&("Z>
M]L-WZ,^KR9=<+D0L1Z-!&COO)[O<M[_[OLMI(0,K^7C^0^1@S,-]1AO_+#__
MD3H%C'HO.$>1'7O:RCN:V=Q*-#2IFXM%OIA(>8?4*V](;%!DV8;4WG&-&_,X
MT&^OYLLD3#C__B=8Q?9)E=X_-Q2J%?E'$,T9/_DL1_2F;DR<9&)F8-Y3E=^2
M5,;C+%\BWZK!9['ZK^:T*,F=CKKW,TK/>_=Z<O,ZUCSJ*?_[=RK6H/4JAS*;
M3LIDE%C0__GP4$W9VAQIH2FDD>?CVDO;;0MAA#>I0F>4_=W6Q^'2U,8J3^/(
MJ>H(6MN0PC%?[,5=VZ\!A%D&F&*OAA.<<C'=?#C#][?H6]UW\?1UK>2MY+H/
M2K=!^J1X7_#2-4 _/>*+]8[1;!\<1Y 9:XA!=K,HY](,X:3ZNW^5?QMDY/)P
M;0P89F;YVNED6XW6:+<5OK6L1E];UV+'*%RZ%_E7G<(C?>FA;&HP>]> ;:.V
MWAA?@;:F_\^/M]1+>%%C%H.2_4('Q[NO=VKJ']:;S>(N4_XQ?^EJ]OQ_F@!M
MR,X/CF>E2S\U5U)UYL9>\)-?DO>-';/K3\)!V%_+E(*FHQQ0 / R,(?RFPN]
M-+*%0O:^5S[#_!1C_=(BW36@7:66JG\M=XQ+HLNH7J';22_CY]%HG)&@EV.H
M>"AZO^3.GTH&TT>?M!]&?P<$Q1.]8"9@X 1#G&(4?XB[?=QL%:U("Z3TJ4<F
M;G(=_!?VWC(LSJY;$RR")3@DN!0!$BRX:X7PXL&#>X#@'KR@D 02*(K@">XN
M(;A+06'!+4#0@N!0A18^O'VNJZ?/-^=\I\_T7#U]]<R/];?V\^QG[;7N>]=:
MZ_Z^PY%;P_&?'7?.1=^4NC3CH"/Z#:EH&Q/0A"T.-$Z- J#H2P[X> _8T]XG
M2'T#NF[H]+W@EQ%47<';3]!F60V=[[$%^FMH>(V(HC3X ZR"N+<DN2%.ZW;]
M7JEX2;9E?L$33L-<\YP;T11O*7$RTT(!UC** C-%"5W&;#^$TG"(^CSF?V:G
M;V:#UCTF&CC*FU)=>STKBP1 \ P2RU<FK1+ KJ?,#)L^]*PR$% A-^G'9LGZ
MC?AM#4^?9NCI[M'QU*R5 L-/'_'B6T8UM]@:IQ3W$$_) X;+".S=$"PV] CG
M_>>.=$K&V(/5/;A#^S++%=WQ@L_K/6!>\RU<G,?\U8C*!"1-=8-1_1<[>E,^
M#:D+(^F R^/7*M(N;@T"QHM>QZ[<L-]$E"OK*Z?( I]:[>%UJF/QY?TJZLZ"
MHK']W[AL%[R/&$C/COQ' 9[X;U_F@)W**Z67B4SY;KP<Z">!1T.[MP$^;W2:
M]ZC$O]ZROVJDIK/]R<Y,291_)+F"/.VZ$9*&/!'V!0F:O1*(MX7R FC9CE-W
M=R0L81Z?68WP\SADNFXM@9W:!V=4A400,F%.>K<%6D-OO$?BXO@X^WT0"PO5
MS59_)*'3C: 4L2S2OXE]V)F2_L&FU<BC1<3+/1J@_.RB?;,T?^OQ]IEC'*?G
M[:N-E_ALEG:% 091%J]3#*CQ."9F)+(>++Z*H_NBT2G4P$5:I(&HC=+4%AU?
MN.:;17OP?MU[[?G'T%,%#J'8I-G[;8?MUA9 O)%(%U->/ZN5?W94.0N32[(Z
MJ7H8L>.D5ML$%50GK(V+;[K*MPQ:^A 2Y"G>7^4Q7F?H72%*V$^KVB]!X%47
M"N?3Z"''Z)10!CT@0B^:P ,Z.J\N1+*(RU-C(QA*FB=IJ/B+ >!L'X2R5;HU
MCJAGD&ZWK,#$M4M!] TO1%"FETD4@?E%0? =9P5MXKTNRXMQ*?53,H0\P=!S
M2KK&[RKO)/#AE*OUF08-=Y*4]3]H;7ADE24BXG=JU@8:.I#!Y5@3+M[GO;F!
M_#S=R:NT]V%BFW ]:=.9X-Z7W1%Z,G/,N^$M$XLYVS4]A"]_EH3$.L]9LRR_
M"56:=_YUU+'/5YHI@U#TB#/[Z*-;0A>G&]XLX:B;2/]AIJAWB0,C@QR=P^])
MR13$*#!DLJ)$X/C3X*=20K6JV!M3Z]4$RO!B7@!]>$C/Y2S\QFEE<]]M-6O?
M&W465[)<.=M6VUXK%V3'>>HNY@5CU*"QWC8_M."[=KE)X,/_'-GC%IXRM'((
M[!P5'H/7N9Q2]/$^=,ZM7O^BV">^V/"L[(>(V6&@[.9G7:*MH@&F@*"WIU=5
M%T$]F5QW@+" :]Z9_"N-3_-]'ZH2_D2XB![_?-@I.OE9OAY+AC+Q.@_G[7?0
M:EJPS+6$@2PV9F2^X(> @*%?Z".%UY;,QU0>G7WJ35W25,CJFRR(DQKH$]TW
ME &,QZ ;1%&^W)^EWH@G7ID.&671) FXL-EL'!6_Y&H!U0IHG3NJ?8/X<P9#
M<CX(_L:UW7??33J/]KBFO@"RB"'N /.ZJZ6A:QT?ZMMY:]5_-8W9NHDJ ([^
MDG5=\IC&QV=8B2M;O8_4''8A[UJO2*.$S2!=YX/!WBUUCW/#E($[ PGQH,TL
MCU&14Q%;3'CW/%\TC^Q0Q385W7#EPR-O0IL,"1H0=YC$D_::R))K8T[_WCJ,
M5.YM44S!-9'"=6'"M=ZW 3^QLS",&QJ@* RDVYJ=5,8R\7I?K>$UYJ]9=[P?
MA<!4H B&$ WR9F.\H%5&M#/[3]CM[T0C"ZAP"&F[ #PT,WO=P_0.$ VR6@Z_
M?6'-C%JPKT$^,'N^L8J]]>'KI4=,(RM@'8"?&?LKNO<6*V9A-0MA%OC7YR</
M:Q?67O-! 32(5R1"H_$:&@Y7T@RG17I]UZIW@*A[^D@W2LMQ])9_QZG5MO1$
MI[X=NE?K-N_H%LF_[ "DW+>9%%&7G"N\>B\ :+!Z\UTK.^GW@L9#Y\<A'E-;
MMT.@NF=%^X^MRN$>13% T\EWO"YODE5<3!.>1$%:L0B0[/CX(9VD]XLX'C)>
MZTT8+Z_.]F3XRJ-Q4/X!H<V35GK?M ZU8EGR _50^6'IMH]D'J$. 9@K$XSM
MVE^SPFH+T8P*;Y/%G/R)U 7=:00  CC%,@)'QPF-L3XPY5(K6^XE-\.ZANV.
M5%D=4P4#PN@8=E\-,77AIO9@I_:4G>!E;8LL2=ZZ*Z.=,3G9I+P=O'G[">7\
MQM:/2>,1<HMLV<"V]#!!42B4+*!"=O9LY-MWF\G:4]#Q7/DSP /QJP-(6_AL
M(60.E6D^<VK9L;]Q:7KYU4XUT&H'LH*_D&B B%[M6. ZDLZBM-=7#^^,Z#]Z
M@KPU%/,Z_-(!7P9J85RNS!=;7BR)_!8(F3&@BH-:!BBFGVPRQJK_!FJ'8<K@
MAVXG(LDN;+7P>QS0:7"1Y3%ND140V3DZ'[;U9Q>QQ*[P8EDD\P=U I1!R;W5
M4\FJ.UYR5L;_2O+:ZIN:DV0LK$Z1N6&H6$J("E\Z!<PD&$BAZ+="2!BQ^\F"
M[1Z#,/P8*>.[^) U*G\2]Y4E^2WERP'V[/+H0YHM.N>/?"+#HM.= T8'2/E9
MQD=5(QY7O$,>3^GN_8K5T0A<^]E'X,OP,> L?G,#^_<!-BB@]AXDA]P!2$[J
M.8NOA= _RQ*?2T7#!_!IGKHD9"6&_P:^[)F\;"=V,^JX\KU]E#"RVT9)&- $
M.0*6G#\[['.+F'=_OKN&_W&E"YNT?"%\M/X.8'U!MWD(<B(-/^.IU_QDS,I@
M=R[&9'\]17?AV-<% =3ZY8G= 0C RG_$IPY3M!K9-YY%+B;)R9!0AZFB1YR*
M)MTZWF7()"G!Z?N-G]-<O7'BP-_H9/O]';FQDK6*/$AG^$JS[=]QC1M<;C'?
M^ T4E1YDVG'Q).#T<'\(I3,<;$&3UK!7WVR[_FV=R$:A01I6U'A*&>Y_3T@)
M,2"GEL&VZ<,W1!'AZAY9*;Z*\P&^K-7EPWQ]H)J/I3FQG0$R3;IMQFZD"_U#
M1YSL/O3VV-C%0,[]8>]+B][14-% G:4AM<FH](^:I,W[ [M'KWR.,S5D=YE"
M4B6^"]R34R^(R!V@/[7<E25PC9,OX<;&?1:$THF-)!A)SF1$VZZ'AU#-S,G)
M] D=X+Q'+.4'1*W=OH!TR<^[83N>!9"&BU20:D_QY#=43]=1Q5 \MY2+>RG]
M(Z;77;G?/'OE1L3JZA58R%"/!RSGAB/.^V!NF YKX Z0:>D5?BKM714!<HT)
M-,24H'4&S9C\ZJH(# TOC ,-1VA</;X-,.H-X9J>+)"M')'FI?3A6Y#3J*9P
M&2\.W3ZPF)3^/4K_&6Z5OAH%79@8C]J] [A) 7FV+S]<DN2X!%F[S\SJ>[V8
M.<>)&>_O$-8<47R#!>.'?(!0!H?XD2(C]\70-?"QG:4GJ/./SK6^/N%7<O4I
M%$\)5I,J'_4_[=CXBB.(K%3JCEX9)7LQ6*3<NMSA>OALZG%CV#T?:G=58L62
MZ^>Q, [N@I#]P<BS1PG? :A-8ZCAU )*7G0_H3\;HAXTO7G91TRF\]-/2NN\
M-XC$02<Z9]_@10%3K'GS-D3]>C1N@%LUD_772'[.(]=)M8ES$\BWG<U5TGWM
M-9>8,K#A>*W]'/[!R:].&V=K#,^D;&OU+JQS;/G[<E3K2T-,%3(E2N13NE4V
M=!# X$XX@H3Y$TBP0SW,J_RO#,%2]4EYL5HMS;9!6<TU'B,>UU:!R-_KUA*4
ML>S[<:N/9$W4@68M<2E<5#0O94#;E1ZC6J1%YMQ(2*T (<9!:8(S.')9%690
M9SP27)-P_6U@&X32L/B8;)MYNVDQP^:SS#[O1D[Y%?KX$U)W)P"E@N!N'P=9
M0\*-2>#XH<YVMC2+@2]F9;PRV7P #)F /AEN'H@CC^K5K1R$V/M&GAW;43;X
MJ^$",=P]B$L4@T3+:[VH!STZV%^@M:@3S@_J]DB&"9R'," /?1 :>@)?!U,U
M\MN/53T&.;<UXMVNB6_M3X. JQ9AU[)=M1T/[26]PC-FFIT%TH]'])1*KH>]
M15;4D7RQ 1]<7:2I<^<+:? SNIND+4-<Q3>EXQ:*I%GF;L<",G\O;QFKC%X?
M0T,'=GN^]3$*3&4I5++[MPS\/K&"%N$ZOK=UXUBXC@W.;<6ZI;UVG6*('OTT
MPY]']-B):3*>/WA/!18-A=1J>'4W[)TC*U1!F*_7IM.S'L^0=49)&@&6%T@:
M:91XR8\#BYG=H17XT)^U#OW TS<MT^7.0F=I0X'.UK+O2QM'-8I^W>JM%IVI
MU;>_G2^*$1E:TUC#ZQ04@KHN=H[N!#D.9^UYK:@9D<<@JL5?6]DV06$$F>/A
MZ:7'4\A4'S/X@C73E,YIR@7KI*LL.T9RVJ@ ;1[U=?\FARHXQ'5 =CK:'WVU
MNI_LBRE%:-P!MJX*^Q&>HMAQ,$_Q\C30G.]J;['9)=NL@D?M:) $0@"&'1*
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M(P_##4@_C9N(T6F_>*FE?.&WT'6SP' $]0QNQT#0A/ [P!-I;KLU/J(=@9T
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M()H.)U+\:UJ'\JIK>;MROU"2KEP'T4*GD.M5B_,%:PE&FG"8N]/@8]6;G#N
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M8$S#?U.K^TMZL&F3P>9X])@I-Q>"MP7+AMB]"O&X:BVB96<@[QSHW,+'COJ
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M]6*\<KNP[WS=N<9KE)WV>>48[#(]'9.NU-E$[5MV56\A],<$,G>.%-M_CK8
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MM[*[,O7?Q'JE1(OI<=39:V.20'OIA89J^FF_J&_IE)4] 0 \ >^_ZK[72*H
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MP>(C,3.CQ/Q(D4GJ;CIQ= O(!O>)+GA[QS#[AX"L[ZU8NK!$.F,A4**=FZU
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M_*_BY3%74.W]=\33%_< *E!HG[1%N#D-/[#!JS:="_08[T.6&[\]*?4K[#<
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MP#\K5R"GSCO0[:$\=XV(O[=)I@:@E:W'-29+/AI8L#YD%2TP>P@QK(GQ<G(
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M?K Q/1OH-MA[$E.0CRY$_E4S!XU-T#_^!FW+?2$I)+9_CO2<-[ E]B@T,'$
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M-EL*0$A[71?NVD79)ZL=-G'D;L\"R9]!LX@Z#=&3C?A((WQC"B^ATPV#_^A
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M 5J"ZX'Z6?*=L+*Q<%O+ZES%UV(!WUAR?FHZ=?8V B]20KCE#6,R.:)*O_%
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M_)B)%#V,</38=P+.$/7<3XK;2SR^V'4UR[)^%1CYCJ"]^94W3I&_V].Z%.)
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M^O0ED$*$._+$!T>?6HY[8I=5]N4)G.:U43D3\B\5:KH7(+_QCIV*U%.:A<_
MK(\W%K* MU_/'C1)[@%H>$:^%QI:-\53(GIN:WL\;_3NLGQ7:(XR]//BT]5/
M,*5F;K"GW[S]\%FYRW ,1I*%:(#L\?)++:5HPQ-+N7%;16A.M3 C'R&]5E")
M0:FM::VA?PO_1O_ H>7W=B8^1^SB/K"IIC\SQ@CO_O[3#FIB,SOMB+]G'KN)
M-ZXSOW0]S^0]MU8\C39[]5L(>'?=\)+= [U-%(@H2Z%K@)^M5%=))(9]TDC[
MZUX,$C2MN+NUK];2 1DL>OM^? !>N1\T #Q)PNOVX*X :SRU& UN! Z*6)'
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MT$(,,(9^"6>3B#)6U+7*>Y)513#()T@?#A"=[M"C-L:^P')MWCO#@%4>[K#
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M,Q(C>=36@M26B6R%![3!"9 7\?LU4@!O0-7>02[:0R?I\X-7>%V [Q(Q\:Z
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MPR1-?.Q@Z(4I@2A$',;4IS *TX@G"(5!E.H8=R=+-#7&EAMKVD@K]]*+E;P
M/SV5G+:EX>6.>_TON>NF\P5K3DD!QV4NU):;[S:^LBY FN4X%T^+$<VKNFR^
M>;&]VWQ-[MH5>RO:(@SOQ*9 K.*LZ605)-Y48UCO&O0,U]/GEYIA.^JL&7B]
MDKJ 1IF+-A6Q3-#=:0$:-2[$Z&3S.?@[GS-YM[<:9*E-M_>W9R-;P]:2#7VZ
M/*/:V-;@V[7![35L8J.+88GE_=BR2D_,!=<C/X+,D<4>(IG/UX]B&!.*<.CS
MP.%*_E)[6Y\:ITOQ0".?CL6X"YF*E7T"$ /3U!H#(_-Y%PP=>_D$4$8RD'7
MT;2(#RC?;P+OOC2BS7M WFTC]]!#!LST%<_Y==IDK[WE,GA,$.'EHGXH2LE]
MEX_%(J]G@J.<(,(^C$.7RE C#A/FAI")OY%(2..FZJ5I5'J<&H.M! 7X&6="
ME3D'J=@)+[./:WS*2H K<)UM& ?F/RFN-(T;@:6)M@1T+3-HA;:-I095VL9T
M)/JT@*T>J^K@U,NT2@V-Q[XZ>FTQLM:+YLE-^3\68C9]>!;_N1.MM-&^,Y($
MS/6=!+HN363P X(D3$(8)(BGA&"$7*6\@$=[FAHKKP4%C:1 BFH8.'X87K4M
MM170AN9@,[R,TH[V8F$QS>C^?D9/*]JK[KXTHOTOF&PQV:.@'9G4IDEO<U_R
MYCRJVR^D"46<Q53L-XG@")ZZ$ ?"H..4)0FC..5JN4./=S4UDM@6%JRDU=E]
M]4*KLB^U!=C0=S\'L#+:LO:"IK-_M07>6+<]QB!J;FU5<.G?Y_:V,.*F5T63
M[1VPTAL&+/J-_XWGO,3S^<O[0FRQW[7A-=>+\J8HZ[289T7K,93IG$OIMSHA
M4OC&P?U2>L"*I@YU%W74U*!X6JK0E+]N=# J8&( O0:+##L$(U&+R5!88AMS
M_'HIR*#9\7C)7.<MLCJA&<,\8]T5Z-)E\7TV7]2<S3R&N(>I![W0XW*CR"!.
MPPC&7N*F* P\5R\?X8%^IF8!+L4$/\_E5=\%8*V<%VOOZY/]L0]![GLIBUR"
M( H"!R(<$(A]%,/0PVX0A6)O'E"]:H 60!\G?&D']B7J@T&MMD^W -_ Z^T*
MMY7W^07HI+28UZT?!EL)W0[T,FXFMWY57Z5P._*XX>D=?>!L(0\)UY[FU9V\
M1Y@E-$PQIA2F*1>LG/@Q3!+*('41CIPD]GVF5XOH8%=3(^:EI/+L>D-6\'LC
MK>X!WF&$%4_PK. V]!&>(63Z9WA'T;!UB'>XHW%/\8XJ_.H8[_@;9F3Q7NYL
M,[)H',7Q2S.'@PA3UW,#&,I3/.2'#A26'(%IE'J$QBQ&L:_#$GOZF!H];(H(
MGEH9NRCS6--FV(>H&BN<B-/ =+ %42>>/0[HT=W2Q[^OAU&_^AX5=S_WOD<-
M3IKN.'W(BWEQ__)W7++OPM+X*D8#W_/+G,E"$D\/<LNX/.D@*?(0$?L(I_$7
M(X3!)$U<F-"4DD!L*Q*7*9_?:W4]-598"P^6TDL'ST;^SKM^0P>-\R>] 5$X
M]1L,YH%)I1=AG+--?$T.^O2 UCCC&PSPD8[W=("W=*QG!%GOB9Y>B^,=YAEI
MNG6.9]:"P=+0^B!75_DG_+VZ+F_Y_6+>AA/\K7CFS?;T>E&N@PP^XY=+]BRY
M=_YR*7:1M!:_?KNHLIQ7LE0O7E3\U^JNN)P+@M[XU5=Y?\+OU9+CGU&R"7%C
M!X",&)D+"&1%UW(- KA?HM <QV_D>Y"EN?$2"8 ;*)IG2*=Q4P5<P@$6E0Q9
MP1*1[2>J#A2CVY4SS2D-]I[^W!II&9C$'+.TOIQW4'L7JC.)-MZ*=U[LMY;.
M,XMR8K3G5?ZTJ*M/_)G/_67RT2@(Q70*H?@CA2@-*,08(\C]-(P2QTT<7RM)
M1T]?4]N -;(!WS"R<0^6:@<QEA :V#[8C$9L!;T '6 #9!!5P,1V%.&>GLX3
M'WA8Y8.1?SVOF#A<5I?ON5B@FWT KA=BJ%[NRD55?^.7XD<+\I^"MNZ*NP?>
M7?@WUTF7]!^+K&IR@+1O-;_%@KW852Z>W=_D)=7Q-CR'8!/Z!B\K@,%27&'1
M=/*"6@I\ ;Z+O;3\>8N#M(-D-/?2C:9U!\!K,+H&VB<:.*1A)E]9=;&"!#28
M  &*D8U^GAFEXXHY]9DUEHOG%&:8+3?2<XYIOWOJ620;T>WUG,AON].>51(S
MZ_R3Z.<Z?5=REBV9C+@H<&CBPX 1'R(:$A@S+OXI['&*0A9Z::!CE+_N8G*V
MN*S%5*2@E5'/)-\#H)HE?AHL R_^VX@,8',?UMZ2J;VG@U$M[,,*[AK6/4]:
M2E8L_GC,ZIJS=_@IJ_%\%B0Q1DZ4BMUVQ" BJ?A;Z"(8> [EOHOC.%6Z!U7N
M<6I??">6=/ 6<IY4W>,0QFHL8!6Y@4EA7Q;@E;B@DW? '+^'H!DJD^^K_LZ;
MK_>0^D>S\AY\T:BHQV[C7::?+[QN4P(UKEOK'+&>'Z94^ED1+Q+61)1P&'N1
M!XD?)!Z/.4^Q>HH>W=ZG1CN;?H<;]Q,R6ULKOE9)!<V14#CS&!+?<Y!3FP'O
M:A/ASL=3*;.O!="U*EL,!_YHM2[4!L%:Q0LSQ([4P-!L=,RJ&&;Z[M3),&S$
M* [T,W[Y4M2W;1(XF0.NS0>_*-L:[QLNOSIQH+JM3HBGOO'FAEG&'':I\<"]
M5*"K;;$H 6]TV"P\9Q@(JHV]5B#HD&,P7B"H_EA8BP0U!?!()*AVLV-&@IKJ
MO!,):MR,O3)VE3"F;W@I?X#OY?Y]\=A<QC]SP:.WO%Z4^2PFC">)$\.$(+'-
MIK$+L1<( SBA! 51XE'?.[7$G8(<4[.";TJ^4XB-XB<9R-@I<7I=,97!43*'
MQX!\<,/X4/VQZD)NVIOZ/)TNX%KL2U;:- 9;J\\X0W)Z&3C+0W/V$G$VALA*
M%3D-8$TJS*DT?_;J<QH8J%2FTVE.;]UB/)O=E9AE^?W7ET=2S&>.3U :40]R
M'HB5" 4AC)TH@%'L!8[K4)_'KLI*]*KEJ:TMG7"@E>[T;^*@PGL.'2M._W)?
M/+\1[[3GC>(OZV/&URV-,J$/*K"<HH<?,+M]V$PJU,[S997/!#LL\H( NMAQ
M($J3%.($,QCA)$TBAZ5.K)4XXV!/4YN4VX*"BI?/&5V5G]6M^7L<:)<CZA,F
MOG$J:[JG+($D#5/H!"$*G)#Q*(WTTF58@7J<A!E'P+:%L=KUCA7<!C80=P"3
M0MJK3*L,A*5+G,/]C'IY<U3=W4N;XR^8L?%G7/[!Z\NGI[+ ]$'Z;S:V;!.$
ME?UCP9>)+5WJ8$H3Z :)9 POA(00#R8XH,SU/):F6LEOU;J=&D^W4H.EV'I4
MH8BT&F_8QV]@$EF)> %V4!S >40/'4O,HMCIJ#2C!\0NYVB^?:HS2K7R('^?
M571>R,(Q,Y<Q'@0XA&X4RR,RXD(2"IN0AX2F*0TCC)5J(JAU-S7"N2OZ/"9,
M\%2C%WLHC7:K6UV =50(6 L[A+])'RC6G4WV=G8F3Y,^Q0^[F?2^9>B66N3W
M=[Q\?,])O6I]%M$HHJ$?03]@*42.2V#L1U3\#06"13R?)DJG&+V]3(TCFEG_
MW,SZ(@5,B*KIH+H72C6>.!F@@>E!R@>E@$!*N,D0%CU5^S"PY:RZMX]Q_57[
MU'SELMK[L-DG_X5O%(V?N93%!'L!Y'$8RT\=PR3 "!(>NRYGD1^R9%;+Y5/M
M4]]J7>L37_4QW#26A_A93DN.*R[+9+9_^V594!.WCDNBQ\6\EH>;[?6T877,
M;9P=0L/ "PB,4!+)C1^%1+"IL,12ZF-Y;)QH.?N;XSQ25=0SX:S&M\;H#<RS
M$KCNDLIVH<^]*ENBU>VV1Z73O6KMTNC^AXS\K"YS=KTHUS;9)7O.*EZ^*Q9S
M]I;?/? [7-[S^CK]E-79?3.?5PD$BK+SF.A^H>6*-4#'$YKXW]J,4=(5:.T#
M)-.#2!T!E4H"PILHP[K14]IH\Y6F&TE'9-1AMJ6LH5?7$".MY?AUYA$?SS=L
MN)&WYD,VX%@<<3,;HN<Q/=$&1&['66W(G@S3:,M:S9Q=-SEC[A_JCVUA]_S^
M%M?\:Y&6J]]<Y8S_^/H=/\G?=&2!T\@+A+D(_82DLNBR!Y/(<R!Q4\Z1SV+$
M0ZU,VZ=(,S43\^OUQUO-C-LG#8::73D:Q ,OQYT>8"4N6&D"I,#@9XG_+QN_
M;_0!4J'V ?N7$5:PM94%_"19QDT4;@.V5[G$K31J&NCP=AWC?YM5?U275570
M3+3/OF7UP]8:4#6A_4*B6H;V"V$655UJ9)"TV=^$ON_.(9]L9?THI6YR<]XI
M![X+[78,LVJ9ZZ/J5!3_;G4TCYVP-9RZ415G&-9QXRVL#J_-< S+R!\/U+#5
MX<@A')9Q>AW<8;N#$S,7KJ^UJDLB?73HL=KR*DU,B'?WWJQ6X/>EJ$,DV^M!
MQ':VO7U=G2?=7H_2!_/M];UC.+&+DF?W^;M%6?*<OMR5.*]$JW)_*3:KS3^[
MO*(WQ3P3#ZS"F5.$:4PH@V$2$HB2A+1^8G[DIZD7!SQRM!*'&$LRM7U?IPA8
M:@(V5=%,\FD\.HJ<- ;F0Q-6']S-P=VF'J!5!/S>_:D2^Z]/;*?":HOUC.48
MEQ)/A>L57Y[<X*D.;E=5M>#E99IF\ZSIJ2U'/T/(]=T(NS#QD0=1C (8IWX*
M4YQX:1J2!/F&V98.]#@U<EP+? %:D<&&S.#W5FK-2G7'<5>C0ZMH#DQ[IP)Y
M@D_<$7"LN\4=ZN],GG%'U#_L''?L19/")FT:IR;N_754H3S0FB6A%R$G=2%)
M/"3L-"[LM##@D ;(XVZ:<@>GRI'GQ_N;&N$LT[NUV1Q($U>[CCB7R>UU:GX<
MAUOAQ,XNB /SS!*_1MH#<<FWUE'4J7)B%<VQ*I*<BJIFT1!EC/H+?!QO9L1B
M',HZ;1?.4'_-\$:U%H;D+7\24^5!MO]^46;YO2QG5;#6X59LFI.((PQ=XC*(
M<$1A["<,^CQU$4&>RSPRR_F]/.2ZT[@\/=:QTG>0M-_!J^X'_!:*QT>9LUMF
M0)8N=RL%-"]/C^*N>$%J!<:1+D&EK&!#6-!*"UIQ+VP[0"MC8^L2\VA_XUY4
MJJK_ZC)2^<43..>AF(LWJC;OT>IPFC*?(U<8?5[B^! %/(5Q(G:<-,!.Y I#
MD%"M0(G#74W-\OORX0Y<?OWZX>ZK 9'L!U.#04Z&:&#J: 6[ )=U6X.WR819
M%^!&L'!>#W+>?QP7F[2QOZ/Q^:)7X;U$T?^&&4.\*QHSIW5?EQ=I;WE.'QYQ
M^4=W0A)3DH:^2R"/L=@F!FD(,8K$-I%0BKPP2*(PUN&)8QU.C2VVY 528+"2
MV/!8ZBCF:G1B$\FA-XLG@:A-**K(6**5H]V-2BZJRN]2C/)[9D1SR^D<5U66
M9K3I069CO"QHUA[&UZW-\T7ZN-[A'YN+SUW1+CTSSW'3"(4<(C^-(1+V"TQ<
M0F#@1GY,0@^YCF^P/3I9L(ENGX2T8M.TK9MT0&_V4]U2\M_7V4L!IE2,)Q:3
MH'6O^=OEY8T>KYT^Q&K$-\Z(C<.,N[JT 667U^^N+KJ;RWJU:?O21A (I0Z9
M9_8HU!K&ECCV='E&)6%K\.VRM+V&35U8/^3"[+K*ZV*];[V\+SEO/*UD5$)3
M37;?+S5]5T_M:$)?>>?5R*5&@FNE2^-*;(!7<K<108U:^Q\P]U0]>=1T753'
M'+UQ?5-/'T6;#JFV<#[NB7IR3R.[H-I"YK7OJ;66#4_UNA(QU^D'W%3TK@3M
M-X4"W^(JHY<Y>Y_-%]+,W"XT0I(D]6-90-L//)D1)8$)=U+HL9!$3A"E/,1:
M1WYF<DQMA[]9<:<1O'$.ZT0'2]6D%08:Y31/#0T'2_%(<?@A&/JJ8@/]UUA?
M[!D1C>H\^D>1I^%IZYS24(IQ#S%/@^K5">>)S1D7*A-=7>6?9'SM39D]B]WY
MKU_?%F59?!?4([C^4_:8U4T]UJ823G5)LKG8,=\5E_0A$T3_]^S^X6_BZ?I!
MWA%7[0W.728FO-!$0%D\9O3##_%J)6P3=0OX7+)-B!E6$,C3B;D$ 3RU*(!?
M__+U+X LD6BLLKG$H@D ZM#XEW^./3?ZUPK@%A6Y2\8M+N!!  /N&V0:5Y\*
ML/9^M);@2"KB'3PR*7"+CY'M?;8IIEU4;-I3;=3B9-.9<E:+H)UOA!6*J9U!
MN+&+LIT/_SW%W<XHC''NMZ;T7.,6L30-9@QYB4M< G$2^!")?\+8IPSR("0,
M8<]#:J5#>WN9VH9EY<  ?KO\].L'<//A%GS]^^7M!_"SH*U%Q62AI/:<7[->
MP'Z0*4D()0&"D<<CB.)8[!OC*(7<3WR'NQYE/IH]-2>/7VM<UB-!O=OC@( O
M,[^U238O .'W62Z-5,G;K1P#8>]Q/W2=((6^DTHWG1##Q",>=+PX=C!R:,*7
MV'_(V:C(+_L;$7>>,V/03=+.'8;)7OJY/7V,G8;NL)I[TM'U/'QB#'5;6O0S
MQU63H2._E:DZY,(B=X#5KWE!9*4.N?V[RI\6]:TTF.@R9F)]<B)H/PEBAT,?
M\P0BQ&)(DLB!)/1D[J$ 8;W*]9;EF]IJ\G7Q^(C+EYUZTQOAWN(7&['T8*D_
M^+62W^(G80W,@0\:E77#6"V/O-J9V1G'<^ =\WK0+I:EK%>C)?UNEOHUAVK5
M!=A4L1U L*WDH&=M XV#[<P EJ0[3S(!N] >S#]@N1NS=>1#FG):B_W'#]KP
MF-R97.?O</4@_R>])H45(2GL5G!9F=&:,_F+RYQM_V#CR:N<SA?2Y'B?54]%
MA>=BS[-X:LXB*Z&"V$4MA+JK[+^S.$[#@$0NC%DH+644R[L61VQ'XI@C1#R$
ME*JY3D>EJ:U6+2)R34J[^'[>8=.<J@#:+6&"NZA0O+DX:/["UQ#H+5+G'P/%
M=>W\@DYH*5S/DR4<;7(_,2^DCA?-?\&&JA=@C4+WB)P[.S_<?F,%#UCB QJ
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M8XVOJ>>ES1%0]-"TTN4Y/#EM8G7 X]-J%P:K==>_ZQ WOA%S>IFPE6+7132
M..011*F/(>%B_0V1'W.QLQ$-4>55=W\?4UL].RF!$!.ZL2QI>SAZ4!E'A47O
M='2&/O1_#8S)T>$!A#26D=.1&FDYT)E*>CS>#T$O'Q]X=3Q>[9=]BQ^//&K
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M1UM)B8UD&#<[\2DPO4I3?%)C9@RYLCO?%8^/1=Z(,/-CUXLBFL#(B1.(?!Y
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MW+9$ ID/P$3>D,F$^7'/&IPO.K4)>REBKA-!%R-N Y",P01A'Z8)BOR(QG[
MU$NNJ<TYO9.BI;HKO=92#M:D@Y9V+=&E!+W2&6$;T,%/A@Y+<97A")(F9H B
MI%IG@&UH1Y/\IR&V)N1U,#HAVI6&&E.@Z_"V)\:U7C5S77\A3XPN%^PV^]*4
MY.O[U^L%KNN-:Q0%211D60JCV!6U,CT*D\AE,/13Y/E9Z.) Z^[4B?FF)K17
MY(K<$DDP2%^!)%G/)7T*9C4/M$7P!A;0QW$;M.6M(D"6?,JG9AO5A:S(^K['
M6/6U<^]FKIK%R50>GWH.8TDL2N\CB"A!$,>>!Q.?4B<@3H ]I1M4_=-,39:L
M.QOJ7_0^@J.:U#@?G<&UN762M1I&9URJ/ 2!]9N4.Y-<Z/KD(4:/WYD\^+1A
MVPU</XG_??SW,G_!"Q%[NF>BV 1I&!6_X/K,[@^VGIPC$1.B;@2IQV)QPRW@
MAF(<0>(&* S=@":9-W]F55[2+PVN&C4!<19-.E_*/F7#?32"2*F;$_$7MB'W
M"J3L,2]$%2:9$2LITNSR<=82XM3W71I3Z#(G@8C%&4P\[$ W14[BN3%"@=,M
MX<>"3G(!5W1=9/D8_^E%%D[M.!EM*08^=01E5[*5,/BX#?^&=M ^TG:=W_GA
M]AL6&\380-96)YFS:!FWY8P-V-[TIK$RJ-D)^@GGU;_P8LG>O\[JFC52)9_]
MR.NY$[@^C1"&)(X<B%R&8(Q1 @E#<<A/3)S$6GULCLXT-=U94K<R( 6!FOUK
MCD.J)O2L #6P0-/ 2%LTG>3?DM@Y/L^H(N4DN_OBXO0+5B+SU_@Y;_!")*_6
MAX*3;A;X@>-P<SH*B5"]*,2>GT(4>8%+2.8GJ9)A;3;]U(1&1RYX%/0.$)P_
MM1I&T7F+&%\F/+]"77(P0'S^%.IG!>@MHG_9"/TYJW!NB%X11,T8_:E1+QFD
M5^3X1)1>=12C\LDO.>6&9;T]1Q?-C%V"'9IX,*7(A\A#!":I2R -_2@C% =N
MJ-2/XM1$4SL>UJ1>[7XM6J5]C\.J(/TM@36PG#^&DTF O0\PK0+(5H ;K>JQ
MYD;3K7!\$HP398V/OS]F+>.37.P5,#[]O&F+LW_B%_8AS[*<+!?-ZQ>Q$?+B
M\4C#(,WN9@9C3T@6=)VRGC@3@*ZY '7'QG:]G)VN6>;]S$S60K>5V<!K,FX7
M,_VUL=F\[ PH3_<M,QE\Y)9E9_#_MEO9.8,9I@/A=2K 7943=L>J+T^XXE:5
M&U/LLA#B-$P@$H644^*FD"1^YH0$)X'G:>4!'9EH:DKB;9:Q2GP]SX)*$90!
MM: 3O,L+L*SIYB>*U05.(JWFD+2!W\!GA2!QG?]S!229HIP)D(1:3/HY 86M
M;)]CTXR;YG."V3?Y/:>>/S^Q1Z26K_('YH'K82?-*$Q(F$+$B ]Q0"F,W33#
M49)X*0Y,4WNV)YJ:G%@GKNBT?#N)IIHLL('1X+["K10?0>/5.M5GF"R?0S@,
MD.>S,\W%,GT.,=N7ZW/P><-LG_+;M[*0\D7*E?JFKI>,SE-"(H]@'_JQ&T-$
M,P:Q$X4B$X2X,48!4KOP<6*>J8F!EDQ0MT>>U MJD$M2I<;0_D1353B&L9IT
ML(#<P,*A ZW3$UHBN7R09%K,KNC'P5;>Q)%9QLV(Z&?U3:[#B<<-W"A?ENF,
M?LN+7%;-%34S'RLF"U%T)CJ)?!1&;@!=ED401=B%J9\D7%E CIN0""6INM/Y
MU&Q3DQ*<7KA+,%A3K.$?.0FR@D_*)G1#VQ,]J)FXET["I^%&L@GC2.ZB\^#4
M<PVIPM/K CHYR'BN'E5^=EPZRB^9Q/=8VFQZK7_*?S"ZU00NRCP<1H$#71)R
M98PP'\911&"6!HR1.$@XUNH1OKZIIB9I!;%@0^T5D/3J%JKM1U<ET&<+LZ%#
M?<?A,HKV]>*F$^^SA=]8$3^#;:<9]%-!I#_LUSO"B($_%4YV0W]*;QA(T;NJ
M?,EKT:KZIIA=5XSFS2=,\D7>O/Z&7V5Q^-MEM;&D12_#BHFMI"X*SIUC0M)B
MPPK@IBT&1'(#LHX=&8V2[2P GW([_$37/!G%!<]>)@W),^9RC22<;"R;)2EF
M"]U>07?V)./)0EMX[(A+:X/JM[#KI/3KQQ_DB6]!]IEOR[F7.0%F?@!C&G@0
MA3&&V(M"2)D;NHQ$)&;*_1,/33 U'71%(U@1"025=AK9]?%OU,KNX("C-;/K
M8V>[G5WO<V:.[%_+XO&!5=^$<C'':1+CR,?0<R,7(C?T8,)H!"."0B^A$4N9
MUCV;[<&GMCVEKOI.5'HI,[#D3Y95(^N24_$+X;O&HG,P$4WBQ2/_Z0572>#+
M:W'_Z0=77IP W( /C$AI\9?_<$/G[[Y[!<2^:JO''/J5=P4X%\^,B"37Q:NF
M2WQGM0+71<A-8NCZR($H(03&@<.7S$593(D?88KG+ZQ*RZ'7:WN2 ?WEN*I>
M14Z"O'%R!G!J 013, ;6/@594- EZ^G;BQ,<8M=2<&!GZ%$C H>8V@\#''S&
M3)BNJNS/"OI[4>V5W-_2-)CLUL4% '_P4UFQ_+&X7E:B5?FK+'V*B5!#;I^9
M<)@5C[.,"\0'_&.6"A<::>:,QBEV? )]+.0TPS%,J>_#.$R3)(FBB!*MZD0C
MT3VU(V#=BD)(Z^6:<7EQ"KQ;B,X4_UM/S(RU =0DV 27=6#AN-531&1:K$VX
M]CA>L7D%UKRTU]P[IL&*:[#%-G]"\ LXP^#/%<L6KYB.O$B61/I85(]Z6HR\
M%/L'T=C3FW3 YALA_%PVZY1SEF89(UD*?==E7 ?U0QBCR(<LRD(4!V$61^HW
M;_='G]IY(<@#DCZ=ELK[D"DX2\\!8F )N\' J+_T/A@ZS9S/ &4D%Z,..)H]
MB8\PW]\ >/^E$;OM'J%WM[7ML8?.3<YM^].^?A AYSQ=-N(:Z4=<B=I0M1"F
M,\*WPW*!&RYLGY\K1G*Y,3ZPS=_G$4EPFD4A) BE$+F>(^X 8(@3)XXCUPUP
MJ!0\'H2ZJ4G&SZP!G9-/W _8J-)XBX&_O:-;+/PBVH=OO.R:A47MKK6:.GVQ
M%1Q8I&_IR1UC5V"'-;#B;:U:;S$(MCD4M_&WEGB('&>+V%M/C+9!VX6RJ2W"
M>CP%V^8D9U_TNBZ+.J>LS4D2G?BX1DUOBRT5>D[]P,6)FT(O\#%$H>M#3!G7
M<S-& S=FA&38\/;7Z=FG)N/OJI(P1FL@MA$HNPMBQK>_5. /0^P3%$#7#4,.
MOY]QXX(BR!<C\K(L3&(_U7-P#[8 XWC _U'QCP2L%F)(Z-5.Q,'@'/C$V[NB
MMT,[6!$O]),M\@>YN*>.FOW;? IS7^J*GSHL/??^- 8Q.TO6I1BZ0C6_Y@6[
M:=BW>N[R__.=.(3,)02B&&&81BR!0>HDCN^[ON=JG1M'9YK:&;$F=%5L"?PI
M: 626,W:A<?A51-.5D ;6! 9XJ4M<DYB84F\')]G5%%RDMU]L7'ZA7-=$ON]
MEU/&0N8Y+O0\X@K':033U$]@ZF<!2DD2Q,@U<R],O.?UAM#Z;ZU4%H#7?^N0
MK\$GH5YN/06^E OZMSL^_Y-HY&7J)S!K?FT%UM'L]W%:6I_$Q+I=?=$FU2?9
M/6[OVFP[S<A342[*QYS@Q4U1E"]2KZEG!;TIZ)(;U,*LKI;/\J>_X=?/[!&W
M.48WW.@FS>\:\0=KDTWH*]GA">0;IF0$.._8$LF^*[YD1G"QY@SDDC6P-*OJ
M9&\!=7HQ7V(AQVK6;'%!;35UM@UW?]=G:[.-V!;:-D*[?:.MCVX@J87N>)OM
M)IQ?E]]2_F-ZSU[*Q4M>/(IDL]FW<EDTORT73?Z\R/F'G?B$A3C$T"%)"E$J
M_%T.YE8D]L+(12%)B?I]16,RIJ8PKH@&U8KJ-D472[K!MS7A&L+8?(T43L]1
MD!_XM)16Z&T&6B[ B@WA*^M68\V)S$,%+2]7X+=QET/C+!QE648Z^X9<'KTC
M[VQ4>X\X\]''.]+.1F#G"#M_M/.<F?*H[)JBK:WS>8@"ZL5N!KW Y2=3$$4P
M1BZ!&+LH3F./A&YJXM \.-O4#J!UC;-J36(; RO* O(=TG!*%HS^3?P39QE?
M,AD7-\YMZ%\*/>?GV0"/Y "5.ONF"^*:5/LNT%Y$++M!#\]U$5=H+]O'W*']
M+QF5F>8RC=WG]==Z5M<ED5_*'WGS]/#$/K#G1?DJZ[MFM\NJJV^M4V;:;.P)
M?0U_,'$=F8%*, 'PF@OPG;,!FB?&-=\5(R)^*2XJDZZTNE&A:</5T"HT/?RJ
MC%=HVG1UK)6:/@_,$Z6F#0<?L]3T>?SOE9H^<S #^?>YE)7FGLH%?T&D.)4O
M>'%3WXM&F%SE^U16UZQJ<%[\QJI'KMJH2S^SD2<D^SZ7;97(E@.9."I8 'G-
M]:Z6"9"5_(MJV0#?6CZ,?+&&RZ A]H9?CI&$GNFR6))XY^'8*^\,AQY/VIW'
M^XZL.W,H/4E75\W\-_PC_[;\UGTX;D!IZE /THC$$*5)"N/$1Y"EF1/$:9#Z
M*5,Q']^,/#53\9_YXY.:''H+4K^0/XOU@45W1Y?%.R]'N>TST/A+6\89_]?&
M,'L[WBB?\5$V5A_G\0=,>_B\9VTD@]'WK_]@!:OPXN.R*I\9+CYR:LMO.;DN
M"YJW$1"]'CX&8T]HEW9]8E+6Q?WXP96^@L>6#[!B!+".$T#6K)AW\3%9#=TN
M/@.ORKA=?$Q6QV8?GS/ /-W'QV3PD?OXG,'_VSX^YPQF<CGY5TR^WF:_YERI
MX8.^WA2=4B-MN*V,,D[:C+X(=6#Q.A/WET4AL/?+.B]8K7-+U^)\$Y*3,[#@
M? D'QF+%F;C4MU+P.\?&EG=;?KAXQ2# DD/Y4-KQ:"1 K2ZGSCWC"RWK2()V
MB.6U=<EY .3[+TC;G'#$R]4#X+1[,7N("0PDNKC"T51+>5GC8_'(1Y5WSK[P
M><JJ^[+3*$,(Q1&,HQ1#Y&('QBF-(?5I0+$3.2BERDDS"A-.S>3<)AG\!7][
M_CO8HEQ#WJJ K7 J6H9PX,.N'SW04FUR>JF@J7$H649UI+-&"5U+AX<&0KUG
M@LHXXXEZ#:YV)+C.>X9]%VZZ$IG7HD+FKUMI*[.J$I4@Y %Q4Q!1FHA^6(KI
M/W..<?UT6]WAJLGQHOOW]L53<3>.!2&%2>B%$'D1ACA#,41^D%+B4,?)@KG,
MX67T0:-UPR#4*GUR2?O)O:%Y2)]] 06E@+*,5=)#GQ><>?'-M?5,!?DO_&#7
M;&HPS)(K'"J77<$1FU"LF 22RROPZVZBWS:KHL!=RRQHN04=>^"V AW#ZQ^I
M7&0><\TUFV!<?.W';*!QR3V@WXUCT*4YV<ECF-G'[0(R*()O.H@,.YM^K?P/
MW9?UP%^=^VGJ!TGBP=AG$40D3B$.D@Q&(0FPEV#'04H%R/<'GIK1MJ(-".+L
ME,0_Q*Y1*?R=@48K@7^(_.W2]P=_;Q0DFU5LQG?PAUSX+?(L9_1-@:)901^>
M& >OK)A\X7/9R(81;8+0?5O _:'D#]U5I6A&+PIN"M_(K*Y94S\\X:;U?\N1
MQ0R;QCVWV>P+_Z@63+:;U+"L)TKZA%2H/Q@0/>JQS,RF&Y2VN[F0%B>9<-RL
MD +?VS>+LFE[P*RR^KI:_: I98+?\QJRE:,42]3X+W&S#F!UR FW:KW&3KR
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M3T?0O9UB:H)LM\7.GRV1FC&  T"J2:CSX!E< FTA<P4>^ 2G\=$6,,<AL"1
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M5_E9$#FD&_ULM!OH8C,Y8U<*Y:9H&)^^N2E^EZR\9Q_RA:BV<9/]P61+QTV
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MK/&U]F*K(,=L(3:P3&O!$MK-'E0F$JX7,PUI9PN[D23?40PMR4$5.'IE8N\
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M!.*%:/>R#C-1Q"(2,A_2*$L@\H0_G(8,1F&*7!I[)&/JQ2B4IYW:$;%-IVQ
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M5F<NA9JD&@3@@:75[/;Z!LR:+3];4X([7 EH[5](TT;(DJ!2GW=48:4-Q[[
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M8'1)FEQ<&,4_/OYX9D7-;H40YX1<EW5S4J5#@9,&GI_"Q'424=<M@''B1C!
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M(D@CQ"!R70H3ER;02YTHBUR?XDBK>O/^!%,3!"U]H)9I4E?@/YV_.HXK:I2
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M.'77@JV@TSDI$CN0K\$#>(4>4'<)%Y5\1P%XH2]3S!6&^O"I7M[=F,G' =X
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MBKF/(/,#)M<7@6'F\1B&%$<AR0(>QE8[ZU7+DUL-N,ZKE))96O@55(96V 6
MH2TE5U19G;K;F[I=/?LR1ZMVQS49N^J\^:S?/. 8N::/G"UF_$;HO?4[5<VV
M;O=8!"$/">Q#A$0J_^,)F D40(R\S!>!'Q'?KM3LX;ZF]GDN1=6E3G6A3O(*
MM+AN^]HNF U#8?V -W3Z@#MN]G&QXXCT%2#KZ&G<2-EQE=^$S Q>.35V)G>U
MTFVX9"^ZZ/9=>2F$YJ?C]>5\Y7\TU5*ET:JDT\'?\^;/>^;' </"ATE&,$1!
MJMB,$Q]&5-#41RB1B[Y;8.T$J:9FCM8!H&_2-<.S_+\Y [_BO*C!+RJAW;KD
M<C]C9QN$&VE$1HO0Z9"GVMDM55+A_[52%]NE%R_:RLY@J1OX9:G=X=$[(8K7
M ]J]A_A.D>E,\;\>8#P<'.RC\9ZJJ+Y[O9,MZ:Q;[D6,>\*#/B(4(AHF,(OC
M!*(L8*E/$S\R2_DVZ&MREO9-D4J@1'4BF>^"V,QT]@3<P ;1$;/3"WN^16.H
MNIX;/9VWK.=;E8]6]=SSBD,.Z-=2S'_@BF_5!?<"CGP4A3#, FDHXB2%V ^X
MW":&V$\QYR+"QG=#]O4P-?.PE-$B1W,O<-V??R]P#+W3:\4[H>3\7F0L\E)/
M16BDC-,=I'I*'^U2OC,Q=.^+XZ5\=LF]E<S9^:"# 5NY4QNG,]_S^>,;@O5Z
MFV%]FXY=1]$OJ73!U.]NQ/N\IHK^^/*IK.;Y?^/FI[>R^7SQ=,\1)B+E$8P%
M$Q"A5#E2<IL;25-)Y<_2#!MM;L^EP-3,[TIN%5]BK>3_CC=$5[]X;H2WL$3G
MF!L&2\#$1WRT ]6+K1/5'Q*!/74WZIW"&Q=OBW5H).0?JUET(\ 2C7_?A$/]
MXO:GF$46R^7$9]-(J_'$9Y6=$W#&(>WT,<XAUW@NS!E1W_*0SBF'XVGC0@KV
MKX644_&RS&O;N[0'7I_0HK46$30R#G-C]@@0?9U['>IFW$.O(\J^.?$Z]KQ3
M69)EQ/8._Z4_F^U/ZG-9O.=L0>>Y2HO!?WWX2S$0\2O\G,_Q3)_4;/+\[\9R
MKPOY3O.YZMP.$84DB%@&1:2RS2D-8)8D"$9)&M$T"0@7_/Z%5Z0T+'4RIO0V
M7^.F#L-]E%(_R%8* MKH!1[T =J:_TQPTWS+<\P)@_W"=,=YM".Y"R!E;#RS
M-YZ;F@9K_?6#+0(7H,6@/53=*GERL>_ 3OX,M&@<RV4Z^\RQJE,SU1DT6N6;
M"<\DV^(ZYQC+(^5Z1A5IS ) Y\!ZIZ30641PB\3.Y';EKOQ==CJ7_[]95(K"
M9"'W(I?OWE]]+Q<S]D7)RN5O5L5$/L[X7[G.7'XU/T7IJZ\)+7:M2BK7Y*E5
M2A.NUEHMQ6&!@=0,_%"J@4KKIA]85S$2:_6<>$=Z&T&[\-7H(SE>3*K/$>TO
MN-0KX,<B1OUT-FH8J%=\=F,[_3;NQ!U_67&Y3,@-&KLK52J!"A:55.4G,15H
M6MUIW"2EK&U(X$_H8$(6^3L'ZGR7-YJHSUC1":D/=ZE,$UZFZXO2^2;';>U(
MPW[*\%CQJ8\T3.,1HY\X7+TQFO< [!%J\E-Z&)-CO <D=LC"^VC1P6JV?O77
MQ;-BP/_"\R>RJ&H=G/_"9YJP%U?SUWL4$$H8PC#E'$.D:D$1'C*8>5F89BCU
M26)TN\:FTZF=YZL=RN)Y23?)&R5 W6@!?OE<SCD(#5/;K< W6)P&@'3@9:B5
M&+0B@RV9U<'EK*']5F(/@*G%BC( MB.M';U@;+=*6(+5N1Z8MC6>Y;?4;LO&
MV[Y[TL'/S8^"LXVL_-:/HCP((Q$C&&:(JPSY%&(B8I@P[ >9Q\/$BRUJTG?W
M-C7[O4%6HP569%@;-UZ<0N('<+8Z_C@=O=$.+/8"Y[(=.(J@TS' Z4B.'KBW
MFXJN,?5N8 RCX <:.4?<NEN? Y'F(R^Y)8G<XM<FSKSLY5;.D4=UWS",,HJ0
M])%]$1&(A._#-$)$T1)AY'/I-=OQ$!WL:6IVMA44B%+5ZUI?/WQNY65V%Y,.
M(VR6A],+;@-;V%9&=>2V/M%;RME?)LY1*'I*Q3G<SZBY.$?5W4W&.?Z"@U/V
M'XK N2Q^DX)_7&AJUX^8ZJ#G^W(VP]7R/N721?-X$@3(@R'UJ#0;A$ <^Q0F
M ?6BR$LS&IN[:'9]3\V0M-(#)3YHY0=+!2Y H\+J.K.%]V$Y) ;>W'! #VQY
M[#!V<?4LP;9P_(8#?20WL*<);N<5NJ'6Z2-:-CF>Q^BFZY;_Z-A$+PR9>QC/
M=*[$FYSI[>2)AJDG87$4$J2H?Q-/+B080Q+'/J1^RC/&<9#YW@D\F*?(-K6%
M9O.:14M8NU0/J$OBNY<HWMZ\V$FZ<N-=ZG/TS7SC,XWI\#DG(P_GJ627?0 _
M#*7E29*=D[BR#TB/T%/VTL6)"\7&;9K;<I;3U^:_:_Y;+TX3A#UI]U.JZI($
M'L29'\ @"Q&+ L3\B#DM \=ZGJZ1W[Q*Y\I9?!1W2P/<)YJCF==-("] (S'X
MH_US6))@4[SZMHI'^SV/S3.%XZ!%,V[ *37K-_S"/Y;5$V=7GVX4K>_O^%7]
M^Y(Q7?</S]3/=7'SCXNYE./[8TX?Y4-?%^2_.)U_J^_**UZIU+*O\VI!U2.L
MK1Y8/.A\"9M$KM'$F=!7^YV#1_RBH[)2;Z 4U&QPJKB<^AG *^6;7^9-03FA
M ;@ /Q0$^NFZ 0$L-(,<;7  ]0H(()9(-*E*COEBX\T9J^RR2<Z=\7+1SC6'
M>DMB&WW\CJ2\C2?/F ERHZ.\DTXW?O^N*<MMAW?E%_ZPF*FY^WKS(MWA_.%Q
MKH6Z4LG3G_D#5G==9J_73_+CG*_3J,NBOL+UX\=9^>.F6A74O2J+1E'Y>%GS
M#;7+>E[?%-_JF^I&?IK5CUS]5G4HV[X4@NNVWRWJO."U;7;T3Z#+M%9DE=F[
M-(4JLW<%&RB7N"VM)M77*8H5=B#7X&W>K)#P70 J 01"(BCGX=**2G-,ER!>
MJ!<EC)NVFBH@56A$FF/Y5KD$4S[3H@FPAE/W1EI G=/ ?X)I8IUQ_A/H-$V'
MXJ?^!/I,K?^)9M#Q+/Z?09F1+PS\#) <O)OP,PGO%E']'1?X0<<_I+?XE5<O
M.54WB^MWN.;JLL5]ZD4DB'D$&<E2B$2*8"J(!UF6D22@81"&5@5&CG4XM?BI
MDDONW99"*P(2N]CI483-0J9]XC:PA[<656^36V$5N8)<I32>2N#^HJ.FT/04
M%#W:W:BQ4%/E=T.@QN^=>%+3D)M]XM(\!JV3R3$A*(DYQ-3S(>*8PS2D"20(
MQZE(>$HP<CJ;>=O7U*R)E@T$CJ<O>["T/&\Y#:$1#[ ;02] "]CQ39?[F<IA
M3/H^1=G3TWG.30ZK?/"DI..54TL3K0IJL.NZ7O ER[@J)AC[)(%IC'Q59Y!*
MSX,+R$06\2P).4L=JP[M[W!JMF(S*7HM,6A$=BTE= !K,S/2)X(#VY).\ :P
M)J;0]%ZMYT!W9RK$TZW\X1H[1]YSB#+?8KD%^UBJ2^.W5:DXE98Q+KF;R:+,
MPS#$.%&5<^2.)L8$1C&-T\03H1_[QJGF![N9FC71@H*_X:?G?X!&7K 4V"*0
M>1A5@V!Y+U@-;#<Z8'()_![&RR+2V@MN(X4V7::97=3P*!J=8;K#;X\7%SNJ
MP58@ZOC3=M:1\?S^0S'/YZ\?GGCUD!</OU;EC_GC5?GTC(O7>^P)#_L)A1A3
M 1')&"0LC%6=,1Q+MRLCS*A>T)%^IF8?&U'!4E;0" M::4^?NX9P[/$/:D[_
M[:%\^7?90N,:R+^L/8)C[8XRK0V56\YKT\?=-A;O.9DK+T+=3] 1U4]YP6_$
M5<59/K^L*D4IHW,@/_/Y?9HD81(Q#V:QR" *P@@2' KH![YT!1 266@5B[#I
M?&J?P'LN>+6=A:+/A^SV&E;PF^T[A@)U8%]"B0V6<@,M^ 50HBLBG49XL"G]
M!9#R][<E<4&MI^V)5=>C;E5<0-G=MCBUX;"%N:3_6N05_R>N\G)1KXZ/K@N5
M,*8[D&[![:)2ATCUC?B-,V5*;RI-.:C^MJATRLXRR>>=EG;V>EFPZX+KXZ3\
MA<M_76T1%:H3J\L7G,]4PK[LX7TN^\O)0B?QEXKC\!%7_+&<234LO/^?1YL)
MF9 6-/#2H+9QK)^O<=.4 \\M<LJV_.U_I4'@_>.Q@5#_R_^'.M^O6BSU:;[.
M,-S,3B1<VWMUYE\PV<$*5/UONDMLJO,-\!):+03; %>E-6B"U U\G7)B?YZ)
M8[.I^WFTFN N\W_:9]'3UOCGFU.=>_6?2)WQ@@<_$2C[HAD_H?BNN]!F,]6H
MV/B):L?#61 0BF.("*80^9$'">(93(G(DB1(4S\,[#:<>_N9VMY2BJ1,\*)H
M"X'*7293VZ-\N3URVFGNA]AT4WDR<.?8/_:\1>S$H+?=X/Y>1M[X=:KZ=H_7
M_;C+B90T,4]RI*71H7A6;U74%CX721(S2+)86H6,"IAY*(1!*'R/A@@E@7F1
M]HZ.IF86=D0]5G[;#E23(ZE^H!KZ4&HO2D[G41UPV9Q(]0/;6&=2=I/,\CCJ
M.!3=!U(=[X]X)'5<B^U#*8/G74QD50I>USH9NLU)W+63?D;")(4H#1E$-*4P
M2YG\6\!2'"9!G*34W$X>Z6URQG)#WF56K=7A_3%T30QFCY@-;37WP76*[3P&
MGXT![1'&L:QH!YQ]V5)#5+H-ZK%&1K2JAOILFU;3EUQ.%+;J11N?8]R+-!-R
MJYI $9$,HC ((!$>@8DO0AZC0(2>>1T,1R&F9HVWJL;+K2T[Z?3TI.$Q.7T9
M'O2ACT(V\;X1X/#IZLW>T]41QL$F_#_\>(P5BQ]J7"QCWZ<!VAV(=FQ[Q*CP
M:=IOAVA/;,MA7;JKL*(8;?)_<EZOPK-EM>UB(1]QSD,$0X((1)KGDX8"B@RE
MW*<)]V63I@N1::]36WE:N<%*\#;?<E-^"VMG#+[!,C,$I .O*R9HGK!K,$;7
M8O$8 N615@L+M'M:&&S!ZEP)C!L;S_3;ZK=EZZU?=N'[>>3%=_Y-FD7^PBO\
MP.\>^6TYEW,MQ[./9?6IK.N;0JXZ"[F*-%=".+LNOM7?\]GL'?\=/Q2YR#EK
MZ(R6-:]E(^H@\$8T;T@EU"L6S#VC2S4AFZ>4!S\X6-0<S%K]+S1GV?,2 IVX
M,),@*'80W,#0UC7A*@M",8;\D%"H](BG)1@K6K2\Q4.WJ3(JU XI7V+2O.Y&
MD#?^9++AQ)GTI!J+W682DZLOCIJSC6@WV\SX8HW(&W,VS+<98,XGAE,11%H^
M<<7>(&6@2L@7S>?P5?Y=)=M<_I77]PF.D0@XABP,U*%)',,,^1F,_41MG;P4
M9>;')R8]3FWKU,BL24@86$G=4I,L!0=_*-'MZOH9@&_@E/0-Z<!NQ#G1M*J4
MV"^JHU5+-$"WMYJ)YA =J9MHT-"8M1/-]=JIGVCQXJD$&-=,=2#7BDI/;2_.
MTM3#'DSB-(+2/@>0A!Z#F 0"9R%)$V%%N76HH^D9YS5GPUI2*_MQ%-MN(]PG
M8H/;7A>P3N"UV(]$[WP6.]V<B<=BO[*'^2L./&]_,_M]N[9\S&N*9[=<FAKV
M4?Y,+G@Q17X8>9 E 8:(TQ@2X7LP( &BA$>$)49T.)V]3,TD+ 4%C:2@$15H
M6?NYDWT4"J<;V8=;'>T^]E'%-F]C'W_8;8W;/"Q:%I#[PI]P7JBJ0655E3]4
M^!'+X9>_N4<H3#,_1E $'H<H% 02)KC<GV1I%F9>$B&KXFUVW4]M\C=;2["Z
MMV"W!%I";[8P#@?HP,OEI^UKU^MJDROIP4I\L)2_OV74#;>>%E?+SD==<MV
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M:;G".(H]*'QUS30-!,PB56929(013D1" N/ WK'>IN:UM?(")3!H)3Z>T>N
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MN8TDA&E*0^CCQ/,SSE#(C"ZJ6/0YM>FM:,$6G &RF(-%\2PE!$Q1'Z@HN0I
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M$12^0'$FIU&0.5*O64@Q-2?X *>$Z]FRS7C8'BD/A/)H)\E@J< %.,CDH=4
M2@^@%1F$CLT!R-Y/C6UD.--AL0-,A\^(71IS.1HNG]Y<"?\=O[[C7Q?DO]3E
M\?*JK)[+"L_Y)_["9TT,[@[_97$R>EH7$_HTE2;[*!J>\"L@7/I*6A_E-M&E
M1G"F5%(G*NK=.?[+R;\^=91L#FW'&ZVQ#GG[&+6^SH?[0;?[//G$/D8\?^X'
MC>WSZI[:=+"EZQZO2NG;%J]?U,R^*R]?>"5]V<]\?JE/3U>G!H2Q,.'2H_0C
M50^",@_BD&8P8XGP0Q\SGU+C/!S;WJ?F6&IQ30^"W? V6*R&1'$\Q[&5_0)H
MZ<%="5KY]3%NHX').4X/F%LL/4-B/]):8SD&/:TJKL!U+B/6C8ZW;KCJN[50
M.#?B&H)H,FG>MQDUUT43X5 "?.3\%K\JG_Z>I1%/ KD&A"SQ5/5+3ZX&$8,8
M97'*.8X]#]O%'$RZG=I:L)81",[!<R.E;8S!"'#3H$+?, Z^&"Q3N-YOIG!M
M "O%!K='@'6(&=C@U%N0P*C3D:,"-D"\#0-8O>WBJ]Y]Y=5+3GF]5>$44=\C
MA(00A7$$D2\BF 6,P2"((U\$@B'.S3W2O7U,S=9<WX&EF#9^T'[\3#S,DU$9
MVG2L 3FAENX!@&S<P9.!&LOI>P-87WY=)P+=WMO^5T?TT3IEW_;$NA\]]<BG
M=>_N%"?-%SY?5,6]E_G,"S(!I4M%(8K4+4*.$<Q(&+.8$Y$0HQJ,)IU-S=YI
MT4"E90-$5ZDM"_#Y\I^N1SA[\+4]J3D-M3/LJQL0&U&'.'$Y#$CO!RM[NCK3
M^<EAI0\?DW2\X\C552WJ.>?2RZKO18 Q]E@"41(%$'E!!$E*!,Q$3'"<!3CR
MC>)S>]J>FE5X5^**J2AY*V/]_ZJ=E^6Q[B9V9B; $9&!O_A6*K5%ZO$Z[AY=
M^Z*@VFAY7$ZIMRJ](8G:\XC;EWDS?^25*LN7M\S5*E^6()]PP1G$GB!RPR*7
M\XSX"'H)(PGVXH CW^83W=?)U+Y5+2/8$-(I!7DOG&9?[:D@#?SY6N-C_2EW
M =#3-[VWBU$_[BXE=[_RSF==KXHVG/9X=HMS=EU<X>=<+O+WB2^==N'[D+$T
MA4@('Z81#R$+":4XPTD06F5E'>AG:A_]6DSP+.54P3S:2&I[=7(_K&9??@]@
M#?SQ;^!TV^)T=00GARN'G2CT=FMP?R\C7_SK5/7MW;WNQQTBE9_X0U[/-*/T
M3?6%/RQF:G1>[_!?#7WTWIH7S0:AK"SN%/31SX2^@PUU)-9RO[]42*6SM,2Y
M!\O2Y$NUG+*5>ADQBT#AV",W4EBQIQ'L*1;9)\B=D<M>.AHOSMDG+EM1T5X;
M=LYFRHN'Z^)F43553^7/RIG\\>5O^</C>_Y0<7XCON3UGQ;''_;-3LBJKJ17
M?H5***R;:K!YJP' X%'J )A60L53*JF&DQ5UP=\ZV6:P<1@UW\9Z/'K-NW'"
MT"#UQJ[=L;-OG+3>DX#CUDX?)+7?"D5)\ZZLJO*'E$*ZJICF\]>65S6-!,D$
MCF 8J",BGR.(Y8X3<I_X% ?(HV'HSEG;V??4MIZ-L."YK-3'? IW;3?D9EO0
M@8 <>.%04H.UV*H^@@9U)3E8BGX!&N&'HKTU0FP0%MSNGL](BFL$23='KED3
M+O?MN6Q2+EKSR_D<TS_K2SJO;\1W7-U4G_%\4>'9^[S&M;(#O^/7'7=0VE67
M(KY]]SFA[W"E&L"-;A>*A4Q?B?Z!*[7/*AH- 5NJJ"^*O-E@*6=C37OF=FN^
M[Z&UN21_QB$>ZT[\0$/=U]WW@4:@^ZI[WYV.>+-](+RV+[(/U8F;P_IU06K^
MKX7\5CZ\R/^L6()$&GI^$">0!9A#Q!,JG5/$H,<1RA).LX@9I6D>Z6=JCNA:
M3*#E=.=?.@2LF0O: UP#+W-.2%D[ED=PZ,F)/-3+J [C$55WG<-CCSO%X\1,
MFY;+@GU=/#_/7J\><5ZHS7']&W[AOV$F?R.MTE59R%WU@M^5ZL>716NE%-V&
MM%%JK_TQ+W!!<SQ;%0Z7;W[1E*[2VKEXC&<3;D+?W H#S?Y?:Q14F#XO=-"I
M!H]28_D?IG^O/ W:@J'N'NM?XF+I?6@Z'N5[-&$ML01%O=.@HEMI>'BU3W.B
M,WJ^Z645M/P)IMEHH<^I3+?>HJEG'MPC,=ES23=F9/?,([ 3'SZW-,XW/1M&
M@=MREM/7-7^1B$.,LC""89I@B! -888]Z;JCP&,((1Z*V/)NY]Z.IN:VM[3A
M4E#;A.*#4)KYZ7T -+C3L,3F C12@C_:/P<B=>J&I+\KF?N[&?L29J>R>ZY=
M=C]O7Y#^?>L,2 OT=?XT_Z#""U=E57%-U?QQAA_N$>99$HL DHCX$"5!*BU"
MC" GB1<G61;XV.B6@5EW4S,.2XG!RD:#K])U:NXH:_G!6@'PAU*AA\_!#BNG
M(O<&S8]6]=Y<U>4G8?E63W?TOO(B+ZNOG"ZJ?/YZ73!.YIP5O*XU%\-5V7 S
M:*:&>\)9DJ8^A3P*!40\9C#UXPP*S!E)4,I29'4[YR1IIO99:0FE]]Y2CFC_
MYL0+?E:#8[I CP3Y*&E!VU<$&U7 4I<+L*G-14,  Y8*-20Q ]XD= %VJ*N&
M5K*<]RZB"VQ'+RLZ->IR=*QJ0@C%R5O/J[RI#?&^?))[J'O$!0\$(Y %P?_?
MW;?U1HXK:;[/KR"PF$$?P.S1A;KM  .X[*H^WJTJ>VQ7%Q;]8%"\V-I.2VY)
MZ6K/KU^24EZ=J229DE*UP#E==EHB(SXR(X(1P0@&42)^2GTJ; [JII$;>3PA
M7+O.P_YYIB85%Y2"=5+!'PVQ1J';_=#JQ-=[ 6SH2/D(6)D$K'O!;*S0LQUV
MA@'D@XATAX+WOSYB4/<@#YOAV<./]V2)?OS[A>45.^>UG*UMPGK-/S'V'6="
M/BO_4?:<SH70DJ\]T)0$;HA2Z'.>B%-<Q"$.70Z)%S-*<!I$#GJHY35U2VO4
ME"(CV;ND:[COA*QZQQH>*I R7I1,_$ZR2A58/=(V-5XN2_MTR$4X@8W:LG,&
ML&1HU81:.OAE?;"&*>7ZWV!K0$/5%N&AC%5C>DYKL-K"=]!HM1[XJ!Y#E0P"
MS)G XCJ7OGLY;?ZXD6CSFYB]NJKE.XL^$HOR:5=U)>L.?'_*R-,7_*;(9O)!
ME95YS643P4^SXL?Y*\YFLJ+:IZ*\S*1J2>=R[/MBD9C^5,PH,[E-.'$6)B27
MUEK7_-O_B#TW^@]Y?:.%3 8DR1*TK4P\\"AQ UFM.MNL-:U9]J^5S6QD&9,S
M\$,"J**@I8*P>46!*(6=:E?+!8X +X $0D/)S, EE'+DY163%LTCNR5-<F_8
M]5J:)"M3/!K\U-N]][Y/D]XVFEVCILG#*7I.31.)G2?)GX1F"^OI.Q.$?,R%
MG7:5U\7Y_>W=N;Q')V7;_1.NA2%7B"/8-]E$F97U(J-",#2;RXXS7W#Y)ZOE
M9Y^SO^89%>S*7X1]IXJ\J(?OLF?!37E?W#^)L<ZKJB"9;$7[/:N?!//?*G;-
M97<%Z<;4MYDF2?B$+*7O3$ET)A$20E_(9PP$2  O4!)2'JM#ML0)S%4'=])
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M.<O9-6\:HBYLU"]9GCW/GR^PV'CBUV^U^+3)#5\U67AP,(TH"ACT7%<F>*
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MM+G6+"7(B[HB:UK@8A-+ST$X\4,'4L>55_2]&&(:)) &'F%>&".2)F:-UH]
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M8K=9]:<8X(F58J2KO!DURQ^O\N;]U<CZ083343>A[[( 8:/26Y:#:DFM6&F
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MA;#>+"= ?8J=$ 60A7X"$9/.648CB!TW]%V6>BC2<L[NGV)J4G!)X1'%&78
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M7JC0_:*B"4='1L6K^7JZ_O9Z.L-?SS]'7$YL+BDCN4>..P?*)@Y.&0?D.+&
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M1@*IWFKO&^GHMC6B>4+5-@UCYP2WD>T#*N=H1G< E+.<-WT<PNQ=F.8W\\N
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M?\*[BSUKL\)']OF<G0N+SRG*DH'GB+7=J8"XZ3U@O)*DF.*MSM??;^="([A
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MP3DQ:78VSW?W=;6G'%E.2A8(Q>M:3$W&5R8S+%N'3EG.5?/7R'WH&G>:RC#
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M_-7%J\EU[,*8&%+M?B83IXN2D0OHLD<RMZ*+7'J=FA>=[D58X\%EDKF$,C!
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M03B$]1W@YBS_G_,+VV#U85%;4L[3=(9WMO1A<2@WH]$I2%D@"I=!E60A6!/
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M.'0S2YZ(:S+9[:>MG5KFL)5';M8\G/H94  =J*7+"OM;;L'MS0@;"E/! ,I
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MY(![:8H32L9L#X30HPON!Z'O+C(]!+O[@= '3)_FB]EB2Z62V<\97;40+.=
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M##'N;Q<]XW8^&QA+S031 :AN6+49K;,\*V4ZFUY(JKJ2,1.#T!?PJ4XL#\:
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M[;=/Q.S5)!GNR2#-@*;6("1&:E?X#"4;E#(IS]APV7#WZ>G0;!\264<(H3]
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M1:[1$XOTCF4R5@6G:PA+!I^E!V-R0*5RS+SU1*)=M)P<<=GZW!O@1J5+0D;
MK259BEP B):L=".%8\(&-*[U&]E.8D;.:&F!@WNQE2:,[U)C/);2/%CEP3-5
M((Q5B8"L]D94!JRJ XZ9#!!KSB;S :6+=)'HUG-;AJM$^"FLIJNW96N!;Q=_
MWCH()2?T/D)-UZ)+NM:[)YW %LUX[3=>=.N\GOTHZ[82X1"4;"ND 83201."
MOZ[P;7FU6D\_UT+ZB>?>,DV&F-6Y#IF7!CQ]"8%'7K1.PKC6SY%W*1BWU]=
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M'.F9E-USBJ]' VN_)NTGY&H?\OG/U')^4(MM5QMQ[X/GP@J0/!O2<C5K1&
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M3OOR_5D8[<V$M4WPOU$Z?T_YXO32>_C^Z/3L_-T1W9PD6^LN!]-6I['5(A5
M'3/(@BJ0*T0/*W6?,+R?768D?.S/T,TBU!T+)_S=YJ3<.8J.ON1B%>32BM9\
M31!;W)7]3<UWS$4TTX)#SZ^SKB/_>DC9B[X#:*K?V<ODLU!IQ[H^@J.2LD\6
MLLNV-2]AH>LK0=+*MN$\3CV<';BW:MJRC75=^X40U(OL R#G[_]U<73^Y]>;
M<$,5(UPTW@#YP/Y"RA*"K180E:(:^9"JMV.U?2?KCH=>&#\=B#]$VZ&WF\MY
M&5>5K;\>G?WSNS^_HY/\Z3.>_O.JQEH4%$D)MOC8]C-!>SX,YC:4@ZJWBF+
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M+U4-Q9.=!)5GEYF6^W=(@>+.I!W 4?KAY.R"[;-\/].5Z>!C*W$L+4?-2&\
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MT93:%""I@53(/FBLF,U+KM6TI4;IM;43'Y_H*=&!J -!Y/>3T^WGL8442NW
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M27/X,!:B'A7!VRB+3\Y"R8Z]RE@E!'8S@3 $E[(KH>[2W.8;'L[4"5-[<6(
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MM"E6OE3LW%8GL**V!M5B:?//[FRHPOQQ_,(%V#H26.^FBC\^W_6%C]57I4V
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MY86/;EY]B'5I%,H#'Z"=0+-Q%K6'5'.-MAB53/<R^D>[& LLN_#V(5SV(_0
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M749#PJ#RP?5VG8=/[9[%U9=3N^>0> "0[)<?K"-&'U($\K'U+"&F757L0.J
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M4)]R'*^=ELIW?ZR1I,5DT1P(@Q>AY4<FT4'MB]1V2 :ZX27'67Z64,DR] B
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MY#V?+I58)92&>S_!XYD5+B.JP(!?2K/"N=*:W'?1R7](]N(D"(S.7IPBCQB
M]7H^3*ISE2:P+8TH)-S]"2>\!/7"9-*67"MMG??\V'>;O3A)_-.S%Z?((G29
MTMG\^L[^+MN_[/S"P>NK^G;U_W250$=Y;EU1D"P7.$F69404U) B%YR519*7
M-GM-VQKYKNA3%">)MCD=GV,XE$8;/,[I-"^<)H921Y@H&>$6#!Z9.>EHQI-R
M=[! 9"'Z:%+1_-R&/N45^OQ:Q=R&%7VJ0$NMU**7WVUKEST0:<*-45E*5&F
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M.?: ^6;GYS5PUW[%Z7&%I)ISK4FN-*BALH"M(0'!L#$2SDQBZ.Y<C*,7]H2
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MA_++OR]6AM],9_7CIH9G2 +^83=V=*\/K!/-^H,#5V,J/3A/W)<%1M^^/WW
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MH]B9%WZ+H,[=R+8/M?=9VQN'1WU[V<#54_75*LO,?FS< 0MI%O/+MFI:T-%
M\[IHM]AU]O  3)4SX,P0P$"W&GIB!Z_M8,\N%?M?;%=XT:_A_"FAJ7>SFE';
M)EA8ZMVP,:H-='9O:RP!'EIH+B,3PSV[Q9X];#D,X<>^;A0$0P6$_+,UI#4X
M9&MO;IL^L^[7]2S;(8$)<2W_LEB9=3:?V_N'/O5N;_[3DQ8;R[:N0T>$"=9?
M,.I&(3!4A"BXT,(>:EMYG^?(A.YAZ+6XCL(.>D_5-]_XT'?W>80%_["#%H6%
M++/918MF\$X>Z;33[N1TC )AJ!#5&PHB=+W=YW^P^LE<-WL:1:T+"E?^E>^8
MVC*U".[@-XR"2+A:$@_,"WO6[(5R;TYA(V TS;[+^J_N\[\7<C84W(-VV8^L
M[W7&)SL$;:S-8R8=-:<F8Q2,0@5RWDX,H?M\]<?DQZK5B_MNCM[<[@?^^F)8
MYM8J^@/T _K'0#A#'<YUTYO_J M@3'=(PFO:[J)=GK<?-NZTK]C3O?U:+=O
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M/_O6U$,J=N4JNY4LL[3Z!M<O4-:TMO_"IADC[F?8P ^K!G>7;?/PBR(^)#J
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M[2 =+WX-J,[>G_!41KC 1X.8^,-3$8R$M\6@:Q,6* T3X%)E]!I$5[-UA;&
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MR(X-=8V8' Q@D? H>):38*5]^N/MF2C9'!*C%5M1@K.A[2ON)F9[--S,[F<
M#V]%P 6S0%>U!/<*) X00(DTSM[!+U(Y ^4#D!=J&72B6*=UUGZR7BE6 PU5
M3!,<DZ  <VMN?5!/)8D:'.^-'^&]6(5I<O^154G3V15!LVI_S,^^SM8XY-=B
MMZ<%_[G+ V#B8Q[>\E&\]:A**K-MXPN]EGJC==#L.4>41I=72%VB+@+Y[:6A
MB;W>UU69,C6J*=\'2(T % EJV7:F>SE+1 2_J;Q%4Y35V@!\. RE1W?F*2 5
MY3IMF[0K_+4&"1RS>ND5(',J,.XC(P-14)0EP#FJ<$[N7W*KV/;!#OM6[539
MN;H1.B)1;Y-R&,$N*OEX,KMF3!YK51":YN"3\M4T0"-YP,3#M!?*N&^4R"0M
M%9*02INDTS/#C-YX+!,0:-X24!QJ=2-]C/3WU:T F%56B5.+R\"F2]^2+MW;
M8\/JH,JV<9(?2O]D-4RQ8H)T!YD+.7T98EW,YE/,;/B]#^O 0&E/B&AI-)M2
M.G8"[^Z#KOD),PU#[HFQ03C+F9B[L&P-9$5JFY.)"N-OI;%D'I1B-G*+&^/+
M4VTFOPR#C'V')=F,9BZX%LNN\/8Q2XP5"[%T,>/,IZY5&E /%.9,^QPWCDFL
M[<,=]@2Q0DM9AC+++1B"5&.F<>5RH;+ "9^G>Q>X]94"1C)OH,*V[W90_A2]
M]WGO1I5#Y$%.(&5#_+28=9U+ZMM&O.&8)<@C 3'7Y^3&9'8(/3R>^NDJ"38\
M>LR&QYRAHLS[18\Z1.HO<,P\D-#ZMC4FBF$BB\(8?# 6I508 SL#<T0.8%82
MFG%6FX?:'18H '?)7,C&.U;4P/+3,+&50IBOUD,5F@CB]O[.M+#_A8A"*48Q
M!1!'",(LS),+P86$ 1#F-UR&M"HS'FX5@3O?S)PF]8EX$85M#EYBXW$?7.%?
MLG-QYPGAQT_>=(7!U-O_>@QYCXD:'B6PORQ3Y_._5B/3ZI)R&)EC"/H6.Z90
M+ULNXSU0]U@,G$59AZF.4Q1 5G+12# ^:.".52-H19NRF"+;GH5*Z7NV6QZ&
M\C$NY=N"FGS\*XH9=ONBD'NSH,6R(QX" ,<Q-&MM8DP(1B4)]_H&*^7TDIWA
M$(/+=\Q9+4ECJ5\HK!\#HD!Z/[%< V/10+\@BTCTX75*M5JV=(-4+TP?"9TI
MVG&L7=SQP3 4DP'-&=L+@I<%/PT .T.EU_VMSQ.;7242=DP5'T@#W[>'GT*3
M?O 5"&^QFY.-_T*(P0T'P;-5RRSBBP?VOE(\55EW<7*@4),]*?%!#X^+).1:
MR:>3E<HG4SJZSN5@]:?HX!=:^^-K\X=@ ,/:N*G%IL,Z7&N@<RDVU:+/6Q[6
M+1QKR>N^BT=2LCHFG6&)1MT:_&26YZS3+?G;&G1.Q@9-QF[)Y$GD?/2\LJ\*
M**@=%BGP70(.WG2%N3<XBLZQV#N7"GR71((3E1^A:8N!NH$;=K">]PG&-;.8
MIBEF,,7N,DJSLI]M*7>LZW:?8&]S@LWV-WE8Z-Z9G@D8C\OJ0>':W'',CJI[
M^Q7\>4!/P1^'2^22T8I-="KL$0?8$#BC>)("3/L!GB)"^%@G-381:__I:&';
MIO"?/ N,9TT"IPB;49X;&7!?V"DYPX7( -Q3/%&TX,S8?UFJ^J#DN>I2ZL7O
M91&O^TN72=?&AY N*4.P*8E^?ITW83EG&2N1"S;K]<^5>>G0CA!WPDMS.0<^
M+PS1MF!K8@X;)9L\N[2^!FAI^.SM4N>/YH&Y_+;Q5QE[(@QY)%2Z,857=7#*
MY%G1VFKPV]4>G.I>U#N%=D_8UHGZ/=7/+[H=NFR=-.KGU,N@PUIG].DE\JW;
M8=^P@\OT*SH73J/!3EQVWOKNMION*3OY4:$WU> 5W?8WN(-7]6;7;5^VW:Z+
M?S.G5FNU3YUFS657]>Y%A29J.%?9G)VNTW7QHNE>L1^M]I?7<*1V3+X':T2^
M'<P!9#V1:B%/XY4>HJDR5H^8QV-!#H/)6J .I6#CA-J<R$/("-PUZ5<8Z&L\
MXXO>7!J)*%#:$YBIRTX7#\"5,N>9[9OC&1K9#,,Y@Q3T/[W$5&>3KG]=U'JX
M1M3:ACL!!J+A_HK)U+WSQ) "L.(.O=HX')_G,F&190Z"6=\[=[DU;="&&<#S
M#Z0>V"L<E_<HJ!0;%."G!7I.3.<-8[L^1,J,76&>+[=O*].\0&^!QP;@CJ.)
MND24@>I0X:EAJL&S%O'KXI>C->*7FDJIH@3PMO)#W?=;?@SXB,6 :RHF4-J4
M['AJF ?*)I,8V*-BO)T*D5C>%B)1UX*"3=A3(I%)BJ=9HG&,BK)4>;,*6,]I
MP2'CD?76@-5P03Q)M4GLSG;7 N[%$L!$JT8& \[4 )Z!C(VRB@L.(TB(HO/'
M,5=F$FCYG(5]V;8Y!+"):?/\NU5T/3D^=%C0<[!'X/<XL=PZ O"(PNX*KJ@]
MO @"*$WZ2@,V,<((S"E]+#6!;?0$S!GD9Y?H=7CXA(ZAP5T,NF)]E9; Q#RT
M&QM#T!1X4&B4 \SNL*PB]C!3Z"/@AGV5*$*W/^=1K(J1]#C8 B:6*/"@K%:1
M](J8PI*()!E7G 3"IXY([GAT)QM-0O<\5#WL7@+@:!+7P$5-#08"Q:/C)17J
MO 9.?,2]Q-0!6#!\BR1)P\*KNXA[;@.S]#"\][<W1^\_VNI^L_2\)FS6'F(6
M\MM*X9B<B9?:)Z:ME?$R[*(EK=\7;!O[DQG*"T$#V;K]?//HI!2::P)E<.H=
M%Z/@5S9ND5"H.*^],KC(2TTH4!NI.;M GL:S2D$@[V@PY;[IQ6!:&@8 AM+^
MKJ$GV\@N>[U&S8I+FB27RD/T0@/F4TC%LL^T9AHWDB#Y0*Q%/?2,$6F8V/2Q
MP>Z4P-W64D;(X7JI8BU>R 79CLQ^K>C+N1ES$DEH[%@078#]F%"'N!]1,,E,
M;QZ@Y0+LQVU,I\K**D0WOQIX)"(S,C;[N+\F/S4MQ\ 4%R"!KRDO8TV8?();
M"41P@TK$,&H&<1R <@C!X<FL01K)P3-;KL=OE#3-GK#R4J6]I#(?Z/$8PM1'
M!!$_#LC!!4@ZI6-CKZ 2P?IH;!Y"XE)CUTL4D*G-3LWGMQQR$RP&P,C/W7A]
MKD$X8,6HM@V)4.2/[QJ&SE;PNHREMVMD+%T(CL/+8"CU[5+RQ!O835YHNV_E
M.<#[/C'F]P(Z_05,&$EAN47G]9\J"FT#92UL8YW,B^:AI5%.4L^<N#8]=3+*
MU>#H)'F#L D'/<X,EU=%ON_6B'Q/I;8'BP&9KC'X5DO*I/:F,M[CI/&LL@!;
M3T"&96:5&J+W:7>FO.Q>RTO8L+5PIQBB8JW/<:,X\S9R!&)CRLQ\8ZX]T&LF
M,D]@>I.#1\V,3)%G>C9I:?/SL.1IZ=E29T5"9MQ:,:/T<5&$G[.RK2T!&D9?
M@,=B#@=050HY*0%6DH!W;-ZA\$_J4PR_Q6 8JI&P/  DKH6I,8FSYAZC@F49
MV%/$AMC)SC1G@K/%989MP3\L./<3O15-<4?FAV9NJW5$31N#2;9=S)2@H90V
MOHBUW.FK2&"+EE%1(56P+T<:F7-OIG.'+P;9=?X&,%B3@IV71[%F>3WFF,,C
MI\I7C;$^W\3LK*7NDPJ&^_3U!)EB-3;\8Z>9[K[Y)$6\PDPGBI4/^P5/]9+J
MZL^HE!@^.IQ_M."_3,P>S1>SRW\'T-'6&HCFLAB$]2;F,9MNI\.HA7'K;&8+
M8_*$/4X.YY1A;K)4?EJ,^LVKJUN*<P^PA&BRO\SAT0L :';MQTFKW6Y=N>VE
M&]65;/F+OD?FB=MY^Z&:$[6EX-V#M]75$?')R)S"8"<AV,-Q@M%Q.AD.I-BP
M;:?.J"TR&A(@"=']PY.NRP" G)/U ,!#_7]6X.DM\.H88Q1)CNDG:VD>,;<G
MPO+MPM13-<$:LW26KQ7O=S'*:3^H]:4(@.8PQ-HR!FL6V,#X@AX]%\4MKOA:
M6CPM?LVS6R,O5Z&V]U2[#?5=4^+IY D5N.0W4<RP]DKA2SZ1($JK]MR_?ZMW
M?URT&J?KJ[D7?Y?2*J5A!8D";+Q97T!51@ _26F">GH=>O.Q/U?;3VS.FH#@
M6/9OGB+.!_QRC5PNR=!QV]_KM8U@>S[!-OTU;F4$[D:H;83:XX7:QH0W)GP7
M"W4F3?CI8L\';/7E Y+O2Q60+)<R<$Z_UIOU3K?M=.O?7>:<N\WNNNJU\1?_
MED&'+?KRWDV\:_4J[JL@>=-G7Z7OAR)14?FV<R_P=7_1TQ&PKSSBU_2="39+
MNZ&Y\M!<1_6Y[(&M(0?EV\<]8BNL=IK*'D-<Y=(2]OOD-SKN5^@XTV-E(V'*
M(V$V6FU#<QNM]@):;09Q;?)XFSQ>60R%FM-T3NM.D]6_7KKMNM-@)T[S"S9&
MJ+6^?G7;-;=$]L.2*<Z-/'\9>?Z%)WT]BEB#7VLE[\JWEWLR?6K%SV4]; 3\
M1L"71L"W&@VGZ[9!LC\N:+N8KE]Z&U=NH]%A9T[[O$4:JL*:U$0(M]7IM&IU
MNOH/-,0JG?4?1OZ QKW\!JCJ7#AMEW7;WSI=:L$'MYWF#]AQU:E65I@7W$)5
MS$'VZ$B,0(W"'-XF5%TBA=SMPV0Q^UN5G?-$\+1\F[FGD:>7/*V2O^/)_$LM
M8KFP\^0\_;91ORM5O\OG7O?W5I]\+<LI).?R$NML_C'^FHS_N YT220<;BT6
MY-.'9-:)U^92P(;J)JGN9'.:^,'O8_Z]I_P1_.HG@_#SOP%02P,$%     @
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M\L+,>$3M5)6(7:?Y8;I491H! YTJO?E&DQ34IH/XYWM?G);&7JU-TW#.$H[
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MP;V6N!U_24M/UY[X/9?PWJ^S/ UI#-O_WVO]?0F^JR#.(!8ED$;[6]I AU(
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M!$DD2<^1L*'4%G.=ITZC9:$J,SJ$"%];=H#0B #!5L6_S(X(.&P=/X0)5W?
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MYJ[)O]Q';GZKV]$#=RO[-U!+ P04    " #7-5Q86V?UO]D$  #Z%0  %P
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M;ZPUI3*-@]<N/:B,MQ'H["VL&41299RB:83NP@(M0.L5BBNTT8%'-N'<K5H
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M<VPM,C R,S$R,S$N:'1M4$L! A0#%     @ US5<6&8FJMZ@,   C]X! !$
M             ( !\G(( &)X<VPM,C R,S$R,S$N>'-D4$L! A0#%     @
MUS5<6/<D9IPU&P  31(! !4              ( !P:,( &)X<VPM,C R,S$R
M,S%?8V%L+GAM;%!+ 0(4 Q0    ( -<U7%BBQ=*0S,,  (7E"  5
M      "  2F_" !B>'-L+3(P,C,Q,C,Q7V1E9BYX;6Q02P$"% ,4    " #7
M-5Q86,F :--G  ! =0  %               @ $H@PD 8GAS;"TR,#(S,3(S
M,5]G,2YJ<&=02P$"% ,4    " #7-5Q8Z=W?ESP>  "B*0  %
M    @ $MZPD 8GAS;"TR,#(S,3(S,5]G,BYJ<&=02P$"% ,4    " #7-5Q8
MG3(@>:$?   *60  %               @ &;"0H 8GAS;"TR,#(S,3(S,5]G
M,RYJ<&=02P$"% ,4    " #7-5Q8^PEZU3U' 0!$K $ %
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M,#DN:'1M4$L! A0#%     @ US5<6%3J:)X) P  <A8  !<
M ( !GL(- &)X<VPM,C R,S$R,S%X97@R,3$N:'1M4$L! A0#%     @ US5<
M6*J="&U; P  R H  !<              ( !W,4- &)X<VPM,C R,S$R,S%X
M97@R,S$N:'1M4$L! A0#%     @ US5<6.L[W 4Z"   B2@  !<
M     ( !;,D- &)X<VPM,C R,S$R,S%X97@S,3$N:'1M4$L! A0#%     @
MUS5<6!O;XHDM"   RB@  !<              ( !V]$- &)X<VPM,C R,S$R
M,S%X97@S,3(N:'1M4$L! A0#%     @ US5<6-W-63<X"   &RD  !<
M         ( !/=H- &)X<VPM,C R,S$R,S%X97@S,3,N:'1M4$L! A0#%
M  @ US5<6"/!V\?4!   G!4  !<              ( !JN(- &)X<VPM,C R
M,S$R,S%X97@S,C$N:'1M4$L! A0#%     @ US5<6/[B9G[3!   G!4  !<
M             ( !L^<- &)X<VPM,C R,S$R,S%X97@S,C(N:'1M4$L! A0#
M%     @ US5<6%MG];_9!   ^A4  !<              ( !N^P- &)X<VPM
M,C R,S$R,S%X97@S,C,N:'1M4$L! A0#%     @ US5<6/75N>OW%   HWX
M !<              ( !R?$- &)X<VPM,C R,S$R,S%X97@Y-S$N:'1M4$L!
M A0#%     @ US5<6%E%VVG6!0  >Q   !<              ( !]08. &)X
K<VPM,C R,S$R,S%X97@Y.3$N:'1M4$L%!@     5 !4 BP4    -#@    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>bxsl-20231231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bxsl="http://www.bxsl.com/20231231"
  xmlns:cef="http://xbrl.sec.gov/cef/2023"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bxsl-20231231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <instant>2024-02-20</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">bxsl:DelayedDrawTermLoansAndRevolversMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:PriceDeclinesInTheMediumAndLargeSizedUSCorporateDebtMarketMayAdverselyAffectTheFairValueOfOurPortfolioReducingOurNAVThroughIncreasedNetUnrealizedDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AbilityToAchieveInvestmentObjectivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheInabilityOfTheAdviserToMaintainOrDevelopTheseRelationshipsOrTheFailureOfTheseRelationshipsToGenerateInvestmentOpportunitiesCouldAdverselyAffectOurBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayFaceIncreasingCompetitionForInvestmentOpportunitiesWhichCouldDelayDeploymentOfOurCapitalReduceReturnsAndResultInLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayHaveDifficultySourcingInvestmentOpportunitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeFaceRisksAssociatedWithTheDeploymentOfOurCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:UncertaintyAsToTheValueOfOurPortfolioInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ThereIsARiskThatInvestorsInOurSharesMayNotReceiveDistributionsOrThatOurDistributionsMayDecreaseOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheAmountOfAnyDistributionsWeMayMakeIsUncertainOurDistributionsMayExceedOurEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeHaveNotEstablishedAnyLimitOnTheAmountOfFundsWeMayUseFromAvailableSourcesSuchAsBorrowingsIfAnyOrProceedsFromSecuritiesOfferingsToFundDistributionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AsAPublicCompanyWeAreSubjectToRegulationsEffortsToComplyWithSuchRegulationsWillInvolveSignificantExpendituresAndNonComplianceWithSuchRegulationsMayAdverselyAffectUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ChangesInLawsOrRegulationsGoverningOurOperationsMayAdverselyAffectOurBusinessOrCauseUsToAlterOurBusinessStrategyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:FinancialRegulatoryChangesInTheUnitedStatesCouldAdverselyAffectOurBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAreSubjectToRegulatoryOversightWhichCouldNegativelyImpactOurOperationsCashFlowOrFinancialConditionImposeAdditionalCostsOnUsOrOtherwiseAdverselyAffectOurBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheImpactOfFinancialReformLegislationOnUsIsUncertainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayExperienceFluctuationsInOurQuarterlyResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TransactionsDenominatedInForeignCurrenciesSubjectUsToForeignCurrencyRisksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:GeneralEconomicConditionsCouldAdverselyAffectThePerformanceOfOurInvestmentsAndOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:InflationAndSupplyChainRisksHaveHadAndMayContinueToHaveAnAdverseImpactOnOurFinancialConditionAndResultsOfOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayBeImpactedByGeneralEuropeanEconomicConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ItMayBeDifficultToBringSuitOrForeclosureInNonUSCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ObligationsCouldHaveAnAdverseEffectOnTheAbilityOfBlackstoneCreditAndItsMiFIDAuthorizedEEAAffiliatesToObtainAndResearchInConnectionWithTheProvisionOfAnInvestmentServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AnyUnrealizedLossesWeExperienceOnOurPortfolioMayBeAnIndicationOfFutureRealizedLossesWhichCouldReduceOurIncomeAvailableForDistributionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TerroristAttacksActsOfWarOrNaturalDisastersMayAdverselyAffectOurOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ForceMajeureEventsMayAdverselyAffectOurOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AnotherPandemicOrGlobalHealthCrisisLikeTheCOVID19PandemicMayAdverselyImpactOurPerformanceAndResultsOfOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:CybersecurityRisksAndDataProtectionCouldResultInTheLossOfDataInterruptionsInOurBusinessDamageToOurReputationAndSubjectUsToRegulatoryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayNotBeAbleToObtainAndMaintainAllRequiredStateLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ComplianceWithTheSECsRegulationBestInterestByParticipatingBrokerDealersMayNegativelyImpactOurAbilityToRaiseCapitalInAPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AsADelawareStatutoryTrustWeAreSubjectToTheControlShareAcquisitionStatuteContainedInTheDelawareStatutoryTrustActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ExclusiveForumAndJuryTrialWaiverProvisionsThatCouldLimitAShareholdersAbilityToBringAClaimMayCauseTheCompanyToIncurAdditionalCostsAssociatedWithSuchActionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurBoardMayChangeOurOperatingPoliciesAndStrategiesWithoutPriorNoticeOrShareholderApprovalTheEffectsOfWhichMayBeAdverseToOurResultsOfOperationsAndFinancialConditionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurBoardMayAmendOurDeclarationOfTrustWithoutPriorShareholderApprovalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:CertainProvisionsOfOurDeclarationOfTrustCouldDeterTakeoverAttemptsAndHaveAnAdverseImpactOnTheValueOfOurCommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurInvestmentsInProspectivePortfolioCompaniesMayBeRiskyAndWeCouldLoseAllOrPartOfOurInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAreExposedToRisksAssociatedWithChangesInInterestRatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurPortfolioCompaniesMayIncurDebtThatRanksEquallyWithOrSeniorToOurInvestmentsInSuchCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ThereMayBeCircumstancesWhereOurDebtInvestmentsCouldBeSubordinatedToClaimsOfOtherCreditorsOrWeCouldBeSubjectToLenderLiabilityClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeGenerallyDoNotControlOurPortfolioCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAreSubjectToRisksRelatedToESGInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAndOurInvestmentAdviserCouldBeTheTargetOfLitigationOrRegulatoryInvestigationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:SecondPriorityLiensOnCollateralSecuringDebtInvestmentsThatWeMakeToOurPortfolioCompaniesMayBeSubjectToControlBySeniorCreditorsWithFirstPriorityLiensMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:EconomicRecessionsOrDownturnsOrRestrictionsOnTradeCouldImpairOurPortfolioCompaniesAndAdverselyAffectOurOperatingResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurInvestmentsInCLOsMayBeRiskierThanADirectInvestmentInTheDebtOrOtherSecuritiesOfTheUnderlyingCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ACovenantBreachOrOtherDefaultByOurPortfolioCompaniesMayAdverselyAffectOurOperatingResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurPortfolioCompaniesMayBeHighlyLeveragedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurPortfolioMayBeConcentratedInALimitedNumberOfIndustriesWhichMaySubjectUsToARiskOfSignificantLossIfThereIsADownturnInAParticularIndustryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayBeSubjectToRisksAssociatedWithOurInvestmentsInTheSoftwareIndustryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OperationsOurInvestmentsInTheHealthcareProvidersAndServicesIndustryFaceConsiderableUncertaintiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:InvestingInLargePrivateUSBorrowersMayLimitTheCompanysAbilityToAchieveHighGrowthRatesDuringTimesOfEconomicExpansionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:InvestingInPrivateCompaniesInvolvesANumberOfSignificantRisksAnyOneOfWhichCouldHaveAMaterialAdverseEffectOnOurOperatingResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayNotRealizeGainsFromOurEquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AnInvestmentStrategyFocusedPrimarilyOnPrivatelyHeldCompaniesPresentsCertainChallengesIncludingButNotLimitedToTheLackOfAvailableInformationAboutTheseCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurInvestmentsInSecuritiesOrAssetsOfPubliclyTradedCompaniesAreSubjectToTheRisksInherentInInvestingInPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ALackOfLiquidityInCertainOfOurInvestmentsMayAdverselyAffectOurBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayNotHaveTheFundsOrAbilityToMakeAdditionalInvestmentsInOurPortfolioCompaniesOrToFundOurUnfundedDebtCommitmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurInvestmentsMayIncludeOriginalIssueDiscountAndPaymentInKindInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayEnterIntoATRSAgreementThatExposesUsToCertainRisksIncludingMarketRiskLiquidityRiskAndOtherRisksSimilarToThoseAssociatedWithTheUseOfLeverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayEnterIntoRepurchaseAgreementsOrReverseRepurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayEnterIntoSecuritiesLendingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:EnterIntoCreditDefaultSwapsOrOtherDerivativeTransactionsWhichExposeUsToCertainRisksAssociatedWithTheUseOfLeverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AcquireVariousFinancialInstrumentsForPurposesOfHedgingOrReducingOurRisksWhichMayBeCostlyAndIneffectiveAndCouldReduceOurCashAvailableForDistributionToOurShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:PrepaymentsOfOurDebtInvestmentsByOurPortfolioCompaniesCouldAdverselyImpactOurResultsOfOperationsAndReduceOurReturnOnEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TechnologicalInnovationsAndIndustryDisruptionsMayNegativelyImpactUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayInvestThroughVariousJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAreSubjectToRisksAssociatedWithInvestingAlongsideOtherThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMaySyndicateCoInvestmentOpportunitiesWhichMayBeCostlyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayUseAWideRangeOfInvestmentTechniquesThatCouldExposeUsToADiverseRangeOfRisksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:FaceConflictsOfInterestCausedByCompensationArrangementsWithUsAndOurAffiliatesWhichCouldResultInActionsThatAreNotInTheBestInterestsOfOurShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayBeObligatedToPayTheAdviserIncentiveCompensationEvenIfWeIncurANetLossDueToADeclineInTheValueOfOurPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheIncentiveFeeBasedOnIncomeTakesIntoAccountOurPastPerformanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ThereMayBeConflictsOfInterestRelatedToObligationsThatTheAdvisersSeniorManagementAndInvestmentTeamHaveToOtherClientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AdviserAreNotProhibitedFromRaisingMoneyForOrManagingOtherEntitiesThatMakeTheSameTypesOfInvestmentsThatWeTargetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurSharesMayBePurchasedByTheAdviserOrItsAffiliatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheAdviserReliesOnKeyPersonnelTheLossOfAnyOfWhomCouldImpairItsAbilityToSuccessfullyManageUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AnyMaterialAdverseChangeInItsFinancialConditionOrOurRelationshipWithTheAdviserCouldHaveAMaterialAdverseEffectOnOurBusinessAndAbilityToAchieveOurInvestmentObjectivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:PayToTheAdviserWillBeDeterminedWithoutIndependentAssessmentOnOurBehalfAndTheseTermsMayBeLessAdvantageousToUsThanIfSuchTermsHadBeenTheSubjectOfArmsLengthNegotiationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheAdvisersInfluenceOnConductingOurOperationsGivesItTheAbilityToIncreaseItsFeesWhichMayReduceTheAmountOfCashFlowAvailableForDistributionToOurShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ThereMayBeTrademarkRiskAsWeDoNotOwnTheBlackstoneNameMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayBeSubjectToAdditionalPotentialConflictsOfInterestsAsAConsequenceOfBlackstonesStatusAsAPublicCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheRequirementThatWeInvestASufficientPortionOfOurAssetsInQualifyingAssetsCouldPrecludeUsFromInvestingInAccordanceWithOurCurrentBusinessStrategyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:FailureToMaintainOurStatusAsABDCWouldReduceOurOperatingFlexibilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:RegulationsGoverningOurOperationAsABDCAndRICWillAffectOurAbilityToRaiseAdditionalCapitalOrBorrowForInvestmentPurposesWhichMayHaveANegativeEffectOnOurGrowthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurAbilityToEnterIntoTransactionsWithOurAffiliatesIsRestrictedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAreUncertainOfOurSourcesForFundingOurFutureCapitalNeedsOurAbilityToAcquireInvestmentsAndToExpandOurOperationsWillBeAdverselyAffectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeAreANonDiversifiedInvestmentCompanyAndThereforeWeAreNotLimitedWithRespectToTheProportionOfOurAssetsThatMayBeInvestedInSecuritiesOfASingleIssuerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WhenWeUseLeverageThePotentialForLossOnAmountsInvestedInUsWillBeMagnifiedAndMayIncreaseTheRiskOfInvestingInUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayDefaultUnderOurCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurCreditRatingsMayNotReflectAllRisksOfAnInvestmentInOurDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheTradingMarketOrMarketValueOfOurIssuedDebtSecuritiesMayFluctuateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TermsRelatingToRedemptionMayMateriallyAdverselyAffectOurNoteholdersReturnOnAnyDebtSecuritiesThatWeMayIssueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:IfWeIssuePreferredSharesOrConvertibleDebtSecuritiesTheNetAssetValueOfOurCommonSharesMayBecomeMoreVolatileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:HoldersOfAnyPreferredSharesThatWeMayIssueWillHaveTheRightToElectCertainMembersOfOurBoardAndHaveClassVotingRightsOnCertainMattersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ProvisionsInACreditFacilityMayLimitOurInvestmentDiscretionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ChangesInInterestRatesMayAffectOurCostOfCapitalAndNetInvestmentIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ComplianceWithSECRule18f4GoverningDerivativesAndUseOfLeverageMayLimitOurInvestmentDiscretionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeHaveFormedCLOsAndMayFormAdditionalCLOsInTheFutureWhichMaySubjectUsToCertainStructuredFinancingRisksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeWillBeSubjectToCorporateLevelIncomeTaxIfWeAreUnableToQualifyAsARICUnderSubchapterMOfTheCodeOrToSatisfyRICDistributionRequirementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayHaveDifficultyPayingOurRequiredDistributionsIfWeRecognizeIncomeBeforeOrWithoutReceivingCashRepresentingSuchIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:SomeOfOurInvestmentsMayBeSubjectToCorporateLevelIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:OurPortfolioInvestmentsMayPresentSpecialTaxIssuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:LegislativeOrRegulatoryTaxChangesCouldAdverselyAffectInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeCannotAssureYouThatTheMarketPriceOfCommonSharesWillNotDeclineBelowTheIPOPriceOrBelowOurNAVTheMarketPriceOfCommonSharesMayBeVolatileAndMayFluctuateSubstantiallyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:AShareholdersInterestInUsWillBeDilutedIfWeIssueAdditionalSharesWhichCouldReduceTheOverallValueOfAnInvestmentInUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:WeMayHaveDifficultyPayingDistributionsAndTheTaxCharacterOfAnyDistributionsIsUncertainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:RiskOfDistributionsExceedingTaxableEarningsAndProfitsCausingReturnOfCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ShareholdersWillExperienceDilutionInTheirOwnershipPercentageIfTheyDoNotParticipateInOurDividendReinvestmentPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:ShareholdersMayExperienceDilutionInTheNetAssetValueOfTheirSharesIfTheyDoNotParticipateInOurDividendReinvestmentPlanAndIfOurSharesAreTradingAtADiscountToNetAssetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:NoShareholderApprovalIsRequiredForCertainMergersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:InvestingInOurSharesInvolvesAHighDegreeOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:TheNAVOfOurSharesMayFluctuateSignificantlyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:SalesOfSubstantialAmountsOfOurCommonSharesInThePublicMarketMayHaveAnAdverseEffectOnTheMarketPriceOfOurCommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">bxsl:VariousPotentialAndActualConflictsOfInterestWillAriseAndThereAreConflictsThatMayNotBeIdentifiedOrResolvedInAMannerFavorableToUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Corfin Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Corfin Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Frontgrade Technologies Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Linquest Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MAG DS Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Magneto Components BuyCo, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Maverick Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>TCFI AEVEX, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AerospaceAndDefenseSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AGI-CFI Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AGI-CFI Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ENV Bidco AB 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ENV Bidco AB 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Livingston International, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mode Purchaser, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mode Purchaser, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Redwood Services Group, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RoadOne Inc</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RWL Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC 4</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AirFreightLogisticsSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Fencing Supply Group Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jacuzzi Brands, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jacuzzi Brands, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>L&amp;S Mechanical Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Lindstrom, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Windows Acquisition Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:BuildingProductsSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Formulations Parent Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bazaarvoice, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bazaarvoice, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CFS Brands, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>FusionSite Midco, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>FusionSite Midco, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Iris Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Java Buyer, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Java Buyer, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>JSS Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>JSS Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Knowledge Pro Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>KPSKY Acquisition, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>KPSKY Acquisition, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Onex Baltimore Buyer, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Onex Baltimore Buyer, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Veregy Consolidated, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:CommercialServicesSuppliesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ASP Endeavor Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>COP Home Services TopCo IV, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ConstructionEngineeringSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ContainerAndPackagingSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BP Purchaser, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BradyIFS Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BradyIFS Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bution Holdco 2, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Dana Kepner Company, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Genuine Cable Group, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NDC Acquisition Corp. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NDC Acquisition Corp. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tailwind Colony Holding Corporation 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tailwind Colony Holding Corporation 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Unified Door &amp; Hardware Group, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DistributorsSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BPPH2 Limited</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cambium Learning Group, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Endeavor Schools Holdings LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Endeavor Schools Holdings LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Go Car Wash Management Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Groundworks, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ConsumerSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Barbri Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>More Cowbell II, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>More Cowbell II, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SelectQuote, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:FinancialServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Acquisition, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Acquisition, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DiversifiedTelecommunicationServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Qualus Power Services Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Qualus Power Services Corp. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricUtilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Emergency Power Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Shoals Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricalEquipmentSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Albireo Energy, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Albireo Energy, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Albireo Energy, LLC 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CPI Intermediate Holdings Inc</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Phoenix 1 Buyer Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectronicEquipmentInstrumentsComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Abaco Energy Technologies, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ISQ Hawkeye Holdco, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tetra Technologies, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:EnergySectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Quality Distribution LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Quality Distribution LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:GroundTransportationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bamboo US BidCo LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bamboo US BidCo LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CPI Buyer, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GCX Corporation Buyer, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GCX Corporation Buyer, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareEquipmentSuppliesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>123Dentist, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ADCS Clinics Intermediate Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ADCS Clinics Intermediate Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerivet Partners Management, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerivet Partners Management, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CCBlue Bidco, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>DCA Investment Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>DCA Investment Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Epoch Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Kwol Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Navigator Acquiror, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Odyssey Holding Company, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Odyssey Holding Company, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>PPV Intermediate Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Smile Doctors, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Snoopy Bidco, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Stepping Stones Healthcare Services, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The GI Alliance Management, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>UMP Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>UMP Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Unified Physician Management, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>WHCG Purchaser III, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>WHCG Purchaser III, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Color Intermediate LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Edifecs, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Edifecs, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Healthcomp Holding Company, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Neptune Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NMC Crimson Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NMC Crimson Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Project Ruby Ultimate Parent Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RPBLS Midco, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RPBLS Midco, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Alera Group, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CFCo LLC (Benefytt Technologies, Inc.)</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Daylight Beta Parent LLC (Benefytt Technologies, Inc.)</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Foundation Risk Partners Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Galway Borrower, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC 5</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>PGIS Intermediate Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>PGIS Intermediate Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SG Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Shelf Bidco Ltd</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 4</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>World Insurance Associates, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:InsuranceSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Donuts, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AI Altius Bidco, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AI Altius Bidco, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Infostretch Corporation</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Inovalon Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing, S.A.R.L 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing, S.A.R.L 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing, S.A.R.L 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing, S.A.R.L 4</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing, S.A.R.L 5</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Razor Holdco, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Red River Technology, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>S&amp;P Global Engineering Solutions</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc. 4</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ITServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MHE Intermediate Holdings 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MHE Intermediate Holdings 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MachineryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Armada Parent, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trader Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Eagle Midstream Canada Finance, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>KKR Alberta Midstream Finance Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:OilGasConsumableFuelsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PaperForestProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Doc Generici (Diocle S.p.A.)</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Ergomed Plc</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PharmaceuticalsSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ALKU, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Apex Companies, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CFGI Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Clearview Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Guidehouse, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>IG Investments Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Kaufman Hall &amp; Associates, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Legacy Intermediate, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Material Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Minotaur Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Pavion Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Petrus Buyer Inc</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sherlock Buyer Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Thevelia US, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Titan Investment Company, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trinity Partners Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>West Monroe Partners, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>West Monroe Partners, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ProfessionalServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Castle Management Borrower, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:RealEstateManagementDevelopmentSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Anaplan, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Beeline, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc.  3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bluefin Holding, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Brave Parent Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Circana Group, L.P. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Circana Group, L.P. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Circana Group, L.P.  2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Circana Group, L.P. 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Community Brands ParentCo, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Confine Visual Bidco</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Confine Visual Bidco</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Connatix Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Coupa Software Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Crewline Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Denali Bidco Ltd 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Denali Bidco Ltd 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Diligent Corporation</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Discovery Education, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Discovery Education, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Episerver, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Experity, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GI Consilio Parent, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Gigamon Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GovernmentJobs.com, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC 4</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>LD Lower Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Lightbox Intermediate, LP</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Magnesium BorrowerCo, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Magnesium BorrowerCo, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Medallia, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Medallia, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monk Holding Co. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monk Holding Co. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NAVEX TopCo, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Nintex Topco Limited</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Oranje Holdco Inc</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Relativity ODA, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Spitfire Parent, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Spitfire Parent, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Stamps.com, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Triple Lift, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Triple Lift, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>WPEngine, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SoftwareSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CustomInk, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Lytx, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Porcelain Acquisition Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Capstone Logistics, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Frontline Road Safety, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Frontline Road Safety, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Helix TS, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Helix TS, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Italian Motorway Holdings S.&#xe0;.r.l</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Roadsafe Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Roadsafe Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Roadsafe Holdings, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Safety Borrower Holdings LP 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Safety Borrower Holdings LP 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-488">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>TRP Infrastructure Services, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TransportationInfrastructureSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd. 4</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Buyer, LLC 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Victory Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Inovalon Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Thevelia US, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc. 4</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-499">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Healthcomp Holding Company, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Micross Topco, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AGI Group Holdings LP - A2 Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mode Holdings, L.P. - Class A-2 Common Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AirFreightLogisticsSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GTCR Investors LP - A-1 Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Box Co-Invest Blocker, LLC - Class A Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Box Co-Invest Blocker, LLC - Class C Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>EIS Acquisition Holdings, LP - Class A Common Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DistributorsSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cambium Holdings, LLC - Senior Preferred Interests</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>THL Fund IX Investors (Plymouth II), LP</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class A Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class B Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class Additional A Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class Additional B Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DiversifiedTelecommunicationServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GCX Corporation Group Holdings, L.P. - Class A-2 Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AVE Holdings I Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Holdings, LP - A-1 Common Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Holdings, LP - A-2 Common Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus Midco 2 S.&#xc0;. R.L - Additional Vehicle Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus Midco 2 S.&#xc0;. R.L - Vehicle Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Healthcomp Holding Company, LLC - Preferred Interest</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CFCo LLC (Benefytt Technologies, Inc.) - Class B Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Shelf Holdco Ltd Common Equity</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:InsuranceSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NC Ocala Co-Invest Beta, L.P. - LP Interest</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>OHCP V TC COI, LP. - LP Interest</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-533">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tricor Horizon, LP</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ProfessionalServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-535">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Connatix Parent, LLC - Class L Common Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Descartes Holdings, Inc</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Expedition Holdco, LLC - Class A Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-538">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Expedition Holdco, LLC - Class B Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Lobos Parent, Inc. - Series A Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Holdings, Inc. - Series A Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-541">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mimecast Limited</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>TPG IX Newark CI, L.P. - LP Interests</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-543">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Zoro Common Equity</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Zoro Series A Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-545">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SoftwareSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CustomInk, LLC - Series A Preferred Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Frontline Road Safety Investments, LLC - Class A Common Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Ncp Helix Holdings, LLC. - Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TransportationInfrastructureSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD)</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-552">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-553">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:InvestmentPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-555">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>State Street Institutional U.S. Government Money Market Fund</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-556">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Other Cash and Cash Equivalents</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-557">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-558">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:QualifyingAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:NonQualifyingAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>123Dentist, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-561">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ADCS Clinics Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-564">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AI Altius Bidco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Alera Group, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-566">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-567">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-568">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-569">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerivet Partners Management, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Anaplan, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Apex Companies, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-572">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Armada Parent, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-573">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Armada Parent, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-574">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-575">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bamboo US BidCo LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-576">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bamboo US BidCo LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-577">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bazaarvoice, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-578">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Beeline, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-579">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Beeline, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-580">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-581">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bluefin Holding, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-582">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BradyIFS Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-583">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BradyIFS Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-584">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Brave Parent Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-585">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Brave Parent Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-586">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-587">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-588">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-589">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cambium Learning Group, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-590">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Castle Management Borrower, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-591">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CFGI Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-592">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CFS Brands, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-593">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CFS Brands, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-594">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Circana Group, L.P., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-595">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Clearview Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-596">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Clearview Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-597">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Community Brands ParentCo, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-598">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Community Brands ParentCo, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Confine Visual Bidco, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-600">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Connatix Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>COP Home Services TopCo IV, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>COP Home Services TopCo IV, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Coupa Software Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Coupa Software Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-605">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CPI Buyer, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CPI Intermediate Holdings Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-607">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Crewline Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Denali Bidco Ltd, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Discovery Education, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Doc Generici (Diocle S.p.A.), Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Emergency Power Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Endeavor Schools Holdings LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ENV Bidco AB, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Episerver, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Ergomed Plc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Experity, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Fencing Supply Group Acquisition, LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-620">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Fencing Supply Group Acquisition, LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Formulations Parent Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Foundation Risk Partners Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Foundation Risk Partners Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Freya Bidco Limited, Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Freya Bidco Limited, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Freya Bidco Limited, Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Freya Bidco Limited, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Frontgrade Technologies Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Frontline Road Safety, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>FusionSite Midco, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-631">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>FusionSite Midco, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-632">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Galway Borrower, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-633">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GI Consilio Parent, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-634">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-635">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-636">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Gigamon Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-637">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GovernmentJobs.com, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-638">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-639">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Groundworks, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Groundworks, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-641">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-642">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-643">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-644">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-645">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Icefall Parent Inc, Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-646">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Icefall Parent Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-647">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>IG Investments Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-648">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Inova Pharmaceutical, Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-649">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Inova Pharmaceutical, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-650">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Inovalon Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-651">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-652">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-653">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Iris Buyer, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-654">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Iris Buyer, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-655">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ISQ Hawkeye Holdco, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-656">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ISQ Hawkeye Holdco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-657">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Java Buyer, Inc., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Java Buyer, Inc., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-659">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Knowledge Pro Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-660">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Knowledge Pro Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-661">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Kwol Acquisition, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-662">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Magnesium BorrowerCo, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-663">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Magneto Components BuyCo, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-664">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Magneto Components BuyCo, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-665">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-666">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-667">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Material Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-668">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mercury Bidco Globe Limited, Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-669">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mercury Bidco Globe Limited, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-670">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MHE Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-671">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monk Holding Co., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-672">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing, S.A.R.L, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-673">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>More Cowbell II, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-674">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>More Cowbell II, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-675">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MPG Parent Holdings LLC, Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-676">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MPG Parent Holdings LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-677">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MPG Parent Holdings LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-678">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Revolver 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-679">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Revolver 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-680">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-681">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Revolver 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-682">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Revolver 4</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-683">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NAVEX TopCo, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Navigator Acquiror, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-685">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NDC Acquisition Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-686">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Neptune Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NMC Crimson Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-688">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Onex Baltimore Buyer, Inc., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-689">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Onex Baltimore Buyer, Inc., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-690">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Oranje Holdco Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-691">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Pavion Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-692">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Pavion Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Petrus Buyer Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-694">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Petrus Buyer Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-695">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>PGIS Intermediate Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-696">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>PGIS Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-697">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Phoenix 1 Buyer Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-698">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>PPV Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-699">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>PPV Intermediate Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-700">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC, Revolver 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC, Revolver 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-703">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-704">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Pye-Barker Fire &amp; Safety LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Quality Distribution LLC, Revolver 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Quality Distribution LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-707">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Quality Distribution LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-708">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Quality Distribution LLC, Revolver 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Qualus Power Services Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-711">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-712">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Redwood Services Group, LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Redwood Services Group, LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Relativity ODA, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RoadOne Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-716">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RoadOne Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>S&amp;P Global Engineering Solutions, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Safety Borrower Holdings LP, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-722">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sherlock Buyer Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sherlock Buyer Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Smile Doctors, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Smile Doctors, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Snoopy Bidco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Stepping Stones Healthcare Services, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Stepping Stones Healthcare Services, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-732">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trader Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-733">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-735">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-736">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trinity Partners Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-737">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Triple Lift, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-738">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-739">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-740">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>UMP Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-741">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Unified Physician Management, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-742">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-743">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-744">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>West Monroe Partners, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-745">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>WHCG Purchaser III, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-746">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>World Insurance Associates, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-747">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>World Insurance Associates, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-748">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>WPEngine, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-749">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-750">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-751">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment One</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-752">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment Two</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-753">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment Three</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-754">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment Four</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-755">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment Five</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-756">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment Six</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-757">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment Seven</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-758">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">bxsl:BlackstoneDonegalHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-759">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">bxsl:BlackstoneDonegalHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-760">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">bxsl:BlackstoneDonegalHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-761">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-762">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-763">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-764">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Corfin Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-765">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Corfin Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-766">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Linquest Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-767">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MAG DS Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-768">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Maverick Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-769">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>TCFI AEVEX, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-770">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AerospaceAndDefenseSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-771">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AGI-CFI Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-772">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ENV Bidco AB 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-773">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ENV Bidco AB 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-774">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Livingston International, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-775">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mode Purchaser, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-776">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mode Purchaser, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-777">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Redwood Services Group, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-778">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RoadOne Inc</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-779">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RWL Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-780">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-781">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-782">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AirFreightLogisticsSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-783">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Fencing Supply Group Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-784">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jacuzzi Brands, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-785">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>L&amp;S Mechanical Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-786">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Lindstrom, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-787">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Windows Acquisition Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-788">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:BuildingProductsSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-789">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bazaarvoice, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-790">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Java Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-791">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>JSS Holdings, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-792">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>JSS Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-793">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Knowledge Pro Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-794">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>KPSKY Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-795">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Onex Baltimore Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The Action Environmental Group, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-797">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The Action Environmental Group, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-798">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Veregy Consolidated, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-799">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:CommercialServicesSuppliesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-800">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ASP Endeavor Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>COP Home Services TopCo IV, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ConstructionEngineeringSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-805">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ContainerAndPackagingSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BP Purchaser, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-807">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bution Holdco 2, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-808">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Dana Kepner Company, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Dana Kepner Company, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Genuine Cable Group, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-814">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NDC Acquisition Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tailwind Colony Holding Corporation</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Unified Door &amp; Hardware Group, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Unified Door &amp; Hardware Group, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Unified Door &amp; Hardware Group, LLC 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DistributorsSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cambium Learning Group, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Dreambox Learning Holding LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Go Car Wash Management Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ConsumerSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Barbri Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-825">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SelectQuote, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:FinancialServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-827">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Qualus Power Services Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-829">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Emergency Power Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Relay Purchaser, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Shoals Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-832">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricalEquipmentSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-833">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Albireo Energy, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-834">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CPI Intermediate Holdings Inc</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-835">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectronicEquipmentInstrumentsComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-836">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Abaco Energy Technologies, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-837">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ISQ Hawkeye Holdco, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-838">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tetra Technologies, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-839">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:EnergySectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-840">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CPI Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-841">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GCX Corporation Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareEquipmentSuppliesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-843">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>123Dentist, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-844">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-845">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ADCS Clinics Intermediate Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-846">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerivet Partners Management, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-847">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-848">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CCBlue Bidco, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-849">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cross Country Healthcare, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-850">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>DCA Investment Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Epoch Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-852">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Healthcomp Holding Company, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-853">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Healthcomp Holding Company, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-854">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-855">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Navigator Acquiror, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-856">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Odyssey Holding Company, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-857">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>PPV Intermediate Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-858">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Smile Doctors, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-859">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Snoopy Bidco, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-860">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-861">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Stepping Stones Healthcare Services, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-862">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-863">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-864">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The GI Alliance Management, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-865">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Unified Physician Management, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-866">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>United Mutual Acquisition Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-867">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-868">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>WHCG Purchaser III, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-869">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-870">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-871">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-872">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Color Intermediate LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-873">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Edifecs, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-874">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Edifecs, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-876">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NMC Crimson Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-877">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Project Ruby Ultimate Parent Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-878">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RPBLS Midco, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-879">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-880">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Alera Group, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-881">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-882">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Benefytt Technologies, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-883">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Foundation Risk Partners Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-884">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Galway Borrower, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-885">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-886">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-887">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jones Deslauriers Insurance Management, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-888">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>PGIS Intermediate Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-889">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SG Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-890">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Shelf Bidco Ltd</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-891">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-892">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-893">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-894">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tennessee Bidco Limited 4</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-895">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Westland Insurance Group LTD 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-896">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Westland Insurance Group LTD 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-897">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:InsuranceSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-898">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Donuts, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-899">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AI Altius Bidco, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-900">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AI Altius Bidco, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Infostretch Corporation</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Inovalon Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing S.&#xe0;.r.l 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-904">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing S.&#xe0;.r.l 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-905">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing S.&#xe0;.r.l 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing S.&#xe0;.r.l 4</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-907">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Razor Holdco, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Red River Technology, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-910">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ITServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-912">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MHE Intermediate Holdings 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-913">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MHE Intermediate Holdings 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MachineryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Armada Parent, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trader Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Eagle Midstream Canada Finance, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>KKR Alberta Midstream Finance Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:OilGasConsumableFuelsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-920">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-922">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PaperForestProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Doc Generici (Diocle S.p.A.)</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ALKU, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ALKU, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BPPH2 Limited</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CFGI Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Clearview Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-931">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Guidehouse, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-932">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-933">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>IG Investments Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-934">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Kaufman Hall &amp; Associates, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-935">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Legacy Intermediate, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-936">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Material Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Minotaur Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-938">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Petrus Buyer Inc</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-939">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sherlock Buyer Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-940">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Thevelia US, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-941">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Titan Investment Company, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-942">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-943">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trinity Partners Holdings, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-944">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>West Monroe Partners, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-945">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ProfessionalServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-946">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-947">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-948">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:RealEstateManagementDevelopmentSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-949">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Gruden Acquisition, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-950">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Anaplan, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-951">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AxiomSL Group, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-952">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Community Brands ParentCo, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-954">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Confine Visual Bidco</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-955">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Connatix Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-956">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Diligent Corporation</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-957">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Discovery Education, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-958">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Episerver, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-959">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Experity, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-960">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Gigamon Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-961">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GovernmentJobs.com, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-962">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-963">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>LD Lower Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-964">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Lightbox Intermediate, LP</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-965">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Magnesium BorrowerCo, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-966">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Magnesium BorrowerCo, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-967">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Medallia, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-969">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monk Holding Co.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-970">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-971">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Nintex Topco Limited</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-972">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Project Boost Purchaser, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-973">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-974">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Relativity ODA, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-975">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Spitfire Parent, Inc. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-976">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Spitfire Parent, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-977">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Spitfire Parent, Inc. 3</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-978">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Stamps.com, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-979">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The NPD Group L.P. 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-980">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The NPD Group L.P. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-981">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Triple Lift, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-982">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-983">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SoftwareSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-984">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CustomInk, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-985">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Lytx, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-986">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Porcelain Acquisition Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-987">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The Cook &amp; Boardman Group, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-988">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TradingCompaniesDistributorsSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-989">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Capstone Logistics, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-990">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Frontline Road Safety, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-991">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Helix TS, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-992">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Italian Motorway Holdings S.&#xe0;.r.l</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-993">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Roadsafe Holdings, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-994">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Safety Borrower Holdings LP</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-995">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-996">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>TRP Infrastructure Services, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-997">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TransportationInfrastructureSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-998">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-999">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>COP Home Services TopCo IV, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1000">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Buyer, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Victory Buyer, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1004">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Inovalon Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1005">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Thevelia US, LLC 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1006">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc. 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1007">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Micross Topco, Inc.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1009">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AGI Group Holdings LP - A2 Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1010">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mode Holdings, L.P. - Class A-2 Common Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1011">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AirFreightLogisticsSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1012">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Box Co-Invest Blocker, LLC</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1013">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>EIS Acquisition Holdings, LP - Class A Common Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1014">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DistributorsSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cambium Holdings, LLC - Senior Preferred Interests</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Deneb Ultimate Topco, LLC - Class A Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1017">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ConsumerSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1018">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class A Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class B Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class Additional A Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Holdings, LLC - Class Additional B Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DiversifiedTelecommunicationServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GCX Corporation Group Holdings, L.P. - Class A-2 Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AVE Holdings I Corp.</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Holdings, LP - A-1 Common Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Holdings, LP - A-2 Common Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus Midco 2 S.&#xc0;. R.L - Additional Vehicle Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus Midco 2 S.&#xc0;. R.L - Vehicle Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Shelf Holdco Ltd Common Equity</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1032">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NC Ocala Co-Invest Beta, L.P. - LP Interest</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1033">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Guidehouse Holding Corp. - Preferred Equity</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1034">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>OHCP V TC COI, LP. - LP Interest</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1035">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Tricor Horizon, LP</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1036">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ProfessionalServicesSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1037">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Connatix Parent, LLC - Class L Common Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1038">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Expedition Holdco, LLC - Class A Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1039">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Expedition Holdco, LLC - Class B Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1040">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Lobos Parent, Inc. - Series A Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1041">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Holdings, Inc. - Series A Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1042">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mimecast Limited</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1043">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Zoro Common Equity</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1044">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Zoro Series A Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1045">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SoftwareSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CustomInk, LLC - Series A Preferred Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1047">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Frontline Road Safety Investments, LLC - Class A Common Units</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1048">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Ncp Helix Holdings, LLC. - Preferred Shares</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1049">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TransportationInfrastructureSectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1050">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentUnaffiliatedIssuerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1051">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Blackstone Donegal Holdings LP - LP Interests (Westland Insurance Group LTD)</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1052">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1053">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:InvestmentPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1054">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Other Cash and Cash Equivalents</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1055">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1056">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:QualifyingAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1057">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:NonQualifyingAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1058">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>123Dentist, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1059">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1060">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ACI Group Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1061">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ADCS Clinics Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ADCS Clinics Intermediate Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1063">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AI Altius Bidco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1064">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1065">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerilife Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1066">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerivet Partners Management, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1067">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Amerivet Partners Management, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1068">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Anaplan, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1069">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Armada Parent, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1070">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Armada Parent, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1071">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Ascend Buyer, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1072">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AxiomSL Group, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1073">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>AxiomSL Group, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1074">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Bazaarvoice, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1075">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Benefytt Technologies, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1076">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1077">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>BlueCat Networks USA, Inc., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1078">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1079">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Revolver 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1080">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Revolver 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1081">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Caerus US 1, Inc., Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1082">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cambium Learning Group, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1083">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1084">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Canadian Hospital Specialties Ltd., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1085">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CCBlue Bidco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1086">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CFGI Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1087">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CFGI Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1088">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Clearview Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1089">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Clearview Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1090">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Community Brands ParentCo, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1091">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Community Brands ParentCo, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1092">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Confine Visual Bidco, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1093">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Connatix Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1094">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Connatix Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1095">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>COP Home Services TopCo IV, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1096">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CPI Buyer, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1097">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CPI Buyer, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1098">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>CPI Intermediate Holdings Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1099">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Cumming Group, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>DCA Investment Holdings, LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>DCA Investment Holdings, LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Discovery Education, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Discovery Education, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Doc Generici (Diocle S.p.A.), Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Emergency Power Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ENV BIDCO AB, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Episerver, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Experity, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Foundation Risk Partners Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Galway Borrower, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Galway Borrower, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GCX Corporation Buyer, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The GI Alliance Management, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GI Ranger Intermediate, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Gigamon Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Go Car Wash Management Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GovernmentJobs.com, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GovernmentJobs.com, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>GraphPAD Software, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Gruden Acquisition, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Gruden Acquisition, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Healthcomp Holding Company, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Helix TS, LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Helix TS, LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>HIG Orca Acquisition Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>High Street Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>IG Investments Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Inovalon Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Integrity Marketing Acquisition, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ISQ Hawkey Holdco, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>ISQ Hawkey Holdco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Java Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Jayhawk Buyer, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Knowledge Pro Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Knowledge Pro Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>KPSKY Acquisition, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>LD Lower Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Legacy Intermediate, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Legacy Intermediate, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Linquest Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Magnesium BorrowerCo, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Mandolin Technology Intermediate Holdings, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Marcone Yellowstone Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Material Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Material Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MHE Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monk Holding Co., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Monterey Financing S.&#xe0;.r.l, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Revolver 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>MRI Software, LLC, Revolver 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Navigator Acquiror, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NDC Acquisition Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>NMC Crimson Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Onex Baltimore Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Petrus Buyer Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Petrus Buyer Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>PGIS Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Point Broadband Acquisition, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Porcelain Acquisition Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>PPV Intermediate Holdings, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>PPV Intermediate Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Profile Products, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Progress Residential PM Holdings, LLC, Delayed Draw Term Loan 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Project Boost Purchaser, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Project Boost Purchaser, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Qualus Power Services Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Rally Buyer, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Red River Technology, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Redwood Services Group, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Relativity ODA, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Relay Purchaser, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RoadOne Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RoadOne Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Roadsafe Holdings, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RPBLS Midco, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>RWL Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Safety Borrower Holdings LP, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sam Holding Co, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SEKO Global Logistics Network, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sherlock Buyer Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Sherlock Buyer Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Smile Doctors, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Snoopy Bidco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>SpecialtyCare, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Spitfire Parent, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Stepping Stones Healthcare Services, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Stepping Stones Healthcare Services, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The Fertility Partners, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The NPD Group L.P., Revolver 1</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>The NPD Group L.P., Revolver 2</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trader Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trinity Air Consultants Holdings Corp., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Trinity Partners Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Triple Lift, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>TRP Infrastructure Services, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Turing Holdco, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Unified Physician Management, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Unified Physician Management, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>United Mutual Acquisition Holdings, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>US Oral Surgery Management Holdco, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>West Monroe Partners, LLC, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>West Monroe Partners, LLC, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Westland Insurance Group LTD, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>WHCG Purchaser III, Inc., Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>WHCG Purchaser III, Inc., Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc, Delayed Draw Term Loan</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Zendesk Inc, Revolver</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment  One</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment Two</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment Three</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment Four</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment Five</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment Six</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:InvestmentIdentifierAxis.domain>Investment Seven</us-gaap:InvestmentIdentifierAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">bxsl:BlackstoneDonegalHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">bxsl:BlackstoneDonegalHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">us-gaap:InvestmentAffiliatedIssuerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-18</startDate>
            <endDate>2021-10-18</endDate>
        </period>
    </context>
    <context id="c-1234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-06</startDate>
            <endDate>2021-05-06</endDate>
        </period>
    </context>
    <context id="c-1235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-06</startDate>
            <endDate>2020-05-06</endDate>
        </period>
    </context>
    <context id="c-1236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-02</startDate>
            <endDate>2023-05-02</endDate>
        </period>
    </context>
    <context id="c-1237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverNotInPlaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-18</startDate>
            <endDate>2021-10-18</endDate>
        </period>
    </context>
    <context id="c-1238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverInPlaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-28</startDate>
            <endDate>2021-10-28</endDate>
        </period>
    </context>
    <context id="c-1239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-28</startDate>
            <endDate>2021-10-28</endDate>
        </period>
    </context>
    <context id="c-1240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-29</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-18</startDate>
            <endDate>2021-10-18</endDate>
        </period>
    </context>
    <context id="c-1242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverInPlaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-28</startDate>
            <endDate>2021-10-28</endDate>
        </period>
    </context>
    <context id="c-1243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentManagementAgreementIncentiveRateQuarterlyHurdleRateMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentManagementAgreementIncentiveRateAnnualizedHurdleRateMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-28</startDate>
            <endDate>2021-10-28</endDate>
        </period>
    </context>
    <context id="c-1246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:IncomeBasedIncentiveFeesScenarioAxis">bxsl:PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-28</startDate>
            <endDate>2021-10-28</endDate>
        </period>
    </context>
    <context id="c-1247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:IncomeBasedIncentiveFeesScenarioAxis">bxsl:PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverNotInPlaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-28</startDate>
            <endDate>2021-10-28</endDate>
        </period>
    </context>
    <context id="c-1248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:IncomeBasedIncentiveFeesScenarioAxis">bxsl:PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersLessThanOrEqualToCatchUpAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverInPlaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-28</startDate>
            <endDate>2021-10-28</endDate>
        </period>
    </context>
    <context id="c-1249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:IncomeBasedIncentiveFeesScenarioAxis">bxsl:PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverNotInPlaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-28</startDate>
            <endDate>2021-10-28</endDate>
        </period>
    </context>
    <context id="c-1250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:IncomeBasedIncentiveFeesScenarioAxis">bxsl:PreIncentiveFeeNetInvestmentIncomeForTrailingTwelveQuartersGreaterThanCatchUpAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverInPlaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-28</startDate>
            <endDate>2021-10-28</endDate>
        </period>
    </context>
    <context id="c-1251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VoluntaryWaiverScenarioAxis">bxsl:VoluntaryWaiverNotInPlaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-28</startDate>
            <endDate>2021-10-28</endDate>
        </period>
    </context>
    <context id="c-1252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:InvestmentAdvisoryAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-29</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:AdministrationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="c-1254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:AdministrationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:AdministrationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:SubAdministrationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="c-1257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:ExpenseSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-12</startDate>
            <endDate>2018-12-12</endDate>
        </period>
    </context>
    <context id="c-1258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:ExpenseSupportAgreementExcessOperatingFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-12</startDate>
            <endDate>2018-12-12</endDate>
        </period>
    </context>
    <context id="c-1259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:ExpenseSupportAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">bxsl:ExpenseSupportAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AerospaceAndDefenseSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AerospaceAndDefenseSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AirFreightLogisticsSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:AirFreightLogisticsSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:BuildingProductsSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:BuildingProductsSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ChemicalsSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ChemicalsSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:CommercialServicesSuppliesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:CommercialServicesSuppliesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ConstructionEngineeringSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ConstructionEngineeringSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ContainerAndPackagingSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ContainerAndPackagingSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DistributorsSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DistributorsSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ConsumerSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:ConsumerSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:FinancialServicesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:FinancialServicesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DiversifiedTelecommunicationServicesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:DiversifiedTelecommunicationServicesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricalEquipmentSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricalEquipmentSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectronicEquipmentInstrumentsAndComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectronicEquipmentInstrumentsAndComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricUtilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ElectricUtilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:EnergySectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:EnergySectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:GroundTransportationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:GroundTransportationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareEquipmentSuppliesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareEquipmentSuppliesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareProvidersServicesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:HealthCareTechnologySectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:IndustrialConglomeratesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:IndustrialConglomeratesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:InsuranceSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:InsuranceSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:InternetAndDirectMarketingRetailMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:InternetAndDirectMarketingRetailMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ITServicesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ITServicesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MarineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MarineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MediaSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:MediaSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:OilGasAndConsumableFuelsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:OilGasAndConsumableFuelsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PaperAndForestProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PaperAndForestProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PharmaceuticalsSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:PharmaceuticalsSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ProfessionalServicesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:ProfessionalServicesSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:RealEstateManagementDevelopmentSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:RealEstateManagementDevelopmentSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:RoadAndRailMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:RoadAndRailMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SoftwareSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SoftwareSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SpecialtyRetailMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:SpecialtyRetailMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TechnologyHardwareStorageAndPeripheralsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TechnologyHardwareStorageAndPeripheralsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TradingCompaniesDistributorsSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TradingCompaniesDistributorsSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TransportationInfrastructureSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">bxsl:TransportationInfrastructureSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bxsl:BERMUDAAndCAYMANISLANDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bxsl:BERMUDAAndCAYMANISLANDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentOwnedAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesVariableRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesVariableRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFixedRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">bxsl:InvestmentsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">bxsl:InvestmentTypeConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bxsl:DebtSecuritiesFixedRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienRealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienRealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:UnsecuredDebtRealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:EquitySecuritiesRealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:InvestmentsRealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienUnrealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienUnrealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:UnsecuredDebtUnrealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:EquitySecuritiesUnrealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:InvestmentsUnrealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienRealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienRealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:EquitySecuritiesRealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:InvestmentsRealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesFirstLienUnrealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:DebtSecuritiesSecondLienUnrealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:EquitySecuritiesUnrealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bxsl:InvestmentsUnrealizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationAssetRecoverabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputMarketMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationAssetRecoverabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputMarketMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationAssetRecoverabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputMarketMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationAssetRecoverabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputPerformanceMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputPerformanceMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputPerformanceMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputQuotedPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputQuotedPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesFirstLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputQuotedPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bxsl:DebtSecuritiesSecondLienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputPerformanceMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputPerformanceMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bxsl:MeasurementInputPerformanceMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1488">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">bxsl:ValuationYieldAnalysisApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1499">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityForeignCurrencyAdvancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-16</startDate>
            <endDate>2022-09-16</endDate>
        </period>
    </context>
    <context id="c-1506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityDollarAdvancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-16</startDate>
            <endDate>2022-09-16</endDate>
        </period>
    </context>
    <context id="c-1507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-16</startDate>
            <endDate>2022-09-16</endDate>
        </period>
    </context>
    <context id="c-1508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-19</startDate>
            <endDate>2022-05-19</endDate>
        </period>
    </context>
    <context id="c-1510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-19</startDate>
            <endDate>2022-05-19</endDate>
        </period>
    </context>
    <context id="c-1511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-19</startDate>
            <endDate>2022-05-19</endDate>
        </period>
    </context>
    <context id="c-1512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-19</startDate>
            <endDate>2022-05-19</endDate>
        </period>
    </context>
    <context id="c-1513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-19</startDate>
            <endDate>2022-05-19</endDate>
        </period>
    </context>
    <context id="c-1514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-19</startDate>
            <endDate>2022-05-19</endDate>
        </period>
    </context>
    <context id="c-1515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-19</startDate>
            <endDate>2022-05-19</endDate>
        </period>
    </context>
    <context id="c-1516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-19</startDate>
            <endDate>2022-05-19</endDate>
        </period>
    </context>
    <context id="c-1517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-30</startDate>
            <endDate>2023-03-30</endDate>
        </period>
    </context>
    <context id="c-1518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-30</startDate>
            <endDate>2023-03-30</endDate>
        </period>
    </context>
    <context id="c-1519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-30</startDate>
            <endDate>2023-03-30</endDate>
        </period>
    </context>
    <context id="c-1520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-30</startDate>
            <endDate>2023-03-30</endDate>
        </period>
    </context>
    <context id="c-1521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-30</startDate>
            <endDate>2023-03-30</endDate>
        </period>
    </context>
    <context id="c-1522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:CommitmentFeeScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-30</startDate>
            <endDate>2023-03-30</endDate>
        </period>
    </context>
    <context id="c-1523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-09</instant>
        </period>
    </context>
    <context id="c-1524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-09</instant>
        </period>
    </context>
    <context id="c-1525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-09</instant>
        </period>
    </context>
    <context id="c-1526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityForeignCurrencyCommitments2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-09</instant>
        </period>
    </context>
    <context id="c-1527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-28</startDate>
            <endDate>2022-06-28</endDate>
        </period>
    </context>
    <context id="c-1528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-28</startDate>
            <endDate>2022-06-28</endDate>
        </period>
    </context>
    <context id="c-1529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-28</instant>
        </period>
    </context>
    <context id="c-1530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-28</startDate>
            <endDate>2022-06-28</endDate>
        </period>
    </context>
    <context id="c-1531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-28</instant>
        </period>
    </context>
    <context id="c-1532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-28</startDate>
            <endDate>2022-06-28</endDate>
        </period>
    </context>
    <context id="c-1533">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-28</instant>
        </period>
    </context>
    <context id="c-1534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-28</startDate>
            <endDate>2022-06-28</endDate>
        </period>
    </context>
    <context id="c-1535">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-28</instant>
        </period>
    </context>
    <context id="c-1536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bxsl:VariableRateScenarioAxis">bxsl:Scenario4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-28</startDate>
            <endDate>2022-06-28</endDate>
        </period>
    </context>
    <context id="c-1537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-28</startDate>
            <endDate>2022-06-28</endDate>
        </period>
    </context>
    <context id="c-1538">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-28</instant>
        </period>
    </context>
    <context id="c-1539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A3650NotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-15</instant>
        </period>
    </context>
    <context id="c-1541">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A3625NotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-23</instant>
        </period>
    </context>
    <context id="c-1542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A3625NotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-01</instant>
        </period>
    </context>
    <context id="c-1543">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2750NotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-16</instant>
        </period>
    </context>
    <context id="c-1544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2750NotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-27</instant>
        </period>
    </context>
    <context id="c-1545">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2125SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="c-1546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2850NotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="c-1547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A3625NotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2750NotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1552">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2125SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1553">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2850NotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1555">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1556">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1557">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:CitiBankRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1558">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A3650NotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A3625NotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2750NotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1561">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2125SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2850NotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">bxsl:DelayedDrawTermLoansAndRevolversMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1564">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-14</startDate>
            <endDate>2023-08-14</endDate>
        </period>
    </context>
    <context id="c-1565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-14</instant>
        </period>
    </context>
    <context id="c-1566">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-18</startDate>
            <endDate>2023-08-18</endDate>
        </period>
    </context>
    <context id="c-1567">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">bxsl:AtTheMarketOfferingOffering1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1568">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">bxsl:AtTheMarketOfferingOffering1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1569">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-28</startDate>
            <endDate>2021-10-28</endDate>
        </period>
    </context>
    <context id="c-1570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-28</instant>
        </period>
    </context>
    <context id="c-1571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-04</startDate>
            <endDate>2021-11-04</endDate>
        </period>
    </context>
    <context id="c-1572">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2021-09-08</startDate>
            <endDate>2021-09-08</endDate>
        </period>
    </context>
    <context id="c-1573">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-08</startDate>
            <endDate>2021-09-08</endDate>
        </period>
    </context>
    <context id="c-1574">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-1575">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1576">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="c-1577">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c-1578">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-27</startDate>
            <endDate>2023-02-27</endDate>
        </period>
    </context>
    <context id="c-1579">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-10</startDate>
            <endDate>2023-05-10</endDate>
        </period>
    </context>
    <context id="c-1580">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-20</startDate>
            <endDate>2023-06-20</endDate>
        </period>
    </context>
    <context id="c-1581">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-08</startDate>
            <endDate>2023-11-08</endDate>
        </period>
    </context>
    <context id="c-1582">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-18</startDate>
            <endDate>2021-10-18</endDate>
        </period>
    </context>
    <context id="c-1583">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-18</startDate>
            <endDate>2021-10-18</endDate>
        </period>
    </context>
    <context id="c-1584">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-23</startDate>
            <endDate>2022-02-23</endDate>
        </period>
    </context>
    <context id="c-1585">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-18</startDate>
            <endDate>2021-10-18</endDate>
        </period>
    </context>
    <context id="c-1586">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-02</startDate>
            <endDate>2022-05-02</endDate>
        </period>
    </context>
    <context id="c-1587">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-18</startDate>
            <endDate>2021-10-18</endDate>
        </period>
    </context>
    <context id="c-1588">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-30</startDate>
            <endDate>2022-08-30</endDate>
        </period>
    </context>
    <context id="c-1589">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-02</startDate>
            <endDate>2022-11-02</endDate>
        </period>
    </context>
    <context id="c-1590">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-24</startDate>
            <endDate>2021-02-24</endDate>
        </period>
    </context>
    <context id="c-1591">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-07</startDate>
            <endDate>2021-06-07</endDate>
        </period>
    </context>
    <context id="c-1592">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-07</startDate>
            <endDate>2021-06-07</endDate>
        </period>
    </context>
    <context id="c-1593">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-07</startDate>
            <endDate>2021-09-07</endDate>
        </period>
    </context>
    <context id="c-1594">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-07</startDate>
            <endDate>2021-09-07</endDate>
        </period>
    </context>
    <context id="c-1595">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:Dividends9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-18</startDate>
            <endDate>2021-10-18</endDate>
        </period>
    </context>
    <context id="c-1596">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2023-01-31</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-1597">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2023-04-27</startDate>
            <endDate>2023-04-27</endDate>
        </period>
    </context>
    <context id="c-1598">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2023-07-27</startDate>
            <endDate>2023-07-27</endDate>
        </period>
    </context>
    <context id="c-1599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2023-10-26</startDate>
            <endDate>2023-10-26</endDate>
        </period>
    </context>
    <context id="c-1600">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-01-31</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-1601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-05-13</startDate>
            <endDate>2022-05-13</endDate>
        </period>
    </context>
    <context id="c-1602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-08-12</startDate>
            <endDate>2022-08-12</endDate>
        </period>
    </context>
    <context id="c-1603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-11-14</startDate>
            <endDate>2022-11-14</endDate>
        </period>
    </context>
    <context id="c-1604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2021-01-29</startDate>
            <endDate>2021-01-29</endDate>
        </period>
    </context>
    <context id="c-1605">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2021-05-14</startDate>
            <endDate>2021-05-14</endDate>
        </period>
    </context>
    <context id="c-1606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2021-08-13</startDate>
            <endDate>2021-08-13</endDate>
        </period>
    </context>
    <context id="c-1607">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2021-11-12</startDate>
            <endDate>2021-11-12</endDate>
        </period>
    </context>
    <context id="c-1608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-18</instant>
        </period>
    </context>
    <context id="c-1609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b18PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="c-1610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b18PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="c-1611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c-1612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c-1613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c-1614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="c-1615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="c-1616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="c-1617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-1618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-1619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-1620">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="c-1621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="c-1622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="c-1623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="c-1624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="c-1625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="c-1626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-1627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-1628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-1629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-1630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-1631">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-1632">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bxsl:Company10b51PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1633">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c-1634">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c-1635">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-1636">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bxsl:TransferRestrictionsAxis">bxsl:InitialPublicOfferingShareholderTransferRestrictionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-03</instant>
        </period>
    </context>
    <context id="c-1637">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bxsl:TransferRestrictionsAxis">bxsl:InitialPublicOfferingShareholderTransferRestrictionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-1638">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bxsl:TransferRestrictionsAxis">bxsl:InitialPublicOfferingShareholderTransferRestrictionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c-1639">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bxsl:TransferRestrictionsAxis">bxsl:InitialPublicOfferingShareholderTransferRestrictionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-1640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1641">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1642">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-1643">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:DividendsOrdinaryIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1644">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:DividendsCapitalGainsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-1645">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:DividendsOrdinaryIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1646">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">bxsl:DividendsCapitalGainsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-1647">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c-1648">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-1649">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c-1650">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-1651">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-1652">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c-1653">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:SubscriptionFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1654">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:SubscriptionFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1655">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:SubscriptionFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1656">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:SubscriptionFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-1657">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:SubscriptionFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c-1658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:SubscriptionFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-1659">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1660">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1661">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1662">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-1663">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c-1664">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:JacksonHoleFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-1665">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1666">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1667">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1668">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-1669">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c-1670">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BreckenridgeFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-1671">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1672">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1673">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1674">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-1675">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c-1676">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:BigSkyFundingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-1677">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1678">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1679">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1680">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-1681">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c-1682">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-1683">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1685">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1686">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-1687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c-1688">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-1689">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1690">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1691">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1692">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-1693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c-1694">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-1695">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1696">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1697">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1698">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-1699">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c-1700">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:New2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-1701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1703">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1704">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-1705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c-1706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-1707">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-1708">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-1709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-1710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-1711">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c-1712">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bxsl:A2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-1713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736035</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-28</startDate>
            <endDate>2024-02-28</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="sek">
        <measure>iso4217:SEK</measure>
    </unit>
    <unit id="dkk">
        <measure>iso4217:DKK</measure>
    </unit>
    <unit id="nok">
        <measure>iso4217:NOK</measure>
    </unit>
    <unit id="loan">
        <measure>bxsl:loan</measure>
    </unit>
    <unit id="equity_distribution_agreement">
        <measure>bxsl:equity_distribution_agreement</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-32">0001736035</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-33">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-34">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-35">false</dei:AmendmentFlag>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-6" id="f-265" unitRef="shares" xsi:nil="true"/>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" id="f-266" unitRef="shares" xsi:nil="true"/>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-4">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-3">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">814-01299</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">Blackstone Secured Lending Fund</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">82-7020632</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">345 Park Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-11">31st Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-12">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-13">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-14">10154</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-15">(212)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-16">503-2100</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Shares of Beneficial Interest, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">BXSL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-20">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-21">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-22">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-23">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-24">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-25">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-26">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-27">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-28">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-29">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-6" id="f-30" unitRef="usd">4432000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="0" id="f-31" unitRef="shares">191600986</dei:EntityCommonStockSharesOutstanding>
    <cef:InvestmentObjectivesAndPracticesTextBlock contextRef="c-1" id="f-36">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. We believe that Blackstone&#x2019;s investment platform provides us with a competitive advantage in selecting investments, and to achieve our investment objectives, we will leverage the Adviser&#x2019;s investment team&#x2019;s and Blackstone&#x2019;s extensive network of relationships with other sophisticated institutions to source, evaluate and, as appropriate, partner with on transactions. There are no assurances that we will achieve our investment objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under normal market conditions, we generally invest at least 80% of our total assets (net assets plus borrowings for investment purposes) in secured debt investments. Our portfolio is composed primarily of first lien senior secured and unitranche loans. To a lesser extent, we have and may continue to also invest in second lien, third lien, unsecured or subordinated loans and other debt and equity securities. In limited instances we may retain the &#x201c;last out&#x201d; portion of a first-lien loan. In such cases, the &#x201c;first out&#x201d; portion of the first lien loan would receive priority with respect to payment over our &#x201c;last out&#x201d; position. In exchange for the higher risk of loss associated with such &#x201c;last out&#x201d; portion, we would earn a higher rate of interest than the &#x201c;first out&#x201d; position. We do not currently expect to focus on investments in issuers that are distressed or in need of rescue financing. Subject to the limitations of the 1940 Act, we may invest in loans or other securities, the proceeds of which may refinance or otherwise repay debt or securities of companies whose debt is owned by other Blackstone Credit &amp;amp; Insurance funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a BDC, at least 70% of our assets must be the type of &#x201c;qualifying&#x201d; assets listed in Section 55(a) of the 1940 Act, as described herein, which are generally privately-offered securities issued by U.S. private or thinly-traded companies. We may also invest up to 30% of our portfolio opportunistically in &#x201c;non-qualifying&#x201d; portfolio investments, such as investments in non-U.S. companies. We generally intend to distribute substantially all of our available earnings annually by making quarterly cash distributions. We use leverage and intend to continue to use leverage for our investment activities. We use and intend to continue to use leverage, which is permitted up to the maximum amount allowed by the 1940 Act (currently limited to a debt-to-equity ratio of 2:1), to enhance potential returns. See &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Item 7. Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x2014;Financial Condition, Liquidity and Capital Resources&#x2014;Borrowings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2021, the Company priced its initial public offering (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;IPO&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), and the Company's common shares of beneficial interest (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Common Shares&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) began trading on the New York Stock Exchange (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;NYSE&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). See &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Item 8. Consolidated Financial Statements and Supplementary Data&#x2014;Notes to Consolidated Financial Statements&#x2014;Note 8. Net Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our liquidity and capital resources are generated primarily from cash flows from interest, dividends and fees earned from our investments and principal repayments, our credit facilities, debt securitization transactions, and other secured and unsecured debt. We may also generate cash flow from operations, future borrowings and future offerings of securities including public and/or private issuances of debt and/or equity securities through both registered offerings and private offerings. The primary uses of our cash and cash equivalents are for (i) originating loans and purchasing senior secured debt investments, (ii) funding the costs of our operations (including fees paid to our Adviser and expense reimbursements paid to our Administrator), (iii) debt service, repayment and other financing costs of our borrowings and (iv) cash distributions to the holders of our shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To&#160;facilitate public issuances of debt and/or equity securities, in July 2022, we filed a shelf registration statement with the SEC that is effective for a term of three years and expires in July 2025. The amount of securities to be issued pursuant to the shelf registration statement filed in July 2022 was not specified when it was filed and there is no specific dollar limit on the amount of securities we may issue. The securities covered by the registration statement filed in July 2022 include: (i) common shares; (ii) preferred shares; (iii) debt securities; (iv) subscription rights; and (v) warrants. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of any offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and December&#160;31, 2022, our debt consisted of asset based leverage facilities, a revolving credit facility, and unsecured note issuances. We may from time to time enter into additional credit facilities, increase the size of our existing credit facilities or issue further debt securities. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors. In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. As of December&#160;31, 2023 and December&#160;31, 2022, we had an aggregate amount of $4,937.9 million and $5,563.0 million of senior securities outstanding, respectively, and our asset coverage ratio was 200.3% and 174.8%, respectively. We seek to carefully consider our unfunded commitments for the purpose of planning our ongoing financial leverage. Further, we maintain sufficient borrowing capacity within the 150% asset coverage limitation to cover any outstanding unfunded commitments we are required to fund. From time to time we may also repurchase our outstanding debt. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, and other factors. The amounts involved in any such purchase transactions, individually or in the aggregate, may be material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents as of December&#160;31, 2023, taken together with our $1,662.1 million of unused capacity under our credit facilities (subject to borrowing base availability, $1,662.0 million is available to borrow) is expected to be sufficient for our investing activities and to conduct our operations in the near term. Additionally, we held $157.9 million of Level 2 debt investments as of December&#160;31, 2023, which could provide additional liquidity if necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although we have historically been able to obtain sufficient borrowing capacity, a deterioration in economic conditions or any other negative economic developments could restrict our access to financing in the future. We may not be able to find new financing for future investments or liquidity needs and, even if we are able to obtain such financing, such financing may not be on as favorable terms as we have previously obtained. These factors may limit our ability to make new investments and adversely impact our results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, we had &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$154.9 million in cash and cash equivalents. During the year ended December&#160;31, 2023, cash provided by operating activities was $458.8 million, primarily from receipt of interest payments from our investments, partially offset by purchases of investments, net of sales of investments and principal repayments, of $178.1 million.&#160;Cash used in financing activities was $432.2 million during the year, which was primarily as a result of net repayments on our credit facilities and Unsecured Notes of $650.9 million and dividends paid in cash of $438.0 million partially offset by $665.3 million of proceeds from the issuance of our common shares.&lt;/span&gt;&lt;/div&gt;</cef:InvestmentObjectivesAndPracticesTextBlock>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-4" decimals="-5" id="f-37" unitRef="usd">985900000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio contextRef="c-5" decimals="3" id="f-38" unitRef="number">2.003</us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio>
    <us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio contextRef="c-6" decimals="3" id="f-39" unitRef="number">1.748</us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio>
    <cef:RiskFactorsTableTextBlock contextRef="c-1" id="f-40">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Item 1A. Risk Factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investing in our shares involves a number of significant risks. In addition to the other information contained in this annual report, shareholders should consider carefully the following information before making an investment in our Common Shares. The risks set forth below are not the only risks we face. Such additional risks and uncertainties not presently known to us or not presently deemed material by us may also impair our operations and performance. If any of the following events occur, our business, financial condition and results of operations could be materially and adversely affected. In such cases, the NAV of our Common Shares could decline, and shareholders may lose all or part of their investment.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt"&gt;Risks Related to Our Business and Structure&lt;/span&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Price declines in the medium- and large-sized U.S. corporate debt market may adversely affect the fair value of our portfolio, reducing our NAV through increased net unrealized depreciation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Conditions in the medium- and large-sized U.S. corporate debt market may deteriorate, as seen during the recent financial crisis, which may cause pricing levels to similarly decline or be volatile. During the 2008-2009 financial crisis, many institutions were forced to raise cash by selling their interests in performing assets in order to satisfy margin requirements or the equivalent of margin requirements imposed by their lenders and/or, in the case of hedge funds and other investment vehicles, to satisfy widespread redemption requests. This resulted in a forced deleveraging cycle of price declines, compulsory sales, and further price declines, with falling underlying credit values, and other constraints resulting from the credit crisis generating further selling pressure. If similar events occurred in the medium- and large-sized U.S. corporate debt market, our NAV could decline through an increase in unrealized depreciation and incurrence of realized losses in connection with the sale of our investments, which could have a material adverse impact on our business, financial condition and results of operations and the market price of our shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our ability to achieve our investment objectives depends on the ability of the Adviser to manage and support our investment process. If the Adviser or Blackstone Credit &amp;amp; Insurance were to lose any members of their respective senior management teams, our ability to achieve our investment objectives could be significantly harmed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since we have no employees, we depend on the investment expertise, skill and network of business contacts of the broader networks of the Adviser and its affiliates. The Adviser evaluates, negotiates, structures, executes, monitors and services our investments. Our future success depends to a significant extent on the continued service and coordination of Blackstone Credit &amp;amp; Insurance and its senior management team. The departure of any members of Blackstone Credit &amp;amp; Insurance&#x2019;s senior management team could have a material adverse effect on our ability to achieve our investment objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our ability to achieve our investment objectives depends on the Adviser&#x2019;s ability to identify and analyze, and to invest in, finance and monitor companies that meet our investment criteria. The Adviser&#x2019;s capabilities in structuring the investment process, providing competent, attentive and efficient services to us, and facilitating access to financing on acceptable terms depend on the employment of investment professionals in an adequate number and of adequate sophistication to match the corresponding flow of transactions. To achieve our investment objectives, the Adviser may need to hire, train, supervise and manage new investment professionals to participate in our investment selection and monitoring process. The Adviser may not be able to find investment professionals in a timely manner or at all. Failure to support our investment process could have a material adverse effect on our business, financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Investment Advisory Agreement has been approved pursuant to Section 15 of the 1940 Act. In addition, the Investment Advisory Agreement has termination provisions that allow the parties to terminate the agreement. The Investment Advisory Agreement may be terminated at any time, without penalty, by us or by the Adviser, upon 60 days&#x2019; written notice. If the Investment Advisory Agreement is terminated, it may adversely affect the quality of our investment opportunities. In addition, in the event the Investment Advisory Agreement is terminated, it may be difficult for us to replace the Adviser. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Because our business model depends to a significant extent upon relationships with private equity sponsors, investment banks and commercial banks, the inability of the Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser depends on its broader organization&#x2019;s relationships with private equity sponsors, investment banks and commercial banks, and we rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the Adviser or its broader organization fail to maintain their existing relationships or develop new relationships with other sponsors or sources of investment opportunities, we may not be able to grow our investment portfolio. In addition, individuals with whom the Adviser or its broader organizations have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may face increasing competition for investment opportunities, which could delay deployment of our capital, reduce returns and result in losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We compete for investments with other BDCs and investment funds (including private equity funds, mezzanine funds, performing and other credit funds, and funds that invest in CLOs, structured notes, derivatives and other types of collateralized securities and structured products), as well as traditional financial services companies such as commercial banks and other sources of funding. These other BDCs and investment funds might be reasonable investment alternatives to us and may be less costly or complex with fewer and/or different risks than we have. Moreover, alternative investment vehicles, such as hedge funds, have begun to invest in areas in which they have not traditionally invested, including making investments in U.S. private companies. As a result of these new competitors entering the financing markets in which we operate, competition for investment opportunities in U.S. private companies may intensify. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of capital and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have. These characteristics could allow our competitors to consider a wider variety of investments, establish more relationships and offer better pricing and more flexible structuring than we are able to do. We may lose investment opportunities if we do not match our competitors&#x2019; pricing, terms or structure. If we are forced to match our competitors&#x2019; pricing, terms or structure, we may not be able to achieve acceptable returns on our investments or may bear substantial risk of capital loss. A significant part of our competitive advantage stems from the fact that the market for investments in U.S. private companies is underserved by traditional commercial banks and other financial sources. A significant increase in the number and/or the size of our competitors in this target market could force us to accept less attractive investment terms. Furthermore, many of our competitors have greater experience operating under, or are not subject to, the regulatory restrictions that the 1940 Act imposes on us as a BDC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may have difficulty sourcing investment opportunities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We cannot assure investors that we will be able to locate a sufficient number of suitable investment opportunities to allow us to deploy all available capital successfully. In addition, privately-negotiated investments in loans and illiquid securities of private middle market companies require substantial due diligence and structuring, and we cannot assure investors that we will achieve our anticipated investment pace. As a result, investors will be unable to evaluate any future portfolio company investments prior to purchasing our shares. Our shareholders will have no input with respect to investment decisions. These factors increase the uncertainty, and thus the risk, of investing in our shares. To the extent we are unable to deploy all available capital, our investment income and, in turn, our results of operations, will likely be materially adversely affected.&#160;There is no assurance that we will be able to consummate investment transactions or that such transactions will be successful.&#160;Blackstone Credit &amp;amp; Insurance, the Company and their affiliates may also face certain conflicts of interests in connection with any transaction, including any warehousing transaction, involving an affiliate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We face risks associated with the deployment of our capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In light of the nature of our periodic public offerings in relation to our investment strategy and the need to be able to deploy potentially large amounts of capital quickly to capitalize on potential investment opportunities, if we have difficulty identifying suitable investments on attractive terms, there could be a delay between the time we receive net proceeds from the sale of shares of our Common Shares in any periodic public offering and the time we invest the net proceeds. Our proportion of privately-negotiated investments may be lower than expected. We may also from time to time hold cash pending deployment into investments or have less than our targeted leverage, which cash or shortfall in target leverage may at times be significant, particularly at times when we are receiving high amounts of offering proceeds and/or times when there are few attractive investment opportunities. Such cash may be held in an account for the benefit of our shareholders that may be invested in money market accounts or other similar temporary investments, each of which is subject to management fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event we are unable to find suitable investments such cash may be maintained for longer periods which would be dilutive to overall investment returns. This could cause a substantial delay in the time it takes for your investment to realize its full potential return and could adversely affect our ability to pay regular distributions of cash flow from operations to you. It is not anticipated that the temporary investment of such cash into money market accounts or other similar temporary investments pending deployment into investments will generate significant interest, and investors should understand that such low interest payments on the temporarily invested cash may adversely affect overall returns. In the event we fail to timely invest the net proceeds of sales of our Common Shares or do not deploy sufficient capital to meet our targeted leverage, our results of operations and financial condition may be adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;As required by the 1940 Act, a significant portion of our investment portfolio is and will be recorded at fair value as determined in good faith and, as a result, there is and will be uncertainty as to the value of our portfolio investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 1940 Act, we are required to carry our portfolio investments at market value or, if there is no readily available market value, at fair value as determined pursuant to policies adopted by, and subject to the oversight of, our Board. There is not a public market for the securities of the privately-held companies in which we invest. Many of our investments are not publicly-traded or actively traded on a secondary market. As a result, we value these securities quarterly at fair value as determined in good faith as required by the 1940 Act. In connection with striking a NAV as of a date other than quarter end for share issuances and repurchases, the Company will consider whether there has been a material change to such investments as to affect their fair value, but such analysis will be more limited than the quarter end process.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of our valuation process, we will take into account relevant factors in determining the fair value of the Company&#x2019;s investments, without market quotations, many of which are loans, including and in combination, as relevant: (i) the estimated enterprise value of a portfolio company, (ii) the nature and realizable value of any collateral, (iii) the portfolio company&#x2019;s ability to make payments based on its earnings and cash flow, (iv) the markets in which the portfolio company does business, (v) a comparison of the portfolio company&#x2019;s securities to any similar publicly traded securities, and (vi) overall changes in the interest rate environment and the credit markets that may affect the price at which similar investments may be made in the future. Our determinations of fair value may differ materially from the values that would have been used if a ready market for these non-traded securities existed. Due to this uncertainty, our fair value determinations may cause our NAV on a given date to materially differ from the value that we may ultimately realize upon the sale of one or more of our investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;There is a risk that investors in our shares may not receive distributions or that our distributions may decrease over time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may not achieve investment results that will allow us to make a specified or stable level of cash distributions and our distributions may decrease over time. In addition, due to the asset coverage test applicable to us as a BDC, we may be limited in our ability to make distributions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The amount of any distributions we may make is uncertain. Our distributions may exceed our earnings, particularly during the period before we have substantially invested the net proceeds from any securities offering. Therefore, portions of the distributions that we make may represent a return of capital to a shareholder that will lower such shareholder&#x2019;s tax basis in its shares and reduce the amount of funds we have for investment in targeted assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may fund our cash distributions to shareholders from any sources of funds available to us, including offering proceeds, borrowings, net investment income from operations, capital gains proceeds from the sale of assets, non-capital gains proceeds from the sale of assets, dividends or other distributions paid to us on account of preferred and common equity investments in portfolio companies and fee and expense reimbursement waivers from the Adviser or the Administrator, if any. Our ability to pay distributions, if any, might be adversely affected by, among other things, the impact of one or more of the risk factors described in this annual report. In addition, the inability to satisfy the asset coverage test applicable to us as a BDC may limit our ability to pay distributions. All distributions are and will be paid at the discretion of our Board and will depend on our earnings, our financial condition, maintenance of our RIC status, compliance with applicable BDC regulations and such other factors as our Board may deem relevant from time to time. We cannot assure shareholders that we will continue to pay distributions to our shareholders in the future. In the event that we encounter delays in locating suitable investment opportunities, we may pay all or a substantial portion of our distributions from the proceeds of our prior offerings or from borrowings or sources other than cash flow from operations in anticipation of future cash flow, which may constitute a return of shareholders&#x2019; capital. A return of capital is a return of a shareholder&#x2019;s investment, rather than a return of earnings or gains derived from our investment activities. A shareholder will not be subject to immediate taxation on the amount of any distribution treated as a return of capital to the extent of the shareholder&#x2019;s basis in its shares; however, the shareholder&#x2019;s basis in its shares will be reduced (but not below zero) by the amount of the return of capital, which will result in the shareholder recognizing additional gain (or a lower loss) when the shares are sold. To the extent that the amount of the return of capital exceeds the shareholder&#x2019;s basis in its shares, such excess amount will be treated as gain from the sale of the shareholder&#x2019;s shares. Distributions from the proceeds of our prior offerings or from borrowings also could reduce the amount of capital we ultimately invest in our portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We have not established any limit on the amount of funds we may use from available sources, such as borrowings, if any, or proceeds from securities offerings, to fund distributions (which may reduce the amount of capital we ultimately invest in assets).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any distributions made from sources other than cash flow from operations or relying on fee or expense reimbursement waivers, if any, from the Adviser or the Administrator are not based on our investment performance, and can only be sustained if we achieve positive investment performance in future periods and/or the Adviser or the Administrator continues to make such expense reimbursements, if any. The extent to which we pay distributions from sources other than cash flow from operations will depend on various factors, including the level of participation in our dividend reinvestment plan, how quickly we invest the proceeds from this and any future offering and the performance of our investments. Shareholders should also understand that our future repayments to the Adviser will reduce the distributions that they would otherwise receive. There can be no assurance that we will achieve such performance in order to sustain these distributions, or be able to pay distributions at all. The Adviser and the Administrator have no obligation to waive fees or receipt of expense reimbursements, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;As a public reporting company, we are subject to regulations not applicable to private companies, such as provisions of the Sarbanes-Oxley Act. Efforts to comply with such regulations will involve significant expenditures, and non-compliance with such regulations may adversely affect us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a public reporting company, we are subject to the Sarbanes-Oxley Act, and the related rules and regulations promulgated by the SEC. Our management is required to report on our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. We are required to review on an annual basis our internal control over financial reporting, and on a quarterly and annual basis to evaluate and disclose changes in our internal control over financial reporting. Developing and maintaining an effective system of internal controls may require significant expenditures, which may negatively impact our financial performance and our ability to make distributions. This process also will result in a diversion of our management&#x2019;s time and attention. We cannot be certain of when our evaluation, testing and remediation actions will be completed or the impact of the same on our operations. In addition, we may be unable to ensure that the process is effective or that our internal controls over financial reporting are or will be effective in a timely manner. In the event that we are unable to develop or maintain an effective system of internal controls and maintain or achieve compliance with the Sarbanes-Oxley Act and related rules, we may be adversely affected. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Changes in laws or regulations governing our operations may adversely affect our business or cause us to alter our business strategy. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We, our portfolio companies and other counterparties are subject to regulation at the local, state and federal level. New legislation may be enacted or new interpretations, rulings or regulations could be adopted, including those governing the types of investments we are permitted to make, any of which could harm us and our shareholders, potentially with retroactive effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;President Biden may support an enhanced regulatory agenda that imposes greater costs on all sectors and on financial services companies in particular. In addition, uncertainty regarding legislation and regulations affecting the financial services industry or taxation could also adversely impact our business or the business of our portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, any changes to or repeal of the laws and regulations governing our operations relating to permitted investments may cause us to alter our investment strategy to avail ourselves of new or different opportunities. Such changes could result in material differences to our strategies and plans as set forth in this annual report and may result in our investment focus shifting from the areas of expertise of the Adviser to other types of investments in which the Adviser may have less expertise or little or no experience. Thus, any such changes, if they occur, could have a material adverse effect on our financial condition and results of operations and the value of a shareholder&#x2019;s investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial regulatory changes in the United States could adversely affect our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial services industry continues to be the subject of heightened regulatory scrutiny in the United States. There has been active debate over the appropriate extent of regulation and oversight of investment funds and their managers. We may be adversely affected as a result of new or revised regulations imposed by the SEC or other U.S. governmental regulatory authorities or self-regulatory organizations that supervise the financial markets. We also may be adversely affected by changes in the interpretation or enforcement of existing laws and regulations by these governmental authorities and self-regulatory organizations. Further, new regulations or interpretations of existing laws may result in enhanced disclosure obligations, including with respect to climate change or environmental, social and governance factors, which could negatively affect us and materially increase our regulatory burden. Increased regulations generally increase our costs, and we could continue to experience higher costs if new laws require us to spend more time or buy new technology to comply effectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any changes in the regulatory framework applicable to our business, including the changes described above, may impose additional compliance and other costs, increase regulatory investigations of the investment activities of our funds, require the attention of our senior management, affect the manner in which we conduct our business and adversely affect our profitability. The full extent of the impact on us of any new laws, regulations or initiatives that may be proposed is impossible to determine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We, the Adviser and its affiliates are subject to regulatory oversight, which could negatively impact our operations, cash flow or financial condition, impose additional costs on us or otherwise adversely affect our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our business and the businesses of the Adviser and its affiliates are subject to&#160;extensive regulation, including periodic examinations, inquiries and investigations which may result in enforcement and other proceedings, by governmental agencies&#160;and self-regulatory organizations in the jurisdictions in which we and they operate around the world, including the SEC and various other U.S. federal, state&#160;and local agencies. These&#160;authorities have regulatory powers dealing with many aspects of financial services, including the authority to&#160;grant, and in specific circumstances to cancel, permissions to carry on particular activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We, the Adviser and its respective affiliates have received, and may in the future receive, requests for information, inquiries and informal or formal investigations or subpoenas from such regulators from time to time in connection with such inquiries and proceedings and otherwise in the ordinary course of business. These requests could relate to a broad range of matters, including specific practices of our business, the Adviser, our investments or other investments the Adviser or its affiliates make on behalf of their clients, potential conflicts of interest between us and the Adviser or its affiliates, or industry wide practices. SEC actions and initiatives can have an adverse effect on our financial results,&#160;including as a result of the imposition of a sanction, a limitation on our, Blackstone&#x2019;s or our personnel&#x2019;s&#160;activities, or changing our historic practices. Any adverse publicity relating to an investigation, proceeding or imposition of these sanctions could&#160;harm our or Blackstone&#x2019;s reputation and have an&#160;adverse effect on our future fundraising or operations. The costs of responding to legal or regulatory&#160;information requests, any increased reporting, registration and compliance requirements will be borne by us&#160;in the form of legal or other expenses, litigation, regulatory proceedings or penalties, may divert the attention of our management, may cause negative publicity that adversely affects investor sentiment, and may place us at a competitive disadvantage, including to the extent that we, the Adviser or any of its affiliates are required to disclose sensitive business information or alter business practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, efforts by the current administration or future administrations could have further impacts on our industry if previously enacted laws are amended or if new legislative or regulatory reforms are adopted. In addition, a future change in administration may lead to leadership changes at a number of U.S. federal regulatory agencies with oversight over the U.S. financial services industry. Such changes would pose uncertainty with respect to such agencies&#x2019; ongoing policy priorities and could lead to increased regulatory enforcement activity in the financial services industry. Any changes or reforms may impose additional costs on our current or future investments, require the attention of senior management or result in other limitations on our business or investments. We are unable to predict at this time the likelihood or effect of any such changes or reforms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The impact of financial reform legislation on us is uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In light of past market conditions in the U.S. and global financial markets, the U.S. and global economy, legislators, the presidential administration and regulators have increased their focus on the regulation of the financial services industry, including the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Dodd-Frank Act,&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which instituted a wide range of reforms that have impacted all financial institutions to varying degrees. Because these requirements are relatively new and evolving, the full impact such requirements will have on our business, results of operations or financial condition is unclear. While we cannot predict what effect any changes in the laws or regulations or their interpretations would have on us, these changes could be materially adverse to us and our shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any changes in the regulatory framework applicable to our business, including the changes described above, may impose additional compliance and other costs, increase regulatory investigations of the investment activities of our funds, require the attention of our senior management, affect the manner in which we conduct our business and adversely affect our profitability. The full extent of the impact on us of any new laws, regulations or initiatives that may be proposed is impossible to determine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may experience fluctuations in our quarterly results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We could experience fluctuations in our quarterly operating results due to a number of factors, including our ability or inability to make investments in companies that meet our investment criteria, the interest rate payable on the loans or other debt securities we originate or acquire, the level of our expenses (including our borrowing costs), variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our markets and general economic conditions. As a result of these factors, results for any previous period should not be relied upon as being indicative of performance in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transactions denominated in foreign currencies subject us to foreign currency risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hold assets and have made borrowings denominated in foreign currencies and may acquire assets or make borrowings denominated in other foreign currencies, which exposes us to foreign currency risk. As a result, a change in foreign currency exchange rates may have an adverse impact on the valuation of our assets or liabilities, as well as our income and cash flows. As a result of foreign currency fluctuations, the value of our liabilities and expenses may increase or the value of our assets and income may decrease due to factors outside of our control, which can have a negative effect on our NAV and cash available for distribution. Any such changes in foreign currency exchange rates may impact the measurement of such assets or liabilities for purposes of maintaining RIC tax treatment or the requirements under the 1940 Act. We may seek to hedge against currency exchange rate fluctuations by using financial instruments such as futures, options, swaps and forward contracts, subject to the requirements of the 1940 Act, but there is no guarantee such efforts will be successful and such hedging strategies create additional costs. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;We may acquire various financial instruments for purposes of &#x201c;hedging&#x201d; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General economic conditions could adversely affect the performance of our investments and operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We and our portfolio companies are susceptible to the effects of economic slowdowns or recessions. The global growth cycle is in a mature phase and signs of slowdown are evident in certain regions around the world, although most economists continue to expect moderate economic growth in the near term, with limited signals of an imminent recession in the U.S. as consumer and government spending remain healthy. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of non&#x2011;performing loans on the balance sheets of European banks, the effect of the United Kingdom (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;U.K.&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) leaving the European Union (the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x201c;E.U.&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), instability in the Chinese capital markets and the COVID-19 pandemic. Although the broader outlook remains constructive, geopolitical instability continues to pose risk. In particular, the current U.S. political environment and the resulting uncertainties regarding actual and potential shifts in U.S. foreign investment, trade, taxation, economic, environmental and other policies under the current Administration, as well as the impact of geopolitical tension, such as a deterioration in the bilateral relationship between the U.S. and China or the current ongoing conflict between Russia and Ukraine and the escalating conflict in the Middle East, and the rapidly evolving measures in response, could lead to disruption, instability and volatility in the global markets. Certain of our portfolio companies may operate in, or have dealings with, countries subject to sanctions or embargoes imposed by the U.S. government, foreign governments, or the United Nations or other international organizations. U.S. debt ceiling and budget deficit concerns have increased the possibility of additional credit-rating downgrades and economic slowdowns or a recession in the United States. A decreased U.S. government credit rating, any default by the U.S. government on its obligations, or any prolonged U.S. government shutdown, could create broader financial turmoil and uncertainty, which may weigh heavily on our financial performance and the value of our common shares. Unfavorable economic conditions would be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events may limit our investment originations, and limit our ability to grow and could have a material negative impact on our operating results, financial condition, results of operations and cash flows and the fair values of our debt and equity investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any deterioration of general economic conditions may lead to significant declines in corporate earnings or loan performance, and the ability of corporate borrowers to service their debt, any of which could trigger a period of global economic slowdown, and have an adverse impact on the performance and financial results of the Company, and the value and the liquidity of the shares. In an economic downturn, we may have non-performing assets or non-performing assets may increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions&#160;impacted&#160;the value of any collateral securing our senior secured debt in 2023 and may continue to impact such collateral in 2024. A severe recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income, assets and net worth. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on favorable terms or at all. These events could prevent us from increasing investments and harm our operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the failure of certain financial institutions, namely banks, may increase the possibility of a sustained deterioration of financial market liquidity, or illiquidity at clearing, cash management and/or custodial financial institutions. The failure of a bank (or banks) with which we and/or our portfolio companies have a commercial relationship could adversely affect, among other things, our and/or our portfolio companies&#x2019; ability to pursue key strategic initiatives, including by affecting our or our portfolio company&#x2019;s ability to access deposits or borrow from financial institutions on favorable terms. Additionally, if a portfolio company or its sponsor has a commercial relationship with a bank that has failed or is otherwise distressed, the portfolio company may experience issues receiving financial support from a sponsor to support its operations or consummate transactions, to the detriment of their business, financial condition and/or results of operations. In addition, such bank failure(s) could affect, in certain circumstances, the ability of both affiliated and unaffiliated co-lenders, including syndicate banks or other fund vehicles, to undertake and/or execute co-investment transactions with the Company, which in turn may result in fewer co-investment opportunities being made available to the Company or impact the Company&#x2019;s ability to provide additional follow-on support to portfolio companies. The ability of the Company, its subsidiaries and portfolio companies to spread banking relationships among multiple institutions may be limited by certain contractual arrangements, including liens placed on their respective assets as a result of a bank agreeing to provide financing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inflation and supply chain risks have had and may continue to have an adverse impact on our financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inflation in the United States remained elevated throughout 2022 and 2023 and may continue to remain high in the future. While inflation has shown signs of moderating, it remains uncertain whether substantial inflation in the United States will be sustained over an extended period of time or have a significant effect on the United States or other economies. Elevated inflation could have an adverse impact on our operating costs, credit facilities, and general and administrative expenses, as these costs could increase at a rate higher than our revenue. Certain of our portfolio companies are in industries that have been impacted by inflation and global supply chain issues. Recent inflationary pressures have increased the costs of labor, energy and raw materials and have adversely affected consumer spending, economic growth and our portfolio companies&#x2019; operations and such pressures and related volatility may continue during 2024. If such portfolio companies are unable to pass any increases in their costs of operations along to their customers, it could adversely affect their operating results and impact their ability to pay interest and principal on our loans, particularly if interest rates rise in response to inflation. In addition, any projected future decreases in our portfolio companies&#x2019; operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of our investments could result in future realized or unrealized losses and therefore reduce our net assets resulting from operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may be impacted by general European economic conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success of our investment activities could be affected by general economic and market conditions in Europe and in the rest of the world, as well as by changes in applicable laws and regulations (including laws relating to taxation of our investments), trade barriers, currency exchange controls, rate of inflation, currency depreciation, asset re-investment, resource self-sufficiency and national and international political and socioeconomic circumstances in respect of the European and other non-U.S. countries in which we may invest. These factors will affect the level and volatility of securities prices and the liquidity of the Company&#x2019;s investments, which could impair our profitability or result in losses. General fluctuations in the market prices of securities and interest rates may affect our investment opportunities and the value of our investments. We may maintain substantial trading positions that can be adversely affected by the level of volatility in the financial markets; the larger the positions, the greater the potential for loss. Declines in the performance of national economies or the credit markets in certain jurisdictions have had a negative impact on general economic and market conditions globally, and as a result, could have a material adverse effect on our business, financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser&#x2019;s financial condition may be adversely affected by a significant general economic downturn and it may be subject to legal, regulatory, reputational and other unforeseen risks that could have a material adverse effect on the Adviser&#x2019;s businesses and operations (including those of the Company). A recession, slowdown and/or sustained downturn in the global economy (or any particular segment thereof) could have a pronounced impact on the Company and could adversely affect the Company&#x2019;s profitability, impede the ability of the Company&#x2019;s portfolio companies to perform under or refinance their existing obligations and impair the Company&#x2019;s ability to effectively deploy its capital or realize its investments on favorable terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, economic problems in a single country are increasingly affecting other markets and economies. A continuation of this trend could result in problems in one country adversely affecting regional and even global economic conditions and markets. For example, concerns about the fiscal stability and growth prospects of certain European countries in the last economic downturn had a negative impact on most economies of the Eurozone and global markets and the current ongoing conflict between Russia and Ukraine could have a negative impact on those countries and others in the region. The occurrence of similar crises in the future could cause increased volatility in the economies and financial markets of countries throughout a region, or even globally.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any of the foregoing events could result in substantial or total losses to the Company in respect of certain investments, which losses will likely be exacerbated by the presence of leverage in a portfolio company&#x2019;s capital structure. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;It may be difficult to bring suit or foreclosure in non-U.S. countries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because the effectiveness of the judicial systems in the countries in which the Company may invest varies, the Company (or any portfolio company) may have difficulty in foreclosing or successfully pursuing claims in the courts of such countries, as compared to the United States or other countries. Further, to the extent the Company or a portfolio company may obtain a judgment but is required to seek its enforcement in the courts of one of these countries in which the Company invests, there can be no assurance that such courts will enforce such judgment. The laws of other countries often lack the sophistication and consistency found in the United States with respect to foreclosure, bankruptcy, corporate reorganization or creditors&#x2019; rights. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;MiFID II obligations could have an adverse effect on the ability of Blackstone Credit &amp;amp; Insurance and its MiFID-authorized EEA affiliates to obtain and research in connection with the provision of an investment service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Recast European Union Directive on Markets in Financial Instruments (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;MiFID II&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) came into effect on January 3, 2018, and imposes regulatory obligations in respect of providing financial services in the European Economic Area (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;EEA&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) by EEA banks and EEA investment firms providing regulated services (each an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Investment Firm&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). The Adviser is a non-EEA investment company and is, therefore, not subject to MiFID II but can be indirectly affected. The regulatory obligations imposed by MiFID II may impact, and constrain the implementation of, the investment strategy of the Company. MiFID II restricts Investment Firms&#x2019; ability to obtain research in connection with the provision of an investment service. For example, Investment Firms providing portfolio management or independent investment advice may purchase investment research only at their own expense or out of specifically dedicated research payment accounts agreed upon with their clients. Research will also have to be unbundled and paid separately from the trading commission. EEA broker-dealers will unbundle research costs and invoice them to Investment Firms separated from dealing commissions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Therefore, in light of the above, MiFID II could have an adverse effect on the ability of Blackstone Credit &amp;amp; Insurance and its MiFID-authorized EEA affiliates to obtain and to provide research. The new requirements regarding the unbundling of research costs under MiFID II are not consistent with market practice in the United States and the regulatory framework concerning the use of commissions to acquire research developed by the SEC, although the SEC has issued temporary no-action letters to facilitate compliance by firms with the research requirements under MiFID II in a manner that is consistent with the U.S. federal securities laws. Blackstone Credit &amp;amp; Insurance&#x2019;s access to third-party research may nonetheless be significantly limited. Some EEA jurisdictions extend certain MiFID II obligations also to other market participants (e.g., Alternative Investment Fund Managers) under national law. There is very little guidance, and limited market practice, that has developed in preparation for MiFID II. As such, the precise impact of MiFID II on Blackstone Credit &amp;amp; Insurance and the Company cannot be fully predicted at this stage. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Any unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available for distribution.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at the fair value as determined in good faith pursuant to procedures adopted by, and under oversight of, our Board. Decreases in the market value or fair value of our investments relative to amortized cost will be recorded as unrealized depreciation. Any unrealized losses in our portfolio could be an indication of a portfolio company&#x2019;s inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods. In addition, decreases in the market value or fair value of our investments will reduce our NAV.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Terrorist attacks, acts of war or natural disasters may adversely affect our operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Terrorist acts, acts of war or natural disasters may disrupt our operations, as well as the operations of the businesses in which we invest. Such acts, including the current ongoing conflict between Russia and Ukraine and the escalating conflict in the Middle East, have created, and continue to create, economic and political uncertainties and have contributed to recent global economic instability. Future terrorist activities, military or security operations, or natural disasters could further weaken the domestic/global economies and create additional uncertainties, which may negatively impact the businesses in which we invest directly or indirectly and, in turn, could have a material adverse impact on our business, operating results and financial condition. Losses from terrorist attacks and natural disasters are generally uninsurable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Force Majeure events may adversely affect our operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may be affected by force majeure events (e.g., acts of God, fire, flood, earthquakes, outbreaks of an infectious disease, pandemic or any other serious public health concern, war, terrorism, nationalization of industry and labor strikes). Force Majeure events could adversely affect the ability of the Company or a counterparty to perform its obligations. The liability and cost arising out of a failure to perform obligations as a result of a force majeure event could be considerable and could be borne by the Company. Certain Force Majeure events, such as war or an outbreak of an infectious disease, could have a broader negative impact on the global or local economy, thereby affecting us. Additionally, a major governmental intervention into industry, including the nationalization of an industry or the assertion of control, could result in a loss to the Company if an investment is affected, and any compensation provided by the relevant government may not be adequate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Another pandemic or global health crisis like the COVID-19 pandemic may adversely impact our performance and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From 2020 to 2022, in response to the COVID-19 pandemic, many countries instituted quarantine restrictions and took other measures to limit the spread of the virus. This resulted in labor shortages and disruption of supply chains and contributed to prolonged disruption of the global economy. A widespread reoccurrence of another pandemic or global health crisis could increase the possibility of periods of increased restrictions on business operations, which may adversely impact our business, financial condition, results of operations, liquidity and prospects materially and exacerbate many of the other risks discussed in this &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Risk Factors&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; section.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of another pandemic or global health crisis like the COVID-19 pandemic, our portfolio companies may experience decreased revenues and earnings, which may adversely impact our ability to realize value from such investments and in turn reduce our performance revenues. Investments in certain sectors, including hospitality, location-based entertainment, retail, travel, leisure and events, and in certain geographies, office and residential, could be particularly negatively impacted, as was the case during the COVID-19 pandemic. Our portfolio companies may also face increased credit and liquidity risk due to volatility in financial markets, reduced revenue streams and limited access or higher cost of financing, which may result in potential impairment of our investments. In addition, borrowers of loans, notes and other credit instruments may be unable to meet their principal or interest payment obligations or satisfy financial covenants, resulting in a decrease in value of our investments. In the event of significant credit market contraction as a result of a pandemic or similar global health crisis, we may be limited in our ability to sell assets at attractive prices or in a timely manner in order to avoid losses and margin calls from credit providers. Shareholders may also be negatively impacted if we experience a decline in the pace of capital deployment or fundraising.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, a pandemic or global health crisis may pose enhanced operational risks. For example, the employees of our Adviser and/or its affiliates may become sick or otherwise unable to perform their duties for an extended period, and extended public health restrictions and remote working arrangements may affect our Adviser and/or its affiliates by impacting employee morale, integration of new employees and preservation of their culture. Remote working environments may also be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts. Moreover, our third-party service providers could be impacted by an inability to perform due to pandemic-related restrictions or by failures of, or attacks on, their technology platforms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cybersecurity and data protection risks could result in the loss of data, interruptions in our business, and damage to our reputation, and subject us to regulatory actions&#160;, increased costs and financial losses, each of which could have a material adverse effect on our business and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operations are highly dependent on technology platforms and we rely heavily on Blackstone&#x2019;s and its affiliates&#x2019; analytical, financial, accounting, communications and other data processing systems. Blackstone&#x2019;s and its affiliates&#x2019; systems face ongoing cybersecurity threats and attacks, which could result in the loss of confidentiality, integrity or availability of such systems and the data held by such systems. Attacks on Blackstone&#x2019;s and/or its affiliates&#x2019; systems could involve, and in some instances have in the past involved, attempts intended to obtain unauthorized access to our proprietary information, destroy data or disable, degrade or sabotage our systems, or divert or otherwise steal funds, including through the introduction of computer viruses, &#x201c;phishing&#x201d; attempts and other forms of social engineering. Attacks on Blackstone&#x2019;s and/or its affiliates&#x2019; systems could also involve ransomware or other forms of cyber extortion. Cyberattacks and other data security threats could originate from a wide variety of external sources, including cyber criminals, nation state hackers, hacktivists and other outside parties. Cyberattacks and other security threats could also originate from the malicious or accidental acts of insiders, such as employees, consultants, independent contractors or other service providers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There has been an increase in the frequency and sophistication of the cyber and data security threats, with attacks ranging from those common to businesses generally to those that are more advanced and persistent, which may target Blackstone and/or its affiliates because they hold a significant amount of confidential and sensitive information about investors, portfolio companies and potential investments. As a result, Blackstone&#x2019;s and its affiliates&#x2019; may face a heightened risk of a security breach or disruption with respect to this information. Measures taken by Blackstone&#x2019;s and/or its affiliates&#x2019; to ensure the integrity of their systems may not provide adequate protection, especially because cyberattack techniques are continually evolving, may persist undetected over extended periods of time, and may not be mitigated in a timely manner to prevent or minimize the impact of an attack on Blackstone and/or its affiliates&#x2019;, our investors, our portfolio companies or potential investments. If Blackstone&#x2019;s and/or its affiliates&#x2019; systems or those of third party service providers are compromised either as a result of malicious activity or through inadvertent transmittal or other loss of data, do not operate properly or are disabled, or we fail to provide the appropriate regulatory or other notifications in a timely manner, we could suffer financial loss, increased costs, a disruption of our businesses, liability to our counterparties, portfolio companies or fund investors, regulatory intervention or reputational damage. The costs related to cyber or other data security threats or disruptions may not be fully insured or indemnified by other means.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we could also suffer losses in connection with updates to, or the failure to timely update, the technology platforms on which we rely. We are reliant on third party service providers for certain aspects of our business, including for our administration, as well as for certain technology platforms, including cloud-based services. These third-party service providers could also face ongoing cybersecurity threats and compromises of their systems and as a result, unauthorized individuals could gain, and in some past instances have gained, access to certain confidential data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cybersecurity and data protection have become top priorities for regulators around the world. Many jurisdictions in which we, Blackstone and/or its affiliates operate have laws and regulations relating to privacy, data protection and cybersecurity, including, as examples, the General Data Protection Regulation (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;GDPR&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) in the European Union, the U.K. Data Protection Act, and the California Privacy Rights Act (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;CPRA&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). For example, in February 2022, the SEC proposed rules regarding registered investment advisers' and funds' cybersecurity risk management requiring the adoption and implementation of cybersecurity policies and procedures, enhanced disclosure in regulatory filings and prompt reporting of incidents to the SEC, which, if adopted, could increase our compliance costs and potential regulatory liability related to cybersecurity. Some jurisdictions have also enacted or proposed laws requiring companies to notify individuals and government agencies of data security breaches involving certain types of personal data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Breaches in our, Blackstone&#x2019;s and/or its affiliates&#x2019; security or in the security of third party service providers, whether malicious in nature or through inadvertent transmittal or other loss of data, could potentially jeopardize our, Blackstone&#x2019;s and/or its affiliates&#x2019;, including the Adviser&#x2019;s, employees or our shareholders' or counterparties' confidential, proprietary and other information processed and stored in, and transmitted through, computer systems and networks, or otherwise cause interruptions or malfunctions in our, Blackstone&#x2019;s and/or its affiliates&#x2019;, including the Adviser&#x2019;s, employees', our shareholders', our counterparties' or third parties' business and operations, which could result in significant financial losses, increased costs, liability to our shareholders and other counterparties, regulatory intervention and reputational damage. Furthermore, if we, Blackstone and/or its affiliates fail to comply with the relevant laws and regulations or fail to provide the appropriate regulatory or other notifications of breach in a timely matter, it could result in regulatory investigations and penalties, which could lead to negative publicity and reputational harm and may cause our shareholders to lose confidence in the effectiveness of our security measures and Blackstone more generally.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our portfolio companies also rely on data processing systems and the secure processing, storage and transmission of information, including payment and health information, which in some instances are provided by third parties. A disruption or compromise of these systems could have a material adverse effect on the value of these businesses. We may invest in strategic assets having a national or regional profile or in infrastructure, the nature of which could expose them to a greater risk of being subject to a terrorist attack or a security breach than other assets or businesses. Such an event may have material adverse consequences on our investment or assets of the same type or may require portfolio companies to increase preventative security measures or expand insurance coverage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finally, Blackstone&#x2019;s and/or its affiliates&#x2019; and our portfolio companies' technology platforms, data and intellectual property are also subject to a heightened risk of theft or compromise to the extent they engage in operations outside the United States, in particular in those jurisdictions that do not have comparable levels of protection of proprietary information and assets such as intellectual property, trademarks, trade secrets, know-how and customer information and records. In addition, they may be required to compromise protections or forego rights to technology, data and intellectual property in order to operate in or access markets in a foreign jurisdiction. Any such direct or indirect compromise of these assets could have a material adverse impact on us and our portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may not be able to obtain and maintain all required state licenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may be required to obtain various state licenses in order to, among other things, originate commercial loans. Applying for, obtaining and maintaining required licenses can be costly and take several months. There is no assurance that we will obtain, and maintain, all of the licenses that we need on a timely basis. Furthermore, we will be subject to various information and other requirements in order to obtain and maintain these licenses, and there is no assurance that we will satisfy those requirements. Our failure to obtain or maintain licenses might restrict investment options and have other adverse consequences.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Compliance with the SEC&#x2019;s Regulation Best Interest by participating broker-dealers may negatively impact our ability to raise capital in a public offering, which could harm our ability to achieve our investment objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Broker-dealers are required to comply with Regulation Best Interest, which, among other requirements, establishes a new standard of conduct for broker-dealers and their associated persons when making a recommendation of any securities transaction or investment strategy involving securities to a retail customer. The full impact of Regulation Best Interest on participating broker-dealers cannot be determined at this time, and it may negatively impact whether participating broker-dealers and their associated persons recommend the offering to certain retail customers. In particular, under SEC guidance concerning Regulation Best Interest, a broker-dealer recommending an investment in our shares should consider a number of factors, under the care obligation of Regulation Best Interest, including but not limited to cost and complexity of the investment and reasonably available alternatives in determining whether there is a reasonable basis for the recommendation. As a result, high cost, high risk and complex products may be subject to greater scrutiny by broker-dealers. Broker-dealers may recommend a more costly or complex product as long as they have a reasonable basis to believe is in the best interest of a particular retail customer. However, if broker-dealers choose alternatives to our shares, many of which likely exist, such as an investment in listed entities, which may be a reasonable alternative to an investment in us as such investments may feature characteristics like lower cost, nominal commissions at the time of initial purchase, less complexity and lesser or different risks, our ability to raise capital will be adversely affected. If compliance by broker-dealers with Regulation Best Interest negatively impacts our ability to raise capital in a public offering, it may harm our ability to create a diversified portfolio of investments and achieve our investment objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;As a Delaware statutory trust, we are subject to the control share acquisition statute contained in the Delaware Statutory Trust Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is organized as a Delaware statutory trust and thus is subject to the control share acquisition statute contained in Subchapter III of the Delaware Statutory Trust Act (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;DSTA Control Share Statute&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). The DSTA Control Share Statute applies to any closed-end management investment company that has elected to be regulated as a business development company under the 1940 Act organized as a Delaware statutory trust and listed on a national securities exchange, such as the Company. The DSTA Control Share Statute became automatically applicable to the Company on August 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The DSTA Control Share Statute defines &#x201c;control beneficial interests&#x201d; (referred to as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;control shares&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; herein) by reference to a series of voting power thresholds and provides that a holder of control shares acquired in a control share acquisition has no voting rights under the Delaware Statutory Trust Act (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;DSTA&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) or the Company&#x2019;s governing documents with respect to the control shares acquired in the control share acquisition, except to the extent approved by the Company&#x2019;s shareholders by the affirmative vote of two&#x2013;thirds of all the votes entitled to be cast on the matter, excluding all interested shares (generally, shares held by the acquiring person and their associates and shares held by Company insiders).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The DSTA Control Share Statute provides for a series of voting power thresholds above which shares are considered control shares. Whether one of these thresholds of voting power is met is determined by aggregating the holdings of the acquiring person as well as those of his, her or its &#x201c;associates.&#x201d; These thresholds are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) 10% or more, but less than 15% of all voting power;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) 15% or more, but less than 20% of all voting power;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) 20% or more, but less than 25% of all voting power;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4) 25% or more, but less than 30% of all voting power;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5) 30% or more, but less than a majority of all voting power; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6) a majority or more of all voting power.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the DSTA Control Share Statute, once a threshold is reached, an acquirer has no voting rights with respect to shares in excess of that threshold (i.e., the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;control shares&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) until approved by a vote of shareholders, as described above, or otherwise exempted by the Board of Trustees. The DSTA Control Share Statute contains a statutory process for an acquiring person to request a shareholder meeting for the purpose of considering the voting rights to be accorded control shares. An acquiring person must repeat this process at each threshold level.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the DSTA Control Share Statute, an acquiring person&#x2019;s &#x201c;associates&#x201d; are broadly defined to include, among others, relatives of the acquiring person, anyone in a control relationship with the acquiring person, any investment fund or other collective investment vehicle that has the same investment adviser as the acquiring person, any investment adviser of an acquiring person that is an investment fund or other collective investment vehicle and any other person acting or intending to act jointly or in concert with the acquiring person.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Voting power under the DSTA Control Share Statute is the power (whether such power is direct or indirect or through any contract, arrangement, understanding, relationship or otherwise) to directly or indirectly exercise or direct the exercise of the voting power of shares of the Company in the election of the Trustees (either generally or with respect to any subset, series or class of trustees, including any Trustees elected solely by a particular series or class of shares, such as the preferred shares).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any control shares of the Company acquired before August 1, 2022 are not subject to the DSTA Control Share Statute; however, any further acquisitions on or after August 1, 2022 are considered control shares subject to the DSTA Control Share Statute.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The DSTA Control Share Statute requires shareholders to disclose to the Company any control share acquisition within 10 days of such acquisition, and also permits the Company to require a shareholder or an associate of such person to disclose the number of shares owned or with respect to which such person or an associate thereof can directly or indirectly exercise voting power. Further, the DSTA Control Share Statute requires a shareholder or an associate of such person to provide to the Company within 10 days of receiving a request therefor from the Company any information that the Trustees reasonably believe is necessary or desirable to determine whether a control share acquisition has occurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The DSTA Control Share Statute permits the Board, through a provision in the Company&#x2019;s governing documents or by Board action alone, to eliminate the application of the DSTA Control Share Statute to the acquisition of control shares in the Company specifically, generally, or generally by types, as to specifically identified or unidentified existing or future beneficial owners or their affiliates or associates or as to any series or classes of shares. The DSTA Control Share Statute does not provide that the Company can generally &#x201c;opt out&#x201d; of the application of the DSTA Control Share Statute; rather, specific acquisitions or classes of acquisitions may be exempted by the Board, either in advance or retroactively, but other aspects of the DSTA Control Share Statute, which are summarized above, would continue to apply. The DSTA Control Share Statute further provides that the Board of Trustees is under no obligation to grant any such exemptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The foregoing is only a summary of the material terms of the DSTA Control Share Statute. Shareholders should consult their own counsel with respect to the application of the DSTA Control Share Statute to any particular circumstance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our Declaration of Trust includes exclusive forum and jury trial waiver provisions that could limit a shareholder&#x2019;s ability to bring a claim or, if such provisions are deemed inapplicable or unenforceable by a court, may cause the Company to incur additional costs associated with such action.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Declaration of Trust provides that, to the fullest extent permitted by law, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of a duty owed by any trustee, officer or other agent of the Company to the Company or our shareholders, (iii) any action asserting a claim arising pursuant to any provision of Title 12 of the Delaware Code, Delaware statutory or common law, our Declaration of Trust, or (iv) any action asserting a claim governed by the internal affairs doctrine (for the avoidance of doubt, including any claims brought to interpret, apply or enforce the federal securities laws of the United States, including, without limitation, the 1940 Act or the securities or anti-fraud laws of any international, national, state, provincial, territorial, local or other governmental or regulatory authority, including, in each case, the applicable rules and regulations promulgated thereunder) shall be the Court of Chancery of the State of Delaware or, if such court does not have subject matter jurisdiction thereof, any other court in the State of Delaware with subject matter jurisdiction. In addition, our Declaration of Trust provides that no shareholder may maintain a derivative action on behalf of the Company unless holders of at least ten percent (10%) of the outstanding shares join in the bringing of such action. These provisions of our Declaration of Trust may make it more difficult for shareholders to bring a derivative action than a company without such provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Declaration of Trust also includes an irrevocable waiver of the right to trial by jury in all such claims, suits, actions and proceedings. Any person purchasing or otherwise acquiring any of our Common Shares shall be deemed to have notice of and to have consented to these provisions of our Declaration of Trust. These provisions may limit a shareholder&#x2019;s ability to bring a claim in a judicial forum or in a manner that it finds favorable for disputes with the Company or the Company&#x2019;s trustees or officers, which may discourage such lawsuits. Alternatively, if a court were to find the exclusive forum provision or the jury trial waiver provision to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions or in other manners, which could have a material adverse effect on our business, financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notwithstanding any of the foregoing, neither we nor any of our investors are permitted to waive compliance with any provision of the U.S. federal securities laws and the rules and regulations promulgated thereunder.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our Board may change our operating policies and strategies without prior notice or shareholder approval, the effects of which may be adverse to our results of operations and financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board has the authority to modify or waive our current operating policies, investment criteria and strategies without prior notice and without shareholder approval, unless required by the 1940 Act or applicable law. We cannot predict the effect any changes to our current operating policies, investment criteria and strategies would have on our business, NAV, operating results and value of our shares. However, the effects might be adverse, which could negatively impact our ability to pay shareholders distributions and cause shareholders to lose all or part of their investment. Moreover, we have significant flexibility in investing the net proceeds from our continuous offering and may use the net proceeds from our continuous offering in ways with which investors may not agree or for purposes other than those contemplated in this annual report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our Board may amend our Declaration of Trust without prior shareholder approval.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board may, without shareholder vote, subject to certain exceptions, amend or otherwise supplement the Declaration of Trust by making an amendment, a Declaration of Trust supplemental thereto or an amended and restated Declaration of Trust, including without limitation to classify the Board, to impose advance notice bylaw provisions for Trustee nominations or for shareholder proposals, to require super-majority approval of transactions with significant shareholders or other provisions that may be characterized as anti-takeover in nature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain provisions of our Declaration of Trust could deter takeover attempts and have an adverse impact on the value of our common shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Declaration of Trust contains anti-takeover provisions that could have the effect of limiting the ability of other entities or persons to acquire control of the Company or to change the composition of our Board of Trustees. Our Board of Trustees is divided into three classes of trustees serving staggered three-year terms. This provision could delay for up to two years the replacement of a majority of our Board of Trustees. These provisions could have the effect of depriving shareholders of an opportunity to sell their common shares at a premium over prevailing market prices by discouraging a third party from seeking to obtain control over the Company.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt"&gt;Risks Related to Our Investments&lt;/span&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our investments in prospective portfolio companies may be risky, and we could lose all or part of our investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investments in senior secured loans, senior secured bonds, subordinated debt and equity of private U.S. companies, including middle market companies, may be risky and, subject to compliance with our 80% policy, there is no limit on the amount of any such investments in which we may invest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Secured Loans and Senior Secured Bonds. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There is a risk that any collateral pledged by portfolio companies in which we have taken a security interest may decrease in value over time or lose its entire value, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. Such risks have become more pronounced due to rising interest rates and market volatility.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To the extent our debt investment is collateralized by the securities of a portfolio company&#x2019;s subsidiaries, such securities may lose some or all of their value in the event of the bankruptcy or insolvency of the portfolio company. Also, in some circumstances, our security interest may be contractually or structurally subordinated to claims of other creditors. In addition, deterioration in a portfolio company&#x2019;s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the debt. Secured debt that is under-collateralized involves a greater risk of loss. In addition, second lien debt is granted a second priority security interest in collateral, which means that any realization of collateral will generally be applied to pay senior secured debt in full before second lien debt is paid. Similarly, investments in &#x201c;last out&#x201d; pieces of unitranche loans will be similar to second lien loans in that such investments will be junior in priority to the &#x201c;first out&#x201d; piece of the same unitranche loan with respect to payment of principal, interest and other amounts. Consequently, the fact that debt is secured does not guarantee that we will receive principal and interest payments according to the debt&#x2019;s terms, or at all, or that we will be able to collect on the debt should we be forced to enforce our remedies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subordinated Debt. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our subordinated debt investments will generally rank junior in priority of payment to senior debt and will generally be unsecured. This may result in a heightened level of risk and volatility or a loss of principal, which could lead to the loss of the entire investment. These investments may involve additional risks that could adversely affect our investment returns. To the extent interest payments associated with such debt are deferred, such debt may be subject to greater fluctuations in valuations, and such debt could subject us and our shareholders to non-cash income. Because we will not receive any principal repayments prior to the maturity of some of our subordinated debt investments, such investments will be of greater risk than amortizing loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Investments. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may make select equity investments. In addition, in connection with our debt investments, we on occasion may receive equity interests such as warrants or options as additional consideration. The equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Securities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Investments in preferred securities involve certain risks. Certain preferred securities contain provisions that allow an issuer under certain conditions to skip or defer distributions. If the Company owns a preferred security that is deferring its distribution, the Company may be required to include the amount of the deferred distribution in its taxable income for tax purposes although it does not currently receive such amount in cash. In order to receive the special treatment accorded to RICs and their shareholders under the Code and to avoid U.S. federal income and/or excise taxes at the Company level, the Company may be required to distribute this income to shareholders in the tax year in which the income is recognized (without a corresponding receipt of cash). Therefore, the Company may be required to pay out as an income distribution in any such tax year an amount greater than the total amount of cash income the Company actually received, and to sell portfolio securities, including at potentially disadvantageous times or prices, to obtain cash needed for these income distributions. Preferred securities often are subject to legal provisions that allow for redemption in the event of certain tax or legal changes or at the issuer&#x2019;s call. In the event of redemption, the Company may not be able to reinvest the proceeds at comparable rates of return. Preferred securities are subordinated to bonds and other debt securities in an issuer&#x2019;s capital structure in terms of priority for corporate income and liquidation payments, and therefore will be subject to greater credit risk than those debt securities. Preferred securities may trade less frequently and in a more limited volume and may be subject to more abrupt or erratic price movements than many other securities, such as common stocks, corporate debt securities and U.S. government securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-U.S. Securities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may invest in non-U.S. securities, which may include securities denominated in U.S. dollars or in non-U.S. currencies, to the extent permitted by the 1940 Act. Because evidence of ownership of such securities usually is held outside the United States, we would be subject to additional risks if we invested in non-U.S. securities, which include possible adverse political and economic developments, seizure or nationalization of foreign deposits and adoption of governmental restrictions, which might adversely affect or restrict the payment of principal and interest on the non-U.S. securities to shareholders located outside the country of the issuer, whether from currency blockage or otherwise. Because non-U.S. securities may be purchased with and payable in foreign currencies, the value of these assets as measured in U.S. dollars may be affected unfavorably by changes in currency rates and exchange control regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loans Risk&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The loans that the Company may invest in include loans that are first lien, second lien, third lien or that are unsecured. In addition, the loans the Company will invest in will usually be rated below investment grade or may also be unrated. Loans are subject to a number of risks described elsewhere in the prospectus, including credit risk, liquidity risk, below investment grade instruments risk and management risk. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although certain loans in which the Company may invest will be secured by collateral, there can be no assurance that such collateral could be readily liquidated or that the liquidation of such collateral would satisfy the borrower&#x2019;s obligation in the event of non-payment of scheduled interest or principal. In the event of the bankruptcy or insolvency of a borrower, the Company could experience delays or limitations with respect to its ability to realize the benefits of the collateral securing a loan. In the event of a decline in the value of the already pledged collateral, if the terms of a loan do not require the borrower to pledge additional collateral, the Company will be exposed to the risk that the value of the collateral will not at all times equal or exceed the amount of the borrower&#x2019;s obligations under the loans. To the extent that a loan is collateralized by stock in the borrower or its subsidiaries, such stock may lose some or all of its value in the event of the bankruptcy or insolvency of the borrower. Those loans that are under-collateralized involve a greater risk of loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Further, there is a risk that any collateral pledged by portfolio companies in which the Company has taken a security interest may decrease in value over time or lose its entire value, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. To the extent the Company&#x2019;s debt investment is collateralized by the securities of a portfolio company&#x2019;s subsidiaries, such securities may lose some or all of their value in the event of the bankruptcy or insolvency of the portfolio company. Also, in some circumstances, the Company&#x2019;s security interest may be contractually or structurally subordinated to claims of other creditors. In addition, deterioration in a portfolio company&#x2019;s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the debt. Secured debt that is under-collateralized involves a greater risk of loss. In addition, second lien debt is granted a second priority security interest in collateral, which means that any realization of collateral will generally be applied to pay senior secured debt in full before second lien debt is paid. Consequently, the fact that debt is secured does not guarantee that the Company will receive principal and interest payments according to the debt&#x2019;s terms, or at all, or that the Company will be able to collect on the debt should it be forced to enforce remedies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loans are not registered with the SEC, or any state securities commission, and are not listed on any national securities exchange. There is less readily available or reliable information about most loans than is the case for many other types of securities, including securities issued in transactions registered under the Securities Act or registered under the Exchange Act. No active trading market may exist for some loans, and some loans may be subject to restrictions on resale. A secondary market may be subject to irregular trading activity, wide bid/ask spreads and extended trade settlement periods, which may impair the ability to realize full value and thus cause a material decline in the Company&#x2019;s NAV. In addition, the Company may not be able to readily dispose of its loans at prices that approximate those at which the Company could sell such loans if they were more widely-traded and, as a result of such illiquidity, the Company may have to sell other investments or engage in borrowing transactions if necessary to raise cash to meet its obligations. During periods of limited supply and liquidity of loans, the Company&#x2019;s yield may be lower. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some loans are subject to the risk that a court, pursuant to fraudulent conveyance or other similar laws, could subordinate the loans to presently existing or future indebtedness of the borrower or take other action detrimental to lenders, including the Company. Such court action could under certain circumstances include invalidation of loans. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If legislation of state or federal regulations impose additional requirements or restrictions on the ability of financial institutions to make loans, the availability of loans for investment by the Company may be adversely affected. In addition, such requirements or restrictions could reduce or eliminate sources of financing for certain borrowers. This would increase the risk of default. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If legislation or federal or state regulations require financial institutions to increase their capital requirements this may cause financial institutions to dispose of loans that are considered highly levered transactions. Such sales could result in prices that, in the opinion of the Adviser, do not represent fair value. If the Company attempts to sell a loan at a time when a financial institution is engaging in such a sale, the price the Company could get for the loan may be adversely affected. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may acquire loans through assignments or participations. The Company will typically acquire loans through assignment. The purchaser of an assignment typically succeeds to all the rights and obligations of the assigning institution and becomes a lender under the credit agreement with respect to the debt obligation; however, the purchaser&#x2019;s rights can be more restricted than those of the assigning institution, and the Company may not be able to unilaterally enforce all rights and remedies under the loan and with regard to any associated collateral. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A participation typically results in a contractual relationship only with the institution selling the participation interest, not with the borrower. Sellers of participations typically include banks, broker-dealers, other financial institutions and lending institutions. Certain participation agreements also include the option to convert the participation to a full assignment under agreed upon circumstances. The Adviser has adopted best execution procedures and guidelines to mitigate credit and counterparty risk in the atypical situation when the Company must acquire a loan through a participation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In purchasing participations, the Company generally will have no right to enforce compliance by the borrower with the terms of the loan agreement against the borrower, and the Company may not directly benefit from the collateral supporting the debt obligation in which it has purchased the participation. As a result, the Company will be exposed to the credit risk of both the borrower and the institution selling the participation. Further, in purchasing participations in lending syndicates, the Company will not be able to conduct the due diligence on the borrower or the quality of the loan with respect to which it is buying a participation that the Company would otherwise conduct if it were investing directly in the loan, which may result in the Company being exposed to greater credit or fraud risk with respect to the borrower or the loan than the Company expected when initially purchasing the participation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also may originate loans or acquire loans by participating in the initial issuance of the loan as part of a syndicate of banks and financial institutions, or receive its interest in a loan directly from the borrower. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser has established a counterparty and liquidity sub-committee that regularly reviews each broker-dealer counterparty for, among other things, its quality and the quality of its execution. The established procedures and guidelines require trades to be placed for execution only with broker counterparties approved by the counterparty and liquidity sub-committee of the Adviser. The factors considered by the sub-committee when selecting and approving brokers and dealers include, but are not limited to: (i) quality, accuracy, and timeliness of execution, (ii) review of the reputation, financial strength and stability of the financial institution, (iii) willingness and ability of the counterparty to commit capital, (iv) ongoing reliability and (v) access to underwritten offerings and secondary markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Junior, Unsecured Securities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our strategy may entail acquiring securities that are junior or unsecured instruments. While this approach can facilitate obtaining control and then adding value through active management, it also means that certain of the Company&#x2019;s investments may be unsecured. If a portfolio company becomes financially distressed or insolvent and does not successfully reorganize, we will have no assurance (compared to those distressed securities investors that acquire only fully collateralized positions) that we will recover any of the principal that we have invested. Similarly, investments in &#x201c;last out&#x201d; pieces of unitranche loans will be similar to second lien loans in that such investments will be junior in priority to the &#x201c;first out&#x201d; piece of the same unitranche loan with respect to payment of principal, interest and other amounts. Consequently, the fact that debt is secured does not guarantee that we will receive principal and interest payments according to the debt&#x2019;s terms, or at all, or that we will be able to collect on the debt should it be forced to enforce its remedies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While such junior or unsecured investments may benefit from the same or similar financial and other covenants as those enjoyed by the indebtedness ranking more senior to such investments and may benefit from cross-default provisions and security over the issuer&#x2019;s assets, some or all of such terms may not be part of particular Investments. Moreover, our ability to influence an issuer&#x2019;s affairs, especially during periods of financial distress or following insolvency, is likely to be substantially less than that of senior creditors. For example, under typical subordination terms, senior creditors are able to block the acceleration of the junior debt or the exercise by junior debt holders of other rights they may have as creditors. Accordingly, we may not be able to take steps to protect investments in a timely manner or at all, and there can be no assurance that our rate of return objectives or any particular investment will be achieved. In addition, the debt securities in which we will invest may not be protected by financial covenants or limitations upon additional indebtedness, may have limited liquidity and are not expected to be rated by a credit rating agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Early repayments of our investments may have a material adverse effect on our investment objectives. In addition, depending on fluctuations of the equity markets and other factors, warrants and other equity investments may become worthless.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There can be no assurance that attempts to provide downside protection through contractual or structural terms with respect to our investments will achieve their desired effect and potential investors should regard an investment in us as being speculative and having a high degree of risk. Furthermore, we have limited flexibility to negotiate terms when purchasing newly issued investments in connection with a syndication of mezzanine or certain other junior or subordinated investments or in the secondary market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Below Investment Grade Risk. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as &#x201c;junk,&#x201d; have predominantly speculative characteristics with respect to the issuer&#x2019;s capacity to pay interest and repay principal. They may also be difficult to value and illiquid. The major risks of below investment grade securities include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Below investment grade securities may be issued by less creditworthy issuers. Issuers of below investment grade securities may have a larger amount of outstanding debt relative to their assets than issuers of investment grade securities. In the event of an issuer&#x2019;s bankruptcy, claims of other creditors may have priority over the claims of holders of below investment grade securities, leaving few or no assets available to repay holders of below investment grade securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Prices of below investment grade securities are subject to extreme price fluctuations. Adverse changes in an issuer&#x2019;s industry and general economic conditions may have a greater impact on the prices of below investment grade securities than on other higher-rated fixed-income securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Issuers of below investment grade securities may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments, or the unavailability of additional financing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Below investment grade securities frequently have redemption features that permit an issuer to repurchase the security from us before it matures. If the issuer redeems below investment grade securities, we may have to invest the proceeds in securities with lower yields and may lose income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Below investment grade securities may be less liquid than higher-rated fixed-income securities, even under normal economic conditions. There are fewer dealers in the below investment grade securities market, and there may be significant differences in the prices quoted by the dealers. Judgment may play a greater role in valuing these securities and we may be unable to sell these securities at an advantageous time or price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit rating of a high-yield security does not necessarily address its market value risk. Ratings and market value may change from time to time, positively or negatively, to reflect new developments regarding the issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mezzanine Loans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;Our mezzanine loans generally will be subordinated to senior secured loans on a payment basis, are typically unsecured and rank&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;pari passu&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;with other unsecured creditors.&#160;As such, other creditors may rank senior to us in the event of insolvency.&#160;This may result in an above average amount of risk and loss of principal. Our mezzanine debt securities generally will have ratings or implied or imputed ratings below investment grade. They will be obligations of corporations, partnerships or other entities that are generally unsecured, typically are subordinated to other obligations of the obligor and generally have greater credit and liquidity risk than is typically associated with investment grade corporate obligations. Accordingly, the risks associated with mezzanine debt securities include a greater possibility that adverse changes in the financial condition of the obligor or in general economic conditions (including a sustained period of rising interest rates or an economic downturn) may adversely affect the obligor&#x2019;s ability to pay principal and interest on its debt. Many obligors on mezzanine debt securities are highly leveraged, and specific developments affecting such obligors, including reduced cash flow from operations or the inability to refinance debt at maturity, may also adversely affect such obligors&#x2019; ability to meet debt service obligations. Mezzanine debt securities are often issued in connection with leveraged acquisitions or recapitalizations, in which the issuers incur a substantially higher amount of indebtedness than the level at which they had previously operated. Default rates for mezzanine debt securities have historically been higher than has been the case for investment grade securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risk Retention Vehicles&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We may invest in CLO debt and equity tranches and warehouse investments directly or indirectly through an investment in U.S. and/or European vehicles (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Risk Retention Vehicles&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) established for the purpose of satisfying U.S. and/or E.U. regulations that require eligible risk retainers to purchase and retain specified amounts of the credit risk associated with certain CLOs, which vehicles themselves are invested in CLO securities, warehouse investments and/or senior secured obligations. Risk Retention Vehicles will be structured to satisfy the retention requirements by purchasing and retaining the percentage of CLO notes prescribed under the applicable retention requirements (the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Retention Notes&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and will not include Risk Retention Vehicles that are deemed to be controlled by the Adviser or its affiliates (other than Risk Retention Vehicles we control).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indirect investments in CLO equity securities (and in some instances more senior CLO securities) and warehouse investments through entities that have been established to satisfy the U.S. retention requirements and/or the European retention requirements may allow for better economics for us (including through fee rebate arrangements) by creating stronger negotiating positions with CLO managers and underwriting banks who are incentivized to issue CLOs and who require the participation of a Risk Retention Vehicle to enable the CLO securities to be issued. However, Retention Notes differ from other securities of the same ranking since the retention requirements prescribe that such Retention Notes must be held by the relevant risk retainer for a specified period. In the case of European Risk Retention Vehicles, the prescribed holding period is the lifetime of the CLO, and in the case of U.S. Risk Retention Vehicles it is the longer of (x) the period until the CLO has paid down its securities to 33% of their original principal amount, (y) the period until the CLO has sold down its assets to 33% of their original principal amount and (z) two years after the closing of the CLO. In addition, Retention Notes are subject to other restrictions not imposed on other securities of the same ranking; for example, Retention Notes may not be subject to credit risk mitigation, and breach of the retention requirements may result in the imposition of regulatory sanctions or, in the case of the European retention requirements, in claims being brought against the retaining party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x201c;Covenant-lite&#x201d; Obligations.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We may invest in, or obtain exposure to, obligations that may be &#x201c;covenant-lite,&#x201d; which means such obligations lack certain financial maintenance covenants. While these loans may still contain other collateral protections, a covenant-lite loan may carry more risk than a covenant-heavy loan made by the same borrower, as it does not require the borrower to provide affirmation that certain specific financial tests have been satisfied on a routine basis as is required under a covenant-heavy loan agreement. Should a loan we hold begin to deteriorate in quality, our ability to negotiate with the borrower may be delayed under a covenant-lite loan compared to a loan with full maintenance covenants. This may in turn delay our ability to seek to recover its investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consumer Loans.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We may invest in, or obtain exposure to, consumer lending, which involves risk elements in addition to normal credit risk. Consumer loan terms vary according to the type and value of collateral and creditworthiness of the borrower. In underwriting consumer loans, a thorough analysis of the borrower&#x2019;s financial ability to repay the loan as agreed is typically performed. The ability to repay shall be determined by, among others, the borrower&#x2019;s employment history, current financial conditions, and credit background. While these loans typically have higher yields than many other loans, such loans involve risk elements in addition to normal credit risk. Consumer loans may entail greater credit risk than other loans particularly in the case of unsecured consumer loans or consumer loans secured by rapidly depreciable assets, such as automobiles. In such cases, any repossessed collateral for a defaulted consumer loan may not provide an adequate source of repayment of the outstanding loan balance as a result of the greater likelihood of damage, loss or depreciation. In addition, consumer loan collections are dependent on the borrower&#x2019;s continuing financial stability, and thus are more likely to be affected by adverse personal circumstances. During periods of deteriorating economic conditions, such as recessions or periods of rising unemployment, delinquencies and losses generally increase, sometimes dramatically, with respect to consumer loans. Furthermore, the application of various federal and state laws, including bankruptcy and insolvency laws, and/or state consumer protection laws may limit the amount which can be recovered on such loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Bridge Financings.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; From time to time, we may lend to portfolio companies on a short-term, unsecured basis or otherwise invest on an interim basis in portfolio companies in anticipation of a future issuance of equity or long-term debt securities or other refinancing or syndication. Such bridge loans would typically be convertible into a more permanent, long-term security; however, for reasons not always in the Company&#x2019;s control, such long-term securities issuance or other refinancing or syndication may not occur and such bridge loans and interim investments may remain outstanding. In such event, the interest rate on such loans or the terms of such interim investments may not adequately reflect the risk associated with the position taken by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restructurings.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Investments in companies operating in workout or bankruptcy modes present additional legal risks, including fraudulent conveyance, voidable preference and equitable subordination risks. The level of analytical sophistication, both financial and legal, necessary for successful investment in companies experiencing significant business and financial difficulties is unusually high. There is no assurance that we will correctly evaluate the value of the assets collateralizing our loans or the prospects for a successful reorganization or similar action.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We are exposed to risks associated with changes in interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to financial market risks, including changes in interest rates. General interest rate fluctuations may have a substantial negative impact on our investments and investment opportunities and, accordingly, have a material adverse effect on our investment objectives and our rate of return on invested capital. In addition, an increase in interest rates would make it more expensive to use debt for our financing needs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During periods of falling interest rates, payments under the floating rate debt instruments that we hold would generally decrease, resulting in less revenue to us. In the event of a sharply rising interest rate environment, such as during 2022 and 2023, payments under floating rate debt instruments generally would rise and there may be a significant number of issuers of such floating rate debt instruments that would be unable or unwilling to pay such increased interest costs and may otherwise be unable to repay their loans. Investments in floating rate debt instruments may also decline in value in response to rising interest rates if the interest rates of such investments do not rise as much, or as quickly, as market interest rates in general. Similarly, during periods of rising interest rates, fixed-rate debt instruments may decline in value because the fixed rates of interest paid thereunder may be below market interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, an increase in interest rates would make it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase in the amount of incentive fees payable to the Adviser with respect to pre-incentive fee net investment income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our portfolio companies may have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt in which we invest. By their terms, such debt instruments may entitle the holders to receive payment of interest or principal on or before the dates on which we are entitled to receive payments with respect to the debt instruments in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any proceeds. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt instruments in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If one of our portfolio companies were to file for bankruptcy, depending on the facts and circumstances, including the extent to which we actually provided managerial assistance to that portfolio company, a bankruptcy court might re-characterize our debt investment and subordinate all or a portion of our claim to that of other creditors. We may also be subject to lender liability claims for actions taken by us with respect to a borrower&#x2019;s business or instances where we exercise control over the borrower.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We generally do not control our portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not expect to control most of our portfolio companies, even though we may have board representation or board observation rights, and our debt agreements with such portfolio companies may contain certain restrictive covenants. As a result, we are subject to the risk that a portfolio company in which we invest may make business decisions with which we disagree and the management of such company, as representatives of the holders of the company&#x2019;s common equity, may take risks or otherwise act in ways that do not serve our interests as debt investors. Due to the lack of liquidity for our investments in non-traded companies, we may not be able to dispose of our interests in our portfolio companies as readily as we would like or at an appropriate valuation. As a result, a portfolio company may make decisions that could decrease the value of our portfolio holdings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We are subject to risks related to ESG matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Adviser&#x2019;s consideration of ESG factors is intended to aid the Adviser in evaluating the return and risk profile of a given investment and is not expected to by itself determine an investment decision for us, the Adviser&#x2019;s consideration of ESG factors could, to the extent material economic risks associated with an investment are identified, cause the Adviser to consider taking action with respect to a company differently than may have been taken in the absence of such consideration, which could cause us to perform differently compared to funds that do not have such considerations. Further, although the Adviser views application of its ESG framework to be an opportunity to potentially enhance or protect the performance of investments over the long-term, the Adviser cannot guarantee that any consideration of ESG factors or engagement with portfolio companies on ESG, which depends in part on skill and qualitative judgments, will positively impact the performance of any individual portfolio company or us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investors and other stakeholders have become more focused on understanding how companies address a variety of ESG factors. As they evaluate investment decisions, many investors look not only at company disclosures but also to ESG rating systems that have been developed by third parties to allow ESG comparisons among companies. The criteria used in these ratings systems may conflict and change frequently, and we cannot predict how these third parties will score us, nor can we have any assurance that they score us accurately or other companies accurately or that other companies have provided them with accurate data. If our ESG ratings, disclosures or practices do not meet the standards set by such investors or our shareholders, they may choose not to invest in our shares. Relatedly, we risk damage to our reputation, if we do not, or are perceived to not, act responsibly in a number of areas, such as greenhouse gas emissions, energy management, human rights, community relations, workforce health and safety, and business ethics and transparency. Adverse incidents with respect to ESG matters or negative ESG ratings or assessments by third-party ESG raters could impact the value of our brand, or the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There is a growing regulatory interest across jurisdictions in improving transparency regarding the definition, measurement and disclosure of ESG factors in order to allow investors to validate and better understand sustainability claims. New regulatory initiatives related to ESG that are applicable to us could adversely affect our business. For example, the SEC has proposed rules that would require additional disclosures about ESG investment practices by investment advisers and certain funds, including BDCs. These changing rules, regulations and stakeholder expectations have resulted in, and are likely to continue to result in, increased general and administrative expenses and increased management time and attention spent complying with or meeting such regulations and expectations. If we fail or are perceived to fail to comply with applicable rules, regulations and stakeholder expectations, it could negatively impact our reputation and our business results. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We and our investment adviser could be the target of litigation or regulatory investigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We as well as our investment adviser and its affiliates participate in a highly regulated industry and are each subject to regulatory examinations in the ordinary course of business. There can be no assurance that we and our investment adviser and/or any of its affiliates will avoid regulatory investigation and possible enforcement actions stemming therefrom. Our investment adviser is a registered investment adviser and, as such, is subject to the provisions of the Advisers Act. We and our investment adviser are each, from time to time, subject to formal and informal examinations, investigations, inquiries, audits and reviews from numerous regulatory authorities both in response to issues and questions raised in such examinations or investigations and in connection with the changing priorities of the applicable regulatory authorities across the market in general.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment adviser, its affiliates and/or any of their respective principals and employees could also be named as defendants in, or otherwise become involved in, litigation. Litigation and regulatory actions can be time-consuming and expensive and can lead to unexpected losses, which expenses and losses are often subject to indemnification by us. Legal proceedings could continue without resolution for long periods of time and their outcomes, which could materially and adversely affect the value of us or the ability of our investment adviser to manage us, are often impossible to anticipate. Our investment adviser would likely be required to expend significant resources responding to any litigation or regulatory action related to it, and these actions could be a distraction to the activities of our investment adviser.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment activities are subject to the normal risks of becoming involved in litigation by third parties. This risk would be somewhat greater if we were to exercise control or significant influence over a portfolio company&#x2019;s direction. The expense of defending against claims by third parties and paying any amounts pursuant to settlements or judgments would, absent willful misfeasance, bad faith, gross negligence, or reckless disregard of the duties involved by our investment adviser, our administrator, or any of our officers, be borne by us and would reduce our net assets. Our investment adviser and others are indemnified by us in connection with such litigation, subject to certain conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Second priority liens on collateral securing debt investments that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. If there is a default, the value of the collateral may not be sufficient to repay in full both the first priority creditors and us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain debt investments that we make to portfolio companies may be secured on a second priority basis by the same collateral securing first priority debt of such companies. The first priority liens on the collateral will secure the portfolio company&#x2019;s obligations under any outstanding senior debt and may secure certain other future debt that may be permitted to be incurred by the company under the agreements governing the loans. The holders of obligations secured by the first priority liens on the collateral will generally control the liquidation of and be entitled to receive proceeds from any realization of the collateral to repay their obligations in full before us. In addition, the value of the collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from the sale or sales of all of the collateral would be sufficient to satisfy the debt obligations secured by the second priority liens after payment in full of all obligations secured by the first priority liens on the collateral. If such proceeds are not sufficient to repay amounts outstanding under the debt obligations secured by the second priority liens, then we, to the extent not repaid from the proceeds of the sale of the collateral, will only have an unsecured claim against the company&#x2019;s remaining assets, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may also make unsecured debt investments in portfolio companies, meaning that such investments will not benefit from any interest in collateral of such companies. Liens on such portfolio companies&#x2019; collateral, if any, will secure the portfolio company&#x2019;s obligations under its outstanding secured debt and may secure certain future debt that is permitted to be incurred by the portfolio company under its secured debt agreements. The holders of obligations secured by such liens will generally control the liquidation of, and be entitled to receive proceeds from, any realization of such collateral to repay their obligations in full before we are so entitled. In addition, the value of such collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from sales of such collateral would be sufficient to satisfy its unsecured debt obligations after payment in full of all secured debt obligations. If such proceeds were not sufficient to repay the outstanding secured debt obligations, then its unsecured claims would rank equally with the unpaid portion of such secured creditors&#x2019; claims against the portfolio company&#x2019;s remaining assets, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rights we may have with respect to the collateral securing the debt investments we make to our portfolio companies with senior debt outstanding may also be limited pursuant to the terms of one or more intercreditor agreements that we enter into with the holders of senior debt. Under such an intercreditor agreement, at any time that obligations that have the benefit of the first priority liens are outstanding, any of the following actions that may be taken in respect of the collateral will be at the direction of the holders of the obligations secured by the first priority liens: the ability to cause the commencement of enforcement proceedings against the collateral; the ability to control the conduct of such proceedings; the approval of amendments to collateral documents; releases of liens on the collateral; and waivers of past defaults under collateral documents. We may not have the ability to control or direct such actions, even if our rights are adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Economic recessions or downturns or restrictions on trade could impair our portfolio companies and adversely affect our operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The risks associated with our and our portfolio companies&#x2019; businesses are more severe during periods of economic slowdown or recession. In recent years, we have experienced periods of economic slowdown and in some instances, contraction, as countries and industries around the globe grappled with the short- and long-term economic impacts of the COVID-19 pandemic, elevated inflation, supply chain challenges, labor shortages, high interest rates, foreign currency exchange volatility and volatility in global capital markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many of our portfolio companies may be susceptible to economic recessions or downturns and may be unable to repay our debt investments during these periods. Therefore, our non-performing assets are likely to increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions may also decrease the value of any collateral securing our senior secured debt. A prolonged recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income and NAV. Certain of our portfolio companies may also be impacted by tariffs or other matters affecting international trade. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on terms we deem acceptable. These events could prevent us from increasing investments and adversely affect our operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portfolio company&#x2019;s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, acceleration of the time when the loans are due and foreclosure on its assets representing collateral for its obligations, which could trigger cross defaults under other agreements and jeopardize our portfolio company&#x2019;s ability to meet its obligations under the debt investments that we hold and the value of any equity securities we own. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting portfolio company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our investments in CLOs may be riskier than a direct investment in the debt or other securities of the underlying companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When investing in CLOs, we may invest in any level of a CLO&#x2019;s subordination chain, including subordinated (lower-rated) tranches and residual interests (the lowest tranche). CLOs are typically highly levered and therefore, the junior debt and equity tranches that we may invest in are subject to a higher risk of total loss and deferral or nonpayment of interest than the more senior tranches to which they are subordinated. In addition, we will generally have the right to receive payments only from the CLOs, and will generally not have direct rights against the underlying borrowers or entities that sponsored the CLOs. Furthermore, the investments we make in CLOs are at times thinly traded or have only a limited trading market. As a result, investments in such CLOs may be characterized as illiquid securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;A covenant breach or other default by our portfolio companies may adversely affect our operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portfolio company&#x2019;s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, termination of its loans and foreclosure on its secured assets, which could trigger cross-defaults under other agreements and jeopardize a portfolio company&#x2019;s ability to meet its obligations under the debt or equity securities that we hold. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms, which may include the waiver of certain financial covenants, with a defaulting portfolio company. In addition, lenders in certain cases can be subject to lender liability claims for actions taken by them when they become too involved in the borrower&#x2019;s business or exercise control over a borrower. It is possible that we could become subject to a lender&#x2019;s liability claim, including as a result of actions taken if we render significant managerial assistance to the borrower. Furthermore, if one of our portfolio companies were to file for bankruptcy protection, a bankruptcy court might re-characterize our debt holding and subordinate all or a portion of our claim to claims of other creditors, even though we may have structured our investment as senior secured debt. The likelihood of such a re-characterization would depend on the facts and circumstances, including the extent to which we provided managerial assistance to that portfolio company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our portfolio companies may be highly leveraged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of our portfolio companies may be highly leveraged, which may have adverse consequences to these companies and to us as an investor. These companies may be subject to restrictive financial and operating covenants and the leverage may impair these companies&#x2019; ability to finance their future operations and capital needs. As a result, these companies&#x2019; flexibility to respond to changing business and economic conditions and to take advantage of business opportunities may be limited. Further, a leveraged company&#x2019;s income and net assets will tend to increase or decrease at a greater rate than if borrowed money were not used.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our portfolio may be concentrated in a limited number of industries, which may subject us to a risk of significant loss if there is a downturn in a particular industry in which a number of our investments are concentrated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our portfolio may be concentrated in a limited number of industries. Our portfolio will be considered to be concentrated in a particular industry when 25% or greater of its total assets are invested in issuers that are a part of that industry. A downturn in any industry in which we are invested could significantly impact the aggregate returns we realize. We anticipate that we may concentrate our investments in issuers that are part of the software industry, which currently represent close to 25% of our total assets, as a result of additional investments in the software industry and/or fluctuations in the fair value of our investments in the software industry and other industries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If an industry in which we have significant investments suffers from adverse business or economic conditions, as individual industries have historically experienced to varying degrees, a material portion of our investment portfolio could be affected adversely, which, in turn, could adversely affect our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may be subject to risks associated with our investments in the software industry.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The revenue, income (or losses) and valuations of software and other technology-related companies can and often do fluctuate suddenly and dramatically. In addition, because of rapid technological change, the average selling prices of software products have historically decreased over their productive lives. As a result, the average selling prices of software offered by our portfolio companies may decrease over time, which could adversely affect their operating results and, correspondingly, the value of any securities that we may hold. Additionally, companies operating in the software industry are subject to vigorous competition, changing technology, changing client and end-consumer needs, evolving industry standards and frequent introductions of new products and services. Our portfolio companies in the software industry could compete with companies that are larger and could be engaged in a greater range of businesses or have greater financial, technical, sales or other resources than our portfolio companies do. Our portfolio companies could lose market share if their competitors introduce or acquire new products that compete with their software and related services or add new features to existing products. Any deterioration in the results of our portfolio companies due to competition or otherwise could, in turn, materially adversely affect our business, financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our investments in the healthcare providers and services industry face considerable uncertainties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The laws and rules governing the business of healthcare companies and interpretations of those laws and rules are subject to frequent change. Broad latitude is given to the agencies administering those regulations. Existing or future laws and rules could force our portfolio companies engaged in healthcare to change how they do business, restrict revenue, increase costs, change reserve levels and change business practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Healthcare companies often must obtain and maintain regulatory approvals to market many of their products, change prices for certain regulated products and consummate some of their acquisitions and divestitures. Delays in obtaining or failing to obtain or maintain these approvals could reduce revenue or increase costs. Policy changes on the local, state and federal level, such as the expansion of the government&#x2019;s role in the healthcare arena and alternative assessments and tax increases specific to the healthcare industry or healthcare products as part of federal health care reform initiatives, could fundamentally change the dynamics of the healthcare industry.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investing in large private U.S. borrowers may limit the Company&#x2019;s ability to achieve high growth rates during times of economic expansion. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investing in originated assets made to large private U.S. borrowers may result in us underperforming in other segments of the market, particularly during times of economic expansion, because large private U.S. borrowers may be less responsive to competitive challenges and opportunities in the financial markets. As a result, our value may not rise at the same rate, if at all, as other funds that invest in smaller market capitalization companies that are more capable of responding to economic and industrial changes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investing in private companies involves a number of significant risks, any one of which could have a material adverse effect on our operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These risks include that:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing on any guarantees we may have obtained in connection with our investment; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;these companies frequently have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tends to render them more vulnerable to competitors&#x2019; actions and changing market conditions, as well as general economic downturns; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;these companies are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;these companies generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, Trustees and members of the Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;these companies may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may not realize gains from our equity investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain investments that we may make could include warrants or other equity securities. In addition, we may make direct equity investments in portfolio companies. Our goal is ultimately to realize gains upon our disposition of such equity interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. We also may be unable to realize any value if a portfolio company does not have a liquidity event, such as a sale of the business, recapitalization or public offering, which would allow us to sell the underlying equity interests. We intend to seek puts or similar rights to give us the right to sell our equity securities back to the portfolio company issuer. We may be unable to exercise these put rights for the consideration provided in our investment documents if the issuer is in financial distress.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;An investment strategy focused primarily on privately-held companies presents certain challenges, including, but not limited to, the lack of available information about these companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We invest primarily in privately-held companies. Investments in private companies pose significantly greater risks than investments in public companies. First, private companies have reduced access to the capital markets, resulting in diminished capital resources and the ability to withstand financial distress. Second, the depth and breadth of experience of management in private companies tends to be less than that at public companies, which makes such companies more likely to depend on the management talents and efforts of a smaller group of persons and/or persons. Therefore, the decisions made by such management teams and/or the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our investments and, in turn, on us. Third, the investments themselves tend to be less liquid. As such, we may have difficulty exiting an investment promptly or at a desired price prior to maturity or outside of a normal amortization schedule. As a result, the relative lack of liquidity and the potential diminished capital resources of our target portfolio companies may affect our investment returns. Fourth, limited public information generally exists about private companies. Fifth, these companies may not have third-party debt ratings or audited financial statements. We must therefore rely on the ability of the Adviser to obtain adequate information through due diligence to evaluate the creditworthiness and potential returns from investing in these companies. The Adviser typically assesses an investment in a portfolio company based on the Adviser&#x2019;s estimate of the portfolio company&#x2019;s earnings and enterprise value, among other things, and these estimates may be based on limited information and may otherwise be inaccurate, causing the Adviser to make different investment decisions than it may have made with more complete information. These private companies and their financial information are not subject to the Sarbanes-Oxley Act and other rules that govern public companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our investments in securities or assets of publicly-traded companies are subject to the risks inherent in investing in public securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may invest a portion of our portfolio in publicly-traded assets. For example, it is not expected that we will be able to negotiate additional financial covenants or other contractual rights, which we might otherwise be able to obtain in making privately negotiated investments. In addition, by investing in publicly-traded securities or assets, we will be subject to U.S. federal and state securities laws, as well as non-U.S. securities laws, that may, among other things, restrict or prohibit our ability to make or sell an investment. Moreover, we may not have the same access to information in connection with investments in public securities, either when investigating a potential investment or after making an investment, as compared to privately negotiated investments. Furthermore, we may be limited in our ability to make investments and to sell existing investments in public securities because the Firm may be deemed to have material, non-public information regarding the issuers of those securities or as a result of other internal policies. The inability to sell public securities in these circumstances could materially adversely affect our investment results. In addition, an investment may be sold by us to a public company where the consideration received is a combination of cash and stock of the public company, which may, depending on the securities laws of the relevant jurisdiction, be subject to lock-up periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;A lack of liquidity in certain of our investments may adversely affect our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally invest in companies whose securities are not publicly-traded or actively traded on the secondary market, and whose securities are subject to legal and other restrictions on resale or will otherwise be less liquid than publicly-traded securities. The illiquidity of certain of our investments may make it difficult for us to sell these investments when desired. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we had previously recorded these investments. The reduced liquidity of our investments may make it difficult for us to dispose of them at a favorable price, and, as a result, we may suffer losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments. After our initial investment in a portfolio company, we may be called upon from time to time to provide additional funds to such company or have the opportunity to increase our investment through the exercise of a warrant to purchase shares. There is no assurance that we will make, or will have sufficient funds to make, follow-on investments. Any decisions not to make a follow-on investment or any inability on our part to make such an investment may have a negative impact on a portfolio company in need of such an investment, may result in a missed opportunity for us to increase our participation in a successful operation or may reduce the expected return on the investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our investments may include original issue discount and payment-in-kind instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To the extent that we invest in original issue discount or payment-in-kind (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;PIK&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) instruments and the accretion of original issue discount or PIK interest income constitutes a portion of our income, we will be exposed to risks associated with the requirement to include such non-cash income in taxable and accounting income prior to receipt of cash, including the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the higher interest rates on PIK instruments reflect the payment deferral and increased credit risk associated with these instruments, and PIK instruments generally represent a significantly higher credit risk than coupon loans;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;original issue discount and PIK instruments may have unreliable valuations because the accruals require judgments about collectability of the deferred payments and the value of any associated collateral;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;an election to defer PIK interest payments by adding them to the principal on such instruments increases our future investment income which increases our gross assets and, as such, increases the Adviser&#x2019;s future base management fees which, thus, increases the Adviser&#x2019;s future income incentive fees at a compounding rate;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;market prices of PIK instruments and other zero-coupon instruments are affected to a greater extent by interest rate changes, and may be more volatile than instruments that pay interest periodically in cash. While PIK instruments are usually less volatile than zero-coupon debt instruments, PIK instruments are generally more volatile than cash pay securities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the deferral of PIK interest on an instrument increases the loan-to-value ratio, which is a measure of the riskiness of a loan, with respect to such instrument;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;even if the conditions for income accrual under GAAP are satisfied, a borrower could still default when actual payment is due upon the maturity of such loan;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;for accounting purposes, cash distributions to investors representing original issue discount income do not come from paid-in capital, although they may be paid from the offering proceeds. Thus, although a distribution of original issue discount income may come from the cash invested by investors, the 1940 Act does not require that investors be given notice of this fact;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the required recognition of original issue discount or PIK interest for U.S. federal income tax purposes may have a negative impact on liquidity, as it represents a non-cash component of our investment company taxable income that may require cash distributions to shareholders in order to maintain our ability to be subject to tax as a RIC; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;original issue discount may create a risk of non-refundable cash payments to the Adviser based on non-cash accruals that may never be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may enter into a TRS agreement that exposes us to certain risks, including market risk, liquidity risk and other risks similar to those associated with the use of leverage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A total return swap (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;TRS&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) is a contract in which one party agrees to make periodic payments to another party based on the change in the market value of the assets underlying the TRS, which may include a specified security, basket of securities or securities indices during a specified period, in return for periodic payments based on a fixed or variable interest rate. A TRS effectively adds leverage to a portfolio by providing investment exposure to a security or market without owning or taking physical custody of such security or investing directly in such market. Because of the unique structure of a TRS, a TRS often offers lower financing costs than are offered through more traditional borrowing arrangements. The Company would typically have to post collateral to cover this potential obligation. To the extent the Company complied with the applicable requirements of Rule 18f-4, the leverage incurred through TRS will not be considered a borrowing for purposes of the Company&#x2019;s overall leverage limitation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A TRS is subject to market risk, liquidity risk and risk of imperfect correlation between the value of the TRS and the loans underlying the TRS. In addition, we may incur certain costs in connection with the TRS that could in the aggregate be significant. A TRS is also subject to the risk that a counterparty will default on its payment obligations thereunder or that we will not be able to meet our obligations to the counterparty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may enter into repurchase agreements or reverse repurchase agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to our investment objectives and policies, we may invest in repurchase agreements as a buyer for investment purposes. Repurchase agreements typically involve the acquisition by us of debt securities from a selling financial institution such as a bank, savings and loan association or broker-dealer. The agreement provides that we will sell the securities back to the institution at a fixed time in the future for the purchase price plus premium (which often reflects the interests). We do not bear the risk of a decline in the value of the underlying security unless the seller defaults under its repurchase obligation. In the event of the bankruptcy or other default of a seller of a repurchase agreement, we could experience both delays in liquidating the underlying securities and losses, including (1) possible decline in the value of the underlying security during the period in which we seek to enforce its rights thereto; (2) possible lack of access to income on the underlying security during this period; and (3) expenses of enforcing its rights. In addition, as described above, the value of the collateral underlying the repurchase agreement will be at least equal to the repurchase price, including any accrued interest earned on the repurchase agreement. In the event of a default or bankruptcy by a selling financial institution, we generally will seek to liquidate such collateral. However, the exercise of our right to liquidate such collateral could involve certain costs or delays and, to the extent that proceeds from any sale upon a default of the obligation to repurchase were less than the repurchase price, we could suffer a loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to our investment objectives and policies, we invest in repurchase agreements as a seller, also known as a &#x201c;reverse repurchase agreement.&#x201d; Our use of reverse repurchase agreements involves many of the same risks involved in our use of leverage, as the proceeds from reverse repurchase agreements are generally invested in additional portfolio investments. There is a risk that the market value of the securities acquired from the proceeds received in connection with a reverse repurchase agreement may decline below the price of the securities underlying the reverse repurchase agreement that we have sold but remain obligated to repurchase. Reverse repurchase agreements also involve the risk that the counterparty liquidates the securities we delivered to it under the reverse repurchase agreements following the occurrence of an event of default under the applicable repurchase agreement by us. In addition, there is a risk that the market value of the securities we retain may decline. If the buyer of securities under a reverse repurchase agreement were to file for bankruptcy or experiences insolvency, we may be adversely affected. Furthermore, our counterparty may require us to provide additional margin in the form of cash, securities or other forms of collateral under the terms of the derivative contract. Also, in entering into reverse repurchase agreements, we bear the risk of loss to the extent that the proceeds of the reverse repurchase agreement are less than the value of the underlying securities. In addition, the interest costs associated with reverse repurchase agreements transactions, may adversely affect our results of operations and financial condition, and, in some cases, we may be worse off than if we had not used such instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may enter into securities lending agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may from time to time make secured loans of our marginable securities to brokers, dealers and other financial institutions if our asset coverage, as defined in the 1940 Act, is at or above 150% immediately after each such loan. The risks in lending portfolio securities, as with other extensions of credit, consist of possible delay in recovery of the securities or possible loss of rights in the collateral should the borrower fail financially. However, such loans will be made only to brokers and other financial institutions that are believed by the Adviser to be of high credit standing. Securities loans are made to broker-dealers pursuant to agreements requiring that loans be continuously secured by collateral consisting of U.S. government securities, cash or cash equivalents (e.g., negotiable certificates of deposit, bankers&#x2019; acceptances or letters of credit) maintained on a daily mark-to-market basis in an amount at least equal at all times to the market value of the securities lent. If the Company enters into a securities lending arrangement, the Adviser, as part of its responsibilities under the Investment Advisory Agreement, will invest the Company&#x2019;s cash collateral in accordance with the Company&#x2019;s investment objectives and strategies. The Company will pay the borrower of the securities a fee based on the amount of the cash collateral posted in connection with the securities lending program. The borrower will pay to the Company, as the lender, an amount equal to any dividends or interest received on the securities lent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may invest the cash collateral received only in accordance with its investment objectives, subject to the Company&#x2019;s agreement with the borrower of the securities. In the case of cash collateral, the Company expects to pay a rebate to the borrower. The reinvestment of cash collateral will result in a form of effective leverage for the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although voting rights or rights to consent with respect to the loaned securities pass to the borrower, the Company, as the lender, will retain the right to call the loans and obtain the return of the securities loaned at any time on reasonable notice, and it will do so in order that the securities may be voted by the Company if the holders of such securities are asked to vote upon or consent to matters materially affecting the investment. The Company may also call such loans in order to sell the securities involved. When engaged in securities lending, the Company&#x2019;s performance will continue to reflect changes in the value of the securities loaned and will also reflect the receipt of interest through investment of cash collateral by the Company in permissible investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may from time to time enter into credit default swaps or other derivative transactions which expose us to certain risks, including credit risk, market risk, liquidity risk and other risks similar to those associated with the use of leverage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may from time to time enter into credit default swaps or other derivative transactions that seek to modify or replace the investment performance of a particular reference security or other asset. These transactions are typically individually negotiated, non-standardized agreements between two parties to exchange payments, with payments generally calculated by reference to a notional amount or quantity. Swap contracts and similar derivative contracts are not traded on exchanges; rather, banks and dealers act as principals in these markets. These investments may present risks in excess of those resulting from the referenced security or other asset. Because these transactions are not an acquisition of the referenced security or other asset itself, the investor has no right directly to enforce compliance with the terms of the referenced security or other asset and has no voting or other consensual rights of ownership with respect to the referenced security or other asset. In the event of insolvency of a counterparty, we will be treated as a general creditor of the counterparty and will have no claim of title with respect to the referenced security or other asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A credit default swap is a contract in which one party buys or sells protection against a credit event with respect to an issuer, such as an issuer&#x2019;s failure to make timely payments of interest or principal on its debt obligations, bankruptcy or restructuring during a specified period. Generally, if we sell credit protection using a credit default swap, we will receive fixed payments from the swap counterparty and if a credit event occurs with respect to the applicable issuer, we will pay the swap counterparty par for the issuer&#x2019;s defaulted debt securities and the swap counterparty will deliver the defaulted debt securities to us. Generally, if we buy credit protection using a credit default swap, we will make fixed payments to the counterparty and if a credit event occurs with respect to the applicable issuer, we will deliver the issuer&#x2019;s defaulted securities underlying the swap to the swap counterparty and the counterparty will pay us par for the defaulted securities. Alternatively, a credit default swap may be cash settled and the buyer of protection would receive the difference between the par value and the market value of the issuer&#x2019;s defaulted debt securities from the seller of protection.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit default swaps are subject to the credit risk of the underlying issuer. If we are selling credit protection, there is a risk that we will not properly assess the risk of the underlying issuer, a credit event will occur and we will have to pay the counterparty. If we are buying credit protection, there is a risk that we will not properly assess the risk of the underlying issuer, no credit event will occur and we will receive no benefit for the premium paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A derivative transaction is also subject to the risk that a counterparty will default on its payment obligations thereunder or that we will not be able to meet our obligations to the counterparty. In some cases, we may post collateral to secure our obligations to the counterparty, and we may be required to post additional collateral upon the occurrence of certain events such as a decrease in the value of the reference security or other asset. In some cases, the counterparty may not collateralize any of its obligations to us. Derivative investments effectively add leverage to a portfolio by providing investment exposure to a security or market without owning or taking physical custody of such security or investing directly in such market. In addition to the risks described above, such arrangements are subject to risks similar to those associated with the use of leverage. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain categories of credit default swaps are subject to mandatory clearing, and more categories may be subject to mandatory clearing in the future. The counterparty risk for cleared derivatives is generally lower than for uncleared over-the-counter derivative transactions because generally a clearing organization becomes substituted for each counterparty to a cleared derivative contract and, in effect, guarantees the parties&#x2019; performance under the contract as each party to a trade looks only to the clearing house for performance of financial obligations. However, there can be no assurance that a clearing house, or its members, will satisfy the clearing house&#x2019;s obligations (including, but not limited to, financial obligations and legal obligations to segregate margins collected by the clearing house) to the Company. Counterparty risk with respect to certain exchange-traded and over-the-counter derivatives are considered as part of the value at risk provisions of Rule 18f-4. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Risk Factors&#x2014;Risks Related to Debt Financing.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may acquire various financial instruments for purposes of &#x201c;hedging&#x201d; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may seek to hedge against interest rate and currency exchange rate fluctuations and credit risk by using financial instruments such as futures, options, swaps and forward contracts, subject to the requirements of the 1940 Act. These financial instruments may be purchased on exchanges or may be individually negotiated and traded in over-the-counter markets. Use of such financial instruments for hedging purposes may present significant risks, including the risk of loss of the amounts invested. Defaults by the other party to a hedging transaction can result in losses in the hedging transaction. Hedging activities also involve the risk of an imperfect correlation between the hedging instrument and the asset being hedged, which could result in losses both on the hedging transaction and on the instrument being hedged. Use of hedging activities may not prevent significant losses and could increase our losses. Further, hedging transactions may reduce cash available to pay distributions to our shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to the risk that the investments we make in our portfolio companies may be repaid prior to maturity. When this occurs, we will generally reinvest these proceeds in temporary investments, pending their future investment in new portfolio companies. These temporary investments will typically have substantially lower yields than the debt being prepaid and we could experience significant delays in reinvesting these amounts. Any future investment in a new portfolio company may also be at lower yields than the debt that was repaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Additionally, prepayments, net of prepayment fees, could negatively impact our return on equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Technological or other innovations and industry disruptions may negatively impact us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recent trends in the market generally have been toward disrupting the industry with technological or other innovations, and multiple young companies have been successful in capitalizing on this trend toward disruption. In this period of rapid technological and commercial innovation, new businesses and approaches may be created that could affect the Company and/or its portfolio companies or alter the market practices that help frame its strategy. Any of these new approaches could damage the Company&#x2019;s investments, significantly disrupt the market in which it operates and subject it to increased competition, which could materially and adversely affect its business, financial condition and results of investments. Moreover, given the pace of innovation in recent years, the impact on a particular investment may not have been foreseeable at the time we made the investment. Furthermore, we could base investment decisions on views about the direction or degree of innovation that prove inaccurate and lead to losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may invest through various joint ventures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may hold a portion of its investments through partnerships, joint ventures, securitization vehicles or other entities with third-party investors (collectively, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;joint ventures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). Joint venture investments involve various risks, including the risk that we will not be able to implement investment decisions or exit strategies because of limitations on our control under applicable agreements with joint venture partners, the risk that a joint venture partner may become bankrupt or may at any time have economic or business interests or goals that are inconsistent with those of the Company, the risk that a joint venture partner may be in a position to take action contrary to the Company&#x2019;s objectives, the risk of liability based upon the actions of a joint venture partner and the risk of disputes or litigation with such partner and the inability to enforce fully all rights (or the incurrence of additional risk in connection with enforcement of rights) one partner may have against the other, including in connection with foreclosure on partner loans, because of risks arising under state law. In addition, we may, in certain cases, be liable for actions of our joint venture partners. The joint ventures in which we participate may sometimes be allocated investment opportunities that might have otherwise gone entirely to the Company, which may reduce our return on equity. Additionally, our joint venture investments may be held on an unconsolidated basis and at times may be highly leveraged. Such leverage would not count toward the investment limits imposed on us by the 1940 Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We are subject to risks associated with investing alongside other third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;We may invest in joint ventures alongside third parties through joint ventures, partnerships or other entities in the future. Such investments may involve risks not present in investments where a third party is not involved, including the possibility that such third party may at any time have economic or business interests or goals which are inconsistent with ours, or may be in a position to take action contrary to our investment objectives. In addition, we may in certain circumstances be liable for actions of such third party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;More specifically, joint ventures involve a third party that has approval rights over activity of the joint venture. The third party may take actions that are inconsistent with our interests. For example, the third party may decline to approve an investment for the joint venture that we otherwise want the joint venture to make. A joint venture may also use investment leverage which magnifies the potential for gain or loss on amounts invested. Generally, the amount of borrowing by the joint venture is not included when calculating our total borrowing and related leverage ratios and is not subject to asset coverage requirements imposed by the 1940 Act. If the activities of the joint venture were required to be consolidated with our activities because of a change in GAAP rules or SEC staff interpretations, it is likely that we would have to reorganize any such joint venture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may syndicate co-investment opportunities, which may be costly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may make an investment with the expectation of offering a portion of its interests therein as a co-investment opportunity to third-party investors. There can be no assurance that we will be successful in syndicating any such co-investment, in whole or in part, that the closing of such co-investment will be consummated in a timely manner, that any syndication will take place on terms and conditions that will be preferable for the Company or that expenses incurred by us with respect to any such syndication will not be substantial. In the event that we are not successful in syndicating any such co-investment, in whole or in part, we may consequently hold a greater concentration and have more exposure in the related investment than initially was intended, which could make the Company more susceptible to fluctuations in value resulting from adverse economic and/or business conditions with respect thereto. Moreover, an investment by the Company that is not syndicated to co-investors as originally anticipated could significantly reduce our overall investment returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may use a wide range of investment techniques that could expose us to a diverse range of risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser may employ investment techniques or invest in instruments that it believes will help achieve our investment objectives, whether or not such investment techniques or instruments are specifically defined herein, so long as such investments are consistent with our investment strategies and objectives and subject to applicable law. Such investment techniques or instruments may not be thoroughly tested in the market before being employed and may have operational or theoretical shortcomings which could result in unsuccessful investments and, ultimately, losses to us. In addition, any such investment technique or instrument may be more speculative than other investment techniques or instruments specifically described herein and may involve material and unanticipated risks. There can be no assurance that the Adviser will be successful in implementing any such investment technique. Furthermore, the diversification and type of investments may differ substantially from our prior investments.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt"&gt;Risks Related to the Adviser and Its Affiliates&lt;/span&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The Adviser and its affiliates, including our officers and some of our trustees, face conflicts of interest caused by compensation arrangements with us and our affiliates, which could result in actions that are not in the best interests of our shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser and its affiliates receive substantial fees from us in return for their services, and these fees could influence the advice provided to us. We pay to the Adviser an incentive fee that is based on the performance of our portfolio and an annual base management fee that is based on the average value of our gross assets at the end of the two most recently completed calendar quarters. Because the incentive fee is based on the performance of our portfolio, the Adviser may be incentivized to make investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The way in which the incentive fee is determined may also encourage the Adviser to use leverage to increase the return on our investments. In addition, because the base management fee is based on the average value of our gross assets at the end of the two most recently completed calendar quarters, which includes any borrowings for investment purposes, the Adviser may be incentivized to recommend the use of leverage or the issuance of additional equity to make additional investments and increase the average value of our gross assets at the end of the two most recently completed calendar quarters. Under certain circumstances, the use of leverage may increase the likelihood of default, which could disfavor our shareholders. Our compensation arrangements could therefore result in our making riskier or more speculative investments, or relying more on leverage to make investments, than would otherwise be the case. This could result in higher investment losses, particularly during cyclical economic downturns. See&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may be obligated to pay the Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Investment Advisory Agreement entitles the Adviser to receive Pre-Incentive Fee Net Investment Income Returns regardless of any capital losses. In such case, we may be required to pay the Adviser incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or if we incur a net loss for that quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, any Pre-Incentive Fee Net Investment Income Returns may be computed and paid on income that may include interest that has been accrued but not yet received. If a portfolio company defaults on a loan that is structured to provide accrued interest, it is possible that accrued interest previously included in the calculation of the incentive fee will become uncollectible. The Adviser is not under any obligation to reimburse us for any part of the incentive fee it received that was based on accrued income that we never received as a result of a default by an entity on the obligation that resulted in the accrual of such income, and such circumstances would result in our paying an incentive fee on income we never received.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The incentive fee based on income takes into account our past performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Incentive Fee based on income is determined and paid quarterly in arrears at the end of each calendar quarter by reference to our aggregate net investment income, as adjusted, from the calendar quarter then ending and the Trailing Twelve Quarters. The effect of calculating the incentive fee using reference to the Trailing Twelve Quarters is that, in certain circumstances, an incentive fee based on income is payable to the Adviser although our net income for such quarter did not exceed the hurdle rate or the incentive fee will be higher than it would have been if calculated based on our performance for the applicable quarter without taking into account the Trailing Twelve Quarters. For example, if we experience a net loss for any particular quarter, an incentive fee may still be paid to the Adviser if such net loss is less than the net loss for the most recent quarter that preceded the Trailing Twelve Quarters. In such circumstances, the Adviser would be entitled to an incentive fee whereas it would not have been entitled to an incentive fee if calculated solely on the basis of our performance for the applicable quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;There may be conflicts of interest related to obligations that the Adviser&#x2019;s senior management and Investment Team have to Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The members of the senior management and Investment Team of the Adviser serve or may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do, or of investment funds managed by the same personnel. In serving in these multiple capacities, they may have obligations to Other Clients or investors in those entities, the fulfillment of which may not be in our best interests or in the best interest of our shareholders. Our investment objectives may overlap with the investment objectives of such investment funds, accounts or other investment vehicles. In particular, we will rely on the Adviser to manage our day-to-day activities and to implement our investment strategy. The Adviser and certain of its affiliates are presently, and plan in the future to continue to be, involved with activities that are unrelated to us. As a result of these activities, the Adviser, its officers and employees and certain of its affiliates will have conflicts of interest in allocating their time between us and other activities in which they are or may become involved, including the management of its affiliated equipment funds. The Adviser and its officers and employees will devote only as much of its or their time to our business as the Adviser and its officers and employees, in their judgment, determine is reasonably required, which may be substantially less than their full time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We rely, in part, on the Adviser to assist with identifying investment opportunities and making investment recommendations to the Adviser. The Adviser and its affiliates are not restricted from forming additional investment funds, entering into other investment advisory relationships or engaging in other business activities. These activities could be viewed as creating a conflict of interest in that the time and effort of the members of the Adviser, its affiliates and their officers and employees will not be devoted exclusively to our business, but will be allocated between us and such other business activities of the Adviser and its affiliates in a manner that the Adviser deems necessary and appropriate consistent with its fiduciary duties and the 1940 Act. See&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The time and resources that individuals employed by the Adviser devote to us may be diverted and we may face additional competition due to the fact that individuals employed by the Adviser are not prohibited from raising money for or managing other entities that make the same types of investments that we target.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser and individuals employed by the Adviser are generally not prohibited from raising capital for and managing other investment entities that make the same types of investments as those we target. As a result, the time and resources that these individuals may devote to us may be diverted. In addition, we may compete with any such investment entity for the same investors and investment opportunities. We may participate in certain transactions originated by the Adviser or its affiliates under our exemptive relief from the SEC that allows us to engage in co-investment transactions with the Adviser and its affiliates, subject to certain terms and conditions. However, while the terms of the exemptive relief require that the Adviser will be given the opportunity to cause us to participate in certain transactions originated by affiliates of the Adviser, the Adviser may determine that we not participate in those transactions and for certain other transactions (as set forth in guidelines approved by the Board) the Adviser may not have the opportunity to cause us to participate. Affiliates of the Adviser, whose primary business includes the origination of investments or investing in non-originated assets, engage in investment advisory business with accounts that compete with us. See&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us."&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our shares may be purchased by the Adviser or its affiliates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Affiliates of the Adviser have purchased and in the future expect to purchase our shares. The Adviser and its affiliates will not acquire any shares with the intention to resell or re-distribute such shares. The purchase of shares by the Adviser and its affiliates could create certain risks, including, but not limited to, the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the Adviser and its affiliates may have an interest in disposing of our assets at an earlier date so as to recover their investment in our shares; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;substantial purchases of shares by the Adviser and its affiliates may limit the Adviser&#x2019;s ability to fulfill any financial obligations that it may have to us or incurred on our behalf.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The Adviser relies on key personnel, the loss of any of whom could impair its ability to successfully manage us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our future success depends, to a significant extent, on the continued services of the officers and employees of the Adviser or its affiliates. The loss of services of one or more members of the Adviser&#x2019;s management team, including members of the Investment Committee, could adversely affect our financial condition, business and results of operations. The Adviser does not have an employment agreement with any of these key personnel and we cannot guarantee that all, or any particular one, will remain affiliated with us and/or the Adviser. Further, we do not intend to separately maintain key person life insurance on any of these individuals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We depend on the Adviser to select our investments and otherwise conduct our business, and any material adverse change in its financial condition or our relationship with the Adviser could have a material adverse effect on our business and ability to achieve our investment objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our success is dependent upon our relationship with, and the performance of, the Adviser in the acquisition and management of our portfolio investments, and our corporate operations, as well as the persons and firms the Adviser retains to provide services on our behalf. The Adviser may suffer or become distracted by adverse financial or operational problems in connection with Blackstone&#x2019;s business and activities unrelated to us and over which we have no control. Should the Adviser fail to allocate sufficient resources to perform its responsibilities to us for any reason, we may be unable to achieve our investment objectives or to pay distributions to our shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The compensation we pay to the Adviser will be determined without independent assessment on our behalf, and these terms may be less advantageous to us than if such terms had been the subject of arm&#x2019;s-length negotiations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Investment Advisory Agreement will not be entered into on an arm&#x2019;s-length basis with an unaffiliated third party. As a result, the form and amount of compensation we pay the Adviser may be less favorable to us than they might have been had an investment advisory agreement been entered into through arm&#x2019;s-length transactions with an unaffiliated third party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The Adviser&#x2019;s influence on conducting our operations gives it the ability to increase its fees, which may reduce the amount of cash flow available for distribution to our shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser is paid a base management fee calculated as a percentage of our gross assets and unrelated to net income or any other performance base or measure. The Adviser may advise us to consummate transactions or conduct our operations in a manner that, in the Adviser&#x2019;s reasonable discretion, is in the best interests of our shareholders. These transactions, however, may increase the amount of fees paid to the Adviser. The Adviser&#x2019;s ability to influence the base management fee paid to it by us could reduce the amount of cash flow available for distribution to our shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;There may be trademark risk, as we do not own the Blackstone name.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not own the Blackstone name, but we are permitted to use it as part of our corporate name pursuant to the Investment Advisory Agreement. Use of the name by other parties or the termination of the Investment Advisory Agreement may harm our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may be subject to additional potential conflicts of interests as a consequence of Blackstone&#x2019;s status as a public company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a consequence of Blackstone&#x2019;s status as a public company, our officers and trustees, and the employees&#160;of the Adviser may take into account certain considerations and other factors in connection with the management of the business and affairs of us and our affiliates that would not necessarily be taken into account if Blackstone were not a public company. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt"&gt;Risks Related to Business Development Companies&lt;/span&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The requirement that we invest a sufficient portion of our assets in Qualifying Assets could preclude us from investing in accordance with our current business strategy; conversely, the failure to invest a sufficient portion of our assets in Qualifying Assets could result in our failure to maintain our status as a BDC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 1940 Act, a BDC may not acquire any asset other than assets of the type listed in section 55(a) of the 1940 Act described as &#x201c;qualifying&#x201d; assets (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Qualifying Assets&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), unless, at the time of and after giving effect to such acquisition, at least 70% of our total assets are Qualifying Assets. Therefore, we may be precluded from investing in what we believe are attractive investments if such investments are not Qualifying Assets. Conversely, if we fail to invest a sufficient portion of our assets in Qualifying Assets, we could lose our status as a BDC, which would have a material adverse effect on our business, financial condition and results of operations. Similarly, these rules could prevent us from making additional investments in existing portfolio companies, which could result in the dilution of our position, or could require us to dispose of investments at an inopportune time to comply with the 1940 Act. If we were forced to sell non-qualifying investments in the portfolio for compliance purposes, the proceeds from such sale could be significantly less than the current value of such investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Failure to maintain our status as a BDC would reduce our operating flexibility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we do not remain a BDC, we might be regulated as a registered closed-end management investment company under the 1940 Act, which would subject us to substantially more regulatory restrictions under the 1940 Act and correspondingly decrease our operating flexibility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Regulations governing our operation as a BDC and RIC will affect our ability to raise, and the way in which we raise, additional capital or borrow for investment purposes, which may have a negative effect on our growth.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of meeting the annual distribution requirement to avoid paying U.S. federal corporate income tax, as a RIC, we may need to periodically access the capital markets to raise cash in order to fund new investments. We may issue &#x201c;senior securities,&#x201d; as defined under the 1940 Act, including borrowing money from banks or other financial institutions only in amounts such that our asset coverage meets the threshold set forth in the 1940 Act immediately after each such issuance. The 1940 Act currently requires an asset coverage of at least 150% (i.e., the amount of debt may not exceed two-thirds of the value of our assets). Our ability to issue different types of securities is also limited. Compliance with these requirements may unfavorably limit our investment opportunities and reduce our ability in comparison to other companies to profit from favorable spreads between the rates at which we can borrow and the rates at which we can lend. As a BDC, therefore, we intend to continuously issue equity at a rate more frequent than our privately-owned competitors, which may lead to greater shareholder dilution. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For U.S. federal income tax purposes, we are required to recognize taxable income (which may include deferred interest that is accrued as original issue discount) in some circumstances in which we do not receive a corresponding payment in cash and to make distributions with respect to such income in order to avoid corporate income tax as a RIC. Under such circumstances, we may have difficulty meeting the annual distribution requirement necessary to eliminate any corporate income tax as a RIC under the Code. This difficulty in making the required distribution may be amplified to the extent that we are required to pay an incentive fee with respect to such accrued income. As a result, we may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital, or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may not meet the distribution requirements prescribed by the Code for a RIC and as such may become subject to corporate income tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We borrow for investment purposes. If the value of our assets declines, we may be unable to satisfy the asset coverage test, which would prohibit us from paying distributions and could result in a corporate income tax to the Company. If we cannot satisfy the asset coverage test, we may be required to sell a portion of our investments and, depending on the nature of our debt financing, repay a portion of our indebtedness at a time when such sales may be disadvantageous.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 1940 Act, we generally are prohibited from issuing or selling our shares at a price per share, after deducting selling commissions and dealer manager fees, that is below our NAV per share, which may be a disadvantage as compared with other public companies. We may, however, sell our shares, or warrants, options or rights to acquire our shares, at a price below the current NAV of our shares if our Board, including our independent trustees, determine that such sale is in our best interests and the best interests of our shareholders, and our shareholders, as well as those shareholders that are not affiliated with us, approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board, closely approximates the fair value of such securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our ability to enter into transactions with our affiliates is restricted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are prohibited under the 1940 Act from participating in certain transactions with certain of our affiliates (including portfolio companies of Other Clients) without the prior approval of a majority of the independent members of our Board and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of our outstanding voting securities will be our affiliate for purposes of the 1940 Act and generally we will be prohibited from buying or selling any securities from or to such affiliate, absent the prior approval of our Board. However, we may under certain circumstances purchase any such affiliate's loans or securities in the secondary market, which could create a conflict for the Adviser between our interests and the interests of such affiliate, in that the ability of the Adviser to recommend actions in our best interest may be limited. The 1940 Act also prohibits certain &#x201c;joint&#x201d; transactions with certain of our affiliates, which could include investments in the same portfolio company (whether at the same or closely related times), without prior approval of our Board and, in some cases, the SEC. If a person acquires more than 25% of our voting securities, we will be prohibited from buying or selling any security from or to such person or certain of that person&#x2019;s affiliates, or entering into prohibited joint transactions (including certain co-investments) with such persons, absent the prior approval of the SEC. Similar restrictions limit our ability to transact business with our officers, trustees, investment advisers, sub-advisers or their affiliates. As a result of these restrictions, we may be prohibited from buying or selling any security from or to any fund or any portfolio company of a fund managed by the Adviser, or entering into joint arrangements such as certain co-investments with these companies or funds without the prior approval of the SEC, which may limit the scope of investment opportunities that would otherwise be available to us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have obtained exemptive relief from the SEC that allows us to engage in co-investment transactions with the Adviser and its affiliates, subject to certain terms and conditions. However, while the terms of the exemptive relief require that the Adviser will be given the opportunity to cause us to participate in certain transactions originated by affiliates of the Adviser, the Adviser may determine that we not participate in those transactions and for certain other transactions (as set forth in guidelines approved by the Board) the Adviser may not have the opportunity to cause us to participate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We are uncertain of our sources for funding our future capital needs; if we cannot obtain debt or equity financing on acceptable terms, our ability to acquire investments and to expand our operations will be adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds from the sale of shares will be used for our investment opportunities, operating expenses and for payment of various fees and expenses such as base management fees, incentive fees and other expenses. Any working capital reserves we maintain may not be sufficient for investment purposes, and we may require debt or equity financing to operate. Accordingly, in the event that we develop a need for additional capital in the future for investments or for any other reason, these sources of funding may not be available to us. Consequently, if we cannot obtain debt or equity financing on acceptable terms, our ability to acquire investments and to expand our operations will be adversely affected. As a result, we would be less able to create and maintain a broad portfolio of investments and achieve our investment objectives, which may negatively impact our results of operations and reduce our ability to make distributions to our shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We are a non-diversified investment company within the meaning of the 1940 Act, and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are classified as a non-diversified investment company within the meaning of the 1940 Act, which means that we are not limited by the 1940 Act with respect to the proportion of our assets that we may invest in securities of a single issuer. Under the 1940 Act, a &#x201c;diversified&#x201d; investment company is required to invest at least 75% of the value of its total assets in cash and cash items, government securities, securities of other investment companies and other securities limited in respect of any one issuer to an amount not greater than 5% of the value of the total assets of such company and no more than 10% of the outstanding voting securities of such issuer. As a non-diversified investment company, we are not subject to this requirement. To the extent that we assume large positions in the securities of a small number of issuers, or within a particular industry, our NAV may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market&#x2019;s assessment of the issuer. We may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company or to a general downturn in the economy. However, we will be subject to the diversification requirements applicable to RICs under Subchapter M of the Code.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt"&gt;Risks Related to Debt Financing&lt;/span&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;When we use leverage, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us. Leverage may also adversely affect the return on our assets, reduce cash available for distribution to our shareholders, and result in losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The use of borrowings, also known as leverage, increases the volatility of investments by magnifying the potential for loss on invested equity capital. When we use leverage to partially finance our investments, through borrowing from banks and other lenders, shareholders will experience increased risks of investing in our shares. If the value of our assets decreases, leveraging would cause NAV to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Such a decline could negatively affect our ability to make distributions to our shareholders. In addition, our shareholders will bear the burden of any increase in our expenses as a result of our use of leverage, including interest expenses and any increase in the management or incentive fees payable to the Adviser.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use and intend to continue to use leverage to finance our investments. The amount of leverage that we employ will depend on the Adviser&#x2019;s and our Board&#x2019;s assessment of market and other factors at the time of any proposed borrowing. There can be no assurance that leveraged financing will be available to us on favorable terms or at all. However, to the extent that we use leverage to finance our assets, our financing costs will reduce cash available for distributions to shareholders. Moreover, we may not be able to meet our financing obligations and, to the extent that we cannot, we risk the loss of some or all of our assets to liquidation or sale to satisfy the obligations. In such an event, we may be forced to sell assets at significantly depressed prices due to market conditions or otherwise, which may result in losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a BDC, we generally are required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred shares that we may issue in the future, of at least 150%. If this ratio were to fall below 150%, we could not incur additional debt and could be required to sell a portion of our investments to repay some debt when it is disadvantageous to do so. This could have a material adverse effect on our operations and investment activities. Moreover, our ability to make distributions to shareholders may be significantly restricted or we may not be able to make any such distributions whatsoever. The amount of leverage that we will employ will be subject to oversight by our Board of Trustees, a majority of whom are independent Trustees with no material interests in such transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may also enter into reverse repurchase agreements. Transactions under such agreements constitute leverage. When the Company enters into a reverse repurchase agreement, any fluctuations in the market value of either the securities transferred to another party or the securities in which the proceeds may be invested would affect the market value of the Company&#x2019;s assets. As a result, the use of such leverage transactions may increase fluctuations in the market value of the Company&#x2019;s assets compared to what would occur without the use of such transactions. Because reverse repurchase agreements may be considered to be the practical equivalent of borrowing funds, they constitute a form of leverage. If the Company reinvests the proceeds of a reverse repurchase agreement at a rate lower than the cost of the agreement, transacting under such agreement will lower the Company&#x2019;s yield. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although leverage has the potential to enhance overall returns that exceed the Company&#x2019;s cost of funds, they will further diminish returns (or increase losses on capital) to the extent overall returns are less than the Company&#x2019;s cost of funds. In addition, borrowings and reverse repurchase agreements or similar arrangements in which the Company may engage may be secured by the shareholders&#x2019; investments as well as by the Company&#x2019;s assets and the documentation relating to such transactions may provide that during the continuance of a default under such arrangement, the interests of the holders of Common Shares may be subordinated to the interests of the Company&#x2019;s lenders or debt-holders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our credit facilities and unsecured notes impose financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a regulated investment company under the 1940 Act. A failure to renew our facilities or to add new or replacement debt facilities or issue additional debt securities or other evidences of indebtedness could have a material adverse effect on our business, financial condition, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Item 7. Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations &#x2014; Financial Condition, Liquidity and Capital Resources&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information regarding our borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may default under our credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event we default under our credit facilities or other borrowings, our business could be adversely affected as we may be forced to sell a portion of our investments quickly and prematurely at what may be disadvantageous prices to us in order to meet our outstanding payment obligations and/or support working capital requirements under such borrowing facility, any of which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, following any such default, the agent for the lenders under such borrowing facility could assume control of the disposition of any or all of our assets, including the selection of such assets to be disposed and the timing of such disposition, which would have a material adverse effect on our business, financial condition, results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our current or future credit ratings may not reflect all risks of an investment in our debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any current or future credit ratings of us are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our current or future credit ratings will generally affect the market value of our debt securities. Our current or future credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of or trading market for the publicly issued debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The trading market or market value of our issued debt securities may fluctuate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our issued debt securities may or may not have an established trading market. We cannot assure our noteholders that a trading market for our issued debt securities will ever develop or be maintained if developed. In addition to our creditworthiness, many factors may materially adversely affect the trading market for, and market value of, our issued debt securities. These factors include, but are not limited to, the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the time remaining to the maturity of these debt securities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the outstanding principal amount of debt securities with terms identical to these debt securities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the ratings assigned by national statistical ratings agencies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the general economic environment;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the supply of debt securities trading in the secondary market, if any;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the redemption or repayment features, if any, of these debt securities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the level, direction and volatility of market interest rates generally; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;market rates of interest higher or lower than rates borne by the debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our noteholders should also be aware that there may be a limited number of buyers when they decide to sell their debt securities. This too may materially adversely affect the market value of the debt securities or the trading market for the debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Terms relating to redemption may materially adversely affect our noteholders return on any debt securities that we may issue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If our noteholders&#x2019; debt securities are redeemable at our option, we may choose to redeem their debt securities at times when prevailing interest rates are lower than the interest rate paid on their debt securities. In addition, if our noteholders&#x2019; debt securities are subject to mandatory redemption, we may be required to redeem their debt securities also at times when prevailing interest rates are lower than the interest rate paid on their debt securities. In this circumstance, our noteholders may not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as their debt securities being redeemed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;If we issue preferred shares or convertible debt securities, the net asset value of our common shares may become more volatile.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We cannot assure you that the issuance of preferred shares and/or convertible debt securities would result in a higher yield or return to the holders of our common shares. The issuance of preferred shares or convertible debt would likely cause the NAV of our common shares to become more volatile. If the dividend rate on the preferred shares, or the interest rate on the convertible debt securities, were to approach the net rate of return on our investment portfolio, the benefit of such leverage to the holders of our common shares would be reduced. If the dividend rate on the preferred shares, or the interest rate on the convertible debt securities, were to exceed the net rate of return on our portfolio, the use of leverage would result in a lower rate of return to the holders of common shares than if we had not issued the preferred shares or convertible debt securities. Any decline in the NAV of our investment would be borne entirely by the holders of our common shares. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in NAV to the holders of our common shares than if we were not leveraged through the issuance of preferred shares or debt securities. This decline in NAV would also tend to cause a greater decline in the market price, if any, for our common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There is also a risk that, in the event of a sharp decline in the value of our net assets, we would be in danger of failing to maintain required asset coverage ratios, which may be required by the preferred shares or convertible debt, or our current investment income might not be sufficient to meet the dividend requirements on the preferred shares or the interest payments on the debt securities. In order to counteract such an event, we might need to liquidate investments in order to fund the redemption of some or all of the preferred shares or convertible debt. In addition, we would pay (and the holders of our common shares would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred shares, debt securities, convertible debt, or any combination of these securities. Holders of preferred shares or convertible debt may have different interests than holders of common shares and may at times have disproportionate influence over our affairs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Holders of any preferred shares that we may issue will have the right to elect certain members of our Board and have class voting rights on certain matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 1940 Act requires that holders of preferred shares must be entitled as a class to elect two trustees at all times and to elect a majority of the trustees if dividends on such preferred shares are in arrears by two years or more, until such arrearage is eliminated. In addition, certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred shares, including changes in fundamental investment restrictions and conversion to open-end status and, accordingly, preferred shareholders could veto any such changes. Restrictions imposed on the declarations and payment of dividends or other distributions to the holders of our common shares and preferred shares, both by the 1940 Act and by requirements imposed by rating agencies, might impair our ability to maintain our tax treatment as a RIC for U.S. federal income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Provisions in a credit facility may limit our investment discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A credit facility may be backed by all or a portion of our loans and securities on which the lenders will have a security interest. We may pledge up to 100% of our assets and may grant a security interest in all of our assets under the terms of any debt instrument we enter into with lenders. We expect that any security interests we grant will be set forth in a pledge and security agreement and evidenced by the filing of financing statements by the agent for the lenders. In addition, we expect that the custodian for our securities serving as collateral for such loan would include in its electronic systems notices indicating the existence of such security interests and, following notice of occurrence of an event of default, if any, and during its continuance, will only accept transfer instructions with respect to any such securities from the lender or its designee. If we were to default under the terms of any debt instrument, the agent for the applicable lenders would be able to assume control of the timing of disposition of any or all of our assets securing such debt, which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In connection with one or more credit facilities entered into by the Company, distributions to shareholders may be subordinated to payments required in connection with any indebtedness contemplated thereby.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, any security interests and/or negative covenants required by a credit facility may limit our ability to create liens on assets to secure additional debt and may make it difficult for us to restructure or refinance indebtedness at or prior to maturity or obtain additional debt or equity financing. In addition, if our borrowing base under a credit facility were to decrease, we may be required to secure additional assets in an amount sufficient to cure any borrowing base deficiency. In the event that all of our assets are secured at the time of such a borrowing base deficiency, we could be required to repay advances under a credit facility or make deposits to a collection account, either of which could have a material adverse impact on our ability to fund future investments and to make distributions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we may be subject to limitations as to how borrowed funds may be used, which may include restrictions on geographic and industry concentrations, loan size, payment frequency and status, average life, collateral interests and investment ratings, as well as regulatory restrictions on leverage which may affect the amount of funding that may be obtained. There may also be certain requirements relating to portfolio performance, including required minimum portfolio yield and limitations on delinquencies and charge-offs, a violation of which could limit further advances and, in some cases, result in an event of default. An event of default under a credit facility could result in an accelerated maturity date for all amounts outstanding thereunder, which could have a material adverse effect on our business and financial condition. This could reduce our liquidity and cash flow and impair our ability to grow our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the effect of leverage on returns from an investment in our shares assuming various annual returns on our portfolio, net of expenses. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.626%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assumed Return on Our Portfolio (Net of Expenses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;-10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;-5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corresponding return to common stockholder&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;&#160;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-25.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-15.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-5.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Based on (i) $10.1 billion in total assets as of December&#160;31, 2023, (ii) $4.9 billion in outstanding indebtedness, at par, as of December&#160;31, 2023, (iii) $5.0 billion in net assets as of December&#160;31, 2023 and (iv)&#160;an annualized average interest rate, including fees (such as fees on undrawn amounts and amortization of financing costs), on our indebtedness, as of December&#160;31, 2023, of 5.05%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on an outstanding indebtedness, at par, of&#160;$4.9 billion&#160;as of&#160;December&#160;31, 2023 and the weighted average effective annual interest rate, including fees (such as fees on undrawn amounts and amortization of financing costs), of 5.05% as of that date, our investment portfolio at fair value would have had to produce an annual return of approximately 2.46% to cover annual interest payments on the outstanding debt. For more information on our indebtedness, see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Item 7.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x2014;Financial Condition, Liquidity and Capital Resources.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Changes in interest rates may affect our cost of capital and net investment income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since we use debt to finance a portion of our investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In periods of rising interest rates when we have debt outstanding, our cost of funds will increase, which could reduce our net investment income. We expect that our long-term fixed-rate investments will be financed primarily with equity and long-term debt. We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. These techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. These activities may limit our ability to participate in the benefits of lower interest rates with respect to the hedged portfolio. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations. Also, we have limited experience in entering into hedging transactions, and we will initially have to purchase or develop such expertise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Compliance with SEC Rule 18f-4 governing derivatives and use of leverage may limit our investment discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Among other things, Rule 18f-4 under the 1940 Act, eliminates the asset segregation framework arising from prior SEC guidance for covering positions in derivatives and certain financial instruments. Rule 18f-4 also limits a fund&#x2019;s derivatives exposure through a value-at-risk test and requires the adoption and implementation of a derivatives risk management program for certain derivatives users. Subject to certain conditions, limited derivatives users (as defined in Rule 18f-4), such as the Company, however, would not be subject to the full requirements of Rule 18f-4. Under Rule 18f-4, a fund may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the fund has, among other things, a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. The Company has adopted policies and procedures to comply with the requirements of the rule. Compliance with Rule 18f-4 may limit our ability to use derivatives and/or enter into certain other financial contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may form CLOs in the future, which may subject us to certain structured financing risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To finance investments, we may securitize certain of our secured loans or other investments, including through the formation of one or more CLOs, while retaining all or most of the exposure to the performance of these investments. This would involve contributing a pool of assets to a special purpose entity, and selling debt interests in such entity on a non-recourse or limited-recourse basis to purchasers. Depending on how these CLOs are structured, an interest in any such CLO held by us may be considered a &#x201c;non-qualifying&#x201d; portfolio investment for purposes of the 1940 Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the CLOs we may in the future create we will depend in part on distributions from the CLO&#x2019;s assets out of its earnings and cash flows to enable us to make distributions to shareholders. The ability of a CLO to make distributions will be subject to various limitations, including the terms and covenants of the debt it issues. Also, a CLO may take actions that delay distributions in order to preserve ratings and to keep the cost of present and future financings lower or the CLO may be obligated to retain cash or other assets to satisfy over-collateralization requirements commonly provided for holders of the CLO&#x2019;s debt, which could impact our ability to receive distributions from the CLO. If we do not receive cash flow from any such CLO that is necessary to satisfy the annual distribution requirement for maintaining RIC status, and we are unable to obtain cash from other sources necessary to satisfy this requirement, we may not maintain our qualification as a RIC, which would have a material adverse effect on an investment in the shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, a decline in the credit quality of loans in a CLO due to poor operating results of the relevant borrowers, declines in the value of loan collateral or increases in defaults, among other things, may force a CLO to sell certain assets at a loss, reducing their earnings and, in turn, cash potentially available for distribution to us for distribution to shareholders. To the extent that any losses are incurred by the CLO in respect of any collateral, such losses will be borne first by us as owner of equity interests in the CLO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The manager for a CLO that we create may be the Company, the Adviser or an affiliate, and such manager may be entitled to receive compensation for structuring and/or management services. To the extent the Adviser or an affiliate other than the Company serves as manager and the Company is obligated to compensate the Adviser or the affiliate for such services, we, the Adviser or the affiliate will implement offsetting arrangements to assure that we, and indirectly, our shareholders, pay no additional management fees to the Adviser or the affiliate in connection therewith. To the extent we serve as manager, we will waive any right to receive fees for such services from the Company (and indirectly its shareholders) or any affiliate.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.4pt"&gt;Federal Income Tax Risks&lt;/span&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We will be subject to corporate-level income tax if we are unable to maintain RIC tax treatment under Subchapter M of the Code or satisfy RIC distribution requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To obtain and maintain RIC tax treatment under Subchapter M of the Code, we must, among other things, meet annual distribution, income source and quarterly asset diversification requirements. If we do not qualify for or maintain RIC tax treatment for any reason and are subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For federal income tax purposes, we may be required to recognize taxable income in circumstances in which we do not receive a corresponding payment in cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount (such as zero-coupon securities, debt instruments with PIK interest or, in certain cases, increasing interest rates or debt instruments that were issued with warrants), we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. We may also have to include in income other amounts that we have not yet received in cash, such as deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. We anticipate that a portion of our income may constitute original issue discount or other income required to be included in taxable income prior to receipt of cash. Furthermore, we have elected to amortize market discount and include such amounts in our taxable income on a current basis, instead of upon disposition of the applicable debt obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because any original issue discount, market discount or other amounts accrued will be included in our investment company taxable income for the year of the accrual, we may be required to make a distribution to our shareholders in order to satisfy the annual distribution requirement, even though we will not have received any corresponding cash amount. As a result, we may have difficulty meeting the annual distribution requirement necessary to eliminate any corporate income tax as a RIC under Subchapter M of the Code. We may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may not qualify for or maintain RIC tax treatment and thus we may become subject to corporate-level income tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Some of our investments may be subject to corporate-level income tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may invest in certain debt and equity investments through taxable subsidiaries and the taxable income of these taxable subsidiaries will be subject to federal and state corporate income taxes. We may invest in certain foreign debt and equity investments which could be subject to foreign taxes (such as income tax, withholding and value added taxes).&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our portfolio investments may present special tax issues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expects to invest in debt securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Investments in these types of instruments may present special tax issues for the Company. U.S. federal income tax rules are not entirely clear about issues such as when the Company may cease to accrue interest, original issue discount or market discount, when and to what extent deductions may be taken for bad debts or worthless instruments, how payments received on obligations in default should be allocated between principal and income and whether exchanges of debt obligations in a bankruptcy or workout context are taxable. These and other issues will be addressed by the Company, to the extent necessary, to preserve its status as a RIC and to distribute sufficient income to not become subject to U.S. federal income tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legislative or regulatory tax changes could adversely affect investors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At any time, the federal income tax laws governing RICs or the administrative interpretations of those laws or regulations may be amended. Any of those new laws, regulations or interpretations may take effect retroactively and could adversely affect the taxation of us or our shareholders. Therefore, changes in tax laws, regulations or administrative interpretations or any amendments thereto could diminish the value of an investment in our shares or the value or the resale potential of our investments.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.73pt"&gt;Risks Related to an Investment in the Common Shares&lt;/span&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We cannot assure you that the market price of common shares will not decline below the IPO price or below our NAV. The market price of common shares may be volatile and may fluctuate substantially.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We currently list our common shares on the NYSE under the symbol &#x201c;BXSL.&#x201d; We cannot assure you that the trading market can be sustained. In addition, we cannot predict the prices at which our common shares will trade. Shares of closed-end management investment companies, including BDCs, frequently trade at a discount from their NAV and our shares may also be discounted in the market. This characteristic of closed-end management investment companies is separate and distinct from the risk that our NAV per share may decline. We cannot predict whether our common shares will trade at, above or below NAV. The risk of loss associated with this characteristic of closed-end management investment companies may be greater for investors expecting to sell common shares purchased in the offering soon after the offering. In addition, if our common shares trades below its NAV, we will generally not be able to sell additional common shares to the public at its market price without first obtaining the approval of a majority of our shareholders (including a majority of our unaffiliated shareholders) and our independent directors for such issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The market price and liquidity of the market for our common shares may be si&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;gnificantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;significant volatility in the market price and trading volume of securities of BDCs or other companies in the sector in which we operate, which are not necessarily related to the operating performance of these companies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;loss of RIC or BDC status;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in earnings or variations in operating results;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in the value of our portfolio of investments;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in accounting guidelines governing valuation of our investments;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;any shortfall in revenue or net income or any increase in losses from levels expected by shareholders or securities analysts;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;departure of either of the Adviser or certain of its respective key personnel;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;operating performance of companies comparable to us;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;general economic trends and other external factors; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;loss of a major funding source.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;A shareholder&#x2019;s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our shareholders do not have preemptive rights to purchase any shares we issue in the future. Our charter authorizes us to issue an unlimited number of shares. Our Board may elect to sell additional shares in the future or issue equity interests in private offerings. To the extent we issue additional equity interests at or below NAV, your percentage ownership interest in us may be diluted. In addition, depending upon the terms and pricing of any additional offerings and the value of our investments, you may also experience dilution in the book value and fair value of your shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 1940 Act, we generally are prohibited from issuing or selling our common shares at a price below NAV per share, which may be a disadvantage as compared with certain public companies. We may, however, sell our common shares, or warrants, options, or rights to acquire our common shares, at a price below the current NAV of our common shares if our Board and independent directors determine that such sale is in our best interests and the best interests of our shareholders, and our shareholders, including a majority of those shareholders that are not affiliated with us, approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board, closely approximates the fair value of such securities (less any distributing commission or discount). If we raise additional funds by issuing common shares or senior securities convertible into, or exchangeable for, our common shares, then the percentage ownership of our shareholders at that time will decrease and you will experience dilution.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may have difficulty paying distributions and the tax character of any distributions is uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally intend to distribute substantially all of our available earnings annually by paying distributions on a quarterly basis, as determined by the Board in its discretion. We cannot assure shareholders that we will achieve investment results that will allow us to make a specified level of cash distributions (particularly during the early stages of our operations) or year-to-year increases in cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this annual report. Due to the asset coverage test applicable to us under the 1940 Act as a BDC, we may be limited in our ability to make distributions. In addition, if we enter into a credit facility or any other borrowing facility, for so long as such facility is outstanding, we anticipate that we may be required by its terms to use all payments of interest and principal that we receive from our current investments as well as any proceeds received from the sale of our current investments to repay amounts outstanding thereunder, which could adversely affect our ability to make distributions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furthermore, the tax treatment and characterization of our distributions may vary significantly from time to time due to the nature of our investments. The ultimate tax characterization of our distributions made during a taxable year may not finally be determined until after the end of that taxable year. We may make distributions during a taxable year that exceed our investment company taxable income and net capital gains for that taxable year. In such a situation, the amount by which our total distributions exceed investment company taxable income and net capital gains generally would be treated as a return of capital up to the amount of a shareholder&#x2019;s tax basis in the shares, with any amounts exceeding such tax basis treated as a gain from the sale or exchange of such shares. A return of capital generally is a return of a shareholder&#x2019;s investment rather than a return of earnings or gains derived from our investment activities. Moreover, we may pay all or a substantial portion of our distributions from the proceeds of the sale of our shares or from borrowings or sources other than cash flow from operations in anticipation of future cash flow, which could constitute a return of shareholders&#x2019; capital and will lower such shareholders&#x2019; tax basis in our shares, which may result in increased tax liability to shareholders when they sell such shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Distributions on our common shares may exceed our taxable earnings and profits. Therefore, portions of the distributions that we pay may represent a return of capital to you. A return of capital is a return of a portion of your original investment in common shares. As a result, a return of capital will (i) lower your tax basis in your shares and thereby increase the amount of capital gain (or decrease the amount of capital loss) realized upon a subsequent sale or redemption of such shares, and (ii) reduce the amount of funds we have for investment in portfolio companies. We have not established any limit on the extent to which we may use offering proceeds to fund distributions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may pay our distributions from offering proceeds in anticipation of future cash flow, which may constitute a return of your capital and will lower your tax basis in your shares, thereby increasing the amount of capital gain (or decreasing the amount of capital loss) realized upon a subsequent sale or redemption of such shares, even if such shares have not increased in value or have, in fact, lost value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shareholders will experience dilution in their ownership percentage if they do not participate in our dividend reinvestment plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All distributions declared in cash payable to shareholders that are participants in our dividend reinvestment plan will generally be automatically reinvested in common shares if the investor opts in to the plan. As a result, shareholders that do not elect to participate in our dividend reinvestment plan may experience dilution over time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shareholders may experience dilution in the net asset value of their shares if they do not participate in our dividend reinvestment plan and if our shares are trading at a discount to net asset value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All distributions declared in cash payable to shareholders that are participants in our dividend reinvestment plan will generally be automatically reinvested in common shares if the investor opts in to the plan. As a result, shareholders that do not elect to participate in our dividend reinvestment plan may experience accretion to the NAV of their shares if our shares are trading at a premium to NAV and dilution if our shares are trading at a discount to NAV. The level of accretion or discount would depend on various factors, including the proportion of our shareholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;No shareholder approval is required for certain mergers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board may undertake to approve mergers between us and certain other funds or vehicles.&#160;Subject to the requirements of the 1940 Act and NYSE rules, such mergers will not require shareholder approval so shareholders will not be given an opportunity to vote on these matters unless such mergers are reasonably anticipated to result in a material dilution of the NAV per share of the Company.&#160;These mergers may involve funds managed by affiliates of Blackstone Credit &amp;amp; Insurance.&#160;The Board may also convert the form and/or jurisdiction of organization, including to take advantage of laws that are more favorable to maintaining board control in the face of dissident shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investing in our shares involves a high degree of risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The investments we make in accordance with our investment objectives may result in a higher amount of risk than alternative investment options and volatility or loss of principal. Our investments in portfolio companies may be highly speculative and aggressive and, therefore, an investment in our shares may not be suitable for someone with lower risk tolerance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The NAV of our shares may fluctuate significantly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The NAV and liquidity, if any, of the market for our shares may be significantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;significant volatility in the market price and trading volume of securities of BDCs or other companies in the sector in which we operate, which are not necessarily related to the operating performance of these companies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;loss of RIC or BDC status;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in earnings or variations in operating results;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in the value of our portfolio of investments;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in accounting guidelines governing valuation of our investments;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;any shortfall in revenue or net income or any increase in losses from levels expected by shareholders or securities analysts;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;departure of either of the Adviser or certain of its respective key personnel;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;operating performance of companies comparable to us;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;general economic trends and other external factors; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;loss of a major funding source.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sales of substantial amounts of our common shares in the public market may have an adverse effect on the market price of our common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales of substantial amounts of our common shares, or the availability of such common shares for sale, could adversely affect the prevailing market prices for our common shares. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser, Blackstone Credit &amp;amp; Insurance, Blackstone and their respective affiliates will be subject to certain conflicts of interest with respect to the services the Adviser and the Administrator provide to us. These conflicts will arise primarily from the involvement of Blackstone Credit &amp;amp; Insurance, Blackstone and their respective affiliates (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Firm&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), in other activities that may conflict with our activities. You should be aware that individual conflicts will not necessarily be resolved in favor of your interest. The foregoing list of conflicts does not purport to be a complete enumeration or explanation of the actual and potential conflicts involved in an investment in the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For purposes of this discussion and ease of reference, the following terms shall have the meanings as set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Blackstone Credit &amp;amp; Insurance Clients&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; means, collectively, the investment funds, client accounts (including managed accounts) and proprietary accounts and/or other similar arrangements (including such arrangements in which the Company or one or more Other Blackstone Credit &amp;amp; Insurance Clients own interests) that Blackstone Credit &amp;amp; Insurance may establish, advise or sub-advise from time to time and to which Blackstone Credit &amp;amp; Insurance provides investment management or sub-advisory services (other than the Company and any such funds and accounts in which the Company has an interest), in each case including any alternative investment vehicles and additional capital vehicles relating thereto and any vehicles established by Blackstone Credit &amp;amp; Insurance to exercise its side-by-side or other general partner investment rights as set forth in their respective governing documents; provided, that for the avoidance of doubt, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Other Blackstone Credit &amp;amp; Insurance Clients&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; shall not include Blackstone Credit &amp;amp; Insurance in its role as principal of any account, including any such accounts for which Blackstone Credit &amp;amp; Insurance or an affiliate thereof acts as an advisor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Blackstone Clients&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; means, collectively, the investment funds, client accounts (including managed accounts) and proprietary accounts and/or other similar arrangements (including such arrangements in which the Company or one or more Blackstone Clients own interests) that Blackstone may establish, advise or sub-advise from time to time and to which Blackstone provides investment management or sub-advisory services (other than the Company, any such funds and accounts in which the Company has an interest and Other Blackstone Credit &amp;amp; Insurance Clients), in each case including any alternative investment vehicles and additional capital vehicles relating thereto and any vehicles established by Blackstone to exercise its side-by-side or other general partner investment rights as set forth in their respective governing documents; provided that, for the avoidance of doubt, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Blackstone Clients&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; shall not include Blackstone in its role as principal of any account, including any accounts for which Blackstone or an affiliate thereof acts as an advisor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Clients&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; means, collectively, Other Blackstone Credit &amp;amp; Insurance Clients and Blackstone Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Based Compensation and Management Fees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The existence of the incentive fees payable to Blackstone Credit &amp;amp; Insurance may create a greater incentive for Blackstone Credit &amp;amp; Insurance to make more speculative investments on behalf of the Company, or to time the purchase or sale of investments in a manner motivated by the personal interests of Blackstone Credit &amp;amp; Insurance and/or Blackstone personnel. However, the fact that the hurdle rate for the incentive fee based on income is calculated on an aggregate basis each quarter and that realized and unrealized losses are netted against realized gains for the incentive fee based on capital gains should reduce the incentives for the Adviser to make more speculative investments or otherwise time the purchase or sale of investments. Our Board of Trustees will seek to monitor these conflicts but there can be no assurances that such monitoring will fully mitigate any such conflicts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the manner in which the Adviser&#x2019;s entitlement to incentive fees is determined may result in a conflict between its interests and the interests of shareholders with respect to the sequence and timing of disposals of investments, as the Adviser may want to dispose of lower yielding investments in favor of higher yielding ones. With respect to the Adviser&#x2019;s entitlement to incentive fees on capital gains, the Adviser may be incentivized to realize capital gains prior to a year end if such gains, net of realized and unrealized losses, would result in an incentive fee on capital gains.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The Firm&#x2019;s Policies and Procedures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Firm has implemented policies and procedures to address conflicts that arise as a result of its various activities, as well as regulatory and other legal considerations. Specified policies and procedures implemented by the Firm to mitigate potential conflicts of interest and address certain regulatory requirements and contractual restrictions are expected to reduce the synergies across the Firm&#x2019;s various businesses that the Company expects to draw on for purposes of pursuing attractive investment opportunities. Because the Firm has many different asset management and advisory businesses, including private equity, a credit business, a hedge fund business, a capital markets group, a life sciences business and a real estate advisory business, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would otherwise be subject if it had just one line of business. In addressing these conflicts and regulatory, legal and contractual requirements across its various businesses and to protect against the inappropriate sharing and/or use of information between the Company and the other business units at the Firm, the Firm has implemented certain policies and procedures (e.g., information wall policy) regarding the sharing of information that could reduce the positive synergies that the Company expects to utilize for purposes of identifying and managing attractive investments. For example, the Firm will from time to time come into possession of material non-public information with respect to companies, including companies in which the Company has investments or might be considering making an investment or companies that are clients of the Firm. As a consequence, that information, which could be of benefit to the Company, might become restricted to those other respective businesses and otherwise be unavailable to the Company. It is also possible that the Company could be restricted from trading despite the fact that the Company did not receive such information. There can be no assurance, however, that any such policies and/or procedures will be effective in accomplishing their stated purpose and/or that they will not otherwise adversely affect the ability of the Company to effectively achieve its investment objective by unduly limiting the investment flexibility of the Company and/or the flow of otherwise appropriate information between Blackstone Credit &amp;amp; Insurance and other business units at the Firm. Personnel of the Firm could be unable, for example, to assist with the activities of the Company as a result of these walls. There can be no assurance that additional restrictions will not be imposed that would further limit the ability of the Firm to share information internally.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, to the extent that the Firm is in possession of material non-public information or is otherwise restricted from trading in certain securities, the Company and the Adviser could also be deemed to be in possession of such information or otherwise restricted. Additionally, the terms of confidentiality or other agreements with or related to companies in which any Other Client has or has considered making an investment or which is otherwise a client of the Firm will from time to time restrict or otherwise limit the ability of the Company and/or its portfolio companies and their affiliates to make investments in or otherwise engage in businesses or activities competitive with such companies. The Firm could enter into one or more strategic relationships in certain regions or with respect to certain types of investments that, although intended to provide greater opportunities for the Company, could require the Company to share such opportunities or otherwise limit the amount of an opportunity the Company can otherwise take.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allocation of Personnel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser and its members, officers and employees will devote as much of their time to the activities of the Company as they deem necessary to conduct its business affairs in an appropriate manner. By the terms of the Investment Advisory Agreement, the Firm is not restricted from forming additional investment funds, from entering into other investment advisory relationships or from engaging in other business activities, even though such activities have the potential to be in competition with the Company and/or to involve substantial time and resources of the Adviser. Firm personnel, including members of the investment committee, will work on other projects, serve on other committees (including boards of directors) and source potential investments for and otherwise assist the investment programs of Other Clients and their portfolio companies, including other investment programs to be developed in the future. Certain members of Blackstone Credit &amp;amp; Insurance&#x2019;s investment team are also members of Other Clients&#x2019; investment teams and will continue to serve in those roles (which could be their primary responsibility) and as a result, not all of their business time will be devoted to Blackstone or the Company. Certain non-investment professionals are not dedicated solely to the Company and are permitted to perform work for Other Clients which is expected to detract from the time such persons devote to the Company. These activities could be viewed as creating a conflict of interest in that the time and effort of the members of the Adviser and its officers and employees will not be devoted exclusively to the business of the Company, but will be allocated between the business of the Company and the management of the monies of such other advisees of the Adviser. Time spent on these other initiatives diverts attention from the activities of the Company, which could negatively impact the Company and shareholders. Furthermore, Blackstone Credit &amp;amp; Insurance and Blackstone Credit &amp;amp; Insurance personnel derive financial benefit from these other activities, including fees and performance-based compensation. Firm personnel outside of Blackstone Credit &amp;amp; Insurance can share in the fees and performance-based compensation from the Company; similarly, Blackstone Credit &amp;amp; Insurance personnel can share in the fees and performance-based compensation generated by Other Clients. These and other factors create conflicts of interest in the allocation of time by Firm personnel. Blackstone Credit &amp;amp; Insurance&#x2019;s determination of the amount of time necessary to conduct the Company&#x2019;s activities will be conclusive, and shareholders rely on Blackstone Credit &amp;amp; Insurance&#x2019;s judgment in this regard.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Outside Activities of Principals and Other Personnel and their Related Parties&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Certain of the principals and employees of the Adviser will, in certain circumstances, be subject to a variety of conflicts of interest relating to their responsibilities to the Company, Other Clients and their respective portfolio companies, and their outside personal or business activities, including as members of investment or advisory committees or boards of directors of or advisors to investment funds, corporations, foundations or other organizations. Such positions create a conflict if such other entities have interests that are adverse to those of the Company, including if such other entities compete with the Company for investment opportunities or other resources. The other managed accounts and/or investment funds in which such individuals may become involved may have investment objectives that overlap with the Company. Furthermore, certain principals and employees of the Adviser are likely to have a greater financial interest in the performance of such other funds or accounts than the performance of the Company. Such involvement is expected to create conflicts of interest in making investments on behalf of the Company and such other funds and accounts. Although such principals and employees will seek to limit any such conflicts in a manner that is in accordance with their fiduciary duties to the Company, there can be no assurance they will be resolved favorably for the Company. Also, Blackstone personnel, Firm employees, including employees of the Adviser, are generally permitted to invest in alternative investment funds, private equity funds, credit funds, real estate funds, hedge funds and other investment vehicles, as well as engage in other personal trading activities relating to companies, assets, securities or instruments (subject to the Firm&#x2019;s Code of Ethics requirements), some of which will involve conflicts of interests. Such personal securities transactions will, in certain circumstances, relate to securities or instruments which can be expected to also be held or acquired by Other Clients, the Company, or otherwise relate to portfolio companies in which the Company has or acquires a different principal investment (including, for example, with respect to seniority), which is expected to give rise to conflicts of interest related to misaligned interests between the Company and such persons. There could be situations in which such alternative investment funds invest in the same portfolio companies as the Company and there could be situations in which such alternative investment funds purchase securities from, or sell securities to, the Company if permitted under the 1940 Act and other applicable law. There can be no assurance that conflicts of interest arising out of such activities will be resolved in favor of the Company. Shareholders will not receive any benefit from any such investments, and the financial incentives of Firm personnel in such other investments could be greater than their financial incentives in relation to the Company and are not expected to receive notice should the Company make investments in which such persons hold direct or indirect interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, certain employees and other professionals of the Firm have family members or relatives employed by such advisers and service providers (or their affiliates) or otherwise actively involved in industries and sectors in which the Company invests, and/or have business, financial, personal or other relationships with companies in such industries and sectors (including the advisors and service providers described above) or other industries, which gives rise to potential or actual conflicts of interest. For example, such family members or relatives might be employees, officers, directors, personnel or owners of companies or assets that are actual or potential investments of the Company or other counterparties of the Company and its portfolio companies and/or assets. Moreover, in certain instances, the Company or its portfolio companies can be expected to issue loans to or acquire securities from, or otherwise transact with, companies that are owned by such family members or relatives or in respect of which such family members or relatives have other involvement. These relationships have the potential to influence Blackstone, the Adviser and/or Blackstone Credit &amp;amp; Insurance in deciding whether to select, recommend or create such service providers to perform services for the Company or portfolio companies (the cost of which will generally be borne directly or indirectly by the Company or such portfolio companies, as applicable). Notwithstanding the foregoing, investment transactions relating to the Company that require the use of a service provider will generally be allocated to service providers on the basis of best execution, the evaluation of which includes, among other considerations, such service provider&#x2019;s provision of certain investment-related services and research that the Adviser believes to be of benefit to the Company. To the extent that the Firm determines appropriate, conflict mitigation strategies can be expected to be put in place with respect to a particular circumstance, such as internal information barriers or recusal, disclosure or other steps determined appropriate by the Firm. The shareholders rely on the Firm to manage these conflicts in its sole discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Secondments and Internships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Certain personnel of Blackstone and its affiliates, including consultants, will, in certain circumstances, be seconded to one or more portfolio companies, vendors and service providers and vendors or shareholders or other investors of the Company and Other Clients to provide finance, accounting, operational support, data management and other similar services, including the sourcing of investments for the Company or other parties. The salaries, benefits, overhead and other similar expenses for such personnel during the secondment could be borne by Blackstone and its affiliates or the organization for which the personnel are working or both. In addition, personnel of portfolio companies, vendors, service providers (including law firms and accounting firms) and shareholders or other investors of the Company and Other Clients will, in certain circumstances, be seconded to, serve internships at or otherwise provide consulting services to, Blackstone, the Company, Other Clients and portfolio companies of the Company and Other Clients. While often the Company, Other Clients and their respective portfolio companies are the beneficiaries of these types of arrangements, Blackstone is from time to time a beneficiary of these arrangements as well, including in circumstances where the vendor, personnel or service provider or otherwise also provides services to the Company, Other Clients, their respective portfolio companies or Blackstone in the ordinary course. Blackstone, the Company, Other Clients or their portfolio companies could receive benefits from these arrangements at no cost, or alternatively could pay all or a portion of the fees, compensation or other expenses in respect of these arrangements. If a portfolio company pays the cost it will be borne directly or indirectly by the Company. To the extent such fees, compensation or other expenses are borne by the Company, including indirectly through its portfolio companies or reimbursement of Blackstone for such costs, the management fee will not be reduced as a result of these arrangements or any fees, expense reimbursements or other costs related thereto. The personnel described above may provide services in respect of multiple matters, including in respect of matters related to Blackstone, the Company, Other Clients, portfolio companies, each of their respective affiliates and related parties, and any costs of such personnel may be allocated accordingly, Blackstone will endeavor in good faith to allocate the costs of these arrangements, if any, to Blackstone, the Company, Other Clients, portfolio companies and other parties based on time spent by the personnel or another methodology Blackstone deems appropriate in a particular circumstance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Blackstone Credit &amp;amp; Insurance and its personnel and related parties will receive intangible and other benefits, discounts and perquisites arising or resulting from their activities on behalf of the Company, the value of which will not reduce the management fees or incentive fees or otherwise be shared with the Company or its portfolio companies. For example, airline travel or hotel stays incurred as Fund expenses, as set forth in the Investment Advisory Agreement and Administration Agreement (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Fund Expenses&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), often result in &#x201c;miles&#x201d; or &#x201c;points&#x201d; or credit in loyalty or status programs, and certain purchases made by credit card will result in &#x201c;credit card points, &#x201c;cash back&#x201d; or rebates in addition to such loyalty or status program miles or points. Such benefits and/or amounts will, whether or not de minimis or difficult to value, inure exclusively to the benefit of Blackstone Credit &amp;amp; Insurance, its affiliates or their personnel (and not the Company and/or portfolio companies) even though the cost of the underlying service is borne by the Company and/or portfolio companies. (See also&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Service Providers, Vendors and Other Counterparties Generally&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Portfolio Company Relationships Generally&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; herein.) Similarly, Blackstone Credit &amp;amp; Insurance, its affiliates and their personnel and related parties, and third parties designated by the foregoing, also receive discounts on products and services provided by portfolio companies and customers or suppliers of such portfolio companies. Such other benefits or fees have the potential to give rise to conflicts of interest in connection with the Company&#x2019;s investment activities, and while the Adviser and Blackstone Credit &amp;amp; Insurance will seek to resolve any such conflicts in a fair and equitable manner, there is no assurance that any such conflicts will be resolved in favor of the Company. See also&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Service Providers, Vendors and Other Counterparties Generally&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Portfolio Company Relationships Generally&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Advisors, Industry Experts and Operating Partners&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Blackstone Credit &amp;amp; Insurance is expected to engage and retain strategic advisors, consultants, senior advisors, executive advisors, industry experts, operating partners, deal sourcers, consultants and other similar professionals (which is expected to include current and former executives or other personnel of Blackstone and/or Blackstone Credit &amp;amp; Insurance, as well as current and former executives or other personnel of Blackstone&#x2019;s and/or Blackstone Credit &amp;amp; Insurance&#x2019;s portfolio companies) (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Senior and Other Advisors&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) who are not employees or affiliates of Blackstone Credit &amp;amp; Insurance and who will, from time to time, receive payments from, or allocations of a profits interest with respect to, portfolio companies (as well as from Blackstone Credit &amp;amp; Insurance or the Company). In particular, in some cases, consultants, including those with a &#x201c;Senior Advisor&#x201d; title, have been and will be engaged with the responsibility to source, diligence and recommend transactions to Blackstone Credit &amp;amp; Insurance or to undertake a build-up strategy to originate, acquire and develop assets and businesses in a particular sector or involving a particular strategy, potentially on a full-time and/or exclusive basis and notwithstanding any overlap with the responsibilities of Blackstone Credit &amp;amp; Insurance under the Investment Advisory Agreement, the compensation to such consultants is expected to be borne fully by the Company and/or portfolio companies (with no reduction or offset to management fee payable by the Company) and not Blackstone Credit &amp;amp; Insurance. Similarly, the Company, Other Clients and their portfolio companies are expected to retain and pay compensation to Senior and Other Advisors to provide services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any amounts paid by the Company or a portfolio company to Senior and Other Advisors in connection with the above services, including cash fees, profits, or equity interests in a portfolio company, discretionary bonus awards, performance-based compensation (e.g., promote), sourcing fees, retainers and expense reimbursements, will be treated as Company Expenses or expenses of the portfolio company, as the case may be, and will not, even if they have the effect of reducing any retainers or minimum amounts otherwise payable by Blackstone Credit &amp;amp; Insurance, be chargeable to Blackstone Credit &amp;amp; Insurance or be deemed paid to or received by Blackstone Credit &amp;amp; Insurance, and such amounts will not reduce the management fees or incentive fees payable. Amounts charged by Senior and Other Advisors will not necessarily be confirmed as being comparable to market rates for such services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To the extent permitted by applicable law and/or any applicable SEC granted exemptive or no action relief, these Senior and Other Advisors often have the right or could be offered the ability to (i) co-invest alongside the Company, including in the specific investments in which they are involved (and for which they can be entitled to receive performance-related incentive fees, which will reduce the Company&#x2019;s returns), (ii) otherwise participate in equity plans for management of any such portfolio company, or (iii) invest directly in the Company or in a vehicle controlled by the Company subject to reduced or waived advisory fees and/or incentive fees, including after the termination of their engagement by or other status with the Firm. Such co-investment and/or participation (which generally will result in the Company being allocated a smaller share of the applicable investment) will not be considered as part of the Firm&#x2019;s side-by-side co-investment rights. Such co-investment and/or participation could vary by transaction (and such participation can, depending on its structure, reduce the Company&#x2019;s returns. Additionally, and notwithstanding the foregoing, these Senior and Other Advisors, as well as other Blackstone Clients could be (or could have the preferred right to be) investors in Blackstone Credit &amp;amp; Insurance&#x2019;s portfolio companies (which, in some cases, can involve agreements to pay performance fees, or allocate profits interests, to such persons in connection with the Company&#x2019;s investment therein, which will reduce the Company&#x2019;s returns) and/or Other Clients. Such Senior and Other Advisors, as well as other Blackstone Clients, could also, subject to applicable law, have rights to co-invest with the Company on a side-by-side basis, which rights are generally offered on a no-fee/no-carried interest basis and generally result in the Company being allocated a smaller share of an investment than would otherwise be the case in the absence of such side-by-side participation. Senior and Other Advisors&#x2019; benefits described in this paragraph will, in certain circumstances, continue after termination of status as a Senior and Other Advisors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The time, dedication and scope of work of, and the nature of the relationship with, each of the Senior and Other Advisors vary considerably. In certain cases, they could advise the Adviser and/or Blackstone Credit &amp;amp; Insurance on transactions, provide the Adviser and/or Blackstone with industry-specific insights and feedback on investment themes, assist in transaction due diligence, or make introductions to and provide reference checks on management teams. In other cases, they take on more extensive roles (and could be exclusive service providers to Blackstone Credit &amp;amp; Insurance) and serve as executives or directors on the boards of portfolio companies or contribute to the identification and origination of new investment opportunities. The Company expects to rely on these Senior and Other Advisors to recommend Blackstone as a preferred investment partner, identify investments, source opportunities, and otherwise carry out its investment program, but there is no assurance that these advisers will continue to be involved with the Company for any length of time. In certain instances, Blackstone Credit &amp;amp; Insurance can be expected to have formal or informal arrangements with these Senior and Other Advisors (which may or may not be terminable upon notice by any party), and in other cases the relationships are more informal. They are either compensated (including pursuant to retainers and expense reimbursement, and, in any event, pursuant to negotiated arrangements that will not be confirmed as being comparable to the market rates for such services) by Blackstone, the Company, and/or portfolio companies or otherwise uncompensated or entitled to deferred compensation until occurrence of a future event, such as commencement of a formal engagement. In certain cases, they have certain attributes of Blackstone Credit &amp;amp; Insurance &#x201c;employees&#x201d; (e.g., they can be expected to have dedicated offices at Blackstone Credit &amp;amp; Insurance, receive administrative support from Blackstone Credit &amp;amp; Insurance personnel, participate in general meetings and events for Blackstone Credit &amp;amp; Insurance personnel, work on Blackstone Credit &amp;amp; Insurance matters as their primary or sole business activity, service Blackstone exclusively, have Blackstone-related e-mail addresses and/or business cards and participate in certain benefit arrangements typically reserved for Blackstone employees, etc.) even though they are not considered Blackstone Credit &amp;amp; Insurance employees, affiliates or personnel for purposes of the Investment Advisory Agreement between the Company and Blackstone Credit &amp;amp; Insurance. Under many of these arrangements, there can be no assurance that the amount of compensation paid in a particular period of time will be proportional to the amount of hours worked or the amount or tangible work product generated by the Senior and Other Advisors during such time. Some Senior and Other Advisors work only for the Company and its portfolio companies, while others may have other clients. In particular, in some cases, Senior and Other Advisors, including those with a &#x201c;Senior Advisor&#x201d; or &#x201c;Operating Advisor&#x201d; title, have been and will be engaged with the responsibility to source and recommend transactions to the Adviser potentially on a full-time and/or exclusive basis and, notwithstanding any overlap with the responsibilities of the Adviser under the Investment Advisory Agreement, the compensation to such Senior and Other Advisors will be borne fully portfolio companies (with no reduction to management fees) and not the Adviser. Senior and Other &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advisors could have conflicts of interest between their work for the Company and its portfolio companies, on the one hand, and themselves or other clients, on the other hand, and Blackstone Credit &amp;amp; Insurance is limited in its ability to monitor and mitigate these conflicts. Blackstone Credit &amp;amp; Insurance expects, where applicable, to allocate the costs of such Senior and Other Advisors to the Company and/or applicable portfolio companies, and to the extent any such costs are allocated to the Company, they would be treated as Company Expenses. Payments or allocations to Senior and Other Advisors will not be reduced by the management fee, and can be expected to increase the overall costs and expenses borne indirectly by investors in the Company. There can be no assurance that any of the Senior and Other Advisors, to the extent engaged, will continue to serve in such roles and/or continue their arrangements with Blackstone Credit &amp;amp; Insurance, the Company and/or any portfolio companies for the duration of the relevant investments or throughout the term of the Company. Additionally, from time to time, Senior and Other Advisors provide services on behalf of both the Company and Other Clients, and any work performed by Senior and Other Advisors retained on behalf of the Company could benefit the Other Clients (and alternatively, work performed by Senior and Other Advisors on behalf of Other Clients could benefit the Company), and Blackstone Credit &amp;amp; Insurance shall have no obligation to allocate any portion of the costs to be borne by the Company in respect of such Senior and Other Advisors to the Other Clients, except as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As an example of the foregoing, in certain investments including involving a &#x201c;platform company,&#x201d; the Company will, in certain circumstances, enter into an arrangement with one or more individuals (who could be former personnel of the Firm or current or former personnel of portfolio companies of the Company or Other Clients, generally will have experience or capability in sourcing or managing investments, and could form a management team) to undertake a new business line or a build-up strategy to acquire and develop assets and businesses in a particular sector or involving a particular strategy. The services provided by such individuals or relevant portfolio company, as the case may be, could include the following with respect to investments: origination or sourcing, due diligence, evaluation, negotiation, servicing, development, management (including turnaround) and disposition. The individuals or relevant portfolio company could be compensated with a salary and equity incentive plan, including a portion of profits derived from the Company or a portfolio company or asset of the Company (which, to the extent permitted by applicable law and/or any applicable SEC granted exemptive or no action relief, can take the form of a management fee and/or profits allocation (whether paid directly to such individuals or to an affiliate entity controlled by such individuals), or other long-term incentive plans. Compensation could also be based on assets under management, a waterfall similar to a carried interest, respectively, or another similar metric. The Company could initially bear the cost of overhead (including rent, utilities, benefits, salary or retainers for the individuals or their affiliates entities) and the sourcing, diligence and analysis of investments, as well as the compensation for the individuals and entity undertaking the build-up strategy. Such expenses could be borne directly by the Company as Company Expenses (or broken deal expenses, if applicable) or indirectly through expenditures by a portfolio company. None the fees, costs or expenses described above will reduce the management fee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Adviser will, in certain circumstances, engage third parties as Senior and Other Advisors (or in another similar capacity) in order to advise it with respect to existing investments, specific investment opportunities, and economic and industry trends. Such Senior and Other Advisors can receive reimbursement of reasonable related expenses by portfolio companies or the Company and could have the opportunity to invest in a portion of the equity and/or debt available to the Company for investment that would otherwise be taken by the Adviser and its affiliates. If such Senior and Other Advisors generate investment opportunities on the Company&#x2019;s behalf, such Senior and Other Advisors are permitted to receive special additional fees or allocations which have the potential to not be comparable to those received by a third party in an arm&#x2019;s length transaction and such additional fees or allocations would be borne fully by the Company and/or portfolio companies (with no reduction or offset to management fees) and not Blackstone Credit &amp;amp; Insurance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Minority Investments in Asset Management Firms&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Blackstone and Other Clients, including Blackstone Strategic Capital Holdings (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;BSCH&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and its related parties, regularly make minority investments in alternative asset management firms that are not affiliated with Blackstone, the Company, Other Clients and their respective portfolio companies, and which from time to time engage in similar investment transactions, including with respect to purchase and sale of investments, with these asset management firms and their advised funds and portfolio companies. Typically, the Blackstone related party with an interest in the asset management firm would be entitled to receive a share of carried interest/performance based incentive compensation and net fee income or revenue share generated by the various products, vehicles, funds and accounts managed by that third party asset management firm that are included in the transaction or activities of the third party asset management firm, or a subset of such activities such as transactions with a Blackstone related party. In addition, while such minority investments are generally structured so that Blackstone does not &#x201c;control&#x201d; such third party asset management firms, Blackstone could nonetheless be afforded certain governance rights in relation to such investments (typically in the nature of &#x201c;protective&#x201d; rights, negative control rights or anti-dilution arrangements, as well as certain reporting and consultation rights) that afford Blackstone the ability to influence the firm. Although Blackstone and Other Clients, including BSCH, do not intend to control such third &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;party asset management firms, there can be no assurance that all third parties will similarly conclude that such investments are non-control investments or that, due to the provisions of the governing documents of such third party asset management firms or the interpretation of applicable law or regulations, investments by Blackstone and Other Clients, including BSCH, will not be deemed to have control elements for certain contractual, regulatory or other purposes. While such third party asset managers will not be deemed affiliated with the Company within the meaning of the 1940 Act, Blackstone expects to, under certain circumstances, be in a position to influence the management and operations of such asset managers and the existence of its economic/revenue sharing interest therein can give rise to conflicts of interest. Participation rights in a third party asset management firm (or other similar business), negotiated governance arrangements and/or the interpretation of applicable law or regulations could expose the investments of the Company to claims by third parties in connection with such investments (as indirect owners of such asset management firms or similar businesses) that would have an adverse financial or reputational impact on the performance of the Company. The Company, its affiliates and their respective portfolio companies are expected to, from time to time engage in transactions with, and buy and sell investments from, any such third party asset managers and their sponsored funds and transactions and other commercial arrangements between such third party asset managers and the Company and its portfolio companies are not subject to approval by the Board of Trustees. There can be no assurance that the terms of these transactions between parties related to Blackstone, on the one hand, and the Company and its portfolio companies, on the other hand, will be at arm&#x2019;s length or that Blackstone will not receive a benefit from such transactions, which can be expected to incentivize Blackstone to cause these transactions to occur. Such conflicts related to investments in and arrangements with other asset management firms will not necessarily be resolved in favor of the Company. Shareholders will not be entitled to receive notice or disclosure of the terms or occurrence of either the investments in alternative asset management firms or transactions therewith and will not receive any benefit from such transactions. By executing a subscription agreement with respect to the Company, each shareholder acknowledges these conflicts related to investments in and arrangements with other asset management firms, acknowledges that these conflicts will not necessarily be resolved in favor of the Company, agrees that shareholders will not be entitled to receive notice or disclosure of the terms or occurrence of either the investments in alternative asset management firms or transactions therewith, otherwise understands that shareholders will not receive any benefit from such transactions, consents to all such transactions and arrangements to the fullest extent permitted by law, and waives any claim against Blackstone and releases Blackstone from any liability arising from the existence of any such conflict of interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, from time to time, certain advisors and service providers (including law firms) temporarily provide their personnel to Blackstone, Other Clients or their portfolio companies pursuant to various arrangements including at cost or at no cost. (See also &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;Secondments and Internships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; herein.) While often the Company, Other Clients and their portfolio companies are the beneficiaries of these types of arrangements, Blackstone is from time to time a beneficiary of these arrangements as well, including in circumstances where the advisor or service provider also provides services to the Company, Other Clients or Blackstone in the ordinary course. Blackstone, the Company, Other Clients or their portfolio companies could receive benefits from these arrangements at no cost, or alternatively could pay all or a portion of the fees, compensation or other expenses in respect of these arrangements. The management fee will not be offset or reduced as a result of these arrangements or any fees, expense reimbursements or other costs related thereto. The personnel described above could provide services in respect of multiple matters, including in respect of matters related to Blackstone, the Company, Other Clients, portfolio companies, each of their respective affiliates and related parties, and Blackstone will endeavor in good faith to allocate the costs of these arrangements, if any, to Blackstone, the Company, Other Clients, portfolio companies and other parties based on time spent by the personnel or another methodology the Firm deems appropriate in a particular circumstance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Multiple Blackstone Business Lines. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone has multiple business lines, including the Blackstone Capital Markets Group, which Blackstone Credit &amp;amp; Insurance, the Company, Other Clients, portfolio companies of the Company and Other Clients and third parties will, in certain circumstances, engage for debt and equity financings and to provide other investment banking, brokerage, investment advisory or other services. As a result of these activities, Blackstone is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than if it had one line of business. For example, from time to time, Blackstone could come into possession of information that limits the Company&#x2019;s ability to engage in potential transactions. Similarly, other Blackstone businesses and their personnel could be prohibited by law or contract from sharing information with Blackstone that would be relevant to monitoring the investments and other activities. These types of restrictions from time to time will negatively impact the ability of the Company to implement its investment program. Finally, Blackstone personnel who are members of the investment team or investment committee could be excluded from participating in certain investment decisions due to conflicts involving other Blackstone businesses or for other reasons, including other business activities, in which case the Company will not benefit from their experience. The shareholders will not receive a benefit from any fees earned by Blackstone or its personnel from these other businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone is under no obligation to decline any engagements or investments in order to make an investment opportunity available to the Company. Blackstone has long-term relationships with a significant number of corporations and their senior management. Blackstone will consider those relationships when evaluating an investment opportunity, which has the potential to result in Blackstone choosing not to make such an investment due to such relationships (e.g., investments in a competitor of a client or other person with whom Blackstone has a relationship). The Company could be required to sell or hold existing investments as a result of investment banking relationships or other relationships that Blackstone has or will have or transactions or investments that Blackstone makes or has made. (See&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;also&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Allocation of Investment Opportunities&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Portfolio Company Relationships&#x201d;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) Therefore, there can be no assurance that all potentially suitable investment opportunities that come to the attention of Blackstone will be made available to the Company. The Company is also permitted to co-invest with Other Clients or other persons with whom Blackstone has a relationship in particular investment opportunities, and other aspects of these Blackstone relationships could influence the decisions made by Blackstone with respect to the investments and otherwise result in a conflict (see also&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014;Other Clients; Allocation of Investment Opportunities&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; herein). Company would otherwise have to buy or sell certain assets, and may require that the Company dispose of an investment at an inopportune time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Blackstone Policies and Procedures; Information Walls.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Blackstone has implemented policies and procedures to address conflicts that arise as a result of its various activities, as well as regulatory and other legal considerations. Some of these policies and procedures, such as Blackstone&#x2019;s information wall policy, are implemented by Blackstone to mitigate potential conflicts of interest and address certain regulatory requirements and contractual restrictions will reduce the synergies and collaboration across Blackstone&#x2019;s various businesses that the Company expects to draw on for purposes of identifying, pursuing and managing attractive investment opportunities. Because Blackstone has many different asset management and advisory businesses, including private equity, growth equity, a credit business, a hedge fund business, a capital markets group, a life sciences business and a real estate advisory business, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would otherwise be subject if it had just one line of business. In addressing these conflicts and regulatory, legal and contractual requirements across its various businesses and to protect against the inappropriate sharing and/or use of information between the Company and the other business units at Blackstone, Blackstone has implemented certain policies and procedures (e.g., Blackstone&#x2019;s information wall policy) regarding the sharing of information that have the potential to reduce the positive synergies and collaborations that the Company could otherwise expect to utilize for purposes of identifying and managing attractive investments. For example, Blackstone will from time to time come into possession of material non-public information with respect to companies in which Other Clients have investments or might be considering making an investment or companies that are clients of Blackstone. As a consequence, that information, which could be of benefit to the Company, might become restricted to those other respective businesses and otherwise be unavailable to the Company. It is also possible that the Company could be restricted from trading despite the fact that the Company did not receive such information. There can be no assurance, however, that any such policies and/or procedures will be effective in accomplishing their stated purpose and/or that they will not otherwise adversely affect the ability of the Company to effectively achieve its investment objective by unduly limiting the investment flexibility of the Company and/or the flow of otherwise appropriate information between Blackstone Credit &amp;amp; Insurance and other business units at Blackstone. For example, in some instances, personnel of Blackstone would be unable to assist with the activities of the Company as a result of these walls. There can be no assurance that additional restrictions will not be imposed that would further limit the ability of Blackstone to share information internally. In addition, due to these restrictions, it is possible that the Company will not be able to initiate a transaction that it otherwise might have initiated and will not be able to purchase or sell an investment that it otherwise might have purchased or sold, which could negatively affect its operations or performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, to the extent that Blackstone is in possession of material non-public information or is otherwise restricted from making certain investments, the Company and the Adviser would also be deemed to be in possession of such information or otherwise restricted. Additionally, the terms of confidentiality or other agreements with or related to companies in which any Blackstone fund has or has considered making an investment or which is otherwise a client of Blackstone will from time to time restrict or otherwise limit the ability of the Company and/or its portfolio companies and their affiliates to make investments in or otherwise engage in businesses or activities competitive with such companies. Blackstone has in the past entered into, and reserves the right to enter into in the future, one or more strategic relationships in certain regions or with respect to certain types of investments that, although intended to provide greater opportunities for the Company, require the Company to share such opportunities or otherwise limit the amount of an opportunity the Company can otherwise take. (See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&#x2014;Allocation of Investment Opportunities&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Data&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Firm receives, generates and/or obtains various kinds of data and information from the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and limited partners in Other Clients and service providers, including but not limited to data and information relating to or created in connection with business operations, financial information results, trends, budgets, energy usage, plans, ESG, carbon emissions and related metrics, customer and user data, employee and contractor data, supplier and cost data, and other related data and information, some of which is sometimes referred to as &#x201c;alternative data&#x201d; or &#x201c;big data&#x201d;. The Firm can be expected to be better able to anticipate macroeconomic and other trends, and otherwise develop investment themes or identify specific investment, trading or business opportunities, as a result of its access to (and rights regarding, including use, ownership, distribution and derived works rights over) this data and information from the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and limited partners in Other Clients, related parties and service providers. The Firm has entered and will continue to enter into information sharing and use, measurement and other arrangements, which will give the Firm access to (and rights regarding, including ownership, use, distribution and derived works rights over) data that it would not otherwise obtain in the ordinary course, with the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and in Other Clients, as well as with related parties and service providers. Further, this alternative data is expected to be aggregated across the Company, Other Clients and their respective portfolio companies. Although the Firm believes that these activities improve the Firm&#x2019;s investment management activities on behalf of the Company and Other Clients, information obtained from the Company and its portfolio companies, and investors in the Company and in Other Clients also provides material benefits to Blackstone or Other Clients without compensation or other benefit accruing to the Company or its shareholders. For example, information from a portfolio company in which the Company holds an interest can be expected to enable the Firm to better understand a particular industry, enhance the Firm&#x2019;s ability to provide advice or direction to a portfolio company&#x2019;s management team on strategy or operations and enable the Firm to execute trading and investment strategies in reliance on that understanding for Blackstone and Other Clients that do not own an interest in the portfolio company, typically without compensation or benefit to the Company or its portfolio companies. Blackstone would serve as the repository for data described in this paragraph, including with ownership and use rights therein. The Firm is also permitted to share data from a portfolio company (on an anonymized basis) with a portfolio company of an Other Client, which has the potential to increase a competitive disadvantage for, and indirectly harm, such portfolio company (although the opposite may be true as well, in which case a portfolio company of the Company may receive data from a portfolio company of an Other Client). In addition, the Firm could have an incentive to pursue an investment in a particular company based on the data and information expected to be received or generated in connection with such investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furthermore, except for contractual obligations to third parties to maintain confidentiality of certain information or otherwise limit the scope and purpose of its use or distribution, and regulatory limitations on the use of material nonpublic information, the Firm is generally free to use and distribute data and information from the Company&#x2019;s activities to assist in the pursuit of the Firm&#x2019;s various other activities, including but not limited to trading activities or use for the benefit of the Firm and/or an Other Client. Any confidentiality obligations in the operative documents do not limit the Firm&#x2019;s ability to do so. For example, the Firm&#x2019;s ability to trade in securities of an issuer relating to a specific industry can, subject to applicable law, be enhanced by information of a portfolio company in the same or related industry. Such trading or other business activities is expected to provide a material benefit to the Firm without compensation or other benefit to the Company or shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sharing and use of &#x201c;big data&#x201d; and other information presents potential conflicts of interest and the shareholders acknowledge and agree that any benefits received by the Firm or its personnel (including fees (in cash or in kind), costs and expenses) will not reduce the management fees or incentive fees payable to the Adviser or otherwise shared with the Company or its shareholders. As a result, the Adviser has an incentive to pursue investments that have data and information that can be utilized in a manner that benefits the Firm or Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Data Management Services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Blackstone or an affiliate of Blackstone formed in the future may provide data management services to portfolio companies and investors in the Company and in Other Clients and will provide such services directly to the Company and Other Clients (collectively,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x201c;Data Holders&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Such services are expected to include assistance with obtaining, analyzing, curating, processing, packaging, organizing, mapping, holding, transforming, enhancing, marketing and selling such data (among other related data management and consulting services) for monetization through licensing or sale arrangements with third parties and, subject to applicable law and the limitations in the Investment Advisory Agreement and any other applicable contractual limitations, with the Company, Other Clients, portfolio companies, investors in the Company and in Other Clients, and other Blackstone affiliates and associated entities (including funds in which Blackstone and Other Clients make investments, and portfolio companies thereof). If Blackstone enters into data services arrangements with portfolio companies and receives compensation from such portfolio companies for such data services, the Company will indirectly bear its share of such compensation based on its pro rata ownership of such portfolio companies. Where Blackstone believes appropriate, data from one Data Holder will be aggregated or pooled with data from other Data Holders. Any revenues arising &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;from such aggregated or pooled data sets would be allocated between applicable Data Holders on a fair and reasonable basis as determined by Blackstone Credit &amp;amp; Insurance in its sole discretion, with Blackstone Credit &amp;amp; Insurance able to make corrective allocations should it determine subsequently that such corrections were necessary or advisable. Blackstone is expected to receive compensation for such data management services, which is expected to include a percentage of the revenues generated through any licensing or sale arrangements with respect to the relevant data, and which compensation is also expected to include fees, royalties and cost and expense reimbursement (including start-up costs and allocable overhead associated with personnel working on relevant matters (including salaries, benefits and other similar expenses)). Additionally, Blackstone is expected to share and distribute the products from such data management services within Blackstone or its affiliates (including Other Clients or their portfolio companies) at no charge and, in such cases, the Data Holders will not receive any financial or other benefit from having provided such data to Blackstone. The potential receipt of such compensation by Blackstone creates incentives for Blackstone to cause the Company to invest in portfolio companies with a significant amount of data that it might not otherwise have invested in or on terms less favorable than it otherwise would have sought to obtain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Blackstone and Blackstone Credit &amp;amp; Insurance Strategic Relationships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Blackstone and Blackstone Credit &amp;amp; Insurance have entered, and it can be expected that Blackstone and Blackstone Credit &amp;amp; Insurance in the future will enter, into both (i) strategic relationships with investors (and/or one or more of their affiliates) that involve an overall relationship with Blackstone or Blackstone Credit &amp;amp; Insurance (which will afford such investor special rights and benefits) that could (but is not required to) incorporate one or more strategies (including, but not limited to, a different sector and/or geographical focus within the same or a different Blackstone business unit) in addition to the Company&#x2019;s strategy and (ii) arrangements that involve an agreement or understanding to make an investment in or a capital commitment to (as applicable) the Company and one or more Other Clients, as applicable (which can include a subscription or capital commitment, as applicable, already made recently to another Other Client) (any such overall relationship and/or multi-fund arrangement in the foregoing (i) and (ii), (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Strategic Relationships&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), with terms and conditions applicable solely to such investor and its investment in multiple Blackstone or Blackstone Credit &amp;amp; Insurance strategies that would not apply to any other investor&#x2019;s investment in the Company. A Strategic Relationship often involves (but is not required to involve) an investor agreeing to make a capital commitment to or investment in (as applicable) multiple Blackstone or Blackstone Credit &amp;amp; Insurance Clients, one of which could include the Company. Shareholders will not receive a copy of any agreement memorializing such a Strategic Relationship program (even if in the form of a side letter) or receive any other disclosure or reporting of the terms of or existence of any Strategic Relationship and will be unable to elect in the &#x201c;most-favored-nations&#x201d; election process (if any) any rights or benefits afforded through a Strategic Relationship (for the avoidance of doubt, no further disclosure or reporting information will be shared with the shareholders about any Strategic Relationship). Specific examples of such additional rights and benefits have included and can be expected to include, among others, specialized reporting, discounts or reductions on and/or reimbursements or rebates of management fees or carried interest (as applicable), secondment of personnel from the investor to Blackstone or Blackstone Credit &amp;amp; Insurance (or vice versa), rights to participate in the investment review and evaluation process, as well as priority rights or targeted amounts for co-investments alongside Blackstone Credit &amp;amp; Insurance or Blackstone funds (including, without limitation, preferential or favorable allocation of co-investment and preferential terms and conditions related to co-investment or other participation in Blackstone or Blackstone Credit &amp;amp; Insurance Clients (including in respect of any carried interest (as applicable) and/or management fees to be charged with respect thereto, as well as any additional discounts, reductions, reimbursements or rebates with respect thereto or other penalties that may result if certain target co-investment allocations or other conditions under such arrangements are not achieved)). Any co-investment that is part of a Strategic Relationship could include co-investment in investments made by the Company. Blackstone, including its personnel (including Blackstone Credit &amp;amp; Insurance personnel), reserves the right to receive compensation from Strategic Relationships and could be incentivized to allocate investment opportunities away from the Company to or source investment opportunities for Strategic Relationships. Strategic Relationships will in certain circumstances, result in fewer co-investment opportunities (or reduced or no allocations) being made available to shareholders, subject to the 1940 Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance Value Creation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Blackstone Credit &amp;amp; Insurance Value Creation is a global platform that is part of Blackstone&#x2019;s Portfolio Operations Group (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Portfolio Operations Group&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and seeks to provide access to a range of cost-saving, revenue-generating and best-practice sharing opportunities for Blackstone Credit &amp;amp; Insurance portfolio companies. The Portfolio Operations Group is organized into seven functional areas, across geographic regions and industry verticals:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Procurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Blackstone&#x2019;s group purchasing program harnesses spending from portfolio companies across more than 75 categories, including IT hardware and software, office supplies, shipping, energy and telecommunications.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Healthcare Cost Containment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Blackstone&#x2019;s Equity Healthcare team partners with portfolio companies to optimize the strategy and value of healthcare spending by reducing cost and improving the quality of healthcare services received by employees and their dependents. Equity Healthcare is one of the largest private sector purchasers of healthcare services in the United States and has helped drive cumulative healthcare cost savings to portfolio companies and strengthened portfolio companies&#x2019; ability to attract and retain talent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lean Process&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The lean process team seeks to drive transformational improvements focused on material and information flows by reducing waste and non-value add activities across manufacturing functions. It develops prescriptive solutions for portfolio companies and aligns with senior leadership to support tailored strategies and guide management teams in executing and sustaining improved workflow processes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leadership and Talent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The Portfolio Operations Group employs the following strategies to optimize leadership and organizational performance: (i) delivering fit-for-purpose resources to portfolio companies, which include non-executive chairpersons, board members, advisors, and operating specialists, (ii) strengthening company teams and organizational practices through assisting with restructuring, integrations and growth actions, and (iii) convening conferences for portfolio company executives to share best practices and improve alignment to the Firm.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sustainability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: By improving the operation and maintenance of mechanical systems, the Portfolio Operations Group seeks to reduce energy spend while improving productivity, safety, and environmental performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Technology / BPO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Blackstone&#x2019;s Technology / BPO team helps the portfolio management teams recruit/upgrade their information technology leadership teams; import contemporary operating systems and application software to address their respective business priorities; leverage portfolio investments in technology companies to promote and serve the overall portfolio interests; and evaluate and negotiate preferred partnerships with digital/technology suppliers, advisors, and consultants from around the world.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Data Science&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The Firm has invested in a team of data scientists and engineers to help the portfolio companies realize operational efficiencies and drive new revenue through data and analytics. This team focuses on (i) building predictive models to enhance decision making; (ii) leveraging big data within operations; (iii) data visualization to democratize access to information; and (iv) data monetization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Members of Blackstone&#x2019;s Portfolio Operations Group (including Blackstone Credit &amp;amp; Insurance Value Creation), who are Blackstone employees, are permitted to provide services to the Company&#x2019;s portfolio companies, including without limitation those related to the functional areas described above and other similar management consulting, operational and financial matters and are permitted to participate in the Firm co-investment rights. Any payments made or fees paid (which fees or payments will also in certain instances be structured as a reimbursement of internal compensation costs for time spent) by such portfolio companies to Blackstone for services rendered to such portfolio companies will generally be no greater than what would be paid in an arm&#x2019;s-length transaction for similar overalls services, and such payments or fees received will not reduce the management fee payable by the Company. As a result, Blackstone is likely to be incentivized to cause members of the Portfolio Operations Group to spend more time on the Company&#x2019;s portfolio companies as compared to portfolio companies of Other Clients that do reduce the management fee. On the other hand, there can be no assurance that members of the Portfolio Operations Group will be able to provide their services to portfolio companies and/or that any individuals within the Portfolio Operations Group will remain employed by Blackstone through the life of the Company. The level of involvement and role of Blackstone&#x2019;s Portfolio Operations Group within each part of Blackstone with respect to any of the Company&#x2019;s portfolio companies are expected to vary, including having no involvement or role at all. In addition, the Portfolio Operations Group will provide services to the Company&#x2019;s portfolio companies as described in more detail in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014;Firm Affiliated Service Providers&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, including facilitation of arrangements for Portfolio Companies relating to group procurement (such as the group purchasing organization) and other operational, administrative or management related matters from third parties or Firm affiliates, and other similar operational initiatives. These services can result in commissions or similar payments, including related to a portion of the savings achieved by the portfolio companies. See also &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&#x2014;Other Fees&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&#x2014;Group Procurement; Discounts&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&#x2014;Firm Affiliated Service Providers&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information regarding such programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Buying and Selling Investments or Assets from Certain Related Parties&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company and its portfolio companies may purchase investments or assets from or sell investments or assets to shareholders, other portfolio companies of the Company, portfolio companies of Other Clients or their respective related parties. Purchases and sales of investments or assets between the Company or its portfolio companies, on the one hand, and shareholders, other portfolio companies of the Company, portfolio companies of Other Clients or their respective related parties, on the other hand, are not, unless required by applicable law, subject to the approval of the Board of Trustees or any shareholder. These transactions involve conflicts of interest, as the Firm may receive fees and other benefits, directly or indirectly, from or otherwise have interests in both parties to the transaction, including different financial incentives Blackstone could have with respect to the parties to the transaction. For example, there can be no assurance that any investment or asset sold by the Company to a shareholder, other portfolio companies of the Company, portfolio company of Other Clients or any of their respective related parties will not be valued or allocated a sale price that is lower than might otherwise have been the case if such asset were sold to a third party rather than to a shareholder, portfolio company of Other Clients or any of their respective related parties. The Firm will not be required to solicit third party bids or obtain a third party valuation prior to causing the Company or any of its portfolio companies to purchase or sell any asset or investment from or to a shareholder, other portfolio companies of the Company, portfolio company of Other Clients or any of their respective related parties as provided above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Firm Businesses, Activities and Relationships. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of its regular business, Blackstone provides a broad range of investment banking, advisory and other services. In addition, from time to time, the Firm will provide services in the future beyond those currently provided. Shareholders will not receive any benefit from any fees relating to such services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the regular course of its capital markets, investment banking, real estate advisory and other businesses, Blackstone represents potential purchasers, sellers and other involved parties, including corporations, financial buyers, management, shareholders and institutions, with respect to transactions that could give rise to other transactions that are suitable for the Company. In such a case, a Blackstone advisory client would typically require Blackstone to act exclusively on its behalf. Such advisory client requests have the potential to preclude all Blackstone-affiliated clients, including the Company, from participating in related transactions that would otherwise be suitable. Blackstone will be under no obligation to decline any such engagements in order to make an investment opportunity available to the Company. In connection with its capital markets, investment banking, advisory, real estate and other businesses, Blackstone comes into possession of information that limits its ability to engage in potential transactions. The Company&#x2019;s activities are expected to be constrained as a result of the inability of Blackstone personnel to use such information. For example, employees of Blackstone from time to time are prohibited by law or contract from sharing information with members of the Company&#x2019;s investment team. Additionally, there are expected to be circumstances in which one or more individuals associated with Blackstone affiliates (including clients) will be precluded from providing services related to the Company&#x2019;s activities because of certain confidential information available to those individuals or to other parts of Blackstone (e.g., trading can be restricted). Where Blackstone affiliates are engaged to find buyers or financing sources for potential sellers of assets, the seller can permit the Company to act as a participant in such transactions (as a buyer or financing partner), which would raise certain conflicts of interest inherent in such a situation (including as to the negotiation of the purchase price).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may invest in securities of the same issuers as Other Clients, other investment vehicles, accounts and clients of the Firm and the Adviser. To the extent that the Company holds interests that are different (or more senior or junior) than those held by such Other Clients, Blackstone Credit &amp;amp; Insurance may be presented with decisions involving circumstances where the interests of such Other Clients are in conflict with those of the Company. Furthermore, it is possible the Company&#x2019;s interest could be subordinated or otherwise adversely affected by virtue of such Other Clients&#x2019; involvement and actions relating to its investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the 1940 Act limits the Company&#x2019;s ability to undertake certain transactions with its affiliates that are registered under the 1940 Act or regulated as BDCs under the 1940 Act. As a result of these restrictions, the Company could be prohibited from executing &#x201c;joint&#x201d; transactions with such affiliates, which could include investments in the same portfolio company (whether at the same or different times). These limitations have the potential to limit the scope of investment opportunities that would otherwise be available to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance has received an exemptive order that permits certain funds, among other things, to co-invest with certain other persons, including certain affiliates of Blackstone Credit &amp;amp; Insurance, and certain funds managed and controlled by Blackstone Credit &amp;amp; Insurance and its affiliates subject to certain terms and conditions. In addition, other present and future activities of the Firm and its affiliates (including Blackstone Credit &amp;amp; Insurance and the Adviser) will from time to time give rise to additional conflicts of interest relating to the Firm and its investment activities. In the event that any such conflict of interest arises, the Adviser will attempt to resolve such conflicts in a fair and equitable manner. Investors should be aware that, subject to applicable law, conflicts will not necessarily be resolved in favor of the Company&#x2019;s interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transactions with Clients of Blackstone Insurance Solutions and Asset Based Finance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Blackstone Insurance Solutions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;BIS&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) is the business segment of Blackstone Credit &amp;amp; Insurance that provides investment advisory services to insurers, including among others, (i) Fidelity Life Insurance Company and certain of its affiliates (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;FGL&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), (ii) Everlake Life Insurance Company and certain of its affiliates (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Everlake&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), (iii) certain subsidiaries of Corebridge Financial, Inc. (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Corebridge&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and (iv) certain subsidiaries of Resolution Life Group Holdings Ltd. (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Resolution Life&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Certain of the insurers for which BIS provides services are, or may be in the future, owned, directly or indirectly, by Blackstone, the Company, or Other Clients, in whole or in part. Actual or potential conflicts of interest will likely arise in relation to the funds, vehicles or accounts BIS advises or sub-advises, including accounts where an insurer (including, without limitation, each of FGL, Everlake, Corebridge and Resolution Life) participates in investments directly and there is no separate vehicle controlled by Blackstone (for the purposes of this paragraph only, collectively, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;BIS Clients&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Blackstone Credit &amp;amp; Insurance also advises funds and accounts focused on asset-based finance, including insurers and other types of investors (for the purposes of this paragraph only, collectively, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;ABF Clients&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and each BIS Client and ABF Client is an Other Client for&#160;purposes other than this paragraph). BIS Clients have invested and are expected to continue investing in Other Clients and/or the Company. For greater clarity, any references herein to Blackstone Credit &amp;amp; Insurance or Other Blackstone Credit &amp;amp; Insurance Clients do not include BIS, BIS Clients or ABF Clients. Certain BIS Clients and certain ABF Clients have investment objectives that overlap with those of the Company (and Blackstone Credit &amp;amp; Insurance, or a business segment thereof, has entered into sub-management agreements with BIS to manage (for a fee, which such fees may be shared with BIS) the assets of certain such BIS Clients with respect to investments that overlap in part with the Company&#x2019;s investment directive) or its portfolio companies and such BIS Clients and ABF Clients may invest, as permitted by applicable law and the Company&#x2019;s co-investment exemptive relief, alongside (or in lieu of) the Company or such portfolio companies in certain investments, which will reduce the investment opportunities otherwise available to the Company or such portfolio companies. BIS Clients and ABF Clients will also engage in a variety of activities, including participating in transactions related to the Company and/or its portfolio companies (e.g., as originators, co-originators, counterparties or otherwise). Other transactions in which BIS Clients or ABF Clients will participate include, without limitation, investments in debt or other securities issued by portfolio companies or other forms of financing to portfolio companies (including special purpose vehicles established by the Company or such portfolio companies). When investing alongside the Company or its portfolio companies or in other transactions related to the Company or its portfolio companies, BIS Clients or ABF Clients may not invest or divest at the same time or on the same terms as the Company or the applicable portfolio companies or at a different time or on different terms. BIS Clients and ABF Clients will also from time to time acquire investments and portfolio companies directly or indirectly from the Company, as permitted by applicable law and the Company&#x2019;s co-investment exemptive relief. In circumstances where Blackstone Credit &amp;amp; Insurance determines in good faith that the conflict of interest is mitigated in whole or in part through various measures that Blackstone, Blackstone Credit &amp;amp; Insurance or the Adviser implements, the Adviser may determine to proceed with the applicable transaction (subject to oversight by the Board of Trustees and the applicable law to which the Company is subject). In order to seek to mitigate any potential conflicts of interest with respect to such transactions (or other transactions involving BIS Clients or ABF Clients), Blackstone reserves the right, in its sole discretion, to involve independent members of the board of a portfolio company or a third party stakeholder in the transaction to negotiate price and terms on behalf of the BIS Clients or ABF Clients or otherwise cause the BIS Clients or ABF Clients to &#x201c;follow the vote&#x201d; thereof, and/or cause an independent client representative or other third party to approve the investment or otherwise represent the interests of one or more of the parties to the transaction. In addition, Blackstone or the Adviser may limit the percentage interest of the BIS Clients or ABF Clients participating in such transaction, or obtain appropriate price quotes or other benchmarks, or, alternatively, a third-party price opinion or other document to support the reasonableness of the price and terms of the transaction. From time to time, the applicable BIS Clients or ABF Clients participating in a transaction will be required to consent thereto (including in circumstances where the Adviser does not seek the consent of the Board of Trustees). There can be no assurance that any such measures or other measures that may be implemented by Blackstone will be effective at mitigating any actual or potential conflicts of interest. Moreover, under certain circumstances (e.g., where a BIS Client or ABF Client participates in a transaction directly (and not through a vehicle controlled by Blackstone) and independently consents to participating in a transaction), a BIS Client or ABF Client (or any other Blackstone Client participating via a similar arrangement) will not be an &#x201c;Affiliate&#x201d; as defined under the 1940 Act. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allocation of Portfolios&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Firm will, in certain circumstances, have an opportunity to acquire a portfolio or pool of assets, securities and instruments that it determines should be divided and allocated among the Company and Other Clients. Such allocations generally would be based on the Firm&#x2019;s assessment of the expected returns and risk profile of each of the assets. For example, some of the assets in a pool will have an opportunistic return profile, while others will have a return profile not appropriate for the Company. Also, a pool can contain both debt and equity instruments that the Firm determines should be allocated to different funds. In all of these situations, the combined purchase price paid to a seller would be allocated among the multiple assets, securities and instruments in the pool and therefore among the Company and Other Clients acquiring any of the assets, securities and instruments, although the Firm could, in certain circumstances, allocate value to the Company and such Other Clients on a different basis than the contractual purchase price. Similarly, there will likely be circumstances in which the Company and Other Clients will sell assets in a single or related transactions to a buyer. In some cases, a counterparty will require an allocation of value in the purchase or sale contract, though the Firm could determine such allocation of value is not accurate and should not be relied upon. The Firm will generally rely upon internal analysis to determine the ultimate allocation of value, though it could also obtain third party valuation reports. Regardless of the methodology for allocating value, the Firm will have conflicting duties to the Company and Other Clients when they buy or sell assets together in a portfolio, including as a result of different financial incentives the Firm has with respect to different vehicles, most clearly when the fees and compensation, including performance-based compensation, earned from the different vehicles differ. There can be no assurance that an investment of the Company will not be valued or allocated a purchase price that is higher or lower than it might otherwise have been allocated if such investment were acquired or sold independently rather than as a component of a portfolio shared with Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Holding Entities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Firm may determine that for legal, tax, regulatory, accounting, administrative or other reasons the Company should hold a particular investment (or a portion of an investment or pool of assets) through a single holding entity through which the Company and one or more Other Clients hold different investments (or a different portion of such investment or pool of assets), including where such investment or pool has been divided and allocated among the Company and such Other Clients. Over time, it is possible that the Company and/or Other Clients may make different decisions with respect to the investments held through such holding entities and therefore may have differing economic rights, obligations or liabilities with respect to a holding entity. In such circumstances, the economic rights, liabilities and obligations in respect of the investment (or portion of an investment or pool of assets) that is indirectly held by the Company would be specifically attributed to the Company, and the Company would be deemed to hold its investment (or portion of an investment or pool of assets) separately from, and not jointly with, such Other Clients (and vice versa in respect of the investments (or portion of an investment or pool of assets) held indirectly through such holding entity by such Other Clients).&#160;Furthermore, certain holding structures may require a newly-established manager, advisor, service provider or other entity intended to address certain legal, tax, regulatory, accounting, administrative or other considerations applicable to the Company and/or Other Clients. It is possible that the Company or an affiliate will be initially responsible for the costs and expenses of establishing such holding structure (including any such newly-established entities) prior to, and/or, in anticipation of, Other Clients participating through such structure for their investments and it is expected that such Other Clients reimburse the Company or the Company would reimburse such affiliate for any such costs and expenses on a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; pro rata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Affiliate Transactions and Investments in Different Levels of Capital Structure&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company and the Other Clients may make investments at different levels of an issuer&#x2019;s capital structure or otherwise in different classes of an issuer&#x2019;s securities or loans, subject to the limitations of the 1940 Act. While less common, subject to applicable law, from time to time the Company could hold an investment in a different layer of the capital structure than an investor or another party with which Blackstone has a material relationship, in which case Blackstone could have an incentive to cause the Company or the portfolio company to offer more favorable terms to such parties (including, for instance, financing arrangements). Certain such investments inherently give rise to conflicts of interest or perceived conflicts of interest between or among the various classes of securities or loans that are expected to be held by such entities. To the extent the Company holds securities or loans that are different (including with respect to their relative seniority) than those held by an Other Client, the Adviser and its affiliates will be presented with decisions when the interests of the funds are in conflict. For example, conflicts could arise where the Company lends funds to a portfolio company while an Other Client invests in equity securities of such portfolio company. In this circumstance, for example, if such portfolio company were to go into bankruptcy, become insolvent or otherwise be unable to meet its payment obligations or comply with its debt covenants, conflicts of interest could arise between the holders of different types of securities or loans as to what actions the portfolio company should take. In addition, purchases or sales of securities or loans for the account of the Company (particularly marketable securities) will be bunched or aggregated with orders for Other Clients, including other funds. It is frequently not possible to receive the same price or execution on the entire volume of securities sold, and the various prices could be averaged, which has the potential to be disadvantageous to the Company. Further conflicts could arise after the Company and Other Clients have made their respective initial investments. For example, if additional financing is necessary as a result of financial or other difficulties, it is not always &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the best interests of the Company to provide such additional financing. If the Other Clients were to lose their respective investments as a result of such difficulties, the ability of the Adviser to recommend actions in the best interests of the Company might be impaired. Any applicable co-investment exemptive order issued by the SEC may restrict the Company&#x2019;s ability to participate in follow-on financings. Blackstone Credit &amp;amp; Insurance may in its sole discretion take steps to reduce the potential for adversity between the Company and the Other Clients, including causing the Company and/or such Other Clients to take certain actions that, in the absence of such conflict, it would not take. Such conflicts will be more difficult if the Company and Other Clients hold significant or controlling interests in competing or different tranches of a portfolio company&#x2019;s capital structure. Equity holders and debt holders have different (and often competing) motives, incentives, liquidity goals and other interests with respect to a portfolio company. In addition, there could be circumstances where Blackstone Credit &amp;amp; Insurance agrees to implement certain procedures to ameliorate conflicts of interest that involve a forbearance of rights relating to the Company or Other Clients, such as where Blackstone Credit &amp;amp; Insurance is expected to cause the Company or Other Clients to decline to exercise certain control-and/or foreclosure-related rights with respect to a portfolio company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Further, the Company is prohibited under the 1940 Act from participating in certain transactions with certain of affiliates (including portfolio companies of Other Clients) without the prior approval of a majority of the independent members of the Board of Trustees and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of the outstanding voting securities may be an affiliate of the Company for purposes of the 1940 Act and generally the Company will be prohibited from buying or selling any securities from or to such affiliate, absent the prior approval of the Board of Trustees. However, the Company may under certain circumstances purchase any such affiliate&#x2019;s loans or securities in the secondary market, which could create a conflict for the Adviser between the Company&#x2019;s interests and the interests of such affiliate, in that the ability of the Adviser to recommend actions in the Company&#x2019;s best interest may be limited. The 1940 Act also prohibits certain &#x201c;joint&#x201d; transactions with certain affiliates, which could include investments in the same portfolio company (whether at the same or closely related times), without prior approval of the Board of Trustees and, in some cases, the SEC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, conflicts may arise in determining the amount of an investment, if any, to be allocated among potential investors and the respective terms thereof. There can be no assurance that any conflict will be resolved in favor of the Company, and each shareholder acknowledges and agrees that in some cases, subject to applicable law, a decision by Blackstone Credit &amp;amp; Insurance to take any particular action could have the effect of benefiting an Other Client and therefore may not have been in the best interests of, and may be adverse to, the Company. There can be no assurance that the return on the Company&#x2019;s investment will be equivalent to or better than the returns obtained by the Other Clients participating in the same or similar transactions. The shareholders will not receive any benefit from fees paid to any affiliate of the Adviser in respect of any Other Client&#x2019;s investment in a portfolio company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Financing Counterparties. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may invest in companies or other entities in which Other Clients make an investment in a different part of the capital structure (and vice versa) subject to the requirements of the 1940 Act and the Company&#x2019;s co-investment exemptive order. The Adviser requests in the ordinary course proposals from lenders and other sources to provide financing to the Company and its portfolio companies. Blackstone Credit &amp;amp; Insurance takes into account various facts and circumstances it deems relevant in selecting financing sources, including whether a potential lender has expressed an interest in evaluating debt financing opportunities, whether a potential lender has a history of participating in debt financing opportunities generally and with the Firm in particular, the size of the potential lender&#x2019;s loan amount, the timing of the relevant cash requirement, the availability of other sources of financing, the creditworthiness of the lender, whether the potential lender has demonstrated a long-term or continuing commitment to the success of Blackstone, Blackstone Credit &amp;amp; Insurance and their funds, and such other factors that Blackstone and Blackstone Credit &amp;amp; Insurance deem relevant under the circumstances. The cost of debt alone is not determinative.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is possible that shareholders, Other Clients, their portfolio companies, co-investors and other parties with material relationships with the Firm, such as shareholders of and lenders to the Firm and lenders to Other Clients and their portfolio companies (as well as Blackstone itself), could provide additional financing to portfolio companies of the Company, subject to the requirements of the 1940 Act. The Firm could have incentives to cause the Company and its portfolio companies to accept less favorable financing terms from a shareholder, Other Clients, their portfolio companies, Blackstone, and other parties with material relationships with the Firm than it would from a third party. If the Company occupies a different, and in particular, a more senior, position in the capital structure than a shareholder, Other Client, their portfolio companies and other parties with material relationships with Blackstone, Blackstone could have an incentive to cause the Company or portfolio company to offer financing terms that are more favorable to such parties. In the case of a related party financing between the Company or its portfolio companies, on the one hand, and Blackstone or Other Clients&#x2019; portfolio companies, on the other hand, to the extent permitted by the 1940 Act, the Adviser could, but is not obligated to, rely on a third party agent to confirm the terms offered by the counterparty are consistent with market terms, or the Adviser could instead rely on its own internal analysis, which the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adviser believes is often superior to third party analysis given the Firm&#x2019;s scale in the market. If however any of the Firm, the Company, an Other Client or any of their portfolio companies delegates to a third party, such as another member of a financing syndicate or a joint venture partner, the negotiation of the terms of the financing, the transaction will be assumed to be conducted on an arms-length basis, even though the participation of the Firm related vehicle impacts the market terms. For example, in the case of a loan extended to the Company or a portfolio company by a financing syndicate in which an Other Client has agreed to participate on terms negotiated by a third party participant in the syndicate, it might have been necessary to offer better terms to the financing provider to fully subscribe the syndicate if the Other Client had not participated. It is also possible that the frequent participation of Other Clients in such syndicates could dampen interest among other potential financing providers, thereby lowering demand to participate in the syndicate and increasing the financing costs to the Company. The Adviser does not believe either of these effects is significant, but no assurance can be given to shareholders that these effects will not be significant in any circumstance. Unless required by applicable law, the Adviser will not seek any consent or approvals from shareholders or the Board of Trustees in the case of any of these conflicts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Firm could cause actions adverse to the Company to be taken for the benefit of Other Clients that have made an investment more senior in the capital structure of a portfolio company than the Company (e.g., provide financing to a portfolio company, the equity of which is owned by the Company) and, vice versa, actions may be taken for the benefit of the Company and its portfolio companies that are adverse to Other Clients. The Firm could seek to implement procedures to mitigate conflicts of interest in these situations such as (i) a forbearance of rights, including some or all non-economic rights, by the Company or relevant Other Client (or their respective portfolio companies, as the case may be) by, for example, agreeing to follow the vote of a third party in the same tranche of the capital structure, or otherwise deciding to recuse itself with respect to both normal course ongoing matters (such as consent rights with respect to loan modifications in intercreditor agreements) and also decisions on defaults, foreclosures, workouts, restructurings and other similar matters, (ii) causing the Company or relevant Other Client (or their respective portfolio companies, as the case may be) to hold only a non-controlling interest in any such portfolio company, (iii) retaining a third party loan servicer, administrative agent or other agent to make decisions on behalf of the Company or relevant Other Client (or their respective portfolio companies, as the case may be), or (iv) create groups of personnel within the Firm separated by information barriers (which may be temporary and limited purpose in nature), each of which would advise one of the clients that has a conflicting position with other clients. As an example, to the extent an Other Client holds an interest in a loan or security that is different (including with respect to relative seniority) than those held by the Company or its portfolio companies, the Firm can decline to exercise, or delegate to a third party, certain control, foreclosure and other similar governance rights of the Other Client. In these cases, the Firm would generally act on behalf of one of its clients, though the other client would generally retain certain control rights, such as the right to consent to certain actions taken by the trustee or administrative or other agent of the investment, including a release, waiver, forgiveness or reduction of any claim for principal or interest; extension of maturity date or due date of any payment of any principal or interest; release or substitution of any material collateral; release, waiver, termination or modification of any material provision of any guaranty or indemnity; subordination of any lien; and release, waiver or permission with respect to any covenants. The efficacy of following the vote of third-party creditors will be limited in circumstances where the Company or Other Client acquires all or substantially all of a relevant instrument, tranche or class of securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with negotiating loans and bank financings in respect of Blackstone Credit &amp;amp; Insurance-sponsored transactions, Blackstone Credit &amp;amp; Insurance will generally obtain the right to participate (for its own account or an Other Client) in a portion of the financings with respect to such Blackstone Credit &amp;amp; Insurance-sponsored transactions on the same terms negotiated by third parties with the Firm or other terms the Adviser determines to be consistent with the market. Although the Firm could rely on third parties to verify market terms, the Firm may nonetheless have influence on such third parties. No assurance can be given that negotiating with a third party, or verification of market terms by a third party, will ensure that the Company and its portfolio companies receive market terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, it is anticipated that in a bankruptcy proceeding the Company&#x2019;s interests will likely be subordinated or otherwise adverse to the interests of Other Clients with ownership positions that are more senior to those of the Company. For example, an Other Client that has provided debt financing to an investment of the Company will be permitted to take actions for its benefit, particularly if the Company&#x2019;s investment is in financial distress, which adversely impact the value of the Company&#x2019;s subordinated interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although Other Clients can be expected to provide financing to the Company and its portfolio companies subject to the requirements of the 1940 Act, there can be no assurance that any Other Client will indeed provide any such financing with respect to any particular investment. Participation by Other Clients in some but not all financings of the Company and its portfolio companies has the potential to adversely impact the ability of the Company and its portfolio companies to obtain financing from third parties when Other Clients do not participate, as it could serve as a negative signal to market participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any financing provided by a shareholder or an affiliate to the Company or a portfolio company is not an investment in the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The respective investment programs of the Company and the Other Clients may or may not be substantially similar. Blackstone Credit &amp;amp; Insurance and/or Blackstone may give advice to, and recommend securities for, Other Clients that may differ from advice given to, or securities recommended or bought for, the Company, even though their investment objectives may be the same as or similar to those of the Company. While Blackstone Credit &amp;amp; Insurance will seek to manage potential conflicts of interest in a fair and equitable manner, the portfolio strategies employed by Blackstone Credit &amp;amp; Insurance and Blackstone in managing their respective Other Clients are likely to conflict from time to time with the transactions and strategies employed by the Adviser in managing the Company and may affect the prices and availability of the securities and instruments in which the Company invests. Participation in specific investment opportunities may be appropriate, at times, for both the Company and Other Clients. In any event, it is the policy of Blackstone Credit &amp;amp; Insurance to allocate investment opportunities and sale opportunities on a basis deemed by Blackstone Credit &amp;amp; Insurance, in its sole discretion, to be fair and equitable over time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Conflicting Fiduciary Duties to Debt Funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Other Clients include funds and accounts that make investments in senior secured loans, distressed debt, subordinated debt, high-yield securities, commercial mortgage-backed securities and other debt instruments. As discussed above, it is expected that these Other Clients or investors therein will be offered the opportunity, subject to applicable law, to provide financing with respect to investments made by the Company and its portfolio companies. The Firm owes a fiduciary duty and/or other obligations to these Other Clients as well as to the Company and will encounter conflicts in the exercise of these duties and/or obligations. For example, if an Other Client purchases high-yield securities or other debt instruments of a portfolio company of the Company, or otherwise occupies a senior (or other different) position in the capital structure of an investment relative to the Company, the Firm will encounter conflicts in providing advice to the Company and to these Other Clients with regard to appropriate terms of such high-yield securities or other instruments, the enforcement of covenants, the terms of recapitalizations and the resolution of workouts or bankruptcies, among other matters. For example, in a bankruptcy proceeding, in circumstances where the Company holds an equity investment in a portfolio company, the holders of such portfolio company&#x2019;s debt instruments (which can include one or more Other Clients) could take actions for their benefit (particularly in circumstances where such portfolio company faces financial difficulties or distress) that subordinate or adversely impact the value of the Company&#x2019;s investment in such portfolio company. More commonly, the Company could hold an investment that is senior in the capital structure, such as a debt instrument, to an Other Client. Although measures described in &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Financing Counterparties&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; above can mitigate these conflicts, they cannot completely eliminate them. These conflicts related to fiduciary duties to such Other Clients will not necessarily be resolved in favor of the Company, and investors will not always be entitled to receive notice or disclosure of the occurrence of these conflicts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Similarly, certain Other Clients can be expected to invest in securities of publicly traded companies that are actual or potential investments of the Company or its portfolio companies. The trading activities of those vehicles can differ from or be inconsistent with activities that are undertaken for the account of the Company or its portfolio companies in any such securities or related securities. In addition, the Company could not pursue an investment in a portfolio company otherwise within the investment mandate of the Company as a result of such trading activities by Other Clients. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Blackstone and Blackstone Credit &amp;amp; Insurance Clients; Allocation of Investment Opportunities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Certain inherent conflicts of interest arise from the fact that the Adviser, Blackstone Credit &amp;amp; Insurance and Blackstone provide investment management, advisory and sub-advisory services to the Company and Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance and/or Blackstone may give advice to, and recommend securities for, Other Clients that may differ from advice given to, or securities recommended or bought for, the Company, even though their investment objectives may be the same as or similar to those of the Company. Blackstone Credit &amp;amp; Insurance has adopted guidelines and policies, which can be expected to be updated from time to time, regarding allocation of investment opportunities. While Blackstone Credit &amp;amp; Insurance will seek to manage potential conflicts of interest in a fair and equitable manner, the portfolio strategies employed by Blackstone Credit &amp;amp; Insurance and Blackstone in managing their respective Other Clients are likely to conflict from time to time with the transactions and strategies employed by the Adviser in managing the Company and may affect the prices and availability of the securities and instruments in which the Company invests. Participation in specific investment opportunities may be appropriate, at times, for both the Company and Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance provides investment management services to Other Blackstone Credit &amp;amp; Insurance Clients. In addition, Blackstone provides investment management services to Blackstone Clients. Blackstone Credit &amp;amp; Insurance will share appropriate investment opportunities (and sale opportunities) (including, without limitation, secondary market transactions and certain syndicated primary issuance transactions (which generally will not be originated investments)) with Other Clients and the Company in accordance with Firm-wide allocation policies, which generally provide for sharing pro rata based on targeted acquisition size (generally based on available capacity) or targeted sale size (or, in some sales cases, the aggregate positions held by the Company and the applicable Other Clients), taking into account actual and anticipated investments and capital commitments (as appropriate), available cash, asset-based leverage and relative capital of the Company and the applicable Other Clients and such other factors as Blackstone Credit &amp;amp; Insurance determines in good faith to be appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To the extent an opportunity is shared with one or more Other Clients, Blackstone Credit &amp;amp; Insurance expects that such Other Clients generally will invest on substantially the same economic terms available to the Company (including sharing of transaction fees and expenses) and generally will exit investments at the same time and on substantially the same economic terms as the Company, and on a pro rata basis with the Company subject to legal, tax, regulatory, accounting or applicable considerations (including the terms of the governing agreements of, or portfolio management considerations applicable to, the Company or such Other Clients); provided that the Company may syndicate a portion of an investment where Other Clients do not also syndicate a portion of the investment. (See also&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014;Transactions with Clients of Blackstone Insurance Solutions and Asset Based Finance.&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allocation Methodology Considerations. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notwithstanding the foregoing, Blackstone Credit &amp;amp; Insurance may also consider the following factors in making any allocation determinations, and such factors may result in a different allocation of investment and/or sale opportunities: (i)&#160;the risk-return and target return profile of the proposed investment relative to the Company&#x2019;s and the Other Clients&#x2019; current risk profiles; (ii)&#160;the Company&#x2019;s and/or the Other Clients&#x2019; investment strategies, mandates, guidelines, limitations, restrictions, terms and objectives (including whether such objectives are considered solely in light of the specific investment under consideration or in the context of the respective portfolios&#x2019; overall holdings), other contractual provisions (including Other Clients with minimum allocation provisions), focus (including investment focus on a classification attributable to an investment, such as maturity), parameters and investor preferences of the Company and the Other Clients (including, without limitation, with respect to Other Clients that expect to invest in or alongside other funds or across asset classes based on expected return (such as certain managed accounts or other investment vehicles (whether now in existence or which may be established in the future)) with similar investment strategies and objectives); (iii) diversification and concentration considerations in the Company&#x2019;s or the Other Clients&#x2019; portfolios (including the potential for the proposed investment to create an industry, sector, geography, region, location, market or issuer imbalance in the Company&#x2019;s and Other Clients&#x2019; portfolios, as applicable) and taking into account any existing non-pro rata investment positions in the portfolio of the Company and Other Clients; (iv)&#160;liquidity considerations of the Company and the relevant Other Clients (including warehouse vehicles or arrangements (such as CLO warehouses and Blackstone-controlled or third party warehouse arrangements) established for the benefit of current Other Clients or potential future Other Clients), including during a ramp-up (which includes the period prior to or after the initial closing of an Other Client during which its manager is deploying funds already invested or committed (or that its manager anticipates will be invested or committed) and can continue for a period during an Other Client&#x2019;s fundraising and/or acceptance of future subscriptions as deemed appropriate by the Firm, including to protect against zero or de minimis allocations or in anticipation of future subscriptions) or wind-down of one or more of the Company or such Other Clients, proximity to the end of the Company&#x2019;s or Other Clients&#x2019; specified term or investment period, any redemption/withdrawal requests, anticipated future contributions and available cash; (v)&#160;legal, tax, accounting and other considerations or consequences; (vi)&#160;regulatory or contractual provisions, obligations, terms, limitations, restrictions or consequences relating to the Company or Other Clients (including, without limitation, requirements under the 1940 Act and any related rules, orders, guidance or other authority applicable to the Company or Other Clients); (vii) avoiding a de minimis or odd lot allocation; (viii)&#160;availability and degree of leverage and any requirements or other terms of the investment, or of any existing leverage facilities; (ix)&#160;the Company&#x2019;s or Other Clients&#x2019; investment focus on a classification attributable to an investment or issuer of an investment, including, without limitation, investment strategy, geography, location, industry or business sector; (x)&#160;the nature and extent of involvement in the transaction on the part of the respective teams of investment professionals dedicated to the Company or such Other Clients; (xi)&#160;the management of any actual or potential conflict of interest; (xii)&#160;with respect to investments that are made available to Blackstone Credit &amp;amp; Insurance by counterparties pursuant to negotiated trading platforms (e.g., ISDA contracts), the absence of such relationships which may not be available for the Company and all Other Clients; (xiii)&#160;co-investment arrangements, (xiv)&#160;available capital of the Company and such Other Clients, (xv) sourcing of the investment, (xvi)&#160;the specific nature (including size, type, amount, liquidity, holding period, anticipated maturity and minimum investment criteria) of the investment, (xvii)&#160;expected investment return, (xviii)&#160;expected cash characteristics (such as cash-on-cash yield, distribution rates or volatility of cash flows), (xix) capital expenditure required &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as part of the investment, (xx)&#160;portfolio diversification and concentration concerns (including, but not limited to, whether a particular fund already has its desired exposure to the investment, sector, industry, geographic region or markets in question), (xxi) relation to existing investments in a fund, if applicable (e.g., &#x201c;follow on&#x201d; to existing investment, joint venture or other partner to existing investment, or same security as existing investment), (xxii) timing expected to be necessary to execute an investment, (xxiii) whether Blackstone Credit &amp;amp; Insurance believes that allocating investment opportunities to an investor will help establish, recognize, strengthen and/or cultivate relationships that may provide indirectly longer-term benefits (including strategic, sourcing or similar benefits) to the Company, Other Clients and/or Blackstone and (xxiv) any other considerations deemed relevant by Blackstone Credit &amp;amp; Insurance in good faith.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to the requirements of the 1940 Act and the Company&#x2019;s co-investment exemptive order, Blackstone Credit &amp;amp; Insurance shall not have any obligation to present any investment opportunity (or portion of any investment opportunity) to the Company if Blackstone Credit &amp;amp; Insurance determines in good faith that such opportunity (or portion thereof) should not be presented to the Company, including for any one or a combination of the reasons described above, or if Blackstone Credit &amp;amp; Insurance is otherwise restricted from presenting such investment opportunity to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment Alongside Regulated Funds. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition,&#160;Blackstone Credit &amp;amp; Insurance has received an exemptive order from the SEC that permits certain existing and future Other Blackstone Credit &amp;amp; Insurance Clients that are closed-end management investment companies that have elected to be regulated as a BDC or are registered under the 1940 Act and who intend to rely on the exemptive order (each a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x201c;Regulated Fund&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and collectively, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Regulated Funds&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), including the Company, among other things, to co-invest with certain other persons, including certain affiliates of Blackstone Credit &amp;amp; Insurance, and certain funds managed and controlled by Blackstone Credit &amp;amp; Insurance and its affiliates, including the Company and Other Blackstone Credit &amp;amp; Insurance Clients, subject to certain terms and conditions. For so long as any privately negotiated investment opportunity falls within certain established investment criteria of one or more Regulated Funds, such investment opportunity shall also be offered to such Regulated Fund(s). In the event that the aggregate targeted investment sizes of the Company, such Other Blackstone Credit &amp;amp; Insurance Clients and such Regulated Fund(s) that are allocated an investment opportunity exceed the amount of such investment opportunity, allocation of such investment opportunity to each of the Company, such Other Blackstone Credit &amp;amp; Insurance Clients and Regulated Fund(s) will be reduced proportionately based on their respective &#x201c;available capital&#x201d; as defined in the co-investment exemptive order, which may result in allocation to the Company in an amount less than what it would otherwise have been if such Other Blackstone Credit &amp;amp; Insurance Client(s) and Regulated Fund(s) did not participate in such investment opportunity. The co-investment exemptive order also restricts the ability of the Company (or any such Other Blackstone Credit &amp;amp; Insurance Client) from investing in any privately negotiated investment opportunity alongside a Regulated Fund except at the same time and on same terms, as described in the exemptive order. As a result, the Company risks being unable to make investments in different parts of the capital structure of the same issuer in which a Regulated Fund has invested or seeks to invest, and Regulated Funds risk being unable to make investments in different parts of the capital structure of the same issuer in which the Company has invested or seeks to invest. The Company may be unable to participate in or effect certain transactions, or take certain actions in respect of certain investments, on account of applicable restrictions under the 1940 Act, related guidance from the SEC and/or the Company&#x2019;s exemptive order.&#160;For example, the Company may be restricted from participating in certain transactions or taking certain actions in respect of portfolio companies in which certain funds managed and controlled by Blackstone Credit &amp;amp; Insurance and its affiliates and/or a Regulated Fund has also invested, which may include, but is not limited to declining to vote, participating in a potential co-investment opportunity (as such participation may not comply with the conditions of the co-investment exemptive order), exercising rights with respect to any such investment, and/or declining to participate in follow-on investments. The Company may also be required to sell an investment to avoid potential violations of the 1940 Act and/or related rules thereunder or for other reasons. In such cases, the Company&#x2019;s interests in an investment may be adversely affected, including by resulting in the dilution of or decrease in the value of the Company&#x2019;s investment, or otherwise by resulting in the Company being put in a disadvantageous position with respect to the investment as compared to Other Blackstone Credit &amp;amp; Insurance Clients, including other Regulated Funds. Whether the Company participates or declines to participate in any such action or transaction will be made by the Adviser in its sole discretion and will take into account the Adviser&#x2019;s fiduciary duties and applicable law, including the 1940 Act, the rules thereunder and/or the exemptive order. There is no assurance that any such determination will be resolved in favor of the Company&#x2019;s interests. The rules promulgated by the SEC under the 1940 Act, as well as any related guidance from the SEC and/or the terms of the exemptive order itself, are subject to change, and Blackstone Credit &amp;amp; Insurance could undertake to amend the exemptive order (subject to SEC approval), obtain additional exemptive relief, or otherwise be subject to other requirements in respect of co-investments involving the Company, any Other Blackstone Credit &amp;amp; Insurance Client and any Regulated Funds, any of which could impact the amount of any allocation made available to Regulated Funds and thereby affect (and potentially decrease) the allocation made to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Moreover, with respect to Blackstone Credit &amp;amp; Insurance&#x2019;s ability to allocate investment opportunities, including where such opportunities are within the common objectives and guidelines of the Company and one or more Other Clients (which allocations are to be made on a basis that Blackstone Credit &amp;amp; Insurance believes in good faith to be fair and reasonable), Blackstone Credit &amp;amp; Insurance and Blackstone have established general guidelines and policies, which it can be expected to update from time to time, for determining how such allocations are to be made, which, among other things, set forth principles regarding what constitutes &#x201c;debt&#x201d; or &#x201c;debt-like&#x201d; investments, criteria for defining &#x201c;control-oriented equity&#x201d; or &#x201c;infrastructure&#x201d; investments, guidance regarding allocation for certain types of investments (e.g., distressed assets) and other matters. In addition, certain Other Clients can receive certain priority or other allocation rights with respect to certain investments, subject to various conditions set forth in such Other Clients&#x2019; respective governing agreements. The application of those guidelines and conditions could result in the Company or Other Clients not participating (and/or not participating to the same extent) in certain investment opportunities in which they would have otherwise participated had the related allocations been determined without regard to such guidelines and conditions and based only on the circumstances of those particular investments. Additionally, investment opportunities sourced by Blackstone Credit &amp;amp; Insurance will be allocated in accordance with Blackstone&#x2019;s and Blackstone Credit &amp;amp; Insurance&#x2019;s allocation policies, which provide that investment opportunities will be allocated in whole or in part to other business units of the Firm on a basis that Blackstone and Blackstone Credit &amp;amp; Insurance believe in good faith to be fair and reasonable, based on various factors, including the involvement of the respective teams from Blackstone Credit &amp;amp; Insurance and such other business units. It should also be noted that investment opportunities sourced by business units of the Firm other than Blackstone Credit &amp;amp; Insurance will be allocated in accordance with such business units&#x2019; allocation policies, which will result in such investment opportunities being allocated, in whole or in part, away from Blackstone Credit &amp;amp; Insurance, the Company and Other Blackstone Credit &amp;amp; Insurance Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When Blackstone Credit &amp;amp; Insurance determines not to pursue some or all of an investment opportunity for the Company that would otherwise be within the Company&#x2019;s objectives and strategies, and Blackstone or Blackstone Credit &amp;amp; Insurance provides the opportunity or offers the opportunity to Other Clients (or other parties, including portfolio companies), Blackstone or Blackstone Credit &amp;amp; Insurance, including their personnel (including Blackstone Credit &amp;amp; Insurance personnel), will, in certain circumstances, receive compensation from the Other Clients and/or other parties, whether or not in respect of a particular investment, including an allocation of carried interest or referral fees, and any such compensation could be greater than amounts paid by the Company to Blackstone Credit &amp;amp; Insurance. As a result, Blackstone Credit &amp;amp; Insurance (including Blackstone Credit &amp;amp; Insurance personnel who receive such compensation) could be incentivized to allocate investment opportunities away from the Company to or source investment opportunities for Other Clients and/or other parties. In addition, in some cases Blackstone or Blackstone Credit &amp;amp; Insurance can be expected to earn greater fees when Other Clients participate alongside or instead of the Company in an investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance makes good faith determinations for allocation decisions based on expectations that will, in certain circumstances, prove inaccurate. Information unavailable to Blackstone Credit &amp;amp; Insurance, or circumstances not foreseen by Blackstone Credit &amp;amp; Insurance at the time of allocation, can cause an investment opportunity to yield a different return than expected. Conversely, an investment that Blackstone Credit &amp;amp; Insurance expects to be consistent with the Company&#x2019;s return objectives will, in certain circumstances, fail to achieve them.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser is permitted, but will be under no obligation to, provide co-investment opportunities relating to investments made by the Company to Fund shareholders, Other Clients, investors in such Other Clients, subject to the Company&#x2019;s exemptive relief and the 1940 Act. Such co-investment opportunities may be offered to such parties in the Adviser&#x2019;s discretion subject to the Company&#x2019;s exemptive relief. From time to time, Blackstone Credit &amp;amp; Insurance may form one or more funds or accounts to co-invest in transactions with the Company (or transactions alongside any of the Company and one or more Other Clients). Furthermore, for the avoidance of doubt, to the extent that the Company has received its target amount in respect of an investment opportunity, any remaining portion of such investment opportunity initially allocated to the Company may be allocated to Other Clients or to co-investors in Blackstone Credit &amp;amp; Insurance&#x2019;s discretion pursuant to the Company&#x2019;s exemptive relief.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Orders may be combined for the Company and other participating Other Clients, and if any order is not filled at the same price, they may be allocated on an average price basis. Similarly, if an order on behalf of more than one account cannot be fully executed under prevailing market conditions, securities may be allocated among the different accounts on a basis that Blackstone Credit &amp;amp; Insurance or its affiliates consider equitable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, it can be expected that the Firm will, from time to time, enter into arrangements or strategic relationships with third parties, including other asset managers, financial firms or other businesses or companies, that, among other things, provide for referral, sourcing or sharing of investment opportunities. Blackstone or Blackstone Credit &amp;amp; Insurance may pay management fees and performance-based compensation in connection with such arrangements. Blackstone or Blackstone Credit &amp;amp; Insurance may also provide for or receive reimbursement of certain expenses incurred or received in connection with these arrangements, including diligence expenses and general overhead, administrative, deal sourcing and related corporate expenses. The amount of these rebates may relate to allocations of co-investment opportunities and increase if certain co-investment allocations are not made. While it is possible that the Company will, along with the Firm itself, benefit from the existence of those arrangements and/or relationships, it is also possible that investment opportunities that would otherwise be presented to or made by the Company would instead be referred (in whole or in part) to such third party, or, as indicated above, to other third parties, either as a contractual obligation or otherwise, resulting in fewer opportunities (or reduced allocations) being made available to the Company and/or shareholders. This means that co-investment opportunities that are sourced by the Company may be allocated to investors that are not shareholders. For example, a firm with which the Firm has entered into a strategic relationship may be afforded with &#x201c;first-call&#x201d; rights on a particular category of investment opportunities, although there is not expected to be substantial overlap in the investment strategies and/or objectives between the Company and any such firm. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Investments Inside the Company&#x2019;s Mandate that are not Pursued by the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under certain circumstances, Blackstone or Blackstone Credit &amp;amp; Insurance can be expected to determine not to pursue some or all of an investment opportunity within the Company&#x2019;s mandate, including without limitation, as a result of business, reputational or other reasons applicable to the Company, Other Clients, their respective portfolio companies or Blackstone. In addition, Blackstone Credit &amp;amp; Insurance will, in certain circumstances, determine that the Company should not pursue some or all of an investment opportunity, including, by way of example and without limitation, because the Company has already invested sufficient capital in the investment, sector, industry, geographic region or markets in question, as determined by Blackstone Credit &amp;amp; Insurance in its good faith discretion, or the investment is not appropriate for the Company for other reasons as determined by Blackstone Credit &amp;amp; Insurance in its good faith reasonable sole discretion. In any such case Blackstone or Blackstone Credit &amp;amp; Insurance could, thereafter, offer such opportunity to other parties, including Other Clients or portfolio companies or limited partners or shareholders of the Company or Other Clients, joint venture partners, related parties or third parties. Any such Other Clients could be advised by a different Blackstone or Blackstone Credit &amp;amp; Insurance business group with a different investment committee, which could determine an investment opportunity to be more attractive than Blackstone Credit &amp;amp; Insurance believes to be the case. In any event, there can be no assurance that Blackstone Credit &amp;amp; Insurance&#x2019;s assessment will prove correct or that the performance of any investments actually pursued by the Company will be comparable to any investment opportunities that are not pursued by the Company. Blackstone and Blackstone Credit &amp;amp; Insurance, including their personnel, are permitted to receive compensation from any such party that makes the investment, including an allocation of carried interest or referral fees, and any such compensation could be greater than amounts paid by the Company to Blackstone Credit &amp;amp; Insurance. In some cases, Blackstone or Blackstone Credit &amp;amp; Insurance earns greater fees when Other Clients participate alongside or instead of the Company in an investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Situations can arise where certain assets held by the Company are transferred to Other Clients and vice versa. Such transactions will be conducted in accordance with, and subject to, the Adviser&#x2019;s contractual obligations to the Company and applicable law, including the 1940 Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Co-Investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will co-invest with its shareholders, limited partners and/or shareholders of the Other Clients, the Firm&#x2019;s affiliates and other parties with whom Blackstone Credit &amp;amp; Insurance has a material relationship. The allocation of co-investment opportunities is entirely and solely in the discretion of Blackstone Credit &amp;amp; Insurance, subject to applicable law. In addition to participation by Consultants in specific transactions or investment opportunities, Consultants and/or other Firm employees may be permitted to participate in the Firm&#x2019;s side-by-side co-investment rights. Such rights generally do not provide for an advisory fee or carried interest payable by participants therein and generally result in the Company being allocated a smaller share of an investment than would otherwise be the case in the absence of such side-by-side. Furthermore, Other Clients will be permitted (or have a preferred right) to participate in the Firm&#x2019;s side-by-side co-investment rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain circumstances, Blackstone Credit &amp;amp; Insurance will determine that a co-investment opportunity should be offered to one or more third parties (such investors, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Co-Investors&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and will maintain sole discretion with respect to which Co-Investors are offered any such opportunity. It is expected that many investors who will, in certain circumstances, have expressed an interest in co-investment opportunities will not be allocated any co-investment opportunities or will, in certain circumstances, receive a smaller amount of co-investment opportunities than the amount requested. Any co-investments offered by Blackstone Credit &amp;amp; Insurance will be on such terms and conditions (including with respect to advisory fees, performance-based compensation and related arrangements and/or other fees applicable to co-investors) as Blackstone Credit &amp;amp; Insurance determines to be appropriate in its sole discretion on a case-by-case basis, which may differ amongst co-investors with respect to the same co-investment. In addition, the performance of Other Clients co-investing with the Company is not considered for purposes of calculating the incentive fee payable by the Company to the Adviser. Furthermore, the Company and co-investors will often have different investment objectives and limitations, such as return objectives and maximum hold period. Blackstone Credit &amp;amp; Insurance, as a result, will have conflicting incentives in making decisions with respect to such opportunities. Even if the Company and any such parties invest in the same securities on similar terms, conflicts of interest will still arise as a result of differing investment profiles of the investors, among other items.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;General Co-Investment Considerations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; There are expected to be circumstances where an amount that would otherwise have been invested by the Company is instead allocated to co-investors (who could be shareholders of the Company or limited partners of Other Clients) or supplemental capital vehicles, and there is no guarantee that any shareholders will be offered any particular co-investment opportunity. Each co-investment opportunity (should any exist) is likely to be different, and allocation of each such opportunity will depend on the facts and circumstances specific to that unique situation (e.g., timing, industry, size, geography, asset class, projected holding period, exit strategy and counterparty). Different situations will require that the various facts and circumstances of each opportunity be weighted differently, as Blackstone Credit &amp;amp; Insurance deems relevant to such opportunity. Such factors are likely to include, among others, whether a co-investor adds strategic value, industry expertise or other similar synergies; whether a potential co-investor has expressed an interest in evaluating co-investment opportunities; whether a potential co-investor has an overall strategic relationship with the Firm; whether a potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of Blackstone, Blackstone Credit &amp;amp; Insurance, the Company, Other Clients or other co-investments (including whether a potential co-investor will help establish, recognize, strengthen and/or cultivate relationships that can provide indirectly longer-term benefits to the Company or Other Clients and their respective underlying portfolio companies, or whether the potential co-investor has significant capital under management by the Firm or intends to increase such amount); the ability of a potential co-investor to commit to a co-investment opportunity within the required timeframe of the particular transaction; Blackstone Credit &amp;amp; Insurance&#x2019;s assessment of a potential co-investor&#x2019;s ability to invest an amount of capital that fits the needs of the investment (taking into account the amount of capital needed as well as the maximum number of investors that can realistically participate in the transaction); whether the co-investor is considered &#x201c;strategic&#x201d; to the investment because it is able to offer the Company certain benefits, including but not limited to, the ability to help consummate the investment, the ability to aid in operating or monitoring the portfolio company or the possession of certain expertise; the transparency, speed and predictability of the potential co-investor&#x2019;s investment process; whether the Firm has previously expressed a general intention to seek to offer co-investment opportunities to such potential co-investor; whether a potential co-investor has the financial and operational resources and other relevant wherewithal to evaluate and participate in a co-investment opportunity; the familiarity the Firm has with the personnel and professionals of the investor in working together in investment contexts (which may include such potential co-investor&#x2019;s history of investment in other Firm co-investment opportunities); the extent to which a potential co-investor has committed to an Other Client; the size of such potential co-investor&#x2019;s interest to be held in the underlying portfolio company as a result of the Company&#x2019;s investment (which is likely to be based on the size of the potential co-investor&#x2019;s capital commitment or investment in the Company); the extent to which a potential co-investor has been provided a greater amount of co-investment opportunities relative to others; the ability of a potential co-investor to invest in potential add-on acquisitions for the portfolio company or participate in defensive investments; the likelihood that the potential co-investor would require governance rights that would complicate or jeopardize the transaction (or, alternatively, whether the investor would be willing to defer to the Firm and assume a more passive role in governing the portfolio company); any interests a potential co-investor might have in any competitors of the underlying portfolio company; the tax profile of the potential co-investor and the tax characteristics of the investment (including whether the potential co-investor would require particular structuring implementation or covenants that would not otherwise be required but for its participation or whether such co-investor&#x2019;s participation is beneficial to the overall structuring of the investment); whether a potential co-investor&#x2019;s participation in the transaction would subject the Company and/or the portfolio company to additional regulatory requirements, review and/or scrutiny, including any necessary governmental approvals required to consummate the investment; the potential co-investor&#x2019;s interaction with the potential management team of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;portfolio company; whether the potential co-investor has any existing positions in the portfolio company (whether in the same security in which the Company is investing or otherwise); whether there is any evidence to suggest that there is a heightened risk with respect to the potential co-investor maintaining confidentiality; whether the potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of the Company, other affiliated funds and/or other co-investments, including the size of such commitment; whether the potential co-investor has any known investment policies and restrictions, guideline limitations or investment objectives that are relevant to the transaction, including the need for distributions; whether the expected holding period and risk-return profile of the investment is consistent with the stated goals of the investor; and such other factors as the Adviser deems relevant and believes to be appropriate under the circumstances. Furthermore, in connection with any such co-investment by third-party co-investors, the Adviser can establish one or more investment vehicles managed or advised by the Firm to facilitate such co-investors&#x2019; investment alongside the Company. The factors listed in the foregoing sentence are neither presented in order of importance nor weighted, except that Blackstone Credit &amp;amp; Insurance has historically primarily relied upon the following two factors in making the determination to offer co-investment opportunities to co-investors: (i) whether the potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of the Company (including whether a potential co-investor will help establish, recognize, strengthen and/or cultivate relationships that can provide indirectly longer-term benefits to the Company or Other Clients and their respective underlying portfolio companies), other affiliated funds, and/or other co-investments, including the size of any such commitment and fee revenue or profits generated for the benefit of Blackstone Credit &amp;amp; Insurance or Blackstone as a result thereof and (ii) the ability of a potential co-investor to process a co-investment decision within the required timeline of the particular transaction. Except as otherwise described herein, co-investors generally will not share Broken Deal Expenses with the Company and Other Clients, with the result that the Company and such Other Clients will bear all such Broken Deal Expenses, and such expenses can be significant. However, the Adviser does not intend to offer any such co-investment opportunities to shareholders in their capacity as shareholders. Blackstone Credit &amp;amp; Insurance may (but is not required to) establish co-investment vehicles (including dedicated or &#x201c;standing&#x201d; co-investment vehicles) for one or more investors (including third party investors and investors in the Company) in order to co-invest alongside the Company in one or more future investments. The existence of these vehicles could reduce the opportunity for other shareholders to receive allocations of co-investment. In addition, the allocation of investments to Other Clients, including as described under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Other Blackstone and Blackstone Credit &amp;amp; Insurance Clients; Allocation of Investment Opportunities&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; herein, may result in fewer co-investment opportunities (or reduced allocations) being made available to shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Additional Potential Conflicts of Interest with respect to Co-Investment; Strategic Relationships Involving Co-Investment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In addition, the Adviser and/or its affiliates will in certain circumstances be incentivized to offer certain potential co-investors (including, by way of example, as a part of an overall strategic relationship with the Firm) opportunities to co-invest because the extent to which any such co-investor participates in (or is offered) co-investment opportunities can impact the amount of performance-based compensation and/or management fees or other fees paid by the co-investor. The amount of carried interest or expenses charged and/or management fees paid by the Company may be less than or exceed such amounts charged or paid by co-investment vehicles pursuant to the terms of such vehicles&#x2019; partnership agreements and/or other agreements with co-investors, and such variation in the amount of fees and expenses may create an economic incentive for Blackstone Credit &amp;amp; Insurance to allocate a greater or lesser percentage of an investment opportunity to the Company or such co-investment vehicles or co-investors, as the case may be. In addition, other terms of existing and future co-investment vehicles may differ materially, and in some instances may be more favorable to Blackstone Credit &amp;amp; Insurance, than the terms of the Company, and such different terms may create an incentive for Blackstone Credit &amp;amp; Insurance to manage such vehicles, which could result in the Company receiving a lesser percentage of an investment opportunity than if such co-investment vehicles did not exist. Such relationships will from time to time give rise to conflicts of interest, and there can be no assurance that such conflicts of interest will be resolved in favor of the Company. Accordingly, any investment opportunities that would have otherwise been offered or allocated, in whole or in part, to the Company can be reduced and made available to co-investment vehicles. Co-investments may be offered by the Adviser on such terms and conditions as the Adviser determines in its discretion on a case-by-case basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fund Co-Investment Opportunities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a BDC regulated under the 1940 Act, the Company is subject to certain limitations relating to co-investments and joint transactions with affiliates, which likely will in certain circumstances limit the Company&#x2019;s ability to make investments or enter into other transactions alongside the Other Clients. There can be no assurance that such regulatory restrictions will not adversely affect the Company&#x2019;s ability to capitalize on attractive investment opportunities. However, subject to the 1940 Act and any applicable co-investment exemptive order issued by the SEC, the Company may co-invest with Other Clients (including co-investment or other vehicles in which the Firm or its personnel invest and that co-invest with such Other Clients) in investments that are suitable for the Company and one or more of such Other Clients. Even if the Company and any such Other Clients and/or co-investment or other vehicles invest in the same securities, conflicts of interest may still arise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions. Such order may restrict our ability to enter into follow-on investments or other transactions. Pursuant to such order, we may co-invest in a negotiated deal with certain affiliates of the Adviser or certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions. We may also receive an allocation in such a deal alongside affiliates pursuant to other mechanisms to the extent permitted by the 1940 Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Portfolio Companies Alongside Other Clients. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company will co-invest with Other Clients (including co-investment or other vehicles in which the Firm or its personnel invest and that co-invest with such Other Clients) in investments that are suitable for both the Company and such Other Clients, as permitted by applicable law and/or any applicable SEC-granted order. Even if the Company and any such Other Clients invest in the same securities or loans, conflicts of interest are still expected to arise. For example, it is possible that as a result of legal, tax, regulatory, accounting, political, national security or other considerations, the terms of such investment (and divestment thereof) (including with respect to price and timing) for the Company and such other funds and vehicles are not the same. Additionally, the Company and such Other Clients and/or vehicles will generally have different investment periods and/or investment objectives (including return profiles) and Blackstone Credit &amp;amp; Insurance, as a result, could have conflicting goals with respect to the amount, price and timing of disposition opportunities. As such, subject to applicable law and any applicable order issued by the SEC, the Company and/or such Other Clients may dispose of any such shared investment at different times and on different terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Firm Involvement in Financing of Third Party Dispositions by the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company is permitted from time to time dispose of all or a portion of an investment by way of accepting a third-party purchaser&#x2019;s bid where the Firm or one or more Other Clients is providing financing as part of such bid or acquisition of the investment or underlying assets thereof. This generally would include the circumstance where the Firm or one or more Other Clients is making commitments to provide financing at or prior to the time such third-party purchaser commits to purchase such investments or assets from the Company. Such involvement of the Firm or one or more Other Clients as such a provider of debt financing in connection with the potential acquisition of portfolio investments by third parties from the Company may give rise to potential or actual conflicts of interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Self-Administration of the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance expects to provide certain fund administration services to the Company rather than engage or rely on a third party administrator to perform such services. The costs for providing these services are not included in the management fee under the Investment Advisory Agreement and will be paid separately by the Company. Blackstone Credit &amp;amp; Insurance also reserves the right to charge the Company a reduced rate for these services, or to reduce or waive such charges entirely, subject to the 1940 Act. Blackstone Credit &amp;amp; Insurance&#x2019;s ability to determine the reimbursement obligation from the Company creates a conflict of interest. Blackstone Credit &amp;amp; Insurance addresses this conflict by reviewing its fund administration costs to ensure that it is comparable and fair with regard to equivalent services performed by a non-affiliated third party at a rate negotiated on an arm&#x2019;s length basis. The Board of Trustees periodically reviews the reimbursement obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Outsourcing. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to the oversight and, in certain circumstances, approval by the Board of Trustees of the Company, Blackstone may outsource to third parties several of the services performed for the Company and/or its portfolio entities, including services (such as administrative, legal, accounting, tax, diligence, modeling, ongoing monitoring, preparation of internal templates and/or memos or other related services) that may be or historically have been performed in-house by Blackstone and its personnel. For certain third-party service providers, the fees, costs and expenses of such service providers will be borne by the Company, and in other circumstances, the fees, costs and expenses of such service providers will be borne by Blackstone. Certain third-party service providers and/or their employees will dedicate substantially all of their business time to the Company, Other Clients and/or their respective portfolio entities, while others will have other clients. In certain cases, third-party service providers and/or their employees may spend a significant amount of time at Blackstone offices, have dedicated office space at Blackstone, receive administrative support from Blackstone personnel or participate in meetings and events for Blackstone personnel, even though they are not Blackstone employees or affiliates. This creates a conflict of interest because Blackstone will have an incentive to outsource services to third parties due to a number of factors, including because retaining third parties will reduce Blackstone&#x2019;s internal overhead and compensation costs for employees who would otherwise perform such services in-house.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The involvement of third-party service providers may present a number of risks due to Blackstone&#x2019;s reduced control over the functions that are outsourced. There can be no assurances that Blackstone will be able to identify, prevent or mitigate the risks of engaging third-party service providers. The Company may suffer adverse consequences from actions, errors or failures to act by such third parties, and will have obligations, including indemnity obligations, and limited recourse against them. Outsourcing may not occur uniformly for all Blackstone managed vehicles and accounts and, accordingly, certain costs may be incurred by (or allocated to) the Company through the use of third-party service providers that are not incurred by (or allocated to) Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Material, Non-Public Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance will come into possession of confidential information with respect to an issuer and other actual or prospective portfolio companies. Blackstone Credit &amp;amp; Insurance can be restricted from buying, originating or selling securities, loans, or derivatives on behalf of the Company until such time as the information becomes public or is no longer deemed material such that it would preclude the Company from participating in an investment. Disclosure of such information to the Adviser&#x2019;s personnel responsible for the affairs of the Company will be on a need-to-know basis only, and the Company might not be free to act upon any such information. Therefore, the Company will not always have access to confidential information in the possession of Blackstone Credit &amp;amp; Insurance that might be relevant to an investment decision to be made for the Company. In addition, Blackstone Credit &amp;amp; Insurance, in an effort to avoid buying or selling restrictions on behalf of the Company or Other Clients, can choose to forego an opportunity to receive (or elect not to receive) information that other market participants or counterparties, including those with the same positions in the issuer as the Company, are eligible to receive or have received, even if possession of such information would otherwise be advantageous to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Break-up and other Similar Fees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Break-up or topping fees with respect to the Company&#x2019;s investments can be paid to Blackstone Credit &amp;amp; Insurance. Alternatively, the Company could receive the break-up or topping fees directly. Break-up or topping fees paid to Blackstone Credit &amp;amp; Insurance or the Company in connection with a transaction could be allocated, or not, to Other Clients or co-investment vehicles that invest (or are expected to invest) alongside the Company, as determined by Blackstone Credit &amp;amp; Insurance to be appropriate in the circumstances. Generally, Blackstone Credit &amp;amp; Insurance would not allocate break-up or topping fees with respect to a potential investment to the Company, an Other Client or co-investment vehicle unless such person would also share in Broken Deal Expenses related to the potential investment. With respect to fees received by Blackstone Credit &amp;amp; Insurance relating to the Company&#x2019;s investments or from unconsummated transactions, shareholders will not receive the benefit of any fees relating to the Company&#x2019;s investments (including, without limitation, as described above). In the case of fees for services as a director of a portfolio company, the management fee will not be reduced to the extent any Firm personnel continues to serve as a director after the Company has exited (or is in the process of exiting) the applicable portfolio company and/or following the termination of such employee&#x2019;s employment with the Firm. For the avoidance of doubt, although the financial advisory and restructuring business of Blackstone has been spun out, to the extent any investment banking fees, consulting (including management consulting) fees, syndication fees, capital markets syndication and advisory fees (including underwriting fees), origination fees, servicing fees, healthcare consulting / brokerage fees, fees relating to group purchasing, financial advisory fees and similar fees for arranging acquisitions and other major financial restructurings, loan servicing and/or other types of insurance fees, operations fees, financing fees, fees for asset services, title insurance fees, and other similar fees and annual retainers (whether in cash or in kind) are received by Blackstone, such fees will not be required to be shared with the Company or the shareholders and will not reduce the management fee payable by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Broken Deal Expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Any expenses that may be incurred by the Company for actual investments as described herein may also be incurred by the Company with respect to broken deals (i.e., investments that are not consummated) (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Broken Deal Expenses&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Unless required by law or regulation, Blackstone Credit &amp;amp; Insurance is not required to and, in most circumstances, will not seek reimbursement of Broken Deal Expenses (i.e., expenses incurred in pursuit of an investment that is not consummated) from third parties, including counterparties to the potential transaction or potential co-investors. Examples of such Broken Deal Expenses include, but are not limited to, reverse termination fees, extraordinary expenses such as litigation costs and judgments, meal, travel and entertainment expenses incurred, deposits or down payments which are forfeited in connection with unconsummated transactions, costs from onboarding (i.e., KYC) investment entities with a financial institution, commitment fees that become payable in connection with a proposed investment, consulting fees and expenses (including all expenses incurred in connection with any tax audit or investigation settlement), printing and publishing expenses, costs of negotiating co-investment documentation (including non-disclosure agreements with counterparties), and legal, accounting, tax and other due diligence and pursuit costs and expenses and broken deal expenses associated with services provided by portfolio companies, which may include expenses incurred prior to the commencement of the Company&#x2019;s investment activities. Any such Broken Deal Expenses could, in the sole discretion of Blackstone Credit &amp;amp; Insurance, be allocated solely to the Company and not to Other Clients or co-investment vehicles that could have made the investment, even when the Other Client or co-investment vehicle commonly invests alongside the Company in its investments or the Firm or Other Clients in their investments. In such cases, the Company&#x2019;s shares of expenses would increase. The Adviser expects that until a potential investment of the Company is formally allocated to an Other Client (it being understood that final allocation decisions are typically made shortly prior to closing an investment), the Company is expected to bear the broken deal expenses for such investment, which may result in substantial amounts of broken deal expenses. In the event Broken Deal Expenses are allocated to an Other Client or a co-investment vehicle, Blackstone Credit &amp;amp; Insurance or the Company will, in certain circumstances, advance such fees and expenses without charging interest until paid by the Other Client or co-investment vehicle, as applicable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Firm Business Activities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Firm, Other Clients, their portfolio companies, and personnel and related parties of the foregoing will receive fees and compensation, including performance-based and other incentive fees, for products and services provided to the Company and its portfolio companies, such as fees for asset management (including, without limitation, management fees and carried interest/incentive arrangements), development and property management; portfolio operations support (such as those provided by Blackstone&#x2019;s Portfolio Operations Group); arranging, underwriting (including without limitation, evaluation regarding value creation opportunities and ESG risk mitigation); syndication or refinancing of a loan or investment (or other additional fees, including acquisition fees, loan modification or restructuring fees); servicing; loan servicing; special servicing; administrative services; advisory services on purchase or sale of an asset or company; investment banking and capital markets services; placement agent services; fund administration; internal legal and tax planning services; information technology products and services; insurance procurement; brokerage; solutions and risk management services; data extraction and management products and services; fees for monitoring and oversight of loans or title insurance provided to portfolio companies or third parties; and other products and services. For example, the Firm or Other Clients may, directly or indirectly through a portfolio entity, from time to time acquire loans or other assets for the purpose of syndicating some or all the assets to the Company and/or Other Clients, and may receive syndication or other fees in connection therewith. Such parties will also provide products and services for fees to the Firm, Other Clients and their portfolio companies, and their personnel and related parties, as well as third parties. Through its innovations group, Blackstone incubates (or otherwise invests in) businesses that are expected to provide goods and services to the Company (subject to the requirements of the 1940 Act and applicable guidance) and Other Clients and their portfolio companies, as well as other Firm-related parties and third parties. By contracting for a product or service from a business related to the Firm, the Company and its portfolio companies would provide not only current income to the business and its stakeholders, but could also create significant enterprise value in them, which would not be shared with the Company or shareholders and could benefit the Firm directly and indirectly. Also, the Firm, Other Clients and their portfolio companies, and their personnel and related parties may receive compensation or other benefits, such as through additional ownership interests or otherwise, directly related to the consumption of products and services by the Company and its portfolio companies. The Company and its portfolio companies will incur expenses in negotiating for any such fees and services, which will be treated as Fund Expenses. In addition, the Firm may receive fees associated with capital invested by co-investors relating to investments in which the Company participates or otherwise, in connection with a joint venture in which the Company participates (subject to the 1940 Act) or otherwise with respect to assets or other interests retained by a seller or other commercial counterparty with respect to which the Firm performs services. Finally, the Firm and its personnel and related parties will, in certain circumstances, also receive compensation in connection with origination activities, referrals and other related activities of such business, and unconsummated transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will, as determined by Blackstone Credit &amp;amp; Insurance and as permitted by the governing fund documents, bear the cost of fund administration, compliance and accounting (including, without limitation, maintaining financial records, filing of the Company&#x2019;s tax returns, overseeing the calculation of the Company&#x2019;s net asset value, compliance monitoring (including diligence and oversight of the Company&#x2019;s other service providers), preparing reports to the Company&#x2019;s shareholders and reports filed with the SEC and other regulators, preparing materials and coordinating meetings of the Board, managing the payment of expenses, the payment and receipt of funds for investments and the performance of administrative and professional services rendered by others, providing office space, equipment and office services), in house legal, tax planning and other related services provided by Firm personnel and related parties to the Company and its portfolio companies, including the allocation of their compensation and related overhead otherwise payable by the Firm, or pay for their services at market rates, as discussed above in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Self-Administration of the Company.&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Such allocations or charges can be based on any of the following methodologies: (i) requiring personnel to periodically record or allocate their historical time spent with respect to the Company or the Firm approximating the proportion of certain personnel&#x2019;s time spent with respect to the Company, and in each case allocating their compensation (including, without limitation, salary, bonus and benefits) and allocable overhead based on time spent, or charging their time spent at market rates, (ii) the assessment of an overall dollar amount (based on a fixed fee or percentage of assets under management) that the Firm believes represents a fair recoupment of expenses and a market rate for such services or (iii) any other similar methodology determined by the Firm to be appropriate under the circumstances. Certain Firm personnel will provide services to few, or only one, of the Company and Other Clients, in which case the Firm could rely upon rough approximations of time spent by the employee for purposes of allocating the salary and overhead of the person if the market rate for services is clearly higher than allocable salary and overhead. However, any methodology (including the choice thereof) involves inherent conflicts and may result in incurrence of greater expenses by the Company and its portfolio companies than would be the case if such services were provided by third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance, Other Clients and their portfolio companies, and their affiliates, personnel and related parties could continue to receive fees, including performance-based or incentive fees, for the services described in the preceding paragraphs with respect to investments sold by the Company or a portfolio company to a third party buyer after the sale is consummated. Such post-disposition involvement will give rise to potential or actual conflicts of interest, particularly in the sale process. Moreover, Blackstone Credit &amp;amp; Insurance, Other Clients and their portfolio companies, and their affiliates, personnel and related parties could acquire a stake in the relevant asset as part of the overall service relationship, at the time of the sale or thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance does not have any obligation to ensure that fees for products and services contracted by the Company or its portfolio companies are at market rates unless the counterparty is considered an affiliate of the Firm and given the breadth of the Firm&#x2019;s investments and activities Blackstone Credit &amp;amp; Insurance may not be aware of every commercial arrangement between the Company and its portfolio companies, on the one hand, and the Firm, Other Clients and their portfolio companies, and personnel and related parties of the foregoing, on the other hand.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as set forth above, the Company and shareholders will not receive the benefit (e.g., through a reduction to the management fee or otherwise) of any fees or other compensation or benefit received by Blackstone Credit &amp;amp; Insurance, its affiliates or their personnel and related parties. (See also &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&#x2014;Service Providers, Vendors and Other Counterparties Generally&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014;Other Firm Business Activities.&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Securities and Lending Activities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone, its affiliates and their related parties and personnel will from time to time participate in underwriting or lending syndicates with respect to current or potential portfolio companies, or will otherwise act as arrangers of financing, including with respect to the public offering and/or private placement of debt or equity securities issued by, or loan proceeds borrowed by the Company and its portfolio companies, or otherwise in arranging financing (including loans) for such portfolio companies or advise on such transactions. Such underwritings or engagements can be on a firm commitment basis or can be on an uncommitted &#x201c;best efforts&#x201d; basis, and the underwriting or financing parties are under no duty to provide any commitment unless specifically set forth in the relevant contract. Blackstone may also provide placement or other similar services to purchasers or sellers of securities, including loans or instruments issued by portfolio companies. There could also be circumstances in which the Company commits to purchase any portion of such issuance from the portfolio company that a Blackstone broker-dealer intends to syndicate to third parties. As a result thereof, subject to the limitations of the 1940 Act, Blackstone may be permitted to receive commissions or other compensation, thereby creating a potential conflict of interest. This could include, by way of example, fees and/ or commissions for equity syndications to co-investment vehicles. In certain cases, subject to the limitations of the 1940 Act, a Blackstone broker-dealer will, from time to time, act as the managing underwriter, or a member of the underwriting syndicate or broker for the Company or its portfolio companies, or as dealer, broker or advisor to a counterparty to the Company or a portfolio company, and purchase securities from or sell securities to the Company, Other Clients or portfolio companies of the Company or Other Clients or advise on such &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;transactions. Blackstone will also from time to time, on behalf of the Company or other parties to a transaction involving the Company or its portfolio companies, effect transactions, including transactions in the secondary markets that result in commissions or other compensation paid to Blackstone by the Company or its portfolio companies or the counterparty to the transaction, thereby creating a potential conflict of interest. This could include, by way of example, fees and/or commissions for equity syndications to co-investment vehicles. Subject to applicable law, Blackstone will from time to time receive underwriting fees, discounts, placement commissions, loan modification or restructuring fees, servicing fees, capital markets advisory fees, lending arrangement fees, asset/property management fees, insurance (including title insurance) incentive fees and consulting fees, monitoring fees, commitment fees, syndication fees, origination fees, organizational fees, operational fees, loan servicing fees, and financing and divestment fees (or, in each case, rebates in lieu of any such fees, whether in the form of purchase price discounts or otherwise, even in cases where Blackstone, an Other Client or its portfolio companies are purchasing debt) or other compensation with respect to the foregoing activities, which are not required to be shared with the Company. In addition, the management fee with respect to a shareholder generally will not be reduced by such amounts. Therefore, Blackstone will from time to time have a potential conflict of interest regarding the Company and the other parties to those transactions to the extent it receives commissions, discounts or other compensation from such other parties. The Board of Trustees, in its sole discretion, will approve any transactions, subject to the limitations of the 1940 Act, in which a Blackstone broker-dealer acts as an underwriter, as broker for the Company, or as dealer, broker or advisor, on the other side of a transaction with the Company only where the Board of Trustees believes in good faith that such transactions are appropriate for the Company and, by executing a subscription agreement for shares in the Company, a shareholder consents to all such transactions, along with the other transactions involving conflicts of interest described herein, to the fullest extent permitted by law.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When Blackstone serves as underwriter with respect to securities of the Company or its portfolio companies, the Company and such portfolio companies could from time to time be subject to a &#x201c;lock-up&#x201d; period following the offering under applicable regulations during which time the Company or portfolio company would be unable to sell any securities subject to the &#x201c;lock-up.&#x201d; This could prejudice the ability of the Company and its portfolio companies to dispose of such securities at an opportune time. In addition, Blackstone Capital Markets can serve as underwriter in connection with the sale of securities by the Company or its portfolio companies. Conflicts would be expected to arise because such engagement would result in Blackstone Capital Markets receiving selling commissions or other compensation in connection with such sale. (See also&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014;Portfolio Company Relationships Generally&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;below).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone and Blackstone Credit &amp;amp; Insurance employees are generally permitted to invest in alternative investment funds, real estate funds, hedge funds or other investment vehicles, including potential competitors of the Company. The Company will not receive any benefit from any such investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PJT&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. On October 1, 2015, Blackstone spun off its financial and strategic advisory services, restructuring and reorganization advisory services, and its Park Hill fund placement businesses and combined these businesses with PJT Partners Inc. (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;PJT&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), an independent financial advisory firm founded by Paul J. Taubman. While PJT operates independently from Blackstone and is not an affiliate thereof, it is expected that there will be substantial overlapping ownership between Blackstone and PJT for a considerable period of time going forward. Therefore, conflicts of interest will arise in connection with transactions between or involving the Company and its portfolio companies, on the one hand, and PJT, on the other. The pre-existing relationship between Blackstone and its former personnel, the overlapping ownership and co-investment and other continuing arrangements between PJT and Blackstone can be expected to influence Blackstone Credit &amp;amp; Insurance to select or recommend PJT to perform services for the Company or its portfolio companies, the cost of which will generally be borne directly or indirectly by the Company. Given that PJT is no longer an affiliate of Blackstone, Blackstone and its affiliates will be free to cause the Company and portfolio companies to transact with PJT generally without restriction under the applicable governing documents, notwithstanding the relationship between Blackstone and PJT. In addition, one or more investment vehicles controlled by Blackstone may be established to facilitate participation in Blackstone&#x2019;s side-by-side investment program by employees and/or partners of PJT. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Portfolio Company Relationships Generally&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company&#x2019;s portfolio companies, including special purpose vehicles that might be formed in connection with investments, are expected to be counterparties to or participants in agreements, transactions or other arrangements with the Company, Other Clients, and/or portfolio companies of the Company and Other Clients or other Blackstone affiliates and/or any portfolio companies of the foregoing for the provision of goods and services, purchase and sale of assets and other matters (including information-sharing and/or consulting). For example, from time to time, certain portfolio companies of the Company or Other Clients will provide or recommend goods or services to Blackstone, the Company, Other Clients, or other portfolio companies of the Company or Other Clients (including &#x201c;platform&#x201d; investments of the Company and Other Clients). As another example, it can also be expected that the management of one or more portfolio &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;companies may consult with one another (or with one or more portfolio companies of an Other Client) in respect of seeking its expertise, industry view, or otherwise on a particular topic including but not limited to an asset and/or the purchase and /or sale thereof. Moreover, the Company and/or an Other Client can consult with a portfolio company or a portfolio company of an Other Client as part of the investment diligence for a potential investment by the Company or such Other Client. As a result of, or as part of such interactions or otherwise, personnel (including one or more members of the management team) at one portfolio company may also transfer to or become employed by another portfolio company (or a portfolio company of an Other Client), the Company, Blackstone or their respective affiliates (or vice versa). Any such transfer may result in payments by the entity that such personnel is going to, to the entity such personnel is departing from. Although the Firm might determine that such agreements, transactions or other arrangements are consistent with the requirements of such Other Clients&#x2019; offering and/or governing agreements, such agreements, transactions or other arrangements might not have otherwise been entered into but for the affiliation with Blackstone Credit &amp;amp; Insurance and/or Blackstone. These agreements, transactions or other agreements involve fees, commissions, servicing payments and/or discounts to Blackstone Credit &amp;amp; Insurance, any Blackstone affiliate (including personnel) or a portfolio company, none of which reduce the management fee payable by the Company. This may give rise to actual or potential conflicts of interest for the Adviser, the Company and/or their respective affiliates, as such agreements, transactions and arrangements may be more favorable for one portfolio company than another, thus benefiting the Company or Other Clients at the expense of the other. For example, the Firm reserves the right to cause, or offer the opportunity to, portfolio companies to enter into agreements regarding group procurement (such as the group purchasing organization), benefits management, purchase of title and/or other insurance policies (which could be pooled across portfolio companies and discounted due to scale) and other operational, administrative or management related matters from a third party or a Firm affiliate, and other similar operational initiatives that can result in commissions or similar payments, including related to a portion of the savings achieved by the portfolio company. Such agreements, transactions or other arrangements will generally be entered into without the consent or direct involvement of the Company and/or such Other Client or the consent of the Board of Trustees and/or the shareholders of the Company or such Other Client (including, without limitation, in the case of minority and/or non-controlling investments by the Company in such portfolio companies or the sale of assets from one portfolio company to another) and/or such Other Client. In any such case, the Company might not be involved in the negotiation process, and there can be no assurance that the terms of any such agreement, transaction or other arrangement will be as favorable to the Company as otherwise would be the case if the counterparty were not related to the Firm.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, it is possible that certain portfolio companies of Other Clients or companies in which Other Clients have an interest will compete with the Company for one or more investment opportunities. It is also possible that certain portfolio companies of Other Clients will engage in activities that will have adverse consequences on the Company and/or its portfolio companies. As an example of the latter, the laws and regulations of certain jurisdictions (e.g., bankruptcy, environmental, consumer protection and/or labor laws) would not recognize the segregation of assets and liabilities as between separate entities and could permit recourse against the assets of not just the entity that has incurred the liabilities, but also the other entities that are under common control with, or part of the same economic group as, such entity. In such circumstances, the assets of the Company and/or its portfolio companies potentially will be used to satisfy the obligations or liabilities of one or more Other Clients, their portfolio companies and/or affiliates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, from time to time, Blackstone and affiliates of Blackstone and Blackstone portfolio companies could also establish other investment products, vehicles and platforms focusing on specific asset classes or industry sectors that fall within the Company&#x2019;s investment strategy, which would possibly compete with the Company for investment opportunities (it being understood that such arrangements would give rise to conflicts of interest that would not necessarily be resolved in favor of the Company).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain portfolio companies have established or invested in, or can be expected to in the future establish or invest in, vehicles that are managed exclusively by the portfolio company (and not the Company or the Firm or any of its affiliates) and that invest in asset classes or industry sectors (such as cyber security) that fall within the Company&#x2019;s investment strategy. Such vehicles, which would not be considered affiliates of the Firm and would not be subject to the Firm&#x2019;s policies and procedures, have the potential to compete with the Company for investment opportunities. Portfolio companies and affiliates of the Firm will also establish other investment products, vehicles and platforms focusing on specific asset classes or industry sectors (such as reinsurance) that can be expected to compete with the Company for investment opportunities (it being understood that such arrangements can give rise to conflicts of interest that would not necessarily be resolved in favor of the Company). In addition, the Company reserves the right to hold non-controlling interests in certain portfolio companies and, as a result, such portfolio companies could engage in activities outside of the Company&#x2019;s control that would have adverse consequences on the Company and/or its other portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone has also entered into certain investment management arrangements whereby it provides investment management services for compensation to insurance companies including (i) FGL and certain of its affiliates, (ii) Everlake and certain of its affiliates and (iii) certain subsidiaries of Corebridge and (iv) certain subsidiaries of Resolution Life. As of the date of the date hereof, Blackstone owns a 9.9% equity interest in the parent company of Everlake and Blackstone Clients own the remaining equity interests in the parent company of Everlake, and Blackstone owns a 9.9% equity interest in Corebridge. The foregoing insurance company investment management arrangements will involve investments by such insurance company clients across a variety of asset classes (including investments that would otherwise be appropriate for the Company). As a result, in addition to the compensation Blackstone receives for providing investment management services to insurance companies in which Blackstone or an Other Client owns an interest, in certain instances Blackstone receives additional compensation in its capacity as an indirect owner of such insurance companies and/or Other Clients. In the future Blackstone will likely enter into similar arrangements with other portfolio companies of the Company, Other Clients or other insurance companies. Such arrangements have the potential to reduce the allocations of investments to the Company, and Blackstone could be incentivized to allocate investments away from the Company to such insurance company client under such investment management arrangements or other vehicles/accounts to the extent the economic arrangements related thereto are more favorable to Blackstone relative to the terms of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Further, portfolio companies with respect to which the Firm can elect members of the board of directors or a managing member could, as a result, subject the Company and/or such directors or managing member to fiduciary obligations to make decisions that they believe to be in the best interests of any such portfolio company. Although in most cases the interests of the Company and any such portfolio company will be aligned, this will not always be the case. This has the potential to create conflicts of interest between the relevant director&#x2019;s or managing member&#x2019;s obligations to any such portfolio company and its stakeholders, on the one hand, and the interests of the Company, on the other hand. Although Blackstone Credit &amp;amp; Insurance will generally seek to minimize the impact of any such conflicts, there can be no assurance they will be resolved favorably for the Company. For instance, such positions could impair the ability of the Company to sell the securities of an issuer in the event a director receives material non- public information by virtue of their role, which would have an adverse effect on the Company. Furthermore, an employee of Blackstone serving as a director to a portfolio company owes a fiduciary duty and/or other obligations to the portfolio company, on the one hand, and the Company, on the other hand, and such employee could be in a position where they must make a decision that is either not in the best interest of the Company, or is not in the best interest of the portfolio company. Blackstone personnel serving as directors can make decisions for a portfolio company that negatively impact returns received by the Company as an investor in the portfolio company. In addition, to the extent an employee serves as a director on the board of more than one portfolio company, such employees&#x2019; fiduciaries duties among the two portfolio companies can be expected to create a conflict of interest. In general, the Adviser and Blackstone personnel will be entitled to indemnification from the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Portfolio Company Service Providers and Vendors&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Subject to applicable law, the Company, Other Clients, portfolio companies of each of the foregoing and Blackstone Credit &amp;amp; Insurance can be expected to engage portfolio companies of the Company and Other Clients to provide some or all of the following services: (a)&#160;corporate support services (including, without limitation, accounts payable, accounts receivable, accounting/audit (e.g., valuation support services), account management (e.g., treasury, customer due diligence), insurance, procurement, placement, brokerage and consulting services, cash management, accounts receivable financing, corporate secretarial and executive assistant services, domiciliation, data management, directorship services, finance/budget, human resources (e.g., the onboarding and ongoing development of personnel), communication, public relations and publicity, information technology and software systems support, corporate governance and entity management (e.g., liquidation, dissolution and/or otherwise end of term services), risk management and compliance, internal compliance, know-your-client reviews and refreshes, judicial processes, legal, environmental due diligence support(e.g., review of property condition reports, energy consumption), climate accounting services, ESG program management services, engineering services, services related to the sourcing, development and implementation of renewable energy, ESG data collection and reporting services, capital planning services, operational coordination (i.e., coordination with joint venture partners, property managers), risk management, reporting (such as tax reporting, debt reporting or other reporting), tax and treasury, tax analysis and compliance (e.g., CIT and VAT compliance), transfer pricing and internal risk control, treasury and valuation services) and other services; (b) loan services (including, without limitation, monitoring, restructuring and work-out of performing, sub-performing and nonperforming loans, administrative services, and cash management); (c) management services (i.e., management by a portfolio company, Blackstone affiliate or third party (e.g., a third-party manager or operating partner) of operational services); (d) operational services (i.e., general management of day to day operations), including, without limitation, personnel, construction management (such as management of general contractors on capital projects), leasing services (such as leasing strategy, management of third party brokers, negotiation of major leases and negotiation of leases), project management (such as management of development projects, project design and execution, vendor management, and turnkey services); (e) risk management (tax and treasury); (f) transaction support services (including, without &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;limitation, acquisition support; customer due diligence and related onboarding; liquidation; reporting; managing relationships with brokers, banks and other potential sources of investments, identifying potential investments, coordinating with investors, assembling relevant information, conducting financial and market analyses and modelling, coordinating closing/post-closing procedures for acquisitions, dispositions and other transactions, coordinating design and development works (such as recommending and implementing design decisions); and providing diligence and negotiation support to acquire the same; marketing and distribution, overseeing brokers, lawyers, accountants and other advisors, working with consultants and third parties to pursue entitlements; providing in-house legal, ESG and accounting services, assisting with due diligence, preparation of project feasibilities, site visits, transaction consulting and specification of technical analysis and review of (i) design and structural work, (ii) certifications, (iii) operations and maintenance manuals and (iv) statutory documents); (g) insurance procurement, placement, brokerage and consulting services; and (h)&#160;other services. Similarly, Blackstone Credit &amp;amp; Insurance, Other Clients and their portfolio companies can be expected to engage portfolio companies of the Company to provide some or all of these services. Some of the services performed by portfolio company service providers could also be performed by Blackstone Credit &amp;amp; Insurance from time to time and vice versa. Fees paid by the Company or its portfolio companies to or value created by other portfolio company service providers do not reduce the management fee payable by the Company and are not otherwise shared with the Company. In certain circumstances, Blackstone can be expected to play a substantial role in overseeing the personnel of portfolio company service providers that provide services to the Company, Other Clients and/or their portfolio companies on an ongoing basis, including with respect to the selection, hiring, retention and compensation of such personnel. For example, Blackstone expects that certain portfolio company service providers, as described below, with Blackstone&#x2019;s oversight, will establish a team of personnel to provide support services exclusively to the Company and its portfolio companies (and/or other investment funds or accounts managed or controlled by Blackstone). Further, Blackstone has multiple business lines, which may result in competition with a portfolio company for high performing executive talent and presents actual and potential conflicts of interest. For example, Blackstone may &#x201c;poach&#x201d; a portfolio company executive, or such executive may interview with Blackstone during the applicable contractual period with respect to such person&#x2019;s existing position and later be hired by Blackstone after such period. A portfolio company may want to retain such executives or other employees, and regardless, Blackstone is under no obligation to avoid interviewing or hiring such employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Portfolio companies of the Company and Other Clients some of which can be expected to provide services to the Company and its portfolio companies include, without limitation, the following, and could include additional portfolio companies that might be formed or acquired in the future: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;BTIG&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. BTIG, LLC (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;BTIG&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) is a global financial services firm in which certain Blackstone entities own a strategic minority investment. BTIG provides institutional trading, investment banking, research and related brokerage services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CoreTrust&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. On September 30, 2022, certain Blackstone private equity funds and related entities closed the previously announced acquisition of a majority interest in CoreTrust (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;CoreTrust Acquisition&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), a group purchasing organization that provides purchasing services to member companies, which includes portfolio companies owned, in whole or in part, by certain Blackstone-managed funds. CoreTrust is expected to provide group purchasing services to the Company, portfolio companies, Other Clients and Blackstone. Generally, CoreTrust generates revenue from vendors based on a percentage of the amount of products or services purchased by its member companies and benefit plans maintained by its member companies. CoreTrust has historically shared a portion of the revenue generated through purchases made by Blackstone portfolio companies and paid Blackstone a consulting fee. Blackstone stopped accepting such revenue sharing arrangements and consulting fee upon the closing of the CoreTrust Acquisition. However, Blackstone may in its sole discretion reinstitute such or similar revenue sharing arrangements with CoreTrust in the future. In addition, prior to the CoreTrust Acquisition, CoreTrust generated revenue in respect of certain portfolio companies (the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x201c;Applicable Portfolio Companies&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) from certain health and welfare benefit plan-related vendors (the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x201c;Applicable Vendors&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). For legal and regulatory reasons&lt;/span&gt;&lt;span style="background-color:#dddddd;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;following the CoreTrust Acquisition, CoreTrust is limited in its ability to generate revenue from the Applicable Vendors in respect of portfolio companies&#x2019; health benefit plans based on a percentage of the amount of products or services purchased by such plans. As a result, for Applicable Portfolio Companies and other portfolio companies that become CoreTrust members, CoreTrust intends to rebate all revenue received from Applicable Vendors to each such Portfolio Company&#x2019;s applicable benefit plan. CoreTrust also intends to enter into with each Applicable Portfolio Company (and with other portfolio companies that become CoreTrust members) a separate agreement that will include the payment of an access fee in return for allowing such portfolio companies to use the goods and services provided by the Applicable Vendors through CoreTrust. The amount of the access fee will generally be determined either as a percentage of total company revenues or as a fixed fee (in each case subject to periodic review by CoreTrust and the Applicable Portfolio Company) and might not be subject to benchmarking, and the access fee could be greater or less than the amount of the revenue that CoreTrust previously generated from Applicable Vendors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Optiv&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Optiv Security, Inc. is a portfolio company held by certain Blackstone private equity funds that provides a full slate of information security services and solutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PSAV&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. PSAV, Inc. is a portfolio company held by certain Blackstone private equity funds that provides outsourced audiovisual services and event production.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Refinitiv&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. On October 1, 2018, a consortium led by Blackstone announced that private equity funds managed by Blackstone had completed an acquisition of Thomson Reuters&#x2019; Financial &amp;amp; Risk business (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Refinitiv&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). On January 29, 2021, Refinitiv was sold to London Stock Exchange Group (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;LSEG&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), with Blackstone private equity funds receiving a minority stake in LSEG. Refinitiv operates a pricing service that provides valuation services and may provide goods and services for the Company and its portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Kryalos. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone through one or more of its funds has made a minority investment in Kryalos, an operating partner in certain real estate investments made by Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Peridot Financial Services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Peridot&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; and Global Supply Chain Finance &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;GSCF&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone through one or more of its funds has made majority investments into Peridot and GSCF, which provide supply chain financing and accounts receivable services globally.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;RE Tech Advisors &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;RE Tech&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Blackstone through one or more of its funds has made a majority investment in RE Tech, an energy audit/consulting firm that identifies and implements energy efficiency programs, calculates return on investment and tracks performance post-completion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legence (f.k.a Therma Holdings) (&#x201c;Legence&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Legence is a portfolio company held by certain Blackstone private equity funds that provides carbon reduction and energy management services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revantage.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revantage is a portfolio entity of certain Blackstone Clients that provides corporate support services, including, without limitation, accounting, legal, tax, treasury, information technology and human resources and operational services and management services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There may be instances where current and former employees of Other Clients&#x2019; portfolio companies are seconded to or temporarily hired by the Company&#x2019;s portfolio companies or, at times, the Company&#x2019;s investments directly. Such secondments or temporary hiring of current and former employees of Other Clients&#x2019; portfolio companies by the Company&#x2019;s portfolio companies (or its investments) may result in a potential conflict of interest between the Company&#x2019;s portfolio companies and those of such Other Clients. The costs of such employees are expected to be borne by the Company or its relevant portfolio companies, as applicable, and the fees paid by the Company or such portfolio companies to, other portfolio company service providers or vendors do not offset or reduce the management fee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its portfolio companies will compensate one or more of these service providers and vendors owned by the Company or Other Clients, including through incentive based compensation payable to their management teams and other related parties. The incentive based compensation paid with respect to a portfolio company or asset of the Company or Other Clients will vary from the incentive based compensation paid with respect to other portfolio companies and assets of the Company and Other Clients; as a result the management team or other related parties can be expected to have greater incentives with respect to certain assets and portfolio companies relative to others, and the performance of certain assets and portfolio companies can be expected to provide incentives to retain management that also service other assets and portfolio companies. Some of these service providers and vendors owned or controlled by the Company or Other Clients may charge the Company and its portfolio companies for goods and services at rates generally consistent with those available in the market for similar goods and services. The discussion regarding the determination of market rates under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&#x2014;Firm Affiliated Service Providers&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; herein applies equally in respect of the fees and expenses of the portfolio company service providers, if charged at rates generally consistent with those available in the market. Other service providers and vendors owned and/or controlled by the Company or Other Clients pass through expenses on a cost reimbursement, no-profit or break-even basis, in which case the service provider allocates costs and expenses directly associated with work performed for the benefit of the Company and its portfolio companies to them, along with any related tax costs and an allocation of the service provider&#x2019;s overhead, including any of the following: salaries, wages, benefits and travel expenses; marketing and advertising fees and expenses; legal, accounting and other professional fees and disbursements; office space and equipment; insurance premiums; technology expenditures, including hardware and software costs; costs to engage recruitment firms to hire employees; diligence expenses; one-time costs, including costs related to building-out and winding-down a portfolio company; costs that are of a limited &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;duration or non-recurring (such as start-up or technology build-up costs, one-time technology and systems implementation costs, employee on-boarding and severance payments, and readiness of initial public offerings and other infrastructure costs); taxes; and other operating and capital expenditures. Any of the foregoing costs (including in prior periods, such as where any such costs are amortized over an extended period), although allocated in a particular period, will, in certain circumstances, relate to activities occurring outside the period, and further will, in certain circumstances, be of a general and administrative nature that is not specifically related to particular services, and therefore the Company could pay more than its &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;pro rata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; portion of fees for services. In addition, in certain circumstances, Blackstone also relies on the management team of a portfolio company with respect to the determination of costs and expenses and allocation thereof and does not oversee or participate in such determinations or allocations. Moreover, to the extent a portfolio company uses an allocated cost model with respect to fees, costs and expenses, such fees, costs and expenses are typically estimated and/or accrued quarterly (or on another regular periodic basis) but not finalized until year-end and as a result, such year-end true-up is subject to fluctuation and increases such that for a given year, the year-end cumulative amount with respect to fees, costs and expenses may be greater than the sum of the quarterly estimates (or other periodic estimates where applicable) and/or accruals and therefore the Company could bear more fees, costs and expenses at year-end than had been anticipated throughout the year. The allocation of overhead among the entities and assets to which services are provided can be expected to be based on any of a number of different methodologies, including, without limitation, &#x201c;cost&#x201d; basis as described above, &#x201c;time-allocation&#x201d; basis, &#x201c;per unit&#x201d; basis, &#x201c;per square footage&#x201d; basis or &#x201c;fixed percentage&#x201d; basis, and the particular methodology used to allocate such overhead among the entities and assets to which services are provided are expected to vary depending on the types of services provided and the applicable asset class involved, and could, in certain circumstances, change from one period to another. There can be no assurance that a different manner of allocation would result in the Company and its portfolio companies bearing less or more costs and expenses. In addition, a portfolio company that uses a &#x201c;cost&#x201d; basis methodology may, in certain circumstances, change its allocation methodology, for example, to charging a flat fee for a particular service or instance (or vice versa) or to another methodology described herein or otherwise, and such changes may increase or reduce the amounts received by such portfolio companies for the same services, and shareholders will not necessarily be entitled to receive notice or disclosure of such changes in allocation methodology. In certain instances, particularly where such service providers and vendors are located in Europe or Asia, such service providers and vendors will charge the Company and its portfolio companies for goods and services at cost plus a percentage of cost for transfer pricing or other tax, legal, regulatory, accounting or other reasons or even decide to amortize any costs or expenses to address accounting or operational considerations. Further, the Company and its portfolio companies may compensate one or more of these service providers and vendors owned by the Company or Other Clients through incentive-based compensation payable to their management teams and other related parties. The incentive-based compensation paid with respect to a portfolio company or asset of the Company or Other Clients will vary from the incentive based compensation paid with respect to other portfolio companies and assets of the Company and Other Clients; as a result the management team or other related parties can be expected to have greater incentives with respect to certain assets and portfolio companies relative to others, and the performance of certain assets and portfolio companies could provide incentives to retain management that also service other assets and portfolio companies. Blackstone Credit &amp;amp; Insurance will not always perform or obtain benchmarking analysis or third-party verification of expenses with respect to services provided on a cost reimbursement, no profit or break even basis, or in respect of incentive-based compensation. There can be no assurances that amounts charged by portfolio company service providers that are not controlled by the Company or Other Clients will be consistent with market rates or that any benchmarking, verification or other analysis will be performed with respect to such charges. If benchmarking is performed, the related expenses will be borne by the Company, Other Clients and their respective portfolio companies and will not reduce the management fee. A portfolio company service provider will, in certain circumstances, subcontract certain of its responsibilities to other portfolio companies. In such circumstances, the relevant subcontractor could invoice the portfolio company for fees (or in the case of a cost reimbursement arrangement, for allocable costs and expenses) in respect of the services provided by the subcontractor. The portfolio company, if charging on a cost reimbursement, no-profit or break-even basis, would in turn allocate those costs and expenses as it allocates other fees and expenses as described above. Similarly, Other Clients, their portfolio companies and Blackstone Credit &amp;amp; Insurance can be expected to engage portfolio companies of the Company to provide services, and these portfolio companies will generally charge for services in the same manner described above, but the Company and its portfolio companies generally will not be reimbursed for any costs (such as start-up costs or technology build-up costs) relating to such portfolio companies incurred prior to such engagement. Some of the services performed by these service providers could also be performed by Blackstone Credit &amp;amp; Insurance from time to time and vice versa. Fees paid by the Company or its portfolio companies to these service providers do not the management fee payable to the Adviser.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Where compensation paid to an affiliated service provider from the Company or its portfolio company is based on market rates, such compensation will not be based on the cost incurred by the applicable service provider and therefore will likely result in a profit to such service provider. In the event the service provider is an affiliate of Blackstone Credit &amp;amp; Insurance, Blackstone Credit &amp;amp; Insurance experiences a conflict of interest in determining the terms of any such engagement. There can be no assurance that an unaffiliated third party would not charge a lesser rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Service Providers, Vendors and Other Counterparties Generally&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Certain third party advisors and other service providers and vendors or their affiliates to the Company and its portfolio companies (including accountants, administrators, paying agents, depositories, lenders, bankers, brokers, attorneys, consultants, title agents and investment or commercial banking firms) are owned by the Firm, the Company or Other Clients or provide goods or services to, or have other business, personal, financial or other relationships with, the Firm, the Other Clients and their respective portfolio companies and affiliates and personnel. Such advisors and service providers referred to above could be investors in the Company, affiliates of the Adviser, sources of financing and investment opportunities or co-investors or commercial counterparties or entities in which the Firm and/or Other Clients have an investment, and payments by the Company and/or such entities can be expected to indirectly benefit the Firm, the Other Clients and their respective portfolio companies or any affiliates or personnel. Also, advisors, lenders, investors, commercial counterparties, vendors and service providers (including any of their affiliates or personnel) to the Company and its portfolio companies could have other commercial or personal relationships with the Firm, Other Clients and their respective portfolio companies, or any affiliates, personnel or family members of personnel of the foregoing. Although the Firm selects service providers and vendors it believes are most appropriate in the circumstances based on its knowledge of such service providers and vendors (which knowledge is generally greater in the case of service providers and vendors that have other relationships to the Firm), the relationship of service providers and vendors to the Firm as described above will influence the Firm in deciding whether to select, recommend or form such an advisor or service provider to perform services for the Company, subject to applicable law, or a portfolio company, the cost of which will generally be borne directly or indirectly by the Company and can be expected to incentivize the Firm to engage such service provider over a third party, utilize the services of such service providers and vendors more frequently than would be the case absent the conflict, or to pay such service providers and vendors higher fees or commissions, resulting in higher fees and expenses being borne by the Company, than would be the case absent the conflict. The incentive could be created by current income and/or the generation of enterprise value in a service provider or vendor; the Firm can be expected to also have an incentive to invest in or create service providers and vendors to realize on these opportunities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Firm has a practice of not entering into any arrangements with advisors, vendors or service providers that provide lower rates or discounts to the Firm itself compared to those it enters into on behalf of the Company and its portfolio companies for the same services. However, legal fees for unconsummated transactions are often charged at a discounted rate, such that if the Company and its portfolio companies consummate a higher percentage of transactions with a particular law firm than the Firm, the Company, Other Clients and their portfolio companies, the shareholders could indirectly pay a higher net effective rate for the services of that law firm than the Firm, the Company or Other Clients or their portfolio companies. Also, advisors, vendors and service providers often charge different rates or have different arrangements for different types of services. For example, advisors, vendors and service providers often charge fees based on the complexity of the matter as well as the expertise and time required to handle it. Therefore, to the extent the types of services used by the Company and its portfolio companies are different from those used by the Firm, Other Clients and their portfolio companies, and their affiliates and personnel, the Company and its portfolio companies can be expected to pay different amounts or rates than those paid by such other persons. Similarly, the Firm, the Company, the Other Clients and their portfolio companies and affiliates can be expected to enter into agreements or other arrangements with vendors and other similar counterparties (whether such counterparties are affiliated or unaffiliated with the Firm) from time to time whereby such counterparty will, in certain circumstances, charge lower rates (or no fee) or provide discounts or rebates for such counterparty&#x2019;s products or services depending on certain factors, including without limitation the volume of transactions entered into with such counterparty by the Firm, the Company and its investment and/or portfolio companies in the aggregate or other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to applicable law, the Company, Other Clients and their portfolio companies are expected to enter into joint ventures with third parties to which the service providers and vendors described above will, in certain circumstances, provide services. In some of these cases, the third party joint venture partner may be permitted to negotiate to not pay its &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;pro rata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; share of fees, costs and expenses to be allocated as described above, in which case the Company, Other Clients and their portfolio companies that also use the services of the portfolio company service provider will, directly or indirectly, pay the difference, or the portfolio company service provider will bear a loss equal to the difference.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Firm might, from time to time, encourage service providers to funds and investments to use, generally at market rates and/or on arm&#x2019;s length terms (and/or on the basis of best execution, if applicable), the Firm-affiliated service providers in connection with the business of the Company, portfolio companies, and unaffiliated entities. This practice creates a conflict of interest because it provides an indirect benefit to the Firm in the form of added business for the Firm-affiliated service providers without any reduction to the Company&#x2019;s management fee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain portfolio companies that provide services to the Company, Other Clients and/or portfolio companies or assets of the Company and/or Other Clients could be transferred between and among the Company and/or Other Clients (where the Company may be a seller or a buyer in any such transfer) for minimal or no consideration (based on a third-party valuation confirming the same). Such transfers may give rise to actual or potential conflicts of interest for Blackstone Credit &amp;amp; Insurance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Firm Affiliated Service Providers. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s, the Firm&#x2019;s and/or portfolio companies&#x2019; advisers and other service providers, or their affiliates (including accountants, administrators, lenders, bankers, brokers, attorneys, consultants, and investment or commercial banking firms) also provide goods or services to, or have business, personal, financial or other relationships with, the Firm, its affiliates and portfolio companies. Such advisers and service providers (or their affiliates) may be investors in the Company, affiliates of the Firm, sources of investment opportunities, co-investors, commercial counterparties and/or portfolio companies in which the Firm and/or the Company has an investment. Accordingly, payments by the Company and/or such entities may indirectly benefit the Company and/or its affiliates, including the Firm and Other Clients. No fees charged by these service providers and vendors will reduce the management fees payable to the Adviser. Furthermore, the Firm, the Other Clients and their portfolio companies and their affiliates and related parties will use the services of these Firm affiliates, including at different rates. Although the Firm believes the services provided by its affiliates are equal or better than those of third parties, the Firm directly benefits from the engagement of these affiliates, and there is therefore an inherent conflict of interest such as those described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because the Firm has many different businesses, including the Blackstone Capital Markets Group, which Blackstone investment teams and portfolio companies can engage to provide underwriting and capital market advisory services, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would be subject if it had just one line of business. To the extent Blackstone determines appropriate, conflict mitigation strategies would be put in place with respect to a particular circumstance, such as internal information barriers or recusal, disclosure or other steps determined appropriate by the Adviser. Service providers affiliated with the Firm, which are generally expected to receive competitive market rate fees (as determined by the Adviser or its affiliates) with respect to certain investments, include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.07pt"&gt;Aquicore&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Aquicore is a cloud-based platform that tracks, analyzes and predicts key metrics in real estate, focused on the reduction of energy consumption. Blackstone holds a minority investment in Aquicore.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"&gt;Equity Healthcare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Equity Healthcare LLC (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Equity Healthcare&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) is a Blackstone affiliate that negotiates with providers of standard administrative services and insurance carriers for health benefit plans and other related services for cost discounts, quality of service monitoring, data services and clinical consulting. Because of the combined purchasing power of its client participants, which include unaffiliated third parties, Equity Healthcare is able to negotiate pricing terms that are believed to be more favorable than those that the portfolio companies could obtain for themselves on an individual basis. The fees received by Equity Healthcare in connection with services provided to investments will not reduce the management fee payable by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;c.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.07pt"&gt;LNLS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Lexington National Land Services (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;LNLS&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) is a Blackstone affiliate that (i) acts as a title agent in facilitating and issuing title insurance, (ii) provides title support services for title insurance underwriters and (iii) acts as escrow agent in connection with investments by the Company, Other Clients and their portfolio companies, affiliates and related parties, and third parties. In exchange for such services LNLS earns fees which would have otherwise been paid to third parties. If LNLS is involved in a transaction in which the Company participates, Blackstone will benchmark the relevant costs to the extent market data is available except when LNLS is providing such services in a state where the insurance premium or escrow fee, as applicable, is regulated by the state or when LNLS is part of a syndicate of title insurance companies where the insurance premium is negotiated by other title insurance underwriters or their agents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"&gt;Refinitiv&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. See &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;Portfolio Company Service Providers and Vendors&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, Blackstone acquired a 9.9% interest in Corebridge, and in connection therewith has entered into a long-term asset management partnership with certain subsidiaries and/or affiliates of Corebridge to serve as the exclusive external manager with respect to certain asset classes within their investment portfolio, for compensation. While Blackstone will not control Corebridge, the aforementioned investment in Corebridge and asset management arrangements could incentivize Blackstone to cause (and Blackstone will benefit indirectly from causing) the Company and/or its portfolio companies to engage Corebridge or its affiliates (including Corebridge Financial, Inc. and its other affiliates and subsidiaries) to provide various services and engage in other transactions and otherwise present conflicts of interests as a result of Blackstone&#x2019;s interest and relationship therewith.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain Blackstone-affiliated service providers and their respective personnel will receive a management promote, an incentive fee and other performance-based compensation in respect of investments, sales or other transaction volume. Furthermore, Blackstone-affiliated service providers can be expected to charge costs and expenses based on allocable overhead associated with personnel working on relevant matters (including salaries, benefits and other similar expenses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with such relationships, Blackstone Credit &amp;amp; Insurance and, if required by applicable law, the Board of Trustees, will make determinations of competitive market rates based on its consideration of a number of factors, which are generally expected to include Blackstone Credit &amp;amp; Insurance&#x2019;s experience with non-affiliated service providers, benchmarking data and other methodologies determined by Blackstone Credit &amp;amp; Insurance to be appropriate under the circumstances (i.e., rates that fall within a range that Blackstone Credit &amp;amp; Insurance has determined is reflective of rates in the applicable market and certain similar markets, though not necessarily equal to or lower than the median rate of comparable firms and in certain circumstances, is expected to be in the top of the range). In respect of benchmarking, while Blackstone Credit &amp;amp; Insurance often obtains benchmarking data regarding the rates charged or quoted by third parties for services similar to those provided by Blackstone Credit &amp;amp; Insurance affiliates in the applicable market or certain similar markets, relevant comparisons would not be available for a number of reasons, including, without limitation, as a result of a lack of a substantial market of providers or users of such services or the confidential or bespoke nature of such services (e.g., different assets could receive different services). In addition, benchmarking data is based on general market and broad industry overviews, rather than determined on an asset by asset basis. As a result, benchmarking data does not take into account specific characteristics of individual assets then invested in by the Company (such as location or size), or the particular characteristics of services provided. Further, it could be difficult to identify comparable third-party service providers that provide services of a similar scope and scale as the Firm-affiliated service providers that are the subject of the benchmarking analysis or to obtain detailed information about pricing of a service comparable to that being provided to the Company from third-party service providers if such service providers anticipate that Blackstone will not in fact engage their services. For these reasons, such market comparisons would not necessarily result in precise market terms for comparable services. Expenses to obtain benchmarking data will be borne by the Company, Other Clients and their respective portfolio companies and will not reduce the management fee. Finally, in certain circumstances Blackstone Credit &amp;amp; Insurance may determine that third party benchmarking is unnecessary, including in circumstances where the price for a particular good or service is mandated by law (e.g., title insurance in rate regulated states) or because in Blackstone Credit &amp;amp; Insurance&#x2019;s view no comparable service provider offering such good or service (or an insufficient number of comparable service providers for a reasonable comparison) exists or because Blackstone Credit &amp;amp; Insurance has access to adequate market data (including from third party clients of the Firm-affiliated service provider that is the subject of the benchmarking analysis) to make the determination without reference to third party benchmarking. For example, in certain circumstances a Firm-affiliated service provider or a portfolio company service provider could provide services to third parties, in which case if the rates charged to such third parties are consistent with the rates charged to the Company, Other Clients and their respective portfolio companies, then a separate benchmarking analysis of such rates is not expected to be prepared. Some of the services performed by Firm-affiliated service providers could also be performed by the Firm from time to time and vice versa. Fees paid by the Company or its portfolio companies to or value created in Firm affiliated service providers or vendors do not reduce the management fee. These conflicts related to Firm-affiliated service providers will not necessarily be resolved in favor of the Company, and shareholders might not be entitled to receive notice or disclosure of the occurrence of these conflicts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advisers and service providers, or their affiliates, often charge different rates, including below-market or no fee, or have different arrangements for different types of services. With respect to service providers, for example, the fee for a given type of work could vary depending on the complexity of the matter as well as the expertise required and demands placed on the service provider. Therefore, to the extent the types of services used by the Company and/or portfolio companies differ from those used by the Firm and its affiliates (including personnel), Blackstone Credit &amp;amp; Insurance and/or Blackstone or their respective affiliates (including personnel) potentially will pay different amounts or rates than those paid by the Company and/or portfolio companies. However, Blackstone Credit &amp;amp; Insurance and its affiliates have a longstanding practice of not entering into any arrangements with advisers or service providers that could provide for lower rates or discounts than those available to the Company, Other Clients and/or portfolio companies for the same services. Furthermore, it is possible that certain advisers and service providers will provide services exclusively to the Firm and its affiliates, including the Company, Other Clients and their portfolio companies, although such advisers and service providers would not be considered employees of Blackstone or Blackstone Credit &amp;amp; Insurance. Similarly, Blackstone, Blackstone Credit &amp;amp; Insurance, each of their respective affiliates, the Company, the Other Clients and/or their portfolio companies, can enter into agreements or other arrangements with vendors and other similar counterparties (whether such counterparties are affiliated or unaffiliated with the Firm) from time to time whereby such counterparty would charge lower rates (or no fee) and/or provide discounts or rebates for such counterparty&#x2019;s products and/or services depending on certain factors, including volume of transactions entered into with such counterparty by the Firm, its affiliates, the Company, the Other Clients and their portfolio companies in the aggregate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, investment banks or other financial institutions, as well as certain Blackstone employees, are expected to also be investors in the Company. These institutions and employees are a potential source of information and ideas that could benefit the Company. Blackstone has procedures in place reasonably designed to prevent the inappropriate use of such information by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transactions with Portfolio Companies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Firm and portfolio companies of the Company and Other Clients operate in multiple industries and provide products and services to or otherwise contract with the Company and its portfolio companies, among others. In the alternative, the Firm could form a joint venture with such a company to implement such referral arrangement. For example, such arrangements could include the establishment of a joint venture or other business arrangement between the Firm, on the one hand, and a portfolio company of the Company, portfolio company of an Other Client or third party, on the other hand, pursuant to which the joint venture or business provides services (including, without limitation, corporate support services, loan management services, management services, operational services, ongoing account services (e.g., interacting and coordinating with banks generally and with regard to their know your client requirements), risk management services, data management services, consulting services, brokerage services, sustainability and clean energy consulting services, insurance procurement, placement, brokerage and consulting services, and other services) to portfolio companies of the Company (and portfolio companies of Other Clients) that are referred to the joint venture or business by the Firm. The Firm, the Company and Other Clients and their respective portfolio companies and personnel and related parties of the foregoing can be expected to make referrals or introductions to the Company or portfolio companies of the Company or Other Clients in an effort, in part, to increase the customer base of such companies or businesses (and therefore the value of the investment held by the Company or Other Client, which would also benefit the Firm financially through its participation in such joint venture or business) or because such referrals or introductions will, in certain circumstances, result in financial benefits, such as cash payments, additional equity ownership, participation in revenue share and/or milestones benefiting the referring or introducing party that are tied or related to participation by the portfolio companies of the Company and/or of Other Clients, accruing to the party making the introduction. Such joint venture or business could use data obtained from such portfolio companies (see&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Data&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;elsewhere herein). Furthermore, such introductions or referrals could involve the transfer of certain personnel or employees among Blackstone and the Company&#x2019;s portfolio companies and Other Clients which might result in a termination fee or similar payments being due and payable from one such entity to another. The Company and the shareholders typically will not share in any fees, economics, equity or other benefits accruing to the Firm, Other Clients and their portfolio companies as a result of the introduction of the Company and its portfolio companies. Moreover, payments made to the Firm in connection with such arrangements will not reduce the management fee payable to the Adviser. There could, however, be instances in which the applicable arrangements provide that the Company or its portfolio companies share in some or all of any resulting financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) based on structures and allocation methodologies determined in the sole discretion of the Firm. Conversely, where the Company or one of its portfolio companies is the referring or introducing party, rather than receiving all of the financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) for similar types of referrals and/or introductions, such financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) could be similarly shared with the participating Other Clients or their respective portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Firm is also permitted to enter into commercial relationships with third party companies, including those in which the Company considered making an investment (but ultimately chose not to pursue). For example, the Firm could enter into an introducer engagement with such company, pursuant to which the Firm introduces the company to unaffiliated third parties (which can include current and former portfolio companies and portfolio companies of Other Clients and/or their respective employees) in exchange for a fee from, or equity interest in, such company. Even though the Firm could benefit financially from this commercial relationship, the Firm will be under no obligation to reimburse the Company for Broken Deal Expenses incurred in connection with its consideration of the prospective investment and such arrangements will not be subject to the management fee payable to the Adviser and otherwise described herein.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, the Firm or an affiliate thereof will from time to time hold equity or other investments in companies or businesses (even if they are not &#x201c;affiliates&#x201d; of the Firm) that provide services to or otherwise contract with portfolio companies. Blackstone and Blackstone Credit &amp;amp; Insurance have in the past entered (and can be expected in the future to enter) into relationships with companies in the information technology, corporate services and related industries whereby Blackstone acquires an equity or similar interest in such company. In connection with such relationships, Blackstone and/or Blackstone Credit &amp;amp; Insurance reserves the right to also make referrals and/or introductions to portfolio companies (which could result in financial incentives (including additional equity ownership) and/or milestones benefitting Blackstone and/or Blackstone Credit &amp;amp; Insurance that are tied or related to participation by portfolio companies). Such joint venture or business could use data obtained from portfolio companies of the Company and/or portfolio companies of Other Clients. These arrangements are expected to be entered into without the consent or direct involvement of the Company. The Company and the shareholders will not share in any fees or economics accruing to Blackstone and/or Blackstone Credit &amp;amp; Insurance as a result of these relationships and/or participation by portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to transactions or agreements with portfolio companies (including, for the avoidance of doubt, long-term incentive plans), at times if officers unrelated to the Firm have not yet been appointed to represent a portfolio company, the Firm is permitted to negotiate and execute agreements between the Firm and/or the Company on the one hand, and the portfolio company or its affiliates, on the other hand, without arm&#x2019;s length representation of the portfolio company, which could entail a conflict of interest in relation to efforts to enter into terms that are arm&#x2019;s length. Among the measures the Firm can be expected to use to mitigate such conflicts are to involve outside counsel to review and advise on such agreements and provide insights into commercially reasonable terms, or establish separate groups with information barriers within the Firm to advise on each side of the negotiation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Leasing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Subject to applicable law, the Company and its portfolio companies may lease property to or from Blackstone, Other Clients and their portfolio companies and affiliates and other related parties. The leases are generally expected to, but might not always, be at market rates. Blackstone can be expected to confirm market rates by reference to other leases it is aware of in the market, which Blackstone expects to be generally indicative of the market given the scale of Blackstone&#x2019;s real estate business. Blackstone can be expected to, but might not always, nonetheless have conflicts of interest in making these determinations, and with regard to other decisions related to such assets and investments. There can be no assurance that the Company and its portfolio companies will lease to or from any such related parties on terms as favorable to the Company and its portfolio companies as would apply if the counterparties were unrelated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross-Guarantees and Cross-Collateralization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. While Blackstone Credit &amp;amp; Insurance generally seeks to use reasonable efforts to avoid cross-guarantees and other similar arrangements, a counterparty, lender or other participant in any transaction to be pursued by the Company other than alternative investment vehicles and/or the Other Clients could require or prefer facing only one fund entity or group of entities, which can result in any of the Company, such Other Clients, the portfolio companies, such Other Clients&#x2019; portfolio companies and/or other vehicles being jointly and severally liable for such applicable obligation (subject to any limitations set forth in the applicable governing documents thereof), which in each case could result in the Company, such Other Clients, such portfolio companies and portfolio companies, and/or vehicles entering into a back-to-back or other similar reimbursement agreement, subject to applicable law. In such situation, better financing terms could be available through a cross-collateralized arrangement, but it is not expected that any of the Company or such Other Clients or vehicles would be compensated (or provide compensation to the other) for being primarily liable vis-&#xe0;-vis such third party counterparty. Also, it is expected that cross-collateralization will generally occur at portfolio companies rather than the Company for obligations that are not recourse to the Company except in limited circumstances such as &#x201c;bad boy&#x201d; events. Any cross-collateralization arrangements with Other Clients could result in the Company losing its interests in otherwise performing investments due to poorly performing or non-performing investments of Other Clients in the collateral pool.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Similarly, a lender could require that it face only one portfolio company of the Company and Other Clients, even though multiple portfolio companies of the Company and Other Clients benefit from the lending, which will typically result in (i) the portfolio company facing the lender being solely liable with respect to the entire obligation, and therefore being required to contribute amounts in respect of the shortfall attributable to other portfolio companies, and (ii) portfolio companies of the Company and Other Clients being jointly and severally liable for the full amount of the obligation, liable on a cross-collateralized basis or liable for an equity cushion (which cushion amount can vary depending upon the type of financing or refinancing (e.g., cushions for refinancings could be smaller)). The portfolio companies of the Company and Other Clients benefiting from a financing may enter into a back-to-back or other similar reimbursement agreements whereby each agrees that no portfolio company bears more than its &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;pro rata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; portion of the debt and related obligations. It is not expected that the portfolio companies would be compensated (or provide compensation to other portfolio companies) for being primarily liable, or jointly liable, for other portfolio companies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;pro rata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; share of any financing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint Venture Partners&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company will from time to time enter into one or more joint venture arrangements with third party joint venture partners. Investments made with joint venture partners will often involve performance-based compensation and other fees payable to such joint venture partners, as determined by the Adviser in its sole discretion. The joint venture partners could provide services similar to those provided by the Adviser to the Company. Yet, no compensation or fees paid to the joint venture partners would reduce the management fees payable by the Company. Additional conflicts would arise if a joint venture partner is related to the Firm in any way, such as a limited partner investor in, lender to, a shareholder of, or a service provider to the Firm, the Company, Other Clients, or their respective portfolio companies, or any affiliate, personnel, officer or agent of any of the foregoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Group Procurement; Discounts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company, subject to applicable law, and certain portfolio companies will enter into agreements regarding group procurement (including, but not limited to, CoreTrust, an independent group purchasing organization), benefits management, purchase of title and/or other insurance policies (which can be expected to include brokerage and/or placement thereof, and will from time to time be pooled across portfolio companies and discounted due to scale, including through sharing of deductibles and other forms of shared risk retention) from a third party or an affiliate of Blackstone Credit &amp;amp; Insurance and/or Blackstone, and other operational, administrative or management related initiatives. The Firm will allocate the cost of these various services and products purchased on a group basis among the Company, Other Clients and their portfolio companies. Some of these arrangements result in commissions, discounts, rebates or similar payments to Blackstone Credit &amp;amp; Insurance and/or Blackstone or their affiliates (including personnel), or Other Clients and their portfolio companies, including as a result of transactions entered into by the Company and its portfolio companies and/or related to a portion of the savings achieved by the portfolio companies. Such commissions or payment will not reduce the management fee. The Firm can be expected to also receive consulting, usage or other fees from the parties to these group procurement arrangements. To the extent that a portfolio company of an Other Client is providing such a service, such portfolio company and such Other Client will benefit. Further, the benefits received by a particular portfolio company providing the service could be greater than those received by the Company and its portfolio companies receiving the service. Conflicts exist in the allocation of the costs and benefits of these arrangements, and shareholders rely on the Adviser to handle them in its sole discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Diverse Shareholder Group&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s shareholders are expected to be based in a wide variety of jurisdictions and take a wide variety of forms. The shareholders may have conflicting investment, tax and other interests with respect to their investments in the Company and with respect to the interests of investors in other investment vehicles managed or advised by the Adviser and Blackstone Credit &amp;amp; Insurance that may participate in the same investments as the Company. The conflicting interests of individual shareholders with respect to other shareholders and relative to investors in other investment vehicles would generally relate to or arise from, among other things, the nature of investments made by the Company and such other partnerships, the structuring or the acquisition of investments and the timing of disposition of investments. As a consequence, conflicts of interest may arise in connection with the decisions made by the Adviser or Blackstone Credit &amp;amp; Insurance, including with respect to the nature or structuring of investments that may be more beneficial for one investor than for another investor, especially with respect to investors&#x2019; individual tax situations. In addition, the Company may make investments that may have a negative impact on related investments made by the shareholders in separate transactions, such as credit investments that, by consequence of the exercise of remedies related to such investments, adversely impact equity-like investments in respect of those same issuers. In selecting and structuring investments appropriate for the Company, the Adviser or Blackstone Credit &amp;amp; Insurance will consider the investment and tax objectives of the Company and the shareholders (and those of investors in other investment vehicles managed or advised by the Adviser or Blackstone Credit &amp;amp; Insurance) as a whole, not the investment, tax or other objectives of any shareholder individually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, certain shareholders also may be investors in Other Clients, including supplemental capital vehicles and co-investment vehicles that invest alongside the Company in one or more investments, consistent with applicable law and/or any applicable SEC-granted order. Shareholders also might include affiliates of the Firm, such as Other Clients, affiliates of portfolio companies of the Company or Other Clients, charities, foundations or other entities or programs associated with Firm personnel and/or current or former Firm employees, the Firm&#x2019;s senior advisors and/or operating partners and any affiliates, funds or persons may also invest in the Company through the vehicles established in connection with the Firm&#x2019;s side-by-side co-investment rights, subject to applicable law, in each case, without being subject to management fees, and shareholders will not be afforded the benefits of such arrangements. Some of the foregoing Firm related parties are sponsors of feeder vehicles that could invest in the Company as shareholders. The Firm related sponsors of feeder vehicles generally charge their investors additional fees, including performance based fees, which could provide the Firm current income and increase the value of its ownership position in them. The Firm will therefore have incentives to refer potential investors to these feeder vehicles. All of these Firm related shareholders will have equivalent rights to vote and withhold consents as nonrelated shareholders. Nonetheless, the Firm could have the ability to influence, directly or indirectly, these Firm related shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is also possible that the Company or its portfolio companies will be a counterparty (such counterparties dealt with on an arm&#x2019;s-length basis) or participant in agreements, transactions or other arrangements with a shareholder or an affiliate of a shareholder. Such transactions may include agreements to pay performance fees to operating partners, a management team and other related persons in connection with the Company&#x2019;s investment therein, which will reduce the Company&#x2019;s returns. Such shareholders described in the previous sentences may therefore have different information about the Firm and the Company than shareholders not similarly positioned. In addition, conflicts of interest may arise in dealing with any such shareholders, and the Adviser and its affiliates may not be motivated to act solely in accordance with its interests relating to the Company. Similar information disparity may occur as a result of shareholders monitoring their investments in vehicles such as the Company differently. For example, certain shareholders may periodically request from the Adviser information regarding the Company, its investments and/or portfolio companies that is not otherwise set forth in (or has yet to be set forth) in the reporting and other information required to be delivered to all shareholders. In such circumstances, the Adviser may provide such information to such shareholders, subject to applicable law and regulations. Unless required by applicable law, the Adviser will not be obligated to affirmatively provide such information to all shareholders (although the Adviser will generally provide the same information upon request and treat shareholders equally in that regard). As a result, certain shareholders may have more information about the Company than other shareholders, and, unless required by applicable law, the Adviser will have no duty to ensure all shareholders seek, obtain or process the same information regarding the Company, its investments and/or portfolio companies. Therefore, certain shareholders may be able to take actions on the basis of such information which, in the absence of such information, other shareholders do not take. Furthermore, at certain times the Firm may be restricted from disclosing to the shareholders material non-public information regarding any assets in which the Company invests, particularly those investments in which an Other Client or portfolio company that is publicly registered co-invests with the Company. In addition, investment banks or other financial institutions, as well as Firm personnel, may also be shareholders. These institutions and personnel are a potential source of information and ideas that could benefit the Company, and may receive information about the Company and its portfolio companies in their capacity as a service provider or vendor to the Company and its portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Possible Future Activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Firm and its affiliates are expected to expand the range of services that it provides over time. Except as provided herein, the Firm and its affiliates will not be restricted in the scope of its business or in the performance of any such services (whether now offered or undertaken in the future) even if such activities could give rise to conflicts of interest, and whether or not such conflicts are described herein. The Firm and its affiliates have, and will continue to develop, relationships with a significant number of companies, financial sponsors and their senior managers, including relationships with clients who might hold or might have held investments similar to those intended to be made by the Company. These clients could themselves represent appropriate investment opportunities for the Company or could compete with the Company for investment opportunities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restrictions Arising under the Securities Laws&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Firm&#x2019;s activities and the activities of Other Clients (including the holding of securities positions or having one of its employees on the board of directors of a portfolio company) could result in securities law restrictions on transactions in securities held by the Company, affect the prices of such securities or the ability of such entities to purchase, retain or dispose of such investments, or otherwise create conflicts of interest, any of which could have an adverse impact on the performance of the Company and thus the return to the shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 1940 Act may limit the Company&#x2019;s ability to undertake certain transactions with or alongside its affiliates that are registered under the 1940 Act. As a result of these restrictions, the Company may be prohibited from executing &#x201c;joint&#x201d; transactions with the Company&#x2019;s 1940 Act registered affiliates, which could include investments in the same portfolio company (whether at the same or different times) or buying investments from, or selling them to, Other Clients. These limitations have the potential to limit the scope of investment opportunities that would otherwise be available to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shareholders&#x2019; Outside Activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. A shareholder shall be entitled to and can be expected to have business interests and engage in activities in addition to those relating to the Company, including business interests and activities in direct competition with the Company and its portfolio companies, and can engage in transactions with, and provide services to, the Company or its portfolio companies (which will, in certain circumstances, include providing leverage or other financing to the Company or its portfolio companies as determined by the Adviser in its sole discretion). None of the Company, any shareholder or any other person shall have any rights by virtue of the Company&#x2019;s operative documents or any related agreements in any business ventures of any shareholder. The shareholder, and in certain cases the Adviser, will have conflicting loyalties in these situations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Insurance. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser will cause the Company to purchase, and/or bear premiums, fees, costs and expenses (including any expenses or fees of insurance brokers) for insurance to insure the Company and the Board of Trustees against liability in connection with the activities of the Company. This includes a portion of any premiums, fees, costs and expenses for one or more &#x201c;umbrella,&#x201d; group or other insurance policies maintained by the Firm that cover the Company and one or more of the Other Clients, the Adviser, Blackstone Credit &amp;amp; Insurance and/or Blackstone (including their respective directors, officers, employees, agents, representatives, independent client representative (if any) and other indemnified parties). The Adviser will make judgments about the allocation of premiums, fees, costs and expenses for such &#x201c;umbrella,&#x201d; group or other insurance policies among the Company, one or more Other Clients, the Adviser, Blackstone Credit &amp;amp; Insurance and/or Blackstone on a fair and reasonable basis, subject to approval by the Board of Trustees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Technological and Scientific Innovations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Recent technological and scientific innovations have disrupted numerous established industries and those with incumbent power in them.&#160;As technological and scientific innovation continues to advance rapidly, it could impact one or more of the Company&#x2019;s strategies.&#160;Moreover, given the pace of innovation in recent years, the impact on a particular portfolio company might not have been foreseeable at the time the Company made such investment and could adversely impact the Company and/or its portfolio companies. Furthermore, Blackstone Credit &amp;amp; Insurance could base investment decisions on views about the direction or degree of innovation that prove inaccurate and lead to losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Additional Potential Conflicts of Interest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The officers, directors, members, managers, employees and personnel of the Adviser may trade in securities for their own accounts, subject to restrictions and reporting requirements as may be required by law or the Firm&#x2019;s policies, or otherwise determined from time to time by the Adviser. In addition, certain Other Clients may be subject to the 1940 Act or other regulations that, due to the role of the Firm, could restrict the ability of the Company to buy investments from, to sell investments to or to invest in the same securities as, such Other Clients. Such regulations may have the effect of limiting the investment opportunities available to the Company. In addition, as a consequence of Blackstone&#x2019;s status as a public company, the officers, directors, members, managers and personnel of the Adviser may take into account certain considerations and other factors in connection with the management of the business and affairs of the Company and its affiliates that would not necessarily be taken into account if Blackstone were not a public company. The directors of Blackstone have fiduciary duties to shareholders of the public company that may conflict with their duties to the Company. Finally, although the Firm believes its positive reputation in the marketplace provides benefit to the Company and Other Clients, the Adviser could decline to undertake investment activity or transact with a counterparty on behalf of the Company for reputational reasons, and this decision could result in the Company foregoing a profit or suffering a loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our liquidity and capital resources are generated primarily from cash flows from interest, dividends and fees earned from our investments and principal repayments, our credit facilities, debt securitization transactions, and other secured and unsecured debt. We may also generate cash flow from operations, future borrowings and future offerings of securities including public and/or private issuances of debt and/or equity securities through both registered offerings and private offerings. The primary uses of our cash and cash equivalents are for (i) originating loans and purchasing senior secured debt investments, (ii) funding the costs of our operations (including fees paid to our Adviser and expense reimbursements paid to our Administrator), (iii) debt service, repayment and other financing costs of our borrowings and (iv) cash distributions to the holders of our shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To&#160;facilitate public issuances of debt and/or equity securities, in July 2022, we filed a shelf registration statement with the SEC that is effective for a term of three years and expires in July 2025. The amount of securities to be issued pursuant to the shelf registration statement filed in July 2022 was not specified when it was filed and there is no specific dollar limit on the amount of securities we may issue. The securities covered by the registration statement filed in July 2022 include: (i) common shares; (ii) preferred shares; (iii) debt securities; (iv) subscription rights; and (v) warrants. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of any offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and December&#160;31, 2022, our debt consisted of asset based leverage facilities, a revolving credit facility, and unsecured note issuances. We may from time to time enter into additional credit facilities, increase the size of our existing credit facilities or issue further debt securities. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors. In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. As of December&#160;31, 2023 and December&#160;31, 2022, we had an aggregate amount of $4,937.9 million and $5,563.0 million of senior securities outstanding, respectively, and our asset coverage ratio was 200.3% and 174.8%, respectively. We seek to carefully consider our unfunded commitments for the purpose of planning our ongoing financial leverage. Further, we maintain sufficient borrowing capacity within the 150% asset coverage limitation to cover any outstanding unfunded commitments we are required to fund. From time to time we may also repurchase our outstanding debt. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, and other factors. The amounts involved in any such purchase transactions, individually or in the aggregate, may be material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents as of December&#160;31, 2023, taken together with our $1,662.1 million of unused capacity under our credit facilities (subject to borrowing base availability, $1,662.0 million is available to borrow) is expected to be sufficient for our investing activities and to conduct our operations in the near term. Additionally, we held $157.9 million of Level 2 debt investments as of December&#160;31, 2023, which could provide additional liquidity if necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although we have historically been able to obtain sufficient borrowing capacity, a deterioration in economic conditions or any other negative economic developments could restrict our access to financing in the future. We may not be able to find new financing for future investments or liquidity needs and, even if we are able to obtain such financing, such financing may not be on as favorable terms as we have previously obtained. These factors may limit our ability to make new investments and adversely impact our results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, we had &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$154.9 million in cash and cash equivalents. During the year ended December&#160;31, 2023, cash provided by operating activities was $458.8 million, primarily from receipt of interest payments from our investments, partially offset by purchases of investments, net of sales of investments and principal repayments, of $178.1 million.&#160;Cash used in financing activities was $432.2 million during the year, which was primarily as a result of net repayments on our credit facilities and Unsecured Notes of $650.9 million and dividends paid in cash of $438.0 million partially offset by $665.3 million of proceeds from the issuance of our common shares.&lt;/span&gt;&lt;/div&gt;</cef:RiskFactorsTableTextBlock>
    <cef:RiskTextBlock contextRef="c-7" id="f-41">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Price declines in the medium- and large-sized U.S. corporate debt market may adversely affect the fair value of our portfolio, reducing our NAV through increased net unrealized depreciation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Conditions in the medium- and large-sized U.S. corporate debt market may deteriorate, as seen during the recent financial crisis, which may cause pricing levels to similarly decline or be volatile. During the 2008-2009 financial crisis, many institutions were forced to raise cash by selling their interests in performing assets in order to satisfy margin requirements or the equivalent of margin requirements imposed by their lenders and/or, in the case of hedge funds and other investment vehicles, to satisfy widespread redemption requests. This resulted in a forced deleveraging cycle of price declines, compulsory sales, and further price declines, with falling underlying credit values, and other constraints resulting from the credit crisis generating further selling pressure. If similar events occurred in the medium- and large-sized U.S. corporate debt market, our NAV could decline through an increase in unrealized depreciation and incurrence of realized losses in connection with the sale of our investments, which could have a material adverse impact on our business, financial condition and results of operations and the market price of our shares.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-8" id="f-42">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our ability to achieve our investment objectives depends on the ability of the Adviser to manage and support our investment process. If the Adviser or Blackstone Credit &amp;amp; Insurance were to lose any members of their respective senior management teams, our ability to achieve our investment objectives could be significantly harmed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since we have no employees, we depend on the investment expertise, skill and network of business contacts of the broader networks of the Adviser and its affiliates. The Adviser evaluates, negotiates, structures, executes, monitors and services our investments. Our future success depends to a significant extent on the continued service and coordination of Blackstone Credit &amp;amp; Insurance and its senior management team. The departure of any members of Blackstone Credit &amp;amp; Insurance&#x2019;s senior management team could have a material adverse effect on our ability to achieve our investment objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our ability to achieve our investment objectives depends on the Adviser&#x2019;s ability to identify and analyze, and to invest in, finance and monitor companies that meet our investment criteria. The Adviser&#x2019;s capabilities in structuring the investment process, providing competent, attentive and efficient services to us, and facilitating access to financing on acceptable terms depend on the employment of investment professionals in an adequate number and of adequate sophistication to match the corresponding flow of transactions. To achieve our investment objectives, the Adviser may need to hire, train, supervise and manage new investment professionals to participate in our investment selection and monitoring process. The Adviser may not be able to find investment professionals in a timely manner or at all. Failure to support our investment process could have a material adverse effect on our business, financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;The Investment Advisory Agreement has been approved pursuant to Section 15 of the 1940 Act. In addition, the Investment Advisory Agreement has termination provisions that allow the parties to terminate the agreement. The Investment Advisory Agreement may be terminated at any time, without penalty, by us or by the Adviser, upon 60 days&#x2019; written notice. If the Investment Advisory Agreement is terminated, it may adversely affect the quality of our investment opportunities. In addition, in the event the Investment Advisory Agreement is terminated, it may be difficult for us to replace the Adviser.</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-9" id="f-43">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Because our business model depends to a significant extent upon relationships with private equity sponsors, investment banks and commercial banks, the inability of the Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser depends on its broader organization&#x2019;s relationships with private equity sponsors, investment banks and commercial banks, and we rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the Adviser or its broader organization fail to maintain their existing relationships or develop new relationships with other sponsors or sources of investment opportunities, we may not be able to grow our investment portfolio. In addition, individuals with whom the Adviser or its broader organizations have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-10" id="f-44">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may face increasing competition for investment opportunities, which could delay deployment of our capital, reduce returns and result in losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We compete for investments with other BDCs and investment funds (including private equity funds, mezzanine funds, performing and other credit funds, and funds that invest in CLOs, structured notes, derivatives and other types of collateralized securities and structured products), as well as traditional financial services companies such as commercial banks and other sources of funding. These other BDCs and investment funds might be reasonable investment alternatives to us and may be less costly or complex with fewer and/or different risks than we have. Moreover, alternative investment vehicles, such as hedge funds, have begun to invest in areas in which they have not traditionally invested, including making investments in U.S. private companies. As a result of these new competitors entering the financing markets in which we operate, competition for investment opportunities in U.S. private companies may intensify. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of capital and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have. These characteristics could allow our competitors to consider a wider variety of investments, establish more relationships and offer better pricing and more flexible structuring than we are able to do. We may lose investment opportunities if we do not match our competitors&#x2019; pricing, terms or structure. If we are forced to match our competitors&#x2019; pricing, terms or structure, we may not be able to achieve acceptable returns on our investments or may bear substantial risk of capital loss. A significant part of our competitive advantage stems from the fact that the market for investments in U.S. private companies is underserved by traditional commercial banks and other financial sources. A significant increase in the number and/or the size of our competitors in this target market could force us to accept less attractive investment terms. Furthermore, many of our competitors have greater experience operating under, or are not subject to, the regulatory restrictions that the 1940 Act imposes on us as a BDC.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-11" id="f-45">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may have difficulty sourcing investment opportunities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We cannot assure investors that we will be able to locate a sufficient number of suitable investment opportunities to allow us to deploy all available capital successfully. In addition, privately-negotiated investments in loans and illiquid securities of private middle market companies require substantial due diligence and structuring, and we cannot assure investors that we will achieve our anticipated investment pace. As a result, investors will be unable to evaluate any future portfolio company investments prior to purchasing our shares. Our shareholders will have no input with respect to investment decisions. These factors increase the uncertainty, and thus the risk, of investing in our shares. To the extent we are unable to deploy all available capital, our investment income and, in turn, our results of operations, will likely be materially adversely affected.&#160;There is no assurance that we will be able to consummate investment transactions or that such transactions will be successful.&#160;Blackstone Credit &amp;amp; Insurance, the Company and their affiliates may also face certain conflicts of interests in connection with any transaction, including any warehousing transaction, involving an affiliate.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-12" id="f-46">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We face risks associated with the deployment of our capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In light of the nature of our periodic public offerings in relation to our investment strategy and the need to be able to deploy potentially large amounts of capital quickly to capitalize on potential investment opportunities, if we have difficulty identifying suitable investments on attractive terms, there could be a delay between the time we receive net proceeds from the sale of shares of our Common Shares in any periodic public offering and the time we invest the net proceeds. Our proportion of privately-negotiated investments may be lower than expected. We may also from time to time hold cash pending deployment into investments or have less than our targeted leverage, which cash or shortfall in target leverage may at times be significant, particularly at times when we are receiving high amounts of offering proceeds and/or times when there are few attractive investment opportunities. Such cash may be held in an account for the benefit of our shareholders that may be invested in money market accounts or other similar temporary investments, each of which is subject to management fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event we are unable to find suitable investments such cash may be maintained for longer periods which would be dilutive to overall investment returns. This could cause a substantial delay in the time it takes for your investment to realize its full potential return and could adversely affect our ability to pay regular distributions of cash flow from operations to you. It is not anticipated that the temporary investment of such cash into money market accounts or other similar temporary investments pending deployment into investments will generate significant interest, and investors should understand that such low interest payments on the temporarily invested cash may adversely affect overall returns. In the event we fail to timely invest the net proceeds of sales of our Common Shares or do not deploy sufficient capital to meet our targeted leverage, our results of operations and financial condition may be adversely affected.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-13" id="f-47">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;As required by the 1940 Act, a significant portion of our investment portfolio is and will be recorded at fair value as determined in good faith and, as a result, there is and will be uncertainty as to the value of our portfolio investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 1940 Act, we are required to carry our portfolio investments at market value or, if there is no readily available market value, at fair value as determined pursuant to policies adopted by, and subject to the oversight of, our Board. There is not a public market for the securities of the privately-held companies in which we invest. Many of our investments are not publicly-traded or actively traded on a secondary market. As a result, we value these securities quarterly at fair value as determined in good faith as required by the 1940 Act. In connection with striking a NAV as of a date other than quarter end for share issuances and repurchases, the Company will consider whether there has been a material change to such investments as to affect their fair value, but such analysis will be more limited than the quarter end process.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of our valuation process, we will take into account relevant factors in determining the fair value of the Company&#x2019;s investments, without market quotations, many of which are loans, including and in combination, as relevant: (i) the estimated enterprise value of a portfolio company, (ii) the nature and realizable value of any collateral, (iii) the portfolio company&#x2019;s ability to make payments based on its earnings and cash flow, (iv) the markets in which the portfolio company does business, (v) a comparison of the portfolio company&#x2019;s securities to any similar publicly traded securities, and (vi) overall changes in the interest rate environment and the credit markets that may affect the price at which similar investments may be made in the future. Our determinations of fair value may differ materially from the values that would have been used if a ready market for these non-traded securities existed. Due to this uncertainty, our fair value determinations may cause our NAV on a given date to materially differ from the value that we may ultimately realize upon the sale of one or more of our investments.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-14" id="f-48">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;There is a risk that investors in our shares may not receive distributions or that our distributions may decrease over time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may not achieve investment results that will allow us to make a specified or stable level of cash distributions and our distributions may decrease over time. In addition, due to the asset coverage test applicable to us as a BDC, we may be limited in our ability to make distributions.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-15" id="f-49">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The amount of any distributions we may make is uncertain. Our distributions may exceed our earnings, particularly during the period before we have substantially invested the net proceeds from any securities offering. Therefore, portions of the distributions that we make may represent a return of capital to a shareholder that will lower such shareholder&#x2019;s tax basis in its shares and reduce the amount of funds we have for investment in targeted assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may fund our cash distributions to shareholders from any sources of funds available to us, including offering proceeds, borrowings, net investment income from operations, capital gains proceeds from the sale of assets, non-capital gains proceeds from the sale of assets, dividends or other distributions paid to us on account of preferred and common equity investments in portfolio companies and fee and expense reimbursement waivers from the Adviser or the Administrator, if any. Our ability to pay distributions, if any, might be adversely affected by, among other things, the impact of one or more of the risk factors described in this annual report. In addition, the inability to satisfy the asset coverage test applicable to us as a BDC may limit our ability to pay distributions. All distributions are and will be paid at the discretion of our Board and will depend on our earnings, our financial condition, maintenance of our RIC status, compliance with applicable BDC regulations and such other factors as our Board may deem relevant from time to time. We cannot assure shareholders that we will continue to pay distributions to our shareholders in the future. In the event that we encounter delays in locating suitable investment opportunities, we may pay all or a substantial portion of our distributions from the proceeds of our prior offerings or from borrowings or sources other than cash flow from operations in anticipation of future cash flow, which may constitute a return of shareholders&#x2019; capital. A return of capital is a return of a shareholder&#x2019;s investment, rather than a return of earnings or gains derived from our investment activities. A shareholder will not be subject to immediate taxation on the amount of any distribution treated as a return of capital to the extent of the shareholder&#x2019;s basis in its shares; however, the shareholder&#x2019;s basis in its shares will be reduced (but not below zero) by the amount of the return of capital, which will result in the shareholder recognizing additional gain (or a lower loss) when the shares are sold. To the extent that the amount of the return of capital exceeds the shareholder&#x2019;s basis in its shares, such excess amount will be treated as gain from the sale of the shareholder&#x2019;s shares. Distributions from the proceeds of our prior offerings or from borrowings also could reduce the amount of capital we ultimately invest in our portfolio companies.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-16" id="f-50">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We have not established any limit on the amount of funds we may use from available sources, such as borrowings, if any, or proceeds from securities offerings, to fund distributions (which may reduce the amount of capital we ultimately invest in assets).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any distributions made from sources other than cash flow from operations or relying on fee or expense reimbursement waivers, if any, from the Adviser or the Administrator are not based on our investment performance, and can only be sustained if we achieve positive investment performance in future periods and/or the Adviser or the Administrator continues to make such expense reimbursements, if any. The extent to which we pay distributions from sources other than cash flow from operations will depend on various factors, including the level of participation in our dividend reinvestment plan, how quickly we invest the proceeds from this and any future offering and the performance of our investments. Shareholders should also understand that our future repayments to the Adviser will reduce the distributions that they would otherwise receive. There can be no assurance that we will achieve such performance in order to sustain these distributions, or be able to pay distributions at all. The Adviser and the Administrator have no obligation to waive fees or receipt of expense reimbursements, if any.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-17" id="f-51">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;As a public reporting company, we are subject to regulations not applicable to private companies, such as provisions of the Sarbanes-Oxley Act. Efforts to comply with such regulations will involve significant expenditures, and non-compliance with such regulations may adversely affect us.&lt;/span&gt;&lt;/div&gt;As a public reporting company, we are subject to the Sarbanes-Oxley Act, and the related rules and regulations promulgated by the SEC. Our management is required to report on our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. We are required to review on an annual basis our internal control over financial reporting, and on a quarterly and annual basis to evaluate and disclose changes in our internal control over financial reporting. Developing and maintaining an effective system of internal controls may require significant expenditures, which may negatively impact our financial performance and our ability to make distributions. This process also will result in a diversion of our management&#x2019;s time and attention. We cannot be certain of when our evaluation, testing and remediation actions will be completed or the impact of the same on our operations. In addition, we may be unable to ensure that the process is effective or that our internal controls over financial reporting are or will be effective in a timely manner. In the event that we are unable to develop or maintain an effective system of internal controls and maintain or achieve compliance with the Sarbanes-Oxley Act and related rules, we may be adversely affected.</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-18" id="f-52">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Changes in laws or regulations governing our operations may adversely affect our business or cause us to alter our business strategy. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We, our portfolio companies and other counterparties are subject to regulation at the local, state and federal level. New legislation may be enacted or new interpretations, rulings or regulations could be adopted, including those governing the types of investments we are permitted to make, any of which could harm us and our shareholders, potentially with retroactive effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;President Biden may support an enhanced regulatory agenda that imposes greater costs on all sectors and on financial services companies in particular. In addition, uncertainty regarding legislation and regulations affecting the financial services industry or taxation could also adversely impact our business or the business of our portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, any changes to or repeal of the laws and regulations governing our operations relating to permitted investments may cause us to alter our investment strategy to avail ourselves of new or different opportunities. Such changes could result in material differences to our strategies and plans as set forth in this annual report and may result in our investment focus shifting from the areas of expertise of the Adviser to other types of investments in which the Adviser may have less expertise or little or no experience. Thus, any such changes, if they occur, could have a material adverse effect on our financial condition and results of operations and the value of a shareholder&#x2019;s investment.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-19" id="f-53">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial regulatory changes in the United States could adversely affect our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial services industry continues to be the subject of heightened regulatory scrutiny in the United States. There has been active debate over the appropriate extent of regulation and oversight of investment funds and their managers. We may be adversely affected as a result of new or revised regulations imposed by the SEC or other U.S. governmental regulatory authorities or self-regulatory organizations that supervise the financial markets. We also may be adversely affected by changes in the interpretation or enforcement of existing laws and regulations by these governmental authorities and self-regulatory organizations. Further, new regulations or interpretations of existing laws may result in enhanced disclosure obligations, including with respect to climate change or environmental, social and governance factors, which could negatively affect us and materially increase our regulatory burden. Increased regulations generally increase our costs, and we could continue to experience higher costs if new laws require us to spend more time or buy new technology to comply effectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any changes in the regulatory framework applicable to our business, including the changes described above, may impose additional compliance and other costs, increase regulatory investigations of the investment activities of our funds, require the attention of our senior management, affect the manner in which we conduct our business and adversely affect our profitability. The full extent of the impact on us of any new laws, regulations or initiatives that may be proposed is impossible to determine.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-20" id="f-54">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We, the Adviser and its affiliates are subject to regulatory oversight, which could negatively impact our operations, cash flow or financial condition, impose additional costs on us or otherwise adversely affect our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our business and the businesses of the Adviser and its affiliates are subject to&#160;extensive regulation, including periodic examinations, inquiries and investigations which may result in enforcement and other proceedings, by governmental agencies&#160;and self-regulatory organizations in the jurisdictions in which we and they operate around the world, including the SEC and various other U.S. federal, state&#160;and local agencies. These&#160;authorities have regulatory powers dealing with many aspects of financial services, including the authority to&#160;grant, and in specific circumstances to cancel, permissions to carry on particular activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We, the Adviser and its respective affiliates have received, and may in the future receive, requests for information, inquiries and informal or formal investigations or subpoenas from such regulators from time to time in connection with such inquiries and proceedings and otherwise in the ordinary course of business. These requests could relate to a broad range of matters, including specific practices of our business, the Adviser, our investments or other investments the Adviser or its affiliates make on behalf of their clients, potential conflicts of interest between us and the Adviser or its affiliates, or industry wide practices. SEC actions and initiatives can have an adverse effect on our financial results,&#160;including as a result of the imposition of a sanction, a limitation on our, Blackstone&#x2019;s or our personnel&#x2019;s&#160;activities, or changing our historic practices. Any adverse publicity relating to an investigation, proceeding or imposition of these sanctions could&#160;harm our or Blackstone&#x2019;s reputation and have an&#160;adverse effect on our future fundraising or operations. The costs of responding to legal or regulatory&#160;information requests, any increased reporting, registration and compliance requirements will be borne by us&#160;in the form of legal or other expenses, litigation, regulatory proceedings or penalties, may divert the attention of our management, may cause negative publicity that adversely affects investor sentiment, and may place us at a competitive disadvantage, including to the extent that we, the Adviser or any of its affiliates are required to disclose sensitive business information or alter business practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, efforts by the current administration or future administrations could have further impacts on our industry if previously enacted laws are amended or if new legislative or regulatory reforms are adopted. In addition, a future change in administration may lead to leadership changes at a number of U.S. federal regulatory agencies with oversight over the U.S. financial services industry. Such changes would pose uncertainty with respect to such agencies&#x2019; ongoing policy priorities and could lead to increased regulatory enforcement activity in the financial services industry. Any changes or reforms may impose additional costs on our current or future investments, require the attention of senior management or result in other limitations on our business or investments. We are unable to predict at this time the likelihood or effect of any such changes or reforms.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-21" id="f-55">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The impact of financial reform legislation on us is uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In light of past market conditions in the U.S. and global financial markets, the U.S. and global economy, legislators, the presidential administration and regulators have increased their focus on the regulation of the financial services industry, including the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Dodd-Frank Act,&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which instituted a wide range of reforms that have impacted all financial institutions to varying degrees. Because these requirements are relatively new and evolving, the full impact such requirements will have on our business, results of operations or financial condition is unclear. While we cannot predict what effect any changes in the laws or regulations or their interpretations would have on us, these changes could be materially adverse to us and our shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any changes in the regulatory framework applicable to our business, including the changes described above, may impose additional compliance and other costs, increase regulatory investigations of the investment activities of our funds, require the attention of our senior management, affect the manner in which we conduct our business and adversely affect our profitability. The full extent of the impact on us of any new laws, regulations or initiatives that may be proposed is impossible to determine.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-22" id="f-56">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may experience fluctuations in our quarterly results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We could experience fluctuations in our quarterly operating results due to a number of factors, including our ability or inability to make investments in companies that meet our investment criteria, the interest rate payable on the loans or other debt securities we originate or acquire, the level of our expenses (including our borrowing costs), variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our markets and general economic conditions. As a result of these factors, results for any previous period should not be relied upon as being indicative of performance in future periods.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-23" id="f-57">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transactions denominated in foreign currencies subject us to foreign currency risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hold assets and have made borrowings denominated in foreign currencies and may acquire assets or make borrowings denominated in other foreign currencies, which exposes us to foreign currency risk. As a result, a change in foreign currency exchange rates may have an adverse impact on the valuation of our assets or liabilities, as well as our income and cash flows. As a result of foreign currency fluctuations, the value of our liabilities and expenses may increase or the value of our assets and income may decrease due to factors outside of our control, which can have a negative effect on our NAV and cash available for distribution. Any such changes in foreign currency exchange rates may impact the measurement of such assets or liabilities for purposes of maintaining RIC tax treatment or the requirements under the 1940 Act. We may seek to hedge against currency exchange rate fluctuations by using financial instruments such as futures, options, swaps and forward contracts, subject to the requirements of the 1940 Act, but there is no guarantee such efforts will be successful and such hedging strategies create additional costs. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;We may acquire various financial instruments for purposes of &#x201c;hedging&#x201d; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders.&#x201d;&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-24" id="f-58">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General economic conditions could adversely affect the performance of our investments and operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We and our portfolio companies are susceptible to the effects of economic slowdowns or recessions. The global growth cycle is in a mature phase and signs of slowdown are evident in certain regions around the world, although most economists continue to expect moderate economic growth in the near term, with limited signals of an imminent recession in the U.S. as consumer and government spending remain healthy. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of non&#x2011;performing loans on the balance sheets of European banks, the effect of the United Kingdom (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;U.K.&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) leaving the European Union (the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x201c;E.U.&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), instability in the Chinese capital markets and the COVID-19 pandemic. Although the broader outlook remains constructive, geopolitical instability continues to pose risk. In particular, the current U.S. political environment and the resulting uncertainties regarding actual and potential shifts in U.S. foreign investment, trade, taxation, economic, environmental and other policies under the current Administration, as well as the impact of geopolitical tension, such as a deterioration in the bilateral relationship between the U.S. and China or the current ongoing conflict between Russia and Ukraine and the escalating conflict in the Middle East, and the rapidly evolving measures in response, could lead to disruption, instability and volatility in the global markets. Certain of our portfolio companies may operate in, or have dealings with, countries subject to sanctions or embargoes imposed by the U.S. government, foreign governments, or the United Nations or other international organizations. U.S. debt ceiling and budget deficit concerns have increased the possibility of additional credit-rating downgrades and economic slowdowns or a recession in the United States. A decreased U.S. government credit rating, any default by the U.S. government on its obligations, or any prolonged U.S. government shutdown, could create broader financial turmoil and uncertainty, which may weigh heavily on our financial performance and the value of our common shares. Unfavorable economic conditions would be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events may limit our investment originations, and limit our ability to grow and could have a material negative impact on our operating results, financial condition, results of operations and cash flows and the fair values of our debt and equity investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any deterioration of general economic conditions may lead to significant declines in corporate earnings or loan performance, and the ability of corporate borrowers to service their debt, any of which could trigger a period of global economic slowdown, and have an adverse impact on the performance and financial results of the Company, and the value and the liquidity of the shares. In an economic downturn, we may have non-performing assets or non-performing assets may increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions&#160;impacted&#160;the value of any collateral securing our senior secured debt in 2023 and may continue to impact such collateral in 2024. A severe recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income, assets and net worth. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on favorable terms or at all. These events could prevent us from increasing investments and harm our operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the failure of certain financial institutions, namely banks, may increase the possibility of a sustained deterioration of financial market liquidity, or illiquidity at clearing, cash management and/or custodial financial institutions. The failure of a bank (or banks) with which we and/or our portfolio companies have a commercial relationship could adversely affect, among other things, our and/or our portfolio companies&#x2019; ability to pursue key strategic initiatives, including by affecting our or our portfolio company&#x2019;s ability to access deposits or borrow from financial institutions on favorable terms. Additionally, if a portfolio company or its sponsor has a commercial relationship with a bank that has failed or is otherwise distressed, the portfolio company may experience issues receiving financial support from a sponsor to support its operations or consummate transactions, to the detriment of their business, financial condition and/or results of operations. In addition, such bank failure(s) could affect, in certain circumstances, the ability of both affiliated and unaffiliated co-lenders, including syndicate banks or other fund vehicles, to undertake and/or execute co-investment transactions with the Company, which in turn may result in fewer co-investment opportunities being made available to the Company or impact the Company&#x2019;s ability to provide additional follow-on support to portfolio companies. The ability of the Company, its subsidiaries and portfolio companies to spread banking relationships among multiple institutions may be limited by certain contractual arrangements, including liens placed on their respective assets as a result of a bank agreeing to provide financing.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-25" id="f-59">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inflation and supply chain risks have had and may continue to have an adverse impact on our financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inflation in the United States remained elevated throughout 2022 and 2023 and may continue to remain high in the future. While inflation has shown signs of moderating, it remains uncertain whether substantial inflation in the United States will be sustained over an extended period of time or have a significant effect on the United States or other economies. Elevated inflation could have an adverse impact on our operating costs, credit facilities, and general and administrative expenses, as these costs could increase at a rate higher than our revenue. Certain of our portfolio companies are in industries that have been impacted by inflation and global supply chain issues. Recent inflationary pressures have increased the costs of labor, energy and raw materials and have adversely affected consumer spending, economic growth and our portfolio companies&#x2019; operations and such pressures and related volatility may continue during 2024. If such portfolio companies are unable to pass any increases in their costs of operations along to their customers, it could adversely affect their operating results and impact their ability to pay interest and principal on our loans, particularly if interest rates rise in response to inflation. In addition, any projected future decreases in our portfolio companies&#x2019; operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of our investments could result in future realized or unrealized losses and therefore reduce our net assets resulting from operations.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-26" id="f-60">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may be impacted by general European economic conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success of our investment activities could be affected by general economic and market conditions in Europe and in the rest of the world, as well as by changes in applicable laws and regulations (including laws relating to taxation of our investments), trade barriers, currency exchange controls, rate of inflation, currency depreciation, asset re-investment, resource self-sufficiency and national and international political and socioeconomic circumstances in respect of the European and other non-U.S. countries in which we may invest. These factors will affect the level and volatility of securities prices and the liquidity of the Company&#x2019;s investments, which could impair our profitability or result in losses. General fluctuations in the market prices of securities and interest rates may affect our investment opportunities and the value of our investments. We may maintain substantial trading positions that can be adversely affected by the level of volatility in the financial markets; the larger the positions, the greater the potential for loss. Declines in the performance of national economies or the credit markets in certain jurisdictions have had a negative impact on general economic and market conditions globally, and as a result, could have a material adverse effect on our business, financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser&#x2019;s financial condition may be adversely affected by a significant general economic downturn and it may be subject to legal, regulatory, reputational and other unforeseen risks that could have a material adverse effect on the Adviser&#x2019;s businesses and operations (including those of the Company). A recession, slowdown and/or sustained downturn in the global economy (or any particular segment thereof) could have a pronounced impact on the Company and could adversely affect the Company&#x2019;s profitability, impede the ability of the Company&#x2019;s portfolio companies to perform under or refinance their existing obligations and impair the Company&#x2019;s ability to effectively deploy its capital or realize its investments on favorable terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, economic problems in a single country are increasingly affecting other markets and economies. A continuation of this trend could result in problems in one country adversely affecting regional and even global economic conditions and markets. For example, concerns about the fiscal stability and growth prospects of certain European countries in the last economic downturn had a negative impact on most economies of the Eurozone and global markets and the current ongoing conflict between Russia and Ukraine could have a negative impact on those countries and others in the region. The occurrence of similar crises in the future could cause increased volatility in the economies and financial markets of countries throughout a region, or even globally.&lt;/span&gt;&lt;/div&gt;Any of the foregoing events could result in substantial or total losses to the Company in respect of certain investments, which losses will likely be exacerbated by the presence of leverage in a portfolio company&#x2019;s capital structure.</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-27" id="f-61">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;It may be difficult to bring suit or foreclosure in non-U.S. countries.&lt;/span&gt;&lt;/div&gt;Because the effectiveness of the judicial systems in the countries in which the Company may invest varies, the Company (or any portfolio company) may have difficulty in foreclosing or successfully pursuing claims in the courts of such countries, as compared to the United States or other countries. Further, to the extent the Company or a portfolio company may obtain a judgment but is required to seek its enforcement in the courts of one of these countries in which the Company invests, there can be no assurance that such courts will enforce such judgment. The laws of other countries often lack the sophistication and consistency found in the United States with respect to foreclosure, bankruptcy, corporate reorganization or creditors&#x2019; rights.</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-28" id="f-62">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;MiFID II obligations could have an adverse effect on the ability of Blackstone Credit &amp;amp; Insurance and its MiFID-authorized EEA affiliates to obtain and research in connection with the provision of an investment service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Recast European Union Directive on Markets in Financial Instruments (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;MiFID II&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) came into effect on January 3, 2018, and imposes regulatory obligations in respect of providing financial services in the European Economic Area (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;EEA&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) by EEA banks and EEA investment firms providing regulated services (each an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Investment Firm&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). The Adviser is a non-EEA investment company and is, therefore, not subject to MiFID II but can be indirectly affected. The regulatory obligations imposed by MiFID II may impact, and constrain the implementation of, the investment strategy of the Company. MiFID II restricts Investment Firms&#x2019; ability to obtain research in connection with the provision of an investment service. For example, Investment Firms providing portfolio management or independent investment advice may purchase investment research only at their own expense or out of specifically dedicated research payment accounts agreed upon with their clients. Research will also have to be unbundled and paid separately from the trading commission. EEA broker-dealers will unbundle research costs and invoice them to Investment Firms separated from dealing commissions. &lt;/span&gt;&lt;/div&gt;Therefore, in light of the above, MiFID II could have an adverse effect on the ability of Blackstone Credit &amp;amp; Insurance and its MiFID-authorized EEA affiliates to obtain and to provide research. The new requirements regarding the unbundling of research costs under MiFID II are not consistent with market practice in the United States and the regulatory framework concerning the use of commissions to acquire research developed by the SEC, although the SEC has issued temporary no-action letters to facilitate compliance by firms with the research requirements under MiFID II in a manner that is consistent with the U.S. federal securities laws. Blackstone Credit &amp;amp; Insurance&#x2019;s access to third-party research may nonetheless be significantly limited. Some EEA jurisdictions extend certain MiFID II obligations also to other market participants (e.g., Alternative Investment Fund Managers) under national law. There is very little guidance, and limited market practice, that has developed in preparation for MiFID II. As such, the precise impact of MiFID II on Blackstone Credit &amp;amp; Insurance and the Company cannot be fully predicted at this stage.</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-29" id="f-63">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Any unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available for distribution.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at the fair value as determined in good faith pursuant to procedures adopted by, and under oversight of, our Board. Decreases in the market value or fair value of our investments relative to amortized cost will be recorded as unrealized depreciation. Any unrealized losses in our portfolio could be an indication of a portfolio company&#x2019;s inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods. In addition, decreases in the market value or fair value of our investments will reduce our NAV.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-30" id="f-64">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Terrorist attacks, acts of war or natural disasters may adversely affect our operations.&lt;/span&gt;&lt;/div&gt;Terrorist acts, acts of war or natural disasters may disrupt our operations, as well as the operations of the businesses in which we invest. Such acts, including the current ongoing conflict between Russia and Ukraine and the escalating conflict in the Middle East, have created, and continue to create, economic and political uncertainties and have contributed to recent global economic instability. Future terrorist activities, military or security operations, or natural disasters could further weaken the domestic/global economies and create additional uncertainties, which may negatively impact the businesses in which we invest directly or indirectly and, in turn, could have a material adverse impact on our business, operating results and financial condition. Losses from terrorist attacks and natural disasters are generally uninsurable.</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-31" id="f-65">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Force Majeure events may adversely affect our operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may be affected by force majeure events (e.g., acts of God, fire, flood, earthquakes, outbreaks of an infectious disease, pandemic or any other serious public health concern, war, terrorism, nationalization of industry and labor strikes). Force Majeure events could adversely affect the ability of the Company or a counterparty to perform its obligations. The liability and cost arising out of a failure to perform obligations as a result of a force majeure event could be considerable and could be borne by the Company. Certain Force Majeure events, such as war or an outbreak of an infectious disease, could have a broader negative impact on the global or local economy, thereby affecting us. Additionally, a major governmental intervention into industry, including the nationalization of an industry or the assertion of control, could result in a loss to the Company if an investment is affected, and any compensation provided by the relevant government may not be adequate.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-32" id="f-66">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Another pandemic or global health crisis like the COVID-19 pandemic may adversely impact our performance and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From 2020 to 2022, in response to the COVID-19 pandemic, many countries instituted quarantine restrictions and took other measures to limit the spread of the virus. This resulted in labor shortages and disruption of supply chains and contributed to prolonged disruption of the global economy. A widespread reoccurrence of another pandemic or global health crisis could increase the possibility of periods of increased restrictions on business operations, which may adversely impact our business, financial condition, results of operations, liquidity and prospects materially and exacerbate many of the other risks discussed in this &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Risk Factors&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; section.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of another pandemic or global health crisis like the COVID-19 pandemic, our portfolio companies may experience decreased revenues and earnings, which may adversely impact our ability to realize value from such investments and in turn reduce our performance revenues. Investments in certain sectors, including hospitality, location-based entertainment, retail, travel, leisure and events, and in certain geographies, office and residential, could be particularly negatively impacted, as was the case during the COVID-19 pandemic. Our portfolio companies may also face increased credit and liquidity risk due to volatility in financial markets, reduced revenue streams and limited access or higher cost of financing, which may result in potential impairment of our investments. In addition, borrowers of loans, notes and other credit instruments may be unable to meet their principal or interest payment obligations or satisfy financial covenants, resulting in a decrease in value of our investments. In the event of significant credit market contraction as a result of a pandemic or similar global health crisis, we may be limited in our ability to sell assets at attractive prices or in a timely manner in order to avoid losses and margin calls from credit providers. Shareholders may also be negatively impacted if we experience a decline in the pace of capital deployment or fundraising.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, a pandemic or global health crisis may pose enhanced operational risks. For example, the employees of our Adviser and/or its affiliates may become sick or otherwise unable to perform their duties for an extended period, and extended public health restrictions and remote working arrangements may affect our Adviser and/or its affiliates by impacting employee morale, integration of new employees and preservation of their culture. Remote working environments may also be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts. Moreover, our third-party service providers could be impacted by an inability to perform due to pandemic-related restrictions or by failures of, or attacks on, their technology platforms.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-33" id="f-67">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cybersecurity and data protection risks could result in the loss of data, interruptions in our business, and damage to our reputation, and subject us to regulatory actions&#160;, increased costs and financial losses, each of which could have a material adverse effect on our business and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operations are highly dependent on technology platforms and we rely heavily on Blackstone&#x2019;s and its affiliates&#x2019; analytical, financial, accounting, communications and other data processing systems. Blackstone&#x2019;s and its affiliates&#x2019; systems face ongoing cybersecurity threats and attacks, which could result in the loss of confidentiality, integrity or availability of such systems and the data held by such systems. Attacks on Blackstone&#x2019;s and/or its affiliates&#x2019; systems could involve, and in some instances have in the past involved, attempts intended to obtain unauthorized access to our proprietary information, destroy data or disable, degrade or sabotage our systems, or divert or otherwise steal funds, including through the introduction of computer viruses, &#x201c;phishing&#x201d; attempts and other forms of social engineering. Attacks on Blackstone&#x2019;s and/or its affiliates&#x2019; systems could also involve ransomware or other forms of cyber extortion. Cyberattacks and other data security threats could originate from a wide variety of external sources, including cyber criminals, nation state hackers, hacktivists and other outside parties. Cyberattacks and other security threats could also originate from the malicious or accidental acts of insiders, such as employees, consultants, independent contractors or other service providers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There has been an increase in the frequency and sophistication of the cyber and data security threats, with attacks ranging from those common to businesses generally to those that are more advanced and persistent, which may target Blackstone and/or its affiliates because they hold a significant amount of confidential and sensitive information about investors, portfolio companies and potential investments. As a result, Blackstone&#x2019;s and its affiliates&#x2019; may face a heightened risk of a security breach or disruption with respect to this information. Measures taken by Blackstone&#x2019;s and/or its affiliates&#x2019; to ensure the integrity of their systems may not provide adequate protection, especially because cyberattack techniques are continually evolving, may persist undetected over extended periods of time, and may not be mitigated in a timely manner to prevent or minimize the impact of an attack on Blackstone and/or its affiliates&#x2019;, our investors, our portfolio companies or potential investments. If Blackstone&#x2019;s and/or its affiliates&#x2019; systems or those of third party service providers are compromised either as a result of malicious activity or through inadvertent transmittal or other loss of data, do not operate properly or are disabled, or we fail to provide the appropriate regulatory or other notifications in a timely manner, we could suffer financial loss, increased costs, a disruption of our businesses, liability to our counterparties, portfolio companies or fund investors, regulatory intervention or reputational damage. The costs related to cyber or other data security threats or disruptions may not be fully insured or indemnified by other means.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we could also suffer losses in connection with updates to, or the failure to timely update, the technology platforms on which we rely. We are reliant on third party service providers for certain aspects of our business, including for our administration, as well as for certain technology platforms, including cloud-based services. These third-party service providers could also face ongoing cybersecurity threats and compromises of their systems and as a result, unauthorized individuals could gain, and in some past instances have gained, access to certain confidential data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cybersecurity and data protection have become top priorities for regulators around the world. Many jurisdictions in which we, Blackstone and/or its affiliates operate have laws and regulations relating to privacy, data protection and cybersecurity, including, as examples, the General Data Protection Regulation (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;GDPR&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) in the European Union, the U.K. Data Protection Act, and the California Privacy Rights Act (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;CPRA&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). For example, in February 2022, the SEC proposed rules regarding registered investment advisers' and funds' cybersecurity risk management requiring the adoption and implementation of cybersecurity policies and procedures, enhanced disclosure in regulatory filings and prompt reporting of incidents to the SEC, which, if adopted, could increase our compliance costs and potential regulatory liability related to cybersecurity. Some jurisdictions have also enacted or proposed laws requiring companies to notify individuals and government agencies of data security breaches involving certain types of personal data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Breaches in our, Blackstone&#x2019;s and/or its affiliates&#x2019; security or in the security of third party service providers, whether malicious in nature or through inadvertent transmittal or other loss of data, could potentially jeopardize our, Blackstone&#x2019;s and/or its affiliates&#x2019;, including the Adviser&#x2019;s, employees or our shareholders' or counterparties' confidential, proprietary and other information processed and stored in, and transmitted through, computer systems and networks, or otherwise cause interruptions or malfunctions in our, Blackstone&#x2019;s and/or its affiliates&#x2019;, including the Adviser&#x2019;s, employees', our shareholders', our counterparties' or third parties' business and operations, which could result in significant financial losses, increased costs, liability to our shareholders and other counterparties, regulatory intervention and reputational damage. Furthermore, if we, Blackstone and/or its affiliates fail to comply with the relevant laws and regulations or fail to provide the appropriate regulatory or other notifications of breach in a timely matter, it could result in regulatory investigations and penalties, which could lead to negative publicity and reputational harm and may cause our shareholders to lose confidence in the effectiveness of our security measures and Blackstone more generally.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our portfolio companies also rely on data processing systems and the secure processing, storage and transmission of information, including payment and health information, which in some instances are provided by third parties. A disruption or compromise of these systems could have a material adverse effect on the value of these businesses. We may invest in strategic assets having a national or regional profile or in infrastructure, the nature of which could expose them to a greater risk of being subject to a terrorist attack or a security breach than other assets or businesses. Such an event may have material adverse consequences on our investment or assets of the same type or may require portfolio companies to increase preventative security measures or expand insurance coverage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finally, Blackstone&#x2019;s and/or its affiliates&#x2019; and our portfolio companies' technology platforms, data and intellectual property are also subject to a heightened risk of theft or compromise to the extent they engage in operations outside the United States, in particular in those jurisdictions that do not have comparable levels of protection of proprietary information and assets such as intellectual property, trademarks, trade secrets, know-how and customer information and records. In addition, they may be required to compromise protections or forego rights to technology, data and intellectual property in order to operate in or access markets in a foreign jurisdiction. Any such direct or indirect compromise of these assets could have a material adverse impact on us and our portfolio companies.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-34" id="f-68">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may not be able to obtain and maintain all required state licenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may be required to obtain various state licenses in order to, among other things, originate commercial loans. Applying for, obtaining and maintaining required licenses can be costly and take several months. There is no assurance that we will obtain, and maintain, all of the licenses that we need on a timely basis. Furthermore, we will be subject to various information and other requirements in order to obtain and maintain these licenses, and there is no assurance that we will satisfy those requirements. Our failure to obtain or maintain licenses might restrict investment options and have other adverse consequences.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-35" id="f-69">&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Compliance with the SEC&#x2019;s Regulation Best Interest by participating broker-dealers may negatively impact our ability to raise capital in a public offering, which could harm our ability to achieve our investment objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Broker-dealers are required to comply with Regulation Best Interest, which, among other requirements, establishes a new standard of conduct for broker-dealers and their associated persons when making a recommendation of any securities transaction or investment strategy involving securities to a retail customer. The full impact of Regulation Best Interest on participating broker-dealers cannot be determined at this time, and it may negatively impact whether participating broker-dealers and their associated persons recommend the offering to certain retail customers. In particular, under SEC guidance concerning Regulation Best Interest, a broker-dealer recommending an investment in our shares should consider a number of factors, under the care obligation of Regulation Best Interest, including but not limited to cost and complexity of the investment and reasonably available alternatives in determining whether there is a reasonable basis for the recommendation. As a result, high cost, high risk and complex products may be subject to greater scrutiny by broker-dealers. Broker-dealers may recommend a more costly or complex product as long as they have a reasonable basis to believe is in the best interest of a particular retail customer. However, if broker-dealers choose alternatives to our shares, many of which likely exist, such as an investment in listed entities, which may be a reasonable alternative to an investment in us as such investments may feature characteristics like lower cost, nominal commissions at the time of initial purchase, less complexity and lesser or different risks, our ability to raise capital will be adversely affected. If compliance by broker-dealers with Regulation Best Interest negatively impacts our ability to raise capital in a public offering, it may harm our ability to create a diversified portfolio of investments and achieve our investment objectives.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-36" id="f-70">&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;As a Delaware statutory trust, we are subject to the control share acquisition statute contained in the Delaware Statutory Trust Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is organized as a Delaware statutory trust and thus is subject to the control share acquisition statute contained in Subchapter III of the Delaware Statutory Trust Act (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;DSTA Control Share Statute&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). The DSTA Control Share Statute applies to any closed-end management investment company that has elected to be regulated as a business development company under the 1940 Act organized as a Delaware statutory trust and listed on a national securities exchange, such as the Company. The DSTA Control Share Statute became automatically applicable to the Company on August 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The DSTA Control Share Statute defines &#x201c;control beneficial interests&#x201d; (referred to as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;control shares&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; herein) by reference to a series of voting power thresholds and provides that a holder of control shares acquired in a control share acquisition has no voting rights under the Delaware Statutory Trust Act (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;DSTA&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) or the Company&#x2019;s governing documents with respect to the control shares acquired in the control share acquisition, except to the extent approved by the Company&#x2019;s shareholders by the affirmative vote of two&#x2013;thirds of all the votes entitled to be cast on the matter, excluding all interested shares (generally, shares held by the acquiring person and their associates and shares held by Company insiders).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The DSTA Control Share Statute provides for a series of voting power thresholds above which shares are considered control shares. Whether one of these thresholds of voting power is met is determined by aggregating the holdings of the acquiring person as well as those of his, her or its &#x201c;associates.&#x201d; These thresholds are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) 10% or more, but less than 15% of all voting power;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) 15% or more, but less than 20% of all voting power;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) 20% or more, but less than 25% of all voting power;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4) 25% or more, but less than 30% of all voting power;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5) 30% or more, but less than a majority of all voting power; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6) a majority or more of all voting power.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the DSTA Control Share Statute, once a threshold is reached, an acquirer has no voting rights with respect to shares in excess of that threshold (i.e., the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;control shares&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) until approved by a vote of shareholders, as described above, or otherwise exempted by the Board of Trustees. The DSTA Control Share Statute contains a statutory process for an acquiring person to request a shareholder meeting for the purpose of considering the voting rights to be accorded control shares. An acquiring person must repeat this process at each threshold level.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the DSTA Control Share Statute, an acquiring person&#x2019;s &#x201c;associates&#x201d; are broadly defined to include, among others, relatives of the acquiring person, anyone in a control relationship with the acquiring person, any investment fund or other collective investment vehicle that has the same investment adviser as the acquiring person, any investment adviser of an acquiring person that is an investment fund or other collective investment vehicle and any other person acting or intending to act jointly or in concert with the acquiring person.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Voting power under the DSTA Control Share Statute is the power (whether such power is direct or indirect or through any contract, arrangement, understanding, relationship or otherwise) to directly or indirectly exercise or direct the exercise of the voting power of shares of the Company in the election of the Trustees (either generally or with respect to any subset, series or class of trustees, including any Trustees elected solely by a particular series or class of shares, such as the preferred shares).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any control shares of the Company acquired before August 1, 2022 are not subject to the DSTA Control Share Statute; however, any further acquisitions on or after August 1, 2022 are considered control shares subject to the DSTA Control Share Statute.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The DSTA Control Share Statute requires shareholders to disclose to the Company any control share acquisition within 10 days of such acquisition, and also permits the Company to require a shareholder or an associate of such person to disclose the number of shares owned or with respect to which such person or an associate thereof can directly or indirectly exercise voting power. Further, the DSTA Control Share Statute requires a shareholder or an associate of such person to provide to the Company within 10 days of receiving a request therefor from the Company any information that the Trustees reasonably believe is necessary or desirable to determine whether a control share acquisition has occurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The DSTA Control Share Statute permits the Board, through a provision in the Company&#x2019;s governing documents or by Board action alone, to eliminate the application of the DSTA Control Share Statute to the acquisition of control shares in the Company specifically, generally, or generally by types, as to specifically identified or unidentified existing or future beneficial owners or their affiliates or associates or as to any series or classes of shares. The DSTA Control Share Statute does not provide that the Company can generally &#x201c;opt out&#x201d; of the application of the DSTA Control Share Statute; rather, specific acquisitions or classes of acquisitions may be exempted by the Board, either in advance or retroactively, but other aspects of the DSTA Control Share Statute, which are summarized above, would continue to apply. The DSTA Control Share Statute further provides that the Board of Trustees is under no obligation to grant any such exemptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The foregoing is only a summary of the material terms of the DSTA Control Share Statute. Shareholders should consult their own counsel with respect to the application of the DSTA Control Share Statute to any particular circumstance.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-37" id="f-71">&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our Declaration of Trust includes exclusive forum and jury trial waiver provisions that could limit a shareholder&#x2019;s ability to bring a claim or, if such provisions are deemed inapplicable or unenforceable by a court, may cause the Company to incur additional costs associated with such action.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Declaration of Trust provides that, to the fullest extent permitted by law, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of a duty owed by any trustee, officer or other agent of the Company to the Company or our shareholders, (iii) any action asserting a claim arising pursuant to any provision of Title 12 of the Delaware Code, Delaware statutory or common law, our Declaration of Trust, or (iv) any action asserting a claim governed by the internal affairs doctrine (for the avoidance of doubt, including any claims brought to interpret, apply or enforce the federal securities laws of the United States, including, without limitation, the 1940 Act or the securities or anti-fraud laws of any international, national, state, provincial, territorial, local or other governmental or regulatory authority, including, in each case, the applicable rules and regulations promulgated thereunder) shall be the Court of Chancery of the State of Delaware or, if such court does not have subject matter jurisdiction thereof, any other court in the State of Delaware with subject matter jurisdiction. In addition, our Declaration of Trust provides that no shareholder may maintain a derivative action on behalf of the Company unless holders of at least ten percent (10%) of the outstanding shares join in the bringing of such action. These provisions of our Declaration of Trust may make it more difficult for shareholders to bring a derivative action than a company without such provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Declaration of Trust also includes an irrevocable waiver of the right to trial by jury in all such claims, suits, actions and proceedings. Any person purchasing or otherwise acquiring any of our Common Shares shall be deemed to have notice of and to have consented to these provisions of our Declaration of Trust. These provisions may limit a shareholder&#x2019;s ability to bring a claim in a judicial forum or in a manner that it finds favorable for disputes with the Company or the Company&#x2019;s trustees or officers, which may discourage such lawsuits. Alternatively, if a court were to find the exclusive forum provision or the jury trial waiver provision to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions or in other manners, which could have a material adverse effect on our business, financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notwithstanding any of the foregoing, neither we nor any of our investors are permitted to waive compliance with any provision of the U.S. federal securities laws and the rules and regulations promulgated thereunder.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-38" id="f-72">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our Board may change our operating policies and strategies without prior notice or shareholder approval, the effects of which may be adverse to our results of operations and financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board has the authority to modify or waive our current operating policies, investment criteria and strategies without prior notice and without shareholder approval, unless required by the 1940 Act or applicable law. We cannot predict the effect any changes to our current operating policies, investment criteria and strategies would have on our business, NAV, operating results and value of our shares. However, the effects might be adverse, which could negatively impact our ability to pay shareholders distributions and cause shareholders to lose all or part of their investment. Moreover, we have significant flexibility in investing the net proceeds from our continuous offering and may use the net proceeds from our continuous offering in ways with which investors may not agree or for purposes other than those contemplated in this annual report.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-39" id="f-73">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our Board may amend our Declaration of Trust without prior shareholder approval.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board may, without shareholder vote, subject to certain exceptions, amend or otherwise supplement the Declaration of Trust by making an amendment, a Declaration of Trust supplemental thereto or an amended and restated Declaration of Trust, including without limitation to classify the Board, to impose advance notice bylaw provisions for Trustee nominations or for shareholder proposals, to require super-majority approval of transactions with significant shareholders or other provisions that may be characterized as anti-takeover in nature.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-40" id="f-74">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain provisions of our Declaration of Trust could deter takeover attempts and have an adverse impact on the value of our common shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Declaration of Trust contains anti-takeover provisions that could have the effect of limiting the ability of other entities or persons to acquire control of the Company or to change the composition of our Board of Trustees. Our Board of Trustees is divided into three classes of trustees serving staggered three-year terms. This provision could delay for up to two years the replacement of a majority of our Board of Trustees. These provisions could have the effect of depriving shareholders of an opportunity to sell their common shares at a premium over prevailing market prices by discouraging a third party from seeking to obtain control over the Company.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-41" id="f-75">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our investments in prospective portfolio companies may be risky, and we could lose all or part of our investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investments in senior secured loans, senior secured bonds, subordinated debt and equity of private U.S. companies, including middle market companies, may be risky and, subject to compliance with our 80% policy, there is no limit on the amount of any such investments in which we may invest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Secured Loans and Senior Secured Bonds. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There is a risk that any collateral pledged by portfolio companies in which we have taken a security interest may decrease in value over time or lose its entire value, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. Such risks have become more pronounced due to rising interest rates and market volatility.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To the extent our debt investment is collateralized by the securities of a portfolio company&#x2019;s subsidiaries, such securities may lose some or all of their value in the event of the bankruptcy or insolvency of the portfolio company. Also, in some circumstances, our security interest may be contractually or structurally subordinated to claims of other creditors. In addition, deterioration in a portfolio company&#x2019;s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the debt. Secured debt that is under-collateralized involves a greater risk of loss. In addition, second lien debt is granted a second priority security interest in collateral, which means that any realization of collateral will generally be applied to pay senior secured debt in full before second lien debt is paid. Similarly, investments in &#x201c;last out&#x201d; pieces of unitranche loans will be similar to second lien loans in that such investments will be junior in priority to the &#x201c;first out&#x201d; piece of the same unitranche loan with respect to payment of principal, interest and other amounts. Consequently, the fact that debt is secured does not guarantee that we will receive principal and interest payments according to the debt&#x2019;s terms, or at all, or that we will be able to collect on the debt should we be forced to enforce our remedies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subordinated Debt. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our subordinated debt investments will generally rank junior in priority of payment to senior debt and will generally be unsecured. This may result in a heightened level of risk and volatility or a loss of principal, which could lead to the loss of the entire investment. These investments may involve additional risks that could adversely affect our investment returns. To the extent interest payments associated with such debt are deferred, such debt may be subject to greater fluctuations in valuations, and such debt could subject us and our shareholders to non-cash income. Because we will not receive any principal repayments prior to the maturity of some of our subordinated debt investments, such investments will be of greater risk than amortizing loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Investments. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may make select equity investments. In addition, in connection with our debt investments, we on occasion may receive equity interests such as warrants or options as additional consideration. The equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Securities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Investments in preferred securities involve certain risks. Certain preferred securities contain provisions that allow an issuer under certain conditions to skip or defer distributions. If the Company owns a preferred security that is deferring its distribution, the Company may be required to include the amount of the deferred distribution in its taxable income for tax purposes although it does not currently receive such amount in cash. In order to receive the special treatment accorded to RICs and their shareholders under the Code and to avoid U.S. federal income and/or excise taxes at the Company level, the Company may be required to distribute this income to shareholders in the tax year in which the income is recognized (without a corresponding receipt of cash). Therefore, the Company may be required to pay out as an income distribution in any such tax year an amount greater than the total amount of cash income the Company actually received, and to sell portfolio securities, including at potentially disadvantageous times or prices, to obtain cash needed for these income distributions. Preferred securities often are subject to legal provisions that allow for redemption in the event of certain tax or legal changes or at the issuer&#x2019;s call. In the event of redemption, the Company may not be able to reinvest the proceeds at comparable rates of return. Preferred securities are subordinated to bonds and other debt securities in an issuer&#x2019;s capital structure in terms of priority for corporate income and liquidation payments, and therefore will be subject to greater credit risk than those debt securities. Preferred securities may trade less frequently and in a more limited volume and may be subject to more abrupt or erratic price movements than many other securities, such as common stocks, corporate debt securities and U.S. government securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-U.S. Securities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may invest in non-U.S. securities, which may include securities denominated in U.S. dollars or in non-U.S. currencies, to the extent permitted by the 1940 Act. Because evidence of ownership of such securities usually is held outside the United States, we would be subject to additional risks if we invested in non-U.S. securities, which include possible adverse political and economic developments, seizure or nationalization of foreign deposits and adoption of governmental restrictions, which might adversely affect or restrict the payment of principal and interest on the non-U.S. securities to shareholders located outside the country of the issuer, whether from currency blockage or otherwise. Because non-U.S. securities may be purchased with and payable in foreign currencies, the value of these assets as measured in U.S. dollars may be affected unfavorably by changes in currency rates and exchange control regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loans Risk&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The loans that the Company may invest in include loans that are first lien, second lien, third lien or that are unsecured. In addition, the loans the Company will invest in will usually be rated below investment grade or may also be unrated. Loans are subject to a number of risks described elsewhere in the prospectus, including credit risk, liquidity risk, below investment grade instruments risk and management risk. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although certain loans in which the Company may invest will be secured by collateral, there can be no assurance that such collateral could be readily liquidated or that the liquidation of such collateral would satisfy the borrower&#x2019;s obligation in the event of non-payment of scheduled interest or principal. In the event of the bankruptcy or insolvency of a borrower, the Company could experience delays or limitations with respect to its ability to realize the benefits of the collateral securing a loan. In the event of a decline in the value of the already pledged collateral, if the terms of a loan do not require the borrower to pledge additional collateral, the Company will be exposed to the risk that the value of the collateral will not at all times equal or exceed the amount of the borrower&#x2019;s obligations under the loans. To the extent that a loan is collateralized by stock in the borrower or its subsidiaries, such stock may lose some or all of its value in the event of the bankruptcy or insolvency of the borrower. Those loans that are under-collateralized involve a greater risk of loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Further, there is a risk that any collateral pledged by portfolio companies in which the Company has taken a security interest may decrease in value over time or lose its entire value, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. To the extent the Company&#x2019;s debt investment is collateralized by the securities of a portfolio company&#x2019;s subsidiaries, such securities may lose some or all of their value in the event of the bankruptcy or insolvency of the portfolio company. Also, in some circumstances, the Company&#x2019;s security interest may be contractually or structurally subordinated to claims of other creditors. In addition, deterioration in a portfolio company&#x2019;s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the debt. Secured debt that is under-collateralized involves a greater risk of loss. In addition, second lien debt is granted a second priority security interest in collateral, which means that any realization of collateral will generally be applied to pay senior secured debt in full before second lien debt is paid. Consequently, the fact that debt is secured does not guarantee that the Company will receive principal and interest payments according to the debt&#x2019;s terms, or at all, or that the Company will be able to collect on the debt should it be forced to enforce remedies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loans are not registered with the SEC, or any state securities commission, and are not listed on any national securities exchange. There is less readily available or reliable information about most loans than is the case for many other types of securities, including securities issued in transactions registered under the Securities Act or registered under the Exchange Act. No active trading market may exist for some loans, and some loans may be subject to restrictions on resale. A secondary market may be subject to irregular trading activity, wide bid/ask spreads and extended trade settlement periods, which may impair the ability to realize full value and thus cause a material decline in the Company&#x2019;s NAV. In addition, the Company may not be able to readily dispose of its loans at prices that approximate those at which the Company could sell such loans if they were more widely-traded and, as a result of such illiquidity, the Company may have to sell other investments or engage in borrowing transactions if necessary to raise cash to meet its obligations. During periods of limited supply and liquidity of loans, the Company&#x2019;s yield may be lower. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some loans are subject to the risk that a court, pursuant to fraudulent conveyance or other similar laws, could subordinate the loans to presently existing or future indebtedness of the borrower or take other action detrimental to lenders, including the Company. Such court action could under certain circumstances include invalidation of loans. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If legislation of state or federal regulations impose additional requirements or restrictions on the ability of financial institutions to make loans, the availability of loans for investment by the Company may be adversely affected. In addition, such requirements or restrictions could reduce or eliminate sources of financing for certain borrowers. This would increase the risk of default. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If legislation or federal or state regulations require financial institutions to increase their capital requirements this may cause financial institutions to dispose of loans that are considered highly levered transactions. Such sales could result in prices that, in the opinion of the Adviser, do not represent fair value. If the Company attempts to sell a loan at a time when a financial institution is engaging in such a sale, the price the Company could get for the loan may be adversely affected. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may acquire loans through assignments or participations. The Company will typically acquire loans through assignment. The purchaser of an assignment typically succeeds to all the rights and obligations of the assigning institution and becomes a lender under the credit agreement with respect to the debt obligation; however, the purchaser&#x2019;s rights can be more restricted than those of the assigning institution, and the Company may not be able to unilaterally enforce all rights and remedies under the loan and with regard to any associated collateral. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A participation typically results in a contractual relationship only with the institution selling the participation interest, not with the borrower. Sellers of participations typically include banks, broker-dealers, other financial institutions and lending institutions. Certain participation agreements also include the option to convert the participation to a full assignment under agreed upon circumstances. The Adviser has adopted best execution procedures and guidelines to mitigate credit and counterparty risk in the atypical situation when the Company must acquire a loan through a participation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In purchasing participations, the Company generally will have no right to enforce compliance by the borrower with the terms of the loan agreement against the borrower, and the Company may not directly benefit from the collateral supporting the debt obligation in which it has purchased the participation. As a result, the Company will be exposed to the credit risk of both the borrower and the institution selling the participation. Further, in purchasing participations in lending syndicates, the Company will not be able to conduct the due diligence on the borrower or the quality of the loan with respect to which it is buying a participation that the Company would otherwise conduct if it were investing directly in the loan, which may result in the Company being exposed to greater credit or fraud risk with respect to the borrower or the loan than the Company expected when initially purchasing the participation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also may originate loans or acquire loans by participating in the initial issuance of the loan as part of a syndicate of banks and financial institutions, or receive its interest in a loan directly from the borrower. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser has established a counterparty and liquidity sub-committee that regularly reviews each broker-dealer counterparty for, among other things, its quality and the quality of its execution. The established procedures and guidelines require trades to be placed for execution only with broker counterparties approved by the counterparty and liquidity sub-committee of the Adviser. The factors considered by the sub-committee when selecting and approving brokers and dealers include, but are not limited to: (i) quality, accuracy, and timeliness of execution, (ii) review of the reputation, financial strength and stability of the financial institution, (iii) willingness and ability of the counterparty to commit capital, (iv) ongoing reliability and (v) access to underwritten offerings and secondary markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Junior, Unsecured Securities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our strategy may entail acquiring securities that are junior or unsecured instruments. While this approach can facilitate obtaining control and then adding value through active management, it also means that certain of the Company&#x2019;s investments may be unsecured. If a portfolio company becomes financially distressed or insolvent and does not successfully reorganize, we will have no assurance (compared to those distressed securities investors that acquire only fully collateralized positions) that we will recover any of the principal that we have invested. Similarly, investments in &#x201c;last out&#x201d; pieces of unitranche loans will be similar to second lien loans in that such investments will be junior in priority to the &#x201c;first out&#x201d; piece of the same unitranche loan with respect to payment of principal, interest and other amounts. Consequently, the fact that debt is secured does not guarantee that we will receive principal and interest payments according to the debt&#x2019;s terms, or at all, or that we will be able to collect on the debt should it be forced to enforce its remedies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While such junior or unsecured investments may benefit from the same or similar financial and other covenants as those enjoyed by the indebtedness ranking more senior to such investments and may benefit from cross-default provisions and security over the issuer&#x2019;s assets, some or all of such terms may not be part of particular Investments. Moreover, our ability to influence an issuer&#x2019;s affairs, especially during periods of financial distress or following insolvency, is likely to be substantially less than that of senior creditors. For example, under typical subordination terms, senior creditors are able to block the acceleration of the junior debt or the exercise by junior debt holders of other rights they may have as creditors. Accordingly, we may not be able to take steps to protect investments in a timely manner or at all, and there can be no assurance that our rate of return objectives or any particular investment will be achieved. In addition, the debt securities in which we will invest may not be protected by financial covenants or limitations upon additional indebtedness, may have limited liquidity and are not expected to be rated by a credit rating agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Early repayments of our investments may have a material adverse effect on our investment objectives. In addition, depending on fluctuations of the equity markets and other factors, warrants and other equity investments may become worthless.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There can be no assurance that attempts to provide downside protection through contractual or structural terms with respect to our investments will achieve their desired effect and potential investors should regard an investment in us as being speculative and having a high degree of risk. Furthermore, we have limited flexibility to negotiate terms when purchasing newly issued investments in connection with a syndication of mezzanine or certain other junior or subordinated investments or in the secondary market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Below Investment Grade Risk. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as &#x201c;junk,&#x201d; have predominantly speculative characteristics with respect to the issuer&#x2019;s capacity to pay interest and repay principal. They may also be difficult to value and illiquid. The major risks of below investment grade securities include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Below investment grade securities may be issued by less creditworthy issuers. Issuers of below investment grade securities may have a larger amount of outstanding debt relative to their assets than issuers of investment grade securities. In the event of an issuer&#x2019;s bankruptcy, claims of other creditors may have priority over the claims of holders of below investment grade securities, leaving few or no assets available to repay holders of below investment grade securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Prices of below investment grade securities are subject to extreme price fluctuations. Adverse changes in an issuer&#x2019;s industry and general economic conditions may have a greater impact on the prices of below investment grade securities than on other higher-rated fixed-income securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Issuers of below investment grade securities may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments, or the unavailability of additional financing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Below investment grade securities frequently have redemption features that permit an issuer to repurchase the security from us before it matures. If the issuer redeems below investment grade securities, we may have to invest the proceeds in securities with lower yields and may lose income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Below investment grade securities may be less liquid than higher-rated fixed-income securities, even under normal economic conditions. There are fewer dealers in the below investment grade securities market, and there may be significant differences in the prices quoted by the dealers. Judgment may play a greater role in valuing these securities and we may be unable to sell these securities at an advantageous time or price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit rating of a high-yield security does not necessarily address its market value risk. Ratings and market value may change from time to time, positively or negatively, to reflect new developments regarding the issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mezzanine Loans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;Our mezzanine loans generally will be subordinated to senior secured loans on a payment basis, are typically unsecured and rank&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;pari passu&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;with other unsecured creditors.&#160;As such, other creditors may rank senior to us in the event of insolvency.&#160;This may result in an above average amount of risk and loss of principal. Our mezzanine debt securities generally will have ratings or implied or imputed ratings below investment grade. They will be obligations of corporations, partnerships or other entities that are generally unsecured, typically are subordinated to other obligations of the obligor and generally have greater credit and liquidity risk than is typically associated with investment grade corporate obligations. Accordingly, the risks associated with mezzanine debt securities include a greater possibility that adverse changes in the financial condition of the obligor or in general economic conditions (including a sustained period of rising interest rates or an economic downturn) may adversely affect the obligor&#x2019;s ability to pay principal and interest on its debt. Many obligors on mezzanine debt securities are highly leveraged, and specific developments affecting such obligors, including reduced cash flow from operations or the inability to refinance debt at maturity, may also adversely affect such obligors&#x2019; ability to meet debt service obligations. Mezzanine debt securities are often issued in connection with leveraged acquisitions or recapitalizations, in which the issuers incur a substantially higher amount of indebtedness than the level at which they had previously operated. Default rates for mezzanine debt securities have historically been higher than has been the case for investment grade securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risk Retention Vehicles&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We may invest in CLO debt and equity tranches and warehouse investments directly or indirectly through an investment in U.S. and/or European vehicles (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Risk Retention Vehicles&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) established for the purpose of satisfying U.S. and/or E.U. regulations that require eligible risk retainers to purchase and retain specified amounts of the credit risk associated with certain CLOs, which vehicles themselves are invested in CLO securities, warehouse investments and/or senior secured obligations. Risk Retention Vehicles will be structured to satisfy the retention requirements by purchasing and retaining the percentage of CLO notes prescribed under the applicable retention requirements (the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Retention Notes&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and will not include Risk Retention Vehicles that are deemed to be controlled by the Adviser or its affiliates (other than Risk Retention Vehicles we control).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indirect investments in CLO equity securities (and in some instances more senior CLO securities) and warehouse investments through entities that have been established to satisfy the U.S. retention requirements and/or the European retention requirements may allow for better economics for us (including through fee rebate arrangements) by creating stronger negotiating positions with CLO managers and underwriting banks who are incentivized to issue CLOs and who require the participation of a Risk Retention Vehicle to enable the CLO securities to be issued. However, Retention Notes differ from other securities of the same ranking since the retention requirements prescribe that such Retention Notes must be held by the relevant risk retainer for a specified period. In the case of European Risk Retention Vehicles, the prescribed holding period is the lifetime of the CLO, and in the case of U.S. Risk Retention Vehicles it is the longer of (x) the period until the CLO has paid down its securities to 33% of their original principal amount, (y) the period until the CLO has sold down its assets to 33% of their original principal amount and (z) two years after the closing of the CLO. In addition, Retention Notes are subject to other restrictions not imposed on other securities of the same ranking; for example, Retention Notes may not be subject to credit risk mitigation, and breach of the retention requirements may result in the imposition of regulatory sanctions or, in the case of the European retention requirements, in claims being brought against the retaining party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x201c;Covenant-lite&#x201d; Obligations.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We may invest in, or obtain exposure to, obligations that may be &#x201c;covenant-lite,&#x201d; which means such obligations lack certain financial maintenance covenants. While these loans may still contain other collateral protections, a covenant-lite loan may carry more risk than a covenant-heavy loan made by the same borrower, as it does not require the borrower to provide affirmation that certain specific financial tests have been satisfied on a routine basis as is required under a covenant-heavy loan agreement. Should a loan we hold begin to deteriorate in quality, our ability to negotiate with the borrower may be delayed under a covenant-lite loan compared to a loan with full maintenance covenants. This may in turn delay our ability to seek to recover its investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consumer Loans.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We may invest in, or obtain exposure to, consumer lending, which involves risk elements in addition to normal credit risk. Consumer loan terms vary according to the type and value of collateral and creditworthiness of the borrower. In underwriting consumer loans, a thorough analysis of the borrower&#x2019;s financial ability to repay the loan as agreed is typically performed. The ability to repay shall be determined by, among others, the borrower&#x2019;s employment history, current financial conditions, and credit background. While these loans typically have higher yields than many other loans, such loans involve risk elements in addition to normal credit risk. Consumer loans may entail greater credit risk than other loans particularly in the case of unsecured consumer loans or consumer loans secured by rapidly depreciable assets, such as automobiles. In such cases, any repossessed collateral for a defaulted consumer loan may not provide an adequate source of repayment of the outstanding loan balance as a result of the greater likelihood of damage, loss or depreciation. In addition, consumer loan collections are dependent on the borrower&#x2019;s continuing financial stability, and thus are more likely to be affected by adverse personal circumstances. During periods of deteriorating economic conditions, such as recessions or periods of rising unemployment, delinquencies and losses generally increase, sometimes dramatically, with respect to consumer loans. Furthermore, the application of various federal and state laws, including bankruptcy and insolvency laws, and/or state consumer protection laws may limit the amount which can be recovered on such loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Bridge Financings.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; From time to time, we may lend to portfolio companies on a short-term, unsecured basis or otherwise invest on an interim basis in portfolio companies in anticipation of a future issuance of equity or long-term debt securities or other refinancing or syndication. Such bridge loans would typically be convertible into a more permanent, long-term security; however, for reasons not always in the Company&#x2019;s control, such long-term securities issuance or other refinancing or syndication may not occur and such bridge loans and interim investments may remain outstanding. In such event, the interest rate on such loans or the terms of such interim investments may not adequately reflect the risk associated with the position taken by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restructurings.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Investments in companies operating in workout or bankruptcy modes present additional legal risks, including fraudulent conveyance, voidable preference and equitable subordination risks. The level of analytical sophistication, both financial and legal, necessary for successful investment in companies experiencing significant business and financial difficulties is unusually high. There is no assurance that we will correctly evaluate the value of the assets collateralizing our loans or the prospects for a successful reorganization or similar action.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-42" id="f-76">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We are exposed to risks associated with changes in interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to financial market risks, including changes in interest rates. General interest rate fluctuations may have a substantial negative impact on our investments and investment opportunities and, accordingly, have a material adverse effect on our investment objectives and our rate of return on invested capital. In addition, an increase in interest rates would make it more expensive to use debt for our financing needs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During periods of falling interest rates, payments under the floating rate debt instruments that we hold would generally decrease, resulting in less revenue to us. In the event of a sharply rising interest rate environment, such as during 2022 and 2023, payments under floating rate debt instruments generally would rise and there may be a significant number of issuers of such floating rate debt instruments that would be unable or unwilling to pay such increased interest costs and may otherwise be unable to repay their loans. Investments in floating rate debt instruments may also decline in value in response to rising interest rates if the interest rates of such investments do not rise as much, or as quickly, as market interest rates in general. Similarly, during periods of rising interest rates, fixed-rate debt instruments may decline in value because the fixed rates of interest paid thereunder may be below market interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, an increase in interest rates would make it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase in the amount of incentive fees payable to the Adviser with respect to pre-incentive fee net investment income.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-43" id="f-77">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our portfolio companies may have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt in which we invest. By their terms, such debt instruments may entitle the holders to receive payment of interest or principal on or before the dates on which we are entitled to receive payments with respect to the debt instruments in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any proceeds. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt instruments in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-44" id="f-78">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If one of our portfolio companies were to file for bankruptcy, depending on the facts and circumstances, including the extent to which we actually provided managerial assistance to that portfolio company, a bankruptcy court might re-characterize our debt investment and subordinate all or a portion of our claim to that of other creditors. We may also be subject to lender liability claims for actions taken by us with respect to a borrower&#x2019;s business or instances where we exercise control over the borrower.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-45" id="f-79">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We generally do not control our portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not expect to control most of our portfolio companies, even though we may have board representation or board observation rights, and our debt agreements with such portfolio companies may contain certain restrictive covenants. As a result, we are subject to the risk that a portfolio company in which we invest may make business decisions with which we disagree and the management of such company, as representatives of the holders of the company&#x2019;s common equity, may take risks or otherwise act in ways that do not serve our interests as debt investors. Due to the lack of liquidity for our investments in non-traded companies, we may not be able to dispose of our interests in our portfolio companies as readily as we would like or at an appropriate valuation. As a result, a portfolio company may make decisions that could decrease the value of our portfolio holdings.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-46" id="f-80">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We are subject to risks related to ESG matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Adviser&#x2019;s consideration of ESG factors is intended to aid the Adviser in evaluating the return and risk profile of a given investment and is not expected to by itself determine an investment decision for us, the Adviser&#x2019;s consideration of ESG factors could, to the extent material economic risks associated with an investment are identified, cause the Adviser to consider taking action with respect to a company differently than may have been taken in the absence of such consideration, which could cause us to perform differently compared to funds that do not have such considerations. Further, although the Adviser views application of its ESG framework to be an opportunity to potentially enhance or protect the performance of investments over the long-term, the Adviser cannot guarantee that any consideration of ESG factors or engagement with portfolio companies on ESG, which depends in part on skill and qualitative judgments, will positively impact the performance of any individual portfolio company or us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investors and other stakeholders have become more focused on understanding how companies address a variety of ESG factors. As they evaluate investment decisions, many investors look not only at company disclosures but also to ESG rating systems that have been developed by third parties to allow ESG comparisons among companies. The criteria used in these ratings systems may conflict and change frequently, and we cannot predict how these third parties will score us, nor can we have any assurance that they score us accurately or other companies accurately or that other companies have provided them with accurate data. If our ESG ratings, disclosures or practices do not meet the standards set by such investors or our shareholders, they may choose not to invest in our shares. Relatedly, we risk damage to our reputation, if we do not, or are perceived to not, act responsibly in a number of areas, such as greenhouse gas emissions, energy management, human rights, community relations, workforce health and safety, and business ethics and transparency. Adverse incidents with respect to ESG matters or negative ESG ratings or assessments by third-party ESG raters could impact the value of our brand, or the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations.&lt;/span&gt;&lt;/div&gt;There is a growing regulatory interest across jurisdictions in improving transparency regarding the definition, measurement and disclosure of ESG factors in order to allow investors to validate and better understand sustainability claims. New regulatory initiatives related to ESG that are applicable to us could adversely affect our business. For example, the SEC has proposed rules that would require additional disclosures about ESG investment practices by investment advisers and certain funds, including BDCs. These changing rules, regulations and stakeholder expectations have resulted in, and are likely to continue to result in, increased general and administrative expenses and increased management time and attention spent complying with or meeting such regulations and expectations. If we fail or are perceived to fail to comply with applicable rules, regulations and stakeholder expectations, it could negatively impact our reputation and our business results.</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-47" id="f-81">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We and our investment adviser could be the target of litigation or regulatory investigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We as well as our investment adviser and its affiliates participate in a highly regulated industry and are each subject to regulatory examinations in the ordinary course of business. There can be no assurance that we and our investment adviser and/or any of its affiliates will avoid regulatory investigation and possible enforcement actions stemming therefrom. Our investment adviser is a registered investment adviser and, as such, is subject to the provisions of the Advisers Act. We and our investment adviser are each, from time to time, subject to formal and informal examinations, investigations, inquiries, audits and reviews from numerous regulatory authorities both in response to issues and questions raised in such examinations or investigations and in connection with the changing priorities of the applicable regulatory authorities across the market in general.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment adviser, its affiliates and/or any of their respective principals and employees could also be named as defendants in, or otherwise become involved in, litigation. Litigation and regulatory actions can be time-consuming and expensive and can lead to unexpected losses, which expenses and losses are often subject to indemnification by us. Legal proceedings could continue without resolution for long periods of time and their outcomes, which could materially and adversely affect the value of us or the ability of our investment adviser to manage us, are often impossible to anticipate. Our investment adviser would likely be required to expend significant resources responding to any litigation or regulatory action related to it, and these actions could be a distraction to the activities of our investment adviser.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment activities are subject to the normal risks of becoming involved in litigation by third parties. This risk would be somewhat greater if we were to exercise control or significant influence over a portfolio company&#x2019;s direction. The expense of defending against claims by third parties and paying any amounts pursuant to settlements or judgments would, absent willful misfeasance, bad faith, gross negligence, or reckless disregard of the duties involved by our investment adviser, our administrator, or any of our officers, be borne by us and would reduce our net assets. Our investment adviser and others are indemnified by us in connection with such litigation, subject to certain conditions.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-48" id="f-82">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Second priority liens on collateral securing debt investments that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. If there is a default, the value of the collateral may not be sufficient to repay in full both the first priority creditors and us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain debt investments that we make to portfolio companies may be secured on a second priority basis by the same collateral securing first priority debt of such companies. The first priority liens on the collateral will secure the portfolio company&#x2019;s obligations under any outstanding senior debt and may secure certain other future debt that may be permitted to be incurred by the company under the agreements governing the loans. The holders of obligations secured by the first priority liens on the collateral will generally control the liquidation of and be entitled to receive proceeds from any realization of the collateral to repay their obligations in full before us. In addition, the value of the collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from the sale or sales of all of the collateral would be sufficient to satisfy the debt obligations secured by the second priority liens after payment in full of all obligations secured by the first priority liens on the collateral. If such proceeds are not sufficient to repay amounts outstanding under the debt obligations secured by the second priority liens, then we, to the extent not repaid from the proceeds of the sale of the collateral, will only have an unsecured claim against the company&#x2019;s remaining assets, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may also make unsecured debt investments in portfolio companies, meaning that such investments will not benefit from any interest in collateral of such companies. Liens on such portfolio companies&#x2019; collateral, if any, will secure the portfolio company&#x2019;s obligations under its outstanding secured debt and may secure certain future debt that is permitted to be incurred by the portfolio company under its secured debt agreements. The holders of obligations secured by such liens will generally control the liquidation of, and be entitled to receive proceeds from, any realization of such collateral to repay their obligations in full before we are so entitled. In addition, the value of such collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from sales of such collateral would be sufficient to satisfy its unsecured debt obligations after payment in full of all secured debt obligations. If such proceeds were not sufficient to repay the outstanding secured debt obligations, then its unsecured claims would rank equally with the unpaid portion of such secured creditors&#x2019; claims against the portfolio company&#x2019;s remaining assets, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rights we may have with respect to the collateral securing the debt investments we make to our portfolio companies with senior debt outstanding may also be limited pursuant to the terms of one or more intercreditor agreements that we enter into with the holders of senior debt. Under such an intercreditor agreement, at any time that obligations that have the benefit of the first priority liens are outstanding, any of the following actions that may be taken in respect of the collateral will be at the direction of the holders of the obligations secured by the first priority liens: the ability to cause the commencement of enforcement proceedings against the collateral; the ability to control the conduct of such proceedings; the approval of amendments to collateral documents; releases of liens on the collateral; and waivers of past defaults under collateral documents. We may not have the ability to control or direct such actions, even if our rights are adversely affected.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-49" id="f-83">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Economic recessions or downturns or restrictions on trade could impair our portfolio companies and adversely affect our operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The risks associated with our and our portfolio companies&#x2019; businesses are more severe during periods of economic slowdown or recession. In recent years, we have experienced periods of economic slowdown and in some instances, contraction, as countries and industries around the globe grappled with the short- and long-term economic impacts of the COVID-19 pandemic, elevated inflation, supply chain challenges, labor shortages, high interest rates, foreign currency exchange volatility and volatility in global capital markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many of our portfolio companies may be susceptible to economic recessions or downturns and may be unable to repay our debt investments during these periods. Therefore, our non-performing assets are likely to increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions may also decrease the value of any collateral securing our senior secured debt. A prolonged recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income and NAV. Certain of our portfolio companies may also be impacted by tariffs or other matters affecting international trade. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on terms we deem acceptable. These events could prevent us from increasing investments and adversely affect our operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portfolio company&#x2019;s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, acceleration of the time when the loans are due and foreclosure on its assets representing collateral for its obligations, which could trigger cross defaults under other agreements and jeopardize our portfolio company&#x2019;s ability to meet its obligations under the debt investments that we hold and the value of any equity securities we own. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting portfolio company.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-50" id="f-84">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our investments in CLOs may be riskier than a direct investment in the debt or other securities of the underlying companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When investing in CLOs, we may invest in any level of a CLO&#x2019;s subordination chain, including subordinated (lower-rated) tranches and residual interests (the lowest tranche). CLOs are typically highly levered and therefore, the junior debt and equity tranches that we may invest in are subject to a higher risk of total loss and deferral or nonpayment of interest than the more senior tranches to which they are subordinated. In addition, we will generally have the right to receive payments only from the CLOs, and will generally not have direct rights against the underlying borrowers or entities that sponsored the CLOs. Furthermore, the investments we make in CLOs are at times thinly traded or have only a limited trading market. As a result, investments in such CLOs may be characterized as illiquid securities.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-51" id="f-85">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;A covenant breach or other default by our portfolio companies may adversely affect our operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portfolio company&#x2019;s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, termination of its loans and foreclosure on its secured assets, which could trigger cross-defaults under other agreements and jeopardize a portfolio company&#x2019;s ability to meet its obligations under the debt or equity securities that we hold. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms, which may include the waiver of certain financial covenants, with a defaulting portfolio company. In addition, lenders in certain cases can be subject to lender liability claims for actions taken by them when they become too involved in the borrower&#x2019;s business or exercise control over a borrower. It is possible that we could become subject to a lender&#x2019;s liability claim, including as a result of actions taken if we render significant managerial assistance to the borrower. Furthermore, if one of our portfolio companies were to file for bankruptcy protection, a bankruptcy court might re-characterize our debt holding and subordinate all or a portion of our claim to claims of other creditors, even though we may have structured our investment as senior secured debt. The likelihood of such a re-characterization would depend on the facts and circumstances, including the extent to which we provided managerial assistance to that portfolio company.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-52" id="f-86">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our portfolio companies may be highly leveraged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of our portfolio companies may be highly leveraged, which may have adverse consequences to these companies and to us as an investor. These companies may be subject to restrictive financial and operating covenants and the leverage may impair these companies&#x2019; ability to finance their future operations and capital needs. As a result, these companies&#x2019; flexibility to respond to changing business and economic conditions and to take advantage of business opportunities may be limited. Further, a leveraged company&#x2019;s income and net assets will tend to increase or decrease at a greater rate than if borrowed money were not used.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-53" id="f-87">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our portfolio may be concentrated in a limited number of industries, which may subject us to a risk of significant loss if there is a downturn in a particular industry in which a number of our investments are concentrated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our portfolio may be concentrated in a limited number of industries. Our portfolio will be considered to be concentrated in a particular industry when 25% or greater of its total assets are invested in issuers that are a part of that industry. A downturn in any industry in which we are invested could significantly impact the aggregate returns we realize. We anticipate that we may concentrate our investments in issuers that are part of the software industry, which currently represent close to 25% of our total assets, as a result of additional investments in the software industry and/or fluctuations in the fair value of our investments in the software industry and other industries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If an industry in which we have significant investments suffers from adverse business or economic conditions, as individual industries have historically experienced to varying degrees, a material portion of our investment portfolio could be affected adversely, which, in turn, could adversely affect our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-54" id="f-88">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may be subject to risks associated with our investments in the software industry.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The revenue, income (or losses) and valuations of software and other technology-related companies can and often do fluctuate suddenly and dramatically. In addition, because of rapid technological change, the average selling prices of software products have historically decreased over their productive lives. As a result, the average selling prices of software offered by our portfolio companies may decrease over time, which could adversely affect their operating results and, correspondingly, the value of any securities that we may hold. Additionally, companies operating in the software industry are subject to vigorous competition, changing technology, changing client and end-consumer needs, evolving industry standards and frequent introductions of new products and services. Our portfolio companies in the software industry could compete with companies that are larger and could be engaged in a greater range of businesses or have greater financial, technical, sales or other resources than our portfolio companies do. Our portfolio companies could lose market share if their competitors introduce or acquire new products that compete with their software and related services or add new features to existing products. Any deterioration in the results of our portfolio companies due to competition or otherwise could, in turn, materially adversely affect our business, financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-55" id="f-89">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our investments in the healthcare providers and services industry face considerable uncertainties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The laws and rules governing the business of healthcare companies and interpretations of those laws and rules are subject to frequent change. Broad latitude is given to the agencies administering those regulations. Existing or future laws and rules could force our portfolio companies engaged in healthcare to change how they do business, restrict revenue, increase costs, change reserve levels and change business practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Healthcare companies often must obtain and maintain regulatory approvals to market many of their products, change prices for certain regulated products and consummate some of their acquisitions and divestitures. Delays in obtaining or failing to obtain or maintain these approvals could reduce revenue or increase costs. Policy changes on the local, state and federal level, such as the expansion of the government&#x2019;s role in the healthcare arena and alternative assessments and tax increases specific to the healthcare industry or healthcare products as part of federal health care reform initiatives, could fundamentally change the dynamics of the healthcare industry.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-56" id="f-90">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investing in large private U.S. borrowers may limit the Company&#x2019;s ability to achieve high growth rates during times of economic expansion. &lt;/span&gt;&lt;/div&gt;Investing in originated assets made to large private U.S. borrowers may result in us underperforming in other segments of the market, particularly during times of economic expansion, because large private U.S. borrowers may be less responsive to competitive challenges and opportunities in the financial markets. As a result, our value may not rise at the same rate, if at all, as other funds that invest in smaller market capitalization companies that are more capable of responding to economic and industrial changes.</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-57" id="f-91">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investing in private companies involves a number of significant risks, any one of which could have a material adverse effect on our operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These risks include that:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing on any guarantees we may have obtained in connection with our investment; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;these companies frequently have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tends to render them more vulnerable to competitors&#x2019; actions and changing market conditions, as well as general economic downturns; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;these companies are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;these companies generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, Trustees and members of the Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;these companies may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity.</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-58" id="f-92">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may not realize gains from our equity investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain investments that we may make could include warrants or other equity securities. In addition, we may make direct equity investments in portfolio companies. Our goal is ultimately to realize gains upon our disposition of such equity interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. We also may be unable to realize any value if a portfolio company does not have a liquidity event, such as a sale of the business, recapitalization or public offering, which would allow us to sell the underlying equity interests. We intend to seek puts or similar rights to give us the right to sell our equity securities back to the portfolio company issuer. We may be unable to exercise these put rights for the consideration provided in our investment documents if the issuer is in financial distress.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-59" id="f-93">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;An investment strategy focused primarily on privately-held companies presents certain challenges, including, but not limited to, the lack of available information about these companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We invest primarily in privately-held companies. Investments in private companies pose significantly greater risks than investments in public companies. First, private companies have reduced access to the capital markets, resulting in diminished capital resources and the ability to withstand financial distress. Second, the depth and breadth of experience of management in private companies tends to be less than that at public companies, which makes such companies more likely to depend on the management talents and efforts of a smaller group of persons and/or persons. Therefore, the decisions made by such management teams and/or the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our investments and, in turn, on us. Third, the investments themselves tend to be less liquid. As such, we may have difficulty exiting an investment promptly or at a desired price prior to maturity or outside of a normal amortization schedule. As a result, the relative lack of liquidity and the potential diminished capital resources of our target portfolio companies may affect our investment returns. Fourth, limited public information generally exists about private companies. Fifth, these companies may not have third-party debt ratings or audited financial statements. We must therefore rely on the ability of the Adviser to obtain adequate information through due diligence to evaluate the creditworthiness and potential returns from investing in these companies. The Adviser typically assesses an investment in a portfolio company based on the Adviser&#x2019;s estimate of the portfolio company&#x2019;s earnings and enterprise value, among other things, and these estimates may be based on limited information and may otherwise be inaccurate, causing the Adviser to make different investment decisions than it may have made with more complete information. These private companies and their financial information are not subject to the Sarbanes-Oxley Act and other rules that govern public companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-60" id="f-94">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our investments in securities or assets of publicly-traded companies are subject to the risks inherent in investing in public securities.&lt;/span&gt;&lt;/div&gt;We may invest a portion of our portfolio in publicly-traded assets. For example, it is not expected that we will be able to negotiate additional financial covenants or other contractual rights, which we might otherwise be able to obtain in making privately negotiated investments. In addition, by investing in publicly-traded securities or assets, we will be subject to U.S. federal and state securities laws, as well as non-U.S. securities laws, that may, among other things, restrict or prohibit our ability to make or sell an investment. Moreover, we may not have the same access to information in connection with investments in public securities, either when investigating a potential investment or after making an investment, as compared to privately negotiated investments. Furthermore, we may be limited in our ability to make investments and to sell existing investments in public securities because the Firm may be deemed to have material, non-public information regarding the issuers of those securities or as a result of other internal policies. The inability to sell public securities in these circumstances could materially adversely affect our investment results. In addition, an investment may be sold by us to a public company where the consideration received is a combination of cash and stock of the public company, which may, depending on the securities laws of the relevant jurisdiction, be subject to lock-up periods.</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-61" id="f-95">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;A lack of liquidity in certain of our investments may adversely affect our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally invest in companies whose securities are not publicly-traded or actively traded on the secondary market, and whose securities are subject to legal and other restrictions on resale or will otherwise be less liquid than publicly-traded securities. The illiquidity of certain of our investments may make it difficult for us to sell these investments when desired. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we had previously recorded these investments. The reduced liquidity of our investments may make it difficult for us to dispose of them at a favorable price, and, as a result, we may suffer losses.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-62" id="f-96">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may not have the funds or ability to make additional investments in our portfolio companies or to fund our unfunded debt commitments. After our initial investment in a portfolio company, we may be called upon from time to time to provide additional funds to such company or have the opportunity to increase our investment through the exercise of a warrant to purchase shares. There is no assurance that we will make, or will have sufficient funds to make, follow-on investments. Any decisions not to make a follow-on investment or any inability on our part to make such an investment may have a negative impact on a portfolio company in need of such an investment, may result in a missed opportunity for us to increase our participation in a successful operation or may reduce the expected return on the investment.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-63" id="f-97">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our investments may include original issue discount and payment-in-kind instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To the extent that we invest in original issue discount or payment-in-kind (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;PIK&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) instruments and the accretion of original issue discount or PIK interest income constitutes a portion of our income, we will be exposed to risks associated with the requirement to include such non-cash income in taxable and accounting income prior to receipt of cash, including the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the higher interest rates on PIK instruments reflect the payment deferral and increased credit risk associated with these instruments, and PIK instruments generally represent a significantly higher credit risk than coupon loans;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;original issue discount and PIK instruments may have unreliable valuations because the accruals require judgments about collectability of the deferred payments and the value of any associated collateral;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;an election to defer PIK interest payments by adding them to the principal on such instruments increases our future investment income which increases our gross assets and, as such, increases the Adviser&#x2019;s future base management fees which, thus, increases the Adviser&#x2019;s future income incentive fees at a compounding rate;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;market prices of PIK instruments and other zero-coupon instruments are affected to a greater extent by interest rate changes, and may be more volatile than instruments that pay interest periodically in cash. While PIK instruments are usually less volatile than zero-coupon debt instruments, PIK instruments are generally more volatile than cash pay securities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the deferral of PIK interest on an instrument increases the loan-to-value ratio, which is a measure of the riskiness of a loan, with respect to such instrument;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;even if the conditions for income accrual under GAAP are satisfied, a borrower could still default when actual payment is due upon the maturity of such loan;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;for accounting purposes, cash distributions to investors representing original issue discount income do not come from paid-in capital, although they may be paid from the offering proceeds. Thus, although a distribution of original issue discount income may come from the cash invested by investors, the 1940 Act does not require that investors be given notice of this fact;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the required recognition of original issue discount or PIK interest for U.S. federal income tax purposes may have a negative impact on liquidity, as it represents a non-cash component of our investment company taxable income that may require cash distributions to shareholders in order to maintain our ability to be subject to tax as a RIC; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;original issue discount may create a risk of non-refundable cash payments to the Adviser based on non-cash accruals that may never be realized.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-64" id="f-98">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may enter into a TRS agreement that exposes us to certain risks, including market risk, liquidity risk and other risks similar to those associated with the use of leverage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A total return swap (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;TRS&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) is a contract in which one party agrees to make periodic payments to another party based on the change in the market value of the assets underlying the TRS, which may include a specified security, basket of securities or securities indices during a specified period, in return for periodic payments based on a fixed or variable interest rate. A TRS effectively adds leverage to a portfolio by providing investment exposure to a security or market without owning or taking physical custody of such security or investing directly in such market. Because of the unique structure of a TRS, a TRS often offers lower financing costs than are offered through more traditional borrowing arrangements. The Company would typically have to post collateral to cover this potential obligation. To the extent the Company complied with the applicable requirements of Rule 18f-4, the leverage incurred through TRS will not be considered a borrowing for purposes of the Company&#x2019;s overall leverage limitation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A TRS is subject to market risk, liquidity risk and risk of imperfect correlation between the value of the TRS and the loans underlying the TRS. In addition, we may incur certain costs in connection with the TRS that could in the aggregate be significant. A TRS is also subject to the risk that a counterparty will default on its payment obligations thereunder or that we will not be able to meet our obligations to the counterparty.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-65" id="f-99">&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may enter into repurchase agreements or reverse repurchase agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to our investment objectives and policies, we may invest in repurchase agreements as a buyer for investment purposes. Repurchase agreements typically involve the acquisition by us of debt securities from a selling financial institution such as a bank, savings and loan association or broker-dealer. The agreement provides that we will sell the securities back to the institution at a fixed time in the future for the purchase price plus premium (which often reflects the interests). We do not bear the risk of a decline in the value of the underlying security unless the seller defaults under its repurchase obligation. In the event of the bankruptcy or other default of a seller of a repurchase agreement, we could experience both delays in liquidating the underlying securities and losses, including (1) possible decline in the value of the underlying security during the period in which we seek to enforce its rights thereto; (2) possible lack of access to income on the underlying security during this period; and (3) expenses of enforcing its rights. In addition, as described above, the value of the collateral underlying the repurchase agreement will be at least equal to the repurchase price, including any accrued interest earned on the repurchase agreement. In the event of a default or bankruptcy by a selling financial institution, we generally will seek to liquidate such collateral. However, the exercise of our right to liquidate such collateral could involve certain costs or delays and, to the extent that proceeds from any sale upon a default of the obligation to repurchase were less than the repurchase price, we could suffer a loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to our investment objectives and policies, we invest in repurchase agreements as a seller, also known as a &#x201c;reverse repurchase agreement.&#x201d; Our use of reverse repurchase agreements involves many of the same risks involved in our use of leverage, as the proceeds from reverse repurchase agreements are generally invested in additional portfolio investments. There is a risk that the market value of the securities acquired from the proceeds received in connection with a reverse repurchase agreement may decline below the price of the securities underlying the reverse repurchase agreement that we have sold but remain obligated to repurchase. Reverse repurchase agreements also involve the risk that the counterparty liquidates the securities we delivered to it under the reverse repurchase agreements following the occurrence of an event of default under the applicable repurchase agreement by us. In addition, there is a risk that the market value of the securities we retain may decline. If the buyer of securities under a reverse repurchase agreement were to file for bankruptcy or experiences insolvency, we may be adversely affected. Furthermore, our counterparty may require us to provide additional margin in the form of cash, securities or other forms of collateral under the terms of the derivative contract. Also, in entering into reverse repurchase agreements, we bear the risk of loss to the extent that the proceeds of the reverse repurchase agreement are less than the value of the underlying securities. In addition, the interest costs associated with reverse repurchase agreements transactions, may adversely affect our results of operations and financial condition, and, in some cases, we may be worse off than if we had not used such instruments.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-66" id="f-100">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may enter into securities lending agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may from time to time make secured loans of our marginable securities to brokers, dealers and other financial institutions if our asset coverage, as defined in the 1940 Act, is at or above 150% immediately after each such loan. The risks in lending portfolio securities, as with other extensions of credit, consist of possible delay in recovery of the securities or possible loss of rights in the collateral should the borrower fail financially. However, such loans will be made only to brokers and other financial institutions that are believed by the Adviser to be of high credit standing. Securities loans are made to broker-dealers pursuant to agreements requiring that loans be continuously secured by collateral consisting of U.S. government securities, cash or cash equivalents (e.g., negotiable certificates of deposit, bankers&#x2019; acceptances or letters of credit) maintained on a daily mark-to-market basis in an amount at least equal at all times to the market value of the securities lent. If the Company enters into a securities lending arrangement, the Adviser, as part of its responsibilities under the Investment Advisory Agreement, will invest the Company&#x2019;s cash collateral in accordance with the Company&#x2019;s investment objectives and strategies. The Company will pay the borrower of the securities a fee based on the amount of the cash collateral posted in connection with the securities lending program. The borrower will pay to the Company, as the lender, an amount equal to any dividends or interest received on the securities lent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may invest the cash collateral received only in accordance with its investment objectives, subject to the Company&#x2019;s agreement with the borrower of the securities. In the case of cash collateral, the Company expects to pay a rebate to the borrower. The reinvestment of cash collateral will result in a form of effective leverage for the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although voting rights or rights to consent with respect to the loaned securities pass to the borrower, the Company, as the lender, will retain the right to call the loans and obtain the return of the securities loaned at any time on reasonable notice, and it will do so in order that the securities may be voted by the Company if the holders of such securities are asked to vote upon or consent to matters materially affecting the investment. The Company may also call such loans in order to sell the securities involved. When engaged in securities lending, the Company&#x2019;s performance will continue to reflect changes in the value of the securities loaned and will also reflect the receipt of interest through investment of cash collateral by the Company in permissible investments.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-67" id="f-101">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may from time to time enter into credit default swaps or other derivative transactions which expose us to certain risks, including credit risk, market risk, liquidity risk and other risks similar to those associated with the use of leverage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may from time to time enter into credit default swaps or other derivative transactions that seek to modify or replace the investment performance of a particular reference security or other asset. These transactions are typically individually negotiated, non-standardized agreements between two parties to exchange payments, with payments generally calculated by reference to a notional amount or quantity. Swap contracts and similar derivative contracts are not traded on exchanges; rather, banks and dealers act as principals in these markets. These investments may present risks in excess of those resulting from the referenced security or other asset. Because these transactions are not an acquisition of the referenced security or other asset itself, the investor has no right directly to enforce compliance with the terms of the referenced security or other asset and has no voting or other consensual rights of ownership with respect to the referenced security or other asset. In the event of insolvency of a counterparty, we will be treated as a general creditor of the counterparty and will have no claim of title with respect to the referenced security or other asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A credit default swap is a contract in which one party buys or sells protection against a credit event with respect to an issuer, such as an issuer&#x2019;s failure to make timely payments of interest or principal on its debt obligations, bankruptcy or restructuring during a specified period. Generally, if we sell credit protection using a credit default swap, we will receive fixed payments from the swap counterparty and if a credit event occurs with respect to the applicable issuer, we will pay the swap counterparty par for the issuer&#x2019;s defaulted debt securities and the swap counterparty will deliver the defaulted debt securities to us. Generally, if we buy credit protection using a credit default swap, we will make fixed payments to the counterparty and if a credit event occurs with respect to the applicable issuer, we will deliver the issuer&#x2019;s defaulted securities underlying the swap to the swap counterparty and the counterparty will pay us par for the defaulted securities. Alternatively, a credit default swap may be cash settled and the buyer of protection would receive the difference between the par value and the market value of the issuer&#x2019;s defaulted debt securities from the seller of protection.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit default swaps are subject to the credit risk of the underlying issuer. If we are selling credit protection, there is a risk that we will not properly assess the risk of the underlying issuer, a credit event will occur and we will have to pay the counterparty. If we are buying credit protection, there is a risk that we will not properly assess the risk of the underlying issuer, no credit event will occur and we will receive no benefit for the premium paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A derivative transaction is also subject to the risk that a counterparty will default on its payment obligations thereunder or that we will not be able to meet our obligations to the counterparty. In some cases, we may post collateral to secure our obligations to the counterparty, and we may be required to post additional collateral upon the occurrence of certain events such as a decrease in the value of the reference security or other asset. In some cases, the counterparty may not collateralize any of its obligations to us. Derivative investments effectively add leverage to a portfolio by providing investment exposure to a security or market without owning or taking physical custody of such security or investing directly in such market. In addition to the risks described above, such arrangements are subject to risks similar to those associated with the use of leverage. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain categories of credit default swaps are subject to mandatory clearing, and more categories may be subject to mandatory clearing in the future. The counterparty risk for cleared derivatives is generally lower than for uncleared over-the-counter derivative transactions because generally a clearing organization becomes substituted for each counterparty to a cleared derivative contract and, in effect, guarantees the parties&#x2019; performance under the contract as each party to a trade looks only to the clearing house for performance of financial obligations. However, there can be no assurance that a clearing house, or its members, will satisfy the clearing house&#x2019;s obligations (including, but not limited to, financial obligations and legal obligations to segregate margins collected by the clearing house) to the Company. Counterparty risk with respect to certain exchange-traded and over-the-counter derivatives are considered as part of the value at risk provisions of Rule 18f-4. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Risk Factors&#x2014;Risks Related to Debt Financing.&#x201d;&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-68" id="f-102">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may acquire various financial instruments for purposes of &#x201c;hedging&#x201d; or reducing our risks, which may be costly and ineffective and could reduce our cash available for distribution to our shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may seek to hedge against interest rate and currency exchange rate fluctuations and credit risk by using financial instruments such as futures, options, swaps and forward contracts, subject to the requirements of the 1940 Act. These financial instruments may be purchased on exchanges or may be individually negotiated and traded in over-the-counter markets. Use of such financial instruments for hedging purposes may present significant risks, including the risk of loss of the amounts invested. Defaults by the other party to a hedging transaction can result in losses in the hedging transaction. Hedging activities also involve the risk of an imperfect correlation between the hedging instrument and the asset being hedged, which could result in losses both on the hedging transaction and on the instrument being hedged. Use of hedging activities may not prevent significant losses and could increase our losses. Further, hedging transactions may reduce cash available to pay distributions to our shareholders.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-69" id="f-103">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to the risk that the investments we make in our portfolio companies may be repaid prior to maturity. When this occurs, we will generally reinvest these proceeds in temporary investments, pending their future investment in new portfolio companies. These temporary investments will typically have substantially lower yields than the debt being prepaid and we could experience significant delays in reinvesting these amounts. Any future investment in a new portfolio company may also be at lower yields than the debt that was repaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Additionally, prepayments, net of prepayment fees, could negatively impact our return on equity.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-70" id="f-104">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Technological or other innovations and industry disruptions may negatively impact us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recent trends in the market generally have been toward disrupting the industry with technological or other innovations, and multiple young companies have been successful in capitalizing on this trend toward disruption. In this period of rapid technological and commercial innovation, new businesses and approaches may be created that could affect the Company and/or its portfolio companies or alter the market practices that help frame its strategy. Any of these new approaches could damage the Company&#x2019;s investments, significantly disrupt the market in which it operates and subject it to increased competition, which could materially and adversely affect its business, financial condition and results of investments. Moreover, given the pace of innovation in recent years, the impact on a particular investment may not have been foreseeable at the time we made the investment. Furthermore, we could base investment decisions on views about the direction or degree of innovation that prove inaccurate and lead to losses.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-71" id="f-105">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may invest through various joint ventures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may hold a portion of its investments through partnerships, joint ventures, securitization vehicles or other entities with third-party investors (collectively, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;joint ventures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). Joint venture investments involve various risks, including the risk that we will not be able to implement investment decisions or exit strategies because of limitations on our control under applicable agreements with joint venture partners, the risk that a joint venture partner may become bankrupt or may at any time have economic or business interests or goals that are inconsistent with those of the Company, the risk that a joint venture partner may be in a position to take action contrary to the Company&#x2019;s objectives, the risk of liability based upon the actions of a joint venture partner and the risk of disputes or litigation with such partner and the inability to enforce fully all rights (or the incurrence of additional risk in connection with enforcement of rights) one partner may have against the other, including in connection with foreclosure on partner loans, because of risks arising under state law. In addition, we may, in certain cases, be liable for actions of our joint venture partners. The joint ventures in which we participate may sometimes be allocated investment opportunities that might have otherwise gone entirely to the Company, which may reduce our return on equity. Additionally, our joint venture investments may be held on an unconsolidated basis and at times may be highly leveraged. Such leverage would not count toward the investment limits imposed on us by the 1940 Act.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-72" id="f-106">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We are subject to risks associated with investing alongside other third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;We may invest in joint ventures alongside third parties through joint ventures, partnerships or other entities in the future. Such investments may involve risks not present in investments where a third party is not involved, including the possibility that such third party may at any time have economic or business interests or goals which are inconsistent with ours, or may be in a position to take action contrary to our investment objectives. In addition, we may in certain circumstances be liable for actions of such third party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;More specifically, joint ventures involve a third party that has approval rights over activity of the joint venture. The third party may take actions that are inconsistent with our interests. For example, the third party may decline to approve an investment for the joint venture that we otherwise want the joint venture to make. A joint venture may also use investment leverage which magnifies the potential for gain or loss on amounts invested. Generally, the amount of borrowing by the joint venture is not included when calculating our total borrowing and related leverage ratios and is not subject to asset coverage requirements imposed by the 1940 Act. If the activities of the joint venture were required to be consolidated with our activities because of a change in GAAP rules or SEC staff interpretations, it is likely that we would have to reorganize any such joint venture.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-73" id="f-107">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may syndicate co-investment opportunities, which may be costly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may make an investment with the expectation of offering a portion of its interests therein as a co-investment opportunity to third-party investors. There can be no assurance that we will be successful in syndicating any such co-investment, in whole or in part, that the closing of such co-investment will be consummated in a timely manner, that any syndication will take place on terms and conditions that will be preferable for the Company or that expenses incurred by us with respect to any such syndication will not be substantial. In the event that we are not successful in syndicating any such co-investment, in whole or in part, we may consequently hold a greater concentration and have more exposure in the related investment than initially was intended, which could make the Company more susceptible to fluctuations in value resulting from adverse economic and/or business conditions with respect thereto. Moreover, an investment by the Company that is not syndicated to co-investors as originally anticipated could significantly reduce our overall investment returns.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-74" id="f-108">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may use a wide range of investment techniques that could expose us to a diverse range of risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser may employ investment techniques or invest in instruments that it believes will help achieve our investment objectives, whether or not such investment techniques or instruments are specifically defined herein, so long as such investments are consistent with our investment strategies and objectives and subject to applicable law. Such investment techniques or instruments may not be thoroughly tested in the market before being employed and may have operational or theoretical shortcomings which could result in unsuccessful investments and, ultimately, losses to us. In addition, any such investment technique or instrument may be more speculative than other investment techniques or instruments specifically described herein and may involve material and unanticipated risks. There can be no assurance that the Adviser will be successful in implementing any such investment technique. Furthermore, the diversification and type of investments may differ substantially from our prior investments.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-75" id="f-109">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The Adviser and its affiliates, including our officers and some of our trustees, face conflicts of interest caused by compensation arrangements with us and our affiliates, which could result in actions that are not in the best interests of our shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser and its affiliates receive substantial fees from us in return for their services, and these fees could influence the advice provided to us. We pay to the Adviser an incentive fee that is based on the performance of our portfolio and an annual base management fee that is based on the average value of our gross assets at the end of the two most recently completed calendar quarters. Because the incentive fee is based on the performance of our portfolio, the Adviser may be incentivized to make investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The way in which the incentive fee is determined may also encourage the Adviser to use leverage to increase the return on our investments. In addition, because the base management fee is based on the average value of our gross assets at the end of the two most recently completed calendar quarters, which includes any borrowings for investment purposes, the Adviser may be incentivized to recommend the use of leverage or the issuance of additional equity to make additional investments and increase the average value of our gross assets at the end of the two most recently completed calendar quarters. Under certain circumstances, the use of leverage may increase the likelihood of default, which could disfavor our shareholders. Our compensation arrangements could therefore result in our making riskier or more speculative investments, or relying more on leverage to make investments, than would otherwise be the case. This could result in higher investment losses, particularly during cyclical economic downturns. See&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.&#x201d;&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-76" id="f-110">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may be obligated to pay the Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Investment Advisory Agreement entitles the Adviser to receive Pre-Incentive Fee Net Investment Income Returns regardless of any capital losses. In such case, we may be required to pay the Adviser incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or if we incur a net loss for that quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, any Pre-Incentive Fee Net Investment Income Returns may be computed and paid on income that may include interest that has been accrued but not yet received. If a portfolio company defaults on a loan that is structured to provide accrued interest, it is possible that accrued interest previously included in the calculation of the incentive fee will become uncollectible. The Adviser is not under any obligation to reimburse us for any part of the incentive fee it received that was based on accrued income that we never received as a result of a default by an entity on the obligation that resulted in the accrual of such income, and such circumstances would result in our paying an incentive fee on income we never received.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-77" id="f-111">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The incentive fee based on income takes into account our past performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Incentive Fee based on income is determined and paid quarterly in arrears at the end of each calendar quarter by reference to our aggregate net investment income, as adjusted, from the calendar quarter then ending and the Trailing Twelve Quarters. The effect of calculating the incentive fee using reference to the Trailing Twelve Quarters is that, in certain circumstances, an incentive fee based on income is payable to the Adviser although our net income for such quarter did not exceed the hurdle rate or the incentive fee will be higher than it would have been if calculated based on our performance for the applicable quarter without taking into account the Trailing Twelve Quarters. For example, if we experience a net loss for any particular quarter, an incentive fee may still be paid to the Adviser if such net loss is less than the net loss for the most recent quarter that preceded the Trailing Twelve Quarters. In such circumstances, the Adviser would be entitled to an incentive fee whereas it would not have been entitled to an incentive fee if calculated solely on the basis of our performance for the applicable quarter.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-78" id="f-112">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;There may be conflicts of interest related to obligations that the Adviser&#x2019;s senior management and Investment Team have to Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The members of the senior management and Investment Team of the Adviser serve or may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do, or of investment funds managed by the same personnel. In serving in these multiple capacities, they may have obligations to Other Clients or investors in those entities, the fulfillment of which may not be in our best interests or in the best interest of our shareholders. Our investment objectives may overlap with the investment objectives of such investment funds, accounts or other investment vehicles. In particular, we will rely on the Adviser to manage our day-to-day activities and to implement our investment strategy. The Adviser and certain of its affiliates are presently, and plan in the future to continue to be, involved with activities that are unrelated to us. As a result of these activities, the Adviser, its officers and employees and certain of its affiliates will have conflicts of interest in allocating their time between us and other activities in which they are or may become involved, including the management of its affiliated equipment funds. The Adviser and its officers and employees will devote only as much of its or their time to our business as the Adviser and its officers and employees, in their judgment, determine is reasonably required, which may be substantially less than their full time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We rely, in part, on the Adviser to assist with identifying investment opportunities and making investment recommendations to the Adviser. The Adviser and its affiliates are not restricted from forming additional investment funds, entering into other investment advisory relationships or engaging in other business activities. These activities could be viewed as creating a conflict of interest in that the time and effort of the members of the Adviser, its affiliates and their officers and employees will not be devoted exclusively to our business, but will be allocated between us and such other business activities of the Adviser and its affiliates in a manner that the Adviser deems necessary and appropriate consistent with its fiduciary duties and the 1940 Act. See&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.&#x201d;&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-79" id="f-113">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The time and resources that individuals employed by the Adviser devote to us may be diverted and we may face additional competition due to the fact that individuals employed by the Adviser are not prohibited from raising money for or managing other entities that make the same types of investments that we target.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser and individuals employed by the Adviser are generally not prohibited from raising capital for and managing other investment entities that make the same types of investments as those we target. As a result, the time and resources that these individuals may devote to us may be diverted. In addition, we may compete with any such investment entity for the same investors and investment opportunities. We may participate in certain transactions originated by the Adviser or its affiliates under our exemptive relief from the SEC that allows us to engage in co-investment transactions with the Adviser and its affiliates, subject to certain terms and conditions. However, while the terms of the exemptive relief require that the Adviser will be given the opportunity to cause us to participate in certain transactions originated by affiliates of the Adviser, the Adviser may determine that we not participate in those transactions and for certain other transactions (as set forth in guidelines approved by the Board) the Adviser may not have the opportunity to cause us to participate. Affiliates of the Adviser, whose primary business includes the origination of investments or investing in non-originated assets, engage in investment advisory business with accounts that compete with us. See&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014; Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us."&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-80" id="f-114">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our shares may be purchased by the Adviser or its affiliates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Affiliates of the Adviser have purchased and in the future expect to purchase our shares. The Adviser and its affiliates will not acquire any shares with the intention to resell or re-distribute such shares. The purchase of shares by the Adviser and its affiliates could create certain risks, including, but not limited to, the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the Adviser and its affiliates may have an interest in disposing of our assets at an earlier date so as to recover their investment in our shares; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;substantial purchases of shares by the Adviser and its affiliates may limit the Adviser&#x2019;s ability to fulfill any financial obligations that it may have to us or incurred on our behalf.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-81" id="f-115">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The Adviser relies on key personnel, the loss of any of whom could impair its ability to successfully manage us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our future success depends, to a significant extent, on the continued services of the officers and employees of the Adviser or its affiliates. The loss of services of one or more members of the Adviser&#x2019;s management team, including members of the Investment Committee, could adversely affect our financial condition, business and results of operations. The Adviser does not have an employment agreement with any of these key personnel and we cannot guarantee that all, or any particular one, will remain affiliated with us and/or the Adviser. Further, we do not intend to separately maintain key person life insurance on any of these individuals.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-82" id="f-116">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We depend on the Adviser to select our investments and otherwise conduct our business, and any material adverse change in its financial condition or our relationship with the Adviser could have a material adverse effect on our business and ability to achieve our investment objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our success is dependent upon our relationship with, and the performance of, the Adviser in the acquisition and management of our portfolio investments, and our corporate operations, as well as the persons and firms the Adviser retains to provide services on our behalf. The Adviser may suffer or become distracted by adverse financial or operational problems in connection with Blackstone&#x2019;s business and activities unrelated to us and over which we have no control. Should the Adviser fail to allocate sufficient resources to perform its responsibilities to us for any reason, we may be unable to achieve our investment objectives or to pay distributions to our shareholders.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-83" id="f-117">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The compensation we pay to the Adviser will be determined without independent assessment on our behalf, and these terms may be less advantageous to us than if such terms had been the subject of arm&#x2019;s-length negotiations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Investment Advisory Agreement will not be entered into on an arm&#x2019;s-length basis with an unaffiliated third party. As a result, the form and amount of compensation we pay the Adviser may be less favorable to us than they might have been had an investment advisory agreement been entered into through arm&#x2019;s-length transactions with an unaffiliated third party.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-84" id="f-118">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The Adviser&#x2019;s influence on conducting our operations gives it the ability to increase its fees, which may reduce the amount of cash flow available for distribution to our shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser is paid a base management fee calculated as a percentage of our gross assets and unrelated to net income or any other performance base or measure. The Adviser may advise us to consummate transactions or conduct our operations in a manner that, in the Adviser&#x2019;s reasonable discretion, is in the best interests of our shareholders. These transactions, however, may increase the amount of fees paid to the Adviser. The Adviser&#x2019;s ability to influence the base management fee paid to it by us could reduce the amount of cash flow available for distribution to our shareholders.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-85" id="f-119">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;There may be trademark risk, as we do not own the Blackstone name.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not own the Blackstone name, but we are permitted to use it as part of our corporate name pursuant to the Investment Advisory Agreement. Use of the name by other parties or the termination of the Investment Advisory Agreement may harm our business.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-86" id="f-120">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may be subject to additional potential conflicts of interests as a consequence of Blackstone&#x2019;s status as a public company.&lt;/span&gt;&lt;/div&gt;As a consequence of Blackstone&#x2019;s status as a public company, our officers and trustees, and the employees&#160;of the Adviser may take into account certain considerations and other factors in connection with the management of the business and affairs of us and our affiliates that would not necessarily be taken into account if Blackstone were not a public company.</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-87" id="f-121">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The requirement that we invest a sufficient portion of our assets in Qualifying Assets could preclude us from investing in accordance with our current business strategy; conversely, the failure to invest a sufficient portion of our assets in Qualifying Assets could result in our failure to maintain our status as a BDC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 1940 Act, a BDC may not acquire any asset other than assets of the type listed in section 55(a) of the 1940 Act described as &#x201c;qualifying&#x201d; assets (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Qualifying Assets&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), unless, at the time of and after giving effect to such acquisition, at least 70% of our total assets are Qualifying Assets. Therefore, we may be precluded from investing in what we believe are attractive investments if such investments are not Qualifying Assets. Conversely, if we fail to invest a sufficient portion of our assets in Qualifying Assets, we could lose our status as a BDC, which would have a material adverse effect on our business, financial condition and results of operations. Similarly, these rules could prevent us from making additional investments in existing portfolio companies, which could result in the dilution of our position, or could require us to dispose of investments at an inopportune time to comply with the 1940 Act. If we were forced to sell non-qualifying investments in the portfolio for compliance purposes, the proceeds from such sale could be significantly less than the current value of such investments.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-88" id="f-122">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Failure to maintain our status as a BDC would reduce our operating flexibility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we do not remain a BDC, we might be regulated as a registered closed-end management investment company under the 1940 Act, which would subject us to substantially more regulatory restrictions under the 1940 Act and correspondingly decrease our operating flexibility.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-89" id="f-123">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Regulations governing our operation as a BDC and RIC will affect our ability to raise, and the way in which we raise, additional capital or borrow for investment purposes, which may have a negative effect on our growth.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of meeting the annual distribution requirement to avoid paying U.S. federal corporate income tax, as a RIC, we may need to periodically access the capital markets to raise cash in order to fund new investments. We may issue &#x201c;senior securities,&#x201d; as defined under the 1940 Act, including borrowing money from banks or other financial institutions only in amounts such that our asset coverage meets the threshold set forth in the 1940 Act immediately after each such issuance. The 1940 Act currently requires an asset coverage of at least 150% (i.e., the amount of debt may not exceed two-thirds of the value of our assets). Our ability to issue different types of securities is also limited. Compliance with these requirements may unfavorably limit our investment opportunities and reduce our ability in comparison to other companies to profit from favorable spreads between the rates at which we can borrow and the rates at which we can lend. As a BDC, therefore, we intend to continuously issue equity at a rate more frequent than our privately-owned competitors, which may lead to greater shareholder dilution. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For U.S. federal income tax purposes, we are required to recognize taxable income (which may include deferred interest that is accrued as original issue discount) in some circumstances in which we do not receive a corresponding payment in cash and to make distributions with respect to such income in order to avoid corporate income tax as a RIC. Under such circumstances, we may have difficulty meeting the annual distribution requirement necessary to eliminate any corporate income tax as a RIC under the Code. This difficulty in making the required distribution may be amplified to the extent that we are required to pay an incentive fee with respect to such accrued income. As a result, we may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital, or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may not meet the distribution requirements prescribed by the Code for a RIC and as such may become subject to corporate income tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We borrow for investment purposes. If the value of our assets declines, we may be unable to satisfy the asset coverage test, which would prohibit us from paying distributions and could result in a corporate income tax to the Company. If we cannot satisfy the asset coverage test, we may be required to sell a portion of our investments and, depending on the nature of our debt financing, repay a portion of our indebtedness at a time when such sales may be disadvantageous.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 1940 Act, we generally are prohibited from issuing or selling our shares at a price per share, after deducting selling commissions and dealer manager fees, that is below our NAV per share, which may be a disadvantage as compared with other public companies. We may, however, sell our shares, or warrants, options or rights to acquire our shares, at a price below the current NAV of our shares if our Board, including our independent trustees, determine that such sale is in our best interests and the best interests of our shareholders, and our shareholders, as well as those shareholders that are not affiliated with us, approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board, closely approximates the fair value of such securities.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-90" id="f-124">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our ability to enter into transactions with our affiliates is restricted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are prohibited under the 1940 Act from participating in certain transactions with certain of our affiliates (including portfolio companies of Other Clients) without the prior approval of a majority of the independent members of our Board and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of our outstanding voting securities will be our affiliate for purposes of the 1940 Act and generally we will be prohibited from buying or selling any securities from or to such affiliate, absent the prior approval of our Board. However, we may under certain circumstances purchase any such affiliate's loans or securities in the secondary market, which could create a conflict for the Adviser between our interests and the interests of such affiliate, in that the ability of the Adviser to recommend actions in our best interest may be limited. The 1940 Act also prohibits certain &#x201c;joint&#x201d; transactions with certain of our affiliates, which could include investments in the same portfolio company (whether at the same or closely related times), without prior approval of our Board and, in some cases, the SEC. If a person acquires more than 25% of our voting securities, we will be prohibited from buying or selling any security from or to such person or certain of that person&#x2019;s affiliates, or entering into prohibited joint transactions (including certain co-investments) with such persons, absent the prior approval of the SEC. Similar restrictions limit our ability to transact business with our officers, trustees, investment advisers, sub-advisers or their affiliates. As a result of these restrictions, we may be prohibited from buying or selling any security from or to any fund or any portfolio company of a fund managed by the Adviser, or entering into joint arrangements such as certain co-investments with these companies or funds without the prior approval of the SEC, which may limit the scope of investment opportunities that would otherwise be available to us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have obtained exemptive relief from the SEC that allows us to engage in co-investment transactions with the Adviser and its affiliates, subject to certain terms and conditions. However, while the terms of the exemptive relief require that the Adviser will be given the opportunity to cause us to participate in certain transactions originated by affiliates of the Adviser, the Adviser may determine that we not participate in those transactions and for certain other transactions (as set forth in guidelines approved by the Board) the Adviser may not have the opportunity to cause us to participate.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-91" id="f-125">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We are uncertain of our sources for funding our future capital needs; if we cannot obtain debt or equity financing on acceptable terms, our ability to acquire investments and to expand our operations will be adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds from the sale of shares will be used for our investment opportunities, operating expenses and for payment of various fees and expenses such as base management fees, incentive fees and other expenses. Any working capital reserves we maintain may not be sufficient for investment purposes, and we may require debt or equity financing to operate. Accordingly, in the event that we develop a need for additional capital in the future for investments or for any other reason, these sources of funding may not be available to us. Consequently, if we cannot obtain debt or equity financing on acceptable terms, our ability to acquire investments and to expand our operations will be adversely affected. As a result, we would be less able to create and maintain a broad portfolio of investments and achieve our investment objectives, which may negatively impact our results of operations and reduce our ability to make distributions to our shareholders.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-92" id="f-126">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We are a non-diversified investment company within the meaning of the 1940 Act, and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are classified as a non-diversified investment company within the meaning of the 1940 Act, which means that we are not limited by the 1940 Act with respect to the proportion of our assets that we may invest in securities of a single issuer. Under the 1940 Act, a &#x201c;diversified&#x201d; investment company is required to invest at least 75% of the value of its total assets in cash and cash items, government securities, securities of other investment companies and other securities limited in respect of any one issuer to an amount not greater than 5% of the value of the total assets of such company and no more than 10% of the outstanding voting securities of such issuer. As a non-diversified investment company, we are not subject to this requirement. To the extent that we assume large positions in the securities of a small number of issuers, or within a particular industry, our NAV may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market&#x2019;s assessment of the issuer. We may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company or to a general downturn in the economy. However, we will be subject to the diversification requirements applicable to RICs under Subchapter M of the Code.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-93" id="f-127">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;When we use leverage, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us. Leverage may also adversely affect the return on our assets, reduce cash available for distribution to our shareholders, and result in losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The use of borrowings, also known as leverage, increases the volatility of investments by magnifying the potential for loss on invested equity capital. When we use leverage to partially finance our investments, through borrowing from banks and other lenders, shareholders will experience increased risks of investing in our shares. If the value of our assets decreases, leveraging would cause NAV to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Such a decline could negatively affect our ability to make distributions to our shareholders. In addition, our shareholders will bear the burden of any increase in our expenses as a result of our use of leverage, including interest expenses and any increase in the management or incentive fees payable to the Adviser.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use and intend to continue to use leverage to finance our investments. The amount of leverage that we employ will depend on the Adviser&#x2019;s and our Board&#x2019;s assessment of market and other factors at the time of any proposed borrowing. There can be no assurance that leveraged financing will be available to us on favorable terms or at all. However, to the extent that we use leverage to finance our assets, our financing costs will reduce cash available for distributions to shareholders. Moreover, we may not be able to meet our financing obligations and, to the extent that we cannot, we risk the loss of some or all of our assets to liquidation or sale to satisfy the obligations. In such an event, we may be forced to sell assets at significantly depressed prices due to market conditions or otherwise, which may result in losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a BDC, we generally are required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred shares that we may issue in the future, of at least 150%. If this ratio were to fall below 150%, we could not incur additional debt and could be required to sell a portion of our investments to repay some debt when it is disadvantageous to do so. This could have a material adverse effect on our operations and investment activities. Moreover, our ability to make distributions to shareholders may be significantly restricted or we may not be able to make any such distributions whatsoever. The amount of leverage that we will employ will be subject to oversight by our Board of Trustees, a majority of whom are independent Trustees with no material interests in such transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may also enter into reverse repurchase agreements. Transactions under such agreements constitute leverage. When the Company enters into a reverse repurchase agreement, any fluctuations in the market value of either the securities transferred to another party or the securities in which the proceeds may be invested would affect the market value of the Company&#x2019;s assets. As a result, the use of such leverage transactions may increase fluctuations in the market value of the Company&#x2019;s assets compared to what would occur without the use of such transactions. Because reverse repurchase agreements may be considered to be the practical equivalent of borrowing funds, they constitute a form of leverage. If the Company reinvests the proceeds of a reverse repurchase agreement at a rate lower than the cost of the agreement, transacting under such agreement will lower the Company&#x2019;s yield. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although leverage has the potential to enhance overall returns that exceed the Company&#x2019;s cost of funds, they will further diminish returns (or increase losses on capital) to the extent overall returns are less than the Company&#x2019;s cost of funds. In addition, borrowings and reverse repurchase agreements or similar arrangements in which the Company may engage may be secured by the shareholders&#x2019; investments as well as by the Company&#x2019;s assets and the documentation relating to such transactions may provide that during the continuance of a default under such arrangement, the interests of the holders of Common Shares may be subordinated to the interests of the Company&#x2019;s lenders or debt-holders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our credit facilities and unsecured notes impose financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a regulated investment company under the 1940 Act. A failure to renew our facilities or to add new or replacement debt facilities or issue additional debt securities or other evidences of indebtedness could have a material adverse effect on our business, financial condition, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Item 7. Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations &#x2014; Financial Condition, Liquidity and Capital Resources&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information regarding our borrowings.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-94" id="f-128">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may default under our credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event we default under our credit facilities or other borrowings, our business could be adversely affected as we may be forced to sell a portion of our investments quickly and prematurely at what may be disadvantageous prices to us in order to meet our outstanding payment obligations and/or support working capital requirements under such borrowing facility, any of which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, following any such default, the agent for the lenders under such borrowing facility could assume control of the disposition of any or all of our assets, including the selection of such assets to be disposed and the timing of such disposition, which would have a material adverse effect on our business, financial condition, results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-95" id="f-129">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our current or future credit ratings may not reflect all risks of an investment in our debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any current or future credit ratings of us are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our current or future credit ratings will generally affect the market value of our debt securities. Our current or future credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of or trading market for the publicly issued debt securities.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-96" id="f-130">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The trading market or market value of our issued debt securities may fluctuate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our issued debt securities may or may not have an established trading market. We cannot assure our noteholders that a trading market for our issued debt securities will ever develop or be maintained if developed. In addition to our creditworthiness, many factors may materially adversely affect the trading market for, and market value of, our issued debt securities. These factors include, but are not limited to, the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the time remaining to the maturity of these debt securities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the outstanding principal amount of debt securities with terms identical to these debt securities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the ratings assigned by national statistical ratings agencies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the general economic environment;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the supply of debt securities trading in the secondary market, if any;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the redemption or repayment features, if any, of these debt securities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the level, direction and volatility of market interest rates generally; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;market rates of interest higher or lower than rates borne by the debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our noteholders should also be aware that there may be a limited number of buyers when they decide to sell their debt securities. This too may materially adversely affect the market value of the debt securities or the trading market for the debt securities.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-97" id="f-131">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Terms relating to redemption may materially adversely affect our noteholders return on any debt securities that we may issue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If our noteholders&#x2019; debt securities are redeemable at our option, we may choose to redeem their debt securities at times when prevailing interest rates are lower than the interest rate paid on their debt securities. In addition, if our noteholders&#x2019; debt securities are subject to mandatory redemption, we may be required to redeem their debt securities also at times when prevailing interest rates are lower than the interest rate paid on their debt securities. In this circumstance, our noteholders may not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as their debt securities being redeemed.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-98" id="f-132">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;If we issue preferred shares or convertible debt securities, the net asset value of our common shares may become more volatile.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We cannot assure you that the issuance of preferred shares and/or convertible debt securities would result in a higher yield or return to the holders of our common shares. The issuance of preferred shares or convertible debt would likely cause the NAV of our common shares to become more volatile. If the dividend rate on the preferred shares, or the interest rate on the convertible debt securities, were to approach the net rate of return on our investment portfolio, the benefit of such leverage to the holders of our common shares would be reduced. If the dividend rate on the preferred shares, or the interest rate on the convertible debt securities, were to exceed the net rate of return on our portfolio, the use of leverage would result in a lower rate of return to the holders of common shares than if we had not issued the preferred shares or convertible debt securities. Any decline in the NAV of our investment would be borne entirely by the holders of our common shares. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in NAV to the holders of our common shares than if we were not leveraged through the issuance of preferred shares or debt securities. This decline in NAV would also tend to cause a greater decline in the market price, if any, for our common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There is also a risk that, in the event of a sharp decline in the value of our net assets, we would be in danger of failing to maintain required asset coverage ratios, which may be required by the preferred shares or convertible debt, or our current investment income might not be sufficient to meet the dividend requirements on the preferred shares or the interest payments on the debt securities. In order to counteract such an event, we might need to liquidate investments in order to fund the redemption of some or all of the preferred shares or convertible debt. In addition, we would pay (and the holders of our common shares would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred shares, debt securities, convertible debt, or any combination of these securities. Holders of preferred shares or convertible debt may have different interests than holders of common shares and may at times have disproportionate influence over our affairs.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-99" id="f-133">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Holders of any preferred shares that we may issue will have the right to elect certain members of our Board and have class voting rights on certain matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 1940 Act requires that holders of preferred shares must be entitled as a class to elect two trustees at all times and to elect a majority of the trustees if dividends on such preferred shares are in arrears by two years or more, until such arrearage is eliminated. In addition, certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred shares, including changes in fundamental investment restrictions and conversion to open-end status and, accordingly, preferred shareholders could veto any such changes. Restrictions imposed on the declarations and payment of dividends or other distributions to the holders of our common shares and preferred shares, both by the 1940 Act and by requirements imposed by rating agencies, might impair our ability to maintain our tax treatment as a RIC for U.S. federal income tax purposes.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-100" id="f-134">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Provisions in a credit facility may limit our investment discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A credit facility may be backed by all or a portion of our loans and securities on which the lenders will have a security interest. We may pledge up to 100% of our assets and may grant a security interest in all of our assets under the terms of any debt instrument we enter into with lenders. We expect that any security interests we grant will be set forth in a pledge and security agreement and evidenced by the filing of financing statements by the agent for the lenders. In addition, we expect that the custodian for our securities serving as collateral for such loan would include in its electronic systems notices indicating the existence of such security interests and, following notice of occurrence of an event of default, if any, and during its continuance, will only accept transfer instructions with respect to any such securities from the lender or its designee. If we were to default under the terms of any debt instrument, the agent for the applicable lenders would be able to assume control of the timing of disposition of any or all of our assets securing such debt, which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In connection with one or more credit facilities entered into by the Company, distributions to shareholders may be subordinated to payments required in connection with any indebtedness contemplated thereby.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, any security interests and/or negative covenants required by a credit facility may limit our ability to create liens on assets to secure additional debt and may make it difficult for us to restructure or refinance indebtedness at or prior to maturity or obtain additional debt or equity financing. In addition, if our borrowing base under a credit facility were to decrease, we may be required to secure additional assets in an amount sufficient to cure any borrowing base deficiency. In the event that all of our assets are secured at the time of such a borrowing base deficiency, we could be required to repay advances under a credit facility or make deposits to a collection account, either of which could have a material adverse impact on our ability to fund future investments and to make distributions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we may be subject to limitations as to how borrowed funds may be used, which may include restrictions on geographic and industry concentrations, loan size, payment frequency and status, average life, collateral interests and investment ratings, as well as regulatory restrictions on leverage which may affect the amount of funding that may be obtained. There may also be certain requirements relating to portfolio performance, including required minimum portfolio yield and limitations on delinquencies and charge-offs, a violation of which could limit further advances and, in some cases, result in an event of default. An event of default under a credit facility could result in an accelerated maturity date for all amounts outstanding thereunder, which could have a material adverse effect on our business and financial condition. This could reduce our liquidity and cash flow and impair our ability to grow our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the effect of leverage on returns from an investment in our shares assuming various annual returns on our portfolio, net of expenses. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.626%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assumed Return on Our Portfolio (Net of Expenses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;-10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;-5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corresponding return to common stockholder&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;&#160;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-25.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-15.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-5.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Based on (i) $10.1 billion in total assets as of December&#160;31, 2023, (ii) $4.9 billion in outstanding indebtedness, at par, as of December&#160;31, 2023, (iii) $5.0 billion in net assets as of December&#160;31, 2023 and (iv)&#160;an annualized average interest rate, including fees (such as fees on undrawn amounts and amortization of financing costs), on our indebtedness, as of December&#160;31, 2023, of 5.05%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on an outstanding indebtedness, at par, of&#160;$4.9 billion&#160;as of&#160;December&#160;31, 2023 and the weighted average effective annual interest rate, including fees (such as fees on undrawn amounts and amortization of financing costs), of 5.05% as of that date, our investment portfolio at fair value would have had to produce an annual return of approximately 2.46% to cover annual interest payments on the outstanding debt. For more information on our indebtedness, see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Item 7.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x2014;Financial Condition, Liquidity and Capital Resources.&#x201d;&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:EffectsOfLeverageTableTextBlock contextRef="c-1" id="f-135">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the effect of leverage on returns from an investment in our shares assuming various annual returns on our portfolio, net of expenses. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.626%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assumed Return on Our Portfolio (Net of Expenses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;-10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;-5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corresponding return to common stockholder&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;&#160;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-25.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-15.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-5.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Based on (i) $10.1 billion in total assets as of December&#160;31, 2023, (ii) $4.9 billion in outstanding indebtedness, at par, as of December&#160;31, 2023, (iii) $5.0 billion in net assets as of December&#160;31, 2023 and (iv)&#160;an annualized average interest rate, including fees (such as fees on undrawn amounts and amortization of financing costs), on our indebtedness, as of December&#160;31, 2023, of 5.05%.&lt;/span&gt;&lt;/div&gt;</cef:EffectsOfLeverageTableTextBlock>
    <cef:EffectsOfLeveragePurposeTextBlock contextRef="c-1" id="f-136">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the effect of leverage on returns from an investment in our shares assuming various annual returns on our portfolio, net of expenses. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below.&lt;/span&gt;</cef:EffectsOfLeveragePurposeTextBlock>
    <cef:ReturnAtMinusTenPercent contextRef="c-1" decimals="4" id="f-137" unitRef="number">-0.2552</cef:ReturnAtMinusTenPercent>
    <cef:ReturnAtMinusFivePercent contextRef="c-1" decimals="4" id="f-138" unitRef="number">-0.1528</cef:ReturnAtMinusFivePercent>
    <cef:ReturnAtZeroPercent contextRef="c-1" decimals="4" id="f-139" unitRef="number">-0.0503</cef:ReturnAtZeroPercent>
    <cef:ReturnAtPlusFivePercent contextRef="c-1" decimals="4" id="f-140" unitRef="number">0.0521</cef:ReturnAtPlusFivePercent>
    <cef:ReturnAtPlusTenPercent contextRef="c-1" decimals="4" id="f-141" unitRef="number">0.1545</cef:ReturnAtPlusTenPercent>
    <cef:RiskTextBlock contextRef="c-101" id="f-142">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Changes in interest rates may affect our cost of capital and net investment income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since we use debt to finance a portion of our investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In periods of rising interest rates when we have debt outstanding, our cost of funds will increase, which could reduce our net investment income. We expect that our long-term fixed-rate investments will be financed primarily with equity and long-term debt. We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. These techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. These activities may limit our ability to participate in the benefits of lower interest rates with respect to the hedged portfolio. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations. Also, we have limited experience in entering into hedging transactions, and we will initially have to purchase or develop such expertise.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-102" id="f-143">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Compliance with SEC Rule 18f-4 governing derivatives and use of leverage may limit our investment discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Among other things, Rule 18f-4 under the 1940 Act, eliminates the asset segregation framework arising from prior SEC guidance for covering positions in derivatives and certain financial instruments. Rule 18f-4 also limits a fund&#x2019;s derivatives exposure through a value-at-risk test and requires the adoption and implementation of a derivatives risk management program for certain derivatives users. Subject to certain conditions, limited derivatives users (as defined in Rule 18f-4), such as the Company, however, would not be subject to the full requirements of Rule 18f-4. Under Rule 18f-4, a fund may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the fund has, among other things, a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. The Company has adopted policies and procedures to comply with the requirements of the rule. Compliance with Rule 18f-4 may limit our ability to use derivatives and/or enter into certain other financial contracts.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-103" id="f-144">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may form CLOs in the future, which may subject us to certain structured financing risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To finance investments, we may securitize certain of our secured loans or other investments, including through the formation of one or more CLOs, while retaining all or most of the exposure to the performance of these investments. This would involve contributing a pool of assets to a special purpose entity, and selling debt interests in such entity on a non-recourse or limited-recourse basis to purchasers. Depending on how these CLOs are structured, an interest in any such CLO held by us may be considered a &#x201c;non-qualifying&#x201d; portfolio investment for purposes of the 1940 Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the CLOs we may in the future create we will depend in part on distributions from the CLO&#x2019;s assets out of its earnings and cash flows to enable us to make distributions to shareholders. The ability of a CLO to make distributions will be subject to various limitations, including the terms and covenants of the debt it issues. Also, a CLO may take actions that delay distributions in order to preserve ratings and to keep the cost of present and future financings lower or the CLO may be obligated to retain cash or other assets to satisfy over-collateralization requirements commonly provided for holders of the CLO&#x2019;s debt, which could impact our ability to receive distributions from the CLO. If we do not receive cash flow from any such CLO that is necessary to satisfy the annual distribution requirement for maintaining RIC status, and we are unable to obtain cash from other sources necessary to satisfy this requirement, we may not maintain our qualification as a RIC, which would have a material adverse effect on an investment in the shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, a decline in the credit quality of loans in a CLO due to poor operating results of the relevant borrowers, declines in the value of loan collateral or increases in defaults, among other things, may force a CLO to sell certain assets at a loss, reducing their earnings and, in turn, cash potentially available for distribution to us for distribution to shareholders. To the extent that any losses are incurred by the CLO in respect of any collateral, such losses will be borne first by us as owner of equity interests in the CLO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The manager for a CLO that we create may be the Company, the Adviser or an affiliate, and such manager may be entitled to receive compensation for structuring and/or management services. To the extent the Adviser or an affiliate other than the Company serves as manager and the Company is obligated to compensate the Adviser or the affiliate for such services, we, the Adviser or the affiliate will implement offsetting arrangements to assure that we, and indirectly, our shareholders, pay no additional management fees to the Adviser or the affiliate in connection therewith. To the extent we serve as manager, we will waive any right to receive fees for such services from the Company (and indirectly its shareholders) or any affiliate.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-104" id="f-145">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We will be subject to corporate-level income tax if we are unable to maintain RIC tax treatment under Subchapter M of the Code or satisfy RIC distribution requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To obtain and maintain RIC tax treatment under Subchapter M of the Code, we must, among other things, meet annual distribution, income source and quarterly asset diversification requirements. If we do not qualify for or maintain RIC tax treatment for any reason and are subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-105" id="f-146">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For federal income tax purposes, we may be required to recognize taxable income in circumstances in which we do not receive a corresponding payment in cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount (such as zero-coupon securities, debt instruments with PIK interest or, in certain cases, increasing interest rates or debt instruments that were issued with warrants), we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. We may also have to include in income other amounts that we have not yet received in cash, such as deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. We anticipate that a portion of our income may constitute original issue discount or other income required to be included in taxable income prior to receipt of cash. Furthermore, we have elected to amortize market discount and include such amounts in our taxable income on a current basis, instead of upon disposition of the applicable debt obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because any original issue discount, market discount or other amounts accrued will be included in our investment company taxable income for the year of the accrual, we may be required to make a distribution to our shareholders in order to satisfy the annual distribution requirement, even though we will not have received any corresponding cash amount. As a result, we may have difficulty meeting the annual distribution requirement necessary to eliminate any corporate income tax as a RIC under Subchapter M of the Code. We may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may not qualify for or maintain RIC tax treatment and thus we may become subject to corporate-level income tax.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-106" id="f-147">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Some of our investments may be subject to corporate-level income tax.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may invest in certain debt and equity investments through taxable subsidiaries and the taxable income of these taxable subsidiaries will be subject to federal and state corporate income taxes. We may invest in certain foreign debt and equity investments which could be subject to foreign taxes (such as income tax, withholding and value added taxes).&lt;/span&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-107" id="f-148">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our portfolio investments may present special tax issues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expects to invest in debt securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Investments in these types of instruments may present special tax issues for the Company. U.S. federal income tax rules are not entirely clear about issues such as when the Company may cease to accrue interest, original issue discount or market discount, when and to what extent deductions may be taken for bad debts or worthless instruments, how payments received on obligations in default should be allocated between principal and income and whether exchanges of debt obligations in a bankruptcy or workout context are taxable. These and other issues will be addressed by the Company, to the extent necessary, to preserve its status as a RIC and to distribute sufficient income to not become subject to U.S. federal income tax.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-108" id="f-149">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legislative or regulatory tax changes could adversely affect investors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At any time, the federal income tax laws governing RICs or the administrative interpretations of those laws or regulations may be amended. Any of those new laws, regulations or interpretations may take effect retroactively and could adversely affect the taxation of us or our shareholders. Therefore, changes in tax laws, regulations or administrative interpretations or any amendments thereto could diminish the value of an investment in our shares or the value or the resale potential of our investments.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-109" id="f-150">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We cannot assure you that the market price of common shares will not decline below the IPO price or below our NAV. The market price of common shares may be volatile and may fluctuate substantially.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We currently list our common shares on the NYSE under the symbol &#x201c;BXSL.&#x201d; We cannot assure you that the trading market can be sustained. In addition, we cannot predict the prices at which our common shares will trade. Shares of closed-end management investment companies, including BDCs, frequently trade at a discount from their NAV and our shares may also be discounted in the market. This characteristic of closed-end management investment companies is separate and distinct from the risk that our NAV per share may decline. We cannot predict whether our common shares will trade at, above or below NAV. The risk of loss associated with this characteristic of closed-end management investment companies may be greater for investors expecting to sell common shares purchased in the offering soon after the offering. In addition, if our common shares trades below its NAV, we will generally not be able to sell additional common shares to the public at its market price without first obtaining the approval of a majority of our shareholders (including a majority of our unaffiliated shareholders) and our independent directors for such issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The market price and liquidity of the market for our common shares may be si&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;gnificantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;significant volatility in the market price and trading volume of securities of BDCs or other companies in the sector in which we operate, which are not necessarily related to the operating performance of these companies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;loss of RIC or BDC status;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in earnings or variations in operating results;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in the value of our portfolio of investments;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in accounting guidelines governing valuation of our investments;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;any shortfall in revenue or net income or any increase in losses from levels expected by shareholders or securities analysts;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;departure of either of the Adviser or certain of its respective key personnel;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;operating performance of companies comparable to us;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;general economic trends and other external factors; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;loss of a major funding source.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-110" id="f-151">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;A shareholder&#x2019;s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our shareholders do not have preemptive rights to purchase any shares we issue in the future. Our charter authorizes us to issue an unlimited number of shares. Our Board may elect to sell additional shares in the future or issue equity interests in private offerings. To the extent we issue additional equity interests at or below NAV, your percentage ownership interest in us may be diluted. In addition, depending upon the terms and pricing of any additional offerings and the value of our investments, you may also experience dilution in the book value and fair value of your shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 1940 Act, we generally are prohibited from issuing or selling our common shares at a price below NAV per share, which may be a disadvantage as compared with certain public companies. We may, however, sell our common shares, or warrants, options, or rights to acquire our common shares, at a price below the current NAV of our common shares if our Board and independent directors determine that such sale is in our best interests and the best interests of our shareholders, and our shareholders, including a majority of those shareholders that are not affiliated with us, approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board, closely approximates the fair value of such securities (less any distributing commission or discount). If we raise additional funds by issuing common shares or senior securities convertible into, or exchangeable for, our common shares, then the percentage ownership of our shareholders at that time will decrease and you will experience dilution.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-111" id="f-152">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;We may have difficulty paying distributions and the tax character of any distributions is uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally intend to distribute substantially all of our available earnings annually by paying distributions on a quarterly basis, as determined by the Board in its discretion. We cannot assure shareholders that we will achieve investment results that will allow us to make a specified level of cash distributions (particularly during the early stages of our operations) or year-to-year increases in cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this annual report. Due to the asset coverage test applicable to us under the 1940 Act as a BDC, we may be limited in our ability to make distributions. In addition, if we enter into a credit facility or any other borrowing facility, for so long as such facility is outstanding, we anticipate that we may be required by its terms to use all payments of interest and principal that we receive from our current investments as well as any proceeds received from the sale of our current investments to repay amounts outstanding thereunder, which could adversely affect our ability to make distributions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furthermore, the tax treatment and characterization of our distributions may vary significantly from time to time due to the nature of our investments. The ultimate tax characterization of our distributions made during a taxable year may not finally be determined until after the end of that taxable year. We may make distributions during a taxable year that exceed our investment company taxable income and net capital gains for that taxable year. In such a situation, the amount by which our total distributions exceed investment company taxable income and net capital gains generally would be treated as a return of capital up to the amount of a shareholder&#x2019;s tax basis in the shares, with any amounts exceeding such tax basis treated as a gain from the sale or exchange of such shares. A return of capital generally is a return of a shareholder&#x2019;s investment rather than a return of earnings or gains derived from our investment activities. Moreover, we may pay all or a substantial portion of our distributions from the proceeds of the sale of our shares or from borrowings or sources other than cash flow from operations in anticipation of future cash flow, which could constitute a return of shareholders&#x2019; capital and will lower such shareholders&#x2019; tax basis in our shares, which may result in increased tax liability to shareholders when they sell such shares.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-112" id="f-153">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Distributions on our common shares may exceed our taxable earnings and profits. Therefore, portions of the distributions that we pay may represent a return of capital to you. A return of capital is a return of a portion of your original investment in common shares. As a result, a return of capital will (i) lower your tax basis in your shares and thereby increase the amount of capital gain (or decrease the amount of capital loss) realized upon a subsequent sale or redemption of such shares, and (ii) reduce the amount of funds we have for investment in portfolio companies. We have not established any limit on the extent to which we may use offering proceeds to fund distributions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may pay our distributions from offering proceeds in anticipation of future cash flow, which may constitute a return of your capital and will lower your tax basis in your shares, thereby increasing the amount of capital gain (or decreasing the amount of capital loss) realized upon a subsequent sale or redemption of such shares, even if such shares have not increased in value or have, in fact, lost value.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-113" id="f-154">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shareholders will experience dilution in their ownership percentage if they do not participate in our dividend reinvestment plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All distributions declared in cash payable to shareholders that are participants in our dividend reinvestment plan will generally be automatically reinvested in common shares if the investor opts in to the plan. As a result, shareholders that do not elect to participate in our dividend reinvestment plan may experience dilution over time.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-114" id="f-155">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shareholders may experience dilution in the net asset value of their shares if they do not participate in our dividend reinvestment plan and if our shares are trading at a discount to net asset value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All distributions declared in cash payable to shareholders that are participants in our dividend reinvestment plan will generally be automatically reinvested in common shares if the investor opts in to the plan. As a result, shareholders that do not elect to participate in our dividend reinvestment plan may experience accretion to the NAV of their shares if our shares are trading at a premium to NAV and dilution if our shares are trading at a discount to NAV. The level of accretion or discount would depend on various factors, including the proportion of our shareholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to shareholders.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-115" id="f-156">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;No shareholder approval is required for certain mergers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board may undertake to approve mergers between us and certain other funds or vehicles.&#160;Subject to the requirements of the 1940 Act and NYSE rules, such mergers will not require shareholder approval so shareholders will not be given an opportunity to vote on these matters unless such mergers are reasonably anticipated to result in a material dilution of the NAV per share of the Company.&#160;These mergers may involve funds managed by affiliates of Blackstone Credit &amp;amp; Insurance.&#160;The Board may also convert the form and/or jurisdiction of organization, including to take advantage of laws that are more favorable to maintaining board control in the face of dissident shareholders.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-116" id="f-157">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investing in our shares involves a high degree of risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The investments we make in accordance with our investment objectives may result in a higher amount of risk than alternative investment options and volatility or loss of principal. Our investments in portfolio companies may be highly speculative and aggressive and, therefore, an investment in our shares may not be suitable for someone with lower risk tolerance.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-117" id="f-158">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The NAV of our shares may fluctuate significantly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The NAV and liquidity, if any, of the market for our shares may be significantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;significant volatility in the market price and trading volume of securities of BDCs or other companies in the sector in which we operate, which are not necessarily related to the operating performance of these companies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;loss of RIC or BDC status;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in earnings or variations in operating results;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in the value of our portfolio of investments;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;changes in accounting guidelines governing valuation of our investments;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;any shortfall in revenue or net income or any increase in losses from levels expected by shareholders or securities analysts;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;departure of either of the Adviser or certain of its respective key personnel;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;operating performance of companies comparable to us;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;general economic trends and other external factors; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;loss of a major funding source.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-118" id="f-159">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sales of substantial amounts of our common shares in the public market may have an adverse effect on the market price of our common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales of substantial amounts of our common shares, or the availability of such common shares for sale, could adversely affect the prevailing market prices for our common shares. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock contextRef="c-119" id="f-160">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Various potential and actual conflicts of interest will arise, and there are conflicts that may not be identified or resolved in a manner favorable to us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser, Blackstone Credit &amp;amp; Insurance, Blackstone and their respective affiliates will be subject to certain conflicts of interest with respect to the services the Adviser and the Administrator provide to us. These conflicts will arise primarily from the involvement of Blackstone Credit &amp;amp; Insurance, Blackstone and their respective affiliates (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Firm&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), in other activities that may conflict with our activities. You should be aware that individual conflicts will not necessarily be resolved in favor of your interest. The foregoing list of conflicts does not purport to be a complete enumeration or explanation of the actual and potential conflicts involved in an investment in the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For purposes of this discussion and ease of reference, the following terms shall have the meanings as set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Blackstone Credit &amp;amp; Insurance Clients&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; means, collectively, the investment funds, client accounts (including managed accounts) and proprietary accounts and/or other similar arrangements (including such arrangements in which the Company or one or more Other Blackstone Credit &amp;amp; Insurance Clients own interests) that Blackstone Credit &amp;amp; Insurance may establish, advise or sub-advise from time to time and to which Blackstone Credit &amp;amp; Insurance provides investment management or sub-advisory services (other than the Company and any such funds and accounts in which the Company has an interest), in each case including any alternative investment vehicles and additional capital vehicles relating thereto and any vehicles established by Blackstone Credit &amp;amp; Insurance to exercise its side-by-side or other general partner investment rights as set forth in their respective governing documents; provided, that for the avoidance of doubt, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Other Blackstone Credit &amp;amp; Insurance Clients&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; shall not include Blackstone Credit &amp;amp; Insurance in its role as principal of any account, including any such accounts for which Blackstone Credit &amp;amp; Insurance or an affiliate thereof acts as an advisor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Blackstone Clients&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; means, collectively, the investment funds, client accounts (including managed accounts) and proprietary accounts and/or other similar arrangements (including such arrangements in which the Company or one or more Blackstone Clients own interests) that Blackstone may establish, advise or sub-advise from time to time and to which Blackstone provides investment management or sub-advisory services (other than the Company, any such funds and accounts in which the Company has an interest and Other Blackstone Credit &amp;amp; Insurance Clients), in each case including any alternative investment vehicles and additional capital vehicles relating thereto and any vehicles established by Blackstone to exercise its side-by-side or other general partner investment rights as set forth in their respective governing documents; provided that, for the avoidance of doubt, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Blackstone Clients&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; shall not include Blackstone in its role as principal of any account, including any accounts for which Blackstone or an affiliate thereof acts as an advisor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Clients&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; means, collectively, Other Blackstone Credit &amp;amp; Insurance Clients and Blackstone Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Based Compensation and Management Fees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The existence of the incentive fees payable to Blackstone Credit &amp;amp; Insurance may create a greater incentive for Blackstone Credit &amp;amp; Insurance to make more speculative investments on behalf of the Company, or to time the purchase or sale of investments in a manner motivated by the personal interests of Blackstone Credit &amp;amp; Insurance and/or Blackstone personnel. However, the fact that the hurdle rate for the incentive fee based on income is calculated on an aggregate basis each quarter and that realized and unrealized losses are netted against realized gains for the incentive fee based on capital gains should reduce the incentives for the Adviser to make more speculative investments or otherwise time the purchase or sale of investments. Our Board of Trustees will seek to monitor these conflicts but there can be no assurances that such monitoring will fully mitigate any such conflicts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the manner in which the Adviser&#x2019;s entitlement to incentive fees is determined may result in a conflict between its interests and the interests of shareholders with respect to the sequence and timing of disposals of investments, as the Adviser may want to dispose of lower yielding investments in favor of higher yielding ones. With respect to the Adviser&#x2019;s entitlement to incentive fees on capital gains, the Adviser may be incentivized to realize capital gains prior to a year end if such gains, net of realized and unrealized losses, would result in an incentive fee on capital gains.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The Firm&#x2019;s Policies and Procedures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Firm has implemented policies and procedures to address conflicts that arise as a result of its various activities, as well as regulatory and other legal considerations. Specified policies and procedures implemented by the Firm to mitigate potential conflicts of interest and address certain regulatory requirements and contractual restrictions are expected to reduce the synergies across the Firm&#x2019;s various businesses that the Company expects to draw on for purposes of pursuing attractive investment opportunities. Because the Firm has many different asset management and advisory businesses, including private equity, a credit business, a hedge fund business, a capital markets group, a life sciences business and a real estate advisory business, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would otherwise be subject if it had just one line of business. In addressing these conflicts and regulatory, legal and contractual requirements across its various businesses and to protect against the inappropriate sharing and/or use of information between the Company and the other business units at the Firm, the Firm has implemented certain policies and procedures (e.g., information wall policy) regarding the sharing of information that could reduce the positive synergies that the Company expects to utilize for purposes of identifying and managing attractive investments. For example, the Firm will from time to time come into possession of material non-public information with respect to companies, including companies in which the Company has investments or might be considering making an investment or companies that are clients of the Firm. As a consequence, that information, which could be of benefit to the Company, might become restricted to those other respective businesses and otherwise be unavailable to the Company. It is also possible that the Company could be restricted from trading despite the fact that the Company did not receive such information. There can be no assurance, however, that any such policies and/or procedures will be effective in accomplishing their stated purpose and/or that they will not otherwise adversely affect the ability of the Company to effectively achieve its investment objective by unduly limiting the investment flexibility of the Company and/or the flow of otherwise appropriate information between Blackstone Credit &amp;amp; Insurance and other business units at the Firm. Personnel of the Firm could be unable, for example, to assist with the activities of the Company as a result of these walls. There can be no assurance that additional restrictions will not be imposed that would further limit the ability of the Firm to share information internally.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, to the extent that the Firm is in possession of material non-public information or is otherwise restricted from trading in certain securities, the Company and the Adviser could also be deemed to be in possession of such information or otherwise restricted. Additionally, the terms of confidentiality or other agreements with or related to companies in which any Other Client has or has considered making an investment or which is otherwise a client of the Firm will from time to time restrict or otherwise limit the ability of the Company and/or its portfolio companies and their affiliates to make investments in or otherwise engage in businesses or activities competitive with such companies. The Firm could enter into one or more strategic relationships in certain regions or with respect to certain types of investments that, although intended to provide greater opportunities for the Company, could require the Company to share such opportunities or otherwise limit the amount of an opportunity the Company can otherwise take.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allocation of Personnel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser and its members, officers and employees will devote as much of their time to the activities of the Company as they deem necessary to conduct its business affairs in an appropriate manner. By the terms of the Investment Advisory Agreement, the Firm is not restricted from forming additional investment funds, from entering into other investment advisory relationships or from engaging in other business activities, even though such activities have the potential to be in competition with the Company and/or to involve substantial time and resources of the Adviser. Firm personnel, including members of the investment committee, will work on other projects, serve on other committees (including boards of directors) and source potential investments for and otherwise assist the investment programs of Other Clients and their portfolio companies, including other investment programs to be developed in the future. Certain members of Blackstone Credit &amp;amp; Insurance&#x2019;s investment team are also members of Other Clients&#x2019; investment teams and will continue to serve in those roles (which could be their primary responsibility) and as a result, not all of their business time will be devoted to Blackstone or the Company. Certain non-investment professionals are not dedicated solely to the Company and are permitted to perform work for Other Clients which is expected to detract from the time such persons devote to the Company. These activities could be viewed as creating a conflict of interest in that the time and effort of the members of the Adviser and its officers and employees will not be devoted exclusively to the business of the Company, but will be allocated between the business of the Company and the management of the monies of such other advisees of the Adviser. Time spent on these other initiatives diverts attention from the activities of the Company, which could negatively impact the Company and shareholders. Furthermore, Blackstone Credit &amp;amp; Insurance and Blackstone Credit &amp;amp; Insurance personnel derive financial benefit from these other activities, including fees and performance-based compensation. Firm personnel outside of Blackstone Credit &amp;amp; Insurance can share in the fees and performance-based compensation from the Company; similarly, Blackstone Credit &amp;amp; Insurance personnel can share in the fees and performance-based compensation generated by Other Clients. These and other factors create conflicts of interest in the allocation of time by Firm personnel. Blackstone Credit &amp;amp; Insurance&#x2019;s determination of the amount of time necessary to conduct the Company&#x2019;s activities will be conclusive, and shareholders rely on Blackstone Credit &amp;amp; Insurance&#x2019;s judgment in this regard.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Outside Activities of Principals and Other Personnel and their Related Parties&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Certain of the principals and employees of the Adviser will, in certain circumstances, be subject to a variety of conflicts of interest relating to their responsibilities to the Company, Other Clients and their respective portfolio companies, and their outside personal or business activities, including as members of investment or advisory committees or boards of directors of or advisors to investment funds, corporations, foundations or other organizations. Such positions create a conflict if such other entities have interests that are adverse to those of the Company, including if such other entities compete with the Company for investment opportunities or other resources. The other managed accounts and/or investment funds in which such individuals may become involved may have investment objectives that overlap with the Company. Furthermore, certain principals and employees of the Adviser are likely to have a greater financial interest in the performance of such other funds or accounts than the performance of the Company. Such involvement is expected to create conflicts of interest in making investments on behalf of the Company and such other funds and accounts. Although such principals and employees will seek to limit any such conflicts in a manner that is in accordance with their fiduciary duties to the Company, there can be no assurance they will be resolved favorably for the Company. Also, Blackstone personnel, Firm employees, including employees of the Adviser, are generally permitted to invest in alternative investment funds, private equity funds, credit funds, real estate funds, hedge funds and other investment vehicles, as well as engage in other personal trading activities relating to companies, assets, securities or instruments (subject to the Firm&#x2019;s Code of Ethics requirements), some of which will involve conflicts of interests. Such personal securities transactions will, in certain circumstances, relate to securities or instruments which can be expected to also be held or acquired by Other Clients, the Company, or otherwise relate to portfolio companies in which the Company has or acquires a different principal investment (including, for example, with respect to seniority), which is expected to give rise to conflicts of interest related to misaligned interests between the Company and such persons. There could be situations in which such alternative investment funds invest in the same portfolio companies as the Company and there could be situations in which such alternative investment funds purchase securities from, or sell securities to, the Company if permitted under the 1940 Act and other applicable law. There can be no assurance that conflicts of interest arising out of such activities will be resolved in favor of the Company. Shareholders will not receive any benefit from any such investments, and the financial incentives of Firm personnel in such other investments could be greater than their financial incentives in relation to the Company and are not expected to receive notice should the Company make investments in which such persons hold direct or indirect interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, certain employees and other professionals of the Firm have family members or relatives employed by such advisers and service providers (or their affiliates) or otherwise actively involved in industries and sectors in which the Company invests, and/or have business, financial, personal or other relationships with companies in such industries and sectors (including the advisors and service providers described above) or other industries, which gives rise to potential or actual conflicts of interest. For example, such family members or relatives might be employees, officers, directors, personnel or owners of companies or assets that are actual or potential investments of the Company or other counterparties of the Company and its portfolio companies and/or assets. Moreover, in certain instances, the Company or its portfolio companies can be expected to issue loans to or acquire securities from, or otherwise transact with, companies that are owned by such family members or relatives or in respect of which such family members or relatives have other involvement. These relationships have the potential to influence Blackstone, the Adviser and/or Blackstone Credit &amp;amp; Insurance in deciding whether to select, recommend or create such service providers to perform services for the Company or portfolio companies (the cost of which will generally be borne directly or indirectly by the Company or such portfolio companies, as applicable). Notwithstanding the foregoing, investment transactions relating to the Company that require the use of a service provider will generally be allocated to service providers on the basis of best execution, the evaluation of which includes, among other considerations, such service provider&#x2019;s provision of certain investment-related services and research that the Adviser believes to be of benefit to the Company. To the extent that the Firm determines appropriate, conflict mitigation strategies can be expected to be put in place with respect to a particular circumstance, such as internal information barriers or recusal, disclosure or other steps determined appropriate by the Firm. The shareholders rely on the Firm to manage these conflicts in its sole discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Secondments and Internships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Certain personnel of Blackstone and its affiliates, including consultants, will, in certain circumstances, be seconded to one or more portfolio companies, vendors and service providers and vendors or shareholders or other investors of the Company and Other Clients to provide finance, accounting, operational support, data management and other similar services, including the sourcing of investments for the Company or other parties. The salaries, benefits, overhead and other similar expenses for such personnel during the secondment could be borne by Blackstone and its affiliates or the organization for which the personnel are working or both. In addition, personnel of portfolio companies, vendors, service providers (including law firms and accounting firms) and shareholders or other investors of the Company and Other Clients will, in certain circumstances, be seconded to, serve internships at or otherwise provide consulting services to, Blackstone, the Company, Other Clients and portfolio companies of the Company and Other Clients. While often the Company, Other Clients and their respective portfolio companies are the beneficiaries of these types of arrangements, Blackstone is from time to time a beneficiary of these arrangements as well, including in circumstances where the vendor, personnel or service provider or otherwise also provides services to the Company, Other Clients, their respective portfolio companies or Blackstone in the ordinary course. Blackstone, the Company, Other Clients or their portfolio companies could receive benefits from these arrangements at no cost, or alternatively could pay all or a portion of the fees, compensation or other expenses in respect of these arrangements. If a portfolio company pays the cost it will be borne directly or indirectly by the Company. To the extent such fees, compensation or other expenses are borne by the Company, including indirectly through its portfolio companies or reimbursement of Blackstone for such costs, the management fee will not be reduced as a result of these arrangements or any fees, expense reimbursements or other costs related thereto. The personnel described above may provide services in respect of multiple matters, including in respect of matters related to Blackstone, the Company, Other Clients, portfolio companies, each of their respective affiliates and related parties, and any costs of such personnel may be allocated accordingly, Blackstone will endeavor in good faith to allocate the costs of these arrangements, if any, to Blackstone, the Company, Other Clients, portfolio companies and other parties based on time spent by the personnel or another methodology Blackstone deems appropriate in a particular circumstance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Blackstone Credit &amp;amp; Insurance and its personnel and related parties will receive intangible and other benefits, discounts and perquisites arising or resulting from their activities on behalf of the Company, the value of which will not reduce the management fees or incentive fees or otherwise be shared with the Company or its portfolio companies. For example, airline travel or hotel stays incurred as Fund expenses, as set forth in the Investment Advisory Agreement and Administration Agreement (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Fund Expenses&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), often result in &#x201c;miles&#x201d; or &#x201c;points&#x201d; or credit in loyalty or status programs, and certain purchases made by credit card will result in &#x201c;credit card points, &#x201c;cash back&#x201d; or rebates in addition to such loyalty or status program miles or points. Such benefits and/or amounts will, whether or not de minimis or difficult to value, inure exclusively to the benefit of Blackstone Credit &amp;amp; Insurance, its affiliates or their personnel (and not the Company and/or portfolio companies) even though the cost of the underlying service is borne by the Company and/or portfolio companies. (See also&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Service Providers, Vendors and Other Counterparties Generally&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Portfolio Company Relationships Generally&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; herein.) Similarly, Blackstone Credit &amp;amp; Insurance, its affiliates and their personnel and related parties, and third parties designated by the foregoing, also receive discounts on products and services provided by portfolio companies and customers or suppliers of such portfolio companies. Such other benefits or fees have the potential to give rise to conflicts of interest in connection with the Company&#x2019;s investment activities, and while the Adviser and Blackstone Credit &amp;amp; Insurance will seek to resolve any such conflicts in a fair and equitable manner, there is no assurance that any such conflicts will be resolved in favor of the Company. See also&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Service Providers, Vendors and Other Counterparties Generally&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Portfolio Company Relationships Generally&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Advisors, Industry Experts and Operating Partners&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Blackstone Credit &amp;amp; Insurance is expected to engage and retain strategic advisors, consultants, senior advisors, executive advisors, industry experts, operating partners, deal sourcers, consultants and other similar professionals (which is expected to include current and former executives or other personnel of Blackstone and/or Blackstone Credit &amp;amp; Insurance, as well as current and former executives or other personnel of Blackstone&#x2019;s and/or Blackstone Credit &amp;amp; Insurance&#x2019;s portfolio companies) (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Senior and Other Advisors&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) who are not employees or affiliates of Blackstone Credit &amp;amp; Insurance and who will, from time to time, receive payments from, or allocations of a profits interest with respect to, portfolio companies (as well as from Blackstone Credit &amp;amp; Insurance or the Company). In particular, in some cases, consultants, including those with a &#x201c;Senior Advisor&#x201d; title, have been and will be engaged with the responsibility to source, diligence and recommend transactions to Blackstone Credit &amp;amp; Insurance or to undertake a build-up strategy to originate, acquire and develop assets and businesses in a particular sector or involving a particular strategy, potentially on a full-time and/or exclusive basis and notwithstanding any overlap with the responsibilities of Blackstone Credit &amp;amp; Insurance under the Investment Advisory Agreement, the compensation to such consultants is expected to be borne fully by the Company and/or portfolio companies (with no reduction or offset to management fee payable by the Company) and not Blackstone Credit &amp;amp; Insurance. Similarly, the Company, Other Clients and their portfolio companies are expected to retain and pay compensation to Senior and Other Advisors to provide services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any amounts paid by the Company or a portfolio company to Senior and Other Advisors in connection with the above services, including cash fees, profits, or equity interests in a portfolio company, discretionary bonus awards, performance-based compensation (e.g., promote), sourcing fees, retainers and expense reimbursements, will be treated as Company Expenses or expenses of the portfolio company, as the case may be, and will not, even if they have the effect of reducing any retainers or minimum amounts otherwise payable by Blackstone Credit &amp;amp; Insurance, be chargeable to Blackstone Credit &amp;amp; Insurance or be deemed paid to or received by Blackstone Credit &amp;amp; Insurance, and such amounts will not reduce the management fees or incentive fees payable. Amounts charged by Senior and Other Advisors will not necessarily be confirmed as being comparable to market rates for such services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To the extent permitted by applicable law and/or any applicable SEC granted exemptive or no action relief, these Senior and Other Advisors often have the right or could be offered the ability to (i) co-invest alongside the Company, including in the specific investments in which they are involved (and for which they can be entitled to receive performance-related incentive fees, which will reduce the Company&#x2019;s returns), (ii) otherwise participate in equity plans for management of any such portfolio company, or (iii) invest directly in the Company or in a vehicle controlled by the Company subject to reduced or waived advisory fees and/or incentive fees, including after the termination of their engagement by or other status with the Firm. Such co-investment and/or participation (which generally will result in the Company being allocated a smaller share of the applicable investment) will not be considered as part of the Firm&#x2019;s side-by-side co-investment rights. Such co-investment and/or participation could vary by transaction (and such participation can, depending on its structure, reduce the Company&#x2019;s returns. Additionally, and notwithstanding the foregoing, these Senior and Other Advisors, as well as other Blackstone Clients could be (or could have the preferred right to be) investors in Blackstone Credit &amp;amp; Insurance&#x2019;s portfolio companies (which, in some cases, can involve agreements to pay performance fees, or allocate profits interests, to such persons in connection with the Company&#x2019;s investment therein, which will reduce the Company&#x2019;s returns) and/or Other Clients. Such Senior and Other Advisors, as well as other Blackstone Clients, could also, subject to applicable law, have rights to co-invest with the Company on a side-by-side basis, which rights are generally offered on a no-fee/no-carried interest basis and generally result in the Company being allocated a smaller share of an investment than would otherwise be the case in the absence of such side-by-side participation. Senior and Other Advisors&#x2019; benefits described in this paragraph will, in certain circumstances, continue after termination of status as a Senior and Other Advisors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The time, dedication and scope of work of, and the nature of the relationship with, each of the Senior and Other Advisors vary considerably. In certain cases, they could advise the Adviser and/or Blackstone Credit &amp;amp; Insurance on transactions, provide the Adviser and/or Blackstone with industry-specific insights and feedback on investment themes, assist in transaction due diligence, or make introductions to and provide reference checks on management teams. In other cases, they take on more extensive roles (and could be exclusive service providers to Blackstone Credit &amp;amp; Insurance) and serve as executives or directors on the boards of portfolio companies or contribute to the identification and origination of new investment opportunities. The Company expects to rely on these Senior and Other Advisors to recommend Blackstone as a preferred investment partner, identify investments, source opportunities, and otherwise carry out its investment program, but there is no assurance that these advisers will continue to be involved with the Company for any length of time. In certain instances, Blackstone Credit &amp;amp; Insurance can be expected to have formal or informal arrangements with these Senior and Other Advisors (which may or may not be terminable upon notice by any party), and in other cases the relationships are more informal. They are either compensated (including pursuant to retainers and expense reimbursement, and, in any event, pursuant to negotiated arrangements that will not be confirmed as being comparable to the market rates for such services) by Blackstone, the Company, and/or portfolio companies or otherwise uncompensated or entitled to deferred compensation until occurrence of a future event, such as commencement of a formal engagement. In certain cases, they have certain attributes of Blackstone Credit &amp;amp; Insurance &#x201c;employees&#x201d; (e.g., they can be expected to have dedicated offices at Blackstone Credit &amp;amp; Insurance, receive administrative support from Blackstone Credit &amp;amp; Insurance personnel, participate in general meetings and events for Blackstone Credit &amp;amp; Insurance personnel, work on Blackstone Credit &amp;amp; Insurance matters as their primary or sole business activity, service Blackstone exclusively, have Blackstone-related e-mail addresses and/or business cards and participate in certain benefit arrangements typically reserved for Blackstone employees, etc.) even though they are not considered Blackstone Credit &amp;amp; Insurance employees, affiliates or personnel for purposes of the Investment Advisory Agreement between the Company and Blackstone Credit &amp;amp; Insurance. Under many of these arrangements, there can be no assurance that the amount of compensation paid in a particular period of time will be proportional to the amount of hours worked or the amount or tangible work product generated by the Senior and Other Advisors during such time. Some Senior and Other Advisors work only for the Company and its portfolio companies, while others may have other clients. In particular, in some cases, Senior and Other Advisors, including those with a &#x201c;Senior Advisor&#x201d; or &#x201c;Operating Advisor&#x201d; title, have been and will be engaged with the responsibility to source and recommend transactions to the Adviser potentially on a full-time and/or exclusive basis and, notwithstanding any overlap with the responsibilities of the Adviser under the Investment Advisory Agreement, the compensation to such Senior and Other Advisors will be borne fully portfolio companies (with no reduction to management fees) and not the Adviser. Senior and Other &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advisors could have conflicts of interest between their work for the Company and its portfolio companies, on the one hand, and themselves or other clients, on the other hand, and Blackstone Credit &amp;amp; Insurance is limited in its ability to monitor and mitigate these conflicts. Blackstone Credit &amp;amp; Insurance expects, where applicable, to allocate the costs of such Senior and Other Advisors to the Company and/or applicable portfolio companies, and to the extent any such costs are allocated to the Company, they would be treated as Company Expenses. Payments or allocations to Senior and Other Advisors will not be reduced by the management fee, and can be expected to increase the overall costs and expenses borne indirectly by investors in the Company. There can be no assurance that any of the Senior and Other Advisors, to the extent engaged, will continue to serve in such roles and/or continue their arrangements with Blackstone Credit &amp;amp; Insurance, the Company and/or any portfolio companies for the duration of the relevant investments or throughout the term of the Company. Additionally, from time to time, Senior and Other Advisors provide services on behalf of both the Company and Other Clients, and any work performed by Senior and Other Advisors retained on behalf of the Company could benefit the Other Clients (and alternatively, work performed by Senior and Other Advisors on behalf of Other Clients could benefit the Company), and Blackstone Credit &amp;amp; Insurance shall have no obligation to allocate any portion of the costs to be borne by the Company in respect of such Senior and Other Advisors to the Other Clients, except as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As an example of the foregoing, in certain investments including involving a &#x201c;platform company,&#x201d; the Company will, in certain circumstances, enter into an arrangement with one or more individuals (who could be former personnel of the Firm or current or former personnel of portfolio companies of the Company or Other Clients, generally will have experience or capability in sourcing or managing investments, and could form a management team) to undertake a new business line or a build-up strategy to acquire and develop assets and businesses in a particular sector or involving a particular strategy. The services provided by such individuals or relevant portfolio company, as the case may be, could include the following with respect to investments: origination or sourcing, due diligence, evaluation, negotiation, servicing, development, management (including turnaround) and disposition. The individuals or relevant portfolio company could be compensated with a salary and equity incentive plan, including a portion of profits derived from the Company or a portfolio company or asset of the Company (which, to the extent permitted by applicable law and/or any applicable SEC granted exemptive or no action relief, can take the form of a management fee and/or profits allocation (whether paid directly to such individuals or to an affiliate entity controlled by such individuals), or other long-term incentive plans. Compensation could also be based on assets under management, a waterfall similar to a carried interest, respectively, or another similar metric. The Company could initially bear the cost of overhead (including rent, utilities, benefits, salary or retainers for the individuals or their affiliates entities) and the sourcing, diligence and analysis of investments, as well as the compensation for the individuals and entity undertaking the build-up strategy. Such expenses could be borne directly by the Company as Company Expenses (or broken deal expenses, if applicable) or indirectly through expenditures by a portfolio company. None the fees, costs or expenses described above will reduce the management fee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Adviser will, in certain circumstances, engage third parties as Senior and Other Advisors (or in another similar capacity) in order to advise it with respect to existing investments, specific investment opportunities, and economic and industry trends. Such Senior and Other Advisors can receive reimbursement of reasonable related expenses by portfolio companies or the Company and could have the opportunity to invest in a portion of the equity and/or debt available to the Company for investment that would otherwise be taken by the Adviser and its affiliates. If such Senior and Other Advisors generate investment opportunities on the Company&#x2019;s behalf, such Senior and Other Advisors are permitted to receive special additional fees or allocations which have the potential to not be comparable to those received by a third party in an arm&#x2019;s length transaction and such additional fees or allocations would be borne fully by the Company and/or portfolio companies (with no reduction or offset to management fees) and not Blackstone Credit &amp;amp; Insurance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Minority Investments in Asset Management Firms&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Blackstone and Other Clients, including Blackstone Strategic Capital Holdings (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;BSCH&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and its related parties, regularly make minority investments in alternative asset management firms that are not affiliated with Blackstone, the Company, Other Clients and their respective portfolio companies, and which from time to time engage in similar investment transactions, including with respect to purchase and sale of investments, with these asset management firms and their advised funds and portfolio companies. Typically, the Blackstone related party with an interest in the asset management firm would be entitled to receive a share of carried interest/performance based incentive compensation and net fee income or revenue share generated by the various products, vehicles, funds and accounts managed by that third party asset management firm that are included in the transaction or activities of the third party asset management firm, or a subset of such activities such as transactions with a Blackstone related party. In addition, while such minority investments are generally structured so that Blackstone does not &#x201c;control&#x201d; such third party asset management firms, Blackstone could nonetheless be afforded certain governance rights in relation to such investments (typically in the nature of &#x201c;protective&#x201d; rights, negative control rights or anti-dilution arrangements, as well as certain reporting and consultation rights) that afford Blackstone the ability to influence the firm. Although Blackstone and Other Clients, including BSCH, do not intend to control such third &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;party asset management firms, there can be no assurance that all third parties will similarly conclude that such investments are non-control investments or that, due to the provisions of the governing documents of such third party asset management firms or the interpretation of applicable law or regulations, investments by Blackstone and Other Clients, including BSCH, will not be deemed to have control elements for certain contractual, regulatory or other purposes. While such third party asset managers will not be deemed affiliated with the Company within the meaning of the 1940 Act, Blackstone expects to, under certain circumstances, be in a position to influence the management and operations of such asset managers and the existence of its economic/revenue sharing interest therein can give rise to conflicts of interest. Participation rights in a third party asset management firm (or other similar business), negotiated governance arrangements and/or the interpretation of applicable law or regulations could expose the investments of the Company to claims by third parties in connection with such investments (as indirect owners of such asset management firms or similar businesses) that would have an adverse financial or reputational impact on the performance of the Company. The Company, its affiliates and their respective portfolio companies are expected to, from time to time engage in transactions with, and buy and sell investments from, any such third party asset managers and their sponsored funds and transactions and other commercial arrangements between such third party asset managers and the Company and its portfolio companies are not subject to approval by the Board of Trustees. There can be no assurance that the terms of these transactions between parties related to Blackstone, on the one hand, and the Company and its portfolio companies, on the other hand, will be at arm&#x2019;s length or that Blackstone will not receive a benefit from such transactions, which can be expected to incentivize Blackstone to cause these transactions to occur. Such conflicts related to investments in and arrangements with other asset management firms will not necessarily be resolved in favor of the Company. Shareholders will not be entitled to receive notice or disclosure of the terms or occurrence of either the investments in alternative asset management firms or transactions therewith and will not receive any benefit from such transactions. By executing a subscription agreement with respect to the Company, each shareholder acknowledges these conflicts related to investments in and arrangements with other asset management firms, acknowledges that these conflicts will not necessarily be resolved in favor of the Company, agrees that shareholders will not be entitled to receive notice or disclosure of the terms or occurrence of either the investments in alternative asset management firms or transactions therewith, otherwise understands that shareholders will not receive any benefit from such transactions, consents to all such transactions and arrangements to the fullest extent permitted by law, and waives any claim against Blackstone and releases Blackstone from any liability arising from the existence of any such conflict of interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, from time to time, certain advisors and service providers (including law firms) temporarily provide their personnel to Blackstone, Other Clients or their portfolio companies pursuant to various arrangements including at cost or at no cost. (See also &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;Secondments and Internships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; herein.) While often the Company, Other Clients and their portfolio companies are the beneficiaries of these types of arrangements, Blackstone is from time to time a beneficiary of these arrangements as well, including in circumstances where the advisor or service provider also provides services to the Company, Other Clients or Blackstone in the ordinary course. Blackstone, the Company, Other Clients or their portfolio companies could receive benefits from these arrangements at no cost, or alternatively could pay all or a portion of the fees, compensation or other expenses in respect of these arrangements. The management fee will not be offset or reduced as a result of these arrangements or any fees, expense reimbursements or other costs related thereto. The personnel described above could provide services in respect of multiple matters, including in respect of matters related to Blackstone, the Company, Other Clients, portfolio companies, each of their respective affiliates and related parties, and Blackstone will endeavor in good faith to allocate the costs of these arrangements, if any, to Blackstone, the Company, Other Clients, portfolio companies and other parties based on time spent by the personnel or another methodology the Firm deems appropriate in a particular circumstance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Multiple Blackstone Business Lines. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone has multiple business lines, including the Blackstone Capital Markets Group, which Blackstone Credit &amp;amp; Insurance, the Company, Other Clients, portfolio companies of the Company and Other Clients and third parties will, in certain circumstances, engage for debt and equity financings and to provide other investment banking, brokerage, investment advisory or other services. As a result of these activities, Blackstone is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than if it had one line of business. For example, from time to time, Blackstone could come into possession of information that limits the Company&#x2019;s ability to engage in potential transactions. Similarly, other Blackstone businesses and their personnel could be prohibited by law or contract from sharing information with Blackstone that would be relevant to monitoring the investments and other activities. These types of restrictions from time to time will negatively impact the ability of the Company to implement its investment program. Finally, Blackstone personnel who are members of the investment team or investment committee could be excluded from participating in certain investment decisions due to conflicts involving other Blackstone businesses or for other reasons, including other business activities, in which case the Company will not benefit from their experience. The shareholders will not receive a benefit from any fees earned by Blackstone or its personnel from these other businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone is under no obligation to decline any engagements or investments in order to make an investment opportunity available to the Company. Blackstone has long-term relationships with a significant number of corporations and their senior management. Blackstone will consider those relationships when evaluating an investment opportunity, which has the potential to result in Blackstone choosing not to make such an investment due to such relationships (e.g., investments in a competitor of a client or other person with whom Blackstone has a relationship). The Company could be required to sell or hold existing investments as a result of investment banking relationships or other relationships that Blackstone has or will have or transactions or investments that Blackstone makes or has made. (See&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;also&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Allocation of Investment Opportunities&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Portfolio Company Relationships&#x201d;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) Therefore, there can be no assurance that all potentially suitable investment opportunities that come to the attention of Blackstone will be made available to the Company. The Company is also permitted to co-invest with Other Clients or other persons with whom Blackstone has a relationship in particular investment opportunities, and other aspects of these Blackstone relationships could influence the decisions made by Blackstone with respect to the investments and otherwise result in a conflict (see also&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014;Other Clients; Allocation of Investment Opportunities&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; herein). Company would otherwise have to buy or sell certain assets, and may require that the Company dispose of an investment at an inopportune time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Blackstone Policies and Procedures; Information Walls.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Blackstone has implemented policies and procedures to address conflicts that arise as a result of its various activities, as well as regulatory and other legal considerations. Some of these policies and procedures, such as Blackstone&#x2019;s information wall policy, are implemented by Blackstone to mitigate potential conflicts of interest and address certain regulatory requirements and contractual restrictions will reduce the synergies and collaboration across Blackstone&#x2019;s various businesses that the Company expects to draw on for purposes of identifying, pursuing and managing attractive investment opportunities. Because Blackstone has many different asset management and advisory businesses, including private equity, growth equity, a credit business, a hedge fund business, a capital markets group, a life sciences business and a real estate advisory business, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would otherwise be subject if it had just one line of business. In addressing these conflicts and regulatory, legal and contractual requirements across its various businesses and to protect against the inappropriate sharing and/or use of information between the Company and the other business units at Blackstone, Blackstone has implemented certain policies and procedures (e.g., Blackstone&#x2019;s information wall policy) regarding the sharing of information that have the potential to reduce the positive synergies and collaborations that the Company could otherwise expect to utilize for purposes of identifying and managing attractive investments. For example, Blackstone will from time to time come into possession of material non-public information with respect to companies in which Other Clients have investments or might be considering making an investment or companies that are clients of Blackstone. As a consequence, that information, which could be of benefit to the Company, might become restricted to those other respective businesses and otherwise be unavailable to the Company. It is also possible that the Company could be restricted from trading despite the fact that the Company did not receive such information. There can be no assurance, however, that any such policies and/or procedures will be effective in accomplishing their stated purpose and/or that they will not otherwise adversely affect the ability of the Company to effectively achieve its investment objective by unduly limiting the investment flexibility of the Company and/or the flow of otherwise appropriate information between Blackstone Credit &amp;amp; Insurance and other business units at Blackstone. For example, in some instances, personnel of Blackstone would be unable to assist with the activities of the Company as a result of these walls. There can be no assurance that additional restrictions will not be imposed that would further limit the ability of Blackstone to share information internally. In addition, due to these restrictions, it is possible that the Company will not be able to initiate a transaction that it otherwise might have initiated and will not be able to purchase or sell an investment that it otherwise might have purchased or sold, which could negatively affect its operations or performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, to the extent that Blackstone is in possession of material non-public information or is otherwise restricted from making certain investments, the Company and the Adviser would also be deemed to be in possession of such information or otherwise restricted. Additionally, the terms of confidentiality or other agreements with or related to companies in which any Blackstone fund has or has considered making an investment or which is otherwise a client of Blackstone will from time to time restrict or otherwise limit the ability of the Company and/or its portfolio companies and their affiliates to make investments in or otherwise engage in businesses or activities competitive with such companies. Blackstone has in the past entered into, and reserves the right to enter into in the future, one or more strategic relationships in certain regions or with respect to certain types of investments that, although intended to provide greater opportunities for the Company, require the Company to share such opportunities or otherwise limit the amount of an opportunity the Company can otherwise take. (See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&#x2014;Allocation of Investment Opportunities&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Data&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Firm receives, generates and/or obtains various kinds of data and information from the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and limited partners in Other Clients and service providers, including but not limited to data and information relating to or created in connection with business operations, financial information results, trends, budgets, energy usage, plans, ESG, carbon emissions and related metrics, customer and user data, employee and contractor data, supplier and cost data, and other related data and information, some of which is sometimes referred to as &#x201c;alternative data&#x201d; or &#x201c;big data&#x201d;. The Firm can be expected to be better able to anticipate macroeconomic and other trends, and otherwise develop investment themes or identify specific investment, trading or business opportunities, as a result of its access to (and rights regarding, including use, ownership, distribution and derived works rights over) this data and information from the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and limited partners in Other Clients, related parties and service providers. The Firm has entered and will continue to enter into information sharing and use, measurement and other arrangements, which will give the Firm access to (and rights regarding, including ownership, use, distribution and derived works rights over) data that it would not otherwise obtain in the ordinary course, with the Company, Other Clients, portfolio companies of the Company and Other Clients, investors in the Company and in Other Clients, as well as with related parties and service providers. Further, this alternative data is expected to be aggregated across the Company, Other Clients and their respective portfolio companies. Although the Firm believes that these activities improve the Firm&#x2019;s investment management activities on behalf of the Company and Other Clients, information obtained from the Company and its portfolio companies, and investors in the Company and in Other Clients also provides material benefits to Blackstone or Other Clients without compensation or other benefit accruing to the Company or its shareholders. For example, information from a portfolio company in which the Company holds an interest can be expected to enable the Firm to better understand a particular industry, enhance the Firm&#x2019;s ability to provide advice or direction to a portfolio company&#x2019;s management team on strategy or operations and enable the Firm to execute trading and investment strategies in reliance on that understanding for Blackstone and Other Clients that do not own an interest in the portfolio company, typically without compensation or benefit to the Company or its portfolio companies. Blackstone would serve as the repository for data described in this paragraph, including with ownership and use rights therein. The Firm is also permitted to share data from a portfolio company (on an anonymized basis) with a portfolio company of an Other Client, which has the potential to increase a competitive disadvantage for, and indirectly harm, such portfolio company (although the opposite may be true as well, in which case a portfolio company of the Company may receive data from a portfolio company of an Other Client). In addition, the Firm could have an incentive to pursue an investment in a particular company based on the data and information expected to be received or generated in connection with such investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furthermore, except for contractual obligations to third parties to maintain confidentiality of certain information or otherwise limit the scope and purpose of its use or distribution, and regulatory limitations on the use of material nonpublic information, the Firm is generally free to use and distribute data and information from the Company&#x2019;s activities to assist in the pursuit of the Firm&#x2019;s various other activities, including but not limited to trading activities or use for the benefit of the Firm and/or an Other Client. Any confidentiality obligations in the operative documents do not limit the Firm&#x2019;s ability to do so. For example, the Firm&#x2019;s ability to trade in securities of an issuer relating to a specific industry can, subject to applicable law, be enhanced by information of a portfolio company in the same or related industry. Such trading or other business activities is expected to provide a material benefit to the Firm without compensation or other benefit to the Company or shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sharing and use of &#x201c;big data&#x201d; and other information presents potential conflicts of interest and the shareholders acknowledge and agree that any benefits received by the Firm or its personnel (including fees (in cash or in kind), costs and expenses) will not reduce the management fees or incentive fees payable to the Adviser or otherwise shared with the Company or its shareholders. As a result, the Adviser has an incentive to pursue investments that have data and information that can be utilized in a manner that benefits the Firm or Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Data Management Services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Blackstone or an affiliate of Blackstone formed in the future may provide data management services to portfolio companies and investors in the Company and in Other Clients and will provide such services directly to the Company and Other Clients (collectively,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x201c;Data Holders&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Such services are expected to include assistance with obtaining, analyzing, curating, processing, packaging, organizing, mapping, holding, transforming, enhancing, marketing and selling such data (among other related data management and consulting services) for monetization through licensing or sale arrangements with third parties and, subject to applicable law and the limitations in the Investment Advisory Agreement and any other applicable contractual limitations, with the Company, Other Clients, portfolio companies, investors in the Company and in Other Clients, and other Blackstone affiliates and associated entities (including funds in which Blackstone and Other Clients make investments, and portfolio companies thereof). If Blackstone enters into data services arrangements with portfolio companies and receives compensation from such portfolio companies for such data services, the Company will indirectly bear its share of such compensation based on its pro rata ownership of such portfolio companies. Where Blackstone believes appropriate, data from one Data Holder will be aggregated or pooled with data from other Data Holders. Any revenues arising &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;from such aggregated or pooled data sets would be allocated between applicable Data Holders on a fair and reasonable basis as determined by Blackstone Credit &amp;amp; Insurance in its sole discretion, with Blackstone Credit &amp;amp; Insurance able to make corrective allocations should it determine subsequently that such corrections were necessary or advisable. Blackstone is expected to receive compensation for such data management services, which is expected to include a percentage of the revenues generated through any licensing or sale arrangements with respect to the relevant data, and which compensation is also expected to include fees, royalties and cost and expense reimbursement (including start-up costs and allocable overhead associated with personnel working on relevant matters (including salaries, benefits and other similar expenses)). Additionally, Blackstone is expected to share and distribute the products from such data management services within Blackstone or its affiliates (including Other Clients or their portfolio companies) at no charge and, in such cases, the Data Holders will not receive any financial or other benefit from having provided such data to Blackstone. The potential receipt of such compensation by Blackstone creates incentives for Blackstone to cause the Company to invest in portfolio companies with a significant amount of data that it might not otherwise have invested in or on terms less favorable than it otherwise would have sought to obtain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Blackstone and Blackstone Credit &amp;amp; Insurance Strategic Relationships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Blackstone and Blackstone Credit &amp;amp; Insurance have entered, and it can be expected that Blackstone and Blackstone Credit &amp;amp; Insurance in the future will enter, into both (i) strategic relationships with investors (and/or one or more of their affiliates) that involve an overall relationship with Blackstone or Blackstone Credit &amp;amp; Insurance (which will afford such investor special rights and benefits) that could (but is not required to) incorporate one or more strategies (including, but not limited to, a different sector and/or geographical focus within the same or a different Blackstone business unit) in addition to the Company&#x2019;s strategy and (ii) arrangements that involve an agreement or understanding to make an investment in or a capital commitment to (as applicable) the Company and one or more Other Clients, as applicable (which can include a subscription or capital commitment, as applicable, already made recently to another Other Client) (any such overall relationship and/or multi-fund arrangement in the foregoing (i) and (ii), (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Strategic Relationships&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), with terms and conditions applicable solely to such investor and its investment in multiple Blackstone or Blackstone Credit &amp;amp; Insurance strategies that would not apply to any other investor&#x2019;s investment in the Company. A Strategic Relationship often involves (but is not required to involve) an investor agreeing to make a capital commitment to or investment in (as applicable) multiple Blackstone or Blackstone Credit &amp;amp; Insurance Clients, one of which could include the Company. Shareholders will not receive a copy of any agreement memorializing such a Strategic Relationship program (even if in the form of a side letter) or receive any other disclosure or reporting of the terms of or existence of any Strategic Relationship and will be unable to elect in the &#x201c;most-favored-nations&#x201d; election process (if any) any rights or benefits afforded through a Strategic Relationship (for the avoidance of doubt, no further disclosure or reporting information will be shared with the shareholders about any Strategic Relationship). Specific examples of such additional rights and benefits have included and can be expected to include, among others, specialized reporting, discounts or reductions on and/or reimbursements or rebates of management fees or carried interest (as applicable), secondment of personnel from the investor to Blackstone or Blackstone Credit &amp;amp; Insurance (or vice versa), rights to participate in the investment review and evaluation process, as well as priority rights or targeted amounts for co-investments alongside Blackstone Credit &amp;amp; Insurance or Blackstone funds (including, without limitation, preferential or favorable allocation of co-investment and preferential terms and conditions related to co-investment or other participation in Blackstone or Blackstone Credit &amp;amp; Insurance Clients (including in respect of any carried interest (as applicable) and/or management fees to be charged with respect thereto, as well as any additional discounts, reductions, reimbursements or rebates with respect thereto or other penalties that may result if certain target co-investment allocations or other conditions under such arrangements are not achieved)). Any co-investment that is part of a Strategic Relationship could include co-investment in investments made by the Company. Blackstone, including its personnel (including Blackstone Credit &amp;amp; Insurance personnel), reserves the right to receive compensation from Strategic Relationships and could be incentivized to allocate investment opportunities away from the Company to or source investment opportunities for Strategic Relationships. Strategic Relationships will in certain circumstances, result in fewer co-investment opportunities (or reduced or no allocations) being made available to shareholders, subject to the 1940 Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance Value Creation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Blackstone Credit &amp;amp; Insurance Value Creation is a global platform that is part of Blackstone&#x2019;s Portfolio Operations Group (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Portfolio Operations Group&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and seeks to provide access to a range of cost-saving, revenue-generating and best-practice sharing opportunities for Blackstone Credit &amp;amp; Insurance portfolio companies. The Portfolio Operations Group is organized into seven functional areas, across geographic regions and industry verticals:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Procurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Blackstone&#x2019;s group purchasing program harnesses spending from portfolio companies across more than 75 categories, including IT hardware and software, office supplies, shipping, energy and telecommunications.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Healthcare Cost Containment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Blackstone&#x2019;s Equity Healthcare team partners with portfolio companies to optimize the strategy and value of healthcare spending by reducing cost and improving the quality of healthcare services received by employees and their dependents. Equity Healthcare is one of the largest private sector purchasers of healthcare services in the United States and has helped drive cumulative healthcare cost savings to portfolio companies and strengthened portfolio companies&#x2019; ability to attract and retain talent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lean Process&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The lean process team seeks to drive transformational improvements focused on material and information flows by reducing waste and non-value add activities across manufacturing functions. It develops prescriptive solutions for portfolio companies and aligns with senior leadership to support tailored strategies and guide management teams in executing and sustaining improved workflow processes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leadership and Talent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The Portfolio Operations Group employs the following strategies to optimize leadership and organizational performance: (i) delivering fit-for-purpose resources to portfolio companies, which include non-executive chairpersons, board members, advisors, and operating specialists, (ii) strengthening company teams and organizational practices through assisting with restructuring, integrations and growth actions, and (iii) convening conferences for portfolio company executives to share best practices and improve alignment to the Firm.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sustainability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: By improving the operation and maintenance of mechanical systems, the Portfolio Operations Group seeks to reduce energy spend while improving productivity, safety, and environmental performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Technology / BPO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Blackstone&#x2019;s Technology / BPO team helps the portfolio management teams recruit/upgrade their information technology leadership teams; import contemporary operating systems and application software to address their respective business priorities; leverage portfolio investments in technology companies to promote and serve the overall portfolio interests; and evaluate and negotiate preferred partnerships with digital/technology suppliers, advisors, and consultants from around the world.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Data Science&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The Firm has invested in a team of data scientists and engineers to help the portfolio companies realize operational efficiencies and drive new revenue through data and analytics. This team focuses on (i) building predictive models to enhance decision making; (ii) leveraging big data within operations; (iii) data visualization to democratize access to information; and (iv) data monetization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Members of Blackstone&#x2019;s Portfolio Operations Group (including Blackstone Credit &amp;amp; Insurance Value Creation), who are Blackstone employees, are permitted to provide services to the Company&#x2019;s portfolio companies, including without limitation those related to the functional areas described above and other similar management consulting, operational and financial matters and are permitted to participate in the Firm co-investment rights. Any payments made or fees paid (which fees or payments will also in certain instances be structured as a reimbursement of internal compensation costs for time spent) by such portfolio companies to Blackstone for services rendered to such portfolio companies will generally be no greater than what would be paid in an arm&#x2019;s-length transaction for similar overalls services, and such payments or fees received will not reduce the management fee payable by the Company. As a result, Blackstone is likely to be incentivized to cause members of the Portfolio Operations Group to spend more time on the Company&#x2019;s portfolio companies as compared to portfolio companies of Other Clients that do reduce the management fee. On the other hand, there can be no assurance that members of the Portfolio Operations Group will be able to provide their services to portfolio companies and/or that any individuals within the Portfolio Operations Group will remain employed by Blackstone through the life of the Company. The level of involvement and role of Blackstone&#x2019;s Portfolio Operations Group within each part of Blackstone with respect to any of the Company&#x2019;s portfolio companies are expected to vary, including having no involvement or role at all. In addition, the Portfolio Operations Group will provide services to the Company&#x2019;s portfolio companies as described in more detail in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014;Firm Affiliated Service Providers&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, including facilitation of arrangements for Portfolio Companies relating to group procurement (such as the group purchasing organization) and other operational, administrative or management related matters from third parties or Firm affiliates, and other similar operational initiatives. These services can result in commissions or similar payments, including related to a portion of the savings achieved by the portfolio companies. See also &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&#x2014;Other Fees&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&#x2014;Group Procurement; Discounts&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&#x2014;Firm Affiliated Service Providers&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information regarding such programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Buying and Selling Investments or Assets from Certain Related Parties&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company and its portfolio companies may purchase investments or assets from or sell investments or assets to shareholders, other portfolio companies of the Company, portfolio companies of Other Clients or their respective related parties. Purchases and sales of investments or assets between the Company or its portfolio companies, on the one hand, and shareholders, other portfolio companies of the Company, portfolio companies of Other Clients or their respective related parties, on the other hand, are not, unless required by applicable law, subject to the approval of the Board of Trustees or any shareholder. These transactions involve conflicts of interest, as the Firm may receive fees and other benefits, directly or indirectly, from or otherwise have interests in both parties to the transaction, including different financial incentives Blackstone could have with respect to the parties to the transaction. For example, there can be no assurance that any investment or asset sold by the Company to a shareholder, other portfolio companies of the Company, portfolio company of Other Clients or any of their respective related parties will not be valued or allocated a sale price that is lower than might otherwise have been the case if such asset were sold to a third party rather than to a shareholder, portfolio company of Other Clients or any of their respective related parties. The Firm will not be required to solicit third party bids or obtain a third party valuation prior to causing the Company or any of its portfolio companies to purchase or sell any asset or investment from or to a shareholder, other portfolio companies of the Company, portfolio company of Other Clients or any of their respective related parties as provided above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Firm Businesses, Activities and Relationships. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of its regular business, Blackstone provides a broad range of investment banking, advisory and other services. In addition, from time to time, the Firm will provide services in the future beyond those currently provided. Shareholders will not receive any benefit from any fees relating to such services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the regular course of its capital markets, investment banking, real estate advisory and other businesses, Blackstone represents potential purchasers, sellers and other involved parties, including corporations, financial buyers, management, shareholders and institutions, with respect to transactions that could give rise to other transactions that are suitable for the Company. In such a case, a Blackstone advisory client would typically require Blackstone to act exclusively on its behalf. Such advisory client requests have the potential to preclude all Blackstone-affiliated clients, including the Company, from participating in related transactions that would otherwise be suitable. Blackstone will be under no obligation to decline any such engagements in order to make an investment opportunity available to the Company. In connection with its capital markets, investment banking, advisory, real estate and other businesses, Blackstone comes into possession of information that limits its ability to engage in potential transactions. The Company&#x2019;s activities are expected to be constrained as a result of the inability of Blackstone personnel to use such information. For example, employees of Blackstone from time to time are prohibited by law or contract from sharing information with members of the Company&#x2019;s investment team. Additionally, there are expected to be circumstances in which one or more individuals associated with Blackstone affiliates (including clients) will be precluded from providing services related to the Company&#x2019;s activities because of certain confidential information available to those individuals or to other parts of Blackstone (e.g., trading can be restricted). Where Blackstone affiliates are engaged to find buyers or financing sources for potential sellers of assets, the seller can permit the Company to act as a participant in such transactions (as a buyer or financing partner), which would raise certain conflicts of interest inherent in such a situation (including as to the negotiation of the purchase price).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may invest in securities of the same issuers as Other Clients, other investment vehicles, accounts and clients of the Firm and the Adviser. To the extent that the Company holds interests that are different (or more senior or junior) than those held by such Other Clients, Blackstone Credit &amp;amp; Insurance may be presented with decisions involving circumstances where the interests of such Other Clients are in conflict with those of the Company. Furthermore, it is possible the Company&#x2019;s interest could be subordinated or otherwise adversely affected by virtue of such Other Clients&#x2019; involvement and actions relating to its investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the 1940 Act limits the Company&#x2019;s ability to undertake certain transactions with its affiliates that are registered under the 1940 Act or regulated as BDCs under the 1940 Act. As a result of these restrictions, the Company could be prohibited from executing &#x201c;joint&#x201d; transactions with such affiliates, which could include investments in the same portfolio company (whether at the same or different times). These limitations have the potential to limit the scope of investment opportunities that would otherwise be available to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance has received an exemptive order that permits certain funds, among other things, to co-invest with certain other persons, including certain affiliates of Blackstone Credit &amp;amp; Insurance, and certain funds managed and controlled by Blackstone Credit &amp;amp; Insurance and its affiliates subject to certain terms and conditions. In addition, other present and future activities of the Firm and its affiliates (including Blackstone Credit &amp;amp; Insurance and the Adviser) will from time to time give rise to additional conflicts of interest relating to the Firm and its investment activities. In the event that any such conflict of interest arises, the Adviser will attempt to resolve such conflicts in a fair and equitable manner. Investors should be aware that, subject to applicable law, conflicts will not necessarily be resolved in favor of the Company&#x2019;s interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transactions with Clients of Blackstone Insurance Solutions and Asset Based Finance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Blackstone Insurance Solutions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;BIS&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) is the business segment of Blackstone Credit &amp;amp; Insurance that provides investment advisory services to insurers, including among others, (i) Fidelity Life Insurance Company and certain of its affiliates (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;FGL&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), (ii) Everlake Life Insurance Company and certain of its affiliates (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Everlake&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), (iii) certain subsidiaries of Corebridge Financial, Inc. (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Corebridge&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and (iv) certain subsidiaries of Resolution Life Group Holdings Ltd. (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Resolution Life&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Certain of the insurers for which BIS provides services are, or may be in the future, owned, directly or indirectly, by Blackstone, the Company, or Other Clients, in whole or in part. Actual or potential conflicts of interest will likely arise in relation to the funds, vehicles or accounts BIS advises or sub-advises, including accounts where an insurer (including, without limitation, each of FGL, Everlake, Corebridge and Resolution Life) participates in investments directly and there is no separate vehicle controlled by Blackstone (for the purposes of this paragraph only, collectively, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;BIS Clients&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Blackstone Credit &amp;amp; Insurance also advises funds and accounts focused on asset-based finance, including insurers and other types of investors (for the purposes of this paragraph only, collectively, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;ABF Clients&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and each BIS Client and ABF Client is an Other Client for&#160;purposes other than this paragraph). BIS Clients have invested and are expected to continue investing in Other Clients and/or the Company. For greater clarity, any references herein to Blackstone Credit &amp;amp; Insurance or Other Blackstone Credit &amp;amp; Insurance Clients do not include BIS, BIS Clients or ABF Clients. Certain BIS Clients and certain ABF Clients have investment objectives that overlap with those of the Company (and Blackstone Credit &amp;amp; Insurance, or a business segment thereof, has entered into sub-management agreements with BIS to manage (for a fee, which such fees may be shared with BIS) the assets of certain such BIS Clients with respect to investments that overlap in part with the Company&#x2019;s investment directive) or its portfolio companies and such BIS Clients and ABF Clients may invest, as permitted by applicable law and the Company&#x2019;s co-investment exemptive relief, alongside (or in lieu of) the Company or such portfolio companies in certain investments, which will reduce the investment opportunities otherwise available to the Company or such portfolio companies. BIS Clients and ABF Clients will also engage in a variety of activities, including participating in transactions related to the Company and/or its portfolio companies (e.g., as originators, co-originators, counterparties or otherwise). Other transactions in which BIS Clients or ABF Clients will participate include, without limitation, investments in debt or other securities issued by portfolio companies or other forms of financing to portfolio companies (including special purpose vehicles established by the Company or such portfolio companies). When investing alongside the Company or its portfolio companies or in other transactions related to the Company or its portfolio companies, BIS Clients or ABF Clients may not invest or divest at the same time or on the same terms as the Company or the applicable portfolio companies or at a different time or on different terms. BIS Clients and ABF Clients will also from time to time acquire investments and portfolio companies directly or indirectly from the Company, as permitted by applicable law and the Company&#x2019;s co-investment exemptive relief. In circumstances where Blackstone Credit &amp;amp; Insurance determines in good faith that the conflict of interest is mitigated in whole or in part through various measures that Blackstone, Blackstone Credit &amp;amp; Insurance or the Adviser implements, the Adviser may determine to proceed with the applicable transaction (subject to oversight by the Board of Trustees and the applicable law to which the Company is subject). In order to seek to mitigate any potential conflicts of interest with respect to such transactions (or other transactions involving BIS Clients or ABF Clients), Blackstone reserves the right, in its sole discretion, to involve independent members of the board of a portfolio company or a third party stakeholder in the transaction to negotiate price and terms on behalf of the BIS Clients or ABF Clients or otherwise cause the BIS Clients or ABF Clients to &#x201c;follow the vote&#x201d; thereof, and/or cause an independent client representative or other third party to approve the investment or otherwise represent the interests of one or more of the parties to the transaction. In addition, Blackstone or the Adviser may limit the percentage interest of the BIS Clients or ABF Clients participating in such transaction, or obtain appropriate price quotes or other benchmarks, or, alternatively, a third-party price opinion or other document to support the reasonableness of the price and terms of the transaction. From time to time, the applicable BIS Clients or ABF Clients participating in a transaction will be required to consent thereto (including in circumstances where the Adviser does not seek the consent of the Board of Trustees). There can be no assurance that any such measures or other measures that may be implemented by Blackstone will be effective at mitigating any actual or potential conflicts of interest. Moreover, under certain circumstances (e.g., where a BIS Client or ABF Client participates in a transaction directly (and not through a vehicle controlled by Blackstone) and independently consents to participating in a transaction), a BIS Client or ABF Client (or any other Blackstone Client participating via a similar arrangement) will not be an &#x201c;Affiliate&#x201d; as defined under the 1940 Act. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allocation of Portfolios&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Firm will, in certain circumstances, have an opportunity to acquire a portfolio or pool of assets, securities and instruments that it determines should be divided and allocated among the Company and Other Clients. Such allocations generally would be based on the Firm&#x2019;s assessment of the expected returns and risk profile of each of the assets. For example, some of the assets in a pool will have an opportunistic return profile, while others will have a return profile not appropriate for the Company. Also, a pool can contain both debt and equity instruments that the Firm determines should be allocated to different funds. In all of these situations, the combined purchase price paid to a seller would be allocated among the multiple assets, securities and instruments in the pool and therefore among the Company and Other Clients acquiring any of the assets, securities and instruments, although the Firm could, in certain circumstances, allocate value to the Company and such Other Clients on a different basis than the contractual purchase price. Similarly, there will likely be circumstances in which the Company and Other Clients will sell assets in a single or related transactions to a buyer. In some cases, a counterparty will require an allocation of value in the purchase or sale contract, though the Firm could determine such allocation of value is not accurate and should not be relied upon. The Firm will generally rely upon internal analysis to determine the ultimate allocation of value, though it could also obtain third party valuation reports. Regardless of the methodology for allocating value, the Firm will have conflicting duties to the Company and Other Clients when they buy or sell assets together in a portfolio, including as a result of different financial incentives the Firm has with respect to different vehicles, most clearly when the fees and compensation, including performance-based compensation, earned from the different vehicles differ. There can be no assurance that an investment of the Company will not be valued or allocated a purchase price that is higher or lower than it might otherwise have been allocated if such investment were acquired or sold independently rather than as a component of a portfolio shared with Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Holding Entities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Firm may determine that for legal, tax, regulatory, accounting, administrative or other reasons the Company should hold a particular investment (or a portion of an investment or pool of assets) through a single holding entity through which the Company and one or more Other Clients hold different investments (or a different portion of such investment or pool of assets), including where such investment or pool has been divided and allocated among the Company and such Other Clients. Over time, it is possible that the Company and/or Other Clients may make different decisions with respect to the investments held through such holding entities and therefore may have differing economic rights, obligations or liabilities with respect to a holding entity. In such circumstances, the economic rights, liabilities and obligations in respect of the investment (or portion of an investment or pool of assets) that is indirectly held by the Company would be specifically attributed to the Company, and the Company would be deemed to hold its investment (or portion of an investment or pool of assets) separately from, and not jointly with, such Other Clients (and vice versa in respect of the investments (or portion of an investment or pool of assets) held indirectly through such holding entity by such Other Clients).&#160;Furthermore, certain holding structures may require a newly-established manager, advisor, service provider or other entity intended to address certain legal, tax, regulatory, accounting, administrative or other considerations applicable to the Company and/or Other Clients. It is possible that the Company or an affiliate will be initially responsible for the costs and expenses of establishing such holding structure (including any such newly-established entities) prior to, and/or, in anticipation of, Other Clients participating through such structure for their investments and it is expected that such Other Clients reimburse the Company or the Company would reimburse such affiliate for any such costs and expenses on a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; pro rata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Affiliate Transactions and Investments in Different Levels of Capital Structure&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company and the Other Clients may make investments at different levels of an issuer&#x2019;s capital structure or otherwise in different classes of an issuer&#x2019;s securities or loans, subject to the limitations of the 1940 Act. While less common, subject to applicable law, from time to time the Company could hold an investment in a different layer of the capital structure than an investor or another party with which Blackstone has a material relationship, in which case Blackstone could have an incentive to cause the Company or the portfolio company to offer more favorable terms to such parties (including, for instance, financing arrangements). Certain such investments inherently give rise to conflicts of interest or perceived conflicts of interest between or among the various classes of securities or loans that are expected to be held by such entities. To the extent the Company holds securities or loans that are different (including with respect to their relative seniority) than those held by an Other Client, the Adviser and its affiliates will be presented with decisions when the interests of the funds are in conflict. For example, conflicts could arise where the Company lends funds to a portfolio company while an Other Client invests in equity securities of such portfolio company. In this circumstance, for example, if such portfolio company were to go into bankruptcy, become insolvent or otherwise be unable to meet its payment obligations or comply with its debt covenants, conflicts of interest could arise between the holders of different types of securities or loans as to what actions the portfolio company should take. In addition, purchases or sales of securities or loans for the account of the Company (particularly marketable securities) will be bunched or aggregated with orders for Other Clients, including other funds. It is frequently not possible to receive the same price or execution on the entire volume of securities sold, and the various prices could be averaged, which has the potential to be disadvantageous to the Company. Further conflicts could arise after the Company and Other Clients have made their respective initial investments. For example, if additional financing is necessary as a result of financial or other difficulties, it is not always &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the best interests of the Company to provide such additional financing. If the Other Clients were to lose their respective investments as a result of such difficulties, the ability of the Adviser to recommend actions in the best interests of the Company might be impaired. Any applicable co-investment exemptive order issued by the SEC may restrict the Company&#x2019;s ability to participate in follow-on financings. Blackstone Credit &amp;amp; Insurance may in its sole discretion take steps to reduce the potential for adversity between the Company and the Other Clients, including causing the Company and/or such Other Clients to take certain actions that, in the absence of such conflict, it would not take. Such conflicts will be more difficult if the Company and Other Clients hold significant or controlling interests in competing or different tranches of a portfolio company&#x2019;s capital structure. Equity holders and debt holders have different (and often competing) motives, incentives, liquidity goals and other interests with respect to a portfolio company. In addition, there could be circumstances where Blackstone Credit &amp;amp; Insurance agrees to implement certain procedures to ameliorate conflicts of interest that involve a forbearance of rights relating to the Company or Other Clients, such as where Blackstone Credit &amp;amp; Insurance is expected to cause the Company or Other Clients to decline to exercise certain control-and/or foreclosure-related rights with respect to a portfolio company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Further, the Company is prohibited under the 1940 Act from participating in certain transactions with certain of affiliates (including portfolio companies of Other Clients) without the prior approval of a majority of the independent members of the Board of Trustees and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of the outstanding voting securities may be an affiliate of the Company for purposes of the 1940 Act and generally the Company will be prohibited from buying or selling any securities from or to such affiliate, absent the prior approval of the Board of Trustees. However, the Company may under certain circumstances purchase any such affiliate&#x2019;s loans or securities in the secondary market, which could create a conflict for the Adviser between the Company&#x2019;s interests and the interests of such affiliate, in that the ability of the Adviser to recommend actions in the Company&#x2019;s best interest may be limited. The 1940 Act also prohibits certain &#x201c;joint&#x201d; transactions with certain affiliates, which could include investments in the same portfolio company (whether at the same or closely related times), without prior approval of the Board of Trustees and, in some cases, the SEC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, conflicts may arise in determining the amount of an investment, if any, to be allocated among potential investors and the respective terms thereof. There can be no assurance that any conflict will be resolved in favor of the Company, and each shareholder acknowledges and agrees that in some cases, subject to applicable law, a decision by Blackstone Credit &amp;amp; Insurance to take any particular action could have the effect of benefiting an Other Client and therefore may not have been in the best interests of, and may be adverse to, the Company. There can be no assurance that the return on the Company&#x2019;s investment will be equivalent to or better than the returns obtained by the Other Clients participating in the same or similar transactions. The shareholders will not receive any benefit from fees paid to any affiliate of the Adviser in respect of any Other Client&#x2019;s investment in a portfolio company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Financing Counterparties. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may invest in companies or other entities in which Other Clients make an investment in a different part of the capital structure (and vice versa) subject to the requirements of the 1940 Act and the Company&#x2019;s co-investment exemptive order. The Adviser requests in the ordinary course proposals from lenders and other sources to provide financing to the Company and its portfolio companies. Blackstone Credit &amp;amp; Insurance takes into account various facts and circumstances it deems relevant in selecting financing sources, including whether a potential lender has expressed an interest in evaluating debt financing opportunities, whether a potential lender has a history of participating in debt financing opportunities generally and with the Firm in particular, the size of the potential lender&#x2019;s loan amount, the timing of the relevant cash requirement, the availability of other sources of financing, the creditworthiness of the lender, whether the potential lender has demonstrated a long-term or continuing commitment to the success of Blackstone, Blackstone Credit &amp;amp; Insurance and their funds, and such other factors that Blackstone and Blackstone Credit &amp;amp; Insurance deem relevant under the circumstances. The cost of debt alone is not determinative.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is possible that shareholders, Other Clients, their portfolio companies, co-investors and other parties with material relationships with the Firm, such as shareholders of and lenders to the Firm and lenders to Other Clients and their portfolio companies (as well as Blackstone itself), could provide additional financing to portfolio companies of the Company, subject to the requirements of the 1940 Act. The Firm could have incentives to cause the Company and its portfolio companies to accept less favorable financing terms from a shareholder, Other Clients, their portfolio companies, Blackstone, and other parties with material relationships with the Firm than it would from a third party. If the Company occupies a different, and in particular, a more senior, position in the capital structure than a shareholder, Other Client, their portfolio companies and other parties with material relationships with Blackstone, Blackstone could have an incentive to cause the Company or portfolio company to offer financing terms that are more favorable to such parties. In the case of a related party financing between the Company or its portfolio companies, on the one hand, and Blackstone or Other Clients&#x2019; portfolio companies, on the other hand, to the extent permitted by the 1940 Act, the Adviser could, but is not obligated to, rely on a third party agent to confirm the terms offered by the counterparty are consistent with market terms, or the Adviser could instead rely on its own internal analysis, which the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adviser believes is often superior to third party analysis given the Firm&#x2019;s scale in the market. If however any of the Firm, the Company, an Other Client or any of their portfolio companies delegates to a third party, such as another member of a financing syndicate or a joint venture partner, the negotiation of the terms of the financing, the transaction will be assumed to be conducted on an arms-length basis, even though the participation of the Firm related vehicle impacts the market terms. For example, in the case of a loan extended to the Company or a portfolio company by a financing syndicate in which an Other Client has agreed to participate on terms negotiated by a third party participant in the syndicate, it might have been necessary to offer better terms to the financing provider to fully subscribe the syndicate if the Other Client had not participated. It is also possible that the frequent participation of Other Clients in such syndicates could dampen interest among other potential financing providers, thereby lowering demand to participate in the syndicate and increasing the financing costs to the Company. The Adviser does not believe either of these effects is significant, but no assurance can be given to shareholders that these effects will not be significant in any circumstance. Unless required by applicable law, the Adviser will not seek any consent or approvals from shareholders or the Board of Trustees in the case of any of these conflicts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Firm could cause actions adverse to the Company to be taken for the benefit of Other Clients that have made an investment more senior in the capital structure of a portfolio company than the Company (e.g., provide financing to a portfolio company, the equity of which is owned by the Company) and, vice versa, actions may be taken for the benefit of the Company and its portfolio companies that are adverse to Other Clients. The Firm could seek to implement procedures to mitigate conflicts of interest in these situations such as (i) a forbearance of rights, including some or all non-economic rights, by the Company or relevant Other Client (or their respective portfolio companies, as the case may be) by, for example, agreeing to follow the vote of a third party in the same tranche of the capital structure, or otherwise deciding to recuse itself with respect to both normal course ongoing matters (such as consent rights with respect to loan modifications in intercreditor agreements) and also decisions on defaults, foreclosures, workouts, restructurings and other similar matters, (ii) causing the Company or relevant Other Client (or their respective portfolio companies, as the case may be) to hold only a non-controlling interest in any such portfolio company, (iii) retaining a third party loan servicer, administrative agent or other agent to make decisions on behalf of the Company or relevant Other Client (or their respective portfolio companies, as the case may be), or (iv) create groups of personnel within the Firm separated by information barriers (which may be temporary and limited purpose in nature), each of which would advise one of the clients that has a conflicting position with other clients. As an example, to the extent an Other Client holds an interest in a loan or security that is different (including with respect to relative seniority) than those held by the Company or its portfolio companies, the Firm can decline to exercise, or delegate to a third party, certain control, foreclosure and other similar governance rights of the Other Client. In these cases, the Firm would generally act on behalf of one of its clients, though the other client would generally retain certain control rights, such as the right to consent to certain actions taken by the trustee or administrative or other agent of the investment, including a release, waiver, forgiveness or reduction of any claim for principal or interest; extension of maturity date or due date of any payment of any principal or interest; release or substitution of any material collateral; release, waiver, termination or modification of any material provision of any guaranty or indemnity; subordination of any lien; and release, waiver or permission with respect to any covenants. The efficacy of following the vote of third-party creditors will be limited in circumstances where the Company or Other Client acquires all or substantially all of a relevant instrument, tranche or class of securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with negotiating loans and bank financings in respect of Blackstone Credit &amp;amp; Insurance-sponsored transactions, Blackstone Credit &amp;amp; Insurance will generally obtain the right to participate (for its own account or an Other Client) in a portion of the financings with respect to such Blackstone Credit &amp;amp; Insurance-sponsored transactions on the same terms negotiated by third parties with the Firm or other terms the Adviser determines to be consistent with the market. Although the Firm could rely on third parties to verify market terms, the Firm may nonetheless have influence on such third parties. No assurance can be given that negotiating with a third party, or verification of market terms by a third party, will ensure that the Company and its portfolio companies receive market terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, it is anticipated that in a bankruptcy proceeding the Company&#x2019;s interests will likely be subordinated or otherwise adverse to the interests of Other Clients with ownership positions that are more senior to those of the Company. For example, an Other Client that has provided debt financing to an investment of the Company will be permitted to take actions for its benefit, particularly if the Company&#x2019;s investment is in financial distress, which adversely impact the value of the Company&#x2019;s subordinated interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although Other Clients can be expected to provide financing to the Company and its portfolio companies subject to the requirements of the 1940 Act, there can be no assurance that any Other Client will indeed provide any such financing with respect to any particular investment. Participation by Other Clients in some but not all financings of the Company and its portfolio companies has the potential to adversely impact the ability of the Company and its portfolio companies to obtain financing from third parties when Other Clients do not participate, as it could serve as a negative signal to market participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any financing provided by a shareholder or an affiliate to the Company or a portfolio company is not an investment in the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The respective investment programs of the Company and the Other Clients may or may not be substantially similar. Blackstone Credit &amp;amp; Insurance and/or Blackstone may give advice to, and recommend securities for, Other Clients that may differ from advice given to, or securities recommended or bought for, the Company, even though their investment objectives may be the same as or similar to those of the Company. While Blackstone Credit &amp;amp; Insurance will seek to manage potential conflicts of interest in a fair and equitable manner, the portfolio strategies employed by Blackstone Credit &amp;amp; Insurance and Blackstone in managing their respective Other Clients are likely to conflict from time to time with the transactions and strategies employed by the Adviser in managing the Company and may affect the prices and availability of the securities and instruments in which the Company invests. Participation in specific investment opportunities may be appropriate, at times, for both the Company and Other Clients. In any event, it is the policy of Blackstone Credit &amp;amp; Insurance to allocate investment opportunities and sale opportunities on a basis deemed by Blackstone Credit &amp;amp; Insurance, in its sole discretion, to be fair and equitable over time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Conflicting Fiduciary Duties to Debt Funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Other Clients include funds and accounts that make investments in senior secured loans, distressed debt, subordinated debt, high-yield securities, commercial mortgage-backed securities and other debt instruments. As discussed above, it is expected that these Other Clients or investors therein will be offered the opportunity, subject to applicable law, to provide financing with respect to investments made by the Company and its portfolio companies. The Firm owes a fiduciary duty and/or other obligations to these Other Clients as well as to the Company and will encounter conflicts in the exercise of these duties and/or obligations. For example, if an Other Client purchases high-yield securities or other debt instruments of a portfolio company of the Company, or otherwise occupies a senior (or other different) position in the capital structure of an investment relative to the Company, the Firm will encounter conflicts in providing advice to the Company and to these Other Clients with regard to appropriate terms of such high-yield securities or other instruments, the enforcement of covenants, the terms of recapitalizations and the resolution of workouts or bankruptcies, among other matters. For example, in a bankruptcy proceeding, in circumstances where the Company holds an equity investment in a portfolio company, the holders of such portfolio company&#x2019;s debt instruments (which can include one or more Other Clients) could take actions for their benefit (particularly in circumstances where such portfolio company faces financial difficulties or distress) that subordinate or adversely impact the value of the Company&#x2019;s investment in such portfolio company. More commonly, the Company could hold an investment that is senior in the capital structure, such as a debt instrument, to an Other Client. Although measures described in &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Financing Counterparties&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; above can mitigate these conflicts, they cannot completely eliminate them. These conflicts related to fiduciary duties to such Other Clients will not necessarily be resolved in favor of the Company, and investors will not always be entitled to receive notice or disclosure of the occurrence of these conflicts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Similarly, certain Other Clients can be expected to invest in securities of publicly traded companies that are actual or potential investments of the Company or its portfolio companies. The trading activities of those vehicles can differ from or be inconsistent with activities that are undertaken for the account of the Company or its portfolio companies in any such securities or related securities. In addition, the Company could not pursue an investment in a portfolio company otherwise within the investment mandate of the Company as a result of such trading activities by Other Clients. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Blackstone and Blackstone Credit &amp;amp; Insurance Clients; Allocation of Investment Opportunities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Certain inherent conflicts of interest arise from the fact that the Adviser, Blackstone Credit &amp;amp; Insurance and Blackstone provide investment management, advisory and sub-advisory services to the Company and Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance and/or Blackstone may give advice to, and recommend securities for, Other Clients that may differ from advice given to, or securities recommended or bought for, the Company, even though their investment objectives may be the same as or similar to those of the Company. Blackstone Credit &amp;amp; Insurance has adopted guidelines and policies, which can be expected to be updated from time to time, regarding allocation of investment opportunities. While Blackstone Credit &amp;amp; Insurance will seek to manage potential conflicts of interest in a fair and equitable manner, the portfolio strategies employed by Blackstone Credit &amp;amp; Insurance and Blackstone in managing their respective Other Clients are likely to conflict from time to time with the transactions and strategies employed by the Adviser in managing the Company and may affect the prices and availability of the securities and instruments in which the Company invests. Participation in specific investment opportunities may be appropriate, at times, for both the Company and Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance provides investment management services to Other Blackstone Credit &amp;amp; Insurance Clients. In addition, Blackstone provides investment management services to Blackstone Clients. Blackstone Credit &amp;amp; Insurance will share appropriate investment opportunities (and sale opportunities) (including, without limitation, secondary market transactions and certain syndicated primary issuance transactions (which generally will not be originated investments)) with Other Clients and the Company in accordance with Firm-wide allocation policies, which generally provide for sharing pro rata based on targeted acquisition size (generally based on available capacity) or targeted sale size (or, in some sales cases, the aggregate positions held by the Company and the applicable Other Clients), taking into account actual and anticipated investments and capital commitments (as appropriate), available cash, asset-based leverage and relative capital of the Company and the applicable Other Clients and such other factors as Blackstone Credit &amp;amp; Insurance determines in good faith to be appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To the extent an opportunity is shared with one or more Other Clients, Blackstone Credit &amp;amp; Insurance expects that such Other Clients generally will invest on substantially the same economic terms available to the Company (including sharing of transaction fees and expenses) and generally will exit investments at the same time and on substantially the same economic terms as the Company, and on a pro rata basis with the Company subject to legal, tax, regulatory, accounting or applicable considerations (including the terms of the governing agreements of, or portfolio management considerations applicable to, the Company or such Other Clients); provided that the Company may syndicate a portion of an investment where Other Clients do not also syndicate a portion of the investment. (See also&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014;Transactions with Clients of Blackstone Insurance Solutions and Asset Based Finance.&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allocation Methodology Considerations. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notwithstanding the foregoing, Blackstone Credit &amp;amp; Insurance may also consider the following factors in making any allocation determinations, and such factors may result in a different allocation of investment and/or sale opportunities: (i)&#160;the risk-return and target return profile of the proposed investment relative to the Company&#x2019;s and the Other Clients&#x2019; current risk profiles; (ii)&#160;the Company&#x2019;s and/or the Other Clients&#x2019; investment strategies, mandates, guidelines, limitations, restrictions, terms and objectives (including whether such objectives are considered solely in light of the specific investment under consideration or in the context of the respective portfolios&#x2019; overall holdings), other contractual provisions (including Other Clients with minimum allocation provisions), focus (including investment focus on a classification attributable to an investment, such as maturity), parameters and investor preferences of the Company and the Other Clients (including, without limitation, with respect to Other Clients that expect to invest in or alongside other funds or across asset classes based on expected return (such as certain managed accounts or other investment vehicles (whether now in existence or which may be established in the future)) with similar investment strategies and objectives); (iii) diversification and concentration considerations in the Company&#x2019;s or the Other Clients&#x2019; portfolios (including the potential for the proposed investment to create an industry, sector, geography, region, location, market or issuer imbalance in the Company&#x2019;s and Other Clients&#x2019; portfolios, as applicable) and taking into account any existing non-pro rata investment positions in the portfolio of the Company and Other Clients; (iv)&#160;liquidity considerations of the Company and the relevant Other Clients (including warehouse vehicles or arrangements (such as CLO warehouses and Blackstone-controlled or third party warehouse arrangements) established for the benefit of current Other Clients or potential future Other Clients), including during a ramp-up (which includes the period prior to or after the initial closing of an Other Client during which its manager is deploying funds already invested or committed (or that its manager anticipates will be invested or committed) and can continue for a period during an Other Client&#x2019;s fundraising and/or acceptance of future subscriptions as deemed appropriate by the Firm, including to protect against zero or de minimis allocations or in anticipation of future subscriptions) or wind-down of one or more of the Company or such Other Clients, proximity to the end of the Company&#x2019;s or Other Clients&#x2019; specified term or investment period, any redemption/withdrawal requests, anticipated future contributions and available cash; (v)&#160;legal, tax, accounting and other considerations or consequences; (vi)&#160;regulatory or contractual provisions, obligations, terms, limitations, restrictions or consequences relating to the Company or Other Clients (including, without limitation, requirements under the 1940 Act and any related rules, orders, guidance or other authority applicable to the Company or Other Clients); (vii) avoiding a de minimis or odd lot allocation; (viii)&#160;availability and degree of leverage and any requirements or other terms of the investment, or of any existing leverage facilities; (ix)&#160;the Company&#x2019;s or Other Clients&#x2019; investment focus on a classification attributable to an investment or issuer of an investment, including, without limitation, investment strategy, geography, location, industry or business sector; (x)&#160;the nature and extent of involvement in the transaction on the part of the respective teams of investment professionals dedicated to the Company or such Other Clients; (xi)&#160;the management of any actual or potential conflict of interest; (xii)&#160;with respect to investments that are made available to Blackstone Credit &amp;amp; Insurance by counterparties pursuant to negotiated trading platforms (e.g., ISDA contracts), the absence of such relationships which may not be available for the Company and all Other Clients; (xiii)&#160;co-investment arrangements, (xiv)&#160;available capital of the Company and such Other Clients, (xv) sourcing of the investment, (xvi)&#160;the specific nature (including size, type, amount, liquidity, holding period, anticipated maturity and minimum investment criteria) of the investment, (xvii)&#160;expected investment return, (xviii)&#160;expected cash characteristics (such as cash-on-cash yield, distribution rates or volatility of cash flows), (xix) capital expenditure required &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as part of the investment, (xx)&#160;portfolio diversification and concentration concerns (including, but not limited to, whether a particular fund already has its desired exposure to the investment, sector, industry, geographic region or markets in question), (xxi) relation to existing investments in a fund, if applicable (e.g., &#x201c;follow on&#x201d; to existing investment, joint venture or other partner to existing investment, or same security as existing investment), (xxii) timing expected to be necessary to execute an investment, (xxiii) whether Blackstone Credit &amp;amp; Insurance believes that allocating investment opportunities to an investor will help establish, recognize, strengthen and/or cultivate relationships that may provide indirectly longer-term benefits (including strategic, sourcing or similar benefits) to the Company, Other Clients and/or Blackstone and (xxiv) any other considerations deemed relevant by Blackstone Credit &amp;amp; Insurance in good faith.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to the requirements of the 1940 Act and the Company&#x2019;s co-investment exemptive order, Blackstone Credit &amp;amp; Insurance shall not have any obligation to present any investment opportunity (or portion of any investment opportunity) to the Company if Blackstone Credit &amp;amp; Insurance determines in good faith that such opportunity (or portion thereof) should not be presented to the Company, including for any one or a combination of the reasons described above, or if Blackstone Credit &amp;amp; Insurance is otherwise restricted from presenting such investment opportunity to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment Alongside Regulated Funds. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition,&#160;Blackstone Credit &amp;amp; Insurance has received an exemptive order from the SEC that permits certain existing and future Other Blackstone Credit &amp;amp; Insurance Clients that are closed-end management investment companies that have elected to be regulated as a BDC or are registered under the 1940 Act and who intend to rely on the exemptive order (each a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x201c;Regulated Fund&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and collectively, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Regulated Funds&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), including the Company, among other things, to co-invest with certain other persons, including certain affiliates of Blackstone Credit &amp;amp; Insurance, and certain funds managed and controlled by Blackstone Credit &amp;amp; Insurance and its affiliates, including the Company and Other Blackstone Credit &amp;amp; Insurance Clients, subject to certain terms and conditions. For so long as any privately negotiated investment opportunity falls within certain established investment criteria of one or more Regulated Funds, such investment opportunity shall also be offered to such Regulated Fund(s). In the event that the aggregate targeted investment sizes of the Company, such Other Blackstone Credit &amp;amp; Insurance Clients and such Regulated Fund(s) that are allocated an investment opportunity exceed the amount of such investment opportunity, allocation of such investment opportunity to each of the Company, such Other Blackstone Credit &amp;amp; Insurance Clients and Regulated Fund(s) will be reduced proportionately based on their respective &#x201c;available capital&#x201d; as defined in the co-investment exemptive order, which may result in allocation to the Company in an amount less than what it would otherwise have been if such Other Blackstone Credit &amp;amp; Insurance Client(s) and Regulated Fund(s) did not participate in such investment opportunity. The co-investment exemptive order also restricts the ability of the Company (or any such Other Blackstone Credit &amp;amp; Insurance Client) from investing in any privately negotiated investment opportunity alongside a Regulated Fund except at the same time and on same terms, as described in the exemptive order. As a result, the Company risks being unable to make investments in different parts of the capital structure of the same issuer in which a Regulated Fund has invested or seeks to invest, and Regulated Funds risk being unable to make investments in different parts of the capital structure of the same issuer in which the Company has invested or seeks to invest. The Company may be unable to participate in or effect certain transactions, or take certain actions in respect of certain investments, on account of applicable restrictions under the 1940 Act, related guidance from the SEC and/or the Company&#x2019;s exemptive order.&#160;For example, the Company may be restricted from participating in certain transactions or taking certain actions in respect of portfolio companies in which certain funds managed and controlled by Blackstone Credit &amp;amp; Insurance and its affiliates and/or a Regulated Fund has also invested, which may include, but is not limited to declining to vote, participating in a potential co-investment opportunity (as such participation may not comply with the conditions of the co-investment exemptive order), exercising rights with respect to any such investment, and/or declining to participate in follow-on investments. The Company may also be required to sell an investment to avoid potential violations of the 1940 Act and/or related rules thereunder or for other reasons. In such cases, the Company&#x2019;s interests in an investment may be adversely affected, including by resulting in the dilution of or decrease in the value of the Company&#x2019;s investment, or otherwise by resulting in the Company being put in a disadvantageous position with respect to the investment as compared to Other Blackstone Credit &amp;amp; Insurance Clients, including other Regulated Funds. Whether the Company participates or declines to participate in any such action or transaction will be made by the Adviser in its sole discretion and will take into account the Adviser&#x2019;s fiduciary duties and applicable law, including the 1940 Act, the rules thereunder and/or the exemptive order. There is no assurance that any such determination will be resolved in favor of the Company&#x2019;s interests. The rules promulgated by the SEC under the 1940 Act, as well as any related guidance from the SEC and/or the terms of the exemptive order itself, are subject to change, and Blackstone Credit &amp;amp; Insurance could undertake to amend the exemptive order (subject to SEC approval), obtain additional exemptive relief, or otherwise be subject to other requirements in respect of co-investments involving the Company, any Other Blackstone Credit &amp;amp; Insurance Client and any Regulated Funds, any of which could impact the amount of any allocation made available to Regulated Funds and thereby affect (and potentially decrease) the allocation made to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Moreover, with respect to Blackstone Credit &amp;amp; Insurance&#x2019;s ability to allocate investment opportunities, including where such opportunities are within the common objectives and guidelines of the Company and one or more Other Clients (which allocations are to be made on a basis that Blackstone Credit &amp;amp; Insurance believes in good faith to be fair and reasonable), Blackstone Credit &amp;amp; Insurance and Blackstone have established general guidelines and policies, which it can be expected to update from time to time, for determining how such allocations are to be made, which, among other things, set forth principles regarding what constitutes &#x201c;debt&#x201d; or &#x201c;debt-like&#x201d; investments, criteria for defining &#x201c;control-oriented equity&#x201d; or &#x201c;infrastructure&#x201d; investments, guidance regarding allocation for certain types of investments (e.g., distressed assets) and other matters. In addition, certain Other Clients can receive certain priority or other allocation rights with respect to certain investments, subject to various conditions set forth in such Other Clients&#x2019; respective governing agreements. The application of those guidelines and conditions could result in the Company or Other Clients not participating (and/or not participating to the same extent) in certain investment opportunities in which they would have otherwise participated had the related allocations been determined without regard to such guidelines and conditions and based only on the circumstances of those particular investments. Additionally, investment opportunities sourced by Blackstone Credit &amp;amp; Insurance will be allocated in accordance with Blackstone&#x2019;s and Blackstone Credit &amp;amp; Insurance&#x2019;s allocation policies, which provide that investment opportunities will be allocated in whole or in part to other business units of the Firm on a basis that Blackstone and Blackstone Credit &amp;amp; Insurance believe in good faith to be fair and reasonable, based on various factors, including the involvement of the respective teams from Blackstone Credit &amp;amp; Insurance and such other business units. It should also be noted that investment opportunities sourced by business units of the Firm other than Blackstone Credit &amp;amp; Insurance will be allocated in accordance with such business units&#x2019; allocation policies, which will result in such investment opportunities being allocated, in whole or in part, away from Blackstone Credit &amp;amp; Insurance, the Company and Other Blackstone Credit &amp;amp; Insurance Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When Blackstone Credit &amp;amp; Insurance determines not to pursue some or all of an investment opportunity for the Company that would otherwise be within the Company&#x2019;s objectives and strategies, and Blackstone or Blackstone Credit &amp;amp; Insurance provides the opportunity or offers the opportunity to Other Clients (or other parties, including portfolio companies), Blackstone or Blackstone Credit &amp;amp; Insurance, including their personnel (including Blackstone Credit &amp;amp; Insurance personnel), will, in certain circumstances, receive compensation from the Other Clients and/or other parties, whether or not in respect of a particular investment, including an allocation of carried interest or referral fees, and any such compensation could be greater than amounts paid by the Company to Blackstone Credit &amp;amp; Insurance. As a result, Blackstone Credit &amp;amp; Insurance (including Blackstone Credit &amp;amp; Insurance personnel who receive such compensation) could be incentivized to allocate investment opportunities away from the Company to or source investment opportunities for Other Clients and/or other parties. In addition, in some cases Blackstone or Blackstone Credit &amp;amp; Insurance can be expected to earn greater fees when Other Clients participate alongside or instead of the Company in an investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance makes good faith determinations for allocation decisions based on expectations that will, in certain circumstances, prove inaccurate. Information unavailable to Blackstone Credit &amp;amp; Insurance, or circumstances not foreseen by Blackstone Credit &amp;amp; Insurance at the time of allocation, can cause an investment opportunity to yield a different return than expected. Conversely, an investment that Blackstone Credit &amp;amp; Insurance expects to be consistent with the Company&#x2019;s return objectives will, in certain circumstances, fail to achieve them.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser is permitted, but will be under no obligation to, provide co-investment opportunities relating to investments made by the Company to Fund shareholders, Other Clients, investors in such Other Clients, subject to the Company&#x2019;s exemptive relief and the 1940 Act. Such co-investment opportunities may be offered to such parties in the Adviser&#x2019;s discretion subject to the Company&#x2019;s exemptive relief. From time to time, Blackstone Credit &amp;amp; Insurance may form one or more funds or accounts to co-invest in transactions with the Company (or transactions alongside any of the Company and one or more Other Clients). Furthermore, for the avoidance of doubt, to the extent that the Company has received its target amount in respect of an investment opportunity, any remaining portion of such investment opportunity initially allocated to the Company may be allocated to Other Clients or to co-investors in Blackstone Credit &amp;amp; Insurance&#x2019;s discretion pursuant to the Company&#x2019;s exemptive relief.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Orders may be combined for the Company and other participating Other Clients, and if any order is not filled at the same price, they may be allocated on an average price basis. Similarly, if an order on behalf of more than one account cannot be fully executed under prevailing market conditions, securities may be allocated among the different accounts on a basis that Blackstone Credit &amp;amp; Insurance or its affiliates consider equitable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, it can be expected that the Firm will, from time to time, enter into arrangements or strategic relationships with third parties, including other asset managers, financial firms or other businesses or companies, that, among other things, provide for referral, sourcing or sharing of investment opportunities. Blackstone or Blackstone Credit &amp;amp; Insurance may pay management fees and performance-based compensation in connection with such arrangements. Blackstone or Blackstone Credit &amp;amp; Insurance may also provide for or receive reimbursement of certain expenses incurred or received in connection with these arrangements, including diligence expenses and general overhead, administrative, deal sourcing and related corporate expenses. The amount of these rebates may relate to allocations of co-investment opportunities and increase if certain co-investment allocations are not made. While it is possible that the Company will, along with the Firm itself, benefit from the existence of those arrangements and/or relationships, it is also possible that investment opportunities that would otherwise be presented to or made by the Company would instead be referred (in whole or in part) to such third party, or, as indicated above, to other third parties, either as a contractual obligation or otherwise, resulting in fewer opportunities (or reduced allocations) being made available to the Company and/or shareholders. This means that co-investment opportunities that are sourced by the Company may be allocated to investors that are not shareholders. For example, a firm with which the Firm has entered into a strategic relationship may be afforded with &#x201c;first-call&#x201d; rights on a particular category of investment opportunities, although there is not expected to be substantial overlap in the investment strategies and/or objectives between the Company and any such firm. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Investments Inside the Company&#x2019;s Mandate that are not Pursued by the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under certain circumstances, Blackstone or Blackstone Credit &amp;amp; Insurance can be expected to determine not to pursue some or all of an investment opportunity within the Company&#x2019;s mandate, including without limitation, as a result of business, reputational or other reasons applicable to the Company, Other Clients, their respective portfolio companies or Blackstone. In addition, Blackstone Credit &amp;amp; Insurance will, in certain circumstances, determine that the Company should not pursue some or all of an investment opportunity, including, by way of example and without limitation, because the Company has already invested sufficient capital in the investment, sector, industry, geographic region or markets in question, as determined by Blackstone Credit &amp;amp; Insurance in its good faith discretion, or the investment is not appropriate for the Company for other reasons as determined by Blackstone Credit &amp;amp; Insurance in its good faith reasonable sole discretion. In any such case Blackstone or Blackstone Credit &amp;amp; Insurance could, thereafter, offer such opportunity to other parties, including Other Clients or portfolio companies or limited partners or shareholders of the Company or Other Clients, joint venture partners, related parties or third parties. Any such Other Clients could be advised by a different Blackstone or Blackstone Credit &amp;amp; Insurance business group with a different investment committee, which could determine an investment opportunity to be more attractive than Blackstone Credit &amp;amp; Insurance believes to be the case. In any event, there can be no assurance that Blackstone Credit &amp;amp; Insurance&#x2019;s assessment will prove correct or that the performance of any investments actually pursued by the Company will be comparable to any investment opportunities that are not pursued by the Company. Blackstone and Blackstone Credit &amp;amp; Insurance, including their personnel, are permitted to receive compensation from any such party that makes the investment, including an allocation of carried interest or referral fees, and any such compensation could be greater than amounts paid by the Company to Blackstone Credit &amp;amp; Insurance. In some cases, Blackstone or Blackstone Credit &amp;amp; Insurance earns greater fees when Other Clients participate alongside or instead of the Company in an investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Situations can arise where certain assets held by the Company are transferred to Other Clients and vice versa. Such transactions will be conducted in accordance with, and subject to, the Adviser&#x2019;s contractual obligations to the Company and applicable law, including the 1940 Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Co-Investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will co-invest with its shareholders, limited partners and/or shareholders of the Other Clients, the Firm&#x2019;s affiliates and other parties with whom Blackstone Credit &amp;amp; Insurance has a material relationship. The allocation of co-investment opportunities is entirely and solely in the discretion of Blackstone Credit &amp;amp; Insurance, subject to applicable law. In addition to participation by Consultants in specific transactions or investment opportunities, Consultants and/or other Firm employees may be permitted to participate in the Firm&#x2019;s side-by-side co-investment rights. Such rights generally do not provide for an advisory fee or carried interest payable by participants therein and generally result in the Company being allocated a smaller share of an investment than would otherwise be the case in the absence of such side-by-side. Furthermore, Other Clients will be permitted (or have a preferred right) to participate in the Firm&#x2019;s side-by-side co-investment rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain circumstances, Blackstone Credit &amp;amp; Insurance will determine that a co-investment opportunity should be offered to one or more third parties (such investors, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Co-Investors&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and will maintain sole discretion with respect to which Co-Investors are offered any such opportunity. It is expected that many investors who will, in certain circumstances, have expressed an interest in co-investment opportunities will not be allocated any co-investment opportunities or will, in certain circumstances, receive a smaller amount of co-investment opportunities than the amount requested. Any co-investments offered by Blackstone Credit &amp;amp; Insurance will be on such terms and conditions (including with respect to advisory fees, performance-based compensation and related arrangements and/or other fees applicable to co-investors) as Blackstone Credit &amp;amp; Insurance determines to be appropriate in its sole discretion on a case-by-case basis, which may differ amongst co-investors with respect to the same co-investment. In addition, the performance of Other Clients co-investing with the Company is not considered for purposes of calculating the incentive fee payable by the Company to the Adviser. Furthermore, the Company and co-investors will often have different investment objectives and limitations, such as return objectives and maximum hold period. Blackstone Credit &amp;amp; Insurance, as a result, will have conflicting incentives in making decisions with respect to such opportunities. Even if the Company and any such parties invest in the same securities on similar terms, conflicts of interest will still arise as a result of differing investment profiles of the investors, among other items.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;General Co-Investment Considerations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; There are expected to be circumstances where an amount that would otherwise have been invested by the Company is instead allocated to co-investors (who could be shareholders of the Company or limited partners of Other Clients) or supplemental capital vehicles, and there is no guarantee that any shareholders will be offered any particular co-investment opportunity. Each co-investment opportunity (should any exist) is likely to be different, and allocation of each such opportunity will depend on the facts and circumstances specific to that unique situation (e.g., timing, industry, size, geography, asset class, projected holding period, exit strategy and counterparty). Different situations will require that the various facts and circumstances of each opportunity be weighted differently, as Blackstone Credit &amp;amp; Insurance deems relevant to such opportunity. Such factors are likely to include, among others, whether a co-investor adds strategic value, industry expertise or other similar synergies; whether a potential co-investor has expressed an interest in evaluating co-investment opportunities; whether a potential co-investor has an overall strategic relationship with the Firm; whether a potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of Blackstone, Blackstone Credit &amp;amp; Insurance, the Company, Other Clients or other co-investments (including whether a potential co-investor will help establish, recognize, strengthen and/or cultivate relationships that can provide indirectly longer-term benefits to the Company or Other Clients and their respective underlying portfolio companies, or whether the potential co-investor has significant capital under management by the Firm or intends to increase such amount); the ability of a potential co-investor to commit to a co-investment opportunity within the required timeframe of the particular transaction; Blackstone Credit &amp;amp; Insurance&#x2019;s assessment of a potential co-investor&#x2019;s ability to invest an amount of capital that fits the needs of the investment (taking into account the amount of capital needed as well as the maximum number of investors that can realistically participate in the transaction); whether the co-investor is considered &#x201c;strategic&#x201d; to the investment because it is able to offer the Company certain benefits, including but not limited to, the ability to help consummate the investment, the ability to aid in operating or monitoring the portfolio company or the possession of certain expertise; the transparency, speed and predictability of the potential co-investor&#x2019;s investment process; whether the Firm has previously expressed a general intention to seek to offer co-investment opportunities to such potential co-investor; whether a potential co-investor has the financial and operational resources and other relevant wherewithal to evaluate and participate in a co-investment opportunity; the familiarity the Firm has with the personnel and professionals of the investor in working together in investment contexts (which may include such potential co-investor&#x2019;s history of investment in other Firm co-investment opportunities); the extent to which a potential co-investor has committed to an Other Client; the size of such potential co-investor&#x2019;s interest to be held in the underlying portfolio company as a result of the Company&#x2019;s investment (which is likely to be based on the size of the potential co-investor&#x2019;s capital commitment or investment in the Company); the extent to which a potential co-investor has been provided a greater amount of co-investment opportunities relative to others; the ability of a potential co-investor to invest in potential add-on acquisitions for the portfolio company or participate in defensive investments; the likelihood that the potential co-investor would require governance rights that would complicate or jeopardize the transaction (or, alternatively, whether the investor would be willing to defer to the Firm and assume a more passive role in governing the portfolio company); any interests a potential co-investor might have in any competitors of the underlying portfolio company; the tax profile of the potential co-investor and the tax characteristics of the investment (including whether the potential co-investor would require particular structuring implementation or covenants that would not otherwise be required but for its participation or whether such co-investor&#x2019;s participation is beneficial to the overall structuring of the investment); whether a potential co-investor&#x2019;s participation in the transaction would subject the Company and/or the portfolio company to additional regulatory requirements, review and/or scrutiny, including any necessary governmental approvals required to consummate the investment; the potential co-investor&#x2019;s interaction with the potential management team of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;portfolio company; whether the potential co-investor has any existing positions in the portfolio company (whether in the same security in which the Company is investing or otherwise); whether there is any evidence to suggest that there is a heightened risk with respect to the potential co-investor maintaining confidentiality; whether the potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of the Company, other affiliated funds and/or other co-investments, including the size of such commitment; whether the potential co-investor has any known investment policies and restrictions, guideline limitations or investment objectives that are relevant to the transaction, including the need for distributions; whether the expected holding period and risk-return profile of the investment is consistent with the stated goals of the investor; and such other factors as the Adviser deems relevant and believes to be appropriate under the circumstances. Furthermore, in connection with any such co-investment by third-party co-investors, the Adviser can establish one or more investment vehicles managed or advised by the Firm to facilitate such co-investors&#x2019; investment alongside the Company. The factors listed in the foregoing sentence are neither presented in order of importance nor weighted, except that Blackstone Credit &amp;amp; Insurance has historically primarily relied upon the following two factors in making the determination to offer co-investment opportunities to co-investors: (i) whether the potential co-investor has demonstrated a long-term and/or continuing commitment to the potential success of the Company (including whether a potential co-investor will help establish, recognize, strengthen and/or cultivate relationships that can provide indirectly longer-term benefits to the Company or Other Clients and their respective underlying portfolio companies), other affiliated funds, and/or other co-investments, including the size of any such commitment and fee revenue or profits generated for the benefit of Blackstone Credit &amp;amp; Insurance or Blackstone as a result thereof and (ii) the ability of a potential co-investor to process a co-investment decision within the required timeline of the particular transaction. Except as otherwise described herein, co-investors generally will not share Broken Deal Expenses with the Company and Other Clients, with the result that the Company and such Other Clients will bear all such Broken Deal Expenses, and such expenses can be significant. However, the Adviser does not intend to offer any such co-investment opportunities to shareholders in their capacity as shareholders. Blackstone Credit &amp;amp; Insurance may (but is not required to) establish co-investment vehicles (including dedicated or &#x201c;standing&#x201d; co-investment vehicles) for one or more investors (including third party investors and investors in the Company) in order to co-invest alongside the Company in one or more future investments. The existence of these vehicles could reduce the opportunity for other shareholders to receive allocations of co-investment. In addition, the allocation of investments to Other Clients, including as described under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Other Blackstone and Blackstone Credit &amp;amp; Insurance Clients; Allocation of Investment Opportunities&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; herein, may result in fewer co-investment opportunities (or reduced allocations) being made available to shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Additional Potential Conflicts of Interest with respect to Co-Investment; Strategic Relationships Involving Co-Investment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In addition, the Adviser and/or its affiliates will in certain circumstances be incentivized to offer certain potential co-investors (including, by way of example, as a part of an overall strategic relationship with the Firm) opportunities to co-invest because the extent to which any such co-investor participates in (or is offered) co-investment opportunities can impact the amount of performance-based compensation and/or management fees or other fees paid by the co-investor. The amount of carried interest or expenses charged and/or management fees paid by the Company may be less than or exceed such amounts charged or paid by co-investment vehicles pursuant to the terms of such vehicles&#x2019; partnership agreements and/or other agreements with co-investors, and such variation in the amount of fees and expenses may create an economic incentive for Blackstone Credit &amp;amp; Insurance to allocate a greater or lesser percentage of an investment opportunity to the Company or such co-investment vehicles or co-investors, as the case may be. In addition, other terms of existing and future co-investment vehicles may differ materially, and in some instances may be more favorable to Blackstone Credit &amp;amp; Insurance, than the terms of the Company, and such different terms may create an incentive for Blackstone Credit &amp;amp; Insurance to manage such vehicles, which could result in the Company receiving a lesser percentage of an investment opportunity than if such co-investment vehicles did not exist. Such relationships will from time to time give rise to conflicts of interest, and there can be no assurance that such conflicts of interest will be resolved in favor of the Company. Accordingly, any investment opportunities that would have otherwise been offered or allocated, in whole or in part, to the Company can be reduced and made available to co-investment vehicles. Co-investments may be offered by the Adviser on such terms and conditions as the Adviser determines in its discretion on a case-by-case basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fund Co-Investment Opportunities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a BDC regulated under the 1940 Act, the Company is subject to certain limitations relating to co-investments and joint transactions with affiliates, which likely will in certain circumstances limit the Company&#x2019;s ability to make investments or enter into other transactions alongside the Other Clients. There can be no assurance that such regulatory restrictions will not adversely affect the Company&#x2019;s ability to capitalize on attractive investment opportunities. However, subject to the 1940 Act and any applicable co-investment exemptive order issued by the SEC, the Company may co-invest with Other Clients (including co-investment or other vehicles in which the Firm or its personnel invest and that co-invest with such Other Clients) in investments that are suitable for the Company and one or more of such Other Clients. Even if the Company and any such Other Clients and/or co-investment or other vehicles invest in the same securities, conflicts of interest may still arise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions. Such order may restrict our ability to enter into follow-on investments or other transactions. Pursuant to such order, we may co-invest in a negotiated deal with certain affiliates of the Adviser or certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions. We may also receive an allocation in such a deal alongside affiliates pursuant to other mechanisms to the extent permitted by the 1940 Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Portfolio Companies Alongside Other Clients. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company will co-invest with Other Clients (including co-investment or other vehicles in which the Firm or its personnel invest and that co-invest with such Other Clients) in investments that are suitable for both the Company and such Other Clients, as permitted by applicable law and/or any applicable SEC-granted order. Even if the Company and any such Other Clients invest in the same securities or loans, conflicts of interest are still expected to arise. For example, it is possible that as a result of legal, tax, regulatory, accounting, political, national security or other considerations, the terms of such investment (and divestment thereof) (including with respect to price and timing) for the Company and such other funds and vehicles are not the same. Additionally, the Company and such Other Clients and/or vehicles will generally have different investment periods and/or investment objectives (including return profiles) and Blackstone Credit &amp;amp; Insurance, as a result, could have conflicting goals with respect to the amount, price and timing of disposition opportunities. As such, subject to applicable law and any applicable order issued by the SEC, the Company and/or such Other Clients may dispose of any such shared investment at different times and on different terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Firm Involvement in Financing of Third Party Dispositions by the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company is permitted from time to time dispose of all or a portion of an investment by way of accepting a third-party purchaser&#x2019;s bid where the Firm or one or more Other Clients is providing financing as part of such bid or acquisition of the investment or underlying assets thereof. This generally would include the circumstance where the Firm or one or more Other Clients is making commitments to provide financing at or prior to the time such third-party purchaser commits to purchase such investments or assets from the Company. Such involvement of the Firm or one or more Other Clients as such a provider of debt financing in connection with the potential acquisition of portfolio investments by third parties from the Company may give rise to potential or actual conflicts of interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Self-Administration of the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance expects to provide certain fund administration services to the Company rather than engage or rely on a third party administrator to perform such services. The costs for providing these services are not included in the management fee under the Investment Advisory Agreement and will be paid separately by the Company. Blackstone Credit &amp;amp; Insurance also reserves the right to charge the Company a reduced rate for these services, or to reduce or waive such charges entirely, subject to the 1940 Act. Blackstone Credit &amp;amp; Insurance&#x2019;s ability to determine the reimbursement obligation from the Company creates a conflict of interest. Blackstone Credit &amp;amp; Insurance addresses this conflict by reviewing its fund administration costs to ensure that it is comparable and fair with regard to equivalent services performed by a non-affiliated third party at a rate negotiated on an arm&#x2019;s length basis. The Board of Trustees periodically reviews the reimbursement obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Outsourcing. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to the oversight and, in certain circumstances, approval by the Board of Trustees of the Company, Blackstone may outsource to third parties several of the services performed for the Company and/or its portfolio entities, including services (such as administrative, legal, accounting, tax, diligence, modeling, ongoing monitoring, preparation of internal templates and/or memos or other related services) that may be or historically have been performed in-house by Blackstone and its personnel. For certain third-party service providers, the fees, costs and expenses of such service providers will be borne by the Company, and in other circumstances, the fees, costs and expenses of such service providers will be borne by Blackstone. Certain third-party service providers and/or their employees will dedicate substantially all of their business time to the Company, Other Clients and/or their respective portfolio entities, while others will have other clients. In certain cases, third-party service providers and/or their employees may spend a significant amount of time at Blackstone offices, have dedicated office space at Blackstone, receive administrative support from Blackstone personnel or participate in meetings and events for Blackstone personnel, even though they are not Blackstone employees or affiliates. This creates a conflict of interest because Blackstone will have an incentive to outsource services to third parties due to a number of factors, including because retaining third parties will reduce Blackstone&#x2019;s internal overhead and compensation costs for employees who would otherwise perform such services in-house.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The involvement of third-party service providers may present a number of risks due to Blackstone&#x2019;s reduced control over the functions that are outsourced. There can be no assurances that Blackstone will be able to identify, prevent or mitigate the risks of engaging third-party service providers. The Company may suffer adverse consequences from actions, errors or failures to act by such third parties, and will have obligations, including indemnity obligations, and limited recourse against them. Outsourcing may not occur uniformly for all Blackstone managed vehicles and accounts and, accordingly, certain costs may be incurred by (or allocated to) the Company through the use of third-party service providers that are not incurred by (or allocated to) Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Material, Non-Public Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance will come into possession of confidential information with respect to an issuer and other actual or prospective portfolio companies. Blackstone Credit &amp;amp; Insurance can be restricted from buying, originating or selling securities, loans, or derivatives on behalf of the Company until such time as the information becomes public or is no longer deemed material such that it would preclude the Company from participating in an investment. Disclosure of such information to the Adviser&#x2019;s personnel responsible for the affairs of the Company will be on a need-to-know basis only, and the Company might not be free to act upon any such information. Therefore, the Company will not always have access to confidential information in the possession of Blackstone Credit &amp;amp; Insurance that might be relevant to an investment decision to be made for the Company. In addition, Blackstone Credit &amp;amp; Insurance, in an effort to avoid buying or selling restrictions on behalf of the Company or Other Clients, can choose to forego an opportunity to receive (or elect not to receive) information that other market participants or counterparties, including those with the same positions in the issuer as the Company, are eligible to receive or have received, even if possession of such information would otherwise be advantageous to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Break-up and other Similar Fees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Break-up or topping fees with respect to the Company&#x2019;s investments can be paid to Blackstone Credit &amp;amp; Insurance. Alternatively, the Company could receive the break-up or topping fees directly. Break-up or topping fees paid to Blackstone Credit &amp;amp; Insurance or the Company in connection with a transaction could be allocated, or not, to Other Clients or co-investment vehicles that invest (or are expected to invest) alongside the Company, as determined by Blackstone Credit &amp;amp; Insurance to be appropriate in the circumstances. Generally, Blackstone Credit &amp;amp; Insurance would not allocate break-up or topping fees with respect to a potential investment to the Company, an Other Client or co-investment vehicle unless such person would also share in Broken Deal Expenses related to the potential investment. With respect to fees received by Blackstone Credit &amp;amp; Insurance relating to the Company&#x2019;s investments or from unconsummated transactions, shareholders will not receive the benefit of any fees relating to the Company&#x2019;s investments (including, without limitation, as described above). In the case of fees for services as a director of a portfolio company, the management fee will not be reduced to the extent any Firm personnel continues to serve as a director after the Company has exited (or is in the process of exiting) the applicable portfolio company and/or following the termination of such employee&#x2019;s employment with the Firm. For the avoidance of doubt, although the financial advisory and restructuring business of Blackstone has been spun out, to the extent any investment banking fees, consulting (including management consulting) fees, syndication fees, capital markets syndication and advisory fees (including underwriting fees), origination fees, servicing fees, healthcare consulting / brokerage fees, fees relating to group purchasing, financial advisory fees and similar fees for arranging acquisitions and other major financial restructurings, loan servicing and/or other types of insurance fees, operations fees, financing fees, fees for asset services, title insurance fees, and other similar fees and annual retainers (whether in cash or in kind) are received by Blackstone, such fees will not be required to be shared with the Company or the shareholders and will not reduce the management fee payable by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Broken Deal Expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Any expenses that may be incurred by the Company for actual investments as described herein may also be incurred by the Company with respect to broken deals (i.e., investments that are not consummated) (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Broken Deal Expenses&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Unless required by law or regulation, Blackstone Credit &amp;amp; Insurance is not required to and, in most circumstances, will not seek reimbursement of Broken Deal Expenses (i.e., expenses incurred in pursuit of an investment that is not consummated) from third parties, including counterparties to the potential transaction or potential co-investors. Examples of such Broken Deal Expenses include, but are not limited to, reverse termination fees, extraordinary expenses such as litigation costs and judgments, meal, travel and entertainment expenses incurred, deposits or down payments which are forfeited in connection with unconsummated transactions, costs from onboarding (i.e., KYC) investment entities with a financial institution, commitment fees that become payable in connection with a proposed investment, consulting fees and expenses (including all expenses incurred in connection with any tax audit or investigation settlement), printing and publishing expenses, costs of negotiating co-investment documentation (including non-disclosure agreements with counterparties), and legal, accounting, tax and other due diligence and pursuit costs and expenses and broken deal expenses associated with services provided by portfolio companies, which may include expenses incurred prior to the commencement of the Company&#x2019;s investment activities. Any such Broken Deal Expenses could, in the sole discretion of Blackstone Credit &amp;amp; Insurance, be allocated solely to the Company and not to Other Clients or co-investment vehicles that could have made the investment, even when the Other Client or co-investment vehicle commonly invests alongside the Company in its investments or the Firm or Other Clients in their investments. In such cases, the Company&#x2019;s shares of expenses would increase. The Adviser expects that until a potential investment of the Company is formally allocated to an Other Client (it being understood that final allocation decisions are typically made shortly prior to closing an investment), the Company is expected to bear the broken deal expenses for such investment, which may result in substantial amounts of broken deal expenses. In the event Broken Deal Expenses are allocated to an Other Client or a co-investment vehicle, Blackstone Credit &amp;amp; Insurance or the Company will, in certain circumstances, advance such fees and expenses without charging interest until paid by the Other Client or co-investment vehicle, as applicable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Firm Business Activities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Firm, Other Clients, their portfolio companies, and personnel and related parties of the foregoing will receive fees and compensation, including performance-based and other incentive fees, for products and services provided to the Company and its portfolio companies, such as fees for asset management (including, without limitation, management fees and carried interest/incentive arrangements), development and property management; portfolio operations support (such as those provided by Blackstone&#x2019;s Portfolio Operations Group); arranging, underwriting (including without limitation, evaluation regarding value creation opportunities and ESG risk mitigation); syndication or refinancing of a loan or investment (or other additional fees, including acquisition fees, loan modification or restructuring fees); servicing; loan servicing; special servicing; administrative services; advisory services on purchase or sale of an asset or company; investment banking and capital markets services; placement agent services; fund administration; internal legal and tax planning services; information technology products and services; insurance procurement; brokerage; solutions and risk management services; data extraction and management products and services; fees for monitoring and oversight of loans or title insurance provided to portfolio companies or third parties; and other products and services. For example, the Firm or Other Clients may, directly or indirectly through a portfolio entity, from time to time acquire loans or other assets for the purpose of syndicating some or all the assets to the Company and/or Other Clients, and may receive syndication or other fees in connection therewith. Such parties will also provide products and services for fees to the Firm, Other Clients and their portfolio companies, and their personnel and related parties, as well as third parties. Through its innovations group, Blackstone incubates (or otherwise invests in) businesses that are expected to provide goods and services to the Company (subject to the requirements of the 1940 Act and applicable guidance) and Other Clients and their portfolio companies, as well as other Firm-related parties and third parties. By contracting for a product or service from a business related to the Firm, the Company and its portfolio companies would provide not only current income to the business and its stakeholders, but could also create significant enterprise value in them, which would not be shared with the Company or shareholders and could benefit the Firm directly and indirectly. Also, the Firm, Other Clients and their portfolio companies, and their personnel and related parties may receive compensation or other benefits, such as through additional ownership interests or otherwise, directly related to the consumption of products and services by the Company and its portfolio companies. The Company and its portfolio companies will incur expenses in negotiating for any such fees and services, which will be treated as Fund Expenses. In addition, the Firm may receive fees associated with capital invested by co-investors relating to investments in which the Company participates or otherwise, in connection with a joint venture in which the Company participates (subject to the 1940 Act) or otherwise with respect to assets or other interests retained by a seller or other commercial counterparty with respect to which the Firm performs services. Finally, the Firm and its personnel and related parties will, in certain circumstances, also receive compensation in connection with origination activities, referrals and other related activities of such business, and unconsummated transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will, as determined by Blackstone Credit &amp;amp; Insurance and as permitted by the governing fund documents, bear the cost of fund administration, compliance and accounting (including, without limitation, maintaining financial records, filing of the Company&#x2019;s tax returns, overseeing the calculation of the Company&#x2019;s net asset value, compliance monitoring (including diligence and oversight of the Company&#x2019;s other service providers), preparing reports to the Company&#x2019;s shareholders and reports filed with the SEC and other regulators, preparing materials and coordinating meetings of the Board, managing the payment of expenses, the payment and receipt of funds for investments and the performance of administrative and professional services rendered by others, providing office space, equipment and office services), in house legal, tax planning and other related services provided by Firm personnel and related parties to the Company and its portfolio companies, including the allocation of their compensation and related overhead otherwise payable by the Firm, or pay for their services at market rates, as discussed above in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Self-Administration of the Company.&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Such allocations or charges can be based on any of the following methodologies: (i) requiring personnel to periodically record or allocate their historical time spent with respect to the Company or the Firm approximating the proportion of certain personnel&#x2019;s time spent with respect to the Company, and in each case allocating their compensation (including, without limitation, salary, bonus and benefits) and allocable overhead based on time spent, or charging their time spent at market rates, (ii) the assessment of an overall dollar amount (based on a fixed fee or percentage of assets under management) that the Firm believes represents a fair recoupment of expenses and a market rate for such services or (iii) any other similar methodology determined by the Firm to be appropriate under the circumstances. Certain Firm personnel will provide services to few, or only one, of the Company and Other Clients, in which case the Firm could rely upon rough approximations of time spent by the employee for purposes of allocating the salary and overhead of the person if the market rate for services is clearly higher than allocable salary and overhead. However, any methodology (including the choice thereof) involves inherent conflicts and may result in incurrence of greater expenses by the Company and its portfolio companies than would be the case if such services were provided by third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance, Other Clients and their portfolio companies, and their affiliates, personnel and related parties could continue to receive fees, including performance-based or incentive fees, for the services described in the preceding paragraphs with respect to investments sold by the Company or a portfolio company to a third party buyer after the sale is consummated. Such post-disposition involvement will give rise to potential or actual conflicts of interest, particularly in the sale process. Moreover, Blackstone Credit &amp;amp; Insurance, Other Clients and their portfolio companies, and their affiliates, personnel and related parties could acquire a stake in the relevant asset as part of the overall service relationship, at the time of the sale or thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Credit &amp;amp; Insurance does not have any obligation to ensure that fees for products and services contracted by the Company or its portfolio companies are at market rates unless the counterparty is considered an affiliate of the Firm and given the breadth of the Firm&#x2019;s investments and activities Blackstone Credit &amp;amp; Insurance may not be aware of every commercial arrangement between the Company and its portfolio companies, on the one hand, and the Firm, Other Clients and their portfolio companies, and personnel and related parties of the foregoing, on the other hand.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as set forth above, the Company and shareholders will not receive the benefit (e.g., through a reduction to the management fee or otherwise) of any fees or other compensation or benefit received by Blackstone Credit &amp;amp; Insurance, its affiliates or their personnel and related parties. (See also &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&#x2014;Service Providers, Vendors and Other Counterparties Generally&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014;Other Firm Business Activities.&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Securities and Lending Activities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone, its affiliates and their related parties and personnel will from time to time participate in underwriting or lending syndicates with respect to current or potential portfolio companies, or will otherwise act as arrangers of financing, including with respect to the public offering and/or private placement of debt or equity securities issued by, or loan proceeds borrowed by the Company and its portfolio companies, or otherwise in arranging financing (including loans) for such portfolio companies or advise on such transactions. Such underwritings or engagements can be on a firm commitment basis or can be on an uncommitted &#x201c;best efforts&#x201d; basis, and the underwriting or financing parties are under no duty to provide any commitment unless specifically set forth in the relevant contract. Blackstone may also provide placement or other similar services to purchasers or sellers of securities, including loans or instruments issued by portfolio companies. There could also be circumstances in which the Company commits to purchase any portion of such issuance from the portfolio company that a Blackstone broker-dealer intends to syndicate to third parties. As a result thereof, subject to the limitations of the 1940 Act, Blackstone may be permitted to receive commissions or other compensation, thereby creating a potential conflict of interest. This could include, by way of example, fees and/ or commissions for equity syndications to co-investment vehicles. In certain cases, subject to the limitations of the 1940 Act, a Blackstone broker-dealer will, from time to time, act as the managing underwriter, or a member of the underwriting syndicate or broker for the Company or its portfolio companies, or as dealer, broker or advisor to a counterparty to the Company or a portfolio company, and purchase securities from or sell securities to the Company, Other Clients or portfolio companies of the Company or Other Clients or advise on such &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;transactions. Blackstone will also from time to time, on behalf of the Company or other parties to a transaction involving the Company or its portfolio companies, effect transactions, including transactions in the secondary markets that result in commissions or other compensation paid to Blackstone by the Company or its portfolio companies or the counterparty to the transaction, thereby creating a potential conflict of interest. This could include, by way of example, fees and/or commissions for equity syndications to co-investment vehicles. Subject to applicable law, Blackstone will from time to time receive underwriting fees, discounts, placement commissions, loan modification or restructuring fees, servicing fees, capital markets advisory fees, lending arrangement fees, asset/property management fees, insurance (including title insurance) incentive fees and consulting fees, monitoring fees, commitment fees, syndication fees, origination fees, organizational fees, operational fees, loan servicing fees, and financing and divestment fees (or, in each case, rebates in lieu of any such fees, whether in the form of purchase price discounts or otherwise, even in cases where Blackstone, an Other Client or its portfolio companies are purchasing debt) or other compensation with respect to the foregoing activities, which are not required to be shared with the Company. In addition, the management fee with respect to a shareholder generally will not be reduced by such amounts. Therefore, Blackstone will from time to time have a potential conflict of interest regarding the Company and the other parties to those transactions to the extent it receives commissions, discounts or other compensation from such other parties. The Board of Trustees, in its sole discretion, will approve any transactions, subject to the limitations of the 1940 Act, in which a Blackstone broker-dealer acts as an underwriter, as broker for the Company, or as dealer, broker or advisor, on the other side of a transaction with the Company only where the Board of Trustees believes in good faith that such transactions are appropriate for the Company and, by executing a subscription agreement for shares in the Company, a shareholder consents to all such transactions, along with the other transactions involving conflicts of interest described herein, to the fullest extent permitted by law.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When Blackstone serves as underwriter with respect to securities of the Company or its portfolio companies, the Company and such portfolio companies could from time to time be subject to a &#x201c;lock-up&#x201d; period following the offering under applicable regulations during which time the Company or portfolio company would be unable to sell any securities subject to the &#x201c;lock-up.&#x201d; This could prejudice the ability of the Company and its portfolio companies to dispose of such securities at an opportune time. In addition, Blackstone Capital Markets can serve as underwriter in connection with the sale of securities by the Company or its portfolio companies. Conflicts would be expected to arise because such engagement would result in Blackstone Capital Markets receiving selling commissions or other compensation in connection with such sale. (See also&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;&#x2014;Portfolio Company Relationships Generally&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;below).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone and Blackstone Credit &amp;amp; Insurance employees are generally permitted to invest in alternative investment funds, real estate funds, hedge funds or other investment vehicles, including potential competitors of the Company. The Company will not receive any benefit from any such investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PJT&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. On October 1, 2015, Blackstone spun off its financial and strategic advisory services, restructuring and reorganization advisory services, and its Park Hill fund placement businesses and combined these businesses with PJT Partners Inc. (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;PJT&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), an independent financial advisory firm founded by Paul J. Taubman. While PJT operates independently from Blackstone and is not an affiliate thereof, it is expected that there will be substantial overlapping ownership between Blackstone and PJT for a considerable period of time going forward. Therefore, conflicts of interest will arise in connection with transactions between or involving the Company and its portfolio companies, on the one hand, and PJT, on the other. The pre-existing relationship between Blackstone and its former personnel, the overlapping ownership and co-investment and other continuing arrangements between PJT and Blackstone can be expected to influence Blackstone Credit &amp;amp; Insurance to select or recommend PJT to perform services for the Company or its portfolio companies, the cost of which will generally be borne directly or indirectly by the Company. Given that PJT is no longer an affiliate of Blackstone, Blackstone and its affiliates will be free to cause the Company and portfolio companies to transact with PJT generally without restriction under the applicable governing documents, notwithstanding the relationship between Blackstone and PJT. In addition, one or more investment vehicles controlled by Blackstone may be established to facilitate participation in Blackstone&#x2019;s side-by-side investment program by employees and/or partners of PJT. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Portfolio Company Relationships Generally&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company&#x2019;s portfolio companies, including special purpose vehicles that might be formed in connection with investments, are expected to be counterparties to or participants in agreements, transactions or other arrangements with the Company, Other Clients, and/or portfolio companies of the Company and Other Clients or other Blackstone affiliates and/or any portfolio companies of the foregoing for the provision of goods and services, purchase and sale of assets and other matters (including information-sharing and/or consulting). For example, from time to time, certain portfolio companies of the Company or Other Clients will provide or recommend goods or services to Blackstone, the Company, Other Clients, or other portfolio companies of the Company or Other Clients (including &#x201c;platform&#x201d; investments of the Company and Other Clients). As another example, it can also be expected that the management of one or more portfolio &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;companies may consult with one another (or with one or more portfolio companies of an Other Client) in respect of seeking its expertise, industry view, or otherwise on a particular topic including but not limited to an asset and/or the purchase and /or sale thereof. Moreover, the Company and/or an Other Client can consult with a portfolio company or a portfolio company of an Other Client as part of the investment diligence for a potential investment by the Company or such Other Client. As a result of, or as part of such interactions or otherwise, personnel (including one or more members of the management team) at one portfolio company may also transfer to or become employed by another portfolio company (or a portfolio company of an Other Client), the Company, Blackstone or their respective affiliates (or vice versa). Any such transfer may result in payments by the entity that such personnel is going to, to the entity such personnel is departing from. Although the Firm might determine that such agreements, transactions or other arrangements are consistent with the requirements of such Other Clients&#x2019; offering and/or governing agreements, such agreements, transactions or other arrangements might not have otherwise been entered into but for the affiliation with Blackstone Credit &amp;amp; Insurance and/or Blackstone. These agreements, transactions or other agreements involve fees, commissions, servicing payments and/or discounts to Blackstone Credit &amp;amp; Insurance, any Blackstone affiliate (including personnel) or a portfolio company, none of which reduce the management fee payable by the Company. This may give rise to actual or potential conflicts of interest for the Adviser, the Company and/or their respective affiliates, as such agreements, transactions and arrangements may be more favorable for one portfolio company than another, thus benefiting the Company or Other Clients at the expense of the other. For example, the Firm reserves the right to cause, or offer the opportunity to, portfolio companies to enter into agreements regarding group procurement (such as the group purchasing organization), benefits management, purchase of title and/or other insurance policies (which could be pooled across portfolio companies and discounted due to scale) and other operational, administrative or management related matters from a third party or a Firm affiliate, and other similar operational initiatives that can result in commissions or similar payments, including related to a portion of the savings achieved by the portfolio company. Such agreements, transactions or other arrangements will generally be entered into without the consent or direct involvement of the Company and/or such Other Client or the consent of the Board of Trustees and/or the shareholders of the Company or such Other Client (including, without limitation, in the case of minority and/or non-controlling investments by the Company in such portfolio companies or the sale of assets from one portfolio company to another) and/or such Other Client. In any such case, the Company might not be involved in the negotiation process, and there can be no assurance that the terms of any such agreement, transaction or other arrangement will be as favorable to the Company as otherwise would be the case if the counterparty were not related to the Firm.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, it is possible that certain portfolio companies of Other Clients or companies in which Other Clients have an interest will compete with the Company for one or more investment opportunities. It is also possible that certain portfolio companies of Other Clients will engage in activities that will have adverse consequences on the Company and/or its portfolio companies. As an example of the latter, the laws and regulations of certain jurisdictions (e.g., bankruptcy, environmental, consumer protection and/or labor laws) would not recognize the segregation of assets and liabilities as between separate entities and could permit recourse against the assets of not just the entity that has incurred the liabilities, but also the other entities that are under common control with, or part of the same economic group as, such entity. In such circumstances, the assets of the Company and/or its portfolio companies potentially will be used to satisfy the obligations or liabilities of one or more Other Clients, their portfolio companies and/or affiliates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, from time to time, Blackstone and affiliates of Blackstone and Blackstone portfolio companies could also establish other investment products, vehicles and platforms focusing on specific asset classes or industry sectors that fall within the Company&#x2019;s investment strategy, which would possibly compete with the Company for investment opportunities (it being understood that such arrangements would give rise to conflicts of interest that would not necessarily be resolved in favor of the Company).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain portfolio companies have established or invested in, or can be expected to in the future establish or invest in, vehicles that are managed exclusively by the portfolio company (and not the Company or the Firm or any of its affiliates) and that invest in asset classes or industry sectors (such as cyber security) that fall within the Company&#x2019;s investment strategy. Such vehicles, which would not be considered affiliates of the Firm and would not be subject to the Firm&#x2019;s policies and procedures, have the potential to compete with the Company for investment opportunities. Portfolio companies and affiliates of the Firm will also establish other investment products, vehicles and platforms focusing on specific asset classes or industry sectors (such as reinsurance) that can be expected to compete with the Company for investment opportunities (it being understood that such arrangements can give rise to conflicts of interest that would not necessarily be resolved in favor of the Company). In addition, the Company reserves the right to hold non-controlling interests in certain portfolio companies and, as a result, such portfolio companies could engage in activities outside of the Company&#x2019;s control that would have adverse consequences on the Company and/or its other portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone has also entered into certain investment management arrangements whereby it provides investment management services for compensation to insurance companies including (i) FGL and certain of its affiliates, (ii) Everlake and certain of its affiliates and (iii) certain subsidiaries of Corebridge and (iv) certain subsidiaries of Resolution Life. As of the date of the date hereof, Blackstone owns a 9.9% equity interest in the parent company of Everlake and Blackstone Clients own the remaining equity interests in the parent company of Everlake, and Blackstone owns a 9.9% equity interest in Corebridge. The foregoing insurance company investment management arrangements will involve investments by such insurance company clients across a variety of asset classes (including investments that would otherwise be appropriate for the Company). As a result, in addition to the compensation Blackstone receives for providing investment management services to insurance companies in which Blackstone or an Other Client owns an interest, in certain instances Blackstone receives additional compensation in its capacity as an indirect owner of such insurance companies and/or Other Clients. In the future Blackstone will likely enter into similar arrangements with other portfolio companies of the Company, Other Clients or other insurance companies. Such arrangements have the potential to reduce the allocations of investments to the Company, and Blackstone could be incentivized to allocate investments away from the Company to such insurance company client under such investment management arrangements or other vehicles/accounts to the extent the economic arrangements related thereto are more favorable to Blackstone relative to the terms of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Further, portfolio companies with respect to which the Firm can elect members of the board of directors or a managing member could, as a result, subject the Company and/or such directors or managing member to fiduciary obligations to make decisions that they believe to be in the best interests of any such portfolio company. Although in most cases the interests of the Company and any such portfolio company will be aligned, this will not always be the case. This has the potential to create conflicts of interest between the relevant director&#x2019;s or managing member&#x2019;s obligations to any such portfolio company and its stakeholders, on the one hand, and the interests of the Company, on the other hand. Although Blackstone Credit &amp;amp; Insurance will generally seek to minimize the impact of any such conflicts, there can be no assurance they will be resolved favorably for the Company. For instance, such positions could impair the ability of the Company to sell the securities of an issuer in the event a director receives material non- public information by virtue of their role, which would have an adverse effect on the Company. Furthermore, an employee of Blackstone serving as a director to a portfolio company owes a fiduciary duty and/or other obligations to the portfolio company, on the one hand, and the Company, on the other hand, and such employee could be in a position where they must make a decision that is either not in the best interest of the Company, or is not in the best interest of the portfolio company. Blackstone personnel serving as directors can make decisions for a portfolio company that negatively impact returns received by the Company as an investor in the portfolio company. In addition, to the extent an employee serves as a director on the board of more than one portfolio company, such employees&#x2019; fiduciaries duties among the two portfolio companies can be expected to create a conflict of interest. In general, the Adviser and Blackstone personnel will be entitled to indemnification from the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Portfolio Company Service Providers and Vendors&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Subject to applicable law, the Company, Other Clients, portfolio companies of each of the foregoing and Blackstone Credit &amp;amp; Insurance can be expected to engage portfolio companies of the Company and Other Clients to provide some or all of the following services: (a)&#160;corporate support services (including, without limitation, accounts payable, accounts receivable, accounting/audit (e.g., valuation support services), account management (e.g., treasury, customer due diligence), insurance, procurement, placement, brokerage and consulting services, cash management, accounts receivable financing, corporate secretarial and executive assistant services, domiciliation, data management, directorship services, finance/budget, human resources (e.g., the onboarding and ongoing development of personnel), communication, public relations and publicity, information technology and software systems support, corporate governance and entity management (e.g., liquidation, dissolution and/or otherwise end of term services), risk management and compliance, internal compliance, know-your-client reviews and refreshes, judicial processes, legal, environmental due diligence support(e.g., review of property condition reports, energy consumption), climate accounting services, ESG program management services, engineering services, services related to the sourcing, development and implementation of renewable energy, ESG data collection and reporting services, capital planning services, operational coordination (i.e., coordination with joint venture partners, property managers), risk management, reporting (such as tax reporting, debt reporting or other reporting), tax and treasury, tax analysis and compliance (e.g., CIT and VAT compliance), transfer pricing and internal risk control, treasury and valuation services) and other services; (b) loan services (including, without limitation, monitoring, restructuring and work-out of performing, sub-performing and nonperforming loans, administrative services, and cash management); (c) management services (i.e., management by a portfolio company, Blackstone affiliate or third party (e.g., a third-party manager or operating partner) of operational services); (d) operational services (i.e., general management of day to day operations), including, without limitation, personnel, construction management (such as management of general contractors on capital projects), leasing services (such as leasing strategy, management of third party brokers, negotiation of major leases and negotiation of leases), project management (such as management of development projects, project design and execution, vendor management, and turnkey services); (e) risk management (tax and treasury); (f) transaction support services (including, without &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;limitation, acquisition support; customer due diligence and related onboarding; liquidation; reporting; managing relationships with brokers, banks and other potential sources of investments, identifying potential investments, coordinating with investors, assembling relevant information, conducting financial and market analyses and modelling, coordinating closing/post-closing procedures for acquisitions, dispositions and other transactions, coordinating design and development works (such as recommending and implementing design decisions); and providing diligence and negotiation support to acquire the same; marketing and distribution, overseeing brokers, lawyers, accountants and other advisors, working with consultants and third parties to pursue entitlements; providing in-house legal, ESG and accounting services, assisting with due diligence, preparation of project feasibilities, site visits, transaction consulting and specification of technical analysis and review of (i) design and structural work, (ii) certifications, (iii) operations and maintenance manuals and (iv) statutory documents); (g) insurance procurement, placement, brokerage and consulting services; and (h)&#160;other services. Similarly, Blackstone Credit &amp;amp; Insurance, Other Clients and their portfolio companies can be expected to engage portfolio companies of the Company to provide some or all of these services. Some of the services performed by portfolio company service providers could also be performed by Blackstone Credit &amp;amp; Insurance from time to time and vice versa. Fees paid by the Company or its portfolio companies to or value created by other portfolio company service providers do not reduce the management fee payable by the Company and are not otherwise shared with the Company. In certain circumstances, Blackstone can be expected to play a substantial role in overseeing the personnel of portfolio company service providers that provide services to the Company, Other Clients and/or their portfolio companies on an ongoing basis, including with respect to the selection, hiring, retention and compensation of such personnel. For example, Blackstone expects that certain portfolio company service providers, as described below, with Blackstone&#x2019;s oversight, will establish a team of personnel to provide support services exclusively to the Company and its portfolio companies (and/or other investment funds or accounts managed or controlled by Blackstone). Further, Blackstone has multiple business lines, which may result in competition with a portfolio company for high performing executive talent and presents actual and potential conflicts of interest. For example, Blackstone may &#x201c;poach&#x201d; a portfolio company executive, or such executive may interview with Blackstone during the applicable contractual period with respect to such person&#x2019;s existing position and later be hired by Blackstone after such period. A portfolio company may want to retain such executives or other employees, and regardless, Blackstone is under no obligation to avoid interviewing or hiring such employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Portfolio companies of the Company and Other Clients some of which can be expected to provide services to the Company and its portfolio companies include, without limitation, the following, and could include additional portfolio companies that might be formed or acquired in the future: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;BTIG&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. BTIG, LLC (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;BTIG&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) is a global financial services firm in which certain Blackstone entities own a strategic minority investment. BTIG provides institutional trading, investment banking, research and related brokerage services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CoreTrust&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. On September 30, 2022, certain Blackstone private equity funds and related entities closed the previously announced acquisition of a majority interest in CoreTrust (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;CoreTrust Acquisition&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), a group purchasing organization that provides purchasing services to member companies, which includes portfolio companies owned, in whole or in part, by certain Blackstone-managed funds. CoreTrust is expected to provide group purchasing services to the Company, portfolio companies, Other Clients and Blackstone. Generally, CoreTrust generates revenue from vendors based on a percentage of the amount of products or services purchased by its member companies and benefit plans maintained by its member companies. CoreTrust has historically shared a portion of the revenue generated through purchases made by Blackstone portfolio companies and paid Blackstone a consulting fee. Blackstone stopped accepting such revenue sharing arrangements and consulting fee upon the closing of the CoreTrust Acquisition. However, Blackstone may in its sole discretion reinstitute such or similar revenue sharing arrangements with CoreTrust in the future. In addition, prior to the CoreTrust Acquisition, CoreTrust generated revenue in respect of certain portfolio companies (the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x201c;Applicable Portfolio Companies&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) from certain health and welfare benefit plan-related vendors (the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x201c;Applicable Vendors&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). For legal and regulatory reasons&lt;/span&gt;&lt;span style="background-color:#dddddd;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;following the CoreTrust Acquisition, CoreTrust is limited in its ability to generate revenue from the Applicable Vendors in respect of portfolio companies&#x2019; health benefit plans based on a percentage of the amount of products or services purchased by such plans. As a result, for Applicable Portfolio Companies and other portfolio companies that become CoreTrust members, CoreTrust intends to rebate all revenue received from Applicable Vendors to each such Portfolio Company&#x2019;s applicable benefit plan. CoreTrust also intends to enter into with each Applicable Portfolio Company (and with other portfolio companies that become CoreTrust members) a separate agreement that will include the payment of an access fee in return for allowing such portfolio companies to use the goods and services provided by the Applicable Vendors through CoreTrust. The amount of the access fee will generally be determined either as a percentage of total company revenues or as a fixed fee (in each case subject to periodic review by CoreTrust and the Applicable Portfolio Company) and might not be subject to benchmarking, and the access fee could be greater or less than the amount of the revenue that CoreTrust previously generated from Applicable Vendors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Optiv&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Optiv Security, Inc. is a portfolio company held by certain Blackstone private equity funds that provides a full slate of information security services and solutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PSAV&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. PSAV, Inc. is a portfolio company held by certain Blackstone private equity funds that provides outsourced audiovisual services and event production.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Refinitiv&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. On October 1, 2018, a consortium led by Blackstone announced that private equity funds managed by Blackstone had completed an acquisition of Thomson Reuters&#x2019; Financial &amp;amp; Risk business (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Refinitiv&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). On January 29, 2021, Refinitiv was sold to London Stock Exchange Group (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;LSEG&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), with Blackstone private equity funds receiving a minority stake in LSEG. Refinitiv operates a pricing service that provides valuation services and may provide goods and services for the Company and its portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Kryalos. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone through one or more of its funds has made a minority investment in Kryalos, an operating partner in certain real estate investments made by Other Clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Peridot Financial Services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Peridot&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; and Global Supply Chain Finance &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;GSCF&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone through one or more of its funds has made majority investments into Peridot and GSCF, which provide supply chain financing and accounts receivable services globally.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;RE Tech Advisors &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;RE Tech&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Blackstone through one or more of its funds has made a majority investment in RE Tech, an energy audit/consulting firm that identifies and implements energy efficiency programs, calculates return on investment and tracks performance post-completion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legence (f.k.a Therma Holdings) (&#x201c;Legence&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Legence is a portfolio company held by certain Blackstone private equity funds that provides carbon reduction and energy management services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revantage.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revantage is a portfolio entity of certain Blackstone Clients that provides corporate support services, including, without limitation, accounting, legal, tax, treasury, information technology and human resources and operational services and management services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There may be instances where current and former employees of Other Clients&#x2019; portfolio companies are seconded to or temporarily hired by the Company&#x2019;s portfolio companies or, at times, the Company&#x2019;s investments directly. Such secondments or temporary hiring of current and former employees of Other Clients&#x2019; portfolio companies by the Company&#x2019;s portfolio companies (or its investments) may result in a potential conflict of interest between the Company&#x2019;s portfolio companies and those of such Other Clients. The costs of such employees are expected to be borne by the Company or its relevant portfolio companies, as applicable, and the fees paid by the Company or such portfolio companies to, other portfolio company service providers or vendors do not offset or reduce the management fee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its portfolio companies will compensate one or more of these service providers and vendors owned by the Company or Other Clients, including through incentive based compensation payable to their management teams and other related parties. The incentive based compensation paid with respect to a portfolio company or asset of the Company or Other Clients will vary from the incentive based compensation paid with respect to other portfolio companies and assets of the Company and Other Clients; as a result the management team or other related parties can be expected to have greater incentives with respect to certain assets and portfolio companies relative to others, and the performance of certain assets and portfolio companies can be expected to provide incentives to retain management that also service other assets and portfolio companies. Some of these service providers and vendors owned or controlled by the Company or Other Clients may charge the Company and its portfolio companies for goods and services at rates generally consistent with those available in the market for similar goods and services. The discussion regarding the determination of market rates under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&#x2014;Firm Affiliated Service Providers&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; herein applies equally in respect of the fees and expenses of the portfolio company service providers, if charged at rates generally consistent with those available in the market. Other service providers and vendors owned and/or controlled by the Company or Other Clients pass through expenses on a cost reimbursement, no-profit or break-even basis, in which case the service provider allocates costs and expenses directly associated with work performed for the benefit of the Company and its portfolio companies to them, along with any related tax costs and an allocation of the service provider&#x2019;s overhead, including any of the following: salaries, wages, benefits and travel expenses; marketing and advertising fees and expenses; legal, accounting and other professional fees and disbursements; office space and equipment; insurance premiums; technology expenditures, including hardware and software costs; costs to engage recruitment firms to hire employees; diligence expenses; one-time costs, including costs related to building-out and winding-down a portfolio company; costs that are of a limited &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;duration or non-recurring (such as start-up or technology build-up costs, one-time technology and systems implementation costs, employee on-boarding and severance payments, and readiness of initial public offerings and other infrastructure costs); taxes; and other operating and capital expenditures. Any of the foregoing costs (including in prior periods, such as where any such costs are amortized over an extended period), although allocated in a particular period, will, in certain circumstances, relate to activities occurring outside the period, and further will, in certain circumstances, be of a general and administrative nature that is not specifically related to particular services, and therefore the Company could pay more than its &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;pro rata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; portion of fees for services. In addition, in certain circumstances, Blackstone also relies on the management team of a portfolio company with respect to the determination of costs and expenses and allocation thereof and does not oversee or participate in such determinations or allocations. Moreover, to the extent a portfolio company uses an allocated cost model with respect to fees, costs and expenses, such fees, costs and expenses are typically estimated and/or accrued quarterly (or on another regular periodic basis) but not finalized until year-end and as a result, such year-end true-up is subject to fluctuation and increases such that for a given year, the year-end cumulative amount with respect to fees, costs and expenses may be greater than the sum of the quarterly estimates (or other periodic estimates where applicable) and/or accruals and therefore the Company could bear more fees, costs and expenses at year-end than had been anticipated throughout the year. The allocation of overhead among the entities and assets to which services are provided can be expected to be based on any of a number of different methodologies, including, without limitation, &#x201c;cost&#x201d; basis as described above, &#x201c;time-allocation&#x201d; basis, &#x201c;per unit&#x201d; basis, &#x201c;per square footage&#x201d; basis or &#x201c;fixed percentage&#x201d; basis, and the particular methodology used to allocate such overhead among the entities and assets to which services are provided are expected to vary depending on the types of services provided and the applicable asset class involved, and could, in certain circumstances, change from one period to another. There can be no assurance that a different manner of allocation would result in the Company and its portfolio companies bearing less or more costs and expenses. In addition, a portfolio company that uses a &#x201c;cost&#x201d; basis methodology may, in certain circumstances, change its allocation methodology, for example, to charging a flat fee for a particular service or instance (or vice versa) or to another methodology described herein or otherwise, and such changes may increase or reduce the amounts received by such portfolio companies for the same services, and shareholders will not necessarily be entitled to receive notice or disclosure of such changes in allocation methodology. In certain instances, particularly where such service providers and vendors are located in Europe or Asia, such service providers and vendors will charge the Company and its portfolio companies for goods and services at cost plus a percentage of cost for transfer pricing or other tax, legal, regulatory, accounting or other reasons or even decide to amortize any costs or expenses to address accounting or operational considerations. Further, the Company and its portfolio companies may compensate one or more of these service providers and vendors owned by the Company or Other Clients through incentive-based compensation payable to their management teams and other related parties. The incentive-based compensation paid with respect to a portfolio company or asset of the Company or Other Clients will vary from the incentive based compensation paid with respect to other portfolio companies and assets of the Company and Other Clients; as a result the management team or other related parties can be expected to have greater incentives with respect to certain assets and portfolio companies relative to others, and the performance of certain assets and portfolio companies could provide incentives to retain management that also service other assets and portfolio companies. Blackstone Credit &amp;amp; Insurance will not always perform or obtain benchmarking analysis or third-party verification of expenses with respect to services provided on a cost reimbursement, no profit or break even basis, or in respect of incentive-based compensation. There can be no assurances that amounts charged by portfolio company service providers that are not controlled by the Company or Other Clients will be consistent with market rates or that any benchmarking, verification or other analysis will be performed with respect to such charges. If benchmarking is performed, the related expenses will be borne by the Company, Other Clients and their respective portfolio companies and will not reduce the management fee. A portfolio company service provider will, in certain circumstances, subcontract certain of its responsibilities to other portfolio companies. In such circumstances, the relevant subcontractor could invoice the portfolio company for fees (or in the case of a cost reimbursement arrangement, for allocable costs and expenses) in respect of the services provided by the subcontractor. The portfolio company, if charging on a cost reimbursement, no-profit or break-even basis, would in turn allocate those costs and expenses as it allocates other fees and expenses as described above. Similarly, Other Clients, their portfolio companies and Blackstone Credit &amp;amp; Insurance can be expected to engage portfolio companies of the Company to provide services, and these portfolio companies will generally charge for services in the same manner described above, but the Company and its portfolio companies generally will not be reimbursed for any costs (such as start-up costs or technology build-up costs) relating to such portfolio companies incurred prior to such engagement. Some of the services performed by these service providers could also be performed by Blackstone Credit &amp;amp; Insurance from time to time and vice versa. Fees paid by the Company or its portfolio companies to these service providers do not the management fee payable to the Adviser.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Where compensation paid to an affiliated service provider from the Company or its portfolio company is based on market rates, such compensation will not be based on the cost incurred by the applicable service provider and therefore will likely result in a profit to such service provider. In the event the service provider is an affiliate of Blackstone Credit &amp;amp; Insurance, Blackstone Credit &amp;amp; Insurance experiences a conflict of interest in determining the terms of any such engagement. There can be no assurance that an unaffiliated third party would not charge a lesser rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Service Providers, Vendors and Other Counterparties Generally&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Certain third party advisors and other service providers and vendors or their affiliates to the Company and its portfolio companies (including accountants, administrators, paying agents, depositories, lenders, bankers, brokers, attorneys, consultants, title agents and investment or commercial banking firms) are owned by the Firm, the Company or Other Clients or provide goods or services to, or have other business, personal, financial or other relationships with, the Firm, the Other Clients and their respective portfolio companies and affiliates and personnel. Such advisors and service providers referred to above could be investors in the Company, affiliates of the Adviser, sources of financing and investment opportunities or co-investors or commercial counterparties or entities in which the Firm and/or Other Clients have an investment, and payments by the Company and/or such entities can be expected to indirectly benefit the Firm, the Other Clients and their respective portfolio companies or any affiliates or personnel. Also, advisors, lenders, investors, commercial counterparties, vendors and service providers (including any of their affiliates or personnel) to the Company and its portfolio companies could have other commercial or personal relationships with the Firm, Other Clients and their respective portfolio companies, or any affiliates, personnel or family members of personnel of the foregoing. Although the Firm selects service providers and vendors it believes are most appropriate in the circumstances based on its knowledge of such service providers and vendors (which knowledge is generally greater in the case of service providers and vendors that have other relationships to the Firm), the relationship of service providers and vendors to the Firm as described above will influence the Firm in deciding whether to select, recommend or form such an advisor or service provider to perform services for the Company, subject to applicable law, or a portfolio company, the cost of which will generally be borne directly or indirectly by the Company and can be expected to incentivize the Firm to engage such service provider over a third party, utilize the services of such service providers and vendors more frequently than would be the case absent the conflict, or to pay such service providers and vendors higher fees or commissions, resulting in higher fees and expenses being borne by the Company, than would be the case absent the conflict. The incentive could be created by current income and/or the generation of enterprise value in a service provider or vendor; the Firm can be expected to also have an incentive to invest in or create service providers and vendors to realize on these opportunities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Firm has a practice of not entering into any arrangements with advisors, vendors or service providers that provide lower rates or discounts to the Firm itself compared to those it enters into on behalf of the Company and its portfolio companies for the same services. However, legal fees for unconsummated transactions are often charged at a discounted rate, such that if the Company and its portfolio companies consummate a higher percentage of transactions with a particular law firm than the Firm, the Company, Other Clients and their portfolio companies, the shareholders could indirectly pay a higher net effective rate for the services of that law firm than the Firm, the Company or Other Clients or their portfolio companies. Also, advisors, vendors and service providers often charge different rates or have different arrangements for different types of services. For example, advisors, vendors and service providers often charge fees based on the complexity of the matter as well as the expertise and time required to handle it. Therefore, to the extent the types of services used by the Company and its portfolio companies are different from those used by the Firm, Other Clients and their portfolio companies, and their affiliates and personnel, the Company and its portfolio companies can be expected to pay different amounts or rates than those paid by such other persons. Similarly, the Firm, the Company, the Other Clients and their portfolio companies and affiliates can be expected to enter into agreements or other arrangements with vendors and other similar counterparties (whether such counterparties are affiliated or unaffiliated with the Firm) from time to time whereby such counterparty will, in certain circumstances, charge lower rates (or no fee) or provide discounts or rebates for such counterparty&#x2019;s products or services depending on certain factors, including without limitation the volume of transactions entered into with such counterparty by the Firm, the Company and its investment and/or portfolio companies in the aggregate or other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to applicable law, the Company, Other Clients and their portfolio companies are expected to enter into joint ventures with third parties to which the service providers and vendors described above will, in certain circumstances, provide services. In some of these cases, the third party joint venture partner may be permitted to negotiate to not pay its &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;pro rata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; share of fees, costs and expenses to be allocated as described above, in which case the Company, Other Clients and their portfolio companies that also use the services of the portfolio company service provider will, directly or indirectly, pay the difference, or the portfolio company service provider will bear a loss equal to the difference.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Firm might, from time to time, encourage service providers to funds and investments to use, generally at market rates and/or on arm&#x2019;s length terms (and/or on the basis of best execution, if applicable), the Firm-affiliated service providers in connection with the business of the Company, portfolio companies, and unaffiliated entities. This practice creates a conflict of interest because it provides an indirect benefit to the Firm in the form of added business for the Firm-affiliated service providers without any reduction to the Company&#x2019;s management fee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain portfolio companies that provide services to the Company, Other Clients and/or portfolio companies or assets of the Company and/or Other Clients could be transferred between and among the Company and/or Other Clients (where the Company may be a seller or a buyer in any such transfer) for minimal or no consideration (based on a third-party valuation confirming the same). Such transfers may give rise to actual or potential conflicts of interest for Blackstone Credit &amp;amp; Insurance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Firm Affiliated Service Providers. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s, the Firm&#x2019;s and/or portfolio companies&#x2019; advisers and other service providers, or their affiliates (including accountants, administrators, lenders, bankers, brokers, attorneys, consultants, and investment or commercial banking firms) also provide goods or services to, or have business, personal, financial or other relationships with, the Firm, its affiliates and portfolio companies. Such advisers and service providers (or their affiliates) may be investors in the Company, affiliates of the Firm, sources of investment opportunities, co-investors, commercial counterparties and/or portfolio companies in which the Firm and/or the Company has an investment. Accordingly, payments by the Company and/or such entities may indirectly benefit the Company and/or its affiliates, including the Firm and Other Clients. No fees charged by these service providers and vendors will reduce the management fees payable to the Adviser. Furthermore, the Firm, the Other Clients and their portfolio companies and their affiliates and related parties will use the services of these Firm affiliates, including at different rates. Although the Firm believes the services provided by its affiliates are equal or better than those of third parties, the Firm directly benefits from the engagement of these affiliates, and there is therefore an inherent conflict of interest such as those described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because the Firm has many different businesses, including the Blackstone Capital Markets Group, which Blackstone investment teams and portfolio companies can engage to provide underwriting and capital market advisory services, it is subject to a number of actual and potential conflicts of interest, greater regulatory oversight and more legal and contractual restrictions than that to which it would be subject if it had just one line of business. To the extent Blackstone determines appropriate, conflict mitigation strategies would be put in place with respect to a particular circumstance, such as internal information barriers or recusal, disclosure or other steps determined appropriate by the Adviser. Service providers affiliated with the Firm, which are generally expected to receive competitive market rate fees (as determined by the Adviser or its affiliates) with respect to certain investments, include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.07pt"&gt;Aquicore&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Aquicore is a cloud-based platform that tracks, analyzes and predicts key metrics in real estate, focused on the reduction of energy consumption. Blackstone holds a minority investment in Aquicore.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"&gt;Equity Healthcare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Equity Healthcare LLC (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Equity Healthcare&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) is a Blackstone affiliate that negotiates with providers of standard administrative services and insurance carriers for health benefit plans and other related services for cost discounts, quality of service monitoring, data services and clinical consulting. Because of the combined purchasing power of its client participants, which include unaffiliated third parties, Equity Healthcare is able to negotiate pricing terms that are believed to be more favorable than those that the portfolio companies could obtain for themselves on an individual basis. The fees received by Equity Healthcare in connection with services provided to investments will not reduce the management fee payable by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;c.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.07pt"&gt;LNLS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Lexington National Land Services (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;LNLS&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) is a Blackstone affiliate that (i) acts as a title agent in facilitating and issuing title insurance, (ii) provides title support services for title insurance underwriters and (iii) acts as escrow agent in connection with investments by the Company, Other Clients and their portfolio companies, affiliates and related parties, and third parties. In exchange for such services LNLS earns fees which would have otherwise been paid to third parties. If LNLS is involved in a transaction in which the Company participates, Blackstone will benchmark the relevant costs to the extent market data is available except when LNLS is providing such services in a state where the insurance premium or escrow fee, as applicable, is regulated by the state or when LNLS is part of a syndicate of title insurance companies where the insurance premium is negotiated by other title insurance underwriters or their agents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"&gt;Refinitiv&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. See &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;Portfolio Company Service Providers and Vendors&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, Blackstone acquired a 9.9% interest in Corebridge, and in connection therewith has entered into a long-term asset management partnership with certain subsidiaries and/or affiliates of Corebridge to serve as the exclusive external manager with respect to certain asset classes within their investment portfolio, for compensation. While Blackstone will not control Corebridge, the aforementioned investment in Corebridge and asset management arrangements could incentivize Blackstone to cause (and Blackstone will benefit indirectly from causing) the Company and/or its portfolio companies to engage Corebridge or its affiliates (including Corebridge Financial, Inc. and its other affiliates and subsidiaries) to provide various services and engage in other transactions and otherwise present conflicts of interests as a result of Blackstone&#x2019;s interest and relationship therewith.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain Blackstone-affiliated service providers and their respective personnel will receive a management promote, an incentive fee and other performance-based compensation in respect of investments, sales or other transaction volume. Furthermore, Blackstone-affiliated service providers can be expected to charge costs and expenses based on allocable overhead associated with personnel working on relevant matters (including salaries, benefits and other similar expenses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with such relationships, Blackstone Credit &amp;amp; Insurance and, if required by applicable law, the Board of Trustees, will make determinations of competitive market rates based on its consideration of a number of factors, which are generally expected to include Blackstone Credit &amp;amp; Insurance&#x2019;s experience with non-affiliated service providers, benchmarking data and other methodologies determined by Blackstone Credit &amp;amp; Insurance to be appropriate under the circumstances (i.e., rates that fall within a range that Blackstone Credit &amp;amp; Insurance has determined is reflective of rates in the applicable market and certain similar markets, though not necessarily equal to or lower than the median rate of comparable firms and in certain circumstances, is expected to be in the top of the range). In respect of benchmarking, while Blackstone Credit &amp;amp; Insurance often obtains benchmarking data regarding the rates charged or quoted by third parties for services similar to those provided by Blackstone Credit &amp;amp; Insurance affiliates in the applicable market or certain similar markets, relevant comparisons would not be available for a number of reasons, including, without limitation, as a result of a lack of a substantial market of providers or users of such services or the confidential or bespoke nature of such services (e.g., different assets could receive different services). In addition, benchmarking data is based on general market and broad industry overviews, rather than determined on an asset by asset basis. As a result, benchmarking data does not take into account specific characteristics of individual assets then invested in by the Company (such as location or size), or the particular characteristics of services provided. Further, it could be difficult to identify comparable third-party service providers that provide services of a similar scope and scale as the Firm-affiliated service providers that are the subject of the benchmarking analysis or to obtain detailed information about pricing of a service comparable to that being provided to the Company from third-party service providers if such service providers anticipate that Blackstone will not in fact engage their services. For these reasons, such market comparisons would not necessarily result in precise market terms for comparable services. Expenses to obtain benchmarking data will be borne by the Company, Other Clients and their respective portfolio companies and will not reduce the management fee. Finally, in certain circumstances Blackstone Credit &amp;amp; Insurance may determine that third party benchmarking is unnecessary, including in circumstances where the price for a particular good or service is mandated by law (e.g., title insurance in rate regulated states) or because in Blackstone Credit &amp;amp; Insurance&#x2019;s view no comparable service provider offering such good or service (or an insufficient number of comparable service providers for a reasonable comparison) exists or because Blackstone Credit &amp;amp; Insurance has access to adequate market data (including from third party clients of the Firm-affiliated service provider that is the subject of the benchmarking analysis) to make the determination without reference to third party benchmarking. For example, in certain circumstances a Firm-affiliated service provider or a portfolio company service provider could provide services to third parties, in which case if the rates charged to such third parties are consistent with the rates charged to the Company, Other Clients and their respective portfolio companies, then a separate benchmarking analysis of such rates is not expected to be prepared. Some of the services performed by Firm-affiliated service providers could also be performed by the Firm from time to time and vice versa. Fees paid by the Company or its portfolio companies to or value created in Firm affiliated service providers or vendors do not reduce the management fee. These conflicts related to Firm-affiliated service providers will not necessarily be resolved in favor of the Company, and shareholders might not be entitled to receive notice or disclosure of the occurrence of these conflicts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advisers and service providers, or their affiliates, often charge different rates, including below-market or no fee, or have different arrangements for different types of services. With respect to service providers, for example, the fee for a given type of work could vary depending on the complexity of the matter as well as the expertise required and demands placed on the service provider. Therefore, to the extent the types of services used by the Company and/or portfolio companies differ from those used by the Firm and its affiliates (including personnel), Blackstone Credit &amp;amp; Insurance and/or Blackstone or their respective affiliates (including personnel) potentially will pay different amounts or rates than those paid by the Company and/or portfolio companies. However, Blackstone Credit &amp;amp; Insurance and its affiliates have a longstanding practice of not entering into any arrangements with advisers or service providers that could provide for lower rates or discounts than those available to the Company, Other Clients and/or portfolio companies for the same services. Furthermore, it is possible that certain advisers and service providers will provide services exclusively to the Firm and its affiliates, including the Company, Other Clients and their portfolio companies, although such advisers and service providers would not be considered employees of Blackstone or Blackstone Credit &amp;amp; Insurance. Similarly, Blackstone, Blackstone Credit &amp;amp; Insurance, each of their respective affiliates, the Company, the Other Clients and/or their portfolio companies, can enter into agreements or other arrangements with vendors and other similar counterparties (whether such counterparties are affiliated or unaffiliated with the Firm) from time to time whereby such counterparty would charge lower rates (or no fee) and/or provide discounts or rebates for such counterparty&#x2019;s products and/or services depending on certain factors, including volume of transactions entered into with such counterparty by the Firm, its affiliates, the Company, the Other Clients and their portfolio companies in the aggregate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, investment banks or other financial institutions, as well as certain Blackstone employees, are expected to also be investors in the Company. These institutions and employees are a potential source of information and ideas that could benefit the Company. Blackstone has procedures in place reasonably designed to prevent the inappropriate use of such information by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transactions with Portfolio Companies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Firm and portfolio companies of the Company and Other Clients operate in multiple industries and provide products and services to or otherwise contract with the Company and its portfolio companies, among others. In the alternative, the Firm could form a joint venture with such a company to implement such referral arrangement. For example, such arrangements could include the establishment of a joint venture or other business arrangement between the Firm, on the one hand, and a portfolio company of the Company, portfolio company of an Other Client or third party, on the other hand, pursuant to which the joint venture or business provides services (including, without limitation, corporate support services, loan management services, management services, operational services, ongoing account services (e.g., interacting and coordinating with banks generally and with regard to their know your client requirements), risk management services, data management services, consulting services, brokerage services, sustainability and clean energy consulting services, insurance procurement, placement, brokerage and consulting services, and other services) to portfolio companies of the Company (and portfolio companies of Other Clients) that are referred to the joint venture or business by the Firm. The Firm, the Company and Other Clients and their respective portfolio companies and personnel and related parties of the foregoing can be expected to make referrals or introductions to the Company or portfolio companies of the Company or Other Clients in an effort, in part, to increase the customer base of such companies or businesses (and therefore the value of the investment held by the Company or Other Client, which would also benefit the Firm financially through its participation in such joint venture or business) or because such referrals or introductions will, in certain circumstances, result in financial benefits, such as cash payments, additional equity ownership, participation in revenue share and/or milestones benefiting the referring or introducing party that are tied or related to participation by the portfolio companies of the Company and/or of Other Clients, accruing to the party making the introduction. Such joint venture or business could use data obtained from such portfolio companies (see&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x201c;Data&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;elsewhere herein). Furthermore, such introductions or referrals could involve the transfer of certain personnel or employees among Blackstone and the Company&#x2019;s portfolio companies and Other Clients which might result in a termination fee or similar payments being due and payable from one such entity to another. The Company and the shareholders typically will not share in any fees, economics, equity or other benefits accruing to the Firm, Other Clients and their portfolio companies as a result of the introduction of the Company and its portfolio companies. Moreover, payments made to the Firm in connection with such arrangements will not reduce the management fee payable to the Adviser. There could, however, be instances in which the applicable arrangements provide that the Company or its portfolio companies share in some or all of any resulting financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) based on structures and allocation methodologies determined in the sole discretion of the Firm. Conversely, where the Company or one of its portfolio companies is the referring or introducing party, rather than receiving all of the financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) for similar types of referrals and/or introductions, such financial incentives (including, in some cases, cash payments, additional equity ownership, participation in revenue share and/or milestones) could be similarly shared with the participating Other Clients or their respective portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Firm is also permitted to enter into commercial relationships with third party companies, including those in which the Company considered making an investment (but ultimately chose not to pursue). For example, the Firm could enter into an introducer engagement with such company, pursuant to which the Firm introduces the company to unaffiliated third parties (which can include current and former portfolio companies and portfolio companies of Other Clients and/or their respective employees) in exchange for a fee from, or equity interest in, such company. Even though the Firm could benefit financially from this commercial relationship, the Firm will be under no obligation to reimburse the Company for Broken Deal Expenses incurred in connection with its consideration of the prospective investment and such arrangements will not be subject to the management fee payable to the Adviser and otherwise described herein.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, the Firm or an affiliate thereof will from time to time hold equity or other investments in companies or businesses (even if they are not &#x201c;affiliates&#x201d; of the Firm) that provide services to or otherwise contract with portfolio companies. Blackstone and Blackstone Credit &amp;amp; Insurance have in the past entered (and can be expected in the future to enter) into relationships with companies in the information technology, corporate services and related industries whereby Blackstone acquires an equity or similar interest in such company. In connection with such relationships, Blackstone and/or Blackstone Credit &amp;amp; Insurance reserves the right to also make referrals and/or introductions to portfolio companies (which could result in financial incentives (including additional equity ownership) and/or milestones benefitting Blackstone and/or Blackstone Credit &amp;amp; Insurance that are tied or related to participation by portfolio companies). Such joint venture or business could use data obtained from portfolio companies of the Company and/or portfolio companies of Other Clients. These arrangements are expected to be entered into without the consent or direct involvement of the Company. The Company and the shareholders will not share in any fees or economics accruing to Blackstone and/or Blackstone Credit &amp;amp; Insurance as a result of these relationships and/or participation by portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to transactions or agreements with portfolio companies (including, for the avoidance of doubt, long-term incentive plans), at times if officers unrelated to the Firm have not yet been appointed to represent a portfolio company, the Firm is permitted to negotiate and execute agreements between the Firm and/or the Company on the one hand, and the portfolio company or its affiliates, on the other hand, without arm&#x2019;s length representation of the portfolio company, which could entail a conflict of interest in relation to efforts to enter into terms that are arm&#x2019;s length. Among the measures the Firm can be expected to use to mitigate such conflicts are to involve outside counsel to review and advise on such agreements and provide insights into commercially reasonable terms, or establish separate groups with information barriers within the Firm to advise on each side of the negotiation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Leasing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Subject to applicable law, the Company and its portfolio companies may lease property to or from Blackstone, Other Clients and their portfolio companies and affiliates and other related parties. The leases are generally expected to, but might not always, be at market rates. Blackstone can be expected to confirm market rates by reference to other leases it is aware of in the market, which Blackstone expects to be generally indicative of the market given the scale of Blackstone&#x2019;s real estate business. Blackstone can be expected to, but might not always, nonetheless have conflicts of interest in making these determinations, and with regard to other decisions related to such assets and investments. There can be no assurance that the Company and its portfolio companies will lease to or from any such related parties on terms as favorable to the Company and its portfolio companies as would apply if the counterparties were unrelated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross-Guarantees and Cross-Collateralization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. While Blackstone Credit &amp;amp; Insurance generally seeks to use reasonable efforts to avoid cross-guarantees and other similar arrangements, a counterparty, lender or other participant in any transaction to be pursued by the Company other than alternative investment vehicles and/or the Other Clients could require or prefer facing only one fund entity or group of entities, which can result in any of the Company, such Other Clients, the portfolio companies, such Other Clients&#x2019; portfolio companies and/or other vehicles being jointly and severally liable for such applicable obligation (subject to any limitations set forth in the applicable governing documents thereof), which in each case could result in the Company, such Other Clients, such portfolio companies and portfolio companies, and/or vehicles entering into a back-to-back or other similar reimbursement agreement, subject to applicable law. In such situation, better financing terms could be available through a cross-collateralized arrangement, but it is not expected that any of the Company or such Other Clients or vehicles would be compensated (or provide compensation to the other) for being primarily liable vis-&#xe0;-vis such third party counterparty. Also, it is expected that cross-collateralization will generally occur at portfolio companies rather than the Company for obligations that are not recourse to the Company except in limited circumstances such as &#x201c;bad boy&#x201d; events. Any cross-collateralization arrangements with Other Clients could result in the Company losing its interests in otherwise performing investments due to poorly performing or non-performing investments of Other Clients in the collateral pool.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Similarly, a lender could require that it face only one portfolio company of the Company and Other Clients, even though multiple portfolio companies of the Company and Other Clients benefit from the lending, which will typically result in (i) the portfolio company facing the lender being solely liable with respect to the entire obligation, and therefore being required to contribute amounts in respect of the shortfall attributable to other portfolio companies, and (ii) portfolio companies of the Company and Other Clients being jointly and severally liable for the full amount of the obligation, liable on a cross-collateralized basis or liable for an equity cushion (which cushion amount can vary depending upon the type of financing or refinancing (e.g., cushions for refinancings could be smaller)). The portfolio companies of the Company and Other Clients benefiting from a financing may enter into a back-to-back or other similar reimbursement agreements whereby each agrees that no portfolio company bears more than its &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;pro rata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; portion of the debt and related obligations. It is not expected that the portfolio companies would be compensated (or provide compensation to other portfolio companies) for being primarily liable, or jointly liable, for other portfolio companies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;pro rata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; share of any financing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint Venture Partners&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company will from time to time enter into one or more joint venture arrangements with third party joint venture partners. Investments made with joint venture partners will often involve performance-based compensation and other fees payable to such joint venture partners, as determined by the Adviser in its sole discretion. The joint venture partners could provide services similar to those provided by the Adviser to the Company. Yet, no compensation or fees paid to the joint venture partners would reduce the management fees payable by the Company. Additional conflicts would arise if a joint venture partner is related to the Firm in any way, such as a limited partner investor in, lender to, a shareholder of, or a service provider to the Firm, the Company, Other Clients, or their respective portfolio companies, or any affiliate, personnel, officer or agent of any of the foregoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Group Procurement; Discounts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company, subject to applicable law, and certain portfolio companies will enter into agreements regarding group procurement (including, but not limited to, CoreTrust, an independent group purchasing organization), benefits management, purchase of title and/or other insurance policies (which can be expected to include brokerage and/or placement thereof, and will from time to time be pooled across portfolio companies and discounted due to scale, including through sharing of deductibles and other forms of shared risk retention) from a third party or an affiliate of Blackstone Credit &amp;amp; Insurance and/or Blackstone, and other operational, administrative or management related initiatives. The Firm will allocate the cost of these various services and products purchased on a group basis among the Company, Other Clients and their portfolio companies. Some of these arrangements result in commissions, discounts, rebates or similar payments to Blackstone Credit &amp;amp; Insurance and/or Blackstone or their affiliates (including personnel), or Other Clients and their portfolio companies, including as a result of transactions entered into by the Company and its portfolio companies and/or related to a portion of the savings achieved by the portfolio companies. Such commissions or payment will not reduce the management fee. The Firm can be expected to also receive consulting, usage or other fees from the parties to these group procurement arrangements. To the extent that a portfolio company of an Other Client is providing such a service, such portfolio company and such Other Client will benefit. Further, the benefits received by a particular portfolio company providing the service could be greater than those received by the Company and its portfolio companies receiving the service. Conflicts exist in the allocation of the costs and benefits of these arrangements, and shareholders rely on the Adviser to handle them in its sole discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Diverse Shareholder Group&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s shareholders are expected to be based in a wide variety of jurisdictions and take a wide variety of forms. The shareholders may have conflicting investment, tax and other interests with respect to their investments in the Company and with respect to the interests of investors in other investment vehicles managed or advised by the Adviser and Blackstone Credit &amp;amp; Insurance that may participate in the same investments as the Company. The conflicting interests of individual shareholders with respect to other shareholders and relative to investors in other investment vehicles would generally relate to or arise from, among other things, the nature of investments made by the Company and such other partnerships, the structuring or the acquisition of investments and the timing of disposition of investments. As a consequence, conflicts of interest may arise in connection with the decisions made by the Adviser or Blackstone Credit &amp;amp; Insurance, including with respect to the nature or structuring of investments that may be more beneficial for one investor than for another investor, especially with respect to investors&#x2019; individual tax situations. In addition, the Company may make investments that may have a negative impact on related investments made by the shareholders in separate transactions, such as credit investments that, by consequence of the exercise of remedies related to such investments, adversely impact equity-like investments in respect of those same issuers. In selecting and structuring investments appropriate for the Company, the Adviser or Blackstone Credit &amp;amp; Insurance will consider the investment and tax objectives of the Company and the shareholders (and those of investors in other investment vehicles managed or advised by the Adviser or Blackstone Credit &amp;amp; Insurance) as a whole, not the investment, tax or other objectives of any shareholder individually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, certain shareholders also may be investors in Other Clients, including supplemental capital vehicles and co-investment vehicles that invest alongside the Company in one or more investments, consistent with applicable law and/or any applicable SEC-granted order. Shareholders also might include affiliates of the Firm, such as Other Clients, affiliates of portfolio companies of the Company or Other Clients, charities, foundations or other entities or programs associated with Firm personnel and/or current or former Firm employees, the Firm&#x2019;s senior advisors and/or operating partners and any affiliates, funds or persons may also invest in the Company through the vehicles established in connection with the Firm&#x2019;s side-by-side co-investment rights, subject to applicable law, in each case, without being subject to management fees, and shareholders will not be afforded the benefits of such arrangements. Some of the foregoing Firm related parties are sponsors of feeder vehicles that could invest in the Company as shareholders. The Firm related sponsors of feeder vehicles generally charge their investors additional fees, including performance based fees, which could provide the Firm current income and increase the value of its ownership position in them. The Firm will therefore have incentives to refer potential investors to these feeder vehicles. All of these Firm related shareholders will have equivalent rights to vote and withhold consents as nonrelated shareholders. Nonetheless, the Firm could have the ability to influence, directly or indirectly, these Firm related shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is also possible that the Company or its portfolio companies will be a counterparty (such counterparties dealt with on an arm&#x2019;s-length basis) or participant in agreements, transactions or other arrangements with a shareholder or an affiliate of a shareholder. Such transactions may include agreements to pay performance fees to operating partners, a management team and other related persons in connection with the Company&#x2019;s investment therein, which will reduce the Company&#x2019;s returns. Such shareholders described in the previous sentences may therefore have different information about the Firm and the Company than shareholders not similarly positioned. In addition, conflicts of interest may arise in dealing with any such shareholders, and the Adviser and its affiliates may not be motivated to act solely in accordance with its interests relating to the Company. Similar information disparity may occur as a result of shareholders monitoring their investments in vehicles such as the Company differently. For example, certain shareholders may periodically request from the Adviser information regarding the Company, its investments and/or portfolio companies that is not otherwise set forth in (or has yet to be set forth) in the reporting and other information required to be delivered to all shareholders. In such circumstances, the Adviser may provide such information to such shareholders, subject to applicable law and regulations. Unless required by applicable law, the Adviser will not be obligated to affirmatively provide such information to all shareholders (although the Adviser will generally provide the same information upon request and treat shareholders equally in that regard). As a result, certain shareholders may have more information about the Company than other shareholders, and, unless required by applicable law, the Adviser will have no duty to ensure all shareholders seek, obtain or process the same information regarding the Company, its investments and/or portfolio companies. Therefore, certain shareholders may be able to take actions on the basis of such information which, in the absence of such information, other shareholders do not take. Furthermore, at certain times the Firm may be restricted from disclosing to the shareholders material non-public information regarding any assets in which the Company invests, particularly those investments in which an Other Client or portfolio company that is publicly registered co-invests with the Company. In addition, investment banks or other financial institutions, as well as Firm personnel, may also be shareholders. These institutions and personnel are a potential source of information and ideas that could benefit the Company, and may receive information about the Company and its portfolio companies in their capacity as a service provider or vendor to the Company and its portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Possible Future Activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Firm and its affiliates are expected to expand the range of services that it provides over time. Except as provided herein, the Firm and its affiliates will not be restricted in the scope of its business or in the performance of any such services (whether now offered or undertaken in the future) even if such activities could give rise to conflicts of interest, and whether or not such conflicts are described herein. The Firm and its affiliates have, and will continue to develop, relationships with a significant number of companies, financial sponsors and their senior managers, including relationships with clients who might hold or might have held investments similar to those intended to be made by the Company. These clients could themselves represent appropriate investment opportunities for the Company or could compete with the Company for investment opportunities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restrictions Arising under the Securities Laws&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Firm&#x2019;s activities and the activities of Other Clients (including the holding of securities positions or having one of its employees on the board of directors of a portfolio company) could result in securities law restrictions on transactions in securities held by the Company, affect the prices of such securities or the ability of such entities to purchase, retain or dispose of such investments, or otherwise create conflicts of interest, any of which could have an adverse impact on the performance of the Company and thus the return to the shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 1940 Act may limit the Company&#x2019;s ability to undertake certain transactions with or alongside its affiliates that are registered under the 1940 Act. As a result of these restrictions, the Company may be prohibited from executing &#x201c;joint&#x201d; transactions with the Company&#x2019;s 1940 Act registered affiliates, which could include investments in the same portfolio company (whether at the same or different times) or buying investments from, or selling them to, Other Clients. These limitations have the potential to limit the scope of investment opportunities that would otherwise be available to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shareholders&#x2019; Outside Activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. A shareholder shall be entitled to and can be expected to have business interests and engage in activities in addition to those relating to the Company, including business interests and activities in direct competition with the Company and its portfolio companies, and can engage in transactions with, and provide services to, the Company or its portfolio companies (which will, in certain circumstances, include providing leverage or other financing to the Company or its portfolio companies as determined by the Adviser in its sole discretion). None of the Company, any shareholder or any other person shall have any rights by virtue of the Company&#x2019;s operative documents or any related agreements in any business ventures of any shareholder. The shareholder, and in certain cases the Adviser, will have conflicting loyalties in these situations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Insurance. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser will cause the Company to purchase, and/or bear premiums, fees, costs and expenses (including any expenses or fees of insurance brokers) for insurance to insure the Company and the Board of Trustees against liability in connection with the activities of the Company. This includes a portion of any premiums, fees, costs and expenses for one or more &#x201c;umbrella,&#x201d; group or other insurance policies maintained by the Firm that cover the Company and one or more of the Other Clients, the Adviser, Blackstone Credit &amp;amp; Insurance and/or Blackstone (including their respective directors, officers, employees, agents, representatives, independent client representative (if any) and other indemnified parties). The Adviser will make judgments about the allocation of premiums, fees, costs and expenses for such &#x201c;umbrella,&#x201d; group or other insurance policies among the Company, one or more Other Clients, the Adviser, Blackstone Credit &amp;amp; Insurance and/or Blackstone on a fair and reasonable basis, subject to approval by the Board of Trustees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Technological and Scientific Innovations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Recent technological and scientific innovations have disrupted numerous established industries and those with incumbent power in them.&#160;As technological and scientific innovation continues to advance rapidly, it could impact one or more of the Company&#x2019;s strategies.&#160;Moreover, given the pace of innovation in recent years, the impact on a particular portfolio company might not have been foreseeable at the time the Company made such investment and could adversely impact the Company and/or its portfolio companies. Furthermore, Blackstone Credit &amp;amp; Insurance could base investment decisions on views about the direction or degree of innovation that prove inaccurate and lead to losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Additional Potential Conflicts of Interest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The officers, directors, members, managers, employees and personnel of the Adviser may trade in securities for their own accounts, subject to restrictions and reporting requirements as may be required by law or the Firm&#x2019;s policies, or otherwise determined from time to time by the Adviser. In addition, certain Other Clients may be subject to the 1940 Act or other regulations that, due to the role of the Firm, could restrict the ability of the Company to buy investments from, to sell investments to or to invest in the same securities as, such Other Clients. Such regulations may have the effect of limiting the investment opportunities available to the Company. In addition, as a consequence of Blackstone&#x2019;s status as a public company, the officers, directors, members, managers and personnel of the Adviser may take into account certain considerations and other factors in connection with the management of the business and affairs of the Company and its affiliates that would not necessarily be taken into account if Blackstone were not a public company. The directors of Blackstone have fiduciary duties to shareholders of the public company that may conflict with their duties to the Company. Finally, although the Firm believes its positive reputation in the marketplace provides benefit to the Company and Other Clients, the Adviser could decline to undertake investment activity or transact with a counterparty on behalf of the Company for reputational reasons, and this decision could result in the Company foregoing a profit or suffering a loss.&lt;/span&gt;&lt;/div&gt;</cef:RiskTextBlock>
    <cef:SharePriceTableTextBlock contextRef="c-1" id="f-161">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the net asset value per share of our common stock, the range of high and low closing sales prices of our common stock reported on the NYSE, the closing sales price as a premium (discount) to net asset value and the dividends declared by us in each fiscal quarter since we began trading on the NYSE.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.998%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Price Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Asset Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;High&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Low&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;High Sales Price Premium (Discount) to Net Asset Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Low Sales Price Premium (Discount) to Net Asset Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Dividend Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$26.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22.26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$27.51&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$23.95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$28.77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$26.67&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$28.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$26.06&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$31.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$27.88&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$28.99&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$23.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$25.24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22.11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$24.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22.35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$37.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$27.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low closing sales prices. The NAV shown are based on outstanding shares at the end of the relevant quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Calculated as the respective high or low closing sales price less NAV, divided by NAV (in each case, as of the applicable quarter). &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents the dividend or distribution declared and payable in the relevant quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our liquidity and capital resources are generated primarily from cash flows from interest, dividends and fees earned from our investments and principal repayments, our credit facilities, debt securitization transactions, and other secured and unsecured debt. We may also generate cash flow from operations, future borrowings and future offerings of securities including public and/or private issuances of debt and/or equity securities through both registered offerings and private offerings. The primary uses of our cash and cash equivalents are for (i) originating loans and purchasing senior secured debt investments, (ii) funding the costs of our operations (including fees paid to our Adviser and expense reimbursements paid to our Administrator), (iii) debt service, repayment and other financing costs of our borrowings and (iv) cash distributions to the holders of our shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To&#160;facilitate public issuances of debt and/or equity securities, in July 2022, we filed a shelf registration statement with the SEC that is effective for a term of three years and expires in July 2025. The amount of securities to be issued pursuant to the shelf registration statement filed in July 2022 was not specified when it was filed and there is no specific dollar limit on the amount of securities we may issue. The securities covered by the registration statement filed in July 2022 include: (i) common shares; (ii) preferred shares; (iii) debt securities; (iv) subscription rights; and (v) warrants. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of any offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and December&#160;31, 2022, our debt consisted of asset based leverage facilities, a revolving credit facility, and unsecured note issuances. We may from time to time enter into additional credit facilities, increase the size of our existing credit facilities or issue further debt securities. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors. In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. As of December&#160;31, 2023 and December&#160;31, 2022, we had an aggregate amount of $4,937.9 million and $5,563.0 million of senior securities outstanding, respectively, and our asset coverage ratio was 200.3% and 174.8%, respectively. We seek to carefully consider our unfunded commitments for the purpose of planning our ongoing financial leverage. Further, we maintain sufficient borrowing capacity within the 150% asset coverage limitation to cover any outstanding unfunded commitments we are required to fund. From time to time we may also repurchase our outstanding debt. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, and other factors. The amounts involved in any such purchase transactions, individually or in the aggregate, may be material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents as of December&#160;31, 2023, taken together with our $1,662.1 million of unused capacity under our credit facilities (subject to borrowing base availability, $1,662.0 million is available to borrow) is expected to be sufficient for our investing activities and to conduct our operations in the near term. Additionally, we held $157.9 million of Level 2 debt investments as of December&#160;31, 2023, which could provide additional liquidity if necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although we have historically been able to obtain sufficient borrowing capacity, a deterioration in economic conditions or any other negative economic developments could restrict our access to financing in the future. We may not be able to find new financing for future investments or liquidity needs and, even if we are able to obtain such financing, such financing may not be on as favorable terms as we have previously obtained. These factors may limit our ability to make new investments and adversely impact our results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, we had &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$154.9 million in cash and cash equivalents. During the year ended December&#160;31, 2023, cash provided by operating activities was $458.8 million, primarily from receipt of interest payments from our investments, partially offset by purchases of investments, net of sales of investments and principal repayments, of $178.1 million.&#160;Cash used in financing activities was $432.2 million during the year, which was primarily as a result of net repayments on our credit facilities and Unsecured Notes of $650.9 million and dividends paid in cash of $438.0 million partially offset by $665.3 million of proceeds from the issuance of our common shares.&lt;/span&gt;&lt;/div&gt;</cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="c-120"
      decimals="INF"
      id="f-162"
      unitRef="usdPerShare">26.25</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="c-120"
      decimals="INF"
      id="f-163"
      unitRef="usdPerShare">22.26</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent contextRef="c-120" decimals="3" id="f-164" unitRef="number">0.006</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent contextRef="c-120" decimals="3" id="f-165" unitRef="number">-0.147</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="c-121"
      decimals="INF"
      id="f-166"
      unitRef="usdPerShare">27.51</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="c-121"
      decimals="INF"
      id="f-167"
      unitRef="usdPerShare">23.95</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent contextRef="c-121" decimals="3" id="f-168" unitRef="number">0.046</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent contextRef="c-121" decimals="3" id="f-169" unitRef="number">-0.089</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="c-122"
      decimals="INF"
      id="f-170"
      unitRef="usdPerShare">28.77</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="c-122"
      decimals="INF"
      id="f-171"
      unitRef="usdPerShare">26.67</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent contextRef="c-122" decimals="3" id="f-172" unitRef="number">0.084</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent contextRef="c-122" decimals="3" id="f-173" unitRef="number">0.005</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="c-123"
      decimals="INF"
      id="f-174"
      unitRef="usdPerShare">28.63</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="c-123"
      decimals="INF"
      id="f-175"
      unitRef="usdPerShare">26.06</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent contextRef="c-123" decimals="3" id="f-176" unitRef="number">0.074</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent contextRef="c-123" decimals="3" id="f-177" unitRef="number">-0.023</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="c-124"
      decimals="INF"
      id="f-178"
      unitRef="usdPerShare">31.75</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="c-124"
      decimals="INF"
      id="f-179"
      unitRef="usdPerShare">27.88</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent contextRef="c-124" decimals="3" id="f-180" unitRef="number">0.215</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent contextRef="c-124" decimals="3" id="f-181" unitRef="number">0.067</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="c-125"
      decimals="INF"
      id="f-182"
      unitRef="usdPerShare">28.99</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="c-125"
      decimals="INF"
      id="f-183"
      unitRef="usdPerShare">23.30</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent contextRef="c-125" decimals="3" id="f-184" unitRef="number">0.120</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent contextRef="c-125" decimals="3" id="f-185" unitRef="number">-0.100</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="c-126"
      decimals="INF"
      id="f-186"
      unitRef="usdPerShare">25.24</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="c-126"
      decimals="INF"
      id="f-187"
      unitRef="usdPerShare">22.11</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent contextRef="c-126" decimals="3" id="f-188" unitRef="number">-0.020</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent contextRef="c-126" decimals="3" id="f-189" unitRef="number">-0.142</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="c-127"
      decimals="INF"
      id="f-190"
      unitRef="usdPerShare">24.68</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="c-127"
      decimals="INF"
      id="f-191"
      unitRef="usdPerShare">22.35</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent contextRef="c-127" decimals="3" id="f-192" unitRef="number">-0.048</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent contextRef="c-127" decimals="3" id="f-193" unitRef="number">-0.138</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="c-128"
      decimals="INF"
      id="f-194"
      unitRef="usdPerShare">37.64</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="c-128"
      decimals="INF"
      id="f-195"
      unitRef="usdPerShare">27.63</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent contextRef="c-128" decimals="3" id="f-196" unitRef="number">0.433</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:EffectsOfLeverageTextBlock contextRef="c-1" id="f-197">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our liquidity and capital resources are generated primarily from cash flows from interest, dividends and fees earned from our investments and principal repayments, our credit facilities, debt securitization transactions, and other secured and unsecured debt. We may also generate cash flow from operations, future borrowings and future offerings of securities including public and/or private issuances of debt and/or equity securities through both registered offerings and private offerings. The primary uses of our cash and cash equivalents are for (i) originating loans and purchasing senior secured debt investments, (ii) funding the costs of our operations (including fees paid to our Adviser and expense reimbursements paid to our Administrator), (iii) debt service, repayment and other financing costs of our borrowings and (iv) cash distributions to the holders of our shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To&#160;facilitate public issuances of debt and/or equity securities, in July 2022, we filed a shelf registration statement with the SEC that is effective for a term of three years and expires in July 2025. The amount of securities to be issued pursuant to the shelf registration statement filed in July 2022 was not specified when it was filed and there is no specific dollar limit on the amount of securities we may issue. The securities covered by the registration statement filed in July 2022 include: (i) common shares; (ii) preferred shares; (iii) debt securities; (iv) subscription rights; and (v) warrants. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of any offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and December&#160;31, 2022, our debt consisted of asset based leverage facilities, a revolving credit facility, and unsecured note issuances. We may from time to time enter into additional credit facilities, increase the size of our existing credit facilities or issue further debt securities. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors. In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. As of December&#160;31, 2023 and December&#160;31, 2022, we had an aggregate amount of $4,937.9 million and $5,563.0 million of senior securities outstanding, respectively, and our asset coverage ratio was 200.3% and 174.8%, respectively. We seek to carefully consider our unfunded commitments for the purpose of planning our ongoing financial leverage. Further, we maintain sufficient borrowing capacity within the 150% asset coverage limitation to cover any outstanding unfunded commitments we are required to fund. From time to time we may also repurchase our outstanding debt. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, and other factors. The amounts involved in any such purchase transactions, individually or in the aggregate, may be material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents as of December&#160;31, 2023, taken together with our $1,662.1 million of unused capacity under our credit facilities (subject to borrowing base availability, $1,662.0 million is available to borrow) is expected to be sufficient for our investing activities and to conduct our operations in the near term. Additionally, we held $157.9 million of Level 2 debt investments as of December&#160;31, 2023, which could provide additional liquidity if necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although we have historically been able to obtain sufficient borrowing capacity, a deterioration in economic conditions or any other negative economic developments could restrict our access to financing in the future. We may not be able to find new financing for future investments or liquidity needs and, even if we are able to obtain such financing, such financing may not be on as favorable terms as we have previously obtained. These factors may limit our ability to make new investments and adversely impact our results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, we had &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$154.9 million in cash and cash equivalents. During the year ended December&#160;31, 2023, cash provided by operating activities was $458.8 million, primarily from receipt of interest payments from our investments, partially offset by purchases of investments, net of sales of investments and principal repayments, of $178.1 million.&#160;Cash used in financing activities was $432.2 million during the year, which was primarily as a result of net repayments on our credit facilities and Unsecured Notes of $650.9 million and dividends paid in cash of $438.0 million partially offset by $665.3 million of proceeds from the issuance of our common shares.&lt;/span&gt;&lt;/div&gt;</cef:EffectsOfLeverageTextBlock>
    <dei:AuditorFirmId contextRef="c-1" id="f-198">34</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-199">DELOITTE &amp; TOUCHE LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-200">New York, New York</dei:AuditorLocation>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-129" decimals="-3" id="f-201" unitRef="usd">9934158000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-130" decimals="-3" id="f-202" unitRef="usd">9621233000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-129" decimals="-3" id="f-203" unitRef="usd">9862650000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-130" decimals="-3" id="f-204" unitRef="usd">9560664000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-131" decimals="-3" id="f-205" unitRef="usd">1000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-132" decimals="-3" id="f-206" unitRef="usd">36639000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-131" decimals="-3" id="f-207" unitRef="usd">5790000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-132" decimals="-3" id="f-208" unitRef="usd">56584000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-5" decimals="-3" id="f-209" unitRef="usd">9934159000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-6" decimals="-3" id="f-210" unitRef="usd">9657872000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-5" decimals="-3" id="f-211" unitRef="usd">9868440000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-6" decimals="-3" id="f-212" unitRef="usd">9617248000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-213" unitRef="usd">154857000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-6" decimals="-3" id="f-214" unitRef="usd">131272000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DividendAndInterestReceivable contextRef="c-129" decimals="-3" id="f-215" unitRef="usd">93576000</us-gaap:DividendAndInterestReceivable>
    <us-gaap:DividendAndInterestReceivable contextRef="c-130" decimals="-3" id="f-216" unitRef="usd">97874000</us-gaap:DividendAndInterestReceivable>
    <us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet contextRef="c-5" decimals="-3" id="f-217" unitRef="usd">16450000</us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet>
    <us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet contextRef="c-6" decimals="-3" id="f-218" unitRef="usd">13332000</us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet>
    <us-gaap:ReceivableInvestmentSale contextRef="c-5" decimals="-3" id="f-219" unitRef="usd">1295000</us-gaap:ReceivableInvestmentSale>
    <us-gaap:ReceivableInvestmentSale contextRef="c-6" decimals="-3" id="f-220" unitRef="usd">49269000</us-gaap:ReceivableInvestmentSale>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-221" unitRef="usd">10134618000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-6" decimals="-3" id="f-222" unitRef="usd">9908995000</us-gaap:Assets>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-5" decimals="-3" id="f-223" unitRef="usd">25953000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-6" decimals="-3" id="f-224" unitRef="usd">35289000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt contextRef="c-5" decimals="-3" id="f-225" unitRef="usd">4911930000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-6" decimals="-3" id="f-226" unitRef="usd">5527715000</us-gaap:LongTermDebt>
    <us-gaap:PayableInvestmentPurchase contextRef="c-5" decimals="-3" id="f-227" unitRef="usd">8566000</us-gaap:PayableInvestmentPurchase>
    <us-gaap:PayableInvestmentPurchase contextRef="c-6" decimals="-3" id="f-228" unitRef="usd">20273000</us-gaap:PayableInvestmentPurchase>
    <us-gaap:OtherLiabilities contextRef="c-133" decimals="-3" id="f-229" unitRef="usd">8925000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="c-134" decimals="-3" id="f-230" unitRef="usd">10809000</us-gaap:OtherLiabilities>
    <us-gaap:ManagementFeePayable contextRef="c-5" decimals="-3" id="f-231" unitRef="usd">23034000</us-gaap:ManagementFeePayable>
    <us-gaap:ManagementFeePayable contextRef="c-6" decimals="-3" id="f-232" unitRef="usd">18595000</us-gaap:ManagementFeePayable>
    <bxsl:IncentiveFeePayableIncome contextRef="c-5" decimals="-3" id="f-233" unitRef="usd">34373000</bxsl:IncentiveFeePayableIncome>
    <bxsl:IncentiveFeePayableIncome contextRef="c-6" decimals="-3" id="f-234" unitRef="usd">24773000</bxsl:IncentiveFeePayableIncome>
    <bxsl:IncentiveFeePayableCapitalGains contextRef="c-5" decimals="-3" id="f-235" unitRef="usd">0</bxsl:IncentiveFeePayableCapitalGains>
    <bxsl:IncentiveFeePayableCapitalGains contextRef="c-6" decimals="-3" id="f-236" unitRef="usd">5506000</bxsl:IncentiveFeePayableCapitalGains>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="c-5" decimals="-3" id="f-237" unitRef="usd">39880000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="c-6" decimals="-3" id="f-238" unitRef="usd">45289000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DistributionPayable contextRef="c-5" decimals="-3" id="f-239" unitRef="usd">143052000</us-gaap:DistributionPayable>
    <us-gaap:DistributionPayable contextRef="c-6" decimals="-3" id="f-240" unitRef="usd">96218000</us-gaap:DistributionPayable>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c-5" decimals="-3" id="f-241" unitRef="usd">12817000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c-6" decimals="-3" id="f-242" unitRef="usd">851000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-243" unitRef="usd">5182577000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-6" decimals="-3" id="f-244" unitRef="usd">5750029000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-245" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-6" id="f-246" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-247"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-248"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="0" id="f-249" unitRef="shares">185782408</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="0" id="f-250" unitRef="shares">185782408</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="0" id="f-251" unitRef="shares">160362861</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-6" decimals="0" id="f-252" unitRef="shares">160362861</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-253" unitRef="usd">186000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-6" decimals="-3" id="f-254" unitRef="usd">160000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-5" decimals="-3" id="f-255" unitRef="usd">4701827000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-6" decimals="-3" id="f-256" unitRef="usd">4033113000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-257" unitRef="usd">250028000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-6" decimals="-3" id="f-258" unitRef="usd">125693000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-259" unitRef="usd">4952041000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-260" unitRef="usd">4158966000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-261" unitRef="usd">10134618000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-6" decimals="-3" id="f-262" unitRef="usd">9908995000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-5"
      decimals="2"
      id="f-263"
      unitRef="usdPerShare">26.66</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-6"
      decimals="2"
      id="f-264"
      unitRef="usdPerShare">25.93</us-gaap:NetAssetValuePerShare>
    <us-gaap:InterestIncomeOperatingPaidInCash contextRef="c-1" decimals="-3" id="f-267" unitRef="usd">1089044000</us-gaap:InterestIncomeOperatingPaidInCash>
    <us-gaap:InterestIncomeOperatingPaidInCash contextRef="c-135" decimals="-3" id="f-268" unitRef="usd">796499000</us-gaap:InterestIncomeOperatingPaidInCash>
    <us-gaap:InterestIncomeOperatingPaidInCash contextRef="c-136" decimals="-3" id="f-269" unitRef="usd">610508000</us-gaap:InterestIncomeOperatingPaidInCash>
    <us-gaap:InterestIncomeOperatingPaidInKind contextRef="c-137" decimals="-3" id="f-270" unitRef="usd">47076000</us-gaap:InterestIncomeOperatingPaidInKind>
    <us-gaap:InterestIncomeOperatingPaidInKind contextRef="c-138" decimals="-3" id="f-271" unitRef="usd">40324000</us-gaap:InterestIncomeOperatingPaidInKind>
    <us-gaap:InterestIncomeOperatingPaidInKind contextRef="c-139" decimals="-3" id="f-272" unitRef="usd">8188000</us-gaap:InterestIncomeOperatingPaidInKind>
    <us-gaap:DividendIncomeOperating contextRef="c-1" decimals="-3" id="f-273" unitRef="usd">387000</us-gaap:DividendIncomeOperating>
    <us-gaap:DividendIncomeOperating contextRef="c-135" decimals="-3" id="f-274" unitRef="usd">9307000</us-gaap:DividendIncomeOperating>
    <us-gaap:DividendIncomeOperating contextRef="c-136" decimals="-3" id="f-275" unitRef="usd">219000</us-gaap:DividendIncomeOperating>
    <us-gaap:FeeIncome contextRef="c-1" decimals="-3" id="f-276" unitRef="usd">7010000</us-gaap:FeeIncome>
    <us-gaap:FeeIncome contextRef="c-135" decimals="-3" id="f-277" unitRef="usd">4162000</us-gaap:FeeIncome>
    <us-gaap:FeeIncome contextRef="c-136" decimals="-3" id="f-278" unitRef="usd">5785000</us-gaap:FeeIncome>
    <us-gaap:GrossInvestmentIncomeOperating contextRef="c-1" decimals="-3" id="f-279" unitRef="usd">1143517000</us-gaap:GrossInvestmentIncomeOperating>
    <us-gaap:GrossInvestmentIncomeOperating contextRef="c-135" decimals="-3" id="f-280" unitRef="usd">850292000</us-gaap:GrossInvestmentIncomeOperating>
    <us-gaap:GrossInvestmentIncomeOperating contextRef="c-136" decimals="-3" id="f-281" unitRef="usd">624700000</us-gaap:GrossInvestmentIncomeOperating>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-3" id="f-282" unitRef="usd">266420000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-135" decimals="-3" id="f-283" unitRef="usd">203579000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-136" decimals="-3" id="f-284" unitRef="usd">120469000</us-gaap:InterestExpense>
    <us-gaap:ManagementFeeExpense contextRef="c-1" decimals="-3" id="f-285" unitRef="usd">98122000</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c-135" decimals="-3" id="f-286" unitRef="usd">101707000</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c-136" decimals="-3" id="f-287" unitRef="usd">62401000</us-gaap:ManagementFeeExpense>
    <bxsl:IncomeBasedIncentiveFeeExpense contextRef="c-1" decimals="-3" id="f-288" unitRef="usd">134230000</bxsl:IncomeBasedIncentiveFeeExpense>
    <bxsl:IncomeBasedIncentiveFeeExpense contextRef="c-135" decimals="-3" id="f-289" unitRef="usd">97154000</bxsl:IncomeBasedIncentiveFeeExpense>
    <bxsl:IncomeBasedIncentiveFeeExpense contextRef="c-136" decimals="-3" id="f-290" unitRef="usd">67272000</bxsl:IncomeBasedIncentiveFeeExpense>
    <bxsl:CapitalGainsIncentiveFeeExpense contextRef="c-1" decimals="-3" id="f-291" unitRef="usd">-5506000</bxsl:CapitalGainsIncentiveFeeExpense>
    <bxsl:CapitalGainsIncentiveFeeExpense contextRef="c-135" decimals="-3" id="f-292" unitRef="usd">-11883000</bxsl:CapitalGainsIncentiveFeeExpense>
    <bxsl:CapitalGainsIncentiveFeeExpense contextRef="c-136" decimals="-3" id="f-293" unitRef="usd">16312000</bxsl:CapitalGainsIncentiveFeeExpense>
    <us-gaap:ProfessionalFees contextRef="c-1" decimals="-3" id="f-294" unitRef="usd">6077000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c-135" decimals="-3" id="f-295" unitRef="usd">4011000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c-136" decimals="-3" id="f-296" unitRef="usd">2925000</us-gaap:ProfessionalFees>
    <us-gaap:TrusteeFees contextRef="c-1" decimals="-3" id="f-297" unitRef="usd">907000</us-gaap:TrusteeFees>
    <us-gaap:TrusteeFees contextRef="c-135" decimals="-3" id="f-298" unitRef="usd">853000</us-gaap:TrusteeFees>
    <us-gaap:TrusteeFees contextRef="c-136" decimals="-3" id="f-299" unitRef="usd">571000</us-gaap:TrusteeFees>
    <us-gaap:AdministrativeFeesExpense contextRef="c-1" decimals="-3" id="f-300" unitRef="usd">2250000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="c-135" decimals="-3" id="f-301" unitRef="usd">2672000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="c-136" decimals="-3" id="f-302" unitRef="usd">2370000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-303" unitRef="usd">6115000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-135" decimals="-3" id="f-304" unitRef="usd">6343000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-136" decimals="-3" id="f-305" unitRef="usd">4794000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense contextRef="c-1" decimals="-3" id="f-306" unitRef="usd">508615000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense contextRef="c-135" decimals="-3" id="f-307" unitRef="usd">404436000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense contextRef="c-136" decimals="-3" id="f-308" unitRef="usd">277114000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentCompanyContractualFeeWaived contextRef="c-1" decimals="-3" id="f-309" unitRef="usd">20194000</us-gaap:InvestmentCompanyContractualFeeWaived>
    <us-gaap:InvestmentCompanyContractualFeeWaived contextRef="c-135" decimals="-3" id="f-310" unitRef="usd">25427000</us-gaap:InvestmentCompanyContractualFeeWaived>
    <us-gaap:InvestmentCompanyContractualFeeWaived contextRef="c-136" decimals="-3" id="f-311" unitRef="usd">4195000</us-gaap:InvestmentCompanyContractualFeeWaived>
    <us-gaap:InvestmentCompanyVoluntaryFeeWaived contextRef="c-1" decimals="-3" id="f-312" unitRef="usd">15604000</us-gaap:InvestmentCompanyVoluntaryFeeWaived>
    <us-gaap:InvestmentCompanyVoluntaryFeeWaived contextRef="c-135" decimals="-3" id="f-313" unitRef="usd">13879000</us-gaap:InvestmentCompanyVoluntaryFeeWaived>
    <us-gaap:InvestmentCompanyVoluntaryFeeWaived contextRef="c-136" decimals="-3" id="f-314" unitRef="usd">2333000</us-gaap:InvestmentCompanyVoluntaryFeeWaived>
    <us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement contextRef="c-1" decimals="-3" id="f-315" unitRef="usd">472817000</us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement>
    <us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement contextRef="c-135" decimals="-3" id="f-316" unitRef="usd">365130000</us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement>
    <us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement contextRef="c-136" decimals="-3" id="f-317" unitRef="usd">270586000</us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement>
    <us-gaap:NetInvestmentIncome contextRef="c-1" decimals="-3" id="f-318" unitRef="usd">670700000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome contextRef="c-135" decimals="-3" id="f-319" unitRef="usd">485162000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome contextRef="c-136" decimals="-3" id="f-320" unitRef="usd">354114000</us-gaap:NetInvestmentIncome>
    <us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-321" unitRef="usd">16795000</us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit>
    <us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit contextRef="c-135" decimals="-3" id="f-322" unitRef="usd">1386000</us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit>
    <us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit contextRef="c-136" decimals="-3" id="f-323" unitRef="usd">2438000</us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit>
    <us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax contextRef="c-1" decimals="-3" id="f-324" unitRef="usd">653905000</us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax>
    <us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax contextRef="c-135" decimals="-3" id="f-325" unitRef="usd">483776000</us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax>
    <us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax contextRef="c-136" decimals="-3" id="f-326" unitRef="usd">351676000</us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss contextRef="c-137" decimals="-3" id="f-327" unitRef="usd">-36685000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss contextRef="c-138" decimals="-3" id="f-328" unitRef="usd">-143515000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss contextRef="c-139" decimals="-3" id="f-329" unitRef="usd">101804000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss contextRef="c-140" decimals="-3" id="f-330" unitRef="usd">-14156000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss contextRef="c-141" decimals="-3" id="f-331" unitRef="usd">17022000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss contextRef="c-142" decimals="-3" id="f-332" unitRef="usd">2923000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax contextRef="c-1" decimals="-3" id="f-333" unitRef="usd">-3732000</us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax contextRef="c-135" decimals="-3" id="f-334" unitRef="usd">4344000</us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax contextRef="c-136" decimals="-3" id="f-335" unitRef="usd">-549000</us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax>
    <us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-1" decimals="-3" id="f-336" unitRef="usd">-54573000</us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-135" decimals="-3" id="f-337" unitRef="usd">-122149000</us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-136" decimals="-3" id="f-338" unitRef="usd">104178000</us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss contextRef="c-137" decimals="-3" id="f-339" unitRef="usd">-14488000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss contextRef="c-138" decimals="-3" id="f-340" unitRef="usd">37402000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss contextRef="c-139" decimals="-3" id="f-341" unitRef="usd">7785000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss contextRef="c-140" decimals="-3" id="f-342" unitRef="usd">8283000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss contextRef="c-141" decimals="-3" id="f-343" unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss contextRef="c-142" decimals="-3" id="f-344" unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax contextRef="c-1" decimals="-3" id="f-345" unitRef="usd">18824000</us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax>
    <us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax contextRef="c-135" decimals="-3" id="f-346" unitRef="usd">5527000</us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax>
    <us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax contextRef="c-136" decimals="-3" id="f-347" unitRef="usd">-3217000</us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax>
    <us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-1" decimals="-3" id="f-348" unitRef="usd">12619000</us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-135" decimals="-3" id="f-349" unitRef="usd">42929000</us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-136" decimals="-3" id="f-350" unitRef="usd">4568000</us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax contextRef="c-1" decimals="-3" id="f-351" unitRef="usd">-41954000</us-gaap:RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax>
    <us-gaap:RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax contextRef="c-135" decimals="-3" id="f-352" unitRef="usd">-79220000</us-gaap:RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax>
    <us-gaap:RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax contextRef="c-136" decimals="-3" id="f-353" unitRef="usd">108746000</us-gaap:RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-354" unitRef="usd">611951000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-135" decimals="-3" id="f-355" unitRef="usd">404556000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-136" decimals="-3" id="f-356" unitRef="usd">460422000</us-gaap:NetIncomeLoss>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare
      contextRef="c-1"
      decimals="2"
      id="f-357"
      unitRef="usdPerShare">3.90</us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare
      contextRef="c-135"
      decimals="2"
      id="f-358"
      unitRef="usdPerShare">2.91</us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare
      contextRef="c-136"
      decimals="2"
      id="f-359"
      unitRef="usdPerShare">2.43</us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-360"
      unitRef="usdPerShare">3.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-361"
      unitRef="usdPerShare">3.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-135"
      decimals="2"
      id="f-362"
      unitRef="usdPerShare">2.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-135"
      decimals="2"
      id="f-363"
      unitRef="usdPerShare">2.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-136"
      decimals="2"
      id="f-364"
      unitRef="usdPerShare">3.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-136"
      decimals="2"
      id="f-365"
      unitRef="usdPerShare">3.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-366" unitRef="shares">167615433</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-367" unitRef="shares">167615433</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-135" decimals="0" id="f-368" unitRef="shares">166072919</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-135" decimals="0" id="f-369" unitRef="shares">166072919</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-136" decimals="0" id="f-370" unitRef="shares">144510122</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-136" decimals="0" id="f-371" unitRef="shares">144510122</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-143" decimals="-3" id="f-372" unitRef="usd">130000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-144" decimals="-3" id="f-373" unitRef="usd">3232562000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-145" decimals="-3" id="f-374" unitRef="usd">35117000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-146" decimals="-3" id="f-375" unitRef="usd">3267809000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-147" decimals="-3" id="f-376" unitRef="usd">38000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-148" decimals="-3" id="f-377" unitRef="usd">976063000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-136" decimals="-3" id="f-378" unitRef="usd">976101000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-147" decimals="-3" id="f-379" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-148" decimals="-3" id="f-380" unitRef="usd">38938000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-136" decimals="-3" id="f-381" unitRef="usd">38939000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax contextRef="c-149" decimals="-3" id="f-382" unitRef="usd">351676000</us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax>
    <us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax contextRef="c-136" decimals="-3" id="f-383" unitRef="usd">351676000</us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax>
    <us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-149" decimals="-3" id="f-384" unitRef="usd">4568000</us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-136" decimals="-3" id="f-385" unitRef="usd">4568000</us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-149" decimals="-3" id="f-386" unitRef="usd">104178000</us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-136" decimals="-3" id="f-387" unitRef="usd">104178000</us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:InvestmentCompanyDividendDistribution contextRef="c-149" decimals="-3" id="f-388" unitRef="usd">295792000</us-gaap:InvestmentCompanyDividendDistribution>
    <us-gaap:InvestmentCompanyDividendDistribution contextRef="c-136" decimals="-3" id="f-389" unitRef="usd">295792000</us-gaap:InvestmentCompanyDividendDistribution>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-148" decimals="-3" id="f-390" unitRef="usd">2438000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-149" decimals="-3" id="f-391" unitRef="usd">-2438000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-136" decimals="-3" id="f-392" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-150" decimals="-3" id="f-393" unitRef="usd">169000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-151" decimals="-3" id="f-394" unitRef="usd">4245125000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-152" decimals="-3" id="f-395" unitRef="usd">202185000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-153" decimals="-3" id="f-396" unitRef="usd">4447479000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-154" decimals="-3" id="f-397" unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-155" decimals="-3" id="f-398" unitRef="usd">52380000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-135" decimals="-3" id="f-399" unitRef="usd">52382000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-154" decimals="-3" id="f-400" unitRef="usd">11000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-155" decimals="-3" id="f-401" unitRef="usd">263006000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-135" decimals="-3" id="f-402" unitRef="usd">263017000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax contextRef="c-156" decimals="-3" id="f-403" unitRef="usd">483776000</us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax>
    <us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax contextRef="c-135" decimals="-3" id="f-404" unitRef="usd">483776000</us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax>
    <us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-156" decimals="-3" id="f-405" unitRef="usd">42929000</us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-135" decimals="-3" id="f-406" unitRef="usd">42929000</us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-156" decimals="-3" id="f-407" unitRef="usd">-122149000</us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-135" decimals="-3" id="f-408" unitRef="usd">-122149000</us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:InvestmentCompanyDividendDistribution contextRef="c-156" decimals="-3" id="f-409" unitRef="usd">482434000</us-gaap:InvestmentCompanyDividendDistribution>
    <us-gaap:InvestmentCompanyDividendDistribution contextRef="c-135" decimals="-3" id="f-410" unitRef="usd">482434000</us-gaap:InvestmentCompanyDividendDistribution>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-155" decimals="-3" id="f-411" unitRef="usd">1386000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-156" decimals="-3" id="f-412" unitRef="usd">-1386000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-135" decimals="-3" id="f-413" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-157" decimals="-3" id="f-414" unitRef="usd">160000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-158" decimals="-3" id="f-415" unitRef="usd">4033113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-159" decimals="-3" id="f-416" unitRef="usd">125693000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-417" unitRef="usd">4158966000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-160" decimals="-3" id="f-418" unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-161" decimals="-3" id="f-419" unitRef="usd">665235000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-3" id="f-420" unitRef="usd">665260000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-160" decimals="-3" id="f-421" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-161" decimals="-3" id="f-422" unitRef="usd">20650000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1" decimals="-3" id="f-423" unitRef="usd">20651000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax contextRef="c-162" decimals="-3" id="f-424" unitRef="usd">653905000</us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax>
    <us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax contextRef="c-1" decimals="-3" id="f-425" unitRef="usd">653905000</us-gaap:InvestmentIncomeOperatingAfterExpenseAndTax>
    <us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-162" decimals="-3" id="f-426" unitRef="usd">12619000</us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-1" decimals="-3" id="f-427" unitRef="usd">12619000</us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-162" decimals="-3" id="f-428" unitRef="usd">-54573000</us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax contextRef="c-1" decimals="-3" id="f-429" unitRef="usd">-54573000</us-gaap:UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingAfterTax>
    <us-gaap:InvestmentCompanyDividendDistribution contextRef="c-162" decimals="-3" id="f-430" unitRef="usd">504787000</us-gaap:InvestmentCompanyDividendDistribution>
    <us-gaap:InvestmentCompanyDividendDistribution contextRef="c-1" decimals="-3" id="f-431" unitRef="usd">504787000</us-gaap:InvestmentCompanyDividendDistribution>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-161" decimals="-3" id="f-432" unitRef="usd">17171000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-162" decimals="-3" id="f-433" unitRef="usd">-17171000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-1" decimals="-3" id="f-434" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-163" decimals="-3" id="f-435" unitRef="usd">186000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-164" decimals="-3" id="f-436" unitRef="usd">4701827000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-165" decimals="-3" id="f-437" unitRef="usd">250028000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-438" unitRef="usd">4952041000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-439" unitRef="usd">611951000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-135" decimals="-3" id="f-440" unitRef="usd">404556000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-136" decimals="-3" id="f-441" unitRef="usd">460422000</us-gaap:NetIncomeLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss contextRef="c-1" decimals="-3" id="f-442" unitRef="usd">-50841000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss contextRef="c-135" decimals="-3" id="f-443" unitRef="usd">-126493000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss contextRef="c-136" decimals="-3" id="f-444" unitRef="usd">104727000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-1" decimals="-3" id="f-445" unitRef="usd">-3732000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-135" decimals="-3" id="f-446" unitRef="usd">4344000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-136" decimals="-3" id="f-447" unitRef="usd">-549000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss contextRef="c-1" decimals="-3" id="f-448" unitRef="usd">-6205000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss contextRef="c-135" decimals="-3" id="f-449" unitRef="usd">37402000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss contextRef="c-136" decimals="-3" id="f-450" unitRef="usd">7785000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-1" decimals="-3" id="f-451" unitRef="usd">52865000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-135" decimals="-3" id="f-452" unitRef="usd">47429000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-136" decimals="-3" id="f-453" unitRef="usd">62799000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <bxsl:PaidInKindInterestNoncash contextRef="c-1" decimals="-3" id="f-454" unitRef="usd">51558000</bxsl:PaidInKindInterestNoncash>
    <bxsl:PaidInKindInterestNoncash contextRef="c-135" decimals="-3" id="f-455" unitRef="usd">40324000</bxsl:PaidInKindInterestNoncash>
    <bxsl:PaidInKindInterestNoncash contextRef="c-136" decimals="-3" id="f-456" unitRef="usd">9152000</bxsl:PaidInKindInterestNoncash>
    <bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements contextRef="c-1" decimals="-3" id="f-457" unitRef="usd">5471000</bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements>
    <bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements contextRef="c-135" decimals="-3" id="f-458" unitRef="usd">4008000</bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements>
    <bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements contextRef="c-136" decimals="-3" id="f-459" unitRef="usd">2676000</bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-1" decimals="-3" id="f-460" unitRef="usd">9336000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-135" decimals="-3" id="f-461" unitRef="usd">10405000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-136" decimals="-3" id="f-462" unitRef="usd">7102000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity contextRef="c-1" decimals="-3" id="f-463" unitRef="usd">1483303000</us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity>
    <us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity contextRef="c-135" decimals="-3" id="f-464" unitRef="usd">961768000</us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity>
    <us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity contextRef="c-136" decimals="-3" id="f-465" unitRef="usd">6824327000</us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity>
    <us-gaap:ProceedsFromDispositionOfInvestmentOperatingActivity contextRef="c-1" decimals="-3" id="f-466" unitRef="usd">1305234000</us-gaap:ProceedsFromDispositionOfInvestmentOperatingActivity>
    <us-gaap:ProceedsFromDispositionOfInvestmentOperatingActivity contextRef="c-135" decimals="-3" id="f-467" unitRef="usd">1174176000</us-gaap:ProceedsFromDispositionOfInvestmentOperatingActivity>
    <us-gaap:ProceedsFromDispositionOfInvestmentOperatingActivity contextRef="c-136" decimals="-3" id="f-468" unitRef="usd">2734419000</us-gaap:ProceedsFromDispositionOfInvestmentOperatingActivity>
    <us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable contextRef="c-1" decimals="-3" id="f-469" unitRef="usd">-4298000</us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable>
    <us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable contextRef="c-135" decimals="-3" id="f-470" unitRef="usd">35215000</us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable>
    <us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable contextRef="c-136" decimals="-3" id="f-471" unitRef="usd">41203000</us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable>
    <us-gaap:IncreaseDecreaseInReceivableForInvestmentSold contextRef="c-1" decimals="-3" id="f-472" unitRef="usd">-47974000</us-gaap:IncreaseDecreaseInReceivableForInvestmentSold>
    <us-gaap:IncreaseDecreaseInReceivableForInvestmentSold contextRef="c-135" decimals="-3" id="f-473" unitRef="usd">-93609000</us-gaap:IncreaseDecreaseInReceivableForInvestmentSold>
    <us-gaap:IncreaseDecreaseInReceivableForInvestmentSold contextRef="c-136" decimals="-3" id="f-474" unitRef="usd">28341000</us-gaap:IncreaseDecreaseInReceivableForInvestmentSold>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-3" id="f-475" unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-135" decimals="-3" id="f-476" unitRef="usd">-194000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-136" decimals="-3" id="f-477" unitRef="usd">-384000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInPayableForInvestmentPurchased contextRef="c-1" decimals="-3" id="f-478" unitRef="usd">-11707000</us-gaap:IncreaseDecreaseInPayableForInvestmentPurchased>
    <us-gaap:IncreaseDecreaseInPayableForInvestmentPurchased contextRef="c-135" decimals="-3" id="f-479" unitRef="usd">-15944000</us-gaap:IncreaseDecreaseInPayableForInvestmentPurchased>
    <us-gaap:IncreaseDecreaseInPayableForInvestmentPurchased contextRef="c-136" decimals="-3" id="f-480" unitRef="usd">-12365000</us-gaap:IncreaseDecreaseInPayableForInvestmentPurchased>
    <us-gaap:IncreaseDecreaseInDueToAffiliates contextRef="c-1" decimals="-3" id="f-481" unitRef="usd">-1884000</us-gaap:IncreaseDecreaseInDueToAffiliates>
    <us-gaap:IncreaseDecreaseInDueToAffiliates contextRef="c-135" decimals="-3" id="f-482" unitRef="usd">4168000</us-gaap:IncreaseDecreaseInDueToAffiliates>
    <us-gaap:IncreaseDecreaseInDueToAffiliates contextRef="c-136" decimals="-3" id="f-483" unitRef="usd">1281000</us-gaap:IncreaseDecreaseInDueToAffiliates>
    <us-gaap:IncreaseDecreaseInManagementFeePayable contextRef="c-1" decimals="-3" id="f-484" unitRef="usd">4439000</us-gaap:IncreaseDecreaseInManagementFeePayable>
    <us-gaap:IncreaseDecreaseInManagementFeePayable contextRef="c-135" decimals="-3" id="f-485" unitRef="usd">783000</us-gaap:IncreaseDecreaseInManagementFeePayable>
    <us-gaap:IncreaseDecreaseInManagementFeePayable contextRef="c-136" decimals="-3" id="f-486" unitRef="usd">7535000</us-gaap:IncreaseDecreaseInManagementFeePayable>
    <bxsl:IncreaseDecreaseInIncomeBasedIncentiveFeePayable contextRef="c-1" decimals="-3" id="f-487" unitRef="usd">9600000</bxsl:IncreaseDecreaseInIncomeBasedIncentiveFeePayable>
    <bxsl:IncreaseDecreaseInIncomeBasedIncentiveFeePayable contextRef="c-135" decimals="-3" id="f-488" unitRef="usd">4964000</bxsl:IncreaseDecreaseInIncomeBasedIncentiveFeePayable>
    <bxsl:IncreaseDecreaseInIncomeBasedIncentiveFeePayable contextRef="c-136" decimals="-3" id="f-489" unitRef="usd">4547000</bxsl:IncreaseDecreaseInIncomeBasedIncentiveFeePayable>
    <bxsl:IncreaseDecreaseInCapitalGainsIncentiveFeePayable contextRef="c-1" decimals="-3" id="f-490" unitRef="usd">-5506000</bxsl:IncreaseDecreaseInCapitalGainsIncentiveFeePayable>
    <bxsl:IncreaseDecreaseInCapitalGainsIncentiveFeePayable contextRef="c-135" decimals="-3" id="f-491" unitRef="usd">-11883000</bxsl:IncreaseDecreaseInCapitalGainsIncentiveFeePayable>
    <bxsl:IncreaseDecreaseInCapitalGainsIncentiveFeePayable contextRef="c-136" decimals="-3" id="f-492" unitRef="usd">16312000</bxsl:IncreaseDecreaseInCapitalGainsIncentiveFeePayable>
    <us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="c-1" decimals="-3" id="f-493" unitRef="usd">-5409000</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="c-135" decimals="-3" id="f-494" unitRef="usd">6145000</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="c-136" decimals="-3" id="f-495" unitRef="usd">24429000</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-496" unitRef="usd">11966000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-135" decimals="-3" id="f-497" unitRef="usd">-2244000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-136" decimals="-3" id="f-498" unitRef="usd">2529000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-499" unitRef="usd">458815000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-135" decimals="-3" id="f-500" unitRef="usd">672948000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-136" decimals="-3" id="f-501" unitRef="usd">-3828514000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-1" decimals="-3" id="f-502" unitRef="usd">1440343000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-135" decimals="-3" id="f-503" unitRef="usd">920827000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-136" decimals="-3" id="f-504" unitRef="usd">5778952000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c-1" decimals="-3" id="f-505" unitRef="usd">2091209000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c-135" decimals="-3" id="f-506" unitRef="usd">877152000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c-136" decimals="-3" id="f-507" unitRef="usd">2780121000</us-gaap:RepaymentsOfDebt>
    <bxsl:PaymentsOfDebtIssuanceCostsLineOfCreditArrangements contextRef="c-1" decimals="-3" id="f-508" unitRef="usd">8589000</bxsl:PaymentsOfDebtIssuanceCostsLineOfCreditArrangements>
    <bxsl:PaymentsOfDebtIssuanceCostsLineOfCreditArrangements contextRef="c-135" decimals="-3" id="f-509" unitRef="usd">3789000</bxsl:PaymentsOfDebtIssuanceCostsLineOfCreditArrangements>
    <bxsl:PaymentsOfDebtIssuanceCostsLineOfCreditArrangements contextRef="c-136" decimals="-3" id="f-510" unitRef="usd">9359000</bxsl:PaymentsOfDebtIssuanceCostsLineOfCreditArrangements>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-1" decimals="-3" id="f-511" unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-135" decimals="-3" id="f-512" unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-136" decimals="-3" id="f-513" unitRef="usd">3398000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-1" decimals="-3" id="f-514" unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-135" decimals="-3" id="f-515" unitRef="usd">1607000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-136" decimals="-3" id="f-516" unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfDividends contextRef="c-1" decimals="-3" id="f-517" unitRef="usd">437966000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c-135" decimals="-3" id="f-518" unitRef="usd">423441000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c-136" decimals="-3" id="f-519" unitRef="usd">253776000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-520" unitRef="usd">665260000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-135" decimals="-3" id="f-521" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-136" decimals="-3" id="f-522" unitRef="usd">981102000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-523" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-135" decimals="-3" id="f-524" unitRef="usd">263017000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-136" decimals="-3" id="f-525" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-526" unitRef="usd">-432161000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-135" decimals="-3" id="f-527" unitRef="usd">-648179000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-136" decimals="-3" id="f-528" unitRef="usd">3713400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-529" unitRef="usd">26654000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c-135" decimals="-3" id="f-530" unitRef="usd">24769000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c-136" decimals="-3" id="f-531" unitRef="usd">-115114000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-1" decimals="-3" id="f-532" unitRef="usd">-3069000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-135" decimals="-3" id="f-533" unitRef="usd">3624000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-136" decimals="-3" id="f-534" unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-535" unitRef="usd">131272000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-153" decimals="-3" id="f-536" unitRef="usd">102879000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-146" decimals="-3" id="f-537" unitRef="usd">217993000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-538" unitRef="usd">154857000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-539" unitRef="usd">131272000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-153" decimals="-3" id="f-540" unitRef="usd">102879000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-541" unitRef="usd">256478000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-135" decimals="-3" id="f-542" unitRef="usd">182152000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-136" decimals="-3" id="f-543" unitRef="usd">94552000</us-gaap:InterestPaidNet>
    <bxsl:DistributionCostsIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-544" unitRef="usd">143052000</bxsl:DistributionCostsIncurredButNotYetPaid>
    <bxsl:DistributionCostsIncurredButNotYetPaid contextRef="c-135" decimals="-3" id="f-545" unitRef="usd">96218000</bxsl:DistributionCostsIncurredButNotYetPaid>
    <bxsl:DistributionCostsIncurredButNotYetPaid contextRef="c-136" decimals="-3" id="f-546" unitRef="usd">89715000</bxsl:DistributionCostsIncurredButNotYetPaid>
    <us-gaap:StockIssued1 contextRef="c-1" decimals="-3" id="f-547" unitRef="usd">20651000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-135" decimals="-3" id="f-548" unitRef="usd">52382000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-136" decimals="-3" id="f-549" unitRef="usd">38939000</us-gaap:StockIssued1>
    <bxsl:DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="c-1" decimals="-3" id="f-550" unitRef="usd">0</bxsl:DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction>
    <bxsl:DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="c-135" decimals="-3" id="f-551" unitRef="usd">0</bxsl:DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction>
    <bxsl:DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="c-136" decimals="-3" id="f-552" unitRef="usd">64000</bxsl:DebtIssuanceCostsLineOfCreditArrangementsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="c-1" decimals="-3" id="f-553" unitRef="usd">0</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="c-135" decimals="-3" id="f-554" unitRef="usd">0</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="c-136" decimals="-3" id="f-555" unitRef="usd">92000</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <bxsl:DebtIssuanceCostsIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-556" unitRef="usd">0</bxsl:DebtIssuanceCostsIncurredButNotYetPaid>
    <bxsl:DebtIssuanceCostsIncurredButNotYetPaid contextRef="c-135" decimals="-3" id="f-557" unitRef="usd">0</bxsl:DebtIssuanceCostsIncurredButNotYetPaid>
    <bxsl:DebtIssuanceCostsIncurredButNotYetPaid contextRef="c-136" decimals="-3" id="f-558" unitRef="usd">1573000</bxsl:DebtIssuanceCostsIncurredButNotYetPaid>
    <bxsl:ExciseTaxesPaid contextRef="c-1" decimals="-3" id="f-559" unitRef="usd">5245000</bxsl:ExciseTaxesPaid>
    <bxsl:ExciseTaxesPaid contextRef="c-135" decimals="-3" id="f-560" unitRef="usd">4106000</bxsl:ExciseTaxesPaid>
    <bxsl:ExciseTaxesPaid contextRef="c-136" decimals="-3" id="f-561" unitRef="usd">131000</bxsl:ExciseTaxesPaid>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-166"
      decimals="INF"
      id="f-562"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-166" decimals="4" id="f-563" unitRef="number">0.1146</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-166" decimals="-3" id="f-564" unitRef="usd">198259000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-166" decimals="-3" id="f-565" unitRef="usd">196240000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-166" decimals="-3" id="f-566" unitRef="usd">192311000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-166" decimals="4" id="f-567" unitRef="number">0.0388</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-167"
      decimals="INF"
      id="f-568"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-167" decimals="4" id="f-569" unitRef="number">0.1146</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-167" decimals="-3" id="f-570" unitRef="usd">68557000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-167" decimals="-3" id="f-571" unitRef="usd">67944000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-167" decimals="-3" id="f-572" unitRef="usd">66500000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-167" decimals="4" id="f-573" unitRef="number">0.0134</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-168"
      decimals="INF"
      id="f-574"
      unitRef="number">0.0675</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-168" decimals="4" id="f-575" unitRef="number">0.1210</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-168" decimals="-3" id="f-576" unitRef="usd">2370000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-168" decimals="-3" id="f-577" unitRef="usd">2300000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-168" decimals="-3" id="f-578" unitRef="usd">2370000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-168" decimals="4" id="f-579" unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-169"
      decimals="INF"
      id="f-580"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-169" decimals="4" id="f-581" unitRef="number">0.1123</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-169" decimals="-3" id="f-582" unitRef="usd">9738000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-169" decimals="-3" id="f-583" unitRef="usd">9611000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-169" decimals="-3" id="f-584" unitRef="usd">9592000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-169" decimals="4" id="f-585" unitRef="number">0.0019</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-170"
      decimals="INF"
      id="f-586"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-170" decimals="4" id="f-587" unitRef="number">0.1095</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-170" decimals="-3" id="f-588" unitRef="usd">80440000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-170" decimals="-3" id="f-589" unitRef="usd">76623000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-170" decimals="-3" id="f-590" unitRef="usd">77290000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-170" decimals="4" id="f-591" unitRef="number">0.0156</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-171"
      decimals="INF"
      id="f-592"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-171" decimals="4" id="f-593" unitRef="number">0.1136</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-171" decimals="-3" id="f-594" unitRef="usd">33326000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-171" decimals="-3" id="f-595" unitRef="usd">32284000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-171" decimals="-3" id="f-596" unitRef="usd">32273000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-171" decimals="4" id="f-597" unitRef="number">0.0065</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-172"
      decimals="INF"
      id="f-598"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-172" decimals="4" id="f-599" unitRef="number">0.1160</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-172" decimals="-3" id="f-600" unitRef="usd">18599000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-172" decimals="-3" id="f-601" unitRef="usd">18383000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-172" decimals="-3" id="f-602" unitRef="usd">13763000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-172" decimals="4" id="f-603" unitRef="number">0.0028</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-173"
      decimals="INF"
      id="f-604"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-173" decimals="4" id="f-605" unitRef="number">0.1146</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-173" decimals="-3" id="f-606" unitRef="usd">110230000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-173" decimals="-3" id="f-607" unitRef="usd">109390000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-173" decimals="-3" id="f-608" unitRef="usd">110230000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-173" decimals="4" id="f-609" unitRef="number">0.0223</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-174" decimals="-3" id="f-610" unitRef="usd">512775000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-174" decimals="-3" id="f-611" unitRef="usd">504329000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-174" decimals="4" id="f-612" unitRef="number">0.1018</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-175"
      decimals="INF"
      id="f-613"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-175" decimals="4" id="f-614" unitRef="number">0.1125</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-175" decimals="-3" id="f-615" unitRef="usd">76971000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-175" decimals="-3" id="f-616" unitRef="usd">76054000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-175" decimals="-3" id="f-617" unitRef="usd">74470000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-175" decimals="4" id="f-618" unitRef="number">0.0150</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-176"
      decimals="INF"
      id="f-619"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-176" decimals="4" id="f-620" unitRef="number">0.1118</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-176" decimals="-3" id="f-621" unitRef="usd">18446000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-176" decimals="-3" id="f-622" unitRef="usd">18221000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-176" decimals="-3" id="f-623" unitRef="usd">17847000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-176" decimals="4" id="f-624" unitRef="number">0.0036</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-177"
      decimals="INF"
      id="f-625"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-177" decimals="4" id="f-626" unitRef="number">0.1110</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-177" decimals="-3" id="f-627" unitRef="usd">1006000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-177" decimals="-3" id="f-628" unitRef="usd">986000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-177" decimals="-3" id="f-629" unitRef="usd">1001000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-177" decimals="4" id="f-630" unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-178"
      decimals="INF"
      id="f-631"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-178" decimals="4" id="f-632" unitRef="number">0.0968</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-178" decimals="-3" id="f-633" unitRef="eur">1122000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-178" decimals="-3" id="f-634" unitRef="usd">948000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-178" decimals="-3" id="f-635" unitRef="usd">1079000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-178" decimals="4" id="f-636" unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-179"
      decimals="INF"
      id="f-637"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-179" decimals="4" id="f-638" unitRef="number">0.1095</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-179" decimals="-3" id="f-639" unitRef="usd">127544000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-179" decimals="-3" id="f-640" unitRef="usd">125771000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-179" decimals="-3" id="f-641" unitRef="usd">120848000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-179" decimals="4" id="f-642" unitRef="number">0.0244</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-180"
      decimals="INF"
      id="f-643"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-180" decimals="4" id="f-644" unitRef="number">0.1177</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-180" decimals="-3" id="f-645" unitRef="usd">143110000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-180" decimals="-3" id="f-646" unitRef="usd">141909000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-180" decimals="-3" id="f-647" unitRef="usd">143110000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-180" decimals="4" id="f-648" unitRef="number">0.0289</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-181"
      decimals="INF"
      id="f-649"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-181" decimals="4" id="f-650" unitRef="number">0.1177</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-181" decimals="-3" id="f-651" unitRef="usd">4085000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-181" decimals="-3" id="f-652" unitRef="usd">4026000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-181" decimals="-3" id="f-653" unitRef="usd">4085000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-181" decimals="4" id="f-654" unitRef="number">0.0008</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-182"
      decimals="INF"
      id="f-655"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-182" decimals="4" id="f-656" unitRef="number">0.1170</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-182" decimals="-3" id="f-657" unitRef="usd">4492000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-182" decimals="-3" id="f-658" unitRef="usd">4395000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-182" decimals="-3" id="f-659" unitRef="usd">4430000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-182" decimals="4" id="f-660" unitRef="number">0.0009</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-183"
      decimals="INF"
      id="f-661"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-183" decimals="4" id="f-662" unitRef="number">0.1172</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-183" decimals="-3" id="f-663" unitRef="usd">1098000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-183" decimals="-3" id="f-664" unitRef="usd">1062000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-183" decimals="-3" id="f-665" unitRef="usd">1075000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-183" decimals="4" id="f-666" unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-184"
      decimals="INF"
      id="f-667"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-184" decimals="4" id="f-668" unitRef="number">0.1125</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-184" decimals="-3" id="f-669" unitRef="usd">30323000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-184" decimals="-3" id="f-670" unitRef="usd">29893000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-184" decimals="-3" id="f-671" unitRef="usd">28656000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-184" decimals="4" id="f-672" unitRef="number">0.0058</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-185"
      decimals="INF"
      id="f-673"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-185" decimals="4" id="f-674" unitRef="number">0.1072</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-185" decimals="-3" id="f-675" unitRef="usd">5475000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-185" decimals="-3" id="f-676" unitRef="usd">5431000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-185" decimals="-3" id="f-677" unitRef="usd">5365000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-185" decimals="4" id="f-678" unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-186"
      decimals="INF"
      id="f-679"
      unitRef="number">0.0400</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-186" decimals="4" id="f-680" unitRef="number">0.1250</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-186" decimals="-3" id="f-681" unitRef="usd">180000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-186" decimals="-3" id="f-682" unitRef="usd">175000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-186" decimals="-3" id="f-683" unitRef="usd">167000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-186" decimals="4" id="f-684" unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-187"
      decimals="INF"
      id="f-685"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-187" decimals="4" id="f-686" unitRef="number">0.1066</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-187" decimals="-3" id="f-687" unitRef="usd">791000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-187" decimals="-3" id="f-688" unitRef="usd">785000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-187" decimals="-3" id="f-689" unitRef="usd">775000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-187" decimals="4" id="f-690" unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-188"
      decimals="INF"
      id="f-691"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-188" decimals="4" id="f-692" unitRef="number">0.0889</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-188" decimals="-3" id="f-693" unitRef="eur">1835000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-188" decimals="-3" id="f-694" unitRef="usd">2107000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-188" decimals="-3" id="f-695" unitRef="usd">1985000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-188" decimals="4" id="f-696" unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-189" decimals="-3" id="f-697" unitRef="usd">411763000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-189" decimals="-3" id="f-698" unitRef="usd">404893000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-189" decimals="4" id="f-699" unitRef="number">0.0817</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-190"
      decimals="INF"
      id="f-700"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-190" decimals="4" id="f-701" unitRef="number">0.1164</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-190" decimals="-3" id="f-702" unitRef="usd">53563000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-190" decimals="-3" id="f-703" unitRef="usd">53115000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-190" decimals="-3" id="f-704" unitRef="usd">52735000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-190" decimals="4" id="f-705" unitRef="number">0.0106</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-191"
      decimals="INF"
      id="f-706"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-191" decimals="4" id="f-707" unitRef="number">0.1135</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-191" decimals="-3" id="f-708" unitRef="usd">11318000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-191" decimals="-3" id="f-709" unitRef="usd">11272000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-191" decimals="-3" id="f-710" unitRef="usd">10215000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-191" decimals="4" id="f-711" unitRef="number">0.0021</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-192"
      decimals="INF"
      id="f-712"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-192" decimals="4" id="f-713" unitRef="number">0.1135</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-192" decimals="-3" id="f-714" unitRef="usd">77867000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-192" decimals="-3" id="f-715" unitRef="usd">77592000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-192" decimals="-3" id="f-716" unitRef="usd">70275000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-192" decimals="4" id="f-717" unitRef="number">0.0142</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-193"
      decimals="INF"
      id="f-718"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-193" decimals="4" id="f-719" unitRef="number">0.1170</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-193" decimals="-3" id="f-720" unitRef="usd">12571000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-193" decimals="-3" id="f-721" unitRef="usd">12419000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-193" decimals="-3" id="f-722" unitRef="usd">12006000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-193" decimals="4" id="f-723" unitRef="number">0.0024</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-194"
      decimals="INF"
      id="f-724"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-194" decimals="4" id="f-725" unitRef="number">0.1169</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-194" decimals="-3" id="f-726" unitRef="usd">121136000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-194" decimals="-3" id="f-727" unitRef="usd">120647000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-194" decimals="-3" id="f-728" unitRef="usd">119016000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-194" decimals="4" id="f-729" unitRef="number">0.0240</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-195"
      decimals="INF"
      id="f-730"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-195" decimals="4" id="f-731" unitRef="number">0.1200</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-195" decimals="-3" id="f-732" unitRef="usd">49997000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-195" decimals="-3" id="f-733" unitRef="usd">49498000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-195" decimals="-3" id="f-734" unitRef="usd">49997000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-195" decimals="4" id="f-735" unitRef="number">0.0101</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-196" decimals="-3" id="f-736" unitRef="usd">324543000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-196" decimals="-3" id="f-737" unitRef="usd">314244000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-196" decimals="4" id="f-738" unitRef="number">0.0634</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-197"
      decimals="INF"
      id="f-739"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-197" decimals="4" id="f-740" unitRef="number">0.1113</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-197" decimals="-3" id="f-741" unitRef="usd">8571000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-197" decimals="-3" id="f-742" unitRef="usd">8375000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-197" decimals="-3" id="f-743" unitRef="usd">8386000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-197" decimals="4" id="f-744" unitRef="number">0.0017</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-198"
      decimals="INF"
      id="f-745"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-198" decimals="4" id="f-746" unitRef="number">0.1118</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-198" decimals="-3" id="f-747" unitRef="usd">226169000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-198" decimals="-3" id="f-748" unitRef="usd">226169000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-198" decimals="-3" id="f-749" unitRef="usd">226169000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-198" decimals="4" id="f-750" unitRef="number">0.0457</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-199"
      decimals="INF"
      id="f-751"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-199" decimals="4" id="f-752" unitRef="number">0.1115</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-199" decimals="-3" id="f-753" unitRef="usd">15244000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-199" decimals="-3" id="f-754" unitRef="usd">15244000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-199" decimals="-3" id="f-755" unitRef="usd">15244000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-199" decimals="4" id="f-756" unitRef="number">0.0031</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-200"
      decimals="INF"
      id="f-757"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-200" decimals="4" id="f-758" unitRef="number">0.1134</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-200" decimals="-3" id="f-759" unitRef="usd">118756000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-200" decimals="-3" id="f-760" unitRef="usd">115999000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-200" decimals="-3" id="f-761" unitRef="usd">115897000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-200" decimals="4" id="f-762" unitRef="number">0.0234</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-201"
      decimals="INF"
      id="f-763"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-201" decimals="4" id="f-764" unitRef="number">0.1136</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-201" decimals="-3" id="f-765" unitRef="usd">25981000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-201" decimals="-3" id="f-766" unitRef="usd">25347000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-201" decimals="-3" id="f-767" unitRef="usd">25334000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-201" decimals="4" id="f-768" unitRef="number">0.0051</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-202"
      decimals="INF"
      id="f-769"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-202" decimals="4" id="f-770" unitRef="number">0.1139</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-202" decimals="-3" id="f-771" unitRef="usd">2357000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-202" decimals="-3" id="f-772" unitRef="usd">2224000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-202" decimals="-3" id="f-773" unitRef="usd">2231000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-202" decimals="4" id="f-774" unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-203"
      decimals="INF"
      id="f-775"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-203" decimals="4" id="f-776" unitRef="number">0.1160</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-203" decimals="-3" id="f-777" unitRef="usd">26242000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-203" decimals="-3" id="f-778" unitRef="usd">25409000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-203" decimals="-3" id="f-779" unitRef="usd">25377000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-203" decimals="4" id="f-780" unitRef="number">0.0051</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-204"
      decimals="INF"
      id="f-781"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-204" decimals="4" id="f-782" unitRef="number">0.1123</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-204" decimals="-3" id="f-783" unitRef="usd">5936000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-204" decimals="-3" id="f-784" unitRef="usd">5852000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-204" decimals="-3" id="f-785" unitRef="usd">5919000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-204" decimals="4" id="f-786" unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-205"
      decimals="INF"
      id="f-787"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-205" decimals="4" id="f-788" unitRef="number">0.1112</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-205" decimals="-3" id="f-789" unitRef="usd">366000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-205" decimals="-3" id="f-790" unitRef="usd">347000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-205" decimals="-3" id="f-791" unitRef="usd">353000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-205" decimals="4" id="f-792" unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-206"
      decimals="INF"
      id="f-793"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-206" decimals="4" id="f-794" unitRef="number">0.1147</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-206" decimals="-3" id="f-795" unitRef="usd">283010000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-206" decimals="-3" id="f-796" unitRef="usd">280622000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-206" decimals="-3" id="f-797" unitRef="usd">283010000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-206" decimals="4" id="f-798" unitRef="number">0.0572</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-207"
      decimals="INF"
      id="f-799"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-207" decimals="4" id="f-800" unitRef="number">0.1147</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-207" decimals="-3" id="f-801" unitRef="usd">4888000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-207" decimals="-3" id="f-802" unitRef="usd">4835000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-207" decimals="-3" id="f-803" unitRef="usd">4888000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-207" decimals="4" id="f-804" unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-208"
      decimals="INF"
      id="f-805"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-208" decimals="4" id="f-806" unitRef="number">0.1121</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-208" decimals="-3" id="f-807" unitRef="usd">6111000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-208" decimals="-3" id="f-808" unitRef="usd">5998000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-208" decimals="-3" id="f-809" unitRef="usd">6078000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-208" decimals="4" id="f-810" unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-209"
      decimals="INF"
      id="f-811"
      unitRef="number">0.0535</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-209" decimals="4" id="f-812" unitRef="number">0.1073</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-209" decimals="-3" id="f-813" unitRef="usd">20216000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-209" decimals="-3" id="f-814" unitRef="usd">19938000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-209" decimals="-3" id="f-815" unitRef="usd">20014000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-209" decimals="4" id="f-816" unitRef="number">0.0040</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-210"
      decimals="INF"
      id="f-817"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-210" decimals="4" id="f-818" unitRef="number">0.1076</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-210" decimals="-3" id="f-819" unitRef="usd">2328000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-210" decimals="-3" id="f-820" unitRef="usd">2297000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-210" decimals="-3" id="f-821" unitRef="usd">2305000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-210" decimals="4" id="f-822" unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-211"
      decimals="INF"
      id="f-823"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-211" decimals="4" id="f-824" unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-211" decimals="-3" id="f-825" unitRef="usd">10804000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-211" decimals="-3" id="f-826" unitRef="usd">10661000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-211" decimals="-3" id="f-827" unitRef="usd">10804000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-211" decimals="4" id="f-828" unitRef="number">0.0022</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-212"
      decimals="INF"
      id="f-829"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-212" decimals="4" id="f-830" unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-212" decimals="-3" id="f-831" unitRef="usd">9173000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-212" decimals="-3" id="f-832" unitRef="usd">8986000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-212" decimals="-3" id="f-833" unitRef="usd">9091000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-212" decimals="4" id="f-834" unitRef="number">0.0018</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-213"
      decimals="INF"
      id="f-835"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-213" decimals="4" id="f-836" unitRef="number">0.1164</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-213" decimals="-3" id="f-837" unitRef="usd">20641000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-213" decimals="-3" id="f-838" unitRef="usd">20327000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-213" decimals="-3" id="f-839" unitRef="usd">18680000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-213" decimals="4" id="f-840" unitRef="number">0.0038</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-214" decimals="-3" id="f-841" unitRef="usd">770255000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-214" decimals="-3" id="f-842" unitRef="usd">771394000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-214" decimals="4" id="f-843" unitRef="number">0.1559</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-215"
      decimals="INF"
      id="f-844"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-215" decimals="4" id="f-845" unitRef="number">0.1213</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-215" decimals="-3" id="f-846" unitRef="usd">13626000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-215" decimals="-3" id="f-847" unitRef="usd">13474000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-215" decimals="-3" id="f-848" unitRef="usd">12467000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-215" decimals="4" id="f-849" unitRef="number">0.0025</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-216"
      decimals="INF"
      id="f-850"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-216" decimals="4" id="f-851" unitRef="number">0.1148</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-216" decimals="-3" id="f-852" unitRef="usd">37710000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-216" decimals="-3" id="f-853" unitRef="usd">36552000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-216" decimals="-3" id="f-854" unitRef="usd">37541000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-216" decimals="4" id="f-855" unitRef="number">0.0076</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-217" decimals="-3" id="f-856" unitRef="usd">50026000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-217" decimals="-3" id="f-857" unitRef="usd">50008000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-217" decimals="4" id="f-858" unitRef="number">0.0101</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-218"
      decimals="INF"
      id="f-859"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-218" decimals="4" id="f-860" unitRef="number">0.1190</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-218" decimals="-3" id="f-861" unitRef="usd">18695000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-218" decimals="-3" id="f-862" unitRef="usd">18442000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-218" decimals="-3" id="f-863" unitRef="usd">18415000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-218" decimals="4" id="f-864" unitRef="number">0.0037</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-219"
      decimals="INF"
      id="f-865"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-219" decimals="4" id="f-866" unitRef="number">0.1190</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-219" decimals="-3" id="f-867" unitRef="usd">1975000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-219" decimals="-3" id="f-868" unitRef="usd">1928000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-219" decimals="-3" id="f-869" unitRef="usd">1945000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-219" decimals="4" id="f-870" unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-220"
      decimals="INF"
      id="f-871"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-220" decimals="4" id="f-872" unitRef="number">0.1171</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-220" decimals="-3" id="f-873" unitRef="usd">647000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-220" decimals="-3" id="f-874" unitRef="usd">622000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-220" decimals="-3" id="f-875" unitRef="usd">624000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-220" decimals="4" id="f-876" unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-221" decimals="-3" id="f-877" unitRef="usd">20992000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-221" decimals="-3" id="f-878" unitRef="usd">20984000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-221" decimals="4" id="f-879" unitRef="number">0.0042</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-222"
      decimals="INF"
      id="f-880"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-222" decimals="4" id="f-881" unitRef="number">0.1114</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-222" decimals="-3" id="f-882" unitRef="usd">7258000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-222" decimals="-3" id="f-883" unitRef="usd">7156000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-222" decimals="-3" id="f-884" unitRef="usd">6968000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-222" decimals="4" id="f-885" unitRef="number">0.0014</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-223"
      decimals="INF"
      id="f-886"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-223" decimals="4" id="f-887" unitRef="number">0.1138</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-223" decimals="-3" id="f-888" unitRef="usd">91586000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-223" decimals="-3" id="f-889" unitRef="usd">89656000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-223" decimals="-3" id="f-890" unitRef="usd">89599000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-223" decimals="4" id="f-891" unitRef="number">0.0181</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-224"
      decimals="INF"
      id="f-892"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-224" decimals="4" id="f-893" unitRef="number">0.1137</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-224" decimals="-3" id="f-894" unitRef="usd">2473000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-224" decimals="-3" id="f-895" unitRef="usd">2351000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-224" decimals="-3" id="f-896" unitRef="usd">2372000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-224" decimals="4" id="f-897" unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-225"
      decimals="INF"
      id="f-898"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-225" decimals="4" id="f-899" unitRef="number">0.1173</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-225" decimals="-3" id="f-900" unitRef="usd">70143000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-225" decimals="-3" id="f-901" unitRef="usd">69723000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-225" decimals="-3" id="f-902" unitRef="usd">70143000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-225" decimals="4" id="f-903" unitRef="number">0.0142</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-226"
      decimals="INF"
      id="f-904"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-226" decimals="4" id="f-905" unitRef="number">0.1152</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-226" decimals="-3" id="f-906" unitRef="usd">49700000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-226" decimals="-3" id="f-907" unitRef="usd">49204000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-226" decimals="-3" id="f-908" unitRef="usd">49700000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-226" decimals="4" id="f-909" unitRef="number">0.0100</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-227"
      decimals="INF"
      id="f-910"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-227" decimals="4" id="f-911" unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-227" decimals="-3" id="f-912" unitRef="usd">168219000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-227" decimals="-3" id="f-913" unitRef="usd">166461000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-227" decimals="-3" id="f-914" unitRef="usd">164014000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-227" decimals="4" id="f-915" unitRef="number">0.0331</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-228"
      decimals="INF"
      id="f-916"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-228" decimals="4" id="f-917" unitRef="number">0.1175</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-228" decimals="-3" id="f-918" unitRef="usd">4900000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-228" decimals="-3" id="f-919" unitRef="usd">4832000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-228" decimals="-3" id="f-920" unitRef="usd">4606000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-228" decimals="4" id="f-921" unitRef="number">0.0009</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-229"
      decimals="INF"
      id="f-922"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-229" decimals="4" id="f-923" unitRef="number">0.1200</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-229" decimals="-3" id="f-924" unitRef="usd">1566000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-229" decimals="-3" id="f-925" unitRef="usd">1521000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-229" decimals="-3" id="f-926" unitRef="usd">1471000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-229" decimals="4" id="f-927" unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-230"
      decimals="INF"
      id="f-928"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-230" decimals="4" id="f-929" unitRef="number">0.1177</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-230" decimals="-3" id="f-930" unitRef="usd">1578000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-230" decimals="-3" id="f-931" unitRef="usd">1564000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-230" decimals="-3" id="f-932" unitRef="usd">1483000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-230" decimals="4" id="f-933" unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-231"
      decimals="INF"
      id="f-934"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-231" decimals="4" id="f-935" unitRef="number">0.1095</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-231" decimals="-3" id="f-936" unitRef="usd">13423000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-231" decimals="-3" id="f-937" unitRef="usd">13227000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-231" decimals="-3" id="f-938" unitRef="usd">13288000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-231" decimals="4" id="f-939" unitRef="number">0.0027</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-232"
      decimals="INF"
      id="f-940"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-232" decimals="4" id="f-941" unitRef="number">0.1098</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-232" decimals="-3" id="f-942" unitRef="usd">514000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-232" decimals="-3" id="f-943" unitRef="usd">464000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-232" decimals="-3" id="f-944" unitRef="usd">480000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-232" decimals="4" id="f-945" unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-233"
      decimals="INF"
      id="f-946"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-233" decimals="4" id="f-947" unitRef="number">0.1198</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-233" decimals="-3" id="f-948" unitRef="usd">5695000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-233" decimals="-3" id="f-949" unitRef="usd">5554000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-233" decimals="-3" id="f-950" unitRef="usd">5581000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-233" decimals="4" id="f-951" unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-234"
      decimals="INF"
      id="f-952"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-234" decimals="4" id="f-953" unitRef="number">0.1198</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-234" decimals="-3" id="f-954" unitRef="usd">42312000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-234" decimals="-3" id="f-955" unitRef="usd">42179000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-234" decimals="-3" id="f-956" unitRef="usd">41465000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-234" decimals="4" id="f-957" unitRef="number">0.0084</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-235"
      decimals="INF"
      id="f-958"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-235" decimals="4" id="f-959" unitRef="number">0.1120</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-235" decimals="-3" id="f-960" unitRef="usd">94373000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-235" decimals="-3" id="f-961" unitRef="usd">93742000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-235" decimals="-3" id="f-962" unitRef="usd">92486000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-235" decimals="4" id="f-963" unitRef="number">0.0187</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-236" decimals="-3" id="f-964" unitRef="usd">547634000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-236" decimals="-3" id="f-965" unitRef="usd">543656000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-236" decimals="4" id="f-966" unitRef="number">0.1098</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-237"
      decimals="INF"
      id="f-967"
      unitRef="number">0.0675</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-237" decimals="4" id="f-968" unitRef="number">0.1156</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-237" decimals="-3" id="f-969" unitRef="gbp">26300000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-237" decimals="-3" id="f-970" unitRef="usd">35785000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-237" decimals="-3" id="f-971" unitRef="usd">33272000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-237" decimals="4" id="f-972" unitRef="number">0.0067</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-238"
      decimals="INF"
      id="f-973"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-238" decimals="4" id="f-974" unitRef="number">0.1102</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-238" decimals="-3" id="f-975" unitRef="usd">289143000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-238" decimals="-3" id="f-976" unitRef="usd">287264000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-238" decimals="-3" id="f-977" unitRef="usd">289143000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-238" decimals="4" id="f-978" unitRef="number">0.0584</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-239"
      decimals="INF"
      id="f-979"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-239" decimals="4" id="f-980" unitRef="number">0.1165</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-239" decimals="-3" id="f-981" unitRef="usd">22128000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-239" decimals="-3" id="f-982" unitRef="usd">21617000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-239" decimals="-3" id="f-983" unitRef="usd">21796000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-239" decimals="4" id="f-984" unitRef="number">0.0044</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-240"
      decimals="INF"
      id="f-985"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-240" decimals="4" id="f-986" unitRef="number">0.1164</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-240" decimals="-3" id="f-987" unitRef="usd">4073000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-240" decimals="-3" id="f-988" unitRef="usd">3912000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-240" decimals="-3" id="f-989" unitRef="usd">3944000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-240" decimals="4" id="f-990" unitRef="number">0.0008</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-241"
      decimals="INF"
      id="f-991"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-241" decimals="4" id="f-992" unitRef="number">0.1171</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-241" decimals="-3" id="f-993" unitRef="usd">22503000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-241" decimals="-3" id="f-994" unitRef="usd">22215000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-241" decimals="-3" id="f-995" unitRef="usd">21941000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-241" decimals="4" id="f-996" unitRef="number">0.0044</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-242"
      decimals="INF"
      id="f-997"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate contextRef="c-242" decimals="4" id="f-998" unitRef="number">0.1190</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-242" decimals="-3" id="f-999" unitRef="usd">804000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-242" decimals="-3" id="f-1000" unitRef="usd">784000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-242" decimals="-3" id="f-1001" unitRef="usd">802000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-242"
      decimals="4"
      id="f-1002"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-243" decimals="-3" id="f-1003" unitRef="usd">371577000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-243" decimals="-3" id="f-1004" unitRef="usd">370898000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-243"
      decimals="4"
      id="f-1005"
      unitRef="number">0.0749</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-244"
      decimals="INF"
      id="f-1006"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-244"
      decimals="4"
      id="f-1007"
      unitRef="number">0.1121</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-244" decimals="-3" id="f-1008" unitRef="usd">58939000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-244" decimals="-3" id="f-1009" unitRef="usd">58189000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-244" decimals="-3" id="f-1010" unitRef="usd">58055000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-244"
      decimals="4"
      id="f-1011"
      unitRef="number">0.0117</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-245"
      decimals="INF"
      id="f-1012"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-245"
      decimals="4"
      id="f-1013"
      unitRef="number">0.1173</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-245" decimals="-3" id="f-1014" unitRef="usd">7997000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-245" decimals="-3" id="f-1015" unitRef="usd">7796000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-245" decimals="-3" id="f-1016" unitRef="usd">7866000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-245"
      decimals="4"
      id="f-1017"
      unitRef="number">0.0016</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-246"
      decimals="INF"
      id="f-1018"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-246"
      decimals="4"
      id="f-1019"
      unitRef="number">0.1173</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-246" decimals="-3" id="f-1020" unitRef="usd">209000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-246" decimals="-3" id="f-1021" unitRef="usd">182000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-246" decimals="-3" id="f-1022" unitRef="usd">192000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-246"
      decimals="4"
      id="f-1023"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-247"
      decimals="INF"
      id="f-1024"
      unitRef="number">0.0950</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-247"
      decimals="4"
      id="f-1025"
      unitRef="number">0.1496</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-247"
      decimals="INF"
      id="f-1026"
      unitRef="number">0.0300</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-247" decimals="-3" id="f-1027" unitRef="usd">73931000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-247" decimals="-3" id="f-1028" unitRef="usd">73610000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-247" decimals="-3" id="f-1029" unitRef="usd">66538000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-247"
      decimals="4"
      id="f-1030"
      unitRef="number">0.0134</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-248" decimals="-3" id="f-1031" unitRef="usd">139777000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-248" decimals="-3" id="f-1032" unitRef="usd">132651000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-248"
      decimals="4"
      id="f-1033"
      unitRef="number">0.0267</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-249"
      decimals="INF"
      id="f-1034"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-249"
      decimals="4"
      id="f-1035"
      unitRef="number">0.1151</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-249" decimals="-3" id="f-1036" unitRef="usd">85486000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-249" decimals="-3" id="f-1037" unitRef="usd">84036000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-249" decimals="-3" id="f-1038" unitRef="usd">85486000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-249"
      decimals="4"
      id="f-1039"
      unitRef="number">0.0173</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-250"
      decimals="INF"
      id="f-1040"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-250"
      decimals="4"
      id="f-1041"
      unitRef="number">0.1146</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-250" decimals="-3" id="f-1042" unitRef="usd">38969000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-250" decimals="-3" id="f-1043" unitRef="usd">38308000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-250" decimals="-3" id="f-1044" unitRef="usd">38969000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-250"
      decimals="4"
      id="f-1045"
      unitRef="number">0.0079</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-251" decimals="-3" id="f-1046" unitRef="usd">122344000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-251" decimals="-3" id="f-1047" unitRef="usd">124455000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-251"
      decimals="4"
      id="f-1048"
      unitRef="number">0.0252</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-252"
      decimals="INF"
      id="f-1049"
      unitRef="number">0.0475</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-252"
      decimals="4"
      id="f-1050"
      unitRef="number">0.1024</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-252" decimals="-3" id="f-1051" unitRef="usd">33122000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-252" decimals="-3" id="f-1052" unitRef="usd">32692000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-252" decimals="-3" id="f-1053" unitRef="usd">31962000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-252"
      decimals="4"
      id="f-1054"
      unitRef="number">0.0065</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-253"
      decimals="INF"
      id="f-1055"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-253"
      decimals="4"
      id="f-1056"
      unitRef="number">0.1114</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-253" decimals="-3" id="f-1057" unitRef="usd">32042000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-253" decimals="-3" id="f-1058" unitRef="usd">31372000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-253" decimals="-3" id="f-1059" unitRef="usd">31515000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-253"
      decimals="4"
      id="f-1060"
      unitRef="number">0.0064</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-254" decimals="-3" id="f-1061" unitRef="usd">64064000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-254" decimals="-3" id="f-1062" unitRef="usd">63477000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-254"
      decimals="4"
      id="f-1063"
      unitRef="number">0.0129</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-255"
      decimals="INF"
      id="f-1064"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-255"
      decimals="4"
      id="f-1065"
      unitRef="number">0.1095</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-255" decimals="-3" id="f-1066" unitRef="usd">46229000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-255" decimals="-3" id="f-1067" unitRef="usd">45525000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-255" decimals="-3" id="f-1068" unitRef="usd">46064000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-255"
      decimals="4"
      id="f-1069"
      unitRef="number">0.0093</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-256"
      decimals="INF"
      id="f-1070"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-256"
      decimals="4"
      id="f-1071"
      unitRef="number">0.1128</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-256" decimals="-3" id="f-1072" unitRef="usd">61350000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-256" decimals="-3" id="f-1073" unitRef="usd">60596000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-256" decimals="-3" id="f-1074" unitRef="usd">61350000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-256"
      decimals="4"
      id="f-1075"
      unitRef="number">0.0124</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-257" decimals="-3" id="f-1076" unitRef="usd">106121000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-257" decimals="-3" id="f-1077" unitRef="usd">107414000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-257"
      decimals="4"
      id="f-1078"
      unitRef="number">0.0217</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-258"
      decimals="INF"
      id="f-1079"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-258"
      decimals="4"
      id="f-1080"
      unitRef="number">0.1146</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-258" decimals="-3" id="f-1081" unitRef="usd">78146000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-258" decimals="-3" id="f-1082" unitRef="usd">77371000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-258" decimals="-3" id="f-1083" unitRef="usd">70722000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-258"
      decimals="4"
      id="f-1084"
      unitRef="number">0.0143</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-259"
      decimals="INF"
      id="f-1085"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-259"
      decimals="4"
      id="f-1086"
      unitRef="number">0.1149</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-259" decimals="-3" id="f-1087" unitRef="usd">6327000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-259" decimals="-3" id="f-1088" unitRef="usd">6290000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-259" decimals="-3" id="f-1089" unitRef="usd">5726000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-259"
      decimals="4"
      id="f-1090"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-260"
      decimals="INF"
      id="f-1091"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-260"
      decimals="4"
      id="f-1092"
      unitRef="number">0.1152</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-260" decimals="-3" id="f-1093" unitRef="usd">23455000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-260" decimals="-3" id="f-1094" unitRef="usd">23272000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-260" decimals="-3" id="f-1095" unitRef="usd">21227000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-260"
      decimals="4"
      id="f-1096"
      unitRef="number">0.0043</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-261"
      decimals="INF"
      id="f-1097"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-261"
      decimals="4"
      id="f-1098"
      unitRef="number">0.1087</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-261" decimals="-3" id="f-1099" unitRef="usd">4004000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-261" decimals="-3" id="f-1100" unitRef="usd">3926000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-261" decimals="-3" id="f-1101" unitRef="usd">3924000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-261"
      decimals="4"
      id="f-1102"
      unitRef="number">0.0008</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-262"
      decimals="INF"
      id="f-1103"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-262"
      decimals="4"
      id="f-1104"
      unitRef="number">0.1087</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-262" decimals="-3" id="f-1105" unitRef="usd">25882000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-262" decimals="-3" id="f-1106" unitRef="usd">25577000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-262" decimals="-3" id="f-1107" unitRef="usd">25573000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-262"
      decimals="4"
      id="f-1108"
      unitRef="number">0.0052</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-263" decimals="-3" id="f-1109" unitRef="usd">136436000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-263" decimals="-3" id="f-1110" unitRef="usd">127172000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-263"
      decimals="4"
      id="f-1111"
      unitRef="number">0.0258</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-264"
      decimals="INF"
      id="f-1112"
      unitRef="number">0.0700</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-264"
      decimals="4"
      id="f-1113"
      unitRef="number">0.1246</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-264" decimals="-3" id="f-1114" unitRef="usd">17563000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-264" decimals="-3" id="f-1115" unitRef="usd">17485000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-264" decimals="-3" id="f-1116" unitRef="usd">17563000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-264"
      decimals="4"
      id="f-1117"
      unitRef="number">0.0035</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-265"
      decimals="INF"
      id="f-1118"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-265"
      decimals="4"
      id="f-1119"
      unitRef="number">0.1138</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-265" decimals="-3" id="f-1120" unitRef="usd">938000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-265" decimals="-3" id="f-1121" unitRef="usd">917000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-265" decimals="-3" id="f-1122" unitRef="usd">934000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-265"
      decimals="4"
      id="f-1123"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-266"
      decimals="INF"
      id="f-1124"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-266"
      decimals="4"
      id="f-1125"
      unitRef="number">0.1171</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-266" decimals="-3" id="f-1126" unitRef="usd">17790000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-266" decimals="-3" id="f-1127" unitRef="usd">17756000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-266" decimals="-3" id="f-1128" unitRef="usd">17790000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-266"
      decimals="4"
      id="f-1129"
      unitRef="number">0.0036</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-267" decimals="-3" id="f-1130" unitRef="usd">36158000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-267" decimals="-3" id="f-1131" unitRef="usd">36287000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-267"
      decimals="4"
      id="f-1132"
      unitRef="number">0.0073</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-268"
      decimals="INF"
      id="f-1133"
      unitRef="number">0.0675</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-268"
      decimals="4"
      id="f-1134"
      unitRef="number">0.1211</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-268" decimals="-3" id="f-1135" unitRef="usd">680000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-268" decimals="-3" id="f-1136" unitRef="usd">653000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-268" decimals="-3" id="f-1137" unitRef="usd">681000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-268"
      decimals="4"
      id="f-1138"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-269"
      decimals="INF"
      id="f-1139"
      unitRef="number">0.0638</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-269"
      decimals="4"
      id="f-1140"
      unitRef="number">0.1183</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-269" decimals="-3" id="f-1141" unitRef="usd">18355000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-269" decimals="-3" id="f-1142" unitRef="usd">18083000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-269" decimals="-3" id="f-1143" unitRef="usd">18220000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-269"
      decimals="4"
      id="f-1144"
      unitRef="number">0.0037</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-270" decimals="-3" id="f-1145" unitRef="usd">18736000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-270" decimals="-3" id="f-1146" unitRef="usd">18901000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-270"
      decimals="4"
      id="f-1147"
      unitRef="number">0.0038</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-271"
      decimals="INF"
      id="f-1148"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-271"
      decimals="4"
      id="f-1149"
      unitRef="number">0.1138</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-271" decimals="-3" id="f-1150" unitRef="usd">687000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-271" decimals="-3" id="f-1151" unitRef="usd">662000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-271" decimals="-3" id="f-1152" unitRef="usd">667000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-271"
      decimals="4"
      id="f-1153"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-272"
      decimals="INF"
      id="f-1154"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-272"
      decimals="4"
      id="f-1155"
      unitRef="number">0.0995</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-272" decimals="-3" id="f-1156" unitRef="eur">346000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-272" decimals="-3" id="f-1157" unitRef="usd">355000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-272" decimals="-3" id="f-1158" unitRef="usd">373000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-272"
      decimals="4"
      id="f-1159"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-273"
      decimals="INF"
      id="f-1160"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-273"
      decimals="4"
      id="f-1161"
      unitRef="number">0.1115</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-273" decimals="-3" id="f-1162" unitRef="usd">31059000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-273" decimals="-3" id="f-1163" unitRef="usd">30607000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-273" decimals="-3" id="f-1164" unitRef="usd">30063000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-273"
      decimals="4"
      id="f-1165"
      unitRef="number">0.0061</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-274"
      decimals="INF"
      id="f-1166"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-274"
      decimals="4"
      id="f-1167"
      unitRef="number">0.1100</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-274" decimals="-3" id="f-1168" unitRef="usd">21505000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-274" decimals="-3" id="f-1169" unitRef="usd">21240000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-274" decimals="-3" id="f-1170" unitRef="usd">21182000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-274"
      decimals="4"
      id="f-1171"
      unitRef="number">0.0043</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-275"
      decimals="INF"
      id="f-1172"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-275"
      decimals="4"
      id="f-1173"
      unitRef="number">0.1102</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-275" decimals="-3" id="f-1174" unitRef="usd">5445000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-275" decimals="-3" id="f-1175" unitRef="usd">5387000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-275" decimals="-3" id="f-1176" unitRef="usd">5363000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-275"
      decimals="4"
      id="f-1177"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-276" decimals="-3" id="f-1178" unitRef="usd">58251000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-276" decimals="-3" id="f-1179" unitRef="usd">57648000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-276"
      decimals="4"
      id="f-1180"
      unitRef="number">0.0117</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-277"
      decimals="INF"
      id="f-1181"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-277"
      decimals="4"
      id="f-1182"
      unitRef="number">0.1094</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-277" decimals="-3" id="f-1183" unitRef="cad">1935000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-277" decimals="-3" id="f-1184" unitRef="usd">1423000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-277" decimals="-3" id="f-1185" unitRef="usd">1389000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-277"
      decimals="4"
      id="f-1186"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-278"
      decimals="INF"
      id="f-1187"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-278"
      decimals="4"
      id="f-1188"
      unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-278" decimals="-3" id="f-1189" unitRef="usd">115646000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-278" decimals="-3" id="f-1190" unitRef="usd">113844000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-278" decimals="-3" id="f-1191" unitRef="usd">114347000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-278"
      decimals="4"
      id="f-1192"
      unitRef="number">0.0231</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-279"
      decimals="INF"
      id="f-1193"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-279"
      decimals="4"
      id="f-1194"
      unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-279" decimals="-3" id="f-1195" unitRef="usd">1735000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-279" decimals="-3" id="f-1196" unitRef="usd">1597000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-279" decimals="-3" id="f-1197" unitRef="usd">1619000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-279"
      decimals="4"
      id="f-1198"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-280"
      decimals="INF"
      id="f-1199"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-280"
      decimals="4"
      id="f-1200"
      unitRef="number">0.1179</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-280" decimals="-3" id="f-1201" unitRef="usd">6849000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-280" decimals="-3" id="f-1202" unitRef="usd">6772000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-280" decimals="-3" id="f-1203" unitRef="usd">6849000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-280"
      decimals="4"
      id="f-1204"
      unitRef="number">0.0014</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-281"
      decimals="INF"
      id="f-1205"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-281"
      decimals="4"
      id="f-1206"
      unitRef="number">0.1153</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-281" decimals="-3" id="f-1207" unitRef="usd">1641000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-281" decimals="-3" id="f-1208" unitRef="usd">1614000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-281" decimals="-3" id="f-1209" unitRef="usd">1615000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-281"
      decimals="4"
      id="f-1210"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-282"
      decimals="INF"
      id="f-1211"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-282"
      decimals="4"
      id="f-1212"
      unitRef="number">0.1100</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-282" decimals="-3" id="f-1213" unitRef="usd">1341000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-282" decimals="-3" id="f-1214" unitRef="usd">1307000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-282" decimals="-3" id="f-1215" unitRef="usd">1341000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-282"
      decimals="4"
      id="f-1216"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-283"
      decimals="INF"
      id="f-1217"
      unitRef="number">0.0535</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-283"
      decimals="4"
      id="f-1218"
      unitRef="number">0.1100</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-283" decimals="-3" id="f-1219" unitRef="usd">4259000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-283" decimals="-3" id="f-1220" unitRef="usd">4201000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-283" decimals="-3" id="f-1221" unitRef="usd">4259000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-283"
      decimals="4"
      id="f-1222"
      unitRef="number">0.0009</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-284"
      decimals="INF"
      id="f-1223"
      unitRef="number">0.0450</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-284"
      decimals="4"
      id="f-1224"
      unitRef="number">0.0993</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-284" decimals="-3" id="f-1225" unitRef="cad">29628000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-284" decimals="-3" id="f-1226" unitRef="usd">23468000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-284" decimals="-3" id="f-1227" unitRef="usd">25356000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-284"
      decimals="4"
      id="f-1228"
      unitRef="number">0.0051</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-285"
      decimals="INF"
      id="f-1229"
      unitRef="number">0.0450</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-285"
      decimals="4"
      id="f-1230"
      unitRef="number">0.0993</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-285" decimals="-3" id="f-1231" unitRef="cad">3600000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-285" decimals="-3" id="f-1232" unitRef="usd">2851000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-285" decimals="-3" id="f-1233" unitRef="usd">2683000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-285"
      decimals="4"
      id="f-1234"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-286"
      decimals="INF"
      id="f-1235"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-286"
      decimals="4"
      id="f-1236"
      unitRef="number">0.1170</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-286"
      decimals="INF"
      id="f-1237"
      unitRef="number">0.0275</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-286" decimals="-3" id="f-1238" unitRef="usd">10643000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-286" decimals="-3" id="f-1239" unitRef="usd">10492000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-286" decimals="-3" id="f-1240" unitRef="usd">9046000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-286"
      decimals="4"
      id="f-1241"
      unitRef="number">0.0018</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-287"
      decimals="INF"
      id="f-1242"
      unitRef="number">0.0641</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-287"
      decimals="4"
      id="f-1243"
      unitRef="number">0.1175</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-287" decimals="-3" id="f-1244" unitRef="usd">32866000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-287" decimals="-3" id="f-1245" unitRef="usd">32623000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-287" decimals="-3" id="f-1246" unitRef="usd">32620000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-287"
      decimals="4"
      id="f-1247"
      unitRef="number">0.0066</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-288"
      decimals="INF"
      id="f-1248"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-288"
      decimals="4"
      id="f-1249"
      unitRef="number">0.1185</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-288" decimals="-3" id="f-1250" unitRef="usd">995000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-288" decimals="-3" id="f-1251" unitRef="usd">983000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-288" decimals="-3" id="f-1252" unitRef="usd">990000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-288"
      decimals="4"
      id="f-1253"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-289"
      decimals="INF"
      id="f-1254"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-289"
      decimals="4"
      id="f-1255"
      unitRef="number">0.1155</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-289" decimals="-3" id="f-1256" unitRef="usd">24054000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-289" decimals="-3" id="f-1257" unitRef="usd">23952000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-289" decimals="-3" id="f-1258" unitRef="usd">23934000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-289"
      decimals="4"
      id="f-1259"
      unitRef="number">0.0048</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-290"
      decimals="INF"
      id="f-1260"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-290"
      decimals="4"
      id="f-1261"
      unitRef="number">0.1045</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-290" decimals="-3" id="f-1262" unitRef="usd">153682000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-290" decimals="-3" id="f-1263" unitRef="usd">151942000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-290" decimals="-3" id="f-1264" unitRef="usd">146766000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-290"
      decimals="4"
      id="f-1265"
      unitRef="number">0.0296</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-291"
      decimals="INF"
      id="f-1266"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-291"
      decimals="4"
      id="f-1267"
      unitRef="number">0.1143</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-291" decimals="-3" id="f-1268" unitRef="usd">6872000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-291" decimals="-3" id="f-1269" unitRef="usd">6687000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-291" decimals="-3" id="f-1270" unitRef="usd">6685000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-291"
      decimals="4"
      id="f-1271"
      unitRef="number">0.0013</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-292"
      decimals="INF"
      id="f-1272"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-292"
      decimals="4"
      id="f-1273"
      unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-292" decimals="-3" id="f-1274" unitRef="usd">235327000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-292" decimals="-3" id="f-1275" unitRef="usd">234002000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-292" decimals="-3" id="f-1276" unitRef="usd">218854000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-292"
      decimals="4"
      id="f-1277"
      unitRef="number">0.0442</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-293"
      decimals="INF"
      id="f-1278"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-293"
      decimals="4"
      id="f-1279"
      unitRef="number">0.1113</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-293" decimals="-3" id="f-1280" unitRef="usd">17037000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-293" decimals="-3" id="f-1281" unitRef="usd">16951000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-293" decimals="-3" id="f-1282" unitRef="usd">17037000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-293"
      decimals="4"
      id="f-1283"
      unitRef="number">0.0034</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-294"
      decimals="INF"
      id="f-1284"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-294"
      decimals="4"
      id="f-1285"
      unitRef="number">0.1114</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-294" decimals="-3" id="f-1286" unitRef="usd">1635000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-294" decimals="-3" id="f-1287" unitRef="usd">1623000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-294" decimals="-3" id="f-1288" unitRef="usd">1635000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-294"
      decimals="4"
      id="f-1289"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-295"
      decimals="INF"
      id="f-1290"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-295"
      decimals="4"
      id="f-1291"
      unitRef="number">0.1114</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-295" decimals="-3" id="f-1292" unitRef="usd">1987000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-295" decimals="-3" id="f-1293" unitRef="usd">1960000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-295" decimals="-3" id="f-1294" unitRef="usd">1971000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-295"
      decimals="4"
      id="f-1295"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-296"
      decimals="INF"
      id="f-1296"
      unitRef="number">0.0590</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-296"
      decimals="4"
      id="f-1297"
      unitRef="number">0.1130</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-296" decimals="-3" id="f-1298" unitRef="usd">10858000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-296" decimals="-3" id="f-1299" unitRef="usd">10630000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-296" decimals="-3" id="f-1300" unitRef="usd">10571000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-296"
      decimals="4"
      id="f-1301"
      unitRef="number">0.0021</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-297"
      decimals="INF"
      id="f-1302"
      unitRef="number">0.0675</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-297"
      decimals="4"
      id="f-1303"
      unitRef="number">0.1265</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-297" decimals="-3" id="f-1304" unitRef="usd">313944000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-297" decimals="-3" id="f-1305" unitRef="usd">309682000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-297" decimals="-3" id="f-1306" unitRef="usd">302719000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-297"
      decimals="4"
      id="f-1307"
      unitRef="number">0.0611</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-298"
      decimals="INF"
      id="f-1308"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-298"
      decimals="4"
      id="f-1309"
      unitRef="number">0.1141</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-298" decimals="-3" id="f-1310" unitRef="usd">12054000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-298" decimals="-3" id="f-1311" unitRef="usd">11813000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-298" decimals="-3" id="f-1312" unitRef="usd">11592000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-298"
      decimals="4"
      id="f-1313"
      unitRef="number">0.0023</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-299"
      decimals="INF"
      id="f-1314"
      unitRef="number">0.0400</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-299"
      decimals="4"
      id="f-1315"
      unitRef="number">0.0946</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-299" decimals="-3" id="f-1316" unitRef="usd">182000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-299" decimals="-3" id="f-1317" unitRef="usd">167000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-299" decimals="-3" id="f-1318" unitRef="usd">146000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-299"
      decimals="4"
      id="f-1319"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-300"
      decimals="INF"
      id="f-1320"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-300"
      decimals="4"
      id="f-1321"
      unitRef="number">0.1120</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-300" decimals="-3" id="f-1322" unitRef="usd">2721000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-300" decimals="-3" id="f-1323" unitRef="usd">2678000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-300" decimals="-3" id="f-1324" unitRef="usd">2626000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-300"
      decimals="4"
      id="f-1325"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-301"
      decimals="INF"
      id="f-1326"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-301"
      decimals="4"
      id="f-1327"
      unitRef="number">0.1136</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-301" decimals="-3" id="f-1328" unitRef="usd">5199000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-301" decimals="-3" id="f-1329" unitRef="usd">5130000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-301" decimals="-3" id="f-1330" unitRef="usd">4913000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-301"
      decimals="4"
      id="f-1331"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-302"
      decimals="INF"
      id="f-1332"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-302"
      decimals="4"
      id="f-1333"
      unitRef="number">0.1124</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-302" decimals="-3" id="f-1334" unitRef="cad">4925000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-302" decimals="-3" id="f-1335" unitRef="usd">3810000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-302" decimals="-3" id="f-1336" unitRef="usd">3512000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-302"
      decimals="4"
      id="f-1337"
      unitRef="number">0.0007</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-303"
      decimals="INF"
      id="f-1338"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-303"
      decimals="4"
      id="f-1339"
      unitRef="number">0.1125</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-303" decimals="-3" id="f-1340" unitRef="cad">313000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-303" decimals="-3" id="f-1341" unitRef="usd">142000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-303" decimals="-3" id="f-1342" unitRef="usd">121000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-303"
      decimals="4"
      id="f-1343"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-304"
      decimals="INF"
      id="f-1344"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-304"
      decimals="4"
      id="f-1345"
      unitRef="number">0.1178</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-304" decimals="-3" id="f-1346" unitRef="usd">4942000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-304" decimals="-3" id="f-1347" unitRef="usd">4826000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-304" decimals="-3" id="f-1348" unitRef="usd">4942000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-304"
      decimals="4"
      id="f-1349"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-305"
      decimals="INF"
      id="f-1350"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-305"
      decimals="4"
      id="f-1351"
      unitRef="number">0.1115</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-305" decimals="-3" id="f-1352" unitRef="usd">1095000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-305" decimals="-3" id="f-1353" unitRef="usd">1079000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-305" decimals="-3" id="f-1354" unitRef="usd">1068000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-305"
      decimals="4"
      id="f-1355"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-306"
      decimals="INF"
      id="f-1356"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-306"
      decimals="4"
      id="f-1357"
      unitRef="number">0.1113</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-306" decimals="-3" id="f-1358" unitRef="usd">1505000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-306" decimals="-3" id="f-1359" unitRef="usd">1479000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-306" decimals="-3" id="f-1360" unitRef="usd">1463000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-306"
      decimals="4"
      id="f-1361"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-307"
      decimals="INF"
      id="f-1362"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-307"
      decimals="4"
      id="f-1363"
      unitRef="number">0.1061</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-307" decimals="-3" id="f-1364" unitRef="usd">2102000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-307" decimals="-3" id="f-1365" unitRef="usd">2102000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-307" decimals="-3" id="f-1366" unitRef="usd">2102000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-307"
      decimals="4"
      id="f-1367"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-308"
      decimals="INF"
      id="f-1368"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-308"
      decimals="4"
      id="f-1369"
      unitRef="number">0.1147</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-308" decimals="-3" id="f-1370" unitRef="usd">31780000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-308" decimals="-3" id="f-1371" unitRef="usd">31369000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-308" decimals="-3" id="f-1372" unitRef="usd">31065000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-308"
      decimals="4"
      id="f-1373"
      unitRef="number">0.0063</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-309"
      decimals="INF"
      id="f-1374"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-309"
      decimals="4"
      id="f-1375"
      unitRef="number">0.1145</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-309" decimals="-3" id="f-1376" unitRef="usd">16674000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-309" decimals="-3" id="f-1377" unitRef="usd">15958000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-309" decimals="-3" id="f-1378" unitRef="usd">15734000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-309"
      decimals="4"
      id="f-1379"
      unitRef="number">0.0032</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-310"
      decimals="INF"
      id="f-1380"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-310"
      decimals="4"
      id="f-1381"
      unitRef="number">0.1136</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-310" decimals="-3" id="f-1382" unitRef="usd">43309000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-310" decimals="-3" id="f-1383" unitRef="usd">42785000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-310" decimals="-3" id="f-1384" unitRef="usd">26419000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-310"
      decimals="4"
      id="f-1385"
      unitRef="number">0.0053</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-311"
      decimals="INF"
      id="f-1386"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-311"
      decimals="4"
      id="f-1387"
      unitRef="number">0.1136</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-311" decimals="-3" id="f-1388" unitRef="usd">6706000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-311" decimals="-3" id="f-1389" unitRef="usd">6640000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-311" decimals="-3" id="f-1390" unitRef="usd">4084000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-311"
      decimals="4"
      id="f-1391"
      unitRef="number">0.0008</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-312" decimals="-3" id="f-1392" unitRef="usd">1088582000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-312" decimals="-3" id="f-1393" unitRef="usd">1042073000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-312"
      decimals="4"
      id="f-1394"
      unitRef="number">0.2100</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-313"
      decimals="INF"
      id="f-1395"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-313"
      decimals="4"
      id="f-1396"
      unitRef="number">0.1085</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-313" decimals="-3" id="f-1397" unitRef="usd">9887000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-313" decimals="-3" id="f-1398" unitRef="usd">9735000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-313" decimals="-3" id="f-1399" unitRef="usd">9788000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-313"
      decimals="4"
      id="f-1400"
      unitRef="number">0.0020</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-314"
      decimals="INF"
      id="f-1401"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-314"
      decimals="4"
      id="f-1402"
      unitRef="number">0.1110</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-314" decimals="-3" id="f-1403" unitRef="usd">3163000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-314" decimals="-3" id="f-1404" unitRef="usd">3106000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-314" decimals="-3" id="f-1405" unitRef="usd">3163000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-314"
      decimals="4"
      id="f-1406"
      unitRef="number">0.0006</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-315"
      decimals="INF"
      id="f-1407"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-315"
      decimals="4"
      id="f-1408"
      unitRef="number">0.1121</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-315" decimals="-3" id="f-1409" unitRef="usd">809000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-315" decimals="-3" id="f-1410" unitRef="usd">789000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-315" decimals="-3" id="f-1411" unitRef="usd">791000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-315"
      decimals="4"
      id="f-1412"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-316"
      decimals="INF"
      id="f-1413"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-316"
      decimals="4"
      id="f-1414"
      unitRef="number">0.1095</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-316" decimals="-3" id="f-1415" unitRef="usd">20160000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-316" decimals="-3" id="f-1416" unitRef="usd">19742000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-316" decimals="-3" id="f-1417" unitRef="usd">20160000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-316"
      decimals="4"
      id="f-1418"
      unitRef="number">0.0041</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-317"
      decimals="INF"
      id="f-1419"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-317"
      decimals="4"
      id="f-1420"
      unitRef="number">0.1110</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-317" decimals="-3" id="f-1421" unitRef="usd">13447000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-317" decimals="-3" id="f-1422" unitRef="usd">13296000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-317" decimals="-3" id="f-1423" unitRef="usd">13447000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-317"
      decimals="4"
      id="f-1424"
      unitRef="number">0.0027</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-318"
      decimals="INF"
      id="f-1425"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-318"
      decimals="4"
      id="f-1426"
      unitRef="number">0.1110</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-318" decimals="-3" id="f-1427" unitRef="usd">216910000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-318" decimals="-3" id="f-1428" unitRef="usd">214450000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-318" decimals="-3" id="f-1429" unitRef="usd">216910000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-318"
      decimals="4"
      id="f-1430"
      unitRef="number">0.0438</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-319"
      decimals="INF"
      id="f-1431"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-319"
      decimals="4"
      id="f-1432"
      unitRef="number">0.1125</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-319" decimals="-3" id="f-1433" unitRef="usd">15726000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-319" decimals="-3" id="f-1434" unitRef="usd">15515000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-319" decimals="-3" id="f-1435" unitRef="usd">15726000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-319"
      decimals="4"
      id="f-1436"
      unitRef="number">0.0032</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-320"
      decimals="INF"
      id="f-1437"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-320"
      decimals="4"
      id="f-1438"
      unitRef="number">0.1125</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-320" decimals="-3" id="f-1439" unitRef="usd">720000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-320" decimals="-3" id="f-1440" unitRef="usd">705000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-320" decimals="-3" id="f-1441" unitRef="usd">720000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-320"
      decimals="4"
      id="f-1442"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-321"
      decimals="INF"
      id="f-1443"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-321"
      decimals="4"
      id="f-1444"
      unitRef="number">0.1112</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-321" decimals="-3" id="f-1445" unitRef="usd">98500000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-321" decimals="-3" id="f-1446" unitRef="usd">97540000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-321" decimals="-3" id="f-1447" unitRef="usd">97515000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-321"
      decimals="4"
      id="f-1448"
      unitRef="number">0.0197</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-322"
      decimals="INF"
      id="f-1449"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-322"
      decimals="4"
      id="f-1450"
      unitRef="number">0.1150</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-322" decimals="-3" id="f-1451" unitRef="usd">7000000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-322" decimals="-3" id="f-1452" unitRef="usd">6811000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-322" decimals="-3" id="f-1453" unitRef="usd">6841000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-322"
      decimals="4"
      id="f-1454"
      unitRef="number">0.0014</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-323"
      decimals="INF"
      id="f-1455"
      unitRef="number">0.0609</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-323"
      decimals="4"
      id="f-1456"
      unitRef="number">0.1164</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-323" decimals="-3" id="f-1457" unitRef="usd">71173000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-323" decimals="-3" id="f-1458" unitRef="usd">69903000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-323" decimals="-3" id="f-1459" unitRef="usd">71173000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-323"
      decimals="4"
      id="f-1460"
      unitRef="number">0.0144</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-324"
      decimals="INF"
      id="f-1461"
      unitRef="number">0.0609</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-324"
      decimals="4"
      id="f-1462"
      unitRef="number">0.1163</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-324" decimals="-3" id="f-1463" unitRef="usd">14758000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-324" decimals="-3" id="f-1464" unitRef="usd">14579000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-324" decimals="-3" id="f-1465" unitRef="usd">14719000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-324"
      decimals="4"
      id="f-1466"
      unitRef="number">0.0030</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-325"
      decimals="INF"
      id="f-1467"
      unitRef="number">0.0325</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-325"
      decimals="4"
      id="f-1468"
      unitRef="number">0.0872</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-325" decimals="-3" id="f-1469" unitRef="usd">8375000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-325" decimals="-3" id="f-1470" unitRef="usd">8178000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-325" decimals="-3" id="f-1471" unitRef="usd">8201000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-325"
      decimals="4"
      id="f-1472"
      unitRef="number">0.0017</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-326"
      decimals="INF"
      id="f-1473"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-326"
      decimals="4"
      id="f-1474"
      unitRef="number">0.1125</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-326" decimals="-3" id="f-1475" unitRef="usd">7388000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-326" decimals="-3" id="f-1476" unitRef="usd">7283000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-326" decimals="-3" id="f-1477" unitRef="usd">7388000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-326"
      decimals="4"
      id="f-1478"
      unitRef="number">0.0015</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-327"
      decimals="INF"
      id="f-1479"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-327"
      decimals="4"
      id="f-1480"
      unitRef="number">0.1125</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-327" decimals="-3" id="f-1481" unitRef="usd">1961000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-327" decimals="-3" id="f-1482" unitRef="usd">1947000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-327" decimals="-3" id="f-1483" unitRef="usd">1961000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-327"
      decimals="4"
      id="f-1484"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-328" decimals="-3" id="f-1485" unitRef="usd">483579000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-328" decimals="-3" id="f-1486" unitRef="usd">488503000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-328"
      decimals="4"
      id="f-1487"
      unitRef="number">0.0988</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-329"
      decimals="INF"
      id="f-1488"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-329"
      decimals="4"
      id="f-1489"
      unitRef="number">0.1146</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-329" decimals="-3" id="f-1490" unitRef="usd">3666000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-329" decimals="-3" id="f-1491" unitRef="usd">3635000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-329" decimals="-3" id="f-1492" unitRef="usd">3659000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-329"
      decimals="4"
      id="f-1493"
      unitRef="number">0.0007</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-330"
      decimals="INF"
      id="f-1494"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-330"
      decimals="4"
      id="f-1495"
      unitRef="number">0.1114</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-330" decimals="-3" id="f-1496" unitRef="usd">2154000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-330" decimals="-3" id="f-1497" unitRef="usd">2110000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-330" decimals="-3" id="f-1498" unitRef="usd">2145000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-330"
      decimals="4"
      id="f-1499"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-331"
      decimals="INF"
      id="f-1500"
      unitRef="number">0.0000</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-331"
      decimals="4"
      id="f-1501"
      unitRef="number">0.0000</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-331" decimals="-3" id="f-1502" unitRef="usd">9566000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-331" decimals="-3" id="f-1503" unitRef="usd">1397000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-331" decimals="-3" id="f-1504" unitRef="usd">68000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-331"
      decimals="4"
      id="f-1505"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-332"
      decimals="INF"
      id="f-1506"
      unitRef="number">0.1000</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-332"
      decimals="INF"
      id="f-1507"
      unitRef="number">0.1000</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-332" decimals="-3" id="f-1508" unitRef="usd">5419000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-332" decimals="-3" id="f-1509" unitRef="usd">5475000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-332" decimals="-3" id="f-1510" unitRef="usd">5419000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-332"
      decimals="4"
      id="f-1511"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-333"
      decimals="INF"
      id="f-1512"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-333"
      decimals="4"
      id="f-1513"
      unitRef="number">0.1145</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-333" decimals="-3" id="f-1514" unitRef="usd">15985000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-333" decimals="-3" id="f-1515" unitRef="usd">15729000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-333" decimals="-3" id="f-1516" unitRef="usd">15880000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-333"
      decimals="4"
      id="f-1517"
      unitRef="number">0.0032</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-334"
      decimals="INF"
      id="f-1518"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-334"
      decimals="4"
      id="f-1519"
      unitRef="number">0.1070</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-334" decimals="-3" id="f-1520" unitRef="usd">12247000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-334" decimals="-3" id="f-1521" unitRef="usd">12131000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-334" decimals="-3" id="f-1522" unitRef="usd">12032000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-334"
      decimals="4"
      id="f-1523"
      unitRef="number">0.0024</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-335"
      decimals="INF"
      id="f-1524"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-335"
      decimals="4"
      id="f-1525"
      unitRef="number">0.1125</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-335" decimals="-3" id="f-1526" unitRef="usd">52366000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-335" decimals="-3" id="f-1527" unitRef="usd">51711000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-335" decimals="-3" id="f-1528" unitRef="usd">52366000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-335"
      decimals="4"
      id="f-1529"
      unitRef="number">0.0106</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-336"
      decimals="INF"
      id="f-1530"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-336"
      decimals="4"
      id="f-1531"
      unitRef="number">0.1125</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-336" decimals="-3" id="f-1532" unitRef="usd">11285000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-336" decimals="-3" id="f-1533" unitRef="usd">11028000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-336" decimals="-3" id="f-1534" unitRef="usd">11146000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-336"
      decimals="4"
      id="f-1535"
      unitRef="number">0.0023</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-337"
      decimals="INF"
      id="f-1536"
      unitRef="number">0.0605</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-337"
      decimals="4"
      id="f-1537"
      unitRef="number">0.1154</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-337" decimals="-3" id="f-1538" unitRef="usd">139430000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-337" decimals="-3" id="f-1539" unitRef="usd">138357000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-337" decimals="-3" id="f-1540" unitRef="usd">138022000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-337"
      decimals="4"
      id="f-1541"
      unitRef="number">0.0279</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-338"
      decimals="INF"
      id="f-1542"
      unitRef="number">0.0602</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-338"
      decimals="4"
      id="f-1543"
      unitRef="number">0.1141</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-338" decimals="-3" id="f-1544" unitRef="usd">1880000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-338" decimals="-3" id="f-1545" unitRef="usd">1856000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-338" decimals="-3" id="f-1546" unitRef="usd">1862000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-338"
      decimals="4"
      id="f-1547"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-339"
      decimals="INF"
      id="f-1548"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-339"
      decimals="4"
      id="f-1549"
      unitRef="number">0.1139</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-339" decimals="-3" id="f-1550" unitRef="usd">1281000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-339" decimals="-3" id="f-1551" unitRef="usd">1194000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-339" decimals="-3" id="f-1552" unitRef="usd">1098000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-339"
      decimals="4"
      id="f-1553"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-340"
      decimals="INF"
      id="f-1554"
      unitRef="number">0.0603</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-340"
      decimals="4"
      id="f-1555"
      unitRef="number">0.1152</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-340" decimals="-3" id="f-1556" unitRef="usd">4039000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-340" decimals="-3" id="f-1557" unitRef="usd">4006000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-340" decimals="-3" id="f-1558" unitRef="usd">3998000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-340"
      decimals="4"
      id="f-1559"
      unitRef="number">0.0008</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-341"
      decimals="INF"
      id="f-1560"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-341"
      decimals="4"
      id="f-1561"
      unitRef="number">0.1093</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-341" decimals="-3" id="f-1562" unitRef="usd">4591000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-341" decimals="-3" id="f-1563" unitRef="usd">4546000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-341" decimals="-3" id="f-1564" unitRef="usd">4522000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-341"
      decimals="4"
      id="f-1565"
      unitRef="number">0.0009</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-342"
      decimals="INF"
      id="f-1566"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-342"
      decimals="4"
      id="f-1567"
      unitRef="number">0.1110</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-342" decimals="-3" id="f-1568" unitRef="usd">302000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-342" decimals="-3" id="f-1569" unitRef="usd">252000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-342" decimals="-3" id="f-1570" unitRef="usd">249000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-342"
      decimals="4"
      id="f-1571"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-343"
      decimals="INF"
      id="f-1572"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-343"
      decimals="4"
      id="f-1573"
      unitRef="number">0.1098</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-343" decimals="-3" id="f-1574" unitRef="usd">104974000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-343" decimals="-3" id="f-1575" unitRef="usd">104154000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-343" decimals="-3" id="f-1576" unitRef="usd">103662000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-343"
      decimals="4"
      id="f-1577"
      unitRef="number">0.0209</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-344"
      decimals="INF"
      id="f-1578"
      unitRef="number">0.0634</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-344"
      decimals="4"
      id="f-1579"
      unitRef="number">0.1172</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-344" decimals="-3" id="f-1580" unitRef="usd">5079000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-344" decimals="-3" id="f-1581" unitRef="usd">4947000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-344" decimals="-3" id="f-1582" unitRef="usd">5053000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-344"
      decimals="4"
      id="f-1583"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-345"
      decimals="INF"
      id="f-1584"
      unitRef="number">0.0700</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-345"
      decimals="4"
      id="f-1585"
      unitRef="number">0.1097</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-345"
      decimals="INF"
      id="f-1586"
      unitRef="number">0.0250</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-345" decimals="-3" id="f-1587" unitRef="eur">1835000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-345" decimals="-3" id="f-1588" unitRef="usd">1912000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-345" decimals="-3" id="f-1589" unitRef="usd">2010000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-345"
      decimals="4"
      id="f-1590"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-346"
      decimals="INF"
      id="f-1591"
      unitRef="number">0.0710</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-346"
      decimals="4"
      id="f-1592"
      unitRef="number">0.1253</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-346"
      decimals="INF"
      id="f-1593"
      unitRef="number">0.0250</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-346" decimals="-3" id="f-1594" unitRef="usd">54713000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-346" decimals="-3" id="f-1595" unitRef="usd">53656000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-346" decimals="-3" id="f-1596" unitRef="usd">54303000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-346"
      decimals="4"
      id="f-1597"
      unitRef="number">0.0110</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-347"
      decimals="INF"
      id="f-1598"
      unitRef="number">0.0710</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-347"
      decimals="4"
      id="f-1599"
      unitRef="number">0.1243</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-347"
      decimals="INF"
      id="f-1600"
      unitRef="number">0.0250</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-347" decimals="-3" id="f-1601" unitRef="usd">16298000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-347" decimals="-3" id="f-1602" unitRef="usd">16122000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-347" decimals="-3" id="f-1603" unitRef="usd">16176000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-347"
      decimals="4"
      id="f-1604"
      unitRef="number">0.0033</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-348"
      decimals="INF"
      id="f-1605"
      unitRef="number">0.0728</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-348"
      decimals="4"
      id="f-1606"
      unitRef="number">0.1221</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-348"
      decimals="INF"
      id="f-1607"
      unitRef="number">0.0250</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-348" decimals="-3" id="f-1608" unitRef="gbp">43764000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-348" decimals="-3" id="f-1609" unitRef="usd">59538000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-348" decimals="-3" id="f-1610" unitRef="usd">55366000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-348"
      decimals="4"
      id="f-1611"
      unitRef="number">0.0112</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-349"
      decimals="INF"
      id="f-1612"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-349"
      decimals="4"
      id="f-1613"
      unitRef="number">0.1142</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-349" decimals="-3" id="f-1614" unitRef="usd">38208000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-349" decimals="-3" id="f-1615" unitRef="usd">36970000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-349" decimals="-3" id="f-1616" unitRef="usd">36914000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-349"
      decimals="4"
      id="f-1617"
      unitRef="number">0.0075</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-350" decimals="-3" id="f-1618" unitRef="usd">530726000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-350" decimals="-3" id="f-1619" unitRef="usd">525950000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-350"
      decimals="4"
      id="f-1620"
      unitRef="number">0.1063</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-351"
      decimals="INF"
      id="f-1621"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-351"
      decimals="4"
      id="f-1622"
      unitRef="number">0.1159</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-351" decimals="-3" id="f-1623" unitRef="usd">319179000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-351" decimals="-3" id="f-1624" unitRef="usd">315538000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-351" decimals="-3" id="f-1625" unitRef="usd">319179000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-351"
      decimals="4"
      id="f-1626"
      unitRef="number">0.0645</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-352"
      decimals="INF"
      id="f-1627"
      unitRef="number">0.0975</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-352"
      decimals="INF"
      id="f-1628"
      unitRef="number">0.0975</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-352" decimals="-3" id="f-1629" unitRef="usd">965000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-352" decimals="-3" id="f-1630" unitRef="usd">948000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-352" decimals="-3" id="f-1631" unitRef="usd">960000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-352"
      decimals="4"
      id="f-1632"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-353"
      decimals="INF"
      id="f-1633"
      unitRef="number">0.0518</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-353"
      decimals="4"
      id="f-1634"
      unitRef="number">0.1043</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-353" decimals="-3" id="f-1635" unitRef="usd">6612000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-353" decimals="-3" id="f-1636" unitRef="usd">6522000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-353" decimals="-3" id="f-1637" unitRef="usd">6612000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-353"
      decimals="4"
      id="f-1638"
      unitRef="number">0.0013</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-354"
      decimals="INF"
      id="f-1639"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-354"
      decimals="4"
      id="f-1640"
      unitRef="number">0.1125</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-354" decimals="-3" id="f-1641" unitRef="usd">4925000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-354" decimals="-3" id="f-1642" unitRef="usd">4855000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-354" decimals="-3" id="f-1643" unitRef="usd">4408000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-354"
      decimals="4"
      id="f-1644"
      unitRef="number">0.0009</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-355"
      decimals="INF"
      id="f-1645"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-355"
      decimals="4"
      id="f-1646"
      unitRef="number">0.1172</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-355"
      decimals="INF"
      id="f-1647"
      unitRef="number">0.0275</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-355" decimals="-3" id="f-1648" unitRef="usd">109741000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-355" decimals="-3" id="f-1649" unitRef="usd">107835000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-355" decimals="-3" id="f-1650" unitRef="usd">109329000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-355"
      decimals="4"
      id="f-1651"
      unitRef="number">0.0221</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-356"
      decimals="INF"
      id="f-1652"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-356"
      decimals="4"
      id="f-1653"
      unitRef="number">0.1004</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-356" decimals="-3" id="f-1654" unitRef="sek">2090000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-356" decimals="-3" id="f-1655" unitRef="usd">184000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-356" decimals="-3" id="f-1656" unitRef="usd">206000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-356"
      decimals="4"
      id="f-1657"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-357"
      decimals="INF"
      id="f-1658"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-357"
      decimals="4"
      id="f-1659"
      unitRef="number">0.0993</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-357" decimals="-3" id="f-1660" unitRef="eur">658000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-357" decimals="-3" id="f-1661" unitRef="usd">625000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-357" decimals="-3" id="f-1662" unitRef="usd">721000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-357"
      decimals="4"
      id="f-1663"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-358"
      decimals="INF"
      id="f-1664"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-358"
      decimals="4"
      id="f-1665"
      unitRef="number">0.0997</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-358" decimals="-3" id="f-1666" unitRef="eur">295000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-358" decimals="-3" id="f-1667" unitRef="usd">161000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-358" decimals="-3" id="f-1668" unitRef="usd">220000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-358"
      decimals="4"
      id="f-1669"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-359"
      decimals="INF"
      id="f-1670"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-359"
      decimals="4"
      id="f-1671"
      unitRef="number">0.0989</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-359" decimals="-3" id="f-1672" unitRef="dkk">4819000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-359" decimals="-3" id="f-1673" unitRef="usd">620000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-359" decimals="-3" id="f-1674" unitRef="usd">708000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-359"
      decimals="4"
      id="f-1675"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-360"
      decimals="INF"
      id="f-1676"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-360"
      decimals="4"
      id="f-1677"
      unitRef="number">0.1071</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-360" decimals="-3" id="f-1678" unitRef="nok">5149000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-360" decimals="-3" id="f-1679" unitRef="usd">463000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-360" decimals="-3" id="f-1680" unitRef="usd">503000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-360"
      decimals="4"
      id="f-1681"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-361"
      decimals="INF"
      id="f-1682"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-361"
      decimals="4"
      id="f-1683"
      unitRef="number">0.1123</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-361" decimals="-3" id="f-1684" unitRef="usd">36970000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-361" decimals="-3" id="f-1685" unitRef="usd">36500000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-361" decimals="-3" id="f-1686" unitRef="usd">36693000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-361"
      decimals="4"
      id="f-1687"
      unitRef="number">0.0074</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-362"
      decimals="INF"
      id="f-1688"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-362"
      decimals="4"
      id="f-1689"
      unitRef="number">0.1154</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-362" decimals="-3" id="f-1690" unitRef="usd">79967000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-362" decimals="-3" id="f-1691" unitRef="usd">79175000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-362" decimals="-3" id="f-1692" unitRef="usd">79967000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-362"
      decimals="4"
      id="f-1693"
      unitRef="number">0.0161</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-363"
      decimals="INF"
      id="f-1694"
      unitRef="number">0.0700</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-363"
      decimals="4"
      id="f-1695"
      unitRef="number">0.1238</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-363" decimals="-3" id="f-1696" unitRef="usd">1596000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-363" decimals="-3" id="f-1697" unitRef="usd">1546000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-363" decimals="-3" id="f-1698" unitRef="usd">1596000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-363"
      decimals="4"
      id="f-1699"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-364"
      decimals="INF"
      id="f-1700"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-364"
      decimals="4"
      id="f-1701"
      unitRef="number">0.1140</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-364"
      decimals="INF"
      id="f-1702"
      unitRef="number">0.0250</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-364" decimals="-3" id="f-1703" unitRef="usd">8655000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-364" decimals="-3" id="f-1704" unitRef="usd">8388000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-364" decimals="-3" id="f-1705" unitRef="usd">8546000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-364"
      decimals="4"
      id="f-1706"
      unitRef="number">0.0017</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-365"
      decimals="INF"
      id="f-1707"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-365"
      decimals="4"
      id="f-1708"
      unitRef="number">0.1140</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-365"
      decimals="INF"
      id="f-1709"
      unitRef="number">0.0250</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-365" decimals="-3" id="f-1710" unitRef="usd">4307000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-365" decimals="-3" id="f-1711" unitRef="usd">4222000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-365" decimals="-3" id="f-1712" unitRef="usd">3992000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-365"
      decimals="4"
      id="f-1713"
      unitRef="number">0.0008</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-366"
      decimals="INF"
      id="f-1714"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-366"
      decimals="4"
      id="f-1715"
      unitRef="number">0.1012</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-366"
      decimals="INF"
      id="f-1716"
      unitRef="number">0.0250</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-366" decimals="-3" id="f-1717" unitRef="eur">11159000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-366" decimals="-3" id="f-1718" unitRef="usd">12643000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-366" decimals="-3" id="f-1719" unitRef="usd">12165000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-366"
      decimals="4"
      id="f-1720"
      unitRef="number">0.0025</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-367"
      decimals="INF"
      id="f-1721"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-367"
      decimals="4"
      id="f-1722"
      unitRef="number">0.0997</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-367"
      decimals="INF"
      id="f-1723"
      unitRef="number">0.0250</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-367" decimals="-3" id="f-1724" unitRef="eur">4271000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-367" decimals="-3" id="f-1725" unitRef="usd">4796000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-367" decimals="-3" id="f-1726" unitRef="usd">4509000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-367"
      decimals="4"
      id="f-1727"
      unitRef="number">0.0009</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-368" decimals="-3" id="f-1728" unitRef="usd">269483000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-368" decimals="-3" id="f-1729" unitRef="usd">271135000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-368"
      decimals="4"
      id="f-1730"
      unitRef="number">0.0545</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-369"
      decimals="INF"
      id="f-1731"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-369"
      decimals="4"
      id="f-1732"
      unitRef="number">0.1153</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-369" decimals="-3" id="f-1733" unitRef="usd">2559000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-369" decimals="-3" id="f-1734" unitRef="usd">2525000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-369" decimals="-3" id="f-1735" unitRef="usd">2559000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-369"
      decimals="4"
      id="f-1736"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-370"
      decimals="INF"
      id="f-1737"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-370"
      decimals="4"
      id="f-1738"
      unitRef="number">0.1178</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-370" decimals="-3" id="f-1739" unitRef="usd">249000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-370" decimals="-3" id="f-1740" unitRef="usd">244000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-370" decimals="-3" id="f-1741" unitRef="usd">249000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-370"
      decimals="4"
      id="f-1742"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-371" decimals="-3" id="f-1743" unitRef="usd">2769000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-371" decimals="-3" id="f-1744" unitRef="usd">2808000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-371"
      decimals="4"
      id="f-1745"
      unitRef="number">0.0006</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-372"
      decimals="INF"
      id="f-1746"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-372"
      decimals="4"
      id="f-1747"
      unitRef="number">0.1124</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-372" decimals="-3" id="f-1748" unitRef="usd">25734000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-372" decimals="-3" id="f-1749" unitRef="usd">25360000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-372" decimals="-3" id="f-1750" unitRef="usd">25435000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-372"
      decimals="4"
      id="f-1751"
      unitRef="number">0.0051</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-373"
      decimals="INF"
      id="f-1752"
      unitRef="number">0.0675</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-373"
      decimals="4"
      id="f-1753"
      unitRef="number">0.1219</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-373" decimals="-3" id="f-1754" unitRef="cad">9925000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-373" decimals="-3" id="f-1755" unitRef="usd">6915000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-373" decimals="-3" id="f-1756" unitRef="usd">7300000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-373"
      decimals="4"
      id="f-1757"
      unitRef="number">0.0015</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-374"
      decimals="INF"
      id="f-1758"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-374"
      decimals="4"
      id="f-1759"
      unitRef="number">0.1163</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-374" decimals="-3" id="f-1760" unitRef="usd">65109000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-374" decimals="-3" id="f-1761" unitRef="usd">64357000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-374" decimals="-3" id="f-1762" unitRef="usd">65109000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-374"
      decimals="4"
      id="f-1763"
      unitRef="number">0.0131</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-375"
      decimals="INF"
      id="f-1764"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-375"
      decimals="4"
      id="f-1765"
      unitRef="number">0.1163</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-375" decimals="-3" id="f-1766" unitRef="usd">35421000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-375" decimals="-3" id="f-1767" unitRef="usd">35012000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-375" decimals="-3" id="f-1768" unitRef="usd">35421000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-375"
      decimals="4"
      id="f-1769"
      unitRef="number">0.0072</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-376" decimals="-3" id="f-1770" unitRef="usd">99369000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-376" decimals="-3" id="f-1771" unitRef="usd">100530000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-376"
      decimals="4"
      id="f-1772"
      unitRef="number">0.0203</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-377"
      decimals="INF"
      id="f-1773"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-377"
      decimals="4"
      id="f-1774"
      unitRef="number">0.1099</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-377" decimals="-3" id="f-1775" unitRef="usd">1229000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-377" decimals="-3" id="f-1776" unitRef="usd">1213000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-377" decimals="-3" id="f-1777" unitRef="usd">1189000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-377"
      decimals="4"
      id="f-1778"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-378"
      decimals="INF"
      id="f-1779"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-378"
      decimals="4"
      id="f-1780"
      unitRef="number">0.1095</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-378" decimals="-3" id="f-1781" unitRef="usd">6083000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-378" decimals="-3" id="f-1782" unitRef="usd">6002000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-378" decimals="-3" id="f-1783" unitRef="usd">5857000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-378"
      decimals="4"
      id="f-1784"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-379" decimals="-3" id="f-1785" unitRef="usd">7215000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-379" decimals="-3" id="f-1786" unitRef="usd">7046000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-379"
      decimals="4"
      id="f-1787"
      unitRef="number">0.0014</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-380"
      decimals="INF"
      id="f-1788"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-380"
      decimals="4"
      id="f-1789"
      unitRef="number">0.1042</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-380" decimals="-3" id="f-1790" unitRef="eur">1758000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-380" decimals="-3" id="f-1791" unitRef="usd">1006000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-380" decimals="-3" id="f-1792" unitRef="usd">1349000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-380"
      decimals="4"
      id="f-1793"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-381"
      decimals="INF"
      id="f-1794"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-381"
      decimals="4"
      id="f-1795"
      unitRef="number">0.1160</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-381" decimals="-3" id="f-1796" unitRef="usd">20388000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-381" decimals="-3" id="f-1797" unitRef="usd">20000000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-381" decimals="-3" id="f-1798" unitRef="usd">21260000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-381"
      decimals="4"
      id="f-1799"
      unitRef="number">0.0043</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-382" decimals="-3" id="f-1800" unitRef="usd">21006000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-382" decimals="-3" id="f-1801" unitRef="usd">22609000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-382"
      decimals="4"
      id="f-1802"
      unitRef="number">0.0046</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-383"
      decimals="INF"
      id="f-1803"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-383"
      decimals="4"
      id="f-1804"
      unitRef="number">0.1161</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-383" decimals="-3" id="f-1805" unitRef="usd">798000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-383" decimals="-3" id="f-1806" unitRef="usd">780000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-383" decimals="-3" id="f-1807" unitRef="usd">796000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-383"
      decimals="4"
      id="f-1808"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-384"
      decimals="INF"
      id="f-1809"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-384"
      decimals="4"
      id="f-1810"
      unitRef="number">0.1163</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-384" decimals="-3" id="f-1811" unitRef="usd">1605000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-384" decimals="-3" id="f-1812" unitRef="usd">1565000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-384" decimals="-3" id="f-1813" unitRef="usd">1600000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-384"
      decimals="4"
      id="f-1814"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-385"
      decimals="INF"
      id="f-1815"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-385"
      decimals="4"
      id="f-1816"
      unitRef="number">0.1046</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-385" decimals="-3" id="f-1817" unitRef="usd">6963000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-385" decimals="-3" id="f-1818" unitRef="usd">6861000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-385" decimals="-3" id="f-1819" unitRef="usd">6942000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-385"
      decimals="4"
      id="f-1820"
      unitRef="number">0.0014</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-386"
      decimals="INF"
      id="f-1821"
      unitRef="number">0.0535</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-386"
      decimals="4"
      id="f-1822"
      unitRef="number">0.1070</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-386" decimals="-3" id="f-1823" unitRef="usd">9147000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-386" decimals="-3" id="f-1824" unitRef="usd">9002000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-386" decimals="-3" id="f-1825" unitRef="usd">8909000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-386"
      decimals="4"
      id="f-1826"
      unitRef="number">0.0018</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-387"
      decimals="INF"
      id="f-1827"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-387"
      decimals="4"
      id="f-1828"
      unitRef="number">0.1111</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-387" decimals="-3" id="f-1829" unitRef="usd">80061000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-387" decimals="-3" id="f-1830" unitRef="usd">79273000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-387" decimals="-3" id="f-1831" unitRef="usd">78670000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-387"
      decimals="4"
      id="f-1832"
      unitRef="number">0.0159</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-388"
      decimals="INF"
      id="f-1833"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-388"
      decimals="4"
      id="f-1834"
      unitRef="number">0.1111</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-388" decimals="-3" id="f-1835" unitRef="usd">9653000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-388" decimals="-3" id="f-1836" unitRef="usd">9443000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-388" decimals="-3" id="f-1837" unitRef="usd">9448000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-388"
      decimals="4"
      id="f-1838"
      unitRef="number">0.0019</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-389"
      decimals="INF"
      id="f-1839"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-389"
      decimals="4"
      id="f-1840"
      unitRef="number">0.1111</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-389"
      decimals="INF"
      id="f-1841"
      unitRef="number">0.0200</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-389" decimals="-3" id="f-1842" unitRef="usd">307012000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-389" decimals="-3" id="f-1843" unitRef="usd">304883000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-389" decimals="-3" id="f-1844" unitRef="usd">303558000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-389"
      decimals="4"
      id="f-1845"
      unitRef="number">0.0613</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-390"
      decimals="INF"
      id="f-1846"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-390"
      decimals="4"
      id="f-1847"
      unitRef="number">0.1154</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-390" decimals="-3" id="f-1848" unitRef="usd">19091000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-390" decimals="-3" id="f-1849" unitRef="usd">18825000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-390" decimals="-3" id="f-1850" unitRef="usd">19091000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-390"
      decimals="4"
      id="f-1851"
      unitRef="number">0.0039</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-391"
      decimals="INF"
      id="f-1852"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-391"
      decimals="4"
      id="f-1853"
      unitRef="number">0.1150</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-391" decimals="-3" id="f-1854" unitRef="usd">2939000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-391" decimals="-3" id="f-1855" unitRef="usd">2884000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-391" decimals="-3" id="f-1856" unitRef="usd">2877000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-391"
      decimals="4"
      id="f-1857"
      unitRef="number">0.0006</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-392"
      decimals="INF"
      id="f-1858"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-392"
      decimals="4"
      id="f-1859"
      unitRef="number">0.1148</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-392" decimals="-3" id="f-1860" unitRef="usd">46261000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-392" decimals="-3" id="f-1861" unitRef="usd">45600000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-392" decimals="-3" id="f-1862" unitRef="usd">46011000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-392"
      decimals="4"
      id="f-1863"
      unitRef="number">0.0093</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-393"
      decimals="INF"
      id="f-1864"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-393"
      decimals="4"
      id="f-1865"
      unitRef="number">0.1071</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-393" decimals="-3" id="f-1866" unitRef="usd">24082000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-393" decimals="-3" id="f-1867" unitRef="usd">23741000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-393" decimals="-3" id="f-1868" unitRef="usd">24082000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-393"
      decimals="4"
      id="f-1869"
      unitRef="number">0.0049</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-394"
      decimals="INF"
      id="f-1870"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-394"
      decimals="4"
      id="f-1871"
      unitRef="number">0.1129</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-394" decimals="-3" id="f-1872" unitRef="usd">6766000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-394" decimals="-3" id="f-1873" unitRef="usd">6674000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-394" decimals="-3" id="f-1874" unitRef="usd">6766000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-394"
      decimals="4"
      id="f-1875"
      unitRef="number">0.0014</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-395"
      decimals="INF"
      id="f-1876"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-395"
      decimals="4"
      id="f-1877"
      unitRef="number">0.1145</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-395" decimals="-3" id="f-1878" unitRef="usd">24456000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-395" decimals="-3" id="f-1879" unitRef="usd">24161000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-395" decimals="-3" id="f-1880" unitRef="usd">22431000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-395"
      decimals="4"
      id="f-1881"
      unitRef="number">0.0045</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-396"
      decimals="INF"
      id="f-1882"
      unitRef="number">0.0475</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-396"
      decimals="4"
      id="f-1883"
      unitRef="number">0.1021</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-396" decimals="-3" id="f-1884" unitRef="usd">1964000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-396" decimals="-3" id="f-1885" unitRef="usd">1928000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-396" decimals="-3" id="f-1886" unitRef="usd">1967000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-396"
      decimals="4"
      id="f-1887"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-397"
      decimals="INF"
      id="f-1888"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-397"
      decimals="4"
      id="f-1889"
      unitRef="number">0.1114</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-397" decimals="-3" id="f-1890" unitRef="usd">82156000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-397" decimals="-3" id="f-1891" unitRef="usd">80193000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-397" decimals="-3" id="f-1892" unitRef="usd">80138000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-397"
      decimals="4"
      id="f-1893"
      unitRef="number">0.0162</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-398"
      decimals="INF"
      id="f-1894"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-398"
      decimals="4"
      id="f-1895"
      unitRef="number">0.1199</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-398" decimals="-3" id="f-1896" unitRef="usd">1890000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-398" decimals="-3" id="f-1897" unitRef="usd">1829000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-398" decimals="-3" id="f-1898" unitRef="usd">1882000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-398"
      decimals="4"
      id="f-1899"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-399"
      decimals="INF"
      id="f-1900"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-399"
      decimals="4"
      id="f-1901"
      unitRef="number">0.1120</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-399" decimals="-3" id="f-1902" unitRef="usd">8487000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-399" decimals="-3" id="f-1903" unitRef="usd">8333000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-399" decimals="-3" id="f-1904" unitRef="usd">8267000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-399"
      decimals="4"
      id="f-1905"
      unitRef="number">0.0017</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-400"
      decimals="INF"
      id="f-1906"
      unitRef="number">0.0400</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-400"
      decimals="4"
      id="f-1907"
      unitRef="number">0.0950</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-400" decimals="-3" id="f-1908" unitRef="usd">1296000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-400" decimals="-3" id="f-1909" unitRef="usd">1285000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-400" decimals="-3" id="f-1910" unitRef="usd">1299000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-400"
      decimals="4"
      id="f-1911"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-401"
      decimals="INF"
      id="f-1912"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-401"
      decimals="4"
      id="f-1913"
      unitRef="number">0.1128</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-401" decimals="-3" id="f-1914" unitRef="usd">41488000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-401" decimals="-3" id="f-1915" unitRef="usd">40447000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-401" decimals="-3" id="f-1916" unitRef="usd">39206000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-401"
      decimals="4"
      id="f-1917"
      unitRef="number">0.0079</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-402"
      decimals="INF"
      id="f-1918"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-402"
      decimals="4"
      id="f-1919"
      unitRef="number">0.1129</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-402" decimals="-3" id="f-1920" unitRef="usd">55925000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-402" decimals="-3" id="f-1921" unitRef="usd">55007000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-402" decimals="-3" id="f-1922" unitRef="usd">55812000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-402"
      decimals="4"
      id="f-1923"
      unitRef="number">0.0113</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-403"
      decimals="INF"
      id="f-1924"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-403"
      decimals="4"
      id="f-1925"
      unitRef="number">0.1103</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-403" decimals="-3" id="f-1926" unitRef="usd">22620000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-403" decimals="-3" id="f-1927" unitRef="usd">22394000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-403" decimals="-3" id="f-1928" unitRef="usd">22390000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-403"
      decimals="4"
      id="f-1929"
      unitRef="number">0.0045</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-404"
      decimals="INF"
      id="f-1930"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-404"
      decimals="4"
      id="f-1931"
      unitRef="number">0.1103</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-404" decimals="-3" id="f-1932" unitRef="usd">4756000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-404" decimals="-3" id="f-1933" unitRef="usd">4678000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-404" decimals="-3" id="f-1934" unitRef="usd">4742000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-404"
      decimals="4"
      id="f-1935"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-405"
      decimals="INF"
      id="f-1936"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-405"
      decimals="4"
      id="f-1937"
      unitRef="number">0.1072</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-405" decimals="-3" id="f-1938" unitRef="usd">14746000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-405" decimals="-3" id="f-1939" unitRef="usd">14550000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-405" decimals="-3" id="f-1940" unitRef="usd">14377000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-405"
      decimals="4"
      id="f-1941"
      unitRef="number">0.0029</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-406"
      decimals="INF"
      id="f-1942"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-406"
      decimals="4"
      id="f-1943"
      unitRef="number">0.1072</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-406" decimals="-3" id="f-1944" unitRef="usd">289000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-406" decimals="-3" id="f-1945" unitRef="usd">289000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-406" decimals="-3" id="f-1946" unitRef="usd">281000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-406"
      decimals="4"
      id="f-1947"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-407" decimals="-3" id="f-1948" unitRef="usd">764625000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-407" decimals="-3" id="f-1949" unitRef="usd">761542000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-407"
      decimals="4"
      id="f-1950"
      unitRef="number">0.1541</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-408"
      decimals="INF"
      id="f-1951"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-408"
      decimals="4"
      id="f-1952"
      unitRef="number">0.1084</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-408" decimals="-3" id="f-1953" unitRef="usd">23333000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-408" decimals="-3" id="f-1954" unitRef="usd">22935000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-408" decimals="-3" id="f-1955" unitRef="usd">22940000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-408"
      decimals="4"
      id="f-1956"
      unitRef="number">0.0046</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-409"
      decimals="INF"
      id="f-1957"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-409"
      decimals="4"
      id="f-1958"
      unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-409" decimals="-3" id="f-1959" unitRef="usd">67900000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-409" decimals="-3" id="f-1960" unitRef="usd">67076000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-409" decimals="-3" id="f-1961" unitRef="usd">67900000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-409"
      decimals="4"
      id="f-1962"
      unitRef="number">0.0137</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-410"
      decimals="INF"
      id="f-1963"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-410"
      decimals="4"
      id="f-1964"
      unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-410" decimals="-3" id="f-1965" unitRef="usd">833000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-410" decimals="-3" id="f-1966" unitRef="usd">818000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-410" decimals="-3" id="f-1967" unitRef="usd">833000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-410"
      decimals="4"
      id="f-1968"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-411" decimals="-3" id="f-1969" unitRef="usd">90829000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-411" decimals="-3" id="f-1970" unitRef="usd">91673000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-411"
      decimals="4"
      id="f-1971"
      unitRef="number">0.0185</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-412"
      decimals="INF"
      id="f-1972"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-412"
      decimals="4"
      id="f-1973"
      unitRef="number">0.1185</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-412" decimals="-3" id="f-1974" unitRef="usd">1804000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-412" decimals="-3" id="f-1975" unitRef="usd">1773000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-412" decimals="-3" id="f-1976" unitRef="usd">1794000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-412"
      decimals="4"
      id="f-1977"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-413"
      decimals="INF"
      id="f-1978"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-413"
      decimals="4"
      id="f-1979"
      unitRef="number">0.1064</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-413" decimals="-3" id="f-1980" unitRef="usd">4942000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-413" decimals="-3" id="f-1981" unitRef="usd">4900000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-413" decimals="-3" id="f-1982" unitRef="usd">4939000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-413"
      decimals="4"
      id="f-1983"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-414"
      decimals="INF"
      id="f-1984"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-414"
      decimals="4"
      id="f-1985"
      unitRef="number">0.1138</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-414"
      decimals="INF"
      id="f-1986"
      unitRef="number">0.0200</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-414" decimals="-3" id="f-1987" unitRef="usd">1952000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-414" decimals="-3" id="f-1988" unitRef="usd">1921000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-414" decimals="-3" id="f-1989" unitRef="usd">1913000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-414"
      decimals="4"
      id="f-1990"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-415"
      decimals="INF"
      id="f-1991"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-415"
      decimals="4"
      id="f-1992"
      unitRef="number">0.1142</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-415"
      decimals="INF"
      id="f-1993"
      unitRef="number">0.0200</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-415" decimals="-3" id="f-1994" unitRef="usd">343000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-415" decimals="-3" id="f-1995" unitRef="usd">338000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-415" decimals="-3" id="f-1996" unitRef="usd">336000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-415"
      decimals="4"
      id="f-1997"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-416"
      decimals="INF"
      id="f-1998"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-417"
      decimals="4"
      id="f-1999"
      unitRef="number">0.1135</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-417"
      decimals="INF"
      id="f-2000"
      unitRef="number">0.0200</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-416" decimals="-3" id="f-2001" unitRef="usd">65000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-416" decimals="-3" id="f-2002" unitRef="usd">61000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-416" decimals="-3" id="f-2003" unitRef="usd">61000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-416"
      decimals="4"
      id="f-2004"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-418"
      decimals="INF"
      id="f-2005"
      unitRef="number">0.0725</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-418"
      decimals="4"
      id="f-2006"
      unitRef="number">0.1272</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-418" decimals="-3" id="f-2007" unitRef="usd">22756000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-418" decimals="-3" id="f-2008" unitRef="usd">22163000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-418" decimals="-3" id="f-2009" unitRef="usd">22381000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-418"
      decimals="4"
      id="f-2010"
      unitRef="number">0.0045</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-419"
      decimals="INF"
      id="f-2011"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-419"
      decimals="4"
      id="f-2012"
      unitRef="number">0.1036</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-419" decimals="-3" id="f-2013" unitRef="usd">64078000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-419" decimals="-3" id="f-2014" unitRef="usd">63356000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-419" decimals="-3" id="f-2015" unitRef="usd">63346000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-419"
      decimals="4"
      id="f-2016"
      unitRef="number">0.0128</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-420"
      decimals="INF"
      id="f-2017"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-420"
      decimals="4"
      id="f-2018"
      unitRef="number">0.1121</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-420" decimals="-3" id="f-2019" unitRef="usd">120332000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-420" decimals="-3" id="f-2020" unitRef="usd">118430000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-420" decimals="-3" id="f-2021" unitRef="usd">120332000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-420"
      decimals="4"
      id="f-2022"
      unitRef="number">0.0243</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-421"
      decimals="INF"
      id="f-2023"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-422"
      decimals="4"
      id="f-2024"
      unitRef="number">0.1161</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-422"
      decimals="INF"
      id="f-2025"
      unitRef="number">0.0275</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-421" decimals="-3" id="f-2026" unitRef="usd">77153000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-421" decimals="-3" id="f-2027" unitRef="usd">76001000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-421" decimals="-3" id="f-2028" unitRef="usd">77153000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-421"
      decimals="4"
      id="f-2029"
      unitRef="number">0.0156</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-423"
      decimals="INF"
      id="f-2030"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-423"
      decimals="4"
      id="f-2031"
      unitRef="number">0.1111</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-423" decimals="-3" id="f-2032" unitRef="usd">2484000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-423" decimals="-3" id="f-2033" unitRef="usd">2264000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-423" decimals="-3" id="f-2034" unitRef="usd">2484000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-423"
      decimals="4"
      id="f-2035"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-424"
      decimals="INF"
      id="f-2036"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-424"
      decimals="4"
      id="f-2037"
      unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-424" decimals="-3" id="f-2038" unitRef="usd">4913000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-424" decimals="-3" id="f-2039" unitRef="usd">4835000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-424" decimals="-3" id="f-2040" unitRef="usd">4893000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-424"
      decimals="4"
      id="f-2041"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-425"
      decimals="INF"
      id="f-2042"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-426"
      decimals="4"
      id="f-2043"
      unitRef="number">0.1181</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-426"
      decimals="INF"
      id="f-2044"
      unitRef="number">0.0300</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-425" decimals="-3" id="f-2045" unitRef="usd">16163000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-425" decimals="-3" id="f-2046" unitRef="usd">15813000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-425" decimals="-3" id="f-2047" unitRef="usd">13936000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-425"
      decimals="4"
      id="f-2048"
      unitRef="number">0.0028</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-427"
      decimals="INF"
      id="f-2049"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-427"
      decimals="4"
      id="f-2050"
      unitRef="number">0.1114</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-427" decimals="-3" id="f-2051" unitRef="usd">21591000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-427" decimals="-3" id="f-2052" unitRef="usd">21273000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-427" decimals="-3" id="f-2053" unitRef="usd">19362000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-427"
      decimals="4"
      id="f-2054"
      unitRef="number">0.0039</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-428"
      decimals="INF"
      id="f-2055"
      unitRef="number">0.0750</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-428"
      decimals="4"
      id="f-2056"
      unitRef="number">0.1286</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-428" decimals="-3" id="f-2057" unitRef="usd">1836000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-428" decimals="-3" id="f-2058" unitRef="usd">1791000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-428" decimals="-3" id="f-2059" unitRef="usd">1819000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-428"
      decimals="4"
      id="f-2060"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-429"
      decimals="INF"
      id="f-2061"
      unitRef="number">0.0675</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-429"
      decimals="4"
      id="f-2062"
      unitRef="number">0.1210</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-429" decimals="-3" id="f-2063" unitRef="usd">59936000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-429" decimals="-3" id="f-2064" unitRef="usd">58317000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-429" decimals="-3" id="f-2065" unitRef="usd">58282000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-429"
      decimals="4"
      id="f-2066"
      unitRef="number">0.0118</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-430"
      decimals="INF"
      id="f-2067"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-430"
      decimals="4"
      id="f-2068"
      unitRef="number">0.1119</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-430" decimals="-3" id="f-2069" unitRef="gbp">4022000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-430" decimals="-3" id="f-2070" unitRef="usd">4900000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-430" decimals="-3" id="f-2071" unitRef="usd">2783000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-430"
      decimals="4"
      id="f-2072"
      unitRef="number">0.0006</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-431"
      decimals="INF"
      id="f-2073"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-431"
      decimals="4"
      id="f-2074"
      unitRef="number">0.0984</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-431" decimals="-3" id="f-2075" unitRef="eur">1166000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-431" decimals="-3" id="f-2076" unitRef="usd">1226000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-431" decimals="-3" id="f-2077" unitRef="usd">1268000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-431"
      decimals="4"
      id="f-2078"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-432"
      decimals="INF"
      id="f-2079"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-432"
      decimals="4"
      id="f-2080"
      unitRef="number">0.1128</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-432" decimals="-3" id="f-2081" unitRef="usd">58350000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-432" decimals="-3" id="f-2082" unitRef="usd">58051000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-432" decimals="-3" id="f-2083" unitRef="usd">58350000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-432"
      decimals="4"
      id="f-2084"
      unitRef="number">0.0118</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-433"
      decimals="INF"
      id="f-2085"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-433"
      decimals="4"
      id="f-2086"
      unitRef="number">0.1114</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-433" decimals="-3" id="f-2087" unitRef="usd">3724000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-433" decimals="-3" id="f-2088" unitRef="usd">3683000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-433" decimals="-3" id="f-2089" unitRef="usd">3575000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-433"
      decimals="4"
      id="f-2090"
      unitRef="number">0.0007</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-434"
      decimals="INF"
      id="f-2091"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-434"
      decimals="4"
      id="f-2092"
      unitRef="number">0.1123</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-434" decimals="-3" id="f-2093" unitRef="usd">33090000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-434" decimals="-3" id="f-2094" unitRef="usd">32649000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-434" decimals="-3" id="f-2095" unitRef="usd">31648000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-434"
      decimals="4"
      id="f-2096"
      unitRef="number">0.0064</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-435"
      decimals="INF"
      id="f-2097"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-435"
      decimals="4"
      id="f-2098"
      unitRef="number">0.1075</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-435" decimals="-3" id="f-2099" unitRef="usd">9545000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-435" decimals="-3" id="f-2100" unitRef="usd">9464000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-435" decimals="-3" id="f-2101" unitRef="usd">9081000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-435"
      decimals="4"
      id="f-2102"
      unitRef="number">0.0018</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-436"
      decimals="INF"
      id="f-2103"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-436"
      decimals="4"
      id="f-2104"
      unitRef="number">0.1120</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-436" decimals="-3" id="f-2105" unitRef="usd">14828000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-436" decimals="-3" id="f-2106" unitRef="usd">14618000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-436" decimals="-3" id="f-2107" unitRef="usd">14664000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-436"
      decimals="4"
      id="f-2108"
      unitRef="number">0.0030</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-437"
      decimals="INF"
      id="f-2109"
      unitRef="number">0.0375</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-437"
      decimals="4"
      id="f-2110"
      unitRef="number">0.0894</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-437" decimals="-3" id="f-2111" unitRef="gbp">442000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-437" decimals="-3" id="f-2112" unitRef="usd">564000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-437" decimals="-3" id="f-2113" unitRef="usd">554000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-437"
      decimals="4"
      id="f-2114"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-438"
      decimals="INF"
      id="f-2115"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-438"
      decimals="4"
      id="f-2116"
      unitRef="number">0.1130</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-438" decimals="-3" id="f-2117" unitRef="usd">7327000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-438" decimals="-3" id="f-2118" unitRef="usd">7215000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-438" decimals="-3" id="f-2119" unitRef="usd">7308000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-438"
      decimals="4"
      id="f-2120"
      unitRef="number">0.0015</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-439"
      decimals="INF"
      id="f-2121"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-439"
      decimals="4"
      id="f-2122"
      unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-439" decimals="-3" id="f-2123" unitRef="usd">5169000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-439" decimals="-3" id="f-2124" unitRef="usd">5160000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-439" decimals="-3" id="f-2125" unitRef="usd">5156000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-439"
      decimals="4"
      id="f-2126"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-440"
      decimals="INF"
      id="f-2127"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-440"
      decimals="4"
      id="f-2128"
      unitRef="number">0.1122</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-440" decimals="-3" id="f-2129" unitRef="usd">13518000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-440" decimals="-3" id="f-2130" unitRef="usd">13435000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-440" decimals="-3" id="f-2131" unitRef="usd">13518000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-440"
      decimals="4"
      id="f-2132"
      unitRef="number">0.0027</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-441"
      decimals="INF"
      id="f-2133"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-441"
      decimals="4"
      id="f-2134"
      unitRef="number">0.1119</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-441" decimals="-3" id="f-2135" unitRef="usd">12797000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-441" decimals="-3" id="f-2136" unitRef="usd">12691000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-441" decimals="-3" id="f-2137" unitRef="usd">12797000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-441"
      decimals="4"
      id="f-2138"
      unitRef="number">0.0026</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-442"
      decimals="INF"
      id="f-2139"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-442"
      decimals="4"
      id="f-2140"
      unitRef="number">0.1113</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-442" decimals="-3" id="f-2141" unitRef="usd">6429000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-442" decimals="-3" id="f-2142" unitRef="usd">6389000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-442" decimals="-3" id="f-2143" unitRef="usd">6429000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-442"
      decimals="4"
      id="f-2144"
      unitRef="number">0.0013</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-443"
      decimals="INF"
      id="f-2145"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-443"
      decimals="4"
      id="f-2146"
      unitRef="number">0.1350</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-443" decimals="-3" id="f-2147" unitRef="usd">1062000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-443" decimals="-3" id="f-2148" unitRef="usd">1044000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-443" decimals="-3" id="f-2149" unitRef="usd">1030000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-443"
      decimals="4"
      id="f-2150"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-444"
      decimals="INF"
      id="f-2151"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-444"
      decimals="4"
      id="f-2152"
      unitRef="number">0.1195</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-444" decimals="-3" id="f-2153" unitRef="usd">91518000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-444" decimals="-3" id="f-2154" unitRef="usd">90747000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-444" decimals="-3" id="f-2155" unitRef="usd">90602000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-444"
      decimals="4"
      id="f-2156"
      unitRef="number">0.0183</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-445"
      decimals="INF"
      id="f-2157"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-445"
      decimals="4"
      id="f-2158"
      unitRef="number">0.1061</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-445" decimals="-3" id="f-2159" unitRef="usd">1970000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-445" decimals="-3" id="f-2160" unitRef="usd">1941000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-445" decimals="-3" id="f-2161" unitRef="usd">1886000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-445"
      decimals="4"
      id="f-2162"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-446"
      decimals="INF"
      id="f-2163"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-446"
      decimals="4"
      id="f-2164"
      unitRef="number">0.1121</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-446" decimals="-3" id="f-2165" unitRef="usd">5215000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-446" decimals="-3" id="f-2166" unitRef="usd">5117000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-446" decimals="-3" id="f-2167" unitRef="usd">5203000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-446"
      decimals="4"
      id="f-2168"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-447"
      decimals="INF"
      id="f-2169"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-447"
      decimals="4"
      id="f-2170"
      unitRef="number">0.1094</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-447" decimals="-3" id="f-2171" unitRef="gbp">3408000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-447" decimals="-3" id="f-2172" unitRef="usd">4174000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-447" decimals="-3" id="f-2173" unitRef="usd">4345000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-447"
      decimals="4"
      id="f-2174"
      unitRef="number">0.0009</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-448"
      decimals="INF"
      id="f-2175"
      unitRef="number">0.0375</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-448"
      decimals="4"
      id="f-2176"
      unitRef="number">0.0925</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-448" decimals="-3" id="f-2177" unitRef="usd">8526000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-448" decimals="-3" id="f-2178" unitRef="usd">8442000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-448" decimals="-3" id="f-2179" unitRef="usd">7887000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-448"
      decimals="4"
      id="f-2180"
      unitRef="number">0.0016</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-449"
      decimals="INF"
      id="f-2181"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-449"
      decimals="4"
      id="f-2182"
      unitRef="number">0.1175</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-449" decimals="-3" id="f-2183" unitRef="usd">6965000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-449" decimals="-3" id="f-2184" unitRef="usd">6773000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-449" decimals="-3" id="f-2185" unitRef="usd">6965000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-449"
      decimals="4"
      id="f-2186"
      unitRef="number">0.0014</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-450"
      decimals="INF"
      id="f-2187"
      unitRef="number">0.0375</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-450"
      decimals="4"
      id="f-2188"
      unitRef="number">0.0925</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-450" decimals="-3" id="f-2189" unitRef="usd">284000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-450" decimals="-3" id="f-2190" unitRef="usd">277000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-450" decimals="-3" id="f-2191" unitRef="usd">194000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-450"
      decimals="4"
      id="f-2192"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-451"
      decimals="INF"
      id="f-2193"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-451"
      decimals="4"
      id="f-2194"
      unitRef="number">0.1145</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-451"
      decimals="INF"
      id="f-2195"
      unitRef="number">0.0400</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-451" decimals="-3" id="f-2196" unitRef="usd">364077000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-451" decimals="-3" id="f-2197" unitRef="usd">359655000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-451" decimals="-3" id="f-2198" unitRef="usd">356796000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-451"
      decimals="4"
      id="f-2199"
      unitRef="number">0.0721</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-452"
      decimals="INF"
      id="f-2200"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-452"
      decimals="4"
      id="f-2201"
      unitRef="number">0.1195</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-452"
      decimals="INF"
      id="f-2202"
      unitRef="number">0.0400</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-452" decimals="-3" id="f-2203" unitRef="usd">2136000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-452" decimals="-3" id="f-2204" unitRef="usd">2105000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-452" decimals="-3" id="f-2205" unitRef="usd">2094000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-452"
      decimals="4"
      id="f-2206"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-453"
      decimals="INF"
      id="f-2207"
      unitRef="number">0.0570</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-453"
      decimals="4"
      id="f-2208"
      unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-453" decimals="-3" id="f-2209" unitRef="usd">4804000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-453" decimals="-3" id="f-2210" unitRef="usd">4728000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-453" decimals="-3" id="f-2211" unitRef="usd">4804000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-453"
      decimals="4"
      id="f-2212"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-454"
      decimals="INF"
      id="f-2213"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-454"
      decimals="4"
      id="f-2214"
      unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-454" decimals="-3" id="f-2215" unitRef="usd">189000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-454" decimals="-3" id="f-2216" unitRef="usd">179000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-454" decimals="-3" id="f-2217" unitRef="usd">175000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-454"
      decimals="4"
      id="f-2218"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-455"
      decimals="INF"
      id="f-2219"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-455"
      decimals="4"
      id="f-2220"
      unitRef="number">0.1095</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-455" decimals="-3" id="f-2221" unitRef="usd">51697000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-455" decimals="-3" id="f-2222" unitRef="usd">51310000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-455" decimals="-3" id="f-2223" unitRef="usd">50422000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-455"
      decimals="4"
      id="f-2224"
      unitRef="number">0.0102</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-456"
      decimals="INF"
      id="f-2225"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-456"
      decimals="4"
      id="f-2226"
      unitRef="number">0.1111</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-456" decimals="-3" id="f-2227" unitRef="usd">61303000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-456" decimals="-3" id="f-2228" unitRef="usd">59997000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-456" decimals="-3" id="f-2229" unitRef="usd">59969000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-456"
      decimals="4"
      id="f-2230"
      unitRef="number">0.0121</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-457"
      decimals="INF"
      id="f-2231"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-457"
      decimals="4"
      id="f-2232"
      unitRef="number">0.1150</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-457" decimals="-3" id="f-2233" unitRef="usd">33866000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-457" decimals="-3" id="f-2234" unitRef="usd">33395000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-457" decimals="-3" id="f-2235" unitRef="usd">32511000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-457"
      decimals="4"
      id="f-2236"
      unitRef="number">0.0066</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-458"
      decimals="INF"
      id="f-2237"
      unitRef="number">0.0775</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-458"
      decimals="4"
      id="f-2238"
      unitRef="number">0.1313</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-458" decimals="-3" id="f-2239" unitRef="usd">2000000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-458" decimals="-3" id="f-2240" unitRef="usd">1952000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-458" decimals="-3" id="f-2241" unitRef="usd">2000000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-458"
      decimals="4"
      id="f-2242"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-459"
      decimals="INF"
      id="f-2243"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-459"
      decimals="4"
      id="f-2244"
      unitRef="number">0.1112</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-459" decimals="-3" id="f-2245" unitRef="usd">840000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-459" decimals="-3" id="f-2246" unitRef="usd">827000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-459" decimals="-3" id="f-2247" unitRef="usd">824000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-459"
      decimals="4"
      id="f-2248"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-460"
      decimals="INF"
      id="f-2249"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-460"
      decimals="4"
      id="f-2250"
      unitRef="number">0.1111</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-460" decimals="-3" id="f-2251" unitRef="usd">44000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-460" decimals="-3" id="f-2252" unitRef="usd">42000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-460" decimals="-3" id="f-2253" unitRef="usd">42000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-460"
      decimals="4"
      id="f-2254"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-461"
      decimals="INF"
      id="f-2255"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-461"
      decimals="4"
      id="f-2256"
      unitRef="number">0.1196</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-461" decimals="-3" id="f-2257" unitRef="usd">21458000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-461" decimals="-3" id="f-2258" unitRef="usd">21159000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-461" decimals="-3" id="f-2259" unitRef="usd">21087000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-461"
      decimals="4"
      id="f-2260"
      unitRef="number">0.0043</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-462"
      decimals="INF"
      id="f-2261"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-462"
      decimals="4"
      id="f-2262"
      unitRef="number">0.1096</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-462" decimals="-3" id="f-2263" unitRef="usd">78620000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-462" decimals="-3" id="f-2264" unitRef="usd">77907000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-462" decimals="-3" id="f-2265" unitRef="usd">78620000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-462"
      decimals="4"
      id="f-2266"
      unitRef="number">0.0159</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-463"
      decimals="INF"
      id="f-2267"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-463"
      decimals="4"
      id="f-2268"
      unitRef="number">0.0934</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-463" decimals="-3" id="f-2269" unitRef="eur">10238000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-463" decimals="-3" id="f-2270" unitRef="usd">12231000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-463" decimals="-3" id="f-2271" unitRef="usd">12128000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-463"
      decimals="4"
      id="f-2272"
      unitRef="number">0.0024</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-464"
      decimals="INF"
      id="f-2273"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-464"
      decimals="4"
      id="f-2274"
      unitRef="number">0.1123</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-464" decimals="-3" id="f-2275" unitRef="usd">285199000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-464" decimals="-3" id="f-2276" unitRef="usd">281318000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-464" decimals="-3" id="f-2277" unitRef="usd">278069000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-464"
      decimals="4"
      id="f-2278"
      unitRef="number">0.0562</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-465"
      decimals="INF"
      id="f-2279"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-465"
      decimals="4"
      id="f-2280"
      unitRef="number">0.1127</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-465" decimals="-3" id="f-2281" unitRef="usd">61658000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-465" decimals="-3" id="f-2282" unitRef="usd">60869000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-465" decimals="-3" id="f-2283" unitRef="usd">59500000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-465"
      decimals="4"
      id="f-2284"
      unitRef="number">0.0120</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-466"
      decimals="INF"
      id="f-2285"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-466"
      decimals="4"
      id="f-2286"
      unitRef="number">0.1131</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-466" decimals="-3" id="f-2287" unitRef="usd">2951000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-466" decimals="-3" id="f-2288" unitRef="usd">2855000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-466" decimals="-3" id="f-2289" unitRef="usd">2681000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-466"
      decimals="4"
      id="f-2290"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-467"
      decimals="INF"
      id="f-2291"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-467"
      decimals="4"
      id="f-2292"
      unitRef="number">0.1187</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-467" decimals="-3" id="f-2293" unitRef="usd">66667000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-467" decimals="-3" id="f-2294" unitRef="usd">64607000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-467" decimals="-3" id="f-2295" unitRef="usd">65133000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-467"
      decimals="4"
      id="f-2296"
      unitRef="number">0.0132</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-468"
      decimals="INF"
      id="f-2297"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-469"
      decimals="4"
      id="f-2298"
      unitRef="number">0.1161</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-5"
      decimals="INF"
      id="f-2299"
      unitRef="number">0.0325</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-468" decimals="-3" id="f-2300" unitRef="usd">1623000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-468" decimals="-3" id="f-2301" unitRef="usd">1592000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-468" decimals="-3" id="f-2302" unitRef="usd">1614000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-468"
      decimals="4"
      id="f-2303"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-470" decimals="-3" id="f-2304" unitRef="usd">1718524000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-470" decimals="-3" id="f-2305" unitRef="usd">1706743000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-470"
      decimals="4"
      id="f-2306"
      unitRef="number">0.3450</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-471"
      decimals="INF"
      id="f-2307"
      unitRef="number">0.0618</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-471"
      decimals="4"
      id="f-2308"
      unitRef="number">0.1149</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-471" decimals="-3" id="f-2309" unitRef="usd">163594000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-471" decimals="-3" id="f-2310" unitRef="usd">162568000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-471" decimals="-3" id="f-2311" unitRef="usd">163594000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-471"
      decimals="4"
      id="f-2312"
      unitRef="number">0.0330</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-472"
      decimals="INF"
      id="f-2313"
      unitRef="number">0.0675</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-472"
      decimals="4"
      id="f-2314"
      unitRef="number">0.1221</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-472" decimals="-3" id="f-2315" unitRef="usd">84454000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-472" decimals="-3" id="f-2316" unitRef="usd">83740000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-472" decimals="-3" id="f-2317" unitRef="usd">84454000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-472"
      decimals="4"
      id="f-2318"
      unitRef="number">0.0171</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-473"
      decimals="INF"
      id="f-2319"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-473"
      decimals="4"
      id="f-2320"
      unitRef="number">0.1149</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-473" decimals="-3" id="f-2321" unitRef="usd">54603000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-473" decimals="-3" id="f-2322" unitRef="usd">53487000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-473" decimals="-3" id="f-2323" unitRef="usd">52267000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-473"
      decimals="4"
      id="f-2324"
      unitRef="number">0.0106</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-474"
      decimals="INF"
      id="f-2325"
      unitRef="number">0.0475</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-474"
      decimals="4"
      id="f-2326"
      unitRef="number">0.1021</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-474" decimals="-3" id="f-2327" unitRef="usd">5501000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-474" decimals="-3" id="f-2328" unitRef="usd">5477000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-474" decimals="-3" id="f-2329" unitRef="usd">5501000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-474"
      decimals="4"
      id="f-2330"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-475"
      decimals="INF"
      id="f-2331"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-475"
      decimals="4"
      id="f-2332"
      unitRef="number">0.1155</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-475" decimals="-3" id="f-2333" unitRef="usd">89111000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-475" decimals="-3" id="f-2334" unitRef="usd">88010000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-475" decimals="-3" id="f-2335" unitRef="usd">87637000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-475"
      decimals="4"
      id="f-2336"
      unitRef="number">0.0177</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-476"
      decimals="INF"
      id="f-2337"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-476"
      decimals="4"
      id="f-2338"
      unitRef="number">0.1139</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-476" decimals="-3" id="f-2339" unitRef="usd">10996000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-476" decimals="-3" id="f-2340" unitRef="usd">10780000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-476" decimals="-3" id="f-2341" unitRef="usd">10831000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-476"
      decimals="4"
      id="f-2342"
      unitRef="number">0.0022</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-477"
      decimals="INF"
      id="f-2343"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-477"
      decimals="4"
      id="f-2344"
      unitRef="number">0.1178</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-477" decimals="-3" id="f-2345" unitRef="usd">45584000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-477" decimals="-3" id="f-2346" unitRef="usd">44987000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-477" decimals="-3" id="f-2347" unitRef="usd">44672000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-477"
      decimals="4"
      id="f-2348"
      unitRef="number">0.0090</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-478"
      decimals="INF"
      id="f-2349"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-478"
      decimals="4"
      id="f-2350"
      unitRef="number">0.1175</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-478" decimals="-3" id="f-2351" unitRef="usd">993000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-478" decimals="-3" id="f-2352" unitRef="usd">979000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-478" decimals="-3" id="f-2353" unitRef="usd">973000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-478"
      decimals="4"
      id="f-2354"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-479"
      decimals="INF"
      id="f-2355"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-479"
      decimals="4"
      id="f-2356"
      unitRef="number">0.0935</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-479" decimals="-3" id="f-2357" unitRef="eur">78810000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-479" decimals="-3" id="f-2358" unitRef="usd">81314000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-479" decimals="-3" id="f-2359" unitRef="usd">86349000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-479"
      decimals="4"
      id="f-2360"
      unitRef="number">0.0174</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-480"
      decimals="INF"
      id="f-2361"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-480"
      decimals="4"
      id="f-2362"
      unitRef="number">0.1122</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-480" decimals="-3" id="f-2363" unitRef="usd">29443000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-480" decimals="-3" id="f-2364" unitRef="usd">29099000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-480" decimals="-3" id="f-2365" unitRef="usd">28339000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-480"
      decimals="4"
      id="f-2366"
      unitRef="number">0.0057</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-481"
      decimals="INF"
      id="f-2367"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-481"
      decimals="4"
      id="f-2368"
      unitRef="number">0.1126</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-481" decimals="-3" id="f-2369" unitRef="usd">20592000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-481" decimals="-3" id="f-2370" unitRef="usd">20360000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-481" decimals="-3" id="f-2371" unitRef="usd">19820000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-481"
      decimals="4"
      id="f-2372"
      unitRef="number">0.0040</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-482"
      decimals="INF"
      id="f-2373"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-482"
      decimals="4"
      id="f-2374"
      unitRef="number">0.1129</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-482" decimals="-3" id="f-2375" unitRef="usd">4198000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-482" decimals="-3" id="f-2376" unitRef="usd">4136000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-482" decimals="-3" id="f-2377" unitRef="usd">4040000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-482"
      decimals="4"
      id="f-2378"
      unitRef="number">0.0008</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-483"
      decimals="INF"
      id="f-2379"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-483"
      decimals="4"
      id="f-2380"
      unitRef="number">0.1090</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-483" decimals="-3" id="f-2381" unitRef="usd">5032000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-483" decimals="-3" id="f-2382" unitRef="usd">5007000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-483" decimals="-3" id="f-2383" unitRef="usd">5032000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-483"
      decimals="4"
      id="f-2384"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-484"
      decimals="INF"
      id="f-2385"
      unitRef="number">0.0425</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-484"
      decimals="4"
      id="f-2386"
      unitRef="number">0.1275</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-484" decimals="-3" id="f-2387" unitRef="usd">280000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-484" decimals="-3" id="f-2388" unitRef="usd">277000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-484" decimals="-3" id="f-2389" unitRef="usd">276000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-484"
      decimals="4"
      id="f-2390"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-485"
      decimals="INF"
      id="f-2391"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-485"
      decimals="4"
      id="f-2392"
      unitRef="number">0.1149</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-485" decimals="-3" id="f-2393" unitRef="usd">37845000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-485" decimals="-3" id="f-2394" unitRef="usd">37218000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-485" decimals="-3" id="f-2395" unitRef="usd">37206000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-485"
      decimals="4"
      id="f-2396"
      unitRef="number">0.0075</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-486"
      decimals="INF"
      id="f-2397"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-486"
      decimals="4"
      id="f-2398"
      unitRef="number">0.1150</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-486" decimals="-3" id="f-2399" unitRef="usd">11522000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-486" decimals="-3" id="f-2400" unitRef="usd">11522000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-486" decimals="-3" id="f-2401" unitRef="usd">11378000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-486"
      decimals="4"
      id="f-2402"
      unitRef="number">0.0023</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-487"
      decimals="INF"
      id="f-2403"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-487"
      decimals="4"
      id="f-2404"
      unitRef="number">0.1157</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-487" decimals="-3" id="f-2405" unitRef="usd">15960000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-487" decimals="-3" id="f-2406" unitRef="usd">15663000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-487" decimals="-3" id="f-2407" unitRef="usd">15761000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-487"
      decimals="4"
      id="f-2408"
      unitRef="number">0.0032</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-488"
      decimals="INF"
      id="f-2409"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-488"
      decimals="4"
      id="f-2410"
      unitRef="number">0.1103</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-488" decimals="-3" id="f-2411" unitRef="usd">38887000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-488" decimals="-3" id="f-2412" unitRef="usd">38431000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-488" decimals="-3" id="f-2413" unitRef="usd">34608000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-488"
      decimals="4"
      id="f-2414"
      unitRef="number">0.0070</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-489" decimals="-3" id="f-2415" unitRef="usd">393260000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-489" decimals="-3" id="f-2416" unitRef="usd">392423000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-489"
      decimals="4"
      id="f-2417"
      unitRef="number">0.0792</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-490" decimals="-3" id="f-2418" unitRef="usd">9817402000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-490" decimals="-3" id="f-2419" unitRef="usd">9722061000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-490"
      decimals="4"
      id="f-2420"
      unitRef="number">1.9637</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-491" decimals="-3" id="f-2421" unitRef="usd">9817402000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-491" decimals="-3" id="f-2422" unitRef="usd">9722061000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-491"
      decimals="4"
      id="f-2423"
      unitRef="number">1.9637</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-492"
      decimals="INF"
      id="f-2424"
      unitRef="number">0.0875</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-492"
      decimals="4"
      id="f-2425"
      unitRef="number">0.0875</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-492" decimals="-3" id="f-2426" unitRef="cad">10533000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-492" decimals="-3" id="f-2427" unitRef="usd">8296000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-492" decimals="-3" id="f-2428" unitRef="usd">7075000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-492"
      decimals="4"
      id="f-2429"
      unitRef="number">0.0014</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-493"
      decimals="INF"
      id="f-2430"
      unitRef="number">0.0875</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-493"
      decimals="4"
      id="f-2431"
      unitRef="number">0.1423</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-493" decimals="-3" id="f-2432" unitRef="usd">5183000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-493" decimals="-3" id="f-2433" unitRef="usd">5122000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-493" decimals="-3" id="f-2434" unitRef="usd">4950000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-493"
      decimals="4"
      id="f-2435"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-494" decimals="-3" id="f-2436" unitRef="usd">13418000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-494" decimals="-3" id="f-2437" unitRef="usd">12025000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-494"
      decimals="4"
      id="f-2438"
      unitRef="number">0.0024</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-495"
      decimals="INF"
      id="f-2439"
      unitRef="number">0.0700</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-495"
      decimals="4"
      id="f-2440"
      unitRef="number">0.1264</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-495" decimals="-3" id="f-2441" unitRef="usd">9619000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-495" decimals="-3" id="f-2442" unitRef="usd">9547000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-495" decimals="-3" id="f-2443" unitRef="usd">8970000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-495"
      decimals="4"
      id="f-2444"
      unitRef="number">0.0018</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-496"
      decimals="INF"
      id="f-2445"
      unitRef="number">0.1050</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-496"
      decimals="4"
      id="f-2446"
      unitRef="number">0.1597</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-496"
      decimals="INF"
      id="f-2447"
      unitRef="number">0.1597</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-496" decimals="-3" id="f-2448" unitRef="usd">12294000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-496" decimals="-3" id="f-2449" unitRef="usd">12065000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-496" decimals="-3" id="f-2450" unitRef="usd">12293000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-496"
      decimals="4"
      id="f-2451"
      unitRef="number">0.0025</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-497"
      decimals="INF"
      id="f-2452"
      unitRef="number">0.0675</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-497"
      decimals="4"
      id="f-2453"
      unitRef="number">0.1225</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-497" decimals="-3" id="f-2454" unitRef="usd">4920000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-497" decimals="-3" id="f-2455" unitRef="usd">4801000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-497" decimals="-3" id="f-2456" unitRef="usd">4908000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-497"
      decimals="4"
      id="f-2457"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-498"
      decimals="INF"
      id="f-2458"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-498"
      decimals="4"
      id="f-2459"
      unitRef="number">0.1200</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-498" decimals="-3" id="f-2460" unitRef="usd">3550000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-498" decimals="-3" id="f-2461" unitRef="usd">3516000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-498" decimals="-3" id="f-2462" unitRef="usd">3319000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-498"
      decimals="4"
      id="f-2463"
      unitRef="number">0.0007</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-499" decimals="-3" id="f-2464" unitRef="usd">43347000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-499" decimals="-3" id="f-2465" unitRef="usd">41515000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-499"
      decimals="4"
      id="f-2466"
      unitRef="number">0.0084</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-500" decimals="-3" id="f-2467" unitRef="usd">43347000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-500" decimals="-3" id="f-2468" unitRef="usd">41515000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-500"
      decimals="4"
      id="f-2469"
      unitRef="number">0.0084</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-501"
      decimals="4"
      id="f-2470"
      unitRef="number">0.1375</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-501"
      decimals="INF"
      id="f-2471"
      unitRef="number">0.1375</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-501" decimals="-3" id="f-2472" unitRef="usd">10231000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-501" decimals="-3" id="f-2473" unitRef="usd">9930000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-501" decimals="-3" id="f-2474" unitRef="usd">9924000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-501"
      decimals="4"
      id="f-2475"
      unitRef="number">0.0020</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-502" decimals="-3" id="f-2476" unitRef="usd">9930000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-502" decimals="-3" id="f-2477" unitRef="usd">9924000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-502"
      decimals="4"
      id="f-2478"
      unitRef="number">0.0020</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-503"
      decimals="0"
      id="f-2479"
      unitRef="shares">4767</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-503" decimals="-3" id="f-2480" unitRef="usd">4767000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-503" decimals="-3" id="f-2481" unitRef="usd">4699000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-503"
      decimals="4"
      id="f-2482"
      unitRef="number">0.0009</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-504"
      decimals="0"
      id="f-2483"
      unitRef="shares">902</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-504" decimals="-3" id="f-2484" unitRef="usd">902000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-504" decimals="-3" id="f-2485" unitRef="usd">507000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-504"
      decimals="4"
      id="f-2486"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-505"
      decimals="0"
      id="f-2487"
      unitRef="shares">5486923</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-505" decimals="-3" id="f-2488" unitRef="usd">5487000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-505" decimals="-3" id="f-2489" unitRef="usd">9822000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-505"
      decimals="4"
      id="f-2490"
      unitRef="number">0.0020</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-506" decimals="-3" id="f-2491" unitRef="usd">6389000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-506" decimals="-3" id="f-2492" unitRef="usd">10329000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-506"
      decimals="4"
      id="f-2493"
      unitRef="number">0.0021</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-507"
      decimals="0"
      id="f-2494"
      unitRef="shares">417006</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-507" decimals="-3" id="f-2495" unitRef="usd">417000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-507" decimals="-3" id="f-2496" unitRef="usd">417000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-507"
      decimals="4"
      id="f-2497"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-508"
      decimals="0"
      id="f-2498"
      unitRef="shares">702305</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-508" decimals="-3" id="f-2499" unitRef="usd">702000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-508" decimals="-3" id="f-2500" unitRef="usd">358000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-508"
      decimals="4"
      id="f-2501"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-509"
      decimals="0"
      id="f-2502"
      unitRef="shares">85315</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-509" decimals="-3" id="f-2503" unitRef="usd">83000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-509" decimals="-3" id="f-2504" unitRef="usd">92000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-509"
      decimals="4"
      id="f-2505"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-510"
      decimals="0"
      id="f-2506"
      unitRef="shares">6292</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-510" decimals="-3" id="f-2507" unitRef="usd">3350000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-510" decimals="-3" id="f-2508" unitRef="usd">13455000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-510"
      decimals="4"
      id="f-2509"
      unitRef="number">0.0027</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-511" decimals="-3" id="f-2510" unitRef="usd">4135000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-511" decimals="-3" id="f-2511" unitRef="usd">13905000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-511"
      decimals="4"
      id="f-2512"
      unitRef="number">0.0028</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentInterestRate
      contextRef="c-512"
      decimals="INF"
      id="f-2513"
      unitRef="number">0.1150</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-512"
      decimals="0"
      id="f-2514"
      unitRef="shares">12511857</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-512" decimals="-3" id="f-2515" unitRef="usd">12315000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-512" decimals="-3" id="f-2516" unitRef="usd">15955000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-512"
      decimals="4"
      id="f-2517"
      unitRef="number">0.0032</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-513"
      decimals="0"
      id="f-2518"
      unitRef="shares">248786</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-513" decimals="-3" id="f-2519" unitRef="usd">249000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-513" decimals="-3" id="f-2520" unitRef="usd">249000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-513"
      decimals="4"
      id="f-2521"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-514"
      decimals="0"
      id="f-2522"
      unitRef="shares">6930</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-514" decimals="-3" id="f-2523" unitRef="usd">5877000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-514" decimals="-3" id="f-2524" unitRef="usd">7049000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-514"
      decimals="4"
      id="f-2525"
      unitRef="number">0.0014</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-515"
      decimals="0"
      id="f-2526"
      unitRef="shares">369255</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-515" decimals="-3" id="f-2527" unitRef="usd">1053000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-515" decimals="-3" id="f-2528" unitRef="usd">2492000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-515"
      decimals="4"
      id="f-2529"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-516"
      decimals="0"
      id="f-2530"
      unitRef="shares">1489</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-516" decimals="-3" id="f-2531" unitRef="usd">1263000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-516" decimals="-3" id="f-2532" unitRef="usd">1515000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-516"
      decimals="4"
      id="f-2533"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-517"
      decimals="0"
      id="f-2534"
      unitRef="shares">79358</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-517" decimals="-3" id="f-2535" unitRef="usd">226000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-517" decimals="-3" id="f-2536" unitRef="usd">536000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-517"
      decimals="4"
      id="f-2537"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-518" decimals="-3" id="f-2538" unitRef="usd">8419000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-518" decimals="-3" id="f-2539" unitRef="usd">11592000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-518"
      decimals="4"
      id="f-2540"
      unitRef="number">0.0023</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-519"
      decimals="0"
      id="f-2541"
      unitRef="shares">539</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-519" decimals="-3" id="f-2542" unitRef="usd">539000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-519" decimals="-3" id="f-2543" unitRef="usd">302000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-519"
      decimals="4"
      id="f-2544"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-520"
      decimals="0"
      id="f-2545"
      unitRef="shares">625944</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-520" decimals="-3" id="f-2546" unitRef="usd">607000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-520" decimals="-3" id="f-2547" unitRef="usd">596000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-520"
      decimals="4"
      id="f-2548"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-521"
      decimals="0"
      id="f-2549"
      unitRef="shares">2201</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-521" decimals="-3" id="f-2550" unitRef="usd">392000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-521" decimals="-3" id="f-2551" unitRef="usd">172000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-521"
      decimals="4"
      id="f-2552"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-522"
      decimals="0"
      id="f-2553"
      unitRef="shares">1185</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-522" decimals="-3" id="f-2554" unitRef="usd">211000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-522" decimals="-3" id="f-2555" unitRef="usd">93000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-522"
      decimals="4"
      id="f-2556"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-523" decimals="-3" id="f-2557" unitRef="usd">1210000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-523" decimals="-3" id="f-2558" unitRef="usd">861000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-523"
      decimals="4"
      id="f-2559"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-524"
      decimals="0"
      id="f-2560"
      unitRef="shares">11710</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-524" decimals="-3" id="f-2561" unitRef="usd">12000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-524" decimals="-3" id="f-2562" unitRef="usd">1000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-524"
      decimals="4"
      id="f-2563"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-525"
      decimals="0"
      id="f-2564"
      unitRef="shares">58458</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-525" decimals="-3" id="f-2565" unitRef="usd">58000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-525" decimals="-3" id="f-2566" unitRef="usd">54000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-525"
      decimals="4"
      id="f-2567"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentInterestRate
      contextRef="c-526"
      decimals="INF"
      id="f-2568"
      unitRef="number">0.0600</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-526"
      decimals="0"
      id="f-2569"
      unitRef="shares">9850</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-526" decimals="-3" id="f-2570" unitRef="usd">985000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-526" decimals="-3" id="f-2571" unitRef="usd">985000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-526"
      decimals="4"
      id="f-2572"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-527" decimals="-3" id="f-2573" unitRef="usd">1055000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-527" decimals="-3" id="f-2574" unitRef="usd">1040000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-527"
      decimals="4"
      id="f-2575"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-528"
      decimals="0"
      id="f-2576"
      unitRef="shares">14907400</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-528" decimals="-3" id="f-2577" unitRef="usd">0</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-528" decimals="-3" id="f-2578" unitRef="usd">0</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-528"
      decimals="4"
      id="f-2579"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-529"
      decimals="0"
      id="f-2580"
      unitRef="shares">50000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-529" decimals="-3" id="f-2581" unitRef="usd">50000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-529" decimals="-3" id="f-2582" unitRef="usd">88000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-529"
      decimals="4"
      id="f-2583"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-530" decimals="-3" id="f-2584" unitRef="usd">50000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-530" decimals="-3" id="f-2585" unitRef="usd">88000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-530"
      decimals="4"
      id="f-2586"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-531"
      decimals="0"
      id="f-2587"
      unitRef="shares">2854133</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-531" decimals="-3" id="f-2588" unitRef="usd">2854000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-531" decimals="-3" id="f-2589" unitRef="usd">3054000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-531"
      decimals="4"
      id="f-2590"
      unitRef="number">0.0006</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-532"
      decimals="0"
      id="f-2591"
      unitRef="shares">3500000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-532" decimals="-3" id="f-2592" unitRef="usd">3500000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-532" decimals="-3" id="f-2593" unitRef="usd">6055000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-532"
      decimals="4"
      id="f-2594"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-533"
      decimals="0"
      id="f-2595"
      unitRef="shares">385781</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-533" decimals="-3" id="f-2596" unitRef="usd">386000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-533" decimals="-3" id="f-2597" unitRef="usd">386000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-533"
      decimals="4"
      id="f-2598"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-534" decimals="-3" id="f-2599" unitRef="usd">3886000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-534" decimals="-3" id="f-2600" unitRef="usd">6441000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-534"
      decimals="4"
      id="f-2601"
      unitRef="number">0.0013</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-535"
      decimals="0"
      id="f-2602"
      unitRef="shares">42045</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-535" decimals="-3" id="f-2603" unitRef="usd">462000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-535" decimals="-3" id="f-2604" unitRef="usd">117000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-535"
      decimals="4"
      id="f-2605"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-536"
      decimals="0"
      id="f-2606"
      unitRef="shares">49139</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-536" decimals="-3" id="f-2607" unitRef="usd">213000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-536" decimals="-3" id="f-2608" unitRef="usd">102000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-536"
      decimals="4"
      id="f-2609"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-537"
      decimals="0"
      id="f-2610"
      unitRef="shares">90</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-537" decimals="-3" id="f-2611" unitRef="usd">57000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-537" decimals="-3" id="f-2612" unitRef="usd">40000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-537"
      decimals="4"
      id="f-2613"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-538"
      decimals="0"
      id="f-2614"
      unitRef="shares">90000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-538" decimals="-3" id="f-2615" unitRef="usd">33000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-538" decimals="-3" id="f-2616" unitRef="usd">11000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-538"
      decimals="4"
      id="f-2617"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentInterestRate
      contextRef="c-539"
      decimals="INF"
      id="f-2618"
      unitRef="number">0.1050</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-539"
      decimals="0"
      id="f-2619"
      unitRef="shares">1545</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-539" decimals="-3" id="f-2620" unitRef="usd">1506000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-539" decimals="-3" id="f-2621" unitRef="usd">1819000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-539"
      decimals="4"
      id="f-2622"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-540"
      decimals="0"
      id="f-2623"
      unitRef="shares">3550000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-540" decimals="-3" id="f-2624" unitRef="usd">3444000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-540" decimals="-3" id="f-2625" unitRef="usd">3568000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-540"
      decimals="4"
      id="f-2626"
      unitRef="number">0.0007</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-541"
      decimals="0"
      id="f-2627"
      unitRef="shares">651175</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-541" decimals="-3" id="f-2628" unitRef="usd">651000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-541" decimals="-3" id="f-2629" unitRef="usd">674000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-541"
      decimals="4"
      id="f-2630"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-542"
      decimals="0"
      id="f-2631"
      unitRef="shares">1965727</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-542" decimals="-3" id="f-2632" unitRef="usd">1965000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-542" decimals="-3" id="f-2633" unitRef="usd">1965000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-542"
      decimals="4"
      id="f-2634"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-543"
      decimals="0"
      id="f-2635"
      unitRef="shares">2073</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-543" decimals="-3" id="f-2636" unitRef="usd">21000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-543" decimals="-3" id="f-2637" unitRef="usd">21000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-543"
      decimals="4"
      id="f-2638"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentInterestRate
      contextRef="c-544"
      decimals="INF"
      id="f-2639"
      unitRef="number">0.1250</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-544"
      decimals="0"
      id="f-2640"
      unitRef="shares">373</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-544" decimals="-3" id="f-2641" unitRef="usd">361000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-544" decimals="-3" id="f-2642" unitRef="usd">418000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-544"
      decimals="4"
      id="f-2643"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-545" decimals="-3" id="f-2644" unitRef="usd">8713000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-545" decimals="-3" id="f-2645" unitRef="usd">8735000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-545"
      decimals="4"
      id="f-2646"
      unitRef="number">0.0017</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-546"
      decimals="0"
      id="f-2647"
      unitRef="shares">384520</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-546" decimals="-3" id="f-2648" unitRef="usd">5200000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-546" decimals="-3" id="f-2649" unitRef="usd">7171000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-546"
      decimals="4"
      id="f-2650"
      unitRef="number">0.0014</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-547"
      decimals="0"
      id="f-2651"
      unitRef="shares">27536</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-547" decimals="-3" id="f-2652" unitRef="usd">2909000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-547" decimals="-3" id="f-2653" unitRef="usd">3776000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-547"
      decimals="4"
      id="f-2654"
      unitRef="number">0.0008</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-548"
      decimals="0"
      id="f-2655"
      unitRef="shares">369</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-548" decimals="-3" id="f-2656" unitRef="usd">372000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-548" decimals="-3" id="f-2657" unitRef="usd">536000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-548"
      decimals="4"
      id="f-2658"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-549" decimals="-3" id="f-2659" unitRef="usd">3281000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-549" decimals="-3" id="f-2660" unitRef="usd">4312000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-549"
      decimals="4"
      id="f-2661"
      unitRef="number">0.0009</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-550" decimals="-3" id="f-2662" unitRef="usd">63479000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-550" decimals="-3" id="f-2663" unitRef="usd">89150000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-550"
      decimals="4"
      id="f-2664"
      unitRef="number">0.0178</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-551" decimals="-3" id="f-2665" unitRef="usd">1000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-551" decimals="-3" id="f-2666" unitRef="usd">5790000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-551"
      decimals="4"
      id="f-2667"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-552" decimals="-3" id="f-2668" unitRef="usd">1000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-552" decimals="-3" id="f-2669" unitRef="usd">5790000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-552"
      decimals="4"
      id="f-2670"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-553" decimals="-3" id="f-2671" unitRef="usd">63480000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-553" decimals="-3" id="f-2672" unitRef="usd">94940000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-553"
      decimals="4"
      id="f-2673"
      unitRef="number">0.0190</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-129" decimals="-3" id="f-2674" unitRef="usd">9934158000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-129" decimals="-3" id="f-2675" unitRef="usd">9862650000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-129"
      decimals="4"
      id="f-2676"
      unitRef="number">1.9919</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-131" decimals="-3" id="f-2677" unitRef="usd">1000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-131" decimals="-3" id="f-2678" unitRef="usd">5790000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-131"
      decimals="4"
      id="f-2679"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-554" decimals="-3" id="f-2680" unitRef="usd">9934159000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-554" decimals="-3" id="f-2681" unitRef="usd">9868440000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-554"
      decimals="4"
      id="f-2682"
      unitRef="number">1.9931</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-555" decimals="-3" id="f-2683" unitRef="usd">19961000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-555" decimals="-3" id="f-2684" unitRef="usd">19961000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-555"
      decimals="4"
      id="f-2685"
      unitRef="number">0.0040</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-556" decimals="-3" id="f-2686" unitRef="usd">134896000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-556" decimals="-3" id="f-2687" unitRef="usd">134896000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-556"
      decimals="4"
      id="f-2688"
      unitRef="number">0.0272</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-557" decimals="-3" id="f-2689" unitRef="usd">10089016000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-557" decimals="-3" id="f-2690" unitRef="usd">10023297000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-557"
      decimals="4"
      id="f-2691"
      unitRef="number">2.0243</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <bxsl:InvestmentPercentageOfPortfolioAboveFloorRate contextRef="c-5" decimals="3" id="f-2692" unitRef="number">0.937</bxsl:InvestmentPercentageOfPortfolioAboveFloorRate>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-558"
      decimals="INF"
      id="f-2693"
      unitRef="number">0.70</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-559"
      decimals="3"
      id="f-2694"
      unitRef="number">0.110</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-560" decimals="-3" id="f-2695" unitRef="usd">276000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-560" decimals="-3" id="f-2696" unitRef="usd">68000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-561" decimals="-3" id="f-2697" unitRef="usd">9832000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-561" decimals="-3" id="f-2698" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-562" decimals="-3" id="f-2699" unitRef="usd">14182000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-562" decimals="-3" id="f-2700" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-563" decimals="-3" id="f-2701" unitRef="usd">1301000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-563" decimals="-3" id="f-2702" unitRef="usd">26000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-564" decimals="-3" id="f-2703" unitRef="usd">158000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-564" decimals="-3" id="f-2704" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-565" decimals="-3" id="f-2705" unitRef="usd">1291000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-565" decimals="-3" id="f-2706" unitRef="usd">6000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-566" decimals="-3" id="f-2707" unitRef="usd">243000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-566" decimals="-3" id="f-2708" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-567" decimals="-3" id="f-2709" unitRef="usd">75000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-567" decimals="-3" id="f-2710" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-568" decimals="-3" id="f-2711" unitRef="usd">488000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-568" decimals="-3" id="f-2712" unitRef="usd">5000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-569" decimals="-3" id="f-2713" unitRef="usd">589000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-569" decimals="-3" id="f-2714" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-570" decimals="-3" id="f-2715" unitRef="usd">161000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-570" decimals="-3" id="f-2716" unitRef="usd">1000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-571" decimals="-3" id="f-2717" unitRef="usd">369000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-571" decimals="-3" id="f-2718" unitRef="usd">5000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-572" decimals="-3" id="f-2719" unitRef="usd">1250000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-572" decimals="-3" id="f-2720" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-573" decimals="-3" id="f-2721" unitRef="usd">3000000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-573" decimals="-3" id="f-2722" unitRef="usd">30000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-574" decimals="-3" id="f-2723" unitRef="usd">1293000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-574" decimals="-3" id="f-2724" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-575" decimals="-3" id="f-2725" unitRef="usd">99000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-575" decimals="-3" id="f-2726" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-576" decimals="-3" id="f-2727" unitRef="usd">142000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-576" decimals="-3" id="f-2728" unitRef="usd">3000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-577" decimals="-3" id="f-2729" unitRef="usd">28662000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-577" decimals="-3" id="f-2730" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-578" decimals="-3" id="f-2731" unitRef="usd">591000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-578" decimals="-3" id="f-2732" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-579" decimals="-3" id="f-2733" unitRef="usd">514000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-579" decimals="-3" id="f-2734" unitRef="usd">3000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-580" decimals="-3" id="f-2735" unitRef="usd">277000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-580" decimals="-3" id="f-2736" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-581" decimals="-3" id="f-2737" unitRef="usd">2244000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-581" decimals="-3" id="f-2738" unitRef="usd">34000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-582" decimals="-3" id="f-2739" unitRef="usd">7758000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-582" decimals="-3" id="f-2740" unitRef="usd">155000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-583" decimals="-3" id="f-2741" unitRef="usd">7613000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-583" decimals="-3" id="f-2742" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-584" decimals="-3" id="f-2743" unitRef="usd">7282000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-584" decimals="-3" id="f-2744" unitRef="usd">55000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-585" decimals="-3" id="f-2745" unitRef="usd">3641000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-585" decimals="-3" id="f-2746" unitRef="usd">36000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-586" decimals="-3" id="f-2747" unitRef="usd">836000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-586" decimals="-3" id="f-2748" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-587" decimals="-3" id="f-2749" unitRef="usd">322000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-587" decimals="-3" id="f-2750" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-588" decimals="-3" id="f-2751" unitRef="usd">178000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-588" decimals="-3" id="f-2752" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-589" decimals="-3" id="f-2753" unitRef="usd">43592000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-589" decimals="-3" id="f-2754" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-590" decimals="-3" id="f-2755" unitRef="usd">2917000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-590" decimals="-3" id="f-2756" unitRef="usd">44000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-591" decimals="-3" id="f-2757" unitRef="usd">1050000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-591" decimals="-3" id="f-2758" unitRef="usd">21000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-592" decimals="-3" id="f-2759" unitRef="usd">18177000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-592" decimals="-3" id="f-2760" unitRef="usd">364000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-593" decimals="-3" id="f-2761" unitRef="usd">12118000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-593" decimals="-3" id="f-2762" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-594" decimals="-3" id="f-2763" unitRef="usd">11316000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-594" decimals="-3" id="f-2764" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-595" decimals="-3" id="f-2765" unitRef="usd">898000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-595" decimals="-3" id="f-2766" unitRef="usd">18000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-596" decimals="-3" id="f-2767" unitRef="usd">3668000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-596" decimals="-3" id="f-2768" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-597" decimals="-3" id="f-2769" unitRef="usd">588000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-597" decimals="-3" id="f-2770" unitRef="usd">6000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-598" decimals="-3" id="f-2771" unitRef="usd">345000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-598" decimals="-3" id="f-2772" unitRef="usd">1000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-599" decimals="-3" id="f-2773" unitRef="usd">3043000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-599" decimals="-3" id="f-2774" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-600" decimals="-3" id="f-2775" unitRef="usd">5431000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-600" decimals="-3" id="f-2776" unitRef="usd">448000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-601" decimals="-3" id="f-2777" unitRef="usd">3509000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-601" decimals="-3" id="f-2778" unitRef="usd">38000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-602" decimals="-3" id="f-2779" unitRef="usd">8730000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-602" decimals="-3" id="f-2780" unitRef="usd">131000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-603" decimals="-3" id="f-2781" unitRef="usd">164000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-603" decimals="-3" id="f-2782" unitRef="usd">2000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-604" decimals="-3" id="f-2783" unitRef="usd">126000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-604" decimals="-3" id="f-2784" unitRef="usd">1000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-605" decimals="-3" id="f-2785" unitRef="usd">3214000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-605" decimals="-3" id="f-2786" unitRef="usd">64000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-606" decimals="-3" id="f-2787" unitRef="usd">966000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-606" decimals="-3" id="f-2788" unitRef="usd">10000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-607" decimals="-3" id="f-2789" unitRef="usd">6438000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-607" decimals="-3" id="f-2790" unitRef="usd">156000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-608" decimals="-3" id="f-2791" unitRef="usd">12695000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-608" decimals="-3" id="f-2792" unitRef="usd">190000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-609" decimals="-3" id="f-2793" unitRef="usd">8063000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-609" decimals="-3" id="f-2794" unitRef="usd">60000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-610" decimals="-3" id="f-2795" unitRef="usd">1761000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-610" decimals="-3" id="f-2796" unitRef="usd">3000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-611" decimals="-3" id="f-2797" unitRef="usd">2960000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-611" decimals="-3" id="f-2798" unitRef="usd">118000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-612" decimals="-3" id="f-2799" unitRef="usd">1682000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-612" decimals="-3" id="f-2800" unitRef="usd">591000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-613" decimals="-3" id="f-2801" unitRef="usd">16456000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-613" decimals="-3" id="f-2802" unitRef="usd">165000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-614" decimals="-3" id="f-2803" unitRef="usd">5776000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-614" decimals="-3" id="f-2804" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-615" decimals="-3" id="f-2805" unitRef="usd">433000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-615" decimals="-3" id="f-2806" unitRef="usd">153000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-616" decimals="-3" id="f-2807" unitRef="usd">2064000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-616" decimals="-3" id="f-2808" unitRef="usd">83000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-617" decimals="-3" id="f-2809" unitRef="usd">46934000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-617" decimals="-3" id="f-2810" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-618" decimals="-3" id="f-2811" unitRef="usd">1495000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-618" decimals="-3" id="f-2812" unitRef="usd">15000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-619" decimals="-3" id="f-2813" unitRef="usd">1910000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-619" decimals="-3" id="f-2814" unitRef="usd">24000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-620" decimals="-3" id="f-2815" unitRef="usd">1637000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-620" decimals="-3" id="f-2816" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-621" decimals="-3" id="f-2817" unitRef="usd">1429000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-621" decimals="-3" id="f-2818" unitRef="usd">26000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-622" decimals="-3" id="f-2819" unitRef="usd">2382000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-622" decimals="-3" id="f-2820" unitRef="usd">36000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-623" decimals="-3" id="f-2821" unitRef="usd">6920000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-623" decimals="-3" id="f-2822" unitRef="usd">69000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-624" decimals="-3" id="f-2823" unitRef="usd">1009000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-624" decimals="-3" id="f-2824" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-625" decimals="-3" id="f-2825" unitRef="usd">257000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-625" decimals="-3" id="f-2826" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-626" decimals="-3" id="f-2827" unitRef="usd">1107000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-626" decimals="-3" id="f-2828" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-627" decimals="-3" id="f-2829" unitRef="usd">257000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-627" decimals="-3" id="f-2830" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-628" decimals="-3" id="f-2831" unitRef="usd">516000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-628" decimals="-3" id="f-2832" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-629" decimals="-3" id="f-2833" unitRef="usd">10996000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-629" decimals="-3" id="f-2834" unitRef="usd">137000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-630" decimals="-3" id="f-2835" unitRef="usd">8800000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-630" decimals="-3" id="f-2836" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-631" decimals="-3" id="f-2837" unitRef="usd">2791000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-631" decimals="-3" id="f-2838" unitRef="usd">63000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-632" decimals="-3" id="f-2839" unitRef="usd">2120000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-632" decimals="-3" id="f-2840" unitRef="usd">32000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-633" decimals="-3" id="f-2841" unitRef="usd">561000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-633" decimals="-3" id="f-2842" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-634" decimals="-3" id="f-2843" unitRef="usd">480000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-634" decimals="-3" id="f-2844" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-635" decimals="-3" id="f-2845" unitRef="usd">3040000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-635" decimals="-3" id="f-2846" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-636" decimals="-3" id="f-2847" unitRef="usd">437000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-636" decimals="-3" id="f-2848" unitRef="usd">1000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-637" decimals="-3" id="f-2849" unitRef="usd">677000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-637" decimals="-3" id="f-2850" unitRef="usd">14000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-638" decimals="-3" id="f-2851" unitRef="usd">1062000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-638" decimals="-3" id="f-2852" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-639" decimals="-3" id="f-2853" unitRef="usd">37000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-639" decimals="-3" id="f-2854" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-640" decimals="-3" id="f-2855" unitRef="usd">42000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-640" decimals="-3" id="f-2856" unitRef="usd">1000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-641" decimals="-3" id="f-2857" unitRef="usd">2961000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-641" decimals="-3" id="f-2858" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-642" decimals="-3" id="f-2859" unitRef="usd">3241000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-642" decimals="-3" id="f-2860" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-643" decimals="-3" id="f-2861" unitRef="usd">2254000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-643" decimals="-3" id="f-2862" unitRef="usd">45000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-644" decimals="-3" id="f-2863" unitRef="usd">9396000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-644" decimals="-3" id="f-2864" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-645" decimals="-3" id="f-2865" unitRef="usd">31940000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-645" decimals="-3" id="f-2866" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-646" decimals="-3" id="f-2867" unitRef="usd">3042000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-646" decimals="-3" id="f-2868" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-647" decimals="-3" id="f-2869" unitRef="usd">3583000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-647" decimals="-3" id="f-2870" unitRef="usd">18000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-648" decimals="-3" id="f-2871" unitRef="usd">661000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-648" decimals="-3" id="f-2872" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-649" decimals="-3" id="f-2873" unitRef="usd">102000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-649" decimals="-3" id="f-2874" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-650" decimals="-3" id="f-2875" unitRef="usd">11060000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-650" decimals="-3" id="f-2876" unitRef="usd">138000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-651" decimals="-3" id="f-2877" unitRef="usd">1381000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-651" decimals="-3" id="f-2878" unitRef="usd">14000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-652" decimals="-3" id="f-2879" unitRef="usd">17064000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-652" decimals="-3" id="f-2880" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-653" decimals="-3" id="f-2881" unitRef="usd">3673000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-653" decimals="-3" id="f-2882" unitRef="usd">101000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-654" decimals="-3" id="f-2883" unitRef="usd">3318000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-654" decimals="-3" id="f-2884" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-655" decimals="-3" id="f-2885" unitRef="usd">91000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-655" decimals="-3" id="f-2886" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-656" decimals="-3" id="f-2887" unitRef="usd">51000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-656" decimals="-3" id="f-2888" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-657" decimals="-3" id="f-2889" unitRef="usd">930000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-657" decimals="-3" id="f-2890" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-658" decimals="-3" id="f-2891" unitRef="usd">1276000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-658" decimals="-3" id="f-2892" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-659" decimals="-3" id="f-2893" unitRef="usd">784000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-659" decimals="-3" id="f-2894" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-660" decimals="-3" id="f-2895" unitRef="usd">2633000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-660" decimals="-3" id="f-2896" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-661" decimals="-3" id="f-2897" unitRef="usd">628000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-661" decimals="-3" id="f-2898" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-662" decimals="-3" id="f-2899" unitRef="usd">485000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-662" decimals="-3" id="f-2900" unitRef="usd">12000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-663" decimals="-3" id="f-2901" unitRef="usd">5508000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-663" decimals="-3" id="f-2902" unitRef="usd">138000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-664" decimals="-3" id="f-2903" unitRef="usd">6610000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-664" decimals="-3" id="f-2904" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-665" decimals="-3" id="f-2905" unitRef="usd">916000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-665" decimals="-3" id="f-2906" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-666" decimals="-3" id="f-2907" unitRef="usd">342000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-666" decimals="-3" id="f-2908" unitRef="usd">17000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-667" decimals="-3" id="f-2909" unitRef="usd">848000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-667" decimals="-3" id="f-2910" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-668" decimals="-3" id="f-2911" unitRef="usd">59287000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-668" decimals="-3" id="f-2912" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-669" decimals="-3" id="f-2913" unitRef="usd">14992000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-669" decimals="-3" id="f-2914" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-670" decimals="-3" id="f-2915" unitRef="usd">268000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-670" decimals="-3" id="f-2916" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-671" decimals="-3" id="f-2917" unitRef="usd">830000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-671" decimals="-3" id="f-2918" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-672" decimals="-3" id="f-2919" unitRef="usd">283000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-672" decimals="-3" id="f-2920" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-673" decimals="-3" id="f-2921" unitRef="usd">871000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-673" decimals="-3" id="f-2922" unitRef="usd">11000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-674" decimals="-3" id="f-2923" unitRef="usd">968000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-674" decimals="-3" id="f-2924" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-675" decimals="-3" id="f-2925" unitRef="usd">10763000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-675" decimals="-3" id="f-2926" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-676" decimals="-3" id="f-2927" unitRef="usd">1313000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-676" decimals="-3" id="f-2928" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-677" decimals="-3" id="f-2929" unitRef="usd">2679000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-677" decimals="-3" id="f-2930" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-678" decimals="-3" id="f-2931" unitRef="usd">1516000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-678" decimals="-3" id="f-2932" unitRef="usd">28000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-679" decimals="-3" id="f-2933" unitRef="usd">1822000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-679" decimals="-3" id="f-2934" unitRef="usd">3000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-680" decimals="-3" id="f-2935" unitRef="usd">40238000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-680" decimals="-3" id="f-2936" unitRef="usd">201000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-681" decimals="-3" id="f-2937" unitRef="usd">4024000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-681" decimals="-3" id="f-2938" unitRef="usd">40000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-682" decimals="-3" id="f-2939" unitRef="usd">3086000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-682" decimals="-3" id="f-2940" unitRef="usd">34000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-683" decimals="-3" id="f-2941" unitRef="usd">5394000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-683" decimals="-3" id="f-2942" unitRef="usd">108000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-684" decimals="-3" id="f-2943" unitRef="usd">24746000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-684" decimals="-3" id="f-2944" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-685" decimals="-3" id="f-2945" unitRef="usd">2911000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-685" decimals="-3" id="f-2946" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-686" decimals="-3" id="f-2947" unitRef="usd">933000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-686" decimals="-3" id="f-2948" unitRef="usd">19000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-687" decimals="-3" id="f-2949" unitRef="usd">2617000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-687" decimals="-3" id="f-2950" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-688" decimals="-3" id="f-2951" unitRef="usd">177000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-688" decimals="-3" id="f-2952" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-689" decimals="-3" id="f-2953" unitRef="usd">4729000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-689" decimals="-3" id="f-2954" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-690" decimals="-3" id="f-2955" unitRef="usd">250000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-690" decimals="-3" id="f-2956" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-691" decimals="-3" id="f-2957" unitRef="usd">9565000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-691" decimals="-3" id="f-2958" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-692" decimals="-3" id="f-2959" unitRef="usd">18279000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-692" decimals="-3" id="f-2960" unitRef="usd">183000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-693" decimals="-3" id="f-2961" unitRef="usd">595000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-693" decimals="-3" id="f-2962" unitRef="usd">9000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-694" decimals="-3" id="f-2963" unitRef="usd">272000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-694" decimals="-3" id="f-2964" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-695" decimals="-3" id="f-2965" unitRef="usd">4007000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-695" decimals="-3" id="f-2966" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-696" decimals="-3" id="f-2967" unitRef="usd">469000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-696" decimals="-3" id="f-2968" unitRef="usd">9000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-697" decimals="-3" id="f-2969" unitRef="usd">5009000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-697" decimals="-3" id="f-2970" unitRef="usd">50000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-698" decimals="-3" id="f-2971" unitRef="usd">159000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-698" decimals="-3" id="f-2972" unitRef="usd">1000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-699" decimals="-3" id="f-2973" unitRef="usd">78000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-699" decimals="-3" id="f-2974" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-700" decimals="-3" id="f-2975" unitRef="usd">520000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-700" decimals="-3" id="f-2976" unitRef="usd">17000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-701" decimals="-3" id="f-2977" unitRef="usd">353000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-701" decimals="-3" id="f-2978" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-702" decimals="-3" id="f-2979" unitRef="usd">16623000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-702" decimals="-3" id="f-2980" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-703" decimals="-3" id="f-2981" unitRef="usd">333000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-703" decimals="-3" id="f-2982" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-704" decimals="-3" id="f-2983" unitRef="usd">18278000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-704" decimals="-3" id="f-2984" unitRef="usd">183000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-705" decimals="-3" id="f-2985" unitRef="usd">94000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-705" decimals="-3" id="f-2986" unitRef="usd">3000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-706" decimals="-3" id="f-2987" unitRef="usd">25000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-706" decimals="-3" id="f-2988" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-707" decimals="-3" id="f-2989" unitRef="usd">1931000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-707" decimals="-3" id="f-2990" unitRef="usd">10000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-708" decimals="-3" id="f-2991" unitRef="usd">3000000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-708" decimals="-3" id="f-2992" unitRef="usd">135000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-709" decimals="-3" id="f-2993" unitRef="usd">3737000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-709" decimals="-3" id="f-2994" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-710" decimals="-3" id="f-2995" unitRef="usd">66000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-710" decimals="-3" id="f-2996" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-711" decimals="-3" id="f-2997" unitRef="usd">75000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-711" decimals="-3" id="f-2998" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-712" decimals="-3" id="f-2999" unitRef="usd">53000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-712" decimals="-3" id="f-3000" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-713" decimals="-3" id="f-3001" unitRef="usd">139000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-713" decimals="-3" id="f-3002" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-714" decimals="-3" id="f-3003" unitRef="usd">3292000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-714" decimals="-3" id="f-3004" unitRef="usd">49000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-715" decimals="-3" id="f-3005" unitRef="usd">275000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-715" decimals="-3" id="f-3006" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-716" decimals="-3" id="f-3007" unitRef="usd">163000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-716" decimals="-3" id="f-3008" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-717" decimals="-3" id="f-3009" unitRef="usd">249000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-717" decimals="-3" id="f-3010" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-718" decimals="-3" id="f-3011" unitRef="usd">93000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-718" decimals="-3" id="f-3012" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-719" decimals="-3" id="f-3013" unitRef="usd">6000000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-719" decimals="-3" id="f-3014" unitRef="usd">75000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-720" decimals="-3" id="f-3015" unitRef="usd">9300000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-720" decimals="-3" id="f-3016" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-721" decimals="-3" id="f-3017" unitRef="usd">432000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-721" decimals="-3" id="f-3018" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-722" decimals="-3" id="f-3019" unitRef="usd">2794000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-722" decimals="-3" id="f-3020" unitRef="usd">28000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-723" decimals="-3" id="f-3021" unitRef="usd">1111000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-723" decimals="-3" id="f-3022" unitRef="usd">22000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-724" decimals="-3" id="f-3023" unitRef="usd">2607000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-724" decimals="-3" id="f-3024" unitRef="usd">39000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-725" decimals="-3" id="f-3025" unitRef="usd">1233000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-725" decimals="-3" id="f-3026" unitRef="usd">31000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-726" decimals="-3" id="f-3027" unitRef="usd">15786000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-726" decimals="-3" id="f-3028" unitRef="usd">237000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-727" decimals="-3" id="f-3029" unitRef="usd">865000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-727" decimals="-3" id="f-3030" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-728" decimals="-3" id="f-3031" unitRef="usd">1155000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-728" decimals="-3" id="f-3032" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-729" decimals="-3" id="f-3033" unitRef="usd">155000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-729" decimals="-3" id="f-3034" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-730" decimals="-3" id="f-3035" unitRef="usd">371000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-730" decimals="-3" id="f-3036" unitRef="usd">13000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-731" decimals="-3" id="f-3037" unitRef="usd">127000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-731" decimals="-3" id="f-3038" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-732" decimals="-3" id="f-3039" unitRef="usd">830000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-732" decimals="-3" id="f-3040" unitRef="usd">190000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-733" decimals="-3" id="f-3041" unitRef="usd">402000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-733" decimals="-3" id="f-3042" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-734" decimals="-3" id="f-3043" unitRef="usd">6881000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-734" decimals="-3" id="f-3044" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-735" decimals="-3" id="f-3045" unitRef="usd">11274000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-735" decimals="-3" id="f-3046" unitRef="usd">113000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-736" decimals="-3" id="f-3047" unitRef="usd">1433000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-736" decimals="-3" id="f-3048" unitRef="usd">14000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-737" decimals="-3" id="f-3049" unitRef="usd">4747000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-737" decimals="-3" id="f-3050" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-738" decimals="-3" id="f-3051" unitRef="usd">31468000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-738" decimals="-3" id="f-3052" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-739" decimals="-3" id="f-3053" unitRef="usd">20901000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-739" decimals="-3" id="f-3054" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-740" decimals="-3" id="f-3055" unitRef="usd">440000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-740" decimals="-3" id="f-3056" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-741" decimals="-3" id="f-3057" unitRef="usd">241000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-741" decimals="-3" id="f-3058" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-742" decimals="-3" id="f-3059" unitRef="usd">46867000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-742" decimals="-3" id="f-3060" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-743" decimals="-3" id="f-3061" unitRef="usd">3233000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-743" decimals="-3" id="f-3062" unitRef="usd">73000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-744" decimals="-3" id="f-3063" unitRef="usd">1155000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-744" decimals="-3" id="f-3064" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-745" decimals="-3" id="f-3065" unitRef="usd">17000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-745" decimals="-3" id="f-3066" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-746" decimals="-3" id="f-3067" unitRef="usd">47025000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-746" decimals="-3" id="f-3068" unitRef="usd">470000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-747" decimals="-3" id="f-3069" unitRef="usd">2939000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-747" decimals="-3" id="f-3070" unitRef="usd">59000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-748" decimals="-3" id="f-3071" unitRef="usd">6667000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-748" decimals="-3" id="f-3072" unitRef="usd">200000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-749" decimals="-3" id="f-3073" unitRef="usd">169000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-749" decimals="-3" id="f-3074" unitRef="usd">3000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-750" decimals="-3" id="f-3075" unitRef="usd">361000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-750" decimals="-3" id="f-3076" unitRef="usd">5000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-129" decimals="-3" id="f-3077" unitRef="usd">985936000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-129" decimals="-3" id="f-3078" unitRef="usd">6660000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-751"
      decimals="INF"
      id="f-3079"
      unitRef="number">0</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-752"
      decimals="INF"
      id="f-3080"
      unitRef="number">0.0050</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-753"
      decimals="INF"
      id="f-3081"
      unitRef="number">0.0075</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-754"
      decimals="INF"
      id="f-3082"
      unitRef="number">0.0100</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-755"
      decimals="INF"
      id="f-3083"
      unitRef="number">0.0125</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-756"
      decimals="INF"
      id="f-3084"
      unitRef="number">0.0150</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-757"
      decimals="INF"
      id="f-3085"
      unitRef="number">0.0200</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-758" decimals="-3" id="f-3086" unitRef="usd">56584000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions contextRef="c-759" decimals="-3" id="f-3087" unitRef="usd">0</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions contextRef="c-759" decimals="-3" id="f-3088" unitRef="usd">44921000</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease contextRef="c-759" decimals="-3" id="f-3089" unitRef="usd">-14156000</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease>
    <us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax contextRef="c-759" decimals="-3" id="f-3090" unitRef="usd">8283000</us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-760" decimals="-3" id="f-3091" unitRef="usd">5790000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InterestAndDividendIncomeSecurities contextRef="c-759" decimals="-3" id="f-3092" unitRef="usd">0</us-gaap:InterestAndDividendIncomeSecurities>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-761" decimals="-3" id="f-3093" unitRef="usd">56584000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions contextRef="c-762" decimals="-3" id="f-3094" unitRef="usd">0</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions contextRef="c-762" decimals="-3" id="f-3095" unitRef="usd">44921000</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease contextRef="c-762" decimals="-3" id="f-3096" unitRef="usd">-14156000</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease>
    <us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax contextRef="c-762" decimals="-3" id="f-3097" unitRef="usd">8283000</us-gaap:RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-763" decimals="-3" id="f-3098" unitRef="usd">5790000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InterestAndDividendIncomeSecurities contextRef="c-762" decimals="-3" id="f-3099" unitRef="usd">0</us-gaap:InterestAndDividendIncomeSecurities>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-764"
      decimals="INF"
      id="f-3100"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-764"
      decimals="4"
      id="f-3101"
      unitRef="number">0.1013</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-764" decimals="-3" id="f-3102" unitRef="usd">199393000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-764" decimals="-3" id="f-3103" unitRef="usd">197335000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-764" decimals="-3" id="f-3104" unitRef="usd">195405000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-764"
      decimals="4"
      id="f-3105"
      unitRef="number">0.0470</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-765"
      decimals="INF"
      id="f-3106"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-765"
      decimals="4"
      id="f-3107"
      unitRef="number">0.1013</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-765" decimals="-3" id="f-3108" unitRef="usd">69260000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-765" decimals="-3" id="f-3109" unitRef="usd">68346000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-765" decimals="-3" id="f-3110" unitRef="usd">67874000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-765"
      decimals="4"
      id="f-3111"
      unitRef="number">0.0163</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-766"
      decimals="INF"
      id="f-3112"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-766"
      decimals="4"
      id="f-3113"
      unitRef="number">0.0910</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-766" decimals="-3" id="f-3114" unitRef="usd">9838000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-766" decimals="-3" id="f-3115" unitRef="usd">9632000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-766" decimals="-3" id="f-3116" unitRef="usd">9395000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-766"
      decimals="4"
      id="f-3117"
      unitRef="number">0.0023</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-767"
      decimals="INF"
      id="f-3118"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-767"
      decimals="4"
      id="f-3119"
      unitRef="number">0.1023</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-767" decimals="-3" id="f-3120" unitRef="usd">81319000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-767" decimals="-3" id="f-3121" unitRef="usd">76271000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-767" decimals="-3" id="f-3122" unitRef="usd">74813000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-767"
      decimals="4"
      id="f-3123"
      unitRef="number">0.0180</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-768"
      decimals="INF"
      id="f-3124"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-768"
      decimals="4"
      id="f-3125"
      unitRef="number">0.1098</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-768" decimals="-3" id="f-3126" unitRef="usd">18789000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-768" decimals="-3" id="f-3127" unitRef="usd">18507000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-768" decimals="-3" id="f-3128" unitRef="usd">17004000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-768"
      decimals="4"
      id="f-3129"
      unitRef="number">0.0041</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-769"
      decimals="INF"
      id="f-3130"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-769"
      decimals="4"
      id="f-3131"
      unitRef="number">0.1038</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-769" decimals="-3" id="f-3132" unitRef="usd">111399000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-769" decimals="-3" id="f-3133" unitRef="usd">110163000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-769" decimals="-3" id="f-3134" unitRef="usd">101373000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-769"
      decimals="4"
      id="f-3135"
      unitRef="number">0.0244</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-770" decimals="-3" id="f-3136" unitRef="usd">480254000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-770" decimals="-3" id="f-3137" unitRef="usd">465864000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-770"
      decimals="4"
      id="f-3138"
      unitRef="number">0.1121</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-771"
      decimals="INF"
      id="f-3139"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-771"
      decimals="4"
      id="f-3140"
      unitRef="number">0.0913</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-771" decimals="-3" id="f-3141" unitRef="usd">96395000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-771" decimals="-3" id="f-3142" unitRef="usd">94906000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-771" decimals="-3" id="f-3143" unitRef="usd">95431000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-771"
      decimals="4"
      id="f-3144"
      unitRef="number">0.0229</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-772"
      decimals="INF"
      id="f-3145"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-772"
      decimals="4"
      id="f-3146"
      unitRef="number">0.1073</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-772" decimals="-3" id="f-3147" unitRef="usd">1006000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-772" decimals="-3" id="f-3148" unitRef="usd">983000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-772" decimals="-3" id="f-3149" unitRef="usd">981000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-772"
      decimals="4"
      id="f-3150"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-773"
      decimals="INF"
      id="f-3151"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-773"
      decimals="4"
      id="f-3152"
      unitRef="number">0.0820</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-773" decimals="-3" id="f-3153" unitRef="eur">1122000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-773" decimals="-3" id="f-3154" unitRef="usd">1116000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-773" decimals="-3" id="f-3155" unitRef="usd">1179000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-773"
      decimals="4"
      id="f-3156"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-774"
      decimals="INF"
      id="f-3157"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-774"
      decimals="4"
      id="f-3158"
      unitRef="number">0.1023</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-774" decimals="-3" id="f-3159" unitRef="usd">128852000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-774" decimals="-3" id="f-3160" unitRef="usd">126424000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-774" decimals="-3" id="f-3161" unitRef="usd">127563000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-774"
      decimals="4"
      id="f-3162"
      unitRef="number">0.0307</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-775"
      decimals="INF"
      id="f-3163"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-775"
      decimals="4"
      id="f-3164"
      unitRef="number">0.1057</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-775" decimals="-3" id="f-3165" unitRef="usd">173421000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-775" decimals="-3" id="f-3166" unitRef="usd">171471000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-775" decimals="-3" id="f-3167" unitRef="usd">173421000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-775"
      decimals="4"
      id="f-3168"
      unitRef="number">0.0417</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-776"
      decimals="INF"
      id="f-3169"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-776"
      decimals="4"
      id="f-3170"
      unitRef="number">0.1057</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-776" decimals="-3" id="f-3171" unitRef="usd">4950000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-776" decimals="-3" id="f-3172" unitRef="usd">4864000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-776" decimals="-3" id="f-3173" unitRef="usd">4950000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-776"
      decimals="4"
      id="f-3174"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-777"
      decimals="INF"
      id="f-3175"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-777"
      decimals="4"
      id="f-3176"
      unitRef="number">0.1069</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-777" decimals="-3" id="f-3177" unitRef="usd">2338000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-777" decimals="-3" id="f-3178" unitRef="usd">2297000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-777" decimals="-3" id="f-3179" unitRef="usd">2290000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-777"
      decimals="4"
      id="f-3180"
      unitRef="number">0.0006</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-778"
      decimals="INF"
      id="f-3181"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-778"
      decimals="4"
      id="f-3182"
      unitRef="number">0.1081</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-778" decimals="-3" id="f-3183" unitRef="usd">1067000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-778" decimals="-3" id="f-3184" unitRef="usd">1025000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-778" decimals="-3" id="f-3185" unitRef="usd">1024000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-778"
      decimals="4"
      id="f-3186"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-779"
      decimals="INF"
      id="f-3187"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-779"
      decimals="4"
      id="f-3188"
      unitRef="number">0.1048</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-779" decimals="-3" id="f-3189" unitRef="usd">24133000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-779" decimals="-3" id="f-3190" unitRef="usd">23667000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-779" decimals="-3" id="f-3191" unitRef="usd">23827000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-779"
      decimals="4"
      id="f-3192"
      unitRef="number">0.0057</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-780"
      decimals="INF"
      id="f-3193"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-780"
      decimals="4"
      id="f-3194"
      unitRef="number">0.0600</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-780" decimals="-3" id="f-3195" unitRef="eur">1863000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-780" decimals="-3" id="f-3196" unitRef="usd">2134000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-780" decimals="-3" id="f-3197" unitRef="usd">1978000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-780"
      decimals="4"
      id="f-3198"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-781"
      decimals="INF"
      id="f-3199"
      unitRef="number">0.0475</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-781"
      decimals="4"
      id="f-3200"
      unitRef="number">0.0948</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-781" decimals="-3" id="f-3201" unitRef="usd">6247000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-781" decimals="-3" id="f-3202" unitRef="usd">6174000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-781" decimals="-3" id="f-3203" unitRef="usd">6214000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-781"
      decimals="4"
      id="f-3204"
      unitRef="number">0.0015</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-782" decimals="-3" id="f-3205" unitRef="usd">435061000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-782" decimals="-3" id="f-3206" unitRef="usd">438858000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-782"
      decimals="4"
      id="f-3207"
      unitRef="number">0.1055</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-783"
      decimals="INF"
      id="f-3208"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-783"
      decimals="4"
      id="f-3209"
      unitRef="number">0.1121</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-783" decimals="-3" id="f-3210" unitRef="usd">52187000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-783" decimals="-3" id="f-3211" unitRef="usd">51654000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-783" decimals="-3" id="f-3212" unitRef="usd">52187000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-783"
      decimals="4"
      id="f-3213"
      unitRef="number">0.0125</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-784"
      decimals="INF"
      id="f-3214"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-784"
      decimals="4"
      id="f-3215"
      unitRef="number">0.1032</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-784" decimals="-3" id="f-3216" unitRef="usd">94817000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-784" decimals="-3" id="f-3217" unitRef="usd">94168000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-784" decimals="-3" id="f-3218" unitRef="usd">94817000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-784"
      decimals="4"
      id="f-3219"
      unitRef="number">0.0228</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-785"
      decimals="INF"
      id="f-3220"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-785"
      decimals="4"
      id="f-3221"
      unitRef="number">0.1014</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-785" decimals="-3" id="f-3222" unitRef="usd">12627000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-785" decimals="-3" id="f-3223" unitRef="usd">12431000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-785" decimals="-3" id="f-3224" unitRef="usd">11869000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-785"
      decimals="4"
      id="f-3225"
      unitRef="number">0.0029</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-786"
      decimals="INF"
      id="f-3226"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-786"
      decimals="4"
      id="f-3227"
      unitRef="number">0.1047</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-786" decimals="-3" id="f-3228" unitRef="usd">121977000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-786" decimals="-3" id="f-3229" unitRef="usd">121094000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-786" decimals="-3" id="f-3230" unitRef="usd">120758000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-786"
      decimals="4"
      id="f-3231"
      unitRef="number">0.0290</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-787"
      decimals="INF"
      id="f-3232"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-787"
      decimals="4"
      id="f-3233"
      unitRef="number">0.1123</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-787" decimals="-3" id="f-3234" unitRef="usd">53729000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-787" decimals="-3" id="f-3235" unitRef="usd">53014000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-787" decimals="-3" id="f-3236" unitRef="usd">53729000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-787"
      decimals="4"
      id="f-3237"
      unitRef="number">0.0129</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-788" decimals="-3" id="f-3238" unitRef="usd">332361000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-788" decimals="-3" id="f-3239" unitRef="usd">333360000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-788"
      decimals="4"
      id="f-3240"
      unitRef="number">0.0801</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-789"
      decimals="INF"
      id="f-3241"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-789"
      decimals="4"
      id="f-3242"
      unitRef="number">0.1028</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-789" decimals="-3" id="f-3243" unitRef="usd">228477000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-789" decimals="-3" id="f-3244" unitRef="usd">228477000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-789" decimals="-3" id="f-3245" unitRef="usd">228477000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-789"
      decimals="4"
      id="f-3246"
      unitRef="number">0.0549</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-790"
      decimals="INF"
      id="f-3247"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-790"
      decimals="4"
      id="f-3248"
      unitRef="number">0.1052</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-790" decimals="-3" id="f-3249" unitRef="usd">5023000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-790" decimals="-3" id="f-3250" unitRef="usd">4925000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-790" decimals="-3" id="f-3251" unitRef="usd">4815000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-790"
      decimals="4"
      id="f-3252"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-791"
      decimals="INF"
      id="f-3253"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-791"
      decimals="4"
      id="f-3254"
      unitRef="number">0.1034</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-791" decimals="-3" id="f-3255" unitRef="usd">285912000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-791" decimals="-3" id="f-3256" unitRef="usd">282891000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-791" decimals="-3" id="f-3257" unitRef="usd">285912000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-791"
      decimals="4"
      id="f-3258"
      unitRef="number">0.0688</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-792"
      decimals="INF"
      id="f-3259"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-792"
      decimals="4"
      id="f-3260"
      unitRef="number">0.1034</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-792" decimals="-3" id="f-3261" unitRef="usd">4938000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-792" decimals="-3" id="f-3262" unitRef="usd">4874000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-792" decimals="-3" id="f-3263" unitRef="usd">4938000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-792"
      decimals="4"
      id="f-3264"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-793"
      decimals="INF"
      id="f-3265"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-793"
      decimals="4"
      id="f-3266"
      unitRef="number">0.1004</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-793" decimals="-3" id="f-3267" unitRef="usd">5923000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-793" decimals="-3" id="f-3268" unitRef="usd">5799000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-793" decimals="-3" id="f-3269" unitRef="usd">5858000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-793"
      decimals="4"
      id="f-3270"
      unitRef="number">0.0014</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-794"
      decimals="INF"
      id="f-3271"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-794"
      decimals="4"
      id="f-3272"
      unitRef="number">0.0989</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-794" decimals="-3" id="f-3273" unitRef="usd">22544000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-794" decimals="-3" id="f-3274" unitRef="usd">22169000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-794" decimals="-3" id="f-3275" unitRef="usd">21240000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-794"
      decimals="4"
      id="f-3276"
      unitRef="number">0.0051</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-795"
      decimals="INF"
      id="f-3277"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-795"
      decimals="4"
      id="f-3278"
      unitRef="number">0.1050</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-795" decimals="-3" id="f-3279" unitRef="usd">28023000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-795" decimals="-3" id="f-3280" unitRef="usd">27541000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-795" decimals="-3" id="f-3281" unitRef="usd">27720000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-795"
      decimals="4"
      id="f-3282"
      unitRef="number">0.0067</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-796"
      decimals="INF"
      id="f-3283"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-796"
      decimals="4"
      id="f-3284"
      unitRef="number">0.1066</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-796" decimals="-3" id="f-3285" unitRef="usd">133693000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-796" decimals="-3" id="f-3286" unitRef="usd">132061000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-796" decimals="-3" id="f-3287" unitRef="usd">132022000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-796"
      decimals="4"
      id="f-3288"
      unitRef="number">0.0317</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-797"
      decimals="INF"
      id="f-3289"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-797"
      decimals="4"
      id="f-3290"
      unitRef="number">0.0725</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-797" decimals="-3" id="f-3291" unitRef="usd">11133000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-797" decimals="-3" id="f-3292" unitRef="usd">11096000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-797" decimals="-3" id="f-3293" unitRef="usd">10993000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-797"
      decimals="4"
      id="f-3294"
      unitRef="number">0.0026</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-798"
      decimals="INF"
      id="f-3295"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-798"
      decimals="4"
      id="f-3296"
      unitRef="number">0.1041</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-798" decimals="-3" id="f-3297" unitRef="usd">20886000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-798" decimals="-3" id="f-3298" unitRef="usd">20485000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-798" decimals="-3" id="f-3299" unitRef="usd">17126000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-798"
      decimals="4"
      id="f-3300"
      unitRef="number">0.0041</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-799" decimals="-3" id="f-3301" unitRef="usd">740318000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-799" decimals="-3" id="f-3302" unitRef="usd">739101000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-799"
      decimals="4"
      id="f-3303"
      unitRef="number">0.1777</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-800"
      decimals="INF"
      id="f-3304"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-800"
      decimals="4"
      id="f-3305"
      unitRef="number">0.1106</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-800" decimals="-3" id="f-3306" unitRef="usd">13765000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-800" decimals="-3" id="f-3307" unitRef="usd">13566000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-800" decimals="-3" id="f-3308" unitRef="usd">13042000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-800"
      decimals="4"
      id="f-3309"
      unitRef="number">0.0031</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-801"
      decimals="INF"
      id="f-3310"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-801"
      decimals="4"
      id="f-3311"
      unitRef="number">0.0938</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-801" decimals="-3" id="f-3312" unitRef="usd">22373000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-801" decimals="-3" id="f-3313" unitRef="usd">21850000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-801" decimals="-3" id="f-3314" unitRef="usd">21233000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-801"
      decimals="4"
      id="f-3315"
      unitRef="number">0.0051</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-802" decimals="-3" id="f-3316" unitRef="usd">35416000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-802" decimals="-3" id="f-3317" unitRef="usd">34275000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-802"
      decimals="4"
      id="f-3318"
      unitRef="number">0.0082</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-803"
      decimals="INF"
      id="f-3319"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-803"
      decimals="4"
      id="f-3320"
      unitRef="number">0.1067</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-803" decimals="-3" id="f-3321" unitRef="usd">18886000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-803" decimals="-3" id="f-3322" unitRef="usd">18545000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-803" decimals="-3" id="f-3323" unitRef="usd">18678000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-803"
      decimals="4"
      id="f-3324"
      unitRef="number">0.0045</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-804"
      decimals="INF"
      id="f-3325"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-804"
      decimals="4"
      id="f-3326"
      unitRef="number">0.1067</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-804" decimals="-3" id="f-3327" unitRef="usd">1995000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-804" decimals="-3" id="f-3328" unitRef="usd">1937000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-804" decimals="-3" id="f-3329" unitRef="usd">1975000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-804"
      decimals="4"
      id="f-3330"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-805" decimals="-3" id="f-3331" unitRef="usd">20482000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-805" decimals="-3" id="f-3332" unitRef="usd">20653000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-805"
      decimals="4"
      id="f-3333"
      unitRef="number">0.0050</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-806"
      decimals="INF"
      id="f-3334"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-806"
      decimals="4"
      id="f-3335"
      unitRef="number">0.1024</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-806" decimals="-3" id="f-3336" unitRef="usd">7332000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-806" decimals="-3" id="f-3337" unitRef="usd">7208000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-806" decimals="-3" id="f-3338" unitRef="usd">7094000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-806"
      decimals="4"
      id="f-3339"
      unitRef="number">0.0017</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-807"
      decimals="INF"
      id="f-3340"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-807"
      decimals="4"
      id="f-3341"
      unitRef="number">0.1063</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-807" decimals="-3" id="f-3342" unitRef="usd">72809000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-807" decimals="-3" id="f-3343" unitRef="usd">72131000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-807" decimals="-3" id="f-3344" unitRef="usd">72809000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-807"
      decimals="4"
      id="f-3345"
      unitRef="number">0.0175</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-808"
      decimals="INF"
      id="f-3346"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-808"
      decimals="4"
      id="f-3347"
      unitRef="number">0.1066</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-808" decimals="-3" id="f-3348" unitRef="usd">63291000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-808" decimals="-3" id="f-3349" unitRef="usd">62449000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-808" decimals="-3" id="f-3350" unitRef="usd">62975000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-808"
      decimals="4"
      id="f-3351"
      unitRef="number">0.0151</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-809"
      decimals="INF"
      id="f-3352"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-809"
      decimals="4"
      id="f-3353"
      unitRef="number">0.1066</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-809" decimals="-3" id="f-3354" unitRef="usd">1995000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-809" decimals="-3" id="f-3355" unitRef="usd">1959000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-809" decimals="-3" id="f-3356" unitRef="usd">1985000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-809"
      decimals="4"
      id="f-3357"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-810"
      decimals="INF"
      id="f-3358"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-810"
      decimals="4"
      id="f-3359"
      unitRef="number">0.1017</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-810" decimals="-3" id="f-3360" unitRef="usd">179989000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-810" decimals="-3" id="f-3361" unitRef="usd">177116000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-810" decimals="-3" id="f-3362" unitRef="usd">176389000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-810"
      decimals="4"
      id="f-3363"
      unitRef="number">0.0424</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-811"
      decimals="INF"
      id="f-3364"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-811"
      decimals="4"
      id="f-3365"
      unitRef="number">0.0725</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-811" decimals="-3" id="f-3366" unitRef="usd">1582000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-811" decimals="-3" id="f-3367" unitRef="usd">1525000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-811" decimals="-3" id="f-3368" unitRef="usd">1524000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-811"
      decimals="4"
      id="f-3369"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-812"
      decimals="INF"
      id="f-3370"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-812"
      decimals="4"
      id="f-3371"
      unitRef="number">0.1098</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-812" decimals="-3" id="f-3372" unitRef="usd">4950000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-812" decimals="-3" id="f-3373" unitRef="usd">4866000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-812" decimals="-3" id="f-3374" unitRef="usd">4752000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-812"
      decimals="4"
      id="f-3375"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-813"
      decimals="INF"
      id="f-3376"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-813"
      decimals="4"
      id="f-3377"
      unitRef="number">0.1062</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-813" decimals="-3" id="f-3378" unitRef="usd">1598000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-813" decimals="-3" id="f-3379" unitRef="usd">1581000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-813" decimals="-3" id="f-3380" unitRef="usd">1534000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-813"
      decimals="4"
      id="f-3381"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-814"
      decimals="INF"
      id="f-3382"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-814"
      decimals="4"
      id="f-3383"
      unitRef="number">0.1023</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-814" decimals="-3" id="f-3384" unitRef="usd">14074000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-814" decimals="-3" id="f-3385" unitRef="usd">13749000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-814" decimals="-3" id="f-3386" unitRef="usd">13735000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-814"
      decimals="4"
      id="f-3387"
      unitRef="number">0.0033</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-815"
      decimals="INF"
      id="f-3388"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-815"
      decimals="4"
      id="f-3389"
      unitRef="number">0.1098</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-815" decimals="-3" id="f-3390" unitRef="usd">42774000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-815" decimals="-3" id="f-3391" unitRef="usd">42484000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-815" decimals="-3" id="f-3392" unitRef="usd">42132000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-815"
      decimals="4"
      id="f-3393"
      unitRef="number">0.0101</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-816"
      decimals="INF"
      id="f-3394"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-816"
      decimals="4"
      id="f-3395"
      unitRef="number">0.1052</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-816" decimals="-3" id="f-3396" unitRef="usd">998000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-816" decimals="-3" id="f-3397" unitRef="usd">955000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-816" decimals="-3" id="f-3398" unitRef="usd">953000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-816"
      decimals="4"
      id="f-3399"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-817"
      decimals="INF"
      id="f-3400"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-817"
      decimals="4"
      id="f-3401"
      unitRef="number">0.1041</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-817" decimals="-3" id="f-3402" unitRef="usd">51973000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-817" decimals="-3" id="f-3403" unitRef="usd">51237000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-817" decimals="-3" id="f-3404" unitRef="usd">51064000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-817"
      decimals="4"
      id="f-3405"
      unitRef="number">0.0123</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-818"
      decimals="INF"
      id="f-3406"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-818"
      decimals="4"
      id="f-3407"
      unitRef="number">0.1041</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-818" decimals="-3" id="f-3408" unitRef="usd">42476000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-818" decimals="-3" id="f-3409" unitRef="usd">42098000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-818" decimals="-3" id="f-3410" unitRef="usd">41733000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-818"
      decimals="4"
      id="f-3411"
      unitRef="number">0.0100</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-819" decimals="-3" id="f-3412" unitRef="usd">479358000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-819" decimals="-3" id="f-3413" unitRef="usd">478679000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-819"
      decimals="4"
      id="f-3414"
      unitRef="number">0.1150</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-820"
      decimals="INF"
      id="f-3415"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-820"
      decimals="4"
      id="f-3416"
      unitRef="number">0.0974</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-820" decimals="-3" id="f-3417" unitRef="usd">292101000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-820" decimals="-3" id="f-3418" unitRef="usd">289768000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-820" decimals="-3" id="f-3419" unitRef="usd">292101000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-820"
      decimals="4"
      id="f-3420"
      unitRef="number">0.0702</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-821"
      decimals="INF"
      id="f-3421"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-821"
      decimals="4"
      id="f-3422"
      unitRef="number">0.0944</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-821" decimals="-3" id="f-3423" unitRef="usd">7087000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-821" decimals="-3" id="f-3424" unitRef="usd">6970000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-821" decimals="-3" id="f-3425" unitRef="usd">6661000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-821"
      decimals="4"
      id="f-3426"
      unitRef="number">0.0016</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-822"
      decimals="INF"
      id="f-3427"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-822"
      decimals="4"
      id="f-3428"
      unitRef="number">0.1067</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-822" decimals="-3" id="f-3429" unitRef="usd">22544000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-822" decimals="-3" id="f-3430" unitRef="usd">22141000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-822" decimals="-3" id="f-3431" unitRef="usd">21954000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-822"
      decimals="4"
      id="f-3432"
      unitRef="number">0.0053</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-823" decimals="-3" id="f-3433" unitRef="usd">318879000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-823" decimals="-3" id="f-3434" unitRef="usd">320716000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-823"
      decimals="4"
      id="f-3435"
      unitRef="number">0.0771</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-824"
      decimals="INF"
      id="f-3436"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-824"
      decimals="4"
      id="f-3437"
      unitRef="number">0.1013</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-824" decimals="-3" id="f-3438" unitRef="usd">64465000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-824" decimals="-3" id="f-3439" unitRef="usd">63457000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-824" decimals="-3" id="f-3440" unitRef="usd">63820000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-824"
      decimals="4"
      id="f-3441"
      unitRef="number">0.0153</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-825"
      decimals="INF"
      id="f-3442"
      unitRef="number">0.0800</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-825"
      decimals="4"
      id="f-3443"
      unitRef="number">0.1242</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-825"
      decimals="INF"
      id="f-3444"
      unitRef="number">0.0200</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-825" decimals="-3" id="f-3445" unitRef="usd">74715000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-825" decimals="-3" id="f-3446" unitRef="usd">73984000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-825" decimals="-3" id="f-3447" unitRef="usd">67243000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-825"
      decimals="4"
      id="f-3448"
      unitRef="number">0.0162</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-826" decimals="-3" id="f-3449" unitRef="usd">137441000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-826" decimals="-3" id="f-3450" unitRef="usd">131063000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-826"
      decimals="4"
      id="f-3451"
      unitRef="number">0.0315</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-827"
      decimals="INF"
      id="f-3452"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-827"
      decimals="4"
      id="f-3453"
      unitRef="number">0.1056</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-827" decimals="-3" id="f-3454" unitRef="usd">104875000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-827" decimals="-3" id="f-3455" unitRef="usd">102509000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-827" decimals="-3" id="f-3456" unitRef="usd">101470000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-827"
      decimals="4"
      id="f-3457"
      unitRef="number">0.0244</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-828"
      decimals="INF"
      id="f-3458"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-828"
      decimals="4"
      id="f-3459"
      unitRef="number">0.1001</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-828" decimals="-3" id="f-3460" unitRef="usd">33462000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-828" decimals="-3" id="f-3461" unitRef="usd">32834000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-828" decimals="-3" id="f-3462" unitRef="usd">33092000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-828"
      decimals="4"
      id="f-3463"
      unitRef="number">0.0080</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-829"
      decimals="INF"
      id="f-3464"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-829"
      decimals="4"
      id="f-3465"
      unitRef="number">0.1023</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-829" decimals="-3" id="f-3466" unitRef="usd">44451000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-829" decimals="-3" id="f-3467" unitRef="usd">43549000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-829" decimals="-3" id="f-3468" unitRef="usd">43486000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-829"
      decimals="4"
      id="f-3469"
      unitRef="number">0.0105</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-830"
      decimals="INF"
      id="f-3470"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-830"
      decimals="4"
      id="f-3471"
      unitRef="number">0.1073</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-830" decimals="-3" id="f-3472" unitRef="usd">36670000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-830" decimals="-3" id="f-3473" unitRef="usd">35999000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-830" decimals="-3" id="f-3474" unitRef="usd">36415000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-830"
      decimals="4"
      id="f-3475"
      unitRef="number">0.0088</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-831"
      decimals="INF"
      id="f-3476"
      unitRef="number">0.0325</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-831"
      decimals="4"
      id="f-3477"
      unitRef="number">0.0751</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-831" decimals="-3" id="f-3478" unitRef="usd">83504000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-831" decimals="-3" id="f-3479" unitRef="usd">82123000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-831" decimals="-3" id="f-3480" unitRef="usd">83921000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-831"
      decimals="4"
      id="f-3481"
      unitRef="number">0.0202</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-832" decimals="-3" id="f-3482" unitRef="usd">161671000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-832" decimals="-3" id="f-3483" unitRef="usd">163822000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-832"
      decimals="4"
      id="f-3484"
      unitRef="number">0.0395</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-833"
      decimals="INF"
      id="f-3485"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-833"
      decimals="4"
      id="f-3486"
      unitRef="number">0.1075</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-833" decimals="-3" id="f-3487" unitRef="usd">109041000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-833" decimals="-3" id="f-3488" unitRef="usd">107698000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-833" decimals="-3" id="f-3489" unitRef="usd">101953000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-833"
      decimals="4"
      id="f-3490"
      unitRef="number">0.0245</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-834"
      decimals="INF"
      id="f-3491"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-834"
      decimals="4"
      id="f-3492"
      unitRef="number">0.0968</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-834" decimals="-3" id="f-3493" unitRef="usd">4034000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-834" decimals="-3" id="f-3494" unitRef="usd">3942000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-834" decimals="-3" id="f-3495" unitRef="usd">3943000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-834"
      decimals="4"
      id="f-3496"
      unitRef="number">0.0009</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-835" decimals="-3" id="f-3497" unitRef="usd">111640000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-835" decimals="-3" id="f-3498" unitRef="usd">105896000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-835"
      decimals="4"
      id="f-3499"
      unitRef="number">0.0254</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-836"
      decimals="INF"
      id="f-3500"
      unitRef="number">0.0700</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-836"
      decimals="4"
      id="f-3501"
      unitRef="number">0.1129</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-836" decimals="-3" id="f-3502" unitRef="usd">36437000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-836" decimals="-3" id="f-3503" unitRef="usd">36057000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-836" decimals="-3" id="f-3504" unitRef="usd">36437000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-836"
      decimals="4"
      id="f-3505"
      unitRef="number">0.0088</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-837"
      decimals="INF"
      id="f-3506"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-837"
      decimals="4"
      id="f-3507"
      unitRef="number">0.1063</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-837" decimals="-3" id="f-3508" unitRef="usd">908000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-837" decimals="-3" id="f-3509" unitRef="usd">884000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-837" decimals="-3" id="f-3510" unitRef="usd">893000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-837"
      decimals="4"
      id="f-3511"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-838"
      decimals="INF"
      id="f-3512"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-838"
      decimals="4"
      id="f-3513"
      unitRef="number">0.1063</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-838" decimals="-3" id="f-3514" unitRef="usd">17790000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-838" decimals="-3" id="f-3515" unitRef="usd">17736000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-838" decimals="-3" id="f-3516" unitRef="usd">17790000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-838"
      decimals="4"
      id="f-3517"
      unitRef="number">0.0043</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-839" decimals="-3" id="f-3518" unitRef="usd">54677000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-839" decimals="-3" id="f-3519" unitRef="usd">55120000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-839"
      decimals="4"
      id="f-3520"
      unitRef="number">0.0133</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-840"
      decimals="INF"
      id="f-3521"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-840"
      decimals="4"
      id="f-3522"
      unitRef="number">0.1023</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-840" decimals="-3" id="f-3523" unitRef="usd">30242000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-840" decimals="-3" id="f-3524" unitRef="usd">29624000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-840" decimals="-3" id="f-3525" unitRef="usd">29089000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-840"
      decimals="4"
      id="f-3526"
      unitRef="number">0.0070</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-841"
      decimals="INF"
      id="f-3527"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-841"
      decimals="4"
      id="f-3528"
      unitRef="number">0.0984</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-841" decimals="-3" id="f-3529" unitRef="usd">27225000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-841" decimals="-3" id="f-3530" unitRef="usd">26765000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-841" decimals="-3" id="f-3531" unitRef="usd">26661000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-841"
      decimals="4"
      id="f-3532"
      unitRef="number">0.0064</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-842" decimals="-3" id="f-3533" unitRef="usd">56389000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-842" decimals="-3" id="f-3534" unitRef="usd">55750000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-842"
      decimals="4"
      id="f-3535"
      unitRef="number">0.0134</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-843"
      decimals="INF"
      id="f-3536"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-843"
      decimals="4"
      id="f-3537"
      unitRef="number">0.1036</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-843" decimals="-3" id="f-3538" unitRef="cad">1721000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-843" decimals="-3" id="f-3539" unitRef="usd">1321000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-843" decimals="-3" id="f-3540" unitRef="usd">1220000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-843"
      decimals="4"
      id="f-3541"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-844"
      decimals="INF"
      id="f-3542"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-844"
      decimals="4"
      id="f-3543"
      unitRef="number">0.1013</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-844" decimals="-3" id="f-3544" unitRef="usd">105139000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-844" decimals="-3" id="f-3545" unitRef="usd">103062000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-844" decimals="-3" id="f-3546" unitRef="usd">103013000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-844"
      decimals="4"
      id="f-3547"
      unitRef="number">0.0248</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-845"
      decimals="INF"
      id="f-3548"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-845"
      decimals="4"
      id="f-3549"
      unitRef="number">0.1166</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-845" decimals="-3" id="f-3550" unitRef="usd">8570000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-845" decimals="-3" id="f-3551" unitRef="usd">8428000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-845" decimals="-3" id="f-3552" unitRef="usd">8419000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-845"
      decimals="4"
      id="f-3553"
      unitRef="number">0.0020</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-846"
      decimals="INF"
      id="f-3554"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-846"
      decimals="4"
      id="f-3555"
      unitRef="number">0.1023</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-846" decimals="-3" id="f-3556" unitRef="usd">5857000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-846" decimals="-3" id="f-3557" unitRef="usd">5724000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-846" decimals="-3" id="f-3558" unitRef="usd">5600000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-846"
      decimals="4"
      id="f-3559"
      unitRef="number">0.0013</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-847"
      decimals="INF"
      id="f-3560"
      unitRef="number">0.0450</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-847"
      decimals="4"
      id="f-3561"
      unitRef="number">0.0936</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-847" decimals="-3" id="f-3562" unitRef="cad">30935000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-847" decimals="-3" id="f-3563" unitRef="usd">22693000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-847" decimals="-3" id="f-3564" unitRef="usd">22786000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-847"
      decimals="4"
      id="f-3565"
      unitRef="number">0.0055</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-848"
      decimals="INF"
      id="f-3566"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-848"
      decimals="4"
      id="f-3567"
      unitRef="number">0.0992</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-848"
      decimals="INF"
      id="f-3568"
      unitRef="number">0.0275</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-848" decimals="-3" id="f-3569" unitRef="usd">10442000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-848" decimals="-3" id="f-3570" unitRef="usd">10261000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-848" decimals="-3" id="f-3571" unitRef="usd">9853000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-848"
      decimals="4"
      id="f-3572"
      unitRef="number">0.0024</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-849"
      decimals="INF"
      id="f-3573"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-849"
      decimals="4"
      id="f-3574"
      unitRef="number">0.1014</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-849" decimals="-3" id="f-3575" unitRef="usd">6582000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-849" decimals="-3" id="f-3576" unitRef="usd">6452000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-849" decimals="-3" id="f-3577" unitRef="usd">6582000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-849"
      decimals="4"
      id="f-3578"
      unitRef="number">0.0016</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-850"
      decimals="INF"
      id="f-3579"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-850"
      decimals="4"
      id="f-3580"
      unitRef="number">0.0998</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-850" decimals="-3" id="f-3581" unitRef="usd">33096000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-850" decimals="-3" id="f-3582" unitRef="usd">32744000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-850" decimals="-3" id="f-3583" unitRef="usd">32749000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-850"
      decimals="4"
      id="f-3584"
      unitRef="number">0.0079</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-851"
      decimals="INF"
      id="f-3585"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-851"
      decimals="4"
      id="f-3586"
      unitRef="number">0.1019</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-851" decimals="-3" id="f-3587" unitRef="usd">24307000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-851" decimals="-3" id="f-3588" unitRef="usd">24208000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-851" decimals="-3" id="f-3589" unitRef="usd">24185000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-851"
      decimals="4"
      id="f-3590"
      unitRef="number">0.0058</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-852"
      decimals="INF"
      id="f-3591"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-852"
      decimals="4"
      id="f-3592"
      unitRef="number">0.1042</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-852" decimals="-3" id="f-3593" unitRef="usd">76247000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-852" decimals="-3" id="f-3594" unitRef="usd">75033000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-852" decimals="-3" id="f-3595" unitRef="usd">76247000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-852"
      decimals="4"
      id="f-3596"
      unitRef="number">0.0183</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-853"
      decimals="INF"
      id="f-3597"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-853"
      decimals="4"
      id="f-3598"
      unitRef="number">0.1042</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-853" decimals="-3" id="f-3599" unitRef="usd">32324000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-853" decimals="-3" id="f-3600" unitRef="usd">31675000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-853" decimals="-3" id="f-3601" unitRef="usd">32085000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-853"
      decimals="4"
      id="f-3602"
      unitRef="number">0.0077</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-854"
      decimals="INF"
      id="f-3603"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-854"
      decimals="4"
      id="f-3604"
      unitRef="number">0.0973</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-854" decimals="-3" id="f-3605" unitRef="usd">155273000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-854" decimals="-3" id="f-3606" unitRef="usd">152942000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-854" decimals="-3" id="f-3607" unitRef="usd">153720000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-854"
      decimals="4"
      id="f-3608"
      unitRef="number">0.0370</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-855"
      decimals="INF"
      id="f-3609"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-855"
      decimals="4"
      id="f-3610"
      unitRef="number">0.0998</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-855"
      decimals="INF"
      id="f-3611"
      unitRef="number">0.0511</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-855" decimals="-3" id="f-3612" unitRef="usd">200735000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-855" decimals="-3" id="f-3613" unitRef="usd">199246000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-855" decimals="-3" id="f-3614" unitRef="usd">198728000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-855"
      decimals="4"
      id="f-3615"
      unitRef="number">0.0478</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-856"
      decimals="INF"
      id="f-3616"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-856"
      decimals="4"
      id="f-3617"
      unitRef="number">0.1045</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-856" decimals="-3" id="f-3618" unitRef="usd">18672000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-856" decimals="-3" id="f-3619" unitRef="usd">18522000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-856" decimals="-3" id="f-3620" unitRef="usd">18672000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-856"
      decimals="4"
      id="f-3621"
      unitRef="number">0.0045</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-857"
      decimals="INF"
      id="f-3622"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-857"
      decimals="4"
      id="f-3623"
      unitRef="number">0.1007</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-857" decimals="-3" id="f-3624" unitRef="usd">1796000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-857" decimals="-3" id="f-3625" unitRef="usd">1761000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-857" decimals="-3" id="f-3626" unitRef="usd">1775000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-857"
      decimals="4"
      id="f-3627"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-858"
      decimals="INF"
      id="f-3628"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-858"
      decimals="4"
      id="f-3629"
      unitRef="number">0.1100</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-858" decimals="-3" id="f-3630" unitRef="usd">11462000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-858" decimals="-3" id="f-3631" unitRef="usd">11253000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-858" decimals="-3" id="f-3632" unitRef="usd">11218000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-858"
      decimals="4"
      id="f-3633"
      unitRef="number">0.0027</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-859"
      decimals="INF"
      id="f-3634"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-859"
      decimals="4"
      id="f-3635"
      unitRef="number">0.1076</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-859" decimals="-3" id="f-3636" unitRef="usd">304214000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-859" decimals="-3" id="f-3637" unitRef="usd">298966000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-859" decimals="-3" id="f-3638" unitRef="usd">293329000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-859"
      decimals="4"
      id="f-3639"
      unitRef="number">0.0705</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-860"
      decimals="INF"
      id="f-3640"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-860"
      decimals="4"
      id="f-3641"
      unitRef="number">0.0976</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-860" decimals="-3" id="f-3642" unitRef="usd">12641000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-860" decimals="-3" id="f-3643" unitRef="usd">12331000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-860" decimals="-3" id="f-3644" unitRef="usd">12209000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-860"
      decimals="4"
      id="f-3645"
      unitRef="number">0.0029</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-861"
      decimals="INF"
      id="f-3646"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-861"
      decimals="4"
      id="f-3647"
      unitRef="number">0.1051</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-861" decimals="-3" id="f-3648" unitRef="usd">2774000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-861" decimals="-3" id="f-3649" unitRef="usd">2722000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-861" decimals="-3" id="f-3650" unitRef="usd">2690000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-861"
      decimals="4"
      id="f-3651"
      unitRef="number">0.0006</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-862"
      decimals="INF"
      id="f-3652"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-862"
      decimals="4"
      id="f-3653"
      unitRef="number">0.1013</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-862" decimals="-3" id="f-3654" unitRef="usd">4975000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-862" decimals="-3" id="f-3655" unitRef="usd">4889000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-862" decimals="-3" id="f-3656" unitRef="usd">4776000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-862"
      decimals="4"
      id="f-3657"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-863"
      decimals="INF"
      id="f-3658"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-863"
      decimals="4"
      id="f-3659"
      unitRef="number">0.1046</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-863" decimals="-3" id="f-3660" unitRef="cad">5840000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-863" decimals="-3" id="f-3661" unitRef="usd">4622000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-863" decimals="-3" id="f-3662" unitRef="usd">4287000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-863"
      decimals="4"
      id="f-3663"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-864"
      decimals="INF"
      id="f-3664"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-864"
      decimals="4"
      id="f-3665"
      unitRef="number">0.1049</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-864" decimals="-3" id="f-3666" unitRef="usd">4107000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-864" decimals="-3" id="f-3667" unitRef="usd">3965000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-864" decimals="-3" id="f-3668" unitRef="usd">3998000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-864"
      decimals="4"
      id="f-3669"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-865"
      decimals="INF"
      id="f-3670"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-865"
      decimals="4"
      id="f-3671"
      unitRef="number">0.1050</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-865" decimals="-3" id="f-3672" unitRef="usd">2046000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-865" decimals="-3" id="f-3673" unitRef="usd">2046000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-865" decimals="-3" id="f-3674" unitRef="usd">2046000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-865"
      decimals="4"
      id="f-3675"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-866"
      decimals="INF"
      id="f-3676"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-866"
      decimals="4"
      id="f-3677"
      unitRef="number">0.1009</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-866" decimals="-3" id="f-3678" unitRef="usd">1787000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-866" decimals="-3" id="f-3679" unitRef="usd">1742000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-866" decimals="-3" id="f-3680" unitRef="usd">1738000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-866"
      decimals="4"
      id="f-3681"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-867"
      decimals="INF"
      id="f-3682"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-867"
      decimals="4"
      id="f-3683"
      unitRef="number">0.1018</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-867" decimals="-3" id="f-3684" unitRef="usd">41654000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-867" decimals="-3" id="f-3685" unitRef="usd">40916000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-867" decimals="-3" id="f-3686" unitRef="usd">41169000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-867"
      decimals="4"
      id="f-3687"
      unitRef="number">0.0099</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-868"
      decimals="INF"
      id="f-3688"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-868"
      decimals="4"
      id="f-3689"
      unitRef="number">0.1048</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-868" decimals="-3" id="f-3690" unitRef="usd">44703000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-868" decimals="-3" id="f-3691" unitRef="usd">43840000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-868" decimals="-3" id="f-3692" unitRef="usd">34563000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-868"
      decimals="4"
      id="f-3693"
      unitRef="number">0.0083</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-869" decimals="-3" id="f-3694" unitRef="usd">1121364000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-869" decimals="-3" id="f-3695" unitRef="usd">1107657000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-869"
      decimals="4"
      id="f-3696"
      unitRef="number">0.2662</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-870"
      decimals="INF"
      id="f-3697"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-870"
      decimals="4"
      id="f-3698"
      unitRef="number">0.1008</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-870" decimals="-3" id="f-3699" unitRef="usd">10542000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-870" decimals="-3" id="f-3700" unitRef="usd">10314000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-870" decimals="-3" id="f-3701" unitRef="usd">10207000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-870"
      decimals="4"
      id="f-3702"
      unitRef="number">0.0025</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-871"
      decimals="INF"
      id="f-3703"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-871"
      decimals="4"
      id="f-3704"
      unitRef="number">0.0625</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-871" decimals="-3" id="f-3705" unitRef="usd">2215000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-871" decimals="-3" id="f-3706" unitRef="usd">2171000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-871" decimals="-3" id="f-3707" unitRef="usd">2170000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-871"
      decimals="4"
      id="f-3708"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-872"
      decimals="INF"
      id="f-3709"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-872"
      decimals="4"
      id="f-3710"
      unitRef="number">0.1018</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-872" decimals="-3" id="f-3711" unitRef="usd">20313000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-872" decimals="-3" id="f-3712" unitRef="usd">19818000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-872" decimals="-3" id="f-3713" unitRef="usd">19906000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-872"
      decimals="4"
      id="f-3714"
      unitRef="number">0.0048</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-873"
      decimals="INF"
      id="f-3715"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-873"
      decimals="4"
      id="f-3716"
      unitRef="number">0.1023</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-873" decimals="-3" id="f-3717" unitRef="usd">13585000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-873" decimals="-3" id="f-3718" unitRef="usd">13377000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-873" decimals="-3" id="f-3719" unitRef="usd">13449000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-873"
      decimals="4"
      id="f-3720"
      unitRef="number">0.0032</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-874"
      decimals="INF"
      id="f-3721"
      unitRef="number">0.0750</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-874"
      decimals="4"
      id="f-3722"
      unitRef="number">0.1223</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-874" decimals="-3" id="f-3723" unitRef="usd">219160000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-874" decimals="-3" id="f-3724" unitRef="usd">215762000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-874" decimals="-3" id="f-3725" unitRef="usd">223544000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-874"
      decimals="4"
      id="f-3726"
      unitRef="number">0.0538</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-875"
      decimals="INF"
      id="f-3727"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-875"
      decimals="4"
      id="f-3728"
      unitRef="number">0.1073</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-875" decimals="-3" id="f-3729" unitRef="usd">16007000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-875" decimals="-3" id="f-3730" unitRef="usd">15730000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-875" decimals="-3" id="f-3731" unitRef="usd">15725000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-875"
      decimals="4"
      id="f-3732"
      unitRef="number">0.0038</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-876"
      decimals="INF"
      id="f-3733"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-876"
      decimals="4"
      id="f-3734"
      unitRef="number">0.0974</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-876" decimals="-3" id="f-3735" unitRef="usd">75988000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-876" decimals="-3" id="f-3736" unitRef="usd">74013000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-876" decimals="-3" id="f-3737" unitRef="usd">74829000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-876"
      decimals="4"
      id="f-3738"
      unitRef="number">0.0180</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-877"
      decimals="INF"
      id="f-3739"
      unitRef="number">0.0325</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-877"
      decimals="4"
      id="f-3740"
      unitRef="number">0.0763</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-877" decimals="-3" id="f-3741" unitRef="usd">8461000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-877" decimals="-3" id="f-3742" unitRef="usd">8429000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-877" decimals="-3" id="f-3743" unitRef="usd">8019000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-877"
      decimals="4"
      id="f-3744"
      unitRef="number">0.0019</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-878"
      decimals="INF"
      id="f-3745"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-878"
      decimals="4"
      id="f-3746"
      unitRef="number">0.0941</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-878" decimals="-3" id="f-3747" unitRef="usd">9423000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-878" decimals="-3" id="f-3748" unitRef="usd">9275000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-878" decimals="-3" id="f-3749" unitRef="usd">9329000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-878"
      decimals="4"
      id="f-3750"
      unitRef="number">0.0022</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-879" decimals="-3" id="f-3751" unitRef="usd">368889000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-879" decimals="-3" id="f-3752" unitRef="usd">377178000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-879"
      decimals="4"
      id="f-3753"
      unitRef="number">0.0907</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-880"
      decimals="INF"
      id="f-3754"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-880"
      decimals="4"
      id="f-3755"
      unitRef="number">0.1042</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-880" decimals="-3" id="f-3756" unitRef="usd">3703000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-880" decimals="-3" id="f-3757" unitRef="usd">3673000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-880" decimals="-3" id="f-3758" unitRef="usd">3629000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-880"
      decimals="4"
      id="f-3759"
      unitRef="number">0.0009</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-881"
      decimals="INF"
      id="f-3760"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-881"
      decimals="4"
      id="f-3761"
      unitRef="number">0.0901</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-881" decimals="-3" id="f-3762" unitRef="usd">2101000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-881" decimals="-3" id="f-3763" unitRef="usd">2055000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-881" decimals="-3" id="f-3764" unitRef="usd">2076000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-881"
      decimals="4"
      id="f-3765"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-882"
      decimals="INF"
      id="f-3766"
      unitRef="number">0.0875</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-882"
      decimals="4"
      id="f-3767"
      unitRef="number">0.1209</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-882"
      decimals="INF"
      id="f-3768"
      unitRef="number">0.0775</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-882" decimals="-3" id="f-3769" unitRef="usd">13457000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-882" decimals="-3" id="f-3770" unitRef="usd">13255000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-882" decimals="-3" id="f-3771" unitRef="usd">10896000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-882"
      decimals="4"
      id="f-3772"
      unitRef="number">0.0026</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-883"
      decimals="INF"
      id="f-3773"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-883"
      decimals="4"
      id="f-3774"
      unitRef="number">0.1068</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-883" decimals="-3" id="f-3775" unitRef="usd">27179000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-883" decimals="-3" id="f-3776" unitRef="usd">26823000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-883" decimals="-3" id="f-3777" unitRef="usd">26881000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-883"
      decimals="4"
      id="f-3778"
      unitRef="number">0.0065</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-884"
      decimals="INF"
      id="f-3779"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-884"
      decimals="4"
      id="f-3780"
      unitRef="number">0.0899</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-884" decimals="-3" id="f-3781" unitRef="usd">22169000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-884" decimals="-3" id="f-3782" unitRef="usd">21790000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-884" decimals="-3" id="f-3783" unitRef="usd">21577000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-884"
      decimals="4"
      id="f-3784"
      unitRef="number">0.0052</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-885"
      decimals="INF"
      id="f-3785"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-885"
      decimals="4"
      id="f-3786"
      unitRef="number">0.1073</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-885" decimals="-3" id="f-3787" unitRef="usd">61910000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-885" decimals="-3" id="f-3788" unitRef="usd">60802000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-885" decimals="-3" id="f-3789" unitRef="usd">61282000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-885"
      decimals="4"
      id="f-3790"
      unitRef="number">0.0147</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-886"
      decimals="INF"
      id="f-3791"
      unitRef="number">0.0605</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-886"
      decimals="4"
      id="f-3792"
      unitRef="number">0.1128</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-886" decimals="-3" id="f-3793" unitRef="usd">146487000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-886" decimals="-3" id="f-3794" unitRef="usd">145102000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-886" decimals="-3" id="f-3795" unitRef="usd">141089000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-886"
      decimals="4"
      id="f-3796"
      unitRef="number">0.0339</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-887"
      decimals="INF"
      id="f-3797"
      unitRef="number">0.0425</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-887"
      decimals="4"
      id="f-3798"
      unitRef="number">0.0881</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-887" decimals="-3" id="f-3799" unitRef="cad">86367000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-887" decimals="-3" id="f-3800" unitRef="usd">68216000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-887" decimals="-3" id="f-3801" unitRef="usd">59917000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-887"
      decimals="4"
      id="f-3802"
      unitRef="number">0.0144</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-888"
      decimals="INF"
      id="f-3803"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-888"
      decimals="4"
      id="f-3804"
      unitRef="number">0.1063</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-888" decimals="-3" id="f-3805" unitRef="usd">4627000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-888" decimals="-3" id="f-3806" unitRef="usd">4553000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-888" decimals="-3" id="f-3807" unitRef="usd">4470000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-888"
      decimals="4"
      id="f-3808"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-889"
      decimals="INF"
      id="f-3809"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-889"
      decimals="4"
      id="f-3810"
      unitRef="number">0.0917</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-889" decimals="-3" id="f-3811" unitRef="usd">104974000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-889" decimals="-3" id="f-3812" unitRef="usd">103888000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-889" decimals="-3" id="f-3813" unitRef="usd">104974000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-889"
      decimals="4"
      id="f-3814"
      unitRef="number">0.0252</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-890"
      decimals="INF"
      id="f-3815"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-890"
      decimals="4"
      id="f-3816"
      unitRef="number">0.0675</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-890" decimals="-3" id="f-3817" unitRef="gbp">5091000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-890" decimals="-3" id="f-3818" unitRef="usd">4938000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-890" decimals="-3" id="f-3819" unitRef="usd">4938000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-890"
      decimals="4"
      id="f-3820"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-891"
      decimals="INF"
      id="f-3821"
      unitRef="number">0.0728</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-891"
      decimals="4"
      id="f-3822"
      unitRef="number">0.0847</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-891" decimals="-3" id="f-3823" unitRef="gbp">16190000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-891" decimals="-3" id="f-3824" unitRef="usd">21946000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-891" decimals="-3" id="f-3825" unitRef="usd">19134000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-891"
      decimals="4"
      id="f-3826"
      unitRef="number">0.0046</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-892"
      decimals="INF"
      id="f-3827"
      unitRef="number">0.0700</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-892"
      decimals="4"
      id="f-3828"
      unitRef="number">0.0700</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-892" decimals="-3" id="f-3829" unitRef="gbp">28509000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-892" decimals="-3" id="f-3830" unitRef="usd">38706000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-892" decimals="-3" id="f-3831" unitRef="usd">33693000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-892"
      decimals="4"
      id="f-3832"
      unitRef="number">0.0081</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-893"
      decimals="INF"
      id="f-3833"
      unitRef="number">0.0700</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-893"
      decimals="4"
      id="f-3834"
      unitRef="number">0.1038</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-893" decimals="-3" id="f-3835" unitRef="usd">54034000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-893" decimals="-3" id="f-3836" unitRef="usd">52743000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-893" decimals="-3" id="f-3837" unitRef="usd">53088000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-893"
      decimals="4"
      id="f-3838"
      unitRef="number">0.0128</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-894"
      decimals="INF"
      id="f-3839"
      unitRef="number">0.0700</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-894"
      decimals="4"
      id="f-3840"
      unitRef="number">0.1221</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-894" decimals="-3" id="f-3841" unitRef="usd">15998000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-894" decimals="-3" id="f-3842" unitRef="usd">15796000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-894" decimals="-3" id="f-3843" unitRef="usd">15718000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-894"
      decimals="4"
      id="f-3844"
      unitRef="number">0.0038</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-895"
      decimals="INF"
      id="f-3845"
      unitRef="number">0.0700</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-895"
      decimals="4"
      id="f-3846"
      unitRef="number">0.1139</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-895" decimals="-3" id="f-3847" unitRef="usd">42483000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-895" decimals="-3" id="f-3848" unitRef="usd">39901000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-895" decimals="-3" id="f-3849" unitRef="usd">41209000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-895"
      decimals="4"
      id="f-3850"
      unitRef="number">0.0099</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-896"
      decimals="INF"
      id="f-3851"
      unitRef="number">0.0700</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-896"
      decimals="4"
      id="f-3852"
      unitRef="number">0.1186</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-896" decimals="-3" id="f-3853" unitRef="cad">165350000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-896" decimals="-3" id="f-3854" unitRef="usd">119655000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-896" decimals="-3" id="f-3855" unitRef="usd">118210000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-896"
      decimals="4"
      id="f-3856"
      unitRef="number">0.0284</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-897" decimals="-3" id="f-3857" unitRef="usd">743842000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-897" decimals="-3" id="f-3858" unitRef="usd">722781000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-897"
      decimals="4"
      id="f-3859"
      unitRef="number">0.1738</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-898"
      decimals="INF"
      id="f-3860"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-898"
      decimals="4"
      id="f-3861"
      unitRef="number">0.1043</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-898" decimals="-3" id="f-3862" unitRef="usd">322470000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-898" decimals="-3" id="f-3863" unitRef="usd">318178000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-898" decimals="-3" id="f-3864" unitRef="usd">319245000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-898"
      decimals="4"
      id="f-3865"
      unitRef="number">0.0768</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-899"
      decimals="INF"
      id="f-3866"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-899"
      decimals="4"
      id="f-3867"
      unitRef="number">0.1065</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-899" decimals="-3" id="f-3868" unitRef="usd">5423000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-899" decimals="-3" id="f-3869" unitRef="usd">5320000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-899" decimals="-3" id="f-3870" unitRef="usd">5300000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-899"
      decimals="4"
      id="f-3871"
      unitRef="number">0.0013</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-900"
      decimals="INF"
      id="f-3872"
      unitRef="number">0.0975</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-900"
      decimals="INF"
      id="f-3873"
      unitRef="number">0.0975</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-900" decimals="-3" id="f-3874" unitRef="usd">835000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-900" decimals="-3" id="f-3875" unitRef="usd">814000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-900" decimals="-3" id="f-3876" unitRef="usd">808000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-900"
      decimals="4"
      id="f-3877"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-901"
      decimals="INF"
      id="f-3878"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-901"
      decimals="4"
      id="f-3879"
      unitRef="number">0.1048</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-901" decimals="-3" id="f-3880" unitRef="usd">4975000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-901" decimals="-3" id="f-3881" unitRef="usd">4888000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-901" decimals="-3" id="f-3882" unitRef="usd">4776000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-901"
      decimals="4"
      id="f-3883"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-902"
      decimals="INF"
      id="f-3884"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-902"
      decimals="4"
      id="f-3885"
      unitRef="number">0.1095</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-902"
      decimals="INF"
      id="f-3886"
      unitRef="number">0.0275</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-902" decimals="-3" id="f-3887" unitRef="usd">106179000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-902" decimals="-3" id="f-3888" unitRef="usd">103883000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-902" decimals="-3" id="f-3889" unitRef="usd">104979000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-902"
      decimals="4"
      id="f-3890"
      unitRef="number">0.0252</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-903"
      decimals="INF"
      id="f-3891"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-903"
      decimals="4"
      id="f-3892"
      unitRef="number">0.0814</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-903" decimals="-3" id="f-3893" unitRef="eur">658000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-903" decimals="-3" id="f-3894" unitRef="usd">601000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-903" decimals="-3" id="f-3895" unitRef="usd">704000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-903"
      decimals="4"
      id="f-3896"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-904"
      decimals="INF"
      id="f-3897"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-904"
      decimals="4"
      id="f-3898"
      unitRef="number">0.0842</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-904" decimals="-3" id="f-3899" unitRef="dkk">4819000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-904" decimals="-3" id="f-3900" unitRef="usd">618000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-904" decimals="-3" id="f-3901" unitRef="usd">674000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-904"
      decimals="4"
      id="f-3902"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-905"
      decimals="INF"
      id="f-3903"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-905"
      decimals="4"
      id="f-3904"
      unitRef="number">0.0926</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-905" decimals="-3" id="f-3905" unitRef="nok">5149000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-905" decimals="-3" id="f-3906" unitRef="usd">461000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-905" decimals="-3" id="f-3907" unitRef="usd">510000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-905"
      decimals="4"
      id="f-3908"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-906"
      decimals="INF"
      id="f-3909"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-906"
      decimals="4"
      id="f-3910"
      unitRef="number">0.0865</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-906" decimals="-3" id="f-3911" unitRef="sek">2090000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-906" decimals="-3" id="f-3912" unitRef="usd">184000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-906" decimals="-3" id="f-3913" unitRef="usd">196000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-906"
      decimals="4"
      id="f-3914"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-907"
      decimals="INF"
      id="f-3915"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-907"
      decimals="4"
      id="f-3916"
      unitRef="number">0.0942</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-907" decimals="-3" id="f-3917" unitRef="usd">37347000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-907" decimals="-3" id="f-3918" unitRef="usd">36718000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-907" decimals="-3" id="f-3919" unitRef="usd">36600000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-907"
      decimals="4"
      id="f-3920"
      unitRef="number">0.0088</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-908"
      decimals="INF"
      id="f-3921"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-908"
      decimals="4"
      id="f-3922"
      unitRef="number">0.1038</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-908" decimals="-3" id="f-3923" unitRef="usd">80785000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-908" decimals="-3" id="f-3924" unitRef="usd">79749000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-908" decimals="-3" id="f-3925" unitRef="usd">80180000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-908"
      decimals="4"
      id="f-3926"
      unitRef="number">0.0193</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-909"
      decimals="INF"
      id="f-3927"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-909"
      decimals="4"
      id="f-3928"
      unitRef="number">0.0800</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-909"
      decimals="INF"
      id="f-3929"
      unitRef="number">0.0250</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-909" decimals="-3" id="f-3930" unitRef="eur">16280000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-909" decimals="-3" id="f-3931" unitRef="usd">18129000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-909" decimals="-3" id="f-3932" unitRef="usd">17160000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-909"
      decimals="4"
      id="f-3933"
      unitRef="number">0.0041</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-910"
      decimals="INF"
      id="f-3934"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-910"
      decimals="4"
      id="f-3935"
      unitRef="number">0.1001</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-910" decimals="-3" id="f-3936" unitRef="usd">8437000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-910" decimals="-3" id="f-3937" unitRef="usd">8229000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-910" decimals="-3" id="f-3938" unitRef="usd">8310000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-910"
      decimals="4"
      id="f-3939"
      unitRef="number">0.0020</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-911" decimals="-3" id="f-3940" unitRef="usd">259594000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-911" decimals="-3" id="f-3941" unitRef="usd">260197000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-911"
      decimals="4"
      id="f-3942"
      unitRef="number">0.0625</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-912"
      decimals="INF"
      id="f-3943"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-912"
      decimals="4"
      id="f-3944"
      unitRef="number">0.0950</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-912" decimals="-3" id="f-3945" unitRef="usd">4492000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-912" decimals="-3" id="f-3946" unitRef="usd">4419000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-912" decimals="-3" id="f-3947" unitRef="usd">4331000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-912"
      decimals="4"
      id="f-3948"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-913"
      decimals="INF"
      id="f-3949"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-913"
      decimals="4"
      id="f-3950"
      unitRef="number">0.0975</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-913" decimals="-3" id="f-3951" unitRef="usd">214000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-913" decimals="-3" id="f-3952" unitRef="usd">210000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-913" decimals="-3" id="f-3953" unitRef="usd">208000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-913"
      decimals="4"
      id="f-3954"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-914" decimals="-3" id="f-3955" unitRef="usd">4629000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-914" decimals="-3" id="f-3956" unitRef="usd">4539000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-914"
      decimals="4"
      id="f-3957"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-915"
      decimals="INF"
      id="f-3958"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-915"
      decimals="4"
      id="f-3959"
      unitRef="number">0.1013</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-915" decimals="-3" id="f-3960" unitRef="usd">25997000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-915" decimals="-3" id="f-3961" unitRef="usd">25520000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-915" decimals="-3" id="f-3962" unitRef="usd">25209000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-915"
      decimals="4"
      id="f-3963"
      unitRef="number">0.0061</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-916"
      decimals="INF"
      id="f-3964"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-916"
      decimals="4"
      id="f-3965"
      unitRef="number">0.1040</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-916" decimals="-3" id="f-3966" unitRef="cad">10000000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-916" decimals="-3" id="f-3967" unitRef="usd">7149000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-916" decimals="-3" id="f-3968" unitRef="usd">7185000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-916"
      decimals="4"
      id="f-3969"
      unitRef="number">0.0017</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-917"
      decimals="INF"
      id="f-3970"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-917"
      decimals="4"
      id="f-3971"
      unitRef="number">0.1052</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-917" decimals="-3" id="f-3972" unitRef="usd">74649000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-917" decimals="-3" id="f-3973" unitRef="usd">73602000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-917" decimals="-3" id="f-3974" unitRef="usd">73529000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-917"
      decimals="4"
      id="f-3975"
      unitRef="number">0.0177</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-918"
      decimals="INF"
      id="f-3976"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-918"
      decimals="4"
      id="f-3977"
      unitRef="number">0.1052</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-918" decimals="-3" id="f-3978" unitRef="usd">40611000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-918" decimals="-3" id="f-3979" unitRef="usd">40042000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-918" decimals="-3" id="f-3980" unitRef="usd">40002000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-918"
      decimals="4"
      id="f-3981"
      unitRef="number">0.0096</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-919" decimals="-3" id="f-3982" unitRef="usd">113644000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-919" decimals="-3" id="f-3983" unitRef="usd">113531000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-919"
      decimals="4"
      id="f-3984"
      unitRef="number">0.0273</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-920"
      decimals="INF"
      id="f-3985"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-920"
      decimals="4"
      id="f-3986"
      unitRef="number">0.0936</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-920" decimals="-3" id="f-3987" unitRef="usd">6344000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-920" decimals="-3" id="f-3988" unitRef="usd">6247000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-920" decimals="-3" id="f-3989" unitRef="usd">6186000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-920"
      decimals="4"
      id="f-3990"
      unitRef="number">0.0015</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-921"
      decimals="INF"
      id="f-3991"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-921"
      decimals="4"
      id="f-3992"
      unitRef="number">0.1014</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-921" decimals="-3" id="f-3993" unitRef="usd">1242000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-921" decimals="-3" id="f-3994" unitRef="usd">1221000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-921" decimals="-3" id="f-3995" unitRef="usd">1214000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-921"
      decimals="4"
      id="f-3996"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-922" decimals="-3" id="f-3997" unitRef="usd">7468000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-922" decimals="-3" id="f-3998" unitRef="usd">7400000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-922"
      decimals="4"
      id="f-3999"
      unitRef="number">0.0018</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-923"
      decimals="INF"
      id="f-4000"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-923"
      decimals="4"
      id="f-4001"
      unitRef="number">0.0856</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-923" decimals="-3" id="f-4002" unitRef="eur">1758000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-923" decimals="-3" id="f-4003" unitRef="usd">1478000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-923" decimals="-3" id="f-4004" unitRef="usd">1688000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-923"
      decimals="4"
      id="f-4005"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-924"
      decimals="INF"
      id="f-4006"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-924"
      decimals="4"
      id="f-4007"
      unitRef="number">0.0967</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-924" decimals="-3" id="f-4008" unitRef="usd">74904000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-924" decimals="-3" id="f-4009" unitRef="usd">74352000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-924" decimals="-3" id="f-4010" unitRef="usd">74904000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-924"
      decimals="4"
      id="f-4011"
      unitRef="number">0.0180</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-925"
      decimals="INF"
      id="f-4012"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-925"
      decimals="4"
      id="f-4013"
      unitRef="number">0.0942</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-925" decimals="-3" id="f-4014" unitRef="usd">38118000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-925" decimals="-3" id="f-4015" unitRef="usd">37751000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-925" decimals="-3" id="f-4016" unitRef="usd">38118000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-925"
      decimals="4"
      id="f-4017"
      unitRef="number">0.0092</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-926"
      decimals="INF"
      id="f-4018"
      unitRef="number">0.0687</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-926"
      decimals="4"
      id="f-4019"
      unitRef="number">0.1030</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-926" decimals="-3" id="f-4020" unitRef="gbp">26300000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-926" decimals="-3" id="f-4021" unitRef="usd">35637000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-926" decimals="-3" id="f-4022" unitRef="usd">31794000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-926"
      decimals="4"
      id="f-4023"
      unitRef="number">0.0076</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-927"
      decimals="INF"
      id="f-4024"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-927"
      decimals="4"
      id="f-4025"
      unitRef="number">0.0939</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-927" decimals="-3" id="f-4026" unitRef="usd">7598000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-927" decimals="-3" id="f-4027" unitRef="usd">7449000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-927" decimals="-3" id="f-4028" unitRef="usd">7565000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-927"
      decimals="4"
      id="f-4029"
      unitRef="number">0.0018</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-928"
      decimals="INF"
      id="f-4030"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-928"
      decimals="4"
      id="f-4031"
      unitRef="number">0.0998</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-928" decimals="-3" id="f-4032" unitRef="usd">9240000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-928" decimals="-3" id="f-4033" unitRef="usd">9032000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-928" decimals="-3" id="f-4034" unitRef="usd">9001000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-928"
      decimals="4"
      id="f-4035"
      unitRef="number">0.0022</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-929"
      decimals="INF"
      id="f-4036"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-929"
      decimals="4"
      id="f-4037"
      unitRef="number">0.0892</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-929" decimals="-3" id="f-4038" unitRef="usd">73737000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-929" decimals="-3" id="f-4039" unitRef="usd">72612000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-929" decimals="-3" id="f-4040" unitRef="usd">71088000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-929"
      decimals="4"
      id="f-4041"
      unitRef="number">0.0171</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-930"
      decimals="INF"
      id="f-4042"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-930"
      decimals="4"
      id="f-4043"
      unitRef="number">0.0892</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-930" decimals="-3" id="f-4044" unitRef="usd">1000000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-930" decimals="-3" id="f-4045" unitRef="usd">970000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-930" decimals="-3" id="f-4046" unitRef="usd">970000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-930"
      decimals="4"
      id="f-4047"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-931"
      decimals="INF"
      id="f-4048"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-931"
      decimals="4"
      id="f-4049"
      unitRef="number">0.1063</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-931" decimals="-3" id="f-4050" unitRef="usd">325537000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-931" decimals="-3" id="f-4051" unitRef="usd">322831000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-931" decimals="-3" id="f-4052" unitRef="usd">319027000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-931"
      decimals="4"
      id="f-4053"
      unitRef="number">0.0767</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-932"
      decimals="INF"
      id="f-4054"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-932"
      decimals="4"
      id="f-4055"
      unitRef="number">0.0978</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-932" decimals="-3" id="f-4056" unitRef="usd">23523000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-932" decimals="-3" id="f-4057" unitRef="usd">23133000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-932" decimals="-3" id="f-4058" unitRef="usd">23239000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-932"
      decimals="4"
      id="f-4059"
      unitRef="number">0.0056</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-933"
      decimals="INF"
      id="f-4060"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-933"
      decimals="4"
      id="f-4061"
      unitRef="number">0.1039</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-933" decimals="-3" id="f-4062" unitRef="usd">48167000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-933" decimals="-3" id="f-4063" unitRef="usd">47356000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-933" decimals="-3" id="f-4064" unitRef="usd">47915000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-933"
      decimals="4"
      id="f-4065"
      unitRef="number">0.0115</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-934"
      decimals="INF"
      id="f-4066"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-934"
      decimals="4"
      id="f-4067"
      unitRef="number">0.0963</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-934" decimals="-3" id="f-4068" unitRef="usd">24314000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-934" decimals="-3" id="f-4069" unitRef="usd">23858000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-934" decimals="-3" id="f-4070" unitRef="usd">24131000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-934"
      decimals="4"
      id="f-4071"
      unitRef="number">0.0058</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-935"
      decimals="INF"
      id="f-4072"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-935"
      decimals="4"
      id="f-4073"
      unitRef="number">0.1026</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-935" decimals="-3" id="f-4074" unitRef="usd">5161000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-935" decimals="-3" id="f-4075" unitRef="usd">5047000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-935" decimals="-3" id="f-4076" unitRef="usd">5080000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-935"
      decimals="4"
      id="f-4077"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-936"
      decimals="INF"
      id="f-4078"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-936"
      decimals="4"
      id="f-4079"
      unitRef="number">0.1068</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-936" decimals="-3" id="f-4080" unitRef="usd">24448000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-936" decimals="-3" id="f-4081" unitRef="usd">24042000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-936" decimals="-3" id="f-4082" unitRef="usd">23687000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-936"
      decimals="4"
      id="f-4083"
      unitRef="number">0.0057</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-937"
      decimals="INF"
      id="f-4084"
      unitRef="number">0.0475</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-937"
      decimals="4"
      id="f-4085"
      unitRef="number">0.0917</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-937" decimals="-3" id="f-4086" unitRef="usd">1985000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-937" decimals="-3" id="f-4087" unitRef="usd">1932000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-937" decimals="-3" id="f-4088" unitRef="usd">1903000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-937"
      decimals="4"
      id="f-4089"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-938"
      decimals="INF"
      id="f-4090"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-938"
      decimals="4"
      id="f-4091"
      unitRef="number">0.1070</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-938" decimals="-3" id="f-4092" unitRef="usd">1905000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-938" decimals="-3" id="f-4093" unitRef="usd">1833000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-938" decimals="-3" id="f-4094" unitRef="usd">1831000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-938"
      decimals="4"
      id="f-4095"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-939"
      decimals="INF"
      id="f-4096"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-939"
      decimals="4"
      id="f-4097"
      unitRef="number">0.1048</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-939" decimals="-3" id="f-4098" unitRef="usd">8573000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-939" decimals="-3" id="f-4099" unitRef="usd">8386000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-939" decimals="-3" id="f-4100" unitRef="usd">8223000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-939"
      decimals="4"
      id="f-4101"
      unitRef="number">0.0020</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-940"
      decimals="INF"
      id="f-4102"
      unitRef="number">0.0400</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-940"
      decimals="4"
      id="f-4103"
      unitRef="number">0.0873</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-940" decimals="-3" id="f-4104" unitRef="usd">1309000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-940" decimals="-3" id="f-4105" unitRef="usd">1296000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-940" decimals="-3" id="f-4106" unitRef="usd">1273000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-940"
      decimals="4"
      id="f-4107"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-941"
      decimals="INF"
      id="f-4108"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-941"
      decimals="4"
      id="f-4109"
      unitRef="number">0.1007</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-941" decimals="-3" id="f-4110" unitRef="usd">42028000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-941" decimals="-3" id="f-4111" unitRef="usd">40646000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-941" decimals="-3" id="f-4112" unitRef="usd">40136000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-941"
      decimals="4"
      id="f-4113"
      unitRef="number">0.0097</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-942"
      decimals="INF"
      id="f-4114"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-942"
      decimals="4"
      id="f-4115"
      unitRef="number">0.1018</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-942" decimals="-3" id="f-4116" unitRef="usd">67936000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-942" decimals="-3" id="f-4117" unitRef="usd">66786000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-942" decimals="-3" id="f-4118" unitRef="usd">67079000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-942"
      decimals="4"
      id="f-4119"
      unitRef="number">0.0161</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-943"
      decimals="INF"
      id="f-4120"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-943"
      decimals="4"
      id="f-4121"
      unitRef="number">0.0999</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-943" decimals="-3" id="f-4122" unitRef="usd">4804000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-943" decimals="-3" id="f-4123" unitRef="usd">4710000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-943" decimals="-3" id="f-4124" unitRef="usd">4694000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-943"
      decimals="4"
      id="f-4125"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-944"
      decimals="INF"
      id="f-4126"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-944"
      decimals="4"
      id="f-4127"
      unitRef="number">0.0984</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-944" decimals="-3" id="f-4128" unitRef="usd">14896000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-944" decimals="-3" id="f-4129" unitRef="usd">14623000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-944" decimals="-3" id="f-4130" unitRef="usd">14524000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-944"
      decimals="4"
      id="f-4131"
      unitRef="number">0.0035</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-945" decimals="-3" id="f-4132" unitRef="usd">824282000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-945" decimals="-3" id="f-4133" unitRef="usd">816182000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-945"
      decimals="4"
      id="f-4134"
      unitRef="number">0.1962</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-946"
      decimals="INF"
      id="f-4135"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-946"
      decimals="4"
      id="f-4136"
      unitRef="number">0.1067</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-946" decimals="-3" id="f-4137" unitRef="usd">70324000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-946" decimals="-3" id="f-4138" unitRef="usd">69012000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-946" decimals="-3" id="f-4139" unitRef="usd">70324000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-946"
      decimals="4"
      id="f-4140"
      unitRef="number">0.0169</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-947"
      decimals="INF"
      id="f-4141"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-947"
      decimals="4"
      id="f-4142"
      unitRef="number">0.1067</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-947" decimals="-3" id="f-4143" unitRef="usd">833000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-947" decimals="-3" id="f-4144" unitRef="usd">814000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-947" decimals="-3" id="f-4145" unitRef="usd">833000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-947"
      decimals="4"
      id="f-4146"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-948" decimals="-3" id="f-4147" unitRef="usd">69826000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-948" decimals="-3" id="f-4148" unitRef="usd">71157000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-948"
      decimals="4"
      id="f-4149"
      unitRef="number">0.0171</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-949"
      decimals="INF"
      id="f-4150"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-949"
      decimals="4"
      id="f-4151"
      unitRef="number">0.0775</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-949" decimals="-3" id="f-4152" unitRef="usd">16437000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-949" decimals="-3" id="f-4153" unitRef="usd">16072000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-949" decimals="-3" id="f-4154" unitRef="usd">16167000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-949"
      decimals="4"
      id="f-4155"
      unitRef="number">0.0039</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-950"
      decimals="INF"
      id="f-4156"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-950"
      decimals="4"
      id="f-4157"
      unitRef="number">0.1082</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-950" decimals="-3" id="f-4158" unitRef="usd">1786000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-950" decimals="-3" id="f-4159" unitRef="usd">1749000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-950" decimals="-3" id="f-4160" unitRef="usd">1747000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-950"
      decimals="4"
      id="f-4161"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-951"
      decimals="INF"
      id="f-4162"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-951"
      decimals="4"
      id="f-4163"
      unitRef="number">0.1013</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-951" decimals="-3" id="f-4164" unitRef="usd">42118000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-951" decimals="-3" id="f-4165" unitRef="usd">41401000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-951" decimals="-3" id="f-4166" unitRef="usd">41635000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-951"
      decimals="4"
      id="f-4167"
      unitRef="number">0.0100</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-952"
      decimals="INF"
      id="f-4168"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-952"
      decimals="4"
      id="f-4169"
      unitRef="number">0.1046</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-952" decimals="-3" id="f-4170" unitRef="usd">1959000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-952" decimals="-3" id="f-4171" unitRef="usd">1915000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-952" decimals="-3" id="f-4172" unitRef="usd">1913000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-952"
      decimals="4"
      id="f-4173"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-953"
      decimals="INF"
      id="f-4174"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-953"
      decimals="4"
      id="f-4175"
      unitRef="number">0.1017</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-953" decimals="-3" id="f-4176" unitRef="usd">4963000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-953" decimals="-3" id="f-4177" unitRef="usd">4866000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-953" decimals="-3" id="f-4178" unitRef="usd">4850000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-953"
      decimals="4"
      id="f-4179"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-954"
      decimals="INF"
      id="f-4180"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-954"
      decimals="4"
      id="f-4181"
      unitRef="number">0.1005</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-954" decimals="-3" id="f-4182" unitRef="usd">15921000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-954" decimals="-3" id="f-4183" unitRef="usd">15503000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-954" decimals="-3" id="f-4184" unitRef="usd">15092000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-954"
      decimals="4"
      id="f-4185"
      unitRef="number">0.0036</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-955"
      decimals="INF"
      id="f-4186"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-955"
      decimals="4"
      id="f-4187"
      unitRef="number">0.1014</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-955" decimals="-3" id="f-4188" unitRef="usd">21875000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-955" decimals="-3" id="f-4189" unitRef="usd">21348000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-955" decimals="-3" id="f-4190" unitRef="usd">21220000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-955"
      decimals="4"
      id="f-4191"
      unitRef="number">0.0051</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-956"
      decimals="INF"
      id="f-4192"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-956"
      decimals="4"
      id="f-4193"
      unitRef="number">0.1013</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-956" decimals="-3" id="f-4194" unitRef="usd">58950000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-956" decimals="-3" id="f-4195" unitRef="usd">58458000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-956" decimals="-3" id="f-4196" unitRef="usd">57182000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-956"
      decimals="4"
      id="f-4197"
      unitRef="number">0.0138</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-957"
      decimals="INF"
      id="f-4198"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-957"
      decimals="4"
      id="f-4199"
      unitRef="number">0.0983</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-957" decimals="-3" id="f-4200" unitRef="usd">26600000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-957" decimals="-3" id="f-4201" unitRef="usd">26071000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-957" decimals="-3" id="f-4202" unitRef="usd">25565000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-957"
      decimals="4"
      id="f-4203"
      unitRef="number">0.0061</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-958"
      decimals="INF"
      id="f-4204"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-958"
      decimals="4"
      id="f-4205"
      unitRef="number">0.0998</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-958" decimals="-3" id="f-4206" unitRef="usd">9643000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-958" decimals="-3" id="f-4207" unitRef="usd">9525000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-958" decimals="-3" id="f-4208" unitRef="usd">9117000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-958"
      decimals="4"
      id="f-4209"
      unitRef="number">0.0022</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-959"
      decimals="INF"
      id="f-4210"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-959"
      decimals="4"
      id="f-4211"
      unitRef="number">0.1048</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-959" decimals="-3" id="f-4212" unitRef="usd">15007000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-959" decimals="-3" id="f-4213" unitRef="usd">14743000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-959" decimals="-3" id="f-4214" unitRef="usd">14677000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-959"
      decimals="4"
      id="f-4215"
      unitRef="number">0.0035</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-960"
      decimals="INF"
      id="f-4216"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-960"
      decimals="4"
      id="f-4217"
      unitRef="number">0.0973</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-960" decimals="-3" id="f-4218" unitRef="usd">7471000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-960" decimals="-3" id="f-4219" unitRef="usd">7335000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-960" decimals="-3" id="f-4220" unitRef="usd">7293000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-960"
      decimals="4"
      id="f-4221"
      unitRef="number">0.0018</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-961"
      decimals="INF"
      id="f-4222"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-961"
      decimals="4"
      id="f-4223"
      unitRef="number">0.0988</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-961" decimals="-3" id="f-4224" unitRef="usd">4963000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-961" decimals="-3" id="f-4225" unitRef="usd">4934000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-961" decimals="-3" id="f-4226" unitRef="usd">4828000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-961"
      decimals="4"
      id="f-4227"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-962"
      decimals="INF"
      id="f-4228"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-962"
      decimals="4"
      id="f-4229"
      unitRef="number">0.1023</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-962" decimals="-3" id="f-4230" unitRef="usd">26584000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-962" decimals="-3" id="f-4231" unitRef="usd">26261000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-962" decimals="-3" id="f-4232" unitRef="usd">26222000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-962"
      decimals="4"
      id="f-4233"
      unitRef="number">0.0063</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-963"
      decimals="INF"
      id="f-4234"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-963"
      decimals="4"
      id="f-4235"
      unitRef="number">0.1123</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-963" decimals="-3" id="f-4236" unitRef="usd">92459000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-963" decimals="-3" id="f-4237" unitRef="usd">91310000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-963" decimals="-3" id="f-4238" unitRef="usd">91072000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-963"
      decimals="4"
      id="f-4239"
      unitRef="number">0.0219</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-964"
      decimals="INF"
      id="f-4240"
      unitRef="number">0.0500</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-964"
      decimals="4"
      id="f-4241"
      unitRef="number">0.0973</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-964" decimals="-3" id="f-4242" unitRef="usd">1990000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-964" decimals="-3" id="f-4243" unitRef="usd">1948000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-964" decimals="-3" id="f-4244" unitRef="usd">1920000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-964"
      decimals="4"
      id="f-4245"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-965"
      decimals="INF"
      id="f-4246"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-965"
      decimals="4"
      id="f-4247"
      unitRef="number">0.0918</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-965" decimals="-3" id="f-4248" unitRef="gbp">3443000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-965" decimals="-3" id="f-4249" unitRef="usd">4201000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-965" decimals="-3" id="f-4250" unitRef="usd">4079000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-965"
      decimals="4"
      id="f-4251"
      unitRef="number">0.0010</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-966"
      decimals="INF"
      id="f-4252"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-966"
      decimals="4"
      id="f-4253"
      unitRef="number">0.1017</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-966" decimals="-3" id="f-4254" unitRef="usd">5268000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-966" decimals="-3" id="f-4255" unitRef="usd">5136000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-966" decimals="-3" id="f-4256" unitRef="usd">5177000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-966"
      decimals="4"
      id="f-4257"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-967"
      decimals="INF"
      id="f-4258"
      unitRef="number">0.0375</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-967"
      decimals="4"
      id="f-4259"
      unitRef="number">0.0816</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-967" decimals="-3" id="f-4260" unitRef="usd">9464000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-967" decimals="-3" id="f-4261" unitRef="usd">9352000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-967" decimals="-3" id="f-4262" unitRef="usd">9120000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-967"
      decimals="4"
      id="f-4263"
      unitRef="number">0.0022</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-968"
      decimals="INF"
      id="f-4264"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-968"
      decimals="4"
      id="f-4265"
      unitRef="number">0.1088</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-968"
      decimals="INF"
      id="f-4266"
      unitRef="number">0.0544</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-968" decimals="-3" id="f-4267" unitRef="usd">350678000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-968" decimals="-3" id="f-4268" unitRef="usd">345298000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-968" decimals="-3" id="f-4269" unitRef="usd">343665000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-968"
      decimals="4"
      id="f-4270"
      unitRef="number">0.0826</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-969"
      decimals="INF"
      id="f-4271"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-969"
      decimals="4"
      id="f-4272"
      unitRef="number">0.0967</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-969" decimals="-3" id="f-4273" unitRef="usd">5043000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-969" decimals="-3" id="f-4274" unitRef="usd">4921000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-969" decimals="-3" id="f-4275" unitRef="usd">4929000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-969"
      decimals="4"
      id="f-4276"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-970"
      decimals="INF"
      id="f-4277"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-970"
      decimals="4"
      id="f-4278"
      unitRef="number">0.1023</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-970" decimals="-3" id="f-4279" unitRef="usd">27816000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-970" decimals="-3" id="f-4280" unitRef="usd">27642000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-970" decimals="-3" id="f-4281" unitRef="usd">26405000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-970"
      decimals="4"
      id="f-4282"
      unitRef="number">0.0063</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-971"
      decimals="INF"
      id="f-4283"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-971"
      decimals="4"
      id="f-4284"
      unitRef="number">0.1073</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-971" decimals="-3" id="f-4285" unitRef="usd">34211000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-971" decimals="-3" id="f-4286" unitRef="usd">33637000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-971" decimals="-3" id="f-4287" unitRef="usd">31987000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-971"
      decimals="4"
      id="f-4288"
      unitRef="number">0.0077</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-972"
      decimals="INF"
      id="f-4289"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-972"
      decimals="4"
      id="f-4290"
      unitRef="number">0.0965</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-972" decimals="-3" id="f-4291" unitRef="usd">4795000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-972" decimals="-3" id="f-4292" unitRef="usd">4742000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-972" decimals="-3" id="f-4293" unitRef="usd">4763000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-972"
      decimals="4"
      id="f-4294"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-973"
      decimals="INF"
      id="f-4295"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-973"
      decimals="4"
      id="f-4296"
      unitRef="number">0.0878</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-973" decimals="-3" id="f-4297" unitRef="usd">718000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-973" decimals="-3" id="f-4298" unitRef="usd">700000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-973" decimals="-3" id="f-4299" unitRef="usd">699000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-973"
      decimals="4"
      id="f-4300"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-974"
      decimals="INF"
      id="f-4301"
      unitRef="number">0.1055</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-974"
      decimals="4"
      id="f-4302"
      unitRef="number">0.1189</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-974"
      decimals="INF"
      id="f-4303"
      unitRef="number">0.1155</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-974" decimals="-3" id="f-4304" unitRef="usd">20995000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-974" decimals="-3" id="f-4305" unitRef="usd">20607000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-974" decimals="-3" id="f-4306" unitRef="usd">20631000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-974"
      decimals="4"
      id="f-4307"
      unitRef="number">0.0050</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-975"
      decimals="INF"
      id="f-4308"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-975"
      decimals="4"
      id="f-4309"
      unitRef="number">0.0928</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-975" decimals="-3" id="f-4310" unitRef="usd">55061000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-975" decimals="-3" id="f-4311" unitRef="usd">54269000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-975" decimals="-3" id="f-4312" unitRef="usd">53960000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-975"
      decimals="4"
      id="f-4313"
      unitRef="number">0.0130</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-976"
      decimals="INF"
      id="f-4314"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-976"
      decimals="4"
      id="f-4315"
      unitRef="number">0.0786</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-976" decimals="-3" id="f-4316" unitRef="eur">10369000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-976" decimals="-3" id="f-4317" unitRef="usd">12350000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-976" decimals="-3" id="f-4318" unitRef="usd">10845000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-976"
      decimals="4"
      id="f-4319"
      unitRef="number">0.0026</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-977"
      decimals="INF"
      id="f-4320"
      unitRef="number">0.0600</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-977"
      decimals="4"
      id="f-4321"
      unitRef="number">0.1023</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-977" decimals="-3" id="f-4322" unitRef="usd">20506000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-977" decimals="-3" id="f-4323" unitRef="usd">20137000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-977" decimals="-3" id="f-4324" unitRef="usd">20059000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-977"
      decimals="4"
      id="f-4325"
      unitRef="number">0.0048</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-978"
      decimals="INF"
      id="f-4326"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-978"
      decimals="4"
      id="f-4327"
      unitRef="number">0.1013</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-978" decimals="-3" id="f-4328" unitRef="usd">288101000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-978" decimals="-3" id="f-4329" unitRef="usd">283359000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-978" decimals="-3" id="f-4330" unitRef="usd">280899000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-978"
      decimals="4"
      id="f-4331"
      unitRef="number">0.0675</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-979"
      decimals="INF"
      id="f-4332"
      unitRef="number">0.0625</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-979"
      decimals="4"
      id="f-4333"
      unitRef="number">0.1043</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-979"
      decimals="INF"
      id="f-4334"
      unitRef="number">0.0275</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-979" decimals="-3" id="f-4335" unitRef="usd">75724000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-979" decimals="-3" id="f-4336" unitRef="usd">74324000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-979" decimals="-3" id="f-4337" unitRef="usd">74210000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-979"
      decimals="4"
      id="f-4338"
      unitRef="number">0.0178</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-980"
      decimals="INF"
      id="f-4339"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-980"
      decimals="4"
      id="f-4340"
      unitRef="number">0.1013</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-980" decimals="-3" id="f-4341" unitRef="usd">123212000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-980" decimals="-3" id="f-4342" unitRef="usd">120651000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-980" decimals="-3" id="f-4343" unitRef="usd">121859000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-980"
      decimals="4"
      id="f-4344"
      unitRef="number">0.0293</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-981"
      decimals="INF"
      id="f-4345"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-981"
      decimals="4"
      id="f-4346"
      unitRef="number">0.0961</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-981" decimals="-3" id="f-4347" unitRef="usd">65276000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-981" decimals="-3" id="f-4348" unitRef="usd">64177000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-981" decimals="-3" id="f-4349" unitRef="usd">63876000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-981"
      decimals="4"
      id="f-4350"
      unitRef="number">0.0154</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-982"
      decimals="INF"
      id="f-4351"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-982"
      decimals="4"
      id="f-4352"
      unitRef="number">0.1104</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-982" decimals="-3" id="f-4353" unitRef="usd">1582000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-982" decimals="-3" id="f-4354" unitRef="usd">1544000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-982" decimals="-3" id="f-4355" unitRef="usd">1542000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-982"
      decimals="4"
      id="f-4356"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-983" decimals="-3" id="f-4357" unitRef="usd">1414414000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-983" decimals="-3" id="f-4358" unitRef="usd">1403038000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-983"
      decimals="4"
      id="f-4359"
      unitRef="number">0.3374</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-984"
      decimals="INF"
      id="f-4360"
      unitRef="number">0.0618</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-984"
      decimals="4"
      id="f-4361"
      unitRef="number">0.0718</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-984" decimals="-3" id="f-4362" unitRef="usd">163594000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-984" decimals="-3" id="f-4363" unitRef="usd">162126000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-984" decimals="-3" id="f-4364" unitRef="usd">163594000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-984"
      decimals="4"
      id="f-4365"
      unitRef="number">0.0393</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-985"
      decimals="INF"
      id="f-4366"
      unitRef="number">0.0675</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-985"
      decimals="4"
      id="f-4367"
      unitRef="number">0.1117</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-985" decimals="-3" id="f-4368" unitRef="usd">84454000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-985" decimals="-3" id="f-4369" unitRef="usd">83729000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-985" decimals="-3" id="f-4370" unitRef="usd">81076000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-985"
      decimals="4"
      id="f-4371"
      unitRef="number">0.0195</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-986"
      decimals="INF"
      id="f-4372"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-986"
      decimals="4"
      id="f-4373"
      unitRef="number">0.1048</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-986" decimals="-3" id="f-4374" unitRef="usd">55254000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-986" decimals="-3" id="f-4375" unitRef="usd">53785000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-986" decimals="-3" id="f-4376" unitRef="usd">54829000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-986"
      decimals="4"
      id="f-4377"
      unitRef="number">0.0132</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-987"
      decimals="INF"
      id="f-4378"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-987"
      decimals="4"
      id="f-4379"
      unitRef="number">0.0999</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-987" decimals="-3" id="f-4380" unitRef="usd">49193000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-987" decimals="-3" id="f-4381" unitRef="usd">48981000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-987" decimals="-3" id="f-4382" unitRef="usd">41998000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-987"
      decimals="4"
      id="f-4383"
      unitRef="number">0.0101</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-988" decimals="-3" id="f-4384" unitRef="usd">102766000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-988" decimals="-3" id="f-4385" unitRef="usd">96827000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-988"
      decimals="4"
      id="f-4386"
      unitRef="number">0.0233</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-989"
      decimals="INF"
      id="f-4387"
      unitRef="number">0.0475</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-989"
      decimals="4"
      id="f-4388"
      unitRef="number">0.0913</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-989" decimals="-3" id="f-4389" unitRef="usd">5558000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-989" decimals="-3" id="f-4390" unitRef="usd">5527000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-989" decimals="-3" id="f-4391" unitRef="usd">5350000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-989"
      decimals="4"
      id="f-4392"
      unitRef="number">0.0013</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-990"
      decimals="INF"
      id="f-4393"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-990"
      decimals="4"
      id="f-4394"
      unitRef="number">0.0668</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-990" decimals="-3" id="f-4395" unitRef="usd">90051000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-990" decimals="-3" id="f-4396" unitRef="usd">88785000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-990" decimals="-3" id="f-4397" unitRef="usd">84648000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-990"
      decimals="4"
      id="f-4398"
      unitRef="number">0.0204</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-991"
      decimals="INF"
      id="f-4399"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-991"
      decimals="4"
      id="f-4400"
      unitRef="number">0.1016</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-991" decimals="-3" id="f-4401" unitRef="usd">42303000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-991" decimals="-3" id="f-4402" unitRef="usd">41713000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-991" decimals="-3" id="f-4403" unitRef="usd">42083000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-991"
      decimals="4"
      id="f-4404"
      unitRef="number">0.0101</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-992"
      decimals="INF"
      id="f-4405"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-992"
      decimals="4"
      id="f-4406"
      unitRef="number">0.0735</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-992" decimals="-3" id="f-4407" unitRef="eur">78810000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-992" decimals="-3" id="f-4408" unitRef="usd">81010000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-992" decimals="-3" id="f-4409" unitRef="usd">81376000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-992"
      decimals="4"
      id="f-4410"
      unitRef="number">0.0196</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-993"
      decimals="INF"
      id="f-4411"
      unitRef="number">0.0575</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-993"
      decimals="4"
      id="f-4412"
      unitRef="number">0.1087</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-993" decimals="-3" id="f-4413" unitRef="usd">51884000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-993" decimals="-3" id="f-4414" unitRef="usd">51085000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-993" decimals="-3" id="f-4415" unitRef="usd">51336000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-993"
      decimals="4"
      id="f-4416"
      unitRef="number">0.0123</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-994"
      decimals="INF"
      id="f-4417"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-994"
      decimals="4"
      id="f-4418"
      unitRef="number">0.1046</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-994" decimals="-3" id="f-4419" unitRef="usd">5083000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-994" decimals="-3" id="f-4420" unitRef="usd">5044000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-994" decimals="-3" id="f-4421" unitRef="usd">5028000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-994"
      decimals="4"
      id="f-4422"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-995"
      decimals="INF"
      id="f-4423"
      unitRef="number">0.0525</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-995"
      decimals="4"
      id="f-4424"
      unitRef="number">0.0995</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-995" decimals="-3" id="f-4425" unitRef="usd">42275000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-995" decimals="-3" id="f-4426" unitRef="usd">41506000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-995" decimals="-3" id="f-4427" unitRef="usd">41306000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-995"
      decimals="4"
      id="f-4428"
      unitRef="number">0.0099</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-996"
      decimals="INF"
      id="f-4429"
      unitRef="number">0.0550</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-996"
      decimals="4"
      id="f-4430"
      unitRef="number">0.1008</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-996" decimals="-3" id="f-4431" unitRef="usd">39285000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-996" decimals="-3" id="f-4432" unitRef="usd">38640000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-996" decimals="-3" id="f-4433" unitRef="usd">36464000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-996"
      decimals="4"
      id="f-4434"
      unitRef="number">0.0088</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-997" decimals="-3" id="f-4435" unitRef="usd">353310000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-997" decimals="-3" id="f-4436" unitRef="usd">347591000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-997"
      decimals="4"
      id="f-4437"
      unitRef="number">0.0836</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-998" decimals="-3" id="f-4438" unitRef="usd">9497570000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-998" decimals="-3" id="f-4439" unitRef="usd">9419963000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-998"
      decimals="4"
      id="f-4440"
      unitRef="number">2.2649</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-999"
      decimals="INF"
      id="f-4441"
      unitRef="number">0.0875</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-999"
      decimals="4"
      id="f-4442"
      unitRef="number">0.1313</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-999" decimals="-3" id="f-4443" unitRef="usd">7517000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-999" decimals="-3" id="f-4444" unitRef="usd">7390000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-999" decimals="-3" id="f-4445" unitRef="usd">7178000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-999"
      decimals="4"
      id="f-4446"
      unitRef="number">0.0017</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-1000"
      decimals="INF"
      id="f-4447"
      unitRef="number">0.0875</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-1000"
      decimals="4"
      id="f-4448"
      unitRef="number">0.0875</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-1000" decimals="-3" id="f-4449" unitRef="cad">10533000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1000" decimals="-3" id="f-4450" unitRef="usd">8323000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1000" decimals="-3" id="f-4451" unitRef="usd">7171000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1000"
      decimals="4"
      id="f-4452"
      unitRef="number">0.0017</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-1001"
      decimals="INF"
      id="f-4453"
      unitRef="number">0.0875</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-1001"
      decimals="4"
      id="f-4454"
      unitRef="number">0.1317</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-1001" decimals="-3" id="f-4455" unitRef="usd">5183000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1001" decimals="-3" id="f-4456" unitRef="usd">5106000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1001" decimals="-3" id="f-4457" unitRef="usd">5144000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1001"
      decimals="4"
      id="f-4458"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1002" decimals="-3" id="f-4459" unitRef="usd">13429000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1002" decimals="-3" id="f-4460" unitRef="usd">12315000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1002"
      decimals="4"
      id="f-4461"
      unitRef="number">0.0029</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-1003"
      decimals="INF"
      id="f-4462"
      unitRef="number">0.0700</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-1003"
      decimals="4"
      id="f-4463"
      unitRef="number">0.1135</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-1003" decimals="-3" id="f-4464" unitRef="usd">9619000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1003" decimals="-3" id="f-4465" unitRef="usd">9534000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1003" decimals="-3" id="f-4466" unitRef="usd">8248000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1003"
      decimals="4"
      id="f-4467"
      unitRef="number">0.0020</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-1004"
      decimals="INF"
      id="f-4468"
      unitRef="number">0.1050</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-1004"
      decimals="4"
      id="f-4469"
      unitRef="number">0.1520</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentInterestRate
      contextRef="c-1004"
      decimals="4"
      id="f-4470"
      unitRef="number">0.1520</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentInterestRatePaidInKind
      contextRef="c-1004"
      decimals="4"
      id="f-4471"
      unitRef="number">0.1520</us-gaap:InvestmentInterestRatePaidInKind>
    <us-gaap:InvestmentInterestRate
      contextRef="c-1004"
      decimals="4"
      id="f-4472"
      unitRef="number">0.1520</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-1004" decimals="-3" id="f-4473" unitRef="usd">10358000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1004" decimals="-3" id="f-4474" unitRef="usd">10108000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1004" decimals="-3" id="f-4475" unitRef="usd">10359000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1004"
      decimals="4"
      id="f-4476"
      unitRef="number">0.0025</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-1005"
      decimals="INF"
      id="f-4477"
      unitRef="number">0.0675</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-1005"
      decimals="4"
      id="f-4478"
      unitRef="number">0.1148</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-1005" decimals="-3" id="f-4479" unitRef="usd">4920000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1005" decimals="-3" id="f-4480" unitRef="usd">4783000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1005" decimals="-3" id="f-4481" unitRef="usd">4810000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1005"
      decimals="4"
      id="f-4482"
      unitRef="number">0.0012</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentBasisSpreadVariableRate
      contextRef="c-1006"
      decimals="INF"
      id="f-4483"
      unitRef="number">0.0650</us-gaap:InvestmentBasisSpreadVariableRate>
    <us-gaap:InvestmentInterestRate
      contextRef="c-1006"
      decimals="4"
      id="f-4484"
      unitRef="number">0.1091</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-1006" decimals="-3" id="f-4485" unitRef="usd">3550000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1006" decimals="-3" id="f-4486" unitRef="usd">3509000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1006" decimals="-3" id="f-4487" unitRef="usd">3426000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1006"
      decimals="4"
      id="f-4488"
      unitRef="number">0.0008</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1007" decimals="-3" id="f-4489" unitRef="usd">48753000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1007" decimals="-3" id="f-4490" unitRef="usd">46336000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1007"
      decimals="4"
      id="f-4491"
      unitRef="number">0.0111</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1008"
      decimals="0"
      id="f-4492"
      unitRef="shares">4767</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1008" decimals="-3" id="f-4493" unitRef="usd">4767000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1008" decimals="-3" id="f-4494" unitRef="usd">4767000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1008"
      decimals="4"
      id="f-4495"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1009"
      decimals="0"
      id="f-4496"
      unitRef="shares">902</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1009" decimals="-3" id="f-4497" unitRef="usd">902000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1009" decimals="-3" id="f-4498" unitRef="usd">724000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1009"
      decimals="4"
      id="f-4499"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1010"
      decimals="0"
      id="f-4500"
      unitRef="shares">5486923</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1010" decimals="-3" id="f-4501" unitRef="usd">5487000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1010" decimals="-3" id="f-4502" unitRef="usd">10699000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1010"
      decimals="4"
      id="f-4503"
      unitRef="number">0.0026</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1011" decimals="-3" id="f-4504" unitRef="usd">6389000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1011" decimals="-3" id="f-4505" unitRef="usd">11423000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1011"
      decimals="4"
      id="f-4506"
      unitRef="number">0.0028</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1012"
      decimals="0"
      id="f-4507"
      unitRef="shares">702305</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1012" decimals="-3" id="f-4508" unitRef="usd">702000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1012" decimals="-3" id="f-4509" unitRef="usd">625000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1012"
      decimals="4"
      id="f-4510"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1013"
      decimals="0"
      id="f-4511"
      unitRef="shares">6292</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1013" decimals="-3" id="f-4512" unitRef="usd">3350000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1013" decimals="-3" id="f-4513" unitRef="usd">13282000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1013"
      decimals="4"
      id="f-4514"
      unitRef="number">0.0032</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1014" decimals="-3" id="f-4515" unitRef="usd">4052000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1014" decimals="-3" id="f-4516" unitRef="usd">13907000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1014"
      decimals="4"
      id="f-4517"
      unitRef="number">0.0034</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentInterestRate
      contextRef="c-1015"
      decimals="INF"
      id="f-4518"
      unitRef="number">0.1150</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1015"
      decimals="0"
      id="f-4519"
      unitRef="shares">12511857</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1015" decimals="-3" id="f-4520" unitRef="usd">12315000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1015" decimals="-3" id="f-4521" unitRef="usd">15135000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1015"
      decimals="4"
      id="f-4522"
      unitRef="number">0.0036</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1016"
      decimals="0"
      id="f-4523"
      unitRef="shares">213</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1016" decimals="-3" id="f-4524" unitRef="usd">213000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1016" decimals="-3" id="f-4525" unitRef="usd">168000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1016"
      decimals="4"
      id="f-4526"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1017" decimals="-3" id="f-4527" unitRef="usd">12528000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1017" decimals="-3" id="f-4528" unitRef="usd">15303000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1017"
      decimals="4"
      id="f-4529"
      unitRef="number">0.0036</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1018"
      decimals="0"
      id="f-4530"
      unitRef="shares">6930</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1018" decimals="-3" id="f-4531" unitRef="usd">5877000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1018" decimals="-3" id="f-4532" unitRef="usd">5285000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1018"
      decimals="4"
      id="f-4533"
      unitRef="number">0.0013</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1019"
      decimals="0"
      id="f-4534"
      unitRef="shares">369255</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1019" decimals="-3" id="f-4535" unitRef="usd">1053000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1019" decimals="-3" id="f-4536" unitRef="usd">762000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1019"
      decimals="4"
      id="f-4537"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1020"
      decimals="0"
      id="f-4538"
      unitRef="shares">79358</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1020" decimals="-3" id="f-4539" unitRef="usd">226000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1020" decimals="-3" id="f-4540" unitRef="usd">164000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1020"
      decimals="4"
      id="f-4541"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1021"
      decimals="0"
      id="f-4542"
      unitRef="shares">1489</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1021" decimals="-3" id="f-4543" unitRef="usd">1263000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1021" decimals="-3" id="f-4544" unitRef="usd">1136000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1021"
      decimals="4"
      id="f-4545"
      unitRef="number">0.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1022" decimals="-3" id="f-4546" unitRef="usd">8419000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1022" decimals="-3" id="f-4547" unitRef="usd">7347000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1022"
      decimals="4"
      id="f-4548"
      unitRef="number">0.0018</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1023"
      decimals="0"
      id="f-4549"
      unitRef="shares">539</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1023" decimals="-3" id="f-4550" unitRef="usd">539000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1023" decimals="-3" id="f-4551" unitRef="usd">324000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1023"
      decimals="4"
      id="f-4552"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1024"
      decimals="0"
      id="f-4553"
      unitRef="shares">625944</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1024" decimals="-3" id="f-4554" unitRef="usd">607000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1024" decimals="-3" id="f-4555" unitRef="usd">638000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1024"
      decimals="4"
      id="f-4556"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1025"
      decimals="0"
      id="f-4557"
      unitRef="shares">2201</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1025" decimals="-3" id="f-4558" unitRef="usd">392000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1025" decimals="-3" id="f-4559" unitRef="usd">627000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1025"
      decimals="4"
      id="f-4560"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1026"
      decimals="0"
      id="f-4561"
      unitRef="shares">1185</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1026" decimals="-3" id="f-4562" unitRef="usd">211000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1026" decimals="-3" id="f-4563" unitRef="usd">338000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1026"
      decimals="4"
      id="f-4564"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1027" decimals="-3" id="f-4565" unitRef="usd">1210000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1027" decimals="-3" id="f-4566" unitRef="usd">1603000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1027"
      decimals="4"
      id="f-4567"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1028"
      decimals="0"
      id="f-4568"
      unitRef="shares">11710</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1028" decimals="-3" id="f-4569" unitRef="usd">12000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1028" decimals="-3" id="f-4570" unitRef="usd">1000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1028"
      decimals="4"
      id="f-4571"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1029"
      decimals="0"
      id="f-4572"
      unitRef="shares">58458</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1029" decimals="-3" id="f-4573" unitRef="usd">58000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1029" decimals="-3" id="f-4574" unitRef="usd">53000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1029"
      decimals="4"
      id="f-4575"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1030" decimals="-3" id="f-4576" unitRef="usd">70000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1030" decimals="-3" id="f-4577" unitRef="usd">54000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1030"
      decimals="4"
      id="f-4578"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1031"
      decimals="0"
      id="f-4579"
      unitRef="shares">50000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1031" decimals="-3" id="f-4580" unitRef="usd">50000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1031" decimals="-3" id="f-4581" unitRef="usd">50000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1031"
      decimals="4"
      id="f-4582"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1032"
      decimals="0"
      id="f-4583"
      unitRef="shares">2854133</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1032" decimals="-3" id="f-4584" unitRef="usd">2854000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1032" decimals="-3" id="f-4585" unitRef="usd">2854000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1032"
      decimals="4"
      id="f-4586"
      unitRef="number">0.0007</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentInterestRate
      contextRef="c-1033"
      decimals="INF"
      id="f-4587"
      unitRef="number">0.1150</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1033"
      decimals="0"
      id="f-4588"
      unitRef="shares">15440</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1033" decimals="-3" id="f-4589" unitRef="usd">15133000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1033" decimals="-3" id="f-4590" unitRef="usd">16637000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1033"
      decimals="4"
      id="f-4591"
      unitRef="number">0.0040</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1034"
      decimals="0"
      id="f-4592"
      unitRef="shares">3500000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1034" decimals="-3" id="f-4593" unitRef="usd">3500000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1034" decimals="-3" id="f-4594" unitRef="usd">4410000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1034"
      decimals="4"
      id="f-4595"
      unitRef="number">0.0011</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1035"
      decimals="0"
      id="f-4596"
      unitRef="shares">382469</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1035" decimals="-3" id="f-4597" unitRef="usd">382000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1035" decimals="-3" id="f-4598" unitRef="usd">382000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1035"
      decimals="4"
      id="f-4599"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1036" decimals="-3" id="f-4600" unitRef="usd">19015000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1036" decimals="-3" id="f-4601" unitRef="usd">21429000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1036"
      decimals="4"
      id="f-4602"
      unitRef="number">0.0052</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1037"
      decimals="0"
      id="f-4603"
      unitRef="shares">42045</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1037" decimals="-3" id="f-4604" unitRef="usd">462000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1037" decimals="-3" id="f-4605" unitRef="usd">256000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1037"
      decimals="4"
      id="f-4606"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1038"
      decimals="0"
      id="f-4607"
      unitRef="shares">90</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1038" decimals="-3" id="f-4608" unitRef="usd">57000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1038" decimals="-3" id="f-4609" unitRef="usd">44000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1038"
      decimals="4"
      id="f-4610"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1039"
      decimals="0"
      id="f-4611"
      unitRef="shares">90000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1039" decimals="-3" id="f-4612" unitRef="usd">33000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1039" decimals="-3" id="f-4613" unitRef="usd">21000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1039"
      decimals="4"
      id="f-4614"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentInterestRate
      contextRef="c-1040"
      decimals="INF"
      id="f-4615"
      unitRef="number">0.1050</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1040"
      decimals="0"
      id="f-4616"
      unitRef="shares">1545</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1040" decimals="-3" id="f-4617" unitRef="usd">1506000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1040" decimals="-3" id="f-4618" unitRef="usd">1641000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1040"
      decimals="4"
      id="f-4619"
      unitRef="number">0.0004</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1041"
      decimals="0"
      id="f-4620"
      unitRef="shares">3550000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1041" decimals="-3" id="f-4621" unitRef="usd">3444000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1041" decimals="-3" id="f-4622" unitRef="usd">3408000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1041"
      decimals="4"
      id="f-4623"
      unitRef="number">0.0008</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1042"
      decimals="0"
      id="f-4624"
      unitRef="shares">651175</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1042" decimals="-3" id="f-4625" unitRef="usd">651000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1042" decimals="-3" id="f-4626" unitRef="usd">638000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1042"
      decimals="4"
      id="f-4627"
      unitRef="number">0.0002</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1043"
      decimals="0"
      id="f-4628"
      unitRef="shares">2073</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1043" decimals="-3" id="f-4629" unitRef="usd">21000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1043" decimals="-3" id="f-4630" unitRef="usd">21000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1043"
      decimals="4"
      id="f-4631"
      unitRef="number">0.0000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentInterestRate
      contextRef="c-1044"
      decimals="INF"
      id="f-4632"
      unitRef="number">0.1250</us-gaap:InvestmentInterestRate>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1044"
      decimals="0"
      id="f-4633"
      unitRef="shares">373</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1044" decimals="-3" id="f-4634" unitRef="usd">362000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1044" decimals="-3" id="f-4635" unitRef="usd">362000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1044"
      decimals="4"
      id="f-4636"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1045" decimals="-3" id="f-4637" unitRef="usd">6536000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1045" decimals="-3" id="f-4638" unitRef="usd">6391000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1045"
      decimals="4"
      id="f-4639"
      unitRef="number">0.0016</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1046"
      decimals="0"
      id="f-4640"
      unitRef="shares">384520</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1046" decimals="-3" id="f-4641" unitRef="usd">5200000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1046" decimals="-3" id="f-4642" unitRef="usd">6521000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1046"
      decimals="4"
      id="f-4643"
      unitRef="number">0.0016</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1047"
      decimals="0"
      id="f-4644"
      unitRef="shares">27536</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1047" decimals="-3" id="f-4645" unitRef="usd">2909000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1047" decimals="-3" id="f-4646" unitRef="usd">1920000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1047"
      decimals="4"
      id="f-4647"
      unitRef="number">0.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1048"
      decimals="0"
      id="f-4648"
      unitRef="shares">369</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1048" decimals="-3" id="f-4649" unitRef="usd">372000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1048" decimals="-3" id="f-4650" unitRef="usd">472000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1048"
      decimals="4"
      id="f-4651"
      unitRef="number">0.0001</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1049" decimals="-3" id="f-4652" unitRef="usd">3281000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1049" decimals="-3" id="f-4653" unitRef="usd">2392000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1049"
      decimals="4"
      id="f-4654"
      unitRef="number">0.0006</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1050" decimals="-3" id="f-4655" unitRef="usd">74910000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1050" decimals="-3" id="f-4656" unitRef="usd">94365000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1050"
      decimals="4"
      id="f-4657"
      unitRef="number">0.0230</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-130" decimals="-3" id="f-4658" unitRef="usd">9621233000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-130" decimals="-3" id="f-4659" unitRef="usd">9560664000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-130"
      decimals="4"
      id="f-4660"
      unitRef="number">2.2990</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1051" decimals="-3" id="f-4661" unitRef="usd">36639000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1051" decimals="-3" id="f-4662" unitRef="usd">56584000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1051"
      decimals="4"
      id="f-4663"
      unitRef="number">0.0136</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1052" decimals="-3" id="f-4664" unitRef="usd">36639000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1052" decimals="-3" id="f-4665" unitRef="usd">56584000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1052"
      decimals="4"
      id="f-4666"
      unitRef="number">0.0136</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-132" decimals="-3" id="f-4667" unitRef="usd">36639000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-132" decimals="-3" id="f-4668" unitRef="usd">56584000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-132"
      decimals="4"
      id="f-4669"
      unitRef="number">0.0136</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1053" decimals="-3" id="f-4670" unitRef="usd">9657872000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1053" decimals="-3" id="f-4671" unitRef="usd">9617248000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1053"
      decimals="4"
      id="f-4672"
      unitRef="number">2.3126</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1054" decimals="-3" id="f-4673" unitRef="usd">131272000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1054" decimals="-3" id="f-4674" unitRef="usd">131272000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1054"
      decimals="4"
      id="f-4675"
      unitRef="number">0.0316</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1055" decimals="-3" id="f-4676" unitRef="usd">9789144000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1055" decimals="-3" id="f-4677" unitRef="usd">9748520000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1055"
      decimals="4"
      id="f-4678"
      unitRef="number">2.3442</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <bxsl:InvestmentPercentageOfPortfolioAboveFloorRate contextRef="c-6" decimals="3" id="f-4679" unitRef="number">0.931</bxsl:InvestmentPercentageOfPortfolioAboveFloorRate>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1056"
      decimals="INF"
      id="f-4680"
      unitRef="number">0.70</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1057"
      decimals="INF"
      id="f-4681"
      unitRef="number">0.110</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1058" decimals="-3" id="f-4682" unitRef="usd">270000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1058" decimals="-3" id="f-4683" unitRef="usd">18000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1059" decimals="-3" id="f-4684" unitRef="usd">26295000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1059" decimals="-3" id="f-4685" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1060" decimals="-3" id="f-4686" unitRef="usd">10295000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1060" decimals="-3" id="f-4687" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1061" decimals="-3" id="f-4688" unitRef="usd">1301000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1061" decimals="-3" id="f-4689" unitRef="usd">26000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1062" decimals="-3" id="f-4690" unitRef="usd">468000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1062" decimals="-3" id="f-4691" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1063" decimals="-3" id="f-4692" unitRef="usd">1446000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1063" decimals="-3" id="f-4693" unitRef="usd">14000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1064" decimals="-3" id="f-4694" unitRef="usd">243000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1064" decimals="-3" id="f-4695" unitRef="usd">2000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1065" decimals="-3" id="f-4696" unitRef="usd">150000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1065" decimals="-3" id="f-4697" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1066" decimals="-3" id="f-4698" unitRef="usd">589000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1066" decimals="-3" id="f-4699" unitRef="usd">24000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1067" decimals="-3" id="f-4700" unitRef="usd">2605000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1067" decimals="-3" id="f-4701" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1068" decimals="-3" id="f-4702" unitRef="usd">179000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1068" decimals="-3" id="f-4703" unitRef="usd">21000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1069" decimals="-3" id="f-4704" unitRef="usd">1250000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1069" decimals="-3" id="f-4705" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1070" decimals="-3" id="f-4706" unitRef="usd">3000000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1070" decimals="-3" id="f-4707" unitRef="usd">83000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1071" decimals="-3" id="f-4708" unitRef="usd">1940000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1071" decimals="-3" id="f-4709" unitRef="usd">19000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1072" decimals="-3" id="f-4710" unitRef="usd">2949000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1072" decimals="-3" id="f-4711" unitRef="usd">29000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1073" decimals="-3" id="f-4712" unitRef="usd">3221000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1073" decimals="-3" id="f-4713" unitRef="usd">32000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1074" decimals="-3" id="f-4714" unitRef="usd">28662000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1074" decimals="-3" id="f-4715" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1075" decimals="-3" id="f-4716" unitRef="usd">397000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1075" decimals="-3" id="f-4717" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1076" decimals="-3" id="f-4718" unitRef="usd">309000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1076" decimals="-3" id="f-4719" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1077" decimals="-3" id="f-4720" unitRef="usd">341000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1077" decimals="-3" id="f-4721" unitRef="usd">3000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1078" decimals="-3" id="f-4722" unitRef="usd">1506000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1078" decimals="-3" id="f-4723" unitRef="usd">15000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1079" decimals="-3" id="f-4724" unitRef="usd">732000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1079" decimals="-3" id="f-4725" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1080" decimals="-3" id="f-4726" unitRef="usd">233000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1080" decimals="-3" id="f-4727" unitRef="usd">5000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1081" decimals="-3" id="f-4728" unitRef="usd">320000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1081" decimals="-3" id="f-4729" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1082" decimals="-3" id="f-4730" unitRef="usd">43592000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1082" decimals="-3" id="f-4731" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1083" decimals="-3" id="f-4732" unitRef="usd">5647000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1083" decimals="-3" id="f-4733" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1084" decimals="-3" id="f-4734" unitRef="usd">1376000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1084" decimals="-3" id="f-4735" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1085" decimals="-3" id="f-4736" unitRef="usd">1408000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1085" decimals="-3" id="f-4737" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1086" decimals="-3" id="f-4738" unitRef="usd">1200000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1086" decimals="-3" id="f-4739" unitRef="usd">12000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1087" decimals="-3" id="f-4740" unitRef="usd">1050000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1087" decimals="-3" id="f-4741" unitRef="usd">21000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1088" decimals="-3" id="f-4742" unitRef="usd">898000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1088" decimals="-3" id="f-4743" unitRef="usd">18000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1089" decimals="-3" id="f-4744" unitRef="usd">3668000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1089" decimals="-3" id="f-4745" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1090" decimals="-3" id="f-4746" unitRef="usd">588000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1090" decimals="-3" id="f-4747" unitRef="usd">6000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1091" decimals="-3" id="f-4748" unitRef="usd">345000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1091" decimals="-3" id="f-4749" unitRef="usd">7000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1092" decimals="-3" id="f-4750" unitRef="usd">3046000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1092" decimals="-3" id="f-4751" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1093" decimals="-3" id="f-4752" unitRef="usd">5431000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1093" decimals="-3" id="f-4753" unitRef="usd">109000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1094" decimals="-3" id="f-4754" unitRef="usd">10900000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1094" decimals="-3" id="f-4755" unitRef="usd">109000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1095" decimals="-3" id="f-4756" unitRef="usd">1941000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1095" decimals="-3" id="f-4757" unitRef="usd">21000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1096" decimals="-3" id="f-4758" unitRef="usd">7778000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1096" decimals="-3" id="f-4759" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1097" decimals="-3" id="f-4760" unitRef="usd">3214000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1097" decimals="-3" id="f-4761" unitRef="usd">64000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1098" decimals="-3" id="f-4762" unitRef="usd">966000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1098" decimals="-3" id="f-4763" unitRef="usd">10000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1099" decimals="-3" id="f-4764" unitRef="usd">7896000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1099" decimals="-3" id="f-4765" unitRef="usd">79000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1100" decimals="-3" id="f-4766" unitRef="usd">11923000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1100" decimals="-3" id="f-4767" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1101" decimals="-3" id="f-4768" unitRef="usd">169000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1101" decimals="-3" id="f-4769" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1102" decimals="-3" id="f-4770" unitRef="usd">1000000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1102" decimals="-3" id="f-4771" unitRef="usd">15000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1103" decimals="-3" id="f-4772" unitRef="usd">2960000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1103" decimals="-3" id="f-4773" unitRef="usd">104000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1104" decimals="-3" id="f-4774" unitRef="usd">6773000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1104" decimals="-3" id="f-4775" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1105" decimals="-3" id="f-4776" unitRef="usd">1195000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1105" decimals="-3" id="f-4777" unitRef="usd">141000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1106" decimals="-3" id="f-4778" unitRef="usd">18700000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1106" decimals="-3" id="f-4779" unitRef="usd">187000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1107" decimals="-3" id="f-4780" unitRef="usd">260000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1107" decimals="-3" id="f-4781" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1108" decimals="-3" id="f-4782" unitRef="usd">2064000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1108" decimals="-3" id="f-4783" unitRef="usd">93000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1109" decimals="-3" id="f-4784" unitRef="usd">1495000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1109" decimals="-3" id="f-4785" unitRef="usd">30000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1110" decimals="-3" id="f-4786" unitRef="usd">1401000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1110" decimals="-3" id="f-4787" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1111" decimals="-3" id="f-4788" unitRef="usd">2113000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1111" decimals="-3" id="f-4789" unitRef="usd">53000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1112" decimals="-3" id="f-4790" unitRef="usd">274000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1112" decimals="-3" id="f-4791" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1113" decimals="-3" id="f-4792" unitRef="usd">2000000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1113" decimals="-3" id="f-4793" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1114" decimals="-3" id="f-4794" unitRef="usd">883000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1114" decimals="-3" id="f-4795" unitRef="usd">26000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1115" decimals="-3" id="f-4796" unitRef="usd">1080000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1115" decimals="-3" id="f-4797" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1116" decimals="-3" id="f-4798" unitRef="usd">3040000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1116" decimals="-3" id="f-4799" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1117" decimals="-3" id="f-4800" unitRef="usd">437000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1117" decimals="-3" id="f-4801" unitRef="usd">10000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1118" decimals="-3" id="f-4802" unitRef="usd">1057000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1118" decimals="-3" id="f-4803" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1119" decimals="-3" id="f-4804" unitRef="usd">677000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1119" decimals="-3" id="f-4805" unitRef="usd">14000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1120" decimals="-3" id="f-4806" unitRef="usd">2144000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1120" decimals="-3" id="f-4807" unitRef="usd">21000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1121" decimals="-3" id="f-4808" unitRef="usd">2124000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1121" decimals="-3" id="f-4809" unitRef="usd">32000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1122" decimals="-3" id="f-4810" unitRef="usd">6429000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1122" decimals="-3" id="f-4811" unitRef="usd">64000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1123" decimals="-3" id="f-4812" unitRef="usd">2100000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1123" decimals="-3" id="f-4813" unitRef="usd">26000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1124" decimals="-3" id="f-4814" unitRef="usd">3000000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1124" decimals="-3" id="f-4815" unitRef="usd">38000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1125" decimals="-3" id="f-4816" unitRef="usd">23952000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1125" decimals="-3" id="f-4817" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1126" decimals="-3" id="f-4818" unitRef="usd">138000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1126" decimals="-3" id="f-4819" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1127" decimals="-3" id="f-4820" unitRef="usd">767000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1127" decimals="-3" id="f-4821" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1128" decimals="-3" id="f-4822" unitRef="usd">1542000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1128" decimals="-3" id="f-4823" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1129" decimals="-3" id="f-4824" unitRef="usd">3390000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1129" decimals="-3" id="f-4825" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1130" decimals="-3" id="f-4826" unitRef="usd">2254000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1130" decimals="-3" id="f-4827" unitRef="usd">45000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1131" decimals="-3" id="f-4828" unitRef="usd">11830000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1131" decimals="-3" id="f-4829" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1132" decimals="-3" id="f-4830" unitRef="usd">2150000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1132" decimals="-3" id="f-4831" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1133" decimals="-3" id="f-4832" unitRef="usd">11060000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1133" decimals="-3" id="f-4833" unitRef="usd">138000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1134" decimals="-3" id="f-4834" unitRef="usd">347000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1134" decimals="-3" id="f-4835" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1135" decimals="-3" id="f-4836" unitRef="usd">91000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1135" decimals="-3" id="f-4837" unitRef="usd">1000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1136" decimals="-3" id="f-4838" unitRef="usd">90000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1136" decimals="-3" id="f-4839" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1137" decimals="-3" id="f-4840" unitRef="usd">1897000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1137" decimals="-3" id="f-4841" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1138" decimals="-3" id="f-4842" unitRef="usd">30000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1138" decimals="-3" id="f-4843" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1139" decimals="-3" id="f-4844" unitRef="usd">1032000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1139" decimals="-3" id="f-4845" unitRef="usd">8000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1140" decimals="-3" id="f-4846" unitRef="usd">1145000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1140" decimals="-3" id="f-4847" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1141" decimals="-3" id="f-4848" unitRef="usd">143000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1141" decimals="-3" id="f-4849" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1142" decimals="-3" id="f-4850" unitRef="usd">15684000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1142" decimals="-3" id="f-4851" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1143" decimals="-3" id="f-4852" unitRef="usd">958000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1143" decimals="-3" id="f-4853" unitRef="usd">10000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1144" decimals="-3" id="f-4854" unitRef="usd">2000000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1144" decimals="-3" id="f-4855" unitRef="usd">20000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1145" decimals="-3" id="f-4856" unitRef="usd">4975000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1145" decimals="-3" id="f-4857" unitRef="usd">50000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1146" decimals="-3" id="f-4858" unitRef="usd">485000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1146" decimals="-3" id="f-4859" unitRef="usd">12000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1147" decimals="-3" id="f-4860" unitRef="usd">349000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1147" decimals="-3" id="f-4861" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1148" decimals="-3" id="f-4862" unitRef="usd">342000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1148" decimals="-3" id="f-4863" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1149" decimals="-3" id="f-4864" unitRef="usd">918000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1149" decimals="-3" id="f-4865" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1150" decimals="-3" id="f-4866" unitRef="usd">1802000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1150" decimals="-3" id="f-4867" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1151" decimals="-3" id="f-4868" unitRef="usd">230000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1151" decimals="-3" id="f-4869" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1152" decimals="-3" id="f-4870" unitRef="usd">2038000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1152" decimals="-3" id="f-4871" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1153" decimals="-3" id="f-4872" unitRef="usd">467000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1153" decimals="-3" id="f-4873" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1154" decimals="-3" id="f-4874" unitRef="usd">1516000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1154" decimals="-3" id="f-4875" unitRef="usd">55000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1155" decimals="-3" id="f-4876" unitRef="usd">4200000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1155" decimals="-3" id="f-4877" unitRef="usd">347000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1156" decimals="-3" id="f-4878" unitRef="usd">49175000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1156" decimals="-3" id="f-4879" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1157" decimals="-3" id="f-4880" unitRef="usd">2911000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1157" decimals="-3" id="f-4881" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1158" decimals="-3" id="f-4882" unitRef="usd">26585000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1158" decimals="-3" id="f-4883" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1159" decimals="-3" id="f-4884" unitRef="usd">2247000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1159" decimals="-3" id="f-4885" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1160" decimals="-3" id="f-4886" unitRef="usd">595000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1160" decimals="-3" id="f-4887" unitRef="usd">9000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1161" decimals="-3" id="f-4888" unitRef="usd">272000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1161" decimals="-3" id="f-4889" unitRef="usd">8000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1162" decimals="-3" id="f-4890" unitRef="usd">330000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1162" decimals="-3" id="f-4891" unitRef="usd">7000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1163" decimals="-3" id="f-4892" unitRef="usd">20703000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1163" decimals="-3" id="f-4893" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1164" decimals="-3" id="f-4894" unitRef="usd">14481000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1164" decimals="-3" id="f-4895" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1165" decimals="-3" id="f-4896" unitRef="usd">116000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1165" decimals="-3" id="f-4897" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1166" decimals="-3" id="f-4898" unitRef="usd">170000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1166" decimals="-3" id="f-4899" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1167" decimals="-3" id="f-4900" unitRef="usd">237000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1167" decimals="-3" id="f-4901" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1168" decimals="-3" id="f-4902" unitRef="usd">413000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1168" decimals="-3" id="f-4903" unitRef="usd">9000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1169" decimals="-3" id="f-4904" unitRef="usd">16623000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1169" decimals="-3" id="f-4905" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1170" decimals="-3" id="f-4906" unitRef="usd">333000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1170" decimals="-3" id="f-4907" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1171" decimals="-3" id="f-4908" unitRef="usd">591000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1171" decimals="-3" id="f-4909" unitRef="usd">3000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1172" decimals="-3" id="f-4910" unitRef="usd">905000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1172" decimals="-3" id="f-4911" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1173" decimals="-3" id="f-4912" unitRef="usd">4259000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1173" decimals="-3" id="f-4913" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1174" decimals="-3" id="f-4914" unitRef="usd">110000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1174" decimals="-3" id="f-4915" unitRef="usd">2000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1175" decimals="-3" id="f-4916" unitRef="usd">205000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1175" decimals="-3" id="f-4917" unitRef="usd">2000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1176" decimals="-3" id="f-4918" unitRef="usd">25880000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1176" decimals="-3" id="f-4919" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1177" decimals="-3" id="f-4920" unitRef="usd">133000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1177" decimals="-3" id="f-4921" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1178" decimals="-3" id="f-4922" unitRef="usd">3292000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1178" decimals="-3" id="f-4923" unitRef="usd">49000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1179" decimals="-3" id="f-4924" unitRef="usd">7143000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1179" decimals="-3" id="f-4925" unitRef="usd">71000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1180" decimals="-3" id="f-4926" unitRef="usd">255000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1180" decimals="-3" id="f-4927" unitRef="usd">4000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1181" decimals="-3" id="f-4928" unitRef="usd">226000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1181" decimals="-3" id="f-4929" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1182" decimals="-3" id="f-4930" unitRef="usd">2900000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1182" decimals="-3" id="f-4931" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1183" decimals="-3" id="f-4932" unitRef="usd">20000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1183" decimals="-3" id="f-4933" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1184" decimals="-3" id="f-4934" unitRef="usd">6452000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1184" decimals="-3" id="f-4935" unitRef="usd">65000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1185" decimals="-3" id="f-4936" unitRef="usd">373000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1185" decimals="-3" id="f-4937" unitRef="usd">4000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1186" decimals="-3" id="f-4938" unitRef="usd">29731000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1186" decimals="-3" id="f-4939" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1187" decimals="-3" id="f-4940" unitRef="usd">5500000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1187" decimals="-3" id="f-4941" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1188" decimals="-3" id="f-4942" unitRef="usd">294000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1188" decimals="-3" id="f-4943" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1189" decimals="-3" id="f-4944" unitRef="usd">399000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1189" decimals="-3" id="f-4945" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1190" decimals="-3" id="f-4946" unitRef="usd">2794000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1190" decimals="-3" id="f-4947" unitRef="usd">28000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1191" decimals="-3" id="f-4948" unitRef="usd">1111000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1191" decimals="-3" id="f-4949" unitRef="usd">22000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1192" decimals="-3" id="f-4950" unitRef="usd">710000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1192" decimals="-3" id="f-4951" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1193" decimals="-3" id="f-4952" unitRef="usd">15786000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1193" decimals="-3" id="f-4953" unitRef="usd">237000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1194" decimals="-3" id="f-4954" unitRef="usd">614000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1194" decimals="-3" id="f-4955" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1195" decimals="-3" id="f-4956" unitRef="usd">1155000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1195" decimals="-3" id="f-4957" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1196" decimals="-3" id="f-4958" unitRef="usd">3689000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1196" decimals="-3" id="f-4959" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1197" decimals="-3" id="f-4960" unitRef="usd">441000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1197" decimals="-3" id="f-4961" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1198" decimals="-3" id="f-4962" unitRef="usd">74000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1198" decimals="-3" id="f-4963" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1199" decimals="-3" id="f-4964" unitRef="usd">28000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1199" decimals="-3" id="f-4965" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1200" decimals="-3" id="f-4966" unitRef="usd">315000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1200" decimals="-3" id="f-4967" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1201" decimals="-3" id="f-4968" unitRef="usd">7729000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1201" decimals="-3" id="f-4969" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1202" decimals="-3" id="f-4970" unitRef="usd">4416000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1202" decimals="-3" id="f-4971" unitRef="usd">44000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1203" decimals="-3" id="f-4972" unitRef="usd">620000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1203" decimals="-3" id="f-4973" unitRef="usd">11000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1204" decimals="-3" id="f-4974" unitRef="usd">10916000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1204" decimals="-3" id="f-4975" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1205" decimals="-3" id="f-4976" unitRef="usd">6881000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1205" decimals="-3" id="f-4977" unitRef="usd">69000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1206" decimals="-3" id="f-4978" unitRef="usd">1433000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1206" decimals="-3" id="f-4979" unitRef="usd">14000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1207" decimals="-3" id="f-4980" unitRef="usd">4747000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1207" decimals="-3" id="f-4981" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1208" decimals="-3" id="f-4982" unitRef="usd">7101000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1208" decimals="-3" id="f-4983" unitRef="usd">71000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1209" decimals="-3" id="f-4984" unitRef="usd">3239000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1209" decimals="-3" id="f-4985" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1210" decimals="-3" id="f-4986" unitRef="usd">241000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1210" decimals="-3" id="f-4987" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1211" decimals="-3" id="f-4988" unitRef="usd">77000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1211" decimals="-3" id="f-4989" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1212" decimals="-3" id="f-4990" unitRef="usd">1275000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1212" decimals="-3" id="f-4991" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1213" decimals="-3" id="f-4992" unitRef="usd">3666000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1213" decimals="-3" id="f-4993" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1214" decimals="-3" id="f-4994" unitRef="usd">3233000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1214" decimals="-3" id="f-4995" unitRef="usd">32000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1215" decimals="-3" id="f-4996" unitRef="usd">3848000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1215" decimals="-3" id="f-4997" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1216" decimals="-3" id="f-4998" unitRef="usd">1443000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1216" decimals="-3" id="f-4999" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1217" decimals="-3" id="f-5000" unitRef="usd">572000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1217" decimals="-3" id="f-5001" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1218" decimals="-3" id="f-5002" unitRef="usd">4454000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1218" decimals="-3" id="f-5003" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1219" decimals="-3" id="f-5004" unitRef="usd">10490000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1219" decimals="-3" id="f-5005" unitRef="usd">0</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1220" decimals="-3" id="f-5006" unitRef="usd">361000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1220" decimals="-3" id="f-5007" unitRef="usd">5000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1221" decimals="-3" id="f-5008" unitRef="usd">169000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-1221" decimals="-3" id="f-5009" unitRef="usd">3000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-6" decimals="-3" id="f-5010" unitRef="usd">690256000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue contextRef="c-6" decimals="-3" id="f-5011" unitRef="usd">3057000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmountFairValue>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-1222"
      decimals="INF"
      id="f-5012"
      unitRef="number">0</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-1223"
      decimals="INF"
      id="f-5013"
      unitRef="number">0.0050</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-1224"
      decimals="INF"
      id="f-5014"
      unitRef="number">0.0075</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-1225"
      decimals="INF"
      id="f-5015"
      unitRef="number">0.0100</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-1226"
      decimals="INF"
      id="f-5016"
      unitRef="number">0.0125</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-1227"
      decimals="INF"
      id="f-5017"
      unitRef="number">0.0150</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentInterestRateFloor
      contextRef="c-1228"
      decimals="INF"
      id="f-5018"
      unitRef="number">0.0200</us-gaap:InvestmentInterestRateFloor>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1229" decimals="-3" id="f-5019" unitRef="usd">35683000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions contextRef="c-1230" decimals="-3" id="f-5020" unitRef="usd">3879000</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions contextRef="c-1230" decimals="-3" id="f-5021" unitRef="usd">0</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease contextRef="c-1230" decimals="-3" id="f-5022" unitRef="usd">17022000</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-758" decimals="-3" id="f-5023" unitRef="usd">56584000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InterestAndDividendIncomeSecurities contextRef="c-1230" decimals="-3" id="f-5024" unitRef="usd">0</us-gaap:InterestAndDividendIncomeSecurities>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1231" decimals="-3" id="f-5025" unitRef="usd">35683000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions contextRef="c-1232" decimals="-3" id="f-5026" unitRef="usd">3879000</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions contextRef="c-1232" decimals="-3" id="f-5027" unitRef="usd">0</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease contextRef="c-1232" decimals="-3" id="f-5028" unitRef="usd">17022000</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-761" decimals="-3" id="f-5029" unitRef="usd">56584000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InterestAndDividendIncomeSecurities contextRef="c-1232" decimals="-3" id="f-5030" unitRef="usd">0</us-gaap:InterestAndDividendIncomeSecurities>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-5031">Organization&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blackstone Secured Lending Fund (together with its consolidated subsidiaries, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Company&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), is a Delaware statutory trust formed on March 26, 2018, and structured as an externally managed, non-diversified closed-end management investment company.&#160;On October 26, 2018, the Company elected to be regulated as a business development company (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;BDC&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) under the Investment Company Act of 1940, as amended (together with the&#160;rules and regulations promulgated thereunder, the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x201c;1940 Act&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). In addition, the Company has elected to be treated for U.S. federal income tax purposes, and intends to qualify annually, as a regulated investment company (a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;RIC&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), under Subchapter M of the Internal Revenue Code of 1986, as amended (together with the&#160;rules and regulations promulgated thereunder, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Code&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is externally managed by Blackstone Credit BDC Advisors LLC (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Adviser&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) an affiliate of Blackstone Alternative Credit Advisors LP (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Administrator&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and, collectively with its affiliates in the credit, asset based finance, and insurance asset management business unit of Blackstone Inc. (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Blackstone&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Blackstone Credit &amp;amp; Insurance,&#x201d; or &#x201c;BXCI&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement (the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x201c;Administration Agreement&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&#160;References herein to information about Blackstone Credit &amp;amp; Insurance from December 31, 2023 or prior refers solely to the Adviser and Blackstone Alternative Credit Advisors LP, collectively with their credit-focused affiliates within Blackstone Credit &amp;amp; Insurance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation.&#160;The Company seeks to achieve its investment objectives primarily through originated loans and other securities, including syndicated loans, of private U.S. companies, typically in the form of first lien senior secured and unitranche loans (including first out/last out loans), and to a lesser extent, second lien, third lien, unsecured and subordinated loans and other debt and equity securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company commenced its loan origination and investment activities on November 20, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On October 28, 2021, the Company priced its initial public offering (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;IPO&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;), and the Company's common shares of beneficial interest (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;Common Shares&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;) began trading on the New York Stock Exchange (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;NYSE&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;). See &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 8&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-5032">Significant Accounting Policies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;GAAP&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and pursuant to the requirements for reporting on Form 10-K and Article 6 of Regulation S-X. As an investment company, the Company applies the accounting and reporting guidance in Accounting Standards Codification (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;ASC&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) Topic 946, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Services &#x2013; Investment Companies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;ASC 946&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) issued by the Financial Accounting Standards Board (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;FASB&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, all adjustments considered necessary for the fair presentation of the consolidated financial statements for the periods presented have been included.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior period information has been reclassified to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Such amounts could differ from those estimates and such differences could be material.&#160;Assumptions and estimates regarding the valuation of investments involve a higher degree of judgment and complexity and these assumptions and estimates may be significant to the consolidated financial statements. Actual results may ultimately differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As provided under ASC 946, the Company will not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company consolidated the results of the Company&#x2019;s wholly-owned subsidiaries which are considered to be investment companies.&#160;As of December&#160;31, 2023, the Company's consolidated subsidiaries were BGSL Jackson Hole Funding LLC (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Jackson Hole Funding&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), BGSL Breckenridge Funding LLC (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Breckenridge Funding&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), BGSL Big Sky Funding LLC (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Big Sky Funding&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), BGSL Investments LLC (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;BGSL Investments&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), BXSL Associates GP (Lux) S.&#xe0; r.l, BXSL Direct Lending (Lux) SCSp, BXSL C-1 LLC, and BXSL C-2 Funding LLC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of demand deposits and highly liquid investments, such as money market funds, with original maturities of three months or less. Cash and cash equivalents are carried at cost, which approximates fair value. The Company deposits its cash and cash equivalents with financial institutions and, at times, may exceed the Federal Deposit Insurance Corporation insured limit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment transactions are recorded on a trade date basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized gains or losses are measured by the difference between the net proceeds received (excluding prepayment fees, if any) and the amortized cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include investments charged off during the period, net of recoveries, and is recorded within Net realized gain (loss) on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net change in unrealized gains or losses primarily reflects the change in investment values, including the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period, and is recorded within Net change in unrealized appreciation (depreciation) on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Valuation of Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to report its investments, including those for which current market values are not readily available, at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company values its investments in accordance with ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;ASC 820&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the applicable measurement date, and Rule 2a-5 under the 1940 Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is based on observable market prices or parameters or derived from such prices or parameters when such quotations are readily available.&#160;In accordance with&#160;Rule 2a-5 under the 1940 Act, a market quotation is &#x201c;readily available&#x201d; only when it is a quoted price (unadjusted) in active markets for identical instruments that a fund can access at the measurement date, provided that such a quotation is not considered to be readily available if it is not reliable.&#160;The Company utilizes mid-market pricing (i.e., mid-point of average bid and ask prices) to value these investments.&#160;These market quotations are obtained from independent pricing services, if available; otherwise generally from at least two principal market makers or primary market dealers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Where prices or inputs are not available or, in the judgment of the Board, not reliable, valuation techniques based on the facts and circumstances of the particular investment will be utilized. These valuation approaches involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments&#x2019; complexity. In the absence of observable, reliable market prices, the Company values its investments using various valuation methodologies applied on a consistent basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An enterprise value (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;EV&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) analysis is generally performed to determine the value of equity investments, control debt investments and non-control debt investments that are credit-impaired, and to determine if debt investments are credit impaired. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser will generally utilize approaches including the market approach, the income approach or both approaches, as appropriate, when calculating EV.&#160;The primary method for determining EV for non-control investments, and control investments without reliable projections, uses a multiple analysis whereby appropriate multiples are applied to the portfolio company&#x2019;s earnings before interest, taxes, depreciation and amortization (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;EBITDA&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) or another key financial metric (e.g., such as revenues, cash flows or net income) (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Performance Multiple&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&#160;Performance Multiples are typically determined based upon a review of publicly traded comparable companies and market comparable transactions, if any.&#160;The second method for determining EV (and primary method for control investments with reliable projections) uses a discounted cash flow analysis whereby future expected cash flows and the anticipated terminal value of the portfolio company are discounted to determine a present value using estimated discount rates.&#160;The income approach is generally used when the Adviser has visibility into the long term projected cash flows of a portfolio company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If debt investments are credit-impaired, which occurs when there is insufficient coverage under the enterprise value analysis through the respective investment&#x2019;s position in the capital structure, the Adviser generally uses the enterprise value &#x201c;waterfall&#x201d; approach or a recovery method (if a liquidation or restructuring is deemed likely) to determine fair value. For debt investments that are not determined to be credit-impaired, the Adviser generally uses a market interest rate yield analysis to determine fair value. To determine fair value using a yield analysis, the expected cash flows are projected based on the contractual terms of the debt security and discounted back to the measurement date based on a market yield.&#160;A market yield is determined based upon an assessment of current and expected market yields for similar investments and risk profiles.&#160;The Company considers the current contractual interest rate, the maturity and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the enterprise value of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, the Company depends on primary market data, including newly funded transactions, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable.&#160;The fair value of loans with call protection is generally capped at par plus applicable prepayment premium in effect at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 820 prioritizes the use of observable market prices derived from such prices. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The levels used for classifying investments are not necessarily an indication of the risk associated with investing in these securities. The three levels of the fair value hierarchy are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level 1:&#160;Inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date. The types of financial instruments included in Level 1 include unrestricted securities, including equities and derivatives, listed in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level 2:&#160;Inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. The types of financial instruments in this category include less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities and certain over-the-counter derivatives where the fair value is based on observable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level 3:&#160;Inputs to the valuation methodology are unobservable and significant to overall fair value measurement. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in this category include debt and equity investments in privately held entities, collateralized loan obligations (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;CLOs&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and certain over-the-counter derivatives where the fair value is based on unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment&#x2019;s level within the fair value hierarchy is based on the lowest level of input that is significant to the overall fair value measurement. The Adviser&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.&#160;Transfers between levels, if any, are recognized at the beginning of the quarter in which the transfer occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the source of the inputs, including any markets in which its investments are trading (or any markets in which securities with similar attributes are trading), in determining fair value. When an investment is valued based on prices provided by reputable dealers or pricing services (that is, broker quotes), the Company subjects those prices to various criteria in making the determination as to whether a particular investment would qualify for treatment as a Level 2 or Level 3 investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company&#x2019;s investments may fluctuate from period to period, and these differences could be material. Additionally, the fair value of the Company&#x2019;s investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that the Company may ultimately realize. Further, such investments are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If the Company was required to liquidate a portfolio investment in a forced or liquidation sale, it could realize significantly less than the value at which the Company has recorded it. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected in the valuations currently assigned.&#160;See &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Item 7. Management&#x2019;s Discussion and Analysis of Financial Conditions and Results of Operations&#x2014;Critical Accounting Estimates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables/Payables From Investments Sold/Purchased&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables/payables from investments sold/purchased consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes all derivative instruments as assets or liabilities at fair value in its consolidated financial statements. Derivative contracts entered into by the Company are not designated in hedge accounting relationships and all changes in fair value are recognized through current period gains or losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company has commitments and risks resulting from its investment transactions, which may include those involving derivative instruments. Derivative instruments are measured in terms of the notional contract amount and derive their value based upon one or more underlying instruments. While the notional amount gives some indication of the Company&#x2019;s derivative activity, it generally is not exchanged, but is only used as the basis on which interest and other payments are exchanged. Derivative instruments are subject to various risks similar to non-derivative instruments including market, credit, liquidity, and operational risks. The Company manages these risks on an aggregate basis as part of its risk management process.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Forward Purchase Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forward purchase agreements are recognized at fair value through current period gains or losses on the date on which the contract is entered into and are subsequently re-measured at fair value. All forward purchase agreements are carried as assets when fair value is positive and as liabilities when fair value is negative.&#160;A forward purchase agreement is derecognized when the obligation specified in the contract is discharged, canceled or expired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts denominated in foreign currencies are translated into U.S. dollars on the following basis: (i)&#160;investments and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates effective on the last business day of the period; and (ii)&#160;purchases and sales of investments, borrowings and repayments of such borrowings, income, and expenses denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates prevailing on the transaction dates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company includes net changes in fair values on investments held resulting from foreign exchange rate fluctuations in Translation of assets and liabilities in foreign currencies on the Consolidated Statements of Operations, if any. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign security and currency translations may involve certain considerations and risks not typically associated with investing in U.S. companies and U.S. government securities. These risks include, but are not limited to, currency fluctuations and revaluations and future adverse political, social and economic developments, which could cause investments in foreign markets to be less liquid and prices more volatile than those of comparable U.S. companies or U.S. government securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income is recorded on an accrual basis and includes the accretion of discounts and amortizations of premiums.&#160;Discounts from and premiums to par value on debt investments purchased are accreted/amortized into interest income over the life of the respective security using the effective interest method.&#160;The amortized cost of debt investments represents the original cost, including loan origination fees and upfront fees received that are deemed to be an adjustment to yield, adjusted for the accretion of discounts and amortization of premiums, if any.&#160;Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income in the current period. For the years ended December&#160;31, 2023, 2022 and 2021 the Company recorded $19.3 million, $4.9 million and $60.9 million, respectively, in non-recurring interest income (e.g., prepayment premiums, accelerated accretion of upfront loan origination fees and unamortized discounts). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;PIK Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has loans in its portfolio that contain payment-in-kind (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;PIK&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) provisions.&#160;PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity.&#160;Such income is included in payment-in-kind interest income in the Consolidated Statements of Operations.&#160;If at any point the Company believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status.&#160;When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through payment-in-kind interest income.&#160;To satisfy the Company&#x2019;s annual RIC distribution requirements, this non-cash source of income must be included in determining the amounts to be paid out to shareholders in the form of dividends, even though the Company has not yet collected cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividend Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividend income on preferred equity securities is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fee Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may receive various fees in the ordinary course of business such as structuring, consent, waiver, amendment, syndication and other miscellaneous fees as well as fees for managerial assistance rendered by the Company to the portfolio companies.&#160;Such fees are recognized as income when earned or the services are rendered.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Accrual Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loans are generally placed on non-accrual status when there is reasonable doubt whether principal or interest will be collected in full.&#160;Accrued interest is generally reversed when a loan is placed on non-accrual status. Additionally, any original issue discount and market discount are no longer accreted to interest income as of the date the loan is placed on non-accrual status.&#160;Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management&#x2019;s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management&#x2019;s judgment, are likely to remain current. Management may make exceptions to this treatment and&#160;determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Organization Expenses and Offering Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records expenses related to public equity offerings as a reduction of capital upon completion of an offering of registered securities. The costs associated with any renewals of a shelf registration statement will be expensed as incurred. For the year ended December&#160;31, 2023, the Company incurred $0.4 million of offering costs in connection with its follow-on offering which were charged as a reduction of paid-in-capital. For the year ended December&#160;31, 2022, the Company incurred no offering costs. For the year ended December&#160;31, 2021, the Company incurred $1.6 million of offering costs relating to its IPO which were charged as a reduction of paid-in-capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Financing Costs and Debt Issuance Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred financing and debt issuance costs represent fees and other direct incremental costs incurred in connection with the Company&#x2019;s borrowings.&#160;These expenses are deferred and amortized into interest expense over the life of the related debt instrument. Deferred financing costs related to revolving credit facilities are presented separately as an asset on the Company&#x2019;s Consolidated Statements of Assets and Liabilities.&#160;Debt issuance costs related to any issuance of installment debt or notes are presented net against the outstanding debt balance of the related security.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to be treated as a BDC under the 1940 Act.&#160;The Company also has elected to be treated as a RIC under the Code.&#160;So long as the Company maintains its status as a RIC, it generally will not pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that it distributes at least annually to its shareholders as dividends. Rather, any tax liability related to income earned and distributed by the Company would represent obligations of the Company&#x2019;s investors and would not be reflected in the consolidated financial statements of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are &#x201c;more-likely-than-not&#x201d; to be sustained by the applicable tax authority. Tax positions not deemed to meet the &#x201c;more-likely-than-not&#x201d; threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To qualify for and maintain qualification as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to qualify for RIC tax treatment, the Company must distribute to its shareholders, for each taxable year, at least 90% of the sum of (i) its &#x201c;investment company taxable income&#x201d; for that year (without regard to the deduction for dividends paid), which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses and (ii) its net tax-exempt income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, based on the excise tax distribution requirements, the Company is subject to a 4% nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner in each taxable year an amount at least equal to the sum of (i) 98% of its ordinary income for the calendar year, (ii) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October&#160;31 in that calendar year and (iii)&#160;any income realized, but not distributed, in prior years. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to corporate income tax is considered to have been distributed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2023, 2022 and 2021, the Company incurred $16.8 million, $1.4 million and $2.4 million, respectively, of U.S. federal excise tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Distributions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To the extent that the Company has taxable income available, the Company intends to make quarterly distributions to its shareholders.&#160;Distributions to shareholders are recorded on the record date.&#160;All distributions will be paid at the discretion of the Board and will depend on the Company&#x2019;s earnings, financial condition, maintenance of the Company's tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Reference Rate Reform (Topic 848)&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides optional expedients and exceptions for applying &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GAAP&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Interbank Offered Rate (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;LIBOR&#x201d;&lt;/span&gt;) or another reference rate expected to be discontinued because of reference rate reform. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848), which expanded the scope of Topic 848 to include derivative instruments impacted by discounting transition. ASU 2020-04 and ASU 2021-01 are effective for all entities through December 31, 2022. The expedients and exceptions provided by the amendments do not apply to contract modifications and hedging relationships entered into or evaluated after December 31, 2022, except for hedging transactions as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which deferred the sunset day of this guidance to December 31, 2024. There has been no material impact of these standards on the Company&#x2019;s financial position, results of operations or cash flows</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-5033">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;GAAP&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and pursuant to the requirements for reporting on Form 10-K and Article 6 of Regulation S-X. As an investment company, the Company applies the accounting and reporting guidance in Accounting Standards Codification (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;ASC&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) Topic 946, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Services &#x2013; Investment Companies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;ASC 946&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) issued by the Financial Accounting Standards Board (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;FASB&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, all adjustments considered necessary for the fair presentation of the consolidated financial statements for the periods presented have been included.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior period information has been reclassified to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-5034">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Such amounts could differ from those estimates and such differences could be material.&#160;Assumptions and estimates regarding the valuation of investments involve a higher degree of judgment and complexity and these assumptions and estimates may be significant to the consolidated financial statements. Actual results may ultimately differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-5035">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As provided under ASC 946, the Company will not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company consolidated the results of the Company&#x2019;s wholly-owned subsidiaries which are considered to be investment companies.&#160;As of December&#160;31, 2023, the Company's consolidated subsidiaries were BGSL Jackson Hole Funding LLC (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Jackson Hole Funding&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), BGSL Breckenridge Funding LLC (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Breckenridge Funding&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), BGSL Big Sky Funding LLC (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Big Sky Funding&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), BGSL Investments LLC (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;BGSL Investments&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), BXSL Associates GP (Lux) S.&#xe0; r.l, BXSL Direct Lending (Lux) SCSp, BXSL C-1 LLC, and BXSL C-2 Funding LLC.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-5036">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of demand deposits and highly liquid investments, such as money market funds, with original maturities of three months or less. Cash and cash equivalents are carried at cost, which approximates fair value. The Company deposits its cash and cash equivalents with financial institutions and, at times, may exceed the Federal Deposit Insurance Corporation insured limit.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c-1" id="f-5037">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment transactions are recorded on a trade date basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized gains or losses are measured by the difference between the net proceeds received (excluding prepayment fees, if any) and the amortized cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include investments charged off during the period, net of recoveries, and is recorded within Net realized gain (loss) on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net change in unrealized gains or losses primarily reflects the change in investment values, including the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period, and is recorded within Net change in unrealized appreciation (depreciation) on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Valuation of Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to report its investments, including those for which current market values are not readily available, at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company values its investments in accordance with ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;ASC 820&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the applicable measurement date, and Rule 2a-5 under the 1940 Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is based on observable market prices or parameters or derived from such prices or parameters when such quotations are readily available.&#160;In accordance with&#160;Rule 2a-5 under the 1940 Act, a market quotation is &#x201c;readily available&#x201d; only when it is a quoted price (unadjusted) in active markets for identical instruments that a fund can access at the measurement date, provided that such a quotation is not considered to be readily available if it is not reliable.&#160;The Company utilizes mid-market pricing (i.e., mid-point of average bid and ask prices) to value these investments.&#160;These market quotations are obtained from independent pricing services, if available; otherwise generally from at least two principal market makers or primary market dealers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Where prices or inputs are not available or, in the judgment of the Board, not reliable, valuation techniques based on the facts and circumstances of the particular investment will be utilized. These valuation approaches involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments&#x2019; complexity. In the absence of observable, reliable market prices, the Company values its investments using various valuation methodologies applied on a consistent basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An enterprise value (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;EV&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) analysis is generally performed to determine the value of equity investments, control debt investments and non-control debt investments that are credit-impaired, and to determine if debt investments are credit impaired. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser will generally utilize approaches including the market approach, the income approach or both approaches, as appropriate, when calculating EV.&#160;The primary method for determining EV for non-control investments, and control investments without reliable projections, uses a multiple analysis whereby appropriate multiples are applied to the portfolio company&#x2019;s earnings before interest, taxes, depreciation and amortization (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;EBITDA&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) or another key financial metric (e.g., such as revenues, cash flows or net income) (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Performance Multiple&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&#160;Performance Multiples are typically determined based upon a review of publicly traded comparable companies and market comparable transactions, if any.&#160;The second method for determining EV (and primary method for control investments with reliable projections) uses a discounted cash flow analysis whereby future expected cash flows and the anticipated terminal value of the portfolio company are discounted to determine a present value using estimated discount rates.&#160;The income approach is generally used when the Adviser has visibility into the long term projected cash flows of a portfolio company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If debt investments are credit-impaired, which occurs when there is insufficient coverage under the enterprise value analysis through the respective investment&#x2019;s position in the capital structure, the Adviser generally uses the enterprise value &#x201c;waterfall&#x201d; approach or a recovery method (if a liquidation or restructuring is deemed likely) to determine fair value. For debt investments that are not determined to be credit-impaired, the Adviser generally uses a market interest rate yield analysis to determine fair value. To determine fair value using a yield analysis, the expected cash flows are projected based on the contractual terms of the debt security and discounted back to the measurement date based on a market yield.&#160;A market yield is determined based upon an assessment of current and expected market yields for similar investments and risk profiles.&#160;The Company considers the current contractual interest rate, the maturity and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the enterprise value of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, the Company depends on primary market data, including newly funded transactions, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable.&#160;The fair value of loans with call protection is generally capped at par plus applicable prepayment premium in effect at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 820 prioritizes the use of observable market prices derived from such prices. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The levels used for classifying investments are not necessarily an indication of the risk associated with investing in these securities. The three levels of the fair value hierarchy are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level 1:&#160;Inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date. The types of financial instruments included in Level 1 include unrestricted securities, including equities and derivatives, listed in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level 2:&#160;Inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. The types of financial instruments in this category include less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities and certain over-the-counter derivatives where the fair value is based on observable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level 3:&#160;Inputs to the valuation methodology are unobservable and significant to overall fair value measurement. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in this category include debt and equity investments in privately held entities, collateralized loan obligations (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;CLOs&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and certain over-the-counter derivatives where the fair value is based on unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment&#x2019;s level within the fair value hierarchy is based on the lowest level of input that is significant to the overall fair value measurement. The Adviser&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.&#160;Transfers between levels, if any, are recognized at the beginning of the quarter in which the transfer occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the source of the inputs, including any markets in which its investments are trading (or any markets in which securities with similar attributes are trading), in determining fair value. When an investment is valued based on prices provided by reputable dealers or pricing services (that is, broker quotes), the Company subjects those prices to various criteria in making the determination as to whether a particular investment would qualify for treatment as a Level 2 or Level 3 investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company&#x2019;s investments may fluctuate from period to period, and these differences could be material. Additionally, the fair value of the Company&#x2019;s investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that the Company may ultimately realize. Further, such investments are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If the Company was required to liquidate a portfolio investment in a forced or liquidation sale, it could realize significantly less than the value at which the Company has recorded it. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected in the valuations currently assigned.&#160;See &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Item 7. Management&#x2019;s Discussion and Analysis of Financial Conditions and Results of Operations&#x2014;Critical Accounting Estimates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables/Payables From Investments Sold/Purchased&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables/payables from investments sold/purchased consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c-1" id="f-5038">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes all derivative instruments as assets or liabilities at fair value in its consolidated financial statements. Derivative contracts entered into by the Company are not designated in hedge accounting relationships and all changes in fair value are recognized through current period gains or losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company has commitments and risks resulting from its investment transactions, which may include those involving derivative instruments. Derivative instruments are measured in terms of the notional contract amount and derive their value based upon one or more underlying instruments. While the notional amount gives some indication of the Company&#x2019;s derivative activity, it generally is not exchanged, but is only used as the basis on which interest and other payments are exchanged. Derivative instruments are subject to various risks similar to non-derivative instruments including market, credit, liquidity, and operational risks. The Company manages these risks on an aggregate basis as part of its risk management process.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Forward Purchase Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forward purchase agreements are recognized at fair value through current period gains or losses on the date on which the contract is entered into and are subsequently re-measured at fair value. All forward purchase agreements are carried as assets when fair value is positive and as liabilities when fair value is negative.&#160;A forward purchase agreement is derecognized when the obligation specified in the contract is discharged, canceled or expired.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-5039">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts denominated in foreign currencies are translated into U.S. dollars on the following basis: (i)&#160;investments and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates effective on the last business day of the period; and (ii)&#160;purchases and sales of investments, borrowings and repayments of such borrowings, income, and expenses denominated in foreign currencies are translated into U.S. dollars based upon currency exchange rates prevailing on the transaction dates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company includes net changes in fair values on investments held resulting from foreign exchange rate fluctuations in Translation of assets and liabilities in foreign currencies on the Consolidated Statements of Operations, if any. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign security and currency translations may involve certain considerations and risks not typically associated with investing in U.S. companies and U.S. government securities. These risks include, but are not limited to, currency fluctuations and revaluations and future adverse political, social and economic developments, which could cause investments in foreign markets to be less liquid and prices more volatile than those of comparable U.S. companies or U.S. government securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c-1" id="f-5040">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income is recorded on an accrual basis and includes the accretion of discounts and amortizations of premiums.&#160;Discounts from and premiums to par value on debt investments purchased are accreted/amortized into interest income over the life of the respective security using the effective interest method.&#160;The amortized cost of debt investments represents the original cost, including loan origination fees and upfront fees received that are deemed to be an adjustment to yield, adjusted for the accretion of discounts and amortization of premiums, if any.&#160;Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income in the current period. For the years ended December&#160;31, 2023, 2022 and 2021 the Company recorded $19.3 million, $4.9 million and $60.9 million, respectively, in non-recurring interest income (e.g., prepayment premiums, accelerated accretion of upfront loan origination fees and unamortized discounts). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;PIK Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has loans in its portfolio that contain payment-in-kind (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;PIK&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) provisions.&#160;PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity.&#160;Such income is included in payment-in-kind interest income in the Consolidated Statements of Operations.&#160;If at any point the Company believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status.&#160;When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through payment-in-kind interest income.&#160;To satisfy the Company&#x2019;s annual RIC distribution requirements, this non-cash source of income must be included in determining the amounts to be paid out to shareholders in the form of dividends, even though the Company has not yet collected cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividend Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividend income on preferred equity securities is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fee Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may receive various fees in the ordinary course of business such as structuring, consent, waiver, amendment, syndication and other miscellaneous fees as well as fees for managerial assistance rendered by the Company to the portfolio companies.&#160;Such fees are recognized as income when earned or the services are rendered.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Accrual Income&lt;/span&gt;&lt;/div&gt;Loans are generally placed on non-accrual status when there is reasonable doubt whether principal or interest will be collected in full.&#160;Accrued interest is generally reversed when a loan is placed on non-accrual status. Additionally, any original issue discount and market discount are no longer accreted to interest income as of the date the loan is placed on non-accrual status.&#160;Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management&#x2019;s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management&#x2019;s judgment, are likely to remain current. Management may make exceptions to this treatment and&#160;determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-5" id="f-5041" unitRef="usd">19300000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-135" decimals="-5" id="f-5042" unitRef="usd">4900000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-136" decimals="-5" id="f-5043" unitRef="usd">60900000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:StockholdersEquityPolicyTextBlock contextRef="c-1" id="f-5044">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Organization Expenses and Offering Expenses&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-1" decimals="-5" id="f-5045" unitRef="usd">400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-135" decimals="INF" id="f-5046" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-136" decimals="-5" id="f-5047" unitRef="usd">1600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:DebtPolicyTextBlock contextRef="c-1" id="f-5048">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Financing Costs and Debt Issuance Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred financing and debt issuance costs represent fees and other direct incremental costs incurred in connection with the Company&#x2019;s borrowings.&#160;These expenses are deferred and amortized into interest expense over the life of the related debt instrument. Deferred financing costs related to revolving credit facilities are presented separately as an asset on the Company&#x2019;s Consolidated Statements of Assets and Liabilities.&#160;Debt issuance costs related to any issuance of installment debt or notes are presented net against the outstanding debt balance of the related security.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-5049">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to be treated as a BDC under the 1940 Act.&#160;The Company also has elected to be treated as a RIC under the Code.&#160;So long as the Company maintains its status as a RIC, it generally will not pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that it distributes at least annually to its shareholders as dividends. Rather, any tax liability related to income earned and distributed by the Company would represent obligations of the Company&#x2019;s investors and would not be reflected in the consolidated financial statements of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are &#x201c;more-likely-than-not&#x201d; to be sustained by the applicable tax authority. Tax positions not deemed to meet the &#x201c;more-likely-than-not&#x201d; threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To qualify for and maintain qualification as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to qualify for RIC tax treatment, the Company must distribute to its shareholders, for each taxable year, at least 90% of the sum of (i) its &#x201c;investment company taxable income&#x201d; for that year (without regard to the deduction for dividends paid), which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses and (ii) its net tax-exempt income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, based on the excise tax distribution requirements, the Company is subject to a 4% nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner in each taxable year an amount at least equal to the sum of (i) 98% of its ordinary income for the calendar year, (ii) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October&#160;31 in that calendar year and (iii)&#160;any income realized, but not distributed, in prior years. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to corporate income tax is considered to have been distributed.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-5050" unitRef="usd">16800000</us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit>
    <us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit contextRef="c-135" decimals="-5" id="f-5051" unitRef="usd">1400000</us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit>
    <us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit contextRef="c-136" decimals="-5" id="f-5052" unitRef="usd">2400000</us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit>
    <us-gaap:InvestmentCompanyDistributionPolicyTextBlock contextRef="c-1" id="f-5053">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Distributions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To the extent that the Company has taxable income available, the Company intends to make quarterly distributions to its shareholders.&#160;Distributions to shareholders are recorded on the record date.&#160;All distributions will be paid at the discretion of the Board and will depend on the Company&#x2019;s earnings, financial condition, maintenance of the Company's tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentCompanyDistributionPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-5054">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Reference Rate Reform (Topic 848)&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides optional expedients and exceptions for applying &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GAAP&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Interbank Offered Rate (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;LIBOR&#x201d;&lt;/span&gt;) or another reference rate expected to be discontinued because of reference rate reform. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848), which expanded the scope of Topic 848 to include derivative instruments impacted by discounting transition. ASU 2020-04 and ASU 2021-01 are effective for all entities through December 31, 2022. The expedients and exceptions provided by the amendments do not apply to contract modifications and hedging relationships entered into or evaluated after December 31, 2022, except for hedging transactions as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which deferred the sunset day of this guidance to December 31, 2024. There has been no material impact of these standards on the Company&#x2019;s financial position, results of operations or cash flows</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-5055">Agreements and Related Party Transactions&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment Advisory Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2018, the Company entered into the original investment advisory agreement with the Adviser. The Adviser is responsible for originating prospective investments, conducting research and due diligence investigations on potential investments, analyzing investment opportunities, negotiating and structuring the Company&#x2019;s investments and monitoring its investments and portfolio companies on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 18, 2021, the Company entered into an amended and restated investment advisory agreement (as amended and restated, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Investment Advisory Agreement&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), pursuant to which the Adviser manages the Company on a day-to-day basis. The Investment Advisory Agreement is substantially the same as the prior investment advisory agreement except, following the IPO, the incentive fee on income became subject to a twelve-quarter lookback quarterly hurdle rate of 1.50% as opposed to a single quarter measurement and became subject to an Incentive Fee Cap (as defined below) based on the Company&#x2019;s Cumulative Net Return (as defined below). The amendment to the Investment Advisory Agreement does not result in higher fees (on a cumulative basis) payable to the Adviser than the fees that would have otherwise been payable to the Adviser under the original investment advisory agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company pays the Adviser a fee for its services under the Investment Advisory Agreement consisting of two components: a management fee and an incentive fee. The cost of both the management fee and the incentive fee is borne by the shareholders. The initial term of the Investment Advisory Agreement was two years from October 1, 2018, and on May 6, 2020 and May 6, 2021, it was renewed and approved by the Board, including a majority of trustees who are not parties to the Investment Advisory Agreement or &#x201c;interested persons&#x201d; (as such term is defined in Section 2(a)(19) of the 1940 Act) (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Independent Trustees&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), for a one-year period. On October 18, 2021, the Board approved the amended and restated Investment Advisory Agreement for an initial term ending May 31, 2022. Unless earlier terminated, the Investment Advisory Agreement will renew automatically for successive annual periods, provided that such continuance is specifically approved at least annually by the vote of the Board and by the vote of a majority of the Independent Trustees. The Investment Advisory Agreement was most recently renewed and approved by the Board, including majority of the Independent Trustees, on May 2, 2023 for a one-year period ending on May 31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Adviser implemented a waiver effective from the consummation of the IPO to extend the Company&#x2019;s pre-IPO fee structure for a period of two years. With the waiver in place, instead of having the base management fee and each incentive fee increase to 1.00% and 17.5%, respectively, following the IPO, each such fee remained at 0.75% and 15.0% for a period of two years following the IPO (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Waiver Period&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). As a result of the fee waiver, the pre-listing management fee and incentive fee rates paid by the Company to the Adviser did not increase during the Waiver Period. Amounts waived by the Adviser are not subject to recoupment by the Adviser. The Waiver Period ended on October 28, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Base Management Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Starting from the consummation of the IPO, the management fee pursuant to the Investment Advisory Agreement is payable quarterly in arrears at an annual rate of 1.0% of the average value of the Company&#x2019;s gross assets at the end of the two most recently completed calendar quarters. For purposes of the Investment Advisory Agreement, "gross assets" means the Company&#x2019;s total assets determined on a consolidated basis in accordance with GAAP, excluding undrawn commitments but including assets purchased with borrowed amounts. The management fee was calculated for the quarter ended December 31, 2021, and the quarter ended December 31, 2023, at a weighted rate calculated based on the fee rates applicable before and after the consummation of the IPO and the expiration of the Waiver Period based on the number of days in the calendar quarter before and after the consummation of the IPO and the expiration of the Waiver Period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the consummation of the IPO, the management fee was 0.75% of the average value of the Company&#x2019;s gross assets at the end of the two most recently completed calendar quarters. In order to maintain the same management fee arrangement that the Company had in place prior to the IPO for a period of time following the consummation of the IPO, the Adviser voluntarily waived its right to receive the base management fee in excess of 0.75% of the average value of the Company&#x2019;s gross assets at the end of the two most recently completed calendar quarters during the Waiver Period. Amounts waived by the Adviser are not subject to recoupment by the Adviser.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2023, 2022 and 2021, base management fees were $98.1 million, $101.7 million and $62.4 million, respectively, of which $20.2 million, $25.4 million and $4.2 million, respectively, were waived. As of December&#160;31, 2023 and December&#160;31, 2022, $23.0 million and $18.6 million, respectively, was payable to the Adviser relating to management fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Incentive Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The incentive fees consist of two components that are determined independently of each other, with the result that one component may be payable even if the other is not. One component is based on income and the other component is based on capital gains, each as described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(i) Income based incentive fees:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The first part of the incentive fee, an income based incentive fee, is calculated and payable quarterly in arrears based on the Company&#x2019;s Pre-Incentive Fee Net Investment Income Returns as defined in the Investment Advisory Agreement.&#160;Pre-Incentive Fee Net Investment Income Returns means, as the context requires, either the dollar value of, or percentage rate of return on the value of the Company&#x2019;s net assets at the end of the immediately preceding quarter from, interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies) accrued during the calendar quarter, minus the Company&#x2019;s operating expenses accrued for the quarter (including the management fee, expenses payable under the Administration Agreement, and any interest expense or fees on any credit facilities or outstanding debt and dividends paid on any issued and outstanding preferred shares, but excluding the incentive fee.&#160;Pre-Incentive Fee Net Investment Income Returns includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with PIK interest and zero-coupon securities)), accrued income that the Company has not yet received in cash.&#160;Pre-incentive fee net investment income excludes any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The Company excludes the impact of expense support payments and recoupments from pre-incentive fee net investment income. Shareholders may be charged a fee on an income amount that is higher than the income they may ultimately receive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-Incentive Fee Net Investment Income Returns, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, is compared to a &#x201c;hurdle rate&#x201d; of return of 1.5% per quarter (6.0% annualized). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Investment Advisory Agreement, the Company is required to pay an income based incentive fee of 17.5% (15% prior to the consummation of the IPO), with a 1.5% hurdle and 100% catch-up. However, the Adviser has implemented a voluntary waiver with respect to the income based incentive fee during the Waiver Period. The Adviser has voluntarily waived its right to receive an income based incentive fee above 15% during the Waiver Period and amounts waived by the Adviser are not subject to recoupment by the Adviser.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company pays the Adviser an income based incentive fee based on its aggregate pre-incentive fee net investment income, as adjusted as described above, from the calendar quarter then ending and the eleven preceding calendar quarters (such period, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;Trailing Twelve Quarters&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The hurdle amount for the income based incentive fee is determined on a quarterly basis and is equal to 1.5% multiplied by the Company&#x2019;s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters. The hurdle amount is calculated after making appropriate adjustments for issuances by the Company of common shares, including issuances pursuant to its dividend reinvestment plan and distributions that occurred during the relevant Trailing Twelve Quarters. The income based incentive fee for any partial period will be appropriately prorated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the income based incentive fee, the Company will pay the Adviser a quarterly incentive fee based on the amount by which (A) aggregate pre-incentive fee net investment income in respect of the relevant Trailing Twelve Quarters exceeds (B) the hurdle amount for such Trailing Twelve Quarters. The amount of the excess of (A) over (B) described in this paragraph for such Trailing Twelve Quarters is referred to as the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;Excess Income Amount&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The income based incentive fee for each quarter will be determined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:32.5pt"&gt;No income based incentive fee is payable to the Adviser for any calendar quarter for which there is no Excess Income Amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:32.5pt"&gt;The Adviser will be paid 100% of the pre-incentive fee net investment income in respect of the Trailing Twelve Quarters, if any, that exceeds the hurdle amount for such Trailing Twelve Quarters, but is less than or equal to an amount, which we refer to as the &#x201c;Catch-up Amount,&#x201d; determined as the sum of 1.82% (7.27% annualized) (1.76% (7.06% annualized) during the Waiver Period), multiplied by the Company&#x2019;s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters that is included in the calculation of the incentive fee based on income.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt"&gt;The Adviser will be paid 17.5% (15% during the Waiver Period), of the pre-incentive fee net investment income in respect of the Trailing Twelve Quarters that exceeds the Catch-up Amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The amount of the income based incentive fee that will be paid to the Adviser for a particular quarter will equal the excess of (a) the income based incentive fee so calculated over (b) the aggregate income based incentive fee that was paid in respect of the first eleven calendar quarters included in the relevant Trailing Twelve Quarters subject to the Incentive Fee Cap as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The income based incentive fee that will be paid to the Adviser for a particular quarter is subject to a cap (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;Incentive Fee Cap&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;). The Incentive Fee Cap for any quarter is an amount equal to (a) 17.5% (15% prior to the end of the Waiver Period) of the Cumulative Net Return (as defined below) during the relevant Trailing Twelve Quarters minus (b) the aggregate income based incentive fee that was paid in respect of the first eleven calendar quarters (or the portion thereof) included in the relevant Trailing Twelve Quarters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;Cumulative Net Return&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; means (x) the pre-incentive fee net investment income in respect of the relevant Trailing Twelve Quarters minus (y) any Net Capital Loss (as defined below), if any, in respect of the relevant Trailing Twelve Quarters. If, in any quarter, the Incentive Fee Cap is zero or a negative value, the Company will pay no income based incentive fee to the Adviser for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is a positive value but is less than the income based incentive fee that is payable to the Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company will pay an income based incentive fee to the Adviser equal to the Incentive Fee Cap for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is equal to or greater than the income based incentive fee that is payable to the Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company will pay an income based incentive fee to the Adviser equal to the incentive fee calculated as described above for such quarter without regard to the Incentive Fee Cap.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;Net Capital Loss&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;in respect of a particular period means the difference, if positive, between (i) aggregate capital losses, whether realized or unrealized, in such period and (ii) aggregate capital gains, whether realized or unrealized, in such period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;These calculations are prorated for any period of less than three months and adjusted for any share issuances or repurchases during the relevant quarter. As the consummation of the IPO occurred on a date other than the first day of a calendar quarter, the income based incentive fee with respect to the Company&#x2019;s pre-incentive fee net investment income was calculated for such calendar quarter at a weighted rate calculated based on the fee rates applicable before and after the consummation of the IPO based on the number of days in such calendar quarter before and after the consummation of the IPO. In no event will the amendments to the income based incentive fee include the incentive fee cap and allow the Adviser to receive greater cumulative income based incentive fees under the Investment Advisory Agreement than it would have under the prior investment advisory agreement. Amounts waived by the Adviser are not subject to recoupment by the Adviser.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(ii) Capital gains based incentive fee:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Starting from the completion of the IPO, the second part of the incentive fee, a capital gains incentive fee, is determined and payable in arrears as of the end of each calendar year in an amount equal to 17.5% of realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees as calculated in accordance with GAAP. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the IPO, the second part of the incentive fee, a capital gains incentive fee, was determined and payable in arrears as of the end of each calendar year in an amount equal to 15.0% of realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees as calculated in accordance with GAAP. However, similar to the voluntary waivers referenced above, the Adviser voluntarily waived its right to receive a capital gains based incentive fee above 15% from the date of consummation of the IPO through the Waiver Period. The Company will accrue, but will not pay, a capital gains incentive fee with respect to unrealized appreciation because a capital gains incentive fee would be owed to the Adviser if the Company were to sell the relevant investment and realize a capital gain. Amounts waived by the Adviser are not subject to recoupment by the Adviser.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2023, 2022 and 2021, the Company accrued income based incentive fees of $134.2 million, $97.2 million and $67.3 million, respectively, of which $15.6 million $13.9 million and $2.3 million, respectively, were waived. As of December&#160;31, 2023 and December&#160;31, 2022, $34.4 million and $24.8 million, respectively, was payable to the Adviser for income based incentive fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2023 and 2022, the Company reversed previously accrued capital gains incentive fees of $(5.5) million and $(11.9) million, respectively. For the year ended December&#160;31, 2021, the Company accrued $16.3 million of capital gains incentive fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Administration Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2018, the Company entered into an Administration Agreement with the Administrator. Under the terms of the Administration Agreement, the Administrator provides, or oversees the performance of, administrative and compliance services, including, but not limited to, maintaining financial records, overseeing the calculation of NAV, compliance monitoring (including diligence and oversight of the Company&#x2019;s other service providers), preparing reports to shareholders and reports filed with the United States Securities and Exchange Commission (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;SEC&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), preparing materials and coordinating meetings of the Company&#x2019;s Board, managing the payment of expenses and the performance of administrative and professional services rendered by others and providing office space, equipment and office services. The Administrator may also offer to provide, on the Company&#x2019;s behalf, managerial assistance to the Company&#x2019;s portfolio companies. The initial term of the agreement was two years from October 1, 2018. Unless earlier terminated, the Administration Agreement will renew automatically for successive annual periods, provided that such continuance is approved at least annually by (i) the vote of the Board or by a majority vote of the outstanding voting securities of the Company and (ii) the vote of a majority of the Independent Trustees. The Administration Agreement was most recently renewed and approved by the Board, including a majority of the Independent Trustees, on May 2, 2023, for a one-year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For providing these services, the Company will reimburse the Administrator for its costs, expenses and allocable portion of overhead (including rent, office equipment and utilities) and other expenses incurred by the Administrator in performing its administrative obligations under the Administration Agreement, including but not limited to: (i) the Company&#x2019;s chief compliance officer, chief financial officer and their respective staffs; (ii) investor relations, legal, operations and other non-investment professionals (including information technology professionals) at the Administrator that perform duties for the Company; and (iii) any internal audit group personnel of Blackstone or any of its affiliates. The Administrator has elected to forgo any reimbursement for rent and other occupancy costs for the years ended December&#160;31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2023, 2022 and 2021, the Company incurred $2.2 million, $2.7 million and $2.4 million, respectively, in expenses under the Administration Agreement, which were recorded in Administrative service expenses in the Company&#x2019;s Consolidated Statements of Operations. As of December&#160;31, 2023 and December&#160;31, 2022, $1.1 million and $1.2 million, respectively, was unpaid and included in &#x201c;Due to affiliates&#x201d; in the Consolidated Statements of Assets and Liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sub-Administration and Custody Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2018, the Administrator entered into a sub-administration agreement (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Sub-Administration Agreement&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) with State Street Bank and Trust Company (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Sub-Administrator&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) under which the Sub-Administrator provides various accounting and administrative services to the Company.&#160;The Sub-Administrator also serves as the Company&#x2019;s custodian (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Custodian&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&#160;The initial term of the Sub-Administration Agreement is two years from the effective date and after expiration of the initial term and the Sub-Administration Agreement shall automatically renew for successive one-year periods, unless a written notice of non-renewal is delivered prior to 120 days prior to the expiration of the initial term or renewal term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Expense Support and Conditional Reimbursement Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 12, 2018, the Company entered into an Expense Support and Conditional Reimbursement Agreement (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Expense Support Agreement&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) with the Adviser pursuant to which the Adviser was able to elect to pay certain expenses of the Company on the Company&#x2019;s behalf (each, an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Expense Payment&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), provided that no portion of the payment was used to pay any interest of the Company. Any Expense Payment that the Adviser committed to pay was to be paid by the Adviser to the Company in any combination of cash or other immediately available funds no later than forty-five days after such commitment was made in writing, and/or offset against amounts due from the Company to the Adviser or its affiliates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Expense Support Agreement, following any calendar quarter in which Available Operating Funds (as defined below) exceeded the cumulative distributions accrued to the Company&#x2019;s shareholders based on distributions declared with respect to record dates occurring in such calendar quarter (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Excess Operating Funds&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), the Company was required to pay such Excess Operating Funds, or a portion thereof, to the Adviser until such time as all Expense Payments made by the Adviser to the Company within three years prior to the last business day of such calendar quarter were reimbursed. Any payments required to be made by the Company to the Adviser are referred to herein as a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Reimbursement Payment&#x201d;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Available Operating Funds means the sum of (i) the Company&#x2019;s net investment company taxable income (including net short-term capital gains reduced by net long-term capital losses), (ii) the Company&#x2019;s net capital gains (including the excess of net long-term capital gains over net short-term capital losses) and (iii) dividends and other distributions paid to the Company on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Expense Support Agreement terminated by its own terms on October 28, 2021. The Company&#x2019;s obligation to make Reimbursement Payments survived the termination of the Expense Support Agreement and may be made for a period of up to three years, in accordance with the terms of the Expense Support Agreement. The Company&#x2019;s obligation to make a Reimbursement Payment becomes a liability of the Company on the last business day of the applicable calendar quarter. As of December&#160;31, 2023, there are no amounts subject to the Reimbursement Payment obligation.&lt;/span&gt;&lt;/div&gt;As of December&#160;31, 2023 and December&#160;31, 2022, there was no unreimbursed Expense Payments. For the years ended December&#160;31, 2023, 2022 and 2021, the Adviser made no Expense Payments. For the years ended December&#160;31, 2023, 2022 and 2021, the Company made no Reimbursement Payments related to Expense Payments by the Adviser.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <bxsl:RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate
      contextRef="c-1233"
      decimals="INF"
      id="f-5056"
      unitRef="number">0.0150</bxsl:RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate>
    <bxsl:RelatedPartyTransactionInitialTerm contextRef="c-1233" id="f-5057">P2Y</bxsl:RelatedPartyTransactionInitialTerm>
    <bxsl:RelatedPartyTransactionRenewalTerm contextRef="c-1234" id="f-5058">P1Y</bxsl:RelatedPartyTransactionRenewalTerm>
    <bxsl:RelatedPartyTransactionRenewalTerm contextRef="c-1235" id="f-5059">P1Y</bxsl:RelatedPartyTransactionRenewalTerm>
    <bxsl:RelatedPartyTransactionRenewalTerm contextRef="c-1236" id="f-5060">P1Y</bxsl:RelatedPartyTransactionRenewalTerm>
    <bxsl:RelatedPartyTransactionVoluntaryWaiverPeriod contextRef="c-1233" id="f-5061">P2Y</bxsl:RelatedPartyTransactionVoluntaryWaiverPeriod>
    <us-gaap:ManagementAndServiceFeesBaseRate
      contextRef="c-1237"
      decimals="INF"
      id="f-5062"
      unitRef="number">0.0100</us-gaap:ManagementAndServiceFeesBaseRate>
    <us-gaap:ManagementAndServiceFeesIncentiveRate
      contextRef="c-1237"
      decimals="INF"
      id="f-5063"
      unitRef="number">0.175</us-gaap:ManagementAndServiceFeesIncentiveRate>
    <us-gaap:ManagementAndServiceFeesBaseRate
      contextRef="c-1238"
      decimals="INF"
      id="f-5064"
      unitRef="number">0.0075</us-gaap:ManagementAndServiceFeesBaseRate>
    <us-gaap:ManagementAndServiceFeesIncentiveRate
      contextRef="c-1238"
      decimals="INF"
      id="f-5065"
      unitRef="number">0.150</us-gaap:ManagementAndServiceFeesIncentiveRate>
    <bxsl:RelatedPartyTransactionVoluntaryWaiverPeriod contextRef="c-1239" id="f-5066">P2Y</bxsl:RelatedPartyTransactionVoluntaryWaiverPeriod>
    <us-gaap:ManagementAndServiceFeesRate
      contextRef="c-1240"
      decimals="INF"
      id="f-5067"
      unitRef="number">0.010</us-gaap:ManagementAndServiceFeesRate>
    <us-gaap:ManagementAndServiceFeesRate
      contextRef="c-1241"
      decimals="INF"
      id="f-5068"
      unitRef="number">0.0075</us-gaap:ManagementAndServiceFeesRate>
    <us-gaap:ManagementAndServiceFeesBaseRate
      contextRef="c-1242"
      decimals="INF"
      id="f-5069"
      unitRef="number">0.0075</us-gaap:ManagementAndServiceFeesBaseRate>
    <us-gaap:ManagementFeeExpense contextRef="c-1" decimals="-5" id="f-5070" unitRef="usd">98100000</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c-135" decimals="-5" id="f-5071" unitRef="usd">101700000</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c-136" decimals="-5" id="f-5072" unitRef="usd">62400000</us-gaap:ManagementFeeExpense>
    <us-gaap:InvestmentCompanyContractualFeeWaived contextRef="c-1" decimals="-5" id="f-5073" unitRef="usd">20200000</us-gaap:InvestmentCompanyContractualFeeWaived>
    <us-gaap:InvestmentCompanyContractualFeeWaived contextRef="c-135" decimals="-5" id="f-5074" unitRef="usd">25400000</us-gaap:InvestmentCompanyContractualFeeWaived>
    <us-gaap:InvestmentCompanyContractualFeeWaived contextRef="c-136" decimals="-5" id="f-5075" unitRef="usd">4200000</us-gaap:InvestmentCompanyContractualFeeWaived>
    <us-gaap:ManagementFeePayable contextRef="c-5" decimals="-5" id="f-5076" unitRef="usd">23000000</us-gaap:ManagementFeePayable>
    <us-gaap:ManagementFeePayable contextRef="c-6" decimals="-5" id="f-5077" unitRef="usd">18600000</us-gaap:ManagementFeePayable>
    <us-gaap:ManagementAndServiceFeesIncentiveRate
      contextRef="c-1243"
      decimals="INF"
      id="f-5078"
      unitRef="number">0.015</us-gaap:ManagementAndServiceFeesIncentiveRate>
    <us-gaap:ManagementAndServiceFeesIncentiveRate
      contextRef="c-1244"
      decimals="INF"
      id="f-5079"
      unitRef="number">0.060</us-gaap:ManagementAndServiceFeesIncentiveRate>
    <bxsl:IncomeBasedIncentiveFeesRate
      contextRef="c-1245"
      decimals="INF"
      id="f-5080"
      unitRef="number">0.175</bxsl:IncomeBasedIncentiveFeesRate>
    <bxsl:IncomeBasedIncentiveFeesRate
      contextRef="c-1241"
      decimals="INF"
      id="f-5081"
      unitRef="number">0.15</bxsl:IncomeBasedIncentiveFeesRate>
    <bxsl:RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate
      contextRef="c-1245"
      decimals="INF"
      id="f-5082"
      unitRef="number">0.015</bxsl:RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate>
    <bxsl:ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage
      contextRef="c-1245"
      decimals="INF"
      id="f-5083"
      unitRef="number">1</bxsl:ManagementAndServiceFeesIncomeBasedIncentiveRateCatchUpPercentage>
    <bxsl:IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold
      contextRef="c-1245"
      decimals="INF"
      id="f-5084"
      unitRef="number">0.15</bxsl:IncomeBasedIncentiveFeesVoluntaryWaiverIncentiveRateThreshold>
    <bxsl:RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate
      contextRef="c-1245"
      decimals="INF"
      id="f-5085"
      unitRef="number">0.015</bxsl:RelatedPartyTransactionIncomeBasedIncentiveFeeQuarterlyHurdleRate>
    <bxsl:IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome
      contextRef="c-1246"
      decimals="INF"
      id="f-5086"
      unitRef="number">1</bxsl:IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome>
    <bxsl:IncomeBasedIncentiveFeesCatchUpAmountPercentage
      contextRef="c-1247"
      decimals="4"
      id="f-5087"
      unitRef="number">0.0182</bxsl:IncomeBasedIncentiveFeesCatchUpAmountPercentage>
    <bxsl:IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage
      contextRef="c-1247"
      decimals="4"
      id="f-5088"
      unitRef="number">0.0727</bxsl:IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage>
    <bxsl:IncomeBasedIncentiveFeesCatchUpAmountPercentage
      contextRef="c-1248"
      decimals="4"
      id="f-5089"
      unitRef="number">0.0176</bxsl:IncomeBasedIncentiveFeesCatchUpAmountPercentage>
    <bxsl:IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage
      contextRef="c-1248"
      decimals="4"
      id="f-5090"
      unitRef="number">0.0706</bxsl:IncomeBasedIncentiveFeesCatchUpAmountAnnualizedPercentage>
    <bxsl:IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome
      contextRef="c-1249"
      decimals="INF"
      id="f-5091"
      unitRef="number">0.175</bxsl:IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome>
    <bxsl:IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome
      contextRef="c-1250"
      decimals="INF"
      id="f-5092"
      unitRef="number">0.15</bxsl:IncomeBasedIncentiveFeesPercentageOfPreIncentiveFeeNetInvestmentIncome>
    <bxsl:IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn
      contextRef="c-1251"
      decimals="INF"
      id="f-5093"
      unitRef="number">0.175</bxsl:IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn>
    <bxsl:IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn
      contextRef="c-1242"
      decimals="INF"
      id="f-5094"
      unitRef="number">0.15</bxsl:IncomeBasedIncentiveFeesCapPercentageOfCumulativeNetReturn>
    <bxsl:CapitalGainsBasedIncentiveFeesRate
      contextRef="c-1252"
      decimals="INF"
      id="f-5095"
      unitRef="number">0.175</bxsl:CapitalGainsBasedIncentiveFeesRate>
    <bxsl:CapitalGainsBasedIncentiveFeesRate
      contextRef="c-1241"
      decimals="INF"
      id="f-5096"
      unitRef="number">0.150</bxsl:CapitalGainsBasedIncentiveFeesRate>
    <bxsl:CapitalGainsBasedIncentiveFeesRate
      contextRef="c-1242"
      decimals="INF"
      id="f-5097"
      unitRef="number">0.15</bxsl:CapitalGainsBasedIncentiveFeesRate>
    <bxsl:IncomeBasedIncentiveFeeExpense contextRef="c-1" decimals="-5" id="f-5098" unitRef="usd">134200000</bxsl:IncomeBasedIncentiveFeeExpense>
    <bxsl:IncomeBasedIncentiveFeeExpense contextRef="c-135" decimals="-5" id="f-5099" unitRef="usd">97200000</bxsl:IncomeBasedIncentiveFeeExpense>
    <bxsl:IncomeBasedIncentiveFeeExpense contextRef="c-136" decimals="-5" id="f-5100" unitRef="usd">67300000</bxsl:IncomeBasedIncentiveFeeExpense>
    <us-gaap:InvestmentCompanyVoluntaryFeeWaived contextRef="c-1" decimals="-5" id="f-5101" unitRef="usd">15600000</us-gaap:InvestmentCompanyVoluntaryFeeWaived>
    <us-gaap:InvestmentCompanyVoluntaryFeeWaived contextRef="c-135" decimals="-5" id="f-5102" unitRef="usd">13900000</us-gaap:InvestmentCompanyVoluntaryFeeWaived>
    <us-gaap:InvestmentCompanyVoluntaryFeeWaived contextRef="c-136" decimals="-5" id="f-5103" unitRef="usd">2300000</us-gaap:InvestmentCompanyVoluntaryFeeWaived>
    <bxsl:IncentiveFeePayableIncome contextRef="c-5" decimals="-5" id="f-5104" unitRef="usd">34400000</bxsl:IncentiveFeePayableIncome>
    <bxsl:IncentiveFeePayableIncome contextRef="c-6" decimals="-5" id="f-5105" unitRef="usd">24800000</bxsl:IncentiveFeePayableIncome>
    <bxsl:CapitalGainsIncentiveFeeExpense contextRef="c-1" decimals="-5" id="f-5106" unitRef="usd">-5500000</bxsl:CapitalGainsIncentiveFeeExpense>
    <bxsl:CapitalGainsIncentiveFeeExpense contextRef="c-135" decimals="-5" id="f-5107" unitRef="usd">-11900000</bxsl:CapitalGainsIncentiveFeeExpense>
    <bxsl:CapitalGainsIncentiveFeeExpense contextRef="c-136" decimals="-5" id="f-5108" unitRef="usd">16300000</bxsl:CapitalGainsIncentiveFeeExpense>
    <bxsl:RelatedPartyTransactionInitialTerm contextRef="c-1253" id="f-5109">P2Y</bxsl:RelatedPartyTransactionInitialTerm>
    <us-gaap:AdministrativeFeesExpense contextRef="c-1" decimals="-5" id="f-5110" unitRef="usd">2200000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="c-135" decimals="-5" id="f-5111" unitRef="usd">2700000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="c-136" decimals="-5" id="f-5112" unitRef="usd">2400000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:OtherLiabilities contextRef="c-1254" decimals="-5" id="f-5113" unitRef="usd">1100000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="c-1255" decimals="-5" id="f-5114" unitRef="usd">1200000</us-gaap:OtherLiabilities>
    <bxsl:RelatedPartyTransactionInitialTerm contextRef="c-1256" id="f-5115">P2Y</bxsl:RelatedPartyTransactionInitialTerm>
    <bxsl:RelatedPartyTransactionRenewalTerm contextRef="c-1256" id="f-5116">P1Y</bxsl:RelatedPartyTransactionRenewalTerm>
    <bxsl:RelatedPartyTransactionTerminationNoticePeriod contextRef="c-1256" id="f-5117">P120D</bxsl:RelatedPartyTransactionTerminationNoticePeriod>
    <bxsl:RelatedPartyTransactionExpensePaymentPeriod contextRef="c-1257" id="f-5118">P45D</bxsl:RelatedPartyTransactionExpensePaymentPeriod>
    <bxsl:RelatedPartyTransactionExpensePaymentPeriod contextRef="c-1258" id="f-5119">P3Y</bxsl:RelatedPartyTransactionExpensePaymentPeriod>
    <bxsl:RelatedPartyTransactionExpensePaymentPeriod contextRef="c-1258" id="f-5120">P3Y</bxsl:RelatedPartyTransactionExpensePaymentPeriod>
    <us-gaap:OtherLiabilities
      contextRef="c-1259"
      decimals="INF"
      id="f-5121"
      unitRef="usd">0</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="c-1260"
      decimals="INF"
      id="f-5122"
      unitRef="usd">0</us-gaap:OtherLiabilities>
    <bxsl:ExpenseSupportReimbursementRelatedParty contextRef="c-1" decimals="INF" id="f-5123" unitRef="usd">0</bxsl:ExpenseSupportReimbursementRelatedParty>
    <bxsl:ExpenseSupportReimbursementRelatedParty contextRef="c-135" decimals="INF" id="f-5124" unitRef="usd">0</bxsl:ExpenseSupportReimbursementRelatedParty>
    <bxsl:ExpenseSupportReimbursementRelatedParty contextRef="c-136" decimals="INF" id="f-5125" unitRef="usd">0</bxsl:ExpenseSupportReimbursementRelatedParty>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock contextRef="c-1" id="f-5126">Investments&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The composition of the Company&#x2019;s investment portfolio at cost and fair value was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.654%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.729%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total Investments at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total Investments at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First lien debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,817,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,722,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,497,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,419,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second lien debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unsecured debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,934,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,868,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,657,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,617,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The industry composition of investments at fair value was as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aerospace &amp;amp; Defense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Air Freight &amp;amp; Logistics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chemicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial Services &amp;amp; Supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction &amp;amp; Engineering&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Containers &amp;amp; Packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diversified Consumer Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diversified Financial Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diversified Telecommunication Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrical Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electronic Equipment, Instruments &amp;amp; Components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electric Utilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Energy Equipment &amp;amp; Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ground Transportation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Equipment &amp;amp; Supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Providers &amp;amp; Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Industrial Conglomerates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internet &amp;amp; Direct Marketing Retail&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IT Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Media&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oil, Gas &amp;amp; Consumable Fuels&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paper &amp;amp; Forest Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceuticals &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real Estate Management &amp;amp; Development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Road &amp;amp; Rail&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Retail&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology Hardware, Storage &amp;amp; Peripherals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading Companies &amp;amp; Distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transportation Infrastructure&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Amount rounds to less than 0.1% as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Amount rounds to less than 0.1% as of December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The geographic composition of investments at cost and fair value was as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total Investments at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value as % of Net Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,381,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,317,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bermuda/Cayman Islands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,934,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,868,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;br/&gt;Investments at&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;as % of Net&lt;br/&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,934,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,893,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,657,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,617,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and December&#160;31, 2022, one borrower (one loan) and no borrowers in the portfolio were on non-accrual status, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and December&#160;31, 2022, on a fair value basis, 99.9% and 99.9%, respectively, of our performing debt investments bore interest at a floating rate and 0.1% and 0.1%, respectively, of our performing debt investments bore interest at a fixed rate.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock contextRef="c-1" id="f-5127">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The composition of the Company&#x2019;s investment portfolio at cost and fair value was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.654%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.729%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total Investments at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total Investments at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First lien debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,817,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,722,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,497,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,419,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second lien debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unsecured debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,934,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,868,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,657,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,617,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The industry composition of investments at fair value was as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aerospace &amp;amp; Defense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Air Freight &amp;amp; Logistics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chemicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial Services &amp;amp; Supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction &amp;amp; Engineering&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Containers &amp;amp; Packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diversified Consumer Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diversified Financial Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diversified Telecommunication Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrical Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electronic Equipment, Instruments &amp;amp; Components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electric Utilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Energy Equipment &amp;amp; Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ground Transportation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Equipment &amp;amp; Supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Providers &amp;amp; Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Industrial Conglomerates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internet &amp;amp; Direct Marketing Retail&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IT Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Media&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oil, Gas &amp;amp; Consumable Fuels&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paper &amp;amp; Forest Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceuticals &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real Estate Management &amp;amp; Development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Road &amp;amp; Rail&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Retail&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology Hardware, Storage &amp;amp; Peripherals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading Companies &amp;amp; Distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transportation Infrastructure&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Amount rounds to less than 0.1% as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Amount rounds to less than 0.1% as of December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The geographic composition of investments at cost and fair value was as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total Investments at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value as % of Net Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,381,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,317,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bermuda/Cayman Islands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,934,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,868,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;br/&gt;Investments at&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;as % of Net&lt;br/&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,934,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,893,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,657,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,617,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-491" decimals="-3" id="f-5128" unitRef="usd">9817402000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-491" decimals="-3" id="f-5129" unitRef="usd">9722061000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1261"
      decimals="4"
      id="f-5130"
      unitRef="number">0.985</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-998" decimals="-3" id="f-5131" unitRef="usd">9497570000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-998" decimals="-3" id="f-5132" unitRef="usd">9419963000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1262"
      decimals="4"
      id="f-5133"
      unitRef="number">0.979</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-500" decimals="-3" id="f-5134" unitRef="usd">43347000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-500" decimals="-3" id="f-5135" unitRef="usd">41515000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1263"
      decimals="4"
      id="f-5136"
      unitRef="number">0.004</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1007" decimals="-3" id="f-5137" unitRef="usd">48753000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1007" decimals="-3" id="f-5138" unitRef="usd">46336000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1264"
      decimals="4"
      id="f-5139"
      unitRef="number">0.005</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1265" decimals="-3" id="f-5140" unitRef="usd">9930000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1265" decimals="-3" id="f-5141" unitRef="usd">9924000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1266"
      decimals="4"
      id="f-5142"
      unitRef="number">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1267" decimals="-3" id="f-5143" unitRef="usd">0</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1267" decimals="-3" id="f-5144" unitRef="usd">0</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1268"
      decimals="4"
      id="f-5145"
      unitRef="number">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-553" decimals="-3" id="f-5146" unitRef="usd">63480000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-553" decimals="-3" id="f-5147" unitRef="usd">94940000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1269"
      decimals="4"
      id="f-5148"
      unitRef="number">0.010</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1270" decimals="-3" id="f-5149" unitRef="usd">111549000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1270" decimals="-3" id="f-5150" unitRef="usd">150949000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1271"
      decimals="4"
      id="f-5151"
      unitRef="number">0.016</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-5" decimals="-3" id="f-5152" unitRef="usd">9934159000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-5" decimals="-3" id="f-5153" unitRef="usd">9868440000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1272"
      decimals="INF"
      id="f-5154"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-6" decimals="-3" id="f-5155" unitRef="usd">9657872000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-6" decimals="-3" id="f-5156" unitRef="usd">9617248000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1273"
      decimals="INF"
      id="f-5157"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1274"
      decimals="4"
      id="f-5158"
      unitRef="number">0.052</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1275"
      decimals="4"
      id="f-5159"
      unitRef="number">0.049</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1276"
      decimals="4"
      id="f-5160"
      unitRef="number">0.042</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1277"
      decimals="4"
      id="f-5161"
      unitRef="number">0.047</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1278"
      decimals="4"
      id="f-5162"
      unitRef="number">0.032</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1279"
      decimals="4"
      id="f-5163"
      unitRef="number">0.035</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1280"
      decimals="4"
      id="f-5164"
      unitRef="number">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1281"
      decimals="4"
      id="f-5165"
      unitRef="number">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1282"
      decimals="4"
      id="f-5166"
      unitRef="number">0.078</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1283"
      decimals="4"
      id="f-5167"
      unitRef="number">0.077</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1284"
      decimals="4"
      id="f-5168"
      unitRef="number">0.005</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1285"
      decimals="4"
      id="f-5169"
      unitRef="number">0.004</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1286"
      decimals="4"
      id="f-5170"
      unitRef="number">0.002</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1287"
      decimals="4"
      id="f-5171"
      unitRef="number">0.002</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1288"
      decimals="4"
      id="f-5172"
      unitRef="number">0.057</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1289"
      decimals="4"
      id="f-5173"
      unitRef="number">0.051</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1290"
      decimals="4"
      id="f-5174"
      unitRef="number">0.039</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1291"
      decimals="4"
      id="f-5175"
      unitRef="number">0.035</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1292"
      decimals="4"
      id="f-5176"
      unitRef="number">0.014</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1293"
      decimals="4"
      id="f-5177"
      unitRef="number">0.014</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1294"
      decimals="4"
      id="f-5178"
      unitRef="number">0.014</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1295"
      decimals="4"
      id="f-5179"
      unitRef="number">0.011</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1296"
      decimals="4"
      id="f-5180"
      unitRef="number">0.011</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1297"
      decimals="4"
      id="f-5181"
      unitRef="number">0.017</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1298"
      decimals="4"
      id="f-5182"
      unitRef="number">0.013</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1299"
      decimals="4"
      id="f-5183"
      unitRef="number">0.011</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1300"
      decimals="4"
      id="f-5184"
      unitRef="number">0.006</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1301"
      decimals="4"
      id="f-5185"
      unitRef="number">0.003</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1302"
      decimals="4"
      id="f-5186"
      unitRef="number">0.004</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1303"
      decimals="4"
      id="f-5187"
      unitRef="number">0.006</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1304"
      decimals="4"
      id="f-5188"
      unitRef="number">0.002</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1305"
      decimals="4"
      id="f-5189"
      unitRef="number">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1306"
      decimals="4"
      id="f-5190"
      unitRef="number">0.006</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1307"
      decimals="4"
      id="f-5191"
      unitRef="number">0.006</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1308"
      decimals="4"
      id="f-5192"
      unitRef="number">0.107</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1309"
      decimals="4"
      id="f-5193"
      unitRef="number">0.117</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1310"
      decimals="4"
      id="f-5194"
      unitRef="number">0.051</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1311"
      decimals="4"
      id="f-5195"
      unitRef="number">0.039</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1312"
      decimals="4"
      id="f-5196"
      unitRef="number">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1313"
      decimals="4"
      id="f-5197"
      unitRef="number">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1314"
      decimals="4"
      id="f-5198"
      unitRef="number">0.054</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1315"
      decimals="4"
      id="f-5199"
      unitRef="number">0.081</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1316"
      decimals="4"
      id="f-5200"
      unitRef="number">0.032</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1317"
      decimals="4"
      id="f-5201"
      unitRef="number">0.033</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1318"
      decimals="4"
      id="f-5202"
      unitRef="number">0.029</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1319"
      decimals="4"
      id="f-5203"
      unitRef="number">0.028</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1320"
      decimals="4"
      id="f-5204"
      unitRef="number">0.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1321"
      decimals="4"
      id="f-5205"
      unitRef="number">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1322"
      decimals="4"
      id="f-5206"
      unitRef="number">0.003</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1323"
      decimals="4"
      id="f-5207"
      unitRef="number">0.003</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1324"
      decimals="4"
      id="f-5208"
      unitRef="number">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1325"
      decimals="4"
      id="f-5209"
      unitRef="number">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1326"
      decimals="4"
      id="f-5210"
      unitRef="number">0.010</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1327"
      decimals="4"
      id="f-5211"
      unitRef="number">0.012</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1328"
      decimals="4"
      id="f-5212"
      unitRef="number">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1329"
      decimals="4"
      id="f-5213"
      unitRef="number">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1330"
      decimals="4"
      id="f-5214"
      unitRef="number">0.002</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1331"
      decimals="4"
      id="f-5215"
      unitRef="number">0.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1332"
      decimals="4"
      id="f-5216"
      unitRef="number">0.078</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1333"
      decimals="4"
      id="f-5217"
      unitRef="number">0.088</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1334"
      decimals="4"
      id="f-5218"
      unitRef="number">0.009</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1335"
      decimals="4"
      id="f-5219"
      unitRef="number">0.007</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1336"
      decimals="4"
      id="f-5220"
      unitRef="number">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1337"
      decimals="4"
      id="f-5221"
      unitRef="number">0.002</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1338"
      decimals="4"
      id="f-5222"
      unitRef="number">0.174</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1339"
      decimals="4"
      id="f-5223"
      unitRef="number">0.147</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1340"
      decimals="4"
      id="f-5224"
      unitRef="number">0.017</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1341"
      decimals="4"
      id="f-5225"
      unitRef="number">0.018</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1342"
      decimals="4"
      id="f-5226"
      unitRef="number">0.008</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1343"
      decimals="4"
      id="f-5227"
      unitRef="number">0.007</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1344"
      decimals="4"
      id="f-5228"
      unitRef="number">0.005</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1345"
      decimals="4"
      id="f-5229"
      unitRef="number">0.010</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1346"
      decimals="4"
      id="f-5230"
      unitRef="number">0.040</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1347"
      decimals="4"
      id="f-5231"
      unitRef="number">0.036</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1272"
      decimals="INF"
      id="f-5232"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1273"
      decimals="INF"
      id="f-5233"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1348" decimals="-3" id="f-5234" unitRef="usd">9381707000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1348" decimals="-3" id="f-5235" unitRef="usd">9317684000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1349"
      decimals="4"
      id="f-5236"
      unitRef="number">0.944</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1348"
      decimals="4"
      id="f-5237"
      unitRef="number">1.882</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1350" decimals="-3" id="f-5238" unitRef="usd">275579000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1350" decimals="-3" id="f-5239" unitRef="usd">278103000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1351"
      decimals="4"
      id="f-5240"
      unitRef="number">0.028</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1350"
      decimals="4"
      id="f-5241"
      unitRef="number">0.056</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1352" decimals="-3" id="f-5242" unitRef="usd">436000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1352" decimals="-3" id="f-5243" unitRef="usd">473000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1353"
      decimals="4"
      id="f-5244"
      unitRef="number">0.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1352"
      decimals="4"
      id="f-5245"
      unitRef="number">0.000</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1354" decimals="-3" id="f-5246" unitRef="usd">276437000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1354" decimals="-3" id="f-5247" unitRef="usd">272180000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1355"
      decimals="4"
      id="f-5248"
      unitRef="number">0.028</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1354"
      decimals="4"
      id="f-5249"
      unitRef="number">0.055</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-5" decimals="-3" id="f-5250" unitRef="usd">9934159000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-5" decimals="-3" id="f-5251" unitRef="usd">9868440000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1272"
      decimals="INF"
      id="f-5252"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-5" decimals="4" id="f-5253" unitRef="number">1.993</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1356" decimals="-3" id="f-5254" unitRef="usd">8934926000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1356" decimals="-3" id="f-5255" unitRef="usd">8893051000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1357"
      decimals="4"
      id="f-5256"
      unitRef="number">0.925</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1356"
      decimals="4"
      id="f-5257"
      unitRef="number">2.138</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1358" decimals="-3" id="f-5258" unitRef="usd">510599000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1358" decimals="-3" id="f-5259" unitRef="usd">520368000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1359"
      decimals="4"
      id="f-5260"
      unitRef="number">0.054</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1358"
      decimals="4"
      id="f-5261"
      unitRef="number">0.125</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-1360" decimals="-3" id="f-5262" unitRef="usd">212347000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1360" decimals="-3" id="f-5263" unitRef="usd">203829000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1361"
      decimals="4"
      id="f-5264"
      unitRef="number">0.021</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c-1360"
      decimals="4"
      id="f-5265"
      unitRef="number">0.049</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedAtCost contextRef="c-6" decimals="-3" id="f-5266" unitRef="usd">9657872000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-6" decimals="-3" id="f-5267" unitRef="usd">9617248000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1273"
      decimals="INF"
      id="f-5268"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c-6" decimals="4" id="f-5269" unitRef="number">2.312</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <bxsl:InvestmentOwnedNonaccrualNumberOfLoans contextRef="c-5" decimals="INF" id="f-5270" unitRef="loan">1000000</bxsl:InvestmentOwnedNonaccrualNumberOfLoans>
    <bxsl:InvestmentOwnedNonaccrualNumberOfLoans contextRef="c-6" decimals="INF" id="f-5271" unitRef="loan">0</bxsl:InvestmentOwnedNonaccrualNumberOfLoans>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1362"
      decimals="4"
      id="f-5272"
      unitRef="number">0.999</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1363"
      decimals="4"
      id="f-5273"
      unitRef="number">0.999</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1364"
      decimals="4"
      id="f-5274"
      unitRef="number">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-1365"
      decimals="4"
      id="f-5275"
      unitRef="number">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-5276">Fair Value Measurements&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair value hierarchy of financial instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First lien debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,564,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,722,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second lien debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unsecured debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,710,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,868,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First lien debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,419,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second lien debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,472,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,617,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents changes in the fair value of financial instruments for which Level 3 inputs were used to determine the fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;First Lien Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Second Lien Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unsecured Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,472,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,492,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,508,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from principal repayments and sales of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,114,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,187,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of discount/amortization of premium&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized appreciation (depreciation)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,564,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,710,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments still held as of December&#160;31, 2023 included in change in net unrealized appreciation (depreciation) on the Consolidated Statements of Operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;First&#160;Lien&#160;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Second Lien Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,288,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,501,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from principal repayments and sales of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(980,395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,042,362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of discount/amortization of premium&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized appreciation (depreciation)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118,465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,472,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments still held as of December&#160;31, 2022 included in net change in unrealized appreciation (depreciation) on the Consolidated Statements of Operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;For the years ended December&#160;31, 2023 and 2022, transfers into or out of Level 3 were primarily due to decreased or increased price transparency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents quantitative information about the significant unobservable inputs of the Company&#x2019;s Level 3 financial instruments. The table is not intended to be all-inclusive but instead captures the significant unobservable inputs relevant to the Company&#x2019;s determination of fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.514%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Low&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;High&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in first lien debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,533,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield Analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset Recoverability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market Multiple&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.50x&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,564,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in second lien debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield Analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in unsecured debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield Analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market Approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance Multiple&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.40x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.00x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.47x&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Option Pricing Model &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield Analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,710,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.514%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Low&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;High&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in first lien debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,037,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market quotations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Broker quoted price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in second lien debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance multiple&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.00x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.41x&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Option pricing model&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,472,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Weighted averages are calculated based on fair value of investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant unobservable input used in the yield analysis is the discount rate based on comparable market yields. The significant unobservable input used for market quotations are broker quoted prices provided by independent pricing services. The significant unobservable input used under the market approach is the Performance Multiple. Significant increases in discount rates would result in a significantly lower fair value measurement. Significant decreases in quoted prices or Performance Multiples would result in a significantly lower fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments Not Carried at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s SPV Financing Facilities (as defined in Note 6) and Revolving Credit Facility (as defined in Note 6), as of December&#160;31, 2023 and December&#160;31, 2022, approximates their carrying value as the credit facilities have variable interest based on selected short term rates. These financial instruments would be categorized as Level 3 within the hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair value measurements of the Company's Unsecured Notes (as defined in Note 6) had they been accounted for at fair value. These financial instruments would be categorized as Level 3 as of December&#160;31, 2023 and as Level 2 as of December&#160;31, 2022 within the hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.514%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.229%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,551,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,825,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/div&gt;The carrying amounts of the Company&#x2019;s other assets and liabilities approximate fair value. These financial instruments are categorized as Level 3 within the hierarchy.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-5277">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair value hierarchy of financial instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First lien debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,564,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,722,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second lien debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unsecured debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,710,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,868,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First lien debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,419,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second lien debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,472,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,617,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1366" decimals="-3" id="f-5278" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1367" decimals="-3" id="f-5279" unitRef="usd">157858000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1368" decimals="-3" id="f-5280" unitRef="usd">9564203000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1369" decimals="-3" id="f-5281" unitRef="usd">9722061000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1370" decimals="-3" id="f-5282" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1371" decimals="-3" id="f-5283" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1372" decimals="-3" id="f-5284" unitRef="usd">41515000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1373" decimals="-3" id="f-5285" unitRef="usd">41515000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1374" decimals="-3" id="f-5286" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1375" decimals="-3" id="f-5287" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1376" decimals="-3" id="f-5288" unitRef="usd">9924000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1377" decimals="-3" id="f-5289" unitRef="usd">9924000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1378" decimals="-3" id="f-5290" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1379" decimals="-3" id="f-5291" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1380" decimals="-3" id="f-5292" unitRef="usd">94940000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1381" decimals="-3" id="f-5293" unitRef="usd">94940000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1382" decimals="-3" id="f-5294" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1383" decimals="-3" id="f-5295" unitRef="usd">157858000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1384" decimals="-3" id="f-5296" unitRef="usd">9710582000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-5297" unitRef="usd">9868440000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1385" decimals="-3" id="f-5298" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1386" decimals="-3" id="f-5299" unitRef="usd">144452000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1387" decimals="-3" id="f-5300" unitRef="usd">9275511000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1388" decimals="-3" id="f-5301" unitRef="usd">9419963000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1389" decimals="-3" id="f-5302" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1390" decimals="-3" id="f-5303" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1391" decimals="-3" id="f-5304" unitRef="usd">46336000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1392" decimals="-3" id="f-5305" unitRef="usd">46336000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1393" decimals="-3" id="f-5306" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1394" decimals="-3" id="f-5307" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1395" decimals="-3" id="f-5308" unitRef="usd">150949000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1396" decimals="-3" id="f-5309" unitRef="usd">150949000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1397" decimals="-3" id="f-5310" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1398" decimals="-3" id="f-5311" unitRef="usd">144452000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-1399" decimals="-3" id="f-5312" unitRef="usd">9472796000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-6" decimals="-3" id="f-5313" unitRef="usd">9617248000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-5314">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents changes in the fair value of financial instruments for which Level 3 inputs were used to determine the fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.549%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;First Lien Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Second Lien Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unsecured Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,472,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,492,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,508,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from principal repayments and sales of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,114,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,187,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of discount/amortization of premium&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized appreciation (depreciation)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,564,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,710,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments still held as of December&#160;31, 2023 included in change in net unrealized appreciation (depreciation) on the Consolidated Statements of Operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;First&#160;Lien&#160;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Second Lien Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,288,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,501,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from principal repayments and sales of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(980,395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,042,362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of discount/amortization of premium&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized appreciation (depreciation)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118,465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,472,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized appreciation (depreciation) included in earnings related to financial instruments still held as of December&#160;31, 2022 included in net change in unrealized appreciation (depreciation) on the Consolidated Statements of Operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;For the years ended December&#160;31, 2023 and 2022, transfers into or out of Level 3 were primarily due to decreased or increased price transparency.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1400" decimals="-3" id="f-5315" unitRef="usd">9275511000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1401" decimals="-3" id="f-5316" unitRef="usd">46336000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1402" decimals="-3" id="f-5317" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1403" decimals="-3" id="f-5318" unitRef="usd">150949000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1404" decimals="-3" id="f-5319" unitRef="usd">9472796000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases contextRef="c-1405" decimals="-3" id="f-5320" unitRef="usd">1492985000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases contextRef="c-1406" decimals="-3" id="f-5321" unitRef="usd">1935000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases contextRef="c-1407" decimals="-3" id="f-5322" unitRef="usd">9924000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases contextRef="c-1408" decimals="-3" id="f-5323" unitRef="usd">3915000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases contextRef="c-1409" decimals="-3" id="f-5324" unitRef="usd">1508759000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales contextRef="c-1405" decimals="-3" id="f-5325" unitRef="usd">1114974000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales contextRef="c-1406" decimals="-3" id="f-5326" unitRef="usd">7351000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales contextRef="c-1407" decimals="-3" id="f-5327" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales contextRef="c-1408" decimals="-3" id="f-5328" unitRef="usd">65465000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales contextRef="c-1409" decimals="-3" id="f-5329" unitRef="usd">1187790000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium contextRef="c-1405" decimals="-3" id="f-5330" unitRef="usd">50516000</bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium>
    <bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium contextRef="c-1406" decimals="-3" id="f-5331" unitRef="usd">58000</bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium>
    <bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium contextRef="c-1407" decimals="-3" id="f-5332" unitRef="usd">6000</bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium>
    <bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium contextRef="c-1408" decimals="-3" id="f-5333" unitRef="usd">0</bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium>
    <bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium contextRef="c-1409" decimals="-3" id="f-5334" unitRef="usd">50580000</bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1410" decimals="-3" id="f-5335" unitRef="usd">-15095000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1411" decimals="-3" id="f-5336" unitRef="usd">-49000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1412" decimals="-3" id="f-5337" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1413" decimals="-3" id="f-5338" unitRef="usd">13482000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1414" decimals="-3" id="f-5339" unitRef="usd">-1662000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1415" decimals="-3" id="f-5340" unitRef="usd">-37739000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1416" decimals="-3" id="f-5341" unitRef="usd">586000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1417" decimals="-3" id="f-5342" unitRef="usd">-6000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1418" decimals="-3" id="f-5343" unitRef="usd">-7941000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1419" decimals="-3" id="f-5344" unitRef="usd">-45100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 contextRef="c-1405" decimals="-3" id="f-5345" unitRef="usd">4938000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 contextRef="c-1406" decimals="-3" id="f-5346" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 contextRef="c-1407" decimals="-3" id="f-5347" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 contextRef="c-1408" decimals="-3" id="f-5348" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 contextRef="c-1409" decimals="-3" id="f-5349" unitRef="usd">4938000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 contextRef="c-1405" decimals="-3" id="f-5350" unitRef="usd">91939000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 contextRef="c-1406" decimals="-3" id="f-5351" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 contextRef="c-1407" decimals="-3" id="f-5352" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 contextRef="c-1408" decimals="-3" id="f-5353" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 contextRef="c-1409" decimals="-3" id="f-5354" unitRef="usd">91939000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1420" decimals="-3" id="f-5355" unitRef="usd">9564203000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1421" decimals="-3" id="f-5356" unitRef="usd">41515000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1422" decimals="-3" id="f-5357" unitRef="usd">9924000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1423" decimals="-3" id="f-5358" unitRef="usd">94940000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1424" decimals="-3" id="f-5359" unitRef="usd">9710582000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss contextRef="c-1405" decimals="-3" id="f-5360" unitRef="usd">-38013000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss contextRef="c-1406" decimals="-3" id="f-5361" unitRef="usd">374000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss contextRef="c-1407" decimals="-3" id="f-5362" unitRef="usd">-6000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss contextRef="c-1408" decimals="-3" id="f-5363" unitRef="usd">-6437000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss contextRef="c-1409" decimals="-3" id="f-5364" unitRef="usd">-44082000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1425" decimals="-3" id="f-5365" unitRef="usd">9288184000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1426" decimals="-3" id="f-5366" unitRef="usd">42880000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1427" decimals="-3" id="f-5367" unitRef="usd">170265000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1428" decimals="-3" id="f-5368" unitRef="usd">9501329000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases contextRef="c-1429" decimals="-3" id="f-5369" unitRef="usd">934505000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases contextRef="c-1430" decimals="-3" id="f-5370" unitRef="usd">5949000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases contextRef="c-1431" decimals="-3" id="f-5371" unitRef="usd">12400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases contextRef="c-1432" decimals="-3" id="f-5372" unitRef="usd">952854000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales contextRef="c-1429" decimals="-3" id="f-5373" unitRef="usd">980395000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales contextRef="c-1430" decimals="-3" id="f-5374" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales contextRef="c-1431" decimals="-3" id="f-5375" unitRef="usd">61967000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales contextRef="c-1432" decimals="-3" id="f-5376" unitRef="usd">1042362000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium contextRef="c-1429" decimals="-3" id="f-5377" unitRef="usd">45133000</bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium>
    <bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium contextRef="c-1430" decimals="-3" id="f-5378" unitRef="usd">137000</bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium>
    <bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium contextRef="c-1431" decimals="-3" id="f-5379" unitRef="usd">0</bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium>
    <bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium contextRef="c-1432" decimals="-3" id="f-5380" unitRef="usd">45270000</bxsl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAmortizationOfPremium>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1433" decimals="-3" id="f-5381" unitRef="usd">-2125000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1434" decimals="-3" id="f-5382" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1435" decimals="-3" id="f-5383" unitRef="usd">41486000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1436" decimals="-3" id="f-5384" unitRef="usd">39361000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1437" decimals="-3" id="f-5385" unitRef="usd">-118465000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1438" decimals="-3" id="f-5386" unitRef="usd">-2630000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1439" decimals="-3" id="f-5387" unitRef="usd">-11235000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-1440" decimals="-3" id="f-5388" unitRef="usd">-132330000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 contextRef="c-1429" decimals="-3" id="f-5389" unitRef="usd">108674000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 contextRef="c-1430" decimals="-3" id="f-5390" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 contextRef="c-1431" decimals="-3" id="f-5391" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 contextRef="c-1432" decimals="-3" id="f-5392" unitRef="usd">108674000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 contextRef="c-1429" decimals="-3" id="f-5393" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 contextRef="c-1430" decimals="-3" id="f-5394" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 contextRef="c-1431" decimals="-3" id="f-5395" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 contextRef="c-1432" decimals="-3" id="f-5396" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1400" decimals="-3" id="f-5397" unitRef="usd">9275511000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1401" decimals="-3" id="f-5398" unitRef="usd">46336000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1403" decimals="-3" id="f-5399" unitRef="usd">150949000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-1404" decimals="-3" id="f-5400" unitRef="usd">9472796000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss contextRef="c-1429" decimals="-3" id="f-5401" unitRef="usd">-119180000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss contextRef="c-1430" decimals="-3" id="f-5402" unitRef="usd">-2629000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss contextRef="c-1431" decimals="-3" id="f-5403" unitRef="usd">24528000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss contextRef="c-1432" decimals="-3" id="f-5404" unitRef="usd">-97281000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c-1" id="f-5405">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents quantitative information about the significant unobservable inputs of the Company&#x2019;s Level 3 financial instruments. The table is not intended to be all-inclusive but instead captures the significant unobservable inputs relevant to the Company&#x2019;s determination of fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.514%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Low&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;High&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in first lien debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,533,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield Analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset Recoverability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market Multiple&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.50x&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,564,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in second lien debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield Analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in unsecured debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield Analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market Approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance Multiple&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.40x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.00x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.47x&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Option Pricing Model &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield Analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,710,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.514%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Low&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;High&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in first lien debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,037,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market quotations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Broker quoted price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in second lien debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance multiple&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.00x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.41x&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Option pricing model&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yield analysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,472,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Weighted averages are calculated based on fair value of investments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1441" decimals="-3" id="f-5406" unitRef="usd">9533700000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1442"
      decimals="4"
      id="f-5407"
      unitRef="number">0.0768</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1443"
      decimals="4"
      id="f-5408"
      unitRef="number">0.3089</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1444"
      decimals="4"
      id="f-5409"
      unitRef="number">0.1031</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1445" decimals="-3" id="f-5410" unitRef="usd">30503000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1446"
      decimals="2"
      id="f-5411"
      unitRef="number">10.5</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1447"
      decimals="2"
      id="f-5412"
      unitRef="number">10.5</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1448"
      decimals="2"
      id="f-5413"
      unitRef="number">10.5</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1368" decimals="-3" id="f-5414" unitRef="usd">9564203000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1449" decimals="-3" id="f-5415" unitRef="usd">41515000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1450"
      decimals="4"
      id="f-5416"
      unitRef="number">0.1018</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1451"
      decimals="4"
      id="f-5417"
      unitRef="number">0.1438</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1452"
      decimals="4"
      id="f-5418"
      unitRef="number">0.1269</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1453" decimals="-3" id="f-5419" unitRef="usd">9924000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1454"
      decimals="4"
      id="f-5420"
      unitRef="number">14.9</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1455"
      decimals="4"
      id="f-5421"
      unitRef="number">14.9</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1456"
      decimals="4"
      id="f-5422"
      unitRef="number">14.9</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1457" decimals="-3" id="f-5423" unitRef="usd">60007000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1458"
      decimals="2"
      id="f-5424"
      unitRef="number">6.4</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1459"
      decimals="2"
      id="f-5425"
      unitRef="number">30</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1460"
      decimals="2"
      id="f-5426"
      unitRef="number">11.47</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1461" decimals="-3" id="f-5427" unitRef="usd">28531000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1462"
      decimals="4"
      id="f-5428"
      unitRef="number">0.3200</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1463"
      decimals="4"
      id="f-5429"
      unitRef="number">0.5500</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1464"
      decimals="4"
      id="f-5430"
      unitRef="number">0.4286</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1465" decimals="-3" id="f-5431" unitRef="usd">6402000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1466"
      decimals="4"
      id="f-5432"
      unitRef="number">0.1075</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1467"
      decimals="4"
      id="f-5433"
      unitRef="number">0.1792</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1468"
      decimals="4"
      id="f-5434"
      unitRef="number">0.1417</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1380" decimals="-3" id="f-5435" unitRef="usd">94940000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1384" decimals="-3" id="f-5436" unitRef="usd">9710582000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1469" decimals="-3" id="f-5437" unitRef="usd">9037133000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1470"
      decimals="4"
      id="f-5438"
      unitRef="number">0.0683</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1471"
      decimals="4"
      id="f-5439"
      unitRef="number">0.1984</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1472"
      decimals="4"
      id="f-5440"
      unitRef="number">0.1013</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1473" decimals="-3" id="f-5441" unitRef="usd">238378000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1474"
      decimals="4"
      id="f-5442"
      unitRef="number">82.00</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1475"
      decimals="4"
      id="f-5443"
      unitRef="number">96.75</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1476"
      decimals="4"
      id="f-5444"
      unitRef="number">94.19</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1387" decimals="-3" id="f-5445" unitRef="usd">9275511000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1477" decimals="-3" id="f-5446" unitRef="usd">46336000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1478"
      decimals="4"
      id="f-5447"
      unitRef="number">0.1043</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1479"
      decimals="4"
      id="f-5448"
      unitRef="number">0.1425</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1480"
      decimals="4"
      id="f-5449"
      unitRef="number">0.1260</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1481" decimals="-3" id="f-5450" unitRef="usd">105782000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1482"
      decimals="2"
      id="f-5451"
      unitRef="number">5.5</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1483"
      decimals="2"
      id="f-5452"
      unitRef="number">29</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1484"
      decimals="2"
      id="f-5453"
      unitRef="number">13.41</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1485" decimals="-3" id="f-5454" unitRef="usd">22481000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1486"
      decimals="4"
      id="f-5455"
      unitRef="number">0.3000</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1487"
      decimals="4"
      id="f-5456"
      unitRef="number">0.5000</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1488"
      decimals="4"
      id="f-5457"
      unitRef="number">0.4346</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1489" decimals="-3" id="f-5458" unitRef="usd">22686000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1490"
      decimals="4"
      id="f-5459"
      unitRef="number">0.1131</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1491"
      decimals="4"
      id="f-5460"
      unitRef="number">0.1375</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
      contextRef="c-1492"
      decimals="4"
      id="f-5461"
      unitRef="number">0.1274</us-gaap:InvestmentCompanyInvestmentOwnedFairValueMeasurementInput>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1395" decimals="-3" id="f-5462" unitRef="usd">150949000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c-1399" decimals="-3" id="f-5463" unitRef="usd">9472796000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-5464">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant unobservable input used in the yield analysis is the discount rate based on comparable market yields. The significant unobservable input used for market quotations are broker quoted prices provided by independent pricing services. The significant unobservable input used under the market approach is the Performance Multiple. Significant increases in discount rates would result in a significantly lower fair value measurement. Significant decreases in quoted prices or Performance Multiples would result in a significantly lower fair value measurement.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock contextRef="c-1" id="f-5465">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair value measurements of the Company's Unsecured Notes (as defined in Note 6) had they been accounted for at fair value. These financial instruments would be categorized as Level 3 as of December&#160;31, 2023 and as Level 2 as of December&#160;31, 2022 within the hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.514%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.229%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,551,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,825,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:LongTermDebtFairValue contextRef="c-1493" decimals="-3" id="f-5466" unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-1494" decimals="-3" id="f-5467" unitRef="usd">397481000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-1495" decimals="-3" id="f-5468" unitRef="usd">763085000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-1496" decimals="-3" id="f-5469" unitRef="usd">740171000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-1497" decimals="-3" id="f-5470" unitRef="usd">643814000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-1498" decimals="-3" id="f-5471" unitRef="usd">619144000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-1499" decimals="-3" id="f-5472" unitRef="usd">583633000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-1500" decimals="-3" id="f-5473" unitRef="usd">546117000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-1501" decimals="-3" id="f-5474" unitRef="usd">561129000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-1502" decimals="-3" id="f-5475" unitRef="usd">522809000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-1503" decimals="-3" id="f-5476" unitRef="usd">2551661000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-1504" decimals="-3" id="f-5477" unitRef="usd">2825722000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-5478">Borrowings&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the 1940 Act, with certain limitations, the Company is allowed to borrow amounts such that its asset coverage, as defined in the 1940 Act, is at least 150% after such borrowing. As of December&#160;31, 2023 and December&#160;31, 2022, the Company&#x2019;s asset coverage was 200.3% and 174.8%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;SPV Financing Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following wholly-owned subsidiaries of the Company have entered into secured financing facilities, as described below: Jackson Hole Funding, Breckenridge Funding and Big Sky Funding which are collectively referred to as the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;SPVs&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and such secured financing facilities described below are collectively referred to as the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;SPV Financing Facilities&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The obligations of each SPV to the lenders under the applicable SPV Financing Facility are secured by a first priority security interest in all of the applicable SPV&#x2019;s portfolio investments and cash. The obligations of each SPV under the applicable SPV Financing Facility are non-recourse to the Company, and the Company&#x2019;s exposure to the credit facility is limited to the value of its investment in the applicable SPV.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the SPV Financing Facilities, the applicable SPV has made certain customary representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar facilities. Each SPV Financing Facility contains customary events of default for similar financing transactions, including if a change of control of the applicable SPV occurs. Upon the occurrence and during the continuation of an event of default, the lenders under the applicable SPV Financing Facility may declare the outstanding advances and all other obligations under the applicable SPV Financing Facility immediately due and payable. The occurrence of an event of default triggers a requirement that the applicable SPV obtain the consent of the lenders under the applicable SPV Financing Facility prior to entering into any sale or disposition with respect to portfolio investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and December&#160;31, 2022, the Company was in compliance with all covenants and other requirements of each of the SPV Financing Facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jackson Hole Funding Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On November 16, 2018, Jackson Hole Funding, the Company&#x2019;s wholly-owned subsidiary that holds primarily originated loan investments, entered into a senior secured revolving credit facility (which was subsequently amended and restated on December 16, 2021, and amended effective as of September 16, 2022, November 15, 2023 and December 18, 2023, and as further amended from time to time, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;&#x201c;Jackson Hole Funding Facility&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;) with JPMorgan Chase Bank, National Association (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;&#x201c;JPM&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;). JPM serves as administrative agent, Citibank, N.A., serves as collateral agent and securities intermediary, Virtus Group, LP serves as collateral administrator and the Company serves as portfolio manager under the Jackson Hole Funding Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advances under the Jackson Hole Funding Facility bear interest at a per annum rate equal to the benchmark in effect for the currency of the applicable advances (which is the three-month Term SOFR for dollar advances), plus the applicable margin of 2.375% per annum for certain foreign currency advances to 2.525% per annum for dollar advances. Jackson Hole Funding pays a commitment fee of 0.48% per annum on the average daily unused amount of the financing commitments until November 28, 2025. Jackson Hole Funding also pays to JPM an administrative agency fee, in addition to certain other fees, each as agreed between Jackson Hole Funding and JPM.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maximum commitment amount of the Jackson Hole Funding Facility as of December&#160;31, 2023 was $500.0 million. The Jackson Hole Funding Facility has an accordion feature, subject to the satisfaction of various conditions, which could bring total commitments under the Jackson Hole Funding Facility to up to $900.0 million. Proceeds from borrowings under the Jackson Hole Funding Facility may be used to fund portfolio investments by Jackson Hole Funding and to make advances under delayed draw term loans where Jackson Hole Funding is a lender. The period during which Jackson Hole Funding may make borrowings under the Jackson Hole Funding Facility expires on November 28, 2025 and the Jackson Hole Funding Facility is scheduled to mature on May 17, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breckenridge Funding Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 21, 2018, Breckenridge Funding, the Company&#x2019;s wholly-owned subsidiary that holds primarily syndicated loan investments, entered into a senior secured revolving credit facility (which was subsequently amended on June 11, 2019, August 2, 2019, September 27, 2019, April 13, 2020, October 5, 2021, February 28, 2022, May 19, 2022, November 1, 2023 and January 17, 2024, and as further amended from time to time, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;Breckenridge Funding Facility&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;) with BNP Paribas (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;BNP&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;). BNP serves as administrative agent, Wells Fargo Bank, National Association (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;Wells Fargo&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;) serves as collateral agent and the Company serves as servicer under the Breckenridge Funding Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Advances under the Breckenridge Funding Facility bear interest at a per annum rate equal to the three-month Term SOFR (or other base rate) in effect, plus an applicable margin of 1.70%, 2.05% or 2.30% per annum, as applicable, depending on the nature of the advances being requested under the facility. Breckenridge Funding pays a commitment fee of 0.70% per annum if the unused facility amount is greater than 50% or 0.35% per annum if the unused facility amount is less than or equal to 50% and greater than 25%, based on the average daily unused amount of the financing commitments until December 21, 2024, in addition to certain other fees as agreed between Breckenridge Funding and BNP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proceeds from borrowings under the Breckenridge Funding Facility may be used to fund portfolio investments by Breckenridge Funding and to make advances under delayed draw and revolving loans where Breckenridge Funding is a lender. The period during which Breckenridge Funding may make borrowings under the Breckenridge Funding Facility for the remaining commitment amounts expires on December 21, 2024 and the Breckenridge Funding Facility is scheduled to mature on December 21, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Big Sky Funding Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 10, 2019, Big Sky Funding, the Company&#x2019;s wholly-owned subsidiary, entered into a senior secured revolving credit facility (which was subsequently amended on December 30, 2020 and September 30, 2021 and amended and restated on June 29, 2022, and amended on March 30, 2023 and as further amended from time to time, the (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;Big Sky Funding Facility&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;) with Bank of America, N.A. (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;Bank of America&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;). Bank of America serves as administrative agent, Wells Fargo serves as collateral administrator and the Company serves as manager under the Big Sky Funding Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Advances under the Big Sky Funding Facility bear interest at a per annum rate equal to the one-month Term SOFR in effect, plus the applicable margin of (a) until September 25, 2024, 1.80% per annum, and (b) from and after September 25, 2024, a range between 2.10% and 2.45% per annum depending on the nature of the collateral securing the advances. Big Sky Funding is required to utilize a minimum percentage of 80% of the financing commitments. Unused amounts below such minimum utilization amount accrue a fee at a rate of 1.60% per annum. In addition, Big Sky Funding pays an unused fee of 0.45% per annum on the daily unused amount of the financing commitments in excess of the minimum utilization amount, commencing three months after the closing date of the Big Sky Funding Facility.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proceeds from borrowings under the Big Sky Funding Facility may be used to fund portfolio investments by Big Sky Funding and to make advances under revolving loans or delayed draw term loans where Big Sky Funding is a lender. The period during which Big Sky Funding may make borrowings under the Big Sky Funding Facility expires on March 30, 2026 and the Big Sky Funding Facility is scheduled to mature on September 30, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline"&gt;Revolving Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On June 15, 2020, the Company entered into a senior secured revolving credit facility (which was most recently amended on June 9, 2023 and as further amended from time to time, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;Revolving Credit Facility&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;) with Citibank, N.A. (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;&#x201c;Citi&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;) serving as administrative agent and collateral agent.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Credit Facility provides for borrowings in U.S. dollars and certain agreed upon foreign currencies. Borrowings under the Revolving Credit Facility are subject to compliance with a borrowing base. A portion of the Revolving Credit Facility consists of funded term loans in the aggregate principal amount of $385.0 million and the Revolving Credit Facility provides for the issuance of letters of credit on behalf of the Company in an aggregate face amount not to exceed $175.0 million. Proceeds from the borrowings under the Revolving Credit Facility may be used for general corporate purposes of the Company and its subsidiaries in the ordinary course of business. Availability of the revolver under the Revolving Credit Facility will terminate on June 28, 2027 (other than with respect to the foreign currency commitments of certain lenders in the amount of $200.0 million, which expire on June 28, 2026) and all amounts outstanding under the Revolving Credit Facility must be repaid by June 28, 2028 (other than with respect to the foreign currency commitments of certain lenders in the amount of $200.0 million which mature on June 28, 2027) pursuant to an amortization schedule.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loans under the Revolving Credit Facility bear interest at a per annum rate equal to, (x) for loans for which the Company elects the base rate option, the &#x201c;alternate base rate&#x201d; (which is the greatest of (a) the prime rate as publicly announced by Citi, (b) the sum of (i) the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System plus (ii) 0.5% and (c) one month adjusted Term SOFR plus 1% per annum) plus (A) if the gross borrowing base is equal to or greater than 1.6 times the combined revolving debt amount, 0.75%, or (B) if the gross borrowing base is less than 1.6 times the combined revolving debt amount, 0.875%, and (y) for all other loans, the applicable benchmark rate for the related interest period for such borrowing plus (A) if the gross borrowing base is equal to or greater than 1.6 times the combined revolving debt amount, 1.75%, or (B) if the gross borrowing base is less than 1.6 times the combined revolving debt amount, 1.875%. The Company will pay an unused fee of 0.375% per annum on the daily unused amount of the revolver commitments. The Company will pay letter of credit participation fees and a fronting fee on the average daily amount of any lender&#x2019;s exposure with respect to any letters of credit issued under the Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s obligations to the lenders under the Revolving Credit Facility are secured by a first priority security interest in substantially all of the Company&#x2019;s assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Revolving Credit Facility, the Company has made certain customary representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar facilities. In addition, the Company must comply with the following financial covenants: (a) the Company must maintain a minimum shareholders&#x2019; equity, measured as of each fiscal quarter end; and (b) the Company must maintain at all times a 150% asset coverage ratio.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Credit Facility contains customary events of default for similar financing transactions. Upon the occurrence and during the continuation of an event of default, Citi may terminate the commitments and declare the outstanding advances and all other obligations under the Revolving Credit Facility immediately due and payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and December&#160;31, 2022, the Company was in compliance with all covenants and other requirements of the Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Unsecured Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued unsecured notes, as further described below: 2023 Notes, 2026 Notes, New 2026 Notes, 2027 Notes and 2028 Notes (each as defined below) which are collectively referred to herein as the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Unsecured Notes&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Unsecured Notes contain certain covenants, including covenants requiring the Company to comply with the asset coverage requirements of Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the 1940 Act, whether or not it is subject to those requirements, and to provide financial information to the holders of the Unsecured Notes and the Trustee (as defined below) if the Company is no longer subject to the reporting requirements under the Exchange Act. These covenants are subject to important limitations and exceptions that are described in each respective indenture governing the Unsecured Notes (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Unsecured Notes Indentures&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, on the occurrence of a &#x201c;change of control repurchase event,&#x201d; as defined in each respective Unsecured Notes Indenture, the Company will generally be required to make an offer to purchase the outstanding Unsecured Notes at a price equal to 100% of the principal amount of such Unsecured Notes plus accrued and unpaid interest to the repurchase date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and December&#160;31, 2022, the Company was in compliance with all covenants and other requirements of each of the Unsecured Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 15, 2020, the Company issued $400.0 million aggregate principal amount of 3.650% notes due July 14, 2023 (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;2023 Notes&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) pursuant to an indenture (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Base Indenture&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and a supplemental indenture, each dated as of July 15, 2020 (and together with the Base Indenture, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;2023 Notes Indenture&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), between the Company and U.S. Bank National Association (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Trustee&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2023 Notes bore interest at a rate of 3.650% per year payable semi-annually on January 14 and July 14 of each year, which commenced on January 14, 2021. The 2023 Notes were general unsecured obligations of the Company that ranked senior in right of payment to all of the Company&#x2019;s existing and future indebtedness that was expressly subordinated in right of payment to the 2023 Notes, ranked pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, ranked effectively junior to any of the Company&#x2019;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and ranked structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#x2019;s subsidiaries, financing vehicles or similar facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2023 Notes matured on July 14, 2023 and were paid off consistent with the terms of the 2023 Notes Indenture. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2026 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 23, 2020 and December 1, 2020, the Company issued $500.0 million aggregate principal amount and $300.0 million aggregate principal amount, respectively, of 3.625% notes due 2026 (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;2026 Notes&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) pursuant to a supplemental indenture, dated as of October 23, 2020 (and together with the Base Indenture, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;2026 Notes Indenture&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), to the Base Indenture between the Company and the Trustee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2026 Notes will mature on January 15, 2026 and may be redeemed in whole or in part at the Company&#x2019;s option at any time or from time to time at the redemption prices set forth in the 2026 Notes Indenture. The 2026 Notes bear interest at a rate of 3.625% per year payable semi-annually on January 15 and July 15 of each year, commencing on July 15, 2021. The 2026 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2026 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company&#x2019;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New 2026 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 16, 2021 and April 27, 2021, the Company issued $400.0 million aggregate principal amount and $300.0 million aggregate principal amount, respectively, of 2.750% notes due 2026 (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;New 2026 Notes&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) pursuant to a supplemental indenture, dated as of March 16, 2021 (and together with the Base Indenture, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;New 2026 Notes Indenture&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), to the Base Indenture between the Company and the Trustee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The New 2026 Notes will mature on September 16, 2026 and may be redeemed in whole or in part at the Company&#x2019;s option at any time or from time to time at the redemption prices set forth in the New 2026 Notes Indenture. The New 2026 Notes bear interest at a rate of 2.750% per year payable semi-annually on March 16 and September 16 of each year, commencing on September 16, 2021. The New 2026 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company&#x2019;s existing and future indebtedness that is expressly subordinated in right of payment to the New 2026 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company&#x2019;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#x2019;s subsidiaries, financing vehicles or similar facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2027 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 23, 2021, the Company issued $650.0 million aggregate principal amount of 2.125% notes due 2027 (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;2027 Notes&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) pursuant to a supplemental indenture, dated as of July 23, 2021 (and together with the Base Indenture, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;2027 Notes Indenture&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), to the Base Indenture between the Company and the Trustee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2027 Notes will mature on February 15, 2027 and may be redeemed in whole or in part at the Company&#x2019;s option at any time or from time to time at the redemption prices set forth in the 2027 Notes Indenture. The 2027 Notes bear interest at a rate of 2.125% per year payable semi-annually on February 15 and August 15 of each year, commencing on February 15, 2022. The 2027 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company&#x2019;s existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company&#x2019;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#x2019;s subsidiaries, financing vehicles or similar facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2028 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2021, the Company issued $650.0 million in aggregate principal amount of its 2.850% notes due 2028 (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;2028 Notes&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) pursuant to a supplemental indenture, dated as of September 30, 2021 (and together with the Base Indenture, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;2028 Notes Indenture&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), to the Base Indenture between the Company and the Trustee. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2028 Notes will mature on September 30, 2028 and may be redeemed in whole or in part at the Company&#x2019;s option at any time or from time to time at the redemption prices set forth in the 2028 Notes Indenture. The 2028 Notes bear interest at a rate of 2.850% per year payable semi-annually on March 30 and September 30 of each year, commencing on March 30, 2022. The 2028 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company&#x2019;s existing and future indebtedness that is expressly subordinated in right of payment to the 2028 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company&#x2019;s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#x2019;s subsidiaries, financing vehicles or similar facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company&#x2019;s outstanding debt obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.584%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Principal&lt;br/&gt;Committed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding&lt;br/&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized Debt Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unused&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Portion &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jackson Hole Funding Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breckenridge Funding Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Big Sky Funding Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Credit Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,092,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,092,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,937,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,911,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,662,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,662,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The unused portion is the amount upon which commitment fees, if any, are based.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The amount available reflects any limitations related to each respective credit facility&#x2019;s borrowing base.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Under the Jackson Hole Funding Facility, the Company may borrow in U.S. dollars (USD) or certain other permitted currencies. As of December&#160;31, 2023, the Company had no borrowings denominated in currencies other than USD. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Under the Revolving Credit Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2023, the Company had non-USD borrowings denominated in the following currencies:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt"&gt;Canadian Dollars (CAD) 1.0 million&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt"&gt;Euros (EUR) 94.4 million&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt"&gt;British Pounds (GBP) 66.9 million&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.584%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Principal Committed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized Debt Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unused&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Portion &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jackson Hole Funding Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breckenridge Funding Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Big Sky Funding Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Credit Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,625,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;693,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,550,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,563,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,527,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The unused portion is the amount upon which commitment fees, if any, are based.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The amount available reflects any limitations related to each respective credit facility&#x2019;s borrowing base.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Under the Jackson Hole Funding Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2022, the Company had no borrowings denominated in currencies other than USD.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Under the Revolving Credit Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2022, the Company had borrowings denominated in the following currencies:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt"&gt;Canadian Dollars (CAD) 355.9 million&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt"&gt;Euros (EUR) 97.9 million&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt"&gt;British Pounds (GBP) 66.6 million&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of&#160;December&#160;31, 2023 and December&#160;31, 2022,&#160;$38.7 million and $44.5 million, respectively, of interest expense and $1.2 million and $0.8 million, respectively, of unused commitment fees were included in interest payable. For the years ended December&#160;31, 2023, 2022 and 2021, the weighted average interest rate on all borrowings outstanding was 4.93%, 3.46%, and 2.92% (including unused fees and accretion of net discounts on unsecured debt), respectively, and the average principal debt outstanding was $5,275.4 million, $5,732.6 million and $4,000.8 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of interest expense were as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowing interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility unused fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of original issue discount and debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio contextRef="c-5" decimals="3" id="f-5479" unitRef="number">2.003</us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio>
    <us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio contextRef="c-6" decimals="3" id="f-5480" unitRef="number">1.748</us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1505"
      decimals="INF"
      id="f-5481"
      unitRef="number">0.02375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1506"
      decimals="INF"
      id="f-5482"
      unitRef="number">0.02525</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-1507"
      decimals="INF"
      id="f-5483"
      unitRef="number">0.0048</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c-1508"
      decimals="INF"
      id="f-5484"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <bxsl:LineOfCreditFacilityAccordionFeatureIncreaseLimit
      contextRef="c-1508"
      decimals="INF"
      id="f-5485"
      unitRef="usd">900000000</bxsl:LineOfCreditFacilityAccordionFeatureIncreaseLimit>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1509"
      decimals="INF"
      id="f-5486"
      unitRef="number">0.0170</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1510"
      decimals="INF"
      id="f-5487"
      unitRef="number">0.0205</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1511"
      decimals="INF"
      id="f-5488"
      unitRef="number">0.0230</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-1512"
      decimals="INF"
      id="f-5489"
      unitRef="number">0.0070</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <bxsl:LineOfCreditFacilityUnusedCapacityPercentage
      contextRef="c-1513"
      decimals="INF"
      id="f-5490"
      unitRef="number">0.50</bxsl:LineOfCreditFacilityUnusedCapacityPercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-1514"
      decimals="INF"
      id="f-5491"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <bxsl:LineOfCreditFacilityUnusedCapacityPercentage
      contextRef="c-1515"
      decimals="INF"
      id="f-5492"
      unitRef="number">0.50</bxsl:LineOfCreditFacilityUnusedCapacityPercentage>
    <bxsl:LineOfCreditFacilityUnusedCapacityPercentage
      contextRef="c-1516"
      decimals="INF"
      id="f-5493"
      unitRef="number">0.25</bxsl:LineOfCreditFacilityUnusedCapacityPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1517"
      decimals="INF"
      id="f-5494"
      unitRef="number">0.0180</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1518"
      decimals="INF"
      id="f-5495"
      unitRef="number">0.0210</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1519"
      decimals="INF"
      id="f-5496"
      unitRef="number">0.0245</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <bxsl:LineOfCreditFacilityMinimumCapacityUtilizationPercentage
      contextRef="c-1520"
      decimals="INF"
      id="f-5497"
      unitRef="number">0.80</bxsl:LineOfCreditFacilityMinimumCapacityUtilizationPercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-1521"
      decimals="INF"
      id="f-5498"
      unitRef="number">0.0160</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-1522"
      decimals="INF"
      id="f-5499"
      unitRef="number">0.0045</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c-1523"
      decimals="INF"
      id="f-5500"
      unitRef="usd">385000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c-1524"
      decimals="INF"
      id="f-5501"
      unitRef="usd">175000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c-1525"
      decimals="INF"
      id="f-5502"
      unitRef="usd">200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c-1526"
      decimals="INF"
      id="f-5503"
      unitRef="usd">200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1527"
      decimals="INF"
      id="f-5504"
      unitRef="number">0.005</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1528"
      decimals="INF"
      id="f-5505"
      unitRef="number">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <bxsl:LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier
      contextRef="c-1529"
      decimals="INF"
      id="f-5506"
      unitRef="number">1.6</bxsl:LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1530"
      decimals="INF"
      id="f-5507"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <bxsl:LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier
      contextRef="c-1531"
      decimals="INF"
      id="f-5508"
      unitRef="number">1.6</bxsl:LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1532"
      decimals="INF"
      id="f-5509"
      unitRef="number">0.00875</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <bxsl:LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier
      contextRef="c-1533"
      decimals="INF"
      id="f-5510"
      unitRef="number">1.6</bxsl:LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1534"
      decimals="INF"
      id="f-5511"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <bxsl:LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier
      contextRef="c-1535"
      decimals="INF"
      id="f-5512"
      unitRef="number">1.6</bxsl:LineOfCreditFacilityCombinedRevolvingDebtAmountMultiplier>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-1536"
      decimals="INF"
      id="f-5513"
      unitRef="number">0.01875</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-1537"
      decimals="INF"
      id="f-5514"
      unitRef="number">0.00375</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <bxsl:DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio
      contextRef="c-1538"
      decimals="INF"
      id="f-5515"
      unitRef="number">1.50</bxsl:DebtInstrumentCovenantComplianceRequiredAssetCoverageRatio>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-1539"
      decimals="INF"
      id="f-5516"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c-1540"
      decimals="INF"
      id="f-5517"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1540"
      decimals="INF"
      id="f-5518"
      unitRef="number">0.03650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1540"
      decimals="INF"
      id="f-5519"
      unitRef="number">0.03650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c-1541"
      decimals="INF"
      id="f-5520"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c-1542"
      decimals="INF"
      id="f-5521"
      unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1542"
      decimals="INF"
      id="f-5522"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1541"
      decimals="INF"
      id="f-5523"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1541"
      decimals="INF"
      id="f-5524"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1542"
      decimals="INF"
      id="f-5525"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c-1543"
      decimals="INF"
      id="f-5526"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c-1544"
      decimals="INF"
      id="f-5527"
      unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1544"
      decimals="INF"
      id="f-5528"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1543"
      decimals="INF"
      id="f-5529"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1543"
      decimals="INF"
      id="f-5530"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1544"
      decimals="INF"
      id="f-5531"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c-1545"
      decimals="INF"
      id="f-5532"
      unitRef="usd">650000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1545"
      decimals="INF"
      id="f-5533"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1545"
      decimals="INF"
      id="f-5534"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c-1546"
      decimals="INF"
      id="f-5535"
      unitRef="usd">650000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1546"
      decimals="INF"
      id="f-5536"
      unitRef="number">0.02850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-1546"
      decimals="INF"
      id="f-5537"
      unitRef="number">0.02850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c-1" id="f-5538">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company&#x2019;s outstanding debt obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.584%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Principal&lt;br/&gt;Committed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding&lt;br/&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized Debt Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unused&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Portion &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jackson Hole Funding Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breckenridge Funding Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Big Sky Funding Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Credit Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,092,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,092,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,937,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,911,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,662,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,662,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The unused portion is the amount upon which commitment fees, if any, are based.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The amount available reflects any limitations related to each respective credit facility&#x2019;s borrowing base.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Under the Jackson Hole Funding Facility, the Company may borrow in U.S. dollars (USD) or certain other permitted currencies. As of December&#160;31, 2023, the Company had no borrowings denominated in currencies other than USD. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Under the Revolving Credit Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2023, the Company had non-USD borrowings denominated in the following currencies:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt"&gt;Canadian Dollars (CAD) 1.0 million&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt"&gt;Euros (EUR) 94.4 million&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt"&gt;British Pounds (GBP) 66.9 million&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.584%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Principal Committed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized Debt Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unused&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Portion &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jackson Hole Funding Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breckenridge Funding Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Big Sky Funding Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Credit Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,625,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;693,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,550,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,563,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,527,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The unused portion is the amount upon which commitment fees, if any, are based.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The amount available reflects any limitations related to each respective credit facility&#x2019;s borrowing base.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Under the Jackson Hole Funding Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2022, the Company had no borrowings denominated in currencies other than USD.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Under the Revolving Credit Facility, the Company may borrow in USD or certain other permitted currencies. As of December&#160;31, 2022, the Company had borrowings denominated in the following currencies:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt"&gt;Canadian Dollars (CAD) 355.9 million&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt"&gt;Euros (EUR) 97.9 million&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:24.2pt"&gt;British Pounds (GBP) 66.6 million&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of interest expense were as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowing interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility unused fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of original issue discount and debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1508" decimals="-3" id="f-5539" unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1508" decimals="-3" id="f-5540" unitRef="usd">233019000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1508" decimals="-3" id="f-5541" unitRef="usd">233019000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount contextRef="c-1508" decimals="-3" id="f-5542" unitRef="usd">266981000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-1508" decimals="-3" id="f-5543" unitRef="usd">266981000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1547" decimals="-3" id="f-5544" unitRef="usd">1025000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1547" decimals="-3" id="f-5545" unitRef="usd">741700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1547" decimals="-3" id="f-5546" unitRef="usd">741700000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount contextRef="c-1547" decimals="-3" id="f-5547" unitRef="usd">283300000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-1547" decimals="-3" id="f-5548" unitRef="usd">283300000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1548" decimals="-3" id="f-5549" unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1548" decimals="-3" id="f-5550" unitRef="usd">480906000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1548" decimals="-3" id="f-5551" unitRef="usd">480906000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount contextRef="c-1548" decimals="-3" id="f-5552" unitRef="usd">19094000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-1548" decimals="-3" id="f-5553" unitRef="usd">19094000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1549" decimals="-3" id="f-5554" unitRef="usd">1775000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1549" decimals="-3" id="f-5555" unitRef="usd">682258000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1549" decimals="-3" id="f-5556" unitRef="usd">682258000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount contextRef="c-1549" decimals="-3" id="f-5557" unitRef="usd">1092742000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-1549" decimals="-3" id="f-5558" unitRef="usd">1092662000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-1550" decimals="-3" id="f-5559" unitRef="usd">800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1550" decimals="-3" id="f-5560" unitRef="usd">800000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1550" decimals="-3" id="f-5561" unitRef="usd">796343000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-1550" decimals="-3" id="f-5562" unitRef="usd">3657000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-1551" decimals="-3" id="f-5563" unitRef="usd">700000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1551" decimals="-3" id="f-5564" unitRef="usd">700000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1551" decimals="-3" id="f-5565" unitRef="usd">695206000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-1551" decimals="-3" id="f-5566" unitRef="usd">4794000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-1552" decimals="-3" id="f-5567" unitRef="usd">650000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1552" decimals="-3" id="f-5568" unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1552" decimals="-3" id="f-5569" unitRef="usd">641412000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-1552" decimals="-3" id="f-5570" unitRef="usd">8588000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-1553" decimals="-3" id="f-5571" unitRef="usd">650000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1553" decimals="-3" id="f-5572" unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1553" decimals="-3" id="f-5573" unitRef="usd">641086000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-1553" decimals="-3" id="f-5574" unitRef="usd">8914000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-5" decimals="-3" id="f-5575" unitRef="usd">6600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-5" decimals="-3" id="f-5576" unitRef="usd">4937883000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-5" decimals="-3" id="f-5577" unitRef="usd">4911930000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-5" decimals="-3" id="f-5578" unitRef="usd">25953000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount contextRef="c-5" decimals="-3" id="f-5579" unitRef="usd">1662117000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-5" decimals="-3" id="f-5580" unitRef="usd">1662037000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c-1508"
      decimals="INF"
      id="f-5581"
      unitRef="eur">0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1549" decimals="-5" id="f-5582" unitRef="cad">1000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1549" decimals="-5" id="f-5583" unitRef="eur">94400000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1549" decimals="-5" id="f-5584" unitRef="gbp">66900000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1554" decimals="-3" id="f-5585" unitRef="usd">400000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1554" decimals="-3" id="f-5586" unitRef="usd">360019000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1554" decimals="-3" id="f-5587" unitRef="usd">360019000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount contextRef="c-1554" decimals="-3" id="f-5588" unitRef="usd">39981000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-1554" decimals="-3" id="f-5589" unitRef="usd">39981000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1555" decimals="-3" id="f-5590" unitRef="usd">825000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1555" decimals="-3" id="f-5591" unitRef="usd">825000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1555" decimals="-3" id="f-5592" unitRef="usd">825000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount contextRef="c-1555" decimals="-3" id="f-5593" unitRef="usd">0</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-1555" decimals="-3" id="f-5594" unitRef="usd">0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1556" decimals="-3" id="f-5595" unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1556" decimals="-3" id="f-5596" unitRef="usd">499606000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1556" decimals="-3" id="f-5597" unitRef="usd">499606000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount contextRef="c-1556" decimals="-3" id="f-5598" unitRef="usd">394000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-1556" decimals="-3" id="f-5599" unitRef="usd">394000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1557" decimals="-3" id="f-5600" unitRef="usd">1625000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1557" decimals="-3" id="f-5601" unitRef="usd">678378000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1557" decimals="-3" id="f-5602" unitRef="usd">678378000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount contextRef="c-1557" decimals="-3" id="f-5603" unitRef="usd">946622000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-1557" decimals="-3" id="f-5604" unitRef="usd">936004000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-1558" decimals="-3" id="f-5605" unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1558" decimals="-3" id="f-5606" unitRef="usd">400000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1558" decimals="-3" id="f-5607" unitRef="usd">398850000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-1558" decimals="-3" id="f-5608" unitRef="usd">1150000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-1559" decimals="-3" id="f-5609" unitRef="usd">800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1559" decimals="-3" id="f-5610" unitRef="usd">800000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1559" decimals="-3" id="f-5611" unitRef="usd">794559000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-1559" decimals="-3" id="f-5612" unitRef="usd">5441000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-1560" decimals="-3" id="f-5613" unitRef="usd">700000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1560" decimals="-3" id="f-5614" unitRef="usd">700000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1560" decimals="-3" id="f-5615" unitRef="usd">693432000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-1560" decimals="-3" id="f-5616" unitRef="usd">6568000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-1561" decimals="-3" id="f-5617" unitRef="usd">650000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1561" decimals="-3" id="f-5618" unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1561" decimals="-3" id="f-5619" unitRef="usd">638669000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-1561" decimals="-3" id="f-5620" unitRef="usd">11332000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-1562" decimals="-3" id="f-5621" unitRef="usd">650000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-1562" decimals="-3" id="f-5622" unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-1562" decimals="-3" id="f-5623" unitRef="usd">639202000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-1562" decimals="-3" id="f-5624" unitRef="usd">10798000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-6" decimals="-3" id="f-5625" unitRef="usd">6550000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-6" decimals="-3" id="f-5626" unitRef="usd">5563003000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt contextRef="c-6" decimals="-3" id="f-5627" unitRef="usd">5527715000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-6" decimals="-3" id="f-5628" unitRef="usd">35289000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount contextRef="c-6" decimals="-3" id="f-5629" unitRef="usd">986997000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-6" decimals="-3" id="f-5630" unitRef="usd">976379000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c-1554"
      decimals="INF"
      id="f-5631"
      unitRef="eur">0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1557" decimals="-5" id="f-5632" unitRef="cad">355900000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1557" decimals="-5" id="f-5633" unitRef="eur">97900000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-1557" decimals="-5" id="f-5634" unitRef="gbp">66600000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <bxsl:InterestPayableInterestExpense contextRef="c-5" decimals="-5" id="f-5635" unitRef="usd">38700000</bxsl:InterestPayableInterestExpense>
    <bxsl:InterestPayableInterestExpense contextRef="c-6" decimals="-5" id="f-5636" unitRef="usd">44500000</bxsl:InterestPayableInterestExpense>
    <bxsl:InterestPayableDebtInstrumentUnusedBorrowingCapacityFee contextRef="c-5" decimals="-5" id="f-5637" unitRef="usd">1200000</bxsl:InterestPayableDebtInstrumentUnusedBorrowingCapacityFee>
    <bxsl:InterestPayableDebtInstrumentUnusedBorrowingCapacityFee contextRef="c-6" decimals="-5" id="f-5638" unitRef="usd">800000</bxsl:InterestPayableDebtInstrumentUnusedBorrowingCapacityFee>
    <us-gaap:LongTermDebtWeightedAverageInterestRateOverTime contextRef="c-1" decimals="4" id="f-5639" unitRef="number">0.0493</us-gaap:LongTermDebtWeightedAverageInterestRateOverTime>
    <us-gaap:LongTermDebtWeightedAverageInterestRateOverTime
      contextRef="c-135"
      decimals="4"
      id="f-5640"
      unitRef="number">0.0346</us-gaap:LongTermDebtWeightedAverageInterestRateOverTime>
    <us-gaap:LongTermDebtWeightedAverageInterestRateOverTime
      contextRef="c-136"
      decimals="4"
      id="f-5641"
      unitRef="number">0.0292</us-gaap:LongTermDebtWeightedAverageInterestRateOverTime>
    <us-gaap:LongTermDebtAverageAmountOutstanding contextRef="c-1" decimals="-5" id="f-5642" unitRef="usd">5275400000</us-gaap:LongTermDebtAverageAmountOutstanding>
    <us-gaap:LongTermDebtAverageAmountOutstanding contextRef="c-135" decimals="-5" id="f-5643" unitRef="usd">5732600000</us-gaap:LongTermDebtAverageAmountOutstanding>
    <us-gaap:LongTermDebtAverageAmountOutstanding contextRef="c-136" decimals="-5" id="f-5644" unitRef="usd">4000800000</us-gaap:LongTermDebtAverageAmountOutstanding>
    <us-gaap:InterestExpenseBorrowings contextRef="c-1" decimals="-3" id="f-5645" unitRef="usd">246642000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings contextRef="c-135" decimals="-3" id="f-5646" unitRef="usd">187035000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings contextRef="c-136" decimals="-3" id="f-5647" unitRef="usd">107900000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityFee contextRef="c-1" decimals="-3" id="f-5648" unitRef="usd">4971000</us-gaap:DebtInstrumentUnusedBorrowingCapacityFee>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityFee contextRef="c-135" decimals="-3" id="f-5649" unitRef="usd">2131000</us-gaap:DebtInstrumentUnusedBorrowingCapacityFee>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityFee contextRef="c-136" decimals="-3" id="f-5650" unitRef="usd">2791000</us-gaap:DebtInstrumentUnusedBorrowingCapacityFee>
    <bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements contextRef="c-1" decimals="-3" id="f-5651" unitRef="usd">5471000</bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements>
    <bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements contextRef="c-135" decimals="-3" id="f-5652" unitRef="usd">4008000</bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements>
    <bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements contextRef="c-136" decimals="-3" id="f-5653" unitRef="usd">2676000</bxsl:AmortizationOfDebtIssuanceCostsLineOfCreditArrangements>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-1" decimals="-3" id="f-5654" unitRef="usd">9336000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-135" decimals="-3" id="f-5655" unitRef="usd">10405000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-136" decimals="-3" id="f-5656" unitRef="usd">7102000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-3" id="f-5657" unitRef="usd">266420000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-135" decimals="-3" id="f-5658" unitRef="usd">203579000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-136" decimals="-3" id="f-5659" unitRef="usd">120469000</us-gaap:InterestExpense>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-5660" unitRef="usd">256478000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-135" decimals="-3" id="f-5661" unitRef="usd">182152000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-136" decimals="-3" id="f-5662" unitRef="usd">94552000</us-gaap:InterestPaidNet>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-5663">Commitments and Contingencies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Portfolio Company Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investment portfolio may contain debt investments which are in the form of lines of credit or delayed draw commitments, which require us to provide funding when requested by portfolio companies in accordance with underlying loan agreements.&#160;As of December&#160;31, 2023 and December&#160;31, 2022 the Company had unfunded commitments, including delayed draw terms loans and revolvers, with an aggregate amount of $985.9 million and $690.3 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, from time to time, the Adviser and its affiliates may commit to an investment on behalf of the investment vehicles it manages, including the Company. Certain terms of these investments are not finalized at the time of the commitment and each respective investment vehicle's allocation may change prior to the date of funding. In this regard, as of December&#160;31, 2023 and December&#160;31, 2022, the Company estimates that $221.3 million and $16.5 million, respectively, of investments that were committed but not yet funded. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company may become a party to certain legal proceedings incidental to the normal course of its business. At December&#160;31, 2023 and December&#160;31, 2022, management is not aware of any material pending legal proceedings.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-4" decimals="-5" id="f-5664" unitRef="usd">985900000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1563" decimals="-5" id="f-5665" unitRef="usd">690300000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount contextRef="c-5" decimals="-5" id="f-5666" unitRef="usd">221300000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount>
    <bxsl:InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount contextRef="c-6" decimals="-5" id="f-5667" unitRef="usd">16500000</bxsl:InvestmentCompanyFinancialCommitmentToInvesteeEstimatedFutureAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-5668">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 8. Net Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shares Issued&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has the authority to issue an unlimited number of common shares of beneficial interest at $0.001 per share par value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 14, 2023, the Company completed a follow-on offering under its shelf registration statement, issuing 6,500,000 of its common shares of beneficial interest at a price to the underwriters of $26.78 per share. Net of underwriting fees, the Company received cash proceeds, before offering expenses, of $174.1 million. On August 18, 2023, the underwriters exercised, in full, their option to purchase an additional 975,000 shares of common shares, which resulted in cash proceeds, before offering expenses, of $26.1 million. The Company incurred offering expenses of $0.4 million in connection with the follow-on offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2023, the Company is party to five separate equity distribution agreements&#160;with sales agents (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity Distribution Agreements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), pursuant to which the Company may sell, from time to time, up to an aggregate sales price of $400.0&#160;million of its common shares of beneficial interest. Sales of common shares made pursuant to the Equity Distribution Agreements may be made in negotiated transactions or transactions that are deemed to be &#x201c;at-the-market&#x201d; offerings as defined in Rule 415(a)(5) under the Securities Act of 1933, as amended. Actual sales depend on a variety of factors including market conditions, the trading price of the Company&#x2019;s common shares, the Company&#x2019;s capital needs, and the Company&#x2019;s determination of the appropriate sources of funding to meet such needs. As of December&#160;31, 2023, common shares with an aggregate sales price of $328.9 million remained available for issuance under the Equity Distribution Agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total common shares issued and proceeds received, for the year ended December&#160;31, 2023, through the &#x201c;at-the-market&#x201d; offering program (dollars in thousands except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.636%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.018%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issuances of Common Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Common Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Placement Fees/Offering Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Share Price &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x201c;At-the-market&#x201d; Offering&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,144,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Represents the net offering price per share after deducting placement fees and commissions and offering expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No common shares were issued for the year ended December&#160;31, 2022, other than those issued through the Company's dividend reinvestment program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2021, the Company priced its IPO, issuing 9,180,000 of its common shares of beneficial interest at a public offering price of $26.15 per share. Net of underwriting fees, the Company received cash proceeds, before offering expenses, of $230.6 million. On November 4, 2021, the underwriters exercised their option to purchase an additional 1,377,000 shares of common shares, which resulted in cash proceeds, before offering expenses, of $33.8 million. The Company&#x2019;s common shares began trading on the NYSE under the symbol &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;BXSL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; on October 28, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the listing of the Company&#x2019;s common shares on the NYSE, the Board decided to eliminate any outstanding fractional common shares (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Fractional Shares&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), as permitted by Delaware law by rounding down the number of Fractional Shares held by each of our shareholders to the nearest whole share and paying each shareholder cash for such Fractional Shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to September 8, 2021, the Company entered into additional subscription agreements (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Subscription Agreements&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) with investors providing for the private placement of the Company&#x2019;s shares. Under the terms of the Subscription Agreements, investors are required to fund drawdowns to purchase the Company&#x2019;s shares up to the amount of their respective Capital Commitment on an as-needed basis each time the Company delivers a drawdown notice to its investors. As of September 8, 2021, all Capital Commitments in the amount of $3,926.3 million ($80.0 million from affiliates of the Adviser) had been drawn. As of December&#160;31, 2021, the Company had received Capital Commitments totaling $3,926.3 million ($713.3 million remaining undrawn), of which $80.0 million ($8.0 million remaining undrawn) were from affiliates of the Adviser.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total common shares issued and proceeds received related to the Company&#x2019;s capital drawdowns and IPO for the year ended December&#160;31, 2021 (dollars in millions except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Share Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Common Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Proceeds&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 8, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,869,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 8, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,723,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,557,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,149,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Includes proceeds (net of any underwriting fees) from our initial public offering and the underwriter's exercise of the over-allotment option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distributions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s distributions declared and payable for the year ended December&#160;31, 2023 (dollars in thousands except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Date Declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Record Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 10, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 20, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 26, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 26, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividend Reinvestment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has adopted a dividend reinvestment plan (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;DRIP&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), pursuant to which it reinvests all cash dividends declared by the Board on behalf of its shareholders who do not elect to receive their dividends in cash. As a result, if the Board and the Company declares, a cash dividend or other distribution, then the Company&#x2019;s shareholders who have not opted out of its dividend reinvestment plan will have their cash distributions automatically reinvested in additional shares as described below, rather than receiving the cash dividend or other distribution. Starting from the consummation of the IPO, the number of shares to be issued to a shareholder is determined by dividing the total dollar amount of the cash dividend or distribution payable to a shareholder by the market price per common share at the close of regular trading on the NYSE on the payment date of a distribution, or if no sale is reported for such day, the average of the reported bid and ask prices. However, if the market price per share on the payment date of a cash dividend or distribution exceeds the most recently computed NAV per share, the Company will issue shares at the greater of (i) the most recently computed NAV per share and (ii) 95% of the current market price per share (or such lesser discount to the current market price per share that still exceeded the most recently computed NAV per share). For example, if the most recently computed NAV per share is $25.00 and the market price on the payment date of a cash dividend is $24.00 per share, the Company will issue shares at $24.00 per share. If the most recently computed NAV per share is $25.00 and the market price on the payment date of a cash dividend is $27.00 per share, the Company will issue shares at $25.65 per share (95% of the current market price). If the most recently computed NAV per share is $25.00 and the market price on the payment date of a cash dividend is $26.00 per share, the Company will issue shares at $25.00 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders who receive distributions in the form of shares will generally be subject to the same U.S. federal, state and local tax consequences as if they received cash distributions; however, since their cash distributions will be reinvested, those shareholders will not receive cash with which to pay any applicable taxes. The Company intends to use newly issued shares to implement the plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to our dividend reinvestment plan, the following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company&#x2019;s DRIP during the year ended December&#160;31, 2023 (dollars in thousands except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.198%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.523%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;DRIP Shares Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;DRIP Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 26, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company's DRIP during the year ended December&#160;31, 2022 (dollars in thousands except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.523%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;DRIP Shares Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;DRIP Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 13, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 12, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 14, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,054,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company's DRIP during the year ended December&#160;31, 2021 (dollars in thousands except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;DRIP Shares Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;DRIP Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 14, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 13, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 12, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 18, 2021, the Board approved a share repurchase plan (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Company 10b5-1 Plan&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), to acquire up to approximately $262 million (representing the net proceeds from the IPO) in the aggregate of our common shares at prices below our NAV per share over a specified period, in accordance with the guidelines specified in Rule 10b-18 and Rule 10b5-1 of the Exchange Act.&#160;The Company 10b5-1 Plan terminated by its own terms in November 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2023, the Board authorized a share repurchase plan, under which we may repurchase up to $250 million in the aggregate of our outstanding common shares in the open market at prices below our NAV per share for a one-year term, in accordance with the guidelines specified in Rule 10b-18 of the Exchange Act (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Company 10b-18 Plan&#x201d;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and together with the Company 10b5-1 Plan, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;Share Repurchase Plans&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2023 and December&#160;31, 2021, the Company did not repurchase any of its shares under the Share Repurchase Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the shares repurchased under the Company 10b5-1 Plan during the year ended December&#160;31, 2022 (dollars in thousands except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.570%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total Number of Shares Purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Average Price Paid per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 1 - April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 1 - May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 1 - June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 1 - July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,394,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,394,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 1 - August 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,223,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,223,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 1 - September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,251,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,251,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 1 - October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,959,931&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,959,931&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shareholder Transfer Restrictions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For shareholders who held common shares prior to the IPO, without the consent of the Adviser:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;prior to January 3, 2022, a shareholder was not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber any common share held by such shareholder prior to the IPO (and any DRIP shares received with respect to such common shares);&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;prior to March 1, 2022, a shareholder was not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber 90% of the common shares held by such shareholder prior to the IPO (and any DRIP shares received with respect to such common shares);&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;prior to May 1, 2022, a shareholder was not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber 75% of the common shares held by such shareholder prior to the IPO (and any DRIP shares received with respect to such common shares); and&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;prior to July 1, 2022, a shareholder was not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber 50% of the common shares held by such shareholder prior to the date of the IPO (and any DRIP shares received with respect to such common shares).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This means that, as a result of these transfer restrictions, without the consent of the Adviser, a shareholder who owned 100 common shares on the date of the IPO could not sell any of such shares until January 3, 2022; prior to March 1, 2022, such shareholder could only sell up to 10 of such shares; prior to May 1, 2022, such shareholder could only sell up to 25 of such shares; prior to July 1, 2022, such shareholder could only sell up to 50 of such shares; and after July 1, 2022, such shareholder could sell all of such shares. Consent by the Adviser to waive any of the foregoing transfer restrictions is subject to the consent of the representatives on behalf of the underwriters in the IPO. In addition, the Company&#x2019;s trustees have agreed for a period of 180 days after the date of the IPO and the Company&#x2019;s executive officers who are not trustees have agreed for a period of 180 days after the date of the IPO, not to transfer (whether by sale, gift, merger, by operation of law or otherwise) their common shares without the prior written consent of the representatives on behalf of the underwriters in the IPO, subject to certain exceptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-5669"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-1564"
      decimals="INF"
      id="f-5670"
      unitRef="shares">6500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-1565"
      decimals="INF"
      id="f-5671"
      unitRef="usdPerShare">26.78</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-1564" decimals="-5" id="f-5672" unitRef="usd">174100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-1566"
      decimals="INF"
      id="f-5673"
      unitRef="shares">975000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-1566" decimals="-5" id="f-5674" unitRef="usd">26100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-1566" decimals="-5" id="f-5675" unitRef="usd">400000</us-gaap:PaymentsOfStockIssuanceCosts>
    <bxsl:NumberOfEquityDistributionAgreements
      contextRef="c-5"
      decimals="INF"
      id="f-5676"
      unitRef="equity_distribution_agreement">5</bxsl:NumberOfEquityDistributionAgreements>
    <bxsl:SaleOfStockNumberOfSharesIssuedInTransactionValue contextRef="c-5" decimals="INF" id="f-5677" unitRef="usd">400000000</bxsl:SaleOfStockNumberOfSharesIssuedInTransactionValue>
    <bxsl:SaleOfStockRemainingAuthorizedAmount contextRef="c-5" decimals="-5" id="f-5678" unitRef="usd">328900000</bxsl:SaleOfStockRemainingAuthorizedAmount>
    <us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock contextRef="c-1" id="f-5679">&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total common shares issued and proceeds received, for the year ended December&#160;31, 2023, through the &#x201c;at-the-market&#x201d; offering program (dollars in thousands except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.636%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.018%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issuances of Common Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Common Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Placement Fees/Offering Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Share Price &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x201c;At-the-market&#x201d; Offering&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,144,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Represents the net offering price per share after deducting placement fees and commissions and offering expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-1567"
      decimals="0"
      id="f-5680"
      unitRef="shares">17144870</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-1567" decimals="-3" id="f-5681" unitRef="usd">466821000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-1567" decimals="-3" id="f-5682" unitRef="usd">1297000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1567" decimals="-3" id="f-5683" unitRef="usd">465524000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-1568"
      decimals="2"
      id="f-5684"
      unitRef="usdPerShare">27.15</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-1569"
      decimals="INF"
      id="f-5685"
      unitRef="shares">9180000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-1570"
      decimals="INF"
      id="f-5686"
      unitRef="usdPerShare">26.15</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-1569" decimals="-5" id="f-5687" unitRef="usd">230600000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-1571"
      decimals="INF"
      id="f-5688"
      unitRef="shares">1377000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-1571" decimals="-5" id="f-5689" unitRef="usd">33800000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:InvestmentCompanyCommittedCapital contextRef="c-1572" decimals="-5" id="f-5690" unitRef="usd">3926300000</us-gaap:InvestmentCompanyCommittedCapital>
    <us-gaap:InvestmentCompanyCommittedCapital contextRef="c-1573" decimals="-5" id="f-5691" unitRef="usd">80000000</us-gaap:InvestmentCompanyCommittedCapital>
    <us-gaap:InvestmentCompanyCommittedCapital contextRef="c-1572" decimals="-5" id="f-5692" unitRef="usd">3926300000</us-gaap:InvestmentCompanyCommittedCapital>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-153" decimals="-5" id="f-5693" unitRef="usd">713300000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <us-gaap:InvestmentCompanyCommittedCapital contextRef="c-1574" decimals="-5" id="f-5694" unitRef="usd">80000000</us-gaap:InvestmentCompanyCommittedCapital>
    <us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount contextRef="c-1575" decimals="-5" id="f-5695" unitRef="usd">8000000</us-gaap:InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount>
    <us-gaap:ScheduleOfStockByClassTextBlock contextRef="c-1" id="f-5696">&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total common shares issued and proceeds received related to the Company&#x2019;s capital drawdowns and IPO for the year ended December&#160;31, 2021 (dollars in millions except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Share Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Common Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Proceeds&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 8, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,869,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 8, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,723,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,557,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,149,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Includes proceeds (net of any underwriting fees) from our initial public offering and the underwriter's exercise of the over-allotment option.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-1576"
      decimals="0"
      id="f-5697"
      unitRef="shares">13869637</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <bxsl:StockIssuedDuringPeriodValueNewIssuesGross contextRef="c-1576" decimals="-5" id="f-5698" unitRef="usd">357000000.0</bxsl:StockIssuedDuringPeriodValueNewIssuesGross>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-1572"
      decimals="0"
      id="f-5699"
      unitRef="shares">13723035</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <bxsl:StockIssuedDuringPeriodValueNewIssuesGross contextRef="c-1572" decimals="-5" id="f-5700" unitRef="usd">356300000</bxsl:StockIssuedDuringPeriodValueNewIssuesGross>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-1577"
      decimals="0"
      id="f-5701"
      unitRef="shares">10557000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <bxsl:StockIssuedDuringPeriodValueNewIssuesGross contextRef="c-1577" decimals="-5" id="f-5702" unitRef="usd">264400000</bxsl:StockIssuedDuringPeriodValueNewIssuesGross>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-136"
      decimals="0"
      id="f-5703"
      unitRef="shares">38149672</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <bxsl:StockIssuedDuringPeriodValueNewIssuesGross contextRef="c-136" decimals="-5" id="f-5704" unitRef="usd">977700000</bxsl:StockIssuedDuringPeriodValueNewIssuesGross>
    <us-gaap:DividendsDeclaredTableTextBlock contextRef="c-1" id="f-5705">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s distributions declared and payable for the year ended December&#160;31, 2023 (dollars in thousands except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Date Declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Record Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 10, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 20, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 26, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 26, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s distributions declared and payable for the year ended December&#160;31, 2022 (dollars in thousands except per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Date Declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Record Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 18, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 18, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 13, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 18, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 16, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 13, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 23, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 13, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 18, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 16, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 12, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 12, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 18, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 18, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 14, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 14, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="30" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:17.68pt"&gt;Represents a special distribution.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s distributions declared and payable for the year ended December&#160;31, 2021 (dollars in thousands except per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.390%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Date Declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Record Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Per Share Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 24, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 14, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 13, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 13, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 12, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 12, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 18, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DividendsDeclaredTableTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1578"
      decimals="INF"
      id="f-5706"
      unitRef="usdPerShare">0.7000</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1578" decimals="-3" id="f-5707" unitRef="usd">112400000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1579"
      decimals="INF"
      id="f-5708"
      unitRef="usdPerShare">0.7000</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1579" decimals="-3" id="f-5709" unitRef="usd">115783000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1580"
      decimals="INF"
      id="f-5710"
      unitRef="usdPerShare">0.7700</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1580" decimals="-3" id="f-5711" unitRef="usd">133552000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1581"
      decimals="INF"
      id="f-5712"
      unitRef="usdPerShare">0.7700</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1581" decimals="-3" id="f-5713" unitRef="usd">143052000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1"
      decimals="INF"
      id="f-5714"
      unitRef="usdPerShare">2.9400</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1" decimals="-3" id="f-5715" unitRef="usd">504787000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1582"
      decimals="INF"
      id="f-5716"
      unitRef="usdPerShare">0.1000</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1582" decimals="-3" id="f-5717" unitRef="usd">16927000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1583"
      decimals="INF"
      id="f-5718"
      unitRef="usdPerShare">0.1500</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1583" decimals="-3" id="f-5719" unitRef="usd">25454000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1584"
      decimals="INF"
      id="f-5720"
      unitRef="usdPerShare">0.5300</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1584" decimals="-3" id="f-5721" unitRef="usd">89937000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1585"
      decimals="INF"
      id="f-5722"
      unitRef="usdPerShare">0.2000</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1585" decimals="-3" id="f-5723" unitRef="usd">33995000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1586"
      decimals="INF"
      id="f-5724"
      unitRef="usdPerShare">0.5300</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1586" decimals="-3" id="f-5725" unitRef="usd">89169000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1587"
      decimals="INF"
      id="f-5726"
      unitRef="usdPerShare">0.2000</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1587" decimals="-3" id="f-5727" unitRef="usd">32976000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1588"
      decimals="INF"
      id="f-5728"
      unitRef="usdPerShare">0.6000</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1588" decimals="-3" id="f-5729" unitRef="usd">97094000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1589"
      decimals="INF"
      id="f-5730"
      unitRef="usdPerShare">0.6000</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1589" decimals="-3" id="f-5731" unitRef="usd">96882000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-135"
      decimals="INF"
      id="f-5732"
      unitRef="usdPerShare">2.9100</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-135" decimals="-3" id="f-5733" unitRef="usd">482434000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1590"
      decimals="INF"
      id="f-5734"
      unitRef="usdPerShare">0.5000</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1590" decimals="-3" id="f-5735" unitRef="usd">65052000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1591"
      decimals="INF"
      id="f-5736"
      unitRef="usdPerShare">0.3736</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1591" decimals="-3" id="f-5737" unitRef="usd">48734000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1592"
      decimals="INF"
      id="f-5738"
      unitRef="usdPerShare">0.1264</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1592" decimals="-3" id="f-5739" unitRef="usd">18241000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1593"
      decimals="INF"
      id="f-5740"
      unitRef="usdPerShare">0.3750</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1593" decimals="-3" id="f-5741" unitRef="usd">54250000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1594"
      decimals="INF"
      id="f-5742"
      unitRef="usdPerShare">0.1250</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1594" decimals="-3" id="f-5743" unitRef="usd">19800000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1595"
      decimals="INF"
      id="f-5744"
      unitRef="usdPerShare">0.5300</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-1595" decimals="-3" id="f-5745" unitRef="usd">89715000</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-136"
      decimals="INF"
      id="f-5746"
      unitRef="usdPerShare">2.0300</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-136" decimals="-3" id="f-5747" unitRef="usd">295792000</us-gaap:DividendsCommonStock>
    <bxsl:DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare
      contextRef="c-1"
      decimals="INF"
      id="f-5748"
      unitRef="number">0.95</bxsl:DividendReinvestmentPlanMinimumShareIssuancePricePercentageOfCurrentMarketPricePerShare>
    <bxsl:ScheduleOfDividendReinvestmentPlanTableTextBlock contextRef="c-1" id="f-5749">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to our dividend reinvestment plan, the following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company&#x2019;s DRIP during the year ended December&#160;31, 2023 (dollars in thousands except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.198%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.523%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;DRIP Shares Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;DRIP Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 26, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company's DRIP during the year ended December&#160;31, 2022 (dollars in thousands except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.523%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;DRIP Shares Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;DRIP Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 13, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 12, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 14, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,054,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the amounts and shares issued to shareholders who have not opted out of the Company's DRIP during the year ended December&#160;31, 2021 (dollars in thousands except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;DRIP Shares Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;DRIP Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 14, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 13, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 12, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bxsl:ScheduleOfDividendReinvestmentPlanTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1596" decimals="-3" id="f-5750" unitRef="usd">5132000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-1596"
      decimals="0"
      id="f-5751"
      unitRef="shares">208510</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1597" decimals="-3" id="f-5752" unitRef="usd">5439000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-1597"
      decimals="0"
      id="f-5753"
      unitRef="shares">213130</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1598" decimals="-3" id="f-5754" unitRef="usd">4635000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-1598"
      decimals="0"
      id="f-5755"
      unitRef="shares">172888</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1599" decimals="-3" id="f-5756" unitRef="usd">5445000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-1599"
      decimals="0"
      id="f-5757"
      unitRef="shares">205149</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1" decimals="-3" id="f-5758" unitRef="usd">20651000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan contextRef="c-1" decimals="0" id="f-5759" unitRef="shares">799677</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1600" decimals="-3" id="f-5760" unitRef="usd">11469000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-1600"
      decimals="0"
      id="f-5761"
      unitRef="shares">417379</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1601" decimals="-3" id="f-5762" unitRef="usd">16501000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-1601"
      decimals="0"
      id="f-5763"
      unitRef="shares">640829</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1602" decimals="-3" id="f-5764" unitRef="usd">11470000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-1602"
      decimals="0"
      id="f-5765"
      unitRef="shares">455148</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1603" decimals="-3" id="f-5766" unitRef="usd">12942000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-1603"
      decimals="0"
      id="f-5767"
      unitRef="shares">541489</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-135" decimals="-3" id="f-5768" unitRef="usd">52382000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-135"
      decimals="0"
      id="f-5769"
      unitRef="shares">2054845</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1604" decimals="-3" id="f-5770" unitRef="usd">11179000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-1604"
      decimals="0"
      id="f-5771"
      unitRef="shares">443639</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1605" decimals="-3" id="f-5772" unitRef="usd">8674000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-1605"
      decimals="0"
      id="f-5773"
      unitRef="shares">339398</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1606" decimals="-3" id="f-5774" unitRef="usd">9142000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-1606"
      decimals="0"
      id="f-5775"
      unitRef="shares">352656</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-1607" decimals="-3" id="f-5776" unitRef="usd">9944000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-1607"
      decimals="0"
      id="f-5777"
      unitRef="shares">327082</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan contextRef="c-136" decimals="-3" id="f-5778" unitRef="usd">38939000</us-gaap:StockIssuedDuringPeriodValueDividendReinvestmentPlan>
    <us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan
      contextRef="c-136"
      decimals="0"
      id="f-5779"
      unitRef="shares">1462775</us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-1608" decimals="-6" id="f-5780" unitRef="usd">262000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-1609" decimals="-6" id="f-5781" unitRef="usd">250000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1 contextRef="c-1610" id="f-5782">P1Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1"
      decimals="INF"
      id="f-5783"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-136"
      decimals="INF"
      id="f-5784"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <bxsl:ScheduleOfSharesRepurchasedTableTextBlock contextRef="c-1" id="f-5785">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the shares repurchased under the Company 10b5-1 Plan during the year ended December&#160;31, 2022 (dollars in thousands except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.570%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total Number of Shares Purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Average Price Paid per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 1 - April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 1 - May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 1 - June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 1 - July 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,394,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,394,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 1 - August 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,223,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,223,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 1 - September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,251,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,251,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 1 - October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,959,931&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,959,931&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bxsl:ScheduleOfSharesRepurchasedTableTextBlock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1611"
      decimals="0"
      id="f-5786"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <bxsl:StockRepurchasedDuringPeriodAverageCostPerShare
      contextRef="c-1611"
      decimals="2"
      id="f-5787"
      unitRef="usdPerShare">0</bxsl:StockRepurchasedDuringPeriodAverageCostPerShare>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1612"
      decimals="0"
      id="f-5788"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-1613" decimals="-3" id="f-5789" unitRef="usd">262000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1614"
      decimals="0"
      id="f-5790"
      unitRef="shares">774558</us-gaap:StockRepurchasedDuringPeriodShares>
    <bxsl:StockRepurchasedDuringPeriodAverageCostPerShare
      contextRef="c-1614"
      decimals="2"
      id="f-5791"
      unitRef="usdPerShare">25.24</bxsl:StockRepurchasedDuringPeriodAverageCostPerShare>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1615"
      decimals="0"
      id="f-5792"
      unitRef="shares">774558</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-1616" decimals="-3" id="f-5793" unitRef="usd">242447000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1617"
      decimals="0"
      id="f-5794"
      unitRef="shares">1313782</us-gaap:StockRepurchasedDuringPeriodShares>
    <bxsl:StockRepurchasedDuringPeriodAverageCostPerShare
      contextRef="c-1617"
      decimals="2"
      id="f-5795"
      unitRef="usdPerShare">24.49</bxsl:StockRepurchasedDuringPeriodAverageCostPerShare>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1618"
      decimals="0"
      id="f-5796"
      unitRef="shares">1313782</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-1619" decimals="-3" id="f-5797" unitRef="usd">210275000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1620"
      decimals="0"
      id="f-5798"
      unitRef="shares">2394113</us-gaap:StockRepurchasedDuringPeriodShares>
    <bxsl:StockRepurchasedDuringPeriodAverageCostPerShare
      contextRef="c-1620"
      decimals="2"
      id="f-5799"
      unitRef="usdPerShare">23.20</bxsl:StockRepurchasedDuringPeriodAverageCostPerShare>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1621"
      decimals="0"
      id="f-5800"
      unitRef="shares">2394113</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-1622" decimals="-3" id="f-5801" unitRef="usd">154736000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1623"
      decimals="0"
      id="f-5802"
      unitRef="shares">2223389</us-gaap:StockRepurchasedDuringPeriodShares>
    <bxsl:StockRepurchasedDuringPeriodAverageCostPerShare
      contextRef="c-1623"
      decimals="2"
      id="f-5803"
      unitRef="usdPerShare">24.22</bxsl:StockRepurchasedDuringPeriodAverageCostPerShare>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1624"
      decimals="0"
      id="f-5804"
      unitRef="shares">2223389</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-1625" decimals="-3" id="f-5805" unitRef="usd">100886000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1626"
      decimals="0"
      id="f-5806"
      unitRef="shares">2251657</us-gaap:StockRepurchasedDuringPeriodShares>
    <bxsl:StockRepurchasedDuringPeriodAverageCostPerShare
      contextRef="c-1626"
      decimals="2"
      id="f-5807"
      unitRef="usdPerShare">24.14</bxsl:StockRepurchasedDuringPeriodAverageCostPerShare>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1627"
      decimals="0"
      id="f-5808"
      unitRef="shares">2251657</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-1628" decimals="-3" id="f-5809" unitRef="usd">46527000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1629"
      decimals="0"
      id="f-5810"
      unitRef="shares">2002432</us-gaap:StockRepurchasedDuringPeriodShares>
    <bxsl:StockRepurchasedDuringPeriodAverageCostPerShare
      contextRef="c-1629"
      decimals="2"
      id="f-5811"
      unitRef="usdPerShare">23.67</bxsl:StockRepurchasedDuringPeriodAverageCostPerShare>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1630"
      decimals="0"
      id="f-5812"
      unitRef="shares">2002432</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-1631" decimals="-3" id="f-5813" unitRef="usd">0</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-135"
      decimals="0"
      id="f-5814"
      unitRef="shares">10959931</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1632"
      decimals="0"
      id="f-5815"
      unitRef="shares">10959931</us-gaap:StockRepurchasedDuringPeriodShares>
    <bxsl:InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction
      contextRef="c-1633"
      decimals="INF"
      id="f-5816"
      unitRef="number">0.90</bxsl:InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction>
    <bxsl:InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction
      contextRef="c-1634"
      decimals="INF"
      id="f-5817"
      unitRef="number">0.75</bxsl:InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction>
    <bxsl:InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction
      contextRef="c-1635"
      decimals="INF"
      id="f-5818"
      unitRef="number">0.50</bxsl:InitialPublicOfferingShareholderTransferRestrictionsPercentageOfShareTransferRestriction>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1636"
      decimals="INF"
      id="f-5819"
      unitRef="shares">100</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1637"
      decimals="INF"
      id="f-5820"
      unitRef="shares">10</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1638"
      decimals="INF"
      id="f-5821"
      unitRef="shares">25</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="c-1639"
      decimals="INF"
      id="f-5822"
      unitRef="shares">50</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-5823">Earnings Per Share&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.941%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For The Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase (decrease) in net assets resulting from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding (basic and diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,615,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,072,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,510,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per share (basic and diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-5824">&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.941%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For The Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase (decrease) in net assets resulting from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding (basic and diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,615,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,072,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,510,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per share (basic and diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-5825" unitRef="usd">611951000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-135" decimals="-3" id="f-5826" unitRef="usd">404556000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-136" decimals="-3" id="f-5827" unitRef="usd">460422000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-5828" unitRef="shares">167615433</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-5829" unitRef="shares">167615433</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-135"
      decimals="0"
      id="f-5830"
      unitRef="shares">166072919</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-135"
      decimals="0"
      id="f-5831"
      unitRef="shares">166072919</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-136"
      decimals="0"
      id="f-5832"
      unitRef="shares">144510122</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-136"
      decimals="0"
      id="f-5833"
      unitRef="shares">144510122</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-5834"
      unitRef="usdPerShare">3.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-5835"
      unitRef="usdPerShare">3.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-135"
      decimals="2"
      id="f-5836"
      unitRef="usdPerShare">2.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-135"
      decimals="2"
      id="f-5837"
      unitRef="usdPerShare">2.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-136"
      decimals="2"
      id="f-5838"
      unitRef="usdPerShare">3.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-136"
      decimals="2"
      id="f-5839"
      unitRef="usdPerShare">3.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-5840">Income Taxes&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments, as gains and losses are generally not included in taxable income until they are realized; (2) income or loss recognition on exited investments; (3) non-deductible U.S federal excise taxes; and (4) other non-deductible expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company makes certain adjustments to the classification of net assets as a result of permanent book-to-tax differences, which include differences in the book and tax basis of certain assets and liabilities, and non-deductible federal taxes or losses among other items. To the extent these differences are permanent, they are charged or credited to additional paid in capital, undistributed net investment income or undistributed net realized gains on investments, as appropriate. For the years ended December&#160;31, 2023, 2022 and 2021, permanent differences were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.892%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.941%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For The Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Undistributed net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated net realized gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paid In Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,984)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022 and 2021, permanent differences were principally related to $16.8 million, $1.4 million and $2.4 million, respectively, of U.S. federal excise taxes and $0.2 million, $0.2 million and $0.0 million, respectively, of non-deductible offering costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For tax purposes, the Company may elect to defer any portion of a post-October capital loss or late-year ordinary loss to the first day of the following fiscal year. As of December&#160;31, 2023, 2022 and 2021, there were none. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following reconciles the increase in net assets resulting from operations to taxable income for the years ended December&#160;31, 2023, 2022 and 2021:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For The Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net increase (decrease) in net assets resulting from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized (appreciation) depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Realized gains (losses) for tax not included in book income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible capital gains incentive fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-deductible expenses and excise taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net post-October capital loss deferral (reversal)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Taxable/distributable income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Tax information for the fiscal year ended December&#160;31, 2023 is estimated and is not considered final until the Company files its tax return.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated gains (losses) as calculated on a tax basis for the years ended December&#160;31, 2023, 2022 and 2021 were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For The Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributable ordinary income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributable capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other temporary book/tax differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized appreciation/(depreciation) on investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total accumulated under-distributed (over-distributed) earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost and unrealized gain (loss) of the Company&#x2019;s investments, as calculated on a tax basis, at December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For The Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrealized appreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrealized depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net change in unrealized appreciation (depreciation)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax cost of investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,927,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,658,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,855,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, $456.8 million and $47.9 million of the dividends declared were derived from ordinary income and capital gains, respectively, as determined on a tax basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, $470.0 million and $12.4 million of the dividends declared were derived from ordinary income and capital gains, respectively, as determined on a tax basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the dividends declared during the year ended December&#160;31, 2021 were derived from ordinary income, as determined on a tax basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;BGSL Investments, a wholly-owned subsidiary that was formed in 2019, is a Delaware LLC which has elected to be treated as a corporation for U.S. tax purposes. As such, BGSL Investments is subject to U.S. Federal, state and local taxes. For the Company's tax year ended December&#160;31, 2023, BGSL Investments activity did not result in a material provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Management has analyzed the Company&#x2019;s tax positions taken, or to be taken, on federal income tax returns for all open tax years, and has concluded that no provision for income tax is required in the Company&#x2019;s financial statements. The Company&#x2019;s federal tax returns are subject to examination by the Internal Revenue Service for a period of three fiscal years after they are filed.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <bxsl:InvestmentCompanyChangeInNetAssetsTableTextBlock contextRef="c-1" id="f-5841">For the years ended December&#160;31, 2023, 2022 and 2021, permanent differences were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.892%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.941%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For The Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Undistributed net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated net realized gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paid In Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,984)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</bxsl:InvestmentCompanyChangeInNetAssetsTableTextBlock>
    <us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease contextRef="c-1640" decimals="-3" id="f-5842" unitRef="usd">32895000</us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease>
    <us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease contextRef="c-1641" decimals="-3" id="f-5843" unitRef="usd">60532000</us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease>
    <us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease contextRef="c-1642" decimals="-3" id="f-5844" unitRef="usd">-17556000</us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease>
    <us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease contextRef="c-162" decimals="-3" id="f-5845" unitRef="usd">-15911000</us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease>
    <us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease contextRef="c-156" decimals="-3" id="f-5846" unitRef="usd">-58963000</us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease>
    <us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease contextRef="c-149" decimals="-3" id="f-5847" unitRef="usd">19994000</us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease>
    <us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease contextRef="c-161" decimals="-3" id="f-5848" unitRef="usd">-16984000</us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease>
    <us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease contextRef="c-155" decimals="-3" id="f-5849" unitRef="usd">1569000</us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease>
    <us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease contextRef="c-148" decimals="-3" id="f-5850" unitRef="usd">-2438000</us-gaap:InvestmentCompanyTaxReclassificationIncreaseDecrease>
    <us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-5851" unitRef="usd">16800000</us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit>
    <us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit contextRef="c-135" decimals="-5" id="f-5852" unitRef="usd">1400000</us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit>
    <us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit contextRef="c-136" decimals="-5" id="f-5853" unitRef="usd">2400000</us-gaap:InvestmentIncomeOperatingTaxExpenseBenefit>
    <bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome contextRef="c-1" decimals="-5" id="f-5854" unitRef="usd">200000</bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome contextRef="c-135" decimals="-5" id="f-5855" unitRef="usd">200000</bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome contextRef="c-136" decimals="-5" id="f-5856" unitRef="usd">0</bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseOfferingCostsIncreaseDecreaseInTaxableIncome>
    <us-gaap:FederalIncomeTaxNoteTextBlock contextRef="c-1" id="f-5857">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following reconciles the increase in net assets resulting from operations to taxable income for the years ended December&#160;31, 2023, 2022 and 2021:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For The Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net increase (decrease) in net assets resulting from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized (appreciation) depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Realized gains (losses) for tax not included in book income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible capital gains incentive fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-deductible expenses and excise taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net post-October capital loss deferral (reversal)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Taxable/distributable income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Tax information for the fiscal year ended December&#160;31, 2023 is estimated and is not considered final until the Company files its tax return.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost and unrealized gain (loss) of the Company&#x2019;s investments, as calculated on a tax basis, at December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For The Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrealized appreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrealized depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net change in unrealized appreciation (depreciation)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax cost of investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,927,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,658,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,855,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FederalIncomeTaxNoteTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-5858" unitRef="usd">611951000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-135" decimals="-3" id="f-5859" unitRef="usd">404556000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-136" decimals="-3" id="f-5860" unitRef="usd">460422000</us-gaap:NetIncomeLoss>
    <bxsl:InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome contextRef="c-1" decimals="-3" id="f-5861" unitRef="usd">54573000</bxsl:InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome contextRef="c-135" decimals="-3" id="f-5862" unitRef="usd">122149000</bxsl:InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome contextRef="c-136" decimals="-3" id="f-5863" unitRef="usd">-104178000</bxsl:InvestmentTaxBasisReconciliationNetUnrealizedDepreciationAppreciationOnInvestmentsIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome contextRef="c-1" decimals="-3" id="f-5864" unitRef="usd">-917000</bxsl:InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome contextRef="c-135" decimals="-3" id="f-5865" unitRef="usd">-60000</bxsl:InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome contextRef="c-136" decimals="-3" id="f-5866" unitRef="usd">310000</bxsl:InvestmentTaxBasisReconciliationOtherRealizedGainsLossesDifferencesIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome contextRef="c-1" decimals="-3" id="f-5867" unitRef="usd">-5506000</bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome contextRef="c-135" decimals="-3" id="f-5868" unitRef="usd">-11883000</bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome contextRef="c-136" decimals="-3" id="f-5869" unitRef="usd">16312000</bxsl:InvestmentTaxBasisReconciliationNonDeductibleTaxExpenseCapitalGainsIncentiveFeeIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome contextRef="c-1" decimals="-3" id="f-5870" unitRef="usd">16984000</bxsl:InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome contextRef="c-135" decimals="-3" id="f-5871" unitRef="usd">1542000</bxsl:InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome contextRef="c-136" decimals="-3" id="f-5872" unitRef="usd">2412000</bxsl:InvestmentTaxBasisReconciliationOtherNonDeductibleTaxExpenseIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome contextRef="c-1" decimals="-3" id="f-5873" unitRef="usd">0</bxsl:InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome contextRef="c-135" decimals="-3" id="f-5874" unitRef="usd">0</bxsl:InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome contextRef="c-136" decimals="-3" id="f-5875" unitRef="usd">-4293000</bxsl:InvestmentTaxBasisReconciliationCapitalLossCarryoverIncreaseDecreaseInTaxableIncome>
    <bxsl:InvestmentCompanyDistributableEarningsLossBeforeDeductions contextRef="c-1" decimals="-3" id="f-5876" unitRef="usd">677085000</bxsl:InvestmentCompanyDistributableEarningsLossBeforeDeductions>
    <bxsl:InvestmentCompanyDistributableEarningsLossBeforeDeductions contextRef="c-135" decimals="-3" id="f-5877" unitRef="usd">516304000</bxsl:InvestmentCompanyDistributableEarningsLossBeforeDeductions>
    <bxsl:InvestmentCompanyDistributableEarningsLossBeforeDeductions contextRef="c-136" decimals="-3" id="f-5878" unitRef="usd">370985000</bxsl:InvestmentCompanyDistributableEarningsLossBeforeDeductions>
    <bxsl:InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock contextRef="c-1" id="f-5879">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated gains (losses) as calculated on a tax basis for the years ended December&#160;31, 2023, 2022 and 2021 were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For The Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributable ordinary income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributable capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other temporary book/tax differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized appreciation/(depreciation) on investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total accumulated under-distributed (over-distributed) earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bxsl:InvestmentCompanyComponentsOfDistributableEarningsAccumulatedLossesTableTextBlock>
    <us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss contextRef="c-5" decimals="-3" id="f-5880" unitRef="usd">281140000</us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss>
    <us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss contextRef="c-6" decimals="-3" id="f-5881" unitRef="usd">104577000</us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss>
    <us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss contextRef="c-153" decimals="-3" id="f-5882" unitRef="usd">104080000</us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss>
    <us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss contextRef="c-5" decimals="-3" id="f-5883" unitRef="usd">26953000</us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss>
    <us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss contextRef="c-6" decimals="-3" id="f-5884" unitRef="usd">37000000</us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss>
    <us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss contextRef="c-153" decimals="-3" id="f-5885" unitRef="usd">3229000</us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss>
    <bxsl:InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences contextRef="c-5" decimals="-3" id="f-5886" unitRef="usd">0</bxsl:InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences>
    <bxsl:InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences contextRef="c-6" decimals="-3" id="f-5887" unitRef="usd">-5506000</bxsl:InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences>
    <bxsl:InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences contextRef="c-153" decimals="-3" id="f-5888" unitRef="usd">-17389000</bxsl:InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences>
    <us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation contextRef="c-5" decimals="-3" id="f-5889" unitRef="usd">-58065000</us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation>
    <us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation contextRef="c-6" decimals="-3" id="f-5890" unitRef="usd">-10194000</us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation>
    <us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation contextRef="c-153" decimals="-3" id="f-5891" unitRef="usd">109941000</us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-5892" unitRef="usd">250028000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <bxsl:RetainedEarningsAccumulatedDeficitAudited contextRef="c-6" decimals="-3" id="f-5893" unitRef="usd">125877000</bxsl:RetainedEarningsAccumulatedDeficitAudited>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-153" decimals="-3" id="f-5894" unitRef="usd">199861000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TaxBasisOfInvestmentsGrossUnrealizedAppreciation contextRef="c-5" decimals="-3" id="f-5895" unitRef="usd">86757000</us-gaap:TaxBasisOfInvestmentsGrossUnrealizedAppreciation>
    <us-gaap:TaxBasisOfInvestmentsGrossUnrealizedAppreciation contextRef="c-6" decimals="-3" id="f-5896" unitRef="usd">88353000</us-gaap:TaxBasisOfInvestmentsGrossUnrealizedAppreciation>
    <us-gaap:TaxBasisOfInvestmentsGrossUnrealizedAppreciation contextRef="c-153" decimals="-3" id="f-5897" unitRef="usd">132173000</us-gaap:TaxBasisOfInvestmentsGrossUnrealizedAppreciation>
    <us-gaap:TaxBasisOfInvestmentsGrossUnrealizedDepreciation contextRef="c-5" decimals="-3" id="f-5898" unitRef="usd">146095000</us-gaap:TaxBasisOfInvestmentsGrossUnrealizedDepreciation>
    <us-gaap:TaxBasisOfInvestmentsGrossUnrealizedDepreciation contextRef="c-6" decimals="-3" id="f-5899" unitRef="usd">129296000</us-gaap:TaxBasisOfInvestmentsGrossUnrealizedDepreciation>
    <us-gaap:TaxBasisOfInvestmentsGrossUnrealizedDepreciation contextRef="c-153" decimals="-3" id="f-5900" unitRef="usd">22232000</us-gaap:TaxBasisOfInvestmentsGrossUnrealizedDepreciation>
    <us-gaap:TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet contextRef="c-5" decimals="-3" id="f-5901" unitRef="usd">-59338000</us-gaap:TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet>
    <us-gaap:TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet contextRef="c-6" decimals="-3" id="f-5902" unitRef="usd">-40943000</us-gaap:TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet>
    <us-gaap:TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet contextRef="c-153" decimals="-3" id="f-5903" unitRef="usd">109941000</us-gaap:TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet>
    <us-gaap:TaxBasisOfInvestmentsCostForIncomeTaxPurposes contextRef="c-5" decimals="-3" id="f-5904" unitRef="usd">9927777000</us-gaap:TaxBasisOfInvestmentsCostForIncomeTaxPurposes>
    <us-gaap:TaxBasisOfInvestmentsCostForIncomeTaxPurposes contextRef="c-6" decimals="-3" id="f-5905" unitRef="usd">9658192000</us-gaap:TaxBasisOfInvestmentsCostForIncomeTaxPurposes>
    <us-gaap:TaxBasisOfInvestmentsCostForIncomeTaxPurposes contextRef="c-153" decimals="-3" id="f-5906" unitRef="usd">9855692000</us-gaap:TaxBasisOfInvestmentsCostForIncomeTaxPurposes>
    <us-gaap:DividendsCommonStock contextRef="c-1643" decimals="-5" id="f-5907" unitRef="usd">456800000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock contextRef="c-1644" decimals="-5" id="f-5908" unitRef="usd">47900000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock contextRef="c-1645" decimals="-5" id="f-5909" unitRef="usd">470000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock contextRef="c-1646" decimals="-5" id="f-5910" unitRef="usd">12400000</us-gaap:DividendsCommonStock>
    <us-gaap:InvestmentCompanyFinancialHighlightsTextBlock contextRef="c-1" id="f-5911">Financial Highlights and Senior Securities&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the financial highlights for the years ended December&#160;31, 2023, 2022, 2021, 2020, 2019 and for the period ended December 31, 2018:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For The Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Per Share Data &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net asset value, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized and realized gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase (decrease) in net assets resulting from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions declared &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.00)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase (decrease) in net assets from capital share transactions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.09)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total increase (decrease) in net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net asset value, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,782,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,362,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,274,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,661,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,289,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,621,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return based on NAV &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return based on market value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ratios:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ratio of net expenses to average net assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ratio of net investment income to average net assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Portfolio turnover rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,952,041&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,158,966&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,447,479&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,267,809&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,673,117&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,365&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset coverage ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The per share data was derived by using the weighted average shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The per share data for distributions was derived by using the actual shares outstanding at the date of the relevant transactions (refer to Note 8).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Total return is calculated as the change in NAV per share during the period, plus distributions per share (assuming dividends and distributions are reinvested in accordance with the Company's dividend reinvestment plan) divided by the beginning NAV per share. Total return does not include sales load.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Total return based on market value is calculated as the change in market value per share during the respective periods, taking into account distributions, if any, reinvested in accordance with the Company&#x2019;s dividend reinvestment plan. The beginning market value per share is based on the initial public offering price of $26.15 per share and not annualized.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Amounts are annualized except for expense support amounts relating to organizational costs and management fee and income based incentive fee waivers by the Adviser (refer to Note 3). For the years ended December&#160;31, 2023, 2022, 2021, 2020, 2019 and the period ended December 31, 2018, the ratio of total operating expenses to average net assets was 11.7%, 9.3%, 7.4%, 6.4%, 8.5%, and 14.1% respectively, on an annualized basis, excluding the effect of expense support/(recoupment) and management fee and income based incentive fee waivers by the Adviser which represented (0.8)%, (0.9)%, (0.2)%, (0.1)%, (0.0)% and 5.2%, respectively, of average net assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The period ended December 31, 2018 represents the period from November 20, 2018 (commencement of operations) to December 31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is information about the Company&#x2019;s senior securities as of the dates indicated in the below table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.114%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class and Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Amount Outstanding Exclusive of Treasury Securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Coverage per Unit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Involuntary Liquidating Preference per Unit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Market Value per Unit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Subscription Facility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Jackson Hole Funding Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,151&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,278&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Breckenridge Funding Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,151&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,278&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Big Sky Funding facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revolving Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023 Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.114%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class and Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Amount Outstanding Exclusive of Treasury Securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Coverage per Unit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Involuntary Liquidating Preference per Unit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Market Value per Unit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;New 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Total amount of each class of senior securities outstanding at the end of the period presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Asset coverage per unit is the ratio of the carrying value of our total assets, less all liabilities excluding indebtedness represented by senior securities in this table, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The amount to which such class of senior security would be entitled upon our involuntary liquidation in preference to any security junior to it. The &#x201c;-&#x201d; in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Not applicable because the senior securities are not registered for public trading.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The Subscription Facility was terminated on November 3, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The 2023 Notes matured on July 14, 2023 and were paid off consistent with the terms of the 2023 Notes Indenture.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentCompanyFinancialHighlightsTextBlock>
    <us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock contextRef="c-1" id="f-5912">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the financial highlights for the years ended December&#160;31, 2023, 2022, 2021, 2020, 2019 and for the period ended December 31, 2018:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For The Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Period Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Per Share Data &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net asset value, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in unrealized and realized gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase (decrease) in net assets resulting from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions declared &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.00)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase (decrease) in net assets from capital share transactions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.09)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total increase (decrease) in net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net asset value, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,782,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,362,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,274,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,661,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,289,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,621,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return based on NAV &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return based on market value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ratios:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ratio of net expenses to average net assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ratio of net investment income to average net assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Portfolio turnover rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,952,041&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,158,966&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,447,479&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,267,809&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,673,117&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,365&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset coverage ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The per share data was derived by using the weighted average shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The per share data for distributions was derived by using the actual shares outstanding at the date of the relevant transactions (refer to Note 8).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Total return is calculated as the change in NAV per share during the period, plus distributions per share (assuming dividends and distributions are reinvested in accordance with the Company's dividend reinvestment plan) divided by the beginning NAV per share. Total return does not include sales load.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Total return based on market value is calculated as the change in market value per share during the respective periods, taking into account distributions, if any, reinvested in accordance with the Company&#x2019;s dividend reinvestment plan. The beginning market value per share is based on the initial public offering price of $26.15 per share and not annualized.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Amounts are annualized except for expense support amounts relating to organizational costs and management fee and income based incentive fee waivers by the Adviser (refer to Note 3). For the years ended December&#160;31, 2023, 2022, 2021, 2020, 2019 and the period ended December 31, 2018, the ratio of total operating expenses to average net assets was 11.7%, 9.3%, 7.4%, 6.4%, 8.5%, and 14.1% respectively, on an annualized basis, excluding the effect of expense support/(recoupment) and management fee and income based incentive fee waivers by the Adviser which represented (0.8)%, (0.9)%, (0.2)%, (0.1)%, (0.0)% and 5.2%, respectively, of average net assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The period ended December 31, 2018 represents the period from November 20, 2018 (commencement of operations) to December 31, 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-6"
      decimals="2"
      id="f-5913"
      unitRef="usdPerShare">25.93</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-153"
      decimals="2"
      id="f-5914"
      unitRef="usdPerShare">26.27</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-146"
      decimals="2"
      id="f-5915"
      unitRef="usdPerShare">25.20</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-1647"
      decimals="2"
      id="f-5916"
      unitRef="usdPerShare">26.02</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-1648"
      decimals="2"
      id="f-5917"
      unitRef="usdPerShare">24.57</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-1649"
      decimals="2"
      id="f-5918"
      unitRef="usdPerShare">25.00</us-gaap:NetAssetValuePerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare
      contextRef="c-1"
      decimals="2"
      id="f-5919"
      unitRef="usdPerShare">3.90</us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare
      contextRef="c-135"
      decimals="2"
      id="f-5920"
      unitRef="usdPerShare">2.91</us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare
      contextRef="c-136"
      decimals="2"
      id="f-5921"
      unitRef="usdPerShare">2.43</us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare
      contextRef="c-1650"
      decimals="2"
      id="f-5922"
      unitRef="usdPerShare">2.51</us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare
      contextRef="c-1651"
      decimals="2"
      id="f-5923"
      unitRef="usdPerShare">2.18</us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare
      contextRef="c-1652"
      decimals="2"
      id="f-5924"
      unitRef="usdPerShare">0.17</us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c-1"
      decimals="2"
      id="f-5925"
      unitRef="usdPerShare">-0.24</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c-135"
      decimals="2"
      id="f-5926"
      unitRef="usdPerShare">-0.47</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c-136"
      decimals="2"
      id="f-5927"
      unitRef="usdPerShare">0.76</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c-1650"
      decimals="2"
      id="f-5928"
      unitRef="usdPerShare">-0.22</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c-1651"
      decimals="2"
      id="f-5929"
      unitRef="usdPerShare">0.96</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c-1652"
      decimals="2"
      id="f-5930"
      unitRef="usdPerShare">-0.57</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
      contextRef="c-1"
      decimals="2"
      id="f-5931"
      unitRef="usdPerShare">3.66</us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
      contextRef="c-135"
      decimals="2"
      id="f-5932"
      unitRef="usdPerShare">2.44</us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
      contextRef="c-136"
      decimals="2"
      id="f-5933"
      unitRef="usdPerShare">3.19</us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
      contextRef="c-1650"
      decimals="2"
      id="f-5934"
      unitRef="usdPerShare">2.29</us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
      contextRef="c-1651"
      decimals="2"
      id="f-5935"
      unitRef="usdPerShare">3.14</us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
      contextRef="c-1652"
      decimals="2"
      id="f-5936"
      unitRef="usdPerShare">-0.40</us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare>
    <us-gaap:InvestmentCompanyDistributionToShareholdersPerShare
      contextRef="c-1"
      decimals="2"
      id="f-5937"
      unitRef="usdPerShare">2.94</us-gaap:InvestmentCompanyDistributionToShareholdersPerShare>
    <us-gaap:InvestmentCompanyDistributionToShareholdersPerShare
      contextRef="c-135"
      decimals="2"
      id="f-5938"
      unitRef="usdPerShare">2.91</us-gaap:InvestmentCompanyDistributionToShareholdersPerShare>
    <us-gaap:InvestmentCompanyDistributionToShareholdersPerShare
      contextRef="c-136"
      decimals="2"
      id="f-5939"
      unitRef="usdPerShare">2.03</us-gaap:InvestmentCompanyDistributionToShareholdersPerShare>
    <us-gaap:InvestmentCompanyDistributionToShareholdersPerShare
      contextRef="c-1650"
      decimals="2"
      id="f-5940"
      unitRef="usdPerShare">2.30</us-gaap:InvestmentCompanyDistributionToShareholdersPerShare>
    <us-gaap:InvestmentCompanyDistributionToShareholdersPerShare
      contextRef="c-1651"
      decimals="2"
      id="f-5941"
      unitRef="usdPerShare">2.00</us-gaap:InvestmentCompanyDistributionToShareholdersPerShare>
    <us-gaap:InvestmentCompanyDistributionToShareholdersPerShare
      contextRef="c-1652"
      decimals="2"
      id="f-5942"
      unitRef="usdPerShare">0</us-gaap:InvestmentCompanyDistributionToShareholdersPerShare>
    <us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
      contextRef="c-1"
      decimals="2"
      id="f-5943"
      unitRef="usdPerShare">0.01</us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare>
    <us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
      contextRef="c-135"
      decimals="2"
      id="f-5944"
      unitRef="usdPerShare">0.13</us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare>
    <us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
      contextRef="c-136"
      decimals="2"
      id="f-5945"
      unitRef="usdPerShare">-0.09</us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare>
    <us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
      contextRef="c-1650"
      decimals="2"
      id="f-5946"
      unitRef="usdPerShare">-0.81</us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare>
    <us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
      contextRef="c-1651"
      decimals="2"
      id="f-5947"
      unitRef="usdPerShare">0.31</us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare>
    <us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
      contextRef="c-1652"
      decimals="2"
      id="f-5948"
      unitRef="usdPerShare">-0.03</us-gaap:InvestmentCompanyTaxReturnOfCapitalDistributionPerShare>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
      contextRef="c-1"
      decimals="2"
      id="f-5949"
      unitRef="usdPerShare">0.73</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
      contextRef="c-135"
      decimals="2"
      id="f-5950"
      unitRef="usdPerShare">-0.34</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
      contextRef="c-136"
      decimals="2"
      id="f-5951"
      unitRef="usdPerShare">1.07</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
      contextRef="c-1650"
      decimals="2"
      id="f-5952"
      unitRef="usdPerShare">-0.82</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
      contextRef="c-1651"
      decimals="2"
      id="f-5953"
      unitRef="usdPerShare">1.45</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
      contextRef="c-1652"
      decimals="2"
      id="f-5954"
      unitRef="usdPerShare">-0.43</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-5"
      decimals="2"
      id="f-5955"
      unitRef="usdPerShare">26.66</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-6"
      decimals="2"
      id="f-5956"
      unitRef="usdPerShare">25.93</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-153"
      decimals="2"
      id="f-5957"
      unitRef="usdPerShare">26.27</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-146"
      decimals="2"
      id="f-5958"
      unitRef="usdPerShare">25.20</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-1647"
      decimals="2"
      id="f-5959"
      unitRef="usdPerShare">26.02</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c-1648"
      decimals="2"
      id="f-5960"
      unitRef="usdPerShare">24.57</us-gaap:NetAssetValuePerShare>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="0" id="f-5961" unitRef="shares">185782408</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="0" id="f-5962" unitRef="shares">160362861</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-153"
      decimals="0"
      id="f-5963"
      unitRef="shares">169274033</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-146"
      decimals="0"
      id="f-5964"
      unitRef="shares">129661586</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-1647"
      decimals="0"
      id="f-5965"
      unitRef="shares">64289742</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-1648"
      decimals="0"
      id="f-5966"
      unitRef="shares">9621319</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:InvestmentCompanyTotalReturn contextRef="c-1" decimals="4" id="f-5967" unitRef="number">0.147</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="c-135"
      decimals="4"
      id="f-5968"
      unitRef="number">0.103</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="c-136"
      decimals="4"
      id="f-5969"
      unitRef="number">0.126</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="c-1650"
      decimals="4"
      id="f-5970"
      unitRef="number">0.065</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="c-1651"
      decimals="4"
      id="f-5971"
      unitRef="number">0.144</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="c-1652"
      decimals="4"
      id="f-5972"
      unitRef="number">-0.017</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturnMarketValue contextRef="c-1" decimals="4" id="f-5973" unitRef="number">0.374</us-gaap:InvestmentCompanyTotalReturnMarketValue>
    <us-gaap:InvestmentCompanyTotalReturnMarketValue
      contextRef="c-135"
      decimals="4"
      id="f-5974"
      unitRef="number">-0.261</us-gaap:InvestmentCompanyTotalReturnMarketValue>
    <us-gaap:InvestmentCompanyTotalReturnMarketValue
      contextRef="c-136"
      decimals="4"
      id="f-5975"
      unitRef="number">0.321</us-gaap:InvestmentCompanyTotalReturnMarketValue>
    <bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements contextRef="c-1" decimals="4" id="f-5976" unitRef="number">0.109</bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements
      contextRef="c-135"
      decimals="4"
      id="f-5977"
      unitRef="number">0.084</bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements
      contextRef="c-136"
      decimals="4"
      id="f-5978"
      unitRef="number">0.072</bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements
      contextRef="c-1650"
      decimals="4"
      id="f-5979"
      unitRef="number">0.065</bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements
      contextRef="c-1651"
      decimals="4"
      id="f-5980"
      unitRef="number">0.085</bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements
      contextRef="c-1652"
      decimals="4"
      id="f-5981"
      unitRef="number">0.089</bxsl:InvestmentCompanyExpenseRatioIncludingFeeWaiverAndReimbursements>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossRatio contextRef="c-1" decimals="4" id="f-5982" unitRef="number">0.146</us-gaap:InvestmentCompanyInvestmentIncomeLossRatio>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossRatio
      contextRef="c-135"
      decimals="4"
      id="f-5983"
      unitRef="number">0.111</us-gaap:InvestmentCompanyInvestmentIncomeLossRatio>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossRatio
      contextRef="c-136"
      decimals="4"
      id="f-5984"
      unitRef="number">0.093</us-gaap:InvestmentCompanyInvestmentIncomeLossRatio>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossRatio
      contextRef="c-1650"
      decimals="4"
      id="f-5985"
      unitRef="number">0.104</us-gaap:InvestmentCompanyInvestmentIncomeLossRatio>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossRatio
      contextRef="c-1651"
      decimals="4"
      id="f-5986"
      unitRef="number">0.085</us-gaap:InvestmentCompanyInvestmentIncomeLossRatio>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossRatio
      contextRef="c-1652"
      decimals="4"
      id="f-5987"
      unitRef="number">0.061</us-gaap:InvestmentCompanyInvestmentIncomeLossRatio>
    <us-gaap:InvestmentCompanyPortfolioTurnover contextRef="c-1" decimals="4" id="f-5988" unitRef="number">0.134</us-gaap:InvestmentCompanyPortfolioTurnover>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c-135"
      decimals="4"
      id="f-5989"
      unitRef="number">0.099</us-gaap:InvestmentCompanyPortfolioTurnover>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c-136"
      decimals="4"
      id="f-5990"
      unitRef="number">0.354</us-gaap:InvestmentCompanyPortfolioTurnover>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c-1650"
      decimals="4"
      id="f-5991"
      unitRef="number">0.468</us-gaap:InvestmentCompanyPortfolioTurnover>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c-1651"
      decimals="4"
      id="f-5992"
      unitRef="number">0.315</us-gaap:InvestmentCompanyPortfolioTurnover>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c-1652"
      decimals="4"
      id="f-5993"
      unitRef="number">0</us-gaap:InvestmentCompanyPortfolioTurnover>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-5994" unitRef="usd">4952041000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-5995" unitRef="usd">4158966000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-153" decimals="-3" id="f-5996" unitRef="usd">4447479000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-146" decimals="-3" id="f-5997" unitRef="usd">3267809000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-1647" decimals="-3" id="f-5998" unitRef="usd">1673117000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-1648" decimals="-3" id="f-5999" unitRef="usd">236365000</us-gaap:StockholdersEquity>
    <us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio contextRef="c-5" decimals="3" id="f-6000" unitRef="number">2.003</us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio>
    <us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio contextRef="c-6" decimals="3" id="f-6001" unitRef="number">1.748</us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio>
    <us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio
      contextRef="c-153"
      decimals="3"
      id="f-6002"
      unitRef="number">1.802</us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio>
    <us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio
      contextRef="c-146"
      decimals="3"
      id="f-6003"
      unitRef="number">2.300</us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio>
    <us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio
      contextRef="c-1647"
      decimals="3"
      id="f-6004"
      unitRef="number">2.151</us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio>
    <us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio
      contextRef="c-1648"
      decimals="3"
      id="f-6005"
      unitRef="number">2.278</us-gaap:InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-1570"
      decimals="2"
      id="f-6006"
      unitRef="usdPerShare">26.15</us-gaap:SaleOfStockPricePerShare>
    <bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements contextRef="c-1" decimals="4" id="f-6007" unitRef="number">0.117</bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements
      contextRef="c-135"
      decimals="4"
      id="f-6008"
      unitRef="number">0.093</bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements
      contextRef="c-136"
      decimals="4"
      id="f-6009"
      unitRef="number">0.074</bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements
      contextRef="c-1650"
      decimals="4"
      id="f-6010"
      unitRef="number">0.064</bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements
      contextRef="c-1651"
      decimals="4"
      id="f-6011"
      unitRef="number">0.085</bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements
      contextRef="c-1652"
      decimals="4"
      id="f-6012"
      unitRef="number">0.141</bxsl:InvestmentCompanyExpenseRatioBeforeFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements contextRef="c-1" decimals="4" id="f-6013" unitRef="number">-0.008</bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements
      contextRef="c-135"
      decimals="4"
      id="f-6014"
      unitRef="number">-0.009</bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements
      contextRef="c-136"
      decimals="4"
      id="f-6015"
      unitRef="number">-0.002</bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements
      contextRef="c-1650"
      decimals="4"
      id="f-6016"
      unitRef="number">-0.001</bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements
      contextRef="c-1651"
      decimals="4"
      id="f-6017"
      unitRef="number">-0.000</bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements>
    <bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements
      contextRef="c-1652"
      decimals="4"
      id="f-6018"
      unitRef="number">0.052</bxsl:InvestmentCompanyExpenseRatioFeeWaiverAndReimbursements>
    <cef:SeniorSecuritiesTableTextBlock contextRef="c-1" id="f-6019">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is information about the Company&#x2019;s senior securities as of the dates indicated in the below table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.114%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class and Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Amount Outstanding Exclusive of Treasury Securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Coverage per Unit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Involuntary Liquidating Preference per Unit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Market Value per Unit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Subscription Facility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Jackson Hole Funding Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,151&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,278&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Breckenridge Funding Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,151&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,278&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Big Sky Funding facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revolving Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023 Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.114%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.761%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class and Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Amount Outstanding Exclusive of Treasury Securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Coverage per Unit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Involuntary Liquidating Preference per Unit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Market Value per Unit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;New 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Total amount of each class of senior securities outstanding at the end of the period presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Asset coverage per unit is the ratio of the carrying value of our total assets, less all liabilities excluding indebtedness represented by senior securities in this table, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The amount to which such class of senior security would be entitled upon our involuntary liquidation in preference to any security junior to it. The &#x201c;-&#x201d; in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;Not applicable because the senior securities are not registered for public trading.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The Subscription Facility was terminated on November 3, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt"&gt;The 2023 Notes matured on July 14, 2023 and were paid off consistent with the terms of the 2023 Notes Indenture.&lt;/span&gt;&lt;/div&gt;</cef:SeniorSecuritiesTableTextBlock>
    <cef:SeniorSecuritiesAmt contextRef="c-1653" decimals="-5" id="f-6020" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1653"
      decimals="1"
      id="f-6021"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1654" decimals="-5" id="f-6022" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1654"
      decimals="1"
      id="f-6023"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1655" decimals="-5" id="f-6024" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1655"
      decimals="1"
      id="f-6025"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1656" decimals="-5" id="f-6026" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1656"
      decimals="1"
      id="f-6027"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1657" decimals="-5" id="f-6028" unitRef="usd">119800000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1657"
      decimals="1"
      id="f-6029"
      unitRef="usdPerShare">2151</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1658" decimals="-5" id="f-6030" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1658"
      decimals="1"
      id="f-6031"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1659" decimals="-5" id="f-6032" unitRef="usd">233000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1659"
      decimals="1"
      id="f-6033"
      unitRef="usdPerShare">2003</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1660" decimals="-5" id="f-6034" unitRef="usd">360000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1660"
      decimals="1"
      id="f-6035"
      unitRef="usdPerShare">1748</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1661" decimals="-5" id="f-6036" unitRef="usd">361000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1661"
      decimals="1"
      id="f-6037"
      unitRef="usdPerShare">1802</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1662" decimals="-5" id="f-6038" unitRef="usd">362300000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1662"
      decimals="1"
      id="f-6039"
      unitRef="usdPerShare">2300</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1663" decimals="-5" id="f-6040" unitRef="usd">514200000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1663"
      decimals="1"
      id="f-6041"
      unitRef="usdPerShare">2151</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1664" decimals="-5" id="f-6042" unitRef="usd">120000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1664"
      decimals="1"
      id="f-6043"
      unitRef="usdPerShare">2278</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1665" decimals="-5" id="f-6044" unitRef="usd">741700000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1665"
      decimals="1"
      id="f-6045"
      unitRef="usdPerShare">2003</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1666" decimals="-5" id="f-6046" unitRef="usd">825000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1666"
      decimals="1"
      id="f-6047"
      unitRef="usdPerShare">1748</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1667" decimals="-5" id="f-6048" unitRef="usd">568700000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1667"
      decimals="1"
      id="f-6049"
      unitRef="usdPerShare">1802</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1668" decimals="-5" id="f-6050" unitRef="usd">569000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1668"
      decimals="1"
      id="f-6051"
      unitRef="usdPerShare">2300</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1669" decimals="-5" id="f-6052" unitRef="usd">820300000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1669"
      decimals="1"
      id="f-6053"
      unitRef="usdPerShare">2151</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1670" decimals="-5" id="f-6054" unitRef="usd">65000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1670"
      decimals="1"
      id="f-6055"
      unitRef="usdPerShare">2278</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1671" decimals="-5" id="f-6056" unitRef="usd">480900000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1671"
      decimals="1"
      id="f-6057"
      unitRef="usdPerShare">2003</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1672" decimals="-5" id="f-6058" unitRef="usd">499600000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1672"
      decimals="1"
      id="f-6059"
      unitRef="usdPerShare">1748</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1673" decimals="-5" id="f-6060" unitRef="usd">499600000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1673"
      decimals="1"
      id="f-6061"
      unitRef="usdPerShare">1802</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1674" decimals="-5" id="f-6062" unitRef="usd">200300000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1674"
      decimals="1"
      id="f-6063"
      unitRef="usdPerShare">2300</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1675" decimals="-5" id="f-6064" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1675"
      decimals="1"
      id="f-6065"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1676" decimals="-5" id="f-6066" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1676"
      decimals="1"
      id="f-6067"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1677" decimals="-5" id="f-6068" unitRef="usd">682300000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1677"
      decimals="1"
      id="f-6069"
      unitRef="usdPerShare">2003</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1678" decimals="-5" id="f-6070" unitRef="usd">678400000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1678"
      decimals="1"
      id="f-6071"
      unitRef="usdPerShare">1748</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1679" decimals="-5" id="f-6072" unitRef="usd">915000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1679"
      decimals="1"
      id="f-6073"
      unitRef="usdPerShare">1802</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1680" decimals="-5" id="f-6074" unitRef="usd">182900000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1680"
      decimals="1"
      id="f-6075"
      unitRef="usdPerShare">2300</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1681" decimals="-5" id="f-6076" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1681"
      decimals="1"
      id="f-6077"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1682" decimals="-5" id="f-6078" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1682"
      decimals="1"
      id="f-6079"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1683" decimals="-5" id="f-6080" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1683"
      decimals="1"
      id="f-6081"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1684" decimals="-5" id="f-6082" unitRef="usd">400000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1684"
      decimals="1"
      id="f-6083"
      unitRef="usdPerShare">1748</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1685" decimals="-5" id="f-6084" unitRef="usd">400000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1685"
      decimals="1"
      id="f-6085"
      unitRef="usdPerShare">1802</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1686" decimals="-5" id="f-6086" unitRef="usd">400000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1686"
      decimals="1"
      id="f-6087"
      unitRef="usdPerShare">2300</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1687" decimals="-5" id="f-6088" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1687"
      decimals="1"
      id="f-6089"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1688" decimals="-5" id="f-6090" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1688"
      decimals="1"
      id="f-6091"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1689" decimals="-5" id="f-6092" unitRef="usd">800000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1689"
      decimals="1"
      id="f-6093"
      unitRef="usdPerShare">2003</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1690" decimals="-5" id="f-6094" unitRef="usd">800000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1690"
      decimals="1"
      id="f-6095"
      unitRef="usdPerShare">1748</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1691" decimals="-5" id="f-6096" unitRef="usd">800000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1691"
      decimals="1"
      id="f-6097"
      unitRef="usdPerShare">1802</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1692" decimals="-5" id="f-6098" unitRef="usd">800000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1692"
      decimals="1"
      id="f-6099"
      unitRef="usdPerShare">2300</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1693" decimals="-5" id="f-6100" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1693"
      decimals="1"
      id="f-6101"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1694" decimals="-5" id="f-6102" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1694"
      decimals="1"
      id="f-6103"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1695" decimals="-5" id="f-6104" unitRef="usd">700000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1695"
      decimals="1"
      id="f-6105"
      unitRef="usdPerShare">2003</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1696" decimals="-5" id="f-6106" unitRef="usd">700000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1696"
      decimals="1"
      id="f-6107"
      unitRef="usdPerShare">1748</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1697" decimals="-5" id="f-6108" unitRef="usd">700000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1697"
      decimals="1"
      id="f-6109"
      unitRef="usdPerShare">1802</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1698" decimals="-5" id="f-6110" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1698"
      decimals="1"
      id="f-6111"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1699" decimals="-5" id="f-6112" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1699"
      decimals="1"
      id="f-6113"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1700" decimals="-5" id="f-6114" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1700"
      decimals="1"
      id="f-6115"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1701" decimals="-5" id="f-6116" unitRef="usd">650000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1701"
      decimals="1"
      id="f-6117"
      unitRef="usdPerShare">2003</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1702" decimals="-5" id="f-6118" unitRef="usd">650000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1702"
      decimals="1"
      id="f-6119"
      unitRef="usdPerShare">1748</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1703" decimals="-5" id="f-6120" unitRef="usd">650000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1703"
      decimals="1"
      id="f-6121"
      unitRef="usdPerShare">1802</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1704" decimals="-5" id="f-6122" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1704"
      decimals="1"
      id="f-6123"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1705" decimals="-5" id="f-6124" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1705"
      decimals="1"
      id="f-6125"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1706" decimals="-5" id="f-6126" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1706"
      decimals="1"
      id="f-6127"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1707" decimals="-5" id="f-6128" unitRef="usd">650000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1707"
      decimals="1"
      id="f-6129"
      unitRef="usdPerShare">2003</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1708" decimals="-5" id="f-6130" unitRef="usd">650000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1708"
      decimals="1"
      id="f-6131"
      unitRef="usdPerShare">1748</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1709" decimals="-5" id="f-6132" unitRef="usd">650000000.0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1709"
      decimals="1"
      id="f-6133"
      unitRef="usdPerShare">1802</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1710" decimals="-5" id="f-6134" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1710"
      decimals="1"
      id="f-6135"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1711" decimals="-5" id="f-6136" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1711"
      decimals="1"
      id="f-6137"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt contextRef="c-1712" decimals="-5" id="f-6138" unitRef="usd">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="c-1712"
      decimals="1"
      id="f-6139"
      unitRef="usdPerShare">0</cef:SeniorSecuritiesCvgPerUnit>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-6140">Subsequent Events&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s management evaluated subsequent events through the date of issuance of the consolidated financial statements.&#160;There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of December&#160;31, 2023, except as discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;28, 2024 the Board declared a distribution of $0.77 per share, which is payable on April 26, 2024, to shareholders of record as of March 31, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1713"
      decimals="INF"
      id="f-6141"
      unitRef="usdPerShare">0.77</us-gaap:CommonStockDividendsPerShareDeclared>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#f-3600"
          xlink:label="f-3600"
          xlink:type="locator"/>
        <link:footnote id="fn-17" xlink:label="fn-17" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Unless otherwise indicated, all debt and equity investments held by the Company (which such term &#x201c;Company&#x201d; shall include the Company&#x2019;s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December&#160;31, 2022, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in </xhtml:span><xhtml:div style="margin-top:2pt;padding-left:36pt"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><xhtml:br/><xhtml:br/><xhtml:br/><xhtml:br/><xhtml:br/>thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company&#x2019;s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.</xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3600"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnote id="fn-23" xlink:label="fn-23" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion, although the investment may be subject to unused commitment fees. Negative cost and fair value results from unamortized fees, which are capitalized to the investment cost. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. See below for more information on the Company&#x2019;s unfunded commitments:</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3600"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnote id="fn-20" xlink:label="fn-20" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">These investments were valued using unobservable inputs and are considered Level 3 investments. Fair value was determined in good faith by or under the direction of the Board of Trustees (see Note 2 and Note 5), pursuant to the Company&#x2019;s valuation policy.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3600"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnote id="fn-21" xlink:label="fn-21" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:26.68pt">These debt investments are not pledged as collateral under any of the Company's credit facilities. For other debt investments that are pledged to the Company's credit facilities, a single investment may be divided into parts that are individually pledged as collateral to separate credit facilities. Any other debt investments listed above are pledged to financing facilities and are not available to satisfy the creditors of the Company.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3600"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnote id="fn-19" xlink:label="fn-19" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3600"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnote id="fn-27" xlink:label="fn-27" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was 1.00%</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3600"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3601"
          xlink:label="f-3601"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3601"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3601"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3601"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3601"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3601"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3602"
          xlink:label="f-3602"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3602"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3602"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3602"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3602"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3602"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3603"
          xlink:label="f-3603"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3603"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3603"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3603"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3603"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3604"
          xlink:label="f-3604"
          xlink:type="locator"/>
        <link:footnote id="fn-18" xlink:label="fn-18" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Variable rate loans to the portfolio companies bear interest at a rate that is determined by reference to either LIBOR (&#x201c;L&#x201d;), Canadian Dollar Offered Rate (&#x201c;CDOR&#x201d; or &#x201c;C&#x201d;), Sterling Overnight Interbank Average Rate (&#x201c;SONIA&#x201d; or &#x201c;S&#x201d;), Euro Interbank Offer Rate (&#x201c;Euribor&#x201d; or &#x201c;E&#x201d;), Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;), Stockholm Interbank Offered Rate (&#x201c;STIBOR&#x201d; or &#x201c;T&#x201d;), Copenhagen Interbank Offered Rate (&#x201c;CIBOR&#x201d; or &#x201c;CI&#x201d;, Norwegian Interbank Offered Rate (&#x201c;NIBOR&#x201d; or &#x201c;N&#x201d;), or an alternate base rate (commonly based on the Federal Funds Rate (&#x201c;F&#x201d;) or the U.S. Prime Rate (&#x201c;P&#x201d;)), which generally resets periodically. For each loan, the Company has indicated the reference rate used and provided the spread and the interest rate in effect as of December&#160;31, 2022. Variable rate loans typically include an interest reference rate floor feature. As of December&#160;31, 2022, 93.1% of the debt portfolio at fair value had an interest rate floor above zero. Rates on equity instruments represents contractual dividend rates on certain preferred equity positions.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3604"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3604"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3604"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3604"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3604"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnote id="fn-30" xlink:label="fn-30" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">For unsettled positions the interest rate does not include the base rate.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3604"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3605"
          xlink:label="f-3605"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3605"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3605"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3605"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3605"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3606"
          xlink:label="f-3606"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3606"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3606"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3606"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3606"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3606"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1899"
          xlink:label="f-1899"
          xlink:type="locator"/>
        <link:footnote id="fn-1" xlink:label="fn-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">Unless otherwise indicated, all debt and equity investments held by the Company (which such term &#x201c;Company&#x201d; shall include the Company&#x2019;s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December&#160;31, 2023, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company&#x2019;s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1899"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnote id="fn-4" xlink:label="fn-4" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">These investments were valued using unobservable inputs and are considered Level 3 investments. Fair value was determined in good faith by or under the direction of the Board of Trustees (see Note 2), pursuant to the Company&#x2019;s valuation policy.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1899"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnote id="fn-7" xlink:label="fn-7" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Position or portion thereof is an unfunded commitment, and no interest is being earned on the unfunded portion, although the investment may be subject to unused commitment fees. Negative cost and fair value results from unamortized fees, which are capitalized to the investment cost. The unfunded commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. See below for more information on the Company&#x2019;s unfunded commitments:</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1899"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnote id="fn-10" xlink:label="fn-10" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The interest rate floor on these investments as of December&#160;31, 2023 was 0.75%.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1899"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnote id="fn-5" xlink:label="fn-5" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:26.68pt">These investments are not pledged as collateral under any of the Company's credit facilities. For other debt investments that are pledged to the Company's credit facilities, a single investment may be divided into parts that are individually pledged as collateral to separate credit facilities. Any other debt investments listed above are pledged to financing facilities and are not available to satisfy the creditors of the Company.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1899"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3607"
          xlink:label="f-3607"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3607"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3607"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3607"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3607"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1898"
          xlink:label="f-1898"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1898"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1898"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1898"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1898"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1898"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3608"
          xlink:label="f-3608"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3608"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3608"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3608"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3608"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1897"
          xlink:label="f-1897"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1897"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1897"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1897"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1897"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1897"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnote id="fn-3" xlink:label="fn-3" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1897"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3609"
          xlink:label="f-3609"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3609"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3609"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3609"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnote id="fn-25" xlink:label="fn-25" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was 0.50%</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3609"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1896"
          xlink:label="f-1896"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1896"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1896"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1896"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1896"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1896"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1895"
          xlink:label="f-1895"
          xlink:type="locator"/>
        <link:footnote id="fn-13" xlink:label="fn-13" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For unsettled positions the interest rate does not include the base rate.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1895"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1895"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1895"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1895"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnote id="fn-2" xlink:label="fn-2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Variable rate loans to the portfolio companies bear interest at a rate that is determined by reference to either Canadian Dollar Offered Rate (&#x201c;CDOR&#x201d; or &#x201c;C&#x201d;), Sterling Overnight Interbank Average Rate (&#x201c;SONIA&#x201d; or &#x201c;S&#x201d;), Euro Interbank Offer Rate (&#x201c;Euribor&#x201d; or &#x201c;E&#x201d;), Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;), Stockholm Interbank Offered Rate (&#x201c;STIBOR&#x201d; or &#x201c;ST&#x201d;), Copenhagen Interbank Offered Rate (&#x201c;CIBOR&#x201d; or &#x201c;CI&#x201d;), Norwegian Interbank Offered Rate (&#x201c;NIBOR&#x201d; or &#x201c;N&#x201d;), or an alternate base rate (commonly based on the Federal Funds Rate (&#x201c;F&#x201d;) or the U.S. Prime Rate (&#x201c;P&#x201d;)), which generally resets periodically. For each loan, the Company has indicated the reference rate used and provided the spread and the interest rate in effect as of December&#160;31, 2023. Variable rate loans typically include an interest reference rate floor feature. As of December&#160;31, 2023, 93.7% of the debt portfolio at fair value had an interest rate floor above zero. Rates on equity instruments represents contractual dividend rates on certain preferred equity positions.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1895"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1895"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1895"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1894"
          xlink:label="f-1894"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1894"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1894"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1894"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1894"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1894"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1894"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1893"
          xlink:label="f-1893"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1893"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1893"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1893"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1893"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnote id="fn-6" xlink:label="fn-6" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:26.68pt">The investment is not a qualifying asset under Section 55(a) of the Investment Company Act of 1940, as amended (together with the rules and regulations promulgated thereunder, the &#x201c;1940 Act&#x201d;). The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70% of the Company&#x2019;s total assets. As of December&#160;31, 2023, non-qualifying assets represented 11.0% of total assets as calculated in accordance with regulatory requirements.<xhtml:br/><xhtml:br/></xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1893"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1892"
          xlink:label="f-1892"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1892"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1892"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1892"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1892"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1892"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1891"
          xlink:label="f-1891"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1891"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1891"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1891"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1891"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1891"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1891"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1890"
          xlink:label="f-1890"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1890"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1890"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1890"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1890"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1890"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3620"
          xlink:label="f-3620"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3620"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3620"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3620"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3621"
          xlink:label="f-3621"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3621"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3621"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3621"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3622"
          xlink:label="f-3622"
          xlink:type="locator"/>
        <link:footnote id="fn-22" xlink:label="fn-22" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">The investment is not a qualifying asset under Section 55(a) of the 1940 Act. The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70% of the Company&#x2019;s total assets. As of December&#160;31, 2022, non-qualifying assets represented 11.0% of total assets as calculated in accordance with regulatory requirements.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3622"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3622"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnote id="fn-26" xlink:label="fn-26" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was 0.75%</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3622"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3622"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3623"
          xlink:label="f-3623"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3623"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3623"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3623"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3623"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3623"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3623"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3624"
          xlink:label="f-3624"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3624"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3624"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3624"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3624"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3625"
          xlink:label="f-3625"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3625"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3625"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3625"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3625"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3625"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3626"
          xlink:label="f-3626"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3626"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3626"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3626"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3626"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3627"
          xlink:label="f-3627"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3627"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3627"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3627"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3627"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3628"
          xlink:label="f-3628"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3628"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3628"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3628"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3628"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3629"
          xlink:label="f-3629"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3629"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3629"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3629"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3629"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3629"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3629"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3610"
          xlink:label="f-3610"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3610"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3610"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3610"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3610"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3610"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3610"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3612"
          xlink:label="f-3612"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3612"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3612"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3612"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3612"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3613"
          xlink:label="f-3613"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3613"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3613"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3613"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3613"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3613"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3614"
          xlink:label="f-3614"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3614"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3614"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3614"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3614"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3615"
          xlink:label="f-3615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3615"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3615"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3615"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3615"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3616"
          xlink:label="f-3616"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3616"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3616"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3616"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3617"
          xlink:label="f-3617"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3617"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3617"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3617"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3617"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3617"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3618"
          xlink:label="f-3618"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3618"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3618"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3618"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3619"
          xlink:label="f-3619"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3619"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3619"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3619"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3619"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1859"
          xlink:label="f-1859"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1859"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1859"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1859"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1859"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1859"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1859"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1859"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1858"
          xlink:label="f-1858"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1858"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1858"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1858"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1858"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1858"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1858"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1857"
          xlink:label="f-1857"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1857"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1857"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1857"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1857"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnote id="fn-11" xlink:label="fn-11" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The interest rate floor on these investments as of December&#160;31, 2023 was 1.00%</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1857"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1856"
          xlink:label="f-1856"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1856"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1856"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1856"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1856"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1856"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1855"
          xlink:label="f-1855"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1855"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1855"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1855"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1855"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1855"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1855"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1854"
          xlink:label="f-1854"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1854"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1854"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1854"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1854"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1854"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1853"
          xlink:label="f-1853"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1853"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1853"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1853"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1853"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1853"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1853"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1853"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1852"
          xlink:label="f-1852"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1852"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1852"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1852"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1852"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1852"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1852"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1851"
          xlink:label="f-1851"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1851"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1851"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1851"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1851"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1851"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1850"
          xlink:label="f-1850"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1850"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1850"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1850"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1850"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1850"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1869"
          xlink:label="f-1869"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1869"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1869"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1869"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1868"
          xlink:label="f-1868"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1868"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1868"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1868"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1867"
          xlink:label="f-1867"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1867"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1867"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1867"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1867"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1866"
          xlink:label="f-1866"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1866"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1866"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1866"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1865"
          xlink:label="f-1865"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1865"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1865"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1865"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1865"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1865"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1864"
          xlink:label="f-1864"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1864"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1864"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1864"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1864"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1863"
          xlink:label="f-1863"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1863"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1863"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1863"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1863"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1863"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1862"
          xlink:label="f-1862"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1862"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1862"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1862"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1862"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1862"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1861"
          xlink:label="f-1861"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1861"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1861"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1861"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1861"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1861"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1861"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1860"
          xlink:label="f-1860"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1860"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1860"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1860"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1860"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1860"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1879"
          xlink:label="f-1879"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1879"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1879"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1879"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1879"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1879"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1879"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1878"
          xlink:label="f-1878"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1878"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1878"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1878"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1878"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1878"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1877"
          xlink:label="f-1877"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1877"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1877"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1877"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1877"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1877"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1877"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1877"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1876"
          xlink:label="f-1876"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1876"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1876"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1876"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1876"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1876"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1876"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1875"
          xlink:label="f-1875"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1875"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1875"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1875"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1874"
          xlink:label="f-1874"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1874"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1874"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1874"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1873"
          xlink:label="f-1873"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1873"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1873"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1873"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1873"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1872"
          xlink:label="f-1872"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1872"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1872"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1872"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1871"
          xlink:label="f-1871"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1871"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1871"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1871"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1871"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1871"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1870"
          xlink:label="f-1870"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1870"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1870"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1870"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1870"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1889"
          xlink:label="f-1889"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1889"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1889"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1889"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1889"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1889"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1889"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1889"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1888"
          xlink:label="f-1888"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1888"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1888"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1888"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1888"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1888"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1888"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1887"
          xlink:label="f-1887"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1887"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1887"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnote id="fn-8" xlink:label="fn-8" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">There are no interest rate floors on these investments.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1887"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1886"
          xlink:label="f-1886"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1886"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1886"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1886"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1885"
          xlink:label="f-1885"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1885"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1885"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1885"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1885"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1884"
          xlink:label="f-1884"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1884"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1884"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1884"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1883"
          xlink:label="f-1883"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1883"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1883"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1883"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1883"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1883"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1882"
          xlink:label="f-1882"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1882"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1882"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1882"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1882"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1881"
          xlink:label="f-1881"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1881"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1881"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1881"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1881"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1881"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1880"
          xlink:label="f-1880"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1880"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1880"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1880"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1880"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1880"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3680"
          xlink:label="f-3680"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3680"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3680"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3680"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3680"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3681"
          xlink:label="f-3681"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3681"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3681"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3681"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3681"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3682"
          xlink:label="f-3682"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3682"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3682"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3682"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3682"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3683"
          xlink:label="f-3683"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3683"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3683"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3683"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3683"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3683"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3683"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3684"
          xlink:label="f-3684"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3684"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3684"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3684"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3684"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3685"
          xlink:label="f-3685"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3685"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3685"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3685"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3685"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3685"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3686"
          xlink:label="f-3686"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3686"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3686"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3686"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3686"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3687"
          xlink:label="f-3687"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3687"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3687"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3687"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3687"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3688"
          xlink:label="f-3688"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3688"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3688"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3688"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3688"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3688"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3689"
          xlink:label="f-3689"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3689"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3689"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3689"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3689"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3689"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3689"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3689"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1019"
          xlink:label="f-1019"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1019"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1019"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1019"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1019"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1019"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1018"
          xlink:label="f-1018"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1018"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1018"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1018"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1018"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2349"
          xlink:label="f-2349"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2349"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2349"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2349"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2349"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2349"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1017"
          xlink:label="f-1017"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1017"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1017"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1017"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2348"
          xlink:label="f-2348"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2348"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2348"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2348"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1016"
          xlink:label="f-1016"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1016"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1016"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1016"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2347"
          xlink:label="f-2347"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2347"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2347"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2347"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1015"
          xlink:label="f-1015"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1015"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1015"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1015"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1015"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2346"
          xlink:label="f-2346"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2346"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2346"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2346"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2346"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1014"
          xlink:label="f-1014"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1014"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1014"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1014"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2345"
          xlink:label="f-2345"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2345"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2345"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2345"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1013"
          xlink:label="f-1013"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1013"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1013"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1013"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1013"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1013"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2344"
          xlink:label="f-2344"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2344"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2344"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2344"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2344"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2344"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1012"
          xlink:label="f-1012"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1012"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1012"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1012"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1012"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2343"
          xlink:label="f-2343"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2343"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2343"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2343"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2343"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1011"
          xlink:label="f-1011"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1011"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1011"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2342"
          xlink:label="f-2342"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2342"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2342"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2342"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1010"
          xlink:label="f-1010"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1010"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1010"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2341"
          xlink:label="f-2341"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2341"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2341"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2341"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2340"
          xlink:label="f-2340"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2340"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2340"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2340"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2340"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3670"
          xlink:label="f-3670"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3670"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3670"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3670"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3670"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3671"
          xlink:label="f-3671"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3671"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3671"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3671"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3671"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3671"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3671"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3672"
          xlink:label="f-3672"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3672"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3672"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3672"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3672"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3673"
          xlink:label="f-3673"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3673"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3673"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3673"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3673"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3673"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3674"
          xlink:label="f-3674"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3674"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3674"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3674"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3674"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3675"
          xlink:label="f-3675"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3675"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3675"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3675"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3675"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3676"
          xlink:label="f-3676"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3676"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3676"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3676"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3676"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3677"
          xlink:label="f-3677"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3677"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3677"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3677"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3677"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3677"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3677"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3678"
          xlink:label="f-3678"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3678"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3678"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3678"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3678"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3679"
          xlink:label="f-3679"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3679"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3679"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3679"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3679"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3679"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1029"
          xlink:label="f-1029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1029"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1029"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1029"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1028"
          xlink:label="f-1028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1028"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1028"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1028"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1028"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2359"
          xlink:label="f-2359"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2359"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2359"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2359"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2359"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2359"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1027"
          xlink:label="f-1027"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1027"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1027"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1027"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2358"
          xlink:label="f-2358"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2358"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2358"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2358"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2358"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2358"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2358"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1026"
          xlink:label="f-1026"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1026"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1026"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1026"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1026"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1026"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2357"
          xlink:label="f-2357"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2357"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2357"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2357"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2357"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2357"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1025"
          xlink:label="f-1025"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1025"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1025"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1025"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1025"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1025"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2356"
          xlink:label="f-2356"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2356"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2356"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2356"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2356"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2356"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2356"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2356"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1024"
          xlink:label="f-1024"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1024"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1024"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1024"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1024"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2355"
          xlink:label="f-2355"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2355"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2355"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2355"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2355"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2355"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2355"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1023"
          xlink:label="f-1023"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1023"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1023"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1023"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2354"
          xlink:label="f-2354"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2354"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2354"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2354"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2354"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1022"
          xlink:label="f-1022"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1022"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1022"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1022"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2353"
          xlink:label="f-2353"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2353"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2353"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2353"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2353"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1021"
          xlink:label="f-1021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1021"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1021"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1021"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1021"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2352"
          xlink:label="f-2352"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2352"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2352"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2352"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2352"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2352"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1020"
          xlink:label="f-1020"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1020"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1020"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1020"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2351"
          xlink:label="f-2351"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2351"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2351"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2351"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2351"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2350"
          xlink:label="f-2350"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2350"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2350"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2350"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2350"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2350"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2350"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1039"
          xlink:label="f-1039"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1039"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1039"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1038"
          xlink:label="f-1038"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1038"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1038"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2369"
          xlink:label="f-2369"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2369"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2369"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2369"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1037"
          xlink:label="f-1037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1037"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1037"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1037"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2368"
          xlink:label="f-2368"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2368"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2368"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2368"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2368"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2368"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1036"
          xlink:label="f-1036"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1036"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1036"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2367"
          xlink:label="f-2367"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2367"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2367"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2367"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2367"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1035"
          xlink:label="f-1035"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1035"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1035"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1035"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1035"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2366"
          xlink:label="f-2366"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2366"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2366"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2366"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1034"
          xlink:label="f-1034"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1034"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1034"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1034"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2365"
          xlink:label="f-2365"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2365"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2365"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2365"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2364"
          xlink:label="f-2364"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2364"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2364"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2364"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2364"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2363"
          xlink:label="f-2363"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2363"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2363"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2363"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2362"
          xlink:label="f-2362"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2362"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2362"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2362"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2362"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2362"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1030"
          xlink:label="f-1030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1030"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1030"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1030"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2361"
          xlink:label="f-2361"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2361"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2361"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2361"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2361"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2360"
          xlink:label="f-2360"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2360"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2360"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2360"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2360"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2360"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3690"
          xlink:label="f-3690"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3690"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3690"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3690"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3690"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3690"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3691"
          xlink:label="f-3691"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3691"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3691"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3691"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3691"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3691"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3691"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3692"
          xlink:label="f-3692"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3692"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3692"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3692"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3692"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3692"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3693"
          xlink:label="f-3693"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3693"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3693"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3693"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3693"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3693"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3694"
          xlink:label="f-3694"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3694"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3694"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3697"
          xlink:label="f-3697"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3697"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3697"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3697"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3697"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3697"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3698"
          xlink:label="f-3698"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3698"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3698"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3698"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3698"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3698"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3698"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3698"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3699"
          xlink:label="f-3699"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3699"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3699"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3699"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3699"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3699"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1049"
          xlink:label="f-1049"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1049"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1049"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1049"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2379"
          xlink:label="f-2379"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2379"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2379"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2379"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2379"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2379"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2378"
          xlink:label="f-2378"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2378"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2378"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2378"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2377"
          xlink:label="f-2377"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2377"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2377"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2377"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1045"
          xlink:label="f-1045"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1045"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1045"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2376"
          xlink:label="f-2376"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2376"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2376"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2376"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2376"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1044"
          xlink:label="f-1044"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1044"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1044"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2375"
          xlink:label="f-2375"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2375"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2375"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2375"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1043"
          xlink:label="f-1043"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1043"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1043"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1043"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2374"
          xlink:label="f-2374"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2374"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2374"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2374"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2374"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2374"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1042"
          xlink:label="f-1042"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1042"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1042"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2373"
          xlink:label="f-2373"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2373"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2373"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2373"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2373"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1041"
          xlink:label="f-1041"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1041"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1041"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1041"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1041"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2372"
          xlink:label="f-2372"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2372"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2372"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2372"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1040"
          xlink:label="f-1040"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1040"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1040"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1040"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2371"
          xlink:label="f-2371"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2371"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2371"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2371"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2370"
          xlink:label="f-2370"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2370"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2370"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2370"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2370"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3640"
          xlink:label="f-3640"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3640"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3640"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3640"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3640"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3640"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3641"
          xlink:label="f-3641"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3641"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3641"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3641"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3641"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3641"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3641"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3641"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3642"
          xlink:label="f-3642"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3642"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3642"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3642"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3642"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3642"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3643"
          xlink:label="f-3643"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3643"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3643"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3643"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3643"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3643"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3643"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3644"
          xlink:label="f-3644"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3644"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3644"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3644"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3644"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3644"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3645"
          xlink:label="f-3645"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3645"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3645"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3645"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3645"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3645"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3646"
          xlink:label="f-3646"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3646"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3646"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3646"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3646"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3647"
          xlink:label="f-3647"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3647"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3647"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3647"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3647"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3647"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3647"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2309"
          xlink:label="f-2309"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2309"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2309"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnote id="fn-16" xlink:label="fn-16" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">These loans are &#x201c;last-out&#x201d; portions of loans. The &#x201c;last-out&#x201d; portion of the Company's loan investment generally earns a higher interest rate than the &#x201c;first-out&#x201d; portion, and in exchange the &#x201c;first-out&#x201d; portion would generally receive priority with respect to payment principal, interest and any other amounts due thereunder over the &#x201c;last-out&#x201d; portion.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2309"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2309"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3648"
          xlink:label="f-3648"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3648"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3648"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3648"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3648"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2308"
          xlink:label="f-2308"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2308"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2308"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2308"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2308"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2308"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2308"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3649"
          xlink:label="f-3649"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3649"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3649"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3649"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3649"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3649"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2307"
          xlink:label="f-2307"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2307"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2307"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2307"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2307"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2307"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2304"
          xlink:label="f-2304"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2304"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2304"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2303"
          xlink:label="f-2303"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2303"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2303"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2303"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2303"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2303"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2302"
          xlink:label="f-2302"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2302"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2302"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2302"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2302"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2302"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2301"
          xlink:label="f-2301"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2301"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2301"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2301"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2301"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2301"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2301"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2300"
          xlink:label="f-2300"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2300"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2300"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2300"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2300"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2300"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3630"
          xlink:label="f-3630"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3630"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3630"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3630"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3630"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3631"
          xlink:label="f-3631"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3631"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3631"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3631"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3631"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3631"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3632"
          xlink:label="f-3632"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3632"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3632"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3632"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3632"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3633"
          xlink:label="f-3633"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3633"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3633"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3633"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3633"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3634"
          xlink:label="f-3634"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3634"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3634"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3634"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3634"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3635"
          xlink:label="f-3635"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3635"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3635"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3635"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3635"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3635"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3635"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3636"
          xlink:label="f-3636"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3636"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3636"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3636"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3636"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3637"
          xlink:label="f-3637"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3637"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3637"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3637"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3637"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3637"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2319"
          xlink:label="f-2319"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2319"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2319"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2319"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2319"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3638"
          xlink:label="f-3638"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3638"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3638"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3638"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3638"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2318"
          xlink:label="f-2318"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2318"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2318"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2318"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3639"
          xlink:label="f-3639"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3639"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3639"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3639"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3639"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2317"
          xlink:label="f-2317"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2317"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2317"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2317"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2316"
          xlink:label="f-2316"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2316"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2316"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2316"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2316"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2315"
          xlink:label="f-2315"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2315"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2315"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2315"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2314"
          xlink:label="f-2314"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2314"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2314"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2314"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2314"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2314"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2313"
          xlink:label="f-2313"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2313"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2313"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2313"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2313"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2312"
          xlink:label="f-2312"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2312"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2312"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2312"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2312"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2311"
          xlink:label="f-2311"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2311"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2311"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2311"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2311"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2310"
          xlink:label="f-2310"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2310"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2310"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2310"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2310"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2310"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3660"
          xlink:label="f-3660"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3660"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3660"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3660"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3660"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3660"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3660"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3661"
          xlink:label="f-3661"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3661"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3661"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3661"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3661"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3661"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3661"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3661"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3662"
          xlink:label="f-3662"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3662"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3662"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3662"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3662"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3662"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3662"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3663"
          xlink:label="f-3663"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3663"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3663"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3663"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3663"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3663"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3663"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3664"
          xlink:label="f-3664"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3664"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3664"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3664"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3664"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3665"
          xlink:label="f-3665"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3665"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3665"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3665"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3665"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3665"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3665"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3666"
          xlink:label="f-3666"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3666"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3666"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3666"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3666"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3667"
          xlink:label="f-3667"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3667"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3667"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3667"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3667"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3667"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3668"
          xlink:label="f-3668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3668"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3668"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3668"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3668"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3669"
          xlink:label="f-3669"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3669"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3669"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3669"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3669"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2329"
          xlink:label="f-2329"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2329"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2329"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2329"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2328"
          xlink:label="f-2328"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2328"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2328"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2328"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2328"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2327"
          xlink:label="f-2327"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2327"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2327"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2327"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2326"
          xlink:label="f-2326"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2326"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2326"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2326"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2326"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2326"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2325"
          xlink:label="f-2325"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2325"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2325"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2325"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2325"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2324"
          xlink:label="f-2324"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2324"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2324"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2324"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2323"
          xlink:label="f-2323"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2323"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2323"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2323"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2322"
          xlink:label="f-2322"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2322"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2322"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2322"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2322"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2321"
          xlink:label="f-2321"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2321"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2321"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2321"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2320"
          xlink:label="f-2320"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2320"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2320"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2320"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2320"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2320"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3650"
          xlink:label="f-3650"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3650"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3650"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3650"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3650"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3651"
          xlink:label="f-3651"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3651"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3651"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3651"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3651"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3652"
          xlink:label="f-3652"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3652"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3652"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3652"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3652"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3652"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3653"
          xlink:label="f-3653"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3653"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3653"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3653"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3653"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3653"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3653"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3653"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3654"
          xlink:label="f-3654"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3654"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3654"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3654"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3654"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3654"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3655"
          xlink:label="f-3655"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3655"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3655"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3655"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3655"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3655"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3655"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3656"
          xlink:label="f-3656"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3656"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3656"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3656"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3656"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3656"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3657"
          xlink:label="f-3657"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3657"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3657"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3657"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3657"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3657"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3658"
          xlink:label="f-3658"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3658"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3658"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3658"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3658"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3658"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3658"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3659"
          xlink:label="f-3659"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3659"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3659"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3659"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3659"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3659"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3659"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3659"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3659"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1009"
          xlink:label="f-1009"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1009"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1009"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1009"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1008"
          xlink:label="f-1008"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1008"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1008"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2339"
          xlink:label="f-2339"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2339"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2339"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2339"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1007"
          xlink:label="f-1007"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1007"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1007"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1007"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1007"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2338"
          xlink:label="f-2338"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2338"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2338"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2338"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2338"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2338"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1006"
          xlink:label="f-1006"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1006"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1006"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1006"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2337"
          xlink:label="f-2337"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2337"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2337"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2337"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2337"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2336"
          xlink:label="f-2336"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2336"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2336"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2336"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2336"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2335"
          xlink:label="f-2335"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2335"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2335"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2335"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2335"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2334"
          xlink:label="f-2334"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2334"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2334"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2334"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2334"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2334"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1002"
          xlink:label="f-1002"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1002"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1002"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1002"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2333"
          xlink:label="f-2333"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2333"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2333"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2333"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2333"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1001"
          xlink:label="f-1001"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1001"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1001"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1001"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2332"
          xlink:label="f-2332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2332"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2332"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2332"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2332"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2332"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2332"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1000"
          xlink:label="f-1000"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1000"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1000"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1000"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1000"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2331"
          xlink:label="f-2331"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2331"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2331"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2331"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2331"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2331"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2330"
          xlink:label="f-2330"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2330"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2330"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2330"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4130"
          xlink:label="f-4130"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4130"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4130"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4130"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4130"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-799"
          xlink:label="f-799"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-799"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-799"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-799"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4131"
          xlink:label="f-4131"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4131"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4131"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4131"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4131"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4132"
          xlink:label="f-4132"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4132"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4132"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4135"
          xlink:label="f-4135"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4135"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4135"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4135"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4135"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4136"
          xlink:label="f-4136"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4136"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4136"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4136"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4136"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4136"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4136"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4137"
          xlink:label="f-4137"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4137"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4137"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4137"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4137"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4138"
          xlink:label="f-4138"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4138"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4138"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4138"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4138"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4138"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4139"
          xlink:label="f-4139"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4139"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4139"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4139"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4139"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-790"
          xlink:label="f-790"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-790"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-790"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-790"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-790"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-793"
          xlink:label="f-793"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-793"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-793"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-793"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-794"
          xlink:label="f-794"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-794"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-794"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-794"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-794"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1099"
          xlink:label="f-1099"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1099"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1099"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1099"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1099"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-791"
          xlink:label="f-791"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-791"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-791"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-791"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1098"
          xlink:label="f-1098"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1098"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1098"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1098"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1098"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1098"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1098"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-792"
          xlink:label="f-792"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-792"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-792"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-792"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1097"
          xlink:label="f-1097"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1097"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1097"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1097"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1097"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1097"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-797"
          xlink:label="f-797"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-797"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-797"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1096"
          xlink:label="f-1096"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1096"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1096"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1096"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-798"
          xlink:label="f-798"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-798"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-798"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1095"
          xlink:label="f-1095"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1095"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1095"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1095"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-795"
          xlink:label="f-795"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-795"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-795"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1094"
          xlink:label="f-1094"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1094"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1094"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1094"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1094"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-796"
          xlink:label="f-796"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-796"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-796"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-796"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1093"
          xlink:label="f-1093"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1093"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1093"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1093"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-788"
          xlink:label="f-788"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-788"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-788"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-788"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-788"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-788"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4120"
          xlink:label="f-4120"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4120"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4120"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4120"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4120"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-789"
          xlink:label="f-789"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-789"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-789"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-789"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4121"
          xlink:label="f-4121"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4121"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4121"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4121"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4121"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4121"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4121"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4122"
          xlink:label="f-4122"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4122"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4122"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4122"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4122"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4123"
          xlink:label="f-4123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4123"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4123"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4123"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4123"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4123"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4124"
          xlink:label="f-4124"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4124"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4124"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4124"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4124"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4125"
          xlink:label="f-4125"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4125"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4125"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4125"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4125"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4126"
          xlink:label="f-4126"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4126"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4126"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4126"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4126"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4127"
          xlink:label="f-4127"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4127"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4127"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4127"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4127"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4127"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4127"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4128"
          xlink:label="f-4128"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4128"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4128"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4128"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4128"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4129"
          xlink:label="f-4129"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4129"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4129"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4129"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4129"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4129"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-782"
          xlink:label="f-782"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-782"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-782"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-782"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-782"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-782"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-783"
          xlink:label="f-783"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-783"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-783"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-783"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-780"
          xlink:label="f-780"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-780"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-780"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-780"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-781"
          xlink:label="f-781"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-781"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-781"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-781"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-781"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-786"
          xlink:label="f-786"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-786"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-786"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-786"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-787"
          xlink:label="f-787"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-787"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-787"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-787"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-787"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-784"
          xlink:label="f-784"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-784"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-784"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-784"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-784"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-785"
          xlink:label="f-785"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-785"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-785"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-785"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4151"
          xlink:label="f-4151"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4151"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4151"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4151"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4151"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4151"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4151"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4151"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4152"
          xlink:label="f-4152"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4152"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4152"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4152"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4152"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4152"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4153"
          xlink:label="f-4153"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4153"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4153"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4153"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4153"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4153"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4153"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4154"
          xlink:label="f-4154"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4154"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4154"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4154"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4154"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4154"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4155"
          xlink:label="f-4155"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4155"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4155"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4155"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4155"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4155"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4156"
          xlink:label="f-4156"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4156"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4156"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4156"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4156"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4156"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4157"
          xlink:label="f-4157"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4157"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4157"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4157"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4157"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4157"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4157"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4157"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4158"
          xlink:label="f-4158"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4158"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4158"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4158"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4158"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4158"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4159"
          xlink:label="f-4159"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4159"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4159"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4159"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4159"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4159"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4159"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4160"
          xlink:label="f-4160"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4160"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4160"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4160"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4160"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4160"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4161"
          xlink:label="f-4161"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4161"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4161"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4161"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4161"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4161"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4140"
          xlink:label="f-4140"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4140"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4140"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4140"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4140"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4141"
          xlink:label="f-4141"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4141"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4141"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4141"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4141"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4142"
          xlink:label="f-4142"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4142"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4142"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4142"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4142"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4142"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4142"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4143"
          xlink:label="f-4143"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4143"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4143"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4143"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4143"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4144"
          xlink:label="f-4144"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4144"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4144"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4144"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4144"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4144"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4145"
          xlink:label="f-4145"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4145"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4145"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4145"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4145"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4146"
          xlink:label="f-4146"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4146"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4146"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4146"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4146"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4147"
          xlink:label="f-4147"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4147"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4147"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4150"
          xlink:label="f-4150"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4150"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4150"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4150"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4150"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4150"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-757"
          xlink:label="f-757"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-757"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-757"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-757"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-757"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-757"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2390"
          xlink:label="f-2390"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2390"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2390"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2390"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2390"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2390"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-758"
          xlink:label="f-758"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-758"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-758"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-758"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-758"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-758"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-758"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-755"
          xlink:label="f-755"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-755"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-755"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-756"
          xlink:label="f-756"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-756"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-756"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-759"
          xlink:label="f-759"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-759"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-759"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-759"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-759"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1059"
          xlink:label="f-1059"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1059"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1059"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1059"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1058"
          xlink:label="f-1058"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1058"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1058"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1058"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1058"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2389"
          xlink:label="f-2389"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2389"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2389"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2389"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2389"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2389"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1057"
          xlink:label="f-1057"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1057"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1057"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1057"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2388"
          xlink:label="f-2388"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2388"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2388"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2388"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2388"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2388"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2388"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1056"
          xlink:label="f-1056"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1056"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1056"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1056"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1056"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1056"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2387"
          xlink:label="f-2387"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2387"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2387"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2387"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2387"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2387"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-750"
          xlink:label="f-750"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-750"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-750"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-750"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1055"
          xlink:label="f-1055"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1055"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1055"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1055"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1055"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2386"
          xlink:label="f-2386"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2386"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2386"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2386"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2386"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2386"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2386"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2386"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1054"
          xlink:label="f-1054"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1054"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1054"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2385"
          xlink:label="f-2385"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2385"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2385"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2385"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2385"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2385"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2385"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1053"
          xlink:label="f-1053"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1053"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1053"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2384"
          xlink:label="f-2384"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2384"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2384"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2384"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2384"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-753"
          xlink:label="f-753"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-753"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-753"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1052"
          xlink:label="f-1052"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1052"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1052"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1052"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2383"
          xlink:label="f-2383"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2383"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2383"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2383"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2383"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-754"
          xlink:label="f-754"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-754"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-754"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-754"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1051"
          xlink:label="f-1051"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1051"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1051"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2382"
          xlink:label="f-2382"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2382"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2382"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2382"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2382"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2382"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-751"
          xlink:label="f-751"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-751"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-751"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-751"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1050"
          xlink:label="f-1050"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1050"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1050"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1050"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1050"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2381"
          xlink:label="f-2381"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2381"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2381"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2381"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2381"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-752"
          xlink:label="f-752"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-752"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-752"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-752"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-752"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2380"
          xlink:label="f-2380"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2380"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2380"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2380"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2380"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2380"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2380"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-746"
          xlink:label="f-746"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-746"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-746"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-746"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-746"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-746"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1070"
          xlink:label="f-1070"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1070"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1070"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1070"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-747"
          xlink:label="f-747"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-747"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-747"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-747"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-744"
          xlink:label="f-744"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-744"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-744"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-744"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-744"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-744"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-745"
          xlink:label="f-745"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-745"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-745"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-745"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-745"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-748"
          xlink:label="f-748"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-748"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-748"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-748"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-748"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-749"
          xlink:label="f-749"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-749"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-749"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-749"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1069"
          xlink:label="f-1069"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1069"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1069"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1069"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1069"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1068"
          xlink:label="f-1068"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1068"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1068"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1068"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1068"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2399"
          xlink:label="f-2399"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2399"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2399"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2399"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1067"
          xlink:label="f-1067"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1067"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1067"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1067"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1067"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1067"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2398"
          xlink:label="f-2398"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2398"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2398"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2398"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2398"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2398"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1066"
          xlink:label="f-1066"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1066"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1066"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1066"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1066"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2397"
          xlink:label="f-2397"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2397"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2397"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2397"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2397"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1065"
          xlink:label="f-1065"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1065"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1065"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1065"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1065"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1065"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1065"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2396"
          xlink:label="f-2396"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2396"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2396"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2396"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2396"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1064"
          xlink:label="f-1064"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1064"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1064"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1064"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1064"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1064"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2395"
          xlink:label="f-2395"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2395"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2395"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2395"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2395"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-742"
          xlink:label="f-742"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-742"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-742"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-742"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-742"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-742"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-742"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2394"
          xlink:label="f-2394"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2394"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2394"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2394"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2394"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2394"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-743"
          xlink:label="f-743"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-743"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-743"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-743"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-743"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-743"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2393"
          xlink:label="f-2393"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2393"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2393"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2393"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2393"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-740"
          xlink:label="f-740"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-740"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-740"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-740"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-740"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-740"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-740"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-740"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2392"
          xlink:label="f-2392"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2392"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2392"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2392"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2392"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2392"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2392"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-741"
          xlink:label="f-741"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-741"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-741"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-741"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-741"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-741"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1060"
          xlink:label="f-1060"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1060"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1060"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1060"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2391"
          xlink:label="f-2391"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2391"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2391"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2391"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2391"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2391"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-779"
          xlink:label="f-779"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-779"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-779"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-779"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1081"
          xlink:label="f-1081"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1081"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1081"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1081"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1080"
          xlink:label="f-1080"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1080"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1080"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1080"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1080"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1080"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-777"
          xlink:label="f-777"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-777"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-777"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-777"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-778"
          xlink:label="f-778"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-778"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-778"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-778"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-778"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4110"
          xlink:label="f-4110"
          xlink:type="locator"/>
        <link:footnote id="fn-24" xlink:label="fn-24" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">There are no interest rate floors on these investments.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4110"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4110"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4110"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4110"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4111"
          xlink:label="f-4111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4111"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4111"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4111"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4111"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4111"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4112"
          xlink:label="f-4112"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4112"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4112"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4112"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4112"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4113"
          xlink:label="f-4113"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4113"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4113"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4113"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4113"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4114"
          xlink:label="f-4114"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4114"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4114"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4114"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4114"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4115"
          xlink:label="f-4115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4115"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4115"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4115"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4115"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4115"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4115"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4116"
          xlink:label="f-4116"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4116"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4116"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4116"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4116"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4117"
          xlink:label="f-4117"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4117"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4117"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4117"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4117"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4117"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4118"
          xlink:label="f-4118"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4118"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4118"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4118"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4118"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4119"
          xlink:label="f-4119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4119"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4119"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4119"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4119"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1079"
          xlink:label="f-1079"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1079"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1079"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1079"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1079"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-771"
          xlink:label="f-771"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-771"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-771"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-771"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-772"
          xlink:label="f-772"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-772"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-772"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-772"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-772"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-770"
          xlink:label="f-770"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-770"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-770"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-770"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-770"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-770"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1075"
          xlink:label="f-1075"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1075"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1075"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-775"
          xlink:label="f-775"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-775"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-775"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-775"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-775"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1074"
          xlink:label="f-1074"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1074"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1074"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-776"
          xlink:label="f-776"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-776"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-776"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-776"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-776"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-776"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1073"
          xlink:label="f-1073"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1073"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1073"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1073"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-773"
          xlink:label="f-773"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-773"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-773"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-773"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1072"
          xlink:label="f-1072"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1072"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1072"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-774"
          xlink:label="f-774"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-774"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-774"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-774"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1071"
          xlink:label="f-1071"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1071"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1071"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1071"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1071"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-768"
          xlink:label="f-768"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-768"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-768"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-768"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1092"
          xlink:label="f-1092"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1092"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1092"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1092"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1092"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1092"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-769"
          xlink:label="f-769"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-769"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-769"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-769"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-769"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1091"
          xlink:label="f-1091"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1091"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1091"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1091"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1091"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-766"
          xlink:label="f-766"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-766"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-766"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-766"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-766"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1090"
          xlink:label="f-1090"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1090"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1090"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1090"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-767"
          xlink:label="f-767"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-767"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-767"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-767"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4100"
          xlink:label="f-4100"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4100"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4100"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4100"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4100"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4101"
          xlink:label="f-4101"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4101"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4101"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4101"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4101"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4102"
          xlink:label="f-4102"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4102"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4102"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4102"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4102"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4103"
          xlink:label="f-4103"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4103"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4103"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4103"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4103"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4103"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4103"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4104"
          xlink:label="f-4104"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4104"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4104"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4104"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4104"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4105"
          xlink:label="f-4105"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4105"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4105"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4105"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4105"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4105"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4106"
          xlink:label="f-4106"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4106"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4106"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4106"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4106"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4107"
          xlink:label="f-4107"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4107"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4107"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4107"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4107"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4108"
          xlink:label="f-4108"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4108"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4108"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4108"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4108"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4109"
          xlink:label="f-4109"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4109"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4109"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4109"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4109"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4109"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4109"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-760"
          xlink:label="f-760"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-760"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-760"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-760"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-760"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-760"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1089"
          xlink:label="f-1089"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1089"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1089"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1089"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-761"
          xlink:label="f-761"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-761"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-761"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-761"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-761"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1088"
          xlink:label="f-1088"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1088"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1088"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1088"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1088"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1087"
          xlink:label="f-1087"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1087"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1087"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1087"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1086"
          xlink:label="f-1086"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1086"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1086"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1086"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1086"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1086"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-764"
          xlink:label="f-764"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-764"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-764"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-764"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-764"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-764"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1085"
          xlink:label="f-1085"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1085"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1085"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1085"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1085"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-765"
          xlink:label="f-765"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-765"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-765"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-765"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1084"
          xlink:label="f-1084"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1084"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1084"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1084"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-762"
          xlink:label="f-762"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-762"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-762"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-762"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-762"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1083"
          xlink:label="f-1083"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1083"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1083"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1083"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-763"
          xlink:label="f-763"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-763"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-763"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-763"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-763"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1082"
          xlink:label="f-1082"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1082"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1082"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1082"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1082"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-713"
          xlink:label="f-713"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-713"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-713"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-713"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-713"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-713"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-714"
          xlink:label="f-714"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-714"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-714"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-714"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-711"
          xlink:label="f-711"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-711"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-711"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-711"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-712"
          xlink:label="f-712"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-712"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-712"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-712"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-712"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-717"
          xlink:label="f-717"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-717"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-717"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-717"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-718"
          xlink:label="f-718"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-718"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-718"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-718"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-718"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-718"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-715"
          xlink:label="f-715"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-715"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-715"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-715"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-715"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-716"
          xlink:label="f-716"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-716"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-716"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-716"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-719"
          xlink:label="f-719"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-719"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-719"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-719"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-719"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-719"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-719"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1939"
          xlink:label="f-1939"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1939"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1939"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1939"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1939"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1938"
          xlink:label="f-1938"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1938"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1938"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1938"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1937"
          xlink:label="f-1937"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1937"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1937"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1937"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1937"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1937"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1936"
          xlink:label="f-1936"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1936"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1936"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1936"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1936"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1935"
          xlink:label="f-1935"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1935"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1935"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1935"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1935"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1934"
          xlink:label="f-1934"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1934"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1934"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1934"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1934"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1933"
          xlink:label="f-1933"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1933"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1933"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1933"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1933"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1933"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1932"
          xlink:label="f-1932"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1932"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1932"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1932"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1932"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1931"
          xlink:label="f-1931"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1931"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1931"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1931"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1931"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1931"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1931"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1930"
          xlink:label="f-1930"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1930"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1930"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1930"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1930"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1930"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-710"
          xlink:label="f-710"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-710"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-710"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-710"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-702"
          xlink:label="f-702"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-702"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-702"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-702"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-702"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-703"
          xlink:label="f-703"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-703"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-703"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-703"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-703"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-703"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-700"
          xlink:label="f-700"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-700"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-700"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-700"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-700"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-700"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-701"
          xlink:label="f-701"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-701"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-701"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-701"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-701"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-701"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-701"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-706"
          xlink:label="f-706"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-706"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-706"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-706"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-706"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-707"
          xlink:label="f-707"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-707"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-707"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-707"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-707"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-707"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-704"
          xlink:label="f-704"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-704"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-704"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-704"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-704"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-705"
          xlink:label="f-705"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-705"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-705"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-705"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-705"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-708"
          xlink:label="f-708"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-708"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-708"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-708"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-709"
          xlink:label="f-709"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-709"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-709"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-709"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-709"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1948"
          xlink:label="f-1948"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1948"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1948"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1947"
          xlink:label="f-1947"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1947"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1947"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1947"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1947"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1946"
          xlink:label="f-1946"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1946"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1946"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1946"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1946"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1945"
          xlink:label="f-1945"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1945"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1945"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1945"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1945"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1945"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1944"
          xlink:label="f-1944"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1944"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1944"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1944"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1944"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1943"
          xlink:label="f-1943"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1943"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1943"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1943"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1943"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1943"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1943"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1942"
          xlink:label="f-1942"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1942"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1942"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1942"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1942"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1942"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1941"
          xlink:label="f-1941"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1941"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1941"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1941"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1940"
          xlink:label="f-1940"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1940"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1940"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1940"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-735"
          xlink:label="f-735"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-735"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-735"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-735"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-735"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-736"
          xlink:label="f-736"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-736"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-736"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-733"
          xlink:label="f-733"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-733"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-733"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-733"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-733"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-733"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-734"
          xlink:label="f-734"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-734"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-734"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-734"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-734"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-739"
          xlink:label="f-739"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-739"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-739"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-739"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-739"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-739"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-739"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1959"
          xlink:label="f-1959"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1959"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1959"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1959"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1959"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1958"
          xlink:label="f-1958"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1958"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1958"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1958"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1958"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1958"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1958"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1957"
          xlink:label="f-1957"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1957"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1957"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1957"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1957"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1957"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1956"
          xlink:label="f-1956"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1956"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1956"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1956"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1956"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1955"
          xlink:label="f-1955"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1955"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1955"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1955"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1955"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1954"
          xlink:label="f-1954"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1954"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1954"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1954"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1954"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1954"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1953"
          xlink:label="f-1953"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1953"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1953"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1953"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1953"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1952"
          xlink:label="f-1952"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1952"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1952"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1952"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1952"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1952"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1952"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1951"
          xlink:label="f-1951"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1951"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1951"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1951"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1951"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1951"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-731"
          xlink:label="f-731"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-731"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-731"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-731"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-731"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-731"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-731"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-732"
          xlink:label="f-732"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-732"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-732"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-732"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-732"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-730"
          xlink:label="f-730"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-730"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-730"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-730"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-730"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-730"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-724"
          xlink:label="f-724"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-724"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-724"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-724"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-724"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-725"
          xlink:label="f-725"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-725"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-725"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-725"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-725"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-725"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-722"
          xlink:label="f-722"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-722"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-722"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-722"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-722"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-723"
          xlink:label="f-723"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-723"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-723"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-723"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-723"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-728"
          xlink:label="f-728"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-728"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-728"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-728"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-729"
          xlink:label="f-729"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-729"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-729"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-729"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-726"
          xlink:label="f-726"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-726"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-726"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-726"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-727"
          xlink:label="f-727"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-727"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-727"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-727"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-727"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1969"
          xlink:label="f-1969"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1969"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1969"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1968"
          xlink:label="f-1968"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1968"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1968"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1968"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1968"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1967"
          xlink:label="f-1967"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1967"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1967"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1967"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1967"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1966"
          xlink:label="f-1966"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1966"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1966"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1966"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1966"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1966"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1965"
          xlink:label="f-1965"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1965"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1965"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1965"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1965"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1964"
          xlink:label="f-1964"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1964"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1964"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1964"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1964"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1964"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1964"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1963"
          xlink:label="f-1963"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1963"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1963"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1963"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1963"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1963"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1962"
          xlink:label="f-1962"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1962"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1962"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1962"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1962"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1961"
          xlink:label="f-1961"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1961"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1961"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1961"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1961"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1960"
          xlink:label="f-1960"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1960"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1960"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1960"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1960"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1960"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-720"
          xlink:label="f-720"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-720"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-720"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-720"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-720"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-721"
          xlink:label="f-721"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-721"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-721"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-721"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-721"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-721"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4173"
          xlink:label="f-4173"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4173"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4173"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4173"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4173"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4173"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4174"
          xlink:label="f-4174"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4174"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4174"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4174"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4174"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4174"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4175"
          xlink:label="f-4175"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4175"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4175"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4175"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4175"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4175"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4175"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4175"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4176"
          xlink:label="f-4176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4176"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4176"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4176"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4176"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4176"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4177"
          xlink:label="f-4177"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4177"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4177"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4177"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4177"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4177"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4177"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4178"
          xlink:label="f-4178"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4178"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4178"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4178"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4178"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4178"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4179"
          xlink:label="f-4179"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4179"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4179"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4179"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4179"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4179"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4180"
          xlink:label="f-4180"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4180"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4180"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4180"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4180"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4180"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4181"
          xlink:label="f-4181"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4181"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4181"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4181"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4181"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4181"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4181"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4181"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4182"
          xlink:label="f-4182"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4182"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4182"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4182"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4182"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4182"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4183"
          xlink:label="f-4183"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4183"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4183"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4183"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4183"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4183"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4183"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4162"
          xlink:label="f-4162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4162"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4162"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4162"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4162"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4163"
          xlink:label="f-4163"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4163"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4163"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4163"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4163"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4163"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4163"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4164"
          xlink:label="f-4164"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4164"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4164"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4164"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4164"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4165"
          xlink:label="f-4165"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4165"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4165"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4165"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4165"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4165"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4166"
          xlink:label="f-4166"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4166"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4166"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4166"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4166"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4167"
          xlink:label="f-4167"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4167"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4167"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4167"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4167"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4168"
          xlink:label="f-4168"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4168"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4168"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4168"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4168"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4168"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1909"
          xlink:label="f-1909"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1909"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1909"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnote id="fn-9" xlink:label="fn-9" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The interest rate floor on these investments as of December&#160;31, 2023 was 0.50%.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1909"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1909"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1909"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4169"
          xlink:label="f-4169"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4169"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4169"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4169"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4169"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4169"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4169"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4169"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1908"
          xlink:label="f-1908"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1908"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1908"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1908"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1908"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1907"
          xlink:label="f-1907"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1907"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1907"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1907"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1907"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1907"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1907"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1906"
          xlink:label="f-1906"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1906"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1906"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1906"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1906"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1906"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1905"
          xlink:label="f-1905"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1905"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1905"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1905"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1905"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1904"
          xlink:label="f-1904"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1904"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1904"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1904"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1904"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1903"
          xlink:label="f-1903"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1903"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1903"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1903"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1903"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1903"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1902"
          xlink:label="f-1902"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1902"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1902"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1902"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1902"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1901"
          xlink:label="f-1901"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1901"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1901"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1901"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1901"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1901"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1901"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1900"
          xlink:label="f-1900"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1900"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1900"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1900"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1900"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1900"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4170"
          xlink:label="f-4170"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4170"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4170"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4170"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4170"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4170"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4171"
          xlink:label="f-4171"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4171"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4171"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4171"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4171"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4171"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4171"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4172"
          xlink:label="f-4172"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4172"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4172"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4172"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4172"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4172"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4195"
          xlink:label="f-4195"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4195"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4195"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4195"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4195"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4196"
          xlink:label="f-4196"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4196"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4196"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4196"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4197"
          xlink:label="f-4197"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4197"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4197"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4197"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4198"
          xlink:label="f-4198"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4198"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4198"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4198"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4198"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4199"
          xlink:label="f-4199"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4199"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4199"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4199"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4199"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4199"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4199"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1919"
          xlink:label="f-1919"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1919"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1919"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1919"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1919"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1919"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1919"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1918"
          xlink:label="f-1918"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1918"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1918"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1918"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1918"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1918"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1917"
          xlink:label="f-1917"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1917"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1917"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1917"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1917"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1916"
          xlink:label="f-1916"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1916"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1916"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1916"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1916"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1915"
          xlink:label="f-1915"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1915"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1915"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1915"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1915"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1915"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1914"
          xlink:label="f-1914"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1914"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1914"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1914"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1914"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1913"
          xlink:label="f-1913"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1913"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1913"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1913"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1913"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1913"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1913"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1912"
          xlink:label="f-1912"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1912"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1912"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1912"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1912"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1912"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1911"
          xlink:label="f-1911"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1911"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1911"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1911"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1911"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1910"
          xlink:label="f-1910"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1910"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1910"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1910"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1910"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4184"
          xlink:label="f-4184"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4184"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4184"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4184"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4184"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4184"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4185"
          xlink:label="f-4185"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4185"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4185"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4185"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4185"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4185"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4186"
          xlink:label="f-4186"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4186"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4186"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4186"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4186"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4186"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4187"
          xlink:label="f-4187"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4187"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4187"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4187"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4187"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4187"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4187"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4187"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4188"
          xlink:label="f-4188"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4188"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4188"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4188"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4188"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4188"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4189"
          xlink:label="f-4189"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4189"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4189"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4189"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4189"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4189"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4189"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1929"
          xlink:label="f-1929"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1929"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1929"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1929"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1929"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1928"
          xlink:label="f-1928"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1928"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1928"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1928"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1928"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1927"
          xlink:label="f-1927"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1927"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1927"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1927"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1927"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1927"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1926"
          xlink:label="f-1926"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1926"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1926"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1926"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1926"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1925"
          xlink:label="f-1925"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1925"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1925"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1925"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1925"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1925"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1925"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1924"
          xlink:label="f-1924"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1924"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1924"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1924"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1924"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1924"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1923"
          xlink:label="f-1923"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1923"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1923"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1923"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1923"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1922"
          xlink:label="f-1922"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1922"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1922"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1922"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1922"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1921"
          xlink:label="f-1921"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1921"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1921"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1921"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1921"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1921"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1920"
          xlink:label="f-1920"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1920"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1920"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1920"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1920"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4190"
          xlink:label="f-4190"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4190"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4190"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4190"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4190"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4190"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4191"
          xlink:label="f-4191"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4191"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4191"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4191"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4191"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4191"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4192"
          xlink:label="f-4192"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4192"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4192"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4192"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4193"
          xlink:label="f-4193"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4193"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4193"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4193"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4193"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4193"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4194"
          xlink:label="f-4194"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4194"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4194"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4194"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3720"
          xlink:label="f-3720"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3720"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3720"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3720"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3721"
          xlink:label="f-3721"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3721"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3721"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3721"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3722"
          xlink:label="f-3722"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3722"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3722"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3722"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3722"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3722"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3723"
          xlink:label="f-3723"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3723"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3723"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3723"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3724"
          xlink:label="f-3724"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3724"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3724"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3724"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3724"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3725"
          xlink:label="f-3725"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3725"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3725"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3725"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3726"
          xlink:label="f-3726"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3726"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3726"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3726"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3727"
          xlink:label="f-3727"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3727"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3727"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3727"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3727"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3728"
          xlink:label="f-3728"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3728"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3728"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3728"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3728"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3728"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3728"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3729"
          xlink:label="f-3729"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3729"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3729"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3729"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3729"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3710"
          xlink:label="f-3710"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3710"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3710"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3710"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3710"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3710"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3711"
          xlink:label="f-3711"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3711"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3711"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3711"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3712"
          xlink:label="f-3712"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3712"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3712"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3712"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3712"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3713"
          xlink:label="f-3713"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3713"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3713"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3713"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3714"
          xlink:label="f-3714"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3714"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3714"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3714"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3715"
          xlink:label="f-3715"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3715"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3715"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3715"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3716"
          xlink:label="f-3716"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3716"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3716"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3716"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3716"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3716"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3717"
          xlink:label="f-3717"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3717"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3717"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3717"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3718"
          xlink:label="f-3718"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3718"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3718"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3718"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3718"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3719"
          xlink:label="f-3719"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3719"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3719"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3719"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3740"
          xlink:label="f-3740"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3740"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3740"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3740"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3740"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3741"
          xlink:label="f-3741"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3741"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3741"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3742"
          xlink:label="f-3742"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3742"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3742"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3742"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3743"
          xlink:label="f-3743"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3743"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3743"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3744"
          xlink:label="f-3744"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3744"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3744"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3745"
          xlink:label="f-3745"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3745"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3745"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3745"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3745"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2409"
          xlink:label="f-2409"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2409"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2409"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2409"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2409"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3746"
          xlink:label="f-3746"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3746"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3746"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3746"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3746"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3746"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3746"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2408"
          xlink:label="f-2408"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2408"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2408"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2408"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3747"
          xlink:label="f-3747"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3747"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3747"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3747"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3747"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2407"
          xlink:label="f-2407"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2407"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2407"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2407"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3748"
          xlink:label="f-3748"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3748"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3748"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3748"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3748"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3748"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2406"
          xlink:label="f-2406"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2406"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2406"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2406"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2406"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3749"
          xlink:label="f-3749"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3749"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3749"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3749"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3749"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2405"
          xlink:label="f-2405"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2405"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2405"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2405"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2404"
          xlink:label="f-2404"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2404"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2404"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2404"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2404"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2404"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2403"
          xlink:label="f-2403"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2403"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2403"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2403"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2403"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2402"
          xlink:label="f-2402"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2402"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2402"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2402"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2401"
          xlink:label="f-2401"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2401"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2401"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2401"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2400"
          xlink:label="f-2400"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2400"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2400"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2400"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2400"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3730"
          xlink:label="f-3730"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3730"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3730"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3730"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3730"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3730"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3731"
          xlink:label="f-3731"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3731"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3731"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3731"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3731"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3732"
          xlink:label="f-3732"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3732"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3732"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3732"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3732"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3733"
          xlink:label="f-3733"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3733"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3733"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3733"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3733"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3734"
          xlink:label="f-3734"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3734"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3734"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3734"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3734"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3734"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3734"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3735"
          xlink:label="f-3735"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3735"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3735"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3735"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3735"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3736"
          xlink:label="f-3736"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3736"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3736"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3736"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3736"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3736"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2418"
          xlink:label="f-2418"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2418"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2418"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3737"
          xlink:label="f-3737"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3737"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3737"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3737"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3737"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3738"
          xlink:label="f-3738"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3738"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3738"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3738"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3738"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3739"
          xlink:label="f-3739"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3739"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3739"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2415"
          xlink:label="f-2415"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2415"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2415"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2414"
          xlink:label="f-2414"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2414"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2414"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2414"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2413"
          xlink:label="f-2413"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2413"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2413"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2413"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2412"
          xlink:label="f-2412"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2412"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2412"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2412"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2412"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2411"
          xlink:label="f-2411"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2411"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2411"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2411"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2410"
          xlink:label="f-2410"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2410"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2410"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2410"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2410"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2410"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1979"
          xlink:label="f-1979"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1979"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1979"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1979"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1979"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1979"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1979"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1979"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1978"
          xlink:label="f-1978"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1978"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1978"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1978"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1978"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1978"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1978"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1977"
          xlink:label="f-1977"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1977"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1977"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1977"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1977"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1977"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1976"
          xlink:label="f-1976"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1976"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1976"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1976"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1976"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1976"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1975"
          xlink:label="f-1975"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1975"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1975"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1975"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1975"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1975"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1975"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1974"
          xlink:label="f-1974"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1974"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1974"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1974"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1974"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1974"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1973"
          xlink:label="f-1973"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1973"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1973"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1973"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1973"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1973"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1973"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1973"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1972"
          xlink:label="f-1972"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1972"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1972"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1972"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1972"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1972"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1972"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1989"
          xlink:label="f-1989"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1989"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1989"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1989"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1989"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1988"
          xlink:label="f-1988"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1988"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1988"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1988"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1988"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1988"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1987"
          xlink:label="f-1987"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1987"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1987"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1987"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1987"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1986"
          xlink:label="f-1986"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1986"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1986"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1986"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1986"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1986"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1986"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1985"
          xlink:label="f-1985"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1985"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1985"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1985"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1985"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1985"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1985"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1984"
          xlink:label="f-1984"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1984"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1984"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1984"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1984"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1984"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1983"
          xlink:label="f-1983"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1983"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1983"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1983"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1983"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1983"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1982"
          xlink:label="f-1982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1982"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1982"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1982"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1982"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1982"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1981"
          xlink:label="f-1981"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1981"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1981"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1981"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1981"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1981"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1981"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1980"
          xlink:label="f-1980"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1980"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1980"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1980"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1980"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1980"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3700"
          xlink:label="f-3700"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3700"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3700"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3700"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3700"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3700"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3700"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3701"
          xlink:label="f-3701"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3701"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3701"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3701"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3701"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3701"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3702"
          xlink:label="f-3702"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3702"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3702"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3702"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3702"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3702"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3703"
          xlink:label="f-3703"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3703"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3703"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3703"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3703"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3703"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3704"
          xlink:label="f-3704"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3704"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3704"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3704"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3704"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3704"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3704"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3704"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1999"
          xlink:label="f-1999"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1999"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1999"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1999"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1999"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1999"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1999"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1999"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3705"
          xlink:label="f-3705"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3705"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3705"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3705"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3705"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3705"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1998"
          xlink:label="f-1998"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1998"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1998"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1998"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1998"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1998"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1998"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3706"
          xlink:label="f-3706"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3706"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3706"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3706"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3706"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3706"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3706"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1997"
          xlink:label="f-1997"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1997"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1997"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1997"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1997"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3707"
          xlink:label="f-3707"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3707"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3707"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3707"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3707"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3707"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1996"
          xlink:label="f-1996"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1996"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1996"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1996"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1996"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3708"
          xlink:label="f-3708"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3708"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3708"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3708"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3708"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3708"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1995"
          xlink:label="f-1995"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1995"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1995"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1995"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1995"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1995"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3709"
          xlink:label="f-3709"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3709"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3709"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3709"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1994"
          xlink:label="f-1994"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1994"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1994"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1994"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1994"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1993"
          xlink:label="f-1993"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1993"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1993"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1993"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1993"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1993"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1993"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1992"
          xlink:label="f-1992"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1992"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1992"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1992"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1992"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1992"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1992"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1991"
          xlink:label="f-1991"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1991"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1991"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1991"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1991"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1991"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1990"
          xlink:label="f-1990"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1990"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1990"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1990"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1990"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1139"
          xlink:label="f-1139"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1139"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1139"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1139"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1139"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1139"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1138"
          xlink:label="f-1138"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1138"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1138"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1138"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1137"
          xlink:label="f-1137"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1137"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1137"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1137"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1136"
          xlink:label="f-1136"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1136"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1136"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1136"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1136"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2467"
          xlink:label="f-2467"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2467"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2467"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1135"
          xlink:label="f-1135"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1135"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1135"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1135"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1134"
          xlink:label="f-1134"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1134"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1134"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1134"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1134"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1134"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1133"
          xlink:label="f-1133"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1133"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1133"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1133"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1133"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2464"
          xlink:label="f-2464"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2464"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2464"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2463"
          xlink:label="f-2463"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2463"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2463"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2463"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2462"
          xlink:label="f-2462"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2462"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2462"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2462"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2461"
          xlink:label="f-2461"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2461"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2461"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2461"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2461"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2460"
          xlink:label="f-2460"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2460"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2460"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2460"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3790"
          xlink:label="f-3790"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3790"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3790"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3790"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3790"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3790"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3791"
          xlink:label="f-3791"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3791"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3791"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3791"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3791"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3791"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3792"
          xlink:label="f-3792"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3792"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3792"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3792"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3792"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3792"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3792"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3792"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3793"
          xlink:label="f-3793"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3793"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3793"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3793"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3793"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3793"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3794"
          xlink:label="f-3794"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3794"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3794"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3794"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3794"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3794"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3794"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3795"
          xlink:label="f-3795"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3795"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3795"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3795"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3795"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3795"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3796"
          xlink:label="f-3796"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3796"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3796"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3796"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3796"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3796"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3797"
          xlink:label="f-3797"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3797"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3797"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3797"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3797"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3797"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3798"
          xlink:label="f-3798"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3798"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3798"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3798"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3798"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3798"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3798"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3798"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3799"
          xlink:label="f-3799"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3799"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3799"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3799"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3799"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3799"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1149"
          xlink:label="f-1149"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1149"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1149"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1149"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1149"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1149"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1149"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1149"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1149"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1148"
          xlink:label="f-1148"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1148"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1148"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1148"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1148"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1148"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1148"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1148"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1144"
          xlink:label="f-1144"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1144"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1144"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1144"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1144"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2475"
          xlink:label="f-2475"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2475"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2475"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2475"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1143"
          xlink:label="f-1143"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1143"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1143"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1143"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1143"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2474"
          xlink:label="f-2474"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2474"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2474"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2474"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1142"
          xlink:label="f-1142"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1142"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1142"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1142"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1142"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1142"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2473"
          xlink:label="f-2473"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2473"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2473"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2473"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2473"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1141"
          xlink:label="f-1141"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1141"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1141"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1141"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1141"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2472"
          xlink:label="f-2472"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2472"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2472"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2472"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1140"
          xlink:label="f-1140"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1140"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1140"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1140"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1140"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1140"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1140"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2471"
          xlink:label="f-2471"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2471"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2471"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2471"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2471"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2471"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2470"
          xlink:label="f-2470"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2470"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2470"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2470"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2470"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1159"
          xlink:label="f-1159"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1159"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1159"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1159"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1159"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1159"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1158"
          xlink:label="f-1158"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1158"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1158"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1158"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1158"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1158"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1157"
          xlink:label="f-1157"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1157"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1157"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1157"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1157"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1157"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1157"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2488"
          xlink:label="f-2488"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2488"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2488"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1156"
          xlink:label="f-1156"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1156"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1156"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1156"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1156"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1156"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1155"
          xlink:label="f-1155"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1155"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1155"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1155"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1155"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1155"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1155"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1155"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1154"
          xlink:label="f-1154"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1154"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1154"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1154"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1154"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1154"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1154"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1153"
          xlink:label="f-1153"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1153"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1153"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1153"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1153"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1153"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1153"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2484"
          xlink:label="f-2484"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2484"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2484"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1152"
          xlink:label="f-1152"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1152"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1152"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1152"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1152"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1152"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1152"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1151"
          xlink:label="f-1151"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1151"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1151"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1151"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1151"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1151"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1151"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1151"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1150"
          xlink:label="f-1150"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1150"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1150"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1150"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1150"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1150"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1150"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2480"
          xlink:label="f-2480"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2480"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2480"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1169"
          xlink:label="f-1169"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1169"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1169"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1169"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1169"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1169"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1168"
          xlink:label="f-1168"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1168"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1168"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1168"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1168"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2499"
          xlink:label="f-2499"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2499"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2499"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1167"
          xlink:label="f-1167"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1167"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1167"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1167"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1167"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1167"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1167"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1166"
          xlink:label="f-1166"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1166"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1166"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1166"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1166"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1166"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1165"
          xlink:label="f-1165"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1165"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1165"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1165"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1165"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1164"
          xlink:label="f-1164"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1164"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1164"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1164"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1164"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2495"
          xlink:label="f-2495"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2495"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2495"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1163"
          xlink:label="f-1163"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1163"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1163"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1163"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1163"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1163"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1162"
          xlink:label="f-1162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1162"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1162"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1162"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1162"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1161"
          xlink:label="f-1161"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1161"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1161"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1161"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1161"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1161"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1161"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1160"
          xlink:label="f-1160"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1160"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1160"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1160"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1160"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1160"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3760"
          xlink:label="f-3760"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3760"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3760"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3760"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3760"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3761"
          xlink:label="f-3761"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3761"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3761"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3761"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3761"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3761"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3761"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3762"
          xlink:label="f-3762"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3762"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3762"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3762"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3762"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3763"
          xlink:label="f-3763"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3763"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3763"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3763"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3763"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3763"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3764"
          xlink:label="f-3764"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3764"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3764"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3764"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3764"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3765"
          xlink:label="f-3765"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3765"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3765"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3765"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3765"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3766"
          xlink:label="f-3766"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3766"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3766"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3766"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3766"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3767"
          xlink:label="f-3767"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3767"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3767"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3767"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3767"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3767"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3767"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3769"
          xlink:label="f-3769"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3769"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3769"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3769"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3769"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2429"
          xlink:label="f-2429"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2429"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2429"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2429"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2429"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2429"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2428"
          xlink:label="f-2428"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2428"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2428"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2428"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2428"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2428"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2427"
          xlink:label="f-2427"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2427"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2427"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2427"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2427"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2427"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2427"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2426"
          xlink:label="f-2426"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2426"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2426"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2426"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2426"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2426"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2425"
          xlink:label="f-2425"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2425"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2425"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2425"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2425"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2425"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2425"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2425"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-591"
          xlink:label="f-591"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-591"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-591"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2424"
          xlink:label="f-2424"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2424"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2424"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2424"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2424"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2424"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2424"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-592"
          xlink:label="f-592"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-592"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-592"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-592"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-592"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-592"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-592"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-590"
          xlink:label="f-590"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-590"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-590"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2421"
          xlink:label="f-2421"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2421"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2421"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-595"
          xlink:label="f-595"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-595"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-595"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-595"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-595"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-595"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-595"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-596"
          xlink:label="f-596"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-596"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-596"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-596"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-596"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-596"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-593"
          xlink:label="f-593"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-593"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-593"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-593"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-593"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-593"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-593"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-593"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-594"
          xlink:label="f-594"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-594"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-594"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-594"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-594"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-594"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-599"
          xlink:label="f-599"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-599"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-599"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-599"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-599"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-599"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-597"
          xlink:label="f-597"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-597"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-597"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-597"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-597"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-597"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-598"
          xlink:label="f-598"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-598"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-598"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-598"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-598"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3750"
          xlink:label="f-3750"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3750"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3750"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3750"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3750"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3751"
          xlink:label="f-3751"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3751"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3751"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3754"
          xlink:label="f-3754"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3754"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3754"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3754"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3754"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3755"
          xlink:label="f-3755"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3755"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3755"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3755"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3755"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3755"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3755"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3756"
          xlink:label="f-3756"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3756"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3756"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3756"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3756"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3757"
          xlink:label="f-3757"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3757"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3757"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3757"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3757"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3757"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3758"
          xlink:label="f-3758"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3758"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3758"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3758"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3758"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3759"
          xlink:label="f-3759"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3759"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3759"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3759"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3759"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1108"
          xlink:label="f-1108"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1108"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1108"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1108"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2439"
          xlink:label="f-2439"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2439"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2439"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2439"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2439"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1107"
          xlink:label="f-1107"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1107"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1107"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1107"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1106"
          xlink:label="f-1106"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1106"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1106"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1106"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1106"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1105"
          xlink:label="f-1105"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1105"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1105"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1105"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2436"
          xlink:label="f-2436"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2436"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2436"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-580"
          xlink:label="f-580"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-580"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-580"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-580"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-580"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-580"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1104"
          xlink:label="f-1104"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1104"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1104"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1104"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1104"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1104"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2435"
          xlink:label="f-2435"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2435"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2435"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2435"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-581"
          xlink:label="f-581"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-581"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-581"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-581"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-581"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-581"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-581"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1103"
          xlink:label="f-1103"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1103"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1103"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1103"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1103"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2434"
          xlink:label="f-2434"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2434"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2434"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2434"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1102"
          xlink:label="f-1102"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1102"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1102"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1102"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1102"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2433"
          xlink:label="f-2433"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2433"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2433"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2433"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2433"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1101"
          xlink:label="f-1101"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1101"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1101"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1101"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1101"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2432"
          xlink:label="f-2432"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2432"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2432"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2432"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-584"
          xlink:label="f-584"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-584"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-584"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-584"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-584"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1100"
          xlink:label="f-1100"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1100"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1100"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1100"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1100"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1100"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2431"
          xlink:label="f-2431"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2431"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2431"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2431"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2431"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2431"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-585"
          xlink:label="f-585"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-585"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-585"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-585"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-585"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2430"
          xlink:label="f-2430"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2430"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2430"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2430"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2430"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-582"
          xlink:label="f-582"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-582"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-582"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-582"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-582"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-583"
          xlink:label="f-583"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-583"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-583"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-583"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-583"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-583"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-588"
          xlink:label="f-588"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-588"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-588"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-589"
          xlink:label="f-589"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-589"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-589"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-589"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-586"
          xlink:label="f-586"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-586"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-586"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-586"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-587"
          xlink:label="f-587"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-587"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-587"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-587"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-587"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3780"
          xlink:label="f-3780"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3780"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3780"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3780"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3780"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3780"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3780"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3780"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3781"
          xlink:label="f-3781"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3781"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3781"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3781"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3781"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3781"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3782"
          xlink:label="f-3782"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3782"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3782"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3782"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3782"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3782"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3782"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3783"
          xlink:label="f-3783"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3783"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3783"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3783"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3783"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3783"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3784"
          xlink:label="f-3784"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3784"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3784"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3784"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3784"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3784"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3785"
          xlink:label="f-3785"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3785"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3785"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3785"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3785"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3785"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3786"
          xlink:label="f-3786"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3786"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3786"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3786"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3786"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3786"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3786"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3786"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3787"
          xlink:label="f-3787"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3787"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3787"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3787"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3787"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3787"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3788"
          xlink:label="f-3788"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3788"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3788"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3788"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3788"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3788"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3788"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3789"
          xlink:label="f-3789"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3789"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3789"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3789"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3789"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3789"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1119"
          xlink:label="f-1119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1119"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1119"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1119"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1119"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1119"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1118"
          xlink:label="f-1118"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1118"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1118"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1118"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1118"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2449"
          xlink:label="f-2449"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2449"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2449"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2449"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2449"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1117"
          xlink:label="f-1117"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1117"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnote id="fn-12" xlink:label="fn-12" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The interest rate floor on these investments as of December&#160;31, 2023 was 1.50%.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1117"
          xlink:to="fn-12"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2448"
          xlink:label="f-2448"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2448"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2448"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2448"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1116"
          xlink:label="f-1116"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1116"
          xlink:to="fn-12"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1116"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2447"
          xlink:label="f-2447"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2447"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2447"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2447"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2447"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2447"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1115"
          xlink:label="f-1115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1115"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1115"
          xlink:to="fn-12"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1115"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2446"
          xlink:label="f-2446"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2446"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2446"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2446"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2446"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2446"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1114"
          xlink:label="f-1114"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1114"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1114"
          xlink:to="fn-12"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2445"
          xlink:label="f-2445"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2445"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2445"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2445"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2445"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1113"
          xlink:label="f-1113"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1113"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1113"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1113"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1113"
          xlink:to="fn-12"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2444"
          xlink:label="f-2444"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2444"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2444"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2444"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1112"
          xlink:label="f-1112"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1112"
          xlink:to="fn-12"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1112"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1112"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2443"
          xlink:label="f-2443"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2443"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2443"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2443"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2442"
          xlink:label="f-2442"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2442"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2442"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2442"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2442"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2441"
          xlink:label="f-2441"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2441"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2441"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2441"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2440"
          xlink:label="f-2440"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2440"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2440"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2440"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2440"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2440"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3770"
          xlink:label="f-3770"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3770"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3770"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3770"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3770"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3770"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3771"
          xlink:label="f-3771"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3771"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3771"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3771"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3771"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3772"
          xlink:label="f-3772"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3772"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3772"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3772"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3772"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3773"
          xlink:label="f-3773"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3773"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3773"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3773"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3773"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3774"
          xlink:label="f-3774"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3774"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3774"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3774"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3774"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3774"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3774"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3775"
          xlink:label="f-3775"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3775"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3775"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3775"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3775"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3776"
          xlink:label="f-3776"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3776"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3776"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3776"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3776"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3776"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3777"
          xlink:label="f-3777"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3777"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3777"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3777"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3777"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3778"
          xlink:label="f-3778"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3778"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3778"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3778"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3778"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3779"
          xlink:label="f-3779"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3779"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3779"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3779"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3779"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3779"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1129"
          xlink:label="f-1129"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1129"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1129"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1129"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1128"
          xlink:label="f-1128"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1128"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1128"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1128"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2459"
          xlink:label="f-2459"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2459"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2459"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2459"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2459"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2459"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1127"
          xlink:label="f-1127"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1127"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1127"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1127"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1127"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2458"
          xlink:label="f-2458"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2458"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2458"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2458"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2458"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1126"
          xlink:label="f-1126"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1126"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1126"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1126"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2457"
          xlink:label="f-2457"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2457"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2457"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2457"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2457"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2457"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1125"
          xlink:label="f-1125"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1125"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1125"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1125"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1125"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1125"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2456"
          xlink:label="f-2456"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2456"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2456"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2456"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2456"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2456"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1124"
          xlink:label="f-1124"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1124"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1124"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1124"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1124"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2455"
          xlink:label="f-2455"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2455"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2455"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2455"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2455"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2455"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2455"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1123"
          xlink:label="f-1123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1123"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1123"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1123"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2454"
          xlink:label="f-2454"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2454"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2454"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2454"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2454"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2454"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1122"
          xlink:label="f-1122"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1122"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1122"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1122"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2453"
          xlink:label="f-2453"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2453"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2453"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2453"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2453"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2453"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2453"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2453"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1121"
          xlink:label="f-1121"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1121"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1121"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1121"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1121"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2452"
          xlink:label="f-2452"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2452"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2452"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2452"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2452"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2452"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2452"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1120"
          xlink:label="f-1120"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1120"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1120"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1120"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2451"
          xlink:label="f-2451"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2451"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2451"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2451"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2450"
          xlink:label="f-2450"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2450"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2450"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2450"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4250"
          xlink:label="f-4250"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4250"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4250"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4250"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4251"
          xlink:label="f-4251"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4251"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4251"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4251"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-678"
          xlink:label="f-678"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-678"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-678"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-678"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-678"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4252"
          xlink:label="f-4252"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4252"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4252"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4252"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-679"
          xlink:label="f-679"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-679"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-679"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-679"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-679"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-679"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-679"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4253"
          xlink:label="f-4253"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4253"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4253"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4253"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4253"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4253"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4254"
          xlink:label="f-4254"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4254"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4254"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4254"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4255"
          xlink:label="f-4255"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4255"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4255"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4255"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4255"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4256"
          xlink:label="f-4256"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4256"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4256"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4256"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4257"
          xlink:label="f-4257"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4257"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4257"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4257"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4258"
          xlink:label="f-4258"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4258"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4258"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4258"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4258"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4258"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4259"
          xlink:label="f-4259"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4259"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4259"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4259"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4259"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4259"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4259"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4259"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-672"
          xlink:label="f-672"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-672"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-672"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-672"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-672"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-673"
          xlink:label="f-673"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-673"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-673"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-673"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-673"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-673"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-670"
          xlink:label="f-670"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-670"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-670"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-670"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-670"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-670"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-671"
          xlink:label="f-671"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-671"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-671"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-671"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-671"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-676"
          xlink:label="f-676"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-676"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-676"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-676"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-676"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-676"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-677"
          xlink:label="f-677"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-677"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-677"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-677"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-677"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-674"
          xlink:label="f-674"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-674"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-674"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-674"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-674"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-674"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-674"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-675"
          xlink:label="f-675"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-675"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-675"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-675"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-675"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4260"
          xlink:label="f-4260"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4260"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4260"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4260"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4260"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4260"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-669"
          xlink:label="f-669"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-669"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-669"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-669"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-669"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4240"
          xlink:label="f-4240"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4240"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4240"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4240"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-667"
          xlink:label="f-667"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-667"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-667"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-667"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-667"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-667"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4241"
          xlink:label="f-4241"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4241"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4241"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4241"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4241"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4241"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-668"
          xlink:label="f-668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-668"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-668"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-668"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-668"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-668"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-668"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4242"
          xlink:label="f-4242"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4242"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4242"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4242"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4243"
          xlink:label="f-4243"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4243"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4243"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4243"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4243"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4244"
          xlink:label="f-4244"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4244"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4244"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4244"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4245"
          xlink:label="f-4245"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4245"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4245"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4245"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4246"
          xlink:label="f-4246"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4246"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4246"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4246"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4247"
          xlink:label="f-4247"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4247"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4247"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4247"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4247"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4247"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4248"
          xlink:label="f-4248"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4248"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4248"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4248"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4249"
          xlink:label="f-4249"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4249"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4249"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4249"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4249"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-661"
          xlink:label="f-661"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-661"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-661"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-661"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-661"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-661"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-662"
          xlink:label="f-662"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-662"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-662"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-662"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-662"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-662"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-662"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-660"
          xlink:label="f-660"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-660"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-660"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-660"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-665"
          xlink:label="f-665"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-665"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-665"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-665"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-665"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-666"
          xlink:label="f-666"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-666"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-666"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-666"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-666"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-663"
          xlink:label="f-663"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-663"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-663"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-663"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-663"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-664"
          xlink:label="f-664"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-664"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-664"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-664"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-664"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-664"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4272"
          xlink:label="f-4272"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4272"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4272"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4272"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4272"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4272"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4272"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4273"
          xlink:label="f-4273"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4273"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4273"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4273"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4273"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4274"
          xlink:label="f-4274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4274"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4274"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4274"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4274"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4274"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4275"
          xlink:label="f-4275"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4275"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4275"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4275"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4275"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4276"
          xlink:label="f-4276"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4276"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4276"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4276"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4276"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4277"
          xlink:label="f-4277"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4277"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4277"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4277"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4277"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4278"
          xlink:label="f-4278"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4278"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4278"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4278"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4278"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4278"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4278"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4279"
          xlink:label="f-4279"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4279"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4279"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4279"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4279"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-690"
          xlink:label="f-690"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-690"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-690"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-690"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-690"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-691"
          xlink:label="f-691"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-691"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-691"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-691"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-691"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-691"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-694"
          xlink:label="f-694"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-694"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-694"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-694"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-694"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-694"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-695"
          xlink:label="f-695"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-695"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-695"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-695"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-695"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-692"
          xlink:label="f-692"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-692"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-692"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-692"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-692"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-692"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-692"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-693"
          xlink:label="f-693"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-693"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-693"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-693"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-693"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4280"
          xlink:label="f-4280"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4280"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4280"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4280"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4280"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4280"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-696"
          xlink:label="f-696"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-696"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-696"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-696"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-696"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4281"
          xlink:label="f-4281"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4281"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4281"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4281"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4281"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-697"
          xlink:label="f-697"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-697"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-697"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4282"
          xlink:label="f-4282"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4282"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4282"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4282"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4282"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4261"
          xlink:label="f-4261"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4261"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4261"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4261"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4261"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4261"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4261"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4262"
          xlink:label="f-4262"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4262"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4262"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4262"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4262"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4262"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-689"
          xlink:label="f-689"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-689"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-689"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-689"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-689"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4263"
          xlink:label="f-4263"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4263"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4263"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4263"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4263"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4263"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4264"
          xlink:label="f-4264"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4264"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4264"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4265"
          xlink:label="f-4265"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4265"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4265"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4265"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4265"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4267"
          xlink:label="f-4267"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4267"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4267"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4268"
          xlink:label="f-4268"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4268"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4268"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4268"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4269"
          xlink:label="f-4269"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4269"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4269"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-680"
          xlink:label="f-680"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-680"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-680"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-680"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-680"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-680"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-680"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-680"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-683"
          xlink:label="f-683"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-683"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-683"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-683"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-683"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-683"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-684"
          xlink:label="f-684"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-684"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-684"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-684"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-684"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-684"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-681"
          xlink:label="f-681"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-681"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-681"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-681"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-681"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-681"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-682"
          xlink:label="f-682"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-682"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-682"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-682"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-682"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-682"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-682"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-687"
          xlink:label="f-687"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-687"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-687"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-687"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-687"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-688"
          xlink:label="f-688"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-688"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-688"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-688"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-688"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-688"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-685"
          xlink:label="f-685"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-685"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-685"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-685"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-685"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-685"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4270"
          xlink:label="f-4270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4270"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4270"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-686"
          xlink:label="f-686"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-686"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-686"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-686"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-686"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-686"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-686"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4271"
          xlink:label="f-4271"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4271"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4271"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4271"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4271"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-636"
          xlink:label="f-636"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-636"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-636"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-636"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-636"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-636"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-637"
          xlink:label="f-637"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-637"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-637"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-637"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-637"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-637"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-634"
          xlink:label="f-634"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-634"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-634"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-634"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-634"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-634"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-634"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-635"
          xlink:label="f-635"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-635"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-635"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-635"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-635"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-635"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4210"
          xlink:label="f-4210"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4210"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4210"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4210"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4210"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4210"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4211"
          xlink:label="f-4211"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4211"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4211"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4211"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4211"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4211"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4211"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4211"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-638"
          xlink:label="f-638"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-638"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-638"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-638"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-638"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-638"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-638"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4212"
          xlink:label="f-4212"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4212"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4212"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4212"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4212"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4212"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-639"
          xlink:label="f-639"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-639"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-639"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-639"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-639"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4213"
          xlink:label="f-4213"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4213"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4213"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4213"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4213"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4213"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4213"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4214"
          xlink:label="f-4214"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4214"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4214"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4214"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4214"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4214"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4215"
          xlink:label="f-4215"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4215"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4215"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4215"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4215"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4215"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4216"
          xlink:label="f-4216"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4216"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4216"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4216"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4216"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4217"
          xlink:label="f-4217"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4217"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4217"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4217"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4217"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4217"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4217"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4218"
          xlink:label="f-4218"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4218"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4218"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4218"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4218"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4219"
          xlink:label="f-4219"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4219"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4219"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4219"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4219"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4219"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1178"
          xlink:label="f-1178"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1178"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1178"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1177"
          xlink:label="f-1177"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1177"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1177"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1177"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1177"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1176"
          xlink:label="f-1176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1176"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1176"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1176"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1176"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1175"
          xlink:label="f-1175"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1175"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1175"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1175"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1175"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1175"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1174"
          xlink:label="f-1174"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1174"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1174"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1174"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1174"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-632"
          xlink:label="f-632"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-632"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-632"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-632"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-632"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-632"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-632"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-632"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1173"
          xlink:label="f-1173"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1173"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1173"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1173"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1173"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1173"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1173"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-633"
          xlink:label="f-633"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-633"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-633"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-633"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-633"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-633"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1172"
          xlink:label="f-1172"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1172"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1172"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1172"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1172"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1172"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-630"
          xlink:label="f-630"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-630"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-630"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-630"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-630"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1171"
          xlink:label="f-1171"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1171"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1171"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1171"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1171"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-631"
          xlink:label="f-631"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-631"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-631"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-631"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-631"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-631"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-631"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1170"
          xlink:label="f-1170"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1170"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1170"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1170"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1170"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-625"
          xlink:label="f-625"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-625"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-625"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-625"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-625"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-625"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1191"
          xlink:label="f-1191"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1191"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1191"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1191"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1191"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1191"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-626"
          xlink:label="f-626"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-626"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-626"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-626"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-626"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-626"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-626"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1190"
          xlink:label="f-1190"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1190"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1190"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1190"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1190"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1190"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1190"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-623"
          xlink:label="f-623"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-623"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-623"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-623"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-624"
          xlink:label="f-624"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-624"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-624"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-624"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-629"
          xlink:label="f-629"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-629"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-629"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-629"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-629"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4200"
          xlink:label="f-4200"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4200"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4200"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4200"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4200"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-627"
          xlink:label="f-627"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-627"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-627"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-627"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-627"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4201"
          xlink:label="f-4201"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4201"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4201"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4201"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4201"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4201"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-628"
          xlink:label="f-628"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-628"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-628"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-628"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-628"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-628"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4202"
          xlink:label="f-4202"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4202"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4202"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4202"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4202"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4203"
          xlink:label="f-4203"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4203"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4203"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4203"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4203"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4204"
          xlink:label="f-4204"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4204"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4204"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4204"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4204"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4204"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4205"
          xlink:label="f-4205"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4205"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4205"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4205"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4205"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4205"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4205"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4205"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4206"
          xlink:label="f-4206"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4206"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4206"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4206"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4206"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4206"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4207"
          xlink:label="f-4207"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4207"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4207"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4207"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4207"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4207"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4207"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4208"
          xlink:label="f-4208"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4208"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4208"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4208"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4208"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4208"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4209"
          xlink:label="f-4209"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4209"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4209"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4209"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4209"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4209"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1189"
          xlink:label="f-1189"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1189"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1189"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1189"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1189"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1189"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1188"
          xlink:label="f-1188"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1188"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1188"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1188"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1188"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1188"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1188"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1188"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1187"
          xlink:label="f-1187"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1187"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1187"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1187"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1187"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1187"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1187"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1186"
          xlink:label="f-1186"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1186"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1186"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1186"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1186"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1186"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1186"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1185"
          xlink:label="f-1185"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1185"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1185"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1185"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1185"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1185"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1185"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-621"
          xlink:label="f-621"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-621"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-621"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-621"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1184"
          xlink:label="f-1184"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1184"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1184"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1184"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1184"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1184"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1184"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1184"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-622"
          xlink:label="f-622"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-622"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-622"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-622"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-622"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1183"
          xlink:label="f-1183"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1183"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1183"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1183"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1183"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1183"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1183"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1182"
          xlink:label="f-1182"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1182"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1182"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1182"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1182"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1182"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1182"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1182"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1182"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-620"
          xlink:label="f-620"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-620"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-620"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-620"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-620"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-620"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1181"
          xlink:label="f-1181"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1181"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1181"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1181"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1181"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1181"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1181"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1181"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-658"
          xlink:label="f-658"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-658"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-658"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-658"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-658"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-659"
          xlink:label="f-659"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-659"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-659"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-659"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-656"
          xlink:label="f-656"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-656"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-656"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-656"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-656"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-656"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4230"
          xlink:label="f-4230"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4230"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4230"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4230"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4230"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-657"
          xlink:label="f-657"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-657"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-657"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-657"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4231"
          xlink:label="f-4231"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4231"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4231"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4231"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4231"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4231"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4232"
          xlink:label="f-4232"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4232"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4232"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4232"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4232"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4233"
          xlink:label="f-4233"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4233"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4233"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4233"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4233"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4234"
          xlink:label="f-4234"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4234"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4234"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4234"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4234"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4235"
          xlink:label="f-4235"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4235"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4235"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4235"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4235"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4235"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4235"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4236"
          xlink:label="f-4236"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4236"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4236"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4236"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4236"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4237"
          xlink:label="f-4237"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4237"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4237"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4237"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4237"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4237"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4238"
          xlink:label="f-4238"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4238"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4238"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4238"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4238"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4239"
          xlink:label="f-4239"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4239"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4239"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4239"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4239"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-650"
          xlink:label="f-650"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-650"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-650"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-650"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-650"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-650"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1199"
          xlink:label="f-1199"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1199"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1199"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1199"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1199"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-651"
          xlink:label="f-651"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-651"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-651"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-651"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1198"
          xlink:label="f-1198"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1198"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1198"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1198"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1198"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1198"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1197"
          xlink:label="f-1197"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1197"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1197"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1197"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1197"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1197"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1196"
          xlink:label="f-1196"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1196"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1196"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1196"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1196"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1196"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1196"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-654"
          xlink:label="f-654"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-654"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-654"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-654"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1195"
          xlink:label="f-1195"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1195"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1195"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1195"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1195"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1195"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-655"
          xlink:label="f-655"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-655"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-655"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-655"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-655"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1194"
          xlink:label="f-1194"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1194"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1194"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1194"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1194"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1194"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1194"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1194"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-652"
          xlink:label="f-652"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-652"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-652"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-652"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-652"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1193"
          xlink:label="f-1193"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1193"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1193"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1193"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1193"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1193"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1193"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-653"
          xlink:label="f-653"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-653"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-653"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-653"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1192"
          xlink:label="f-1192"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1192"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1192"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1192"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1192"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1192"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-647"
          xlink:label="f-647"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-647"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-647"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-647"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-648"
          xlink:label="f-648"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-648"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-648"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-648"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-645"
          xlink:label="f-645"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-645"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-645"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-645"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-646"
          xlink:label="f-646"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-646"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-646"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-646"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-646"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4220"
          xlink:label="f-4220"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4220"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4220"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4220"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4220"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4221"
          xlink:label="f-4221"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4221"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4221"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4221"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4221"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4222"
          xlink:label="f-4222"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4222"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4222"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4222"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4222"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-649"
          xlink:label="f-649"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-649"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-649"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-649"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-649"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4223"
          xlink:label="f-4223"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4223"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4223"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4223"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4223"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4223"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4223"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4224"
          xlink:label="f-4224"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4224"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4224"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4224"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4224"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4225"
          xlink:label="f-4225"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4225"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4225"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4225"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4225"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4225"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4226"
          xlink:label="f-4226"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4226"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4226"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4226"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4226"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4227"
          xlink:label="f-4227"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4227"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4227"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4227"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4227"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4228"
          xlink:label="f-4228"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4228"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4228"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4228"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4228"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4229"
          xlink:label="f-4229"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4229"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4229"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4229"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4229"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4229"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4229"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-640"
          xlink:label="f-640"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-640"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-640"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-640"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-640"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-640"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-643"
          xlink:label="f-643"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-643"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-643"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-643"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-643"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-644"
          xlink:label="f-644"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-644"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-644"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-644"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-644"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-644"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-641"
          xlink:label="f-641"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-641"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-641"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-641"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-641"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-642"
          xlink:label="f-642"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-642"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-642"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-642"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-642"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-614"
          xlink:label="f-614"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-614"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-614"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-614"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-614"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-614"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-615"
          xlink:label="f-615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-615"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-615"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-615"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-613"
          xlink:label="f-613"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-613"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-613"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-613"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-613"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-618"
          xlink:label="f-618"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-618"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-618"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-618"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-619"
          xlink:label="f-619"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-619"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-619"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-619"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-619"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-616"
          xlink:label="f-616"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-616"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-616"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-616"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-616"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-617"
          xlink:label="f-617"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-617"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-617"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-617"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-610"
          xlink:label="f-610"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-610"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-610"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-603"
          xlink:label="f-603"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-603"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-603"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-603"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-604"
          xlink:label="f-604"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-604"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-604"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-604"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-604"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-601"
          xlink:label="f-601"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-601"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-601"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-601"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-601"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-602"
          xlink:label="f-602"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-602"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-602"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-602"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-607"
          xlink:label="f-607"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-607"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-607"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-607"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-607"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-608"
          xlink:label="f-608"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-608"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-608"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-608"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-605"
          xlink:label="f-605"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-605"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-605"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-605"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-605"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-605"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-606"
          xlink:label="f-606"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-606"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-606"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-606"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-609"
          xlink:label="f-609"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-609"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-609"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-609"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-600"
          xlink:label="f-600"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-600"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-600"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-600"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4294"
          xlink:label="f-4294"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4294"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4294"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4294"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4294"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4295"
          xlink:label="f-4295"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4295"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4295"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4295"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4295"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4296"
          xlink:label="f-4296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4296"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4296"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4296"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4296"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4296"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4296"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4297"
          xlink:label="f-4297"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4297"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4297"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4297"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4297"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4298"
          xlink:label="f-4298"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4298"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4298"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4298"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4298"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4298"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4299"
          xlink:label="f-4299"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4299"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4299"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4299"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4299"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4283"
          xlink:label="f-4283"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4283"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4283"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4283"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4283"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4284"
          xlink:label="f-4284"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4284"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4284"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4284"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4284"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4284"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4284"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4285"
          xlink:label="f-4285"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4285"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4285"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4285"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4285"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4286"
          xlink:label="f-4286"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4286"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4286"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4286"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4286"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4286"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4287"
          xlink:label="f-4287"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4287"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4287"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4287"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4287"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4288"
          xlink:label="f-4288"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4288"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4288"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4288"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4288"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4289"
          xlink:label="f-4289"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4289"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4289"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4289"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4289"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4290"
          xlink:label="f-4290"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4290"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4290"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4290"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4290"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4290"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4290"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4291"
          xlink:label="f-4291"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4291"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4291"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4291"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4291"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4292"
          xlink:label="f-4292"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4292"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4292"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4292"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4292"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4292"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4293"
          xlink:label="f-4293"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4293"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4293"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4293"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4293"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3840"
          xlink:label="f-3840"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3840"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3840"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3840"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3840"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3840"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3840"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3840"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3841"
          xlink:label="f-3841"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3841"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3841"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3841"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3841"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3841"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3842"
          xlink:label="f-3842"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3842"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3842"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3842"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3842"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3842"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3842"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3843"
          xlink:label="f-3843"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3843"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3843"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3843"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3843"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3843"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3844"
          xlink:label="f-3844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3844"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3844"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3844"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3844"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3844"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3845"
          xlink:label="f-3845"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3845"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3845"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3845"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3845"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3845"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2507"
          xlink:label="f-2507"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2507"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2507"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3846"
          xlink:label="f-3846"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3846"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3846"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3846"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3846"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3846"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3846"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3846"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3847"
          xlink:label="f-3847"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3847"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3847"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3847"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3847"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3847"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3848"
          xlink:label="f-3848"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3848"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3848"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3848"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3848"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3848"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3848"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3849"
          xlink:label="f-3849"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3849"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3849"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3849"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3849"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3849"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2503"
          xlink:label="f-2503"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2503"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2503"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3830"
          xlink:label="f-3830"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3830"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3830"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3830"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3830"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3830"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3830"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3831"
          xlink:label="f-3831"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3831"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3831"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3831"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3831"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3831"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3832"
          xlink:label="f-3832"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3832"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3832"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3832"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3832"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3832"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3833"
          xlink:label="f-3833"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3833"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3833"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3833"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3833"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3833"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2519"
          xlink:label="f-2519"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2519"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2519"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3834"
          xlink:label="f-3834"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3834"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3834"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3834"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3834"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3834"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3834"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3834"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3835"
          xlink:label="f-3835"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3835"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3835"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3835"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3835"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3835"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3836"
          xlink:label="f-3836"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3836"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3836"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3836"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3836"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3836"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3836"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3837"
          xlink:label="f-3837"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3837"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3837"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3837"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3837"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3837"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2515"
          xlink:label="f-2515"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2515"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2515"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3838"
          xlink:label="f-3838"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3838"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3838"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3838"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3838"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3838"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3839"
          xlink:label="f-3839"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3839"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3839"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3839"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3839"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3839"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2513"
          xlink:label="f-2513"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2513"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2513"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2513"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3860"
          xlink:label="f-3860"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3860"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3860"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3860"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3861"
          xlink:label="f-3861"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3861"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3861"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3861"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3861"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3861"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3862"
          xlink:label="f-3862"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3862"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3862"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3862"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3863"
          xlink:label="f-3863"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3863"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3863"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3863"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3863"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3864"
          xlink:label="f-3864"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3864"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3864"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3864"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3865"
          xlink:label="f-3865"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3865"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3865"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3865"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3866"
          xlink:label="f-3866"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3866"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3866"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3866"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3866"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3866"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3867"
          xlink:label="f-3867"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3867"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3867"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3867"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3867"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3867"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3867"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3867"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3868"
          xlink:label="f-3868"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3868"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3868"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3868"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3868"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3868"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3869"
          xlink:label="f-3869"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3869"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3869"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3869"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3869"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3869"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3869"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2527"
          xlink:label="f-2527"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2527"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2527"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2523"
          xlink:label="f-2523"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2523"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2523"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3850"
          xlink:label="f-3850"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3850"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3850"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3850"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3850"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3850"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3851"
          xlink:label="f-3851"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3851"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3851"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3851"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3851"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3851"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3851"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3852"
          xlink:label="f-3852"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3852"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3852"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3852"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3852"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3852"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3852"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3852"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3852"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3853"
          xlink:label="f-3853"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3853"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3853"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3853"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3853"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3853"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3853"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3854"
          xlink:label="f-3854"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3854"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3854"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3854"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3854"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3854"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3854"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3854"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3855"
          xlink:label="f-3855"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3855"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3855"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3855"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3855"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3855"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3855"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3856"
          xlink:label="f-3856"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3856"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3856"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3856"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3856"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3856"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3856"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1209"
          xlink:label="f-1209"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1209"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1209"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1209"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1209"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3857"
          xlink:label="f-3857"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3857"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3857"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1208"
          xlink:label="f-1208"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1208"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1208"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1208"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1208"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1208"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1207"
          xlink:label="f-1207"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1207"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1207"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1207"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1207"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1206"
          xlink:label="f-1206"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1206"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1206"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1206"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1206"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1206"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1206"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1205"
          xlink:label="f-1205"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1205"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1205"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1205"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1205"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1205"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1204"
          xlink:label="f-1204"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1204"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1204"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1204"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2535"
          xlink:label="f-2535"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2535"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2535"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1203"
          xlink:label="f-1203"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1203"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1203"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1203"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1202"
          xlink:label="f-1202"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1202"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1202"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1202"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1202"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1201"
          xlink:label="f-1201"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1201"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1201"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1201"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1200"
          xlink:label="f-1200"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1200"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1200"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1200"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1200"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1200"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2531"
          xlink:label="f-2531"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2531"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2531"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3800"
          xlink:label="f-3800"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3800"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3800"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3800"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3800"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3800"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3800"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3801"
          xlink:label="f-3801"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3801"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3801"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3801"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3801"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3801"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3802"
          xlink:label="f-3802"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3802"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3802"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3802"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3802"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3802"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3803"
          xlink:label="f-3803"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3803"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3803"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3803"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3803"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3803"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3803"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3804"
          xlink:label="f-3804"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3804"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3804"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3804"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3804"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3804"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3804"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3804"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3804"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3805"
          xlink:label="f-3805"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3805"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3805"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3805"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3805"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3805"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3805"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3806"
          xlink:label="f-3806"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3806"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3806"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3806"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3806"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3806"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3806"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3806"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3807"
          xlink:label="f-3807"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3807"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3807"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3807"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3807"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3807"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3807"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3808"
          xlink:label="f-3808"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3808"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3808"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3808"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3808"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3808"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3808"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3809"
          xlink:label="f-3809"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3809"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3809"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3809"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3820"
          xlink:label="f-3820"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3820"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3820"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3820"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3821"
          xlink:label="f-3821"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3821"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3821"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3821"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3821"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3821"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3822"
          xlink:label="f-3822"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3822"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3822"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3822"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3822"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3822"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3822"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3822"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3823"
          xlink:label="f-3823"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3823"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3823"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3823"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3823"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3823"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3824"
          xlink:label="f-3824"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3824"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3824"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3824"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3824"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3824"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3824"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3825"
          xlink:label="f-3825"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3825"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3825"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3825"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3825"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3825"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3826"
          xlink:label="f-3826"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3826"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3826"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3826"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3826"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3826"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3827"
          xlink:label="f-3827"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3827"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3827"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3827"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3827"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3827"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3828"
          xlink:label="f-3828"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3828"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3828"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3828"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3828"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3828"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3828"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3828"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3829"
          xlink:label="f-3829"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3829"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3829"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3829"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3829"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3829"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3810"
          xlink:label="f-3810"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3810"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3810"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3810"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3810"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3810"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3811"
          xlink:label="f-3811"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3811"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3811"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3811"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3812"
          xlink:label="f-3812"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3812"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3812"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3812"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3812"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3813"
          xlink:label="f-3813"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3813"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3813"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3813"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3814"
          xlink:label="f-3814"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3814"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3814"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3814"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3815"
          xlink:label="f-3815"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3815"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3815"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3815"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3816"
          xlink:label="f-3816"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3816"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3816"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3816"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3816"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3816"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3817"
          xlink:label="f-3817"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3817"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3817"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3817"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3818"
          xlink:label="f-3818"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3818"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3818"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3818"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3818"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3819"
          xlink:label="f-3819"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3819"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3819"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3819"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1259"
          xlink:label="f-1259"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1259"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1259"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1259"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1258"
          xlink:label="f-1258"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1258"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1258"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1258"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1257"
          xlink:label="f-1257"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1257"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1257"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1257"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1257"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2588"
          xlink:label="f-2588"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2588"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2588"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1256"
          xlink:label="f-1256"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1256"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1256"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1256"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1255"
          xlink:label="f-1255"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1255"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1255"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1255"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1255"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1255"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1254"
          xlink:label="f-1254"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1254"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1254"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1254"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1254"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1253"
          xlink:label="f-1253"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1253"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1253"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1253"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1252"
          xlink:label="f-1252"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1252"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1252"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1252"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2583"
          xlink:label="f-2583"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2583"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2583"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1251"
          xlink:label="f-1251"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1251"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1251"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1251"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1251"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2582"
          xlink:label="f-2582"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2582"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2582"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1250"
          xlink:label="f-1250"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1250"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1250"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1250"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2581"
          xlink:label="f-2581"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2581"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2581"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2581"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2580"
          xlink:label="f-2580"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2580"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2580"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1269"
          xlink:label="f-1269"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1269"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1269"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1269"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1269"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1269"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1269"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1268"
          xlink:label="f-1268"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1268"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1268"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1268"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1268"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1268"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1267"
          xlink:label="f-1267"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1267"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1267"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1267"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1267"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1267"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1267"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1267"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2598"
          xlink:label="f-2598"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2598"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2598"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1266"
          xlink:label="f-1266"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1266"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1266"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1266"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1266"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1266"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1266"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2597"
          xlink:label="f-2597"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2597"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2597"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1265"
          xlink:label="f-1265"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1265"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1265"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1265"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2596"
          xlink:label="f-2596"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2596"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2596"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2596"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1264"
          xlink:label="f-1264"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1264"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1264"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1264"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2595"
          xlink:label="f-2595"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2595"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2595"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1263"
          xlink:label="f-1263"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1263"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1263"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1263"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1263"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1262"
          xlink:label="f-1262"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1262"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1262"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1262"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1261"
          xlink:label="f-1261"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1261"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1261"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1261"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1261"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1261"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2592"
          xlink:label="f-2592"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2592"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2592"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1260"
          xlink:label="f-1260"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1260"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1260"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1260"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1260"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4310"
          xlink:label="f-4310"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4310"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4310"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4310"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4311"
          xlink:label="f-4311"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4311"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4311"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4311"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4311"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4312"
          xlink:label="f-4312"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4312"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4312"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4312"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4313"
          xlink:label="f-4313"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4313"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4313"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4313"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4314"
          xlink:label="f-4314"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4314"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4314"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4314"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4314"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4315"
          xlink:label="f-4315"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4315"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4315"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4315"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4315"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4315"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4315"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4316"
          xlink:label="f-4316"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4316"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4316"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4316"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4316"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4317"
          xlink:label="f-4317"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4317"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4317"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4317"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4317"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4317"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4318"
          xlink:label="f-4318"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4318"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4318"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4318"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4318"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4319"
          xlink:label="f-4319"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4319"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4319"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4319"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4319"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1279"
          xlink:label="f-1279"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1279"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1279"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1279"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1279"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1279"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1278"
          xlink:label="f-1278"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1278"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1278"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1278"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1278"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1277"
          xlink:label="f-1277"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1277"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1277"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1277"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1277"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1276"
          xlink:label="f-1276"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1276"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1276"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1276"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1276"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1275"
          xlink:label="f-1275"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1275"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1275"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1275"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1275"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1275"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1274"
          xlink:label="f-1274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1274"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1274"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1274"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1274"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1273"
          xlink:label="f-1273"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1273"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1273"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1273"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1273"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1273"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1273"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1272"
          xlink:label="f-1272"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1272"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1272"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1272"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1272"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1272"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1271"
          xlink:label="f-1271"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1271"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1271"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1271"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1271"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1271"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1270"
          xlink:label="f-1270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1270"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1270"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1270"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1270"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1270"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1290"
          xlink:label="f-1290"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1290"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1290"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1290"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1290"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1290"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1290"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4300"
          xlink:label="f-4300"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4300"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4300"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4300"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4300"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4301"
          xlink:label="f-4301"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4301"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4301"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4301"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4301"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4302"
          xlink:label="f-4302"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4302"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4302"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4302"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4302"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4302"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4302"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4304"
          xlink:label="f-4304"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4304"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4304"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4304"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4304"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4305"
          xlink:label="f-4305"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4305"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4305"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4305"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4305"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4305"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4306"
          xlink:label="f-4306"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4306"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4306"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4306"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4306"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4307"
          xlink:label="f-4307"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4307"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4307"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4307"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4307"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4308"
          xlink:label="f-4308"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4308"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4308"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4308"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4309"
          xlink:label="f-4309"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4309"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4309"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4309"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4309"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4309"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1289"
          xlink:label="f-1289"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1289"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1289"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1289"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1288"
          xlink:label="f-1288"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1288"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1288"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1288"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1287"
          xlink:label="f-1287"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1287"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1287"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1287"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1287"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1286"
          xlink:label="f-1286"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1286"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1286"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1286"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1285"
          xlink:label="f-1285"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1285"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1285"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1285"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1285"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1285"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1284"
          xlink:label="f-1284"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1284"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1284"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1284"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1284"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1283"
          xlink:label="f-1283"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1283"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1283"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1283"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1282"
          xlink:label="f-1282"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1282"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1282"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1282"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1281"
          xlink:label="f-1281"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1281"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1281"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1281"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1281"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1280"
          xlink:label="f-1280"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1280"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1280"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1280"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3880"
          xlink:label="f-3880"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3880"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3880"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3880"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3881"
          xlink:label="f-3881"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3881"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3881"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3881"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3881"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3882"
          xlink:label="f-3882"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3882"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3882"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3882"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3883"
          xlink:label="f-3883"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3883"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3883"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3883"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3884"
          xlink:label="f-3884"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3884"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3884"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3884"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3884"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3885"
          xlink:label="f-3885"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3885"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3885"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3885"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3885"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3885"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3885"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3887"
          xlink:label="f-3887"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3887"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3887"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3887"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3887"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3888"
          xlink:label="f-3888"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3888"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3888"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3888"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3888"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3888"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3889"
          xlink:label="f-3889"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3889"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3889"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3889"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3889"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1219"
          xlink:label="f-1219"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1219"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1219"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1219"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1219"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1218"
          xlink:label="f-1218"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1218"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1218"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1218"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1218"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1218"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1218"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1217"
          xlink:label="f-1217"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1217"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1217"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1217"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1217"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1217"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1216"
          xlink:label="f-1216"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1216"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1216"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1216"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1216"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1216"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1215"
          xlink:label="f-1215"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1215"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1215"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1215"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1215"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1215"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2546"
          xlink:label="f-2546"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2546"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2546"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1214"
          xlink:label="f-1214"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1214"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1214"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1214"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1214"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1214"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1214"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1213"
          xlink:label="f-1213"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1213"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1213"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1213"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1213"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1213"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1212"
          xlink:label="f-1212"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1212"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1212"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1212"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1212"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1212"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1212"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1212"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1211"
          xlink:label="f-1211"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1211"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1211"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1211"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1211"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1211"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1211"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2542"
          xlink:label="f-2542"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2542"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2542"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1210"
          xlink:label="f-1210"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1210"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1210"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1210"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1210"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3870"
          xlink:label="f-3870"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3870"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3870"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3870"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3870"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3870"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3871"
          xlink:label="f-3871"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3871"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3871"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3871"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3871"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3871"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3872"
          xlink:label="f-3872"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3872"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3872"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3872"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3872"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3873"
          xlink:label="f-3873"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3873"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3873"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3873"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3873"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3873"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3873"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3874"
          xlink:label="f-3874"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3874"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3874"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3874"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3874"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3875"
          xlink:label="f-3875"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3875"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3875"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3875"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3875"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3875"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3876"
          xlink:label="f-3876"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3876"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3876"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3876"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3876"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3877"
          xlink:label="f-3877"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3877"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3877"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3877"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3877"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3878"
          xlink:label="f-3878"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3878"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3878"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3878"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3879"
          xlink:label="f-3879"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3879"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3879"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3879"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3879"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3879"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1229"
          xlink:label="f-1229"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1229"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1229"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1229"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1229"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1229"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1229"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1228"
          xlink:label="f-1228"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1228"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1228"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1228"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1228"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1228"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1227"
          xlink:label="f-1227"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1227"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1227"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1227"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1227"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1227"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1226"
          xlink:label="f-1226"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1226"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1226"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1226"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1226"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1226"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1226"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1225"
          xlink:label="f-1225"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1225"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1225"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1225"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1225"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1225"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1224"
          xlink:label="f-1224"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1224"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1224"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1224"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1224"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1224"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1224"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1224"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1223"
          xlink:label="f-1223"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1223"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1223"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1223"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1223"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1223"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1223"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2554"
          xlink:label="f-2554"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2554"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2554"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1222"
          xlink:label="f-1222"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1222"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1222"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1222"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1222"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1221"
          xlink:label="f-1221"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1221"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1221"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1221"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1221"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1220"
          xlink:label="f-1220"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1220"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1220"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1220"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1220"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1220"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2550"
          xlink:label="f-2550"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2550"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2550"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1239"
          xlink:label="f-1239"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1239"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1239"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1239"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1239"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1238"
          xlink:label="f-1238"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1238"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1238"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1238"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1237"
          xlink:label="f-1237"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1237"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1237"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1237"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1237"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1237"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2568"
          xlink:label="f-2568"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2568"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2568"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2568"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2568"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1236"
          xlink:label="f-1236"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1236"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1236"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1236"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1236"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1236"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2567"
          xlink:label="f-2567"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2567"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2567"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1235"
          xlink:label="f-1235"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1235"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1235"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1235"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1235"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2566"
          xlink:label="f-2566"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2566"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2566"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1234"
          xlink:label="f-1234"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1234"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1234"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1234"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1234"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1234"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2565"
          xlink:label="f-2565"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2565"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2565"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2565"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1233"
          xlink:label="f-1233"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1233"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1233"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1233"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1233"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1233"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2564"
          xlink:label="f-2564"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2564"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2564"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1232"
          xlink:label="f-1232"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1232"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1232"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1232"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1232"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1232"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1232"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1231"
          xlink:label="f-1231"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1231"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1231"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1231"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1231"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1231"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1230"
          xlink:label="f-1230"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1230"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1230"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1230"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1230"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1230"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1230"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1230"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2561"
          xlink:label="f-2561"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2561"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2561"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3890"
          xlink:label="f-3890"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3890"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3890"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3890"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3890"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3891"
          xlink:label="f-3891"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3891"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3891"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3891"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3891"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3891"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3892"
          xlink:label="f-3892"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3892"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3892"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3892"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3892"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3892"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3892"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3892"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3893"
          xlink:label="f-3893"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3893"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3893"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3893"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3893"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3893"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3894"
          xlink:label="f-3894"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3894"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3894"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3894"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3894"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3894"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3894"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3895"
          xlink:label="f-3895"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3895"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3895"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3895"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3895"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3895"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3896"
          xlink:label="f-3896"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3896"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3896"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3896"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3896"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3896"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3897"
          xlink:label="f-3897"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3897"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3897"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3897"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3897"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3898"
          xlink:label="f-3898"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3898"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3898"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3898"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3898"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3898"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3898"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3899"
          xlink:label="f-3899"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3899"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3899"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3899"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3899"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1249"
          xlink:label="f-1249"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1249"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1249"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1249"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1249"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1249"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1248"
          xlink:label="f-1248"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1248"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1248"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1248"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1248"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1247"
          xlink:label="f-1247"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1247"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1247"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1247"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1246"
          xlink:label="f-1246"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1246"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1246"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1246"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2577"
          xlink:label="f-2577"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2577"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2577"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1245"
          xlink:label="f-1245"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1245"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1245"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1245"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1245"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1244"
          xlink:label="f-1244"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1244"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1244"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1244"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1243"
          xlink:label="f-1243"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1243"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1243"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1243"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1243"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1243"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1242"
          xlink:label="f-1242"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1242"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1242"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1242"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1242"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1241"
          xlink:label="f-1241"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1241"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1241"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1241"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1240"
          xlink:label="f-1240"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1240"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1240"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1240"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2570"
          xlink:label="f-2570"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2570"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2570"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4371"
          xlink:label="f-4371"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4371"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4371"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4371"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4372"
          xlink:label="f-4372"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4372"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4372"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4372"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4372"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4373"
          xlink:label="f-4373"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4373"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4373"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4373"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4373"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4373"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4373"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4374"
          xlink:label="f-4374"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4374"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4374"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4374"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4374"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4375"
          xlink:label="f-4375"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4375"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4375"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4375"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4375"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4375"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4376"
          xlink:label="f-4376"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4376"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4376"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4376"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4376"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4377"
          xlink:label="f-4377"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4377"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4377"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4377"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4377"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4378"
          xlink:label="f-4378"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4378"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4378"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4379"
          xlink:label="f-4379"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4379"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4379"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4379"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4379"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4380"
          xlink:label="f-4380"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4380"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4380"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4381"
          xlink:label="f-4381"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4381"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4381"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4381"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4360"
          xlink:label="f-4360"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4360"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4360"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4360"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4361"
          xlink:label="f-4361"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4361"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4361"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4361"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4361"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4361"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4362"
          xlink:label="f-4362"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4362"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4362"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4362"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4363"
          xlink:label="f-4363"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4363"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4363"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4363"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4363"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4364"
          xlink:label="f-4364"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4364"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4364"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4364"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4365"
          xlink:label="f-4365"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4365"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4365"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4365"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4366"
          xlink:label="f-4366"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4366"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4366"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4366"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4367"
          xlink:label="f-4367"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4367"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4367"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4367"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4367"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4367"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4368"
          xlink:label="f-4368"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4368"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4368"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4368"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4369"
          xlink:label="f-4369"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4369"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4369"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4369"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4369"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4370"
          xlink:label="f-4370"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4370"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4370"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4370"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4393"
          xlink:label="f-4393"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4393"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4393"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4393"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4394"
          xlink:label="f-4394"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4394"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4394"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4394"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4394"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4394"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4395"
          xlink:label="f-4395"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4395"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4395"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4395"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4396"
          xlink:label="f-4396"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4396"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4396"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4396"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4396"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4397"
          xlink:label="f-4397"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4397"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4397"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4397"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4398"
          xlink:label="f-4398"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4398"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4398"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4398"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4399"
          xlink:label="f-4399"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4399"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4399"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4399"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4399"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4382"
          xlink:label="f-4382"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4382"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4382"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4383"
          xlink:label="f-4383"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4383"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4383"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4384"
          xlink:label="f-4384"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4384"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4384"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4387"
          xlink:label="f-4387"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4387"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4387"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4387"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4388"
          xlink:label="f-4388"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4388"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4388"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4388"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4388"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4388"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4389"
          xlink:label="f-4389"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4389"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4389"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4389"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4390"
          xlink:label="f-4390"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4390"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4390"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4390"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4390"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4391"
          xlink:label="f-4391"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4391"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4391"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4391"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4392"
          xlink:label="f-4392"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4392"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4392"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4392"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-999"
          xlink:label="f-999"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-999"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-999"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-999"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-997"
          xlink:label="f-997"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-997"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-997"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-997"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-997"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-998"
          xlink:label="f-998"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-998"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-998"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-998"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-998"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-998"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4330"
          xlink:label="f-4330"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4330"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4330"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4330"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4331"
          xlink:label="f-4331"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4331"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4331"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4331"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4332"
          xlink:label="f-4332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4332"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4332"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4332"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4332"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4333"
          xlink:label="f-4333"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4333"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4333"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4333"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4333"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4333"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4333"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4335"
          xlink:label="f-4335"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4335"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4335"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4335"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4335"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4336"
          xlink:label="f-4336"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4336"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4336"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4336"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4336"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4336"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4337"
          xlink:label="f-4337"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4337"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4337"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4337"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4337"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4338"
          xlink:label="f-4338"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4338"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4338"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4338"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4338"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4339"
          xlink:label="f-4339"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4339"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4339"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4339"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4339"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1299"
          xlink:label="f-1299"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1299"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1299"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1299"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1299"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1299"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-991"
          xlink:label="f-991"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-991"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-991"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-991"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1298"
          xlink:label="f-1298"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1298"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1298"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1298"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1298"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-992"
          xlink:label="f-992"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-992"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-992"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-992"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-992"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1297"
          xlink:label="f-1297"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1297"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1297"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1297"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1297"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1297"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1297"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1296"
          xlink:label="f-1296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1296"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1296"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1296"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1296"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1296"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-990"
          xlink:label="f-990"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-990"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-990"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-990"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1295"
          xlink:label="f-1295"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1295"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1295"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1295"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1295"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1295"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-995"
          xlink:label="f-995"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-995"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-995"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1294"
          xlink:label="f-1294"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1294"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1294"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1294"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1294"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1294"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-996"
          xlink:label="f-996"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-996"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-996"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1293"
          xlink:label="f-1293"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1293"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1293"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1293"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1293"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1293"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1293"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-993"
          xlink:label="f-993"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-993"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-993"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1292"
          xlink:label="f-1292"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1292"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1292"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1292"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1292"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1292"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-994"
          xlink:label="f-994"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-994"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-994"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-994"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1291"
          xlink:label="f-1291"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1291"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1291"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1291"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1291"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1291"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1291"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1291"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-988"
          xlink:label="f-988"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-988"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-988"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-988"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-988"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-989"
          xlink:label="f-989"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-989"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-989"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-989"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-986"
          xlink:label="f-986"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-986"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-986"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-986"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-986"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-986"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-987"
          xlink:label="f-987"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-987"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-987"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-987"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4320"
          xlink:label="f-4320"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4320"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4320"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4320"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4320"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4321"
          xlink:label="f-4321"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4321"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4321"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4321"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4321"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4321"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4321"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4322"
          xlink:label="f-4322"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4322"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4322"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4322"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4322"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4323"
          xlink:label="f-4323"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4323"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4323"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4323"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4323"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4323"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4324"
          xlink:label="f-4324"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4324"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4324"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4324"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4324"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4325"
          xlink:label="f-4325"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4325"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4325"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4325"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4325"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4326"
          xlink:label="f-4326"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4326"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4326"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4326"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4327"
          xlink:label="f-4327"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4327"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4327"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4327"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4327"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4327"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4328"
          xlink:label="f-4328"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4328"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4328"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4328"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4329"
          xlink:label="f-4329"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4329"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4329"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4329"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4329"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-980"
          xlink:label="f-980"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-980"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-980"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-980"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-980"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-981"
          xlink:label="f-981"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-981"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-981"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-984"
          xlink:label="f-984"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-984"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-984"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-985"
          xlink:label="f-985"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-985"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-985"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-985"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-985"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-982"
          xlink:label="f-982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-982"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-982"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-982"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-983"
          xlink:label="f-983"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-983"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-983"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4350"
          xlink:label="f-4350"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4350"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4350"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4350"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4350"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4351"
          xlink:label="f-4351"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4351"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4351"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4351"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4351"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4352"
          xlink:label="f-4352"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4352"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4352"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4352"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4352"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4352"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4352"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4353"
          xlink:label="f-4353"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4353"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4353"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4353"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4353"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4354"
          xlink:label="f-4354"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4354"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4354"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4354"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4354"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4354"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4355"
          xlink:label="f-4355"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4355"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4355"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4355"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4355"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4356"
          xlink:label="f-4356"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4356"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4356"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4356"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4356"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4357"
          xlink:label="f-4357"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4357"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4357"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4340"
          xlink:label="f-4340"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4340"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4340"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4340"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4340"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4340"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4340"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4341"
          xlink:label="f-4341"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4341"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4341"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4341"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4341"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4342"
          xlink:label="f-4342"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4342"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4342"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4342"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4342"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4342"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4343"
          xlink:label="f-4343"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4343"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4343"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4343"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4343"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4344"
          xlink:label="f-4344"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4344"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4344"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4344"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4344"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4345"
          xlink:label="f-4345"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4345"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4345"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4345"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4345"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4346"
          xlink:label="f-4346"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4346"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4346"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4346"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4346"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4346"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4346"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4347"
          xlink:label="f-4347"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4347"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4347"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4347"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4347"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4348"
          xlink:label="f-4348"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4348"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4348"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4348"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4348"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4348"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4349"
          xlink:label="f-4349"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4349"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4349"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4349"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4349"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-955"
          xlink:label="f-955"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-955"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-955"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-955"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-956"
          xlink:label="f-956"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-956"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-956"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-953"
          xlink:label="f-953"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-953"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-953"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-953"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-953"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-954"
          xlink:label="f-954"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-954"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-954"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-959"
          xlink:label="f-959"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-959"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-959"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-959"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-959"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-957"
          xlink:label="f-957"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-957"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-957"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-958"
          xlink:label="f-958"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-958"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-958"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-958"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-951"
          xlink:label="f-951"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-951"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-951"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-952"
          xlink:label="f-952"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-952"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-952"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-952"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-950"
          xlink:label="f-950"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-950"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-950"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-944"
          xlink:label="f-944"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-944"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-944"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-944"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-945"
          xlink:label="f-945"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-945"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-945"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-945"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-942"
          xlink:label="f-942"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-942"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-942"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-942"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-943"
          xlink:label="f-943"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-943"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-943"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-943"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-943"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-948"
          xlink:label="f-948"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-948"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-948"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-949"
          xlink:label="f-949"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-949"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-949"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-949"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-946"
          xlink:label="f-946"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-946"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-946"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-946"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-947"
          xlink:label="f-947"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-947"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-947"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-947"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-947"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-940"
          xlink:label="f-940"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-940"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-940"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-940"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-940"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-941"
          xlink:label="f-941"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-941"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-941"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-941"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-941"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-941"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-977"
          xlink:label="f-977"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-977"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-977"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-977"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-978"
          xlink:label="f-978"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-978"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-978"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-978"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-975"
          xlink:label="f-975"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-975"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-975"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-975"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-976"
          xlink:label="f-976"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-976"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-976"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-976"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-976"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-979"
          xlink:label="f-979"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-979"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-979"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-979"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3900"
          xlink:label="f-3900"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3900"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3900"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3900"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3900"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3900"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3901"
          xlink:label="f-3901"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3901"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3901"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3901"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3901"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3902"
          xlink:label="f-3902"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3902"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3902"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3902"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3902"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3903"
          xlink:label="f-3903"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3903"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3903"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3903"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3903"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3904"
          xlink:label="f-3904"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3904"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3904"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3904"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3904"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3904"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3904"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3905"
          xlink:label="f-3905"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3905"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3905"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3905"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3905"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3906"
          xlink:label="f-3906"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3906"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3906"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3906"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3906"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3906"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3907"
          xlink:label="f-3907"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3907"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3907"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3907"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3907"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3908"
          xlink:label="f-3908"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3908"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3908"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3908"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3908"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3909"
          xlink:label="f-3909"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3909"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3909"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3909"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3909"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-970"
          xlink:label="f-970"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-970"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-970"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-970"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-970"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-970"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-973"
          xlink:label="f-973"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-973"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-973"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-973"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-973"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-974"
          xlink:label="f-974"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-974"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-974"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-974"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-974"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-974"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-971"
          xlink:label="f-971"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-971"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-971"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-971"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-971"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-972"
          xlink:label="f-972"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-972"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-972"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-972"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-972"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-967"
          xlink:label="f-967"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-967"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-967"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-967"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-967"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-967"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-968"
          xlink:label="f-968"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-968"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-968"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-968"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-968"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-968"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-968"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-969"
          xlink:label="f-969"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-969"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-969"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-969"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-969"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-962"
          xlink:label="f-962"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-962"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-962"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-963"
          xlink:label="f-963"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-963"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-963"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-960"
          xlink:label="f-960"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-960"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-960"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-961"
          xlink:label="f-961"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-961"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-961"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-961"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-911"
          xlink:label="f-911"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-911"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-911"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-911"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-911"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-912"
          xlink:label="f-912"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-912"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-912"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-910"
          xlink:label="f-910"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-910"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-910"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-910"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-915"
          xlink:label="f-915"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-915"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-915"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-916"
          xlink:label="f-916"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-916"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-916"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-916"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-916"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-913"
          xlink:label="f-913"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-913"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-913"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-913"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-914"
          xlink:label="f-914"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-914"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-914"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-919"
          xlink:label="f-919"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-919"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-919"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-919"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-919"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-917"
          xlink:label="f-917"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-917"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-917"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-917"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-917"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-917"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-918"
          xlink:label="f-918"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-918"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-918"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-918"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-900"
          xlink:label="f-900"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-900"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-900"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-901"
          xlink:label="f-901"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-901"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-901"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-901"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-904"
          xlink:label="f-904"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-904"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-904"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-904"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-905"
          xlink:label="f-905"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-905"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-905"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-905"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-905"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-902"
          xlink:label="f-902"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-902"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-902"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-903"
          xlink:label="f-903"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-903"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-903"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-908"
          xlink:label="f-908"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-908"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-908"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-909"
          xlink:label="f-909"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-909"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-909"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-906"
          xlink:label="f-906"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-906"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-906"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-907"
          xlink:label="f-907"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-907"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-907"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-907"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-933"
          xlink:label="f-933"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-933"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-933"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-933"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-934"
          xlink:label="f-934"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-934"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-934"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-934"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-931"
          xlink:label="f-931"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-931"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-931"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-931"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-931"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-932"
          xlink:label="f-932"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-932"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-932"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-932"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-937"
          xlink:label="f-937"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-937"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-937"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-937"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-938"
          xlink:label="f-938"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-938"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-938"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-935"
          xlink:label="f-935"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-935"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-935"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-935"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-935"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-936"
          xlink:label="f-936"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-936"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-936"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-939"
          xlink:label="f-939"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-939"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-939"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-930"
          xlink:label="f-930"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-930"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-930"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-930"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-922"
          xlink:label="f-922"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-922"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-922"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-922"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-922"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-922"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-923"
          xlink:label="f-923"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-923"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-923"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-923"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-923"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-923"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-923"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-920"
          xlink:label="f-920"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-920"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-920"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-920"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-921"
          xlink:label="f-921"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-921"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-921"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-921"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-926"
          xlink:label="f-926"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-926"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-926"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-926"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-926"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-927"
          xlink:label="f-927"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-927"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-927"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-927"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-927"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-924"
          xlink:label="f-924"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-924"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-924"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-924"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-924"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-925"
          xlink:label="f-925"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-925"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-925"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-925"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-925"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-925"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-928"
          xlink:label="f-928"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-928"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-928"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-928"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-928"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-929"
          xlink:label="f-929"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-929"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-929"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-929"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-929"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-929"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3960"
          xlink:label="f-3960"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3960"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3960"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3960"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3960"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3961"
          xlink:label="f-3961"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3961"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3961"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3961"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3961"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3961"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3962"
          xlink:label="f-3962"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3962"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3962"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3962"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3962"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3963"
          xlink:label="f-3963"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3963"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3963"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3963"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3963"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3964"
          xlink:label="f-3964"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3964"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3964"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3964"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3964"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3964"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3965"
          xlink:label="f-3965"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3965"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3965"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3965"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3965"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3965"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3965"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3965"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3966"
          xlink:label="f-3966"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3966"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3966"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3966"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3966"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3966"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2628"
          xlink:label="f-2628"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2628"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2628"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3967"
          xlink:label="f-3967"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3967"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3967"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3967"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3967"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3967"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3967"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3968"
          xlink:label="f-3968"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3968"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3968"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3968"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3968"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3968"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3969"
          xlink:label="f-3969"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3969"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3969"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3969"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3969"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3969"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2624"
          xlink:label="f-2624"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2624"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2624"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2620"
          xlink:label="f-2620"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2620"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2620"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3950"
          xlink:label="f-3950"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3950"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3950"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3950"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3950"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3950"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3950"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3951"
          xlink:label="f-3951"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3951"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3951"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3951"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3951"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3952"
          xlink:label="f-3952"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3952"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3952"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3952"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3952"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3952"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3953"
          xlink:label="f-3953"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3953"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3953"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3953"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3953"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3954"
          xlink:label="f-3954"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3954"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3954"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3954"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3954"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1309"
          xlink:label="f-1309"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1309"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1309"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1309"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1309"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1309"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1309"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1309"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3955"
          xlink:label="f-3955"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3955"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3955"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1308"
          xlink:label="f-1308"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1308"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1308"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1308"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1308"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1308"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1308"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2639"
          xlink:label="f-2639"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2639"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2639"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2639"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1307"
          xlink:label="f-1307"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1307"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1307"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1307"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1307"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1306"
          xlink:label="f-1306"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1306"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1306"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1306"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1306"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3958"
          xlink:label="f-3958"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3958"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3958"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3958"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3958"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1305"
          xlink:label="f-1305"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1305"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1305"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1305"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1305"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1305"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2636"
          xlink:label="f-2636"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2636"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2636"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3959"
          xlink:label="f-3959"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3959"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3959"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3959"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3959"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3959"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3959"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1304"
          xlink:label="f-1304"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1304"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1304"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1304"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1304"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1303"
          xlink:label="f-1303"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1303"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1303"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1303"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1303"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1303"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1303"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2634"
          xlink:label="f-2634"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2634"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2634"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1302"
          xlink:label="f-1302"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1302"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1302"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1302"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1302"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1302"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2633"
          xlink:label="f-2633"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2633"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2633"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1301"
          xlink:label="f-1301"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1301"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1301"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1301"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1301"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2632"
          xlink:label="f-2632"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2632"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2632"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2632"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1300"
          xlink:label="f-1300"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1300"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1300"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1300"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1300"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2631"
          xlink:label="f-2631"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2631"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2631"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3980"
          xlink:label="f-3980"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3980"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3980"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3980"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3980"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3981"
          xlink:label="f-3981"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3981"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3981"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3981"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3981"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3982"
          xlink:label="f-3982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3982"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3982"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3985"
          xlink:label="f-3985"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3985"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3985"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3985"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3985"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3986"
          xlink:label="f-3986"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3986"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3986"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3986"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3986"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3986"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3986"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3987"
          xlink:label="f-3987"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3987"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3987"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3987"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3987"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3988"
          xlink:label="f-3988"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3988"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3988"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3988"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3988"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3988"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1319"
          xlink:label="f-1319"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1319"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1319"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1319"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1319"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1319"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3989"
          xlink:label="f-3989"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3989"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3989"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3989"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3989"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1318"
          xlink:label="f-1318"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1318"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1318"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1318"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1318"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1318"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1317"
          xlink:label="f-1317"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1317"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1317"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1317"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1317"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1317"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1317"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2648"
          xlink:label="f-2648"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2648"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2648"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1316"
          xlink:label="f-1316"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1316"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1316"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1316"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1316"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1316"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1315"
          xlink:label="f-1315"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1315"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1315"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1315"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1315"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1315"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1315"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1315"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1314"
          xlink:label="f-1314"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1314"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1314"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1314"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1314"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1314"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1314"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1313"
          xlink:label="f-1313"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1313"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1313"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1313"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1313"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1313"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1312"
          xlink:label="f-1312"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1312"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1312"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1312"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1312"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1312"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1311"
          xlink:label="f-1311"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1311"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1311"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1311"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1311"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1311"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1311"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1310"
          xlink:label="f-1310"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1310"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1310"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1310"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1310"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1310"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2641"
          xlink:label="f-2641"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2641"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2641"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3970"
          xlink:label="f-3970"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3970"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3970"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3970"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3970"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3971"
          xlink:label="f-3971"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3971"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3971"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3971"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3971"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3971"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3971"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3972"
          xlink:label="f-3972"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3972"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3972"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3972"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3972"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3973"
          xlink:label="f-3973"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3973"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3973"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3973"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3973"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3973"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3974"
          xlink:label="f-3974"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3974"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3974"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3974"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3974"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3975"
          xlink:label="f-3975"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3975"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3975"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3975"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3975"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3976"
          xlink:label="f-3976"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3976"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3976"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3976"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3976"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3977"
          xlink:label="f-3977"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3977"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3977"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3977"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3977"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3977"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3977"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3978"
          xlink:label="f-3978"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3978"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3978"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3978"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3978"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1329"
          xlink:label="f-1329"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1329"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1329"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1329"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1329"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1329"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1329"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3979"
          xlink:label="f-3979"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3979"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3979"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3979"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3979"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3979"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1328"
          xlink:label="f-1328"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1328"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1328"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1328"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1328"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1328"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1327"
          xlink:label="f-1327"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1327"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1327"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1327"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1327"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1327"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1327"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1327"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1326"
          xlink:label="f-1326"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1326"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1326"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1326"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1326"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1326"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1326"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1325"
          xlink:label="f-1325"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1325"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1325"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1325"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1325"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2656"
          xlink:label="f-2656"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2656"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2656"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1324"
          xlink:label="f-1324"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1324"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1324"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1324"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1324"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1323"
          xlink:label="f-1323"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1323"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1323"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1323"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1323"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1323"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1322"
          xlink:label="f-1322"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1322"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1322"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1322"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1322"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1321"
          xlink:label="f-1321"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1321"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1321"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1321"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1321"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1321"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1321"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2652"
          xlink:label="f-2652"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2652"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2652"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1320"
          xlink:label="f-1320"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1320"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1320"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1320"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1320"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1320"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3920"
          xlink:label="f-3920"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3920"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3920"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3920"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3921"
          xlink:label="f-3921"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3921"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3921"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3921"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3921"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3922"
          xlink:label="f-3922"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3922"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3922"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3922"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3922"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3922"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3922"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3923"
          xlink:label="f-3923"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3923"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3923"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3923"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3923"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3924"
          xlink:label="f-3924"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3924"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3924"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3924"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3924"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3924"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3925"
          xlink:label="f-3925"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3925"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3925"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3925"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3925"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3926"
          xlink:label="f-3926"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3926"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3926"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3926"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3926"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3927"
          xlink:label="f-3927"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3927"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3927"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3927"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3927"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3927"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3927"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3928"
          xlink:label="f-3928"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3928"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3928"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3928"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3928"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3928"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3928"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3928"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3928"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3910"
          xlink:label="f-3910"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3910"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3910"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3910"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3910"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3910"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3910"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3911"
          xlink:label="f-3911"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3911"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3911"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3911"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3911"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3912"
          xlink:label="f-3912"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3912"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3912"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3912"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3912"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3912"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3913"
          xlink:label="f-3913"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3913"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3913"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3913"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3913"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3914"
          xlink:label="f-3914"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3914"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3914"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3914"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3914"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3915"
          xlink:label="f-3915"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3915"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3915"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3915"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3916"
          xlink:label="f-3916"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3916"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3916"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3916"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3916"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3916"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3917"
          xlink:label="f-3917"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3917"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3917"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3917"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3918"
          xlink:label="f-3918"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3918"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3918"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3918"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3918"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3919"
          xlink:label="f-3919"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3919"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3919"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3919"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3940"
          xlink:label="f-3940"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3940"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3940"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3943"
          xlink:label="f-3943"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3943"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3943"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3943"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3943"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3943"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2607"
          xlink:label="f-2607"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2607"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2607"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3944"
          xlink:label="f-3944"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3944"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3944"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3944"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3944"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3944"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3944"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3944"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3945"
          xlink:label="f-3945"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3945"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3945"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3945"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3945"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3945"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3946"
          xlink:label="f-3946"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3946"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3946"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3946"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3946"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3946"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3946"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3947"
          xlink:label="f-3947"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3947"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3947"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3947"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3947"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3947"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2603"
          xlink:label="f-2603"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2603"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2603"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3948"
          xlink:label="f-3948"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3948"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3948"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3948"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3948"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3948"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3949"
          xlink:label="f-3949"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3949"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3949"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3949"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3949"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3930"
          xlink:label="f-3930"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3930"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3930"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3930"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3930"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3930"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3930"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3931"
          xlink:label="f-3931"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3931"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3931"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3931"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3931"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3931"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3931"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3931"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3932"
          xlink:label="f-3932"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3932"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3932"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3932"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3932"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3932"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3932"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2618"
          xlink:label="f-2618"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2618"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2618"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2618"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3933"
          xlink:label="f-3933"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3933"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3933"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3933"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3933"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3933"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3933"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3934"
          xlink:label="f-3934"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3934"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3934"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3934"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3934"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3934"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3935"
          xlink:label="f-3935"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3935"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3935"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3935"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3935"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3935"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3935"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3935"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2615"
          xlink:label="f-2615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2615"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2615"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3936"
          xlink:label="f-3936"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3936"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3936"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3936"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3936"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3936"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3937"
          xlink:label="f-3937"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3937"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3937"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3937"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3937"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3937"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3937"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3938"
          xlink:label="f-3938"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3938"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3938"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3938"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3938"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3938"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3939"
          xlink:label="f-3939"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3939"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3939"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3939"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3939"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3939"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2611"
          xlink:label="f-2611"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2611"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2611"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4410"
          xlink:label="f-4410"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4410"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4410"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4410"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4410"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4411"
          xlink:label="f-4411"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4411"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4411"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4411"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4411"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4412"
          xlink:label="f-4412"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4412"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4412"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4412"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4412"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4412"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4412"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4413"
          xlink:label="f-4413"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4413"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4413"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4413"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4413"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4414"
          xlink:label="f-4414"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4414"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4414"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4414"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4414"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4414"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4415"
          xlink:label="f-4415"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4415"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4415"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4415"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4415"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4416"
          xlink:label="f-4416"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4416"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4416"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4416"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4416"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4417"
          xlink:label="f-4417"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4417"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4417"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4417"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4417"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4417"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4418"
          xlink:label="f-4418"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4418"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4418"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4418"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4418"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4418"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4418"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4418"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4419"
          xlink:label="f-4419"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4419"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4419"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4419"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4419"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4419"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1379"
          xlink:label="f-1379"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1379"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1379"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1379"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1379"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1378"
          xlink:label="f-1378"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1378"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1378"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1378"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1378"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1377"
          xlink:label="f-1377"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1377"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1377"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1377"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1377"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1377"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1376"
          xlink:label="f-1376"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1376"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1376"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1376"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1376"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1375"
          xlink:label="f-1375"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1375"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1375"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1375"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1375"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1375"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1375"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1374"
          xlink:label="f-1374"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1374"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1374"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1374"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1374"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1374"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1373"
          xlink:label="f-1373"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1373"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1373"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1373"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1372"
          xlink:label="f-1372"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1372"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1372"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1372"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1371"
          xlink:label="f-1371"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1371"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1371"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1371"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1371"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1370"
          xlink:label="f-1370"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1370"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1370"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1370"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4400"
          xlink:label="f-4400"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4400"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4400"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4400"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4400"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4400"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4400"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4401"
          xlink:label="f-4401"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4401"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4401"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4401"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4401"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4402"
          xlink:label="f-4402"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4402"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4402"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4402"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4402"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4402"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4403"
          xlink:label="f-4403"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4403"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4403"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4403"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4403"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4404"
          xlink:label="f-4404"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4404"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4404"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4404"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4404"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4405"
          xlink:label="f-4405"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4405"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4405"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4405"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4405"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4406"
          xlink:label="f-4406"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4406"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4406"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4406"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4406"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4406"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4406"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4407"
          xlink:label="f-4407"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4407"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4407"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4407"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4407"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4408"
          xlink:label="f-4408"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4408"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4408"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4408"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4408"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4408"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4409"
          xlink:label="f-4409"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4409"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4409"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4409"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4409"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1389"
          xlink:label="f-1389"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1389"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1389"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1389"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1389"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1389"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1389"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1388"
          xlink:label="f-1388"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1388"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1388"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1388"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1388"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1388"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1387"
          xlink:label="f-1387"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1387"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1387"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1387"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1387"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1387"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1387"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1387"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1386"
          xlink:label="f-1386"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1386"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1386"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1386"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1386"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1386"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1386"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1385"
          xlink:label="f-1385"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1385"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1385"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1385"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1385"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1384"
          xlink:label="f-1384"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1384"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1384"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1384"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1384"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1383"
          xlink:label="f-1383"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1383"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1383"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1383"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1383"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1383"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1382"
          xlink:label="f-1382"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1382"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1382"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1382"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1382"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1381"
          xlink:label="f-1381"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1381"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1381"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1381"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1381"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1381"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1381"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1380"
          xlink:label="f-1380"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1380"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1380"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1380"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1380"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1380"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4430"
          xlink:label="f-4430"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4430"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4430"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4430"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4430"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4430"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4430"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3100"
          xlink:label="f-3100"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3100"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3100"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3100"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4431"
          xlink:label="f-4431"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4431"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4431"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4431"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4431"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3101"
          xlink:label="f-3101"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3101"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3101"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3101"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3101"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3101"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4432"
          xlink:label="f-4432"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4432"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4432"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4432"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4432"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4432"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3102"
          xlink:label="f-3102"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3102"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3102"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3102"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4433"
          xlink:label="f-4433"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4433"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4433"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4433"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4433"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3103"
          xlink:label="f-3103"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3103"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3103"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3103"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3103"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4434"
          xlink:label="f-4434"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4434"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4434"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4434"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4434"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3104"
          xlink:label="f-3104"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3104"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3104"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3104"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4435"
          xlink:label="f-4435"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4435"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4435"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3105"
          xlink:label="f-3105"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3105"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3105"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3105"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3106"
          xlink:label="f-3106"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3106"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3106"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3106"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3107"
          xlink:label="f-3107"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3107"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3107"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3107"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3107"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3107"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4438"
          xlink:label="f-4438"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4438"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4438"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3108"
          xlink:label="f-3108"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3108"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3108"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3108"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3109"
          xlink:label="f-3109"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3109"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3109"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3109"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3109"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1399"
          xlink:label="f-1399"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1399"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1399"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1399"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1399"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1398"
          xlink:label="f-1398"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1398"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1398"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1398"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1398"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1398"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1397"
          xlink:label="f-1397"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1397"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1397"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1397"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1397"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1396"
          xlink:label="f-1396"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1396"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1396"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1396"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1396"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1396"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1396"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1395"
          xlink:label="f-1395"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1395"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1395"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1395"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1395"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1395"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1392"
          xlink:label="f-1392"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1392"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1392"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1391"
          xlink:label="f-1391"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1391"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1391"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1391"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1391"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1391"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1390"
          xlink:label="f-1390"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1390"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1390"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1390"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1390"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1390"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4420"
          xlink:label="f-4420"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4420"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4420"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4420"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4420"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4420"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4420"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4421"
          xlink:label="f-4421"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4421"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4421"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4421"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4421"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4421"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4422"
          xlink:label="f-4422"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4422"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4422"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4422"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4422"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4422"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4423"
          xlink:label="f-4423"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4423"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4423"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4423"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4423"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4424"
          xlink:label="f-4424"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4424"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4424"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4424"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4424"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4424"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4424"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4425"
          xlink:label="f-4425"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4425"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4425"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4425"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4425"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4426"
          xlink:label="f-4426"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4426"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4426"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4426"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4426"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4426"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4427"
          xlink:label="f-4427"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4427"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4427"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4427"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4427"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4428"
          xlink:label="f-4428"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4428"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4428"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4428"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4428"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4429"
          xlink:label="f-4429"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4429"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4429"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4429"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4429"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1339"
          xlink:label="f-1339"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1339"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1339"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1339"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1339"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1339"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1339"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1339"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1339"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1338"
          xlink:label="f-1338"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1338"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1338"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1338"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1338"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1338"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1338"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1338"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1337"
          xlink:label="f-1337"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1337"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1337"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1337"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1337"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1337"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1336"
          xlink:label="f-1336"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1336"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1336"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1336"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1336"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1336"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2667"
          xlink:label="f-2667"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2667"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnote id="fn-14" xlink:label="fn-14" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">Under the 1940 Act, the Company would be deemed to &#x201c;control&#x201d; a portfolio company if the Company owned more than 25% of its outstanding voting securities and/or held the power to exercise control over the management or policies of the portfolio company. As of December&#160;31, 2023, the Company does not &#x201c;control&#x201d; any of these portfolio companies. Under the 1940 Act, the Company would be deemed an &#x201c;affiliated person&#x201d; of a portfolio company if the Company owns 5% or more of the portfolio company&#x2019;s outstanding voting securities. As of December&#160;31, 2023, the Company&#x2019;s non-controlled/affiliated investments were as follows:</xhtml:span><xhtml:div style="padding-left:36pt"><xhtml:table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.901%"><xhtml:tr><xhtml:td style="width:1.0%"/><xhtml:td style="width:28.978%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:8.191%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:0.429%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:8.033%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:0.429%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:8.033%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:0.429%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:8.191%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:0.429%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:9.136%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:0.429%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:7.876%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:0.429%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:8.988%"/><xhtml:td style="width:0.1%"/></xhtml:tr><xhtml:tr><xhtml:td colspan="3" style="padding:0 1pt"/><xhtml:td
              colspan="3"
              style="padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:div style="text-align:center"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value as of December&#160;31, 2022</xhtml:span></xhtml:div></xhtml:td><xhtml:td colspan="3" style="padding:0 1pt"/><xhtml:td
              colspan="3"
              style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Additions</xhtml:span></xhtml:td><xhtml:td colspan="3" style="padding:0 1pt"/><xhtml:td
              colspan="3"
              style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Reductions</xhtml:span></xhtml:td><xhtml:td colspan="3" style="padding:0 1pt"/><xhtml:td
              colspan="3"
              style="padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:div style="text-align:center"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net change in Unrealized Gains (Losses)</xhtml:span></xhtml:div></xhtml:td><xhtml:td colspan="3" style="padding:0 1pt"/><xhtml:td
              colspan="3"
              style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Realized Gain (Loss)</xhtml:span></xhtml:td><xhtml:td colspan="3" style="padding:0 1pt"/><xhtml:td
              colspan="3"
              style="padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:div style="text-align:center"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value as of December&#160;31, 2023</xhtml:span></xhtml:div></xhtml:td><xhtml:td colspan="3" style="padding:0 1pt"/><xhtml:td
              colspan="3"
              style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend and Interest Income</xhtml:span></xhtml:td></xhtml:tr><xhtml:tr><xhtml:td
              colspan="3"
              style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlled/Affiliated Investments</xhtml:span></xhtml:td><xhtml:td
              colspan="3"
              style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><xhtml:td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><xhtml:td
              colspan="3"
              style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><xhtml:td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><xhtml:td
              colspan="3"
              style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><xhtml:td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><xhtml:td
              colspan="3"
              style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><xhtml:td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><xhtml:td
              colspan="3"
              style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><xhtml:td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><xhtml:td
              colspan="3"
              style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><xhtml:td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><xhtml:td
              colspan="3"
              style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></xhtml:tr><xhtml:tr><xhtml:td
              colspan="3"
              style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Blackstone Donegal Holdings LP</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,584&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><xhtml:td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><xhtml:td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#x2014;&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><xhtml:td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><xhtml:td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(44,921)</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><xhtml:td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><xhtml:td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,156)</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><xhtml:td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><xhtml:td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,283&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><xhtml:td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><xhtml:td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,790&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><xhtml:td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><xhtml:td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#x2014;&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></xhtml:tr><xhtml:tr><xhtml:td
              colspan="3"
              style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">56,584</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><xhtml:td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#x2014;</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><xhtml:td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(44,921)</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><xhtml:td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14,156)</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><xhtml:td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,283</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><xhtml:td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,790</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><xhtml:td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#x2014;</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></xhtml:tr></xhtml:table></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2667"
          xlink:to="fn-14"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2667"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1335"
          xlink:label="f-1335"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1335"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1335"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1335"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1335"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1335"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1335"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2666"
          xlink:label="f-2666"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2666"
          xlink:to="fn-14"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2666"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2666"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1334"
          xlink:label="f-1334"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1334"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1334"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1334"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1334"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1334"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2665"
          xlink:label="f-2665"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2665"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2665"
          xlink:to="fn-14"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2665"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2665"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1333"
          xlink:label="f-1333"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1333"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1333"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1333"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1333"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1333"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1333"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1333"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1332"
          xlink:label="f-1332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1332"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1332"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1332"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1332"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1332"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1332"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1331"
          xlink:label="f-1331"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1331"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1331"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1331"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1331"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1331"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1330"
          xlink:label="f-1330"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1330"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1330"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1330"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1330"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1330"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3990"
          xlink:label="f-3990"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3990"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3990"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3990"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3990"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3991"
          xlink:label="f-3991"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3991"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3991"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3991"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3992"
          xlink:label="f-3992"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3992"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3992"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3992"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3992"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3992"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3993"
          xlink:label="f-3993"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3993"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3993"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3993"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3994"
          xlink:label="f-3994"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3994"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3994"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3994"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3994"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3995"
          xlink:label="f-3995"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3995"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3995"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3995"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3996"
          xlink:label="f-3996"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3996"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3996"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3996"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3997"
          xlink:label="f-3997"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3997"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3997"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1349"
          xlink:label="f-1349"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1349"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1349"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1349"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1349"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1348"
          xlink:label="f-1348"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1348"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1348"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1348"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1348"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1347"
          xlink:label="f-1347"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1347"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1347"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1347"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1347"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1347"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1346"
          xlink:label="f-1346"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1346"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1346"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1346"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1346"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1345"
          xlink:label="f-1345"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1345"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1345"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1345"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1345"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1345"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1345"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1344"
          xlink:label="f-1344"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1344"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1344"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1344"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1344"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1344"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1343"
          xlink:label="f-1343"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1343"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1343"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1343"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1343"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1343"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1343"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1342"
          xlink:label="f-1342"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1342"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1342"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1342"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1342"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1342"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1342"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1341"
          xlink:label="f-1341"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1341"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1341"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1341"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1341"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1341"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1341"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1341"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1340"
          xlink:label="f-1340"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1340"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1340"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1340"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1340"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1340"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1340"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1359"
          xlink:label="f-1359"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1359"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1359"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1359"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1359"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1359"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1359"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1358"
          xlink:label="f-1358"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1358"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1358"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1358"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1358"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1358"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1357"
          xlink:label="f-1357"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1357"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1357"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1357"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1357"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1357"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1357"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1357"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1356"
          xlink:label="f-1356"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1356"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1356"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1356"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1356"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1356"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1356"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1355"
          xlink:label="f-1355"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1355"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1355"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1355"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1355"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1354"
          xlink:label="f-1354"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1354"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1354"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1354"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1354"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1353"
          xlink:label="f-1353"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1353"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1353"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1353"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1353"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1353"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1352"
          xlink:label="f-1352"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1352"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1352"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1352"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1352"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1351"
          xlink:label="f-1351"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1351"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1351"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1351"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1351"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1351"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1351"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1350"
          xlink:label="f-1350"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1350"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1350"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1350"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1350"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1350"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1369"
          xlink:label="f-1369"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1369"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1369"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1369"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1369"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1369"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1368"
          xlink:label="f-1368"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1368"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1368"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1368"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1368"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1367"
          xlink:label="f-1367"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1367"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1367"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1367"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1367"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1367"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1366"
          xlink:label="f-1366"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1366"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1366"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1366"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1366"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1366"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1365"
          xlink:label="f-1365"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1365"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1365"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1365"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1365"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1365"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1365"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1364"
          xlink:label="f-1364"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1364"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1364"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1364"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1364"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1364"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1363"
          xlink:label="f-1363"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1363"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1363"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1363"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1363"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1363"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1363"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1363"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1362"
          xlink:label="f-1362"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1362"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1362"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1362"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1362"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1362"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1362"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1361"
          xlink:label="f-1361"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1361"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1361"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1361"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1361"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1361"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1360"
          xlink:label="f-1360"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1360"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1360"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1360"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1360"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1360"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3161"
          xlink:label="f-3161"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3161"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3161"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3161"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3161"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4492"
          xlink:label="f-4492"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4492"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4492"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3162"
          xlink:label="f-3162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3162"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3162"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3162"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3162"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4493"
          xlink:label="f-4493"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4493"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4493"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4493"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3163"
          xlink:label="f-3163"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3163"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3163"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3163"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4494"
          xlink:label="f-4494"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4494"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4494"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3164"
          xlink:label="f-3164"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3164"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3164"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3164"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3164"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3164"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4495"
          xlink:label="f-4495"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4495"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4495"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3165"
          xlink:label="f-3165"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3165"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3165"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3165"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4496"
          xlink:label="f-4496"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4496"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4496"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3166"
          xlink:label="f-3166"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3166"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3166"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3166"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3166"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4497"
          xlink:label="f-4497"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4497"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4497"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4497"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3167"
          xlink:label="f-3167"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3167"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3167"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3167"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4498"
          xlink:label="f-4498"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4498"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4498"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3168"
          xlink:label="f-3168"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3168"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3168"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3168"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4499"
          xlink:label="f-4499"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4499"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4499"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3169"
          xlink:label="f-3169"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3169"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3169"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3169"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3170"
          xlink:label="f-3170"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3170"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3170"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3170"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3170"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3170"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3171"
          xlink:label="f-3171"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3171"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3171"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3171"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3150"
          xlink:label="f-3150"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3150"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3150"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3150"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3150"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4481"
          xlink:label="f-4481"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4481"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4481"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4481"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4481"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3151"
          xlink:label="f-3151"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3151"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3151"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3151"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3151"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3151"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4482"
          xlink:label="f-4482"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4482"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4482"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4482"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4482"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3152"
          xlink:label="f-3152"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3152"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3152"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3152"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3152"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3152"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3152"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3152"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4483"
          xlink:label="f-4483"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4483"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4483"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4483"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4483"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3153"
          xlink:label="f-3153"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3153"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3153"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3153"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3153"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3153"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4484"
          xlink:label="f-4484"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4484"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4484"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4484"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4484"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3154"
          xlink:label="f-3154"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3154"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3154"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3154"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3154"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3154"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3154"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4485"
          xlink:label="f-4485"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4485"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4485"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4485"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4485"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3155"
          xlink:label="f-3155"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3155"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3155"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3155"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3155"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3155"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4486"
          xlink:label="f-4486"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4486"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4486"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4486"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4486"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3156"
          xlink:label="f-3156"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3156"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3156"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3156"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3156"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3156"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4487"
          xlink:label="f-4487"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4487"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4487"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4487"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4487"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3157"
          xlink:label="f-3157"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3157"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3157"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3157"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3157"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4488"
          xlink:label="f-4488"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4488"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4488"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4488"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4488"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3158"
          xlink:label="f-3158"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3158"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3158"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3158"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3158"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3158"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3158"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3159"
          xlink:label="f-3159"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3159"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3159"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3159"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3159"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3160"
          xlink:label="f-3160"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3160"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3160"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3160"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3160"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3160"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3183"
          xlink:label="f-3183"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3183"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3183"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3183"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3183"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3184"
          xlink:label="f-3184"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3184"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3184"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3184"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3184"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3184"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3185"
          xlink:label="f-3185"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3185"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3185"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3185"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3185"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3186"
          xlink:label="f-3186"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3186"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3186"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3186"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3186"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3187"
          xlink:label="f-3187"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3187"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3187"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3187"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3187"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3188"
          xlink:label="f-3188"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3188"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3188"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3188"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3188"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3188"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3188"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3189"
          xlink:label="f-3189"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3189"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3189"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3189"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3189"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3190"
          xlink:label="f-3190"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3190"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3190"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3190"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3190"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3190"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3191"
          xlink:label="f-3191"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3191"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3191"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3191"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3191"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3192"
          xlink:label="f-3192"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3192"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3192"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3192"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3192"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3193"
          xlink:label="f-3193"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3193"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3193"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3193"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3193"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3193"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3172"
          xlink:label="f-3172"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3172"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3172"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3172"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3172"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3173"
          xlink:label="f-3173"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3173"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3173"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3173"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3174"
          xlink:label="f-3174"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3174"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3174"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3174"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3175"
          xlink:label="f-3175"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3175"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3175"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3175"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3175"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3176"
          xlink:label="f-3176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3176"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3176"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3176"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3176"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3176"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3176"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3177"
          xlink:label="f-3177"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3177"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3177"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3177"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3177"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3178"
          xlink:label="f-3178"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3178"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3178"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3178"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3178"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3178"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3179"
          xlink:label="f-3179"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3179"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3179"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3179"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3179"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3180"
          xlink:label="f-3180"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3180"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3180"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3180"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3180"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3181"
          xlink:label="f-3181"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3181"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3181"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3181"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3181"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3182"
          xlink:label="f-3182"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3182"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3182"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3182"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3182"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3182"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3182"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-876"
          xlink:label="f-876"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-876"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-876"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-876"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4450"
          xlink:label="f-4450"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4450"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4450"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4450"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4450"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4450"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3120"
          xlink:label="f-3120"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3120"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3120"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3120"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4451"
          xlink:label="f-4451"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4451"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4451"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4451"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4451"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4451"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3121"
          xlink:label="f-3121"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3121"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3121"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3121"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3121"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4452"
          xlink:label="f-4452"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4452"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4452"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4452"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4452"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4452"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3122"
          xlink:label="f-3122"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3122"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3122"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3122"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4453"
          xlink:label="f-4453"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4453"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4453"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4453"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3123"
          xlink:label="f-3123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3123"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3123"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3123"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4454"
          xlink:label="f-4454"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4454"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4454"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4454"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3124"
          xlink:label="f-3124"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3124"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3124"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3124"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4455"
          xlink:label="f-4455"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4455"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4455"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4455"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3125"
          xlink:label="f-3125"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3125"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3125"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3125"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3125"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3125"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4456"
          xlink:label="f-4456"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4456"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4456"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4456"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3126"
          xlink:label="f-3126"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3126"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3126"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3126"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4457"
          xlink:label="f-4457"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4457"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4457"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4457"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3127"
          xlink:label="f-3127"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3127"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3127"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3127"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3127"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4458"
          xlink:label="f-4458"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4458"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4458"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4458"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3128"
          xlink:label="f-3128"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3128"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3128"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3128"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3129"
          xlink:label="f-3129"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3129"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3129"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3129"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-870"
          xlink:label="f-870"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-870"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-870"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-871"
          xlink:label="f-871"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-871"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-871"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-871"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-871"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-874"
          xlink:label="f-874"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-874"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-874"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-874"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-874"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-875"
          xlink:label="f-875"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-875"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-875"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-875"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-872"
          xlink:label="f-872"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-872"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-872"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-872"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-872"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-872"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-873"
          xlink:label="f-873"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-873"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-873"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-873"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-867"
          xlink:label="f-867"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-867"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-867"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-868"
          xlink:label="f-868"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-868"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-868"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-868"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-865"
          xlink:label="f-865"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-865"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-865"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-865"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-866"
          xlink:label="f-866"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-866"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-866"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-866"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-866"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3110"
          xlink:label="f-3110"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3110"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3110"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3110"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4441"
          xlink:label="f-4441"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4441"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4441"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4441"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4441"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3111"
          xlink:label="f-3111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3111"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3111"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3111"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4442"
          xlink:label="f-4442"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4442"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4442"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4442"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4442"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-869"
          xlink:label="f-869"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-869"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-869"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3112"
          xlink:label="f-3112"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3112"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3112"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3112"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3112"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3112"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4443"
          xlink:label="f-4443"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4443"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4443"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4443"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4443"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3113"
          xlink:label="f-3113"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3113"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3113"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3113"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3113"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3113"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3113"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3113"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4444"
          xlink:label="f-4444"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4444"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4444"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4444"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4444"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3114"
          xlink:label="f-3114"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3114"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3114"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3114"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3114"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3114"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4445"
          xlink:label="f-4445"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4445"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4445"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4445"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4445"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3115"
          xlink:label="f-3115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3115"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3115"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3115"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3115"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3115"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3115"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4446"
          xlink:label="f-4446"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4446"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4446"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4446"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4446"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3116"
          xlink:label="f-3116"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3116"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3116"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3116"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3116"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3116"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4447"
          xlink:label="f-4447"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4447"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4447"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4447"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4447"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4447"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3117"
          xlink:label="f-3117"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3117"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3117"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3117"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3117"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3117"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4448"
          xlink:label="f-4448"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4448"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4448"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4448"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4448"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4448"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3118"
          xlink:label="f-3118"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3118"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3118"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3118"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4449"
          xlink:label="f-4449"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4449"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4449"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4449"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4449"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4449"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3119"
          xlink:label="f-3119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3119"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3119"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3119"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3119"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3119"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-860"
          xlink:label="f-860"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-860"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-860"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-860"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-860"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-863"
          xlink:label="f-863"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-863"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-863"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-864"
          xlink:label="f-864"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-864"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-864"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-861"
          xlink:label="f-861"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-861"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-861"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-862"
          xlink:label="f-862"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-862"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-862"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-862"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4470"
          xlink:label="f-4470"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4470"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4470"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4470"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4470"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3140"
          xlink:label="f-3140"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3140"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3140"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3140"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3140"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3140"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-898"
          xlink:label="f-898"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-898"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-898"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-898"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3141"
          xlink:label="f-3141"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3141"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3141"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3141"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4472"
          xlink:label="f-4472"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4472"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4472"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4472"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4472"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-899"
          xlink:label="f-899"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-899"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-899"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-899"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-899"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3142"
          xlink:label="f-3142"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3142"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3142"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3142"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3142"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4473"
          xlink:label="f-4473"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4473"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4473"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4473"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4473"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3143"
          xlink:label="f-3143"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3143"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3143"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3143"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4474"
          xlink:label="f-4474"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4474"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4474"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4474"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4474"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3144"
          xlink:label="f-3144"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3144"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3144"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3144"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4475"
          xlink:label="f-4475"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4475"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4475"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4475"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4475"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3145"
          xlink:label="f-3145"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3145"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3145"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3145"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3145"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4476"
          xlink:label="f-4476"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4476"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4476"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4476"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4476"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3146"
          xlink:label="f-3146"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3146"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3146"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3146"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3146"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3146"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3146"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4477"
          xlink:label="f-4477"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4477"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4477"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4477"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4477"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3147"
          xlink:label="f-3147"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3147"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3147"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3147"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3147"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4478"
          xlink:label="f-4478"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4478"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4478"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4478"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4478"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3148"
          xlink:label="f-3148"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3148"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3148"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3148"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3148"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3148"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4479"
          xlink:label="f-4479"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4479"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4479"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4479"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4479"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3149"
          xlink:label="f-3149"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3149"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3149"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3149"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3149"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-892"
          xlink:label="f-892"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-892"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-892"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-892"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-892"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-893"
          xlink:label="f-893"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-893"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-893"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-893"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-893"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-893"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-890"
          xlink:label="f-890"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-890"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-890"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-890"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-891"
          xlink:label="f-891"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-891"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-891"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-891"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-896"
          xlink:label="f-896"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-896"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-896"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-896"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-897"
          xlink:label="f-897"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-897"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-897"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-897"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-894"
          xlink:label="f-894"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-894"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-894"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-894"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-895"
          xlink:label="f-895"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-895"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-895"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-895"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-895"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4480"
          xlink:label="f-4480"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4480"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4480"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4480"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4480"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-889"
          xlink:label="f-889"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-889"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-889"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-889"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-889"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-887"
          xlink:label="f-887"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-887"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-887"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-887"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-887"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-887"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3130"
          xlink:label="f-3130"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3130"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3130"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3130"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-888"
          xlink:label="f-888"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-888"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-888"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-888"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3131"
          xlink:label="f-3131"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3131"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3131"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3131"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3131"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3131"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4462"
          xlink:label="f-4462"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4462"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4462"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4462"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3132"
          xlink:label="f-3132"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3132"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3132"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3132"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4463"
          xlink:label="f-4463"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4463"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4463"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4463"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3133"
          xlink:label="f-3133"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3133"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3133"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3133"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3133"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4464"
          xlink:label="f-4464"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4464"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4464"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4464"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3134"
          xlink:label="f-3134"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3134"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3134"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3134"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4465"
          xlink:label="f-4465"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4465"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4465"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4465"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3135"
          xlink:label="f-3135"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3135"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3135"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3135"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4466"
          xlink:label="f-4466"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4466"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4466"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4466"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3136"
          xlink:label="f-3136"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3136"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3136"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4467"
          xlink:label="f-4467"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4467"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4467"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4467"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4468"
          xlink:label="f-4468"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4468"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4468"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4468"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4468"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3139"
          xlink:label="f-3139"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3139"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3139"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3139"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-881"
          xlink:label="f-881"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-881"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-881"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-881"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-881"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-882"
          xlink:label="f-882"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-882"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-882"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-880"
          xlink:label="f-880"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-880"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-880"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-880"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-885"
          xlink:label="f-885"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-885"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-885"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-886"
          xlink:label="f-886"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-886"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-886"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-886"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-886"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-883"
          xlink:label="f-883"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-883"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-883"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-883"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-884"
          xlink:label="f-884"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-884"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-884"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-834"
          xlink:label="f-834"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-834"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-834"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-834"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-835"
          xlink:label="f-835"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-835"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-835"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-832"
          xlink:label="f-832"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-832"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-832"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-832"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-832"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-833"
          xlink:label="f-833"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-833"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-833"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-833"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-838"
          xlink:label="f-838"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-838"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-838"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-836"
          xlink:label="f-836"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-836"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-836"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-836"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-830"
          xlink:label="f-830"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-830"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-830"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-830"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-830"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-830"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-831"
          xlink:label="f-831"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-831"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-831"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-831"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-823"
          xlink:label="f-823"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-823"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-823"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-823"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-823"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-824"
          xlink:label="f-824"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-824"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-824"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-824"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-824"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-824"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-821"
          xlink:label="f-821"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-821"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-821"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-822"
          xlink:label="f-822"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-822"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-822"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-827"
          xlink:label="f-827"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-827"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-827"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-827"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-828"
          xlink:label="f-828"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-828"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-828"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-828"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-825"
          xlink:label="f-825"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-825"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-825"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-825"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-826"
          xlink:label="f-826"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-826"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-826"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-826"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-826"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-829"
          xlink:label="f-829"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-829"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-829"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-829"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-829"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-820"
          xlink:label="f-820"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-820"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-820"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-820"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-854"
          xlink:label="f-854"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-854"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-854"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-854"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-854"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-855"
          xlink:label="f-855"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-855"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-855"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-855"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-855"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-859"
          xlink:label="f-859"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-859"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-859"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-859"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-852"
          xlink:label="f-852"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-852"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-852"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-852"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-852"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-853"
          xlink:label="f-853"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-853"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-853"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-853"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-853"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-853"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-850"
          xlink:label="f-850"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-850"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-850"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-850"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-850"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-850"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-851"
          xlink:label="f-851"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-851"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-851"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-851"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-851"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-851"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-851"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-845"
          xlink:label="f-845"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-845"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-845"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-845"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-845"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-845"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-846"
          xlink:label="f-846"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-846"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-846"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-846"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-844"
          xlink:label="f-844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-844"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-844"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-844"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-844"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-849"
          xlink:label="f-849"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-849"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-849"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-849"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-847"
          xlink:label="f-847"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-847"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-847"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-847"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-847"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-848"
          xlink:label="f-848"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-848"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-848"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-848"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3194"
          xlink:label="f-3194"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3194"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3194"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3194"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3194"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3194"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3194"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3194"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3195"
          xlink:label="f-3195"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3195"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3195"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3195"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3195"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3195"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3196"
          xlink:label="f-3196"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3196"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3196"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3196"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3196"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3196"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3196"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3197"
          xlink:label="f-3197"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3197"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3197"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3197"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3197"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3197"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3198"
          xlink:label="f-3198"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3198"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3198"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3198"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3198"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3198"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3199"
          xlink:label="f-3199"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3199"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3199"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3199"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3199"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3199"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-812"
          xlink:label="f-812"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-812"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-812"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-812"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-812"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-812"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-813"
          xlink:label="f-813"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-813"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-813"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-813"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-810"
          xlink:label="f-810"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-810"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-810"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-810"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-811"
          xlink:label="f-811"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-811"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-811"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-811"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-811"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-816"
          xlink:label="f-816"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-816"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-816"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-816"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-817"
          xlink:label="f-817"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-817"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-817"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-817"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-814"
          xlink:label="f-814"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-814"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-814"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-814"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-814"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-815"
          xlink:label="f-815"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-815"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-815"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-815"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-818"
          xlink:label="f-818"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-818"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-818"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-818"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-818"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-819"
          xlink:label="f-819"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-819"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-819"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-801"
          xlink:label="f-801"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-801"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-801"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-802"
          xlink:label="f-802"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-802"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-802"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-802"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-800"
          xlink:label="f-800"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-800"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-800"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-800"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-800"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-805"
          xlink:label="f-805"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-805"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-805"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-805"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-805"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-806"
          xlink:label="f-806"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-806"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-806"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-806"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-806"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-806"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-803"
          xlink:label="f-803"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-803"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-803"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-804"
          xlink:label="f-804"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-804"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-804"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-809"
          xlink:label="f-809"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-809"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-809"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-809"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-807"
          xlink:label="f-807"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-807"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-807"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-807"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-808"
          xlink:label="f-808"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-808"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-808"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-808"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-808"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1419"
          xlink:label="f-1419"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1419"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1419"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1419"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1419"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1418"
          xlink:label="f-1418"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1418"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1418"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1418"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1418"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1417"
          xlink:label="f-1417"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1417"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1417"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1417"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1417"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1416"
          xlink:label="f-1416"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1416"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1416"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1416"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1416"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1416"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1415"
          xlink:label="f-1415"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1415"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1415"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1415"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1415"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1414"
          xlink:label="f-1414"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1414"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1414"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1414"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1414"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1414"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1414"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1413"
          xlink:label="f-1413"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1413"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1413"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1413"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1413"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1413"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1412"
          xlink:label="f-1412"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1412"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1412"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1412"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1412"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1412"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1411"
          xlink:label="f-1411"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1411"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1411"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1411"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1411"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1411"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1410"
          xlink:label="f-1410"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1410"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1410"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1410"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1410"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1410"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1410"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1429"
          xlink:label="f-1429"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1429"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1429"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1429"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1428"
          xlink:label="f-1428"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1428"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1428"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1428"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1428"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1427"
          xlink:label="f-1427"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1427"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1427"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1427"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1426"
          xlink:label="f-1426"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1426"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1426"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1426"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1426"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1426"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1425"
          xlink:label="f-1425"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1425"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1425"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1425"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1425"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1424"
          xlink:label="f-1424"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1424"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1424"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1424"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1423"
          xlink:label="f-1423"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1423"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1423"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1423"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1422"
          xlink:label="f-1422"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1422"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1422"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1422"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1422"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1421"
          xlink:label="f-1421"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1421"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1421"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1421"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1420"
          xlink:label="f-1420"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1420"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1420"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1420"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1420"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1420"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1439"
          xlink:label="f-1439"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1439"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1439"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1439"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1439"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1438"
          xlink:label="f-1438"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1438"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1438"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1438"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1438"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1438"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1438"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1437"
          xlink:label="f-1437"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1437"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1437"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1437"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1437"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1437"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1436"
          xlink:label="f-1436"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1436"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1436"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1436"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1436"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1435"
          xlink:label="f-1435"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1435"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1435"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1435"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1435"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1434"
          xlink:label="f-1434"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1434"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1434"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1434"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1434"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1434"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1433"
          xlink:label="f-1433"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1433"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1433"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1433"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1433"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1432"
          xlink:label="f-1432"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1432"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1432"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1432"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1432"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1432"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1432"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1431"
          xlink:label="f-1431"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1431"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1431"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1431"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1431"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1431"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1430"
          xlink:label="f-1430"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1430"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1430"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1430"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1449"
          xlink:label="f-1449"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1449"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1449"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1449"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1449"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1449"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1448"
          xlink:label="f-1448"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1448"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1448"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1448"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1447"
          xlink:label="f-1447"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1447"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1447"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1447"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1446"
          xlink:label="f-1446"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1446"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1446"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1446"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1446"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1445"
          xlink:label="f-1445"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1445"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1445"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1445"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1444"
          xlink:label="f-1444"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1444"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1444"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1444"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1444"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1444"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1443"
          xlink:label="f-1443"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1443"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1443"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1443"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1443"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1442"
          xlink:label="f-1442"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1442"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1442"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1442"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1442"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1441"
          xlink:label="f-1441"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1441"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1441"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1441"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1441"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1440"
          xlink:label="f-1440"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1440"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1440"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1440"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1440"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1440"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1409"
          xlink:label="f-1409"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1409"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1409"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1409"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1409"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1409"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1408"
          xlink:label="f-1408"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1408"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1408"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1408"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1408"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1408"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1408"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1408"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1407"
          xlink:label="f-1407"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1407"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1407"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1407"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1407"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1407"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1407"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1406"
          xlink:label="f-1406"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1406"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1406"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1406"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1406"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1406"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1405"
          xlink:label="f-1405"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1405"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1405"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1405"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1405"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1405"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1404"
          xlink:label="f-1404"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1404"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1404"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1404"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1404"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1404"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1404"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1403"
          xlink:label="f-1403"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1403"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1403"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1403"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1403"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1403"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1402"
          xlink:label="f-1402"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1402"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1402"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1402"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1402"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1402"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1402"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1402"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1401"
          xlink:label="f-1401"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1401"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1401"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1401"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1401"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1401"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1401"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1400"
          xlink:label="f-1400"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1400"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1400"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1400"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1400"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4530"
          xlink:label="f-4530"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4530"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4530"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3200"
          xlink:label="f-3200"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3200"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3200"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3200"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3200"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3200"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3200"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3200"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4531"
          xlink:label="f-4531"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4531"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4531"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4531"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3201"
          xlink:label="f-3201"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3201"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3201"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3201"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3201"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3201"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4532"
          xlink:label="f-4532"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4532"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4532"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3202"
          xlink:label="f-3202"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3202"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3202"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3202"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3202"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3202"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3202"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4533"
          xlink:label="f-4533"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4533"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4533"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3203"
          xlink:label="f-3203"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3203"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3203"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3203"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3203"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3203"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4534"
          xlink:label="f-4534"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4534"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4534"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3204"
          xlink:label="f-3204"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3204"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3204"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3204"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3204"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3204"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4535"
          xlink:label="f-4535"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4535"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4535"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4535"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3205"
          xlink:label="f-3205"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3205"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3205"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4536"
          xlink:label="f-4536"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4536"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4536"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4537"
          xlink:label="f-4537"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4537"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4537"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4538"
          xlink:label="f-4538"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4538"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4538"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3208"
          xlink:label="f-3208"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3208"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3208"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3208"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3208"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4539"
          xlink:label="f-4539"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4539"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4539"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4539"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3209"
          xlink:label="f-3209"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3209"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3209"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3209"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3209"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3209"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3209"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1499"
          xlink:label="f-1499"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1499"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1499"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1499"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1499"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1499"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1498"
          xlink:label="f-1498"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1498"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1498"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1498"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1498"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1498"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1497"
          xlink:label="f-1497"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1497"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1497"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1497"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1497"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1497"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1497"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1496"
          xlink:label="f-1496"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1496"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1496"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1496"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1496"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1496"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1495"
          xlink:label="f-1495"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1495"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1495"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1495"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1495"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1495"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1495"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1495"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1494"
          xlink:label="f-1494"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1494"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1494"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1494"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1494"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1494"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1494"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1493"
          xlink:label="f-1493"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1493"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1493"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1493"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1493"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1492"
          xlink:label="f-1492"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1492"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1492"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1492"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1492"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1491"
          xlink:label="f-1491"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1491"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1491"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1491"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1491"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1491"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1490"
          xlink:label="f-1490"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1490"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1490"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1490"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1490"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4520"
          xlink:label="f-4520"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4520"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4520"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4520"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4521"
          xlink:label="f-4521"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4521"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4521"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4522"
          xlink:label="f-4522"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4522"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4522"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4523"
          xlink:label="f-4523"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4523"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4523"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4524"
          xlink:label="f-4524"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4524"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4524"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4524"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4525"
          xlink:label="f-4525"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4525"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4525"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4526"
          xlink:label="f-4526"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4526"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4526"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4527"
          xlink:label="f-4527"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4527"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4527"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4550"
          xlink:label="f-4550"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4550"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4550"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4550"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3220"
          xlink:label="f-3220"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3220"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3220"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3220"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3220"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4551"
          xlink:label="f-4551"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4551"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4551"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3221"
          xlink:label="f-3221"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3221"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3221"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3221"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3221"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3221"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3221"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4552"
          xlink:label="f-4552"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4552"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4552"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3222"
          xlink:label="f-3222"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3222"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3222"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3222"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3222"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4553"
          xlink:label="f-4553"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4553"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4553"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3223"
          xlink:label="f-3223"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3223"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3223"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3223"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3223"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3223"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4554"
          xlink:label="f-4554"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4554"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4554"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4554"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3224"
          xlink:label="f-3224"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3224"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3224"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3224"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3224"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4555"
          xlink:label="f-4555"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4555"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4555"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3225"
          xlink:label="f-3225"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3225"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3225"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3225"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3225"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4556"
          xlink:label="f-4556"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4556"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4556"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3226"
          xlink:label="f-3226"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3226"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3226"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3226"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4557"
          xlink:label="f-4557"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4557"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4557"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3227"
          xlink:label="f-3227"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3227"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3227"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3227"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3227"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3227"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4558"
          xlink:label="f-4558"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4558"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4558"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4558"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3228"
          xlink:label="f-3228"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3228"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3228"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3228"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4559"
          xlink:label="f-4559"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4559"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4559"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3229"
          xlink:label="f-3229"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3229"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3229"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3229"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3229"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4540"
          xlink:label="f-4540"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4540"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4540"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3210"
          xlink:label="f-3210"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3210"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3210"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3210"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3210"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4541"
          xlink:label="f-4541"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4541"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4541"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3211"
          xlink:label="f-3211"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3211"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3211"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3211"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3211"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3211"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4542"
          xlink:label="f-4542"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4542"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4542"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3212"
          xlink:label="f-3212"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3212"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3212"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3212"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3212"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4543"
          xlink:label="f-4543"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4543"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4543"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4543"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3213"
          xlink:label="f-3213"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3213"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3213"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3213"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3213"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4544"
          xlink:label="f-4544"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4544"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4544"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3214"
          xlink:label="f-3214"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3214"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3214"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3214"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4545"
          xlink:label="f-4545"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4545"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4545"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3215"
          xlink:label="f-3215"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3215"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3215"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3215"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3215"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3215"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4546"
          xlink:label="f-4546"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4546"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4546"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3216"
          xlink:label="f-3216"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3216"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3216"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3216"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3217"
          xlink:label="f-3217"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3217"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3217"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3217"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3217"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3218"
          xlink:label="f-3218"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3218"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3218"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3218"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4549"
          xlink:label="f-4549"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4549"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4549"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3219"
          xlink:label="f-3219"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3219"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3219"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3219"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1459"
          xlink:label="f-1459"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1459"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1459"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1459"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1458"
          xlink:label="f-1458"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1458"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1458"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1458"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1458"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1457"
          xlink:label="f-1457"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1457"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1457"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1457"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1456"
          xlink:label="f-1456"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1456"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1456"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1456"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1456"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1456"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1455"
          xlink:label="f-1455"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1455"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1455"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1455"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1455"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1454"
          xlink:label="f-1454"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1454"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1454"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1454"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1454"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1453"
          xlink:label="f-1453"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1453"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1453"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1453"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1453"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1452"
          xlink:label="f-1452"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1452"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1452"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1452"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1452"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1452"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1451"
          xlink:label="f-1451"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1451"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1451"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1451"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1451"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1450"
          xlink:label="f-1450"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1450"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1450"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1450"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1450"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1450"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1450"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1469"
          xlink:label="f-1469"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1469"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1469"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1469"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1468"
          xlink:label="f-1468"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1468"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1468"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1468"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1468"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1468"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1467"
          xlink:label="f-1467"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1467"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1467"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1467"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1467"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1466"
          xlink:label="f-1466"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1466"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1466"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1466"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1466"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1465"
          xlink:label="f-1465"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1465"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1465"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1465"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1465"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1464"
          xlink:label="f-1464"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1464"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1464"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1464"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1464"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1464"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1463"
          xlink:label="f-1463"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1463"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1463"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1463"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1463"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1462"
          xlink:label="f-1462"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1462"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1462"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1462"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1462"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1462"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1462"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1461"
          xlink:label="f-1461"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1461"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1461"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1461"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1461"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1461"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1460"
          xlink:label="f-1460"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1460"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1460"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1460"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4510"
          xlink:label="f-4510"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4510"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4510"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4511"
          xlink:label="f-4511"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4511"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4511"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4512"
          xlink:label="f-4512"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4512"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4512"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4512"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4513"
          xlink:label="f-4513"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4513"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4513"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4514"
          xlink:label="f-4514"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4514"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4514"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4515"
          xlink:label="f-4515"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4515"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4515"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4519"
          xlink:label="f-4519"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4519"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4519"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1479"
          xlink:label="f-1479"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1479"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1479"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1479"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1479"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1479"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1478"
          xlink:label="f-1478"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1478"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1478"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1478"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1478"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1477"
          xlink:label="f-1477"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1477"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1477"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1477"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1477"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1476"
          xlink:label="f-1476"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1476"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1476"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1476"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1476"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1476"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1475"
          xlink:label="f-1475"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1475"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1475"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1475"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1475"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1474"
          xlink:label="f-1474"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1474"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1474"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1474"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1474"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1474"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1474"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1473"
          xlink:label="f-1473"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1473"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1473"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1473"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1473"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1473"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1472"
          xlink:label="f-1472"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1472"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1472"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1472"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1471"
          xlink:label="f-1471"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1471"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1471"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1471"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1470"
          xlink:label="f-1470"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1470"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1470"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1470"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1470"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4500"
          xlink:label="f-4500"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4500"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4500"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4501"
          xlink:label="f-4501"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4501"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4501"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4501"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4502"
          xlink:label="f-4502"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4502"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4502"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4503"
          xlink:label="f-4503"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4503"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4503"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4504"
          xlink:label="f-4504"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4504"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4504"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4507"
          xlink:label="f-4507"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4507"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4507"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4508"
          xlink:label="f-4508"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4508"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4508"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4508"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4509"
          xlink:label="f-4509"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4509"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4509"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1489"
          xlink:label="f-1489"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1489"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1489"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1489"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1489"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1489"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1489"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1488"
          xlink:label="f-1488"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1488"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1488"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1488"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1488"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1488"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1485"
          xlink:label="f-1485"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1485"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1485"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1484"
          xlink:label="f-1484"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1484"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1484"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1484"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1484"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1483"
          xlink:label="f-1483"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1483"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1483"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1483"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1483"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1482"
          xlink:label="f-1482"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1482"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1482"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1482"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1482"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1482"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1481"
          xlink:label="f-1481"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1481"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1481"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1481"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1481"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1480"
          xlink:label="f-1480"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1480"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1480"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1480"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1480"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1480"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1480"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3282"
          xlink:label="f-3282"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3282"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3282"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3282"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3282"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3283"
          xlink:label="f-3283"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3283"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3283"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3283"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnote id="fn-28" xlink:label="fn-28" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was 1.25%.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3283"
          xlink:to="fn-28"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3284"
          xlink:label="f-3284"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3284"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3284"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3284"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3284"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3284"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3284"
          xlink:to="fn-28"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3285"
          xlink:label="f-3285"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3285"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3285"
          xlink:to="fn-28"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3285"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3285"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3286"
          xlink:label="f-3286"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3286"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3286"
          xlink:to="fn-28"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3286"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3286"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3286"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3287"
          xlink:label="f-3287"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3287"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3287"
          xlink:to="fn-28"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3287"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3287"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3288"
          xlink:label="f-3288"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3288"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3288"
          xlink:to="fn-28"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3288"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3288"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3289"
          xlink:label="f-3289"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3289"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3289"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3289"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3289"
          xlink:to="fn-28"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3290"
          xlink:label="f-3290"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3290"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3290"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3290"
          xlink:to="fn-28"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3290"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3290"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3290"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3291"
          xlink:label="f-3291"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3291"
          xlink:to="fn-28"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3291"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3291"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3291"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3292"
          xlink:label="f-3292"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3292"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3292"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3292"
          xlink:to="fn-28"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3292"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3292"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3271"
          xlink:label="f-3271"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3271"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3271"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3271"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3271"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3272"
          xlink:label="f-3272"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3272"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3272"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3272"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3272"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3272"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3272"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3273"
          xlink:label="f-3273"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3273"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3273"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3273"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3273"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3274"
          xlink:label="f-3274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3274"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3274"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3274"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3274"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3274"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3275"
          xlink:label="f-3275"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3275"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3275"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3275"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3275"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3276"
          xlink:label="f-3276"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3276"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3276"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3276"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3276"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3277"
          xlink:label="f-3277"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3277"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3277"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3277"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3277"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3278"
          xlink:label="f-3278"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3278"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3278"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3278"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3278"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3278"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3278"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3279"
          xlink:label="f-3279"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3279"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3279"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3279"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3279"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3280"
          xlink:label="f-3280"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3280"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3280"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3280"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3280"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3280"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3281"
          xlink:label="f-3281"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3281"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3281"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3281"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3281"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3293"
          xlink:label="f-3293"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3293"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3293"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3293"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3293"
          xlink:to="fn-28"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3294"
          xlink:label="f-3294"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3294"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3294"
          xlink:to="fn-28"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3294"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3294"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3295"
          xlink:label="f-3295"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3295"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3295"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3295"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3296"
          xlink:label="f-3296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3296"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3296"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3296"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3296"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3296"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3297"
          xlink:label="f-3297"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3297"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3297"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3297"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3298"
          xlink:label="f-3298"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3298"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3298"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3298"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3298"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3299"
          xlink:label="f-3299"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3299"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3299"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3299"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4570"
          xlink:label="f-4570"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4570"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4570"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4570"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4571"
          xlink:label="f-4571"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4571"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4571"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4571"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3241"
          xlink:label="f-3241"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3241"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3241"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3241"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3241"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4572"
          xlink:label="f-4572"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4572"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4572"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4572"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3242"
          xlink:label="f-3242"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3242"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3242"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3242"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3242"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3242"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3242"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4573"
          xlink:label="f-4573"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4573"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4573"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4573"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4573"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3243"
          xlink:label="f-3243"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3243"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3243"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3243"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3243"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4574"
          xlink:label="f-4574"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4574"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4574"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4574"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3244"
          xlink:label="f-3244"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3244"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3244"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3244"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3244"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3244"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4575"
          xlink:label="f-4575"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4575"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4575"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4575"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3245"
          xlink:label="f-3245"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3245"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3245"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3245"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3245"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4576"
          xlink:label="f-4576"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4576"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4576"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3246"
          xlink:label="f-3246"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3246"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3246"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3246"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3246"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3247"
          xlink:label="f-3247"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3247"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3247"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3247"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3247"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3248"
          xlink:label="f-3248"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3248"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3248"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3248"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3248"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3248"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3248"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4579"
          xlink:label="f-4579"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4579"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4579"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4579"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3249"
          xlink:label="f-3249"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3249"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3249"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3249"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3249"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4560"
          xlink:label="f-4560"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4560"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4560"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3230"
          xlink:label="f-3230"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3230"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3230"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3230"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4561"
          xlink:label="f-4561"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4561"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4561"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3231"
          xlink:label="f-3231"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3231"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3231"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3231"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4562"
          xlink:label="f-4562"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4562"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4562"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4562"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3232"
          xlink:label="f-3232"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3232"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3232"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3232"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3232"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4563"
          xlink:label="f-4563"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4563"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4563"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3233"
          xlink:label="f-3233"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3233"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3233"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3233"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3233"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3233"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3233"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4564"
          xlink:label="f-4564"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4564"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4564"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3234"
          xlink:label="f-3234"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3234"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3234"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3234"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3234"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4565"
          xlink:label="f-4565"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4565"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4565"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3235"
          xlink:label="f-3235"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3235"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3235"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3235"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3235"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3235"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3236"
          xlink:label="f-3236"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3236"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3236"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3236"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3236"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3237"
          xlink:label="f-3237"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3237"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3237"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3237"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3237"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4568"
          xlink:label="f-4568"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4568"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4568"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4568"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3238"
          xlink:label="f-3238"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3238"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3238"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4569"
          xlink:label="f-4569"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4569"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4569"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4569"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4569"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3260"
          xlink:label="f-3260"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3260"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3260"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3260"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3260"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3260"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4591"
          xlink:label="f-4591"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4591"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4591"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3261"
          xlink:label="f-3261"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3261"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3261"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3261"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4592"
          xlink:label="f-4592"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4592"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4592"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3262"
          xlink:label="f-3262"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3262"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3262"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3262"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3262"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4593"
          xlink:label="f-4593"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4593"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4593"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4593"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3263"
          xlink:label="f-3263"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3263"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3263"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3263"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4594"
          xlink:label="f-4594"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4594"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4594"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3264"
          xlink:label="f-3264"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3264"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3264"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3264"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4595"
          xlink:label="f-4595"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4595"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4595"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3265"
          xlink:label="f-3265"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3265"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3265"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3265"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3265"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4596"
          xlink:label="f-4596"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4596"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4596"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3266"
          xlink:label="f-3266"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3266"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3266"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3266"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3266"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3266"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3266"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4597"
          xlink:label="f-4597"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4597"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4597"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4597"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3267"
          xlink:label="f-3267"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3267"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3267"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3267"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3267"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4598"
          xlink:label="f-4598"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4598"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4598"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3268"
          xlink:label="f-3268"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3268"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3268"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3268"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3268"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3268"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4599"
          xlink:label="f-4599"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4599"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4599"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3269"
          xlink:label="f-3269"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3269"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3269"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3269"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3269"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3270"
          xlink:label="f-3270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3270"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3270"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3270"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3270"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4580"
          xlink:label="f-4580"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4580"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4580"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4580"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4580"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3250"
          xlink:label="f-3250"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3250"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3250"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3250"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3250"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3250"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4581"
          xlink:label="f-4581"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4581"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4581"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4581"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3251"
          xlink:label="f-3251"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3251"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3251"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3251"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3251"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4582"
          xlink:label="f-4582"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4582"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4582"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4582"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3252"
          xlink:label="f-3252"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3252"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3252"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3252"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3252"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4583"
          xlink:label="f-4583"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4583"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4583"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3253"
          xlink:label="f-3253"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3253"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3253"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3253"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4584"
          xlink:label="f-4584"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4584"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4584"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4584"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3254"
          xlink:label="f-3254"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3254"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3254"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3254"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3254"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3254"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4585"
          xlink:label="f-4585"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4585"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4585"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3255"
          xlink:label="f-3255"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3255"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3255"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3255"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4586"
          xlink:label="f-4586"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4586"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4586"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3256"
          xlink:label="f-3256"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3256"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3256"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3256"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3256"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3257"
          xlink:label="f-3257"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3257"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3257"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3257"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4588"
          xlink:label="f-4588"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4588"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4588"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3258"
          xlink:label="f-3258"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3258"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3258"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3258"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4589"
          xlink:label="f-4589"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4589"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4589"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4589"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3259"
          xlink:label="f-3259"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3259"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3259"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3259"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4590"
          xlink:label="f-4590"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4590"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4590"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1539"
          xlink:label="f-1539"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1539"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1539"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1539"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1539"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1539"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1539"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1538"
          xlink:label="f-1538"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1538"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1538"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1538"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1538"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1538"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1537"
          xlink:label="f-1537"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1537"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1537"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1537"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1537"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1537"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1537"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1537"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1536"
          xlink:label="f-1536"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1536"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1536"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1536"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1536"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1536"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1536"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1535"
          xlink:label="f-1535"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1535"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1535"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1535"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1535"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1535"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1534"
          xlink:label="f-1534"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1534"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1534"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1534"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1534"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1534"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1533"
          xlink:label="f-1533"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1533"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1533"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1533"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1533"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1533"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1533"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1532"
          xlink:label="f-1532"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1532"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1532"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1532"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1532"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1532"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1531"
          xlink:label="f-1531"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1531"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1531"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1531"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1531"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1531"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1531"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1531"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1530"
          xlink:label="f-1530"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1530"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1530"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1530"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1530"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1530"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1530"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1549"
          xlink:label="f-1549"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1549"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1549"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1549"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1549"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1549"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1549"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1549"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1548"
          xlink:label="f-1548"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1548"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1548"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1548"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1548"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1548"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1548"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1547"
          xlink:label="f-1547"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1547"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1547"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1547"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1547"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1546"
          xlink:label="f-1546"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1546"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1546"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1546"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1546"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1545"
          xlink:label="f-1545"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1545"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1545"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1545"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1545"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1545"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1544"
          xlink:label="f-1544"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1544"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1544"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1544"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1544"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1543"
          xlink:label="f-1543"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1543"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1543"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1543"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1543"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1543"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1543"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1542"
          xlink:label="f-1542"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1542"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1542"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1542"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1542"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1542"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1541"
          xlink:label="f-1541"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1541"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1541"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1541"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1541"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1541"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1540"
          xlink:label="f-1540"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1540"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1540"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1540"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1540"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1540"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1559"
          xlink:label="f-1559"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1559"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1559"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1559"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1559"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1558"
          xlink:label="f-1558"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1558"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1558"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1558"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1558"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1557"
          xlink:label="f-1557"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1557"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1557"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1557"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1557"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1557"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1556"
          xlink:label="f-1556"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1556"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1556"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1556"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1556"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1555"
          xlink:label="f-1555"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1555"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1555"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1555"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1555"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1555"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1555"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1554"
          xlink:label="f-1554"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1554"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1554"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1554"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1554"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1554"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1553"
          xlink:label="f-1553"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1553"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1553"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1553"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1553"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1553"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1552"
          xlink:label="f-1552"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1552"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1552"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1552"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1552"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1552"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1551"
          xlink:label="f-1551"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1551"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1551"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1551"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1551"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1551"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1551"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1550"
          xlink:label="f-1550"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1550"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1550"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1550"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1550"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1550"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1569"
          xlink:label="f-1569"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1569"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1569"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1569"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1569"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1569"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1569"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1568"
          xlink:label="f-1568"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1568"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1568"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1568"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1568"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1568"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1567"
          xlink:label="f-1567"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1567"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1567"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1567"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1567"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1567"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1567"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1567"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1566"
          xlink:label="f-1566"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1566"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1566"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1566"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1566"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1566"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1566"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1565"
          xlink:label="f-1565"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1565"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1565"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1565"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1565"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1564"
          xlink:label="f-1564"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1564"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1564"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1564"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1564"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1563"
          xlink:label="f-1563"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1563"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1563"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1563"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1563"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1563"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1562"
          xlink:label="f-1562"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1562"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1562"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1562"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1562"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1561"
          xlink:label="f-1561"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1561"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1561"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1561"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1561"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1561"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1561"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1560"
          xlink:label="f-1560"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1560"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1560"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1560"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1560"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1560"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1509"
          xlink:label="f-1509"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1509"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1509"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1509"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1509"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1508"
          xlink:label="f-1508"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1508"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1508"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1508"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1507"
          xlink:label="f-1507"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1507"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1507"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1507"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1507"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1507"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1506"
          xlink:label="f-1506"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1506"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1506"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1506"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1506"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1505"
          xlink:label="f-1505"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1505"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnote id="fn-15" xlink:label="fn-15" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">Loan was on non-accrual status as of December&#160;31, 2023.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1505"
          xlink:to="fn-15"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1505"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1505"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1505"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1504"
          xlink:label="f-1504"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1504"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1504"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1504"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1504"
          xlink:to="fn-15"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1504"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1503"
          xlink:label="f-1503"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1503"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1503"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1503"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1503"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1503"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1503"
          xlink:to="fn-15"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1502"
          xlink:label="f-1502"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1502"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1502"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1502"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1502"
          xlink:to="fn-15"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1502"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1501"
          xlink:label="f-1501"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1501"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1501"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1501"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1501"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1501"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1501"
          xlink:to="fn-15"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1501"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1500"
          xlink:label="f-1500"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1500"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1500"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1500"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1500"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1500"
          xlink:to="fn-15"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1500"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1519"
          xlink:label="f-1519"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1519"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1519"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1519"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1519"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1519"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1519"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1519"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1518"
          xlink:label="f-1518"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1518"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1518"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1518"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1518"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1518"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1518"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1517"
          xlink:label="f-1517"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1517"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1517"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1517"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1517"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1516"
          xlink:label="f-1516"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1516"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1516"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1516"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1516"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1515"
          xlink:label="f-1515"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1515"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1515"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1515"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1515"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1515"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1514"
          xlink:label="f-1514"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1514"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1514"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1514"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1514"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1513"
          xlink:label="f-1513"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1513"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1513"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1513"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1513"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1513"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1513"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1512"
          xlink:label="f-1512"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1512"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1512"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1512"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1512"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1512"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1511"
          xlink:label="f-1511"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1511"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1511"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1511"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1510"
          xlink:label="f-1510"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1510"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1510"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1510"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1529"
          xlink:label="f-1529"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1529"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1529"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1529"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1529"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1528"
          xlink:label="f-1528"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1528"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1528"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1528"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1528"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1527"
          xlink:label="f-1527"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1527"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1527"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1527"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1527"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1527"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1526"
          xlink:label="f-1526"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1526"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1526"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1526"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1526"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1525"
          xlink:label="f-1525"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1525"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1525"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1525"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1525"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1525"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1525"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1524"
          xlink:label="f-1524"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1524"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1524"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1524"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1524"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1524"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1523"
          xlink:label="f-1523"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1523"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1523"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1523"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1523"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1523"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1522"
          xlink:label="f-1522"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1522"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1522"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1522"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1522"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1522"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1521"
          xlink:label="f-1521"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1521"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1521"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1521"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1521"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1521"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1521"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1520"
          xlink:label="f-1520"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1520"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1520"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1520"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1520"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1520"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4650"
          xlink:label="f-4650"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4650"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4650"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3320"
          xlink:label="f-3320"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3320"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3320"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3320"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3320"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3320"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3320"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4651"
          xlink:label="f-4651"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4651"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4651"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3321"
          xlink:label="f-3321"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3321"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3321"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3321"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3321"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4652"
          xlink:label="f-4652"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4652"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4652"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3322"
          xlink:label="f-3322"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3322"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3322"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3322"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3322"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3322"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3323"
          xlink:label="f-3323"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3323"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3323"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3323"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3323"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3324"
          xlink:label="f-3324"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3324"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3324"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3324"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3324"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4655"
          xlink:label="f-4655"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4655"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4655"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3325"
          xlink:label="f-3325"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3325"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3325"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3325"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3326"
          xlink:label="f-3326"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3326"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3326"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3326"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3326"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3326"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3327"
          xlink:label="f-3327"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3327"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3327"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3327"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4658"
          xlink:label="f-4658"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4658"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4658"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3328"
          xlink:label="f-3328"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3328"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3328"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3328"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3328"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3329"
          xlink:label="f-3329"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3329"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3329"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3329"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4640"
          xlink:label="f-4640"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4640"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4640"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3310"
          xlink:label="f-3310"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3310"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3310"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3310"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3310"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4641"
          xlink:label="f-4641"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4641"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4641"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4641"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3311"
          xlink:label="f-3311"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3311"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3311"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3311"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3311"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3311"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3311"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4642"
          xlink:label="f-4642"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4642"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4642"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3312"
          xlink:label="f-3312"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3312"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3312"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3312"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3312"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4643"
          xlink:label="f-4643"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4643"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4643"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3313"
          xlink:label="f-3313"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3313"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3313"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3313"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3313"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3313"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4644"
          xlink:label="f-4644"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4644"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4644"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3314"
          xlink:label="f-3314"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3314"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3314"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3314"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3314"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4645"
          xlink:label="f-4645"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4645"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4645"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4645"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3315"
          xlink:label="f-3315"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3315"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3315"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3315"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3315"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4646"
          xlink:label="f-4646"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4646"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4646"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3316"
          xlink:label="f-3316"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3316"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3316"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3316"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4647"
          xlink:label="f-4647"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4647"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4647"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3317"
          xlink:label="f-3317"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3317"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3317"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4648"
          xlink:label="f-4648"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4648"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4648"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3318"
          xlink:label="f-3318"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3318"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3318"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4649"
          xlink:label="f-4649"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4649"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4649"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4649"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3319"
          xlink:label="f-3319"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3319"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3319"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3319"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3319"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4670"
          xlink:label="f-4670"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4670"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4670"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3340"
          xlink:label="f-3340"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3340"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3340"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3340"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3341"
          xlink:label="f-3341"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3341"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3341"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3341"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3341"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3341"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3342"
          xlink:label="f-3342"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3342"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3342"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3342"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4673"
          xlink:label="f-4673"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4673"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4673"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3343"
          xlink:label="f-3343"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3343"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3343"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3343"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3343"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3344"
          xlink:label="f-3344"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3344"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3344"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3344"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3345"
          xlink:label="f-3345"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3345"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3345"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3345"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4676"
          xlink:label="f-4676"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4676"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4676"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3346"
          xlink:label="f-3346"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3346"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3346"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3346"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3347"
          xlink:label="f-3347"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3347"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3347"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3347"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3347"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3347"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3348"
          xlink:label="f-3348"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3348"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3348"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3348"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3349"
          xlink:label="f-3349"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3349"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3349"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3349"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3349"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2009"
          xlink:label="f-2009"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2009"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2009"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2009"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2009"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2009"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2009"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2008"
          xlink:label="f-2008"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2008"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2008"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2008"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2008"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2008"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2008"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2008"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2007"
          xlink:label="f-2007"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2007"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2007"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2007"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2007"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2007"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2007"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2006"
          xlink:label="f-2006"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2006"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2006"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2006"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2006"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2006"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2006"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2006"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2006"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2005"
          xlink:label="f-2005"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2005"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2005"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2005"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2005"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2005"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2005"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2005"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2004"
          xlink:label="f-2004"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2004"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2004"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2004"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2004"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2004"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2003"
          xlink:label="f-2003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2003"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2003"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2003"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2003"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2003"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2002"
          xlink:label="f-2002"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2002"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2002"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2002"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2002"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2002"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2002"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2001"
          xlink:label="f-2001"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2001"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2001"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2001"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2001"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2001"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2000"
          xlink:label="f-2000"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2000"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2000"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2000"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2000"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2000"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2000"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2000"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3330"
          xlink:label="f-3330"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3330"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3330"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3330"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4661"
          xlink:label="f-4661"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4661"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4661"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3331"
          xlink:label="f-3331"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3331"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3331"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4664"
          xlink:label="f-4664"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4664"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4664"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3334"
          xlink:label="f-3334"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3334"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3334"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3334"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3335"
          xlink:label="f-3335"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3335"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3335"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3335"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3335"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3335"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3336"
          xlink:label="f-3336"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3336"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3336"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3336"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4667"
          xlink:label="f-4667"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4667"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4667"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3337"
          xlink:label="f-3337"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3337"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3337"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3337"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3337"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3338"
          xlink:label="f-3338"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3338"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3338"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3338"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3339"
          xlink:label="f-3339"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3339"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3339"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3339"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2019"
          xlink:label="f-2019"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2019"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2019"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2019"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2018"
          xlink:label="f-2018"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2018"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2018"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2018"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2018"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2018"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2017"
          xlink:label="f-2017"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2017"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2017"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2017"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2017"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2014"
          xlink:label="f-2014"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2014"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2014"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2012"
          xlink:label="f-2012"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2012"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2012"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2012"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2011"
          xlink:label="f-2011"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2011"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2011"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2010"
          xlink:label="f-2010"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2010"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2010"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2010"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2010"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2010"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2010"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4610"
          xlink:label="f-4610"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4610"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4610"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4611"
          xlink:label="f-4611"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4611"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4611"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4612"
          xlink:label="f-4612"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4612"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4612"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4612"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4613"
          xlink:label="f-4613"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4613"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4613"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4614"
          xlink:label="f-4614"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4614"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4614"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4616"
          xlink:label="f-4616"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4616"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4616"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4617"
          xlink:label="f-4617"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4617"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4617"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4617"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4618"
          xlink:label="f-4618"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4618"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4618"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4619"
          xlink:label="f-4619"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4619"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4619"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1579"
          xlink:label="f-1579"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1579"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1579"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1579"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1579"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1579"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1579"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1579"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1579"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1578"
          xlink:label="f-1578"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1578"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1578"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1578"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1578"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1578"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1578"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1578"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1577"
          xlink:label="f-1577"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1577"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1577"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1577"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1576"
          xlink:label="f-1576"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1576"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1576"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1576"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1575"
          xlink:label="f-1575"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1575"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1575"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1575"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1575"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1574"
          xlink:label="f-1574"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1574"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1574"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1574"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1573"
          xlink:label="f-1573"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1573"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1573"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1573"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1573"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1573"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1572"
          xlink:label="f-1572"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1572"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1572"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1572"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1572"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1571"
          xlink:label="f-1571"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1571"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1571"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1571"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1571"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1571"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1570"
          xlink:label="f-1570"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1570"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1570"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1570"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1570"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1570"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4600"
          xlink:label="f-4600"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4600"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4600"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4603"
          xlink:label="f-4603"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4603"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4603"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4604"
          xlink:label="f-4604"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4604"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4604"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4604"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4605"
          xlink:label="f-4605"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4605"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4605"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4606"
          xlink:label="f-4606"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4606"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4606"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4607"
          xlink:label="f-4607"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4607"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4607"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4608"
          xlink:label="f-4608"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4608"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4608"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4608"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4609"
          xlink:label="f-4609"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4609"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4609"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1589"
          xlink:label="f-1589"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1589"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1589"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1589"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1589"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1589"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1588"
          xlink:label="f-1588"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1588"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1588"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1588"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1588"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1588"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1588"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1587"
          xlink:label="f-1587"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1587"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1587"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1587"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1587"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1587"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1586"
          xlink:label="f-1586"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1586"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1586"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1586"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1586"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1586"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1586"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1586"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1585"
          xlink:label="f-1585"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1585"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1585"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1585"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1585"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1585"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1585"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1585"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1584"
          xlink:label="f-1584"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1584"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1584"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1584"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1584"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1584"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1584"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1583"
          xlink:label="f-1583"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1583"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1583"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1583"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1583"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1583"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1583"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1582"
          xlink:label="f-1582"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1582"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1582"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1582"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1582"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1582"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1582"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1581"
          xlink:label="f-1581"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1581"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1581"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1581"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1581"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1581"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1581"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1581"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1580"
          xlink:label="f-1580"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1580"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1580"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1580"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1580"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1580"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1580"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4630"
          xlink:label="f-4630"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4630"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4630"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3300"
          xlink:label="f-3300"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3300"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3300"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3300"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4631"
          xlink:label="f-4631"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4631"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4631"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3301"
          xlink:label="f-3301"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3301"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3301"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3301"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3302"
          xlink:label="f-3302"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3302"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3302"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4633"
          xlink:label="f-4633"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4633"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4633"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3303"
          xlink:label="f-3303"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3303"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3303"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4634"
          xlink:label="f-4634"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4634"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4634"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4634"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3304"
          xlink:label="f-3304"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3304"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3304"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3304"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3304"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4635"
          xlink:label="f-4635"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4635"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4635"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3305"
          xlink:label="f-3305"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3305"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3305"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3305"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3305"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3305"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3305"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4636"
          xlink:label="f-4636"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4636"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4636"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3306"
          xlink:label="f-3306"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3306"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3306"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3306"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3306"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4637"
          xlink:label="f-4637"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4637"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4637"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3307"
          xlink:label="f-3307"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3307"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3307"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3307"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3307"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3307"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3308"
          xlink:label="f-3308"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3308"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3308"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3308"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3308"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3309"
          xlink:label="f-3309"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3309"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3309"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3309"
          xlink:to="fn-25"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3309"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1599"
          xlink:label="f-1599"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1599"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1599"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1599"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1599"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1599"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1599"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1599"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1598"
          xlink:label="f-1598"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1598"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1598"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1598"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1598"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1598"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1598"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1597"
          xlink:label="f-1597"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1597"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1597"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1597"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1597"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1597"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1596"
          xlink:label="f-1596"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1596"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1596"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1596"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1596"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1596"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1595"
          xlink:label="f-1595"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1595"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1595"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1595"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1595"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1595"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1595"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1594"
          xlink:label="f-1594"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1594"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1594"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1594"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1594"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1594"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1593"
          xlink:label="f-1593"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1593"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1593"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1593"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1593"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1593"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1593"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1593"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1592"
          xlink:label="f-1592"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1592"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1592"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1592"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1592"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1592"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1592"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1592"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1591"
          xlink:label="f-1591"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1591"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1591"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1591"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1591"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1591"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1591"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1590"
          xlink:label="f-1590"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1590"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1590"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1590"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1590"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1590"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4620"
          xlink:label="f-4620"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4620"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4620"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4621"
          xlink:label="f-4621"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4621"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4621"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4621"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4622"
          xlink:label="f-4622"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4622"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4622"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4623"
          xlink:label="f-4623"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4623"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4623"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4624"
          xlink:label="f-4624"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4624"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4624"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4625"
          xlink:label="f-4625"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4625"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4625"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4625"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4626"
          xlink:label="f-4626"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4626"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4626"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4627"
          xlink:label="f-4627"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4627"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4627"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4628"
          xlink:label="f-4628"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4628"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4628"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4629"
          xlink:label="f-4629"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4629"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4629"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4629"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2071"
          xlink:label="f-2071"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2071"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2071"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2071"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2071"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2071"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2071"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2070"
          xlink:label="f-2070"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2070"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2070"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2070"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2070"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2070"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2070"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2070"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2069"
          xlink:label="f-2069"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2069"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2069"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2069"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2069"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2069"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2069"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2068"
          xlink:label="f-2068"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2068"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2068"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2068"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2068"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2068"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2068"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2068"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2068"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2067"
          xlink:label="f-2067"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2067"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2067"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2067"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2067"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2067"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2067"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2067"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2066"
          xlink:label="f-2066"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2066"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2066"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2066"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2066"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2066"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2065"
          xlink:label="f-2065"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2065"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2065"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2065"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2065"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2065"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2064"
          xlink:label="f-2064"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2064"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2064"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2064"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2064"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2064"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2064"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2063"
          xlink:label="f-2063"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2063"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2063"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2063"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2063"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2063"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2062"
          xlink:label="f-2062"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2062"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2062"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2062"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2062"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2062"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2062"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2062"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2061"
          xlink:label="f-2061"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2061"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2061"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2061"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2061"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2061"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2061"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2082"
          xlink:label="f-2082"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2082"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2082"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2082"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2082"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3392"
          xlink:label="f-3392"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3392"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3392"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3392"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3392"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2081"
          xlink:label="f-2081"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2081"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2081"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2081"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3393"
          xlink:label="f-3393"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3393"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3393"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3393"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3393"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2080"
          xlink:label="f-2080"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2080"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2080"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2080"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2080"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2080"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3394"
          xlink:label="f-3394"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3394"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3394"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3394"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3395"
          xlink:label="f-3395"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3395"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3395"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3395"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3395"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3395"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3396"
          xlink:label="f-3396"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3396"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3396"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3396"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3397"
          xlink:label="f-3397"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3397"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3397"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3397"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3397"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3398"
          xlink:label="f-3398"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3398"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3398"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3398"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3399"
          xlink:label="f-3399"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3399"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3399"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3399"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2079"
          xlink:label="f-2079"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2079"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2079"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2079"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2079"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2078"
          xlink:label="f-2078"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2078"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2078"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2078"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2078"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2078"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2077"
          xlink:label="f-2077"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2077"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2077"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2077"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2077"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2077"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2076"
          xlink:label="f-2076"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2076"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2076"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2076"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2076"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2076"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2076"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2075"
          xlink:label="f-2075"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2075"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2075"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2075"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2075"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2075"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2074"
          xlink:label="f-2074"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2074"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2074"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2074"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2074"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2074"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2074"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2074"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2073"
          xlink:label="f-2073"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2073"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2073"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2073"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2073"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2073"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2073"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2072"
          xlink:label="f-2072"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2072"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2072"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2072"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2072"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2072"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2072"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2093"
          xlink:label="f-2093"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2093"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2093"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2093"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2093"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2092"
          xlink:label="f-2092"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2092"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2092"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2092"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2092"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2092"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2092"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2091"
          xlink:label="f-2091"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2091"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2091"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2091"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2091"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2091"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2090"
          xlink:label="f-2090"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2090"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2090"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2090"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2089"
          xlink:label="f-2089"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2089"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2089"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2089"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2088"
          xlink:label="f-2088"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2088"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2088"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2088"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2088"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2087"
          xlink:label="f-2087"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2087"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2087"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2087"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2086"
          xlink:label="f-2086"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2086"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2086"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2086"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2086"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2086"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2085"
          xlink:label="f-2085"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2085"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2085"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2085"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2085"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2084"
          xlink:label="f-2084"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2084"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2084"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2084"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2083"
          xlink:label="f-2083"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2083"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2083"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2083"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2099"
          xlink:label="f-2099"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2099"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2099"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2099"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2099"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2099"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2098"
          xlink:label="f-2098"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2098"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2098"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2098"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2098"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2098"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2098"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2098"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2097"
          xlink:label="f-2097"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2097"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2097"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2097"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2097"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2097"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2097"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2096"
          xlink:label="f-2096"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2096"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2096"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2096"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2096"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2095"
          xlink:label="f-2095"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2095"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2095"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2095"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2095"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2094"
          xlink:label="f-2094"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2094"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2094"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2094"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2094"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2094"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3360"
          xlink:label="f-3360"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3360"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3360"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3360"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3361"
          xlink:label="f-3361"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3361"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3361"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3361"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3361"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3362"
          xlink:label="f-3362"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3362"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3362"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3362"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3363"
          xlink:label="f-3363"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3363"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3363"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3363"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3364"
          xlink:label="f-3364"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3364"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3364"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3364"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3364"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3364"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3365"
          xlink:label="f-3365"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3365"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3365"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3365"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3365"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3365"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3365"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3365"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3366"
          xlink:label="f-3366"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3366"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3366"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3366"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3366"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3366"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3367"
          xlink:label="f-3367"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3367"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3367"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3367"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3367"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3367"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3367"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3368"
          xlink:label="f-3368"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3368"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3368"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3368"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3368"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3368"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3369"
          xlink:label="f-3369"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3369"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3369"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3369"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3369"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3369"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2029"
          xlink:label="f-2029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2029"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2029"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2029"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2028"
          xlink:label="f-2028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2028"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2028"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2028"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2027"
          xlink:label="f-2027"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2027"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2027"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2027"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2027"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2026"
          xlink:label="f-2026"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2026"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2026"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2026"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2025"
          xlink:label="f-2025"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2025"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2025"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2025"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2025"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2025"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2024"
          xlink:label="f-2024"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2024"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2024"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2024"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2024"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2024"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2023"
          xlink:label="f-2023"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2023"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2023"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2023"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2023"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2022"
          xlink:label="f-2022"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2022"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2022"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2022"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2021"
          xlink:label="f-2021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2021"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2021"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2021"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2020"
          xlink:label="f-2020"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2020"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2020"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2020"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2020"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3350"
          xlink:label="f-3350"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3350"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3350"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3350"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3351"
          xlink:label="f-3351"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3351"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3351"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3351"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3352"
          xlink:label="f-3352"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3352"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3352"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3352"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3353"
          xlink:label="f-3353"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3353"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3353"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3353"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3353"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3353"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3354"
          xlink:label="f-3354"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3354"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3354"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3354"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3355"
          xlink:label="f-3355"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3355"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3355"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3355"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3355"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3356"
          xlink:label="f-3356"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3356"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3356"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3356"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3357"
          xlink:label="f-3357"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3357"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3357"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3357"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3358"
          xlink:label="f-3358"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3358"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3358"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3358"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3359"
          xlink:label="f-3359"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3359"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3359"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3359"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3359"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3359"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2039"
          xlink:label="f-2039"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2039"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2039"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2039"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2039"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2039"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2039"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2038"
          xlink:label="f-2038"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2038"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2038"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2038"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2038"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2038"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2037"
          xlink:label="f-2037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2037"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2037"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2037"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2037"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2037"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2037"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2037"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2036"
          xlink:label="f-2036"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2036"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2036"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2036"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2036"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2036"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2036"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2035"
          xlink:label="f-2035"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2035"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2035"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2035"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2035"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2034"
          xlink:label="f-2034"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2034"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2034"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2034"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2034"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2033"
          xlink:label="f-2033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2033"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2033"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2033"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2033"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2033"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2032"
          xlink:label="f-2032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2032"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2032"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2032"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2032"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2031"
          xlink:label="f-2031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2031"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2031"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2031"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2031"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2031"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2031"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2030"
          xlink:label="f-2030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2030"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2030"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2030"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2030"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2030"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3381"
          xlink:label="f-3381"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3381"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3381"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3381"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3381"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3382"
          xlink:label="f-3382"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3382"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3382"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3382"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3382"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3383"
          xlink:label="f-3383"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3383"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3383"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3383"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3383"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3383"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3383"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3384"
          xlink:label="f-3384"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3384"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3384"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3384"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3384"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3385"
          xlink:label="f-3385"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3385"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3385"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3385"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3385"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3385"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3386"
          xlink:label="f-3386"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3386"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3386"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3386"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3386"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3387"
          xlink:label="f-3387"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3387"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3387"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3387"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3387"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3388"
          xlink:label="f-3388"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3388"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3388"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3388"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3388"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3389"
          xlink:label="f-3389"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3389"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3389"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3389"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3389"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3389"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3389"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2049"
          xlink:label="f-2049"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2049"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2049"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2049"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2049"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2049"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2049"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2048"
          xlink:label="f-2048"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2048"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2048"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2048"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2048"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2048"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2047"
          xlink:label="f-2047"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2047"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2047"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2047"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2047"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2047"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2046"
          xlink:label="f-2046"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2046"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2046"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2046"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2046"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2046"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2046"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2045"
          xlink:label="f-2045"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2045"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2045"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2045"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2045"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2045"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2044"
          xlink:label="f-2044"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2044"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2044"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2044"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2044"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2044"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2044"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2044"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2043"
          xlink:label="f-2043"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2043"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2043"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2043"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2043"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2043"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2043"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2043"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2042"
          xlink:label="f-2042"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2042"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2042"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2042"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2042"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2042"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2042"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2041"
          xlink:label="f-2041"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2041"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2041"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2041"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2041"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2041"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2040"
          xlink:label="f-2040"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2040"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2040"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2040"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2040"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2040"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3390"
          xlink:label="f-3390"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3390"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3390"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3390"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3390"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3391"
          xlink:label="f-3391"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3391"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3391"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3391"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3391"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3391"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2060"
          xlink:label="f-2060"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2060"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2060"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2060"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2060"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2060"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2060"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3370"
          xlink:label="f-3370"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3370"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3370"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3370"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3370"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3371"
          xlink:label="f-3371"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3371"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3371"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3371"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3371"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3371"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3371"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3372"
          xlink:label="f-3372"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3372"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3372"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3372"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3372"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3373"
          xlink:label="f-3373"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3373"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3373"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3373"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3373"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3373"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3374"
          xlink:label="f-3374"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3374"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3374"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3374"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3374"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3375"
          xlink:label="f-3375"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3375"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3375"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3375"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3375"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3376"
          xlink:label="f-3376"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3376"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3376"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3376"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3376"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3377"
          xlink:label="f-3377"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3377"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3377"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3377"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3377"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3377"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3377"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3378"
          xlink:label="f-3378"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3378"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3378"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3378"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3378"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3379"
          xlink:label="f-3379"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3379"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3379"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3379"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3379"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3379"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2059"
          xlink:label="f-2059"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2059"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2059"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2059"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2059"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2059"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2059"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2058"
          xlink:label="f-2058"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2058"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2058"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2058"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2058"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2058"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2058"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2058"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2057"
          xlink:label="f-2057"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2057"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2057"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2057"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2057"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2057"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2057"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2056"
          xlink:label="f-2056"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2056"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2056"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2056"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2056"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2056"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2056"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2056"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2056"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2055"
          xlink:label="f-2055"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2055"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2055"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2055"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2055"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2055"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2055"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2055"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2054"
          xlink:label="f-2054"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2054"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2054"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2054"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2054"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2054"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2053"
          xlink:label="f-2053"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2053"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2053"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2053"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2053"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2053"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2052"
          xlink:label="f-2052"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2052"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2052"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2052"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2052"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2052"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2052"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2051"
          xlink:label="f-2051"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2051"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2051"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2051"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2051"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2051"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2050"
          xlink:label="f-2050"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2050"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2050"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2050"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2050"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2050"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2050"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2050"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3380"
          xlink:label="f-3380"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3380"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3380"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3380"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3380"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1609"
          xlink:label="f-1609"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1609"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1609"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1609"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1609"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1609"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1609"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1608"
          xlink:label="f-1608"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1608"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1608"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1608"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1608"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1608"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1607"
          xlink:label="f-1607"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1607"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1607"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1607"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1607"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1607"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1607"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1607"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1606"
          xlink:label="f-1606"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1606"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1606"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1606"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1606"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1606"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1606"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1606"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1605"
          xlink:label="f-1605"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1605"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1605"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1605"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1605"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1605"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1605"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1604"
          xlink:label="f-1604"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1604"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1604"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1604"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1604"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1604"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1603"
          xlink:label="f-1603"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1603"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1603"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1603"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1603"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1603"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1602"
          xlink:label="f-1602"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1602"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1602"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1602"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1602"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1602"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1602"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1601"
          xlink:label="f-1601"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1601"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1601"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1601"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1601"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1601"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1600"
          xlink:label="f-1600"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1600"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1600"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1600"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1600"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1600"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1600"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1600"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1659"
          xlink:label="f-1659"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1659"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1659"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1659"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1659"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1659"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1659"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1659"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1658"
          xlink:label="f-1658"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1658"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1658"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1658"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1658"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1658"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1658"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1657"
          xlink:label="f-1657"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1657"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1657"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1657"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1657"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1657"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1656"
          xlink:label="f-1656"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1656"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1656"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1656"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1656"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1656"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1655"
          xlink:label="f-1655"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1655"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1655"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1655"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1655"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1655"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1655"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1654"
          xlink:label="f-1654"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1654"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1654"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1654"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1654"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1654"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1653"
          xlink:label="f-1653"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1653"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1653"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1653"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1653"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1653"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1653"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1653"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1652"
          xlink:label="f-1652"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1652"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1652"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1652"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1652"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1652"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1652"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1651"
          xlink:label="f-1651"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1651"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1651"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1651"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1651"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1650"
          xlink:label="f-1650"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1650"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1650"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1650"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1650"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1669"
          xlink:label="f-1669"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1669"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1669"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1669"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1669"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1669"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1669"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1668"
          xlink:label="f-1668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1668"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1668"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1668"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1668"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1668"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1668"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1667"
          xlink:label="f-1667"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1667"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1667"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1667"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1667"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1667"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1667"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1667"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1666"
          xlink:label="f-1666"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1666"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1666"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1666"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1666"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1666"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1666"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1665"
          xlink:label="f-1665"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1665"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1665"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1665"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1665"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1665"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1665"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1665"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1665"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1664"
          xlink:label="f-1664"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1664"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1664"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1664"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1664"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1664"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1664"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1664"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1663"
          xlink:label="f-1663"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1663"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1663"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1663"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1663"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1663"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1662"
          xlink:label="f-1662"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1662"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1662"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1662"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1662"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1662"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1661"
          xlink:label="f-1661"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1661"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1661"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1661"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1661"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1661"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1661"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1660"
          xlink:label="f-1660"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1660"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1660"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1660"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1660"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1660"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1679"
          xlink:label="f-1679"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1679"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1679"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1679"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1679"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1679"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1679"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1678"
          xlink:label="f-1678"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1678"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1678"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1678"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1678"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1678"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1677"
          xlink:label="f-1677"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1677"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1677"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1677"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1677"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1677"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1677"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1677"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1676"
          xlink:label="f-1676"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1676"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1676"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1676"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1676"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1676"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1676"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1675"
          xlink:label="f-1675"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1675"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1675"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1675"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1675"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1675"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1674"
          xlink:label="f-1674"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1674"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1674"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1674"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1674"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1674"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1673"
          xlink:label="f-1673"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1673"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1673"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1673"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1673"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1673"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1673"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1672"
          xlink:label="f-1672"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1672"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1672"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1672"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1672"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1672"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1671"
          xlink:label="f-1671"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1671"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1671"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1671"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1671"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1671"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1671"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1671"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1670"
          xlink:label="f-1670"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1670"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1670"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1670"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1670"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1670"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1670"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1689"
          xlink:label="f-1689"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1689"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1689"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1689"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1689"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1689"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1688"
          xlink:label="f-1688"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1688"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1688"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1688"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1688"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1687"
          xlink:label="f-1687"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1687"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1687"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1687"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1686"
          xlink:label="f-1686"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1686"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1686"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1686"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1685"
          xlink:label="f-1685"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1685"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1685"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1685"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1685"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1684"
          xlink:label="f-1684"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1684"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1684"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1684"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1683"
          xlink:label="f-1683"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1683"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1683"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1683"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1683"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1683"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1682"
          xlink:label="f-1682"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1682"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1682"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1682"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1682"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1681"
          xlink:label="f-1681"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1681"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1681"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1681"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1681"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1681"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1680"
          xlink:label="f-1680"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1680"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1680"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1680"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1680"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1680"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1618"
          xlink:label="f-1618"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1618"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1618"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1617"
          xlink:label="f-1617"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1617"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1617"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1617"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1617"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1616"
          xlink:label="f-1616"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1616"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1616"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1616"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1616"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1615"
          xlink:label="f-1615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1615"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1615"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1615"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1615"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1615"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1614"
          xlink:label="f-1614"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1614"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1614"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1614"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1614"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1613"
          xlink:label="f-1613"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1613"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1613"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1613"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1613"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1613"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1613"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1612"
          xlink:label="f-1612"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1612"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1612"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1612"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1612"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1612"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1611"
          xlink:label="f-1611"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1611"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1611"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1611"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1611"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1611"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1610"
          xlink:label="f-1610"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1610"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1610"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1610"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1610"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1610"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1629"
          xlink:label="f-1629"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1629"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1629"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1629"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1629"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1628"
          xlink:label="f-1628"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1628"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1628"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1628"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1628"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1628"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1628"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1627"
          xlink:label="f-1627"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1627"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1627"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1627"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1627"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1627"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1626"
          xlink:label="f-1626"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1626"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1626"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1626"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1625"
          xlink:label="f-1625"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1625"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1625"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1625"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1624"
          xlink:label="f-1624"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1624"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1624"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1624"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1624"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1623"
          xlink:label="f-1623"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1623"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1623"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1623"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1622"
          xlink:label="f-1622"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1622"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1622"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1622"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1622"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1622"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1621"
          xlink:label="f-1621"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1621"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1621"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1621"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1621"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1639"
          xlink:label="f-1639"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1639"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1639"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1639"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1639"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1639"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1638"
          xlink:label="f-1638"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1638"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1638"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1638"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1638"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1637"
          xlink:label="f-1637"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1637"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1637"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1637"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1637"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1636"
          xlink:label="f-1636"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1636"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1636"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1636"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1636"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1636"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1635"
          xlink:label="f-1635"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1635"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1635"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1635"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1635"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1634"
          xlink:label="f-1634"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1634"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1634"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1634"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1634"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1634"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1634"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1633"
          xlink:label="f-1633"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1633"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1633"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1633"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1633"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1633"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1632"
          xlink:label="f-1632"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1632"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1632"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1632"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1632"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1631"
          xlink:label="f-1631"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1631"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1631"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1631"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1631"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1630"
          xlink:label="f-1630"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1630"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1630"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1630"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1630"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1630"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1649"
          xlink:label="f-1649"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1649"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1649"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1649"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1649"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1649"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1648"
          xlink:label="f-1648"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1648"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1648"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1648"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1648"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1647"
          xlink:label="f-1647"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1647"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1647"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1647"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1647"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1647"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1647"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1646"
          xlink:label="f-1646"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1646"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1646"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1646"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1646"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1646"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1646"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1645"
          xlink:label="f-1645"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1645"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1645"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1645"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1645"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1645"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1644"
          xlink:label="f-1644"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1644"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1644"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1644"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1644"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1643"
          xlink:label="f-1643"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1643"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1643"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1643"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1643"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1642"
          xlink:label="f-1642"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1642"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1642"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1642"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1642"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1642"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1641"
          xlink:label="f-1641"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1641"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1641"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1641"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1641"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1640"
          xlink:label="f-1640"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1640"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1640"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1640"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1640"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1640"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1640"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3440"
          xlink:label="f-3440"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3440"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3440"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3440"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3441"
          xlink:label="f-3441"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3441"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3441"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3441"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3442"
          xlink:label="f-3442"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3442"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3442"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3442"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3443"
          xlink:label="f-3443"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3443"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3443"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3443"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3443"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3443"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3445"
          xlink:label="f-3445"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3445"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3445"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3445"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3446"
          xlink:label="f-3446"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3446"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3446"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3446"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3446"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3447"
          xlink:label="f-3447"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3447"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3447"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3447"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3448"
          xlink:label="f-3448"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3448"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3448"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3448"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3449"
          xlink:label="f-3449"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3449"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3449"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3449"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2109"
          xlink:label="f-2109"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2109"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2109"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2109"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2109"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2109"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2109"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2108"
          xlink:label="f-2108"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2108"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2108"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2108"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2108"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2107"
          xlink:label="f-2107"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2107"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2107"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2107"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2107"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2106"
          xlink:label="f-2106"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2106"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2106"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2106"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2106"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2106"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2105"
          xlink:label="f-2105"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2105"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2105"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2105"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2105"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2104"
          xlink:label="f-2104"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2104"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2104"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2104"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2104"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2104"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2104"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2103"
          xlink:label="f-2103"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2103"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2103"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2103"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2103"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2103"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2102"
          xlink:label="f-2102"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2102"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2102"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2102"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2102"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2102"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2101"
          xlink:label="f-2101"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2101"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2101"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2101"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2101"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2101"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2100"
          xlink:label="f-2100"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2100"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2100"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2100"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2100"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2100"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2100"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3430"
          xlink:label="f-3430"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3430"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3430"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3430"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3430"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3430"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3431"
          xlink:label="f-3431"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3431"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3431"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3431"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3431"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3432"
          xlink:label="f-3432"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3432"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3432"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3432"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3432"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3433"
          xlink:label="f-3433"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3433"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3433"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3433"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3434"
          xlink:label="f-3434"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3434"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3434"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3435"
          xlink:label="f-3435"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3435"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3435"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3436"
          xlink:label="f-3436"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3436"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3436"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3436"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3437"
          xlink:label="f-3437"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3437"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3437"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3437"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3437"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3437"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3438"
          xlink:label="f-3438"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3438"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3438"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3438"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3439"
          xlink:label="f-3439"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3439"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3439"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3439"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3439"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2119"
          xlink:label="f-2119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2119"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2119"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2119"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2119"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2118"
          xlink:label="f-2118"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2118"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2118"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2118"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2118"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2118"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2117"
          xlink:label="f-2117"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2117"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2117"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2117"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2117"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2116"
          xlink:label="f-2116"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2116"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2116"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2116"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2116"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2116"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2116"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2115"
          xlink:label="f-2115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2115"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2115"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2115"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2115"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2115"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2114"
          xlink:label="f-2114"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2114"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2114"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2114"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2114"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2114"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2113"
          xlink:label="f-2113"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2113"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2113"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2113"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2113"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2113"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2112"
          xlink:label="f-2112"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2112"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2112"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2112"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2112"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2112"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2112"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2111"
          xlink:label="f-2111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2111"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2111"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2111"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2111"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2111"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2110"
          xlink:label="f-2110"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2110"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2110"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2110"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2110"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2110"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2110"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2110"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3460"
          xlink:label="f-3460"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3460"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3460"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3460"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3460"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3461"
          xlink:label="f-3461"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3461"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3461"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3461"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3461"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3461"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3462"
          xlink:label="f-3462"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3462"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3462"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3462"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3462"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3463"
          xlink:label="f-3463"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3463"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3463"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3463"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3463"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3464"
          xlink:label="f-3464"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3464"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3464"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3464"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3464"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3464"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3465"
          xlink:label="f-3465"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3465"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3465"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3465"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3465"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3465"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3465"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3465"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3466"
          xlink:label="f-3466"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3466"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3466"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3466"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3466"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3466"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3467"
          xlink:label="f-3467"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3467"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3467"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3467"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3467"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3467"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3467"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3468"
          xlink:label="f-3468"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3468"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3468"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3468"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3468"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3468"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3469"
          xlink:label="f-3469"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3469"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3469"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3469"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3469"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3469"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2129"
          xlink:label="f-2129"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2129"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2129"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2129"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2128"
          xlink:label="f-2128"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2128"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2128"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2128"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2128"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2128"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2127"
          xlink:label="f-2127"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2127"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2127"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2127"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2127"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2126"
          xlink:label="f-2126"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2126"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2126"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2126"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2126"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2125"
          xlink:label="f-2125"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2125"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2125"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2125"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2125"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2124"
          xlink:label="f-2124"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2124"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2124"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2124"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2124"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2124"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2123"
          xlink:label="f-2123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2123"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2123"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2123"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2123"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2122"
          xlink:label="f-2122"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2122"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2122"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2122"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2122"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2122"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2122"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2121"
          xlink:label="f-2121"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2121"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2121"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2121"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2121"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2121"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2120"
          xlink:label="f-2120"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2120"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2120"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2120"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2120"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3450"
          xlink:label="f-3450"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3450"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3450"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3451"
          xlink:label="f-3451"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3451"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3451"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3452"
          xlink:label="f-3452"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3452"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3452"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3452"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3452"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3453"
          xlink:label="f-3453"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3453"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3453"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3453"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3453"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3453"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3453"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3454"
          xlink:label="f-3454"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3454"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3454"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3454"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3454"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3455"
          xlink:label="f-3455"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3455"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3455"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3455"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3455"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3455"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3456"
          xlink:label="f-3456"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3456"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3456"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3456"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3456"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3457"
          xlink:label="f-3457"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3457"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3457"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3457"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3457"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3458"
          xlink:label="f-3458"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3458"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3458"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3458"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3458"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3459"
          xlink:label="f-3459"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3459"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3459"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3459"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3459"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3459"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3459"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2139"
          xlink:label="f-2139"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2139"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2139"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2139"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2139"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2138"
          xlink:label="f-2138"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2138"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2138"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2138"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2137"
          xlink:label="f-2137"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2137"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2137"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2137"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2136"
          xlink:label="f-2136"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2136"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2136"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2136"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2136"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2135"
          xlink:label="f-2135"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2135"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2135"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2135"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2134"
          xlink:label="f-2134"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2134"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2134"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2134"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2134"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2134"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2133"
          xlink:label="f-2133"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2133"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2133"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2133"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2133"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2132"
          xlink:label="f-2132"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2132"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2132"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2132"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2131"
          xlink:label="f-2131"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2131"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2131"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2131"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2130"
          xlink:label="f-2130"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2130"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2130"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2130"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2130"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3400"
          xlink:label="f-3400"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3400"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3400"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3401"
          xlink:label="f-3401"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3401"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3401"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3401"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3401"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3402"
          xlink:label="f-3402"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3402"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3402"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3403"
          xlink:label="f-3403"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3403"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3403"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3403"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3404"
          xlink:label="f-3404"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3404"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3404"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3405"
          xlink:label="f-3405"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3405"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3405"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3406"
          xlink:label="f-3406"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3406"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3406"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3407"
          xlink:label="f-3407"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3407"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3407"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3407"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3407"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3408"
          xlink:label="f-3408"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3408"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3408"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3409"
          xlink:label="f-3409"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3409"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3409"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3409"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1699"
          xlink:label="f-1699"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1699"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1699"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1699"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1699"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1699"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1698"
          xlink:label="f-1698"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1698"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1698"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1698"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1698"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1698"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1697"
          xlink:label="f-1697"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1697"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1697"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1697"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1697"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1697"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1697"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1696"
          xlink:label="f-1696"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1696"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1696"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1696"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1696"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1696"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1695"
          xlink:label="f-1695"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1695"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1695"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1695"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1695"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1695"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1695"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1695"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1694"
          xlink:label="f-1694"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1694"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1694"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1694"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1694"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1694"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1694"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1693"
          xlink:label="f-1693"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1693"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1693"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1693"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1692"
          xlink:label="f-1692"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1692"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1692"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1692"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1691"
          xlink:label="f-1691"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1691"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1691"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1691"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1691"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1690"
          xlink:label="f-1690"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1690"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1690"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1690"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3420"
          xlink:label="f-3420"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3420"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3420"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3420"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3420"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3421"
          xlink:label="f-3421"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3421"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3421"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3421"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3421"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3422"
          xlink:label="f-3422"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3422"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3422"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3422"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3422"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3422"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3422"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3423"
          xlink:label="f-3423"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3423"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3423"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3423"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3423"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3424"
          xlink:label="f-3424"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3424"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3424"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3424"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3424"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3424"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3425"
          xlink:label="f-3425"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3425"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3425"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3425"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3425"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3426"
          xlink:label="f-3426"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3426"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3426"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3426"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3426"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3427"
          xlink:label="f-3427"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3427"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3427"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3427"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3427"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3428"
          xlink:label="f-3428"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3428"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3428"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3428"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3428"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3428"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3428"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3429"
          xlink:label="f-3429"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3429"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3429"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3429"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3429"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3410"
          xlink:label="f-3410"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3410"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3410"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3411"
          xlink:label="f-3411"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3411"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3411"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3412"
          xlink:label="f-3412"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3412"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3412"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3412"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3413"
          xlink:label="f-3413"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3413"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3413"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3414"
          xlink:label="f-3414"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3414"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3414"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3415"
          xlink:label="f-3415"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3415"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3415"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3415"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3415"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3416"
          xlink:label="f-3416"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3416"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3416"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3416"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3416"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3416"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3416"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3417"
          xlink:label="f-3417"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3417"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3417"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3417"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3417"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3418"
          xlink:label="f-3418"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3418"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3418"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3418"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3418"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3418"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3419"
          xlink:label="f-3419"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3419"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3419"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3419"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3419"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2192"
          xlink:label="f-2192"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2192"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2192"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2192"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2192"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2192"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2191"
          xlink:label="f-2191"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2191"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2191"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2191"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2191"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2191"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2190"
          xlink:label="f-2190"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2190"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2190"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2190"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2190"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2190"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2190"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2189"
          xlink:label="f-2189"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2189"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2189"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2189"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2189"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2189"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2188"
          xlink:label="f-2188"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2188"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2188"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2188"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2188"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2188"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2188"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2188"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2187"
          xlink:label="f-2187"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2187"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2187"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2187"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2187"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2187"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2187"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2186"
          xlink:label="f-2186"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2186"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2186"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2186"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2186"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2185"
          xlink:label="f-2185"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2185"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2185"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2185"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2185"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2184"
          xlink:label="f-2184"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2184"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2184"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2184"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2184"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2184"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2183"
          xlink:label="f-2183"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2183"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2183"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2183"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2183"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2182"
          xlink:label="f-2182"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2182"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2182"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2182"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2182"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2182"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2182"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2199"
          xlink:label="f-2199"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2199"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2199"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2199"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2198"
          xlink:label="f-2198"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2198"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2198"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2198"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2197"
          xlink:label="f-2197"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2197"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2197"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2197"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2197"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2196"
          xlink:label="f-2196"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2196"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2196"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2196"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2195"
          xlink:label="f-2195"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2195"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2195"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2195"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2195"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2194"
          xlink:label="f-2194"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2194"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2194"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2194"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2194"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2194"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2193"
          xlink:label="f-2193"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2193"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2193"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2193"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2193"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-579"
          xlink:label="f-579"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-579"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-579"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-579"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-579"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-579"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-570"
          xlink:label="f-570"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-570"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-570"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-570"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-573"
          xlink:label="f-573"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-573"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-573"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-573"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-574"
          xlink:label="f-574"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-574"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-574"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-574"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-574"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-574"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-574"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-571"
          xlink:label="f-571"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-571"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-571"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-571"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-571"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-572"
          xlink:label="f-572"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-572"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-572"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-572"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-577"
          xlink:label="f-577"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-577"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-577"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-577"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-577"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-577"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-577"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-578"
          xlink:label="f-578"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-578"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-578"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-578"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-578"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-578"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-575"
          xlink:label="f-575"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-575"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-575"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-575"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-575"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-575"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-575"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-575"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-576"
          xlink:label="f-576"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-576"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-576"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-576"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-576"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-576"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-568"
          xlink:label="f-568"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-568"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-568"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-568"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-568"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-569"
          xlink:label="f-569"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-569"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-569"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-569"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-569"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-569"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-562"
          xlink:label="f-562"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-562"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-562"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-562"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-562"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-563"
          xlink:label="f-563"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-563"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-563"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-563"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-563"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-563"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-566"
          xlink:label="f-566"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-566"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-566"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-566"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-567"
          xlink:label="f-567"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-567"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-567"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-567"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-564"
          xlink:label="f-564"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-564"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-564"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-564"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-565"
          xlink:label="f-565"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-565"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-565"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-565"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-565"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3480"
          xlink:label="f-3480"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3480"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3480"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3480"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3481"
          xlink:label="f-3481"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3481"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3481"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3481"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3482"
          xlink:label="f-3482"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3482"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3482"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3482"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3483"
          xlink:label="f-3483"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3483"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3483"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3484"
          xlink:label="f-3484"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3484"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3484"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3485"
          xlink:label="f-3485"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3485"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3485"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3485"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3485"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3486"
          xlink:label="f-3486"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3486"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3486"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3486"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3486"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3486"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3486"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3487"
          xlink:label="f-3487"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3487"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3487"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3487"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3487"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3488"
          xlink:label="f-3488"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3488"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3488"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3488"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3488"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3488"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3489"
          xlink:label="f-3489"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3489"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3489"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3489"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3489"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2149"
          xlink:label="f-2149"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2149"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2149"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2149"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2149"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2148"
          xlink:label="f-2148"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2148"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2148"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2148"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2148"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2148"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2147"
          xlink:label="f-2147"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2147"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2147"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2147"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2147"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2146"
          xlink:label="f-2146"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2146"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2146"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2146"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2146"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2146"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2146"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2145"
          xlink:label="f-2145"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2145"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2145"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2145"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2145"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2145"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2144"
          xlink:label="f-2144"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2144"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2144"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2144"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2143"
          xlink:label="f-2143"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2143"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2143"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2143"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2142"
          xlink:label="f-2142"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2142"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2142"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2142"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2142"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2141"
          xlink:label="f-2141"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2141"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2141"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2141"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2140"
          xlink:label="f-2140"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2140"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2140"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2140"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2140"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2140"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3490"
          xlink:label="f-3490"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3490"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3490"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3490"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3490"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3470"
          xlink:label="f-3470"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3470"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3470"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3470"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3470"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3470"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3471"
          xlink:label="f-3471"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3471"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3471"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3471"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3471"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3471"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3471"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3471"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3472"
          xlink:label="f-3472"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3472"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3472"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3472"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3472"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3472"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3473"
          xlink:label="f-3473"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3473"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3473"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3473"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3473"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3473"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3473"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3474"
          xlink:label="f-3474"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3474"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3474"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3474"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3474"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3474"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3475"
          xlink:label="f-3475"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3475"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3475"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3475"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3475"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3475"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3476"
          xlink:label="f-3476"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3476"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3476"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3476"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3477"
          xlink:label="f-3477"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3477"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3477"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3477"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3477"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3477"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3478"
          xlink:label="f-3478"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3478"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3478"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3478"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3479"
          xlink:label="f-3479"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3479"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3479"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3479"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3479"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2159"
          xlink:label="f-2159"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2159"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2159"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2159"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2159"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2158"
          xlink:label="f-2158"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2158"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2158"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2158"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2158"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2158"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2158"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2157"
          xlink:label="f-2157"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2157"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2157"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2157"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2157"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2157"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2156"
          xlink:label="f-2156"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2156"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2156"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2156"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2155"
          xlink:label="f-2155"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2155"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2155"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2155"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2154"
          xlink:label="f-2154"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2154"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2154"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2154"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2154"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2153"
          xlink:label="f-2153"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2153"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2153"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2153"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2152"
          xlink:label="f-2152"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2152"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2152"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2152"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2152"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2152"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2151"
          xlink:label="f-2151"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2151"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2151"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2151"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2151"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2150"
          xlink:label="f-2150"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2150"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2150"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2150"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2150"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2170"
          xlink:label="f-2170"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2170"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2170"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2170"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2170"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2170"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2169"
          xlink:label="f-2169"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2169"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2169"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2169"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2169"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2168"
          xlink:label="f-2168"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2168"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2168"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2168"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2168"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2168"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2167"
          xlink:label="f-2167"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2167"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2167"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2167"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2167"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2167"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2166"
          xlink:label="f-2166"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2166"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2166"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2166"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2166"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2166"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2166"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2165"
          xlink:label="f-2165"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2165"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2165"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2165"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2165"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2165"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2164"
          xlink:label="f-2164"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2164"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2164"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2164"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2164"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2164"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2164"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2164"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2163"
          xlink:label="f-2163"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2163"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2163"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2163"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2163"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2163"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2163"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2162"
          xlink:label="f-2162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2162"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2162"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2162"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2162"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2161"
          xlink:label="f-2161"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2161"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2161"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2161"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2161"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2160"
          xlink:label="f-2160"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2160"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2160"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2160"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2160"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2160"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2181"
          xlink:label="f-2181"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2181"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2181"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2181"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2181"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2181"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3491"
          xlink:label="f-3491"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3491"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3491"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3491"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3491"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2180"
          xlink:label="f-2180"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2180"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2180"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2180"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2180"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3492"
          xlink:label="f-3492"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3492"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3492"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3492"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3492"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3492"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3492"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3493"
          xlink:label="f-3493"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3493"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3493"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3493"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3493"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3494"
          xlink:label="f-3494"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3494"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3494"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3494"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3494"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3494"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3495"
          xlink:label="f-3495"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3495"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3495"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3495"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3495"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3496"
          xlink:label="f-3496"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3496"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3496"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3496"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3496"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2179"
          xlink:label="f-2179"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2179"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2179"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2179"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2179"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2178"
          xlink:label="f-2178"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2178"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2178"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2178"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2178"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2178"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2177"
          xlink:label="f-2177"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2177"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2177"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2177"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2177"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2176"
          xlink:label="f-2176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2176"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2176"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2176"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2176"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2176"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2176"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2175"
          xlink:label="f-2175"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2175"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2175"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2175"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2175"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2175"
          xlink:to="fn-9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2174"
          xlink:label="f-2174"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2174"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2174"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2174"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2173"
          xlink:label="f-2173"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2173"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2173"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2173"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2172"
          xlink:label="f-2172"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2172"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2172"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2172"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2172"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2171"
          xlink:label="f-2171"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2171"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2171"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2171"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1709"
          xlink:label="f-1709"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1709"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1709"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1709"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1709"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1709"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1709"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1709"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1709"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1708"
          xlink:label="f-1708"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1708"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1708"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1708"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1708"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1708"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1708"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1708"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1708"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1707"
          xlink:label="f-1707"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1707"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1707"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1707"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1707"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1707"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1707"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1707"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1706"
          xlink:label="f-1706"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1706"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1706"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1706"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1706"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1706"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1705"
          xlink:label="f-1705"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1705"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1705"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1705"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1705"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1705"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1704"
          xlink:label="f-1704"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1704"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1704"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1704"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1704"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1704"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1704"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1703"
          xlink:label="f-1703"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1703"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1703"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1703"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1703"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1703"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1702"
          xlink:label="f-1702"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1702"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1702"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1702"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1702"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1702"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1702"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1702"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1701"
          xlink:label="f-1701"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1701"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1701"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1701"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1701"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1701"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1701"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1701"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1700"
          xlink:label="f-1700"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1700"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1700"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1700"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1700"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1700"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1700"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1719"
          xlink:label="f-1719"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1719"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1719"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1719"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1719"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1718"
          xlink:label="f-1718"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1718"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1718"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1718"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1718"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1718"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1717"
          xlink:label="f-1717"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1717"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1717"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1717"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1717"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1716"
          xlink:label="f-1716"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1716"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1716"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1716"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1716"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1716"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1716"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1715"
          xlink:label="f-1715"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1715"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1715"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1715"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1715"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1715"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1715"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1714"
          xlink:label="f-1714"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1714"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1714"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1714"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1714"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1714"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1713"
          xlink:label="f-1713"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1713"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1713"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1713"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1713"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1713"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1713"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1712"
          xlink:label="f-1712"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1712"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1712"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1712"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1712"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1712"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1712"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1711"
          xlink:label="f-1711"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1711"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1711"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1711"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1711"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1711"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1711"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1711"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1710"
          xlink:label="f-1710"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1710"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1710"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1710"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1710"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1710"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1710"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1728"
          xlink:label="f-1728"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1728"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1728"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1727"
          xlink:label="f-1727"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1727"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1727"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1727"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1727"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1726"
          xlink:label="f-1726"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1726"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1726"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1726"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1726"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1725"
          xlink:label="f-1725"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1725"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1725"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1725"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1725"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1725"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1724"
          xlink:label="f-1724"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1724"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1724"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1724"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1724"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1723"
          xlink:label="f-1723"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1723"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1723"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1723"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1723"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1723"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1723"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1722"
          xlink:label="f-1722"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1722"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1722"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1722"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1722"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1722"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1722"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1721"
          xlink:label="f-1721"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1721"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1721"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1721"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1721"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1721"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1720"
          xlink:label="f-1720"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1720"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1720"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1720"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1720"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1779"
          xlink:label="f-1779"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1779"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1779"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1779"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1779"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1779"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1778"
          xlink:label="f-1778"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1778"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1778"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1778"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1777"
          xlink:label="f-1777"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1777"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1777"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1777"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1776"
          xlink:label="f-1776"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1776"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1776"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1776"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1776"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1775"
          xlink:label="f-1775"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1775"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1775"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1775"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1774"
          xlink:label="f-1774"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1774"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1774"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1774"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1774"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1774"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1773"
          xlink:label="f-1773"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1773"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1773"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1773"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1773"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1770"
          xlink:label="f-1770"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1770"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1770"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1789"
          xlink:label="f-1789"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1789"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1789"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1789"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1789"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1789"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1789"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1789"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1789"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1788"
          xlink:label="f-1788"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1788"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1788"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1788"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1788"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1788"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1788"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1788"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1785"
          xlink:label="f-1785"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1785"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1785"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1784"
          xlink:label="f-1784"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1784"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1784"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1784"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1784"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1783"
          xlink:label="f-1783"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1783"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1783"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1783"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1783"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1782"
          xlink:label="f-1782"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1782"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1782"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1782"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1782"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1782"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1781"
          xlink:label="f-1781"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1781"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1781"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1781"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1781"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1780"
          xlink:label="f-1780"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1780"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1780"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1780"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1780"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1780"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1780"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3500"
          xlink:label="f-3500"
          xlink:type="locator"/>
        <link:footnote id="fn-29" xlink:label="fn-29" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was 1.50%</xhtml:span><xhtml:div style="padding-left:36pt;text-indent:-36pt"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14)</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">The interest rate floor on these investments as of December&#160;31, 2022 was 2.00%</xhtml:span></xhtml:div><xhtml:div style="padding-left:36pt;text-indent:-36pt"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(15)</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.68pt">For unsettled positions the interest rate does not include the base rate.</xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3500"
          xlink:to="fn-29"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3500"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3500"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3501"
          xlink:label="f-3501"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3501"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3501"
          xlink:to="fn-29"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3501"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3501"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3501"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3502"
          xlink:label="f-3502"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3502"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3502"
          xlink:to="fn-29"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3502"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3503"
          xlink:label="f-3503"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3503"
          xlink:to="fn-29"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3503"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3503"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3503"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3504"
          xlink:label="f-3504"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3504"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3504"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3504"
          xlink:to="fn-29"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3505"
          xlink:label="f-3505"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3505"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3505"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3505"
          xlink:to="fn-29"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3506"
          xlink:label="f-3506"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3506"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3506"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3506"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3506"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3507"
          xlink:label="f-3507"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3507"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3507"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3507"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3507"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3507"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3507"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3508"
          xlink:label="f-3508"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3508"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3508"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3508"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3508"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1799"
          xlink:label="f-1799"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1799"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1799"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1799"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1799"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1799"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3509"
          xlink:label="f-3509"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3509"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3509"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3509"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3509"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3509"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1798"
          xlink:label="f-1798"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1798"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1798"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1798"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1798"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1798"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1797"
          xlink:label="f-1797"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1797"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1797"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1797"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1797"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1797"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1797"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1796"
          xlink:label="f-1796"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1796"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1796"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1796"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1796"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1796"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1795"
          xlink:label="f-1795"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1795"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1795"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1795"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1795"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1795"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1795"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1795"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1794"
          xlink:label="f-1794"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1794"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1794"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1794"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1794"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1794"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1794"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1793"
          xlink:label="f-1793"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1793"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1793"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1793"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1793"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1793"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1793"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1792"
          xlink:label="f-1792"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1792"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1792"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1792"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1792"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1792"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1792"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1791"
          xlink:label="f-1791"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1791"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1791"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1791"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1791"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1791"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1791"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1791"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1790"
          xlink:label="f-1790"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1790"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1790"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1790"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1790"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1790"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1790"
          xlink:to="fn-8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1739"
          xlink:label="f-1739"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1739"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1739"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1739"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1739"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1738"
          xlink:label="f-1738"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1738"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1738"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1738"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1738"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1738"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1738"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1737"
          xlink:label="f-1737"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1737"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1737"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1737"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1737"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1737"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1736"
          xlink:label="f-1736"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1736"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1736"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1736"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1736"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1736"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1735"
          xlink:label="f-1735"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1735"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1735"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1735"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1735"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1735"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1734"
          xlink:label="f-1734"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1734"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1734"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1734"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1734"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1734"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1734"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1733"
          xlink:label="f-1733"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1733"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1733"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1733"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1733"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1733"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1732"
          xlink:label="f-1732"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1732"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1732"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1732"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1732"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1732"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1732"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1732"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1731"
          xlink:label="f-1731"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1731"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1731"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1731"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1731"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1731"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1731"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1749"
          xlink:label="f-1749"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1749"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1749"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1749"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1749"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1749"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1748"
          xlink:label="f-1748"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1748"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1748"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1748"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1748"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1747"
          xlink:label="f-1747"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1747"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1747"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1747"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1747"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1747"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1747"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1746"
          xlink:label="f-1746"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1746"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1746"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1746"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1746"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1746"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1743"
          xlink:label="f-1743"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1743"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1743"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1742"
          xlink:label="f-1742"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1742"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1742"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1742"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1742"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1741"
          xlink:label="f-1741"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1741"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1741"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1741"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1741"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1740"
          xlink:label="f-1740"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1740"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1740"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1740"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1740"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1740"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1759"
          xlink:label="f-1759"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1759"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1759"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1759"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1759"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1759"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1759"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1758"
          xlink:label="f-1758"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1758"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1758"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1758"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1758"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1758"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1757"
          xlink:label="f-1757"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1757"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1757"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1757"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1757"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1757"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1757"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1756"
          xlink:label="f-1756"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1756"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1756"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1756"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1756"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1756"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1756"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1755"
          xlink:label="f-1755"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1755"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1755"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1755"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1755"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1755"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1755"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1755"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1754"
          xlink:label="f-1754"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1754"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1754"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1754"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1754"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1754"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1754"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1753"
          xlink:label="f-1753"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1753"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1753"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1753"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1753"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1753"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1753"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1753"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1753"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1752"
          xlink:label="f-1752"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1752"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1752"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1752"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1752"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1752"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1752"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1752"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1751"
          xlink:label="f-1751"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1751"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1751"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1751"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1751"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1750"
          xlink:label="f-1750"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1750"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1750"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1750"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1750"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1769"
          xlink:label="f-1769"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1769"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1769"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1769"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1769"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1768"
          xlink:label="f-1768"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1768"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1768"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1768"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1768"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1767"
          xlink:label="f-1767"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1767"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1767"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1767"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1767"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1767"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1766"
          xlink:label="f-1766"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1766"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1766"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1766"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1766"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1765"
          xlink:label="f-1765"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1765"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1765"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1765"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1765"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1765"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1765"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1764"
          xlink:label="f-1764"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1764"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1764"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1764"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1764"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1764"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1763"
          xlink:label="f-1763"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1763"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1763"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1763"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1763"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1762"
          xlink:label="f-1762"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1762"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1762"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1762"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1762"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1761"
          xlink:label="f-1761"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1761"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1761"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1761"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1761"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1761"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1760"
          xlink:label="f-1760"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1760"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1760"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1760"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1760"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3560"
          xlink:label="f-3560"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3560"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3560"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3560"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3560"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3560"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3560"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3561"
          xlink:label="f-3561"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3561"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3561"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3561"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3561"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3561"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3561"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3561"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3561"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3562"
          xlink:label="f-3562"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3562"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3562"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3562"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3562"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3562"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3562"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3563"
          xlink:label="f-3563"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3563"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3563"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3563"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3563"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3563"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3563"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3563"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3564"
          xlink:label="f-3564"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3564"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3564"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3564"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3564"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3564"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3564"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3565"
          xlink:label="f-3565"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3565"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3565"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3565"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3565"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3565"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3565"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3566"
          xlink:label="f-3566"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3566"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3566"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3566"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3566"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3567"
          xlink:label="f-3567"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3567"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3567"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3567"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3567"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3567"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3567"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3569"
          xlink:label="f-3569"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3569"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3569"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3569"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3569"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2229"
          xlink:label="f-2229"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2229"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2229"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2229"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2229"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2228"
          xlink:label="f-2228"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2228"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2228"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2228"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2228"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2228"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2227"
          xlink:label="f-2227"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2227"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2227"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2227"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2227"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2226"
          xlink:label="f-2226"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2226"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2226"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2226"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2226"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2226"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2226"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2225"
          xlink:label="f-2225"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2225"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2225"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2225"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2225"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2225"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2224"
          xlink:label="f-2224"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2224"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2224"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2224"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2224"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2223"
          xlink:label="f-2223"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2223"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2223"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2223"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2223"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2222"
          xlink:label="f-2222"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2222"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2222"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2222"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2222"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2222"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2221"
          xlink:label="f-2221"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2221"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2221"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2221"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2221"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2220"
          xlink:label="f-2220"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2220"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2220"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2220"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2220"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2220"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2220"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3550"
          xlink:label="f-3550"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3550"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3550"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3550"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3550"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3551"
          xlink:label="f-3551"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3551"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3551"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3551"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3551"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3551"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3552"
          xlink:label="f-3552"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3552"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3552"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3552"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3552"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3553"
          xlink:label="f-3553"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3553"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3553"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3553"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3553"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3554"
          xlink:label="f-3554"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3554"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3554"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3554"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3554"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3554"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3555"
          xlink:label="f-3555"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3555"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3555"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3555"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3555"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3555"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3555"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3555"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3556"
          xlink:label="f-3556"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3556"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3556"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3556"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3556"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3556"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3557"
          xlink:label="f-3557"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3557"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3557"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3557"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3557"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3557"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3557"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3558"
          xlink:label="f-3558"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3558"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3558"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3558"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3558"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3558"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3559"
          xlink:label="f-3559"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3559"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3559"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3559"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3559"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3559"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2239"
          xlink:label="f-2239"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2239"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2239"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2239"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2239"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2239"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2238"
          xlink:label="f-2238"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2238"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2238"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2238"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2238"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2238"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2238"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2238"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2237"
          xlink:label="f-2237"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2237"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2237"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2237"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2237"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2237"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2237"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2236"
          xlink:label="f-2236"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2236"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2236"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2236"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2236"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2235"
          xlink:label="f-2235"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2235"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2235"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2235"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2235"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2234"
          xlink:label="f-2234"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2234"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2234"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2234"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2234"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2234"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2233"
          xlink:label="f-2233"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2233"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2233"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2233"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2233"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2232"
          xlink:label="f-2232"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2232"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2232"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2232"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2232"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2232"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2232"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2231"
          xlink:label="f-2231"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2231"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2231"
          xlink:to="fn-6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2231"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2231"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2231"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2230"
          xlink:label="f-2230"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2230"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2230"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2230"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2230"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3580"
          xlink:label="f-3580"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3580"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3580"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3580"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3580"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3580"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3580"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3581"
          xlink:label="f-3581"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3581"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3581"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3581"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3581"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3582"
          xlink:label="f-3582"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3582"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3582"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3582"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3582"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3582"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3583"
          xlink:label="f-3583"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3583"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3583"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3583"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3583"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3584"
          xlink:label="f-3584"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3584"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3584"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3584"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3584"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3585"
          xlink:label="f-3585"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3585"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3585"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3585"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3586"
          xlink:label="f-3586"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3586"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3586"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3586"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3586"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3586"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3587"
          xlink:label="f-3587"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3587"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3587"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3587"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3588"
          xlink:label="f-3588"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3588"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3588"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3588"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3588"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3589"
          xlink:label="f-3589"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3589"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3589"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3589"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2249"
          xlink:label="f-2249"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2249"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2249"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2249"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2249"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2249"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2249"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2248"
          xlink:label="f-2248"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2248"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2248"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2248"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2248"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2248"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2247"
          xlink:label="f-2247"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2247"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2247"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2247"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2247"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2247"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2246"
          xlink:label="f-2246"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2246"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2246"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2246"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2246"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2246"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2246"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2245"
          xlink:label="f-2245"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2245"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2245"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2245"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2245"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2245"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2244"
          xlink:label="f-2244"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2244"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2244"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2244"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2244"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2244"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2244"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2244"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2243"
          xlink:label="f-2243"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2243"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2243"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2243"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2243"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2243"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2243"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2242"
          xlink:label="f-2242"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2242"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2242"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2242"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2242"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2242"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2241"
          xlink:label="f-2241"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2241"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2241"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2241"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2241"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2241"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2240"
          xlink:label="f-2240"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2240"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2240"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2240"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2240"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2240"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2240"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3570"
          xlink:label="f-3570"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3570"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3570"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3570"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3570"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3570"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3571"
          xlink:label="f-3571"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3571"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3571"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3571"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3571"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3572"
          xlink:label="f-3572"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3572"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3572"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3572"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3572"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3573"
          xlink:label="f-3573"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3573"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3573"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3573"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3574"
          xlink:label="f-3574"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3574"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3574"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3574"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3574"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3574"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3575"
          xlink:label="f-3575"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3575"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3575"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3575"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3576"
          xlink:label="f-3576"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3576"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3576"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3576"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3576"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3577"
          xlink:label="f-3577"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3577"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3577"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3577"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3578"
          xlink:label="f-3578"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3578"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3578"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3578"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3579"
          xlink:label="f-3579"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3579"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3579"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3579"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3579"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2259"
          xlink:label="f-2259"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2259"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2259"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2259"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2259"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2258"
          xlink:label="f-2258"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2258"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2258"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2258"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2258"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2258"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2257"
          xlink:label="f-2257"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2257"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2257"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2257"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2257"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2256"
          xlink:label="f-2256"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2256"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2256"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2256"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2256"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2256"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2256"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2255"
          xlink:label="f-2255"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2255"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2255"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2255"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2255"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2255"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2254"
          xlink:label="f-2254"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2254"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2254"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2254"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2254"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2254"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2253"
          xlink:label="f-2253"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2253"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2253"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2253"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2253"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2253"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2252"
          xlink:label="f-2252"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2252"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2252"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2252"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2252"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2252"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2252"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2251"
          xlink:label="f-2251"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2251"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2251"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2251"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2251"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2251"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2250"
          xlink:label="f-2250"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2250"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2250"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2250"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2250"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2250"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2250"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2250"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3520"
          xlink:label="f-3520"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3520"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3520"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3521"
          xlink:label="f-3521"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3521"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3521"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3521"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3521"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3522"
          xlink:label="f-3522"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3522"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3522"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3522"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3522"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3522"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3522"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3523"
          xlink:label="f-3523"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3523"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3523"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3523"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3523"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3524"
          xlink:label="f-3524"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3524"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3524"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3524"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3524"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3524"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3525"
          xlink:label="f-3525"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3525"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3525"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3525"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3525"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3526"
          xlink:label="f-3526"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3526"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3526"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3526"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3526"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3527"
          xlink:label="f-3527"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3527"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3527"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3527"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3527"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3527"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3528"
          xlink:label="f-3528"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3528"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3528"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3528"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3528"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3528"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3528"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3528"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3529"
          xlink:label="f-3529"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3529"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3529"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3529"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3529"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3529"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3510"
          xlink:label="f-3510"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3510"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3510"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3510"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3510"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3511"
          xlink:label="f-3511"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3511"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3511"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3511"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3511"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3512"
          xlink:label="f-3512"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3512"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3512"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3512"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3512"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3513"
          xlink:label="f-3513"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3513"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3513"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3513"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3513"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3513"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3513"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3514"
          xlink:label="f-3514"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3514"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3514"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3514"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3514"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3515"
          xlink:label="f-3515"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3515"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3515"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3515"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3515"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3515"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3516"
          xlink:label="f-3516"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3516"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3516"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3516"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3516"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3517"
          xlink:label="f-3517"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3517"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3517"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3517"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3517"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3518"
          xlink:label="f-3518"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3518"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3518"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3518"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3519"
          xlink:label="f-3519"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3519"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3519"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3540"
          xlink:label="f-3540"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3540"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3540"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3540"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3540"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3540"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3541"
          xlink:label="f-3541"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3541"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3541"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3541"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3541"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3541"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3542"
          xlink:label="f-3542"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3542"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3542"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3542"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3542"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3542"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3543"
          xlink:label="f-3543"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3543"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3543"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3543"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3543"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3543"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3543"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3543"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3544"
          xlink:label="f-3544"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3544"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3544"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3544"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3544"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3544"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3545"
          xlink:label="f-3545"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3545"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3545"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3545"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3545"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3545"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3545"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3546"
          xlink:label="f-3546"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3546"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3546"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3546"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3546"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3546"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3547"
          xlink:label="f-3547"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3547"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3547"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3547"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3547"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3547"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3548"
          xlink:label="f-3548"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3548"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3548"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3548"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3548"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3549"
          xlink:label="f-3549"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3549"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3549"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3549"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3549"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3549"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3549"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2209"
          xlink:label="f-2209"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2209"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2209"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2209"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2209"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2208"
          xlink:label="f-2208"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2208"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2208"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2208"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2208"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2208"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2208"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2207"
          xlink:label="f-2207"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2207"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2207"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2207"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2207"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2207"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2206"
          xlink:label="f-2206"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2206"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2206"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2206"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2205"
          xlink:label="f-2205"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2205"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2205"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2205"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2204"
          xlink:label="f-2204"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2204"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2204"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2204"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2204"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2203"
          xlink:label="f-2203"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2203"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2203"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2203"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2202"
          xlink:label="f-2202"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2202"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2202"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2202"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2202"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2202"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2201"
          xlink:label="f-2201"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2201"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2201"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2201"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2201"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2201"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2200"
          xlink:label="f-2200"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2200"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2200"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2200"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2200"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3530"
          xlink:label="f-3530"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3530"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3530"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3530"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3530"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3530"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3530"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3531"
          xlink:label="f-3531"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3531"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3531"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3531"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3531"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3531"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3532"
          xlink:label="f-3532"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3532"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3532"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3532"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3532"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3532"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3533"
          xlink:label="f-3533"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3533"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3533"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3533"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3534"
          xlink:label="f-3534"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3534"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3534"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3535"
          xlink:label="f-3535"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3535"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3535"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3536"
          xlink:label="f-3536"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3536"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3536"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3536"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3536"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3536"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3537"
          xlink:label="f-3537"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3537"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3537"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3537"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3537"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3537"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3537"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3537"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3538"
          xlink:label="f-3538"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3538"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3538"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3538"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3538"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3538"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3539"
          xlink:label="f-3539"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3539"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3539"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3539"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3539"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3539"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3539"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2219"
          xlink:label="f-2219"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2219"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2219"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2219"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2219"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2219"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2218"
          xlink:label="f-2218"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2218"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2218"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2218"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2218"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2217"
          xlink:label="f-2217"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2217"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2217"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2217"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2217"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2216"
          xlink:label="f-2216"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2216"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2216"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2216"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2216"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2216"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2215"
          xlink:label="f-2215"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2215"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2215"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2215"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2215"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2214"
          xlink:label="f-2214"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2214"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2214"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2214"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2214"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2214"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2214"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2213"
          xlink:label="f-2213"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2213"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2213"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2213"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2213"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2213"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2212"
          xlink:label="f-2212"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2212"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2212"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2212"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2212"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2211"
          xlink:label="f-2211"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2211"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2211"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2211"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2211"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2210"
          xlink:label="f-2210"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2210"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2210"
          xlink:to="fn-16"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2210"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2210"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2210"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4010"
          xlink:label="f-4010"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4010"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4010"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4010"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4011"
          xlink:label="f-4011"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4011"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4011"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4011"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4012"
          xlink:label="f-4012"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4012"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4012"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4012"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4013"
          xlink:label="f-4013"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4013"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4013"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4013"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4013"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4013"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4014"
          xlink:label="f-4014"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4014"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4014"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4014"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4015"
          xlink:label="f-4015"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4015"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4015"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4015"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4015"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4016"
          xlink:label="f-4016"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4016"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4016"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4016"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4017"
          xlink:label="f-4017"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4017"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4017"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4017"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4018"
          xlink:label="f-4018"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4018"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4018"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4018"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4018"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4018"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4019"
          xlink:label="f-4019"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4019"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4019"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4019"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4019"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4019"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4019"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4019"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4000"
          xlink:label="f-4000"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4000"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4000"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4000"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4000"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4000"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4001"
          xlink:label="f-4001"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4001"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4001"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4001"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4001"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4001"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4001"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4001"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4002"
          xlink:label="f-4002"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4002"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4002"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4002"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4002"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4002"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4003"
          xlink:label="f-4003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4003"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4003"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4003"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4003"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4003"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4003"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4004"
          xlink:label="f-4004"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4004"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4004"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4004"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4004"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4004"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4005"
          xlink:label="f-4005"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4005"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4005"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4005"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4005"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4005"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4006"
          xlink:label="f-4006"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4006"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4006"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4006"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4007"
          xlink:label="f-4007"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4007"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4007"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4007"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4007"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4007"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4008"
          xlink:label="f-4008"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4008"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4008"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4008"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4009"
          xlink:label="f-4009"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4009"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4009"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4009"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4009"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4030"
          xlink:label="f-4030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4030"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4030"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4030"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4030"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4030"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4031"
          xlink:label="f-4031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4031"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4031"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4031"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4031"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4031"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4031"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4031"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4032"
          xlink:label="f-4032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4032"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4032"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4032"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4032"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4032"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4033"
          xlink:label="f-4033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4033"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4033"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4033"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4033"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4033"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4033"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4034"
          xlink:label="f-4034"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4034"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4034"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4034"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4034"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4034"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4035"
          xlink:label="f-4035"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4035"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4035"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4035"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4035"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4035"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4036"
          xlink:label="f-4036"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4036"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4036"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4036"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4036"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4037"
          xlink:label="f-4037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4037"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4037"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4037"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4037"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4037"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4037"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4038"
          xlink:label="f-4038"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4038"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4038"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4038"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4038"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4039"
          xlink:label="f-4039"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4039"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4039"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4039"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4039"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4039"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4040"
          xlink:label="f-4040"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4040"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4040"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4040"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4040"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4020"
          xlink:label="f-4020"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4020"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4020"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4020"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4020"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4020"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4021"
          xlink:label="f-4021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4021"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4021"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4021"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4021"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4021"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4021"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4022"
          xlink:label="f-4022"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4022"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4022"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4022"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4022"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4022"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4023"
          xlink:label="f-4023"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4023"
          xlink:to="fn-22"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4023"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4023"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4023"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4023"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4024"
          xlink:label="f-4024"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4024"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4024"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4024"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4024"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4025"
          xlink:label="f-4025"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4025"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4025"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4025"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4025"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4025"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4025"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4026"
          xlink:label="f-4026"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4026"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4026"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4026"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4026"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4027"
          xlink:label="f-4027"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4027"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4027"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4027"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4027"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4027"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4028"
          xlink:label="f-4028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4028"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4028"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4028"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4028"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4029"
          xlink:label="f-4029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4029"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4029"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4029"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4029"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2269"
          xlink:label="f-2269"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2269"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2269"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2269"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2268"
          xlink:label="f-2268"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2268"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2268"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2268"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2268"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2268"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2267"
          xlink:label="f-2267"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2267"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2267"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2267"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2267"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2266"
          xlink:label="f-2266"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2266"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2266"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2266"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2265"
          xlink:label="f-2265"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2265"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2265"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2265"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2264"
          xlink:label="f-2264"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2264"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2264"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2264"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2264"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2263"
          xlink:label="f-2263"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2263"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2263"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2263"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2262"
          xlink:label="f-2262"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2262"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2262"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2262"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2262"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2262"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2261"
          xlink:label="f-2261"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2261"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2261"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2261"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2261"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2260"
          xlink:label="f-2260"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2260"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2260"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2260"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2260"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2280"
          xlink:label="f-2280"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2280"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2280"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2280"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2280"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2280"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3590"
          xlink:label="f-3590"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3590"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3590"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3590"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3591"
          xlink:label="f-3591"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3591"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3591"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3591"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3591"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3592"
          xlink:label="f-3592"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3592"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3592"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3592"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3592"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3592"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3592"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3593"
          xlink:label="f-3593"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3593"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3593"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3593"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3593"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3594"
          xlink:label="f-3594"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3594"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3594"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3594"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3594"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3594"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3595"
          xlink:label="f-3595"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3595"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3595"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3595"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3595"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3596"
          xlink:label="f-3596"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3596"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3596"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3596"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3596"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3597"
          xlink:label="f-3597"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3597"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3597"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3597"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3597"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3597"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3598"
          xlink:label="f-3598"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3598"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3598"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3598"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3598"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3598"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3598"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3598"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3599"
          xlink:label="f-3599"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3599"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3599"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3599"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3599"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3599"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2279"
          xlink:label="f-2279"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2279"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2279"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2279"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2279"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2278"
          xlink:label="f-2278"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2278"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2278"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2278"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2277"
          xlink:label="f-2277"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2277"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2277"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2277"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2276"
          xlink:label="f-2276"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2276"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2276"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2276"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2276"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2275"
          xlink:label="f-2275"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2275"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2275"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2275"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2274"
          xlink:label="f-2274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2274"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2274"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2274"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2274"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2274"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2273"
          xlink:label="f-2273"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2273"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2273"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2273"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2273"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2272"
          xlink:label="f-2272"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2272"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2272"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2272"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2271"
          xlink:label="f-2271"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2271"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2271"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2271"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2270"
          xlink:label="f-2270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2270"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2270"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2270"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2270"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2291"
          xlink:label="f-2291"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2291"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2291"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2291"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2291"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2291"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2290"
          xlink:label="f-2290"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2290"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2290"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2290"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2290"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2289"
          xlink:label="f-2289"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2289"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2289"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2289"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2289"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2288"
          xlink:label="f-2288"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2288"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2288"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2288"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2288"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2288"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2287"
          xlink:label="f-2287"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2287"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2287"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2287"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2287"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2286"
          xlink:label="f-2286"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2286"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2286"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2286"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2286"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2286"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2286"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2285"
          xlink:label="f-2285"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2285"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2285"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2285"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2285"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2285"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2284"
          xlink:label="f-2284"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2284"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2284"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2284"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2283"
          xlink:label="f-2283"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2283"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2283"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2283"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2282"
          xlink:label="f-2282"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2282"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2282"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2282"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2282"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2281"
          xlink:label="f-2281"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2281"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2281"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2281"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2299"
          xlink:label="f-2299"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2299"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2299"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2299"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2299"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2299"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2299"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2299"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2298"
          xlink:label="f-2298"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2298"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2298"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2298"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2298"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2298"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2298"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2298"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2297"
          xlink:label="f-2297"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2297"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2297"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2297"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2297"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2297"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2297"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2296"
          xlink:label="f-2296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2296"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2296"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2296"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2296"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2295"
          xlink:label="f-2295"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2295"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2295"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2295"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2295"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2294"
          xlink:label="f-2294"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2294"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2294"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2294"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2294"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2294"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2293"
          xlink:label="f-2293"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2293"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2293"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2293"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2293"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2292"
          xlink:label="f-2292"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2292"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2292"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2292"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2292"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2292"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2292"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4096"
          xlink:label="f-4096"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4096"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4096"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4096"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4096"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4097"
          xlink:label="f-4097"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4097"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4097"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4097"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4097"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4097"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4097"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4098"
          xlink:label="f-4098"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4098"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4098"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4098"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4098"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4099"
          xlink:label="f-4099"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4099"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4099"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4099"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4099"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4099"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1819"
          xlink:label="f-1819"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1819"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1819"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1819"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1819"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1818"
          xlink:label="f-1818"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1818"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1818"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1818"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1818"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1818"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1817"
          xlink:label="f-1817"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1817"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1817"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1817"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1817"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1816"
          xlink:label="f-1816"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1816"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1816"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1816"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1816"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1816"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1816"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1815"
          xlink:label="f-1815"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1815"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1815"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1815"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1815"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1815"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1814"
          xlink:label="f-1814"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1814"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1814"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1814"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1814"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1814"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1813"
          xlink:label="f-1813"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1813"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1813"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1813"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1813"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1813"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1812"
          xlink:label="f-1812"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1812"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1812"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1812"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1812"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1812"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1812"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1811"
          xlink:label="f-1811"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1811"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1811"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1811"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1811"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1811"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1810"
          xlink:label="f-1810"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1810"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1810"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1810"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1810"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1810"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1810"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1810"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4085"
          xlink:label="f-4085"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4085"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4085"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4085"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4085"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4086"
          xlink:label="f-4086"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4086"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4086"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4087"
          xlink:label="f-4087"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4087"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4087"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4087"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4088"
          xlink:label="f-4088"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4088"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4088"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4089"
          xlink:label="f-4089"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4089"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4089"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1829"
          xlink:label="f-1829"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1829"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1829"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1829"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1829"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1828"
          xlink:label="f-1828"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1828"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1828"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1828"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1828"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1828"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1828"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1827"
          xlink:label="f-1827"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1827"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1827"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1827"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1827"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1827"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1826"
          xlink:label="f-1826"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1826"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1826"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1826"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1826"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1826"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1825"
          xlink:label="f-1825"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1825"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1825"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1825"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1825"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1825"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1824"
          xlink:label="f-1824"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1824"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1824"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1824"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1824"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1824"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1824"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1823"
          xlink:label="f-1823"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1823"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1823"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1823"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1823"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1823"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1822"
          xlink:label="f-1822"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1822"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1822"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1822"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1822"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1822"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1822"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1822"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1821"
          xlink:label="f-1821"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1821"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1821"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1821"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1821"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1821"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1821"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1820"
          xlink:label="f-1820"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1820"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1820"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1820"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1820"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4090"
          xlink:label="f-4090"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4090"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4090"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4090"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4090"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4091"
          xlink:label="f-4091"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4091"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4091"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4091"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4091"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4091"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4091"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4092"
          xlink:label="f-4092"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4092"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4092"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4092"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4092"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4093"
          xlink:label="f-4093"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4093"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4093"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4093"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4093"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4093"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4094"
          xlink:label="f-4094"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4094"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4094"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4094"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4094"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4095"
          xlink:label="f-4095"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4095"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4095"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4095"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4095"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1839"
          xlink:label="f-1839"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1839"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1839"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1839"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1839"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1838"
          xlink:label="f-1838"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1838"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1838"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1838"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1838"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1837"
          xlink:label="f-1837"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1837"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1837"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1837"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1837"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1836"
          xlink:label="f-1836"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1836"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1836"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1836"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1836"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1836"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1835"
          xlink:label="f-1835"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1835"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1835"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1835"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1835"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1834"
          xlink:label="f-1834"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1834"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1834"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1834"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1834"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1834"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1834"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1833"
          xlink:label="f-1833"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1833"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1833"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1833"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1833"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1833"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1832"
          xlink:label="f-1832"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1832"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1832"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1832"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1832"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1831"
          xlink:label="f-1831"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1831"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1831"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1831"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1831"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1830"
          xlink:label="f-1830"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1830"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1830"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1830"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1830"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1830"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1849"
          xlink:label="f-1849"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1849"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1849"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1849"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1849"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1849"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1849"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1848"
          xlink:label="f-1848"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1848"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1848"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1848"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1848"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1848"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1847"
          xlink:label="f-1847"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1847"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1847"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1847"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1847"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1847"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1847"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1847"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1846"
          xlink:label="f-1846"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1846"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1846"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1846"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1846"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1846"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1846"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1845"
          xlink:label="f-1845"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1845"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1845"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1845"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1844"
          xlink:label="f-1844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1844"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1844"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1844"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1843"
          xlink:label="f-1843"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1843"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1843"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1843"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1843"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1842"
          xlink:label="f-1842"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1842"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1842"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1842"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1841"
          xlink:label="f-1841"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1841"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1841"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1841"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1841"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1841"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1840"
          xlink:label="f-1840"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1840"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1840"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1840"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1840"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1840"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4052"
          xlink:label="f-4052"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4052"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4052"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4052"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4052"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4053"
          xlink:label="f-4053"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4053"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4053"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4053"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4053"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4054"
          xlink:label="f-4054"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4054"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4054"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4054"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4054"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4054"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4055"
          xlink:label="f-4055"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4055"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4055"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4055"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4055"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4055"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4055"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4055"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4056"
          xlink:label="f-4056"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4056"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4056"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4056"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4056"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4056"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4057"
          xlink:label="f-4057"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4057"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4057"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4057"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4057"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4057"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4057"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4058"
          xlink:label="f-4058"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4058"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4058"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4058"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4058"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4058"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4059"
          xlink:label="f-4059"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4059"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4059"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4059"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4059"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4059"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4060"
          xlink:label="f-4060"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4060"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4060"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4060"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4060"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4060"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4061"
          xlink:label="f-4061"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4061"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4061"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4061"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4061"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4061"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4061"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4061"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4062"
          xlink:label="f-4062"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4062"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4062"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4062"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4062"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4062"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4041"
          xlink:label="f-4041"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4041"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4041"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4041"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4041"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4042"
          xlink:label="f-4042"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4042"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4042"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4042"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4043"
          xlink:label="f-4043"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4043"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4043"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4043"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4043"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4043"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4044"
          xlink:label="f-4044"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4044"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4044"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4044"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4045"
          xlink:label="f-4045"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4045"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4045"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4045"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4045"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4046"
          xlink:label="f-4046"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4046"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4046"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4046"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4047"
          xlink:label="f-4047"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4047"
          xlink:to="fn-27"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4047"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4047"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4048"
          xlink:label="f-4048"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4048"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4048"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4048"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4048"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4049"
          xlink:label="f-4049"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4049"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4049"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4049"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4049"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4049"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4049"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4050"
          xlink:label="f-4050"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4050"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4050"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4050"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4050"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4051"
          xlink:label="f-4051"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4051"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4051"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4051"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4051"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4051"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4074"
          xlink:label="f-4074"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4074"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4074"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4074"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4074"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4074"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4075"
          xlink:label="f-4075"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4075"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4075"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4075"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4075"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4075"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4075"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4076"
          xlink:label="f-4076"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4076"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4076"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4076"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4076"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4076"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4077"
          xlink:label="f-4077"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4077"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4077"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4077"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4077"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4077"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4078"
          xlink:label="f-4078"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4078"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4078"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4078"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4078"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4078"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4079"
          xlink:label="f-4079"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4079"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4079"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4079"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4079"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4079"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4079"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4079"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4080"
          xlink:label="f-4080"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4080"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4080"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4080"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4080"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4080"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4081"
          xlink:label="f-4081"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4081"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4081"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4081"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4081"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4081"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4081"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4082"
          xlink:label="f-4082"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4082"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4082"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4082"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4082"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4082"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4083"
          xlink:label="f-4083"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4083"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4083"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4083"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4083"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4083"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4084"
          xlink:label="f-4084"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4084"
          xlink:to="fn-24"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4084"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4063"
          xlink:label="f-4063"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4063"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4063"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4063"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4063"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4063"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4063"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4064"
          xlink:label="f-4064"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4064"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4064"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4064"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4064"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4064"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4065"
          xlink:label="f-4065"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4065"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4065"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4065"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4065"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4065"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4066"
          xlink:label="f-4066"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4066"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4066"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4066"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4066"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4067"
          xlink:label="f-4067"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4067"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4067"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4067"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4067"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4067"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4067"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4068"
          xlink:label="f-4068"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4068"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4068"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4068"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4068"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4069"
          xlink:label="f-4069"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4069"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4069"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4069"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4069"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4069"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1809"
          xlink:label="f-1809"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1809"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1809"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1809"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1809"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1809"
          xlink:to="fn-7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1809"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1808"
          xlink:label="f-1808"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1808"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1808"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1808"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1808"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1807"
          xlink:label="f-1807"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1807"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1807"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1807"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1807"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1806"
          xlink:label="f-1806"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1806"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1806"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1806"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1806"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1806"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1805"
          xlink:label="f-1805"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1805"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1805"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1805"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1805"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1804"
          xlink:label="f-1804"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1804"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1804"
          xlink:to="fn-13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1804"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1804"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1804"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1804"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1803"
          xlink:label="f-1803"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1803"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1803"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1803"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1803"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1803"
          xlink:to="fn-10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1800"
          xlink:label="f-1800"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1800"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1800"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4070"
          xlink:label="f-4070"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4070"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4070"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4070"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4070"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4071"
          xlink:label="f-4071"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4071"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4071"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4071"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4071"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4072"
          xlink:label="f-4072"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4072"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4072"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4072"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4072"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4072"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4073"
          xlink:label="f-4073"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4073"
          xlink:to="fn-26"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4073"
          xlink:to="fn-18"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4073"
          xlink:to="fn-23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4073"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4073"
          xlink:to="fn-30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4073"
          xlink:to="fn-21"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4073"
          xlink:to="fn-20"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-839"
          xlink:label="f-839"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-840"
          xlink:label="f-840"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-837"
          xlink:label="f-837"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-839"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-840"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-837"
          xlink:to="fn-11"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-4654"
          xlink:label="f-4654"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4639"
          xlink:label="f-4639"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3333"
          xlink:label="f-3333"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4638"
          xlink:label="f-4638"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3753"
          xlink:label="f-3753"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4566"
          xlink:label="f-4566"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4506"
          xlink:label="f-4506"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4674"
          xlink:label="f-4674"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4666"
          xlink:label="f-4666"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4439"
          xlink:label="f-4439"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4440"
          xlink:label="f-4440"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3138"
          xlink:label="f-3138"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4663"
          xlink:label="f-4663"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4669"
          xlink:label="f-4669"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4149"
          xlink:label="f-4149"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4516"
          xlink:label="f-4516"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4653"
          xlink:label="f-4653"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4460"
          xlink:label="f-4460"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4659"
          xlink:label="f-4659"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3695"
          xlink:label="f-3695"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3207"
          xlink:label="f-3207"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3941"
          xlink:label="f-3941"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4529"
          xlink:label="f-4529"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3984"
          xlink:label="f-3984"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3239"
          xlink:label="f-3239"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4657"
          xlink:label="f-4657"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4490"
          xlink:label="f-4490"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4148"
          xlink:label="f-4148"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4577"
          xlink:label="f-4577"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4517"
          xlink:label="f-4517"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4578"
          xlink:label="f-4578"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4671"
          xlink:label="f-4671"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4436"
          xlink:label="f-4436"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4678"
          xlink:label="f-4678"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3696"
          xlink:label="f-3696"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4656"
          xlink:label="f-4656"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3858"
          xlink:label="f-3858"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4459"
          xlink:label="f-4459"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4567"
          xlink:label="f-4567"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4461"
          xlink:label="f-4461"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4668"
          xlink:label="f-4668"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3752"
          xlink:label="f-3752"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4489"
          xlink:label="f-4489"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3998"
          xlink:label="f-3998"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4385"
          xlink:label="f-4385"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4660"
          xlink:label="f-4660"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4662"
          xlink:label="f-4662"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3332"
          xlink:label="f-3332"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4134"
          xlink:label="f-4134"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4665"
          xlink:label="f-4665"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4359"
          xlink:label="f-4359"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4133"
          xlink:label="f-4133"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4672"
          xlink:label="f-4672"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3137"
          xlink:label="f-3137"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4548"
          xlink:label="f-4548"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3206"
          xlink:label="f-3206"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4528"
          xlink:label="f-4528"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4505"
          xlink:label="f-4505"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4675"
          xlink:label="f-4675"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3983"
          xlink:label="f-3983"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3999"
          xlink:label="f-3999"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4491"
          xlink:label="f-4491"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4677"
          xlink:label="f-4677"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3942"
          xlink:label="f-3942"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4547"
          xlink:label="f-4547"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4601"
          xlink:label="f-4601"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4437"
          xlink:label="f-4437"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4386"
          xlink:label="f-4386"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4602"
          xlink:label="f-4602"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3956"
          xlink:label="f-3956"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3859"
          xlink:label="f-3859"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3240"
          xlink:label="f-3240"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-3957"
          xlink:label="f-3957"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-4358"
          xlink:label="f-4358"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4654"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4639"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3333"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4638"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3753"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4566"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4506"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4674"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4666"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4439"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4440"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3138"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4663"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4669"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4149"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4516"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4653"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4460"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4659"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3695"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3207"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3941"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4529"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3984"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3239"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4657"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4490"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4148"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4577"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4517"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4578"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4671"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4436"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4678"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3696"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4656"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3858"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4459"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4567"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4461"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4668"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3752"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4489"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3998"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4385"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4660"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4662"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3332"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4134"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4665"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4359"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4133"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4672"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3137"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4548"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3206"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4528"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4505"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4675"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3983"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3999"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4491"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4677"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3942"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4547"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4601"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4437"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4386"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4602"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3956"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3859"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3240"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3957"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-4358"
          xlink:to="fn-17"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2477"
          xlink:label="f-2477"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2469"
          xlink:label="f-2469"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1950"
          xlink:label="f-1950"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1772"
          xlink:label="f-1772"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2437"
          xlink:label="f-2437"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2423"
          xlink:label="f-2423"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2478"
          xlink:label="f-2478"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1486"
          xlink:label="f-1486"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2013"
          xlink:label="f-2013"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1745"
          xlink:label="f-1745"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2015"
          xlink:label="f-2015"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1744"
          xlink:label="f-1744"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1771"
          xlink:label="f-1771"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1180"
          xlink:label="f-1180"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2416"
          xlink:label="f-2416"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-698"
          xlink:label="f-698"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2306"
          xlink:label="f-2306"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1970"
          xlink:label="f-1970"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1619"
          xlink:label="f-1619"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2016"
          xlink:label="f-2016"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1394"
          xlink:label="f-1394"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2422"
          xlink:label="f-2422"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1801"
          xlink:label="f-1801"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2476"
          xlink:label="f-2476"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1730"
          xlink:label="f-1730"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1179"
          xlink:label="f-1179"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2468"
          xlink:label="f-2468"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2465"
          xlink:label="f-2465"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1802"
          xlink:label="f-1802"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1949"
          xlink:label="f-1949"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1971"
          xlink:label="f-1971"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1393"
          xlink:label="f-1393"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2438"
          xlink:label="f-2438"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1787"
          xlink:label="f-1787"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1620"
          xlink:label="f-1620"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2305"
          xlink:label="f-2305"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1786"
          xlink:label="f-1786"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-699"
          xlink:label="f-699"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1729"
          xlink:label="f-1729"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2420"
          xlink:label="f-2420"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2417"
          xlink:label="f-2417"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2419"
          xlink:label="f-2419"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-737"
          xlink:label="f-737"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-612"
          xlink:label="f-612"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2466"
          xlink:label="f-2466"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-611"
          xlink:label="f-611"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-738"
          xlink:label="f-738"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1487"
          xlink:label="f-1487"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2477"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2469"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1950"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1772"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2437"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2423"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2478"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1486"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2013"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1745"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2015"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1744"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1771"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1180"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2416"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-698"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2306"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1970"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1619"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2016"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1394"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2422"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1801"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2476"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1730"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1179"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2468"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2465"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1802"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1949"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1971"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1393"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2438"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1787"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1620"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2305"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1786"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-699"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1729"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2420"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2417"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2419"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-737"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-612"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2466"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-611"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-738"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1487"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-3497"
          xlink:label="f-3497"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-3497"
          xlink:to="fn-19"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-1061"
          xlink:label="f-1061"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-856"
          xlink:label="f-856"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2680"
          xlink:label="f-2680"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2686"
          xlink:label="f-2686"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2491"
          xlink:label="f-2491"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2510"
          xlink:label="f-2510"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2557"
          xlink:label="f-2557"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1145"
          xlink:label="f-1145"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1031"
          xlink:label="f-1031"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2584"
          xlink:label="f-2584"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2677"
          xlink:label="f-2677"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2689"
          xlink:label="f-2689"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2683"
          xlink:label="f-2683"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2668"
          xlink:label="f-2668"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-964"
          xlink:label="f-964"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1109"
          xlink:label="f-1109"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2573"
          xlink:label="f-2573"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2674"
          xlink:label="f-2674"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-841"
          xlink:label="f-841"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-877"
          xlink:label="f-877"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1046"
          xlink:label="f-1046"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2644"
          xlink:label="f-2644"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2538"
          xlink:label="f-2538"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1003"
          xlink:label="f-1003"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1130"
          xlink:label="f-1130"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2599"
          xlink:label="f-2599"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2671"
          xlink:label="f-2671"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2662"
          xlink:label="f-2662"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2659"
          xlink:label="f-2659"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-1076"
          xlink:label="f-1076"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1061"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-856"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2680"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2686"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2491"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2510"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2557"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1145"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1031"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2584"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2677"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2689"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2683"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2668"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-964"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1109"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2573"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2674"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-841"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-877"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1046"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2644"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2538"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1003"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1130"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2599"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2671"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2662"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2659"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-1076"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-2655"
          xlink:label="f-2655"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2506"
          xlink:label="f-2506"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2563"
          xlink:label="f-2563"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2530"
          xlink:label="f-2530"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2543"
          xlink:label="f-2543"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2482"
          xlink:label="f-2482"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2594"
          xlink:label="f-2594"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2489"
          xlink:label="f-2489"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2536"
          xlink:label="f-2536"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2614"
          xlink:label="f-2614"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2609"
          xlink:label="f-2609"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2508"
          xlink:label="f-2508"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2593"
          xlink:label="f-2593"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2626"
          xlink:label="f-2626"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2571"
          xlink:label="f-2571"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2541"
          xlink:label="f-2541"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2490"
          xlink:label="f-2490"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2608"
          xlink:label="f-2608"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2651"
          xlink:label="f-2651"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2549"
          xlink:label="f-2549"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2485"
          xlink:label="f-2485"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2587"
          xlink:label="f-2587"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2534"
          xlink:label="f-2534"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2649"
          xlink:label="f-2649"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2579"
          xlink:label="f-2579"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2483"
          xlink:label="f-2483"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2625"
          xlink:label="f-2625"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2547"
          xlink:label="f-2547"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2623"
          xlink:label="f-2623"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2553"
          xlink:label="f-2553"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2630"
          xlink:label="f-2630"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2528"
          xlink:label="f-2528"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2486"
          xlink:label="f-2486"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2518"
          xlink:label="f-2518"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2653"
          xlink:label="f-2653"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2629"
          xlink:label="f-2629"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2504"
          xlink:label="f-2504"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2552"
          xlink:label="f-2552"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2500"
          xlink:label="f-2500"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2545"
          xlink:label="f-2545"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2602"
          xlink:label="f-2602"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2643"
          xlink:label="f-2643"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2650"
          xlink:label="f-2650"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2516"
          xlink:label="f-2516"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2529"
          xlink:label="f-2529"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2591"
          xlink:label="f-2591"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2562"
          xlink:label="f-2562"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2551"
          xlink:label="f-2551"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2590"
          xlink:label="f-2590"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2572"
          xlink:label="f-2572"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2548"
          xlink:label="f-2548"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2610"
          xlink:label="f-2610"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2487"
          xlink:label="f-2487"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2604"
          xlink:label="f-2604"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2521"
          xlink:label="f-2521"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2605"
          xlink:label="f-2605"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2560"
          xlink:label="f-2560"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2502"
          xlink:label="f-2502"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2479"
          xlink:label="f-2479"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2647"
          xlink:label="f-2647"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2556"
          xlink:label="f-2556"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2522"
          xlink:label="f-2522"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2524"
          xlink:label="f-2524"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2555"
          xlink:label="f-2555"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2481"
          xlink:label="f-2481"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2525"
          xlink:label="f-2525"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2589"
          xlink:label="f-2589"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2498"
          xlink:label="f-2498"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2619"
          xlink:label="f-2619"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2622"
          xlink:label="f-2622"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2501"
          xlink:label="f-2501"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2621"
          xlink:label="f-2621"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2627"
          xlink:label="f-2627"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2617"
          xlink:label="f-2617"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2497"
          xlink:label="f-2497"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2533"
          xlink:label="f-2533"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2505"
          xlink:label="f-2505"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2637"
          xlink:label="f-2637"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2576"
          xlink:label="f-2576"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2520"
          xlink:label="f-2520"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2640"
          xlink:label="f-2640"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2569"
          xlink:label="f-2569"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2654"
          xlink:label="f-2654"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2638"
          xlink:label="f-2638"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2635"
          xlink:label="f-2635"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2613"
          xlink:label="f-2613"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2616"
          xlink:label="f-2616"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2537"
          xlink:label="f-2537"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2544"
          xlink:label="f-2544"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2657"
          xlink:label="f-2657"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2494"
          xlink:label="f-2494"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2532"
          xlink:label="f-2532"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2496"
          xlink:label="f-2496"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2517"
          xlink:label="f-2517"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2658"
          xlink:label="f-2658"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2509"
          xlink:label="f-2509"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2578"
          xlink:label="f-2578"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2526"
          xlink:label="f-2526"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2606"
          xlink:label="f-2606"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2612"
          xlink:label="f-2612"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2642"
          xlink:label="f-2642"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-2514"
          xlink:label="f-2514"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2655"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2506"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2563"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2530"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2543"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2482"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2594"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2489"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2536"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2614"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2609"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2508"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2593"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2626"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2571"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2541"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2490"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2608"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2651"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2549"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2485"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2587"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2534"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2649"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2579"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2483"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2625"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2547"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2623"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2553"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2630"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2528"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2486"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2518"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2653"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2629"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2504"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2552"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2500"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2545"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2602"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2643"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2650"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2516"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2529"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2591"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2562"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2551"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2590"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2572"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2548"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2610"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2487"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2604"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2521"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2605"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2560"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2502"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2479"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2647"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2556"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2522"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2524"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2555"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2481"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2525"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2589"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2498"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2619"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2622"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2501"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2621"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2627"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2617"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2497"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2533"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2505"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2637"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2576"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2520"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2640"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2569"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2654"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2638"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2635"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2613"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2616"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2537"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2544"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2657"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2494"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2532"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2496"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2517"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2658"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2509"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2578"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2526"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2606"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2612"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2642"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-2514"
          xlink:to="fn-4"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
